<SEC-DOCUMENT>0001292814-24-001607.txt : 20240426
<SEC-HEADER>0001292814-24-001607.hdr.sgml : 20240426
<ACCEPTANCE-DATETIME>20240426163717
ACCESSION NUMBER:		0001292814-24-001607
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		161
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240426
DATE AS OF CHANGE:		20240426

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Afya Ltd
		CENTRAL INDEX KEY:			0001771007
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-EDUCATIONAL SERVICES [8200]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38992
		FILM NUMBER:		24884529

	BUSINESS ADDRESS:	
		STREET 1:		ALAMEDA OSCAR NIEMEYER, NO 119
		STREET 2:		SALA 504 VILA DA SERRA
		CITY:			NOVA LIMA, MINAS GERAIS
		STATE:			D5
		ZIP:			00000
		BUSINESS PHONE:		55 (31) 3515 7500

	MAIL ADDRESS:	
		STREET 1:		ALAMEDA OSCAR NIEMEYER, NO 119
		STREET 2:		SALA 504 VILA DA SERRA
		CITY:			NOVA LIMA, MINAS GERAIS
		STATE:			D5
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>afyaform20f_2023.htm
<DESCRIPTION>FORM 20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:afya="http://afya.com.br/20231231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02F_IFRS%2D2023_currency_srt -->
<!-- Field: Set; Name: xdx; ID: xdx_035_afya_afya.com.br_20231231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20230101_20231231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DDocumentFiscalYearFocus_2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001771007 -->
<!-- Field: Set; Name: xdx; ID: xdx_07C_SO_afyaform20f__2023.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_065_USD_0_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_060_USDPShares_0_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_06C_N_5_Number -->
<!-- Field: Set; Name: xdx; ID: xdx_061_BRL_1_iso4217%2D%2DBRL -->
<!-- Field: Set; Name: xdx; ID: xdx_062_BRLPShares_3_iso4217%2D%2DBRL_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000004" name="dei:DocumentFiscalYearFocus">2023</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000005" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000006" name="dei:EntityCentralIndexKey">0001771007</ix:nonNumeric>
  <ix:nonFraction name="afya:NotePayableCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl0140" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0270" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0271" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0272" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0312" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0319" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0320" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0321" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0322" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0328" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0329" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0330" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0331" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0337" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0339" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0340" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0341" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0343" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0346" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0347" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0349" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0350" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0352" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0355" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0358" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0359" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0361" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0364" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0367" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0368" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0370" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0373" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0374" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0375" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0377" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0379" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0382" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0383" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0384" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0385" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0386" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="xdx2ixbrl0387" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0400" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-01-012022-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0401" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-01-012022-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0402" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0403" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0409" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-01-012022-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0410" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-01-012022-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0411" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0412" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0418" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2022-01-012022-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0419" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0421" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2022-01-012022-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0422" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2022-01-012022-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0424" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0427" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2022-01-012022-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0428" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2022-01-012022-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0429" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2022-01-012022-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0431" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2022-01-012022-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0433" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0436" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2022-01-012022-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0437" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2022-01-012022-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0438" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0439" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2022-01-012022-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0440" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2022-01-012022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="xdx2ixbrl0441" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0454" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0455" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0456" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0457" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0463" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0464" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0465" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0466" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0472" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0473" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0475" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0476" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0478" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0481" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0482" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0483" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0485" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0487" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0490" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0491" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0492" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0493" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0499" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0502" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0503" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0505" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0508" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0511" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0512" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0514" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0517" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0518" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0519" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0520" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0521" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="xdx2ixbrl0522" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:PurchaseOfAcquisitionOfNoncontrollingInterests" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0656" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:PurchaseOfAcquisitionOfNoncontrollingInterests" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0657" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RestrictedCashOfInvestingActivities" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0667" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RestrictedCashOfInvestingActivities" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0668" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0704" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1270" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1306" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1318" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1324" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="xdx2ixbrl1326" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1330" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1342" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1379" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1415" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1427" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1433" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="xdx2ixbrl1435" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1439" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1451" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1465" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="xdx2ixbrl1469" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1471" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="xdx2ixbrl1479" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1513" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1543" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="xdx2ixbrl1547" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1549" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="xdx2ixbrl1557" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1591" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1623" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="xdx2ixbrl1627" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1629" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="xdx2ixbrl1637" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1671" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="xdx2ixbrl1792" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="xdx2ixbrl1816" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="xdx2ixbrl1828" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="xdx2ixbrl1830" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="xdx2ixbrl1832" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2022-05-23_custom_GlicMember" id="xdx2ixbrl1876" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NoncurrentAssetsOfRelatedParty1" contextRef="AsOf2022-12-31" id="xdx2ixbrl2094" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:AccountsPayableToSellingShareholders" contextRef="AsOf2023-12-31" id="xdx2ixbrl2096" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="AsOf2023-12-31" id="xdx2ixbrl2099" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:AccountsPayableCurrent1" contextRef="AsOf2023-12-31" id="xdx2ixbrl2102" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NoncurrentPayablesToRelatedParties1" contextRef="AsOf2023-12-31" id="xdx2ixbrl2105" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NoncurrentPayablesToRelatedParties1" contextRef="AsOf2022-12-31" id="xdx2ixbrl2106" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2022-01-012022-12-31_custom_EMIVEPatrulha24HorasLtdaMember" id="xdx2ixbrl2116" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2021-01-012021-12-31_custom_EMIVEPatrulha24HorasLtdaMember" id="xdx2ixbrl2118" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:Dividend" contextRef="AsOf2022-12-31" id="xdx2ixbrl2244" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="AsOf2022-12-31" id="xdx2ixbrl2247" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember" id="xdx2ixbrl2331" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2369" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2371" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2382" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2393" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2394" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="xdx2ixbrl2397" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl2400" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2415" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2424" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2426" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2427" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="xdx2ixbrl2428" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="xdx2ixbrl2430" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="xdx2ixbrl2431" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2432" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2437" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="xdx2ixbrl2441" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="xdx2ixbrl2442" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2448" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2470" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2479" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2481" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2482" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2490" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2492" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2498" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2503" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2504" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="xdx2ixbrl2507" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl2510" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2523" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2525" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2531" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2536" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2542" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2545" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2547" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2553" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2558" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2564" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2569" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2575" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2578" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2580" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2586" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2591" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2597" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2598" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2602" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2608" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2613" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2619" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2624" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2630" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2635" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2636" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="xdx2ixbrl2637" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="xdx2ixbrl2639" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2641" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2642" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2646" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2652" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl2718" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl2780" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2938" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2940" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2954" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2958" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2959" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2968" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2977" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2979" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2993" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2995" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2999" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3000" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3008" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3022" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3024" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3038" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3044" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3045" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3053" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3067" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3069" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3083" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="xdx2ixbrl3211" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="xdx2ixbrl3213" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="xdx2ixbrl3219" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="xdx2ixbrl3221" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember" id="xdx2ixbrl3279" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember" id="xdx2ixbrl3281" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember" id="xdx2ixbrl3295" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember" id="xdx2ixbrl3297" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember" id="xdx2ixbrl3307" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember" id="xdx2ixbrl3309" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember" id="xdx2ixbrl3319" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember" id="xdx2ixbrl3321" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember" id="xdx2ixbrl3331" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember" id="xdx2ixbrl3333" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_RXPROMember" id="xdx2ixbrl3367" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_RXPROMember" id="xdx2ixbrl3369" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_GlicMember" id="xdx2ixbrl3379" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_GlicMember" id="xdx2ixbrl3381" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_DelReyMember" id="xdx2ixbrl3389" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_DelReyMember" id="xdx2ixbrl3393" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_DelReyMember" id="xdx2ixbrl3397" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NotePayable" contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="xdx2ixbrl3482" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:DepreciationExpenseLeaseLiabilities" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl3587" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RightofuseAssetsInterestExpense" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl3589" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfLeaseLiabilities" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl3593" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfInterest" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl3597" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RightofuseAssetsCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl3609" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:DepreciationExpenseLeaseLiabilities" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3631" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RightofuseAssetsInterestExpense" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3633" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfLeaseLiabilities" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3637" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfInterest" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3641" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RightofuseAssetsCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl3653" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:DepreciationExpenseLeaseLiabilities" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl3679" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RightofuseAssetsInterestExpense" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl3681" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfLeaseLiabilities" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl3685" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfInterest" contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl3689" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RightofuseAssetsCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl3701" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_RXPROMember" id="xdx2ixbrl3745" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_GuaranhunsMember" id="xdx2ixbrl3749" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_GlicMember" id="xdx2ixbrl3761" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_DelReyMember" id="xdx2ixbrl3767" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="xdx2ixbrl3801" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:AccountsPayableToSellingShareholdersBusinessCombinations" contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="xdx2ixbrl3815" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:ContingentConsiderationOnBusinessCombinations" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="xdx2ixbrl3819" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:Reversals" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="xdx2ixbrl3825" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:Reversals" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" id="xdx2ixbrl3829" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RemeasurementOfEarnouts" contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="xdx2ixbrl3833" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RemeasurementOfEarnouts" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" id="xdx2ixbrl3835" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="xdx2ixbrl3839" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" id="xdx2ixbrl3841" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2023-12-31" id="xdx2ixbrl3975" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:CurrentLiabilities1" contextRef="AsOf2023-12-31" id="xdx2ixbrl3981" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NoncurrentLiabilities1" contextRef="AsOf2023-12-31" id="xdx2ixbrl3987" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NoncurrentLiabilities1" contextRef="AsOf2022-12-31" id="xdx2ixbrl3989" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2023-12-31_custom_NotesPayableMember" id="xdx2ixbrl4035" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2023-12-31_custom_NotesPayableMember" id="xdx2ixbrl4037" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4125" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4127" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4129" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4139" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4157" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4159" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4165" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4167" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4169" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4185" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4187" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4189" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4199" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4217" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4219" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NotePayables" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4225" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NotePayables" contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4227" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NotePayables" contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4229" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4235" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4237" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl4239" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember" id="xdx2ixbrl4265" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2023-01-012023-12-31_custom_DividendsPayableMember" id="xdx2ixbrl4289" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31_custom_LoansAndFinancingMember" id="xdx2ixbrl4319" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember" id="xdx2ixbrl4335" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2022-01-012022-12-31_custom_DividendsPayableMember" id="xdx2ixbrl4343" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl4357" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2021-01-012021-12-31_custom_DividendsPayableMember" id="xdx2ixbrl4397" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2023-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" id="xdx2ixbrl4424" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember" id="xdx2ixbrl4428" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2022-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" id="xdx2ixbrl4444" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2022-12-31_ifrs-full_Level3OfFairValueHierarchyMember" id="xdx2ixbrl4448" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2022-01-012022-12-31_ifrs-full_ShareOptionsMember" id="xdx2ixbrl4746" unitRef="N" xs:nil="true"/>
  <ix:nonFraction name="afya:WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="xdx2ixbrl4750" unitRef="BRLPShares" xs:nil="true"/>
  <ix:nonFraction name="afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" contextRef="From2022-01-012022-12-31_ifrs-full_ShareOptionsMember" id="xdx2ixbrl4754" unitRef="N" xs:nil="true"/>
  <ix:nonFraction name="afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" contextRef="From2021-01-012021-12-31_ifrs-full_ShareOptionsMember" id="xdx2ixbrl4756" unitRef="N" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2021-12-31_custom_RestrictedStockUnitsMember" id="xdx2ixbrl4836" unitRef="N" xs:nil="true"/>
  <ix:nonFraction name="afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" contextRef="From2022-01-012022-12-31_custom_RestrictedStockUnitsMember" id="xdx2ixbrl4844" unitRef="N" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2022-01-012022-12-31_custom_RestrictedStockUnitsMember" id="xdx2ixbrl4848" unitRef="N" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2022-01-012022-12-31_custom_RestrictedStockUnitsMember" id="xdx2ixbrl4852" unitRef="N" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2020-12-31" id="xdx2ixbrl4922" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2020-12-31" id="xdx2ixbrl4924" unitRef="BRLPShares" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2023-01-012023-12-31_custom_DigitalServicesMember" id="xdx2ixbrl5067" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember" id="xdx2ixbrl5069" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember" id="xdx2ixbrl5105" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember" id="xdx2ixbrl5109" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2022-01-012022-12-31_custom_DigitalServicesMember" id="xdx2ixbrl5129" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember" id="xdx2ixbrl5131" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2022-01-012022-12-31_custom_ContinuingEducationMember" id="xdx2ixbrl5167" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember" id="xdx2ixbrl5189" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember" id="xdx2ixbrl5191" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember" id="xdx2ixbrl5197" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember" id="xdx2ixbrl5221" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember" id="xdx2ixbrl5227" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RecognisedDeferredTaxAssets" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl5400" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RecognisedDeferredTaxAssets" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl5401" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="xdx2ixbrl5501" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_IClinicMember" id="xdx2ixbrl5559" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_custom_IClinicMember" id="xdx2ixbrl5561" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_CliquefarmaMember" id="xdx2ixbrl5565" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_custom_CliquefarmaMember" id="xdx2ixbrl5567" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_RXPROMember" id="xdx2ixbrl5571" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_custom_RXPROMember" id="xdx2ixbrl5573" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RemeasurementOfEarnOut" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl5579" unitRef="BRL" xs:nil="true"/>
  <ix:nonFraction name="afya:RemeasurementOfEarnOut" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl5581" unitRef="BRL" xs:nil="true"/>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="afya-20231231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-01-01to2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ClassBOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-042022-05-05_custom_BertelsmannMember_ifrs-full_OrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BertelsmannMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-04</xbrli:startDate>
        <xbrli:endDate>2022-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_BertelsmannMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BertelsmannMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_BertelsmannMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BertelsmannMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_BertelsmannMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BertelsmannMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_BertelsmannMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BertelsmannMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_SubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_SubsidiariesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AfyaParticipacoesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AfyaParticipacoesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroIntegradoDeSaudeDeTeresinaCISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroIntegradoDeSaudeDeTeresinaCISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_MedcelEditoraEventosS.A.MedcelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelEditoraEventosS.A.MedcelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_MedcelEditoraEventosS.A.MedcelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelEditoraEventosS.A.MedcelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoS.A.FASAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoS.A.FASAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ESMCEducacaoSuperiorLtdaESMCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ESMCEducacaoSuperiorLtdaESMCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaenseDeEducacaoECulturaLtda.IPECMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaenseDeEducacaoECulturaLtda.IPECMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorS.A.UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorS.A.UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeEnsinoSaoLucasLtda.UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeEnsinoSaoLucasLtda.UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeSolutionsS.A.MedicinaeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeSolutionsS.A.MedicinaeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtda.CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtda.CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiaDaInformacaoLtda.ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiaDaInformacaoLtda.ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SociedadeEducacionalDePalhocaSALtda.Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalDePalhocaSALtda.Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SociedadeEducacionalDePalhocaSALtda.Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalDePalhocaSALtda.Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesDeTecnologiaLtda.RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesDeTecnologiaLtda.RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROLOGTransporteELogisticaLtda.RXPROLOGMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROLOGTransporteELogisticaLtda.RXPROLOGMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:BMVAtividadesMedicasLtda.AlemDaMedicinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:BMVAtividadesMedicasLtda.AlemDaMedicinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardiopapersSolucoesDigitaisLtda.CardioPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardiopapersSolucoesDigitaisLtda.CardioPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ProgramOfSocialIntegrationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:TeachingActivitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_TeachingActivitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ContributionForTheFinancingOfSocialSecurityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:TeachingActivitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ProgramOfSocialIntegrationMember_custom_NonTeachingActivitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ProgramOfSocialIntegrationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:NonTeachingActivitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_NonTeachingActivitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ContributionForTheFinancingOfSocialSecurityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:NonTeachingActivitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AmendmentsToIAS1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AmendmentsToIAS8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AmendmentsToIAS12Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS12Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AmendmentsToIAS12OneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS12OneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_IFRS17Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">ifrs-full:IFRS17Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AmendmentsToIFRS16Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIFRS16Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AmendmentsToIAS1OneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS1OneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AmendmentsToIAS7AndIFRS7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS7AndIFRS7Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-02_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-01-02_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-02_custom_AcquisitionOfDelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfDelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-292023-01-02_custom_AcquisitionOfDelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfDelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-29</xbrli:startDate>
        <xbrli:endDate>2023-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AcquisitionOfDelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfDelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-04_custom_AlemDaMedicinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-032022-03-04_custom_AlemDaMedicinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-03</xbrli:startDate>
        <xbrli:endDate>2022-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AlemDaMedicinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-05_custom_AcquisitionOfCardioPapersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfCardioPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-042022-04-05_custom_AcquisitionOfCardioPapersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfCardioPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-04</xbrli:startDate>
        <xbrli:endDate>2022-04-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-042022-04-05_custom_CardioPapersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CardioPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-04</xbrli:startDate>
        <xbrli:endDate>2022-04-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CardioPapersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CardioPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-23_custom_AcquisitionOfGlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfGlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-222022-05-23_custom_AcquisitionOfGlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfGlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-22</xbrli:startDate>
        <xbrli:endDate>2022-05-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-222022-05-23_custom_GlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:GlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-22</xbrli:startDate>
        <xbrli:endDate>2022-05-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_GlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:GlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-01-02_ifrs-full_LicencesAndFranchisesMember_custom_AcquisitionOfDelReyMember_custom_WithAndWithoutMethodMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfDelReyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:WithAndWithoutMethodMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-01-02_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfDelReyMember_ifrs-full_MultiperiodExcessEarningsMethodMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfDelReyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">ifrs-full:MultiperiodExcessEarningsMethodMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-05_custom_CardioPapersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardioPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-23_custom_GlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-032022-03-04_custom_AlemDaMedicinaMember1360038046">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-03</xbrli:startDate>
        <xbrli:endDate>2022-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-042022-04-05_custom_CardioPapersMember1360038093">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardioPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-04</xbrli:startDate>
        <xbrli:endDate>2022-04-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-222022-05-23_custom_GlicMember1360038140">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-22</xbrli:startDate>
        <xbrli:endDate>2022-05-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-032022-03-04_ifrs-full_BrandNamesMember_custom_AlemDaMedicinaMember_custom_ReliefFromRoyaltyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReliefFromRoyaltyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-03</xbrli:startDate>
        <xbrli:endDate>2022-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-032022-03-04_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AlemDaMedicinaMember_ifrs-full_MultiperiodExcessEarningsMethodMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">ifrs-full:MultiperiodExcessEarningsMethodMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-03</xbrli:startDate>
        <xbrli:endDate>2022-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-032022-03-04_custom_EducationalContentMember_custom_AlemDaMedicinaMember_custom_ReplacementCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">afya:EducationalContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReplacementCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-03</xbrli:startDate>
        <xbrli:endDate>2022-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-032022-03-04_ifrs-full_TechnologybasedIntangibleAssetsMember_custom_AlemDaMedicinaMember_custom_ReplacementCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReplacementCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-03</xbrli:startDate>
        <xbrli:endDate>2022-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-042022-04-05_ifrs-full_BrandNamesMember_custom_AcquisitionOfCardioPapersMember_custom_ReliefFromRoyaltyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfCardioPapersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReliefFromRoyaltyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-04</xbrli:startDate>
        <xbrli:endDate>2022-04-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-042022-04-05_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfCardioPapersMember_ifrs-full_MultiperiodExcessEarningsMethodMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfCardioPapersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">ifrs-full:MultiperiodExcessEarningsMethodMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-04</xbrli:startDate>
        <xbrli:endDate>2022-04-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-042022-04-05_custom_EducationalContentMember_custom_AcquisitionOfCardioPapersMember_custom_ReplacementCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">afya:EducationalContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfCardioPapersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReplacementCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-04</xbrli:startDate>
        <xbrli:endDate>2022-04-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-042022-04-05_custom_CopyrightMember_custom_AcquisitionOfCardioPapersMember_custom_ReliefFromRoyaltyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">afya:CopyrightMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfCardioPapersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReliefFromRoyaltyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-04</xbrli:startDate>
        <xbrli:endDate>2022-04-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-222022-05-23_ifrs-full_BrandNamesMember_custom_AcquisitionOfGlicMember_custom_ReliefFromRoyaltyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfGlicMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReliefFromRoyaltyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-22</xbrli:startDate>
        <xbrli:endDate>2022-05-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-222022-05-23_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfGlicMember_ifrs-full_MultiperiodExcessEarningsMethodMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfGlicMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">ifrs-full:MultiperiodExcessEarningsMethodMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-22</xbrli:startDate>
        <xbrli:endDate>2022-05-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-05-222022-05-23_ifrs-full_TechnologybasedIntangibleAssetsMember_custom_AcquisitionOfGlicMember_custom_ReplacementCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfGlicMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReplacementCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-22</xbrli:startDate>
        <xbrli:endDate>2022-05-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_BankCertificatesOfDepositMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:BankCertificatesOfDepositMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_BankCertificatesOfDepositMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:BankCertificatesOfDepositMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_USDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">afya:USDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_USDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">afya:USDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TuitionFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:TuitionFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TuitionFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:TuitionFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EducationalContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EducationalContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_FIESMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:FIESMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_FIESMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:FIESMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EducationalCreditsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalCreditsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EducationalCreditsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalCreditsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_MobileAppSubscriptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:MobileAppSubscriptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_MobileAppSubscriptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:MobileAppSubscriptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OthersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:OthersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OthersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:OthersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsNeitherPastDueNorImpairedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsNeitherPastDueNorImpairedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_CurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_CurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LaterThanOneEightyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneEightyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LaterThanOneEightyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneEightyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_UEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_UEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EMIVEPatrulha24HorasLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:EMIVEPatrulha24HorasLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_EMIVEPatrulha24HorasLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:EMIVEPatrulha24HorasLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EMIVEPatrulha24HorasLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:EMIVEPatrulha24HorasLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LeaseAgreements1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-052018-09-06_custom_LeaseAgreements1Member_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-05</xbrli:startDate>
        <xbrli:endDate>2018-09-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-052018-09-06_custom_LeaseAgreements1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-05</xbrli:startDate>
        <xbrli:endDate>2018-09-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-28</xbrli:startDate>
        <xbrli:endDate>2019-10-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-28</xbrli:startDate>
        <xbrli:endDate>2019-10-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-28</xbrli:startDate>
        <xbrli:endDate>2019-10-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-28</xbrli:startDate>
        <xbrli:endDate>2021-08-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-28</xbrli:startDate>
        <xbrli:endDate>2021-08-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-23</xbrli:startDate>
        <xbrli:endDate>2018-04-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EducationContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EducationalPlatformMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SoftwareInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EducationContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EducationalPlatformMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SoftwareInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ITPACGaranhunsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ITPACGaranhunsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelAndCBBWMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelAndCBBWMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PracticeManagementToolsAndElectronicPrescriptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PracticeManagementToolsAndElectronicPrescriptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ClinicalDecisionSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ClinicalDecisionSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnifipMocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnifipMocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_GlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_GlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CarryingAmountsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CarryingAmountsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CustomerRelationshipsMedicineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:CustomerRelationshipsMedicineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CustomerRelationshipsOtherCoursesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:CustomerRelationshipsOtherCoursesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EducationContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DevelopedTechnologyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:DevelopedTechnologyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwentyTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwentyTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TwentyTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwentyTwentySevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwentyTwentySevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TwentyTwentySevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwentyTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwentyTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TwentyTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwentyTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwentyTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TwentyTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwentyTwentyEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwentyTwentyEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TwentyTwentyEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-082019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-08</xbrli:startDate>
        <xbrli:endDate>2019-05-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-05-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-28_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-29_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-01-31_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-31_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-042020-05-05_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-04</xbrli:startDate>
        <xbrli:endDate>2020-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-05_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-082020-11-09_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-08</xbrli:startDate>
        <xbrli:endDate>2020-11-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-09_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-072021-04-08_custom_MedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-07</xbrli:startDate>
        <xbrli:endDate>2021-04-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-08_custom_MedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-122021-05-13_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-12</xbrli:startDate>
        <xbrli:endDate>2021-05-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-13_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-032021-08-04_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-03</xbrli:startDate>
        <xbrli:endDate>2021-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-04_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012021-10-02_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2021-10-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-02_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-042021-11-05_custom_ITPACGaranhunsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ITPACGaranhunsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-04</xbrli:startDate>
        <xbrli:endDate>2021-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-05_custom_ITPACGaranhunsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ITPACGaranhunsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-222022-03-23_custom_GlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-22</xbrli:startDate>
        <xbrli:endDate>2022-03-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-23_custom_GlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-292023-01-02_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-29</xbrli:startDate>
        <xbrli:endDate>2023-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-292023-02-01_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-29</xbrli:startDate>
        <xbrli:endDate>2023-02-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_currency_EUR_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_IPEMEDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPEMEDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_IPEMEDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPEMEDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_MedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_MedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_GuaranhunsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GuaranhunsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_GuaranhunsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GuaranhunsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_AlemDaMedicinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_AlemDaMedicinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CardiPapersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardiPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CardiPapersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardiPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_GlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_GlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_TradeReceivablesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_TradeReceivablesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_NotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_NotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LoansAndFinancingTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LoansAndFinancingTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LoansAndFinancingThreeMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LoansAndFinancingThreeMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ForeignCurrencyExposuresMember_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:ForeignCurrencyExposuresMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_IncreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:IncreaseForeignCurrencyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DecreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:DecreaseForeignCurrencyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LoansAndFinancingMember1360068625">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LoansAndFinancingMember1360068953">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember1360068984">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember1360069062">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DividendsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_DividendsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_DividendsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_Level2OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_Level2OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-07-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-07-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-07-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-07-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-122023-02-13_custom_OptionsGrantedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OptionsGrantedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-12</xbrli:startDate>
        <xbrli:endDate>2023-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-162023-04-17_custom_OptionsGrantedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OptionsGrantedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-16</xbrli:startDate>
        <xbrli:endDate>2023-04-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-302023-08-01_custom_OptionsGrantedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OptionsGrantedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-30</xbrli:startDate>
        <xbrli:endDate>2023-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-302023-10-01_custom_OptionsGrantedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OptionsGrantedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-30</xbrli:startDate>
        <xbrli:endDate>2023-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-292023-12-01_custom_OptionsGrantedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OptionsGrantedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-29</xbrli:startDate>
        <xbrli:endDate>2023-12-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ShareBasedCompensationPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ShareBasedCompensationPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ShareBasedCompensationPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RestrictedStockUnits1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnits1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RestrictedStockUnits2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnits2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RestrictedStockUnits3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnits3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-012022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-292023-02-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-29</xbrli:startDate>
        <xbrli:endDate>2023-02-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-162023-04-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-16</xbrli:startDate>
        <xbrli:endDate>2023-04-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-302023-08-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-30</xbrli:startDate>
        <xbrli:endDate>2023-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-302023-10-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-30</xbrli:startDate>
        <xbrli:endDate>2023-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-292023-12-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-29</xbrli:startDate>
        <xbrli:endDate>2023-12-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember1360072343">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RSUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_IncrementalStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OriginalPlanMember_custom_IncrementalStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_RSUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_RSUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_RSUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IPCAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IPCAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IPCAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IPCAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_CDIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:CDIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_CDIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:CDIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IPCAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IPCAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_CDIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:CDIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IPCAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IPCAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IPCAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IPCAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_CDIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:CDIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_CDIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:CDIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IPCAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IPCAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OriginalPlanMember_custom_CDIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:CDIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-13_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-17_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-01_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-01_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-01_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-122023-02-13_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-12</xbrli:startDate>
        <xbrli:endDate>2023-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-162023-04-17_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-16</xbrli:startDate>
        <xbrli:endDate>2023-04-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-302023-08-01_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-30</xbrli:startDate>
        <xbrli:endDate>2023-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-10-01_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-302023-12-01_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-30</xbrli:startDate>
        <xbrli:endDate>2023-12-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-122023-02-13_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-12</xbrli:startDate>
        <xbrli:endDate>2023-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-122023-02-13_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-12</xbrli:startDate>
        <xbrli:endDate>2023-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-162023-04-17_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-16</xbrli:startDate>
        <xbrli:endDate>2023-04-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-162023-04-17_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-16</xbrli:startDate>
        <xbrli:endDate>2023-04-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-302023-08-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-30</xbrli:startDate>
        <xbrli:endDate>2023-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-302023-08-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-30</xbrli:startDate>
        <xbrli:endDate>2023-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-10-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-10-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-302023-12-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-30</xbrli:startDate>
        <xbrli:endDate>2023-12-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-302023-12-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-30</xbrli:startDate>
        <xbrli:endDate>2023-12-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ClassBOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-27_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-27_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-24_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentTransactionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentTransactionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentTransactionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OneSubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:OneSubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OtherAssetsNonCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">afya:OtherAssetsNonCurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OtherAssetsNonCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">afya:OtherAssetsNonCurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_IClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_IClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_IClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-232024-01-24_custom_FaculdadesIntegradasPadraoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">afya:FaculdadesIntegradasPadraoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-23</xbrli:startDate>
        <xbrli:endDate>2024-01-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-01-24_custom_FaculdadesIntegradasPadraoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">afya:FaculdadesIntegradasPadraoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-01-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="N">
      <xbrli:measure>afya:Number</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="BRL">
      <xbrli:measure>iso4217:BRL</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="BRLPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:BRL</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 3.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->


<p style="font: 14pt Times New Roman, Times, Serif; margin: 0 0 3pt; text-align: center">UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 3pt; text-align: center">Washington, D.C. 20549</p>

<!-- Field: Rule-Page --><div style="margin: 1pt 3in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>FORM <span id="xdx_905_edei--DocumentType_c20230101__20231231_zkJU6F98A5e5"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000016" name="dei:DocumentType">20-F</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">(Mark One)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.5in"><span id="xdx_907_edei--DocumentRegistrationStatement_c20230101__20231231_zEcR2UZJ7rhb"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000017" name="dei:DocumentRegistrationStatement">&#9744;</ix:nonNumeric></span></td><td><b>REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>OR</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.5in"><span id="xdx_90B_edei--DocumentAnnualReport_c20230101__20231231_zzEUGT7aEQhd"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleantrue" id="Fact000018" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></td><td><b>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE<br/>
ACT OF 1934<br/>
For the fiscal year ended <span id="xdx_905_edei--DocumentPeriodEndDate_c20230101__20231231_zuZMshbwRG6k"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:datemonthdayyearen" id="Fact000019" name="dei:DocumentPeriodEndDate"><span id="xdx_902_edei--CurrentFiscalYearEndDate_c20230101__20231231_zPV01yoU6fe"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:datemonthdayen" id="Fact000020" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric></span>, 2023</ix:nonNumeric></span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>OR</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.5in"><span id="xdx_909_edei--DocumentTransitionReport_c20230101__20231231_zK36g85BkGTh"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000021" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></td><td><b>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE<br/>
ACT OF 1934</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>OR</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.5in"><span id="xdx_906_edei--DocumentShellCompanyReport_c20230101__20231231_zQkO7XMQD8F1"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000022" name="dei:DocumentShellCompanyReport">&#9744;</ix:nonNumeric></span></td><td><b>SHELL
                                            COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934<br/>
                                            Date of event requiring this shell company report<br/>
                                            For the transition period from <span style="text-decoration: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>to&#160;<span style="text-decoration: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                                            </span>.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Commission file number: <span id="xdx_90D_edei--EntityFileNumber_c20230101__20231231_zG7v38X7txZ6"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000023" name="dei:EntityFileNumber">001-38992</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span style="font-size: 14pt"><b><span id="xdx_906_edei--EntityRegistrantName_c20230101__20231231_zfiUkXFJmeM4"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000024" name="dei:EntityRegistrantName">AFYA LIMITED</ix:nonNumeric></span><br/>
</b></span><span style="font-size: 9pt">(Exact name of Registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt; text-align: center"><span style="font-size: 12pt">N/A<br/>
<span style="font-size: 9pt">(Translation of Registrant&#8217;s name into English)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt; text-align: center"><span style="font-size: 11pt"><b>The <span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20230101__20231231_zkL4qI08RvVj"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:edgarprovcountryen" id="Fact000025" name="dei:EntityIncorporationStateCountryCode">Cayman Islands</ix:nonNumeric></span></b><br/>
</span><span style="font-size: 9pt">(Jurisdiction of incorporation or organization)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt; text-align: center"><span style="font-size: 11pt"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20230101__20231231_zx2h9m451vof"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000026" name="dei:EntityAddressAddressLine1">Alameda Oscar Niemeyer</ix:nonNumeric></span></b><b><span style="font-size: 11pt">, <span id="xdx_907_edei--EntityAddressAddressLine2_c20230101__20231231_zwgsfeBZm0Al"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000027" name="dei:EntityAddressAddressLine2">No. 119</ix:nonNumeric></span></span></b><b><span style="font-size: 11pt">, Room <span id="xdx_901_edei--EntityAddressPostalZipCode_c20230101__20231231_z5nBtDXAEx17"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000028" name="dei:EntityAddressPostalZipCode">504</ix:nonNumeric></span></span></b><br/>
Vila da Serra, Nova Lima<br/> <span id="xdx_905_edei--EntityAddressCityOrTown_c20230101__20231231_zd39O8TSJlH3"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000029" name="dei:EntityAddressCityOrTown">Minas Gerais</ix:nonNumeric></span> &#8211; MG, <span id="xdx_90D_edei--EntityAddressCountry_c20230101__20231231_zMEfOIYJa23l"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:countrynameen" id="Fact000030" name="dei:EntityAddressCountry">Brazil</ix:nonNumeric></span><br/>
<span style="font-size: 9pt">(Address of principal executive offices) </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt; text-align: center"><span style="font-size: 11pt"><b><span id="xdx_90B_edei--ContactPersonnelName_c20230101__20231231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z9IwAjiZJzCl" title="Contact Personnel Name"><ix:nonNumeric contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000032" name="dei:ContactPersonnelName">Virgilio Deloy Capobianco Gibbon</ix:nonNumeric></span><br/>
Chief Executive Officer<br/>
Tel.: +<span id="xdx_90F_edei--CityAreaCode_c20230101__20231231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zWYGweJue45g" title="City Area Code"><ix:nonNumeric contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000034" name="dei:CityAreaCode">55</ix:nonNumeric></span> (31) <span id="xdx_90A_edei--LocalPhoneNumber_c20230101__20231231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zeMUqB1NDEY5" title="Local Phone Number"><ix:nonNumeric contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000036" name="dei:LocalPhoneNumber">3515-7550</ix:nonNumeric></span> Email: <span id="xdx_902_edei--ContactPersonnelEmailAddress_c20230101__20231231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zB83D2Z7xeLk" title="Contact Personnel Email Address"><ix:nonNumeric contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000038" name="dei:ContactPersonnelEmailAddress">ir@afya.com.br</ix:nonNumeric></span><br/>
<span id="xdx_902_edei--EntityAddressAddressLine1_c20230101__20231231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zP75dmjuvWkh" title="Entity Address, Address Line One"><ix:nonNumeric contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000040" name="dei:EntityAddressAddressLine1">Alameda Oscar Niemeyer</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20230101__20231231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zm9epZKiTEI8" title="Entity Address, Address Line Two"><ix:nonNumeric contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000042" name="dei:EntityAddressAddressLine2">No. 119</ix:nonNumeric></span>, Room <span id="xdx_90B_edei--EntityAddressPostalZipCode_c20230101__20231231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zerwFkdLAzqf"><ix:nonNumeric contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000043" name="dei:EntityAddressPostalZipCode">504</ix:nonNumeric></span><br/>
Vila da Serra, Nova Lima, <span id="xdx_904_edei--EntityAddressCityOrTown_c20230101__20231231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zwRpjRYdw8l4" title="Entity Address, City or Town"><ix:nonNumeric contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000045" name="dei:EntityAddressCityOrTown">Minas Gerais</ix:nonNumeric></span><br/>
<span id="xdx_90C_edei--EntityAddressCountry_c20230101__20231231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zW9Ez3J5LDnd" title="Entity Address, Country"><ix:nonNumeric contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" format="ixt-sec:countrynameen" id="Fact000047" name="dei:EntityAddressCountry">Brazil</ix:nonNumeric></span><br/>
</b></span><span style="font-size: 9pt">(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Securities registered or to be registered pursuant to Section 12(b)
of the Act:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 38%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"><b>Title
    of each class</b></p></td>
    <td style="width: 31%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"><b>Trading
    Symbol(s)</b></p></td>
    <td style="width: 31%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"><b>Name
    of each exchange on which registered</b></p></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-bottom: 5pt; padding-left: 2.9pt; text-align: center"><span style="font-size: 8pt"><span id="xdx_90A_edei--Security12bTitle_c20230101__20231231_zOryK5lpr8Yf"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000048" name="dei:Security12bTitle">Class A common shares, par value US$0.00005 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-bottom: 5pt; padding-left: 2.9pt; text-align: center"><span style="font-size: 8pt"><span id="xdx_902_edei--TradingSymbol_c20230101__20231231_zqYGXoXL7B1c"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000049" name="dei:TradingSymbol">AFYA</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-bottom: 5pt; padding-left: 2.9pt; text-align: center"><span style="font-size: 8pt"><span id="xdx_900_edei--SecurityExchangeName_c20230101__20231231_znrVlAOVDHn7"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:exchnameen" id="Fact000050" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Global Select Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Securities registered or to be registered pursuant to Section 12(g)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>None</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Securities for which there is a reporting obligation pursuant to
Section 15(d) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>None</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Indicate the number of outstanding shares of each of the issuer&#8217;s
classes of capital or common stock as of the close of the period covered by the annual report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">The number of outstanding shares as of December 31, 2023 was <span id="xdx_905_edei--EntityCommonStockSharesOutstanding_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_z8LT1S0jThMd"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-12-31_custom_ClassAOrdinarySharesMember" id="Fact000051" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47,920,068</ix:nonFraction> </span>Class
A common shares and <span id="xdx_909_edei--EntityCommonStockSharesOutstanding_iI_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_z9LsIOtpMTud"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-12-31_custom_ClassBOrdinarySharesMember" id="Fact000052" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,802,763</ix:nonFraction> </span>Class
B common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Indicate by check mark if the registrant is a well-known seasoned
issuer, as defined in Rule 405 of the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt; text-align: center"><span id="xdx_908_edei--EntityWellKnownSeasonedIssuer_c20230101__20231231_zR9lJaIsyEG"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000053" name="dei:EntityWellKnownSeasonedIssuer">Yes</ix:nonNumeric></span> <span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt">&#9746;</span>	No
<span style="font-size: 10pt">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">If this report is an annual or transition report, indicate by check
mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt; text-align: center">Yes <span style="font-size: 10pt">&#9744;</span>	<span id="xdx_90B_edei--EntityVoluntaryFilers_c20230101__20231231_zG9iOtsB1qp4"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000054" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>
<span style="font-size: 10pt">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt"><b>Note</b> &#8211; Checking the box above will not relieve any registrant
required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">Indicate by check mark whether the registrant (1)&#160;has filed
all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements
for the past 90 days.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt; text-align: center"><span id="xdx_906_edei--EntityCurrentReportingStatus_c20230101__20231231_zb8WJzjgXFH3"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000055" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> <span style="font-size: 10pt">&#9746;</span>	No
<span style="font-size: 10pt">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">Indicate by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt; text-align: center"><span id="xdx_908_edei--EntityInteractiveDataCurrent_c20230101__20231231_zkeVI1wmWtja"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000056" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> <span style="font-size: 10pt">&#9746;</span>	No
<span style="font-size: 10pt">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221;
&#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="display: none">&#9744;</span></p>

<p style="font: 10pt/90% Times New Roman, Times, Serif; margin: 0 0 4pt; text-indent: 0.25in"><span id="xdx_90C_edei--EntityFilerCategory_c20230101__20231231_zBffhWkP62w"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:entityfilercategoryen" id="Fact000057" name="dei:EntityFilerCategory">Large Accelerated Filer</ix:nonNumeric></span> &#9746;	Accelerated
Filer &#9744;</p>

<p style="font: 10pt/90% Times New Roman, Times, Serif; margin: 0 0 4pt; text-indent: 0.25in">Non-accelerated Filer &#9744;	Emerging
growth company <span id="xdx_908_edei--EntityEmergingGrowthCompany_c20230101__20231231_z63Aw34T3cYg" title="Entity Emerging Growth Company"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000059" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">If an emerging growth company that prepares its financial statements
in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards&#8224; provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">&#8224; The term &#8220;new or revised financial accounting standard&#8221;
refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">If securities are registered pursuant to Section 12(b) of the Act,
indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to
previously issued financial statements. <span id="xdx_90B_edei--DocumentFinStmtErrorCorrectionFlag_c20230101__20231231_zM5bN0zPoMAf" title="Document Financial Statement Error Correction [Flag]"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000061" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">Indicate by check mark whether any of those error corrections are
restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers
during the relevant recovery period pursuant to &#167; 240.10D-1(b). &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">Indicate by check mark whether the registrant has filed a report
on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section
404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
<span id="xdx_908_edei--IcfrAuditorAttestationFlag_c20230101__20231231_zCviCcBrKC17"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleantrue" id="Fact000062" name="dei:IcfrAuditorAttestationFlag">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">Indicate by check mark which basis of accounting the registrant has
used to prepare the financial statements included in this filing:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt 0.5in">&#9744;	U.S. GAAP</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt 0.5in">&#9746;	<span id="xdx_90F_edei--DocumentAccountingStandard_c20230101__20231231_zOTO8FEIsEF5" title="Document Accounting Standard"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000064" name="dei:DocumentAccountingStandard">International Financial Reporting Standards</ix:nonNumeric></span> as issued
by the International Accounting Standards Board</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt 0.5in">&#9744;	Other</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">If &#8220;Other&#8221; has been checked in response to the previous
question, indicate by check mark which financial statement item the registrant has elected to follow.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt; text-align: center">&#9744; Item 17	&#9744; Item 18</p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">If this is an annual report, indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt; text-align: center">Yes <span style="font-size: 10pt">&#9744;</span>	No
<span style="font-size: 10pt"><span id="xdx_90D_edei--EntityShellCompany_dbF_c20230101__20231231_zrkRuUZGXckg" title="Entity Shell Company"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000066" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 3.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span style="text-transform: uppercase"><span id="form20f_001"></span><b>table
of contents</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 2.6in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: right"><span style="text-decoration: underline">Page</span></p>



<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; text-transform: uppercase">
    <td style="width: 90%; text-align: left; text-indent: -22.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 22.5pt"><a href="#form20f_002">PART I INTRODUCTION</a></td>
    <td style="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_002">1</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_003">ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_003">5</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_004">ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_004">5</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_005">ITEM 3. KEY INFORMATION</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_005">5</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_006">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;[Reserved]</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_006">5</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_007">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Capitalization and Indebtedness</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_007">5</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_008">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Reasons for the Offer and Use of Proceeds</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_008">5</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_009">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Risk Factors</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_009">5</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_010">ITEM 4. INFORMATION ON THE COMPANY</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_010">45</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_011">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;History and Development of the Company</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_011">45</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_012">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Business Overview</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_012">49</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_013">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Organizational Structure</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_013">95</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_014">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Property, Plant and Equipment</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_014">95</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_015">ITEM 4A. UNRESOLVED STAFF COMMENTS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_015">95</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_016">ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_016">96</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_017">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating Results</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_017">96</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_018">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Liquidity and Capital Resources</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_018">112</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_019">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Research and Development, Patents and Licenses</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_019">115</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_020">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trend Information</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_020">115</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_021">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Critical Accounting Estimates</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_021">116</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_022">ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_022">116</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_023">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Directors and Senior Management</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_023">116</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_024">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Compensation</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_024">120</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_025">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Board Practices</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_025">121</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_026">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employees</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_026">124</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_027">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share Ownership</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_027">125</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_028">F. &#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_028">125</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_029">ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_029">125</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_030">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Major Shareholders</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_030">125</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_031">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Related Party Transactions</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_031">128</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_032">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interests of Experts and Counsel</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_032">130</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_033">ITEM 8. FINANCIAL INFORMATION</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_033">130</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_034">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Consolidated Statements and Other Financial Information</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_034">130</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_035">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Significant Changes</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_035">134</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_036">ITEM 9. THE OFFER AND LISTING</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_036">134</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_037">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Offer and Listing Details</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_037">134</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_038">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plan of Distribution</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_038">135</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_039">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Markets</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_039">135</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_040">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Selling Shareholders</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_040">135</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_041">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dilution</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_041">135</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_042">F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Expenses of the Issue</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_042">135</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_043">ITEM 10. ADDITIONAL INFORMATION</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_043">135</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_044">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share Capital</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_044">135</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_045">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Memorandum and Articles of Association</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_045">135</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_046">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material Contracts</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_046">152</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_047">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exchange Controls</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_047">152</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_048">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Taxation</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_048">152</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_049">F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dividends and Paying Agents</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_049">156</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_050">G.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Statement by Experts</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_050">156</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_051">H.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Documents on Display</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_051">156</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_052">I.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsidiary Information</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_052">156</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_053">J.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Annual Report to Security Holders</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_053">156</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_054">ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_054">157</a></td></tr>
</table>
<!-- Field: Page; Sequence: 4; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="width: 90%; text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_055">ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</a></td>
    <td style="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_055">158</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_056">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Debt Securities</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_056">158</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_057">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Warrants and Rights</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_057">158</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_058">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Securities</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_058">158</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_059">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;American Depositary Shares</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_059">158</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; text-transform: uppercase">
    <td style="text-align: left; text-indent: -22.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 22.5pt"><a href="#form20f_060">PART II</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_060">159</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_061">ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_061">159</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_062">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defaults</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_062">159</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_063">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Arrears and delinquencies</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_063">159</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_064">ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_064">159</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_065">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material modifications to instruments</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_065">159</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_066">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material modifications to rights</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_066">159</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_067">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Withdrawal or substitution of assets</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_067">159</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_068">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Change in trustees or paying agents</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_068">159</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_069">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Use of proceeds</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_069">159</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_070">ITEM 15. CONTROLS AND PROCEDURES</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_070">159</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_071">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosure Controls and Procedures</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_071">159</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_072">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Management&#8217;s Annual Report on Internal Control Over Financial Reporting</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_072">159</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_073">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Attestation Report of the Registered Public Accounting Firm</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_073">160</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#form20f_074">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Changes in Internal Control Over Financial Reporting</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_074">160</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_075">ITEM 16. RESERVED</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_075">160</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_076">ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_076">160</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_077">ITEM 16B. CODE OF ETHICS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_077">160</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_078">ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_078">161</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_079">ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_079">161</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_080">ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_080">161</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_081">ITEM 16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_081">163</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_082">ITEM 16G. CORPORATE GOVERNANCE</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_082">163</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_083">ITEM 16H. MINE SAFETY DISCLOSURE</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_083">164</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_084">ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_084">164</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_085">ITEM 16J. INSIDER TRADING POLICIES</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_085">164</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_086">ITEM 16K. CYBERSECURITY</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_086">164</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; text-transform: uppercase">
    <td style="text-align: left; text-indent: -22.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 22.5pt"><a href="#form20f_087">PART III</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_087">166</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_088">ITEM 17. FINANCIAL STATEMENTS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_088">166</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_089">ITEM 18. FINANCIAL STATEMENTS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_089">166</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#form20f_090">ITEM 19. EXHIBITS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_090">166</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; text-transform: uppercase">
    <td style="text-align: left; text-indent: -22.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 22.5pt"><a href="#form20f_091">Index to Financial Statements</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#form20f_091">F-1</a></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->
<table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 20pt 0 10pt; text-transform: uppercase; text-align: center"><span id="form20f_002"></span>PART I<br/>
INTRODUCTION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Certain Definitions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Unless otherwise indicated or the context otherwise
requires, all references in this annual report to &#8220;Afya&#8221; or the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221;
&#8220;ours,&#8221; &#8220;us&#8221; or similar terms refer to Afya Limited, together with its subsidiaries; all references in this annual
report to &#8220;Afya Brazil&#8221; refer to Afya Participa&#231;&#245;es S.A. (formerly NRE Participa&#231;&#245;es S.A.); all
references in this annual report to &#8220;Medcel&#8221; refer to Medcel Editora e Eventos S.A.; and all references in this annual report to &#8220;IPTAN&#8221; refer to IPTAN&#8212;Instituto de Ensino Superior Presidente Tancredo
de Almeida Neves S.A., &#8220;IESVAP&#8221; refer to Instituto de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A., &#8220;CCSI&#8221;
refer to Centro de Ci&#234;ncias em Sa&#250;de de Itajub&#225; S.A., &#8220;IESP&#8221; refer to Instituto de Ensino Superior do
Piau&#237; S.A., &#8220;FADEP&#8221; refer to FADEP&#8212;Faculdade Educacional de Pato Branco Ltda., &#8220;FASA&#8221; refer to Instituto
Educacional Santo Agostinho S.A., &#8220;IPEMED&#8221; refer to Instituto de Pesquisa e Ensino M&#233;dico do Estado de Minas Gerais
Ltda., &#8220;IPEC&#8221; refer to Instituto Paraense de Educa&#231;&#227;o e Cultura Ltda., &#8220;UniRedentor&#8221; refer to Sociedade
Universit&#225;ria Redentor S.A., &#8220;UniSL&#8221; refer to Centro Universit&#225;rio S&#227;o Lucas Ltda., &#8220;PEBMED&#8221;
refer to PEBMED Institui&#231;&#227;o de Pesquisa M&#233;dica e Servi&#231;os Tecnol&#243;gicos da &#193;rea da Sa&#250;de
S.A., &#8220;FESAR&#8221; refer to Faculdade de Ensino Superior da Amaz&#244;nia Reunida, &#8220;MedPhone&#8221; refer to MedPhone Tecnologia
em Sa&#250;de Ltda., &#8220;FCMPB&#8221; refer to Centro Superior de Ci&#234;ncias da Sa&#250;de S/S Ltda., &#8220;UnifipMoc&#8221;
refer to Sociedade Padr&#227;o de Educa&#231;&#227;o Superior Ltda., &#8220;iClinic&#8221; refer to iClinic Desenvolvimento de Software
Ltda, &#8220;Medicinae&#8221; refer to Medicinae Solutions S.A., &#8220;Medical Harbour&#8221; refer to Medical Harbour Aparelhos M&#233;dico-Hospitalares
e Servi&#231;os em Tecnologia Ltda., &#8220;Cliquefarma&#8221; refer to Cliquefarma Drogarias Online Ltda., &#8220;Shosp&#8221; refer
to Shosp Tecnologia da Informa&#231;&#227;o Ltda., &#8220;Unigranrio&#8221; refer to Companhia Nilza Cordeiro Herdy de Edua&#231;&#227;o
e Cultura, and Policl&#237;nica e Centro de Est&#233;tica Duque de Caxias Ltda., collectively, &#8220;RX PRO&#8221; refer to RX PRO
Solu&#231;&#245;es de Tecnologia Ltda., &#8220;Garanhuns&#8221; refer to Faculdade ITPAC Garanhuns - Instituto Tocantinense Presidente
Antonio Carlos Ltda., &#8220;Al&#233;m da Medicina&#8221; refer to BMV Atividades M&#233;dicas Ltda., &#8220;CardioPapers&#8221; refer
to Cardiopapers Solu&#231;&#245;es Digitais Ltda., &#8220;Glic&#8221; refer to Quasar Telemedicina Desenvolvimento de Sistemas Computacionais
Ltda., &#8220;DelRey&#8221; refer to Sociedade Educacional e Cultural Sergipe DelRey Ltda., &#8220;UNIVA&#199;O&#8221; refer Uni&#227;o
Educacional do Vale do A&#231;o S.A., &#8220;ITPAC Aragua&#237;na&#8221; refer to ITPAC - Instituto Tocantinense Presidente Ant&#244;nio
Carlos S.A., and &#8220;ITPAC Porto&#8221; refer to ITPAC Porto - Instituto Tocantinense Presidente Ant&#244;nio Carlos Porto S.A.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The term &#8220;Esteves Family&#8221; refers
to Nicolau Carvalho Esteves, Ros&#226;ngela de Oliveira Tavares Esteves, NRE Capital Ventures Ltd. and NRE B Ventures Ltd., collectively,
our former controlling shareholders. The term &#8220;Bertelsmann&#8221; refers to Bertelsmann SE &amp; Co. KGaA and Erste WV G&#252;tersloh
GmbH, collectively, our current controlling shareholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The term &#8220;Brazil&#8221; refers to the
Federative Republic of Brazil and the phrase &#8220;Brazilian government&#8221; refers to the federal government of Brazil. &#8220;Central
Bank&#8221; refers to the Brazilian Central Bank <i>(Banco Central do Brasil).</i> References in the annual report to &#8220;<i>real,</i>&#8221;
&#8220;<i>reais</i>&#8221; or &#8220;R$&#8221; refer to the Brazilian <i>real,</i> the official currency of Brazil and references to &#8220;U.S.
dollar,&#8221; &#8220;U.S. dollars&#8221; or &#8220;US$&#8221; refer to U.S. dollars, the official currency of the United States.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Financial Information</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is a Cayman Islands exempted company with
limited liability duly registered with the Cayman Islands Registrar of Companies and was incorporated on March 22, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The consolidated financial information of Afya
contained in this annual report is derived from our audited consolidated financial statements as of December 31, 2023 and 2022 and for
the years ended December 31, 2023, 2022 and 2021, together with the notes thereto. All references herein to &#8220;our financial statements,&#8221;
&#8220;our audited consolidated financial information,&#8221; and &#8220;our audited consolidated financial statements&#8221; are to Afya&#8217;s
consolidated financial statements included elsewhere in this annual report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is a holding company, and as such, the
primary source of revenue derives from its interest in its operational companies in Brazil. As a result, Afya&#8217;s functional currency
as well as of its subsidiaries is the Brazilian <i>real</i>. We prepare our annual consolidated financial statements in accordance with
International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 6; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The financial results of the companies that
we acquire in any given period (such companies, the &#8220;Acquired Companies&#8221;) are included in our historical results as of the
date of closing of the respective acquisition. See &#8220;Item 4. Information on the Company&#8212;B. Business Overview&#8212;Our Recent
Acquisitions&#8221; for further details on entities acquired since January 1, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our fiscal year ends on December 31 of each
year, so all references to a particular fiscal year are to the applicable year ended December 31.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Historical Undergraduate Programs Combined Tuition Fees</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The term &#8220;historical undergraduate programs
combined tuition fees&#8221; refers to the sum equal to the total tuition fees charged to undergraduate students, as recorded in the historical
operating information of Afya Brazil and the Acquired Companies, since the consummation of their respective acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The historical undergraduate programs combined
tuition fees information included elsewhere in this annual report (i)&#160;was derived from historical operating information for Afya
Brazil and for each of the Acquired Companies since the consummation of their respective acquisition; (ii)&#160;is akin to gross tuition
fees charged to undergraduate students; (iii)&#160;differs from the tuition fees set forth in our audited consolidated financial statements,
which are presented as the sum of (a)&#160;gross tuition fees charged to undergraduate students, (b)&#160;gross tuition fees charged to
graduate students, and (c)&#160;scholarships; and (iv)&#160;does not represent revenue as disclosed in our audited consolidated financial
statements included elsewhere in this annual report. For the years ended December 31, 2023, 2022 and 2021, historical undergraduate programs
combined tuition fees charged to undergraduate students by us were R$3,266.8 million, R$2,635.4 million and R$1,990.1 million, respectively.
Historical undergraduate programs combined tuition fees does not include tuition fees we charge graduate students.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our consolidated operating history and recent
acquisitions may make it difficult for investors to evaluate our business, financial condition, results of operations and prospects. We
experienced rapid and significant expansion in recent years to the effects of the acquisition of the Acquired Companies. Because the historical
and operational information included elsewhere in this annual report may not be representative of our results and operations as a consolidated
company, investors may have limited financial and operational information on which to evaluate us and their investment decision. See &#8220;Item
3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Our operating history as a consolidated
company, our recent acquisitions and the comparability of our results may make it difficult for investors to evaluate our business, financial
condition, results of operations and prospects.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Company&#8217;s past performance, as reflected
in the historical undergraduate programs combined tuition fees information included elsewhere in this annual report, may not be indicative
of its future performance or any future anticipated synergies, future operating efficiencies or cost savings that may result from these
acquisitions.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Convenience Translation</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The reporting currency for our audited consolidated
financial statements is the Brazilian <i>real</i> and, solely for the convenience of the reader, we have provided convenience translations
into U.S. dollars using the selling exchange rates published by the Central Bank on its website. Unless otherwise indicated, convenience
translations from <i>reais</i> into U.S. dollars in this annual report use the Central Bank offer exchange rate published on December
31, 2023, which was R$4.8413 per US$1.00. No representation is made that the Brazilian <i>reais </i>amounts referred to could have been,
or could be, converted into U.S. dollars at any particular rate.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Market Data</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">This annual report contains data related to
economic conditions in the market in which we operate. The information contained in this annual report concerning economic conditions
is based on publicly available information from third-party sources that we believe to be reasonable. Market data and certain industry
forecast data used in this annual report were obtained from internal reports and studies, where appropriate, as well as estimates, market
research, publicly available information (including information available from the United States Securities and Exchange Commission website)
and industry publications. We obtained the information included in this annual report relating to the industry in which we operate, as
well as the estimates concerning market shares, through internal research, a report by a third-party consulting firm commissioned by
us, public information and publications on the industry prepared by official public sources, such as the Central Bank, the Brazilian
Institute of Geography and Statistics <i>(Instituto Brasileiro de Geografia e Estat&#237;stica),</i> or the IBGE, the Organisation
for Economic Co-operation and Development, or OECD, the Brazilian Ministry of Education <i>(Minist&#233;rio da Educa&#231;&#227;o),
</i>or MEC, the An&#237;sio Teixeira National Institute of Educational Studies and Research <i>(Instituto Nacional de Estudos e Pesquisas
Educacionais An&#237;sio Teixeira),</i> or the INEP, the Institute of Applied Economic Research <i>(Instituto de Pesquisa Econ&#244;mica
Aplicada),</i> or the IPEA, the Brazilian Medical Association (<i>Associa&#231;&#227;o M&#233;dica Brasileira)</i>, or AMB as well
as private sources, such as Bloomberg, consulting and research companies in the Brazilian and international education industry, the Brazilian
Economic Institute of Funda&#231;&#227;o Getulio Vargas <i>(Instituto Brasileiro de Economia da Funda&#231;&#227;o Getulio Vargas),
</i>or FGV/IBRE, the Association of American Medical Colleges, or AAMC among others.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Industry publications, governmental publications
and other market sources, including those referred to above, generally state that the information they include has been obtained from
sources believed to be reliable, but that the accuracy and completeness of such information is not guaranteed. While we are not aware
of any misstatements regarding the market and industry data presented herein, our estimates involve risks and uncertainties and are subject
to change based on various factors, including those discussed in the section entitled &#8220;Item 3. Key Information&#8212;D. Risk Factors.&#8221;
Except as disclosed in this annual report, none of the publications, reports or other published industry sources referred to in this annual
report were commissioned by us or prepared at our request. Except as disclosed in this annual report, we have not sought or obtained the
consent of any of these sources to include such market data in this annual report.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Rounding</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have made rounding adjustments to some of
the figures included in this annual report. Accordingly, numerical figures shown as totals in some tables may not be an arithmetic aggregation
of the figures that preceded them.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Forward-Looking Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">This annual report on Form 20-F contains information
that constitute forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities
Exchange Act of 1934, as amended, or Exchange Act, that are not based on historical facts and are not assurances of future results. The
forward-looking statements contained in this annual report, which address our expected business and financial performance, among other
matters, contain words such as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221;
&#8220;plan,&#8221; &#8220;aim,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221;
&#8220;likely,&#8221; &#8220;potential&#8221; and similar expressions. We have made forward-looking statements that address, among other
things, our current expectations, plans, forecasts, projections and strategies about future events and financial trends that affect, or
may affect, our business, industry, market share, reputation, financial condition, results of operations, margins, cash flow and/or the
market price of our common shares, all of which are subject to known and unknown risks and uncertainties. Our actual results may differ
materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those
identified under the section entitled &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8221; in this annual report. These risks and
uncertainties include factors relating to:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to implement our business strategy;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in government regulations and legislation applicable to the education industry in Brazil, both in the traditional and distance
learning segments, including tax regulations and/or legislation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>government interventions, including changes in, or termination of, education industry programs such as the Higher Education Student
Financing Fund (<i>Fundo de Financiamento ao Estudante do Ensino Superior</i>), or FIES, and/or the University for All Program (<i>Programa
Universidade para Todos</i>), or PROUNI, both in the traditional and distance learning segments, that affect the economic or tax regime,
the collection of tuition fees or the regulatory framework applicable to educational institutions;</td></tr></table>


<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in the financial condition of the students enrolling in our institutions in general and in the competitive conditions in the
education industry, both in the traditional and distance learning segments, or changes in the financial condition of our institutions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to adapt to technological changes in the educational sector, including in relation to distance learning programs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the availability of government authorizations on terms and conditions and within periods acceptable to us;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>developments with respect to actual or potential epidemics, pandemics, outbreaks or other public health crises in Brazil and globally;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to continue attracting and retaining new students;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to maintain the academic quality of our programs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to compete and conduct our business in the future;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the success of operating initiatives, including advertising and promotional efforts and new product, service and concept development
by us and our competitors;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in consumer demands and preferences and technological advances, and our ability to innovate to respond to such changes;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the availability of qualified personnel and the ability to retain such personnel;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our capitalization and level of indebtedness;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the interests of our controlling shareholders;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a decline in the number of students enrolled in our programs or the amount of tuition we can charge;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in labor, distribution and other operating costs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our compliance with, and changes to, government laws, regulations and tax matters that currently apply to us;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>general economic, financial, political, demographic and business conditions in Brazil, as well as any other countries we may serve
in the future and their impact on our business;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>fluctuations in interest, inflation and exchange rates in Brazil and any other countries we may serve in the future;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>other factors that may affect our financial condition, liquidity and results of operations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the effectiveness of our risk management policies and procedures, including our internal control over financial reporting; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the other factors discussed under the section &#8220;Risk Factors&#8221; in this annual report on Form 20-F.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Prospective investors are cautioned that any
such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results
may differ materially from those in the forward-looking statements. The accompanying information contained in this annual report on Form
20-F, including without limitation the information set forth under the heading &#8220;Item 5. Operating and Financial Review and Prospects,&#8221;
identifies important factors that could cause such differences. In light of the risks, uncertainties and assumptions associated with forward-looking
statements, you should not place undue reliance on any forward-looking statements. Additional risks that we may currently deem immaterial
or that are not presently known to us could also cause the forward-looking events discussed in this annual report on Form 20-F not to
occur.</p>


<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our forward-looking statements speak only as
of the date of this annual report on Form 20-F, and we do not undertake any obligation to update them in light of new information or future
developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect
the occurrence of unanticipated events.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_003"></span>ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_004"></span>ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_005"></span>ITEM 3. KEY INFORMATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_006"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;[Reserved]</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_007"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Capitalization
and Indebtedness</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_008"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Reasons for the
Offer and Use of Proceeds</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_009"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Risk Factors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0in"><b>Summary of Risk Factors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">An investment in our Class A common shares
is subject to a number of risks, including risks relating to our business and industry, risks relating to Brazil and risks relating to
our Class A common shares. The following list summarizes some, but not all, of these risks. Please read the information in the section
entitled &#8220;Risk Factors&#8221; for a more thorough description of these and other risks.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Certain Risks Relating to Our Business and Industry</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>We may not be able to identify and acquire new medical higher education institutions or meet our strategic and financial goals
in connection with any business acquisition we seek, and difficulties in effectively integrating and managing a growing number of acquisitions
may adversely affect our strategic objectives.</i> We expect to continue to acquire medical higher education institutions and healthtech
companies as part of our strategy to expand our operations, including through acquisitions that may be material in size and/or of strategic
relevance. We cannot assure you that we will continue to be able to identify post-secondary education institutions focused on medicine
that provide suitable acquisition opportunities, or to acquire such institutions on favorable terms when necessary. In addition, we may
face significant challenges in the process of integrating the operations of any acquired companies with our existing business, such as
the inability to manage a greater number of geographically dispersed employees and create and implement efficient uniform controls, procedures
and policies, in addition to the incurrence of high or unexpected integration costs.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>We may require additional funds to continue our expansion strategy. If we are unable to obtain adequate financing on favorable
terms to complete any potential acquisition and implement our expansion plans, our growth strategy may be materially and adversely affected.</i>
If adequate funds are not available or are not available on acceptable terms, we may not be able to fund our expansion, take advantage
of acquisition opportunities, develop or enhance our portfolio of products and services or respond to competitive pressures, which could
have a material adverse effect on our business, results of operations and financial condition.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Our revenues are highly concentrated in the tuition fees we charge for our medical courses and other health sciences programs,
and any economic, market or regulatory factors adversely affecting such medical courses and health sciences programs could lead to
decreased demand in the medical and health courses we offer, which could materially adversely affect us</i>. Economic, market or regulatory
factors affecting either the amount of tuition fees we are able to charge for the medical courses and health sciences programs we offer
or the ability of our students to pay such tuition fees could result in significantly decreased demand for our services.</td></tr></table>


<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Changes to the rules or delays or suspension of tuition payments made through FIES may adversely affect our cash flows and our
business. </i>We are subject to the risks associated with delays in the transfer of monthly tuition payments from the FIES program operated
by the Brazilian federal government, as well as to changes to the rules to renew FIES contracts.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>If we lose the benefits of federal tax exemptions provided under the PROUNI program, our business, financial condition and results
of operations may be materially adversely affected. </i>We may be disqualified from the PROUNI program and lose our tax exemptions if
we do not comply with certain requirements, such as providing total or partial scholarships for low-income students eligible for the program,
granting partial scholarships, and submitting to MEC semi-annual records of attendance, achievement and dropout of students receiving
scholarships, among others.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Our operating history as a consolidated company, our recent acquisitions and the comparability of our results may make it difficult
for investors to evaluate our business, financial condition, results of operations and prospects. </i>Because the historical information
included elsewhere in this annual report may not be representative of our results as a consolidated company, investors may have limited
financial information on which to evaluate us, their investment decision and our prior performance.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>An increase in delays and/or defaults in the payment of tuition fees may adversely affect our income and cash flows.</i> We depend
on the full and timely payment of the tuition we charge our students, including tuition payments we receive through FIES, which is largely
outside of our control.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Certain Risks Relating to Brazil</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>The Brazilian federal government has exercised, and continues to exercise, significant influence over the Brazilian economy. This
involvement as well as Brazil&#8217;s political and economic conditions could harm us and the price of our Class A common shares. </i>The
Brazilian government&#8217;s actions to control inflation and other policies and regulations have often involved, among other measures,
increases or decreases in interest rates, changes in fiscal policies, wage and price controls, foreign exchange rate controls, blocking
access to bank accounts, currency devaluations, capital controls and import and export restrictions. Uncertainty over whether the Brazilian
federal government will implement reforms or changes in policy or regulation affecting these or other factors in the future may affect
economic performance and contribute to economic uncertainty in Brazil.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Economic uncertainty and political instability in Brazil may harm our business and the price of our Class A common shares. </i>Political
crises have affected and continue to affect the confidence of investors and the general public, which have historically resulted in economic
deceleration and heightened volatility in the securities offered by companies with significant operations in Brazil.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Inflation and certain measures by the Brazilian government to curb inflation have historically harmed the Brazilian economy and
Brazilian capital markets, and high levels of inflation in the future would harm our business and the price of our Class A common shares.
</i>Inflation, policies adopted to curb inflationary pressures and uncertainties regarding possible future governmental intervention have
contributed to economic uncertainty and heightened volatility in the Brazilian capital markets.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Exchange rate instability may have adverse effects on the Brazilian economy, us and the price of our Class A common shares. </i>The
Brazilian government has implemented various economic plans and used various exchange rate policies, including sudden devaluations, periodic
mini-devaluations (during which the frequency of adjustments has ranged from daily to monthly), exchange controls, dual exchange rate
markets and a floating exchange rate system. In addition, domestic and international reactions to restrictive economic policies could
have a negative impact on the Brazilian economy.</td></tr></table>


<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Infrastructure and workforce deficiency in Brazil may impact economic growth and have a material adverse effect on us. </i>Growth
is limited by inadequate infrastructure, including potential energy shortages and deficient transportation, logistics and telecommunication
sectors, general strikes, the lack of a qualified labor force, and the lack of private and public investments in these areas, which limit
productivity and efficiency.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Developments and the perceptions of risks in other countries, including other emerging markets, the United States and Europe, may
harm the Brazilian economy and the price of our Class A common shares. </i>The market for securities offered by companies with significant
operations in Brazil is influenced by economic and market conditions in Brazil and, to varying degrees, market conditions in other Latin
American and emerging markets, as well as the United States, Europe and other countries. To the extent the conditions of the global markets
or economy deteriorate, the business of companies with significant operations in Brazil may be harmed.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Certain Risks Relating to Our Class A Common
Shares</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>An active trading market for our Class A common shares may not be sustainable. If an active trading market is not maintained, investors
may not be able to resell their shares and our ability to raise capital in the future may be impaired. </i>Although our Class A common
shares are listed and being traded on the Nasdaq Global Select Market, an active trading market for our shares may not be maintained.
The stock market in general has experienced substantial price and volume fluctuations that have often been unrelated or disproportionate
to the operating performance of particular companies affected.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>The concentration of ownership and voting power in Bertelsmann, our controlling shareholder, limits your ability to influence corporate
matters.</i> Bertelsmann, our controlling shareholder, owns 66.4% of our outstanding Class B common shares as of the date of this annual
report, which, together with its ownership of 35.0% of our outstanding Class A common shares, represent approximately 50.3% of our outstanding
share capital and 63.4% of the voting power of our outstanding share capital, and, together with the Esteves Family, controls all matters
requiring shareholder approval. This concentration of ownership and voting power limits your ability to influence corporate matters. The
decisions of Bertelsmann and the Esteves Family on these matters may be contrary to your expectations or preferences, and they may take
actions that could be contrary to your interests. So long as Bertelsmann and the Esteves Family continue to beneficially own a sufficient
number of Class B common shares, even if they beneficially own significantly less than 50% of our outstanding share capital, acting together,
they will be able to effectively control the outcome of all decisions at our shareholders&#8217; meetings.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Class A common shares eligible for future sale may cause the market price of our Class A common shares to drop significantly. </i>The
market price of our Class A common shares may decline as a result of sales of a large number of our Class A common shares in the market
(including Class A common shares issuable upon conversion of Class B common shares) or the perception that these sales may occur. Our
shareholders or entities controlled by them or their permitted transferees will be able to sell their shares in the public market from
time to time without registering them, subject to certain limitations on the timing, amount and method of those sales imposed by regulations
promulgated by the SEC.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Our Articles of Association contain anti-takeover provisions that may discourage a third party from acquiring us and adversely
affect the rights of holders of our Class A common shares. </i>Our Articles of Association contain certain provisions that could limit
the ability of others to acquire our control, including a provision that grants authority to our board of directors to establish and issue
from time to time one or more series of preferred shares without action by our shareholders and to determine, with respect to any series
of preferred shares, the terms and rights of that series.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>If securities or industry analysts publish inaccurate or unfavorable research, about our business, the price of our Class A common
shares and our trading volume could decline. </i>The trading market for our Class A common shares will depend in part on the research
and reports that securities or industry analysts publish about us, our business, our market or our competitors. In the event one or more
of the analysts who covers us downgrades us or releases negative publicity about our Class A common shares, our share price would likely
decline.</td></tr></table>


<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>It is unlikely that we will declare any dividends on our common shares in the foreseeable future and therefore, you must rely on
price appreciation of our common shares for a return on your investment. </i>We do not anticipate paying any dividends in the foreseeable
future. Instead, we intend to retain earnings, if any, to fund the operation of our business and future growth. Any decision to declare
and pay dividends in the future will be made at the discretion of our general meeting of shareholders, acting pursuant to a proposal by
our board of directors, or by our board, and will depend on, among other things, our results of operations, cash requirements, financial
condition, contractual restrictions and other factors.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol"><sup>&#183;</sup></span></td><td><i>There can be no assurance that we will not be a passive foreign investment company, or PFIC, for any taxable year, which could
subject United States investors in our Class A common shares to significant adverse U.S. federal income tax consequences</i>. Based on
the composition of our income and assets and the value of our assets, including goodwill (the implied value of which we estimate based
on the price of our Class A common shares), we believe that we were not a PFIC for the taxable year of 2023. However, because we hold
a substantial amount of cash (relative to the assets shown on our balance sheet) and because our PFIC status for any taxable year will
depend on the composition of our income and assets and the value of our assets from time to time (which may be determined, in part, by
reference to the market price of our Class A common shares, which could be volatile), there can be no assurance that we will not be a
PFIC for any taxable year.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0in"><b>Certain Risks Relating to Our Business and
Industry</b></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We may not be able to identify and acquire new
medical higher education institutions or meet our strategic and financial goals in connection with any business acquisition we seek, and
difficulties in effectively integrating and managing a growing number of acquisitions may adversely affect our strategic objectives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We expect to continue to acquire medical higher
education institutions, as part of our strategy to expand our operations, including through acquisitions that may be material in size
and/or of strategic relevance, and healthtech companies, as part of our strategy to become the partner of choice for every physician in
Brazil not only through educational products, but also providing digital services relevant to their daily routine. We cannot assure you
that we will continue to be able to identify post-secondary education institutions focused on medicine that provide suitable acquisition
opportunities, or to acquire such institutions on favorable terms when necessary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, our previous and any future acquisitions
involve a number of risks and challenges that may have a material adverse effect on our business and results, including the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the acquisition may not contribute to our commercial strategy or the image of our institution;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a future acquisition may be subject to approval by Brazil&#8217;s Administrative Council for Economic Defense <i>(Conselho Administrativo
de Defesa Econ&#244;mica,</i> or CADE) or other regulatory authorities, which may deny the necessary approvals for, or impose conditions
or restrictions on, the acquisition;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>we may face contingent and/or successor liabilities (either currently known or unknown to us) in connection with, among others things,
(i)&#160;judicial and/or administrative proceedings of the acquired institutions, including but not limited to, regulatory, tax, labor,
social security, environmental and intellectual property proceedings, and (ii)&#160;financial, reputational and technical issues, including
with respect to accounting practices, financial statement disclosures and internal controls, anti-corruption, anti-bribery or anti-money
laundering issues, as well as other regulatory matters, all of which may not be sufficiently indemnifiable under the relevant acquisition
agreement;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the acquisition process may require additional funds and/or may be time-consuming, and the attention of our management may be diverted
from their day-to-day responsibilities and our operations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our investments in acquisitions may not generate the expected returns, and we may mismanage administrative and financial resources
as part of the integration process;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the business model of the institutions we acquire may differ from ours, and we may be unable to adapt them to our business model or
do so efficiently;</td></tr></table>


<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>we may not be able to integrate efficiently and successfully the operations of the institutions we acquire, including their personnel,
financial systems, distribution or operating procedures;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>certain acquisitions may impact our financial reporting obligations and the preparation of our consolidated financial statements,
resulting in delays to such preparation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the acquisitions may generate goodwill, the impairment of which will result in the reduction of our net income and dividends, and
our financial statements may be affected as a result of the application of our accounting policies to the results of our acquisitions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the transfer of management of the target institution resulting from a change of control or corporate restructuring must be notified
to the MEC within 60 days from the consummation of the acquisition, and MEC may impose additional restrictions on its reaccreditation;
and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>we may be unable to provide the acquired company with the necessary resources to support its operations and if, by the time of the
reaccreditation of the acquired company with the MEC, the MEC finds that we have failed to meet any applicable reaccreditation requirements,
it may impose additional restrictions or conditions on the reaccreditation of the acquired company.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, we may face significant challenges
in the process of integrating the operations of any acquired companies with our existing business, such as the inability to manage a greater
number of geographically dispersed employees and create and implement efficient uniform controls, procedures and policies, in addition
to the incurrence of high or unexpected integration costs. As of the date of this annual report: (i) we have fully integrated the operations
of 24 of our acquisitions; and (ii) we are in the process of integrating the operations of another nine of our acquisitions with our existing
business, namely, Shosp, Cliquefarma, Medical Harbour, Medicinae, iClinic, RX PRO, Al&#233;m da Medicina, Cardiopapers and Glic. The
anticipated benefits of the acquisitions we may pursue will not be achieved unless we successfully and efficiently integrate the acquired
companies into our operations and effectively manage, market and apply our business strategy to them. We may also be unable to integrate
faculty and personnel with different professional experiences and from different corporate cultures, and our relationship with current
and new employees, including professors, may be impaired.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We may require additional funds to continue our
expansion strategy. If we are unable to obtain adequate financing on favorable terms to complete any potential acquisition and implement
our expansion plans, our growth strategy may be materially and adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In the future, we may need to raise additional
capital to fund our expansion (organically or through strategic acquisitions), to obtain new licenses or develop new or enhanced products
or services or to respond to competitive pressures. Our ability to raise additional funds will depend on financial, economic and other
factors, many of which are beyond our control. For example, financial markets have been negatively impacted by current macroeconomic trends,
including high interest rates and rising inflation. Adequate funding may not be available on terms favorable to us or at all, particularly
in light of these conditions. If adequate funds are not available or are not available on acceptable terms, we may not be able to fund
our expansion, take advantage of acquisition opportunities, develop or enhance our portfolio of products and services or respond to competitive
pressures, which could have a material adverse effect on our business, results of operations and financial condition. If we raise additional
funds through the issuance of equity or convertible debt securities, our shareholders will experience dilution and the securities that
we issue may have rights, preferences and privileges senior to those of our shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Moreover, any additional funds raised through
debt financing will likely require our compliance with restrictive covenants that impose operating and financial restrictions on us, including
restrictions on our ability to incur additional indebtedness, create liens, make acquisitions, dispose of assets and make restricted payments,
among others. In addition, such indebtedness may require us to maintain certain financial ratios. These restrictions may limit our ability
to obtain future financings, to withstand a future downturn in our business or the economy in general, or to otherwise conduct necessary
corporate activities. A breach of any such covenant would likely result in a default under the applicable agreement, which, if not waived,
could result in acceleration of the indebtedness outstanding. For more information, see &#8220;Item 5. Operating and Financial Review
and Prospects&#8212;B. Liquidity and Capital Resources&#8212;Indebtedness.&#8221;</p>


<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Our revenues are highly concentrated in the tuition
fees we charge for our medical courses and other health sciences programs, and any economic, market or regulatory factors adversely affecting
such medical courses and health sciences programs could lead to decreased demand in the medical and health courses we offer, which could
materially adversely affect us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A significant portion of our historical undergraduate
programs combined tuition fees are currently concentrated in the tuition fees we charge for our medical courses and other health sciences
programs across our network. For the years ended December 31, 2023, 2022 and 2021, 90.7%, 89.9% and 88.0%, respectively, of total historical
undergraduate programs combined tuition fees were derived from tuition fees we or our subsidiaries charged for medical courses and other
health sciences programs. Therefore, economic, market or regulatory factors affecting either the amount of tuition fees we are able to
charge for the medical courses and health sciences programs we offer or the ability of our students to pay such tuition fees could result
in significantly decreased demand for our services, which could materially adversely affect us.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Changes to the rules or delays or suspension
of tuition payments made through FIES may adversely affect our cash flows and our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Some of our students finance their tuition
fees through the Higher Education Student Financing Fund <i>(Fundo de Financiamento ao Estudante do Ensino Superior,</i> or FIES) created
by the Brazilian federal government, and operated through the National Fund for Educational Development <i>(Fundo Nacional de Desenvolvimento
da Educa&#231;&#227;o,</i> or FNDE), which offers financing to low-income students enrolled in undergraduate programs in private higher
education institutions. As of the date of this annual report, we have adhered to FIES as most recently amended by the Brazilian federal
government. As revised, FIES provides financial support for low-income students throughout Brazil, in particular in the North, Northeast
and Midwest regions. As a result, we have exposure to risks associated with delays in the transfer of monthly tuition payments from the
FIES program operated by the Brazilian federal government.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Should (i)&#160;the Brazilian federal government
terminate or reduce the transfer of monthly payments to our institutions that participate in FIES, (ii)&#160;we fail to meet the requirements
for participation in the programs, or our students benefiting from FIES fail to meet the requirements for enrollment in the programs,
or (iii)&#160;the Brazilian federal government extend the term to make reimbursements under FIES or adversely change their rules, our
results of operations and cash flow may be materially adversely affected. We may also experience a decline in revenues and a decline in
the number of students at our campuses from the FIES program.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Moreover, recent changes to the rules to renew
FIES contracts, as well as the shutdown of the system to enter into new student financing agreements, may negatively affect the number
of students enrolled in our courses, causing a reduction in our revenues. For more information regarding the changes to FIES contracts,
see &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Regulatory Overview.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">If we lose the benefits of federal tax exemptions
provided under the PROUNI program, our business, financial condition and results of operations may be materially adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Some of our students participate in the University
for All Program <i>(Programa Universidade para Todos,</i> or PROUNI program). Through the PROUNI program, the Brazilian federal government
grants a number of full and partial scholarships to low-income undergraduate students in private higher education institutions. As a result
of our participation in the PROUNI program, we benefit from certain federal tax exemptions relating to bachelor&#8217;s and associate&#8217;s
degree programs, such as (i)&#160;income tax, (ii)&#160;Social Contribution Tax on Gross Revenue (<i>Programa de Integra&#231;&#227;o
Social</i>, or PIS), (iii)&#160;Social Security Financing Tax on Gross Revenue (<i>Contribui&#231;&#227;o para o Financiamento da
Seguridade Social</i>, or COFINS), and (iv)&#160;Social Contribution Tax on Net Profit (<i>Contribui&#231;&#227;o Social sobre o Lucro
L&#237;quido</i>, or CSLL), regarding our revenues from undergraduate and associate programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We may be disqualified from the PROUNI program
and lose our tax exemptions if we do not comply with certain requirements, such as providing total or partial scholarships for low-income
students eligible for the program, granting partial scholarships, and submitting to MEC semi-annual records of attendance, achievement
and dropout of students receiving scholarships, among others. See &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Regulatory
Overview.&#8221; If we lose our tax exemptions or are unable to comply with other, more stringent requirements that may be introduced
in the future, our business, financial condition and results of operations could be materially adversely affected.</p>


<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">There is a risk that additional changes in
tax laws may prohibit, interrupt or modify the use of existing tax exemptions, and we cannot assure you that we will fully maintain such
tax and other benefits related to PROUNI in the event the tax laws are amended further. Any suspension, accelerated default, repayment
or inability to renew our tax exemptions may have an adverse effect on our results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Constitutional Amendment Proposal No. 45/2020
was approved and subsequently promulgated in Constitutional Amendment No. 132, on December 20, 2023, which proposes a new tax to substitute
PIS and COFINS (and other state and municipal taxes) with no tax exemptions. The Brazilian Congress is now focused on regulating the Constitutional
Amendment with complementary law projects that could have an impact on the sector.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of the date of this annual report, Bill
No. 3,887/2020, which expressly revokes the PIS and COFINS tax exemptions for the PROUNI program is under review by the Brazilian congress.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If we lose our tax exemptions and incentives,
if we are unable to comply with future requirements or if changes in the law limit our ability to maintain these tax benefits, our business,
financial condition and results of operations may be significantly and adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Our operating history as a consolidated company,
our recent acquisitions and the comparability of our results may make it difficult for investors to evaluate our business, financial condition,
results of operations and prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our operating history as a consolidated company
and recent acquisitions may make it difficult for you to evaluate our business, financial condition, results of operations and prospects.
Because the historical information included elsewhere in this annual report may not be representative of our results as a consolidated
company, investors may have limited financial information on which to evaluate us, their investment decision and our prior performance.
Our results of operations for the year ended December 31, 2023 are not directly comparable to our results of operations for the year ended
December 31, 2022, and our results of operations for the year ended December 31, 2022 are not directly comparable to our results of operations
for the year ended December 31, 2021, due to the effects of the acquisition of the Acquired Companies. Our ability to forecast our future
operating results, including revenue, cash flows and profitability, as well as the operational inefficiencies that we may face as we continue
to integrate the Acquired Companies, is limited and subject to a number of uncertainties. Moreover, past performance is no assurance of
future returns.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We do not currently control some of our equity
investments, which could adversely affect our ability to commercialize our products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We acquire interests in third parties for the
expansion, development or commercialization of our products. Currently, we have a 30.0% interest in UEPC, a medical school located in
the Federal District that offers higher education and post-graduate courses, both in person and through long-distance learning. We do
not currently have a controlling interest in UEPC and any disagreements or disputes with these or any other companies where we have or
in which we may decide to acquire a minority interest could adversely affect our ability to develop and commercialize our products and,
in turn, our financial condition and results of operations. The failure to continue any investment arrangement or to resolve disagreements
with current or future companies where we have a minority interest could materially and adversely affect our ability to transact the business
that is the subject of such investment arrangement, which would in turn negatively affect our financial condition and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">The interests of our management team may be focused
on the short-term market price of our Class A common shares, which may not coincide with your interests. In addition, our shareholders
may suffer dilution of their interests in our share capital and in the value of their investments due to the issuance of new shares for
settlement of our share-based incentive plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our directors and officers, among others, own
shares issued by us and are beneficiaries under our share-based incentive plans. Our current stock option plan for our managers and employees
was approved in August 2019 (as amended in July 2020, July 2022 and July 2023) and reserves up to 4% of our common shares at any time
(excluding treasury shares) for issuance under this new equity incentive plan. In addition, on July 8, 2022, we created a restricted stock
units program and reserved up to 1.2% of our common shares at any time for issuance under this new plan.</p>


<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Due to the issuance of stock options or restricted
stock program, or RSUs, to members of our management team, a significant portion of their compensation is closely tied to our results
of operations and, more specifically to the trading price of our Class A common shares, which may lead such individuals to direct our
business and conduct our activities with an emphasis on short-term profit generation. As a result of these factors, the interests of our
management team may not coincide with the interests of our other shareholders that have longer-term investment objectives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Once options have been exercised by the participants
and/or the common shares to be issued under the restricted stock units program have vested, our board of directors will determine whether
our capital stock should be increased through the issuance of new shares to be subscribed by participants, or if they will be settled
through shares held in treasury. In the event settlement occurs through the issuance of new shares, our shareholders will suffer dilution,
of their interests in our share capital and in the value of their investments, up to a maximum of 5.2% of our common shares at any time.
In case new stock options or RSUs are granted, whether under existing plans or new plans that may be approved by our shareholders at the
shareholders&#8217; meeting, our shareholders will be subject to additional dilution.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For additional information on our share-based
incentive plans, see &#8220;Item 6. Directors, Senior Management and Employees&#8212;B. Compensation&#8212;Long-Term Incentive Plans.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">An increase in delays and/or defaults in the
payment of tuition fees may adversely affect our income and cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We depend on the full and timely payment of
the tuition we charge our students, including tuition payments we receive through FIES. Adverse changes in the macroeconomic environment
and the earnings capacity of our students, may lead to an increase in payment delinquency or default by our students and negatively impact
our ability to collect our accounts receivable. An increase in payment delinquency or default by our students may have a material adverse
effect on our cash flows and our business, including our ability to meet our obligations. Our allowance for expected credit losses expenses
as a percentage of our revenue was 2.6%, 1.8% and 2.8% for the years ended December 31, 2023, 2022 and 2021, respectively. There is no
guarantee that our allowance for expected credit losses expenses will not increase in the following years. Our inability to collect our
accounts receivable on a timely basis, if at all, could cause our allowance for expected credit losses expenses to increase in the future,
and materially and adversely affect our financial condition, liquidity and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Difficulties in identifying, opening and efficiently
managing new campuses or in obtaining regulatory authorizations and accreditations on a timely basis as part of our organic growth strategy
may adversely affect our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our organic strategy includes expanding by
opening new campuses and integrating them into our educational network. This growth plan creates significant challenges in terms of maintaining
our teaching quality and culture, as a result of the complexity and difficulty of effectively managing a greater number of campuses and
programs. If we are unable to maintain our current quality standards, we may lose market share and be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Establishing new campuses poses important challenges
and requires us to make significant investments in infrastructure, marketing, personnel and other pre-operational expenses, mainly identifying
new sites for lease or purchase. We prioritize identifying strategic sites, negotiating the purchase or lease of properties, building
or refurbishing facilities (including libraries, laboratories and classrooms), obtaining local permits, hiring and training faculty and
staff, and investing in administration and support.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are also required to register our new campuses
with MEC, before opening and operating them, as well as having our new programs accredited by MEC in order to issue official degrees and
certificates to our students. If we do not succeed in identifying and establishing our campuses in a cost-effective manner or in obtaining
such authorizations or accreditations on a timely basis, or if MEC imposes restrictions or conditions on our accreditation requests for
new campuses, our business may be adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We may not be able to successfully expand our
presence and performance in the distance learning business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We may face difficulties in successfully operating
our distance learning program and in implementing and investing in the technologies necessary to operate a successful distance learning
program, where the technological needs, the expectations of our customers and market standards change rapidly. We have to quickly modify
our products and services to adapt to new distance learning technologies, practices and standards. We may be adversely affected if current
or future competitors introduce products or service platforms that are superior to those we offer, or if our resources are not adequate
to develop and adapt our technological capabilities rapidly enough to maintain our competitive position.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, the success of our distance learning
programs depends on the general population having easy and affordable access to the internet, as well as on other technological factors
that are outside of our control. If the internet becomes inaccessible or access costs increase to levels higher than current prices, or
if the number of students interested in distance learning educational methods does not increase, we may be unable to successfully implement
our distance learning program strategy, which would have an adverse effect on our growth strategy.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We face significant competition in each program
we offer and each geographic region in which we operate. If we fail to compete efficiently, we may lose market share and our profitability
may be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We compete with various public and private
post-secondary education institutions, including distance learning institutions. Our competitors may offer programs or courses similar
to or better than those offered by us, have access to more funds, be more prestigious or well-regarded within the academic community,
have more conveniently located campuses with better infrastructure, or charge lower tuition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The expansion of medicine courses in Brazil
are subject to restrictive requirements, under the &#8220;<i>Mais M&#233;dicos</i>&#8221; program. Among the criteria that support the
creation of medical schools seats, two relevant aspects are (i) the importance of these new openings in a specified region, and (ii) the
sufficiency of the current medical infrastructure in both public regional hospitals and in the applicant medical institution in order
to obtain government authorization. In connection with these requirements, and in order to evaluate the impacts of the opening of medical
courses in Brazil, on April 5, 2018, MEC issued Ordinance No. 328/2018, pursuant to which, among other measures, MEC imposed a five-year
suspension on the granting of authorizations for the creation of new medical education courses. This ordinance was revoked on April 5,
2023 by MEC through Ordinance No. 650/2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">However, following the enactment of Ordinance
No. 328/2018, certain educational institutions began to judicially challenging these restrictions before Brazilian courts and sought to
compel MEC to receive and review requests (i) for new medicine courses, not observing the public call requirements set forth in Article
3 of Law No. 12,871/2013, or the <i>&#8220;Mais M&#233;dicos&#8221; Law</i>, and (ii) for an increase in the number of medicine seats
for existing undergraduate courses, in each case by alleging that these rules amounted to an undue restriction on freedom of competition.
In response to those judicial claims, the Brazilian National Association of Private Universities (<i>Associa&#231;&#227;o Nacional
das Universidades Particulares</i>) filed the Declaratory Action of Constitutionality (<i>A&#231;&#227;o Declarat&#243;ria de Constitucionalidade</i>)
No. 81 towards the Brazilian Federal Supreme Court (<i>Supremo Tribunal Federal</i>), or the Brazilian Supreme Court, to discuss the constitutionality
of Article 3 of the <i>&#8220;Mais M&#233;dicos&#8221; Law</i>. Such proceedings are currently pending a final decision.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Brazilian Supreme Court may decide (i)
against the constitutionality of Article 3 of the <i>&#8220;Mais M&#233;dicos&#8221; Law</i> and against the legality of other restrictions
imposed on the increase on medicine seats, and (ii) in favor of requiring MEC to conclude the analysis of requests for new medical courses
and increased medicine seats through judicial claims. Until a decision is reached by the Brazilian Supreme Court, there is a risk that
new medical courses and increased medicine seats are permitted through judicial claims. Consequently, our competition may increase, and
we may be required to reduce our tuition or increase our operating expenses (including our costs per student) in order to compete effectively,
retain or attract students or to pursue new market opportunities and reduce our ability to fill all of our medical seats capacity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Furthermore, we were awarded seven new undergraduate
campuses as part of the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, all of which are located in remote regions of Brazil and which
operations are subject to the verification by the MEC of the satisfactory implementation by Afya Brazil of all regulatory requirements.
We cannot assure you that there will be sufficient student demand to fill all medical school seats available at such campuses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a result of the foregoing, our revenues
and profitability may decrease. We cannot assure you that we will be able to compete successfully against our current or future competitors.
If we are unable to maintain our competitive position or otherwise respond to competitive pressures effectively, we may lose our market
share, our profits may decrease and we may be adversely affected.</p>


<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For more information, see &#8220;Item 4. Information
on the Company&#8212;Business Overview&#8212;Regulatory Overview.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We may not be able to update, improve or offer
the content of our existing programs to our students on a cost-effective basis, which may materially adversely affect our ability to attract
and retain students.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">To differentiate ourselves and remain competitive,
we must continually update our courses and develop new educational programs, including through the adoption of new technological tools.
Updates to our current courses and the development of new educational programs may not be readily accepted by our students or by the market.
Also, we may not be able to introduce new educational programs at the same pace as our competitors or at the pace required by the labor
market. If we do not adequately modify our educational programs in response to market demand, whether due to financial restrictions, unusual
technological changes or otherwise, our ability to attract and retain students may be impaired and we may be materially adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">If we continue to grow, we may not be able to
appropriately manage the expansion of our business and staff, the increased complexity of our software and platforms, or grow in our addressable
market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are currently experiencing a period of significant
expansion and are facing a number of expansion-related issues, such as the acquisition and retention of experienced and talented personnel,
cash flow management, corporate culture and efficacy of internal controls, among others. These issues and the significant amount of time
spent on addressing them may result in the diversion of our management&#8217;s attention from other business issues and opportunities.
In addition, we believe that our corporate culture and values are critical to our success, and we have invested a significant amount of
time and resources building them. If we fail to preserve our corporate culture and values, our ability to recruit, retain and develop
personnel and to effectively implement our strategic plans may be harmed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We must constantly update our software, enhance
and improve our billing, transaction and other business systems, and add and train new software designers and engineers, as well as other
personnel. This process is time intensive and expensive, and may lead to higher costs in the future. Furthermore, we may need to enter
into relationships with various strategic partners other online service providers and other third parties necessary to our business. The
increased complexity of managing multiple commercial relationships could lead to execution problems that can affect current and future
revenues, and operating margins.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We cannot assure you that our current and planned
platform and systems, procedures and controls, personnel and third-party relationships will be adequate to support our future operations.
In addition, our current expansion has placed significant strain on management and on our operational and financial resources, and this
strain is expected to continue. Our failure to manage growth effectively could seriously harm our business, results of operations and
financial condition.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">The ability to attract, recruit, retain and develop
key personnel and qualified employees is critical to our success and growth. If we lose key personnel, our business, financial condition
and results of operations may be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In order for us to successfully compete and
grow, we must attract, recruit, retain and develop the necessary personnel who can provide the needed expertise across the entire spectrum
of our intellectual capital needs. While we have a number of our key personnel who have substantial experience with our operations, we
must also develop our personnel to provide succession plans capable of maintaining continuity in the midst of the inevitable unpredictability
of human capital. However, the market for qualified personnel is competitive, and we may not succeed in recruiting additional personnel
or may fail to effectively replace key current personnel who depart with qualified or effective successors. We must continue to hire additional
personnel to execute our strategic plans. Our effort to retain and develop personnel may also result in significant additional expenses,
which could adversely affect our profitability. We cannot assure you that qualified employees will continue to be employed, that we will
manage them successfully, or that, in the future, we will be able to attract qualified personnel with similar skills and expertise at
equivalent cost and retain them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are also dependent upon the ability and
experience of a number of our key personnel who have substantial experience with our operations. Many of our key personnel have worked
for us for a significant amount of time or were recruited by us specifically due to their industry experience. It is possible that the
failure to retain or attract the services of one or a combination of our senior executives, board members (including those with M&amp;A
experience related to our industry), or key managers, could have a material adverse effect on our business, financial condition and results
of operations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are also working to advance culture change
through the implementation of diversity, equity and inclusion, or DEI initiatives throughout our organization. For example, in 2021, we
undertook a public commitment by signing onto the United Nations Global Compact and committing to achieve gender equity by having women
occupying half of our managerial positions by 2030. If we do not (or are perceived not to) successfully implement these initiatives,
our ability to recruit, attract and retain talent may be adversely impacted. Additionally, we may be perceived as insufficiently committing
to diversity, equity, and inclusion or environmental, social, and governance initiatives, which may adversely affect our reputation and,
consequently, our results of operations and financial condition.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt"><span style="background-color: white">Any increase
in the attrition rates of students in our education programs may adversely affect our results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: white">We believe
that our attrition rates are primarily related to the personal motivation and financial situation of our current and potential students,
as well as to socioeconomic conditions in Brazil. Significant changes in future attrition rates and/or failure to re-enroll may affect
our enrollment numbers, </span>such as in the context of economic uncertainty or volatility, <span style="background-color: white">and
may have a material adverse effect on our revenues and our results of operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We may be held liable for extraordinary events
that may occur at our campuses, which may have an adverse effect on our image and, consequently, our results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We may be held liable for the actions of officers,
directors, professors or other employees at our campuses, including allegations of non-compliance by officers, directors, professors or
other employees with specific legislation and regulations implemented by MEC relating to our programs. In the event of accidents, injuries
or other damages affecting students, professors, other employees or third parties at our campuses, we may face claims alleging that we
were negligent, provided inadequate supervision or were otherwise liable for the injury. Injury could be caused by or otherwise arise
from the actions or negligence of our students, employees, contractors or visitors on our premises, including due to failures in our in-access
control and security systems. If any such event were to occur, our facilities may be perceived to be unsafe, which may make our students
unwilling to enroll at or attend our schools. We may also be subject to claims alleging that officers, directors, professors or other
employees committed moral or sexual harassment or other unlawful acts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Moreover, we operate clinics, outpatient facilities,
and laboratories that serve a large number of patients annually, with physicians and students performing procedures. Non-compliance with
health and safety standards, regulations, and laws can result in serious consequences, including death or physical injury to students,
patients and other persons on our premises. We cannot assure you that we will be at all times able to comply with all such regulations
or guarantee the safety of all persons on our premises, as well as the safety of patients.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our insurance coverage may not cover certain
indemnifications we may be required to pay, be insufficient to cover these types of claims, or may not cover certain acts or events. We
may also not be able to renew our current insurance policies under the same terms. Such liability claims may affect our reputation and
harm our financial results. See &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Insurance.&#8221; In addition,
we may also be subject to legal proceedings by current and/or former students alleging breaches of rights granted by the Brazilian Consumer
Protection Code <i>(C&#243;digo de Defesa do Consumidor),</i> and to legal proceedings by current and/or former employees alleging breaches
of applicable labor laws. Even if unsuccessful, these claims may cause negative publicity, reduce enrollment numbers, increase student
attrition rates, entail substantial expenses and divert the time and attention of our management, materially adversely affecting our results
of operations and financial condition.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We may face restrictions and penalties under
the Brazilian Consumer Protection Code in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil has a series of strict consumer protection
laws, referred to collectively as the Consumer Protection Code <i>(C&#243;digo de Defesa do Consumidor).</i> These laws apply to all
companies in Brazil that supply products or services to Brazilian consumers. They include protection against misleading and deceptive
advertising, protection against coercive or unfair business practices and protection in the formation and interpretation of contracts,
usually in the form of civil liabilities and administrative penalties for violations.</p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">These penalties are often levied by the Brazilian
Consumer Protection Agencies <i>(Funda&#231;&#227;o de Prote&#231;&#227;o e Defesa do Consumidor,</i> or PROCONs), which oversee
consumer issues on a district-by-district basis. Companies that operate across Brazil may face penalties from multiple PROCONs, as well
as from the National Secretariat for Consumers <i>(Secretaria Nacional do Consumidor</i>, or SENACON). Companies may settle claims made
by consumers via PROCONs by paying compensation for violations directly to consumers and through a mechanism that allows them to adjust
their conduct, called a conduct adjustment agreement <i>(Termo de Ajustamento de Conduta,</i> or TAC).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Brazilian public prosecutors may also commence
investigations of alleged violations of consumer rights and require companies to enter into TACs. Companies that violate TACs face potential
enforcement proceedings and other potential penalties such as fines, as set forth in the relevant TAC. Brazilian public prosecutors may
also file public civil actions against companies who violate consumer rights or competition rules, seeking strict adherence to the consumer
protection laws and compensation for any damages to consumers. In certain cases, we may also face investigations and/or sanctions by the
CADE, in the event our business practices are found to affect the competitiveness of the markets in which we operate or the consumers
in such markets.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Any change or review of the tax treatment of
our activities, or the loss or reduction in tax benefits on the sale of books (including digital content) may materially adversely affect
us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Brazilian Federal Constitution, in Article
150, exempts production, sale and resale activities involving books. In this sense, Medcel is not taxed by the federal VAT (tax on industrial
activity, or &#8220;IPI&#8221;), the state VAT (tax on sale or resale of products, or &#8220;ICMS&#8221;) and the municipal VAT (tax on
services, or &#8220;ISS&#8221;). According to Brazilian federal law No. 10,865/2004, the Company is also benefited from a zero tax rate
on Federal Social Contributions, PIS and COFINS, which are calculated on gross revenue. If the Brazilian government or tax authority or
the Brazilian superior courts decide to change or review the tax treatment for the production or sales of books (including digital books
and e-readers), and we are unable to pass any cost increase onto our students, our results may be materially adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Moreover, in October 2021, more than 130 countries
agreed to implement a minimum tax regime for multinational groups, known as Pillar Two, to reform the international corporate taxation.
Pillar Two aims to ensure that multinational groups in scope are liable to a minimum effective corporate tax rate of 15 per cent per country.
In December 2021, the OECD released the Pillar Two model rules&#8212;accompanied by commentary and guidelines&#8212;which are due to be
passed into national legislation but adapted by local conditions. In response to the OECD&#8217;s Pillar Two rules, the amendments to
IAS 12 were introduced and include: (i) a mandatory temporary exception to the recognition and disclosure of deferred taxes arising from
the jurisdictional implementation of the Pillar Two model rules; and (ii) disclosure requirements for affected entities to help users
of the financial statements better understand an entity&#8217;s exposure to Pillar Two income taxes arising from this legislation, especially
prior to the effective date. The countries where we have our tax domicile have not yet enacted any tax legislation in connection with
Pillar Two, but we cannot assure you when and whether any such jurisdictions will adopt such rules and that any such rules may not have
a material adverse effect on our results of operations and financial condition.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">If we are unable to maintain consistent educational
quality throughout our network, including the educational materials of our post-secondary education institutions, or keep or adequately
train our faculty members or maintain our physical infrastructure, we may be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our teaching faculty, including teachers and
professors at our post-secondary education institutions, is essential for maintaining the quality of our programs and the strength of
our brand and reputation. We promote training in order for our faculty to attain and maintain the qualifications we require and for us
to provide updating programs on trends and changes in their areas. Due to shortages in the supply of qualified professors, competition
for hiring and retaining qualified professionals has increased substantially. We cannot assure you that we will succeed in retaining our
current professors or recruiting or training new professors who meet our quality standards, particularly as we continue to expand our
operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The quality of our academic curricula and the
infrastructure of our campuses are also key elements of the quality of the education we provide. We cannot assure you that we will succeed
in identifying facilities with adequate infrastructure for our new campuses, develop adequate infrastructure in properties we acquire
or have enough resources to continue expanding through acquisitions or development of new projects. In addition, we cannot assure you
that we will be able to develop academic curricula for our new programs with the same levels of excellence as existing programs and meeting
the standards set forth by MEC. Shortages of qualified professors, adequate infrastructure or quality academic curricula for new programs
according to our business model and the parameters set forth by MEC, may have a material adverse effect on our business.</p>


<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Moreover, infrastructure vulnerabilities can
lead to adverse events with significant impacts on our reputation to the extent they may expose students and faculty to physical injury.
As of the date of this annual report, we have dozens of campuses spread across Brazil, and we cannot assure that all of them will be adequately
conserved and have safety practices that are appropriately observed. Structural problems in any such facilities may include faulty floors
and ceilings, premises that are intermittently closed due to lack of safety or appropriate licenses, areas prone to flooding, exposed
electrical wiring and other issues that may increase the risk of personal injury to our students, faculty and other on our premises. If
any such events were to occur, our reputation would be materially and adversely affected, which could thereby to a significant adverse
effect on our results of operations and financial condition.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Our business depends on the continued success
of the brands of each of our institutions, as well as the &#8220;Afya&#8221; brand, and if we fail to maintain and enhance the recognition
of our brands, we may face difficulty enrolling new students, and our reputation and operating results may be harmed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We believe that market awareness of our brands
has contributed significantly to the success of our business. Maintaining and enhancing our brands is critical to our efforts to grow
student enrollments. Failure to maintain and enhance our brand recognition could have a material and adverse effect on our business, operating
results and financial condition. We have devoted significant resources to our brand promotion efforts in recent years, but we cannot assure
you that these efforts will be successful. If we are unable to further enhance our brand recognition, or if we incur excessive marketing
and promotion expenses, or if our brand image is negatively impacted by any negative publicity, our business and results of operations
may be materially and adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">If we are not able to maintain our current MEC
evaluation ratings and the evaluation ratings of our students, we may be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We and our students are regularly evaluated
and rated by MEC. If our campuses, programs or students receive lower scores from MEC than in previous years in any of its evaluations,
including the IGC <i>(&#205;ndice Geral de Cursos),</i> and the Student Performance National Exam <i>(Exame Nacional de Desempenho de
Estudantes,</i> or ENADE), we may experience a reduction in enrollments and be adversely affected by perceptions of decreased educational
quality, which may negatively affect our reputation and, consequently, our results of operations and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Finally, in the event that any of our programs
receive unsatisfactory evaluations, the post-secondary education institution offering the programs may be required to enter into an agreement
with MEC setting forth proposed measures and timetables to improve the program and remedy the unsatisfactory evaluation. Non-compliance
with the terms of the agreement may result in additional penalties on the institution. These penalties could include, but are not limited
to, suspending our ability to enroll students in our programs, denial of accreditation or re-accreditation of our institutions or prohibiting
us from holding regular class sessions, all of which can adversely affect our results of operations and financial condition.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We are subject to supervision by MEC and, consequently,
may suffer sanctions as a result of non-compliance with any regulatory requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Brazilian Federal Law No. 10,861/2004, regulated
by Decree No. 9,235/2017, implemented the activities of supervision of post-secondary education entities and courses in the Brazilian
federal education system. MEC&#8217;s Secretariat of Regulation and Supervision of Higher Education, or SERES, is responsible for the
regular and special supervision of the corresponding courses and programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Regular supervision derives from complaints
and allegations by students, parents and faculty members, as well as by public entities and the press. These complaints and allegations
involve specific cases of entities with courses showing evidence of irregularities or deficiencies. We are subject to those complaints
and representations. Special supervision, on the other hand, may be commenced by MEC itself, based on its post-secondary education regularity
and quality standards, and involves more than one course or entity, grouped according to the criteria chosen for the special supervision.
These criteria may include unsatisfactory results in the ENADE and the Difference Indicator between Expected and Actual Performance <i>(Indicador
de Diferen&#231;a entre os Desempenhos Observado e Esperado),</i> among other quality indicators, the history of course evaluations
by INEP, as well as compliance with specific legal requirements as, for example, the minimum ratio between faculty members with master&#8217;s
or doctorate degrees or certain mandatory digitization requirements with respect to academic documents for our students under MEC&#8217;s
recent digital academic collection rules. Administrative irregularities can include, among others: (i)&#160;unlicensed or irregular post-secondary
courses; (ii)&#160;any outsourcing of post-secondary education activities; (iii)&#160;the failure to file a re-accreditation or recognition
or renewal request with respect to post-secondary education courses within the time periods enacted by MEC pursuant to Decree No. 9,235/2017;
(iv)&#160;failure to comply with the rules and requirements for maximum occupancy of authorized vacancies approved by MEC; and (v) failure
to comply with any penalties imposed by the MEC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If MEC concludes, as part of its supervisory
activities, that an irregularity constitutes an imminent risk or threat to students or the public interest, it may impose the following
measures on the relevant educational institution for a period to be determined by SERES: (i)&#160;suspend the admission of new students;
(ii)&#160;suspend the offering of undergraduate or postgraduate <i>lato sensu </i>courses; (iii)&#160;suspend the institution&#8217;s
discretionary ability to, among other things, create new post-secondary courses and establish course curricula, if applicable; (iv)&#160;suspend
the license to establish new distance learning programs; (v)&#160;override any ongoing regulatory requests filed by the institution and
prohibit new regulatory requests; (vi)&#160;suspend participation in FIES; (vii)&#160;suspend participation in PROUNI; and (viii)&#160;suspend
or restrict participation in other federal education programs. The educational institution can contest the MEC&#8217;s findings by filing
motions with MEC or with Brazilian courts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Upon completion of the supervisory process
and to the extent MEC concludes that there are administrative irregularities, SERES may apply the penalties provided for by Law No. 9,394/1996,
namely (i)&#160;discontinue courses; (ii)&#160;directly intervene in the educational institution; (iii)&#160;temporarily suspend the institution&#8217;s
discretionary ability to, among other things, create new post-secondary courses and establish course curricula, if applicable; (iv)&#160;disqualify
the institution as an educational institution; (v)&#160;reduce the number of student vacancies; (vi)&#160;temporarily suspend new student
enrollments; or (vii)&#160;temporarily suspend courses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Moreover, we and our subsidiaries face the
risk of unintentionally surpassing the MEC&#8217;s authorized medical or other enrollment limits due to court-mandated student enrollments,
which do not count towards our allocated enrollment limit. Inaccurate assessment of these judicial demands, such as misinterpreting obligations
like discounts as enrollments under litigation, may result in exceeding our authorized enrollment limits. This breach by us, or by any
of the companies that we have acquired or may acquire, could lead to regulatory penalties, reputational harm, and strain our resources,
compromising our educational quality.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">The post-secondary education sector is highly
regulated, and our failure to comply with existing or future laws and regulations could significantly impact our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are subject to various federal laws and
extensive government regulations by MEC, <i>Conselho Nacional de Educa&#231;&#227;o</i> (National Education Council, or CNE), INEP,
FIES and the National Post-secondary Education Assessment Commission <i>(Comiss&#227;o Nacional de Avalia&#231;&#227;o da Educa&#231;&#227;o
Superior,</i> or CONAES), among others, including, but not limited to the <i>&#8220;Mais M&#233;dicos&#8221; Law</i>, which created
the &#8220;<i>Mais M&#233;dicos</i>&#8221; program.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Brazilian education regulations define three
types of post-secondary education institutions: (i)&#160;colleges, (ii)&#160;university centers and (iii)&#160;universities. The three
categories depend on previous accreditation by MEC to operate. Colleges differ from the other categories with respect to the programs
offered, as colleges depend on previous authorization from MEC to implement new programs, while university centers and universities are
not subject to such requirements, except for courses in law, medicine, psychology, nursing and dentistry, which require the prior approval
of MEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">All accredited educational institutions require
the prior approval of MEC to create campuses outside their headquarters. All post-secondary education programs must be recognized by MEC
as a requirement, together with registration of the program, to validate the diplomas issued by them. However, pursuant to article 101
of Ordinance No. 23/2017 of MEC, issued diplomas may be valid even if the program is not formally recognized by MEC, so long as the educational
institution has filed the request with MEC to certify the program, and the request is pending formal review and approval by MEC. As a
result, any failure to comply with legal and regulatory requirements by post-secondary education entities may result in the imposition
of sanctions by MEC, as well as damage to the program&#8217;s reputation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">MEC must authorize our campuses located outside
our headquarters before they can start their operations and programs. For further information, see &#8220;Item 4. Information on the
Company&#8212;Business Overview&#8212;Regulatory Overview.&#8221; Distance learning programs, as well as on-campus learning, are also
subject to strict accreditation requirements for their implementation and operation. We must comply with all such requirements in order
to obtain and renew all authorizations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We cannot assure you we will be able to comply
with these regulations and maintain the validity of our authorizations, enrollments and accreditations in the future. If we fail to comply
with these regulatory requirements, MEC could place limitations on our operations, including cancellation of programs, reduction in the
number of positions we offer to students, termination of our ability to issue degrees and certificates and revocation of our accreditation,
any of which could adversely affect our financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We cannot assure you that we will obtain accreditation
or re-accreditation of our post-secondary education institutions, or that our courses will receive authorization or reauthorization as
scheduled, or that they will have all of the accreditations, re-accreditations, authorizations and re-authorizations required by MEC.
The absence of such accreditations and authorizations from the MEC or any delays in obtaining them could adversely affect our financial
condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, we may also be adversely affected
by any changes in the laws and regulations applicable to post-secondary education institutions, particularly by changes related to: (i)&#160;any
revocation of accreditation of private educational institutions; (ii)&#160;the imposition of controls on monthly tuition payments or restrictions
on the profitability of private educational institutions; (iii)&#160;faculty credentials; (iv)&#160;academic requirements for courses
and curricula; (v)&#160;infrastructure requirements of campuses, such as libraries, laboratories and administrative support; (vi)&#160;the
&#8220;<i>Mais M&#233;dicos</i>&#8221; program; and (vii)&#160;the promulgation by the MEC of new rules and regulations affecting post-secondary
education, in particular with respect to distance learning programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We may be materially adversely affected if
we are unable to obtain these authorizations, accreditations and course recognitions in a timely manner, if we cannot introduce new courses
as quickly as our competitors, if we are not able to or do not comply with any new rules or regulations promulgated by the MEC or if laws
and regulations are passed adverse to the business and operations of post-secondary education institutions.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Our success depends on our ability to operate
in strategically located property that is easily accessible by public transportation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We believe that urban mobility, inadequate
public transportation systems and high transportation costs in many Brazilian cities make the location and accessibility of campuses a
decisive factor for students choosing an educational institution. Therefore, a key component of the success of our business consists in
finding, renting and/or buying strategically located property that meets the needs of our students. We cannot guarantee that we will be
able to keep our current property or acquire new property that is strategically located in the future. In addition, acquisition costs,
costs associated with improvements, construction, and repairs of existing properties and rental values for the properties we use might
increase in the future and could have a material adverse effect on our business. Finally, due to demographic and socioeconomic changes
in the regions in which we operate, we cannot guarantee that the location of our campuses will continue to be attractive and convenient
to students.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Failure to protect or enforce our intellectual
property and other proprietary rights could adversely affect our business and financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We rely and expect to continue to rely on
a combination of trademark, copyright, patent and trade secret protection laws, as well as confidentiality and license agreements with
our employees, consultants and third parties with whom we have relationships to protect our intellectual property and proprietary rights.
As of the date of this annual report, we had no issued patents and one patent application pending in Brazil. As of December 31, 2023,
we owned 375 trademark registrations in Brazil, and we have also sought to register 12 trademarks abroad, in the United States, the European
Union, Mexico and Colombia. As of the date of this annual report, we have 169 pending trademark applications in Brazil and unregistered
trademarks that we use to promote our brand, and also own 344 registered domain names in Brazil and 21 registered international domain
names, and have registered two softwares in Brazil. From time to time, we expect to file additional patent, copyright and trademark applications
in Brazil and abroad. Nevertheless, these applications may not be approved or otherwise provide the full protection we seek. Any dismissal
of our &#8220;AFYA&#8221; trademark application may impact our business. Third parties may challenge any patents, copyrights, trademarks
and other intellectual property and proprietary rights owned or held by us. Third parties may knowingly or unknowingly infringe, misappropriate
or otherwise violate our patents, copyrights, trademarks and other proprietary rights, and we may not be able to prevent infringement,
misappropriation or other violation without substantial expense to us.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Furthermore, we cannot guarantee that:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our intellectual property and proprietary rights will provide competitive advantages to us;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our competitors or others will not design around our intellectual property or proprietary rights;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to assert or enforce our intellectual property or proprietary rights against potential competitors or to settle current
or future disputes will not be limited by our agreements with third parties;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our intellectual property and proprietary rights will be enforced in jurisdictions where competition may be intense or where legal
protection may be weak;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>any of the patents, trademarks, copyrights, trade secrets or other intellectual property or proprietary rights that we presently employ
in our business will not lapse or be invalidated, circumvented, challenged or abandoned; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>we will not lose the ability to assert or enforce our intellectual property or proprietary rights against or to license our intellectual
property or proprietary rights to others and collect royalties or other payments.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If we pursue litigation to assert or enforce
our intellectual property or proprietary rights, an adverse decision in any of these legal actions could limit our ability to assert our
intellectual property or proprietary rights, limit the value of our intellectual property or proprietary rights or otherwise negatively
impact our business, financial condition and results of operations. If the protection of our intellectual property and proprietary rights
is inadequate to prevent use or misappropriation by third parties, the value of our brand and other intangible assets may be diminished,
competitors may be able to more effectively mimic our service and methods of operations, the perception of our business and service to
customers and potential customers may become confused in the marketplace and our ability to attract customers may be adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We may in the future be subject to intellectual
property claims, which are costly to defend and, if we do not succeed in defending such claims, could harm our business, financial condition
and operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">From time to time, third parties may allege
in the future that we or our business infringes, misappropriates or otherwise violates their intellectual property or proprietary rights,
including with respect to our publications. Many companies, including various &#8220;non-practicing entities&#8221; or &#8220;patent trolls,&#8221;
are devoting significant resources to developing or acquiring patents that could potentially affect many aspects of our business. We have
not exhaustively searched patents related to our technology. In addition, the publishing industry has been, and we expect in the future
will continue to be, the target of counterfeiting and piracy. We may implement measures in an effort to protect against these potential
liabilities that could require us to spend substantial resources. Any costs incurred as a result of liability or asserted liability relating
to sales of unauthorized or counterfeit educational materials could harm our business, reputation and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Third parties may initiate litigation against
us without warning. Others may send us letters or other communications that make allegations without initiating litigation. We have in
the past and may in the future receive such communications, which we assess on a case-by-case basis. We may elect not to respond to the
communication if we believe it is without merit or we may attempt to resolve disputes out of court by electing to pay royalties or other
fees for licenses. If we are forced to defend ourselves against intellectual property claims, whether they are with or without merit or
are determined in our favor, we may face costly litigation, diversion of technical and management personnel, inability to use our current
website or inability to market our service or merchandise our products. As a result of a dispute, we may have to develop non-infringing
technology, including partially or fully revising any publication that infringes intellectual property rights, enter into licensing agreements,
adjust our merchandising or marketing activities or take other action to resolve the claims. These actions, if required, may be unavailable
on terms acceptable to us or may be costly or unavailable. If we are unable to obtain sufficient rights or develop non-infringing intellectual
property or otherwise alter our business practices, as appropriate, on a timely basis, our reputation or brand, our business and our competitive
position may be affected adversely and we may be subject to an injunction or be required to pay or incur substantial damages and/or fees
and/or royalties.</p>


<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Most of our services are provided using proprietary
software and our software is mainly developed by our employees, who assign to us their copyrights over the software. In this regard, though
applicable law establishes that employers shall have full title over rights relating to software developed by their employees, we could
be subject to lawsuits by former employees claiming ownership of such software. As a result, we may be required to obtain licenses of
such software, incurring costs relating to payments of royalties and/or damages and we may be forced to cease the use of such software.
If we are unable to use certain of our proprietary software as a result of any of the foregoing or otherwise, this could have a material
adverse effect on our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, we use open source software in
connection with certain of our products and services. Companies that incorporate open source software into their products have, from time
to time, faced claims challenging the ownership of open source software and/or compliance with open source license terms. As a result,
we could be subject to suits by parties claiming ownership of what we believe to be open source software or non-compliance with open source
licensing terms. Some open source software licenses require users who distribute or use open source software as part of their software
to publicly disclose all or part of the source code to such software and/or make available any derivative works of the open source code
on unfavorable terms or at no cost. Any requirement to disclose our proprietary source code or pay damages for breach of contract could
have a material adverse effect on our business, financial condition and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Unfavorable decisions in our legal, arbitration
or administrative proceedings may adversely affect us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are, and we, our controlling shareholders,
directors or officers may be in the future, party to legal, arbitration and administrative investigations, inspections and proceedings
arising from the ordinary course of our business or from nonrecurring corporate, tax, criminal or regulatory events, involving our suppliers,
students, faculty members, as well as environmental, competition and tax authorities, especially with respect to civil, tax, criminal
and labor claims. We cannot guarantee that the results of these proceedings will be favorable to us or that we have made sufficient provisions
for liabilities that may arise as a result of these or other proceedings. Adverse decisions on material legal, arbitration or administrative
proceedings may damage our reputation and may adversely affect our results of operations and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, Mr. Nicolau Carvalho Esteves,
our co-chairman, is currently party to a public civil proceeding filed by the federal prosecutor&#8217;s office against Mr. Carvalho Esteves
and other individuals in connection with certain irregular administrative acts alleged to have taken place during each of their respective
terms as Health Secretary of the State of Tocantins <i>(Secret&#225;rio de Sa&#250;de do Estado de Tocantins)</i> between 2012 and
2014, a position held by Mr. Carvalho Esteves for a period of four months, from March 9, 2012 to July 20, 2012. In February 2022, a decision
was issued, dismissing the motions submitted by the public prosecutor&#8217;s office, and an appeal was filed by the public prosecutor&#8217;s
office. Mr. Nicolau Carvalho Esteves has presented counterarguments to the appeal, and, as of the date of this annual report, the appeal
is pending judgment by the court. The risk of loss in these proceedings is classified as remote by external counsel. If Mr. Carvalho Esteves
is found liable, he may be subject to penalties, including a three-year prohibition on him or any legal entity under his control transacting
with public entities or being granted tax incentives/benefits. We cannot guarantee that the results of these proceedings will be favorable
to Mr. Carvalho Esteves and any adverse decision may&#160;damage our reputation, which may have an adverse effect on our business, results
of operations and the price of our Class A common shares. For further information, see &#8220;Item 6. Directors, Senior Management and
Employees&#8212;A. Directors and Senior Management&#8212;Legal Proceedings.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Failure to obtain or maintain licenses and permits
with respect to our real estate or construction projects in a timely manner may result in penalties, including closures of some of our
campuses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The use of all of our buildings, including
our operational and administrative buildings, is subject to the successful issuance of an occupancy permit <i>(Habite-se),</i> or equivalent
certificate, issued by the municipality where the property is located, certifying that the building was constructed in compliance with
applicable zoning and municipal regulations. In addition, non-residential properties are required to have a use and operations license
and/or permit, issued by the competent municipality, and a fire department inspection certificate, issued by the fire department, prior
to being used regularly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are currently in the process of obtaining
and/or renewing these licenses for some of the real estate we use. The absence of such licenses may result in penalties ranging from
fines to forced demolition of the areas that were not built in compliance with applicable codes or, in the worst-case scenario, the temporary
or permanent closure of the campus or branch lacking the licenses and permits to the extent the relevant penalties and fines have not
been paid and the licenses and permits have not been obtained following notifications from the relevant authorities. Any penalties imposed,
and in particular, the forced closure of any of our campuses or branches, may result in a material adverse effect on our business. Moreover,
in the event of any accident at our campuses or branches, the lack of such licenses may result in civil and criminal liability, as well
as cause the cancellation of insurance policies, if any, for the respective campus or branch and may damage our reputation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, we routinely undertake complex
construction, expansion and renovation projects at our campuses, which require additional construction licenses and permits, including
with respect to the environmental licensing of any such projects. Our failure to obtain or maintain any such licenses or permits during
the course of these projects may lead to delays to or the incurrence of additional costs in connection with these projects (including
as a result of fines or other penalties imposed by governmental authorities as a result of our failure to obtain any such licenses or
permits), in addition to material adverse effects to our results of operations, financial condition and reputation.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We may not be able to maintain or renew our existing
leases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We lease substantially all of the properties
on our campuses. According to Brazilian lease laws, a lessee has the right to renew existing leases for subsequent terms equal to the
original term of the lease. In order for a lessee to enforce this right, the following criteria must be met (i)&#160;the non-residential
lease agreement must have a fixed term equal to or greater than five consecutive years, or, in the event there is more than one agreement
or amendment thereto regarding the same real estate, the aggregate term in such agreement or amendment must be greater than five consecutive
years (ii)&#160;the lessee must have been using the property for the same purpose for a minimum and continuous period of three years and
(iii)&#160;the lessee must claim the right of automatic renewal at the most one year and at least six months prior to the end of the term
of the lease agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Lease agreements with terms lasting less than
five years are not entitled to a right of compulsory renewal and, as a result, the lessor has the right to refuse renewal of the lease
upon expiration of its term. The lease agreements relating to our campuses generally have terms lasting from five to 30 years and are
renewable in accordance with applicable Brazilian lease laws. If we are forced to close any of our campuses due to the termination of
a lease agreement and our inability to renew the lease, our business and results of operations may be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, most of our lease agreements are
not registered with the relevant real estate registries. We therefore do not have a right of first refusal over the applicable property
in the event of a sale by its landlord and the subsequent purchaser may require that we vacate the property.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Acquisitions of educational institutions, in
certain circumstances, must be approved by the Administrative Council for Economic Defense.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Brazilian legislation provides that acquisitions
of educational institutions meeting certain requirements must be approved by Brazil&#8217;s Administrative Council for Economic Defense
<i>(Conselho Administrativo de Defesa Econ&#244;mica,</i> or CADE) prior to the completion of the acquisition if one of the companies
or group of companies involved has gross annual revenues in Brazil of at least R$750.0 million in the year immediately prior to the acquisition
and any other party or group of companies involved has gross income of at least R$75.0 million in that same period. As part of this process,
CADE must determine whether the specific operation affects the competitiveness of the market in question or the consumers in such markets.
CADE may not approve our future acquisitions or may condition approval of our acquisitions on our disposal of some of the operations of
the target of the acquisition, or impose restrictions on the operations and commercialization of the target. Failure to obtain approval
for future acquisitions or any conditional approvals of future acquisitions may result in expenses that may adversely affect our results
of operations and financial condition. As a result of our growth strategy through acquisitions of new entities, we may need additional
funds to implement our strategy. Therefore, if we cannot obtain adequate financing to conclude any potential acquisition and implement
our expansion plans, our growth strategy will be affected. See &#8220;&#8212;We may require additional funds to continue our expansion
strategy. If we are unable to obtain adequate financing on favorable terms to complete any potential acquisition and implement our expansion
plans, our growth strategy may be materially and adversely affected.&#8221;</p>


<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Some of the properties that we occupy are owned
by companies controlled by one of our significant shareholders. Therefore, we are exposed to conflicts of interest, since the administration
of such properties may conflict with our interests, those of such significant shareholder and those of our other shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Some of the properties we occupy, including
properties where some of our campuses are located, are owned and operated by companies controlled by one of our significant shareholders.
Therefore, the interests of our significant shareholder in the administration of such property may conflict with our interests and those
of our other shareholders. For further information, see &#8220;Item 7. Major Shareholders and Related Party Transactions&#8212;Related
Party Transactions&#8221; and note 8 to our audited consolidated financial statements.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Our holding company structure makes us dependent
on the operations of our subsidiaries. We depend on dividend distributions by our subsidiaries, and we may be adversely affected if the
performance of our subsidiaries is not positive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are a Cayman Islands exempted company with
limited liability. Our material assets are our direct and indirect equity interests in our subsidiaries. We control a number of subsidiary
companies that carry out the business activities of our corporate group. Our ability to comply with our financial obligations and to pay
dividends to our shareholders depends on our ability to receive distributions from the companies we control, which in turn depends on
the cash flow and profits of those companies. There is no guarantee that the cash flow and profits of our controlled companies will be
sufficient for us to comply with our financial obligations and pay dividends or interest on shareholders&#8217; equity to our shareholders.
Furthermore, exchange rate fluctuation will affect the U.S. dollar value of any distributions our subsidiaries make with respect to our
equity interests in those subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, the Brazilian federal government
recently stated that the income tax exemption on the distribution of dividends may be repealed and income tax assessed on the distribution
of dividends in the future, and that applicable taxes on the payment of interest on shareholders&#8217; equity may be increased in the
future. Any repeal of the income tax exemption on the distribution of dividends and any increase in applicable taxes on the payment of
interest on shareholders&#8217; equity may adversely affect us.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We cannot guarantee that our suppliers will not
engage in improper practices, including inappropriate labor practices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">To meet the needs of our students and offer
greater comfort and quality in all areas and aspects of our activities, we depend on service providers and suppliers for services such
as cleaning, surveillance, telemarketing and security. In the event that our service providers engage in such improper business practices,
our customers&#8217; perception of our business may be adversely affected, which may adversely affect our business, results of operations
and our reputation. For example, we may be adversely affected if these third-party service providers and suppliers do not meet their obligations
under Brazilian labor laws, including with respect to supplying appropriate protective equipment or training to employees that are designated
to work on our premises. According to Brazilian labor law, we may be liable to the employees of these service providers and suppliers
for labor obligations of these service providers and suppliers to the extent such service providers and suppliers fail to indemnify such
employees pursuant to court orders, and we may also be fined by the relevant authorities. This risk is particularly relevant if these
suppliers are involved in sensitive labor issues, such as violations of human rights, discriminatory acts, child labor and direct or indirect
use of forced labor or modern slavery. Any such litigation could impact our customers&#8217; perception of our business, and adverse decisions
may compel us to disburse material amounts in connection therewith, which may adversely affect our business, results of operations and
our reputation.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We could be adversely affected if we are unable
to pass on increases in our costs and expenses to our students by adjusting our monthly tuition fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our primary source of income is the monthly
tuition payments we charge to our students. Our payroll costs and expenses account for the majority of the costs of services and general
and administrative expenses, or 51.1%, 53.1% and 53.1% of such costs and expenses for the years ended December 31, 2023, 2022 and 2021,
respectively. Our faculty and administrative employees are represented by labor unions in the higher education sector and are covered
by collective bargaining agreements or similar arrangements determining the number of working hours, minimum compensation, vacations
and fringe benefits, among other terms. These agreements are subject to annual renegotiation and may be so modified. We could also be
adversely affected if we fail to achieve and maintain cooperative relationships with our professors&#8217; or administrative employees&#8217;
unions or face strikes, stoppages or other labor disruptions by our professors or employees, or if we are unable to pass on any increase
in costs arising from the renegotiation of collective bargaining agreements to the monthly tuition fees paid by students, which may have
a material adverse effect on our business.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, our utilities expenses (comprised
mainly of water, electricity and telephone expenses) represent in aggregate approximately 1.0%, 1.1% and 0.8% of our costs of services
and general and administrative expenses for the years ended December 31, 2023, 2022 and 2021, respectively. Personnel costs and expenses,
lease values and the cost of electricity are adjusted regularly using indices that reflect changes in inflation levels. If we are not
able to transfer any increases in our costs and expenses to students by increasing the amounts of their monthly tuition fees, for example
as a result of ongoing political and economic instability in Brazil or globally, our operating results may be adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">If we are not able to attract and retain students,
or are unable to do so without decreasing our tuition fees, our revenues may decline.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The success of our business depends primarily
on the number of students enrolled in our programs and the tuition fees that they pay. Our ability to attract and retain students depends
mainly on the tuition fees we charge, the convenient locations of our facilities, the infrastructure of our campuses and the quality of
our programs as perceived by our existing and potential students. These factors are affected by, among other things, our ability to (i)&#160;respond
to increasing competitive pressures, (ii)&#160;develop our educational systems to address changing market trends and demands from post-secondary
education institutions and students, (iii)&#160;develop new programs and enhance existing programs to respond to changes in market trends
and student demands, (iv)&#160;adequately prepare our students for careers in their chosen professional occupations, (v)&#160;successfully
implement our expansion strategy, (vi)&#160;manage our growth while maintaining our teaching quality and (vii)&#160;effectively market
and sell our programs to a broader base of prospective students. If we are unable to continue to attract new students to enroll in our
programs and to retain our current students without significantly decreasing tuition, for example as a result of changes in our students&#8217;
preferences due to economic uncertainty or volatility, our revenues and our business may decline and we may be adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Our Digital Services segment is subject to seasonal
fluctuations, which may cause our operating results to fluctuate from quarter-to-quarter and adversely impact our working capital and
liquidity throughout the year, adversely affecting our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya has three reporting segments: (1) Undergrad,
which provides educational services through undergraduate courses related to medicine, other health sciences and other undergraduate programs;
(2) Continuing Education, which provides specialization programs and graduate courses for physicians; and (3) Digital Services, which
provides digital solutions for all stages of a medical career. This business unit is divided into Business to Physician (which encompasses
Content &amp; Technology for Medical Education, Clinical Decision Software, Practice Management Tools &amp; Electronic Medical Records,
Physician-Patient Relationship, Telemedicine, and Digital Prescription), and Business to Business (which provides access and demand for
the healthcare players).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Undergrad segment revenues are related to the
intake process and monthly tuition fees charged to students over the period; accordingly, this segment generally is not subject to significant
fluctuations from quarter to quarter. Continuing Education segment revenues are related to monthly intakes and tuition fees and generally
is not subject to significant fluctuations from quarter to quarter. Digital Services is comprised mainly of Medcel, Pebmed, and iClinic
revenues. While Pebmed and iClinic generally do not experience significant fluctuations resulting from seasonality, Medcel&#8217;s revenue
is concentrated in the first and last quarter of the fiscal year due to the period of enrollments of Medcel&#8217;s clients. In addition,
the majority of Medcel&#8217;s revenues are derived from printed books and e-books, which are recognized at the point in time when control
is transferred to the customer. Consequently, the Digital Services segment generally has higher revenues and results of operations in
the first and last quarters of the fiscal year than in the second and third quarters of the fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In recent years, the overall macroeconomic
environment in Brazil has undergone significant volatility as a result of adverse political and economic pressures. Adverse macroeconomic
conditions have led to a contraction in the disposable income of both existing and potential clientele within our Continuing Education
segment, prompting a deferral of their intentions to pursue residency and post-graduate specialization endeavors. Consequently, this resulted
in diminished demand for our residency preparatory courses and medical post-graduate specialization programs during that timeframe.</p>


<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Accordingly, we expect quarterly fluctuations
in our revenues and operating results to continue. These fluctuations could result in volatility and adversely affect our liquidity and
cash flows. As our business grows, these seasonal fluctuations may become more pronounced. As a result, we believe that sequential quarterly
comparisons of our financial results may not provide an accurate assessment of our financial position.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We face risks relating to our Digital Services
segment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We may face risks relating to the expansion,
including through acquisitions, of our Digital Services segment, which provides content and technology for medical education, clinical
decisions software, practice management tools and electronic medical records, doctor-patient relationship, telemedicine and digital prescriptions.
Companies operating in this segment are subject to significant execution risk since they are providing new digital features and developing
a new market, where the technological needs, the expectations of our customers and market standards change rapidly. As such, we may have
to quickly modify our products and services to adapt to new digital education technologies, practices and standards. In addition, an error
in the design, programming or validation of clinical decisions software could lead to inappropriate assignment or dosing of patients,
which could give rise to patient safety issues and/or liability claims against us, amongst other things, any of which could have a material
adverse effect on our financial condition, results of operations and reputation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, the success of our digital education
programs depends on the general population having easy and affordable access to the internet, as well as on other technological factors
that are outside of our control. If the internet becomes inaccessible or access costs increase to levels higher than current prices, or
if the number of students interested in digital education educational methods does not increase, we may be unable to successfully implement
our digital education program strategy, which would have an adverse effect on our growth strategy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Finally, we also face operational risks relating
to the integration of any such companies to build our ecosystem, including userbase and platform integration risks, among other risks.
As a result, any acquisitions we may make in this segment involve a number of uncertainties, risks and challenges that may have a material
adverse effect on our business and results of operations, and result in the risk of impairment. See also &#8220;&#8212;We may not be able
to identify and acquire new medical higher education institutions or meet our strategic and financial goals in connection with any business
acquisition we seek, and difficulties in effectively integrating and managing a growing number of acquisitions may adversely affect our
strategic objectives.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We are subject to environmental laws and regulations,
which may become more stringent in the future and increase our obligations and capital expenditures with respect to their compliance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are subject to several environmental municipal,
state and federal laws. Compliance with these laws and regulations is monitored by governmental agencies and bodies that may impose administrative,
civil and criminal sanctions on us. Violations of these laws and regulations may result in the imposition of criminal and administrative
sanctions, as well as civil liability, seeking redress for alleged environmental damages and damages to third parties. Causing environmental
damage may lead to administrative sanctions, which may include, among other consequences, penalties such as fines (ranging from R$50 to
R$50 million), revocation of our licenses and authorizations, and the temporary or permanent suspension of our activities. There is no
limit to the amount that the courts may award to cover the costs of remediation in the case of civil liability or, if the environmental
damage cannot be repaired, the payment of an indemnity. In addition, a claim seeking compensation for environmental damages is not subject
to a statute of limitations. The enactment of more stringent laws and regulations or more stringent interpretations of existing laws and
regulations may force us to increase our capital expenditures relating to environmental compliance, therefore diverting funds from previously
planned investments. These changes could have a material adverse effect on us. Governmental agencies or other authorities may also significantly
delay or deny the issuance of permits and authorizations required for our operations, preventing us from making constructions and improvements
in our campuses. In addition, the improper disposal of solid waste, as well as accidents resulting from the transportation of such wastes,
may give rise to administrative, civil and criminal sanctions. Considering the provision on strict and joint environmental civil liability,
the hiring of third parties to provide services for the collection, transportation and final disposal of waste does not exempt us from
liability for any environmental damage caused by such third parties.</p>


<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We may be adversely affected if the government
changes its investment strategy in education.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">According to Brazilian Federal Law No. 9,394/1996,
as amended, providing education is a duty of the government and of the family, and private education is permitted, in accordance with
the terms set forth by the Brazilian constitution and applicable laws and regulations. Certain public institutions may have certain competitive
advantages over us in the admissions process, as they do not charge tuition fees and may be perceived to be more prestigious than private
institutions, but the limited number of positions available and the competitive nature of the admission process to public institutions
significantly restricts access to these institutions by students. However, the Brazilian government may change its policy and increase
the competition we face by (i)&#160;increasing the level of public investment in basic education and post-secondary education in general,
opening a higher amount of positions and increasing the quality of education offered by public entities; and (ii)&#160;shifting resources
from institutions that are centers of excellence and research to public post-secondary education institutions. The introduction and extension
of affirmative action admission policies by federal and state institutions based on income, race or ethnicity criteria could also heighten
the level of competition in the industry. Any policy change affecting the level of public investment in any aspect of the education sector
may adversely affect us. As of the date of this annual report, our management is not aware of any pending policy changes or proposed legislation
affecting the level of public investment in the education sector in Brazil.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Government agencies, MEC and third parties may
conduct inspections, file administrative proceedings or initiate litigation against us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Because we operate in a highly regulated industry,
government agencies, MEC or third parties may conduct inspections, file administrative proceedings or initiate litigation for non-compliance
with regulations against us or the institutions we purchase. If the results of these proceedings or litigations are unfavorable to us,
or if we are unable to successfully defend our cases, we may be required to pay monetary damages or be subject to fines, limitations,
injunctions or other penalties. Even if we adequately address issues raised by an inspection conducted by an agency or successfully defend
our case in an administrative proceeding or court action, we may have to set aside significant financial and management resources to settle
issues raised by these proceedings or to those lawsuits or claims. Administrative proceedings or court actions brought against us may
damage our reputation, even if such lawsuits or claims are without merit.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Our success depends on our ability to monitor
and adapt to technological changes in the education sector and maintain a technological infrastructure that works adequately and without
interruption.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Information technology is an essential factor
for our growth. Our information technology systems and tools may become obsolete or insufficient, or we may have difficulties in following
and adapting to technological changes in the education sector, particularly in the distance learning segment where the technological needs
and expectations of our customers and market standards change rapidly and we must quickly adapt to new distance learning technology, practices
and standards. Moreover, our competitors may introduce better products or service platforms. Our success depends on our ability to efficiently
improve our current products while developing and introducing new products that are accepted in the marketplace. Additionally, a failure
to upgrade our technology, features, content, security infrastructure, network infrastructure, or other infrastructure associated with
our platform could harm our business. Adverse consequences could include unanticipated disruptions, slower response times, bugs, degradation
in levels of customer support, impaired quality of users&#8217; experiences of our educational platform and delays in reporting accurate
financial information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our business, particularly our distance learning
segment, depends on our information technology infrastructure functioning properly and without interruptions. Several problems regarding
our information technology structure, such as viruses, hackers, system interruptions and technical difficulties regarding our satellite
transmissions of data, sound and image, may have a material adverse effect on us and our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, we face risks associated with
unauthorized access to our systems, including by hackers and due to failures of our electronic security measures. These unauthorized entries
into our systems can result in the theft of proprietary or sensitive information, including student information, or cause interruptions
in the operation of our systems. As a result, we may be forced to incur considerable expenses to protect our systems from electronic security
breaches and to mitigate our exposure to technological problems and interruptions.</p>


<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Internet Act (Law No. 12,965/2014) applies
only to personal data collected through the internet, and establishes other principles and rules with respect to the privacy and protection
of the personal and behavioral data of internet users. The Internet Act guarantees, among others, the privacy of internet and privately
stored communications. Any data processing activity is subject to the data subject&#8217;s informed, free and express consent. Decree
No. 8,771/2016, which regulates the Internet Act, requires internet app providers to maintain certain security measures in connection
with the storage of personal data, including: (i)&#160;strict controls on access to personal data; (ii)&#160;authentication safeguards;
(iii)&#160;detailed data inventories (e.g., date, time and duration of access to the data, identity of the employee that accessed the
data and the actions taken), and (iv)&#160;use of IT solutions to ensure the data is protected (for example, data encryption or other
equivalent protective measures). If we fail to comply with the provisions of the Internet Act, we may be subject to sanctions and penalties,
including damages, which will be assessed based on the nature and degree of our non-compliance, among other factors.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Failure to prevent or detect a malicious cyber-attack
on our systems and databases could result in a misappropriation of confidential information or access to highly sensitive information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Cyber-attacks are becoming more sophisticated
and pervasive. Across our business, we hold large volumes of personally identifiable information, including that of employees, institutions,
customers, students and parents, legal guardians, patients, physicians and clients (B2B and B2C). Individuals have tried and may continue
to try to gain unauthorized access to our data in order to misappropriate such information for potentially fraudulent purposes, and our
security measures may fail to prevent such unauthorized access. A breach of our systems could result in a devastating impact on our reputation,
financial condition or student experience. In addition, if we were unable to prove that our systems are properly designed to detect an
intrusion, we could be subject to severe penalties and loss of existing or future business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In particular, data protection and privacy
laws are developing rapidly to take into account the changes in cultural and consumer attitudes towards the protection of personal data.
In operating our business and selling our products and services to customers, we and our subsidiaries collect, use, store, transmit and
otherwise process employee and customer data, including sensitive personal data. As a result, we and our subsidiaries are subject to a
variety of laws and regulations in Brazil, as well as contractual obligations, regarding data privacy, security and protection. In many
cases, these laws and regulations apply not only to third-party transactions, but also to transfers of information between or among us,
our subsidiaries and other parties with which we have commercial relationships.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Privacy, information security, and data protection
are significant issues globally. The regulatory framework governing the collection, processing, storage, use and sharing of certain information,
particularly financial and other personal data, is rapidly evolving and is likely to continue to be subject to uncertainty and varying
interpretations. The occurrence of unanticipated events and the development of evolving technologies often rapidly drive the adoption
of legislation or regulation affecting the use, collection or other processing of data and the manner in which we conduct our business.
Any failure or perceived failure by us to comply with our privacy policies or any applicable privacy, security or data protection, information
security or consumer protection-related laws, regulations, orders or industry standards in one or more jurisdictions could expose us to
costly litigation, significant awards, fines or judgments, civil and criminal penalties or negative publicity, and could materially and
adversely affect our business, financial condition and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We rely upon a third-party data center service
provider to host certain aspects of our platform and content and any disruption to, or interference with, our use of such services could
impair our ability to deliver our platform, resulting in customer dissatisfaction, damaging our reputation, and harming our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We utilize data center hosting facilities from
a global third-party service provider to make certain content available on our platform. Our operations depend, in part, on our provider&#8217;s
ability to protect its facilities against damage or interruption from natural disasters, power or telecommunications failures, criminal
acts and similar events. The occurrence of spikes in user volume, traffic, natural disasters, acts of terrorism, vandalism or sabotage,
or a decision to close a facility without adequate notice, or other unanticipated problems at our provider&#8217;s facilities could result
in lengthy interruptions in the availability of our platform, which would adversely affect our business.</p>


<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Failure to comply with data privacy regulations
could result in reputational damage to our brands and adversely affect our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Any perceived or actual unauthorized disclosure
of personally identifiable information, whether through breach of our network by an unauthorized party, employee theft, misuse or error
or otherwise, could harm our reputation, impair our ability to attract and retain our customers, or subject us to claims or litigation
arising from damages suffered by individuals. Failure to adequately protect personally identifiable information could potentially lead
to penalties, significant remediation costs, reputational damage, the cancellation of existing contracts and difficulty in competing for
future business. In addition, we could incur significant costs in complying with relevant laws and regulations regarding the unauthorized
disclosure of personal information, which may be affected by any changes to data privacy legislation at both the federal and state levels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In particular, on August 14, 2018, the President
of Brazil approved the LGPD, which came completely into force on August 1, 2021. The LGPD is a comprehensive data protection law establishing
general principles and obligations that apply across multiple economic sectors and contractual relationships. The LGPD applies to individuals
or legal, private or government entities, who process personal data in Brazil or collect personal data in Brazil or, further, when the
processing activities have the purpose of offering or supplying goods or services to data subjects located in Brazil. The LGPD establishes
detailed rules for the collection, use, processing, storage and any operation carried out with personal data (including personal data
of clients, suppliers, employees and patients of our medical schools), and affects all economic sectors, including the relationship between
customers and suppliers of goods and services, employees and employers and other relationships in which personal data is collected, whether
in a digital or physical environment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Specifically, the LGPD establishes, among other
things, data subjects&#8217; rights, the legal basis for personal data protection, requirements for obtaining consent from data owners,
obligations and requirements related to security incidents, data leaks and international data transfers, as well as the creation of the
National Data Protection Authority (<i>Autoridade Nacional de Prote&#231;&#227;o de Dados</i>, &#8220;ANPD&#8221;), for the purposes
of monitoring, implementing and supervising compliance with the LGPD in Brazil. In the event of non-compliance with the LGPD, we may be
subject to penalties, including (1)&#160;warnings, with the impositions of a deadline for the adoption of corrective measures; (2)&#160;a
one-time fine for each violation of up to 2% (subject to an upper limit of R$50,000,000) of our revenue; (3)&#160;a daily fine (subject
to an upper limit of R$50,000,000); (4)&#160;public disclosure of the violation after due investigation and confirmation of its occurrence;
(5)&#160;the restriction of access to the personal data to which the violation relates, until corrective measures are implemented; (6)&#160;deletion
of the personal data to which the violation relates; (7)&#160;partial suspension of the databases to which the violation relates for up
to six months, which can be extended for an equal period until corrective measures are implemented; (8)&#160;suspension of the personal
data processing activities to which the violation relates for up to 12 months; and (9)&#160;partial or full prohibition on personal data
processing activities. In addition, the LGPD creates a private cause of action, which means we are subject to both class-based and individual
claims for violations of the LGPD. The application of sanctions by the ANPD has been further regulated by the Regulations on the Application
of Administrative Sanctions, dated February 27, 2023, as a result of which the ANPD will now be able to apply administrative sanctions
based on clearer and more established guidelines and requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Data protection is an important issue for us.
We consider the LGPD as an opportunity to further develop and continuously improve our data protection processes. Since 2021, we have
been offering training on the LGPD on our e-learning platform to teach our employees the principles of data protection. This training
is mandatory for all employees, including our management. As part of this development and improvement process, we have also introduced
governance models and technical improvements to comply with legal requirements, reduce the risk of data breaches and guarantee the rights
of stakeholders with regard to their data security and privacy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">While we are in the process of putting in place
systems and processes to comply with the LGPD, we cannot assure you that our LGPD compliance efforts will be deemed appropriate or sufficient
by regulatory authorities, in particular ANPD, or by courts, such as the Brazilian Public Prosecution Office (<i>Minist&#233;rio P&#250;blico</i>).
Moreover, as the LGPD requires further regulation from the ANPD regarding several aspects of the law, which are yet unknown, we may have
difficulty adapting our systems and processes to the new legislation due to the legislation&#8217;s complexity. The changes have impacted,
and could further adversely impact, our business by increasing our operational and compliance costs.</p>


<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Any additional privacy laws, rules or regulations
enacted or approved in Brazil or in other jurisdictions in which we operate could cause us to incur costs to correct the breaches or failures,
expose us to uninsured liability, increase our risk of regulatory scrutiny, subject us to lawsuits and administrative procedures, and
result in the imposition of material penalties and fines under state and federal laws or regulations, which could seriously harm our business,
financial condition or results of operations. Any failure, real or perceived, by us to comply with our privacy policies or with any regulatory
requirements or orders or other local, state, federal or international privacy or consumer protection-related laws and regulations could
cause customers to reduce their purchases of our products and services and could materially and adversely affect our business.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We are subject to anti-corruption, anti-bribery
and anti-money laundering laws and regulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We operate in jurisdictions that have a high
risk for corruption and we are subject to various anti-corruption, anti-bribery and anti-money laundering laws and regulations, including
the Brazilian Federal Law No. 12,846/2013, also known as the Clean Company Act (and Decree No. 11,129/2022 that regulates the Clean Company
Act), Brazilian Federal Law No. 9,613/1998, as amended by Brazilian Federal Law No. 12,683/2012, and Brazilian Federal Law No. 8,429/1992,
as amended by Brazilian Federal Law No. 14,230/2022, in addition to the United States Foreign Corrupt Practices Act of 1977, as amended,
or the FCPA. Both the Clean Company Act and the FCPA impose liability against companies who engage in bribery of government officials,
either directly or through intermediaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Anti-corruption laws are interpreted broadly
and prohibit us and our collaborators from authorizing, offering, or directly or indirectly providing improper payments or benefits to
recipients in the public or private sector. Although we strongly condemn the practice of corruption and bribery by promoting a culture
of ethics and through our integrity program, we or our collaborators may have direct and indirect interactions with government agencies
and state-affiliated entities and universities in the course of our business. We use third-party collaborators, and strategic partners,
law firms, and other representatives for regulatory compliance, patent registration, deregulation advocacy, field testing, and other purposes.
We can be held liable for the corrupt or other illegal activities of these third-party collaborators, our employees, representatives,
contractors, partners, and agents, even if we do not explicitly authorize such activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Anti-money laundering, anti-bribery, anti-corruption
and sanctions laws and regulations to which we are subject require us, among other things, to conduct full customer due diligence (including
sanctions and politically exposed person screening) and to keep our customer, account and transaction information up to date. We have
implemented and are in the process of reviewing our policies and procedures detailing what is required from those responsible, but all
such policies may not be completed or may not be fully in effect as of the date of this annual report (in particular, our policies relating
to sanctions laws and regulations). In addition, we rely heavily on our employees to assist us by spotting such illegal and improper activities
and reporting them, and our employees have varying degrees of experience in recognizing criminal tactics and understanding the level of
sophistication of criminal organizations. In addition, we rely upon our relevant counterparties to a large degree to maintain and appropriately
apply their own appropriate compliance measures, procedures and internal policies. Accordingly, there can be no assurance that all of
our employees, representatives, contractors, partners, or agents will comply with these laws at all times. If we are unable to apply the
necessary scrutiny and oversight of employees, third parties to whom we outsource certain tasks and processes or counterparties, we increase
the risk of regulatory breach.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Violations of &#8211; or even accusations of
or associations with violations of &#8211; anti-corruption, anti-bribery and anti-money laundering laws and regulations could result in
criminal liability, administrative and civil lawsuits, significant fines and penalties (including being added to &#8220;black lists&#8221;
that would prohibit certain parties from engaging in transactions with us), forfeiture of significant assets and reputational harm. Non-compliance
with these laws could subject us to whistleblower complaints, investigations, sanctions, settlements, prosecution, injunctions, suspension
and debarment from contracting with certain governments or other persons, the loss of export privileges, reputational harm, adverse media
coverage, and other collateral consequences. If any subpoenas or investigations are launched, or governmental or other sanctions are imposed,
or if we do not prevail in any possible civil or criminal litigation, our business, results of operations, and financial condition could
be materially harmed. In addition, responding to any action will likely result in a materially significant diversion of management&#8217;s
attention and resources and significant defense costs and other professional fees. Enforcement actions and sanctions could further harm
our reputation, business, results of operations, and financial condition.</p>


<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If any person in the Cayman Islands knows or
suspects, or has reasonable grounds for knowing or suspecting that another person is engaged in criminal conduct or money laundering,
or is involved with terrorism or terrorist financing and property, and the information for that knowledge or suspicion came to their attention
in the course of business in the regulated section, or other trade, profession, business or employment, the person will be required to
report such knowledge or suspicion to (i)&#160;the Financial Reporting Authority of the Cayman Islands, or the FRA, pursuant to the Proceeds
of Crime Act (As Revised) of the Cayman Islands, if the disclosure relates to criminal conduct or money laundering, or (ii)&#160;a police
officer of the rank of constable or higher, or the FRA, pursuant to the Terrorism Act (As Revised) of the Cayman Islands, if the disclosure
relates to involvement with terrorism or terrorist financing and property. Such report shall not be treated as a breach of confidence
or of any restriction upon the disclosure of information imposed by any enactment or otherwise.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">If we fail to maintain effective internal controls
over financial reporting, we may be unable to accurately report our results of operations, meet our reporting obligations or prevent fraud.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Disclosure controls and procedures over financial
reporting are designed to provide reasonable assurance that information required to be disclosed by the Company is accumulated and communicated
to management, and recorded, processed, summarized and reported in accordance with applicable rules. These disclosure controls and procedures
have inherent limitations which include the possibility that judgments in decision-making can be faulty and that breakdowns occur because
of errors or mistakes. Additionally, controls can be circumvented by any unauthorized management override of controls. Consequently, our
businesses are exposed to risk from potential noncompliance with policies, employee misconduct or negligence and fraud, which could result
in regulatory sanctions, civil claims and serious reputational or financial harm. It is not always possible to deter employee misconduct
and the precautions we take to prevent and detect this activity may not always be effective. Finally, we may also not be able to adapt
the disclosure and internal controls environment of companies that we acquire within the permitted one-year period. Accordingly, because
of the inherent limitations in the internal control system, misstatements due to error or fraud may occur and not be detected. For details
of the controls mentioned above, see the section of this annual report entitled &#8220;Item 15. Controls and Procedures&#8212;B. Management&#8217;s
Annual Report on Internal Control Over Financial Reporting.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We cannot assure that significant deficiencies
or material weaknesses in our internal control over financial reporting will not be identified in the future. In addition, if we fail
to maintain the adequacy of our internal control over financial reporting, as the laws, regulations and policies standards are modified,
supplemented or amended from time to time, we may not be able to conclude on an ongoing basis that we have effective internal control
over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act of 2002. If we fail to maintain an effective internal
control environment, we could suffer material misstatements in our financial statements, fail to meet our reporting obligations or fail
to prevent fraud, which would likely cause investors to lose confidence in our reported financial information, the trading price of our
Class A common shares could decline, and we could be subject to sanctions or investigations by NASDAQ, the SEC or other regulatory authorities.
Failure to remedy any future material weakness in our internal controls over financial reporting, or to implement or maintain other effective
control systems required of public companies in the United States, could also restrict our future access to capital markets and reduce
or eliminate the trading market for our Class A common shares.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We may be adversely affected by the ongoing armed
conflicts between Russia and Ukraine and Israel and Hamas.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a result of the current geopolitical tensions
and conflict between Russia and Ukraine, and the recognition by Russia of the independence of the self-proclaimed republics of Donetsk
and Luhansk in the Donbas region of Ukraine, the governments of the United States, the European Union, Japan and other jurisdictions have
recently announced the imposition of sanctions on certain industry sectors and parties in Russia, Belarus and the regions of Donetsk and
Luhansk, as well as enhanced export controls on certain products and industries. These and any additional sanctions and export controls,
as well as any counter responses by the governments of Russia or other jurisdictions, could adversely affect, directly or indirectly,
the global supply chain, with negative implications on the availability of raw materials, energy prices, and our customers, as well as
the local and global financial markets and financial services industry and the global economy in general.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, on October 7, 2023, Hamas launched
an attack on Israel targeting Israeli civilians. In response, Israel declared war against Hamas, attacking Hamas targets in Gaza and
the region. The war is causing a humanitarian crisis and the escalation of the conflict and any resulting conflicts in the region could
lead to higher oil and gas prices, the imposition of sanctions, travel and import/export restrictions, increased inflationary pressures
and market volatility, among other potential consequences. In response to the war in Gaza, since mid-November 2023, Houthi rebels in
Yemen have targeted and carried out attacks on commercial shipping vessels travelling through the Red Sea which may result in further
disruptions in supply chains. It is unclear whether these challenges and uncertainties will be contained or resolved, and what effects
they may have on the global political and economic conditions in the long term.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Climate change can create transition risks, physical
risks and other risks that could adversely affect us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Climate risk is a transversal risk that can
be an aggravating factor for the types of traditional risks that we manage in the ordinary course of business, including, without limitation,
the risks described in this &#8220;Risk Factors&#8221; section. Based on the classifications used by the Taskforce on Climate-Related
Financial Disclosures, we consider that there are two primary sources of climate change-related financial risks: physical and transition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Physical risks resulting from climate change
can be event-driven (acute) or long-term shifts (chronic) in climate patterns:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 36.75pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Acute physical risks include increased severity of extreme weather events, such as drought, hurricanes, or floods;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 36.75pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Chronic physical risks include changes in precipitation patterns and extreme variability in weather patterns, rising mean temperatures,
chronic heat waves or rising sea levels;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The main physical risks that can impact us
are acute physical risks that can disrupt our supply chain, or prevent our schools from operating normally.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Transition risks refer to actions to address
mitigation and adaptation requirements related to climate change, and they can fall into various categories such as market and technology
changes:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 36.75pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Market risk may manifest through shifts in supply and demand for certain commodities, products, and services, as climate-related risks
and opportunities are increasingly considered.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 36.75pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Technology risk arises from improvements or innovations to support the transition to a lower-carbon, energy-efficient economic system
that can have a significant impact on companies to the extent that new technology displaces old systems and disrupts some parts of the
existing economic system. One of our strategies to minimize our carbon footprint <span style="background-color: white">is to reduce the
number of physical pages we print as part our printed educational materials by making those educational materials available to students
digitally on our online platform.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Policy actions generally fall into two categories:
those that attempt to constrain actions that contribute to the adverse effects of climate change and those that seek to promote adaptation
to climate change. The risk associated with, and the financial impact of policy changes depend on the nature and timing of the policy
change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our schools may be adversely affected by increased
regulatory requirements going forward as a result of the increasing importance of environmental matters, which may indirectly affect our
business. This and other changes in regulations in Brazil and international markets may expose us to increased compliance costs, limit
our ability to pursue certain business opportunities and provide certain products and services, each of which could adversely affect our
business, financial condition, and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We may not be successful in meeting our environmental,
social and corporate governance, or ESG, commitments, which may have a material adverse effect on our business, financial condition, reputation
and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The market is increasingly concerned with
how companies assess and manage ESG risks to protect themselves and create opportunities to generate value. As part of this trend, we
have made certain ESG commitments, and we strive to maintain socially responsible business practices, including fostering social investments
and structuring programs to generate a positive social impact through in areas related to our business, such as employability, education
and culture. Failure to meet our ESG commitments or to pursue these socially responsible business practices, partially or at all, may
have a material adverse effect on our business, reputation, financial condition and results of operations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">There has been an increase in ESG rules and
regulations applicable to our business and we expect this tendency to continue. Given the pace of legislative developments in this area,
we may not be able to comply with the new regulations in their totality. We are also exposed to the risk that future ESG rules and regulations
may adversely affect our ability to conduct our business by requiring us to reduce the value of our assets or reduce their useful life,
facing increased compliance costs or taking other actions that may be adverse to us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our activities may also impact the lives and
socioeconomic dynamics of communities, especially those neighboring our campuses. These impacts may include truck, vehicle and pedestrian
traffic, construction, noise and environmental pollution, and the effects of lower-quality, free services that we may provide to such
communities. As a result, there may be stoppages in our operations by virtue of demonstrations in surrounding communities, as well. If
we do not establish an effective communication channel with such communities, we may face challenges in the operation of educational institutions
and project execution, which could jeopardize our reputation and impede the attainment of our strategic objectives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, our suppliers may engage in conduct
that violates human rights and for which we may be held liable in civil, labor, criminal and administrative proceedings, including for
damages and remediation costs. As a result, we may face difficulties in obtaining or maintaining operating licenses, and our reputation
may be negatively affected.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Our operations and projects are exposed to occupational
health and safety and accident risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are subject to laws and regulations governing
health and safety matters, protecting both members of the public and their employees and contractors. Some of the tasks undertaken by
our employees and contractors, including our maintenance employees, can be inherently dangerous and have the potential to result in serious
injury or death. Moreover, in the ordinary course of our business, we undertake complex construction, expansion and renovation projects
that may subject to our employees or contractors to the risk of harm. Any breach of these obligations, or serious accidents involving
our employees, contractors or members of the public could expose us to adverse regulatory consequences, including the forfeit or suspension
of operating licenses, potential litigation, claims for material financial compensation, reputational damage, fines or other legislative
sanction, all of which have the potential to impact the results of our operating entities and our ability to make distributions. In addition,
any insurance coverage that we may have obtained with respect to such obligations may not cover certain indemnifications we may be required
to pay, be insufficient to cover these types of claims, or may not cover certain acts or events.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Public health outbreaks, epidemics or pandemics
have adversely affected and may continue to adversely affect our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Public health outbreaks, epidemics or pandemics
could materially adversely impact our business. Such public health crises may negatively impact the global economy, disrupt supply chains,
and create significant volatility in global financial markets. For instance, the recent outbreak of COVID-19 pandemic led to interruptions
of our on-campus activities to varying degrees, with a significant portion of our nonpractical educational activities being temporarily
offered through our online platform (rather than on-site), and the calendar of our practical educational activities being rescheduled
to when authorities allowed on-campus activities to resume. The ultimate extent of any such epidemics, pandemics, outbreaks or other public
health crises on our business, financial condition and results of operations would depend on future developments, which are highly uncertain
and cannot be predicted with any certainty. Such developments could therefore have a material adverse effect on our business, financial
condition and results of operations, and it may also have the effect of heightening many of the other risks described in this &#8220;Risk
Factors&#8221; section.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Certain Risks Relating to Brazil</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">The Brazilian federal government has exercised,
and continues to exercise, significant influence over the Brazilian economy. This involvement as well as Brazil&#8217;s political and
economic conditions could harm us and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Brazilian federal government frequently
exercises significant influence over the Brazilian economy and occasionally makes significant changes in policy and regulations. The
Brazilian government&#8217;s actions to control inflation and other policies and regulations have often involved, among other measures,
increases or decreases in interest rates, changes in fiscal policies, wage and price controls, foreign exchange rate controls, blocking
access to bank accounts, currency devaluations, capital controls and import and export restrictions. We have no control over and cannot
predict what measures or policies the Brazilian government may take in the future. We and the market price of our securities may be harmed
by changes in Brazilian government policies, as well as general economic factors, including, without limitation:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>growth or downturn of the Brazilian economy;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>interest rates and monetary policies;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>exchange rates and currency fluctuations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>inflation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>liquidity of the domestic capital and lending markets;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>import and export controls;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>exchange controls and restrictions on remittances abroad and payments of dividends;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>modifications to laws and regulations according to political, social and economic interests;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>fiscal policy and changes in tax laws;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>economic, political and social instability, including general strikes and mass demonstrations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the regulatory framework governing the educational industry;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>labor and social security regulations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>energy and water shortages and rationing;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>commodity prices;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in demographics, in particular declining birth rates, which will result in a decrease in the number of enrolled students in
education in the future; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>other political, diplomatic, social and economic developments in or affecting Brazil.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Uncertainty over whether the Brazilian federal
government will implement reforms or changes in policy or regulation affecting these or other factors in the future may affect economic
performance and contribute to economic uncertainty in Brazil, which may have an adverse effect on our activities and consequently our
operating results, and may also adversely affect the trading price of our Class A common shares. Recent economic and political instability
has led to a negative perception of the Brazilian economy and higher volatility in the Brazilian securities markets, which also may adversely
affect us and our Class A common shares. See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;Significant Factors Affecting
Our Results of Operations&#8212;Brazilian Macroeconomic Environment.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Economic uncertainty and political instability
in Brazil may harm our business and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil&#8217;s political environment has historically
influenced, and continues to influence, the performance of the country&#8217;s economy. Political crises have affected and continue to
affect the confidence of investors and the general public, which have historically resulted in economic deceleration and heightened volatility
in the securities offered by companies with significant operations in Brazil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The recent economic instability in Brazil
has contributed to a decline in market confidence in the Brazilian economy as well as to a deteriorating political environment. In addition,
various ongoing investigations into allegations of money laundering and corruption being conducted by the Office of the Brazilian Federal
Prosecutor have negatively impacted the Brazilian economy and political environment. The potential outcome of these investigations is
uncertain, but they have already had an adverse impact on the image and reputation of the implicated companies, and on the general market
perception of the Brazilian economy. We cannot predict whether the ongoing investigations will result in further political and economic
instability, or if new allegations against government officials and/or executives of private companies will arise in the future.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, political demonstrations in Brazil
over the last few years have affected the development of the Brazilian economy and investors&#8217; perceptions of Brazil. For example,
street protests, which started in mid-2013 and continued through 2016, demonstrated the public&#8217;s dissatisfaction with the worsening
Brazilian economic condition (including an increase in inflation and fuel prices as well as rising unemployment), and the perception of
widespread corruption. Moreover, on October 30, 2022, Luis In&#225;cio Lula da Silva won the Brazilian presidential election and took
office on January 1, 2023. It is unclear if and for how long the political divisions that arose before the election will continue under
President Lula&#8217;s presidency and the effects that such divisions will have on his ability to govern Brazil and implement reforms.
Since the results of the presidential election were announced and as of the date of this annual report, certain groups formed by extreme
supporters of the defeated candidate have been organizing public demonstrations and protests against the electronic ballot boxes and the
existence of an alleged conspiracy against their candidate. Any attempts to contest or otherwise undermine the results of the election,
or other potential threats to the democratic system, may result in deterioration of the political environment and, as a consequence, affect
the confidence of investors and the general public. The continuation of any such political divisions may result in a congressional impasse,
political unrest, protests or strikes that materially adversely affect us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, uncertainties relating to the
implementation by the new Brazilian government of changes to monetary, fiscal and social security policy and related legislation (including
as a result of the 2024 municipal elections, the coming elections of the presidencies in the senate and the lower house in 2025, the relationship
between the executive, legislative and judiciary branches and the relationships among the leading political parties) may contribute to
economic instability. These uncertainties and new measures may increase the volatility of the Brazilian capital markets. Aa failure by
the Brazilian government to implement necessary reforms may result in diminished confidence in the Brazilian government&#8217;s budgetary
condition and fiscal stance, which could result in downgrades of Brazil&#8217;s sovereign foreign credit rating by credit rating agencies,
negatively impact Brazil&#8217;s economy, and lead to further depreciation of the <i>real</i> and an increase in inflation and interest
rates, which could adversely affect our business, financial condition and results of operations. Any of the above factors may harm the
Brazilian economy and, consequently, our business and the price of our Class A common shares.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Inflation and certain measures by the Brazilian
government to curb inflation have historically harmed the Brazilian economy and Brazilian capital markets, and high levels of inflation
in the future would harm our business and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In the past, Brazil has experienced extremely
high rates of inflation. Inflation and some of the measures taken by the Brazilian government in an attempt to curb inflation have had
significant negative effects on the Brazilian economy generally. Inflation, policies adopted to curb inflationary pressures and uncertainties
regarding possible future governmental intervention have contributed to economic uncertainty and heightened volatility in the Brazilian
capital markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">According to the National Consumer Price Index
(<i>&#205;ndice Nacional de Pre&#231;os ao Consumidor Amplo</i>, or IPCA), which is published by the Brazilian Institute for Geography
and Statistics (<i>Instituto Brasileiro de Geografia e Estat&#237;stica</i>, or IBGE), Brazilian inflation rates were 10.1%, 5.8%, and
4.6% as of December&#160;31, 2021, 2022, and 2023, respectively. Brazil may experience high levels of inflation in the future and inflationary
pressures may lead to the Brazilian government intervening in the economy and introducing policies that could harm our business and the
trading price of our Class&#160;A common shares. In the past, the Brazilian government&#8217;s interventions included the maintenance
of a restrictive monetary policy with high interest rates that restricted credit availability and reduced economic growth, causing volatility
in interest rates. For example, on March 17, 2021, the Monetary Policy Committee (<i>Comit&#234; de Pol&#237;tica Monet&#225;ria
do Banco Central do Brasil</i>), or COPOM, raised the official base interest rate (<i>Sistema Especial de Liquida&#231;&#227;o e Cust&#243;dia</i>)
or the SELIC rate, to 2.75% and further raised the SELIC rate to 3.50% on May 5, 2021, to 4.25% on June 16, 2021, to 5.25% on August 4,
2021, to 6.25% on September 22, 2021, to 7.75% on October 27, 2021, to 9.25% on December 8, 2021, to 10.75% on February 2, 2022, to 11.75%
on March 16, 2022, to 12.75% on May 4, 2022, to 13.25% on June 15, 2022 and to 13.75% on August 3, 2022. In 2023, COPOM reversed this
trend, decreasing the SELIC rate to 13.25% on August 3, 2023, to 12.75% on September 21, 2023, to 12.25% on November 3, 2023, to 11.75%
on December 14, 2023, to 11.25% on January 31, 2024 and to 10.75% on March 20, 2024. As of April 26, 2024, the SELIC rate was 10.75%.
Conversely, more lenient government and Central Bank policies and interest rate decreases have triggered and may continue to trigger increases
in inflation in the future, and, consequently, may lead to increased volatility and the need for sudden and significant interest rate
increases, which could negatively affect us and our financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Exchange rate instability may have adverse effects
on the Brazilian economy, us and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Brazilian currency has been historically
volatile and has been devalued frequently over the past three decades. Throughout this period, the Brazilian government has implemented
various economic plans and used various exchange rate policies, including sudden devaluations, periodic mini-devaluations (during which
the frequency of adjustments has ranged from daily to monthly), exchange controls, dual exchange rate markets and a floating exchange
rate system. Although long-term depreciation of the real is generally linked to the rate of inflation in Brazil, depreciation of the real
occurring over shorter periods of time has resulted in significant variations in the exchange rate between the real, the U.S. dollar and
other currencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The real/U.S. dollar exchange rate reported
by the Central Bank was R$5.196 per US$1.00 on December 31, 2020, which reflected a 22.4% depreciation in the real against the U.S. dollar
during 2020. The real/U.S. dollar exchange rate reported by the Central Bank was R$5.580 per US$1.00 on December 31, 2021, which reflected
a 7.3% depreciation in the real against the U.S. dollar during 2021. On December 31, 2022, the exchange rate of U.S. dollar as reported
by the Central Bank was R$5.218 per US$1.00, which reflected a 6.5% appreciation in the real against the U.S. dollar since December 31,
2021. The real/U.S. dollar exchange rate reported by the Central Bank was R$4.841 per US$1.00 on December 31, 2023, which reflected a
7.2% appreciation in the real against the U.S. dollar during 2023. As of April 24, 2024, the exchange rate for the sale of U.S. dollars
as reported by the Central Bank was R$5.159 per US$1.00, which reflected a depreciation of 6.6% in the real against the U.S. dollar since
December 31, 2023. There can be no assurance that the real will not again depreciate or appreciate against the U.S. dollar or other currencies
in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A devaluation of the <i>real</i> relative to
the U.S. dollar could create inflationary pressures in Brazil and cause the Brazilian government to, among other measures, increase interest
rates. Any depreciation of the <i>real</i> may generally restrict access to the international capital markets. It would also reduce the
U.S. dollar value of our results of operations. Restrictive macroeconomic policies could reduce the stability of the Brazilian economy
and harm our results of operations and profitability. In addition, domestic and international reactions to restrictive economic policies
could have a negative impact on the Brazilian economy. These policies and any reactions to them may harm us by curtailing access to foreign
financial markets and prompting further government intervention. A devaluation of the <i>real</i> relative to the U.S. dollar may also,
as in the context of the current economic slowdown, decrease consumer spending, increase deflationary pressures and reduce economic growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On the other hand, an appreciation of the real
relative to the U.S. dollar and other foreign currencies may deteriorate the Brazilian foreign exchange current accounts. Depending on
the circumstances, either devaluation or appreciation of the <i>real</i> relative to the U.S. dollar and other foreign currencies could
restrict the growth of the Brazilian economy, as well as our business, results of operations and profitability.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Infrastructure and workforce deficiency in Brazil
may impact economic growth and have a material adverse effect on us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our performance depends on the overall health
and growth of the Brazilian economy. Brazilian GDP growth has fluctuated over the past few years, with a contraction of 4.1% in 2020,
a growth of 4.6% in 2021, a growth of 3.0% in 2022, and a growth of 2.9% in 2023. Growth is limited by inadequate infrastructure, including
potential energy shortages and deficient transportation, logistics and telecommunication sectors, general strikes, the lack of a qualified
labor force, and the lack of private and public investments in these areas, which limit productivity and efficiency. Any of these factors
could lead to labor market volatility and generally impact income, purchasing power and consumption levels, which could limit growth and
ultimately have a material adverse effect on us.</p>


<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Developments and the perceptions of risks in
other countries, including other emerging markets, the United States and Europe, may harm the Brazilian economy and the price of our Class
A common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The market for securities offered by companies
with significant operations in Brazil is influenced by economic and market conditions in Brazil and, to varying degrees, market conditions
in other Latin American and emerging markets, as well as the United States, Europe and other countries. To the extent the conditions of
the global markets or economy deteriorate, including as a result of, among other things, the ongoing war between Russian and the Ukraine,
the business of companies with significant operations in Brazil may be harmed. The weakness in the global economy has been marked by,
among other adverse factors, lower levels of consumer and corporate confidence, decreased business investment and consumer spending, increased
unemployment, reduced income and asset values in many areas, reduction of China&#8217;s growth rate, currency volatility and limited availability
of credit and access to capital. Developments or economic conditions in other emerging market countries have at times significantly affected
the availability of credit to companies with significant operations in Brazil and resulted in considerable outflows of funds from Brazil,
decreasing the amount of foreign investments in Brazil. These developments, as well as potential crises and forms of political instability
arising therefrom or any other as of yet unforeseen development, may harm our business and the price of our Class&#160;A common shares.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Any further downgrading of Brazil&#8217;s credit
rating could reduce the trading price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We and the trading price of our Class A common
shares may be harmed by investors&#8217; perceptions of risks related to Brazil&#8217;s sovereign debt credit rating. Rating agencies
regularly evaluate Brazil and its sovereign credit ratings, which are based on a number of factors, including macroeconomic trends, fiscal
and budgetary conditions, indebtedness metrics and the perspective of changes in any of these factors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The rating agencies began to review Brazil&#8217;s
sovereign credit rating in September 2015. Subsequently, the three major rating agencies downgraded Brazil&#8217;s investment-grade status:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In 2015, Standard&#160;&amp; Poor&#8217;s initially downgraded Brazil&#8217;s credit rating from BBB-negative to BB-positive and subsequently
downgraded it again from BB-positive to BB, maintaining its negative outlook, citing a worse credit situation since the first downgrade.
On January&#160;11, 2018, Standard&#160;&amp; Poor&#8217;s further downgraded Brazil&#8217;s credit rating from BB to BB-negative, and
on December&#160;11, 2019, the agency affirmed the rating at BB- and revised the outlook on Brazil to positive. On April&#160;7, 2020,
the rating was reaffirmed as BB- with a stable outlook, reflecting uncertainties stemming from the coronavirus pandemic, along with how
extraordinary government spending would adversely affect the fiscal performance in 2020. <span style="background-color: white">On November
30, 2021 and June 15, 2022, Standard &amp; Poor&#8217;s further reaffirmed Brazil&#8217;s rating </span>at BB- with a stable outlook.
On December 19, 2023, the rating was upgraded to BB with a stable outlook, reflecting the rating agency&#8217;s expectation that Brazil
will make slow progress in addressing fiscal imbalances and that its still weak economic prospects, balanced by a strong external position
and monetary policy is helping to re-anchor inflation expectations.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In December 2015, Moody&#8217;s placed Brazil&#8217;s Baa3&#8217;s issue and bond ratings under review for downgrade and subsequently
downgraded the issue and bond ratings to below investment grade, at Ba2 with a negative outlook, citing the prospect of a further deterioration
in Brazil&#8217;s debt indicators, taking into account the low growth environment and the challenging political scenario. On April&#160;9,
2018, Moody&#8217;s revised the outlook to stable, reaffirming the Ba2 rating. In September 2020, Moody&#8217;s maintained Brazil&#8217;s
credit rating at Ba2 with a stable outlook. In May 2020, Moody&#8217;s confirmed Brazil&#8217;s long-term foreign currency sovereign credit
rating at Ba2 maintaining the stable outlook. On <span style="background-color: white">May 25, 2021, April 12, 2022 and October 20, 2023,
Moody&#8217;s further reaffirmed Brazil&#8217;s rating </span>at Ba2 with a stable outlook.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Fitch downgraded Brazil&#8217;s sovereign credit rating to BB-positive with a negative outlook, citing the rapid expansion of the
country&#8217;s budget deficit and the worse-than-expected recession. In February 2018, Fitch downgraded Brazil&#8217;s sovereign credit
rating again to BB-negative, citing, among other reasons, fiscal deficits, the increasing burden of public debt and an inability to implement
reforms that would structurally improve Brazil&#8217;s public finances. In November 2020, Fitch Ratings affirmed Brazil&#8217;s long-term
foreign currency sovereign credit rating at BB- with a negative outlook. On December 14, 2021, Fitch
further reaffirmed Brazil&#8217;s credit rating at BB-negative with a negative outlook. On July 14, 2022, while reaffirming Brazil&#8217;s
credit rating at BB-negative, Fitch changed its outlook on Brazil&#8217;s credit rating to a positive outlook. On
July 26, 2023, Fitch upgraded Brazil&#8217;s credit rating at BB and changed its outlook on Brazil&#8217;s credit rating to a stable outlook.</td></tr></table>


<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil&#8217;s sovereign credit rating is currently
rated below investment grade by the three main credit rating agencies. Consequently, the prices of securities offered by companies with
significant operations in Brazil have been negatively affected. A prolongation or worsening of the current Brazilian recession and continued
political uncertainty, among other factors, could lead to further ratings downgrades. Any further downgrade of Brazil&#8217;s sovereign
foreign credit ratings could heighten investors&#8217; perception of risk and, as a result, cause the trading price of our Class A common
shares to decline.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Certain Risks Relating to Our Class A Common Shares</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">An active trading market for our Class A common
shares may not be sustainable. If an active trading market is not maintained, investors may not be able to resell their shares and our
ability to raise capital in the future may be impaired.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Although our Class A common shares are listed
and being traded on the Nasdaq Global Select Market, an active trading market for our shares may not be maintained. If an active market
for our Class A common shares is not maintained, it may be difficult for you to sell shares without depressing the market price for the
shares or at all. An inactive trading market may also impair our ability to raise capital to continue to fund operations by selling shares
and may impair our ability to acquire other companies or technologies by using our shares as consideration. In addition to the risks described
above, the market price of our Class A common shares may be influenced by many factors, some of which are beyond our control, including:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>announcements by us or our competitors of significant contracts or acquisitions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>technological innovations by us or competitors;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the failure of financial analysts to cover our Class A common shares or changes in financial estimates by analysts;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>actual or anticipated variations in our operating results;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in financial estimates by financial analysts, or any failure by us to meet or exceed any of these estimates, or changes in
the recommendations of any financial analysts that elect to follow our Class A common shares or the shares of our competitors;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>future sales of our shares; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>investor perceptions of us and the industries in which we operate.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, the stock market in general has
experienced substantial price and volume fluctuations that have often been unrelated or disproportionate to the operating performance
of particular companies affected. These broad market and industry factors may materially harm the market price of our Class A common shares,
regardless of our operating performance. In the past, following periods of volatility in the market price of certain companies&#8217;
securities, securities class action litigation has been instituted against these companies. This litigation, if instituted against us,
could adversely affect our financial condition or results of operations. If a market is not maintained, the liquidity and price of our
Class A common shares could be seriously harmed.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">The concentration of ownership and voting power
in Bertelsmann, our controlling shareholder, limits your ability to influence corporate matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Bertelsmann, our controlling shareholder,
as of the date of this annual report, owns 66.4% of our outstanding Class B common shares, which, together with its ownership of 35.0%
of our outstanding Class A common shares, represent approximately 50.3% of our outstanding share capital and 63.4% of the voting power
of our outstanding share capital, and, together with the Esteves Family, controls all matters requiring shareholder approval. Our Class
B common shares are entitled to 10 votes per share and our Class A common shares, which are the common shares trading on NASDAQ, are
entitled to one vote per share. Our Class B common shares are convertible into an equivalent number of Class A common shares and generally
convert into Class A common shares upon transfer subject to limited exceptions. As a result, Bertelsmann and the Esteves Family will
control the outcome of all of our decisions at our shareholders&#8217; meetings, and Bertelsmann alone is able to elect a majority of
the members of our board of directors. The decisions of Bertelsmann and the Esteves Family on these matters may be contrary to your expectations
or preferences, and they may take actions that could be contrary to your interests. They are able to prevent any other shareholders,
including you, from blocking these actions. For further information regarding shareholdings in our company, see &#8220;Item 7. Major
Shareholders and Related Party Transactions&#8212;A. Major Shareholders.&#8221;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">So long as Bertelsmann and the Esteves Family
continue to beneficially own a sufficient number of Class B common shares, even if they beneficially own significantly less than 50% of
our outstanding share capital, acting together, they will be able to effectively control the outcome of all decisions at our shareholders&#8217;
meetings. For example, if our Class B common shares amounted to 15% of our outstanding common shares, beneficial owners of our Class B
common shares (consisting of the Esteves Family and Bertelsmann), would collectively control 63.8% of the voting power of our outstanding
common shares. If Bertelsmann sells or transfers any of its Class B common shares, they will generally convert automatically into Class
A common shares, subject to limited exceptions, such as transfers to affiliates, to trustees for the holder or its affiliates and certain
transfers to U.S. tax exempt organizations. The fact that any Class B common shares convert into Class A common shares if Bertelsmann
sells or transfers them means that Bertelsmann will in many situations continue to control a majority of the combined voting power of
our outstanding share capital, due to the voting rights of any Class B common shares that it will retain. However, if our Class B common
shares at any time represent less than 10% of the total number of shares in the capital of the Company outstanding, the Class B common
shares then outstanding will automatically convert into Class A common shares. For a description of our dual class equity structure, see
&#8220;Item 10. Additional Information&#8212;B. Memorandum and Articles of Association&#8212;Description of Share Capital.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Class A common shares eligible for future sale
may cause the market price of our Class A common shares to drop significantly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The market price of our Class A common shares
may decline as a result of sales of a large number of our Class A common shares in the market (including Class A common shares issuable
upon conversion of Class B common shares) or the perception that these sales may occur. These sales, or the possibility that these sales
may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, we have 47,920,068
Class A common shares and 45,802,763 Class B common shares outstanding, which, except as set forth below, are freely tradable without
restriction or further registration under the Securities Act by persons other than our affiliates within the meaning of Rule 144 of the
Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our shareholders or entities controlled by
them or their permitted transferees will be able to sell their shares in the public market from time to time without registering them,
subject to certain limitations on the timing, amount and method of those sales imposed by regulations promulgated by the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If any of our shareholders, the affiliated
entities controlled by them or their respective permitted transferees were to sell a large number of their shares, including common shares
issuable upon conversion of the Series A perpetual convertible preferred shares, the market price of our Class A common shares may decline
significantly. In addition, the perception in the public markets that sales by them might occur may also adversely affect the market price
of our Class A common shares.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Our Articles of Association contain anti-takeover
provisions that may discourage a third party from acquiring us and adversely affect the rights of holders of our Class A common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association contain certain
provisions that could limit the ability of others to acquire our control, including a provision that grants authority to our board of
directors to establish and issue from time to time one or more series of preferred shares without action by our shareholders and to determine,
with respect to any series of preferred shares, the terms and rights of that series. These provisions could have the effect of depriving
our shareholders of the opportunity to sell their shares at a premium over the prevailing market price by discouraging third parties from
seeking to obtain our control in a tender offer or similar transactions.</p>


<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">If securities or industry analysts publish inaccurate
or unfavorable research, about our business, the price of our Class A common shares and our trading volume could decline.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The trading market for our Class A common shares
will depend in part on the research and reports that securities or industry analysts publish about us, our business, our market or our
competitors. In the event one or more of the analysts who covers us downgrades us or releases negative publicity about our Class A common
shares, our share price would likely decline.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Further, as we are not required to publish
quarterly financial information, if we cease to publish that information, any analysts covering us may not have enough information to
compare us to our peers on a regular basis and may choose to cease coverage. If one or more of these analysts ceases to cover us or fails
to regularly publish reports on us, interest in our Class A common shares may decrease, which may cause our share price or trading volume
to decline.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">It is unlikely that we will declare any dividends
on our common shares in the foreseeable future and therefore, you must rely on price appreciation of our common shares for a return on
your investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We do not anticipate paying any dividends in
the foreseeable future. Instead, we intend to retain earnings, if any, to fund the operation of our business and future growth. Any decision
to declare and pay dividends in the future will be made at the discretion of our general meeting of shareholders, acting pursuant to a
proposal by our board of directors, or by our board, and will depend on, among other things, our results of operations, cash requirements,
financial condition, contractual restrictions (including under our outstanding Series A perpetual convertible preferred shares) and other
factors that our general meeting of shareholders or board of directors may deem relevant. Accordingly, investors will most likely have
to rely on sales of their common shares, which may increase or decrease in value, as the only way to realize cash from their investment.
As a result, capital appreciation in the price of our Class A common shares, if any, will be your only source of gain on an investment
in our Class A common shares. There is no guarantee that the price of our common shares will ever exceed the price that you pay.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Our Series A perpetual convertible preferred
shares have rights, preferences and privileges that are not held by, and are preferential to, the rights of our common shares, which could
adversely affect our liquidity and financial condition, and may result in the interests of the holders of our Series A perpetual convertible
preferred shares differing from those of our common shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Series A perpetual convertible preferred
shares ranks senior to our common shares with respect to dividend rights and rights on the distribution of assets on any voluntary or
involuntary liquidation, dissolution or winding up of our affairs. The holders of Series A perpetual convertible preferred shares have
the right to receive a liquidation preference entitling them to be paid out of our assets available for distribution to stockholders before
any payment may be made to holders of any other class or series of our share capital, an amount equal to the greater of (a) the sum of
the original liquidation preference plus all accrued but unpaid dividends or (b) the amount that such holder would have been entitled
to receive upon our liquidation, dissolution and winding up if all outstanding shares of such series of Series A perpetual convertible
preferred shares had been converted into common shares immediately prior to such liquidation, dissolution or winding up. In addition,
the holders of the Series A perpetual convertible preferred shares are entitled to a cumulative dividend at the rate of 6.5% per annum.
The holders of the Series A perpetual convertible preferred shares are also entitled to participate in dividends declared or paid on our
common shares on an as-converted basis. The holders of our Series A perpetual convertible preferred shares also have the right, subject
to certain exceptions, to require us to repurchase all or any portion of the Series A perpetual convertible preferred shares upon certain
change of control events at the repurchase price set forth in the applicable certificate of designations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">These dividend and share repurchase obligations
could impact our liquidity and reduce the amount of cash flows available for general corporate purposes. Our obligations to the holders
of the Series A perpetual convertible preferred shares could also limit our ability to obtain additional financing or increase our borrowing
costs, which could have an adverse effect on our financial condition. These preferential rights could also result in divergent interests
between the holders of shares of Series A perpetual convertible preferred shares and holders of our common shares.</p>


<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">The issuance of Series A perpetual convertible
preferred shares reduces the relative voting power of holders of our common stock, and the conversion and sale of those shares would dilute
the ownership of holders of common shares and may adversely affect the market price of our common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, 150,000 Series A perpetual
convertible preferred shares were outstanding, representing approximately 6.6% of our outstanding common shares, including the Series
A perpetual convertible preferred shares on an as-converted basis. Holders of Series A perpetual convertible preferred shares are entitled
to a cumulative dividend at the rate of 6.5% per annum. Because holders of our Series A perpetual convertible preferred shares are entitled
to vote on certain matters described in &#8220;&#8212;SoftBank and any other holders of our Series A perpetual convertible preferred shares
may exercise influence over us,&#8221; the issuance of the Series A perpetual convertible preferred shares, and the subsequent issuance
of additional Series A perpetual convertible preferred shares, effectively reduce the relative voting power of the holders of our common
shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, the conversion of the Series A
perpetual convertible preferred shares into common shares would dilute the ownership interest of existing holders of our common shares.
Furthermore, any sales in the public market of the common shares issuable upon conversion of the Series A perpetual convertible preferred
shares would increase the number of shares of our common shares available for public trading, and could adversely affect prevailing market
prices of our common shares. Sales of a substantial number of shares of our common shares in the public market, or the perception that
such sales might occur, could have a material adverse effect on the price of our common shares.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">SoftBank and any other holders of our Series
A perpetual convertible preferred shares may exercise influence over us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, outstanding Series
A perpetual convertible preferred shares represented approximately 6.6% of our outstanding common shares, including the Series A perpetual
convertible preferred shares on an as-converted basis. The terms of the Series A perpetual convertible preferred shares require the approval
of a majority of our Series A perpetual convertible preferred shares by a separate class vote for us to take the following decisions,
among others described in the respective certificate of designations:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>amend our organizational documents in a manner that would have an adverse effect on the Series A perpetual convertible preferred shares;
or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>issue securities that are senior to, or equal in priority with, the Series A perpetual convertible preferred shares.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Circumstances may occur in which the interests
of SoftBank and its affiliates could diverge from, or even conflict with, the interests of our other shareholders. For example, the existence
of SoftBank as a significant shareholder may have the effect of delaying or preventing changes in control or management or limiting the
ability of our other shareholders to approve transactions that they may deem to be in our best interests. SoftBank and its affiliates
may seek to cause us to take courses of action that, in their judgment, could enhance its investment in us but which might involve risks
to our other shareholders or adversely affect us or our other shareholders.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Our dual class equity structure means our shares
will not be included in certain indices. We cannot predict the impact this may have on our share price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In 2017, FTSE Russell, S&amp;P Dow Jones and
MSCI announced changes to their eligibility criteria for inclusion of shares of public companies on certain indices to exclude companies
with multiple classes of shares of common stock from being added to such indices. FTSE Russell announced plans to require new constituents
of its indices to have at least five percent of their voting rights in the hands of public stockholders, whereas S&amp;P Dow Jones announced
that companies with multiple share classes, such as ours, will not be eligible for inclusion in the S&amp;P 500, S&amp;P MidCap 400 and
S&amp;P SmallCap 600, which together make up the S&amp;P Composite 1500. MSCI also opened public consultations on their treatment of no-vote
and multi-class structures and temporarily barred new multi-class listings from its ACWI Investable Market Index and U.S. Investable Market
2500 Index; however, in October 2018, MSCI announced its decision to include equity securities &#8220;with unequal voting structures&#8221;
in its indices and to launch a new index that specifically includes voting rights in its eligibility criteria.</p>


<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We cannot assure you that other stock indices
will not take a similar approach to FTSE Russell, S&amp;P Dow Jones and MSCI in the future. Under the announced policies, our dual class
equity structure would make us ineligible for inclusion in any of these indices and, as a result, mutual funds, exchange-traded funds
and other investment vehicles that attempt to passively track these indices will not invest in our stock. It continues to be somewhat
unclear what effect, if any, these policies will have on the valuations of publicly traded companies excluded from the indices, but in
certain situations they may depress these valuations compared to those of other similar companies that are included. Exclusion from indices
could make our Class A common shares less attractive to investors and, as a result, the market price of our Class A common shares could
be adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">The dual class equity structure of our common
stock has the effect of concentrating voting control with Bertelsmann; this will limit or preclude your ability to influence corporate
matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Each Class A common share entitles its holder
to one vote per share, and each Class B common share entitles its holder to 10 votes per share, so long as the total number of the issued
and outstanding Class B common shares is at least 10% of the total number of shares outstanding. Due to the 10-to-one voting ratio between
our Class B and Class A common shares, the beneficial owners of our Class B common shares (composed of the Esteves Family and Bertelsmann)
collectively will continue to control a majority of the combined voting power of our common shares and therefore be able to control all
matters submitted to our shareholders so long as the total number of the issued and outstanding Class B common shares is at least 10%
of the total number of shares outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, our Articles of Association provide
that at any time when there are Class A common shares in issue, additional Class B common shares may only be issued pursuant to (1)&#160;a
share split, subdivision of shares or similar transaction or where a dividend or other distribution is paid by the issue of shares or
rights to acquire shares or following capitalization of profits, (2)&#160;a merger, consolidation, or other business combination involving
the issuance of Class B common shares as full or partial consideration, or (3)&#160;an issuance of Class A common shares, whereby holders
of the Class B common shares are entitled to purchase a number of Class B common shares that would allow them to maintain their proportional
ownership interests in Afya (following an offer by us to each holder of Class B common shares to issue to such holder, upon the same economic
terms and at the same price, such number of Class B common shares as would ensure such holder may maintain a proportional ownership interest
in Afya pursuant to our Articles of Association).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Future transfers by holders of Class B common
shares will generally result in those shares converting to Class A common shares, subject to limited exceptions, such as certain transfers
effected to permitted transferees or for estate planning or charitable purposes. The conversion of Class B common shares to Class A common
shares will have the effect, over time, of increasing the relative voting power of those holders of Class B common shares who retain their
shares in the long term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In light of the above provisions relating to
the issuance of additional Class B common shares, the fact that future transfers by holders of Class B common shares will generally result
in those shares converting to Class A common shares, subject to limited exceptions as provided in the Articles of Association; as well
as the 10-to-one voting ratio of our Class B common shares and Class A common shares, holders of our Class B common shares will in many
situations continue to maintain control of all matters requiring shareholder approval. This concentrated control will limit or preclude
your ability to influence corporate matters for the foreseeable future. For a description of our dual class equity structure, see &#8220;Item
10. Additional Information&#8212;B. Memorandum and Articles of Association&#8212;Description of Share Capital&#8212;Voting Rights.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We are a Cayman Islands exempted company with
limited liability. The rights of our shareholders, including with respect to fiduciary duties and corporate opportunities, may be different
from the rights of shareholders governed by the laws of U.S. jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are a Cayman Islands exempted company with
limited liability. Our corporate affairs are governed by our Articles of Association and by the laws of the Cayman Islands. The rights
of shareholders and the responsibilities of members of our board of directors may be different from the rights of shareholders and responsibilities
of directors in companies governed by the laws of U.S. jurisdictions. In particular, as a matter of Cayman Islands law, directors of a
Cayman Islands company owe fiduciary duties to the company and separately a duty of care, diligence and skill to the company.</p>


<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, directors and officers
owe the following fiduciary duties: (i)&#160;duty to act in good faith in what the director or officer believes to be in the best interests
of the company as a whole; (ii)&#160;duty to exercise powers for the purposes for which those powers were conferred and not for a collateral
purpose; (iii)&#160;directors should not improperly fetter the exercise of future discretion; (iv)&#160;duty to exercise powers fairly
as between different sections of shareholders; (v)&#160;duty to exercise independent judgment; and (vi)&#160;duty not to put themselves
in a position in which there is a conflict between their duty to the company and their personal interests. Our Articles of Association
have varied this last obligation by providing that a director must disclose the nature and extent of his or her interest in any contract
or arrangement, and following such disclosure and subject to any separate requirement under applicable law or the listing rules of the
Nasdaq, and unless disqualified by the chairman of the relevant meeting, such director may vote in respect of any transaction or arrangement
in which he or she is interested and may be counted in the quorum at the meeting. Conversely, under Delaware corporate law, a director
has a fiduciary duty to the corporation and its stockholders (made up of two components) and the director&#8217;s duties prohibit self-dealing
by a director and mandate that the best interest of the corporation and its shareholders take precedence over any interest possessed by
a director, officer or controlling shareholder and not shared by the shareholders generally. See &#8220;Item 10. Additional Information&#8212;B.
Memorandum and Articles of Association&#8212;Description of Share Capital&#8212;Principal Differences between Cayman Islands and U.S.
Corporate Law.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We may need to raise additional capital in the
future by issuing securities, use our Class A common shares as acquisition consideration or enter into corporate transactions with an
effect similar to a merger, which may dilute your interest in our share capital and affect the trading price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We may need to raise additional funds to grow
our business and implement our growth strategy going forward through public or private issuances of common shares or securities convertible
into, or exchangeable for, our common shares, which may dilute your interest in our share capital or result in a decrease in the market
price of our common shares. In addition, we may also use our Class A common shares as acquisition consideration or enter into mergers
or other similar transactions in the future, which may dilute your interest in our share capital or result in a decrease in the market
price of our Class A common shares. Any fundraising through the issuance of shares or securities convertible into or exchangeable for
shares, the use of our Class A common shares as acquisition consideration, or the participation in corporate transactions with an effect
similar to a merger, may dilute your interest in our capital stock or result in a decrease in the market price of our Class A common shares.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">As a foreign private issuer, we have different
disclosure and other requirements than U.S. domestic registrants and non-emerging growth companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a foreign private issuer, we are subject
to different disclosure and other requirements than domestic U.S. registrants. For example, as a foreign private issuer, in the United
States, we are not subject to the same disclosure requirements as a domestic U.S. registrant under the Exchange Act, including the requirements
to prepare and issue quarterly reports on Form 10-Q or to file current reports on Form 8-K upon the occurrence of specified significant
events, the proxy rules applicable to domestic U.S. registrants under Section 14 of the Exchange Act or the insider reporting and short-swing
profit rules applicable to domestic U.S. registrants under Section 16 of the Exchange Act. In addition, we rely on exemptions from certain
U.S. rules which permit us to follow Cayman Islands legal requirements rather than certain of the requirements that are applicable to
U.S. domestic registrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We follow Cayman Islands laws and regulations
that are applicable to Cayman Islands companies. However, Cayman Islands laws and regulations applicable to Cayman Islands companies do
not contain any provisions comparable to the U.S. proxy rules, the U.S. rules relating to the filing of reports on Form 10-Q or 8-K or
the U.S. rules relating to liability for insiders who profit from trades made in a short period of time, as referred to above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Furthermore, foreign private issuers are required
to file their annual report on Form 20-F within 120 days after the end of each fiscal year, while U.S. domestic issuers that are accelerated
filers are required to file their annual report on Form 10-K within 75 days after the end of each fiscal year. Foreign private issuers
are also exempt from Regulation Fair Disclosure, aimed at preventing issuers from making selective disclosures of material information,
although we will be subject to Cayman Islands laws and regulations having substantially the same effect as Regulation Fair Disclosure.
As a result of the above, even though we are required to file reports on Form 6-K disclosing the limited information which we have made
or are required to make public pursuant to Cayman Islands law, or are required to distribute to shareholders generally, and that is material
to us, you may not receive information of the same type or amount that is required to be disclosed to shareholders of a U.S. company.</p>


<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">As a foreign private issuer, we rely on permitted
exemptions from certain Nasdaq corporate governance standards applicable to U.S. issuers, including the requirement that a majority of
an issuer&#8217;s directors consist of independent directors. This may afford less protection to holders of our Class A common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Section 5605 of the Nasdaq equity rules requires
listed companies to have, among other things, a majority of their board members be independent, and to have independent director oversight
of executive compensation, nomination of directors and corporate governance matters. As a foreign private issuer, however, we are permitted
to, and we will, follow home country practice in lieu of the above requirements. See &#8220;Item 10. Additional Information&#8212;B. Memorandum
and Articles of Association&#8212;Description of Share Capital&#8212;Principal Differences between Cayman Islands and U.S. Corporate Law.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">We may lose our foreign private issuer status,
which would then require us to comply with the Exchange Act&#8217;s domestic reporting regime and cause us to incur significant legal,
accounting and other expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In order to maintain our current status as
a foreign private issuer, either (a)&#160;more than 50% of our Class A common shares must be either directly or indirectly owned of record
by non-residents of the United States or (b)(i)&#160;a majority of our executive officers or directors may not be U.S. citizens or residents,
(ii)&#160;more than 50% of our assets cannot be located in the United States and (iii)&#160;our business must be administered principally
outside the United States. If we lose this status, we would be required to comply with the Exchange Act reporting and other requirements
applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We may also
be required to make changes in our corporate governance practices in accordance with various SEC and Nasdaq rules. The regulatory and
compliance costs to us under U.S. securities laws if we are required to comply with the reporting requirements applicable to a U.S. domestic
issuer may be significantly higher than the costs we will incur as a foreign private issuer.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Our shareholders may face difficulties in protecting
their interests because we are a Cayman Islands exempted company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our corporate affairs are governed by our Articles
of Association, by the Companies Act (As Revised) of the Cayman Islands and the common law of the Cayman Islands. The rights of shareholders
to take action against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors to us under
Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived
in part from comparatively limited judicial precedent in the Cayman Islands as well as that from English common law, which has persuasive,
but not binding, authority on a court in the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our
directors under Cayman Islands law are not as clearly established as they would be under statutes or judicial precedent in some jurisdictions
in the United States. In particular, the Cayman Islands has a less exhaustive body of securities laws than the United States. In addition,
some U.S. states, such as Delaware, have more fulsome and judicially interpreted bodies of corporate law than the Cayman Islands.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a result of all of the above, public shareholders
may have more difficulty in protecting their interests in the face of actions taken by management, members of the board of directors or
controlling shareholders than they would as shareholders of a corporation incorporated in a jurisdiction in the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">While Cayman Islands law allows a dissenting
shareholder to express the shareholder&#8217;s view that a court-sanctioned reorganization (by way of a scheme of arrangement) of a Cayman
Islands company would not provide fair value for the shareholder&#8217;s shares, Cayman Islands statutory law does not specifically provide
for shareholder appraisal rights in connection with a court sanctioned reorganization (by way of a scheme of arrangement). This may make
it more difficult for you to assess the value of any consideration you may receive in a merger or consolidation (by way of a scheme of
arrangement) or to require that the acquirer gives you additional consideration if you believe the consideration offered is insufficient.
However, Cayman Islands statutory law provides a mechanism for a dissenting shareholder in a statutory merger or consolidation to apply
to the Grand Court of the Cayman Islands for a determination of the fair value of the dissenter&#8217;s shares if it is not possible for
the company and the dissenter to agree on a fair price within the time limits prescribed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Shareholders of Cayman Islands exempted companies
(such as us) have no general rights under Cayman Islands law to inspect corporate records and accounts or to obtain copies of lists of
shareholders. Our directors have discretion under our Articles of Association to determine whether or not, and under what conditions,
our corporate records may be inspected by our shareholders, but are not obliged to make them available to our shareholders. This may
make it more difficult for you to obtain information needed to establish any facts necessary for a shareholder motion or to solicit proxies
from other shareholders in connection with a proxy contest.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">United States civil liabilities and certain judgments
obtained against us by our shareholders may not be enforceable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are a Cayman Islands exempted company and
substantially all of our assets are located outside of the United States. In addition, the majority of our directors and officers are
nationals and residents of countries other than the United States. A substantial portion of the assets of these persons is located outside
of the United States. As a result, it may be difficult to effect service of process within the United States upon these persons. It may
also be difficult to enforce in U.S. courts judgments obtained in U.S. courts based on the civil liability provisions of the U.S. federal
securities laws against us and our officers and directors who are not resident in the United States and the substantial majority of whose
assets are located outside of the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Further, it is unclear if original actions
predicated on civil liabilities based solely upon U.S. federal securities laws are enforceable in courts outside the United States, including
in the Cayman Islands and Brazil. Courts of the Cayman Islands may not, in an original action in the Cayman Islands, recognize or enforce
judgments of U.S. courts predicated upon the civil liability provisions of the securities laws of the United States or any state of the
United States on the grounds that such provisions are penal in nature. Although there is no statutory enforcement in the Cayman Islands
of judgments obtained in the United States, courts of the Cayman Islands will recognize and enforce a foreign judgment of a court of competent
jurisdiction if such judgment is final, for a liquidated sum, provided it is not in respect of taxes or a fine or penalty, is not inconsistent
with a Cayman Islands&#8217; judgment in respect of the same matters, and was not obtained in a manner which is contrary to the public
policy of the Cayman Islands. In addition, a Cayman Islands court may stay proceedings if concurrent proceedings are being brought elsewhere.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Judgments of Brazilian courts to enforce our
obligations with respect to our Class A common shares may be payable only in <span style="font-style: normal">reais</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Most of our assets are located in Brazil. If
proceedings are brought in the courts of Brazil seeking to enforce our obligations in respect of our Class A common shares, we may not
be required to discharge our obligations in a currency other than the <i>real.</i> Under Brazilian exchange control laws, an obligation
in Brazil to pay amounts denominated in a currency other than the <i>real </i>may only be satisfied in Brazilian currency at the exchange
rate, as determined by the Central Bank, in effect on the date the judgment is obtained, and such amounts are then adjusted to reflect
exchange rate variations through the effective payment date. The then-prevailing exchange rate may not afford non-Brazilian investors
with full compensation for any claim arising out of or related to our obligations under the Class A common shares.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Our Class A common shares may not be a suitable
investment for all investors, as an investment in our Class A common shares presents risks and the possibility of financial losses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The investment in our Class A common shares
is subject to risks. Investors who wish to invest in our Class A common shares are thus subject to asset losses, including loss of the
entire value of their investment, as well as other risks, including those related to our Class A common shares, us, the sector in which
we operate, our shareholders and the general macroeconomic environment in Brazil, among other risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Each potential investor in our Class A common
shares must therefore determine the suitability of that investment in light of its own circumstances. In particular, each potential investor
should:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>have sufficient knowledge and experience to make a meaningful evaluation of our Class A common shares, the merits and risks of investing
in our Class A common shares and the information contained in this annual report;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>have access to, and knowledge of, appropriate analytical tools to evaluate, in the context of its particular financial situation,
an investment in our Class A common shares and the impact our Class A common shares will have on its overall investment portfolio;</td></tr></table>


<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>have sufficient financial resources and liquidity to bear all of the risks of an investment in our Class A common shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>understand thoroughly the terms of our Class A common shares and be familiar with the behavior of any relevant indices and financial
markets; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>be able to evaluate (either alone or with the help of a financial adviser) possible scenarios for economic, interest rate and other
factors that may affect its investment and its ability to bear the applicable risks.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">There can be no assurance that we will not be
a passive foreign investment company, or PFIC, for any taxable year, which could subject United States investors in our Class A common
shares to significant adverse U.S. federal income tax consequences.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Internal Revenue Code of 1986, as
amended (the &#8220;Code&#8221;), we will be a PFIC for any taxable year in which, after the application of certain look-through rules
with respect to subsidiaries, either (i) 75% or more of our gross income consists of &#8220;passive income,&#8221; or (ii) 50% or more
of the average quarterly value of our assets consists of assets that produce, or are held for the production of, &#8220;passive income.&#8221;
Passive income generally includes dividends, interest, certain non-active rents and royalties, and capital gains. Cash is generally a
passive asset for these purposes. Goodwill is an active asset to the extent attributable to activities that produce active income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Based on the composition of our income and
assets and the value of our assets, including goodwill (the implied value of which we estimate based on the price of our Class A common
shares), we believe that we were not a PFIC for the taxable year of 2023. However, because we hold a substantial amount of cash (relative
to the assets shown on our balance sheet) and because our PFIC status for any taxable year will depend on the composition of our income
and assets and the value of our assets from time to time (which may be determined, in part, by reference to the market price of our Class
A common shares, which could be volatile), there can be no assurance that we will not be a PFIC for any taxable year. If our Class A common
share price declines while we continue to hold a substantial amount of cash for any taxable year, our risk of being or becoming a PFIC
will increase. In addition, as we continue to expand our business through acquisitions and organically, our risk of becoming a PFIC will
increase if we engage in activities that generate substantial passive income. Moreover, the extent to which our goodwill will be treated
as an active asset is not entirely clear. If we are a PFIC for any taxable year during which a U.S. investor holds Class A common shares,
we generally will continue to be treated as a PFIC with respect to that U.S. investor for all succeeding years during which the U.S. investor
holds Class A common shares, even if we ceased to meet the threshold requirement for PFIC status. Such a U.S. investor may be subject
to certain adverse U.S. federal income tax consequences. See &#8220;Item 10. Additional Information&#8212;10.E. Taxation&#8212;U.S. Federal
Income Tax Considerations&#8212;Passive Foreign Investment Company Rules.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_010"></span>ITEM 4. INFORMATION ON THE COMPANY</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_011"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;History and Development
of the Company</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya Limited is a publicly held company listed
on the Nasdaq since July 2019, and therefore subject to certain reporting requirements of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We were incorporated on March 22, 2019 as a
Cayman Islands exempted company with limited liability duly registered with the Cayman Islands Registrar of Companies. Our corporate purposes
are unrestricted and we have the authority to carry out any object not prohibited by law as provided by Section 7(4) of the Companies
Act (As Revised) of the Cayman Islands, or the Companies Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our affairs are governed principally by (i)&#160;our
Amended and Restated Memorandum and Articles of Association; (ii)&#160;the Companies Act; and (iii)&#160;the common law of the Cayman
Islands. As provided in our Amended and Restated Memorandum and Articles of Association, subject to Cayman Islands law, we have full capacity
to carry on or undertake any business or activity, do any act or enter into any transaction, and, for such purposes, full rights, powers
and privileges. Our registered office is c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman
Islands.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The SEC maintains an internet site (http://www.sec.gov)
that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.</p>


<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our internet address is https://ir.afya.com.br/.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Our History</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center"><img src="image_023.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We founded Afya Brazil with the goal of revolutionizing
medical education in Brazil by providing a more effective, individualized and intuitive learning experience. In order to achieve that,
we have assembled institutions that collectively will help us fulfill our mission. The combination of Afya Brazil, one of the largest
Brazilian medical education groups, and Medcel, one of the leaders in residency exams preparatory courses, was the first step toward achieving
our goal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya benefits from over 24 years of medical
education experience through Afya Brazil and Medcel, both of which were founded and managed by physicians, with a focus on academic excellence
and deep roots in technology and innovation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We were founded in 1999 with the opening of
our first medical school, Centro Universit&#225;rio ITPAC, by the Esteves Family, a family of medical professionals with a passion for
medical education. Since its inception, our focus has been medical and related health courses. As of December 31, 2023, 20,201 physicians
had graduated with us since the founding of our predecessor companies. Over the last decade, Afya Brazil grew into a large medical education
group, with several campuses and as of December 31, 2023, had 66,034 undergrad students, of which 42,563 were health-related students
and 23,471 were non-health related students.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Medcel, which was merged into Afya Brazil in
2019, was founded by Dr. Atilio Barbosa in 2004, a pioneer in online medical preparatory courses. In 2007, Medcel launched a proprietary
platform to broadcast online classes. Over the years, Medcel evolved from its online platform into an adaptive digital learning environment
where students can access digital media, watch medical case studies, listen to podcasts and answer personalized quizzes. Finally, in 2018,
Medcel began offering its high-quality tech-enabled content in different formats and to other academic institutions. As of December 31,
2023, Medcel had 7,563 enrolled students and provided residency preparatory courses to 17 partner institutions, as part of our B2B distribution
network.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In 2016, the private equity group Crescera
Investimentos (formerly Bozano Investimentos) joined forces with Afya Brazil and Medcel, laying out the foundations for the creation of
the largest medical education group in Brazil. Crescera has since sold its interest in Afya to Bertelsmann. See &#8220;&#8212; Acquisition
of Crescera Shares by Bertelsmann&#8221; below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The industry expertise of the founders of Afya
Brazil and Medcel combined with the governance and financial support of Crescera Investimentos allowed the group to dive deeper into its
mission as a thematic educational service provider focused on the lifelong learning career of physicians in Brazil. We achieve this through
the production and distribution of high-quality content through technology.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In order to achieve our goals, we have laid
the foundations of Afya focusing on a four-step process:</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Management Professionalization</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our highly skilled and experienced management
team has extensive experience in the education industry and were hired from some of the best health, education and technology institutions
in Brazil. Our management team is part of a company-wide strategy to attract and retain the best talent. Our CEO, Virgilio Deloy Capobianco
Gibbon, has over 15 years of experience in education. Our CFO, Luis Andr&#233; Blanco, has over 14 years of experience as CFO, and
L&#233;lio de Souza Junior, our Vice President of Innovation &amp; Digital Services, has more than 24 years of experience in tech companies.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 51 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Integration of Processes &amp; Services</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In order to create synergies, we have developed
several initiatives to improve operational efficiency and to integrate processes across all our campuses and operations. Our high standard
Shared Services Center and Integrated Systems (ERP + Academic System + Learning Management System) went live in October 2017. These initiatives
will help us grow our student base and keep our marginal costs low.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In 2017, we began to roll out the integration
of the educational curriculum throughout all medical school units. This rollout begins with the new entrants curriculum and will be fully
completed as the course matures its students. Accordingly, we have been streamlining the teaching methodology and quality across our undergraduate
medical courses. Since the second half of 2019, all undergraduate medical students have access to our fully integrated Educational Curriculum.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Continuing Innovation</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We take a blended approach to our methodology,
integrating in-person teaching with online tools and features. By integrating face-to-face and online features through data collection
and analysis, we are able to individualize the student experience at all times. Through seven key initiatives, we create a 100% student-centric
ecosystem. These initiatives include: Medical content mapping, proprietary methodological assembly, significant learning experiences,
comprehensive adaptive learning, daily learning process evaluation, and practical learning and knowledge.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Organic Growth and Entry into Adjacent Markets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In 2018, the MEC awarded new licenses to Afya
Brazil, allowing it, subject to the verification by the MEC of the satisfactory implementation by Afya Brazil of all regulatory requirements,
to operate seven new medical schools through the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, with an aggregate amount of 350 new
medical school seats per year. As of December 31, 2023, six of these campuses are already operating, as described below. We expect an
additional campus to start operations in 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On May 9, 2019, we consummated the acquisition
of IPEMED, marking our entry into the medical graduate and specialization segment. IPEMED is a leading medical graduate school founded
in 2006. As of December 31, 2023, we reached almost 5,000 students across fifteen different campuses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On October 2, 2020, we announced that the Secretary
of Regulation and Supervision of Higher Education of the MEC granted authorization to Afya to operate the undergraduate medicine course
in Santa In&#234;s in the State of Maranh&#227;o, under the &#8220;<i>Mais M&#233;dicos II</i>&#8221; program. This medical school
was the first authorized in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program for Afya and contributed 50 seats to
our operating seats base. Santa In&#234;s is one of the seven undergraduate campuses Afya was awarded in 2018 in connection with the
&#8220;<i>Mais M&#233;dicos</i>&#8221; program, the largest number awarded to any education group. This campus has been operational
since October 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On December 30, 2020, the Secretary of Regulation
and Supervision of Higher Education of the MEC granted the authorization to Afya operate the undergraduate medicine course in Cruzeiro
do Sul in the State of Acre, under &#8220;<i>Mais M&#233;dicos II</i>&#8221; program. This medical school is the second authorized school
in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program for Afya and contributed 50 seats to our operating seats base.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On February 23, 2022, we announced that the
Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (&#8220;MEC&#8221;) authorized the operations
of the medical schools in Abaetutuba, in the State of Par&#225;, and Itacoatiara, in the State of Amazonas, both under the &#8220;<i>Mais
M&#233;dicos II</i>&#8221; program. With the authorizations, Afya reaches its third and fourth authorized schools to start operating
under the <i>Mais Medicos II</i> program. Each medical school contributed with 50 seats. These campuses have been operational since February
2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On March 16, 2022, the Secretary of Regulation
and Supervision of Higher Education of MEC authorized the operation of medical schools in Bragan&#231;a, in the State of Par&#225;,
and Manacapuru, in the State of Amazonas, both under the &#8220;<i>Mais M&#233;dicos II</i>&#8221; program (our fifth and sixth authorized
schools under the <i>Mais Medicos II</i> program, respectively). Each medical school contributed with 50 seats. These campuses have been
operational since March 2022.</p>


<!-- Field: Page; Sequence: 52 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On March 18, 2022, the Secretary of Regulation
and Supervision of Higher Education of MEC authorized 28 seats additional at Centro Universit&#225;rio S&#227;o Lucas Ji-Parana in
the city of Ji-Parana, located in the state of Rond&#244;nia. With this authorization, we reached 2,759 approved seats. The earn-out
related to the seats approval is R$800,000 per seat, adjusted by the CDI rate from the closing until the payment date, of which 50% was
paid in April 2022 and the remaining amount is payable in cash by March 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On December 29, 2022, Afya announced that MEC
authorized the increase of 64 medical seats of Faculdade Santo Agostinho, in the city of Itabuna, located in the state of Bahia. No additional
commitment is required regarding this authorization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On January 24, 2024, Afya announced that MEC
authorized the increase of 40 medical seats at the Faculdades Integradas Padr&#227;o (FIP Guanambi) campus, in the city of Guanambi,
located in the state of Bahia, which will result in an additional payment of R$49.6 million. With the authorization, we reached 100 medical
seats on this campus, and 3,203 total approved seats.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The acquisitions of PEBMED, MedPhone, iClinic,
Medicinae, Medical Harbour, Cliquefarma, Shosp, RX PRO, Al&#233;m da Medicina, CardioPapers and Glic marked our evolution in the digital
health services sector, complementing our end-to-end offering to healthcare professionals. For more information on PEBMED, MedPhone, iClinic,
Medicinae, Medical Harbour, Cliquefarma, Shosp, RX PRO, Al&#233;m da Medicina, CardioPapers and Glic, see &#8220;&#8212;B. Business
Overview.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Initial Public Offering and Equity Follow-on Offering</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In July 2019, we completed our initial public
offering, in which we sold an aggregate of 15,805,841 of our Class A common shares at a public offering price of US$19.00 per common share.
We received approximately US$242.7 million of net proceeds from our initial public offering (i.e., after deducting underwriting discounts,
commissions and offering expenses). Our shares began trading on the Nasdaq Global Select Market on July 19, 2019, under the symbol &#8220;AFYA.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In February 2020, we completed an equity follow-on
offering, in which we sold an aggregate of 3,260,480 of our Class A common shares at a public offering price of US$27.50 per common share.
We received approximately US$86.6 million of net proceeds from our follow-on offering (i.e., after deducting underwriting discounts, commissions
and offering expenses).</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">SoftBank Investment</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On April 26, 2021, we announced that the SoftBank
Latin America Fund, or SoftBank, agreed to purchase R$822 million, equivalent to US$150 million, of Afya&#8217;s Series A perpetual convertible
preferred shares, subject to customary closing conditions. In addition, Crescera Educacional II Fundo de Investimento em Participa&#231;&#245;es
Multiestrat&#233;gia and certain members of the Esteves family agreed to sell 2,270,208 Class A common shares to SoftBank. In connection
with such sale, at the time, Paulo Passoni from SoftBank was appointed as a board member of Afya, being replaced by Maria Tereza Azevedo
in 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The key terms of the Series A perpetual convertible
preferred shares, as set forth under the relevant certificate of designations, are: (i) 6.5% per annum cumulative dividend payable quarterly
and in Brazilian <i>reais</i> (payable in U.S. dollars in Brazilian <i>reais</i> equivalent); (ii) SoftBank shall have the right at any
time, to convert its Series A perpetual convertible preferred shares into 5,917,888 common shares, at an initial conversion price established
at US$25.35; (iii) SoftBank shall have the right to redeem any time after the 5<sup>th</sup> year anniversary at 105% premium; and (iv)
Afya will have the right to force conversion after the 3<sup>rd</sup> year anniversary if forced conversion trigger conditions are satisfied.
For further information, see &#8220;Item 5. Operating and Financial Review and Prospects&#8212;B. Liquidity and Capital Resources&#8212;Indebtedness&#8212;Series
A Perpetual Convertible Shares&#8221; and note 13.2.1 to our audited consolidated financial statements included elsewhere in this annual
report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, SoftBank and its affiliates
would beneficially own approximately 6.6% of the total shares of the Company (on an as-converted basis for the Series A perpetual convertible
preferred shares).</p>


<!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Acquisition of Crescera Shares by Bertelsmann</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On June 7, 2021, an affiliate of Bertelsmann
acquired the entirety of the 23,074,134 Class B Afya&#8217;s common shares held by Crescera Educacional II Fundo de Investimento em Participa&#231;&#245;es
Multiestrategia, or &#8220;Crescera Educacional,&#8221; pursuant to a provision in Afya&#8217;s amended and restated memorandum and articles
of association then in effect and the shareholders agreement between certain members of the Esteves family and Crescera Educacional, which
granted Bertelsmann the right to acquire Crescera Educacional&#8217;s Class B common shares and become a party to the shareholders&#8217;
agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Bertelsmann is a media, services and education
company that operates in about 50 countries around the world. It includes the entertainment group RTL Group, the trade book publisher
Penguin Random House, the music company BMG, the service provider Arvato, the Bertelsmann Printing Group, the Bertelsmann Education Group
and Bertelsmann Investments, an international network of funds. Since Afya&#8217;s inception, Bertelsmann has indirectly held a stake
in Afya through its investment in Crescera Educacional. In connection with and following such transaction, Bertelsmann appointed Kay
Krafft, Shobhna Mohn, Christina Krebs and Benedikt Dalkmann as members of our board of directors.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Acquisition of our Corporate Control by Bertelsmann</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On May 5, 2022, we announced the closing of
the transaction whereby Bertelsmann acquired 6,000,000 of our Class B common shares from the Esteves Family at a purchase price of US$26.90
per share. As a result of the closing of the transaction, Bertelsmann came to beneficially own approximately a 57.5% voting interest in
Afya. We further announced that we entered into a new CEO executive employment agreement with Virgilio Deloy Capobianco Gibbon, extending
its period through May 2027. The extension was made in connection with the increase of Bertelsmann&#8217;s stake in Afya to continue to
execute the expansion in the medical education business and the deployment of the Afya digital health services strategy.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_012"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Business Overview</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are the leading medical education group
in Brazil based on number of private medical school seats, according to a MEC report as of December 31, 2023, delivering an end-to-end
physician-centric ecosystem that serves and empowers students to be lifelong medical learners from the moment they join us as medical
students through their medical residency preparation, graduation program, medical post-graduate specialization programs and continuing
medical education activities, or CME, including through digital health services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our innovative methodological approach combines
integrated content, interactive learning, and an adaptive experience for lifelong medical learners. Through our educational content and
technology-enabled activities, we focus on effective, personalized learning that mirrors one-on-one tutoring.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have the largest medical education footprint
in Brazil. Our undergraduate and graduate campuses are spread across 19 Brazilian states, and our digital medical platform is available
across Brazil. As of December 31, 2023, our network of 47 undergraduate and graduate medical school campuses consisted of 32 undergrad
operating units (i.e., units that have been approved by MEC and that have commenced operations) and one approved unit (i.e., a unit that
have been approved by MEC but that have not yet commenced operations), compared to 30 units as of December 31, 2022 and as of December
31, 2021, respectively. As of December 31, 2023, our network of 3,163 medical school seats consisted of 3,113 operating seats (seats that
have been approved by MEC and that have commenced operations) and 50 approved seats (seats that have been approved by MEC but that have
not yet commenced operations), compared to 2,773 and 2,481 operating seats as of December 31, 2022 and as of December 31, 2021, respectively.
We plan to expand our network by opening, subject to the verification by the MEC of the satisfactory implementation by Afya Brazil of
all regulatory requirements, the seven approved medical school campuses we were awarded in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221;
program (the Brazilian federal government initiative to reduce shortages of doctors in the most underserved and vulnerable regions of
Brazil) by December 31, 2023, taking our total to 32 operating medical school campuses in 19 Brazilian states and approximately 3,113
operating medical school seats per year. As of December 31, 2023, we had increased our network of medical school seats to 3,163 seats
3,113 of which were operating from 2,823 as of December 31, 2022 due to the acquisition of DelRey.</p>


<!-- Field: Page; Sequence: 54 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Following our acquisition of Medcel in the
first quarter of 2019 and IPEMED in the second quarter of 2019, we also offer residency preparatory courses and medical postgraduate specialization
programs, delivering printed and digital content, an online medical education platform and practical medical training.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The acquisition of PEBMED, MedPhone, iClinic,
Medicinae, Medical Harbour, Cliquefarma, Shosp, RX PRO, Al&#233;m da Medicina, CardioPapers and Glic marked our evolution in the digital
health services sector, complementing our end-to-end offering to healthcare professionals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Through PEBMED, we acquired three different
products: (i)&#160;Whitebook, a mobile and web application that assists doctors and medical professionals in clinical daily decision-making;
(ii)&#160;Nursebook, a mobile application that assists nurses in clinical decision-making; (iii) Portal PEBMED, a website that offers
free content, including opinions, papers and updates in connection with medical news and scientific publications. PEBMED has more than
200,000 monthly active users on the Whitebook platform and approximately 500,000 monthly active users to Portal PEBMED. The acquisition
expanded our products and services offerings and offers significant cross-sell and upsell opportunities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: white">iClinic
is a SaaS model physician focused technology company and one of the leading medical practice management software in Brazil. They seek
to empower doctors to be more independent and have more control over their careers by digitalizing their daily routine, so they can increase
their productivity and deliver better healthcare services. Their portfolio includes: (i)&#160;</span>Electronic Medical Record: the first
electronic medical record as a SaaS model in Brazil focused on the physician experience; (ii)&#160;Clinical Management System: with this
software doctors can schedule patients online, organize their financial records, use marketing tools to promote their clinics and others;
(iii)&#160;Telemedicine: a platform to provide online consultations fully integrated with doctor&#8217;s schedule and records; and (iv)&#160;Physicians
Marketplace: a website that connects doctors and patients to schedule consultations. <span style="background-color: white">As of December
31, 2023, the software had almost 26,263 users. The platform is currently used for almost 23 million medical consultations per year, of
which around 151,503 were through telemedicine and prescribed more than 7,649,132 electronic medical prescriptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Medicinae is a healthcare technology company
specializing in healthcare payments and financial services. It offers a financial platform that allows healthcare professionals to manage
receivables in an efficient and scalable way using FIDC (receivables investment fund). We believe Medicinae relieves a number of challenges
in the healthcare payments industry, by reducing long payment cycles for professionals and consolidating financial information, improving
the consumer financial experience.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Medical Harbour offers educational health and
medical imaging solutions through an interactive platform for anatomical study, 3D virtual dissection and analysis of medical images,
which allow the exploration, and knowledge of human anatomy with digital resources: (i)&#160;educational health solutions: Athena Hub
specialized in anatomy was created to support dynamic teaching and allow physicians, teachers and students to interact and manipulate
a real human body on a digital platform. Considering the high prices, restriction policies and difficulty on maintaining a human body
for anatomy classes, Athena Hub allows students to interact with a digital human body instead of the aged and degenerate bodies for educational
purposes. The solution count with virtual body, anatomy modules, and real exam analysis with photorealistic rendering. And (ii)&#160;medical
imaging solutions: Athena DICOM and MH Cloud specialized in medical imaging with a range of products that simplifies radiology and teleradiology.
Allow physicians to visualize, manipulate, share and store medical imaging with the certification of ANVISA (Brazilian Health Agency).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Cliquefarma is a healthtech company operating
a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices in Brazil. Users of Cliquefarma can
search for medications or healthcare products and compare prices from over 5,661 pharmacies in Brazil. The traffic generated is monetized
through a cost-per-click model, where drugstores pay for each click on their ads, and a cost-per-acquisition model, where drugstores pay
for each concluded sale. In 2023, Cliquefarma generated traffic of 15.2 million visitors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Shosp is a clinical management software that
offers all functionalities needed for clinics all over Brazil to manage their financials, patients&#8217; appointments, medical records,
marketing, and others. The acquisition of Shosp reinforces the digital prescription digital pillar and creates synergies with iClinic
and Medicinae solutions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">RX PRO is a digital platform that connects
physicians with the pharmaceutical industry, providing specialized and personalized marketing for those companies, in a more convenient
way for physicians. RX PRO has already delivered free samples to more than 62,000 physicians with an innovative digital experience, with
a Net Promoter Score, or NPS, of 76.9 and as of the date of this annual report has 10 pharmaceutical companies using its platform. RX
PRO is monetized by providing a B2B subscription service to the pharmaceutical industry.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Al&#233;m da Medicina is an online medical
content platform for physicians and medical students that provides educational tools and technical medical content to assist them throughout
their careers. Its robust content includes mentoring for residency, soft skills, finance, accounting, and investment basics for physicians.
Al&#233;m da Medicina had more than 7,000 subscribers as of December 31, 2023, and more than 125,000 followers on Instagram.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">CardioPapers is the main medical content and
education platform in the Cardiology field, offering courses and books developed by physicians and for physicians, covering all phases
of the medical career, aligned with Afya&#8217;s overall business strategy. CardioPapers had 8,535 students in 2023 and almost 285,000
followers on Instagram. The platform includes more than ten courses, such as a cardiology specialist degree preparatory course, cardiological
emergencies course, preoperative course, dyslipidemia course, electrocardiogram (EKG) course and diabetes course, exploring the cardiologic
medical field and also expanding to other medical areas.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Glic is a free diabetes care and management
app solution for physicians and patients that uses technology to improve diabetes education and daily routine practices, connecting users,
devices and healthcare providers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition to health sciences courses, which
comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine,
we also offer degree programs and courses in other subjects and disciplines across several of our campuses, including undergraduate and
postgraduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. These non-health
courses are not part of our core business, although the number of non-health sciences courses we offer has increased as a consequence
of our strategic acquisitions of multi-disciplinary schools with strong health sciences programs, which are our principal focus. Although
non-health courses are not part of our growth strategy, we expect to continue to offer them to the extent they generate local demand.
Following our acquisition of Medcel in the first quarter of 2019 and IPEMED in the second quarter of 2019, we also offer residency preparatory
courses and medical post-graduate specialization programs, delivering printed and digital content, an online medical education platform
and practical medical training.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, we had 66,034 enrolled
students, compared to 58,200 enrolled students as of December 31, 2022, representing an increase of 13.5% for 2023, and 61,118 enrolled
students as of December 31, 2021, representing a decrease of 4.8% for 2022. See &#8220;Item 4. Information on the Company&#8212;B. Business
Overview&#8212;Our Recent Acquisitions.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our business model is characterized by high
revenue visibility and operating leverage. Approximately 90% of our historical revenue for the years ended December 31, 2023, 2022 and
2021 was composed of the monthly tuition fees we charge students enrolled in our undergraduate and graduate courses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our ability to execute our business model and
strategy, primarily through our (i) acquisitions (which represented approximately 45.2% of our total growth in terms of revenue in 2023,
48.0% of our total growth in terms of revenue in 2022 and 80.5% of our total growth in terms of revenue in 2021) and (ii) organic growth
(which represented approximately 54.8% of our total growth in terms of revenue in 2023, 52.0% of our total growth in terms of revenue
in 2022, and 19.5% of our total growth in terms of revenue in 2021), has led to growth, profitability and cash generation:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Our revenue totaled RS$2,875.9 million, R$2,329.1 million and R$1,719.4 million in the years ended December 31, 2023, 2022 and 2021,
respectively, representing a compound annual growth rate, or CAGR, of 29.3% since 2021;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Medical school&#8217;s tuition fees represented 78.8%, 77.1% and 75.9% of our historical undergraduate programs combined tuition fees
in 2023, 2022 and 2021, respectively. The average monthly ticket for medical school tuition fees was R$10,210 for the year ended December
31, 2023, which represented an increase of 7.0% from R$ 9,538 for year ended December 31, 2022, which, in turn, represented an increase
of 10.7% from R$8,615 for year ended December 31, 2021;</td></tr></table>


<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Residency preparatory course, continuing medical education, medical post graduate specialization programs offerings and digital services
totaled R$376.1 million, R$298.8 million and R$224.9 million in revenue for the years ended December 31, 2023, 2022 and 2021, respectively;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We generated net income of R$405.4 million, R$392.7 million and R$242.3 million in the years ended December 31, 2023, 2022 and 2021,
respectively, representing a CAGR of 29.4% since 2021;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Our Adjusted EBITDA totaled R$1,165.7 million, R$961.9 million and R$754.8 million in the years ended December 31, 2023, 2022 and
2021, respectively, representing a CAGR of 24.3% since 2021;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Our Operating Cash Conversion Ratio was 97.1%, 94.4% and 100.8% for the years ended December 31, 2023, 2022 and 2021, respectively.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Quality is a cornerstone of our value proposition.
As of December 31, 2023, our average General Course Index score, which is measured and published by MEC, and is based on certain institutional
planning and development, academic, and management criteria, was 3.26 on a scale of 1 to 5, compared to the Brazilian average of 3.18.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In 2018, we were also awarded seven new undergraduate
campuses in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, the largest number awarded to any education group, with
a total of 350 new medical school seats.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In October 2020, the MEC authorized the operation of 50 seats in Santa In&#234;s in the State of Maranh&#227;o. The operations of this
medical school started in the second semester of 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In December 2020, the MEC authorized the operation
of 50 seats in in Cruzeiro do Sul in the State of Acre. The operations of this medical school started in the first semester of 2021.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In 2021, the MEC authorized the operation of
120 medical school seats in Garanhuns, in the city of Garanhuns, State of Pernambuco. These operations of the medical school started in
the second semester of 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In March 2022, the MEC authorized the increase
of 28 seats of Centro Universit&#225;rio S&#227;o Lucas, located in the city of Ji-Parana, State of Rond&#244;nia. The operation of such additional
seats started on June 21, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In December 2022, the MEC authorized the increase of 64 medical seats of Faculdade Santo Agostinho, located in the city of Itabuna, State
of Bahia. The operation of such additional seats started in the first semester of
2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In 2022, the successful opening of four &#8220;<i>Mais
M&#233;dicos</i>&#8221; campuses&#8212;Abaetetuba, Bragan&#231;a, Itacoatiara, and Manacapuru&#8212;added 200 new medical seats to
our portfolio. As of the date of this annual report, six of these campuses are already in operation. The continued operation of certain
of these campuses was subject to the verification by MEC of the satisfactory implementation by Afya Brazil of all regulatory requirements.
See &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Our Geographic Presence.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Our Recent Acquisitions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The entry point to a medical career begins
in undergraduate institutions, so part of our mission is to consolidate this market. Accordingly, expanding our operations through acquisitions
has been a key component of our growth strategy. We have been able to apply our operating business model to our acquisitions, allowing
us to add quality, value and increase profitability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, we have equipped ourselves through
key initiatives for strategic and relevant acquisitions to our portfolio, including: the creation of a Shared Services Center dedicated
to serving our campuses and running our integration processes, the centralization of content creation and the creation of a dedicated
sales team for each market we operate in.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our recent acquisitions, which were all made
through Afya Brazil, include:</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">iClinic</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On January 21, 2021, we acquired 100% of the
total share capital of iClinic. iClinic is a SaaS model physician focused technology company and the leading practice management software
in Brazil. This software empowers doctors to be more independent and have more control over the non-medicine aspect of their practices
by digitalizing their daily routine, so they can increase their productivity and deliver better healthcare. The aggregate purchase price
of R$191.1 million is comprised of: (i) R$119.6 million, or 62.6%, was paid in cash; and (ii) R$71.5 million, or 37.4%, was settled with
Afya&#8217;s shares on the transaction closing date.</p>


<!-- Field: Page; Sequence: 57 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Medicinae</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On March 25, 2021, we acquired 100% of the
total share capital of Medicinae, a leading Brazilian healthcare technology company that specializes in healthcare payments and financial
services. The aggregate purchase price of R$9.2 million is comprised of: (i) R$5.6 million of which 100% was paid in cash on the transaction
closing date; and (ii) an earn-out (&#8220;contingent consideration&#8221;) of up of R$4.4 million is payable in connection with product
development goals for 2021 and revenue achievements for 2022. The contingent consideration of R$3.6 million was based on the facts and
circumstances at the acquisition date. There was no contingent consideration balance as of December 31, 2023 and 2022.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Medical Harbour</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">On April 8, 2021, we acquired 100% of the total share capital of Medical
Harbour, which offers educational health and medical imaging solutions through an interactive platform for anatomical study, 3D virtual
dissection and analysis of medical images, which allow the exploration, and knowledge of human anatomy with digital resources. The aggregate
purchase price of R$11.3 million is comprised of: (i) R$5.0 million of which 100% was paid in cash on the transaction closing date; and
(ii) an earn-out (&#8220;contingent consideration&#8221;) of up to R$9.0 million is payable in connection with product development goals
for 2021 and 2022 and revenue achievements for 2023. The contingent consideration of R$3.0 million will be paid in 2024 and is based on
the present value of the obligation considering the facts and circumstances as of December 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Cliquefarma</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On April 16, 2021, we acquired 100% of the
total share capital of Cliquefarma, a healthtech company operating a free-to-use website that tracks prescription drugs, cosmetics and
personal hygiene product prices in Brazil. The aggregate purchase price of R$22.1 million is comprised of: (i) R$16.2 million paid in
cash; (ii) R$3.0 million settled with Afya&#8217;s shares on the transaction closing date; and (iii) an earn-out (&#8220;contingent consideration&#8221;)
of R$3.0 million, which was reversed in 2022 due to the failure to achieve the relevant product development targets. There was no contingent
consideration balance as of December 31, 2023 and 2022.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Shosp</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On May 13, 2021, we acquired 100% of the total
share capital of Shosp, a clinical management software that offers all functionalities needed for clinics all over Brazil to manage their
financials, patients appointments, medical records, marketing, and others. Afya&#8217;s intention is to reinforce the Digital Services
operating segment. The aggregate purchase price of R$7.9 million is comprised of: (i) R$5.9 million paid in cash; (ii) R$454 thousand
in consideration to be transferred; and (iii) an earn-out (&#8220;contingent consideration&#8221;) of up to R$1.8 million payable in relation
to product development. The first contingent consideration installment of R$0.5 million was paid in August 2023 as a result of the achievement
of the relevant product development targets, and a second contingent consideration installment in the amount of R$0.5 million will be
paid until 2026.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">UnifipMoc</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On June 1, 2021, we acquired 100% of the total
share capital of UnifipMoc. The aggregate purchase price was R$328.3 million paid in cash at date of acquisition. As of December 31, 2022,
there were 40 additional seats still pending approval, which, if approved by MEC, would result in a potential additional payment of up
to R$50.0 million. UnifipMoc is a post-secondary education institution with governmental authorization to offer on-campus, undergraduate
degree programs in medicine and healthcare, as well as in other courses, in the states of Minas Gerais and Bahia.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Unigranrio</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On August 4, 2021, we acquired 100% of the
total share capital of Unigranrio. The original aggregate purchase price was R$626.1 million, which was later adjusted to R$619.0 million
as result of net debt adjustments. R$375.7 million, or 60% of the purchase price, was paid in cash on the closing date, and the remaining
R$243.3 million, or 40%, is payable in four equal annual installments through 2022 to 2025, adjusted by the CDI rate. There are 82 additional
seats still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$90.2 million. Unigranrio
is a post-secondary education institution with government authorization to offer on-campus, undergraduate medical and health-related courses
in the state of Rio de Janeiro and Santa Catarina.</p>


<!-- Field: Page; Sequence: 58 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Following our acquisition of the Unigranrio
entities, on September 21, 2022, we liquidated and dissolved Sociedade Educacional de Palho&#231;a S/S Ltda., and on January 16, 2023
we completed the merger of Instituto de Ensino Superior de Palho&#231;a S/S with and into Companhia Nilza Cordeiro Herdy de Edua&#231;&#227;o
e Cultura, in order to simplify our corporate structure.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">RX PRO</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On October 1, 2021, we acquired 100% of the
total share capital of RX PRO, a solution that connects physicians with the pharmaceutical industry, providing specialized and personalized
marketing for those companies, in a more convenient way for physicians. RX PRO does this by delivering free samples to a community of
pre-selected physicians and offering medical updates regarding pharmaceutical products and treatments in a fast and efficient way for
doctors. RX PRO incorporates the digital prescription pillar and further strengthens Afya&#8217;s digital ecosystem thesis. The aggregate
purchase price paid to sellers was R$45.6 million, of which R$30.3 million was paid in cash and R$5.1 million paid in Afya stock. An earn-out
of up to R$21 million can be paid related to gross revenue achievements for 2022, 2023 and 2024. The contingent consideration of R$1.8
million accounted for on December 31, 2022 was remeasured and reversed in 2023 due to the failure to achieve gross revenue targets.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Garanhuns</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On November 5, 2021, the Secretary of Regulation
and Supervision of the MEC authorized the operation of a medical school in Garanhuns in the State of Pernambuco. This authorization is
in connection with a previous request made by ITPAC, a subsidiary of Afya Brazil, to expand their operation and open a branch in the city
of Garanhuns, before the consolidation of Afya. As a result, we acquired 100% of Garanhuns. The purchase price is as follows: (i) R$54.0
million was paid in cash on the closing date of the transaction; and (ii) R$54.0 million was paid in two equal installments, adjusted
by the CDI rate, in November 2022 and November 2023.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Al&#233;m da Medicina</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On March 4, 2022, we acquired 100% of the total
share capital of Al&#233;m da Medicina. This business combination incorporates new capabilities to the content &amp; technology for
the medical education pillar and further strengthens Afya&#8217;s digital ecosystem. The aggregate purchase price of R$26.8 million is
comprised of: (i) R$14.9 million paid in cash on the transaction closing date; (ii) an earn-out (&#8220;contingent consideration&#8221;)
of up of R$ 19.2 million is payable in connection with revenue target achievements for 2023 and 2024; and (iii) a price adjustment related
to net debt of R$0.8 million in favor of selling shareholders. The contingent consideration of R$18.3 million is based on the estimated
payment considering the facts and circumstances as of December 31, 2023.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">CardioPapers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On April 5, 2022, we acquired 100% of the total
share capital of CardioPapers. The aggregate purchase price of R$42 million is comprised of: (i) R$34.9 million paid in cash on the transaction
closing date; (ii) an earn-out (&#8220;contingent consideration&#8221;) of up of R$15 million is payable in connection with revenue target
achievements for 2023 and 2024 and other goals relating to market credentials for 2023 and 2024; and (iii) price adjustment related to
net debt of R$0.3 million in favor of Afya Brazil. The contingent consideration of R$14.2 million is based on the estimated payment considering
the facts and circumstances as of December 31, 2023.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Glic</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On May 23, 2022, we acquired 100% of the share
capital of Glic. Glic is a free diabetes care and management app solution for physicians and patients that uses technology to improve
diabetes education and daily routine practices, connecting users, devices and healthcare providers. The aggregate purchase price of R$30.6
million comprised of: (i) R$21.6 million paid in cash on the transaction closing date; and (ii) an earn-out (&#8220;contingent consideration&#8221;)
of up of R$12.0 million is payable in connection with revenue target achievements for 2023 and 2024 and product development goals. The
contingent consideration of R$9.5 million accounted for in December 31, 2022 was partially paid in 2023 (in the amount of R$3.0 million)
and the remaining balance was remeasured and reversed in 2023 considering the facts and circumstances as of December 31, 2023.</p>


<!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">DelRey</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On January 2, 2023, we acquired 100% of the
total share capital of DelRey, which acquisition encompasses the operations of Centro Universit&#225;rio Tiradentes Alagoas, or UNIMA,
and Faculdade Tiradentes Jaboat&#227;o dos Guararapes, or FCM Jaboat&#227;o. The transaction does not include the &#8220;UNIMA&#8221;
and &#8220;FCM Jaboat&#227;o&#8221; trademarks, which were licensed to Afya during the first year of operation. The aggregate purchase
price was R$816.2 million is as follows: (i) R$575.0 million paid in cash on the transaction&#8217;s closing date; and (ii) R$234.0 million
to be paid in three annual installments of R$134.0 million in January 2024, R$50.0 million in January 2025 and R$50.0 million in January
2026, as adjusted by the SELIC rate. The aggregate purchase also includes R$7.2 million estimated at fair value as of the date of acquisition
relating to an offer of our digital solutions free of charge until December 31, 2030 for medical students of universities owned by the
sellers but which were not a part of this transaction. There are 84 additional seats still pending approval which, if approved by MEC,
will result in a potential additional payment of up to R$105.0 million, as adjusted by the IPCA rate between the closing date and the
date of its effective payment.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Our Competitive Strengths</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Continuous focus on disrupting traditional medical
education</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We have an in-depth understanding of medical education and the related issues faced by students in Brazil. As the largest medical
education group in Brazil on a per-seat basis, according to MEC, we are able to identify trends and adapt our services accordingly;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We have developed a methodological approach to learning that incorporates individualization and technology in both digital and physical
format;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We currently produce content that is centralized, continuously updated and available to all our institutions and students;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We have the largest operating infrastructure in medical education in Brazil on a per-seat basis, according to MEC, with more than
649 partner teaching hospitals and clinics and almost 267,917 physicians and specialists in our ecosystem;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We believe we have developed the first instructional medical web series created globally, and we have completed the first two seasons
and have already begun working on the third season;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We believe we are the first education group in Brazil to offer a fully digital and customized service for medical residency exam preparation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We believe we are the first player to offer supplemental medical education content to third-party institutions through a business-to-business
model; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We started offering content and clinical tools for healthcare professionals, including mobile and web apps.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">High-quality standards</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Quality is a cornerstone of our value proposition.
Our operating infrastructure and innovative methodological approach have achieved high levels of satisfaction across our medical schools.
Through our digital platforms, we monitor our students&#8217; learning experience using several criteria and variables. Our NPS, a widely
known survey methodology that measures the willingness of customers to recommend a company&#8217;s products and services, was 26 for
medical students that graduated more than five years ago, 25 for medical students that graduated more than two years ago and less than
five years ago, and 40 for medical students that graduated less than two years ago. This gradual improvement in our NPS score shows our
continuing commitment to high-quality education and the medical careers of our students. Additionally, according to the latest results
released by the Brazilian government on April 2, 2024, our average General Course Index, which is measured and published by MEC, and
is based on certain institutional planning and development, academic and management criteria, was 3.26 on a scale of 1 to 5, compared
to the Brazilian average of 3.18. See &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Regulatory Overview&#8212;Regulatory
Processes of Post-secondary Education Institutions&#8212;Accreditation of Post-secondary Education Institutions and Authorization and
Recognition of Programs&#8221; for further information on the <i>General Course Index.</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, through our online medical education
platform that offers distance learning residency preparatory courses, we are able to monitor our students&#8217; learning experience using
several criteria and variables, including the educational materials they access and use, frequently asked questions, their study hours
and schedule, and their attendance record. Furthermore, as a result of the quality of the content and methodology and the differentiated
services offered by Medcel, third-party medical schools proactively contact it seeking to adopt Medcel&#8217;s medical education content
to improve their medical students&#8217; learning experience and academic scores. As of December 31, 2023, 17 third-party schools had
adopted Medcel&#8217;s medical education content compared to approximately 16 as of December 31, 2022.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">The nature of our business model</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Attractive financial model:</i> We have
a strong combination of significantly low customer acquisition costs, calculated as the sum of sales and marketing and personnel expenses
divided by student additions, which were approximately R$1,415, R$1,882 and R$2,016 per student as of December 31, 2023, 2022 and 2021,
respectively, high occupancy rates of approximately 100% of medical seats in our medical schools as of December 31, 2023, 2022 and 2021,
and strong operating cash conversion of 97.1%, 94.4% and 100.8% as of December 31, 2023, 2022 and 2021, respectively. As of December 31,
2023, our Life Time Value (LTV) was R$423,308, calculated as the sum of R$70,551 gross income per student divided by 17% (to account for
one-sixth of the student base graduating every year). As of December 31, 2022, our Life Time Value (LTV) was R$425,658, calculated as
the sum of R$70,943 gross income per student divided by 17% (to account for one-sixth of the student base graduating every year). As of
December 31, 2021, our Life Time Value (LTV) was R$353,404, calculated as the sum of R$58,901 gross income per student divided by 16.7%
(to account for one-sixth of the student base graduating every year).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Contracted growth:</i> We have contracted
growth visibility into medical schools that are in the initial six years of operations as a result of the six-year maturation cycle of
our medical school seats. This cycle begins when a medical school becomes operational, with a first year medical school class that progresses
through the required six years as the next classes begin behind it, and ends when the medical school has six school years of medical students
and has therefore reached capacity at maturation (i.e., the maximum number of approved seats). Since the maximum number of medical seats
per medical school is set by regulation, the only way to grow our medical school seats, and thus our numbers of enrollments, is through
acquisitions or starting new medical schools. As of December 31, 2023, we had 3,163 approved medical school seats out of an expected total
capacity of 22,744 medical school enrollments by 2028, which gives us visibility as to the growth potential of our revenues over the period.
See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;Medical School Regulatory Capacity and Capacity at Maturation.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>End-to-end ecosystem:</i> Successfully integrating
the businesses we invest in or acquire, allows us to offer an end-to-end physician-centric ecosystem. The point of entry of one business
unit is the point of exit from another, which increases cross-selling and upselling opportunities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Difficult to replicate:</i> We believe the
combination of regulatory barriers, demand and supply imbalance and our end-to-end physician-centric ecosystem are difficult to replicate
and that it would take a significant amount of time for competitors to reach the scale of our operation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Self-reinforcing network effects of our
education cycle:</i> As we aim to be the trusted content and knowledge partner for lifelong medical learners in Brazil, we have created
and have been nurturing an education cycle that entails differentiation, talented stakeholders and recognition. Our continuous focus on
implementing all stages of our cycle has allowed us to continuously expand our footprint.</p>


<!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt; text-align: center"><img src="image_028.jpg" alt=""/></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Extensive M&amp;A track record</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have extensive capabilities in, and a strong
track record of, identifying, negotiating and successfully integrating acquisitions. We have developed an integration model, operated
by a dedicated team responsible for analyzing, mapping and integrating the systems of our acquired businesses, that we believe enables
us to fully integrate the businesses we acquire in an efficient manner and within 12 months of their acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our integration model is composed of four stages:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Stage 1 (Preliminary Analysis): Preliminary analysis of the available infrastructure, organizational structure and teaching model
of the acquired business to identify potential integration issues.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Stage 2 (Detailed Mapping): Detailed migration diagnosis and mapping of the systems, processes and teaching model of the acquired
business to be integrated into our centralized shared-services center and academic model.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Stage 3 (Integration/Migration): Centralization and migration of the systems and processes into our shared services center and standardization
of the teaching model of the acquired business.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Stage 4 (Ongoing Support): Post migration/integration remote and on-site support and monitoring to stabilize the integrated operations
of the acquired business.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our consolidated operating history and our
recent acquisitions entail a number of challenges, such as effectively integrating the operations of any acquired companies with our existing
business and managing a growing number of campuses. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating
to Our Business and Industry&#8212;We may not be able to identify and acquire new medical higher education institutions or meet our strategic
and financial goals in connection with any business acquisition we seek, and difficulties in effectively integrating and managing a growing
number of campuses may adversely affect our strategic objectives&#8221; and &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain
Risks Relating to Our Business and Industry&#8212;Our operating history as a consolidated company, our recent acquisitions and the comparability
of our results may make it difficult for investors to evaluate our business, financial condition, results of operations and prospects.&#8221;</p>


<!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Purpose driven culture</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Medical education requires a core human value:
compassion. As we endeavor to revolutionize medical education in Brazil, we believe that by training and educating better physicians we
are helping people and their communities across Brazil. This mission has united families and entrepreneurs, executives and sponsors with
over 20 years of know-how and expertise in the education sector. Our internal satisfaction survey conducted in 2023 showed employee satisfaction
levels of 89 out of a possible 100, based on several criteria, such as trust in, and a commitment to, our values, leadership satisfaction,
work satisfaction, learning and development, and active participation in our activities, reinforcing our strong commitment to our mission
and purpose.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Our Growth Strategies</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We aim to continue to grow organically and
through acquisitions and to generate greater shareholder value by implementing the following strategic initiatives:</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Maturation of current number of authorized medical
school seats</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We benefit from contracted growth visibility
in our medical schools that are in the initial six years of operations, which we derive from two main sources: (1)&#160;the six-year maturation
cycle of our medical school seats, which begins when a medical school becomes operational, with a first year medical school class which
progresses through the required six years as the next classes begin behind it, and which ends when the medical school has six school years
of medical students and has therefore reached capacity at maturation (i.e., the maximum number of approved seats), and (2)&#160;new enrollments
from our seven awarded campuses in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Since the maximum number of medical seats per
medical school is set by applicable regulations, the only way to grow our medical school seats, and thus our number of enrollments, is
through acquisitions or starting new medical schools. As of the date of this annual report, assuming full compliance with applicable regulations
and that our seven new &#8220;<i>Mais M&#233;dicos</i>&#8221; campuses mature as expected with 50 medical seats for each campus, we
estimate reaching a total medical student base of 23,062 students by 2030. See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;Medical
School Regulatory Capacity and Capacity at Maturation&#8221; and &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks
Relating to Our Business and Industry&#8212;The post-secondary education sector is highly regulated, and our failure to comply with existing
or future laws and regulations could significantly impact our business.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Open new campuses in connection with the &#8220;Mais
M&#233;dicos&#8221; program</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In 2018, we were also awarded seven new undergraduate
campuses in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, the largest number awarded to any education group, with
a total of 350 new medical school seats. The operation of such campuses is subject to the verification by MEC of the satisfactory implementation
by Afya Brazil of all regulatory requirements. As of the date of this annual report, MEC had inspected six of the campuses, and the final
verification was published in: (i)&#160;October 2020 for ITPAC Santa In&#234;s; (ii)&#160;December 2020 for ITPAC Cruzeiro do Sul; (iii)
February 2022 for ITPAC Abaetetuba; (iv) February 2022 for ITPAC Itacoatiara; (v)&#160;March 2022 for ITPAC Bragan&#231;a; and (vi)
March 2022 for ITPAC Manacapuru.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Expand our medical residency preparation enrollments
base</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We expect that competition for medical residencies
will increase as the number of graduating physicians grows and the number of available residency seats remains static. We plan to continue
to grow our medical residency exam preparation student enrollments, leveraging the academic outcome, scalability and learning experience
of our digital platform.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Expand our graduate programs enrollments base</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Due to the shortage of medical residency seats
and the growing demand for medical graduate courses, we believe we will be able to expand our current offering in this segment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We intend to continue developing our business-to-business
strategy by increasing the number of partners and student enrollments through increased marketing and sales effort.</p>


<!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Cross-sell across our existing medical student
base</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Because our solutions target the lifelong education
journey of medical students, we have identified an opportunity to increase student enrollments at a low marginal cost driven by cross-selling
opportunities, such as increasing the number of former undergraduate students subscribing to our medical residency exam solutions and
the number of former undergraduate and/or medical residency students applying to our graduate and CME courses.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Expand our B2B capabilities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">B2B contracts are effective customer entry
points to our products and services. Students are familiar with our platforms, increasing our brand equity and helping us attract more
physicians to enroll in preparatory courses, graduate programs and CME products.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Expand our distribution channels</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We plan to continuously expand our distribution
network by increasing our presence in direct and third-party channels, launching graduate courses or CME for third-party continuing medical
education hubs (including, but not limited to, hospitals, clinics and other medical schools) to grow our graduate medical footprint, through
partnerships with such third-party continuing medical education hubs.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Leverage infrastructure and extract synergies
from acquisitions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We believe we have been able to successfully
integrate our acquisitions into our ecosystem. We plan to implement several measures to improve the profitability of recent acquisitions,
including but not limited to:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Streamlining fee discounts and scholarship policies;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Integrating operations with our shared-services center;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Streamlining faculty training in line with our career plan; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Integrating teaching models into our academic model.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Continue to selectively pursue M&amp;A opportunities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We plan to selectively pursue acquisitions
that will complement our current medical education services offering and/or enhance our product portfolio, such as digital content platforms,
continuing medical education institutions and other medical certification companies, among others. We are currently evaluating possible
acquisition opportunities and submit non-binding proposals from time to time. We believe that we have developed a strong capability and
track record of acquisitions. In 2023, we acquired an additional 15% of CCSI, consolidating our ownership of 75% of its total share capital.
In addition, we also acquired DelRey, which acquisition increased our total number of approved medical school seats from 2,823 as of December
31, 2022 to 3,163 as of December 31, 2023. In 2022, we acquired or invested in three companies. In 2021, we acquired or invested in nine
companies, which increased our medical school seats by more than 27.4% over the year. In 2020, we acquired or invested in six companies,
which increased our medical school seats by more than 36% over the year. Our acquisition of Medcel enabled us to access the medical residency
preparation market, and the acquisition of IPEMED, enabled us to enter the graduate and specialization courses market. Our acquisition
strategy is mainly focused on expanding our medical school footprint by adding new institutions to our existing portfolio.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Enter into new markets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We believe our end-to-end physician-centric
ecosystem is equipped to serve medical students in complementary segments where our innovative, methodological, data-driven approach can
continue to disrupt traditional vendors and legacy business models. We believe opportunities exist in new sectors and regions of Brazil.
In the future, we intend to focus on expanding further into continuing medical education. We may also seek to grow our business by selectively
expanding into international markets with similar fundamentals.</p>


<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Develop new products</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We plan to continuously evolve our platform
and offer solutions that keep up with the growing demands of our students. We have a planned pipeline of new products, including new medical
web-series seasons, corporate medical training, new extension health programs, a tutoring suite, a peer-to-peer suite and a virtual reality
product.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Our Geographic Presence</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our headquarters and most of our shared services
operations are located in Nova Lima, in the State of Minas Gerais. Our content creation and dedicated sales team is located in S&#227;o
Paulo, in the State of S&#227;o Paulo.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, our network consisted
of a total of 47 undergraduate and graduate campuses: (i) 32 undergraduate campuses are operating units (units that have been approved
by MEC and that have commenced operations), 30 of which offer a medical course, and one of which that has been approved by MEC but has
not yet commenced operations, and (ii) 15 graduate campuses that offer medicine- and health-related courses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We plan to expand our network by opening one
approved undergraduate medical school campuses we were awarded in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program
by 2024. As of December 31, 2023, we had 7,563 students enrolled in our online prep-courses spread across Brazil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The chart and table below illustrate our current
footprint of undergraduate and graduate medical schools, as of date of this annual report.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 28%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 7pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"><span style="font-weight: normal">Campus</span></p></td>
    <td style="white-space: nowrap; width: 6%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 7pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"><span style="font-weight: normal">State</span></p></td>
    <td style="white-space: nowrap; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 7pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"><span style="font-weight: normal">Brand</span></p></td>
    <td style="white-space: nowrap; width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 7pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"><span style="font-weight: normal">Year
    of Acquisition</span></p></td>
    <td style="white-space: nowrap; width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 7pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"><span style="font-weight: normal">Approved
    Seats(1)</span></p></td>
    <td style="white-space: nowrap; width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 7pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"><span style="font-weight: normal">Semester(2)</span></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Porto	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">TO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">ITPAC</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Before 2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">120</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.04</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Pato Branco	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PR</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">FADEP</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.17</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Pato Branco	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PR</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">FADEP</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">60</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.19</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Itajub&#225;	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">MG</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">CCSI</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">87</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">01.68</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Parna&#237;ba	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PI</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">IESVAP</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">80</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.15</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Palmas	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">TO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">ITPAC</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">120</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.17</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Teresina	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PI</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">IESP</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">110</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.04</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Teresina	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PI</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">IESP</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">61</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.17</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">S&#227;o Jo&#227;o Del Rei	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">MG</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">UNIPTAN</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">38</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.15</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">S&#227;o Jo&#227;o Del Rei	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">MG</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">UNIPTAN</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">11</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.16</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Aragua&#237;na	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">TO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">UNITPAC</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">80</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.06</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Ipatinga	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">MG</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">UNIVA&#199;O</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">100</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">01.99</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Marab&#225;	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">FACIMPA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">120</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.19</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Vit&#243;ria da Conquista	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">BA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">FASA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">100</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">01.15</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Itabuna	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">BA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">FASA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">85</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.18</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Camet&#225;	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">To be started</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Cruzeiro do Sul	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">AC</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">01.21</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Santa In&#234;s	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">AM</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.20</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Manacapuru	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">AM</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.22</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Itacoatiara	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">MA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.22</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Abaetetuba	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.22</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Bragan&#231;a	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.22</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Itaperuna	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">RJ</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">UniRedentor</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">112</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.15</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Jo&#227;o Pessoa	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">FCMPB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">24</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.17</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Jo&#227;o Pessoa	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">FCMPB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">33</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.18</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Jo&#227;o Pessoa	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">FCMPB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">80</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.16</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Jo&#227;o Pessoa	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">FCMPB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">20</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.18</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Reden&#231;&#227;o	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">FESAR</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">120</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.18</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Porto Velho	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">RO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">UniSL</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">52</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.19</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Porto Velho	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">RO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">UniSL</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">130</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.05</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Ji-Paran&#225;	</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">RO</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">UniSL</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">28</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.21</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Guanambi	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">BA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">FIP Guanambi</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">60</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.18</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Guanambi	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">BA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">FIP Guanambi</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">40</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">01.24</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Garanhuns	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PE</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">ITPAC</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">120</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.21</td></tr>

<tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; width: 28%; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Montes Claros	</td>
    <td style="white-space: nowrap; width: 6%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">MG</td>
    <td style="white-space: nowrap; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt">UNIFIPMOC</td>
    <td style="white-space: nowrap; width: 15%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; width: 15%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">100</td>
    <td style="white-space: nowrap; vertical-align: bottom; width: 13%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.07</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Duque de Caxias	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">RJ</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">UNIGRANRIO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">110</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">01.97</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Duque de Caxias	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">RJ</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">UNIGRANRIO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">88</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.17</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Rio de Janeiro	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">RJ</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">UNIGRANRIO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">110</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.04</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Itabuna	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">BA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">FASA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">64</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">01.23</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Alagoas	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">AL</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt">UNIMA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2023</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">100</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.14</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Alagoas	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">AL</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">UNIMA </td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2023</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">40</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">02.16</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Jaboat&#227;o	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PE</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">FCM Jaboat&#227;o </td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2023</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">100</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">01.18</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; text-indent: 0in">Jaboat&#227;o	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">PE</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">FCM Jaboat&#227;o </td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">2023</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">100</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">01.19</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Number of medical seats presented are estimated.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Schools with six or more years of operations are considered fully matured.</td></tr></table>

<!-- Field: Page; Sequence: 65 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Industry Overview</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Introduction to Brazil&#8217;s education environment</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil&#8217;s education environment has become
increasingly open to private capital. At the same time, the government has continued to play an important role through the municipalities,
states, and federal government.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Post-secondary education</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Higher education in Brazil differs significantly
from pre-secondary education. The majority of higher education schools are under private management and account for approximately 88%
(both for profit and nonprofit) of all higher education institutions, according to Sinopse Estat&#237;stica da Educa&#231;&#227;o
Superior. Higher education institutions are divided into three categories depending on the number of courses they offer, seniority of
the teaching staff, and amount of research they conduct: they can be classified as colleges, university centers or universities. Typical
post-secondary programs take between four to six years to complete. While some courses in these programs only occur during a certain period
of the day (i.e., morning, afternoon, or evening), others are offered as full day courses. Tuition is paid on a monthly basis, primarily
out of pocket by students and their families. Government financing is available, but not easily accessible. The main programs are FIES
and PROUNI, which together accounted, in Brazil, for 23.5% of total financing in 2022 prior to more regulated policies in recent years,
according to Sinopse Estat&#237;stica da Educa&#231;&#227;o Superior.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Introduction to Brazil&#8217;s medical education
industry</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In Brazil, aspiring physicians apply to medical
school following graduation from secondary education. Medical school in Brazil is a six-year undergraduate program. Upon graduation, medical
students gain a license and can start working as a generalist physician. At this point, they usually consider alternatives to gain a certification
for one or more medical specialties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The first and most common path to obtaining
a medical specialty certification is through a medical residency program. If a candidate chooses the medical residency path, the student
must pass an entrance examination, referred to as R1 exam administered by each institution offering a residency program. After getting
approved by a residency institution, the student then starts the first year of residency with the support of a government study grant
throughout the specialization period. If the physician wants to pursue a subspecialty, he or she will need additional years of study,
which may or may not require incremental entrance tests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Medical professionals that do not choose or
fail to be admitted into a residency program can still pursue a medical specialty certification through other alternatives. For instance,
a generalist can take the specialist certification exam to become a specialist after meeting a variety of eligibility criteria. Those
criteria can include internships, hours of work under supervision of a medical specialist, or hours of study in a certified graduate program,
among other methods. Depending on the desired level of medical specialty, it can take four to 10 years for a generalist to meet the criteria
and, in this context, graduate programs can be a shorter path to reach eligibility sooner.</p>


<!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As medical science continues to evolve very
rapidly, medical professionals must seek ways to stay up to date on those developments. For that purpose, physicians and other medical
professionals tend to use numerous sources of continuing medical education, or CME, including short term programs, scientific paper digests,
and medical congresses, among others.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Medical education system: Brazil vs. United States</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">While Brazil mandates that students pursue
a six-year specific undergraduate medical education, a student in the United States must typically earn a four-year undergraduate degree
prior to applying for medical school. Although no specific undergraduate degree is required, pre-medical, biology, and health focused
majors are recommended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A U.S. student must apply to medical school
programs upon finishing an undergraduate degree, typically taking another four years to complete medical school. As is the case in Brazil,
the U.S. medical school application process is highly competitive and has historically seen increasing medical course applications. In
2022, 22,710 U.S. students were enrolled out of 55,189 medical school applicants, representing an applicants per enrolled student ratio
of 2.4x. Additionally, the number of medical school applicants increased at a 2.0% Compound Annual Growth Rate, or CAGR from 2012 to 2022,
according to the AAMC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">While Brazilian students have the option to
either pursue a medical residency or work as a generalist after graduating, U.S. students are required to go through a residency program
after completing medical school to become an authorized physician. To do this, the student must enroll in the National Residency Matching
Program, or NRMP, which matches physician applicants to U.S. residency training programs. In 2023, 42,952 U.S. medical school graduates
applied for 40,375 residency positions, representing an applicants per enrolled student ratio of 1.1x. To complete the program and become
an authorized physician, each student must also pass the United States Medical Licensing Examination, or USMLE.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The diagram below illustrates the structure
and timeline of the Brazilian medical education system relative to the United States:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="image_029.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: MEC</i></p>


<!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="image_030.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: AAMC</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Regulatory overview and &#8220;<i>Mais M&#233;dicos</i>&#8221;
program</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Medical education in Brazil is subject to regulatory
terms that aim to define the supply of medical seats across the country. Since 2013, the Brazilian government put initiatives in place
to increase the number of annual medical school and residency vacancies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In 2013, the <i>&#8220;Mais M&#233;dicos&#8221;
Law</i> defined the rules for the creation of new medical courses in Brazil to address issues such as the unequal distribution of doctors
across Brazilian states. Among the criteria that support the creation of medical schools seats, two relevant aspects are (i)&#160;the
importance of these new openings in a specified region and (ii)&#160;the sufficiency of the current medical infrastructure in both public
regional hospitals and in the applicant medical institution in order to obtain government authorization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">To reduce the shortage of doctors and mitigate
the perceived healthcare inequality, the Brazilian federal government implemented a strategic initiative called &#8220;<i>Mais M&#233;dicos</i>.&#8221;
The program&#8217;s main objectives included addressing the provision of doctors for primary care in municipalities, strengthening health
care infrastructure, and allocating medical workforce to underserved areas.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Regarding academics, &#8220;<i>Mais M&#233;dicos</i>&#8221;
implemented short- and long-term measures to improve the Brazilian medical training system in both quantitative and qualitative ways.
Among these measures was the opening of new medical school slots, in both undergraduate courses and residency programs. From its creation
in 2013 until the date of this annual report, MEC, through SERES, announced three public calls for the selection of proposals for the
authorization of medical courses on a national scale, the &#8220;<i>Mais M&#233;dicos I</i>&#8221; program in 2013, the &#8220;<i>Mais
M&#233;dicos II</i>&#8221; program in 2018, and the &#8220;<i>Mais M&#233;dicos III</i>&#8221; program in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">&#8220;<i>Mais M&#233;dicos I</i>&#8221;
and &#8220;<i>Mais M&#233;dicos II</i>&#8221; jointly authorized the opening of 58 new medicine courses and, initially, 4,971 new seats
in medical schools, which may be increased by up to 100 seats, each in accordance with the &#8220;<i>Mais M&#233;dicos</i>&#8221; regulation.
With the increase in annual offerings through &#8220;<i>Mais M&#233;dicos</i>,&#8221; on April 5, 2018 MEC announced that the government
had decided to freeze the new offering of medical seats for a period of five years, pursuant to Ordinance No. 328/2018. The decision was
based on a need to evaluate the impact of opening new medicine courses in Brazil. However, on April 5, 2023, MEC issued Ordinance No.
650/2023, which revoked the suspension under Ordinance No. 328/2018 and set new rules for the opening of new medicine courses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Following the issuance of the Ordinance No.
650/23, on October 4, 2023, MEC, through SERES, exercising its legal powers and based on Article 3 of the <i>&#8220;Mais M&#233;dicos&#8221;
Law</i> announced the public call for the selection of proposals for the authorization of medical courses on a national scale. The rules
for the new &#8220;<i>Mais M&#233;dicos III</i>&#8221; program set forth the criteria for new undergraduate medical school seats. This
new program will allow the opening of 5,700 new undergraduate seats, to be distributed across 95 cities with a limit of 60 seats per institution.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Although the &#8220;<i>Mais M&#233;dicos</i>&#8221;
program requires a public call prior to the authorization of a new medicine course, some educational institutions have been judicially
challenging this restriction before Brazilian courts to compel MEC to receive and review requests for new medicine courses outside the
&#8220;<i>Mais M&#233;dicos</i>&#8221; program rules by alleging that these rules are an undue restriction on freedom of competition.
Certain courts may ultimately compel the MEC to receive and review these requests. For more information, see&#8221; Item 3. Key Information&#8212;D.
Risk Factors&#8212;We face significant competition in each program we offer and each geographic region in which we operate. If we fail
to compete efficiently, we may lose market share and our profitability may be adversely affected.&#8221;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 68 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, the increase in medical seats
in existing undergraduate courses is regulated by Ordinance No. 1,771, dated September 1, 2023, which allowed educational institutions
to request an increase in medical seats by submitting a request to MEC. As of the date of this annual report, those requests are still
under MEC&#8217;s analysis.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Brazilian medical education quantitative assessment</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Given the national regulatory framework, expanding
medical seats depends mostly on quality attributes and the need for additional doctors in the given geography. The number of medical seats
remained approximately unchanged between 2005 and 2012, but increased at a faster pace from 2012 to 2014 to mitigate the shortage of physicians
in the country.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">&#8220;Mais M&#233;dicos I&#8221; and &#8220;Mais
M&#233;dicos II&#8221; jointly authorized the opening of 58 new medicine courses and, initially, 4,971 new seats in medical schools,
which may be subject to an increase of up to 100 seats, each in accordance with the &#8220;<i>Mais M&#233;dicos</i>&#8221; regulation.
Furthermore, the new &#8220;<i>Mais M&#233;dicos III</i>&#8221; program will authorize the opening of up to 5,700 new undergraduate
seats.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">From 2012 to 2022, first-year enrollments in
private medical schools have increased by 20,386, representing a 10.6% CAGR, compared to an additional 2,901 public medical first-year
enrollments during that period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">According to the Demografia M&#233;dica do
Brasil report&#8212;which is co-produced by the Brazilian Medical Association (<i>Associa&#231;&#227;o M&#233;dica Brasileira</i>)
and the University of S&#227;o Paulo, Brazil, or Demografia M&#233;dica&#8212;the number of physicians in Brazil increased from 310,800
to 562,200 from 2010 to January 2023, representing an 80.8% increase. With that demand in place, a supply of new healthcare professionals
is expected to keep growing to keep up with the increased demand for public and private health services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">By January 2023, the total number of physicians
in Brazil increased to 562,229 professionals, implying 2.60 doctors per 1,000 inhabitants.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">Projection of the number of physicians in
Brazil (2019 to 2028)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="image_031.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: </i>Demografia M&#233;dica,
2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 69 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Fundamentals of medical education in Brazil</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The medical education market in Brazil is supported
mainly by the higher demand for medical courses than the actual seats offering, the low and uneven medical density when compared to the
Organization of Economic Cooperation and Development, or OECD average, Brazil&#8217;s fast aging population, and compelling financial
rewards for those seeking to pursue a medical career.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Brazil&#8217;s aging population</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil&#8217;s aging population is expected
to drive an increase in demand for physicians and other healthcare service providers. Brazil&#8217;s aging ratio is twice that of the
United Kingdom and three times that of the United States. Compared to 1995, life expectancy at birth is up from 66 years to 76 years,
driven primarily by medical and health improvements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">By 2030, 13.5% of the Brazilian population
is expected to be older than 65 years, compared to 7.3% in 2010. Furthermore, in 2060, the percentage of the population of 60 years and
older is expected to exceed the number of people of 19 years and under, according to the <i>Instituto Brasileiro de Geografia e Estat&#237;stica</i>,
or IBGE.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">Population distribution by age group&#8212;Brazil</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="image_032.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: </i>IBGE.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Increase in medical services demand</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The long-suppressed demand for health services
in Brazil is expected to continue to increase given demographic changes in Brazil as well as a larger portion of the population being
able to access private healthcare services. As of December 31, 2022, Private Health Insurance penetration in Brazil reached 24.7%, according
to data from ANS. This is lower than countries such as Germany, Australia and the United States, which according to the OECD have 33.9%,
54.9% and 63.0% penetration, respectively. Even with the expected increase in medical graduation, the demand for healthcare services is
expected to surpass the current supply of physicians by medical schools creating a continued demand for medical courses and graduate education.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">According to Demografia M&#233;dica, Brazil
had 2.6 doctors per 1,000 inhabitants in 2022, which is considerably below the international average and the average of developed countries,
which have been through the demographic changes that are expected to happen in Brazil. For example, according to Demografia M&#233;dica,
Italy had an average of 4.13 doctors per 1,000 inhabitants in 2022. Considering the projections of a total of 564,363 physicians in 2023
versus Brazil&#8217;s population growth over the same period, Brazil would still have approximately 2.6 doctors per 1,000 inhabitants,
which is still below the OECD average.</p>


<!-- Field: Page; Sequence: 70 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">Doctors per thousand inhabitants, according
to selected OECD countries (2022).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="image_033.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: </i>OECD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Shortage and distribution of medical professionals
in Brazil</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil&#8217;s low medical density and inequality
in physician distribution is illustrated in the figure below. S&#227;o Paulo and Rio de Janeiro have 3.6 and 4.2 doctors per 1,000 inhabitants,
respectively, while the states of Par&#225; and Acre have 1.3 and 1.7 doctors per inhabitant, respectively. The north and northeast
regions are Brazil&#8217;s most underserved areas and have been the focus of governmental physician assignment programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">With the new &#8220;<i>Mais M&#233;dicos
III</i>&#8221; program and the increase of physicians in the upcoming years, it is expected that Brazil&#8217;s medical density will reach
3.3 doctors per 1,000 inhabitants, which would still be below the OECD average of 3.73 in 2022.</p>


<!-- Field: Page; Sequence: 71 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">Distribution of doctors according to Brazilian
states&#8212;2023</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center"><img src="image_026.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: </i>Demografia M&#233;dica,
2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Compelling financial rewards for pursuing a medical
career</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">One of the notable arguments for pursuing a
medical career in Brazil is the financial outcome for the future physician, with higher salaries and fast payback. The main points of
view that support the increasing demand for medical education analysis are: (i) nearly 100% employability of medical school graduates
in Brazil; (ii) significantly higher salaries for medical school graduates than those enrolled in engineering courses (by approximately
44%), and (iii) a five-year post-graduation average payback period.</p>


<!-- Field: Page; Sequence: 72 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt; text-align: center"><img src="image_034.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: Instituto de Pesquisa Econ&#244;mica
Aplicada&#8212;IPEA, Brazilian Ministry of Labor, CAGED, eSocial, Empregador Web, Third-party consulting firm analysis.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Even when considering the comparatively high
tuition paid during the six-year medical undergraduate program, its above average income after graduation results in an average payback
period of five years, a relatively short period compared to other undergraduate education majors.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Supply and demand imbalance for medical education</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The number of medical school applicants has
declined consistently since 2014, with a CAGR of 10.8% for the years 2014 to 2022. This decline results primarily from a small decrease
in the number of applicants per year, followed by an increase in the number of seats openings for medical schools in the same period.
Although the number of medical schools applicants has declined, there remains a significant gap between the demand and supply of medical
education, which is expected to drive continued competitiveness in medical entrance exams.</p>


<!-- Field: Page; Sequence: 73 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">Applicants/openings for medical schools</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="image_035.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: Demografia M&#233;dica,
2023.</i></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">Total openings for medical school (in thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="image_036.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: Demografia M&#233;dica,
2023.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Since 2021, the number of applicants per openings
for medical residency increased according to the National Residency Exam, ENARE.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">Applicants/openings for medical residency</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="image_037.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: ENARE.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Expansion in graduate programs and CME</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The number of public and private medical graduate
courses is not measured by any institution, as it is developing and growing as residency slots become increasingly restricted. Typically,
educational institutions partner with hospitals to provide an adequate infrastructure for teaching students. Unlike residencies, students
pay out-of-pocket monthly tuition of around R$4,000, according to a third-party consulting firm. These are usually one to two-year courses
and there is currently no government student financing for this segment.</p>


<!-- Field: Page; Sequence: 74 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Market assessment and forecasts on medical education</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Medical schools</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of 2022, there were 389 medical schools
in Brazil, of which 69% are private and 31% are governmentally run, according to MEC. In terms of student seats, the relative distribution
is comparable: 77% are private while 23% are governmentally run. The market is also highly fragmented. A student that begins a medical
school program at the age of 18 would typically be expected to complete the program at 24 years old.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The medical schools segment shows that the
current supply of students&#8217; seats in medical courses has not been sufficient to service the growth in demand for medical education
in Brazil. The total number of enrolled medical students in private schools reached 157,000 in 2022 and is expected to increase to approximately
173,000 in 2028, assuming there will not be new openings by the government in the next five years.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt; text-align: center">Total students enrolled in private universities
(in thousands)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 10pt; margin-bottom: 10pt; text-align: center"><img src="image_038.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: INEP, third-party consulting
firm analysis. 2022-2028 figures are projections made in 2019.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">With the increasing demand creating a favorable
scenario for medical school tuition, a rise in the average current tuition is expected to post a 5.1% CAGR in the next seven years and
to reach R$154,000 in 2028, according to a third-party consulting firm. Both increases in the number of enrolled students and average
tuition support a market 6.9% CAGR between 2022 and 2028, implying that the 2022 R$17.9 billion market would grow to become a R$26.7 billion
market by 2028.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Residency and preparatory courses</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The number of medical residency student slots
available each year is regulated by the MEC and the Ministry of Health. Only hospitals are allowed to offer residency slots and no educational
institution does it unless it has its own teaching hospital. Each student receives a scholarship from the government for the duration
of their residency (from one to two years). Given the perceived lack of funding from the government, the number of residency students
seats is expected to remain approximately unchanged in the future.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">Openings for medical residency (in thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="image_039.jpg" alt=""/></p>


<p style="border-bottom: Black 0.5pt solid; font: 5pt Times New Roman, Times, Serif; margin: 0 5.5in 2.5pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: MEC. </i></p>

<!-- Field: Page; Sequence: 75 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">According to Demografia M&#233;dica, in 2023,
there were 789 hospitals that offered residency programs. The market is fragmented and the number of students&#8217; seats varies depending
on the specialty the physician is looking for. In 2023, five main areas of interest corresponded to the first choice of approximately
48% of recently graduated students applying to residency programs. A student that begins a medical residency program at the age of 24
would typically be expected to complete the program at 26 or 27 years old, depending on the student&#8217;s chosen specialty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Assuming that 80% of the students enrolled
in the fifth and sixth years of medical schools have an interest in taking the R1 test and that the R3 students will continue to grow
at current rates, the preparatory courses segment is expected to grow from its projected market size in 2022 of R$2.2 billion to approximately
R$3.4 billion by 2028, at a 7.2% CAGR.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Graduate programs</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Similar dynamics affect the graduate segment,
in which a student that begins a graduate program at the age of 24 would typically be expected to complete the program at 26 or 27 years
old, depending on the chosen course. Graduate courses are expected to benefit from the increase in new physicians graduating over the
coming years, and have an average duration of two to three years. The 2022 graduate market accounts for a total of R$6.1 billion and is
expected to grow at a 13.3% CAGR until 2028. According to a third-party consulting firm, the implied applicant/opening ratio for medical
residency programs was 7.1 in 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">This increase is primarily supported by the
continuing need for specialization, which is expected to raise the 2 107,000 students in 2022 to approximately 179,000 students by end
of 2028. A factor that supports the demand is the possibility of a student pursuing more than a single specialization along their career.
In line with the increasing number of enrollments, the demand for specialization is expected to see price increases during the same period,
implying a CAGR of 4.0%.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">Specialization students (in thousands)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="image_040.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: MEC, third-party consulting
firm analysis. 2022-2028 figures are projections.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">CME</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Doctors and other medical professionals are
expected to continuously educate themselves on evolving developments within their practice throughout their careers. Consequently, the
CME market in Brazil is expected to experience an increase in demand as the number of medical school graduates increases. The total number
of physicians in Brazil is expected to increase from 535,869 in 2022 to approximately 752,832 in 2028.</p>


<!-- Field: Page; Sequence: 76 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">Total physicians in Brazil (in millions)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="image_041.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: Scheffer M. et al., Third-party
consulting firm analysis. 2023-2028 figures are projections.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">With both expected growth in the number of
physicians between 2018 and 2023 and a tuition adjustment over this period, the CME market is expected to reach a total value of R$4.4
billion by 2028, compared to R$2.3 billion in 2022, implying an 11.6% CAGR. The increase is also supported by the need for continued education
on new technologies and procedures, two recurring topics in the medical education segment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Another important element of the CME market
is that it is currently not mandatory for doctors to regularly take CME courses. We expect this to change and become more in line with
other countries, where physicians must show their respective medical associations that they are up to date.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Other health non-medical school programs</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Other health-related undergraduate courses
which include dentistry, pharmacy, nutrition, physiotherapy, psychology, nursing, and physical education, enrolled a total of 1.9 million
students in 2022, representing a R$29.1 billion market. Although the impact of regulation and macroeconomic factors are comparable to
those of medical school programs, fundamentals of other health non-medical school programs differ from those of medical schools because
of consumer preferences, and the number of students is expected to remain flat. For health-related non-medical schools, average tuition
growth rates are expected to be in line with consumer inflation. These other health-related courses are expected to grow at a 5.7% CAGR
between 2022 and 2028, reaching a total addressable market of R$40.5 billion.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">Non-medical health students enrolled (in
millions)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><img src="image_042.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: INEP, Third-party consulting
firm analysis. 2022-2028 figures are projections made in 2019.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 77 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Total health education market potential</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Considering all medical segments combined,
there was an addressable market related to medical careers of approximately R$28.5 billion in 2022 and encompassing over 800,000 lifelong
medical learners, composed of:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a R$17.9 billion addressable medical school market, calculated as (i)&#160;the number of medical student enrollments totaling 157,000,
based on historical enrollment trends, and the addition of new medical schools seats (as published by the MEC), <i>multiplied by </i>(ii)&#160;the
estimated R$114,000 average annual tuition per student, based on an average of the annual tuition fees charged by private medical schools
in Brazil;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a R$2.2 billion addressable residency preparatory courses market, calculated as (i)&#160;the number of medical residency candidates
totaling 121,700, based on historical medical school graduation records and the number of medical school residency candidates (as published
by the MEC), <i>multiplied by</i> (ii)&#160;the estimated R$18,000 average annual course fees per candidate, based on an average of the
annual course fees charged by the four largest residency preparatory course providers in Brazil;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a R$6.1 billion addressable medical specialization courses market, calculated as (i)&#160;the number of physicians seeking specialization
courses totaling 107,000, based on historical medical school graduation and medical specialization course enrollment records (as published
by the MEC), <i>multiplied by</i> (ii)&#160;the estimated R$57,000 average annual course fees per physician, based on an average of the
annual course fees charged by the four largest medical specialization course providers in Brazil; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a R$2.3 billion addressable continuing medical education, or CME, market, calculated as (i)&#160;the number of physicians seeking
CME courses totaling 535,900, based on the number of active physicians in Brazil (as published by the Brazilian Medical Association <i>(Associa&#231;&#227;o
M&#233;dica Brasileira))</i>, <i>multiplied by</i> (ii)&#160;the estimated R$4,300 annual average amount spent per physician on CME
courses, based on the findings of a primary survey conducted by a third-party consulting firm.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The total addressable market is expected to
grow to R$47.3 billion and to over 1,200,000 lifelong medical learners by 2028. If the other health-related non-medical courses are added
to this figure, the addressable market increases to R$57.6 billion in 2022 and a projected R$87.8 billion in 2028.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Market Opportunity</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">According to a third-party consulting firm,
the total addressable market for the medical and healthcare career segment in Brazil was R$66.5 billion as of March 31, 2020, composed
of (i)&#160;a R$14.0 billion medical school market, (ii)&#160;a R$1.5 billion residency preparatory courses market, (iii)&#160;a R$4.8
billion medical specialization courses market, (iv)&#160;a R$1.8 billion continuing medical education market, (v)&#160;a R$23.0 billion
other health courses market and (vi)&#160;a R$21.4 billion medical digital services market. We estimate that we currently capture approximately
1.5% of the total addressable market based on our revenue for the last 12 months ended June 30, 2020. This market encompasses over 800,000
lifelong medical learners in Brazil, composed of 136,000 medical students, 91,000 students seeking residency preparatory courses, 90,000
specialization courses and 500,000 physicians seeking to enroll in specialization courses and CME, respectively, and 1,680,000 students
in other health courses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Medical education in Brazil benefits from a
combination of demographic and social factors, such as the expected increase in the number of people over 65 due to the increase in average
life expectancy, as well as the shortage of medical professionals in Brazil, which has resulted in an imbalance between supply and demand.
It also benefits from macroeconomic and financial factors, such as the increase in average household income, which has resulted in an
increase in demand for medical services and an increase in private and public healthcare spending. Accordingly, we expect the medical
education market in Brazil to continue to grow.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, given our end-to-end and physician-centric
ecosystem, our strong business model, and our reputation for quality, we believe that we are well positioned to take advantage of the
favorable growth dynamics of the medical education market in Brazil. According to a third-party consulting firm, the total addressable
market for medical education is expected to grow at a CAGR of 10.4% from 2020 to 2025, reaching R$23.0 billion in 2025. Including other
healthcare education services, the addressable market is expected to grow at a CAGR of 9.6% in the same period, reaching R$105.3 billion
by 2025.</p>


<!-- Field: Page; Sequence: 78 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 23%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Information</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Medical<br/>
    School</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Preparatory<br/>
    Courses for<br/>
    Residency</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Specialization<br/>
    Courses</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Continuing<br/>
    Medical<br/>
    Education</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Other
    Health Courses</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Medical
    Digital Services</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Total</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Total market (2020)(1) R$ billion	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">14.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.8</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1.8</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">23.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">21.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">66.5</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Total market (2025)(1) R$ billion	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">23.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">9.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">35.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">32.2</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">105.3</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">CAGR (5 years)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">10.4%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">14.9%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">13.6%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">10.8%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">8.8%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">8.5%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">9.6%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">AVG Ticket (2020)(1) R$	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">103,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">16,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">53,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3,900</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">14,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Total number of students (2020)(1)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">136,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">91,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">90,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">500,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,680,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Total number of students (2025)(1)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">171,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">143,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">142,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">600,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,110,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Afya&#8217;s market share (2020)(2)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">6.7%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">12.6%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.0%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: Third-party consulting firm
as of March 31, 2020.</i></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Estimated by the third-party consulting firm.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Afya&#8217;s total students 2020 / total number of students 2020, by segment.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Underlying Trends of Medical Education in Brazil</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition to a large and underpenetrated
total addressable market, we have identified other trends that contribute to the strength of the markets we serve:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Increased life expectancy and demand for medical services: </b>The Brazilian population is aging at the fastest rate in its recent
history. Average life expectancy is currently 76.2 years, and the number of people over 65 should double from 7% of the total population
in 2012 to 14% of the total population in 2033. This has led to, and is expected to continue to drive, increased demand for healthcare
professionals. In addition, private healthcare spending and public healthcare spending in Brazil grew at a CAGR of 14.0% and 11.8%, respectively,
from 2010 to 2015, primarily due to an increase in demand for medical services as a result of an aging population and an increase in average
household income. These trends have continued since 2015 to date.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Shortage of medical professionals in Brazil: </b>There is a shortage of medical professionals in Brazil, primarily due to the uneven
socio-economic environment. On average, Brazilian cities with less than 50,000 inhabitants, which corresponds to approximately 90% of
all cities in Brazil, have less than one physician per 1,000 residents. Brazil is expected to have an average of 3.07 physicians per 1,000
inhabitants by 2028, below the average of 3.4 for 2018 Organization for Economic Cooperation and Development, or OECD, countries.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Attractive financial incentives: </b>The medical profession is lucrative. Medical professionals are highly employable, with salaries
that are on average more than three times higher than the average salary for other professions such as engineering, nursing and law, and
1.9 to 3.8 times higher than the net present value of engineering, nursing or law programs in Brazil.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Supply and demand imbalance for medical education: </b>The number of available medical course seats in Brazil is controlled by
MEC, which has limited medical school intakes to current levels until 2023, resulting in a significant imbalance between supply and demand.
In the last three years, medical schools have on average received five applications per available medical course seat, and four applications
per available residency program vacancy, and the number of applications are expected to increase. We believe that graduate courses will gradually become a more popular,
high-demand destination for physicians that are not admitted into residency programs.</td></tr></table>


<!-- Field: Page; Sequence: 79 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>CME Expansion: </b>The growing number of physicians in Brazil and the demand for ongoing education on new medical procedures, drugs,
technologies and developments will continue to drive demand for CME.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Technological innovation is driving medical education: </b>The current generation of medical students and professionals requires
instantly accessible digital content. Over 600,000 biomedical articles have been published globally every year since 2005, and it is critical
for lifelong learners to be able to access information and learning methodologies regardless of location and physical availability.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Limited scope of existing product offerings: </b>By generally limiting their focus on individual aspects of a student&#8217;s education
cycle, traditional education providers have struggled to build comprehensive student track records and profile databases. Consequently,
there is a general lack of integrated platforms that apply accumulated student information to efficiently tailor experiences to, or produce
bespoke materials for, the particular needs of each student.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We believe we are well-positioned to take advantage
of this market and its trends, bringing a more effective, personal and diversified service to our students, which will enable us to continue
to grow our market share.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Our Competition</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We believe we are the only company in Brazil
with a focus on the entire learning career of a physician. However, several companies provide solutions that compete in some of the markets
in which we operate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We compete directly or indirectly with other
post-secondary institutions that offer medical courses or any of the other higher education courses in our portfolio. This market is very
fragmented and currently, there are more than 300 other institutions that offer medical courses in Brazil. The following table sets forth
our main competitors and the number of approved medical seats they had as of December 31, 2023:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Number
    of Approved Medical Seats</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 86%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Company</p></td>
    <td style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">As
    of<br/>
    December 31, 2023</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Afya Brazil	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3,163</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Player 1	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,842</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Player 2	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,586</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Player 3	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">580</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Player 4	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">521</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The market for graduate medical courses is
relatively new and a few small players operate in this segment.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Our Products and Services</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We offer the following educational products
and services to lifelong medical learners enrolled across our evolving distribution network, as well as to third-party medical schools.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Medical Schools</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>A fully integrated core curriculum is offered to our medical school students across all our campuses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>All our medical students have access to our supplemental instructional platforms as part of the internship module of their medical
course, which we implemented for all incoming medical students of the fifth and sixth academic year.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2023, this product had 21,446 enrolled students, and had total historical combined tuition fees of R$2,573.7
                                                                                                             million for the year ended December 31, 2023, which represented 32.5% and 78.8% of our total number of undergraduate enrolled
                                                                                                             students and our historical undergraduate programs combined tuition fees, respectively. As of December 31, 2022, this product had
                                                                                                             17,968 enrolled students, and had total historical combined tuition fees of R$2,032.9
million for the year ended December 31, 2022, which represented 30.9% and 77.1% of our total number of undergraduate enrolled students
and our historical undergraduate programs combined tuition fees, respectively. As of December 31, 2021, this product had 16,017 enrolled
students, and had total historical combined tuition fees of R$1,511.4 million for the year ended December 31, 2021, which represented
26.2% and 75.9% of our total number of our undergraduate enrolled students and our historical undergraduate programs combined tuition
fees, respectively.</td></tr></table>


<!-- Field: Page; Sequence: 80 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Medical Residency Preparatory Courses</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Instructional content in digital format is offered to medical students and newly graduated physicians to prepare them for medical
residency exams.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Supplementary instructional content in digital format is offered to third-party medical schools that adopt our services.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2023, we had 7,563 enrolled students in our medical residency preparatory courses. As of December 31, 2022, we
had 14,569 enrolled students in our medical residency preparatory courses. As of December 31, 2021, we had 21,631 enrolled students in
our medical residency preparatory courses.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Graduate Courses</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Graduate medical courses are offered to our medical school students across all our campuses. These students also have access to some
of our supplemental instructional platforms.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Supplemental instructional content for different medical specializations is offered to individual lifelong medical learners in our
graduate courses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2023, we had 4,976 enrolled students in our graduate courses. As of December 31, 2022, we had 4,280 enrolled students
in our graduate courses. As of December 31, 2021, we had 3,189 enrolled students in our graduate courses.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Other Programs</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Other national core curriculum is offered to all students across all of our undergraduate campuses: healthcare degrees and a subset
of non-healthcare degrees, including business and engineering degrees offered by the companies we invested in or acquired.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2023, these programs had 44,588 enrolled students, and had total combined tuition fees of R$693.1 million for the
year ended December 31, 2023, which represented 67.5% and 21.2% of our total number of enrolled students and our historical undergraduate
programs combined tuition fees, respectively. As of December 31, 2022, these programs had 40,232 enrolled students, and had total combined
tuition fees of R$2,241.8 million for the year ended December 31, 2022, which represented 69% and 22.8% of our total number of enrolled
students and our historical undergraduate programs combined tuition fees, respectively. As of December 31, 2021, these programs had 45,101
enrolled students, and had total combined tuition fees of R$478.7 million for the year ended December 31, 2021, which represented 73.8%
and 24.1% of our total number of enrolled students and our historical undergraduate programs combined tuition fees, respectively.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Digital health services</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Subscription-based mobile app and website portal focused on assisting health professionals and students with clinical decision-making
for 30 medical specializations through tools such as medical calculators, charts and updated content, including prescriptions, clinical
scores, medical procedures and laboratory exams, among others.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Free instructional content we offer to physicians, healthcare professionals and students.</td></tr></table>


<!-- Field: Page; Sequence: 81 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2023, we had approximately 260,710 monthly active users, consisting of approximately: 16,539 in Content and Technology
for Medical Education, 221,762 in Clinical Decision Software, 20,936 in Clinical Management Tools and 1,473 in Physician-Patient Relationship.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Our acquisition of PEBMED marked our entry in the digital health services sector, which we believe adds value to our platform. In
particular, our acquisition of PEBMED included the Whitebook product, which added approximately 125,300 active users to our platform and
increase our penetration in the segments in which we already operate through digital health services.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following chart sets forth our market share
by career aging cohort as of December 31, 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt; text-align: center"><img src="image_044.jpg" alt=""/></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Our Lifelong Medical Learner Clients</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, we had a total of
84,222 students across all our segments, including 21,446 enrolled in our undergraduate medical programs. As of December 31, 2023, we
had 7,563 enrolled students in our medical residency preparatory courses and 4,976 enrolled students in our medical specialization programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition to health sciences courses, which
comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine,
we also offer degree programs and courses in other non-health sciences subjects and disciplines across several of our campuses, including
undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy.
These non-health sciences courses are not part of our core business&#8212;the number we offer has increased as a consequence of our strategic
acquisitions in recent years of multi-disciplinary schools with strong health sciences programs, which are our principal focus. Although
non-health courses are not part of our growth strategy, we expect to continue to offer them to the extent they generate local demand.
These non-health sciences programs represented 9.3%, 10.1% and 12.0% of total historical undergraduate programs combined tuition fees
for all courses offered in 2023, 2022 and 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The attractive dynamics for medical education
in Brazil, including high demand for medical services and low medical density, combined with the exceptional rewards a physician receives
(e.g., high wages, fast payback), create the perfect environment for us, with high demand for health sciences programs throughout the
entire medical career. This scenario enables us to target a unique student profile during our selection process, capturing the most capable
individuals in Brazil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">According to Educainsights, medical students
are, at the outset of their medical journey, different from students that pursue other career paths. For example, while 27% of students
from non-medical undergraduate courses have a private high school background, that number increases to 82% for medical students. In addition,
64% and 65% of medical students have a father and mother with at least a higher education diploma, respectively, while for non-medical
courses, these figures are 16% and 22%, respectively. As a result, we are able to create a distinguished network of Afya students, which
we believe is essential to the success of our long-term brand building initiatives.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 82 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following chart sets forth certain differences
between medical and non-medical students in Brazil:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt; text-align: center"><img src="image_045.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, as of December 31, 2023, we had
17 contracts with other partner companies, which represents our B2B segment. These partnerships allow us to increase our distribution
outreach to other institutions around the country and help us achieve our mission.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Student Financing and Incentive Programs</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Student financing program&#8212;Fundo de
Financiamento Estudantil (</i>&#8220;<i>FIES</i>&#8221;<i>)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">FIES is a MEC program created by Law No. 10,260/2001
to provide financing to undergraduate students who are unable to finance their own education. After going through several reforms from
2015 onwards, as of the date of this annual report, the FIES program is provided in the following categories:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Public FIES (2018)&#8212;Extended to persons with a per capita income of up to three minimum wages, with zero interest rate, with
the credit risk being divided between the government and the private Higher Education Institutions, or HEIs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Private FIES (2018)&#8212;Extended to persons with a per capital income of up to five minimum wages, with low interest rates. Regional
funds and private financial institutions, provide the financing; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Social FIES (2024)&#8212;Reserves at least 50% of FIES vacancies in each selection process for students with a per capita family income
of up to half a minimum wage, with zero interest rate.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In the Public FIES and the Social FIES, the
financing is provided by federal government funds and contributions from HEIs through the FG-FIES fund. With respect to this fund, on
November 1, 2023, Law No. 14,719 was enacted and set a maximum contribution limit to the FG-FIES at 27.5%. This limit applies to contributions
made by maintaining entities voluntarily joining the program after the fifth year of their participation. In addition, as part of the
conditions and rules of the FIES program, private higher education institutions that apply for the program can immediately increase up
to 10% of their authorized vacancies annually.</p>


<!-- Field: Page; Sequence: 83 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For more information, see &#8220;Item 3. Key
Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Changes to the rules or delays or suspension
of tuition payments made through FIES may adversely affect our cash flows and our business&#8221; for further information.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Incentive program&#8212;Programa Universidade Para
Todos</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Programa Universidade Para Todos,</i> or
PROUNI, was established in 2005 through Law No. 10,096/2005, which offers full and partial scholarships (50%), in private HEIs for undergraduate
and subsequent courses of specific training, to Brazilian students without a higher education diploma. Additionally, the Government offers
federal tax exemptions to the higher education institutions adhering to PROUNI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Private higher education institutions, whether
for profit or not, may join PROUNI by signing a term of adhesion (valid for 10 years), and at least (i)&#160;offer a full scholarship
for every 10.7 students who pay a regular monthly fee and are regularly enrolled at the end of the previous school year; or (ii)&#160;an
integral scholarship for every 22 students who pay the regular monthly tuition fees in specific undergraduate and subsequent courses,
provided they also offer scholarships of 50%, in amounts necessary so that the sum of the benefits granted is equivalent to 8.5% of its
annual revenue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The tax exemptions (in whole or in part) for
HEIs that participate in this program are the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>IRPJ (income tax) and CSLL (social contribution), with respect to the portion of net income in proportion to revenues from traditional
and technology undergraduate programs; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>COFINS (Contribution for the Financing of Social Security) and PIS (Program of Social Integration), concerning revenues from traditional
and technology undergraduate programs.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, as part of the conditions and
rules of the PROUNI program, private higher education institutions that apply for the program can immediately increase up to 10% of their
authorized vacancies annually, except for law and medicine courses, which are subject to annual approvals by MEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, our exposure to PROUNI
was 9.3% of our student base. Although we fulfilled all required scholarships to receive 100% of tax exemption, PROUNI does not cover
our operation outside of our undergraduate programs.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Other private financing program</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya offers private financing program through
external partners (Banco Santander, Bradesco, Sicoob, CashMe and Alume) for undergraduate students. The credit risk is taken 100% by the
partner.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Key Benefits for our Lifelong Medical Learners</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We believe the end-to-end physician-centric
ecosystem we have been developing for our students sets us apart from our peers, as we deliver content and learning activities that are
tailored to each student&#8217;s needs. This contributes to a more interactive and enjoyable learning process for our students, breaking
away from a teaching system that we perceive as presenting students with an overwhelming amount of content, unengaging classes and scattered
information. We achieve this based on three main pillars: innovative data-oriented methodology, a cutting-edge platform and state-of-the-art
operating environment.</p>


<!-- Field: Page; Sequence: 84 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt; text-align: center"><img src="image_046.jpg" alt=""/></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Innovative, Data-oriented Methodology</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our proprietary methodology to support our
students&#8217; lifelong medical education is based on the following concepts:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Standardized medical curricula:</i> The
organization of our medical curricula around interdisciplinary macro-medical topics to guide the development of in-person teaching plans
and online learning tools, offering a scalable solution for schools through weekly synchronized content;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Active learning:</i> Educational strategy
to foster independent, critical and creative student thinking, as well as encourage effective teamwork through case-based problem-solving
exercises, debates and small-group discussions;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Blended learning:</i> Balanced in-person
teaching with technology-assisted activities to improve student and teacher efficiency and results; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Adaptive learning:</i> A personalized instruction
and assessment tool that provides training and content tailor-made to each student&#8217;s individual profile. Students can access real-time
feedback on areas in which they can improve, effective learning methods and teaching/study plans that are most suitable for them.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Cutting-Edge Digital Platform</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We deliver modern, bespoke verbal and practical
teaching. We continuously invest in creating innovative, technology-enabled activities and features to enhance our platform. We offer
our medical school students doing internships or studying for residency exams the following features through our digital platform:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Web portal and in-app communication:</i>
Online platform combining supplementary instructional content and a personalized communication tool for students, through which they can
also access our content offline;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Assessment tool</i>: Broad database suite
composed of quizzes and problem-solving activities, through which students can choose the subjects they would like to focus on, with additional
teacher-led instructional content;</p>


<!-- Field: Page; Sequence: 85 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Tutoring/mentoring platform</i>: An online
monitoring and support platform for both undergraduate and graduate medical students. The platform allows tutors to interact with students
through emails, video calls, voice calls and push notifications, and keeps records of such interactions. It also allows students to ask
the tutors questions and schedule appointments. The platform also tracks individual student performance and progress; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Digital health services platform</i>: A
combination of mobile and web applications focused on helping physicians, nurses, healthcare professionals and medical students in their
clinical decision-making and providing medical references and updates for the medical community.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">State-of-the-Art Operating Environment</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For us, individualized learning should be used
not just when offering content or technology-supported activities, but also during in-person encounters. Our professors can use our resources
to approach lessons more objectively, focusing on each student&#8217;s needs:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Modern teaching facilities:</i> We have
designed our classrooms to engage students in active learning. We rely on cutting-edge didactical equipment and simulation labs and state-of-the-art
realistic simulation technologies;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Medical specializations centers:</i> Our
campuses offer simulation centers and clinics where students can practice primary and secondary care, leveraging the learning process
and providing medical assistance to the local population; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Practical learning network:</i> Throughout
the internship cycle, our students can access over 649 partner teaching hospitals and clinics, the largest network of any education group
in Brazil.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Evolving Distribution Network</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We believe that an effective end-to-end physician-centric
ecosystem goes beyond offering the largest and most complete operating infrastructure to the students enrolled at our campuses and with
access to our digital platforms. Through our evolving distribution model, we also expect to empower lifelong medical learners across our
growing network of diversified partner teaching hospitals, clinics and third-party medical schools by increasing our products and services
offerings as we continue to expand our business-to-business, or B2B capabilities. Our partnerships include renowned institutions such
as the Brazilian Cancer Foundation, which joined our network in January 2020.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Seasonality of Operations</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya has three reporting segments: (1) Undergrad,
which provides educational services through undergraduate courses related to medicine, other health sciences and other undergraduate programs;
(2) Continuing Education, which provides specialization programs and graduate courses; and (3) Digital Services, which provides content
and technology for medical education, clinical decisions software, practice management tools and electronic medical records, doctor-patient
relationship, telemedicine and digital prescription.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Undergrad segment revenues are related to the
intake process and monthly tuition fees charged to students over the period; accordingly, this segment generally is not subject to significant
fluctuations from quarter to quarter. Continuing Education segment revenues are related to monthly intakes and tuition fees and generally
is not subject to significant fluctuations from quarter to quarter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Digital Services is comprised mainly of Pebmed,
Medcel, and iClinic revenues. While Pebmed and iClinic generally do not experience significant fluctuations resulting from seasonality,
Medcel&#8217;s revenue is concentrated in the first and last quarter of the fiscal year due to the period of enrollments of Medcel&#8217;s
clients. In addition, the majority of Medcel&#8217;s revenues are derived from printed books and e-books, which are recognized at the
point in time when control is transferred to the customer. Consequently, the Digital Services segment generally has higher revenues and
results of operations in the first and last quarters of the fiscal year than in the second and third quarters of the fiscal year.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Marketing and Sales</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our marketing strategy is focused on identifying,
qualifying and converting potential students into enrollments.</p>


<!-- Field: Page; Sequence: 86 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We execute our marketing strategy as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Identification: </b>We use online and offline media channels to distribute relevant content for all decision-making phases of current
and future physicians, so that they interact with our solutions throughout their learning careers.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Qualification: </b>After we obtain data on a potential student, we identify his/her needs by offering content that matches his/her
academic phase. In addition, through our score models, we can identify potential students that are more likely to enroll with us.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Conversion: </b>From that point on, we contact our sales department (online and inside sales) to convert potential students into
enrolled students through structured sales campaigns and continuous monitoring of conversion indices.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As our business model is end-to-end and physician-centric,
we aim to accompany our lifelong learners at each stage of their careers. Therefore, our sales funnels are calibrated according to the
segment&#8217;s supply-demand curve (graduation, preparatory, etc.), level of competition and other strategic variables.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For example, in medical schools, the most challenging
task is to identify potential students interested in attending medical school in a given cycle, since conversion typically occurs organically
due to the high demand for these courses. Our challenge is to attract and enroll the best ENEM students in our medical schools. With respect
to the medical residency preparatory phase and graduate programs, our main focus is to show potential students the benefits of our methodology
in terms of results and cost-benefit in order to guide them towards adopting our solutions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our marketing and sales efforts are supported
by Insider, Braze and Active Campaign, as well as other online analytical tools such as Hubspot and Salesforce products (Sales Cloud,
Marketing Cloud and Einstein).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our business model, combined with the use of
CRM tools gives us a unique competitive advantage: The ability to identify, market and offer products to virtually all medical students
and physicians in Brazil.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Technology and Intellectual Property</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Technology</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In recent years, we have implemented several
initiatives to improve operational efficiency and to integrate processes across several campuses and operations. We plan to continue this
process in the future to fully consolidate Afya Brazil&#8217;s integrated systems with those of our recent acquisitions.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Shared Services Center</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have invested in a modern Shared Services
Center, or SSC, to process back-office and non-student facing transactions that has idle capacity and is expected to enable student base
growth with low marginal costs.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Integrated Systems</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have adopted third-party systems to handle
our internal systems in a fully integrated manner:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Enterprise Resource Planning, or ERP: </b>TOTVS ERP RM is the leading solution in the Education Industry in Brazil and delivers
a flexible systemic solution that fits our companies&#8217; processes to improve management and organization. At the same time, it allows
high governance of the processes, with complete control of all back-office activities, preventing operational errors and allowing efficient
tax-related calculations and control of government obligations. Salesforce optimizes our sales and customer relationship management processes,
facilitating streamlined lead management, sales forecasting, and customer engagement. Its robust analytics capabilities offer valuable
insights into sales performance and customer behavior, enabling data-driven decision-making and strategic planning. Additionally, ServiceNow
enhances internal workflows and IT service management, empowering teams to efficiently handle incidents, changes, and service requests.
Its intuitive interface and automation bolster productivity and customer satisfaction. Moreover, ServiceNow&#8217;s robust
reporting and analytics offer valuable insights, facilitating data-driven decision-making and continuous improvement.</td></tr></table>


<!-- Field: Page; Sequence: 87 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Academic System: </b>TOTVS RM Educacional is a mature platform that allows the configuration of the student payment plan attached
to the disciplines enrolled and processes preventing manual financial transactions and making the process more flexible and efficient.
This system includes both Student and Faculty Portals, with features that allow mobile frequency monitoring and provide payment solutions
to students and also manages the faculties&#8217; timesheet and payroll.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Learning Management System, or LMS: </b>Canvas LMS is a cloud-native, highly scalable system that connects all digital learning
tools and evaluation resources accessed nationally by our faculties and students.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of the date of this annual report, iClinic,
Medical Harbour, Cliquefarma, Shosp, RX Pro, Al&#233;m da Medicina, CardioPapers and Glic independently operate their own ERP systems.
We are working to migrate the systems from the companies described above in order to fully incorporate them into our integrated systems.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Intellectual Property</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We rely on a combination of copyright, trademark
and trade secret laws, as well as employee and third-party non-disclosure, confidentiality and other types of contractual arrangements
to establish, maintain and enforce our intellectual property rights, including with respect to our proprietary rights related to our products
and services. In addition, we license technology from third parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of the date of this annual report, we had
no issued patents and one patent application pending in Brazil. As of December 31, 2023, we owned 375 trademark registrations in Brazil,
and we have also sought to register trademarks abroad, in the United States, in the European Union, Portugal, Mexico and Colombia. As
of the date of this annual report, we have 169 pending trademark applications in Brazil and unregistered trademarks that we use to promote
our brand, and also own 344 registered domain names in Brazil and 21 registered international domain names, and have registered two software
in Brazil.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Insurance</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have insurance policies with reputable insurers
in amounts considered sufficient by our management to cover potential losses arising from indemnities that we may have to pay to third
parties as a result of our operations. The policies for our operating units have an aggregate coverage limit of up to approximately R$345.8
million. The Company and its subsidiaries have a risk management program with the purpose of delimiting the risks, seeking in the market
coverage compatible with its size and operations. We seek coverage against risks that are compatible with our scale and type of operations,
considering the nature of our activities, the risks we are exposed to, market practices in our industry, and the advice of our insurance
consultants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">While we believe our insurance contracts reflect
standard market practices, there are certain types of risks that may not be covered by the policies (such as war, terrorism, acts of God
and force majeure, liability for certain harm or interruption of certain activities). Therefore, if any of these uncovered events occur,
we may be obliged to incur additional costs to remedy the situation, reconstitute our assets and/or indemnify our customers, which may
adversely affect us. Furthermore, even in the event that we incur a loss that is covered by our policies, we cannot assure that damages
awarded by our insurers will be sufficient to cover the losses arising from the insured event. See &#8220;Item 3. Key Information&#8212;D.
Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;We may be held liable for extraordinary events that may occur
at our campuses, which may have an adverse effect on our image and, consequently, our results of operations.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Regulatory Overview</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Brazilian Constitution establishes education
as a right for all citizens and a duty of the State and the family. Accordingly, the government is required to provide all Brazilian citizens
with access to free primary education with compulsory attendance. Private investment in education is permitted as long as entities providing
education services comply with the applicable rules and regulations.</p>


<!-- Field: Page; Sequence: 88 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Brazilian education system is organized
under a cooperative management among federal, state and municipal governments. The federal branch is required to organize and coordinate
the federal educational system in order to guarantee equal opportunity and quality of education throughout Brazil. The states and the
Federal District are required to focus on secondary education, while municipalities are responsible for providing pre-primary school and
primary education.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Private Higher Education Institutions are part
of the federal educational system and their activities are regulated by the federal government, and universities have didactic, scientific
and administrative autonomy as provided by the Brazilian Constitution.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, Law No. 9,394 of December 20,
1996, named by National Education Guidelines Law <i>(Lei de Diretrizes e Bases da Educa&#231;&#227;o,</i> or LDB) provides the guidelines
for the provision of educational services in Brazil and sets forth the federal government&#8217;s duty to, among others: (i)&#160;coordinate
the national education system; (ii)&#160;prepare the National Education Plan; (iii)&#160;provide technical and financial assistance to
the states, the Federal District and municipalities; and (iv)&#160;define, in cooperation with other federal entities, the responsibilities
and guidelines for primary and secondary education, with the federal government&#8217;s priority in post-secondary education, issuing
rules and regulations regarding undergraduate and graduate programs, and carrying out the activities relating to the accreditation of
institutions, authorization and recognition of courses and monitoring and evaluation of the educational system as a whole.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, the federal government, through
Law No. 10,172 of January 9, 2001, implemented the first National Education Plan <i>(Plano Nacional de Educa&#231;&#227;o,</i> or
PNE), with a duration of 10 years from the date of its publication. The PNE established objectives for post-secondary education to be
met by all branches of government. The primary goal was to offer post-secondary education to at least 30% of the population aged 18 to
24 by 2010. After the expiration of the first PNE, a new plan was enacted and the objectives were revised for the period of 2014 to 2024,
consolidated by Law No. 13,005 of June 25, 2014.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The new goals consist of: (1)&#160;increasing
post-secondary education enrollment rates to 50% of the population aged 18 to 24; (2)&#160;increasing the quality of post-secondary education
by raising the proportion of academic staff with master&#8217;s degrees and doctorate degrees to 75%, of which at least 35% shall be doctorates;
and (3)&#160;increasing progressively <i>stricto sensu</i> postgraduate programs. Such goals apply to each federation territory, and provide
orientation for the private education sector.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Finally, each of the federal, state and municipal
governments are required to prepare a 10-year education plan and to establish policies, guidelines and objectives applicable to the segment
of the Brazilian education system over which it has responsibility.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Post-secondary Education</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The post-secondary education sector is subject
to comprehensive government regulation. Its purpose is to ensure the quality of educational services, through evaluations of the ability
of educational institutions to meet minimum standards established by CNE and approved by MEC. This evaluation includes the analysis of
pedagogical projects, the infrastructure of Higher Educational Institutions, or HEIs, and their academic staff, and the results of such
evaluations are considered in the proceedings for opening new units and new courses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Therefore, activities and courses offered by
HEIs in Brazil depend on authorizations and are subject to ongoing regulation, guided by the results of quality assessments. The federal
responsibility to regulate, monitor and evaluate post-secondary education institutions and programs is exercised by the MEC, the CNE,
the INEP and the CONAES.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Ministry of Education</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Ministry of Education, or MEC, is the highest
authority for post-secondary education within the Brazilian national education system, whose competence consists, among other prerogatives,
of the following: (1)&#160;confirming CNE&#8217;s accreditation decisions for post-secondary education institutions; (2)&#160;confirming
evaluation systems and criteria adopted by the INEP; (3)&#160;confirming opinions and regulation proposals from the CNE; (4)&#160;issuing
rules and instructions for compliance with laws, decrees and regulations pertaining to education issues; and (5)&#160;regulating and monitoring
the post-secondary education system through its secretariats.</p>


<!-- Field: Page; Sequence: 89 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">National Education Council</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The National Education Council, or CNE, is
a consulting and decision-making body monitored by the MEC, collectively comprised of the Chamber of Primary and Secondary Education,
or CEB, and the Chamber of Post-secondary Education, or CES, each composed of 12 members appointed by the President of Brazil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">CNE is required, among other responsibilities,
to: (i)&#160;issue regulations to implement MEC&#8217;s guidelines, as well as advise and support MEC in its activities and decisions;
(ii)&#160;decide on accreditation applications and renewals from post-secondary education institutions engaged in distance learning, based
on the opinion of the relevant secretariats; (iii)&#160;propose guidelines and deliberate on the preparation of the evaluation instruments
for accreditation and re-accreditation of institutions to be elaborated by INEP; (iv)&#160;issue guidelines to be observed by SERES for
accreditation and re-accreditation of universities, university centers and colleges; (v)&#160;determine, through the CES, the inclusion
and exclusion of course designation from the catalog of advanced technology courses; (vi)&#160;rule on appeals of decisions issued by
SERES, CEB or CES; and (vii)&#160;analyze and propose questions regarding the application of post-secondary education legislation to the
MEC.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">An&#237;sio Teixeira National Institute for
Educational Research</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The An&#237;sio Teixeira National Institute
for Educational Research, or INEP, is a federal body linked to the MEC whose main responsibilities are, among others, to: (i)&#160;design,
plan, coordinate and operationalize actions for the evaluation of HEIs, undergraduate courses and government schools, as well as the National
Student Performance Examination, or ENADE, the examinations and assessments of undergraduate students; (ii)&#160;design, plan, coordinate,
operationalize and evaluate indicators related to post-secondary education resulting from examinations and inputs from official databases,
the establishment and maintenance of databases of specialized evaluators and collaborators, including the appointment of evaluation committees;
(iii)&#160;prepare and submit to MEC the instruments for external evaluation <i>(in loco),</i> in accordance with the guidelines proposed
by the SERES and by other competent bodies; (iv)&#160;design, plan, evaluate and update the indicators for the external evaluation instruments
in place, in accordance with the guidelines proposed by CONAES; (v)&#160;chair the Technical Committee for Evaluation Monitoring; and
(vi)&#160;plan, coordinate, operationalize and evaluate the actions necessary to achieve its objectives.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">National Higher Education Evaluation Commission</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The National Higher Education Evaluation Commission,
or CONAES, is a coordination and monitoring body of the National Higher Education Evaluation System, or SINAES, monitored by MEC, composed
of a President and 13 members, including one representative of the INEP, one representative of the <i>Funda&#231;&#227;o de Coordena&#231;&#227;o
de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior</i> (Foundation for the Coordination of Improvement of Post-secondary Education
Personnel, or CAPES), three representatives of the MEC (one of which must come from the body responsible for the regulation and monitoring
of post-secondary education), one representative of the student body of post-secondary education institutions, one representative of the
academic staff of post-secondary education institutions, one representative of the administrative body of post-secondary education institutions,
and five members appointed by the Minister of Education, with distinguished scientific, philosophic and artistic knowledge and proven
expertise in post-secondary evaluation or management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Among other activities CONAES is required to:
(i)&#160;propose and evaluate the dynamics, procedures and mechanisms for institutional evaluation, courses and student performance; (ii)&#160;establish
guidelines for the organization of evaluation committees, analyze reports, prepare opinions and submit recommendations to the competent
bodies; (iii)&#160;formulate proposals for the development of HEIs, based on the analysis and recommendations produced in the evaluation
processes; (iv)&#160;communicate with the state educational systems, with the aim to establish common actions and criteria for the evaluation
and supervision of post-secondary education; and (v)&#160;annually submit for approval by the Minister of Education the list of courses
for which students will apply for the ENADE.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Organization of Post-secondary Education Institutions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In order to allow post-secondary education
institutions to fulfill their objectives, the LDB also provides that post-secondary education includes the following programs:</p>


<!-- Field: Page; Sequence: 90 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Undergraduate courses,</i> including traditional and technological undergraduate courses, offering specific training and diplomas
to students, open to candidates who have completed high school or equivalent and who have been approved in the respective selection or
entrance examinations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Post-graduate courses,</i> including master&#8217;s and doctoral degrees, specialization courses, further training courses and
others, open to candidates who hold a diploma in an undergraduate course and who meet the requirements laid down by educational institutions;
and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Extension courses,</i> understood as any academic, technical or cultural activity that is not included as an integral and compulsory
part of the undergraduate and postgraduate curriculum, in which the students receive certificates. Such courses are open to candidates
who meet the requirements established in each case by educational institutions.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">According to the LDB, post-secondary education
can be provided by public or private institutions. A private post-secondary education institution must be controlled, managed and supported
by an individual or a legal entity with responsibility for financing its supported entities. Post-secondary education institutions may
be supported by for-profit or not-for-profit private institutions, or supporting entities, as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Private in the strict sense:</i> private for-profit institutions created and maintained by one or more private individuals or legal
entities;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Community:</i> incorporated by groups of individuals or by one or more legal entities and that include representatives of the community
in their organizational structure;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Confessional:</i> incorporated by groups of individuals or by one or more legal entities that meet the specific confessional and
ideological orientation and that include representatives of the community in their organizational structure; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Philanthropic,</i> in the form of the applicable regulations.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">According to their organization and academic
prerogatives, post-secondary education institutions can be:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Colleges:</i> colleges are public or private HEIs offering post-secondary programs in one or more areas, maintained by a single
supporting entity and with isolated management and direction. Colleges are allowed to offer programs along several levels, namely bachelor&#8217;s,
associate&#8217;s, specialization and graduate programs (master&#8217;s and doctorate degrees). Colleges have minimum requirements with
regard to the qualification of faculty members and their labor practices, and cannot establish new campuses, courses, or spots without
prior authorization from MEC;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>University Centers:</i> university centers are public or private education institutions offering several bachelor&#8217;s, associate&#8217;s
and graduate programs, and are expected to provide appropriate work conditions, education and qualification opportunities for their professors.
To be considered a university center, the institution shall comply with such requirements: (i)&#160;at least one-fifth of the faculty
members of a university center must hold a master&#8217;s or doctorate degree; (ii)&#160;at least 20% of the faculty members must work
on a full-time basis; (iii)&#160;at least eight undergraduate courses shall be recognized and have obtained a satisfactory concept in
the on-site external evaluation carried out by INEP; (iv)&#160;have an institutionalized extension program in the areas of knowledge covered
by their undergraduate courses; (v)&#160;have a scientific initiation program with a project supervised by doctoral or masters professors,
which may include programs of professional or technological initiation and initiation to teaching; (vi)&#160;have obtained an Institutional
Concept, or CI, greater than or equal to four in the on-site external evaluation performed by INEP; and (vii)&#160;have not been penalized
as a result of an administrative supervision process in the last two years; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Universities:</i> universities are public or private education institutions offering several post-secondary programs,
                                                                                                             continuing education and research development. Like University Centers, certain requirements for university re-accreditation must be
                                                                                                             observed, namely: (i)&#160;one-third of the academic staff is hired on a full-time basis; (ii)&#160;one-third of the faculty members
                                                                                                             must have a master&#8217;s or doctoral degree; (iii)&#160;at least 60.0% of the undergraduate courses shall be recognized and have a
                                                                                                             satisfactory concept obtained in the evaluation proceedings carried out by INEP; (iv)&#160;have an institutionalized extension
                                                                                                             program in the areas of knowledge covered by their undergraduate courses; (v)&#160;have
a scientific initiation program with a project supervised by master&#8217;s or doctoral professors, which may include programs of professional
or technological initiation and initiation to teaching; (vi)&#160;have obtained CI greater than or equal to four in the external evaluation
carried out by INEP; (vii)&#160;regularly offer four master&#8217;s degree courses and two PhD courses recognized by MEC; and (viii)&#160;have
not been penalized as a result of an administrative supervision process in the last two years.</td></tr></table>


<!-- Field: Page; Sequence: 91 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The LDB provides that the following powers
are granted to universities and university centers in the exercise of their autonomy, amongst others: (i)&#160;to create, organize and
discontinue post-secondary education programs on their premises, subject to the applicable regulation; (ii)&#160;to establish the curricula
for programs, subject to the applicable general guidelines; (iii)&#160;to establish plans, programs and projects in connection with scientific
research, artistic production and extra-curricular activities; (iv)&#160;to establish the number of student offerings available; and (v)&#160;to
create and change their bylaws in accordance with the applicable general rules, as well as to award degrees, diplomas and other certificates.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Distance Learning</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Distance learning in Brazil is regulated by
article 80 of the LDB, by Decrees 9,057 and 9,235, both of 2017, by Ordinances No. 11 and 23, both of 2017, and CNE&#8217;s Resolution
No. 1, of 2016.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Distance learning is defined as the educational
method in which didactic and pedagogic processes are conducted through information and communication media and technologies, with students
and teachers interacting in educational activities while located in different locations or at different times.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to the applicable regulations, distance
learning is subject to different factors compared to traditional methods, including: (i)&#160;reduced transmission costs in commercial
channels of sound and audiovisual broadcasting; (ii)&#160;concession of channels with exclusive educational purposes; and (iii)&#160;minimal
time reservation, with no onus on the public authorities, by the concessionaries of commercial channels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Distance learning can be offered at the following
levels and as part of the following educational methods: (i)&#160;primary and secondary education, as long as it is used only to supplement
learning processes or in emergency situations; (ii)&#160;education for young people and adults, according to specific legal criteria;
(iii)&#160;special education, according to specific legal criteria; (iv)&#160;professional education, covering technical programs at the
secondary level and technological programs at the post-secondary level; and (v)&#160;post-secondary education, covering graduate, master&#8217;s
programs, specializations, and doctorate studies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Graduate courses (bachelor&#8217;s, licentiate
and technological) may be offered using distance learning methods whenever a post-secondary institution is regularly accredited by the
MEC for this purpose.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to Decree No. 9,057, 2017, institutional
accreditation and reaccreditation, as well as the authorization and recognition of courses and their renewal will be subject to on-site
evaluation, with the aim to verify the existence and suitability of the method, infrastructure, technology and personnel that may enable
the execution of the activities provided in the Institutional Development Plan or PDI and the Pedagogical Project of the Course, or PPC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">HEIs accredited for the offering of post-secondary
education in the distance modality that hold autonomy prerogatives (universities and university centers) do not require authorization
for operation of the post-secondary course in the distance modality, but shall inform the MEC about the offering of the course within
60 days of the date of creation of such course, for the purposes of supervision, evaluation and recognition. Also, accredited HEIs must
inform the MEC about the creation of distance learning supporting units and the alteration of their addresses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Although distance learning is defined by the
absence of direct contact between students and teachers, there are activities that must be conducted on-site, such as tutorials, evaluations,
internships, professional practice, laboratory and dissertation defense, which are to be provided in the educational and development projects
of the institution and the course. Accordingly, the distance learning institutions must provide the necessary infrastructure for the students
to conduct those activities, using the headquarters of the education institution or smaller supporting units throughout the country. Distance
learning supporting units are no longer subject to on-site evaluation or required to obtain prior authorization of MEC in order to be
set up or operated. Pursuant to Ordinance No. 11/2017, such units can be created by a unilateral decision of the institution itself.</p>


<!-- Field: Page; Sequence: 92 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Distance courses and programs must be projected
with the same defined duration for the respective on-site courses. The evaluation of the performance of students for the purposes of promotion,
conclusion of the course and obtainment of diplomas and certificates must be conducted through the conclusion of the programmed activities
and on-site exams by the accredited HEIs, following procedures and criteria defined in respective PPC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The evaluation of the distance learning courses
is performed in a very similar manner as the evaluation of on-site courses. In the event of any irregularity or non-compliance to any
of the previously established conditions set by the MEC, the competent body may initiate an administrative proceeding that may result
in one or more penalties, such as: (i)&#160;forfeiture of accreditation or reaccreditation to operate as a distance learning institution;
(ii)&#160;intervention; (iii)&#160;temporary suspension of autonomy prerogatives; (iv)&#160;initiate reaccreditation proceedings; (v)&#160;reduction
of available vacancies within courses; (vi)&#160;temporary suspension of new students admissions; and (vii)&#160;temporary suspension
of courses offered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Diplomas and certificates for distance learning
courses and programs from accredited institutions are valid throughout the national territory and institutions are not entitled to set
different criteria for diplomas issued for distance learning courses and those issued for on-site courses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Distance learning courses may be offered only
by HEIs that hold specific accreditations for this purpose. It is MEC&#8217;s responsibility to promote the accreditation acts of post-secondary
institutions. To act outside the institution&#8217;s local geographic reach, the institution shall require an extraterritorial accreditation
to the MEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Distance learning courses or programs require
periodic renewal. Also, the accredited institution must initiate the authorized coursework within 24 months from the accreditation, and
if the institution does not implement the authorized activities in such time frame, it will be subject to an administrative proceeding
that may result in the canceling of the given authorization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to Decree No. 9,057/2017, post-secondary
courses may be offered in the distance learning modality through a partnership between an accredited distance HEI and another company.
In this case, applicable regulations establish that educational activities must be conducted in the facilities of the accredited HEI,
which will be responsible before MEC for the regularity of the teaching and learning processes. Accordingly, the HEI must inform MEC of
its partnerships, describing their purpose and most relevant aspects, in order for MEC to be able to assess eventual irregularities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In any case, distance learning courses and
programs are subject to the evaluation rules of the SINAES in the same manner that on-site courses are.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Regulatory Processes of Post-secondary Education Institutions</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Accreditation of Post-secondary Education Institutions
and Authorization and Recognition of Courses</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A post-secondary education institution is initially
accredited as a college. The accreditation as a university or university center is only granted after the institution has operated as
a college and met satisfactory quality standards, including positive assessments in the SINAES. In addition, the HEI must fulfill other
legal requirements that could vary according to the respective category, such as the requirement that a certain percentage of faculty
members meet minimum graduation standards (i.e., a doctorate or master&#8217;s degree), and specific types of labor regimes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The application for qualification of a post-secondary
education institution must be supported by various documents, including:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Supporting entity:</i> (i)&#160;incorporation documents, duly registered with the competent body, evidencing its existence and
legal capacity, in accordance with civil legislation; (ii)&#160;proof of registration in the National Taxpayer&#8217;s Registry or, CNPJ;
(iii)&#160;certificates of tax and social security compliance; (iv)&#160;proof of ownership of assets capable of supporting the education
institution; (v)&#160;financial statements; and (vi)&#160;consent form executed by the supporting entity&#8217;s legal representative,
vouching for the veracity and regularity of the provided information and the financial capability of the supporting entity; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Post-secondary education institution:</i> (i)&#160;proof of payment of the on-site evaluation fee related to the external evaluation
to be performed by INEP; (ii)&#160;PDI; (iii)&#160;bylaws and internal regulations; (iv)&#160;identification and qualification of managers,
with a description of their academic and administrative experience; (v)&#160;receipt of regularity and availability
of the teaching facilities; (vi)&#160;plan of accessibility assurance, pursuant to the regulation and followed by a technical report by
a competent professional or public body; and (vii)&#160;compliance with the legal requirements related to the safety of the building,
including having an escape route in case of fire, proved by a specific report issued by the competent public body.</td></tr></table>


<!-- Field: Page; Sequence: 93 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In relation to the accreditation process of
a new post-secondary educational institution and linked course authorizations, MEC may issue a temporary accreditation act to expedite
the operation, pursuant to article 24 of Decree No. 9,235/2017, as long as the supporting entity complies with all the following requirements:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>all self-supporting post-secondary education institutions have been reaccredited in the last five years obtaining an average Institutional
Score <i>(Conceito Institucional)</i> greater or equal to &#8220;4&#8221;;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>none of its post-secondary education institutions have been subject to administrative penalties by MEC in the last two years; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the courses to be offered by the new post-secondary institution, which are limited to a maximum of five courses, must already be offered
by other institutions supported by the same supporting entity and duly recognized by MEC in the last five years with a Program Score <i>(Conceito
de Curso)</i> greater or equal to &#8220;4.&#8221;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Following the initial accreditation as a post-secondary
education institution, colleges depend on an authorization issued by the MEC to offer post-secondary education courses. Within their autonomy,
universities and university centers do not depend on authorization by the MEC to create the majority of post-secondary education courses
and campuses in the same city as its headquarters, except for medicine, dentistry, psychology, nursery and law courses, which necessarily
must be previously authorized by the MEC. In any other cases, institutions are required to inform the MEC about the programs they offer
for purposes of monitoring, evaluation and further recognition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In the authorization for post-secondary on-site
courses of the federal education system the external in loco evaluation can be waived after documentary analysis if the following requirements
are met: (i)&#160;having an Institutional Score <i>(Conceito Institucional)</i> greater than or equal to &#8220;3&#8221;; (ii)&#160;absence
of a supervision process; and (iii)&#160;the institution offers other courses in the same area of knowledge which meet the minimum evaluation
standards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Requesting authorization for a course must
be supported by the following documents, among others: (i)&#160;proof of payment of the on-site evaluation fee; (ii)&#160;the PPC, outlining
the number of students, classes, description of the program and other relevant academic elements, and describing the facilities, technology
and staff for the distance learning support units, if applicable; (iii)&#160;list of faculty members, together with the relevant agreements
entered into with the education institution, together with their respective titles, working hours and work regime; and (iv)&#160;proof
of availability of the teaching facilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Universities and university centers may also
apply for the accreditation of a campus not located in the same city as its headquarters, provided that it is located in the same state.
Such campuses and programs must integrate the same set of universities or university centers and will only enjoy autonomous prerogatives
if there is compliance with the same headquarters requirements and if a high quality degree is shown, through an average Institutional
Score <i>(Conceito Institucional)</i> greater or equal to &#8220;4.&#8221; Therefore, even in the case of universities or university centers,
prior authorization from the MEC is necessary to create any courses on campuses not located in the same city as the university&#8217;s
headquarters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Once authorization for a given program has
been issued, post-secondary education institutions, including university centers and universities, must also file a request for the recognition
of the program as a condition for the national validation of the respective diploma. The requirement must be filed with MEC after the
midway point of the term established for the completion of the corresponding program and three-quarters completion of such term, and must
include the following documents, among others: (i)&#160;PPC, including the number of students, schedules and other pertinent academic
information, (ii)&#160;list of faculty members, listed in the national registry of instructors, and (iii)&#160;proof of availability of
the teaching facilities.</p>


<!-- Field: Page; Sequence: 94 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Authorization and recognition of courses, as
well as accreditation of post-secondary education institutions must have a limited term and be renewed periodically following the regular
evaluation process, currently established according to the evaluation cycles of the SINAES.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our post-secondary education institutions are
accredited by the MEC and their courses are duly authorized. We also make every effort to comply with all applicable regulations to maintain
our institutions and courses compliant with MEC regulations.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Modification of Supporting Entity</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to Decree No. 9,235/2017 and Ordinance
No. 23/2017, modification of a supporting entity occurs whenever there is a change in the supporting entity or its controlling shareholder,
affecting the decision-making process. Although it no longer depends on the approval of MEC, MEC must be informed within 60 days of the
consummation of the event for the purposes of updating the registration with MEC. Such notice must be followed by all the legal documents
related to the alteration, duly registered and the term of commitment executed by the legal representatives of both the current and new
supporting entities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The new supporting entity or controlling shareholder
must meet the requirements necessary for the accreditation of a post-secondary education institution, which will be assessed by MEC in
the context of the institution&#8217;s reaccreditation proceedings. Additionally, the LDB also provides that educational institutions
must inform the MEC of any change in their bylaws, which must be registered with the competent bodies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The transfer of programs or courses between
HEIs is strictly prohibited and may subject the involved entities to penalties such as: (i)&#160;suspension of new students&#8217; admission;
(ii)&#160;suspension of the offering of undergraduate or postgraduate <i>lato sensu</i> courses; (iii)&#160;suspension of the institution&#8217;s
autonomy to, among others, create new post-secondary courses and establish course curricula, if applicable; (iv)&#160;suspension of the
license to establish new distance-learning programs; (v)&#160;override any ongoing regulatory requests filed by the institution and prohibit
the filing of any new regulatory requests; (vi)&#160;suspension of the participation in the FIES; (vii)&#160;suspension of the participation
in PROUNI; and (viii)&#160;suspension or restriction to participate in other federal educational programs.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Financing Alternatives for Students: Incentive Programs</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Programs providing public funding to students
enrolled with private higher education institutions have been a major public policy to expand access to post-secondary education in Brazil,
especially for the low-income segment of the population. The most important programs are the following.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">University for All Program</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The University for All Program, or PROUNI is
a tax incentive program created through the Provisional Measure No. 213, of September 10, 2004, later converted into Law No. 11,096, of
January 13, 2005, that addresses the exemption of certain federal taxes imposed to post-secondary institutions that grant scholarships
to low-income students enrolled in undergraduate courses and technology graduate courses. By granting tax incentives to IES, PROUNI has
played an important role in inciting the growth and private investment in the post-secondary education sector.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Private post-secondary institutions may adhere
to PROUNI by the execution of a specific agreement with MEC, valid for 10 years and renewable for the same period. Such agreement must
be emended every semester with an additional term establishing the number of scholarships to be offered in each course, unit and class,
and what percentage of scholarships shall be granted to indigenous and afro-Brazilians. In order to participate in PROUNI, an educational
institution must:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>be up to date with its tax obligations; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>comply with the following requirements: (1)&#160;offer at least one full-time scholarship to every 10.7 regularly paying students
enrolled at the end of the past school year, excluding the full-time scholarships granted through PROUNI or by the institution; or (2)&#160;offer
one full-time scholarship to every 22 regularly paying students enrolled in traditional and technological graduation courses, provided
that it also offers scholarships (50% of the tuition) with a value equal to 8.5% of the paying students&#8217; annual revenue, available
to students enrolled in traditional and technological graduation courses at the school year.</td></tr></table>


<!-- Field: Page; Sequence: 95 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The ratio between the number of scholarships
and the number of regularly paying students must be complied with annually. If the entity does not comply with the ratio during a school
year because of the withdrawal of students, the institution must adjust the number of scholarships in a proportionate matter for the subsequent
school year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to Normative Ruling No. 1,394, of
September 12, 2013, issued by the Brazilian Federal Revenue Office, a post-secondary education institution that has adhered to the PROUNI
is exempt, totally or partly, from the following taxes for the duration of the adherence period:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Income Tax (&#8220;IRPJ&#8221;) and Social Contribution on Net Income (&#8220;CSLL&#8221;), with respect to the net income proportionate
to the revenue derived from the Undergraduate Degree Programs and Extension courses; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Contribution for Social Security Financing (&#8220;Cofins&#8221;) and Contribution to the Social Integration Plan (&#8220;PIS&#8221;),
with respect to the revenue derived from the traditional and technological graduation courses.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In case a post-secondary education institution
requires its exclusion from the PROUNI, its tax incentives will be suspended from the date of the solicitation and will not be applicable
for the entire period of the basis of calculation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Normative Ruling No. 1,394, of September 12,
2013, introduced new provisions regarding the tax exemptions granted by PROUNI, in particular the form to calculate the extension of the
benefits. According to this Normative Ruling, in addition to the tax exemptions obtained by HEI signatories to PROUNI, tax exemptions
are calculated based on the Proportion of Effective Occupation of the Scholarships, or POEB, and the exemption related to IRPJ would be
calculated without taking into account the additional 10%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">According to Article 7, II, amended by Normative
Ruling No. 1,417, dated September 6, 2013, the calculation of the exemption also includes the additional 10% of IRPJ, in addition to the
CSLL rate. The amount calculated is the amount of the IRPJ and CSLL exemption, respectively, which may be deducted from the IRPJ and CSLL
in relation to the totality of our activities. Accordingly, with the issuance of Normative Ruling No. 1,417, of September&#160;6, 2013,
the IRPJ / CSLL exemption on our operating income proportionate to the POEB will also include the additional 10% of IRPJ.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Moreover, considering that Normative Ruling
No. 1,417, dated September 6, 2013, creates a potential limit to the amount of the tax exemption, the application of these new provisions
will result in a reduction in value of the tax exemption obtained. Nevertheless, the legality of the provisions introduced by Normative
Ruling No. 1,417, of September 6, 2013, is being discussed before the judiciary, with several motions still pending.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Other modifications of the fiscal incentive
granted by PROUNI were established by Normative Ruling No. 1,476, of July 1, 2014, which also amends the aforementioned Normative Ruling
No. 1,417, of September 6, 2013, in order to (i)&#160;exclude several amounts from the concept of profit of the holding, which impacts
the enjoyment of the exemption related to CSLL and IRPJ; and (ii)&#160;exclude the POEB from the applicable calculation, specifically
for HEI with terms of adherence to PROUNI signed up to June 26, 2011, which also affects the calculation of the exemption specifically
enjoyed for the terms of adhesion celebrated in the period prior to that date.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Student Financing Program</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The <i>Programa de Financiamento Estudantil</i>
(Student Financing Program, or FIES), created by Law No. 10,260, of July 12, 2001, is a MEC program to finance students that cannot bear
the total costs of their education. FIES has been the most important program for the expansion of access to higher education in Brazil
during the last decade, and it is currently responsible for a significant part of the revenues of the majority of private higher education
institutions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">FIES consists of funding granted by the National
Fund for Educational Development, or FNDE to students regularly enrolled in an on-site course of a post-secondary private HEI registered
in the FIES that has been positively evaluated by the MEC. After a specific selection proceeding, students may be partially or wholly
funded by FIES and, in that case, FNDE will be responsible for crediting the corresponding amount due by the student to the private higher
education institution.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Payments are made with government bonds whose
primary purpose is to compensate tax debts from the private higher education institution. In case there are no debts to be compensated,
the institution can resell the bonds to the government by means of a specific proceeding that currently occurs on monthly basis. The
frequency of these proceedings could vary according to public financial constraints and the discretion of FNDE.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 96 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">FIES has been substantially reshaped by Law
No 13,530, dated December 7, 2017, and currently the program is not as broad as it used to be. According to applicable regulations, in
order to enroll students that have been selected by FIES, private higher education institutions are required to contribute to the fund
13% of the amount due by the student to the institution as consideration for the educational services rendered in the first year of studies.
This amount is subject to change in the following years and could vary between 10% and 25% of the consideration due, depending on specific
circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On March 1, 2024, MEC issued Ordinance No.
167/2024, establishing the Social FIES program. This program reserves at least 50% of FIES vacancies in each selection process for students
with a per capita family income of up to half a minimum wage, registered in the Central Registry of Social Programs of the Federal Government
(Cad&#218;nico). These eligible students can receive 100% financing for tuition fees at universities, subject to the availability of
the FIES budget.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">National Higher Education Evaluation System</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The National Higher Education Evaluation System,
or SINAES was created by Law No. 10,861 of April 14, 2004, with the purpose of evaluating post-secondary education institutions, undergraduate
courses and measuring student academic performance. The main objective of this evaluation system is to assess the quality of education
in the country, providing guidelines for MEC to decide upon institutional reaccreditation, recognition and renewal of recognition of courses.
Additionally, SINAES is responsible for improving the quality of post-secondary education in Brazil given that MEC can identify deficiencies
and establish specific conditions for institutions to remedy their issues and resume their operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The SINAES is monitored and coordinated by
the CONAES and INEP has a very important role in all processes. The results of the evaluation of post-secondary education institutions
and their programs are public and represented on a five level scale as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Level 5 indicates excellent conditions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Level 4 indicates more than satisfactory conditions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Levels 3 indicates satisfactory conditions; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Levels 1 and 2 indicate unsatisfactory conditions.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to applicable regulations, evaluation
processes consist of a preliminary assessment of several conditions relating to the institution and its courses, such as infrastructure,
titles of faculty members, work schedule of faculty members and student performance. Every year INEP establishes a method to evaluate
those elements and for them to correspond to a number in the five level scale.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The preliminary assessment is a complex process
based on quality indicators as follows:</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;National
Student Performance Examination</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The National Student Performance Examination,
or ENADE, is a test applied to a number of students that are completing courses. It evaluates students&#8217; knowledge regarding the
content provided in the curricular guidelines of the respective undergraduate course, their skills and competencies. ENADE&#8217;s results
are considered in the composition of quality indexes for courses and institutions.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Preliminary
Course Concept</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Preliminary Course Concept, or CPC, is
compound of the ENADE score, the Difference Indicator between Observed and Expected Performance, or IDD, and factors that include teacher
titles, the work schedule of faculty staff and infrastructure of the institution. It is an indicator of the state of undergraduate courses
in the country. CPC 1 and 2 courses are automatically included in the INEP examiner&#8217;s visit schedule for on-site verification of
teaching conditions. Courses with a concept equal to or greater than 3 can choose not to receive the visit of the evaluators and, thus,
transform the CPC into a permanent concept (the Course Concept). The CPC is released every year for a specific group of courses along
with the results of ENADE.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 97 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;General
Course Index</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The General Course Index, or IGC, of the institution
summarizes in a single indicator the results of CPC and the evaluation of master&#8217;s and doctorate courses of each educational institution.
With regard to graduate courses, CAPES indexes are used and adapted to the scale according to a methodology provided by INEP, given that
they are organized in a different manner. IGC also goes from 1 to 5 and is published by INEP/MEC, after the release of the results of
ENADE and CPC. The IGC is a criterion in the accreditation and re-accreditation processes of institutions and also in the authorization
process for new courses: institutions with IGCs less than 3, for example, may have their applications for new courses rejected by the
MEC. Similarly, the indicator is used to guide the expansion of quality education: institutions with good performance are exempted from
the authorization of the MEC to open courses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: white"><i>(d)</i></span><i>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Indicator
of Difference Between Observed and Expected Performance</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Indicator of Difference Between Observed
and Expected Performance, or IDD, is aimed at providing a reference of the contribution of the course to the learning of each student.
For that purpose, it compares the results of the ENADE with the performance of the same student in the ENEM. The indicator has a scale
of 1 to 5.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Following preliminary assessments, all institutions
are typically subject to an on-site evaluation to confirm the results. However, given the size of the system, MEC gives institutions the
option to convert the results of the preliminary assessments into final results and, therefore, forgo on-site evaluations. For institutions
that obtain unsatisfactory levels, MEC on-site evaluations are mandatory.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Even before the on-site evaluation, MEC is
entitled to apply precautionary measures when preliminary assessments of the institution or course are not considered satisfactory, such
as: (i)&#160;suspension of new enrollments within the respective course or the entire institution; (ii)&#160;reduction of vacancies; and
(iii)&#160;suspension of all regulatory proceedings for institutional reaccreditation, new authorizations, recognitions or renewals of
recognitions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Should the level be confirmed as less than
three by the on-site evaluation, MEC may propose a term of commitment to the institution, in order for it to correct the unsatisfactory
conditions within a specific deadline. Failure to uphold, in full or in part, the conditions established in the term of commitment may
result in one or more penalties to be applied by the MEC, such as: (i)&#160;temporary suspension of the opening of a selection process
of graduation courses; (ii)&#160;disqualification from the operating authorization of the higher education institution or recognition
of courses offered; and (iii)&#160;warning, suspension or cancellation of the mandate of the officer responsible for the action not executed,
in the case of public HEI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">After the on-site evaluations, institutions
and courses obtain definitive quality concepts, as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Institutional
Concept, which is the result of the on-site evaluation of the institution performed by INEP; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Course
Concept, which is the result of the on-site evaluation of the course performed by INEP.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Accreditation for Postgraduate programs</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Lato sensu</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Post-secondary HEIs accredited for offering
undergraduate courses and that have at least one regular undergraduate course or a <i>stricto sensu</i> postgraduate course can offer
<i>lato sensu </i>postgraduate in the subjects in which they are accredited, either on-site or through distance learning.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The offering of postgraduate programs does
not require an authorization to operate, even if it is offered by a college. However, it must be notified to MEC, through MEC&#8217;s
system (e-MEC), within 60 days of the date of creation of such course.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The <i>lato sensu</i> postgraduate courses
are aimed at students who hold a diploma in an undergraduate course and satisfy the criteria of the institution that is offering the
postgraduate course. The postgraduate courses must meet the following requirements: (i)&#160;curriculum with a minimum study load of
360 hours; and (ii)&#160;a teaching staff composed of at least 50% masters- or doctorate-level graduates of <i>stricto sensu</i> postgraduate
courses.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 98 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Stricto sensu</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The authorization and recognition of <i>stricto
sensu</i> postgraduate courses (masters and doctorates) must be evaluated by CAPES, submitted to CNE&#8217;s deliberation and approved
by MEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The HEIs can only initiate masters and doctorate
courses activities following publication of the homologation of CNE&#8217;s favorable opinion by MEC in the Official Gazette.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As part of its analysis, CAPES must consider
the general requirements and the specific parameters of the subject area to which each course is linked. The general requirements are:
(i)&#160;alignment of the proposal with the postgraduate planning of the institution; (ii)&#160;suitability and justification of the proposal
for the regional or national development and its economic and social importance; (iii)&#160;clarity and consistency of the proposal with
detailed information on its objectives, area of concentration, lines of research, curricular structure, discipline and bibliographic references;
(iv)&#160;clarity of the criteria adopted to select the students, justifications for the profile of the aimed formation and profile of
the egress; (v)&#160;proof that the teaching staff has academic, didactic, technical and scientific competence and qualifications related
to the purpose of the course; (vi)&#160;a permanent teaching staff to ensure the regularity and quality of teaching, research and orientation
activities; (vii)&#160;indication of up to five intellectual productions of each permanent teacher; and (viii)&#160;physical and technological
infrastructure of teaching and research adequate for the development of the proposed activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Authorizations of new <i>stricto sensu</i>
postgraduate courses must be requested at specific dates, as defined by CAPES and published in the Official Gazette.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">The &#8220;Mais M&#233;dicos&#8221; program</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The <i>&#8220;Mais M&#233;dicos&#8221; Law</i>
established the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, an initiative designed to address medical professional shortages in
certain municipalities and underserved regions of Brazil and improve healthcare infrastructure and services, implementing short- and long-term
measures to improve the Brazilian medical training system in both quantitative and qualitative ways. This law establishes specific regulations
for medical courses, including criteria for approving the creation of new courses in Brazil involving the definition of its location,
the mandatory contribution to the public health infrastructure according to the specific categories established by Ordinance No. 16/2014
issued by MEC (i.e., training of health professionals, building or reforming of health service structure, purchasing of medical equipment
and supplies and study grant to the medical residency program) and also the conditions for public-private partnerships to implement the
course.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Within the &#8220;<i>Mais M&#233;dicos</i>&#8221;
program, supporting entities are no longer able to choose the location of their courses or establish all conditions of supply, which have
been transferred to MEC. The proceedings to implement a medical course, therefore, are more bureaucratic and time consuming. Basically,
MEC publishes a public auction notice to select municipalities that will receive medical courses. After this selection, it issues another
public auction notice with the criteria for private higher institutions to compete for the right to implement courses in the municipalities
previously selected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">From its creation in 2013 until the date of
this annual report, MEC, through SERES, announced three public calls for the selection of proposals for the authorization of medical courses
on a national scale, the &#8220;<i>Mais M&#233;dicos I</i>&#8221; program in 2013, the &#8220;<i>Mais M&#233;dicos II</i>&#8221; program
in 2018, and the &#8220;<i>Mais M&#233;dicos III</i>&#8221; program in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">&#8220;<i>Mais M&#233;dicos I</i>&#8221;
and &#8220;<i>Mais M&#233;dicos II</i>&#8221; jointly authorized the opening of 58 new medicine courses and, initially, 4,971 new seats
in medical schools, which may be increased by up to 100 seats, each in accordance with the &#8220;<i>Mais M&#233;dicos</i>&#8221; regulation.
With the increase in annual offerings through &#8220;<i>Mais M&#233;dicos</i>,&#8221; on April 5, 2018 MEC announced that the government
had decided to freeze the new offering of medical seats for a period of five years, pursuant to Ordinance No. 328/2018. The decision was
based on a need to evaluate the impact of opening new medicine courses in Brazil. However, on April 5, 2023, MEC issued Ordinance No.
650/2023, which revoked the suspension under Ordinance No. 328/2018 and set new rules for the opening of new medicine courses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Following the issuance of the Ordinance No.
650/23, on October 4, 2023, MEC, through SERES, exercising its legal powers and based on Article 3 of the <i>&#8220;Mais M&#233;dicos&#8221;
Law</i> announced the public call for the selection of proposals for the authorization of medical courses on a national scale. The rules
for the new &#8220;<i>Mais M&#233;dicos III</i>&#8221; program set forth the criteria for new undergraduate medical school seats. This
new program will authorize the opening of up to 5,700 new undergraduate seats, to be distributed across 95 cities with a limit of 60
seats per institution.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 99 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_013"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Organizational
Structure</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">All of our subsidiaries are incorporated in
Brazil. The following is a chart of our current corporate structure as of the date of this annual report:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt; text-align: center"><img src="image_047.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Except for UEPC, all subsidiaries are controlled and/or wholly-owned by Afya Brazil.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>UNINOVAFAPI refers to IESP.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>ADMED refers to Al&#233;m da Medicina.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_014"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Property, Plant
and Equipment</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our corporate headquarters are located in Nova
Lima, State of Minas Gerais. It consists of 1,425 square meters of space under two leases, one expiring in June 2024, and the other expiring
in January 2025.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition to our corporate headquarters and
as of December 31, 2023, we leased almost all of our operational, sales, and administrative facilities. We believe that our facilities
are suitable and adequate for our business as presently conducted, however, we periodically review our facility requirements and may acquire
new space to meet the needs of our business or consolidate and dispose of facilities that are no longer required.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_015"></span><span style="color: #0D0E00">ITEM 4A. </span>UNRESOLVED STAFF
COMMENTS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">None.</p>


<!-- Field: Page; Sequence: 100 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_016"></span>ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_017"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating Results</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Overview</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are the leading medical education group
in Brazil based on the number of medical school seats, as published by MEC as of December 31, 2023, delivering an end-to-end physician-centric
ecosystem that serves and empowers students to be lifelong medical learners from the moment they join us as medical students through their
medical residency preparation, graduation program, and CME.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our innovative methodological approach combines
integrated content, interactive learning, and an adaptive experience for lifelong medical learners. Through our educational content and
technology-enabled activities, we focus on effective, personalized learning that mirrors one-on-one tutoring.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, we had 66,034 enrolled
students, compared to 58,200 enrolled students as of December 31, 2022, representing an increase of 13.5% for the period, and compared
to 61,118 enrolled students as of December 31, 2021, representing a decrease of 4.8% for the period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our ability to execute our business model and
strategy, primarily through our (i) acquisitions (which represented approximately 45.2% of our total growth in terms of revenue in 2023,
48% of our total growth in terms of revenue in 2022 and 80.5% of our total growth in terms of revenue in 2021) and (ii) organic growth
(which represented approximately 54.8% of our total growth in terms of revenue in 2023, 52% of our total growth in terms of revenue in
2022, and 19.5% of our total growth in terms of revenue in 2021), has led to growth, profitability and cash generation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In 2018, we were also awarded seven new undergraduate
campuses in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, the largest number awarded to any education group, with
a total of 350 new medical school seats. The operation of such campuses is subject to the verification by MEC of the satisfactory implementation
by Afya Brazil of all regulatory requirements. As of the date of this annual report, MEC already inspected six of these campuses and already
issued the authorization to operate. Accordingly, we plan to expand our network, and expect to open an additional campus starting in 2023,
taking our total to 32 campuses in 19 Brazilian states and approximately 3,203 available medical school seats per year.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Our Growth</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our revenue growth and increased profitability
have been driven by:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 17.45pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Maturation of current number of authorized medical school seats</b> &#8211; Anticipated and contracted growth visibility until
2030 from new medical seats awarded to our schools, that are in the process of maturing, and new seats from our awarded campuses in connection
with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program and which became operational in 2022;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 17.45pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Ability to set price</b> &#8211; readjustment of tuition fees paid by students enrolled in our medical schools above published
inflation indexes. In 2023, we increased our net average ticket by 8.2% compared to 2022 for all medical courses, excluding courses at
the UNIMA and FCM Jaboat&#227;o campuses. This increase significantly surpassed the 4.6% IPCA inflation rate for the same period, which
we believe shows the robustness of our business and our ability to adjust prices for students;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 17.45pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Expansion of medical residency preparation and graduate programs enrollments</b> &#8211; Increase in number of students adopting
our digital platform, as well as partners and students enrolling in our medical graduate courses;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 17.45pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Deepening of relationships across lifelong medical learners base</b> &#8211; Cross-selling opportunities such as increasing the
number of former undergraduate students subscribing to our medical residency prep solutions and the number of former undergraduate and/or
medical residency prep students applying to our graduate and CME courses;</td></tr></table>


<!-- Field: Page; Sequence: 101 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 17.45pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>M&amp;A</b> &#8211; Acquisition or investment in businesses that complement our medical education services offering. In 2023, we
acquired DelRey and an additional 15% of CCSI, consolidating our ownership of 75% of its total share capital. In 2022, we acquired or
invested in three companies, Al&#233;m da Medicina, CardioPapers, and Glic, which increased our Digital Services segment by 25.0% when
compared to December 31, 2021. In 2021, we acquired or invested in nine companies, UnifipMoc, Unigranrio and Garanhuns, medical schools
which increased our medical school seats by more than 37% when compared to December 31, 2020, and iClinic, Medicinae, Medical Harbour,
Cliquefarma, Shosp and RX PRO, digital health services companies that strengthened our digital business strategy. In 2020, we acquired
or invested in six companies, UniRedentor, UniSL, FESAR and FCMPB, medical schools which increased our medical school seats by more than
36% when compared to December 31, 2019, and PEBMED and MedPhone, digital health services companies that strengthened our digital business
strategy; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 17.45pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Synergies extraction</b> &#8211; Successful implementation of several measures to improve the profitability of recent acquisitions,
such as streamlining fee discounts and scholarship policies, integrating operations with our shared-services center; and aligning newly
acquired faculty teams with our career plan.</td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Key Business Metrics</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We review the following key metrics to evaluate
our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions:</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Contribution of Medicine to Total historical
undergraduate programs combined tuition fees</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We believe the metric that best demonstrates
our focus on medical education and its relevance to our products and services offering is historical undergraduate programs combined tuition
fees from medicine as a percentage of our total undergraduate programs combined tuition fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For the years ended December 31, 2023, 2022
and 2021, historical undergraduate programs combined tuition fees from medicine were 78.8%, 77.1% and 75.9%, respectively, of total undergraduate
programs combined tuition fees.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Historical undergraduate programs combined tuition
fees*</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following table sets forth information
that was derived from the historical operating information of Afya Brazil and each of the Acquired Companies since the date of acquisition.
It does not represent revenue as disclosed in our financial statements included elsewhere in this annual report, which are presented as
the sum of (a)&#160;gross tuition fees charged to undergraduate students, (b)&#160;gross tuition fees charged to graduate students and
(c)&#160;scholarships.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td colspan="4" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">For
    the Year Ended December 31,</p></td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 56%; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td style="vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023<span style="font-weight: normal">&#160;&#160;&#160;</span></p></td>
    <td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td>
    <td style="vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2021</p></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding: 1pt 2.9pt 2pt; vertical-align: top; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(in US$ millions(1))</td>
    <td colspan="3" style="padding: 1pt 2.9pt 2pt; vertical-align: bottom; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(in R$ millions)</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td colspan="4" style="padding: 1pt 2.9pt 2pt; vertical-align: top; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(except percentages)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Medical school programs	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">531.6</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,573.7</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,032.9</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,511.4</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Other undergraduate health sciences programs	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">80.3</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">388.8</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">336.2</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">239.5</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Other undergraduate programs(2)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">62.9</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">304.3</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">266.3</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">239.2</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Undergraduate programs combined tuition fees</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>674.8</b></p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>3,266.8</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2,635.4</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,990.1</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">% Medicine(3)	</td>
    <td style="vertical-align: top; padding-right: -6pt; padding-left: 2.9pt; text-align: right">78.8%</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">78.8%</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">77.1%</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">75.9%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">% Health sciences programs(4)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">11.9%</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">11.9%</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">12.7%</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">88.0%</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">*</td><td>Historical undergraduate programs combined tuition fees is the sum equal to the total tuition fees charged to undergraduate students,
as derived from historical operating information of Afya Brazil and the Acquired Companies for the years ended December 31, 2023, 2022
and 2021. For the years ended December 31, 2023, 2022 and 2021, historical undergraduate programs combined tuition fees charged to undergraduate
students by us were R$3,266.8 million, R$2,635.4 million and R$1,990.1 million, respectively. Historical undergraduate programs combined
tuition fees does not include tuition fees we charge graduate students. We present historical undergraduate programs combined tuition
fees because, given our limited operating history and that our historical financial information and operational information
included elsewhere in this annual report may not be representative of our results and operations as a consolidated company, we believe
that it may help investors assess the past operating results of the Acquired Companies as combined with Afya Brazil. This metric also
shows the percentage of revenues we derive from our medicine and health sciences programs, which are our core business. We present historical
undergraduate programs combined tuition fees as the sum of gross tuition fees charged to undergraduate students, which differs from the
tuition fees set forth in our financial statements, which are presented as the sum of (a) gross tuition fees charged to undergraduate
students, (b) gross tuition fees charged to graduate students and (c) scholarships which are presented as the sum of gross tuition fees
charged to students net of cancellations, discounts and taxes, and which also include revenue from admission fees and income from leases,
among others. The past performance of Afya Brazil and the Acquired Companies, as reflected in the historical undergraduate programs combined
tuition fees information, may not be indicative of our future performance or any future anticipated synergies, future operating efficiencies
or cost savings that may result from these acquisitions. For further information, see &#8220;Part I&#8212;Introduction&#8212;Financial
Information&#8212;Historical Undergraduate Programs Combined Tuition Fees.&#8221;</td></tr></table>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>For convenience purposes only, amounts in <i>reais</i> for the year ended December 31, 2023 have been translated to U.S. dollars using
an exchange rate of R$4.8413 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2023, as reported by the Central
Bank. These translations should not be considered representations that any such amounts have been, could have been or could be converted
at that or any other exchange rate.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Represents all non-health sciences undergraduate programs.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>Calculated as medical school programs divided by the historical undergraduate programs combined tuition fees.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(4)</td><td>Calculated as the sum of medical school programs and other undergraduate health sciences programs, divided by the historical undergraduate
programs combined tuition fees.</td></tr></table>
<!-- Field: Page; Sequence: 102 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Medical School Regulatory Capacity and Capacity
at Maturation</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Medical school regulatory capacity and capacity
at maturation are operating metrics that provide visibility into our medical school enrollments contracted growth given the supply and
demand imbalance in the medical school market and the fact that our medical schools have historically operated very close to their regulatory
capacity. Accordingly, the gradual increase in our capacity helps explain the increase in our medical school enrollments, which in turn
helps explain our medical school enrollments contracted growth. Contracted growth refers only to schools that are in the initial six years
of operation. In addition, since the maximum number of medical seats per medical school is set by applicable regulations, the only way
to grow our medical school seats, and therefore our number of enrollments, is through acquisitions or starting new medical schools.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Medical school regulatory capacity is defined
by the number of medical school seats available per year awarded by the MEC <i>plus</i> the additional seats associated with PROUNI and
FIES, <i>multiplied by</i> the number of years of operations since the seats were awarded, up to the sixth year of operations (maturation).
Capacity at maturation represents the maximum number of approved seats at a medical school six years after becoming operational. Our medical
schools have a six-year maturation cycle because medical school programs in Brazil are for a duration of six years. A maturation cycle
represents the period starting when a medical school commences its operations with a first year medical school class of students which
progresses through the required six years as the next classes begin behind it, and ends when the medical school has six school years of
medical students and has therefore reached capacity at maturation (i.e., the maximum number of approved seats).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For illustration, a medical school that is
awarded 100 seats from the MEC has the opportunity to add up to 20 additional seats:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 205.6pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>10 more seats by adhering to PROUNI (one seat for every 10.7 seats awarded by MEC); and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 205.6pt"/><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>10 more seats by adhering to FIES (10% of the seats awarded by MEC).</td></tr></table>


<!-- Field: Page; Sequence: 103 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">Illustrative evolution of regulatory capacity
per medical school</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center"><img src="image_048.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our medical school regulatory capacity by seats
was 3,163, 2,823 and 2,731 seats and our capacity at maturation was 22,774, 20,325 and 19,663, as of December 31, 2023, 2022 and 2021,
respectively. Assuming our medical schools continue to operate at full capacity, we estimate reaching a total medical student base of
23,062 students by 2030.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Medical School Occupancy Rate</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The occupancy rate of our medical schools is
the ratio of the number of students effectively enrolled divided by the regulatory capacity in a given period. While we believe retention
rates are an important measure of quality and customer satisfaction, we believe that occupancy rate is a more meaningful metric as it
captures not only our ability to retain students but also to find new students to compensate for eventual dropouts. Our management does
not separately measure retention rates to make decisions about our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following table sets forth our medical
seats occupancy rate as of the dates indicated.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">As
    of December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; width: 61%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2021</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Occupancy rate	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">~100.0%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">~100.0%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">~100.0%</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Non-GAAP Financial Measures</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">This annual report presents our Adjusted EBITDA
and Operating Cash Conversion Ratio information for the convenience of investors, which are non-GAAP financial measures. A non-GAAP financial
measure is generally defined as one that purports to measure financial performance but excludes or includes amounts that would not be
so adjusted in the most comparable GAAP measure. Although Adjusted EBITDA and Operating Cash Conversion Ratio are used by investors and
securities analysts in their evaluation of companies, these measures have limitations as analytical tools, and you should not consider
them in isolation or as substitutes for the IFRS measures of earnings. Additionally, our calculations of Adjusted EBITDA and Operating
Cash Conversion Ratio may be different from the calculations used by other companies, including our competitors in the education services
industry, and therefore, our measures may not be comparable to those of other companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We present Adjusted EBITDA because we believe
this measure provides investors with a supplemental measure of the financial performance of our core operations that facilitates period-to-period
comparisons on a consistent basis. We calculate our Adjusted EBITDA as net income <i>plus/minus</i> finance result <i>plus</i> income
taxes expense <i>plus</i> depreciation and amortization <i>plus</i> interest received on late payments of monthly tuition fees, <i>minus</i>
income share associate, <i>plus</i> share-based compensation expense <i>plus/minus</i> non-recurring expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We also present Operating Cash Conversion Ratio
because we believe this measure provides investors with a measure of how efficiently we convert our EBITDA into cash. We calculate our
Operating Cash Conversion Ratio as the cash flows from operations <i>plus/minus</i> income taxes paid <i>divided by</i> Adjusted EBITDA
<i>plus/minus</i> non-recurring expenses.</p>


<!-- Field: Page; Sequence: 104 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following tables set forth the Adjusted
EBITDA reconciliation to our net income and the Operating Cash Conversion Ratio reconciliation to our cash flow from operations for the
years ended December 31, 2023, 2022 and 2021, in each case, our most recent directly comparable financial measures calculated and presented
in accordance with IFRS.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Reconciliation between Net Income and Adjusted
EBITDA</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="4" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">For
    the Year Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; width: 56%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2021</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(in US$ millions(1))</td>
    <td colspan="3" style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(in R$ millions)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Net income	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">83.7</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">405.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">392.8</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">242.3</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Finance result	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">71.7</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">347.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">247.9</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">179.2</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Income taxes expense	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">24.2</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">35.7</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">31.2</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Depreciation and amortization	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">59.8</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">289.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">206.2</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">154.2</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Interest received(2)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">6.9</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">33.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">27.2</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">23.0</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Share of income of associate	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(2.0)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(9.5)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(12.2)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(11.8)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Share-based compensation expense	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">6.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">31.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">31.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">43.4</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Non-recurring expenses(3):</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">9.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">44.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">33.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">93.3</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 8.65pt; padding-left: 17.3pt; text-indent: -8.65pt">Integration of new companies(4)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.8</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">28.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">24.8</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">18.9</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 8.65pt; padding-left: 17.3pt; text-indent: -8.65pt">M&amp;A advisory and due diligence(5)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">12.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">13.5</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 8.65pt; padding-left: 17.3pt; text-indent: -8.65pt">Gain on tax amnesty(6)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(3.5)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(16.8)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 8.65pt; padding-left: 17.3pt; text-indent: -8.65pt">Expansion projects(7)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">0.9</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">10.2</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 8.65pt; padding-left: 17.3pt; text-indent: -8.65pt">Restructuring expenses(8)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">12.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">12.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">17.4</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 8.65pt; padding-left: 17.3pt; text-indent: -8.65pt">Mandatory discounts in tuition fees(9)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">0.8</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">3.8</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(9.9)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">33.4</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Adjusted EBITDA</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>240.8</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,165.7</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>961.9</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>754.8</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>For convenience purposes only, amounts in reais for the year ended December 31, 2023 have been translated to U.S. dollars using an
exchange rate of R$4.8413 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2023, as reported by the Central
Bank. These translations should not be considered representations that any such amounts have been, could have been or could be converted
at that or any other exchange rate. See &#8220;&#8212;Exchange Rates&#8221; for further information about recent fluctuations in exchange
rates.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Consists of interest received on late payments of monthly tuition fees.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>We believe these adjustments are appropriate to provide additional information to investors about certain material non-cash or non-recurring
items that we do not expect to continue at the same level in the future.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(4)</td><td>Consists of expenses related to the integration of recently acquired companies, such as expenses with personnel and third-party consulting
firms.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(5)</td><td>Consists of expenses related to professional and consultant fees in connection with due diligence services for our M&amp;A transactions.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(6)</td><td>On August 10, 2023, Unigranrio entered into a tax amnesty program on interest and penalties to settle a tax proceeding in respect
to ISS (city tax on services) with the municipality of Rio de Janeiro, which resulted in a payment of R$14.9 million to settle the claim.
The selling shareholders of Unigranrio agreed to pay R$5.4 million regarding this matter. We had a provision of R$53.3 million and an
indemnification asset from the selling shareholders of R$20.0 million (in light of the indemnification clauses as defined at acquisition
of Unigranrio), in respect to such tax proceeding. The difference between the provision, indemnification asset and the actual paid amount
was recorded in Other income (expenses), net on the consolidated statement of income and comprehensive income.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0; text-align: right"/><td style="width: 0.25in">(7)</td><td style="text-align: justify">Consists of expenses related to professional and consultant fees in connection with the opening
of new campuses.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(8)</td><td>Consists of expenses related to the employee redundancies in connection with the organizational restructuring of our acquired companies.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(9)</td><td>Consists of mandatory discounts in tuition fees granted by state decrees and individual/collective legal proceedings and public civil
proceedings due to COVID-19 on-site class restriction, and excludes any recovery of these discounts that were invoiced based on a decision
by the Brazilian Supreme Court with respect to this matter that deemed such discounts to be unconstitutional.</td></tr></table>


<!-- Field: Page; Sequence: 105 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Reconciliation between Cash Flow from Operations
and Operating Cash Conversion Ratio</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="4" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">For
    the Year Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; width: 64%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td style="width: 9%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 9%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 9%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td>
    <td style="width: 9%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2021</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(in US$ millions(1))</td>
    <td colspan="3" style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(in R$ millions)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="4" style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(except percentages)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Net cash flows from operating activities	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">215.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,043.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">843.9</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">630.8</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Income taxes paid	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">9.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">45.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">33.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">35.7</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Net cash flows from operating activities, before income taxes paid	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">224.9</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,088.8</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">877.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">666.5</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Adjusted EBITDA	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">240.8</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,165.7</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">961.9</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">754.8</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Integration of new companies(2)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">9.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">28.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">24.8</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">18.9</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">M&amp;A advisory and due diligence(3)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">12.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">13.5</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Gain on tax amnesty(4)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(3.5)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(16.8)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Expansion projects(5)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">0.9</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">10.2</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Restructuring expenses(6)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">12.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">12.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">17.4</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Mandatory discounts in tuition fees(7)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">0.8</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3.8</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(9.9)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">33.4</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Adjusted EBITDA ex. non-recurring expenses	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">231.7</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">1,121.6</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">928.8</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">661.4</p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Operating Cash Conversion Ratio(8)</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>97.1%</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>97.1%</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>94.4%</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>100.8%</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>For convenience purposes only, amounts in reais for the year ended December 31, 2023 have been translated to U.S. dollars using an
exchange rate of R$4.8413 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2023, as reported by the Central
Bank. These translations should not be considered representations that any such amounts have been, could have been or could be converted
at that or any other exchange rate. See &#8220;&#8212;Exchange Rates&#8221; for further information about recent fluctuations in exchange
rates.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Consists of expenses related to the integration of recently acquired companies, such as expenses with personnel and third-party consulting
firms.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>Consists of expenses related to professional and consultant fees in connection with due diligence services for our M&amp;A transactions.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(4)</td><td>On August 10, 2023, Unigranrio entered into a tax amnesty program on interest and penalties to settle a tax proceeding in respect
to ISS (city tax on services) with the municipality of Rio de Janeiro, which resulted in a payment of R$14.9 million to settle the claim.
The selling shareholders of Unigranrio agreed to pay R$5.4 million regarding this matter. We had a provision of R$53.3 million and an
indemnification asset from the selling shareholders of R$20.0 million (in light of the indemnification clauses as defined at acquisition
of Unigranrio), in respect to such tax proceeding. The difference between the provision, indemnification asset and the actual paid amount
was recorded in Other income (expenses), net on the consolidated statement of income and comprehensive income.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(5)</td><td>Consists of expenses related to professional and consultant fees in connection with the opening of new campuses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(6)</td><td>Consists of expenses related to the employee redundancies in connection with the organizational restructuring of our acquired companies.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(7)</td><td>Consists of mandatory discounts in tuition fees granted by state decrees and individual/collective legal proceedings and public civil
proceedings due to COVID-19 on-site class restriction, and excludes any recovery of these discounts that were invoiced based on a decision
by the Brazilian Supreme Court with respect to this matter that deemed such discounts to be unconstitutional.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(8)</td><td>We calculate Operating Cash Conversion Ratio as the cash flows from operations <i>plus/minus</i> income taxes paid divided by Adjusted
EBITDA <span style="background-color: white"><i>plus/minus</i> non-recurring expenses</span>.</td></tr></table>


<!-- Field: Page; Sequence: 106 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Operating Data (Historical)</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Key Revenue Drivers &#8211; Undergrad Segment</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">As
    of and For the Year Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 64%; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2021</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>UNDERGRAD SEGMENT</b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b><i>Medical School</i></b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Approved Seats	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3,163</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,823</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,731</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Operating Seats	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3,113</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,773</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,481</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Total Students (end of period)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">21,446</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">17,968</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">16,017</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Average Total Students	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">21,154</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">17,761</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">14,492</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 27.35pt; text-indent: -9.35pt">Average Total Students (ex-Acquisitions)(1)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">19,040</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">15,883</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">10,872</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Tuition Fees (Total) (in R$ thousands)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2,573,704</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2,032,888</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,511,442</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Tuition Fees (ex-Acquisitions) (in R$ thousands)(1)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2,332,745</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,791,590</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,123,944</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Medical School Gross Avg. Ticket (ex-Acquisitions)(R$/month)(1)(2)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>10,210</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>9,400</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>8,615</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Medical School Net Avg. Ticket (ex-Acquisitions)(R$/month)(1)(3)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>8,548</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>7,896</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>6,433</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b><i>Undergraduate Health Science</i></b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Total Students (end of period)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">21,117</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">17,967</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">19,882</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Average Total Students	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">21,365</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">19,441</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">15,918</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Average Total Students (ex-Acquisitions)(1)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">19,690</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">15,293</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">11,173</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Tuition Fees (Total) (in R$ thousands)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>388,799</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>336,238</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>239,512</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Tuition Fees (ex-Acquisitions) (in R$ thousands)(1)</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>359,647</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>249,550</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>148,381</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b><i>Other Undergraduate</i></b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Total Students (end of period)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">23,471</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">22,265</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">25,219</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Average Total Students	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">24,336</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">23,376</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">20,198</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 8.65pt; padding-left: 17.3pt; text-indent: -8.65pt">Average Total Students (ex-Acquisitions)(1)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">21,170</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">16,209</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">10,734</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Tuition Fees (Total)(in R$ thousands)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>304,276</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>266,306</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>239,235</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Tuition Fees (ex-Acquisitions)(in R$ thousands)(1)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>263,275</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>200,690</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>147,239</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b><i>Total Tuition Fees</i></b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Tuition Fees (Total)(in R$ thousands)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>3,266,778</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2,635,432</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,990,189</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Tuition Fees (ex-Acquisitions)(in R$ thousands)(1)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2,955,667</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2,241,830</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,419,574</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b><i>Revenue</i></b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Revenue (Total)(in R$ thousands)</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2,511,018</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2,037,889</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,498,408</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Revenue (ex-Acquisitions)(in R$ thousands)(1)</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2,270,917</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,777,484</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,136,404</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Ex-Acquisitions&#8221; figures accounts for revenue received by our acquired companies in a given period only after the date of their
acquisition, i.e. for a period of less than 12 months, and excludes any revenue prior to such date. For the year ended December 31, 2023,
&#8220;ex-Acquisitions&#8221; excludes: the acquisition of DelRey, which closed on January 2, 2023. For the year ended December 31, 2022,
&#8220;ex-Acquisitions&#8221; excludes: UnifipMoc and FIP Guanambi (from January to May 2022; closing of the UnifipMoc and FIP Guanambi
acquisitions was in June 2021); Unigranrio (from January to July 2022; closing of the Unigranrio acquisition was in August 2021); and
Garanhuns (from January to October 2022; closing of the Garanhuns acquisition was in November 2021). For the year ended December 31, 2021,
&#8220;ex-Acquisitions&#8221; excludes: UniRedentor (for January 2021; closing of the UniRedentor acquisition was on January 31, 2020);
UniSL (from January to April 2021; closing of the UniSL acquisition was in May 2020); FCMPB (from January to October 2021; closing of
the FCMPB acquisition was in November 2020); FESAR (from January to October 2021; closing of the FESAR acquisition was in November 2020);
UnifipMoc and FIP Guanambi (from June to December 2021; closing of the UnifipMoc and FIP Guanambi acquisitions was in June 2021); Unigranrio
(from August to December 2021; closing of the Unigranrio acquisition was in August 2021); and Garanhuns (from November to December 2021; closing of the Garanhuns acquisition was in November 2021).</td></tr></table>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Medical School Gross Avg. Ticket (ex-Acquisitions) is calculated as Tuition Fees (ex-Acquisitions) divided by the Average Total Students
(ex-Acquisitions), divided by the number of months in the period.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>Medical School Net Average Ticket (ex-Acquisitions) disclosure is presented beginning with the year ended December 31, 2021 (and future
periods), as information for calculation of this metric is not available for prior periods.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 107 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Key Revenue Drivers &#8211; Continuing Education
Segment</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">As
    of and For the Year Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 64%; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2021</p></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>CONTINUING EDUCATION SEGMENT</b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b><i>Medical Specialization &amp; Others</i></b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Total Students (end of period)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4,976</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4,280</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3,189</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Average Total Students	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4,838</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3,835</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3,252</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 27.35pt; text-indent: -9.35pt">Average Total Students (ex-Acquisitions)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4,838</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3,835</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3,064</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Revenue (Total)(in R$ thousands)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>146,827</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>108,806</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>72,983</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Revenue (ex-Acquisitions)(in R$ thousands)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>146,827</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>108,806</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>70,822</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Key Revenue Drivers &#8211; Digital Services
Segment</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">As
    of and For the Year Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 64%; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2021</p></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>DIGITAL SERVICES SEGMENT</b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b><i>Content &amp; Technology for Medical Education</i></b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Medcel Active Payers</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 27.35pt; text-indent: -9.35pt">Prep Courses &amp; CME - B2P	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">7,563</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">14,569</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">17,171</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 27.35pt; text-indent: -9.35pt">Prep Courses &amp; CME - B2B	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5,649</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5,887</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4,460</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Al&#233;m da Medicina Active Payers	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">7,557</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">6,081</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Cardio Papers Active Payers	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">9,202</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5,034</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Medical Harbour Active Payers	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">12,133</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">7,668</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#8212;</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b><i>Clinical Decision Software</i></b></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Whitebook Active Payers	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">153,541</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">137,767</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">125,372</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b><i>Clinical Management Tools</i>(2)</b></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">iClinic Active Payers	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">26,293</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">22,764</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">17,978</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Shosp Active Payers	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">3,768</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">2,915</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">2,305</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Digital Services Total Active Payers (end of period)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>225,706</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>202,685</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>167,286</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Revenue (Total)(in R$ thousands)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>229,286</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>189,984</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>151,958</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: 10.45pt">Revenue - B2P (in R$ thousands)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">190,838</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">166,515</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">142,716</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: 10.45pt">Revenue - B2B (in R$ thousands)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">38,448</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">23,469</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">9,242</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Revenue (ex-Acquisitions)(in R$ thousands)(1)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>222,196</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>157,943</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>99,003</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>&#8220;Ex-Acquisitions&#8221; figures accounts for revenue received by our acquired companies in a given period only after the date
of their acquisition, i.e. for a period of less than 12 months, and excludes any revenue prior to such date. For the year ended December
31, 2023, &#8220;ex-Acquisitions&#8221; excludes: the acquisition of DelRey, which closed on January 2, 2023. For the year ended December
31, 2022, &#8220;ex-Acquisitions&#8221; excludes: iClinic (for January 2022; closing of the iClinic acquisition was in January 2021);
Medicinae (from January to March 2022; closing of the Medicinae acquisition was in March 2021); Medical Harbour (from January to April
2022; closing of the Medical Harbour acquisition was in April 2021); Cliquefarma (from January to April 2022; closing of the Cliquefarma
acquisition was in April 2021); Shosp (from January to May 2022; closing of the Shosp acquisition was in May 2021); RX PRO (from January
to September, 2022; closing of the RX PRO acquisition was in October 2021); and Al&#233;m da Medicina, CardioPapers and Glic (all from January to December, 2022; closing of the Al&#233;m da Medicina, CardioPapers and Glic acquisitions only occurred in 2022). For the year ended December 31, 2021, &#8220;ex-Acquisitions&#8221; excludes: PEBMED (from January to July 2021; closing of the PEBMED acquisition was in July 2020); MedPhone (from January to October 2021; closing of the MedPhone acquisition was in November 2020); iClinic (from January to December 2021; closing of the iClinic acquisition was in January 2021); Medicinae (from March to December 2021; closing of the Medicinae acquisition was in March 2021); Medical Harbour (from April to December 2021; closing of the Medical Harbour acquisition was in April 2021); Cliquefarma (from April to December 2021; closing of the Cliquefarma acquisition was in April 2021); Shosp (from May to December 2021; closing of the Shosp acquisition was in May 2021); and RX PRO (from October to December 2021; closing of the RX PRO acquisition was in October 2021).</td></tr></table>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Clinical management tools include our telemedicine and digital prescription features.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 108 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Key Operational Drivers &#8211; Digital Services
Segment &#8211; Monthly Active Users (MaU)</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">As
    of and For the Year Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; width: 64%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2021</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>DIGITAL SERVICES SEGMENT</b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Content &amp; Technology for Medical Education	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">20,215</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">16,539</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">16,205</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Clinical Decision Software	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">219,420</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">221,762</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">194,308</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Clinical Management Tools(1)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">26,703</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">20,936</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">37,030</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Physician-Patient Relationship	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">1,579</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">1,473</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#8212;</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Total Monthly Active Users (MaU) - Digital Services(2)</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>267,917</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>260,710</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>247,543</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Clinical management tools include our telemedicine and digital prescription features and, beginning in the year ended December 31,
2022, excludes users other than payors.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Monthly Active Users (MaU) represents the number of unique individuals that consumed digital services content in each one of our products
in the last 30 days of a specific period, and includes MaU from Shosp, Medicinae, Al&#233;m da Medicina, CardioPapers and Glic beginning
in the year ended December 31, 2022.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Revenue and Revenue Mix</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 50%; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td colspan="5" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">For
    the Year Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023
    Ex Acquisitions(1)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">%
    Change</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">%
    Change Ex Acquisitions(1)</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td colspan="5" style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(in R$ millions)</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Revenue Mix</b></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Undergrad	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,511.1</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,271.0</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,037.9</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">23.2%</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">11.4%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Adjusted Undergrad(2)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,509.2</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,269.1</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,028.0</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">23.7%</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">11.9%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Continuing Education	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">146.8</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">146.8</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">108.8</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">34.9%</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">34.9%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Digital Services	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">229.3</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">222.2</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">190.0</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">20.7%</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">17.0%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Inter-segment transactions	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(11.2)</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(11.2)</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(7.6)</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">47.2%</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">47.2%</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Total Reported Revenue</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2,875.9</b></p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2,628.7</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2,329.1</b></p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>23.5%</b></p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>12.9%</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>For the year ended December 31, 2023, &#8220;ex-Acquisitions&#8221; excludes: the acquisition of DelRey, which closed on January 2,
2023.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Consists of mandatory discounts in tuition fees granted by state decrees and individual/collective legal proceedings and public civil
proceedings due to COVID-19 on-site class restriction, and excludes any recovery of these discounts that were invoiced based on a decision
by the Brazilian Supreme Court with respect to this matter that deemed such discounts to be unconstitutional.</td></tr></table>


<!-- Field: Page; Sequence: 109 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Exchange Rates</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Brazilian foreign exchange system allows
the purchase and sale of foreign currency and the international transfer of <i>reais</i> by any person or legal entity, regardless of
the amount, subject to certain regulatory procedures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The real/U.S. dollar exchange rate reported
by the Central Bank was R$5.196 per US$1.00 on December 31, 2020, which reflected a 28.9% depreciation in the real against the U.S. dollar
during 2020. As of December 31, 2021, the exchange rate for the sale of U.S. dollars as reported by the Central Bank was R$5.580 per US$1.00,
which reflected a 7.3% depreciation in the real against the U.S. during 2021. On December 31, 2022, the exchange rate of U.S. dollar as
reported by the Central Bank was R$5.218 per US$1.00, which reflected a 6.5% appreciation in the real against the U.S. dollar since December
31, 2021. As of April 26, 2023, the exchange rate for the sale of U.S. dollars as reported by the Central Bank was R$5.059 per US$1.00,
which reflected an appreciation of 3.1% in the real against the U.S. dollar since December 31, 2022. The real/U.S. dollar exchange rate
reported by the Central Bank was R$4.8413 per US$1.00 on December 31, 2023, which reflected a 7.2% appreciation in the real against the
U.S. dollar during 2023. There can be no assurance that the real will not again depreciate or appreciate against the U.S. dollar or other
currencies in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Central Bank has intervened occasionally
in the foreign exchange market to attempt to control instability in foreign exchange rates. We cannot predict whether the Central Bank
or the Brazilian government will continue to allow the <i>real</i> to float freely or will intervene in the exchange rate market by re-implementing
a currency band system or otherwise. The <i>real</i> may depreciate or appreciate substantially against the U.S. dollar in the future.
Furthermore, Brazilian law provides that, whenever there is a serious imbalance in Brazil&#8217;s balance of payments or there are serious
reasons to foresee a serious imbalance, temporary restrictions may be imposed on remittances of foreign capital abroad. We cannot assure
you that the Brazilian government will not place restrictions on remittances of foreign capital abroad in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following table sets forth, for the periods
indicated, the high, low, average and period-end exchange rates for the purchase of U.S. dollars expressed in Brazilian <i>reais</i> per
U.S. dollar. The monthly and annual average rates are calculated by using the average of reported exchange rates by the Central Bank on
each day during a monthly period and on the last day of each month during an annual period, respectively.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 60%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Year</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Period-end</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Average(1)</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Low(2)</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">High(3)</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">2019	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.031</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3.946</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3.652</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.260</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">2020	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.196</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.158</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.021</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.937</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">2021	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.580</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.395</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.920</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.839</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">2022	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.218</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.165</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.618</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.704</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.8413</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.9953</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.4459</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.7202</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source:</i> Central Bank.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Represents the average of the exchange rates on the closing of each day during the year.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Represents the minimum of the exchange rates on the closing of each day during the year.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>Represents the maximum of the exchange rates on the closing of each day during the year.</td></tr></table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 64%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Month</p></td>
    <td style="width: 9%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Period-end</p></td>
    <td style="width: 9%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Average(1)</p></td>
    <td style="width: 9%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Low(2)</p></td>
    <td style="width: 9%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">High(3)</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">October 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.0575</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.0648</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.1918</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.948</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">November 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.9355</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.8983</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.0194</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.8575</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">December 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.8413</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.8972</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.9580</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.8306</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">January 2024	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.9535</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.9144</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.8543</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.9715</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">February 2024	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.9833</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.9644</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.9303</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.0053</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">March 2024	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.9962</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.9801</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">4.9364</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.0352</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">April 2024 (through April 24, 2024)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.1592</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.1259</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.0080</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">5.2635</td></tr>
  </table>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source:</i> Central Bank.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Represents the average of the exchange rates on the closing of each day during the month.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Represents the minimum of the exchange rates on the closing of each day during the month.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>Represents the maximum of the exchange rates on the closing of each day during the month.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 110 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Significant Factors Affecting Our Results of Operations</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We believe that our results of operations and
financial performance will be driven by the following trends and factors:</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Regulatory Environment and &#8220;Mais M&#233;dicos&#8221;
Program</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our business is significantly influenced by
the regulatory environment of the educational industry in Brazil. We are subject to various federal laws and extensive government regulations
by MEC, CNE, INEP, FIES and CONAES, among others. In particular, medical education in Brazil is subject to regulations that aim to control
the supply of medical seats across Brazil and their geographic allocation including, but not limited to the <i>&#8220;Mais M&#233;dicos&#8221;
Law</i>, which created the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, whose main objectives include addressing the provision of
doctors for primary care in municipalities, strengthen health care infrastructure and allocate medical workforce to vulnerable areas.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">With the increase in annual offerings through
&#8220;<i>Mais M&#233;dicos,</i>&#8221; on April 5, 2018, MEC issued Ordinance No. 328/2018, pursuant to which, among other measures,
MEC imposed a five-year suspension on the granting of authorizations for the creation of new medical education courses. However, on April
5, 2023, MEC issued Ordinance No. 650/2023, which revoked the suspension under Ordinance No. 328/18 and set new rules for the opening
of new medicine courses. In particular, MEC will be required to conduct a public call for new courses, i.e., through the <i>Mais M&#233;dicos</i>
program pursuant to the <i>&#8220;Mais M&#233;dicos&#8221; Law</i>, and subject any such courses to the prior review by the Interministerial
Commission for Health Education Management (<i>Comiss&#227;o Interministerial de Gest&#227;o da Educa&#231;&#227;o na Sa&#250;de</i>).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On October 4, 2023, Ministry of Education,
through SERES, exercising its legal powers and based on Article 3 of the <i>&#8220;Mais M&#233;dicos&#8221; Law</i>, announced the public
call and set the rules, procedures, decision-making standards and the calendar in connection with the fulfillment of medicine course vacancies,
this will result in the creation of new medical education courses or medicine course vacancies, which will in turn increase competition.
As a result, we may be required to reduce our tuition fees or increase our operating expenses (including our costs per student) in order
to retain or attract students or to pursue new market opportunities and reduce our ability to fill all our medical seats capacity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For further information, see &#8220;Item 4.
Information on the Company&#8212;Business Overview&#8212;Regulatory Overview,&#8221; &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain
Risks Relating to Our Business and Industry&#8212;The post-secondary education sector is highly regulated, and our failure to comply with
existing or future laws and regulations could significantly impact our business,&#8221; &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain
Risks Relating to Our Business and Industry&#8212;We are subject to supervision by MEC and, consequently, may suffer sanctions as a result
of non-compliance with any regulatory requirements&#8221; and &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;We face significant
competition in each program we offer and each geographic region in which we operate. If we fail to compete efficiently, we may lose market
share and our profitability may be adversely affected.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Scholarships, Student Financing and Tax Benefits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A large number of our students fund their tuition
fees through financing from FIES. In addition, we participate in the PROUNI scholarship program, and we benefit from tax benefits in return.
For more information on our students enrolled in these programs, see &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Regulatory
Overview&#8212;Financing Alternatives for Students: Incentive Programs&#8212;University for All Program&#8221; &#8220;Regulatory Overview&#8212;Financing
Alternatives for Students: Incentive Programs&#8212;Student Financing Program (FIES),&#8221; &#8220;Item 3. Key Information&#8212;D. Risk
Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Changes to the rules or delays or suspension of tuition payments
made through FIES may adversely affect our cash flows and our business,&#8221; and &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain
Risks Relating to Our Business and Industry&#8212;If we lose the benefits of federal tax exemptions provided under the PROUNI program,
our business, financial condition and results of operations may be materially adversely affected.&#8221; In addition to PROUNI and FIES,
Afya participates in private financing programs through external partners (Santander, Bradesco, Sicoob, CashMe and Alume) for undergraduate
students.</p>


<!-- Field: Page; Sequence: 111 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Brazilian Macroeconomic Environment</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">All of our operations are located in Brazil.
As a result, our revenues and profitability are affected by political and economic developments in Brazil and the effect that these factors
have on the availability of credit, disposable income, employment rates and average wages in Brazil. Our operations, and the industry
in general, may be affected changes in economic conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil is the largest economy in Latin America,
as measured by gross domestic product, or GDP. The following table shows data for real GDP, inflation and interest rates in Brazil and
the U.S. dollar/<i>real</i> exchange rate at the dates and for the periods indicated.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">For
    the Year Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; width: 70%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2021</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Real growth (contraction) in gross domestic product	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>2.9%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>2.9%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>4.6%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Inflation (IGP-M)(1)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>(3.2)%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>5.5%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>17.8%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Inflation (IPCA)(2)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>4.6%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>5.8%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>10.1%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Long-term interest rates&#8212;TJLP (average)(3)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>5.7%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>7.2%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>4.8%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">CDI interest rate(4)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>13.2%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>13.7%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>9.1%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Period-end exchange rate&#8212;<i>reais</i> per US$1.00	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>4.841</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>5.218</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>5.581</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Average exchange rate&#8212;<i>reais</i> per US$1.00(5)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>4.995</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>5.165</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>5.412</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Appreciation (depreciation) of the <i>real</i> vs. US$ in the period(6)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>7.2%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>6.5%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>(7.3)%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Unemployment rate(7)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>7.4%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>7.9%</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span>11.1%</span></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source:</i> FGV, IBGE, Central Bank
and Bloomberg.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Inflation (IGP-M) is the general market price index measured by the FGV.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Inflation (IPCA) is a broad consumer price index measured by the IBGE.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>TJLP is the Brazilian long-term interest rate (average of monthly rates for the period).</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(4)</td><td>The CDI <i>(certificado de dep&#243;sito interbanc&#225;rio)</i> interest rate is an average of interbank overnight rates in Brazil.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(5)</td><td>Average of the exchange rate on each business day of the year.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(6)</td><td>Comparing the US$ closing selling exchange rate as reported by the Central Bank at the end of the period&#8217;s last day with the
day immediately prior to the first day of the period discussed.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(7)</td><td>Average unemployment rate for the year as measured by the IBGE.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Inflation directly affects our current operating
costs and expenses, adjusted by reference to indexes that reflect the inflation rate such as the IGP-M or IPCA, primarily as a result
of annual adjustments to faculty member and employee salaries. Historically, inflation has been more than offset by the tuition fees we
charge our students.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our financial performance is also marginally
tied to fluctuations in interest rates, such as the CDI rate, because such fluctuations affect the value of our financial investments.
We are also exposed to fluctuations in interest rates on our accounts payable to selling shareholders which are indexed to the CDI, IPCA
and SELIC.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Acquisitions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We may face significant challenges in the process
of integrating the operations of our acquired companies. If we are not able to manage these integrations effectively, our results of operations
may be affected. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;We
may not be able to identify and acquire new medical higher education institutions or meet our strategic and financial goals in connection
with any business acquisition we seek, and difficulties in effectively integrating and managing a growing number of acquisitions may adversely
affect our strategic objectives&#8221; and &#8220;Item 4. Information on the Company&#8212;B. Business Overview&#8212;Our Recent Acquisitions.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Business Segments</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have three operating segments, as follows:</p>


<!-- Field: Page; Sequence: 112 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Undergrad, which provides educational services through undergraduate courses related to medicine, other health sciences and other
undergraduate programs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Continuing Education, which provides specialization programs and graduate courses; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Digital Services, which provides content and technology for medical education, clinical decisions software, practice management tools
and electronic medical records, doctor-patient relationship, telemedicine and digital prescription.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Segment information is presented consistently
with the internal reports provided to our chief executive officer, who is our chief operating decision maker (CODM) and is responsible
for allocating resources, assessing the performance of our operating segments, and making our strategic decisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">No operating segments have been aggregated
to form the above reportable operating segments. There is only one geographic region and the results are monitored and evaluated as a
single business.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Description of Principal Line Items</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Revenue</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our revenue consists primarily of tuition fees
charged for medical courses. We also generate revenue from tuition fees for other undergraduate courses, student fees, certain education-related
activities, digital education content and subscription of digital services.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Cost of services</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Cost of services includes expenses related
to payroll, rent, hospital agreements, utilities and depreciation and amortization. Cost of services amounted to 38.6%, 36.9% and 37.9%
of our revenue in the years ended December 31, 2023, 2022 and 2021, respectively.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Operating expenses</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our operating expenses includes expenses for
personnel, general and administrative, management and officer compensation, marketing and other income (expenses), net.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Personnel.</i> Personnel expenses consist
of wages, overtime, benefits (meal vouchers, transportation vouchers and medical and dental insurance, among others), profit sharing,
social contribution and payroll taxes. In Brazil, social contribution and payroll taxes consist of the Brazilian Social Security Institute
<i>(Instituto Nacional do Seguro Social)</i> contribution, or INSS, and the Brazilian Unemployment Severance Fund <i>(Fundo de Garantia
do Tempo de Servi&#231;o)</i> contribution, or FGTS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Selling, general and administrative.</i>
Selling, general and administrative expenses mainly consist of: (i)&#160;building infrastructure expenses, such as leases and property
maintenance; (ii)&#160;utilities expenses; (iii)&#160;expenses for computer system maintenance and office automation, such as software
licenses, as well as for integrated accounting, treasury, financial planning and cost management systems; (iv)&#160;sales and marketing
expenses; (v)&#160;allowance for expected credit losses; and (vi)&#160;amounts paid for professional services, such as consultants, auditors
and outside counsel.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Other income (expenses), net.</i> Other
income (expenses), net, consists mainly of miscellaneous income and/or expense items.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Finance result</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our finance result includes finance income
and finance expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our finance income consists mainly of income
from interest earned on financial investments and interest received on late payments from students. Our finance expenses consist mainly
of interest expenses from accounts payable to selling shareholders, loans and financing, lease liabilities, notes payable and banking
fees.</p>


<!-- Field: Page; Sequence: 113 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We also have cash and cash equivalents denominated
in U.S. dollars, and accordingly, we have foreign exchange gain or losses from the changes in U.S. dollars against the Brazilian <i>real.</i></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Income taxes expenses</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Income taxes expenses includes current income
taxes and social contribution.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Historical Consolidated Results of Operations</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Year Ended December 31, 2023 Compared to the
Year Ended December 31, 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following table sets forth our historical
consolidated income statement data for the years ended December&#160;31, 2023 and 2022:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">For
    the Year Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; width: 67%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Change
    (%)</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(in R$ millions, except for percentages)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Revenue	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,875.9</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,329.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">23.5%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Cost of services	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(1,109.8)</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(859.6)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">29.1%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Gross profit</b></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,766.1</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,469.5</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>20.2%</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Selling, general and administrative expenses	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(1,014.7)</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(798.2)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">27.1%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Other income (expenses), net	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">15.6</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(7.3)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">n.m.</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Operating income</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>767.1</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>664.1</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>15.5%</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Finance income	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">110.6</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">102.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">8.4%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Finance expenses	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(457.6)</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(349.9)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">30.8%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Finance result</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>(347.0)</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>(247.9)</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>40.0%</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Share of income of associate	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">9.5</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">12.2</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(22.1)%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Income before income taxes</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>429.6</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>428.4</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>0.3%</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Income taxes expenses	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(24.2)</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(35.7)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(32.2)%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-bottom: 1pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Net income</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pt; text-align: right"><b>405.4</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pt; text-align: right"><b>392.8</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pt; text-align: center"><b>3.3%</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in">n.m. = not meaningful</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Revenue</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Revenue for the year ended December 31, 2023
was R$2,875.9 million, an increase of R$546.8 million, or 23.5%, from R$2,329.1 million for the year ended December 31, 2022. On a per
segment basis, our revenue was primarily affected by the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Undergrad segment, revenue for the year ended December 31, 2023 was R$2,511.0 million, an increase of 23.2%, or R$473.1 million,
from R$2,037.9 million for the year ended December 31, 2022. This increase was primarily attributable to: (i) an increase of 12.3% in
our total number of operating seats, from 2,773 seats in 2022 to 3,113 seats in 2023, as a result of the DelRey acquisition; and (ii)
increase of 8.2% in the net average ticket of Medical programs, from an average ticket of R$7,898 in 2022 compared to R$8,548 in 2023;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Continuing Education segment, revenue for the year ended December 31, 2023 was R$146.8 million, an increase of 34.9%, or R$38.0
million, from R$108.8 million for the year ended December 31, 2022. This increase was primarily attributable to a 26.1% increase in average
total students (from 3,835 paying students in 2022 compared to 4,838 paying students in 2023); and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Digital Services segment, revenue for the year ended December 31, 2023 was R$229.3 million, an increase of 20.7%, or R$39.3
million, from R$190.0 million for the year ended December 31, 2022. This increase was primarily attributable to an increase of 11.4% in
Digital Services total active payers (from 202,685 active payers in 2022 to 225,706 active payers in 2023).</td></tr></table>


<!-- Field: Page; Sequence: 114 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Cost of services</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Cost of services for the year ended December
31, 2023 was R$1,109.8 million, an increase of R$250.2 million, or 29.1%, from R$859.6 million for the year ended December 31, 2022. As
a percentage of revenue, our cost of services increased to 39% for the year ended December 31, 2023, compared to 37% for the year ended
December 31, 2022. On a per segment basis, our cost of services was primarily affected by the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Undergrad segment, cost of services for the year ended December 31, 2023 was R$998.0 million, an increase of R$234.8 million,
or 30.8%, from R$763.2 million for the year ended December 31, 2022. This increase was primarily attributable to: (i) the consolidation
of the results of operations for the year ended December 31, 2023 of DelRey in 2023, resulting in an increase of R$106.9 million in our
Undergrad segment&#8217;s cost of services; (ii) an increase of R$57.9 million applied to salaries and wages, both related to increase
in the number of personnel and yearly readjustment of wages; and (iii) other cost-related effects, such as an increase in costs from hospital
and medical agreements and facilities and utilities;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Continuing Education segment, cost of services for the year ended December 31, 2023 was R$62.8 million, an increase of R$6.2
million, or 11.0%, from R$56.6 million for the year ended December 31, 2022. This increase was primarily attributable to (i) an increase
in costs associated with the opening of new IPEMED units in 2023, and (ii) a general increase in expenses with salaries across our operating
units as a result of an increase in the number of personnel and annual readjustment of wages; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Digital Services segment, cost of services for the year ended December 31, 2023 was R$60.3 million, an increase of R$12.9 million,
or 27.2%, from R$47.4 million for the year ended December 31, 2022. This increase was primarily attributable to an increase in costs with
consultancy and third-party services in the amount of R$6.2 million, mostly as a result of the hiring of consultancy services for projects
aiming to increase the efficiency of operations of companies in our Digital Services segment.</td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Gross profit</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a result of the foregoing, gross profit
for the year ended December 31, 2023 was R$1,766.1 million, an increase of R$296,6 million, or 20.2%, from R$1,469.5 million for the year
ended December 31, 2022. On a per segment basis, our gross profit was the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Undergrad segment, gross profit for the year ended December 31, 2023 was R$1,513.0 million, an increase of R$238.3 million,
or 18.7%, from R$1,274.7 million for the year ended December 31, 2022;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Continuing Education segment, gross profit for the year ended December 31, 2023 was R$84.0 million, an increase of R$31.7 million,
or 60.6%, from R$52.3 million for the year ended December 31, 2022; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Digital Services segment, gross profit for the year ended December 31, 2023 was R$169.0 million, an increase of R$26.4 million,
or 18.5%, from R$142.6 million for the year ended December 31, 2022.</td></tr></table>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Selling, general and administrative expenses</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Selling, general and administrative expenses
for the year ended December 31, 2023 was R$1,014.7 million, an increase of R$216.5 million, or 27.1%, from R$798.2 million for the year
ended December 31, 2022. This increase was primarily attributable to: (i) the consolidation of the results of operations of DelRey in
2023, resulting in an increase of R$38.3 million in our selling, general and administrative expenses in 2023; (ii) an increase of R$25.9
million in sales and marketing expenses, mostly related to rebranding efforts, marketing campaigns and advertising expenses; (iii) an
increase of R$29.4 million in maintenance expenses, mostly related to periodic conservation procedures on equipment and furniture of educational
institutions; and (iv) an increase of R$76.5 million in payroll expenses as a result of an in the total number of personnel and yearly
readjustment of wages.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Other income (expenses), net</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Other income, net for the year ended December
31, 2023 was R$15.6 million, a variation of R$22.9 million from other expenses, net of R$7.3 million in the year ended December 31, 2022,
which was primarily due to the tax amnesty program on interest and penalties entered into by Unigranrio in order to settle a tax proceeding
in respect to ISS (city tax on services) with the municipality of Rio de Janeiro.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 115 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Operating income</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For the reasons discussed above, operating
income for the year ended December 31, 2023 was R$767.1 million, an increase of R$103.1 million, or 15.5%, from R$664.0 million for the
year ended December 31, 2022.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Finance result</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Finance result for the year ended December
31, 2023 was a net finance expense of R$347.0 million, compared to a net finance expense of R$247.9 million for the year ended December
31, 2022, for the reasons described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Finance income.</i> Finance income for the
year ended December 31, 2023 was R$110.6 million, an increase of R$8.6 million, from R$102.0 million for the year ended December 31, 2022.
This increase was primarily attributable to (i) an increase in interest received of R$6.3 million, and (ii)&#160;an increase in income
from financial investments of R$5.9 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Finance expenses.</i> Finance expenses for
the year ended December 31, 2023 was R$457.6 million, an increase of R$107,7 million, from R$349.9 million for the year ended December
31, 2022. This increase was primarily attributable to (i) an increase in interest expenses on lease liabilities of R$12.3 million, as
a result of the companies acquired and new lease agreements in the period (including those associated with the acquired company); and
(ii) an increase in interest expense of R$85.4 million, mainly as a result of debentures issued in December 2022.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Income before income taxes</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a result of the foregoing, income before
income taxes for the year ended December 31, 2023 was R$429.6 million, an increase of R$1.2 million, or 0.3%, from R$428.4 million for
the year ended December 31, 2022.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Income taxes expenses</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Income taxes expenses for the year ended December
31, 2023 was R$24.2 million, a decrease of R$11.5 million, from R$35.7 million for the year ended December 31, 2022, and the effective
tax rate decreased from 8.33% for the year ended December 31, 2022, to 5.62% for the ended year December 31, 2023. This decrease in our
effective tax rate was primarily attributable to the effects of: (i) an increase in the amount of PROUNI fiscal incentives received, from
R$270.1 million in 2022 to R$310.0 million in 2023; and (ii) an increase in our unrecognized deferred tax assets from R$117.4 million
in 2022 to R$154.1 million in 2023.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Net income</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a result of the foregoing, our net income
for the year ended December 31, 2023 was R$405.4 million, an increase of R$12.6 million, or 3.2%, from R$392.8 million for the year ended
December 31, 2022.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Year Ended December 31, 2022 Compared to the
Year Ended December 31, 2021</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For a discussion of our results of operations
for the year ended December 31, 2022 compared to the year ended December 31, 2021, please see &#8220;Item 5. Operating and Financial Review
and Prospects&#8212;A. Operating Results&#8212;Year Ended December 31, 2022 Compared to the Year Ended December 31, 2021&#8221; of our
annual report on Form 20-F for the year ended December 31, 2022, filed with the SEC on April 28, 2023.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Critical Accounting Estimates and Assumptions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our consolidated financial statements are
prepared in conformity with IFRS. In preparing our audited consolidated financial statements, we make assumptions, judgments and estimates
that can have a significant impact on amounts reported in our consolidated financial statements. We base our assumptions, judgments and
estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results
could differ materially from these estimates under different assumptions or conditions. We regularly reevaluate our assumptions, judgments
and estimates. Our material accounting policies are described in note 2 and our critical accounting estimates and assumptions are described
in note 3 to our audited consolidated financial statements included elsewhere in this annual report.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 116 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Recent Accounting Pronouncements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The new and amended standards and interpretations
that were applied for the first time in 2023 did not have a significant impact on the Company&#8217;s consolidated financial statements.
The Company have not adopted new and amended standards and interpretations that are not yet effective.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_018"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Liquidity and Capital
Resources</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, we had R$553 million
in cash and cash equivalents. We believe that our current available cash and cash equivalents and the cash flows from our operating activities
will be sufficient to meet our working capital requirements and capital expenditures in the ordinary course of business for the next 12
months. Future cash needs in the short and long term will be funded by our operating cash flow and from funds raised in the debt or equity
capital markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following table shows the historical cash
flows for the years ended December 31, 2023, 2022 and 2021:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">For
    the Year Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; width: 67%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2021</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(in R$ millions)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Cash Flow Data</b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Net cash flows from operating activities	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,043.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">843.9</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">630.9</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Net cash flows used in investing activities	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(1,143.0)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(591.5)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(1,274.1)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Net cash flows (used in) from financing activities	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(439.9)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">92.9</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">364.7</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Operating Activities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We had net cash flows from operating activities
of R$1,043.6 million in 2023, an increase of R$199.7 million, or 23.6%, as compared to R$843.9 million in 2022, mainly due to: (i) the
acquisition of DelRey, which was concluded in January 2023 and which led to an increase in income before income taxes, depreciation and
amortization and accrued interest increased in the amount of R$169.8 million, which is reflected in our net cash flows from operations
activities; and (ii) an increase in changes in other assets from R$(1.0) million to R$77.5 million, primarily due to the tax amnesty program
on interest and penalties entered into by Unigranrio to settle a tax proceeding in respect to ISS (city tax on service) with the municipality
of Rio de Janeiro. This increase was partly offset by provisions for legal proceedings of R$53.3 million.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Investing Activities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We had net cash flows used in investing activities
of R$1,143.0 million in 2023, as compared to net cash flows used in investing activities of R$591.5 million in 2022 mainly as a result
of an increase of R$585.3 million in cash used in the acquisition of subsidiaries, net of cash acquired and interest paid from such acquisitions,
from R$301.2 million in 2022 to R$886.5 million in 2023, mainly as result of cash consideration paid in the acquisition of DelRey in 2023.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Financing Activities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We had net cash flows used in financing activities
of R$439.9 million in 2023, as compared to a net cash generated from financing activities of R$92.9 million in 2022, mainly due to a decrease
of proceeds from loans and financing of R$491.6 million in 2023 when compared to 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For a discussion of changes in our consolidated
cash flows in the year ended December 31, 2022 compared to the year ended December 31, 2021, see our annual report on Form 20-F for the
fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023.</p>


<!-- Field: Page; Sequence: 117 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Liquidity</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our management has responsibility for monitoring
liquidity risk. In order to achieve the Company&#8217;s objective, our management regularly reviews the risk and maintains appropriate
reserves, including bank credit facilities with first tier financial institutions. Our management also continuously monitors projected
and actual cash flows and the combination of the maturity profiles of the financial assets and liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The main requirements for financial resources
used by the Company arise from the need to make payments for suppliers, operating expenses, labor and social obligations, loans and financing
and accounts payable to selling shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our total liquidity, which we calculate as
the sum of cash and cash equivalents, decreased by 49.4%, from R$1,093.1 million as of December 31, 2022 to R$553.0 million as of December
31, 2023.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Indebtedness</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, we had outstanding
debt, comprised of our loans and financings, in the aggregate amount of R$1,800.8 million. The following table summarizes our loans and
financings as of December 31, 2023 and 2022:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 34%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Financial
    institution</p></td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Currency</p></td>
    <td style="width: 19%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Interest
    rate</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Maturity</p></td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4" style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">(in
    R$ thousands)</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Banco Ita&#250; Unibanco S.A.	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">Brazilian real</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">CDI + 1.90% p.y.</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2025</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">412,880</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">518,134</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">FINEP	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">Brazilian real</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">TJLP p.y.</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2027</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">11,193</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">8,418</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Banco Ita&#250; Unibanco S.A.	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">Brazilian real</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">CDI + 1.75% p.y.</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2024</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">21,405</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">32,252</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Softbank	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">Brazilian real</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">6.5% p.y.</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2026</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">825,957</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">824,258</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Debentures	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">Brazilian real</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">CDI + 1.80% p.y.</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2028</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">529,340</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">499,839</p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Total Loans and Financing</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,800,775</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,882,901</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Current	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">179,252</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">145,202</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Non-current	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,621,523</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,737,699</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Loans</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On October 1, 2020 (as amended on September
28, 2022), Afya Brazil entered into a loan with Banco Ita&#250; Unibanco S.A. in the principal amount of R$500.0 million. The loan incurs
interest at the CDI rate <i>plus</i> 1.62% per year, through September 28, 2022, and 1.90% per year, as of September 28, 2022. The loan
is repayable in three installments in October 2023, April 2024 and October 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On July 23, 2019, Medcel entered into a loan
of R$16.2 million with Financiadora de Estudos e Projetos (&#8220;FINEP&#8221;), a governmental agency focused on financing investments
on R&amp;D, which has an interest rate based on TJLP (Long term interest rate), and maturity in 2027. The first and second tranches of
R$6.7 million and R$4.1 million, respectively, were drawn down in October 2019 and December 2020, respectively, in order to develop the
Medical web series and other digital content. There are no financial covenants under this agreement. The total loan balance is guaranteed
by a bank warranty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On October 28, 2020, UnifipMoc entered into
a loan with Banco Ita&#250; Unibanco S.A. in the amount of R$30.0 million. On June 30, 2021 this agreement was amended and is now adjusted
by the CDI rate plus an interest rate of 1.75% per year and is repayable in three installments in July 2023, January 2024 and July 2024.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Debentures</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On December 16, 2022, Afya Brazil issued 500,000
simple, non-convertible, unsecured debentures in a single series, each with a par value of R$1.00, totaling an aggregate amount of R$500.0
million, by means of a public distribution with restricted placement efforts in the Brazilian market, under the terms of the Brazilian
Securities and Exchange Commission (<i>Comiss&#227;o de Valores Mobili&#225;rios</i>) Rule No. 476. We expect to use the proceeds
of the offering for general corporate purposes, strengthening its cash position, and extending its debt maturity profile. The debentures
were issued with a maturity date of January 15, 2028, with the principal to be amortized in two equal installments payable on January
15, 2027 and January 15, 2028, corresponding to the fourth and fifth years of the transaction, respectively. The debentures bear interest
at 100% of the CDI rate <i>plus</i> 1.80% per year, payable semi-annually on January 15 and July 15 of each year, until the maturity
date.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 118 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The debentures are subject to certain obligations
including financial covenants. Under the terms of the debentures, we are required to maintain a net debt (excluding our Series A perpetual
convertible preferred shares and our lease liabilities) to Adjusted EBITDA ratio of below or equal to 3.0x, as of the end of each fiscal
year, until the maturity date. Adjusted EBITDA considers, for purposes of this ratio, is calculated as net income <i>plus</i> (i) income
taxes expenses, (ii) net financial result (excluding interest expenses on lease liabilities), (iii) depreciation and amortization expenses
(excluding right-of-use depreciation expenses), (iv) share-based compensation expenses, (v) share of income of associate, (vi) interest
received and (vii) non-recurring expenses. As of December 31, 2023, we were in compliance with all obligations set forth under the terms
of the debentures.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Series A Perpetual Convertible Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On April 26, 2021, we issued and sold 150,000
shares of perpetual convertible preferred shares designated as Series A perpetual convertible preferred shares, with a par value of U.S.$0.00005
per share, for US$150.0 million, equivalent to R$821.8 million, on the issuance date. The Series A perpetual convertible preferred shares
is a class of equity security that ranks senior to the common shares with respect to dividend rights or rights upon liquidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Each Series A perpetual convertible preferred
share is entitled to a cash dividend of 6.5% per annum and is convertible, at the holder&#8217;s discretion, into our Class A common shares
at an initial conversion price of US$25.35. We may require the conversion of any or all of the Series A perpetual convertible preferred
shares at any time on or after the three-year anniversary of the original issuance date if certain conditions set forth in the certificate
of designation are met (if for 20 out of 30 consecutive trading days prior, Afya&#8217;s stock price is equal or above 150% of the conversion
rate). We may also redeem any or all of the Series A perpetual convertible preferred shares for cash, shares of its common shares or a
combination thereof at its election, at any time on or after the seven-year anniversary of the original issuance date as determined in
the certificate of designation. On or after the five-year anniversary of the original issuance date, the holders of the Series A perpetual
convertible preferred shares shall have the right to redeem all of the outstanding Series A perpetual convertible preferred shares for
cash, our common shares or a combination thereof (at our election, subject to certain conditions) to be determined in the certificate
of designation. Upon the occurrence of a change of control, the holders will have the right to redeem their Series A perpetual convertible
preferred shares for cash at a price set forth in the certificate of designation. The Series A perpetual convertible preferred shares
will be entitled to the same voting rights as the common shares only when converted into common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We determined that the Series A perpetual convertible
preferred shares should be classified as a financial liability at amortized cost upon their issuance since they are redeemable primarily
according to the decision of the holder and there is a contractual obligation to deliver assets (cash, common shares or a combination
thereof) that could not be avoided by us in an event of redemption. The financial liability is denominated in Brazilian <i>Reais</i> and
thus not subject to foreign exchange changes. In addition, as the entire instrument is classified as a liability, the embedded put option
to redeem the Series A perpetual convertible preferred shares for cash is an embedded derivative. The embedded derivative will not be
treated separately once the exercise price of the option is closely related to the host contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The initial transaction costs that are directly
attributable to the issuance of Series A perpetual convertible preferred shares were measured at fair value together with the financial
liability on initial measurement. The transaction costs totaled R$13.0 million, including legal counsels and advisors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For further information on our loans and financing,
see note 13.2.1 to the audited consolidated financial statements, included elsewhere in this annual report.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Share Buyback Program</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For further information on our share buyback
program, see note 17 (c) to the audited consolidated financial statements, included elsewhere in this annual report, Exhibit 2.1, &#8220;Description
of Securities Registered Under Section 12 of the Exchange Act - Share Repurchases&#8221; and &#8220;Item 16E. Purchases Of Equity Securities
By The Issuer And Affiliated Purchasers.&#8221;</p>


<!-- Field: Page; Sequence: 119 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Tabular Disclosure of Contractual Obligations</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following is a summary of our contractual
obligations, based on contractual undiscounted amounts, as of December 31, 2023:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="5" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Payments
    Due by Period as of December 31, 2023</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; width: 45%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Total</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Less
    than<br/>
    1 year</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">1
    &#8211; 3 years</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">3
    &#8211; 5 years</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">More
    than<br/>
    5 years</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="5" style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(in R$ thousands)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Trade payables	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">108,222 </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">108,222 </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">- </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">- </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">- </span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Loans and financing (1)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">2,250,562 </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">298,981 </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">1,383,255 </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">568,326 </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">- </span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Lease liabilities	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">1,923,128 </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">137,735 </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">268,724 </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">255,456 </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">1,261,213 </span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Accounts payable to selling shareholders	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">619,171 </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">387,693 </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">231,478 </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">- </span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="font-size: 9pt">- </span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Advances from customers	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">153,485</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">153,485</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">-</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">-</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">-</p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Total</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>5,054,568 </b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,086,116</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,883,457</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>823,782</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>1,261,213</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Loans and financing include the obligations related to our Series A perpetual convertible preferred shares discussed in note 13.2.1
to our audited consolidated financial statements included elsewhere in this annual report.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Future cash needs in the&#160;short and long
term will be funded by our operating cash flow and from proceeds raised in the debt or equity capital markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, we did not have any
off-balance sheet arrangements.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Principal Capital Expenditures</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: white">We made
capital expenditures (consisting of purchase of property and equipment and intangible assets) of R$218.4 million, R$318.2 million and
R$276.8 million in 2023, 2022 and 2021, respectively. During these years, our capital expenditures mainly included expenditures related
to the expansion and maintenance of our campuses and headquarters including leasehold improvements, the integration of our acquisitions,
the implementation of our shared services center, and the development of the project that led to the certification of seven new greenfield
medical schools as part of the &#8220;<i>Mais M&#233;dicos</i>&#8221; program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: white">For 2024,
we have budgeted capital expenditures of R$257.3 million, mostly to support the growth in our business and operations. We expect to meet
our capital expenditure needs for the foreseeable future from our operating cash flow and our existing cash and cash equivalents. Our
future capital requirements may be adjusted from time to time as they depend on several factors, including our growth rate, the expansion
of our research and development efforts, employee headcount, marketing and sales activities, the introduction of new features to our existing
products, the continued market acceptance of our products. </span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_019"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Research and Development,
Patents and Licenses</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of the date of this annual report, we had
no issued patents and one patent application pending in Brazil. As of December 31, 2023, we owned 375 trademark registrations in Brazil,
and we have also sought to register trademarks abroad, in the United States, in the European Union, Portugal, Mexico and Colombia, and
we have also sought to register 12 trademarks outside Brazil, which are still in progress. As of the date of this annual report, we had
no issued patents and one patent application pending in Brazil. As of the date of this annual report, we have 169 pending trademark applications
in Brazil and unregistered trademarks that we use to promote our brand, and also own 344 registered domain names in Brazil and 21 registered
international domain names, and have registered two softwares in Brazil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">See &#8220;Item 4. Information on the Company&#8212;Technology
and Intellectual Property.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_020"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trend Information</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Other than as disclosed elsewhere in this
annual report, we are not aware of any other trends, uncertainties, demands, commitments or events for the year ended December 31, 2023
that are reasonably likely to have a material and adverse effect on our revenues, income, profitability, liquidity or capital resources,
or that would cause the disclosed financial information to be not necessarily indicative of future results of operations or financial
conditions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 120 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_021"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Critical Accounting
Estimates</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our consolidated financial statements have
been prepared in accordance with IFRS, as issued by the IASB. In preparing our audited consolidated financial statements, we make assumptions,
judgments and estimates that can have a significant impact on amounts reported in our consolidated financial statements. We base our assumptions,
judgments and estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual
results could differ materially from these estimates under different assumptions or conditions. We regularly reevaluate our assumptions,
judgments and estimates, presenting our critical accounting estimates in note 3 of our audited consolidated financial statements included
elsewhere in this annual report.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_022"></span>ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_023"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Directors and Senior
Management</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are managed by our board of directors and
by our senior management, pursuant to our Amended and Restated Memorandum and Articles of Association and the Cayman Islands Companies
Act (As Revised).</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Board of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors is currently composed
of 11 members. Each of our director shall hold office for a two (2) year term and are eligible for re-election. Under our Amended and
Restated Memorandum and Articles of Association: (i) Bertelsmann, for so long as it holds a number of our Class B common shares in excess
of 10% of the total number of outstanding Class B common shares (referred to herein as the &#8220;Ownership Threshold&#8221;), shall be
entitled to appoint, at its sole discretion, up to seven of our directors, and shall be entitled at any time to remove, substitute or
replace any of its appointed directors for any reason in its sole discretion; (ii) the Esteves Family, for so long as it holds our Class
B common shares in excess of the Ownership Threshold, shall be entitled to appoint, at its sole discretion, up to two of our directors,
and shall be entitled at any time to remove, substitute or replace any of its appointed directors for any reason in its sole discretion;
and (iii) Bertelsmann and the Esteves Family, for so long as they hold our Class B common shares in excess of the Ownership Threshold
shall be entitled to jointly appoint, at their sole discretion, up to one (1) director and shall be entitled at any time to remove, substitute
or replace their appointed director for any reason in their sole discretion (provided that if only one of Bertelsmann and the Esteves
Family holds Class B common shares in excess of the Ownership Threshold, then only Bertelsmann or the Esteves Family, as applicable, shall
have these rights). Directors appointed by the board of directors hold office until the next annual general meeting. Our directors do
not have a retirement age requirement under our Articles of Association. Subject to the foregoing, the directors shall be elected by an
ordinary resolution of our shareholders, which requires the affirmative vote of a simple majority of the votes cast on the resolution
by the shareholders entitled to vote who are present, in person or by proxy, at the meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following table lists the current members
of our board of directors:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 51%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Name</p></td>
    <td style="text-align: left; width: 7%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Age</p></td>
    <td style="width: 42%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Position</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Nicolau Carvalho Esteves	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">71</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Co-Chairman</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Kay Krafft	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">53</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Co-Chairman</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Shobhna Mohn	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">59</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Benedikt Dalkmann	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">39</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Christina Krebs	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">50</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Renato Tavares Esteves	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">36</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Maria Tereza Azevedo	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">41</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Jo&#227;o Paulo Seibel de Faria	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">48</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Independent Director*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Vanessa Claro Lopes	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">48</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Independent Director*</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Miguel Filisbino Pereira de Paula	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">62</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Independent Director*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Marcelo Ken Suhara	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">50</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Independent Director*</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">*</td><td>Member of our Audit Committee. At our annual shareholders&#8217; meeting held on June 15, 2023, Vanessa Claro Lopes, Jo&#227;o Paulo
Seibel de Faria and Miguel Filisbino Pereira de Paula were re-elected as independent directors of the Company, and Marcelo Ken Suhara was elected
as an independent director of the Company, each to serve for a two-year term.</td></tr></table>


<!-- Field: Page; Sequence: 121 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following is a brief summary of the business
experience of our directors. Unless otherwise indicated, the current business addresses for our directors is Alameda Oscar Niemeyer,
No. 119, rooms 502, 504, 1,501 and 1,503, Vila da Serra, Nova Lima, Minas Gerais, Brazil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Nicolau Carvalho Esteves</i>. Nicolau Carvalho
Esteves is co-chairman of our board of directors, a position he has held since May 2022 after having held the position of chairman since
July 2019. He is a qualified orthopedist and has over 25 years of experience in the education industry. He was the chairman of the board
of directors of Afya Brazil from August 2016 to December 2019, when the board of directors of Afya Brazil was extinguished. He is the
founding shareholder of the following companies, for which he served as Chief Executive Officer for the periods indicated (i)&#160;ITPAC&#8212;Instituto
Tocantinense Presidente Ant&#244;nio Carlos S.A. (1999-2016); (ii)&#160;ITPAC Porto&#8212;Instituto Tocantinense Presidente Ant&#244;nio
Carlos Porto S.A. (2008-2016); (iii)&#160;IPTAN&#8212;Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (2003-2016)
and (iv)&#160;Instituto de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A. (2016-2018). He is also a member of the board
of directors of Emive Participa&#231;&#245;es S.A, a position he has held since January 2024. He holds a Medicine degree from Faculdade de Medicina
de Barbacena, a master&#8217;s degree in business administration from FGV, a master&#8217;s degree in Corporate Finance from Funda&#231;&#227;o
Dom Cabral, a master&#8217;s degree in business administration from FEAD and a Business Administration degree from AIEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Kay Krafft</i>. Kay Krafft is co-chairman
of our board of directors, a position he has held since May 2022 after having held the position of director since August 2021. He is the
founding CEO of Bertelsmann Education Group. Until 2014, he was Chief Investment Officer of music rights management company BMG, building
up the company from a start-up to a major player in the music industry through acquisitions as well as the establishment of an international
presence. Before joining BMG&#8217;s Executive Board, he served as EVP and global head of M&amp;A at Bertelsmann while implementing major
portfolio adjustments during this time. Prior to joining Bertelsmann, Kay Krafft was a partner at professional services firm Deloitte.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Shobhna Mohn</i>. Shobhna Mohn is a member
of our board of directors, a position she has held since August 2021. She is Chief Strategy Officer at Bertelsmann Investments. Currently,
Shobhna is responsible for the strategic design and execution of Bertelsmann&#8217;s global VC investment funds in China, India, Brazil,
US/Europe as well as investments in Africa and Southeast Asia. Her focus is on governance, insights, knowledge exchange, identification
and steering of long-term strategic holdings. Main target areas of focus are on growth platforms such as e-commerce services, fintech,
logistics, education and health. As a member of the Investment Committees that evaluate and approve Bertelsmann&#8217;s VC investment
targets, she has played a key role in the VC investments of over Euro 1.9 billion since 2006 in more than 500 Investments with a current
global portfolio of 350 investments. Shobhna is a member of the Bertelsmann Group Management Committee since 2019. She has been at Bertelsmann
since 1996 in various roles including Growth Regions Strategy, Investor Relations, and Venture Capital. She holds Bachelor&#8217;s (B.A.)
and master&#8217;s degrees (both M.A. and M.Phil) in Mathematics from the Delhi University in India, and a M.Phil degree in Operations
Research/Management Science from Columbia Business School in New York, USA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Benedikt Dalkmann</i>. Benedikt Dalkmann
is a member of our board of directors, a position he has held since May 2022, in addition to being Chief Financial Officer of Bertelsmann
Education Group. He has played a formative role in developing the Group since its foundation in 2015, including the expansion of Relias
into a major player in U.S. healthcare education through acquisitions, as well as the establishment of an international presence. Before
joining the Education Group, Benedikt worked as Director of Strategy &amp; Investments at Bertelsmann Group. Other experiences include
a period in Venture Capital at Holtzbrinck, and in management consulting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Christina Krebs</i>. Christina Krebs is
a member of our board of directors, a position she has held since May 2022, in addition to being the Chief People Officer of Bertelsmann
Education Group and the Chief People Officer at Relias, a Bertelsmann Education Group company. Since 2020, Christina held multiple roles
at Relias including VP, Client Care and VP, Integration, where she helped integrate multiple healthcare technology companies into the
Relias portfolio. Before joining Relias, Christina was a partner at the professional services firm, ScottMadden Management Consultants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Renato Tavares Esteves.</i> Renato Tavares
Esteves is a member of our board of directors, a position he has held since July 2019. He was a member of the board of directors of Afya
Brazil from August 2016 to December 2019, when the board of directors of Afya Brazil was extinguished. He served as executive officer
of the following companies: <i>Instituto de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A., UNIVA&#199;O&#8212;Uni&#227;o
Educacional do Vale do A&#231;o S.A., IPTAN&#8212;Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A., ITPAC&#8212;Instituto
Tocantinense Presidente Ant&#244;nio Carlos S.A.,</i> and <i>Instituto de Ensino Superior do Piau&#237; S.A.&#8212;IESP. </i>He is
also a member of the board of directors of Emive Participa&#231;&#245;es S.A, a position he has held since January 2024. He holds a degree
in medicine from Faculdade de Medicina de Barbacena, and a master&#8217;s degree in business administration and Corporate Finance from
FGV.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 122 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Maria Tereza Azevedo</i>. Maria Tereza Azevedo
is a member of our board of directors, a position she has held since April 2022. She joined Softbank LatAm fund in 2021 as Investment
Director leading the Education industry. Prior to joining Softbank, she was an Executive Director at Santander and Director at UBS Investment
Bank leading the TMT strategy and LatAm Education and the Technology, Media, and Telecommunications teams, respectively. She has extensive
experience in helping LatAm companies access the equity capital markets and holds a master&#8217;s degree in Corporate Finance and a bachelor&#8217;s
degree in economic sciences from IBMEC. Maria Tereza also serves as a board member of UOL Edtech, Descomplica, Camino Educa&#231;&#227;o,
Open Co, Glorify and Alice Sa&#250;de.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Vanessa Claro Lopes</i>. Vanessa Claro Lopes
is a member of our board of directors and an independent member of our audit, risks and ethics committee, positions she has held since
July 2019. She is currently an independent member of the board of directors of Lojas Americanas S.A., member of the fiscal councils of
Cosan S.A. and Comgas S.A., the chairperson of the audit committee at Tegma Logistica S.A., a member of the audit committee at Embraer
S.A. and Lojas Americanas S.A and a member of the financial committee at Lojas Americanas SA. She was formerly the chairperson of the
fiscal council of Via Varejo S.A. from 2014 to 2018, a member of the fiscal council of Terra Santa Agro S.A. from 2016 to 2018, a member
of the fiscal council of Gerdau S.A. from 2016 to 2017 and a member of the fiscal councils of Est&#225;cio Participa&#231;&#245;es
S.A. and Renova Energia S.A. from 2017 to 2019 and Cosan Logistica SA from 2019 to 2021. With over 29 years&#8217; experience in corporate
governance and internal and external audits of large private and listed companies, she started her career in 1995 at PricewaterhouseCoopers
in advisory services and was responsible for the creation of the revenue assurance specialists department in Brazil for the telecoms sector.
She was an executive officer and the head of the internal accounting department of TAM S.A. from 2010 to 2014, an executive officer and
the head of the internal accounting department of Globex Utilidades S.A. (Grupo P&#227;o de A&#231;&#250;car) from 2004 to 2010
and a coordinator and the head of the accounting department of Grupo Telefonica from 2000 to 2004. She holds an MBA from EAESP/FGV, a
master&#8217;s degree in management systems from Universidade Federal Fluminense (UFF), a master&#8217;s degree in computer networks from
S&#227;o Judas University, an accounting degree from Universidade Federal Fluminense (UFF) and a systems analysis degree from FATEC/BS.
She was formerly a professor of audit systems and information security at Objetivo University from 1997 to 1998.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Jo&#227;o Paulo Seibel de Faria</i>. Jo&#227;o
Paulo Seibel de Faria is a member of our board of directors and an independent member of our audit, risks and ethics committee, positions
he has held since August 2020. He is currently the CFO of OLX, a position he has held since August 26, 2020. He has 30 years of experience
in companies like Arthur Andersen S/C, Ericsson Telecomunica&#231;&#245;es, Microsoft, Didi Chuxing, OLX and Patria Investiments.
He spent 18 years at Microsoft in different leadership roles in Latin America and the U.S. in sales, marketing and in finance, including
his last role as chief financial officer in Brazil. Mr. Faria holds a bachelor&#8217;s degree in business management from FAAP and an
Executive MBA from Insper (both in S&#227;o Paulo). Additionally, he holds several executive sessions in leadership, strategy and global
business environment from Funda&#231;&#227;o Dom Cabral, INSEAD and Devry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Miguel Filisbino Pereira de Paula</i>.
Miguel Filisbino Pereira de Paula is a member of our board of directors and an independent member of our audit, risks and ethics committee
and People &amp; ESG Committee, which positions he has held since August 2020. He has over 30 years&#8217; experience in C-level positions
and serving on the advisory boards and boards of directors of large companies, such as Gerdau S.A., Votorantim Cimentos S.A., Yduqs S.A.
and Companhia Brasileira de Distribui&#231;&#227;o d/b/a GPA). Miguel has held the position of director (since March 2024) and chairman
of the people committee (since February 2021) at Loja do Mec&#226;nico, a privately held company, as is also an operating partner of
private equity funds, such as Crescera Capital and EB Capital&#8217;s investees. In these companies, he has held positions such as executive
director and/or vice president in the areas of human resources and management, and in business support areas, such as deliveries, shared
service center, information technology and related areas. During his executive career, he has led major turnaround projects in companies
and/or business units of these groups, always focusing on processes, people, new organizational concepts and governance models, and he
has been directly and/or indirectly responsible for hiring and developing many executives for management positions in these organizations.
Since January 2020, he has been involved in the advisory boards or boards of directors as well as head of human resources and ESG committees
at several companies and private equity Funds. He holds a degree in business administration from Universidade Luterana do Brasil, an
MBA in retail management from the University of S&#227;o Paulo and an MBA in human resources management from Pontif&#237;cia Universidade
Cat&#243;lica do Rio Grande do Sul. He completed several courses in leadership and business management in Brazil, at the Kellogg School
of Management: in the United States and at the Union of Japanese Scientists and Engineers (JUSE).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 123 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Marcelo Ken Suhara</i>. Marcelo Ken Suhara
has a combined 26 years of experience in initial public offering advisory services, financial reporting, accounting and audit. He was
a partner in the capital markets center at Ernst &amp; Young in S&#227;o Paulo from 2011 to March 2022. He also worked in the capital
markets group at PricewaterhouseCoopers from 2001 to 2010, and in audit at Arthur Andersen from 1998 to 2000 and Coopers &amp; Lybrand
from 1996 to 1998. He has extensive experience in initial public offerings, equity and debt offerings in the Brazilian and international
capital markets, and advised companies on financial reporting and regulatory matters on capital markets transactions, and on SEC rules
and regulations. He holds a bachelor&#8217;s degree in business management from <i>Pontificia Universidade Catolica</i> and a bachelor&#8217;s
degree in accounting from <i>Universidade Paulista</i> and is a Brazilian Certified Accountant registered at CRC &#8211; <i>Conselho Regional
de Contabilidade</i> (Brazilian Regional Accounting Council).</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Executive Officers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our executive officers are responsible for
the management and representation of our company. We have a strong centralized team led by Virgilio Deloy Capobianco Gibbon, our CEO,
with broad experience in the education industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following table lists our current executive
officers.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 45%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Name</p></td>
    <td style="text-align: left; width: 6%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Age</p></td>
    <td style="width: 49%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Position</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Virgilio Deloy Capobianco Gibbon	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">49</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">Chief Executive Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Luis Andr&#233; Carpintero Blanco	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">50</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">Chief Financial Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">L&#233;lio de Souza Junior	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: left">50</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">Vice President of Innovation &amp; Digital Services</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following is a brief summary of the business
experience of our executive officers. Unless otherwise indicated, the current business addresses for our executive officers is Alameda
Oscar Niemeyer, No 119, rooms 502, 504, 1,501 and 1,503, Vila da Serra, Nova Lima, Minas Gerais, Brazil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Virgilio Deloy Capobianco Gibbon.</i> Virgilio
Deloy Capobianco Gibbon is our Chief Executive Officer, a position he has held since July 2019. He has been the Chief Executive Officer
of Afya Brazil since August 2016. Prior to joining us, he was Chief Operating Officer and Chief Financial Officer of Est&#225;cio Participa&#231;&#227;o
S.A., from March 2010 to March 2012, and March 2012 to June 2016, respectively. He was also Executive Director of Business Consulting
and Education Industry at TOTVS Consulting from October 2007 to December 2009, and Senior Manager of Business Consulting at Accenture
from 2000 to 2007. He holds a degree in economics from PUC-RJ and has completed management programs from FGV, Stanford and Harvard University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Luis Andr&#233; Blanco.</i> Luis Andr&#233;
Blanco is our Chief Financial Officer, a position he has held since April 2020. Prior to joining us, he served as CFO for OdontoPrev for
10 years, where he oversaw corporate finance &#8211; treasury, financial planning, M&amp;A, tax and accounting operations, legal and compliance.
Prior to that, Luis served as a Financial Officer at Vivo S.A. from 2003 to 2009 and also as CFO at <i>Tele Centro &#8211; Oeste Celular
Participa&#231;&#245;es</i> from 2000 to 2003. Luis holds a bachelor&#8217;s degree in engineering from the Federal University of
Rio de Janeiro and an executive program degree from University of Westminster, London, England.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>L&#233;lio de Souza Junior.</i> L&#233;lio
de Souza Junior is our Vice President of Innovation &amp; Digital Services, a position he has held since January 2022. Prior to joining
us, he served as CEO for Intelie for 5 years, where he had the chance to support the internationalization of the company, the acquisition
process by RigNet (later on acquired by Viasat, NASDAQ: VSAT) and to experience a very well succeeded growth history. Prior to that, Lelio
served as a Corporate Officer at TOTVS from 2008 &#8211; 2016 and also as Senior Manager in Accenture from 2000-2008. Lelio holds a bachelor&#8217;s
degree in Mechanical Engineering from the Federal University of Minas Gerais (UFMG) and executive programs degrees from University of
Wharton, Pennsylvania, USA and Insper, S&#227;o Paulo, Brazil.</p>


<!-- Field: Page; Sequence: 124 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Family Relationships</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Nicolau Carvalho Esteves, the co-chairman of
our board of directors, is the father of Renato Tavares Esteves, one of our directors.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Legal Proceedings</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In 2016, the federal prosecutors&#8217; office
filed a public civil proceeding against Mr. Nicolau Carvalho Esteves, our co-chairman, and certain other individuals, for irregular administrative
acts alleged to have taken place during each of their respective terms as Health Secretary of the State of Tocantins <i>(Secret&#225;rio
de Sa&#250;de do Estado de Tocantins)</i> between 2012 and 2014, a position held by Mr. Carvalho Esteves for a period of four months,
from March 9, 2012 to July 20, 2012. The prosecution alleges that Mr. Carvalho Esteves and the other individuals did not apply federal
funds in compliance with mandatory budgeting rules required by applicable federal statutes. On September 19, 2017, the lower court dismissed
the federal prosecutor&#8217;s claims on the basis that the alleged improper acts were carried out to allow the public healthcare system
in the State of Tocantins to continue to provide basic healthcare services, given there were insufficient public funds allocated for that
purpose at the time. The federal prosecutor&#8217;s office appealed the lower court&#8217;s decision and on October 30, 2018, the federal
court of appeals granted the appeal to overturn the lower court&#8217;s decision and to nullify the evidentiary phase of the proceedings
on the procedural technicality that the State of Tocantins had not been properly notified of its right to file its motion on evidence.
On May 3, 2019, Mr. Carvalho Esteves filed an appeal of the federal court of appeals decision with the Supreme Court of Justice. In February
2022, a decision was issued, dismissing the motions submitted by the public prosecutor&#8217;s office, and an appeal was filed by the
public prosecutor&#8217;s office. Mr. Nicolau Carvalho Esteves has presented counterarguments to the appeal, and, as of the date of this
annual report, the appeal is pending judgment by the court. The risk of loss in these proceedings is classified as remote by external
counsel. If Mr. Carvalho Esteves is found liable, he may be subject to penalties, including a three-year prohibition on him or any legal
entity under his control transacting with public entities or being granted tax incentives/benefits, including Afya.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_024"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Compensation</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, we are not required
to disclose compensation paid to our senior management on an individual basis and we have not otherwise publicly disclosed this information
elsewhere.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our executive officers, directors and management
receive fixed and variable compensation. They also receive benefits in line with market practice in Brazil. The fixed component of their
compensation is set on market terms and adjusted annually.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The variable component consists of cash bonuses
and awards of shares (or the cash equivalent). Cash bonuses or paid to executive officers and members of our management based on previously
agreed targets for the business. Shares (or the cash equivalent) are awarded under our share-based long-term incentive plans, as discussed
below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following table sets forth the fixed and
variable compensation of our key management personnel for the periods indicated:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">For
    the Year Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; width: 67%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2021</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 1pt; padding-bottom: 2pt; text-align: center; line-height: 9pt">&#160;</td>
    <td colspan="3" style="padding-top: 1pt; padding-bottom: 2pt; text-align: center; line-height: 9pt"><span style="font-size: 9pt"><b>(in R$ millions)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Short-term employee benefits	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">17.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">13.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">11.9</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Share-based compensation plans	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">21.4</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">13.1</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">20.3</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Total compensation</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>38.4</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>26.7</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>32.2</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Long-Term Incentive Plans</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Afya Long-Term Incentive Plan</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On August 30, 2019, our board of directors
approved the establishment of the new equity incentive plan, or the LTIP, as amended on July 29, 2020, with the purpose of advancing the
interests of our shareholders by enhancing our ability to attract, retain and motivate individuals to perform at the highest level.</p>


<!-- Field: Page; Sequence: 125 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The LTIP and the applicable option agreement
to be entered into between us and the beneficiary, or the Option Agreement, governs the issuance of equity incentive awards with respect
to our Class A common shares, or the Options. The calculation of the strike price of the Option will be set forth in the applicable Option
Agreement, as approved by the board of directors, upon the granting of the Option to the beneficiary. If a beneficiary is dismissed by
us, resigns, retires or dies, the portion of his or her Options under the LTIP that has vested at that date will be satisfied, but the
non-vested portion will be canceled. If a beneficiary is terminated for cause, all of his or her Options under the LTIP will be canceled.
The maximum aggregate number of shares that can be issued to beneficiaries under the LTIP may not exceed 4% of our share capital at any
time, excluding treasury shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On July 8, 2022, our people and ESG committee
approved a change in the strike price of the current share-based compensation plan. All tranches still to be vested had their strike price
modified compared to the IPO price in Brazilian reais (R$71.22), adjusted from the IPO date until the exercise date using the CDI rate,
excluding dividends. The already vested tranches remained on the previous settled strike price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On July 31, 2023, our people and ESG committee
approved a further change in the LTIP. All holders of options granted before July 11, 2022, with a strike price based on the IPO price
in Brazilian <i>reais</i> or above, were offered the possibility to exchange options for a number of RSUs with conversion ratios based
on the fair value of the original plan, as of the date of the modification, such that beneficiaries will have a &#8216;value for value&#8217;
benefit of settling their awards for no cash consideration and thus the total fair value of the modified award remained the same as the
original plan, resulting in a weighted average conversion ratio of 0.12 RSU per stock option. Moreover, our people and ESG committee approved
a change in the index rate to the strike prices of its granted stock options, such that strike prices are now adjusted by the IPCA rate
instead of the CDI rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On February 13, 2023, April 17, 2023, August
1, 2023, October 1, 2023 and December 1, 2023, we granted 15,000, 30,000, 153,000, 37,000 and 232,000 stock options, respectively. As
of December 31, 2023, a total of 1,696,064 stock options were outstanding under the LTIP. For further information about vesting periods
and strike price, see note 16.b.1 to our audited consolidated financial statements.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Restricted Stock Units Program</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On July 8, 2022, our board of directors approved
our restricted stock units program, or the RSU program, for employees. The participant&#8217;s right to effectively receive ownership
of RSUs will be conditioned on the participant&#8217;s continuance as an employee or director in the business group from the grant date
until vesting. Employees will be entitled to these shares in a proportion of 10%, 20%, 30% and 40% each year. On February 2, April 17,
August 1, October 1 and December 1, 2023, 8,000, 16,000, 153,490, 63,000 and 76,600 RSUs were granted to our executives, respectively,
with vesting periods from May 2024 to May 2027. The total number of outstanding RSUs subject to the RSU program will not exceed, on any
date, 1.2% of the total number of our shares, excluding treasury shares. As of December 31, 2023, a total of 854,331 RSUs were outstanding
under the RSU program. For further information about the RSU program, see note 16.b.2 to our audited consolidated financial statements.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_025"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Board Practices</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Duties of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a matter of Cayman Islands law, a director
of a Cayman Islands company is considered a fiduciary of the company. Accordingly, directors owe fiduciary duties to their companies to
act in accordance with the best interests of the company, to exercise their powers for the purposes for which they are conferred and not
to place themselves in a position where there is a conflict between their personal interests and their duty to the company. Accordingly,
a director owes a company a duty not to make a profit based on his or her position as director (unless the company permits him or her
to do so) and a duty not to put himself or herself in a position where the interests of the company conflict with his or her personal
interests or his or her duties to a third party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">However, a company&#8217;s articles of association
may permit a director to vote on a matter in which he or she has a personal interest if he or she has disclosed the nature of his or her
interest to the board of directors. Our Articles of Association provide that a director must disclose the nature and extent of any material
interests in any contract or arrangement, and that he or she may vote at any meeting on any resolution concerning an interested matter,
provided he or she has disclosed the nature of his or her interest and has not been disqualified by the chairman of the relevant meeting.</p>


<!-- Field: Page; Sequence: 126 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A director of a Cayman Islands company also
owes to the company duties to exercise independent judgment in carrying out his or her functions and to exercise reasonable skill, care
and diligence, which has both objective and subjective elements. Recent Cayman Islands case law confirmed that directors must exercise
the care, skill and diligence that would be exercised by a reasonably diligent person having the general knowledge, skill and experience
reasonably to be expected of a person acting as a director. Additionally, a director must exercise the knowledge, skill and experience
that he or she actually possesses.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Election and Terms of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">See &#8220;Item 10. Additional Information.&#8212;B.
Memorandum and Articles of Association&#8212;Appointment, Disqualification and Removal of Directors.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Board Committees</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors has established an audit,
risks and ethics committee and a compensation committee. On May 5, 2022, our board of directors voted to dissolve our business expansion
committee, such that the approval of any mergers and acquisitions, which was previously within the purview of the business expansion committee,
will now be submitted to the board of directors itself. In the future, our board of directors may establish other committees, as it deems
appropriate, to assist with its responsibilities.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Audit, Risks and Ethics Committee</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The audit, risks and ethics committee, or the
audit committee, which consists of Vanessa Claro Lopes (elected to the committee on July 8, 2019), Jo&#227;o Paulo Seibel de Faria (elected
to the committee on August 26, 2020), Miguel Filisbino Pereira de Paula (elected to the committee on August 26, 2020), and Marcelo Ken
Suhara (elected to the committee on June 22, 2023) assists our board of directors in overseeing our accounting and financial reporting
processes and the audits of our financial statements. In addition, the audit committee is directly responsible for the appointment, compensation,
retention and oversight of the work of our independent registered public accounting firm. Jo&#227;o Paulo Seibel de Faria serves as
chairman of the audit committee. The audit committee consists exclusively of members of our supervisory board who are financially literate,
and Marcelo Ken Suhara is considered an &#8220;audit committee financial expert&#8221; as defined by the SEC. Our board of directors has
determined that Vanessa Claro Lopes, Jo&#227;o Paulo Seibel de Faria, Miguel Filisbino Pereira de Paula and Marcelo Ken Suhara satisfy
the &#8220;independence&#8221; requirements set forth in Rule 10A-3 under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On December 14, 2023, our board of directors
approved the amendment of the audit committee charter. The audit committee complies with applicable SEC and Nasdaq rules. Notwithstanding
anything to the contrary established in the audit committee charter, the audit committee is responsible for, among other things:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the appointment, compensation, retention and oversight of any auditor or accounting firm engaged for the purpose of preparing or issuing
an audit report or performing other audit, review or attest services;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>pre-approval of the audit services and non-audit services to be provided by our independent auditor before the auditor is engaged
to render such services;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>review and discussions with the independent auditor its responsibilities under generally accepted auditing standards, the planned
scope and timing of the independent auditor&#8217;s annual audit plan(s) and significant findings from the audit;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>obtaining and review of a report from the independent auditor describing all relationships between the independent auditor and the
Company consistent with the applicable PCAOB requirements regarding the independent auditor&#8217;s communications with the audit committee
concerning independence;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>confirming and evaluating the rotation of the audit partners on the audit engagement team as required by law;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>review with management and the independent auditor, in separate meetings whenever the audit committee deems appropriate, any analyses
or other written communications prepared by the management and/or the independent auditor setting forth significant financial reporting
issues and judgments made in connection with the preparation of the financial statements, including analyses of the effects of alternative IFRS methods on the financial statements; and other critical accounting policies and practices of the Company;</td></tr></table>


<!-- Field: Page; Sequence: 127 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>review, in conjunction with the Chief Executive Officer and Chief Financial Officer of the Company, the Company&#8217;s disclosure
controls and procedures and internal control over financial reporting;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>establishing procedures for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal
accounting controls or auditing matters, and the confidential, anonymous submission by employees of the Company of concerns regarding
questionable accounting or auditing matters;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>approving or ratifying any related person transaction (as defined in our related person transaction policy) in accordance with our
related person transaction policy;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>oversee the effectiveness of our cybersecurity program; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>periodically monitor the prevention, detection, mitigation, and remediation of cybersecurity threats and incidents and report its
findings to our board of directors.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The audit committee meets as often as it determines
is appropriate to carry out its responsibilities, but in any event, pursuant to its charter, the audit committee ordinarily meets at least
six times per year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Information contained on our website shall
not constitute, or be deemed incorporated as, a part of this annual report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, our audit committee monitors ongoing
compliance with our code of ethics and related compliance policies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><b><i>People and ESG Committee</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Since our initial public offering, we have
established a compensation committee. The compensation committee, assists our board of directors in reviewing and approving the compensation
structure, including all forms of compensation, relating to our directors and executive officers. As permitted by the listing requirements
of Nasdaq, we have opted out of Nasdaq Listing Rule 5605(d), which requires that a compensation committee consist entirely of independent
directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On January 29, 2021, our board of directors
approved the compensation committee charter and included the responsibility for the committee to indicate and recommend for board approval
the appointment of our independent directors, directors and executive officer. On May 26, 2021 our board of directors approved the amendment
of the internal bylaws of the compensation committee to change its name to People and ESG Committee and also to include strategic sustainability
matters and approve reports, adhere to national and/or international protocols, agreements, principles or treaties to be discussed and
recommended by the committee. Notwithstanding anything to the contrary established in the audit committee charter, the committee also
reviews the total compensation package for our executive officers and directors and recommends to the board of directors for determination
the compensation of each of our directors and executive officers, and will periodically review and approve any long-term incentive compensation
or equity plans, programs or similar arrangements, annual bonuses and employee pension and benefits plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On May 5, 2022, our board of directors approved
an amendment to the bylaws of our People and ESG Committee to give full authority to the People and ESG Committee to approve certain matters.
On October 6, 2022, the board of directors approved the review of certain aspects of these bylaws, e.g., to include new responsibilities
for the People and ESG Committee related to the review and approval of pension plans, compensation instruments that are not regulated
collectively, and the execution, termination or amendment of certain material and relevant employment agreements. Following its adoption,
our People and ESG Committee is also responsible for the administration of certain aspects of our compensation recoupment policy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of the date of this annual report our People
and ESG Committee consists of Rafael Munerato de Almeida, Renato Tavares Esteves, Miguel Filisbino Pereira de Paula, Kay Krafft and Christina
Krebs. Miguel Filisbino Pereira de Paula serves as chairman of the People and ESG Committee.</p>


<!-- Field: Page; Sequence: 128 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">See &#8220;Item 6. Directors, Senior Management
and Employees&#8212;F. Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><b><i>Controlled Company Exception</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Bertelsmann beneficially owns the majority
of our Class B common shares, representing 63.4% of the voting power of our outstanding share capital. As a result, we are a &#8220;controlled
company&#8221; within the meaning of the corporate governance standards of the Nasdaq corporate governance rules. Under these rules, a
company of which more than 50% of the voting power in the election of directors is held by an individual, group or another company is
a &#8220;controlled company&#8221; and may elect not to comply with certain corporate governance requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a &#8220;controlled company,&#8221; we may
elect not to comply with certain corporate governance standards, including the requirements (1) that a majority of our board of directors
consist of independent directors; (2) that our board of directors have a compensation committee that is comprised entirely of independent
directors with a written charter addressing the committee&#8217;s purpose and responsibilities; and (3) that our board of directors have
a nominating and corporate governance committee that is comprised entirely of independent directors with a written charter addressing
the committee&#8217;s purpose and responsibilities. For so long as we qualify as a controlled company, we may take advantage of these
exemptions. Accordingly, our shareholders may not have the same protections afforded to shareholders of companies that are subject to
all of these corporate governance requirements. In the event that we cease to be a &#8220;controlled company&#8221; and our common shares
continue to be listed on the Nasdaq, we will be required to comply with the corporate governance standards within the applicable transition
periods.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Board Diversity Matrix</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Board
    Diversity Matrix (as of December 31, 2023)</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Country of Principal Executive Offices:</td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt">Brazil</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Foreign Private Issuer:</td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt">Yes (the Cayman Islands)</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Disclosure Prohibited under Home Country Law:</td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt">No</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Total Number of Directors:</td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt">11</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 10pt 5.4pt 2pt; width: 56%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 10pt 0 2pt; text-align: center">Female</p></td>
    <td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 10pt 0 2pt; text-align: center">Male</p></td>
    <td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 10pt 0 2pt; text-align: center">Non-Binary</p></td>
    <td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 10pt 0 2pt; text-align: center">Did
    Not Disclose Gender</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b>Part I: Gender Identity</b></td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Directors:</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b>Part II: Demographic Background</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Underrepresented Individual in Home Country Jurisdiction:</td>
    <td colspan="4" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">LGBTQ+:</td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#8212;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Did not Disclose Demographic Background:</td>
    <td colspan="4" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_026"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employees</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, we had 9,680 employees,
8% of which were based in our offices in Nova Lima and 92% of which were based in other cities elsewhere in Brazil. We also engage temporary
employees and consultants as needed to support our operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The table below breaks down our full-time personnel
by function as of December 31, 2023:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 78%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Function</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Number
    of Employees</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">%
    of Total</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Management	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">77</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">0.8%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Shared Services Center and IT, Sales and Marketing	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">918</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">9.5%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Faculties	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3,652</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">37.7%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">General and Administrative	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">5.033</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">52.0%</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Total</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>9,680</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>100.0%</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our employees in Brazil are represented by
the labor unions of independent sales agents and of consulting, information, research and accounting firms for the geographic area in
which they render services. We believe we have a constructive relationship with these unions, as we have never experienced strikes, work
stoppages or disputes leading to any form of downtime.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 129 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_027"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share Ownership</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For information regarding the share ownership
of our directors and senior management, see &#8220;Item 7. Major Shareholders and Related Party Transactions&#8212;A. Major Shareholders.&#8221;
For information as to stock options or RSUs granted to our directors, executive officers and other employees, see &#8220;Item 6. Directors,
Senior Management and Employees&#8212;B. Compensation&#8212;Long-Term Incentive Plans.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_028"></span>F. &#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosure of
a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have adopted a compensation recoupment policy
on November 30, 2023. Please see Exhibit 97.1 to this annual report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have not been required to prepare an accounting
restatement at any time during or after our last completed fiscal year and no recovery of awarded compensation is required pursuant to
our compensation recoupment policy.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_029"></span>ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_030"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Major Shareholders</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following table and accompanying footnotes
presents information relating to the beneficial ownership of our Class A common shares, our Class B common shares, and our Series A perpetual
convertible preferred shares as of the date of this annual report:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>each person or group of affiliated persons, known by us to own beneficially 5% or more of our outstanding shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>each of our executive officers and directors individually; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>all executive officers and directors as a group.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The number of common shares beneficially owned
by each entity, person, executive officer or director is determined in accordance with the rules of the SEC, and the information is not
necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares over
which the individual has sole or shared voting power or investment power as well as any shares that the individual has the right to acquire
within 60 days through the exercise of any option, warrant or other right. Except as otherwise indicated, and subject to applicable community
property laws, the persons named in the table have sole voting and investment power with respect to all common shares held by that person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Unless otherwise indicated below, the business
address for each beneficial owner is c/o Afya, Alameda Oscar Niemeyer, No. 119, rooms 502, 504, 1,501 and 1,503, Vila da Serra, Nova Lima,
Minas Gerais, Brazil.</p>

<!-- Field: Page; Sequence: 130 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Shares
    Beneficially Owned</p></td>
    <td rowspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">%
    of Total Voting Power(2)</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="4" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Common
    Shares</p></td>
    <td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Preferred
    Shares</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Class
    A</p></td>
    <td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Class
    B</p></td>
    <td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Series
    A</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Shareholders(1)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Shares</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">%</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Shares</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">%</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Shares</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">%</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">%</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt"><b>5% Shareholders Party to our Shareholders&#8217; Agreement</b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Bertelsmann SE &amp; Co. KGaA (3)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">16,137,280</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">35.0%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">29,074,134</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">66.4%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">63.4%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Nicolau Carvalho Esteves (4)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">2,113,811</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">4.6%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">14,728,629</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">33.6%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">30.9%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Ros&#226;ngela de Oliveira Tavares Esteves(3)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">2,113,811</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">4.6%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">14,728,629</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">33.6%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">30.9%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Renato Tavares Esteves (5)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">2,545,844</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">5.5%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">0.5%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Vanessa Tavares Esteves (6)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">2,435,440</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">5.3%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">0.5%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">L&#237;lian Tavares Esteves de Carvalho (7)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">2,529,711</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">5.5%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">0.5%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt"><b>Other 5% Shareholders</b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="width: 31%">&#160;</td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 9%">&#160;</td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 10%">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 31%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Ronald Baron (8)	</td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">3,277,281</td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">7.1%</td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="width: 9%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">0.7%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">SoftBank Group Corp. (9)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">2,433,323</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">5.3%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">150,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">100%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">0.5%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">FMR LLC (10)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">2,931,679</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">6.4%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">0.6%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt"><b>Other Executive Officers and Directors (11)</b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Kay Krafft (12)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Shobhna Mohn (13)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Benedikt Dalkmann(14)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Christina Krebs(15)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Jo&#227;o Paulo Seibel de Faria	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Miguel Filisbino Pereira de Paula	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Maria Tereza Azevedo	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Vanessa Claro Lopes	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">1,315</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">*</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Rafael Munerato de Almeida	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Marcelo Ken Suhara	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">L&#233;lio de Souza Junior	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">*</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">*</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Luis Andr&#233; Carpintero Blanco	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">42,136</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">*</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 9pt; text-indent: -9.35pt">Virgilio Deloy Capobianco Gibbon	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">386,878</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">*</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">*</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">*</td><td>Represents beneficial ownership of less than 1% of the respective class of our outstanding shares.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>As of the date of this annual report, we have 46,146,590 outstanding Class A common shares (49,920,068 total Class A common shares,
of which 3,773,478 are common shares held in treasury), 43,802,763 Class B common shares, and 150,000 Series A perpetual convertible preferred
shares of our authorized share capital issued and outstanding.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Percentage of total voting power represents voting power with respect to all of our Class A common shares and Class B common shares,
as a single class. Holders of our Class B common shares are entitled to 10 votes per share, whereas holders of our Class A common shares
are entitled to one vote per share. For more information about the voting rights of our Class A common shares and Class B common shares,
see &#8220;Item 10. Additional Information&#8212;B. Memorandum and Articles of Association&#8212;Description of Share Capital.&#8221;
The terms of our Series A perpetual convertible preferred shares require the approval of a majority of our Series A perpetual convertible
preferred shares voting as a separate class for us to take the following decisions, among others described in the certificate of designations:
(1) amend our organizational documents in a manner that would have an adverse effect on the Series A perpetual convertible preferred shares;
and (2) issue securities that are senior to, or equal in priority with, the Series A perpetual convertible preferred shares; except as
provided in the certificate of designations, our Series A perpetual convertible preferred shares otherwise are not entitled to vote.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>Based on a statement by Bertelsmann SE &amp; Co. KGaA and Erste WV G&#252;tersloh
GmbH on Schedule 13D filed on March 19, 2024, the date of the last available Schedule 13D filed by such person with the SEC. Such person&#8217;s
business address is at Carl-Bertelsmann-Strasse 270, 33311 G&#252;tersloh, Germany.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(4)</td><td>Based on (i) a statement by Nicolau Carvalho Esteves, Ros&#226;ngela de Oliveira Tavares Esteves, NRE Capital Ventures Limited and
NRE B Ventures Limited on Schedule 13G filed on February 20, 2024, the date of the last available Schedule 13G filed by such persons with
the SEC, and (ii) written communications delivered by such persons to the Company on or about March 18, 2024, stating that NRE B Ventures
Limited had exercised its right to convert 2,000,000 Class B common shares into 2,000,000 Class A common shares. Nicolau Carvalho Esteves
is a member of our board of directors. Includes 113,811 Class A common shares and 10,707,489 Class B common shares held of record by NRE
Capital Ventures Limited, a company controlled by Nicolau Carvalho Esteves and Ros&#226;ngela de Oliveira Tavares Esteves, who hold 100%
of its shares in joint tenancy, 2,000,000 Class A common shares and 4,000,000 Class B common shares held of record by NRE B Ventures Limited,
a company controlled by NRE Capital Ventures Limited, 13,916 Class B common shares held of record by Nicolau Carvalho Esteves, and 7,224
Class B common shares held of record by Ros&#226;ngela de Oliveira Tavares Esteves.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(5)</td><td>Based on a statement by Renato Tavares Esteves, RTE Capital Ventures Ltd. and RTE B Ventures Ltd. on Schedule 13G filed on February
20, 2024, the date of the last available Schedule 13G filed by such persons with the SEC. Renato Tavares Esteves is a member of our board
of directors. Consists of 765,047 Class A common shares held of record by Renato Tavares Esteves, 234,953 Class A common shares held of
record by RTE Capital Ventures Ltd., which is wholly-owned by Renato Tavares Esteves, and 1,545,844 Class A common shares held of record
by RTE B Ventures Ltd., which is wholly-owned by RTE Capital Ventures Ltd.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(6)</td><td>Based on a statement by Vanessa Tavares Esteves, VTE Capital Ventures Ltd. and VTE B Ventures Ltd. on Schedule 13G filed on February
20, 2024, the date of the last available Schedule 13G filed by such persons with the SEC. Consists of 654,643 Class A common shares held
of record by Vanessa Tavares Esteves, ) 345,357 Class A common shares held of record by VTE Capital Ventures Ltd., which is wholly-owned by Vanessa Tavares Esteves, and 1,435,440 Class A common shares held of record by VTE B Ventures Ltd., which is wholly-owned by VTE Capital Ventures Ltd.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(7)</td><td>Based on a statement by Lilian Tavares Esteves de Carvalho, LTE Capital Ventures Ltd. and LTE B Ventures Ltd. on Schedule 13G filed
on February 20, 2024, the date of the last available Schedule 13G filed by such persons with the SEC. Consists of 748,914 Class A common
shares held of record by L&#237;lian Tavares Esteves de Carvalho, 250,736 Class A common shares held of record by LTE Capital Ventures
Ltd., which is wholly-owned by L&#237;lian Tavares Esteves de Carvalho, and 1,530,061 Class A common shares held of record by LTE B
Ventures Ltd., which is wholly-owned by LTE Capital Ventures Ltd.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(8)</td><td>Based on a statement on Schedule 13G filed on February 14, 2024, by BAMCO, Inc., Baron Capital Group, Inc., Baron Capital Management,
Inc., and Ronald Baron, the date of the last available Schedule 13G by such persons with the SEC. Such persons&#8217; business address
is 767 Fifth Avenue, 49th Floor, New York, NY 10153.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(9)</td><td>Based on a statement on Schedule 13G filed on May 13, 2021 by SoftBank Group Corp. the date of the last available Schedule 13G by
such person with the SEC. Such person&#8217;s business address is 1-7-1 Kaigan, Minato-ku, Tokyo 105-7537 Japan.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(10)</td><td>Based on a statement on Schedule 13G filed on February 14, 2024, by FMR LLC, the date of the last available Schedule 13G by such person
with the SEC. Such person&#8217;s business address is 245 Summer Street, Boston, MA 02210.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(11)</td><td>Disclosure regarding the equity interest held by Messrs. Nicolau Carvalho Esteves and Renato Tavares Esteves, both members of our
board of directors, in us, is above.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(12)</td><td>Mr. Kay Krafft, a member of our board of directors, is the founding CEO of Bertelsmann Education Group. Mr. Krafft disclaims beneficial
ownership of the shares held by Bertelsmann except to the extent, if any, of his pecuniary interest therein.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(13)</td><td>Ms. Shobhna Mohn, a member of our board of directors, is the Chief Strategy Officer at Bertelsmann Investments. Ms. Mohn disclaims
beneficial ownership of the shares held by Bertelsmann except to the extent, if any, of her pecuniary interest therein.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(14)</td><td>Mr. Benedikt Dalkmann, a member of our board of directors, is the Chief Financial Officer at Bertelsmann Education Group. Mr. Dalkmann
disclaims beneficial ownership of the shares held by Bertelsmann except to the extent, if any, of his pecuniary interest therein.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(15)</td><td>Ms. Christina Krebs, a member of our board of directors, is the Chief People Officer at Bertelsmann Investments. Ms. Krebs disclaims
beneficial ownership of the shares held by Bertelsmann except to the extent, if any, of her pecuniary interest therein.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 131 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: white">The holders
of our Class A common shares and Class B common shares have identical rights, except that the Esteves Family and Bertelsmann as holders
of Class B common shares (i)&#160;are entitled to 10 votes per share, whereas holders of our Class A common shares are entitled to one
vote per share, (ii)&#160;have certain conversion rights and (iii)&#160;are entitled to maintain a proportional ownership interest by
purchasing additional Class B common shares in the event that additional Class A common shares are issued. For more information see &#8220;Item
10. Additional Information&#8212;B. </span>Memorandum and Articles of Association&#8212;Description of Share Capital&#8212;Preemptive
or Similar Rights&#8221; and &#8220;Item 10. Additional Information&#8212;B. Memorandum and Articles of Association&#8212;Description
of Share Capital&#8212;Conversion.&#8221; Each Class B common share is convertible into one Class A common share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are not aware of any other shareholder that
beneficially owns more than 5% of our common shares nor of any arrangements the operation of which may at a subsequent date result in
a change of control of the company.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Shareholders&#8217; Agreement</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On July 7, 2019, Crescera and certain members
of the Esteves family entered into a shareholders&#8217; agreement, or the Original Shareholders&#8217; Agreement. The Original Shareholders&#8217;
Agreement specified that Crescera could not transfer its shares in the Company, in whole or in part, without first offering them to Bertelsmann,
which will have the option to acquire such shares. On June 7, 2021, in connection with the acquisition by Bertelsmann of all Afya shares
held by Crescera as of such date pursuant to a share purchase agreement also entered into on such date, the Original Shareholders&#8217;
Agreement was terminated and certain members of the Esteves family and Bertelsmann determined to enter into an amended and restated shareholders&#8217;
agreement, or the A&amp;R Shareholders&#8217; Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The A&amp;R Shareholders&#8217; Agreement
provides that the parties shall cooperate to ensure that Afya enters into a customary registration rights agreement with the parties.
Further, (i) while Bertelsmann holds an interest in Afya, or (ii) for a period of five years from the moment the Original Shareholder
ceases to hold an interest in the Company (whichever occurs earlier), certain members of the Esteves family is bound by a non-compete
obligation preventing it from directly or indirectly carrying on a competing business that is in direct competition with us, subject
to certain limited exceptions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 132 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->127<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_031"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Related Party Transactions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition to the compensation arrangements
with directors and executive officers described under &#8220;Item 6. Directors, Senior Management and Employees&#8212;B. Compensation&#8221;
and certain other rights of certain of the holders of our common shares as described under &#8220;&#8212;A. Major Shareholders&#8212;Shareholders&#8217;
Agreement,&#8221; the following is a description of material transactions since January 1, 2021 and each currently proposed transaction
in which the amount involved in the transactions is material to us and any related party.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Lease Agreements</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Lease agreements with RVL Esteves Gest&#227;o
Imobili&#225;ria S.A.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya Brazil has entered into lease agreements
with RVL Esteves Gest&#227;o Imobili&#225;ria S.A. (&#8220;RVL&#8221;), an entity controlled by the shareholder Nicolau Carvalho Esteves
and of which Mr. Renato Esteves is an executive officer, as described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On June 21, 2016, RVL entered into lease agreements
(as amended on April 26, 2018) with ITPAC Aragua&#237;na and ITPAC Porto, pursuant to which RVL agreed to lease campuses to those entities
in the cities of Aragua&#237;na and Porto Nacional, both located in the State of Tocantins. The lease agreements are adjustable in accordance
with the provisions of each lease agreement. The lease agreements are for an initial term of 20 years and are renewable for an additional
20 years subject to the provisions of each lease agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On November 1, 2016, RVL entered into a lease
agreement with Afya Brazil, pursuant to which RVL agreed to lease to Afya Brazil certain offices in the city of Nova Lima, State of Minas
Gerais, where Afya Brazil&#8217;s executive offices are located. On February 9, 2019, the agreement was amended to extend lease terms
and adjust the lease amounts, subject to certain discount conditions set forth in the lease agreement and adjustable in accordance with
the provisions of the lease agreement. The lease agreement is for an initial term of five years and may be renewable for an additional
five years subject to the provisions of the lease agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On September 6, 2018, RVL entered into a lease
agreement with ITPAC Aragua&#237;na, pursuant to which RVL agreed to lease to ITPAC the new ITPAC campus by RVL in the city of Palmas,
State of Tocantins. The lease agreement is for an amount equal to 7.5% of the monthly revenue of ITPAC during the prior semester and will
be effective (and become due) once the new ITPAC campus becomes operational, subject to the provisions of the lease agreement. Since 2022,
the campus is fully operational. The lease agreement is for an initial term of 20 years and is renewable for an additional 20 years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On October 30, 2019, RVL entered into a lease
agreement with IPTAN, pursuant to which RVL agreed to lease to IPTAN the new IPTAN medical campus in the city of Santa In&#234;s, State
of Maranh&#227;o. The lease agreement is for a monthly amount equal to (i) up to June 2020, R$12 and (ii) from July 2020 until March
2024, 6.5% of the monthly revenue of IPTAN during the prior semester, adjusted in accordance with the provisions of the lease agreement.
The lease agreement is for an initial term of five years starting in January 2021 when the campus becomes operational and may be renewable
for an additional five years subject to the provisions of the lease agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On August 2, 2021, RVL entered into a lease
agreement with ITPAC Aragua&#237;na, pursuant to which RVL agreed to lease to ITPAC the new ITPAC Garanhuns medical campus, in the city
of Garanhuns, State of Pernambuco. The lease agreement is for a monthly amount equal to (i) up to June 2022, R$40; (ii) from July 2022
until December 2028, 6.5% of the monthly revenue of ITPAC Garanhuns during the prior semester, in each case adjusted in accordance with
the provisions of the lease agreement; and (iii) as from January 2029, the monthly amount should be adjusted by the inflation rate (IPCA).
The lease agreement is for a term of 20 years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The lease payments in connection with the lease
agreements with RVL totaled R$23.4 million, R$20.4 million and R$15.3 million in the years ended December 31, 2023, 2022 and 2021, respectively.</p>


<!-- Field: Page; Sequence: 133 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->128<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Lease agreement with UNIVA&#199;O Patrimonial
Ltda.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On July 14, 2016, UNIVA&#199;O Patrimonial
Ltda., an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Ms. Ros&#226;ngela Esteves is the chief executive
officer, entered into a lease agreement with UNIVA&#199;O, a subsidiary of Afya Brazil, pursuant to which UNIVA&#199;O Patrimonial
Ltda. agreed to lease the UNIVA&#199;O campus to UNIVA&#199;O, located in the city of Ipatinga, State of Minas Gerais. The lease agreement
is adjustable in accordance with the provisions of the lease agreement. The lease agreement is for an initial term of 20 years and is
renewable for an additional 20 years subject to the provisions of the lease agreement. The lease payments in connection with this lease
agreement totaled R$3.6 million, R$3.4 million and R$3.2 million in the years ended December 31, 2023, 2022 and 2021, respectively.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Lease agreement with IESVAP Patrimonial Ltda.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On April 25, 2018, IESVAP Patrimonial Ltda.,
an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato Esteves is an executive officer, entered into
a lease agreement with IESVAP, a subsidiary of Afya Brazil, pursuant to which IESVAP Patrimonial Ltda. agreed to lease the IESVAP campus
to IESVAP located in the city of Parna&#237;ba, State of Piau&#237;. The lease agreement is for an amount equal to 7.5% of the monthly
revenue of IESVAP until maturation. The lease agreement is for an initial term of 20 years and is renewable for an additional 20 years
subject to the provisions of the lease agreement. The lease payments in connection with this lease agreement totaled R$5.2 million, R$4.9
million and R$4.6 million in the years ended December 31, 2023, 2022 and 2021, respectively.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">ITPAC Garanhuns Assignment Agreement</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On March 28, 2019, our shareholder Nicolau
Carvalho Esteves entered into an agreement with Afya Brazil. According to this agreement, he transferred to Afya Brazil the right to develop
the ITPAC Garanhuns greenfield unit, a medical school in Garanhuns, State of Pernambuco, contingent upon pending authorization by MEC.
The consummation of this transfer depends on MEC&#8217;s approval of the ITPAC Garanhuns medical school authorization within 10 years
from the agreement&#8217;s execution. The purchase price, contingent upon MEC&#8217;s approval within the specified timeframe, amounts
to R$900,000 multiplied by the number of medical school seats authorized by MEC, projected at 120 seats once operational.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In 2008, the Brazilian federal government and
the federal public prosecutor initiated two public civil proceedings seeking the suspension of activities at the Garanhuns Greenfield
unit, citing irregular status with MEC. On November 5, 2021, SERES authorized the operation of the medical school in Garanhuns, Pernambuco.
This authorization secured 120 medical seats for Afya, resulting in a purchase price of R$108 million. Payment terms include 50% in cash
on the transaction&#8217;s closing date and 50% in two equal annual installments, adjusted by the CDI rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">See note 8 to our audited consolidated financial
statements.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Related Person Transaction Policy</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On January 29, 2021, our board of directors
approved the related party transactions and conflicts of interests&#8217; policy that set forth our guidelines and procedures regarding
agreements with related parties. On December 19, 2022, our board of directors approved an amendment to our policy in order to reflect
certain revised approval thresholds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our related person transaction policy states
that related person transactions must be approved or ratified by our executive officers and board of directors. In determining whether
to approve or ratify a transaction with a related person, our executive officers or board of directors will consider all relevant facts
and circumstances, including without limitation the commercial reasonableness of the terms, of the transaction the benefit and perceived
benefit, or lack thereof, to us, opportunity costs of alternate transaction, the materiality and character of the related person&#8217;s
direct or indirect interest and the actual or apparent conflict of interest of the related person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to the related transaction policy,
our executive officers or board of directors will not approve or ratify a related person transaction unless it has determined that, upon
consideration of all relevant information, such transaction is in, or not inconsistent with, our best interests and the best interests
of our shareholders.</p>


<!-- Field: Page; Sequence: 134 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->129<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Indemnification Agreements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have executed indemnification agreements
with our directors and executive officers. The indemnification agreements and our Articles of Association require us to indemnify our
directors and executive officers to the fullest extent permitted by law.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Employment Agreements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Virgilio Deloy Capobianco Gibbon, L&#233;lio
de Souza Junior and Luis Andr&#233; Carpintero Blanco entered into employment agreements with the Company. None of our directors have
entered into service agreements with the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For a description of the compensation paid
to our directors and executive officers, see &#8220;Item 6. Directors, Senior Management and Employees&#8212;B. Compensation.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Long-Term Incentive Plans</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">See &#8220;Item 6. Directors, Senior Management
and Employees&#8212;B. Compensation&#8212;Long-Term Incentive Plans.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_032"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interests of Experts
and Counsel</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_033"></span>ITEM 8. FINANCIAL INFORMATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_034"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Consolidated Statements
and Other Financial Information</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">See Exhibits.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Legal and Administrative Proceedings</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">From time to time, we are involved in disputes
that arise in the ordinary course of our business. Any claims against us, whether meritorious or not, can be time consuming, result in
costly litigation, require significant management time and result in the diversion of significant operational resources.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We and our subsidiaries are subject to a number
of judicial and administrative proceedings in the Brazilian court systems, including civil, labor and tax law and social security claims
and other proceedings, which we believe are common and incidental to business operations in Brazil, in general. We recognize provisions
for legal proceedings in our financial statements, when we are advised by independent outside counsel that (i)&#160;it is probable that
an outflow of resources will be required to settle the obligation, and (ii)&#160;a reliable estimate can be made of the amount of the
obligation. The assessment of the likelihood of loss includes analysis by outside counsel of available evidence, the hierarchy of laws,
available case law, recent court rulings and their relevance in the legal system. Our provisions for probable losses arising from these
matters are estimated and periodically adjusted by management. In making these adjustments our management relies on the opinions of our
external legal advisors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, we had provisions
recorded in our audited consolidated financial statements in connection with legal proceedings for which we believe a loss is probable,
in an aggregate amount of R$104.3 million, and had made judicial deposits in an aggregate amount of R$14.2 million. However, legal proceedings
are inherently unpredictable and subject to significant uncertainties. If one or more cases were to result in a judgment against us in
any reporting period for amounts that exceeded our management&#8217;s expectations, the impact on our operating results or financial condition
for that reporting period could be material.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, under the terms of the share
purchase and sale agreements between us and the selling shareholders of certain subsidiaries acquired by us, such selling shareholders
are exclusively responsible for any liabilities (including labor, tax and civil liabilities), which are or will be the subject of a claim
by any third party, arising from an act or fact that occurred, whether by action or inaction, prior to or on the closing dates of the
respective acquisitions, and such selling shareholders have agreed to indemnify us and our subsidiaries in the event of any losses relating
to any such contingent liabilities. Accordingly, our provisioned amounts related to such contingent liabilities are recorded as non-current
liabilities, with a corresponding amount recorded as non-current other assets; as of December 31, 2023, we have recorded R$81.9 million
as other non-current assets with respect to provisioned amounts relating to such contingent liabilities.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 135 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->130<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Civil Matters</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, we and our
subsidiaries were party to approximately 8,826 civil proceedings, 3,577<span style="font-size: 8pt"> </span>of which are
collection proceedings in which we are plaintiffs, 4,743 of which are other judicial proceedings and 506<span style="font-size: 8pt">&#160; </span>of
which are administrative proceedings. The civil claims to which we are a party generally relate to consumer claims, including those
related to student complaints. We believe these proceedings are unlikely to have a material adverse impact, individually, or in the
aggregate, on our results of operations or financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On October 9, 2012, a civil suit was filed
by Marly Luzia Bernardes Rocha against ITPAC Porto and others, alleging (i)&#160;that Municipal Law No. 1780/03 in connection with IESPEN&#8217;s
creation is unconstitutional, and therefore that IESPEN&#8217;s dissolution and assignment of all its contingencies to ITPAC Porto should
be voided; (ii)&#160;that ITPAC Porto acted in bad faith and failed in its duties to pay for corresponding material damages, loss of profits,
loss of opportunity and moral damages; (iii)&#160;that Maria Aurora Pinto Leite e Silva and Celso Eduardo Avelar Freire, shareholders
of IESPEN, did not pay up corporate capital; and (iv)&#160;that ITPAC Porto should compensate the plaintiffs for alleged illicit enrichment
in connection with the dissolution. On January 12, 2014, ITPAC filed its defense, which is pending review by the competent lower court.
On November 13, 2016, the lower court froze 8% of ITPAC Porto&#8217;s monthly revenues in favor of the plaintiffs, and the freeze order
was overturned on January 12, 2017. We estimate the amount of any claim for damages that may be imposed on us as a result of these proceedings
to be approximately R$27.1 million, with the likelihood of loss as possible.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In 2008, two public civil proceedings were
filed by the Brazilian federal government and the federal public prosecutor for the suspension of the activities of the Garanhuns Greenfield
unit, claiming that the status of the Garanhuns Greenfield unit with the MEC was irregular. As of the date of this annual report, the
activities of the Garanhuns Greenfield unit are suspended pursuant to a judgment of the 23rd Federal Court of the State of Pernambuco.
On February 27, 2020, the Superior Court of Justice confirmed the judgment of the 23rd Federal Court of the State of Pernambuco and the
Garanhuns Greenfield unit remains suspended. Afya Brazil is currently in discussions with MEC to obtain the necessary authorizations for
the Garanhuns Greenfield unit, and to the extent those authorizations are obtained, this proceeding will be extinguished. In July 2019,
ITPAC Aragua&#237;na filed an administrative proceeding requesting MEC&#8217;s reappraisal of its previous decision that denied the
request of transferring the administrative proceeding related to the medical course authorization, filed in 2011, from the state educational
system to the federal educational system, pursuant to applicable regulation. On September 2, 2020, MEC published Ordinance no. 722 recognizing
the right of ITPAC and determining the review of the regularization request formulated in 2011 by the institution. On November 5, 2021,
the instruction authorizing the start of educational activities was published.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On November 30, 2019, a public proceeding was
filed by Domingos Borges da Silva against Centro de Ensino S&#227;o Lucas, other educational institutions and the city hall of Porto
Velho, alleging (i) that the defendants were purportedly not granting all the full scholarships to undergraduate students from &#8220;<i>Programa
de Inclus&#227;o Social Universidade Para Todos &#8211; Faculdade da Prefeitura</i>,&#8221; provided by Municipal Law No. 1,887/10 and
modified by Municipal Law No. 2,284/16; (ii) that due to the lack of full scholarships, the Treasury was being jeopardized because the
agreement was for tax waive in exchange to the full scholarships for the beneficiary from the referred Program; (iii) therefore, the plaintiff
requires to be awarded a preliminary injunction to revoke Municipal Laws Nos. 1,887/10 and 2,284/16 and the suspension of the adhesion
contracts to the Program signed by the defendants; and (iv) that the defendants should be liable for alleged material damages and loss
of profits. On January 13, 2020, the lower court denied the preliminary injunction. On March 3, 2020, S&#227;o Lucas was served. The
lawsuit was not ruled by the lower court yet. It is important to highlight that Centro de Ensino S&#227;o Lucas is currently granting
scholarships from the Program and, by December 2020, there were 290 scholarships being offered. We estimate the amount of any claim for
damages that may be imposed on us as a result of this proceeding to be approximately of R$14.1 million, with the likelihood of loss as
possible.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The provisions related to civil proceedings
whose likelihood of loss is assessed as probable are R$21.3 million as of December 31, 2023. There are other civil proceedings assessed
by management and our legal counsels as having a possible risk of loss, for which no provisions are recognized, in the amount of R$51.3
million as of December 31, 2023.</p>


<!-- Field: Page; Sequence: 136 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->131<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Labor Matters</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, we and our
subsidiaries were party to approximately 303<span style="font-size: 8pt">&#160;</span>labor proceedings, 233 of which are judicial
proceedings and 70 of which are administrative proceedings. The principal labor proceedings to which we are a party were filed by
former employees or service providers seeking enforcement of labor rights allegedly not provided by us. The judicial proceedings
relate to employment bonds (judicial proceedings filed by former service providers), overtime, premiums for hazardous workplace
conditions, statutory severance, fines for severance payment delays, and compensation for workplace-related accidents. The
administrative proceedings relate to the alleged failure by us to comply with certain labor laws, including with respect to working
hours, the registration of employment agreements, disabled workers&#8217; hiring quotas and the protection of underage workers and
apprentices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The provisions related to labor proceedings
whose likelihood of loss is assessed as probable are R$22.7 million as of December 31, 2023. There are other labor proceedings assessed
by management and our legal counsels as having a possible risk of loss, for which no provisions are recognized, in the amount of R$32.6
million as of December 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt"><b><i>Tax and Social Security Matters</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, certain of our subsidiaries
were party to 77 tax and social security proceedings, 51 of which are judicial proceedings and 26 of which are administrative proceedings,
for which we did not record any provisions based on the advice of our external legal counsel that the likelihood of loss is possible.
The tax claims to which these subsidiaries are party are mostly tax foreclosures filed by Brazilian federal and municipal tax authorities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">ITPAC Porto is party to one tax foreclosure
proceeding filed by the Brazilian federal government on July 12, 2010 for the collection of social security contribution on payroll debts
in the total historical amount of R$1.5 million, for which we did not record any provisions based on the advice of our external legal
counsel that the likelihood of loss is possible. As of the date of this annual report, the amount of this proceeding is approximately
R$3.2 million and the proceeding is pending the decision of the lower court.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">UniSL is party to tax proceeding filed by city
of Porto Velho on July 19, 2017 for having allegedly incurred in insufficient payment of ISS taxes in the total historical amount of R$6.0
million. As of the date of this annual report, the amount of this proceeding is approximately R$7.8 million <span style="font-size: 8pt"></span>and
the likelihood of loss as possible. On March 31, 2023, there was a monocratic decision dismissing the defense, and reducing the fine applied
from 150% to 80%<span style="font-size: 8pt"></span>. An appeal was filed, which is pending judgment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">After a lawsuit initiated by Unigranrio concerning
the annulment of three tax assessments linked to tax immunities in the collection of ISS taxes, Unigranrio entered into a tax amnesty
program on August 10, 2023. This program aimed to address interest and penalties related to a tax proceeding concerning ISS (city tax
on services) with the municipality of Rio de Janeiro. As a result, Unigranrio made a payment of R$14.9 million to settle the claim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The provisions related to taxes proceedings
whose likelihood of loss is assessed as probable are R$60.3 million as of December 31, 2023. There are other tax proceedings assessed
by management and our legal counsels as having a possible risk of loss, for which no provisions are recognized, in the amount of R$5.6
million as of December 31, 2023.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">&#8220;Mais M&#233;dicos&#8221; Proceedings</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On January 15, 2019, Sociedade de Ensino Superior
Est&#225;cio de S&#225; Ltda., or SESES, filed a writ against SERES, requesting a judicial review of SERES&#8217;s decision to disqualify
the SESES bid to open a medical school in the city of Bragan&#231;a, State of Par&#225;, as part of the public procurement for the
&#8220;<i>Mais M&#233;dicos</i>&#8221; program, and award it to ITPAC Porto. The lower court granted a preventive injunction in favor
of SESES, suspending SERES&#8217;s award of the medical school to ITPAC Porto. ITPAC Porto joined these proceedings as a co-defendant.
On March 6, 2019, the federal prosecutor issued an opinion to dismiss the writ. On September 11, 2019, the lower court dismissed the
writ and revoked the suspension of the award of the medical school granted by MEC to ITPAC Porto, and we became authorized by MEC to
open and operate a medical school in the city of Bragan&#231;a. After the court denied SESES&#8217;s appeal, it filed a special appeal
to the Brazilian Superior Court of Justice (<i>Superior Tribunal de Justi&#231;a</i>), which is currently pending review<span style="font-size: 8pt"></span>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 137 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->132<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On January 31, 2019, Brasil Educa&#231;&#227;o
S.A., or BR Educa&#231;&#227;o, filed proceedings against SERES, requesting a judicial review of SERES&#8217;s decision to disqualify
the BR Educa&#231;&#227;o bid to open a school in the city of Abaetetuba, State of Par&#225;, as part of the public procurement
for the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, and award it to ITPAC Porto. ITPAC Porto joined these proceedings as a co-defendant.
The lower court granted a preventive injunction in favor of BR Educa&#231;&#227;o, suspending SERES&#8217;s award of the medical school
to ITPAC Porto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">This injunction was subsequently repealed by
the Federal Court of Appeals upon preliminary review. As of the date of this annual report, the proceedings are pending the issuance of
the final decision by the lower court and the Federal Court of Appeals, and ITPAC Porto is authorized by MEC to open and operate a medical
school in the city of Abaetetuba.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On February 2, 2019, in proceedings separate
to those of BR Educa&#231;&#227;o, Faculdades Integradas Caraj&#225;s S/C Ltda., or Faculdades Caraj&#225;s, filed a writ against
SERES, requesting a judicial review of SERES&#8217;s decision to disqualify the Faculdades Caraj&#225;s bid to open a medical school
in the city of Abaetetuba, State of Par&#225;, as part of the public procurement for the &#8220;<i>Mais M&#233;dicos</i>&#8221; program,
and award it to ITPAC Porto. The lower court granted a preventive injunction in favor of Faculdades Caraj&#225;s, suspending SERES&#8217;s
award of the school to ITPAC Porto. On October 10, 2019, Faculdades Caraj&#225;s filed a motion to dismiss the writ, and the writ was
dismissed by the lower court on January 10, 2020. Consequently, ITPAC Porto is authorized by MEC to open and operate a medical school
in the city of Abaetetuba.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In July 2019, Instituto Metropolitano de Ensino
Ltda., or IME, filed a lawsuit against SERES requesting the cancellation of the results of the public procurement for the &#8220;<i>Mais
M&#233;dicos</i>&#8221; program in connection with the awards granted to IPTAN and ITPAC Aragua&#237;na to open medical schools in
the cities of Itacoatiara and Manacapuru, located in the State of Amazonas. IME alleges that SERES&#8217;s final decision with respect
to IME&#8217;s participation in the public procurement was irregular. On September 11, 2019, the lower court granted a preventive injunction
in favor of IME, suspending SERES&#8217;s award of the medical schools to IPTAN and ITPAC Aragua&#237;na. IPTAN and ITPAC Aragua&#237;na
joined these proceedings as co-defendants. The preventive injunction was suspended following an appeal filed by SERES, and SERES, IPTAN
and ITPAC Aragua&#237;na filed their responses to IME&#8217;s allegations. As of the date of this annual report, these proceedings are
pending the decision of the lower court. On February 14, 2020, the preventive injunction granted in favor of IME to suspend the results
of the public procurement in the cities of Itacoatiara and Manacapuru was revoked by the Federal Court of Appeals. This decision gave
a suspensive effect for the appeal filed by IPTAN and ITPAC Aragua&#237;na, rendering the decisions of the first instance without effect.
On July 9, 2020, the lawsuit was dismissed and terminated following IME&#8217;s withdrawal of a related lawsuit.<span style="font-size: 8pt">&#160;&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Dividends and Dividend Policy</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have not adopted a dividend policy with
respect to future distributions of dividends. The amount of any distributions will depend on many factors such as our results of operations,
financial condition, cash requirements, prospects and other factors deemed relevant by our board of directors and, where applicable, our
shareholders. We currently intend to retain all available funds and any future earnings, if any, to fund the development and expansion
of our business and we do not anticipate paying any cash dividends in the foreseeable future. See &#8220;Item 3. Key Information&#8212;D.
Risk Factors&#8212;Certain Risks Relating to Our Class A Common Shares&#8212;It is unlikely that we will declare any dividends on our
common shares in the foreseeable future and therefore, you must rely on price appreciation of our common shares for a return on your investment.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We may make any future determination to pay
dividends based on an ordinary shareholder resolution, but no dividend may exceed the amount recommended by our board of directors. Even
if our board of directors recommends a dividend payment, the form, frequency and amount will depend on a number of factors, including
our future operations and earnings, our capital requirements and surplus, our general financial condition, impositions of restrictions
on conversions and remittances of funds abroad in the jurisdictions where we operate, contractual restrictions and other factors that
the board of directors may deem relevant. Cash dividends on our common shares, if any, will be paid in U.S. dollars.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are a holding company incorporated in the
Cayman Islands. We rely on dividends and distributions from our subsidiaries in Brazil for our cash requirements, including funds to
pay our operating expenses, service any debt we may incur and pay dividends and other cash distributions to our shareholders. Also, payments
of dividends from Afya Brazil to Afya Limited may be made according to cash requirements. Our holding company structure makes us dependent
on the operations of our subsidiaries and therefore, any determination to pay dividends in the future will depend on our ability to receive
distributions from them. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Our
holding company structure makes us dependent on the operations of our subsidiaries. We depend on dividend distributions by our subsidiaries,
and we may be adversely affected if the performance of our subsidiaries is not positive.&#8221;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 138 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->133<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Certain Cayman Islands Legal Requirements Related to Dividends</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Companies Act and our Articles of
Association, a Cayman Islands company may pay a dividend out of either its profit or share premium account, but a dividend may not be
paid if this would result in the company being unable to pay its debts as they fall due in the ordinary course of business. According
to our Articles of Association, dividends can be declared and paid out of funds lawfully available to us, which include the share premium
account. Dividends, if any, would be paid in proportion to the number of common shares a shareholder holds. For further information, see
&#8220;Item 10. Additional Information&#8212;E. Taxation&#8212;Cayman Islands Tax Considerations.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Certain Brazilian Legal Requirements Related to Dividends</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our ability to pay dividends is directly related
to positive and distributable net results from our Brazilian subsidiaries. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain
Risks Relating to Our Business and Industry&#8212;Our holding company structure makes us dependent on the operations of our subsidiaries.
We depend on dividend distributions by our subsidiaries, and we may be adversely affected if the performance of our subsidiaries is not
positive.&#8221; Our Brazilian subsidiaries are required under Federal Law No. 6,404 dated December 15, 1976, as amended, to distribute
a mandatory minimum dividend to shareholders each year, which cannot be lower than 25% of their income for the prior year, unless a lower
mandatory minimum dividend is provided for in such subsidiary by-laws or such distribution is suspended by a decision of such subsidiary&#8217;s
shareholders at its annual shareholders&#8217; meeting based on a report by its board of directors that such distribution would be incompatible
with its financial condition at that time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, if, for any legal reasons due
to new laws or bilateral agreements between countries, our Brazilian subsidiaries are unable to pay dividends to Cayman Islands companies,
or if a Cayman Islands company becomes incapable of receiving them, we may not be able to make any dividend payments in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of the date of this annual report, Afya
Brazil and certain of our subsidiaries are required by their respective bylaws to distribute the following minimum dividends to shareholders:
(i)&#160;Afya Brazil, ITPAC Aragua&#237;na, ITPAC Porto, IESP, IPTAN, UEPC, FASA, UniRedentor, PEBMED, FESAR, iClinic, Medicinae, Medcel,
IESVAP, UNIVA&#199;O, Unigranrio, IESP&#8212;at least 25% of adjusted net profit in each fiscal year; and (ii)&#160;CCSI&#8212;at least
2% of net profit in each fiscal year. FADEP, IPEMED, IPEC, UniSL, FCMPB, Medical Harbour, Cliquefarma, Al&#233;m da Medicina, CardioPapers,
Glic, Shosp, UnifipMoc, RX-PRO and DelRey are limited liability companies and their articles of association do not stipulate a mandatory
minimum dividend.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have not declared or paid any dividends
to our shareholders since our incorporation in the Cayman Islands on March 22, 2019.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_035"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Significant Changes</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Except as disclosed elsewhere in this annual
report, we have not experienced any significant changes since the date of our audited consolidated financial statements included in this
annual report.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_036"></span>ITEM 9. THE OFFER AND LISTING</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_037"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Offer and Listing
Details</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On July 19, 2019, we completed our initial
public offering. On February 7, 2020, we completed a follow-on offering. Our common shares have been listed on the Nasdaq since July 19,
2019 under the symbol &#8220;AFYA.&#8221; Prior to that date, there was no public trading market for our common shares.</p>


<!-- Field: Page; Sequence: 139 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->134<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_038"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plan of Distribution</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_039"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Markets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">See &#8220;&#8212;A. Offer and Listing Details&#8221;
above.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_040"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Selling Shareholders</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_041"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dilution</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_042"></span>F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Expenses of the
Issue</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_043"></span>ITEM 10. ADDITIONAL INFORMATION</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_044"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share Capital</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_045"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Memorandum and
Articles of Association</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Description of Share Capital</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We were incorporated on March 22, 2019 as a
Cayman Islands exempted company with limited liability duly registered with the Cayman Islands Registrar of Companies. Our corporate purposes
are unrestricted and we have the authority to carry out any object not prohibited by law as provided by Section 7(4) of the Companies
Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our affairs are governed principally by (i)&#160;our
Amended and Restated Memorandum and Articles of Association; (ii)&#160;the Companies Act; and (iii)&#160;the common law of the Cayman
Islands. As provided in our Amended and Restated Memorandum and Articles of Association, subject to Cayman Islands law, we have full capacity
to carry on or undertake any business or activity, do any act or enter into any transaction, and, for such purposes, full rights, powers
and privileges. Our registered office is c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman
Islands.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association authorize the issuance
of share capital of up to 1,000,000,000 shares of a nominal or par value of US$0.00005 each, which, at the date of this annual report,
comprise 500,000,000 Class A common shares and 250,000,000 Class B common shares (which may be converted into Class A common shares in
the manner contemplated in our Articles of Association), and 250,000,000 shares of such class or classes (howsoever designated) and having
the rights that our board of directors may determine. As of the date of this annual report, we have 46,146,590 outstanding Class A common
shares (49,920,068 total Class A common shares, of which 3,773,478 are common shares held in treasury), 43,802,763 Class B common shares,
and 150,000 Series A perpetual convertible preferred shares of our authorized share capital issued and outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following is a summary of the material
provisions of our authorized share capital and our Articles of Association.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Share Capital</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Amended and Restated Memorandum and Articles
of Association currently authorize two classes of common shares: Class A common shares, which are entitled to one vote per share, and
Class B common shares, which are entitled to 10 votes per share and to maintain a proportional ownership interest in the event that additional
Class A common shares are issued. Any holder of Class B common shares may convert his or her shares at any time into Class A common shares
on a share-for-share basis. The rights of the two classes of common shares are otherwise identical, except as described in our Amended
and Restated Memorandum and Articles of Association. The implementation of this dual class equity structure was required by the Esteves
Family and Crescera, our principal shareholders in the year of 2019, as a condition of undertaking the initial public offering of our
common shares. See &#8220;&#8212;Anti-Takeover Provisions in Our Articles of Association&#8212;Two Classes of Common Shares.&#8221;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 140 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->135<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, our total authorized
share capital was US$50,000, divided into 1,000,000,000 shares par value US$0.00005 each, of which:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>500,000,000 shares are designated as Class A common shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>250,000,000 shares are designated as Class B common shares; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>250,000,000 shares of such class or classes (howsoever designated) and having the rights as the Board may determine.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023 and 2022, the Company&#8217;s
issued and outstanding share capital was R$17,000 represented by 93,722,831 shares comprised by 47,920,068 Class A common shares and 45,802,763
Class B common shares. In addition, as of December 31, 2023, 150,000 Series A perpetual convertible preferred shares were outstanding,
representing approximately 6.6% of our outstanding common shares, including the Series A perpetual convertible preferred shares on an
as-converted basis. For more information on our Series A perpetual convertible preferred shares, please refer no note 13.2.1 to our audited
consolidated financial statements included elsewhere in this annual report.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Treasury Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, Afya had 3,773,478
common shares in treasury.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Issuance of Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Except as expressly provided in our Articles
of Association, our board of directors has general and unconditional authority to allot, grant options over, offer or otherwise deal with
or dispose of any unissued shares in the company&#8217;s capital without the approval of our shareholders (whether forming part of the
original or any increased share capital), either at a premium or at par, with or without preferred, deferred or other special rights or
restrictions, whether in regard to dividend, voting, return of capital or otherwise and to such persons, on such terms and conditions,
and at such times as the directors may decide, but so that no share shall be issued at a discount, except in accordance with the provisions
of the Companies Act. In accordance with its Articles of Association, Afya shall not issue bearer shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association provide that at
any time that there are Class A common shares in issue, additional Class B common shares may only be issued pursuant to (i)&#160;a share
split, subdivision of shares or similar transaction or where a dividend or other distribution is paid by the issue of shares or rights
to acquire shares or following capitalization of profits, (ii)&#160;a merger, consolidation, or other business combination, or (iii)&#160;an
issuance of shares including Class A common shares or any other class of share designated as a common share pursuant to the Articles of
Association, whereby each holder of the Class B common shares is entitled to purchase a number of Class B common shares that would allow
it to maintain its proportional ownership interests in Afya (following an offer by Afya to each holder of Class B common shares to issue
to such holder, upon the same economic terms and at the same price, such number of Class B common shares as would ensure such holder may
maintain a proportional ownership interest in Afya pursuant to our Articles of Association). In light of: (a)&#160;the above provisions;
(b)&#160;the fact that future transfers by holders of Class B common shares will generally result in those shares converting to Class
A common shares, subject to limited exceptions as provided in the Articles of Association; and (c)&#160;the ten-to-one voting ratio between
our Class B common shares and Class A common shares, means that holders of our Class B common shares will in many situations continue
to maintain control of all matters requiring shareholder approval.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">This concentration of ownership and voting
power will limit or preclude your ability to influence corporate matters for the foreseeable future. For more information see &#8220;&#8212;Preemptive
or Similar Rights.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association also provide that
the issuance of non-voting common shares requires the affirmative vote of a majority of the then-outstanding Class A common shares and
the prior written consent of a Bertelsmann Director and Esteves Family Director as set out below in &#8220;&#8212;Proceedings of the Board
of Directors.&#8221;</p>


<!-- Field: Page; Sequence: 141 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->136<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Fiscal Year</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our fiscal year begins on January 1 of each
year and ends on December 31 of the same year.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Voting Rights</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The holders of the Class A common shares and
Class B common shares have identical rights, except that (i)&#160;the holder of Class B common shares is entitled to 10 votes per share,
whereas holders of Class A common shares are entitled to one vote per share, (ii)&#160;Class B common shares have certain conversion rights
and (iii)&#160;the holders of Class B common shares are entitled to maintain their proportional ownership interest in the event that common
shares and/or preferred shares are proposed to be issued. For more information see below &#8220;&#8212;Preemptive or Similar Rights&#8221;
and &#8220;&#8212;Conversion.&#8221; The holders of Class A common shares and Class B common shares vote together as a single class on
all matters (including the election of directors) submitted to a vote of shareholders, except as provided below and as otherwise required
by law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association provide as follows
regarding the respective rights of holders of Class A common shares and Class B common shares:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: white">(i)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Class
consents from the holders of Class A common shares or Class B common shares, as applicable, shall be required for any variation to the
rights attached to their respective class of shares, however, the directors may treat any two or more classes of shares as forming one
class if they consider that all such classes would be affected in the same way by the proposal;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
rights conferred on holders of Class A common shares shall not be deemed to be varied by the creation or issue of further Class B common
shares and vice versa; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
rights attaching to the Class A common shares and the Class B common shares shall not be deemed to be varied by the creation or issue
of further shares ranking pari passu therewith, the redemption or purchase of any shares of any class by the Company, the cancellation
of authorised but unissued shares of that class or the creation or issue of shares with preferred or other rights, including, without
limitation, shares with enhanced or weighted voting rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As set forth in the Articles of Association,
the holders of Class A common shares and Class B common shares, respectively, do not have the right to vote separately if the number of
authorized shares of such class is increased or decreased. Rather, the number of authorized Class A common shares and Class B common shares
may be increased or decreased (but not below the number of shares of such class then outstanding) by the affirmative vote of the holders
of a majority of the voting power of the issued and outstanding Class A common shares and Class B common shares, voting together in a
general meeting.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Preemptive or Similar Rights</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares and Class B common
shares are not entitled to preemptive rights upon transfer and are not subject to conversion (except as described below under &#8220;&#8212;Conversion&#8221;),
redemption or sinking fund provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class B common shares are entitled to maintain
a proportional ownership interest in the event that additional common and/or preferred shares are issued. As such, if Afya issues common
and/or preferred shares, it must first make an offer to each holder of Class B common shares to issue to such holder on the same economic
terms such number of Class B common shares as would ensure such holder may maintain a proportional ownership interest in Afya. This right
to maintain a proportional ownership interest may be waived by all of the holders of Class B common shares, such waiver to remain effective
until the date specified therein or 12 months from the date of the waiver.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Conversion</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The outstanding Class B common shares are
convertible at any time as follows: (i)&#160;at the option of the holder, a Class B common share may be converted at any time into one
Class A common share or (ii)&#160;upon the election of the holders of all the then issued and outstanding Class B common shares, all
outstanding Class B common shares may be converted into a like number of Class A common shares. In addition, each Class B common share
will convert automatically into one Class A common share upon any transfer, whether or not for value, except for certain transfers described
in the Articles of Association, including transfers to holders of Class B common shares, to affiliates, to and between the Esteves Family,
Bertelsmann, their family members and their respective children, heirs and successors, trusts solely for the benefit of the shareholder
or their affiliates, and to partnerships, corporations and other entities exclusively owned or controlled by the Class B shareholder
or their affiliates and certain transfers to organizations that are exempt from taxation under Section 501(c)(3) of the Internal Revenue
Code of 1986, as amended. Furthermore, each Class B common share will convert automatically into one Class A common share and no Class
B common shares will be issued thereafter if, at any time, the total number of the issued and outstanding Class B common shares is less
than 10% of the total number of shares outstanding. To the extent that Bertelsmann or the Esteves Family cease to be a Class B common
shareholder, the rights nominally vested to each shall vest in their permitted transferee within the meaning of our Articles of Association.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 142 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->137<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">No class of our common shares may be subdivided
or combined unless the other class of common shares is concurrently subdivided or combined in the same proportion and in the same manner.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Equal Status</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Except as expressly provided in our Articles
of Association, Class A common shares and Class B common shares have the same rights and privileges and rank equally, share ratably and
are identical in all respects as to all matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In the event of any merger, consolidation,
scheme, arrangement or other business combination requiring the approval of our shareholders entitled to vote thereon (whether or not
Afya is the surviving entity), the holders of Class A common shares shall have the right to receive, or the right to elect to receive,
the same form of consideration as the holders of Class B common shares, and the holders of Class A common shares shall have the right
to receive, or the right to elect to receive, at least the same amount of consideration on a per share basis as the holders of Class B
common shares. In the event of any (i)&#160;tender or exchange offer to acquire any Class A common shares or Class B common shares by
any third-party pursuant to an agreement to which Afya is a party, or (ii)&#160;any tender or exchange offer by Afya to acquire any Class
A common shares or Class B common shares, the holders of Class A common shares shall have the right to receive, or the right to elect
to receive, the same form of consideration as the holders of Class B common shares, and the holders of Class A common shares shall have
the right to receive, or the right to elect to receive, at least the same amount of consideration on a per share basis as the holders
of Class B common shares.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Record Dates</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For the purpose of determining shareholders
entitled to notice of, or to vote at any general meeting of shareholders or any adjournment thereof, or shareholders entitled to receive
dividend or other distribution payments, or in order to make a determination of shareholders for any other purpose, Our board of directors
may set a record date which shall not exceed 40 clear days prior to the date where the determination will be made.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">General Meetings of Shareholders</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a condition of admission to a shareholders&#8217;
meeting, a shareholder must be duly registered as a shareholder of Afya at the applicable record date for that meeting and, in order to
vote, all calls or installments then payable by such shareholder to Afya in respect of the shares that such shareholder holds must have
been paid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to any special rights or restrictions
as to voting then attached to any shares, at any general meeting every shareholder who is present in person or by proxy (or, in the case
of a shareholder being a corporation, by its duly authorized representative not being himself or herself a shareholder entitled to vote)
shall have one vote per Class A common share and 10 votes per Class B common share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a Cayman Islands exempted company, Afya
is not obliged by the Companies Act to call annual general meetings; however, the Articles of Association provide that in each year the
company will hold an annual general meeting of shareholders, at a time determined by the board of directors. For the annual general meeting
of shareholders the agenda will include, among other things, the presentation of the annual accounts and the report of the directors (if
any). In addition, the agenda for an annual general meeting of shareholders will only include such items as have been included therein
by the board of directors.</p>


<!-- Field: Page; Sequence: 143 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->138<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Also, Afya may, but is not required to (unless
required by the laws of the Cayman Islands), hold other extraordinary general meetings during the year. General meetings of shareholders
are generally expected to take place in Nova Lima, Brazil, but may be held elsewhere if the directors so decide.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act provides shareholders a limited
right to request a general meeting and does not provide shareholders with any right to put any proposal before a general meeting in default
of a company&#8217;s Articles of Association. However, these rights may be provided in a company&#8217;s Articles of Association. Our
Articles of Association provide that upon the requisition of one or more shareholders representing not less than one-third of the voting
rights entitled to vote at general meetings, the board will convene an extraordinary general meeting and put the resolutions so requisitioned
to a vote at such meeting. The Articles of Association provide no other right to put any proposals before annual general meetings or extraordinary
general meetings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to regulatory requirements, the annual
general meeting and any extraordinary general meetings must be called by not less than 10 clear calendar days&#8217; notice prior to the
relevant shareholders meeting and convened by a notice discussed below. Alternatively, upon the prior consent of all holders entitled
to receive notice, with regards to the annual general meeting, and a majority in number of the members (which shall include Bertelsmann
and the Esteves Family) together holding at least 95% in par value of the shares entitled to attend and vote, with regards to an extraordinary
general meeting, that meeting may be convened by a shorter notice and in a manner deemed appropriate by those holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya will give notice of each general meeting
of shareholders by publication on its website and in any other manner that it may be required to follow in order to comply with Cayman
Islands law, Nasdaq and SEC requirements. The holders of registered shares may be given notice of a shareholders&#8217; meeting by means
of letters sent to the addresses of those shareholders as registered in our shareholders&#8217; register, or, subject to certain statutory
requirements, by electronic means.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><b>Holders whose shares are registered in the
name of DTC or its nominee, which we expect will be the case for all holders of Class A common shares, will not be a shareholder or member
of the company and must rely on the procedures of DTC regarding notice of shareholders&#8217; meetings and the exercise of rights of a
holder of the Class A common shares.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A quorum for a general meeting consists of
any one or more persons holding or representing by proxy not less than one-third of the aggregate voting power of all shares in issue
and entitled to vote upon the business to be transacted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A resolution put to a vote at a general meeting
shall be decided on a poll. An ordinary resolution to be passed by the shareholders at a general meeting requires the affirmative vote
of a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote, present in person or by proxy and voting
at the meeting. A special resolution requires the affirmative vote on a poll of no less than two-thirds of the votes cast by the shareholders
entitled to vote who are present in person or by proxy at a general meeting. Both ordinary resolutions and special resolutions may also
be passed by a unanimous written resolution signed by all the shareholders of our Company, as permitted by the Companies Act and our Articles
of Association.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to our Articles of Association, general
meetings of shareholders are to be chaired by the co-chairman of our board of directors appointed by Bertelsmann or in his absence, the
co-chairman of the board of directors appointed by the Esteves Family. If both such co-chairmen are absent, the directors present at the
meeting shall appoint one of them to be chairman of the general meeting. If neither the chairmen nor another director is present at the
general meeting within 15 minutes after the time appointed for holding the meeting, the shareholders present in person or by proxy and
entitled to vote may elect any one of the shareholders to be chairman. The order of business at each meeting shall be determined by the
chairman of the meeting and he or she shall have the right and authority to prescribe such rules, regulations and procedures and to do
all such acts and things as are necessary or desirable for the proper conduct of the meeting, including, without limitation, the establishment
of procedures for the maintenance of order and safety, limitations on the time allotted to questions or comments on the affairs of the
Company, restrictions on entry to such meeting after the time prescribed for the commencement thereof, and the opening and closing of
the polls. The chairman shall not have the right to vote in his capacity as chairman and shall not have a casting vote.</p>


<!-- Field: Page; Sequence: 144 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->139<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Liquidation Rights</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If Afya is voluntarily wound up, the liquidator,
after taking into account and giving effect to the rights of preferred and secured creditors and to any agreement between Afya and any
creditors that the claims of such creditors shall be subordinated or otherwise deferred to the claims of any other creditors and to any
contractual rights of set-off or netting of claims between Afya and any person or persons (including without limitation any bilateral
or any multi-lateral set-off or netting arrangements between the company and any person or persons) and subject to any agreement between
Afya and any person or persons to waive or limit the same, shall apply our property in satisfaction of its liabilities <i>pari passu</i>
and subject thereto shall distribute the property amongst the shareholders according to their rights and interests in Afya.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Special Matters</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya may not without the prior written consent
of (i)&#160;Bertelsmann for so long as it holds Class B common shares in excess of the Ownership Threshold and (ii)&#160;the Esteves Family
for so long as it holds Class B common shares in excess of the Ownership Threshold: change the number of directors; amend its Memorandum
and Articles of Association; vary the rights attaching to shares; approve the winding-up, liquidation or dissolution of Afya; or take
certain actions in respect of its share capital as set out in the Articles of Association; register as an exempted limited duration company;
or approve the transfer by way of continuation of Afya to a jurisdiction outside the Cayman Islands.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Anti-Corruption and Anti-Money Laundering</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association contain stringent
anti-corruption, anti-money laundering and certain other related measures applicable to us, our officers and directors, and its service
providers. The Articles of Association provide that if one of our shareholders is found to have been involved in an act of corruption,
money laundering or other related irregular act, the directors shall convene a meeting to consider the circumstances of such incident,
and establish a course of action to be taken against such shareholder. The actions range from (i)&#160;suspending such shareholder from
his/her duties as a director, officer and/or employee (if applicable) of the Company; (ii)&#160;terminating such duties; (iii)&#160;directing
such shareholder to transfer the entirety of his/her shareholding in the Company to his/her children and/or heirs; or (iv)&#160;if such
transfer is not possible, resolve that the shares in the Company owned by such shareholder be mandatorily redeemed by us. Further, our
Articles of Association provide that we shall not engage the services of any provider that has been found to violate applicable anti-corruption
laws, and further provide that we and our shareholders shall not violate applicable anti-corruption laws.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Changes to Capital</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the restrictions contained in the
Articles of Association and summarized above in &#8220;&#8212;Special Matters,&#8221; Afya may from time to time by ordinary resolution:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>increase its share capital by such sum, to be divided into shares of such amount, as the resolution shall prescribe;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>consolidate and divide all or any of its share capital into shares of a larger amount than its existing shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>convert all or any of its paid-up shares into stock and reconvert that stock into paid up shares of any denomination;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>subdivide its existing shares or any of them into shares of a smaller amount, provided that in the subdivision the proportion between
the amount paid and the amount, if any, unpaid on each reduced share shall be the same as it was in the case of the share from which the
reduced share is derived; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and
diminish the amount of its share capital by the amount of the shares so canceled.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our shareholders may by special resolution,
subject to confirmation by the Grand Court of the Cayman Islands on an application by the Company for an order confirming such reduction,
reduce its share capital or any capital redemption reserve in any manner permitted by law.</p>


<!-- Field: Page; Sequence: 145 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->140<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, subject to the provisions of the
Companies Act and our Articles of Association, Afya may:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>issue shares on terms that they are to be redeemed or are liable to be redeemed;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>purchase its own shares (including any redeemable shares); and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>make a payment in respect of the redemption or purchase of its own shares in any manner authorized by the Companies Act, including
out of its own capital.</td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Transfer of Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to any applicable restrictions set
forth in the Articles of Association, any shareholder of Afya may transfer all or any of his or her common shares by an instrument of
transfer in the usual or common form or in the form prescribed by the Nasdaq or any other form approved by the Company&#8217;s board of
directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares are traded on the
Nasdaq in book-entry form and may be transferred in accordance with our Articles of Association and Nasdaq&#8217;s rules and regulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">However, our board of directors may, in its
absolute discretion, decline to register any transfer of any common share which is either not fully paid up to a person of whom it does
not approve or is issued under any share incentive scheme for employees which contains a transfer restriction that is still applicable
to such common share. The board of directors may also decline to register any transfer of any common share unless:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the instrument of transfer is lodged with Afya, accompanied by the certificate (if any) for the common shares to which it relates
and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the instrument of transfer is in respect of only one class of shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the instrument of transfer is properly stamped, if required;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the common shares transferred are free of any lien in favor of Afya; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>in the case of a transfer to joint holders, the transfer is not to more than four joint holders.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If the directors refuse to register a transfer
they are required, within 15 business days after the date on which the instrument of transfer was lodged, to send to the transferee notice
of such refusal.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Share Repurchases</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act and the Articles of Association
permit Afya to purchase its own shares, subject to certain restrictions. The board of directors may only exercise this power on behalf
of Afya, and subject to the Companies Act, the Articles of Association and to any applicable requirements imposed from time to time by
the SEC, the Nasdaq, or by any recognized stock exchange on which our securities are listed. Set forth below is a description of our share
repurchase programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>1<sup>st</sup> Share Repurchase Program</i>.
Our Board of Directors approved a share buyback program on December 23, 2020. Under the share buyback program, Afya may repurchase up
to 1,015,844 of its outstanding Class A common shares in the open market, based on prevailing market prices, or in privately negotiated
transactions, over a period beginning on December 24, 2020 continuing until the earlier of the completion of the repurchase or December
31, 2021, depending upon market conditions. We repurchased the shares to execute the stock option program for the executives of the company
and utilized our existing funds to fund repurchases made under this program. Our Board of Directors also authorized management to appoint
BofA Securities, Inc. as our agent to purchase the shares on our behalf in the open market. It is our intention such purchases benefit
from the safe harbor provided by Rule 10b-18 (&#8220;Rule 10b-18&#8221;) promulgated by the SEC under the Exchange Act. Accordingly, we
shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability of Rule 10b-18
for purchases of our common shares under the program. The share buyback program was completed on October 21, 2021, upon the completion
of the purchase of the full amount of Class A common shares permitted under the program.</p>


<!-- Field: Page; Sequence: 146 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->141<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>2<sup>nd</sup> Share Repurchase Program</i>.
After the completion of our first share repurchase program on October 21, 2021 that resulted in the purchase of 1,015,844 Class A common
shares, our Board of Directors approved a new share repurchase program on October 27, 2021, or the second share repurchase program. Under
the second share repurchase program, Afya may repurchase up to 1,383,108 of its outstanding Class A common shares in the open market,
based on prevailing market prices, or in privately negotiated transactions, beginning on October 28, 2021 until the earlier of the completion
of the repurchase or December 31, 2022, depending upon market conditions. We repurchased the shares to execute the stock option program
for the executives of the company and utilized our existing funds to fund repurchases made under this program. The Board of Directors
of Afya also authorized management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market.
It is Afya&#8217;s intention that such purchases benefit from the safe harbor provided by Rule 10b-18 promulgated by the SEC under the
Exchange Act. Accordingly, Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize
the availability of Rule 10b-18 for purchases under the program. The second share repurchase program was completed on January 14, 2022,
upon the purchase of the full amount of Class A common shares permitted under the second share repurchase program.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>3<sup>rd</sup> Share Repurchase Program</i>.
After the completion of our second share repurchase program, which resulted in the purchase of 1,383,108 Class A common shares, our Board
of Directors approved a new share repurchase program on January 27, 2022, or the third share repurchase program. Under the third share
repurchase program, Afya may repurchase up to 1,874,457 of its outstanding Class A common shares which represents 4% of its free float,
in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning on January 27, 2022, until the
earlier of the completion of the repurchase or December 31, 2022, depending upon market conditions. We repurchased the shares for use
in our stock option program, as consideration in business combination transactions and for general corporate purposes and utilized our
existing funds and dividends received from Afya Brazil to fund repurchases made under this program. The Board of Directors of Afya also
authorized management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market. It is Afya&#8217;s
intention that such purchases benefit from the safe harbor provided by Rule 10b-18 promulgated by the SEC under the Exchange Act. Accordingly,
Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability of Rule
10b-18 for purchases under the program. The third share repurchase program was completed on May 4, 2022, upon the purchase of the full
amount of Class A common shares permitted under the third share repurchase program.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><i>4th Share Repurchase Program</i>. After
the completion of our third share repurchase program, which resulted in the purchase of 1,874,457 Class A common shares, our board of
directors has approved a new share repurchase program on March 23, 2023, or the fourth share repurchase program. Under the fourth share
repurchase program, Afya may repurchase up to 2,000,000 of its outstanding Class A common shares, in the open market, based on prevailing
market prices, or in privately negotiated transactions, beginning on April 3, 2023 until the earlier of the completion of the repurchase
or December 31, 2024, depending upon market conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The share repurchases may be made from time
to time through open market transactions and are subject to market and business conditions, levels of available liquidity, cash requirements
for other purposes, regulatory, and other relevant factors. Afya intends to repurchase the shares for use in its stock option and RSU
programs, as consideration in future business combination transactions and for general corporate purposes. Afya expects to utilize its
existing funds and future dividends to be received from Afya Brazil and/or strike price funds to be received in connection with any option
exercises under its stock option program, to fund repurchases made under this program. Afya&#8217;s Board of Directors will review the
share repurchase program periodically and may authorize adjustments to its terms and size or suspend or discontinue the program.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Board of Directors of Afya also authorized
management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market. It is Afya&#8217;s intention
that such purchases benefit from the safe harbors provided by Rules 10b-18 and 10b5-1 promulgated by the SEC under the Exchange Act. Accordingly,
Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability of Rules
10b-18 or 10b5-1 for purchases under the program.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Dividends and Capitalization of Profits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have not adopted a dividend policy with
respect to payments of any future dividends by Afya. Subject to the Companies Act, our shareholders may, by resolution passed by a simple
majority of the voting rights entitled to vote at a general meeting, declare dividends (including interim dividends) to be paid to shareholders
but no dividend shall be declared in excess of the amount recommended by the board of directors. The board of directors may also declare
dividends. Dividends may be declared and paid out of funds lawfully available to Afya. Except as otherwise provided by the rights attached
to shares and the Articles of Association of Afya, all dividends shall be paid in proportion to the number of Class A common shares or
Class B common shares a shareholder holds at the date the dividend is declared (or such other date as may be set as a record date); but,
(i)&#160;if any share is issued on terms providing that it shall rank for dividend as from a particular date, that share shall rank for
dividend accordingly, and (ii)&#160;where we have shares in issue which are not fully paid up (as to par value) we may pay dividends
in proportion to the amounts paid up on each share.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 147 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->142<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The holders of Class A common shares and Class
B common shares shall be entitled to share equally in any dividends that may be declared in respect of our common shares from time to
time. In the event that a dividend is paid in the form of Class A common shares or Class B common shares, or rights to acquire Class A
common shares or Class B common shares, (i)&#160;the holders of Class A common shares shall receive Class A common shares, or rights to
acquire Class A common shares, as the case may be; and (ii)&#160;the holders of Class B common shares shall receive Class B common shares,
or rights to acquire Class B common shares, as the case may be.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Series A perpetual convertible preferred shares
rank senior to our common with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation,
dissolution or winding up of the affairs of the Company. The holders of Series A perpetual convertible preferred shares are entitled to
a cumulative dividend at the rate of 6.5% per annum, payable quarterly in arrears. Dividends are payable in kind through the issuance
of additional Series A perpetual convertible preferred shares, in cash, or in any combination of both, at our discretion. The holders
of the Series A perpetual convertible preferred shares are also entitled to participate in dividends declared or paid on our common stock
on an as-converted basis.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Appointment, Disqualification and Removal of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is managed by its board of directors.
The Articles of Association provide that, unless otherwise determined by a special resolution of shareholders, the board of directors
will be composed of four to 14 directors, with the number being determined by a majority of the directors then in office. There are no
provisions relating to retirement of directors upon reaching any age limit. The Articles of Association also provide that, while our shares
are admitted to trading on Nasdaq, the board of directors must always comply with the residency and citizenship requirements of the U.S.
securities laws applicable to foreign private issuers. Bertelsmann for so long as it holds Class B common shares in excess of the Ownership
Threshold may appoint up to seven directors at its discretion (and is entitled at any time to remove substitute or replace such directors)
(&#8220;Bertelsmann Directors&#8221;), and the Esteves Family for so long as it holds Class B common shares in excess of the Ownership
Threshold may appoint up to two directors at its discretion (and is entitled at any time to remove substitute or replace such directors)
(&#8220;Esteves Family Directors&#8221;), in addition for so long as both hold Class B common shares in excess of the Ownership Threshold,
they may appoint a further director (the &#8220;Joint Director&#8221;) and are entitled at any time to remove, substitute or replace the
Joint Director (provided that if only one of Bertelsmann and the Esteves Family holds Class B Common Shares in excess of the Ownership
Threshold, then only Bertelsmann or the Esteves Family, as applicable, shall have such right). The Board of Directors shall have one (1)
co-chairman appointed by Bertelsmann, for so long as it holds Class B Common Shares in excess of the Ownership Threshold and one (1) co-chairman
appointed by the Esteves Family, for so long as it holds Class B Common Shares in excess of the Ownership Threshold, thereafter, the chairman
of the Board of Directors shall be appointed by a majority of the Directors then in office.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing, the Articles of Association
provide that directors shall be elected by an ordinary resolution of our shareholders, which requires the affirmative vote of a simple
majority of the votes cast on the resolution by the shareholders entitled to vote who are present, in person or by proxy, at the meeting.
Each director shall be appointed and elected for a two-year term or until his or her death, resignation or removal, and is eligible for
re-election.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For the names of our directors, see &#8220;Item
6. Directors, Senior Management and Employees&#8212;A. Directors and Senior Management&#8212;Board of Directors.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Any vacancies on the board of directors that
arise other than in respect of the Bertelsmann and/or Esteves Family director appointments set out above or upon the removal of a director
by resolution passed at a general meeting can be filled by the remaining directors (notwithstanding that they may constitute less than
a quorum). Any such appointment shall be as an interim director to fill such vacancy until the next annual general meeting of shareholders.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 148 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->143<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing, additions to the
existing board (within the limits set pursuant to the Articles of Association) may be made by ordinary resolution of the shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors has an audit committee
in place. See &#8220;Item 6. Directors, Senior Management and Employees&#8212;A. Directors and Senior Management&#8212;Audit Committee.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Grounds for Removing a Director</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A director may be removed with or without cause
by ordinary resolution, save that each Bertelsmann Director may only be removed by Bertelsmann at its discretion and each Esteves Family
Director may only be removed by the Esteves Family at its discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The notice of general meeting must contain
a statement of the intention to remove the director and must be served on the director not less than 10 calendar days before the meeting.
The director is entitled to attend the meeting and be heard on the motion for his removal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The office of a director will be vacated automatically
if he or she (i)&#160;becomes prohibited by law from being a director, (ii)&#160;becomes bankrupt or makes an arrangement or composition
with his creditors, (iii)&#160;dies or is in the opinion of all his co-directors, incapable by reason of mental disorder of discharging
his duties as director, (iv)&#160;resigns his office by notice to us or (v)&#160;has for more than six months been absent without permission
of the directors from meetings of the board of directors held during that period, and the remaining directors resolve that his or her
office be vacated. Further, the Directors may remove a Director as set out above in &#8220;&#8212;Anti-Corruption.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Proceedings of the Board of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Articles of Association provide that our
business is to be managed and conducted by the board of directors, save that Afya may not without (i)&#160;the consent of a Bertelsmann
Director while there is a Bertelsmann Director and (ii)&#160;the consent of an Esteves Family Director while there is an Esteves Family
Director: create new classes of shares, issue new shares, options, warrants or convertible securities of similar nature conferring the
right upon the holders thereof to subscribe for purchase or receive any class of shares or securities in the capital of Afya; repurchase
or redeem any shares; execute and/or terminate any shareholders&#8217; agreement, quotaholders&#8217; agreement, or any other agreements
related to our interest in any subsidiary; approve our financial statements; effect any follow-on offerings of Afya; approve the listing
and/or the delisting of our securities with any designated stock exchange; conduct, negotiate, terminate and/or amend any business, agreement,
or transaction between Afya and any related party valued in excess of R$10.0 million, provided that, (A) if the Related Party is the Esteves
Family (or an Affiliate thereof), then the consent of the Esteves Family Director shall not be required and (B) if the Related Party is
Bertelsmann (or an Affiliate thereof), then the consent of the Bertelsmann Director shall not be required; approve any sale or encumbrance,
for the benefit of a person of shares issued by any subsidiary, or the admission of any new partner or shareholder in such subsidiaries;
carry out any investments outside the scope of the core business of Afya (as set out in the Articles of Association); incorporate any
entity; appoint or terminate the engagement of any auditor that is not an Authorized Auditor as set out in the Articles of Association;
provide any guarantee in respect of any person or related person of any of our shareholders, director and/or officers inter alia; or take
actions in connection with the Company&#8217;s Anti-Corruption measures, provided that if the Anti-Corruption measures relate to either
Bertelsmann or the Esteves Family, then the consent of the Esteves Family Director or the Bertelsmann Director respectively shall not
be required.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The quorum necessary for the board meeting
shall be a simple majority of the directors then in office (subject to there being a minimum of two directors present), and business at
any meeting shall be decided by a majority of votes. In the case of an equality of votes, neither the chairmen of the board nor the chairman
of the meeting shall have a casting vote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing and the provisions
of the Articles of Association, the board of directors may regulate its proceedings as they determine is appropriate. Board meetings shall
be held bi-monthly and shall take place either in Nova Lima, Brazil, or at such other place as the directors may determine.</p>


<!-- Field: Page; Sequence: 149 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->144<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the provisions of the Articles of
Association, to any directions given by ordinary resolution of the shareholders and the listing rules of the Nasdaq, the board of directors
may from time to time at its discretion exercise all powers of Afya, including, subject to the Companies Act, the power to issue debentures,
bonds and other securities of the company, whether outright or as collateral security for any debt, liability or obligation of our company
or of any third-party.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Inspection of Books and Records</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Holders of Afya shares have no general right
under Cayman Islands law to inspect or obtain copies of the list of shareholders or corporate records of the Company. However, the board
of directors may determine from time to time whether and to what extent our accounting records and books shall be open to inspection by
shareholders who are not members of the board of directors. Notwithstanding the above, the Articles of Association provide shareholders
with the right to receive annual financial statements and upon request agreements executed by the Company and its Related Parties (as
defined in the Articles of Association), shareholder agreements to which the Company is a party and details of any incentive plan. Such
right to receive annual financial statements may be satisfied by publishing the same on the company&#8217;s website or filing such annual
reports as we are required to file with the SEC.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Register of Shareholders</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares are held through
DTC, and DTC or Cede &amp; Co., as nominee for DTC, and recorded in the shareholders&#8217; register as the holder of our Class A common
shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, Afya must keep a
register of shareholders that includes:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the names and addresses of the shareholders, a statement of the shares held by each member and of the amount paid or agreed to be
considered as paid, on the shares of each member;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>whether voting rights attach to the shares in issue;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the date on which the name of any person was entered on the register as a member; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the date on which any person ceased to be a member.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, the register of shareholders
of Afya is prima facie evidence of the matters set out therein (i.e., the register of shareholders will raise a presumption of fact on
the matters referred to above unless rebutted) and a shareholder registered in the register of shareholders is deemed as a matter of Cayman
Islands law to have <i>prima facie</i> legal title to the shares as set against his or her name in the register of shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">However, there are certain limited circumstances
where an application may be made to a Cayman Islands court for a determination on whether the register of members reflects the correct
legal position. Further, the Cayman Islands court has the power to order that the register of members maintained by a company should be
rectified where it considers that the register of members does not reflect the correct legal position. If an application for an order
for rectification of the register of members were made in respect of our ordinary shares, then the validity of such shares may be subject
to re-examination by a Cayman Islands court.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Exempted Company</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is an exempted company with limited liability
under the Companies Act. The Companies Act distinguishes between ordinary resident companies and exempted companies. Any company that
is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted
company. The requirements for an exempted company are essentially the same as for an ordinary company except for the exemptions and privileges
listed below:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company does not have to file an annual return of its shareholders with the Registrar of Companies;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company&#8217;s register of shareholders is not open to inspection;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company does not have to hold an annual general meeting;</td></tr></table>


<!-- Field: Page; Sequence: 150 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->145<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may issue shares with no par value;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for
20 years in the first instance);</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may register as a limited duration company; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may register as a segregated portfolio company.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">&#8220;Limited liability&#8221; means that
the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in exceptional
circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances
in which a court may be prepared to pierce or lift the corporate veil).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are subject to reporting and other informational
requirements of the Exchange Act, as applicable to foreign private issuers. Except as otherwise disclosed in this annual report, we comply
with the Nasdaq rules in lieu of following home country practice.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Anti-Takeover Provisions in Our Articles of Association</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Some provisions of the Articles of Association
may discourage, delay or prevent a change in control of Afya or management that shareholders may consider favorable. In particular, the
capital structure of Afya concentrates ownership of voting rights in the hands of the Esteves Family and Bertelsmann. These provisions,
which are summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are
also designed to encourage persons seeking to acquire control of Afya to first negotiate with the board of directors. However, these provisions
could also have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary
fluctuations in the market price of the Class A common shares that often result from actual or rumored hostile takeover attempts. These
provisions may also have the effect of preventing changes in the management of Afya. It is possible that these provisions could make it
more difficult to accomplish transactions that shareholders may otherwise deem to be in their best interests.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Two Classes of Common Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class B common shares of Afya are entitled
to 10 votes per share, while the Class A common shares are entitled to one vote per share. Since they own of all of the Class B common
shares of Afya, the Esteves Family and Bertelsmann currently have the ability to elect all directors and to determine the outcome of most
matters submitted for a vote of shareholders. This concentrated voting control could discourage others from initiating any potential merger,
takeover, or other change of control transaction that other shareholders may view as beneficial.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">So long as the Esteves Family and Bertelsmann
have the ability to determine the outcome of most matters submitted to a vote of shareholders, third parties may be deterred in their
willingness to make an unsolicited merger, takeover, or other change of control proposal, or to engage in a proxy contest for the election
of directors. As a result, the fact that Afya has two classes of common shares may have the effect of depriving you as a holder of Class
A common shares of an opportunity to sell your Class A common shares at a premium over prevailing market prices and make it more difficult
to replace the directors and management of Afya.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Preferred Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors is given wide powers
to issue one or more classes or series of shares with preferred rights. Such preferences may include, for example, dividend rights, conversion
rights, redemption privileges, enhanced voting powers and liquidation preferences.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Despite the anti-takeover provisions described
above, under Cayman Islands law, our board of directors may only exercise the rights and powers granted to them under the Articles of
Association, for what they believe in good faith to be in the best interests of Afya.</p>


<!-- Field: Page; Sequence: 151 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->146<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For further information on our outstanding
Series A perpetual convertible preferred shares, see &#8220;Item 5. Operating and Financial Review and Prospects&#8212;B. Liquidity and
Capital Resources&#8212;Indebtedness&#8212;Series A Perpetual Convertible Shares&#8221; and note 13.2.1(d) to our audited consolidated
financial statements included elsewhere in this annual report.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Protection of Non-Controlling Shareholders</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Grand Court of the Cayman Islands may,
on the application of shareholders holding not less than one fifth of the shares of Afya in issue, appoint an inspector to examine the
Company&#8217;s affairs and report thereon in a manner as the Grand Court shall direct.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the provisions of the Companies
Act, any shareholder may petition the Grand Court of the Cayman Islands which may make a winding up order, if the court is of the opinion
that this winding up is just and equitable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Notwithstanding the U.S. securities laws and
regulations that are applicable to Afya, general corporate claims against Afya by its shareholders must, as a general rule, be based on
the general laws of contract or tort applicable in the Cayman Islands or their individual rights as shareholders as established by our
Articles of Association.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Cayman Islands courts ordinarily would
be expected to follow English case law precedents, which permit a minority shareholder to commence a representative action against Afya,
or derivative actions in our name, to challenge (i)&#160;an act which is ultra vires or illegal, (ii)&#160;an act which constitutes a
fraud against the minority and the wrongdoers themselves control Afya, and (iii)&#160;an irregularity in the passing of a resolution that
requires a qualified (or special) majority.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Registration Rights and Restricted Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Although no shareholders of Afya have formal
registration rights, they or entities controlled by them or their permitted transferees will be able to sell their shares in the public
market from time to time without registering them, subject to certain limitations on the timing, amount and method of those sales imposed
by regulations promulgated by the SEC.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Principal Differences between Cayman Islands and U.S. Corporate
Law</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act was modeled originally after
similar laws in England and Wales but does not follow subsequent statutory enactments in England and Wales. In addition, the Companies
Act differs from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of the significant differences
between the provisions of the Companies Act applicable to Afya and the laws applicable to companies incorporated in the United States
and their shareholders.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Mergers and Similar Arrangements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act permits mergers or consolidations
between two Cayman Islands companies, or between a Cayman Islands company and a company incorporated in another jurisdiction (provided
that is facilitated by the laws of that other jurisdiction).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Where the merger or consolidation is between
two Cayman Islands companies the directors of each company must approve a written plan of merger or consolidation, which must then be
authorized by (a)&#160;a special resolution (usually a majority of 66 2/3 % in value) of the shareholders of each company; and (b)&#160;such
other authorization, if any, as may be specified in such constituent company&#8217;s articles of association. No shareholder resolution
is required for a merger between a parent company (i.e., a company that owns at least 90% of the issued shares of each class in a subsidiary
company) and its subsidiary company. The consent of each holder of a fixed or floating security interest of a constituent company must
be obtained, unless the court waives such requirement. If the Cayman Islands Registrar of Companies is satisfied that the requirements
of the Companies Act (which includes certain other formalities) have been complied with, the Registrar of Companies will register the
plan of merger or consolidation. Where the merger or consolidation involves a foreign company, the procedure is similar, save that with
respect to the foreign company, the director of the Cayman Islands company is required to make a declaration to the effect that, having
made due enquiry, he is of the opinion that the requirements set out below have been met: (i) that the merger or consolidation is permitted
or not prohibited by the constitutional documents of the foreign company and by the laws of the jurisdiction in which the foreign company
is incorporated, and that those laws and any requirements of those constitutional documents have been or will be complied with; (ii)&#160;that
no petition or other similar proceeding has been filed and remains outstanding or order made or resolution adopted to wind up or liquidate
the company in any foreign jurisdictions; (iii)&#160;that no receiver, trustee, administrator or other similar person has been appointed
in any jurisdiction and is acting in respect of the foreign company, its affairs or property or any part thereof; (iv)&#160;that no scheme,
order, compromise or similar arrangement has been entered into or made in any jurisdiction whereby the rights of creditors of the foreign
company are and continue to be suspended or restricted.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 152 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->147<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Moreover, Cayman Islands law also has separate
statutory provisions that facilitate the reconstruction or amalgamation of companies, in certain circumstances, schemes of arrangement
will generally be more suited for complex mergers or other transactions involving widely held companies, commonly referred to in the Cayman
Islands as a &#8220;scheme of arrangement&#8221; which may be tantamount to a merger. In the event that a merger was sought pursuant to
a scheme of arrangement (the procedure of which are more rigorous and take longer to complete than the procedures typically required to
consummate a merger in the United States), the arrangement in question must be approved by, if a shareholder scheme, shareholders representing
three-fourths in value of each class of shareholders with whom the arrangement is to be made or, if a creditor scheme, a majority in number
of each class of creditors with whom the arrangement is to be made, and who must in addition represent three-fourths in value of each
such class of creditors, as the case may be, that are present and voting either in person or by proxy at a meeting or meetings summoned
for that purpose. The convening of the meetings and subsequently the terms of the arrangement must be sanctioned by the Grand Court of
the Cayman Islands. While a dissenting shareholder would have the right to express to the court the view that the transaction should not
be approved, the court can be expected to approve the arrangement if it satisfies itself that:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Afya is not proposing to act illegally or beyond the scope of its corporate authority and the statutory provisions as to majority
vote have been complied with;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the shareholders have been fairly represented at the meeting in question;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the arrangement is such as a businessman would reasonably approve; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act or that would amount
to a &#8220;fraud on the minority.&#8221;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If a scheme of arrangement or takeover offer
(as described below) is approved, any dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise
ordinarily be available to dissenting shareholders of United States corporations, providing rights to receive payment in cash for the
judicially determined value of the shares.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Squeeze-out Provisions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">When a takeover offer is made and accepted
by holders of 90.0% of the shares to whom the offer is made within four months, the offeror may, within a two-month period, require the
holders of the remaining shares to transfer such shares on the terms of the offer. An objection may be made to the Grand Court of the
Cayman Islands but is unlikely to succeed unless there is evidence of fraud, bad faith, collusion or inequitable treatment of the shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Further, transactions similar to a merger,
reconstruction and/or an amalgamation may in some circumstances be achieved through other means to these statutory provisions, such as
a share capital exchange, asset acquisition or control, through contractual arrangements, of an operating business.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Shareholders&#8217; Suits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Maples and Calder (Cayman) LLP, our Cayman
Islands counsel is not aware of any reported class action having been brought in a Cayman Islands court. Derivative actions have been
brought in the Cayman Islands courts, and the Cayman Islands courts have confirmed the availability for such actions. In most cases, we
will be the proper plaintiff in any claim based on a breach of duty owed to us, and a claim against (for example) our officers or directors
usually may not be brought by a shareholder. However, based on English authorities, which would in all likelihood be of persuasive authority
and be applied by a court in the Cayman Islands, exceptions to the foregoing principle apply in circumstances in which:</p>


<!-- Field: Page; Sequence: 153 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->148<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a company is acting or proposing to act illegally or beyond the scope of its authority;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the act complained of, although not beyond the scope of the authority, could be effected if duly authorized by more than the number
of votes which have actually been obtained; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>those who control the company are perpetrating a &#8220;fraud on the minority.&#8221;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A shareholder may have a direct right of action
against us where the individual rights of that shareholder have been infringed or are about to be infringed.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Borrowing Powers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our directors may exercise all the powers of
Afya to borrow money and to mortgage or charge its undertaking, property and assets (present and future) and uncalled capital or any part
thereof and to issue debentures, debenture stock, mortgages, bonds and other such securities whether outright or as security for any debt,
liability or obligation of Afya or of any third party. Such powers may be varied by a special resolution of shareholders (requiring a
two-thirds majority vote).</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Indemnification of Directors and Executive Officers
and Limitation of Liability</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act does not limit the extent
to which a company&#8217;s articles of association may provide for indemnification of directors and officers, except to the extent that
it may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or
the consequences of committing a crime. Our Articles of Association provide that we shall indemnify and hold harmless our directors and
officers against all actions, proceedings, costs, charges, expenses, losses, damages, liabilities, judgments, fines, settlements and other
amounts incurred or sustained by such directors or officers, other than by reason of such person&#8217;s dishonesty, willful default or
fraud, in or about the conduct of our company&#8217;s business or affairs (including as a result of any mistake of judgment) or in the
execution or discharge of his duties, powers, authorities or discretions, including without prejudice to the generality of the foregoing,
any costs, expenses, losses or liabilities incurred by such director or officer in defending (whether successfully or otherwise) any civil,
criminal or other proceedings concerning Afya or our affairs in any court whether in the Cayman Islands or elsewhere. This standard of
conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Insofar as indemnification for liabilities
arising under the Securities Act may be permitted to Our directors, officers or persons controlling the Company under the foregoing provisions,
we have been informed that, in the opinion of the SEC, this indemnification is against public policy as expressed in the Securities Act
and is therefore unenforceable.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Directors&#8217; and Controlling Shareholders&#8217;
Fiduciary Duties</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a matter of Cayman Islands law, a director
of a Cayman Islands company is in the position of a fiduciary with respect to the company. Accordingly, directors and officers owe the
following fiduciary duties: (1) duty to act in good faith in what the director or officer believes to be in the best interests of the
company as a whole; (2) duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose;
(3) directors should not improperly fetter the exercise of future discretion; (4) duty to exercise powers fairly as between different
sections of shareholders; (5) duty to exercise independent judgment; and (6) duty not to put themselves in a position in which there is
a conflict between their duty to the company and their personal interests. However, this obligation may be varied by the company&#8217;s
articles of association, which may permit a director to vote on a matter in which he has a personal interest provided that he has disclosed
that nature of his interest to the board of directors. With respect to the duty of directors to avoid conflicts of interest, our Articles
of Association vary from the applicable provisions of Cayman Islands law mentioned above by providing that a director must disclose the
nature and extent of his or her interest in any contract or arrangement, and following such disclosure and subject to any separate requirement
under applicable law or the listing rules of the Nasdaq, and unless disqualified by the chairman of the relevant meeting, such director
may vote in respect of any transaction or arrangement in which he or she is interested and may be counted in the quorum at the meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A director of a Cayman Islands company also
owes to the company duties to exercise independent judgment in carrying out his functions and to exercise reasonable skill, care and
diligence, which has both objective and subjective elements. Recent Cayman Islands case law confirmed that directors must exercise the
care, skill and diligence that would be exercised by a reasonably diligent person having the general knowledge, skill and experience
reasonably to be expected of a person acting as a director.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 154 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->149<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, a director must exercise the
knowledge, skill and experience which he or she actually possesses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A general notice may be given to the board
of directors to the effect that (i)&#160;the director is a member or officer of a specified company or firm and is to be regarded as interested
in any contract or arrangement which may after the date of the notice be made with that company or firm; or (ii)&#160;he or she is to
be regarded as interested in any contract or arrangement which may after the date of the notice to the board of directors be made with
a specified person who is connected with him or her, will be deemed sufficient declaration of interest. This notice shall specify the
nature of the interest in question. Following the disclosure being made pursuant to our Articles of Association and subject to any separate
requirement under applicable law or the listing rules of the Nasdaq, and unless disqualified by the chairman of the relevant meeting,
a director may vote in respect of any transaction or arrangement in which he or she is interested and may be counted in the quorum at
the meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In comparison, under Delaware corporate law,
a director of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two components: the duty
of care and the duty of loyalty. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent
person would exercise under similar circumstances. Under this duty, a director must inform himself or herself of, and disclose to shareholders,
all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director act in
a manner he or she reasonably believes to be in the best interests of the corporation. He or she must not use his or her corporate position
for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best interest of the corporation
and its shareholders take precedence over any interest possessed by a director, officer or controlling shareholder and not shared by the
shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the
honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence
of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, a director must
prove the procedural fairness of the transaction, and that the transaction was of fair value to the corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Furthermore, as a matter of Cayman Islands
law and in contrast to the position under Delaware corporate law, controlling shareholders of Cayman Islands companies do not owe fiduciary
duties to those companies, other than the limited duty that applies to all shareholders to exercise their votes to amend a company&#8217;s
articles of association in good faith in the interests of the company. The absence of this minority shareholder protection might impact
the ability of minority shareholders to protect their interests.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Shareholder Proposals</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Delaware General Corporation Law,
a shareholder has the right to put any proposal before the annual meeting of shareholders, provided it complies with the notice provisions
in the governing documents. The Delaware General Corporation Law does not provide shareholders an express right to put any proposal before
the annual meeting of shareholders, but Delaware corporations generally afford shareholders an opportunity to make proposals and nominations
provided that they comply with the notice provisions in the certificate of incorporation or bylaws. A special meeting may be called by
the board of directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling
special meetings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act provides shareholders with
only limited rights to requisition a general meeting and does not provide shareholders with any right to put any proposal before a general
meeting. However, these rights may be provided in a company&#8217;s articles of association. Our Articles of Association provide that
upon the requisition of one or more shareholders representing not less than one-third of the voting rights entitled to vote at general
meetings, the board will convene an extraordinary general meeting and put the resolutions so requisitioned to a vote at such meeting.
The Articles of Association provide no other right to put any proposals before annual general meetings or extraordinary general meetings.</p>


<!-- Field: Page; Sequence: 155 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->150<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Cumulative Voting</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Delaware General Corporation Law,
cumulative voting for elections of directors is not permitted unless the corporation&#8217;s certificate of incorporation specifically
provides for it.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Cumulative voting potentially facilitates the
representation of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which
the shareholder is entitled on a single director, which increases the shareholder&#8217;s voting power with respect to electing such director.
As permitted under Cayman Islands law, our Articles of Association do not provide for cumulative voting. As a result, the shareholders
of Afya are not afforded any less protections or rights on this issue than shareholders of a Delaware corporation.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Removal of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The office of a director shall be vacated automatically
if, among other things, he or she (i)&#160;becomes prohibited by law from being a director, (ii)&#160;becomes bankrupt or makes an arrangement
or composition with his creditors, (iii)&#160;dies or is in the opinion of all his co-directors, incapable by reason of mental disorder
of discharging his duties as director, (iv)&#160;resigns his office by notice to us or (v)&#160;has for more than six months been absent
without permission of the directors from meetings of the board of directors held during that period, and the remaining directors resolve
that his/her office be vacated.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Transaction with Interested Shareholders</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Delaware General Corporation Law provides
that, unless the corporation has specifically elected not to be governed by this statute, it is prohibited from engaging in certain business
combinations with an &#8220;interested shareholder&#8221; for three years following the date that this person becomes an interested shareholder.
An interested shareholder generally is a person or a group who or which owns or owned 15% or more of the target&#8217;s outstanding voting
shares or who or which is an affiliate or associate of the corporation and owned 15% or more of the corporation&#8217;s outstanding voting
shares within the past three years. This has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the
target in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on
which the shareholder becomes an interested shareholder, the board of directors approves either the business combination or the transaction
which resulted in the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware corporation to negotiate
the terms of any acquisition transaction with the target&#8217;s board of directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Cayman Islands law has no comparable statute.
As a result, Afya cannot avail itself of the types of protections afforded by the Delaware business combination statute. However, although
Cayman Islands law does not regulate transactions between a company and its significant shareholders, it does provide that the board of
directors owe duties to ensure that these transactions are entered into bona fide in the best interests of the company and for a proper
corporate purpose and, as noted above, a transaction may be subject to challenge if it has the effect of constituting a fraud on the minority
shareholders.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Dissolution; Winding Up</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Delaware General Corporation Law,
unless the board of directors approves the proposal to dissolve, dissolution must be approved by shareholders holding 100% of the total
voting power of the corporation. If the dissolution is initiated by the board of directors it may be approved by a simple majority of
the corporation&#8217;s outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation
a supermajority voting requirement in connection with dissolutions initiated by the board. Under Cayman Islands law, a company may be
wound up by either an order of the courts of the Cayman Islands or by a special resolution of its members or, if the company resolves
by ordinary resolution that it be wound up because it is unable to pay its debts as they fall due. The court has authority to order winding
up in a number of specified circumstances including where it is, in the opinion of the court, just and equitable to do so.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Companies Act, Afya may be dissolved,
liquidated or wound up by a special resolution of shareholders (requiring a two-thirds majority vote). Our Articles of Association also
give its board of directors authority to petition the Cayman Islands Court to wind up Afya.</p>


<!-- Field: Page; Sequence: 156 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->151<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Variation of Rights of Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Delaware General Corporation Law,
a corporation may vary the rights of a class of shares with the approval of a majority of the outstanding shares of that class, unless
the certificate of incorporation provides otherwise. Under our Articles of Association, if the share capital is divided into more than
one class of shares, the rights attached to any class may only be varied with the written consent of the holders of two-thirds of the
shares of that class or the sanction of a special resolution passed at a separate meeting of the holders of the shares of that class.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Also, except with respect to share capital
(as described above), alterations to our Articles of Association may only be made by special resolution of shareholders (requiring a two-thirds
majority vote).</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Amendment of Governing Documents</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Delaware General Corporation Law,
a corporation&#8217;s certificate of incorporation may be amended only if adopted and declared advisable by the board of directors and
approved by a majority of the outstanding shares entitled to vote, and the bylaws may be amended with the approval of a majority of the
outstanding shares entitled to vote and may, if so provided in the certificate of incorporation, also be amended by the board of directors.
Under Cayman Islands law, our Articles of Association generally (and save for certain amendments to share capital described in this section)
may only be amended by special resolution of shareholders (requiring a two-thirds majority vote).</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Rights of Non-Resident or Foreign Shareholders</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">There are no limitations imposed by our Articles
of Association on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our shares. In addition, there
are no provisions in the Articles of Association governing the ownership threshold above which shareholder ownership must be disclosed.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_046"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material Contracts</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For information concerning certain contracts
important to our business, see &#8220;Item 5. Operating and Financial Review and Prospects&#8212;B. Liquidity and Capital Resources&#8221;
and &#8220;Item 4. Information on the Company&#8212;B. Business Overview&#8212;Our Recent Acquisitions.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Except as otherwise described in this annual
report on Form 20-F, we have not entered into any material contracts other than in the ordinary course of business.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_047"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exchange Controls</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Cayman Islands currently has no exchange
control restrictions.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_048"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Taxation</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Cayman Islands Tax Considerations</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Cayman Islands laws currently levy no taxes
on individuals or corporations based upon profits, income, gains or appreciation and there is no taxation in the nature of inheritance
tax or estate duty or withholding tax applicable to us or to any holder of Class A common shares. There are no other taxes likely to be
material to us levied by the government of the Cayman Islands except for stamp duties which may be applicable on instruments executed
in, or after execution brought within the jurisdiction of the Cayman Islands. No stamp duty is payable in the Cayman Islands on transfers
of shares of Cayman Islands companies except those which hold interests in land in the Cayman Islands. The Cayman Islands is not party
to any double tax treaties which are applicable to any payments made by or to our company. There are no exchange control regulations or
currency restrictions in the Cayman Islands.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a Cayman Islands exempted company with limited
liability, we are entitled, upon application, to receive an undertaking as to tax concessions pursuant to Section 6 of the Tax Concessions
Act (As Revised). This undertaking would provide that, for a period of 20 years from the date of issue of the undertaking, no law thereafter
enacted in the Cayman Islands imposing any taxes to be levied on profits, income, gains or appreciation will apply to us or our operations.</p>


<!-- Field: Page; Sequence: 157 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->152<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Payments of dividends and capital in respect
of our Class A common shares will not be subject to taxation in the Cayman Islands and no withholding will be required on the payment
of a dividend or capital to any holder of our Class A common shares, nor will gains derived from the disposal of our Class A common shares
be subject to Cayman Islands income or corporation tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">There is no income tax treaty or convention
currently in effect between the United States and the Cayman Islands.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">U.S. Federal Income Tax Considerations</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following is a description of the material
U.S. federal income tax consequences to the U.S. Holders described below of owning and disposing of Class A common shares, but it does
not purport to be a comprehensive description of all tax considerations that may be relevant to a particular person&#8217;s decision to
own the securities. This discussion applies to you only if you hold Class A common shares as capital assets for U.S. federal income tax
purposes. In addition, it does not describe any state, local or non-U.S. tax consequences or all of the tax consequences that may be relevant
in light of your particular circumstances, including alternative minimum tax consequences, the potential application of the provisions
of the Code known as the Medicare contribution tax and tax consequences applicable to you if you are subject to special rules, such as:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>one of certain financial institutions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a dealer or trader in securities who uses a mark-to-market method of tax accounting;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a person holding a Class A common shares as part of a straddle, wash sale, conversion transaction or integrated transaction or entering
into a constructive sale with respect to a Class A common share;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a person whose functional currency for U.S. federal income tax purposes is not the U.S. dollar;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an entity classified as partnerships for U.S. federal income tax purposes;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a tax-exempt entity, an &#8220;individual retirement account&#8221; or a &#8220;Roth IRA&#8221;;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a person who acquired our Class A common shares pursuant to the exercise of an employee stock option or otherwise as compensation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a U.S. expatriate or certain former citizen of the United States;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a person that owns or is deemed to own ten percent or more of our stock (by vote or value); or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a person holding shares in connection with a trade or business conducted outside of the United States.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If you are an entity classified as a partnership
for U.S. federal income tax purposes, the U.S. federal income tax treatment of a partner will generally depend on the status of the partner
and your activities. Partnerships holding Class A common shares and partners in such partnerships should consult their tax advisers as
to the particular U.S. federal income tax consequences of holding and disposing of the Class A common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">This discussion is based on the Internal Revenue
Code of 1986, as amended (the &#8220;Code&#8221;), administrative pronouncements, judicial decisions, and final, temporary and proposed
Treasury regulations all as of the date hereof, any of which is subject to change, possibly with retroactive effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">You are a &#8220;U.S. Holder&#8221; if for
U.S. federal income tax purposes you are a beneficial owner of Class A common shares and:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a citizen or individual resident of the United States;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a corporation created or organized in or under the laws of the United States, any state therein or the District of Columbia; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an estate or trust the income of which is subject to U.S. federal income taxation regardless of its source.</td></tr></table>


<!-- Field: Page; Sequence: 158 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->153<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Taxation of Distributions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following is subject to the discussion
in &#8220;&#8212;Passive Foreign Investment Company Rules&#8221; below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As discussed above under &#8220;Item 8. Financial
Information&#8212;Dividends and Dividend Policy,&#8221; we do not currently intend to pay dividends. In the event that we pay dividends,
distributions paid on our Class A common shares, other than certain <i>pro rata</i> distributions of Class A common shares, will be treated
as dividends for U.S. federal income tax purposes to the extent paid out of our current or accumulated earnings and profits (as determined
under U.S. federal income tax principles). Because we do not maintain calculations of our earnings and profits under U.S. federal income
tax principles, it is expected that distributions generally will be reported to you as dividends. Subject to applicable limitations, dividends
paid to certain non-corporate U.S. Holders may be eligible for taxation as &#8220;qualified dividend income&#8221; and therefore may be
taxable at rates applicable to long-term capital gains, provided the Class A common shares are treated as readily tradeable on an established
securities market in the United States. You should consult your tax adviser regarding the availability of the reduced tax rate on dividends
in your particular circumstances. The amount of any dividend will be treated as foreign-source dividend income and will not be eligible
for the dividends-received deduction generally available to U.S. corporations under the Code. Dividends will be included in your income
on the date of receipt.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As discussed in &#8220;&#8212;Cayman Island
Tax Considerations,&#8221; there are currently no applicable withholding taxes under Cayman Island law. However, if any non-U.S. income
taxes were withheld from distributions on your Class A common shares, the amount of the withheld tax would be includible in your income
as a dividend. Subject to applicable limitations, some of which vary depending upon your circumstances, the non-U.S. withholding tax may
be potentially creditable against your U.S. federal income tax liability. Certain Treasury regulations impose additional requirements
for non-U.S. taxes to be eligible for foreign tax credit, which applicability are further modified by recently released notices from the
IRS, and we cannot assure you that any non-U.S. income taxes would be creditable against your U.S. federal income tax liability. Subject
to generally applicable limitations under U.S. law, you may be able to elect to deduct otherwise creditable withholding taxes. Even if
the non-U.S. withholding taxes are not creditable, you may be entitled to deduct such taxes, subject to applicable limitations under the
Code. The rules governing foreign tax credits are complex, and you should consult your tax adviser regarding the creditability or deductibility
of non-U.S. taxes, if any, in your particular circumstances (including any applicable limitations).</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Sale or Other Disposition of Class A Common Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following is subject to the discussion
in &#8220;&#8212;<i>Passive Foreign Investment Company Rules</i>&#8221; below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For U.S. federal income tax purposes, gain
or loss realized on the sale or other disposition of a Class A common share will be capital gain or loss, and will be long-term capital
gain or loss if you have held the Class A common share for more than one year. The amount of the gain or loss will equal the difference
between your tax basis in the Class A common share disposed of and the amount realized on the disposition, in each case as determined
in U.S. dollars. This gain or loss will generally be U.S.-source gain or loss for foreign tax credit purposes. Long-term capital gains
of non-corporate U.S. Holders are eligible for reduced rates of taxation. The deductibility of capital losses is subject to limitations.
If any non-U.S. taxes were imposed on gains from dispositions of the Class A common shares, it is expected that those taxes would not
be creditable against your U.S. federal income tax liability. You should consult your tax adviser regarding the U.S. federal income tax
consequences if any non-U.S. income taxes were imposed on disposition gains.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Passive Foreign Investment Company Rules</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Code, we will be a PFIC for any taxable
year in which, after the application of certain &#8220;look-through&#8221; rules with respect to subsidiaries, either (i) 75% or more
of our gross income consists of &#8220;passive income,&#8221; or (ii) 50% or more of the average quarterly value of our assets consists
of assets that produce, or are held for the production of, &#8220;passive income.&#8221; For purposes of the above calculations, we will
be treated as if we hold our proportionate share of the assets of, and receive directly our proportionate share of the income of, any
other corporation in which we directly or indirectly own at least 25%, by value, of the shares of such corporation. Passive income generally
includes dividends, interest, certain non-active rents or royalties and investment gains. Cash is generally a passive asset for these
purposes. Goodwill is an active asset to the extent attributable to activities that produce active income.</p>


<!-- Field: Page; Sequence: 159 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->154<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Based on the composition of our income and
assets and the value of our assets, including goodwill (the implied value of which we estimate based on the price of our Class A common
shares), we believe that we were not a PFIC for the taxable year of 2023. However, because we hold a substantial amount of cash (relative
to the assets shown on our balance sheet) and because our PFIC status for any taxable year will depend on the composition of our income
and assets and the value of our assets from time to time (which may be determined, in part, by reference to the market price of our Class
A common shares, which could be volatile), there can be no assurance that we will not be a PFIC for any taxable year. If our Class A common
share price declines while we continue to hold a substantial amount of cash for any taxable year, our risk of being or becoming a PFIC
will increase. In addition, as we continue to expand our business through acquisitions and organically, our risk of becoming a PFIC will
increase if we engage in activities that generate substantial passive income. Moreover, the extent to which our goodwill will be treated
as an active asset is not entirely clear. If we were a PFIC for any taxable year during which you hold Class A common shares, we generally
would continue to be treated as a PFIC with respect to you for all succeeding years during which you hold Class A common shares, even
if we ceased to meet the threshold requirements for PFIC status.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If we were a PFIC for any taxable year and
any of our subsidiaries or other companies in which we owned or were treated as owning equity interests were also a PFIC (any such entity,
a &#8220;Lower-tier PFIC&#8221;), you would be deemed to own a proportionate amount (by value) of the shares of each Lower-tier PFIC and
would be subject to U.S. federal income tax according to the rules described in the subsequent paragraph on (i) certain distributions
by a Lower-tier PFIC and (ii) dispositions of shares of Lower-tier PFICs, in each case as if you held such shares directly, even though
you would not receive the proceeds of those distributions or dispositions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If we were a PFIC for any taxable year during
which you held any of our Class A common shares, you could be subject to adverse tax consequences. Generally, gain recognized upon a disposition
(including, under certain circumstances, a pledge) of Class A common shares would be allocated ratably over your holding period for the
shares. The amounts allocated to the taxable year of disposition and to years before we became a PFIC would be taxed as ordinary income.
The amount allocated to each other taxable year would be subject to tax at the highest rate in effect for that taxable year for individuals
or corporations, as appropriate, and an interest charge would be imposed on the tax on such amount. Further, to the extent that distributions
received on your Class A common shares in a taxable year exceeded 125% of the average of the annual distributions on those shares during
the preceding three taxable years or your holding period, whichever was shorter, the excess distributions would be subject to taxation
in the same manner as gain, described immediately above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Alternatively, if we were a PFIC and if the
Class A common shares were &#8220;regularly traded&#8221; on a &#8220;qualified exchange,&#8221; you could be eligible to make a mark-to-
market election that would result in tax treatment different from the general tax treatment for PFICs described above. The Class A common
shares would be treated as &#8220;regularly traded&#8221; in any calendar year in which more than a <i>de minimis </i>quantity of the
Class A common shares were traded on a qualified exchange on at least 15 days during each calendar quarter. The Nasdaq, on which the Class
A common shares are listed, is a qualified exchange for this purpose. Once made, the election cannot be revoked without the consent of
the IRS unless the shares cease to be marketable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If you make the mark-to-market election, you
generally will recognize as ordinary income any excess of the fair market value of your Class A common shares at the end of each taxable
year over their adjusted tax basis, and will recognize an ordinary loss in respect of any excess of the adjusted tax basis of the Class
A common shares over their fair market value at the end of the taxable year (but only to the extent of the net amount of income previously
included as a result of the mark-to-market election). If you make the election, your tax basis in your Class A common shares will be adjusted
to reflect these income or loss amounts. Any gain recognized on the sale or other disposition of Class A common shares in a year when
we are a PFIC will be treated as ordinary income and any loss will be treated as an ordinary loss (but only to the extent of the net amount
of income previously included as a result of the mark-to-market election, with any excess treated as a capital loss). This election cannot
be made with respect to any of our subsidiaries the shares of which are not regularly traded. Accordingly, you may continue to be subject
to tax under the PFIC excess distribution regime with respect to any lower-tier PFICs notwithstanding your mark-to-market election for
the Class A common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We do not intend to provide information necessary
for you to make a qualifying electing fund election which would result in alternative treatment.</p>


<!-- Field: Page; Sequence: 160 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->155<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, if we were a PFIC for any taxable
year in which we paid a dividend or for the prior taxable year, the preferential dividend rates discussed above with respect to dividends
paid to certain non-corporate U.S. Holders would not apply.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If you own Class A common shares during any
year in which we are a PFIC, you generally must file annual reports on IRS Form 8621 (or any successor form) with respect to us, generally
with your federal income tax return for that year. A failure to file one or more of these forms as required may toll the running of the
statute of limitations in respect of each of your taxable years for which such form is required to be filed. As a result, the taxable
years with respect to which you fail to file the form may remain open to assessment by the IRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">You should consult your tax adviser regarding
whether we are a PFIC and the potential application of the PFIC rules.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Information Reporting and Backup Withholding</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Payments of dividends and sales proceeds that
are made within the United States or through certain U.S.-related financial intermediaries generally are subject to information reporting,
and may be subject to backup withholding, unless (i) you are a corporation or other exempt recipient or (ii) in the case of backup withholding,
you provide a correct taxpayer identification number and certify that you are not subject to backup withholding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Backup withholding is not an additional tax.
The amount of any backup withholding from a payment to you will be allowed as a refund or credit against your U.S. federal income tax
liability and may entitle you to a refund, provided that the required information is timely furnished to the IRS.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Foreign Financial Asset Reporting</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Certain U.S. Holders who are individuals (and
certain specified entities) may be required to report information relating to their ownership of Class A common shares, or non-U.S. accounts
through which Class A common shares are held. You should consult your tax adviser regarding your reporting obligations with respect to
the Class A common shares.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_049"></span>F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dividends and Paying
Agents</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_050"></span>G.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Statement by Experts</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_051"></span>H.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Documents on Display</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are subject to the informational requirements
of the Exchange Act applicable to foreign private issuers. Accordingly, we are required to file reports and other information with the
SEC, including annual reports on Form 20-F within four months from the end of each of our fiscal years, and reports on Form 6-K. You can
read our SEC filings over the Internet at the SEC&#8217;s website at www.sec.gov. You may also read and copy any document we file with
the SEC at its public reference room at 100 F. Street, N.E., Washington, D.C. 20549. You may obtain copies of these documents upon the
payment of the fees prescribed by the SEC. Please call the SEC at 1-800-SEC-0330 for further information about the public reference room.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_052"></span>I.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsidiary Information</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">See note 2.2 to our audited consolidated financial
statements for a description of the Company&#8217;s subsidiaries.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_053"></span>J.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Annual Report to
Security Holders</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If we are required to provide an annual report
to security holders in response to the requirements of Form 6-K, we will submit the annual report to security holders in electronic format
in accordance with the EDGAR Filer Manual.</p>


<!-- Field: Page; Sequence: 161 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->156<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_054"></span>ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are exposed to market risks in the ordinary
course of our business, including the effects of interest rate changes and foreign currency fluctuations. We monitor market, credit and
operational risks in line with the objectives in capital management, supported by the oversight of our Board of Directors, in decisions
related to capital management and to ensure their consistency with our objectives and assessment of risks. Information relating to quantitative
and qualitative disclosures about these market risks is described below.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Interest Rate Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Interest rate risk is the risk that the fair
value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company&#8217;s
exposure to the risk of changes in market interest rates relates primarily to the Company&#8217;s cash equivalents, loans and financing
and accounts payable to selling shareholders with floating interest rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following table demonstrates the sensitivity
to a reasonably possible change in the current interest rates on cash equivalents, loans and financing and accounts payable to selling
shareholders. With all variables held constant, the Company&#8217;s income before income taxes is affected through the impact on floating
interest rate, as follows:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 40%; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td style="width: 20%; padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Balance
    as of December 31, 2023</p></td>
    <td style="width: 26%; padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Index
    &#8211; % per year</p></td>
    <td style="width: 14%; padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Base
    rate</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td colspan="3" style="padding: 1pt 5pt 2pt 3pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(amounts in R$ thousands, unless otherwise stated)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Cash equivalents	</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">518,111</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: center">100.8% CDI&#160;&#160;</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">60,846</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Loans and financing	</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">(529,340)</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: center">CDI + 1.80%</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">(71,196)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Loans and financing	</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">(412,880)</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: center">CDI + 1.90%</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">(55,945)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Loans and financing	</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">(11,193)</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: center">TJLP</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">(733)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Loans and financing	</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">(21,405)</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: center">&#160;CDI + 1.75%</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">(2,868)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Accounts payable to selling shareholders	</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">(274,428)</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: center">CDI</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">(31,971)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Accounts payable to selling shareholders	</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">(256,488)</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: center">SELIC</td>
    <td style="padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(29,881)</p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Net exposure</b>	</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">&#160;</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>(131,748)</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td colspan="2" style="padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Increase
    in basis points</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 45%; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td style="width: 24%; padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">+75</p></td>
    <td style="width: 31%; padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">+150</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">&#160;</td>
    <td colspan="2" style="padding: 1pt 5pt 2pt 3pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(amounts in R$ thousands, unless otherwise stated)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Effect on profit before tax	</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: right">(7,407)</td>
    <td style="padding-right: 5pt; padding-left: 3pt; text-align: center">(14,814)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For further information, see note 13.4.1 to
our audited consolidated financial statements included elsewhere in this annual report.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Foreign Currency Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Foreign currency risk is the risk that the
fair value or future cash flows of an exposure will fluctuate because of changes in foreign exchange rates. Our exposure to the risk of
changes in foreign exchange rates relates to cash and cash equivalents denominated in U.S. dollars in the amount of R$23.2 million as
of December 31, 2023 (R$24.4 million as of December 31, 2022). See note 13.4.1 to our audited consolidated financial statements for a
sensitivity analysis of the impact of a hypothetical 10% change in the exchange rate variation on our cash and cash equivalents as of
December 31, 2023.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Credit Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Credit risk is the risk that a counterparty
will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. We are exposed to credit
risk from our operating activities (primarily trade receivables) and from our financing activities, including cash and cash equivalents
and restricted cash. We manage customer credit risk based on the established policy, procedures and control relating to customer credit
risk management. Outstanding customer receivables are regularly monitored. Credit risk from balances with banks and financial institutions
is managed by our treasury department in accordance with our policy. Investments of surplus funds are made only with approved counterparties
and within limits assigned to each counterparty.</p>


<!-- Field: Page; Sequence: 162 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->157<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our maximum exposure to credit risk for the
components of the statements of financial position as of December 31, 2023 and 2022 is the carrying amounts of our financial assets. For
more information, see note 13.4.2 to our audited consolidated financial statements.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Liquidity Risk</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our management is responsible for monitoring
liquidity risk. To this end, management regularly reviews the risk and maintains appropriate reserves, including bank credit facilities
with first-tier financial institutions. Management also continuously monitors projected and actual cash flows and the combination of the
maturity profiles of the financial assets and liabilities. The main requirements for financial resources used by us arise from the need
to make payments for suppliers, operating expenses, labor and social obligations, loans and financing and accounts payable to selling
shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For more information, see &#8220;Item 5. Operating
and Financial Review and Prospects&#8212;F. Tabular Disclosure of Contractual Obligations.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_055"></span>ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_056"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Debt Securities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_057"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Warrants and Rights</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_058"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Securities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_059"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;American Depositary
Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>


<!-- Field: Page; Sequence: 163 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->158<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 20pt 0 10pt; text-align: center"><span id="form20f_060"></span>PART II</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_061"></span>ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_062"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defaults</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">No matters to report.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_063"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Arrears and delinquencies</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">No matters to report.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_064"></span>ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS
AND USE OF PROCEEDS</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_065"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material modifications
to instruments</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_066"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material modifications
to rights</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_067"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Withdrawal or substitution
of assets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_068"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Change in trustees
or paying agents</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_069"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Use of proceeds</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_070"></span>ITEM 15. CONTROLS AND PROCEDURES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_071"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosure Controls
and Procedures</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have evaluated, with the participation of
our chief executive officer and chief financial officer, the effectiveness of our &#8220;disclosure controls and procedures,&#8221; as
such term is defined in Rule 13a-15(e) and 15d-15(e) of the Exchange Act, as of December 31, 2023. There are inherent limitations to the
effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding
of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of
achieving their control objectives. Based upon our evaluation, our chief executive officer and chief financial officer concluded that
our disclosure controls and procedures were effective as of December 31, 2023 to provide reasonable assurance that information required
to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within
the time periods specified in the applicable rules and forms, and that it is accumulated and communicated to our management, including
our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_072"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Management&#8217;s
Annual Report on Internal Control Over Financial Reporting</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our management is responsible for establishing
and maintaining effective internal control over financial reporting as defined in Rule 13a-15(f) of the Exchange Act. Our internal control
over financial reporting is designed to provide reasonable assurance to our management and board of directors regarding the preparation
and fair presentation of published financial statements. Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk
that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures
may deteriorate.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 164 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->159<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In accordance with guidance issued by the Securities
and Exchange Commission, companies are permitted to exclude acquisitions from their final assessment of internal control over financial
reporting for the first fiscal year in which the acquisition occurred. As such, our management&#8217;s evaluation of internal control
over financial reporting excluded the internal control activities of DelRey, acquired in January 2023, as discussed in note 5 to our audited
consolidated financial statements. We have included the financial results of DelRey in the consolidated financial statements from the
date of its acquisition. DelRey represented approximately 2.2% and 2.4% of our consolidated total equity and consolidated total assets,
respectively, as of December 31, 2023 and 8.3% and 19.3% of our consolidated revenue and consolidated net income, respectively, for the
year then ended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our management, with the participation of the
Chief Executive Officer and Chief Financial Officer, under the oversight of our board of directors, evaluated the effectiveness of the
Company&#8217;s internal control over financial reporting as of December 31, 2023. In making this assessment, management used the criteria
set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control &#8211; Integrated Framework (2013),
or COSO 2013. Based on this assessment,      management believes that, as of December 31, 2023, our internal control
over financial reporting was effective, based on those criteria.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_073"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Attestation Report
of the Registered Public Accounting Firm</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The effectiveness of internal control over
financial reporting as of December 31, 2023, which did not include an evaluation of the internal control over financial reporting of DelRey,
has been audited by Ernst &amp; Young Auditores Independentes S/S Ltda., or EY, the independent registered public accounting firm that
also audited our consolidated financial statements as of and for the year then ended. EY has issued an attestation report on the effectiveness
of our internal controls over financial reporting as of December 31, 2023. Their attestation report on internal controls over financial
reporting is included herein.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_074"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Changes in Internal
Control Over Financial Reporting</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In the year ended December 31, 2023, we completed
the implementation of the ServiceNow system, which manages all service management processes, IT service management processes and other
corporate services for the Company. Consequently, we removed our old system (Fluig) from the ITGC scope. Except for these changes, there
were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange
Act) during the year ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_075"></span>ITEM 16. RESERVED</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_076"></span>ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The audit committee, which currently consists
of Vanessa Claro Lopes, Jo&#227;o Paulo Seibel de Faria, Miguel Filisbino Pereira de Paula and Marcelo Ken Suhara, assists our board
of directors in overseeing our accounting and financial reporting processes and the audits of our financial statements. In addition, the
audit committee is directly responsible for the appointment, compensation, retention and oversight of the work of our independent registered
public accounting firm. Jo&#227;o Paulo Seibel de Faria serves as Chair of the audit committee. The audit committee consists exclusively
of members of our board of directors who are financially literate, and Marcelo Ken Suhara qualifies as &#8220;audit committee financial
expert&#8221; as defined in Item 16A of Form 20-F. Our board of directors has determined that Vanessa Claro Lopes, Jo&#227;o Paulo Seibel
de Faria, Miguel Filisbino Pereira de Paula and Marcelo Ken Suhara satisfy the &#8220;independence&#8221; requirements set forth in Rule
10A-3 under the Exchange Act. For more information, see &#8220;Item 6. Directors, Senior Management and Employees&#8212;C. Board Practices&#8212;Board
Committees&#8212;Audit Committee.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_077"></span>ITEM 16B. CODE OF ETHICS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our activities are subject to a code of ethics,
which is applicable to all our members and entities, including our directors, officers, managers, teachers and other staff (including
interns). Our code of ethics is also applicable to relevant third parties involved in our activities, such as suppliers, consultants
and other service providers. Our code of ethics describes our mission, vision and values and provides the relevant conduct standards
that must be followed by our members and entities. It regulates our interactions with our suppliers, students, clients, competitor suppliers
and governmental entities and agents. Our code of ethics also sets forth fundamental rules of conduct related to the safeguarding of
our financial books and records, conflict of interest situations, the protection of our confidential information and assets and our compliance
with applicable laws and relevant information on whistleblowing procedures. The Code of Ethics is included as an exhibit to this annual
report. We have also posted a copy of our code of business conduct and ethics on our website at https://ir.afya.com.br/corporate-governance/documents-charters.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></p>


<!-- Field: Page; Sequence: 165 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->160<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_078"></span>ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><b><i>Audit and Non-Audit Fees</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following table sets forth the aggregate
fees by categories specified below in connection with certain professional services rendered by Ernst &amp; Young Auditores Independentes
S/S Ltda., our principal accountants, for the periods indicated. Our independent registered public accounting firm was Ernst &amp; Young
Auditores Independentes S/S Ltda. for the years ended December 31, 2023 and 2022.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Year
    Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; width: 76%; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2023<span style="font-weight: normal">&#160;&#160;&#160;&#160;&#160;</span></p></td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">2022</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding: 1pt 2.9pt 2pt; font-size: 8pt; text-align: center; line-height: 9pt; font-weight: bold">(in R$ millions)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Audit fees (1)	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">7.7</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">6.9</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Tax fees(2)	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">0.2</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">0.2</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">All other fees	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">-</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">0.1</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Total fees</b>	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>7.9</b></p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>7.2</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Audit fees include fees for the audit of our annual consolidated financial statements; audit of the effectiveness of internal control
over financial reporting, audit of statutory financial statements of subsidiaries; review of our interim financial statements, and audit
of financial statements of acquired businesses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Tax fees consist of fees for services rendered in connection with the review of our ECF (<i>Escritura&#231;&#227;o Cont&#225;bil
Fiscal</i>) Brazilian tax reporting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The policy of our audit committee is to pre-approve
all audit and non-audit services provided by Ernst &amp; Young Auditores Independentes S/S Ltda., including audit services, audit-related
services, tax services and other services as described above, other than those for <i>de minimus</i> services that are approved by the
audit committee prior to the completion of the audit.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_079"></span>ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Company does not rely on any exemptions
from the listing standards for audit committees. See &#8220;Item 6. Directors, Senior Management and Employees&#8212;A. Directors and
Senior Management&#8212;Audit Committee&#8221; for details regarding our board of directors and audit committee.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_080"></span>ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND
AFFILIATED PURCHASERS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Set forth below, in tabular format, is disclosure
on the repurchase of our Class A common shares by us or on our behalf, or by or on behalf of an &#8220;affiliated purchaser&#8221; (as
defined under Rule 10b-18(a)(3) under the Exchange Act), for the year ended December 31, 2023:</p>


<!-- Field: Page; Sequence: 166 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->161<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center; text-indent: 0.25in"><b>Shares Repurchased by
the Company</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 38%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Period</p></td>
    <td style="width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Total
    Number of Shares Purchased (1)</p></td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Average
    Price Paid per Share</p></td>
    <td style="width: 17%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Total
    Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)</p></td>
    <td style="width: 17%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Maximum
    Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased under the Plans or Programs</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">January 1 to January 31, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td></tr>

<tr style="background-color: White">
    <td style="vertical-align: bottom; width: 38%; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">February 1 to February 29, 2023	</td>
    <td style="vertical-align: top; width: 15%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; width: 13%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">March 1 to March 31, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">April 1 to April 30, 2023	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">96,766</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">R$58.78</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">96,766</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,880,427</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">May 1 to May 31, 2023	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">105,654</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">R$57.71</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">105,654</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,774,773</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">June 1 to June 30, 2023	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">13,919</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">R$60.60</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">13,919</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,760,854</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">July 1 to July 31, 2023	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,760,854</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">August 1 to August 31, 2023	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,760,854</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">September 1 to September 30, 2023	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,760,854</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">October 1 to October 31, 2023	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,760,854</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">November 1 to November 30, 2023	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#8212;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,760,854</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">December 1 to December 31, 2023	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#8212;</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#8212;</p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#8212;</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,760,854</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 27.35pt; text-indent: -9.35pt"><b>Total</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>216,339</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>R$57.17</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>216,339</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>For more information on our share repurchase programs, see &#8220;Item 10. Additional Information&#8212;B. Memorandum and Articles
of Association&#8212;Share Repurchases.&#8221;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Our board of directors has approved our fourth share repurchase program on March 23, 2023. Under the fourth share repurchase program,
Afya may repurchase up to 2,000,000 of its outstanding Class A common shares, in the open market, based on prevailing market prices, or
in privately negotiated transactions, beginning on April 3, 2023 until the earlier of the completion of the repurchase or December 31,
2024, depending upon market conditions.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center; text-indent: 0in"><b>Shares Purchased by Bertelsmann</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 36%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Period</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Total
    Number of Shares Purchased</p></td>
    <td style="width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Average
    Price Paid per Share(1)</p></td>
    <td style="width: 18%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Total
    Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)</p></td>
    <td style="width: 21%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Maximum
    Number (or Approximate R$ Value) of Shares that May Yet Be Purchased under the Plans or Programs(1)</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">January 1 to January 31, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,114,549</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$69.18</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">1,114,549</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">R$1,078,940,875.43</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">February 1 to February 29, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">582,315</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$64.99</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">582,315</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$1,041,097,340.25</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">March 1 to March 31, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">925,433</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$54.43</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">925,433</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$990,729,447.97</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">April 1 to April 30, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">787,050</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$57.89</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">787,050</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$945,169,752.47</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">May 1 to May 31, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">609,871</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$56.48</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">609,871</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$910,721,330.86</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">June 1 to June 30, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">624,041</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$63.85</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">624,041</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$870,879,295.86</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">July 1 to July 31, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">792,047</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$73.81</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">792,047</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$812,417,942.61</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">August 1 to August 31, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">618,021</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$73.19</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">618,021</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$767,186,328.87</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">September 1 to September 30, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">548,341</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$77.19</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">548,341</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$724,857,403.92</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">October 1 to October 31, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">482,938</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$75.61</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">482,938</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$688,341,349.23</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">November 1 to November 30, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">689,688</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$89.69</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">689,688</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$626,484,239.06</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">December 1 to December 31, 2023	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">504,445</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">R$103.38</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">504,445</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;R$574,335,370.96</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 27.35pt; text-indent: -9.35pt"><b>Total</b>	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>8,278,739</b></p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>R$ 71.64</b></p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>8,278,739</b></p></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center; text-indent: 0in"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>For convenience purposes only, amounts in <i>reais</i> in this column have been converted from U.S. dollars using an exchange rate
of R$4.8413 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2023, as reported by the Central Bank. These translations
should not be considered representations that any such amounts have been, could have been or could be converted at that or any other exchange
rate.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="background-color: white">(2)</span></td><td><span style="background-color: white">On May 26, 2022, Bertelsmann entered into a trading plan pursuant to Rule 10b5-1 under the Exchange
Act with an unaffiliated third-party broker (the &#8220;Bertelsmann Existing Trading Plan&#8221;)</span>, which was publicly announced
on May 27, 2022<span style="background-color: white">. Under the Bertelsmann Existing Trading Plan, the broker is authorized and directed
to purchase Class A common shares of the Company in open market transactions on behalf of Bertelsmann, subject to certain conditions,
with an aggregate purchase price of up to US$129.0 million, beginning on June 27, 2022, until the earlier of the completion of the repurchase or September 25, 2023, unless terminated earlier in accordance with its terms. See Amendment No. 6 to the report on Schedule 13D filed by Bertelsmann with the SEC on May 27, 2022. On December 15, 2022, Bertelsmann entered into an amendment to the Bertelsmann Existing Trading Plan (the &#8220;Bertelsmann Trading Plan Amendment&#8221;), which was publicly announced on December 16, 2022. Under the Bertelsmann Trading Plan Amendment, the broker is authorized and directed to purchase an additional number of Class A common shares of the Company in open market transactions on behalf of Bertelsmann, subject to certain conditions, with an aggregate purchase price of up to US$200.0 million. Such additional purchases may only commence once the purchases under the Bertelsmann Existing Trading Plan have been completed but in no event before January 16, 2023. In addition, the Bertelsmann Trading Plan Amendment extended the term of the Bertelsmann Existing Trading Plan to May 31, 2024, unless terminated earlier in accordance with its terms. See Amendment No. 13 to the report on Schedule 13D filed by Bertelsmann with the SEC on December 16, 2022.</span></td></tr></table>


<!-- Field: Page; Sequence: 167 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->162<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_081"></span>ITEM 16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">None.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_082"></span>ITEM 16G. CORPORATE GOVERNANCE</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Cayman Islands law restricts transactions between
a company and its directors unless there are provisions in the Articles of Association which provide a mechanism to alleviate possible
conflicts of interest. Additionally, Cayman Islands law imposes on directors&#8217; duties of care and skill and fiduciary duties to the
companies which they serve. Under our Articles of Association, a director must disclose the nature and extent of his interest in any contract
or arrangement, and following such disclosure and subject to any separate requirement under applicable law or the listing rules of the
Nasdaq, and unless disqualified by the chairman of the relevant meeting, the interested director may vote in respect of any transaction
or arrangement in which he or she is interested. The interested director shall be counted in the quorum at such meeting and the resolution
may be passed by a majority of the directors present at the meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><b><i>Foreign Private Issuer Status</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing and our Articles of
Association, our directors may exercise all the powers of Afya to vote compensation to themselves or any member of their body in the absence
of an independent quorum. Our Articles of Association provide that, in the event a Compensation Committee is established, it shall be
made up of such number of independent directors as is required from time to time by the Nasdaq rules (or as otherwise may be required
by law). We currently have no intention to establish a Compensation Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a foreign private issuer, we are permitted
to follow home country practice in lieu of certain Nasdaq corporate governance rules, subject to certain requirements. We currently rely,
and will continue to rely, on the foreign private issuer exemption with respect to the following rules:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Nasdaq Rule 5605(b), which requires that independent directors comprise a majority of a company&#8217;s board of directors. As allowed
by the laws of the Cayman Islands, independent directors do not comprise a majority of our board of directors.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Nasdaq Rule 5605(e)(1), which requires that a company have a nominations committee comprised solely of &#8220;independent directors&#8221;
as defined by Nasdaq. As allowed by the laws of the Cayman Islands, we do not have a nominations committee nor do we have any current
intention to establish one.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Nasdaq Rule 5605(d) &amp; (e), which require that compensation for our executive officers and selection of our director nominees be
determined by a majority of independent directors. As allowed by the laws of the Cayman Islands, we do not have a nomination and corporate
governance committee or remuneration committee nor do we have any current intention to establish either.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Nasdaq Rule 5635, which requires an issuer to obtain shareholder approval prior to an issuance of securities (in certain circumstances)
in connection with certain events, including: (i) the acquisition of the stock or assets of another company; (ii) equity-based compensation
of officers, directors, employees or consultants; (iii) a change of control; and (iv) private placements. Cayman Islands law does not require shareholder approval prior to an issuance of securities to the extent the securities are authorized.</td></tr></table>


<!-- Field: Page; Sequence: 168 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->163<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_083"></span>ITEM 16H. MINE SAFETY DISCLOSURE</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_084"></span>ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT
INSPECTIONS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_085"></span>ITEM 16J. INSIDER TRADING POLICIES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_086"></span>ITEM 16K. CYBERSECURITY</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 9pt"><b><i>Overview</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Company has policies and procedures in
place to address information technology and cybersecurity risks as part of its corporate risk management process. This includes activities
such as risk identification, classification, and mitigation, as well as the development of action plans aligned with industry best practices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Cybersecurity initiatives at Afya are overseen
by our chief information security office, or CISO. The CISO&#8217;s responsibilities include defining and aligning action plans with Afya&#8217;s
corporate risk management team. Additionally, the CISO serves as the Data Protection Officer, handling privacy and data protection matters
and defining cybersecurity strategies for the entire company. This includes ensuring effective monitoring, threat detection, response
to events and incidents, and overall cybersecurity management. Cybersecurity monitoring with respect to our newly acquired companies is
managed from the outset by our IT technical team. Exposure to risk during this period is naturally greater as such acquired company is
not always mature in terms of cybersecurity issues, but we seek to mitigate these risks by making adjustments to their practices and applying
our policies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 9pt"><b><i>Risk Management and Strategy</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya has comprehensive policies, procedures,
and a dedicated risk management team responsible for addressing corporate risks across various themes, including strategic, operational,
financial, and compliance areas. Within each theme, Afya identifies and manages risks related to quality, procurement, cybersecurity,
privacy and data protection, financial reporting, legal compliance, and regulatory matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Company follows a structured approach,
including a risk matrix with defined risk levels and criticality, which guides the need for risk treatment and the development of action
plans. These plans are monitored by the responsible parties for each theme under the oversight of the risk and controls directorate. Furthermore,
Afya has a rigorous supplier assessment process that evaluates cybersecurity, privacy, and data protection requirements before onboarding
suppliers. This process aligns with frameworks such as COSO-ERM and COSO Internal Control - Integrated Framework. To ensure compliance
with industry standards and enhance cybersecurity maturity levels, Afya engages specialized companies to review its plans and procedures,
aiming to adopt market best practices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The company has established the audit, risk,
and ethics committee to oversee risk management guidelines through a structured approach known as the three lines of defense:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>First Line of Defense</i>: This comprises risk owners who are responsible for executing processes, identifying risks, and implementing
action plans. Working closely with the risk and controls directorate, they proactively identify potential risks within their operations,
including financial, operational, and cybersecurity aspects. This includes analyzing activities and relationships with suppliers and third
parties.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Second Line of Defense</i>: The compliance, corporate risks, and internal controls area collaborate with risk owners to monitor
risks and action plans. The risk and controls directorate coordinates progress and action plans in partnership with internal audit teams
and other Afya units such as the technology team, the information security team, and the privacy team. They report their findings to the audit, risk, and ethics committee.</td></tr></table>


<!-- Field: Page; Sequence: 169 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->164<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Third Line of Defense</i>: Represented by the Internal Audit team, this line conducts independent evaluations for management. They
perform substantive tests of internal controls to detect operational and financial deviations resulting from failures or fraudulent activities.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For the monitoring and response to cyber incidents,
Afya has teams responsible for detecting and monitoring the company&#8217;s environment, threat intelligence service, intrusion testing,
and verifying the coverage and effectiveness of its detection and monitoring tools.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 9pt"><b><i>Governance</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya places significant emphasis on cybersecurity
within its information technology area, covering areas such as incident management, information technology governance, privacy and data
protection, cybersecurity, infrastructure, and systems management. These efforts are led by our chief information officer, or CIO, and
our CISO. The CISO, drawing from extensive experience in leading technology and information security departments in large companies, is
responsible for developing and executing effective security strategies tailored to the organization&#8217;s specific threats and business
goals. This includes ensuring compliance with relevant information security and data privacy regulations, conducting training for the
security team and promoting user awareness to keep stakeholders informed about emerging technologies and threats.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya&#8217;s governance structure includes
the audit, risk, and ethics committee, which oversees risks identified by the risk and controls directorate, including cyber risks. The
audit, risk, and ethics committee reports to our board of directors, which sets strategic objectives and monitors the company&#8217;s
risk landscape and corresponding action plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya&#8217;s cybersecurity team operates through
a technical committee that meets biweekly to monitor and improve infrastructure and technology related to cybersecurity. The team identifies
potential improvements, which are then evaluated by the management committee to determine their feasibility and potential project status
under directorate oversight. Afya continually adopts technological solutions to enhance monitoring, detection, recovery, and protection
capabilities within the organization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In terms of disaster preparedness, Afya has
a comprehensive disaster recovery plan that includes a dedicated committee, trigger mechanisms, and defined recovery points focused on
the company&#8217;s infrastructure. Additionally, Afya maintains a robust business continuity plan involving key teams and critical service
mapping, with criteria for defining criticality, financial impact, and brand reputation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya&#8217;s privacy team is responsible for
addressing risks and controls related to personal data. They adhere to industry best practices such as ISO27000, LGPD, GDPR, and the NIST
Cybersecurity Framework, leveraging governance, risk management and compliance solutions to support their risk management processes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">According to processes and controls established
by Afya, as of December 31, 2023, no events were identified that could indicate the materialization of risks or the identification of
material incidents under the cybersecurity aspect that affected or could affect the business strategy, results of operations, or financial
condition of the company. Minor incidents that occurred during the period were identified, treated, and communicated in accordance with
the protocols, policies, and procedures established for response. However, despite our efforts, we cannot eliminate all risks from cybersecurity
threats, or provide assurances that we have not experienced an undetected cybersecurity incident.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For more information about these risks, please
see &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks Relating to Our Business and Industry&#8212; Failure to prevent or
detect a malicious cyber-attack on our systems and databases could result in a misappropriation of confidential information or access
to highly sensitive information&#8221; and &#8220;&#8212;Our success depends on our ability to monitor and adapt to technological changes
in the education sector and maintain a technological infrastructure that works adequately and without interruption&#8221; in this annual
report.</p>


<!-- Field: Page; Sequence: 170 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->165<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 20pt 0 10pt; text-align: center"><span id="form20f_087"></span>PART III</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_088"></span>ITEM 17. FINANCIAL STATEMENTS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have responded to Item 18 in lieu of this
item.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_089"></span>ITEM 18. FINANCIAL STATEMENTS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">See our consolidated financial statements beginning
on page F-1.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span id="form20f_090"></span>ITEM 19. EXHIBITS</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Exhibit<br/>
    No.</p></td>
    <td style="width: 90%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Description</p></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-3_1.htm">1.1</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-3_1.htm">Memorandum and Articles of Association of Afya (incorporated herein by reference to Exhibit 3.1 to the Registration Statement on Form F-1 filed with the SEC on July 9, 2019, File No. 333-232309).</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281422001951/ex01-2.htm">1.2</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281422001951/ex01-2.htm">Amended and Restated Memorandum and Articles of Association of Afya adopted on July 23, 2021, effective as of August 5, 2021 (incorporated herein by reference to Exhibit 1.2 to the annual report on Form 20-F for the year ended December 31, 2021, filed with the SEC on April 29, 2021).</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281421002044/ex99-2.htm">1.3</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281421002044/ex99-2.htm">Certificate of Designations of Series A Perpetual Convertible Preferred Shares of Afya dated May 3, 2021 (incorporated herein by reference to Exhibit 99.2 of the Registrant&#8217;s Report on Form 6-K filed with the SEC on May 3, 2021).</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281423001938/ex01-4.htm">1.4</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281423001938/ex01-4.htm">Amended and Restated Memorandum and Articles of Association of Afya adopted on April 29, 2022, effective as of May 4, 2022 (incorporated by reference to Exhibit 1.4 of the Registrant&#8217;s Annual Report on Form 20-F filed with the SEC on April 28, 2023).</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="ex02-1.htm">2.1*</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="ex02-1.htm"><span style="background-color: white">Description of Securities registered under Section 12 of the Exchange Act.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_3.htm">4.1 &#8224;</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_3.htm">English translation of Purchase Agreement dated as of November 27, 2018, among NRE Participa&#231;&#245;es S.A., JC JOINT Fundo de Investimento em Participa&#231;&#245;es Multiestrat&#233;gia, Breno Miranda Trabulo Pinheiro Correia and Cristina Maria Miranda de Sousa (incorporated herein by reference to Exhibit 10.3 to the Registration Statement on Form F-1 filed with the SEC on July 9, 2019, File No. 333-232309).</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_4.htm">4.2 &#8224;</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_4.htm">English translation of Purchase Agreement dated as of December 5, 2018, among NRE Participa&#231;&#245;es S.A., Jo&#227;o Carlos Ribeiro Pedroso, Leoni Margarida Bertolin, Jos&#233; Carlos Janu&#225;rio, Ricardo Pedroso, Daiane Pedroso Canto and RD Administra&#231;&#227;o e Participa&#231;&#227;o Ltda. (incorporated herein by reference to Exhibit 10.4 to the Registration Statement on Form F-1 filed with the SEC on July 9, 2019, File No. 333-232309).</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281421001953/ex4-3.htm">4.3</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281421001953/ex4-3.htm">English translation of Bank Note (<i>C&#233;dula de Cr&#233;dito Banc&#225;rio</i>) issued by Afya Participa&#231;&#245;es S.A. on September 23, 2020 (incorporated herein by reference to Exhibit 4.5 to the annual report on Form 20-F for the year ended December 31, 2020, filed with the SEC on April 30, 2021).</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="ex08-1.htm">8.1*</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="ex08-1.htm">List of Subsidiaries.</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000095010319008297/dp108627_ex1401.htm">11.1</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000095010319008297/dp108627_ex1401.htm">English translation of the Code of Ethics of Afya (incorporated herein by reference to Exhibit 14.1 to the Registration Statement on Form F-1 filed with the SEC on June 24, 2019, File No. 333-232309).</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="ex12-1.htm">12.1*</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="ex12-1.htm">Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act.</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="ex12-2.htm">12.2*</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="ex12-2.htm">Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act.</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="ex13-1.htm">13.1*</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="ex13-1.htm">Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act.</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="ex13-2.htm">13.2*</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="ex13-2.htm">Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act.</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="ex23-1.htm">23.1*</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="ex23-1.htm">Consent of Ernst &amp; Young Auditores Independentes S.S. Ltda.<span style="font-size: 8pt">&#160;</span></a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right"><a href="ex97-1.htm">97.1*</a></td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in"><a href="ex97-1.htm">Compensation recoupment policy, dated November 30, 2023.</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">101.INS*</td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in">Inline XBRL Instance Document</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">101.SCH*</td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in">Inline XBRL Taxonomy Extension Schema Document</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">101.CAL*</td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in">Inline XBRL Taxonomy Extension Calculation Linkbase Document</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">101.DEF*</td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in">Inline XBRL Taxonomy Extension Definition Linkbase Document</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">101.LAB*</td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in">Inline XBRL Taxonomy Extension Label Linkbase Document</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">101.PRE*</td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in">Inline XBRL Taxonomy Extension Presentation Linkbase Document</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 9pt; text-align: right">104*</td>
    <td style="vertical-align: bottom; padding-right: 9.35pt; font-size: 9pt; text-indent: 0in">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).</td></tr>
  </table>
<p style="font: 1pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 1pt 5.5in 1pt 0in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">*</td><td>Filed herewith.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in">&#8224; Certain provisions, exhibits
and schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 171 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->166<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">SIGNATURES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The registrant hereby certifies that it meets
all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report
on Form 20-F on its behalf.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; float: right; width: 50%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="2" style="padding-right: 5.75pt; padding-bottom: 24pt"><b>AFYA LIMITED</b></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 14%; padding-right: 5.75pt">By:</td>
    <td style="border-bottom: Black 1pt solid; width: 86%; padding-right: 5.75pt">/s/ Virgilio Deloy Capobianco Gibbon</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt">&#160;</td>
    <td style="padding-right: 5.75pt">Name:	Virgilio Deloy Capobianco Gibbon</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt">&#160;</td>
    <td style="padding-right: 5.75pt">Title:	Chief Executive Officer</td></tr>
  </table><div style="clear: both"></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; float: right; width: 50%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="2" style="padding-right: 5.75pt; padding-bottom: 24pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 14%; padding-right: 5.75pt">By:</td>
    <td style="border-bottom: Black 1pt solid; width: 86%; padding-right: 5.75pt">/s/ Luis Andr&#233; Carpintero Blanco</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt">&#160;</td>
    <td style="padding-right: 5.75pt">Name:	Luis Andr&#233; Carpintero Blanco</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt">&#160;</td>
    <td style="padding-right: 5.75pt">Title:	Chief Financial Officer</td></tr>
  </table><div style="clear: both"></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Date: April 26, 2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 172 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->167<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#form20f_001">Table of Contents</a></td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page --> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 20pt 0 10pt; text-transform: uppercase; text-align: center"><span id="form20f_091"></span>Index to
Financial Statements</p>





















































<p style="font: 10pt Times New Roman,serif; margin: 0"></p>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Audited Consolidated Statements&#8212;Afya Limited</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: right"><span style="text-decoration: underline">Page</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 91%; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><a href="#fp_001">Reports of Independent Registered Public Accounting Firm (PCAOB ID: <span id="xdx_908_edei--AuditorFirmId_c20230101__20231231_z0sTRnAoxvD6"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000067" name="dei:AuditorFirmId">1448</ix:nonNumeric></span>)	</a></td>
    <td style="vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#fp_001">F-1</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><a href="#fp_002">Consolidated Statements of Financial Position as of December 31, 2023 and 2022	</a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#fp_002">F-5</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><a href="#fp_003">Consolidated Statements of Income and Comprehensive Income for the years ended December 31, 2023, 2022 and 2021	</a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#fp_003">F-6</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><a href="#fp_004">Consolidated Statements of Changes in Equity for the years ended December 31, 2023, 2022 and 2021	</a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#fp_004">F-7</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><a href="#fp_005">Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 and 2021	</a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#fp_005">F-8</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><a href="#fp_006">Notes to the Consolidated Financial Statements for the years ended December 31, 2023, 2022 and 2021	</a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><a href="#fp_006">F-9</a></td></tr>
  </table>

<!-- Field: Page; Sequence: 173; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>


<p style="font: 16pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>&#160;</b></p>

<p style="font: 16pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>Afya Limited</b></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>&#160;</b></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>&#160;</b></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>Consolidated financial statements</b></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>as of December 31, 2023 and 2022 and</b></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>for the years ended December 31, 2023, 2022 and 2021</b></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 174 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: #333333"><b><span id="fp_001"></span>Report of Independent Registered
Public Accounting Firm</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">To the Shareholders and the Board of Directors of</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Afya Limited</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><b>Opinion on the Financial Statements</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">We have audited the accompanying
consolidated statements of financial position of Afya Limited (the Company) as of December 31, 2023 and 2022, the related consolidated
statements of income and comprehensive income, changes in equity and cash flows for each of the three years in the period ended December
31, 2023, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the
consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31,
2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023,
in conformity with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board - IASB.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">We also have audited, in accordance
with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial
reporting as of December 31, 2023, based on criteria established in Internal Control-Integrated Framework issued by the Committee of
Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated March 14, 2024 expressed an unqualified opinion
thereon.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black"><b>Basis for Opinion</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">These financial statements are
the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements
based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the
Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">We conducted our audits in accordance
with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures
to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that
respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well
as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black"><b>Critical Audit Matter</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">The critical audit matter communicated
below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated
to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved
our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way
our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below,
providing a separate opinion on the critical audit matter or on the account or disclosure to which it relates.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<!-- Field: Page; Sequence: 175; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 12pt/106% Times New Roman, Times, Serif; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 12pt/106% Times New Roman, Times, Serif; width: 86%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; line-height: 106%"><b>Accounting for Business combinations</b></span></td></tr>

<tr style="vertical-align: top">
    <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0"><i>&#160;</i></p>
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0"><i>Description of the Matter</i></p></td>
    <td style="font: 12pt/106% Times New Roman, Times, Serif; width: 86%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; line-height: 106%">&#160;</span><span style="font-size: 10pt; line-height: 106%"><br/>
<span style="font-family: Arial, Helvetica, Sans-Serif">As described in Note 5 to the consolidated financial statements, the Company, through its wholly owned subsidiary Afya Participa&#231;&#245;es S.A., completed the acquisition of Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#8220;DelRey&#8221;) on January 2, 2023 for a total aggregated purchase consideration of R$816,236&#160;thousand. Such transaction was accounted for as business combination, in accordance with the requirements of IFRS 3 <i>Business Combinations, </i>and the Company applied the acquisition method of accounting, which included estimating the fair value of assets acquired and liabilities assumed for the acquisition, including acquired intangible assets.</span><br/>
<br/>
<span style="font-family: Arial, Helvetica, Sans-Serif">Auditing the Company's accounting for such acquisition was complex due to the significant estimation uncertainty in the Company&#8217;s determination of the fair value of identified intangible assets of R$728,777&#160;thousand, which principally consisted of licenses and customer relationships. The significant estimation uncertainty was primarily due to the sensitivity of the respective fair values to underlying assumptions about the future performance of the acquired business. The Company used discounted cash flow models to measure licenses and customer relationships. The significant assumptions used to estimate the value of these intangible assets included discount rates and certain assumptions that form the basis of the forecasted results, such as revenue growth rates and projected profit margins. These significant assumptions are forward looking and could be affected by future economic events and market conditions.</span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0"><i>&#160;</i></p>
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0"><i>How We Addressed the Matter in Our Audit</i></p></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0">We obtained an understanding, evaluated the design and tested the operating
    effectiveness of the Company's controls over its accounting for the business combination, including controls over the recognition and
    measurement of licenses and customer relationships intangible assets. For example, we tested controls over management's evaluation of
    underlying assumptions in the valuation models applied, and we also tested management's controls over the data used in the valuation models.</p>
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0"><br/>
    To test the estimated fair value of the licenses and customer relationships intangible assets, we performed audit procedures that included,
    among others, evaluating the valuation methodology and the significant assumptions used by the Company&#8217;s independent valuation specialist;
    obtaining the reports prepared by the Company&#180;s independent valuation specialist; testing the completeness and accuracy of underlying
    data used in the estimation of fair value of intangible assets acquired; involving our valuation specialists to assist with our evaluation
    of the methodology and significant assumptions used by the Company&#8217;s independent valuation specialist. For example, we compared
    the significant assumptions used by the Company&#8217;s independent valuation specialist to the ones used in relation to past acquisitions
    and available third-party industry information. Specifically, when assessing the significant assumptions, we focused on discount rates,
    revenue growth rates and projected profit margins.</p>
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0">We also assessed the Company&#8217;s disclosures in Note 5 to the consolidated
    financial statements.</p></td></tr>
  </table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">/s/ <span id="xdx_90D_edei--AuditorName_c20230101__20231231_zYXJmV6GYXG9"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000068" name="dei:AuditorName">ERNST
&amp; YOUNG</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">Auditores Independentes S/S
Ltda.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">We&#160;have&#160;served&#160;as&#160;the&#160;Company's&#160;auditor&#160;since&#160;2016.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span id="xdx_90B_edei--AuditorLocation_c20230101__20231231_z3mSRlCA4wJa" style="color: Black"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000069" name="dei:AuditorLocation">Belo
Horizonte, Brazil</ix:nonNumeric></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><span style="color: Black">March 14, 2024</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: #333333"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"></p>

<!-- Field: Page; Sequence: 176 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>Report of Independent Registered Public Accounting
Firm </b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">To the Shareholders and the Board of Directors of</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Afya Limited</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Opinion on Internal Control Over Financial Reporting</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">We have audited Afya Limited&#8217;s internal control over financial reporting
as of December 31, 2023, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Afya Limited (the Company) maintained,
in all material respects, effective internal control over financial reporting as of December&#160;31, 2023, based on the COSO criteria.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt">As indicated in the accompanying Management&#8217;s
Annual Report on Internal Control over Financial Reporting, management&#8217;s assessment of and conclusion on the effectiveness of internal
control over financial reporting did not include the internal controls of Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#8220;DelRey&#8221;),
which is included in the 2023 consolidated financial statements of the Company and constituted 2.2% and 2.4% of its equity and total
assets, respectively, as of December 31, 2023 and 8.3% and 19.3% of revenue and net income, respectively, for the year then ended. Our
audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial
reporting of DelRey.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 10pt">We also have audited, in accordance with the standards of the Public Company Accounting
Oversight Board (United States) (PCAOB), the Company&#8217;s consolidated statements of financial position as of December 31, 2023 and
2022, the related consolidated statements of income and comprehensive income, changes in equity and cash flows for each of the three
years in the period ended December 31, 2023, and the related notes and our report dated March 14, 2024 expressed an unqualified
opinion thereon<span style="color: #333333">.</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><b>Basis for Opinion</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">The Company&#8217;s management is responsible
for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control
over financial reporting included in the accompanying Management&#8217;s Annual Report on Internal Control over Financial Reporting. Our
responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a
public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the
U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">We conducted our audit in accordance with the standards of the PCAOB. Those
standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial
reporting was maintained in all material respects.</p>


<!-- Field: Page; Sequence: 177 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Our audit included obtaining an understanding of internal control over financial
reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal
control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that
our audit provides a reasonable basis for our opinion.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Definition and Inherent Limitations of Internal Control Over Financial
Reporting</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">A company&#8217;s internal control over financial reporting is a process
designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting
includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded
as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts
and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and
(3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s
assets that could have a material effect on the financial statements.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk
that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures
may deteriorate.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">/s/ ERNST &amp; YOUNG</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Auditores Independentes S/S Ltda.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Belo Horizonte, Brazil</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">March 14, 2024</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<!-- Field: Page; Sequence: 178 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C0504D"><b><span id="fp_002"></span>Afya Limited</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Consolidated statements of financial position</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">As of December 31, 2023 and 2022</p>

<p style="border-bottom: Black 0.5pt solid; font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><i>(In thousands of Brazilian reais)</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" id="xdx_30C_111_pn3n3_z3jxaHu8fi2f" summary="xdx: Statement - Consolidated statements of financial position" style="width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_49B_20231231_z4r6yTFEcKnl" style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_49A_20221231_z6X67Fs8H1Al" style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; width: 57%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Notes</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; white-space: nowrap; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2023</b></span></td>
    <td style="width: 1%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; white-space: nowrap; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2022</b></span></td></tr>
  <tr id="xdx_40E_eifrs-full--AssetsAbstract_iB_zFxYkmEiLOJ2">
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Assets</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentAssetsAbstract_iB_zuM00F8Tn681">
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Current assets</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CashAndCashEquivalents_i01I_pn3n3_maCAziMt_zsP9ZQvNsdnj" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Cash and cash equivalents</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">6</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2023-12-31" id="Fact000077" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">553,030</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2022-12-31" id="Fact000078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,093,082</ix:nonFraction></span></td></tr>
  <tr id="xdx_40C_eifrs-full--CurrentTradeReceivables_i01I_pn3n3_maCAziMt_zvtm5nzRUk58" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Trade receivables</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">7</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="AsOf2023-12-31" id="Fact000080" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">546,438</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="AsOf2022-12-31" id="Fact000081" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">452,831</ix:nonFraction></span></td></tr>
  <tr id="xdx_407_eifrs-full--Inventories_i01I_pn3n3_maCAziMt_zckKNlW4gBe8" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Inventories</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:Inventories" contextRef="AsOf2023-12-31" id="Fact000083" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,382</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:Inventories" contextRef="AsOf2022-12-31" id="Fact000084" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,190</ix:nonFraction></span></td></tr>
  <tr id="xdx_40C_eifrs-full--CurrentTaxAssets_i01I_pn3n3_maCAziMt_zap6UEWyNgfl" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Recoverable taxes</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentTaxAssets" contextRef="AsOf2023-12-31" id="Fact000086" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,751</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentTaxAssets" contextRef="AsOf2022-12-31" id="Fact000087" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,809</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_eifrs-full--OtherCurrentAssets_i01I_pn3n3_maCAziMt_zKX5A4eWoeC2" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Other assets</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">9</span></td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf2023-12-31" id="Fact000089" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,905</ix:nonFraction></span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf2022-12-31" id="Fact000090" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,745</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_eifrs-full--CurrentAssets_i01TI_pn3n3_mtCAziMt_maAzBIg_zCWztH6peTv2" style="background-color: White">
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total current assets</b></span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2023-12-31" id="Fact000092" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,203,506</ix:nonFraction></b></span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2022-12-31" id="Fact000093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,637,657</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--NoncurrentAssetsAbstract_i01B" style="background-color: White">
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Non-current assets</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_406_ecustom--NoncurrentTradeReceivable_i02I_pn3n3_maNAzbfa_zCIwzhIxKXil" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Trade receivables</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">7</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:NoncurrentTradeReceivable" contextRef="AsOf2023-12-31" id="Fact000098" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,485</ix:nonFraction></span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:NoncurrentTradeReceivable" contextRef="AsOf2022-12-31" id="Fact000099" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,568</ix:nonFraction></span></td></tr>
  <tr id="xdx_404_eifrs-full--OtherNoncurrentAssets_i02I_pn3n3_maNAzbfa_zNlkgD6x6Em1" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Other assets</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">9</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf2023-12-31" id="Fact000101" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">117,346</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf2022-12-31" id="Fact000102" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">191,756</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_eifrs-full--InvestmentsInSubsidiariesJointVenturesAndAssociates_i02I_pn3n3_maNAzbfa_zmZQADJV4hxe" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Investment in associate</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">10</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="AsOf2023-12-31" id="Fact000104" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,834</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="AsOf2022-12-31" id="Fact000105" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,907</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_eifrs-full--PropertyPlantAndEquipment_i02I_pn3n3_maNAzbfa_zb8LlReL0JC6" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Property and equipment</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">11</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2023-12-31" id="Fact000107" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">608,685</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2022-12-31" id="Fact000108" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">542,087</ix:nonFraction></span></td></tr>
  <tr id="xdx_409_eifrs-full--RightofuseAssets_i02I_pn3n3_maNAzbfa_zKOS1OwpOdFb" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Right-of-use assets</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">13.2.2</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2023-12-31" id="Fact000110" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">767,609</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2022-12-31" id="Fact000111" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">690,073</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_eifrs-full--IntangibleAssetsOtherThanGoodwill_i02I_pn3n3_maNAzbfa_zHuKpMtUlyk6" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Intangible assets</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">12</span></td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-12-31" id="Fact000113" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,796,016</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2022-12-31" id="Fact000114" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,041,491</ix:nonFraction></span></td></tr>
  <tr id="xdx_40F_eifrs-full--NoncurrentAssets_i02TI_pn3n3_mtNAzbfa_maAzBIg_z5c7QlES0Il2" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 4.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total non-current assets</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2023-12-31" id="Fact000116" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,380,975</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2022-12-31" id="Fact000117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,561,882</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--Assets_iTI_pn3n3_mtAzBIg_zsj2xw0emfpk" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total assets</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2023-12-31" id="Fact000119" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,584,481</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2022-12-31" id="Fact000120" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,199,539</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--LiabilitiesAbstract_iB" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CurrentLiabilitiesAbstract_i01B" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Current liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--TradeAndOtherCurrentPayables_i02I_pn3n3_maCLzt3C_z1LlSfWNDZUe" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Trade payables</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayables" contextRef="AsOf2023-12-31" id="Fact000128" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,222</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayables" contextRef="AsOf2022-12-31" id="Fact000129" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,482</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_eifrs-full--ShorttermBorrowings_i02I_pn3n3_maCLzt3C_zm4CDRqkK54j" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Loans and financing</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">13.2.1</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ShorttermBorrowings" contextRef="AsOf2023-12-31" id="Fact000131" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">179,252</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ShorttermBorrowings" contextRef="AsOf2022-12-31" id="Fact000132" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">145,202</ix:nonFraction></span></td></tr>
  <tr id="xdx_407_eifrs-full--CurrentLeaseLiabilities_i02I_pn3n3_maCLzt3C_z0lxNaHmLZe7" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Lease liabilities</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">13.2.2</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2023-12-31" id="Fact000134" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,898</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2022-12-31" id="Fact000135" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,459</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_eifrs-full--TradeAndOtherCurrentPayablesToRelatedParties_i02I_pn3n3_maCLzt3C_zZOiQtzEDiFl" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Accounts payable to selling shareholders</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">13.2.3</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" contextRef="AsOf2023-12-31" id="Fact000137" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">353,998</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" contextRef="AsOf2022-12-31" id="Fact000138" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">261,711</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_ecustom--NotePayableCurrent_i02I_pn3n3_maCLzt3C_zmuB1oAOXdF3" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Notes payable</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">13.2.4</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0140">-</span></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:NotePayableCurrent" contextRef="AsOf2022-12-31" id="Fact000141" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,176</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_eifrs-full--CurrentDepositsFromCustomers_i02I_pn3n3_maCLzt3C_zar8T7yhAWVd" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Advances from customers</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentDepositsFromCustomers" contextRef="AsOf2023-12-31" id="Fact000143" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,485</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentDepositsFromCustomers" contextRef="AsOf2022-12-31" id="Fact000144" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">133,050</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_eifrs-full--CurrentRecognisedLiabilitiesDefinedBenefitPlan_i02I_pn3n3_maCLzt3C_zkUoz54gBbca" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Labor and social obligations</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="AsOf2023-12-31" id="Fact000146" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">192,294</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="AsOf2022-12-31" id="Fact000147" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">154,518</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_ecustom--CurrentTaxesPayable_i02I_pn3n3_maCLzt3C_zza5CI2CCl2h" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Taxes payable</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:CurrentTaxesPayable" contextRef="AsOf2023-12-31" id="Fact000149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,765</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:CurrentTaxesPayable" contextRef="AsOf2022-12-31" id="Fact000150" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,221</ix:nonFraction></span></td></tr>
  <tr id="xdx_403_eifrs-full--CurrentTaxLiabilitiesCurrent_i02I_pn3n3_maCLzt3C_zdlIBmLnUpZ" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Income taxes payable</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000152" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,880</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="AsOf2022-12-31" id="Fact000153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,151</ix:nonFraction></span></td></tr>
  <tr id="xdx_40D_eifrs-full--OtherCurrentLiabilities_i02I_pn3n3_maCLzt3C_z25AiOQOjpk6" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Other liabilities</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -3.85pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf2023-12-31" id="Fact000155" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,773</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -3.4pt; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf2022-12-31" id="Fact000156" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,719</ix:nonFraction></span></td></tr>
  <tr id="xdx_40D_eifrs-full--CurrentLiabilities_i02TI_pn3n3_mtCLzt3C_maLzhbz_zFOncV1pOs03" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 4.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Total current liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2023-12-31" id="Fact000158" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,058,567</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2022-12-31" id="Fact000159" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">905,689</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--NoncurrentLiabilitiesAbstract_i01B" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Non-current liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--LongtermBorrowings_i02I_pn3n3_maNLznQV_z3KXdRaw96Z9" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Loans and financing</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">13.2.1</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="AsOf2023-12-31" id="Fact000164" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,621,523</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="AsOf2022-12-31" id="Fact000165" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,737,699</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--NoncurrentLeaseLiabilities_i02I_pn3n3_maNLznQV_z4jU4CZZWL6" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Lease liabilities</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">13.2.2</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2023-12-31" id="Fact000167" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">837,671</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2022-12-31" id="Fact000168" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">737,066</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_eifrs-full--NoncurrentPayablesToRelatedParties_i02I_pn3n3_maNLznQV_zaTULVzNBZ33" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Accounts payable to selling shareholders</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">13.2.3</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:NoncurrentPayablesToRelatedParties" contextRef="AsOf2023-12-31" id="Fact000170" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">212,869</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:NoncurrentPayablesToRelatedParties" contextRef="AsOf2022-12-31" id="Fact000171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">266,967</ix:nonFraction></span></td></tr>
  <tr id="xdx_40D_ecustom--NoncurrentTaxesPayable_i02I_pn3n3_maNLznQV_zDT55Wq4hVxh" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Taxes payable</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:NoncurrentTaxesPayable" contextRef="AsOf2023-12-31" id="Fact000173" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">88,198</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:NoncurrentTaxesPayable" contextRef="AsOf2022-12-31" id="Fact000174" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">92,888</ix:nonFraction></span></td></tr>
  <tr id="xdx_403_eifrs-full--LongtermLegalProceedingsProvision_i02I_pn3n3_maNLznQV_z7MUDH3Kd6nh" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Provision for legal proceedings</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">23</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:LongtermLegalProceedingsProvision" contextRef="AsOf2023-12-31" id="Fact000176" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">104,361</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:LongtermLegalProceedingsProvision" contextRef="AsOf2022-12-31" id="Fact000177" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">195,854</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_eifrs-full--OtherNoncurrentLiabilities_i02I_pn3n3_maNLznQV_zDdK9A9deDJf" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Other liabilities</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -3.85pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf2023-12-31" id="Fact000179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,280</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -3.4pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf2022-12-31" id="Fact000180" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,218</ix:nonFraction></span></td></tr>
  <tr id="xdx_40F_eifrs-full--NoncurrentLiabilities_i02TI_pn3n3_mtNLznQV_maLzhbz_zPprT6S3jAH" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Total non-current liabilities</b></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2023-12-31" id="Fact000182" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,882,902</ix:nonFraction></b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2022-12-31" id="Fact000183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,043,692</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_408_eifrs-full--Liabilities_iTI_pn3n3_mtLzhbz_maEALzSEY_z8Qrnq4V0xgc" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Total liabilities</b></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf2023-12-31" id="Fact000185" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,941,469</ix:nonFraction></b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf2022-12-31" id="Fact000186" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,949,381</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--EquityAbstract_iB" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Equity</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="font: 12pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--IssuedCapital_i01I_pn3n3_maEATOOzt9Y_zVZXq06smzmc" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Share capital</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">17</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2023-12-31" id="Fact000191" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2022-12-31" id="Fact000192" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></span></td></tr>
  <tr id="xdx_403_eifrs-full--AdditionalPaidinCapital_i01I_pn3n3_maEATOOzt9Y_zDFp66omXxQ1" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Additional paid-in capital</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:AdditionalPaidinCapital" contextRef="AsOf2023-12-31" id="Fact000194" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,365,200</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:AdditionalPaidinCapital" contextRef="AsOf2022-12-31" id="Fact000195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,375,344</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_eifrs-full--TreasuryShares_i01NI_pn3n3_di_msEATOOzt9Y_z14wqqjXdbab" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Treasury shares</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; text-align: center">&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:TreasuryShares" contextRef="AsOf2023-12-31" id="Fact000197" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">299,150</ix:nonFraction>)</span></td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:TreasuryShares" contextRef="AsOf2022-12-31" id="Fact000198" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">304,947</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_401_eifrs-full--ReserveOfSharebasedPayments_i01I_pn3n3_maEATOOzt9Y_zbSkZO572xhg" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Share-based compensation reserve</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ReserveOfSharebasedPayments" contextRef="AsOf2023-12-31" id="Fact000200" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">155,073</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ReserveOfSharebasedPayments" contextRef="AsOf2022-12-31" id="Fact000201" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">123,538</ix:nonFraction></span></td></tr>
  <tr id="xdx_40C_eifrs-full--RetainedEarnings_i01I_pn3n3_maEATOOzt9Y_zyfHy4uTD5S4" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Retained earnings</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf2023-12-31" id="Fact000203" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,380,365</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf2022-12-31" id="Fact000204" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,004,886</ix:nonFraction></span></td></tr>
  <tr id="xdx_40D_eifrs-full--EquityAttributableToOwnersOfParent_i01TI_pn3n3_mtEATOOzt9Y_maEz587_zw7aAHJNnSCc" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Equity attributable to equity holders of the parent</b></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf2023-12-31" id="Fact000206" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,601,505</ix:nonFraction></b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf2022-12-31" id="Fact000207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,198,838</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40B_eifrs-full--NoncontrollingInterests_i01I_pn3n3_maEz587_zCAuRR65nhR8" style="background-color: White">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Non-controlling interests</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf2023-12-31" id="Fact000209" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,507</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf2022-12-31" id="Fact000210" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,320</ix:nonFraction></span></td></tr>
  <tr id="xdx_40C_eifrs-full--Equity_i01TI_pn3n3_mtEz587_maEALzSEY_zEtoBr2yjnI6" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Total equity</b></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31" id="Fact000212" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,643,012</ix:nonFraction></b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31" id="Fact000213" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,250,158</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--EquityAndLiabilities_iTI_pn3n3_mtEALzSEY_zwM2wtjkb4wd" style="background-color: rgb(213,234,234)">
    <td style="font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Total liabilities and equity</b></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2023-12-31" id="Fact000215" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,584,481</ix:nonFraction></b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1.5pt double; font: 12pt/115% Times New Roman, Times, Serif; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2022-12-31" id="Fact000216" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,199,539</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The accompanying notes are an integral part of the consolidated financial
statements.</p>


<!-- Field: Page; Sequence: 179 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C0504D"><b><span id="fp_003"></span>Afya Limited</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Consolidated statements of income and comprehensive income</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For the years ended December 31, 2023, 2022 and 2021</p>

<p style="border-bottom: Black 0.5pt solid; font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><i>(In thousands of Brazilian reais, except
for earnings per share information)</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" id="xdx_306_113_pn3n3_z3tU9zFK7Uie" summary="xdx: Statement - Consolidated statements of income and comprehensive income" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_495_20230101__20231231_z62hAbjthfHg" style="padding-right: 7.05pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_499_20220101__20221231_zcEvQm8Xr9pk" style="padding-right: 7.05pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_499_20210101__20211231_zIrbjiegB2X5" style="padding-right: 7pt; padding-left: 3.5pt; text-align: center; line-height: 10.5pt">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; width: 44%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Notes</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--Revenue_maGPzyip_zxAY8rnYWCj5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Revenue</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19</span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-01to2023-12-31" id="Fact000218" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2022-01-012022-12-31" id="Fact000219" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,329,057</ix:nonFraction></span></td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31" id="Fact000220" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></span></td></tr>
  <tr id="xdx_409_eifrs-full--CostOfSales_iN_pn3n3_di_msGPzyip_zzlhifsyJbf4" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost of services</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">20</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2023-01-01to2023-12-31" id="Fact000222" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,109,813</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2022-01-012022-12-31" id="Fact000223" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">859,552</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2021-01-012021-12-31" id="Fact000224" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">652,300</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_408_eifrs-full--GrossProfit_iT_pn3n3_mtGPzyip_maPLFOAziWO_z0wr8sjqMih" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross profit</b></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-01to2023-12-31" id="Fact000226" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,766,100</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2022-01-012022-12-31" id="Fact000227" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,469,505</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-012021-12-31" id="Fact000228" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,067,071</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--GeneralAndAdministrativeExpense_iN_pn3n3_di_msPLFOAziWO_zi2c6NQrexrf" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Selling, general and administrative expenses</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">20</span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2023-01-01to2023-12-31" id="Fact000230" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,014,684</ix:nonFraction>)</span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31" id="Fact000231" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">798,153</ix:nonFraction>)</span></td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2021-01-012021-12-31" id="Fact000232" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">622,615</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_400_eifrs-full--OtherOperatingIncomeExpense_maPLFOAziWO_zgJK2jMiaoR1" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other income (expenses), net</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:OtherOperatingIncomeExpense" contextRef="From2023-01-01to2023-12-31" id="Fact000234" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,645</ix:nonFraction></span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:OtherOperatingIncomeExpense" contextRef="From2022-01-012022-12-31" id="Fact000235" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,252</ix:nonFraction>)</span></td>
    <td style="padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:OtherOperatingIncomeExpense" contextRef="From2021-01-012021-12-31" id="Fact000236" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,561</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--ProfitLossFromOperatingActivities_iT_pn3n3_mtPLFOAziWO_maPLBTzdiV_zR3HysXBqrMi" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating income</b></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000238" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">767,061</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2022-01-012022-12-31" id="Fact000239" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">664,100</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2021-01-012021-12-31" id="Fact000240" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">440,895</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinanceIncome_maFICzW1W_z8Ps8lpwk1Kc" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;&#160;Finance income</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21</span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2023-01-01to2023-12-31" id="Fact000242" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,642</ix:nonFraction></span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2022-01-012022-12-31" id="Fact000243" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">102,042</ix:nonFraction></span></td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2021-01-012021-12-31" id="Fact000244" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,566</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_eifrs-full--FinanceCosts_iN_pn3n3_di_msFICzW1W_zAZN19M6G4Y3" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;&#160;Finance expenses</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2023-01-01to2023-12-31" id="Fact000246" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">457,616</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2022-01-012022-12-31" id="Fact000247" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">349,893</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2021-01-012021-12-31" id="Fact000248" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">243,796</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_405_eifrs-full--FinanceIncomeCost_iT_pn3n3_mtFICzW1W_maPLBTzdiV_zspciwZoL9w7" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Finance result</b></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:FinanceIncomeCost" contextRef="From2023-01-01to2023-12-31" id="Fact000250" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">346,974</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:FinanceIncomeCost" contextRef="From2022-01-012022-12-31" id="Fact000251" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">247,851</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:FinanceIncomeCost" contextRef="From2021-01-012021-12-31" id="Fact000252" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">179,230</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_maPLBTzdiV_zTZf75E3ghBl" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share of income of associate</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10</span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From2023-01-01to2023-12-31" id="Fact000254" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,495</ix:nonFraction></span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From2022-01-012022-12-31" id="Fact000255" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,184</ix:nonFraction></span></td>
    <td style="padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From2021-01-012021-12-31" id="Fact000256" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,797</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--ProfitLossBeforeTax_iT_pn3n3_mtPLBTzdiV_maPLzBpM_zYv6ZbK8okr4" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2023-01-01to2023-12-31" id="Fact000258" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">429,582</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2022-01-012022-12-31" id="Fact000259" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">428,433</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-012021-12-31" id="Fact000260" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">273,462</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--IncomeTaxExpenseContinuingOperations_iN_pn3n3_di_msPLzBpM_z46NUnD7Ofdi" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income taxes expenses</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">22</span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2023-01-01to2023-12-31" id="Fact000262" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,166</ix:nonFraction>)</span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2022-01-012022-12-31" id="Fact000263" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,677</ix:nonFraction>)</span></td>
    <td style="padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-01-012021-12-31" id="Fact000264" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,179</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--ProfitLoss_iT_pn3n3_mtPLzBpM_maCIzVzV_zDSZ9clG3DSl" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net income</b></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-01to2023-12-31" id="Fact000266" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,416</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-01-012022-12-31" id="Fact000267" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">392,756</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31" id="Fact000268" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,283</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--OtherComprehensiveIncome_maCIzVzV_zgT61jDh4rX2" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other comprehensive income</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0270">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0271">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0272">-</span></span></td></tr>
  <tr id="xdx_406_eifrs-full--ComprehensiveIncome_iT_pn3n3_mtCIzVzV_zJrJomVC6yqd" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total comprehensive income</b></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-01to2023-12-31" id="Fact000274" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,416</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-01-012022-12-31" id="Fact000275" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">392,756</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31" id="Fact000276" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,283</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--ProfitLossAttributableToAbstract_iB" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income attributable to</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_409_eifrs-full--ProfitLossAttributableToOwnersOfParent_i01_pn3n3_maCILzVFt_zTjXQCqqW1lj" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;&#160;Equity holders of the parent</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From2023-01-01to2023-12-31" id="Fact000282" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">386,324</ix:nonFraction></span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From2022-01-012022-12-31" id="Fact000283" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">373,569</ix:nonFraction></span></td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From2021-01-012021-12-31" id="Fact000284" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,326</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_eifrs-full--ProfitLossAttributableToNoncontrollingInterests_i01_pn3n3_maCILzVFt_zV0uwVL0FQBf" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;&#160;Non-controlling interests</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From2023-01-01to2023-12-31" id="Fact000286" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,092</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From2022-01-012022-12-31" id="Fact000287" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,187</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From2021-01-012021-12-31" id="Fact000288" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,957</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_ecustom--ComprehensiveIncomeLoss_iT_mtCILzVFt_zSTudpCWKeCj" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><b style="display: none">Total comprehensive income</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:ComprehensiveIncomeLoss" contextRef="From2023-01-01to2023-12-31" id="Fact000290" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,416</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:ComprehensiveIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000291" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">392,756</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 7pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:ComprehensiveIncomeLoss" contextRef="From2021-01-012021-12-31" id="Fact000292" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,283</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_405_eifrs-full--BasicEarningsPerShareAbstract_iB_zn2UfGh27Iz5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Basic earnings per share</b></span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--BasicEarningsLossPerShare_i01_pip0_zFXgg5Ukamwb" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Per common share</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18</span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2023-01-01to2023-12-31" id="Fact000298" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">4.30</ix:nonFraction></span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2022-01-012022-12-31" id="Fact000299" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">4.14</ix:nonFraction></span></td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2021-01-012021-12-31" id="Fact000300" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">2.39</ix:nonFraction></span></td></tr>

  <tr id="xdx_40A_eifrs-full--DilutedEarningsPerShareAbstract_i01B_zwnL2HSquWN7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap">
    <p style="font: 8pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Diluted earnings per share</b></p></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"></span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"/>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"></span></td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt"/></tr>
<tr id="xdx_406_eifrs-full--DilutedEarningsLossPerShare_i01_pip0_zAOvGGZJGvjg" style="background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Per common share</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18</span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2023-01-01to2023-12-31" id="Fact000306" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">4.27</ix:nonFraction></span></td>
    <td style="padding-right: 7.05pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2022-01-012022-12-31" id="Fact000307" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">4.12</ix:nonFraction></span></td>
    <td style="padding-right: 7pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2021-01-012021-12-31" id="Fact000308" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">2.37</ix:nonFraction></span></td></tr>
</table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The accompanying notes are an integral part of the consolidated financial
statements.</p>


<!-- Field: Page; Sequence: 180 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C0504D"><span id="fp_004"></span><b>Afya Limited</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Consolidated statements of changes in equity</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For the years ended December 31, 2023, 2022 and 2021</p>

<p style="border-bottom: Black 0.5pt solid; font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><i>(In thousands of Brazilian reais)</i></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" id="xdx_305_114_pn3n3_zKZ5BazyDWk5" summary="xdx: Statement - Consolidated statements of changes in equity" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4B9_ifrs-full--ComponentsOfEquityAxis_ifrs-full--IssuedCapitalMember_zwfaGjfxN8R6" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4B6_ifrs-full--ComponentsOfEquityAxis_ifrs-full--AdditionalPaidinCapitalMember_zNBbeLZNnrYi" style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4BC_ifrs-full--ComponentsOfEquityAxis_ifrs-full--TreasurySharesMember_z9Jb9Eeitgk4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4BA_ifrs-full--ComponentsOfEquityAxis_ifrs-full--ReserveOfSharebasedPaymentsMember_zjkEnwGT1lj4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4B4_ifrs-full--ComponentsOfEquityAxis_ifrs-full--RetainedEarningsMember_zuHPmQh3h5L9" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4B5_ifrs-full--ComponentsOfEquityAxis_ifrs-full--EquityAttributableToOwnersOfParentMember_zoVuIaqiWqye" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4B9_ifrs-full--ComponentsOfEquityAxis_ifrs-full--NoncontrollingInterestsMember_zPGHtTfEEroh" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4BF_zrqFLOBueoFe" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td colspan="6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Equity attributable to equity holders of the parent</b></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; width: 47%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td style="width: 4%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Notes</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 4%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Share capital</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 8%; padding-right: 0.25pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Additional paid-in capital</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Treasury shares</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Share-based compensation reserve</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Retained earnings</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Total</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Non-controlling interests</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Total equity</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_438_c20210101__20211231_eifrs-full--Equity_iS_zQUyicai6ub8" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Balances at December 31, 2020</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_IssuedCapitalMember" id="Fact000310" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000311" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,323,488</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><span style="-sec-ix-hidden: xdx2ixbrl0312">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000313" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,724</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_RetainedEarningsMember" id="Fact000314" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">407,991</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000315" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,782,220</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000316" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,560</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31" id="Fact000317" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,833,780</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_403_eifrs-full--ProfitLoss_zRM7P94Ad3pa" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Net income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0319">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0320">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0321">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0322">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="Fact000323" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,326</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000324" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,326</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000325" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,957</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31" id="Fact000326" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,283</ix:nonFraction></span></td></tr>
  <tr id="xdx_404_eifrs-full--ComprehensiveIncome_z8BXS2KnedJb" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Total comprehensive income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0328">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0329">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0330">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0331">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="Fact000332" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,326</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000333" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,326</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000334" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,957</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31" id="Fact000335" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,283</ix:nonFraction></span></td></tr>
  <tr id="xdx_408_ecustom--CapitalIncreaseWithCash_zfCdwtcrTlsj" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Capital increase</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0337">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000338" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,500</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0339">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0340">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0341">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000342" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,500</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0343">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31" id="Fact000344" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,500</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_ecustom--TreasuryShares1_zaD5pMuFxLOb" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Treasury shares</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">17.c</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0346">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0347">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" id="Fact000348" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">213,722</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0349">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0350">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000351" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">213,722</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0352">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31" id="Fact000353" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">213,722</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_400_ecustom--TreasurySharesTransferredFromExerciseOfOptions_zqH8OwBl4eej" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Treasury shares transferred from exercise of options</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">16.b.1</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0355">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000356" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">21,861</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" id="Fact000357" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,197</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0358">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0359">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000360" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,336</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0361">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31" id="Fact000362" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,336</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_ecustom--TreasurySharesTransferredFromSharesContributionOnBusinessCombination_zrjyYgJk8Dl4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Treasury shares transferred from shares contribution on business combinations</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0364">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000365" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">783</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" id="Fact000366" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,895</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0367">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0368">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000369" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,112</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0370">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31" id="Fact000371" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,112</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_zh0sCwidPChe" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Share-based compensation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">16.b</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0373">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0374">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0375">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000376" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,377</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0377">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000378" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,377</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0379">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31" id="Fact000380" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,377</ix:nonFraction></span></td></tr>
  <tr id="xdx_409_eifrs-full--DividendsPaid_iN_di_zjFqGVnWF8n1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Dividends declared </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">17.b</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0382">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0383">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0384">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0385">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0386">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0387">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000388" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,648</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2021-01-012021-12-31" id="Fact000389" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,648</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_438_c20220101__20221231_eifrs-full--Equity_iS_zLUqi8F7UWLk" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Balances at December 31, 2021</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_IssuedCapitalMember" id="Fact000391" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000392" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,375,344</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_TreasurySharesMember" id="Fact000393" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">152,630</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000394" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">94,101</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_RetainedEarningsMember" id="Fact000395" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">631,317</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000396" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,948,149</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000397" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,869</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31" id="Fact000398" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,000,018</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--ProfitLoss_zKPiZaoRYOB" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Net income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0400">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0401">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0402">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0403">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-01-012022-12-31_ifrs-full_RetainedEarningsMember" id="Fact000404" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">373,569</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-01-012022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000405" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">373,569</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-01-012022-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000406" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,187</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-01-012022-12-31" id="Fact000407" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">392,756</ix:nonFraction></span></td></tr>
  <tr id="xdx_407_eifrs-full--ComprehensiveIncome_zlwHsPiybHpi" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Total comprehensive income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0409">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0410">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0411">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0412">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-01-012022-12-31_ifrs-full_RetainedEarningsMember" id="Fact000413" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">373,569</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-01-012022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000414" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">373,569</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-01-012022-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000415" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,187</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2022-01-012022-12-31" id="Fact000416" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">392,756</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_ecustom--TreasuryShares1_zBfS3nxhKmIl" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Treasury shares</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">17.c</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0418">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0419">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2022-01-012022-12-31_ifrs-full_TreasurySharesMember" id="Fact000420" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">152,317</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0421">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0422">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2022-01-012022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000423" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">152,317</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0424">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2022-01-012022-12-31" id="Fact000425" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">152,317</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_402_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_zsFsXs1z9dt5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Share-based compensation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">16.b</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0427">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0428">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0429">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000430" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,437</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0431">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2022-01-012022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000432" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,437</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0433">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2022-01-012022-12-31" id="Fact000434" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,437</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_eifrs-full--DividendsPaid_iN_di_z4m8zpWIu3K7" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Dividends declared </span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">17.b</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0436">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0437">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0438">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0439">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0440">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0441">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2022-01-012022-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000442" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,736</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2022-01-012022-12-31" id="Fact000443" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,736</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_438_c20230101__20231231_eifrs-full--Equity_iS_zq0VfVMs0W0d" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Balances at December 31, 2022</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_IssuedCapitalMember" id="Fact000445" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000446" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,375,344</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_TreasurySharesMember" id="Fact000447" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">304,947</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000448" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">123,538</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_RetainedEarningsMember" id="Fact000449" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,004,886</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000450" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,198,838</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000451" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,320</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31" id="Fact000452" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,250,158</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--ProfitLoss_zNQAuD8VAazl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Net income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0454">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0455">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0456">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="Fact000458" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">386,324</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000459" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">386,324</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000460" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,092</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-01to2023-12-31" id="Fact000461" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,416</ix:nonFraction></span></td></tr>
  <tr id="xdx_407_eifrs-full--ComprehensiveIncome_zTwV02I2PrLa" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Total comprehensive income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0463">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0464">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0465">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0466">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="Fact000467" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">386,324</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000468" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">386,324</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000469" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,092</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-01to2023-12-31" id="Fact000470" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,416</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_ecustom--TreasuryShares1_zIV9PMDuM1Bi" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Treasury shares </span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">17.c</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0472">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0473">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="Fact000474" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,369</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0475">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0476">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000477" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,369</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0478">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2023-01-01to2023-12-31" id="Fact000479" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,369</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_402_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_zwJSyKIWQEfa" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Share-based compensation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">16.b</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0481">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0482">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000484" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,535</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0485">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000486" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,535</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0487">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-01to2023-12-31" id="Fact000488" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,535</ix:nonFraction></span></td></tr>
  <tr id="xdx_40F_ecustom--AcquisitionOfNoncontrollingInterests_iP3ifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_zQCRYLA1aRgi" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Acquisition of non-controlling interests</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0490">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0491">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0492">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0493">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="Fact000494" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,845</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000495" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,845</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000496" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,155</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-01to2023-12-31" id="Fact000497" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">21,000</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_400_ecustom--RestrictedSharesTransferredToExecutives_iP3custom--AcquisitionOfNoncontrollingInterests_zWkGPYMnf1Pj" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Restricted shares transferred to executives</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">16.b.2</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0499">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000500" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,491</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="Fact000501" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,722</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0502">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000504" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,769</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0505">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-01to2023-12-31" id="Fact000506" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,769</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40F_ecustom--TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions_iP3custom--RestrictedSharesTransferredToExecutives_zXKnWoznezt8" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Treasury shares transferred to executives from exercise of stock options</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">16.b.1</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0508">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000509" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,653</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="Fact000510" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,444</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0512">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000513" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,791</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0514">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-01to2023-12-31" id="Fact000515" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,791</ix:nonFraction></span></td></tr>
  <tr id="xdx_401_eifrs-full--DividendsPaid_iN_di_zckg4Jlfx7d5" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">Dividends declared </span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">17.b</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0517">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0518">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0519">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0520">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0521">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl0522">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000523" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,750</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-01to2023-12-31" id="Fact000524" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,750</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_430_c20230101__20231231_eifrs-full--Equity_iE_zpdUkiaS6f53" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>Balances at December 31, 2023</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_IssuedCapitalMember" id="Fact000526" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000527" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,365,200</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_TreasurySharesMember" id="Fact000528" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">299,150</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000529" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">155,073</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_RetainedEarningsMember" id="Fact000530" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,380,365</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000531" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,601,505</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000532" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,507</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31" id="Fact000533" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,643,012</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The accompanying notes are an integral part of the consolidated financial
statements.</p>


<!-- Field: Page; Sequence: 181 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C0504D"><span id="fp_005"></span><b>Afya Limited</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Consolidated statements of cash flows</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For the years ended December 31, 2023, 2022 and 2021</p>

<p style="border-bottom: Black 0.5pt solid; font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><i>(In thousands of Brazilian reais)</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" id="xdx_30B_112_pn3n3_zFQ91Z10EPsf" summary="xdx: Statement - Consolidated statements of cash flows" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">&#160;</td>
    <td id="xdx_49B_20230101__20231231_zzED0y05Jbrj" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td id="xdx_491_20220101__20221231_zafvekJfeUjk" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 9.5pt">&#160;</td>
    <td id="xdx_498_20210101__20211231_zKTfYRxXpl4c" style="vertical-align: top; text-align: center; line-height: 9.5pt">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Notes</b></span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2021</b></span></td></tr>
  <tr id="xdx_408_eifrs-full--CashFlowsFromUsedInOperatingActivitiesAbstract_iB">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating activities</b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncomeLossBeforeIncomeTaxes_i01N_pn3n3_di_msAFRPLzvdO_zNyVrTQi5OJ4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income before income taxes</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncomeLossBeforeIncomeTaxes" contextRef="From2023-01-01to2023-12-31" id="Fact000539" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">429,582</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncomeLossBeforeIncomeTaxes" contextRef="From2022-01-012022-12-31" id="Fact000540" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">428,433</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncomeLossBeforeIncomeTaxes" contextRef="From2021-01-012021-12-31" id="Fact000541" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">273,462</ix:nonFraction></span></td></tr>
  <tr id="xdx_404_eifrs-full--AdjustmentsForReconcileProfitLossAbstract_i01B" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Adjustments to reconcile income before income taxes</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--AdjustmentsForDepreciationAndAmortisationExpense_i02_pn3n3_maAFRPLzvdO_zQkjS5CfFTi4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; width: 59%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Depreciation and amortization</span></td>
    <td style="vertical-align: top; width: 11%; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">20</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="From2023-01-01to2023-12-31" id="Fact000547" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">289,511</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="From2022-01-012022-12-31" id="Fact000548" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">206,220</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; width: 10%; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="From2021-01-012021-12-31" id="Fact000549" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">154,220</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_ecustom--WriteoffOfPropertyAndEquipment_i02_pn3n3_maAFRPLzvdO_zxLE1fPyuiG6" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Write-off of property and equipment</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:WriteoffOfPropertyAndEquipment" contextRef="From2023-01-01to2023-12-31" id="Fact000551" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,910</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:WriteoffOfPropertyAndEquipment" contextRef="From2022-01-012022-12-31" id="Fact000552" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,697</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:WriteoffOfPropertyAndEquipment" contextRef="From2021-01-012021-12-31" id="Fact000553" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,604</ix:nonFraction></span></td></tr>
  <tr id="xdx_406_ecustom--WriteoffOfIntangibleAssets_i02_pn3n3_maAFRPLzvdO_zKujzoC25wh7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Write-off of intangible assets</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-01to2023-12-31" id="Fact000555" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">413</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2022-01-012022-12-31" id="Fact000556" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2021-01-012021-12-31" id="Fact000557" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,374</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_ecustom--AllowanceForDoubtfulAccountsOfOpeartingActivities_i02_pn3n3_maAFRPLzvdO_zCdkxt3NZFS6" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Allowance for expected credit losses </span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AllowanceForDoubtfulAccountsOfOpeartingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000559" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,552</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AllowanceForDoubtfulAccountsOfOpeartingActivities" contextRef="From2022-01-012022-12-31" id="Fact000560" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,708</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AllowanceForDoubtfulAccountsOfOpeartingActivities" contextRef="From2021-01-012021-12-31" id="Fact000561" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">47,819</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_eifrs-full--AdjustmentsForSharebasedPayments_i02_pn3n3_maAFRPLzvdO_zRBmhtrK8ZIf" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share-based compensation expense</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">20</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From2023-01-01to2023-12-31" id="Fact000563" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,535</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From2022-01-012022-12-31" id="Fact000564" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,274</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From2021-01-012021-12-31" id="Fact000565" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,377</ix:nonFraction></span></td></tr>
  <tr id="xdx_401_eifrs-full--AdjustmentsForUnrealisedForeignExchangeLossesGains_i02_pn3n3_maAFRPLzvdO_z8ilQnF0zpH1" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Net foreign exchange differences</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" contextRef="From2023-01-01to2023-12-31" id="Fact000567" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">681</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" contextRef="From2022-01-012022-12-31" id="Fact000568" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">852</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" contextRef="From2021-01-012021-12-31" id="Fact000569" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,973</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_ecustom--AccruedInterestOfOpeartingActivities_i02_pn3n3_maAFRPLzvdO_zHWE0UEPoP91" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accrued interest </span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AccruedInterestOfOpeartingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000571" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">285,447</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AccruedInterestOfOpeartingActivities" contextRef="From2022-01-012022-12-31" id="Fact000572" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">200,081</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AccruedInterestOfOpeartingActivities" contextRef="From2021-01-012021-12-31" id="Fact000573" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,437</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--InterestExpenseOnLeaseLiabilities_i02_pn3n3_maAFRPLzvdO_z8DfjOWASpY2" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accrued lease interest</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13.2.2, 13.5, 21</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2023-01-01to2023-12-31" id="Fact000575" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,849</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2022-01-012022-12-31" id="Fact000576" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">88,571</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2021-01-012021-12-31" id="Fact000577" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,212</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_ecustom--ShareOfIncomeOfAssociateOfOpeartingActivities_i02N_pn3n3_di_msAFRPLzvdO_zWHvFclMeHyc" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share of income of associate</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:ShareOfIncomeOfAssociateOfOpeartingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000579" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,495</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:ShareOfIncomeOfAssociateOfOpeartingActivities" contextRef="From2022-01-012022-12-31" id="Fact000580" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,184</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:ShareOfIncomeOfAssociateOfOpeartingActivities" contextRef="From2021-01-012021-12-31" id="Fact000581" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,797</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--AdjustmentsForProvisions_i02_pn3n3_maAFRPLzvdO_zTGTyGxBEBtg" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Provision (reversal) for legal proceedings</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForProvisions" contextRef="From2023-01-01to2023-12-31" id="Fact000583" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">56,825</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForProvisions" contextRef="From2022-01-012022-12-31" id="Fact000584" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">766</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForProvisions" contextRef="From2021-01-012021-12-31" id="Fact000585" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,664</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--IncreaseDecreaseInOperatingLiabilities1Abstract_i02B_zGTb8WJe47Lh" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Changes in assets and liabilities</b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_i03_pn3n3_maAFRPLzvdO_zaT6m7lc37kd" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade receivables</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="From2023-01-01to2023-12-31" id="Fact000591" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">131,336</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="From2022-01-012022-12-31" id="Fact000592" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">129,165</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="From2021-01-012021-12-31" id="Fact000593" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">79,665</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--AdjustmentsForDecreaseIncreaseInInventories_i03_pn3n3_maAFRPLzvdO_ztcSTfFkr29e" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inventories</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From2023-01-01to2023-12-31" id="Fact000595" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,947</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From2022-01-012022-12-31" id="Fact000596" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">363</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From2021-01-012021-12-31" id="Fact000597" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,720</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40D_ecustom--IncreaseDecreaseInRecoverableTaxes_i03N_pn3n3_di_msAFRPLzvdO_zW0gLKyGZ56d" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Recoverable taxes</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:IncreaseDecreaseInRecoverableTaxes" contextRef="From2023-01-01to2023-12-31" id="Fact000599" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,353</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:IncreaseDecreaseInRecoverableTaxes" contextRef="From2022-01-012022-12-31" id="Fact000600" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,230</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:IncreaseDecreaseInRecoverableTaxes" contextRef="From2021-01-012021-12-31" id="Fact000601" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,327</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_407_eifrs-full--AdjustmentsForDecreaseIncreaseInOtherAssets_i03_pn3n3_maAFRPLzvdO_zuYrhKc11F1l" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other assets</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" contextRef="From2023-01-01to2023-12-31" id="Fact000603" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,480</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" contextRef="From2022-01-012022-12-31" id="Fact000604" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,048</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" contextRef="From2021-01-012021-12-31" id="Fact000605" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">19,425</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_409_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_i03_pn3n3_maAFRPLzvdO_zha1SEFwfiPf" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade payables</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2023-01-01to2023-12-31" id="Fact000607" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,500</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2022-01-012022-12-31" id="Fact000608" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,975</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2021-01-012021-12-31" id="Fact000609" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,479</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_eifrs-full--AdjustmentsForIncomeTaxExpense_i03_pn3n3_maAFRPLzvdO_z5tVhMxJXNtf" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Taxes payable</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncomeTaxExpense" contextRef="From2023-01-01to2023-12-31" id="Fact000611" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,278</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncomeTaxExpense" contextRef="From2022-01-012022-12-31" id="Fact000612" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,915</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncomeTaxExpense" contextRef="From2021-01-012021-12-31" id="Fact000613" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,902</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_406_eifrs-full--AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_i03_pn3n3_maAFRPLzvdO_zDqLpqaNJeN1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Advances from customers</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" contextRef="From2023-01-01to2023-12-31" id="Fact000615" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,892</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" contextRef="From2022-01-012022-12-31" id="Fact000616" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,387</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" contextRef="From2021-01-012021-12-31" id="Fact000617" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,009</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_eifrs-full--OtherAdjustmentsForNoncashItems_i03_pn3n3_maAFRPLzvdO_zV4mUmOXInAk" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Labor and social obligations</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:OtherAdjustmentsForNoncashItems" contextRef="From2023-01-01to2023-12-31" id="Fact000619" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,525</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:OtherAdjustmentsForNoncashItems" contextRef="From2022-01-012022-12-31" id="Fact000620" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,247</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:OtherAdjustmentsForNoncashItems" contextRef="From2021-01-012021-12-31" id="Fact000621" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,449</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--AdjustmentsForIncreaseDecreaseInOtherLiabilities_i03_pn3n3_maAFRPLzvdO_zXndRJ1jJGti" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other liabilities</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities" contextRef="From2023-01-01to2023-12-31" id="Fact000623" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">42,542</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities" contextRef="From2022-01-012022-12-31" id="Fact000624" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,811</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities" contextRef="From2021-01-012021-12-31" id="Fact000625" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,693</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_404_eifrs-full--AdjustmentsForReconcileProfitLoss_i03T_pn3n3_mtAFRPLzvdO_maCFFUIzbWe_zJtKfIAiLKek" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><b style="display: none">Total</b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="From2023-01-01to2023-12-31" id="Fact000627" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,088,767</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="From2022-01-012022-12-31" id="Fact000628" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">876,988</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="From2021-01-012021-12-31" id="Fact000629" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">666,550</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40B_eifrs-full--IncomeTaxesPaidRefundClassifiedAsOperatingActivities_i02N_pn3n3_di_msCFFUIzbWe_zteuetUymmH7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income taxes paid</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000631" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45,144</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From2022-01-012022-12-31" id="Fact000632" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,089</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From2021-01-012021-12-31" id="Fact000633" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,683</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_407_eifrs-full--CashFlowsFromUsedInOperatingActivities_iT_pn3n3_mtCFFUIzbWe_maIDICAzKQW_zvJgIjupnt0c" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net cash flows from operating activities</b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000635" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,043,623</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2022-01-012022-12-31" id="Fact000636" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">843,899</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2021-01-012021-12-31" id="Fact000637" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">630,867</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--CashFlowsFromUsedInInvestingActivitiesAbstract_iB" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Investing activities</b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_i01N_pn3n3_di_msCFFUIzK4L_zVcHGhSAcWK6" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Acquisition of property and equipment</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000643" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">118,435</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From2022-01-012022-12-31" id="Fact000644" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">168,132</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From2021-01-012021-12-31" id="Fact000645" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">125,869</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_404_ecustom--PurchaseOfIntangibleAssetClassifiedAsInvestingActivities_i01N_pn3n3_di_msCFFUIzK4L_zBUNVPvfJN07" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Acquisition of intangibles assets</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000647" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">126,993</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" contextRef="From2022-01-012022-12-31" id="Fact000648" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,892</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" contextRef="From2021-01-012021-12-31" id="Fact000649" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">150,931</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40F_eifrs-full--DividendsReceived_i01_pn3n3_maCFFUIzK4L_zJ6v30d2QgG" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends received</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2023-01-01to2023-12-31" id="Fact000651" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,900</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2022-01-012022-12-31" id="Fact000652" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,754</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2021-01-012021-12-31" id="Fact000653" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,770</ix:nonFraction></span></td></tr>
  <tr id="xdx_407_ecustom--PurchaseOfAcquisitionOfNoncontrollingInterests_i01N_pn3n3_di_msCFFUIzK4L_zDqsc34NYRBc" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Acquisition of non-controlling interest</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2.2</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:PurchaseOfAcquisitionOfNoncontrollingInterests" contextRef="From2023-01-01to2023-12-31" id="Fact000655" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,000</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0656">-</span></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0657">-</span></span></td></tr>
  <tr id="xdx_40A_eifrs-full--PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_i01N_pn3n3_di_msCFFUIzK4L_zyy37Z63a6v" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Acquisition of subsidiaries, net of cash acquired</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000659" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">815,005</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" contextRef="From2022-01-012022-12-31" id="Fact000660" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">277,649</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" contextRef="From2021-01-012021-12-31" id="Fact000661" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,005,017</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_404_ecustom--PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles_i01N_pn3n3_di_msCFFUIzK4L_zKHWZi94WtV9" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Payments of interest from acquisition of subsidiaries and intangibles</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" contextRef="From2023-01-01to2023-12-31" id="Fact000663" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,518</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" contextRef="From2022-01-012022-12-31" id="Fact000664" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,550</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" contextRef="From2021-01-012021-12-31" id="Fact000665" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,108</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_408_ecustom--RestrictedCashOfInvestingActivities_i01_pn3n3_maCFFUIzK4L_zi0URL1cSGa8" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Restricted cash</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0667">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0668">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:RestrictedCashOfInvestingActivities" contextRef="From2021-01-012021-12-31" id="Fact000669" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,103</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_eifrs-full--CashFlowsFromUsedInInvestingActivities_i01T_pn3n3_mtCFFUIzK4L_maIDICAzKQW_z7XpCnfYuUEa" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net cash flows used in investing activities</b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000671" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,143,051</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="From2022-01-012022-12-31" id="Fact000672" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">591,469</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="From2021-01-012021-12-31" id="Fact000673" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,274,052</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 2.8pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--CashFlowsFromUsedInFinancingActivitiesAbstract_iB" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Financing activities</b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 2.8pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_i01N_pn3n3_di_msCFFUIzvKL_z5iHRy9kCnB2" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Payments of principal of loans and financing</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13.5</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000679" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">112,630</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact000680" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,791</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="From2021-01-012021-12-31" id="Fact000681" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">107,766</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_406_ecustom--RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities_i01N_pn3n3_di_msCFFUIzvKL_zISKRfOvKheb" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Payments of interest of loans and financing</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13.5</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000683" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">175,889</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact000684" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">116,587</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" contextRef="From2021-01-012021-12-31" id="Fact000685" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,310</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--ProceedsFromBorrowingsClassifiedAsFinancingActivities_i01_pn3n3_maCFFUIzvKL_zvnkGqcaMERa" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Proceeds from loans and financing</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13.5</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000687" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,288</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact000688" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">496,885</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" contextRef="From2021-01-012021-12-31" id="Fact000689" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">809,539</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_i01N_pn3n3_di_msCFFUIzvKL_zbk6k2CABZw2" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Payments of lease liabilities</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13.2.2, 13.5</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000691" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,473</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact000692" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,511</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2021-01-012021-12-31" id="Fact000693" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,075</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_407_ecustom--PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities_i01N_pn3n3_di_msCFFUIzvKL_zVBeegtxgY7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Payments of interest of lease liabilities</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13.2.2, 13.5</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000695" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">103,911</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact000696" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">85,001</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2021-01-012021-12-31" id="Fact000697" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,676</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_400_ecustom--TreasuryShares1_i01_maCFFUIzvKL_z0CWpX7Yylng" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Treasury shares buy back</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">17.c</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2023-01-01to2023-12-31" id="Fact000699" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,369</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2022-01-012022-12-31" id="Fact000700" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">152,317</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31" id="Fact000701" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">213,722</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40C_eifrs-full--ProceedsFromExerciseOfOptions_i01_maCFFUIzvKL_zzbA7cf2yxpf" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Proceeds from exercise of stock options</span></td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="From2023-01-01to2023-12-31" id="Fact000703" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,791</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0704">-</span></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="From2021-01-012021-12-31" id="Fact000705" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,336</ix:nonFraction></span></td></tr>
  <tr id="xdx_404_eifrs-full--DividendsPaidClassifiedAsFinancingActivities_i01N_di_msCFFUIzvKL_zZUYK6g8wLNf" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends paid to non-controlling shareholders</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13.5, 17</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000707" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,750</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact000708" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,736</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From2021-01-012021-12-31" id="Fact000709" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,648</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--CashFlowsFromUsedInFinancingActivities_i01T_mtCFFUIzvKL_maIDICAzKQW_zeoMauZyeTzd" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net cash flows generated (used) in financing activities</b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact000711" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">439,943</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact000712" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">92,942</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="From2021-01-012021-12-31" id="Fact000713" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">364,678</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40E_eifrs-full--EffectOfExchangeRateChangesOnCashAndCashEquivalents_i01_maIDICAzKQW_zfuQF4icK5T" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Net foreign exchange differences</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From2023-01-01to2023-12-31" id="Fact000715" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">681</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From2022-01-012022-12-31" id="Fact000716" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">852</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From2021-01-012021-12-31" id="Fact000717" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,973</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_400_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_iT_mtIDICAzKQW_z73QvxMfwj6d" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net increase (decrease) in cash and cash equivalents</b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2023-01-01to2023-12-31" id="Fact000719" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">540,052</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2022-01-012022-12-31" id="Fact000720" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">344,520</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2021-01-012021-12-31" id="Fact000721" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">296,480</ix:nonFraction>)</b></span></td></tr>
  <tr id="xdx_40B_eifrs-full--RestrictedCashAndCashEquivalents_iS_zA5vVTPC8Rvj" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash and cash equivalents at the beginning of the year</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2022-12-31" id="Fact000723" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,093,082</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2021-12-31" id="Fact000724" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">748,562</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2020-12-31" id="Fact000725" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,045,042</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_eifrs-full--RestrictedCashAndCashEquivalents_iE_zpmbXFcsy1Nj" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash and cash equivalents at the end of the year</span></td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2023-12-31" id="Fact000727" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">553,030</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2022-12-31" id="Fact000728" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,093,082</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2021-12-31" id="Fact000729" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">748,562</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The accompanying notes are an integral part of the consolidated financial
statements.</p>


<!-- Field: Page; Sequence: 182; Options: NewSection; Value: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000731" name="ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory"><p id="xdx_801_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_z8WrEoWNcR0j" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><span id="fp_006"></span>1</td><td><span id="xdx_820_zqi6LYe3Ozy1">Corporate information</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-right: 0; margin-left: 0">Afya Limited (&#8220;Afya&#8221;),
collectively with its subsidiaries referred to as the &#8220;Company&#8221;, is a holding company incorporated under the laws of the Cayman
Islands on March 22, 2019. The Company completed its initial public offering (IPO) on July 19, 2019, and its shares are listed on the
Nasdaq under the symbol &#8220;AFYA&#8221;. The Company&#8217;s ultimate parent company is Bertelsmann SE&amp; Co. KGaA (&#8220;Bertelsmann&#8221;),
as a result of Bertelsmann&#8217;s acquisition of control on May 5, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company is formed by a network of higher education and post-graduate
institutions focused on medical schools located in 19 Brazilian States forming the largest educational group by the number of medical
seats in the country. In non-regulated education, Afya provides services that comprise the development and sale of electronically distributed
educational courses on medicine science, related printed and soft skills educational content. The Company also offers solutions to empower
the physicians in their daily routine including supporting clinic decisions through mobile app subscription, delivering practice management
tools through a SaaS (&#8220;Software as a Service&#8221;) model and supporting the patient-physician relationship.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">During the year ended December 31, 2022, the Ministry
of Education (&#8220;MEC&#8221;) authorized the operations of 200 seats of medical schools, under the Mais M&#233;dicos II program across
four medical schools. Each medical school will contribute with 50 seats. In March 2022, MEC authorized the increase of 28 seats of Centro
Universit&#225;rio S&#227;o Lucas, located in the city of Ji-Parana, State of Rond&#244;nia and 64 medical seats of Faculdade Santo
Agostinho, located in the city of Itabuna, State of Bahia. These operations of such medical schools and additional seats started between
the second semester of 2022 and first semester of 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">In November 2021, MEC authorized the operation of 120 medical school seats
in Garanhuns, in the city of Garanhuns, State of Pernambuco. These operations of the medical school started in the second semester of
2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="text-decoration: underline">Bertelsmann increases stake in Afya</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On May 5, 2022, Afya was notified of the closing of the transaction where
Bertelsmann SE&amp; Co. KGaA, or &#8220;Bertelsmann&#8221; acquired <span id="xdx_904_ecustom--AcquiredShares_pip0_c20220504__20220505__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z9fRcbP4TgP5" title="Acquired shares"><ix:nonFraction name="afya:AcquiredShares" contextRef="From2022-05-042022-05-05_custom_BertelsmannMember_ifrs-full_OrdinarySharesMember" id="Fact000733" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">6,000,000</ix:nonFraction></span> Class B common shares of Afya at the purchase price of US$26.90
per share, from Nicolau Carvalho Esteves, Ros&#226;ngela de Oliveira Tavares Esteves and NRE Capital Ventures Ltd (together with Nicolau
Carvalho Esteves and Ros&#226;ngela de Oliveira Tavares Esteves, the &#8220;Esteves Family&#8221;). As result of the closing of the transaction,
Bertelsmann and the Esteves family will beneficially own ~<span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pip0_dp_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember_zyAvSgUPOknf" title="Own percentage"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="From2023-01-012023-12-31_custom_BertelsmannMember" id="Fact000735" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">57.5</ix:nonFraction></span>% and ~<span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pip0_dp_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember_zJIYVz0I4j1g" title="Own percentage"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="From2022-01-012022-12-31_custom_BertelsmannMember" id="Fact000737" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">33.0</ix:nonFraction></span>% voting interest, and ~<span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember_zjAUGW38VYB3" title="Voting interest"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2023-12-31_custom_BertelsmannMember" id="Fact000739" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">31.0</ix:nonFraction></span>% and ~<span id="xdx_909_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember_z4Xtn55IxDa8" title="Voting interest"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2022-12-31_custom_BertelsmannMember" id="Fact000741" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18.0</ix:nonFraction></span>% of the total shares,
respectively, in Afya. The transaction had no effect on Afya&#8217;s consolidated financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="text-decoration: underline">Acquisitions</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span>On January 2, 2023, Afya Participa&#231;&#245;es
S.A. (hereafter referred to as </span>&#8220;<span>Afya Brazil&#8221;), a wholly owned subsidiary of the
Company, acquired </span>Sociedade Educacional e Cultural Sergipe DelRey Ltda<span>. (&#8220;DelRey&#8221;).
DelRey is a post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate
programs in medicine and health, as well as other courses, and </span>encompasses the operations of Centro Universit&#225;rio Tiradentes
Alagoas (&#8220;UNIMA&#8221;) and Faculdade Tiradentes Jaboat&#227;o dos Guararapes (&#8220;FCM Jaboat&#227;o&#8221;)<span>.
See Note 5.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="background-color: white">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span>During the
year ended December 31, 2022, Afya Brazil entered into business combinations transactions for the acquisition of three entities under
the Digital segment. The aggregate consideration transferred was R$ <span id="xdx_90B_eifrs-full--ConsiderationPaidReceived_pn3n3_c20220101__20221231_zFIrnyg4i0A4" title="Aggregate consideration"><ix:nonFraction name="ifrs-full:ConsiderationPaidReceived" contextRef="From2022-01-012022-12-31" id="Fact000743" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99,399</ix:nonFraction></span>, of which R$ <span id="xdx_90E_eifrs-full--ConsiderationPaidReceived_pn3n3_c20220101__20221231__dei--LegalEntityAxis__ifrs-full--SubsidiariesMember_zYlDmSFd9PJ7" title="Aggregate consideration"><ix:nonFraction name="ifrs-full:ConsiderationPaidReceived" contextRef="From2022-01-012022-12-31_ifrs-full_SubsidiariesMember" id="Fact000745" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,381</ix:nonFraction></span> represents the cash paid net of cash acquired
with the subsidiaries (included in cash flows from investing activities) for such business combinations.</span></p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span style="background-color: white"></span></p>


<ix:exclude><!-- Field: Page; Sequence: 183 -->
    <div id="xdx_233_zrd3W7t6XJlh" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_231_zYqQ30uX473d" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span>During the year ended December 31,
2021, Afya Brazil entered into business combinations transactions for the acquisition of two entities under the Undergrad segment and
four entities under the Digital segment. The aggregate consideration transferred was R$ <span id="xdx_901_eifrs-full--ConsiderationPaidReceived_pn3n3_c20210101__20211231_zgUIoDnO0Aof" title="Aggregate consideration"><ix:nonFraction name="ifrs-full:ConsiderationPaidReceived" contextRef="From2021-01-012021-12-31" id="Fact000747" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,234,460</ix:nonFraction></span>, of which R$ <span id="xdx_906_eifrs-full--ConsiderationPaidReceived_pn3n3_c20210101__20211231__dei--LegalEntityAxis__ifrs-full--SubsidiariesMember_zmv6Vi9Spxwf" title="Aggregate consideration"><ix:nonFraction name="ifrs-full:ConsiderationPaidReceived" contextRef="From2021-01-012021-12-31_ifrs-full_SubsidiariesMember" id="Fact000749" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">842,197</ix:nonFraction></span> represents the
cash paid net of cash acquired with the subsidiaries (included in cash flows from investing activities).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="text-decoration: underline">Conflicts worldwide</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">During 2022 and 2023, international conflicts with potential large scale
occurred, including Russia and Ukraine and Israel and Hamas. Those conflicts trigger a number of IFRS accounting considerations affecting
the financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company&#8217;s operations are focused in Brazil and was not directly
impacted by such conflicts. However, the continuous development of such conflicts may impact entities other than those with direct interests
in the involved countries, for instance, as a result of exposure to fluctuations in commodity prices and foreign exchange rates, which
may impact inflation, as well as the possibility of economic sanctions against such countries.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">As of the date of these consolidated financial statements, both conflicts
mentioned above have not significantly impacted Afya&#8217;s operations and results.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000751" name="afya:DisclosureOfMaterialAccountingPoliciesExplanatory"><p id="xdx_80D_ecustom--DisclosureOfMaterialAccountingPoliciesExplanatory_zSJak3PGdxqf" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in">2</td><td><span id="xdx_82A_zTtrBktcqFw4">Material accounting policies</span></td></tr></table>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">&#160;</p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">2.1 Basis for preparation of the consolidated financial
statements</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company&#8217;s consolidated financial statements have been prepared
in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB)
and considers the assumption that the Company will continue in operation for the foreseeable future.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The consolidated financial statements have been prepared on a historical
cost basis, except for contingent consideration (earn-outs) that have been measured at fair value.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Afya Limited is a holding company, as such the primary source of revenue
derives from its interest on the operational companies in Brazil. As result, the Brazilian Real has been determined as the Company&#8217;s
functional currency.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The consolidated financial statements are presented in Brazilian reais (&#8220;BRL&#8221;
or &#8220;R$&#8221;), which is the Company&#8217;s functional and presentation currency. All amounts are rounded to the nearest thousand.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The Company segregated the payments of principal
and interest of loans and financing, lease liabilities, notes payable and accounts payables to selling shareholders in the consolidated
statements of cash flows for the year ended December 31, 2023, in accordance with the provisions set forth in IAS 7 &#8211; Statement
of Cash Flows. As a result, Management revised, retrospectively, the prior periods consolidated statements of cash flows for the years
ended December 31, 2022 and 2021, for comparative purposes. The Company assessed the materiality of this matter and, based on an analysis
of quantitative and qualitative considerations, determined that the segregation of payments of principal and interest on prior periods
over such transactions is not material to its consolidated financial statements. However, even if it is not material, the segregation
of payments of principal and interest regarding such transactions for the years ended December 31, 2022 and 2021 are appropriate for
the users of the consolidated financial statements, considering the comparability of such information over the years presented. The payments
of interest of loans and financing, lease liabilities, notes payable and accounts payables to selling shareholders are classified within
the consolidated statements of cash flows under the same activities of which the payments of principal are classified. As a result, no
change occurred in the net cash flows used in investing activities and net cash flows generated (used) in financing activities in the
consolidated statements of cash flows for the years ended December 31, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">These consolidated financial statements as of and
for the year ended December 31, 2023 were approved by the Board of Directors for issuance on March 14, 2024.<br/>
</p>


<ix:exclude><!-- Field: Page; Sequence: 184 -->
    <div id="xdx_23E_zVMsb6j8HDHd" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_238_zpVApmrsT3I4" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>2.2 Basis consolidation</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The table below is a list of the Company&#8217;s subsidiaries and associate:</p>

<p style="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000753" name="afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89A_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zOClrtiiWnDb" summary="xdx: Disclosure - Material accounting policies (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B7_zcTUTkK5xnpc" style="display: none">Schedule of Company&#8217;s subsidiaries and associate</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Direct and indirect interest</b></span></td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; width: 36%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Name</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 23%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Main activities</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Location</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Investment type</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>December 31, 2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>December 31, 2022</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Afya Participa&#231;&#245;es S.A. (&#8220;Afya Brazil&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zalwy9CGxxW1" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AfyaParticipacoesSAMember" id="Fact000755" name="afya:PrincipalActivities">Holding</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z1RptsvM2mMk" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AfyaParticipacoesSAMember" id="Fact000757" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Nova Lima - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zrpmZKKEiJsd" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AfyaParticipacoesSAMember" id="Fact000759" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z5CjixoKcEja" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_AfyaParticipacoesSAMember" id="Fact000761" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zXyR3NNOcrQ4" title="Direct and indirect interest of subsidiary"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zv9VS7TatyJd" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_AfyaParticipacoesSAMember" id="Fact000763" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_AfyaParticipacoesSAMember" id="Fact000765" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></ix:nonFraction></span></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto Tocantinense Presidente Ant&#244;nio Carlos Porto S.A. - (&#8220;ITPAC Porto&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zH1Ln5sRdeol" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" id="Fact000767" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zwF6v291aIDb" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" id="Fact000769" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Porto Nacional - TO</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zoUGV6PYurG8" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" id="Fact000771" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zB1OKm3apal5" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" id="Fact000773" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zrSl5jEFEnm8" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" id="Fact000775" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto Tocantinense Presidente Ant&#244;nio Carlos S.A. - (&#8220;ITPAC Aragua&#237;na&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zGzEFgreoAt6" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" id="Fact000777" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_z11eSmIJKfBi" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" id="Fact000779" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Aragua&#237;na - TO</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zYznHUPdaUMi" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" id="Fact000781" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zdBbdHbYg3Vk" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" id="Fact000783" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zFZWmVBs9oEh" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" id="Fact000785" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Uni&#227;o Educacional do Vale do A&#231;o S.A. - (&#8220;UNIVA&#199;O&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zgWRd2JlcEhk" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" id="Fact000787" name="afya:PrincipalActivities">Medicine undergraduate degree program</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zPgTSpa6ctni" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" id="Fact000789" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Ipatinga - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zCMh7K0hmkh7" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" id="Fact000791" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z0Z1JBdEy9Hg" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" id="Fact000793" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z2XOJzLnvsv1" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" id="Fact000795" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#8220;IPTAN&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zSbG3bJ6WCT5" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" id="Fact000797" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zYs5VwOf1rs8" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" id="Fact000799" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o Jo&#227;o Del Rei - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zLGxbgGFRCG8" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" id="Fact000801" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zycMe0FDSUxl" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" id="Fact000803" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zQZQwj3pfEwk" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" id="Fact000805" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A. (&#8220;IESVAP&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zHwpFCvWTRWg" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" id="Fact000807" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zmc5S9CWO1hb" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" id="Fact000809" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Parna&#237;ba - PI</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zoUNMxDFdDv1" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" id="Fact000811" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zykEQvDEg8k8" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" id="Fact000813" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_z4qvPwneKpTb" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" id="Fact000815" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Centro de Ci&#234;ncias em Sa&#250;de de Itajub&#225; S.A. (&#8220;CCSI&#8221;) (vi)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z8zjHa6BIeV6" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" id="Fact000817" name="afya:PrincipalActivities">Medicine undergraduate degree program</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zdPwPLBL5Om4" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" id="Fact000819" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Itajub&#225; - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z40USpEPBNzg" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" id="Fact000821" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zQmOpVIxyxr" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" id="Fact000823" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zIrK3aOB0ueb" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" id="Fact000825" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto de Ensino Superior do Piau&#237; S.A. (&#8220;IESP&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zWQzPmy7n1Ff" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" id="Fact000827" name="afya:PrincipalActivities">Undergraduate and graduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_za6I0FudD4Hk" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" id="Fact000829" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Teresina - PI</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_znvFnrd2wAR4" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" id="Fact000831" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_z38eqmX67Z3l" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" id="Fact000833" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zRcqMXWCruCa" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" id="Fact000835" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Centro Integrado de Sa&#250;de de Teresina (&#8220;CIS&#8221;) (v)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zSnBVWW5NM2a" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember" id="Fact000837" name="afya:PrincipalActivities">Outpatient care</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zaXqNKFgDxR" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember" id="Fact000839" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Teresina - PI</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zdFi64odxsi7" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember" id="Fact000841" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_z8MiPemDdctg" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember" id="Fact000843" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">FADEP - Faculdade Educacional de Pato Branco Ltda. (&#8220;FADEP&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zdJiDucq4gx8" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" id="Fact000845" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zKnEUEBh4UXf" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" id="Fact000847" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Pato Branco - PR</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zL3TPqtol0Hc" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" id="Fact000849" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zuJUXviDKN55" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" id="Fact000851" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zK5N5l65p6td" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" id="Fact000853" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Medcel Editora e Eventos S.A. (&#8220;Medcel&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zOYAsenPo6M8" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_MedcelEditoraEventosS.A.MedcelMember" id="Fact000855" name="afya:PrincipalActivities">Medical education content</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_z8IqdtmzImEj" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_MedcelEditoraEventosS.A.MedcelMember" id="Fact000857" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o Paulo - SP</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zZ3VzZhSfMEb" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_MedcelEditoraEventosS.A.MedcelMember" id="Fact000859" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zbxIRxfn1QZb" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_MedcelEditoraEventosS.A.MedcelMember" id="Fact000861" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_z5abhnmUIGai" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_MedcelEditoraEventosS.A.MedcelMember" id="Fact000863" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto Educacional Santo Agostinho S.A. (&#8220;FASA&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_z3CNx3A8HgYa" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" id="Fact000865" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zMddJ12yLnac" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" id="Fact000867" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Montes Claros - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zcG6gvWygcLe" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" id="Fact000869" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zHzTjkrPxdYl" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" id="Fact000871" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zrzeDyWOonPe" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" id="Fact000873" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">ESMC Educa&#231;&#227;o Superior Ltda. (&#8220;ESMC&#8221;) (iii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zYckGhqslUua" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember" id="Fact000875" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zyWCdAa85Bhd" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember" id="Fact000877" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Montes Claros - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_z5BGUTEEMtyl" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember" id="Fact000879" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zHh5b58t4B32" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember" id="Fact000881" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto de Pesquisa e Ensino M&#233;dico do Estado de Minas Gerais Ltda. (&#8220;IPEMED&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_ztZbZLKvSEe5" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" id="Fact000883" name="afya:PrincipalActivities">Graduate</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zjcYM0e8Fgtk" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" id="Fact000885" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Belo Horizonte - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zXl2ZbkjAJO" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" id="Fact000887" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_z0Wxdk02ZiVe" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" id="Fact000889" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zkwIlA8E2VDh" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" id="Fact000891" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto Paraense de Educa&#231;&#227;o e Cultura Ltda. (&#8220;IPEC&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_ztm4EYaPUOTc" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" id="Fact000893" name="afya:PrincipalActivities">Medicine degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zMUQ5LY4iHEh" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" id="Fact000895" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Marab&#225; - PA</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_ziftmOqfGtl5" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" id="Fact000897" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zxQognVwrJUf" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" id="Fact000899" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zCzYBJmQOj9b" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" id="Fact000901" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Sociedade Universit&#225;ria Redentor S.A. (&#8220;UniRedentor&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z1PnvuFrbxW4" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember" id="Fact000903" name="afya:PrincipalActivities">Undergraduate and graduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zNkch2awVkZ8" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember" id="Fact000905" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Itaperuna - RJ</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zQGcr5wQuMWf" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember" id="Fact000907" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zRe0lOTWDiYh" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember" id="Fact000909" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zYIOhEv10Nfh" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember" id="Fact000911" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Centro de Ensino S&#227;o Lucas Ltda. (&#8220;UniSL&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zuBWx7tdWpQ6" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember" id="Fact000913" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_z3opKGOaCFXh" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember" id="Fact000915" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Porto Velho - RO</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zwFO7NNBiXzh" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember" id="Fact000917" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zc8YlpZTM9J5" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember" id="Fact000919" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zQz09AuUBlhi" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember" id="Fact000921" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Peb Med Institui&#231;&#227;o de Pesquisa M&#233;dica e Servi&#231;os Ltda. (&#8220;PebMed&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zwGFvmIXDyef" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" id="Fact000923" name="afya:PrincipalActivities">Content and clinical tools and online platform</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zM5A2jZsx6Aj" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" id="Fact000925" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Rio de Janeiro - RJ</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zlkaSuMeMzIg" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" id="Fact000927" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zWvNQFwIR4rd" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" id="Fact000929" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zl0z015dT019" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" id="Fact000931" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Sociedade de Educa&#231;&#227;o, Cultura e Tecnologia da Amaz&#244;nia S.A. - (&#8220;FESAR&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zhvG7Pp3hpca" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" id="Fact000933" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zyqWTj49rf01" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" id="Fact000935" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Reden&#231;&#227;o - PA</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zTqDWnFqMr9d" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" id="Fact000937" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zpVj7zYLaL92" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" id="Fact000939" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zxS06FOXcYy8" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" id="Fact000941" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Centro Superior de Ci&#234;ncias da Sa&#250;de S/S Ltda. (&#8220;FCMPB&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zxhl3lsinqO2" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" id="Fact000943" name="afya:PrincipalActivities">Medicine degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_ziVT5yMMuZId" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" id="Fact000945" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Jo&#227;o Pessoa - PB</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zheIgQ0Dh8U9" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" id="Fact000947" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zfmHirGKCZNd" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" id="Fact000949" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zuhISMhBKnS8" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" id="Fact000951" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">iClinic Desenvolvimento de Software Ltda. (&#8220;iClinic&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zzGrJmynyihb" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" id="Fact000953" name="afya:PrincipalActivities">Electronic Medical Record, Clinical Management System</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zkcxMakLVvWa" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" id="Fact000955" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Ribeir&#227;o Preto - SP</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zsUxdBU8E9i2" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" id="Fact000957" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zLb3w41wSBWh" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" id="Fact000959" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zx6WPAE9Qkjl" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" id="Fact000961" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Medicinae Solutions S.A. (&#8220;Medicinae&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z4DTs95RBlw3" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember" id="Fact000963" name="afya:PrincipalActivities">Healthcare payments and financial services</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zb5c1OY9Rbsd" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember" id="Fact000965" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Rio de Janeiro - RJ</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zFoDbLSmb2B6" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember" id="Fact000967" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zXqWbgktuVw5" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember" id="Fact000969" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z6KZl2oqbbP1" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember" id="Fact000971" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Medical Harbour Aparelhos M&#233;dico Hospitalares e Servi&#231;os em Tecnologia Ltda. (&#8220;Medical Harbour&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zZhaYklSCn2" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" id="Fact000973" name="afya:PrincipalActivities">Educational health and medical imaging</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zpa5PemScH7b" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" id="Fact000975" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Florian&#243;polis - SC</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zBjdZFmGiZEd" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" id="Fact000977" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zeFv4DEjEF3b" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" id="Fact000979" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zYA3VDldq1e3" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" id="Fact000981" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Cliquefarma Drogarias Online Ltda. (&#8220;Cliquefarma&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zvLiXQTf8LMh" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" id="Fact000983" name="afya:PrincipalActivities">Online platform</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zFusXC5ny7Kc" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" id="Fact000985" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o Paulo - SP</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zbGVANp4Wyce" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" id="Fact000987" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zl9pB8ZtT1Kk" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" id="Fact000989" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_ztbeofn3M1Bi" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" id="Fact000991" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Shosp Tecnologia da Informa&#231;&#227;o Ltda. (&#8220;Shosp&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zQ3WpInHHkl8" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember" id="Fact000993" name="afya:PrincipalActivities">Electronic Medical Record, Clinical Management System</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zVA7XuIDuRoe" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember" id="Fact000995" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Rio de Janeiro - RJ</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zgNHFinkpyvi" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember" id="Fact000997" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_z1QpxW0v4xQc" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember" id="Fact000999" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zAZiw8SIWO57" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember" id="Fact001001" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Sociedade Padr&#227;o de Educa&#231;&#227;o Superior Ltda. (&#8220;UnifipMoc&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zCVP4KK3mVB6" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" id="Fact001003" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zS8FV1BAmsq3" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" id="Fact001005" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Montes Claros - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zO0xBtbGQNik" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" id="Fact001007" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zVhbUTgSUfoi" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" id="Fact001009" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zjFwRhLh9Sml" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" id="Fact001011" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">N&#250;cleo de Aten&#231;&#227;o &#224; Sa&#250;de e de Pr&#225;ticas Profissionalizantes (&#8220;NASPP) (iv)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zvgSfVHkAPV8" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember" id="Fact001013" name="afya:PrincipalActivities">Outpatient care</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zotfy6njizG1" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember" id="Fact001015" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Montes Claros - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zxUrxG5UIAP1" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember" id="Fact001017" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zInDB4qUV6T9" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember" id="Fact001019" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Companhia Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura (&#8220;Unigranrio&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zRFOdKj3VQif" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" id="Fact001021" name="afya:PrincipalActivities">Undergraduate and graduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zqrwrvNl4p75" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" id="Fact001023" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Duque de Caxias - RJ</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zoR14pVTkY8d" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" id="Fact001025" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zEHW5VKRSVA4" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" id="Fact001027" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zIvk9bsGePvd" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" id="Fact001029" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Policl&#237;nica e Centro de Est&#233;tica Duque de Caxias Ltda. (&#8220;Policl&#237;nica&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zP3K1mwjxI3" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" id="Fact001031" name="afya:PrincipalActivities">Outpatient care</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zkV1063VGF7l" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" id="Fact001033" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Duque de Caxias - RJ</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zoHQsfI7pAAg" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" id="Fact001035" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zb3hc3cKhzP3" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" id="Fact001037" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zt053CJMdDD8" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" id="Fact001039" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt">Sociedade Educacional de Palho&#231;a S/A Ltda. (&#8220;SOCIESP&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_z9rg0MXal5Yl" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalDePalhocaSALtda.Member" id="Fact001041" name="afya:PrincipalActivities">Basic Education</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_ztDKDpmWFDIl" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalDePalhocaSALtda.Member" id="Fact001043" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Palho&#231;a - SC</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-size: 7pt"><span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_zwZW0J56ukC" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalDePalhocaSALtda.Member" id="Fact001045" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_z30vgAAgnQoc" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_SociedadeEducacionalDePalhocaSALtda.Member" id="Fact001047" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt">Instituto de Ensino Superior de Palho&#231;a S/S Ltda. (&#8220;IESP PALHO&#199;A&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt"><span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zORhaIV6bks" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember" id="Fact001049" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_z9mQI2YTVdM7" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember" id="Fact001051" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Palho&#231;a - SC</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-size: 7pt"><span id="xdx_908_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zePtyvgsKgOf" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember" id="Fact001053" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zYWb6iWvlh58" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember" id="Fact001055" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">RX PRO Solu&#231;&#245;es de Tecnologia Ltda. (&#8220;RX PRO&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zbsKqs9ZcXG1" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember" id="Fact001057" name="afya:PrincipalActivities">Marketing for pharmaceutical industry</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zgsq6dFy4YT5" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember" id="Fact001059" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o Paulo - SP</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z037R5g6cbE4" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember" id="Fact001061" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z8R6nYdjZy99" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember" id="Fact001063" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zNYzlvXy3qJg" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember" id="Fact001065" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">RX PRO LOG Transporte e Log&#237;stica Ltda. (&#8220;RX PRO LOG&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_z5twhHGud3Mc" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember" id="Fact001067" name="afya:PrincipalActivities">Marketing for pharmaceutical industry</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zGUG4PmwWgnf" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember" id="Fact001069" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o Paulo - SP</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zzS98P9svIwk" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember" id="Fact001071" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zoFtLfXjEffh" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember" id="Fact001073" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_ztZcgDeoVuTh" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember" id="Fact001075" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">BMV Atividades M&#233;dicas Ltda. (&#8220;Al&#233;m da Medicina&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zWxNA72laWWk" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember" id="Fact001077" name="afya:PrincipalActivities">Medical education content</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_znFBaUleq8vj" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember" id="Fact001079" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o Paulo - SP</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_z02DjhG0PmQc" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember" id="Fact001081" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zjWrfOlfth4f" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember" id="Fact001083" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zQly09pywIFk" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember" id="Fact001085" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Cardiopapers Solu&#231;&#245;es Digitais Ltda. (&#8220;CardioPapers&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zWa0LFTFxvhe" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember" id="Fact001087" name="afya:PrincipalActivities">Medical education content</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zIY7kQcj0aca" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember" id="Fact001089" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Recife - PE</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_z676l82ua159" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember" id="Fact001091" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zGzZJe8ufh85" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember" id="Fact001093" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zYuIkYxF7ki4" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember" id="Fact001095" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Quasar Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&#8220;Glic&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zTRc3v0p3fg2" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" id="Fact001097" name="afya:PrincipalActivities">Patient physician relationship</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zegdjERLTTKf" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" id="Fact001099" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Barueri - SP</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zmHwMNmfa6s4" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" id="Fact001101" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zZmHBrwxCsO6" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" id="Fact001103" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zt3uNVeIaDHk" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" id="Fact001105" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#8220;DelRey&#8221;) (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_znVw5RN6Zl6d" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" id="Fact001107" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_ztuAsEFtnwf4" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" id="Fact001109" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Macei&#243; - AL</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zkSsxRXrU1dk" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" id="Fact001111" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zDY9l0MpmWxe" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" id="Fact001113" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Uni&#227;o Educacional do Planalto Central S.A. (&#8220;UEPC&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zzFJjJxjPXp3" title="Principal activities"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" id="Fact001115" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zGU3ji6QI6n2" title="Location"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" id="Fact001117" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Bras&#237;lia - DF</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zC2ujciWITa5" title="Investment type"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" id="Fact001119" name="afya:InvestmentType">Associate</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zBGaKF5Qyzdd" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" id="Fact001121" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zX52vJW5Spj2" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-01-012022-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" id="Fact001123" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction></span>%</span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">See Note 5 for further details of the business combination in 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"/><td style="text-align: justify">IESP was merged by Unigranrio and SOCIESP had its operations closed down, both in January
2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"/><td style="text-align: justify"><span style="color: #212121">ESMC was merged with UnifipMoc in February 2023.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iv)</td><td style="width: 5pt"/><td style="text-align: justify">NASPP was merged with UnifipMoc in July 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(v)</td><td style="width: 5pt"/><td style="text-align: justify">CIS was merged with IESP in December 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="color: #212121">(vi)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="color: #212121">Acquisition</span> of additional interest in CCSI: On October
31, 2023, Afya Brazil acquired an additional 15% interest in CCSI, increasing its ownership interest to 75% of total shares. A cash consideration
of R$21,000 was paid to the non-controlling shareholders. The carrying value of the net assets of CCSI (excluding goodwill on the original
acquisition) was R$10,155, and the difference were recorded in retained earnings in the equity attributable to equity holders of the
parent.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A1_z1VldA3Ni6u9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 185 -->
    <div id="xdx_233_zkBKhIJjBmh2" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_239_zZvyKpN4d8ia" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">The financial information
of the acquired subsidiaries is included in the Company&#8217;s consolidated financial statements beginning on the respective acquisition
dates.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company consolidates the financial information for all entities it controls.
Control is achieved when the Company is exposed to, or has rights, to variable returns from its involvement with the investee and has
the ability to affect those returns through its power over the investee.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Consolidation of a subsidiary begins when the Company obtains control over
the subsidiary and it ceases when the Company loses control of the subsidiary. Assets, liabilities, income and expenses of a subsidiary
acquired or disposed of during the year are included in the consolidated financial statements from the date the Company gains control
until the date the Company ceases to control the subsidiary.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">When necessary, adjustments are made to the financial statements of subsidiaries
in order to bring their accounting policies in line with the Company&#8217;s accounting policies. All intra-group assets and liabilities,
equity, income, expenses and cash flows relating to transactions are eliminated in full on consolidation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">A change in the ownership interest of a subsidiary, without a change of
control, is accounted for as an equity transaction. If the Company loses control over a subsidiary, it derecognizes the related assets
(including goodwill), liabilities, non-controlling interest and other components of equity, while any resulting gain or loss is recognized
in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Non-controlling interests in the results and equity of subsidiaries are
shown separately in the consolidated statements of financial position, consolidated statements of income and comprehensive income and
consolidated statements of changes in equity.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>2.3 Summary of material accounting policies</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">This note provides a description of the material accounting policies adopted
in the preparation of these consolidated financial statements in addition to other policies that have been disclosed in other notes to
these consolidated financial statements. These policies have been consistently applied to all periods presented.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The accounting policies have been consistently applied
to all consolidated companies.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001125" name="afya:BusinessCombinationsAndGoodwillPolicyExplanatory"><p id="xdx_842_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zeqybfC7yksh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>a) <span id="xdx_866_zre99Xd2lFob">Business combinations and goodwill</span> </b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Business combinations are accounted for using the acquisition method. The
cost of an acquisition is measured as the aggregate of the consideration transferred, which is measured at acquisition date fair value,
and the amount of any non-controlling interests in the acquiree. For each business combination, the Company elects whether to measure
the non-controlling interests in the acquiree at fair value or at the proportionate share of the acquiree&#8217;s identifiable net assets.
Acquisition-related costs are expensed as incurred and included in selling, general and administrative expenses.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">When the Company acquires a business, it assesses the financial assets and
liabilities assumed for appropriate classification and designation in accordance with the contractual terms, economic circumstances and
pertinent conditions as of the acquisition date.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Goodwill is initially measured at cost (being the excess of the aggregate
of the consideration transferred and the amount recognized for non-controlling interests and any previous interest held over the net
identifiable assets acquired and liabilities assumed). If the fair value of the net assets acquired is in excess of the aggregate consideration
transferred, the Company re-assesses whether it has correctly identified all of the assets acquired and all of the liabilities assumed
and reviews the procedures used to measure the amounts to be recognized at the acquisition date. If the reassessment still results in
an excess of the fair value of net assets acquired over the aggregate consideration transferred, then the gain is recognized in the consolidated
statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>


<ix:exclude><!-- Field: Page; Sequence: 186 -->
    <div id="xdx_23A_z5qDvxuk3gUd" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23A_zybxIRoQVPYi" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zCaecNrVpmUe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">After initial recognition, goodwill is measured at cost less any accumulated
impairment losses. For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated
to each of the Company&#8217;s cash-generating units that are expected to benefit from the combination, irrespective of whether other
assets or liabilities of the acquire are assigned to those units.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Where goodwill has been allocated to a cash-generating unit (CGU) and part
of the operation within that unit is disposed of, the goodwill associated with the disposed operation is included in the carrying amount
of the operation when determining the gain or loss on disposal. Goodwill disposed in these circumstances is measured based on the relative
values of the disposed operation and the portion of the cash-generating unit retained.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001128" name="afya:CurrentVersusNoncurrentClassificationPoliciesExplanatory"><p id="xdx_848_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zvIOto8tCKJa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b) <span id="xdx_86D_zgfWBvd54Hjf">Current versus non-current classification</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company presents assets and liabilities in the statement of financial
position based on current and non-current classification. An asset is current when it is:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Expected to be realized
or intended to be sold or consumed in the normal operating cycle;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Held primarily for
the purpose of trading;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Expected to be realized
within twelve months after the reporting period; or</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Cash or cash equivalent
unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">All other assets are classified as non-current.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">A liability is current when:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It is expected to
be settled in the normal operating cycle;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It is held primarily
for the purpose of trading;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It is due to be
settled within twelve months after the reporting period; or</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">There is no unconditional
right to defer the settlement of the liability for at least twelve months after the reporting period.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company classifies all other liabilities as non-current.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Deferred tax assets and liabilities are classified as non-current assets
and liabilities.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001130" name="ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zVRK63da52x4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>c) <span id="xdx_866_zgQOUctiUb3i">Fair value measurement</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Fair value is the price that would be received to sell an asset or paid
to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based
on the presumption that the transaction to sell the asset or transfer the liability takes place either: (i) in the principal market for
the asset or liability; or (ii) in the absence of a principal market, in the most advantageous market for the asset or liability.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The principal or the most advantageous market must be accessible by the
Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 187 -->
    <div id="xdx_235_zqmvqn1Rvp64" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_235_zujYlDDCBie2" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The fair value of an asset or a liability is measured using the assumptions
that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">A fair value measurement of a non-financial asset takes into account a market
participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market
participant that would use the asset in its highest and best use.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company uses valuation techniques that are appropriate in the circumstances
and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the
use of unobservable inputs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">All assets and liabilities for which fair value is measured or disclosed
in the financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that
is significant to the fair value measurement as a whole:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level 1 - Quoted
(unadjusted) market prices in active markets for identical assets or liabilities.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level 2 - Valuation
techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level 3 - Valuation
techniques for which the lowest level input that is significant to the fair value measurement is unobservable.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For assets and liabilities that are recognized in the financial statements
at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy by re-assessing
categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting
period.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">At each reporting date, the Company analyzes the movements in the values
of assets and liabilities which are required to be remeasured or reassessed as per the Company&#8217;s accounting policies. For this analysis,
the Company verifies the major inputs applied in the latest valuation by agreeing the information in the valuation computation to contracts
and other relevant documents.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company also compares the change in the fair value of each asset and
liability with relevant external sources to determine whether the change is reasonable.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For the purpose of fair value disclosures, the Company has determined classes
of assets and liabilities on the basis of the nature, characteristics and risks of the asset or liability and the level of the fair value
hierarchy, as explained above.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001132" name="afya:FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory"><p id="xdx_840_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_zKvg01UWdcJ7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>d) <span id="xdx_866_zTFTz8xv3zk6">Financial instruments - initial recognition and measurement</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">A financial instrument is any contract that gives rise to a financial asset
of one entity and a financial liability or equity instrument of another entity.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 14.2pt"/><td style="width: 14.15pt"><b>i)</b></td><td><b>Financial assets</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><b>&#160;</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Initial recognition and measurement</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The classification of financial assets at initial recognition
depends on the financial asset&#8217;s contractual cash flow characteristics and the Company&#8217;s business model for managing them.
With the exception of trade receivables that do not contain a significant financing component or for which the Company has applied the
practical expedient, the Company initially measures a financial asset at its fair value plus, in the case of a financial asset not at
fair value through profit or loss, transaction costs. Trade receivables that do not contain a significant financing component or for
which the Company has applied the practical expedient, are measured at the transaction price determined under IFRS 15.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"></p>


<ix:exclude><!-- Field: Page; Sequence: 188 -->
    <div id="xdx_23C_zmOmwahmRfQ5" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_231_znXxMxg6tuHl" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zR87X5ld40D6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">In order for a financial asset to be classified and measured
at amortized cost or fair value through OCI (Other Comprehensive Income), it needs to give rise to cash flows that are &#8220;solely payments
of principal and interest (SPPI)&#8221; on the principal amount outstanding. This assessment is referred to as the SPPI test and is performed
at an instrument level.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company&#8217;s business model for managing financial assets
refers to how it manages its financial assets in order to generate cash flows. The business model determines whether cash flows will result
from collecting contractual cash flows, selling the financial assets, or both.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Purchases or sales of financial assets that require delivery
of assets within a time frame established by regulation or convention in the market place (regular way trades) are recognized on the trade
date, i.e., the date that the Company commits to purchase or sell the asset.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Subsequent measurement</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">For purposes of subsequent measurement, financial assets are
classified as: financial assets at amortized cost or financial assets at fair value through profit or loss. There are no financial assets
designated as fair value through OCI.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Financial assets at amortized cost</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company measures financial assets at amortized cost if both
of the following conditions are met:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#8226; The financial asset is held within a business model with
the objective to hold financial assets in order to collect contractual cash flows, and</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#8226; The contractual terms of the financial asset give rise
on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial assets at amortized cost are subsequently measured
using the effective interest (EIR) method and are subject to impairment. Gains and losses are recognized in the statement of income when
the asset is derecognized, modified or impaired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Financial assets at fair value through profit
or loss</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial assets at fair value through profit or loss include
financial assets held for trading, financial assets designated upon initial recognition at fair value through profit or loss, or financial
assets mandatorily required to be measured at fair value. Financial assets are classified as held for trading if they are acquired for
the purpose of selling or repurchasing in the near term. Derivatives, including separated embedded derivatives, are also classified as
held for trading unless they are designated as effective hedging instruments. Financial assets with cash flows that are not solely payments
of principal and interest are classified and measured at fair value through profit or loss, irrespective of the business model.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 189 -->
    <div id="xdx_239_zRapxUCSlxk5" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23D_zzXY6Mj0jvqd" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial assets at fair value through profit or loss are carried
in the statement of financial position at fair value with net changes in fair value recognized in the statement of income. This category
includes derivative instruments.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Derecognition</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">A financial asset (or, where applicable, a part of a financial
asset or part of a group of similar financial assets) is primarily derecognized (i.e., removed from the Company&#8217;s statement of financial
position) when:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"/><td style="text-align: justify">The rights to receive cash flows from the asset have expired; or</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"/><td style="text-align: justify">The Company has transferred its rights to receive cash flows from the asset or has assumed
an obligation to pay the received cash flows in full without material delay to a third party under a &#8216;pass-through&#8217; arrangement;
and either (a) the Company has transferred substantially all the risks and rewards of the asset, or (b) the Company has neither transferred
nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset.</td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">When the Company has transferred its rights to receive cash flows
from an asset or has entered into a pass-through arrangement, it evaluates if, and to what extent, it has retained the risks and rewards
of ownership. When it has neither transferred nor retained substantially all of the risks and rewards of the asset, nor transferred control
of the asset, the Company continues to recognize the transferred asset to the extent of its continuing involvement. In that case, the
Company also recognizes an associated liability. The transferred asset and the associated liability are measured on a basis that reflects
the rights and obligations that the Company has retained.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Continuing involvement that takes the form of a guarantee over
the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that
the Company could be required to repay.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Impairment of financial assets</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Further disclosures relating to impairment of financial assets
are also provided in the following notes:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"/><td style="text-align: justify">Significant accounting judgments, estimates and assumptions - Note 3</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"/><td style="text-align: justify">Trade receivables - Note 7</td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company recognizes an allowance for expected credit losses
(ECLs) for all debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual
cash flows due in accordance with the contract and the cash flows the Company expects to receive, discounted at an approximation of the
original effective interest rate. The expected cash flows will include cash flows from the sale of collateral held or other credit enhancements
that are integral to the contractual terms.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">For trade receivables, the Company applies a simplified approach
in calculating ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for credit losses
based on lifetime ECLs at each reporting date. The Company has established a provision matrix that is based on its historical credit loss
experience, adjusted for forward-looking factors specific to the debtors and the economic environment.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company considers a financial asset to be in default
when internal or external information indicates that the Company is unlikely to receive the outstanding contractual amounts in full
before considering any credit enhancements held by the Company. A financial asset is written off when there is no reasonable
expectation of recovering the contractual cash flows.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"></p>


<ix:exclude><!-- Field: Page; Sequence: 190 -->
    <div id="xdx_23C_zl0XJs1xB5R4" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_236_z25nL57qpI1d" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zaoxvws3liQh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><b>ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
liabilities</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Initial recognition and measurement</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial liabilities are classified, at initial recognition,
as financial liabilities at fair value through profit or loss, loans and borrowings, payables, or as derivatives designated as hedging
instruments in an effective hedge, as appropriate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">All financial liabilities are recognized initially at fair value
and, in the case of loans and borrowings and payables, net of directly attributable transaction costs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company&#8217;s financial liabilities include trade payables,
loans and financing, notes payable, lease liabilities, advances from customers and accounts payable to selling shareholders.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Subsequent measurement</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The measurement of financial liabilities depends on their classification,
as described below:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Financial liabilities at fair value through
profit or loss</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial liabilities at fair value through profit or loss include
financial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value through profit or
loss.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial liabilities are classified as held for trading if they
are incurred for the purpose of repurchasing in the near term. This category also includes, when applicable, derivative financial instruments
entered into by the Company that are not designated as hedging instruments in hedge relationships as defined by IFRS 9. Gains or losses
on liabilities held for trading are recognized in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial liabilities designated upon initial recognition at
fair value through profit or loss are designated at the initial date of recognition, and only if the criteria in IFRS 9 are satisfied.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Loans and borrowings</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">After initial recognition, interest-bearing loans and borrowings
are subsequently measured at amortized cost using the EIR method. Gains and losses are recognized in the statement of income when the
liabilities are derecognized as well as through the EIR amortization process.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Amortized cost is calculated by considering any discount or premium
on acquisition and fees or costs that are an integral part of the EIR. The EIR amortization is included as finance expenses in the statement
of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Derecognition</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">A financial liability is derecognized when the obligation under
the liability is discharged or cancelled or expires. When an existing financial liability is replaced by another from the same lender
on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is
treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying
amounts is recognized in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><br/>
</p>


<ix:exclude><!-- Field: Page; Sequence: 191 -->
    <div id="xdx_239_zS77lIKto1d9" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23F_zzZA4dEylYU6" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Offsetting of financial instruments</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial assets and financial liabilities are offset and the
net amount is reported in the statement of financial position if there is a currently enforceable legal right to offset the recognized
amounts and there is an intention to settle on a net basis, to realize the assets and settle the liabilities simultaneously.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001136" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"><p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zSLNqDO7dt11" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>e) <span id="xdx_867_zWpp7npZLiub">Cash and cash equivalents</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Cash and cash equivalents in the statement of financial position comprise
cash at banks and on hand, and short-term financial investments with an original maturity of three months or less, which are subject to
an insignificant risk of changes in value.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For the purpose of the statement of cash flows, cash and cash equivalents
consist of cash and short-term financial investments, as they are considered an integral part of the Company&#8217;s cash management.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001138" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zNJh9Hmg1eQ9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>f) <span id="xdx_860_zaQrZT2wqJl8">Property and equipment</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Property and equipment are stated at cost, net of accumulated depreciation
and accumulated impairment losses, if any.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Subsequent expenditures are capitalized only if it is probable that the
future economic benefits associated with the expenditure will flow to the Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Depreciation is calculated on a straight-line basis over the estimated useful
lives of the assets, as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001140" name="afya:ScheduleOfEstimatedUsefulLivesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_883_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zAZYZOz6Ydq" summary="xdx: Disclosure - Material accounting policies (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B0_zaC2EnOUWqdf" style="display: none">Schedule of estimated useful
lives of the assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Building</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zGZ0Olisj3R3" title="Useful lives of assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_BuildingsMember" format="ixt-sec:duryear" id="Fact001142" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">25</ix:nonNumeric></span> years</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Machinery and equipment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zlijIYD854z1" title="Useful lives of assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_MachineryAndEquipmentsMember" format="ixt-sec:duryear" id="Fact001144" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">10</ix:nonNumeric></span> years</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Vehicles</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zWn083WDFBIa" title="Useful lives of assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_VehiclesMember" format="ixt-sec:duryear" id="Fact001146" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">4</ix:nonNumeric></span> years</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Furniture and fixtures</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zVPzrKtB97bi" title="Useful lives of assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_FixturesAndFittingsMember" format="ixt-sec:duryear" id="Fact001148" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">10</ix:nonNumeric></span> years</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">IT equipment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zdCqKpUaMbQj" title="Useful lives of assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ItEquipmentMember" format="ixt-sec:duryear" id="Fact001150" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">5</ix:nonNumeric></span> years</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Library books</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_z35nlPvrCfH9" title="Useful lives of assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_LibraryBooksMember" format="ixt-sec:duryear" id="Fact001152" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">10</ix:nonNumeric></span> years</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Leasehold improvements</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGUH789gLle1" title="Useful lives of assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact001154" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">5</ix:nonNumeric></span> - <span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zr85b7n2lei4" title="Useful lives of assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact001156" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">20</ix:nonNumeric></span> years</span></td></tr>
  </table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><br/>
</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">An item of property and equipment and any significant part initially recognized
is derecognized upon disposal or when no future economic benefit is expected from its use or disposal. Any gain or loss arising on the
derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included
in the statement of income when the asset is derecognized.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The residual values, useful lives and methods of depreciation of property
and equipment are reviewed at each financial year end and adjusted prospectively, if appropriate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001158" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zjIX2ELhTcF6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>g) <span id="xdx_864_zMeHdQwI1tq">Leases</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company assess at contract inception whether an arrangement is (or contains)
a lease is based on the substance of the arrangement at the inception of the contract. The arrangement is, or contains, a lease if the
arrangement conveys the right to control the use of the identified asset (or assets), even if that asset is (or those assets are) not
explicitly specified in an arrangement for a period of time in exchange for consideration.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><br/>
</p>


<ix:exclude><!-- Field: Page; Sequence: 192 -->
    <div id="xdx_236_zpGnyigdirYg" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_238_z5w4g6R4RPo2" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Company as a lessee</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company applies a single recognition and measurement approach for all
leases, except for short-term leases and leases of low-value assets. The Company recognizes lease liabilities to make lease payments and
right-of-use assets representing the right to use the underlying assets.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Right-of-use assets</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company recognizes right-of-use assets at the commencement date of the
lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation
and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of
lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease
incentives received. Unless the Company is reasonably certain to obtain ownership of the leased asset at the end of the lease term, the
recognized right-of-use assets are depreciated on a straight-line basis over the shorter of its estimated useful life and the lease term.
Right-of-use assets are subject to impairment.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Lease liabilities</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">At the commencement date of the lease, the Company recognizes lease liabilities
measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance
fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected
to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain
to be exercised by the Company and payments of penalties for terminating a lease, if the lease term reflects the Company exercising the
option to terminate. The variable lease payments that do not depend on an index or a rate are recognized as expense in the period on which
the event or condition that triggers the payment occurs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">In calculating the present value of lease payments, the Company uses the
incremental borrowing rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After
the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments
made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change
in the in-substance fixed lease payments or a change in the assessment to purchase the underlying asset.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Short-term leases and leases of low-value assets</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company applies the short-term lease recognition exemption to its short-term
leases of properties (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase
option). It also applies the lease of low-value assets recognition exemption to leases that are considered of low value. Lease payments
on short-term leases and leases of low-value assets are recognized as expense on a straight-line basis over the lease term.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001160" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory"><p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_z7U4La36slmi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>h) <span id="xdx_866_zpxVucjDvpRh">Intangible assets</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets acquired separately are measured on initial recognition
at cost. The cost of intangible assets acquired in a business combination is their fair value at the date of acquisition. Following initial
recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally generated
intangibles are not capitalized and the related expenditure is reflected in the statement of income in the period in which the expenditure
is incurred.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>


<ix:exclude><!-- Field: Page; Sequence: 193 -->
    <div id="xdx_23D_zCEBSkuwTF5i" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23F_zUQQCL5Owbph" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zk7XhTN20Bh8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The useful lives of intangible assets are assessed as finite or indefinite.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets with finite lives are amortized over the useful economic
life and assessed for impairment whenever there is an indication that the intangible asset may be impaired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The amortization period and the amortization method for an intangible asset
with a finite useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected
pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as
appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized
in the statement of income in the expense category that is consistent with the function of the intangible assets.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets with indefinite useful lives are not amortized, but are
tested for impairment annually, either individually or at the cash-generating unit level. The assessment of indefinite life is reviewed
annually to determine whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite
is made on a prospective basis.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">An intangible asset is derecognized upon disposal or when no future economic
benefits are expected from its use or disposal. Any gain or loss arising upon derecognition of the asset (calculated as the difference
between the net disposal proceeds and the carrying amount of the asset) is included in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001163" name="afya:ImpairmentOfNonfinancialAssetsPolicyExplanatory"><p id="xdx_84A_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_zlZZxcLm8cke" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>i) <span id="xdx_862_zW60XKT14Avf">Impairment of non-financial assets</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company assesses, at each reporting date, whether there is an indication
that an asset may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Company estimates
the asset&#8217;s recoverable amount. An asset&#8217;s recoverable amount is the higher of an asset&#8217;s or CGU&#8217;s fair value
less costs of disposal and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate
cash inflows that are largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU
exceeds its recoverable amount, the asset is considered impaired and is written down to its recoverable amount.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">In assessing value in use, the estimated future cash flows are discounted
to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks
specific to the asset. In determining fair value less costs of disposal, recent market transactions are considered. If no such transactions
can be identified, an appropriate valuation model is used. These calculations are corroborated by valuation multiples, quoted share prices
for publicly traded companies or other available fair value indicators.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company bases its impairment calculation on detailed budgets and forecast
calculations, which are prepared separately for each of the Company&#8217;s CGUs to which the individual assets are allocated. These budgets
and forecast calculations generally cover a period of five years, considering the companies activities and maturation period of its graduate
and undergraduate courses. A long-term growth rate is calculated and applied to project future cash flows after the last projected year.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For impairment testing, goodwill acquired through business combinations
and licenses with indefinite useful lives are allocated to their respective CGUs. The Company defined each of its operating subsidiaries
as a CGU, except for digital services segment, which combines subsidiaries of (i) &#8220;Content &amp; Technology for medical education&#8221;;
(ii) &#8220;Clinical Decision Software&#8221;; and (iii) &#8220;Practice Management Tools &amp; Electronic Prescription&#8221;, where
the subsidiaries were combined as one CGU following the business strategic pillars.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>


<ix:exclude><!-- Field: Page; Sequence: 194 -->
    <div id="xdx_238_zK2wr4tWsiU7" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_237_ztoN8UzFJTp8" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_z9eVlRSxgsMd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Whenever applicable, impairment losses of continuing operations are recognized
in the statement of income in expense categories consistent with the function of the impaired asset.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For assets excluding goodwill, an assessment is made at each reporting date
to determine whether there is an indication that previously recognized impairment losses no longer exist or have decreased. If such indication
exists, the Company estimates the asset&#8217;s or CGU&#8217;s recoverable amount. A previously recognized impairment loss is reversed
only if there has been a change in the assumptions used to determine the asset&#8217;s recoverable amount since the last impairment loss
was recognized. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the
carrying amount that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years.
Such reversal is recognized in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Goodwill is tested for impairment annually as at December 31 and when circumstances
indicate that the carrying value may be impaired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Impairment is determined for goodwill by assessing the recoverable amount
of each CGU (or group of CGUs) to which the goodwill relates. When the recoverable amount of the CGU is less than its carrying amount,
an impairment loss is recognized. Impairment losses relating to goodwill cannot be reversed in future periods.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets with indefinite useful lives are tested for impairment
annually as at December 31 at the CGU level, as appropriate, and when circumstances indicate that the carrying value may be impaired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001166" name="afya:DescriptionOfAccountingPolicyForInvestmentsExplanatory"><p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForInvestmentsExplanatory_zmHC9D4CmwBi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>j) <span id="xdx_865_zqfOzwRP2TGf">Investments</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Investments in associates are initially recognized at consideration transferred
and adjusted thereafter for the equity method, being increased or reduced from its interest in the investee's income after the acquisition
date. An associate is an entity over which the Company has significant influence. Significant influence is the power to participate in
the financial and operating policy decisions of the investee, but is not control or joint control over those policies.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001168" name="afya:AccountsPayableToSellingShareholdersPolicyExplanatory"><p id="xdx_845_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_ziQoQhjATxuc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>k) <span id="xdx_86A_zGCeAo5CyYs9">Accounts payable to selling shareholders</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">These amounts represent liabilities related to the acquisitions made by
the Company which are not yet due. Accounts payable to selling shareholders are presented as current liabilities unless payment is not
due within 12 months after the reporting period. They are recognized initially at their fair value and subsequently measured at amortized
cost using the effective interest method, except for the contingent consideration related to earn-outs, which are measured at fair value
through profit or loss.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001170" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory"><p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_z8grFXjufnd3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>l) <span id="xdx_865_zy328twd4Mji">Provisions</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Provisions are recognized when the Company has a present obligation (legal
or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required
to settle the obligation, and a reliable estimate can be made of the amount of the obligation. The expense relating to a provision is
presented in the statement of income, net of any reimbursement, when applicable.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>


<ix:exclude><!-- Field: Page; Sequence: 195 -->
    <div id="xdx_232_zrtmVzvYbIff" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_234_z3txRrVmjRRh" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zFexVGy43fI7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001173" name="afya:DividendsPolicyExplanatory"><p id="xdx_84C_ecustom--DividendsPolicyExplanatory_zJIeCotkaNFe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>m) <span id="xdx_865_zZ0HxIVUJ3wi">Dividends</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company recognizes a liability to pay a dividend when the distribution
is authorized and the distribution is no longer at the discretion of the Company. The distribution is authorized when it is required to
pay a minimum dividend of the net income for the year in accordance with the Brazilian Corporate Law (applicable for Afya Brazil and its
subsidiaries) and the Company&#8217;s By-Laws or is approved by the shareholders. In respect to the consolidated statement of changes
in equity, the amount corresponding to the non-controlling interest over the dividends declared are recognized directly in equity.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001175" name="afya:LaborAndSocialObligationsPolicyExplanatory"><p id="xdx_847_ecustom--LaborAndSocialObligationsPolicyExplanatory_z1fYGR5TdZ9b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>n) <span id="xdx_86C_z1YEpve974k6">Labor and social obligations</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Labor and social obligations are expensed as the related service is provided.
A liability is recognized for the amount expected to be paid if the Company has a present legal or constructive obligation to pay this
amount as a result of past service provided by the employee and the obligation can be estimated reliably.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001177" name="afya:SharebasedPaymentsPolicyExplanatory"><p id="xdx_843_ecustom--SharebasedPaymentsPolicyExplanatory_zalIcnHJTBeb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>o) <span id="xdx_861_zL9WHXQMQFG">Share-based payments</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Certain key executives of the Company receive remuneration in the form of
share-based payments, which includes Stock Options and Restricted Stock Units (&#8220;RSUs&#8221;), whereby the executives render services
as consideration for equity instruments (equity-settled transactions).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The expense of equity-settled transactions is determined by the fair value
at the date when the grant is made using an appropriate valuation model.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">That expense is recognized in selling, general and administrative expenses,
together with a corresponding increase in equity, over the period in which the service and, where applicable, the performance conditions
are fulfilled (the vesting period). The cumulative expense recognized for equity-settled transactions at each reporting date until the
vesting date reflects the extent to which the vesting period has expired and the Company&#8217;s best estimate of the number of equity
instruments that will ultimately vest. The expense or credit in the statement of income for a period represents the movement in cumulative
expense recognized as at the beginning and end of that period.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Service and non-market performance conditions are not considered when determining
the grant date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Company&#8217;s best estimate
of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair
value. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting conditions.
Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless there are also
service and/or performance conditions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">No expense is recognized for awards that do not ultimately vest because
non-market performance and/or service conditions have not been met. Where awards include a market or non-vesting condition, the transactions
are treated as vested irrespective of whether the market or non-vesting condition is satisfied, provided that all other performance and/or
service conditions are satisfied.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">When the terms of an equity-settled award are modified, the minimum expense
recognized is the grant date fair value of the unmodified award, provided the original vesting terms of the award are met. An additional
expense, measured as at the date of modification, is recognized for any modification that increases the total fair value of the share-based
payment transaction, or is otherwise beneficial to the employee. Where an award is cancelled by the entity or by the counterparty, any
remaining element of the fair value of the award is expensed immediately through the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>


<ix:exclude><!-- Field: Page; Sequence: 196 -->
    <div id="xdx_23F_zXCy8F1nJQTg" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_230_zlNzgCBTOFwc" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zM3IM5ESqbGj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The dilutive effect of outstanding options is reflected as additional share
dilution in the computation of diluted earnings per share.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001180" name="ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory"><p id="xdx_840_eifrs-full--DisclosureOfRevenueFromContractsWithCustomersExplanatory_zQ6ltLqCkpUh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>p) <span id="xdx_861_ztnxnOBSMQ0a">Revenue from contracts with customers</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><i>Revenue recognition transferred over time </i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company's revenue consists primarily of tuition fees charged for medical
courses. The Company also generates revenue from tuition fees for other undergraduate courses, student fees, certain education-related
activities, digital education content and subscription of digital services.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Revenues are recognized when services are rendered to the customer and the
performance obligation is satisfied.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Revenue from tuitions, digital education content and electronic medical
records are recognized over time when services are rendered to the customer and the Company satisfies its performance obligation under
the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services.
Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Other revenues are recognized at a point in time when the service is rendered
to the customer at an amount that reflects the consideration to which the Company expects to be entitled in exchange for the service.
Other revenues are presented net of the corresponding discounts, returns and taxes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><i>Revenue recognition transferred at point in time </i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Revenue from sale of printed books, e-books, healthcare payments, online
platforms and marketing for pharmaceutical industry are recognized at the point in time when control of the asset or services is transferred
to the customer, generally on delivery of the goods at the customer&#8217;s location and permission to access the digital content. The
Company considers whether there are other promises in the contract that are separate performance obligations to which a portion of the
transaction price needs to be allocated. In determining the transaction price for the printed books and e-books, the Company considers
the effects of variable consideration, financing component, noncash consideration, and consideration payable to the customer to be not
significant.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company concluded that it is the principal in its revenue arrangements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company assesses collectability on a portfolio basis prior to recording
revenue. Generally, students cannot re-enroll for the next academic session without satisfactory resolution of any past-due amounts. If
a student withdraws from an institution, the Company's obligation to issue a refund depends on the refund policy at that institution and
the timing of the student's withdrawal. Generally, the refund obligations are reduced over the course of the academic term.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Trade receivables</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Trade receivables represent the Company&#8217;s right to an amount of consideration
that is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to accounting policies
of financial assets in Financial instruments - initial recognition and subsequent measurement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>


<ix:exclude><!-- Field: Page; Sequence: 197 -->
    <div id="xdx_231_zMch1Pw58fLh" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_234_zRSufcUQpjP4" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zU7JpJH303Xd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Advances from customers</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Advances from customers (a contract liability) are the obligation to transfer
services to a customer for which the Company has received consideration (or an amount of consideration is due) from the customer, as a
result of pre-paid tuition, digital education content and mobile app subscription for digital medical content received from customers
and is recognized separately in current liabilities, when the payment is received. Advances from customers are recognized as revenue when
the Company performs all obligations related to the contract, generally in the following month.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001183" name="afya:TaxesPolicyExplanation"><p id="xdx_84D_ecustom--TaxesPolicyExplanation_zC3K6LF1DSpc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>q) <span id="xdx_867_znYtC1b6UUee">Taxes</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">The Company&#8217;s
subsidiaries in the undergrad segment joined the PROUNI (<i>Programa Universidade para Todos</i> - University for All Program) program,
which is a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number of
student enrollment for low-income students, and benefits from the exemption of the following federal taxes:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">&#8226; Income taxes
and social contribution</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">&#8226; PIS and COFINS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">The regulation of
PROUNI defines that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS. For income from
other teaching activities, PIS and COFINS are charged at rates of <span id="xdx_906_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_z8nnaMF0qRR8" title="Tax rate"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2023-01-012023-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember" id="Fact001185" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.65</ix:nonFraction></span>% and <span id="xdx_904_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zyr4XxR9tIq7" title="Tax rate"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2023-01-012023-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_TeachingActivitiesMember" id="Fact001187" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.00</ix:nonFraction></span>%, respectively, and for non-teaching activities, PIS
is charged at a rate of <span id="xdx_909_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_z184b5bPceb4" title="Tax rate"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2023-01-012023-12-31_custom_ProgramOfSocialIntegrationMember_custom_NonTeachingActivitiesMember" id="Fact001189" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.65</ix:nonFraction></span>% and to COFINS at <span id="xdx_907_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zSw58OThkk16" title="Tax rate"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2023-01-012023-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_NonTeachingActivitiesMember" id="Fact001191" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.6</ix:nonFraction></span>%.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-weight: normal"><i>Current income taxes</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">Current income taxes
were calculated based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service, specifically
regarding the PROUNI program, which allows exemption of these taxes from traditional and technological graduation activities.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Current income tax assets and liabilities are measured at the amount expected
to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted
or substantively enacted at the reporting date.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Management periodically evaluates positions taken in the tax returns with
respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001193" name="ifrs-full:DisclosureOfTreasurySharesExplanatory"><p id="xdx_84D_eifrs-full--DisclosureOfTreasurySharesExplanatory_zJ6WY0CRmfy3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>r) <span id="xdx_86A_zaUc3hC5yrHg">Treasury shares</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Own equity instruments that are reacquired (treasury shares) are recognized
at cost and deducted from equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the
Company&#8217;s own equity instruments. Any difference between the carrying amount and the consideration, if reissued, is recognized in
the share premium.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><br/>
</p>


<ix:exclude><!-- Field: Page; Sequence: 198 -->
    <div id="xdx_23E_zo4cUu3z6j92" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_239_zfrOaJmMb7A9" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>2.4 Changes in accounting policies and disclosures</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b><i>New standards, interpretations and amendments issued
and adopted by the Company</i></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">In the current year, the Company applied a series of changes to the
IFRSs issued by the International Accounting Standards Board (IASB) that are mandatorily for an accounting period beginning on or after
January 1, 2023, as listed below:</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001195" name="afya:ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_89A_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_zPaMGbNj4N6b" summary="xdx: Disclosure - Material accounting policies (Details 2)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 5.4pt; text-align: center"><span id="xdx_8B0_z2WPlSwTKOIj" style="display: none">Schedule of changes in accounting policies and disclosures</span></td>
    <td style="padding-right: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amendments / standards</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Description</span></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_909_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zVRMHPj7cMrl" title="Standard"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS1Member" id="Fact001197" name="ifrs-full:TitleOfInitiallyAppliedIFRS">Amendments to IAS 1 and IFRS Practice Statement 2 - Making Materiality Judgments</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zPZEstU5FyG8" title="Description"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS1Member" id="Fact001199" name="ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy">The amendments to IAS 1 and IFRS Practice Statement 2 provide guidance and
    examples to help entities apply materiality judgments to accounting policy disclosures. The amendments aim to help entities provide more
    useful accounting policy disclosures by replacing the requirement for entities to disclose their "material" accounting policies
    with a requirement to disclose their "material" accounting policies and adding guidance on how entities apply the concept of
    materiality when making decisions about accounting policy disclosures.</ix:nonNumeric></span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The amendments have had an impact on the Company&#8217;s disclosures of accounting
    policies, but not on the measurement, recognition or presentation of any items in the Company&#8217;s consolidated financial statements.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_905_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_zRiqeDN4JEgk" title="Standard"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS8Member" id="Fact001201" name="ifrs-full:TitleOfInitiallyAppliedIFRS">Amendments to IAS 8 - Accounting Policies, Changes in Accounting Estimates and Errors - Definition of Accounting Estimates</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90D_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_z7GzDbcsH3N" title="Description"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS8Member" id="Fact001203" name="ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy">The amendments to IAS 8 clarify the distinction between changes in accounting
    estimates, changes in accounting policies and correction of errors. They also clarify how entities use measurement techniques and inputs
    to develop accounting estimates.</ix:nonNumeric></span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">These amendments have no significant impact on the Company&#8217;s consolidated
    financial statements.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_z8uwC8KO8NO6" title="Standard"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS12Member" id="Fact001205" name="ifrs-full:TitleOfInitiallyAppliedIFRS">Amendments to IAS 12 - Income Taxes - International Tax Reform - Pillar Two Model Rules</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_zKFcJhEckc75" title="Description"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS12Member" id="Fact001207" name="ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy">In October 2021, more than 130 countries agreed to implement a minimum tax
    regime for multinational groups, known as Pillar Two, to reform the international corporate taxation. Pillar Two aims to ensure that multinational
    groups in scope are liable to a minimum effective corporate tax rate of 15 per cent per country.</ix:nonNumeric></span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">In December 2021, the OECD released the Pillar Two model rules - accompanied
    by commentary and guidelines - which are due to be passed into national legislation but adapted by local conditions.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">In response to the OECD's Pillar Two rules, the amendments to IAS 12 were
    introduced and include: (i) a mandatory temporary exception to the recognition and disclosure of deferred taxes arising from the jurisdictional
    implementation of the Pillar Two model rules; and (ii) disclosure requirements for affected entities to help users of the financial statements
    better understand an entity's exposure to Pillar Two income taxes arising from this legislation, especially prior to the effective date.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The countries where the Company has its tax domicile have not yet enacted
    any tax legislation in connection with Pillar Two. Therefore, these amendments have no significant impact on the Company&#8217;s consolidated
    financial statements as of December 2023</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zFXXi5Sw5Jqk" title="Standard"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS12OneMember" id="Fact001209" name="ifrs-full:TitleOfInitiallyAppliedIFRS">Amendments to IAS 12 Income Taxes - Deferred Tax related to Assets and Liabilities arising from a Single Transaction</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zIcy5ow2bcGl" title="Description"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS12OneMember" id="Fact001211" name="ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy">The amendments to IAS 12 Income Taxes narrow the scope of the initial recognition
    exception, so that it no longer applies to transactions that generate equal taxable and deductible temporary differences, such as leases
    and decommissioning liabilities.</ix:nonNumeric></span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">These amendments have no significant impact on the Company&#8217;s consolidated
    financial statements.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_907_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zKw3rf1kHu1g" title="Standard"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_IFRS17Member" id="Fact001213" name="ifrs-full:TitleOfInitiallyAppliedIFRS">IFRS 17 - Insurance Contracts</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_903_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zPE0liHDKlPd" title="Description"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_IFRS17Member" id="Fact001215" name="ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy">IFRS 17 is a new accounting standard with scope for insurance contracts,
    covering recognition and measurement, presentation and disclosure. IFRS 17 replaces IFRS 4 - Insurance Contracts. IFRS 17 applies to all
    types of insurance contracts (such as life, property and casualty, direct insurance and reinsurance), regardless of the type of entities
    issuing them, as well as to certain guarantees and financial instruments with discretionary participation characteristics; Some scope
    exceptions will apply.</ix:nonNumeric></span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The overall objective of IFRS 17 is to provide a comprehensive accounting
    model for insurance contracts that is most useful and consistent for insurers, covering all relevant accounting aspects.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The Company does not have any contracts that meet the definition of an insurance
    contract under IFRS 17.</p></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 199 -->
    <div id="xdx_23B_zYIINAKj95ub" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_237_zmMYUTBnoc31" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zEtB6fQMVMh2" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b><i>New standards, interpretations and amendments issued
but not yet effective</i></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt">&#160;</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">The new and amended standards and interpretations that are issued,
but not yet effective, up to the date of issuance of the Company&#8217;s consolidated financial statements are presented below. The Company
intends to adopt these new and amended standards and interpretations, if applicable, when they become effective.</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amendments / standards</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Description</span></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_900_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_zfzybCODwgX4" title="Standard"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIFRS16Member" id="Fact001218" name="ifrs-full:TitleOfInitiallyAppliedIFRS">Amendments to IFRS 16: Lease Liability in a Sale and Leaseback</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_z0omFgjvhnbj" title="Description"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIFRS16Member" id="Fact001220" name="ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy">In September 2022, the IASB issued amendments to IFRS 16 to specify the requirements
    that a seller-lessee uses in measuring lease liability arising from a sale and lease back transaction, in order to ensure that the seller-lessee
    does not recognise any amount of the gain or loss that relates to the right of use that it holds.</ix:nonNumeric></span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The amendments are effective for annual financial statements periods beginning
    on or after January 1, 2024 and shall apply retrospectively to sale and leaseback transactions entered into after the initial application
    date of IFRS 16. Early adoption is permitted but must be disclosed.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_90A_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_zDc4i8S4nvJ" title="Standard"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS1OneMember" id="Fact001222" name="ifrs-full:TitleOfInitiallyAppliedIFRS">Amendments to IAS 1: Classification of Liabilities as Current or Non-Current</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_z57sh07ltKLl" title="Description"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS1OneMember" id="Fact001224" name="ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy">In January 2020 and October 2022, the IASB issued amendments to paragraphs
    69 to 76 of IAS 1 to specify the requirements for classifying liabilities as current or non-current. The amendments clarify:</ix:nonNumeric></span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; What is meant by the right to postpone liquidation;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; That the right to defer should exist at the end of the financial reporting
    period;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; That the rating is not affected by the likelihood that the entity
    will exercise its right to defer;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; That only if a derivative embedded in a convertible liability is itself
    an equity instrument, the terms of a liability will not affect its classification.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">In addition, a disclosure requirement has been introduced where a liability
    arising from a loan agreement is classified as non-current and the entity's right to postpone liquidation is contingent on the fulfilment
    of future covenants within twelve months.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024 and should be applied retrospectively.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_90B_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zkHivH8FOKyc" title="Standard"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS7AndIFRS7Member" id="Fact001226" name="ifrs-full:TitleOfInitiallyAppliedIFRS">Supplier Financing Agreements - Amendments to IAS 7 and IFRS 7</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zJDKXm04GSWl" title="Description"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS7AndIFRS7Member" id="Fact001228" name="ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy">In May 2023, the IASB issued amendments to IAS 7 and IFRS 7 to clarify the
    characteristics of supplier financing arrangements and require additional disclosures of such arrangements. The disclosure requirements
    in the amendments are intended to assist users of the financial statements in understanding the effects of financing arrangements with
    suppliers on an entity's obligations, cash flows, and exposure to liquidity risk.</ix:nonNumeric></span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024. Early adoption is permitted but must be disclosed.</p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AA_zkwwkyU46Ft2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">These amendments are not expected to have significant impact on the Company&#8217;s
consolidated financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001230" name="afya:SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory"><p id="xdx_80E_ecustom--SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory_zEQCK9HJIjt7" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in">3</td><td><span id="xdx_824_zv0WS9BcVUMc">Significant accounting judgments, estimates and assumptions</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The preparation of the Company&#8217;s consolidated financial statements
requires management to make judgments, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities,
and the accompanying disclosures. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment
to the carrying amount of assets or liabilities affected in future periods. Accounting estimates and judgments are continually evaluated
and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under
the circumstances. Revisions to estimates are recognized prospectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Other disclosures relating to the Company&#8217;s exposure to risks and
uncertainties includes:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Financial instruments
risk management objectives and policies - Note 13.4</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Sensitivity analysis
disclosures - Note 13.4.1<br/></span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 200 -->
    <div id="xdx_230_zkst3T3NoKXh" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23B_zjaPuOsKJGN2" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>Estimates and assumptions</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The key assumptions about the future and other key sources of estimated
uncertainty as of the reporting date that include a significant risk of a material adjustment to the carrying amounts of assets and liabilities
within the next financial year, are described below. The Company based its assumptions and estimates on parameters available when the
consolidated financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change
due to market changes or circumstances that arise and that are beyond the Company&#8217;s control. Such changes are reflected in the assumptions
when they occur.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Identification and fair-value measurement of assets and
liabilities acquired in a business combination</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>&#160;</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Business combinations are accounted for using the acquisition method. Such
method requires recognizing and measuring the identifiable assets acquired, the liabilities assumed and any non-controlling interest in
the acquiree. The Company, as the acquirer, must classify or designate the identifiable assets and liabilities assumed on the basis of
its own contractual terms, economic conditions, operating and accounting policies and other relevant conditions as at the acquisition
date. Such assessment requires judgments from the Company on the methods used to determine the fair value of the assets acquired and liabilities
assumed, including valuation techniques that may require prospective financial information inputs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Impairment of non-financial assets</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Impairment exists when the carrying value of an asset or cash generating
unit (&#8220;CGU&#8221;) or group of CGUs exceeds its recoverable amount, defined as the higher of its fair value less costs of disposal
and its value in use. The fair value less costs of disposal calculation is based on data available from binding sales transactions, conducted
at arm&#8217;s length, for similar assets or observable market prices less incremental costs of disposing of the asset. The value in use
calculation is based on a discounted cash flow model (&#8220;DCF&#8221; model). The cash flows are derived from the budget for the next
five years and do not include restructuring activities to which the Company has not yet committed or significant future investments that
will enhance the performance of the assets of the CGU being tested. The recoverable amount is sensitive to the discount rate used for
the DCF model as well as to expected future cash-inflows and the growth rate used for extrapolation purposes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">These estimates are most relevant to goodwill and indefinite lived intangible
assets recognized by the Company. The key assumptions used to determine the recoverable amount for each CGU, including a sensitivity analysis,
are disclosed and further explained in Note 12.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Share-based compensation</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>&#160;</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Estimating fair value for share-based payment transactions requires determination
of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination
of the most appropriate inputs to the valuation model including the expected life of the share option or appreciation right, volatility
and dividend yield and making assumptions about them. For the measurement of the fair value of equity-settled transactions, the Company
uses the Binomial model. The assumptions and models used for estimating fair value for share-based payment transactions are disclosed
in Note 16 (b).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Leases - Estimating the incremental borrowing rate</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #263238">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company cannot readily determine the interest rate implicit in the
lease, therefore, it uses its incremental borrowing rate (IBR) to measure lease liabilities. The IBR is the rate of interest that the
Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar
value to the right-of-use asset in a similar economic environment. The IBR therefore reflects what the Company &#8216;would have to pay&#8217;,
which requires estimation when no observable rates are available (such as for subsidiaries that do not enter into financing transactions)
or when they need to be adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary&#8217;s
functional currency).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<ix:exclude><p id="xdx_236_zjSZUY1Pvesd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 201 -->
    <div id="xdx_238_z7hssKhjTNp7" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_233_zKq90MEkAM3l" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zuaahFuZNzj7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company estimates the IBR using observable inputs (such as market interest
rates) when available and is required to make certain entity-specific estimates.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001234" name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory"><p id="xdx_807_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_z9bigRnVCgcd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>4</b></td><td><b><span id="xdx_829_zc3pYihvQUs5">Segment information</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company has three reportable segments as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#8226; Undergrad, which provides educational services
through undergraduate courses related to medicine, other health sciences and other undergraduate programs;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#8226; Continuing Education, which provides specialization
programs and graduate courses in medicine; and</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; Digital Services, which provides content and technology for medical
education, clinical decisions software, practice management tools and electronic medical records, doctor-patient relationship, telemedicine
and digital prescription for physicians and provides access and demand and efficiency for the healthcare players.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Segment information is presented consistently with the internal reports
provided to the Company's Chief Executive Officer (CEO), which is the Chief Operating Decision Maker (CODM) and is responsible for allocating
resources, assessing the performance of the Company's operating segments, and making the Company's strategic decisions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">No operating segments have been aggregated to form the reportable operating
segments. There is only one geographic region, and the results are monitored and evaluated as a single business.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The tables below presents assets and liabilities information for the Company&#8217;s
operating segments as of December 31, 2023 and 2022, respectively:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001236" name="afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_89A_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_zowoJGpjNH8b" summary="xdx: Disclosure - Segment information (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zxn9q4EBFVyh" style="display: none">Schedule of presents assets and liabilities information for the Company&#8217;s
operating segments</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As of December 31, 2023</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total assets</b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zO3h7Wp7wPYa" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001238" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,104,154</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOnePnSHCcM4" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001240" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">180,555</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQHxd17TMF8g" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001242" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">310,989</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziqurXkxL0o" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001244" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,595,698</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zYfNrCb1ugAd" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001246" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</b></span></td>
    <td id="xdx_98C_eifrs-full--Assets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z09d5Usgxfz9" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001248" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,584,481</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current assets</span></td>
    <td id="xdx_981_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z978Uxo0Fvo4" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001250" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,001,156</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgQXgq4yiOY7" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001252" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">86,361</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zAz7p10yNFD8" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001254" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">127,206</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zCCVSl4lGYof" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001256" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,214,723</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zSoFSdMQOXz8" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001258" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</span></td>
    <td id="xdx_98A_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvAvnDhotSz2" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001260" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,203,506</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current assets</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zo7FtF97xjSc" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001262" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,102,998</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhwudu40q5Gd" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001264" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">94,194</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQkIY81gJtul" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001266" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">183,783</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvz1b87huqn1" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001268" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,380,975</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--NoncurrentAssets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z7JU9ksbNGrl" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1270">-</span></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zm6uiTPVAxOi" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001272" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,380,975</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total liabilities and equity</b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z1HSAdrO9dTl" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001274" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,104,154</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvzxiZAwqO9c" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001276" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">180,555</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zUYttPlXFpt8" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001278" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">310,989</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_znu2YfB7XU5e" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001280" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,595,698</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNfHEyX1x9D5" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001282" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</b></span></td>
    <td id="xdx_98E_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmABx0VRazH7" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001284" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,584,481</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current liabilities</span></td>
    <td id="xdx_98B_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zJtwLR0yTTIl" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001286" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">787,658</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zTazWYbkDmqh" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001288" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,447</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zNDe9qws43Nl" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001290" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">194,679</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zy7c74KbQpFa" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001292" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,069,784</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAc9o0e8BeTi" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001294" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</span></td>
    <td id="xdx_98D_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2iJpLRb7Ht5" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001296" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,058,567</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current liabilities</span></td>
    <td id="xdx_984_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zk3Z5c31fPe5" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001298" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,783,855</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRbxmmQl1BLj" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001300" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,608</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zWoOZ6DgfyQd" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001302" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,439</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zardOyOBcGbf" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001304" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,882,902</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zTAxgdvOK1aj" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1306">-</span></span></td>
    <td id="xdx_989_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFFJ8YvbNnHf" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001308" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,882,902</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Equity</span></td>
    <td id="xdx_986_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zGLpQZe6BhZa" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001310" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,532,641</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrQeQvNTqpq" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001312" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,500</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zr1fyIJnaO12" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001314" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,871</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zj0ZjBPXfoLg" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001316" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,643,012</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zdPUe7GA2Uef" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1318">-</span></span></td>
    <td id="xdx_988_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIfaBXPvaDOf" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001320" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,643,012</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other disclosures</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Investments in associate (i) </span></td>
    <td id="xdx_987_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zIZE99QliOdl" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001322" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,834</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7i1VEzE3UI" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1324">-</span></span></td>
    <td id="xdx_989_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zluDbMWRN4b2" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1326">-</span></span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdfQgvy0pgHe" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001328" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,834</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zR8Puf19h888" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1330">-</span></span></td>
    <td id="xdx_98C_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXQqHAwn0WCa" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001332" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,834</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital expenditures (ii)</span></td>
    <td id="xdx_98E_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zYncj3Y1jT32" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001334" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">139,361</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeODFZuHLEk8" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001336" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,178</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zOC6zMUjDJ52" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001338" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,889</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zV6QAQdK9Rvj" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001340" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">218,428</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zDOKDulTzbg1" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1342">-</span></span></td>
    <td id="xdx_987_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zrnAuiua6BD6" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001344" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">218,428</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Investment in UEPC is included in non-current assets in the statement of financial position.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"/><td style="text-align: justify">Capital expenditures consider the acquisitions of property and equipment and intangible assets.<br/></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 202 -->
    <div id="xdx_23D_zRkdvR3s1zoj" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23E_zMDSR2YHCimf" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zJlNKJ99p6vb" style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As of December 31, 2022</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total assets</b></span></td>
    <td id="xdx_987_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zRAE7oqgHOZj" title="Total assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001347" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,775,829</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zolFo5EsoCe" title="Total assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001349" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">149,254</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrxROVSHQG4l" title="Total assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001351" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">275,564</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zzCfWCJ2B3Ld" title="Total assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001353" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,200,647</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zy6vUZYt5VN8" title="Total assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001355" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,108</ix:nonFraction>)</b></span></td>
    <td id="xdx_98A_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zK1l5zvbmCUk" title="Total assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001357" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,199,539</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current assets</span></td>
    <td id="xdx_984_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zshj11nVrpl8" title="Current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001359" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,461,802</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsXRmXsQCIU7" title="Current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001361" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">61,673</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxScDUIatEKc" title="Current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001363" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">115,290</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zeAPq0wY2kUk" title="Current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001365" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,638,765</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_ztMO7e8l3Jr8" title="Current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001367" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,108</ix:nonFraction>)</span></td>
    <td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zyyCbYGJunJi" title="Current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001369" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,637,657</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current assets</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCedULKzJPCa" title="Non-current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001371" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,314,027</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRvtPJWlYvF2" title="Non-current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001373" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,581</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zRAmoep2HWz8" title="Non-current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">160,274</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zHNzsijeAbN8" title="Non-current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001377" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,561,882</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zI0Jap3CKnaf" title="Non-current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1379">-</span></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWCCeMuPxVrk" title="Non-current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001381" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,561,882</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total liabilities and equity</b></span></td>
    <td id="xdx_987_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zlniwGjMLN6e" title="Total liabilities and equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001383" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,775,829</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zxUdxdfwqZi1" title="Total liabilities and equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001385" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">149,254</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z04O7PeF0stc" title="Total liabilities and equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001387" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">275,564</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zlEIAGUNMGcd" title="Total liabilities and equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001389" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,200,647</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z101S8P55Iuf" title="Total liabilities and equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001391" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,108</ix:nonFraction>)</b></span></td>
    <td id="xdx_982_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMMmVLAM4sz" title="Total liabilities and equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001393" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,199,539</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current liabilities</span></td>
    <td id="xdx_980_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zHVKXGs4H7p5" title="Current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001395" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">711,896</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zHopmEGqqt4k" title="Current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001397" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,605</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjmiwW8MXK33" title="Current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001399" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">137,296</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zx46wlx3Egg1" title="Current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001401" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">906,797</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zMp4XkIcdPSf" title="Current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001403" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,108</ix:nonFraction>)</span></td>
    <td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIZ2sxlozLk2" title="Current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001405" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">905,689</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current liabilities</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z8OoURKNYyr4" title="Non-current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001407" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,938,960</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFRiL5i2DiC8" title="Non-current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001409" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,990</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z4wWdA0Xp815" title="Non-current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001411" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,742</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z9Ok6sNrLFn1" title="Non-current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001413" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,043,692</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3mYAqKKub6d" title="Non-current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1415">-</span></span></td>
    <td id="xdx_980_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z54MqKjr7J7l" title="Non-current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001417" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,043,692</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Equity</span></td>
    <td id="xdx_98B_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zDh6dEkO4ubb" title="Equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001419" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,124,973</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJZxGYHnmPA7" title="Equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001421" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,659</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zRHmFb2ANLMh" title="Equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001423" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">97,526</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZLrnFO41nMf" title="Equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001425" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,250,158</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z5tNTpv4DqB4" title="Equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1427">-</span></span></td>
    <td id="xdx_985_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJYqDzfUm4Bk" title="Equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001429" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,250,158</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other disclosures</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Investments in associate (i)</span></td>
    <td id="xdx_984_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zAepd5cXq3vf" title="Investments in associate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001431" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,907</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgYTecDoKIs5" title="Investments in associate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1433">-</span></span></td>
    <td id="xdx_988_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zfteJHFLGTeb" title="Investments in associate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1435">-</span></span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_znDri24KICR2" title="Investments in associate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001437" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,907</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z8cwUgmkU74c" title="Investments in associate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></span></td>
    <td id="xdx_981_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbzIGiW2NEy8" title="Investments in associate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001441" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,907</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital expenditures (ii)</span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zh3P3Ecp5p9" title="Capital expenditures" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001443" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">247,634</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zb9Vt4QPZHX4" title="Capital expenditures" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001445" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,827</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxrEh4Ekk5e8" title="Capital expenditures" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001447" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">61,694</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z6ZTUL27BiNe" title="Capital expenditures" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001449" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">318,155</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zmSDKqDW3PP2" title="Capital expenditures" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1451">-</span></span></td>
    <td id="xdx_98C_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z15F3L6LktE3" title="Capital expenditures" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001453" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">318,155</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Investment in UEPC is included in non-current assets in the statement of financial position.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"/><td style="text-align: justify">Capital expenditures consider the acquisitions of property and equipment and intangible assets.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A1_zB7AHgA9k2c8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">The tables below presents the statements of income for the Company&#8217;s
operating segments for the years ended December 31, 2023, 2022 and 2021:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001455" name="ifrs-full:DisclosureOfOperatingSegmentsExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_89C_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_z5E4H2uYt6ki" summary="xdx: Disclosure - Segment information (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_ztBZVrPUOngh" style="display: none">Schedule of statements of income for the Company&#8217;s
operating segments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td colspan="6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2023</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External customer</span></td>
    <td id="xdx_985_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zW0ANW1KaFfi" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001457" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,511,018</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhE8onfeMyv1" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001459" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">146,827</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zEwTz4RrCU9j" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001461" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">218,068</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z96KAADCrMyk" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001463" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_znadHpbyXdl5" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1465">-</span></span></td>
    <td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfQcC7bwFHll" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001467" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_986_ecustom--InterSegment_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeSteVLWbEf1" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1469">-</span></span></td>
    <td id="xdx_981_ecustom--InterSegment_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrPhohTH1rJi" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1471">-</span></span></td>
    <td id="xdx_98A_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0997bcfBvbb" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001473" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,217</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJZt8gZkzBkg" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001475" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,217</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zyknu0nHf7P4" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:InterSegment" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001477" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</span></td>
    <td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpsu85eiSUDk" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1479">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zgozywOfGwKk" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001481" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,511,018</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z8kLyeqFU1He" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001483" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">146,827</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zv6DROL7NhS5" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001485" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">229,285</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zaUJT6aOECd2" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001487" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,887,130</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zfKAs0NIPNFe" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001489" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfPMenSdwgGg" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001491" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zzAqL1FANVn4" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001493" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">997,973</ix:nonFraction>)</span></td>
    <td id="xdx_984_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbPoUGNXCgwh" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001495" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">62,792</ix:nonFraction>)</span></td>
    <td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z7Fix8dOMcsb" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001497" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">60,265</ix:nonFraction>)</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zHjDYMwJ1A7b" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001499" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,121,030</ix:nonFraction>)</span></td>
    <td id="xdx_980_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zqdzPpPTpl6l" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CostOfSale" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001501" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,217</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfDHZe3oNdt1" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001503" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,109,813</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z6Sv5xr9jVM3" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001505" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,513,045</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z66xVUinoqwc" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001507" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">84,035</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z6ln8JQJdHKb" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001509" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">169,020</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z1aFBm0be9ge" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001511" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,766,100</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z5HgvmdusNxe" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1513">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ze9ihgOAvg6j" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001515" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,766,100</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Selling, general and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zptqXWW6DbI" title="Selling, general and administrative expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001517" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,014,684</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other income, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--OtherGainsLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCPeGXd4czr3" title="Other expenses, net" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001519" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,645</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_982_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2XXFSoS4Eld" title="Operating income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001521" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">767,061</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_981_eifrs-full--FinanceIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbX7VPruAHJ" title="Finance income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001523" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,642</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_ecustom--FinanceExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8amPsYdnHVj" title="Finance expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:FinanceExpense" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001525" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">457,616</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_983_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpcY5FVQSeve" title="Share of income of associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001527" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,495</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_981_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKA8fykmO3p2" title="Income before income taxes" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001529" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">429,582</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMXxKIy3ZZ6d" title="Income taxes expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001531" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">24,166</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_983_eifrs-full--ProfitLoss_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGoN0F0mskdd" title="Net income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001533" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,416</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td colspan="6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External customer</span></td>
    <td id="xdx_985_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zrDg9ZxJO0qh" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001535" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,037,889</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWmjDFLpNA6g" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001537" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,806</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zLviOjNWqDza" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001539" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">182,362</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zff82wLFEEr9" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001541" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,329,057</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAwdwMCw591k" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1543">-</span></span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zBb48rrVbBCc" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001545" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,329,057</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_98A_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zR9b7A66bmh2" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1547">-</span></span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zm8xymixof9" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1549">-</span></span></td>
    <td id="xdx_981_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrtJg8w7fnac" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001551" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,622</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zn1Uz7HokGC" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001553" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,622</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zViKI05Caqej" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:InterSegment" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001555" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,622</ix:nonFraction>)</span></td>
    <td id="xdx_987_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zaTCjiIL9lA9" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1557">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCNpeMSCSDY3" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001559" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,037,889</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj8tKXLhpsJ9" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001561" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,806</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zT4NkcA9XyFe" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001563" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">189,984</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z4QFcNDPOl9a" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001565" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,336,679</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zdIOqhh8D5R3" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Revenue" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001567" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,622</ix:nonFraction>)</b></span></td>
    <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxfGQ8E2iOkl" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001569" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,329,057</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zKtH1D5Ets5f" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001571" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">763,185</ix:nonFraction>)</span></td>
    <td id="xdx_983_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFNJGttMao2k" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001573" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">56,554</ix:nonFraction>)</span></td>
    <td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjCAFpWbYSQj" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001575" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">47,435</ix:nonFraction>)</span></td>
    <td id="xdx_988_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zBbtTvMEcN35" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001577" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">867,174</ix:nonFraction>)</span></td>
    <td id="xdx_981_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zrUu600CUNb2" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CostOfSale" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001579" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,622</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYpF51iHSKo" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001581" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">859,552</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_981_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z0UsPRksf61j" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001583" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,274,704</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvX1RALBKoe4" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001585" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">52,252</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z8o6gf7mDcJ" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001587" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">142,549</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zasbSJr62DU3" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001589" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,469,505</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zXxEeGt8tQm6" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1591">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpFvcPmzkbE4" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001593" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,469,505</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Selling, general and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_985_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zR32kNqjmMzl" title="Selling, general and administrative expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001595" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">798,153</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other expenses, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_985_eifrs-full--OtherGainsLosses_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zb5dNzrx0YT3" title="Other expenses, net" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001597" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,252</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zb1ilX8tm4bg" title="Operating income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001599" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">664,100</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpdBLMb4p1ih" title="Finance income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001601" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">102,042</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_ecustom--FinanceExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zV1veEhJqvG9" title="Finance expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:FinanceExpense" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001603" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">349,893</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zSh6wnAB1hBf" title="Share of income of associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001605" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,184</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98C_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdBl0ViKWKz5" title="Income before income taxes" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001607" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">428,433</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5leDQZLP5Q2" title="Income taxes expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001609" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">35,677</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98C_eifrs-full--ProfitLoss_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zK1M6l0qy6mk" title="Net income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001611" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">392,756</ix:nonFraction></b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 203 -->
    <div id="xdx_23E_zV6EAm2YjqZj" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_237_zABnBR0wjztb" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zrvkDZw6rQDi" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_znqvfW12HOPl" style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="6" style="padding-right: 2pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External customer</span></td>
    <td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zTDgKya8BrL1" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001615" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,498,408</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znB33mhLHpXc" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001617" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,983</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3NiTetUm9v8" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001619" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">147,980</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zXOtu2LDqxzk" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001621" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zUTZBGCjUI21" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1623">-</span></span></td>
    <td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmSQ08quN9A4" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001625" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_983_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zbxTcecIlGD3" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1627">-</span></span></td>
    <td id="xdx_980_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeU9L9pqKpck" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1629">-</span></span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zV7pWJ2sOTw5" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001631" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,978</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zr2BdGWTuYL1" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001633" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,978</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zqqiAKynUJJf" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:InterSegment" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001635" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,978</ix:nonFraction>)</span></td>
    <td id="xdx_985_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z59UgQfM2YTd" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1637">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zcCuU4qd1v68" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001639" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,498,408</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z5uusyxhU9ed" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001641" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,983</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zFsFtlKBbnzb" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001643" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">151,958</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvkeGmqp2E87" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001645" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,723,349</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNFh0pI1WF27" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001647" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,978</ix:nonFraction>)</b></span></td>
    <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zN6qV1KSHbD" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001649" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z2vwf64uAxAe" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001651" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">554,995</ix:nonFraction>)</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhppPyNVwig" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001653" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">50,773</ix:nonFraction>)</span></td>
    <td id="xdx_988_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxztpPHBrttb" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001655" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">50,510</ix:nonFraction>)</span></td>
    <td id="xdx_981_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zpgvmYjn1LT2" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001657" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">656,278</ix:nonFraction>)</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zfM0kbiJVqnl" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CostOfSale" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001659" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,978</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvUd1hIQasq9" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001661" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">652,300</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zItmGSX2wqna" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001663" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">943,413</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z2aBvSMdA4mc" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001665" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,210</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zTzBxFJpmTNf" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001667" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">101,448</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zPbfZadgLDx1" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001669" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,067,071</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z29oWpfJhM3a" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1671">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAtBRk0UFuG4" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001673" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,067,071</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Selling, general and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_987_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpwd2qreyvWj" title="Selling, general and administrative expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001675" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">622,615</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other expenses, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_987_eifrs-full--OtherGainsLosses_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbHVHeJ1sTAi" title="Other expenses, net" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001677" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,561</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zPdnODlGRfjd" title="Operating income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001679" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">440,895</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcAoFk3YfpDf" title="Finance income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001681" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,566</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_982_ecustom--FinanceExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zwG1A8fWY1Q9" title="Finance expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:FinanceExpense" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001683" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">243,796</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zPccjhkJAwqb" title="Share of income of associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001685" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,797</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_986_eifrs-full--ProfitLossBeforeTax_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8nsMy8kF56" title="Income before income taxes" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001687" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">273,462</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z11LPtW5MSV2" title="Income taxes expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001689" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,179</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net income </b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98B_eifrs-full--ProfitLoss_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zk9F8EQJpzRc" title="Net income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001691" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,283</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A6_z4vVXsFx2NA4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>Seasonality of operations</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Undergrad&#8217;s tuition revenues are related to the intake process and
monthly tuition fees charged to students over the period; thus, does not have significant fluctuations during the year. Continuing Education
revenues are related to monthly intakes and tuition fees and do not have a considerable concentration in any period. Digital Services
is comprised mainly of Medcel, Pebmed, and iClinic revenues. While Pebmed and iClinic do not have significant fluctuation regarding seasonality,
Medcel&#8217;s revenue is concentrated in the first and last quarter of the year due to the enrollments. In addition, the majority of
Medcel&#8217;s revenues are derived from printed books and e-books, which are recognized at the point in time when control is transferred
to the customer. Consequently, the Digital Services segment generally has higher revenues and results of operations in the first and last
quarters of the year than in the second and third quarters.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001693" name="ifrs-full:DisclosureOfBusinessCombinationsExplanatory"><p id="xdx_808_eifrs-full--DisclosureOfBusinessCombinationsExplanatory_zsom6hNqSvmf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>5</b></td><td><b><span id="xdx_820_zwktbLeR2yxj">Business combinations</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>5.1 Acquisition in 2023</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The fair values of the identifiable assets acquired and liabilities assumed
as of acquisition date were:</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001695" name="afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_895_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zimvmswtXyFh" summary="xdx: Disclosure - Business combinations (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; line-height: 106%"><span id="xdx_8B0_zdO2J5A9ZQwd" style="display: none">Schedule
    of fair values of the identifiable assets acquired and liabilities assumed acquisition in 2023</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 106%">&#160;</td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 142px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>DelRey</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Cash and cash and equivalents</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zx7q3y2GhePk" title="Cash and cash and equivalents" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001697" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,804</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Trade receivables</span></td>
    <td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztZyakB37YR8" title="Trade receivables" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001699" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,741</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Inventories</span></td>
    <td id="xdx_984_ecustom--Inventories1_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zq4Bedf61RX7" title="Inventories" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="afya:Inventories1" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001701" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">139</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Recoverable taxes</span></td>
    <td id="xdx_981_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zQacF6a5jItb" title="Recoverable taxes" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001703" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">589</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Other assets</span></td>
    <td id="xdx_984_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zE4qyvle0vg9" title="Other assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001705" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,563</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Property and equipment</span></td>
    <td id="xdx_986_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zB3oTwyMWPQk" title="Property and equipment" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001707" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,980</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Right-of-use assets</span></td>
    <td id="xdx_980_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zBFT0oR3njE6" title="Right-of-use assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001709" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,408</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Intangible assets</span></td>
    <td id="xdx_98C_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zHPO44bCNul2" title="Intangible assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001711" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">728,777</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%">&#160;</td>
    <td id="xdx_983_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z1B1YccetCjc" title="Total" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001713" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">870,001</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Trade payables</span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5Gta590Aknc" title="Trade payables" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001715" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,253</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Lease liabilities</span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zEGz0l2HWMzd" title="Lease liabilities" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001717" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,408</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Labor and social obligations</span></td>
    <td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztrARYUpLdo2" title="Labor and social obligations" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001719" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,252</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Taxes and contributions payable</span></td>
    <td id="xdx_98E_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zB8UM0w71vU7" title="Taxes and contributions payable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001721" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,282</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Advances from customers</span></td>
    <td id="xdx_986_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zdhzX7I0nXih" title="Advances from customers" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001723" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,327</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Provision for legal proceedings</span></td>
    <td id="xdx_982_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmyGKUsIkL5d" title="Provision for legal proceedings" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001725" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">152</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Other liabilities</span></td>
    <td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWc3HKBsjTBl" title="Other liabilities" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001727" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,189</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%">&#160;</td>
    <td id="xdx_98B_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z51nK7lk5Uu" title="Financial liabilities recognised as of acquisition date" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001729" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,863</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Total identifiable net assets at fair value</b></span></td>
    <td id="xdx_98A_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5tECIZgEYFj" title="Total identifiable net assets at fair value" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001731" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">741,138</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Goodwill arising on acquisition</span></td>
    <td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztQ18ge7ggB6" title="Goodwill arising on acquisition" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001733" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">75,098</ix:nonFraction></span></td></tr>

<tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Purchase consideration transferred</b></span></td>
    <td id="xdx_984_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zXh6Ovd8Lzc5" title="Purchase consideration transferred" style="border-bottom: black 1pt solid; white-space: nowrap; width: 142px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001735" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">816,236</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Cash paid</span></td>
    <td id="xdx_98D_eifrs-full--CashTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmxeILVsOurd" title="Cash paid" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001737" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">575,000</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Consideration to be transferred</span></td>
    <td id="xdx_980_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zbGfwW67QsFf" title="Consideration to be transferred" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact001739" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">234,000</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Digital solutions (i)</span></td>
    <td id="xdx_985_eifrs-full--CirculationRevenue_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztkxOsTSLjsk" title="Digital solutions" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="ifrs-full:CirculationRevenue" contextRef="From2023-01-012023-01-02_custom_DelReyMember" id="Fact001741" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,236</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b><i>Analysis of cash flows on acquisition:</i></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Transaction costs of the acquisition (included in cash flows from operating activities) </span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zVb799D9T362" title="Transaction costs of the acquisition (included in cash flows from operating activities)" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2023-01-012023-01-02_custom_DelReyMember" id="Fact001743" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,332</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)</span></td>
    <td id="xdx_989_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zUYh2rKgST19" title="Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2023-01-012023-01-02_custom_DelReyMember" id="Fact001745" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">567,196</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Net of cash flow on acquisition </b></span></td>
    <td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zRTlufGOZPqe" title="Net of cash flow on acquisition" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2023-01-012023-01-02_custom_DelReyMember" id="Fact001747" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">579,528</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">The total consideration transferred included the obligation to offer digital solutions, especially
from Medcel, Pebmed and Medical Harbour, through access (free-of-charge) to medical students of other medical schools held by the selling
shareholders, not subject to this acquisition, from 2023 to 2030. This purchase consideration was measured using assumptions such as
numbers of approved medical seats, current digital solutions prices, inflation and present value discount rates. The balances of such
consideration are classified as other liabilities on the statement of financial position.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A1_z2PncZqL5zCc" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 204 -->
    <div id="xdx_23B_zqTebb3Z65xa" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_234_zhuaVCTRUSKh" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zqPj3NJSl3u1" style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_z29n2BRno3Kd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><b>(a) Acquisition
of DelRey</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On January 2, 2023, Afya Brazil acquired <span id="xdx_90B_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_uPure_c20230102__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zqblTZoz79E8" title="Acquired share capital"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2023-01-02_custom_AcquisitionOfDelReyMember" id="Fact001751" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the share capital of DelRey.
<span id="xdx_90C_eifrs-full--DescriptionOfAcquiree_c20221229__20230102__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zwnxUuSFia14" title="Acquired purchase price"><ix:nonNumeric contextRef="From2022-12-292023-01-02_custom_AcquisitionOfDelReyMember" id="Fact001753" name="ifrs-full:DescriptionOfAcquiree">The original aggregate purchase price of R$832,236 was adjusted by R$16,000, in favor of the Company, to R$816,236 comprised by: i) R$809,000
of which R$575,000 was paid in cash on the transaction closing date, and R$234,000 is payable in cash in three annual installments, respectively,
of R$134,000 in January 2024, R$50,000 in January 2025 and R$50,000 in January 2026, adjusted by the SELIC rate; and ii) offer of AFYA&#8217;s
digital solutions free of charge until December 31, 2030, for students of medicine of universities owned by the sellers which are not
part of the transaction. The fair value of this service was estimated at R$7,236 at the acquisition date. There are 84 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$105,000. Given the future event
that will trigger the potential payout is not under the Company&#8217;s control, the probability of such payout cannot be reliably estimated
and accordingly the contingent consideration was not measured at the acquisition date. Should the additional seats be approved, it will
result in additional licenses, which will be measured accordingly if and when approved.</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">DelRey is a post-secondary education institution with governmental authorization
to offer on-campus, undergraduate degrees and graduate programs in medicine and health, as well as other courses, in the States of Alagoas
and Pernambuco. The acquisition contributes 340 medical school seats to Afya. With the acquisition, Afya further consolidates its presence
in the Brazilian Northeast, entering a new State in the region.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The acquisition of DelRey was accounted for under IFRS 3 - Business Combinations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Transaction costs to date amount to R$<span id="xdx_907_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20221229__20230102__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zZjlJGWUVo95" title="Transaction costs"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2022-12-292023-01-02_custom_AcquisitionOfDelReyMember" id="Fact001755" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,332</ix:nonFraction></span> and were expensed and are included
in selling, general and administrative expenses in the consolidated statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">At the acquisition date, the fair value of the trade receivables acquired
is substantially the same as its carrying amount.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The goodwill recognized includes the value of expected synergies arising
from the acquisition, which is not separately recognized. Goodwill is allocated entirely to the Undergrad segment. The goodwill recognized
is not expected to be deductible for income taxes purposes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company did not recognize deferred taxes related
to the business combination because the tax basis and the accounting basis, including fair value adjustments, were the same at the date
of the business combination.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company engaged an independent valuation specialist
to assist Management to assess the fair value of the assets acquired and liabilities assumed at date of acquisition. The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 205 -->
    <div id="xdx_23B_zQDwlHuEAc41" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23F_zCRAKWJxOGsg" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zSA1TljcuQT7" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001758" name="afya:ScheduleOfAcquisitionOfDelReyExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_884_ecustom--ScheduleOfAcquisitionOfDelReyExplanatory_zlxEWMMhwBM9" summary="xdx: Disclosure - Business combinations (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span id="xdx_8BC_zKltqkMykQWc" style="display: none">Schedule of intangible assets acquired</span></td>
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center; line-height: 106%">&#160;</td></tr>
  <tr style="background-color: white">
    <td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 106%"><b>Valuation technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Licenses</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>With-and-without method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20230101__20230102__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesAndFranchisesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfDelReyMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--WithAndWithoutMethodMember_zwY6rn3TsBfc" title="Valuation technique"><ix:nonNumeric contextRef="From2023-01-012023-01-02_ifrs-full_LicencesAndFranchisesMember_custom_AcquisitionOfDelReyMember_custom_WithAndWithoutMethodMember" id="Fact001760" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.</ix:nonNumeric></span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Customer relationships</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Multi-period excess earnings method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20230101__20230102__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfDelReyMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zwWi3nnsHwla" title="Valuation technique"><ix:nonNumeric contextRef="From2023-01-012023-01-02_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfDelReyMember_ifrs-full_MultiperiodExcessEarningsMethodMember" id="Fact001762" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</ix:nonNumeric></span></p></td></tr>
  </table></ix:nonNumeric>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The valuation technique for property and equipment consists of determining
the fair value of an asset by using methodologies like replacement costs and market value.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">DelRey has contributed R$<span id="xdx_90B_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zBLrCkMk6ez9" title="Net revenue"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_custom_AcquisitionOfDelReyMember" id="Fact001764" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">240,107</ix:nonFraction></span> of revenue and R$<span id="xdx_907_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zEaPt8ixA39k" title="Income loss before income taxes"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2023-01-012023-12-31_custom_AcquisitionOfDelReyMember" id="Fact001766" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">82,147</ix:nonFraction></span> of income before
income taxes to the Company in 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">5.2 Acquisitions in 2022</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The fair values of the identifiable assets acquired and liabilities assumed
as of acquisition date were:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001768" name="afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89D_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock_z7pRsCeViO3d" summary="xdx: Disclosure - Business combinations (Details 2)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B4_zpvBWvTaPcqf" style="display: none">Schedule of fair values of the identifiable assets acquired and liabilities assumed
as of acquisition in 2022</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 55%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Al&#233;m da Medicina</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 15%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>CardioPapers</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 15%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Glic</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash and cash and equivalents</span></td>
    <td id="xdx_984_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zZIiyCYjvmrb" title="Cash and cash and equivalents" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001770" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">298</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zh54ljKNPFUk" title="Cash and cash and equivalents" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001772" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,648</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zGjraiCgRBj7" title="Cash and cash and equivalents" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001774" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">151</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade receivables</span></td>
    <td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zT3Go2JZ4FZ6" title="Trade receivables" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001776" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,705</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zYAaVFYffyg1" title="Trade receivables" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001778" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,350</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zNLidwplezO" title="Trade receivables" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001780" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">94</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other assets</span></td>
    <td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zTgi5Q9GrNLd" title="Other Assets As Of Acquisition Date" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001782" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">266</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zBgPEIGbCPPf" title="Other Assets As Of Acquisition Date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001784" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z38j0DjSkSOa" title="Property, plant and equipment recognised as of acquisition date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001786" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Property and equipment</span></td>
    <td id="xdx_987_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zf4v2hxMUcQe" title="Property, plant and equipment recognised as of acquisition date" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001788" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zVNHOGk50XQg" title="Property, plant and equipment recognised as of acquisition date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001790" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zPLTq0N2g24c" title="Property, plant and equipment recognised as of acquisition date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1792">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Intangible assets</span></td>
    <td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zLXUROZduKWk" title="Identifiable intangible assets recognised as of acquisition date" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001794" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,299</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zmS9Vi0Wy22j" title="Identifiable intangible assets recognised as of acquisition date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001796" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,655</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zuOXjEssz5zi" title="Identifiable intangible assets recognised as of acquisition date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001798" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,395</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_986_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zAW2EF13e6gk" title="Total" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001800" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,605</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zoFyaTsS3RX7" title="Total" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001802" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,697</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zZ9h5n2G5ZV5" title="Total" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001804" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,676</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade payables</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zbShxV6woIni" title="Trade and other payables recognised as of acquisition date" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001806" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">705</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zERhoS0Ry21l" title="Trade and other payables recognised as of acquisition date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001808" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,703</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zPCa2JdtRuL2" title="Trade and other payables recognised as of acquisition date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001810" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Labor and social obligations</span></td>
    <td id="xdx_986_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zlx2EepCblV9" title="Labor And Social Obligations As Of Acquisition Date" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001812" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">79</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z8YmyMNVWFG3" title="Labor And Social Obligations As Of Acquisition Date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001814" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zCQXZrQGIX69" title="Labor And Social Obligations As Of Acquisition Date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1816">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Taxes and contributions payable</span></td>
    <td id="xdx_984_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zbBEZ5JfSSs" title="Taxes Payable As Of Acquisition Date" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001818" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,182</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zMuVJGVuvrv7" title="Taxes Payable As Of Acquisition Date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001820" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">352</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zK3d05uactzg" title="Taxes Payable As Of Acquisition Date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001822" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">91</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Advances from customers</span></td>
    <td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zv2fEdTDm4ul" title="Advances From Customers As Of Acquisition Date" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001824" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,185</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zyY2k6Cw4Hke" title="Advances From Customers As Of Acquisition Date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001826" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,893</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z2d2nxKZ7nph" title="Advances From Customers As Of Acquisition Date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1828">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other liabilities</span></td>
    <td id="xdx_986_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zVKPx78yXUtf" title="Other Liabilities As Of Acquisition Date" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1830">-</span></span></td>
    <td id="xdx_987_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zRstoWPCZmkk" title="Other Liabilities As Of Acquisition Date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1832">-</span></span></td>
    <td id="xdx_98F_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zMP0RLEp2bFi" title="Other Liabilities As Of Acquisition Date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001834" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">574</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_987_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zrO1lf7KyW47" title="Total" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001836" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,151</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zPPw8EG1sAkj" title="Total" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001838" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,008</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqjfv8Vj4x07" title="Total" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001840" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">666</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total identifiable net assets at fair value</b></span></td>
    <td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zM7X2sxvzGEd" title="Indemnification assets recognised as of acquisition date" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001842" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,454</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zKqKfGbHRVwk" title="Indemnification assets recognised as of acquisition date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001844" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,689</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zEQ3nRtWIrra" title="Indemnification assets recognised as of acquisition date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001846" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,010</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Goodwill arising on acquisition</span></td>
    <td id="xdx_984_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zLuLArMFsagh" title="Goodwill recognised as of acquisition date" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001848" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,335</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zilRbSQmW8Ta" title="Goodwill recognised as of acquisition date" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001850" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,324</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zNam2rVisFS2" title="Goodwill recognised as of acquisition date" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001852" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,587</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Purchase consideration transferred</b></span></td>
    <td id="xdx_98A_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zumHhHtK96Ej" title="Consideration transferred, acquisition-date fair value" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001854" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,789</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zHoIrWBEllo5" title="Consideration transferred, acquisition-date fair value" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001856" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,013</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zw32cmPQpCo6" title="Consideration transferred, acquisition-date fair value" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001858" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,597</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash paid</span></td>
    <td id="xdx_989_eifrs-full--CashTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zDzK2xio0bjf" title="Cash transferred" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001860" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,952</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--CashTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zkUj9j1s4cqi" title="Cash transferred" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001862" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,924</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--CashTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zDG7s0ngkyQ3" title="Cash transferred" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001864" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,602</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Contingent consideration</span></td>
    <td id="xdx_987_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zFdDMp3rUcE6" title="Contingent consideration recognised as of acquisition date" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001866" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,074</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zdg6jS358aC9" title="Contingent consideration recognised as of acquisition date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001868" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,422</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zvvvsA44uSNh" title="Contingent consideration recognised as of acquisition date" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-05-23_custom_GlicMember" id="Fact001870" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,995</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Consideration to be transferred (Price adjustment)</span></td>
    <td id="xdx_982_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zTVZdxqreU7c" title="Consideration To Be Transferred" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact001872" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">763</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zzci5QDow1ck" title="Consideration To Be Transferred" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact001874" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">333</ix:nonFraction>)</span></td>
    <td id="xdx_988_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z6VexzhOC941" title="Consideration To Be Transferred" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1876">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><i>Analysis of cash flows on acquisition:</i></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transaction costs of the acquisition (included in cash flows from operating activities) </span></td>
    <td id="xdx_987_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zSfoV1AZqZy2" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember1360038046" id="Fact001878" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">227</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zbUM9v1mcATd" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2022-04-042022-04-05_custom_CardioPapersMember1360038093" id="Fact001880" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">274</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zzVPSnEeW1Z3" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2022-05-222022-05-23_custom_GlicMember1360038140" id="Fact001882" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">222</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zN0f44lV96rk" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember1360038046" id="Fact001884" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,654</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zPcPrt3DJFs8" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2022-04-042022-04-05_custom_CardioPapersMember1360038093" id="Fact001886" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,276</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zyu1k6k3vZeh" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2022-05-222022-05-23_custom_GlicMember1360038140" id="Fact001888" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,451</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net of cash flow on acquisition </b></span></td>
    <td id="xdx_980_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zYKuETlqF8S" title="Net of cash flow on acquisition" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember1360038046" id="Fact001890" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,881</ix:nonFraction></b></span></td>
    <td id="xdx_98B_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zGhZTDSsTxzh" title="Net of cash flow on acquisition" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2022-04-042022-04-05_custom_CardioPapersMember1360038093" id="Fact001892" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,550</ix:nonFraction></b></span></td>
    <td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqs1AvI6cNY7" title="Net of cash flow on acquisition" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2022-05-222022-05-23_custom_GlicMember1360038140" id="Fact001894" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,673</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A8_zqEBuY98Mkg6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><b>(a) Acquisition
of Al&#233;m da Medicina</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On March 4, 2022, Afya Brazil acquired <span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zkEkZBk9dmi4"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember" id="Fact001895" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the share capital of BMV
Atividades M&#233;dicas Ltda. (&#8220;Al&#233;m da Medicina&#8221;). <span id="xdx_90E_eifrs-full--DescriptionOfAcquiree_c20220303__20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zB6SuHPnunO" title="Acquired purchase price"><ix:nonNumeric contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember" id="Fact001897" name="ifrs-full:DescriptionOfAcquiree">The aggregate purchase price of R$26,789 is comprised by: i)
R$14,952 paid in cash on the transaction closing date; ii) an earn-out (&#8220;contingent consideration&#8221;) of up to R$19,200 is payable
in connection with revenue target achievements for 2023 and 2024; and iii) price adjustment related to net debt of R$763 in favor of selling
shareholders. The contingent consideration of R$11,074 is based on the present value of the obligation considering the facts and circumstances
at the acquisition date.</ix:nonNumeric></span> See Note 13.2.3 for further details of the earn-out amounts as of December 31, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 206 -->
    <div id="xdx_23E_zU7EbJaOepCd" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23B_zI9zSbvaLple" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zE2H6ouxRY4e" style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="background-color: white">A</span>l&#233;m da Medicina is
a medical content online platform for physicians and medical students that provides educational tools besides technical medical content
that can assist them throughout their careers. Its contents include mentoring for residency, soft skills and finance, accounting, and
investment basics for physicians.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The acquisition of <span style="background-color: white">A</span>l&#233;m
da Medicina was accounted for under IFRS 3 - Business Combinations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Transaction costs to date amount to R$<span id="xdx_903_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20220303__20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_z2VjyNZVa0te" title="Transaction costs"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember" id="Fact001900" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">227</ix:nonFraction></span> and were expensed and are included
in selling, general and administrative expenses in the consolidated statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">At the acquisition date, the fair value of the trade receivables acquired
equals its carrying amount.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The goodwill recognized includes the value of expected synergies arising
from the acquisition, which is not separately recognized. Goodwill is allocated entirely to Digital Services segment. The goodwill recognized
is not expected to be deductible for income taxes purposes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company did not recognize deferred taxes related to the business combination
because the tax basis and the accounting basis, including fair value adjustments, were the same at the date of the business combination.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The valuation techniques used for measuring the fair value of separately
identified intangible assets acquired were as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001902" name="afya:ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_880_ecustom--ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory_zPFM8XBGUaq9" summary="xdx: Disclosure - Business combinations (Details 3)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span id="xdx_8BC_zVhuVsSsJZwf" style="display: none">Schedule of acquisition
of al&#233;m da medicina intangible assets acquired</span></td>
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Trademark</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Relief from royalty</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_905_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zrrJInQTzh4k" title="Valuation technique"><ix:nonNumeric contextRef="From2022-03-032022-03-04_ifrs-full_BrandNamesMember_custom_AlemDaMedicinaMember_custom_ReliefFromRoyaltyMember" id="Fact001904" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</ix:nonNumeric></span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Customer relationships</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Multi-period excess earnings method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zUPkDFOqXpX3" title="Valuation technique"><ix:nonNumeric contextRef="From2022-03-032022-03-04_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AlemDaMedicinaMember_ifrs-full_MultiperiodExcessEarningsMethodMember" id="Fact001906" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</ix:nonNumeric></span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Educational content</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Replacement cost</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--EducationalContentMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zyoHUCxfxK79" title="Valuation technique"><ix:nonNumeric contextRef="From2022-03-032022-03-04_custom_EducationalContentMember_custom_AlemDaMedicinaMember_custom_ReplacementCostMember" id="Fact001908" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</ix:nonNumeric></span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Developed technology intangible assets</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Replacement cost</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zDUiICHyzMXf" title="Valuation technique"><ix:nonNumeric contextRef="From2022-03-032022-03-04_ifrs-full_TechnologybasedIntangibleAssetsMember_custom_AlemDaMedicinaMember_custom_ReplacementCostMember" id="Fact001910" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</ix:nonNumeric></span></p></td></tr>
  </table></ix:nonNumeric>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="background-color: white">A</span>l&#233;m da Medicina has
contributed R$<span id="xdx_90B_eifrs-full--Revenue_pn3n3_c20220303__20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zm3znlRbd2t" title="Net revenue"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember" id="Fact001912" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,859</ix:nonFraction></span> of revenue and R$<span id="xdx_90D_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220303__20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zUdnwFPlfQdj" title="Income loss before income taxes"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember" id="Fact001914" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,448</ix:nonFraction></span> of income before income taxes to the Company in 2022. Should the acquisition had taken place
at the beginning of the year, revenue for the year ended December 31, 2022 would have been increased by R$<span id="xdx_90D_ecustom--IncreaseInRevenue_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_z36o73efrD48" title="Increase in revenue"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2022-01-012022-12-31_custom_AlemDaMedicinaMember" id="Fact001916" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,529</ix:nonFraction></span> and income before income
taxes would have been increased by R$<span id="xdx_90B_ecustom--IncreaseInIncomeBeforeIncomeTaxes_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zBx8NWkaNmDe" title="Increase in income before income taxes"><ix:nonFraction name="afya:IncreaseInIncomeBeforeIncomeTaxes" contextRef="From2022-01-012022-12-31_custom_AlemDaMedicinaMember" id="Fact001918" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">867</ix:nonFraction></span>.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>&#160;</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><b>(b) Acquisition
of CardioPapers</b></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><b>&#160;</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On April 5, 2022, Afya Brazil acquired <span id="xdx_900_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_c20220405__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfCardioPapersMember_z32Ct6u1c6Q8"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2022-04-05_custom_AcquisitionOfCardioPapersMember" id="Fact001919" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the share capital of Cardiopapers
Solu&#231;&#245;es Digitais Ltda. (&#8220;CardioPapers&#8221;). <span id="xdx_909_eifrs-full--DescriptionOfAcquiree_c20220404__20220405__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfCardioPapersMember_zibz7rj4QHge"><ix:nonNumeric contextRef="From2022-04-042022-04-05_custom_AcquisitionOfCardioPapersMember" id="Fact001920" name="ifrs-full:DescriptionOfAcquiree">The aggregate purchase price of R$42,013 is comprised by: i) R$34,924
paid in cash on the transaction closing date; ii) an earn-out (&#8220;contingent consideration&#8221;) of up of R$15,000 is payable in
connection with revenue target achievements for 2023 and 2024 and other goals; and iii) price adjustment related to net debt of R$333
in favor of Afya Brazil. The contingent consideration of R$7,422 is based on the present value of the obligation considering the facts
and circumstances at the acquisition date.</ix:nonNumeric></span> <span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">See Note 13.2.3 for
further details of the earn-out amounts as of December 31, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#160;</span></p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>


<ix:exclude><!-- Field: Page; Sequence: 207 -->
    <div id="xdx_23E_zshvA47QmjAe" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_236_zWNy5A85pLng" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_z8InZvNv1OV" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">CardioPapers is the main medical content and education platform in the Cardiology
field, offering courses and books developed by physicians and for physicians, covering all phases of the medical career, aligned with
Afya&#8217;s overall business strategy.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The acquisition of <span style="background-color: white">CardioPapers</span>
was accounted for under IFRS 3 &#8211; Business Combinations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Transaction costs to date amount to R$<span id="xdx_900_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20220404__20220405__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfCardioPapersMember_zkushzi6bj5c"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2022-04-042022-04-05_custom_AcquisitionOfCardioPapersMember" id="Fact001922" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">274</ix:nonFraction></span> and were
expensed and are included in selling, general and administrative expenses in the consolidated statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">At the acquisition date, the fair value of the trade
receivables acquired equals its carrying amount.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The goodwill recognized includes the value of expected synergies arising
from the acquisition, which is not separately recognized. Goodwill is allocated entirely to Digital Services segment. The goodwill recognized
is not expected to be deductible for income taxes purposes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company did not recognize deferred taxes related
to the business combination because the tax basis and the accounting basis, including fair value adjustments, were the same at the date
of the business combination.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The valuation techniques used for measuring the fair value of separately
identified intangible assets acquired were as follows:</p>

<p style="font: 5pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001924" name="afya:ScheduleOfAcquisitionOfCardioPapersExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_888_ecustom--ScheduleOfAcquisitionOfCardioPapersExplanatory_zKJ2Kqk2FVP8" summary="xdx: Disclosure - Business combinations (Details 4)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span id="xdx_8B8_zabiY7ZPWmx4" style="display: none">Schedule of acquisition
of cardio papers intangible assets acquired</span></td>
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: Black 1pt solid; width: 22%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 78%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Trademark</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Relief from royalty</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zFfWk9vmNik3" title="Valuation technique"><ix:nonNumeric contextRef="From2022-04-042022-04-05_ifrs-full_BrandNamesMember_custom_AcquisitionOfCardioPapersMember_custom_ReliefFromRoyaltyMember" id="Fact001926" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</ix:nonNumeric></span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Customer relationships</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Multi-period excess earnings method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zMMkPniWK904" title="Valuation technique"><ix:nonNumeric contextRef="From2022-04-042022-04-05_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfCardioPapersMember_ifrs-full_MultiperiodExcessEarningsMethodMember" id="Fact001928" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</ix:nonNumeric></span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Educational content</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Replacement cost</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--EducationalContentMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zVwXPUnY1zN4" title="Valuation technique"><ix:nonNumeric contextRef="From2022-04-042022-04-05_custom_EducationalContentMember_custom_AcquisitionOfCardioPapersMember_custom_ReplacementCostMember" id="Fact001930" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</ix:nonNumeric></span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Copyrights</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Relief from royalty</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_902_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--CopyrightMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zJr5B1aMXUGf" title="Valuation technique"><ix:nonNumeric contextRef="From2022-04-042022-04-05_custom_CopyrightMember_custom_AcquisitionOfCardioPapersMember_custom_ReliefFromRoyaltyMember" id="Fact001932" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</ix:nonNumeric></span></p></td></tr>
  </table></ix:nonNumeric>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="background-color: white">CardioPapers </span>has contributed
R$<span id="xdx_906_eifrs-full--Revenue_pn3n3_c20220404__20220405__ifrs-full--BusinessCombinationsAxis__custom--CardioPapersMember_zTFmy9KUdMf6" title="Net revenue"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2022-04-042022-04-05_custom_CardioPapersMember" id="Fact001934" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,934</ix:nonFraction></span> of revenue and R$<span id="xdx_900_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220404__20220405__ifrs-full--BusinessCombinationsAxis__custom--CardioPapersMember_z97oyFhRnRek" title="Income loss before income taxes"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2022-04-042022-04-05_custom_CardioPapersMember" id="Fact001936" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,352</ix:nonFraction></span> of income before income taxes to the Company in 2022. Should the acquisition had taken place at the beginning
of the year, revenue for the year ended December 31, 2022 would have been increased by R$<span id="xdx_908_ecustom--IncreaseInRevenue_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--CardioPapersMember_zvaKBKHlRgPl" title="Increase in revenue"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2022-01-012022-12-31_custom_CardioPapersMember" id="Fact001938" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,117</ix:nonFraction></span> and income before income taxes would have
been decreased by R$<span id="xdx_903_ecustom--DecreaseInIncomeBeforeIncomeTaxes_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--CardioPapersMember_zsqZhyyuWVoh" title="Decrease in income before income taxes"><ix:nonFraction name="afya:DecreaseInIncomeBeforeIncomeTaxes" contextRef="From2022-01-012022-12-31_custom_CardioPapersMember" id="Fact001940" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,041</ix:nonFraction></span>.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:exclude><p id="xdx_234_zTrDkASOOA11" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;<br/>
</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 208 -->
    <div id="xdx_23E_zsqpPhg86iA1" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_233_zDJz86OJRapc" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><b>(c) Acquisition
of Glic</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On May 23, 2022, Afya Brazil acquired <span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_uPure_c20220523__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfGlicMember_zsysAriQbSrb"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2022-05-23_custom_AcquisitionOfGlicMember" id="Fact001942" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the share capital of Quasar
Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&#8220;Glic&#8221;). <span id="xdx_904_eifrs-full--DescriptionOfAcquiree_c20220522__20220523__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfGlicMember_zaIDgHpaSHm5"><ix:nonNumeric contextRef="From2022-05-222022-05-23_custom_AcquisitionOfGlicMember" id="Fact001943" name="ifrs-full:DescriptionOfAcquiree">The aggregate purchase price of R$30,597 is comprised
by: i) R$21,602 paid in cash on the transaction closing date and ii) an earn-out (&#8220;contingent consideration&#8221;) of up of R$12,000
is payable in connection with revenue target achievements for 2023 and 2024 and product development goals. The contingent consideration
of R$8,995 is based on the present value of the obligation considering the facts and circumstances at the acquisition date.</ix:nonNumeric></span> See Note 13.2.3
for further details of the earn-out amounts as of December 31, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Glic is a free diabetes care and management app solution for physicians
and patients that uses technology to improve diabetes education and daily routine practices, connecting users, devices and healthcare
providers.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The acquisition of <span style="background-color: white">Glic</span>
was accounted for under IFRS 3 - Business Combinations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Transaction costs to date amount to R$<span id="xdx_904_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20220522__20220523__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfGlicMember_zx1IgnkR03el"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2022-05-222022-05-23_custom_AcquisitionOfGlicMember" id="Fact001944" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">222</ix:nonFraction></span> and were
expensed and are included in selling, general and administrative expenses in the consolidated statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">At the acquisition date, the fair value of the trade
receivables acquired equals its carrying amount.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The goodwill recognized includes the value of expected synergies arising
from the acquisition, which is not separately recognized. Goodwill is allocated entirely to Digital Services segment. The goodwill recognized
is not expected to be deductible for income taxes purposes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company did not recognize deferred taxes related
to the business combination because the tax basis and the accounting basis, including fair value adjustments, were the same at the date
of the business combination.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The valuation techniques used for measuring the fair value of separately
identified intangible assets acquired were as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001946" name="afya:ScheduleOfAcquisitionOfGlicExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_88F_ecustom--ScheduleOfAcquisitionOfGlicExplanatory_zVSBwnyvEeja" summary="xdx: Disclosure - Business combinations (Details 5)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span id="xdx_8B6_zDGdRJU8YAq6" style="display: none">Schedule of acquisition
of Glic intangible assets acquired</span></td>
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Trademark</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Relief from royalty</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zMuveJAULSJ" title="Valuation technique"><ix:nonNumeric contextRef="From2022-05-222022-05-23_ifrs-full_BrandNamesMember_custom_AcquisitionOfGlicMember_custom_ReliefFromRoyaltyMember" id="Fact001948" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</ix:nonNumeric></span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Customer relationships</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Multi-period excess earnings method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zfqTDuTn1yae" title="Valuation technique"><ix:nonNumeric contextRef="From2022-05-222022-05-23_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfGlicMember_ifrs-full_MultiperiodExcessEarningsMethodMember" id="Fact001950" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</ix:nonNumeric></span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Developed technology intangible assets</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Replacement cost</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zIj8UB7xA1mb" title="Valuation technique"><ix:nonNumeric contextRef="From2022-05-222022-05-23_ifrs-full_TechnologybasedIntangibleAssetsMember_custom_AcquisitionOfGlicMember_custom_ReplacementCostMember" id="Fact001952" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</ix:nonNumeric></span></p></td></tr>
  </table></ix:nonNumeric>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="background-color: white">Glic </span>has contributed R$<span id="xdx_900_eifrs-full--Revenue_pn3n3_c20220522__20220523__ifrs-full--BusinessCombinationsAxis__custom--GlicMember_z049UNtYpJKf" title="Net revenue"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2022-05-222022-05-23_custom_GlicMember" id="Fact001954" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">389</ix:nonFraction></span>
of revenue and R$<span id="xdx_90E_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220522__20220523__ifrs-full--BusinessCombinationsAxis__custom--GlicMember_zSeY7IqBrJGd" title="Income loss before income taxes"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2022-05-222022-05-23_custom_GlicMember" id="Fact001956" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,539</ix:nonFraction></span> of losses before income taxes to the Company in 2022. Should the acquisition had taken place at the beginning of
the year, revenue for the year ended December 31, 2022 would have been increased by R$<span id="xdx_905_ecustom--IncreaseInRevenue_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--GlicMember_zI8bptSokOTd" title="Increase in revenue"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2023-01-012023-12-31_custom_GlicMember" id="Fact001958" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">173</ix:nonFraction></span> and income before income taxes would have been
decreased by R$<span id="xdx_90A_ecustom--DecreaseInIncomeBeforeIncomeTaxes_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--GlicMember_zRXspcH7RoQj" title="Decrease in income before income taxes"><ix:nonFraction name="afya:DecreaseInIncomeBeforeIncomeTaxes" contextRef="From2023-01-012023-12-31_custom_GlicMember" id="Fact001960" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">700</ix:nonFraction></span>.</p>

<ix:exclude><p id="xdx_23C_zBXtepjRCM3g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;<br/>
</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 209 -->
    <div id="xdx_23F_zEtxE7Lm9m75" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23A_z6CHM3T4njAf" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001963" name="afya:DisclosuresOfCashAndCashEquivalentsExplanatory"><p id="xdx_803_ecustom--DisclosuresOfCashAndCashEquivalentsExplanatory_z2KL5dOjhBxe" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>6</b></td><td><b><span id="xdx_820_z1xV6vyTUaOa">Cash and cash equivalents</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001965" name="afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_880_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_zEeZBx7XZqLa" summary="xdx: Disclosure - Cash and cash equivalents (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span><span id="xdx_8BF_zh5yt5OeTomj" style="display: none">Schedule of cash and cash equivalents</span></span></td>
    <td id="xdx_49D_20231231_zpL6JYrCXYmk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_490_20221231_zFavAx2C4l85" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--Cash_iI_pn3n3_zUzq34o500ya" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash and bank deposits</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Cash" contextRef="AsOf2023-12-31" id="Fact001967" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,746</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Cash" contextRef="AsOf2022-12-31" id="Fact001968" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,509</ix:nonFraction></span></td></tr>
  <tr id="xdx_403_eifrs-full--CashEquivalents_iI_pn3n3_z6QuZBiS8NNj" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash equivalents</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CashEquivalents" contextRef="AsOf2023-12-31" id="Fact001970" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">541,284</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CashEquivalents" contextRef="AsOf2022-12-31" id="Fact001971" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,035,573</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_zbWW3LBgxapa" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Cash and cash equivalents&#160;</b></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2023-12-31" id="Fact001973" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">553,030</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2022-12-31" id="Fact001974" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,093,082</ix:nonFraction></b></span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Cash equivalents correspond mainly to financial investments in Bank Certificates
of Deposit (&#8220;CDB&#8221;) with highly rated financial institutions and investments funds managed by highly rated financial institutions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">As of December 31, 2023, the average interest on these investments is equivalent
to <span id="xdx_90C_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_zFvZ0TtIdNIi" title="Percentage of average interest"><ix:nonFraction name="afya:PercenatgeOfAverageInterestOnFinancialInstrument" contextRef="AsOf2023-12-31_custom_BankCertificatesOfDepositMember" id="Fact001976" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.8</ix:nonFraction></span>% of the CDI rate (December 31, 2022: <span id="xdx_90F_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_zfa4v61mjQHf" title="Percentage of average interest"><ix:nonFraction name="afya:PercenatgeOfAverageInterestOnFinancialInstrument" contextRef="AsOf2022-12-31_custom_BankCertificatesOfDepositMember" id="Fact001978" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">99.21</ix:nonFraction></span>%). These funds are available for immediate use and have an insignificant risk of changes
in value. Cash equivalents denominated in U.S. dollars totaled R$<span id="xdx_90D_eifrs-full--CashEquivalents_iI_pn3n3_uBRL_c20231231__srt--CurrencyAxis__custom--USDMember_zq46QBMxHa53" title="Cash equivalents"><ix:nonFraction name="ifrs-full:CashEquivalents" contextRef="AsOf2023-12-31_custom_USDMember" id="Fact001980" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,173</ix:nonFraction></span> as of December 31, 2023 (December 31, 2022: R$<span id="xdx_903_eifrs-full--CashEquivalents_iI_pn3n3_uBRL_c20221231__srt--CurrencyAxis__custom--USDMember_zeLc7Qj5iEB4" title="Cash equivalents"><ix:nonFraction name="ifrs-full:CashEquivalents" contextRef="AsOf2022-12-31_custom_USDMember" id="Fact001982" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,447</ix:nonFraction></span>).</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001984" name="ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory"><p id="xdx_80D_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_zJgHmSqC7mO3" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>7</b></td><td><b><span id="xdx_823_zj3jcZCDfsVc">Trade receivables</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact001986" name="afya:DisclosureOfTradeAndOtherReceivables1Explanatory"><table cellspacing="0" cellpadding="0" id="xdx_89D_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_zcXX8G9OWaqa" summary="xdx: Disclosure - Trade receivables (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B5_z600CWMlcfbj" style="display: none">Schedule of trade accounts receivable</span>&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 56%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Tuition fees</span></td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_z3RSpDso4iwg" title="Trade receivables, gross" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2023-12-31_custom_TuitionFeesMember" id="Fact001988" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">461,066</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zfmx0OUvksu1" title="Trade receivables, gross" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2022-12-31_custom_TuitionFeesMember" id="Fact001990" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">356,074</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Educational content (i)</span></td>
    <td id="xdx_986_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zq6uvsPNNe01" title="Trade receivables, gross" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2023-12-31_custom_EducationalContentMember" id="Fact001992" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,135</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_ztC1kAzguAJ8" title="Trade receivables, gross" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2022-12-31_custom_EducationalContentMember" id="Fact001994" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,913</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">FIES</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zwEBjGFWoAPl" title="Trade receivables, gross" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2023-12-31_custom_FIESMember" id="Fact001996" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,971</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--ReceivablesGross_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zSKLt0sGWCq5" title="Trade receivables, gross" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2022-12-31_custom_FIESMember" id="Fact001998" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,325</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Educational credits (ii)</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zJmkdW14iD8c" title="Trade receivables, gross" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2023-12-31_custom_EducationalCreditsMember" id="Fact002000" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,391</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zU9d4l0KR0Kj" title="Trade receivables, gross" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2022-12-31_custom_EducationalCreditsMember" id="Fact002002" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,535</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Mobile app subscription (iii)</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zSAOFkLWGrfh" title="Trade receivables, gross" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2023-12-31_custom_MobileAppSubscriptionMember" id="Fact002004" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,091</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_z7tDP54jTal" title="Trade receivables, gross" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2022-12-31_custom_MobileAppSubscriptionMember" id="Fact002006" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,675</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Other</span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zGuN1wrWvZQ1" title="Trade receivables, gross" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2023-12-31_custom_OthersMember" id="Fact002008" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,667</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zXIa9zvlJUak" title="Trade receivables, gross" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2022-12-31_custom_OthersMember" id="Fact002010" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,923</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98B_ecustom--ReceivablesGross_pn3n3_c20231231_zJKrwenrbyDi" title="Trade receivables, gross" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2023-12-31" id="Fact002012" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">647,321</ix:nonFraction></b></span></td>
    <td id="xdx_989_ecustom--ReceivablesGross_pn3n3_c20221231_zYn0FhkjQsek" title="Trade receivables, gross" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2022-12-31" id="Fact002014" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">539,445</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(-) Allowance for expected credit losses</span></td>
    <td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20231231_z4sRESQJxHBf" title="Trade receivables, gross" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:AllowanceForDoubtfulAccountsFoReceivable1" contextRef="AsOf2023-12-31" id="Fact002016" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">61,398</ix:nonFraction>)</span></td>
    <td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20221231_zD35E3TKZRmj" title="(-) Allowance for doubtful accounts" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:AllowanceForDoubtfulAccountsFoReceivable1" contextRef="AsOf2022-12-31" id="Fact002018" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">44,046</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_988_eifrs-full--TradeReceivables_pn3n3_c20231231_zBebXSeRT3z1" title="Trade receivables, net" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2023-12-31" id="Fact002020" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">585,923</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--TradeReceivables_pn3n3_c20221231_zJxF016G6r9k" title="Trade receivables, net" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2022-12-31" id="Fact002022" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">495,399</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Current</span></td>
    <td id="xdx_98A_eifrs-full--CurrentTradeReceivables_pn3n3_c20231231_zUoYhNL0Pdr3" title="Current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="AsOf2023-12-31" id="Fact002024" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">546,438</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--CurrentTradeReceivables_pn3n3_c20221231_zAZJhkuW58G2" title="Current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="AsOf2022-12-31" id="Fact002026" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">452,831</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Non-current</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20231231_z8BDiOu7MSmj" title="Non-current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2023-12-31" id="Fact002028" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,485</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20221231_zUPatsWoPpCg" title="Non-current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2022-12-31" id="Fact002030" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,568</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Related to trade receivables from sales of printed books, e-books and medical courses through
digital platform from Medcel, Al&#233;m da Medicina e Cardiopapers.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"/><td style="text-align: justify">Related to the financing programs offered by our subsidiaries to its students that existed
prior to the acquisitions. The Company closed such programs to new enrolments and maintained only the agreements that were outstanding
as of the acquisition date.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"/><td style="text-align: justify">Related to trade receivables from mobile applications subscriptions for digital medical content.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AB_zgWRTXlSuju2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">As of December 31, 2023 and 2022, the aging of trade receivables was as
follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002032" name="afya:DisclosureOfTradeAccountsReceivableByAgingExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_885_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_pn3n3_z31tj6BqoTDc" summary="xdx: Disclosure - Trade receivables (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B1_zXTgmwrQUDpe" style="display: none">Schedule of aging of trade accounts receivable</span>&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; width: 56%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Neither past due nor impaired</span></td>
    <td id="xdx_980_ecustom--ReceivablesGross_pn3n3_c20231231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zNQsuiwSbyN" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2023-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" id="Fact002034" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">323,614</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z48gbuvhYxg4" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2022-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" id="Fact002036" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">261,025</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Past due</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">1 to 30 days</span></td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_z9drAPElUfBe" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2023-12-31_ifrs-full_CurrentMember" id="Fact002038" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">73,563</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zlanM58Kw6u2" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 90%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 90%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2022-12-31_ifrs-full_CurrentMember" id="Fact002040" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,280</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">31 to 90 days</span></td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zWIip0U18ppi" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2023-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" id="Fact002042" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">109,908</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_ztSGptPZz5u4" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2022-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" id="Fact002044" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">90,734</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">91 to 180 days</span></td>
    <td id="xdx_987_ecustom--ReceivablesGross_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zA6OZSZInBqc" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" id="Fact002046" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">85,193</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zbuHuUw6UjC7" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" id="Fact002048" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80,522</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">More than 180 days</span></td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zaHR3SoL7D5b" title="Trade receivable" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2023-12-31_custom_LaterThanOneEightyMember" id="Fact002050" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,043</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zLCdbo4UkXl4" title="Trade receivable" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2022-12-31_custom_LaterThanOneEightyMember" id="Fact002052" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,884</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20231231_zwVCoyJStdvi" title="Trade receivable" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2023-12-31" id="Fact002054" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">647,321</ix:nonFraction></b></span></td>
    <td id="xdx_987_ecustom--ReceivablesGross_iI_pn3n3_c20221231_zVYakiJsJrua" title="Trade receivable" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2022-12-31" id="Fact002056" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">539,445</ix:nonFraction></b></span></td></tr>
  </table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 210 -->
    <div id="xdx_232_zsREg1icBeQa" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_236_zzIcyTF3Dhzf" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zPAllYr38PIc" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The changes in the allowance for doubtful accounts for the years ended December
31, 2023, 2022 and 2021, was as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002059" name="afya:DisclosureOfAllowanceForDoubtfulAccountsExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_888_ecustom--DisclosureOfAllowanceForDoubtfulAccountsExplanatory_pn3n3_z0nx7rfM7TMh" summary="xdx: Disclosure - Trade receivables (Details 2)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B6_zdzK6AXX31de" style="display: none">Schedule of allowance for doubtful accounts</span>&#160;</td>
    <td id="xdx_49C_20230101__20231231_z2BOwPN5i6Xg" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_497_20220101__20221231_z0RVueHiCAv6" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49A_20210101__20211231_zMoJJjpuzmI" style="vertical-align: top; text-align: center; line-height: 115%">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; width: 46%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2021</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iNS_pn3n3_di_zUam11NOQEEa" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Balances at the beginning of the year</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" contextRef="AsOf2022-12-31" id="Fact002061" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,046</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" contextRef="AsOf2021-12-31" id="Fact002062" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45,013</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" contextRef="AsOf2020-12-31" id="Fact002063" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,980</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40B_ecustom--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_pn3n3_zyXSCfdrfozl" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Additions</span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" contextRef="From2023-01-01to2023-12-31" id="Fact002065" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">74,552</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" contextRef="From2022-01-012022-12-31" id="Fact002066" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">42,708</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;(<ix:nonFraction name="afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" contextRef="From2021-01-012021-12-31" id="Fact002067" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">47,819</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40C_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_pn3n3_zZgTPY05MKAa" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Write-offs</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" contextRef="From2023-01-01to2023-12-31" id="Fact002069" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,200</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" contextRef="From2022-01-012022-12-31" id="Fact002070" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,675</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" contextRef="From2021-01-012021-12-31" id="Fact002071" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,786</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iNE_pn3n3_di_z6giHqWxwlq" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Balances at the end of the year</span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(<ix:nonFraction name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" contextRef="AsOf2023-12-31" id="Fact002073" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">61,398</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(<ix:nonFraction name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" contextRef="AsOf2022-12-31" id="Fact002074" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,046</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>&#160;(<ix:nonFraction name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" contextRef="AsOf2021-12-31" id="Fact002075" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45,013</ix:nonFraction>)</b></span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002077" name="ifrs-full:DisclosureOfRelatedPartyExplanatory"><p id="xdx_808_eifrs-full--DisclosureOfRelatedPartyExplanatory_zfeJh2uC6cW9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>8</b></td><td><b><span id="xdx_82F_zvW4OCjo3Nn9">Related parties</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The table below summarizes the balances and transactions with related parties:</p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002079" name="afya:DisclosureOfRelatedPartiesExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_89B_ecustom--DisclosureOfRelatedPartiesExplanatory_zz5MME0AnKVe" summary="xdx: Disclosure - Related parties (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BE_zJDaeOUYjZyl" style="display: none">Schedule of balances and transactions with related
    parties</span>&#160;</td>
    <td id="xdx_491_20231231_zn3QmHsq48Al" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20221231_zvnu1iuT7Mf4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Assets</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn3n3_zFuYFNUYKIGc" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade receivables (i)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:TradeReceivablesRelatedPartyTransactions" contextRef="AsOf2023-12-31" id="Fact002081" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">693</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:TradeReceivablesRelatedPartyTransactions" contextRef="AsOf2022-12-31" id="Fact002082" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">917</ix:nonFraction></span></td></tr>
  <tr id="xdx_401_ecustom--OtherAssetsRelatedPartyTransactions_iI_pn3n3_zWvxBoejrbc3" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other assets (ii)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherAssetsRelatedPartyTransactions" contextRef="AsOf2023-12-31" id="Fact002084" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">285</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherAssetsRelatedPartyTransactions" contextRef="AsOf2022-12-31" id="Fact002085" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,975</ix:nonFraction></span></td></tr>
  <tr id="xdx_406_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_pn3n3" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;<b style="display: none">Total</b></td>
    <td style="border-top: black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:AmountsReceivableRelatedPartyTransactions" contextRef="AsOf2023-12-31" id="Fact002087" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">978</ix:nonFraction></b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:AmountsReceivableRelatedPartyTransactions" contextRef="AsOf2022-12-31" id="Fact002088" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,892</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40A_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_pn3n3_zzaygYW3CdC7" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:TradeAndOtherCurrentPayablesToRelatedParties1" contextRef="AsOf2023-12-31" id="Fact002090" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">792</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:TradeAndOtherCurrentPayablesToRelatedParties1" contextRef="AsOf2022-12-31" id="Fact002091" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,892</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_ecustom--NoncurrentAssetsOfRelatedParty1_iI_pn3n3_zzcllqmLXdW9" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NoncurrentAssetsOfRelatedParty1" contextRef="AsOf2023-12-31" id="Fact002093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">186</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2094">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Liabilities</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_407_ecustom--AccountsPayableToSellingShareholders_iI_pn3n3_zu0Csl4m73X5" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders (iii)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2096">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholders" contextRef="AsOf2022-12-31" id="Fact002097" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,653</ix:nonFraction></span></td></tr>
  <tr id="xdx_40C_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pn3n3_zonsfZ4FmrJ6" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;<b style="display: none">Total</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2099">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="AsOf2022-12-31" id="Fact002100" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,653</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_404_ecustom--AccountsPayableCurrent1_iI_pn3n3_zvFhnwbCB46k" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2102">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableCurrent1" contextRef="AsOf2022-12-31" id="Fact002103" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,653</ix:nonFraction></span></td></tr>
  <tr id="xdx_40F_ecustom--NoncurrentPayablesToRelatedParties1_iI_pn3n3_zxXlnAUn3k9f" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2105">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2106">-</span></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Other income (expenses)</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UEPC (i)</span></td>
    <td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zOeqym0A9OJ2" title="Other income" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2023-01-012023-12-31_custom_UEPCMember" id="Fact002108" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">465</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zZPmWg6lv2Ih" title="Other income" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2022-01-012022-12-31_custom_UEPCMember" id="Fact002110" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">477</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zpvWO0rnBgql" title="Other income" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2021-01-012021-12-31_custom_UEPCMember" id="Fact002112" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">752</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">EMIVE Patrulha 24 Horas Ltda. (iv)</span></td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_z0WxnDBVN9n3" title="Other income" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2023-01-012023-12-31_custom_EMIVEPatrulha24HorasLtdaMember" id="Fact002114" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6</ix:nonFraction>)</span></td>
    <td id="xdx_982_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zifXlPlTqD3a" title="Other income" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2116">-</span></span></td>
    <td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zd7RROSFS2jd" title="Other income" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2118">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231_zkP58e0Bsoy2" title="Other income" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2023-01-01to2023-12-31" id="Fact002120" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">459</ix:nonFraction></b></span></td>
    <td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231_zg8lFoEYk5Kc" title="Other income" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2022-01-012022-12-31" id="Fact002122" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">477</ix:nonFraction></b></span></td>
    <td id="xdx_98F_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231_zUeHmV78JCRj" title="Other income" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2021-01-012021-12-31" id="Fact002124" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">752</ix:nonFraction></b></span></td>
    </tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Leases </b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">RVL Esteves Gest&#227;o Imobili&#225;ria S.A.</span></td>
    <td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zZzd9A7zYkok" title="Lease" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2023-01-012023-12-31_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002126" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,434</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zBfY98haxil2" title="Lease" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2022-01-012022-12-31_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002128" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,394</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zDMGimCI7L9b" title="Lease" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2021-01-012021-12-31_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002130" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,336</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UNIVA&#199;O Patrimonial Ltda.</span></td>
    <td id="xdx_986_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_z5mGjRiVnkab" title="Lease" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2023-01-012023-12-31_custom_UNIVACOPatrimonialLtdaMember" id="Fact002132" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,582</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zinEMFibxGe3" title="Lease" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2022-01-012022-12-31_custom_UNIVACOPatrimonialLtdaMember" id="Fact002134" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,409</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zBhwlsaVSYt5" title="Lease" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2021-01-012021-12-31_custom_UNIVACOPatrimonialLtdaMember" id="Fact002136" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,210</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IESVAP Patrimonial Ltda.</span></td>
    <td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zUwhPZ2Jm8k3" title="Lease" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2023-01-012023-12-31_custom_IESVAPPatrimonialLtdaMember" id="Fact002138" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,170</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zjRKIcxl4Xo9" title="Lease" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2022-01-012022-12-31_custom_IESVAPPatrimonialLtdaMember" id="Fact002140" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,920</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zjbwRaMG2wIh" title="Lease" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2021-01-012021-12-31_custom_IESVAPPatrimonialLtdaMember" id="Fact002142" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,560</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231_zUkngkGsrAJg" title="Lease" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2023-01-01to2023-12-31" id="Fact002144" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,186</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231_zekJvbzrD7vl" title="Lease" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2022-01-012022-12-31" id="Fact002146" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,723</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231_zO694S6i5Dg8" title="Lease" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2021-01-012021-12-31" id="Fact002148" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,106</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Refers to sales of educational content from Medcel to UEPC.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"/><td style="text-align: justify">Refers to expenses to be reimbursed by Bertelsmann SE&amp; Co. KGaA.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"/><td style="text-align: justify">Refers to amounts payable to our shareholder Nicolau Carvalho Esteves regarding the agreement
to which Afya Brazil acquired the right to develop ITPAC Garanhuns medical school, a greenfield unit. The last installment was paid in
November 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iv)</td><td style="width: 5pt"/><td style="text-align: justify">Refers to amounts of expenses related to security services provided by a company of which
one of Afya&#8217;s main shareholders has significant influence.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AB_zFucREYGSd8g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Lease agreements with RVL Esteves Gest&#227;o Imobili&#225;ria
S.A.</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Afya Brazil has entered into lease agreements with RVL Esteves Gest&#227;o
Imobili&#225;ria S.A. (&#8220;RVL&#8221;), an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato
Esteves is an executive officer, as described below:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">On June 21, 2016, RVL entered into lease agreements (as
amended on April 26, 2018) with ITPAC Aragua&#237;na and ITPAC Porto, pursuant to which RVL agreed to lease campuses to those entities
in the cities of Aragua&#237;na and Porto Nacional, both located in the State of Tocantins. The lease agreements are adjustable in
accordance with the provisions of each lease agreement. The lease agreements are for an initial term of <span id="xdx_90B_ecustom--OperatingLeaseTermOfContract_dtY_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_zfQw1xHVqju6" title="Lease term"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member" format="ixt-sec:duryear" id="Fact002150" name="afya:OperatingLeaseTermOfContract">20</ix:nonNumeric></span> years and are renewable for
an additional 20 years subject to the provisions of each lease agreement.</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"></p>


<ix:exclude><!-- Field: Page; Sequence: 211 -->
    <div id="xdx_23E_zeTRdieAYEjg" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_239_z6lsXKQBj6c3" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zFZdWyqV4Wla" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">On November 1, 2016, RVL entered into a lease
agreement with Afya Brazil, pursuant to which RVL agreed to lease to Afya Brazil certain offices in the city of Nova Lima, State of
Minas Gerais, where Afya Brazil&#8217;s executive offices are located. On February 9, 2019, the agreement was amended to extend
lease terms and adjust the lease amounts, subject to certain discount conditions set forth in the lease agreement and adjustable in
accordance with the provisions of the lease agreement. The lease agreement had an initial term of five years which ended on January
31, 2024 and was renewed until the end of June, 2024, subject to the provisions of the lease agreement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">On September 6, 2018, RVL entered into a lease agreement
with ITPAC Aragua&#237;na, pursuant to which RVL agreed to lease to ITPAC the new ITPAC campus by RVL in the city of Palmas, State of
Tocantins. The lease agreement is for an amount equal to <span id="xdx_907_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20180905__20180906__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zEABlcqjtS5i" title="Percentage of revenue"><ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="From2018-09-052018-09-06_custom_LeaseAgreements1Member_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002153" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></span>% of the monthly revenue of ITPAC during the prior semester and will be effective
(and become due) once the new ITPAC campus becomes operational, subject to the provisions of the lease agreement. Since 2022, the campus
is fully operational. The lease agreement is for an initial term of <span id="xdx_907_ecustom--OperatingLeaseTermOfContract_dtY_c20180905__20180906__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_zDLnUDyZaPol" title="Lease term"><ix:nonNumeric contextRef="From2018-09-052018-09-06_custom_LeaseAgreements1Member" format="ixt-sec:duryear" id="Fact002155" name="afya:OperatingLeaseTermOfContract">20</ix:nonNumeric></span> years and is renewable for an additional <span id="xdx_901_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_zjNtSN0BymS3" title="Renewal term"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member" format="ixt-sec:duryear" id="Fact002157" name="afya:LesseeFinancesLeaseRenewalTerm">20</ix:nonNumeric></span> years.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On October 30, 2019, RVL entered into a lease agreement with IPTAN, pursuant
to which RVL agreed to lease to IPTAN the new IPTAN medical campus, in the city of Santa In&#234;s, State of Maranh&#227;o. The lease
agreement is for a monthly amount equal to <span id="xdx_900_ecustom--DescriptionOfLeaseTerm_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zsJOIn9Hqqoi" title="Description of lease term"><ix:nonNumeric contextRef="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002159" name="afya:DescriptionOfLeaseTerm">(i) up to June 2020, R$<span id="xdx_90E_eifrs-full--CashOutflowForLeases_pn3n3_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zD8XWnRwUzC1" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002161" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12</ix:nonFraction></span> and (ii) from July 2020 until March 2024, <span id="xdx_904_eifrs-full--PercentageOfEntitysRevenue_pip0_dp_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zzHtitsQwWed" title="Percentage of revenue"><ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" id="Fact002163" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.5</ix:nonFraction></span>% of the monthly revenue
of IPTAN during the prior semester, adjusted in accordance with the provisions of the lease agreement.</ix:nonNumeric></span> The lease agreement is for an initial
term of five years starting in January 2021, when the campus becomes operational and may be renewable for an additional five years subject
to the provisions of the lease agreement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On August 2, 2021, RVL entered into a lease agreement with ITPAC Aragua&#237;na,
pursuant to which RVL agreed to lease to ITPAC the new ITPAC Garanhuns medical campus, in the city of Garanhuns, State of Pernambuco.
The lease agreement is for a monthly amount equal to <span id="xdx_90D_ecustom--DescriptionOfLeaseTerm_c20210728__20210802__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zanoKdLvfMVk" title="Description of lease term"><ix:nonNumeric contextRef="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002165" name="afya:DescriptionOfLeaseTerm">(i) up to June 2022, R$<span id="xdx_900_eifrs-full--CashOutflowForLeases_pn3n3_c20210728__20210802__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zFt7xfBZKfxa" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002167" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40</ix:nonFraction></span>; (ii) from July 2022 until December 2028, <span id="xdx_90E_eifrs-full--PercentageOfEntitysRevenue_pip0_dp_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zIn7t5Lltjhg" title="Percentage of revenue"><ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" id="Fact002169" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.5</ix:nonFraction></span>% of the monthly
revenue of ITPAC Garanhuns during the prior semester, adjusted in accordance with the provisions of the lease agreement</ix:nonNumeric></span>; and (iii) as
from January 2029, the monthly amount should be adjusted by the inflation rate (IPCA). The lease agreement is for a term of 20 years.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The lease payments in connection with the lease agreements with RVL totaled
R$<span id="xdx_908_eifrs-full--CashOutflowForLeases_pn3n3_uBRL_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zOXhlnBB2999" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,434</ix:nonFraction></span>, R$<span id="xdx_90B_eifrs-full--CashOutflowForLeases_pn3n3_uBRL_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zByW7E0ZE0nd" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2022-01-012022-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002173" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,394</ix:nonFraction></span> and R$<span id="xdx_901_eifrs-full--CashOutflowForLeases_pn3n3_uBRL_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zdU9ftn8i426" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002175" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,336</ix:nonFraction></span> in the years ended December 31, 2023, 2022 and 2021, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Lease agreement with UNIVA&#199;O Patrimonial Ltda.</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On July 14, 2016, UNIVA&#199;O Patrimonial Ltda., an entity controlled
by the shareholder Nicolau Carvalho Esteves and of which Ms. Ros&#226;ngela Esteves is the chief executive officer, entered into a lease
agreement with UNIVA&#199;O, a subsidiary of Afya Brazil, pursuant to which UNIVA&#199;O Patrimonial Ltda. agreed to lease the UNIVA&#199;O
campus to UNIVA&#199;O, located in the city of Ipatinga, State of Minas Gerais. The lease agreement is adjustable in accordance with
the provisions of the lease agreement. The lease agreement is for an initial term of 20 years and is renewable for an additional <span id="xdx_906_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_z0qzgTVGtTyi" title="Renewal term"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" format="ixt-sec:duryear" id="Fact002177" name="afya:LesseeFinancesLeaseRenewalTerm">20</ix:nonNumeric></span> years
subject to the provisions of the lease agreement. The lease payments in connection with this lease agreement totaled R$<span id="xdx_901_eifrs-full--CashOutflowForLeases_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zP9Ey9k6ZNih" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" id="Fact002179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,582</ix:nonFraction></span>, R$<span id="xdx_90A_eifrs-full--CashOutflowForLeases_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zwiGr7Fnv1B1" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2022-01-012022-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" id="Fact002181" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,409</ix:nonFraction></span>
and R$<span id="xdx_900_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zPE0BgUjutBd" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" id="Fact002183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,210</ix:nonFraction></span> in the years ended December 31, 2023, 2022 and 2021, respectively.</p>

<ix:exclude><p id="xdx_234_zyJEsKSAQxqb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;<br/>
</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 212 -->
    <div id="xdx_238_zdi62m8xGXSk" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_234_zD8GeWZuwYm6" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Lease agreement with IESVAP Patrimonial Ltda.</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On April 25, 2018, IESVAP Patrimonial Ltda., an entity controlled by the
shareholder Nicolau Carvalho Esteves and of which Mr. Renato Esteves is an executive officer, entered into a lease agreement with IESVAP,
a subsidiary of Afya Brazil, pursuant to which IESVAP Patrimonial Ltda. agreed to lease the IESVAP campus to IESVAP located in the city
of Parna&#237;ba, State of Piau&#237;. <span id="xdx_908_ecustom--DescriptionOfLeaseTerms_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_z5MRq2KPff9g" title="Description of lease term"><ix:nonNumeric contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" id="Fact002186" name="afya:DescriptionOfLeaseTerms">The lease agreement is for an amount equal to <span id="xdx_909_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zuYYL8WtjOUf" title="Percentage of revenue"><ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" id="Fact002188" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></span>% of the monthly revenue of IESVAP until maturation.</ix:nonNumeric></span>
The lease agreement is for an initial term of <span id="xdx_909_ecustom--OperatingLeaseTermOfContract_dtY_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zUK7vDZH8qsd" title="Lease term"><ix:nonNumeric contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" format="ixt-sec:duryear" id="Fact002190" name="afya:OperatingLeaseTermOfContract">20</ix:nonNumeric></span> years and is renewable for an additional <span id="xdx_903_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zHoVOVXHhwE1" title="Renewal term"><ix:nonNumeric contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" format="ixt-sec:duryear" id="Fact002192" name="afya:LesseeFinancesLeaseRenewalTerm">20</ix:nonNumeric></span> years subject to the provisions of the lease
agreement. The lease payments in connection with this lease agreement totaled R$<span id="xdx_902_eifrs-full--CashOutflowForLeases_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zTToMiCfTpMi" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" id="Fact002194" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,170</ix:nonFraction></span>, R$<span id="xdx_90A_eifrs-full--CashOutflowForLeases_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zk426Pg8a0Q8" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2022-01-012022-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" id="Fact002196" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,920</ix:nonFraction></span> and R$<span id="xdx_90F_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zOlPlmavbRZk" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" id="Fact002198" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,560</ix:nonFraction></span> in the years ended December
31, 2023, 2022 and 2021, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Key management personnel compensation</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Key management personnel compensation included in the Company&#8217;s consolidated
statement of income comprised the following:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002200" name="afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_88A_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_pn3n3_zBHQ94Gh3mnb" summary="xdx: Disclosure - Related parties (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;<span id="xdx_8BA_zXPCFHzISisi" style="display: none">Schedule of key management personnel compensation included in the
    Company's consolidated statement of income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 46%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Short-term employee benefits</span></td>
    <td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20230101__20231231_zBefWbpKb0kj" title="Short-term employee benefits" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="From2023-01-01to2023-12-31" id="Fact002202" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,979</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20220101__20221231_zL4DpyCzWcT6" title="Short-term employee benefits" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="From2022-01-012022-12-31" id="Fact002204" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,564</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20210101__20211231_z0tr1vF34wid" title="Short-term employee benefits" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="From2021-01-012021-12-31" id="Fact002206" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,933</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share-based compensation plans</span></td>
    <td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20230101__20231231_zzQ6LmZGaqj9" title="Share-based compensation plans" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="From2023-01-01to2023-12-31" id="Fact002208" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,380</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20220101__20221231_z1rBtliWHAm5" title="Share-based compensation plans" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="From2022-01-012022-12-31" id="Fact002210" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,116</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20210101__20211231_zumE8186z1wl" title="Share-based compensation plans" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="From2021-01-012021-12-31" id="Fact002212" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,251</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_988_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20230101__20231231_zwdO4xCpG5Fc" title="Total" style="border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" contextRef="From2023-01-01to2023-12-31" id="Fact002214" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,359</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20220101__20221231_zWXbVKaXNqnb" title="Total" style="border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" contextRef="From2022-01-012022-12-31" id="Fact002216" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,680</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20210101__20211231_zE7BELZG7xjb" title="Total" style="border-bottom: black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" contextRef="From2021-01-012021-12-31" id="Fact002218" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,184</ix:nonFraction></b></span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Compensation of the Company&#8217;s key management includes short-term employee
benefits comprised by salaries, labor and social charges, and other ordinary short-term employee benefits. The amounts disclosed in the
table above are the amounts recognized as an expense in selling, general and administrative expenses during the reporting period related
to key management personnel.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The executive officers participate in share-based compensation plans described
in Note 16 (b).</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002220" name="afya:DisclosureOfOtherAssetExplanatory"><p id="xdx_808_ecustom--DisclosureOfOtherAssetExplanatory_zUkQX8TCfXTe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>9</b></td><td><b><span id="xdx_82D_zbvN17fWIDej">Other assets</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">As of December 31, 2023, the Company has R$<span id="xdx_90A_ecustom--OtherAsset_iI_pn3n3_c20231231_zR4sTiSx85Y7" title="Other assets"><ix:nonFraction name="afya:OtherAsset" contextRef="AsOf2023-12-31" id="Fact002222" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">176,251</ix:nonFraction></span> (December 31, 2022: R$<span id="xdx_900_ecustom--OtherAsset_iI_pn3n3_c20221231_zSm84EOT9jQ" title="Other assets"><ix:nonFraction name="afya:OtherAsset" contextRef="AsOf2022-12-31" id="Fact002224" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">243,501</ix:nonFraction></span>)
accounted for as Other assets as follow:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002226" name="afya:DisclosureOfOtherAssetsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89F_ecustom--DisclosureOfOtherAssetsTableTextBlock_z6H21WFiSn0i" summary="xdx: Disclosure - Other assets (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B6_zkyRIMEwd1Lg" style="display: none">&#160;Schedule of other assets</span></td>
    <td id="xdx_499_20231231_zFbdpRwdlcQf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_491_20221231_zkNqgAseLwQ9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_maAzYGA_z9Mu56LaUtra" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Indemnification assets (i)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2023-12-31" id="Fact002228" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">81,855</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2022-12-31" id="Fact002229" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">145,300</ix:nonFraction></span></td></tr>
  <tr id="xdx_40D_ecustom--Advances1_iI_pn3n3_maAzYGA_zIrYAazBnCx8" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:Advances1" contextRef="AsOf2023-12-31" id="Fact002231" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,890</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:Advances1" contextRef="AsOf2022-12-31" id="Fact002232" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,626</ix:nonFraction></span></td></tr>
  <tr id="xdx_40D_ecustom--JudicialDeposits_iI_pn3n3_maAzYGA_zcrVnF3w1gud" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Judicial deposits</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:JudicialDeposits" contextRef="AsOf2023-12-31" id="Fact002234" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,187</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:JudicialDeposits" contextRef="AsOf2022-12-31" id="Fact002235" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,693</ix:nonFraction></span></td></tr>
  <tr id="xdx_403_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_maAzYGA_zR8k57OIjvd" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Prepaid expenses</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentPrepaidExpenses" contextRef="AsOf2023-12-31" id="Fact002237" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,820</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentPrepaidExpenses" contextRef="AsOf2022-12-31" id="Fact002238" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,441</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--OtherReceivables_iI_pn3n3_maAzYGA_zw1VrfPkYxai" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other FIES receivables</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherReceivables" contextRef="AsOf2023-12-31" id="Fact002240" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,674</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherReceivables" contextRef="AsOf2022-12-31" id="Fact002241" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,440</ix:nonFraction></span></td></tr>
  <tr id="xdx_40F_ecustom--Dividend_iI_pn3n3_maAzYGA_zKYcIZiUb9F4" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:Dividend" contextRef="AsOf2023-12-31" id="Fact002243" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,668</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2244">-</span></span></td></tr>
  <tr id="xdx_407_eifrs-full--DeferredTaxAssets_iI_maAzYGA_zM1PBMEoHB5" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Deferred tax assets</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="AsOf2023-12-31" id="Fact002246" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,233</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2247">-</span></span></td></tr>
  <tr id="xdx_40E_ecustom--OtherAssets1_iI_pn3n3_maAzYGA_zVaPkYCCBasc" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other assets</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherAssets1" contextRef="AsOf2023-12-31" id="Fact002249" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,924</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherAssets1" contextRef="AsOf2022-12-31" id="Fact002250" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,001</ix:nonFraction></span></td></tr>
  <tr id="xdx_403_ecustom--Assets1_iTI_pn3n3_mtAzYGA_zRz7Mjg08wGi" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;<b style="display: none">Total</b></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:Assets1" contextRef="AsOf2023-12-31" id="Fact002252" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">176,251</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:Assets1" contextRef="AsOf2022-12-31" id="Fact002253" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">243,501</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40C_ecustom--CurrentAssets1_iI_pn3n3_zJyR4AWUv5Kl" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CurrentAssets1" contextRef="AsOf2023-12-31" id="Fact002255" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,905</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CurrentAssets1" contextRef="AsOf2022-12-31" id="Fact002256" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,745</ix:nonFraction></span></td></tr>
  <tr id="xdx_409_ecustom--NoncurrentAssets1_iI_pn3n3_zxnLTgTCEtZj" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NoncurrentAssets1" contextRef="AsOf2023-12-31" id="Fact002258" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">117,346</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NoncurrentAssets1" contextRef="AsOf2022-12-31" id="Fact002259" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">191,756</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Under the terms of the Share Purchase and Sale Agreements (&#8220;Agreements&#8221;) between
the Company and the selling shareholders of subsidiaries acquired, the Company assesses that the selling shareholders are exclusively
responsible for any provisions (including labor, tax and civil), which are or will be the subject of a claim by any third party, arising
from the act or fact occurred, by action or omission, prior to or on the closing dates of the acquisitions. As disclosed in Note 23(b),
Unigranrio has entered into a tax amnesty program in August 2023 for settling a tax proceeding, which resulted in the write-off of R$20,000
of indemnification assets. The remaining variance is due to the expiration of the related contingent liabilities recognized at business
combinations, mostly due to R$ 28,500 related to tax matters.<br/></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A5_zs4mvPalaBV4" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 213 -->
    <div id="xdx_239_zDULWePKNXm2" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_238_zuJe8STrT2Cb" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zQ0YaJDHC363" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002262" name="ifrs-full:DisclosureOfJointVenturesExplanatory"><p id="xdx_80C_eifrs-full--DisclosureOfJointVenturesExplanatory_zbV3XaqofAI" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>10</b></td><td><b><span id="xdx_823_zX8vooFvyF94">Investment in associate</span></b></td></tr></table>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company holds a 30% interest in UEPC, a medical school located in the
Federal District that offers higher education and post-graduate courses, both in person and long-distance learning. The Company&#8217;s
interest in UEPC is accounted for using the equity method. The table below illustrates the summarized financial information of the Company&#8217;s
investment in UEPC:</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002264" name="afya:DisclosureOfInvestmentsExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_890_ecustom--DisclosureOfInvestmentsExplanatory_z4HLGBn3Kjw5" summary="xdx: Disclosure - Investment in associate (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span id="xdx_8B2_zf9ZwfDtHIt9" style="display: none">Schedule of investment</span></td>
    <td id="xdx_49B_20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zDQwzPX1OZYj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_496_20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z1EfWHBaGETh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentAssets_iI_pn3n3" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember" id="Fact002266" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,004</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember" id="Fact002267" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,651</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentAssets_iI_pn3n3" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember" id="Fact002269" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">120,289</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember" id="Fact002270" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">122,378</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentLiabilities_iNI_pn3n3_di_ztVAsEnp3ln1" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember" id="Fact002272" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,842</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember" id="Fact002273" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,840</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentLiabilities_iNI_pn3n3_di_zy25DbP2Jjoc" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current liabilities</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember" id="Fact002275" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">91,613</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember" id="Fact002276" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">96,442</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_409_ecustom--EquityInAssociate_iI_pn3n3_zw26ITe7A3k4" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Equity</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:EquityInAssociate" contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember" id="Fact002278" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,838</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:EquityInAssociate" contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember" id="Fact002279" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,747</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40D_ecustom--CompanyShareInEquity1_iI_pn3n3_zM8iJDlzm1Hd" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Company&#8217;s share in equity - 30%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CompanyShareInEquity1" contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember" id="Fact002281" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,651</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CompanyShareInEquity1" contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember" id="Fact002282" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,724</ix:nonFraction></span></td></tr>
  <tr id="xdx_40D_eifrs-full--Goodwill_iI_pn3n3" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Goodwill</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember" id="Fact002284" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,183</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember" id="Fact002285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,183</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_pn3n3_z2MVr3LINuJ4" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying amount of the investment</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:InvestmentGrossAmount" contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember" id="Fact002287" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,834</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:InvestmentGrossAmount" contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember" id="Fact002288" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,907</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td id="xdx_498_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zfETjZvp0ou9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_499_20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zjMNmgOWvvce" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_498_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zDIQZLfmuTqi" style="text-align: center; line-height: 10.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--Revenue_pn3n3_z9ofUQhFc654" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Revenue</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002290" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">148,042</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember" id="Fact002291" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">138,584</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" id="Fact002292" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">127,618</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_eifrs-full--CostOfSales_iN_pn3n3_di_zqw2Xki9QeKl" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cost of services</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002294" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,282</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember" id="Fact002295" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,421</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" id="Fact002296" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,935</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_407_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_zkVc8qUOLd4l" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Selling, general and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002298" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,205</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember" id="Fact002299" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,991</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" id="Fact002300" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,025</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_403_eifrs-full--FinanceIncome_iN_pn3n3_di_zDFrby0MZLra" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Finance results</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002302" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,123</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember" id="Fact002303" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,103</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" id="Fact002304" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,585</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40F_eifrs-full--ProfitLossBeforeTax_pn3n3_ztihFdewGr5" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Income before income taxes</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002306" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,432</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember" id="Fact002307" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,069</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" id="Fact002308" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,073</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_z50VfcbUIrC1" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes expenses</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002310" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,782</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember" id="Fact002311" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,456</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" id="Fact002312" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,748</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--ProfitLoss_pn3n3_zHwWe177BJZk" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net income</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002314" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,650</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember" id="Fact002315" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,613</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" id="Fact002316" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,325</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40C_ecustom--CompanyShareOfProfitss_pn3n3_zHRPkXt37XY3" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Company&#8217;s share of income</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:CompanyShareOfProfitss" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002318" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,495</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:CompanyShareOfProfitss" contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember" id="Fact002319" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,184</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1.5pt double; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:CompanyShareOfProfitss" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" id="Fact002320" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,797</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td id="xdx_49C_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zGArAD1AUiTf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_49D_20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zwY9uhvj2sSc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_49E_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zEcDMIw7jRRk" style="text-align: center; line-height: 10.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023 </b></span></td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 18%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iS_pn3n3_zm2ggDiW1Gy5" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening balance</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember" id="Fact002322" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,907</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember" id="Fact002323" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,477</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember" id="Fact002324" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,410</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_ecustom--DividendsReceived1_iS_pn3n3_zOXCrcFwrJi1" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends received</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DividendsReceived1" contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember" id="Fact002326" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,900</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DividendsReceived1" contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember" id="Fact002327" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,754</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DividendsReceived1" contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember" id="Fact002328" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,770</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40C_eifrs-full--DividendsReceived_iN_pn3n3_di_zU7jtTViQvE9" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends receivable (included in Other assets)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002330" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,668</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2331">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" id="Fact002332" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,960</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_408_eifrs-full--ProfitLossOfAcquiree_pn3n3_zqpKcWwd2MJa" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share of income</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfitLossOfAcquiree" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002334" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,495</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfitLossOfAcquiree" contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember" id="Fact002335" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,184</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfitLossOfAcquiree" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" id="Fact002336" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,797</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--InvestmentsInAssociates_iE_pn3n3_zYyHYwFGiFNf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Closing balance</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember" id="Fact002338" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,834</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember" id="Fact002339" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,907</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember" id="Fact002340" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,477</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_z5xunlZ3Ow7l" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company tests the recoverability of the carrying amount of goodwill
at least annually. As of December 31, 2023 and 2022, no impairment had to be recognized for this goodwill.</p>


<ix:exclude><!-- Field: Page; Sequence: 214 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p id="xdx_23F_zsn2ZRbBl7r" style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_234_zDioYGevxKGd" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_z282lGr8H0o" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002343" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory"><p id="xdx_80D_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zY4WDSc7NPAb" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>11</b></td><td><b><span id="xdx_828_z7ejdPwclIY5">Property and equipment</span></b></td></tr></table>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002345" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_892_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_zZEWCyy555d6" summary="xdx: Disclosure - Property and equipment (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B3_zQEl9A6uJj73" style="display: none">Schedule of detailed information about property, plant and
    equipment</span>&#160;</td>
    <td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_z8abgi33upzh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zf8tcOwIqf1k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BD_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zj6SHCcJcB2f" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BF_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zSXYrBl1WoPj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zzUG5hGgRyI7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zo3Rg6lcN4we" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_zZynmJgem435" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zMfBeWOSeudc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zMWIdTkS11c4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B1_zIDp1piHuHJd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 26%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Cost</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Building</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Machinery and equipment</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Lands</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Vehicles</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Furniture and fixtures</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>IT equipment</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Library books</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Leasehold improvements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Construction in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z4MBeggb45d2" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of January 1, 2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002347" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,919</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002348" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">68,503</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="Fact002349" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,401</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002350" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,215</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002351" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,131</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002352" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,511</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002353" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,624</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002354" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">122,005</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002355" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,706</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002356" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">314,015</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zetNm5W9g4k1" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002358" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,384</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002359" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,268</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="Fact002360" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,451</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002361" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">111</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002362" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,075</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002363" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,511</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002364" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,392</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002365" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,720</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002366" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59,957</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002367" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">125,869</ix:nonFraction></span></td></tr>
  <tr id="xdx_43B_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zSwL6zuRCjI2" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Business combinations</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2369">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002370" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,810</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2371">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002372" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">346</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002373" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,684</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002374" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,138</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,142</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002376" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,425</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002377" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,078</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002378" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,623</ix:nonFraction></span></td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zlQD5dHwykTi" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002380" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002381" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,213</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2382">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002383" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">205</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002384" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,862</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002385" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,985</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002386" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">86</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002387" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">550</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002388" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">417</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002389" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,532</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z7IveAahZWEa" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002391" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,068</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002392" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2393">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2394">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002395" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">82</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002396" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2397">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002398" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,376</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002399" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">34,538</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2400">-</span></span></td></tr>
  <tr id="xdx_436_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z2YDC1xxeiS7" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002402" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">52,433</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002403" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,371</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="Fact002404" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,852</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002405" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,467</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002406" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">69,834</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002407" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,184</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002408" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,072</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002409" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">152,976</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002410" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,786</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002411" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">487,975</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_43F_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zHSDlIFCglCf" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002413" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">527</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002414" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,486</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2415">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002416" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">968</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002417" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,047</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002418" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,766</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002419" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">645</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002420" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,667</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002421" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">85,026</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002422" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">168,132</ix:nonFraction></span></td></tr>
  <tr id="xdx_433_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zP3l848kiefg" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Business combinations</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2424">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002425" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2426">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2427">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2428">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002429" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2430">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2431">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2432">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002433" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80</ix:nonFraction></span></td></tr>
  <tr id="xdx_431_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zbiz6XlzuRn8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002435" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002436" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,159</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2437">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002438" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">933</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002439" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">500</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002440" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,992</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2441">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2442">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002443" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">78</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002444" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">15,649</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43B_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zqvhraoiPuhd" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002446" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,884</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002447" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,353</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2448">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002449" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">449</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002450" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,669</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002451" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,600</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002452" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,645</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002453" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,797</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002454" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">30,046</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002455" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">815</ix:nonFraction></span></td></tr>
  <tr id="xdx_43F_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z8apsVYXq2f3" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002457" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">91,857</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002458" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,390</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="Fact002459" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,852</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002460" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,053</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002461" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">90,712</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002462" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">68,593</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002463" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,362</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002464" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">145,846</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002465" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">86,688</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002466" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">641,353</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zV4EVRHS5eck" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002468" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">96</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002469" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,071</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2470">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002471" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">776</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002472" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,914</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002473" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,135</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002474" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">985</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002475" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002476" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,409</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002477" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">118,435</ix:nonFraction></span></td></tr>
  <tr id="xdx_439_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zm0dNpdiARqb" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Business combination</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2479">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002480" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,729</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2481">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2482">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002483" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,384</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002484" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">734</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002485" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,329</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002486" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,741</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002487" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002488" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,980</ix:nonFraction></span></td></tr>
  <tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zzRl6ps9NjDi" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2490">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002491" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,411</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2492">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002493" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">475</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002494" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,443</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002495" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,979</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002496" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,788</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002497" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">286</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2498">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002499" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">27,382</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_434_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z35FEaZs37ga" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002501" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,279</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002502" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,202</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2503">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2504">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002505" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">708</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002506" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">327</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2507">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002508" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,098</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002509" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">110,198</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2510">-</span></span></td></tr>
  <tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zfmaaXRvZw0j" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002512" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">93,232</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002513" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">119,981</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="Fact002514" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,852</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002515" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,354</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002516" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,859</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002517" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">82,810</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002518" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,888</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002519" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">264,448</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002520" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,962</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002521" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">757,386</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Depreciation</b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_434_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zpno1fGEG8C5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of January 1, 2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2523">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002524" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">19,322</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2525">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002526" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">171</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002527" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,089</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002528" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,851</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002529" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,817</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002530" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,384</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2531">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002532" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">53,634</ix:nonFraction>)</b></span></td></tr>
  <tr id="xdx_430_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iNP2custom--WritOffOfPropertyPlantAndEquipment_pn3n3_di_zxG07a0Rjdzl" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002534" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,673</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002535" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,215</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2536">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002537" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">196</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002538" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,601</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002539" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,529</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002540" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,416</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002541" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,831</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2542">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002543" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,461</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zKgSeDrT9dXc" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">&#160;Write-off (i)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2545">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002546" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,146</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2547">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002548" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">147</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002549" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,194</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002550" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,458</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002551" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">633</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002552" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">350</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2553">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002554" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,928</ix:nonFraction></span></td></tr>
  <tr id="xdx_435_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zYE8bGKtX2m1" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002556" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,673</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002557" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">16,391</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2558">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002559" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">220</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002560" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,496</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002561" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,922</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002562" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,600</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002563" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,865</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2564">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002565" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">68,167</ix:nonFraction>)</b></span></td></tr>
  <tr id="xdx_439_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zCgvb9aKLUn" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002567" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,472</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002568" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,166</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2569">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002570" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">284</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002571" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,725</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002572" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,140</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002573" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,415</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002574" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,849</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2575">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002576" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45,051</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43B_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zanpP2KrUvwe" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2578">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002579" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,474</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2580">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002581" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">791</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002582" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002583" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,350</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002584" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002585" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">117</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2586">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002587" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,952</ix:nonFraction></span></td></tr>
  <tr id="xdx_438_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zII350CFvQ64" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002589" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">606</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002590" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,453</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2591">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002592" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002593" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,719</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002594" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,125</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002595" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,940</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002596" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">502</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2597">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2598">-</span></span></td></tr>
  <tr id="xdx_436_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zvwRCn5kCssk" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002600" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,751</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002601" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,630</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2602">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002603" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">288</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002604" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,349</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002605" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">21,837</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002606" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">22,888</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002607" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,099</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2608">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002609" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">99,266</ix:nonFraction>)</b></span></td></tr>
  <tr id="xdx_435_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_ztOLxx2Lfebb" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Depreciation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002611" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,242</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002612" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,900</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2613">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002614" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">325</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002615" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,556</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002616" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,286</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002617" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,327</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002618" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,271</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2619">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002620" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,907</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zM1HTf8u42sb" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002622" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">118</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002623" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,684</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2624">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002625" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002626" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,528</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002627" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,254</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002628" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,563</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002629" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">90</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2630">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002631" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,472</ix:nonFraction></span></td></tr>
  <tr id="xdx_43F_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zJlU59QXGju4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002633" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">196</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002634" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2635">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2636">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2637">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002638" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2639">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002640" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">196</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2641">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2642">-</span></span></td></tr>
  <tr id="xdx_43D_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zoFejK1dwQzc" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002644" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,679</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002645" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">28,843</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2646">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002647" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">198</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002648" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,377</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002649" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">26,872</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002650" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,652</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002651" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">44,476</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2652">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002653" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">148,701</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Net book value</b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2023-12-31_ifrs-full_BuildingsMember" id="Fact002655" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">83,553</ix:nonFraction></b></span></td>
    <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2023-12-31_custom_MachineryAndEquipmentsMember" id="Fact002657" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">91,138</ix:nonFraction></b></span></td>
    <td id="xdx_984_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2023-12-31_ifrs-full_LandMember" id="Fact002659" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,852</ix:nonFraction></b></span></td>
    <td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2023-12-31_ifrs-full_VehiclesMember" id="Fact002661" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,552</ix:nonFraction></b></span></td>
    <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2023-12-31_ifrs-full_FixturesAndFittingsMember" id="Fact002663" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">90,482</ix:nonFraction></b></span></td>
    <td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2023-12-31_custom_ItEquipmentMember" id="Fact002665" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,938</ix:nonFraction></b></span></td>
    <td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2023-12-31_custom_LibraryBooksMember" id="Fact002667" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,236</ix:nonFraction></b></span></td>
    <td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember" id="Fact002669" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">219,972</ix:nonFraction></b></span></td>
    <td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2023-12-31_ifrs-full_ConstructionInProgressMember" id="Fact002671" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,962</ix:nonFraction></b></span></td>
    <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2023-12-31" id="Fact002673" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">608,685</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2022-12-31_ifrs-full_BuildingsMember" id="Fact002675" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">86,106</ix:nonFraction></b></span></td>
    <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2022-12-31_custom_MachineryAndEquipmentsMember" id="Fact002677" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">79,760</ix:nonFraction></b></span></td>
    <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2022-12-31_ifrs-full_LandMember" id="Fact002679" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,852</ix:nonFraction></b></span></td>
    <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2022-12-31_ifrs-full_VehiclesMember" id="Fact002681" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,341</ix:nonFraction></b></span></td>
    <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2022-12-31_ifrs-full_FixturesAndFittingsMember" id="Fact002683" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80,363</ix:nonFraction></b></span></td>
    <td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2022-12-31_custom_ItEquipmentMember" id="Fact002685" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,756</ix:nonFraction></b></span></td>
    <td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2022-12-31_custom_LibraryBooksMember" id="Fact002687" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,474</ix:nonFraction></b></span></td>
    <td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2022-12-31_ifrs-full_LeaseholdImprovementsMember" id="Fact002689" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">127,747</ix:nonFraction></b></span></td>
    <td id="xdx_983_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2022-12-31_ifrs-full_ConstructionInProgressMember" id="Fact002691" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">86,688</ix:nonFraction></b></span></td>
    <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231_pn3n3" title="Net book value" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2022-12-31" id="Fact002693" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">542,087</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Refers to items written-off as result of lack of expectation of future use, in connection
with the Company&#8217;s physical inventory procedures.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AD_zVDj9SFMVf41" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 11pt">The Company assesses at each reporting date,
whether there is an indication that a property and equipment asset may be impaired. If any indication exists, the Company estimates the
asset&#8217;s recoverable amount. There were no indications of impairment of property and equipment as of and for the </span>years <span style="font-size: 11pt">ended
December 31, 2023, 2022 and 2021.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 215 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p id="xdx_23C_zKj9B7BCbiC7" style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_239_zq157C93jKc4" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zF4FknY3qOKh" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002696" name="afya:DisclosureOfIntangibleAssetExplanatory"><p id="xdx_808_ecustom--DisclosureOfIntangibleAssetExplanatory_zpxk3ip5an1f" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>12</b></td><td><b><span id="xdx_82D_zQhFoc3ybzM4">Intangible assets and goodwill</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact002698" name="afya:SummaryOfIntangibleAssetsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_z9SFZ004WEei" summary="xdx: Disclosure - Intangible assets and goodwill (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt"><span id="xdx_8BB_zLquPfqPr8Bb" style="display: none">&#160;Schedule of intangible assets</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td></tr>
  <tr>
    <td style="width: 28%; padding-right: 1.45pt; padding-left: 1.45pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Goodwill </b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Licenses with indefinite useful life </b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Trademark</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Customer relationships</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Software</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Education content</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Developed technology</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Educational platform</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Software in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 4%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Cost</b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of January 1, 2021</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrVs4nJUBvA9" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002700" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">810,656</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zOsUP4LXxWQd" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002702" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,451,270</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfZqZIoN3gme" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002704" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">75,014</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQYrwcgh78ma" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002706" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">283,539</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkLKk2HrHMi3" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002708" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,221</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zke8tn0YX0Rb" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002710" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,305</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zT3slotvRSR7" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002712" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">355</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zViySlwYFhm8" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002714" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,902</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxPWglJrrwsg" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002716" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,297</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeN9grCjSwI7" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2718">-</span></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6CMpPtVlLZ4" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002720" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,684,559</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Additions (vi)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvF23pO4yaQg" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002722" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,000</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyULZJr7rUy4" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002724" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">684</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMuHgpTac5ed" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002726" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,044</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zN4HWHJwhbai" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002728" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">996</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zE7NuDfp5Gnc" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002730" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,686</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zK9nOPUKaPG8" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002732" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,700</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3VGszF3dGSh" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">176,110</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zG89zNqyy2R7" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002736" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,020</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbCREwHIf1s" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002738" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,743</ix:nonFraction>)</span></td>
    <td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvIOCCM6fxme" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002740" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">417</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsEaR8AObK8j" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002742" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,140</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Business combinations</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zGCFGqPXmtZ8" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002744" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">373,680</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRZauQn34Qef" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002746" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">606,136</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhW6NlxD9l6l" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002748" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,355</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziCEbjJ2VSi6" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002750" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">147,054</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCWFJKgYx14g" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002752" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,474</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5M5uUxiZUW9" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002754" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,046</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z61g1bMg0Ftf" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002756" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,599</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgBP8vMOjDcl" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002758" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,267</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAc5XlVajV9c" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002760" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,234,611</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2021</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuKUQ0QxcNR6" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002762" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,184,336</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkyMX8gPOepg" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002764" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,165,406</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztvE8u7ibCCf" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002766" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">133,369</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7wa0fhFQBfg" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002768" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">431,277</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zh6bZ8xBT71e" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002770" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,759</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZRiz76GAXY" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002772" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,305</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zF6u2yMw22Oa" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002774" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,397</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvTgObYwq03e" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002776" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,444</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zA0Wf5zyLd66" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002778" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,847</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRjp7MXSscPk" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2780">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKIR6xabatC6" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002782" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,093,140</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Additions (i) (ii)</span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zFy6RuIPCYK6" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002784" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,100</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUvoPygPAq3d" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002786" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,408</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoLJxtcViQL8" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002788" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxKt1ZXxt9Y2" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002790" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,423</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zpBPCLzDBTZa" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002792" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,231</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR7ixPmQ1mU2" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002794" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,879</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6E7Vd03Mz5e" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002796" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,761</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwNbbNuomi8k" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002798" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,141</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7FnFfMH9im4" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002800" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">150,023</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_982_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zs7brwltqOag" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2022-01-012022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002802" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">22</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zr2u6gQHBWQ" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002804" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">381</ix:nonFraction>)</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zC2lw0uZlgF4" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002806" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zXrK5HfiWKSd" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002808" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9</ix:nonFraction>)</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z3V02sLT2tk3" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2022-01-012022-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002810" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">28</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zAHqoxFsK382" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002812" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">447</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Remeasurement (iii)</span></td>
    <td id="xdx_98A_ecustom--Remesurement_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zt4LxZk4o1b5" title="Remesurement" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:Remesurement" contextRef="From2022-01-012022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002814" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,637</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_987_ecustom--Remesurement_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zSjSRpRi6Ry7" title="Remesurement" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:Remesurement" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002816" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,637</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transfer</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zm7EzOl2JYqf" title="Transfer amount" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2022-01-012022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002818" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,472</ix:nonFraction>)</span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9KFNs0Bmz96" title="Transfer amount" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:Transfer" contextRef="From2022-01-012022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002820" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">530</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLvMGXy2m4la" title="Transfer amount" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:Transfer" contextRef="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002822" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,466</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zE2VFXVKUvl4" title="Transfer" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:Transfer" contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002824" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,433</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMhiJG9r6d2k" title="Transfer" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:Transfer" contextRef="From2022-01-012022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002826" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,953</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxpjg8n9eJWg" title="Transfer" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002828" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">35,499</ix:nonFraction>)</span></td>
    <td id="xdx_982_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgLVjYOX7nSb" title="Transfer" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2022-01-012022-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002830" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">40,226</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zacZqLhiLYSh" title="Transfer" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002832" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">815</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Business combinations</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsw3RHiwQQ0e" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002834" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,246</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhNOvEBUHzQ9" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002836" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,185</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2UV5YPjjBHl" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002838" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,929</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLxhpCOVnyO4" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002840" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zj7IBwHMhQZ" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002842" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,627</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvI0Eg58qRd7" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002844" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,520</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgA0OV25wTO3" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2022-01-012022-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember" id="Fact002846" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,055</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfhtXkzWgI6i" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002848" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">106,595</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZGbWiJzMptc" title="Intangible assets and goodwill, balance at end" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002850" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,257,045</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zid4tDg6Duzk" title="Intangible assets and goodwill, balance at end" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002852" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,189,814</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmgtpoFnBs7i" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002854" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">182,060</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLz7s3H970df" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002856" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">435,816</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfGdNwDCzqY1" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002858" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,300</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqzm1nUYnHBk" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002860" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">69,589</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvs2JUEzY892" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002862" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">90,749</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztWrXATFPEUe" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002864" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,697</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2wUNIGwCnn8" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002866" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,734</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRMz5IwE6sO1" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember" id="Fact002868" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,055</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVF2wAQplVF7" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002870" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,339,859</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Additions</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zGiZtIR7jDNd" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002872" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,314</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zn5r3EFssVV3" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002874" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,827</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zAvY8yKtbY7a" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002876" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,712</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zrGW628YStRh" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002878" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,164</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____z2Wf7ULHomg" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002880" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,976</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____za619doDJEQc" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002882" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99,993</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsqfToq76mWl" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002884" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,235</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHIvsvqICiF4" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002886" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">911</ix:nonFraction>)</span></td>
    <td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAqOqcUZ1fV7" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002888" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">125</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4CyNOZlxFif" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002890" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,271</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Remeasurement (iv)</span></td>
    <td id="xdx_988_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkkyKSrbQW4" title="Remesurement" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:Remesurement" contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002892" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,556</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98E_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zT3GK1cRZFjd" title="Remesurement" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:Remesurement" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002894" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,556</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transfer</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkFVkkEILxHk" title="Transfer amount" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002896" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,708</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQG1r1Cc4mCc" title="Transfer" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002898" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,785</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7wH2IadM7u6" title="Transfer" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002900" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6c1L7rUz7uc" title="Transfer" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002902" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,058</ix:nonFraction>)</span></td>
    <td id="xdx_984_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziSvCId07ll4" title="Transfer" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002904" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">30,451</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Business combination (v)</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHKkn2F9f5R2" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002906" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">75,098</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsTwMyWH84za" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002908" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">586,263</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmHQbEFXgH02" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002910" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">142,451</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlcFMWXcg90h" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002912" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKUlaNc2BSt9" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002914" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">803,875</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfTVpOiyKlCj" title="Intangible assets and goodwill, balance at end" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002916" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,334,699</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyBhyK3VHgF9" title="Intangible assets and goodwill, balance at end" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002918" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,776,077</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXvGNXVeCyx5" title="Intangible assets and goodwill, balance at end" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002920" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">182,060</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCTz7fEVcqWf" title="Intangible assets and goodwill, balance at end" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002922" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">578,267</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMlTARrHb4A3" title="Intangible assets and goodwill, balance at end" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002924" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,150</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRMES8oDqJ57" title="Intangible assets and goodwill, balance at end" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002926" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">84,201</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z43C2DF0VF5i" title="Intangible assets and goodwill, balance at end" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002928" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,477</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zdFlphCY2aH4" title="Intangible assets and goodwill, balance at end" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002930" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,892</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3pRmdFD5jec" title="Intangible assets and goodwill, balance at end" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002932" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,134</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLsa5CtlazLg" title="Intangible assets and goodwill, balance at end" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember" id="Fact002934" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,055</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3HBoyN7Umbe" title="Intangible assets and goodwill, balance at end" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002936" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,243,012</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Amortization</b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of January 1, 2021</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJdlYZWxNtn8" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2938">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z5kPPI9XB7u3" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2940">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxvAAkhuktK5" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002942" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,502</ix:nonFraction>)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8Q9IsXNzc9h" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002944" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">85,832</ix:nonFraction>)</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmbW62Qc5m14" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002946" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,256</ix:nonFraction>)</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z7bke0i420q7" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002948" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,692</ix:nonFraction>)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zg0tZNg5jOMl" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002950" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">32</ix:nonFraction>)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8WB1A0dvnh" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002952" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,235</ix:nonFraction>)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkE5CAAvBZFg" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2954">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>-</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z9bRG8BBvKZc" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002956" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">111,549</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Amortization</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iP2custom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvngUNyQYOW8" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl2958">-</span></span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z6PTZmw3J3Ca" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl2959">-</span></span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4EPdygNyKVc" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002961" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,027</ix:nonFraction>)</span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjeS2aFfrBW7" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002963" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">56,438</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zudlFPP8ECCj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002964" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,844</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zPn81oAhimq4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002965" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,980</ix:nonFraction>)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1oi55s6Gaa9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002966" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">625</ix:nonFraction>)</span></td>
    <td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUkudD4TwWhg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002967" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,608</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvxlt8PwE4g2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl2968">-</span></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRgYc87MKQ78" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002969" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">80,522</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_986_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zB9o870cnC7e" title="Write-off" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002971" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">599</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_980_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRmp754MQROa" title="Write-off" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002973" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">365</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zrdK0dZxDzq9" title="Write-off" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002975" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">234</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2021</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUVFqH5h9816" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2977">-</span></b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zOprGAmmEoQa" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2979">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzpzAPhoTcr" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002981" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,529</ix:nonFraction>)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQJtlGdy8rrk" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002983" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">142,270</ix:nonFraction>)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3f7gnY7krYd" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002985" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,699</ix:nonFraction>)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkfYhmtObfk9" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002987" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">16,672</ix:nonFraction>)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zU9b3749VCr9" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002989" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">657</ix:nonFraction>)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKdgQGoYTPkh" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002991" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,478</ix:nonFraction>)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlEmY6swP4sb" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2993">-</span></b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zk6Bl2dBFlHi" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2995">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAOztK89xXnc" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002997" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">192,305</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Amortization</span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRIqLr58LeHc" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl2999">-</span></span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zZ7uEvAsvJn4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3000">-</span></span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zaOFsDGvO1Kj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003001" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,426</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z5SHk6zZZtp1" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003003" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">70,093</ix:nonFraction>)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIBzUyzLtzXe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003004" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,943</ix:nonFraction>)</span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1KLnEPPvsL5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003005" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,634</ix:nonFraction>)</span></td>
    <td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzUZSVylsrPi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003006" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,436</ix:nonFraction>)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zspCp7XfNRz9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003007" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,874</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFcICCaZcy54" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3008">-</span></span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDgSWPcpEpNk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003009" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">79</ix:nonFraction>)</span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zpqGiDSi1IJ4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003010" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">106,485</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_986_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhw7RbRISOna" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003012" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">365</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKE3GEPFeF56" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003014" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFCuvVlZuYL9" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003016" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">422</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFvp4ObR37Kd" title="Transfer amount" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003018" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">313</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zw5xUo9Mgk51" title="Transfer amount" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:Transfer" contextRef="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003020" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">313</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1Q7lutEHQO8" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3022">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zu5EFWbDZEMe" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3024">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlBnkyvk0ev7" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003026" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,955</ix:nonFraction>)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zR9jM67yGAG3" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003028" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">212,363</ix:nonFraction>)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgDyDdWjDuWa" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003030" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,277</ix:nonFraction>)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZdbPDLMuWx2" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003032" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">26,562</ix:nonFraction>)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbN3g81tOMI6" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003034" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,093</ix:nonFraction>)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhxf7VctRsmj" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003036" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,039</ix:nonFraction>)</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zukZwSmCdKsd" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3038">-</span></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zV5tIWM2QCOa" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003040" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">79</ix:nonFraction>)</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSRIPuk60oai" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003042" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">298,368</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Amortization</span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIIclee4CFP3" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3044">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zLujbAMj9hQ8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3045">-</span></span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQpffWkfUrO" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003046" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,083</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z95ZNUJtiHD6" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003048" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">89,584</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1dLqJhChIH5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003049" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,764</ix:nonFraction>)</span></td>
    <td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmhdnex591ga" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003050" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">15,668</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zPPtr2Ph0rf6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003051" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">21,504</ix:nonFraction>)</span></td>
    <td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvWZ4NvXxo4h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003052" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,778</ix:nonFraction>)</span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuMvzAD5mG47" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3053">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTjLK0f2CxId" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003054" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">105</ix:nonFraction>)</span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNiowokeDkqg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003055" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">151,486</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98C_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8kFhGgLh35b" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003057" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,947</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFrYtYTNmaE9" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003059" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">911</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTzdX7Tjbo3f" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003061" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,858</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transfer</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zcQtpkZ8TRzi" title="Transfer amount" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003063" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6</ix:nonFraction>)</span></td>
    <td id="xdx_982_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zl3R7RlPDiy3" title="Transfer amount" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003065" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zakSIViJpJRd" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3067">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zxFpcVDfyLo8" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3069">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zf2zfeQdub9b" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003071" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">26,038</ix:nonFraction>)</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0nNI8J2TV18" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003073" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">301,947</ix:nonFraction>)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z7snqh43ffZh" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003075" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">24,094</ix:nonFraction>)</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHJJPLfjeOa7" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003077" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">42,230</ix:nonFraction>)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqfARSPMviJc" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003079" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,603</ix:nonFraction>)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8WDvcsqHa9h" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003081" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,900</ix:nonFraction>)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zsAddT3S3ePl" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3083">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztQmxjLn3pcj" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003085" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">184</ix:nonFraction>)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUWCWpRFgOx9" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003087" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">446,996</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Net book value:</b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zZGSmpyy3nLe" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2023-12-31_ifrs-full_GoodwillMember" id="Fact003089" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,334,699</ix:nonFraction></b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zzybL6jFJ5sl" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact003091" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,776,077</ix:nonFraction></b></span></td>
    <td id="xdx_988_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zEzdVnnyc3Sg" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2022-12-31_ifrs-full_BrandNamesMember" id="Fact003093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">156,022</ix:nonFraction></b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zdJp51vna8dk" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember" id="Fact003095" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">276,320</ix:nonFraction></b></span></td>
    <td id="xdx_98B_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z7haIx8TeALb" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember" id="Fact003097" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">47,056</ix:nonFraction></b></span></td>
    <td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zM3WVlTyWfa" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2023-12-31_custom_EducationContentMember" id="Fact003099" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,971</ix:nonFraction></b></span></td>
    <td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zlhXNCCNXK0i" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember" id="Fact003101" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">96,874</ix:nonFraction></b></span></td>
    <td id="xdx_980_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zhwgLjcKB0Ie" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2023-12-31_custom_EducationalPlatformMember" id="Fact003103" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,992</ix:nonFraction></b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zweSqKpBdCcg" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2023-12-31_custom_SoftwareInProgressMember" id="Fact003105" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,134</ix:nonFraction></b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zxd75R6u9n5k" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2023-12-31_custom_OtherMember" id="Fact003107" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">871</ix:nonFraction></b></span></td>
    <td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231_zjABLBpRPTtl" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2023-12-31" id="Fact003109" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,796,016</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_98A_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zhOroOPXFxC8" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2022-12-31_ifrs-full_GoodwillMember" id="Fact003111" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,257,045</ix:nonFraction></b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zonPhVoD51rh" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact003113" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,189,814</ix:nonFraction></b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zYCJD4dpY14h" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2020-12-31_ifrs-full_BrandNamesMember" id="Fact003115" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">167,105</ix:nonFraction></b></span></td>
    <td id="xdx_98E_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zZMrU3EO4Npb" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember" id="Fact003117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,453</ix:nonFraction></b></span></td>
    <td id="xdx_98D_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zqlvgHB4BsE6" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember" id="Fact003119" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,023</ix:nonFraction></b></span></td>
    <td id="xdx_987_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zRNXNQ7OmQYb" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2022-12-31_custom_EducationContentMember" id="Fact003121" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,027</ix:nonFraction></b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zu3tByWXgf42" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember" id="Fact003123" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80,656</ix:nonFraction></b></span></td>
    <td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zdtvT4oTgRKa" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2022-12-31_custom_EducationalPlatformMember" id="Fact003125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,658</ix:nonFraction></b></span></td>
    <td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zMGUPMHfcb2k" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2022-12-31_custom_SoftwareInProgressMember" id="Fact003127" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,734</ix:nonFraction></b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zg4WqQp94Ppg" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2022-12-31_custom_OtherMember" id="Fact003129" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">976</ix:nonFraction></b></span></td>
    <td id="xdx_983_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231_zPLbXUJyuXWf" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2022-12-31" id="Fact003131" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,041,491</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">*</td><td style="width: 5pt"/><td style="text-align: justify">Refers to intangible assets written-off as result of lack of expectation of future use.</td>
</tr></table>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Licenses with indefinite useful life: On March 18, 2022, MEC authorized the increase of 28
seats of Centro de Ensino S&#227;o Lucas, located in the city of Ji-Parana, State of Rond&#244;nia. The earn-out related to the seats
approval is R$800 per seat, adjusted by the CDI rate from the closing until the payment date, of which 50% was paid in April 2022 and
the remaining amount is payable in cash in two equal installments through 2024.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"/><td style="text-align: justify">Goodwill: During the measurement period, the preliminary goodwill for the acquisition of
Unigranrio was adjusted by R$39,100 (R$130,073 initial goodwill) as a result of an increase of liabilities regarding tax contingencies
and judicial deposits to be reimbursed by the selling shareholders.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"/><td style="text-align: justify">Goodwill: During the measurement period, R$8,637 of goodwill arising from the acquisition
of RX PRO was reduced, in connection with management&#8217;s view of remote likelihood of RX PRO achieving the revenue goals estimated
at the terms of the earn-out.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iv)</td><td style="width: 5pt"/><td style="text-align: justify">Goodwill: During the measurement period, results of operation such as revenue differed from
the foreseen, resulting in a remeasurement of the contingent consideration for the acquisitions of Al&#233;m da Medicina, CardioPapers
and Glic by R$4,773, R$5,082 and (R$7,299), respectively, totaling R$2,556 for the year ended December 31, 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(v)</td><td style="width: 5pt"/><td style="text-align: justify">Business combination: On January 2, 2023, Afya Brazil acquired DelRey, a post-secondary education
institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs in medicine and health, as
well as other courses. See Note 5.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(vi)</td><td style="width: 5pt"/><td style="text-align: justify">On November 5, 2021, MEC authorized the operation of 120 medical school seats in Garanhuns,
for which our shareholder Nicolau Carvalho Esteves entered into an agreement with Afya Brazil pursuant to which he assigned to Afya Brazil
the right to develop the ITPAC Garanhuns greenfield unit, a medical school in the city of Garanhuns, State of Pernambuco. Management
assessed the aspects of such transaction and concluded that the transaction does not fall under the definition of business, but an acquisition
of license with indefinite useful life recognized in intangible assets. Total purchase price was R$108,000 of which 50% was paid in cash
on the transaction closing date and 50% in two equal annual installments, adjusted by the CDI rate.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AC_z9mMr2cF8Upi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 216 -->
    <div id="xdx_23D_z44B1qLlLaad" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_230_znhPlKF4f2mi" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Licenses with indefinite useful life include intangible assets acquired
through business combinations. The licenses for medicine and other courses granted by MEC to the companies acquired have no expiration
date and the Company has determined that these assets have indefinite useful lives.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For impairment testing goodwill and licenses with indefinite useful lives
acquired through business combinations are allocated to the respective CGUs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company performed its annual impairment test on December 31, 2023, 2022
and 2021. There was no impairment for goodwill and licenses with indefinite useful lives for the years ended December 31, 2023, 2022 and
2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company tests at least annually the recoverability of the carrying amount
of goodwill and licenses with indefinite useful lives for each CGU. The Company determines the recoverable amount of its CGUs based on
the value-in-use. Estimating these values involves the use of assumptions, judgments and estimates of future cash flows that represent
the Company's best estimate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The carrying amounts of goodwill and licenses with indefinite useful life
by CGU and their carrying amount as of December 31, 2023 and 2022 were as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003133" name="afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_897_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_zzqMOzqQmxu5" summary="xdx: Disclosure - Intangible assets and goodwill (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B9_ziu210ar3Zf5" style="display: none">Schedule of assumptions for impairment test</span>&#160;</td>
    <td colspan="6" style="padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in">&#160;</td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Carrying amount</b></span></td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CGU</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Goodwill</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses with indefinite useful life</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CGU</b></span></td></tr>
  <tr>
    <td style="width: 42%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IPTAN</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zMEWTMkMpEH4" title="Goodwill" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" id="Fact003135" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,446</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zIkXUBa16O7k" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" id="Fact003137" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,446</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z6Fls3KSSqnb" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" id="Fact003139" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,214</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zvfNAJ2RJIMb" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" id="Fact003141" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,214</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_znwjueBf1G89" title="Cash generating units" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" id="Fact003143" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">125,974</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zMDNzNIOnjHl" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" id="Fact003145" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">126,024</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IESVAP</span></td>
    <td id="xdx_98B_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z7ebTmxWG6p4" title="Goodwill" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" id="Fact003147" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,956</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zQvCNbegZtXc" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" id="Fact003149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,956</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zPHJHpr2rKTb" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" id="Fact003151" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">81,366</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zbxbycrv7g5a" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" id="Fact003153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">81,366</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z5S3vE0ekyYh" title="Cash generating units" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" id="Fact003155" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">126,996</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zgwRU3M123M6" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" id="Fact003157" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">129,305</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">CCSI</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zKcobUcnJMq9" title="Goodwill" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" id="Fact003159" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,664</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zJLjxQJG5AKb" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" id="Fact003161" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,664</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zuLKXhrw9nU4" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" id="Fact003163" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,737</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zG64JkeD6Elc" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" id="Fact003165" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,737</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zilNfsjrdUSc" title="Cash generating units" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" id="Fact003167" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,550</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zYALhgNLVtI2" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" id="Fact003169" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,540</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IESP</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zCXXn4mdrD33" title="Goodwill" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" id="Fact003171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">73,838</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zjUFSH9gJEhb" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" id="Fact003173" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">73,838</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zoqOobLHD47c" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" id="Fact003175" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">179,693</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z1jem8KIGXv7" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" id="Fact003177" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">179,693</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zjxNITJg7NW9" title="Cash generating units" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" id="Fact003179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">332,104</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zef18tATxUUa" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" id="Fact003181" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">322,968</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FADEP</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zHtXp28SMVod" title="Goodwill" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" id="Fact003183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,661</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zw6olpzqlRBg" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" id="Fact003185" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,661</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z5uunxL2nnZc" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" id="Fact003187" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,606</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zunecelcRBY8" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" id="Fact003189" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,606</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z6YdRN9vxIl4" title="Cash generating units" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" id="Fact003191" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">148,032</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zewHKSZ1p6Bh" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" id="Fact003193" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,100</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FASA</span></td>
    <td id="xdx_986_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zfgPda5LeHDj" title="Goodwill" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" id="Fact003195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,903</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zjY43R9RRDu1" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" id="Fact003197" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,903</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zhesAjMK4rp2" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" id="Fact003199" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">144,507</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zhZ9picPDTC3" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" id="Fact003201" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">144,507</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zjxz2LQitxP5" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" id="Fact003203" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">322,061</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zCayavTFR9J7" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" id="Fact003205" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">314,967</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IPEMED</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zu2mPxcHrT0c" title="Goodwill" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="Fact003207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,647</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zcshSisPUGgj" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="Fact003209" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,647</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pdn3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z25VZU1CGw25" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3211">-</span></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pdn3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zmqwQXQ9rgZ" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3213">-</span></span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zOlGb0N0iB6a" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="Fact003215" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">183,862</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zidgkAWSlAnj" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="Fact003217" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">192,079</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IPEC</span></td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zm2QANN48k4a" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3219">-</span></span></td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z1QBDqes9YSd" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3221">-</span></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zqF6wqcDIPh2" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="Fact003223" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,000</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zFdSO4LRWNJe" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="Fact003225" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,000</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zgDqQM9L7Sy7" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="Fact003227" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">157,984</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zAKstAcVKdlc" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="Fact003229" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">148,067</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UniRedentor</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z87ar33N0chl" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" id="Fact003231" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,662</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zvJu3I9tjZC9" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" id="Fact003233" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,662</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zfrMkXMcAvT8" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" id="Fact003235" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">121,477</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zGOd5FyX8iqj" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" id="Fact003237" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">121,477</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zjCpXIc7VDhh" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" id="Fact003239" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">234,054</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zsMODGEGb8Ei" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" id="Fact003241" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,600</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UniSL</span></td>
    <td id="xdx_986_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z4cbjCoukwRb" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniSLMember" id="Fact003243" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,420</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z7fmhq1wbJb2" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniSLMember" id="Fact003245" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,420</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____zGllazCKwied" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniSLMember" id="Fact003247" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">273,795</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____zfYzpiAOaFo" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniSLMember" id="Fact003249" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">273,795</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z35OmdMnPQQ6" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniSLMember" id="Fact003251" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">401,143</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z5JFUJwEUbt6" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniSLMember" id="Fact003253" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">398,492</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FESAR</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_ziAUqEIV6Xeg" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FESARMember" id="Fact003255" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,664</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z5FfmjHVNTJi" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FESARMember" id="Fact003257" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,664</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zxzIvEcbBHw6" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FESARMember" id="Fact003259" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">141,616</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zqGIL1Pb9mFf" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FESARMember" id="Fact003261" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">141,616</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zZEQer5sJGkl" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FESARMember" id="Fact003263" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">244,412</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zRvY34SNW7gg" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FESARMember" id="Fact003265" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">244,084</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FCMPB</span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zmPG9b50T1m1" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" id="Fact003267" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,483</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zIx1Xlu3zKY1" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" id="Fact003269" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,483</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z8AxymdEeI6i" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" id="Fact003271" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235,018</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z4vMseSAXgUj" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" id="Fact003273" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235,018</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z2g3pY63APJ" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" id="Fact003275" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">402,140</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z7G87aGR4nG4" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" id="Fact003277" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">415,453</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">ITPAC Garanhuns</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zuzXHHupWVZ8" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3279">-</span></span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zMDyE9rgVERa" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3281">-</span></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zWVTlzHZlvM9" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember" id="Fact003283" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,000</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zisSFrJbq6y6" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember" id="Fact003285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,000</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zlQmANWZhK4d" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember" id="Fact003287" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">116,162</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z9YGEQwdzpAg" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember" id="Fact003289" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">112,628</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Content &amp; Technology for medical education (Pillar 1) *</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zA9Sh42jmvwj" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember" id="Fact003291" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">179,830</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zNUCwkxzTvod" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember" id="Fact003293" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">169,975</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zg6GdQT9FNji" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3295">-</span></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zP9b2nin9i7a" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3297">-</span></span></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z0LxoxdVQMeh" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember" id="Fact003299" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">238,921</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zAR0hZyZQx94" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember" id="Fact003301" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">279,684</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Practice Management Tools &amp; Electronic Prescription (Pillar 3)</span></td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zwD8e2Eeiah" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember" id="Fact003303" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">106,774</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zP3HhvHaUjbe" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember" id="Fact003305" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">106,774</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zxwqa8mctp32" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3307">-</span></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zk2PgnYtM1F5" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3309">-</span></span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zXVQvmlYTnJj" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember" id="Fact003311" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">221,171</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zhgPYaB7lNjg" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember" id="Fact003313" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">216,297</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Clinical Decision Software (Pillar 2)</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zmXoVN7WMiqj" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember" id="Fact003315" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,018</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zY6LpWaXdXS2" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember" id="Fact003317" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,018</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zcbeoEv95rN4" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3319">-</span></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zP2DQyhrM7N6" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3321">-</span></span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zbeRK6tHqDub" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember" id="Fact003323" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">147,897</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z0yd02PIVl3" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember" id="Fact003325" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,526</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cliquefarma</span></td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z00tGT2dLwBa" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember" id="Fact003327" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,588</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8FSSDGoHb77" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember" id="Fact003329" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,588</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zeLIPp5lD43h" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3331">-</span></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zVigd7Gvnm44" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3333">-</span></span></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zzThE07eOMJ6" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember" id="Fact003335" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,789</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z9eg68e21K3f" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember" id="Fact003337" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,045</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UnifipMoc</span></td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z9nQd8jYobjk" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember" id="Fact003339" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,777</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zOvXG46sKnDd" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember" id="Fact003341" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,777</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zOH7Ro3LmCib" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember" id="Fact003343" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">190,247</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zWwTbNSDZeh" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember" id="Fact003345" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">190,247</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z7FFrIMLKMT7" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember" id="Fact003347" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">361,383</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zXKUarNtCjY" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember" id="Fact003349" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">369,007</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Unigranrio</span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zd07evq26Hfi" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" id="Fact003351" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">169,173</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zWodhmw7xVpk" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" id="Fact003353" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">169,173</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zK7zhR1rGyue" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" id="Fact003355" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">421,538</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zRfKUwMsXaH2" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" id="Fact003357" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">421,538</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z2BmuzPN04A6" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" id="Fact003359" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">833,665</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z1Cu9Vl17eKk" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" id="Fact003361" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">854,861</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">RX PRO</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zKbhW2JhCXMj" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_RXPROMember" id="Fact003363" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,809</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHhuDacaoLC8" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_RXPROMember" id="Fact003365" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,809</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zMSRaaenPP52" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3367">-</span></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zG4okLxpIDGd" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3369">-</span></span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zWRot9sQMbpa" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_RXPROMember" id="Fact003371" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,748</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zePr6UTv1Ad3" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_RXPROMember" id="Fact003373" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,675</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Glic *</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zjKwCcFuEwB7" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_GlicMember" id="Fact003375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,288</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zmHxJFF8oZ98" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_GlicMember" id="Fact003377" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,587</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zhsqTTZH106k" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3379">-</span></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zwzdBxCxvZX" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3381">-</span></span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z56RqCQj2qG9" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_GlicMember" id="Fact003383" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,721</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z7BXg6aWZJN7" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_GlicMember" id="Fact003385" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,022</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">DelRey</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z0YiVmvMZTl6" title="Goodwill" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_DelReyMember" id="Fact003387" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">75,098</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmErMfBrBxa" title="Goodwill" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3389">-</span></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zp0ur8iXCXEf" title="Licenses with indefinite useful life" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_DelReyMember" id="Fact003391" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">586,263</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zYqywOBu3Ab8" title="Licenses with indefinite useful life" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3393">-</span></span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zojQOdUk38M4" title="Cash generating units" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_DelReyMember" id="Fact003395" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">854,313</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zIRyssqpra5a" title="Cash generating units" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3397">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zvS7L22Rtc7b" title="Goodwill" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember" id="Fact003399" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,334,699</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zQD2BSZC53P4" title="Goodwill" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember" id="Fact003401" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,257,045</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zXhS9fbGkxSb" title="Licenses with indefinite useful life" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember" id="Fact003403" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,776,077</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zQV4XxDhUbV7" title="Licenses with indefinite useful life" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember" id="Fact003405" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,189,814</ix:nonFraction></b></span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zYT2Rx9a5Aw" title="Cash generating units" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2023-12-31_custom_CarryingAmountsMember" id="Fact003407" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,584,082</ix:nonFraction></b></span></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zYA2RckZNPlh" title="Cash generating units" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2022-12-31_custom_CarryingAmountsMember" id="Fact003409" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,814,424</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">*</td><td style="width: 5pt"/><td style="text-align: justify">See above for further details on goodwill changes in 2023.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A1_zuQkIsJ3rwSe" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">The main assumptions used by the Company to determine
the value in use of the CGUs were:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">Student enrollment - refers to the number of students
that are currently enrolled in each CGU. The growth of students enrolled considers maturation of operations, limited by regulatory seats
approved for each CGU.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 217 -->
    <div id="xdx_233_z1G7uunCKVak" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23B_z0QCB6gpHOj3" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Tuition fees - the monthly fee charged to students. Tuition fees are consistent
with Management best expectations on prices charged and considers inflation for future periods.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Occupancy rate - the occupancy rate of the medical schools is the ratio
of the number of students effectively enrolled divided by the regulatory capacity in a given period.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Regulatory capacity - the regulatory capacity is defined by the number of
medical schools seats available per year awarded by MEC, multiplied by the number of years of operations since the seats were awarded.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Faculty - refers to the cost with faculty in the CGU, which means the amount
paid to teachers and doctors.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Digital content platform revenues - refer to mobile app subscription, clinical
management system, healthcare payments, medical imaging, online courses for digital content users and marketing for pharmaceutical industry.
Business assumptions include management best expectations on long term targets for digital services segment operations, including total
addressable market, market share and target prices including inflation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Capital expenditures - refers to investments to be made on intangible assets
related to developments and platform improvements especially on the digital services CGUs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">Discount rates - discount rates represent the current
market assessment of the risks specific to the CGU being tested. The pre-tax discount rate applied to cash flow projections is between
<span id="xdx_90E_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pid_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z3b2HImOwvag" title="Discount rate applied to cash flow projections"><ix:nonFraction name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" contextRef="AsOf2023-12-31_ifrs-full_BottomOfRangeMember" id="Fact003411" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.48</ix:nonFraction></span>% and <span id="xdx_900_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pid_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zS0zXiFEg0uf" title="Discount rate applied to cash flow projections"><ix:nonFraction name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" contextRef="AsOf2023-12-31_ifrs-full_TopOfRangeMember" id="Fact003413" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15.14</ix:nonFraction></span>% in 2023 (between <span id="xdx_902_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pid_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zo9WACMhePx8" title="Discount rate applied to cash flow projections"><ix:nonFraction name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" contextRef="AsOf2022-12-31_ifrs-full_BottomOfRangeMember" id="Fact003415" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13.14</ix:nonFraction></span>% and <span id="xdx_908_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pid_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8Y29Il9xQVh" title="Discount rate applied to cash flow projections"><ix:nonFraction name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" contextRef="AsOf2022-12-31_ifrs-full_TopOfRangeMember" id="Fact003417" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15.40</ix:nonFraction></span>% in 2022).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">Perpetuity growth rate - refers to growth rate considered
by management on long term periods after the explicit projection period of five <span id="xdx_901_ecustom--ExplicitProjectionPeriod_dtY_c20230101__20231231_z7uvymfzDPXf" title="Explicit projection period" style="display: none"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:duryear" id="Fact003419" name="afya:ExplicitProjectionPeriod">5</ix:nonNumeric></span>
years. The growth rates range from <span id="xdx_90C_ecustom--PerpetuityGrowthRate_pid_dp_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_za6Ng84ehhjg" title="Growth rates"><ix:nonFraction name="afya:PerpetuityGrowthRate" contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_ifrs-full_BrandNamesMember" id="Fact003421" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.5</ix:nonFraction></span>%
to <span id="xdx_90B_ecustom--PerpetuityGrowthRate_pid_dp_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zZHxGzW4x9C3" title="Growth rates"><ix:nonFraction name="afya:PerpetuityGrowthRate" contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_ifrs-full_BrandNamesMember" id="Fact003423" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.8</ix:nonFraction></span>%.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt 10.9pt; text-indent: -10.9pt"><span style="text-decoration: underline">Significant estimate: impact of possible
changes in key assumptions</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span id="xdx_90B_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_z6Laoxh51uUc" title="Description of key assumptions on which management has based cash flow projections"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember" id="Fact003425" name="ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections">An increase of 25 basis points in management&#8217;s estimated
discount rate applied to the cash flow projections of each CGU for the year ended December 31, 2023, or a decrease of 25 basis points
on estimated EBITDA would have not resulted in significant impacts on these consolidated financial statements.</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt; color: #C00000">Other intangible assets</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets, other than goodwill and licenses with indefinite useful
lives, are valued separately for each acquisition and are amortized during each useful life. The useful lives and methods of amortization
of other intangibles are reviewed at each financial year end and adjusted prospectively, if appropriate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The estimated useful lives of intangible assets are as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003427" name="afya:SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_88C_ecustom--SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zElzYaU0osM5" summary="xdx: Disclosure - Intangible assets and goodwill (Details 2)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_zjb6IUsUqjg5" style="display: none">Schedule of estimated
    useful lives of intangible assets</span>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="width: 72%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Customer relationships - medicine</span></td>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsMedicineMember_zq8afRnHTbud" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CustomerRelationshipsMedicineMember" format="ixt-sec:duryear" id="Fact003429" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">6</ix:nonNumeric></span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Customer relationships - other courses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsOtherCoursesMember_zAOTCaqrU9O3" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CustomerRelationshipsOtherCoursesMember" format="ixt-sec:duryear" id="Fact003431" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">4.5</ix:nonNumeric></span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Software license</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zjo7dH7vBiXd" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember" format="ixt-sec:duryear" id="Fact003433" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">5</ix:nonNumeric></span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Education content</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zyWGqGGxn1N5" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_EducationContentMember" format="ixt-sec:duryear" id="Fact003435" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">3</ix:nonNumeric></span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trademarks</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zvRcOQGbg7X5" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_ifrs-full_BrandNamesMember" format="ixt-sec:duryear" id="Fact003437" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">2</ix:nonNumeric></span> - <span id="xdx_903_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zIBFrQClh4Ga" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_ifrs-full_BrandNamesMember" format="ixt-sec:duryear" id="Fact003439" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">30</ix:nonNumeric></span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Developed technology</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyMember_z3qO4r0lhFHe" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_DevelopedTechnologyMember" format="ixt-sec:duryear" id="Fact003441" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">5</ix:nonNumeric></span> years</span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For the years ended December 31, 2023, 2022 and 2021, there were no indicatives
that the Company&#8217;s intangible assets with finite useful lives might be impaired.</p>

<ix:exclude><p id="xdx_233_zRzsljHFi5B4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><br/>
</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 218 -->
    <div id="xdx_23A_zqzi338b0qs6" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_234_za97eFhcL4r" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003444" name="ifrs-full:DisclosureOfFinancialInstrumentsExplanatory"><p id="xdx_806_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_z1Fsf8NZRM34" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>13</b></td><td><b><span id="xdx_82D_zorj3lSPc0a3">Financial assets and financial liabilities</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #0D0E00">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>13.1</b></td><td><b>Financial assets </b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003446" name="afya:FinancialAssetsExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_896_ecustom--FinancialAssetsExplanatory_pn3n3_zJLMLzaNeYWi" summary="xdx: Disclosure - Financial assets and financial liabilities (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B4_zdIUHg3WDrwj" style="display: none">Schedule of financial assets</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>At amortized cost:</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade receivables</span></td>
    <td id="xdx_987_eifrs-full--TradeReceivables_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_znvhRTpgqlal" title="Trade receivables" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2023-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003448" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">585,923</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--TradeReceivables_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zltSo2FYUQFj" title="Trade receivables" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2022-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003450" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">495,399</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRijhHHmHUsi" title="Total" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2023-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003452" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">585,923</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z8eNeDWDgcWj" title="Total" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2022-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003454" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">495,399</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_98F_eifrs-full--CurrentFinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zDSNLhZailvk" title="Current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentFinancialAssets" contextRef="AsOf2023-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003456" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">546,438</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--CurrentFinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zDH89V548f0l" title="Current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentFinancialAssets" contextRef="AsOf2022-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003458" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">452,831</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98F_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z8gvKyGqExqj" title="Non-current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssets" contextRef="AsOf2023-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003460" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,485</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zbyrwCdiwf9h" title="Non-current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssets" contextRef="AsOf2022-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003462" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,568</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_zgYPot13SO5b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>13.2</b></td><td><b>Financial liabilities</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003464" name="afya:FinancialLiabilitiesExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_89E_ecustom--FinancialLiabilitiesExplanatory_pn3n3_zNAamn5fgTHj" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BB_zVLBJXM1nqMi" style="display: none">Schedule of financial liabilities</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>At amortized cost:</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade payables</span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zsZ5z4tBNd16" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003466" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,222</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zaflng1uIr16" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003468" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,482</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGCVA33rQQZe" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003470" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,800,775</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--LoansAndFinancing_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zZDf2YxUiPyj" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003472" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,882,901</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease liabilities</span></td>
    <td id="xdx_98A_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zCR0jnW0qx3f" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003474" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">874,569</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--LeaseLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zahkjH53tg56" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003476" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">769,525</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zvd44yXvyfvi" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003478" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">566,867</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zBUVkdriNaCl" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003480" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">528,678</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes payable</span></td>
    <td id="xdx_987_ecustom--NotePayable_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zG5S5iOcosV8" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3482">-</span></span></td>
    <td id="xdx_982_ecustom--NotePayable_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zA0iGBXV1x2k" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotePayable" contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003484" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,176</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGG5suRO9WQ3" title="Total" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003486" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,350,433</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4vSHarrOjr4" title="Total" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003488" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,314,762</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_989_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4zKHRNZy307" title="Current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilities" contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003490" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">678,370</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zPLNPpcSDgD1" title="Current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilities" contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003492" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">573,030</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_znNl3Ionj775" title="Non-current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilities" contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003494" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,672,063</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zcjxZaF92JNi" title="Non-current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilities" contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003496" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,741,732</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A3_zCXdCLXKngY3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #C00000"><b>13.2.1</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #C00000"><b>Loans and financing</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003498" name="afya:LoansAndFinancingExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_899_ecustom--LoansAndFinancingExplanatory_pn3n3_zx8gg8As9Cd" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 2)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span id="xdx_8BF_z3FjGsB32I6k" style="display: none">Schedule
    of loans and financing</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial institution</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Currency</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Interest rate</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Maturity</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zwhEO91dhfLf" title="Financial institution"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentyFiveMember" id="Fact003500" name="afya:FinancialInstitution">Banco Ita&#250; Unibanco S.A</ix:nonNumeric></span>. (a)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zPovUXEsgu85" title="Interest rate"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentyFiveMember" id="Fact003502" name="ifrs-full:BorrowingsInterestRateBasis">CDI + 1.90% p.y.</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90C_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_z9FbYff3t5Pi" title="Maturity"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentyFiveMember" id="Fact003504" name="ifrs-full:BorrowingsMaturity">2025</ix:nonNumeric></span></span></td>
    <td id="xdx_986_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zxtdhVhnUYl9" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2023-12-31_custom_TwentyTwentyFiveMember" id="Fact003506" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">412,880</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zuTknWjmk7z3" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2022-12-31_custom_TwentyTwentyFiveMember" id="Fact003508" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">518,134</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_z63efS7dHPW6" title="Financial institution"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentySevenMember" id="Fact003510" name="afya:FinancialInstitution">FINEP</ix:nonNumeric></span> (b)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zYY7ZOaEGG5i" title="Interest rate"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentySevenMember" id="Fact003512" name="ifrs-full:BorrowingsInterestRateBasis">TJLP p.y.</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_za4bA5mRwBMi" title="Maturity"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentySevenMember" id="Fact003514" name="ifrs-full:BorrowingsMaturity">2027</ix:nonNumeric></span></span></td>
    <td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zLWcQNCImBv8" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2023-12-31_custom_TwentyTwentySevenMember" id="Fact003516" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,193</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zz5NcqU4jFkf" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2022-12-31_custom_TwentyTwentySevenMember" id="Fact003518" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,418</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zixPvLe2cUm2" title="Financial institution"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentyFourMember" id="Fact003520" name="afya:FinancialInstitution">Banco Ita&#250; Unibanco S.A.</ix:nonNumeric></span> (c)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_ze6xeIWghk6h" title="Interest rate"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentyFourMember" id="Fact003522" name="ifrs-full:BorrowingsInterestRateBasis">CDI + 1.75% p.y.</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_ziloWsxWkwZe" title="Maturity"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentyFourMember" id="Fact003524" name="ifrs-full:BorrowingsMaturity">2024</ix:nonNumeric></span></span></td>
    <td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zAXlGIXZMIRj" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2023-12-31_custom_TwentyTwentyFourMember" id="Fact003526" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,405</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zZsdujsDMr63" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2022-12-31_custom_TwentyTwentyFourMember" id="Fact003528" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,252</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zTtQj1dKJQH5" title="Financial institution"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentySixMember" id="Fact003530" name="afya:FinancialInstitution">Softbank</ix:nonNumeric></span> (d)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zgAcYMbOeJd" title="Interest rate"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentySixMember" id="Fact003532" name="ifrs-full:BorrowingsInterestRateBasis">6.5% p.y.</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_z9JbBX8Z8CKb" title="Maturity"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentySixMember" id="Fact003534" name="ifrs-full:BorrowingsMaturity">2026</ix:nonNumeric></span></span></td>
    <td id="xdx_98F_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zvFybhC9AJYg" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2023-12-31_custom_TwentyTwentySixMember" id="Fact003536" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">825,957</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zkLfVMdMdmXk" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2022-12-31_custom_TwentyTwentySixMember" id="Fact003538" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">824,258</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zhKl4Fl7Ir0j" title="Financial institution"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentyEightMember" id="Fact003540" name="afya:FinancialInstitution">Debentures</ix:nonNumeric></span> (e)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zwYtnJrmhQml" title="Interest rate"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentyEightMember" id="Fact003542" name="ifrs-full:BorrowingsInterestRateBasis">CDI + 1.80% p.y.</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zhF90K588Ozc" title="Maturity"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwentyTwentyEightMember" id="Fact003544" name="ifrs-full:BorrowingsMaturity">2028</ix:nonNumeric></span></span></td>
    <td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zuEihA0v0K7i" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2023-12-31_custom_TwentyTwentyEightMember" id="Fact003546" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">529,340</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zoalALfixzve" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2022-12-31_custom_TwentyTwentyEightMember" id="Fact003548" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">499,839</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_988_ecustom--LoansAndFinancing_iI_pn3n3_c20231231_zJH3pY03LGDf" title="Loans and financing" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2023-12-31" id="Fact003550" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,800,775</ix:nonFraction></b></span></td>
    <td id="xdx_982_ecustom--LoansAndFinancing_iI_pn3n3_c20221231_z5cUqIHiEmq3" title="Loans and financing" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2022-12-31" id="Fact003552" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,882,901</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_98C_ecustom--LoansAndFinancingCurrent_pn3n3_c20231231_zE9O3pNmyqHg" title="Current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancingCurrent" contextRef="AsOf2023-12-31" id="Fact003554" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">179,252</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--LoansAndFinancingCurrent_pn3n3_c20221231_z8ClKkSIN7q8" title="Current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancingCurrent" contextRef="AsOf2022-12-31" id="Fact003556" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">145,202</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_982_ecustom--LoansAndFinancingNonCurrent_pn3n3_c20231231_zG4Rcw4uOJcb" title="Non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancingNonCurrent" contextRef="AsOf2023-12-31" id="Fact003558" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,621,523</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--LoansAndFinancingNonCurrent_pn3n3_c20221231_zkCz0TP20Am7" title="Non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancingNonCurrent" contextRef="AsOf2022-12-31" id="Fact003560" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,737,699</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AA_zdrHceVnbSW2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(a) On October 1, 2020, Afya Brazil entered into a loan with Banco Ita&#250;
Unibanco S.A. in the amount of R$500,000 adjusted by the CDI rate plus an interest rate of 1.62% per year and is repayable in three installments
in October 2022, April 2023 and October 2023. This agreement has financial covenants and the Company should not reduce its EBITDA by 50%
or more year over year. As of December 31, 2023, the Company is compliant with all obligations set forth in this agreement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On September 28, 2022, Afya Brazil signed an amendment with Banco Ita&#250;
Unibanco S.A in order to extend its debt profile, postponing the original repayments dates from 2022 and 2023 to 2023, 2024 and 2025.
Due to such extension, the spread over CDI rate increased from 1.62% p.y to 1.90% p.y.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(b) On July 23, 2019, Medcel entered into a loan of R$16,153 with Financiadora
de Estudos e Projetos (&#8220;FINEP&#8221;), a governmental agency focused on financing investments on R&amp;D, which has an interest
rate based on TJLP (Long term interest rate), and maturity in 2027. The first and second tranches of R$6,734 and R$4,130, respectively,
were drawdown in October 2019 and December 2020, respectively, and new tranches were drawdown in March and June 2023 totaling R$5,288
in order to develop the Medical web series and other digital content. There is no financial covenant related to this agreement. The total
balance is guaranteed by a bank financial guarantee.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 219 -->
    <div id="xdx_23D_zxs3nMGy5Q5e" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_234_ztHPDHCFQOJe" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(c) On October 28, 2020, UnifipMoc entered into a loan with Banco Ita&#250;
Unibanco S.A. in the amount of R$30,000. On June 30, 2021, this agreement was amended and is now adjusted by the CDI rate plus an interest
rate of 1.75% per year and is repayable in three installments in July 2023, January 2024 and July 2024. There is no financial covenant
related to this agreement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(d) On April 26, 2021, the Company issued and sold 150,000 shares of perpetual
convertible preferred shares designated as Series A perpetual convertible preferred shares, with a par value of US$0.00005 per share of
the Company for US$150,000 thousands, equivalent to R$821,805 on the issuance date. The Series A perpetual convertible preferred shares
is a class of equity security that ranks senior to the common shares with respect to dividend rights or rights upon liquidation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Each Series A perpetual convertible preferred share is entitled to a cash
dividend of 6.5% per annum and is convertible, at the holder&#8217;s discretion, into the Company&#8217;s Class A common shares at an
initial conversion price of US$25.35. The Company may require the conversion of any or all of the Series A perpetual convertible preferred
shares at any time on or after the three-year anniversary of the original issuance date if certain conditions set forth in the certificate
of designation are met (if for 20 out of 30 consecutive trading days prior, Afya&#8217;s stock price is equal or above 150% of the conversion
rate). The Company may also redeem any or all of the Series A perpetual convertible preferred shares for cash, shares of its common shares
or a combination thereof at its election, at any time on or after the seven-year anniversary of the original issuance date as determined
in the certificate of designation. On or after the five-year anniversary of the original issuance date, the holders of the Series A convertible
perpetual preferred shares shall have the right to redeem all of the outstanding Series A convertible perpetual preferred shares for cash,
the Company&#8217;s common shares or a combination thereof (at the Company&#8217;s election, subject to certain conditions) to be determined
in the certificate of designation. Upon the occurrence of a change of control, the holders will have the right to redeem their Series
A convertible perpetual preferred shares for cash at a price set forth in the certificate of designation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Series A convertible perpetual preferred shares will be entitled with
the same voting rights of the common shares only when converted into it.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company determined that the Series A perpetual convertible preferred
shares should be classified as financial liability at amortized cost upon their issuance since is redeemable primarily according to the
decision of the holder and there is a contractual obligation to deliver assets (cash, shares of its common shares or a combination thereof)
that could not be avoided by the Company in an event of redemption. The financial liability is denominated in Brazilian Reais and thus
not subject to foreign exchange changes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">In addition, as the entire instrument is classified as a liability, the
embedded put option to redeem the Series A perpetual convertible preferred shares for cash is an embedded derivative. The embedded derivative
will not be treated separately once the exercise price of the option is closely related to the host contract.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The initial transaction costs that are directly attributable to the issuance
of Series A perpetual convertible preferred shares were measured at fair value together with the financial liability on initial measurement.
The transaction costs totaled R$13,030, including legal counsels and advisors.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(e) On December 16, 2022, Afya Brazil issued 500,000 simple, non-convertible,
unsecured debentures in a single series, each with a par value of R$1, totaling an aggregate amount of R$500.000, by means of a public
distribution with restricted placement efforts in the Brazilian market, under the terms of the Brazilian Securities Commission (&#8220;CVM&#8221;)
Rule No. 476. Afya expects to use the proceeds of the offering for general corporate purposes, strengthening its cash position, and extending
its debt maturity profile. The debentures were issued with a maturity date of January 15, 2028, with the principal to be amortized in
two equal installments payable on January 15, 2027 and January 15, 2028, corresponding to the fourth and fifth years of the transaction,
respectively. The debentures bear interest at 100% of the CDI rate (the average of interbank overnight rates in Brazil, based on 252
business days) plus 1.80% per year, payable semi-annually on January 15 and July 15 of each year, until the maturity date.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<ix:exclude><p id="xdx_231_zVARDtxOJUd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 220 -->
    <div id="xdx_23D_zAeoKr7q4nk2" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_237_ziCJpdjEwGZf" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_z0VJIS5P47d4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">This transaction is subject to certain obligations including financial covenants.
According to this offering, Afya shall maintain net debt (excluding Softbank transaction and lease liabilities) to adjusted EBITDA ratio
below or equal to 3.0 x, at the end of each fiscal year, until maturity date. Adjusted EBITDA considers net income plus (i) income taxes
expenses, (ii) net financial result (excluding interest expenses on lease liabilities), (iii) depreciation and amortization expenses (excluding
right-of-use depreciation expenses), (iv) share-based compensation expenses, (v) share of income of associate, (vi) interest received
and (vii) non-recurring expenses. As of December 31, 2023, the Company is compliant with all obligations set forth in the deed of issuance.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The transaction costs that are directly attributable to the issuance of
debentures were measured at fair value together with the financial liability on initial measurement. The transaction costs totaled R$3,115,
including legal counsels and advisors.</p>

<p id="xdx_8A7_zrzHNk8nsqGi" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><b>13.2.2</b></td><td><b>Leases</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company has lease contracts for properties. The lease contracts generally
have maturities in the lease terms between five <span id="xdx_90E_ecustom--ContractualLeaseTerm_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zD6PbyEzv0B9" title="Contractual lease term" style="display: none"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact003564" name="afya:ContractualLeaseTerm">5</ix:nonNumeric></span>
and <span id="xdx_908_ecustom--ContractualLeaseTerm_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zkzUL9zRuq3b"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact003565" name="afya:ContractualLeaseTerm">30</ix:nonNumeric>
</span>years. There are no sublease or variable payments in-substance lease agreements in the period.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The carrying amounts of right-of-use assets and lease liabilities as of
December 31, 2023, 2022 and 2021 and the movements during the years are described below:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003567" name="afya:ScheduleOfLeasesExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_89C_ecustom--ScheduleOfLeasesExplanatory_pn3n3_z2S2V2JTiUQe" summary="xdx: Disclosure - Financial assets and financial liabilities  (Details 3)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B3_z8bEv5AvX4ng" style="display: none">Schedule of  right-of-use assets and lease liabilities</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Right-of-use assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease liabilities</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As of January 1, 2021</span></td>
    <td id="xdx_985_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231_zzm8oscCEqVe" title="Right-of-use assets, balance at beginning" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2020-12-31" id="Fact003569" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">419,074</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--LeaseLiabilities_iS_pn3n3_c20210101__20211231_zHUcS7LloIqb" title="Lease liabilities, balance at beginning" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2020-12-31" id="Fact003571" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">447,703</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_984_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20210101__20211231_zXFrKAWoPbvc" title="Right-of-use assets, additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionsToRightofuseAssets" contextRef="From2021-01-012021-12-31" id="Fact003573" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,689</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20210101__20211231_zU6X8OtdP12c" title="Lease liabilities, additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AdditionsToLeaseLiabilities" contextRef="From2021-01-012021-12-31" id="Fact003575" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,689</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_988_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20210101__20211231_zLg8S1jXq9r" title="Right-of-use assets, remeasurement" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsRemeasurement" contextRef="From2021-01-012021-12-31" id="Fact003577" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">95,962</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20210101__20211231_zNaiKcv9cc01" title="Lease liabilities, remeasurement" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LeaseLiabilitiesRemeasurement" contextRef="From2021-01-012021-12-31" id="Fact003579" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">95,962</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business combinations</span></td>
    <td id="xdx_981_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20210101__20211231_z69SVDxa9073" title="Right-of-use assets, business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsBusinessCombinations" contextRef="From2021-01-012021-12-31" id="Fact003581" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">139,514</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20210101__20211231_zoUsD3VfM932" title="Lease liabilities, business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:BusinessCombinationsLeaseLiabilities" contextRef="From2021-01-012021-12-31" id="Fact003583" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">139,514</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation expense</span></td>
    <td id="xdx_98E_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20210101__20211231_zPMkXpuVkZgb" title="Right-of-use assets, depreciation expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:DepreciationRightofuseAssets" contextRef="From2021-01-012021-12-31" id="Fact003585" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,237</ix:nonFraction>)</span></td>
    <td id="xdx_98F_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20210101__20211231_zs8qnE6TIHy7" title="Lease liabilities, depreciation expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3587">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense</span></td>
    <td id="xdx_981_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20210101__20211231_zjDVV5t6wSg1" title="Right-of-use assets, interest expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3589">-</span></span></td>
    <td id="xdx_981_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20210101__20211231_zTmLwJhXFUpa" title="Lease liabilities, interest expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2021-01-012021-12-31" id="Fact003591" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,212</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of lease liabilities</span></td>
    <td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20210101__20211231_zOurIa33N2ai" title="Right-of-use assets, payments of lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3593">-</span></span></td>
    <td id="xdx_986_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20210101__20211231_zkH2q38KAUWb" title="Lease liabilities, payments of lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" contextRef="From2021-01-012021-12-31" id="Fact003595" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,075</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of interest</span></td>
    <td id="xdx_98F_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20210101__20211231_zDG9GQPJ2pw3" title="Right-of-use assets, payments of interest" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3597">-</span></span></td>
    <td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20210101__20211231_zcpRlWrsnwAi" title="Lease liabilities, payments of interest" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:PaymentsOfInterestLeaseLiabilities" contextRef="From2021-01-012021-12-31" id="Fact003599" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">67,676</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Write-off (i)</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsWriteoff_pn3n3_c20210101__20211231_zxJjvDTk9Rbh" title="Right-of-use assets, Write-off" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:RightofuseAssetsWriteoff" contextRef="From2021-01-012021-12-31" id="Fact003601" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,316</ix:nonFraction>)</span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20210101__20211231_znB8p8dHSy8a" title="Lease liabilities, Write-off" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LeaseLiabilitiesWriteoff" contextRef="From2021-01-012021-12-31" id="Fact003603" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,244</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2021</b></span></td>
    <td id="xdx_98A_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231_ztFQuSUk4o81" title="Right-of-use assets, balance at ending" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2021-12-31" id="Fact003605" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">663,686</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iE_pn3n3_c20210101__20211231_zwU995Xr7y9l" title="Lease liabilities, balance at ending" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2021-12-31" id="Fact003607" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">714,085</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_989_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20211231_zCnkvKVjjYff" title="Right-of-use assets, current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3609">-</span></span></td>
    <td id="xdx_98B_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20211231_zgohRItwed46" title="Lease liabilities, current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2021-12-31" id="Fact003611" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,955</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98E_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20211231_zR0hVh8DWdq4" title="Right-of-use assets, non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsNonCurrent" contextRef="AsOf2021-12-31" id="Fact003613" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">663,686</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20211231_zd0zw6pM76v9" title="Lease liabilities, non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2021-12-31" id="Fact003615" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">689,130</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Right-of-use assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease liabilities</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As of January 1, 2022</span></td>
    <td id="xdx_989_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231_zlxdHP7lsB6g" title="Right-of-use assets, balance at beginning" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2021-12-31" id="Fact003617" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">663,686</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--LeaseLiabilities_iS_pn3n3_c20220101__20221231_zMy7EivATDh1" title="Lease liabilities, balance at beginning" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2021-12-31" id="Fact003619" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">714,085</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20220101__20221231_zkUzBAjoZudl" title="Right-of-use assets, additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionsToRightofuseAssets" contextRef="From2022-01-012022-12-31" id="Fact003621" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,250</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20220101__20221231_zdMwpGke2J8g" title="Lease liabilities, additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AdditionsToLeaseLiabilities" contextRef="From2022-01-012022-12-31" id="Fact003623" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,250</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_983_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20220101__20221231_zLo27DxLkySg" title="Right-of-use assets, remeasurement" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsRemeasurement" contextRef="From2022-01-012022-12-31" id="Fact003625" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,623</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20220101__20221231_zpczl7PdsrKb" title="Lease liabilities, remeasurement" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LeaseLiabilitiesRemeasurement" contextRef="From2022-01-012022-12-31" id="Fact003627" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,623</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation expense</span></td>
    <td id="xdx_98A_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20220101__20221231_zsIqOT0TD00l" title="Right-of-use assets, depreciation expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:DepreciationRightofuseAssets" contextRef="From2022-01-012022-12-31" id="Fact003629" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,684</ix:nonFraction>)</span></td>
    <td id="xdx_988_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20220101__20221231_zc61iPN2iafb" title="Lease liabilities, depreciation expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3631">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20220101__20221231_z8ZyVH5YJXK2" title="Right-of-use assets, interest expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3633">-</span></span></td>
    <td id="xdx_989_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20220101__20221231_zaS3bgdrcWL3" title="Lease liabilities, interest expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2022-01-012022-12-31" id="Fact003635" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">88,571</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of lease liabilities</span></td>
    <td id="xdx_98D_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20220101__20221231_zAtnAxV0hK3l" title="Right-of-use assets, payments of lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3637">-</span></span></td>
    <td id="xdx_988_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20220101__20221231_zFp1eQhddoLb" title="Lease liabilities, payments of lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" contextRef="From2022-01-012022-12-31" id="Fact003639" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">28,511</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of interest</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20220101__20221231_zWPvjnbneWN1" title="Right-of-use assets, payments of interest" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3641">-</span></span></td>
    <td id="xdx_98D_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20220101__20221231_zIEYWMHuW9A7" title="Lease liabilities, payments of interest" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:PaymentsOfInterestLeaseLiabilities" contextRef="From2022-01-012022-12-31" id="Fact003643" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">85,001</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Write-off (i)</span></td>
    <td id="xdx_989_ecustom--RightofuseAssetsWriteoff_pn3n3_c20220101__20221231_zEp14ubf4aE9" title="Right-of-use assets, Write-off" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:RightofuseAssetsWriteoff" contextRef="From2022-01-012022-12-31" id="Fact003645" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">19,802</ix:nonFraction>)</span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20220101__20221231_zy8tQ3J8uoIk" title="Lease liabilities, Write-off" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LeaseLiabilitiesWriteoff" contextRef="From2022-01-012022-12-31" id="Fact003647" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,492</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_98A_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231_zt20Zm1Edac1" title="Right-of-use assets, balance at ending" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2022-12-31" id="Fact003649" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">690,073</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--LeaseLiabilities_iE_pn3n3_c20220101__20221231_zwh8Cddthstb" title="Lease liabilities, balance at ending" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2022-12-31" id="Fact003651" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">769,525</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_98F_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20221231_zhOdB4doCdzd" title="Right-of-use assets, current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3653">-</span></span></td>
    <td id="xdx_98E_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20221231_zeTGzTc8NqR4" title="Lease liabilities, current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2022-12-31" id="Fact003655" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,459</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_988_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20221231_zKAgb5I4C169" title="Right-of-use assets, non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsNonCurrent" contextRef="AsOf2022-12-31" id="Fact003657" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">690,073</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20221231_zG4fAtsBel0h" title="Lease liabilities, non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2022-12-31" id="Fact003659" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">737,066</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 221 -->
    <div id="xdx_230_z38QhUSct7zb" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_234_z5tCt4hZ4LB2" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Right-of-use assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease liabilities</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As of January 1, 2023</span></td>
    <td id="xdx_98E_eifrs-full--RightofuseAssets_iS_pn3n3_c20230101__20231231_zJ5QW0knYgvg" title="Right-of-use assets, balance at beginning" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2022-12-31" id="Fact003661" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">690,073</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--LeaseLiabilities_iS_pn3n3_c20230101__20231231_z9rzREO9aZ4e" title="Lease liabilities, balance at beginning" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2022-12-31" id="Fact003663" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">769,525</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_987_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20230101__20231231_zL8q1ZMxF01d" title="Right-of-use assets, additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionsToRightofuseAssets" contextRef="From2023-01-01to2023-12-31" id="Fact003665" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,328</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20230101__20231231_zF8PDKKNoA74" title="Lease liabilities, additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AdditionsToLeaseLiabilities" contextRef="From2023-01-01to2023-12-31" id="Fact003667" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,328</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_984_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20230101__20231231_zmlrYcYftY4e" title="Right-of-use assets, remeasurement" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsRemeasurement" contextRef="From2023-01-01to2023-12-31" id="Fact003669" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,387</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20230101__20231231_zjshxc8CiJ9g" title="Lease liabilities, remeasurement" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LeaseLiabilitiesRemeasurement" contextRef="From2023-01-01to2023-12-31" id="Fact003671" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,387</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business combination</span></td>
    <td id="xdx_985_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20230101__20231231_zQkxIXV3QY0j" title="Right-of-use assets, business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsBusinessCombinations" contextRef="From2023-01-01to2023-12-31" id="Fact003673" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,408</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20230101__20231231_znya9xJSI7m3" title="Lease liabilities, business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:BusinessCombinationsLeaseLiabilities" contextRef="From2023-01-01to2023-12-31" id="Fact003675" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,408</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation expense</span></td>
    <td id="xdx_986_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20230101__20231231_zpWBB2SsLyMe" title="Right-of-use assets, depreciation expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:DepreciationRightofuseAssets" contextRef="From2023-01-01to2023-12-31" id="Fact003677" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,118</ix:nonFraction>)</span></td>
    <td id="xdx_981_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20230101__20231231_zf88jHsLHpl8" title="Lease liabilities, depreciation expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3679">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense</span></td>
    <td id="xdx_987_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20230101__20231231_zSvjvWhL4v8k" title="Right-of-use assets, interest expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3681">-</span></span></td>
    <td id="xdx_98A_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20230101__20231231_zvrn5y18fJYe" title="Lease liabilities, interest expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2023-01-01to2023-12-31" id="Fact003683" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,849</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of lease liabilities</span></td>
    <td id="xdx_981_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20230101__20231231_zhP3jV9zQof1" title="Right-of-use assets, payments of lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3685">-</span></span></td>
    <td id="xdx_981_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20230101__20231231_zHbnyGwOKiMa" title="Lease liabilities, payments of lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" contextRef="From2023-01-01to2023-12-31" id="Fact003687" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,473</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of interest</span></td>
    <td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20230101__20231231_zP0thVavb4e3" title="Right-of-use assets, payments of interest" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3689">-</span></span></td>
    <td id="xdx_98C_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20230101__20231231_zumiwKY2X5v" title="Lease liabilities, payments of interest" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:PaymentsOfInterestLeaseLiabilities" contextRef="From2023-01-01to2023-12-31" id="Fact003691" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">103,911</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Write-off (i)</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsWriteoff_pn3n3_c20230101__20231231_zb3dBBxzfvNi" title="Right-of-use assets, Write-off" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:RightofuseAssetsWriteoff" contextRef="From2023-01-01to2023-12-31" id="Fact003693" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,469</ix:nonFraction>)</span></td>
    <td id="xdx_98C_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20230101__20231231_zh7AKxCRTijl" title="Lease liabilities, Write-off" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LeaseLiabilitiesWriteoff" contextRef="From2023-01-01to2023-12-31" id="Fact003695" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,544</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20230101__20231231_zlUoyhlLZswa" title="Right-of-use assets, balance at ending" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2023-12-31" id="Fact003697" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">767,609</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--LeaseLiabilities_iE_pn3n3_c20230101__20231231_z16B5lRhZuCj" title="Lease liabilities, balance at ending" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2023-12-31" id="Fact003699" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">874,569</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_982_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20231231_zTtXFjUW87M8" title="Right-of-use assets, current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3701">-</span></span></td>
    <td id="xdx_985_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20231231_zmhwLxJW1k0k" title="Lease liabilities, current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2023-12-31" id="Fact003703" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,898</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_pn3n3_c20231231_zQCPpLweoxoh" title="Right-of-use assets, non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsNonCurrent" contextRef="AsOf2023-12-31" id="Fact003705" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">767,609</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20231231_zrM76p2JsvJf" title="Lease liabilities, non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2023-12-31" id="Fact003707" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">837,671</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Refers to anticipated termination of real estate leasing contracts.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A4_zqpyw4oH6tNc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company recognized lease expense from short-term leases and low-value
assets of R$<span id="xdx_90D_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20230101__20231231_zqK6BzOCK2Q5" title="Amount recognized lease expense from short-term leases and low-value assets"><ix:nonFraction name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" contextRef="From2023-01-01to2023-12-31" id="Fact003709" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,871</ix:nonFraction></span> for the year ended December 31, 2023 (R$<span id="xdx_903_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20220101__20221231_z9XznHz792Yl" title="Amount recognized lease expense from short-term leases and low-value assets"><ix:nonFraction name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" contextRef="From2022-01-012022-12-31" id="Fact003711" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,153</ix:nonFraction></span> and R$<span id="xdx_909_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20210101__20211231_zoUspIehOUO9" title="Amount recognized lease expense from short-term leases and low-value assets"><ix:nonFraction name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" contextRef="From2021-01-012021-12-31" id="Fact003713" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,229</ix:nonFraction></span> for the years ended December 31, 2022 and 2021, respectively).</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><b>13.2.3</b></td><td><b>Accounts payable to selling shareholders</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003715" name="afya:AccountsPayableToSellingShareholdersExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_893_ecustom--AccountsPayableToSellingShareholdersExplanatory_pn3n3_ziliB0JMP9W1" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 4)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zOKpbQr6YHl" style="display: none">Schedule of accounts payable to selling shareholders</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 74%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of IPEMED (a)</span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPEMEDMember_zjtgI6j1eYq" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_IPEMEDMember" id="Fact003717" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,805</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPEMEDMember_zTQZ7KUP2jZa" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_IPEMEDMember" id="Fact003719" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,654</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of UniRedentor (b)</span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zF6jWThx2Bkb" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_UniRedentorMember" id="Fact003721" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,155</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z6NHOhGMEWHl" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_UniRedentorMember" id="Fact003723" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,064</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of UniSL (c)</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zh977wXaQTj2" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_UniSLMember" id="Fact003725" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,064</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zBaa6vYEC4Y4" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_UniSLMember" id="Fact003727" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,301</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of FCMPB (d)</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zLPciQs1PG4k" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_FCMPBMember" id="Fact003729" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,168</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z3z4bxuy59Tf" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_FCMPBMember" id="Fact003731" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">111,755</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Medical Harbour (e)</span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zrBoO00mwD1d" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_MedicalHarbourMember" id="Fact003733" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,000</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zkUvv1YP0P5a" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_MedicalHarbourMember" id="Fact003735" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,053</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Shosp (f)</span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zRMEfKuajtPa" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_ShospMember" id="Fact003737" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">454</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_ztbJtUFpYAbc" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_ShospMember" id="Fact003739" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,206</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Unigranrio (g)</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zXDpRmTor8Jf" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_UnigranrioMember" id="Fact003741" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">156,235</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zUAtEZPbz5Ff" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_UnigranrioMember" id="Fact003743" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">216,716</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of RX PRO (h)</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zcJm9tHQRXEb" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3745">-</span></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zqCSbNCSdrC8" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_RXPROMember" id="Fact003747" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,781</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Guaranhuns (i)</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_ziwmClvDXXSf" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3749">-</span></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_zDNXLGfPllpc" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_GuaranhunsMember" id="Fact003751" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,653</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Al&#233;m da Medicina (j)</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_z3BMOhOC4469" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_AlemDaMedicinaMember" id="Fact003753" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,325</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zf1cqHzkk09b" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_AlemDaMedicinaMember" id="Fact003755" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,996</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of CardioPapers (k)</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_znB8g3Ng7FWg" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_CardiPapersMember" id="Fact003757" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,173</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zoCnYH4KGU7g" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_CardiPapersMember" id="Fact003759" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,979</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Glic (l)</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zZpgf1L6hkHi" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3761">-</span></span></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqUaAylbsOW3" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_GlicMember" id="Fact003763" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,520</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of DelRey (m)</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zkGSxhB2heV2" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_DelReyMember" id="Fact003765" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">256,488</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWh1tD0PtqQ8" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3767">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231_zw28pc3pfnra" title="Opening balance" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31" id="Fact003769" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">566,867</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231_zcGlMoRUF3nf" title="Opening balance" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31" id="Fact003771" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">528,678</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersCurrent_pn3n3_c20231231_ztoL7CLqVncc" title="Current" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersCurrent" contextRef="AsOf2023-12-31" id="Fact003773" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">353,998</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_pn3n3_c20221231_zhwIzkX0JYLl" title="Current" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersCurrent" contextRef="AsOf2022-12-31" id="Fact003775" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">261,711</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_988_ecustom--AccountsPayableToSellingShareholdersNonCurrent_pn3n3_c20231231_zXtBCJlRGiag" title="Non-current" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersNonCurrent" contextRef="AsOf2023-12-31" id="Fact003777" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">212,869</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_pn3n3_c20221231_zQI82jJ7MbM5" title="Non-current" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersNonCurrent" contextRef="AsOf2022-12-31" id="Fact003779" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">266,967</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A4_zmAq9VsnJSLj" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003781" name="afya:AccountsPayableToSellingShareholders1Explanatory"><table cellspacing="0" cellpadding="0" id="xdx_89B_ecustom--AccountsPayableToSellingShareholders1Explanatory_pn3n3_zXgQenVehkk4" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 5)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B5_zEraxvDL7gzi" style="display: none">Schedule of accounts payable</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; width: 64%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening balance</span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zbJULWSraGt8" title="Opening balance" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003783" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">528,678</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z3cUwk7UaRKc" title="Opening balance" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003785" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">679,826</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zgQlOb5Rvnt2" title="Opening balance" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003787" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">518,240</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash flows - Payments and deductions</span></td>
    <td id="xdx_985_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZq02NmwYUpj" title="Cash flows payments and deductions" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:AccountsPayableToSellingShareholderCashFlows" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003789" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">225,460</ix:nonFraction>)</span></td>
    <td id="xdx_989_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zNM1Z8mB8kx" title="Cash flows payments and deductions" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:AccountsPayableToSellingShareholderCashFlows" contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003791" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">236,760</ix:nonFraction>)</span></td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zeRVdp0I9zxk" title="Cash flows payments and deductions" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:AccountsPayableToSellingShareholderCashFlows" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003793" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">180,020</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payment of interest (i) </span></td>
    <td id="xdx_982_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwCc7jojqdJj" title="Payment of interest" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003795" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,989</ix:nonFraction>)</span></td>
    <td id="xdx_989_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOeaGHJ3JUqh" title="Payment of interest" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003797" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,428</ix:nonFraction>)</span></td>
    <td id="xdx_982_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zhYXmvlVfi0b" title="Payment of interest" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003799" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,661</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of licenses </span></td>
    <td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZi0w3oiADTg" title="Acquisition of licenses" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3801">-</span></span></td>
    <td id="xdx_983_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zurbn4TXoPs2" title="Acquisition of licenses" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec" contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003803" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,408</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zvhjw41RaIQf" title="Acquisition of licenses" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003805" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,000</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest</span></td>
    <td id="xdx_98D_eifrs-full--InterestExpense_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZU9mamIs1j" title="Interest" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InterestExpense" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003807" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">85,069</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--InterestExpense_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z2dfGwU41v29" title="Interest" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InterestExpense" contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003809" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">68,064</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--InterestExpense_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zcLYGoNRMarl" title="Interest" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InterestExpense" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003811" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,915</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions - Consideration to be transferred on business combinations</span></td>
    <td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zEDIzqwicxb2" title="Additions consideration to be transferred on business combinations" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersBusinessCombinations" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003813" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">234,000</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zx3JNTpsDtS5" title="Additions consideration to be transferred on business combinations" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3815">-</span></span></td>
    <td id="xdx_987_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zJ5p0YmMzi74" title="Additions consideration to be transferred on business combinations" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersBusinessCombinations" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003817" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">243,816</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Consideration to be transferred on business combinations (earn-outs)</span></td>
    <td id="xdx_988_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zROvmhfczSih" title="Consideration to be transferred on business combinations (earn-outs)" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3819">-</span></span></td>
    <td id="xdx_980_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zL5vNj3woY48" title="Consideration to be transferred on business combinations (earn-outs)" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ContingentConsiderationOnBusinessCombinations" contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003821" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,921</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFV1daN0l1Wi" title="Consideration to be transferred on business combinations (earn-outs)" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ContingentConsiderationOnBusinessCombinations" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003823" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,536</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_98C_ecustom--Reversals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zWVhsxfBtqvh" title="Reversals" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3825">-</span></span></td>
    <td id="xdx_981_ecustom--Reversals_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z2hWFxLGnHRb" title="Reversals" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:Reversals" contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003827" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,353</ix:nonFraction>)</span></td>
    <td id="xdx_98C_ecustom--Reversals_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zumMbbBxg1m" title="Reversals" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3829">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement of earn-outs (ii)</span></td>
    <td id="xdx_987_ecustom--RemeasurementOfEarnouts_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoN25Pe3anMi" title="Remeasurement of earn-outs" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RemeasurementOfEarnouts" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003831" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,556</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--RemeasurementOfEarnouts_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zrZSalRvocjg" title="Remeasurement of earn-outs" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3833">-</span></span></td>
    <td id="xdx_985_ecustom--RemeasurementOfEarnouts_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zRBb15aXcrxd" title="Remeasurement of earn-outs" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3835">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_98F_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmH6rqDHXHr6" title="Other" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003837" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,987</ix:nonFraction>)</span></td>
    <td id="xdx_98C_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmbGyYVfm2Lb" title="Other" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3839">-</span></span></td>
    <td id="xdx_983_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zJbOADQBxQk5" title="Other" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3841">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Closing balance</b></span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zKGOsQlY0Zx7" title="Closing balance" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003843" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">566,867</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFeodshF64R1" title="Closing balance" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003845" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">528,678</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zLsXqSNbZcEe" title="Closing balance" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003847" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">679,826</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Payment of interest from acquisition of subsidiaries are included in cash flows from investing
activities.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"/><td style="text-align: justify">During the measurement period, management&#8217;s expectation has been reviewed based on
performance for revenue goals and the contingent consideration for the acquisition of Al&#233;m da Medicina, CardioPapers and Glic
have been remeasured by R$4,773, R$5,082 and (R$7,299), respectively, totaling R$2,556 as of December 31, 2023. These are measured by
the Company at the present value.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A3_zA6YlBl3bCH1" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 222 -->
    <div id="xdx_237_zMEEJGbdewzb" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23C_zedzdfNyLYsl" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(a) On May 9, 2019, Afya Brazil acquired <span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20190508__20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zNaLsrutma48" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2019-05-082019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="Fact003849" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of IPEMED and R$<span id="xdx_909_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zeDHUUO3ZRpf" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="Fact003851" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45,303</ix:nonFraction></span> is
payable in five equal installments of R$<span id="xdx_90B_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20240229__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zUnFiMnhmLbb" title="Equal installments payables"><span id="xdx_908_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20230228__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zIe25HgbZQQe" title="Equal installments payables"><span id="xdx_903_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20220228__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zz6QYvafjC81" title="Equal installments payables"><span id="xdx_90E_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20210228__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zOHR3I3FOlYa" title="Equal installments payables"><span id="xdx_90A_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20200229__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zuEeDAKl6fdl" title="Equal installments payables"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties1" contextRef="AsOf2024-02-29_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="Fact003853" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties1" contextRef="AsOf2023-02-28_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="Fact003855" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties1" contextRef="AsOf2022-02-28_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="Fact003857" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties1" contextRef="AsOf2021-02-28_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="Fact003859" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties1" contextRef="AsOf2020-02-29_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="Fact003861" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,061</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></span>, adjusted by the CDI rate, and due annually in February 2020, 2021, 2022, 2023 and 2024.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(b) On January 31, 2020, Afya Brazil acquired <span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20200101__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zkfreht98Uj6" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-01-31_custom_UniRedentorMember" id="Fact003863" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of UniRedentor and R$<span id="xdx_908_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_pn3n3" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-01-31_custom_UniRedentorMember" id="Fact003865" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,000</ix:nonFraction></span>
is payable in five equal installments from January 2021 through July 2024, adjusted by the CDI rate. The purchase consideration was adjusted
by R$<span id="xdx_90F_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_pn3n3_c20210131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zr8NiXdFSxXk" title="Equal installments payables"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties" contextRef="AsOf2021-01-31_custom_UniRedentorMember" id="Fact003867" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,503</ix:nonFraction></span> and such amount was deducted from the first installment paid in February 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(c) On May 5, 2020, Afya Brazil acquired <span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zInQgBxYkVV" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-05-042020-05-05_custom_UniSLMember" id="Fact003869" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of UniSL and R$<span id="xdx_907_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z8JajKv9URsg" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-05-05_custom_UniSLMember" id="Fact003871" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,456</ix:nonFraction></span> was
paid in three equal installments through May 2023, adjusted by the CDI rate. The purchase consideration was adjusted by R$<span id="xdx_90B_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_pn3n3_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zeOyypnp911d" title="Equal installments payables"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties" contextRef="AsOf2020-05-05_custom_UniSLMember" id="Fact003873" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,816</ix:nonFraction></span> and such
amount was deducted from the first installment paid on May 5, 2021. The open balance as of December 2023 relates to the amount due from
additional seats and will be paid in 2024.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(d) On November 9, 2020, Afya Brazil acquired <span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z6arrEWXkLd7" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-11-082020-11-09_custom_FCMPBMember" id="Fact003875" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of FCMPB and R$<span id="xdx_904_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zLbHV73MmT0d" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-11-09_custom_FCMPBMember" id="Fact003877" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">188,894</ix:nonFraction></span>
is payable in four installments through November 2024, adjusted by the CDI rate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(e) On April 8, 2021, Afya Brazil acquired <span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20210407__20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zWNxN06TjmSd" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-04-072021-04-08_custom_MedicalHarbourMember" id="Fact003879" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Medical Harbour and an
earn-out of R$<span id="xdx_904_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zdbyudcIhrsj" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-04-08_custom_MedicalHarbourMember" id="Fact003881" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,000</ix:nonFraction></span> is payable in relation to product development goals for 2021 and 2022 and revenue achievements for 2023. The contingent
consideration of R$<span id="xdx_904_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zORIqtkKYUzj" title="Defined benefit obligation, at present value"><ix:nonFraction name="ifrs-full:DefinedBenefitObligationAtPresentValue" contextRef="AsOf2021-04-08_custom_MedicalHarbourMember" id="Fact003883" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,000</ix:nonFraction></span> will be paid in 2024 and is based on the facts and circumstances as of December 31, 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(f) On May 13, 2021, Afya Brazil acquired <span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20210512__20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zFVnHV9gQCNh" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-05-122021-05-13_custom_ShospMember" id="Fact003885" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Shosp which included an
earn-out of R$<span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_ztPBqontJGc5" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-05-13_custom_ShospMember" id="Fact003887" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">513</ix:nonFraction></span> paid in August 2023 related to product development and R$<span id="xdx_90E_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_pn3n3_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zDFDXUVpHG4e" title="Transaction price allocated to remaining performance obligations"><ix:nonFraction name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" contextRef="AsOf2021-05-13_custom_ShospMember" id="Fact003889" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">454</ix:nonFraction></span> will be paid until 2026.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(g) On August 4, 2021, Afya Brazil acquired <span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20210803__20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zgguQYh1FrL8" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-08-032021-08-04_custom_UnigranrioMember" id="Fact003891" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Unigranrio. The adjusted
aggregate purchase price was R$<span id="xdx_908_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_pn3n3_c20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zoSIYbJoyvTf" title="Non-current payables for purchase of energy"><ix:nonFraction name="ifrs-full:NoncurrentPayablesForPurchaseOfEnergy" contextRef="AsOf2021-08-04_custom_UnigranrioMember" id="Fact003893" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">618,956</ix:nonFraction></span> of which 60% was paid in cash on the transaction closing date, and 40% is payable in cash in four
equal installments through 2022 to 2025, adjusted by the CDI rate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(h) On October 1, 2021, Afya Brazil acquired <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20211001__20211002__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zFwBc8lIZZf7" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-10-012021-10-02_custom_RXPROMember" id="Fact003895" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of RX PRO and an earn-out
of up to R$<span id="xdx_90F_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20211002__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zUwl7uEGbFe6" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-10-02_custom_RXPROMember" id="Fact003897" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,000</ix:nonFraction></span> is payable in relation to revenue achievements until 2024. The contingent consideration of R$<span id="xdx_903_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_pn3n3_c20211002__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zjx7Q72tYwFg" title="Transaction price allocated to remaining performance obligations"><ix:nonFraction name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" contextRef="AsOf2021-10-02_custom_RXPROMember" id="Fact003899" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,781</ix:nonFraction></span> accounted for on
December 31, 2022 was remeasured and reversed in 2023 based on the facts and circumstances as of December 31, 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(i) On November 5, 2021, Afya Brazil concluded the acquisition of <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20211104__20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zAk2yb8ODmEe" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-11-042021-11-05_custom_ITPACGaranhunsMember" id="Fact003901" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of
ITPAC Garanhuns and R$<span id="xdx_90B_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_pn3n3_c20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zvFMVjlzAei" title="Transaction price allocated to remaining performance obligations"><ix:nonFraction name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" contextRef="AsOf2021-11-05_custom_ITPACGaranhunsMember" id="Fact003903" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,000</ix:nonFraction></span> was paid in cash on the transaction closing date, and (ii) R$<span id="xdx_90B_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zCGkegGMMGNe" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-11-05_custom_ITPACGaranhunsMember" id="Fact003905" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,000</ix:nonFraction></span> was paid in two equal installments, adjusted
by the CDI rate, in November 2022 and November 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(j) On March 4, 2022, Afya Brazil acquired <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zRvJ7Tr9vwDe" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember1360038046" id="Fact003907" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Al&#233;m da Medicina
and an earn-out of up to R$<span id="xdx_90F_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zaipSB9YW1kd" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact003909" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,200</ix:nonFraction></span> is payable in connection with revenue target achievements and product development goals for 2023 and
2024. The purchase consideration was adjusted by R$<span id="xdx_909_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zUixRAB4BPke" title="Equal installments payables"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact003911" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">763</ix:nonFraction></span> in favor of the selling shareholders. The contingent consideration of R$<span id="xdx_909_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zri2fyk8BQzl" title="Defined benefit obligation"><ix:nonFraction name="ifrs-full:DefinedBenefitObligationAtPresentValue" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921" id="Fact003913" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,325</ix:nonFraction></span>
is based on the estimated payment considering the facts and circumstances as of December 31, 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(k) On <span style="background-color: white">April 5, 2022</span>, Afya
Brazil acquired <span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z6TuhmRGQfN8" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-04-042022-04-05_custom_CardioPapersMember1360038093" id="Fact003915" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of CardioPapers and an earn-out of up to R$<span id="xdx_902_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zDZYFeZEv1tj" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact003917" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,000</ix:nonFraction></span> is payable in connection with revenue target achievements and other
goals regarding credentials in the market for 2023 and 2024. The purchase consideration was adjusted by R$<span id="xdx_90D_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zDl995KdqYej" title="Equal installments payables"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact003919" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">333</ix:nonFraction></span> in favor of Afya. The contingent
consideration of R$<span id="xdx_906_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z5Wdbvnx4NHb" title="Defined benefit obligation"><ix:nonFraction name="ifrs-full:DefinedBenefitObligationAtPresentValue" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact003921" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,173</ix:nonFraction></span> is based on the estimated payment considering the facts and circumstances as of December 31, 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 223 -->
    <div id="xdx_234_zgwxzKdD4l0c" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_233_zNpzlkuPtw96" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(l) On March 23, 2022, Afya Brazil acquired <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20220322__20220323__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zbLmxfxgsZT" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-03-222022-03-23_custom_GlicMember" id="Fact003923" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Glic and an earn-out
of up to R$<span id="xdx_909_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20220323__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zPkbB0l7Fz06" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-03-23_custom_GlicMember" id="Fact003925" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,000</ix:nonFraction></span> is payable in connection with revenue target achievements for 2023 and 2024 and product development goals. The contingent
consideration of R$<span id="xdx_90D_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20220323__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zfk0kiRffsbh" title="Defined benefit obligation"><ix:nonFraction name="ifrs-full:DefinedBenefitObligationAtPresentValue" contextRef="AsOf2022-03-23_custom_GlicMember" id="Fact003927" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,520</ix:nonFraction></span> accounted for in December 31, 2022, was partially paid in 2023 (R$<span id="xdx_908_ecustom--RemainingBalancePaid_pn3n3_c20220322__20220323__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zcgXSxLuKnXb" title="Remaining balance paid"><ix:nonFraction name="afya:RemainingBalancePaid" contextRef="From2022-03-222022-03-23_custom_GlicMember" id="Fact003929" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,000</ix:nonFraction></span>) and the remaining balance was remeasured
and reversed in 2023 considering the facts and circumstances as of December 31, 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(m) On January 2, 2023, Afya Brazil acquired <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zYn0G7J6lxl" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-12-292023-01-02_custom_DelReyMember" id="Fact003931" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of DelRey. The aggregate
purchase price is R$<span id="xdx_904_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z3tEjbF5GGBg" title="Non-current payables for purchase of energy"><ix:nonFraction name="ifrs-full:NoncurrentPayablesForPurchaseOfEnergy" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact003933" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">816,236</ix:nonFraction></span> of which R$<span id="xdx_909_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zZWfE1HpBBg3" title="Transaction price allocated to remaining performance obligations"><ix:nonFraction name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact003935" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">575,000</ix:nonFraction></span> was paid in cash on the transaction closing date, and R$<span id="xdx_908_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zBeNyGONvF09" title="Consideration to be transferred"><ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact003937" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">234,000</ix:nonFraction></span> (which includes R$<span id="xdx_903_eifrs-full--ConsiderationPaidReceived_pn3n3_c20221229__20230201__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zIklZy815Di7" title="Adjustment for purchase consideration"><ix:nonFraction name="ifrs-full:ConsiderationPaidReceived" contextRef="From2022-12-292023-02-01_custom_DelReyMember" id="Fact003939" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,000</ix:nonFraction></span>
purchase consideration adjustment, in favor of the Company) is payable in cash in three annual installments, respectively, of R$<span id="xdx_900_ecustom--FirstAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zQqzf5Nv5JLf" title="First annual installment"><ix:nonFraction name="afya:FirstAnnualInstallmentsPayable" contextRef="From2022-12-292023-01-02_custom_DelReyMember" id="Fact003941" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">134,000</ix:nonFraction></span>
in January 2024, R$<span id="xdx_90F_ecustom--SecondAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zPYWZaMSjgne" title="Second annual installment"><ix:nonFraction name="afya:SecondAnnualInstallmentsPayable" contextRef="From2022-12-292023-01-02_custom_DelReyMember" id="Fact003943" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,000</ix:nonFraction></span> in January 2025 and R$<span id="xdx_90B_ecustom--ThirdAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zZJpWC6k9luk" title="Third annual installment"><ix:nonFraction name="afya:ThirdAnnualInstallmentsPayable" contextRef="From2022-12-292023-01-02_custom_DelReyMember" id="Fact003945" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,000</ix:nonFraction></span> in January 2026, adjusted by the SELIC rate. The aggregate purchase also includes
R$<span id="xdx_90C_ecustom--AcquisitiondateFairValueOfTotalConsiderationTransferred1_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zeJa0QV0XJXe" title="Fair value at the date of acquisition"><ix:nonFraction name="afya:AcquisitiondateFairValueOfTotalConsiderationTransferred1" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact003947" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,236</ix:nonFraction></span> estimated at fair value at the date of acquisition related to an offer of AFYA&#8217;s digital solutions free of charge until
December 31, 2030, for students of medicine of universities owned by the sellers and not part of the transaction.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><b>13.2.4</b></td><td><b>Notes payable</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">With the acquisition of UniSL, Afya Brazil assumed notes payable regarding
the previous acquisition of a portion of the operations of Universidade Luterana do Brasil (ULBRA) by UniSL in auction by the end of 2018.
Two of the UniSL campuses, located in the cities of Ji-Paran&#225; and Porto Velho, State of Rond&#244;nia, were acquired in such transaction.
As of December 31, 2023, all balances of Notes payable were paid and adjusted by 100% of IPCA-E. Below are the carrying amounts of notes
payable and the movements during the years ended December 31, 2023, 2022 and 2021:</p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003949" name="afya:ScheduleOfCarryingAmountOfNotesPayableTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_892_ecustom--ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_pn3n3_zI1MwJVprYy8" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 6)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BD_zNNBqtHMecB5" style="display: none">Schedule of carrying amount of notes payable and the movements</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; width: 64%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 12%; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening balance</span></td>
    <td id="xdx_98E_ecustom--NotesPayables_iS_pn3n3_c20230101__20231231_zZumwW3dqNMe" title="Notes payable beginning" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2022-12-31" id="Fact003951" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,176</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--NotesPayables_iS_pn3n3_c20220101__20221231_z8LuCR28ybW6" title="Notes payable beginning" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2021-12-31" id="Fact003953" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,726</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--NotesPayables_iS_pn3n3_c20210101__20211231_zCzrVPC8Pap" title="Notes payable beginning" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2020-12-31" id="Fact003955" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,181</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments (i)</span></td>
    <td id="xdx_988_ecustom--Payments_pn3n3_c20230101__20231231_zhHb4Q3WxSR" title="Payments" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:Payments" contextRef="From2023-01-01to2023-12-31" id="Fact003957" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">49,347</ix:nonFraction>)</span></td>
    <td id="xdx_988_ecustom--Payments_pn3n3_c20220101__20221231_z8mKdNAzbTLi" title="Payments" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:Payments" contextRef="From2022-01-012022-12-31" id="Fact003959" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,000</ix:nonFraction>)</span></td>
    <td id="xdx_98B_ecustom--Payments_pn3n3_c20210101__20211231_zaNihkfhfaXh" title="Payments" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:Payments" contextRef="From2021-01-012021-12-31" id="Fact003961" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,800</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of interest (i)</span></td>
    <td id="xdx_98D_ecustom--PaymentsOfInterest_pn3n3_c20230101__20231231_z1pus9OrYdvj" title="Payments of interest" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:PaymentsOfInterest" contextRef="From2023-01-01to2023-12-31" id="Fact003963" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">15,529</ix:nonFraction>)</span></td>
    <td id="xdx_986_ecustom--PaymentsOfInterest_pn3n3_c20220101__20221231_zBtjwhQXhlVh" title="Payments of interest" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:PaymentsOfInterest" contextRef="From2022-01-012022-12-31" id="Fact003965" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,008</ix:nonFraction>)</span></td>
    <td id="xdx_981_ecustom--PaymentsOfInterest_pn3n3_c20210101__20211231_zJ0XArvCtfM" title="Payments of interest" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:PaymentsOfInterest" contextRef="From2021-01-012021-12-31" id="Fact003967" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,268</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Monetary indexation</span></td>
    <td id="xdx_98C_ecustom--MonetaryIndexation_pn3n3_c20230101__20231231_zQeOkg94T5fg" title="Monetary indexation" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:MonetaryIndexation" contextRef="From2023-01-01to2023-12-31" id="Fact003969" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,700</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--MonetaryIndexation_pn3n3_c20220101__20221231_zP3D6TCwiAq" title="Monetary indexation" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:MonetaryIndexation" contextRef="From2022-01-012022-12-31" id="Fact003971" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,458</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--MonetaryIndexation_pn3n3_c20210101__20211231_z6xRxKGRfURc" title="Monetary indexation" style="border-bottom: black 1pt solid; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:MonetaryIndexation" contextRef="From2021-01-012021-12-31" id="Fact003973" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,613</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Closing balance</b></span></td>
    <td id="xdx_987_ecustom--NotesPayables_iE_pn3n3_c20230101__20231231_zy2Doo6v6gLd" title="Notes payable ending" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3975">-</span></b></span></td>
    <td id="xdx_98A_ecustom--NotesPayables_iE_pn3n3_c20220101__20221231_zDHYCKvhFUb7" title="Notes payable ending" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2022-12-31" id="Fact003977" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,176</ix:nonFraction></b></span></td>
    <td id="xdx_987_ecustom--NotesPayables_iE_pn3n3_c20210101__20211231_zUJgfkDY7lp6" title="Notes payable ending" style="border-bottom: black 1.5pt double; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2021-12-31" id="Fact003979" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,726</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_988_ecustom--CurrentLiabilities1_iI_pn3n3_c20231231_zImjJr5t7W39" title="Current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3981">-</span></span></td>
    <td id="xdx_982_ecustom--CurrentLiabilities1_pn3n3_c20221231_zTy8tYFM8lri" title="Current" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CurrentLiabilities1" contextRef="AsOf2022-12-31" id="Fact003983" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,176</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--CurrentLiabilities1_iI_pn3n3_c20211231_z4pe24LUNx24" title="Current" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CurrentLiabilities1" contextRef="AsOf2021-12-31" id="Fact003985" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,478</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98E_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20231231_zmPCI95aXc28" title="Non-current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3987">-</span></span></td>
    <td id="xdx_981_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20221231_zTEgZTr2iPGj" title="Non-current" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3989">-</span></span></td>
    <td id="xdx_98C_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20211231_zyS8sbnU0fqb" title="Non-current" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NoncurrentLiabilities1" contextRef="AsOf2021-12-31" id="Fact003991" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,248</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 0 7.1pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">The amounts are included in cash flows from investing activities.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AC_zFeoaMuMnWZf" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>13.3</b></td><td><b>Fair values</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The table below is a comparison of the carrying amounts and fair values
of the Company&#8217;s financial instruments, other than those carrying amounts that are reasonable approximation of fair values:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact003993" name="afya:ScheduleOfFairValuesExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_897_ecustom--ScheduleOfFairValuesExplanatory_pn3n3_zswu6R4455O9" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 7)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B5_zJK6pWxh0tri" style="display: none">Schedule
    of fair values of the company's financial instruments</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td colspan="2">
    <p style="border-bottom: black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2022</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 48%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying amount</b></span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair value</b></span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying amount</b></span></td>
    <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair value</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>Financial assets</b></span></td>
    <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Trade receivables (non-current)</span></td>
    <td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zFs837uome8d" title="Financial assets, at carrying amount" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2023-12-31_ifrs-full_TradeReceivablesMember" id="Fact003995" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,485</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zclm8DkYb8lj" title="Financial assets, at fair value" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2023-12-31_ifrs-full_TradeReceivablesMember" id="Fact003997" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,485</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--FinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zImlu8DZ2jLj" title="Financial assets, at carrying amount" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2022-12-31_ifrs-full_TradeReceivablesMember" id="Fact003999" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,568</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zHcJvwaLckM6" title="Financial assets, at fair value" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2022-12-31_ifrs-full_TradeReceivablesMember" id="Fact004001" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,568</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--FinancialAssets_pn3n3_c20231231_zw4KhUxubaoa" title="Financial assets, at carrying amount" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2023-12-31" id="Fact004003" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,485</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20231231_zTh2iJY77cBb" title="Financial assets, at fair value" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2023-12-31" id="Fact004005" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,485</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--FinancialAssets_pn3n3_c20221231_zNNI9Ii9Tml5" title="Financial assets, at carrying amount" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2022-12-31" id="Fact004007" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,568</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20221231_zNfF5MeDj0j" title="Financial assets, at fair value" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2022-12-31" id="Fact004009" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,568</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial liabilities</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Loans and financing</span></td>
    <td id="xdx_985_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zeDFNFKeKwPd" title="Financial liabilities, at carrying amount" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2023-12-31_custom_LoansAndFinancingMember" id="Fact004011" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,800,775</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z3UdWKCoXkw7" title="Financial liabilities, at fair value" style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2023-12-31_custom_LoansAndFinancingMember" id="Fact004013" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,795,752</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z8MVsGWTu2Pi" title="Financial liabilities, at carrying amount" style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2022-12-31_custom_LoansAndFinancingMember" id="Fact004015" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,882,901</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zqE5UmRKe8D2" title="Financial liabilities, at fair value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2022-12-31_custom_LoansAndFinancingMember" id="Fact004017" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,934,295</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Lease liabilities</span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvTlrrv9bz48" title="Financial liabilities, at carrying amount" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004019" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">874,569</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvZo3z2OSNbj" title="Financial liabilities, at fair value" style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004021" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">874,569</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zG2y35CZMkdc" title="Financial liabilities, at carrying amount" style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004023" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">769,525</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zUFNrm8MIGVk" title="Financial liabilities, at fair value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004025" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">769,525</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Accounts payable to selling shareholders</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOjtCh58N4Gi" title="Financial liabilities, at carrying amount" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact004027" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">566,867</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zWvIfRtuHp5d" title="Financial liabilities, at fair value" style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact004029" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">566,867</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zS0Bu4opkWi2" title="Financial liabilities, at carrying amount" style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact004031" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">528,678</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zyRmfh5Q3zq9" title="Financial liabilities, at fair value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact004033" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">528,678</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Notes payable</span></td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zpjqJYyhcRva" title="Financial liabilities, at carrying amount" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl4035">-</span></span></td>
    <td id="xdx_981_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zuGeihlFqowa" title="Financial liabilities, at fair value" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl4037">-</span></span></td>
    <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zSwW9FMkts7f" title="Financial liabilities, at carrying amount" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2022-12-31_custom_NotesPayableMember" id="Fact004039" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,176</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_z4xfn4Oxzt9h" title="Financial liabilities, at fair value" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2022-12-31_custom_NotesPayableMember" id="Fact004041" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,176</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td>
    <td id="xdx_988_eifrs-full--FinancialLiabilities_pn3n3_c20231231_zUSx8wBY3LO7" title="Financial liabilities, at carrying amount" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2023-12-31" id="Fact004043" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,242,211</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231_zLqaidjInSg2" title="Financial liabilities, at fair value" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2023-12-31" id="Fact004045" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,237,188</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231_zeaXcLuRojA" title="Financial liabilities, at carrying amount" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2022-12-31" id="Fact004047" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,243,280</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231_z4truBUYVEW9" title="Financial liabilities, at fair value" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2022-12-31" id="Fact004049" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,294,674</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A7_zpsam74a5Oih" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 224 -->
    <div id="xdx_235_z097vzVB02n3" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_232_zCqNXpBOVmHl" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The Company assessed that the fair values of current
trade receivables and other current assets, trade payables, advances from customers and other current liabilities approximate their carrying
amounts largely due to the short-term maturities of these instruments. The financial instruments for which the fair value are disclosed
are based on Level 2 fair value measurement hierarchy. There has been no change in fair value hierarchy during the years ended December
31, 2023 and 2022.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The fair value of interest-bearing borrowings and
loans are determined by using the DCF method using a discount rate that reflects the issuer&#8217;s borrowing rate as of the end of the
reporting period. The own non-performance risk at December 31, 2023 was assessed to be insignificant.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>13.4</b></td><td><b>Financial instruments risk management objectives and policies</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The Company&#8217;s main financial liabilities
comprise loans and financing, lease liabilities, accounts payable to selling shareholders, notes payable, trade payables and advances
from customers. The main purpose of these financial liabilities is to finance the Company&#8217;s operations. The Company&#8217;s main
financial assets include trade receivables and cash and cash equivalents.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company is exposed to market risk, credit risk and liquidity risk. The
Company monitors market, credit and liquidity risks in line with the objectives of capital management and counts on the support, monitoring
and oversight of the Board of Directors in decisions related to capital management and its alignment with the objectives and risks. The
Company&#8217;s policy is that no trading of derivatives for speculative purposes may be undertaken. The Board of Directors reviews and
agrees with policies for managing each of these risks, which are summarized below.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><b>13.4.1</b></td><td><b>Market risk</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">Market risk is the risk that the fair value or
future cash flows of a financial instrument will fluctuate because of changes in market prices. The Company&#8217;s exposure to market
risk is related to interest rate and foreign currency risk. The sensitivity analysis in the following sections relates to the position
as of December 31, 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>a) Interest rate risk</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">Interest rate risk is the risk that the fair value
or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company&#8217;s exposure
to the risk of changes in market interest rates relates primarily to the Company&#8217;s cash equivalents, loans and financing, accounts
payable to selling shareholders and notes payable, with floating interest rates.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"><span style="text-decoration: underline">Sensitivity analysis</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below demonstrates the sensitivity to
a reasonably possible change in interest on cash equivalents, loans and financing, accounts payable to selling shareholders and notes
payable. With all variables held constant, the Company&#8217;s income before income taxes is affected through the impact on floating interest
rates, as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004051" name="afya:SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89C_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_pn3n3_zub13kxFjHY3" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 8)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B7_zn2xVc5VR2Zd" style="display: none">Schedule
    of income before income taxes</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Index - % per year</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Base rate</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash equivalents</span></td>
    <td id="xdx_982_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z1CmwrgwRFh5" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2023-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004053" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">518,111</ix:nonFraction></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z1Zhg3fb22H1" title="Index - % per year"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004055" name="afya:IndexRatePerYear">100.8% of CDI</ix:nonNumeric></span></span></td>
    <td id="xdx_988_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zteHpc4PvDha" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:BaseRate" contextRef="From2023-01-012023-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004057" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,846</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zxzsN62UahW1" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2023-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004059" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">529,340</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zzKeMlQQ3cX6" title="Index - % per year"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004061" name="afya:IndexRatePerYear">CDI + 1.8%</ix:nonNumeric></span></span></td>
    <td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zulfA3LnOXTg" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:BaseRate" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004063" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">71,196</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_988_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zjkWW6BQAR6h" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2023-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004065" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">412,880</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zlfYUqzJPSGg" title="Index - % per year"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004067" name="afya:IndexRatePerYear">CDI + 1.9%</ix:nonNumeric></span></span></td>
    <td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zBlEYBtmvmW8" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:BaseRate" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004069" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">55,945</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98D_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zTyOM3VjasWk" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2023-12-31_custom_LoansAndFinancingTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004071" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,193</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zrvQk1NqrTW9" title="Index - % per year"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004073" name="afya:IndexRatePerYear">TJLP</ix:nonNumeric></span></span></td>
    <td id="xdx_980_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zCH9Hf3BA766" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:BaseRate" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004075" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">733</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98A_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z9h6xH398M0f" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2023-12-31_custom_LoansAndFinancingThreeMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004077" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">21,405</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zcUlDXObefI1" title="Index - % per year"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingThreeMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004079" name="afya:IndexRatePerYear">CDI + 1.75%</ix:nonNumeric></span></span></td>
    <td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zCtn58HiZyJ6" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:BaseRate" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingThreeMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004081" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,868</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zM3Xtnp8qMQ8" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004083" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">274,428</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_ztQoSudqoWe8" title="Index - % per year"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004085" name="afya:IndexRatePerYear">CDI</ix:nonNumeric></span></span></td>
    <td id="xdx_984_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zAT1MraOlzd6" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:BaseRate" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004087" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,971</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_981_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z2uOMoIpL1Td" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004089" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">256,488</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zDlhhU9QYMhe" title="Index - % per year"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004091" name="afya:IndexRatePerYear">SELIC</ix:nonNumeric></span></span></td>
    <td id="xdx_98D_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zh7hDPdKbm16" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:BaseRate" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004093" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">29,881</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net exposure</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_980_ecustom--BaseRate_pn3n3_c20230101__20231231_zgkCjjYp6LOh" title="Base rate" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:BaseRate" contextRef="From2023-01-01to2023-12-31" id="Fact004095" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">131,748</ix:nonFraction>)</b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 225 -->
    <div id="xdx_232_zdz869azESlc" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23D_zVZiPJ9Eb3Ld" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zGMp6CGMgXDl" style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Increase in basis points</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; width: 62%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>+75</b></span></td>
    <td style="width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>+150</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effect on profit before tax</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zYFdfJzbbPTi" title="Effect on profit before tax" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2023-01-012023-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004098" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,407</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zN17YZqVBUr" title="Effect on profit before tax" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2023-01-012023-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact004100" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,814</ix:nonFraction>)</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A1_zyGjjL0N75va" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b) Foreign currency risk</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">Foreign currency risk is the risk that the fair
value or future cash flows of exposure will fluctuate because of changes in foreign exchange rates. The Company&#8217;s exposure to the
risk of changes in foreign exchange rates relates to cash and cash equivalents denominated in U.S. dollars in the amount of R$<span id="xdx_90F_eifrs-full--CreditExposure_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zgN12uDQPqW7" title="Exposure risk"><ix:nonFraction name="ifrs-full:CreditExposure" contextRef="AsOf2023-12-31_ifrs-full_CurrencyRiskMember" id="Fact004102" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,173</ix:nonFraction></span> as
of December 31, 2023 (December 31, 2022: R$<span id="xdx_902_eifrs-full--CreditExposure_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zWVXyRnu6jSf" title="Exposure risk"><ix:nonFraction name="ifrs-full:CreditExposure" contextRef="AsOf2022-12-31_ifrs-full_CurrencyRiskMember" id="Fact004104" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,447</ix:nonFraction></span>).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"><span style="text-decoration: underline">Sensitivity analysis</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below demonstrates the sensitivity in
the Company&#8217;s income before income taxes of a <span id="xdx_901_ecustom--SensitivityChangeInTheEuroExchangeRate_pid_dp_c20230101__20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_ztjWtcwc24Vi" title="Percentage of sensitivity change in the Euro exchange rate"><ix:nonFraction name="afya:SensitivityChangeInTheEuroExchangeRate" contextRef="From2023-01-012023-12-31_ifrs-full_CurrencyRiskMember" id="Fact004106" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% change in the U.S. dollar exchange rate (R$<span id="xdx_902_eifrs-full--ClosingForeignExchangeRate_iI_uN_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zkXDuPDCpQQ6" title="Closing foreign exchange rate"><ix:nonFraction name="ifrs-full:ClosingForeignExchangeRate" contextRef="AsOf2023-12-31_ifrs-full_CurrencyRiskMember" id="Fact004108" format="ixt:numdotdecimal" decimals="INF" unitRef="N">4.8413</ix:nonFraction></span> to U.S. dollar <span id="xdx_900_eifrs-full--ClosingForeignExchangeRate_iI_uN_c20231231__srt--CurrencyAxis__currency--EUR__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zSsy2TIyIqjd" title="Closing foreign exchange rate"><ix:nonFraction name="ifrs-full:ClosingForeignExchangeRate" contextRef="AsOf2023-12-31_currency_EUR_ifrs-full_CurrencyRiskMember" id="Fact004110" format="ixt:numdotdecimal" decimals="INF" unitRef="N">1.00</ix:nonFraction></span>) as of December
31, 2023, with all other variables held constant.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004112" name="afya:SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89A_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_pn3n3_zJDMahFm18Ra" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 9)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B4_z3XcUWgWtd94" style="display: none">Schedule of sensitivity foreign currency</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 52%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Exposure</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>+10%</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>-10%</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash equivalents</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zdZM8iqCNood" title="Cash and cash equivalents" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyExposuresMember_ifrs-full_CurrencyRiskMember" id="Fact004114" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,173</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zbBLT6FZyP9k" title="Cash and cash equivalents" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2023-01-012023-12-31_custom_IncreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember" id="Fact004116" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,317</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zx1YxzqAts9c" title="Cash and cash equivalents" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2023-01-012023-12-31_custom_DecreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember" id="Fact004118" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,317</ix:nonFraction>)</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A7_zPyEWEyTMBW1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><b>13.4.2</b></td><td><b>Credit risk</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white">Credit risk is the risk that
a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Company
is exposed to credit risk from its operating activities (primarily trade receivables) and from its financing activities, including cash
and cash equivalents.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white">Customer credit risk is managed
by the Company based on the established policy, procedures and control relating to customer credit risk management. Outstanding customer
receivables are regularly monitored. See Note 7 for additional information on the Company&#8217;s trade receivables.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white">Credit risk from balances
with banks and financial institutions is managed by the Company&#8217;s treasury department in accordance with the Company&#8217;s policy.
Investments of surplus funds are made only with approved counterparties and within limits assigned to each counterparty.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The Company&#8217;s maximum exposure to credit
risk for the components of the statements of financial position on December 31, 2023 and 2022 is the carrying amounts of its financial
assets.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><b>13.4.3</b></td><td><b>Liquidity risk</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company&#8217;s Management has responsibility for monitoring liquidity
risk. In order to achieve the Company&#8217;s objective, Management regularly reviews the risk and maintains appropriate reserves, including
bank credit facilities with first tier financial institutions. Management also continuously monitors projected and actual cash flows and
the combination of the maturity profiles of the financial assets and liabilities.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The main requirements for financial resources used by the Company arise
from the need to make payments for suppliers, operating expenses, labor and social obligations, loans and financing and accounts payable
to selling shareholders.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The tables below summarize the maturity profile
of the Company&#8217;s financial liabilities based on contractual undiscounted amounts:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 226 -->
    <div id="xdx_232_zEr64lBEXdpe" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_237_zb5ENfAE909b" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zFZ6g9YTRAH8" style="font: 12pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004121" name="afya:SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_891_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_pn3n3_zfb5sP9cHG2" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 10)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B6_z7Ix2AYP9vgb" style="display: none">Schedule of maturity profile of financial liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Less than 1 year</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1 to 3 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3 to 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>More than 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade payables</span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zKqpogNzeLQ8" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact004123" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,222</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zlXoRe7b9DBi" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4125">-</span></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zKGhZQnf6hEf" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4127">-</span></span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zd9BIrkyDVK5" title="Trade payables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4129">-</span></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zBPpQDCGIrla" title="Trade payables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember" id="Fact004131" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,222</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_988_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjfA8ZBcwEm7" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact004133" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">298,981</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVKkdOpEPvcb" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004135" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,383,255</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2ND2SJ83wp5" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004137" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">568,326</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zsgghcZXp1nd" title="Loans and financing" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4139">-</span></span></td>
    <td id="xdx_987_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zsZWmnYIZTO4" title="Loans and financing" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember" id="Fact004141" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,250,562</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease liabilities</span></td>
    <td id="xdx_986_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvCWqPqgEbi7" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact004143" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">137,735</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zB2AA8LB5gPf" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004145" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">268,724</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z76RVpz4aMNc" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004147" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">255,456</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJRt5StHaGXh" title="Lease liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,261,213</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmJTIANl8Q96" title="Lease liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember" id="Fact004151" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,923,128</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znPsXiOMCp12" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact004153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">387,693</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zNz2H9JulMXd" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004155" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">231,478</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zX4EmWKbXqT" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4157">-</span></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zB3yZUZGzu3f" title="Accounts payable to selling shareholders" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4159">-</span></span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zXfVv6dplGkf" title="Accounts payable to selling shareholders" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember" id="Fact004161" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">619,171</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances from customers</span></td>
    <td id="xdx_98B_eifrs-full--Advances_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zME4b62JV7sl" title="Advances from customers" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact004163" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,485</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zwzkYT7f58kk" title="Advances from customers" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4165">-</span></span></td>
    <td id="xdx_98C_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr1apcQkETf1" title="Advances from customers" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4167">-</span></span></td>
    <td id="xdx_984_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zUElOKxFqFMj" title="Advances from customers" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4169">-</span></span></td>
    <td id="xdx_98D_eifrs-full--Advances_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeem7BEz0hn3" title="Advances from customers" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember" id="Fact004171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,485</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98F_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zZ8hDu6SFyzh" title="Financial liabilities contractual undiscounted" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact004173" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,086,116</ix:nonFraction></b></span></td>
    <td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z5BDQH8bxtsa" title="Financial liabilities contractual undiscounted" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004175" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,883,457</ix:nonFraction></b></span></td>
    <td id="xdx_985_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zT1uFCFjemLb" title="Financial liabilities contractual undiscounted" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004177" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">823,782</ix:nonFraction></b></span></td>
    <td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zovJFtW5v6Cl" title="Financial liabilities contractual undiscounted" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,261,213</ix:nonFraction></b></span></td>
    <td id="xdx_982_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zU2V63uMcu62" title="Financial liabilities contractual undiscounted" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember" id="Fact004181" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,054,568</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2022</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Less than 1 year</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1 to 3 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3 to 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>More than 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade payables</span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFYjRLe0sr3k" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact004183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,482</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVAgiBhQkOc8" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4185">-</span></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zv6qSV9PNFWe" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4187">-</span></span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJV2gX82sHJ8" title="Trade payables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4189">-</span></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zEo3Amrr3gX4" title="Trade payables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember" id="Fact004191" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,482</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGMolnuvMz5j" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact004193" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">287,741</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmDIPpbkjg9d" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">788,190</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zBbcXIg611D3" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004197" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,237,599</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zS3uZwei8xPe" title="Loans and financing" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4199">-</span></span></td>
    <td id="xdx_98F_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjj4Qt9o90Xi" title="Loans and financing" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember" id="Fact004201" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,313,530</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease liabilities</span></td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z1LhxyYQUb04" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact004203" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">117,506</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zyjqz9jJLsv6" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004205" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">234,688</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr9cmg2QCVU5" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">219,127</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zz9FvZfCyw8j" title="Lease liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004209" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,139,771</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFnZkptdDykf" title="Lease liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember" id="Fact004211" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,711,092</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z5eY9D2z3HK1" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact004213" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">282,481</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zMnsKPFukR34" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004215" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">339,281</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zttMMmQPyQVl" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4217">-</span></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zL5Ew6XkyqPd" title="Accounts payable to selling shareholders" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4219">-</span></span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgdhI4OV14Yb" title="Accounts payable to selling shareholders" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember" id="Fact004221" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">621,762</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes payable</span></td>
    <td id="xdx_983_ecustom--NotePayables_iIP3ifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOfQHd3SH4o3" title="Notes payable" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotePayables" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact004223" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,176</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zDTh1pftWl9g" title="Notes payable" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4225">-</span></span></td>
    <td id="xdx_983_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zkh3l2fqtjIc" title="Notes payable" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4227">-</span></span></td>
    <td id="xdx_98D_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVFde30t5472" title="Notes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4229">-</span></span></td>
    <td id="xdx_981_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztrWQM5u61f4" title="Notes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotePayables" contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember" id="Fact004231" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,176</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances from customers</span></td>
    <td id="xdx_98C_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zXGrzgZK41s7" title="Advances from customers" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact004233" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">133,050</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr6ZS3rPKD85" title="Advances from customers" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4235">-</span></span></td>
    <td id="xdx_98E_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zANnTznH1kXj" title="Advances from customers" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4237">-</span></span></td>
    <td id="xdx_98D_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGd6AVfTyGj2" title="Advances from customers" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4239">-</span></span></td>
    <td id="xdx_982_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zNY8vWl2W63e" title="Advances from customers" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember" id="Fact004241" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">133,050</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z93TKGcwfCkd" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact004243" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">954,436</ix:nonFraction></b></span></td>
    <td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOLa5MgMrUbc" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004245" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,362,159</ix:nonFraction></b></span></td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztILcbHGFaq7" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004247" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,456,726</ix:nonFraction></b></span></td>
    <td id="xdx_983_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znJijWd3Flt9" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact004249" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,139,771</ix:nonFraction></b></span></td>
    <td id="xdx_98C_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOUKujqThra2" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember" id="Fact004251" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,913,092</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A2_zLSjA1Ef5pi3" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>13.5</b></td><td><b>Changes in liabilities arising from financing activities</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004253" name="afya:ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_893_ecustom--ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_pn3n3_znD3NLxzm0s8" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 11)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zOrYKxtipXZd" style="display: none">Schedule of changes in liabilities arising from financing activities</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January 1, 2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 9%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business combination</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: -5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2023</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing (i)</span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zb5oCuVF2yU9" title="Liabilities arising from financing activities, beginning" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2022-12-31_custom_LoansAndFinancingMember1360068625" id="Fact004255" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,882,901</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z1OkdgyXg4N" title="Payments of principal" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember" id="Fact004257" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">112,630</ix:nonFraction>)</span></td>
    <td id="xdx_988_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zz91xZ7KP0W2" title="Payments of interest" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember" id="Fact004259" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">175,889</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzpSINmYrvi" title="Addition" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember" id="Fact004261" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,288</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zdUuGXkS87J4" title="Interest" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember" id="Fact004263" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">197,678</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zRc9ScNgC2Le" title="Business combination" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4265">-</span></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0YRYzOiAbDk" title="Other" style="padding-right: 0.15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember" id="Fact004267" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,427</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0hWMvdNrn02" title="Liabilities arising from financing activities, ending" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2023-12-31_custom_LoansAndFinancingMember1360068953" id="Fact004269" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,800,775</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities (i)</span></td>
    <td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYf8cRihXEla" title="Liabilities arising from financing activities, beginning" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember1360068984" id="Fact004271" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">769,525</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zR2nMfRekJq7" title="Payments of principal" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004273" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,473</ix:nonFraction>)</span></td>
    <td id="xdx_985_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zC97GDXfYtG7" title="Payments of interest" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004275" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">103,911</ix:nonFraction>)</span></td>
    <td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxjk1h1PbXRj" title="Addition" style="padding-right: 0.6pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004277" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,715</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYAjczM65A1j" title="Interest" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004279" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,849</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zVDA8oIuDHE" title="Business combination" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004281" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,408</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYfhJaueJrFa" title="Other" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004283" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,544</ix:nonFraction>)</span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zo0m5A5acNlj" title="Liabilities arising from financing activities, ending" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember1360069062" id="Fact004285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">874,569</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zwtzRK5Fwffl" title="Payments of principal" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_custom_DividendsPayableMember" id="Fact004287" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,750</ix:nonFraction>)</span></td>
    <td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zFo3dpzJSFqe" title="Payments of interest" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4289">-</span></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z8Z0JZ93uE4f" title="Addition" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_custom_DividendsPayableMember" id="Fact004291" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,750</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: -0.15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231_zMKwqychlUL5" title="Liabilities arising from financing activities, beginning" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2022-12-31" id="Fact004293" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,652,426</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zl9R91ymLWLc" title="Payments of principal" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact004295" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">162,853</ix:nonFraction>)</b></span></td>
    <td id="xdx_98E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231_zCKkWkERt6cg" title="Payments of interest" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact004297" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">279,800</ix:nonFraction>)</b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z7rZ7YHdggYe" title="Addition" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact004299" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">101,753</ix:nonFraction></b></span></td>
    <td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zUFpLWbFA4je" title="Interest" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact004301" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">298,527</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zlxTmIH9PCDc" title="Business combination" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact004303" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,408</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zebvvVZYquEf" title="Other" style="border-bottom: black 1pt solid; padding-right: -5.15pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-01to2023-12-31" id="Fact004305" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">117</ix:nonFraction>)</b></span></td>
    <td id="xdx_98E_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231_zIINH3EzP9p1" title="Liabilities arising from financing activities, ending" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2023-12-31" id="Fact004307" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,675,344</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January 1, 2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: -5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2022</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing (i)</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zjeEFgq56np2" title="Liabilities arising from financing activities, beginning" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2021-12-31_custom_LoansAndFinancingMember" id="Fact004309" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,374,876</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zEwNAVSAqorj" title="Payments of principal" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31_custom_LoansAndFinancingMember" id="Fact004311" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,791</ix:nonFraction>)</span></td>
    <td id="xdx_980_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zrrRt69nvtx9" title="Payments of interest" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2022-01-012022-12-31_custom_LoansAndFinancingMember" id="Fact004313" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">116,587</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzU4iMhnx5gk" title="Addition" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31_custom_LoansAndFinancingMember" id="Fact004315" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">496,885</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zCK1Hw1ilUDi" title="Interest" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31_custom_LoansAndFinancingMember" id="Fact004317" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">127,559</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zr0qvCHNkJw7" title="Business combination" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4319">-</span></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zK6r0rlPGix8" title="Other" style="padding-right: 0.15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31_custom_LoansAndFinancingMember" id="Fact004321" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,959</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zCJjUkT2tLHk" title="Liabilities arising from financing activities, ending" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2022-12-31_custom_LoansAndFinancingMember1360068625" id="Fact004323" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,882,901</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities (i)</span></td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zoi3iYocDHK3" title="Liabilities arising from financing activities, beginning" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004325" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">714,085</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvuyDODzqePk" title="Payments of principal" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004327" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">28,511</ix:nonFraction>)</span></td>
    <td id="xdx_984_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zX3KJ3Ib6cSa" title="Payments of interest" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004329" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">85,001</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zHioC4pfibIa" title="Addition" style="padding-right: 0.6pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004331" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,873</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zD32aHFrwWrf" title="Interest" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004333" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">88,571</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zi3ngNPHWwB8" title="Business combination" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4335">-</span></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zBaY0ypLltl" title="Other" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004337" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,492</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxn0fQ2cPZPj" title="Liabilities arising from financing activities, ending" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember1360068984" id="Fact004339" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">769,525</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z0p2NsGW2d24" title="Payments of principal" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31_custom_DividendsPayableMember" id="Fact004341" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">19,736</ix:nonFraction>)</span></td>
    <td id="xdx_984_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zmB1yGQcQtXg" title="Payments of interest" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4343">-</span></span></td>
    <td id="xdx_98C_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zCFdrY8qXPDl" title="Addition" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31_custom_DividendsPayableMember" id="Fact004345" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,736</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: -0.15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231_zUhWEPSqKU1b" title="Liabilities arising from financing activities, beginning" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2021-12-31" id="Fact004347" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,088,961</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zPpSwvF3ojPl" title="Payments of principal" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact004349" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">50,038</ix:nonFraction>)</b></span></td>
    <td id="xdx_98A_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231_z4ktVBIa9ha" title="Payments of interest" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact004351" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">201,588</ix:nonFraction>)</b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zPBmJguotbH7" title="Addition" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact004353" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">617,494</ix:nonFraction></b></span></td>
    <td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_z0KOyBp9fS01" title="Interest" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact004355" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">216,130</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zaq1pYbwsTIg" title="Business combination" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4357">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zB1yN3yN8WUc" title="Other" style="border-bottom: black 1pt solid; padding-right: -5.15pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact004359" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,533</ix:nonFraction>)</b></span></td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231_zJxvR9gCYeu4" title="Liabilities arising from financing activities, ending" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2022-12-31" id="Fact004361" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,652,426</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January 1, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions (ii)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing (i)</span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z37iLiWRrR8d" title="Liabilities arising from financing activities, beginning" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2020-12-31_custom_LoansAndFinancingMember" id="Fact004363" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">617,485</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zsMxQRR4XKhb" title="Payments of principal" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember" id="Fact004365" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">107,766</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z5WS9nNRhurf" title="Payments of interest" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember" id="Fact004367" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,310</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zNuOgl1HATC5" title="Addition" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember" id="Fact004369" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">809,539</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znkh4kSlZoF5" title="Interest" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember" id="Fact004371" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">68,909</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zApx8FKVHoU" title="Business combination" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember" id="Fact004373" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,591</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z7krHWyRiHb4" title="Other" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember" id="Fact004375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">428</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zuxfOb5h6wX2" title="Liabilities arising from financing activities, ending" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2021-12-31_custom_LoansAndFinancingMember" id="Fact004377" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,374,876</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities (i)</span></td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zkn1nQd2fRw2" title="Liabilities arising from financing activities, beginning" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004379" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">447,703</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zaY7drP9ILG7" title="Payments of principal" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004381" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,075</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zGeUJ84mQfvc" title="Payments of interest" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004383" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,676</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zkdzaSaZnVEf" title="Addition" style="padding-right: 0.6pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004385" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">158,651</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zx11PdTD5kS7" title="Interest" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004387" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,212</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z8sAB1z40ZS3" title="Business combination" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004389" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">139,514</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zfzKIphO7WAi" title="Other" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004391" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,244</ix:nonFraction>)</span></td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zUrlgU4Npwe2" title="Liabilities arising from financing activities, ending" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004393" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">714,085</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zjFMBOqxMtgf" title="Payments of principal" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_DividendsPayableMember" id="Fact004395" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,648</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zcTlfTDcIkP7" title="Payments of interest" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4397">-</span></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zU4HEg0KiGh5" title="Addition" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_DividendsPayableMember" id="Fact004399" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,648</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231_zGrVTs3PHlR5" title="Liabilities arising from financing activities, beginning" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2020-12-31" id="Fact004401" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,065,188</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zyWwyGmVEAtl" title="Payments of principal" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31" id="Fact004403" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">146,489</ix:nonFraction>)</b></span></td>
    <td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231_zOWleRFSl2wh" title="Payments of interest" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2021-01-012021-12-31" id="Fact004405" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">117,986</ix:nonFraction>)</b></span></td>
    <td id="xdx_982_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zDU1ZF6KtwW6" title="Addition" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31" id="Fact004407" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">986,838</ix:nonFraction></b></span></td>
    <td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_z8sHp1aaRVdd" title="Interest" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31" id="Fact004409" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">136,121</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zEVPUtEuD818" title="Business combination" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31" id="Fact004411" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">176,105</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zEjF0FDq0qMk" title="Other" style="border-bottom: black 1pt solid; padding-right: -6.25pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31" id="Fact004413" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,816</ix:nonFraction>)</b></span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231_z4jiUHg6srUk" title="Liabilities arising from financing activities, ending" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2021-12-31" id="Fact004415" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,088,961</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Payment of interest of loan and financing and lease liabilities are included in cash flows
from financing activities.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"/><td style="text-align: justify">The additions of loans and financing in 2021 include proceeds from the SoftBank transaction
of R$822,569, net of the transaction costs of R$13,030.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A9_zJbhsBFl9oN8" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 227 -->
    <div id="xdx_239_ziZGHowSZDC3" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_238_zqVztKjee7D" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zxi1aWZt0GCh" style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004418" name="afya:FairValueMeasurementExplanatory"><p id="xdx_808_ecustom--FairValueMeasurementExplanatory_zLFuIZiL3ZG2" style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>14</b></td><td><b><span id="xdx_829_z6gXIlRuPYLc">Fair value measurement</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below provides the fair value measurement
hierarchy of the Company&#8217;s assets and liabilities as of December 31, 2023 and 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004420" name="afya:ScheduleOfFairValueMeasurementExplanaory"><table cellspacing="0" cellpadding="0" id="xdx_884_ecustom--ScheduleOfFairValueMeasurementExplanaory_pn3n3_zXkxqugiNX1j" summary="xdx: Disclosure - Fair value measurement (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span id="xdx_8B3_zoPsNlrfXFT9" style="display: none">Schedule of fair value measurement</span></td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td colspan="4" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Fair value measurement</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 15%; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Quoted prices in active markets (Level 1)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Significant observable inputs (Level 2)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Significant unobservable inputs (Level 3)</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2023 </b></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Assets for which fair values are disclosed</b></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade receivables (non-current)</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231_z6nW6UYVwKll" title="Trade receivable (non-current)" style="vertical-align: bottom; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2023-12-31" id="Fact004422" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,485</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zgMAMHa7C9Y7" title="Trade receivable (non-current)" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4424">-</span></span></td>
    <td id="xdx_988_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zgnKNB61vcL5" title="Trade receivable (non-current)" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2023-12-31_ifrs-full_Level2OfFairValueHierarchyMember" id="Fact004426" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,485</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zz4qBjgPLW78" title="Trade receivable (non-current)" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4428">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Liabilities for which fair values are disclosed</b></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_989_ecustom--LoansAndFinancingLiabilities_pn3n3_c20231231_zmOBDC8nlVr4" title="Loans and financing" style="vertical-align: bottom; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:LoansAndFinancingLiabilities" contextRef="AsOf2023-12-31" id="Fact004430" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,795,752</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_988_ecustom--LoansAndFinancingLiabilities_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z1ChD5t69aU5" title="Loans and financing" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:LoansAndFinancingLiabilities" contextRef="AsOf2023-12-31_ifrs-full_Level2OfFairValueHierarchyMember" id="Fact004432" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,795,752</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_98B_ecustom--LeaseLiabilities1_pn3n3_c20231231_zrCCfiQbcn9l" title="Lease liabilities" style="vertical-align: bottom; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:LeaseLiabilities1" contextRef="AsOf2023-12-31" id="Fact004434" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">874,569</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilities1_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zMnXzltPJyUl" title="Lease liabilities" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:LeaseLiabilities1" contextRef="AsOf2023-12-31_ifrs-full_Level2OfFairValueHierarchyMember" id="Fact004436" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">874,569</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_984_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_pn3n3_c20231231_zCnINyUm3Rqg" title="Accounts payable to selling shareholders" style="vertical-align: bottom; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:TradeAndOtherPayablesToRelatedPartiesLiabilities" contextRef="AsOf2023-12-31" id="Fact004438" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">566,867</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z0poaPp6EtI8" title="Accounts payable to selling shareholders" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:TradeAndOtherPayablesToRelatedPartiesLiabilities" contextRef="AsOf2023-12-31_ifrs-full_Level2OfFairValueHierarchyMember" id="Fact004440" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">566,867</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2022</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Assets for which fair values are disclosed</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade receivables (non-current)</span></td>
    <td id="xdx_98F_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231_zeLkFJ30Gtqc" title="Trade receivable (non-current)" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2022-12-31" id="Fact004442" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,568</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zJf8rpjzeG77" title="Trade receivable (non-current)" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4444">-</span></span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zJnkrYIYbxX7" title="Trade receivable (non-current)" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2022-12-31_ifrs-full_Level2OfFairValueHierarchyMember" id="Fact004446" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,568</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zQcI0wGyDQo7" title="Trade receivable (non-current)" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4448">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Liabilities for which fair values are disclosed</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_pn3n3_c20221231_zQQuhRJa4IT7" title="Loans and financing" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:LoansAndFinancingLiabilities" contextRef="AsOf2022-12-31" id="Fact004450" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,934,295</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_ecustom--LoansAndFinancingLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zCK7lwe0y5Y7" title="Loans and financing" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:LoansAndFinancingLiabilities" contextRef="AsOf2022-12-31_ifrs-full_Level2OfFairValueHierarchyMember" id="Fact004452" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,934,295</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_98B_ecustom--LeaseLiabilities1_iI_pn3n3_c20221231_zvBBXzWtfAna" title="Lease liabilities" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:LeaseLiabilities1" contextRef="AsOf2022-12-31" id="Fact004454" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">769,525</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilities1_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zZ2rXoEUcwBl" title="Lease liabilities" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:LeaseLiabilities1" contextRef="AsOf2022-12-31_ifrs-full_Level2OfFairValueHierarchyMember" id="Fact004456" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">769,525</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_988_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_pn3n3_c20221231_zOLekkhCkSCj" title="Accounts payable to selling shareholders" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:TradeAndOtherPayablesToRelatedPartiesLiabilities" contextRef="AsOf2022-12-31" id="Fact004458" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">528,678</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zgzRSQHH0qJf" title="Accounts payable to selling shareholders" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:TradeAndOtherPayablesToRelatedPartiesLiabilities" contextRef="AsOf2022-12-31_ifrs-full_Level2OfFairValueHierarchyMember" id="Fact004460" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">528,678</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Notes payable</span></td>
    <td id="xdx_986_ecustom--FairValueNotesPayables1_iI_pn3n3_c20221231_zsYf6f6VbNT1" title="Notes payable" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:FairValueNotesPayables1" contextRef="AsOf2022-12-31" id="Fact004462" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">62,176</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98C_ecustom--FairValueNotesPayables1_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zb3OjtRK3R49" title="Notes payable" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:FairValueNotesPayables1" contextRef="AsOf2022-12-31_ifrs-full_Level2OfFairValueHierarchyMember" id="Fact004464" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">62,176</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">There were no transfers between Levels during the
period or year presented.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004466" name="afya:CapitalManagementExplanatory"><p id="xdx_804_ecustom--CapitalManagementExplanatory_zMEDYPMJEDqa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>15</b></td><td><b><span id="xdx_820_zLAVEuMVQG5g">Capital management</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">For the purposes of the Company&#8217;s capital
management, capital considers total equity. The primary objective of the Company&#8217;s capital management is to maximize shareholder
value.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The Company manages its capital structure and makes
adjustments in light of changes in economic conditions and the requirements of the financial covenants.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">In order to achieve this overall objective, the
Company&#8217;s capital management, among other things, aims to ensure that it meets financial covenants that define capital structure
requirements. Breaches in meeting the financial covenants would permit the bank to immediately call loans or debentures. There have been
no breaches of the financial covenants of any loans or debentures in the current and previous periods.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">No changes were made in the objectives, policies
or processes for managing capital during the years ended December 31, 2023 and 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004468" name="afya:LaborAndSocialObligationsExplanatory"><p id="xdx_80F_ecustom--LaborAndSocialObligationsExplanatory_zdY28qPb1jb4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>16</b></td><td><b><span id="xdx_82C_zV2NQ8v9LAmh">Labor and social obligations</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>a) Variable compensation (bonuses)</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company recorded bonuses related to variable compensation of employees and management in cost of services and selling, general and administrative
expenses of R$<span id="xdx_908_ecustom--ShareBasedCompensationOfEmployees_pn3n3_c20230101__20231231_zlUo7BjI9FKb" title="Compensation of employees"><ix:nonFraction name="afya:ShareBasedCompensationOfEmployees" contextRef="From2023-01-01to2023-12-31" id="Fact004470" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,185</ix:nonFraction></span></span><span style="font-size: 8pt; font-weight: normal">, </span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">R$<span id="xdx_908_ecustom--ShareBasedCompensationOfEmployees_pn3n3_c20220101__20221231_zrYRy1wf5zX4" title="Compensation of employees"><ix:nonFraction name="afya:ShareBasedCompensationOfEmployees" contextRef="From2022-01-012022-12-31" id="Fact004472" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,248</ix:nonFraction></span>
and R$<span id="xdx_90A_ecustom--ShareBasedCompensationOfEmployees_pn3n3_c20210101__20211231_zMPu8NPpfAFd" title="Compensation of employees"><ix:nonFraction name="afya:ShareBasedCompensationOfEmployees" contextRef="From2021-01-012021-12-31" id="Fact004474" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,587</ix:nonFraction></span> in the years ended December 31, 2023, 2022 and 2021, respectively.</span></p>

<ix:exclude><p id="xdx_23D_zgDDHksDe1yb" style="font: 14pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<br/>
</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 228 -->
    <div id="xdx_239_zJLweAvLPWn3" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23D_zBbESI4hPONh" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b) Afya Limited share-based compensation plans</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b.1) Stock options plan</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">The stock options plan was approved on
August 30, 2019 and granted to senior executives and other employees of the Company from that date, with subsequent changes in the strike
price, as approved, on July 29, 2020 and July 8, 2022, resulting in the strike price of the tranches still to be vested, at the later
date, having their strike price modified to the IPO price in Brazilian Reais (R$<span id="xdx_902_ecustom--StrikePrice_pid_c20200701__20200729_zyG7ZxYyGXPd" title="Strike price"><span id="xdx_902_ecustom--StrikePrice_pid_c20220701__20220708_zoFbPmC0VAZ" title="Strike price"><ix:nonFraction name="afya:StrikePrice" contextRef="From2020-07-012020-07-29" id="Fact004477" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares"><ix:nonFraction name="afya:StrikePrice" contextRef="From2022-07-012022-07-08" id="Fact004479" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">71.22</ix:nonFraction></ix:nonFraction></span></span>), adjusted from the IPO date until the exercise
date using the Certificado de Dep&#243;sito Interbanc&#225;rio (CDI index), excluding dividends. Such changes were assessed as modifications
by the Company and were accounted in accordance with IFRS 2.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">As result of those modifications, the expense related to the share-based
payment of the Company reflects the cost of the original award at grant date over the vesting period plus the incremental fair values
of the repriced options at modification dates over the vesting period of the stock options.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The average incremental fair value, as result of the modification occurred
on July 8, 2022, was R$<span id="xdx_901_ecustom--AverageIncrementalFairValue_pid_c20230101__20231231_zHt4fVP51zO1" title="Average incremental fair value"><ix:nonFraction name="afya:AverageIncrementalFairValue" contextRef="From2023-01-01to2023-12-31" id="Fact004481" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">3.84</ix:nonFraction></span> Brazilian Reais per option. The table below lists the inputs to the valuation model used to determine the
incremental fair value of the stock options as result of the modification:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004483" name="afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions"><table cellspacing="0" cellpadding="0" id="xdx_896_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_z3DhwKnLSwik" summary="xdx: Disclosure - Labor and social obligations (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span id="xdx_8B4_zIvYQZf8uCva" style="display: none">Schedule of model used to determine the fair value of the stock options</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Modified plan</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Original plan</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_900_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zWfQ7kJCZOq4" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember" id="Fact004485" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">83</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z3r4lWano4O7" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember" id="Fact004487" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">91</ix:nonFraction></span> - R$<span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zAH4XplbAaUb" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember" id="Fact004489" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">140</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zUsG4r93xNva" title="Dividend yield"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember" id="Fact004491" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zuOh5KUvGx59" title="Dividend yield"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_IncrementalStockOptionsMember" id="Fact004493" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_907_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zWjxJMy2IuV5" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember" id="Fact004495" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48</ix:nonFraction></span>% - <span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zlXH4siWVndd" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember" id="Fact004497" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">59</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zcBR9APRGgy7" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember" id="Fact004499" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48</ix:nonFraction></span>% - <span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zrjadRuXnnVh" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember" id="Fact004501" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">59</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zTFwDO4nXAq9" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember" id="Fact004503" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>% - <span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zsdoDHHhSQLk" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember" id="Fact004505" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z8Nn5M5wUes1" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember" id="Fact004507" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>% - <span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z1zWoDL4DXTh" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember" id="Fact004509" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zk2G9NZm5Vtk" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember" format="ixt-sec:duryear" id="Fact004511" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span> - <span id="xdx_905_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zEZ5SsV37D82" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember" format="ixt-sec:duryear" id="Fact004513" name="afya:ExpectedLifeOfStockOptions">4</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zouL0Up0DR1b" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember" format="ixt-sec:duryear" id="Fact004515" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span> - <span id="xdx_901_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zmuhF1ZxeeVj" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember" format="ixt-sec:duryear" id="Fact004517" name="afya:ExpectedLifeOfStockOptions">4</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90D_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zE6LFCFQ2Rw8" title="Share price at the measurement date"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember" id="Fact004519" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">48</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zq2Tsqgjg3F4" title="Share price at the measurement date"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_OriginalPlanMember_custom_IncrementalStockOptionsMember" id="Fact004521" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">48</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Valuation model</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zdRMlGQk6ZPh" title="Model used"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember" id="Fact004523" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zIBsj6YJ7XSi" title="Model used"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_IncrementalStockOptionsMember" id="Fact004525" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_902_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zhM8zKh65ZZb" title="Weighted average fair value at the measurement date"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember" id="Fact004527" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">53.06</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zXwRwA9w7zki" title="Weighted average fair value at the measurement date"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2023-12-31_custom_OriginalPlanMember_custom_IncrementalStockOptionsMember" id="Fact004529" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">49.22</ix:nonFraction></span></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AD_zC0bIJyQTvzf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On July 31, 2023, the People and ESG Committee approved a further change
in the share-based compensation plan to retain talents and reinforce the compensation plan. All the holders of stock options granted before
July 11, 2022, with strike price based on the IPO price in Brazilian Reais or above, were offered the possibility to exchange the stock
options for a number of Restricted Stock Units (RSUs) with conversion ratios based on fair value of the original plan, at modification
date, so that the total fair value of the modified award remains the same as the original plan, resulting in a weighted average conversion
ratio of 0.12 RSUs per stock option. As result, the exchange from stock options to RSUs was deemed as a replacement award and thus assessed
as a modification by the Company and accounted in accordance with IFRS 2, since the beneficiaries will have a 'value for value&#8217;
benefit of settling its award for no cash consideration.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The key inputs to the valuation model used to determine the total fair value
of the stock options for conversion to RSUs are as follows:</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_RSUsMember" escape="true" id="Fact004531" name="afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions"><table cellspacing="0" cellpadding="0" id="xdx_893_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_hifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zhLIGEa0rpP3" summary="xdx: Disclosure - Labor and social obligations (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span id="xdx_8BA_z5mSy3N2tTS3" style="display: none">Schedule of model used to determine the fair value of the stock options</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 71%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Modified plan</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90A_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zWPeKZFIDhb8" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember_ifrs-full_BottomOfRangeMember" id="Fact004533" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">95</ix:nonFraction></span> - R$<span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBTa2NxzE0j2" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember_ifrs-full_TopOfRangeMember" id="Fact004535" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">160</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zMdWZ0PcHFH8" title="Dividend yield"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_RSUsMember" id="Fact004537" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zSLeWRkJ4E96" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_RSUsMember" id="Fact004539" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45</ix:nonFraction></span>% - <span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zEhGVs7g9Bn9" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_RSUsMember" id="Fact004541" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z7xF29NAJTU5" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_RSUsMember" id="Fact004543" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% - <span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zkn5cnlFJlwg" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_RSUsMember" id="Fact004545" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zieLowKDGYmg" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_RSUsMember" format="ixt-sec:duryear" id="Fact004547" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span> - <span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zZVQFRInH7Tc" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_RSUsMember" format="ixt-sec:duryear" id="Fact004549" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z2A86MvYyVSj" title="Share price at the measurement date"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember" id="Fact004551" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">75</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Valuation model</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zOBhyh8aoE2e" title="Model used"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_RSUsMember" id="Fact004553" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average conversion rate (RSUs/Stock options)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z2XpObBbdqna" title="Weighted average fair value at the measurement date"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember" id="Fact004555" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">0.12</ix:nonFraction></span></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AF_zY1LSx8SakB9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">Moreover, the People and ESG Committee also approved, on July 31,
2023, a modification in the index rate to the strike prices of its granted stock options. The result is that strike prices are now adjusted
by the Brazilian inflation rate (IPCA) instead of the CDI rate. These changes were accounted as modifications in accordance with IFRS
2. The average incremental fair value, as result of the modification occurred on such date, was R$2.10 Brazilian Reais per stock option.
The table below lists the inputs to the valuation model used to determine the incremental fair value of the stock options as result of
the modification:</p>
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"></p>


<ix:exclude><!-- Field: Page; Sequence: 229 -->
    <div id="xdx_23F_zWJzy4Wy8A1h" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_234_zO3DBobiFxKg" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zUDHWL5fAAal" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004558" name="afya:ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions"><table cellspacing="0" cellpadding="0" id="xdx_893_ecustom--ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions_pn3n3_z4UiQERxB4J9" summary="xdx: Disclosure - Labor and social obligations (Details 2)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span id="xdx_8BA_zhccjbnvCi5d" style="display: none">Schedule of model used to determine incremental  fair
    value of the stock options</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Modified plan</b></span></td>
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Original plan</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price index</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IPCA</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">CDI</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_z2El9m7f9SL2" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IPCAMember" id="Fact004560" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59</ix:nonFraction></span> - <span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zGASxYwoQ787" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IPCAMember" id="Fact004562" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">104</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zgtuU9sx9Kl8" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_CDIMember" id="Fact004564" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59</ix:nonFraction></span> - <span id="xdx_902_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zW3rkReTWqZe" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_CDIMember" id="Fact004566" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">104</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zOvIgzedMDbd" title="Dividend yield"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IPCAMember" id="Fact004568" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zeE3cOTGw10a" title="Dividend yield"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_CDIMember" id="Fact004570" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zuBMdNKzQm22" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IPCAMember" id="Fact004572" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45</ix:nonFraction></span>% - <span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_z3DAcRpFac0e" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IPCAMember" id="Fact004574" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">54</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zdzLDkpixhT2" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_CDIMember" id="Fact004576" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45</ix:nonFraction></span>% - <span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zbgMv89A3FK4" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_CDIMember" id="Fact004578" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">54</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zZIS1Sllneeg" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IPCAMember" id="Fact004580" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% - <span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zwx37XikBnI1" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IPCAMember" id="Fact004582" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zr2bWwddO581" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_CDIMember" id="Fact004584" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% - <span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zd19mY7PKgma" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_CDIMember" id="Fact004586" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">0 - <span id="xdx_904_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zfRypSrhfeS5" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IPCAMember" format="ixt-sec:duryear" id="Fact004588" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">0 - <span id="xdx_90C_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zmJPSCo43017" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_CDIMember" format="ixt-sec:duryear" id="Fact004590" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zLmNlPfUZTRl" title="Share price at the measurement date"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IPCAMember" id="Fact004592" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">75</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_903_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zKZajR5DadLk" title="Share price at the measurement date"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-31_custom_OriginalPlanMember_custom_CDIMember" id="Fact004594" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">75</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Valuation model</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_znoVYBLM5xC4" title="Model used"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IPCAMember" id="Fact004596" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zo834EhhMccg" title="Model used"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_CDIMember" id="Fact004598" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zzuwfH439Zmf" title="Weighted average fair value at the measurement date"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IPCAMember" id="Fact004600" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">28.10</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zoJYkVFxtvj5" title="Weighted average fair value at the measurement date"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2023-12-31_custom_OriginalPlanMember_custom_CDIMember" id="Fact004602" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">26.00</ix:nonFraction></span></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A1_zi6FQMLADhGc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On February 13, 2023, April 17, 2023, August 1, 2023, October 1, 2023 and
December 1, 2023 the Company granted <span id="xdx_909_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20230212__20230213__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zwk3KsPLh7d1" title="Number of stock option granted"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-02-122023-02-13_custom_OptionsGrantedMember" id="Fact004604" format="ixt:numdotdecimal" decimals="INF" unitRef="N">15,000</ix:nonFraction></span>, <span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20230416__20230417__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zbHAVDMpu31k" title="Number of stock option granted"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-04-162023-04-17_custom_OptionsGrantedMember" id="Fact004606" format="ixt:numdotdecimal" decimals="INF" unitRef="N">30,000</ix:nonFraction></span>, <span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20230730__20230801__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zeCHYaxBMSgc" title="Number of stock option granted"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-07-302023-08-01_custom_OptionsGrantedMember" id="Fact004608" format="ixt:numdotdecimal" decimals="INF" unitRef="N">153,000</ix:nonFraction></span>, <span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20230930__20231001__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zJ8xlD5mKkvb" title="Number of stock option granted"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-09-302023-10-01_custom_OptionsGrantedMember" id="Fact004610" format="ixt:numdotdecimal" decimals="INF" unitRef="N">37,000</ix:nonFraction></span> and <span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20231129__20231201__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zAQddLSdfYnd" title="Number of stock option granted"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-11-292023-12-01_custom_OptionsGrantedMember" id="Fact004612" format="ixt:numdotdecimal" decimals="INF" unitRef="N">232,000</ix:nonFraction></span>, respectively, additional stock options:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004614" name="afya:ScheduleOfAdditionalStockOptionsExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_896_ecustom--ScheduleOfAdditionalStockOptionsExplanatory_zmBpLXFOmjr6" summary="xdx: Disclosure - Labor and social obligations (Details 3)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span id="xdx_8BB_zQI6LsFh3s81" style="display: none">Schedule of additional stock
    options</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>February</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>April</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>August</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>October</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>December</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90E_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zI2m5yXju4wc" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGrante" contextRef="AsOf2023-02-13_ifrs-full_ShareOptionsMember" id="Fact004616" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zqAwQb03Hrke" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGrante" contextRef="AsOf2023-04-17_ifrs-full_ShareOptionsMember" id="Fact004618" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zF76UYqapkn8" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGrante" contextRef="AsOf2023-08-01_ifrs-full_ShareOptionsMember" id="Fact004620" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_900_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zUagWImKfRN9" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGrante" contextRef="AsOf2023-10-01_ifrs-full_ShareOptionsMember" id="Fact004622" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zVYLYb5D7G52" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGrante" contextRef="AsOf2023-12-01_ifrs-full_ShareOptionsMember" id="Fact004624" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z04rFiBw2J8f" title="Dividend yield"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-02-122023-02-13_ifrs-full_ShareOptionsMember" id="Fact004626" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z55pl3l2FVE2" title="Dividend yield"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-04-162023-04-17_ifrs-full_ShareOptionsMember" id="Fact004628" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_903_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zOdnqiZFeUa2" title="Dividend yield"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-302023-08-01_ifrs-full_ShareOptionsMember" id="Fact004630" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zhWYF66lggNc" title="Dividend yield"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-09-292023-10-01_ifrs-full_ShareOptionsMember" id="Fact004632" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zKh0Ngq5PZP9" title="Dividend yield"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-11-302023-12-01_ifrs-full_ShareOptionsMember" id="Fact004634" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zMSmQ4Ih25dl" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-02-122023-02-13_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004636" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">46</ix:nonFraction></span>% - <span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zXpdMIq8WQk8" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-02-122023-02-13_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004638" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">56</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEoAq7hSxmIa" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-04-162023-04-17_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004640" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48</ix:nonFraction></span>% - <span id="xdx_906_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zt4vzQUSOsG9" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-04-162023-04-17_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004642" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">55</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zcggEqL8SdS1" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-302023-08-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004644" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">47</ix:nonFraction></span>% - <span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zueJbo5qPCKh" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-07-302023-08-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004646" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">56</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zzJSvMekUEo2" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-09-292023-10-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004648" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">44</ix:nonFraction></span>% - <span id="xdx_90C_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zSKOFhusMje" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-09-292023-10-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004650" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">56</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z9tUL74e6hyb" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-11-302023-12-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004652" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">34</ix:nonFraction></span>% - <span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_znKqUGV6FTvj" title="Expected volatility"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-11-302023-12-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004654" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">56</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zzU2gnFznmKi" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-02-122023-02-13_ifrs-full_ShareOptionsMember" id="Fact004656" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0rsPOleYlb9" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-04-162023-04-17_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004658" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></span>% - <span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zZ6GDBaK4WVj" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-04-162023-04-17_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004660" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zPdY2n4TWJm5" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-07-302023-08-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004662" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% - <span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zXnNe5r1zhWe" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-07-302023-08-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004664" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zf6lAnJ8vAxa" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-09-292023-10-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004666" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></span>% - <span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zCUrA8wWBcY9" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-09-292023-10-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004668" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zwJfvFgpns6d" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-11-302023-12-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004670" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% - <span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zudkK9AKu8Y3" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-11-302023-12-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" id="Fact004672" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_907_ecustom--ExpectedLifeOfStockOptions_dtY_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zIH3opcItc9" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-02-122023-02-13_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" format="ixt-sec:duryear" id="Fact004674" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span> - <span id="xdx_902_ecustom--ExpectedLifeOfStockOptions_dtY_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zJLwkIeZm43" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-02-122023-02-13_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" format="ixt-sec:duryear" id="Fact004676" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_ecustom--ExpectedLifeOfStockOptions_dtY_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zz0380XqIJ4a" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-04-162023-04-17_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" format="ixt-sec:duryear" id="Fact004678" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span> - <span id="xdx_902_ecustom--ExpectedLifeOfStockOptions_dtY_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z18q86bm81ng" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-04-162023-04-17_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" format="ixt-sec:duryear" id="Fact004680" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_ecustom--ExpectedLifeOfStockOptions_dtY_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zHPbANDExjOf" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-07-302023-08-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" format="ixt-sec:duryear" id="Fact004682" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span> - <span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zj5WY5cQGlzi" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-07-302023-08-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" format="ixt-sec:duryear" id="Fact004684" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_907_ecustom--ExpectedLifeOfStockOptions_dtY_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zKnS23omez9g" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-09-292023-10-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" format="ixt-sec:duryear" id="Fact004686" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span> - <span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zMVpTQMsb6J8" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-09-292023-10-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" format="ixt-sec:duryear" id="Fact004688" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zXePdAhlCI5" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-11-302023-12-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember" format="ixt-sec:duryear" id="Fact004690" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span> - <span id="xdx_90A_ecustom--ExpectedLifeOfStockOptions_dtY_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEW7JPY4XvLh" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-11-302023-12-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember" format="ixt-sec:duryear" id="Fact004692" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_907_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zQLko8vfA155" title="Share price at the measurement date"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-02-13_ifrs-full_ShareOptionsMember" id="Fact004694" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">70.69</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90F_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_ztxGlOcwWQsd" title="Share price at the measurement date"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-04-17_ifrs-full_ShareOptionsMember" id="Fact004696" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">62.51</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90E_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zRgfyPUMecrg" title="Share price at the measurement date"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-08-01_ifrs-full_ShareOptionsMember" id="Fact004698" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">76.45</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zLmZDYCaTePi" title="Share price at the measurement date"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-10-01_ifrs-full_ShareOptionsMember" id="Fact004700" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">79.12</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_909_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zdhuK5StwODi" title="Share price at the measurement date"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2023-12-01_ifrs-full_ShareOptionsMember" id="Fact004702" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">100.97</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Valuation model</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z9NaZQH24Yl3" title="Model used"><ix:nonNumeric contextRef="From2023-02-122023-02-13_ifrs-full_ShareOptionsMember" id="Fact004704" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zfh2wf93wE5e" title="Model used"><ix:nonNumeric contextRef="From2023-04-162023-04-17_ifrs-full_ShareOptionsMember" id="Fact004706" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zYdHs8qHNpv9" title="Model used"><ix:nonNumeric contextRef="From2023-07-302023-08-01_ifrs-full_ShareOptionsMember" id="Fact004708" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z0lRaXRCmcT7" title="Model used"><ix:nonNumeric contextRef="From2023-09-292023-10-01_ifrs-full_ShareOptionsMember" id="Fact004710" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zapjHNvYimal" title="Model used"><ix:nonNumeric contextRef="From2023-11-302023-12-01_ifrs-full_ShareOptionsMember" id="Fact004712" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90B_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z8ySNMeVPjg3" title="Weighted average fair value at the measurement date"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2023-02-13_ifrs-full_ShareOptionsMember" id="Fact004714" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">29.54</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zHByWqOzRNP" title="Weighted average fair value at the measurement date"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2023-04-17_ifrs-full_ShareOptionsMember" id="Fact004716" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">32.04</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zK6XFMlKrTHb" title="Weighted average fair value at the measurement date"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2023-08-01_ifrs-full_ShareOptionsMember" id="Fact004718" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">37.04</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_900_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zwf3EIImkkjl" title="Weighted average fair value at the measurement date"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2023-10-01_ifrs-full_ShareOptionsMember" id="Fact004720" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">38.67</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_908_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zkTKEzdVV6V7" title="Weighted average fair value at the measurement date"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2023-12-01_ifrs-full_ShareOptionsMember" id="Fact004722" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">54.25</ix:nonFraction></span></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A1_zATLrZGTKqMa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below illustrates the number and movements
in stock options for the years ended December 31, 2023, 2022 and 2021:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004724" name="afya:ScheduleOfSharebasedCompensationPlanExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_89E_ecustom--ScheduleOfSharebasedCompensationPlanExplanatory_pn3n3_zCdRaKCRhkqc" summary="xdx: Disclosure - Labor and social obligations (Details 4)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8BF_zUvAvdriz7vi" style="display: none">Schedule of share-based compensation plan</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td colspan="3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>Weighted average strike price</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>(in Brazilian Reais)</b></p></td>
    <td colspan="3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>Number of stock options</b></p></td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="border-top: Black 1pt solid; width: 40%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Outstanding at January 1</span></td>
    <td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zYUJ3ITX4Gtc" title="Weighted average exercise price (in Reais), Outstanding at the beginning" style="width: 18%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2022-12-31_ifrs-full_ShareOptionsMember" id="Fact004726" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">79.47</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKFFpHaJiCm9" title="Number of stock options, Outstanding at the beginning" style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-12-31_ifrs-full_ShareOptionsMember" id="Fact004728" format="ixt:numdotdecimal" decimals="INF" unitRef="N">3,729,287</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z1iQtKHjDEKi" title="Number of stock options, Outstanding at the beginning" style="white-space: nowrap; width: 14%; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2021-12-31_ifrs-full_ShareOptionsMember" id="Fact004730" format="ixt:numdotdecimal" decimals="INF" unitRef="N">3,086,728</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z81sVx0CqOIa" title="Number of stock options, Outstanding at the beginning" style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2020-12-31_ifrs-full_ShareOptionsMember" id="Fact004732" format="ixt:numdotdecimal" decimals="INF" unitRef="N">2,510,983</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Granted</span></td>
    <td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zu5nUAFKx6Uj" title="Weighted average exercise price (in Reais), Granted" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004734" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">60.83</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z2URd955qre7" title="Number of stock options, Granted" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004736" format="ixt:numdotdecimal" decimals="INF" unitRef="N">467,000</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zPP6bNbwVI39" title="Number of stock options, Granted" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2022-01-012022-12-31_ifrs-full_ShareOptionsMember" id="Fact004738" format="ixt:numdotdecimal" decimals="INF" unitRef="N">1,234,919</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zqM5i7m1Jse8" title="Number of stock options, Granted" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-01-012021-12-31_ifrs-full_ShareOptionsMember" id="Fact004740" format="ixt:numdotdecimal" decimals="INF" unitRef="N">1,170,000</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Exercised</span></td>
    <td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zBh72c7DyEE1" title="Weighted average exercise price (in Reais), Exercised" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004742" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">59.67</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zBZ0H1MWhg6a" title="Number of stock options, Exercised" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004744" format="ixt:numdotdecimal" decimals="INF" unitRef="N">164,214</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zob9axieXdni" title="Number of stock options, Exercised" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4746">-</span></span></td>
    <td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zfdjfqnv4EMh" title="Number of stock options, Exercised" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2021-01-012021-12-31_ifrs-full_ShareOptionsMember" id="Fact004748" format="ixt:numdotdecimal" decimals="INF" unitRef="N">442,669</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Stock options exchanged to RSUs</span></td>
    <td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKYMMLtl20F6" title="Weighted average exercise price (in Reais), Stock options exchanged" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4750">-</span></span></td>
    <td id="xdx_98C_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z776cNP8Myfj" title="Number of stock options, Stock options exchanged" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004752" format="ixt:numdotdecimal" decimals="INF" unitRef="N">1,751,599</ix:nonFraction>)</span></td>
    <td id="xdx_982_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zIRw7ywFjna2" title="Number of stock options, Stock options exchanged" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4754">-</span></span></td>
    <td id="xdx_985_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKRjgHtN0oM6" title="Number of stock options, Stock options exchanged" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4756">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Forfeited</span></td>
    <td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z5cH8H3KI0wf" title="Weighted average exercise price (in Reais), Forfeited" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004758" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">110.95</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zMMHPPyJOMof" title="Number of stock options, Forfeited" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004760" format="ixt:numdotdecimal" decimals="INF" unitRef="N">333,111</ix:nonFraction>)</span></td>
    <td id="xdx_98D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zusifHyb97b6" title="Number of stock options, Forfeited" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2022-01-012022-12-31_ifrs-full_ShareOptionsMember" id="Fact004762" format="ixt:numdotdecimal" decimals="INF" unitRef="N">365,749</ix:nonFraction>)</span></td>
    <td id="xdx_98C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zlY5Vp34ZyCj" title="Number of stock options, Forfeited" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2021-01-012021-12-31_ifrs-full_ShareOptionsMember" id="Fact004764" format="ixt:numdotdecimal" decimals="INF" unitRef="N">60,000</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expired</span></td>
    <td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3lvNhkaYni" title="Weighted average exercise price (in Reais), Expired" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004766" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">94.17</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHJf011QlSra" title="Number of stock options, Expired" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004768" format="ixt:numdotdecimal" decimals="INF" unitRef="N">251,299</ix:nonFraction>)</span></td>
    <td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmtG1BROVopg" title="Number of stock options, Expired" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" contextRef="From2022-01-012022-12-31_ifrs-full_ShareOptionsMember" id="Fact004770" format="ixt:numdotdecimal" decimals="INF" unitRef="N">226,611</ix:nonFraction>)</span></td>
    <td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zZhb1XM6sLSg" title="Number of stock options, Expired" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" contextRef="From2021-01-012021-12-31_ifrs-full_ShareOptionsMember" id="Fact004772" format="ixt:numdotdecimal" decimals="INF" unitRef="N">91,586</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31</b></span></td>
    <td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zVZOpG0sn9N9" title="Weighted average exercise price (in Reais), Outstanding at the ending" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember" id="Fact004774" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">64.33</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zxl2aIAuewL3" title="Number of stock options, Outstanding at the ending" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember" id="Fact004776" format="ixt:numdotdecimal" decimals="INF" unitRef="N">1,696,064</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zI6s6YVB2tQf" title="Number of stock options, Outstanding at the ending" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-12-31_ifrs-full_ShareOptionsMember" id="Fact004778" format="ixt:numdotdecimal" decimals="INF" unitRef="N">3,729,287</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zLHmal4NBHD3" title="Number of stock options, Outstanding at the ending" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2021-12-31_ifrs-full_ShareOptionsMember" id="Fact004780" format="ixt:numdotdecimal" decimals="INF" unitRef="N">3,086,728</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Exercisable</b></span></td>
    <td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z8pqSfZnW3Ul" title="Weighted average exercise price (in Reais), Exercisable" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember" id="Fact004782" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">86.23</ix:nonFraction></b></span></td>
    <td id="xdx_98A_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z99Nlqh8pCk2" title="Number of stock options, Exercisable" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:NumberOfStockOptionsExercisable" contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember" id="Fact004784" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">242,235</ix:nonFraction></b></span></td>
    <td id="xdx_980_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zT5QMo9sX9a6" title="Number of stock options, Exercisable" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:NumberOfStockOptionsExercisable" contextRef="AsOf2022-12-31_ifrs-full_ShareOptionsMember" id="Fact004786" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,133,774</ix:nonFraction></b></span></td>
    <td id="xdx_98D_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z54x29IexhT1" title="Number of stock options, Exercisable" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:NumberOfStockOptionsExercisable" contextRef="AsOf2021-12-31_ifrs-full_ShareOptionsMember" id="Fact004788" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">542,061</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_zEkDfwM96Ltd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The share-based compensation expense recognized
in selling, general and administrative expenses in the statement of income for the year ended December 31, 2023 was R$<span id="xdx_903_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zTPfzF8mBysa" title="Share-based compensation expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2023-01-012023-12-31_custom_ShareBasedCompensationPlansMember" id="Fact004790" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,850</ix:nonFraction></span> (R$<span id="xdx_903_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zsiKuCfZAUBh" title="Share-based compensation expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2022-01-012022-12-31_custom_ShareBasedCompensationPlansMember" id="Fact004792" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,242</ix:nonFraction></span>
and R$<span id="xdx_90A_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zmp61F7AO3Cd" title="Share-based compensation expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2021-01-012021-12-31_custom_ShareBasedCompensationPlansMember" id="Fact004794" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,377</ix:nonFraction></span> in 2022 and 2021, respectively).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b.2) Restricted Stock Units (RSU) Program</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">On July 8, 2022, the Company approved the new Restricted
Stock Units (RSU) program for employees. The participant's right to effectively receive ownership of the restricted shares will be conditioned
on the participant's continuance as an employee or director in the business group from the grant date until vesting.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The executives will be entitled to these shares
in a proportion of <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zaTBGtbnU0hk" title="Proportion percentage"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember" id="Fact004796" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>%, <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits1Member_zQSSqBNnx72g" title="Proportion percentage"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnits1Member" id="Fact004798" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>%, <span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits2Member_z4zU3ehqId59" title="Proportion percentage"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnits2Member" id="Fact004800" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction></span>%, <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits3Member_zFdm4VF76ggk" title="Proportion percentage"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnits3Member" id="Fact004802" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">40</ix:nonFraction></span>% each year.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 230 -->
    <div id="xdx_23C_zn68g81jJNXb" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23B_zLLoWU7aIoHc" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">In July 2022 and September 2022, <span id="xdx_903_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20220701__20220731_zP0s67hBCEFg" title="Granted"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2022-07-012022-07-31" id="Fact004804" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">442,546</ix:nonFraction></span> and <span id="xdx_907_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20220901__20220930_z0SF2xRFKkgd" title="Granted"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2022-09-012022-09-30" id="Fact004806" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,678</ix:nonFraction></span>
RSUs were granted, respectively, to Afya&#8217;s executives, with vesting periods from May 2023 to May 2026. Fair values at grant date
were R$<span id="xdx_908_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20220701__20220731_zbBpWgy9n692" title="Fair values at grant date"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2022-07-012022-07-31" id="Fact004808" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">48.24</ix:nonFraction></span> and R$<span id="xdx_904_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20220901__20220930_zkSjtGj2N7z1" title="Fair values at grant date"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2022-09-012022-09-30" id="Fact004810" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">72.59</ix:nonFraction></span>, respectively. On February 2, April 17, August 1, October 1 and December 1, 2023, <span id="xdx_90C_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20230129__20230202_zIIJjqZNHFR7" title="Granted"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2023-01-292023-02-02" id="Fact004812" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,000</ix:nonFraction></span>, <span id="xdx_90A_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20230416__20230417_zUaT08e1peC" title="Granted"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2023-04-162023-04-17" id="Fact004814" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,000</ix:nonFraction></span>, <span id="xdx_903_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20230730__20230801_zCbG0wSyovcd" title="Granted"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2023-07-302023-08-01" id="Fact004816" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">153,490</ix:nonFraction></span>, <span id="xdx_90C_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20230930__20231001_zn3KGsYDqKB7" title="Granted"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2023-09-302023-10-01" id="Fact004818" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,000</ix:nonFraction></span>
and <span id="xdx_90A_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20231129__20231201_zyMbike8uY0h" title="Granted"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2023-11-292023-12-01" id="Fact004820" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">76,600</ix:nonFraction></span> RSUs were granted to Afya&#8217;s executives, respectively, with vesting periods from May 2024 to May 2027. Fair value at grant
date was R$<span id="xdx_90F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230129__20230202_zQt0rZ1DaeT" title="Fair values at grant date"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-01-292023-02-02" id="Fact004822" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">70.69</ix:nonFraction></span>, R$<span id="xdx_903_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230416__20230417_zqHacIFVkLMd" title="Fair values at grant date"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-04-162023-04-17" id="Fact004824" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">62.51</ix:nonFraction></span>, R$<span id="xdx_905_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230730__20230801_zJciokgHtPj8" title="Fair values at grant date"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-07-302023-08-01" id="Fact004826" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">76.45</ix:nonFraction></span>, R$<span id="xdx_904_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230930__20231001_zWXVoU1BSkSk" title="Fair values at grant date"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-09-302023-10-01" id="Fact004828" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">79.12</ix:nonFraction></span> and R$<span id="xdx_90A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20231129__20231201_z8jnt5T7S355" title="Fair values at grant date"><ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-11-292023-12-01" id="Fact004830" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">100.97</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">As described above, on July 31, 2023, the holders
of stock options granted before July 11, 2022 were offered the possibility to exchange the stock options for a number of Restricted Stock
Units (RSUs).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below illustrates the number and movements
in RSUs for the years ended December 31, 2023 and 2022:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004832" name="afya:ScheduleOfStockOptionExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_899_ecustom--ScheduleOfStockOptionExplanatory_pn3n3_zQUnx2ZSX7zd" summary="xdx: Disclosure - Labor and social obligations (Details 5)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8B7_zjd0OcZzxoZa" style="display: none">Schedule of stock option</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Outstanding at January 1</span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zkHv5O8K8dfl" title="Number of stock options, Outstanding at the beginning" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember" id="Fact004834" format="ixt:numdotdecimal" decimals="INF" unitRef="N">447,224</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zBnbf1RfTczd" title="Number of stock options, Outstanding at the beginning" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4836">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Granted</span></td>
    <td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zyvE4WkwR7e3" title="Number of stock options, Granted" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember1360072343" id="Fact004838" format="ixt:numdotdecimal" decimals="INF" unitRef="N">317,090</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zn3u7iko1Pae" title="Number of stock options, Granted" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2022-01-012022-12-31_custom_RestrictedStockUnitsMember" id="Fact004840" format="ixt:numdotdecimal" decimals="INF" unitRef="N">447,224</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Stock options exchanged to RSUs</span></td>
    <td id="xdx_988_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z4aqmEnnuOm4" title="Number of stock options, Stock options exchanged" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember1360072343" id="Fact004842" format="ixt:numdotdecimal" decimals="INF" unitRef="N">215,797</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zgky3WtW64Eb" title="Number of stock options, Stock options exchanged" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4844">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Exercised</span></td>
    <td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zxFBoDpvVtAd" title="Number of stock options, Exercised" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember1360072343" id="Fact004846" format="ixt:numdotdecimal" decimals="INF" unitRef="N">99,576</ix:nonFraction>)</span></td>
    <td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z0sMyiI5LCJi" title="Number of stock options, Exercised" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4848">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Forfeited</span></td>
    <td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zbRUJFWkGI72" title="Number of stock options, Forfeited" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember1360072343" id="Fact004850" format="ixt:numdotdecimal" decimals="INF" unitRef="N">26,104</ix:nonFraction>)</span></td>
    <td id="xdx_988_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zYjd6BBvYxBg" title="Number of stock options, Forfeited" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4852">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31</b></span></td>
    <td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zJWV5I3j3oZ7" title="Number of stock options, Outstanding at the ending" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-12-31_custom_RestrictedStockUnitsMember" id="Fact004854" format="ixt:numdotdecimal" decimals="INF" unitRef="N">854,431</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zOBt3BH1QZxk" title="Number of stock options, Outstanding at the ending" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember" id="Fact004856" format="ixt:numdotdecimal" decimals="INF" unitRef="N">447,224</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A6_z5uEUPnk23Ri" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company accounts for the RSU plan as an equity-settled plan, except
for the portion of labor and social securities obligations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Total RSU expense recognized in selling, general and administrative expenses
in the statement of income for the year ended December 31, 2023 amount R$<span id="xdx_900_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zzktHujnkHb8" title="Share-based compensation expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember1360072343" id="Fact004858" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,685</ix:nonFraction></span> (December 31, 2022: R$<span id="xdx_90C_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zfY9QHQc5f0k" title="Share-based compensation expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2022-01-012022-12-31_custom_RestrictedStockUnitsMember" id="Fact004860" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,032</ix:nonFraction></span>). Labor and social obligations
amount R$<span id="xdx_905_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20231231_zHzP4bgJGO7a" title="social obligations liabilities"><ix:nonFraction name="afya:SocialObligationsLiabilities" contextRef="AsOf2023-12-31" id="Fact004862" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,171</ix:nonFraction></span> as of December 31, 2023 (December 31, 2022: R$<span id="xdx_90A_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20221231_zaHBtmBssjGk" title="social obligations liabilities"><ix:nonFraction name="afya:SocialObligationsLiabilities" contextRef="AsOf2022-12-31" id="Fact004864" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,167</ix:nonFraction></span>).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004866" name="afya:DisclosureOfEquityExplanatory"><p id="xdx_80E_ecustom--DisclosureOfEquityExplanatory_zUs68iYmlM9h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>17</b></td><td><b><span id="xdx_829_zYIWHLrTQ4s1">Equity</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>a) Share capital</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">As of December 31, 2023 and 2022, the Company&#8217;s
share capital was R$<span id="xdx_900_eifrs-full--IssuedCapital_iI_pn3n3_c20231231_z3U78Qe3SOxi" title="Share capital"><span id="xdx_90B_eifrs-full--IssuedCapital_c20221231_pn3n3" title="Share capital"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2023-12-31" id="Fact004868" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2022-12-31" id="Fact004870" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></ix:nonFraction></span> </span>represented by <span id="xdx_900_ecustom--NumberOfSharesIssued1_iI_pid_c20231231_zKV5sBJb9CV4" title="Total number of shares"><span id="xdx_90B_ecustom--NumberOfSharesIssued1_iI_pid_c20221231_zyT2swYCvkJ7" title="Total number of shares"><ix:nonFraction name="afya:NumberOfSharesIssued1" contextRef="AsOf2023-12-31" id="Fact004872" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="afya:NumberOfSharesIssued1" contextRef="AsOf2022-12-31" id="Fact004874" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,722,831</ix:nonFraction></ix:nonFraction></span></span> shares comprised by <span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zK25BtmdMgi" title="Total number of shares"><span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zHVnzKNLP7Sb" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2023-12-31_custom_ClassAOrdinarySharesMember" id="Fact004876" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2022-12-31_custom_ClassAOrdinarySharesMember" id="Fact004878" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47,920,068</ix:nonFraction></ix:nonFraction></span></span> class A common shares and <span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zfVdiuLkcjt1" title="Total number of shares"><span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zx3yWa6vpTx" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2023-12-31_custom_ClassBOrdinarySharesMember" id="Fact004880" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2022-12-31_custom_ClassBOrdinarySharesMember" id="Fact004882" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,802,763</ix:nonFraction></ix:nonFraction></span></span> class B common shares.
As of December 31, 2023 and 2022, the Company&#8217;s authorized capital was US$<span id="xdx_90E_ecustom--IssuedCapitals_iI_pn3n3_c20231231_zMGknDOh2RDk" title="Authorized capital"><span id="xdx_908_ecustom--IssuedCapitals_iI_pn3n3_c20221231_zgIEldpDLn36" title="Authorized capital"><ix:nonFraction name="afya:IssuedCapitals" contextRef="AsOf2023-12-31" id="Fact004884" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL"><ix:nonFraction name="afya:IssuedCapitals" contextRef="AsOf2022-12-31" id="Fact004886" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50</ix:nonFraction></ix:nonFraction></span></span> thousand.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b) Dividends</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">In the year ended December 31, 2023, CCSI and IESVAP
approved the payment of dividends of R$<span id="xdx_90F_ecustom--PaymentOfDividends_pn3n3_c20230101__20231231_zIelqDRK6FZi" title="Payment of dividends"><ix:nonFraction name="afya:PaymentOfDividends" contextRef="From2023-01-01to2023-12-31" id="Fact004888" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,539</ix:nonFraction></span>, which R$<span id="xdx_902_ecustom--DividendDistributed_pn3n3_c20230101__20231231_zSfYzNROHDmj" title="Dividend distributed"><ix:nonFraction name="afya:DividendDistributed" contextRef="From2023-01-01to2023-12-31" id="Fact004890" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,788</ix:nonFraction></span> was distributed to Afya and R$<span id="xdx_90D_eifrs-full--DividendsPaidToNoncontrollingInterests_pn3n3_c20230101__20231231_zMK6ph4Gzcg3" title="Dividends paid to non-controlling interests"><ix:nonFraction name="ifrs-full:DividendsPaidToNoncontrollingInterests" contextRef="From2023-01-01to2023-12-31" id="Fact004892" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,750</ix:nonFraction></span> to non-controlling shareholders (December
31, 2022: R$<span id="xdx_903_ecustom--PaymentOfDividends_pn3n3_c20220101__20221231_zNjTzy7YWTV7" title="Payment of dividends"><ix:nonFraction name="afya:PaymentOfDividends" contextRef="From2022-01-012022-12-31" id="Fact004894" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">66,828</ix:nonFraction></span>, which R$<span id="xdx_906_ecustom--DividendDistributed_pn3n3_c20220101__20221231_z7klf6bBQAB4" title="Dividend distributed"><ix:nonFraction name="afya:DividendDistributed" contextRef="From2022-01-012022-12-31" id="Fact004896" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">47,092</ix:nonFraction></span> was distributed to Afya and R$<span id="xdx_909_eifrs-full--DividendsPaidToNoncontrollingInterests_pn3n3_c20220101__20221231_zWZxAh1TdLoe" title="Dividends paid to non-controlling interests"><ix:nonFraction name="ifrs-full:DividendsPaidToNoncontrollingInterests" contextRef="From2022-01-012022-12-31" id="Fact004898" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,736</ix:nonFraction></span> to non-controlling shareholders and December 31, 2021: R$<span id="xdx_903_ecustom--PaymentOfDividends_pn3n3_c20210101__20211231_zfAfWUK98FYl" title="Payment of dividends"><ix:nonFraction name="afya:PaymentOfDividends" contextRef="From2021-01-012021-12-31" id="Fact004900" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,521</ix:nonFraction></span>,
which R$<span id="xdx_902_ecustom--DividendDistributed_pn3n3_c20210101__20211231_zSWbOU2yYtxc" title="Dividend distributed"><ix:nonFraction name="afya:DividendDistributed" contextRef="From2021-01-012021-12-31" id="Fact004902" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,873</ix:nonFraction></span> was distributed to Afya and R$<span id="xdx_90E_eifrs-full--DividendsPaidToNoncontrollingInterests_pn3n3_c20210101__20211231_zGnw9nmOQdGf" title="Dividends paid to non-controlling interests"><ix:nonFraction name="ifrs-full:DividendsPaidToNoncontrollingInterests" contextRef="From2021-01-012021-12-31" id="Fact004904" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,648</ix:nonFraction></span> to non-controlling shareholders).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>c) Share repurchase program</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On October 27, 2021, the Company&#8217;s board of directors approved a
new share repurchase program. Afya may repurchase up to <span id="xdx_906_ecustom--RepurchaseOfOrdinaryShares_c20211027__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_pdd" title="Repurchase of ordinary shares"><ix:nonFraction name="afya:RepurchaseOfOrdinaryShares" contextRef="AsOf2021-10-27_custom_ClassAOrdinarySharesMember" id="Fact004906" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,383,108</ix:nonFraction></span> of its outstanding Class A common shares in the open market, based
on prevailing market prices, beginning on October 28, 2021, until the earlier of the completion of the repurchase or December 31, 2022,
depending upon market conditions. The Company completed the acquisition of the approved shares repurchase under this buy-back program.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<ix:exclude><p id="xdx_230_zjOLfSllJxce" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 231 -->
    <div id="xdx_231_zDzbvmWTnAB4" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_23F_zkfEBJwyMUa7" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zKV2hp0VYKI9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On January 27, 2022, the Company&#8217;s board of directors approved a new
share repurchase program. Afya may repurchase up to <span id="xdx_902_ecustom--RepurchaseOfOrdinaryShares_iI_c20220127__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zusIXkhOnwl9" title="Repurchase of ordinary shares"><ix:nonFraction name="afya:RepurchaseOfOrdinaryShares" contextRef="AsOf2022-01-27_custom_ClassAOrdinarySharesMember" id="Fact004910" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,874,457</ix:nonFraction></span> of its outstanding Class A common shares in the open market, based on prevailing
market prices, beginning on January 27, 2022, until the earlier of the completion of the repurchase or December 31, 2022, depending upon
market conditions. The Company completed the acquisition of the approved shares repurchase under this buy-back program.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On March 24, 2023, the Company&#8217;s board of directors approved the fourth
share repurchase program. Afya may repurchase up to <span id="xdx_900_ecustom--RepurchaseOfOrdinaryShares_iI_c20230324__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zdtV3YxqxRl" title="Repurchase of ordinary shares"><ix:nonFraction name="afya:RepurchaseOfOrdinaryShares" contextRef="AsOf2023-03-24_custom_ClassAOrdinarySharesMember" id="Fact004912" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> of its outstanding Class A common shares in the open market, based on prevailing
market prices, beginning on March 24, 2023, until the earlier of the completion of the repurchase or December 31, 2024, depending upon
market conditions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">During the year ended December 31, 2023, the Company&#8217;s cash outflow
was R$<span id="xdx_903_ecustom--CashOutflow_pn3n3_c20230101__20231231_zL44vnn2TwX8" title="Cash outflow"><ix:nonFraction name="afya:CashOutflow" contextRef="From2023-01-01to2023-12-31" id="Fact004914" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,369</ix:nonFraction></span> (December 31, 2022: R$<span id="xdx_90A_ecustom--CashOutflow_pn3n3_c20220101__20221231_zyzBQh0e8Y8d" title="Cash outflow"><ix:nonFraction name="afya:CashOutflow" contextRef="From2022-01-012022-12-31" id="Fact004916" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">152,317</ix:nonFraction></span> and December 31, 2021: R$<span id="xdx_90C_ecustom--CashOutflow_pn3n3_c20210101__20211231_zGiGKAVVk1si" title="Cash outflow"><ix:nonFraction name="afya:CashOutflow" contextRef="From2021-01-012021-12-31" id="Fact004918" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">213,722</ix:nonFraction></span>).</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below illustrates the number and movements
in treasury shares during the years ended December 31, 2023, 2022 and 2021:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004920" name="afya:ScheduleOfTreasurySharesMovementExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_882_ecustom--ScheduleOfTreasurySharesMovementExplanatory_zvIQsmqLNYQb" summary="xdx: Disclosure - Equity (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: left; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8B5_z1twcLhelyU4" style="display: none">Schedule illustrates the number and
    movements in treasury shares</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 58%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 19%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Number of treasury shares</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><b>Average price</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><b>(in Brazilian Reais)</b></p></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Outstanding at January 1, 2021</span></td>
    <td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iS_pid_c20210101__20211231_z4RHt0jx9BO8" title="Number of shares, Outstanding, at beginning balance" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4922">-</span></span></td>
    <td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20210101__20211231_zk7ah6CmKiPh" title="Average price, at beginning balance" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4924">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Repurchased</span></td>
    <td id="xdx_985_ecustom--NumberOfSharesRepurchased_pid_c20210101__20211231_zDKZeSbvIu7b" title="Number of shares, Repurchased" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NumberOfSharesRepurchased" contextRef="From2021-01-012021-12-31" id="Fact004926" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,142,051</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--AveragePriceRepurchased_pid_c20210101__20211231_zvkKxHfuJpEb" title="Average price repurchased" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AveragePriceRepurchased" contextRef="From2021-01-012021-12-31" id="Fact004928" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">119.99</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred from exercise of stock options</span></td>
    <td id="xdx_98B_ecustom--TransferredFromExerciseOfStockOptions_pid_c20210101__20211231_z2R8UthoK2Ef" title="Number of shares, Transferred from exercise of stock options" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TransferredFromExerciseOfStockOptions" contextRef="From2021-01-012021-12-31" id="Fact004930" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">442,669</ix:nonFraction>)</span></td>
    <td id="xdx_985_ecustom--AveragePriceTransferredFromExerciseOfStockOptions_pid_c20210101__20211231_z4Jj6TDZ2CZf" title="Average price transferred from exercise of stock options" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AveragePriceTransferredFromExerciseOfStockOptions" contextRef="From2021-01-012021-12-31" id="Fact004932" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">124.26</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred from shares contribution</span></td>
    <td id="xdx_98B_ecustom--TransferredFromSharesContribution_pid_c20210101__20211231_zkJMM1kVKYtg" title="Number of shares, Transferred from shares contribution" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TransferredFromSharesContribution" contextRef="From2021-01-012021-12-31" id="Fact004934" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">44,455</ix:nonFraction>)</span></td>
    <td id="xdx_989_ecustom--AveragePriceTransferredFromSharesContribution_pid_c20210101__20211231_zAFOAIVGSfJk" title="Average price transferred from shares contribution" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AveragePriceTransferredFromSharesContribution" contextRef="From2021-01-012021-12-31" id="Fact004936" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">111.94</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31, 2021</b></span></td>
    <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20210101__20211231_z4040Jq3feud" title="Number of shares, Outstanding, at beginning balance" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2021-12-31" id="Fact004938" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,654,927</ix:nonFraction></b></span></td>
    <td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20220101__20221231_zvNZYSC5Hm97" title="Average price, at beginning balance" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2021-12-31" id="Fact004940" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">92.23</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Repurchased</span></td>
    <td id="xdx_98D_ecustom--NumberOfSharesRepurchased_pid_c20220101__20221231_zDwhGvaAOFgf" title="Number of shares, Repurchased" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NumberOfSharesRepurchased" contextRef="From2022-01-012022-12-31" id="Fact004942" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,131,358</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--AveragePriceRepurchased_pid_c20220101__20221231_zIPESYXXKEHk" title="Average price repurchased" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AveragePriceRepurchased" contextRef="From2022-01-012022-12-31" id="Fact004944" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">71.46</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31, 2022</b></span></td>
    <td id="xdx_984_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20220101__20221231_zYa0l4tCDBp1" title="Number of shares, Outstanding, at ending balance" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2022-12-31" id="Fact004946" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,786,285</ix:nonFraction></b></span></td>
    <td id="xdx_981_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231_z1XsVHTiQ6h4" title="Average price, at beginning balance" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2022-12-31" id="Fact004948" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">80.54</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Repurchased</span></td>
    <td id="xdx_98A_ecustom--NumberOfSharesRepurchased_pid_c20230101__20231231_zI4y64Htsdgg" title="Number of shares, Repurchased" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NumberOfSharesRepurchased" contextRef="From2023-01-01to2023-12-31" id="Fact004950" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">216,339</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--AveragePriceRepurchased_pid_c20230101__20231231_z1weBiUo8r8d" title="Average price repurchased" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AveragePriceRepurchased" contextRef="From2023-01-01to2023-12-31" id="Fact004952" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">57.17</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Delivered under the share-based compensation plan</span></td>
    <td id="xdx_98A_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_iP3custom--AveragePriceRepurchased_pid_c20230101__20231231_zx7lFam1NYQ8" title="Number of treasury shares, delivered under the share-based compensation plan" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" contextRef="From2023-01-01to2023-12-31" id="Fact004954" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">229,146</ix:nonFraction>)</span></td>
    <td id="xdx_982_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_iP3custom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pid_c20230101__20231231_zSVHvaAjjgN" title="Average price, delivered under the share-based compensation plan" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AveragePriceDeliveredUnderSharebasedCompensationPlan" contextRef="From2023-01-01to2023-12-31" id="Fact004956" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">79.28</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31, 2023</b></span></td>
    <td id="xdx_985_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20230101__20231231_zfcB7fnh7kIc" title="Number of shares, Outstanding, at ending balance" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact004958" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,773,478</ix:nonFraction></b></span></td>
    <td id="xdx_986_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231_zJMM77CMs9Ti" title="Average price, at ending balance" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2023-12-31" id="Fact004960" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">79.28</ix:nonFraction></b></span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004962" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory"><p id="xdx_806_eifrs-full--DisclosureOfEarningsPerShareExplanatory_z11RJZojxrId" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>18</b></td><td><b><span id="xdx_82D_z8uVul6IeIn5">Earnings per share (EPS)</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">Basic EPS is calculated by dividing net income
attributable to the equity holders of the Company by the weighted average number of common shares outstanding during the year.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">Diluted EPS is calculated by dividing net income
attributable to the equity holders of the parent by the weighted average number of common shares outstanding during the year plus the
weighted average number of shares that would be issued on conversion of all potential shares with dilutive effects.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Diluted earnings per share are computed including stock options granted
to key management using the treasury shares method when the effect is dilutive. The Company has the stock option and restricted share
unit plans in the category of potentially dilutive shares.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Softbank&#8217;s series A perpetual convertible preferred shares are antidilutive
as of December 31, 2023, 2022 and 2021 and are not included on diluted earnings per share.</p>

<ix:exclude><p id="xdx_236_z3TGlKuWfRt7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><br/>
</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 232 -->
    <div id="xdx_239_z6Z4otaw5ZY8" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_236_zCm0MbOLvxD6" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below reflects the net income and share
data used in the basic and diluted EPS calculations:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004965" name="afya:DisclosureOfEarningsPerShareTableExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_880_ecustom--DisclosureOfEarningsPerShareTableExplanatory_zh4dEsEpi4ga" summary="xdx: Disclosure - Earnings per share (EPS) (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"><span id="xdx_8BD_ztMuxzx63bp4" style="display: none">Schedule of earnings per share</span></td>
    <td id="xdx_494_20230101__20231231_zJeOJSBUDycl" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center">&#160;</td>
    <td id="xdx_491_20220101__20221231_zIvykMcHKZ1h" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center">&#160;</td>
    <td id="xdx_49E_20210101__20211231_zmcGCgKoYDfh" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 58%; padding-right: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr id="xdx_404_ecustom--NumeratorAbstract_iB_zX2qshDNvgyi">
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Numerator</b></span></td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_pn3n3_zdsv90uET2l4" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Net income attributable to equity holders of the parent</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends" contextRef="From2023-01-01to2023-12-31" id="Fact004971" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">386,324</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends" contextRef="From2022-01-012022-12-31" id="Fact004972" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">373,569</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends" contextRef="From2021-01-012021-12-31" id="Fact004973" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,326</ix:nonFraction></span></td></tr>
  <tr id="xdx_404_ecustom--DenominatorAbstract_iB_pn3n3_zIugD1pFkXh7" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Denominator</b></span></td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--WeightedAverageShares_pid_z8fIXOPUpdyh" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 8.6pt; text-align: justify; text-indent: -8.6pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average number of outstanding shares</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="From2023-01-01to2023-12-31" id="Fact004979" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">89,830,351</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="From2022-01-012022-12-31" id="Fact004980" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">90,335,037</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="From2021-01-012021-12-31" id="Fact004981" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,291,480</ix:nonFraction></span></td></tr>
  <tr id="xdx_40C_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pid_zGU1Tq0ty0Ic" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effects of dilution from stock options and restricted share units</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" contextRef="From2023-01-01to2023-12-31" id="Fact004983" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">706,492</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" contextRef="From2022-01-012022-12-31" id="Fact004984" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">329,085</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" contextRef="From2021-01-012021-12-31" id="Fact004985" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">811,818</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--AdjustedWeightedAverageShares_pid_uShares_zrEuz15uV5B1" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify; line-height: 115%; text-indent: -7.1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Weighted average number of outstanding shares adjusted for the effect of dilution</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="From2023-01-01to2023-12-31" id="Fact004987" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">90,536,843</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="From2022-01-012022-12-31" id="Fact004988" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">90,664,122</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="From2021-01-012021-12-31" id="Fact004989" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">94,103,298</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--BasicEarningsLossPerShare_pid_z17TAETfE2Zc" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Basic earnings per share (R$)</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2023-01-01to2023-12-31" id="Fact004991" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">4.30</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2022-01-012022-12-31" id="Fact004992" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">4.14</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2021-01-012021-12-31" id="Fact004993" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">2.39</ix:nonFraction></span></td></tr>
  <tr id="xdx_40C_eifrs-full--DilutedEarningsLossPerShare_pid_ziW3dWZ5nqO4" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Diluted earnings per share (R$)</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2023-01-01to2023-12-31" id="Fact004995" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">4.27</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2022-01-012022-12-31" id="Fact004996" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">4.12</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2021-01-012021-12-31" id="Fact004997" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">2.37</ix:nonFraction></span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact004999" name="ifrs-full:DisclosureOfRevenueExplanatory"><p id="xdx_806_eifrs-full--DisclosureOfRevenueExplanatory_zimIU8wyTOx" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>19</b></td><td><b><span id="xdx_82C_zUsf9qG7uO5f">Revenue</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005001" name="afya:ScheduleOfNetSalesRevenueExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_894_ecustom--ScheduleOfNetSalesRevenueExplanatory_pn3n3_znfpDm4BOzIc" summary="xdx: Disclosure - Revenue (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span id="xdx_8B9_z5BUwrB1hwy9" style="display: none">Schedule of net sales revenue</span></td>
    <td id="xdx_49F_20230101__20231231_z1WObxgz0xtc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49E_20220101__20221231_zcrwSmtQvjz7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49B_20210101__20211231_zs61v7tgdhUl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 58%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ProfessionalFeesExpenses_pn3n3_zwk9c80ObZK8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Tuition fees</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ProfessionalFeesExpenses" contextRef="From2023-01-01to2023-12-31" id="Fact005003" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,505,250</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ProfessionalFeesExpenses" contextRef="From2022-01-012022-12-31" id="Fact005004" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,827,567</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ProfessionalFeesExpenses" contextRef="From2021-01-012021-12-31" id="Fact005005" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,124,589</ix:nonFraction></span></td></tr>
  <tr id="xdx_404_ecustom--OtherRevenue1_pn3n3_zp8xAYUrIeNa" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Other</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:OtherRevenue1" contextRef="From2023-01-01to2023-12-31" id="Fact005007" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">263,937</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:OtherRevenue1" contextRef="From2022-01-012022-12-31" id="Fact005008" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">213,040</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:OtherRevenue1" contextRef="From2021-01-012021-12-31" id="Fact005009" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">167,441</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_ecustom--DeductionAbstract_iB_zdCBlY7sJgra" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Deductions</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeductionOfGrantedDiscounts_pn3n3_zC9iOk8mpbAj" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;Discount and scholarships</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfGrantedDiscounts" contextRef="From2023-01-01to2023-12-31" id="Fact005015" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">240,314</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfGrantedDiscounts" contextRef="From2022-01-012022-12-31" id="Fact005016" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">241,404</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfGrantedDiscounts" contextRef="From2021-01-012021-12-31" id="Fact005017" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">229,254</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_408_ecustom--DeductionOfEarlyPaymentDiscounts_pn3n3_zmb02L9Q1O94" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;Early payment discounts</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfEarlyPaymentDiscounts" contextRef="From2023-01-01to2023-12-31" id="Fact005019" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">195,054</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfEarlyPaymentDiscounts" contextRef="From2022-01-012022-12-31" id="Fact005020" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">92,234</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfEarlyPaymentDiscounts" contextRef="From2021-01-012021-12-31" id="Fact005021" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">49,879</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_404_ecustom--DeductionOfReturnsOfNetRevenue_pn3n3_zlIFg3qx6xXk" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;Returns</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfReturnsOfNetRevenue" contextRef="From2023-01-01to2023-12-31" id="Fact005023" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">27,743</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfReturnsOfNetRevenue" contextRef="From2022-01-012022-12-31" id="Fact005024" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">45,402</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfReturnsOfNetRevenue" contextRef="From2021-01-012021-12-31" id="Fact005025" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">42,373</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40C_ecustom--DeductionOfTaxes_pn3n3_zvkgH40LOO89" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;Taxes</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfTaxes" contextRef="From2023-01-01to2023-12-31" id="Fact005027" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">142,825</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfTaxes" contextRef="From2022-01-012022-12-31" id="Fact005028" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">107,004</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfTaxes" contextRef="From2021-01-012021-12-31" id="Fact005029" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">74,232</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_405_ecustom--DeductionOfProuni_pn3n3_zvB87VooQBn" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;PROUNI</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfProuni" contextRef="From2023-01-01to2023-12-31" id="Fact005031" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">287,338</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfProuni" contextRef="From2022-01-012022-12-31" id="Fact005032" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">225,506</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:DeductionOfProuni" contextRef="From2021-01-012021-12-31" id="Fact005033" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">176,921</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--RevenueFromContractsWithCustomers_pn3n3_zifnEgvdKpp2" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>Revenue from contracts with customers</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="From2023-01-01to2023-12-31" id="Fact005035" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="From2022-01-012022-12-31" id="Fact005036" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,329,057</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b><ix:nonFraction name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="From2021-01-012021-12-31" id="Fact005037" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_zQUWx9J7t8ff" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>Timing of revenue recognition of revenue from contracts with customers:</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--FeeAndCommissionIncome_pn3n3_zj1zLfWnUIA3" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Tuition, digital content and app subscription fees - Transferred over time</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2023-01-01to2023-12-31" id="Fact005043" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,821,251</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2022-01-012022-12-31" id="Fact005044" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,273,578</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2021-01-012021-12-31" id="Fact005045" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,640,889</ix:nonFraction></span></td></tr>
  <tr id="xdx_401_ecustom--NetRevenueOtherTransferredPoint_pn3n3_zjDCMstxDC6e" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Other - Transferred at a point in time</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2023-01-01to2023-12-31" id="Fact005047" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,662</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2022-01-012022-12-31" id="Fact005048" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,479</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2021-01-012021-12-31" id="Fact005049" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">78,482</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A9_zJhXqCdkot71" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">The Company&#8217;s revenue from contracts
with customers are all in Brazil. The Company is not subject to the payment of the Social Integration Program tax (Programa de Integra&#231;&#227;o
Social, or PIS) and the Social Contribution on Revenue tax (Contribui&#231;&#227;o para o Financiamento da Seguridade Social, or COFINS)
on the revenue from under graduation degrees under the PROUNI program.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">The table below presents statements of
income for the Company&#8217;s operating segments for the years ended December 31, 2023, 2022 and 2021:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005051" name="afya:ScheduleOfRevenueBySegmentTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_897_ecustom--ScheduleOfRevenueBySegmentTableTextBlock_pn3n3_zYeN0mE0ZXFe" summary="xdx: Disclosure - Revenue (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span id="xdx_8BC_zLB23Iq3EQPg" style="display: none">Schedule of revenue by segment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: -0.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zi0ZP7NAhEbe" title="Types of services or goods" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2023-01-012023-12-31_custom_UndergradMember" id="Fact005053" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,511,018</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z3TEEuYkhEo4" title="Types of services or goods" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember" id="Fact005055" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">146,827</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zAzJ1KuKMhUf" title="Types of services or goods" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2023-01-012023-12-31_custom_DigitalServicesMember" id="Fact005057" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">229,285</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zn2QPvTh437l" title="Types of services or goods" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact005059" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</b></span></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231_zKtBvJTdd82g" title="Types of services or goods" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2023-01-01to2023-12-31" id="Fact005061" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_98B_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zISyUUEzkRoc" title="Tuition fees" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2023-01-012023-12-31_custom_UndergradMember" id="Fact005063" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,494,121</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zuipgDQ2Xuh7" title="Tuition fees" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember" id="Fact005065" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">146,477</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zgqcuZM55Fvc" title="Tuition fees" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5067">-</span></span></td>
    <td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zM8zwEXoyww4" title="Tuition fees" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5069">-</span></span></td>
    <td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231_zB9QgWnGCdNl" title="Tuition fees" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2023-01-01to2023-12-31" id="Fact005071" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,640,598</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zy90ntUDoZRd" title="Other" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2023-01-012023-12-31_custom_UndergradMember" id="Fact005073" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,897</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7luo5JNsp16" title="Other" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember" id="Fact005075" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">350</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zzNooKxN9xl4" title="Other" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2023-01-012023-12-31_custom_DigitalServicesMember" id="Fact005077" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">229,285</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zrvYooQ9jcLi" title="Other" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact005079" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231_zc4LmfnEaQad" title="Other" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2023-01-01to2023-12-31" id="Fact005081" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235,315</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_z693lSPU446" title="Timing of revenue recognition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2023-01-012023-12-31_custom_UndergradMember" id="Fact005083" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,511,018</ix:nonFraction></b></span></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj839nXLhoB1" title="Timing of revenue recognition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember" id="Fact005085" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">146,827</ix:nonFraction></b></span></td>
    <td id="xdx_982_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zkryQ0ogpLc4" title="Timing of revenue recognition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2023-01-012023-12-31_custom_DigitalServicesMember" id="Fact005087" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">229,285</ix:nonFraction></b></span></td>
    <td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zNRuFiSGn6vk" title="Timing of revenue recognition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact005089" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</b></span></td>
    <td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231_z6VZkjduxU9k" title="Timing of revenue recognition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2023-01-01to2023-12-31" id="Fact005091" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zpQcRHDtECl6" title="Transferred over time" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2023-01-012023-12-31_custom_UndergradMember" id="Fact005093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,494,121</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zb4nPaGgjvHb" title="Transferred over time" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember" id="Fact005095" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">146,827</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zP3BPBeb1ej7" title="Transferred over time" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2023-01-012023-12-31_custom_DigitalServicesMember" id="Fact005097" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">191,520</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zMZqSEbuQcy4" title="Transferred over time" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact005099" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231_zEC2CgkqhdB8" title="Transferred over time" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2023-01-01to2023-12-31" id="Fact005101" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,821,251</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in time</span></td>
    <td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zvwDIInIJVu" title="Transferred at a point in time" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2023-01-012023-12-31_custom_UndergradMember" id="Fact005103" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,897</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7tg3Vfmfxc9" title="Transferred at a point in time" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5105">-</span></span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0rOvSDeONg7" title="Transferred at a point in time" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2023-01-012023-12-31_custom_DigitalServicesMember" id="Fact005107" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,765</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_ztHSmt5Fr2lc" title="Transferred at a point in time" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5109">-</span></span></td>
    <td id="xdx_98E_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231_z04tHxkw1m65" title="Transferred at a point in time" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2023-01-01to2023-12-31" id="Fact005111" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,662</ix:nonFraction></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 233 -->
    <div id="xdx_230_zkDh2A3BPXF2" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_233_zcJ4bJoSuzm7" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zQj3CnyMJZk3" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_234_zgRfrlKQR57j" style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: -0.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_98B_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQ9uzv3KS3x2" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2022-01-012022-12-31_custom_UndergradMember" id="Fact005115" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,037,889</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7AzcS5SYmsb" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2022-01-012022-12-31_custom_ContinuingEducationMember" id="Fact005117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,806</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zGfMf0AXWjk" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2022-01-012022-12-31_custom_DigitalServicesMember" id="Fact005119" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">189,984</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zwlcrNDR31k" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact005121" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,622</ix:nonFraction>)</b></span></td>
    <td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231_z1oJNuCApja3" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2022-01-012022-12-31" id="Fact005123" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,329,057</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zfiWouZlsJ6d" title="Tuition fees" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2022-01-012022-12-31_custom_UndergradMember" id="Fact005125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,023,128</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zz4Tkh7VbVQa" title="Tuition fees" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2022-01-012022-12-31_custom_ContinuingEducationMember" id="Fact005127" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,648</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zkm0oXD1pMal" title="Tuition fees" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5129">-</span></span></td>
    <td id="xdx_98B_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zj0KHscAEw7e" title="Tuition fees" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5131">-</span></span></td>
    <td id="xdx_980_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231_zEHSri1DoqWk" title="Tuition fees" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2022-01-012022-12-31" id="Fact005133" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,131,776</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zHqJpB7G0MXd" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2022-01-012022-12-31_custom_UndergradMember" id="Fact005135" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,761</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z5VjxSw1Mnej" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2022-01-012022-12-31_custom_ContinuingEducationMember" id="Fact005137" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">158</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrBSxDtJMa7g" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2022-01-012022-12-31_custom_DigitalServicesMember" id="Fact005139" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">189,984</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zDTJ3NPMQ4L4" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact005141" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,622</ix:nonFraction>)</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231_zR24lXnHcO73" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2022-01-012022-12-31" id="Fact005143" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">197,281</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zBdqUnzNNjtl" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2022-01-012022-12-31_custom_UndergradMember" id="Fact005145" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,037,889</ix:nonFraction></b></span></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z1wI19CkMpC1" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2022-01-012022-12-31_custom_ContinuingEducationMember" id="Fact005147" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,806</ix:nonFraction></b></span></td>
    <td id="xdx_98A_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zSncGdjYg1z3" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2022-01-012022-12-31_custom_DigitalServicesMember" id="Fact005149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">189,984</ix:nonFraction></b></span></td>
    <td id="xdx_98E_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zPijWuOF51W4" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact005151" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,622</ix:nonFraction>)</b></span></td>
    <td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231_zZ7zF2FahVs4" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2022-01-012022-12-31" id="Fact005153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,329,057</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqLQFUfnWqD7" title="Transferred over time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2022-01-012022-12-31_custom_UndergradMember" id="Fact005155" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,024,373</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zfyDXLtSlg5e" title="Transferred over time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2022-01-012022-12-31_custom_ContinuingEducationMember" id="Fact005157" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,806</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z4roRCgvHBkk" title="Transferred over time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2022-01-012022-12-31_custom_DigitalServicesMember" id="Fact005159" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">145,939</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zeDCAinVuQO2" title="Transferred over time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact005161" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,540</ix:nonFraction>)</span></td>
    <td id="xdx_984_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231_znnnB9B3fWTb" title="Transferred over time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2022-01-012022-12-31" id="Fact005163" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,273,578</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in time</span></td>
    <td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zKSWsRcjNfi9" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2022-01-012022-12-31_custom_UndergradMember" id="Fact005165" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,516</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znBWIkid4crl" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5167">-</span></span></td>
    <td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zC2BilU7YKg2" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2022-01-012022-12-31_custom_DigitalServicesMember" id="Fact005169" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,045</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zJJ1A9BQuwDb" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact005171" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,082</ix:nonFraction>)</span></td>
    <td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231_zfmFpyOK6dXj" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2022-01-012022-12-31" id="Fact005173" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,479</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_989_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zZxFCjZ6r5ie" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2021-01-012021-12-31_custom_UndergradMember" id="Fact005175" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,498,408</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zuLSwLLKmn2a" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember" id="Fact005177" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,983</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zBR5ly7nxCE" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember" id="Fact005179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">151,958</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zpogD8yKpbGj" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact005181" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,978</ix:nonFraction>)</b></span></td>
    <td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231_zJyTK0ykkOS7" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2021-01-012021-12-31" id="Fact005183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_987_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zZjXDbIvuRi9" title="Tuition fees" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2021-01-012021-12-31_custom_UndergradMember" id="Fact005185" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,486,111</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zaDp4rTLcIE8" title="Tuition fees" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember" id="Fact005187" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,983</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zv1OXCLX4i5" title="Tuition fees" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5189">-</span></span></td>
    <td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zFmDKQXGjsg5" title="Tuition fees" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5191">-</span></span></td>
    <td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231_z3KM0dsLcufj" title="Tuition fees" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2021-01-012021-12-31" id="Fact005193" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,559,094</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zaWzuaj8hPwe" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2021-01-012021-12-31_custom_UndergradMember" id="Fact005195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,297</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zmWHomzrJQLe" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5197">-</span></span></td>
    <td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjLntB2JdBp2" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember" id="Fact005199" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">151,958</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zlJiGX2JoqDd" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact005201" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,978</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231_zKkpucWMzCL1" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2021-01-012021-12-31" id="Fact005203" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">160,277</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zrWrviu9ORm2" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2021-01-012021-12-31_custom_UndergradMember" id="Fact005205" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,498,408</ix:nonFraction></b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zVJQuehlkY3i" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember" id="Fact005207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,983</ix:nonFraction></b></span></td>
    <td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zGMiHnPqPGRh" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember" id="Fact005209" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">151,958</ix:nonFraction></b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zmn1hMMQ44tc" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact005211" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,978</ix:nonFraction>)</b></span></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231_zIIrnf2aaSWl" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2021-01-012021-12-31" id="Fact005213" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zeb6DMrsKRP1" title="Transferred over time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2021-01-012021-12-31_custom_UndergradMember" id="Fact005215" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,486,111</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zmucLbC6xnUl" title="Transferred over time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember" id="Fact005217" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,983</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zmOf4zHFDOt3" title="Transferred over time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember" id="Fact005219" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">81,795</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z14jonW2j8rc" title="Transferred over time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5221">-</span></span></td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231_zTeq3L4xEou" title="Transferred over time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2021-01-012021-12-31" id="Fact005223" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,640,889</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in time</span></td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zTlNEe34zHqf" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2021-01-012021-12-31_custom_UndergradMember" id="Fact005225" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,297</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zIRJ5K2ZkY44" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5227">-</span></span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z7iVqnvXaiz4" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember" id="Fact005229" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,163</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_za2aC8xbX7m" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact005231" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,978</ix:nonFraction>)</span></td>
    <td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231_ztARH3Qyy1T5" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2021-01-012021-12-31" id="Fact005233" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">78,482</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_zyEqTRdfdRWl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005235" name="ifrs-full:DisclosureOfExpensesByNatureExplanatory"><p id="xdx_804_eifrs-full--DisclosureOfExpensesByNatureExplanatory_zoroR9a7ZPqa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>20</b></td><td><b><span id="xdx_824_zaRDdm9ppif2">Expenses and costs by nature</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005237" name="afya:SummaryOfExpensesByNatureTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_884_ecustom--SummaryOfExpensesByNatureTableTextBlock_pn3n3_zfdljIcQLPa5" summary="xdx: Disclosure - Expenses and costs by nature (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BE_zl35bW6LMvNe" style="display: none">Schedule of expenses by nature</span></td>
    <td id="xdx_491_20230101__20231231_zLMbmlAE426i" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49B_20220101__20221231_zWeF1SzHqZLc" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49F_20210101__20211231_zHcU4TYvXS4f" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td></tr>
<tr>
    <td style="width: 46%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2021</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--CostOfSales_iN_pn3n3_di_z9lzEJIic082" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Cost of services</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2023-01-01to2023-12-31" id="Fact005239" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,109,813</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2022-01-012022-12-31" id="Fact005240" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">859,552</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2021-01-012021-12-31" id="Fact005241" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">652,300</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--GeneralAndAdministrativeExpense_iN_pn3n3_di_zwHCywEaduul" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Selling, general and administrative expenses</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2023-01-01to2023-12-31" id="Fact005243" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,014,684</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31" id="Fact005244" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">798,153</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2021-01-012021-12-31" id="Fact005245" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">622,615</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_402_eifrs-full--ExpenseByNature_iN_pn3n3_di_zZgzKIs284T8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b style="display: none">Total</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(<ix:nonFraction name="ifrs-full:ExpenseByNature" contextRef="From2023-01-01to2023-12-31" id="Fact005247" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,124,497</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(<ix:nonFraction name="ifrs-full:ExpenseByNature" contextRef="From2022-01-012022-12-31" id="Fact005248" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,657,705</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(<ix:nonFraction name="ifrs-full:ExpenseByNature" contextRef="From2021-01-012021-12-31" id="Fact005249" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,274,915</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--Payroll_pn3n3_zxs1ZZSg5kS" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payroll</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:Payroll" contextRef="From2023-01-01to2023-12-31" id="Fact005251" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,085,144</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:Payroll" contextRef="From2022-01-012022-12-31" id="Fact005252" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">880,664</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:Payroll" contextRef="From2021-01-012021-12-31" id="Fact005253" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">677,564</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40F_ecustom--HospitalAndMedicalAgreements_pn3n3_zlphn7Uriw63" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Hospital and medical agreements</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:HospitalAndMedicalAgreements" contextRef="From2023-01-01to2023-12-31" id="Fact005255" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">86,151</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:HospitalAndMedicalAgreements" contextRef="From2022-01-012022-12-31" id="Fact005256" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">66,065</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:HospitalAndMedicalAgreements" contextRef="From2021-01-012021-12-31" id="Fact005257" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">37,449</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--DepreciationExpense_iN_pn3n3_di_zyIEmwhLbal" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation and amortization</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2023-01-01to2023-12-31" id="Fact005259" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">289,511</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2022-01-012022-12-31" id="Fact005260" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">206,220</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2021-01-012021-12-31" id="Fact005261" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">154,220</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_400_ecustom--LeaseExpenses_pn3n3_zVrgo5WrYMe3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease expenses</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:LeaseExpenses" contextRef="From2023-01-01to2023-12-31" id="Fact005263" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,871</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:LeaseExpenses" contextRef="From2022-01-012022-12-31" id="Fact005264" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,153</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:LeaseExpenses" contextRef="From2021-01-012021-12-31" id="Fact005265" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,229</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_407_eifrs-full--UtilitiesExpense_pn3n3_zDPxw4HSsQD8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Utilities</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:UtilitiesExpense" contextRef="From2023-01-01to2023-12-31" id="Fact005267" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,403</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:UtilitiesExpense" contextRef="From2022-01-012022-12-31" id="Fact005268" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,682</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:UtilitiesExpense" contextRef="From2021-01-012021-12-31" id="Fact005269" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,643</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_402_eifrs-full--RepairsAndMaintenanceExpense_iN_pn3n3_di_z8HqLPNNcpic" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Maintenance</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:RepairsAndMaintenanceExpense" contextRef="From2023-01-01to2023-12-31" id="Fact005271" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">105,919</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:RepairsAndMaintenanceExpense" contextRef="From2022-01-012022-12-31" id="Fact005272" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,475</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:RepairsAndMaintenanceExpense" contextRef="From2021-01-012021-12-31" id="Fact005273" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">47,141</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40C_ecustom--SharesBasedCompensation_pn3n3_zF0LsEahKDA3" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share-based compensation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:SharesBasedCompensation" contextRef="From2023-01-01to2023-12-31" id="Fact005275" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,535</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:SharesBasedCompensation" contextRef="From2022-01-012022-12-31" id="Fact005276" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,274</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:SharesBasedCompensation" contextRef="From2021-01-012021-12-31" id="Fact005277" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">43,377</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_409_ecustom--TaxExpenses_pn3n3_zYSaAQpnfqB8" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tax expenses</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:TaxExpenses" contextRef="From2023-01-01to2023-12-31" id="Fact005279" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,447</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:TaxExpenses" contextRef="From2022-01-012022-12-31" id="Fact005280" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,518</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:TaxExpenses" contextRef="From2021-01-012021-12-31" id="Fact005281" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,997</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40D_eifrs-full--ServicesExpense_iN_pn3n3_di_zpVtYAfw4CBf" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Pedagogical services</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:ServicesExpense" contextRef="From2023-01-01to2023-12-31" id="Fact005283" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,081</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:ServicesExpense" contextRef="From2022-01-012022-12-31" id="Fact005284" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,084</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:ServicesExpense" contextRef="From2021-01-012021-12-31" id="Fact005285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">47,881</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--SalesAndMarketingExpense_iN_pn3n3_di_zzIlxPHPw6v3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Sales and marketing</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:SalesAndMarketingExpense" contextRef="From2023-01-01to2023-12-31" id="Fact005287" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,140</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:SalesAndMarketingExpense" contextRef="From2022-01-012022-12-31" id="Fact005288" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,217</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:SalesAndMarketingExpense" contextRef="From2021-01-012021-12-31" id="Fact005289" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,506</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40C_ecustom--AllowanceForExpectedCreditLosses_pn3n3_z5XH2J91guek" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Allowance for expected credit losses</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2023-01-01to2023-12-31" id="Fact005291" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">74,552</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2022-01-012022-12-31" id="Fact005292" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">42,708</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2021-01-012021-12-31" id="Fact005293" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">47,819</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--TravelExpense_iN_pn3n3_di_zV4ukGYKc7B5" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Travel expenses</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:TravelExpense" contextRef="From2023-01-01to2023-12-31" id="Fact005295" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,098</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:TravelExpense" contextRef="From2022-01-012022-12-31" id="Fact005296" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,003</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:TravelExpense" contextRef="From2021-01-012021-12-31" id="Fact005297" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,542</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40D_ecustom--ConsultingFees_pn3n3_zoyNP63WDNx7" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Consulting fees</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:ConsultingFees" contextRef="From2023-01-01to2023-12-31" id="Fact005299" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">62,630</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:ConsultingFees" contextRef="From2022-01-012022-12-31" id="Fact005300" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">35,326</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:ConsultingFees" contextRef="From2021-01-012021-12-31" id="Fact005301" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">38,818</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40E_ecustom--Other_pn3n3_zZaZ1uhnusJj" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:Other" contextRef="From2023-01-01to2023-12-31" id="Fact005303" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">189,015</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:Other" contextRef="From2022-01-012022-12-31" id="Fact005304" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">168,316</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:Other" contextRef="From2021-01-012021-12-31" id="Fact005305" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">103,729</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40C_ecustom--ExpenseByNatureOne_pn3n3_zBmYGmeYmzgl" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b style="display: none">Total</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(<ix:nonFraction name="afya:ExpenseByNatureOne" contextRef="From2023-01-01to2023-12-31" id="Fact005307" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,124,497</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(<ix:nonFraction name="afya:ExpenseByNatureOne" contextRef="From2022-01-012022-12-31" id="Fact005308" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,657,705</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(<ix:nonFraction name="afya:ExpenseByNatureOne" contextRef="From2021-01-012021-12-31" id="Fact005309" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,274,915</ix:nonFraction>)</b></span></td></tr>
  </table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 234 -->
    <div id="xdx_231_zjKdzGToA7Z9" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_235_zsyvoWc2xHIf" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005311" name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory"><p id="xdx_808_eifrs-full--DisclosureOfFinanceIncomeExpenseExplanatory_zdhfhvX96DFe" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>21</b></td><td><b><span id="xdx_822_zTixJmUYcWqc">Finance result</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005313" name="afya:ScheduleOfFinanceResultTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_888_ecustom--ScheduleOfFinanceResultTableTextBlock_zFCcfPpIzMbf" summary="xdx: Disclosure - Finance result (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zysruc05zkJ2" style="display: none">Schedule of finance result</span></td>
    <td id="xdx_493_20230101__20231231_zB1aXru0IUpa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_499_20220101__20221231_zOpB2wKCv3nl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49C_20210101__20211231_zXwR7e35HFp" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--InvestmentIncome_pn3n3_z8DyQCHSraPi" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income from financial investments</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InvestmentIncome" contextRef="From2023-01-01to2023-12-31" id="Fact005315" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">73,672</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InvestmentIncome" contextRef="From2022-01-012022-12-31" id="Fact005316" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,810</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InvestmentIncome" contextRef="From2021-01-012021-12-31" id="Fact005317" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,773</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--RevenueFromInterest_pn3n3_zr6uiRUlIq0h" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest received</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From2023-01-01to2023-12-31" id="Fact005319" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,450</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From2022-01-012022-12-31" id="Fact005320" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,197</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From2021-01-012021-12-31" id="Fact005321" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,040</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_eifrs-full--OtherFinanceIncome_pn3n3_zZCv6TxcaGa8" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherFinanceIncome" contextRef="From2023-01-01to2023-12-31" id="Fact005323" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,520</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherFinanceIncome" contextRef="From2022-01-012022-12-31" id="Fact005324" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,035</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherFinanceIncome" contextRef="From2021-01-012021-12-31" id="Fact005325" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,753</ix:nonFraction></span></td></tr>
  <tr id="xdx_40D_eifrs-full--FinanceIncome_pn3n3_zaLIzb89Yo15" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance income</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2023-01-01to2023-12-31" id="Fact005327" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,642</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2022-01-012022-12-31" id="Fact005328" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">102,042</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2021-01-012021-12-31" id="Fact005329" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,566</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_408_ecustom--InterestExpense1_pn3n3_z4uac0wnG8d4" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:InterestExpense1" contextRef="From2023-01-01to2023-12-31" id="Fact005331" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">285,447</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:InterestExpense1" contextRef="From2022-01-012022-12-31" id="Fact005332" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">200,081</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:InterestExpense1" contextRef="From2021-01-012021-12-31" id="Fact005333" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">108,437</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40B_ecustom--InterestExpenseOnLeaseLiabilities1_pn3n3_zL7kY0iBWH3g" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense on lease liabilities</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:InterestExpenseOnLeaseLiabilities1" contextRef="From2023-01-01to2023-12-31" id="Fact005335" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">100,849</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:InterestExpenseOnLeaseLiabilities1" contextRef="From2022-01-012022-12-31" id="Fact005336" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">88,571</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:InterestExpenseOnLeaseLiabilities1" contextRef="From2021-01-012021-12-31" id="Fact005337" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">67,212</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40F_ecustom--FinancialDiscountsGrantedExpenses_pn3n3_zbFKVp3xCoe" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Financial discounts granted</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:FinancialDiscountsGrantedExpenses" contextRef="From2023-01-01to2023-12-31" id="Fact005339" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">30,891</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:FinancialDiscountsGrantedExpenses" contextRef="From2022-01-012022-12-31" id="Fact005340" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">24,092</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:FinancialDiscountsGrantedExpenses" contextRef="From2021-01-012021-12-31" id="Fact005341" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">23,193</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_400_eifrs-full--BankAndSimilarCharges_iN_pn3n3_di_zx7WykHrEgmi" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bank fees</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:BankAndSimilarCharges" contextRef="From2023-01-01to2023-12-31" id="Fact005343" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,163</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:BankAndSimilarCharges" contextRef="From2022-01-012022-12-31" id="Fact005344" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,623</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:BankAndSimilarCharges" contextRef="From2021-01-012021-12-31" id="Fact005345" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,878</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_405_eifrs-full--NetForeignExchangeLoss_iN_pn3n3_di_zXz9mKYFxafi" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Foreign exchange loss, net</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NetForeignExchangeLoss" contextRef="From2023-01-01to2023-12-31" id="Fact005347" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">681</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NetForeignExchangeLoss" contextRef="From2022-01-012022-12-31" id="Fact005348" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">852</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NetForeignExchangeLoss" contextRef="From2021-01-012021-12-31" id="Fact005349" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,973</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_405_ecustom--TaxOnFinancialOperations_pn3n3_zhEMHixPeMT1" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IOF taxes (taxes on financial transactions)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TaxOnFinancialOperations" contextRef="From2023-01-01to2023-12-31" id="Fact005351" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,947</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TaxOnFinancialOperations" contextRef="From2022-01-012022-12-31" id="Fact005352" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">178</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TaxOnFinancialOperations" contextRef="From2021-01-012021-12-31" id="Fact005353" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,306</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_400_eifrs-full--OtherFinanceCost_iN_pn3n3_di_zShhuNZiILe4" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:OtherFinanceCost" contextRef="From2023-01-01to2023-12-31" id="Fact005355" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,638</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:OtherFinanceCost" contextRef="From2022-01-012022-12-31" id="Fact005356" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,496</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:OtherFinanceCost" contextRef="From2021-01-012021-12-31" id="Fact005357" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,797</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_409_eifrs-full--FinanceCosts_iN_pn3n3_di_z4ojR9SPoIwd" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance expenses</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2023-01-01to2023-12-31" id="Fact005359" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">457,616</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2022-01-012022-12-31" id="Fact005360" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">349,893</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2021-01-012021-12-31" id="Fact005361" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">243,796</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--FinanceResult_pn3n3_zOFbUfqRwHU6" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance result</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:FinanceResult" contextRef="From2023-01-01to2023-12-31" id="Fact005363" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">346,974</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:FinanceResult" contextRef="From2022-01-012022-12-31" id="Fact005364" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">247,851</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:FinanceResult" contextRef="From2021-01-012021-12-31" id="Fact005365" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">179,230</ix:nonFraction>)</b></span></td></tr>
  </table></ix:nonNumeric>
</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005367" name="afya:DisclosureOfIncomeTaxesExplanatory"><p id="xdx_808_ecustom--DisclosureOfIncomeTaxesExplanatory_z24BJebmWxMb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>22</b></td><td><b><span id="xdx_82B_zTsPcwNP20Td">Income taxes</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Income taxes are comprised of taxation over operations in Brazil, related
to Corporate Income Tax ("IRPJ") and Social Contribution on Net Profit ("CSLL"). According to Brazilian tax legislation,
income taxes and social contribution are assessed and paid by legal entity and not on a consolidated basis.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Reconciliation of income taxes expense</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-weight: normal">The table below is a
reconciliation of income tax expense to profit for the year, calculated by applying the combined Brazilian statutory rates at 34% for
the years ended December 31, 2023, 2022 and 2021:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005369" name="afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_89E_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_z0ZfbEW2o3Kl" summary="xdx: Disclosure - Income taxes (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: White">
    <td style="white-space: nowrap"><span id="xdx_8B9_z0wBWQB93Ms1" style="display: none">Schedule of reconciliation of income tax expense</span></td>
    <td id="xdx_496_20230101__20231231_zMYAmTrC9ZKc" style="vertical-align: bottom; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_499_20220101__20221231_zM9haULjtd83" style="vertical-align: bottom; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_493_20210101__20211231_zQVh9XsezGlg" style="vertical-align: bottom; text-align: center; line-height: 115%">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 46%">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2021</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zX3IuBaK0bf4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income before income taxes</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2023-01-01to2023-12-31" id="Fact005371" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">429,582</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2022-01-012022-12-31" id="Fact005372" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">428,433</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-012021-12-31" id="Fact005373" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">273,462</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_eifrs-full--ApplicableTaxRate_pid_dp_zNs4jixl3bt6" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Combined statutory income taxes rate - %</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2023-01-01to2023-12-31" id="Fact005375" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">34</ix:nonFraction>%</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2022-01-012022-12-31" id="Fact005376" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">34</ix:nonFraction>%</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2021-01-012021-12-31" id="Fact005377" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">34</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_406_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pn3n3_zQ9TPK77mgUj" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes at statutory rates</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" contextRef="From2023-01-01to2023-12-31" id="Fact005379" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">146,058</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" contextRef="From2022-01-012022-12-31" id="Fact005380" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">145,667</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" contextRef="From2021-01-012021-12-31" id="Fact005381" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">92,977</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_405_ecustom--ReconciliationAdjustmentsAbstract_iB_pn3n3_zvRRDuKiX1v7" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reconciliation adjustments:</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_409_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pn3n3_z6DWPRcfgcDe" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tax effect on loss from entities not subject to taxation</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" contextRef="From2023-01-01to2023-12-31" id="Fact005387" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">32,274</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" contextRef="From2022-01-012022-12-31" id="Fact005388" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">32,859</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" contextRef="From2021-01-012021-12-31" id="Fact005389" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">37,794</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_401_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pn3n3_zaZp3u2abVuh" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">PROUNI - Fiscal Incentive (i)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ProgramaUniversidadeParaTodosFiscalIncentive" contextRef="From2023-01-01to2023-12-31" id="Fact005391" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">309,952</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ProgramaUniversidadeParaTodosFiscalIncentive" contextRef="From2022-01-012022-12-31" id="Fact005392" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">270,062</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:ProgramaUniversidadeParaTodosFiscalIncentive" contextRef="From2021-01-012021-12-31" id="Fact005393" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">194,830</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_ecustom--UnrecognisedDeferredTaxAssets_pn3n3_zvEmwvIZLIua" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Unrecognized deferred tax assets</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:UnrecognisedDeferredTaxAssets" contextRef="From2023-01-01to2023-12-31" id="Fact005395" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">154,062</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:UnrecognisedDeferredTaxAssets" contextRef="From2022-01-012022-12-31" id="Fact005396" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">117,377</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:UnrecognisedDeferredTaxAssets" contextRef="From2021-01-012021-12-31" id="Fact005397" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">86,233</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_407_ecustom--RecognisedDeferredTaxAssets_pn3n3_zscGF7xEYmqe" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Recognized deferred tax assets</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="afya:RecognisedDeferredTaxAssets" contextRef="From2023-01-01to2023-12-31" id="Fact005399" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,233</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl5400">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl5401">-</span></span></td></tr>
  <tr id="xdx_403_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_iN_pn3n3_di_zHCeXWnO33ig" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Presumed profit income tax regime effect (ii)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" contextRef="From2023-01-01to2023-12-31" id="Fact005403" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,787</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" contextRef="From2022-01-012022-12-31" id="Fact005404" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,549</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" contextRef="From2021-01-012021-12-31" id="Fact005405" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,066</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_402_ecustom--PermanentAdjustments_pn3n3_zMCum4XkC7Cl" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Permanent adjustments</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:PermanentAdjustments" contextRef="From2023-01-01to2023-12-31" id="Fact005407" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,687</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:PermanentAdjustments" contextRef="From2022-01-012022-12-31" id="Fact005408" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,226</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(<ix:nonFraction name="afya:PermanentAdjustments" contextRef="From2021-01-012021-12-31" id="Fact005409" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,232</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40D_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_pn3n3_zNMf0z9h5Ib1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:TaxExpenseOtherThanIncomeTaxExpense" contextRef="From2023-01-01to2023-12-31" id="Fact005411" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,517</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:TaxExpenseOtherThanIncomeTaxExpense" contextRef="From2022-01-012022-12-31" id="Fact005412" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,939</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:TaxExpenseOtherThanIncomeTaxExpense" contextRef="From2021-01-012021-12-31" id="Fact005413" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,293</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--CurrentTaxExpenseIncome_pn3n3_zUrRtF3ayOx1" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes expense - current</span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(<ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="From2023-01-01to2023-12-31" id="Fact005415" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">24,166</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(<ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="From2022-01-012022-12-31" id="Fact005416" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">35,677</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(<ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="From2021-01-012021-12-31" id="Fact005417" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,179</ix:nonFraction>)</b></span></td></tr>
  <tr id="xdx_400_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_zOWlunh9KMe4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effective rate</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:TaxRateEffectFromChangeInTaxRate" contextRef="From2023-01-01to2023-12-31" id="Fact005419" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.62</ix:nonFraction>%</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:TaxRateEffectFromChangeInTaxRate" contextRef="From2022-01-012022-12-31" id="Fact005420" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.33</ix:nonFraction>%</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><ix:nonFraction name="ifrs-full:TaxRateEffectFromChangeInTaxRate" contextRef="From2021-01-012021-12-31" id="Fact005421" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.40</ix:nonFraction>%</span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">The Company adhered to PROUNI, established by Law 11,096 / 2005, which is a federal program
that exempts companies of paying income taxes and social contribution upon compliance with certain requirements required by said Law.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"/><td style="text-align: justify">Brazilian tax law establishes that companies that generate gross revenues of up to R$78,000
in the prior fiscal year may calculate income taxes as a percentage of gross revenue, using the presumed profit tax regime. The effect
of the presumed profit of certain subsidiaries represents the difference between the taxation based on this method and the amount that
would be due based on the statutory rate applied to the taxable profit of the subsidiaries.<br/></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AA_zqdPE0dPTsr4" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 235 -->
    <div id="xdx_236_zbua0Y78yC98" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_235_zxOgCZFPDa9e" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 10.9pt; text-indent: -10.9pt; color: #C00000">Deferred income taxes</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">As of December 31, 2023, the Company had accumulated unrecognized deferred
income tax assets on temporary differences and tax losses in the amount of R$<span id="xdx_906_eifrs-full--DeferredTaxExpenseIncome_pn3n3_c20230101__20231231_zMJZAHVrVsa9" title="Unrecognized deferred income tax assets"><ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncome" contextRef="From2023-01-01to2023-12-31" id="Fact005423" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,211,909</ix:nonFraction></span> (tax-basis) (December 31, 2022: R$<span id="xdx_905_eifrs-full--DeferredTaxExpenseIncome_pn3n3_c20220101__20221231_zDev7o4A6mC9" title="Unrecognized deferred income tax assets"><ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncome" contextRef="From2022-01-012022-12-31" id="Fact005425" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">778,080</ix:nonFraction></span> (tax-basis))
which does not have any tax planning opportunities available that could support the recognition of these temporary differences as deferred
tax assets. Accordingly, the Company did not recognize deferred tax assets over these amounts, except the amount as of R$<span id="xdx_902_ecustom--RecognizedDeferredTaxAssets_iI_pn3n3_c20231231__ifrs-full--SegmentsAxis__custom--OneSubsidiaryMember_z22Z42u4NxDe" title="Recognized deferred income tax assets"><ix:nonFraction name="afya:RecognizedDeferredTaxAssets" contextRef="AsOf2023-12-31_custom_OneSubsidiaryMember" id="Fact005427" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,508</ix:nonFraction></span> of tax
basis from one subsidiary, where the Company recognize deferred tax assets that is expected to be compensated in next years.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005429" name="afya:DisclosureOfInsuranceContractsAndContingenciesExplanatory"><p id="xdx_80F_ecustom--DisclosureOfInsuranceContractsAndContingenciesExplanatory_zMmZukpJabKd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>23</b></td><td><b><span id="xdx_827_zvlwkEEDUlD9">Insurance contracts and contingencies</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>a) Insurance contracts</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company and its subsidiaries have a risk management program with the
purpose of delimiting the risks, seeking in the market coverage compatible with its size and operations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b) Legal proceedings and contingencies</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The provisions related to labor, civil and taxes proceedings whose likelihood
of loss is assessed as probable are as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005431" name="afya:ScheduleOfLegalProceedingsAndContingencies"><table cellspacing="0" cellpadding="0" id="xdx_891_ecustom--ScheduleOfLegalProceedingsAndContingencies_zybwi3fywxDd" summary="xdx: Disclosure - Insurance contracts and contingencies (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BE_zC3Fs1DV8usk" style="display: none">Schedule of legal proceedings and contingencies</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 39%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Labor</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Civil</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Taxes</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances as of December 31, 2020</b></span></td>
    <td id="xdx_98E_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zkAEFLwgWsWf" title="Balance as of beginning of the year" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005433" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,519</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zeJEVRyDBJ6g" title="Balance as of beginning of the year" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005435" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,280</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zQjqkpw49QV" title="Balance as of beginning of the year" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005437" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,340</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zKg9FIM4sXQh" title="Balance as of beginning of the year" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005439" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,139</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business combinations</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zZbNZQTZkAxa" title="Business combinations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005441" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,597</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zRJ3dLRzO7L6" title="Business combinations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005443" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,017</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z9AmhRyjC2Fk" title="Business combinations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005445" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,638</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zTExp6siSNxi" title="Business combinations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005447" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80,252</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions </span></td>
    <td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zHdWklvfywg7" title="Additions" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005449" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,418</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuTloi09neO1" title="Additions" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005451" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,101</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z8IGVEt5w2l" title="Additions" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005453" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,225</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zKAZqSs0Ec77" title="Additions" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005455" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,744</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zFObFYsdLgRf" title="Reversals" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005457" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,044</ix:nonFraction>)</span></td>
    <td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zq63heHtDPHk" title="Reversals" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005459" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,470</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z4W12NxhRy4l" title="Reversals" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005461" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,334</ix:nonFraction>)</span></td>
    <td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zctkMbHAwS41" title="Reversals" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005463" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,848</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances as of December 31, 2021</b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgELEUzlVt3f" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005465" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,490</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zInWUUH8rfGc" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005467" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,928</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zNBuyde8auG4" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005469" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99,869</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z4jjBQdk6Pfh" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005471" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">148,287</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zaa4p2aDUa78" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005473" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,300</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zOPFThM3ldlk" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005475" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,911</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zS3IfXYifnjf" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005477" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,698</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z7A21rdqDsJf" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005479" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">73,909</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_987_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgVm3uVxqj5h" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005481" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,306</ix:nonFraction>)</span></td>
    <td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zIMOVd5S00i1" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005483" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,175</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zoRjkyJ1PWc6" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005485" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,861</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zcJdsSU4gCP6" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005487" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,342</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances as of December 31, 2022</b></span></td>
    <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zWwJ6gsnjOw1" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005489" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,484</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zTk8bzyfkLw7" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005491" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,664</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zTewyI7913L9" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005493" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">148,706</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zLKZD5wnpf6" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005495" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">195,854</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business combination</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z47gSBFcAYO7" title="Business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005497" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zDS8ELjItj52" title="Business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005499" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">88</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zzpqhMprank8" title="Business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5501">-</span></span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhNpTKiEmi5" title="Business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005503" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">152</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zzCKWAvCASWl" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005505" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,424</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zGIv7povfvL3" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005507" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,875</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zB17EajSVgGd" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005509" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,037</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z79sULeFZkRj" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005511" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,336</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals (i)</span></td>
    <td id="xdx_986_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zbr9LPc9GaP4" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005513" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,251</ix:nonFraction>)</span></td>
    <td id="xdx_98F_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zGf03daQkbmc" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005515" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,327</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zkIeF1ZbZleh" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005517" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">97,403</ix:nonFraction>)</span></td>
    <td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zNgpBoucs75k" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005519" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">109,981</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances as of December 31, 2023</b></span></td>
    <td id="xdx_98A_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zPRVY89kuhXa" title="Balance as of ending of the year" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005521" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,721</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zCHKohCTPeI4" title="Balance as of ending of the year" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005523" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,300</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zWm7ralE2xOk" title="Balance as of ending of the year" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005525" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,340</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zjJOiJq4GCMe" title="Balance as of ending of the year" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005527" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">104,361</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">On August 10, 2023, Unigranrio entered into a tax amnesty program on interest and penalties
to settle a tax proceeding with respect to ISS (tax on services) with the municipality of Rio de Janeiro, which result in a payment of
R$14,819. The selling shareholders of Unigranrio agreed to pay R$5,438 regarding this matter, which was deducted from the accounts payable
to selling shareholders. The Company had a provision of R$53,302 and an indemnification asset from the selling shareholders of R$20,000
(in light of the indemnification clauses as defined at acquisition of Unigranrio), in respect to such tax proceedings. The difference
between the provision, indemnification asset and the actual paid amount was recorded as Other income (expenses), net on the consolidated
statements of income and comprehensive income.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A8_zI4JcdacR5wi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The major labor proceedings to which the Company is a party were filed by
former employees or service providers seeking enforcement of labor rights allegedly not provided by us. The judicial proceedings relates
to employment bonds (judicial proceedings filed by former service providers), overtime, premiums for hazardous workplace conditions, statutory
severance, fines for severance payment delays, and compensation for workplace-related accidents.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The civil claims to which the Company is a party generally relate to consumer
claims, including those related to student complaints.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The tax claims to which the Company is party are mostly tax foreclosures
filed by Brazilian federal and municipal tax authorities.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 236 -->
    <div id="xdx_23E_zqECHKS2Yee2" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div id="xdx_236_zLVGVs3a4rk9" style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">There are other civil, labor, taxes and social security proceedings assessed
by Management and its legal counsels as possible risk of loss, for which no provisions are recognized, as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005529" name="afya:ScheduleOfSocialSecurityProceedingsAssessedByManagement"><table cellspacing="0" cellpadding="0" id="xdx_88C_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagement_z5p7yyyTT2k7" summary="xdx: Disclosure - Insurance contracts and contingencies (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B1_z6q7eUhZ4jv2" style="display: none">Schedule of social
    security proceedings assessed by Management</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Labor</span></td>
    <td id="xdx_986_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zN3rjculUHBh" title="Total" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember" id="Fact005531" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,683</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zVqVER4Uby4j" title="Total" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember" id="Fact005533" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,914</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Civil</span></td>
    <td id="xdx_981_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zsVNSqtEaQ3j" title="Total" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember" id="Fact005535" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,319</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2MRQw4TB9bl" title="Total" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember" id="Fact005537" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59,603</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Taxes and social security</span></td>
    <td id="xdx_989_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zhuJU4lLveEg" title="Total" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember" id="Fact005539" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,669</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_znf651RM4Sq6" title="Total" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember" id="Fact005541" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,931</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Total</b></td>
    <td id="xdx_98D_eifrs-full--OtherProvisions_iI_pn3n3_c20231231_zwOEl0M4UJQi" title="Total" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2023-12-31" id="Fact005543" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">89,671</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--OtherProvisions_iI_pn3n3_c20221231_zQzrT2Rqmn3j" title="Total" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2022-12-31" id="Fact005545" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">78,448</ix:nonFraction></b></span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company has judicial deposits, related to taxes, civil and labor proceedings,
recorded in other assets (non-current) in the amount of R$<span id="xdx_90E_ecustom--JudicialDeposits_iI_pn3n3_c20231231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zPeCG2M068xe" title="Judicial deposits"><ix:nonFraction name="afya:JudicialDeposits" contextRef="AsOf2023-12-31_custom_OtherAssetsNonCurrentMember" id="Fact005547" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,187</ix:nonFraction></span> as of December 31, 2023 (December 31, 2022: R$<span id="xdx_909_ecustom--JudicialDeposits_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zPzXZ9P9GPRe" title="Judicial deposits"><ix:nonFraction name="afya:JudicialDeposits" contextRef="AsOf2022-12-31_custom_OtherAssetsNonCurrentMember" id="Fact005549" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,693</ix:nonFraction></span>).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Under the terms of the Share Purchase and Sale Agreements ("Agreements")
between the Company and the selling shareholders of the subsidiaries acquired, the Company assesses that the selling shareholders are
exclusively responsible for any provisions (including labor, tax and civil), which are or will be the subject of a claim by any third
party, arising from the act or fact occurred, by action or omission, prior to or on the closing dates of the acquisitions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Considering that the provisions for legal proceedings recorded by the Company
that result from causes arising from events occurring prior to the closing dates of the acquisitions, any liability for the amounts to
be disbursed, in case of their effective materialization in loss, belongs exclusively to the selling shareholders. In this context, the
Agreements state that the Company and its subsidiaries are indemnified and therefore exempt from any liability related to said contingent
liabilities and, therefore, the provision amounts related to such contingencies are presented in the non-current liabilities and the correspondent
amount of R$<span id="xdx_90A_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20231231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zXUPlbVGEqEk" title="Contingencies correspondent amount"><ix:nonFraction name="afya:ContingenciesCorrespondentAmount" contextRef="AsOf2023-12-31_custom_OtherAssetsNonCurrentMember" id="Fact005551" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">81,855</ix:nonFraction></span> (December 31, 2022: R$<span id="xdx_905_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zYCST1h2fHu9" title="Contingencies correspondent amount"><ix:nonFraction name="afya:ContingenciesCorrespondentAmount" contextRef="AsOf2022-12-31_custom_OtherAssetsNonCurrentMember" id="Fact005553" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">145,300</ix:nonFraction></span>) is presented in non-current other assets.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005555" name="afya:DisclosureNoncashTransactionsExplanatory"><p id="xdx_80B_ecustom--DisclosureNoncashTransactionsExplanatory_z2yKhkIen5Ya" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>24</b></td><td><b><span id="xdx_828_zZJBPFFeQxph">Non-cash transactions</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">During the years ended December 31, 2023, 2022 and 2021, the Company carried
out non-cash transactions which are not reflected in the statements of cash flows. The main non-cash transactions are as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005557" name="afya:NonCashTransactionsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_889_ecustom--NonCashTransactionsTableTextBlock_zX9Gtt2uTYv9" summary="xdx: Disclosure - Non-cash transactions (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: White">
    <td><span id="xdx_8BF_zv0UAG0oUoZ2" style="display: none">Schedule
    of non-cash transactions</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 67%; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Issuance of shares for acquisition of iClinic</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zM9oStIYWZi9" title="Issuance of shares for acquisition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5559">-</span></span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zVnc83yDKE36" title="Issuance of shares for acquisition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5561">-</span></span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zj2vqVXci4le" title="Issuance of shares for acquisition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_IClinicMember" id="Fact005563" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,500</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Issuance of shares for acquisition of Cliquefarma</span></td>
    <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zv9e8vZ4SiPf" title="Issuance of shares for acquisition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5565">-</span></span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zRkRritwJ53k" title="Issuance of shares for acquisition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5567">-</span></span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zitgAeiaFCXa" title="Issuance of shares for acquisition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember" id="Fact005569" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,000</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Issuance of shares for acquisition of RX PRO</span></td>
    <td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zsawovGyVgfa" title="Issuance of shares for acquisition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5571">-</span></span></td>
    <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zHIakik5bL7i" title="Issuance of shares for acquisition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5573">-</span></span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zeGRggvdhfJl" title="Issuance of shares for acquisition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_RXPROMember" id="Fact005575" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,112</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement of earn-out of Al&#233;m da Medicina, CardioPapers and Glic</span></td>
    <td id="xdx_98C_ecustom--RemeasurementOfEarnOut_pn3n3_c20230101__20231231_zwNYmjkz5dfd" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RemeasurementOfEarnOut" contextRef="From2023-01-01to2023-12-31" id="Fact005577" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,556</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--RemeasurementOfEarnOut_pn3n3_c20220101__20221231_zgj6oKDoCSZa" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5579">-</span></span></td>
    <td id="xdx_980_ecustom--RemeasurementOfEarnOut_pn3n3_c20210101__20211231_zfK7P4Wk73ef" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5581">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Provision for legal proceedings with corresponding indemnification asset</span></td>
    <td id="xdx_98E_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20230101__20231231_ztPbmOAMgq39" title="Provision for legal proceedings with corresponding indemnification asset" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets" contextRef="From2023-01-01to2023-12-31" id="Fact005583" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,000</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20220101__20221231_zAzcZdv0lrhf" title="Provision for legal proceedings with corresponding indemnification asset" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets" contextRef="From2022-01-012022-12-31" id="Fact005585" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,333</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20210101__20211231_zi0x4gkt7eNd" title="Provision for legal proceedings with corresponding indemnification asset" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets" contextRef="From2021-01-012021-12-31" id="Fact005587" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,232</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions and remeasurements of right-of-use assets and lease liabilities</span></td>
    <td id="xdx_98C_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20230101__20231231_zHgJRFYaOd25" title="Additions and remeasurements of right-of-use assets and lease liabilities" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" contextRef="From2023-01-01to2023-12-31" id="Fact005589" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,715</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20220101__20221231_z53G9TtT22ae" title="Additions and remeasurements of right-of-use assets and lease liabilities" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" contextRef="From2022-01-012022-12-31" id="Fact005591" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,873</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20210101__20211231_zXmS2MAg6DMc" title="Additions and remeasurements of right-of-use assets and lease liabilities" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" contextRef="From2021-01-012021-12-31" id="Fact005593" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">158,651</ix:nonFraction></span></td></tr>
  </table></ix:nonNumeric>
</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact005595" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory"><p id="xdx_809_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zDf51uYxiqu5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>25</b></td><td><b><span id="xdx_824_ztzEJnpd5j0c">Subsequent event</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>Medical seats increase in FIP Guanambi</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On January 24, 2024, MEC authorized the increase of 40 medical seats of
Faculdades Integradas Padr&#227;o (FIP Guanambi) located in the city of Guanambi, State of Bahia, which will result in an additional
payment of R$<span id="xdx_909_ecustom--PotentialAdditionalPayment_pn3n3_c20240123__20240124__ifrs-full--TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis__custom--FaculdadesIntegradasPadraoMember_z8bTPlVtHgX6" title="Potential additional payment"><ix:nonFraction name="afya:PotentialAdditionalPayment" contextRef="From2024-01-232024-01-24_custom_FaculdadesIntegradasPadraoMember" id="Fact005597" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,600</ix:nonFraction></span>. With the authorization, Afya reaches 100 medical seats on this campus, and <span id="xdx_90A_ecustom--TotalNumberOfSeatsApporved_iI_uN_c20240124__ifrs-full--TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis__custom--FaculdadesIntegradasPadraoMember_zLbSYb63UOKd" title="Total number of seats apporved"><ix:nonFraction name="afya:TotalNumberOfSeatsApporved" contextRef="AsOf2024-01-24_custom_FaculdadesIntegradasPadraoMember" id="Fact005599" format="ixt:numdotdecimal" decimals="INF" unitRef="N">3,203</ix:nonFraction></span> total approved seats.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_810_ziHrbBKnaWp7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">***</p>



<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence -->&#160;</td></tr></table>
<p style="font: 10pt Times New Roman,serif; margin: 0"></p>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ex02-1.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: right">Exhibit 2.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">DESCRIPTION OF SECURITIES REGISTERED UNDER
SECTION 12 OF THE EXCHANGE ACT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following is a description of our outstanding
securities registered under Section 12 of the Exchange Act as required pursuant to the relevant Items under Form 20-F. As of December
31, 2022, Afya Limited (&ldquo;we,&rdquo; &ldquo;us,&rdquo; and &ldquo;our&rdquo;) had the following series of securities registered pursuant
to Section 12(b) of the Exchange Act:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 34%; padding-right: 2.9pt; padding-left: 2.9pt">
    <P STYLE="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Title
    of each class</P></TD>
    <TD STYLE="width: 33%; padding-right: 2.9pt; padding-left: 2.9pt">
    <P STYLE="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Trading
    Symbol(s)</P></TD>
    <TD STYLE="width: 33%; padding-right: 2.9pt; padding-left: 2.9pt">
    <P STYLE="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Name
    of each exchange on which registered</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Class A common shares, par value US$0.00005 per share</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">AFYA</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Nasdaq Global Select Market</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We were incorporated on March 22, 2019 as a
Cayman Islands exempted company with limited liability duly registered with the Cayman Islands Registrar of Companies. Our corporate purposes
are unrestricted and we have the authority to carry out any object not prohibited by law as provided by Section 7(4) of the Companies
Act (As Revised) of the Cayman Islands, or the Companies Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our affairs are governed principally by (i)&nbsp;our
Amended and Restated Memorandum and Articles of Association; (ii)&nbsp;the Companies Act; and (iii)&nbsp;the common law of the Cayman
Islands. As provided in our Amended and Restated Memorandum and Articles of Association, subject to Cayman Islands law, we have full capacity
to carry on or undertake any business or activity, do any act or enter into any transaction, and, for such purposes, full rights, powers
and privileges. Our registered office is c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman
Islands.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">CLASS A COMMON SHARES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Item 9. General</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">9.A.3 Preemptive rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">See &ldquo;&mdash;Item 10.B Memorandum and
articles of association&mdash;Preemptive or Similar Rights&rdquo; below.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">9.A.5 Type and class of securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023 and 2022, the Company&rsquo;s
issued and outstanding share capital was R$17,000 represented by 93,722,831 shares comprised by 47,920,068 Class A common shares and 45,802,763
Class B common shares. In addition, as of December 31, 2023, 150,000 Series A perpetual convertible preferred shares were outstanding,
representing approximately 6.6% of our outstanding common shares, including the Series A perpetual convertible preferred shares on an
as-converted basis. For more information on our Series A perpetual convertible preferred shares, please refer no note 13.2.1 to our audited
consolidated financial statements included elsewhere in this annual report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, our total authorized
share capital was US$50,000, divided into 1,000,000,000 shares par value US$0.00005 each, of which: (i) 500,000,000 shares are designated
as Class A common shares; (ii)&nbsp;250,000,000 shares are designated as Class B common shares; and (iii) 250,000,000 shares of such class
or classes (howsoever designated) and having the rights as the Board may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Amended and Restated Memorandum and Articles
of Association currently authorize two classes of common shares: Class A common shares, which are entitled to one vote per share, and
Class B common shares, which are entitled to 10 votes per share and to maintain a proportional ownership interest in the event that additional
Class A common shares are issued. Any holder of Class B common shares may convert his or her shares at any time into Class A common shares
on a share-for-share basis. The rights of the two classes of common shares are otherwise identical, except as described in our Amended
and Restated Memorandum and Articles of Association. The implementation of this dual class equity structure was required by the Esteves
Family and Crescera, our principal shareholders in the year of 2019, as a condition of undertaking the initial public offering of our
common shares. See &ldquo;&mdash;Anti-Takeover Provisions in Our Articles of Association&mdash;Two Classes of Common Shares.&rdquo;</P>


<!-- Field: Page; Sequence: 171 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Item 9.A.6. Limitations or qualifications</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Item 9.A.7. Other rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Item 10.B Memorandum and articles of association</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following information describes our Class
A common shares and provisions set forth by our Amended and Restated Memorandum and Articles of Association, the Companies Act; and the
common law of the Cayman Islands. This description is only a summary. You should read and refer to our Amended and Restated Memorandum
and Articles of Association included as Exhibit&nbsp;1.4 to our annual report on Form 20-F for the fiscal year ended December 31, 2023.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Description of Our Amended and Restated Memorandum and Articles
of Association</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">History of Share Capital</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On July 19, 2019, our registration statement
on Form F-1 (File No 333-232309), as amended, was declared effective by the SEC for to our initial public offering of our Class A common
shares, pursuant to which we sold a total of 15,805,841 Class A common shares, par value $0.00005 per share, at a public offering price
of US$19.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On February 6, 2020, our registration statement
on Form F-1 (File No 333-236246), as amended, was declared effective by the SEC for a public offering of our Class A common shares, pursuant
to which we sold a total of 3,260,480 Class A common shares, par value $0.00005 per share, at a public offering price of US$27.50 per
share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On April 26, 2021, we announced that the SoftBank
Latin America Fund, or SoftBank, agreed to purchase R$822 million, equivalent to US$150 million, of Afya&rsquo;s Series A perpetual convertible
preferred shares, subject to customary closing conditions. In addition, Crescera Educacional II Fundo de Investimento em Participa&ccedil;&otilde;es
Multiestrat&eacute;gia, the Esteves Family and certain of their family members agreed to sell 2,270,208 Class A common shares to SoftBank.
In connection with such sale, at the time, Paulo Passoni from SoftBank was appointed as a board member of Afya, being replaced by Maria
Tereza Azevedo in 2022. The key terms of the Series A perpetual convertible preferred shares, as set forth under the relevant certificate
of designations, are: (i) 6.5% per annum cumulative dividend payable quarterly and in Brazilian reais (payable in U.S. dollars in Brazilian
reais equivalent); (ii) SoftBank shall have the right at any time, to convert its Series A perpetual convertible preferred shares into
5,917,888 common shares, at an initial conversion price established at US$25.35; (iii) SoftBank shall have the right to redeem any time
after the 5th year anniversary at 105% premium; and (iv) Afya will have the right to force conversion after the 3rd year anniversary if
forced conversion trigger conditions are satisfied. The Series A perpetual convertible preferred share will be entitled to the same voting
rights as the common shares only when converted into common shares. For further information, see &ldquo;Item 5. Operating and Financial
Review and Prospects&mdash;B. Liquidity and Capital Resources&mdash;Indebtedness&mdash;Series A Perpetual Convertible Shares&rdquo; in
our annual report on Form 20-F for the fiscal year ended December 31, 2023 and note 13.2.1(d) to our audited consolidated financial statements
included elsewhere in our annual report on Form 20-F for the fiscal year ended December 31, 2023. As of December 31, 2023, SoftBank and
its affiliates would beneficially own approximately 6.6% of the total shares of the Company (on an as-converted basis for the Series A
perpetual convertible preferred shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2023, Afya had 3,773,478
common shares in treasury.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">General</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our shareholders adopted our Amended and Restated
Memorandum and Articles of Association, effective as of May 4, 2022, included as Exhibit 1.4 to our annual report on Form 20-F for the
fiscal year ended December 31, 2023. The following summary is subject to and qualified in its entirety by Afya Limited&rsquo;s Amended
and Restated Memorandum and Articles of Association. This is not a summary of all the significant provisions of our Amended and Restated
Memorandum and Articles of Association, of the Companies Act or of the common law of the Cayman Islands and does not purport to be complete.
Capitalized terms used but not defined herein have the meanings given to them in our annual report on Form 20-F for the fiscal year ended
December 31, 2023.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></P>


<!-- Field: Page; Sequence: 172 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Corporate Purposes</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our corporate purposes are unrestricted and
we have the authority to carry out any object not prohibited by law as provided by Section 7(4) of the Companies Act.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Issuance of Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Except as expressly provided in our Articles
of Association, our board of directors has general and unconditional authority to allot, grant options over, offer or otherwise deal with
or dispose of any unissued shares in the company&rsquo;s capital without the approval of our shareholders (whether forming part of the
original or any increased share capital), either at a premium or at par, with or without preferred, deferred or other special rights or
restrictions, whether in regard to dividend, voting, return of capital or otherwise and to such persons, on such terms and conditions,
and at such times as the directors may decide, but so that no share shall be issued at a discount, except in accordance with the provisions
of the Companies Act. In accordance with its Articles of Association, Afya shall not issue bearer shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association provide that at
any time that there are Class A common shares in issue, additional Class B common shares may only be issued pursuant to (i)&nbsp;a share
split, subdivision of shares or similar transaction or where a dividend or other distribution is paid by the issue of shares or rights
to acquire shares or following capitalization of profits, (ii)&nbsp;a merger, consolidation, or other business combination, or (iii)&nbsp;an
issuance of shares including Class A common shares or any other class of share designated as a common share pursuant to the Articles of
Association, whereby each holder of the Class B common shares is entitled to purchase a number of Class B common shares that would allow
it to maintain its proportional ownership interests in Afya (following an offer by Afya to each holder of Class B common shares to issue
to such holder, upon the same economic terms and at the same price, such number of Class B common shares as would ensure such holder may
maintain a proportional ownership interest in Afya pursuant to our Articles of Association). In light of: (a)&nbsp;the above provisions;
(b)&nbsp;the fact that future transfers by holders of Class B common shares will generally result in those shares converting to Class
A common shares, subject to limited exceptions as provided in the Articles of Association; and (c)&nbsp;the ten-to-one voting ratio between
our Class B common shares and Class A common shares, means that holders of our Class B common shares will in many situations continue
to maintain control of all matters requiring shareholder approval. This concentration of ownership and voting power will limit or preclude
your ability to influence corporate matters for the foreseeable future. For more information see &ldquo;&mdash;Preemptive or Similar Rights.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association also provide that
the issuance of non-voting common shares requires the affirmative vote of a majority of the then-outstanding Class A common shares and
the prior written consent of a Bertelsmann Director and Esteves Family Director as set out below in &ldquo;&mdash;Proceedings of the Board
of Directors.&rdquo;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Fiscal Year</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our fiscal year begins on January 1 of each
year and ends on December 31 of the same year.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Voting Rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The holders of the Class A common shares and
Class B common shares have identical rights, except that (i)&nbsp;the holder of Class B common shares is entitled to 10 votes per share,
whereas holders of Class A common shares are entitled to one vote per share, (ii)&nbsp;Class B common shares have certain conversion rights
and (iii)&nbsp;the holders of Class B common shares are entitled to maintain their proportional ownership interest in the event that common
shares and/or preferred shares are proposed to be issued. For more information see below &ldquo;&mdash;Preemptive or Similar Rights&rdquo;
and &ldquo;&mdash;Conversion.&rdquo; The holders of Class A common shares and Class B common shares vote together as a single class on
all matters (including the election of directors) submitted to a vote of shareholders, except as provided below and as otherwise required
by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association provide as follows
regarding the respective rights of holders of Class A common shares and Class B common shares:</P>


<!-- Field: Page; Sequence: 173 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><FONT STYLE="background-color: white">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class
consents from the holders of Class A common shares or Class B common shares, as applicable, shall be required for any variation to the
rights attached to their respective class of shares, however, the directors may treat any two or more classes of shares as forming one
class if they consider that all such classes would be affected in the same way by the proposal;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
rights conferred on holders of Class A common shares shall not be deemed to be varied by the creation or issue of further Class B common
shares and vice versa; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
rights attaching to the Class A common shares and the Class B common shares shall not be deemed to be varied by the creation or issue
of further shares ranking pari passu therewith, the redemption or purchase of any shares of any class by the Company, the cancellation
of authorised but unissued shares of that class or the creation or issue of shares with preferred or other rights, including, without
limitation, shares with enhanced or weighted voting rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As set forth in the Articles of Association,
the holders of Class A common shares and Class B common shares, respectively, do not have the right to vote separately if the number of
authorized shares of such class is increased or decreased. Rather, the number of authorized Class A common shares and Class B common shares
may be increased or decreased (but not below the number of shares of such class then outstanding) by the affirmative vote of the holders
of a majority of the voting power of the issued and outstanding Class A common shares and Class B common shares, voting together in a
general meeting.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Preemptive or Similar Rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares and Class B common
shares are not entitled to preemptive rights upon transfer and are not subject to conversion (except as described below under &ldquo;&mdash;Conversion&rdquo;),
redemption or sinking fund provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class B common shares are entitled to maintain
a proportional ownership interest in the event that additional common and/or preferred shares are issued. As such, if Afya issues common
and/or preferred shares, it must first make an offer to each holder of Class B common shares to issue to such holder on the same economic
terms such number of Class B common shares as would ensure such holder may maintain a proportional ownership interest in Afya. This right
to maintain a proportional ownership interest may be waived by all of the holders of Class B common shares, such waiver to remain effective
until the date specified therein or 12 months from the date of the waiver.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Conversion</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The outstanding Class B common shares are convertible
at any time as follows: (i)&nbsp;at the option of the holder, a Class B common share may be converted at any time into one Class A common
share or (ii)&nbsp;upon the election of the holders of all the then issued and outstanding Class B common shares, all outstanding Class
B common shares may be converted into a like number of Class A common shares. In addition, each Class B common share will convert automatically
into one Class A common share upon any transfer, whether or not for value, except for certain transfers described in the Articles of Association,
including transfers to holders of Class B common shares, to affiliates, to and between the Esteves Family, Bertelsmann, their family members
and their respective children, heirs and successors, trusts solely for the benefit of the shareholder or their affiliates, and to partnerships,
corporations and other entities exclusively owned or controlled by the Class B shareholder or their affiliates and certain transfers to
organizations that are exempt from taxation under Section 501(c)(3) of the Internal Revenue Code of 1986, as amended. Furthermore, each
Class B common share will convert automatically into one Class A common share and no Class B common shares will be issued thereafter if,
at any time, the total number of the issued and outstanding Class B common shares is less than 10% of the total number of shares outstanding.
To the extent that Bertelsmann or the Esteves Family cease to be a Class B common shareholder, the rights nominally vested to each shall
vest in their permitted transferee within the meaning of our Articles of Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">No class of our common shares may be subdivided
or combined unless the other class of common shares is concurrently subdivided or combined in the same proportion and in the same manner.</P>


<!-- Field: Page; Sequence: 174 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Equal Status</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Except as expressly provided in our Articles
of Association, Class A common shares and Class B common shares have the same rights and privileges and rank equally, share ratably and
are identical in all respects as to all matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In the event of any merger, consolidation,
scheme, arrangement or other business combination requiring the approval of our shareholders entitled to vote thereon (whether or not
Afya is the surviving entity), the holders of Class A common shares shall have the right to receive, or the right to elect to receive,
the same form of consideration as the holders of Class B common shares, and the holders of Class A common shares shall have the right
to receive, or the right to elect to receive, at least the same amount of consideration on a per share basis as the holders of Class B
common shares. In the event of any (i)&nbsp;tender or exchange offer to acquire any Class A common shares or Class B common shares by
any third-party pursuant to an agreement to which Afya is a party, or (ii)&nbsp;any tender or exchange offer by Afya to acquire any Class
A common shares or Class B common shares, the holders of Class A common shares shall have the right to receive, or the right to elect
to receive, the same form of consideration as the holders of Class B common shares, and the holders of Class A common shares shall have
the right to receive, or the right to elect to receive, at least the same amount of consideration on a per share basis as the holders
of Class B common shares.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Record Dates</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For the purpose of determining shareholders
entitled to notice of, or to vote at any general meeting of shareholders or any adjournment thereof, or shareholders entitled to receive
dividend or other distribution payments, or in order to make a determination of shareholders for any other purpose, Our board of directors
may set a record date which shall not exceed 40 clear days prior to the date where the determination will be made.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">General Meetings of Shareholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a condition of admission to a shareholders&rsquo;
meeting, a shareholder must be duly registered as a shareholder of Afya at the applicable record date for that meeting and, in order to
vote, all calls or installments then payable by such shareholder to Afya in respect of the shares that such shareholder holds must have
been paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to any special rights or restrictions
as to voting then attached to any shares, at any general meeting every shareholder who is present in person or by proxy (or, in the case
of a shareholder being a corporation, by its duly authorized representative not being himself or herself a shareholder entitled to vote)
shall have one vote per Class A common share and 10 votes per Class B common share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a Cayman Islands exempted company, Afya
is not obliged by the Companies Act to call annual general meetings; however, the Articles of Association provide that in each year the
company will hold an annual general meeting of shareholders, at a time determined by the board of directors. For the annual general meeting
of shareholders the agenda will include, among other things, the presentation of the annual accounts and the report of the directors (if
any). In addition, the agenda for an annual general meeting of shareholders will only include such items as have been included therein
by the board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Also, Afya may, but is not required to (unless
required by the laws of the Cayman Islands), hold other extraordinary general meetings during the year. General meetings of shareholders
are generally expected to take place in Nova Lima, Brazil, but may be held elsewhere if the directors so decide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act provides shareholders a limited
right to request a general meeting and does not provide shareholders with any right to put any proposal before a general meeting in default
of a company&rsquo;s Articles of Association. However, these rights may be provided in a company&rsquo;s Articles of Association. Our
Articles of Association provide that upon the requisition of one or more shareholders representing not less than one-third of the voting
rights entitled to vote at general meetings, the board will convene an extraordinary general meeting and put the resolutions so requisitioned
to a vote at such meeting. The Articles of Association provide no other right to put any proposals before annual general meetings or extraordinary
general meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to regulatory requirements, the annual
general meeting and any extraordinary general meetings must be called by not less than 10 clear calendar days&rsquo; notice prior to
the relevant shareholders meeting and convened by a notice discussed below. Alternatively, upon the prior consent of all holders entitled
to receive notice, with regards to the annual general meeting, and a majority in number of the members (which shall include Bertelsmann
and the Esteves Family) together holding at least 95% in par value of the shares entitled to attend and vote, with regards to an extraordinary
general meeting, that meeting may be convened by a shorter notice and in a manner deemed appropriate by those holders.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></P>


<!-- Field: Page; Sequence: 175 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya will give notice of each general meeting
of shareholders by publication on its website and in any other manner that it may be required to follow in order to comply with Cayman
Islands law, Nasdaq and SEC requirements. The holders of registered shares may be given notice of a shareholders&rsquo; meeting by means
of letters sent to the addresses of those shareholders as registered in our shareholders&rsquo; register, or, subject to certain statutory
requirements, by electronic means.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><B>Holders whose shares are registered in the
name of DTC or its nominee, which we expect will be the case for all holders of Class A common shares, will not be a shareholder or member
of the company and must rely on the procedures of DTC regarding notice of shareholders&rsquo; meetings and the exercise of rights of a
holder of the Class A common shares.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A quorum for a general meeting consists of
any one or more persons holding or representing by proxy not less than one-third of the aggregate voting power of all shares in issue
and entitled to vote upon the business to be transacted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A resolution put to a vote at a general meeting
shall be decided on a poll. An ordinary resolution to be passed by the shareholders at a general meeting requires the affirmative vote
of a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote, present in person or by proxy and voting
at the meeting. A special resolution requires the affirmative vote on a poll of no less than two-thirds of the votes cast by the shareholders
entitled to vote who are present in person or by proxy at a general meeting. Both ordinary resolutions and special resolutions may also
be passed by a unanimous written resolution signed by all the shareholders of our Company, as permitted by the Companies Act and our Articles
of Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to our Articles of Association, general
meetings of shareholders are to be chaired by the co-chairman of our board of directors appointed by Bertelsmann or in his absence, the
co-chairman of the board of directors appointed by the Esteves Family. If both such co-chairmen are absent, the directors present at the
meeting shall appoint one of them to be chairman of the general meeting. If neither the chairmen nor another director is present at the
general meeting within 15 minutes after the time appointed for holding the meeting, the shareholders present in person or by proxy and
entitled to vote may elect any one of the shareholders to be chairman. The order of business at each meeting shall be determined by the
chairman of the meeting and he or she shall have the right and authority to prescribe such rules, regulations and procedures and to do
all such acts and things as are necessary or desirable for the proper conduct of the meeting, including, without limitation, the establishment
of procedures for the maintenance of order and safety, limitations on the time allotted to questions or comments on the affairs of the
Company, restrictions on entry to such meeting after the time prescribed for the commencement thereof, and the opening and closing of
the polls. The chairman shall not have the right to vote in his capacity as chairman and shall not have a casting vote.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Liquidation Rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If Afya is voluntarily wound up, the liquidator,
after taking into account and giving effect to the rights of preferred and secured creditors and to any agreement between Afya and any
creditors that the claims of such creditors shall be subordinated or otherwise deferred to the claims of any other creditors and to any
contractual rights of set-off or netting of claims between Afya and any person or persons (including without limitation any bilateral
or any multi-lateral set-off or netting arrangements between the company and any person or persons) and subject to any agreement between
Afya and any person or persons to waive or limit the same, shall apply our property in satisfaction of its liabilities <I>pari passu</I>
and subject thereto shall distribute the property amongst the shareholders according to their rights and interests in Afya.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Special Matters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya may not without the prior written consent
of (i)&nbsp;Bertelsmann for so long as it holds Class B common shares in excess of the Ownership Threshold and (ii)&nbsp;the Esteves
Family for so long as it holds Class B common shares in excess of the Ownership Threshold: change the number of directors; amend its
Memorandum and Articles of Association; vary the rights attaching to shares; approve the winding-up, liquidation or dissolution of Afya;
or take certain actions in respect of its share capital as set out in the Articles of Association; register as an exempted limited duration
company; or approve the transfer by way of continuation of Afya to a jurisdiction outside the Cayman Islands.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></P>


<!-- Field: Page; Sequence: 176 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Anti-Corruption and Anti-Money Laundering</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association contain stringent
anti-corruption, anti-money laundering and certain other related measures applicable to us, our officers and directors, and its service
providers. The Articles of Association provide that if one of our shareholders is found to have been involved in an act of corruption,
money laundering or other related irregular act, the directors shall convene a meeting to consider the circumstances of such incident,
and establish a course of action to be taken against such shareholder. The actions range from (i)&nbsp;suspending such shareholder from
his/her duties as a director, officer and/or employee (if applicable) of the Company; (ii)&nbsp;terminating such duties; (iii)&nbsp;directing
such shareholder to transfer the entirety of his/her shareholding in the Company to his/her children and/or heirs; or (iv)&nbsp;if such
transfer is not possible, resolve that the shares in the Company owned by such shareholder be mandatorily redeemed by us. Further, our
Articles of Association provide that we shall not engage the services of any provider that has been found to violate applicable anti-corruption
laws, and further provide that we and our shareholders shall not violate applicable anti-corruption laws.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Changes to Capital</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the restrictions contained in the
Articles of Association and summarized above in &ldquo;&mdash;Special Matters,&rdquo; Afya may from time to time by ordinary resolution:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>increase its share capital by such sum, to be divided into shares of such amount, as the resolution shall prescribe;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>consolidate and divide all or any of its share capital into shares of a larger amount than its existing shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>convert all or any of its paid-up shares into stock and reconvert that stock into paid up shares of any denomination;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>subdivide its existing shares or any of them into shares of a smaller amount, provided that in the subdivision the proportion between
the amount paid and the amount, if any, unpaid on each reduced share shall be the same as it was in the case of the share from which the
reduced share is derived; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and
diminish the amount of its share capital by the amount of the shares so canceled.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our shareholders may by special resolution,
subject to confirmation by the Grand Court of the Cayman Islands on an application by the Company for an order confirming such reduction,
reduce its share capital or any capital redemption reserve in any manner permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, subject to the provisions of the
Companies Act and our Articles of Association, Afya may:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>issue shares on terms that they are to be redeemed or are liable to be redeemed;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>purchase its own shares (including any redeemable shares); and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>make a payment in respect of the redemption or purchase of its own shares in any manner authorized by the Companies Act, including
out of its own capital.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Transfer of Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to any applicable restrictions set
forth in the Articles of Association, any shareholder of Afya may transfer all or any of his or her common shares by an instrument of
transfer in the usual or common form or in the form prescribed by the Nasdaq or any other form approved by the Company&rsquo;s board of
directors.</P>


<!-- Field: Page; Sequence: 177 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares are traded on the
Nasdaq in book-entry form and may be transferred in accordance with our Articles of Association and Nasdaq&rsquo;s rules and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">However, our board of directors may, in its
absolute discretion, decline to register any transfer of any common share which is either not fully paid up to a person of whom it does
not approve or is issued under any share incentive scheme for employees which contains a transfer restriction that is still applicable
to such common share. The board of directors may also decline to register any transfer of any common share unless:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the instrument of transfer is lodged with Afya, accompanied by the certificate (if any) for the common shares to which it relates
and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the instrument of transfer is in respect of only one class of shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the instrument of transfer is properly stamped, if required;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the common shares transferred are free of any lien in favor of Afya; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>in the case of a transfer to joint holders, the transfer is not to more than four joint holders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If the directors refuse to register a transfer
they are required, within 15 business days after the date on which the instrument of transfer was lodged, to send to the transferee notice
of such refusal.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Share Repurchases</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act and the Articles of Association
permit Afya to purchase its own shares, subject to certain restrictions. The board of directors may only exercise this power on behalf
of Afya, and subject to the Companies Act, the Articles of Association and to any applicable requirements imposed from time to time by
the SEC, the Nasdaq, or by any recognized stock exchange on which our securities are listed. Set forth below is a description of our share
repurchase programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><I>1<SUP>st</SUP> Share Repurchase Program</I>.
Our Board of Directors approved a share buyback program on December 23, 2020. Under the share buyback program, Afya may repurchase up
to 1,015,844 of its outstanding Class A common shares in the open market, based on prevailing market prices, or in privately negotiated
transactions, over a period beginning on December 24, 2020 continuing until the earlier of the completion of the repurchase or December
31, 2021, depending upon market conditions. We repurchased the shares to execute the stock option program for the executives of the company
and utilized our existing funds to fund repurchases made under this program. Our Board of Directors also authorized management to appoint
BofA Securities, Inc. as our agent to purchase the shares on our behalf in the open market. It is our intention such purchases benefit
from the safe harbor provided by Rule 10b-18 (&ldquo;Rule 10b-18&rdquo;) promulgated by the SEC under the Exchange Act. Accordingly, we
shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability of Rule 10b-18
for purchases of our common shares under the program. The share buyback program was completed on October 21, 2021, upon the completion
of the purchase of the full amount of Class A common shares permitted under the program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><I>2<SUP>nd</SUP> Share Repurchase Program</I>.
After the completion of our first share repurchase program on October 21, 2021 that resulted in the purchase of 1,015,844 Class A common
shares, our Board of Directors approved a new share repurchase program on October 27, 2021, or the second share repurchase program. Under
the second share repurchase program, Afya may repurchase up to 1,383,108 of its outstanding Class A common shares in the open market,
based on prevailing market prices, or in privately negotiated transactions, beginning on October 28, 2021 until the earlier of the completion
of the repurchase or December 31, 2022, depending upon market conditions. We repurchased the shares to execute the stock option program
for the executives of the company and utilized our existing funds to fund repurchases made under this program. The Board of Directors
of Afya also authorized management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market.
It is Afya&rsquo;s intention that such purchases benefit from the safe harbor provided by Rule 10b-18 promulgated by the SEC under the
Exchange Act. Accordingly, Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize
the availability of Rule 10b-18 for purchases under the program. The second share repurchase program was completed on January 14, 2022,
upon the purchase of the full amount of Class A common shares permitted under the second share repurchase program.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></P>


<!-- Field: Page; Sequence: 178 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><I>3<SUP>rd</SUP> Share Repurchase Program</I>.
After the completion of our second share repurchase program, which resulted in the purchase of 1,383,108 Class A common shares, our Board
of Directors approved a new share repurchase program on January 27, 2022, or the third share repurchase program. Under the third share
repurchase program, Afya may repurchase up to 1,874,457 of its outstanding Class A common shares which represents 4% of its free float,
in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning on January 27, 2022, until the
earlier of the completion of the repurchase or December 31, 2022, depending upon market conditions. We repurchased the shares for use
in our stock option program, as consideration in business combination transactions and for general corporate purposes and utilized our
existing funds and dividends received from Afya Brazil to fund repurchases made under this program. The Board of Directors of Afya also
authorized management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market. It is Afya&rsquo;s
intention that such purchases benefit from the safe harbor provided by Rule 10b-18 promulgated by the SEC under the Exchange Act. Accordingly,
Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability of Rule
10b-18 for purchases under the program. The third share repurchase program was completed on May 4, 2022, upon the purchase of the full
amount of Class A common shares permitted under the third share repurchase program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><I>4<SUP>th</SUP> Share Repurchase Program</I>.
After the completion of our third share repurchase program, which resulted in the purchase of 1,874,457 Class A common shares, our board
of directors has approved a new share repurchase program on March 23, 2023, or the fourth share repurchase program. Under the fourth share
repurchase program, Afya may repurchase up to 2,000,000 of its outstanding Class A common shares, in the open market, based on prevailing
market prices, or in privately negotiated transactions, beginning on April 3, 2023 until the earlier of the completion of the repurchase
or December 31, 2024, depending upon market conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The share repurchases may be made from time
to time through open market transactions and are subject to market and business conditions, levels of available liquidity, cash requirements
for other purposes, regulatory, and other relevant factors. Afya intends to repurchase the shares for use in its stock option and restricted
stock units programs, as consideration in future business combination transactions and for general corporate purposes. Afya expects to
utilize its existing funds and future dividends to be received from Afya Brazil and/or strike price funds to be received in connection
with any option exercises under its stock option program, to fund repurchases made under this program. Afya&rsquo;s Board of Directors
will review the share repurchase program periodically and may authorize adjustments to its terms and size or suspend or discontinue the
program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Board of Directors of Afya also authorized
management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market. It is Afya&rsquo;s intention
that such purchases benefit from the safe harbors provided by Rules 10b-18 and 10b5-1 promulgated by the SEC under the Exchange Act. Accordingly,
Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability of Rules
10b-18 or 10b5-1 for purchases under the program.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Dividends and Capitalization of Profits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have not adopted a dividend policy with
respect to payments of any future dividends by Afya. Subject to the Companies Act, our shareholders may, by resolution passed by a simple
majority of the voting rights entitled to vote at a general meeting, declare dividends (including interim dividends) to be paid to shareholders
but no dividend shall be declared in excess of the amount recommended by the board of directors. The board of directors may also declare
dividends. Dividends may be declared and paid out of funds lawfully available to Afya. Except as otherwise provided by the rights attached
to shares and the Articles of Association of Afya, all dividends shall be paid in proportion to the number of Class A common shares or
Class B common shares a shareholder holds at the date the dividend is declared (or such other date as may be set as a record date); but,
(i)&nbsp;if any share is issued on terms providing that it shall rank for dividend as from a particular date, that share shall rank for
dividend accordingly, and (ii)&nbsp;where we have shares in issue which are not fully paid up (as to par value) we may pay dividends in
proportion to the amounts paid up on each share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The holders of Class A common shares and Class
B common shares shall be entitled to share equally in any dividends that may be declared in respect of our common shares from time to
time. In the event that a dividend is paid in the form of Class A common shares or Class B common shares, or rights to acquire Class
A common shares or Class B common shares, (i)&nbsp;the holders of Class A common shares shall receive Class A common shares, or rights
to acquire Class A common shares, as the case may be; and (ii)&nbsp;the holders of Class B common shares shall receive Class B common
shares, or rights to acquire Class B common shares, as the case may be.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></P>


<!-- Field: Page; Sequence: 179 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Series A perpetual convertible preferred shares
rank senior to our common with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation,
dissolution or winding up of the affairs of the Company. The holders of Series A perpetual convertible preferred shares are entitled to
a cumulative dividend at the rate of 6.5% per annum, payable quarterly in arrears. Dividends are payable in kind through the issuance
of additional Series A perpetual convertible preferred shares, in cash, or in any combination of both, at our discretion. The holders
of the Series A perpetual convertible preferred shares are also entitled to participate in dividends declared or paid on our common stock
on an as-converted basis.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Appointment, Disqualification and Removal of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is managed by its board of directors.
The Articles of Association provide that, unless otherwise determined by a special resolution of shareholders, the board of directors
will be composed of four to 14 directors, with the number being determined by a majority of the directors then in office. There are no
provisions relating to retirement of directors upon reaching any age limit. The Articles of Association also provide that, while our shares
are admitted to trading on Nasdaq, the board of directors must always comply with the residency and citizenship requirements of the U.S.
securities laws applicable to foreign private issuers. Bertelsmann for so long as it holds Class B common shares in excess of the Ownership
Threshold may appoint up to seven directors at its discretion (and is entitled at any time to remove substitute or replace such directors)
(&ldquo;Bertelsmann Directors&rdquo;), and the Esteves Family for so long as it holds Class B common shares in excess of the Ownership
Threshold may appoint up to two directors at its discretion (and is entitled at any time to remove substitute or replace such directors)
(&ldquo;Esteves Family Directors&rdquo;), in addition for so long as both hold Class B common shares in excess of the Ownership Threshold,
they may appoint a further director (the &ldquo;Joint Director&rdquo;) and are entitled at any time to remove, substitute or replace the
Joint Director (provided that if only one of Bertelsmann and the Esteves Family holds Class B Common Shares in excess of the Ownership
Threshold, then only Bertelsmann or the Esteves Family, as applicable, shall have such right). The Board of Directors shall have one (1)
co-chairman appointed by Bertelsmann, for so long as it holds Class B Common Shares in excess of the Ownership Threshold and one (1) co-chairman
appointed by the Esteves Family, for so long as it holds Class B Common Shares in excess of the Ownership Threshold, thereafter, the chairman
of the Board of Directors shall be appointed by a majority of the Directors then in office.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing, the Articles of Association
provide that directors shall be elected by an ordinary resolution of our shareholders, which requires the affirmative vote of a simple
majority of the votes cast on the resolution by the shareholders entitled to vote who are present, in person or by proxy, at the meeting.
Each director shall be appointed and elected for a two-year term or until his or her death, resignation or removal, and is eligible for
re-election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For the names of our directors, see &ldquo;Item
6. Directors, Senior Management and Employees&mdash;A. Directors and Senior Management&mdash;Board of Directors.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Any vacancies on the board of directors that
arise other than in respect of the Bertelsmann and/or Esteves Family director appointments set out above or upon the removal of a director
by resolution passed at a general meeting can be filled by the remaining directors (notwithstanding that they may constitute less than
a quorum). Any such appointment shall be as an interim director to fill such vacancy until the next annual general meeting of shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing, additions to the
existing board (within the limits set pursuant to the Articles of Association) may be made by ordinary resolution of the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors has an audit committee
in place. See &ldquo;Item 6. Directors, Senior Management and Employees&mdash;A. Directors and Senior Management&mdash;Audit Committee.&rdquo;</P>


<!-- Field: Page; Sequence: 180 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Grounds for Removing a Director</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A director may be removed with or without cause
by ordinary resolution, save that each Bertelsmann Director may only be removed by Bertelsmann at its discretion and each Esteves Family
Director may only be removed by the Esteves Family at its discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The notice of general meeting must contain
a statement of the intention to remove the director and must be served on the director not less than 10 calendar days before the meeting.
The director is entitled to attend the meeting and be heard on the motion for his removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The office of a director will be vacated automatically
if he or she (i)&nbsp;becomes prohibited by law from being a director, (ii)&nbsp;becomes bankrupt or makes an arrangement or composition
with his creditors, (iii)&nbsp;dies or is in the opinion of all his co-directors, incapable by reason of mental disorder of discharging
his duties as director, (iv)&nbsp;resigns his office by notice to us or (v)&nbsp;has for more than six months been absent without permission
of the directors from meetings of the board of directors held during that period, and the remaining directors resolve that his or her
office be vacated. Further, the Directors may remove a Director as set out above in &ldquo;&mdash;Anti-Corruption.&rdquo;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Proceedings of the Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Articles of Association provide that our
business is to be managed and conducted by the board of directors, save that Afya may not without (i)&nbsp;the consent of a Bertelsmann
Director while there is a Bertelsmann Director and (ii)&nbsp;the consent of an Esteves Family Director while there is an Esteves Family
Director: create new classes of shares, issue new shares, options, warrants or convertible securities of similar nature conferring the
right upon the holders thereof to subscribe for purchase or receive any class of shares or securities in the capital of Afya; repurchase
or redeem any shares; execute and/or terminate any shareholders&rsquo; agreement, quotaholders&rsquo; agreement, or any other agreements
related to our interest in any subsidiary; approve our financial statements; effect any follow-on offerings of Afya; approve the listing
and/or the delisting of our securities with any designated stock exchange; conduct, negotiate, terminate and/or amend any business, agreement,
or transaction between Afya and any related party valued in excess of R$10.0 million, provided that, (A) if the Related Party is the Esteves
Family (or an Affiliate thereof), then the consent of the Esteves Family Director shall not be required and (B) if the Related Party is
Bertelsmann (or an Affiliate thereof), then the consent of the Bertelsmann Director shall not be required; approve any sale or encumbrance,
for the benefit of a person of shares issued by any subsidiary, or the admission of any new partner or shareholder in such subsidiaries;
carry out any investments outside the scope of the core business of Afya (as set out in the Articles of Association); incorporate any
entity; appoint or terminate the engagement of any auditor that is not an Authorized Auditor as set out in the Articles of Association;
provide any guarantee in respect of any person or related person of any of our shareholders, director and/or officers inter alia; or take
actions in connection with the Company&rsquo;s Anti-Corruption measures, provided that if the Anti-Corruption measures relate to either
Bertelsmann or the Esteves Family, then the consent of the Esteves Family Director or the Bertelsmann Director respectively shall not
be required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The quorum necessary for the board meeting
shall be a simple majority of the directors then in office (subject to there being a minimum of two directors present), and business at
any meeting shall be decided by a majority of votes. In the case of an equality of votes, neither the chairmen of the board nor the chairman
of the meeting shall have a casting vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing and the provisions
of the Articles of Association, the board of directors may regulate its proceedings as they determine is appropriate. Board meetings shall
be held bi-monthly and shall take place either in Nova Lima, Brazil, or at such other place as the directors may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the provisions of the Articles of
Association, to any directions given by ordinary resolution of the shareholders and the listing rules of the Nasdaq, the board of directors
may from time to time at its discretion exercise all powers of Afya, including, subject to the Companies Act, the power to issue debentures,
bonds and other securities of the company, whether outright or as collateral security for any debt, liability or obligation of our company
or of any third-party.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Inspection of Books and Records</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Holders of Afya shares have no general right
under Cayman Islands law to inspect or obtain copies of the list of shareholders or corporate records of the Company. However, the board
of directors may determine from time to time whether and to what extent our accounting records and books shall be open to inspection
by shareholders who are not members of the board of directors. Notwithstanding the above, the Articles of Association provide shareholders
with the right to receive annual financial statements and upon request agreements executed by the Company and its Related Parties (as
defined in the Articles of Association), shareholder agreements to which the Company is a party and details of any incentive plan. Such
right to receive annual financial statements may be satisfied by publishing the same on the company&rsquo;s website or filing such annual
reports as we are required to file with the SEC.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></P>


<!-- Field: Page; Sequence: 181 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Register of Shareholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares are held through
DTC, and DTC or Cede &amp; Co., as nominee for DTC, and recorded in the shareholders&rsquo; register as the holder of our Class A common
shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, Afya must keep a
register of shareholders that includes:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the names and addresses of the shareholders, a statement of the shares held by each member and of the amount paid or agreed to be
considered as paid, on the shares of each member;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>whether voting rights attach to the shares in issue;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the date on which the name of any person was entered on the register as a member; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the date on which any person ceased to be a member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, the register of shareholders
of Afya is prima facie evidence of the matters set out therein (i.e., the register of shareholders will raise a presumption of fact on
the matters referred to above unless rebutted) and a shareholder registered in the register of shareholders is deemed as a matter of Cayman
Islands law to have <I>prima facie</I> legal title to the shares as set against his or her name in the register of shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">However, there are certain limited circumstances
where an application may be made to a Cayman Islands court for a determination on whether the register of members reflects the correct
legal position. Further, the Cayman Islands court has the power to order that the register of members maintained by a company should be
rectified where it considers that the register of members does not reflect the correct legal position. If an application for an order
for rectification of the register of members were made in respect of our ordinary shares, then the validity of such shares may be subject
to re-examination by a Cayman Islands court.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Exempted Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is an exempted company with limited liability
under the Companies Act. The Companies Act distinguishes between ordinary resident companies and exempted companies. Any company that
is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted
company. The requirements for an exempted company are essentially the same as for an ordinary company except for the exemptions and privileges
listed below:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company does not have to file an annual return of its shareholders with the Registrar of Companies;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company&rsquo;s register of shareholders is not open to inspection;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company does not have to hold an annual general meeting;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company may issue shares with no par value;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for
20 years in the first instance);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company may register as a limited duration company; and</TD></TR></TABLE>


<!-- Field: Page; Sequence: 182 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company may register as a segregated portfolio company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">&ldquo;Limited liability&rdquo; means that
the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in exceptional
circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances
in which a court may be prepared to pierce or lift the corporate veil).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are subject to reporting and other informational
requirements of the Exchange Act, as applicable to foreign private issuers. Except as otherwise disclosed in this annual report, we comply
with the Nasdaq rules in lieu of following home country practice.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Anti-Takeover Provisions in Our Articles of Association</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Some provisions of the Articles of Association
may discourage, delay or prevent a change in control of Afya or management that shareholders may consider favorable. In particular, the
capital structure of Afya concentrates ownership of voting rights in the hands of the Esteves Family and Bertelsmann. These provisions,
which are summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are
also designed to encourage persons seeking to acquire control of Afya to first negotiate with the board of directors. However, these provisions
could also have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary
fluctuations in the market price of the Class A common shares that often result from actual or rumored hostile takeover attempts. These
provisions may also have the effect of preventing changes in the management of Afya. It is possible that these provisions could make it
more difficult to accomplish transactions that shareholders may otherwise deem to be in their best interests.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Two Classes of Common Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class B common shares of Afya are entitled
to 10 votes per share, while the Class A common shares are entitled to one vote per share. Since they own of all of the Class B common
shares of Afya, the Esteves Family and Bertelsmann currently have the ability to elect all directors and to determine the outcome of most
matters submitted for a vote of shareholders. This concentrated voting control could discourage others from initiating any potential merger,
takeover, or other change of control transaction that other shareholders may view as beneficial.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">So long as the Esteves Family and Bertelsmann
have the ability to determine the outcome of most matters submitted to a vote of shareholders, third parties may be deterred in their
willingness to make an unsolicited merger, takeover, or other change of control proposal, or to engage in a proxy contest for the election
of directors. As a result, the fact that Afya has two classes of common shares may have the effect of depriving you as a holder of Class
A common shares of an opportunity to sell your Class A common shares at a premium over prevailing market prices and make it more difficult
to replace the directors and management of Afya.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Preferred Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors is given wide powers
to issue one or more classes or series of shares with preferred rights. Such preferences may include, for example, dividend rights, conversion
rights, redemption privileges, enhanced voting powers and liquidation preferences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Despite the anti-takeover provisions described
above, under Cayman Islands law, our board of directors may only exercise the rights and powers granted to them under the Articles of
Association, for what they believe in good faith to be in the best interests of Afya.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 0.25in">Series A Perpetual Convertible Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On April 26, 2021, we issued and sold 150,000
shares of perpetual convertible preferred shares designated as Series A perpetual convertible preferred shares, with a par value of U.S.$0.00005
per share, for US$150.0 million, equivalent to R$821.8 million, on the issuance date. The Series A perpetual convertible preferred shares
is a class of equity security that ranks senior to the common shares with respect to dividend rights or rights upon liquidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Each Series A perpetual convertible preferred
share is entitled to a cash dividend of 6.5% per annum and is convertible, at the holder&rsquo;s discretion, into our Class A common
shares at an initial conversion price of US$25.35. We may require the conversion of any or all of the Series A perpetual convertible
preferred shares at any time on or after the three-year anniversary of the original issuance date if certain conditions set forth in
the certificate of designation are met (if for 20 out of 30 consecutive trading days prior, Afya&rsquo;s stock price is equal or above
150% of the conversion rate). We may also redeem any or all of the Series A perpetual convertible preferred shares for cash, shares of
its common shares or a combination thereof at its election, at any time on or after the seven-year anniversary of the original issuance
date as determined in the certificate of designation. On or after the five-year anniversary of the original issuance date, the holders
of the Series A perpetual convertible preferred shares shall have the right to redeem all of the outstanding Series A perpetual convertible
preferred shares for cash, our common shares or a combination thereof (at our election, subject to certain conditions) to be determined
in the certificate of designation. Upon the occurrence of a change of control, the holders will have the right to redeem their Series
A perpetual convertible preferred shares for cash at a price set forth in the certificate of designation. The Series A perpetual convertible
preferred shares will be entitled to the same voting rights as the common shares only when converted into common shares.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"></P>


<!-- Field: Page; Sequence: 183 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For further information on our outstanding
Series A perpetual convertible preferred shares, see &ldquo;Item 5. Operating and Financial Review and Prospects&mdash;B. Liquidity and
Capital Resources&mdash;Indebtedness&mdash;Series A Perpetual Convertible Shares&rdquo; and note 13.2.1(d) to our audited consolidated
financial statements included elsewhere in this annual report.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Protection of Non-Controlling Shareholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Grand Court of the Cayman Islands may,
on the application of shareholders holding not less than one fifth of the shares of Afya in issue, appoint an inspector to examine the
Company&rsquo;s affairs and report thereon in a manner as the Grand Court shall direct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the provisions of the Companies
Act, any shareholder may petition the Grand Court of the Cayman Islands which may make a winding up order, if the court is of the opinion
that this winding up is just and equitable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Notwithstanding the U.S. securities laws and
regulations that are applicable to Afya, general corporate claims against Afya by its shareholders must, as a general rule, be based on
the general laws of contract or tort applicable in the Cayman Islands or their individual rights as shareholders as established by our
Articles of Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Cayman Islands courts ordinarily would
be expected to follow English case law precedents, which permit a minority shareholder to commence a representative action against Afya,
or derivative actions in our name, to challenge (i)&nbsp;an act which is ultra vires or illegal, (ii)&nbsp;an act which constitutes a
fraud against the minority and the wrongdoers themselves control Afya, and (iii)&nbsp;an irregularity in the passing of a resolution that
requires a qualified (or special) majority.</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>3
<FILENAME>ex08-1.htm
<DESCRIPTION>EX-8.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: right">Exhibit 8.01</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">LIST OF SUBSIDIARIES OF AFYA LIMITED</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 86%; padding-right: 2.9pt; padding-left: 2.9pt">
    <P STYLE="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Name
    of Subsidiary</P></TD>
    <TD STYLE="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt">
    <P STYLE="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Jurisdiction
    of Incorporation or Organization</P></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Afya Participa&ccedil;&otilde;es S.A. (&ldquo;Afya Brazil&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Instituto Tocantinense Presidente Ant&ocirc;nio Carlos Porto S.A. (&ldquo;ITPAC Porto&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Instituto Tocantinense Presidente Ant&ocirc;nio Carlos S.A. (&ldquo;ITPAC Aragua&iacute;na&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Uni&atilde;o Educacional do Vale do A&ccedil;o S.A. (&ldquo;UNIVA&Ccedil;O&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&ldquo;IPTAN&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Instituto de Educa&ccedil;&atilde;o Superior do Vale do Parna&iacute;ba S.A. (&ldquo;IESVAP&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Centro de Ci&ecirc;ncias em Sa&uacute;de de Itajub&aacute; S.A. (&ldquo;CCSI&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Instituto de Ensino Superior do Piau&iacute; S.A. (&ldquo;IESP&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">FADEP &ndash; Faculdade Educacional de Pato Branco Ltda. (&ldquo;FADEP&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Medcel Editora e Eventos S.A. (&ldquo;Medcel&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Instituto Educacional Santo Agostinho S.A. (&ldquo;FASA&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Instituto de Pesquisa e Ensino M&eacute;dico do Estado de Minas Gerais Ltda. (&ldquo;IPEMED&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Instituto Paraense de Educa&ccedil;&atilde;o e Cultura Ltda. (&ldquo;IPEC&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Sociedade Universit&aacute;ria Redentor S.A. (&ldquo;UniRedentor&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">Centro Universit&aacute;rio S&atilde;o Lucas Ltda. (&ldquo;UniSL&rdquo;)</TD>
    <TD STYLE="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">PebMed Institui&ccedil;&atilde;o de Pesquisa M&eacute;dica e Servi&ccedil;os Tecnol&oacute;gicos da &Aacute;rea da Sa&uacute;de Ltda. (&ldquo;PEBMED&rdquo;)</TD>
    <TD STYLE="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">Sociedade de Educa&ccedil;&atilde;o, Cultura e Tecnologia da Amaz&ocirc;nia S.A. (&ldquo;FESAR&rdquo;)</TD>
    <TD STYLE="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">Centro Superior de Ci&ecirc;ncias da Sa&uacute;de S/S Ltda. (&ldquo;FCMPB&rdquo;)</TD>
    <TD STYLE="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">iClinic Desenvolvimento de Software Ltda. (&ldquo;iClinic&rdquo;)</TD>
    <TD STYLE="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">Medicinae Solutions S.A. (&ldquo;Medicinae&rdquo;)</TD>
    <TD STYLE="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">Medical Harbour Aparelhos M&eacute;dico Hospitalares e Servi&ccedil;os em Tecnologia Brazil Ltda. (&ldquo;Medical Harbour)</TD>
    <TD STYLE="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">Cliquefarma Drogarias Online Ltda. (&ldquo;Cliquefarma&rdquo;)</TD>
    <TD STYLE="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">Shosp Tecnologia da Informa&ccedil;&atilde;o Ltda. (&ldquo;Shosp&rdquo;)</TD>
    <TD STYLE="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Sociedade Padr&atilde;o de Educa&ccedil;&atilde;o Superior Ltda. (&ldquo;UnifipMoc&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Companhia Nilza Cordeiro Herdy de Educa&ccedil;&atilde;o e Cultura (&ldquo;Unigranrio&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">RX PRO Solu&ccedil;&otilde;es de Tecnologia Ltda. (&ldquo;RX PRO&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">RX PRO LOG Transporte e Log&iacute;stica Ltda. (&ldquo;RX PRO LOG&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Uni&atilde;o Educacional do Planalto Central S.A. (&ldquo;UEPC&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">BMV Atividades M&eacute;dicas Ltda. (&ldquo;Al&eacute;m da Medicina&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Cardiopapers Solu&ccedil;&otilde;es Digitais Ltda. (&ldquo;CardioPapers&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Quasar Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&ldquo;Glic&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt">Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&ldquo;DelRey&rdquo;)</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Brazil</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>4
<FILENAME>ex12-1.htm
<DESCRIPTION>EX-12.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: right">Exhibit 12.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">CERTIFICATION BY THE PRINCIPAL EXECUTIVE
OFFICER</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><FONT STYLE="background-color: white">I,</FONT> Virgilio Deloy Capobianco
Gibbon, certify that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>I have reviewed this annual report on Form 20-F for the year ended December 31, 2023 of Afya Limited (the &ldquo;Company&rdquo;);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>The Company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and have:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD><FONT STYLE="background-color: white">Designed such internal control over &#64257;nancial reporting, or caused such internal control
over &#64257;nancial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of &#64257;nancial
reporting and the preparation of &#64257;nancial statements for external purposes in accordance with generally accepted accounting principles</FONT>;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD>Evaluated the effectiveness of the Company&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD>Disclosed in this report any change in the Company&rsquo;s internal control over financial reporting that occurred during the period
covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal
control over financial reporting; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD>The Company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the Company&rsquo;s auditors and the audit committee of the Company&rsquo;s board of directors (or persons performing the
equivalent functions):</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial information;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s
internal control over financial reporting.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-bottom: 24pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; width: 100%; padding-right: 5.75pt">/s/ Virgilio Deloy Capobianco Gibbon</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.75pt">Virgilio Deloy Capobianco Gibbon</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.75pt">Chief Executive Officer</TD>
    </TR>
  </TABLE><BR STYLE="clear: both">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Date: April 26, 2024</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>5
<FILENAME>ex12-2.htm
<DESCRIPTION>EX-12.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: right">Exhibit 12.2</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">CERTIFICATION BY THE PRINCIPAL FINANCIAL
AND ACCOUNTING OFFICER</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">I, Luis Andr&eacute; Carpintero Blanco, certify that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>I have reviewed this annual report on Form 20-F for the year ended December 31, 2023 of Afya Limited (the &ldquo;Company&rdquo;);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>The Company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and have:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD><FONT STYLE="background-color: white">Designed such internal control over &#64257;nancial reporting, or caused such internal control
over &#64257;nancial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of &#64257;nancial
reporting and the preparation of &#64257;nancial statements for external purposes in accordance with generally accepted accounting principles</FONT>;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD>Evaluated the effectiveness of the Company&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD>Disclosed in this report any change in the Company&rsquo;s internal control over financial reporting that occurred during the period
covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal
control over financial reporting; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD>The Company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the Company&rsquo;s auditors and the audit committee of the Company&rsquo;s board of directors (or persons performing the
equivalent functions):</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial information;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s
internal control over financial reporting.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-bottom: 24pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; width: 100%; padding-right: 5.75pt">/s/ Luis Andr&eacute; Carpintero Blanco</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.75pt">Luis Andr&eacute; Carpintero Blanco</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.75pt">Chief Financial Officer</TD>
    </TR>
  </TABLE><BR STYLE="clear: both">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Date: April 26, 2024</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>6
<FILENAME>ex13-1.htm
<DESCRIPTION>EX-13.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: right"><B>Exhibit 13.1</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
1350 AS ADOPTED<BR>
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections
(a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Afya Limited (the &ldquo;Company&rdquo;),
does hereby certify, to such officer&rsquo;s knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Annual Report on Form 20-F for the year ended December 31, 2023
of the Company (the &ldquo;Report&rdquo;), as filed with the U.S. Securities and Exchange Commission on the date hereof, fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.75pt; padding-bottom: 24pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.75pt">/s/ Virgilio Deloy Capobianco Gibbon</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt">Virgilio Deloy Capobianco Gibbon</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt">Chief Executive Officer</TD></TR>
  </TABLE><BR STYLE="clear: both">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Date: April 26, 2024</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>7
<FILENAME>ex13-2.htm
<DESCRIPTION>EX-13.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: right">Exhibit 13.2</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: center">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
1350 AS ADOPTED<BR>
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections
(a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Afya Limited (the &ldquo;Company&rdquo;),
does hereby certify, to such officer&rsquo;s knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Annual Report on Form 20-F for the year ended December 31, 2023
of the Company (the &ldquo;Report&rdquo;), as filed with the U.S. Securities and Exchange Commission on the date hereof, fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.75pt; padding-bottom: 24pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.75pt">/s/ Luis Andr&eacute; Carpintero Blanco</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt">Luis Andr&eacute; Carpintero Blanco</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt">Chief Financial Officer</TD></TR>
  </TABLE><BR STYLE="clear: both">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Date: April 26, 2024</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>8
<FILENAME>ex23-1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right; color: #333333"><B>Exhibit
23.1</B></P>


<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: #333333"><B>&nbsp;</B></P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: #333333"><B>Consent of Independent Registered
Public Accounting Firm</B></P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">We consent to the incorporation by reference in the following
Registration Statements:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #333333"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">(1)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Registration Statement (Forms S-8
No. 333-268886) pertaining to the Restricted Stock Plan of Afya Limited;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #333333"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">(2)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Registration Statement (Forms S-8
No. 333-268884) pertaining to the Amended and Restated Stock Option Plan of Afya Limited;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #333333"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">(3)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Registration Statement (Forms S-8
No. 333-251147) pertaining to the Long-term Incentive Plan of Afya Limited; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #333333"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">(4)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Registration Statement (Forms S-8
No. 333-232739) pertaining to the Stock Option Plan of Afya Participa&ccedil;&otilde;es S.A.</FONT></TD></TR></TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; color: #333333">of our reports dated March 14, 2024, with respect
to the consolidated financial statements of Afya Limited, and the effectiveness of internal control over financial reporting of Afya Limited,
included in this Annual Report (Form 20-F) for the year ended December 31, 2023.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">/s/ ERNST &amp; YOUNG</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">Auditores Independentes S/S Ltda.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">Belo Horizonte, Brazil</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">April 26, 2024</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>9
<FILENAME>ex97-1.htm
<DESCRIPTION>EX-97.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 97.1</B></P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; text-align: center; background-color: white"><B>AFYA LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>COMPENSATION RECOUPMENT
POLICY<BR>
<BR>
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.75in">This Afya Limited Compensation Recoupment Policy (the
&ldquo;<B>Policy</B>&rdquo;) has been adopted by the Board of Directors (the &ldquo;<B>Board</B>&rdquo;) of Afya Limited (the &ldquo;<B>Company</B>&rdquo;),
effective on November 30<SUP>th</SUP>, 2023. This Policy provides for the recoupment of certain executive compensation in the event of
an accounting restatement resulting from material noncompliance with financial reporting requirements under U.S. federal securities laws
in accordance with the terms and conditions set forth herein. This Policy is intended to comply with the requirements of Section 10D of
the Exchange Act (as defined below) and Section 5608 of the Nasdaq Listing Rules (the &ldquo;<B>Listing Rule</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-size: 10pt">1.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>Definitions</U>. For the purposes of this Policy, the following terms shall have the meanings
set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B>Committee</B>&rdquo; means the People and ESG Committee of the Company or any successor
committee thereof. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B>Covered Compensation</B>&rdquo; means any Incentive-based Compensation &ldquo;received&rdquo;
(as defined below) by a Covered Executive during the applicable Recoupment Period; <I>provided</I> that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in"><BR>
(i) such Incentive-based Compensation was received by such Covered Executive (A) on or after the Effective Date, (B) after he or she commenced
service as an Executive Officer and (C) while the Company had a class of securities publicly listed on a United States national securities
exchange; and<BR>
&#9;<BR>
(ii) such Covered Executive served as an Executive Officer at any time during the performance period applicable to such Incentive-based
Compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">For purposes of this Policy, Incentive-based &#9;Compensation is &ldquo;<B>received</B>&rdquo;
by a Covered Executive during the fiscal period in which the Financial Reporting Measure applicable to such Incentive-based Compensation
(or portion thereof) is attained, even if the payment or grant of such Incentive-based Compensation is made thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B>Covered Executive</B>&rdquo; means any current or former Executive Officer.<BR>
<BR>
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B>Effective Date</B>&rdquo; means the date on which the Listing Rule becomes effective. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B>Exchange Act</B>&rdquo; means the U.S. Securities Exchange Act of 1934, as amended. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B>Executive Officer</B>&rdquo; means, with respect to the Company, (i) its president, (iii)
its principal financial officer, (iv) its principal accounting officer (or if there is no such accounting officer, its controller), (v)
any vice-president of the Company and its Subsidiaries in charge of a principal business unit, division or function (such as sales, administration
or finance), (vi) any other officer who performs a policy-making function for the Company (including any officer of the Company&rsquo;s
parent(s) or subsidiaries if they perform policy-making functions for the Company) and (vii) any other person who performs similar policy-making
functions for the Company. Policy-making function is not intended to include policy-making functions that are not significant. The determination
as to an individual&rsquo;s status as an Executive Officer shall be made by the Committee and such determination shall be final, conclusive
and binding on such individual and all other interested persons.<BR>
<BR>
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B>Financial Reporting Measure</B>&rdquo; means any (i) measure that is determined and presented
in accordance with the accounting principles used in preparing the Company&rsquo;s financial statements, (ii) share price measure or (iii)&nbsp;total
shareholder return measure (and any measures that are derived wholly or in part from any measure referenced in clause (i), (ii) or (iii)
above). For the avoidance of doubt, any such measure does not need to be presented within the Company&rsquo;s financial statements or
included in a filing with the U.S. Securities and Exchange Commission to constitute a Financial Reporting Measure.<BR>
<BR>
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B>Financial Restatement</B>&rdquo; means a restatement of the Company&rsquo;s financial
statements due to the Company&rsquo;s material noncompliance with any financial reporting requirement under U.S. federal securities laws
that is required in order to correct:<BR>
<BR></FONT></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD><FONT STYLE="font-size: 10pt">an error in previously issued financial statements that is material to the previously issued financial
statements; or<BR>
<BR>
</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in; text-align: right"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            error that would result in a material misstatement if the error was (A) corrected in the
                                            current &#9;period or (B) left uncorrected in the current period.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">For purposes of this Policy, a Financial Restatement shall not be deemed
to occur in the event of a revision of the Company&rsquo;s financial statements due to an out-of-period adjustment (i.e., when the error
is immaterial to the previously issued financial statements and the correction of the error is also immaterial to the current period)
or a retrospective: (1) application of a change in accounting principles; (2) revision to reportable segment information due to a change
in the structure of the Company&rsquo;s internal organization; (3) reclassification due to a discontinued operation; (4) application of
a change in reporting entity, such as from a reorganization of entities under common control; (5) revision for share splits, reverse share
splits, share dividends or other changes in capital structure; or (6) adjustment to provisional amounts in connection with a prior business
combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B>Incentive-based Compensation&rdquo;</B> means any compensation (including, for the avoidance
of doubt, any cash or equity or equity-based compensation, whether deferred or current) that is granted, earned and/or vested based wholly
or in part upon the achievement of a Financial Reporting Measure. For purposes of this Policy, &ldquo;Incentive-based Compensation&rdquo;
shall also be deemed to include any amounts which were determined based on (or were otherwise calculated by reference to) Incentive-based
Compensation (including, without limitation, any amounts under any long-term disability, life insurance or supplemental retirement or
severance plan or agreement or any notional account that is based on Incentive-based Compensation, as well as any earnings accrued thereon).<B><BR>
<BR>
</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B>Nasdaq</B>&rdquo; means the NASDAQ Global Select Market, or any successor thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B>Recoupment Period</B>&rdquo; means the three fiscal years completed immediately preceding
the date of any applicable Recoupment Trigger Date. Notwithstanding the foregoing, the Recoupment Period additionally includes any transition
period (that results from a change in the Company&rsquo;s fiscal year) within or immediately following those three completed fiscal years,
provided that a transition period between the last day of the Company&rsquo;s previous fiscal year end and the first day of its new fiscal
year that comprises a period of nine (9) to twelve (12) months shall be deemed a completed fiscal year.<BR>
<BR>
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B>Recoupment Trigger Date</B>&rdquo; means the earlier of (i)&nbsp;the date that the Board
(or a committee thereof or the officer(s) of the Company authorized to take such action if Board action is not required) concludes, or
reasonably should have concluded, that the Company is required to prepare a Financial Restatement, and (ii) the date on which a court,
regulator or other legally authorized body directs the Company to prepare a Financial Restatement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD><FONT STYLE="font-size: 10pt"><U>Recoupment of Erroneously Awarded Compensation</U>. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">In the event of a Financial Restatement, if the amount of any Covered Compensation received by a
Covered Executive (the &ldquo;<B>Awarded Compensation</B>&rdquo;) exceeds the amount of such Covered Compensation that would have otherwise
been received by such Covered Executive if calculated based on the Financial Restatement (the &ldquo;<B>Adjusted Compensation</B>&rdquo;),
the Company shall reasonably promptly recover from such Covered Executive an amount equal to the excess of the Awarded Compensation over
the Adjusted Compensation, each calculated on a pre-tax basis (such excess amount, the &ldquo;<B>Erroneously Awarded Compensation</B>&rdquo;).<BR>
<BR>
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT> <FONT STYLE="font-size: 10pt">If (i)&nbsp;the Financial Reporting Measure applicable to the relevant Covered Compensation is share
price or total shareholder return (or any measure derived wholly or in part from either of such measures) and (ii)&nbsp;the amount of
Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in the Financial Restatement,
then the amount of Erroneously Awarded Compensation shall be determined (on a pre-tax basis) based on the Company&rsquo;s reasonable estimate
of the effect of the Financial Restatement on the Company&rsquo;s share price or total shareholder return (or the derivative measure thereof)
upon which such Covered Compensation was received.<BR>
<BR>
</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT> <FONT STYLE="font-size: 10pt">For the avoidance of doubt, the Company&rsquo;s obligation to recover Erroneously Awarded Compensation
is not dependent on (i) if or when the restated financial statements are filed or (ii) any fault of any Covered Executive for the accounting
errors or other actions leading to a Financial Restatement.<BR>
<BR>
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in; text-indent: 23.4pt"><FONT STYLE="font-size: 10pt">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Notwithstanding anything to the contrary in Sections 2&#8206;(a) through &#8206;(c) hereof, the Company
shall not be required to recover any Erroneously Awarded Compensation if both (x) the conditions set forth in either of the following
clauses (i), (ii), or (iii) are satisfied and (y) the Board&rsquo;s committee of independent directors responsible for executive compensation
decisions (or, in the absence of such a committee, a majority of the independent directors serving on the Board) has determined that recovery
of the Erroneously Awarded Compensation would be impracticable:<BR>
<BR>
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">the direct expense paid to a third party to assist in enforcing the recovery of the Erroneously Awarded
Compensation under this Policy would exceed the amount of such Erroneously Awarded Compensation to be recovered; <I>provided</I> that,
before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation pursuant to this Section 2&#8206;(d),
the Company shall have first made a reasonable attempt to recover such Erroneously Awarded Compensation, document such reasonable attempt(s)
to make such recovery and provide that documentation to the Nasdaq; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">recovery of the Erroneously Awarded Compensation would violate the laws of the Cayman Islands to
the extent such law was adopted prior to November 28, 2022 (<I>provided</I> that, before concluding that it would be impracticable to
recover any amount of Erroneously Awarded Compensation pursuant to this Section 2(d)), the Company shall have first obtained an opinion
of home country counsel of the Cayman Islands, that is acceptable to the Nasdaq, that recovery would result in such a violation, and the
Company must provide such opinion to the Nasdaq; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.75in">(iii) recovery of the Erroneously Awarded
Compensation would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of
the Company, to fail to meet the requirements of Sections 401(a)(13) or 411(a) of the U.S. Internal Revenue Code of 1986, as amended (the
&ldquo;<B>Code</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in; text-indent: 23.4pt"><FONT STYLE="font-size: 10pt">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">The Company shall not indemnify any Covered Executive, directly or indirectly, for any losses that
such Covered Executive may incur in connection with the recovery of Erroneously Awarded Compensation pursuant to this Policy, including
through the payment of insurance premiums or gross-up payments. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.05in; text-indent: 23.4pt"><FONT STYLE="font-size: 10pt">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">The Committee shall determine, in its sole discretion, the manner and timing in which any Erroneously
Awarded Compensation shall be recovered from a Covered Executive in accordance with applicable law, including, without limitation, by
(i) requiring reimbursement of Covered Compensation previously paid in cash; (ii) seeking recovery of any gain realized on the vesting,
exercise, settlement, sale, transfer or other disposition of any equity or equity-based awards; (iii) offsetting the Erroneously Awarded
Compensation amount from any compensation otherwise owed by the Company or any of its affiliates to the Covered Executive; (iv) cancelling
outstanding vested or unvested equity or equity-based awards; and/or (v) taking any other remedial and recovery action permitted by applicable
law. For the avoidance of doubt, except as set forth in Section 2(d), in no event may the Company accept an amount that is less than the
amount of Erroneously Awarded Compensation; <I>provided</I> that, to the extent necessary to avoid any adverse tax consequences to the
Covered Executive pursuant to Section 409A of the Code (or any other applicable tax law), to the extent practicable, any offsets against
amounts under any nonqualified deferred compensation plans (as defined under Section 409A of the Code) (or any compensation deferred pursuant
to any other applicable tax law) shall be made in compliance with Section 409A of the Code or such other applicable tax law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 22.5pt"><FONT STYLE="font-size: 10pt">3.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>Administration</U>. This Policy shall be administered by the Committee. All decisions of the
Committee shall be final, conclusive and binding upon the Company and the Covered Executives, their beneficiaries, executors, administrators
and any other legal representative. The Committee shall have full power and authority to (i) administer and interpret this Policy; (ii)
correct any defect, supply any omission and reconcile any inconsistency in this Policy; and (iii) make any other determination and take
any other action that the Committee deems necessary or desirable for the administration of this Policy and to comply with applicable
law (including Section 10D of the Exchange Act) and applicable stock market or exchange rules and regulations. Notwithstanding anything
to the contrary contained herein, to the extent permitted by Section 10D of the Exchange Act and the Listing Rule, the Board may, in
its sole discretion, at any time and from time to time, administer this Policy in the same manner as the Committee.</FONT></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 22.5pt"><FONT STYLE="font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 22.5pt"><FONT STYLE="font-size: 10pt">4.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>Amendment/Termination</U>. Subject to Section 10D of the Exchange Act and the Listing Rule, this
Policy may be amended or terminated by the Committee at any time. To the extent that any applicable law, or stock market or exchange rules
or regulations require recovery of Erroneously Awarded Compensation in circumstances in addition to those specified herein, nothing in
this Policy shall be deemed to limit or restrict the right or obligation of the Company to recover Erroneously Awarded Compensation to
the fullest extent required by such applicable law, stock market or exchange rules and regulations. Unless otherwise required by applicable
law, this Policy shall no longer be effective from and after the date that the Company no longer has a class of securities publicly listed
on a United States national securities exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 22.5pt"><FONT STYLE="font-size: 10pt">5.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>Interpretation</U>. Notwithstanding anything to the contrary herein, this Policy is intended to
comply with the requirements of Section 10D of the Exchange Act and the Listing Rule (and any applicable regulations, administrative interpretations
or stock market or exchange rules and regulations adopted in connection therewith). The provisions of this Policy shall be interpreted
in a manner that satisfies such requirements and this Policy shall be operated accordingly. If any provision of this Policy would otherwise
frustrate or conflict with this intent, the provision shall be interpreted and deemed amended so as to avoid such conflict.<BR>
<BR>
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 22.5pt"><FONT STYLE="font-size: 10pt">6.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt"><U>Other Compensation Clawback/Recoupment Rights</U>. Any right of recoupment under this Policy is
in addition to, and not in lieu of, any other remedies, rights or requirements with respect to the clawback or recoupment of any compensation
that may be available to the Company pursuant to the terms of any other recoupment or clawback policy of the Company (or any of its affiliates)
that may be in effect from time to time, any provisions in any employment agreement, offer letter, equity plan, equity award agreement
or similar plan or agreement, and any other legal remedies available to the Company, as well as applicable law, stock market or exchange
rules, listing standards or regulations; <I>provided</I>, <I>however</I>, that any amounts recouped or clawed back under any other policy
that would be recoupable under this Policy shall count toward any required clawback or recoupment under this Policy and vice versa.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 22.5pt"><FONT STYLE="font-size: 10pt">7.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <FONT STYLE="font-size: 10pt"><U>Exempt Compensation</U>. Notwithstanding anything to the contrary herein, the Company has no
obligation under this Policy to seek recoupment of amounts paid to a Covered Executive which are granted, vested or earned based solely
upon the occurrence or non-occurrence of nonfinancial events. Such exempt compensation includes, without limitation, base salary, time-vesting
awards, retention plans, compensation awarded on the basis of the achievement of metrics that are not Financial Reporting Measures or
compensation awarded solely at the discretion of the Committee or the Board, <I>provided </I>that such amounts are in no way contingent
on, and were not in any way granted on the basis of, the achievement of any Financial Reporting Measure performance goal.<BR>
<BR>
</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">8.</FONT></TD><TD><FONT STYLE="font-size: 10pt"><U>Miscellaneous</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 40.5pt"><FONT STYLE="font-size: 10pt">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">Any applicable award agreement or other document setting forth the terms and conditions of any compensation
covered by this Policy shall be deemed to include the restrictions imposed herein and incorporate this Policy by reference and, in the
event of any inconsistency, the terms of this Policy will govern. For the avoidance of doubt, this Policy applies to all compensation
that is received on or after the Effective Date, regardless of the date on which the award agreement or other document setting forth the
terms and conditions of the Covered Executive&rsquo;s compensation became effective, including, without limitation, compensation received
under the Afya Long-Term Incentive Plan, the Restricted Stock Units Program and any successor plan to each of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 40.5pt"><FONT STYLE="font-size: 10pt">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">This Policy shall be binding and enforceable against all Covered Executives and their beneficiaries,
heirs, executors, administrators or other legal representatives.<BR>
<BR>
</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 40.5pt"><FONT STYLE="font-size: 10pt">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">All issues concerning the construction, validity, enforcement and interpretation of this Policy and
all related documents, including, without limitation, any employment agreement, offer letter, equity award agreement or similar agreement,
shall be governed by, and construed in accordance with, the laws of Brazil, without giving effect to any choice of law or conflict of
law rules or provisions (whether of Brazil or any other jurisdiction) that would cause the application of the laws of any jurisdiction
other than Brazil. <FONT STYLE="color: #C0504D"><BR>
<BR>
</FONT></FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 40.5pt"><FONT STYLE="font-size: 10pt">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;
</FONT> <FONT STYLE="font-size: 10pt">The Covered Executives, their beneficiaries, executors, administrators and any other legal representative
and the Company shall initially attempt to resolve all claims, disputes or controversies arising under, out of or in connection with this
Policy by conducting good faith negotiations amongst themselves. To ensure the timely and economical resolution of disputes that arise
in connection with this Policy, any and all disputes, claims or causes of action arising from or relating to the enforcement, performance
or interpretation of this Policy shall be resolved to the fullest extent permitted by law by final, binding and confidential arbitration,
by a single arbitrator, in City of New York, conducted by Judicial Arbitration and Mediation Services, Inc. (&ldquo;<B>JAMS</B>&rdquo;)
under the applicable JAMS rules. To the fullest extent permitted by law, the Covered Executives, their beneficiaries, executors, administrators
and any other legal representative and the Company, shall waive (and shall hereby be deemed to have waived) (1) the right to resolve any
such dispute through a trial by jury or judge or administrative proceeding; and (2) any objection to arbitration taking place in City
of New York. The arbitrator shall: (i) have the authority to compel adequate discovery for the resolution of the dispute and to award
such relief as would otherwise be permitted by law; and (ii) issue a written arbitration decision, to include the arbitrator&rsquo;s essential
findings and conclusions and a statement of the award. The arbitrator shall be authorized to award any or all remedies that any party
would be entitled to seek in a court of law. Any such award rendered shall be enforceable by any court having jurisdiction and, to the
fullest extent permitted by law, the Covered Executives, their beneficiaries, executors, administrators and any other legal representative
and the Company shall waive (and shall hereby be deemed to have waived) the right to resolve any such dispute regarding enforcement of
such award through a trial by jury.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 40.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 40.5pt"><FONT STYLE="font-size: 10pt">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">If any provision of this Policy is determined to be unenforceable or invalid under any applicable
law, such provision will be applied to the maximum extent permitted by applicable law and shall automatically be deemed amended in a manner
consistent with its objectives to the extent necessary to conform to any limitations required under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #C0504D">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #C0504D">&nbsp;</P>



<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE>
<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_023.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $O!(<# 2(  A$! Q$!_\0
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MLON_X(^BFYZ?,O)Q]3Z#YNM*"#T(/T.:::>S3] 7HUZBT444QA1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /#_V9/\ DW#X
M _\ 9%_AA_ZA6B5[A7A_[,G_ ";A\ ?^R+_##_U"M$KW"@ HHHH ***^#/VB
M_P#@I+^RM^RO\;?"_P"SY\8_%'B71?B9XO\ @7\8?VC-%T[2_!NNZ]ILGPO^
M!?ACQ/XO^(6I7&KZ;;RV=OJ=CH?@_79[#1Y'^VZE+;1V\">9<0A@#[SHK\-?
M@7_P<5?\$O/C_P#$+X4?#?PU\3?BAX.U3XX^(;'PC\)_$7Q6^!7Q0^'7P_\
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M8-!;2?"/!/\ P2&_9YU#0)V\9?M0ZKXGU7QMJ.D>-OVFI/A[>_#W0_!OQO\
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MZY;PK%I6EZI?>+M3T6#PSX;=X+-CX?T;3M$MH[18;.UMD=Y4@MT50H_5,O\
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M9';7;Q0[Y$5,B>']H,^,#)K]Q>QZ1=2Z_=6=CX3BFN-"T^X7P]X9@\/:6;R
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M?$;]DCX(_$K]MCQG\*_$/P=^#VL:$)M%NO$OCO3-;\3>(]3\1Z;:)I_B;3_
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MUF$UHC:;X<M]2N=)N;BSNI]'U/7=+UI8X;:WEG/X"_M%?\% /VD_VA/V3?\
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M.?R5\"_M.?\ !/']H^9/BAX3_8=\/^+3K?[.>N_M1_M-^.=2\)?"*QUOX0>
M?&OB/XAZ+X_T?XBW U>75/B-XTN/$_PL\>Q>+/"_A";Q)]HFT6.>XF>:\M(V
MB5DW;:^GEY'\N1O9)N[22;2M=Q2BW;6UW%NUW;FM=VN_HK]E[_@L-\"OVL_'
M_P *?A_\-_ WC6TO_BM\2_VA?A[I]YKFJ>#DCT6Q^!?@/0OB3I'CC5+/3M>O
M[YO#'Q=\)>(=/O\ P4+6&75-.D6[M?%%AI-Y:S6PXGQ!_P %G/"/@#Q;XK\/
M?%/]F_XF>"M*\*?%?]HGX+7'B/3O%G@7Q_\ :O'?[.7P3OOCCXBMT\-^![_6
M?%%MI&O^'X+'3-,URZTJ/3M*U'4HY_$TVC:=!)='Q6W_ &I_^">_B_XP? SP
M5X\_X)\Z+X<^+?Q8\$^!?B!\'I+OP%\#]7N_^%'ZE\&?C)\1/AIXZA\0>%-6
MNET.T;P]\*?%?@Y/!AFC\2>'I=2TI;O34\.W+WT6%X'_ ."FO[$'Q6TNY^*=
MK^PQJNA^&I_$'CGQ)XO^+WQ'T+X,>#?A]HWC?XE_!+X=CQ3;Z]\3]4UUO#L/
MQ'^*OPV^)-GX$FTC4]2L=2\4Z3H?B+3)YY=)MK8WJ&>Y:U_P6DTO0/#OB7Q;
MJ7[*GQ(B\.>'?"/[&/C#[=#\2?A9?W5Y8_MRZIH^E?"*U71],UB^UA+W3I]4
MG?Q=!!97LEC%8&72TU>&^T^6X[_Q9_P5ITKPIX(_:$^)4G[-_P 0=2\"?LK6
M_@VP^.&MVWC/P5I]YH?C7QFF@7]IX5\->&-=GTGQ5XHAL/#_ (IT/6[WQ!_8
MVDV-PL]Y8:3#J5[IUPE?)VM_MX_L67_P_P!;U7Q/_P $YKR?X47O[,G[*?Q[
MUR:^TCX WD=S\%S\7&^$7[/%C<^%!XG;6#>_"SQEIT\OAO0VLE;P;:6(N-->
MUNUCMZXSXI_M_P#_  3(\#:'X%\>?%+_ ()_RS>#OBEI7A"#X3>)(?AG\*_%
MUUX\^!VF_%'6?!EWXXOM#L]4N-9TG2OASJ]N/$Q\&>)+=O%KZ+J<3Z%ILU[!
M<:=" ?MO^R9^UKX)_:^\._%OQ5X"T/Q'HNB?"GX]_$;X"RW'B>RDTF\\2:I\
M-UT,W_B>PT:]CMM;TC1]3;7(18V'B/3M*UR+R)&N]/CADM9[CZLKX^_89^+O
MP5_:*_9_TC]H_P" W@.T\ ^"OCSXM^(?Q O;>&Q\/6E_XK\46WC36/!.O>/=
M=N/#-S>Z=J^K>+I_!\>HG5YKRYU"ZT_^SX[\PW=O/;Q?8- !1110!%*5&,C.
M2%/K@L/;VSU[?2OBGXX^(OC1??&3P7\.OA/XAO-#MK_X>:YXMU.*Q3PI%++-
MI_B*RTI9/,\3V%[$X\J=O+MK7RG+,\TK,B83[3F^\O\ NM_(U\/_ !IU%-.^
M/0N&OX].F;]ECXH06<WVV*QGDU";7K,65O87,LD!&H2S -:"&1;CS4!APX5A
MI]F/=MZWMT;_ $6Q]CP'&^>XJK'!X3'U<+D&=U\/AL;@/[2H3Q5/#Y=+#U'@
MO9U7B94%B<0Z-!0;J594WST[<\/&_'7Q#^.'P^UV7P[K'C?XV:AJEOI-EK5W
M#X=T#X*ZO%9V>I3WEO9"6:+2TQ/-+I]VZP!#(+=%F/&<Y$/Q@^-R:<OB:R\:
M_$KR-"^(7P]\+^)-,\::/\*=.B%KXL\0:99&26UTG3%U>YMY[*YG$#64B9<!
MO,&R1!E_#G]HG]FSX+ZWXA\1>%XOBGJFDWOPX\+GQ/'>:?XR\1ZWJ'B+3M6O
M;:WMM*T[Q!-+J5U>K:7\[RV^CH(_)1IGBE5 U=C\1?B=X5^)WAWQ[KWANX6.
MROOBE^SA9V<%Q-9QW=\^E>+[.:^FM+6*=IYX;4WMLMPP\U86,L;$%"*5DG92
MOK;2ZTZ._JUOU5NQ^]5<JQU#%8/+<?X<T<%@YU<OP]7B7,N'\-E\Z]7'/%X6
MM%Y1'#YA/+<12IUX5:,)XN<H)4*TJT'+]S['^V;^UMJO[*,G[.)TCX9ZG\43
M\<OC]I_P=OM&\/SM)XKTVQU#P#XY\8OJ_A?1OW4/B#4[>X\)6]O)IMYJ&E6D
M6G7%]?2ZA&;5(Y?RC_9Y_P""[NM?%7PG\3_B+\1/A9\,_ASX6^&/P>T/XAGP
MY9^.]=U_QYXV\4>*OAO<>*_#G@;PII+:)8WUUJVH>*6L/#"6UGH>L2R![XPR
M-?6HM)/TZ_X*&_MA:9^Q+\ )/B[!\.H/C)\1;WQEX;\)?"3X11ZA_9>L^.O&
M6KO/)J4.D7\&A>)=1LSX>\%6WB;Q/J-[IVB7LUMINE7"2+'#=.S?!,W_  5@
M^'&L>&_BS\7?AK\'?@#K'P_^%^J?"+P;X)M_$7Q T_PY\7_%^J?%+1OAKJ&D
M?$JW\(6_@74(_#_[//@W4OB8MMXA^(\>KWS6MGX,\<WMOID;Z+=0Q$U:35[V
M?Z(_E"F[QB]E*G&:CORJ?ON-^MG4M>RO:]E<] _9/_X*WZE^TYXJC^%6H^"O
MA5\&_C)%^S,/'6L^"OB%\1M7TZ[T/]IK1OB?XM^'?CCX%R:1?^&=*\4ZGI?A
MZ+0-,U^#5].T.3Q+>6.LQE_#4(1&D^=HO^"WWQMT?X6^!_'7BC]F;P/J>I_$
M7]FSX8?M":1%X$\<^*]3\->$H/B1^U[X?_9BBT?XA:OJ_A33+W2K2PL]6N/$
M$>HZ/INM37^OVZ^'[2QELHY]976\2_\ !9#3/"7B+XNZ=KO[,?PLU'QW\*/#
MVKZAX7\5Z1\0K=_"?Q^^(VD_M%>"?@_>Z)^S[XKU'X?V^L_$.UBT#QE!XNU+
M4]#L+[7-*UJPN-#O=&,+1:JW$:S_ ,%Q8_#'PAG^*WB?]F;X,^%]&U#X>^,]
M3^$7A>Y^*YU_4?BUJOPX\4>/+/7O!NG3^%/AOJ]A\-+;1+SP*NN%?B-!H0N)
M'GN-/LWGCTV;4H-#U+5?^"NO[1?AKXI:3\-/%/PD_9STM=5_:R_:5_9;;Q1#
M\3?&QTRPOOV=OA[X(\>77BFZCUWPUX;MC:>)%\<V6FPV9U6*YLOL,UW''?\
MVE+:W] T;_@KCXYO=-^$/B^;X6_#'6M/^+_[6,?[."? [P5\0=5UW]J7X<Z;
M!J/Q)TNZU_Q]\.;K1M.TRT\27C^ K75--\.IJMMIC:+KMM=+XAO+@V]K<^6_
M&[_@K;XE^#7BGXP:-\2?V2/A)X[\/_"O]HC6O@:T'@/XC:CXH\8>(_%)_98\
M-?M,IXL@\.ZW\)K2VAM+CP[XETWPYXADDU";5+>/2-;UO_3-+L8%?R3X^_\
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MF?5]8EE-WJVGE-+U*2ZL(H84_1A00H#=>??/)P3P.2.3@8SGD]2ZB@ HHHH
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M5TSP]I\&GV5]XG\47TNJ>(M<N(K=(TFU/6-0F>]U"]93+<S/(S!<UZ&@PH&
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MGWNEQ:;=^.?%6KZ#]DOFBEE/]@ZEK-UI?GQRP*]O<?9#-;[I?+8;\K[]Y4>
MOEIM!R!L7 ()((&, @DG/J2:4(H.1G(_VF/\S0YPK'!.%)P."< G /8FDWVN
MEVVZOL[=?S-LQS/,LWQ4\;FV/Q.8XN:C&6(Q=:=>JXPORISJ)2LG*4EO9RD^
M:[;:X'H/RHVK_='Y#V_P'Y#T%> ^$/VE/A#X\^,OQ(^ 7A?Q6]]\3_A/::=>
M^--!DTV^M8K&#4DBEC%IJ-Q:K9ZD\"7%L+R.UED:W^TJP9MD@C]_^M2<(T(@
MZ*HX"\*!\J@@#IT ) '0 D#K0%4$D*H)Y)  )//).,GJ?S/K3J* $*J1@J".
M>" 1R"#P?4$@^H)'0F@@'J >_('7UI:* "BBB@ HHHH *KM&2H7'!)' [\X8
M#KD'!X*DA>"!P;%(5!ZBFG;_ #ZKT$[NUFXM-24E9M-.ZT>Z?5=4?+6K?LC_
M  <UO5)=9UF#QOJ6J/J=_JT=Y=?$KQT9+*^U*X>YNI--5?$$::?$'<I!!:I'
M'!;A;>-1$BJ/</ ?@70O 'AVU\-:$VKW&FV5S>W-L_B#6]3\2:E$U_=RWLT?
M]JZU=7U^UO%+,T=M UP8[:!$AB58U KL_+7T/_?3?XT91..1WZ,W4^N#S_3G
MI5.2M[MT^K6E_N9[&,XAX@S+"TL#F&=9AC<#0=-T,)B,35J8>C[*$J=+V5*4
M8TZ2IPE*,8TW&*C)QY9(<%5<[55<XS@ 9QTSCTR<>E+2*P89!R/H1ZCO]#2U
M!Y 4444 %%%% !1110 4A4-U /U /8CN#V)_.EHH X?Q9X/T;7[+4X&MK/3M
M2U6PNK2/Q%:Z;I,^M:;</;&WM=1LY-3T^^MWO+ NLUH;J":*-HD5HWC9DKY<
M3]C;2?[5EUV'XU_&$:W/IYTZ746N_ CRFVV!"WV0^"GLA*7/FM*MJN7P,!<+
M7VRRJV-PSCW(ZX]"/04T1(I) ()&#\S$8SGH6QU'I6BDN7KS*^M]'KUU[==6
MNFA[F6<4<1Y+2Q.'RK-Z^$P^,BJ>)II1K.I24%3=)2Q%'$>SI.,8_NZ4Z,'R
MQ;C>,>7F/#OA+1_#]MIZ065C-J-C90V<^MMIFE6FJ:A(D"QW-]=/I]C:11W.
MH3>9<WB6L4%NTTTA2)5.T=454]0#]0#Z>OT'Y#TH"@'('ZFO!?BO^TE\(?@K
MXT^%7@/XC>*9="\2_&?Q&?"_@&QCTO4+^+4=462RM\7MS96L]OI=F]YJ%E9_
M:[YXHUGNT9GCMXKB:&&[N]V_77\V_4\BK6K5YNI7K5:]1MMU*TYSF^:4IM7G
M4J-+FG)J*:BFVU%7/>=B<?*O!)'RC@G.2.."<G)ZG)]32[5SG:N<YS@9STSG
MKG  H!!S@YP<'V. <'\"#]#2TC(;L3IL7'(^Z.A!!'3N&8'V)]32A5 P% &<
MX  &?7CO[TM% #=B?W5ZD_='4@ GIU( !]@!VI0 HPH ''   X  X'H  /0
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M>)%L?M&;?^J* ]%[^/ .IPWX<CN/FZ@'MM%%% !1110 4444 %%%% !1110
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M6/P\\:^*;7X;^+=+\6_!7XN7<32V7PN^+NEQ^'=<UV-0S-<>"M<M[K4?"'Q
MMR(KAE_X0[Q'K%ZD-M/<3V,-LGG$ ^I**!R ?6B@ HI"=H)/0 D\@=!GJ2 /
MJ2!ZD"O+?BK\:?AC\$M A\3_ !/\7Z?X5TR[NCI^DV]Q'=7VM^(]5*EUT?PO
MX:TN"^\1>)M8**TPTS0M+O[T0+)<-"MO%+(@!ZG17PW)^T;^T/XPS/\ "O\
M95U72-#=1+I_B/\ :#^(>@?"Q]3AD4>6\?@C0XO'/Q#TM0?WC?\ "0^&]*E>
M(,(89)"B,Q/C-^V3X?077B?]FKX7^.+6/=)/:?!CX_+/KCQD_>T^U^+W@GX7
M:?>RVZ$O+:-J<(G5'%I++-Y<$@!]ST5\X_"7]J#X9?%37KOP$O\ PD7P_P#B
MSIEL;W5?A%\3]$NO!_CZ"T5=\VH:18:BS6/C#1;<?/-KO@[4M>TJ")X'N;BU
M^TVZ/]&!@V<9XZY!Z^F>AP<@X)P00>010 ZBBD)P,X)]AC/L.2!R>!SU(S@9
M( %I&X!.,\'@X&>.F3P,^_'K7C'Q@_: ^%7P-T_3KGXA>)?L6I^()7MO"?A'
M1+"_\3^._&5\BAFLO"7@SP_!J'B+7)$9HH[FYM; Z;8-<0-J5[:0RK(? W^/
MG[4GBQ)+GX=_LKV7A32G,O\ 9^I?M!_%O1?!.I:A"&(BNY?!G@#2OB5XJT*,
M!':XL=?L--U:/(!L0=BR@'N_A#;_ ,+D^,Y"@,=(^%>YAY>6_P")/XIQN"HL
MHQSCSI).OR%1E:]MK\Z-&^(G[7'@7QAXQ\:>,?V:_!_C^P\56GA:TN;#X"_&
MBTUK6M*B\,V6IPRWMGI/Q;TGX8+KT<ZZB[+8Z-;6FI>9$(WBOR8W'TO\'_VD
M_A9\9KS5] \-ZKJFB>/?#<(E\6?"OQWHNH^#/B9X54R+'YVK^$M>CM[Z73 \
MD4:>(=)DU/P[<22Q)!JLLLBJ0#Z HI 0P##." 1D%3@C(RK $'U! (Z$ TM
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M[2-6L=RIJ.CZO;66JZ?,?(O;6&?Y*] H ***:S!<9SRP48!/+' X ) SU)X
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MXUU;]I3X[7WC_P 0>%_ =KX_\5^';4:QX&T[Q1?S2>&](NM,T?PKI=UXLO\
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M^'7C7Q-XUU>_UVSUOP_<^)/"NO:QXF\;Z[/XF'AJ73XM)%Q;VUK;:>UB&?\
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M3Q%?#QE&;^_K[_@IU^Q5!?RZ-I/Q1\0^,_$$UU\*[#P]X7^'OPP\?^/?$WQ
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M,/V;I?AI^Q_X0^$_Q>T"8?$WXM^#M6\5?M6#5[W3M:U?Q9\<?B[H\\_QEO\
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M_+ECQ(>=CC+'>.26)(Y498$Y*CY@,X$)_P VK>]K*[Z]'H_P=NFCO@7CG,^
M,?F>9Y3A,%B<;C\HQ^6X:OB:N98=Y1B\;-N.=9=' 8R-*>8T*$ZV$HT\THYM
MEV%HXK&U<)@J6.QN(Q\?P+T#]E#]H;Q+X(\!>&;G]F1_A'?_  -_8/\ CG\
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MUU^R7\-+MII]<BT\?M+>,=+O D/PE^$&I.'U3P@^IVCN;7XH_%C33+X>\/\
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MZ5\<_C=\ ?B9\._C_P"(O$_PW27X*^ ? -K\,S=^%?&Z?\)#-XKC^(O@+3_
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M'YAB,)&KS3E&A6S/,LSJ*DZTZDO9.48P]K*M3MBZ="O3_'3XF_LA?'S]H?\
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M*)^%G)0!3C_BEAQQQP..PH_X8\_9"_Z-7_9L_P##$_"S_P"9>OJ(1J !M4X
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MV%I]-?\ !.CXQ^,_B2W[57@_Q3\0?B%XZL/A#\;=(\,>"#\8+WP;J_Q8\/\
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M]X*^,=C8* D.FGXE>"=,D\*>-9;*-5BL+WQ)X-\/7KVXQJ^IZG?[M1E^\:*
M/SEU'XO_ +4UAKWAWPG)^QSI]CK7BB;5+;1]5U#]I'P#+X:FGT?39=7O3-#8
M:+)XFCB6SC9ALT^60E2'$:N)!TTG[.OQ\^,\,FG_ +1?Q2T3P?\ #B\ 35/@
MU^SB_B#0!XJM'=7?2O'GQEUUX/'5_H+QA8KO0_!-AX&GN666.?Q'>:9<SZ=+
M]$>/ Y^*OP0"ARAU;X@*YQ(5 /@2ZP&9;J$(#\V"T-T,@XCC;]ZGM:\@=N!P
M.G2@# \+>%O#O@OPYHOA/PGH>E>&O#7AW3[;2M#T'1+&#3=)TG3K./RK:SL+
M*U5(+>WB086-%ZEF8N[,S=!110 5X[\9_@7\/?CMX<LM \<:=?I=:)J<&N^$
M?%OAK5;SPSXZ\!^([4J;7Q'X*\6:7)#JF@ZK#Y:),())-/U6T#Z7K=CJ.DW-
MS9R^Q44#3:::;36S3LUZ-'P=+X)_;.^&8%GHNL?"O]IGPM;%A:W?C<WOPC^,
MOV=AB*+5-9\.VFJ?#7Q3?1 LDVK?V!X*651'*=+ENFFG-5/&G[8>H,UG8_L?
M>'] N0VP:GXM_:.\)7^@,[@+YRQ>%?#ESKZVB'E]]F;M%!:&"655,GWT1D8I
MH0 @\\?3_"@&VTTVVG=-=&FFFFNMTVGW3L]#X3_X9;^)WQD:W_X:L^)&D:KX
M*AGMKI_@!\%+75O"?PNUN:VFBGBB^)'B[6)I/B+\2M-BEBA+: ;GP?X6U..*
M2+Q+X?\ $$,PMT^X]/T^PTFQLM,TNQM--TW3K2WL-/T[3[:&SL;"QM(4M[2R
MLK2W2.WM;2U@CC@M[>"..&"&-(HD5%51<HH$M(J*NHQ^&-WRQOORQO:-[*]D
MKV78**** "JMY96>HVMS8ZA:6U]8WEO/9WEG>0175I=VEU$\%S:W-M.KPSV]
MQ!))#/#*CQRQ221NK([*;5% 'Y^S_!WXV?LW3RK\!-/L/C'\"FG:>#X!^)M>
M3P]XY^&*S2O-=V_P9^(.IFXL-5\)@NTEE\._&YC_ +$"/;>'O$36<MGI%CD7
M7[8_PE\.6TDGQ,T'XU_!J\M(RVHV'Q(^"OCYET\* Q+ZOX,T;Q5HUW:$ RQZ
MI!>QQ308D9HPP4?HNRAA@YQ_GGZCL>U>6?' R1?!OXI/ \D<@\!^*2C1'#*3
MI%WDJ-K#)R0000P)4\'@!ZVO=V32U>B>K2ULDWJ[)7>]SY#3]J&+Q@HL_@A\
M$/CG\9-6N5?[%<GP5J/PH^'T,XB$EM_;OC[XDVFF1Z;;W#F,@6VDZA,]JTDZ
MV\SJ(F]&^&/[/OCG6_&FC?&7]I37_#GBOQQX<EFG^&GPU\%0WT?PC^#)O+?R
M+C4]*&K.-6\>_$6XMV:VO/B'XBAMS8VK?8/"FA:#&]Y?7OUYIP$EA92,QD+V
M5L=S$$D- F6! 4 OU; &35X#'KUSR<_@/0#L!Q0*24K<R4K;<WO6ZZ<W-;77
M2P!0O08SC]!@?D,#Z "EHHH&9&OZ'I/B;1-6\.Z]I6GZYH>NZ=>Z/K.C:M:P
M7VEZKI6I6\EIJ&GZC97*207EC>6TLD%U;2HT<T+O&P(8@_GU'X.^-O[*!BT+
MPYX>\2_M&?LT:?'#%X:TO2;\:E^T5\%K!9"&T."WUFXC@^-WP^TN)X(O#\*W
MMG\1]"M6ATR:3Q#8V9O5_1RF&-223NR<=&8=,8^Z1Z ^M ?I_7D? &G?MD?L
MO:@QBU#XU^#/ NHP.T%]HGQ:GN/A%K>EW"',D&J:=\0H/#A@EA4@2RI/<V;M
MN\BZF3)":E^V-^S9!/#8^&_B=IWQ2UV\=X]-\+_!'3-6^,&O:O,G)M].@\#V
MVJZ=OD4XCN;S5;&T#/%_I!,F!]T:KX:\.Z\@CUW0M'UM%78%UC2['4E"9)*
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MIKMO?M;N]!<RZJ2T;UC):)7DWHW:"LZCM:%US/57LT55^U?(SE -H'!+Y))
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MXB^$_P"TM\=_@W+\&O /CWP/X:U;P+X[\$WC:-\&_'GQ$;XJQ^ =4;Q)X/\
M$,,G@SPGK4,VF^!Y',-UI'A:TM=$CU"\M["&8?9R?LR_#&":TN['3=1TR[M9
M;*0W-E=6R27"6.F:GH:03K):W"F-M*UG5+.-DQ<6MO=N;2:WD) T=/\ V>?
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M$]).A>#_  ];6GA?1] \/^'/"'A'1S):Z'X<T72;:SBN;R_U.X:ZU*_NKN0
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M2L]TKVL.67^]&4:U:5DM.;DC[M6%977*^;WJ<>ND>:/6Y^0WQ:^ G[8VJ?\
M!3'4_B9X;MOC9J7[)>H27%SJ/A/3/B'%IWAN7QU'^S5\1O!%GXAT[0SX]L;J
MW\-2^,-7\-W#6$-EIT+^)]GB8:<%L%O8_/=!_9S_ &L[3X3?LS>&?!WPN_:
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MHNG:]+XHU?Q+/I.JWUIHNG:596G[G[1C;SCTR>.<\'.1@_=QC;@;<8H"*.@
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MX?\ LS,Z<\-F5:E'&1</K$<'4J0Y*,X5\50G5P4:E.-:4EX;X=\*^+- \">
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M[K_B'47LM&TNTABD,:2/=3M'8V=Q<1?DQXD_:$_;,BD\8?#NT^(?CG2?B_\
MM<>&O@9X[^%\OB#X>:YI?@?X'OKWQJTGX?\ Q0\ _!>6'2X=7EL/#_PLUJVU
M8>*?&_V?Q%>:]I&L>-GT&PL=5T[2[;^@'4/#'AW6H;.VUOP_HVKVVFW\&KZ=
M;ZKIEAJ-O8:O!]H,.J64%W!,EIJ4'VF<17T*QW,0GF$4JB60-L2V\<JL"IRP
M<;E9ED&]-C%)%97C?:%"NCHZ$*58;17Y2NOQ.S<>:5N:?+:/M)625YM.;LDK
MO30_4$DKVT5Y-1Z03;:IQ[QII\D'K>,8N[W/Q:\9_P#!1_XB?#/3OB%X'M?
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MRRQCX9?LGO(\:,/VK?!H1Y'B"-(GE <-(RH54M&[9+?.C-\P\D>&_P#!3?\
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M<6FGR0030P0Q2K(D2 =C'''%&D42)%%&BQQQQJJ1QHBA41$4!51% 554 *H
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M7/VJXEV64WVC ^*7_!8#]L73?C?^T-:_"O\ :M_9/UK6?A+^W#X,_9-^$/[
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MA?Z4$)(R>Y)ZY YZ ^@Z=NG0=!^2'@+_ ();:_'^T?\ "C]H;]H[]M3]H?\
M:T?]GGQ1XR\<?L^?#SXGZ5\-?#WA?X9^,?&6DWWAR[\02WG@;POHFL^+[W3?
M#FH7NCZ+_P )#=RBRAN!,69U(/ZVQ*54@@@[Y"<G.=SLV[T^;.X@  $D
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M/ANVTR6RER/ /Z4E\M!M!48)XW#.<C.<G)/S+UY^9<]1EVY?[P_,5_/%X/\
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M#7A#XC:9:>$;;P-IDU]X-U"]?4-4@UU #^D[(.<$''7D<?7TI:_G/M?V=_\
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M[3=8L;S3-4M;;4-.U"TNM/O[*ZCCGM;RRO(VM[JUN89 R2PSQEHI8G!5P2K
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MSI7B#1[_ %!]!BS/S4^B?'UQ_P %2M._:3\2:M\(O$?Q;\3?!^Y_:@_94M_
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M]M/]C;7OBQX?^'$O["FMV_Q?^(_Q&_:2L-$\%>)])^"?AOXG7.N>,OAIX_\
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MHGC1WMI_BS+##\,H8Q'X89;NX^(#3JW@Z"S-S)XA19IM,CN8+6Y=.HU/]O\
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M3XDZ1^QSK^N^&W\,?L[?#J'0/$_[4EAXZ_:4L+*QN[*U^#OB_3IX[OP[X?\
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MG=);,A@CGNAJ7G2)"8U$<;YC &0@#5KK:ZT5[O3TWWZVT^&RORIW/W+*>/>
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M)-63XJ1_":YOSX(FTSPO;1_#[6QX-EO_ !UXEU"_\-6NB:=)X<N[E>M^,/\
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MX1?#"PUR_P##C>#;[6;/P!X4M=6O/"'V&#2?^$5N]1@TF.[N/#?]EVEKIO\
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M_:(L+.X\0Z?XXL9[M/\ A9%\+5?B#JVF:YXDFAL;KQF]I(+K6='TS5!:B**
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M2\#>&+^R4>.9XKKQJ%M;K2Y8 /&%S##<>*0(\>()XHIM6^UR1HP\^UC]DO\
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M@3\$-$LIM.T;X-_"K2=/N!H@N+#3/AYX1L+*<>&=9NO$?AL36MKI$4$H\/\
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M:;]L'3="N?#'Q;^/OQ=UZS\6^$I]:\'^%I/CU^T[X4_:1T72M-T%OBGHEO\
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MGP]TSX4ZCX%7X:>.?#/@?6?!O@C]FK3?V?OAW='4]'^)2^,[+Q%;7%G/XO\
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M-?$VS\??%#P3KWQ9\5? /X=?!_X3_'71/V@?C1H__"B;SX<^$;[P/XDU72_
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M73[^YMOC%XQ\0Z3:>)/ T=J+;PA96EOX_L+O5_%FFVVG2?T ?LO> O''PO\
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M"6DZI<2>,M*%S9WD^FZSHVD3ZLMMJNF1IJ=O:W-[;VTH6[FCD_*KX:?MP?\
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MME>V5^?#MU'=6/FSV\/G-NH5-%SR7/&4HI2E:2BHW:2TTO!--JUUT3M]7E_
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M;>(=4U]QKVE^,+[Q5)9RV7B#6+6XT>>P8RV<R365O]]1CY<D#.6Y [;SCMU
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M^P6%M\2_#&G^+?"GBZU$&BV6NG4KO1KV_MK&Z6>RGNOI7P]^QO\ \$_[FY^
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M'[;P)8:/X>U;Q9>W?C?5O$'PETO1_!UNWAO0]4UBPF\27^F)JUG:-)I)O3+
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M)+<"W\-ZF+>35[367BNHEA /Z&CJ%@/-!OK,&!0\^;F$>2A?8'ER_P"[4O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
AHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_026.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_026.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '> IL# 2(  A$! Q$!_\0
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MO@])O^_+_P"%'V^#TF_[\O\ X468<R+-%5OM\'I-_P!^7_PH^WP>DW_?E_\
M"BS#F19HJM]O@])O^_+_ .%'V^#TF_[\O_A19AS(LT56^WP>DW_?E_\ "C[?
M!Z3?]^7_ ,*+,.9%FBJWV^#TF_[\O_A1]O@])O\ OR_^%%F',BS15;[?!Z3?
M]^7_ ,*/M\'I-_WY?_"BS#F19HJM]O@])O\ OR_^%'V^#TF_[\O_ (468<R+
M-%5OM\'I-_WY?_"C[?!Z3?\ ?E_\*+,.9%FBJWV^#TF_[\O_ (4?;X/2;_OR
M_P#A19AS(LT56^WP>DW_ 'Y?_"C[?!Z3?]^7_P *+,.9%FBJWV^#TF_[\O\
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MH:5K^H7>E7MY=::D1@N)84 N% ;9*R')/ QM&3W[4)XM2XBM/LEA+/<7$LT
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ME7,S795(;EHXKF"U,AGC&!N"#/\ %N&1P0N> :DE\+136=U$^IZA]HNM@FO
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MEM;PVRQ8A96CC& "3&6&>^",^V!A>Y8?O")JEQ)J.GQI*WERWEU#(&5>0@?
MZ= 5'OZUOUE-H4!DMI([BXB>"Z>Z5D*\ER2RG*GY3N(]?>M6IE;H-7ZA1114
ME!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 4K+_ (_]1_Z[+_Z+2KM4K+_C_P!1_P"NR_\ HM*NU4MR8[!1169/?S1>
M)++3U">3/;32L2.<HT8&/^^C22N-NQIT5@6GBB.ZOUMOLCJCW<MHLGFH3OC+
M@DKG< =AYQZ5=37M+DM$NTO$-L_W9L'9C .2<8 P1R>*;BT',C2HK/N-8L[=
MYHF<^='&\FUE900HR?F(Q4]K>"YGNX@A7[/((R<_>RBOG_Q['X4K,+HLT5E:
MEK?]F?:'>QN9(+:-9)IEV@ '/W<D%B,9('MC)XI9-;C2XF5;:5X()D@FG!4*
MKMM[$Y(&Y<GMGO@X?*PNC4HK(77";J"%]/NHQ</)' S[1O9 QY&<@$*<$^V<
M9%6+#5%OKFXMS"T<L 5F^964ALXP0>ORG(ZCCU%+E871?HHHI#"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&*3V''<J44^*)YG"(,GKUQ@>M3/:#86AF2<K]\(#D>_/4>]%T%F10PM,Q (
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M-W*2L7*R[];F/5[*[ALY;F-(9HW$3("I8QD?>8?W3TJQY6I?\_=I_P" K?\
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MM1DYB*C P>O3\Z%4CV%R,YG1-.'_  G.MVS7VJ/!8):201R:C.Z@NKEL@O\
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ML%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC\>M<4\/S:P.J-:VDCU.BO.?^$ZU;_GG:_\ ?!_QKL= U<ZUIOVAHO+=6V.
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MH"O\1!Q4T&I3Q:@M[*QGE&03(QR01CKU%:%I<Z&+H.UM/&(_WH=Y=Q+ YV8
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MZUT7A;P[=#5UN+VW>*. ;UW=V[?XU,W%)W944VU9'H%%%%>8=X4444 %%%%
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M*W:=9$)R[31J^U1R3DC/2M6YF^T7,DN,!FR!Z#M4-.]F<]6E[+KN14444S
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M8%85:OL]+&M.GSD&G64>G:?#:Q* (U /N>Y_.K5%%><W?4[TK!1112 ****
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M+B&2>_%^\D*QC4(X/D6241[U$/! +9P3G@9ZUK1Z%91V,EAL8V#1)$ML6.U
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M#745GQ:-;I>QW<DMS/+$2T/G3%A$2,' ]<$C)R>3ZUH5,FF]!Q304A(5220
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M)M,9Q]T@],\8/45SMGX:UN*_\(2""6T:.XU">7:@=;,2X*(>WM]2:I0CU?\
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M-/S/^-']@Z7_ ,^:?F?\:T:* ,[^P=+_ .?-/S/^-']@Z7_SYI^9_P :T:*
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M&V[Q(-N?3.>M2O/#'(D<DL:._P!Q68 M]!WKE9;6"W\%:K;SQ6Z:A)92WMS
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MP6+5%5TOK9R!YH1C_#("C?D<&K2(\APBLQ]AFBPK%VZ\M=+LUB!PQ9FW==W
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M;_OTO^%']DZ=_P ^%M_WZ7_"KE% %/\ LG3O^?"V_P"_2_X4?V3IW_/A;?\
M?I?\*N44 4_[)T[_ )\+;_OTO^%']DZ=_P ^%M_WZ7_"KE% %/\ LG3O^?"V
M_P"_2_X4?V3IW_/A;?\ ?I?\*N44 4_[)T[_ )\+;_OTO^%']DZ=_P ^%M_W
MZ7_"KE% %/\ LG3O^?"V_P"_2_X4?V3IW_/A;?\ ?I?\*N44 1P6\-M'L@AC
MB3.=J*%&?7BI*** "BBB@ HHHH *9++'!$TLKJD:C+,QP /<UA>(/%VGZ$CQ
MEQ/> <0(>1_O'M7ENM^)-1UV8M=2E8?X8$)"#\.Y]S6L*3D2Y6.Y\3^)-#UC
M2I]-AU*-'9E_>/$Y3@YX('M7"'1[<CY-:TYO09D7^:5E45UQARJR9FW<T&T:
M]5&EA6.Y1!EGMI!)M'J0#D?B*@;4;U[7[*UW,T'_ #S+G;^50Q2R02"2&1XY
M%Z,C$$?B*TXM:>X!@U11=6[\%RH\V/\ VE;KGV/!IZ@9-1/#E_,C;8_<@<-]
M1WK0U"PET^Y\M_FC<;HI1]V1.S#_ #Q52GN(LZ%>K;:]I\DX,92X1B.Q 89P
M>_%?0%?/VGQ1S:G:1RJ&1IT!!]-PKV\"[TP*!YEY: X.?FFC'_LX_P#'O]ZN
M6ONC2!I45'!<0W4(E@D62,]&4_F/K4E<Y84444 %%%% !1110 4444 %%%%
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M:/[-C_Y^+O\ \"'_ ,: +M%4O[-C_P"?B[_\"'_QH_LV/_GXN_\ P(?_ !H
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M-2L(M4TV>RGSY<R[21U'H1]#6L*LD]27%'@-%>GZQ\/+0Z,J:4C?;8OXG?\
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M **** "BBB@ HHHH **** "BBB@ JGJFF6^KZ?+97(/ER#J,94^H]ZN44)V
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K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_028.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_028.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ,]!!T# 2(  A$! Q$!_\0
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M<]_]U1G\Q4E%-+ ,%YR1GIQW[_@: &RG 0GH)%/\Z>&##(.1TI< ]1FF\@X
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M0/4 Y_I2KP03QR/?'/3\_P"=1-<Y*L, #/#$@\@CD=>/Z9SCHB74+G*L"YR
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M3Z3/('<@G\L?XB@YR, $<YYP1TP??OD4 -)#*VWGAA^..E,&1')D$9SC/NH
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MIZT &#@GC"MM/7).0,CVYZ?K2A6;."!@XYSZ ]OK2 L5(V,0QW9##KD'(RO
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M[VW\,#%.HI/FSU7&>FTYQ]=W7WQ^%  0<C!X&<CUXX_+K2T4ASV('U&?Y$4
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MJ6@ HHHH **** "BBB@ HHIK_=;_ '3_ "- #J*:OW5_W1_*F19VG.>O?/\
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MW/0U7LE_=^YDN<VM_ON9IMB9 Y5&(Q@YY'?@YQ@DDG(/N>]20P ,S;(PKKV
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MJ-\VU]DM>G5_*^JW^\!P!!R6+<=, ?CP!3B 00>A&#]#1122NTEU_P""_P!
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M^Q_WT?\ "CS3_L?]]'_"JN.1\HQYK^YQN7'KQUX].*<0/F^Z 5) )Q@MG_\
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M'7@YY]*EH **** "BBB@ HHHH **** "D!##(.1Z_P">O^12TASP%P!D9SV
MQP !Z?3% "T444 %%%% !1110 4444 %%%% !1110 57[M_O-_Z$:L5 %9BV
M,<.PY)'.2>P/K0 W(^3_ &6);V!D!&?PY^E-)^8D>61DD9[\]_ZT_D$@]1UQ
MR.@/MV/I10 $1=0V2.FXY!(Z \=#WI@],)_P'KWZ^W]<4_!P#QAB .3G).,$
M;>QZ\G&#UI <_GC]"01Q]TX.#U]J % 7)#':,#&#CUST_#_)I1MWKM)(YY)S
MR%;//T*_G0 6) QQC.21USCH#Z&@@H59N0&;A>3R@ Z@?W230 !EVR#/+,Y4
M>H(XQ]>U-^H.",C(X(]OS'7UI<$?*>JX!QTZ ^W8TIZ1?[A_DE #< $' 'S+
MS@?WA22]7]"/E.>Y50/?GD=NN<YP:=TP?1E_]"%))\P./8_D1GIZXH(G)K3N
MM^J,6ZEE2Y@5FB^SD.7!=A,&4$H(T0;G&.OH<<BN.U/QYX9T"Y@L-;\1:79:
MC?L1!;:EJ=E8L@4MMPD\\9Y&23C!(P 2 *Z+6 K26P:)G+,620%E\HJ%ZX&#
MDCE2P!&3STK^>[]JGP5'X6_:5U3Q5^TUX$\4^-_ACK+[?"WB+PSJ&HVNG>%6
M,J^5/J2VT\"B-3@@XDW%<%0,X#Z'(,EIYF[*K^]E?EBW"SU2ZJ]M5]Y_0E;W
M#WJ-<6UY'<V5T(WL[BS>.XC=5^4J)8V.2G W$XY.21R&?:+QP9$E$3LACW3;
M0UNPR(F,.-RL&.0CH"2.5&*_'F3]J/QKHNL^"/@E^R=8Z%KT<7AZ'4SXB\52
M3W=E;6\Y8"-Y(WG8O;I&%?>NT'&)2,FLL_\ !0'XD1^%=5T"]\+V[?&>Q\:)
MX;M4L\#PSK5P9WMKB\>-Y!<):V[X9MZ*YCR&C4_*'HDVWMM;;SOZ>1ZV+\-\
M^J5_:0E'ZO!*32:B^6;]WF3=ME\M=C]@[KQ':Z=96\NKZK!IQ>X:W&I7LUO9
MV[,VT +]I>)7ZYW*#MSU!( UH]0B,5N(;R.XB=&#WV $*X+M+Z,K*NY7QL89
M8,P(-?C'\6O'/QGU3X>V]M^T?\//!VLEO$^GR:1-X.O+^SBN5NQ%+#;2'-L&
MDBV9F;Y%8@ACM&2WQ)^V-\6?A[XH\!>&FN?A[<^"?$US#H,6BZ>L\^KV2-9"
MWCMYKC8L8:!,)*9)Q)O5L*^0:S=2"=F[?UOY!'PWS&ORN,TGHI)U%:R>K7*[
M._Z6>I^O7AWX@^&?%.HZMIN@:]9ZAJ7ARX:WU.UMIHI2Y<A KA#\K(RMR2 ,
MCKS6S;:W8:G<7,&D7^G7?V&0VVLVZW0FNH) ?F01QN=C$#(&T<L.<U^4O[$=
MY)#\3?C[=HK1S7NL6\D8A9RL/F22.4+NI4'YP<+NP" ..3\[Z3\;?'7P%O\
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MQ!J?P>C\<>%SJ,>M> =:L]:*6,CI/>6-FT<TD42IN"AE5P-Q"MD9* DK\?\
MCCXPW/[2NL_L]> -"F3[+9Z;:^(?$YGN[@207-G &N(-1DMW?&'8KY>6&_;E
ME4$K+DHZ/M<^LR[A;%9M!2P+]HX*]:\H6@K)WLK-;VUN?NK:2RR3%[2.W:UN
MPDL=XEQ]H5OED D549D6+@CA0""#W7/(:=\3?"6O:UJ_AS1-?TW4M;T%_)UW
M34F1IX"3@KY0*O&5)X^7J?O9-?D-XQ_;(^-GPI\;>$M$#_#.\\'-XMM?#$5G
MH\MY=:V]D";<I?#+)#\Q4EV=0&#9!P0OEVF_&34/A+\:/VB/B3X?T* WZWVE
M/J"7<WF6\K:E>P1.84W88H)2?E(P ,%CQ34X=6_Z^3/:I>&V>S;4HPM[.4UR
MRCKNX[MZ-6;MY['[ZV\CM%N$R?8!G=YKNKHW]Q'(WY#>_P W7)%5[I]4:2&2
M"/3FA7:"[3R*1; X\PJW#OLRR]3N^]@<5^4GQ\_;Q\:?"O4OAQ#9:)H>JZ?X
MU\,C6I+5BT+6\_D)*[-N(Q]XA,EB2,$+C-<K\)?V^_B7J'Q:\$>#?&%AX*O?
M#GQ WBS;PK97[ZCH\<Q50FH3O$( BJ_S")I-Q&,KP1LIP=DI;V2NNKLE?7NU
M\CR,5X=9JL'.I.FX252;;]HDO=<G*W=:-JSMY;W_ %SU?Q)HWA\03ZOXCL+&
MSU614LHK^^M+)/-6,N1'-<RP_*P!'RG(YSSBK6E:]%J,275OJ6FWEN_S0-I-
M[#?QRPCC=,T<DC8SDL_Y<#(_%#_@I+/X$N_B'\&8_B*VK2^!F>Z6[L=+N-02
M1WD^57:"RFBF>, $# #!MN0J$N/FKX)_%OQM^S?X'^*GCCX5>&-3U#P9-XMC
MTOP'9>+)]3BTYK6^98+=D74Y&E6W6X)$A$FYCE51A@E3EK*&C:^)K5+^N]SV
ML'X?8R62T,5"I"\^:+C.5-3M9V<=5)23Z-/KL?TI7$U['*K8=EE=MD5IB1R%
M RV&)!V\9"DCKM.015B.X=$<O>SW$FXC:R(KVQY)#*O!"YZN-H( STK\=I_V
MQ?VFO"_A3P9HOBKP9X*A^*OQ1O(3X2BT2.Z?2(]/4&:XEU,,$9@BE RPJ00"
MQ8 KN?:_MH?&CP4/B'HGQ;\+>%Y?&?@_0&UO39/#9E33;^-D+16KI))%*I#G
MYA)$$+ DRC.3F<&%\/LVK2J-.,M791G!]5K;MNM&OR/V#M[LW0>2VE>=[7Y)
M(9$56F;(##RU (4GH=H3&-IQU '.+D2SZ=%NQ-;RHKL7!)#+NRX0G&T@?,>G
M4U^%UY_P4!_::\#>&=$^(GQ5^'_@0^$_$%F+[1TT5YH+^S25]ELFI/=[(9I
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MCGWH#L2!L89/7CCWI]% "$D D GV'6F;V_YYM^E244 (I)&2I7GH?YTTL02
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MG(.<GH1T/!'MWT,_.N>#L)*^G*YY^O% #Z*:RAL9SQZ''6@!4&,^_)Y_7Z4
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M4DDORKE!(W& 1GY^.YZ?,0"?8\F@F2D_A=K:OT^Y_@<9XQ\.6'B?PKXAT#4
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MZ;L'U+QGX4ND\;^,-3^&&B:Y9:9K_P ,[864:+<!X9S;Q><J;4P),C;MY()
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MI=HVA3R  .?;I_*EI 0<X(..N#G'U]* %/(/;W'6F;#_ 'W_ !(_'L.U/HH
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M^^__ 'T?RZ]J /$/BM\$M#^).A0:(91HD%O,9EN+"-(GY'0",+A^!A^F1W)
MI?A[\#_"'PY\*+X5TVVBO;.XN#=7QO84D%W>2L[M<.IW@NQ/4L",G)KVHQ;F
M9"S,JCY5)..-IP3[D@9],CH *:$E;(9%7;AD(ZY!Z8XSP> V<=!B@"EI>B6&
MDQ"*QM+>TC)5C';1I$F<$'*@#H/N^F3WK3\K8Y:, $]1T],YY.<X'3'W1UJ2
M,-M&_P"]C!/J 3@X_'KU/4T^@ H/0XY/8=,T44 -!;/*@#UW9_3 IU%% "$L
M,84'UR<8_0T#..1@^F<_KQ2T4 %,!?/* #N=V<?I3Z* "D)88PH/KDXQ^AI&
M;:I8C.,?J<4Z@! 21R,'TSG^@I'Y! !)(('H,C'/I3J:1R<?Q<-DGITXYXXS
MTQ0 U=X"@J,  $[O3C.,?IFGG..!D^F<?KS2@8&/3BB@!F7_ +@_[[_^QIP+
M'.5 ],'.?T%+10 TE@>%!'J6Q_0TU%8%B0!DY&#GNQ_K3\\D>@!_,G_"@'(!
M]0#^= "GH<<GL.F::"V>5 'KNS^F!3J* "BBB@"(?ZUOH?Y1U+40_P!:WT_I
M'4M !1110 4444 %%%% !1110 4444 -*Y<-GH,8_/\ ^*-.J,L?,49^4CD8
M'7#]^O85)0 4444 %%%% !1110 4444 %%%% !5<]3R00S8(Z_>(_D:L57[G
MW<C\"^#^E "8(V\_>)'3IA@O'KP<\]Z=Y<G8ICMG.?QP,9^E*X ,8'3/N>KH
M>],(R6Z_>;N?[Q]Z  $E5'& 2P]><\?^/?I3@C$;E;!R1CH, D=0">PI0H*
M\YW =2!C?MQ@''3CI[]>:C!)"J3D;TXZ8W;BPR,'GK0 XAP1O(;(..3QTSV'
M7C\J3;N(7C#,3GOPIX^G'YTI #,!V( R2>P/?/>A?OK_ +S#\D!'_H1_R!0
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ML?XAZLP'U+$#]: %S_J^>A/7J!YBXSGGIZT\^3DYVYR<_7O36^^_U'_H*TE
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M*Q"8*C<,-QO8]<;0<G!R<_B"<C8!(E*EDXR8]HP .H)&['&3R<C(&3W) >W
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M10 4444 %%%% !1110 4444 %%%% !5?NW^\W_H1JQ5?NW^\W_H1H /^>?\
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M:0>.!R,GJ176?L@?L[1^#M(C^(?B^W^V>(]::.X\N[C61[9I(R6(:16*J#R
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M]H;<I)(#<<\_='?\33\CU'YTN.OOR?RQ_("FE%)R5!)[T .I  HP. /7W/\
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MX/0'CC_:8?CTIV?F([;5/YEO\!4:H<!@[ L 3C'?G^9- $U%%(02" 2/<=:
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M?E]1UK#O;**\C:QNK9+FREC=;F*0+M9'RK=<-D=P.#CH!6TP(<L1@9'(Y)P
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MN^0MW"DX]QG(_,8I5.0#Z@'\Q04+55O,$F05)!P 1QDKGKR0-IQCV'?FK)(
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M0 4444 %%%% !1110 4A. 3Z#/U]OQI::RAA@YQZ9X/U'0].] %*:;=P!U!
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MX+D*-6FA9U%L+0NHF>7S5 'E$./F*GBOZ/IK=9HI$)\SS5*!'#./F&&!7/
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M\Q<D$!QDY&#D\5ZS;:C#<6ZSV!BNXG&X^5(&(4A03C)ST/.1R0.@.?QJUO\
M88^)_AZV;6?A+\0VUVPBC$\21W)5I?* *@?."Y9=V0#G(ST(%9'@S]I/XM?
MK5XO#_Q/M-4@MH3Y$EW<02F!V0A<[G9LY"G)Z >GS8P4I)JT;>=O^ :2HW5E
M)7_PR_K[[=]C]MUZ?,I#=2"Y7'?H 0  1W_PJQ%QAAP6(4]^ VT#MVQSWKYM
M^%_[1_@3XBVT"QZI;1W\ZQ".)?ON[@;<@C@L"/E/'(."<U]%Q2AH1)N5(S\R
ML7)8Y.0P')&3R!T['O7=&=H1OJ_N[,Y^1W:NM+:V=GKTZ_UJ7_+7)//.<\GN
M03CTY%1[!YFW+8V;OO'KNQ4,<APP$N]R/E&2><CLQZGG@\\<#.09(PS%=^X'
M8<D$YR'; W=2,>_/!]*I33=K?BA-6=A02HDP>A !/./G9>_M4FT.%8DY*CH2
M!Z_UI0BC/?/7=SG!)[^YS]:4J#CEA@8PI('Y"K$("0%&?XV7\%WX_D.>M/(R
M"/48IGECU?KG[QZG.3]3D_F:-@_O/_WV: &M& I(+9 )')ZCD?K3D)(.3D@X
MZ8[ _P!:/+!ZL_\ WT:!&!T+CZ,: %9 QR2>F."149'ELNTGYC\V3G/*C\#S
MUI^P?WG_ .^S2&,'J6..F6/'^<#\J )*8$"D$%N/4DBC8/[S_P#?9HV#^\__
M 'V: ';1NW=\;?PSG^=(RAL9SQZ''6DV#^\__?9HV#^\_P#WV: $7Y7V#.-N
M[GDYSCKZ8[42_P"K;\/_ $(5')A,-ENA&=QSR5P-V1QU."<=3ZTA)**Q/& 2
MK$_WR1D$\CH#D'@9'2@")GVM\IX'(+,><' QVZ@DY!X('%!G8C!*X[X;!]>N
M*CED0?/@8(.!QG@L2 O)&1G&.O;!P:A\Z+:22J#(&64''(Z>H/'S#U] :"'*
MV\7_ %\BSYGL/^_C?X4X3E>!ZY^\#^K8/:J$DAV?Z,HER<%B3A0"#D'DYR,8
M[@GMBE,T2@*SJ'P-VW#8;@X/!'(STX[$=*:5W8A5KR4>5JZ;O*48Q5N[9?,S
MG.,C/KM('T ]?J/7VJN_"$YQQ'[<%5!_#DGZ\U4%Q&7V)(03R68L1S@ G. 2
M5X]CT/%*[3NP6+8Z@D&3S!MR#Q\H],<*!Q@]ABJ]F^Z^Y_JRW4IK252FF]DI
M1;O\GIZ['R=^V#X(O/$OPUCUC1=.-YKOAZ\-Y:X4M*BKO<@;/FP2BITRN?E(
M.:@_90\:^*?$G@*QTKQCHMSI>IV@,B&821[PDCH@Y5<KL (!!R,9&1S]4W:0
MS6[PS%)8[A=LD+X,9$1SRC@J2Q.[)&<D]023)9VNG6T<+)%:6SHNU/(BC@4)
MQG<(D0 @G//<MZG/.Z<DW97U>R?<?/'O'7;WHJ_H:J22+M0\[.C-@C/WCGIW
MV]S@\'-3F9SP=N,CC)!X.1U7U]N:I>:RR&5Y(EMB&"'=G+D')&>><#G@D8.<
M 8KF\R< Q,J I)([;"C9)VJ <'AE8/G/..@P7&G*Z=MGM9^?D7%.:;BE)KHI
M)MKJU;HMG?J:OG,O3:,^K9YZ<?*/Q_"G>>_ISZY7&?YXS^-9(NXMQV,+DM@_
MNF:3RP<]0>V>V>_TJ?S5?Y2Q@9B-N\]\G ZD#.1QT&5P<XK6R_F2TO:S^[Y?
MUH1&7/[7E2;I:M<RO)>7;OJ7/,)SP""?FPW)();C@8Y/KTIQE8@ JW'NH/3'
M)&#5!EG;='"REAP6XP#UYP1R<;01V(R0>*A+2$*RW"[(P4GSG(D8,%X/(^;\
M\87)I%^ZH<\JE.*_E=[_ 'K0T]_^R?Q<_P!,TX3,HP%/'N#U.>I /YUE_:%0
MS;K@;(HH\R#=@7!R&3G.<E@ ">2,8/ JPK(/E=WW* 6P6P<C(. ?0\XQT/&*
M-^J7K?\ 34S=2"5^>-N]]/\ @%SSI/1?QZ_C@4T.1@XZ8/WR>GL5Q_(?2J9N
M8G)2-]LAZ;F!SCK@>GH>"1D@8Q2K/ [-&9&1L85MQP"<\Y!QP<<9.,' ZY+6
MZI^E_P!3-8FA)V56'_@2_P RZ9F88*GGW Z'/4 G\J;O/]W_ ,?;_"L];@!7
MW/N*%1N!;&W(W'D DCIT!&#GBIO/0211 Y:4%EZX" #!)/<G.<G.<@XIV\TO
M)J7Z&TI02^.,M+Z.WYEL2NO3: 3W8GGZD>W2D\PL22 2?1R/;H!5-9[>2::W
M#GSXUSD9VKR0!@Y&<@GUYY&*56;RV+;25_B0@'N!SG'3:,9&XY8CD4*+;LFK
M]];?HR'445S.RCW<D6]Y&#MZ$'[Y/3V(Q^=.,S$8*G!]QSZ8P0>O?H.XQFJR
M,IC.9>QPW.<8R2<9(([CUXX!&5 5!F23@YVG)SUQG)Y' ^A]L\UR/JX_=+\"
MHRC*/.I1<>MFG9=7\ET6I9BR[%7ZX)!!(Z8&.N.I].>,=Q5E5"YQGGU.>E4+
M9XGD<+(20A)PS$@!@./;IG&>W;DZ &.Y/U.:EJSL-23^%\R[H9Y:\G+<\GYC
M3"@#A<M@C^\?1_\  5*5R<Y8?1B!^E-\L9SEL^NXY[]_Q/YFD,DJ-T&&;)R!
MGKQD#@X_ 5(>01Z^G6HR@Z%FY[%SR/I0 J$D')R0<=,=@?ZT^FJ@7H3SZDD=
MN<>O'6G4 1#_ %K?0_RCJ6HA_K6^A_E'4M !1110 4444 %%%% !1110 444
M4 %%-+ ,%YR1GIQW[_@:=0 4444 %%%% !1136.%)SC /)['MU]Z *+CY<8Y
MR,>_&&QT!QCGFLV0;KAD=/W0BD:7_9!P 3TX/!XSR#V/#[B:0-A,]<]> <XP
M2<]#@ < #YCUJM/<^3"T]X2B( (P "THP20PX)'N<YYQ@9S=/XGZ?Y&-6A&O
M+"QE*T88GG;NE>SOR.^\?Q/RL_X*6?$W5M"\ ^'?ACX1\0VOAWQ-\0[J?2["
M\O+K['';)+&^;B:X1T**97&UF(V\'L*^>?@]^UAXO^ 7[//@CP08Q\0/BO<Z
MY)X.L(9[^6XAOIV+&2[:8>;@6NXLPP057&<O7TC\>?V)=6_:-_:"TSQ9\0Y[
MR[^&VC6-O-I.DVTDD1,HC"M&LL3(R.'7=D')9L=Z\,\=_P#!/3X@^$[A->^#
MMY!%)X>\2RZ[HUAJC^=(I9>4269RP8D[3AEW\KGJ*C$):N-VEJ^Z27E\S]OR
M:IPC4R>C@,5.@\:Z<I-RY$G*SY8QEH]9:;WVMTO[?:?'G]JVP^'VO2>,? G@
MK2?%#ZA!'HM]=:E)#H?V*)5=+AFEBCS<PF1U^7H58Y]?'/"'_!17QE8Z9\2M
M-^)^A^&3XL\#PP/97&A7<LNGZO=3.L5G YD4LWF;U9RBD8&!R<U)\6?@;^UW
M\:?AOI3^(Y=/CU72;A&?PO:>9 CQ*X/GRO!(OG&;[KKG*@XP1R/)=#_X)Z_&
M3Q#J7Q!O/%8T#0&\0^'+#_A'K.QM))(EUG3%B>,W+HS$2'R2OS,=QR<9()YD
MTU>TEVNE_7<[<EP?!F'G7EF<<.H*3<4JD91;N^1:N^]KV[]K,Q-4^-WQ\\:_
M'#X.^)OBQX3T6Q\-_P!F7FOZ6+'4;NW6STU2UQ"UQA$$BE%3*@G&<<8.?37_
M ."BOQ.?74UG1O#_ ((E^'%QX@B\(AUO+MM8F5)C:&]VA3MBE*A\$D@OR.#F
M;0OV7_VI_&_BWX;P_$&#0;+PIX/T2[\/3316,Z/>0B)H1([+A<[5&,-DCDY(
MK-\%?L5_%;X;^)-6\/0^#O#7B#P5)XHBUJTO[NPFD>'S+T7#%'+ *J*<*<;2
M-H& :?)4G94W9]7Y?\/_ ,$WQRX,E6]M2>"ITEIR*2:MT^)Z/9]+:_/IO'?[
M?7QVLO%?B_0OAC\-O"^L>'_!6C0:_K>I:A>7:W$$#DM*+9%B*;\+\@8X+=ZQ
M=(_;\\8_$K3/%/AGQSX#&@Z1XK\#3:CH.MV][<@W:Q0O%.T:&%3$(I=XCV-N
M8#(/)%>S6?[)7Q#L?$'QNU2>>PLA\0/"8T?2[&WL)E@%P0PCC4D8XY!&2%)S
M[UYI/^PC\7KK2/!NDBYCMI-(\&WFDS/Y675KF29T5#QQM.-N,C<.I'-NAB%;
MWWJK[_D94I\$RYFJV&B]TTZ>]MDWTT3^7F<Q\.?VO_&WA7P+X&^&/P1\&)XC
M\=ZQ;R:G(-=N+N:RFMUG9)<.\<T@DP"26X/R\C'/ZT_ _P 9?$?Q7X2L)_B+
MX8AT/Q0I07T;R V'#(TD=H=B2NVV0H"0!A1SQ7Y6Z?\ L;?M'?"F]^'OCGX8
M7FD7OB+0M+N-'N=/O+;>TB22[Y)(PP^<X!ZCY>1A0"#^I_P!/Q1N/"J77Q;C
MT^W\2/<$2VL+*@7:81N49R 3O&T  LK8 /)N,91BE)WDMWZNZ_!_YGQ/$ZRJ
M4:LL#[&::CRSBXW=DHZ6[--/YV\OIM"H4KGNP P1QS@8.2.!QD]!GI48(('T
M&#[C ./H>.U'&6)Z@DD<<#)QTST7 X)'7N34I5=A/!.TD'WQN'\@??OQ5'YS
M'XG;5=7Y^7S& @,I/ !.3Z?*1_,TJL Q8G ._!^K C\QS2 ,<[0#@XY..< ^
MGN* 2#G )&00>G49_44&@KLK$8(( ;/XE<?R_2DH))(X4=@!W+$#G\J3G.W
MW9 QD8R1D<^XZ<=>* '%@510>1C(],*0<_CQ3> 0?=23[ C/Y 4]E"JAP W
M.._RX.?IC/X<=::3C_..O')[#U- "QL%SN.,JN,^V<_ED4W/)('!8G../F8[
M2?KVI5&6 .PCG(#!L\'MWYY_#-*%SYBKS@KC/'1B<9.<XP0#0 W/L><8]P>!
MCZ]OUI2?E5?X@Q)'< [B,_F/SIVQLIP, (#STVG)^M(WWV^H_P#05H 2GH0
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M(%R6N4QAD+APH9B#A1@;OER, IS;A?LM-]DM+_\  ,)QY7KO=W[77;]#QO\
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M)9Z/%/ ;VS_>(C"$E@@#(% ).,[>O'&37[-26L+VZ&>$.&P@"@*57YAM&U<
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MZ7E[VFOGHO4_I[\9?'/X=^#()[SQ+XZTR!H ?/M4NDFD^4_,JY=<Y'!QQDX
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MF6!C;RSGY2#\IQU)'"D@CJ3T]*\/^+?%>A72S:;KVH65Q$5,"17$@B+* %W
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M5R!P-H^4<\<YZ<<8ST]JN54E^^<;<XVD-P"I"G).1SQCZ=J ,.YMI&$PY*3
M[E&2I10?D*MG[W XXP3P#T^;/%7[+7P3\7>(V\3:]X&TZXU27'VAXHO)6Y*G
M<KS1QX5WW@2 G'(!(R!7U6H95;). ,YVX8D'/?J/E].=W<5$/*+ NN< Y.!G
MH>_;DY) ]^U!K0S*MATXTY.#=]4EIV:O>UM'OI;2Q\K>-OV8_@SX^M='TWQ#
MX*L;RVT&%(=-6.$0/%"C';&)$ )3#L"#U4X(&.=6V_9G^#\>@Z7X=/@;2UTS
M1=1BU738/LZ#[-?P$M'<(64@L)L2'();&,KGY?I%?)C8%4[;AD9)YZ=LC';'
M\(.2"<REED((5<8QWQZ]F'J<YR1C'3%*45)6DKIV\MM>AU3SK'UX>QEBZLH.
MSY;K[+NMM='YGB&H?!7X>ZEJ]_X@O?"^GW&L:AIJ:7<7LL"/)]B11&T(X "M
M&JJ .,+\W/3DM(_99^"]AINLZ3#X(TU-/UCS&U"S,">1/+,662<(5*K*Z94G
M!^8[_P#8KZ@41D<JN1DD<CY0QYR2>W0DD?A2Q>6KOE0%8\<<?*Q'/X8)SP3G
M'I4*E!7LK7\V$,TS&G?V>,KT[JS]G-P;2V3<;-I/5)Z)ZK4^3_"7[)OP4\'B
M;^Q/!=E;@7*3JC+OB61#N4HA&$"YX"X7.<CO7<W_ ,%/AW?:SJ?B2]\+:?<Z
MEJ.E1Z5>N\*;)+""'R$@10 4Q$<#E@<8QR*]R"ID[5!5F4GKU/!"D$8 R.>2
M3P20*?)&H1@J9+#;C)/)P0><]QTQSGJ!FA4J:^ROFV_S*EF^9SMSXW$3LK+G
MFY:/6VMWOKZGS_X(^"GP[^&\VH7'@G0+30%\0(@OU@3;N*JJ_NE4#8& *R Y
MSG.>.?//%O[)7P5\5>)$\2:KX1L[K6'N5DEF\I5BG7S!(5N8@ DD;OG<K*2<
M$EB&51];2-#Y8EF@+>1&T@"J"3Y0 ;"XY(&W@$8(/8U\YZ;^TEX)O/B#>>";
MUK>RU2*0P013,R2.P8H>,@<G( QN!&<@$8'2IO=?=*2_)_>/#YQFN$K>WPV/
MQ5"K[.5+FI5903A._-%QBU%WYGJTVKZ-&MX.^ 7PS^&_BB?Q1X,\-V>AZE>V
M[6]Q%IB1V]D\<GWLVJ*%W ' ((Y SZ#<?X/>!_[?U?Q*-"M_[6UZV:TU2Y9$
M+W5LX8/$YV9(;=\VX_PX&>M>I0V\=P1=PS?+\K!<@_*<$8!7..<J,'MG) -:
M:&-F((4@L 3SD')!SR>HZ$8!/;I1[*G:W*MK=?\ ,P6.QBKRQ/UFM[>?QU7-
MN4M;W=W9RNVW*W,V[WN?-VE?LW_"G1M.M](TWPI86EA:ZL^MQP10HJ'4)6WO
M-(H4!MWSC _O\GY26P?$?[(WP*\4:_#XFU?P/IPUB&02BZLXA;DRJ %8A%'.
M <DEN3G!P*^L7" X11@]>FX8QC&<A3G(((Y .>:9M0\'*YXRVTY]A@#DG'X
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M!7W.#_WRQ_F!0#DM[' _[Y4_S)H C7B1E'"XSCMG"<_J:EJ(?ZUOH?Y1U+0
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MLG?!34?$^JW?Q)\:6]Q?7>MS&^$MQN,:LTC,#&I5BJ!7"GG (Y.151^)>O\
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M5\4B[CM-6T>[633QM++ X$X+*&'F$,>!G(QP", X''OX&O>SYMTK>]U^]_\
M W/\T?&;P/SC@*M.IC<#3=+VLU?#+G@TI.SYHTVVFK>]/5]?/^G?PAX]L=>L
MHYH9X'=HU9@K@C>W!/3N0!D$$<UZ3;W4%R%V9+'.<\JW!.03V.._7.*_##X-
M_M"W^ESQ12RE;9 @VRG<VUF .<,.<$GCL#QS7ZK_  Q^*6D>)K9")U:9E0!4
M((R\:GKN(&25P.N>G.,?0T\13MI=_?;\+VMUZ'\Y>Q<KPII1Y=7=<C:7351?
MRM??0^@(&D9W#;E4'(;!^8^F!R.,'/;@'M5I4!R6^8AN"<@XP"/?@DUGP7 D
M4ORN#\IZA^ ?TSG/4CISS5C>X().Y6P"1G@$DC\,9&[KW'(YWBU4VTWT32Z=
M+?AY^;,)1G"7+)*WW_C_ ),B'REL-MY88"L> QP,@$?D<CCTQ44T;.BK'A49
M2D@  +*I.<\$@=3P=QR>M7A!&1N#/@\_>QU_#UI4B"Y).5.3CD\<X_\ '?J2
M223G%9^S=W_GIOV[]^@CY(_:>^"UC\1_"+RV=KNU&W5^%56+,J95F([ #)QQ
MQSR*^3?V1?C+K7@OQ'J'P1\=1J+*S!6QNKHF*,*\D:I"#(/E*AV4'HPW;CQ7
MZR&VBQ+$Z!TD)<AAE3N)7;C!]1@#DYQTSG\JOVQ/@AJFC7"?$KP=]HMKS3;@
MW=RUNP^8!I79'5%#,O[M3M/0+D<9%3)\CL[7M?92\MVOP*C*RM;S.._:S^"F
MJ_#3QK9?&/X?.R:'JMS'<:O:V:D+YQQ++,Q0F-OXB"2,;B  ,U]R_LU_%ZU^
M)GA.SEBND%_:1&&:"1AO9E5P.'Y#*5S@=,\]23YI\ _B1H7[1GP@F\&^(6@E
MU>*RN+&9'*I*98HS%N4,3A@5'.W.2>>,5\5?#35-=_9P^.[>!]6>2VT*]U>6
M.S67=O:,N^P[F(#@]-P4X'L36;J:[?I^!?.K:IG[EQYV)G@[%R,@\X&>1P?J
M.*4  8 P.>/K6-INJVVJV$5W9N9(Y4CD'/9U#$!ATP"&X)]^#BM-=Y903D%6
MSTS@],X[]/RXQAL]<?AC_A7Y(R)@H!R!^II:8J*#D$DC_:S[<BGTP$*@]1_.
MC:,8QQZ4UE4G))!Q_>QZTX * !GCUY- "@8&!T' HHR/449!Z'- !2  9QWZ
MTM)D=,C/IF@!:*3('4@?C1D8SD8]<\>G\Z *C8! 'F ;@,$=#D9SSC'7)Z\\
M X-#("I!)(Z8)R.OH!^5321EF5@<<J3R>QY[XP1QCCD ^N5,?JQ[=AZ^PH)<
M8O623[NR>G7\"FT8P!M#=L888&/I_L@?E4D<.\'^$J0,9/(P,=,?3FI]G^TW
M_?'_ -:GHNW/).3SD8Z#TP* 2I)WA\7I;3KL5O)*^9@=5P6)_P!D=!U/J3[8
MR2 *C\N0X/E'C[I!'&?3M_2M"B@HI)"QQN.SD';P.A&,=3VR?J.ISB0Q. 3N
MSP<<G@D8SSZ?RZ<\5*0)%#8Y'(!X((['V)&#[<BFXQ@NN!_LDDDX/!'IU/U
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M"O48.>F,#!Z<GGGVI#""/E)4Y'(/WN<Y;CD\G'X<\F@"I^YV_>*JK8RV#\W
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MMX?L[J)K@!Q$0C1L0"S!P>00<AL@=< #'H/QP^-GQAO-7O+^T@EF*[CPI)<
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MC)\%%*]M&[)O;9:CX+8F0$+Z8P1TRRYZD8YP0#GOT&:Z*W@565ESEL*VT''
MQGH!@=CSGITYJI;19.X*,#Y1@]1CJ<]1CKW(R0>!70V=NQ!/S<D ;<=\$^G'
M/ '7V[^=B=ODOS9]QE6!7M-K?=W_ *?WERT@1!M'WB%R,$\X]0#WSGD<J2>O
M&U;1@X()."<X';))Y].YQG)*CTJ*&V("Y!.[@]!TSDG/3GGDGKG!P%K<M;5L
MJ"!UR<\8ZEL<=>1V  (QGMP'W^7Y=&HU=6LUT[6^[73YVZ%BT@SAE&3CL>@)
M!/#$'/&1D MWS\V.JM(451P#@#)X7'+' )*CG@C;G'WN,@U0LH!M( SR/3!&
M<9QU/KQC/)XSBN@AM\JORG_9QP1SR21QGJ3C&,< DD >BNW;YGWV6Y8N6/NN
MU^R?3LFO/Y;^<\<49E48 !QP.0WS=<#(.".<\\#&0374V5ME"57/S@G ZX48
M)/0X/H6QCO63966^8*%"\9V]>X.#Z'.1^ ZFN[L[(P1[>1YF"3V7G  /KZG
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M[;Q[X.AL+JZA>_L88K>6-I2TIDCA5&5E/S9W*1P"/?')^S(&;>#AN1U;"YY
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M!5%[DEL(5 'J<=.O.,9/.,XQUR<X$9NB &WY7;N)Y!QR,!1ER00,D C!Z]Z
M-($$D#.1UR"/YCG\*IW4<4P:&:))T>/#12JKQD9;JK*5YQSGK@>@IL5_&X (
M(<]1E<^V><#/H3D=&P:=+=!"H"*Q8#:"1GKW]OUX/J* ,RRTVPT^4BRTFRLR
MY.9+2&&%FW'.6,:!B23DX)QUSQFMW<% 7N,$]< 'EB3] QYY)[<UG&_4(S;
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MCIUJ( A=QR.< $8X"9SGJ><X[8ISDG=D]-X'';./QZ"G29)V]@ ??)W#K]*
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M,$X!]5^('B>Y\2ZQ?2&;RK:"5KF]F=U"KI\9)N!N9@%)",<9[A@06&/Y:_\
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M8U..O  &"1P*>!@ >@Q0 Q&++DC&>GN/7\?_ *]/H(R"/48I@0*006X]22*
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MD$\GJ.P K"H^9:+M^?R-HQY5:Y\V_$"_NOC!^UU9Z;<#[59^'[DV\1'*((R
M!DY (!.<8(SD\9S^RWA[28=$T.UTZU41B%8PW (^55# =,@D*3GJ>#ZC\E?V
M,/#[>*_B1XE^(=VDDS#4[AX#]X;VDE"C>Q.#M)(7.,=^H'[#1 [9&;:K,@R!
MC&2  ,C [\\8QM]:SIIQ7*UYW^5K6,Y_$_E^2-( *#T'<^F>YJN[ACNY(!4
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MSI?P^\::#X4U[3+J2#5[F*QM+@G,XEF5O+7 *H,.%R<G*YQVKS?Q)^V1X?\
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MR%#9.-K#W(&/T)H 1V50"PR-PQ['GG\*?UZ4UBP'R@$Y[G''//\ *A2Q'S
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MKZ4H.&4_[6/SRO\ 6E93N)#*,XX/7H!Z^U  SAL  \'/(QQ@C^M-Z8/H5/X
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M)QP>>P/;&><XJ)J\6O(JDKS2WN?F[^U+XW>XN=2M%F15=-BA9.2=H( ^;H<
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M5/[M]^Y N/WI(*[B<'[Q.#@CH#@9%?EI^WO?+-KGA?1XP6FNM1L]B$#>?WB
M;  "W!8<YQR2>*YJLY13M)K5]5TOY>0'V-^REH$7ASX+^%K81K#+/'+=/G<<
MM*D.XXR,9P#U/4^U?1J@%MH((Y?<HP0>%V\[N #T^E>>_"?3VTKX?^$;!\;T
MT:U=UVX*EX58AP> Q(!  '0\8!)] !)P<D';C(QG&]O;V'^<UO!MQBWJVE<!
M0,9'H2/P7Y1^)QD^]&!Z#\A2_P#US^)Y/ZTH5R 0HP1D?-V/X50#=H"JV.2Q
M&,# QNY'&<_*._K[87 /49I!R!R<=0.."<\^O<]^_L,+@DX R<$]<<#'^(H
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M/T;!X;DY>9+5Q_'E\T_+?;L%I;(N26R ,]O[Q.<X/& .F#TZ9(K0#9WI@9(
M. >#R.#G''0\>P[YKJ-JL00O*@8[_*<J",XZ 9Z?*.]2H51,[NO&>N,9]![Y
MQW) Z<UFDI37.E+5[[;=]/(^B=3ZM3O"\=.G5MVUNGV\EOW0,H0$KDD#;STY
M/H ,G!)Z^F<\TWS&P1\O.>GJ2>^2,<@?CUX-/+*P8#!&.,9W;@=QP">0>.QS
MTST%1G"D \Y&X]B0"<CMSQR,=,]Z[:-.%U[J>B[_ ,R\^WF?)YGF,[3]^3MJ
MKM:/77X=/ZLBPB@H6.>2"5[ D@G& #P6YYX(YR 09X\!E& 1CWSD Y88[Y)Y
M]CCM4$>\@@ X/08X '3 SGH!D <<$D58C!;YCRW 4=SG&2 ,8 4Y'3GK@X [
ME""O:*_'T[GY[FF.7LW)MMM2UNKWNO+IN_3U))5+8 ^7IG! XY!./F/(P!]
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M!C)S^/3^E!4-P1D9S^/^36PA@1=A4$D-@YXSVQCCV':GLH8%3G!QTZ\'-*
M !T P/H*0@$8/3C]#D?K0 8Y!] 1^>/\!2T@4 Y YQCJ>AQ_@*6@!I*J<D_>
MPOY9Q_/D_2F.H6(J,XR!SUY8?3UI[*K?>&<9QU[]?Y4V7_5M^'_H0H :@W;V
M8X)ROR] "J\C/.>!W_"B155=V,E0!ST/;YL8R>2<\<_E4H4+P!@9S^/^100&
M!!&0?_U]J (]J;]NU<;-W?.<X]>E.\M/[HIV!G=CG&,^V<X].M+0!$\0*D*
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M5:<@,JLPVN"2#P!LP001SDG/\SP.)8G+KN/0@$$?B".IZ$8SW^F"0"6BBB@
MHHHH **** (CGS5Z]/?'1_P]*EHHH **** "BBB@ HHHH **** ,\E5D/F*!
M\IPP8?*,_> ZX_NXQ_=[9/Y,_ME&;4OV@/AI8*P:--0M&* 9S@,3E1QP< DC
MKP22<5^L3(C2EQF20*T+H""J@ ;6QD9Y[C(&<'&./R8_:-,NH_M7> (5/R)=
MIA,DY7(.?3.2F ,_,0<#!KDQ&NW;IWT_$:3>R;]$W^1^JWAE532-(C7GRM,M
M(SVR?*8YQVP!M Z@'&>.=XXW-C'48QZ8'Z9S^.?>L[2(O+M+90 %2&!  ,8
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M1 ("(P5!=U4XW,""&P ?L=_:VF_:GL(]2L7G50[VHNT:]#-@X"YR <$\J!D
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M]&[-]MS]JP^"C>DTKVIPOLK/E6FA:MK<'!('<< G''R@<8&.<\9ZD@$G&Y!
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M$D#JN,YK\8/V3<?;X>"Q#,HR<GC8<@G@>^!TSD^G[,:*P>TBF!W>8B( S?*
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M![?=4>CE1]%W@?H*0*"KMDY7.,'CA0>1WY-)SZD\DX/J<Y/U.3^='/(R0#U
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M=5U\SX?'MUY-R>ET_.^J7=::W_ A$NUHU(_AF^G.&Y/KVXR./J:^I/V<V/\
M9^HMM.UIP%'<8/TYZ_7K7RN^4,(.<,9%QGH#QCZ;@<_UP#7UY^SO;%="N9.
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M>C:"]^TL/AVZWW!M6BW_ "AOG09'/RC;G.!WOACXR?M=I\-?C[J47BZ.YMM
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MY 'Y9_Q-1NH$94=,C]6'^-2U'+]QL>W_ *$* '(25!/7G)Z="1_2ER/4?G3
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MZ4 7&D"N%.0.>V<D#<?<8!';DYIZEB#N&WG@9!X['BN<DUNTMI?L]W)"ETQ
M6%I!YC'JP 8]0-O'7D9S5Z.]E"!V"8;!4$8X/0@J<'N#SQ@9[4 :KDA21UR!
MZ]2!_6@,"HR1RHR..XYXK+^WER$_=Y/8Y._G((QT QZ'./REW,0#N()Y(R,
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M*,\X]@?SS_A0 44 Y /J,T4 %%%% !129&<9YQG'M2T %%%% !1110 4444
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M3:_\!=9>WC+2Z==M('V;W"+*7"XXQU+?KV.?Y^=-0I%$&7YU!5E]&4[,],
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MIO8'G&<4JQ8(! P.@ P.OIZXSST7.>.M.^4=3EB0<_CQ]!C]/P%311LW)!
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MC%!W<;=OODD?E@&@!F9&Y&$[889/UX[?X5(,X&>N.?K2#=CYL9]B2,?B!2T
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MR.D4[@#C&>Q_SWZCVI:9']P?5L?3<<?ACI3ZV("BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ I&8*,GU _/\ P&2?84M0ORZY_P!C]7.>* 'N3M<*</M)
M7C/K@@<YY'3'IZUF"9BZ84^8PD#$<9*AES@$8&1_#@9!'! K4S]XD?=].I&T
M-Q^)Q6'J=VEA;75VP_X];.XNL=>51R1C'.<8P>.!QS07!)O770^"/AW\2?&?
MB?\ :;\6^&&U:Y3P_H^H75L+0;#$ZQ22*8_N_0@DEUY*MN 8?H8ZJ,A N7*
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M.O'K0O)8#D^7(/QWGC]1^8I"I'RG@84D Y[X)Q@<@+D#)!XXS4J#YBP&$((
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M4<94J<D>Q ).3G@9SBOO4DJI/ "G'7^)<$=N1[G' /'3/SS^TGH?]L_"SQ'
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MG@YCB*25U4@]+;_\#RL2<X"\DGKQR>F!TZXQDX]^O!MQQ#&6) *@9.>X S[
M$Y'J><D 5#&K%E8@%<_=!^8,'Z8Q@^V3TSR :OH-Y&0  5'S=,L<9/'08.><
M>_%;TXRU]U].GJ? YECTI25XV7/9W;>RU6FM_2UM2+RG4E.=I.XGTSRO?KD8
MSGMS5N!)"Z$G*J0<'&& Z^GH1C@#!Z\TR0[)6&#C;@XP><C!'(S\HW#ICYB/
M0VT91L8JQ /'J  >2,]!T_0#D5KR2;LHMO\ /\3\MS?,$I5%S1OKUZ:Z[=?Z
M[E['4C"#. H&<_GDY/0C)'7@'D-"'>&W=2,Y &2 ,<$<9]<XP0,9-,5U;)"=
M\+T.>.@Y/3.3VX(Z9 N1*6#  #(! S@?*>O ]2,'H<=:TA":O>+6WY^I^;9U
MCU[-VDGNV[KR\MWO\A53J?F(Z9(P!@'/!'T.<=?8<V8E;Y2&?I@$XQNZ8]\
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M<I!P#]"#C)!]L?CTI"@#(H+8;=GGG@9&#V_"@!OJ/[Q09],-UQCGK[?C4X&
M!Z #\ABH64*R8)Y(SDYZ,F/YFIZ "BBB@ HHHH **** "BBB@!A7+AL]!C&.
MOWN^?]KTH=2XP#MYSG\^.H]::[,&P" , \C/4GW]J;N?^\/^^?\ Z] "%2IV
MYR3MYQS\S$>IZ=1[YIVYH_E(! /#$XR3\QXQ@=2!SVR<<"FG).2>>,'&.AR.
M/KUH)8YR<YZ@C*\=, ]/ZGKVP )UR>>23U/<Y'0XZ>E+_"RX&&(.?3&.,8YZ
M>HZ^W(!C]?;KSP.P]!1QD9) SR1G.,'TYZXH 5B6(R,8ST)YSCV'I[TW&/\
MZY)_G0.O&=N<#/KCIGUX)QVS@D'BEH ?&/O'W _(9_\ 9OTJ,K@E<GC !Y'4
M YP#CO\ X\\TH+#.T@9.>1GG 'K["CG)).2>O;L!_(4 ,=2P90P7>PR<;L$D
M^Z]-PYR#\H^E<-\0K,ZEX4UO347S';3YBPP#CY N<8[##8Z''3%=Y5">$/;S
MQ,BN\T<R@,-VXF/.&(ZKD9VG&X=>3R ?DG^QMJ\7@_XW?$S0=0<Q"ZF188L8
M5&=#M*C)W%RW.,8P!S7ZWP@*88%;#;1*YX.4/(.[ SGAL'I[BOQDUV=OAS^U
MYH=S-;_9M/U:ZCCN %\N";?<% 92, E " 26Q^!K]D8CYTC;!A94CGB=6./*
MD0,J[AP5Q@;1GD=L'&$OB?K_ ) ;HQ@8Z8&/IVI:9$,1J,Y..3[Y.?KSGGO3
MZJGN_3]0"BBBM0"BBB@ HHHH **"0.IQ]:3YMW4;<=.X/'Z=: %HHHH ****
M "BBB@ HHHH #G!QUQQ]:J74CHNU,#*MN/< HPR%QS@C.-PSC%6CD@@'!(.#
MZ'UJE>1,^R16(\L2-MR,-B-\#:3@\GZUC6V_[=E^2&MUZK\S\8OC2]OJ7[3O
M@R%V$C0:O&=K<D$29!VYXR<''/3KWKZB_::UCQ=X".E_%?P=-]K.D6EM;7VF
MP;F#P111^:6C4G<0,@#:N,D'<.GR1\5=3MO!/[4]CXL\4VDHT6WNO.&Y0T"E
M&#JR AE4G8PZD;3BOHOX:?%W0_V@O$'Q8\'0*#:2Z9<G2+:<!X01"RH\,;'*
M.6Q@XR_&  *Y+^3_ *^9N?./Q[_:*\%?'GP!X=NM-TAK7QM!<V4]Y&8SE#"Z
M&;;^[5@P.25QC'!R<Y_2?]F#[<?AEX>^W96?[-'N9@=VP)&5!!Z9Z<DXZ@G
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M;ZZ?/5_UZD5%L_D34445U&84444 %%%% !1110 4444 %%%% !1110 4444
M%%%1OR'!Z! P^N6/_LHH <PW*0#C.,'KT(/]*_.G_@H'XE@MO!.B>&$F*SZM
MJ*1O'CEU,B#..IRS8&#P/IQ^A!!,JJ'*A@QX. "K%<#!QT&3QG/KFOR._:TU
M#_A-_P!H#PGX.M"URNGM&TT+ O$)/,4@A5RN1M&>#@G/3@<E=J*E>^KOIKI8
M#[K_ &;-%;0?AMX8LG39G3+*9<#&1);*QSDY[Y/7)QQSQ](*,2,/3<?^^BK?
MU(]\5Q/@72QI/A/0;(A5>WT^SB.!@CRXX4VCC@8<Y7^6VNY4D[>GS(6/N?D_
MQ_E6E#6E"W1IZZ=_\P'T445N 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% "!0 0!P<Y'UZTUU)&1PPZ'..O4=^H_7%-EZKZ88]2/[OI47RD@;L9
M/)W'C@GN<=0!^- #LEBF1RK $^OS+^1&"#VSR,@\6*KX *@,&Y![<89?3UR>
MOI5B@ HHHH **** "BBB@ HHHH A?;Y@W8Q@9S_P/^N/TI"81T"MST!Q^/-3
M';U./J<?S--S'ZI^:T 0Y7/&%&!QD=><G@^F/RJ1$5ER0"26Y_X$0/TI&89P
MH1A@$GW)/'&?2G*ZXY*J><C(&,$COZ]: (R8P2-@X)'4=CCH2*:"ORAB"._/
MH#U[]<5/NC]4_-:C5\D;E0 ]_3@D=1CMB@ 9DPH4C ;./3AOZFFY'J/S%39C
M]4_-::S*" H1LYSTXQCTSUS0 Q3&<[B"<\9],#^N:.,G;]W/'IT&<?CG\<U(
MF&!RJ@@XX'L#Z>]1L/F<#CG'YJM "9'/(.!G@U!(-LL1)R(CO;!R<."I!XP0
M.I]1@<=:L$Y*YV@;@<  #CKDGMC)QZ\?5)=K$X/9.5Y.0Q...N< 8]Z /R2_
M;JTQ?#WC+P[XHA@='M+JQG-P@"J!)<R$@,.^,GCKCIS7Z4?#[7?[?\#^$-6@
ME6476BV$D\I8\GR$WJ2<$D@Y'8?AFOEK]M?P7_PD_@*ZF$*[X8%=)<Y8&'S'
M!.,YVY)(Q\H'S8 R)_V(/'J^)OA3::++<&6]\.SK92DE6'EP/Y>SN 0!TZ]@
M,9K"7Q/U_P @/NB($("3URP'8 \@#U'<'OGI4E1Q<1K].,]<9.,_AV[5)54]
MWZ?J 4445J 4444 %%%% "$ C!&0>U+THHH **** "BBB@ HHHH **** "H)
MQG;TSA\9SC) ';)/7I@Y[X&2)Z:Z[ACITY[CD$X_*HG'FMKIJG\P/GKXB? ;
MP7\226U^QB:X) 6X4#Y"2VTY* DE21U!SWQQ7YI/IUM^S3^TWH:V>RUT/56B
MM;I3E/M,,TFS>"  &"]N<G'S#'/[3RQG=]X?=7K@9_>*?89P/P S7Y6?\% /
M"<T%WH7C6VLGGETAX)I980S>6D;F1E.P'.[8IZDJ" WWAGFJP5.+=KVMU?5V
M*4FGJV_(\T_:,TBP\ _M#^$O'FEA(-,U^\BO'G V*8KS>2"0 A=BV6!)[9]:
M_6;P%J\6M>%["\MI1(TUK#(KCKCRXW.<$CD$G@G/KTK\[OBOHNG_ !Y_9ET;
MQMH\8_MOPGI=C=JH'[V,PP1+)N5,G"DXR0,8P<#BNP_8C^,0U_PY;^$M7N0F
MLZ;_ *,4<+N**PCPRD@DG:3TP0#C@&L(.\[^GYDO5_,_1I+AA'&71@Q!R"WI
MCD\9)YYXXP?P?N\WI@ \ ]<$#.#D=>_3\<\U%P0"?F<%2S 9 &XY+$?*!C=D
M'ZG/6ID*EEVD'DYP1_=;TKT*>S]?T0I)233V8@AP>H)Y& <$>O?V^H[4R:(>
M4PW$;FW''<X& >0>H !XZ@&K>!UP,^N*BG&4.!GKV]58#\S@#WP/2K>N^HH0
MC3UBK.][[GF?C3P?#XBT^6!HU,A5ER$4DX4L.O)ZDCA>2>:_(GX^_!.ZL;G4
MIHK=E12SDJKJP5G8@?*!R < #CIV&!^V4@9@-A"_-EB2 6![#.. "N3SC;SC
M%>/_ !1\ 0^)]*OS'%&TTD1W,RGU)!/4$D],YRIXRO)XL1%37+RVCJGUU^Y6
MN.IB*WNWC"RLFXQM-VZ\ZLWYZ7V/YA?'G@&TUVSFTK5+/S(@TD5LTB 2(Q!4
M%\@X&[DD8.<C&!S^5GQ/^%>K_#;6KTO:K/IL\CO')#NV1J6) <GC&&RWTX Y
MS_1E\9_@KJ6C7%Q=QQ3+LGF9FC4JI!/ !&<CT&<D'@XZ?"GQ#\!:;XFL9M-U
M2UVNZO$TKHX.X!A]\@*H).,@\G&#C%>)5PT4YM)6:M:RVWWZVMM;3[C^M/!'
MQHQ7"$L)1Q&.I4\$ITX5J<DG)4[R<FG*36_+T6Y^-,167<$42$;@<*<*V >>
M2,X)[_PCZU:A92%1<AN,Y[$'IP#T(ZD>I]17KWQ5^$>I^ =4:YTB)WL)<E_D
M9P(\H& P" -KY<GD#'3'S>81H@7Y!\A)Z8P6 &23G YQSCCH0"#7FSP\4[J%
MGW>JM^"/]#L@X_RGCG+_ *YAJT*CG3BWRRA=.,?B;O&Z3>L;7MI?NY"0H5NW
M0D8SCD#&1R1T[<<\G M)&!R,=BN,G&._./7I_/. D41!&1C<< G)!))'!/#=
M0  <X!YP.;7D@8!.#CH9,'\L=">!BHA!7::VLM-.K[?@?,YEC8T,34HJH[)R
M:OHM>WO.[75MZZ:=VQ1%B'[#..YZ=3SC)],9Z$GUT$CVG<1\JDDC(P/H3CD9
M#9R.O/3F!%*KM QGHN"3R.W&2!CDD'.#^-W"E5!R.6/NQR2>1QD 9XSCOP":
MUC!<R_JW_!Z'YWGN/C%3<9*3=TO>2>[];[O\B9#DK@XSD #H/ER,^^> 0<<9
M'<&W$A?&T@$$D\<$87KS[X(]\=!FJ\<60-H!&3]TEL' R,CJQ'/.<#/&!6I!
M"-C$#!..F20/7/(&3P>X&X=.F_*DMOS_ *N?E>=9C^[DG+6^NJT\F_Z\^C%6
M+",RD8&.?]T>O/3&3GMP,YR'J0P*KM7/4'GKTXR!R ._'J309%#A 1UP>3C<
M!SGG'0@<Y/+=^LT40^[@\<\Y!&#UZ9R<@XQC!Z=ZTI1U3OLVK6[M?U_PY^:Y
MACTU+W^D[MM);2]-?+K;T8+$0 -P[=,\G)Z#IU.3@X&,XP<5:12JD'@ *#SS
M@;N#V!/'&>^*<!L !'S>IXR<8&,XXV@DC^1HRN".,XYYZD9SZY.3C/(!Y/09
M]:E%66VU^FM_\NA^8YWCTG.*J7;6Z:[Z=^G:S%$9;)++GIEP<XXX&&&1UR?7
MI4L:,HZ_+\W Z$]. 02HZG&3R,D>KQ@'!'7D$X)YXY_'TSUYQS3MRC@E1[$@
M?YY_7-="I1DDVEKTMUVZW/SVM655RC)W7,VW=/OIIJM_ZT(F4_,Q8GJ1\K#'
M!QSZ#IR.GY4L0!&[&2#@'T^4<?J:DR/J#CL<'/'7&"/YT# 4$X P,D\#\:TA
M",+J*M?<\]T:=*3]FFN?WI7=[M.RWUV8,P09/3./\_E30ZMD@G"XSGL#GGKS
MZD=\#D4[*MQE3[9!]OZXJ*0*RL%*GY2!@@$LW QC/( .!@DG&!D5>G7^OR_,
MENR;WL#/\VU S8ZL6()/7'3J <]#QDCTITJ>64E9E.,@P*=\C@'/RJ"-O0C!
M^[DCGO';Q,D V(!,SE5W<,<MC.&.3C.._0=,<>T_#;X47VK7J:OK8:.VA>-H
M5D5@DR #)&0 < @N,G!!!P0<9U))I*/;5]'V_'S9DY.[U>KVN5_AK\.KWQ)=
M"]U"$1Z8I#*DA=9?E<$EN " .H YXQW(^[_"G@R200Z=811-;%4C"1JX8MM.
M22!UX&>.1QZDTO#6@*6BL-*M4$2@ M&,J"6QR3P221P3DGCD X_0;]GWX+7N
MI!)[C3W 25&+O&1C< 0Q'93U&1@ @@X.:XHN4[.I\5]]M>]OZ\C6E)2BW/1I
M7M>W^7I_5CT;]GGX-M%]GN;JR58RMO)'YBD')3));&<$_-^/.<9K]5/#>AV^
MCZ=;Q1>7N2*/Y5[9"@<D8!&#CMU^@YOP)X&M-%TV"-X%+(J;2%4;&4] 1Z$X
MP22 #Q7I$4:QRJ@  3"@'N Q7H2<\L,'D'! (KTJ$4H7MK>QR5ZV\8Z:][_?
MHGU_4N11H$!&"222P&"221GZ^E.5,$LV"<DKC/').?J<\CV')J2BMSCW=^O<
M***,CCD<]/?Z?D:3=DWV5P*US@A$)(+L "#CD$9)_ G\:^<OV@?BA9?#WP1K
M4T]SY5S' 7BVLH+D8 4!B6X;!R#@]L5[#XI\06NAZ7=:C>R>7! K/O88+$(^
M0I) X.,@$XXP1S7XN?'CX@:S^T!\5-&\!>&6EN=)EU!;?4&MF4H8HG<R>8Z!
M^-J<Y(YX/(P.>I4GHDTEK9=OG_7G<VHTHR;E)7\KV\OT['<_LB^$+WQGX_\
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M[G\#470Y 4<$<@D=NP!.??IU]:>X)< 8R5 Y]MY_I1Y;^J_D?\: &#)))QT
MX! []B <\]>GY&C&<G:#@98G'3G\^AI_EOZK^1_QIP0@."1\RX& >.O^- $6
M!Z#\A0<8.>12^N>Q(_(D?THP3\H_BR,GMP3_ $H 0K@X90,YQC!Z8SV]Q2X
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M"<XY['DXZ<Y!JK=QLT0/#+(HW(0.@&<Y/'0\DC(S@9%:$O ![!N?;@C^9 I
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MJ<XXZBOVCT'3DTO3+"P0 I9VUO;C:JJ@$<97 "\'YB.1GDY/3-?(W[,?[/\
M8?#CP[;7KQB'4]0ACN900/.,C1*S!V.&#%F)()^G?/V5"IB:*(D<H21U.0,Y
M/8'TQTZ#J<JE"IH[+2W1[:-]=Q5IIZ1>S:?SWV_X9;;EPJ"", 9!&<#N,4R-
M-@QU)ZG^0]3CW]?2I**[CF"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH 0L 0.<G.,#TQG/YU4N0=R/L#>7RI) ^9F"GGL .3SSG@=:G:948JW!
M!!)Z@^G7TY_"J<MPRR N08&C*C:,E90>6.><!67!'.<^H F3LFT!\!?M\>,&
MT;X>P>%K*5UO/$5_:6[11, SQW%S&&)4<D8!SGDG/3<*]D_96\'0^%/AEH0
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M//N,XP>O;UJ&5S&K%1DG:#@9P/F&1[G)^F/>@+-Z)ZO;^NQ&SY4Y)QP>W/\
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M110 4444 5ITD;;M/RY&\>@!Y8#/)], GBL^]TZ.[M+BTE59+2:/:T;*&!'
M. ZD<Y)([GU-;-1R_P"K;(SD8QZY(Q^M<TX\TGLK-]-]%Z#4FMC\A/VJ?V5)
MH+\>*?!;7.EW&EW?_"2PZI8/LN!J*GSVL&\IHW6W+1JJIN" 8.W X]1_9=_:
M8TWXJZ1<_"_XG64-GXB@M!ILTETJNMX(T:W220N&57,<><Y))^\=O-?H)K.D
MIJVDW%I>107*3JH(:,,RAOE?C/S$*2<9'4],BOR;_:3_ &7/$?A;7O\ A/\
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M  QP<\C(Z$?UI$/RJ,;""<J,=<'/X=_8@"G@@X(.<\BG==U]Z$,5-N=Q&#M
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M_ ?_ $!*VIX=4TT^K73MIU1+K2EO>Z_FO?O;IH48[$1C;&JQDL'XQG(R,DX
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MP[#\D+']H_1KCXR:)XH\1>)/%7A-HO \&M:UX9\I3;74B1/,@ =D!+%2F=K
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MZ4 (^[*L5P%(SSD\LO0#Z5*#D CH0#^=0EV8!=NW)49W X^8=N,_G4P& !Z
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MRN2I7).<*,* *MZ#^TC\)M4UI?#UKX\TRYUR=Y4%O)<$6RNA8LB.1Y1 520
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MVFZ;81"*((C1Q*&61, NKX_B4=R &('3FO4K?3X+6WBMK2)(84C1!M51N5%
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M;/K=_P# N?AGJ_[._P 4D\*_LN-;>#[J*\^']U/'K BMQ'.D.QA$DQ0!CD\
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M110 4444 %%%% !3)/N'ZK_Z$*;(2"N"1PQ./;;_ (U'G/5R1UP2.W/;TZT
M+W7_ 'E_]"%6*K<$,<_=V8.>F6.3Z5.IRJD]2H/Z4 .HHHH **** "BBB@ H
MHHH A89D YP0,XX/&\_S%#+LP5)R3MYYX(ST]?E%2$+G<1SPH/<9./ZU&P("
M@G<V23],$?U% " %V^8_PGI\O0C'_H1_2E10\:[L]6/''4L#^'-+&!\Q[YQG
MVPIQ^?-,8[6*ABH!& " .0#W]R: #ID>A(_(D=L#MV 'H*<J@>6V3D]<GCE&
M)X[4P]#SV)S[GG/]:L8'''3I[<8_D<4 1N",$,V2<9R.F">@&!T';]2:C()S
MEF.U'8=.HQWQD#Z8SWR.*EDZ+_O?^RM34 );//R@?@2V?SP/RH >HRJDLV2
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M:IEU7.'* 9P5X &=V[DC(7J+$D6P)&%"C[Q'J1D\]>/;'X&OQO\ 'G_!31O
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M=OQ: JD\< D^F&'ZC!_(C\LBD,9&"BE6S@$@'J#SU[$ D\=,9YJW12:NFNZ
MK!)0O.TMMP3@$9_V1P>1[\G'  Q4R!@/FQG/8 #H/3WS[XI]%9^S?\WX?\$
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M<$9Q[]*4.IQ@YR< @$@GGOC';)]!R: '44A(&.O/H"?SP#C\:0,I[]!N.<C
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M7!Z9P",YYLQ7RQ2RP+>Q7MWM\U;6.2(RQP[N R*V_.TX#$=ADYSG\EO$>C>
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M[^X]J6B@ HHHH **** "BBB@ HHHH 8P)>,XX&_)],CBGT44 %%%% !1110
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M:K86-N]U>W4%K;H,F6:58X\8!;YY-B97G(#$#')';.T_Q7X>U=C'I.KV&HR
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M@N+^UL8GNKMH8+2&%E23SX<%!][>6D/R@D'=G@Y /I!#JME?6=G-8W5O>6[
MRF[BFB,<:<8C,I.T/GL2> 3@X&?R)$_QEU+X9#4_$/Q%%QI_B[PGJ6L6B6%O
M(MWILB&0"!F9B-T;%0Q 7(4\*!6K\)IM6\(?LS6=WJ_Q7NIDU?6IH;F:=9#J
MT1,S)%%;,'+<MA57(!Z#)Q0!^F7C#QMH?@GPZ_B[7G>VM(K]+7Y9O,"L[[$8
MF-F5@QR?J, 8(KL]*U&WUFVLM<LYQ<66I00W$!08(1XP0!P#D#DDCJ!SUK\:
M;+Q_XH\3?!WXJ>&O%^I7FI6OACQEH2>&;G4;>:SNKFWN[R&.=[DSD;E%NY,1
M7Y0V?O'FOUH^%<97P'X4\N0&(:19J@VD[<1HHRQ/48!)R><D<F@#U*3_ %8&
M2<XR3P3A203T[@'M4U0R',:GIGG&<_P-W[_6IJ "BBB@!"H88(R.O-+110 4
M444 %%%% !1110 4444 %%%% $+\L#V91CWP23_Z$.OK]:;2MQL7NJ<^G.!Q
M_P!\G]*2@!&Z'Z'^56:K'D$>H-6 <@$=P#^= "T444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %,0$;\C&78CZ'&#3Z* "FGY02JY))
M.!W)YR3_ )]!3J* $) !)Z#KP3_+FC(R!W.<<'MU]AU'6EHH *:753@DYQG@
M$\?@#Z4ZB@! 01D=/Q'0X[\TM%% !3'!.S SAU)^@SDT^B@"C<(SR!6!,+#+
MA0<LP&%Y&< 9Z'TSCG-<AXN\%:+XQTJ?3M3T^"[B$<L:+<HCJN]&7<F]6P5Y
M!(QNZY(.!W;MM X)R<<8XX)SSQVIHR%#YR K,>,$Y(8<<C@ CK6,OB?R_) ?
MBE\6O@I\1/V>_%S?$/X43WL5G;N;F33+02&W96>0R_Z,I6-T?/"[1QC  ''W
M+^SW^U%X2^,.FBTU.2TTSQM;1P0ZAIDCB*>>4N!^ZB<C<-Q _=E^W!!%?4>M
M^'],\3V<^F:I;))%*C(6 YQGUW9P.W )SD@ D5^4GQ[_ &8]?^'VIKXY^&C3
MZ;JMK<-/%>6Q*H /W@6X,:?,C%0$./J5 .)VU[ ?K6-L+JD,D<<K ,T#LHDQ
MCNIY88R00"#C.,FM195X1W7S0,LN1D=_ITK\X/V;?VOM.\9FR\#?%E?^$9^(
M6DI':0:C=D16>JQ@B.-V+$;G?;RQ4!3@KN)*C]"(I9 GF;8[CSQN%Q&\;+M?
M 'S(S*058,,$@KC'/!OG?9?C_F!M!T)P&!))&.>H&2#Z$=\TNX$E<\CDC\O\
M1_G-9]HI1MC$ER3(QR2O*E0%.!]3D =NM7UP1NQ@MUSUXX_I6B=TGW 4$'.#
MG!(/U'44$A023@#_ /5VID?\?_71OZ5(0#P>1_AS3 :=I(4\D?,!CTXSZ=^,
M_4=.&OE@PVG *X_VOFY]L<=ZDP,Y[XQGV_R** &1L"H .2%7/MQ_]8TX$$ C
MH>G!'\^:;&I4$'&2>WH !W^G^>E/H **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BD)"C).!2T (?X>2/F[=\ G'T('Z5 TB
M@D;!W!.#DG)4'*@XRV>^?3M4S=4_WC_Z U1)G?)@XY7MG(WRY'X^M '.:U:6
M>H65YIUXDYM+ZVDL[L6[-%*]M<!HY560#,:D,V2!T) SM&/E2/\ 8\^!UC>0
MW*:;XB:VEOA>1Z6OB*Z?1!>;R_VB6VPT0DR3GY=P+-Q@YKZYU6\CL8);J::*
M&WBW_:);ATBA2$ %W=V.%5%8DDG)';(X\W7XG_#F)IK2Q\9^&W5][B.>_A9(
MY5X8JQ/WE;(Q]T9^]QR >2:A^R=\+I_&">.[,>(K'Q; UI$+F/7KNVAEL[,(
MD%LL:%8V14X)X7 ))!/,&M_LH?![6?$.HZW):>)[2^U?/]K1Z9KMS!9Z[&NT
M&.]&0)-S#+>8N,@!N"37L[?$OP,VF3ZY#XQT2[LK6X%O=W*7$4MO:XP9$1PV
M]\ $_("1R ">M]?&_@JZTA/%D?B+2W\+K*EO%J\-RAMX[AD.])R,;&SP PSO
M*#!R2 "GI?@OPYH'AVP\%Z9IITG0+2)K/2C8RL+^V<J5DN%F3:T4LN[)9MK;
MDW$8.3Y9H?[,/PGT+6/$%[=VFL^(M3\36MQ9:M?^(;^755,-P&5U19%_=LI/
MRMO)!&\=B.4U/]J*&?Q?XE\/>%;+2M7@\,V\=P]XMRI5TDRJN[<\N/G'!!&&
MR,D5Z[I?Q5T%O"VC>*O&][IWAZ#62J0*UVN]I6.Q3Y8!&UB"=VXG;COQ0!YS
MH'[)7P@\'ZI'XDT'2-;FU^SM+VUT-;_7+FYLK::>&3(L[=F$=LAW@\948 )#
M# \2^"_[&WAG3K_Q%XH^)=IK%[J[^,[K5-/TQ-6G.EQ-)<^8CS6RM]G9P<[B
MP5L@G:I.*^RM6^*7@72H[:YU'Q?H,.F787[,ZW"M<.&5=GDC*XDD9E5<'C/)
M+<#SGQ-\>(/#OQ2\#?#=M/2ZTWQ\D,^FZW$_F?+( T!9/E)94*L[$%B>3\QV
M@ \4M_V3M,UGXY>*/'7C2SNG\+74EF=)T^&YFDMDEM<- TB@A &8 ,H4LN""
M #7TA<_ [X7)>ZE>WGA^*6Y\1PQV+[B'MEMXHEBCROS*'VH,$C<"<@<9'IGB
M#Q7H7A6*&Y\2ZM8Z-:^:(5%W*J+<[G*I(J,X*8P3N],D ]!SGB+QYX5\-:?'
MJNI^+M%TZUU)&N]'.H2QJEU&%+(UN""6#E2B,!C)ZCK0!YYX._9R^'7A.+6C
MILGB5],UB.YM-1T?5-4ENM-,,VX.+6R<A8HT\QA$L>W'< *N8;?]G/X365KH
MRKX?U"XL_#-TVHZ#-<:I*3IMXTI8RP*23;*&&!T50HRV"*P/@S^T1I/Q.?Q'
MJ6N06OA\:;KC:%H>H/=XTK695+HI@);:TA*)UP2V[/12?H'^WM*,VH6T%[I<
MNKZ=;(VMV<EWBUMK)V+-/("H53L=60@8*\LV 10!Y3=_L^?"Z_.LP7>C7EQ+
MXT@E&JN-7(FN&5 Z.DV&99;<*KP/@!9%W(3U-7P]^S?\/_#FA7_AV*_\;_V-
MJUL=/DM]3\67VI1% 2 H1W9 O.W9RJKP0%P3Z-:?$[X=ZI)>+I?BG0[Q?#<3
M3WEW;W,3BTBB)26)BI( "\=N<].2N3?_ !7\"Q:'K_B6U\4Z-J>G:):'5WMX
M[I<Q_)EE8'!7*$;<?+G)WXQ0!5A^"G@2R\/Z5X?N-/N;C3-,TJ[TB*%92&:S
MN'RSL-H)8DY8@;L;F.5!:N!E_9'^#\FCQZ!>6^N'3ENAJ5G9P:I/&L$H8RI+
M'MW)$RLWRN1D?W<\5H>$/VB?#7Q&O?#B^!X[+5DUN-#J(>^\F6R0DAI85^</
M&HRLC*<C)QGG/I<?Q+^'EWK@\'67C/2AXEGE:!-+6YCEO$V /-"#NX\L *Y)
M  8#)R* /,=-_9F^%UGIE_I,5MK,HURZ@GFEUJ\;5&EEM)/-M_WDBJI7*@#(
M#+\N<$$GZ%T;1[30;*QTK3]J65K"D*HIRJA!G/EY)3+=<# YSQFN0N_B3\/]
M(O);+5_%^BZ?<V\HM%L[F]BCEAF(VA]IQM=V' !(R0"5Z#L["X6X=#!Y<EI(
MB2VU];NLT=TCKN#JZD+R#ZXP,#'8 Z*7[@^ON/X&['G\^:EJ*7[H^I_] :I:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBFG?GY0N/<D'/X T 1O\ ?_X"
MO\VIM&23DG)P!TQP,_XFB@ J9/N+_NK_ "%0U,GW%_W5_D* '4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%,1BV[/9V4?08H 5
M&W*&QC.?T)%.J.+_ %:_C_Z$:DH **#G!QUQQ]::H<'YB",=ACF@!U%-8,<;
M2!ZY&?I2KN ^8@G/88XH 6BBF8?/WEQGICG&>F?7% #Z*:Y(4D=<@>O4@?UI
M/F95((!(!.1D<CG]: $DZ+_O?^RM29^0*>Z#GGN,=@:7:6&'.>01MXQU!_G2
MQ'**3Z8_(D#]!7/43;:3:=UJE?IV CP #@C<>C<Y&.P^4?0],@X)Q63J>G6E
M];/9ZBJ7-M.C)+;3A7BD4@A0WR@[5YY')'7%;2[]S;L;><>O7C]/YCWQ!-#&
M[)N!.3G@X(.Y>1Z<L34Q4E?FDWVNK6 _-_\ :(_9"T[7G/B3PG#+;ZI$&E@:
MVDDB$4T;F1%0QR D!L84@8S@<XK)_9Y_:C?PY<Q?"/XN-/IOB""<V=MJ%UB&
M!HX$,<1:5T0MO5%!9G/J"217Z8RP+*/*<G;N;*\<@@G*CD=L@$X'(YQ@_#W[
M07[+.D?$H7GB;0B+/6HT+PM'%Y5SYL9!:12!DJ.20N2>N>@J@/LZPU*UN;6U
MGL+B.]MIX_W%[ Z2Q-P=H+9/<G+=AP>I%7Q<RAA&6#M_$4 8+DC;N[\@\>N/
MPK\:? GQO^+_ .S-J">%_B/9W6J> Y+AK>SO4$TEQ$(V E:42*-@,(4+\Y5<
M$@]37ZD?#/XI>$/B9HUMJ_A*^MFMY55YK5YD-XC/N_=^2C%V(8$ECR<C@ '&
MT?A7]=6!Z[%G#9Z[LD^I*J2?Q-.+895Q][=^&!FH/-2)1N<*SGY5?@@XY!QD
M]%[\^HS2[P77<R$C+ *23M; X&!D#()(YQSBJ L44PL,!LX!/.1Z9R/8\<^F
M#0I)).X,I^[CMUSG]._;/% #Z*:P<GY2 ,=QGFG#.!GKCGZT %%%% !1110
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M"Q4%B"3@C QP0.* '44PB3)PRXSQQVH DR,LN,\\=J 'T444 %%%% !1110
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M3'ZTHX5U[*RX'I^\(Z]3T[DTH4,V&&1@G&2.<KZ?4T -'T ]AG'?GGN?Z4]
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M@$ 'L#MR2,=>XQBDX/?\CZ<]OY=^_%+UPI!=0"0HP,8P <C!.,X.22<YYY-
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M <=QSVZ9Q^/UIV0O W)WV@!O;.3DC.,8]L]Z )Z*** "DP#U /X49 (&>3G
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M@]0!_GB@!/+.U5#8+=0O4\');G!SP"#QR1S@&LRZTZQOY8VECS+:MD.$&X<
MJ 2N>_/S!>OL*UEX88'7(.!VXR?P./PS374AF()4,P.XX.?E''/OG\J (8F!
MVJJ-M' #'HJY"@G'R\A>!VQ4V!D]?O-CD] 3COZ4O7((^H/Y_P"!H&<<*V.V
M ,8[=Z $/0_0_P J?(5!7&.C=!GNOI3>M-+K%\V57.5R1Z\]NI&.GZT +GJ
M,E@ N01CDY/(XZCD=P*>O[LD'G(4\9Z\@\DY/0?X"J[SA7V,V'QN0$A01Z@$
MX R ,MGC/J:>)VV$DKNSP05(QA<<Y*Y9CUZ8S@ X% :=5<,GOO\ R'^%#G(S
MO'0D\G/3]:5)F*YW+D9R"">Y(YSGICWQ]:7>O]XGVV*,^V<<9]: M;9)=^9*
M7YI6(F1%<R@@M@<C)).>.V>,Y[BL;5_#^DZY;36VH0+=6\ZE9;:6)71U+$E2
MK9!S@$\'L<;N1NEH\<  Y'//KSV[C(I&=<9R>,]!ST([]!SG(Y&.A!-)J_:U
MMK?J"NG?2ZM9I<NWIUOU."@^'G@RV\KR?#.GJ(D"(6A0MY:C 0G P@_A0':>
M3B@> _"2W=A.GAZQB:PFFN;,);Q@1W,F[)4@ QY4 EEVY..>!GM8,A)"X(4\
M@ELY&".I^[TZ'&"3P,C,B(2JD2-AEX#*&*DX^;.,C.<CM^0PN6/9&GMZJ_Y?
M5EY*M)?A?\/U.+L?"OA_2;J^O]+T:RM]1U*Y8ZA<);HKLDC,"6. SDQG;RS
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MW$CZX.:.1U4C/KZ]?6@!T> 6YQPO4_[W3/\ 2H_X/^ _TI>" <9[C(]?K2T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2>,\8] ,X_'DYI_EG^^?R'^%-(VG&<\ YQCJ2.WTH :>0?H:>T@(("OD@@9
MQR,<\T",D [B,@'&!QD9I@Y [9VCZ9(']: %YX &2>WT!)_0'\:0')Q^G.1]
M>,?D3VXZX55W$@D@*>V,GEAU[=.WJ12LH11EL $ $*,YP?Y\YSGMC'.0!IY!
M7!SN+9[8V;>N>N:"VYLL&*]EQR. .1GC)SGD\8Z9(H!!Z$D>I&#GN./P_.GJ
MA89W$<G@ =B1W^E #!],#)P#V&3@?@*6D)4$@NV02/NCM2@$E1T)Z]\<$_TH
M **5E*X.XG)QR .Q/;Z4GH/4@?F0/ZT %.60*,%6)!/0 CDD^OO2^6?[Y_(?
MX5&VU207;(_V1W&:  < ?04M !(8YQM4-C'4\\?3CM2'@$^@-  ?H#UX.<?7
MCN/ZF@E<$;,-V*C*GV.3T/?CWIQ&TXSG@'.,=21V^E)0 @_SSGV'Z ?XGJ3&
M!]Q3[DG)]S[FEP2K-G&W/&!SA0>>_?'%.$>Y02Q^8 XP.XZ4 1DKD[&&#QCY
M@?<?=(P>HR1R3R <TZD)8J?N\K_='IZTX*2Q3=TYS@9/"GZ?Q?H*   L2!CC
M&<DCKG'0'T-(.0#ZT[F,\?-N'?C 7Z ]=WX8[U'R%SGH=N,>B;L_GQ]* '4=
M,'K@@\=>""<4_P L_P!\_D/\*9STS_%MS_P+;GZ]_3- "9^]P?G((Z<8<MSS
MQP?SXH&..&W?Q$].AR!STS@@8IRJ6+#=C;QD <\L.<_[O;UIWEG^^?R'^% #
M**5EVD#.<@]0!C&/3ZTJH6&=Q')X '8D=_I0 VD/0XZ]OKV_6I/+/]\_D/\
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M>A_,?X4 6:*@"R$ B3&0#^?--#$X^<\]LC\NE %FBFJ<JI/4J#^E.H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH B,:J"1G*C(R21D<CC\*8"PR5/+=<C
MJ221],EC2 L0,LQR.1D8YZCI1P>_3TZ@CI^M $@W%MK[6&,C@8[#/.?4CU_
MBFL &X 'RCH,=V]*:21R7/IDD=^HZ=\#\J7GJ22?4^G^2:  %P"%(P,D\9QD
MY/UZDX]!CJ1F555@"54D@$_*.I&3VJ+D=&(SZ>O3TI 3T#GCC (X]NE  N<+
MM^]QCI_=.>I Z9[BE99'!#':.N[Y1C'7D,3R,CIWZCK2=,<XQT.>G;O['%+R
M>"S'/;(Y'?M0!YQ\0? .A_$70]1\.^)HC=Z5>O%((?XHI;<2#S$!'/F"1<
MD%,5XE)^RQ\-)K33-..FL(=)C\E)E"FXEMW;+6\KG)9"H&Y<+PW7I7UBZ*XP
MV"3@+G'!Z+@<?=S^77M2K;GJVTG.<D<\8QT/;K0!X+9?L_\ PYTBTTBVT+18
M=(@T>[AN;*-(T"M/&<RF6,Y!:;;@,=O=BW-?)7Q^_9I^(OB?XDZCXO\ "MO8
MW5EJNF0:;;.YC,VB.B;6NH@6#_*Q\S:@RQ7"D\5^ESHN65U9L@!L ;6 Y Y!
M/&?7Z<8Q&82H!BD9"  R9W;4'S$ \!2!C!YVD^AH ^/- _96\/7'@+PQX?\
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M9L;CG!(QC=T)SZ8KP_P-\5[34=+U;7O&TNFZ);0ZBVC6Q::(YECE*N?F)P,
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M?;+$I\A&U1D[@2 I;UXY ) )Y'<^E-_>Y5E8-%MQDYR5/0'G Z*.>N<G XH
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M#';0JFT11Q*5*D8&>6!&.X^N+T@(XVX&& QSGIC.!Q^.: $/W0,<@29!ZC+
MC(ZY/49Z]:4X4EE*L#N^48.,G<1@9[]#C.>#U& L"S'!P2,<'T ]/:DR/?\
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MG(&3U^8#MCC@]A0 T'  (*\ ?,,9Z#C/N1^8I<^S8_O8.W\_KQ0"&.7W'@<
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MC]!D?2@\@]>AX[YZ8QZYI<NA(Z9YZ;O;J/IT_P @"N1G YYY..O/3''7IVH
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@P>,$\]_\*6B@ ^O7_.:*** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_029.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_029.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &J \<# 2(  A$! Q$!_\0
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M\2MF]"G+E7O'#];E+X8GU-U]Z7H*^0]%_:2E\!ZCY&LO.UDDJQ3VEQ_K;?\
MW:^J="UJQ\0:/:ZCI\T=S9742RQ2HV5=6KU*%>&(7- Z*.(C77NFK25%YE2U
MTK8Z1:*93Z8!13/XJ=0 M%,?[E,_[YH FHIB4Z@!:*** "BDS1F@!:**2@!:
M*910 ^BBF?Q4 /HI-U#?=- "T4RB.@!]%)FB@!:*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH 8P'&37SI^TE\)[_P"+WB[0
M--GNVT_PSI\?VJ=HV^:>5F;Y/R0?]]U]%MCBOGG]HCXN/\)/&F@SZG:&Y\.:
ME#Y32Q??MY59OG_[Y=?^^:^5XDEBXY=/ZG\7_MO4?[K_ )?_  G@'[3WB'2O
MACX9LO '@SQC:> -0NOWMY<.F^X:)O\ ;_VZ^,7^'OCKPW*GB7P9XZ7Q5<6J
M_:)7TF\WW$7^_%OKZ&_;P^$;_%I=*^*G@F)?$,5O!]GU&WM_GEB5?X]E?%7A
M-=<7Q!;VWA]=0AU-G\I4M%=)6_V/_P!NOJN"Z.6_V1SUN7G^US'@XJ4O:\M#
MX3](O@/JFE?MD_!;[5XHMOLWBW2Y?L%Y?0_([2_WWKZ4_9I\):[\/_"MUX=U
MJ=;RWLYV:SN=WWXFKP?X)ZA;?L]_"%-0\>2VT/BK4_\ 2+BWMT5+M_\ KNJU
M[U^S7XYU+XF>%[WQ%>6*Z;I]Q<NEG;_Q;%_BK\PP/M_[=J_5OX!Z\/JW)_T\
M.Y\;?$[P_P" ?L_]LWBV;7'^K5U^]6EX7\8:1XNTQ+_2+Z&\LG^57B;^*OG_
M /:LA:/QAX*N2\EI"C2^9=I!YNW_ (#7GWA&'5X?![VEI_:%GI]YXF2);ZW7
M[/+=1,_SNVW[J5^D\Q]13RVE5PD:W/[Q]M^?$,9=<_[U,FN8X8W9Y%4*N[K7
MQM\6/$FHV^O:E8Z,M_I6IZ/)%%9RM/*\LJ_WD3^Y6POC ZU\:+*WDU#6+"*W
MM5:2%I7\F\G;^#96G,1_9$N6,^8][L/B]X>U#5M%TV*>3[1J\;/:H\6W<J?>
MKO5KY*\#VNI3?$#X:W,\5R\JP7J/*R_=^=_OU[5XR\/_ ! U#6/-\/\ B:TT
MW3]B_P"CS6*R_-_O549<QPXG#1I5.6,CN=>URQ\/Z/<ZEJ,R06=LN^25_NJ*
MY&Z^-/AJUOKNV:Y9WM=._M*5E7_EW_OUR?Q3TOQ!;? 'Q%:Z[>+K>J?9VW36
MT&P/\_\ =KR&?2;R36M79;.?8W@A5_U7\7]RIE+E.C!8.E6_BR/K+PSXEL?%
MFAV6KZ?)YEI>1+-$S?*=K5K-(JCDJ*^,9/&&H>#?!,NF32ZE#<:CX9M_[,AM
M]_RM\Z/M_NO]RK>K^)-1TO4O"%]+>WVM7<EM;HV@M*RRP,R;7E3;1S&SRAWY
MHS]T^LK7Q%IM]=7-M;7T,UQ;<3(DBED^HK0:5$7YV5?QKXDUC[1X;\0?%1;&
M75H=;E@M[BV=&?>T3,F]_P#>KKOB!=1^%M,\-Z&ZZDZ:C;-/)?7UY+L679_'
M_M5',/\ LI.I&$9GT[J'B#3M+GM8KF\@AEN=PAC9_FD_W:H^%_&6F>+K.>ZT
M]Y#%%*T+>8NWYEZU\AVUM>:UX?\ AGJ7B"YU1YFO);66X>5T=?O[*M6^J^)_
M#?P]3Q/#+JDUQX?UB7S+=]V^XMV^39_M4>T-993",>7VOO'V<TR(I+.N*@N[
MN.R@FNIY%2&-&=F]%KXV\0:GXLA\-^']4U"]U!-'UC49;C44FD?]U$^_RD;^
MZGW*]Z\'PWO_  I.9+G4VUN3[+/Y5QM^^NWY5H]J<=?+/81C*4_M'8>$/B-X
M?\=:;<7VC:C#>6T#,DS1MNVE:L^&?&NC^,+">[TF^BO+>*5K=W5OEW+]ZOBS
MPSI_B#P/X:\.#0[.Y2W\8Q?8+I%3;]G?Y]TW_CU;^H6.O^!_ %Y9:0)K32[?
MQ#]GO9HOEW1?)][_ &:/:'H2RBAS<L:OQ2]T^TOM",NY77%<+JGQB\/Z/JEW
M8RSR?:+6>*WEV1_Q2_<KYPU*_P!=TKX9WL^F^);O4M#;58O/^R??M;7^-$?[
MU9\TS_9==O-!_M)[)M8TWR)I=[NR[/\ ;_AH]H9QRF,7+GF?:R7"2#AL_+N_
MW:I>(/$%GX=TB[O[J3_1[:,O)L^9A7R_X*\4O9>.-:'BB?6&\3Q7C)9V\$CJ
MC6^SY=G\.VL'2/$5WXBU*_NK9+NVBOM/O'N['S7E?>K+L\W_ &_]RKYC.GE/
M[SEE+W3ZQ\-^*=/\4^&K37;&7.G3Q>:C2K_#6+X9^,?A3Q9KTFCZ7JD-W?1*
MW[M#][;_ ':\ZTG0]7OOV3+?3[%)X=3_ +)=4B^Z^[YJY7P3\2?#-G\.?[/T
M_0ID\3:;IC>?;6\'E2Q,B?/^]^]1S''#!TY<UOYCZF6:/H)%_P"^J#-$H_UB
MC_@5?%W@_P 1:S)K7B)]-N;U--N=">[$44C.B7'_ ,75OQ!:^(=!^&O@>^CN
M]22TU1U?6IKN5W?_ &-_]U:7M#MEE')4C3E4^(^R/.CQG>N/]ZCSHU_Y:*/Q
MKXL\0W_B"PB\*VVI>(I]2\-2Q2[KYVV1,W\&[;\WR?PUOM9Z[J5O\,]*G\0:
MEJ]E>7DJ7-]:RM%OBV?=>GS$5<I]C'F]K$^MD=7^ZU253L(%MK.*--VU5VKN
M;=5M:H\ 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 SL>*Y^S\<:)?6M[<P:E
M]O8MLN9-W^J_WJW9,LC;>M?,-G\.?$5A_:&GVFD20Z;XHGN/[3^;9Y']Q_\
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M=N:X3XK?#73?B)X;EM9U^S7L'[VSNT7][;O_ 'J C*C4]WE.]CD\S:P;Y:E
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M#/P-:_#[PGI^BVF^9(/]9-*OSRNWS,[?\"KLNAH.?$3YZG,+2T44CG"BBB@
MHHHH **** "BBB@ HHHH ***2@"-S^[8U\??&#Q#_P )#X\U!MV^"U_=15]:
MZM-Y.EW;_P!V)C_X[7Q!J$WVF_NY?XVG;=7FXZ7+$_0.#L-&MBY57]DKT/\
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M#_G_ (/^_JT?VU8?\_\ !_W]6@+/L7Z1JH_VU8?\_P#!_P!_5H;6M/\ ^?\
MMO\ OZM 6?8MBJVI7B:;8W%R_P!R&-G;^=<UXY\>0^$O#5[J5G;?VW/;IO\
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M\NCRZ *_V=-NQ8_E_P!VK=,\NGT %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4E+10!YYXZ^#'A?XD:E;ZAK5BTUW!'Y*2HVWY=V:Y[_AE?P)W
MT^3_ +_M7L.RDV^]!M&M4C'EYCQW_AEOP/\ \^,__?\ :C_AEOP/_P ^,_\
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MU(T8J.4[?:5.7E/D_4/V1W\<?$JZU+5[F[L?#UG/_HL*76ZXN&^]OW_PIO\
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MX\W[/(L2_P"MW5WVCZK%XM\;Q:K%IES816=JT6^[BV.S-_ E=O)H<&JQ(E]
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M&8[/[GR_WJ />(=NQ/+^Y_#\U/=%=OF6OG#7/C%XP\&^'? GV;PU]C_MZ/\
MLJ"Q==S07N_]UO;^XZ+_ ./UA>%?C5\6+CQEXG@U[PW]CTK3XO*;RHM\R/\
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MA_4-4TNQ;4X+UX+745=$3[ZILJQX>\/^([:;[*LMS#:WD\_S3-\\"+]SY?\
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MB@!]%,HH ?13*/FH ?13** 'T4RB@!]%,HH ?13/,J!+A'D>-9%:5=NY/[M
M%JBBB@ HHHH *3;2T4 %)MI:* $VT;:6B@!FU:?110 FT>E&VEHH 3;2T44
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MF8_**_/CXR?ME>._B=XHOO#GPEL[B&TLW96O;=?](G7[N]/]FO:_V^/BO=>
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M[Q;O]JN'_P""=+LGQ:\1[?D9=.^_7V;^U9\%_P#A=GPGO=(MODU:V/VJQ?\
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^+_%-WXGOX9],TQ4^SV-DY_UJ_\ /5EH-53/5:*2EH,@HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!#CJ%'_"M]>_Z''4*@/9Q_F/2/,HW"O-_^%;Z]_P!#CJ%'_"M]>_Z''4*
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MR'@GXB:;XXT[[3;2+$RLR20S?*Z5UR]*<9<Q$J<H2Y9#]M&VBEH 3;1MI:*
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$0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_030.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_030.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $Z \T# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPSK]CK4. S?9)@[)_O+U6NP2D=,91G[T1]%%%(L**** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:SCS'%F.$PF%C^XJ\TCUREHHK8\$**** "BBB@ HHHH **** "BBB@ HHHH
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MV9)96@98MW^_751UXW\(_"^I>&/&GB/^T--NT^U2M+'?>?\ Z(R_["5[)'0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI^YO\FO+?^%>^.O^BAWO_@';_P#QJG?\*[\>?]%&O?\ P#M__B*KF)^K4_\
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MSXV:E#K6@RP7+V<7E-8W#;$;_;2O*C1C]?\ 9'XY[7]S[4YCPE-]I\+Z5/\
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M?\*Y\=_]%$O?_ .U_P#C5>5S'V?U:G_S]C^)ZEN;_)HW-_DUY?\ \*[\>?\
M11KW_P  [?\ ^(I/^%<^.O\ HH=Y_P" =K_\:HY@^K4_^?L?Q/4=S?Y-&YO\
MFO+_ /A7?CS_ **->_\ @';_ /Q%'_"N_'G_ $4:]_\  .W_ /B*.8/JU/\
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MM=W6S?*R6K-\D6_^[7=8VTTG% ?WI$4-NL0PJXJ<T9IU,<8\H4444B@HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBF4 /HI%I: "BDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&:
M %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6BDS1
MF@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6BBB@ HHI* %HHHH **
M3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6
MBDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&:
M%HI,T9H 6BDS1F@!:*3-&: %HHHH 9L_VFHV+LV_PT^B@!GET;%V[:?10 SR
MZ/+I]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% ')_$+Q4_@OP^-42#SHHIXEN?^F<3-AWK:
MTW5+;5+5+FVGCG@D7<LD3;EJS=0)<0/')&LJ-_ W\5>677PCU#PO=37/@C69
M-$25M[Z?,OFVS-_LK_#0:1C&7NL]87H:4\>]>51^)_B+I[>7>>'+&[3;]^WN
MFW57_P"%J>-/^A&N/^^ZGF-HX6<E[IZW^/Z4?C^E>3K\4/&A_P"9%NO^^J/^
M%H^-?^A#N?\ O[3YBOJ=3NOO/6/Q_2C\?TKR?_A:/C7_ *$.Y_[^T?\ "T?&
MO_0AW/\ W]HY@^IU/+[SUC\?TH_']*\G_P"%H^-?^A#N?^_M,_X6EXU_Z$2Y
M_P"_M','U.IY?>>M_C^E'X_I7D__  M'QK_T(=S_ -_:/^%H^-?^A#N?^_M'
M,'U.IY?>>L?C^E'X_I7DG_"TO&O_ $(ES_W]I_\ PM'QK_T(=S_W]HY@^IU/
M+[SUC\?TH_']*\G_ .%H^-?^A#N?^_M'_"T?&O\ T(=S_P!_:.8/J=3R^\]8
M_']*/Q_2O)_^%H^-?^A#N?\ O[1_PM'QK_T(=S_W]HY@^IU/+[SUC\?TH_']
M*\G_ .%H^-?^A#N?^_M'_"T?&O\ T(=S_P!_:.8/J=3R^\]8_']*/Q_2O)_^
M%H^-?^A#N?\ O[1_PM'QK_T(=S_W]HY@^IU/+[SUC\?TH_']*\G_ .%H^-?^
MA#N?^_M'_"T?&O\ T(=S_P!_:.8/J=3R^\]8_']*/Q_2O)_^%H^-?^A#N?\
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M1\:_]"'<_P#?VCF#ZG4\OO/6/Q_2C\?TKR?_ (6CXU_Z$.Y_[^T?\+1\:_\
M0AW/_?VCF#ZG4\OO/6/Q_2C\?TKR?_A:/C7_ *$.Y_[^T?\ "T?&O_0AW/\
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MF'<UE;[-^^7YDW?-_LUC+FB=>'C3E_%D>OW'Q$T&TM[6>74(TANO]4]0:O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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C HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_031.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_031.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %B HT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:>.&_CR85/\ JB6X4#GN#R>>30!W-%1V\IGMXY3$\1902D@PR^QJ2@ HHHH
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M/*3S2IDP-Q7IGOBGT %%%% !1110 R8J()"Q(7:<D=0,5YS=VN@V^G)8Z?\
M:+>Y2VA^U7]G:X38^"/.7/(;J>I&<Y%>BW!"VTK%0P"$X/?BN'LA#INEQ)=>
M&YDL]2$;33:?,\X' QY@;#*N,#C=Z4 =YVHHHH **** "BBB@ HHHH ****
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M(\7._P#<WZK\SN****ZSX4*\N^*7_(4L/^N+?^A5ZC7EWQ2_Y"EA_P!<6_\
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M^&7_ "+$O_7T_P#Z"M:TOB/$SS_=/FOU.SHHHKK/A@KQGXA?\CE<_P#7./\
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MBNFCLSX_B'^-#T_4****W/FRGJ__ "!;_P#Z]Y/_ $$U\^#H*^@]7_Y M_\
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M!-?/@Z"OH/5_^0+?_P#7O)_Z":^?!T%<U;='UW#W\.IZK\A:***P/IBQ8_\
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MY_\ 9&KRRO4_BE_R!K'_ *^?_9&KRRN2K\1]YDG^YQ]7^84445D>P=A\-/\
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MNO\ *MZ.[/G>(/X$/7]#9HHHKI/C0KPWQA_R-^I_]=?Z"O<J\-\8?\C?J?\
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MA/BL_P#]Y7^%?FPHHHK8\ Q_%?\ R*FJ?]>S_P J\)KW;Q7_ ,BIJG_7L_\
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M6C?\@/3_ /KVC_\ 016]'=GS/$/\.GZO\B[11172?(A7S]K'_(<U'_KZE_\
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MV0_[T_1_H<O1117*?;!7JWPO_P"1?N_^OL_^@+7E->K?"_\ Y%^[_P"OL_\
MH"UK2^(\7._]S?JOS.XHHHKK/A0KR[XI?\A2P_ZXM_Z%7J->7?%+_D*6'_7%
MO_0JRJ_">QDO^^1]'^1P5%%%<A]X%>E_"K_CVU3_ 'X_Y-7FE>E_"K_CVU3_
M 'X_Y-6E+XCR<Y_W*?R_,]#HHHKL/@0HHHH X3XI?\@:Q_Z^?_9&KRRO4_BE
M_P @:Q_Z^?\ V1J\LKDJ_$?>9)_N<?5_F%%%%9'L'8?#3_D:F_Z]7_FM>O5Y
M#\-/^1J;_KU?^:UZ]771^$^'SW_>_DOU"BBBM3PSD_B-_P BE)_UV3^=>.U[
M%\1O^12D_P"NR?SKQVN6M\1]OD/^Z_-_H%%%%8GNG3> /^1SLO\ =D_] :O:
M*\7\ ?\ (YV7^[)_Z U>T5U4?A/BL_\ ]Y7^%?FPHHHK8\ Q_%?_ "*FJ?\
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MJRJ_">WD7^]_)_H<;1117(?<A7K?PR_Y%B7_ *^G_P#05KR2O6_AE_R+$O\
MU]/_ .@K6M+XCQ,\_P!T^:_4[.BBBNL^&"O&?B%_R.5S_P!<X_\ T&O9J\9^
M(7_(Y7/_ %SC_P#0:QK?">]D/^]/T?Z'+T445RGVP5ZM\+_^1?N_^OL_^@+7
ME->K?"__ )%^[_Z^S_Z M:TOB/%SO_<WZK\SN****ZSX4*\N^*7_ "%+#_KB
MW_H5>HUY=\4O^0I8?]<6_P#0JRJ_">QDO^^1]'^1P5%%%<A]X%>E_"K_ (]M
M4_WX_P"35YI7I?PJ_P"/;5/]^/\ DU:4OB/)SG_<I_+\ST.BBBNP^!"BBB@#
MA/BE_P @:Q_Z^?\ V1J\LKU/XI?\@:Q_Z^?_ &1J\LKDJ_$?>9)_N<?5_F%%
M%%9'L'8?#3_D:F_Z]7_FM>O5Y#\-/^1J;_KU?^:UZ]771^$^'SW_ 'OY+]0H
MHHK4\,Y/XC?\BE)_UV3^=>.U[%\1O^12D_Z[)_.O':Y:WQ'V^0_[K\W^@444
M5B>Z=-X _P"1SLO]V3_T!J]HKQ?P!_R.=E_NR?\ H#5[1751^$^*S_\ WE?X
M5^;"BBBMCP#'\5_\BIJG_7L_\J\)KW;Q7_R*FJ?]>S_RKPFN:MNC['A_^#/U
M_0****P/HS6\,?\ (T:7_P!?*?SKWBO!_#'_ "-&E_\ 7RG\Z]XKIH[,^/XA
M_C0]/U"BBBMSYLIZO_R!;_\ Z]Y/_037SX.@KZ#U?_D"W_\ U[R?^@FOGP=!
M7-6W1]=P]_#J>J_(6BBBL#Z8L6/_ "$+;_KJO\Q7T-7SS8_\A"V_ZZK_ #%?
M0U=%'J?)\0_%3^?Z!11170?+B/\ <;Z5\Y5]&O\ <;Z5\Y5SUNA]5P[_ ,O/
ME^H4445SGU0A^Z?I7T%HW_(#T_\ Z]H__017SZ?NGZ5]!:-_R ]/_P"O:/\
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M7D?Q,_Y&F/\ Z]4_]":LJOPGMY%_O?R?Z'&T445R'W(5ZW\,O^18E_Z^G_\
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MDJ_$?>9)_N<?5_F%%%%9'L'8?#3_ )&IO^O5_P":UZ]7D/PT_P"1J;_KU?\
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M[R?^@FOGP=!7-6W1]=P]_#J>J_(6BBBL#Z8L6/\ R$+;_KJO\Q7T-7SS8_\
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M+G&3Z5S<'B6ZM(M:_MFVAB;2K<7,KVSED*;"Q&6 P1M/YB@#H_)B_P">:?\
M?(H\F+_GFG_?(KF=$\37]YJPTW4M/BM[B:Q%_;B&7>"F0"K$@88%@/0U?TG4
M]0N+J_M+ZVMUN+58W MY2RG>&PI) P1M_44 :_DQ'_EDG_?(I/L\'_/&/_OD
M5FZ!JEUJD%V;VT2UGM[EH&C23>!A5/7'7YOTK6H C^SP?\\8_P#OD4?9X/\
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M.14GB/Q+>Z1HQUJRLH+C3X[=;AS)*5DE#=$C4 _-C'7KD"@#I/)B_P">:?\
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M'X]9M8[..W^SB>5;QW5ER 0HV@\Y./K6U9RRS6-O+/&(YGC5G0'.UB,D?@:
M'_9X/^>,?_?(H^SP?\\8_P#OD5)10!']G@_YXQ_]\B@00CI$@_X"*DK-UJ[U
M"SLC-I\%O(R!GD:XE*(B@$]@30!?\F+_ )YI_P!\BCR8O^>:?]\BN>7Q'=WF
ME:+)8VL OM4C\Q8[B0A(U";F)(!)[ 8'<&I6UG4+OPY:ZGIMK;&22+S)A<RE
M4BPI+#(&3R,?K0!N>3%_SS3_ +Y%(8(3UB0_\!%<QJ7BZ6WT31[^&T2 :E@M
M)?.8XK4>67_>L!QG&T>Y%;/A_4Y=9T&RU&>SDLY;B,.T$G5#Z4 :(    P!T
M I:** "BBB@"IJ=K/>Z=/;6UX]G+*I43HH+)GN,]ZR[;PV\'A]-*^V(! \;V
MKPVRQB'805&W)!&1^.:WZ* ,>ST6>PT^[2WO\7]U,9I;MH0<MP/N9QC QC/O
M3=-T:]TSP\FF1:H&DB4)#<-;CY5&."N<&MJB@#,T71DT>*Y_?R7%Q=SFXN)I
M, NY 7@#@#"@ #TK3HHH **** (+R*:>SEBM[DVTSJ0DP0,4/J >#^-85MX4
M/_".7.B:CJ#WEO,/O^6$<,6+%B<G<Q;G)[UTE% &);:'>06UZ6U>1]0N8EB6
M[$" Q*H.W"]#@LQY[FJEMX/1?"]QH-W?23PRDL)E39(&)W%R23N8M\Q)ZFNF
MHH R-'T,Z;=WE]<7CWE]>;/-E9 @PHPH"CI_C6O110 4444 -D#-&RHVQB"
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' HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_032.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_032.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $N <<# 2(  A$! Q$!_\0
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M%% !1110 4444 %%%% !2%L4$X%<1XKTWQ1K.M6UE9W8T_1 I>YN8V'F$@<
M9Z<T =OFDW>U>'67CC78?!OB*"/4A=7-MJ*6-C>L@Y#$#)]2!6QIT^N^#O&^
ME:?>:Q+J-CJ=J[N)@-RS*I)((' XH ]:W4FX"OG6T\=7&KWLE[=^+Y-/OWN=
MEK;K;Y@1=W D.._UKM-2N-;\6^/KK0+?6)+*ST^R29GMU ,DI'!R<\<B@#U;
M?CJ,4NZO ->\::R?AK!Y^HO'?VFK&RN;F)>60;N?R_E5[PKJ6DWOB?3X;7QU
MJ5Y,9 PMY(" _L3B@#W('-%-4YS3J "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "N,^(]YXAMO#,D7AJWEDOISL\R
M+[T0XR1[UV=)B@#Q[P-IMS"\NGW7A:^@N[V%UNM6NI-S,2._?&>U8AT_Q1)X
M4C\ G09PR7.W[=_RR\K/7ZU[YBC!]: ///&&@W]SJ7A46<#RQ6=P#*P_A4*1
MDUA>+M(OM.\>2ZU?Z')XATVXMS%#"@W&W;/H1CFO8,48H X/X5:'J.B>%Y$O
MX6MC-</+':DY\E">!7>CI110 4444 %%%% !1110 4444 %%%% !1110 44A
M.*7- !1110 AZ5Y=\4+CQ7=S6^F:/87CZ>V&NI;5@'D']T'M7J5)B@#QJ70K
MK5? 5UI^E^%YM'N+&6.X@BE;<;EE())/J<59TR+6_&7C32+Z]T:?3+32[:1'
M:?J\I7;Q[<UZYCWHQ[T ?/C>']6L/#]]X._X1-I[F>Y)AU)5&S:6^\3C((!K
MI+BPUOP/XQ?5K?2KC5;2\L8[>3R.6611C)SVKU_'O1@^M '@NJ^"]>;X>6TA
MTUI[^YU?[?-:#DJG.%/Y\UT6B:G?IK%GCX:I9$N%:Y4@&,=STKUC%&* !:6@
M<44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%<UXL\2
M2>';.*:*!9B[8P3BN2'Q2O/^@;'_ -]U+DD=M# UZ\>>G&Z/4<T9KR__ (6E
M=_\ 0-C_ .^Z/^%I7?\ T#8_^^Z7.C?^R<7_ "'J&:,UY?\ \+2N_P#H&Q_]
M]T?\+2N_^@;'_P!]T<Z#^R<7_(>H9HS7EW_"T[O_ *!L?_?='_"TKS_H&Q_]
M]T<Z#^R,9_(>HYHS7E__  M*[_Z!L?\ WW1_PM2[_P"@;'_WW1SH'E.,7V#U
M#-&:\O\ ^%J7?_0,C_[[I/\ A:=W_P! V/\ [[H]HA?V3B_Y#U'-&:\O_P"%
MI7?_ $#8_P#ONC_A:=W_ - V/_ONCG0_[)QG\AZAFC->7_\ "U+O_H&1_P#?
M='_"T[O_ *!D?_?='.A?V5B_Y#U GBN>;6;H>/4T?Y?LQL#<>^[?C^5<>?BE
M=_\ 0-C_ .^Z3PMXBD\1?$YIY;=83'IA4 '.<R9IJ29E6P&(HQYZD;(]3HI!
M2U1PA1110 4444 %%%% "$9%8$>KW+>-)=*.WR%M1+TYW9K>.<UYGXG\02>'
M?B!YT< F,MCC!.,8(I-V-*5*56:A!:L]-S1FO+O^%I7G_0.C_P"^Z/\ A:5W
M_P! V/\ [[J>='>LIQ;^P>HYHS7E_P#PM*[_ .@;'_WW1_PM*[_Z!L?_ 'W1
MSH?]D8S^0]0S1FO+_P#A:5W_ - V/_ONC_A:5W_T#8_^^Z.=!_9&,_D/4,T9
MKR__ (6E=_\ 0-C_ .^Z3_A:=W_T#8_^^Z.=!_9.+_D/4<T9KR__ (6E=_\
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M"/O*>N: /:12TU?SS3J &FO&OB2/^*XA_P"O,_S%>RGK7C7Q*_Y'B'_KS/\
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M>.2<?Q4 MSKQ28J(7-OC_7Q_]]"E^U6__/>/_OL4!RLDQ1BH_M5O_P ]X_\
MOL4?:K?_ )[Q_P#?8H'ROL28HQ4?VJW_ .>\?_?8H^U6_P#SWC_[[% <K[$F
M*,5']JM_^>\?_?8H^U6__/>/_OL4!ROL28HQ4?VJW_Y[Q_\ ?8H^U6__ #WC
M_P"^Q0'*^Q)BE Z5%]JM_P#GO'_WV*#=6X_Y;Q_]]"@.5]B>BH%N87;:LR,3
MV!J84"M;<6BBB@ HHHH **** "BBB@ I,CUKAY_&6IVTWVV72MNCFZ^S*YD
MD;G;NQCIFHY/'.I?O]0BTC.CV]Q]G>1Y )&P<%@OI0!WM&:P?$GB Z'I$=W'
M!Y\L\J10INV@LW3)["N>/CZ[A6ZL;JPC35;>:.$@3 Q$N"5.['M0!W^:*Y/2
M?%YU2+3T6U*W%P[K(-V50+U-=4IR.N: .+^);,N@H58@^8.AQW%>3>9)_P ]
M7_[Z->L?$S_D )_UT'\Z\EKGJ-W/L\EA&6&U74=YLG_/5_\ OHT>;)_SU?\
M[Z--HK.[[GM^SA_*ON0[S9/^>K_]]&CS9/\ GJ__ 'T:;12N^X>SA_*ON0[S
M9/\ GJ__ 'T:/-D_YZO_ -]&FT47?</9P_E7W(=YLG_/5_\ OHT>;)_SU?\
M[Z--HHN^X>SA_*ON0[S9/^>K_P#?1H\V3_GJ_P#WT:;11=]P]G#^5?<AWFR?
M\]7_ .^C1YLG_/5_^^C3:*+ON'LX?RK[D.\V3_GJ_P#WT:/-D_YZO_WT:;11
M=]P]G#^5?<AWFR?\]7_[Z-'F2?\ /63_ +Z--HIW?<7LH?RK[D+YDG_/1_\
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MVHI8V\+V19E1(P Q(')^F.*H2> F66XL[6_DBT6\E\ZZM=H)9L@D!L9 ..:
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M^^S2_P#"0ZO_ -!&?_OLT>UB']A5OYD>^9HS7@?_  D.K_\ 01G_ .^C2?\
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M[(>M>-?$G_D>(/\ KS/\Q45-CT<L_P!ZB<K1117*?H-PHHHH$%%%% !1110
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MZ*]U17GOXXHRHAAB9@/.D&2Y [CH/SKJ.H!H \E^)G_(?@'_ $Q_K6=\,_\
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M4HUU6.$PREHOW<BG/.,\$9_2M&PT";3O#KZ=%=;KB4NTMP5ZL^2Q KH<4F*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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+ "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_033.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_033.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %L LX# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BD/W3]*P/%"NVDK)%?1VDD4
MFY7E?:K':PP3^.?PH W\@]#2UPG@A([>\NHS>VDDC1*S16LA<$Y/SM[G.*[I
M?NCC% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 !Z5D
M:S::;>6L4.IQPO"904#_ -X D?UK7[5F:QI$6L6/V:1WCPV]7C."IP1_(F@#
M+T'^PY=2N)]'BMT8($D,0VYP3V_K73+]T9K!T/PU%HTCR_:IKB1D$8,G&%&>
M/UK>'04 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOQ'W>2?[K\V%=]\+_P#CYU'_ '8__9JX&N^^%_\ Q\ZC_NQ_^S4J?Q(VS?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX7_\?.H_[L?_ +-13^)&N;_[I+Y?F>FBG"FBG"NSJ?GPM%%% PHHHH ****
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MH'2BN)[GZ1'8Z'P-_P C=:?1OY5[6.U>*>!O^1NM/HW\J]K':NJC\)\3GO\
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MZC_NQ_\ LU%/XD:YO_NDOE^9Z:*<*:*<*[.I^?"T444#"BBB@ HHHH ****
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MN!7CU=#X(&?%=K]&_I4*K)O5'=BLEH4J4IIO1'M()QUS7FOQ0_X^M/\ H_\
M2O2\?+7F?Q/_ ./K3_H_]*UGK$\3*O\ >HG 444#K7$S]#V>AWWPO -]?9_N
MK_6O3Z\Q^%W_ !_7_P#NK_6O3J[*?PGP&<?[V_E^1BZC_P ?C?2JG>K>H_\
M'XWTJIWK0\D/\:V-*_X]/^!5C_XUL:5_QZ?\"H N/]VOG[5?^0S??]?,G_H1
MKZ!D^[7S[JO_ "&;[_KYD_\ 0C7/6Z'TW#W\2?HOS*M*OWU_WA24J_?7_>%8
M=3ZR6Q]!6/\ QYP_]<U_E57Q!_R KW_KDW\JM6/_ !YP_P#7-?Y55\0?\@*]
M_P"N3?RKN>Q^9P_C+U7YG@J_='TI:1?NCZ4M<+/TV)K>%_\ D9]._P"NR_SK
MW3N:\+\+_P#(SZ=_UV7^=>Z=S751V/CN(/X\?3]3DOB)_P BPW_71?YUY%7K
MOQ$_Y%AO^NB_SKR*LJNYZ60_[M\PKL/AM_R,K_\ 7$UQ]=A\-O\ D97_ .N)
MI4_B/0S+_=)^AZ[VKS3XI?ZVP_&O2^U>:?%+_6V'XUM5^$^/RG_>H_/\CSWO
M11WHKEZ'Z!T/2_A?_P >5[_UT'\J]"]:\]^%_P#QY7O_ %T'\J]"]:[8?"C\
M[S/_ 'N9X5XJ_P"1IU#_ *Z&L>MCQ5_R-.H?]=#6/7'/XS[G!_[M#T"O:/ G
M_(J6GTKQ>O:/ G_(J6GTK2C\3/*X@_@+U_0WKK_CRF_W#_*OGN7_ %TG^\?Y
MU]"77_'E-_N'^5?/<O\ KI/]X_SJJ_0Y>'_^7GR&]Z4?>'UI.]*/O#ZUSGU#
MV/H.Q_X\+?\ W%_E63XS_P"13U#_ '!_,5K6/_'A;_[B_P JR?&?_(IZA_N#
M^8KN?PGYQA_]ZC_B7YGB(Z44#I17$]S](CL=#X&_Y&ZT^C?RKVL=J\4\#?\
M(W6GT;^5>UCM751^$^)SW_>EZ'"?%#_D#VO_ %\#_P!!->75ZC\4/^0/:_\
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MQS^,^YP?^[0] KVCP)_R*EI]*\7KVCP)_P BI:?2M*/Q,\KB#^ O7]#>NO\
MCRF_W#_*OGN7_72?[Q_G7T)=?\>4W^X?Y5\]R_ZZ3_>/\ZJOT.7A_P#Y>?(;
MWI1]X?6D[TH^\/K7.?4/8^@['_CPM_\ <7^59/C/_D4]0_W!_,5K6/\ QX6_
M^XO\JR?&?_(IZA_N#^8KN?PGYQA_]ZC_ (E^9XB.E% Z45Q/<_2(['0^!O\
MD;K3Z-_*O:QVKQ3P-_R-UI]&_E7M8[5U4?A/B<]_WI>APGQ0_P"0/:_]? _]
M!->75ZC\4/\ D#VO_7P/_037EU85-SWLD_W1>K"N^^%__'SJ/^['_P"S5P-=
M]\+_ /CYU'_=C_\ 9J*?Q(US?_=)?+\STT4X4T4X5V=3\^%HHHH&%-8XQZTZ
MFN 5YH \_P#$DL,/B0EUN;J /&9X$12JDX"_>89_"NH\-+:IHML+-W> YV[Q
M@K[8[8Z51UBX\-6VLI-J=Q!'>Q+NP2<X[9 K3T"ZM;W289[-E:!R2I48!YH
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M_D6#_P!=V_I7D5>N_#?_ )%@_P#79OZ55+XCBSW_ '7YHZ_M7A?BK_D:+_\
MZZ?X5[H:\+\5?\C1?_\ 73_"M*WPH\C(?X\O0QZ1ONGZ4M(WW3]*YC[-GO/A
MO_D7K+_KD*O7O_'E/_N'^54?#?\ R+UE_P!<A5Z]_P"/*?\ W#_*N[[)^:5?
M]X?K^I\^2_Z^7_?;^=,I\O\ KY?]]OYTRN)[GZ3#9%C3_P#D)6O_ %U7^8KZ
M"C_U:_05\^Z?_P A*U_ZZK_,5]!1_P"K7Z"NBCLSY3B#^)#T,/QE_P BG?\
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MT_2EI&^Z?I7,?9L]Y\-_\B]9?]<A5Z]_X\I_]P_RJCX;_P"1>LO^N0J]>_\
M'E/_ +A_E7=]D_-*O^\/U_4^?)?]?+_OM_.F4^7_ %\O^^W\Z97$]S])ALBQ
MI_\ R$K7_KJO\Q7T%'_JU^@KY]T__D)6O_75?YBOH*/_ %:_05T4=F?*<0?Q
M(>AA^,O^13O_ /<_J*\1[_A7MWC+_D4[_P#W/ZBO$>_X5-;='9D'\"7K^@5T
M7@?_ )&RU^C5SM=%X'_Y&RU^C5G#XCU\=_NU3T9[1W%>:_%'_CZT_P"C_P!*
M]*[BO-?BC_Q]:?\ 1_Z5UU/A/B,K_P![1Y_0.M% ZUP,_0WN=_\ "[_C^O\
M_=7^M>FBO,OA=_Q_7_\ NK_6O317;3^$_/\ ./\ >WZ+\C&U'_C\;Z54[U;U
M'_C\;Z54[UH>4'^-;&E?\>G_  *L?_&MC2O^/3_@5 %R3[M?/NJ_\AF^_P"O
MF3_T(U]!2?=KY]U7_D,WW_7S)_Z$:YZW0^FX>_B3]%^95I5^^O\ O"DI5^^O
M^\*PZGUDMCZ"L?\ CSA_ZYK_ "JKX@_Y 5[_ -<F_E5JQ_X\X?\ KFO\JJ^(
M/^0%>_\ 7)OY5W/8_,X?QEZK\SP5?NCZ4M(OW1]*6N%GZ;$UO"__ ",^G?\
M79?YU[IW->%^%_\ D9]._P"NR_SKW3N:ZJ.Q\=Q!_'CZ?J<E\1/^18;_ *Z+
M_.O(J]=^(G_(L-_UT7^=>15E5W/2R'_=OF%=A\-O^1E?_KB:X^NP^&W_ ",K
M_P#7$TJ?Q'H9E_ND_0]=[5YI\4O];8?C7I?:O-/BE_K;#\:VJ_"?'Y3_ +U'
MY_D>>]Z*.]%<O0_0.AZ7\+_^/*]_ZZ#^5>A>M>>_"_\ X\KW_KH/Y5Z%ZUVP
M^%'YWF?^]S/"O%7_ "-.H?\ 70UCUL>*O^1IU#_KH:QZXY_&?<X/_=H>@5[1
MX$_Y%2T^E>+U[1X$_P"14M/I6E'XF>5Q!_ 7K^AO77_'E-_N'^5?/<O^ND_W
MC_.OH2Z_X\IO]P_RKY[E_P!=)_O'^=57Z'+P_P#\O/D-[TH^\/K2=Z4?>'UK
MG/J'L?0=C_QX6_\ N+_*LGQG_P BGJ'^X/YBM:Q_X\+?_<7^59/C/_D4]0_W
M!_,5W/X3\XP_^]1_Q+\SQ$=**!THKB>Y^D1V.A\#?\C=:?1OY5[6.U>*>!O^
M1NM/HW\J]K':NJC\)\3GO^]+T.$^*'_('M?^O@?^@FO+J]1^*'_('M?^O@?^
M@FO+JPJ;GO9)_NB]6%=]\+_^/G4?]V/_ -FK@:[[X7_\?.H_[L?_ +-13^)&
MN;_[I+Y?F>FBG"FBG"NSJ?GPM%%% QC\,&KQOQ__ ,C9.?5%_D*]D?J*\<^(
M'_(VS_[B_P JRJ['N9#IBGZ/]#EZ***XTM3[AVL>R^!N?"EG["NDD^[7.>!.
M?"EG]#71O]VO0CL?FF*M]9GZL\"U;_D,WO\ UW;^=4ZN:M_R&;W_ *[M_.J=
M<,MS]&H?PH^B_)"-T/TKZ&LO^/2'_<'\J^>6Z'Z5]#67_'I#_N#^5;T=V?-\
M0[4_G^AS?Q)_Y$34?]P?S%?,X^Z*^F/B3_R(FH_[@_F*^9Q]T5R8SXCMX;_@
M2]7^@?Q"M[P5_P CKI'_ %\K_.L'^(5O>"O^1UTC_KY7^=<U/XT>]BOX$_1_
MD?4O\(K@_BA_R"[/_KM_0UWG\(K@_BA_R"[/_KM_0U[,_A/SG*_]\A_71GE_
M>BCO17"S]$CNCKOAQ_R,S?\ 7 _S%>NG[U>1?#C_ )&9O^N!_F*]=/WJ[J7P
MGP6<_P"]?UYGD_Q*_P"0_!_UQ_K7&5V?Q*_Y#\'_ %Q_K7&5S5/B/K<K_P!T
MI^G^85Z[\-_^18/_ %V;^E>15Z[\-_\ D6#_ -=F_I3H_$<6>_[K\T=>:\+\
M5?\ (T7_ /UT_P *]T->%^*O^1HO_P#KI_A6E;9'D9#_ +Q+T,>D;[I^E+2-
M]T_2N8^S9[SX;_Y%ZR_ZY"KU[_QY3_[A_E5'PW_R+UE_UR%7KW_CRG_W#_*N
M[[)^:5?]X?K^I\^2_P"OE_WV_G3*?+_KY?\ ?;^=,KB>Y^DPV18T_P#Y"5K_
M -=5_F*^@H_]6OT%?/NG_P#(2M?^NJ_S%?04?^K7Z"NBCLSY3B#^)#T,/QE_
MR*=__N?U%>(]_P *]N\9?\BG?_[G]17B/?\ "IK;H[,@_@2]?T"NB\#_ /(V
M6OT:N=KHO __ "-EK]&K.'Q'KX[_ ':IZ,]H[BO-?BC_ ,?6G_1_Z5Z5W%>:
M_%'_ (^M/^C_ -*ZZGPGQ&5_[VCS^@=:*!UK@9^AO<[_ .%W_']?_P"ZO]:]
M-%>9?"[_ (_K_P#W5_K7IHKMI_"?G^<?[V_1?D8VH_\ 'XWTJIWJWJ/_ !^-
M]*J=ZT/*#_&MC2O^/3_@58_^-;&E?\>G_ J +DGW:^?=5_Y#-]_U\R?^A&OH
M*3[M?/NJ_P#(9OO^OF3_ -"-<];H?3</?Q)^B_,JTJ_?7_>%)2K]]?\ >%8=
M3ZR6Q]!6/_'G#_US7^55?$'_ " KW_KDW\JM6/\ QYP_]<U_E57Q!_R KW_K
MDW\J[GL?F</XR]5^9X*OW1]*6D7[H^E+7"S]-B:WA?\ Y&?3O^NR_P Z]T[F
MO"_"_P#R,^G?]=E_G7NG<UU4=CX[B#^/'T_4Y+XB?\BPW_71?YUY%7KOQ$_Y
M%AO^NB_SKR*LJNYZ60_[M\PKL/AM_P C*_\ UQ-<?78?#;_D97_ZXFE3^(]#
M,O\ =)^AZ[VKS3XI?ZVP_&O2^U>:?%+_ %MA^-;5?A/C\I_WJ/S_ "//>]%'
M>BN7H?H'0]+^%_\ QY7O_70?RKT+UKSWX7_\>5[_ -=!_*O0O6NV'PH_.\S_
M -[F>%>*O^1IU#_KH:QZV/%7_(TZA_UT-8]<<_C/N<'_ +M#T"O:/ G_ "*E
MI]*\7KVCP)_R*EI]*TH_$SRN(/X"]?T-ZZ_X\IO]P_RKY[E_UTG^\?YU]"77
M_'E-_N'^5?/<O^ND_P!X_P ZJOT.7A__ )>?(;WI1]X?6D[TH^\/K7.?4/8^
M@['_ (\+?_<7^59/C/\ Y%/4/]P?S%:UC_QX6_\ N+_*LGQG_P BGJ'^X/YB
MNY_"?G&'_P!ZC_B7YGB(Z44#I17$]S](CL=#X&_Y&ZT^C?RKVL=J\4\#?\C=
M:?1OY5[6.U=5'X3XG/?]Z7H<)\4/^0/:_P#7P/\ T$UY=7J/Q0_Y ]K_ -?
M_P#037EU85-SWLD_W1>K"N^^%_\ Q\ZC_NQ_^S5P-=]\+_\ CYU'_=C_ /9J
M*?Q(US?_ '27R_,]-%.%-%.%=G4_/A:***!C7[5XW\0/^1MG_P!Q?Y5[(_:O
M&_B!_P C;/\ [B_RK*KL>YD/^]?)_H<O1117*?<,]G\"?\BI9_0UT;_=KG/
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M5_F*^@H_]6OT%?/NG_\ (2M?^NJ_S%?04?\ JU^@KHH[,^4X@_B0]##\9?\
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MLEL?05C_ ,></_7-?Y55\0?\@*]_ZY-_*K5C_P ></\ US7^55?$'_("O?\
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M-?Y55\0?\@*]_P"N3?RKN>Q^9P_C+U7YG@J_='TI:1?NCZ4M<+/TV)K>%_\
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M!_[M#T"O:/ G_(J6GTKQ>O:/ G_(J6GTK2CNSRN(/X"]?T-ZZ_X\IO\ </\
M*OGN7_72?[Q_G7T)=?\ 'E-_N'^5?/<O^ND_WC_.JK]#EX?_ .7GR&]Z4?>'
MUI.]*/O#ZUSGU#V/H.Q_X\+?_<7^59/C/_D4]0_W!_,5K6/_ !X6_P#N+_*L
MGQG_ ,BGJ'^X/YBNY_"?G&'_ -ZA_B7YGB(Z44#I17$]S](CL=#X&_Y&ZT^C
M?RKVL=J\4\#?\C=:?1OY5[6.U=5'X3XG/?\ >EZ'"?%#_D#VO_7P/_037EU>
MH_%#_D#VO_7P/_037EU85-SWLD_W1>K"N^^%_P#Q\ZC_ +L?_LU<#7??"_\
MX^=1_P!V/_V:BG\2-<W_ -TE\OS/313A313A79U/SX6BBB@8U^U>-_$#_D;9
M_P#<7^5>R/VKQOX@?\C;/_N+_*LJNQ[F0_[U\G^AR]%%%<I]PSV?P)_R*EG]
M#71O]VN<\"?\BI9_0UT;_=KNCL?FN*_WF?JSP'5_^0S>_P#7=OYU3JYJ_P#R
M&;W_ *[M_.J=<,MS]%H?PH^B_)"-T/TKZ&LO^/2'_<'\J^>6Z'Z5]#67_'I#
M_N#^5;T=V?-\0[4_G^AS?Q)_Y$34?]P?S%?,X^Z*^F/B3_R(FH_[@_F*^9Q]
MT5R8SXCMX;_@2]7^@?Q"M[P5_P CKI'_ %\K_.L'^(5O>"O^1UTC_KY7^=<U
M/XT>]BOX$_1_D?4O\(K@_BA_R"[/_KM_0UWG:N#^*'_(+M/^NW]#7LS^$_.<
MK_WR']=&>7]Z*.]%<+/T2.Z.O^''_(S-_P!<#_,5ZXW6O(_AQ_R,S?\ 7 _S
M%>N-UKNI?"?!9S_O7]>9Y/\ $K_D/P?]<?ZUQE=G\2O^0_!_UQ_K7&5S5/B/
MK,J_W.GZ!7KOPW_Y%<_]=F_I7D5>N_#?_D5S_P!=F_I3I?$<>>_[K\T=>:\+
M\5?\C1?_ /73_"O=#7A?BK_D:+__ *Z?X5K6^%'D9#_O$O0QZ1ONGZ4M(WW3
M]*Y3[-GO/AO_ )%ZR_ZY"KU[_P >4_\ N'^54?#?_(O67_7(5>O/^/*?_</\
MJ[OLGYI5_P!X?K^I\^2_Z^7_ 'V_G3*?-_KY?]]OYTRN)[GZ3#9%C3_^0E:_
M]=5_F*^@H_\ 5K]!7S[I_P#R$K7_ *ZK_,5]!1_ZM?H*Z*.S/E.(/XD/0P_&
M7_(IW_\ N?U%>(]_PKV[QE_R*=__ +G]17B/?\*BMNCLR#^!+U_0*Z+P/_R-
MEK]&KG:Z+P/_ ,C9:_1JB'Q'KX[_ ':IZ,]H[BO-?BC_ ,?6G_1_Z5Z5W%>:
M_%'_ (^M/^C_ -*ZZGPGQ&5_[VCS^@=:*!UK@9^AO<[_ .%W_']?_P"ZO]:]
M.KS'X7?\?U__ +J_UKTZNVG\)\!G'^]OT7Y&+J/_ !^-]*J=ZMZC_P ?C?2J
MG>M#R0_QK8TK_CT_X%6/_C6QI7_'I_P*@"Y)]VOGW5?^0S??]?,G_H1KZ"D^
M[7S[JO\ R&;[_KYD_P#0C7/6Z'TW#W\2?HOS*M*OWU_WA24J_?7_ 'A6'4^L
MEL?05C_QYP_]<U_E57Q!_P @*]_ZY-_*K5C_ ,></_7-?Y55\0?\@*]_ZY-_
M*NY['YG#^,O5?F>"K]T?2EI%^Z/I2UPL_38FMX7_ .1GT[_KLO\ .O=.YKPO
MPO\ \C/IW_785[IW-=5'8^.X@_CQ]/U.2^(G_(L-_P!=%_G7D5>N_$3_ )%A
MO^NB_P Z\BK*KN>ED/\ NWS"NP^&W_(RO_UQ-<?78?#;_D97_P"N)I4_B/0S
M+_=)^AZ[VKS3XI?ZVP_&O2^U>:?%+_6V'XUM5^$^/RG_ 'J/S_(\][T4=Z*Y
M>A^@=#TOX7_\>5[_ -=!_*O0O6O/?A?_ ,>5[_UT'\J]"]:[8?"C\[S/_>YG
MA7BK_D:=0_ZZ&L>MCQ5_R-.H?]=#6/7'4^,^ZP7^[0] KVCP+_R*EI]*\7KV
MCP+_ ,BG:?2M*.[/(XA_@+U_0WKO_CSF_P!P_P J^>Y?]<_^\?YU]"7?_'G-
M_N'^5?/DO^MD_P!X_P ZJOT.;A_:I\AG>E'WA]:3O2C[P^M<Y]0]CZ#L?^/"
MW_ZYK_*LGQG_ ,BEJ'^X/YBM:Q_X\+?_ *YK_*LGQG_R*6H?[@_F*[G\)^<8
M?_>H?XE^9XB.E% Z45Q/<_2%L=#X&_Y&ZT^C?RKVL=J\4\#?\C=:?1OY5[6.
MU=5'X3XG/?\ >EZ'"?%#_D#VO_7P/_037EU>H_%#_D#VO_7P/_037EU85-SW
MLD_W1>K"N^^%_P#Q\ZC_ +L?_LU<#7??"_\ X^]1_P!V/_V:BG\2-<W_ -TE
M\OS/313A31UIPKLZGY\+24M% QCGMD9KQOQZ'/BNX.UB"JX('L*]C>-7/S#/
M%5I;&UD;?);QL0.K*#4RCS*QW8#&+"5?:6OT/G_:W]QORI"K8^ZP_P" U[^N
MFV3=+6#'^X*7^S++_GUA_P"^!6/L/,]M\1*UO9F%X'8KX7M$)(./3WKI)&_=
MM@C(%-2VAC "1JH'0+Q4AAC_ +M;I:6/FJL^>HZB6YX'JZL-9OLJW^O;M[U3
MVM_<;\J]_;3[(DDVT1/<E!0NGV)'-I#_ -^Q6+H=3Z..?\L%'DV/G]E8J<*V
M?H:^@;!PUG$=PX0?RI/[-L3_ ,NL/_? J<01]E%:4X<IYN99BL;RZ6L<K\26
M)\#Z@H/5!T^M?-XBDV ;&SC^Z:^N9+6"1"DD2.IZAAD55_LG3@W%C;?]^A6-
M6A[1W-LMS;ZE!PY;W/E#RY/^>3Y^AK<\&JZ>,-*<QL-MPF?E/K7TL-)TX\?8
M;;/_ %R%"Z7IZ,&6S@5AT*Q@&LX83EE<[Z_$2JTY0Y-]-T61(& .[CZUPGQ-
M);2[/&6Q-DX&>,&NY\J-."M->UMYOEDB1@.1N&:ZY1NK'SF%K>QK*IO8^?=K
M?W6_[Y-)M;/W&[]J^@!IED/^76#_ +X%!TVRQ_QZP?\ ? K'V)]&N(5UA^)Y
M9\.05\2G((!@;DCW%>NDC/4?G5>.PM8FW1P1H>F54"IO)C'\-:PCRJQX.,Q/
MUFISVL>4?$C)UZ# )_=]0*X_:W]QORKZ!DL+68YD@1R.,LH)IO\ 9UE_SZ0?
M]\"HG3YG<]7"9W["BJ;C>Q\_[6Y^1ORKUOX<_+X8YX_?-UX]*Z7^S;+_ )](
M/^^!4T=K!&NU(E1?11@40I\KN98[-OK5+V?+;7N.+9/!%>'>*%;_ (2:^.UC
MF3((%>X^1'UV_K4#Z?9NY=K:)F/4LH-7./,K'%@,9]4J.=KW/G[:W]QORH96
MVGY&Z?W:^@/[.LO^?2#_ +X%']FV1_Y=(/\ O@5E[$]O_6!?R?BBGX=)7P_9
M GGRA5V[8FRF&1GRVZ5*MO&BA54 #H/2E,"$8(K>VECYB4^:;GYW/GN56\^3
M*M]]OX?>F[6_N-^5>_\ ]FV8_P"72 _5!1_9ME_SZ0?]\"L'1/IH\0))+D_$
M\(L$8ZE:X5L^:O;WKWV(GRTRPQM%1#3K(,"+6$$<@A!4_D1YSM_6M:<>4\?,
M<=]<DG:UC#\8G/A2_P <_(.GU%>*;3Q\C_\ ?-?0SVT+H5:-64]0>0:@_LZR
M_P"?2#_O@5,Z?,[G1@,T^J0<.6]W?<\ VM_<;\JW_!.1XKMC@@8/.#Q7L']G
M67_/I!_WP*6/3K2)]Z6\:MZA0*4:=G<[,1GOM:3IJ-KE@8SR1^=>:_$\%KNP
MQS\K].<=*](\E,XVU')96TI'F0H^.FX9K2:YE8\/"5_J]55+7/GS:W'RMR/0
MTNQNRM_WS7OXTVR Q]E@_P"^!0=-LL?\>L'_ 'P*P]B?0OB%65H?B>=_#'*W
MU^3D HN,C'/->F;Q_>_6HH[*WA_U<**3UVKBG>7&3@+S6\(<J/G\;B/K%9U=
MKF7J!'VMNXP*JY%=";:%CDQ@FD^S0_\ /-:HY3GB16QIC#[,1D#YJLBUAZ^4
MM.%O$!P@% #9G"IG<*\"U16_M>^.UN;F3L?[QKWYH(^/EJN=.LBQ+6T1).3\
M@YJ)PYD>GEV/6#G*35[GS_M;^XWY4JJQ=?E;[P[5[\=.L<?\>D/_ 'P*1=.L
M?^?6'_O@5"H]3UO]8+IKD'6#8LH=Q&=H%4M?D_XDEXN<DQMT^E:H@C7HO2F-
M;PMD,@(/4&MNECYE32J<]NI\\JK!0"K'_@)I=K?W&_*O?_[/L<_\>D/_ 'P*
M:VG60Y^R08_W!7/["Y],N(4HVY+GBWAH./$FGD(PQ,I)QVS7N@8#J1^=5DL+
M-65TMH@1T(0"K'D1# QQ6T(\NAX^88Y8RHI6M8Y+XB'=X;<*"<2)T^M>2[6/
M\#_E7T+):031[)(PZ^C#-0'3;)>EI!^*"IG3YCJP.:K"4G#DN> [6_N-^5==
M\.R4\02$J1^Z(R17J)TZQ'_+I"?^ "I([2UB.8X(T/JJ@5,:5G<VQ.=JM2=+
MEW)@PVCYA7FOQ.):>Q &<9Z<UZ0L$>,;:CEL[:7'FP1OCIN7-:RCS*QX^#K_
M %>JJEKV/GS:V -C9'L:-ISRK?E7OPTZQ)/^B0_]\"G?V=8]K6'/^X*P= ^A
M_P!85?X#B/AD=EE>A@03(,9%=\7_ -H?G4<=G;Q B.%$SUVC%2&!"/NUNE96
M/F\565:JZB6YX?XI#GQ-?G:?]83D*361M;^ZW_?->_R6%F[%WMXF8]25&32C
M3;$C_CUA_P"_8K&5&[N?04<^5.DJ?)L?/^T]-K9_W37LO@4[?"UJ">@Z'BML
M:999S]EA_P"^!4L=K#&H5(U51T XJXPY3CS'-%BX**C;[AEXW^AS8.?D/3Z5
M\_R*_G294_>(X!KZ&\B,C[M5CI=EG/V6(GW045(<YCEV8?4V]+W/ =K?W&_*
MD"MD?*W7TKZ _LZR_P"?2#_O@4?V;9?\^D'_ 'P*S]B>L^(%_)^*%L6Q96X)
M_P"6:]_:LCQF2?"E_@Y^0<#O\PK>$$8 &T<4U[6&1"CQAE/4'D&M^ECYJ-3E
MJJIV=SYY"MC[C?E05;^XW_?->_C3+)1C[+#^*"E_LVR_Y](/^^!6'L3Z7_6%
M?R?B>0>!E8>++4E6 PW)'3BO9F?& "!FHDL+1'#);Q(PZ%5 -2^0F<XYSFMH
M1Y58\3'XSZW652UM+'#?$S+:/:X^8^?R/P->8[6_N-^5?0<EE!*,2Q*X!R P
MS3/[-LO^?2#_ +X%9RI\SN=N S?ZK15)QN?/^UO[C?E7>?#(,MY?'! (3KQG
MK7HG]FV7_/I!_P!\"GQV%K$28X40GKL&*4:=G<TQF<K$4G3Y;7\R16ZY8=?I
M4BG/<&F>1'P-OZTY$5,[1C-;GSRT5A]%%(6 .*!C7SVZU#+,D,4CRG;&@)9L
M9XI;BXBMXVFD;"HI8_2N1U+5[FQU:"_=?-TFX10DN3LB!')88Y]J -G1-=M]
M7NKN*W="(&P"K9WJ1D'VK<QFL/3-/TR[NX=;LX#!(R%1M&P.O8D5NB@/,3;3
M0<_X4^H9'*JVT!FYPN>OI0!5OM0M[$#S98D=^(UD?;N;TS4&CZU:ZO"VP".X
MC)$T)8$H1].H]ZY&;6M/\50)INKV$EM=;MR2(-ZQ.#@9...?45TNB>&;?37^
MV-!$NH.FR62(L%<>N":=P-Q0#GC%.V@4*,#FE8X&:+@-;ITYJC=ZE:V,T"7+
ME/.;:C8^4'W/:JVOZQ<:59M):6+W,JH9"N<#:O)Y]<9Q6;)9R2W8&T7VEW^#
M)$6^:!CW7_9_E2N!TP()PI&[KP>U/\ON3SZUFZ3HD6D12+'--,\C99Y7R<=A
M6K0*RV&>7G[QS36RK8[8ZT_>,G/&.N:YG5[Z76M/NH]$GWO;2*)54X\P _,B
MMV)&1G%%PL6;GQ-96>K265RRQ+&@9I7..3T &.:V8)8KF%)87#QN,JPZ$5RF
MGW5OXEL'MWA$5X$_>-Y.[R1G[FX]\5T]A:16-I%:P@B.) JY]*+A9%C;S2D=
MZ4G R::6!!'0^] Q">/K6!;^+])FNGMI7>UE$IB47"[0Y'7!Z?GBJ&IZMJIU
M>>V@N(+,VZ>9%',F1=+WPV>/UJ32]%M]3N_[:G@1H[J 9@D&=DF>2/K1<+'5
M* RA@00?2G!<=Z1%"(J@  #  [4N: $)VXX)SZ56OKV*QLI[J7<8X5+$*,DU
M)<W$-O TT\@CB7&YB< <URRZQ!!K]\NIW12)8P;9#]R5#U(]3_C0!O:5J<.J
MVBS)M4\$J&W;<],GIFM#;7-:/X>MH+R.]M+BXBLGS*EGC"ASP2>_3M73T[A9
M"8I">:=52^FE@M))(8/.=1G8#C</\:0%+7=8BT73VN92 2<)G."?0GM5C3]1
MMM0MXWAGB=V0,RHV<9KEI+Z'4+Z.-)%N;/4B8;BSEY>!P,Y STX_E71:+H5E
MI%N$MDRP&WS&'S8ZX)IW"R-1><T[%(HVDY/!Z4NX8I (W"YK/N-6MK6[@MYR
MR&?(1R/DW?W<^M1W^H6UREUIMOJ$4-_LP,]5)Z<5SFE7+7BMH&K64GGAMFU0
M2%4#_6[_ %)/3M0!V:R*V0.HZU*!Q6?I>CPZ3;&&&263<<L\K;F)]S],5HC@
M8HN%A,4QR%Y/X^U.+@=B?I7)^(_%"V5Z;"W6>.\11*"\.Z*5><KD'- %P^++
M$7! @G:V$GE&Z51Y8;I@\YZ^U;J_/TZ8KA]/L8_$EN;O2+@VMG<OMO[26,G:
MZGG;TP3_ (5W,48B0(HPJ@ <T"LAP0]SFD\O'(.#3SP*89% Y.,G S1<+(;+
M,(HV<JS84MA16-H?B2#5X7<E(V5CF,GE!G W9Q@^U9.K:G=0:W>*)4C>*)6M
M4F<I$X[L2 <D'C%3:7HUKK(M];F@DM9Y0&GA0XCE8<!B._3CI0,ZT'(I:1<X
MYH+ '!H 1R .:HZGJ$>F:=->20R2K$NXI&,L:DU"_M["V%Q<.4B# $[20,]S
M6+J1N[:^^T)F\TZY4)+"N"4S_$OJ* +FE^(M,U>3R+>4I<@ M!(,.N1GZ?K6
MN(\=_P!*Q/#_ (>AT:W6/"22([%9F7Y]I.0">^!Q^%;U.X/43%,&"Q&.].WC
M('K6==ZE:0W/V-[R*"Z=2R*YY^M("MKVNP:+922L0)0A=5?(!QVR <5HV5Q%
MJ-E#=PN&AF0.I'<$9KGH]7=9ETK6;$SW3-M1HX]\<J'^/GI[BM[2M+MM)M6M
MK162'>6"%LA<\X'H*=P+:IM&!2A<=\TXG%-+ #)S2 #P"<UBWWB/3=.OQ9WL
MC1.5W;V7Y ,XZU)=ZO;2S76GQW/D3QQ\S-C:C$<=3R>]8#Z=<^(9;>+481'=
M6D@%QCF*ZB/7'L>N/6@#L()H9XEDAD1T/1E.14NT&J]G86]A L%K$L<2]%7H
M*L@XP#UH 3A:9*P12QP%'))["G,P4$DX Y/TKFM1\0/9:[!:3Q$6<HQ&0NX3
M,>,9S@8ZT 3KXHL!J,4!DC-O./W5RL@*EO[I':MU0#VQ7&VO@O1[JYF*0V\^
MFN^X("0T4@/\)!Z5V<<0C55'0#%.X"[*7'%+32X!Q@T@*US<1VT,DTK8CC!+
M'&<"L_1=>AUB2\2$H1;R;05;.5['I7+ZKXCU7^T9$ATJ9;BR8D0!PZW,?<XX
MQ['G%=+I>E64T\.N06TEG<3Q?/%]T8/9E]10*QN+DCTI<>]"@@<T$XH&!.!5
M'4M2M]/M6EFD5"0=@<X#-C@9[9JQ-=00O$DDJHTK;8PW\1QG KB!K.JG6Y],
MO-.CU-$D.Y$0*T2'[K<\,* .MT?48]8TN"^BQLE7. V=I],U?V"LO2='M=*$
MOV-'CBG;>82WRQGT [5K4[A9"8I"<9]J/,&<<YK&U'7K&SO%LI+DK/+A057(
MC+<*6/;G\Z0#]4U^RTBXMXKS>IGW;6520,#)S5ZSN[;4(!/:SI+$>C(<BN3O
M;6]UB$Z/?[DOH'$L%T@^290>0?0E21CWKJ-+TRTTNW,5G;I IP65,XS3N%D7
M N.]*1[TI.*87&T]N^32 ,XZUC)X@MVUJ;3V79Y04;F."['LJ]QQUJIXBOB^
MD17%J[O:I<#[28LEMG(./Q(JK)::7XKG22QEFCFM4 CO8Q@@'@KR.>!1<#K,
M@XP0<U(!Q5>TM%L[2.W0LRH,98Y)]ZL@8&*+A83% %+10 FX>M032K&CRD%@
MHR HY--FN8+6(/<2)&I.!Z$US.L:I(\TL7F_8+RT)E@,C?N[A?3\: *$NMVG
MBI)=.N6_L]G3?;3QR\CG&&!& ?8UJ^&]%U&UT](-3NC.D:>5Y#HK(<<!@??T
MJ;2M)LKS9K"VHB-Y&LDUNR@KN(SGD=:Z&/ITQQT]* &Q1A.B@#T' %2T4'..
M.M %6ZU&SL1&;JX2$2-M4N<9-<?<1W]MXQMYY+AS;3R[HKA6S&J?\\RH[^AI
MVLM/K-I<:7-;Q1:O;L9K8$;TEQR,9QUZ$5LZ%X?@T>R5%>X?> 629]X4^WI0
M!;M-&MK._N[J),&[8/(, @-CK^-:29V\C%*H"J . !2T (2 0">356>\@:1K
M2.XC%T5)5,C(]\5F>(?$,&B-$KPO-*ZE]B$ A1U.3UQZ5RYTN34-8BU31[]F
MLYW9Q+&@,T$A!ZYZI[4 6=#UC7+FYET^[M%OHD;R;F5!L,;'CH3\P[\$5T6@
M>'DT.'8+B:XD( ,DK?PCH,5<T^R^RY=RK7#X\V15VAR!UQS5^@ I-ZXSD4M<
MYJ6/$%I<V-AJ)M2'\N294ZGN%.: #7]?729H4ELGN+6=6+R(X&T = ._&>]5
M--L[.[O(-6\/7'D1_=N+<QD+(/<'D,*9;V4VM:8=*U:W>"ZLI8W$JC*/M8$,
MOUQR#ZUU<,:1IQ&%/? QF@!8X4C+%$52W+;1C)J3H,F@4C<B@!'90IRP SW.
M*Y/Q!=#4M(G>PFN4N;"02R1(=KLHZX]1C.*BU;6]'UF"ZT6]>XLF:3RDD8[<
MN.000?:H]!\*21W\5]<7%RLL(,;8FWQSH1P>F<>W/UH GTO1[S6--C'B$P7<
M1 DA=04D0YZ$CKQ]*ZR.,0HL<:@(HP .U.5=JA0  . !VI] "!@.,\U6O;VW
ML;62ZN)%2&,?,QZ &G32+'O;[S $A>YX[5Q=KXHBU6>[T[4X$AMY$VKA68HV
M<!7&.#W':@"3Q&MUJ:Q:CI.IF6S"[+BVC57#*?XL'N/3WK0\-:%<6EDT>I2P
M7\08-:[X-K1+Z<DTSPOX9CTU!=W ;[>Q82,K85U[?+TZ5U*_C0 U4PX(&%]*
MDHHH *C*9'3)SGKWJ2B@"@FFVD=VUVEI$MRPP9 H!-75X'/!IU(: $)7(SU[
M5SOB3Q))HK1116ZR.ZE]\C[4XQ\H(!^;G@5;UF]0 Z>DX@N[B-A [ A2WIGU
MYKGXH+^XE@T#5K2UFA:(L3$S,\; C#%B.O6@"*ZTJU\4ZI9W]L0894"7@CRD
MD; 97D\C!+5V=I9K9VT<"%GV#&^0Y9A[FDLK2.TB5$7+  ,Y #-CH3ZU<H *
M:74'!(%+D>HKF]?\1G1;Z.&:P:6TEC+-,CC/!Y '?J.] %CQ(]VVBSS:?<F%
MXL/OC4,2HZXK)TA-1\16L,FJ6D7E#]Y;7L,FV1AV#)C@GN,FF:=!>3X?1+I?
M[(N&WNEPC>9 >X4'J#Z'I786L,=O;K'$@1!T &* "WA$(95C5 3G"@#)J;.*
M*BN9HX(3+*P5%Y)/:@!EY>065I+<7$FR*-<L<=*Y'5;V#Q1H=P;+SEN;1A((
M7?RW/&1T/0@U+)K?_$\N-.U:$+:S)F'./+:+'+%O7)Z>U2:'X7M+*X>[B?S8
M))!+;R98.%(^ZV3\P]..E $GA_2[M[&*35+E+Z-U$L2S1#=%GG;GOCI72JA5
M0H "CC ':C&.,8%/!XH 0.HX)P>N/2H)KJVCDC62:)'?[@9@"3[>M4==U:+1
MK*2[DBDE('RQQC):N4UW29]9CM-9L)?-BF5#*L?S-%C^*,GH?4&@"9]:UJ+7
MKO2IK.+4H2Y)@1=C+$>AR20>XQQTK>T?0(M.F:99KEHV7]U!(W$*G^&I]+TZ
M6+9<WTL<]X$V"9(MA*=0",GGFM84 ( <YP,GK3J** ,+Q!J=[I^GE].LVNYC
MG(0_= ZGZUB:M80>++*PO[&43#(BG<* Y0_>Z_=(YK8N;&]LM76^L"TL,[@7
M-NS<>FY?0^W>M*UTZVLI)VM8%B,K%WQT+>N* (M-TF/3+=88GFD122IE;<P!
M[9]*T5(7@GGWI5^[37X(.,T *QQBL'7+^Z\IH=*W2SQRJ)XXL&15)YP#QTIE
M[XAM);UM*ANFCNGRB3*F51_3Z^U94<>J2ZU8B2R>'48) MS=Q_ZJ>+^(^N?0
M=C0 IMK;Q,][&^EK:ZB,(SRG<-N/]DXR!7565JUI:0VPRPB0)N)R<#_/6GV]
MK#;,YAA5-[;FQU)]35J@ J.1U12[,%5022>PIY95!+$ #DDFN/UWQ9;6M[+:
M^9L:V93<),GRR1G^Z>G2@";6;B36=,M[K3M\]NDGF26ZMM:XC'H?U]ZIZ%96
MNL1WMNBS2Z.<&$3$AXWQR 3SP:GT_P /W%EJ*2Z7>K_9,Q60JV691V13TVFN
MLA550A5VC)XQB@"*RM(;*W2WMXA'$@PJCM5@D 9/2EJK?WUO86CW%S($C7'U
M)[ >] $L\R0V\DK9*HI8X&3@5Q&N:E'KFAP:UI-Q<-]F?YXXVV, >#D<],YZ
M=J?JNH:G>QVNL:%>%;2(%+BV>'<1ZG&0>/2K/A?0I[4-=W:Q*[,VP0$A7C/0
M,I'44 7M(TB],4,^LO!<W<.##-$AC.".0>>:Z 9P,C!IPZ44 )D#K5>ZNU@C
M;8!)-M)6(, SX[#-5=6U>WTQ8S+YKO(?DCA7<S?A7$ZA#<:IJ=MJ^FW#M#),
M%=F4F2U<<8VY'RDD T 0:C?:CJNL7%M:W ,CJ)K:TNDV/%(ISA6'?],5WEC:
M;FCOIX!'?/"$E*G/X4MK:.R0SZA#;R7L8XDC3IVXST_.M!1SDD_C0  $?_6I
MV10>AYK-U+54T^V:<Q-+'&1YHC.2@]2* *VO7>H06,@TFV%S>$X W "/US[X
MSCWK FTJU\56L-_92%;E61;N&3*"4*?NN!R"#R"*6.WU73FAFL-0CNH[NY#J
MBVY^93][<VXXP,_X5UT-I%!-+)'"J22G,C*.I]: &Z?8)8VB0H9'"]#*^XC/
M;-7![C%*O2D<A5))  YYH &/'!YKG+_7(DUIM(N!LCDBP2V<R;N,)CTYS3->
MO+C4M'E;1YF;RG_?"/AW0 Y"$\9Z5EZ/;3^(M*A@U*V8&++6]\DN98STVGY1
MAL'F@"QINFZQI>HFSMF2YTZ4Y2X=O]2@ZIM'4G/6NMBMT@4K%&L8]%  J&PL
MX["UBMH0VQ!U8Y)/O5V@ HHHH **** ,+6_#T.L@&2>:*6+F!D. C==V.A-+
MI]E-?V$2:_9V\EU Q&X+E6P>& /3/7':MS -% #4 5<#&!T IU%% !0>E%%
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M+ 1EL_>QC//UQ[4 +H-C>OJMUJ%Y:Q6;E%A9(CD2E<G?^.:Z4*,8]*4#&:
M* %Q0>E%% %*_LTU"PGM9 ,2I@'T..*R_#OAV#2+5))(E.H%2)IQD&3GJ1TK
MH,48YS0  8I:** "BBB@ HHHH **** "BBB@ HHHH **** $P*6BB@ H(S11
M0 A4'J*-HSTI:* $VC.<4M%% !1@444 )@4M%% !1110 4FT9Z4M% !1110
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<B@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_034.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_034.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *S L@# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"B@#B/#K7WAVRN;6'PGX@F$]W-=%GEL1@R.6(XN.@S6O_P )#JG_ $)FN?\
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M;IZ8K<H Y_\ X3OP?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH
MY_\ X3OP?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH Y_\ X3OP
M?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH Y_\ X3OP?_T->A_^
M#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH XKQ+KO@CQ/X<O=%NO&&CQ0W:
M;&>+48=R\@\9;U%8>@IX.TKQ/_PD5_\ $33M4U%;3['&TMY:Q(D600-J8YXZ
M^YKU&B@#G_\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJZ"B@#
MG_\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7H?\ X,8?_BJZ"B@#G_\ A._!
M_P#T->A_^#&'_P"*J*Y\:>#;JUFMW\6:($E1D8KJ,((!&./FKI:* /'=&T7P
M3I=WHS3?$FQO+/19&DL;5[RT18V.<[F7#-R<]:]"_P"$[\'_ /0UZ'_X,8?_
M (JN@HH Y_\ X3OP?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JN@HH
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M\IQ'&A=CZ #)H Y"VTS68? <&F6$%[8:M'!;QI--=*ZQR *"WWVR@P<KC!'
M'/'/.GB"?4=1TI?[7.I)X>MC$J:E@0W;-,#(S;U# L%.0#PN-O\ #79P>*'-
MU;6UUH]Y$[K")YD>-H8))!\J'+!R<X&0F.>W.*L?C&T&E:IKCZ-?K!:IO65(
ME=KF$;OF4@X&"KY5RI7C(&X4 8R:)XX?4[J235GB NIY(61"R/&581H29]H
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M(S^ _(4ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!16/JOBC1]&;R[R\42XSY2 LWY#I^-<GJ7Q1C7*Z98ES_P ]+@X'_?(_QJ'.
M*W9W4,OQ->SA!V[[+\3T0D 9)Q4;7$"_>FC'U85P&G^(+CQ%H[S78C$\%QM(
MC&!M9<C^1I]4FFKHYZ]&="HZ<]T=Y'/#*2(Y4<CJ%8&I*\WU6>:V\.ZC+!*\
M4@$>'1B"/WB]Q7&Q>)-;A_U>JW@]C*2/UJ)5%%V/1P653Q=)U(R2UMK<]ZHK
MQ:#Q]XBAP#?+(/22)3_3-;%A\4+V-P-0LH9D[M"2C?KD']*2JQ-*F1XJ*NK/
MT?\ F>HT5S&G^/M!OY%C-P]L[' $Z;1^8R!^)KID=70,C!E/((.0:T33V/*J
MT*M%VJ1:]1:***9B%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5P6M?$2;2M9NK!=,CD$#[0YF(SQZ8KO:\,\8?\C=J?_7;
M^@K*K)I:'M9-AJ6(JRC55TE^IT__  M6?_H$1_\ @0?_ (FC_A:L_P#T"(__
M  (/_P 37GM%8>TEW/I_[)P7\GXO_,]1T3XB3:MK-K8-IL<0G?:7$Q..">F/
M:N]KP[P;_P C?IO_ %U/_H)KW&MZ4FUJ?,9SAJ6'K1C25DU^H4445J>*%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/TY^G-.L[^TU!'>TN(Y@C;7V-G:<9P?3@@_C0!9HHHH **** "BBB@ HHHH
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M[+/DL]P2B_K$.NC_ ,SH:***W/F HHHH **** "BBB@ HHHH **** "BBB@
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M:=XAM-3NOL\,<ROM+9< # ^AK7H **** "BBB@ HHHH **** "BBB@ HHHH
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M &Q;^8KNZX3PC_R&_P#MBW\Q7=T %%%% !1110 4444 %%%% !1110 4444
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M/K]#C\S6-6":NCZ#)\?.G55";O%[>3/*Z***Y3[0**** "BBB@ HHHH ]?\
MAQ>M=>&/)<DFVE:,?3AA_.NOKSSX5R9MM3B_NO&WYAA_2O0Z[:;O%'YYFD%#
M%U$N]_OU"BBBK/."BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPSQA_R
M-VI_]=OZ"O<Z\,\8?\C=J?\ UV_H*QK;'T7#_P#'GZ?J8E%%%<I]D;O@W_D;
M]-_ZZG_T$U[C7AW@W_D;]-_ZZG_T$U[C751V/C>(/X\?3]0HHHK8^="BBB@
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M-CITURJ!S&,A2<9YKF/^$TG_ .?./_OLUO>(/^0#=_[H_F*\YH ZC_A-)_\
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MH **** "BBB@ HHHH **** "O:/ VBKI/A^*1X]MU= 2RD]<?PC\ ?S)KAO
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M]$_[Z% #Z*9YT7_/1/\ OH4>=%_SU3_OH4 /HIGG1?\ /1/^^A1YT7_/1/\
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MUORHV/\ W&_*@#J?#_\ R#/^!FM6LC071-,P[!3O/!.*U/.B_P">B?\ ?0H
M?13/.B_YZ)_WT*/.B_YZ)_WT* 'T4U75_NL&^AS10 ZBBB@ HHHH **** "B
MBB@ H(!&",@T44 <[J7@C0M25C]C6WE;_EI!\A!^G0_E7)W?PMNU)-GJ,,@[
M"9"I_,9KTZBH=.+Z'HT,SQ5%6C/3SU_,\0O/!7B"R)W:=)*H_B@(?]!S66^E
M:C$<2:?=I_O0L/Z5]!T5FZ*[GIPX@JI>]!/[T?._V.Z'_+M-_P!\&GKIU\_W
M+*X;_=B8_P!*^A:*7L?,T_UAE_S[_'_@'A%KX6UV[8"+2[D9[R)L'YMBM^S^
M&6K3*&N;BVMP>JY+L/RX_6O6**I48]3FJY]B9? E'\?S..TKX<Z19?->%[Z3
M_;^51_P$'^9KJK6SMK& 06D$<$0Y"1J%'Z5/16BBEL>16Q5:N[U)-_UVV"BB
MBJ.<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *C,$)))B
MC)/?:*DHH C^SP?\\8_^^11]G@_YXQ_]\BI** (_L\'_ #QC_P"^11Y$/_/)
M/^^17+^([W4-/\26-Y#)=M8VUK)+<VT,9<3 O&G0?Q*&+#Z&L26ZUR.XM1JE
MU)#YUW)),ANVMTB!AA81AU5LA2S #HQ!YH ]#\B+_GDG_?(H\B+_ )Y)_P!\
MBO.TU#5%%S):7E[/>F]O8[B!V9EAMU\WRW"_PXVQ@$==W>M'6;J86VK2-J5]
M!J,-J3801.5$G[@-N"X^<ERXR<XV]L4 =GY$.,>4F/\ =%'V>#_GC'_WR*\W
MDOO$MO/<7*W-Y);3:C8VOELAS",0,S+Q]UMTBM[X]ZZ'P7<7%P-0-Y<-)<"X
ME&U[II&51*X7,94"/@#&"<B@#I_L\'_/&/\ [Y%'V>#_ )XQ_P#?(J2B@"/[
M/#_SQC_[Y%'V>#_GC'_WR*DHH C^SP?\\8_^^11]G@_YXQ_]\BI*XO4;JZ7Q
M1J"?:60)"#;I]M="3Y1/RQ!=K\]R?Y4 =A]GA_YXQ_\ ?(H\B'_GE'_WR*\T
ML]7\2BQTRRN&U!"+:+[7>B$N_DOM;S1P1O'*'@D8+8Z4R]U'69H(X+"?488?
M,NHA/'<-<;QLC*NCL@) +-C.<$$9(H ].\B'_GDG_?(H\B'_ )Y)_P!\BO/K
MF_UX->6]_+)&UO<6T+2"9[>*1<2Y<.JL5##83C.#Q4IO+W_A)]2C^V2^3'I\
M36:_;9/F<Q,247;B7D EB0>G% '>?9X<8\F/_OD4?9X?^>,?_?(KS>XN_$%G
M8I!YUXLX6Y=E25YL#[%N0[V4$_O 2.!AL@9XI+;4]=_M"UTZ]NM3A@BL8UNK
MM822RE@1*#M(W$81CCY?F/& : /2?L\'_/&/_OD4?9X?^>,?_?(K%\)7<UWI
M4QE2<+'<R1QO+.9A(H/#*Y52RG)QD=NM;U $?V>#_GC'_P!\BC[/!_SQC_[Y
M%244 1_9X/\ GC'_ -\BC[/!_P \8_\ OD5)10!']GAS_J8_^^11Y$/_ #RC
M_P"^17"^*;KQ!9W^LW6GS7+VJ6T4/D*N?++!\2QX_B#;01Z'/&*OSW^H/J5M
M8PS3_:5U@M-& >+7:QR>/N?=Y]<#K0!U?D0_\\D_[Y%'D0_\\H_^^17G,4^N
MV_AJ=KJZN89E^SS")[IV:Y4Q$E5FVYC9F!^7;P4QT;-:MY?:]((;K3X[GS4N
MA*+2X4*94^R(QB;LIW%N>@<>G% '8_9X3_RQC_[Y%'V>#_GC'_WR*\]&K:M+
M##-=M=(JP0R6L9G>W:X+9+\A&WN"% C.!SSUKT:@"/[/#_SQC_[Y%'V>#_GC
M'_WR*DHH C^SP8QY,?\ WR*/L\/_ #QC_P"^14E% $?V>#_GC'_WR*/L\/\
MSQC_ .^14E% $?V>'_GC'_WR*/L\/_/&/_OD5)7-S:T-.\77\=]<LEH-/@DA
M0@D,^Z;?M'=L!.![4 =!Y$/_ #RC_P"^11]GA_YY1_\ ?(KSRWU[Q':DWFH6
ME_';Q3QWCQ/&&)MY0RO&-N<^4Q5AWQVK7\*3:W<W\D&K23AM/1D<E<+<&4AU
M;WVJ-O'<F@#K/L\/_/&/_OD4?9X/^>,?_?(J2B@"/[/#_P \8_\ OD4?9X/^
M>,?_ 'R*DHH :D:)]Q%7Z#%%.HH **** "BBB@ HHHH **** "BBB@ HHHH
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MP?D &<Y W8!S@W+'P]?Z1JENME$9=.%PSE;C82ARH\P;2N6(+?,0QP@SRY-
M'94A( ))  ZDUQ>M>'=5O;[6)[>:=(YY;1HX$,6R<(5W%BP+#&#T*YQWJ&:Z
MO++6+'29&BA\P;_+%T$8[I9>%B'^LW?)D_P@9/>@#N(I8YX4FAD62*10R.AR
MK \@@CJ*?7%V6E^(K+1;2RA=U$=O;!_,82%6".)%&V1#@$1]& ^O.=S2;;4H
MK^YDOYY9(_)A2+<0%+!?WC;03@EL=2?;OD V**Y+P_I.KV.GV\=QYT;0I;JD
M0F7:OSGS> <'Y2.N>G'-6H(-5_LZT6ZAO&GSF\\JX4%VV'E/G 5-W88[<=:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML## DG'3C'.1D:3\0/%$P\(W%Y!I,T/B))@L%O%)&\3HA*_.SL""<=ACWZT
M>J45POP_\8ZGXDGOK36XK:RU*U ,NGBWDBEA^8C)+,1(I&"&&.IXZ$]U0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!6U#4+/2K":^O[F.VM85W22R-A5
M%26MS#>VD-W;OO@GC62-P"-RL,@\^QKG?&?@31_'&G&UU,3K(@_<S13,/*;U
M"YVG\0?Y5=TSPU;:=I-G8FYO9#;0)"76\F0-M4#(4/@=.G:@#:HK/_L:U_YZ
MWW_@?/\ _%T?V-:_\];[_P #Y_\ XN@#0HK/_L:U_P">M]_X'S__ !=']C6O
M_/6^_P# ^?\ ^+H T**S_P"QK7_GK??^!\__ ,71_8UK_P ];[_P/G_^+H T
M**S_ .QK7_GK??\ @?/_ /%T?V-:_P#/6^_\#Y__ (N@#0HK/_L:U_YZWW_@
M?/\ _%T?V-:_\];[_P #Y_\ XN@#0HK/_L:U_P">M]_X'S__ !=']C6O_/6^
M_P# ^?\ ^+H T**S_P"QK7_GK??^!\__ ,71_8UK_P ];[_P/G_^+H T**S_
M .QK7_GK??\ @?/_ /%T?V-:_P#/6^_\#Y__ (N@#0HK/_L:U_YZWW_@?/\
M_%T?V-:_\];[_P #Y_\ XN@#0HK/_L:U_P">M]_X'S__ !=']C6O_/6^_P#
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MZ^'WAB^BLXKK36FCM$$<:27,I!4,6 <;OWG))^?/4UK?V-:_\];[_P #Y_\
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M\];[_P #Y_\ XN@#0HK/_L:U_P">M]_X'S__ !=']C6O_/6^_P# ^?\ ^+H
MT**S_P"QK7_GK??^!\__ ,71_8UK_P ];[_P/G_^+H T**S_ .QK7_GK??\
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M?V-:_P#/6^_\#Y__ (N@#0HK/_L:U_YZWW_@?/\ _%T?V-:_\];[_P #Y_\
MXN@!=6UK3-"MXKC5;V&S@EE$*RS-M3>02 3T'0\G J\CK(BNC!D895E.01ZB
MN0\7_#S3_&&DPZ;<7M_!"MPLSD7#R%@ 1@!V(!YZX-;V@Z%8>&]'@TO34D2T
M@&$625G(_%B<>N!Q0!I4444 %%%% !1110 4444 %%%% !1110 4444 %%9=
MY+<3:S;V$-R]M&UO),[QJI8D,@4#<",?,V>,_=YZYJ66O3&=K*XB22>&_73Y
M)D.U7;[.LQD"\[1SC;D_6@#?HK@[/X@7]S)#YOA](HI+>*],OVX,$MW<QDD;
M =X(!"]"N<LI&TZVJ^*6LI(;=+7YY[V6R63S/N%;=YM^,<_<QCWSGM0!TU%<
M9_PF-S:IHEO)!;3RW]O&OF&["R>>T+2 F(*<1G9@MG()X4CFH=/\7ZK'X,TO
M6=2L(99YM,%_*MO<$AHAY)9\&,$-MD=M@R/EQDYR #N:*XR_\>_98@T&GQR.
M\ET85ENA%YT-NRJ[(2IR[,P"+T8<[@*U-<U]],M+6^ACWPM#-.T3_*S!(6D
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M!8  9R<X%R]\97NG VU[I5I#J4MTD%M$VH8A96C:3>\I0;,*C@@*W( !.<@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'(/0UM44 <\?!&@LZ,]O=.5"AM]_.WF[7+J9,O\ O"&8D%\D=L8%73X=TO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBN&\&^#=%'AJPNKK3K26_EMV6:=)!)OW
MAE;YE)!R"1D'O0!W-%8<'@[P];6-U90Z3;I;7>SSXP#B3:<KGZ&HV\#>&&M8
M[9M%M3#&[2(F#@,P4,>O<*OY4 =!16#>^$O#5_+;17>F6LLD%NL,*-U6)>@
MST&?UJ>#PMH=KJYU:#38$OR[R&< [MS9W'\<G\Z ->BN?B\#>&(8YHX]%M52
M=!'* #\R[@V#SZJI_"I/^$.\/?V9_9O]DV_V+SOM'DX.WS-NW=]<<4 ;E%<_
M+X&\,31PQR:+:LD"&.($'Y5W%L#GU9C^-1>#FO6_M_[;=?:,:S<"'_25F\N+
MY=J<$[,<_(<$>@H Z6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HKC?[$U-L.D,D+O="95,BA;8>9&3C#'@HA!QU);@!C6IX>T^\
MLI[E[A#%&\4*A"X;=(JD._!/WB1[G'- &]1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5S_A2$00ZN!IT]ENU6Y<B9B?.R^?,7('R
MMU Y'N:Z"N;\'_9?*UL6KW+ :Q=>9YX P^[Y@N#]WTSS0!TE%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5\Y/\ ?;ZU]&U\Y/\ ?;ZUSUNA]5P[_P O/E^HE6]*_P"0S8_]?,?_ *$*
MJ5;TK_D,V/\ U\Q_^A"L%N?3U/@EZ/\ )GT'1117>?EP4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%1SSPVT#SW$J10H-SR2,%51ZDGI0!)111
M0 4444 %%%5[[4++2[1[O4+NWM+9,;YKB01HN3@98D <D"@"Q14-I>6U_:QW
M5G<PW-O(,QS0N'1QZ@C@TY;B%KF2W6:,SQJKO$&&Y58D*2.H!*M@]]I]* )*
M*CFGAMU5II4C#.$4NP&6)P ,]R> *DH **** "BBB@ KGO"EP]P-:W7TMWY>
MK7$8\P$>4 1^[&2>!VKH:Y_PK([G6P\EJ^W59PHMT"[1QP^ ,OZDY/N: .@H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "OG)_OM]:^C:^<G^^WUKGK=#ZKAW_EY\OU$JWI7_(9L?^OF
M/_T(54JWI7_(9L?^OF/_ -"%8+<^GJ?!+T?Y,^@Z***[S\N"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BF3&189#"B/*%)178JI;' ) .![X/T-9;7'B
M(:?&Z:5I9O2Y#PG4I!&$[$/Y&2?;:/K0!KUD>*;*XU'PMJ=G:1^9<36[)&FX
M#<2.F3Q5I9=3.I"-K.S%ALR9A=,9=_IY?EXQ[[_PJO\ :-?^R7#?V9IGVE7
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MT7-JWVU\RMZ./*_=CW!?Z4 <?!XLO=1OH-5M7^S6<VG2O!!<0N1(ZL@V$;E
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M *^8_P#T(5@MSZ>I\$O1_DSZ#HHHKO/RX**** "BBB@ HHHH **** "BBB@
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M7_(X7'_7./\ ]!%<M74_$+_D<+C_ *YQ_P#H(KEJSG\3/4P'^ZT_1'2^ ?\
MD<['Z2?^BVKJ+UG;0/&P86H"WQ"^0%!QLB^_C^+Z\XQ7+^ ?^1SL?I)_Z+:N
MFNXWCT3QT7M5@5K_ '*RD_O1Y<7S')/.<CC XZ5M3^!GS^:?\C&E_P!N_P#I
M1YI1117.?6'LGP[_ .1/M_\ KI)_Z$:X7XA_\CA/_P!<H_\ T&NZ^'?_ ")]
MO_UTD_\ 0C7"_$/_ )'"?_KE'_Z#71/^&CY7 ?\ (TJ_]O?FCE:Z;P!_R.5G
M_NR?^@-7,UTW@#_D<K/_ '9/_0&K&'Q(]_'?[M4]'^1WWQ$_Y$^X_P"ND?\
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MQ%O/?6Y:1W^U21VS*9E=D9B,N=K9C'/( / X%:6AZ*VD_:'EN5GEF\M=RQ[
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MI_ SY_-/^1C2_P"W?_2CS6BBBN<^L/9/AW_R)]O_ -=)/_0C7"_$/_D<)_\
MKE'_ .@UW7P[_P"1/M_^NDG_ *$:X7XA_P#(X3_]<H__ $&NB?\ #1\K@/\
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MC_U\Q_\ H0JI5O2O^0S8_P#7S'_Z$*P6Y]/4^"7H_P F?0=%%%=Y^7!1110
M4444 >)>(_\ D9=2_P"OE_YUF5I^(_\ D9=2_P"OE_YUF4 !Z5[GH_\ R!+#
M_KVC_P#017AAZ5[GH_\ R!+#_KVC_P#010!=HHHH **** "BBLS4?$&EZ3.L
M-]="&1UWJI1CD9QV!]* (3KP'B%=+%N2"YB,N_D.(Q)]W'3!ZYZ]JLZ=J$E]
M/>Q/#&GV641%HY"ZLVT,1RHZ9'XY':LIO%/A5Y_/:Y@:;;M\PV[%L>F=N<5)
M'XO\-0J5BOHT4DL0L+@9)R3]WUH Z&BJFGZE9ZK;&XLIA+$&*[@I'(^HJW0
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M$^6S_P#WE?X5^;.EHHHK8\ **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\F?0=%%%=Y^7!1110 4444 >)>(_^1EU+_KY?^=9E:?B/_D9=2_Z^7_G690
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M@HH Y_\ X03P?_T*FA_^"Z'_ .)H_P"$$\'_ /0J:'_X+H?_ (FN@HH Y_\
MX03P?_T*FA_^"Z'_ .)H_P"$$\'_ /0J:'_X+H?_ (FN@HH Y_\ X03P?_T*
MFA_^"Z'_ .)H_P"$$\'_ /0J:'_X+H?_ (FN@HH Y_\ X03P?_T*FA_^"Z'_
M .)H_P"$$\'_ /0J:'_X+H?_ (FN@HH Y_\ X03P?_T*FA_^"Z'_ .)H_P"$
M$\'_ /0J:'_X+H?_ (FN@HH Y_\ X03P?_T*FA_^"Z'_ .)H_P"$$\'_ /0J
M:'_X+H?_ (FN@HH Y_\ X03P?_T*FA_^"Z'_ .)H_P"$$\'_ /0J:'_X+H?_
M (FN@HH Y_\ X03P?_T*FA_^"Z'_ .)H_P"$$\'_ /0J:'_X+H?_ (FN@HH
MY_\ X03P?_T*FA_^"Z'_ .)H_P"$$\'_ /0J:'_X+H?_ (FN@HH Y_\ X03P
M?_T*FA_^"Z'_ .)H_P"$$\'_ /0J:'_X+H?_ (FN@HH Y_\ X03P?_T*FA_^
M"Z'_ .)H_P"$$\'_ /0J:'_X+H?_ (FN@HH Y_\ X03P?_T*FA_^"Z'_ .)H
M_P"$$\'_ /0J:'_X+H?_ (FN@HH Y_\ X03P?_T*FA_^"Z'_ .)H_P"$$\'_
M /0J:'_X+H?_ (FN@HH Y_\ X03P?_T*FA_^"Z'_ .)H_P"$$\'_ /0J:'_X
M+H?_ (FN@HH Y_\ X03P?_T*FA_^"Z'_ .)H_P"$$\'_ /0J:'_X+H?_ (FN
M@HH Y_\ X03P?_T*FA_^"Z'_ .)H_P"$$\'_ /0J:'_X+H?_ (FN@HH X'5_
M@]X/UC6;._DTV*VBMEP;2SB2"*4YSE]H!/IU%=W%%'!"D,,:QQ(H5$48"@=
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M1O,/E!Y_@8$'USVQSV]%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO'(WF*BQDA1O^7.]N<D# X.2:IR>.=06+4W^QQ*;>98E#&/=;@R%=TBF8'&
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M,T7E_:/W9?[[.6P4VY)<]L8[4 3W^N:?I>GQ7][+)#;2E0':!\KD$_, ,J,
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@4 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_035.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_035.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "J LT# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#OT*FM/B%KTU[!$\D&UY%4XB'0FG[6(GD6*2OI]_\ P#URBBBM3PPHHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M /D7-4_Z])?_ $ TGL73CS347U:_-%7_ (2_P_\ ]!6W_,T?\)?X?_Z"MO\
MF:\,HKF]LSZ__5^A_._P/<_^$O\ #_\ T%;?\S1_PE_A_P#Z"MO^9KPRBCVS
M#_5^A_._P/<_^$O\/_\ 05M_S-6;+Q!I.HW M[._BFF()"*><"O ZZSX=?\
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MBJ.0\5\>_P#(Z:A_VS_]%K7-UTGCW_D=-0_[9_\ HM:YNN&7Q,_2L%_NU/\
MPK\@HHHJ3J"BBB@#Z%T__D&6O_7%/Y"K-5M/_P"09:_]<4_D*LUWH_+I_$_5
MA1113(/G&BBBO//U0**** "K.G_\A.U_Z[)_,56JSI__ "$[7_KLG\Q0B)_"
M_1GT+1117H'Y<%9VO_\ (N:I_P!>DO\ Z :T:SM?_P"1<U3_ *])?_0#2>QK
M1_BQ]5^:/ J***X#]/"BBB@ KK/AU_R-L?\ UQ?^5<G76?#K_D;8_P#KB_\
M*JA\2.+,/]UJ>C/8J***[C\X"N>\8Z[=>'M'CN[2.%Y&G6,B4$C!5CV(]*Z&
MN+^)W_(LP?\ 7VO_ * ]3-VBVCMP$(U,3"$U=-_YG-?\+/UO_GUT_P#[]O\
M_%T?\+/UO_GUT_\ []O_ /%UQ5%<GM)=S[?^S,'_ ,^U_7S.U_X6?K?_ #ZZ
M?_W[?_XNC_A9^M_\^NG_ /?M_P#XNN*HH]I+N']F8/\ Y]K^OF=K_P +/UO_
M )]=/_[]O_\ %UT_@SQ;?^(KRZAO(;9%BC#*858'.<<Y)KR.N^^%O_(4O_\
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MLZ?_ ,A.U_Z[)_,4(B?POT9]"T445Z!^7!6=K_\ R+FJ?]>DO_H!K1K.U_\
MY%S5/^O27_T TGL:T?XL?5?FCP*BBBN _3PHHHH *ZSX=?\ (VQ_]<7_ )5R
M==9\.O\ D;8_^N+_ ,JJ'Q(XLP_W6IZ,]BHHHKN/S@*XOXG?\BS!_P!?:_\
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M TGL:T?XL?5?FCP*BBBN _3PHHHH *ZSX=?\C;'_ -<7_E7)UUGPZ_Y&V/\
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M73_^09:_]<4_D*LU6T__ )!EK_UQ3^0JS7>C\NG\3]6%%%%,@^<:***\\_5
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MO)_BA_R,=K_UZ+_Z&]95?A/:R/\ WQ>C.)HHHKD/N@HHHH *]J\!?\B78?\
M;3_T8U>*U[5X"_Y$NP_[:?\ HQJVH_$>!G_^[1_Q+\F=)11174?%!7@GB/\
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M\(OH7_0)L_\ OT*/^$7T+_H$V?\ WZ%'L7W#_6&E_P ^W]Z*7@+_ )$O3_\
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M6D,L;1R!GC<%65G8A@>H(S29<)<LU+LU^9\\45[Q_P (OH7_ $";/_OT*/\
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M@39_]^A1_P (OH7_ $";/_OT*R]B^Y[7^L-+_GV_O1X/17O'_"+Z%_T";/\
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MXAT5M);5AK&GG35.#>"Y3R0<XQOSMZG'7K4^J7UEIFEW%]J,D<5G ADE>3H
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M -BSU3PXGQ.FMK&^TI;N6S>.:*":,2/.)<LK ')< '(//!H [:BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
5110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_036.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_036.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "Q KD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BJ]]>P:=:/=7!D\M,9$432.23@
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ME7%E ]U8/9R1^6PC@S([QM&!U">:R[3C("\K78_;[/\ Y^X/^_@_QH^WV?\
MS]P?]_!_C1<.279_<<UJ/A6\N/!W_")6DUK%IQLX[,7#AC(D:J%;Y.C,0.#D
M8)Z''/5QQK%$D:_=10HSZ"H?M]G_ ,_<'_?P?XU-'(DJ!XW5U/1E.0:8G%K=
M#J***"0HHKQS7/%.N6VOZC!#J4R11W,B(HQ@ ,0!43FH[G?@L#/&2<8-*W<]
MCJ*2W@FEAEEAC>2!B\3,H)C8J5)4]CAB,CL2.]>(_P#"8>(/^@K/^8_PH_X3
M#Q!_T%9_S'^%9^V1Z?\ J_7_ )U^)[G17AG_  F'B#_H*S_F/\*/^$P\0?\
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M_P#$T?\ "?>)?^@@/^_$?_Q-<VWWC]:2N'GEW/TGZEAO^?<?N1TO_"?>)?\
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M'V 4444 :.@?\C'I?_7W%_Z&*]]KP+0/^1CTO_K[B_\ 0Q7OM=-'9GR'$/\
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MH"(QA<8KUF.*.($1HJ L6(48R2<D_4FGT <0;*^G\#VVD7UM</<:Q=2+<^7
M5$44TKRR;P"WEC82N"QP2!D]:[9$6-%1%"JHP% P *6B@ HHHH *JW.IV%E(
M([J^MH'(W!9954D>N"?:K5>3_%#_ )&2V_Z]%_\ 0WJ)RY5<[\OPJQ5=4I.V
MC_ ]'_M_1O\ H+6'_@2G^-']OZ-_T%K#_P "4_QKP*BL?;/L?0?ZO4O^?C^Y
M'OO]OZ-_T%K#_P "4_QH_M_1O^@M8?\ @2G^->!44>V?8/\ 5ZE_S\?W(]]_
MM_1O^@M8?^!*?XUHU\XU]&K]T?2M*<^8\C,\NC@^7EDW>_X"T445J>.9VO\
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M#IMHK62U%J&F\M1@JLNX !@ #E&/7!&>-S_A(-%_Z"]A_P"!*?XT?\)!HO\
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MI7_7Y#_Z&*:W,J_\*7H_R9[Y1117>?F 5SGCW_D2]0_[9_\ HQ:Z.N<\>_\
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M_P#1;54?B1RXW_=JG^%_D>UT445W'YJ%<7\3O^19@_Z^U_\ 0'KM*XOXG?\
M(LP?]?:_^@/45/A9WY;_ +Y3]?\ ,\EHHHKB/T4**** "O:? /\ R)=C]9/_
M $8U>+5[3X!_Y$NQ^LG_ *,:MJ/Q'@9__NR_Q+\F=+11174?%!7@GB/_ )&;
M5?\ K[E_]#->]UX)XC_Y&;5?^ON7_P!#-85MD?2</?Q9^B_,S****YC[ ***
M* -'0/\ D8]+_P"ON+_T,5[[7@6@?\C'I?\ U]Q?^ABO?:Z:.S/D.(?XM/T?
MYA1116Y\T%%%% '%?$__ )%JV_Z_%_\ 0'KR:O6?B?\ \BU;?]?B_P#H#UY-
M7)5^(^ZR/_<UZO\ 0****R/:"BBB@#V+X<_\BE'_ -=G_G765R?PY_Y%*/\
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M;"BBBF8GSDWWC]:2E;[Q^M)7GGZH%%%% !71^ _^1TT__MI_Z+:N<KH_ ?\
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M>/UI*5OO'ZTE>>?J@4444 %='X#_ .1TT_\ [:?^BVKG*Z/P'_R.FG_]M/\
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M"KWW7_\ D7-4_P"O27_T UX%7-6W1]?P]_"J>J_(****P/I0HHHH [7X8?\
M(S7'_7HW_H:5ZS7DWPP_Y&:X_P"O1O\ T-*]9KKI?"?"YY_OC]%^H4445J>*
M><_%7[ND_6;_ -DKS>O2/BK]W2?K-_[)7F]<=7XF??Y/_N4/G^;"BBBLSU0H
MHHH ][\.?\BSI7_7I%_Z *TZS/#G_(LZ5_UZ1?\ H K3KO6Q^8U_XLO5_FPH
MHHIF)\Y-]X_6DI6^\?K25YY^J!1110 5T?@/_D=-/_[:?^BVKG*Z/P'_ ,CI
MI_\ VT_]%M51^)'+C?\ =JG^%_D>UT445W'YJ%<7\3O^19@_Z^U_] >NTKB_
MB=_R+,'_ %]K_P"@/45/A9WY;_OE/U_S/):***XC]%"BBB@ KVGP#_R)=C]9
M/_1C5XM7M/@'_D2['ZR?^C&K:C\1X&?_ .[+_$OR9TM%%%=1\4%>">(_^1FU
M7_K[E_\ 0S7O=>">(_\ D9M5_P"ON7_T,UA6V1])P]_%GZ+\S,HHHKF/L HH
MHH T= _Y&/2_^ON+_P!#%>^UX%H'_(QZ7_U]Q?\ H8KWVNFCLSY#B'^+3]'^
M84445N?-$<JES&!NV[OFP<<8/]<4GD)_>D_[^-_C4M% %2ZTNROHA%=P+<1@
M[@LI+@'UP>_)JI_PB^A?] FS_P"_0K6J*XN(+2VEN;F:.&")2\DLC!511R22
M> !ZTK(TC5G%6C)KYO\ S,[_ (1?0O\ H$V?_?H4?\(OH7_0)L_^_0J:+7='
MN-+?5(=5L9-/CSONTN$,2XZY<' Q]:E_M33_ .S/[3^W6O\ 9^SS/M7G+Y6S
M^]OSC'OFBR'[>K_,_O?^94_X1?0O^@39_P#?H4?\(OH7_0)L_P#OT*OS7UI;
M61O)[J"*U"AC.\@5 #T.X\8Y%3T60>WJ_P S^]_YE6VTVTLX?)M81!$#G9$2
MHS]!4OD)_>D_[^-_C4M%,S;;=V0B!<MDR8SQ^\;T^M+Y"?WI/^_C?XU+10(S
M)O#NCW$S33Z;;2RN<L[H&)/N33/^$7T+_H$V?_?H5K53O-7TS3[FVMKW4;2V
MN+IMEO%-.J-,V0,("<L<D# ]12LC55JBT4G][_S*O_"+Z%_T";/_ +]"C_A%
M]"_Z!-G_ -^A4\FN:1#JJ:7+JEDFHR %+1KA!*V>>$SD]#VJV;B$7(MC-'YY
M0R"+<-Q4$ MCKC) S[T60>WJ_P S^]_YF;_PB^A?] FS_P"_0IT?AO1894EB
MTRU21"&5EC *D="#V-.L/$6B:I>26>G:SI]Y=1J6>&WNDD=0" 25!) !('XU
MI460>VJ_S/[W_F1>0G]Z3_OXW^--D@&T;#)G</\ EHW3(SW]*GHIF1%Y"?WI
M/^_C?XU'<:?:W<#07,?G1-C='(Q93@YY!/K5FB@:;3NC)_X1?0O^@39_]^A1
M_P (OH7_ $";/_OT*U20 23@#J35"PUW1]5MYKC3M5L;R"'_ %LEO<)(L?&?
MF*D@<>M*R-/;U?YG][_S(?\ A%]"_P"@39_]^A1_PB^A?] FS_[]"K=EJFGZ
MC9?;;&^M;JTY_?P3*\?'7Y@<<4UM7TQ=*_M5M1M!IVT/]K,Z^5M)P#OSC&?>
MBR#V]7^9_>_\RM_PB^A?] FS_P"_0JS:Z386*LMG;);JQRPAR@)]\5-9WEKJ
M%I'=V5S#<VT@RDT,@=&'3@C@U/19"E5G)6E)OYO_ #(O(3^])_W\;_&D\A=Y
MYDQ@8_>-_C4U%,S(O(3^])_W\;_&JEUH>F7T@DN[*&XD VAI1O('ID]N36A1
M05&4HN\78R?^$7T+_H$V?_?H4?\ "+Z%_P! FS_[]"K6I:OIFC0+/JFHVEC"
M[;%DNIUB4MC. 6(&< \>U-OM:TK2YX(-0U.RM)K@XACN)UC:4Y PH)!/)'3U
MI61?MZO\S^]_YE?_ (1?0O\ H$V?_?H4?\(OH7_0)L_^_0K2DN(8I8HI)HTD
MF)$:,P!<@9( [X )XK+3Q9X<EU :?'X@TI[TR>4+=;R,R%\XV[<YSGC%%D'M
MZO\ ,_O?^8[_ (1?0O\ H$V?_?H5H_9T]9/^_C?XU+118F4Y2^)M_,@E@'E/
ML,F_:=O[QNOYT[R$_O2?]_&_QJ6BF0026D,L;1R!GC<%65G8A@>H(S5#_A%]
M"_Z!-G_WZ%:U%*R+C4G'X6U\W_F9/_"+Z%_T";/_ +]"C_A%]"_Z!-G_ -^A
M4UIKVCW^H3:?9ZM8W-[!N\ZVAN$>2/:=K;E!R,$@'/0U+8ZKIVJ"8Z??VMV(
M7,<IMYEDV,/X6P3@^QHLBO;U?YG][_S*G_"+Z%_T";/_ +]"C_A%]"_Z!-G_
M -^A5EM9TM+&>^?4K-;.!RDUP9U$<; X(9LX!!X(/>I+#4++5+1;O3[RWN[9
MR0LUO*LB'!P<,"1UHL@]O5_F?WO_ #(+70]+L93+:6,-O(1M+Q#82/3([<"K
M?D)_>D_[^-_C4M%,B4I2=Y.Y 8!YJX,FS:<_O&Z\8[_6G>0G]Z3_ +^-_C4M
M%!)2N]'T^_V?;+6.XV9V^=\^W/7&>G056_X1?0O^@39_]^A6M5:_U"RTNT:[
MU"\M[2V0@--<2K&@R<#+$@=:5D:1JU(JRDU\W_F4O^$7T+_H$V?_ 'Z%'_"+
MZ%_T";/_ +]"I;S7]&T^R@O;W5K"VM+C!AGFN41),C(VL3@Y'/':K5Q?6EI%
M'+<W4$,<CK&CR2!0S,<*H)ZDGH.]%D/V]7^9_>_\RA_PB^A?] FS_P"_0H_X
M1?0O^@39_P#?H5;DU73H=3ATR6_M4OYU+Q6K3*)9%&<E4SDCY3R!V/I5NBR#
MV]7^9_>_\R".SAAB2*)62- %5%=@% Z #/%.\A/[TG_?QO\ &I:*9EN010#R
MDWF3?M&[]XW7\Z=Y"?WI/^_C?XU+10!D_P#"+Z%_T";3_OT*/^$7T+_H$V?_
M 'Z%:U9XUW1VU<Z2-5L3J8ZV8N$\X<;ON9W=.>G3FE9&OMZO\S^]_P"9#_PB
M^A?] FS_ ._0H_X1?0O^@39_]^A5FWUC3+R_GL+;4;2>\M_]=;Q3JTD7;YE!
MR/QI+36=+U![I++4K.Y:T;;<"&=7,)YX?!^4\'KZ&BR#V]7^9_>_\RO_ ,(O
MH7_0)L_^_0J2#P_I%K.LUOIUO#*OW7C3:P[<$5+INL:9K,+S:7J-I?1(VQGM
M9UE56QG!*DX/(J[19 ZU1JSD_O?^9%Y"?WI/^_C?XTUX/FCVF3&[YOWC=,'W
M]<5/13,B+R$_O2?]_&_QJ&ZTNROHA%=P+<1@[@DI+@'UP?K5NB@:;3NC)_X1
M?0O^@39_]^A1_P (OH7_ $";/_OT*T;FY@L[:2YNIXX((E+R2RN%5%'4DG@"
MJHUO23I']K#5+(Z;C/VS[0GDXSM^_G;UXZ]>*5D:>WJ_S/[W_F0?\(OH7_0)
ML_\ OT*/^$7T+_H$V?\ WZ%27/B'1++3X+^ZUC3X+*XQY-Q+<HL<F1D;6)P>
M.>*M?;[/[/!<?:X/)N"HAD\P;92WW=IZ'/;'6BR#V]7^9_>_\RC_ ,(OH7_0
M)L_^_0J[;Z?:VD*PVT7DQ+G:D;%5'?@ U9HHLB95)R5I-OYO_,B\A/[TG_?Q
MO\:;' -IWF3.X_\ +1NF>._I4]%,@B\A/[TG_?QO\:H2>&]%FE>673+9Y')9
MG:,$L3U)/>M2BBQ49RC\+L9/_"+Z%_T";/\ []"C_A%]"_Z!-G_WZ%6+K6M*
ML;ZWL;O4[.WN[D@0033JDDI)P-JDY;GCBD;6])35ETE]4LEU)QE;,W""9AC/
M"9W= 3TZ4K(OV]7^9_>_\R#_ (1?0O\ H$V?_?H4?\(OH7_0)L_^_0JU#J^F
MW&I3:;!J-I+?P+NEM4F5I8QQRR Y Y'4=Q3=/UK2M7:9=-U.SO6@(686TZR&
M,G. VTG'0]?0T60>WJ_S/[W_ )D,?AO18I%DCTNU21"&5EC *D="#5_R$_O2
M?]_&_P :EHIV(E.4OB=R!X=H!0R;@R]9">,C/4^E3T44$A1110 51UG4=-TC
M29[_ %>:*"Q@ >22495>1CCN<XQWSC%7J* /)CK=EJ]SI7B,W5I_9HUW[3>J
MES'*+1/L[10/.4)5"2BMR?E+ $Y%-U)](3X>>-[R]>R2TOKF]FT=[DJHE9K4
M*&AW=2S"0@KUR2.M>MT4 >4ZO=3:OH$-U;V$^JZ)9Z,QAEL;BW>+[48V5FD#
M2J<Q@#  /+,>JBO4;>5YK:*62"2W=U#-#(5+(3V.TD9'L2/>I:* "BBB@ HH
MHH *X/XC:II4ENGAFXU'3+&XU55%S/>3QQ^3:AB6<;B-S$@JH'<D]%-=Y10!
MYO/J>C2Z'J>CI=VLFK76HM+!:JX::;=*'BD5>K+Y>PAQP O7BMB35?#=M\1+
M:&&_TJ+4);:XCN(TFC$KRE[?:K ')8A3@'G ..E=A10!Y]X9U 6_B2RTK0-=
M.N:&UM*UP"(F.GN"#&"\:KC=EAL?+?)GL:]!HHH **** "BBB@""\FMK>QN)
MKUXTM8XV>9I<;%0#+%L\8QG->4ZOK^G^+;+4]1TVXMI[.*YL%DMXIDDEDLX9
M]\LKQ*2RI^\(VL <)D@9KUVB@#A=+NM(N?$/BK6I;BR?P]/%9K]KD=3;22)Y
M@<AC\IQF)2?4 =17#^'KZTG\.^ )&\01:?I]E:W$=U=QO$PMKDA#&KF0,D;E
M=^"PS@L!@D5[E10!D^&KJ6]T*&>:Z-WN>41W)"CSXA(PCD^4!3N0*V5 !SD#
M!K6HHH **** "BBB@#EO'6NZ;H^D&"YO+"VU"_1[:S:]950%L!F8MQL4$,WK
M@#DD \];W?A_1=,O=/EU:SN;*?1K:TT]C,K_ &U461"L8!/F'=_"N>6'J*]*
MHH X2\U'0-(U+PNNHW^EVNL1LBW!GFC2<)]EF W$G=MW$ 9XR?>M>>W35_'4
M#-('@T6W,GE9R/M$W"D^ZQJW_?T&NDHH **** "BBB@ HHHH \D\5:Y;>+GU
M;3O#]Y9-)I^GW4-O%%.GVFZN&4ATBC!W[556R<?,6&,A<UNZ-=:9J7C.VU#2
M9()=*M=!:VNI8B/*C;S(V2-^P95$GRGE0><9KOJ* /%K#5='D\&ZM9Z;K6GV
MDR>(YYK>XCN(@EDGVDF.=@05\OH ",-N !&01Z!X$GDN=-U&::_MM2E?4)"U
M_:$>3<@JNUD R %7;&1EN8VY)S74T4 %%%% !1110 5B^*/$&E^&M)_M#4Y8
M$*MMMA,P7?,0=J@G@$\C)P ,DD#-;5% 'F?ARZT/PS'I;77B#2IM.73YXOMJ
M7""W:X:822HAS@?>&%ZX7IQ61>MI.C_#G0(M6>RLM32_@EMX[MECGCMC?*_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
$% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_037.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_037.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !Q KH# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BL/6/%VD:'JECIE
MW-(;R]ECCCCBB9]OF/L1G(&$4MP"2,X.,X.$O_%VE:==7<$[RE;)HDNYDC)2
MW,OW Q]\@G&< @G (H W:*KWU[%IUE+=S[C'&,X1=S,>@4#N22 !ZFHM'U6U
MUS1[35+(L;:ZC$L1=<':>F10!=HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ K+M_$>CWFOW.AVU_%-J5M$)9X(\MY:
MYQ\Q P#G^'.>1Q6I7"VD\3_%DR6^GZA';'3'M3,VFSQPF83%V^<H%Y )W9P<
M\$DB@#K;'5]/U.>]AL;N.X>RF-O<>6<B.0 $J3TR,\^AX/(J+4==L-+N8K:X
M:X>>4;EBMK66X8+G&YA&K%5SQDX%8.AZM:0:OKWDZ=JD43.)HE_LFXB5U2)0
MP4M&!G(( SD]LUS_ (ETS5!XAUZ^LUUI=0O;:V.C261D6(2H&RLVT[  Q!(F
M^7#'&3NH ]0HIL>_RT\S&_ W;>F>^*=0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%8*^*H?[6ALWTV_C@
MGN7M(;YA&87E3=N7 <N.4<990"1UY&9M6U_^S;M+2#2[_4KIHFG:*S$>4C!
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M (T?\)'K?_08O_\ P(?_ !H]LNP?ZO5?YU]S/>Z*\$_X2/6_^@Q?_P#@0_\
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M)AX@_P"@K/\ F/\ "C_A,/$'_05G_,?X5B44<S[A]5H?R+[E_D;?_"8>(/\
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MW7%)OF9^BX.C3>'IMQ6RZ+MZ&G_PD>M_]!B__P# A_\ &C_A(];_ .@Q?_\
M@0_^-9E%3=G3["E_*ON7^1I_\)'K?_08O_\ P(?_ !H_X2/6_P#H,7__ ($/
M_C6911=A["E_*ON7^1I_\)'K?_08O_\ P(?_ !H_X2/6_P#H,7__ ($/_C69
M11=A["E_*ON7^1I_\)'K?_08O_\ P(?_ !H_X2/6_P#H,7__ ($/_C6911=A
M["E_*ON7^1I_\)'K?_08O_\ P(?_ !H_X2/6_P#H,7__ ($/_C6911=A["E_
M*ON7^1I_\)'K?_08O_\ P(?_ !H_X2/6_P#H,7__ ($/_C6911=A["E_*ON7
M^1I_\)'K?_08O_\ P(?_ !H_X2/6_P#H,7__ ($/_C6911=A["E_*ON7^1I_
M\)'K?_08O_\ P(?_ !KTWX=7MU?>'[B6[N9KB073*&E<L0-B<9/U->/UZS\,
M/^1:N?\ K\;_ - 2M:3?,>/G5*G'"-QBEJNB_P CM:***ZCXD**** "BBB@
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MDCN",$=JFHY8]@^NXG_GY+[V<O\ \*]\.?\ /I)_W^;_ !H_X5[X<_Y])/\
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MWLY?_A7OAS_GTD_[_-_C1_PKWPY_SZ2?]_F_QKJ**.6/8/KN)_Y^2^]G+_\
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M=,CU.XU6QAL)<>7=27"+$^>F')P<]N:.6/8/KN)_Y^2^]F-_PKWPY_SZ2?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
>444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_038.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_038.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !I KP# 2(  A$! Q$!_\0
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MO[&WO+9]\%Q&LL;8QE6&0<'V-3U3TFVGL]'LK6ZDCDN(8$CD>-0JE@H!(
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M\@,P!Q\WO1[6(I9+BXIR:6GF>G4445J>,%%%% %?[?9_\_<'_?P?XT?;[/\
MY^X/^_@_QKYZ;[Q^M)7/[;R/K/\ 5Z/_ #\?W?\ !/H;[?9_\_<'_?P?XT?;
M[/\ Y^X/^_@_QKYYHI>V\A_ZO1_Y^/[O^"?0WV^S_P"?N#_OX/\ &C[?9_\
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MQ_.DHH 7<W]X_G1N;^\?SI** .U^&1)\33Y)/^B-_P"A)7K->2_#'_D9I_\
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MYXF:YA2Q?)[--6OOYV):*B\I_P#GXD_)?\*/*?\ Y^)/R7_"M3Q26O!/$?\
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M-Z?HAE.G+)#YV-_S[LXSC[V?4U4*;C*[.+'YO0Q&'E2@G=V[=_4UZ*B\I_\
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MCRG_ .?B3\E_PIF!Y9\4/^1CM?\ KT7_ -#>N)KW/5/"NEZU<K<:A')-*J;
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M#CYDR.5YY&=BN&OM"U77UU"YU"Q\C43$8K+:ZF&*-91(%+;BQ:0HFYMH
MX)8 WU\5:2]B]VDETP27R6@%C.9U?&<&'9Y@X^;[O3GIS3[OQ1H]E96E[/=,
M+2[4/'<)"[QA#CYW95(C7YA\SD >M8]Q:^($EU:]LK7R9M2EBB3$B-);0JA!
MEP3L:3).%R1T))Y6I-2TF:;0[#08-,F_L<PB.[CWQF4QKM B^^!\X!W-DG'
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MH **** "BBB@ HHHH **** ,N7Q%ID&L1Z5++*EU(_EH6MY!$S[=VP2[=F[
MSMW9]JCMO%&DWC70AGF/V9#(Q-K*HD0$@M$2O[T9&,IN'(]1FE=6FH:EXH@:
M^T]_[,L)5ELVBE0^9*5(,D@)! 7<P"@'/4]@*FG6&N6%M9%=/C:;2M)>RA5K
M@8N928P"/[JXA!R<'Y\8XY -4^+-'_LU;\37#Q-/]F\M+.9IEEP3L,(3S%;
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MR,@N;=G!(AC&5B."<@L$!Y.5#9ZT =%!,EQ;QSQ$F.10ZD@@D$9'!Y%2444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
544 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_039.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_039.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $5 FD# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB^K7YHSO^$]\-?\ 02_\@2?_ !-'_">^&O\ H)?^0)/_ (FO%**YO;2/LO[
MPW\TOP_R/:_^$]\-?]!+_P @2?\ Q-'_  GOAK_H)?\ D"3_ .)KQ2BCVT@_
ML##?S2_#_(]K_P"$]\-?]!+_ ,@2?_$T?\)[X:_Z"7_D"3_XFO%**/;2#^P,
M-_-+\/\ (]K_ .$]\-?]!+_R!)_\31_PGOAK_H)?^0)/_B:\4HH]M(/[ PW\
MTOP_R/:_^$]\-?\ 02_\@2?_ !-'_">^&O\ H)?^0)/_ (FO%**/;2#^P,-_
M-+\/\CVO_A/?#7_02_\ ($G_ ,35BP\7:'J=['9V=]YMQ)G:GE.N< D\E0.@
M->&5TG@+_D=-/_[:?^BVIQJR;L88C),/3HRFF[I-]/\ (]JHHHKI/D0HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5F^(?^1:U7_KSF_\
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M\BUJO_7G-_Z :\#KFK;H^OX>_A5/5?D%%%%8'TH4444 %%%% !1110 4444
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M_P"@&O Z]\\0_P#(M:K_ -><W_H!KP.N:MNCZ_A[^%4]5^04445@?2A1110
M4444 %%%% !1110!TG@+_D=-/_[:?^BVKVJO%? 7_(Z:?_VT_P#1;5[5751^
M$^+S_P#WF/\ A_5A1116Q\^%%%% !1110 4444 %%%% !1110 4444 %%%%
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MFGW#"3,1F--N3NRO?D\ ZWA2XO+G10]Y+>3,)75)KVW$$TB@]60*H7G(' X
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M/!($GM[:)I;3>9([_P"U+/\ :"3\Q8]0P.1CI@#![  VZ*** "BBB@ HHHH
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MQ7P%_P CII__ &T_]%M7M5=5'X3XO/\ _>8_X?U84445L?/A1110 5F^(?\
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MCP.BBBN _3PHHHH **** "BBB@ HHHH *Z3P%_R.FG_]M/\ T6U<W72> O\
MD=-/_P"VG_HMJJ/Q(Y<;_NU3_"_R/:J***[C\U"BBB@ HHHH S?$/_(M:K_U
MYS?^@&O Z]\\0_\ (M:K_P!><W_H!KP.N:MNCZ_A[^%4]5^04445@?2A1110
M 4444 %%%% !1110!TG@+_D=-/\ ^VG_ *+:O:J\5\!?\CII_P#VT_\ 1;5[
M5751^$^+S_\ WF/^']6%%%%;'SX4444 %9OB'_D6M5_Z\YO_ $ UI5F^(?\
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M\BUJO_7G-_Z :\#KFK;H^OX>_A5/5?D%%%%8'TH4444 %%%% !1110 4444
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M $";K_OW1_PBFO?] FZ_[XKW:BCV*#_6"O\ R+\3PG_A%->_Z!-U_P!^Z/\
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MSN6MWE@C,:2_*K!@I9BO#@8W'D'GL&6OA72+309=#2":339$\LP7%U+-M7
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1** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image_040.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_040.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !I KP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%PR[3*$&XCTSUQP*?'&D2;(T5%R3A1@<\FO*/^%GZW_SZZ?_ -^W_P#BZ/\
MA9^M_P#/KI__ '[?_P"+H]K$/[#QG9??_P  ]9HKR;_A9^M_\^NG_P#?M_\
MXNC_ (6?K?\ SZZ?_P!^W_\ BZ/:Q#^P\9V7W_\  /6:*Y[P;KUUXATB6[NX
MX4D2<Q 1 @8"J>Y//)KH:T3NKH\JM2E1J.G/=!1113,B.6>&  S2I&#T+L!G
M\ZB_M"R_Y_+?_OZO^-<5\4_^09I__79OY5Y?6,ZO*[6/H,#D\<3155SM>_0^
MA?[0LO\ G\M_^_J_XT?VA9?\_EO_ -_5_P :^>J*CVWD=O\ J]'_ )^/[O\
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M?^OR;_T,UG4FXK0]?*L#3Q<Y1J-JRZ>IZS_PGOAK_H)?^0)/_B:/^$]\-?\
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M ,71_P +/UO_ )]=/_[]O_\ %UQ5%'M)=P_LS!_\^U_7S.U_X6?K?_/KI_\
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MG_\ O,?\/ZL****V/GPHHHH \F^)_P#R,MM_UYK_ .AO7%5VOQ/_ .1EMO\
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M9OB!)=1T"]L[>&4S2Q[5#(0,TI;,WP[4:T&]KK\T>%45TO\ P@>O_P#/LO\
MWU_]:C_A ]?_ .?9?^^O_K5Q<DNQ^@?VAA?^?B^\YJBNE_X0/7_^?9?^^O\
MZU'_  @>O_\ /LO_ 'U_]:CDEV#^T,+_ ,_%]YS5%=+_ ,('K_\ S[+_ -]?
M_6H_X0/7_P#GV7_OK_ZU')+L']H87_GXOO.:HKI?^$#U_P#Y]E_[Z_\ K4?\
M('K_ /S[+_WU_P#6HY)=@_M#"_\ /Q?>>P:?_P @RU_ZXI_(59JE:3&&R@B>
M&;<D:J<1GJ!4WVH?\\IO^_9KN1^=3=Y,GHJ#[4/^>4W_ '[-'VH?\\IO^_9H
M)/$_%_\ R-NI?]=C_(5B5W'B#PAK.HZ_>WEO;9AEDW*6.#BLS_A ]?\ ^?9?
M^^O_ *U<<H2N]#] P^.PT:,$ZBO9=?)'-45TO_"!Z_\ \^R_]]?_ %J/^$#U
M_P#Y]E_[Z_\ K5/)+L;_ -H87_GXOO.:HKI?^$#U_P#Y]E_[Z_\ K4?\('K_
M /S[+_WU_P#6HY)=@_M#"_\ /Q?><U172_\ "!Z__P ^R_\ ?7_UJ/\ A ]?
M_P"?9?\ OK_ZU')+L']H87_GXOO.T^&'_(M7/_7XW_H"5VM<GX)T^[T+19K6
M]@<2O<-(-BEA@JH_H:Z7[4/^>4W_ '[-=<%:*/A<PG&>*J2B[IO_ ")Z*@^U
M#_GE-_W[-'VH?\\IO^_9JSB.(^*?_(,T_P#Z[-_*O+Z]<\<Z5>Z]96D5C Y:
M*0LV]2O&*XC_ (0/7_\ GV7_ +Z_^M7+4BW+1'V>4XNA3PL8SFD]>OF<U172
M_P#"!Z__ ,^R_P#?7_UJ/^$#U_\ Y]E_[Z_^M6?)+L>I_:&%_P"?B^\YJBNE
M_P"$#U__ )]E_P"^O_K4?\('K_\ S[+_ -]?_6HY)=@_M#"_\_%]YS5%=+_P
M@>O_ //LO_?7_P!:C_A ]?\ ^?9?^^O_ *U')+L']H87_GXOO$\!?\CII_\
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MY8]!Z#$4O@G1IIX+AVU3[1#"8$F75[M9-A8L06$N6Y/<GH!T  Z&B@ HHHH
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M".E2PQQ2MJ4L:9!635+EO,!ZJ^9/WB_[+9')&.36X %    '  I:* "BBB@
MHHHH **** "BBB@#(U;PSIFM7EM>7BW8N+966&2WOIK<H&^]_JW7K@4L?AK2
MH=4744@D%RN#DW$A1F"[0[(6VL^WC>06QWK6HH Q+3PEH]DUUY<-Q)%=B03V
M]Q>330/O.7S$[E.3GMW/K5S2M&L-%MVAL8G4.<N\DKRR.<8&YW)9L# &3P
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A6T%G:Q6UM$L4$2A(XT& JC@ 5+110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image_041.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_041.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %8 HH# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH J:GJ=IH^G2W]]+Y5O$ 6;:6/)P  .2<GM5?3O$.F:M;V\
M]C<^;'<2-&AV%3N4$D$$ @X'>D\02+%IJN;=KAQ<0^5&KA,R;UV_,>@SC-8-
MA=1ZGXFM+Z?17LITEFMA*+@$O(J$,&0##*/F ;.?H#0!V5%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!.?W>,8Y#'D=['A+1;[2FOI;JWM+&*X9/*L+.9I8X=HP6W,J_,W?"@<"K/\
MPF7AW_H*P?K_ (4?\)EX=_Z"L'Z_X4N9=S7ZK7_D?W/_ "-VBL+_ (3+P[_T
M%8/U_P *W:::>QE.E4I_'%KU5@HHHIF85XIJWB76X=9OXH]4NE1+B1542'
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M++3K>P>Y>!6WW,IFE9F)+,?Z<=*XC_A:EO\ ] F7_O\ #_"C_A:EO_T"9?\
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M.HY6UML?0G]IV'_/];?]_5_QH_M.P_Y_K;_OZO\ C7SW16?MGV/1_P!7H?\
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MI_\ 78UA6V1]%P__ !Y^GZF+1117,?9!7MW@C_D3=-_W&_\ 0C7B->W>"/\
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M;N_(****HY3E?B!>W5AX;$UI<2P2^>B[XV*G&#QD5Y?_ ,)+KO\ T&+W_O\
M-7I7Q+_Y%5?^OE/Y&O(:Y:K?,?:9)2IRPMY13U?1>7D:G_"2Z[_T&+W_ +_-
M1_PDNN_]!B]_[_-67165WW/:^KT?Y%]R_P CN? FM:I?>)XX;K4+F>(QN2DD
MI89QZ5ZK7CGPZ_Y&Z+_KD_\ *O8ZZJ3]T^,SR$8XE**MHOU"BBBM3Q#FO'W_
M ")E]]8__1BUXM7M/C[_ )$R^^L?_HQ:\6KEK?$?:Y!_NS_Q/\D%%%%8GOFK
MX8_Y&G2O^OI/YU[S7@WAC_D:=*_Z^D_G7O-=-'9GQ_$/\:'I^H4445N?-F1X
MI_Y%35?^O63_ -!->$5[OXI_Y%35?^O63_T$UX17-6W1]CP]_!GZ_H%%%%8'
MT9:TS_D+V/\ U\1_^A"OH2OGO3/^0O8_]?$?_H0KZ$KIH[,^2XA^.GZ/\T%%
M%%;GS!!??\>%S_UR;^1KYW'05]$7W_'A<_\ 7)OY&OG<=!7-6Z'UG#WPU/E^
MHM%%%8'U HZBOHT=!7SD.HKZ-'05T4>I\KQ%_P N_G^@4445T'RH5\_ZU_R'
MM1_Z^I?_ $,U] 5\_P"M?\A[4?\ KZE_]#-85MD?3</?Q*GHOS*-%%%<Q]<%
M>_Z'_P B_IO_ %ZQ?^@"O *]_P!#_P"1?TW_ *]8O_0!6]'=GS/$/\.GZO\
M(OT445TGR(5\ZW'_ !]3?]=&_F:^BJ^=;C_CZF_ZZ-_,USUNA]3P[O4^7ZD=
M%%%<Y]6%>]>&O^17TK_KTB_]!%>"U[UX:_Y%?2O^O2+_ -!%;T=V?-\0_P *
M'J_R-2BBBND^/"O"_%W_ "-FI_\ 78U[I7A?B[_D;-3_ .NQK"MLCZ+A_P#C
MS]/U,6BBBN8^R"O;O!'_ ")NF_[C?^A&O$:]N\$?\B;IO^XW_H1K:C\1\]Q!
M_N\?7]&=!11174?&!1110 45YCX\U_5M-\2?9[*_F@B\A&V(1C)+<_I7,_\
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M+7JM>5?"[_D.WG_7M_[,M>JUUTOA/A,[_P!\?HOR"BBBM3QCC_B7_P BJO\
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M+7=5VT_A1^>9I_OE3U_1!1115GG'E_Q3_P"0EI__ %Q;^=<#7??%/_D):?\
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MJ?\ UV->Z5X7XN_Y&S4_^NQK"MLCZ+A_^//T_4Q:***YC[(*]N\$?\B;IO\
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M_P"R+7=5POPM_P"0'>_]?7_LBUW5=M/X4?GF:?[Y4]?T044459YQY?\ %/\
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M-_H%%%%9'N'5_#K_ )&Z+_KD_P#*O8Z\<^'7_(W1?]<G_E7L==5'X3XC/O\
M>EZ+]0HHHK8\(YKQ]_R)E]]8_P#T8M>+5[3X^_Y$R^^L?_HQ:\6KEK?$?:Y!
M_NS_ ,3_ "04445B>^:OAC_D:=*_Z^D_G7O->#>&/^1ITK_KZ3^=>\UTT=F?
M'\0_QH>GZA1116Y\V9'BG_D5-5_Z]9/_ $$UX17N_BG_ )%35?\ KUD_]!->
M$5S5MT?8\/?P9^OZ!1116!]&6M,_Y"]C_P!?$?\ Z$*^A*^>],_Y"]C_ -?$
M?_H0KZ$KIH[,^2XA^.GZ/\T%%%%;GS!!??\ 'A<_]<F_D:^=QT%?1%]_QX7/
M_7)OY&OG<=!7-6Z'UG#WPU/E^HM%%%8'U HZBOHT=!7SD.HKZ-'05T4>I\KQ
M%_R[^?Z!11170?*A7S_K7_(>U'_KZE_]#-?0%?/^M?\ (>U'_KZE_P#0S6%;
M9'TW#W\2IZ+\RC1117,?7!7O^A_\B_IO_7K%_P"@"O *]_T/_D7]-_Z]8O\
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MZ+793^%'Y_F_^^S^7Y(****T/+.$^*7_ "!K'_KY_P#937EE>I_%+_D#6/\
MU\_^RFO+*Y*OQ'WF2?[G'U?YA11161[!W/PN_P"0[>?]>W_LRUZK7E7PN_Y#
MMY_U[?\ LRUZK772^$^$SO\ WQ^B_(****U/&./^)?\ R*J_]?*?R->0UZ]\
M2_\ D55_Z^4_D:\AKDJ_$?<9%_NGS?Z!11161[AU?PZ_Y&Z+_KD_\J]CKQSX
M=?\ (W1?]<G_ )5['751^$^(S[_>EZ+]0HHHK8\(YKQ]_P B9??6/_T8M>+5
M[3X^_P"1,OOK'_Z,6O%JY:WQ'VN0?[L_\3_)!1116)[YJ^&/^1ITK_KZ3^=>
M\UX-X8_Y&G2O^OI/YU[S731V9\?Q#_&AZ?J%%%%;GS9D>*?^14U7_KUD_P#0
M37A%>[^*?^14U7_KUD_]!->$5S5MT?8\/?P9^OZ!1116!]&6M,_Y"]C_ -?$
M?_H0KZ$KY[TS_D+V/_7Q'_Z$*^A*Z:.S/DN(?CI^C_-!1116Y\P07W_'A<_]
M<F_D:^=QT%?1%]_QX7/_ %R;^1KYW'05S5NA]9P]\-3Y?J+1116!]0*.HKZ-
M'05\Y#J*^C1T%=%'J?*\1?\ +OY_H%%%%=!\J%?/^M?\A[4?^OJ7_P!#-?0%
M?/\ K7_(>U'_ *^I?_0S6%;9'TW#W\2IZ+\RC1117,?7!7O^A_\ (OZ;_P!>
ML7_H KP"O?\ 0_\ D7]-_P"O6+_T 5O1W9\SQ#_#I^K_ "+]%%%=)\B%?.MQ
M_P ?4W_71OYFOHJOG6X_X^IO^NC?S-<];H?4\.[U/E^I'1117.?5A7O7AK_D
M5]*_Z](O_017@M>]>&O^17TK_KTB_P#016]'=GS?$/\ "AZO\C4HHHKI/CPK
MPOQ=_P C9J?_ %V->Z5X7XN_Y&S4_P#KL:PK;(^BX?\ X\_3]3%HHHKF/L@K
MV[P1_P B;IO^XW_H1KQ&O;O!'_(FZ;_N-_Z$:VH_$?/<0?[O'U_1G04445U'
MQ@4444 >0?$G_D;!_P!>R?S:N0KK_B3_ ,C8/^O9/YM7(5Q3^)GZ-EW^Z4_1
M!1114'<>J?"W_D!WO_7U_P"R+7=5POPM_P"0'>_]?7_LBUW5=M/X4?GF:?[Y
M4]?T044459YQY?\ %/\ Y"6G_P#7%OYUP-=]\4_^0EI__7%OYUP-<=3XF?H6
M5?[G3]/U84445F>D>D_"K_5:K_O1?^S5Z+7G7PJ_U6J_[T7_ +-7HM=E/X4?
MG^;_ .^S^7Y(****T/+.$^*7_(&L?^OG_P!E->65ZG\4O^0-8_\ 7S_[*:\L
MKDJ_$?>9)_N<?5_F%%%%9'L'<_"[_D.WG_7M_P"S+7JM>5?"[_D.WG_7M_[,
MM>JUUTOA/A,[_P!\?HOR"BBBM3QCC_B7_P BJO\ U\I_(UY#7KWQ+_Y%5?\
MKY3^1KR&N2K\1]QD7^Z?-_H%%%%9'N'5_#K_ )&Z+_KD_P#*O8Z\<^'7_(W1
M?]<G_E7L==5'X3XC/O\ >EZ+]0HHHK8\(YKQ]_R)E]]8_P#T8M>+5[3X^_Y$
MR^^L?_HQ:\6KEK?$?:Y!_NS_ ,3_ "04445B>^:OAC_D:=*_Z^D_G7O->#>&
M/^1ITK_KZ3^=>\UTT=F?'\0_QH>GZA1116Y\V9'BG_D5-5_Z]9/_ $$UX17N
M_BG_ )%35?\ KUD_]!->$5S5MT?8\/?P9^OZ!1116!]&6M,_Y"]C_P!?$?\
MZ$*^A*^>],_Y"]C_ -?$?_H0KZ$KIH[,^2XA^.GZ/\T%%%%;GS!!??\ 'A<_
M]<F_D:^=QT%?1%]_QX7/_7)OY&OG<=!7-6Z'UG#WPU/E^HM%%%8'U HZBOHT
M=!7SD.HKZ-'05T4>I\KQ%_R[^?Z!11170?*A7S_K7_(>U'_KZE_]#-?0%?/^
MM?\ (>U'_KZE_P#0S6%;9'TW#W\2IZ+\RC1117,?7!7O^A_\B_IO_7K%_P"@
M"O *]_T/_D7]-_Z]8O\ T 5O1W9\SQ#_  Z?J_R+]%%%=)\B%?.MQ_Q]3?\
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M .C%KQ:N6M\1]KD'^[/_ !/\D%%%%8GOFKX8_P"1ITK_ *^D_G7O->#>&/\
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MY73)^M8U8N5K'O9-C*.&<_:NU[=/4\WHKT;_ (57_P!14_\ ?K_Z]'_"J_\
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M)(AZ,C @_C3ZYGP-Y3Z'-<1)#%]HNGF:W@^Y 3CY <#.!@G QDFNFH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!02 "2< =3110!#!>6MT6%O<PS%?O"-PV/KBIJ** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>image_042.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_042.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !P L$# 2(  A$! Q$!_\0
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MDU".[T-:BO)_^%GZS_SZV'_?#_\ Q5'_  L_6?\ GUL/^^'_ /BJS]K$]?\
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M<9#<W=M91"6ZN(H(R=H:5PHSZ9-5/[?T;_H+6'_@0G^-<[\3?^18A_Z^D_\
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MQ5/B9^A95_N=/T_5A1114'I!1110 4444 ='X#_Y'33_ /MI_P"BVKVNO%/
M?_(Z:?\ ]M/_ $6U>UUU4?A/B\__ -YC_A_5A1116Q\^9WB#_D6]4_Z])?\
MT UX%7OOB#_D6]4_Z])?_0#7@5<U;='U_#W\*IZK\@HHHK ^E"BBB@ HHHH
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MIWAJTBO9[F:Y<&:3[3,\KQER6\O<Q)(4$*,G^&MNBB@ HHHH **** "BBB@
MJMJ A.G7/VF=[>#RV,LJ2&,HF/F(8<KQGD8(Z@@U9J&ZM+:^MGMKNWBN+>08
M>*9 ZL/<'@T <+81ZA/%HVE:A=ZA!9WUQ=RQJUTZW)A7YH8VE!$@.#N/S;L#
M!/45%I,U_J4'AZ:+4;O^U_M#K(#<.8VLHIG5I'CSM8N@4!B-VYU(. <=PVCZ
M8UNMNVG69A5_,6,P+M#8QN QC..]-_L32?M"7']EV7G(BQK)]G3<JK]U0<9
M'8=J .+TB]U"3QRDLJ7ZV5Q=W4,5ZUZTEO=!=Q6)8-V(BNQOGVC=Y1.3OKT.
JJD>EZ?#=F[BL;5+DEB9EA4/EOO'.,\]_6K= !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>image_044.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_044.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %; ED# 2(  A$! Q$!_\0
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MML;BTD,<B*\H4X8=.M '745Q_AGQ(\?@6XNM9F$E]HHFM]0;/+20Y!;_ ($
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M5BR$XP,CK@4 =>[K&C.[!549+$X 'K2(ZR(KHP9&&593D$>HK*\5?\B?K?\
MUX3_ /HMJXOPY\0EL/#GA_[?H&J6FD21062ZG.$5/,V  E,[PA(X<C'(H ]+
MHKG=*\7VNH-KZW-O)8MHEP\5P)B.4"[A(/\ 9(R1]*T]#U(ZSH=CJ9MGMOM<
M*S"&0Y9589&??!% %^BO/M&M+WQV+W6+S6]3M+);V:#3[?3KDVZB.-RF]RHR
MY9E)P<@#MUKH+R^U?0K2SM+73+_Q#<L)"TX>&':JD8WLQ5=Q# # YVL<"@#H
M:*Y)_'EI%X,OO$4UC<Q'3YFM[NS<CS(I%<(RY&0>H.1G((J)_'YL]#_M35/#
M^I6(GECAT^UD,;3WC29VJ$#?(W'(;&* .RHKF-+\7O/J5SIVLZ/<Z-=06OVP
M">2.1'A!PS!T)&5.,CMD>M9EK\2#/;V6I3^&]3M-"O9DAAU"<QC!=MJ,T8;<
MJ,3PV.X/0B@#NJ*Y"[\<2IXHO/#^F^'M0U*\LRAF:)D2-(V16W%W(&?FP%ZG
M::Z^@ HKR2VU[7IO%EIXN-Y,OAVYU5]'%D7)B\GA(Y\= 3,K9;KA@*[?7?%4
MNF:U;:-IVC76JZC/ UR8H9(XUCC4A=S,Y &2< 4 =)17!W'BR75O U]J=U8:
MEI AO$MBL%S&)PPG6-AD9"_-P01R,XZ@UHZ_XT?1_$=OH-GH=_JE_<6WVB-+
M8H% W$'>S$! ,=2>I [T =717(1?$+3_ /A%+O6KFSNK>:SN393V#!3,MQN"
MB,8.#DLN#G&#FET?QCJ6H>*3H-]X8NM-F6W^TO)+<Q.H0Y (VD[OF&..G>@#
MKJ*X[QQK.JVU_P"']"T:=;:ZUB[:)[DH&,4*)N<J#QNQTSD5=L/#P\.R-?#Q
M#K$UM&K/<QZA<_:$90IY!890@X/RD#@C'H =)48GA:=H!*AF50S1AAN ]<>E
M>?M\51%I*:]-X6UB/PX[ #43Y>=I. YBW;]A/?'3'KBJ%SK<^G?&?4_[.TFZ
MU:YN=(M_*BMG15VAF)9G<A5&.F3R2 * /4Z*X^S^(NEW7@^[\0-:WD1LYVM)
M[$H#.+@,%\H*#@L2RXY[]J2P\=RMX@L=%UOP]J&C7.H*S6;S/')'*5&2I9&.
MUL=C_AD [&BN-MO'%YJ6I7]II/AB^O4L+B6VN+CSHXHQ(A8!1O(+9P.F0-PS
M3_ OB/7/$%G))JNCM;()KA5N1-&5)29D$>U23D 8)Z':3W% '7T444 %%%%
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M6TO2+#1;(6FG6J6\(.XA>2S=V8GEB?4DFKM 'C'B[3-2TS0O$,$\,:-KOB:
M6<+L";M&"8567/EDE#\QP1CMQ70^$K;^P/%2P:MH]W!JNJP,L5[/JK7YD2+D
MH68*5 # ],'\L]SJNCZ=KED;/4[.&Z@)W!)%SM;LRGJK#L1@BJ>C>%-%T"5Y
MM/LRL[KM,TTTDTFW^Z'D9B!P. <<4 9/CG0=7U&71=8T$PMJFCW1G2&9MJSQ
MLI5TSV)'0FI;R?7/$-I-I9\/S:;:W5M-#<7%[<0EEW1LJA%B=\_,1R2. >*Z
MJB@#R^ZT_P 8ZC\-4\'/H"07[6Z64E^;F+[*(Q@%P WF9*CIL')-;FB>'+[3
M/B'>WQA)TW^R+:SAG++EW0G(QG(XQVQ7:44 >56O@OQ!%HOB-DM(DU ^*#K&
MGQ32KLN$5T89*D[=P##G!!QTK9O]/USQ5XK\.74^CR:3IVDS-=3&ZFB>263:
M554$3L-HSR21]..>\HH Y[PEIMYID&K+>0^4;C5KJYB&\-NC=R5;@\9';K5?
MP;;ZGI45YI-]I<T4:7EU/%>"2-HI4DF:10 'WAL/SE0..M=310 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)$;YP3C^]7"59T__ )"=K_UV3^8H4Y=R9Y;A%%OV:_KYGT+1117:?GH4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>3?
M$_\ Y&6V_P"O-?\ T-Z]9KR;XG_\C+;?]>:_^AO657X3VLC_ -\7H_T.*HHH
MKD/N@JSI_P#R$[7_ *[)_,56JSI__(3M?^NR?S%"(G\+]&?0M%%%>@?EP444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>
M3?$__D9;;_KS7_T-Z]9KR;XG_P#(RVW_ %YK_P"AO657X3VLC_WQ>C_0XJBB
MBN0^Z"K.G_\ (3M?^NR?S%5JLZ?_ ,A.U_Z[)_,4(B?POT9]"T445Z!^7!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK_Z&]>LUY-\3_P#D9;;_ *\U_P#0WK*K\)[61_[XO1_H<51117(?=!5G3_\
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M9_+\D%%%%:'E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB_\ VQ_]GKT>O./A3_S%_P#MC_[/7H]=E+X4? 9Q_OL_E^2"BBBM#R@HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH S?$/_(M:K_UYS?\ H!KP.O?/
M$/\ R+6J_P#7G-_Z :\#KFK;H^OX>_A5/5?D%%%%8'TH5ZA\+/\ D&:A_P!=
ME_E7E]>H?"S_ )!FH?\ 79?Y5I2^(\?.O]SEZK\SOJ***[#X,**** "BBB@
MHHHH *\F^)__ ",MM_UYK_Z&]>LUY-\3_P#D9;;_ *\U_P#0WK*K\)[61_[X
MO1_H<51117(?=!5G3_\ D)VO_79/YBJU6=/_ .0G:_\ 79/YBA$3^%^C/H6B
MBBO0/RX**** "BBB@ HHHH *K:A_R#+K_KB_\C5FJVH?\@RZ_P"N+_R-)EP^
M)>J/GJBBBN _40HHHH ]'^%/_,7_ .V/_L]>CUYQ\*?^8O\ ]L?_ &>O1Z[*
M7PH^ SC_ 'V?R_)!1116AY04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 9OB'_D6M5_Z\YO\ T UX'7OGB'_D6M5_Z\YO_0#7@=<U;='U_#W\*IZK
M\@HHHK ^E"O4/A9_R#-0_P"NR_RKR^O4/A9_R#-0_P"NR_RK2E\1X^=?[G+U
M7YG?4445V'P84444 %%%% !1110 5Y-\3_\ D9;;_KS7_P!#>O6:\F^)_P#R
M,MM_UYK_ .AO657X3VLC_P!\7H_T.*HHHKD/N@JSI_\ R$[7_KLG\Q5:K.G_
M /(3M?\ KLG\Q0B)_"_1GT+1117H'Y<%%%% !1110 4444 %5M0_Y!EU_P!<
M7_D:LU6U#_D&77_7%_Y&DRX?$O5'SU1117 ?J(4444 >C_"G_F+_ /;'_P!G
MKT>O./A3_P Q?_MC_P"SUZ/792^%'P&<?[[/Y?D@HHHK0\H**** "BBB@ HH
MHH ***QK?Q7HMUJ:Z?%=L9G=HXW,$BQ2NOWE24KL=A@Y56)X/H< &S169J_B
M#3M"17OWG565G)AM99@BKC+-L4[%&>K8%-;Q)I U"SL5O5DGNT62'RE:1"K
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M),?W3_*O,/#OA_4I/AQ87NI7BR?9=">.SLHK0Q-&7AP?,)9B[8P. HZ\9Q@
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M65M(A<R%7B4@M_>Y'7WJ?R8C(DGE)O0%4;:,J#U /;H/RI]% !1110 4444
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>image_045.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_045.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" *D!!T# 2(  A$! Q$!_\0
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M_P!IGP5\#_'_ .POXW^#F@>)]S77BW78;^*WL$1"^\B[TVR!!*_+R&./N\T
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MDO\ =B_[Z'_Q-1M.X)!1,]\-Q^&!CI7\Y/\ P]]^/G_1J_C/_OF3_P"(I?\
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M2A&5#(=RGMS7#_$KX_> _A)<>$K/QOXFBC@\9ZH=+TZYA@1X9)5565&GC;"
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MG&=IY7TQG\"E_P""OGQ^!D'_  RCXVCD9Q#)#/OVQ$199ANC5B=V3\RHV<Y
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MUU[1_ GA;2]9L@5MM2L=%L+6[B0AAM2:&!'0!6(!5E..]>G>6?[P_P"^3_\
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MT,\VFZM96U_9320.)(6EM[F*2-C'(%D1MH964$,*Z?RS_>'_ 'R?_BJ/+/\
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M2=W%2?=VOI\CUUGW$$4HPSK,J<4K*$,96C%+1:1C)):)7TUZW/&_^%)?#?\
MZ%+1O_ "U_\ C='_  I+X;_]"EHW_@!:_P#QNO9/*C_O'\U_PH\J/^\?S7_"
MER1_EC^'^0_[>XA_Z'F9_P#A97_^3/&_^%)?#?\ Z%+1O_ "U_\ C=/'P5^&
MJC!\):%GDY;3[8G_ -%#^OUKV'RH_P"\?S7_  H\J,'DGH""2.^?IZ4^6/\
M)'\/\A//.(IKE6>YHKZW6-KIZ>?/YGD(^#'PU7./"/A_GUTZV]_]BE/P:^&^
M"!X1T$$XP5TZVW=?]S&/6O7O*B]?_'J/*C/ )Z$D@],8_#UHY8_R+\/\B/[6
MXBB^;^W\VTU_W_$=/^XAY /@S\.U(*^%=&1@1M9;"U5E;/RLI"9!!P01T/-6
M/^%0^".VAV'_ 'YA_P#B*]6\J/\ O'\U_P */*C_ +Q_[Z7_  IV\E^'^1:S
M[B-?\S[-?_"VO^LSQ[_A3'PVQ(9?"VCRN\I=G>SMRY(!7KY8SU/7.?7M7YT?
MM*_\$EOV?/V@?%DGCVX@U_0=<>VCLY!X=U1--M"D3DAO)BM6Q(0S*6WX.!E0
M<D_KN;*W<88D[OF//<DG/89YQGN/6HOLJI&T"8QNW!P<$@D'GGDCIZ>PS6;H
M47>]..N^EM?O\^ECVLB\0>-.',34QN7<09OAL15IRHU:M''5.>K2E9.$W-54
MTU%?93MM):GP=^RA^Q)\(/V3-)O='^'ECJ@N]3MX8M3U/4KM;V_N3'(9SYDI
M@C&"[,.% *=26Y'W?;IYJEW5H^@"@X'3D].I&,]O2D^R(9 ^THS\?*/F.!@Y
M//M]<=>35V"U$28\R1@>1D]/PQQ_6M8J,$E&*48Z**TWU>KN]VV[]3YK.LYS
M;B/-,5F&:8S$XR==PE?$S]K/F5.$9-R<8MW<;J\G;R6A;HHHH, HI"RCJP'U
M(H!!Z$'Z&@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F.I;C:"/4]<\^X_
MPI]%'XB:;5DW'S6_H0J'3HI88Z;@.>I/)ZGZ?CVIYW,,;<9QGD'W_G3Z* UT
MNV];^OJ0[&]/U'^--V-@;DR?^ _U-6**!_+_ #^\C ( !09  /*]<4O/]P?F
M/\*?10*W]Z7WK_(9S_<'YC_"CG^X/S'^%/HH%;^]+\/\AG/9!^8I<M_=_P#'
MA3J* Y?[TOO_ . -RW]W_P >%-+/_P \\^^X"I**!I6ZM^K&;=_+KM(X'S'I
M]5(_R*1H^FWKGG+-C&#ZY[X[5)10,AV/_L_]]'_XF@QN01\O(QU/_P 34U%
M!1110 F!NS@9Q][OWX]>YI:** (R7Z!..?XAU'3O],C&/<TA\PX 7 [_ ##@
MGKGD$X_6I:* TO>RO:W4B'F=#VQ@_+SZGK_G^3"KD\J>O7?VSZ9X^E6**!63
M;;2=^G1>A7*,!POOP0/P)XYY/3(]ZDC##.X$=,9;=TS[G&*DHH'IV5^_7_(*
M*** "BBB@")D8L2-N"0>20>@']T^E)L?_9_[Z/\ \34U% $2JRDG .0!@'W)
MSR!3\M_=_P#'A3J*!-7ZM>C&Y;^[_P"/"C+?W?\ QX4ZB@7+_>E]XW+?W?\
MQX4G)ZH#^(Z?K3Z* Y?[TOO_ . ,Y_N#\Q_A1R.1&,_4#]<4^B@=O[S_  _R
M(]TG_//_ ,?6C=)_SS_\?6I*3<H."P!],C- QI'?9SW^;_Z_^%1LC;B0J]L8
MQGISR2M3T4/46O5M^MOT1$JG#;ASVZ?T)[^])M8\D'.!U/\ 3)Q4U%%BD^6]
MDKOK8*1NA^A_E2T4"*#L$1F:145%W;2H))VY)Y/?&/P/4YKBI_B!I,#LDB7
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MZ!]G_P!^8?\ XBC^R+3_ *!]G_WYA_\ B* .._X6/HO]V]_3_&C_ (6/HO\
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MT_QH_P"%CZ+_ ';W]/\ &NQ_LBT_Z!]G_P!^8?\ XBC^R+3_ *!]G_WYA_\
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M._X6/HO]V]_3_&C_ (6/HO\ =O?T_P :['^R+3_H'V?_ 'YA_P#B*/[(M/\
MH'V?_?F'_P"(H X[_A8^B_W;W]/\:/\ A8^B_P!V]_3_ !KL?[(M/^@?9_\
M?F'_ .(H_LBT_P"@?9_]^8?_ (B@#CO^%CZ+_=O?T_QH_P"%CZ+_ ';W]/\
M&NQ_LBT_Z!]G_P!^8?\ XBC^R+3_ *!]G_WYA_\ B* .._X6/HO]V]_3_&C_
M (6/HO\ =O?T_P :['^R+3_H'V?_ 'YA_P#B*/[(M/\ H'V?_?F'_P"(H X[
M_A8^B_W;W]/\:/\ A8^B_P!V]_3_ !KL?[(M/^@?9_\ ?F'_ .(H_LBT_P"@
M?9_]^8?_ (B@#CO^%CZ+_=O?T_QH_P"%CZ+_ ';W]/\ &NQ_LBT_Z!]G_P!^
M8?\ XBC^R+3_ *!]G_WYA_\ B* .._X6/HO]V]_3_&C_ (6/HO\ =O?T_P :
M['^R+3_H'V?_ 'YA_P#B*/[(M/\ H'V?_?F'_P"(H X[_A8^B_W;W]/\:/\
MA8^B_P!V]_3_ !KL?[(M/^@?9_\ ?F'_ .(H_LBT_P"@?9_]^8?_ (B@#CO^
M%CZ+_=O?T_QH_P"%CZ+_ ';W]/\ &NQ_LBT_Z!]G_P!^8?\ XBC^R+3_ *!]
MG_WYA_\ B* .._X6/HO]V]_3_&C_ (6/HO\ =O?T_P :['^R+3_H'V?_ 'YA
M_P#B*/[(M/\ H'V?_?F'_P"(H X[_A8^B_W;W]/\:/\ A8^B_P!V]_3_ !KL
M?[(M/^@?9_\ ?F'_ .(H_LBT_P"@?9_]^8?_ (B@#CO^%CZ+_=O?T_QH_P"%
MCZ+_ ';W]/\ &NQ_LBT_Z!]G_P!^8?\ XBC^R+3_ *!]G_WYA_\ B* .._X6
M/HO]V]_3_&C_ (6/HO\ =O?T_P :['^R+3_H'V?_ 'YA_P#B*/[(M/\ H'V?
M_?F'_P"(H X[_A8^B_W;W]/\:/\ A8^B_P!V]_3_ !KL?[(M/^@?9_\ ?F'_
M .(H_LBT_P"@?9_]^8?_ (B@#CO^%CZ+_=O?T_QH_P"%CZ+_ ';W]/\ &NQ_
MLBT_Z!]G_P!^8?\ XBC^R+3_ *!]G_WYA_\ B* .._X6/HO]V]_3_&C_ (6/
MHO\ =O?T_P :['^R+3_H'V?_ 'YA_P#B*/[(M/\ H'V?_?F'_P"(H X[_A8^
MB_W;W]/\:/\ A8^B_P!V]_3_ !KL?[(M/^@?9_\ ?F'_ .(H_LBT_P"@?9_]
M^8?_ (B@#CO^%CZ+_=O?T_QH_P"%CZ+_ ';W]/\ &NQ_LBT_Z!]G_P!^8?\
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MZ!]G_P!^8?\ XBC^R+3_ *!]G_WYA_\ B* .._X6/HO]V]_3_&C_ (6/HO\
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MT_QH_P"%CZ+_ ';W]/\ &NQ_LBT_Z!]G_P!^8?\ XBC^R+3_ *!]G_WYA_\
MB* .2A^(6DW$L<$2W?FS.L<>_&W>Y"KNYZ9(S_(]*[:V;[4OFY&<=1R![$Y!
MW<GD_4CIBN-)M 0186:D$$$0PY'N,*#D=>"/K6E!"(5PH"C^Z, ?7@ >PX&.
M>N: )AP /0"EHHH **** "BHP^59L?=SQGKC/M[4PS$-MV\;<DYZ=?\ 9]O;
MK^;Y6[Z;:,.O+U[$]%49;P("0(\!@,O($'3+ $CD@8./?U!%#7@^79Y3;@&
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M_&EHH 3 ]_S/^-&![_F?\:6B@!,#W_,_XT8'O^9_QI:* $P/?\S_ (T8'O\
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M'*&DPS[5!0JNUBA#8+#!(4GO3S.@PI9!+C>T1E D6,8W.1NQA0>0">>,\$T
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M,_F)&"Q&%D=HA&@"G+$OQC! J&'7+2[W,DL'EI)+&)%N8RC[#&NY6##.7=$
M ;!89/(H W\#W_,_XT8'O^9_QK+6\*9S$3(7\I8Q(I#,5W\,6 P$4MG@=?3D
M_M>T"L[2(J#S,-YB$2^2#YYA .YQ"05<X!!!XXH U,#W_,_XT8'O^9_QK.74
M5:(3%55%5C*/-C9HMDA20MM)4J@#$X8L",%<Y%-&I*23M#*PA:(H7)*7#E(V
M?=&BJ"0<@%F'ITR :>![_F?\:,#W_,_XU76Y#*C*C$2.43((R0"23\N57@C)
M Y XYJ);S)C78&+&17V,"$,;,I^\%8@,I!.WZ9H NX'O^9_QHP/?\S_C6?)J
M*1"$NJJ92H ,@&?,?RXPIP0S,Q7CC@G!)&*:NHAS$JQAS(=A=) T8EVLQB!P
M'W*%R=RH,9YS@4 :6![_ )G_ !HP/?\ ,_XU56Z&&+^6-N[<5<LJA3@AFV !
M@3@C_P#533=J8XG1H2THR@,F ZDCE"%);(/ VC)H N8'O^9_QHP/?\S_ (U7
M%R"2NU@XRP&#ADZ@J2!EB/X3@@YS[I)=)$5,F(HR 6DE94521\HY/)/- %G
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MJ$*W=N+A5NXG0PJJ^6R,K@_-Q\KVG[$7[2/C?P3\>X_%WAS1?#/BGXC>,O\
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M]J[X?> M-^*_Q#?PKI>A: K6GB#0XM \+6T^9/LS7&IV<$\DVH7&PHXED//
M45\P?M;_ +!7QT\;^"]+U7X0:= GC#4O'^H:MXI\.IXAM_#UC#X/B6&UT.&W
MA>\L8K?3K;3XHH[G3T=5:0_O86=<@ _:KQU\0M$\!^ -=^*%[(LGAO0]"UKQ
M)X@U59E6,:)HNDW5Z9;>?<L:1W0M8_)DWJ")0RD9%?CM\+/^"H/Q8^(41U#X
MF_ 1OA9X0^+7@'Q-J'[/OB>+5-1GUCQ1=>0AT"+4;2]L[6VAN-2MIX+RW6RN
M+UY$#.A<+D_>%C\!/&&I_L3:Y^S_ .,M76?Q7XC^%>O^$;J]GNTNX8M5US1;
MK3K"UFD"2C[%8SW-O''*8VA$4*N6=>3^9GP&_9<_;C\=WG[/?PM_:6^&7A?P
MA\+OV7/ D.C>"?$&EZUH]W>^(_%_AO0(=%\-7Z-9ZI?3JDRP2W$YD@M$!<;T
M0_( #MO^")'Q>^.'QA_9D^(7Q4^,C>*?[:N?B5XZT73K#Q'J5QJ-M9Z?I$UH
M+>X2:ZM;>2'.Q]D81E4!5W$=+7_!/[]LKX@ZNO[?6G?&+Q _B.?X6?'[Q--\
M*VE,4,DG@_5]*^T:5I\;9C,\5CJ-C>P,(U=8QM7<S$U]F_\ !/3]G[QW^SM^
MS4_PI^*%I#'XPO/%?CF\EC@OH-0MY;7Q!<W=[IUU++!*\7,42IN(!0HR\$$'
M\;_CW_P3+_;FU3Q)\$]7^ MYX2T>W7XB_%'5/CC')JUE9OX@\&:QXJTZ]\&Q
M2.0J:C):Z4-7&(F=X!<['(+8 !Y[^PI_P4#_ &I? NA_M<?%GXX^(-5^*5[;
M_$#4]'^$?PY CL;-?[>\;Z+X9\.PP3K"UR]M92WS3/-&DI^P1O($)&!]Y^ O
M^"V6B^+? 7QPN/$7P/\ &?ASXL_ _4M'T>\^&UK=J[^+=<UW4GLX=.TV66)+
MTR 1O=2A+7S%@25PI"X/S-XS_P""7/[14'AO]H5M(\%:)K*KXHTWQG\%]!TO
MQ%;646L1:1XAT.];1+]DU"T> 3Z9::B09YH<7&PB99,5SG@W_@F=^U7=>#_C
M%\1;_P"%_P //"'Q>D\=>#OB5\)]"TS7K&YO==NM$N+R+5=-\1ZJ-2O(;B%K
M*_=%^UZD%:=H]LN: /3]=_X*.?&/Q9XU^(FN_%'X<?%7X,^$/#_PT^'EUH?@
M_P -^8NL:GJFM>-[O3;O4TN[ZUM99[5+2[MDG9$"IY4BX/!/LWQ6_P""M_Q"
M\(>+-;\,_L^_LO\ CSXU^ /ACIX\._$#XG6^I7D\VEZQ8.L5]9PV.G:;=V-W
M>6@6X,S3W=M-YD95D4'(XOQE^R]^W7^TD/$/B_XN?#GPCX3U8^#_  3X*T+P
MSINN:5;R?8='\4-K.KSRO;ZI.B2%8TF1Y;E6D7"HIR0>/'[,'_!27]EW6?BU
MX!_9,\%_#GQ!X ^*_B7Q1\0V\1^*M3TN8V6K^(KX:A>:?J45]>0LX@.H2B!)
M+:93%'A)&4#(![OXY_X*Y_%SP-XOU;5?^&9]4;X$Z)XET#1-5\::IJEY:Z]M
MOCIMM=7-I9&Q:SD59[IM@>\7Y5.>1S]-?LM_'#Q?\3_VE_CW;_V]>ZKX/@^&
M_@/QGX(TB]*L=&NM<N/&"/!)LR'B>.&SCBDWL97C; ^7G\1OBY_P3D_X**^/
MY_CGX?N/ NB^);GQ9XWT[Q7X1\77'C>WMO##6D-WH]\J0Z0=;M[2*)1;SHL!
MTL# (VGC/[7?L/\ [._Q[^&VK>+_ !7\<['PUINK^(?A/\-? MG9:3<61LK<
M^$I];><HM@QVI#)JR%)7<EP!G[M 'X^_MF?'+QKK?[3WBKP#^UI\?_C9^ROX
M)TGP#H6J?"KQ1\-)K?PUINL:I+XEO;2Z;69-2:*VUF%4D4-!$T4B1Q;C*PP!
M]=Z?^WS\5_V>O!GPO^!/PJT8_P#!03XH?\(=KWCRZ\>^$]2O=-4^!/\ A(;^
M/PU>:S8:2/$ .J&U9K6\NE>**>YM)5 &S%2?%']G#]N;3/B?XKT77/@K\,OV
MM/A'KNF))X.A\<0>$]8OO VM^??RW-I;7OB.YT^^L[2:&2SG6%)I+<2;FC =
MG)^>_AY^QU_P4<_94\2^%_CC\"OAG\./$'C[Q3X*\4>$/&GP\N-<TGR/!46J
M^*+_ %RQTBQ9M3M-/@TG2XKX)'%9WTT$#2LISD$ '3:O_P %7OC'K?Q:^&OB
MGPA\&?B-=#4?"%SJ/C#X37L<T)TZYTZUU&/6K-9X[>2[W6?V62^A,D2M)"B,
MX3<2/M;XL_\ !5,P> O@KJ?P(^%6L?$[XL?&&T-U;>#[F[\I/!EI_9PU+4H=
M3_LZWO+G[0!$;>U@EMQYLT>TNAR:\Q^!_P"QA^UE/XJ\)?%#XZ:;\.+3Q9_P
MKWQ/H&OVNAB 0V/BO6-)U>PT02#3HV2XCA6\L8;JX6297"R-([_,Q\*\,_L+
M?MD?LV)\)OBU\'O!GA+Q_P#$[0([K3?$OAV/4M/L[-M/N--NH%N8XM0NM+CG
MS+<2L&MYVD*1,0"5H ]DT#_@LUXC\:? Q==\%_LR>+]1^/L/Q%U;P+>_!F;5
M;L3Z?)I%A87D_B2\EBL)=2BL)EU&".VA-CY<C>9EP0,\#X@_X*,?&+XSVGP]
ML;71/$/P'^(GPZ^,$_@/XN^#;R3:-1U,Z3X/\0VMQ;I>6\=R^C7?]NM:0R2P
MPG?%<(JML%>3_#K]BS_@H;\.M,D_:2MOAQ\/M0_:@UKXC^([WQ!X-M=:T>#2
M1X"U33=#M].N$F_M&WL9;V&[TF2*0+?O,@E4$8)KV+PC^PC^U9\4M6\1_&GX
MV^%/#^B?%CQY\:--\8Z]X:L-<TSR+;P?X?T?PE8>'[?_ $:]GB6YC_LB]\Y!
M<O-( IE+;AD ^G_^"OOQ=^.7PS_95TG5OA<GB*VLKKQ#X67XC^)O"-S=?\)%
MH?A.=(I-=N;(P0E+>Y6'*6^XQQR2O&&=2Y-?F7\&/B[KO@/P#\6_C9^RO^VW
MJW[0>G:%\ ?B'KOB+X%?%ZYLM6\;^'/$5AHT6H:!K6EQV-Y-=69L]218M1CE
MC8/;PS29#0;3^R7[??PK_:I\7>!/"^J?LNOHFO>-_#FOZ+-KWP^\9FR?PGXH
M\-03F6XTR6&_5=-FNT+Q>6+JXC+"$?,5P3^6-O\ L"_M=_$KXP>(?B'>? GX
M>_ C28/A3\5-&CM_#5UH/AVY\9^./&W@W6=!TO3=2C\.ZA)]KT:+4KVVG"WQ
M2")@)(VR&H ^W?V$O^"@?B7XY6/@WX;_ !'\':]I7Q(F\!GQK?>)+*Z!@N[-
M9M;,V;&\LG2)4.FQVGFX8C[2@#J6Q5#4/^"KLOB'1?"$'PL^ WB_Q?XX\>:_
M\0O#MAX8=K=T\-'P1XEU3PU->7J6>GR71MM;DTNYU!W*JR0R JQ"C'RMX=_9
MF_X*7?!OQI\*_B;\.OAK\/\ 6O$M]\.?$/PW^(>EW&O6=S::;IB/=SZ-=:>)
M]52")Y+F56FEMY"_WPP W Y7P _8>_;K_9YTKX+_ !?M_#'A'Q#\<M'OOB)=
M_$OPY9ZQ8R65K9>-O&GB.]TM[)OM<%G,]MI.L"5VBN7,;)B0D@Y .F_9M_X*
MF^(/!_[*=UXB^(&CWGCOX_\ C;]H;XL^$/!/PQU+56L]3TM8OB7XET+2-,UF
M-4^W'3-.%F(I%%JY6W1?E)&*]0U;_@M+<67P:\&>,[?]G+QCXA^(WC'X\K^S
MO%\-]*U"2-=-\;VNDSZQ:W[WMO9RWDF@PS6T\<UPUHLA51F'.:^3/$W_  2H
M_:0U32=&^-6N^$_#GC+]HI/B3\0/'\O@*S\1:?I=C86_BWQ_XD\3636\\-[I
MUD+BWLM7A;<FH,ROE=[$$U],_ #_ ()\_'70?#?P$U3Q1\/_  EX*\5>$_VE
M)/BA\1=$M]7@U!IO#=QX;O+"36DOH[V_1]8AO[A441W@N2K.P5ER: /,/B__
M ,%A_P!H'7/@Y\2)? GP.O\ X<_&SX2?$WX7Z%XMTG4=1NM1TV7PUXZA\0R1
M3VD4^G1307,?]AS),KVX4EX&$F9-J^Q:/_P5U^,OBWXBCPA\+_V:=4\6^'O
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M0J6B@"HL"_-L QN/\3+@\#  &,8 ([#.!TI'1$P7 YSCEF^O4<=?QJY00#U
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M:]T[CZ'^:U)^98K"_4\=B*&J]E4J0L]_=DU_7WB]U_WE_P#0A5BJ_=?]Y?\
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M!]<X.??!)YH:VBQG Z<\#YV P">.3@8YSQQTXH _G5_8"_X(R:A^Q[^T9/\
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MB<?>!XZ8]<_3C/\ *YX#_P""PG[0G["_Q,T/X%_\%;?A6?!FBZS=:CH7@_\
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M[\,WT7@^#5D4Z=#KD-LQBBU 3QSPBVU&13$1+"\3"494CK[GY(V&.,(A;&"
M ,X!SD8)(XQGT&..*>+9=JAB-V &/RD$CJ?4\],]!TQUK/I9:*]]6OZ^X^=\
M0_$CB'Q%SBGF&:X;V?LXN=.2C4C%^TY(R2<Y3?PQ3WTTTOJ_YF/@9^RMXC_:
M ^-OP_D\??LKZU\!;KX97^O>*_B3XSUG0[:TL_'OBN>.#2[&3PBUBJF>WM;Z
MYN-22>(6T2P,"J@X YSQ5X"_;I_9GU+XY?LI?#'X5ZSXQ^'WQJ^*/B'Q?X5^
M)>CQK-HV@>'?'6GZ?:ZEI^JE[>6:TO/[1%W>7"E\R$NX8L2:_J22UA* L78J
M3@XSP.VX9(&.N#UP2.U2QV\8R8D!/&2Z*Q'I@OM(QST)Q[=T?(4_9\K;:]II
M9=>E]?2Y^9F@?!GQW\"_V./AQ^SMX4TRSU?Q1%X&_P"$-N+J$00&"[U1W76;
MR"65#/%;V7VZ:>61-FU$9ACK7PS^T3_P3W^+&I:I\/I_"=MI_P 2K)K+4-&6
M--06T3X;W^MRV,]GXBMXI6)NC;1V\Y:ZA42IN,@/)K^AB6W4+ODC5BO"DHC.
MN[@[&+,5S_%C[W0YJ%=.MBPEP4DC/F;5"KG8<X(  V]ER/NG@8R*"CRKX$>"
M]8^'/PQ\.>$M>NH[S7-*M8XKZ1)C<'#'()=N6!QT'^.?;!T'T';'Z=OI5<@
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MVB;D ,<[4VOZ"EU?6[ZSIAO='W:?JC6.H0!](EO$6YM%U*V$L;VC/;*)E$J
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M+110 4444 %%%(> 3Z T +14(D<@'"\^Y_PH,C@$X7CW/^% $U%%% !1110
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MSL5(  .<]<]L>GUJM-YD@ 4HN#DDD_='7'3G.,4XVNK[7U'%I-.6W7TU_P"
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MZ)*C.N ^,/(!MW'/JVTYSO;'IQ_GTXZ'OU-*RY! .W/<=?>@#YD_:+^"U_\
M&?X9WWPTTCQUXC^&YU>[@GNM>\&VVFG48[>!E?RF2]M;B$1S,H#,(PQV[=V*
MC^"_[,O@3X0_!73/@HL<_B_P[%#JW]NW/B.UM+F;Q/?Z]<S7FN7^KVRPBUD?
M4;B>621%B6/#L@4( M?2XM(_GRTA:0*K.'*-L7.$W)@[<DG [G\Y$@2, *7
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M<( -DA;=N&23DY^@C'DD[F ]%P/3N!^G3GZ4C1!E*F27!!!PY!YXZC!'X$4
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M"IQN+$C'.XCD=P!P/PZ=J<J!6+98Y &"<]">>>?UH < !T 'T%+110 4444
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MM/\ X1'0?^@9!_WV_P#\31_PB.@_] R#_OM__B: ,S_A9/@[_H++_P!^)_\
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MM/\ X1'0?^@9!_WV_P#\31_PB.@_] R#_OM__B: ,S_A9/@[_H++_P!^)_\
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M@_\ 0,@_[[?_ .)H S/^%D^#O^@LO_?B?_XW1_PLGP=_T%E_[\3_ /QNM/\
MX1'0?^@9!_WV_P#\31_PB.@_] R#_OM__B: ,S_A9/@[_H++_P!^)_\ XW1_
MPLGP=_T%E_[\3_\ QNM/_A$=!_Z!D'_?;_\ Q-'_  B.@_\ 0,@_[[?_ .)H
M S/^%D^#O^@LO_?B?_XW1_PLGP=_T%E_[\3_ /QNM/\ X1'0?^@9!_WV_P#\
M31_PB.@_] R#_OM__B: ,S_A9/@[_H++_P!^)_\ XW1_PLGP=_T%E_[\3_\
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MK+PI>:K?Q>*=8TU\&V@OM*T6W2UC#0XDE2;46*"09#,#7N_[(G_!/6./Q/\
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M_P +)\'?]!9?^_$__P ;K3_X1'0?^@9!_P!]O_\ $T?\(CH/_0,@_P"^W_\
MB: ,S_A9/@[_ *"R_P#?B?\ ^-T?\+)\'?\ 067_ +\3_P#QNM/_ (1'0?\
MH&0?]]O_ /$T?\(CH/\ T#(/^^W_ /B: ,S_ (63X._Z"R_]^)__ (W1_P +
M)\'?]!9?^_$__P ;K3_X1'0?^@9!_P!]O_\ $T?\(CH/_0,@_P"^W_\ B: ,
MS_A9/@[_ *"R_P#?B?\ ^-T?\+)\'?\ 067_ +\3_P#QNM/_ (1'0?\ H&0?
M]]O_ /$T?\(CH/\ T#(/^^W_ /B: ,S_ (63X._Z"R_]^)__ (W1_P +)\'?
M]!9?^_$__P ;K3_X1'0?^@9!_P!]O_\ $T?\(CH/_0,@_P"^W_\ B: ,S_A9
M/@[_ *"R_P#?B?\ ^-T?\+)\'?\ 067_ +\3_P#QNM/_ (1'0?\ H&0?]]O_
M /$T?\(CH/\ T#(/^^W_ /B: ,S_ (63X._Z"R_]^)__ (W1_P +)\'?]!9?
M^_$__P ;K3_X1'0?^@9!_P!]O_\ $T?\(CH/_0,@_P"^W_\ B: ,S_A9/@[_
M *"R_P#?B?\ ^-T?\+)\'?\ 067_ +\3_P#QNM/_ (1'0?\ H&0?]]O_ /$T
M?\(CH/\ T#(/^^W_ /B: ,S_ (63X._Z"R_]^)__ (W1_P +)\'?]!9?^_$_
M_P ;K3_X1'0?^@9!_P!]O_\ $T?\(CH/_0,@_P"^W_\ B: ,S_A9/@[_ *"R
M_P#?B?\ ^-T?\+)\'?\ 067_ +\3_P#QNM/_ (1'0?\ H&0?]]O_ /$T?\(C
MH/\ T#(/^^W_ /B: ,S_ (63X._Z"R_]^)__ (W1_P +)\'?]!9?^_$__P ;
MK3_X1'0?^@9!_P!]O_\ $T?\(CH/_0,@_P"^W_\ B: ,S_A9/@[_ *"R_P#?
MB?\ ^-T?\+)\'?\ 067_ +\3_P#QNM/_ (1'0?\ H&0?]]O_ /$T?\(CH/\
MT#(/^^W_ /B: ,S_ (63X._Z"R_]^)__ (W1_P +)\'?]!9?^_$__P ;K3_X
M1'0?^@9!_P!]O_\ $T?\(CH/_0,@_P"^W_\ B: ,S_A9/@[_ *"R_P#?B?\
M^-T?\+)\'?\ 067_ +\3_P#QNM/_ (1'0?\ H&0?]]O_ /$T?\(CH/\ T#(/
M^^W_ /B: ,S_ (63X._Z"R_]^)__ (W1_P +)\'?]!9?^_$__P ;K3_X1'0?
M^@9!_P!]O_\ $T?\(CH/_0,@_P"^W_\ B: ,S_A9/@[_ *"R_P#?B?\ ^-T?
M\+)\'?\ 067_ +\3_P#QNM/_ (1'0?\ H&0?]]O_ /$T?\(CH/\ T#(/^^W_
M /B: ,S_ (63X._Z"R_]^)__ (W1_P +)\'?]!9?^_$__P ;K3_X1'0?^@9!
M_P!]O_\ $T?\(CH/_0,@_P"^W_\ B: ,S_A9/@[_ *"R_P#?B?\ ^-T?\+)\
M'?\ 067_ +\3_P#QNM/_ (1'0?\ H&0?]]O_ /$T?\(CH/\ T#(/^^W_ /B:
M ,S_ (63X._Z"R_]^)__ (W1_P +)\'?]!9?^_$__P ;K3_X1'0?^@9!_P!]
MO_\ $T?\(CH/_0,@_P"^W_\ B: ,S_A9/@[_ *"R_P#?B?\ ^-T?\+)\'?\
M067_ +\3_P#QNM/_ (1'0?\ H&0?]]O_ /$T?\(CH/\ T#(/^^W_ /B: ,S_
M (63X._Z"R_]^)__ (W1_P +)\'?]!9?^_$__P ;K3_X1'0?^@9!_P!]O_\
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M<'ISV) ZT"Y9KXN2VVDKN_I^9;HJ*, %L#'"_P VJ6@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *INY,AQ@@8!''."P'...FX=^<$XQBU( R.IZ%2#],5DR-%$47>
M3T!/<#M_7/?CC@4TK_>9U)J$59<U24XQA3O9RYM&[ZO3T9,9H@2"BYR1SMR2
M#COR<UY%\6?BGX0^%/A?Q!XL\6:G9Z%8:7IEQ?\ VN^N8=-CNWM8#*EK#=M)
M&7D<J(]@SDX '8XOQ@^-O@/X0>&M;\8^,O$.GZ'I.B6=Q<SW%[<1^;<- I)@
MTZS)::YG+@1+'!$[-(P4 L:_$_P=\-/B;_P4G^.;?%/XGVWB:W_95T-XY?#'
M@C64N-(L/$%]$\-M:WKZ5(HFGBDGM6NV,I50LH8CD Z3I.$8R;O>VEK;WWUO
MLF]CZ?+\H2E1Q./J*AAW#G:G!OGFN5JBG)QC>:;?,V]->6^@GP__ &N/VDO^
M"B7C3Q%\-? MO?\ P8^$MEY[:G\0H;2X?4M;TW[2;8V7AW4C%%$EU/;3;FF6
M5G1)%90=Q-?J3^SE^Q5\$_V<;"7_ (13P\VL^*==CFN_$GCGQ"3J_B37M0FD
MBGGFU:\O%F82/(P-K%&51(E8#-?2'P]\#>'_  98)HV@^%-*\+Z-IXBAL+'3
M;6"V5_+18VF=8L[\QI$$=CDX.2,5Z>K!K@J(\((R VW R"N1]1P/;M6>W_ _
MX8O.<Y24<-DU+^S:=E&=2C4C/FO>[:A&"=[+W>=I7M=[E"VT^.*W1DB0O$H4
M +Y:H!C: B +A1@!< 8R.G%6T$^"=J9)Z 'D 8S_ "_3WJ[@97@?>7L/[PJS
M2/FKN3YZO[RMNZKT;?5VUW>N_P!Y6R.Y'YT9'J/S%6:*!$<71O\ >_\ 95J2
MBB@!&!((!QTY_'/J.O0\U@W^GO=-^Z81E<Y*C!."1D]@,@]S]X^F:WZ* /RU
M_;5_X)8_LA?MHI/XC^)_PTTO2/BAI5C++X/^-'A:231/'?@_5K/&HZ;K>G7]
M@+<75Q8ZD%F1;OS$98A&V48BOP6U?_@IW^WQ_P $J?V@/ WP/_;.C;X_?LV:
MQXCA\*6?QZUK0I_#FLZ+9(T?]F:IJFH6\2Z7-.T$B1W+33!':-V!&XU_8W<J
M^[$/[SA?E?D'./E&[C&.2/?&:\0^-WP0^%/Q\\#:Q\./B_\ #GP_\0/"'B2T
MNM+UW0O%&CQ:G#);7<3Q2RV4LB/):21E@T4\,L3P@ HRL 0 =I\-OB9X4^)O
MAS2O%'@_6]+U[1-?TJRUJQO]-O;>\A6'4(5GA@:6WEE3>$93]\9SPIZUZ1#+
MD*">[ [L#N.F,>N<G.?2OXNOA]\/OB+_ ,$ _P!J^[\>^-KKX@-_P3N^.-Y?
M^&9=)AO[_P =Z5\/]=L[R2Y\+:K>*)+Z;POI-O;7/DQW9E@0",HQ^0"OZS_@
M7\;OA=^T!X \/?$GX.>+]'\;^!_%MC'JFFZ[H^JQ:O:R;E4RVTMRL\SPWMH[
M&&ZM)"LENZA"B'- 'OQ8AU7L0?T!_P ]OQI]4+>2-C&QF9GDWJJDY!V9!Q@8
M&!Z<<5?H **** "BBB@ HHHH **** "BBB@ HHHH **0XP<],'/T[U#B ^GY
MM_C0!/14&(/;\V_QHQ![?FW^- $]%08@]OS;_&E AYQCH3U;H._7J/SZX[T
M3457$T+YY^X?<8*\D<<G'7'(],XIWVB'^_\ ^.M_\30!-13/,7U/X*Q_D*/,
M7U/_ 'RW^% #Z*B8Q,1N//;.X''TX_.H9&A3: RJ7;:"23G()QSD=J +=%5H
MY8RQ0,C%%R2HR1GZ9[=<5-YB^I_[Y;_"@!]%0 A#EY1@#N_7MR"<$<]AG..<
M\T?N&);(.>^6Y]QSC'N.* )Z*AWPJ-@<+GG[V&^HSD]OT-",HR?,W@],98C!
M/7 )'X]P<<<  FHIH=20 3D],AA[]P!VJ%YK93EW0$'N<=#DGTXZD]P#UQP
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MJMU#96>HW]X8+"WL(;JZN)[DM)'';01M(;IQ&ZX0%59E)#%%8<9S7XU_$_\
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MMZUI_AVV$Q.(Y-8CNIGD(1XR @@4#YN"3D'C#YHP7-*UD[N_9;G?D^#>/S?
M0C3K56YI*G1ASU7>5[QI]5=6;OI=]D?E[X$^%WQ#_;L_;6U_XO\ B^YU34OV
M;_A7XD%EX5T'5'G_ +#U^>VFN;FX:WTQ&^R74:7OD*9I4DW[%;D8 _HN\*V%
MIIFG+IUI86>FVEDBQ6UC8A/LMM$IV(D0C1$5MAPZJ/E)(R>M?#W[ '@)/AO^
MSG\/[*9TEU.^TI=?U.XC^>-[W55-U,3GDA"^U1V  R:^_-,@217DR<RLP)&
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MDD\MU.3PQ[FJMNA$$(4,ZB- K':"PVC#$$@@D<D$#FK: A0",')XX[L3VR*
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MS]G5&B*RP3B>!G 8F7RW4$@@;MN.!S7QIX%_:_\ #>G_  XO]3^(.LR0>(?
M'@;PGK>J_:H+@/J]QK/A:SU)KB)(@?M;274-RFR,;T8$$#()\DN/VOI)_C)X
M(U<^*=0T_P ,ZYX.3Q*/#<D5RBW4+^'+C74;R-C!0UB@G8,ZB-@8GVRJ4$U>
M;2]MV]M4VU=O9]-K=-"Z^3<7YG5HUL1.NIX2#5%N%5-\RBWR>[9VY(N35[.2
MYFVV?0'C[]A/X$_$SQ/JOB35/"SZ-XCO;6TM;GQ+H5W+8:QJVG^1';3Z7<;0
M4:REA1$D\L"4I&,R9)8=5X'_ &,O@1\-+'PGH_A_PA:PVO@;Q)<>+-*DEDN&
MN?[=O+"?3VO/.:8R-MM+J>/:[2*69B O-?'/@+_@I+IOB#Q?X07Q#X2U_1_"
M_CZ^M-/\-^-KW1[NSTE(]30R6\WGR2#R(Y+92R32Q*F "#R*W_B/_P %*/AS
MX)\;:YHVF2W7B3PEX4.DV6M^,;+2;^_TNTU+5&E:"QEO8EV/<<994#>6K(7Q
MN6LUU?R^>Z.MY7QE4A.GB8YC5PL*4IRM0Q+AHE&-Y<EM&WO*^[2TN?K+8%(S
M((T"1R>6XW*$;<1M.7  <!54+E<@ Y8YXT2<2!,9&20PZ?=.1CGN.<'K7$_#
MSQ;I_CKPEH/BS3V=[;6]'T_4K<-&Z+Y%Y#YT$B*XX\Q&!QU'&X \#MQR5++A
MLGWP,=CU /&0><YXI'YS*$Z6)Q5.M?VD7.+C*ZE%IVLT]58?W7_>7_T(58JO
MW7_>7_T(58H)(9,1AM@"E@S$@#J .WOGV_7->4_$>"23PGXW2VQ)=OX0UJ5;
M>&%/.N&6UF )E^9RS*!$L0!W8 SG@>KRJS#Y1GY7'4#DXQU/M67+8"62:22
MONB6WVJR!I%+J^[.[[JD\J2,A2-I!H _SV;K]D;XW> _V;?V1/CYJ/BOXO\
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M ! ^$6AV&IV^I7-QXGLM!TN#5[&ZL=.FA$5^T]Q?WGEWRINF5D0QG;D_2/\
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M-Y\1?$%UXGTNU9KG7IS;+:3QP2-+N?SED_TGS$+(\L7ED2'&M_P4._: \9?
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M+^&]7NM/NK_1-(U"\TN87&G3WUA;W5S97 *EY[6656>WF*( 'BV,IP<FNG4
MD_NPQ7Y5!Q@QC.TG..<@9R<^U3%% )6-=W;A1G/7D>V: /#->_9^^%'B7Q?_
M ,)WK?@OP_JOBS[+!8?VQ>6"2WZ65O-//%;M.&5W2*6XD*%\NN]DW>7L1/4(
M],CMXDM[5X8+1(UB6Q6WA%H$C4)&%BC",I5  "KC! ('&*Z+R]IW*H+$\CC"
M@]2.F,=..O?)YIWEKZ'_ +Z;_&@#C+;PAHL$M_/%I^FVTNI-#]IFALX!<74<
M<<49@N)W5VFCG6("17W%E)!)/S&;2?#6G:-%-!96UK:6\T_FR6Z&54+*28Q
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MBM&664*58D, 1BO9UG@D9)(BK&6/<N'P&4MG*X!R"0>>_/X_SQ>(OV%?BO\
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MXSE<].GW@?TJU10!!Y"^H_[Y7_#G\>/TJ55"C'7N3Z]NG3H ./2G44 %%%%
M!1110 4444 %%%% !2%5/)4$^I -+10 W8G]U?\ OD?X4H51T4#Z #^5+10
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M\7:'<OI>GZ5H$&G^*]9EG\46,>DVNG6B1)8/'%:A=D84*:_<G[+'_>?\U_\
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M!&"1QP1CL/;WJSTH 0JI.2JD^I )I-B?W5_[Y'^%.HH 0*HZ #Z #^5+110
M4444 %%%% !1110 4444 %%%% !1110 444AX!^AH B<G=U(^4="1W;T(]*;
MS_>;_OIO\:@E,C+(ZM)NCBWA55<.?F(4';G.1T'//%>:CQKKVZ4?\(QJ+*DT
MB*PMY,,JG 8#S.AY(/IB@#U'G^\W_?3?XT<_WF_[Z;_&O+_^$TU[_H5M2_\
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M]1G]>M.  Z #Z5Y?_P )IKW_ $*VI?\ @/+_ /'*/^$TU[_H5M2_\!Y?_CE
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MC1S_ 'F_[Z;_ !KR_P#X337O^A6U+_P'E_\ CE'_  FFO?\ 0K:E_P" \O\
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M /4.?[S?]]-_C1S_ 'F_[Z;_ !KR_P#X337O^A6U+_P'E_\ CE'_  FFO?\
M0K:E_P" \O\ \<H ]0Y_O-_WTW^-'/\ >;_OIO\ &O+_ /A-->_Z%;4O_ >7
M_P".4?\ "::]_P!"MJ7_ (#R_P#QR@#U#G^\W_?3?XT<_P!YO^^F_P :\O\
M^$TU[_H5M2_\!Y?_ (Y1_P )IKW_ $*VI?\ @/+_ /'* /4.?[S?]]-_C1S_
M 'F_[Z;_ !KR_P#X337O^A6U+_P'E_\ CE'_  FFO?\ 0K:E_P" \O\ \<H
M]0Y_O-_WTW^-& >O/UY_G7E__"::]_T*VI?^ \O_ ,<H_P"$TU[_ *%;4O\
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M^.4?\)IKW_0K:E_X#R__ !R@#U#G^\W_ 'TW^-'/]YO^^F_QKR__ (337O\
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M$5(X>45%TZC]OI?F=I5E4FKVULU=:7:=C^3?X,_\$>?BG^PSXPN/B%I'P_\
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M^8_PH\H?WG_,?X5)GV/Z?XTM $7E#^\_YC_"CRA_>?\ ,?X5+10!%Y0_O/\
MF/\ "CRA_>?\Q_A4F?8G\OZD49/H?T_QH C\H?WG_,?X4>4/[S_F/\*D+8&2
M"!ZG&/T--$B$X##)X% #?*']Y_S'^%'E#^\_YC_"I:3)]#^G^- $?E#^\_YC
M_"CRA_>?\Q_A4F?8_I_C03@$D'@9[9/TP: (_*']Y_S'^%'E#^\_YC_"I <@
M$ \^O4?6FLVTJ-I.XXXQQ]<F@!OE#^\_YC_"CRA_>?\ ,?X5+10!%Y0_O/\
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MZ)<K?6<'A6Z@2_AG>-Y0#;PZA;%HVD;:LR\_-0!^S*7D3Q*^^-2[!5!;AF)
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M@<]:YV6]A6=BKY8G(!/."O8<C&.A!^G2M"WFMY"I=@"#A0<C#;A@>^" .?\
M$B/=M\7_ *3_ )_TCYF&,H3K3PZ5558-QDG&T;IM.S>MKKKJ:M-#J3@,,X)Q
MGL#@_D>M)YD?]X5A7.LVL+RKYC9BNX[5L*3@RQB3 XX!W9)_D,4CJ-\,I (8
M$$9!R.0:7(/0@UG0WL#1Y#L55Y$! !4A)&3@XP1D8XX[4Y[VW!4-*R[LXSE<
M],XQU(].?8=: +^0.IZ\#W/I2%E! ) )Z#N:J/=P (4<,2V -Q/8@D\XXS_D
MXJ=7C?:<@DXQQSD9Q^7/4XH EHHHH **** "BBB@ HHHH 3(YY'&<\],=<^F
M.]43<H]P\#Q':%W"7H&"]2"""=K$*1V)_"K2])?]]_Y"N \;>+-$\"^&=?\
M%WB34DT_0O#]A/K&I74KJL5M:Z>AN)$)X(\\1D!3DO\ ='6@#J&UBS7>X8>1
M$JEI8W 0!V95+,.Q=65?]K<.U/?4K54\V<M#"H\QI9G C"@9R3R.A!_'Z9_
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M>+_$?[-MQI'AK2?[0UM=-MXH=*M[&=Y3ML;A'01C+!EWQJV!@.3SR#7XU?\
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M)$92C+(BJV!7Z$?LR?\ !,SXR?#+]E7XS>!/&?Q,\(>'_CM\7],U>WUKQAX
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MBT+Q3XO\-PRZ98W'PQTC6$95FFO)0+'5X].E6Y@DBM\W$G+HQ.T5]K?M:?\
M!4_X9?LW_LW_  ]_:)\,_#OQ/\6M-^*]VUOX8\/:7=PZ%($MDWZC=:A>WT<I
MM&B:(1+$D<BRB/>I4-R ?F_X^_X(_P#[3'@GQ=XG^-_P/^+G@:7XT7_B?P'X
MD\&6OB#P]KD?A1=%\':&UMK%KJB6KFY2;4=2GL7C\L@O! XV.R\;'PG_ ."(
M'Q.\(?&?]GK]I;QA\7O"7_"R/ ?C7Q;\2?BKING:!J,/AC6/$GBV'Q0EW9:
MD\WVO[&-4UZ"XCGN8B[QQ,VPE@:Y+XT?\%_M8TWP9\"OC?\ "KX-WWB7PAJV
MI:YIGQ1^%XU.+_A)O#QT,Z-+)>V&M&W^QW\(@NKB 6ZV\;>?$6=BK*![K\0/
M^#A/]GC1?#G@J]^&_P *?B5\7O%_BKPHGC2_\':-<:5ICZ!IMG]IO-5%U>:@
M5CGU+0[2RF>XMXXUCD2%BIR<D ^<_AK_ ,$(?VD/@Y\1M2\:>#OVAO!]R/%W
MBWXV7GBNSO-#U@6>EZ%\7/#;Z3;PZ:([@-//;WJ0I*I5$2 M(> 0.KU#_@A)
M\2-2_9)_9L_9TU;]H;2M(UCX$ZEX^NM9UK0],OK>#6KCQEK6KZO&ELCSJ[E(
MM0L48DG)@D_NC'W3+_P6A_9GE\$ZQXOT_3/%\J:?\*K3XEPVUQ!8,VK7-[#<
M!_#L30WJF/5+5@@+^6T 65VVY"D?/WQ1_P"#A3]E3X:?%;1/AQJO@GQZ(XWT
M\>,-<S8)'X'EOM*L;S3KEK4^<VH&_P#[;BMV4.!$$W8SB@#\LOBW_P $PO&_
MQ'_X*=_LJ_"WPY/\3+W1?V?/V>O@A9?%SQU)H[V7@OQ+J?@;5[X7CC4;B9+>
M[N;C3;NVC,;&:4""5<L$&/Z:OVVOV2==_:8B^ :>%?&^E>#6^#?Q(MO&LLES
M933KJ.DKX8U70!:0B&1%\TS:FLAYVXC;@'I^%_\ P6'_ ."J_P 8OV>OC#^S
M?X4^"/Q#\%?"SP;\;/A_X/\ %<_Q!\8>&[OQ%%?Z1XHU/6$T>Z>STJ.VU*&Y
M-G;&XG@,YB&0BC()KP&'_@L7^V=J'[!EU\;]/E^$VO:FO[08^$>F?M"VNF>(
M[;PA=VBW2$B3P;)<OJMG<S /:27$LCVT<S&0+LV@ 'U9=?\ !$C]I;X,W$7Q
M6_9\^-_@S_A?'AGQMXB\0>%(_%&FZG'X?_X1+Q38R:7KL4C64WVJ#4193N8P
M"$=@J,,5S>E_\$9/V\O"NL^&/BWX'_:#^&5A^T#K_ASQCH'Q:U*^T[7WT:33
MO$\L$5Q:^';RVG6YCG;38=,EGBO' N&M1@8AX^Y_VF?V[/VNO@)\(_V0O$\G
MP[^'.M6'QR^/'PL^&'Q!^(%EK=V^FV/ASQX88Y]0T_3]INA?W3J[*N\Q19C!
M3EC7BOQ8_P""I'CWP3_P41\+?LN:S\2/AG\+/ -KX9TW7=.C\1Z#XLU/7O&N
MNZG%J<96VUC3;.YTBS@@A41O!=I%(PV,A9MV #YQ\>_\$.OVE-'^ ?PL^$'A
M'Q_\'/'^H^%]1A34_B/XKT#Q ?%>@VM^VDQR7OA62PMM2G']F2P7=Q#&SQAO
M+17DA!,BY&B?\$#/CY\//CSKU[X?\?\ P@\?_"_XF:D-4\?^)?B#\.[K4?B"
M^K:M+#J-W?P11Z[*VRUU%(OLTMV%E2.,,RK@8^I_V-/^"S^I_$?]HGXN?LP?
M$#P^_C3X@:#\?_'G@#PS!X*1+#1[;PKI?BW4M+TRXU.XU3R[R9X-.MA.C6\*
M;E4+(2V37]*,?FR>3&\;)YEM!*X=HV\MPREH2Z %F !7.2,]L<T ?RF:C_P;
MU>)+[X4_%WX)ZO\ %OPY:>%/B5\:_"OQ;27P[X8U#2I;?2O#&D>,M-U;3G@2
M2^C:6_?Q-IQ@CW#S%MI1M? Q5^'_ /P14_:"7Q3H/P_^-7Q(\&>)_P!GCX ^
M%?&&E?!BSTGPGJ\.K-?_ ! O/#%S<2W5K>W$MK']@GTFX>1K5=Y:8N0N2!_6
M.+*V#!O+R5$2@EF.!"2T8Z_PDDG^]_%G I3#ES(5#-EN3N(^;:#E=A7HJ]0>
M1GK0!_(CXD_X(B_ML?#.P\:?#C]G3XZ_#F/P1^T3\./%?P]^/5]XNT;78Y]-
MTR_77H=-D\/)93$:@T6E:V(2LH 6ZA9.@S7]'O[#7P!U;]EW]F3X0_ 76-<M
MO$^K?#?PI8:!J/B"TT^?3K?5)K:,LMPD-P[R'$;)$6+$@J4(5@<?67E8D,NT
M;RH0GYS\JDD#!3'<Y.,\]:L6T8C5N.K,>K'[QWM]X X+$F@ @\S+[UP 2!V[
M\#[S=.<=,9[YXLT44 %4KG_CWEZ?ZP_^ACK5VJ=S_P >TLB@D!6?8<#+ YSG
MKR1G&>_&.!0!\&?MH_M/:E^S/X5\++X,\"P_%?XB?$?QUI7@[PWX0U?7[+P_
M:1+JRSSZA>W6IWR/':Z3:6=G+(QCBF<;1@'%?-DO[??CSX9?":?XG?M)?!W2
MOASXHB\6W?@CP%X!\*_$F+Q-H'C-U2:6WN;C4I- TRTTU5MHH0F?M4;2LRQR
M,00.1_X*M>(_V;O#?_"C=0_:[\*>-I/A#/\ $-YH/'O@^\$%IX7UFS\(>*KP
MP^)+>TNO[7EL+VUBDMH);!8V2^DMMR["RGXW_P""='P\^$7[6.I_M@>$O#=O
MJGBC]B#5]5\)MX$EUG4M3&LVWB."UAF%UHDNI0'5+6-U9DNV-V06C3:HWN
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M.!WXZ^](H7!VD')Y((/8<9'X?SI2 1@C(/:D"JO08J)*3>CMIWM^@>70KY)
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MA75_'_C3Q3XB\8>*]9LM&OWL--M-<\+:OI;6UE+,S2W,]GJ6HI-Y9*L8TW
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M$'Q(ETVP_9)UK4=4O=.ALYDL]8@GM='DDC?,JB)Y3921LVT@J5!S@U];P_\
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MP^&9=#LO(AD5Y7TW6'\N1-@D>$2>6&&]"5P X;##X8\$^,OVC=(_:G^%VO\
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M44 %%%% !1110 4444 %%%% !364,,'(Y!X]OJ#3J* *\@"\$\8R2V.,$=<
M<8ZC&3TKCO')NT\)>)I[-6ENTT:_CM#;J6F+26\B?(%+98'&W:,[N179RJQ!
M88X4\'.#WP<=CC!]15=P=P*%%4\2H<%7&.?E.1R<XZ'!Y[T ?RJ> /@[XE^+
M?PU^#'@KXD:1\3-1L],^,/BK6]2T_6(-?:V:VFN-5BC6\6:(>9:NGDF(2,5
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MK*6]I9/I'B[4="URZCFABBM?$"W5S#%903(E_#&T&]9&&]NX_9-^&;R^/?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH .E5Y)%) !)&W. #SDGKD 8XXY'?VJ=NA^A_E5%NH_P!Q
M?YG_ !% '*^+-<LO#>@ZWXMU"XECL/"NCZGK6H(H.PVEG9RW%PS+C<WE1PLR
M !F!!(!-?Q]_\$</@AXU_:E_X*,_'K_@J=JL^GW'P^\8^+OB?;_#&WO8KJYO
M9]+T"\N/A[IE]97EQ!Y*1R1:;(=L<BF-2R=!7] 7_!4_]H+_ (9Y_8Q_:#\4
M"*0O??!KXF6=M=0[3)9W[>&;R"QG56(5PES<HQ3(+;2H.:\Y_P""*_PCM/@]
M_P $T_V3_#K0"SU37OA-H7CF[M6$;R13>.(CXIOT>53E_M%[JDM\1C]V93#D
MA 2 ?K?;JW[HKDAV$[.3]XNC;EP<,-I*]>O8'!K2JE"I46OIL(_\< &>V?Z]
M*NT %%%% !1110 4444 %%%% !1110 4444 %%%% !3&ZI]?ZBGTQNJ?7^HI
MK?Y/\F-;_)_DQEP 8F#':,CG&>_' K$UF.-=.O)''[N.WF=L %BHC;=C')XS
MV!R,#.<C:N3B)L8R,=?KW]C6;=XN('@;:RRJT94Y *NI4Y/XXR.!DG'3",'+
MDK4I_P E6G/3?W94Y?\ MI^&'QKL;O\ 9U_X*+?"'XX20";P9\5K<?##4/(Q
M&MEJMY:RRV+W.TX_>XVI)(NP-\N\-Q7[H:=<P7EM;W%NP,<L7F( 0?W>!W!(
M."0,@X/4=J_'?_@KMIT^E_ GPOX]TW%M?^"/BG\/-?BG(W-'%I^KG[: P  6
M6U;RP2>#WK]%/V<_&P\>?"'X>^)HVRVI^$M)O79BH#/=64$Q).<9)8YYSSQB
MF];MZ=5\WMZ'V^?TEC<GP69W<I04:<Y7_DNDVKN\K];WL[/?3Z%AD4Q@\\DD
M':V2,G!/'<5,&#9P>G7@C^8%4X"6B1B,%E!Q^ ']/\]:L1_Q>Y'\J1\:GS)2
M[I/[]26BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2,H88
M.>N>#BEHH 8$"D$%N/4DBGT44 %%%% !1110 4444 %,,:DDY;DY^\:?10!'
MY2^K?]]&G*H7.,\^ISTIU% !1110 4444 %%%% !1110 4444 %%%% !1110
M 44F1ZC\Q2T %%%% !1110 4444 4;R1XT=HX3+($S&N3M+C=@8!QUYZ=OI7
MD<WBSXB)+*L?A83(LCA'VODQ@D*3\V.<'T^E>RRQHRL656(4X) .,9(Z^AYJ
MO']Y_K_)G 'T & .U 'CW_"7?$?_ *%#_P =?_XNC_A+OB/_ -"A_P".O_\
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M QPW3ZK35^\OU/\ Z"U 'C'_  EWQ'_Z%#_QU_\ XNC_ (2[XC_]"A_XZ_\
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M_P"+H_X2[XC_ /0H?^.O_P#%U[;@>@_(48'H/R% 'B7_  EWQ'_Z%#_QU_\
MXNC_ (2[XC_]"A_XZ_\ \77MN!Z#\A1@>@_(4 >)?\)=\1_^A0_\=?\ ^+H_
MX2[XC_\ 0H?^.O\ _%U[;@>@_(48'H/R% 'B7_"7?$?_ *%#_P =?_XNC_A+
MOB/_ -"A_P".O_\ %U[;@>@_(48'H/R% 'B7_"7?$?\ Z%#_ ,=?_P"+H_X2
M[XC_ /0H?^.O_P#%U[;@>@_(48'H/R% 'B7_  EWQ'_Z%#_QU_\ XNC_ (2[
MXC_]"A_XZ_\ \77MN!Z#\A1@>@_(4 >)?\)=\1_^A0_\=?\ ^+H_X2[XC_\
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MQ'_Z%#_QU_\ XNO;<#T'Y"C ]!^0H$>)?\)=\1_^A0_\=?\ ^+H_X2[XC_\
M0H?^.O\ _%U[;@>@_(48'H/R% 'B7_"7?$?_ *%#_P =?_XNC_A+OB/_ -"A
M_P".O_\ %U[;@>@_(48'H/R% 'B7_"7?$?\ Z%#_ ,=?_P"+H_X2[XC_ /0H
M?^.O_P#%U[;@>@_(48'H/R% 'B7_  EWQ'_Z%#_QU_\ XNC_ (2[XC_]"A_X
MZ_\ \77MN!Z#\A1@>@_(4 >)?\)=\1_^A0_\=?\ ^+H_X2[XC_\ 0H?^.O\
M_%U[;@>@_(48'H/R% 'B7_"7?$?_ *%#_P =?_XNC_A+OB/_ -"A_P".O_\
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M 'B7_"7?$?\ Z%#_ ,=?_P"+H_X2[XC_ /0H?^.O_P#%U[;@>@_(48'H/R%
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M#V]:CWO_ +/_ 'R?_BJQ#KD<D"7$:QM;SR!()"TREMBM,Y=3!N3$2,RX!W,
MN1G(\X\=?&_P'\//#2>+/%&M6FD:)/.;>VO;_P"TQ0RR+*D+H3%;3NCB1U5
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MF@#I(U"J",\JO7T X_G3Z:GW%_W5_D*=0 4444 %%%% !1110 4444 %%%%
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M>8?[H_[Z/_Q-'F'^Z/\ OH__ !- $M%1>8?[H_[Z/_Q-'F'^Z/\ OH__ !-
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M68D!0,DD@ <UE/KFFI=I8F9OMC[C]E\I_M"1JI8SR18WI;<;1<,!$9"J;MS
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M]3L3*Z*5.1@ 'UP!4E5K7B"//'&.>.3T'/>K- !1110 4444 %%%% !1110
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M-K9/!-.75M/DF,$5S')(%D9]AW)'Y;QHR2R#*QR%I%"1N0S_ #;1\IK^+O\
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M $5_+[XJ^.W[?X_9P\'_ +6WA?XY6UIIWB_XZ:;I3>!KZU\)#2X_A9<^+O\
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M*,CU'YBK&!Z#\A1@>@_(4 5\CU'YBD)!Z$=1W]Q5G ]!^0HP/0?D* %HHHH
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M2<\GK0![Y >$;C)*J8Q@A>"<Y'!Q@'IQCMVN4@51T4#Z "EH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBHI,Y7DCANA(_N^A% #+O=Y#;%W-E<+Z
MDD50G>?RU*PY*CD'H#MQWZC/!QQCZU?<GR1R<[P,Y.?OGOUJO(240%FP4YY.
M>=G/UY-5&7+;2]G<F4G&UEJ]O6^FGK8_GY_X+&?L4ZE\2=&/[1/ACQ"+'4_A
MGIHO=6TZY@98)M$5S]L(=&!_B^Z00<9->:?\$7_V;=1^R^)_C[KU]I<^E>*9
MK/1/#T%O#YCA],_>2/EL[-SRK]T<G)STS^IO_!2?6XK/]C3XZ:BA)63P>(6
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M]]YG]L:=/=3PPK<)?G3HT6)XHO,%MN_=Y!P #_0-L7YAM&&(+#L2  "1TX
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MR(MVX( <=OE ]P!@ ]LCDC@T[RT]#_WTW^-/HH **** "BBB@ HHHH ****
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M[Z;_ !H\M?0_]]-_C3Z* &>6OH?^^F_QH\M?0_\ ?3?XT^B@!GEKZ'_OIO\
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M_P * .VP_J_^?PHP_J_^?PKB?^$8UK_H:-3_ ._-O_A1_P (QK7_ $-&I_\
M?FW_ ,* .VP_J_\ G\*,/ZO_ )_"N)_X1C6O^AHU/_OS;_X4?\(QK7_0T:G_
M -^;?_"@#ML/ZO\ Y_"C#^K_ .?PKB?^$8UK_H:-3_[\V_\ A1_PC&M?]#1J
M?_?FW_PH [;#^K_Y_"C#^K_Y_"N)_P"$8UK_ *&C4_\ OS;_ .%'_",:U_T-
M&I_]^;?_  H [;#^K_Y_"C#^K_Y_"N)_X1C6O^AHU/\ [\V_^%'_  C&M?\
M0T:G_P!^;?\ PH [;#^K_P"?PHP_J_\ G\*XG_A&-:_Z&C4_^_-O_A1_PC&M
M?]#1J?\ WYM_\* .VP_J_P#G\*,/ZO\ Y_"N)_X1C6O^AHU/_OS;_P"%'_",
M:U_T-&I_]^;?_"@#ML/ZO_G\*,/ZO_G\*XG_ (1C6O\ H:-3_P"_-O\ X4?\
M(QK7_0T:G_WYM_\ "@#ML/ZO_G\*,/ZO_G\*XG_A&-:_Z&C4_P#OS;_X4?\
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M;?\ PH [;#^K_P"?PHP_J_\ G\*XG_A&-:_Z&C4_^_-O_A1_PC&M?]#1J?\
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M?\(QK7_0T:G_ -^;?_"@#ML/ZO\ Y_"C#^K_ .?PKB?^$8UK_H:-3_[\V_\
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MK_H:-3_[\V_^%'_",:U_T-&I_P#?FW_PH [;#^K_ .?PIK%D4L3)@>@)Z\=
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MM+=.M]NQ[O"^"Q^)S[#++:+Q,Y5\*YT[.24E7A)M1U2:4)-NRLHW;2>O8?\
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M^(=,^'=MX6TKRM=O/%6L63R>*M8U>.+3[.&.T@OYI;!K34;F+9]NR84.UF#
MU]9_LX_L>:3^SM^S>WP*L]9N/&-I9C4;C39_&>?$C1W4\TEW8S745ZWEW+6%
MT8KF(^6KF2)&W]37RM\6O^";<_C#1/!;>&=;LHO$M\=2M_'U[KNFS7MI(-3A
M=QJ6DV4%U;+I6HZ=>^5>:<ZL]O#/%$7A>-=A /L[]J7Q9K/A_P#9^\8:_P"$
M[R.*\M+./4-/NVD\^"_5P[*EA=6LO$FV,L,\888SG-?FQ^R!_P %0=4FTG0O
MAS\9OASXJT+Q5=?#C0?&'@5I'EUB_P#'=A>ZUXETF]O##:17$UDB7VCI$C7
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M>';G6?$>N:]''"?M,VFR);645H9+<-/<AWGC,>QOC#P)_P $EOB\?B=^SO\
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M),Y +']2/B+^T!+\0/V&/B[\:/!H_LN^?X'>,/%&EQ0SAM1T?5XO"]QJ5M!
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MWP+ILNLM\56\13:79?V=J-_/=%)ETVVELU!C@:WF0'G:&&: /ZH9?^"NG[
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MIRI(!)&#@UJ'D'Z&LS4[>:?3Y(HD\V8["J[E!XD5CAG(' '3/.,#- 'Y)_\
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M"6EZ%=^ ]/M;UM4M+[X;:A8!O"^I&2-%A^UZG:6\MQ*A99X_-198PR\_B_\
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MT.#Z#U -"(;8T'/"@<G)Z=SW^M/I!T'0<#@=/P]O2EH **** "BBB@ HHHH
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M%QY;W4KQEIY=_(=W7_>7_P!"%6*K]U_WE_\ 0A5B@ JD\/[YI%$NXXY4C;T
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M]K?4YM"UZRN-(^'F@>)]"\2W5O=V=])K6A:)>WTDZ7K)#(\\LMI#%<NDF^0
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M?,WPO_9\^#UJ[OJ/Q+_:$^&VDQ:>A#1W<-SXA,H2:$'YU98"V[:2K ,/F&0
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M.J*$DH,G/+?EGBI:BUM.VA\Y9K1[K1^JW"BBB@ HHHH **** "BBB@ HHHH
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M_P"RK0!)1110 4444 %%%% !1110 4444 %%%% !1110 5')V_'^E24QP25
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M ]/7I_.@!]%1^:OHW_?)J(2$JS"56"'#E2O!';E /S/'/IR 6:*8&X'!/ Y
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MWK$ZOG))+,,YY&3D'J1GTYSGFI9H+>5QYBC< "#TX^88)(( Z]QGMS5JH9"
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MK]N9?@U\:/BAK7Q;\'_%KP%/XZ\#7<OB-+_3+;3C'K5VK;9YMT1,-O 0H .
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MU/4-*T=-2\*NNM:_KWAO2Y)46]2:/[;J]NBHCMSMH _LBM[TOYJNT:L N%.
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M6&[3&:$10Q'R95 (&20#^D#]E#_@CS^S%^R7\2_"_P 4_ MKXBG\;>%M+O\
M1M%U"^U3[19MI$L#6\5M-;E6$'FQ7$X0!@BE>@Q@]9XT_P"">/['WQ/\?_$=
M+VYN3XWU?XF>'/B]XY\/V6MV\E_9ZO:>%;OPCI3B J[VT$]C+*Y+$LQQ\RJ=
MI_F8^'/_  <%_MR^'+N7Q%X_\+>'=9\+?&R"SD^%"ZAH4OA6+P6]\UQ'IEK<
MZMG5(-8M8#J-J\@:SM[J<6^#<*&K]7/^"7^O?M$_\/*_V\HOVF?&FC^,/%T?
MPK^#WBG2X_#L$MEX4BTG6K&XG@CL8'FDC:>S"LD\HB4RR2DOPJ@ 'VC\:O\
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M.(D (P2"V_EF.&]LG@#L!P/2H#!&_GJ00"C(=K,I(D!W'((.[@8;.5YQC)H
M^#-0_81^!_B'X>_$/P)!:Z[8^&OBU-HLOBM//C,LDGAR>XFA 9D_=QO),Q)
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MF]2K$@!\;< X"G.!CC@?%7PI\'>.Q:R^-/!7A;Q9=:7=-+HRZWI]M<QZ?!E
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MG?6^EM6=@9HB"-Z<@_\ +1/_ (JK:NF!\Z]!_$/3ZUPO_"7^&_\ G_L/T_\
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M\_MK^:?_ !5'_">>&_\ G]M?S3_XJ@#N-Z?WE_[Z'^-&]/[R_P#?0_QKA_\
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M_O+_ -]#_&C>G]Y?^^A_C7#_ /">>&_^?VU_-/\ XJC_ (3SPW_S^VOYI_\
M%4 =QO3^\O\ WT/\:-Z?WE_[Z'^-</\ \)YX;_Y_;7\T_P#BJ/\ A//#?_/[
M:_FG_P 50!W&]/[R_P#?0_QHWI_>7_OH?XUP_P#PGGAO_G]M?S3_ .*H_P"$
M\\-_\_MK^:?_ !5 '<;T_O+_ -]#_&C>G]Y?^^A_C7#_ /">>&_^?VU_-/\
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M ( I_P#&JVL#T'Y"C ]!^0H Q?LVG?\ /J/_  !3_P"-4?9M._Y]1_X I_\
M&JVL#T'Y"C ]!^0H Q?LVG?\^H_\ 4_^-4?9M._Y]1_X I_\:K:P/0?D*,#T
M'Y"@#%^S:=_SZC_P!3_XU1]FT[_GU'_@"G_QJMK ]!^0HP/0?D* ,7[-IW_/
MJ/\ P!3_ .-4?9M._P"?4?\ @"G_ ,:K:P/0?D*,#T'Y"@#%^S:=_P ^H_\
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MC[-IW_/J/_ %/_C5;6!Z#\A1@>@_(4 8OV;3O^?4?^ *?_&J/LVG?\^H_P#
M%/\ XU6U@>@_(48'H/R% &+]FT[_ )]1_P" *?\ QJC[-IW_ #ZC_P  4_\
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MI*MM14[Y.!DY( [\X(Z<U!]NE#.)87@4%E5G56#%2N&0)(SNK9P/E5LD C)
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M^ O$?A55\,?\)E#J6NZIH6L:S;6\FJ_9;GP[;26J1Z?%/.R?9YXG 8&0*-U
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M$^<?*,LP4[/ACX[?#CQ1I7AW5=.\4:=#'XJ4SZ%9ZK(UC>WT2<,]O;7@BGW
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MK.%D4QD$!-QY QNXK^7/7?[7^*%W^Q5X>US6?&.I6>K^'9M0UQX;W4@J7_\
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MRX31HM.U2>RGMKV_ABM-7U2QN]2@M1=,8H[E4:.$@1)^D3VD+@87:1WP<GC
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MQVRR2N2I(!_K5CT^WB5,1."JN,ALG#]> ^3[]_QI$TRUB,+I%DP*$4%6Z<]
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MC1[Y$3<H))!R2O\ JY< @<G9QZBMXKM(Y!R#T&,8(SW/7/MT[]J%^LK1((B
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M:/[@^K?^A&LCX<B>$DY!/0#D@="3_</K5:XMB4&YU"B2-CGYB0KJ_P N%7#
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MQ?WQ^O\ A1Y\7]\?K_A0 TV\+,7*_.R%-P)#!2,?*V<J?0@Y!YI1!$O(7#%
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MPH\^+^^/U_PH EHJ+SXO[X_7_"E,B[=RD'T&<>G;&> <GB@"2BD'(!]0*6@
MHHHH *#P"?2BD/0_0T 4;I))XY!#(8F:,JI*@X.#@GD\<^F1_/S0>%_' >4P
M:_9(K2,P5HW<A2?E_@&#USR>:]1 8 #8W '8?XU)&""Q((X7K[;O\: /*_\
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MB@#R;_A&/'__ $,5A_WX?_"C_A&/'_\ T,5A_P!^'_PKUFB@#R;_ (1CQ_\
M]#%8?]^'_P */^$8\?\ _0Q6'_?A_P#"O6:* /)O^$8\?_\ 0Q6'_?A_\*/^
M$8\?_P#0Q6'_ 'X?_"O6,CGD<9SSTQUSZ8[U$+B LR"5"R_>7<,C..OIU% '
MEG_",>/_ /H8K#_OP_\ A2?\(UX^R1_PD5AD=O(?V]O<?G7J_F1_WTZX^\.O
M/'7V-0//#"TDLLJ)&F [LP 4ML50Q[;B,#UX]: /,/\ A&/'_P#T,5A_WX?_
M  H_X1CQ_P#]#%8?]^'_ ,*]5\Z+<%\Q-Q&X#<,E>.>O3D<^] EB) $B$L-P
M&X<KZ_2@#RC_ (1OQ[_T,=A_X#R?_$U%_8'CLF14\16+O&0&46[YRPR.H Z5
MZH)(]A;>NU1\S9&U0!R2?3BOGSXW_M,_ S]GC3['5_B]\3O!W@.'6&E31QXA
MUZRTA]26W,8N6M_M+[YQ \D:R%5.PR1KWH [)?#OCUL#_A(K $@':;=\C/&#
MQZTX^&O'P.#XBL,C_IWD^OI7)_"3]IGX#_&?0[GQ)\-_BOX&\7:;926T.I7&
MB>(K#45T^>Y5GMX;MH7!A>9(W:,2*N\(Q!X./6K#QGX2U?4=0TO2_$>CW^I:
M;<K::A86M]#-=6=R;:*Z$-Q"C%HW-M)'. PP8G5LX(H Y'_A&_'O_0Q6'_@/
M)_\ $T?\(WX]_P"ABL/_  'D_P#B:]-^T0?/^]C_ ':AI/F'[M3G#,<X"_*W
M()S@XZ4JSPN<+(C';O # DITW?[N>,^M 'F/_"-^/?\ H8K#_P !Y/\ XFC_
M (1OQ[_T,5A_X#R?_$ULZS\3_AWX=\2:5X/UWQIX=TGQ3KL<<NC:!?:G;V^J
M:I%-*8(I+*T=A+.DDX,2%%.9 5'(K0NO'/@VQ\367@R\\3:+;>+-2M7O;#P[
M-?0IJUW:QB1GG@LRWF21JL4A+*" $;T- '+CPSX^/(\16![?ZA_\*7_A&/'_
M /T,5A_WX?\ PKT::\@@*"2XBB$A5$#NPWR/N*JN"!N<*2N>N#D\5S5QX\\(
MVFOZ;X5N?%&BP>)-9MYKO2=#FOTCU/4;6!BDT]G:O())HXF5E=E&%*D&@#G3
MX9\? 9/B*P _ZX/]/2D_X1OQ[_T,5A_X#R?_ !->CK>P,\<9N(F:4R"-0YS(
MT1(<("Q#%&4AO0@^AP\WMH',9N8?,6,RLF\;EB5BC2$==@<%"?[W% 'FO_"-
M^/?^ABL/_ >3_P")H_X1OQ[_ -#%8?\ @/)_\37I<MU;0A&FFCB60H$+L ',
MC!(POKO9E5?4D"F0W]C<@&WNX)@7:,&-PV9$&70=MRC!(.."* /-_P#A&_'O
M_0Q6'_@/)_\ $T?\(WX]_P"ABL/_  'D_P#B:]"U#6-+TFQOM2U/4+2PT_3+
M22^U"\NIDBMK*SA1WEN;B5CMBAC5'+.Q  5O2J^B^(M"\1Z3::]H.K6.KZ+?
M6XN[/5+"X2XLKFV89$\,Z$J\1_O#COTYH X7_A&_'O\ T,5A_P" \G_Q-'_"
M-^/?^ABL/_ >3_XFO2(;^RN2ZV]U#,T<K0.(W#%)DQOB;L'7<NY2<C</6HQJ
MNF-??V8NH6;:CY+W'V$3Q_:Q!&P1Y3!GS!&CLJLVW 9@,\T >=_\(WX]_P"A
MCL/_  'D_P#B:BDT'QU$&,GB.Q4("2?L\A&!WX!KU);B"0'RYHW(SD*PRO;G
M.,<]^G%>(?&W]H;X1?L^^'%\2?%KQYX5\$Z4[I"DOB#6+/3(;F9E9E@B:Y;+
MR,B,P4 Y521G' !NQZ%XYE573Q)8%64,I^S2\@]/X>M.7P]X[?=M\1V!VMM;
M_1Y!@X!_N^A%<U\%_P!HSX.?'S29M3^$WQ#\*>+HK=4-VGA[6;+5)+%V"%K:
MZBMV+0RQB1 ZLH"EUSC(%>WP7EK(C.ES!*(W>.5XV 598O\ 6*W3#)D!\9Q[
M 4 ><?\ "-^/?^ABL/\ P'D_^)H_X1OQ[_T,5A_X#R?_ !->E+>VC&$+<1$W
M"EX '&94"ARZ>JA"')XPIS[4P:A8EI$6[@+PM&DJ"0;HVE"&(,#C;Y@="N>H
M=?6@#SC_ (1OQ[_T,5A_X#R?_$T?\(WX]_Z&*P_\!Y/_ (FO35N('9D2:-G1
M=[JKJQ1.<,V"< X/OZ@4Q;RT92XN82@^\WF+A<L4&[G(RZLH)&-RD9XH \N.
MA^. Q0^)+#<"1C[/)G(./3I4R^'/'CC*^([ CG_E@^>,YXQ[&O0)[BR1GDDN
M$@\A09+IVC\B( ;]KN2%&Q2"2QS@@GTKYK\(?MD_LU^.?B/?_#+PK\8_AQKO
MC+3[Q["?2-+\5Z?=:@+^)C%+:?8D?<;F.8-&\498AU(ZXH ]37P]X[8L!XCL
M"5Z_Z/)WS_L^U._X1OQ[_P!#%8?^ \G_ ,371^'?'G@[Q7)JJ^'?%&@:XVC7
MTNF:HNDW\%T]AJ$#;9[2]6)F,-Q$2JLC@,I;GVZ9+VT=WC2XB=XY?)=0XRDQ
MB6<1$$C#F%UE _N,">M 'FW_  C?CW_H8K#_ ,!Y/_B:/^$;\>_]#%8?^ \G
M_P 378V_B[PO=ZQJOA^UU_2Y]<T-;%]8TJ*[B>^TQ-3!.GM>6ZDR0"] )MRX
M DQ\M;$=]9RY$=U Y61H6"N"1*A8/'_OKM;(']UO2@#S;_A&_'O_ $,5A_X#
MR?\ Q-*/#/CXC(\16!'_ %P?Z>E=YJ^O:)H%I]NUS5;#2;+S8H/M5_<Q6T!F
MG;9#%YDC!=\K?+&N<L> *F74K1X$NXKRW:SF5'AN%EW0RK(H=&1U?!#@[E('
M(YSS0!Y]_P (QX__ .ABL/\ OP_^%(?#/CX=?$5@.W^H?_"NOUWQ5H'ABQDU
M/Q'KFG:)80LBRW>I7/V:"-I"H16D=]H+%TP">=Z]S6C!J=A=VD=]'=V]S831
M">&ZBE9H9(R 5E23<04*MU'7(H \^'AKQ\3@>(K#)_Z=Y/KZ4U_#OCR/&_Q'
M8#/3]Q)_A6WX[^(G@'X9>'KKQ5X]\5Z%X*\/V8!N-<\0ZE%INFVY*/(/-N9V
M$:9BCD< ]51CVKSCX>_M-? SXM:E>Z1\,OBY\//B!J6F:?#JVH6/AKQ%9ZM>
M66E71)@U&XAMV+QV<FT[)B-C8XY&* .N_P"$;\>_]#%8?^ \G_Q-'_"-^/?^
MABL/_ >3_P")KTN.ZMY%#)-&R[B@8.""X8H5]=P<%#D#Y@12R7-O$H>2>)%+
M1J&9U +3,$B7D]9&953U)'- 'F@\,^/CR/$5@>W^H?\ PH/AKQ\.OB*P&?\
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M2/6@#A/^$;\>_P#0QV'''_'O)V_"C_A&_'O3_A([#/IY$G^%>CM?V:)&TEU
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M_P#H8K#_ +\/_A7K-% 'DW_",>/_ /H8K#_OP_\ A1_PC'C_ /Z&*P_[\/\
MX5ZS10!Y-_PC'C__ *&*P_[\/_A1_P (QX__ .ABL/\ OP_^%>LT4 >3?\(Q
MX_\ ^ABL/^_#_P"%'_",>/\ _H8K#_OP_P#A7K-% 'DW_",>/_\ H8K#_OP_
M^%'_  C'C_\ Z&*P_P"_#_X5ZS10!Y-_PC'C_P#Z&*P_[\/_ (4?\(QX_P#^
MABL/^_#_ .%>LT4 >5P>'/',<T4EQKUC+ DB/-$L+@R1*P+H#M."R@J#CC.:
M]!L8ID4+/M.1G@DY.,]P#Q]1WR*TB,@CU!'YU X90<*6/&-N?S]01C/Y8/H
M6.E%(N<#/7 S]<<TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 1+TE_WW_D*\T^(WQ"\._"WP-XK\
M?^+KA[;PWX7T^XU'5)X8FEECMH4#R,$*LCD Y& 1ZY(->DSLJQDR*S*-W"#)
MQZ<GJ1W'IVKGY;:WNHW%P=]E)D&SEA$L9&-I$D;AHV5V!)#*1@\^H /Q%N?^
M"\O_  3YL([N\?QIK+I:B[WP-H]J%>6W#KN<) LORR*%RISEN>M?S!?M._\
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MW'C'7?'%E#:>)?B#J>GQ?\)%J44%O=V]C+-]H$]SMA-U=$++<L 3Q7T7\/\
M]DSP9\.O#.J>'=/O+B[BU7P;<^!]8FGM8UO+RWN--%H98!_&BPK&P#,R[4-
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MO^--<^*'BKQ]HUYX=\2^._$&GQIK4NCK>VUW;Z7$MV]U<&&&UL;:")6N3&R
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M^&.DZ+I4OBOP_P"'WL]2\2Z?HULT5PNH7/[@BVE9O->W,THD+L!EB,S?%/\
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MF_X*C?"SQ;\'_#&O?$W7?)\;3!HM0W:?<A1<1R!6V^4A3:,\8./Y5]Q? ?\
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MO4;G3K[1_'%AK/AZ#7?"%QI]XSRFUTS4-/EL+>S>1X(88ECB8)C/[O?M[?\
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M3HDTCPSINKW<M])IF@R.)T-O:"[GAA,44"'+C:N37>_"W_@EG\*?AE\>]?\
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M^-O%NE_$OQ1X+M_&_B_5?B!K&B:1'&(+G4KRX0S[F@G@C<2;""S*SMO).>:
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>image_046.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_046.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &Z <<# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX4"QJJJ!@ #I2L:^[#S9SFG>$K:-Q=:C(]]=]2\QRH^@[5T21K&H5% 4<<#
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M!KJ$.[H<TS.47'<DHI*!00+1110 4444 %%%% !1110 4444 %%%% !110:
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M6) QSD]*6J.L%ET>\9 =PA8C'7I0..KL9;ZK<WTI^SW=O90!B%DEP6DQW /
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M 8^E=&>:*+%^VGW,S2=$ATGSF222268@R22MECCI6G113,W)MW84HZTE*.M
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M2/C&UL@GCTXJL^LWTC1.TJCR6+(%4  D8/ ]:CBU.[AG6=)MLBIY8(4#"^E
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MZY[&NM0[EW ]:HZQHUKJ]FUO<)G/W6'!4^H-<W;:K?>%YUL]6!EL@=L5XHX
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %(1FEHH ;BC;WIU% #=OM2;*?10 S;[57N[6.ZM98)(U:.0%64]Q5NF
MF@$VMCQ[5/!>M:?>R"QAEE@8Y0Q-@X]#4\'A77-<OH'U*![>*-54E^X'M7K)
M%-_BJ>1;GIO,:DHVY5?:Y%;6J6]ND"( B* !CH!4P3'&!CZ4\4M4>8VV[L3;
M28]J=10 W'M2@4M% "8YZTM%% !1110 4444 %%%% !1110 4444 %%%% !1
1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>image_047.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_047.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &) LT# 2(  A$! Q$!_\0
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X'\1_\
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M9[^3S;E_,9O,;).<$D#ECTQUH \_^*LB6OC/P+=SL([:*_S)*QPJ@/&3D]N
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M0SM=I&<)GKM#$@5I:QX<TG7Y;.74[3SWLI/-MSYC+L;CGY2,]!US0!P&I_\
M)Q>C?]@UO_09:=XRG?5_B79^'K[7;G2-)73S<DP7 A,LA8C&X\'@?H:[V7PY
MI,WB*'Q!):9U2&/RHY_,;A<$8VYV_P 1[=ZK>(O!N@^*V@;6+ 7#P9$;AV1@
M#U&5(R* ///@]%;P>,/&,-I<O=6R2HL<[OO:10\F&+=\^M7?A'_R,7CC_L(_
M^SRUW6B>$]#\.7%U/I%@MK)=8\[:[$-C., D@=3TQ4ND>'-)T*XOKC3;3R);
MZ3S;EO,9M[9)S\Q./O'ICK0!Q?QD81Z-H4SD+''J\+.QZ*,-R:]#M;NVOK9+
MFSN(KB!\[987#JV#@X(X/((J#5M(L-=TZ73]3MDN+67&Z-LCIT((Y!]Q2:-H
M]CH&E0Z9IL)AM(=WEQERV,L6/))/4F@"]1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 $ C!&12*JHNU5"CT Q2T4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1163>^(;.QUB#2WBNI;F55<^3 SK&K$J"[#A02#U]* -:B
MLRQ\0Z7?Z7'J,=Y#' Z*Q\V15,>X9 ;G@^U67U*P3=OO;9=J;VS*HPO')YZ<
MCGW% %JBLJ'Q%IL^M2Z4LX%PD4<JL67;('SC8<_,?E-%[XBTVR2)O/6?S+J.
MTQ RN4=S@;N>!0!JT5F1:_ILMU>0"ZC LU1IIBZ^6-Y8 ;L]<J<_A5F74]/@
M)$U];1D*'.^51A3CGD].1S[T 6J*R=4\0V6E2VL<Q9_M*2RJ8\$!(T+LWTQ@
M?4BJ\/C'1I].-^D[?9Q:->,Q7[J*=K _[0/&* -ZBN=_X3722FFF,7<KZBI>
M&.*W9V50=K%P/N@$X.:?IGC#3-5U'[%"EW%(QD$3SV[)'-L.&V,>&Q@T ;]%
M<[_PF^BG28]122>2.6<V\44<+-+*X[*@Y/'/T(-6K'Q+8:C)8"V\PK>B78S+
MM*/&1N1@>0W)X_V30!L4444 %%%% !1166GB#3I-<DT=)7:\C&7 B;8OR[L%
M\;<X(.,T :E%9.I^)--TI[-9Y6<W<A2+R5W].K''11W-2V6N:?J,YBM;A9/W
M,4RMT#K)NVX]3\C<4 :-%1?:K?:6\^+:IP3O'!]*AAU*UGO9[5)/WD&S=GH=
MX)7![\ T 6Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ.*XA
MF+"*:.0KU",#B@"2BBB@ HHJ-;B%Y6B2:-I%ZH&!(_"@"2BBJYO[,79M3=P"
MX7:3$9!O&[...O.#CZ4 6**** "BBB@ HHHH **** "BBB@ HHHH **JZCJ%
MMI6G3WUVY2WA7<[*I8@?0<FH-,US3]7L_M5K.?+\PQ$2H8V#C^$JP!!Y% &C
M152?4[&VFABFNHDDFD\J-2W)?!./_'3^5-N=5M+66UC>3<US<?9DV?-A]K-@
M^G"F@"[140N8#C$\9W=/G'/./YTHN(6"$31D.<)AA\Q]O6@"2BHQ/"=V)8_E
MX;YAQVYIR.DB!T964]"IR#0 ZBBB@ HHHH **KW>H65@%-Y=V]N'SM\Z0)NQ
MUQDU-'+'-$DL3K)&X#*ZG(8'H0>] #J*** "BBB@ HHHH **** "BH+R[M["
MSFN[J58K>%"\CMT51U-<[_PG^BC3[F[8749@\L^1-"8I)!(<(RA\9!/?IQ0!
MU-%<_IGC#3M6NYX;99!% TB/<2/&$RF,X^;)'/7';Z5K)J=A(T2I?6S-*I:,
M"53O ZD<\CB@"U156+4K&=T2&]MI'DSL5)5);'7&#SBK5 !1110 5S^L^&!K
M&L65^;L0?92K#RX0)3@Y*^9G.T]"N#7044 <*WPT@%NT4&I20!K>"!_+B"[O
M+##)P0<G=Z]NXR*<?AK:'1A8F^D\Q?L^R<1X8>2, '!R0>N,BNGU:35XX8SI
M$%G+(6^<74C( /; /-9/VCQM_P! _1/_  )D_P#B:#>%!SC?F2]78HV_PZLX
M)5D%VVY1;A2(^5\J0N<$DD;MV.O'O20?#N&);4-J)/V5K?RMENJ92)BP#8/S
M,<_>_2K_ -H\;?\ 0/T3_P "9/\ XFH(]3\92WD]JNG:-YD*HS9N9,8;.,?+
M_LFG8OZJ_P">/_@2_P BHGPWA339+/\ M)^?L_ENL(3'D[PN[:06)#\G(.1F
MK$OP_M6T][6*Y$;&*"))3&2T8B!P5.X,,[L]>,=ZM?:/&W_0/T3_ ,"9/_B:
M/M'C;_H'Z)_X$R?_ !-%@^JO^>/_ ($O\B+5O"]Q=7>CB*5I(H;.>PN)6QN"
MR1 "3'&3N4<#UJ.X^']I//*5O)8K:>.-)X(U #[65F(/;<47/X^M6?M'C;_H
M'Z)_X$R?_$UTD1D,*&4*)-HWA3D ]\>U(SJ4G3ZI^CN<C)X"5D2%-2<01W+7
M$;/"&GB+$,VR7.5);<<_[72D?P+-)9?9&UN588C.UOY< 5HS-NW$G/)VNP'3
MKGM7944&)QJ?#Z"TNH;G3]3N8)+:59K?S )0C>7Y;9SU!4*,<8V]:31_#6IZ
M?K-K]I\F6"*[NKQKI&PTKRC W)V/S-TX^4>M=G10 4444 %%%% !7(ZMX+EU
M75+RZ^WQ6L=S$T;BW@97ERFT"4[]K@=?N@\ 9K4UC6=0TVY2*TT&[U!&3<9(
M750IR>.3_G-9W_"4ZU_T)VI?]_8_\:=CIAA:LXJ2M;UC_F06G@&!+Q+J[:RD
M;S)9&AALQ'$-T:H-JDG;C;D]<DU6B^';HUENO;/%O#;0EUL<2 0R,X*-O^0M
MD;NN>36@?%6M 9_X0[4O^_L?^-1P>,-6N;>*XA\(ZB\4J!T82Q\J1D'K18OZ
ME6\O_ H__)%+2_APMG.&N[RVNH_/AE>+[)M1_+60<J6(R?,!X 'R]*L:5X!_
MLO5+*_74=[VH5%C,7R% K*>,\-AAAATP1R#5G_A*=:_Z$[4O^_L?^-'_  E.
MM?\ 0G:E_P!_8_\ &BP?4JWE_P"!1_\ DCJZ*HZ3?7.H67GW6GS6$FXCR9F!
M;'KQ5ZD<LHN+<7T"BBB@D**** "BBB@ HHHH **** "BBB@ HHHH *\LM/#7
MB"P\,&UL=-OH-1$JLSK=PQI)C?QNC=7V9(SDYZ=<$5Z#J][J=FD1TW2?[1+$
M[Q]I6+9Z?>ZYK+_MOQ3_ -"?_P"5.+_"G8Z(8><X\R:^<DOS9RUYX=\60^8F
MGK>11O>3S2^3J!R^\ HRYD7A3N!!//4AJM7FC^-6DU*&*[N&MXFWVCBZVO,)
M'C:1.&!&T*ZKDC&[@CJ-_P#MOQ3_ -"?_P"5.+_"C^V_%/\ T)__ )4XO\*+
M%_5*G>/_ (%'_,R-)TSQ3;ZSH\EP;V2VC5UN?M-YE54M(1\JR'<^"@RV_C'(
M(YCG\+ZQ;P:S=V:R_;+N_=ECBDCB;R6<'<LB[7S@?=+X]JTKGQ3XAM)+:.;P
MD5:XE\J(?VC&<M@G'3C@&K/]M^*?^A/_ /*G%_A18/JE3O'_ ,"C_F<W::!X
MQDM].-]=WXFC:VCGV:@0#'F7SB<-R<&/GKZ<YI8/#7B:YO(!?O<^4JVZF7[4
M"RE3,&8'=G< R<]3^%='_;?BG_H3_P#RIQ?X4?VWXI_Z$_\ \J<7^%%@^J5.
M\?\ P*/^9'X#N-5O]'FO]7:3SI9?*12QV[(P$W 'IN8,WXBNJKF?[;\4_P#0
MG_\ E3B_PK<TZ>[N;*.6]L_L=PV=T'FB3;SQ\PX/'-(SJ4)4U=M?)I_DRU11
M108!1110 4444 %%%% !1110!FZ_I1UO0KO35F$)N$VB0KN"\@] 1Z>HKC[K
MX9R75NJOJD.[S)79#;NT0$@0':#(6#?)G)8_>->A5S^I:_J=E?R6]OX:O;R)
M<8GBD0*V1G@$Y]J#2G2E4=H_FE^;13;P/;[(G1[<72:D]\T[6P9G#%_D)SG(
M#\'/!4'':L[2OAN=-6)3J$3^7,C@BW*[U6.5,,-Y!)\W.1CI[\:7_"4ZU_T)
MVI?]_8_\:BN?&6J6EO)<3^$=1CBC&YF,L? _.G8Z/J5;R_\  H__ "1G+\,8
MVMTBN+RWD"6S01K]D^6/,H<%<L3P 5Y)//6G7'PU:21/(U**&%+Y[M(UM?\
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M#!(;5IB+UCY7EN2R@'[V01GD#@^PK4_X6=X?! VW^3T'V5J7_A9N@?W-0_\
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MH64L0556 'WNX/ZFDD^(9B ,GA3Q$@+!06L\9). .O4FG?\ "?2_]"CXD_\
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MHW_/>;_P&D_^)H W**P_^$OT;_GO-_X#2?\ Q-'_  E^B_\ /Q-_X#2?_$T
M;E%8?_"7Z+_S\2_^ TG_ ,31_P )?HO_ #\2_P#@/)_\30!N45A_\)?HO_/Q
M+_X#R?\ Q-'_  EVB_\ /S+_ . \G_Q- &Y16'_PEVB_\_,G_@/)_P#$T?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(5E:RW,T?AL11+N8CSCQ^=3>9\1_^>7AK\YO\:WO$G_(MZA_UQ:M2BX?7/\
MIW#_ ,!_^V.-\SXC_P#/+PU^<W^-,V?$'S_/^R^%_.V[?,Q+NQZ9STK3E;7E
MUJ80*3:M,J[G4$*GR9(YZ_?_ "YSQ22W>N2VTRK9NCEI!'P.5\L;02#P=YQD
M=@>>A)</KG_3N'_@/_VQ0\SXC_\ /+PU^<W^-'F?$?\ YY>&OSF_QKH=$6]7
M3V%_O\_SYB-YR=GF-L_\=VUHT7#ZY_T[A_X#_P#;'&^9\1_^>7AK\YO\:GLG
M\>F^@%[%H M=X\XPF7?LSSMR<9Q75T47$\7=6]G#_P !_P""%%%%(X@HHHH
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MNI?^ QK4HH R_P"VQ_T#=2_\!C1_;8_Z!NI?^ QK4HH QU\0PO-)"MAJ)DC
M+K]G.0#G'\C4G]MC_H&ZE_X#&BT_Y&/4_P#KC!_[/6I0!E_VV/\ H&ZE_P"
MQH_ML?\ 0-U+_P !C6I10!E_VV/^@;J7_@,:/[;'_0-U+_P&-:E% &/_ ,)#
M#]H\C[!J/F[=^S[.<[<XS4G]MC_H&ZE_X#&@_P#(U#_KQ/\ Z&*U* ,O^VQ_
MT#=2_P# 8T?VV/\ H&ZE_P" QK4HH R_[;'_ $#=2_\  8T?VV/^@;J7_@,:
MU** ,O\ ML?] W4O_ 8T?VV/^@;J7_@,:U** ,>+Q##.K-%8:BX5BA(MSPP.
M"/SJ3^VQ_P! W4O_  &-&A?\>UW_ -?UQ_Z,:M2@#+_ML?\ 0-U+_P !C1_;
M8_Z!NI?^ QK4HH R_P"VQ_T#=2_\!C1_;8_Z!NI?^ QK4HH QX?$,,Z%XK#4
M74,R$BW/WE)!'X$$5)_;8_Z!NI?^ QHT#_CPG_Z_KK_T>]:E &7_ &V/^@;J
M7_@,:/[;'_0-U+_P&-:E% ',Z_K ET"^3^S]07="1N>W( ^IK2_ML?\ 0-U+
M_P !C1XD_P"1;U#_ *XM6I0!E_VV/^@;J7_@,:/[;'_0-U+_ ,!C6I10!E_V
MV/\ H&ZE_P" QJ.?Q##;0/--8:BD:#<S&W. *V*R_$G_ "+6H_\ 7N_\J #^
MVQ_T#=2_\!C1_;8_Z!NI?^ QK4HH R_[;'_0-U+_ ,!C1_;8_P"@;J7_ (#&
MM2B@#+_ML?\ 0-U+_P !C4<?B&&5Y42PU%FB;9(!;GY3@-@_@0?QK8K+TO\
MY">M_P#7XG_HB*@ _ML?] W4O_ 8T?VV/^@;J7_@,:U** ,O^VQ_T#=2_P#
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M &7_ &V/^@;J7_@,:/[;'_0-U+_P&-:E% &7_;8_Z!NI?^ QH_ML?] W4O\
MP&-:E% &7_;8_P"@;J7_ (#&HO\ A)(/M7V;[#J'G[/,V?9SG;G&?SK9K$_Y
MG@_]@W_VI0!/_;8_Z!NI?^ QH_ML?] W4O\ P&-:E% &7_;8_P"@;J7_ (#&
MC^VQ_P! W4O_  &-:E!Z4 0VES%>V<%W 28IXUD0D8)5AD?SJ:LOPU_R*VD?
M]>4/_H K4H *IZO=26.BW]W%M\R"WDE3<,C*J2,_E5RLSQ'_ ,BQJW_7E-_Z
M :#2DDZD4^Z_-'C7_"W_ !-_<L/^_)_^*H_X6_XF_N6'_?D__%5DV6@6SWL;
M7$$WV.1+4H^2 [.%+@-_WW],>U3CPYICI9R1S2?9[IHV21G (1I"N#V!&-I]
MQFM-#]">'RY.WLE]W_!+%S\5?$5UY/F)9?NI1*N(CU'3^+WJ?_A;_B;^Y8?]
M^3_\56,NDQ'2;RYETN>">.5(UC*N=BE6)8\\=.IR*=J6D6#G4(M,AEEN+1]I
M6(,PQO('7G.!SV]*+(I87+[V]DON]//S-?\ X6_XF_N6'_?D_P#Q5;VC_$?7
M+[PSX@U"9;3S[!(&AVQ$#YW*G(SSQ7(3>&K>'RVB4W+Q0NDT$;Y+7"@$KQR/
MO'CJ?+-3:&AC\'>-%,#0$):_NFSE?WAXYYHLC"MA,#*G>G36\>G>27?M^9;_
M .%O^)O[EA_WY/\ \51_PM_Q-_<L/^_)_P#BJR(=*@=[55T]9+=[82+<&1QY
MTOE%O+SG'WQMP #QUYS5O2=#M;RXMDOM,%GFZC$H9G"LC%1M4EN&Y)(/..<C
M&*+(UEA\OBFW26GIY^?D.D^)^ORZG!J#+9^=#&\:XB.,,03D9_V15K_A;_B;
M^Y8?]^3_ /%5@Z5:6+VMN]U$KQL]VTC8.?W<(91P1W.<9&:U(]&T22STR\V*
M $\RYB\P@RAY61 !N)7!"YP>AZ]Z+(<\-@(.SHK[O^#Y%K_A;_B;^Y8?]^3_
M /%5MZ'\3=<O=-UFZN(K-FLK998U$; $EU7GYO0UR,EAI<%EJC"SAD>"W$D3
M/(^=QGV8X89^6K-A#'!:^+XXU"+]B0[!_"3(A*_@3C\*+(RJX3!2@^6DEJNG
MG'S[,T_^%SZ[_P ^&G?]\O\ _%57NOBWK5VUN7L=/'D2B5<*_) (Y^;IS6/H
M&EV%WI[37%NT\P2<A$W,25\G;A0RD_?;N/TJ6/1+6ZMK9!:_99KC]RAFW*QE
M*EE8$L05R-IX&W<,Y/-%D5+!Y=&3BZ2T_KN;?_"Y]=_Y\-._[Y?_ .*K1T#X
MKZSJOB"PT^:RL$BN9TB9D5\@$XXRU<H^B:1)$4MI5>82!U^9LR0JPC8^@R=[
M]<@ 4ND"P7XBZ0FGQE(DNT5NN"P<\C))QC'?KFBR(G@L!*G/DI6:3>STLO7^
MK'KUH_BC4TFN;;4].@@^TSQ)&]FS,%25D&3O&?N^E6/L7B[_ *#.E_\ @ W_
M ,<JUX9_Y \G_7[>?^E$E8\OB*_GM+-;&:W:[:"(SJ1D)*TL:;6Q]WJXQUX]
MJ@^,JUW";BHQLO[J)X](\51WD]TNLZ;YDRHK9L6QA<X_C]S4_P!B\7?]!G2_
M_ !O_CE94/BB_P!0BEDM[BVME\R0#[21&0%= 5R> ^"PY&,UNZ#K2:IYZM,O
MF*4:.-L+)L:&-\E0?5S[47,OK,OY8_\ @*,>\U+Q!I\>HVUS?6CW"1VKPS0V
MQ4)YLQC.5+'/"UI?V5XD_P"AGC_\%R?_ !59OB7_ )".H_\ 7#3O_2MZU=4U
ME[*\N[82Q))]GA:V1L9D=G=2 ._1>.V?>@Z:U3DA&48K7R79#/[*\2?]#/'_
M ."Y/_BJ/[*\2?\ 0SQ_^"Y/_BJR)/$VK0%HIA#N82RPR*G#()53!_VER?J"
M#ZT7'BG4K:\>V?RMQDNGC?R^/*1V0$^Z[<GU&/6BYS?69]E_X"O\C1_L#7_M
MOVO_ (29/-\OR\_V>N-N<_WO6IO[*\2?]#/'_P""Y/\ XJL^3Q)>6<UPT<D>
MHVL<@@BDC4#S)73*KN'!PP"Y']\=Q2'Q%J*F]@;&\(%MI?*VJ[HRI+@G@Y8Y
M'H!1</K,^R_\!7^1H_V5XD_Z&>/_ ,%R?_%4?V5XD_Z&>/\ \%R?_%5F7GB?
M4+::\C6-_+M[:2(3-&"#<K$9/O< @ ;<8ZUM:;<ZD-2%K?$;6B>1 0N_ 90-
MVWC/+=.V*+A]9GV7_@*_R,J+4==NK72[>WO;5;J9KH2SRV^X,(GVC"AAC/UJ
MY]B\7?\ 09TO_P  &_\ CE8Z3RVMI:W$ S-%'JCQC&?F$A(X[\UHWNO7LE\G
M]D26]U KKD+\PD C=W0,/XL!<>^/6@Z,14]E*T8KKT7=D_V+Q=_T&=+_ / !
MO_CE'V+Q=_T&=+_\ &_^.5B-XJU6XLO.M2&++&Z;(QD@PRR=#[HOOC..:N:A
MXAO($U62.]@402VZ1@%#M5S#N?!&<?O&Y)QTHN<_UF7\L?\ P%%BUTCQ5:)(
MD6LZ;AY'E.;%C\S$D_\ +3U-3_8O%W_09TO_ , &_P#CE5XM:NY-0LH/MD)@
M=YP)@57SPC1A<9!S]]A\N,XR,54M]=U>;3Y4GG2.ZBTPWXEBB&V0$ KP<X_B
M4C_9SQFBX?69?RQ_\!1I_8O%W_09TO\ \ &_^.5GZW/XLT71;K4FU33)5MTW
MF,63 MSCKOJTVKW<-R\1OT>>.ZC@6U9%#2(P0E^.> S'(XPOUK&U34;Z_P#
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M5E:C_P A;Q+_ -=-._\ 0Q7;T'57FJ:3C%:^2[1.=^Q>+O\ H,Z7_P" #?\
MQRC[%XN_Z#.E_P#@ W_QRLN/7-<FTRZOT=!'!;H[LRH%!-NC\=\[V[\8S4\O
MB6YT^YC,LL=U;O JKL*L6G=I @W* ,'9MZ=2*+G+]9E_+'_P%$SZ1XJ>^AO#
MK.F^;%&\2_Z"V,.5)_C_ -@?K4_V+Q=_T&=+_P# !O\ XY6-!XDU0R7R3W<
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M0@=\*'Y[8K,L_$^HS-9VLS(MR\,4LC+'@,DDT*JPS[.ZGW7/I1<Y?K,^R_\
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MO7^1D?\ "4^',Y_M[2L_]?<?^-8/C/Q%H=UX/U."VUC3IIGAPD<=RC,QR.
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MUZ*9I*O"2Y7'1>?E;L9'_"26/_/OJO\ X*KG_P"-T?\ "26/_/OJO_@JN?\
MXW6O12,^:E_*_O\ ^ 9'_"26/_/OJO\ X*KG_P"-T?\ "26/_/OJO_@JN?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "@]**#TH R_#7_(KZ3_ -><
M7_H K4K+\-?\BOI/_7G%_P"@"M2@ JA=ZB\%V+6"TEN9S'YNU&5?ESCJQ%7Z
MRS_R-2_]>)_]#% !_:.H_P#0#N/^_P#%_P#%4?VCJ/\ T [C_O\ Q?\ Q5:E
M% &+<:W>VJ(\NB7(#R+&,31'YF(4?Q>I%3?VCJ/_ $ [C_O_ !?_ !5&O?\
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MW_B_^*K4HH R_P"T=1_Z =Q_W_B_^*H_M'4?^@'<?]_XO_BJU*0LJ]6 ^IH
MPUU^Z?49+ :+<_:(XEE9?.BQM)(!SN]0:L_VCJ/_ $ [C_O_ !?_ !54X)$_
MX3J\.]<'3XN_^V];X96Z$'Z&@=C,_M'4?^@'<?\ ?^+_ .*H_M'4?^@'<?\
M?^+_ .*K4HH$9?\ :.H_] .X_P"_\7_Q5']HZC_T [C_ +_Q?_%5J44 9?\
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MI10!E_VCJ/\ T [C_O\ Q?\ Q5']HZC_ - .X_[_ ,7_ ,56I10!E_VCJ/\
MT [C_O\ Q?\ Q5']HZC_ - .X_[_ ,7_ ,56I10!BW6MWME:2W,^B7*Q1*7<
MB:(X _X%4W]HZC_T [C_ +_Q?_%4>)/^19U/_KV?^5:E &7_ &CJ/_0#N/\
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MT=1_Z =Q_P!_XO\ XJC^T=1_Z =Q_P!_XO\ XJM2B@#/T.WFM-!L+:X39-#
MD;KD'!  ZCZ5H444 %9?_,U#_KQ/_H=:E9?_ #-7_;C_ .ST 9FA:2M_H-C=
MW&H:FTTT*NY%]* 21SP&XK0_X1ZW_P"?[5?_  /E_P#BJSM/@N;GP1H\5J[H
M[)!N92PPO&<[2IQCW%5[J+Q"@NFA$QCEPH5)3N5(G53MS]TNF\@Y)Y'.:9V5
MZU159)/J^W=^1K2>&+.90LEWJ;A6# -?2G!!R#][J#3_ /A'K?\ Y_M5_P#
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M5OH%D))(O.'R*HVX7N!U^85>%SIUO(JO8%98-RL"=PB52@."?X<2AOIFJO\
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MW_F<7'IUW'XI?6QHFH%V3'E^=;X#<@G[^.A],^_)K=_M74O^A=O?^_\ !_\
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M5.5.,E=/^M#-BT[2;R%YH(H)([C>6DB;A]^-QR#WVKS[5*=)LFECE>)G>,*
M7D9L[22N<GG!)(SG%5#X9T^.:2:R\^PDD.YS9RF-6/J4^Z3^%+_96I+PGB&[
M([>9!"W\D%!3A2?PR^]/]+HG?1-/DZP,,2>:NV5UV-SRN#\OWCTQUIDITK0S
M+=RRBW,S98-*Q\QN.BY.6.!T&34?]CWTG^N\07Y']V-(4_4)G]:?9^'M-LKS
M[8L#2WF,?:+B1I9!]"Q./PQ0"C27Q2OZ+]7_ )%6W@EUK58=2NK>2&TM<FSA
MF&UV<Y!D9>W' !YY)]*WJ**"*E1S:Z);(AN[6*^LYK2==T4R&-Q[$8K%L[Y%
MCATC708[M&4)*^5CN2A!5D;IG@$KUSG@BN@JO>V-KJ-J]K>0)/ _WD<9%!4)
MQMR36GXK^NPR;3;6>Y>>1'+R1>2^)6"LGS<%0<'[S<X[U4?PUI,@(DM3(2C(
M2\KL2&V9R2<_\LT^FT8IHT.>V %AK%] @X$<K"=1_P!]@M_X]2_9?$"\+JNG
ML/5[!L_I** ]G![37SNOT98&CV*W(N$CD27<S9CF=<DXSD X(^4<'CBHA#I/
MAZ!IV=;=-H3=+*S':.BKN)/?A13/L&M2\3:VD8_Z=K-5/_CY?^5+;^';"&\C
MO9A+>7D?W+BZ<NR_[HZ+^ % U"FOBE?T_P W9$>G+<:EJK:M<6\EO!'$8;2*
M48?#$%W8=LX4 'D 'UK:HHH(J3YW>UD%<]&MSX?:6W-K+=Z.Q)B\A=SVP/5"
MO5DSTQD@<8X%=#10$*G+=-73,:Q7P]J(E^QK92LX E5 -W"%,,.H^4E>>QQ5
MLZ-IS;=UI&VW(&X9X/..>M1W^@:5J<RSW5G&TZ_=G0E)%^CK@_K47]@E/]1J
M^J0CT\\2?^C QH+<:+VDUZJ_XK_(NMIMD\B2-:Q%T8LK;>02=Q_,\_6F#2-.
M6%(190".-D9%V#"E?ND>A':JO]CWO0^(M3QZ;+?^?E4A\/K(,7.J:I.#U!N3
M&#_W["T"Y*?6?X,9J,GA^U,<=V+;S44)%"B[I<#HJJOS'\*BCM)];NH)+NU:
MVTNV(>&VE^_+(/NLX'11V4\YY/05HZ=HFF:3N-A8PP._WG5?G;ZL>3^)J_3*
M]I"'\*]^[_1+;\6%8=Q%=:/JDU_:VSW-E<X:Y@AQO20#'F*#UR  1UX!&>:W
M**1G"?(WI=,IV6IV6IQ,;2Y20CAESAD/HRGD'V-9#^%$FACMY;N3R!;1PNHS
MEBJNN023@?O"<=B!6A?>'],U"Z6[FM@MVHPMS$QCE'_ E(-1?V1?P_\ 'MKU
MX!_=GCCE'Y[0WZT%N-*7PRMZK]5_D4CX8N"PD-\KRD R,\9^9@Z/D8;*YVG.
M.N1Z5+_PC.^U-G+=;K5D ?"8<MY/E<'. ,<XQUJS]E\0+]W5;!O]^P;^DHH^
MR:^W#:M9*/\ IG8MG]9#0+V2_G7X_P"11NO#[[1>7-X-T*N[&.(X)VQ@?*"2
M1^Z&1SG-3V_C#1;JW$L-RTC$[5B2-FD<_P"RH!+?AT[XI\N@SWL+PZAK-[/#
M(I5X46.)&!ZCY5W?K5G2?#^E:&KC3K*.!G^^XRSM]6.2?SIFB6'C!\S;ETMH
MOG?]$0:=;75WJ3ZM?PF$A/*M+=B"T2'!8MCC<Q X[  >M;-%%(PG-S=S*U?3
M;B>6&_TZ817]OD*&/R3(2,QO[''!['FL^&XT%I1!?62Z==,^[RKE-@+<_<?[
MK=3]T]ZZ6H;JTM[VW>WNH(YX7&&CD4,I_ T&D:D6E&HKI=5O_P 'Y_>5I]'T
MR\0^;9PR!LY..N26//U)/U.:7^Q]./F$VD3&12CEADL",')/KW/>J<?ABRM5
MVZ?->6"?W+>X8(/HC94?@*?_ &3J*\)XAO<=A)# W_L@H!PIO:?WI_I<NC3;
M-8FC^SH4==C C.5R3@^V2:P-,@U2YU_45U33H!9L7"R&,9<$( .O<+S][I_#
MC%:7]EZH?O>(+D?[EO"/YJ:0Z!YH(NM5U.X4]5,_E _]^PM,TA[."DFT[^3T
M]-AEY-X>T]S',EMY[AAY,<?F2L&;<?E4%CEN>G6JUKI,FHZM:ZE=6HM+6S3;
M:6I W_[SXZ=!A<\'D\]-;3=%TW2%==/LH;??]]D7YF^IZG\:O4B/:0A?V:^;
M_1=/Q85F:MI7V[R[FVD%OJ-ODV]QC.W/56'=3W'X]16G1090FX/FB8JZ\]H
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M66/^1J?_ *\5_P#0S6I66O\ R-4G_7DO_H;4$&I1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %9:_P#(U2_]>*?^AM6I6'=7D-AX
ME:6Y\Q8WLT566)F!(=B1P#ZB@#<HK+_X2+3/^>TO_@/)_P#$T?\ "1:9_P ]
MI?\ P'D_^)H U**R6\2Z4@!>X=02 ,P2#D]!]VG?\)%IG_/:7_P'D_\ B: -
M2BLO_A(M,_Y[2_\ @/)_\31_PD6F?\]I?_ >3_XF@#4HK+_X2+3/^>TO_@/)
M_P#$T?\ "1:9_P ]I?\ P'D_^)H U**R_P#A(M,_Y[2_^ \G_P 31_PD6F?\
M]I?_  'D_P#B: -2BLO_ (2+3/\ GM+_ . \G_Q-'_"1:9_SVE_\!Y/_ (F@
M#4HK+_X2+3/^>TO_ (#R?_$TG_"1Z7DCSY,C_IWD_P#B: -6BLO_ (2+3/\
MGM+_ . \G_Q-'_"1:9_SVE_\!Y/_ (F@#4HK+_X2+3/^>TO_ (#R?_$T?\)%
MIG_/:7_P'D_^)H U**R_^$BTS_GM+_X#R?\ Q-'_  D6F?\ /:7_ ,!Y/_B:
M -2BLO\ X2+3/^>TO_@/)_\ $T?\)%IG_/:7_P !Y/\ XF@#4HK*7Q)I3J&6
MXD92,@B"0@C_ +YI?^$BTS_GM+_X#R?_ !- &I167_PD6F?\]I?_  'D_P#B
M:/\ A(M,_P">TO\ X#R?_$T :E%9?_"1:9_SVE_\!Y/_ (FC_A(M,_Y[2_\
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M- &I167_ ,)%IG_/:7_P'D_^)H_X2+3/^>TO_@/)_P#$T :E%9?_  D6F?\
M/:7_ ,!Y/_B:/^$BTS_GM+_X#R?_ !- &I167_PD6F?\]I?_  'D_P#B:/\
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M%!)/'"TBWH<J7<*#C;SR118%AIO9K[T=!1112.<**** "BBB@ HHHH ****
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M;%Y86]\(O/$F8FWHT<K1D'!'52#T)J!=#TY(WC2!DB= C1K*X0@*%&5!QG
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M#)/R@]21R3]:JQ^(+I3-)+9%D*!HU0L<-A/DSMZ_,V?3:??'01QK%&L:*%1
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M%+08A1110 4UXTE0I(BNC#!5AD&G44 9+^&=(+%HK3[,QZFUD:'_ - (J/\
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M4\8J>VFU (TLOVDK]L7[T>#Y?E+GY1VWY_SS0(W:*Y>ZNM;_ -7!;SA?,?+
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MA\P[HG'S\?N^O)Y^]T/IQ6_1028*:QJ!FFC:S),+E&"0L3C:Q##G'.%^7/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
&444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>image_048.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_048.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &I!!T# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/6JBKJ6K_P ]]S&I5=.5.*VG?FWMIRVO][W)'(&3MY!ZY]\'MWKY5_;@*/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ,NI2V,ECI]_I831I-'OH;^5-5>& 1&2[>!DFBB /]F+_AXU^Q__ -%6N?\
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M[,,,<].P'\/L* +(^\W_  '^5.IB$DL3[?UI] !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5X5^T'8-)\(/BQ=PI UU:?"_QU<6
M[AYVNHI+?POK4D4BP*3 Z)+@KYL3JTAV2!D^6O=:\?\ CP#%\'?C!<IEY?\
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MZ'#'H/VCQ%/X4\5>8N@SB+3/[4TV]FO$_L3Q(OVUI@=2RQFL* /RIU[XU_M
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MWU2_#9^A_ WT_<*H<&<-R4;+^U(OY/"3E^1^A:_ZV;_KD?Y)5N  JA[AR/\
MR$>/UJDC9DG/81-]>%2K=MRB$?\ /4G\/*/_ -:NM:P<O*'XQD?Y:8AI9C2C
MU^J/_P!)=BY11161H%1R?P?]=%_K4E1R?P?]=%_K0!\<_M]_\FG?%;_>\$?^
MK*\&5_AW:_\ \?TGUC_]$15_N(_M]_\ )IWQ6_WO!'_JRO!E?X=VO_\ '])]
M8_\ T1%0!A4444 *O4?4?SK2L>ES]8_YO6:O4?4?SK2L>ES]8_YO0!_L>_\
M!!'_ )16?L[_ /8P?&C_ -79\0Z_9JTZ?E_Z#7XR_P#!!'_E%9^SO_V,'QH_
M]79\0Z_9JTZ?E_Z#0!:C[_A_6I*CC[_A_6I* "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ IK,% )Z$@?G3JKW.=BXSG>.GT;KCM515Y)=W;\S*M-TZ52:U<
M8W77K%?J-EN7C)Q"6]]V/3_9/K7D?QSF:?X,_&!1%+ 3\*?B#MNEBEN%4_\
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M;5YYY2R1L2B1ECDD @D@ _W4+?Q'I+&;.J>=LGDC(^Q7,?EE=N8L^0-^S/\
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M56X52#QV/<_[7O5D?>;_ (#_ "J"XZ?A_1J11QFO7#6]GJ;DYB5=/!3 &,O
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI,CU'YBER#T(-
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M5/#'_8?@/_4K G\&/QW_ .2X?&'_ +*M\1O_ %+=6KR.\^\G^]_1:]<^._\
MR6_XP_\ 95OB+_ZENK5Y'=\LF.<-SCG' ZUPU?XDOE^2/^@?@?\ Y)#AW_L5
M83_TW DB^X/P_D*KR=OQ_I4\1&T<C\QZ"H'!., GK_2LSZH;-_QY2_[S_P#H
MDU_;[_P2V_Y,D^!/_8B6/_I[\0U_$%-_QY2_[S_^BC7]OO\ P2V_Y,D^!/\
MV(EC_P"GOQ#7HT_L^B_])1_ 'T^_^2/X;_[&B_\ 4:H?HDO^LN/^N3?^@)4T
M'W$_WS_Z+-0K_K+C_KDW_H"5-!]Q/]\_^BS6C^#YQ_\ 2&?Y<UO]_I?]@LOR
M+-%%%9&H5')_!_UT7^M25')_!_UT7^M 'QS^WW_R:=\5O][P1_ZLKP97^'=K
M_P#Q_2?6/_T1%7^XC^WW_P FG?%;_>\$?^K*\&5_AW:__P ?TGUC_P#1$5 &
M%1110 J]1]1_.M*QZ7/UC_F]9J]1]1_.M*QZ7/UC_F] '^Q[_P $$?\ E%9^
MSO\ ]C!\:/\ U=GQ#K]FK3I^7_H-?C+_ ,$$?^45G[.__8P?&C_U=GQ#K]FK
M3I^7_H- %J/O^']:DJ./O^']:DH **** "BBB@ HHHH **** "BBB@ HHHH
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MD_2/ZI_)JMU5G!(CQZK_ %JX]?1_DS'$?P9?XH?^E(CA_P!=_G^Z:\?^+O\
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M-FBBBO)/R(*IWOW(?^OB/^3U<JI>#*P#UN8Q^C5I2_B1]7_Z3,TI?Q(^K_\
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MFC_ /QI_Y.UQI_V-\9_Z<@6:***Q/S8*KR?P?\!_K5BJ\G\'_ ?ZU4=WZ/\
M(QK_ ,-^L?S*0_X^_P 6_P#0#7E'Q;_Y)OXU_P"Q/\3?^F35*]6SBZ)]"?\
MT UY3\6N?AKXU;_J4/$PQ_W!-5[U7;_"OS9[64_\E+PO_P!AN!_]2<&?P:_'
M(.WQN^,J(ZH'^*WQ#W,6*XV^+M7(P1QUR.0>N!7E'D6MD^%O1/+)A0OVF.4
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M>;;LNELT,1/!7W[/FC_"'X3ZI\3?B+IWEW3_ &'^S?"7VRZ?[?M\2)X?O/\
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MA"P@M]$\4?"./P7XAN/^$CM_&UY:6<D%U<W)@O$O+Q+2XB"S0.T;V9^*8_\
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MW6]-UZ_<?X%^,U:-3Q;XT45/_D;8U\S@U'^)![WMKT[ERBBBL3\["J\G\'_
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M\/ZU)4<??\/ZU)0 4444 %%%% !114%Q))'&3'!-<,<KLA:!77*M\^;B:!,
M@#ARV6!"D;B ">BO$?BO\=/AU\$=/M=<^)/B*;PYI]RK[=^DZYK3*89-,M'#
M0^'[#4R"+C5K$$@L&,V\';%,4\=A_;X_90N;<,GQ8GE 9E,EOX(^)$>& )V_
MZ1X0C?(# YVE>1@Y!  /M"BOC5/V\?V4UC8?\+3O#R.7\%_$%G[#@CPIC''.
M?>H/^&^_V2[?*R_%R=2.JR^!_B5)(N>?F:/P<Z'(8%=K' P#@@@ 'VC5>OC4
M?M_?LDCY_P#A;[%<YP? OQ//'7&/^$+ZX_"M&/\ ;F_9KDC1$^(!EO'W8AC\
M&>.E4[6)/S2^'44?N@6YDZ@@<X4@'UTO4?4?SJ>L^QNHKJTM;M)%DBN8H&@D
M5)%\Q9HTDC<K(JNI=6#'>JD9PP!R*T* "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0D#&>Y 'U-+3
M6_A_WA_6@#-G9#Y*SG8S2W@3) ^5)6P<$IG*!2, ]0<GJ?\ .C_X.3/^"AG[
M5_[+O_!1F^^&/PE^)#^$_#$/P-^%WB";3E\%_#C75GU?5CXH-W>B\\6>"M:U
M./S+>ULX/LZWGV5#;&2*&-Y92W^B[=*K"Z+*K&+R?*+ $Q^85\SRR>4W_P >
MW&[^+-?Y9?\ P=KR01?\%7]9GOYV6&;]F;X/VD( DDD^W.WC%HG $;JA$:L!
M*2&4@#('4 _,4?\ !:;]OY!(O_"\)OO?]$Q^!_8X_P"B9^U3Q_\ !9[_ (*"
M/"K+\;YBIW%?^+7_  0Z@L.WPR.><]S7NW_!$OX+?!?XQ:O\;M&^,?PS\*>/
MDL[KX=W'AVY\4>$/!_BN2PM=0TKXDW%XMG)XFTW56L/M;Z-8R7,=O!")S%$9
M@[Q1F'YG_9>^)7[.WP-^.7BBW^*'P9T;XP66NIX/\%> /!WB#X>>!?'&GPZ_
MXBNM,U";4]5T_P 67^@Z'9*+FVATY+^PO5NEL=5NX9+:9)KBXM@#<?\ X+-_
M\%!AR/C?-[C_ (5=\$??)_Y)C2ZC_P %F/\ @H5'!:P:M\7;VSMYO/P)OA?\
M&(V?RW1SL$OPMM2VUS$6Q(-H89R"%;[F^('[,G[/7QK_ &Q?@]#\/O"/A#P/
M\/+[X$?#[XU?%CPCI?@[P_X6M?#^K7/Q2O5\=^&K'0])\(ZEH%_:Z5H>JV6F
M6UI;'Q#;W4=I'9P^(=6LK>/S/C'4O"O@G]JS]G75/B%X-^'W@;PCXB^'WV+^
MT[?1/"VC>$Q/_P )7XYCT2RW/%!J\EYY5CX=NG&W5(/LYN9@?,6Y-O$ ?N/_
M ,&Z7_!2K]KG]H__ (* Z?\ #+XK_%&XU7PZOPVM-6:SD\ _"[2UO[4?&OX(
M>'S:BYT#P7X?U& 75CKFHQ"YAO)3$)#)&KSQPRP_Z1<'D\'I^/U _BK_ "A?
M^#6<V7_#T"P%U+=IJ=O\+[6Q,"E&@00_M"?L]YC#!7!C6XW)A9MNP95?XC_K
M 6J(0N44\#JH_P!KVH N($Q\OOWSW^I[T^D  Z #Z "EH **** (RRAB,A3_
M 'B>G'H>.G%4+EX@N2<G.XX(ZX;/&[C^GI5J? #$#YN,DCW ^O2L69P\$IXW
M!)""1U(0XYY.<GV_"NBC2C)J3[I/:ZNTM?*VWD<WUI4\;A\-)<JK2BKO2ZE)
M*]_F_7H?&WQV_:Y\%? ;Q39:)X@T'7=>U36[":ZLO[/GTBS2&ST_4+RV\K9=
M7JRSC<UPZS+ 25'SMD83P^Y_X*:_#L".>3P!XOM_LS%%9[_P^?GFQ*A&^Y13
MM%N20V<Y'&,U\M?\%)82WQ6\"7=UB!+7PQK $EN<2O'-KM['&6($A8[B<C*X
MWN<<FO@!VMM1\]+5)IU^2=1<"+RSY4;1Y96(.-TA4C;DJ3@\\_3T,II22]V^
ME]/\-[V]'K]Y_=_A5]&C+N,^',!Q!B:CAA\5AUB*DO;RA&-%RG"M)N$DK<D*
MJV=GIO>_[11_\%0/ ,IPOA/Q8.O_ "\^%FZ=_P#C[]ZM/_P4T\"(GF-X5\6!
M0R YG\+@8:15ZF\ &<XS^7-?B-9QVOVB2XAM)IG@#V-Q;JMHMLD\;JTLB1RR
M1 E6*QK('),9V[2,D-22W$HL(%N[O[(\1N3=F&1W:5A<6J;F=%D1V&R0$?+&
M N5/S5K_ &3ANR^X_2L5]$WPSC%NGF%G:ZMC*GG^I^W$W_!3SX>(J!?"_BK<
MY4?\?7A4\L#V-]TR/2OH?X'_ +5?AOXX7TR:+H.M07NG);/%)?S:9A/[0MM5
ME?RX]-FN1+F'2I5?S8_DRC1_QLO\X\D4%OYTEQ:I]JN(Y$LK9HX)(5>7+6[8
M!*QL)%:/<)043I@'=7ZD_P#!.81PW^O;I"-0C31GNXUW;;43VOC9[9(9-@&U
MK=PI6.64*%"$J  >+,<OHT,'6JP24H>SMI_-4A%_@S\B\4?H\\'\'<&9SQ%E
M.,E7QN7O >PI/$5*B?UK,L)@ZC<6[-*E7F_)J_8_:.TC%G;BV!'^BEY)6!.T
MJ29F"[LD';(O7;R#R!@G50"1$D4Y#JK#IT8 C)!(Z'MFJ0PT-R2HRP<,<#YO
MW*#D]2, #GTQT%/@8JL8R0HC3@$X'RD# ''8#IVKYEJS:[,_BS$35*2CIKZK
M>S_/9%H@@\U,O0?0?RICG(!'3G_/Z4]>@^@_E2!.\5);/_*XM0_Q_P# OZU-
M55R0,@D'/7//>@"I?!2V&5G4]57.3PF,8(/!P3ST%?RG_MX?'OP?X4_:+U?3
M-0L;HS+H/A.3Y;[3XAB?35=/EGNHWZ ]L'MD5_59-N<, QW9X;)R.1G!ZC@8
M^G%?Q*?\%/;>"/\ :W\1+)#"X7PGX'8!XT< _P!CH05&W (YP>#R?6MJ6,J8
M9.,-I/F?Y']D?0?PM/$^+6:1FM?]5\2NM[>VAV_K4SI_VE_!;R.RZ=J3(7?;
MY%UI4^/FSAS]N3:<$8Y;//3',/\ PTMX,_Z!FL_]]Z5_\L:^"HI(&$X1$79=
MSJ<1A>!Y8 X'08.!T&3CK4N4]OR_^M6O]J5_ZM_D?ZMRR:C1RI3Y;?[?>]]E
M[?\ 4^[A^TKX'&=^F:QDDD9DTH<'_N)#OGFE_P"&E_ G_0,UC_O[I7_RSKX.
M81D'*J3C RHS^9%9THX&T8/MQW%.6;5I14>;7:VG]?@=53*<(Z[J\JYYT5)Z
MN]_9P_R5C^NO_@DW\0M%\>^&?%,FEI)&8;W7"J2S6LCJ(]/^'#!76VGEVL/M
MD88'=@@@DY7/[,19-HZMU5B#[XG8#L.F*_GV_P""%\:_\('XXD"+YHUCQ,OF
M;5\P*-&^$;;=_P![&[YL9QNYZ\U_0/%D6W).6)/)SDB5B<_B>]<+Q%:H[^]=
MR6EM-TOO[/HM&?X6>/M*-+QHSB,$_==7TLYU';ONKNYNT4451^2A52[Z0?\
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M<_?*/I-_O_\ M*.GKT3_ 'G_ /05JNI.X#)P8R2,\$[RN3ZG: ,GG  Z"K:
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M89QP1T//3'KUH S[DC%TN?FE\D1CO(8ROF!!U?9_'MSM_BQ7^6=_P=K1(/\
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MI6 2902OQ!\;R<[.XSW#'W[U4^$VBR>%O"7Q>LO&>@Z,_@O7_A-XPCTB_O\
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M3[S_ .^O_HM:DB^ZO^^__H"5K'I_V[^3/\M*DV\?AU9:85KKU7_!+*?ZZ?\
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MC?YUM;7$9W^5"NY);6X=L%(L8)PR@GA1CDGMA;SM9PV5@\, 6\MS%:QV[SR
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MPVQZB6+@BW5Q\F5_UGZ?+69+HLIE:19/.>20O<,(V 6X9BTJX0L.#STC//\
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M-NST^=K[6.M4(<K;CVMJ_GI<W?!85KK!\PF.3<"9 <E)+7&1LZ'OS^->P@Y
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M91UL_P#ASR;PW\0/A-:_#Z]T"32?&L%Z8-#T[4]1T?QK9:4-1;2#9-%*UO\
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M ))OXT_[%'Q+_P"F35:4>OI^K/6R3_DJ>&/^P_ ?^I6!/X,?CO\ \EP^,/\
MV5;XC?\ J6ZM7D=Y]Y/][^BUZY\=_P#DN'QA_P"RK?$;_P!2W5J\CO/O)_O?
MT6N&K_$E\OR1_P! _ __ "2'#O\ V*L)_P"FX$D7W!^'\A5>3M^/]*L1?<'X
M?R%5Y.WX_P!*S/JALW_'E+_O/_Z)-?V_?\$MAG]B/X%'T\"6'ZZWXAK^(&;_
M (\I?]Y__1)K^W__ ():_P#)D7P+_P"Q$T__ -/GB&O0AHE_A_\ ;4?P)]/N
M,?\ 4WAQVU_M-/K_ - U0_0^,[I9QC&86/\ XZ@J:(X"+_MGGZ1MV_"J\/\
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M=.?3UJSNF,!^3 XQ\RG^/FN=?Q)?XU^2/HH2Y^+<JDOM93-_^2K_ "/Z>O\
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M>?\ A ?!'//_ "*7AOO_ -P^E7X:>!MR_P#% ^".H_YE+PWZ_P#8/H _)?\
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M!^1__#WC7#Q_PR#^UI^'P O,_P#JRZ3_ (>ZZ[_T:%^UM_X8&\_^>57ZX_\
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M]P.Y'_11J_9K_A7'@%3^]^'W@8XZG_A$?#?N.VG'O4R?#+P$ZAX_ '@94.<
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MH(^5OV>/B.R\D=BN.N#]0#UK_1X_X5M\//\ H1_!G_A*:'_\@TC?#;X>8/\
MQ0_@SCG_ )%30^W/_/C[5YWLGY_^!?\ !/KX?2^\0*?-[/#XNGSQ<)NGBJM/
MF@TTX2Y,5#F@TVG"7-!IM.+3:?\ F^7UC^U6\D$C?L8_M1,$\I03^SK\1SM1
M6=@HRAP@SPN0!7ZN_P#!.K]I_P",_P"SI=>)I?&G['O[5UD=5A\.#27T_P#9
M]\5VQ1M/M/&B:D=VK>(-#*M(VMVVXVQD+EY/M&PM&)?[(&^'/P\D&S_A!_!A
M/3GPIH9]N,V.!U[&J4GPV\"B6)8_ O@J01F0+O\ "?AUO+! ^[YE@V-W(.W&
M<#/:M*5-QJ1>NE_M>3\SX_CGZ1?%G'?"V8<*9EAJM+ X^6%DY.HW&C+#8RAC
M%*G'VK5.525!4YRIQA*<9RC.4HRE&7Y(1_\ !6O6X[UA_P ,A?M:F(1JY3_A
M0-V8RX9,MM_X60%W;!MW'G;QG%6A_P %>-<<OY/['?[5^U'9#N_9\O,[E//W
M?B61C!'H?;I7ZV2?#?P3 0S^ _!+&0A"?^$2\-J1G@#BP.1A?8593X9> MH;
M_A!O!,1?#D+X1\/'<6 )8[;$#)Z'C/%=A_.]E?FLN;^:RYO_  *W-^)^1G_#
MW?Q'_P!&>?M7?^(^WW_SRZ7_ (>\:YW_ &0?VL@>X'P O  >X /Q+X [5^NO
M_"L_ 7_0E>"__"0T#_Y!J,_#+P/DX\!>"&&3ACX2\-Y8=B<V&>>O//K0/SZ]
M^OWGY'?\/>-;_P"C0?VL_P#PP%W_ //+J'_A[IXF\W'_  R!^UCCT_X4!J&/
MO8Z?\+*QTK]=O^%9>"/^A \$?^$EX:_^0*;_ ,*Z\!>;_P B1X+SGI_PB6@=
M-W7/V"@#\>=2_P""M/BJ\#6T'[(_[6%K)+C;./@)J,&S88Y#^]3XD,R[E4IP
MIW;MIP"2/YO_ -M?XA_M!?&+XVS>+_#7['O[4<EO<:3X8L&=/V??&SB6.QMI
MX9X)&L+W5$>)I'3?$;EE/&]$; /]W-U\-_ LLZQIX)\&%FW85?">@1GA%;AQ
M8J1@#GYAD<<YQ49^&O@'*O+X%\&)*N/WI\+:%(^ 2R@,+(D8Z@@\8XJM7%1W
M2;:C9-W:5W?EOLEIS6\EJW^A>'?B?GGA[FTWDN!A*>(I^TK8^"5/$<DG&#PS
MKQE"I[&/LE/V:FHN523E&5]/\Z6YL?VJUD15_8P_:?1%MX57R_V=?B.N2&E!
MSA,' VXQTR>Q%0?8OVJ_^C,_VH__ !'?XC__ !%?Z.-M\._A_("7\&^#I3\J
MC?X4T0[0 3@;K$^O;&<=ZF'PX\ 9Y\#>"\?]BGH//Y6&>/UI<N]TE;O9?<?M
M&+^EKQW2K4X0PU;D3CI&O-1<E9M\JK1C>^M^6[;WNTS_ #B18?M6L./V-OVI
M /0?L\?$@#/KC9CIQ5E;']JS&#^QO^U)M/\ "?V>?B/QU[;,=>:_T9+CX?\
M@*.0+'X'\&;-H+8\*:".=S ];#/0#D'Z<TU?AYX"<@_\(1X/7.>/^$8T0XQ_
MVY#TINE:*FXQM+5-*+?STOT-:GTSN**U\)B,+CZ>(H1]A+$4\94IS6B;4*L,
M5&M&-IQ]V-2*_NG\GW_!-']K?XJ_LX:'XALO%/[('[6=K)>SZM/+&G[/_B."
M-[BXL_ <3[$U'Q)H3-&S:%<*NY'<JH!9B'$/ZG0_\%<M:,=Q!-^R+^URD\4T
MBQM'\ [M3M-Q(1\S?$K?@1!0NT  <?=Q7ZY?\*X\ MN>V\)>#XMA(G1/".B
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M'7XB_P#QNO\ 1T_X5UX$_P"A&\&?^$KH'_R#3/\ A6_@7_H2/!O_ (2N@_\
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MP^'\&1%X&\&(9<32X\+:&2SOG+$M9G))4Y(//<4__A6_@7_H2/!O_A*Z#_\
M(5<=6DY5)-:IV^U;HNC9_2^0_2LXWX5RG!Y!E^'Q>,P>7QJ1H8BMB:U:I.-:
MM4Q#3J5<14FXTYU94X1<VH0A&$5&*C&/^<>UE^U8I '[&O[4G3_HWCXC^_\
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M=?KA_P *R\$?]"!X(_\ "2\-?_(%'_"LO!'_ $('@C_PDO#7_P @4CH/R/\
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MSU.&,N51(MBD'[@)+8*<<G=7R7\*?VL?@W\6_'WQ ^'7AO7[-?$'PM\?^*O
M&J:9-J_A@WEQK/@C6M.T*]N;>TLO$NJ:A+9RWNI06\,EQ9Z=.\N8Y;"TGV12
M=C^U%\5;GX/?##Q/\0+&UCO-0\+_ -B_8=(FN+JWM==_MOQ#X?T2Y^U7%FC/
M;?V9!J;W,'F!_.D4(FT,U?RM^"_"_P"TY^RU^VK\$_CGXR\)WOACPA\?O&/P
MW?XOZ0WCS1=3TK1?'_Q4^+%KXP^(#P6GA3Q+>W>OS:=I?AZZM8M0N])U9M5M
MK?RKC5;^62VMG A2YY-U9IPO=1<EHNBMZ6^ZVZ/Z\+WQCX1TKQ;H/AR\U_0+
M'Q'K\6IWNGZ5)K-C%JEY9VMM/.\\>G75Z+J41K!>F5[6UDA40S991"Y3IYB9
M/MH\K$DL:MYLX=+1S'"Z*&D1E8(-X$ICPP4.00P!K\*?CCXC35/^"IO[&$^D
M_$[Q;;>#/'/PB^)-]#I$%UKT6E7.KVG@_P"+FM7]J-+S;1)'IEG?^'I()KW3
MU$@,,=O,\UG)':_7_P#P44^)7QJ^#_PE\*?%/X>7\4%M\./%5[XJ^)WAR&\U
M72I-9\#:#X=UCQ/J6E-K.F^*]-CS?V>ARPHYT?Q5';?:][^']0>$VUQ2:LTU
M^/=6Z_FM=S=RP=.+C"A^\E%J,_9OEC4;:A4NDU92<.:^BBG*_NL_1V":Y@AL
M1<+ 5WK&&M!*UM%"+.4QR-),V\9=!$KNS*WF1K@R/N&?!<W,=K+]I1+J:5"K
MII://;HA9T;<9&$REHFRA+',BOT10*_ I_V]OBWX_P#V<=6_:0^&<ZWG@W3[
M#PIX3UC29]<\5VTVA?$74;[P?K&J:%#J-YJWA^ZO/[)T7Q)9PG6+'PNVF:@G
MFI!J*F66SMO09?B3^T#X,TGX@^,O&/Q@O/#/PX_X1C4=3LKVXB\:^(=9AN-"
M\/:H(H],N=%^)+3Z;]J\3?8;6\E/AB0RVMTI38MM)J('"/9?.2?3H<CP^9],
M7A4GO^_HMWWZNV^NNOS/VV:_+VR7.GQ70G@==.EB,*R.B11F1RT0,A4*Y12[
M$,#\K $\RRB.]-G9W,#/->1%XG<21I'(D4=Q<B0QNA4EAM50C[6&TA.37\KO
MP6_;F_:CU3]I#XB_#Z]U[5M2^'%S^SCXN^)7A3Q=-XU\7FXNM4F\>:5HFA7:
M:!=>+9Y[!YM"D?4UFFMK34+5Y#922V[[HS^S?[#VA_$?QA\/?"GQQ\>?&KQK
MXE@UWQ%\486\+W=]X@N-+TV+0_B!\0/!5M:Q3:MXGUN29(TLK"5=EC#%'+91
MK#&L @:W3BK7]W3LUZ:*_5;^G8%1Q\&I5\30J4]I1IU*<Y/XN72-Y63=WT73
M<J_M/?\ !1?X9?LL_$>V\&^)_ GQ?\06T6@Z3J&N:QX3\*>&]6\-Z5H^JW.I
M75Y=7NKZCXU\/RV L+.R:XU">ZC6VLH94F:1HV#Q_<?PM^)?A?XP_#_P3\2_
M!MQ+-X;\:^$O#7BC2H[F73I+VRL?$>AV.OV-CJ TJ_U.RAO[>PU.U6[@BU"]
M6.4L([JYB,<\GYV_MJ:I\#K73/$?PK\1>$?!GB'XE?$?0Y/!WB/4/%O@ZW\1
M^*O!/@CQIX>UK0F\8:%XKD\/_89]0\/NUG>:-I<-_+<P75U)(+<*DC)]3?L:
M?#WPK\+O@5X,\(^$/%^M^,='MM'\./#=ZY!):OI1@\&>&M-CT+3;5K:UCM=(
ML;33K:6SMH(S! ;F:.)B%VJC0^O4^Y^(_P#9J6E5&"8(P<YZCI\WO[TNUCV_
M4?XT -KF+Z[LK9KF&Z8+8VFE3>)+W4F=$MU,!=+F0W32);1E85:X*.D<"I^\
M9DC&!U!!!P:^*_VQOB_=?"OX:7NG^%[6VU;QY\0XKGX>^'O#=S)>6'F7_BW0
M/$\&DI:ZW"(=.L9GUG3K>P@FOKJVLK;S6N[F6&!!( #T3X5_'_P%\6_%WQ \
M,>%-4L]4O_AEK,>A:A):7VCWCV\\MQKVGD2+I>M:B07/AV\0?;+.TD_=.4B$
MB3"'T";Q/9SZAIFDQWD=YK#/;/?6,+VDEU;VTMY)$)9[2&1;FW&R6U82/$J;
M)X7R3,A;^1KP[^T7^T!^P!^VC86_Q#\%OH_PY_:5>_\ %7B+5+OQY_:5SIFK
M^'?A9<^,;VTTZQ\&:EK4MQ%%XV^)0TJ2XU/2)GGMEBOK>1R;R^3]ROAGX=\2
M#]O7XZ:?J'Q,\?3:9X4^'NCZ[I_AFXU_4+C38XK/1/@U?R3^4;F33XQ/=WVH
M)+';6L5PPNIG^8RRO*T[;73[WLNZ_+\@H?6UBU*C5HTZ*I6E[6<(^^Y-.REJ
M[QDM5LDWI9L_4)O/2"Z%O%+:WPE'V666-@&7S%$I5)1*LF8@X)$3!=P(VG#*
MD]XL;S26<MI(559]5N+F0EHTMD$UL7\AUA@!C21<O'&'4 [MP9Q^8O[?OQ:^
M+7P!TOX=?M >!_%MQ_P@?A&Q\00_$+P[K%SXBFTO5+KQ!=^%?#?AIVAT7Q3H
MEP6LM2\4FXW/X?\ $>9(+4B32TCFNCX5KW[6'Q'E^"_A[XOZ9J0DTOX[^*?"
MW@_PK9VU_P");!((H_BOH?PC\27=A-)JXNK.:R?6I]1,>I:=IT=]/ (86N+>
M4W(IM:WU??3U6VF^_DK+6YC6H9I6QT;8G#*ES17,ZU.,5%-+=O17O>[M;WEN
M?MC:RO $=H(F749%OTFL_.EMGCN]I5GEED.)6 WLL1,(C*-'G)J**]4O;W-P
M;2XEL_.\V2PD>1+?[0#&FX-,%7S5VJ/.'S%7\OD9K\A/ASXF^/G@WPS\3=4^
M,7QDOO#7@VVT#QI\1O"NIWUMXQ\7:Q9:##I]C<:'IMI/HOQ*U*:RTVWTJUU2
MX@M8M%L9K:Z@=X[*V:YBM)/SM^ G[:?[3WB#4_VMO 'B?Q+/HNO^!?\ A0O_
M  A-U>^(/&7B-[[_ (2>WUG6O$F?LWCB*'3/LME#;QCR]2L_MHE3?]H:!K<G
M,K)6U[_/LM[OO9VN=]6M@L/.=.KA?K%>F^2I7HT76A6FE&]2%>-TURRBE*#E
M%NGO:+1_4L;A!=7%[--;+!::5*+B_60"YMI()/-E\_>W]GQ"%,S2B6$;)/O@
M0Y6OS(_:'_X*F_"3]F;XA'P[\3/#GQ$E\+:?>ZI9'QEI6@^$1I5R;:RTLF6W
MUS6O'OAW1Y86U+6+"PCD%I'N9C;E!=-$TOM7[%6A^-[CX&> OBA\0?B7K?Q&
MNOBQ\,?"WC#4-+U;^V#I=KJOCOP?X4\0W5EIB:YXD\37$.FP2->V]G%?-/-'
M;WT@N;J5_.-Q^5__  7)^$<VL?L\:CX]\"Z-\/+VW\-3@>(]/U#P%:&^TVZU
M?Q_\*-%MH9-8E\2Z(-0=[Z+42T]CI4Z;(527RTD2YFGSV]-_Z_KS.656G6^&
MC."T^*$HKST>S=[>BV/Z$_"FN6GB?3TUK36,>G:@L@593%YC"VN)[*388Y;J
M,XD@FSMG?!9,[3E%ZBW\@L?L[J1',\4PWJQ9D0[L8+8;=L)'R8 /RCH?G#]E
MWQ'?>+O@_P"$]0UG2H_#.K6/]NR:II-G>)?0Q!_%>NK:*US BQ3K-9V:7#"-
MY=AN'B?8ZE3]%6(P)G>!;<2WL[VY5D;[1$\>Y)VV*#'YB!F\N3$BE!N.2!2&
M:55[E69!M&2'#'@G@!LXQGGIUXJQ52^F>WMI+A=NV!'FEW G]S'&[R8P0<X7
MC <^B,>*:T:?YZ+J3.E[:$J7,H^T7+S-J*6J=VWHOAW>FI@M>337&BR0F-M.
MF_M'[?.XRL?EIMM?WR$Q1;YP4^=AYAPBY;(KYR^!_P"U9\*?VB]>\>Z#\-=7
MEUB_^'.O)HFL-;WGA?4+2VU%?"G@3Q:(9WT#7]<N(G&G_$+09Y([N*RG$-RL
M@A$$ME<WO/?M>?%G4/@W\,=:;PK,DWCK5/[-_P"$'\,2-J5E!K/V+Q!X9'B7
M&K6$MM8Z3_9VCZI<:@?MUW9_;W MK;[1,[Q-^ /[-7B#XH?L-_MN^!_AY\1?
M!%[\,_"O[5FB^#KK4[M/'&E:_<3?%GQQ\3?"_P &-'T^SMOAX+VWVW7P_P#A
M!IUXFK^(+.:.WNK62QO=<@L1I>F0%W?\'UO_ %8SCB7@+4W1JXF-DN:G3G4^
M]PC*R>O,NNUT?U&:7XKT/4M;U#P]9ZCID^K6LS)JMO8WUM<75I<(]\I2XMQ=
M3RVLAFT^]0QS6T9S#,H56BD$>VMQYL7VI89RPBFNEM9X]NH7#6A"AH[:)E5S
M&2(P(]JDW%N),O(I'XJ_L/CQ%J'[>'[8(U_XF?$?5K*P^)E[%X0\,ZQXJU/5
M=#>P?Q/^T.EQ%!93F6TTV"SLH].E@@V6:EK.TC1&-M'''],_MT_'SQ5^RLWP
M>^,;:MM\"R^*-6\+^*]+NIM>-B+*Y70?$3W<MMH6H2W-]-;Z;X0U]8HO[#O4
M\J^NH@/-F2"^:?Y[K\/NUZ'4\13J)5L'AUA\1)1C4]I"5).'O.>L[7;ER-*]
MTD[+<_1I%B\NWN&B>*:\8./,W)]F>6!YW6Z4MB$J$>%EPY6=XX^^X0RL$>*X
MC%I;7T^_<;^2:)#Y0"#;&),\0D[L*>61N^:_";XM?MV?&'2_AIX>\:^'TM'T
MCXR^.K34?!FIC5_$]M)I_@WQ)X2UOQ]H4UA"NMVM_:QRZ?H"V2V%W!I$UO;W
MTPN+"UE3[*_*VOQ6_:#^".C^*M3_ &@OVAKG1O#MS_8?_"!)JVB_$GQGXHU;
MR;IK?Q3M\3:!\6O$-OI'V"^U;12?M?ABQ^WZ=+'I\'VE[6;4("_:^]^G^7X^
M?H9NMF+^U1>EOXD?AM;EW^'1:;7/WYGOY8EM&,RVK"^@LI5U816T%]@$O'H[
M((Y+F^N2,:?$S[)D60F/<H(9=:E>P+<3>7:7FEQLIFM].6:XU>$R.%5)8_,$
M$<HNF(D1V&(XY@OSIBOY>=*_;\_:,N/V:OV@Y]7\464_COX;?';XK^%_"LM[
M=>/K[5M-M_!W@&-]#O;OQ WCN07$5GK+2M<6&D7>C>;<E[VPGT[?YA_:7]B:
M\^("?LJ_#_XU>./&VK_$3Q+\5/AS\//&VL0:U=:M)H>C:OKD,M]JECI-GK.O
M^(-4^QQ76O-9QO/JL\L@TJSN'GF0JJ#D[6U?K_7];B="M77UBO5I*=%\L(1G
M#FDI>^WRJUTI)+17]32_:Q_;O^#G[)/BOX>>%OB/J9?6_'GB7P=HNFVKW?A2
M"^@3Q7>^(+*PN9+34_%WA29;9;CP]>#[1'9WV6=5CCNCOCM_L'P+XLTSQ=X:
M\*>+=&N1+HOC?2++Q18L7M)";/6M'L=8L\26L]U;_P#'O>0D^1=W41SF.XFC
M*R/_ !*?\%0_V@OBI\5/$/P3\6?&;X%:1I'Q2M?CE\)/#GARTTGQQHU[HUYX
M9@M?&&HZ5J2K<VWB6YL+_P#X234-6L'63Q- JQ6@NEL;9;E;I_Z\?V*=4E\4
M_LM_L^7]UIJZ1>:7\)?AMI^HZ?'<QW:6NHCX:^$3>6WVA(H8Y_LTTIA$T DA
ME""2.1D(PKO0(XB5?]S4A.,(KE4I1DE:.NC=DE?:W7U/K&&(P[D4*(AM\H L
M6&<E]Q;U8Y7!/'I4]11;G:0[@R_)A0"-O!!R2Q!W$9X"X[YZU/L;T_4?XT/?
M>X*G&DE"+32V:U6OO-?)NQ1O K02QRI)=1R^7BVC&678ZMP(C'+RV)#F1N%.
M,+E3PGCOQ5H'PZ\)>)_'7B*^M].\->%O#FM>-;IKJZL[4F71-,O-8F5)M0N;
M*U:4V%C.5MY;^"$E&:26*-7F3MKRZ_LZ:*YD3_0OG_M"Y9MWV+Y5CM?+A16E
ME^T2N(W\M7V???:N37YV_MS_ !*TFX\,_P##-NAL?%GQ+^)-O_9\GA/-YHKK
MX'\8Z?XN\!-J::YJEE-X5=QK[0Z:NG7>IK(QN?MEQ8+IT4EP4,^@?@)^T-X#
M_:7\"0?$#X2ZO'=:4NK^*-/U2-;O0-0N$O\ 1_&/B7PG=.4T;5_$UM#%-K/A
MC6I;<->QN]L%WQ0SQSVEIZSI'COPOKFL:WHFAZW9:E=>'!IHOH-,O]+OWTW^
MV+=KNTNYTM[FXGA3;#(ZO>QK"Q)VQSH 4_F]_P""<OQ$\2?L;?M9_%']CCXH
MZ!K7@WPUX[U^'6?A/)=>-;;Q(^HW'_"+?$GXW?$>VL],\$Z;J6@^'X-&U?QM
M9VB?VD-(;5;:6&XMFU._@O'7W7_@F/>^)+K]M']LG1/$_P 3O'WB%M)\.? @
MP>$]:\0ZQJ>EZ=<7^A+.LBB[GO-,D6_B8&X6T2!F2ZDCGE#"3--W2ZM*VKT5
MMK=E;?S1QUL+G5;WOKV&4$W))XBC?EN^1<M^=R4'%-/5->31^\UU/";)GBM+
MJ^M/MY.H1P1M-?74QB;=<6Z02I%L:<V\C%3#&(Q+MC4;5+C:R)=W4TS1R6%L
MJ2V,B$^7:QB O?F>8*BDRLI\HR22JK+MS&,BORL_;;^-_P ;?V4/C5X#^,L6
MMV)_9XL](CTCQIHU_P#\)$^FIXA\0)\2[;3))-'T'QH9KZ:&\'A&*.Y3P-J"
M*465[RUCME?3OCGXC?MP?M:>'-(^$W@F30=(L=8_:&U76_!+Z@OB?79+SP3J
ML7B#1?#?ARXTJ:T\;B.^;6+WQ+9M>*UYI\4**(I[VTC\VZ@:FX[6\[I.[V^[
MK;OJCKH8S'8&FZ<XQKMQ:O3?,KRM>2Y;VDTN636KBY1>C9_1#YQ=]D8$:M8?
M:M/O;K*637I.+6+ST.V7((E\I5=WB#.-P %5(=0(O%MFVSR7N[^TKR ![;_1
MHC)9_990RHGR_NI_,B.Z0%4Y&ZOY[]3^/OQ\^'/@>T\+_''X_/X9\5W?Q'@T
M[PE8Z+HOQ,N-6U'3Y](DT_0;&Y\1:7\5?%^GP1WFI6.KPS"<Z?;17-O%?2V]
MI T?VGP?P=^WQ^TQX^_X)Y:U\2+K7[/PQXZT;^S?M>L:3J/CE]=M_P"T?C?=
M:#!GQ"GCQ-1E\W1[-;4>1=-LL[B2QEVP QE.5W=Z_P!+33IIIY&OLL;F,5.%
M?"X1QM:-:M2IRWO_ ,O'%Z_:LEYG]1E_/"MG*]_*H@64QS3:NR61: VYDD$3
M6QM(20A?8S '*R[B0@(^#?BO_P %!/A3\)_B)H_PK_X5M\:?'VMW\.L?9O$7
MP\\)Z#XH\!^'AH4M];W&G^*-:7QOIE_IM[=)I<XTJ!K&>6Y>6T\YX_,D">U_
M"?P7J&D?#&^\+>-?B1XS\>7.I6/B36[KQ7KFHWMQKFEZ5,TNC/-I\^I3ZY.A
MTE;6>>RC2:29;F622&WV-A_QP_:&^ GC/]F/XH'XX_ 7XEZM\=V^(&J^+=1\
M1_#O]H.SNO%GA30I(]2NFTNR\#HOBOX>IX?CCC^(FJ3ZQ)=6^O+JT?AKPI;6
MZZ1+IDDE\-WVO:RO=K5[[=NRUMZG*J6:4*BI8C%T:^$2D^6G6IU?WFT))0;4
M;.Z=K7C9ZIG]%5H6N8;:)I=/N)_WOVW[!-)+8) 9@NQ)"S7"7$L;*8ED8*[)
M=$<1IC4MT6-RB#"H611DG"K@*,DDG  &223W-><^&M5FUO2[/Q#IM@UBFN:A
M:I'8PWD8MM.BL)[_ $^:XD AM#>VYFB6XN+*-+.6<RE$F!4S'TB".9#F8HS\
M[WC7RT=R!N9(S)*T:,V2J-)(R A2[D;C)L67^Z?P_F*SE*1ND2\&Y*S.,Y/[
MX[6(R<@9'8$#UK28$@@?YYK%O)X;3R+J0@&6"*TLU*LRRWLFZ2WB^528]Y4C
MS'V1H/O.IH#F:TUUW^6U_O9YY\6_B=X7^#G@;Q#\1O'E^^F>%_#3:6EQ/#-I
M5M<A=5UK3O#]N8GUV\T[36W7VI62R&>]B&R1A%OG:&%_.?V??VD_!/[3GP=T
M3XX_">YO[SP=JNJ:W )[_P#L"YF%MX8U"\TO6+19/#>L>(-*$AN[%Y8L:M),
MJR?OY;7(@C^$O^"@?COQ%\;]=\.?LH_#/1QXNO\ 67UV+XJ:5%JH\.SZ'-HU
MOX-^(7A%(;GQ+]@\,ZS]N.C:G,[0RZLMBEH5+6=[<6WF?%/_  3*\2:W\ +O
MXL?L ^+-6UCP;>>#_#7B[XI?#VVBU6[U/4-6T/Q;9_#>"+=/X7:X\(:/%<^-
M_%'BJT6(W%A?1-81ZC>67DWIU"Z:;_K^NEM!?5:<ES\\8R>K7,M?^#KVTU/Z
M+M"\1^'/$<=S)HNL6-X;6\FM]46RU"PNY=*U4(CW=A?I!/="RO8_DCFL[G$T
M+ J8U;YC(T]X72YEA@N%#"RBN+=9WVVUX0]Y(Y#K#Y<;VD(:7:?**A3]]\_E
M#_P2YEU>Z@_;2FU/Q_XP\?ZS;?ML?&#P]8Z-XFUC4[R#0K#0X]%E71='NM6E
MN;>RL[+^T;QC':R+82K:VZ6L$3?-)F?M>_M.?$+]C'XU^!;OQ#XG75OA?\9_
M[5^%?@S3=4;Q6ZP_%G5%^&LO@W2[:#1=?U:"VDUU/^$\=M8OO#6D:5IGV95O
M]=M6O4_M0LG=Z:^:7WK^F*^+I>Y2=&5.'P.4HWU]YZW3MS-[.VBT/UUN;AU$
M/V9+:YEC:,^0C2RW*1KN_?F&*0'RE;:AD8%/,8*1R*EEGM'2$6$BZI<0^9LE
MBD2YCM_,(W?:?L;H$\U ZPY0[FC./NN3^&7Q=_:,_:$\.S_#;P,L]YI>I_&V
M\\'>,/#6O:/XJUC3=<TRU^)+ZGI&C>&8KZV\2W DT&RN(/MB6ES-HR/>1Q33
M1Z<(U=H-=^,7Q6\(>"O!GA;Q9\=;H_&#4_\ A(OM7A?P+I'Q"\$2M]BU:'48
M?[1\43?$'QMH^IX\+W-MJ-I_Q-(/L2_;-/\ WEU=BWM'R1_N^?O+^NBW[:#]
MKF#M>5'2^U2/6^VO6[NDTM7N?N;',\L4FHV<VFW<L"/%)-IDTEWN@B43O!&N
M^2$W!8JZ*RJ3NC!(5L&M_:<VVZE)AT^X"6CV4FN@V4$S2J#>%2KJ9=@)#",$
M1/)"& #5_.U\&/VM_CC\<OV=O@G?7WCN7X7^(M<_:K^&_P "_%M[X2NO&[7D
MFC:GX&TJ;7M>DO;?QE!->W[WVKO*]G-=7UO<2Z?;2R&Y?;(/W&MM)\0_#'X2
M6$[Z_=?%[7-)L;1]/OO&'VD3Z_'JFKPF2XO)M3U2^F@:WT[44>)+B\,A%C;1
M'Y@L2"?EM?2^E]KJ_EM9;I%TL9AZ$9J.#ESMWG..'EJ[J4]M)J<U+6_O1EW9
MYK'^UCX'\2_%EO@]X!M=6\?>*]$.C7FM:UHD&C^(?#F@6^H/I$@:_O/#7B/[
M78/IT/B70]0O3J>C^7;VFH)/(TT%Q8++]<:<][OMQ>I#')<0BYE>!91')<21
MYD@)GR5D!#RF) K*L8.=@=3_ "5?LP_$;XG_ +*7P\^#_P"T!X;\4Z1\8_'/
M[07[3WA?X._$31_&FC^([/5-+\.:^]IIMS+I'C.7QM+-/-#I'PM\,_8+;4;?
M5["VN=;NY)K>XBL8[*+^JSX<ZQ=>(_#_ (<\0ZC%/8ZCX@\,Z3XBN-#FO/[2
M@TN76+&RNYELKQ8XX?(M9KF33X$"&8Q;Y"YCD*A)[^C_ "M^7S_$Y\13>,JP
MQ";I1A4C-4V^5M1ES<O*TGKMLO\ /U%>C_3^AK.OUNGMITM%MWE>"5"EQYNQ
MT:-P57R")"[,5  (X+8^;%:2@[6/8CC\,UFW8,B,8I)EF@5IXDBD,7G2Q!MD
M$K$8,,CD!P2H/!W #-(V/C/]HG]L_P #?L\^-/#7A+Q%I_B3Q#<^+?[8^Q:7
MX;T_0=3N_P#B0Z5HFI7/D0W7B70KY_W>MP7$NU;O;%!.Q^SPQJ9I?V9/VV/@
M[^U"_B;2_A]J4^D>*? >N:UX \3>%?&-WX5L/$%KXB\+G0+?6A%HFB>*O$&I
M16,&H^(++3H_[12TU".]BNK2\LX+A(A-^?/_  57L]3T_P")?P,U3P)IOAR]
M\=:?_P +-_LZV\0Z,M_;:I]JT#X=V]W]HGBU7PXT/V+1WO)(O-U9?,D2!$R$
M-M/\Z_\ !/O3O#7@KP)^U/\ M#:M+'IG[4ND^-_CA;>/O@UX1L/^$:\"Z!\4
M;#1O!?CCQ3I/]N06^OVVLW>E?$6TD\*_\))I_C"\L]1T>.VO+34+B. :I, ?
MTD"]GM_ML[11SWRQVMHD%JLDKS"UFGWE(#('<)]IE?<FT[02X 3%1DR[GMM+
MDT@(DD0:VO+BX-W"9%=D\V.&0LC2LTCPAN'C((!QQ^'/[./QX_::^.GBQ_'J
M:\- \-^'O%_B[PQXET+^U/$>K65EJ,6@_;8+9ED\?:4+TVMYK-M;+-::5=6I
M^S17$4L2Y\GA?@G\>OVF?C?HOPNU"/Q'J/A[XFV_Q)\,2_&'PUI7B3Q"=$TK
MP@_B37+"RE@EG\:VT&J)<Z!9:;>W-C!KOB%WFNYX6L8&4VL(!_08DRYB8%+B
MZC/V*[ALV\Y(_*C=Y3LW>=&B7"H@:0AAN1'&YN?CKQO^V1\/?AW^T;\)OV:]
M7T?QW+X]^,MUXKL=(U2;2?#B:<;KPEX0T[Q<7\QO$>F7@6*PU:UBD^Q^&=3)
ME3;-%%&1=3_C_P#'G]OCXU_!RZ_:(\.1^*+#3]9\"VUQKFFZG?MX]OW>P_X7
M;X1^'XE,6B^,+5[<7,=]<@1V^HK/$SLLD3VCN6H_M!?$2/Q1^V3_ ,$V/B'J
M.NV<.JZKJ/[5=U=^*+'2=:AO+&TT+X?>'-.NK^(SWEUK4LMAI5D_EQK>>>_D
M>5:JR/%  #^D==8CE>"TBD;[08(YIVN1"JHN1%*D_E,#$ZN09%$:[!NPRX"U
MC1^+-,O]4OK#1Y;/6-6\/R1V^H1Z9.FH?8)KF)U$5U%:WCS6[LL%PBI<Q1.7
M@F"@F*0C^='XK?M2_%3P[\7O@S:^!_B;XN\5>#_'W[7_ ,._@OXBO4\2>,_#
MDMIH'BGQ/J,>KQVEK>ZP&EE@TN"TE@AN-/N],=K@1RVTY@>"NM_X71XQ_9UT
M+]M/XL0^/_'OB/4[7XG:9#HNB>)?&'B"ZL=+L4^,'BOPI%#;7%B1+$DNCZQ!
M*4MA9HKVMM 81#&84 /Z);U[J![PV:^;Y-J]Z0Z&2-KR&(*D!,2A][Q)"WD!
ME=D;>I&Y356 #R((F33X;_64%Y/;237*&23RTN'*PM,9T*.9BRQ@JNT \*U?
MSS?M#_M7_'SX$_&,>$? ?Q#U+XE^"/&?[/\ <^.M2\1^(=5\;Z3=>"[^X\:^
M(_!6HZMI^F3^,HI;\:#I_A&WU2"*TM;?4[NYU*Y@M;M5C&[5^&_B']JCQU^R
MQ\1_C5I'QY\1ZWXWM?'\-EX%TW[5XVLK1=#OI/AY<SVRWVJ_%=;RR6VTGQ1J
M$J1I?:7#((XX!9^9)-!( ?T(K<,-D06 W=NX6>-3(5B2<F12B;_-&Y41B9@1
MG[GRFKDK(51C,/."J1$&CY;!(4)C><M\N =W;.:_%;]A?]K_ .(?[7&L:(VG
M7D2:)X"A#>.?$%C?>)4D\1S^)_&5NN@0W6GZ]JEG>XT_1_#GB6RADE_X2%0J
MN/\ B70W,-E??M*L3">W"VWGPB")C>-+$I\P/@@PLIE+;?WI?=R3M^]DT :2
MDD#=@'G.,XZ^_/2EI%W #>59N<E5*@\\84LY'& ?F.3SQG 6@ I"2 2!D^F<
M9_$TM(>AZ_AU_"@#"D@DQ>M<$A;O[-B15\Q5^SD#GRB0,G:HW%,GINP:^-OV
M;/V2= _9W\(>,/#VDW7]J:SXG\2^(/%4LP@O;19H=:TO0K%[0"X\2:Y9*TEU
MHD;B1+B"51)\MK%$K/-]KW$GDPNB1O="+;YD2)Y\_P [*5R@(]2WS ?(I(SB
MN&\5^._!/@6WBN/&?BWP[X5M)($$-UKNO:3H=WO>.Y>.(S:K>6<>/+L[J0HK
M$^9;S.N5AD*@'Q;^SI^PWX9_9X^,/QF^(?AR_&K?\-(>-M1\>_$?38[:_MCX
M<U4:EXZ\36-I/=W7B[7?MAFU?QYJ<22Z38^'K<FU8O9-;RPV]ER<O_!.'X0P
M_#[X)_#[P]:"71OA'\:/#GQ1LM5%UXE6*>#1]5\0ZM=J(;WQTTB>5?:_=(S2
MZAJ;DP,4T^2)EB@^ZM/^+'@ ^'[[QN/%/AB+P7$MD8?%)UO14T[4UENVTG[0
M=;_M+^RKU?[3Q;QS+=@>;,L7-Q((ZX>Y_:7^ =GX,\.>,8OC!\*O^$0UK5CI
MEIK%C\0/!G]D7+)=:M%>1PZ@NO+I<T<<NF7Z7*174I2:VN%EC#0S", ^/OVL
M?^"=GA?]I[Q+\,]>?Q N@VWPU\.:GX-W2:9?WT=QII:%]+997\<>'@B)(9U5
MUCU"2;S1YUV0L8JI\/O^";_A/X=:A\(X]+UZ.ZM/@]XUTGQ=X5B^P7T#7\EO
MXST_QIJL<'VCQW?3DQW-FRR&Z_M<)UBM1&1:OZS\9?\ @HM^RQ\$CX!O/%WQ
M+\%G0?'%SXMATEM.\9?#HKK">&;+PY<RS6+:GXWTFSU!85\2:5=226S78CMY
MXYV%N);9I_H6X^.WP@TRZT"'7?BA\,;76+^[EL=%M+7QKX8A+WE[/!9+#/;W
MFL1W3&>2\LA%':!Y9?-8!'9XD8 ^ ?VP/^"7G@?]J/XTZ/\ &"P\1Q^%-8B\
M*:?X-\3?\2[4]<:>S3Q7XF\4:S<2+/\ $+P];6OF77B!-T-GI8E@-MBWNA',
M;>#S'XN?\$9/@]XY^"_@CX3V'BF+05^&O_"2_8O$<FE^)+V(?\)CXKTWQ+<Y
MT^[^*EC&,FT>Q'GZI?9:83Q_9F1;=_TK_:0^).K?#SX!_%'XB^#'T&ZO/#OP
MX\;>/4U/=<SZ7/IVD>#-=UU9+6]TJ_LI9;F66RM;B!A?00/;MYHO(F,<R1?#
MK]H?X)?$M]1T31_B=X*U_6H/LG]K:5H_C3PEJMQ;>8+Z[L/M%C:ZW?W</G6E
MA+<Q?:8AYB0RS0YBC9D /E7XC?\ !./P7X__ &7O"7[/%Y<R3W'P]U?0;_P[
MXL^QZU&HU+PG\/+[P/I&K_V+%XVLX2N^];4OL=]KE[:D'[)<K<J!>+I?LA?\
M$_=$_9'U"?Q%X;UT>(O$>IV>C_VQ<1Z==:<\E]9Z7K]C*S6UUXT\3V<1/_"2
MWXVV]O%%^Y++O#1/;_>"_%'P-)X;_P"$HTKQ/HNI:#+J/V1=4@UK1[S3IKM[
M#^T5L+>]MM0-G)<269CN(K47!E>"02A3$RO79:7J%KJ5AINLZ?Y,\&JVL=[%
M+:>7+%)%-$KQ$O \B.RH^'VRR*) X5R!D@%O34D%O:F=&AG2*Z5H6!+ /<*V
M21@#A$(!&2&R/NG.I3 <R,"HX PV.<'&03]<<#TYZ4^@"&783'NY?<#&.>2K
M*Q'''0#)/ Z^M<GXFTJ?Q#9:MH=X?LFFZQH]]I,TQV3+MU"*>SD)6.6"8?Z/
M.S86:(@+@2(Y#CK)2%&\KN*)(P50&F.%R1".[G&, C)P*H"1#$9"LLQDN#&J
M3 2"W=UW+]H4G]U'$>)<$F/) !S0!\3_ +)?[(7AS]E;3[3P]X:U19K+3_/^
MWJ]K>6XD^U3^)+ZU^;4_$_B"5-DWB*<_N9WW8 DVJT:0YVG_ +&'@1OVE/'/
M[3GB"9IO%_C;POIO@N\T$P:W%/<:#IMKX,C3;=6?B@6:K<R^$DMU>#PY;7<;
MRY%W*4(N?8HOVF_V?]7UJQT>3XO?#;3;^X^T_:8IO'_@JSGE\FT-U#OC;7Y9
MGV0Q!E\R)MJ2!DPC;A\O_P#!0K]L2T_9L^#6O^(]"\4>!%^(?AN:ZNIM(N=;
MC75'TN#P/XL\26TT.GV?B?0M<:UEO+#3X4D>>"W>Y9HXV$I@G0 ]0^#7['G@
M7X)_%'XL_%'PS:RS:A\3=8M=>NO#(&NJ]J#JGCF\BFDU6^\2:M&3(/&5[%Y7
M]FZ:RG269H-UXB6GS%_P[#\-76O107?C*!O CZII&N7FG?V1<+&QT-5MI;!M
M1C^(:ZI'_:5OJ>M-]J1U^QA6V0S,MLT7#?L\?\%$_$WB?QA\"Y/B3?>$?#WA
M/XH_ 3X<^/[ZZU*YU#2=4^T:[X2\:ZXNIV\^O>-[C3?[!U._ATJVTF]F.H/>
MS1:K"+V:9+:8?J/>?%GX6V7@NS\677Q%\ MX-U9=2_L?Q18^+O#K:-X@CTM[
MV#6K?0=;DU)-*U6_L;F":S>*UN95M;R"XM[ORY(G  /'_C=^R7\./C!^SI9?
ML^ZG-'X8\)Z,W@ZVTG6[AM9OK6"#P9!9VFF76T^)M(GECOK*U^QQ?:=?E4-<
M)*\E[<!"_P [?L__ /!/'3_AOXQ\,?$+Q9XF76]1\(:DE_I&G_V1+ICP/<C4
M+2[<RZ;XWOD?]W-:706[L+D$0>5$@\V1Q]U:K\6/A8_@*T\1:EX[\&P^!)X]
M)B.L3^)_#L:[+F"WN=,MO[0N-2.C_P!HR>992RP^>0]NTSVX;,3'YP\6_&;6
M?%?Q#^#^H?"[XH?!Q/!7CO7]0M7T/5?&MTOB;55T>71=.-AI.F^'=4N=)OKR
MZU1-1BCM2]X)TN;1-L5Q-.@ -SPE^R/I?A/X[>(OCGHVH_:+[6+G5WDL39W$
M&V+4/&-MXP:+[3=^);B)@LUM%#YBZ1$3N\P;%#6K<MXK_80^'GB?XV>-_C4X
M^P>(?'UUI6H:_./[<NXQ=V'AU-%C#%?%]OIJ_*98Q]DTRRC+/@QNZK)7T=J7
MQ[^%WAS6['P?XM\=>%_#WB*2*VL[C3IO$_AW2;J?56NY-+E$-IJ>L07TD$E]
M!<P1A[4W+R0&)E,T4D8-4_:1^ ?A:\N=)U_XV?!W2IM.CL[C4].UWXD>#+'6
MQ;ZQ;0ZEHS_8[W7;=QYMI>VET&N(D1[2:&>U:6*2.1P#QO\ 8S_9 T?]D3P3
MKO@7P[J0U/3+O7M8\21,EI<V^;G4].\-6TB[;OQ/XGN-P;1 ,->*K!@RV\8P
MTWW':+M@C)X9U1W'=79%W*1V(/!&!CT%<1X)\9>%O&VA6VN> O%/AGQMH5S/
M<K_PE'AO6].\2>';DVLQMKVTM-;T:ZN[.:\M9$$<\'G-Y#I(DH5E"CM[9@RR
M$'/[UQGJN<+_ *O_ *9_W?:@"S113&D4!B2!MSG) Y SZT #2*N>02.W_P"K
M-4UD>-+N2;_5*\[+T&4 W  H"W*@X."?J<5%-(JQ>>98T7T9PI^\$[G'7W[_
M (5X9!^TI\#]:UZW\#:1\4/ 6H>*;NYBMK?1K/QKX0N]1O8)[T:/%J5KIUKK
MTNHW.F7.HRQ6L%XEHR33NL"J9V6(@&S\9?AU#\7?!-WX.U"0V>D:LMJ99O+D
MN&5++5-*U6W*P0WNF7D@>?38A^[N8]JOO??$"DGAO[,'[+VB?LL?L_ZA\$/"
MLLEUX>O;WQ;_ &9=1VM^/LK^+K=3<N]O?:]XCOFCAOENI6DN]6CB.\(K6L/E
M9^7/^"DW[<5M^S-X+CN_!OQ.^%=MXKL UM_PC^J>-(X;V">+5? EA=1:KI6E
M>+=!U*)UM-9OKBU3<CJ@2:11&)DE?X'_ &VM;\)_M<?$SX/?&[6?"GAWPUH/
M@W3-9TE+O4+O2(S<:E9_#FXCN;9?%OBNVL#;;=7U]7FMM,A?[3!<A99!%>M*
M 7/AM_P2_P# /@#XP_%#XGV_B5SJWQ@T[Q+=:Z$T'796CE\6>/=#\=WL#+_P
MGU_;[4U+0;<_:+73M+C9@$B%M"[64^3\+_\ @EQHOPT\,SZ/H_Q'?3[>\O=&
MEFL)/!E])+/%I^O7-^\:O??$"]N066\G;=$P=1,"%?;$B_I-K?Q>^'VA^'=)
M\::EXQ\'Z+X7US1M'O\ 2_$VK>(=$T[1S::TBWFF,^LW&IPZ?]EOK8J+-K>Z
MFBN;B: 6[RQR!JQYOC;\(-2TBV\7GXC^'K30(KB"--7/B_PQ!H6^ZU*'1XY)
MM0_M:2R^SP:@%BN'%R#%)YB*&GQ%0!\6^./^">&A:YXJTGQCI7C$6VL:/\.[
M#P6L4OA^[62^;3]1N]4$Z)?>-K:&);JZFC552SF1&4A;N1=\2_3'[,G[-^@?
MLU>$)O#OAVQ:>XUCR_[3NHYK\C_B7ZIK]]9;HKK6_$$:?)KT\8\F>'<5+2>8
MVU(>!^('Q0\3W'QL^&,'@OXB_"G4O &M6W@LWEM;^+M0O/$%[%J/BV]2XU2T
MATG4&T6YT>YT5K6.WO91*LU[(JOOM&C%>UV_[07PG@U]?"4OQ+\&V6O:KG^R
MK/6?&7AJVE;[#9-J=]BW;6A>G%D1+_HUM)A7B>;9$WF4 ?0,<BJB*&#A44!@
M0 P"@!L<XSUQD]>M/\T>W_?0_P *^=)OVIOV>K8ZW;GXP?#4WWAR^U+3M6T=
M?B!X(_M>PFTC*7_VK3SXA6:U2UF7[+/]I6!H+K]Q,D3<5ZMX7\9^'?&>DZ7K
MOA?4;77-)U>)9K34-*N['4[,I)8VNHQ[[K3[JZMB9;2]MY8_*FE#K(KJ3$\<
MC@'=4444 %(6"XR0,G SW)Z"D9@HR<]^GM5&\E7RM^]84A;SII96$<44,:L9
M))),X1$'S.[$(J@LQ % %W*)G+ 9)/)]3G^M<YXHTR36],?2T81P7A:"ZN!M
M<1V]Q;W%M.2ADB8A$E#DI*C'&%92=P\H@_:!^$&J>+/^$#L/B9X%F\71:AK.
ME3: OC/PQ)J\5[H(NFU"*72H=:DU.-HXM/NI]CV8E2"-I9XX5239KK\9OA?'
MI5UKMW\1O!EGING"XAU%KWQ?X>MXK.XMX#J$EO>-)J@M[>Y;3FCO5BGF1S8S
M17)"P2*Y /G[]GC]D+PK^S+XL^.7C/PE?_;[_P",_P 1M0^(VM6\=KJ*,=3U
M6_UVXF :^\3>(8_E.N7#YL[32[<A"%L8P5$/@\__  30^&TWQZU;XI)J:6.F
MW\_AC5=:T,VVMW!.H>%+7P[::*AU)O'RW ,]A8ZTP^RZ<D*BZ/VF*YFM[5G_
M $,'Q.^'L%KIFI77C7P5%::UIUKK^DB3Q)HB3:MX?U:(2:1JFF"2_6._T^Y
MEEAO;:26RFC21[6:4*QKA_#'[1OP2\5R>*[?1_B-\/\ 49_">@7'B#Q*(?%_
MA*[O5TV"$3+J9%KKERXT[3K=GAO[V_6VM[26YL8Q,(YB: /DOXD_\$Z?A#XX
M\>KXZGU./1M1U3P"/A#'"\'B.[>Y\,WNLW^L(R ^.K*/;-/=E%*V2WV8CC5
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M) [X.,\@CL0<$>E58X)P+@/'91M)=RLCVZ.CFV<#;+(Q7/V[.2[C,>0I!.*
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MQ#\/[+Q<VHZ-XJ_LG[3:MX=U:P:R_L/6KO6H=SW'Q-N;R?[3=7;R#;>6WEA
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M@^N>,9Q]:SKDQHD<TTKPQ6TR7,TH=8XHX80SR/<R-A4MD4%IF8JJJ,LP )H
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MA('![-_*O._B:#/X \8VIADU#[7X8\0V@T.W#&\\3&XT6_C'AO3_ "<W8O\
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M&KYPK'=C:1\S=#TH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&7M+7Q4UO]HO]K']I[]D'XNV7[,?Q9\'>%_ #?'R7XA:5K_A?QA-<6=KXB\
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MT^Y\%Z[I_B>?QQ;7F@^)M#\(WHO/#D_PEC-K/(-&NM4:V,6ZWT^[61_F@W$
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %0R1&5@CA3!C+*>6=LD%'!!
M1HF0D,I&2>#Q4U% %.*UCCD<BVLTCPOE&*%5DW9D#[SM"XV>6%V\Y\S/&VI(
M(I%B59GWRC=N969@<L2N"XW'"X'/<8'&*L44 ,V#U/Z?X4^BB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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D=PROR;<8'WLYJ>B@!J(J*%4849P,D]22>22>I/>G444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>32
<FILENAME>afya-20231231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6Q5w7xRiXgen8uDa3dMSaSEqbPtxp50OYlBuW9zbdlq/yUhD/ve0ipM+ae2sScJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:afya="http://afya.com.br/20231231" elementFormDefault="qualified" targetNamespace="http://afya.com.br/20231231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://afya.com.br/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/StatementsOfFinancialPosition" id="StatementsOfFinancialPosition">
          <link:definition>00000002 - Statement - Consolidated statements of financial position</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" id="StatementsOfIncomeAndComprehensiveIncome">
          <link:definition>00000003 - Statement - Consolidated statements of income and comprehensive income</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/StatementsOfChangesInEquity" id="StatementsOfChangesInEquity">
          <link:definition>00000004 - Statement - Consolidated statements of changes in equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000005 - Statement - Consolidated statements of cash flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CorporateInformation" id="CorporateInformation">
          <link:definition>00000006 - Disclosure - Corporate information</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPolicies" id="MaterialAccountingPolicies">
          <link:definition>00000007 - Disclosure - Material accounting policies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/SignificantAccountingJudgmentsEstimatesAndAssumptions" id="SignificantAccountingJudgmentsEstimatesAndAssumptions">
          <link:definition>00000008 - Disclosure - Significant accounting judgments, estimates and assumptions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/SegmentInformation" id="SegmentInformation">
          <link:definition>00000009 - Disclosure - Segment information</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinations" id="BusinessCombinations">
          <link:definition>00000010 - Disclosure - Business combinations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CashAndCashEquivalents" id="CashAndCashEquivalents">
          <link:definition>00000011 - Disclosure - Cash and cash equivalents</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/TradeReceivables" id="TradeReceivables">
          <link:definition>00000012 - Disclosure - Trade receivables</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RelatedParties" id="RelatedParties">
          <link:definition>00000013 - Disclosure - Related parties</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/OtherAssets" id="OtherAssets">
          <link:definition>00000014 - Disclosure - Other assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/InvestmentInAssociate" id="InvestmentInAssociate">
          <link:definition>00000015 - Disclosure - Investment in associate</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>00000016 - Disclosure - Property and equipment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwill" id="IntangibleAssetsAndGoodwill">
          <link:definition>00000017 - Disclosure - Intangible assets and goodwill</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" id="FinancialAssetsAndFinancialLiabilities">
          <link:definition>00000018 - Disclosure - Financial assets and financial liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FairValueMeasurement" id="FairValueMeasurement">
          <link:definition>00000019 - Disclosure - Fair value measurement</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CapitalManagement" id="CapitalManagement">
          <link:definition>00000020 - Disclosure - Capital management</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligations" id="LaborAndSocialObligations">
          <link:definition>00000021 - Disclosure - Labor and social obligations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/Equity" id="Equity">
          <link:definition>00000022 - Disclosure - Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/EarningsPerShareEps" id="EarningsPerShareEps">
          <link:definition>00000023 - Disclosure - Earnings per share (EPS)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/Revenue" id="Revenue">
          <link:definition>00000024 - Disclosure - Revenue</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/ExpensesAndCostsByNature" id="ExpensesAndCostsByNature">
          <link:definition>00000025 - Disclosure - Expenses and costs by nature</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinanceResult" id="FinanceResult">
          <link:definition>00000026 - Disclosure - Finance result</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>00000027 - Disclosure - Income taxes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/InsuranceContractsAndContingencies" id="InsuranceContractsAndContingencies">
          <link:definition>00000028 - Disclosure - Insurance contracts and contingencies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/Non-cashTransactions" id="Non-cashTransactions">
          <link:definition>00000029 - Disclosure - Non-cash transactions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/SubsequentEvent" id="SubsequentEvent">
          <link:definition>00000030 - Disclosure - Subsequent event</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" id="MaterialAccountingPoliciesPolicies">
          <link:definition>00000031 - Disclosure - Material accounting policies (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesTables" id="MaterialAccountingPoliciesTables">
          <link:definition>00000032 - Disclosure - Material accounting policies (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/SegmentInformationTables" id="SegmentInformationTables">
          <link:definition>00000033 - Disclosure - Segment information (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsTables" id="BusinessCombinationsTables">
          <link:definition>00000034 - Disclosure - Business combinations (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CashAndCashEquivalentsTables" id="CashAndCashEquivalentsTables">
          <link:definition>00000035 - Disclosure - Cash and cash equivalents (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/TradeReceivablesTables" id="TradeReceivablesTables">
          <link:definition>00000036 - Disclosure - Trade receivables (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RelatedPartiesTables" id="RelatedPartiesTables">
          <link:definition>00000037 - Disclosure - Related parties (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/OtherAssetsTables" id="OtherAssetsTables">
          <link:definition>00000038 - Disclosure - Other assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/InvestmentInAssociateTables" id="InvestmentInAssociateTables">
          <link:definition>00000039 - Disclosure - Investment in associate (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>00000040 - Disclosure - Property and equipment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" id="IntangibleAssetsAndGoodwillTables">
          <link:definition>00000041 - Disclosure - Intangible assets and goodwill (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" id="FinancialAssetsAndFinancialLiabilitiesTables">
          <link:definition>00000042 - Disclosure - Financial assets and financial liabilities (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FairValueMeasurementTables" id="FairValueMeasurementTables">
          <link:definition>00000043 - Disclosure - Fair value measurement (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsTables" id="LaborAndSocialObligationsTables">
          <link:definition>00000044 - Disclosure - Labor and social obligations (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/EquityTables" id="EquityTables">
          <link:definition>00000045 - Disclosure - Equity (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/EarningsPerShareEpsTables" id="EarningsPerShareEpsTables">
          <link:definition>00000046 - Disclosure - Earnings per share (EPS) (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RevenueTables" id="RevenueTables">
          <link:definition>00000047 - Disclosure - Revenue (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/ExpensesAndCostsByNatureTables" id="ExpensesAndCostsByNatureTables">
          <link:definition>00000048 - Disclosure - Expenses and costs by nature (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinanceResultTables" id="FinanceResultTables">
          <link:definition>00000049 - Disclosure - Finance result (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>00000050 - Disclosure - Income taxes (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" id="InsuranceContractsAndContingenciesTables">
          <link:definition>00000051 - Disclosure - Insurance contracts and contingencies (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/Non-cashTransactionsTables" id="Non-cashTransactionsTables">
          <link:definition>00000052 - Disclosure - Non-cash transactions (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CorporateInformationDetailsNarrative" id="CorporateInformationDetailsNarrative">
          <link:definition>00000053 - Disclosure - Corporate information (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails" id="MaterialAccountingPoliciesDetails">
          <link:definition>00000054 - Disclosure - Material accounting policies (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" id="MaterialAccountingPoliciesDetails1">
          <link:definition>00000055 - Disclosure - Material accounting policies (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" id="MaterialAccountingPoliciesDetails2">
          <link:definition>00000056 - Disclosure - Material accounting policies (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" id="MaterialAccountingPoliciesDetailsNarrative">
          <link:definition>00000057 - Disclosure - Material accounting policies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/SegmentInformationDetails" id="SegmentInformationDetails">
          <link:definition>00000058 - Disclosure - Segment information (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/SegmentInformationDetails1" id="SegmentInformationDetails1">
          <link:definition>00000059 - Disclosure - Segment information (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsDetails" id="BusinessCombinationsDetails">
          <link:definition>00000060 - Disclosure - Business combinations (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsDetails1" id="BusinessCombinationsDetails1">
          <link:definition>00000061 - Disclosure - Business combinations (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsDetails2" id="BusinessCombinationsDetails2">
          <link:definition>00000062 - Disclosure - Business combinations (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsDetails3" id="BusinessCombinationsDetails3">
          <link:definition>00000063 - Disclosure - Business combinations (Details 3)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsDetails4" id="BusinessCombinationsDetails4">
          <link:definition>00000064 - Disclosure - Business combinations (Details 4)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsDetails5" id="BusinessCombinationsDetails5">
          <link:definition>00000065 - Disclosure - Business combinations (Details 5)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" id="BusinessCombinationsDetailsNarrative">
          <link:definition>00000066 - Disclosure - Business combinations (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetails" id="CashAndCashEquivalentsDetails">
          <link:definition>00000067 - Disclosure - Cash and cash equivalents (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" id="CashAndCashEquivalentsDetailsNarrative">
          <link:definition>00000068 - Disclosure - Cash and cash equivalents (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/TradeReceivablesDetails" id="TradeReceivablesDetails">
          <link:definition>00000069 - Disclosure - Trade receivables (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/TradeReceivablesDetails1" id="TradeReceivablesDetails1">
          <link:definition>00000070 - Disclosure - Trade receivables (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/TradeReceivablesDetails2" id="TradeReceivablesDetails2">
          <link:definition>00000071 - Disclosure - Trade receivables (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RelatedPartiesDetails" id="RelatedPartiesDetails">
          <link:definition>00000072 - Disclosure - Related parties (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RelatedPartiesDetails1" id="RelatedPartiesDetails1">
          <link:definition>00000073 - Disclosure - Related parties (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RelatedPartiesDetailsNarrative" id="RelatedPartiesDetailsNarrative">
          <link:definition>00000074 - Disclosure - Related parties (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/OtherAssetsDetails" id="OtherAssetsDetails">
          <link:definition>00000075 - Disclosure - Other assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/OtherAssetsDetailsNarrative" id="OtherAssetsDetailsNarrative">
          <link:definition>00000076 - Disclosure - Other assets (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/InvestmentInAssociateDetails" id="InvestmentInAssociateDetails">
          <link:definition>00000077 - Disclosure - Investment in associate (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/PropertyAndEquipmentDetails" id="PropertyAndEquipmentDetails">
          <link:definition>00000078 - Disclosure - Property and equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails" id="IntangibleAssetsAndGoodwillDetails">
          <link:definition>00000079 - Disclosure - Intangible assets and goodwill (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1" id="IntangibleAssetsAndGoodwillDetails1">
          <link:definition>00000080 - Disclosure - Intangible assets and goodwill (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2" id="IntangibleAssetsAndGoodwillDetails2">
          <link:definition>00000081 - Disclosure - Intangible assets and goodwill (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" id="IntangibleAssetsAndGoodwillDetailsNarrative">
          <link:definition>00000082 - Disclosure - Intangible assets and goodwill (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails" id="FinancialAssetsAndFinancialLiabilitiesDetails">
          <link:definition>00000083 - Disclosure - Financial assets and financial liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1" id="FinancialAssetsAndFinancialLiabilitiesDetails1">
          <link:definition>00000084 - Disclosure - Financial assets and financial liabilities (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2" id="FinancialAssetsAndFinancialLiabilitiesDetails2">
          <link:definition>00000085 - Disclosure - Financial assets and financial liabilities (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3" id="FinancialAssetsAndFinancialLiabilitiesDetails3">
          <link:definition>00000086 - Disclosure - Financial assets and financial liabilities  (Details 3)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4" id="FinancialAssetsAndFinancialLiabilitiesDetails4">
          <link:definition>00000087 - Disclosure - Financial assets and financial liabilities (Details 4)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5" id="FinancialAssetsAndFinancialLiabilitiesDetails5">
          <link:definition>00000088 - Disclosure - Financial assets and financial liabilities (Details 5)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6" id="FinancialAssetsAndFinancialLiabilitiesDetails6">
          <link:definition>00000089 - Disclosure - Financial assets and financial liabilities (Details 6)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7" id="FinancialAssetsAndFinancialLiabilitiesDetails7">
          <link:definition>00000090 - Disclosure - Financial assets and financial liabilities (Details 7)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8" id="FinancialAssetsAndFinancialLiabilitiesDetails8">
          <link:definition>00000091 - Disclosure - Financial assets and financial liabilities (Details 8)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9" id="FinancialAssetsAndFinancialLiabilitiesDetails9">
          <link:definition>00000092 - Disclosure - Financial assets and financial liabilities (Details 9)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10" id="FinancialAssetsAndFinancialLiabilitiesDetails10">
          <link:definition>00000093 - Disclosure - Financial assets and financial liabilities (Details 10)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11" id="FinancialAssetsAndFinancialLiabilitiesDetails11">
          <link:definition>00000094 - Disclosure - Financial assets and financial liabilities (Details 11)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" id="FinancialAssetsAndFinancialLiabilitiesDetailsNarrative">
          <link:definition>00000095 - Disclosure - Financial assets and financial liabilities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FairValueMeasurementDetails" id="FairValueMeasurementDetails">
          <link:definition>00000096 - Disclosure - Fair value measurement (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails" id="LaborAndSocialObligationsDetails">
          <link:definition>00000097 - Disclosure - Labor and social obligations (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails1" id="LaborAndSocialObligationsDetails1">
          <link:definition>00000098 - Disclosure - Labor and social obligations (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails2" id="LaborAndSocialObligationsDetails2">
          <link:definition>00000099 - Disclosure - Labor and social obligations (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails3" id="LaborAndSocialObligationsDetails3">
          <link:definition>00000100 - Disclosure - Labor and social obligations (Details 3)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails4" id="LaborAndSocialObligationsDetails4">
          <link:definition>00000101 - Disclosure - Labor and social obligations (Details 4)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails5" id="LaborAndSocialObligationsDetails5">
          <link:definition>00000102 - Disclosure - Labor and social obligations (Details 5)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" id="LaborAndSocialObligationsDetailsNarrative">
          <link:definition>00000103 - Disclosure - Labor and social obligations (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/EquityDetails" id="EquityDetails">
          <link:definition>00000104 - Disclosure - Equity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/EquityDetailsNarrative" id="EquityDetailsNarrative">
          <link:definition>00000105 - Disclosure - Equity (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/EarningsPerShareEpsDetails" id="EarningsPerShareEpsDetails">
          <link:definition>00000106 - Disclosure - Earnings per share (EPS) (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RevenueDetails" id="RevenueDetails">
          <link:definition>00000107 - Disclosure - Revenue (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RevenueDetails1" id="RevenueDetails1">
          <link:definition>00000108 - Disclosure - Revenue (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/ExpensesAndCostsByNatureDetails" id="ExpensesAndCostsByNatureDetails">
          <link:definition>00000109 - Disclosure - Expenses and costs by nature (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinanceResultDetails" id="FinanceResultDetails">
          <link:definition>00000110 - Disclosure - Finance result (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
          <link:definition>00000111 - Disclosure - Income taxes (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>00000112 - Disclosure - Income taxes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails" id="InsuranceContractsAndContingenciesDetails">
          <link:definition>00000113 - Disclosure - Insurance contracts and contingencies (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1" id="InsuranceContractsAndContingenciesDetails1">
          <link:definition>00000114 - Disclosure - Insurance contracts and contingencies (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" id="InsuranceContractsAndContingenciesDetailsNarrative">
          <link:definition>00000115 - Disclosure - Insurance contracts and contingencies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/Non-cashTransactionsDetails" id="Non-cashTransactionsDetails">
          <link:definition>00000116 - Disclosure - Non-cash transactions (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/SubsequentEventDetailsNarrative" id="SubsequentEventDetailsNarrative">
          <link:definition>00000117 - Disclosure - Subsequent event (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="afya-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="afya-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="afya-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="afya-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full" schemaLocation="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="afya_ClassAOrdinarySharesMember" name="ClassAOrdinarySharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ClassBOrdinarySharesMember" name="ClassBOrdinarySharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BertelsmannMember" name="BertelsmannMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AfyaParticipacoesSAMember" name="AfyaParticipacoesSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" name="InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" name="InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" name="UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" name="IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" name="InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" name="CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" name="InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroIntegradoDeSaudeDeTeresinaCISMember" name="CentroIntegradoDeSaudeDeTeresinaCISMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" name="FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedcelEditoraEventosS.A.MedcelMember" name="MedcelEditoraEventosS.A.MedcelMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" name="InstitutoEducacionalSantoAgostinhoS.A.FASAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ESMCEducacaoSuperiorLtdaESMCMember" name="ESMCEducacaoSuperiorLtdaESMCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" name="InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" name="InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember" name="SociedadeUniversitariaRedentorS.A.UniRedentorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroDeEnsinoSaoLucasLtda.UniSLMember" name="CentroDeEnsinoSaoLucasLtda.UniSLMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" name="PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" name="SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" name="CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" name="IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedicinaeSolutionsS.A.MedicinaeMember" name="MedicinaeSolutionsS.A.MedicinaeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" name="MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" name="CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShospTecnologiaDaInformacaoLtda.ShospMember" name="ShospTecnologiaDaInformacaoLtda.ShospMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" name="SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember" name="NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" name="CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" name="PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadeEducacionalDePalhocaSALtda.Member" name="SociedadeEducacionalDePalhocaSALtda.Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember" name="InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember" name="RXPROSolucoesDeTecnologiaLtda.RXPROMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember" name="RXPROLOGTransporteELogisticaLtda.RXPROLOGMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BMVAtividadesMedicasLtda.AlemDaMedicinaMember" name="BMVAtividadesMedicasLtda.AlemDaMedicinaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CardiopapersSolucoesDigitaisLtda.CardioPapersMember" name="CardiopapersSolucoesDigitaisLtda.CardioPapersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" name="QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" name="SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" name="UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MachineryAndEquipmentsMember" name="MachineryAndEquipmentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ItEquipmentMember" name="ItEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LibraryBooksMember" name="LibraryBooksMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProgramOfSocialIntegrationMember" name="ProgramOfSocialIntegrationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TeachingActivitiesMember" name="TeachingActivitiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContributionForTheFinancingOfSocialSecurityMember" name="ContributionForTheFinancingOfSocialSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NonTeachingActivitiesMember" name="NonTeachingActivitiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AmendmentsToIAS1Member" name="AmendmentsToIAS1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AmendmentsToIAS8Member" name="AmendmentsToIAS8Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AmendmentsToIAS12Member" name="AmendmentsToIAS12Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AmendmentsToIAS12OneMember" name="AmendmentsToIAS12OneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AmendmentsToIFRS16Member" name="AmendmentsToIFRS16Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AmendmentsToIAS1OneMember" name="AmendmentsToIAS1OneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AmendmentsToIAS7AndIFRS7Member" name="AmendmentsToIAS7AndIFRS7Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UndergradMember" name="UndergradMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContinuingEducationMember" name="ContinuingEducationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DigitalServicesMember" name="DigitalServicesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TotalReportableSegmentsMember" name="TotalReportableSegmentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdjustmentsAndEliminationsMember" name="AdjustmentsAndEliminationsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DelReyMember" name="DelReyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AcquisitionOfDelReyMember" name="AcquisitionOfDelReyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AlemDaMedicinaMember" name="AlemDaMedicinaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AcquisitionOfCardioPapersMember" name="AcquisitionOfCardioPapersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CardioPapersMember" name="CardioPapersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AcquisitionOfGlicMember" name="AcquisitionOfGlicMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_GlicMember" name="GlicMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WithAndWithoutMethodMember" name="WithAndWithoutMethodMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ReliefFromRoyaltyMember" name="ReliefFromRoyaltyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationalContentMember" name="EducationalContentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ReplacementCostMember" name="ReplacementCostMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CopyrightMember" name="CopyrightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BankCertificatesOfDepositMember" name="BankCertificatesOfDepositMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_USDMember" name="USDMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TuitionFeesMember" name="TuitionFeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FIESMember" name="FIESMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationalCreditsMember" name="EducationalCreditsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MobileAppSubscriptionMember" name="MobileAppSubscriptionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OthersMember" name="OthersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" name="LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaterThanOneEightyMember" name="LaterThanOneEightyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UEPCMember" name="UEPCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EMIVEPatrulha24HorasLtdaMember" name="EMIVEPatrulha24HorasLtdaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RVLEstevesGestaoImobiliariaSAMember" name="RVLEstevesGestaoImobiliariaSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UNIVACOPatrimonialLtdaMember" name="UNIVACOPatrimonialLtdaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IESVAPPatrimonialLtdaMember" name="IESVAPPatrimonialLtdaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseAgreements1Member" name="LeaseAgreements1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" name="InstitutoTocantinensePresidenteAntonioCarlosSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" name="InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationContentMember" name="EducationContentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationalPlatformMember" name="EducationalPlatformMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SoftwareInProgressMember" name="SoftwareInProgressMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherMember" name="OtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CarryingAmountsMember" name="CarryingAmountsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" name="IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" name="InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroDeCienciasEmSaudeDeItajubaSAMember" name="CentroDeCienciasEmSaudeDeItajubaSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" name="InstitutoDeEnsinoSuperiorDoPiauiSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" name="FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoEducacionalSantoAgostinhoSAMember" name="InstitutoEducacionalSantoAgostinhoSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" name="InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" name="InstitutoParaensedeEducacaoeCulturaLtdaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UniRedentorMember" name="UniRedentorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UniSLMember" name="UniSLMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FESARMember" name="FESARMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FCMPBMember" name="FCMPBMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ITPACGaranhunsMember" name="ITPACGaranhunsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedcelAndCBBWMember" name="MedcelAndCBBWMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PracticeManagementToolsAndElectronicPrescriptionMember" name="PracticeManagementToolsAndElectronicPrescriptionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ClinicalDecisionSoftwareMember" name="ClinicalDecisionSoftwareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CliquefarmaMember" name="CliquefarmaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UnifipMocMember" name="UnifipMocMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UnigranrioMember" name="UnigranrioMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RXPROMember" name="RXPROMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CustomerRelationshipsMedicineMember" name="CustomerRelationshipsMedicineMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CustomerRelationshipsOtherCoursesMember" name="CustomerRelationshipsOtherCoursesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DevelopedTechnologyMember" name="DevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TwentyTwentyFiveMember" name="TwentyTwentyFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TwentyTwentySevenMember" name="TwentyTwentySevenMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TwentyTwentyFourMember" name="TwentyTwentyFourMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TwentyTwentySixMember" name="TwentyTwentySixMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TwentyTwentyEightMember" name="TwentyTwentyEightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedicalHarbourMember" name="MedicalHarbourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShospMember" name="ShospMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IPEMEDMember" name="IPEMEDMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_GuaranhunsMember" name="GuaranhunsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CardiPapersMember" name="CardiPapersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersMember" name="AccountsPayableToSellingShareholdersMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingMember" name="LoansAndFinancingMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NotesPayableMember" name="NotesPayableMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CashEquivalents1Member" name="CashEquivalents1Member" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingOneMember" name="LoansAndFinancingOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingTwoMember" name="LoansAndFinancingTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingThreeMember" name="LoansAndFinancingThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersOneMember" name="AccountsPayableToSellingShareholdersOneMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersTwoMember" name="AccountsPayableToSellingShareholdersTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseBasisPointsMember" name="IncreaseBasisPointsMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseBasisPointsOneMember" name="IncreaseBasisPointsOneMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ForeignCurrencyExposuresMember" name="ForeignCurrencyExposuresMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseForeignCurrencyMember" name="IncreaseForeignCurrencyMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DecreaseForeignCurrencyMember" name="DecreaseForeignCurrencyMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendsPayableMember" name="DividendsPayableMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OptionsGrantedMember" name="OptionsGrantedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShareBasedCompensationPlansMember" name="ShareBasedCompensationPlansMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedStockUnitsMember" name="RestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedStockUnits1Member" name="RestrictedStockUnits1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedStockUnits2Member" name="RestrictedStockUnits2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedStockUnits3Member" name="RestrictedStockUnits3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RSUsMember" name="RSUsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ModifiedPlanMember" name="ModifiedPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncrementalStockOptionsMember" name="IncrementalStockOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OriginalPlanMember" name="OriginalPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IPCAMember" name="IPCAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CDIMember" name="CDIMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EliminationInterSegmentTransactionsMember" name="EliminationInterSegmentTransactionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OneSubsidiaryMember" name="OneSubsidiaryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LabourMember" name="LabourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CivilMember" name="CivilMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxesMember" name="TaxesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TypesOfRiskMember" name="TypesOfRiskMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxesAndSocialSecurityMember" name="TaxesAndSocialSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherAssetsNonCurrentMember" name="OtherAssetsNonCurrentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IClinicMember" name="IClinicMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FaculdadesIntegradasPadraoMember" name="FaculdadesIntegradasPadraoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentTradeReceivable" name="NoncurrentTradeReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NotePayableCurrent" name="NotePayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CurrentTaxesPayable" name="CurrentTaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentTaxesPayable" name="NoncurrentTaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ComprehensiveIncomeLoss" name="ComprehensiveIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IfrsStatementLineItems" name="IfrsStatementLineItems" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CapitalIncreaseWithCash" name="CapitalIncreaseWithCash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TreasuryShares1" name="TreasuryShares1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TreasurySharesTransferredFromExerciseOfOptions" name="TreasurySharesTransferredFromExerciseOfOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination" name="TreasurySharesTransferredFromSharesContributionOnBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AcquisitionOfNoncontrollingInterests" name="AcquisitionOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedSharesTransferredToExecutives" name="RestrictedSharesTransferredToExecutives" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" name="TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncomeLossBeforeIncomeTaxes" name="IncomeLossBeforeIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WriteoffOfPropertyAndEquipment" name="WriteoffOfPropertyAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WriteoffOfIntangibleAssets" name="WriteoffOfIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" name="AllowanceForDoubtfulAccountsOfOpeartingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccruedInterestOfOpeartingActivities" name="AccruedInterestOfOpeartingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShareOfIncomeOfAssociateOfOpeartingActivities" name="ShareOfIncomeOfAssociateOfOpeartingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseDecreaseInOperatingLiabilities1Abstract" name="IncreaseDecreaseInOperatingLiabilities1Abstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseDecreaseInRecoverableTaxes" name="IncreaseDecreaseInRecoverableTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" name="PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PurchaseOfAcquisitionOfNoncontrollingInterests" name="PurchaseOfAcquisitionOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" name="PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedCashOfInvestingActivities" name="RestrictedCashOfInvestingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" name="RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" name="PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CorporateInformationAbstract" name="CorporateInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureMaterialAccountingPoliciesAbstract" name="DisclosureMaterialAccountingPoliciesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfMaterialAccountingPoliciesExplanatory" name="DisclosureOfMaterialAccountingPoliciesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract" name="DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory" name="SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureCashAndCashEquivalentsAbstract" name="DisclosureCashAndCashEquivalentsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosuresOfCashAndCashEquivalentsExplanatory" name="DisclosuresOfCashAndCashEquivalentsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOtherAssetsAbstract" name="DisclosureOtherAssetsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfOtherAssetExplanatory" name="DisclosureOfOtherAssetExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureIntangibleAssetsAndGoodwillAbstract" name="DisclosureIntangibleAssetsAndGoodwillAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfIntangibleAssetExplanatory" name="DisclosureOfIntangibleAssetExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureFairValueMeasurementAbstract" name="DisclosureFairValueMeasurementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FairValueMeasurementExplanatory" name="FairValueMeasurementExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureCapitalManagementAbstract" name="DisclosureCapitalManagementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CapitalManagementExplanatory" name="CapitalManagementExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureLaborAndSocialObligationsAbstract" name="DisclosureLaborAndSocialObligationsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaborAndSocialObligationsExplanatory" name="LaborAndSocialObligationsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureEquityAbstract" name="DisclosureEquityAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfEquityExplanatory" name="DisclosureOfEquityExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureIncomeTaxesAbstract" name="DisclosureIncomeTaxesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfIncomeTaxesExplanatory" name="DisclosureOfIncomeTaxesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureInsuranceContractsAndContingenciesAbstract" name="DisclosureInsuranceContractsAndContingenciesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfInsuranceContractsAndContingenciesExplanatory" name="DisclosureOfInsuranceContractsAndContingenciesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureNoncashTransactionsAbstract" name="DisclosureNoncashTransactionsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureNoncashTransactionsExplanatory" name="DisclosureNoncashTransactionsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BusinessCombinationsAndGoodwillPolicyExplanatory" name="BusinessCombinationsAndGoodwillPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" name="CurrentVersusNoncurrentClassificationPoliciesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" name="FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" name="ImpairmentOfNonfinancialAssetsPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory" name="DescriptionOfAccountingPolicyForInvestmentsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersPolicyExplanatory" name="AccountsPayableToSellingShareholdersPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendsPolicyExplanatory" name="DividendsPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaborAndSocialObligationsPolicyExplanatory" name="LaborAndSocialObligationsPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SharebasedPaymentsPolicyExplanatory" name="SharebasedPaymentsPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxesPolicyExplanation" name="TaxesPolicyExplanation" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" name="SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfEstimatedUsefulLivesTableTextBlock" name="ScheduleOfEstimatedUsefulLivesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" name="ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" name="ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" name="ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfDelReyExplanatory" name="ScheduleOfAcquisitionOfDelReyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock" name="ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory" name="ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfCardioPapersExplanatory" name="ScheduleOfAcquisitionOfCardioPapersExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfGlicExplanatory" name="ScheduleOfAcquisitionOfGlicExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" name="DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfTradeAndOtherReceivables1Explanatory" name="DisclosureOfTradeAndOtherReceivables1Explanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" name="DisclosureOfTradeAccountsReceivableByAgingExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory" name="DisclosureOfAllowanceForDoubtfulAccountsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfRelatedPartiesExplanatory" name="DisclosureOfRelatedPartiesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" name="SummaryOfKeyManagementPersonnelCompensationTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfOtherAssetsTableTextBlock" name="DisclosureOfOtherAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfInvestmentsExplanatory" name="DisclosureOfInvestmentsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfIntangibleAssetsTableTextBlock" name="SummaryOfIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" name="SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" name="SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialAssetsExplanatory" name="FinancialAssetsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialLiabilitiesExplanatory" name="FinancialLiabilitiesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingExplanatory" name="LoansAndFinancingExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfLeasesExplanatory" name="ScheduleOfLeasesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersExplanatory" name="AccountsPayableToSellingShareholdersExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholders1Explanatory" name="AccountsPayableToSellingShareholders1Explanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock" name="ScheduleOfCarryingAmountOfNotesPayableTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFairValuesExplanatory" name="ScheduleOfFairValuesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" name="SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" name="SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" name="SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" name="ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFairValueMeasurementExplanaory" name="ScheduleOfFairValueMeasurementExplanaory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions" name="ScheduleOfModelUsedToDetermineFairValueOfStockOptions" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions" name="ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAdditionalStockOptionsExplanatory" name="ScheduleOfAdditionalStockOptionsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfSharebasedCompensationPlanExplanatory" name="ScheduleOfSharebasedCompensationPlanExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfStockOptionExplanatory" name="ScheduleOfStockOptionExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfTreasurySharesMovementExplanatory" name="ScheduleOfTreasurySharesMovementExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfEarningsPerShareTableExplanatory" name="DisclosureOfEarningsPerShareTableExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfNetSalesRevenueExplanatory" name="ScheduleOfNetSalesRevenueExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfRevenueBySegmentTableTextBlock" name="ScheduleOfRevenueBySegmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfExpensesByNatureTableTextBlock" name="SummaryOfExpensesByNatureTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFinanceResultTableTextBlock" name="ScheduleOfFinanceResultTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" name="ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfLegalProceedingsAndContingencies" name="ScheduleOfLegalProceedingsAndContingencies" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement" name="ScheduleOfSocialSecurityProceedingsAssessedByManagement" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NonCashTransactionsTableTextBlock" name="NonCashTransactionsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AcquiredShares" name="AcquiredShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PrincipalActivities" name="PrincipalActivities" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InvestmentType" name="InvestmentType" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CapitalExpenditures" name="CapitalExpenditures" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DepositsFromExternalCustomer" name="DepositsFromExternalCustomer" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InterSegment" name="InterSegment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CostOfSale" name="CostOfSale" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinanceExpense" name="FinanceExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeReceivablesAsOfAcquisitionDate" name="TradeReceivablesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Inventories1" name="Inventories1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RecoverableTaxesAsOfAcquisitionDate" name="RecoverableTaxesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherAssetsAsOfAcquisitionDate" name="OtherAssetsAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightOfUseAssetsAsOfAcquisitionDate" name="RightOfUseAssetsAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesAsOfAcquisitionDate" name="LeaseLiabilitiesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaborAndSocialObligationsAsOfAcquisitionDate" name="LaborAndSocialObligationsAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxesPayableAsOfAcquisitionDate" name="TaxesPayableAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdvancesFromCustomersAsOfAcquisitionDate" name="AdvancesFromCustomersAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" name="ProvisionForLegalProceedingsAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherLiabilitiesAsOfAcquisitionDate" name="OtherLiabilitiesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ConsiderationToBeTransferred" name="ConsiderationToBeTransferred" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NetOfCashFlowOnAcquisition" name="NetOfCashFlowOnAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseInRevenue" name="IncreaseInRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseInIncomeBeforeIncomeTaxes" name="IncreaseInIncomeBeforeIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DecreaseInIncomeBeforeIncomeTaxes" name="DecreaseInIncomeBeforeIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PercenatgeOfAverageInterestOnFinancialInstrument" name="PercenatgeOfAverageInterestOnFinancialInstrument" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ReceivablesGross" name="ReceivablesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AllowanceForDoubtfulAccountsFoReceivable1" name="AllowanceForDoubtfulAccountsFoReceivable1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" name="AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" name="WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeReceivablesRelatedPartyTransactions" name="TradeReceivablesRelatedPartyTransactions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherAssetsRelatedPartyTransactions" name="OtherAssetsRelatedPartyTransactions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeAndOtherCurrentPayablesToRelatedParties1" name="TradeAndOtherCurrentPayablesToRelatedParties1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentAssetsOfRelatedParty1" name="NoncurrentAssetsOfRelatedParty1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholders" name="AccountsPayableToSellingShareholders" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableCurrent1" name="AccountsPayableCurrent1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentPayablesToRelatedParties1" name="NoncurrentPayablesToRelatedParties1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherIncomeRelatedPartyTransactions" name="OtherIncomeRelatedPartyTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OperatingLeaseTermOfContract" name="OperatingLeaseTermOfContract" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LesseeFinancesLeaseRenewalTerm" name="LesseeFinancesLeaseRenewalTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DescriptionOfLeaseTerm" name="DescriptionOfLeaseTerm" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DescriptionOfLeaseTerms" name="DescriptionOfLeaseTerms" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Advances1" name="Advances1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_JudicialDeposits" name="JudicialDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Dividend" name="Dividend" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherAssets1" name="OtherAssets1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Assets1" name="Assets1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CurrentAssets1" name="CurrentAssets1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentAssets1" name="NoncurrentAssets1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherAsset" name="OtherAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EquityInAssociate" name="EquityInAssociate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CompanyShareInEquity1" name="CompanyShareInEquity1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InvestmentGrossAmount" name="InvestmentGrossAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CompanyShareOfProfitss" name="CompanyShareOfProfitss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendsReceived1" name="DividendsReceived1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PropertyPlantAndEquipments" name="PropertyPlantAndEquipments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WritOffOfPropertyPlantAndEquipment" name="WritOffOfPropertyPlantAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PropertyPlantAndEquipmentNetBookValue" name="PropertyPlantAndEquipmentNetBookValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Remesurement" name="Remesurement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Transfer" name="Transfer" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IntangibleAssetsAndGoodwillNetBookValue" name="IntangibleAssetsAndGoodwillNetBookValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CashGeneratingUnits" name="CashGeneratingUnits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ExplicitProjectionPeriod" name="ExplicitProjectionPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PerpetuityGrowthRate" name="PerpetuityGrowthRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancing" name="LoansAndFinancing" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NotePayable" name="NotePayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialInstitution" name="FinancialInstitution" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingCurrent" name="LoansAndFinancingCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingNonCurrent" name="LoansAndFinancingNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsToLeaseLiabilities" name="AdditionsToLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsRemeasurement" name="RightofuseAssetsRemeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesRemeasurement" name="LeaseLiabilitiesRemeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsBusinessCombinations" name="RightofuseAssetsBusinessCombinations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BusinessCombinationsLeaseLiabilities" name="BusinessCombinationsLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DepreciationExpenseLeaseLiabilities" name="DepreciationExpenseLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsInterestExpense" name="RightofuseAssetsInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsPaymentsOfLeaseLiabilities" name="RightofuseAssetsPaymentsOfLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" name="PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsPaymentsOfInterest" name="RightofuseAssetsPaymentsOfInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaymentsOfInterestLeaseLiabilities" name="PaymentsOfInterestLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsWriteoff" name="RightofuseAssetsWriteoff" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesWriteoff" name="LeaseLiabilitiesWriteoff" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsCurrent" name="RightofuseAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsNonCurrent" name="RightofuseAssetsNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersCurrent" name="AccountsPayableToSellingShareholdersCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersNonCurrent" name="AccountsPayableToSellingShareholdersNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholderCashFlows" name="AccountsPayableToSellingShareholderCashFlows" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" name="AccountsPayableToSellingShareholdersAcquisitionOfIpec" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersBusinessCombinations" name="AccountsPayableToSellingShareholdersBusinessCombinations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContingentConsiderationOnBusinessCombinations" name="ContingentConsiderationOnBusinessCombinations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Reversals" name="Reversals" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RemeasurementOfEarnouts" name="RemeasurementOfEarnouts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NotesPayables" name="NotesPayables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Payments" name="Payments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaymentsOfInterest" name="PaymentsOfInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MonetaryIndexation" name="MonetaryIndexation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CurrentLiabilities1" name="CurrentLiabilities1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentLiabilities1" name="NoncurrentLiabilities1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IndexRatePerYear" name="IndexRatePerYear" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BaseRate" name="BaseRate" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NotePayables" name="NotePayables" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialLiabilitiesContractualUndiscounted" name="FinancialLiabilitiesContractualUndiscounted" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" name="IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContractualLeaseTerm" name="ContractualLeaseTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RemainingTradeAndOtherPayablesToRelatedParties" name="RemainingTradeAndOtherPayablesToRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EqualInstallmentsPayablesToRelatedParties1" name="EqualInstallmentsPayablesToRelatedParties1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EqualInstallmentsPayablesToRelatedParties" name="EqualInstallmentsPayablesToRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RemainingBalancePaid" name="RemainingBalancePaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FirstAnnualInstallmentsPayable" name="FirstAnnualInstallmentsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SecondAnnualInstallmentsPayable" name="SecondAnnualInstallmentsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ThirdAnnualInstallmentsPayable" name="ThirdAnnualInstallmentsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AcquisitiondateFairValueOfTotalConsiderationTransferred1" name="AcquisitiondateFairValueOfTotalConsiderationTransferred1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SensitivityChangeInTheEuroExchangeRate" name="SensitivityChangeInTheEuroExchangeRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingLiabilities" name="LoansAndFinancingLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilities1" name="LeaseLiabilities1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" name="TradeAndOtherPayablesToRelatedPartiesLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FairValueNotesPayables1" name="FairValueNotesPayables1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_StrikePriceeAtMeasurementDateShareOptionsGranted" name="StrikePriceeAtMeasurementDateShareOptionsGranted" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ExpectedLifeOfStockOptions" name="ExpectedLifeOfStockOptions" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" name="SharePriceFairValueAtMeasurementDateShareOptionsGranted" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" name="WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_StrikePriceeAtMeasurementDateShareOptionsGrante" name="StrikePriceeAtMeasurementDateShareOptionsGrante" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" name="WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" name="NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" nillable="true" xbrli:periodType="duration" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfStockOptionsExercisable" name="NumberOfStockOptionsExercisable" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShareBasedCompensationOfEmployees" name="ShareBasedCompensationOfEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_StrikePrice" name="StrikePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AverageIncrementalFairValue" name="AverageIncrementalFairValue" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" name="NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SocialObligationsLiabilities" name="SocialObligationsLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" name="WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfSharesRepurchased" name="NumberOfSharesRepurchased" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AveragePriceRepurchased" name="AveragePriceRepurchased" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" name="NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AveragePriceDeliveredUnderSharebasedCompensationPlan" name="AveragePriceDeliveredUnderSharebasedCompensationPlan" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TransferredFromExerciseOfStockOptions" name="TransferredFromExerciseOfStockOptions" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AveragePriceTransferredFromExerciseOfStockOptions" name="AveragePriceTransferredFromExerciseOfStockOptions" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TransferredFromSharesContribution" name="TransferredFromSharesContribution" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AveragePriceTransferredFromSharesContribution" name="AveragePriceTransferredFromSharesContribution" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfSharesIssued1" name="NumberOfSharesIssued1" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IssuedCapitals" name="IssuedCapitals" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaymentOfDividends" name="PaymentOfDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendDistributed" name="DividendDistributed" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RepurchaseOfOrdinaryShares" name="RepurchaseOfOrdinaryShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CashOutflow" name="CashOutflow" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumeratorAbstract" name="NumeratorAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DenominatorAbstract" name="DenominatorAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProfessionalFeesExpenses" name="ProfessionalFeesExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherRevenue1" name="OtherRevenue1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionAbstract" name="DeductionAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfGrantedDiscounts" name="DeductionOfGrantedDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfEarlyPaymentDiscounts" name="DeductionOfEarlyPaymentDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfReturnsOfNetRevenue" name="DeductionOfReturnsOfNetRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfTaxes" name="DeductionOfTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfProuni" name="DeductionOfProuni" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" name="TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NetRevenueOtherTransferredPoint" name="NetRevenueOtherTransferredPoint" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TimingRevenueRecognition" name="TimingRevenueRecognition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Payroll" name="Payroll" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_HospitalAndMedicalAgreements" name="HospitalAndMedicalAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseExpenses" name="LeaseExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SharesBasedCompensation" name="SharesBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxExpenses" name="TaxExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AllowanceForExpectedCreditLosses" name="AllowanceForExpectedCreditLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ConsultingFees" name="ConsultingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Other" name="Other" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ExpenseByNatureOne" name="ExpenseByNatureOne" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InterestExpense1" name="InterestExpense1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InterestExpenseOnLeaseLiabilities1" name="InterestExpenseOnLeaseLiabilities1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialDiscountsGrantedExpenses" name="FinancialDiscountsGrantedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxOnFinancialOperations" name="TaxOnFinancialOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinanceResult" name="FinanceResult" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ReconciliationAdjustmentsAbstract" name="ReconciliationAdjustmentsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" name="TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProgramaUniversidadeParaTodosFiscalIncentive" name="ProgramaUniversidadeParaTodosFiscalIncentive" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UnrecognisedDeferredTaxAssets" name="UnrecognisedDeferredTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RecognisedDeferredTaxAssets" name="RecognisedDeferredTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PermanentAdjustments" name="PermanentAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RecognizedDeferredTaxAssets" name="RecognizedDeferredTaxAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContingenciesCorrespondentAmount" name="ContingenciesCorrespondentAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RemeasurementOfEarnOut" name="RemeasurementOfEarnOut" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets" name="ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" name="AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PotentialAdditionalPayment" name="PotentialAdditionalPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TotalNumberOfSeatsApporved" name="TotalNumberOfSeatsApporved" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>33
<FILENAME>afya-20231231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://afya.com.br/role/Cover" xlink:href="afya-20231231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfFinancialPosition" xlink:href="afya-20231231.xsd#StatementsOfFinancialPosition" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" xlink:href="afya-20231231.xsd#StatementsOfIncomeAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfChangesInEquity" xlink:href="afya-20231231.xsd#StatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfCashFlows" xlink:href="afya-20231231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CorporateInformation" xlink:href="afya-20231231.xsd#CorporateInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPolicies" xlink:href="afya-20231231.xsd#MaterialAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingJudgmentsEstimatesAndAssumptions" xlink:href="afya-20231231.xsd#SignificantAccountingJudgmentsEstimatesAndAssumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformation" xlink:href="afya-20231231.xsd#SegmentInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinations" xlink:href="afya-20231231.xsd#BusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalents" xlink:href="afya-20231231.xsd#CashAndCashEquivalents" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivables" xlink:href="afya-20231231.xsd#TradeReceivables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedParties" xlink:href="afya-20231231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssets" xlink:href="afya-20231231.xsd#OtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociate" xlink:href="afya-20231231.xsd#InvestmentInAssociate" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipment" xlink:href="afya-20231231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwill" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurement" xlink:href="afya-20231231.xsd#FairValueMeasurement" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CapitalManagement" xlink:href="afya-20231231.xsd#CapitalManagement" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligations" xlink:href="afya-20231231.xsd#LaborAndSocialObligations" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Equity" xlink:href="afya-20231231.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEps" xlink:href="afya-20231231.xsd#EarningsPerShareEps" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Revenue" xlink:href="afya-20231231.xsd#Revenue" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNature" xlink:href="afya-20231231.xsd#ExpensesAndCostsByNature" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResult" xlink:href="afya-20231231.xsd#FinanceResult" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxes" xlink:href="afya-20231231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingencies" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Non-cashTransactions" xlink:href="afya-20231231.xsd#Non-cashTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SubsequentEvent" xlink:href="afya-20231231.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesTables" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformationTables" xlink:href="afya-20231231.xsd#SegmentInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsTables" xlink:href="afya-20231231.xsd#BusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:href="afya-20231231.xsd#CashAndCashEquivalentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesTables" xlink:href="afya-20231231.xsd#TradeReceivablesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesTables" xlink:href="afya-20231231.xsd#RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsTables" xlink:href="afya-20231231.xsd#OtherAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociateTables" xlink:href="afya-20231231.xsd#InvestmentInAssociateTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:href="afya-20231231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurementTables" xlink:href="afya-20231231.xsd#FairValueMeasurementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityTables" xlink:href="afya-20231231.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEpsTables" xlink:href="afya-20231231.xsd#EarningsPerShareEpsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RevenueTables" xlink:href="afya-20231231.xsd#RevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNatureTables" xlink:href="afya-20231231.xsd#ExpensesAndCostsByNatureTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResultTables" xlink:href="afya-20231231.xsd#FinanceResultTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesTables" xlink:href="afya-20231231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Non-cashTransactionsTables" xlink:href="afya-20231231.xsd#Non-cashTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:href="afya-20231231.xsd#CorporateInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformationDetails" xlink:href="afya-20231231.xsd#SegmentInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformationDetails1" xlink:href="afya-20231231.xsd#SegmentInformationDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails1" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails2" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails3" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails4" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails5" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:href="afya-20231231.xsd#BusinessCombinationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetails" xlink:href="afya-20231231.xsd#CashAndCashEquivalentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:href="afya-20231231.xsd#CashAndCashEquivalentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesDetails" xlink:href="afya-20231231.xsd#TradeReceivablesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesDetails1" xlink:href="afya-20231231.xsd#TradeReceivablesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesDetails2" xlink:href="afya-20231231.xsd#TradeReceivablesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesDetails" xlink:href="afya-20231231.xsd#RelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesDetails1" xlink:href="afya-20231231.xsd#RelatedPartiesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:href="afya-20231231.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsDetails" xlink:href="afya-20231231.xsd#OtherAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsDetailsNarrative" xlink:href="afya-20231231.xsd#OtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociateDetails" xlink:href="afya-20231231.xsd#InvestmentInAssociateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipmentDetails" xlink:href="afya-20231231.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails6" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails7" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails8" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails9" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails10" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails11" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurementDetails" xlink:href="afya-20231231.xsd#FairValueMeasurementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails1" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails2" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails3" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails4" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails5" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityDetails" xlink:href="afya-20231231.xsd#EquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityDetailsNarrative" xlink:href="afya-20231231.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEpsDetails" xlink:href="afya-20231231.xsd#EarningsPerShareEpsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RevenueDetails" xlink:href="afya-20231231.xsd#RevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RevenueDetails1" xlink:href="afya-20231231.xsd#RevenueDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNatureDetails" xlink:href="afya-20231231.xsd#ExpensesAndCostsByNatureDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResultDetails" xlink:href="afya-20231231.xsd#FinanceResultDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesDetails" xlink:href="afya-20231231.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:href="afya-20231231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingenciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Non-cashTransactionsDetails" xlink:href="afya-20231231.xsd#Non-cashTransactionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SubsequentEventDetailsNarrative" xlink:href="afya-20231231.xsd#SubsequentEventDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfFinancialPosition" xlink:title="00000002 - Statement - Consolidated statements of financial position">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-fullCurrentTradeReceivables" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullCurrentTradeReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-fullInventories" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullInventories" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTaxAssets" xlink:label="loc_ifrs-fullCurrentTaxAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullCurrentTaxAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-fullOtherCurrentAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullOtherCurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentTradeReceivable" xlink:label="loc_afyaNoncurrentTradeReceivable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_afyaNoncurrentTradeReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-fullOtherNoncurrentAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullOtherNoncurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-fullInvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullRightofuseAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayables" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermBorrowings" xlink:label="loc_ifrs-fullShorttermBorrowings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullShorttermBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-fullCurrentLeaseLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotePayableCurrent" xlink:label="loc_afyaNotePayableCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_afyaNotePayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentDepositsFromCustomers" xlink:label="loc_ifrs-fullCurrentDepositsFromCustomers" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentDepositsFromCustomers" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-fullCurrentRecognisedLiabilitiesDefinedBenefitPlan" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CurrentTaxesPayable" xlink:label="loc_afyaCurrentTaxesPayable" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_afyaCurrentTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="loc_ifrs-fullOtherCurrentLiabilities" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-fullLongtermBorrowings" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullLongtermBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-fullNoncurrentLeaseLiabilities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullNoncurrentLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayablesToRelatedParties" xlink:label="loc_ifrs-fullNoncurrentPayablesToRelatedParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullNoncurrentPayablesToRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentTaxesPayable" xlink:label="loc_afyaNoncurrentTaxesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_afyaNoncurrentTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LongtermLegalProceedingsProvision" xlink:label="loc_ifrs-fullLongtermLegalProceedingsProvision" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullLongtermLegalProceedingsProvision" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-fullOtherNoncurrentLiabilities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullOtherNoncurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-fullEquityAttributableToOwnersOfParent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullIssuedCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionalPaidinCapital" xlink:label="loc_ifrs-fullAdditionalPaidinCapital" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullAdditionalPaidinCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-fullTreasuryShares" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullTreasuryShares" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-fullReserveOfSharebasedPayments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullReserveOfSharebasedPayments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-fullRetainedEarnings" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullRetainedEarnings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-fullNoncontrollingInterests" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullNoncontrollingInterests" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAndLiabilities" xlink:to="loc_ifrs-fullLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAndLiabilities" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" xlink:title="00000003 - Statement - Consolidated statements of income and comprehensive income">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-fullGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullGrossProfit" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullGrossProfit" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-fullOtherOperatingIncomeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullOtherOperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-fullFinanceIncomeCost" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceIncomeCost" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceIncomeCost" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullFinanceIncomeCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-fullShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullComprehensiveIncome" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-fullOtherComprehensiveIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullComprehensiveIncome" xlink:to="loc_ifrs-fullOtherComprehensiveIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ComprehensiveIncomeLoss" xlink:label="loc_afyaComprehensiveIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-fullProfitLossAttributableToOwnersOfParent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaComprehensiveIncomeLoss" xlink:to="loc_ifrs-fullProfitLossAttributableToOwnersOfParent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-fullProfitLossAttributableToNoncontrollingInterests" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaComprehensiveIncomeLoss" xlink:to="loc_ifrs-fullProfitLossAttributableToNoncontrollingInterests" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfChangesInEquity" xlink:title="00000004 - Statement - Consolidated statements of changes in equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated statements of cash flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncomeLossBeforeIncomeTaxes" xlink:label="loc_afyaIncomeLossBeforeIncomeTaxes" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaIncomeLossBeforeIncomeTaxes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-fullAdjustmentsForDepreciationAndAmortisationExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDepreciationAndAmortisationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WriteoffOfPropertyAndEquipment" xlink:label="loc_afyaWriteoffOfPropertyAndEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaWriteoffOfPropertyAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WriteoffOfIntangibleAssets" xlink:label="loc_afyaWriteoffOfIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaWriteoffOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:label="loc_afyaAllowanceForDoubtfulAccountsOfOpeartingActivities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaAllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-fullAdjustmentsForSharebasedPayments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForSharebasedPayments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccruedInterestOfOpeartingActivities" xlink:label="loc_afyaAccruedInterestOfOpeartingActivities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaAccruedInterestOfOpeartingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShareOfIncomeOfAssociateOfOpeartingActivities" xlink:label="loc_afyaShareOfIncomeOfAssociateOfOpeartingActivities" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaShareOfIncomeOfAssociateOfOpeartingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="loc_ifrs-fullAdjustmentsForProvisions" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForProvisions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAccountReceivable" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInInventories" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInInventories" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseDecreaseInRecoverableTaxes" xlink:label="loc_afyaIncreaseDecreaseInRecoverableTaxes" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaIncreaseDecreaseInRecoverableTaxes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="loc_ifrs-fullOtherAdjustmentsForNoncashItems" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullOtherAdjustmentsForNoncashItems" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherLiabilities" />
      <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-fullIncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullIncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:label="loc_afyaPurchaseOfIntangibleAssetClassifiedAsInvestingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_afyaPurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsReceived" xlink:label="loc_ifrs-fullDividendsReceived" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullDividendsReceived" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PurchaseOfAcquisitionOfNoncontrollingInterests" xlink:label="loc_afyaPurchaseOfAcquisitionOfNoncontrollingInterests" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_afyaPurchaseOfAcquisitionOfNoncontrollingInterests" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullPurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" xlink:label="loc_afyaPaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_afyaPaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedCashOfInvestingActivities" xlink:label="loc_afyaRestrictedCashOfInvestingActivities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_afyaRestrictedCashOfInvestingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullRepaymentsOfBorrowingsClassifiedAsFinancingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullRepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_afyaRepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_afyaRepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullProceedsFromBorrowingsClassifiedAsFinancingActivities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_afyaPaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_afyaPaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasuryShares1" xlink:label="loc_afyaTreasuryShares1" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_afyaTreasuryShares1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-fullProceedsFromExerciseOfOptions" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullProceedsFromExerciseOfOptions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullDividendsPaidClassifiedAsFinancingActivities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullDividendsPaidClassifiedAsFinancingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformation" xlink:title="00000006 - Disclosure - Corporate information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPolicies" xlink:title="00000007 - Disclosure - Material accounting policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingJudgmentsEstimatesAndAssumptions" xlink:title="00000008 - Disclosure - Significant accounting judgments, estimates and assumptions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformation" xlink:title="00000009 - Disclosure - Segment information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinations" xlink:title="00000010 - Disclosure - Business combinations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalents" xlink:title="00000011 - Disclosure - Cash and cash equivalents" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivables" xlink:title="00000012 - Disclosure - Trade receivables" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedParties" xlink:title="00000013 - Disclosure - Related parties" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssets" xlink:title="00000014 - Disclosure - Other assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociate" xlink:title="00000015 - Disclosure - Investment in associate" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipment" xlink:title="00000016 - Disclosure - Property and equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwill" xlink:title="00000017 - Disclosure - Intangible assets and goodwill" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" xlink:title="00000018 - Disclosure - Financial assets and financial liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurement" xlink:title="00000019 - Disclosure - Fair value measurement" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CapitalManagement" xlink:title="00000020 - Disclosure - Capital management" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligations" xlink:title="00000021 - Disclosure - Labor and social obligations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Equity" xlink:title="00000022 - Disclosure - Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEps" xlink:title="00000023 - Disclosure - Earnings per share (EPS)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Revenue" xlink:title="00000024 - Disclosure - Revenue" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNature" xlink:title="00000025 - Disclosure - Expenses and costs by nature" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResult" xlink:title="00000026 - Disclosure - Finance result" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxes" xlink:title="00000027 - Disclosure - Income taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingencies" xlink:title="00000028 - Disclosure - Insurance contracts and contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactions" xlink:title="00000029 - Disclosure - Non-cash transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEvent" xlink:title="00000030 - Disclosure - Subsequent event" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" xlink:title="00000031 - Disclosure - Material accounting policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesTables" xlink:title="00000032 - Disclosure - Material accounting policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationTables" xlink:title="00000033 - Disclosure - Segment information (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsTables" xlink:title="00000034 - Disclosure - Business combinations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:title="00000035 - Disclosure - Cash and cash equivalents (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesTables" xlink:title="00000036 - Disclosure - Trade receivables (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesTables" xlink:title="00000037 - Disclosure - Related parties (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsTables" xlink:title="00000038 - Disclosure - Other assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateTables" xlink:title="00000039 - Disclosure - Investment in associate (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:title="00000040 - Disclosure - Property and equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" xlink:title="00000041 - Disclosure - Intangible assets and goodwill (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" xlink:title="00000042 - Disclosure - Financial assets and financial liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurementTables" xlink:title="00000043 - Disclosure - Fair value measurement (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:title="00000044 - Disclosure - Labor and social obligations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityTables" xlink:title="00000045 - Disclosure - Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEpsTables" xlink:title="00000046 - Disclosure - Earnings per share (EPS) (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueTables" xlink:title="00000047 - Disclosure - Revenue (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNatureTables" xlink:title="00000048 - Disclosure - Expenses and costs by nature (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultTables" xlink:title="00000049 - Disclosure - Finance result (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesTables" xlink:title="00000050 - Disclosure - Income taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" xlink:title="00000051 - Disclosure - Insurance contracts and contingencies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactionsTables" xlink:title="00000052 - Disclosure - Non-cash transactions (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:title="00000053 - Disclosure - Corporate information (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails" xlink:title="00000054 - Disclosure - Material accounting policies (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" xlink:title="00000055 - Disclosure - Material accounting policies (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" xlink:title="00000056 - Disclosure - Material accounting policies (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" xlink:title="00000057 - Disclosure - Material accounting policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationDetails" xlink:title="00000058 - Disclosure - Segment information (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationDetails1" xlink:title="00000059 - Disclosure - Segment information (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails" xlink:title="00000060 - Disclosure - Business combinations (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails1" xlink:title="00000061 - Disclosure - Business combinations (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails2" xlink:title="00000062 - Disclosure - Business combinations (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails3" xlink:title="00000063 - Disclosure - Business combinations (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails4" xlink:title="00000064 - Disclosure - Business combinations (Details 4)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails5" xlink:title="00000065 - Disclosure - Business combinations (Details 5)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:title="00000066 - Disclosure - Business combinations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetails" xlink:title="00000067 - Disclosure - Cash and cash equivalents (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:title="00000068 - Disclosure - Cash and cash equivalents (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails" xlink:title="00000069 - Disclosure - Trade receivables (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails1" xlink:title="00000070 - Disclosure - Trade receivables (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails2" xlink:title="00000071 - Disclosure - Trade receivables (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetails" xlink:title="00000072 - Disclosure - Related parties (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetails1" xlink:title="00000073 - Disclosure - Related parties (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:title="00000074 - Disclosure - Related parties (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsDetails" xlink:title="00000075 - Disclosure - Other assets (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Assets1" xlink:label="loc_afyaAssets1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Advances1" xlink:label="loc_afyaAdvances1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_afyaAdvances1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_JudicialDeposits" xlink:label="loc_afyaJudicialDeposits" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_afyaJudicialDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-fullCurrentPrepaidExpenses" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_ifrs-fullCurrentPrepaidExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-fullOtherReceivables" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_ifrs-fullOtherReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Dividend" xlink:label="loc_afyaDividend" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_afyaDividend" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-fullDeferredTaxAssets" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_ifrs-fullDeferredTaxAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssets1" xlink:label="loc_afyaOtherAssets1" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_afyaOtherAssets1" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsDetailsNarrative" xlink:title="00000076 - Disclosure - Other assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateDetails" xlink:title="00000077 - Disclosure - Investment in associate (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentDetails" xlink:title="00000078 - Disclosure - Property and equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails" xlink:title="00000079 - Disclosure - Intangible assets and goodwill (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1" xlink:title="00000080 - Disclosure - Intangible assets and goodwill (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2" xlink:title="00000081 - Disclosure - Intangible assets and goodwill (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" xlink:title="00000082 - Disclosure - Intangible assets and goodwill (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails" xlink:title="00000083 - Disclosure - Financial assets and financial liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1" xlink:title="00000084 - Disclosure - Financial assets and financial liabilities (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2" xlink:title="00000085 - Disclosure - Financial assets and financial liabilities (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3" xlink:title="00000086 - Disclosure - Financial assets and financial liabilities  (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4" xlink:title="00000087 - Disclosure - Financial assets and financial liabilities (Details 4)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5" xlink:title="00000088 - Disclosure - Financial assets and financial liabilities (Details 5)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6" xlink:title="00000089 - Disclosure - Financial assets and financial liabilities (Details 6)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7" xlink:title="00000090 - Disclosure - Financial assets and financial liabilities (Details 7)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8" xlink:title="00000091 - Disclosure - Financial assets and financial liabilities (Details 8)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9" xlink:title="00000092 - Disclosure - Financial assets and financial liabilities (Details 9)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10" xlink:title="00000093 - Disclosure - Financial assets and financial liabilities (Details 10)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11" xlink:title="00000094 - Disclosure - Financial assets and financial liabilities (Details 11)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:title="00000095 - Disclosure - Financial assets and financial liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurementDetails" xlink:title="00000096 - Disclosure - Fair value measurement (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails" xlink:title="00000097 - Disclosure - Labor and social obligations (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails1" xlink:title="00000098 - Disclosure - Labor and social obligations (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails2" xlink:title="00000099 - Disclosure - Labor and social obligations (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails3" xlink:title="00000100 - Disclosure - Labor and social obligations (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails4" xlink:title="00000101 - Disclosure - Labor and social obligations (Details 4)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails5" xlink:title="00000102 - Disclosure - Labor and social obligations (Details 5)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:title="00000103 - Disclosure - Labor and social obligations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetails" xlink:title="00000104 - Disclosure - Equity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetailsNarrative" xlink:title="00000105 - Disclosure - Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEpsDetails" xlink:title="00000106 - Disclosure - Earnings per share (EPS) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueDetails" xlink:title="00000107 - Disclosure - Revenue (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueDetails1" xlink:title="00000108 - Disclosure - Revenue (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNatureDetails" xlink:title="00000109 - Disclosure - Expenses and costs by nature (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultDetails" xlink:title="00000110 - Disclosure - Finance result (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetails" xlink:title="00000111 - Disclosure - Income taxes (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:title="00000112 - Disclosure - Income taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails" xlink:title="00000113 - Disclosure - Insurance contracts and contingencies (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1" xlink:title="00000114 - Disclosure - Insurance contracts and contingencies (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" xlink:title="00000115 - Disclosure - Insurance contracts and contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactionsDetails" xlink:title="00000116 - Disclosure - Non-cash transactions (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEventDetailsNarrative" xlink:title="00000117 - Disclosure - Subsequent event (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>34
<FILENAME>afya-20231231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://afya.com.br/role/Cover" xlink:href="afya-20231231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfFinancialPosition" xlink:href="afya-20231231.xsd#StatementsOfFinancialPosition" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" xlink:href="afya-20231231.xsd#StatementsOfIncomeAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfChangesInEquity" xlink:href="afya-20231231.xsd#StatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfCashFlows" xlink:href="afya-20231231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CorporateInformation" xlink:href="afya-20231231.xsd#CorporateInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPolicies" xlink:href="afya-20231231.xsd#MaterialAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingJudgmentsEstimatesAndAssumptions" xlink:href="afya-20231231.xsd#SignificantAccountingJudgmentsEstimatesAndAssumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformation" xlink:href="afya-20231231.xsd#SegmentInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinations" xlink:href="afya-20231231.xsd#BusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalents" xlink:href="afya-20231231.xsd#CashAndCashEquivalents" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivables" xlink:href="afya-20231231.xsd#TradeReceivables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedParties" xlink:href="afya-20231231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssets" xlink:href="afya-20231231.xsd#OtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociate" xlink:href="afya-20231231.xsd#InvestmentInAssociate" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipment" xlink:href="afya-20231231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwill" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurement" xlink:href="afya-20231231.xsd#FairValueMeasurement" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CapitalManagement" xlink:href="afya-20231231.xsd#CapitalManagement" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligations" xlink:href="afya-20231231.xsd#LaborAndSocialObligations" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Equity" xlink:href="afya-20231231.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEps" xlink:href="afya-20231231.xsd#EarningsPerShareEps" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Revenue" xlink:href="afya-20231231.xsd#Revenue" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNature" xlink:href="afya-20231231.xsd#ExpensesAndCostsByNature" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResult" xlink:href="afya-20231231.xsd#FinanceResult" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxes" xlink:href="afya-20231231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingencies" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Non-cashTransactions" xlink:href="afya-20231231.xsd#Non-cashTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SubsequentEvent" xlink:href="afya-20231231.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesTables" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformationTables" xlink:href="afya-20231231.xsd#SegmentInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsTables" xlink:href="afya-20231231.xsd#BusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:href="afya-20231231.xsd#CashAndCashEquivalentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesTables" xlink:href="afya-20231231.xsd#TradeReceivablesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesTables" xlink:href="afya-20231231.xsd#RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsTables" xlink:href="afya-20231231.xsd#OtherAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociateTables" xlink:href="afya-20231231.xsd#InvestmentInAssociateTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:href="afya-20231231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurementTables" xlink:href="afya-20231231.xsd#FairValueMeasurementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityTables" xlink:href="afya-20231231.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEpsTables" xlink:href="afya-20231231.xsd#EarningsPerShareEpsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RevenueTables" xlink:href="afya-20231231.xsd#RevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNatureTables" xlink:href="afya-20231231.xsd#ExpensesAndCostsByNatureTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResultTables" xlink:href="afya-20231231.xsd#FinanceResultTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesTables" xlink:href="afya-20231231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Non-cashTransactionsTables" xlink:href="afya-20231231.xsd#Non-cashTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:href="afya-20231231.xsd#CorporateInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformationDetails" xlink:href="afya-20231231.xsd#SegmentInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformationDetails1" xlink:href="afya-20231231.xsd#SegmentInformationDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails1" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails2" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails3" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails4" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails5" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:href="afya-20231231.xsd#BusinessCombinationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetails" xlink:href="afya-20231231.xsd#CashAndCashEquivalentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:href="afya-20231231.xsd#CashAndCashEquivalentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesDetails" xlink:href="afya-20231231.xsd#TradeReceivablesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesDetails1" xlink:href="afya-20231231.xsd#TradeReceivablesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesDetails2" xlink:href="afya-20231231.xsd#TradeReceivablesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesDetails" xlink:href="afya-20231231.xsd#RelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesDetails1" xlink:href="afya-20231231.xsd#RelatedPartiesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:href="afya-20231231.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsDetails" xlink:href="afya-20231231.xsd#OtherAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsDetailsNarrative" xlink:href="afya-20231231.xsd#OtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociateDetails" xlink:href="afya-20231231.xsd#InvestmentInAssociateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipmentDetails" xlink:href="afya-20231231.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails6" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails7" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails8" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails9" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails10" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails11" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurementDetails" xlink:href="afya-20231231.xsd#FairValueMeasurementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails1" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails2" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails3" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails4" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails5" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityDetails" xlink:href="afya-20231231.xsd#EquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityDetailsNarrative" xlink:href="afya-20231231.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEpsDetails" xlink:href="afya-20231231.xsd#EarningsPerShareEpsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RevenueDetails" xlink:href="afya-20231231.xsd#RevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RevenueDetails1" xlink:href="afya-20231231.xsd#RevenueDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNatureDetails" xlink:href="afya-20231231.xsd#ExpensesAndCostsByNatureDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResultDetails" xlink:href="afya-20231231.xsd#FinanceResultDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesDetails" xlink:href="afya-20231231.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:href="afya-20231231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingenciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Non-cashTransactionsDetails" xlink:href="afya-20231231.xsd#Non-cashTransactionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SubsequentEventDetailsNarrative" xlink:href="afya-20231231.xsd#SubsequentEventDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassAOrdinarySharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassBOrdinarySharesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_50" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_50" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_50" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_50" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_50" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_50" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_50" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_50" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_50" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_50" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_50" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_50" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_50" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_50" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_50" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_50" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_50" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_50" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName_50" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_deiContactPersonnelEmailAddress_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelEmailAddress_50" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag_50" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag_50" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorFirmId_50" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorName_50" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorLocation_50" xlink:type="arc" order="64" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfFinancialPosition" xlink:title="00000002 - Statement - Consolidated statements of financial position" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" xlink:title="00000003 - Statement - Consolidated statements of income and comprehensive income" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfChangesInEquity" xlink:title="00000004 - Statement - Consolidated statements of changes in equity">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-fullComponentsOfEquityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullComponentsOfEquityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-fullEquityMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullEquityMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-fullEquityMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullEquityMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-fullIssuedCapitalMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullIssuedCapitalMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionalPaidinCapitalMember" xlink:label="loc_ifrs-fullAdditionalPaidinCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullAdditionalPaidinCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-fullTreasurySharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullTreasurySharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-fullReserveOfSharebasedPaymentsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullReserveOfSharebasedPaymentsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-fullRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="loc_ifrs-fullEquityAttributableToOwnersOfParentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullEquityAttributableToOwnersOfParentMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-fullNoncontrollingInterestsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullNoncontrollingInterestsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullComprehensiveIncome_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CapitalIncreaseWithCash" xlink:label="loc_afyaCapitalIncreaseWithCash_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalIncreaseWithCash_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasuryShares1" xlink:label="loc_afyaTreasuryShares1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasuryShares1_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasurySharesTransferredFromExerciseOfOptions" xlink:label="loc_afyaTreasurySharesTransferredFromExerciseOfOptions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesTransferredFromExerciseOfOptions_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination" xlink:label="loc_afyaTreasurySharesTransferredFromSharesContributionOnBusinessCombination_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesTransferredFromSharesContributionOnBusinessCombination_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfNoncontrollingInterests" xlink:label="loc_afyaAcquisitionOfNoncontrollingInterests_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquisitionOfNoncontrollingInterests_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedSharesTransferredToExecutives" xlink:label="loc_afyaRestrictedSharesTransferredToExecutives_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRestrictedSharesTransferredToExecutives_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" xlink:label="loc_afyaTreasurySharesTransferredToExecutivesFromExerciseOfStockOptions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesTransferredToExecutivesFromExerciseOfStockOptions_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaid" xlink:label="loc_ifrs-fullDividendsPaid_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaid_90" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated statements of cash flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformation" xlink:title="00000006 - Disclosure - Corporate information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPolicies" xlink:title="00000007 - Disclosure - Material accounting policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingJudgmentsEstimatesAndAssumptions" xlink:title="00000008 - Disclosure - Significant accounting judgments, estimates and assumptions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformation" xlink:title="00000009 - Disclosure - Segment information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinations" xlink:title="00000010 - Disclosure - Business combinations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalents" xlink:title="00000011 - Disclosure - Cash and cash equivalents" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivables" xlink:title="00000012 - Disclosure - Trade receivables" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedParties" xlink:title="00000013 - Disclosure - Related parties" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssets" xlink:title="00000014 - Disclosure - Other assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociate" xlink:title="00000015 - Disclosure - Investment in associate" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipment" xlink:title="00000016 - Disclosure - Property and equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwill" xlink:title="00000017 - Disclosure - Intangible assets and goodwill" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" xlink:title="00000018 - Disclosure - Financial assets and financial liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurement" xlink:title="00000019 - Disclosure - Fair value measurement" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CapitalManagement" xlink:title="00000020 - Disclosure - Capital management" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligations" xlink:title="00000021 - Disclosure - Labor and social obligations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Equity" xlink:title="00000022 - Disclosure - Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEps" xlink:title="00000023 - Disclosure - Earnings per share (EPS)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Revenue" xlink:title="00000024 - Disclosure - Revenue" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNature" xlink:title="00000025 - Disclosure - Expenses and costs by nature" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResult" xlink:title="00000026 - Disclosure - Finance result" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxes" xlink:title="00000027 - Disclosure - Income taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingencies" xlink:title="00000028 - Disclosure - Insurance contracts and contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactions" xlink:title="00000029 - Disclosure - Non-cash transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEvent" xlink:title="00000030 - Disclosure - Subsequent event" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" xlink:title="00000031 - Disclosure - Material accounting policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesTables" xlink:title="00000032 - Disclosure - Material accounting policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationTables" xlink:title="00000033 - Disclosure - Segment information (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsTables" xlink:title="00000034 - Disclosure - Business combinations (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:title="00000035 - Disclosure - Cash and cash equivalents (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesTables" xlink:title="00000036 - Disclosure - Trade receivables (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesTables" xlink:title="00000037 - Disclosure - Related parties (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsTables" xlink:title="00000038 - Disclosure - Other assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateTables" xlink:title="00000039 - Disclosure - Investment in associate (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:title="00000040 - Disclosure - Property and equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" xlink:title="00000041 - Disclosure - Intangible assets and goodwill (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" xlink:title="00000042 - Disclosure - Financial assets and financial liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurementTables" xlink:title="00000043 - Disclosure - Fair value measurement (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:title="00000044 - Disclosure - Labor and social obligations (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:label="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RSUsMember" xlink:label="loc_afyaRSUsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:to="loc_afyaRSUsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions" xlink:label="loc_afyaScheduleOfModelUsedToDetermineFairValueOfStockOptions_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfModelUsedToDetermineFairValueOfStockOptions_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions" xlink:label="loc_afyaScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfAdditionalStockOptionsExplanatory" xlink:label="loc_afyaScheduleOfAdditionalStockOptionsExplanatory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAdditionalStockOptionsExplanatory_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfSharebasedCompensationPlanExplanatory" xlink:label="loc_afyaScheduleOfSharebasedCompensationPlanExplanatory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfSharebasedCompensationPlanExplanatory_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfStockOptionExplanatory" xlink:label="loc_afyaScheduleOfStockOptionExplanatory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfStockOptionExplanatory_30" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityTables" xlink:title="00000045 - Disclosure - Equity (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEpsTables" xlink:title="00000046 - Disclosure - Earnings per share (EPS) (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueTables" xlink:title="00000047 - Disclosure - Revenue (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNatureTables" xlink:title="00000048 - Disclosure - Expenses and costs by nature (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultTables" xlink:title="00000049 - Disclosure - Finance result (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesTables" xlink:title="00000050 - Disclosure - Income taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" xlink:title="00000051 - Disclosure - Insurance contracts and contingencies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactionsTables" xlink:title="00000052 - Disclosure - Non-cash transactions (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:title="00000053 - Disclosure - Corporate information (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BertelsmannMember" xlink:label="loc_afyaBertelsmannMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaBertelsmannMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-fullOrdinarySharesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_ifrs-fullOrdinarySharesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SubsidiariesMember" xlink:label="loc_ifrs-fullSubsidiariesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_ifrs-fullSubsidiariesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquiredShares" xlink:label="loc_afyaAcquiredShares_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquiredShares_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestInSubsidiary_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestInSubsidiary_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-fullConsiderationPaidReceived_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullConsiderationPaidReceived_100" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails" xlink:title="00000054 - Disclosure - Material accounting policies (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AfyaParticipacoesSAMember" xlink:label="loc_afyaAfyaParticipacoesSAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAfyaParticipacoesSAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" xlink:label="loc_afyaUniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" xlink:label="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" xlink:label="loc_afyaCentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroIntegradoDeSaudeDeTeresinaCISMember" xlink:label="loc_afyaCentroIntegradoDeSaudeDeTeresinaCISMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroIntegradoDeSaudeDeTeresinaCISMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" xlink:label="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedcelEditoraEventosS.A.MedcelMember" xlink:label="loc_afyaMedcelEditoraEventosS.A.MedcelMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedcelEditoraEventosS.A.MedcelMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoS.A.FASAMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoS.A.FASAMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ESMCEducacaoSuperiorLtdaESMCMember" xlink:label="loc_afyaESMCEducacaoSuperiorLtdaESMCMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaESMCEducacaoSuperiorLtdaESMCMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" xlink:label="loc_afyaInstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" xlink:label="loc_afyaInstitutoParaenseDeEducacaoECulturaLtda.IPECMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoParaenseDeEducacaoECulturaLtda.IPECMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember" xlink:label="loc_afyaSociedadeUniversitariaRedentorS.A.UniRedentorMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeUniversitariaRedentorS.A.UniRedentorMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroDeEnsinoSaoLucasLtda.UniSLMember" xlink:label="loc_afyaCentroDeEnsinoSaoLucasLtda.UniSLMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroDeEnsinoSaoLucasLtda.UniSLMember_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" xlink:label="loc_afyaPebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaPebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" xlink:label="loc_afyaSociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" xlink:label="loc_afyaCentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" xlink:label="loc_afyaIClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_400" xlink:type="arc" order="401" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedicinaeSolutionsS.A.MedicinaeMember" xlink:label="loc_afyaMedicinaeSolutionsS.A.MedicinaeMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicinaeSolutionsS.A.MedicinaeMember_420" xlink:type="arc" order="421" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_440" xlink:type="arc" order="441" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" xlink:label="loc_afyaCliquefarmaDrogariasOnlineLtda.CliquefarmaMember_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCliquefarmaDrogariasOnlineLtda.CliquefarmaMember_460" xlink:type="arc" order="461" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShospTecnologiaDaInformacaoLtda.ShospMember" xlink:label="loc_afyaShospTecnologiaDaInformacaoLtda.ShospMember_480" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospTecnologiaDaInformacaoLtda.ShospMember_480" xlink:type="arc" order="481" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" xlink:label="loc_afyaSociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_500" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_500" xlink:type="arc" order="501" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember" xlink:label="loc_afyaNucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaNucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_520" xlink:type="arc" order="521" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" xlink:label="loc_afyaCompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_540" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_540" xlink:type="arc" order="541" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" xlink:label="loc_afyaPoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_560" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaPoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_560" xlink:type="arc" order="561" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadeEducacionalDePalhocaSALtda.Member" xlink:label="loc_afyaSociedadeEducacionalDePalhocaSALtda.Member_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeEducacionalDePalhocaSALtda.Member_580" xlink:type="arc" order="581" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_600" xlink:type="arc" order="601" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember" xlink:label="loc_afyaRXPROSolucoesDeTecnologiaLtda.RXPROMember_620" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROSolucoesDeTecnologiaLtda.RXPROMember_620" xlink:type="arc" order="621" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember" xlink:label="loc_afyaRXPROLOGTransporteELogisticaLtda.RXPROLOGMember_640" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROLOGTransporteELogisticaLtda.RXPROLOGMember_640" xlink:type="arc" order="641" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BMVAtividadesMedicasLtda.AlemDaMedicinaMember" xlink:label="loc_afyaBMVAtividadesMedicasLtda.AlemDaMedicinaMember_660" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaBMVAtividadesMedicasLtda.AlemDaMedicinaMember_660" xlink:type="arc" order="661" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CardiopapersSolucoesDigitaisLtda.CardioPapersMember" xlink:label="loc_afyaCardiopapersSolucoesDigitaisLtda.CardioPapersMember_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCardiopapersSolucoesDigitaisLtda.CardioPapersMember_680" xlink:type="arc" order="681" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" xlink:label="loc_afyaQuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaQuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_700" xlink:type="arc" order="701" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" xlink:label="loc_afyaSociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_720" xlink:type="arc" order="721" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" xlink:label="loc_afyaUniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_730" xlink:type="arc" order="731" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PrincipalActivities" xlink:label="loc_afyaPrincipalActivities_760" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPrincipalActivities_760" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="loc_ifrs-fullPrincipalPlaceOfBusinessOfSubsidiary_760" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPrincipalPlaceOfBusinessOfSubsidiary_760" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InvestmentType" xlink:label="loc_afyaInvestmentType_760" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInvestmentType_760" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_760" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_760" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" xlink:title="00000055 - Disclosure - Material accounting policies (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-fullBuildingsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullBuildingsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="loc_afyaMachineryAndEquipmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaMachineryAndEquipmentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-fullVehiclesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullVehiclesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullFixturesAndFittingsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ItEquipmentMember" xlink:label="loc_afyaItEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaItEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LibraryBooksMember" xlink:label="loc_afyaLibraryBooksMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaLibraryBooksMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-fullLeaseholdImprovementsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullLeaseholdImprovementsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" xlink:title="00000056 - Disclosure - Material accounting policies (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InitiallyAppliedIFRSsAxis" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InitiallyAppliedIFRSsMember" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsAxis" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InitiallyAppliedIFRSsMember" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsAxis" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS1Member" xlink:label="loc_afyaAmendmentsToIAS1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIAS1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS8Member" xlink:label="loc_afyaAmendmentsToIAS8Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIAS8Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS12Member" xlink:label="loc_afyaAmendmentsToIAS12Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIAS12Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS12OneMember" xlink:label="loc_afyaAmendmentsToIAS12OneMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIAS12OneMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IFRS17Member" xlink:label="loc_ifrs-fullIFRS17Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_ifrs-fullIFRS17Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIFRS16Member" xlink:label="loc_afyaAmendmentsToIFRS16Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIFRS16Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS1OneMember" xlink:label="loc_afyaAmendmentsToIAS1OneMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIAS1OneMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS7AndIFRS7Member" xlink:label="loc_afyaAmendmentsToIAS7AndIFRS7Member_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIAS7AndIFRS7Member_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TitleOfInitiallyAppliedIFRS" xlink:label="loc_ifrs-fullTitleOfInitiallyAppliedIFRS_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTitleOfInitiallyAppliedIFRS_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:label="loc_ifrs-fullDescriptionOfNatureOfChangeInAccountingPolicy_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfNatureOfChangeInAccountingPolicy_90" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" xlink:title="00000057 - Disclosure - Material accounting policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ProgramOfSocialIntegrationMember" xlink:label="loc_afyaProgramOfSocialIntegrationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="loc_afyaProgramOfSocialIntegrationMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContributionForTheFinancingOfSocialSecurityMember" xlink:label="loc_afyaContributionForTheFinancingOfSocialSecurityMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="loc_afyaContributionForTheFinancingOfSocialSecurityMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-fullProductsAndServicesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="loc_ifrs-fullProductsAndServicesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="loc_ifrs-fullProductsAndServicesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullProductsAndServicesAxis" xlink:to="loc_ifrs-fullProductsAndServicesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="loc_ifrs-fullProductsAndServicesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullProductsAndServicesAxis" xlink:to="loc_ifrs-fullProductsAndServicesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TeachingActivitiesMember" xlink:label="loc_afyaTeachingActivitiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullProductsAndServicesMember" xlink:to="loc_afyaTeachingActivitiesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NonTeachingActivitiesMember" xlink:label="loc_afyaNonTeachingActivitiesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullProductsAndServicesMember" xlink:to="loc_afyaNonTeachingActivitiesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-fullApplicableTaxRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullApplicableTaxRate_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationDetails" xlink:title="00000058 - Disclosure - Segment information (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-fullSegmentConsolidationItemsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-fullOperatingSegmentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" xlink:to="loc_ifrs-fullOperatingSegmentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaUndergradMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaContinuingEducationMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DigitalServicesMember" xlink:label="loc_afyaDigitalServicesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaDigitalServicesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TotalReportableSegmentsMember" xlink:label="loc_afyaTotalReportableSegmentsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaTotalReportableSegmentsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdjustmentsAndEliminationsMember" xlink:label="loc_afyaAdjustmentsAndEliminationsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaAdjustmentsAndEliminationsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAssets_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquityAndLiabilities_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CapitalExpenditures" xlink:label="loc_afyaCapitalExpenditures_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalExpenditures_130" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationDetails1" xlink:title="00000059 - Disclosure - Segment information (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-fullSegmentConsolidationItemsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-fullOperatingSegmentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" xlink:to="loc_ifrs-fullOperatingSegmentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaUndergradMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaContinuingEducationMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DigitalServicesMember" xlink:label="loc_afyaDigitalServicesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaDigitalServicesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TotalReportableSegmentsMember" xlink:label="loc_afyaTotalReportableSegmentsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaTotalReportableSegmentsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdjustmentsAndEliminationsMember" xlink:label="loc_afyaAdjustmentsAndEliminationsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaAdjustmentsAndEliminationsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DepositsFromExternalCustomer" xlink:label="loc_afyaDepositsFromExternalCustomer_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDepositsFromExternalCustomer_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InterSegment" xlink:label="loc_afyaInterSegment_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInterSegment_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CostOfSale" xlink:label="loc_afyaCostOfSale_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCostOfSale_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-fullGrossProfit_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGrossProfit_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullSellingGeneralAndAdministrativeExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullSellingGeneralAndAdministrativeExpense_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherGainsLosses" xlink:label="loc_ifrs-fullOtherGainsLosses_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherGainsLosses_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities_190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinanceIncome_190" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinanceExpense" xlink:label="loc_afyaFinanceExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinanceExpense_190" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-fullAdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_190" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax_190" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations_190" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss_190" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails" xlink:title="00000060 - Disclosure - Business combinations (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaDelReyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeReceivablesAsOfAcquisitionDate" xlink:label="loc_afyaTradeReceivablesAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesAsOfAcquisitionDate_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Inventories1" xlink:label="loc_afyaInventories1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInventories1_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RecoverableTaxesAsOfAcquisitionDate" xlink:label="loc_afyaRecoverableTaxesAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRecoverableTaxesAsOfAcquisitionDate_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssetsAsOfAcquisitionDate" xlink:label="loc_afyaOtherAssetsAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsAsOfAcquisitionDate_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_afyaRightOfUseAssetsAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRightOfUseAssetsAsOfAcquisitionDate_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:label="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxesPayableAsOfAcquisitionDate" xlink:label="loc_afyaTaxesPayableAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTaxesPayableAsOfAcquisitionDate_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:label="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:label="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaOtherLiabilitiesAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherLiabilitiesAsOfAcquisitionDate_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-fullCashTransferred_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashTransferred_30" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ConsiderationToBeTransferred" xlink:label="loc_afyaConsiderationToBeTransferred_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsiderationToBeTransferred_30" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CirculationRevenue" xlink:label="loc_ifrs-fullCirculationRevenue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCirculationRevenue_30" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_30" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_30" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NetOfCashFlowOnAcquisition" xlink:label="loc_afyaNetOfCashFlowOnAcquisition_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetOfCashFlowOnAcquisition_30" xlink:type="arc" order="25" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails1" xlink:title="00000061 - Disclosure - Business combinations (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="loc_ifrs-fullLicencesAndFranchisesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullLicencesAndFranchisesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfDelReyMember" xlink:label="loc_afyaAcquisitionOfDelReyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAcquisitionOfDelReyMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesMember" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesMember" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WithAndWithoutMethodMember" xlink:label="loc_afyaWithAndWithoutMethodMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaWithAndWithoutMethodMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:label="loc_ifrs-fullMultiperiodExcessEarningsMethodMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_ifrs-fullMultiperiodExcessEarningsMethodMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails2" xlink:title="00000062 - Disclosure - Business combinations (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAlemDaMedicinaMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CardioPapersMember" xlink:label="loc_afyaCardioPapersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCardioPapersMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GlicMember" xlink:label="loc_afyaGlicMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaGlicMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeReceivablesAsOfAcquisitionDate" xlink:label="loc_afyaTradeReceivablesAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesAsOfAcquisitionDate_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssetsAsOfAcquisitionDate" xlink:label="loc_afyaOtherAssetsAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsAsOfAcquisitionDate_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:label="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxesPayableAsOfAcquisitionDate" xlink:label="loc_afyaTaxesPayableAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTaxesPayableAsOfAcquisitionDate_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:label="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaOtherLiabilitiesAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherLiabilitiesAsOfAcquisitionDate_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-fullCashTransferred_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashTransferred_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullContingentConsiderationRecognisedAsOfAcquisitionDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullContingentConsiderationRecognisedAsOfAcquisitionDate_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ConsiderationToBeTransferred" xlink:label="loc_afyaConsiderationToBeTransferred_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsiderationToBeTransferred_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NetOfCashFlowOnAcquisition" xlink:label="loc_afyaNetOfCashFlowOnAcquisition_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetOfCashFlowOnAcquisition_70" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails3" xlink:title="00000063 - Disclosure - Business combinations (Details 3)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationalContentMember" xlink:label="loc_afyaEducationalContentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_afyaEducationalContentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAlemDaMedicinaMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesMember" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesMember" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReliefFromRoyaltyMember" xlink:label="loc_afyaReliefFromRoyaltyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaReliefFromRoyaltyMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:label="loc_ifrs-fullMultiperiodExcessEarningsMethodMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_ifrs-fullMultiperiodExcessEarningsMethodMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReplacementCostMember" xlink:label="loc_afyaReplacementCostMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaReplacementCostMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails4" xlink:title="00000064 - Disclosure - Business combinations (Details 4)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationalContentMember" xlink:label="loc_afyaEducationalContentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_afyaEducationalContentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CopyrightMember" xlink:label="loc_afyaCopyrightMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_afyaCopyrightMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfCardioPapersMember" xlink:label="loc_afyaAcquisitionOfCardioPapersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAcquisitionOfCardioPapersMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesMember" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesMember" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReliefFromRoyaltyMember" xlink:label="loc_afyaReliefFromRoyaltyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaReliefFromRoyaltyMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:label="loc_ifrs-fullMultiperiodExcessEarningsMethodMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_ifrs-fullMultiperiodExcessEarningsMethodMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReplacementCostMember" xlink:label="loc_afyaReplacementCostMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaReplacementCostMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails5" xlink:title="00000065 - Disclosure - Business combinations (Details 5)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfGlicMember" xlink:label="loc_afyaAcquisitionOfGlicMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAcquisitionOfGlicMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesMember" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesMember" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReliefFromRoyaltyMember" xlink:label="loc_afyaReliefFromRoyaltyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaReliefFromRoyaltyMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:label="loc_ifrs-fullMultiperiodExcessEarningsMethodMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_ifrs-fullMultiperiodExcessEarningsMethodMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReplacementCostMember" xlink:label="loc_afyaReplacementCostMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaReplacementCostMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:title="00000066 - Disclosure - Business combinations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfDelReyMember" xlink:label="loc_afyaAcquisitionOfDelReyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaAcquisitionOfDelReyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaAlemDaMedicinaMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfCardioPapersMember" xlink:label="loc_afyaAcquisitionOfCardioPapersMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaAcquisitionOfCardioPapersMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CardioPapersMember" xlink:label="loc_afyaCardioPapersMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaCardioPapersMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfGlicMember" xlink:label="loc_afyaAcquisitionOfGlicMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaAcquisitionOfGlicMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GlicMember" xlink:label="loc_afyaGlicMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaGlicMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAcquiree" xlink:label="loc_ifrs-fullDescriptionOfAcquiree_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfAcquiree_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseInRevenue" xlink:label="loc_afyaIncreaseInRevenue_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseInRevenue_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseInIncomeBeforeIncomeTaxes" xlink:label="loc_afyaIncreaseInIncomeBeforeIncomeTaxes_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseInIncomeBeforeIncomeTaxes_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DecreaseInIncomeBeforeIncomeTaxes" xlink:label="loc_afyaDecreaseInIncomeBeforeIncomeTaxes_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDecreaseInIncomeBeforeIncomeTaxes_150" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetails" xlink:title="00000067 - Disclosure - Cash and cash equivalents (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:title="00000068 - Disclosure - Cash and cash equivalents (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BankCertificatesOfDepositMember" xlink:label="loc_afyaBankCertificatesOfDepositMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaBankCertificatesOfDepositMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_USDMember" xlink:label="loc_afyaUSDMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_afyaUSDMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PercenatgeOfAverageInterestOnFinancialInstrument" xlink:label="loc_afyaPercenatgeOfAverageInterestOnFinancialInstrument_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPercenatgeOfAverageInterestOnFinancialInstrument_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashEquivalents" xlink:label="loc_ifrs-fullCashEquivalents_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashEquivalents_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails" xlink:title="00000069 - Disclosure - Trade receivables (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TuitionFeesMember" xlink:label="loc_afyaTuitionFeesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaTuitionFeesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationalContentMember" xlink:label="loc_afyaEducationalContentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaEducationalContentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FIESMember" xlink:label="loc_afyaFIESMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaFIESMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationalCreditsMember" xlink:label="loc_afyaEducationalCreditsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaEducationalCreditsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MobileAppSubscriptionMember" xlink:label="loc_afyaMobileAppSubscriptionMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaMobileAppSubscriptionMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OthersMember" xlink:label="loc_afyaOthersMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaOthersMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReceivablesGross" xlink:label="loc_afyaReceivablesGross_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReceivablesGross_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AllowanceForDoubtfulAccountsFoReceivable1" xlink:label="loc_afyaAllowanceForDoubtfulAccountsFoReceivable1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAllowanceForDoubtfulAccountsFoReceivable1_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-fullTradeReceivables_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeReceivables_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-fullCurrentTradeReceivables_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentTradeReceivables_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="loc_ifrs-fullNoncurrentTradeReceivables_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentTradeReceivables_150" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails1" xlink:title="00000070 - Disclosure - Trade receivables (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" xlink:label="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" xlink:label="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" xlink:label="loc_ifrs-fullFinancialAssetsNeitherPastDueNorImpairedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember" xlink:to="loc_ifrs-fullFinancialAssetsNeitherPastDueNorImpairedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PastDueStatusAxis" xlink:label="loc_ifrs-fullPastDueStatusAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_ifrs-fullPastDueStatusAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PastDueStatusMember" xlink:label="loc_ifrs-fullPastDueStatusMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullPastDueStatusAxis" xlink:to="loc_ifrs-fullPastDueStatusMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PastDueStatusMember" xlink:label="loc_ifrs-fullPastDueStatusMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullPastDueStatusAxis" xlink:to="loc_ifrs-fullPastDueStatusMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentMember" xlink:label="loc_ifrs-fullCurrentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_ifrs-fullCurrentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:label="loc_afyaLaterThanOneMonthsAndNotLaterThanThreeMonthsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_afyaLaterThanOneMonthsAndNotLaterThanThreeMonthsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="loc_ifrs-fullLaterThanThreeMonthsAndNotLaterThanSixMonthsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_ifrs-fullLaterThanThreeMonthsAndNotLaterThanSixMonthsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaterThanOneEightyMember" xlink:label="loc_afyaLaterThanOneEightyMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_afyaLaterThanOneEightyMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReceivablesGross" xlink:label="loc_afyaReceivablesGross_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReceivablesGross_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails2" xlink:title="00000071 - Disclosure - Trade receivables (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetails" xlink:title="00000072 - Disclosure - Related parties (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UEPCMember" xlink:label="loc_afyaUEPCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaUEPCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EMIVEPatrulha24HorasLtdaMember" xlink:label="loc_afyaEMIVEPatrulha24HorasLtdaMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaEMIVEPatrulha24HorasLtdaMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RVLEstevesGestaoImobiliariaSAMember" xlink:label="loc_afyaRVLEstevesGestaoImobiliariaSAMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaRVLEstevesGestaoImobiliariaSAMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UNIVACOPatrimonialLtdaMember" xlink:label="loc_afyaUNIVACOPatrimonialLtdaMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaUNIVACOPatrimonialLtdaMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IESVAPPatrimonialLtdaMember" xlink:label="loc_afyaIESVAPPatrimonialLtdaMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaIESVAPPatrimonialLtdaMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeReceivablesRelatedPartyTransactions" xlink:label="loc_afyaTradeReceivablesRelatedPartyTransactions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesRelatedPartyTransactions_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssetsRelatedPartyTransactions" xlink:label="loc_afyaOtherAssetsRelatedPartyTransactions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsRelatedPartyTransactions_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeAndOtherCurrentPayablesToRelatedParties1" xlink:label="loc_afyaTradeAndOtherCurrentPayablesToRelatedParties1_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherCurrentPayablesToRelatedParties1_210" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentAssetsOfRelatedParty1" xlink:label="loc_afyaNoncurrentAssetsOfRelatedParty1_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNoncurrentAssetsOfRelatedParty1_210" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholders" xlink:label="loc_afyaAccountsPayableToSellingShareholders_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholders_210" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-fullAmountsPayableRelatedPartyTransactions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmountsPayableRelatedPartyTransactions_210" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableCurrent1" xlink:label="loc_afyaAccountsPayableCurrent1_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableCurrent1_210" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentPayablesToRelatedParties1" xlink:label="loc_afyaNoncurrentPayablesToRelatedParties1_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNoncurrentPayablesToRelatedParties1_210" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherIncomeRelatedPartyTransactions" xlink:label="loc_afyaOtherIncomeRelatedPartyTransactions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherIncomeRelatedPartyTransactions_210" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeasesAsLesseeRelatedPartyTransactions" xlink:label="loc_ifrs-fullLeasesAsLesseeRelatedPartyTransactions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeasesAsLesseeRelatedPartyTransactions_210" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetails1" xlink:title="00000073 - Disclosure - Related parties (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:title="00000074 - Disclosure - Related parties (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseAgreements1Member" xlink:label="loc_afyaLeaseAgreements1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaLeaseAgreements1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:label="loc_afyaInstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RVLEstevesGestaoImobiliariaSAMember" xlink:label="loc_afyaRVLEstevesGestaoImobiliariaSAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaRVLEstevesGestaoImobiliariaSAMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UNIVACOPatrimonialLtdaMember" xlink:label="loc_afyaUNIVACOPatrimonialLtdaMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaUNIVACOPatrimonialLtdaMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IESVAPPatrimonialLtdaMember" xlink:label="loc_afyaIESVAPPatrimonialLtdaMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaIESVAPPatrimonialLtdaMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OperatingLeaseTermOfContract" xlink:label="loc_afyaOperatingLeaseTermOfContract_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOperatingLeaseTermOfContract_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-fullPercentageOfEntitysRevenue_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfEntitysRevenue_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LesseeFinancesLeaseRenewalTerm" xlink:label="loc_afyaLesseeFinancesLeaseRenewalTerm_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLesseeFinancesLeaseRenewalTerm_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DescriptionOfLeaseTerm" xlink:label="loc_afyaDescriptionOfLeaseTerm_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDescriptionOfLeaseTerm_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-fullCashOutflowForLeases_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashOutflowForLeases_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DescriptionOfLeaseTerms" xlink:label="loc_afyaDescriptionOfLeaseTerms_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDescriptionOfLeaseTerms_190" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsDetails" xlink:title="00000075 - Disclosure - Other assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsDetailsNarrative" xlink:title="00000076 - Disclosure - Other assets (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateDetails" xlink:title="00000077 - Disclosure - Investment in associate (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AssociatesMember" xlink:label="loc_ifrs-fullAssociatesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_ifrs-fullAssociatesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EquityInAssociate" xlink:label="loc_afyaEquityInAssociate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEquityInAssociate_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CompanyShareInEquity1" xlink:label="loc_afyaCompanyShareInEquity1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompanyShareInEquity1_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-fullGoodwill_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwill_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InvestmentGrossAmount" xlink:label="loc_afyaInvestmentGrossAmount_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInvestmentGrossAmount_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCostOfSales_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullSellingGeneralAndAdministrativeExpense_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullSellingGeneralAndAdministrativeExpense_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinanceIncome_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CompanyShareOfProfitss" xlink:label="loc_afyaCompanyShareOfProfitss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompanyShareOfProfitss_80" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates_80" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DividendsReceived1" xlink:label="loc_afyaDividendsReceived1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendsReceived1_80" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsReceived" xlink:label="loc_ifrs-fullDividendsReceived_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsReceived_80" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="loc_ifrs-fullProfitLossOfAcquiree_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossOfAcquiree_80" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentDetails" xlink:title="00000078 - Disclosure - Property and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_700" xlink:type="arc" order="701" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-fullBuildingsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullBuildingsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="loc_afyaMachineryAndEquipmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaMachineryAndEquipmentsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-fullLandMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullLandMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-fullVehiclesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullVehiclesMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullFixturesAndFittingsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ItEquipmentMember" xlink:label="loc_afyaItEquipmentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaItEquipmentMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LibraryBooksMember" xlink:label="loc_afyaLibraryBooksMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaLibraryBooksMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-fullLeaseholdImprovementsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullLeaseholdImprovementsMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-fullConstructionInProgressMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullConstructionInProgressMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PropertyPlantAndEquipments" xlink:label="loc_afyaPropertyPlantAndEquipments_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPropertyPlantAndEquipments_1610" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1610" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_1610" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullDepreciationPropertyPlantAndEquipment_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDepreciationPropertyPlantAndEquipment_1610" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WritOffOfPropertyPlantAndEquipment" xlink:label="loc_afyaWritOffOfPropertyPlantAndEquipment_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWritOffOfPropertyPlantAndEquipment_1610" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_1610" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PropertyPlantAndEquipmentNetBookValue" xlink:label="loc_afyaPropertyPlantAndEquipmentNetBookValue_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPropertyPlantAndEquipmentNetBookValue_1610" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails" xlink:title="00000079 - Disclosure - Intangible assets and goodwill (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-fullGoodwillMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullGoodwillMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-fullLicencesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullLicencesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-fullComputerSoftwareMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullComputerSoftwareMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationContentMember" xlink:label="loc_afyaEducationContentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationContentMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationalPlatformMember" xlink:label="loc_afyaEducationalPlatformMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationalPlatformMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SoftwareInProgressMember" xlink:label="loc_afyaSoftwareInProgressMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaSoftwareInProgressMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherMember" xlink:label="loc_afyaOtherMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaOtherMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_730" xlink:type="arc" order="732" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwill_1690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwill_1690" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1690" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill_1690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill_1690" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WriteoffOfIntangibleAssets" xlink:label="loc_afyaWriteoffOfIntangibleAssets_1690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWriteoffOfIntangibleAssets_1690" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_1690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_1690" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Remesurement" xlink:label="loc_afyaRemesurement_1690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemesurement_1690" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Transfer" xlink:label="loc_afyaTransfer_1690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTransfer_1690" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IntangibleAssetsAndGoodwillNetBookValue" xlink:label="loc_afyaIntangibleAssetsAndGoodwillNetBookValue_1690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIntangibleAssetsAndGoodwillNetBookValue_1690" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1" xlink:title="00000080 - Disclosure - Intangible assets and goodwill (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CarryingAmountsMember" xlink:label="loc_afyaCarryingAmountsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_afyaCarryingAmountsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:label="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:label="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:label="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:label="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniRedentorMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniSLMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FESARMember" xlink:label="loc_afyaFESARMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFESARMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFCMPBMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ITPACGaranhunsMember" xlink:label="loc_afyaITPACGaranhunsMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaITPACGaranhunsMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedcelAndCBBWMember" xlink:label="loc_afyaMedcelAndCBBWMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedcelAndCBBWMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PracticeManagementToolsAndElectronicPrescriptionMember" xlink:label="loc_afyaPracticeManagementToolsAndElectronicPrescriptionMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaPracticeManagementToolsAndElectronicPrescriptionMember_280" xlink:type="arc" order="282" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ClinicalDecisionSoftwareMember" xlink:label="loc_afyaClinicalDecisionSoftwareMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaClinicalDecisionSoftwareMember_300" xlink:type="arc" order="302" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CliquefarmaMember" xlink:label="loc_afyaCliquefarmaMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCliquefarmaMember_320" xlink:type="arc" order="322" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UnifipMocMember" xlink:label="loc_afyaUnifipMocMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUnifipMocMember_340" xlink:type="arc" order="342" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUnigranrioMember_360" xlink:type="arc" order="362" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember_380" xlink:type="arc" order="382" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GlicMember" xlink:label="loc_afyaGlicMember_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaGlicMember_400" xlink:type="arc" order="402" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaDelReyMember_420" xlink:type="arc" order="422" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-fullGoodwill_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwill_470" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLife_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLife_470" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CashGeneratingUnits" xlink:label="loc_afyaCashGeneratingUnits_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCashGeneratingUnits_470" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2" xlink:title="00000081 - Disclosure - Intangible assets and goodwill (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CustomerRelationshipsMedicineMember" xlink:label="loc_afyaCustomerRelationshipsMedicineMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaCustomerRelationshipsMedicineMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CustomerRelationshipsOtherCoursesMember" xlink:label="loc_afyaCustomerRelationshipsOtherCoursesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaCustomerRelationshipsOtherCoursesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-fullComputerSoftwareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullComputerSoftwareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationContentMember" xlink:label="loc_afyaEducationContentMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationContentMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DevelopedTechnologyMember" xlink:label="loc_afyaDevelopedTechnologyMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaDevelopedTechnologyMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_80" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" xlink:title="00000082 - Disclosure - Intangible assets and goodwill (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-fullGoodwillMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullGoodwillMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfDiscountRatesAppliedToCashFlowProjections_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfDiscountRatesAppliedToCashFlowProjections_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExplicitProjectionPeriod" xlink:label="loc_afyaExplicitProjectionPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExplicitProjectionPeriod_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PerpetuityGrowthRate" xlink:label="loc_afyaPerpetuityGrowthRate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPerpetuityGrowthRate_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_90" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails" xlink:title="00000083 - Disclosure - Financial assets and financial liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="loc_ifrs-fullFinancialAssetsAtAmortisedCostMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_ifrs-fullFinancialAssetsAtAmortisedCostMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-fullTradeReceivables_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeReceivables_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialAssets" xlink:label="loc_ifrs-fullCurrentFinancialAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialAssets_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="loc_ifrs-fullNoncurrentFinancialAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialAssets_30" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1" xlink:title="00000084 - Disclosure - Financial assets and financial liabilities (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtAmortisedCostMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtAmortisedCostMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotePayable" xlink:label="loc_afyaNotePayable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNotePayable_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialLiabilities_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialLiabilities_30" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2" xlink:title="00000085 - Disclosure - Financial assets and financial liabilities (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-fullAggregatedTimeBandsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullAggregatedTimeBandsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-fullAggregatedTimeBandsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullAggregatedTimeBandsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentyFiveMember" xlink:label="loc_afyaTwentyTwentyFiveMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyFiveMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentySevenMember" xlink:label="loc_afyaTwentyTwentySevenMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentySevenMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentyFourMember" xlink:label="loc_afyaTwentyTwentyFourMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyFourMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentySixMember" xlink:label="loc_afyaTwentyTwentySixMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentySixMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentyEightMember" xlink:label="loc_afyaTwentyTwentyEightMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyEightMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialInstitution" xlink:label="loc_afyaFinancialInstitution_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialInstitution_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-fullBorrowingsInterestRateBasis_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsInterestRateBasis_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-fullBorrowingsMaturity_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsMaturity_180" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingCurrent" xlink:label="loc_afyaLoansAndFinancingCurrent_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingCurrent_180" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingNonCurrent" xlink:label="loc_afyaLoansAndFinancingNonCurrent_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingNonCurrent_180" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3" xlink:title="00000086 - Disclosure - Financial assets and financial liabilities  (Details 3)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4" xlink:title="00000087 - Disclosure - Financial assets and financial liabilities (Details 4)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IPEMEDMember" xlink:label="loc_afyaIPEMEDMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIPEMEDMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniRedentorMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniSLMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFCMPBMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUnigranrioMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GuaranhunsMember" xlink:label="loc_afyaGuaranhunsMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaGuaranhunsMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAlemDaMedicinaMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CardiPapersMember" xlink:label="loc_afyaCardiPapersMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCardiPapersMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GlicMember" xlink:label="loc_afyaGlicMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaGlicMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaDelReyMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_290" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersCurrent" xlink:label="loc_afyaAccountsPayableToSellingShareholdersCurrent_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersCurrent_290" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:label="loc_afyaAccountsPayableToSellingShareholdersNonCurrent_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersNonCurrent_290" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5" xlink:title="00000088 - Disclosure - Financial assets and financial liabilities (Details 5)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholderCashFlows" xlink:label="loc_afyaAccountsPayableToSellingShareholderCashFlows_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholderCashFlows_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" xlink:label="loc_afyaAccountsPayableToSellingShareholdersAcquisitionOfIpec_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersAcquisitionOfIpec_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpense" xlink:label="loc_ifrs-fullInterestExpense_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestExpense_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:label="loc_afyaAccountsPayableToSellingShareholdersBusinessCombinations_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersBusinessCombinations_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContingentConsiderationOnBusinessCombinations" xlink:label="loc_afyaContingentConsiderationOnBusinessCombinations_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContingentConsiderationOnBusinessCombinations_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Reversals" xlink:label="loc_afyaReversals_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReversals_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RemeasurementOfEarnouts" xlink:label="loc_afyaRemeasurementOfEarnouts_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemeasurementOfEarnouts_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable_80" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6" xlink:title="00000089 - Disclosure - Financial assets and financial liabilities (Details 6)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7" xlink:title="00000090 - Disclosure - Financial assets and financial liabilities (Details 7)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivablesMember" xlink:label="loc_ifrs-fullTradeReceivablesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_ifrs-fullTradeReceivablesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-fullLeaseLiabilitiesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_ifrs-fullLeaseLiabilitiesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotesPayableMember" xlink:label="loc_afyaNotesPayableMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaNotesPayableMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="loc_ifrs-fullFinancialAssetsAtFairValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsAtFairValue_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtFairValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtFairValue_130" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8" xlink:title="00000091 - Disclosure - Financial assets and financial liabilities (Details 8)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CashEquivalents1Member" xlink:label="loc_afyaCashEquivalents1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaCashEquivalents1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="loc_ifrs-fullTypesOfInterestRatesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullTypesOfInterestRatesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateTypesMember" xlink:label="loc_ifrs-fullInterestRateTypesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfInterestRatesAxis" xlink:to="loc_ifrs-fullInterestRateTypesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateTypesMember" xlink:label="loc_ifrs-fullInterestRateTypesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfInterestRatesAxis" xlink:to="loc_ifrs-fullInterestRateTypesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FloatingInterestRateMember" xlink:label="loc_ifrs-fullFloatingInterestRateMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInterestRateTypesMember" xlink:to="loc_ifrs-fullFloatingInterestRateMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateRiskMember" xlink:label="loc_ifrs-fullInterestRateRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullInterestRateRiskMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingOneMember" xlink:label="loc_afyaLoansAndFinancingOneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingOneMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingTwoMember" xlink:label="loc_afyaLoansAndFinancingTwoMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingTwoMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingThreeMember" xlink:label="loc_afyaLoansAndFinancingThreeMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingThreeMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersOneMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersOneMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersOneMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersTwoMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersTwoMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersTwoMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CashEquivalents1Member" xlink:label="loc_afyaCashEquivalents1Member_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaCashEquivalents1Member_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProbabilityOfDefaultAxis" xlink:label="loc_ifrs-fullProbabilityOfDefaultAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullProbabilityOfDefaultAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForProbabilityOfDefaultMember" xlink:label="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullProbabilityOfDefaultAxis" xlink:to="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForProbabilityOfDefaultMember" xlink:label="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullProbabilityOfDefaultAxis" xlink:to="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseBasisPointsMember" xlink:label="loc_afyaIncreaseBasisPointsMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:to="loc_afyaIncreaseBasisPointsMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseBasisPointsOneMember" xlink:label="loc_afyaIncreaseBasisPointsOneMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:to="loc_afyaIncreaseBasisPointsOneMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IndexRatePerYear" xlink:label="loc_afyaIndexRatePerYear_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIndexRatePerYear_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BaseRate" xlink:label="loc_afyaBaseRate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaBaseRate_180" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_180" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9" xlink:title="00000092 - Disclosure - Financial assets and financial liabilities (Details 9)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:label="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RiskExposuresAxis" xlink:label="loc_ifrs-fullRiskExposuresAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:to="loc_ifrs-fullRiskExposuresAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RiskExposuresMember" xlink:label="loc_ifrs-fullRiskExposuresMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRiskExposuresAxis" xlink:to="loc_ifrs-fullRiskExposuresMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RiskExposuresMember" xlink:label="loc_ifrs-fullRiskExposuresMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRiskExposuresAxis" xlink:to="loc_ifrs-fullRiskExposuresMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ForeignCurrencyExposuresMember" xlink:label="loc_afyaForeignCurrencyExposuresMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRiskExposuresMember" xlink:to="loc_afyaForeignCurrencyExposuresMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseForeignCurrencyMember" xlink:label="loc_afyaIncreaseForeignCurrencyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRiskExposuresMember" xlink:to="loc_afyaIncreaseForeignCurrencyMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DecreaseForeignCurrencyMember" xlink:label="loc_afyaDecreaseForeignCurrencyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRiskExposuresMember" xlink:to="loc_afyaDecreaseForeignCurrencyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-fullCurrencyRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullCurrencyRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10" xlink:title="00000093 - Disclosure - Financial assets and financial liabilities (Details 10)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-fullAggregatedTimeBandsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullAggregatedTimeBandsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-fullAggregatedTimeBandsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullAggregatedTimeBandsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-fullLaterThanOneYearMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanOneYearMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanThreeYearsAndNotLaterThanFiveYearsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanThreeYearsAndNotLaterThanFiveYearsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanFiveYearsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanFiveYearsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-fullLiquidityRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullLiquidityRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotePayables" xlink:label="loc_afyaNotePayables_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNotePayables_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Advances" xlink:label="loc_ifrs-fullAdvances_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdvances_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialLiabilitiesContractualUndiscounted" xlink:label="loc_afyaFinancialLiabilitiesContractualUndiscounted_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialLiabilitiesContractualUndiscounted_110" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11" xlink:title="00000094 - Disclosure - Financial assets and financial liabilities (Details 11)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:to="loc_afyaLoansAndFinancingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-fullLeaseLiabilitiesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:to="loc_ifrs-fullLeaseLiabilitiesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DividendsPayableMember" xlink:label="loc_afyaDividendsPayableMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:to="loc_afyaDividendsPayableMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_250" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_250" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities_250" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_250" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:label="loc_afyaIncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_250" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_250" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_250" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:title="00000095 - Disclosure - Financial assets and financial liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniRedentorMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniSLMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFCMPBMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUnigranrioMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember_250" xlink:type="arc" order="251" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ITPACGaranhunsMember" xlink:label="loc_afyaITPACGaranhunsMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaITPACGaranhunsMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAlemDaMedicinaMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CardioPapersMember" xlink:label="loc_afyaCardioPapersMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCardioPapersMember_310" xlink:type="arc" order="311" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GlicMember" xlink:label="loc_afyaGlicMember_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaGlicMember_330" xlink:type="arc" order="331" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaDelReyMember_350" xlink:type="arc" order="351" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-fullCurrencyRiskMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullCurrencyRiskMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_EUR" xlink:label="loc_currencyEUR_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyEUR_410" xlink:type="arc" order="411" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContractualLeaseTerm" xlink:label="loc_afyaContractualLeaseTerm_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContractualLeaseTerm_430" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-fullExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_430" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_430" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:label="loc_afyaRemainingTradeAndOtherPayablesToRelatedParties_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemainingTradeAndOtherPayablesToRelatedParties_430" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EqualInstallmentsPayablesToRelatedParties1" xlink:label="loc_afyaEqualInstallmentsPayablesToRelatedParties1_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEqualInstallmentsPayablesToRelatedParties1_430" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EqualInstallmentsPayablesToRelatedParties" xlink:label="loc_afyaEqualInstallmentsPayablesToRelatedParties_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEqualInstallmentsPayablesToRelatedParties_430" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="loc_ifrs-fullDefinedBenefitObligationAtPresentValue_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDefinedBenefitObligationAtPresentValue_430" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="loc_ifrs-fullTransactionPriceAllocatedToRemainingPerformanceObligations_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTransactionPriceAllocatedToRemainingPerformanceObligations_430" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" xlink:label="loc_ifrs-fullNoncurrentPayablesForPurchaseOfEnergy_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentPayablesForPurchaseOfEnergy_430" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RemainingBalancePaid" xlink:label="loc_afyaRemainingBalancePaid_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemainingBalancePaid_430" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ConsiderationToBeTransferred" xlink:label="loc_afyaConsiderationToBeTransferred_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsiderationToBeTransferred_430" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-fullConsiderationPaidReceived_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullConsiderationPaidReceived_430" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FirstAnnualInstallmentsPayable" xlink:label="loc_afyaFirstAnnualInstallmentsPayable_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFirstAnnualInstallmentsPayable_430" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SecondAnnualInstallmentsPayable" xlink:label="loc_afyaSecondAnnualInstallmentsPayable_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSecondAnnualInstallmentsPayable_430" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ThirdAnnualInstallmentsPayable" xlink:label="loc_afyaThirdAnnualInstallmentsPayable_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaThirdAnnualInstallmentsPayable_430" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitiondateFairValueOfTotalConsiderationTransferred1" xlink:label="loc_afyaAcquisitiondateFairValueOfTotalConsiderationTransferred1_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquisitiondateFairValueOfTotalConsiderationTransferred1_430" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CreditExposure" xlink:label="loc_ifrs-fullCreditExposure_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCreditExposure_430" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SensitivityChangeInTheEuroExchangeRate" xlink:label="loc_afyaSensitivityChangeInTheEuroExchangeRate_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSensitivityChangeInTheEuroExchangeRate_430" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-fullClosingForeignExchangeRate_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullClosingForeignExchangeRate_430" xlink:type="arc" order="18" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurementDetails" xlink:title="00000096 - Disclosure - Fair value measurement (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-fullMeasurementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullMeasurementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-fullAggregatedMeasurementMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMeasurementAxis" xlink:to="loc_ifrs-fullAggregatedMeasurementMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-fullAggregatedMeasurementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMeasurementAxis" xlink:to="loc_ifrs-fullAggregatedMeasurementMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" xlink:label="loc_ifrs-fullNotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedMeasurementMember" xlink:to="loc_ifrs-fullNotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:to="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:to="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel2OfFairValueHierarchyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" xlink:to="loc_ifrs-fullLevel2OfFairValueHierarchyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel3OfFairValueHierarchyMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" xlink:to="loc_ifrs-fullLevel3OfFairValueHierarchyMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="loc_ifrs-fullNoncurrentTradeReceivables_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentTradeReceivables_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingLiabilities" xlink:label="loc_afyaLoansAndFinancingLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingLiabilities_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseLiabilities1" xlink:label="loc_afyaLeaseLiabilities1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilities1_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" xlink:label="loc_afyaTradeAndOtherPayablesToRelatedPartiesLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherPayablesToRelatedPartiesLiabilities_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FairValueNotesPayables1" xlink:label="loc_afyaFairValueNotesPayables1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFairValueNotesPayables1_90" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails" xlink:title="00000097 - Disclosure - Labor and social obligations (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ModifiedPlanMember" xlink:label="loc_afyaModifiedPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaModifiedPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OriginalPlanMember" xlink:label="loc_afyaOriginalPlanMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaOriginalPlanMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncrementalStockOptionsMember" xlink:label="loc_afyaIncrementalStockOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:to="loc_afyaIncrementalStockOptionsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExpectedLifeOfStockOptions" xlink:label="loc_afyaExpectedLifeOfStockOptions_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExpectedLifeOfStockOptions_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_110" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails1" xlink:title="00000098 - Disclosure - Labor and social obligations (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ModifiedPlanMember" xlink:label="loc_afyaModifiedPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaModifiedPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RSUsMember" xlink:label="loc_afyaRSUsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:to="loc_afyaRSUsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExpectedLifeOfStockOptions" xlink:label="loc_afyaExpectedLifeOfStockOptions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExpectedLifeOfStockOptions_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_70" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails2" xlink:title="00000099 - Disclosure - Labor and social obligations (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ModifiedPlanMember" xlink:label="loc_afyaModifiedPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaModifiedPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OriginalPlanMember" xlink:label="loc_afyaOriginalPlanMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaOriginalPlanMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IPCAMember" xlink:label="loc_afyaIPCAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:to="loc_afyaIPCAMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CDIMember" xlink:label="loc_afyaCDIMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:to="loc_afyaCDIMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExpectedLifeOfStockOptions" xlink:label="loc_afyaExpectedLifeOfStockOptions_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExpectedLifeOfStockOptions_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_130" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails3" xlink:title="00000100 - Disclosure - Labor and social obligations (Details 3)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:label="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOptionsMember" xlink:label="loc_ifrs-fullShareOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:to="loc_ifrs-fullShareOptionsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGrante" xlink:label="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGrante_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGrante_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExpectedLifeOfStockOptions" xlink:label="loc_afyaExpectedLifeOfStockOptions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExpectedLifeOfStockOptions_210" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted_210" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted_210" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_210" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails4" xlink:title="00000101 - Disclosure - Labor and social obligations (Details 4)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOptionsMember" xlink:label="loc_ifrs-fullShareOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_ifrs-fullShareOptionsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" xlink:label="loc_afyaWeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExpiredInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExpiredInSharebasedPaymentArrangement_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfStockOptionsExercisable" xlink:label="loc_afyaNumberOfStockOptionsExercisable_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfStockOptionsExercisable_80" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails5" xlink:title="00000102 - Disclosure - Labor and social obligations (Details 5)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-fullDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="loc_ifrs-fullDefinedBenefitPlansMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="loc_ifrs-fullDefinedBenefitPlansMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnitsMember" xlink:label="loc_afyaRestrictedStockUnitsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansMember" xlink:to="loc_afyaRestrictedStockUnitsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:title="00000103 - Disclosure - Labor and social obligations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OptionsGrantedMember" xlink:label="loc_afyaOptionsGrantedMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaOptionsGrantedMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnitsMember" xlink:label="loc_afyaRestrictedStockUnitsMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaRestrictedStockUnitsMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnits1Member" xlink:label="loc_afyaRestrictedStockUnits1Member_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaRestrictedStockUnits1Member_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnits2Member" xlink:label="loc_afyaRestrictedStockUnits2Member_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaRestrictedStockUnits2Member_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnits3Member" xlink:label="loc_afyaRestrictedStockUnits3Member_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaRestrictedStockUnits3Member_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-fullDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="loc_ifrs-fullDefinedBenefitPlansMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="loc_ifrs-fullDefinedBenefitPlansMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShareBasedCompensationPlansMember" xlink:label="loc_afyaShareBasedCompensationPlansMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansMember" xlink:to="loc_afyaShareBasedCompensationPlansMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnitsMember" xlink:label="loc_afyaRestrictedStockUnitsMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansMember" xlink:to="loc_afyaRestrictedStockUnitsMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShareBasedCompensationOfEmployees" xlink:label="loc_afyaShareBasedCompensationOfEmployees_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaShareBasedCompensationOfEmployees_290" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_StrikePrice" xlink:label="loc_afyaStrikePrice_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePrice_290" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AverageIncrementalFairValue" xlink:label="loc_afyaAverageIncrementalFairValue_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAverageIncrementalFairValue_290" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_290" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees_290" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestInJointVenture_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestInJointVenture_290" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_290" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-fullWeightedAverageSharePriceShareOptionsGranted2019_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageSharePriceShareOptionsGranted2019_290" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SocialObligationsLiabilities" xlink:label="loc_afyaSocialObligationsLiabilities_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSocialObligationsLiabilities_290" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetails" xlink:title="00000104 - Disclosure - Equity (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetailsNarrative" xlink:title="00000105 - Disclosure - Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassAOrdinarySharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassBOrdinarySharesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIssuedCapital_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfSharesIssued1" xlink:label="loc_afyaNumberOfSharesIssued1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfSharesIssued1_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-fullNumberOfSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesIssued_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IssuedCapitals" xlink:label="loc_afyaIssuedCapitals_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIssuedCapitals_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentOfDividends" xlink:label="loc_afyaPaymentOfDividends_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPaymentOfDividends_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DividendDistributed" xlink:label="loc_afyaDividendDistributed_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendDistributed_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:label="loc_ifrs-fullDividendsPaidToNoncontrollingInterests_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaidToNoncontrollingInterests_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RepurchaseOfOrdinaryShares" xlink:label="loc_afyaRepurchaseOfOrdinaryShares_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRepurchaseOfOrdinaryShares_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CashOutflow" xlink:label="loc_afyaCashOutflow_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCashOutflow_130" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEpsDetails" xlink:title="00000106 - Disclosure - Earnings per share (EPS) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueDetails" xlink:title="00000107 - Disclosure - Revenue (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueDetails1" xlink:title="00000108 - Disclosure - Revenue (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_ifrs-fullSegmentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaUndergradMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaContinuingEducationMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DigitalServicesMember" xlink:label="loc_afyaDigitalServicesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaDigitalServicesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EliminationInterSegmentTransactionsMember" xlink:label="loc_afyaEliminationInterSegmentTransactionsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaEliminationInterSegmentTransactionsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-fullProfessionalFeesExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfessionalFeesExpense_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-fullOtherRevenue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherRevenue_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TimingRevenueRecognition" xlink:label="loc_afyaTimingRevenueRecognition_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTimingRevenueRecognition_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FeeAndCommissionIncome" xlink:label="loc_ifrs-fullFeeAndCommissionIncome_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFeeAndCommissionIncome_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NetRevenueOtherTransferredPoint" xlink:label="loc_afyaNetRevenueOtherTransferredPoint_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetRevenueOtherTransferredPoint_160" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNatureDetails" xlink:title="00000109 - Disclosure - Expenses and costs by nature (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultDetails" xlink:title="00000110 - Disclosure - Finance result (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetails" xlink:title="00000111 - Disclosure - Income taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:title="00000112 - Disclosure - Income taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_ifrs-fullSegmentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OneSubsidiaryMember" xlink:label="loc_afyaOneSubsidiaryMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaOneSubsidiaryMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-fullDeferredTaxExpenseIncome_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDeferredTaxExpenseIncome_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RecognizedDeferredTaxAssets" xlink:label="loc_afyaRecognizedDeferredTaxAssets_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRecognizedDeferredTaxAssets_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails" xlink:title="00000113 - Disclosure - Insurance contracts and contingencies (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-fullContingentLiabilitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullContingentLiabilitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-fullContingentLiabilitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullContingentLiabilitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-fullLegalProceedingsContingentLiabilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullContingentLiabilitiesMember" xlink:to="loc_ifrs-fullLegalProceedingsContingentLiabilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-fullClassesOfProvisionsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfProvisionsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherProvisionsMember" xlink:label="loc_ifrs-fullOtherProvisionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullOtherProvisionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherProvisionsMember" xlink:label="loc_ifrs-fullOtherProvisionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullOtherProvisionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LabourMember" xlink:label="loc_afyaLabourMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaLabourMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CivilMember" xlink:label="loc_afyaCivilMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaCivilMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxesMember" xlink:label="loc_afyaTaxesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaTaxesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-fullProvisions_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProvisions_290" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsOtherProvisions_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsOtherProvisions_290" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="loc_ifrs-fullAdditionalProvisionsOtherProvisions_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionalProvisionsOtherProvisions_290" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="loc_ifrs-fullUnusedProvisionReversedOtherProvisions_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUnusedProvisionReversedOtherProvisions_290" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1" xlink:title="00000114 - Disclosure - Insurance contracts and contingencies (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-fullContingentLiabilitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullContingentLiabilitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-fullContingentLiabilitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullContingentLiabilitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-fullLegalProceedingsContingentLiabilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullContingentLiabilitiesMember" xlink:to="loc_ifrs-fullLegalProceedingsContingentLiabilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-fullClassesOfProvisionsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfProvisionsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherProvisionsMember" xlink:label="loc_ifrs-fullOtherProvisionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullOtherProvisionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherProvisionsMember" xlink:label="loc_ifrs-fullOtherProvisionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullOtherProvisionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LabourMember" xlink:label="loc_afyaLabourMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaLabourMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CivilMember" xlink:label="loc_afyaCivilMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaCivilMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxesAndSocialSecurityMember" xlink:label="loc_afyaTaxesAndSocialSecurityMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaTaxesAndSocialSecurityMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TypesOfRiskMember" xlink:label="loc_afyaTypesOfRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_afyaTypesOfRiskMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-fullOtherProvisions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherProvisions_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" xlink:title="00000115 - Disclosure - Insurance contracts and contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-fullClassesOfAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullClassesOfAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-fullClassesOfAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfAssetsAxis" xlink:to="loc_ifrs-fullClassesOfAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-fullClassesOfAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfAssetsAxis" xlink:to="loc_ifrs-fullClassesOfAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssetsNonCurrentMember" xlink:label="loc_afyaOtherAssetsNonCurrentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfAssetsMember" xlink:to="loc_afyaOtherAssetsNonCurrentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_JudicialDeposits" xlink:label="loc_afyaJudicialDeposits_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaJudicialDeposits_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContingenciesCorrespondentAmount" xlink:label="loc_afyaContingenciesCorrespondentAmount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContingenciesCorrespondentAmount_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactionsDetails" xlink:title="00000116 - Disclosure - Non-cash transactions (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IClinicMember" xlink:label="loc_afyaIClinicMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaIClinicMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CliquefarmaMember" xlink:label="loc_afyaCliquefarmaMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaCliquefarmaMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaRXPROMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RemeasurementOfEarnOut" xlink:label="loc_afyaRemeasurementOfEarnOut_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemeasurementOfEarnOut_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets" xlink:label="loc_afyaProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" xlink:label="loc_afyaAdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_130" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEventDetailsNarrative" xlink:title="00000117 - Disclosure - Subsequent event (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:label="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember" xlink:label="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:to="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember" xlink:label="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:to="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FaculdadesIntegradasPadraoMember" xlink:label="loc_afyaFaculdadesIntegradasPadraoMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember" xlink:to="loc_afyaFaculdadesIntegradasPadraoMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PotentialAdditionalPayment" xlink:label="loc_afyaPotentialAdditionalPayment_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPotentialAdditionalPayment_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TotalNumberOfSeatsApporved" xlink:label="loc_afyaTotalNumberOfSeatsApporved_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTotalNumberOfSeatsApporved_30" xlink:type="arc" order="1" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>35
<FILENAME>afya-20231231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_lbl" xml:lang="en-US">Classes of share capital [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="afya_ClassAOrdinarySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ClassAOrdinarySharesMember" xlink:to="afya_ClassAOrdinarySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ClassAOrdinarySharesMember_lbl" xml:lang="en-US">Class A Ordinary Shares [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="afya_ClassBOrdinarySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ClassBOrdinarySharesMember" xlink:to="afya_ClassBOrdinarySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ClassBOrdinarySharesMember_lbl" xml:lang="en-US">Class B Ordinary Shares [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityAxis_lbl" xml:lang="en-US">Components of equity [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalMember_lbl" xml:lang="en-US">Issued capital [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionalPaidinCapitalMember" xlink:label="ifrs-full_AdditionalPaidinCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalPaidinCapitalMember" xlink:to="ifrs-full_AdditionalPaidinCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionalPaidinCapitalMember_lbl" xml:lang="en-US">Additional paid-in capital [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasurySharesMember" xlink:to="ifrs-full_TreasurySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TreasurySharesMember_lbl" xml:lang="en-US">Treasury shares [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:to="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl" xml:lang="en-US">Reserve of share-based payments [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarningsMember" xlink:label="ifrs-full_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarningsMember_lbl" xml:lang="en-US">Retained earnings [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:to="ifrs-full_EquityAttributableToOwnersOfParentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember_lbl" xml:lang="en-US">Equity attributable to owners of parent [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="ifrs-full_NoncontrollingInterestsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterestsMember" xlink:to="ifrs-full_NoncontrollingInterestsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncontrollingInterestsMember_lbl" xml:lang="en-US">Non-controlling interests [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xml:lang="en-US">Categories of related parties [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BertelsmannMember" xlink:label="afya_BertelsmannMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BertelsmannMember" xlink:to="afya_BertelsmannMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BertelsmannMember_lbl" xml:lang="en-US">Bertelsmann [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_OrdinarySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OrdinarySharesMember_lbl" xml:lang="en-US">Ordinary shares [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SubsidiariesMember" xlink:label="ifrs-full_SubsidiariesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SubsidiariesMember" xlink:to="ifrs-full_SubsidiariesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SubsidiariesMember_lbl" xml:lang="en-US">Subsidiaries [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_lbl" xml:lang="en-US">Subsidiaries [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AfyaParticipacoesSAMember" xlink:label="afya_AfyaParticipacoesSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AfyaParticipacoesSAMember" xlink:to="afya_AfyaParticipacoesSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AfyaParticipacoesSAMember_lbl" xml:lang="en-US">Afya Participacoes S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" xlink:to="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_lbl" xml:lang="en-US">Instituto Tocantinense Presidente Antonio Carlos Porto S. A. I T P A C Porto [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" xlink:to="afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_lbl" xml:lang="en-US">Instituto Tocantinense Presidente Antonio Carlos S. A. I T P A C Araguaina [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" xlink:label="afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" xlink:to="afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_lbl" xml:lang="en-US">Uniao Educacional Do Vale Fo Aco S. A. U N I V A C O [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" xlink:label="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" xlink:to="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_lbl" xml:lang="en-US">I P T A N Instituto De Ensino Superior Presidente Tancredo De Almeida Neves S. A. I P T A N [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" xlink:label="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" xlink:to="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_lbl" xml:lang="en-US">Instituto De Educacao Superior Do Vale Do Parnaiba S. A. I E S V A P [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" xlink:label="afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" xlink:to="afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_lbl" xml:lang="en-US">Centro De Ciencias Em Saude De Itajuba S. A. C C S I [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" xlink:label="afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" xlink:to="afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_lbl" xml:lang="en-US">Instituto De Ensino Superior Do Piaui S. A. I E S P [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroIntegradoDeSaudeDeTeresinaCISMember" xlink:label="afya_CentroIntegradoDeSaudeDeTeresinaCISMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroIntegradoDeSaudeDeTeresinaCISMember" xlink:to="afya_CentroIntegradoDeSaudeDeTeresinaCISMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroIntegradoDeSaudeDeTeresinaCISMember_lbl" xml:lang="en-US">Centro Integrado De Saude De Teresina C I S [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" xlink:label="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" xlink:to="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_lbl" xml:lang="en-US">F A D E P Faculdade Educacional De Pato Branco Ltda F A D E P [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedcelEditoraEventosS.A.MedcelMember" xlink:label="afya_MedcelEditoraEventosS.A.MedcelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedcelEditoraEventosS.A.MedcelMember" xlink:to="afya_MedcelEditoraEventosS.A.MedcelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedcelEditoraEventosS.A.MedcelMember_lbl" xml:lang="en-US">Medcel Editora Eventos S. A. Medcel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" xlink:label="afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" xlink:to="afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember_lbl" xml:lang="en-US">Instituto Educacional Santo Agostinho S. A. F A S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ESMCEducacaoSuperiorLtdaESMCMember" xlink:label="afya_ESMCEducacaoSuperiorLtdaESMCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ESMCEducacaoSuperiorLtdaESMCMember" xlink:to="afya_ESMCEducacaoSuperiorLtdaESMCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ESMCEducacaoSuperiorLtdaESMCMember_lbl" xml:lang="en-US">E S M C Educacao Superior Ltda E S M C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" xlink:label="afya_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" xlink:to="afya_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_lbl" xml:lang="en-US">Instituto De Pesquisa E Ensino Medico Fo Estado De Minas Gerais Ltda I P E M E D [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" xlink:label="afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" xlink:to="afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_lbl" xml:lang="en-US">Instituto Paraense De Educacao E Cultura Ltda. I P E C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember" xlink:label="afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember" xlink:to="afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember_lbl" xml:lang="en-US">Sociedade Universitaria Redentor S. A. Uni Redentor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroDeEnsinoSaoLucasLtda.UniSLMember" xlink:label="afya_CentroDeEnsinoSaoLucasLtda.UniSLMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroDeEnsinoSaoLucasLtda.UniSLMember" xlink:to="afya_CentroDeEnsinoSaoLucasLtda.UniSLMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroDeEnsinoSaoLucasLtda.UniSLMember_lbl" xml:lang="en-US">Centro De Ensino Sao Lucas Ltda. Uni S L [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" xlink:label="afya_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" xlink:to="afya_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_lbl" xml:lang="en-US">Peb Med Instituicao De Pesquisa Medica E Servicos Ltda. Peb Med [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" xlink:label="afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" xlink:to="afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_lbl" xml:lang="en-US">Sociedade De Educacao Cultura E Tecnologia Da Amazonia S. A. F E S A R [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" xlink:label="afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" xlink:to="afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_lbl" xml:lang="en-US">Centro Superior De Ciencias Da Saude S S Ltda. F C M P B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" xlink:label="afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" xlink:to="afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_lbl" xml:lang="en-US">I Clinic Desenvolvimento De Software Ltda.i Clinic [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedicinaeSolutionsS.A.MedicinaeMember" xlink:label="afya_MedicinaeSolutionsS.A.MedicinaeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedicinaeSolutionsS.A.MedicinaeMember" xlink:to="afya_MedicinaeSolutionsS.A.MedicinaeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedicinaeSolutionsS.A.MedicinaeMember_lbl" xml:lang="en-US">Medicinae Solutions S. A. Medicinae [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" xlink:label="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" xlink:to="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_lbl" xml:lang="en-US">Medical Harbour Aparelhos Medico Hospitalares E Servicos Em Tecnologia Ltda. Medical Harbour [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" xlink:label="afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" xlink:to="afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_lbl" xml:lang="en-US">Cliquefarma Drogarias Online Ltda. Cliquefarma [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShospTecnologiaDaInformacaoLtda.ShospMember" xlink:label="afya_ShospTecnologiaDaInformacaoLtda.ShospMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShospTecnologiaDaInformacaoLtda.ShospMember" xlink:to="afya_ShospTecnologiaDaInformacaoLtda.ShospMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShospTecnologiaDaInformacaoLtda.ShospMember_lbl" xml:lang="en-US">Shosp Tecnologia Da Informacao Ltda. Shosp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" xlink:label="afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" xlink:to="afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_lbl" xml:lang="en-US">Sociedade Padrao De Educacao Superior Ltda. Unifip Moc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember" xlink:label="afya_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember" xlink:to="afya_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_lbl" xml:lang="en-US">Nucleo De Atencao A Saude E De Praticas Profissionalizantes N A S P P [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" xlink:label="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" xlink:to="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_lbl" xml:lang="en-US">Companhia Nilza Cordeiro Herdy De Educacao E Cultura Unigranrio [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" xlink:label="afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" xlink:to="afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_lbl" xml:lang="en-US">Policlinica E Centro De Estetica Duque De Caxias Ltda. Policlinica [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadeEducacionalDePalhocaSALtda.Member" xlink:label="afya_SociedadeEducacionalDePalhocaSALtda.Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadeEducacionalDePalhocaSALtda.Member" xlink:to="afya_SociedadeEducacionalDePalhocaSALtda.Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadeEducacionalDePalhocaSALtda.Member_lbl" xml:lang="en-US">Sociedade Educacional De Palhoca S A Ltda. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember" xlink:label="afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember" xlink:to="afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_lbl" xml:lang="en-US">Instituto De Ensino Superior De Palhoca S S Ltda. I E S P P A L H O C A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember" xlink:label="afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember" xlink:to="afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember_lbl" xml:lang="en-US">R X P R O Solucoes De Tecnologia Ltda. R X P R O [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember" xlink:label="afya_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember" xlink:to="afya_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_lbl" xml:lang="en-US">R X P R O L O G Transporte E Logistica Ltda. R X P R O L O G [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BMVAtividadesMedicasLtda.AlemDaMedicinaMember" xlink:label="afya_BMVAtividadesMedicasLtda.AlemDaMedicinaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BMVAtividadesMedicasLtda.AlemDaMedicinaMember" xlink:to="afya_BMVAtividadesMedicasLtda.AlemDaMedicinaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BMVAtividadesMedicasLtda.AlemDaMedicinaMember_lbl" xml:lang="en-US">B M V Atividades Medicas Ltda. Alem Da Medicina [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CardiopapersSolucoesDigitaisLtda.CardioPapersMember" xlink:label="afya_CardiopapersSolucoesDigitaisLtda.CardioPapersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CardiopapersSolucoesDigitaisLtda.CardioPapersMember" xlink:to="afya_CardiopapersSolucoesDigitaisLtda.CardioPapersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CardiopapersSolucoesDigitaisLtda.CardioPapersMember_lbl" xml:lang="en-US">Cardiopapers Solucoes Digitais Ltda. Cardio Papers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" xlink:label="afya_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" xlink:to="afya_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_lbl" xml:lang="en-US">Quasar Telemedicina Desenvolvimento De Sistemas Computacionais Ltda. Glic [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" xlink:label="afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" xlink:to="afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_lbl" xml:lang="en-US">Sociedade Educacional E Cultural Sergipe Del Rey Ltda. Del Rey [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" xlink:label="afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" xlink:to="afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_lbl" xml:lang="en-US">Uniao Educacional Do Planalto Central S. A. U E P C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BuildingsMember" xlink:to="ifrs-full_BuildingsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BuildingsMember_lbl" xml:lang="en-US">Buildings [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="afya_MachineryAndEquipmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MachineryAndEquipmentsMember" xlink:to="afya_MachineryAndEquipmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MachineryAndEquipmentsMember_lbl" xml:lang="en-US">Machinery And Equipments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_VehiclesMember" xlink:label="ifrs-full_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_VehiclesMember" xlink:to="ifrs-full_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_VehiclesMember_lbl" xml:lang="en-US">Vehicles [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="ifrs-full_FixturesAndFittingsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FixturesAndFittingsMember" xlink:to="ifrs-full_FixturesAndFittingsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FixturesAndFittingsMember_lbl" xml:lang="en-US">Fixtures and fittings [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ItEquipmentMember" xlink:label="afya_ItEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ItEquipmentMember" xlink:to="afya_ItEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ItEquipmentMember_lbl" xml:lang="en-US">It Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LibraryBooksMember" xlink:label="afya_LibraryBooksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LibraryBooksMember" xlink:to="afya_LibraryBooksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LibraryBooksMember_lbl" xml:lang="en-US">Library Books [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="ifrs-full_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseholdImprovementsMember" xlink:to="ifrs-full_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold improvements [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeAxis_lbl" xml:lang="en-US">Range [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US">Bottom of range [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US">Top of range [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ProgramOfSocialIntegrationMember" xlink:label="afya_ProgramOfSocialIntegrationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProgramOfSocialIntegrationMember" xlink:to="afya_ProgramOfSocialIntegrationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProgramOfSocialIntegrationMember_lbl" xml:lang="en-US">Program Of Social Integration [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesAxis_lbl" xml:lang="en-US">Products and services [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TeachingActivitiesMember" xlink:label="afya_TeachingActivitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TeachingActivitiesMember" xlink:to="afya_TeachingActivitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TeachingActivitiesMember_lbl" xml:lang="en-US">Teaching Activities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContributionForTheFinancingOfSocialSecurityMember" xlink:label="afya_ContributionForTheFinancingOfSocialSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContributionForTheFinancingOfSocialSecurityMember" xlink:to="afya_ContributionForTheFinancingOfSocialSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContributionForTheFinancingOfSocialSecurityMember_lbl" xml:lang="en-US">Contribution For The Financing Of Social Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NonTeachingActivitiesMember" xlink:label="afya_NonTeachingActivitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NonTeachingActivitiesMember" xlink:to="afya_NonTeachingActivitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NonTeachingActivitiesMember_lbl" xml:lang="en-US">Non Teaching Activities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InitiallyAppliedIFRSsAxis" xlink:label="ifrs-full_InitiallyAppliedIFRSsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InitiallyAppliedIFRSsAxis" xlink:to="ifrs-full_InitiallyAppliedIFRSsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InitiallyAppliedIFRSsAxis_lbl" xml:lang="en-US">Initially applied IFRSs [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS1Member" xlink:label="afya_AmendmentsToIAS1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AmendmentsToIAS1Member" xlink:to="afya_AmendmentsToIAS1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AmendmentsToIAS1Member_lbl" xml:lang="en-US">Amendments To I A S 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS8Member" xlink:label="afya_AmendmentsToIAS8Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AmendmentsToIAS8Member" xlink:to="afya_AmendmentsToIAS8Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AmendmentsToIAS8Member_lbl" xml:lang="en-US">Amendments To I A S 8 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS12Member" xlink:label="afya_AmendmentsToIAS12Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AmendmentsToIAS12Member" xlink:to="afya_AmendmentsToIAS12Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AmendmentsToIAS12Member_lbl" xml:lang="en-US">Amendments To I A S 12 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS12OneMember" xlink:label="afya_AmendmentsToIAS12OneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AmendmentsToIAS12OneMember" xlink:to="afya_AmendmentsToIAS12OneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AmendmentsToIAS12OneMember_lbl" xml:lang="en-US">Amendments To I A S 12 One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IFRS17Member" xlink:label="ifrs-full_IFRS17Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IFRS17Member" xlink:to="ifrs-full_IFRS17Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IFRS17Member_lbl" xml:lang="en-US">IFRS 17 [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIFRS16Member" xlink:label="afya_AmendmentsToIFRS16Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AmendmentsToIFRS16Member" xlink:to="afya_AmendmentsToIFRS16Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AmendmentsToIFRS16Member_lbl" xml:lang="en-US">Amendments To I F R S 16 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS1OneMember" xlink:label="afya_AmendmentsToIAS1OneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AmendmentsToIAS1OneMember" xlink:to="afya_AmendmentsToIAS1OneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AmendmentsToIAS1OneMember_lbl" xml:lang="en-US">Amendments To I A S 1 One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS7AndIFRS7Member" xlink:label="afya_AmendmentsToIAS7AndIFRS7Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AmendmentsToIAS7AndIFRS7Member" xlink:to="afya_AmendmentsToIAS7AndIFRS7Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AmendmentsToIAS7AndIFRS7Member_lbl" xml:lang="en-US">Amendments To I A S 7 And I F R S 7 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="ifrs-full_SegmentConsolidationItemsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SegmentConsolidationItemsAxis" xlink:to="ifrs-full_SegmentConsolidationItemsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SegmentConsolidationItemsAxis_lbl" xml:lang="en-US">Segment consolidation items [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="ifrs-full_OperatingSegmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OperatingSegmentsMember" xlink:to="ifrs-full_OperatingSegmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OperatingSegmentsMember_lbl" xml:lang="en-US">Operating segments [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SegmentsAxis_lbl" xml:lang="en-US">Segments [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UndergradMember" xlink:label="afya_UndergradMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UndergradMember" xlink:to="afya_UndergradMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UndergradMember_lbl" xml:lang="en-US">Undergrad [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContinuingEducationMember" xlink:label="afya_ContinuingEducationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContinuingEducationMember" xlink:to="afya_ContinuingEducationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContinuingEducationMember_lbl" xml:lang="en-US">Continuing Education [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DigitalServicesMember" xlink:label="afya_DigitalServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DigitalServicesMember" xlink:to="afya_DigitalServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DigitalServicesMember_lbl" xml:lang="en-US">Digital Services [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TotalReportableSegmentsMember" xlink:label="afya_TotalReportableSegmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TotalReportableSegmentsMember" xlink:to="afya_TotalReportableSegmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TotalReportableSegmentsMember_lbl" xml:lang="en-US">Total Reportable Segments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdjustmentsAndEliminationsMember" xlink:label="afya_AdjustmentsAndEliminationsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdjustmentsAndEliminationsMember" xlink:to="afya_AdjustmentsAndEliminationsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdjustmentsAndEliminationsMember_lbl" xml:lang="en-US">Adjustments And Eliminations [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DelReyMember" xlink:label="afya_DelReyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DelReyMember" xlink:to="afya_DelReyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DelReyMember_lbl" xml:lang="en-US">Del Rey [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="ifrs-full_BusinessCombinationsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ifrs-full_BusinessCombinationsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BusinessCombinationsAxis_lbl" xml:lang="en-US">Business combinations [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfDelReyMember" xlink:label="afya_AcquisitionOfDelReyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AcquisitionOfDelReyMember" xlink:to="afya_AcquisitionOfDelReyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AcquisitionOfDelReyMember_lbl" xml:lang="en-US">Acquisition Of Del Rey [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AlemDaMedicinaMember" xlink:label="afya_AlemDaMedicinaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AlemDaMedicinaMember" xlink:to="afya_AlemDaMedicinaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AlemDaMedicinaMember_lbl" xml:lang="en-US">Alem Da Medicina [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfCardioPapersMember" xlink:label="afya_AcquisitionOfCardioPapersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AcquisitionOfCardioPapersMember" xlink:to="afya_AcquisitionOfCardioPapersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AcquisitionOfCardioPapersMember_lbl" xml:lang="en-US">Acquisition Of Cardio Papers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CardioPapersMember" xlink:label="afya_CardioPapersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CardioPapersMember" xlink:to="afya_CardioPapersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CardioPapersMember_lbl" xml:lang="en-US">Cardio Papers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfGlicMember" xlink:label="afya_AcquisitionOfGlicMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AcquisitionOfGlicMember" xlink:to="afya_AcquisitionOfGlicMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AcquisitionOfGlicMember_lbl" xml:lang="en-US">Acquisition Of Glic [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GlicMember" xlink:label="afya_GlicMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_GlicMember" xlink:to="afya_GlicMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_GlicMember_lbl" xml:lang="en-US">Glic [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="ifrs-full_LicencesAndFranchisesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicencesAndFranchisesMember" xlink:to="ifrs-full_LicencesAndFranchisesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LicencesAndFranchisesMember_lbl" xml:lang="en-US">Licences and franchises [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:label="ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis_lbl" xml:lang="en-US">Method of assessment of expected credit losses [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WithAndWithoutMethodMember" xlink:label="afya_WithAndWithoutMethodMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WithAndWithoutMethodMember" xlink:to="afya_WithAndWithoutMethodMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WithAndWithoutMethodMember_lbl" xml:lang="en-US">With And Without Method [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="ifrs-full_CustomerrelatedIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:to="ifrs-full_CustomerrelatedIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CustomerrelatedIntangibleAssetsMember_lbl" xml:lang="en-US">Customer-related intangible assets [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:label="ifrs-full_MultiperiodExcessEarningsMethodMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:to="ifrs-full_MultiperiodExcessEarningsMethodMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MultiperiodExcessEarningsMethodMember_lbl" xml:lang="en-US">Multi-period excess earnings method [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BrandNamesMember" xlink:label="ifrs-full_BrandNamesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BrandNamesMember" xlink:to="ifrs-full_BrandNamesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BrandNamesMember_lbl" xml:lang="en-US">Brand names [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReliefFromRoyaltyMember" xlink:label="afya_ReliefFromRoyaltyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ReliefFromRoyaltyMember" xlink:to="afya_ReliefFromRoyaltyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ReliefFromRoyaltyMember_lbl" xml:lang="en-US">Relief From Royalty [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationalContentMember" xlink:label="afya_EducationalContentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationalContentMember" xlink:to="afya_EducationalContentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationalContentMember_lbl" xml:lang="en-US">Educational Content [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReplacementCostMember" xlink:label="afya_ReplacementCostMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ReplacementCostMember" xlink:to="afya_ReplacementCostMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ReplacementCostMember_lbl" xml:lang="en-US">Replacement Cost [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="ifrs-full_TechnologybasedIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:to="ifrs-full_TechnologybasedIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TechnologybasedIntangibleAssetsMember_lbl" xml:lang="en-US">Technology-based intangible assets [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CopyrightMember" xlink:label="afya_CopyrightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CopyrightMember" xlink:to="afya_CopyrightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CopyrightMember_lbl" xml:lang="en-US">Copyright [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis_lbl" xml:lang="en-US">Classes of financial assets [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BankCertificatesOfDepositMember" xlink:label="afya_BankCertificatesOfDepositMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BankCertificatesOfDepositMember" xlink:to="afya_BankCertificatesOfDepositMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BankCertificatesOfDepositMember_lbl" xml:lang="en-US">Bank Certificates Of Deposit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_USDMember" xlink:label="afya_USDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_USDMember" xlink:to="afya_USDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_USDMember_lbl" xml:lang="en-US">U S D [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TuitionFeesMember" xlink:label="afya_TuitionFeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TuitionFeesMember" xlink:to="afya_TuitionFeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TuitionFeesMember_lbl" xml:lang="en-US">Tuition Fees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FIESMember" xlink:label="afya_FIESMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FIESMember" xlink:to="afya_FIESMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FIESMember_lbl" xml:lang="en-US">F I E S [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationalCreditsMember" xlink:label="afya_EducationalCreditsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationalCreditsMember" xlink:to="afya_EducationalCreditsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationalCreditsMember_lbl" xml:lang="en-US">Educational Credits [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MobileAppSubscriptionMember" xlink:label="afya_MobileAppSubscriptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MobileAppSubscriptionMember" xlink:to="afya_MobileAppSubscriptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MobileAppSubscriptionMember_lbl" xml:lang="en-US">Mobile App Subscription [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OthersMember" xlink:label="afya_OthersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OthersMember" xlink:to="afya_OthersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OthersMember_lbl" xml:lang="en-US">Others [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:label="ifrs-full_ImpairmentOfFinancialAssetsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:to="ifrs-full_ImpairmentOfFinancialAssetsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ImpairmentOfFinancialAssetsAxis_lbl" xml:lang="en-US">Impairment of financial assets [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" xlink:label="ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" xlink:to="ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember_lbl" xml:lang="en-US">Financial assets neither past due nor impaired [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PastDueStatusAxis" xlink:label="ifrs-full_PastDueStatusAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PastDueStatusAxis" xlink:to="ifrs-full_PastDueStatusAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PastDueStatusAxis_lbl" xml:lang="en-US">Past due status [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentMember" xlink:label="ifrs-full_CurrentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentMember" xlink:to="ifrs-full_CurrentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentMember_lbl" xml:lang="en-US">Current [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:label="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:to="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_lbl" xml:lang="en-US">Later Than One Months And Not Later Than Three Months [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:to="ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_lbl" xml:lang="en-US">Later than three months and not later than six months [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaterThanOneEightyMember" xlink:label="afya_LaterThanOneEightyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaterThanOneEightyMember" xlink:to="afya_LaterThanOneEightyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaterThanOneEightyMember_lbl" xml:lang="en-US">Later Than One Eighty [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UEPCMember" xlink:label="afya_UEPCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UEPCMember" xlink:to="afya_UEPCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UEPCMember_lbl" xml:lang="en-US">U E P C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EMIVEPatrulha24HorasLtdaMember" xlink:label="afya_EMIVEPatrulha24HorasLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EMIVEPatrulha24HorasLtdaMember" xlink:to="afya_EMIVEPatrulha24HorasLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EMIVEPatrulha24HorasLtdaMember_lbl" xml:lang="en-US">E M I V E Patrulha 24 Horas Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RVLEstevesGestaoImobiliariaSAMember" xlink:label="afya_RVLEstevesGestaoImobiliariaSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RVLEstevesGestaoImobiliariaSAMember" xlink:to="afya_RVLEstevesGestaoImobiliariaSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RVLEstevesGestaoImobiliariaSAMember_lbl" xml:lang="en-US">R V L Esteves Gestao Imobiliaria S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UNIVACOPatrimonialLtdaMember" xlink:label="afya_UNIVACOPatrimonialLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UNIVACOPatrimonialLtdaMember" xlink:to="afya_UNIVACOPatrimonialLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UNIVACOPatrimonialLtdaMember_lbl" xml:lang="en-US">U N I V A C O Patrimonial Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IESVAPPatrimonialLtdaMember" xlink:label="afya_IESVAPPatrimonialLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IESVAPPatrimonialLtdaMember" xlink:to="afya_IESVAPPatrimonialLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IESVAPPatrimonialLtdaMember_lbl" xml:lang="en-US">I E S V A P Patrimonial Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseAgreements1Member" xlink:label="afya_LeaseAgreements1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseAgreements1Member" xlink:to="afya_LeaseAgreements1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseAgreements1Member_lbl" xml:lang="en-US">Lease Agreements 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:to="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember_lbl" xml:lang="en-US">Instituto Tocantinense Presidente Antonio Carlos S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:label="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:to="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_lbl" xml:lang="en-US">Institutode Ensino Superior Presidente Trancredode Almeida Neves S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AssociatesMember" xlink:label="ifrs-full_AssociatesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssociatesMember" xlink:to="ifrs-full_AssociatesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssociatesMember_lbl" xml:lang="en-US">Associates [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US">Gross carrying amount [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LandMember" xlink:label="ifrs-full_LandMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LandMember" xlink:to="ifrs-full_LandMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LandMember_lbl" xml:lang="en-US">Land [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="ifrs-full_ConstructionInProgressMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConstructionInProgressMember" xlink:to="ifrs-full_ConstructionInProgressMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConstructionInProgressMember_lbl" xml:lang="en-US">Construction in progress [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xml:lang="en-US">Accumulated depreciation and amortisation [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_lbl" xml:lang="en-US">Classes of intangible assets and goodwill [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GoodwillMember" xlink:label="ifrs-full_GoodwillMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodwillMember" xlink:to="ifrs-full_GoodwillMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GoodwillMember_lbl" xml:lang="en-US">Goodwill [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicencesMember" xlink:label="ifrs-full_LicencesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicencesMember" xlink:to="ifrs-full_LicencesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LicencesMember_lbl" xml:lang="en-US">Licences [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="ifrs-full_ComputerSoftwareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerSoftwareMember" xlink:to="ifrs-full_ComputerSoftwareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComputerSoftwareMember_lbl" xml:lang="en-US">Computer software [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationContentMember" xlink:label="afya_EducationContentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationContentMember" xlink:to="afya_EducationContentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationContentMember_lbl" xml:lang="en-US">Education Content [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationalPlatformMember" xlink:label="afya_EducationalPlatformMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationalPlatformMember" xlink:to="afya_EducationalPlatformMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationalPlatformMember_lbl" xml:lang="en-US">Educational Platform [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SoftwareInProgressMember" xlink:label="afya_SoftwareInProgressMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SoftwareInProgressMember" xlink:to="afya_SoftwareInProgressMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SoftwareInProgressMember_lbl" xml:lang="en-US">Software In Progress [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherMember" xlink:label="afya_OtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherMember" xlink:to="afya_OtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CarryingAmountsMember" xlink:label="afya_CarryingAmountsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CarryingAmountsMember" xlink:to="afya_CarryingAmountsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CarryingAmountsMember_lbl" xml:lang="en-US">Carrying Amounts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:label="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:to="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_lbl" xml:lang="en-US">I P T A N Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:label="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:to="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_lbl" xml:lang="en-US">Instituto De Educacao Superior Do Vale Do Parnaiba S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:label="afya_CentroDeCienciasEmSaudeDeItajubaSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:to="afya_CentroDeCienciasEmSaudeDeItajubaSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroDeCienciasEmSaudeDeItajubaSAMember_lbl" xml:lang="en-US">Centro De Ciencias Em Saude De Itajuba S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:label="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:to="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember_lbl" xml:lang="en-US">Instituto De Ensino Superior Do Piaui S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:label="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:to="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_lbl" xml:lang="en-US">F A D E P Faculdade Educacional De Pato Branco Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:label="afya_InstitutoEducacionalSantoAgostinhoSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:to="afya_InstitutoEducacionalSantoAgostinhoSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoEducacionalSantoAgostinhoSAMember_lbl" xml:lang="en-US">Instituto Educacional Santo Agostinho S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:to="afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_lbl" xml:lang="en-US">Institutode Pesquisae Ensino Medicodo Estadode Minas Gerais Ltda [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:label="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:to="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember_lbl" xml:lang="en-US">Instituto Paraensede Educacaoe Cultura Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniRedentorMember" xlink:label="afya_UniRedentorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UniRedentorMember" xlink:to="afya_UniRedentorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UniRedentorMember_lbl" xml:lang="en-US">Uni Redentor [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniSLMember" xlink:label="afya_UniSLMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UniSLMember" xlink:to="afya_UniSLMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UniSLMember_lbl" xml:lang="en-US">Uni S L [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FESARMember" xlink:label="afya_FESARMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FESARMember" xlink:to="afya_FESARMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FESARMember_lbl" xml:lang="en-US">F E S A R [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FCMPBMember" xlink:label="afya_FCMPBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FCMPBMember" xlink:to="afya_FCMPBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FCMPBMember_lbl" xml:lang="en-US">FCMPB [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ITPACGaranhunsMember" xlink:label="afya_ITPACGaranhunsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ITPACGaranhunsMember" xlink:to="afya_ITPACGaranhunsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ITPACGaranhunsMember_lbl" xml:lang="en-US">I T P A C Garanhuns [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedcelAndCBBWMember" xlink:label="afya_MedcelAndCBBWMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedcelAndCBBWMember" xlink:to="afya_MedcelAndCBBWMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedcelAndCBBWMember_lbl" xml:lang="en-US">Medcel And C B B W [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PracticeManagementToolsAndElectronicPrescriptionMember" xlink:label="afya_PracticeManagementToolsAndElectronicPrescriptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PracticeManagementToolsAndElectronicPrescriptionMember" xlink:to="afya_PracticeManagementToolsAndElectronicPrescriptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PracticeManagementToolsAndElectronicPrescriptionMember_lbl" xml:lang="en-US">Practice Management Tools And Electronic Prescription [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ClinicalDecisionSoftwareMember" xlink:label="afya_ClinicalDecisionSoftwareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ClinicalDecisionSoftwareMember" xlink:to="afya_ClinicalDecisionSoftwareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ClinicalDecisionSoftwareMember_lbl" xml:lang="en-US">Clinical Decision Software [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CliquefarmaMember" xlink:label="afya_CliquefarmaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CliquefarmaMember" xlink:to="afya_CliquefarmaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CliquefarmaMember_lbl" xml:lang="en-US">Cliquefarma [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UnifipMocMember" xlink:label="afya_UnifipMocMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UnifipMocMember" xlink:to="afya_UnifipMocMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UnifipMocMember_lbl" xml:lang="en-US">Unifip Moc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UnigranrioMember" xlink:label="afya_UnigranrioMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UnigranrioMember" xlink:to="afya_UnigranrioMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UnigranrioMember_lbl" xml:lang="en-US">Unigranrio [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROMember" xlink:label="afya_RXPROMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RXPROMember" xlink:to="afya_RXPROMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RXPROMember_lbl" xml:lang="en-US">RXPRO [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CustomerRelationshipsMedicineMember" xlink:label="afya_CustomerRelationshipsMedicineMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CustomerRelationshipsMedicineMember" xlink:to="afya_CustomerRelationshipsMedicineMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CustomerRelationshipsMedicineMember_lbl" xml:lang="en-US">Customer Relationships Medicine [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CustomerRelationshipsOtherCoursesMember" xlink:label="afya_CustomerRelationshipsOtherCoursesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CustomerRelationshipsOtherCoursesMember" xlink:to="afya_CustomerRelationshipsOtherCoursesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CustomerRelationshipsOtherCoursesMember_lbl" xml:lang="en-US">Customer Relationships Other Courses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DevelopedTechnologyMember" xlink:label="afya_DevelopedTechnologyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DevelopedTechnologyMember" xlink:to="afya_DevelopedTechnologyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DevelopedTechnologyMember_lbl" xml:lang="en-US">Developed Technology [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="ifrs-full_FinancialAssetsAtAmortisedCostMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:to="ifrs-full_FinancialAssetsAtAmortisedCostMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsAtAmortisedCostMember_lbl" xml:lang="en-US">Financial assets at amortised cost, class [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xml:lang="en-US">Classes of financial liabilities [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:label="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:to="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_lbl" xml:lang="en-US">Financial liabilities at amortised cost, class [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAxis_lbl" xml:lang="en-US">Maturity [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentyFiveMember" xlink:label="afya_TwentyTwentyFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentyFiveMember" xlink:to="afya_TwentyTwentyFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TwentyTwentyFiveMember_lbl" xml:lang="en-US">2025 [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentySevenMember" xlink:label="afya_TwentyTwentySevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentySevenMember" xlink:to="afya_TwentyTwentySevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TwentyTwentySevenMember_lbl" xml:lang="en-US">2027 [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentyFourMember" xlink:label="afya_TwentyTwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentyFourMember" xlink:to="afya_TwentyTwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TwentyTwentyFourMember_lbl" xml:lang="en-US">2024 [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentySixMember" xlink:label="afya_TwentyTwentySixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentySixMember" xlink:to="afya_TwentyTwentySixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TwentyTwentySixMember_lbl" xml:lang="en-US">2026 [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentyEightMember" xlink:label="afya_TwentyTwentyEightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentyEightMember" xlink:to="afya_TwentyTwentyEightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TwentyTwentyEightMember_lbl" xml:lang="en-US">2028 [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedicalHarbourMember" xlink:label="afya_MedicalHarbourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedicalHarbourMember" xlink:to="afya_MedicalHarbourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedicalHarbourMember_lbl" xml:lang="en-US">Medical Harbour [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShospMember" xlink:label="afya_ShospMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShospMember" xlink:to="afya_ShospMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShospMember_lbl" xml:lang="en-US">Shosp [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksAxis_lbl" xml:lang="en-US">Types of risks [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrencyRiskMember" xlink:label="ifrs-full_CurrencyRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrencyRiskMember" xlink:to="ifrs-full_CurrencyRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrencyRiskMember_lbl" xml:lang="en-US">Currency risk [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_EUR" xlink:label="currency_EUR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_EUR" xlink:to="currency_EUR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_EUR_lbl" xml:lang="en-US">Euro Member Countries, Euro</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IPEMEDMember" xlink:label="afya_IPEMEDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IPEMEDMember" xlink:to="afya_IPEMEDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IPEMEDMember_lbl" xml:lang="en-US">IPEMED [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GuaranhunsMember" xlink:label="afya_GuaranhunsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_GuaranhunsMember" xlink:to="afya_GuaranhunsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_GuaranhunsMember_lbl" xml:lang="en-US">Guaranhuns [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CardiPapersMember" xlink:label="afya_CardiPapersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CardiPapersMember" xlink:to="afya_CardiPapersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CardiPapersMember_lbl" xml:lang="en-US">Cardi Papers [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersMember" xlink:label="afya_AccountsPayableToSellingShareholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersMember" xlink:to="afya_AccountsPayableToSellingShareholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersMember_lbl" xml:lang="en-US">Accounts Payable To Selling Shareholders [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivablesMember" xlink:label="ifrs-full_TradeReceivablesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivablesMember" xlink:to="ifrs-full_TradeReceivablesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeReceivablesMember_lbl" xml:lang="en-US">Trade receivables [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingMember" xlink:label="afya_LoansAndFinancingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingMember" xlink:to="afya_LoansAndFinancingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingMember_lbl" xml:lang="en-US">Loans And Financing [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="ifrs-full_LeaseLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilitiesMember" xlink:to="ifrs-full_LeaseLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilitiesMember_lbl" xml:lang="en-US">Lease liabilities [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotesPayableMember" xlink:label="afya_NotesPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayableMember" xlink:to="afya_NotesPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NotesPayableMember_lbl" xml:lang="en-US">Notes Payable [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CashEquivalents1Member" xlink:label="afya_CashEquivalents1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CashEquivalents1Member" xlink:to="afya_CashEquivalents1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CashEquivalents1Member_lbl" xml:lang="en-US">Cash Equivalents [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="ifrs-full_TypesOfInterestRatesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfInterestRatesAxis" xlink:to="ifrs-full_TypesOfInterestRatesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfInterestRatesAxis_lbl" xml:lang="en-US">Types of interest rates [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FloatingInterestRateMember" xlink:label="ifrs-full_FloatingInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FloatingInterestRateMember" xlink:to="ifrs-full_FloatingInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FloatingInterestRateMember_lbl" xml:lang="en-US">Floating interest rate [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateRiskMember" xlink:label="ifrs-full_InterestRateRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateRiskMember" xlink:to="ifrs-full_InterestRateRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestRateRiskMember_lbl" xml:lang="en-US">Interest rate risk [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingOneMember" xlink:label="afya_LoansAndFinancingOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingOneMember" xlink:to="afya_LoansAndFinancingOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingOneMember_lbl" xml:lang="en-US">Loans And Financing One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingTwoMember" xlink:label="afya_LoansAndFinancingTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingTwoMember" xlink:to="afya_LoansAndFinancingTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingTwoMember_lbl" xml:lang="en-US">Loans And Financing Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingThreeMember" xlink:label="afya_LoansAndFinancingThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingThreeMember" xlink:to="afya_LoansAndFinancingThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingThreeMember_lbl" xml:lang="en-US">Loans And Financing Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersOneMember" xlink:label="afya_AccountsPayableToSellingShareholdersOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersOneMember" xlink:to="afya_AccountsPayableToSellingShareholdersOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersOneMember_lbl" xml:lang="en-US">Accounts Payable To Selling Shareholders One [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersTwoMember" xlink:label="afya_AccountsPayableToSellingShareholdersTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersTwoMember" xlink:to="afya_AccountsPayableToSellingShareholdersTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersTwoMember_lbl" xml:lang="en-US">Accounts Payable To Selling Shareholders Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProbabilityOfDefaultAxis" xlink:label="ifrs-full_ProbabilityOfDefaultAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProbabilityOfDefaultAxis" xlink:to="ifrs-full_ProbabilityOfDefaultAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProbabilityOfDefaultAxis_lbl" xml:lang="en-US">Probability of default [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseBasisPointsMember" xlink:label="afya_IncreaseBasisPointsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseBasisPointsMember" xlink:to="afya_IncreaseBasisPointsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseBasisPointsMember_lbl" xml:lang="en-US">Increase in basis points +75 [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseBasisPointsOneMember" xlink:label="afya_IncreaseBasisPointsOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseBasisPointsOneMember" xlink:to="afya_IncreaseBasisPointsOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseBasisPointsOneMember_lbl" xml:lang="en-US">Increase in basis points +150 [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RiskExposuresAxis" xlink:label="ifrs-full_RiskExposuresAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RiskExposuresAxis" xlink:to="ifrs-full_RiskExposuresAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RiskExposuresAxis_lbl" xml:lang="en-US">Risk variables [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ForeignCurrencyExposuresMember" xlink:label="afya_ForeignCurrencyExposuresMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ForeignCurrencyExposuresMember" xlink:to="afya_ForeignCurrencyExposuresMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ForeignCurrencyExposuresMember_lbl" xml:lang="en-US">Exposure [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseForeignCurrencyMember" xlink:label="afya_IncreaseForeignCurrencyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseForeignCurrencyMember" xlink:to="afya_IncreaseForeignCurrencyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseForeignCurrencyMember_lbl" xml:lang="en-US">Increase in Foreign Currency Sensitivity +10% [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DecreaseForeignCurrencyMember" xlink:label="afya_DecreaseForeignCurrencyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DecreaseForeignCurrencyMember" xlink:to="afya_DecreaseForeignCurrencyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DecreaseForeignCurrencyMember_lbl" xml:lang="en-US">Decrease in Foreign Currency Sensitivity -10% [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="ifrs-full_LaterThanOneYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearMember" xlink:to="ifrs-full_LaterThanOneYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearMember_lbl" xml:lang="en-US">Later than one year [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiquidityRiskMember" xlink:label="ifrs-full_LiquidityRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiquidityRiskMember" xlink:to="ifrs-full_LiquidityRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiquidityRiskMember_lbl" xml:lang="en-US">Liquidity risk [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl" xml:lang="en-US">Later than one year and not later than three years [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_lbl" xml:lang="en-US">Later than three years and not later than five years [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanFiveYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanFiveYearsMember_lbl" xml:lang="en-US">Later than five years [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl" xml:lang="en-US">Liabilities arising from financing activities [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DividendsPayableMember" xlink:label="afya_DividendsPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsPayableMember" xlink:to="afya_DividendsPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendsPayableMember_lbl" xml:lang="en-US">Dividends Payable [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MeasurementAxis" xlink:label="ifrs-full_MeasurementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MeasurementAxis_lbl" xml:lang="en-US">Measurement [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" xlink:label="ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" xlink:to="ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_lbl" xml:lang="en-US">Not measured at fair value in statement of financial position but for which fair value is disclosed [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_LevelsOfFairValueHierarchyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis_lbl" xml:lang="en-US">Levels of fair value hierarchy [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level2OfFairValueHierarchyMember" xlink:to="ifrs-full_Level2OfFairValueHierarchyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 2 of fair value hierarchy [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level3OfFairValueHierarchyMember" xlink:to="ifrs-full_Level3OfFairValueHierarchyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 3 of fair value hierarchy [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OptionsGrantedMember" xlink:label="afya_OptionsGrantedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OptionsGrantedMember" xlink:to="afya_OptionsGrantedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OptionsGrantedMember_lbl" xml:lang="en-US">Options Granted [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="ifrs-full_DefinedBenefitPlansAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DefinedBenefitPlansAxis" xlink:to="ifrs-full_DefinedBenefitPlansAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DefinedBenefitPlansAxis_lbl" xml:lang="en-US">Defined benefit plans [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShareBasedCompensationPlansMember" xlink:label="afya_ShareBasedCompensationPlansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShareBasedCompensationPlansMember" xlink:to="afya_ShareBasedCompensationPlansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShareBasedCompensationPlansMember_lbl" xml:lang="en-US">Share based compensation plans [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnitsMember" xlink:label="afya_RestrictedStockUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedStockUnitsMember" xlink:to="afya_RestrictedStockUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedStockUnitsMember_lbl" xml:lang="en-US">Restricted stock units [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnits1Member" xlink:label="afya_RestrictedStockUnits1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedStockUnits1Member" xlink:to="afya_RestrictedStockUnits1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedStockUnits1Member_lbl" xml:lang="en-US">Restricted stock units 1 [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnits2Member" xlink:label="afya_RestrictedStockUnits2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedStockUnits2Member" xlink:to="afya_RestrictedStockUnits2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedStockUnits2Member_lbl" xml:lang="en-US">Restricted stock units 2 [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnits3Member" xlink:label="afya_RestrictedStockUnits3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedStockUnits3Member" xlink:to="afya_RestrictedStockUnits3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedStockUnits3Member_lbl" xml:lang="en-US">Restricted stock units 3 [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_lbl" xml:lang="en-US">Types of antidilutive instruments [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RSUsMember" xlink:label="afya_RSUsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RSUsMember" xlink:to="afya_RSUsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RSUsMember_lbl" xml:lang="en-US">R S Us [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ModifiedPlanMember" xlink:label="afya_ModifiedPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ModifiedPlanMember" xlink:to="afya_ModifiedPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ModifiedPlanMember_lbl" xml:lang="en-US">Modified Plan [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncrementalStockOptionsMember" xlink:label="afya_IncrementalStockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncrementalStockOptionsMember" xlink:to="afya_IncrementalStockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncrementalStockOptionsMember_lbl" xml:lang="en-US">Incremental Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OriginalPlanMember" xlink:label="afya_OriginalPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OriginalPlanMember" xlink:to="afya_OriginalPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OriginalPlanMember_lbl" xml:lang="en-US">Original Plan [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IPCAMember" xlink:label="afya_IPCAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IPCAMember" xlink:to="afya_IPCAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IPCAMember_lbl" xml:lang="en-US">I P C A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CDIMember" xlink:label="afya_CDIMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CDIMember" xlink:to="afya_CDIMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CDIMember_lbl" xml:lang="en-US">C D I [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOptionsMember" xlink:label="ifrs-full_ShareOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOptionsMember" xlink:to="ifrs-full_ShareOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOptionsMember_lbl" xml:lang="en-US">Share options [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EliminationInterSegmentTransactionsMember" xlink:label="afya_EliminationInterSegmentTransactionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EliminationInterSegmentTransactionsMember" xlink:to="afya_EliminationInterSegmentTransactionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EliminationInterSegmentTransactionsMember_lbl" xml:lang="en-US">Elimination (inter-segment transactions) [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OneSubsidiaryMember" xlink:label="afya_OneSubsidiaryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OneSubsidiaryMember" xlink:to="afya_OneSubsidiaryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OneSubsidiaryMember_lbl" xml:lang="en-US">One Subsidiary [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfContingentLiabilitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis_lbl" xml:lang="en-US">Classes of contingent liabilities [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="ifrs-full_LegalProceedingsContingentLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:to="ifrs-full_LegalProceedingsContingentLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LegalProceedingsContingentLiabilityMember_lbl" xml:lang="en-US">Legal proceedings contingent liability [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="ifrs-full_ClassesOfProvisionsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="ifrs-full_ClassesOfProvisionsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfProvisionsAxis_lbl" xml:lang="en-US">Classes of other provisions [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LabourMember" xlink:label="afya_LabourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LabourMember" xlink:to="afya_LabourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LabourMember_lbl" xml:lang="en-US">Labour [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CivilMember" xlink:label="afya_CivilMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CivilMember" xlink:to="afya_CivilMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CivilMember_lbl" xml:lang="en-US">Civil [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxesMember" xlink:label="afya_TaxesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesMember" xlink:to="afya_TaxesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxesMember_lbl" xml:lang="en-US">Taxes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TypesOfRiskMember" xlink:label="afya_TypesOfRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TypesOfRiskMember" xlink:to="afya_TypesOfRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TypesOfRiskMember_lbl" xml:lang="en-US">Types Of Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxesAndSocialSecurityMember" xlink:label="afya_TaxesAndSocialSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesAndSocialSecurityMember" xlink:to="afya_TaxesAndSocialSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxesAndSocialSecurityMember_lbl" xml:lang="en-US">Taxes And Social Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfAssetsAxis_lbl" xml:lang="en-US">Classes of assets [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssetsNonCurrentMember" xlink:label="afya_OtherAssetsNonCurrentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssetsNonCurrentMember" xlink:to="afya_OtherAssetsNonCurrentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherAssetsNonCurrentMember_lbl" xml:lang="en-US">Other Assets Non Current [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IClinicMember" xlink:label="afya_IClinicMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IClinicMember" xlink:to="afya_IClinicMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IClinicMember_lbl" xml:lang="en-US">I Clinic [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:to="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_lbl" xml:lang="en-US">Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FaculdadesIntegradasPadraoMember" xlink:label="afya_FaculdadesIntegradasPadraoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FaculdadesIntegradasPadraoMember" xlink:to="afya_FaculdadesIntegradasPadraoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FaculdadesIntegradasPadraoMember_lbl" xml:lang="en-US">Faculdades Integradas Padrao [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress" xlink:label="dei_ContactPersonnelEmailAddress" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelEmailAddress" xlink:to="dei_ContactPersonnelEmailAddress_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelEmailAddress_lbl" xml:lang="en-US">Contact Personnel Email Address</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of financial position [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAbstract" xlink:to="ifrs-full_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="ifrs-full_CurrentAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="ifrs-full_CurrentTradeReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTradeReceivables_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories" xlink:label="ifrs-full_Inventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Inventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTaxAssets" xlink:label="ifrs-full_CurrentTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxAssets" xlink:to="ifrs-full_CurrentTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxAssets_lbl" xml:lang="en-US">Recoverable taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentAssets" xlink:label="ifrs-full_OtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentAssets" xlink:to="ifrs-full_OtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="ifrs-full_NoncurrentAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl" xml:lang="en-US">Non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentTradeReceivable" xlink:label="afya_NoncurrentTradeReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentTradeReceivable" xlink:to="afya_NoncurrentTradeReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentTradeReceivable_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="ifrs-full_OtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xml:lang="en-US">Investment in associate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US">Right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US">Total non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets" xlink:label="ifrs-full_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="ifrs-full_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesAbstract" xlink:to="ifrs-full_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermBorrowings" xlink:label="ifrs-full_ShorttermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermBorrowings" xlink:to="ifrs-full_ShorttermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermBorrowings_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotePayableCurrent" xlink:label="afya_NotePayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotePayableCurrent" xlink:to="afya_NotePayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NotePayableCurrent_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentDepositsFromCustomers" xlink:label="ifrs-full_CurrentDepositsFromCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDepositsFromCustomers" xlink:to="ifrs-full_CurrentDepositsFromCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentDepositsFromCustomers_lbl" xml:lang="en-US">Advances from customers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:to="ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan_lbl" xml:lang="en-US">Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CurrentTaxesPayable" xlink:label="afya_CurrentTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentTaxesPayable" xlink:to="afya_CurrentTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CurrentTaxesPayable_lbl" xml:lang="en-US">Taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:to="ifrs-full_CurrentTaxLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="ifrs-full_OtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentLiabilities" xlink:to="ifrs-full_OtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LongtermBorrowings" xlink:label="ifrs-full_LongtermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermBorrowings" xlink:to="ifrs-full_LongtermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_LongtermBorrowings_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayablesToRelatedParties" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayablesToRelatedParties" xlink:to="ifrs-full_NoncurrentPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentTaxesPayable" xlink:label="afya_NoncurrentTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentTaxesPayable" xlink:to="afya_NoncurrentTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentTaxesPayable_lbl" xml:lang="en-US">Taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LongtermLegalProceedingsProvision" xlink:label="ifrs-full_LongtermLegalProceedingsProvision" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermLegalProceedingsProvision" xlink:to="ifrs-full_LongtermLegalProceedingsProvision_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LongtermLegalProceedingsProvision_lbl" xml:lang="en-US">Provision for legal proceedings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="ifrs-full_OtherNoncurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherNoncurrentLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US">Total non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities" xlink:label="ifrs-full_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAbstract_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US">Share capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionalPaidinCapital" xlink:label="ifrs-full_AdditionalPaidinCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalPaidinCapital" xlink:to="ifrs-full_AdditionalPaidinCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionalPaidinCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasuryShares" xlink:label="ifrs-full_TreasuryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasuryShares" xlink:to="ifrs-full_TreasuryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TreasuryShares_lbl" xml:lang="en-US">Treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="ifrs-full_ReserveOfSharebasedPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfSharebasedPayments" xlink:to="ifrs-full_ReserveOfSharebasedPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfSharebasedPayments_lbl" xml:lang="en-US">Share-based compensation reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US">Retained earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent_lbl" xml:lang="en-US">Equity attributable to equity holders of the parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncontrollingInterests" xlink:label="ifrs-full_NoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterests" xlink:to="ifrs-full_NoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncontrollingInterests_lbl" xml:lang="en-US">Non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US">Total equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities" xlink:label="ifrs-full_EquityAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAndLiabilities_lbl" xml:lang="en-US">Total liabilities and equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="ifrs-full_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeStatementAbstract_lbl" xml:lang="en-US">Profit or loss [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Revenue_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales" xlink:label="ifrs-full_CostOfSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CostOfSales_lbl" xml:lang="en-US">Cost of services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossProfit" xlink:label="ifrs-full_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeneralAndAdministrativeExpense" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="ifrs-full_OtherOperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherOperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl" xml:lang="en-US">Other income (expenses), net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US">Operating income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncome" xlink:to="ifrs-full_FinanceIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncome_lbl" xml:lang="en-US">&#160;&#160;Finance income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_FinanceCosts_lbl" xml:lang="en-US">&#160;&#160;Finance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinanceIncomeCost_lbl" xml:lang="en-US">Finance result</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl" xml:lang="en-US">Share of income of associate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US">Income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US">Income taxes expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US">Other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US">Total comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="ifrs-full_ProfitLossAttributableToAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLossAttributableToAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToAbstract_lbl" xml:lang="en-US">Income attributable to</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl" xml:lang="en-US">&#160;&#160;Equity holders of the parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl" xml:lang="en-US">&#160;&#160;Non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ComprehensiveIncomeLoss" xlink:label="afya_ComprehensiveIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ComprehensiveIncomeLoss" xlink:to="afya_ComprehensiveIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="afya_ComprehensiveIncomeLoss_lbl" xml:lang="en-US">Total comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsPerShareAbstract" xlink:label="ifrs-full_BasicEarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsPerShareAbstract" xlink:to="ifrs-full_BasicEarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsPerShareAbstract_lbl" xml:lang="en-US">Basic earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="ifrs-full_BasicEarningsLossPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US">Per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsPerShareAbstract" xlink:to="ifrs-full_DilutedEarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract_lbl" xml:lang="en-US">Diluted earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US">Per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityTable_lbl" xml:lang="en-US">Statement of changes in equity [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="afya_IfrsStatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IfrsStatementLineItems" xlink:to="afya_IfrsStatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IfrsStatementLineItems_lbl" xml:lang="en-US">IfrsStatementLineItems [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Equity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncome_2_lbl" xml:lang="en-US">Total comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CapitalIncreaseWithCash" xlink:label="afya_CapitalIncreaseWithCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CapitalIncreaseWithCash" xlink:to="afya_CapitalIncreaseWithCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CapitalIncreaseWithCash_lbl" xml:lang="en-US">Capital increase</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasuryShares1" xlink:label="afya_TreasuryShares1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TreasuryShares1" xlink:to="afya_TreasuryShares1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TreasuryShares1_lbl" xml:lang="en-US">Treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasurySharesTransferredFromExerciseOfOptions" xlink:label="afya_TreasurySharesTransferredFromExerciseOfOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TreasurySharesTransferredFromExerciseOfOptions" xlink:to="afya_TreasurySharesTransferredFromExerciseOfOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TreasurySharesTransferredFromExerciseOfOptions_lbl" xml:lang="en-US">Treasury shares transferred from exercise of options</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination" xlink:label="afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination" xlink:to="afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination_lbl" xml:lang="en-US">Treasury shares transferred from shares contribution on business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfNoncontrollingInterests" xlink:label="afya_AcquisitionOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AcquisitionOfNoncontrollingInterests" xlink:to="afya_AcquisitionOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AcquisitionOfNoncontrollingInterests_lbl" xml:lang="en-US">Acquisition of non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedSharesTransferredToExecutives" xlink:label="afya_RestrictedSharesTransferredToExecutives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedSharesTransferredToExecutives" xlink:to="afya_RestrictedSharesTransferredToExecutives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedSharesTransferredToExecutives_lbl" xml:lang="en-US">Restricted shares transferred to executives</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" xlink:label="afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" xlink:to="afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions_lbl" xml:lang="en-US">Treasury shares transferred to executives from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaid" xlink:label="ifrs-full_DividendsPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaid" xlink:to="ifrs-full_DividendsPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DividendsPaid_lbl" xml:lang="en-US">Dividends declared</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Equity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of cash flows [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncomeLossBeforeIncomeTaxes" xlink:label="afya_IncomeLossBeforeIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncomeLossBeforeIncomeTaxes" xlink:to="afya_IncomeLossBeforeIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_IncomeLossBeforeIncomeTaxes_lbl" xml:lang="en-US">Income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xml:lang="en-US">Adjustments to reconcile income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WriteoffOfPropertyAndEquipment" xlink:label="afya_WriteoffOfPropertyAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WriteoffOfPropertyAndEquipment" xlink:to="afya_WriteoffOfPropertyAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WriteoffOfPropertyAndEquipment_lbl" xml:lang="en-US">Write-off of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WriteoffOfIntangibleAssets" xlink:label="afya_WriteoffOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WriteoffOfIntangibleAssets" xlink:to="afya_WriteoffOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WriteoffOfIntangibleAssets_lbl" xml:lang="en-US">Write-off of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:label="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:to="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities_lbl" xml:lang="en-US">Allowance for expected credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US">Share-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl" xml:lang="en-US">Net foreign exchange differences</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccruedInterestOfOpeartingActivities" xlink:label="afya_AccruedInterestOfOpeartingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccruedInterestOfOpeartingActivities" xlink:to="afya_AccruedInterestOfOpeartingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccruedInterestOfOpeartingActivities_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xml:lang="en-US">Accrued lease interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShareOfIncomeOfAssociateOfOpeartingActivities" xlink:label="afya_ShareOfIncomeOfAssociateOfOpeartingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShareOfIncomeOfAssociateOfOpeartingActivities" xlink:to="afya_ShareOfIncomeOfAssociateOfOpeartingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_ShareOfIncomeOfAssociateOfOpeartingActivities_lbl" xml:lang="en-US">Share of income of associate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="ifrs-full_AdjustmentsForProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForProvisions" xlink:to="ifrs-full_AdjustmentsForProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForProvisions_lbl" xml:lang="en-US">Provision (reversal) for legal proceedings</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseDecreaseInOperatingLiabilities1Abstract" xlink:label="afya_IncreaseDecreaseInOperatingLiabilities1Abstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="afya_IncreaseDecreaseInOperatingLiabilities1Abstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseDecreaseInOperatingLiabilities1Abstract_lbl" xml:lang="en-US">Changes in assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseDecreaseInRecoverableTaxes" xlink:label="afya_IncreaseDecreaseInRecoverableTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseDecreaseInRecoverableTaxes" xlink:to="afya_IncreaseDecreaseInRecoverableTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_IncreaseDecreaseInRecoverableTaxes_lbl" xml:lang="en-US">Recoverable taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl" xml:lang="en-US">Taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_lbl" xml:lang="en-US">Advances from customers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherAdjustmentsForNoncashItems" xlink:to="ifrs-full_OtherAdjustmentsForNoncashItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems_lbl" xml:lang="en-US">Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash flows from operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Acquisition of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:label="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:to="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Acquisition of intangibles assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsReceived" xlink:label="ifrs-full_DividendsReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsReceived" xlink:to="ifrs-full_DividendsReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsReceived_lbl" xml:lang="en-US">Dividends received</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PurchaseOfAcquisitionOfNoncontrollingInterests" xlink:label="afya_PurchaseOfAcquisitionOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PurchaseOfAcquisitionOfNoncontrollingInterests" xlink:to="afya_PurchaseOfAcquisitionOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_PurchaseOfAcquisitionOfNoncontrollingInterests_lbl" xml:lang="en-US">Acquisition of non-controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Acquisition of subsidiaries, net of cash acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" xlink:label="afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" xlink:to="afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles_lbl" xml:lang="en-US">Payments of interest from acquisition of subsidiaries and intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedCashOfInvestingActivities" xlink:label="afya_RestrictedCashOfInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedCashOfInvestingActivities" xlink:to="afya_RestrictedCashOfInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedCashOfInvestingActivities_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash flows used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Payments of principal of loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" xlink:label="afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" xlink:to="afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Payments of interest of loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Proceeds from loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Payments of lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Payments of interest of lease liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TreasuryShares1" xlink:to="afya_TreasuryShares1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TreasuryShares1_2_lbl" xml:lang="en-US">Treasury shares buy back</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfOptions" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_lbl" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="ifrs-full_DividendsPaidClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_DividendsPaidClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DividendsPaidClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Dividends paid to non-controlling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash flows generated (used) in financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US">Net foreign exchange differences</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents at the beginning of the year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents at the end of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CorporateInformationAbstract" xlink:label="afya_CorporateInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CorporateInformationAbstract" xlink:to="afya_CorporateInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CorporateInformationAbstract_lbl" xml:lang="en-US">Corporate Information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_lbl" xml:lang="en-US">Corporate information</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="afya_DisclosureMaterialAccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:to="afya_DisclosureMaterialAccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureMaterialAccountingPoliciesAbstract_lbl" xml:lang="en-US">Material Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfMaterialAccountingPoliciesExplanatory" xlink:label="afya_DisclosureOfMaterialAccountingPoliciesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfMaterialAccountingPoliciesExplanatory" xlink:to="afya_DisclosureOfMaterialAccountingPoliciesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfMaterialAccountingPoliciesExplanatory_lbl" xml:lang="en-US">Material accounting policies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract" xlink:label="afya_DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract" xlink:to="afya_DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract_lbl" xml:lang="en-US">Significant Accounting Judgments Estimates And Assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory" xlink:label="afya_SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory" xlink:to="afya_SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory_lbl" xml:lang="en-US">Significant accounting judgments, estimates and assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_NotesAndOtherExplanatoryInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract_lbl" xml:lang="en-US">Notes and other explanatory information [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl" xml:lang="en-US">Segment information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsExplanatory_lbl" xml:lang="en-US">Business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureCashAndCashEquivalentsAbstract" xlink:label="afya_DisclosureCashAndCashEquivalentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureCashAndCashEquivalentsAbstract" xlink:to="afya_DisclosureCashAndCashEquivalentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureCashAndCashEquivalentsAbstract_lbl" xml:lang="en-US">Cash And Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosuresOfCashAndCashEquivalentsExplanatory" xlink:label="afya_DisclosuresOfCashAndCashEquivalentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosuresOfCashAndCashEquivalentsExplanatory" xlink:to="afya_DisclosuresOfCashAndCashEquivalentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DisclosuresOfCashAndCashEquivalentsExplanatory_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US">Related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOtherAssetsAbstract" xlink:label="afya_DisclosureOtherAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOtherAssetsAbstract" xlink:to="afya_DisclosureOtherAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOtherAssetsAbstract_lbl" xml:lang="en-US">Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfOtherAssetExplanatory" xlink:label="afya_DisclosureOfOtherAssetExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfOtherAssetExplanatory" xlink:to="afya_DisclosureOfOtherAssetExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DisclosureOfOtherAssetExplanatory_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl" xml:lang="en-US">Investment in associate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureIntangibleAssetsAndGoodwillAbstract" xlink:label="afya_DisclosureIntangibleAssetsAndGoodwillAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureIntangibleAssetsAndGoodwillAbstract" xlink:to="afya_DisclosureIntangibleAssetsAndGoodwillAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureIntangibleAssetsAndGoodwillAbstract_lbl" xml:lang="en-US">Intangible Assets And Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfIntangibleAssetExplanatory" xlink:label="afya_DisclosureOfIntangibleAssetExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfIntangibleAssetExplanatory" xlink:to="afya_DisclosureOfIntangibleAssetExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfIntangibleAssetExplanatory_lbl" xml:lang="en-US">Intangible assets and goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Financial assets and financial liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureFairValueMeasurementAbstract" xlink:label="afya_DisclosureFairValueMeasurementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureFairValueMeasurementAbstract" xlink:to="afya_DisclosureFairValueMeasurementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureFairValueMeasurementAbstract_lbl" xml:lang="en-US">Fair Value Measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FairValueMeasurementExplanatory" xlink:label="afya_FairValueMeasurementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FairValueMeasurementExplanatory" xlink:to="afya_FairValueMeasurementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FairValueMeasurementExplanatory_lbl" xml:lang="en-US">Fair value measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureCapitalManagementAbstract" xlink:label="afya_DisclosureCapitalManagementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureCapitalManagementAbstract" xlink:to="afya_DisclosureCapitalManagementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureCapitalManagementAbstract_lbl" xml:lang="en-US">Capital Management</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CapitalManagementExplanatory" xlink:label="afya_CapitalManagementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CapitalManagementExplanatory" xlink:to="afya_CapitalManagementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CapitalManagementExplanatory_lbl" xml:lang="en-US">Capital management</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="afya_DisclosureLaborAndSocialObligationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureLaborAndSocialObligationsAbstract" xlink:to="afya_DisclosureLaborAndSocialObligationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureLaborAndSocialObligationsAbstract_lbl" xml:lang="en-US">Labor And Social Obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaborAndSocialObligationsExplanatory" xlink:label="afya_LaborAndSocialObligationsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsExplanatory" xlink:to="afya_LaborAndSocialObligationsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LaborAndSocialObligationsExplanatory_lbl" xml:lang="en-US">Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureEquityAbstract" xlink:label="afya_DisclosureEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureEquityAbstract" xlink:to="afya_DisclosureEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DisclosureEquityAbstract_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfEquityExplanatory" xlink:label="afya_DisclosureOfEquityExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfEquityExplanatory" xlink:to="afya_DisclosureOfEquityExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DisclosureOfEquityExplanatory_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US">Earnings per share (EPS)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:label="ifrs-full_DisclosureOfExpensesByNatureExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:to="ifrs-full_DisclosureOfExpensesByNatureExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfExpensesByNatureExplanatory_lbl" xml:lang="en-US">Expenses and costs by nature</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xml:lang="en-US">Finance result</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureIncomeTaxesAbstract" xlink:label="afya_DisclosureIncomeTaxesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureIncomeTaxesAbstract" xlink:to="afya_DisclosureIncomeTaxesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureIncomeTaxesAbstract_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfIncomeTaxesExplanatory" xlink:label="afya_DisclosureOfIncomeTaxesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfIncomeTaxesExplanatory" xlink:to="afya_DisclosureOfIncomeTaxesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfIncomeTaxesExplanatory_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureInsuranceContractsAndContingenciesAbstract" xlink:label="afya_DisclosureInsuranceContractsAndContingenciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureInsuranceContractsAndContingenciesAbstract" xlink:to="afya_DisclosureInsuranceContractsAndContingenciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureInsuranceContractsAndContingenciesAbstract_lbl" xml:lang="en-US">Insurance Contracts And Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfInsuranceContractsAndContingenciesExplanatory" xlink:label="afya_DisclosureOfInsuranceContractsAndContingenciesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfInsuranceContractsAndContingenciesExplanatory" xlink:to="afya_DisclosureOfInsuranceContractsAndContingenciesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfInsuranceContractsAndContingenciesExplanatory_lbl" xml:lang="en-US">Insurance contracts and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureNoncashTransactionsAbstract" xlink:label="afya_DisclosureNoncashTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureNoncashTransactionsAbstract" xlink:to="afya_DisclosureNoncashTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureNoncashTransactionsAbstract_lbl" xml:lang="en-US">Non-cash Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureNoncashTransactionsExplanatory" xlink:label="afya_DisclosureNoncashTransactionsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureNoncashTransactionsExplanatory" xlink:to="afya_DisclosureNoncashTransactionsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureNoncashTransactionsExplanatory_lbl" xml:lang="en-US">Non-cash transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US">Subsequent event</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BusinessCombinationsAndGoodwillPolicyExplanatory" xlink:label="afya_BusinessCombinationsAndGoodwillPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BusinessCombinationsAndGoodwillPolicyExplanatory" xlink:to="afya_BusinessCombinationsAndGoodwillPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BusinessCombinationsAndGoodwillPolicyExplanatory_lbl" xml:lang="en-US">Business combinations and goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" xlink:label="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" xlink:to="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory_lbl" xml:lang="en-US">Current versus non-current classification</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl" xml:lang="en-US">Fair value measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" xlink:label="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" xlink:to="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_lbl" xml:lang="en-US">Financial instruments - initial recognition and measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" xlink:label="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" xlink:to="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory_lbl" xml:lang="en-US">Impairment of non-financial assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory" xlink:label="afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory" xlink:to="afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory_lbl" xml:lang="en-US">Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersPolicyExplanatory" xlink:label="afya_AccountsPayableToSellingShareholdersPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersPolicyExplanatory" xlink:to="afya_AccountsPayableToSellingShareholdersPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AccountsPayableToSellingShareholdersPolicyExplanatory_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xml:lang="en-US">Provisions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DividendsPolicyExplanatory" xlink:label="afya_DividendsPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsPolicyExplanatory" xlink:to="afya_DividendsPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendsPolicyExplanatory_lbl" xml:lang="en-US">Dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaborAndSocialObligationsPolicyExplanatory" xlink:label="afya_LaborAndSocialObligationsPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsPolicyExplanatory" xlink:to="afya_LaborAndSocialObligationsPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LaborAndSocialObligationsPolicyExplanatory_lbl" xml:lang="en-US">Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SharebasedPaymentsPolicyExplanatory" xlink:label="afya_SharebasedPaymentsPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharebasedPaymentsPolicyExplanatory" xlink:to="afya_SharebasedPaymentsPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SharebasedPaymentsPolicyExplanatory_lbl" xml:lang="en-US">Share-based payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl" xml:lang="en-US">Revenue from contracts with customers</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxesPolicyExplanation" xlink:label="afya_TaxesPolicyExplanation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesPolicyExplanation" xlink:to="afya_TaxesPolicyExplanation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxesPolicyExplanation_lbl" xml:lang="en-US">Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTreasurySharesExplanatory" xlink:label="ifrs-full_DisclosureOfTreasurySharesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTreasurySharesExplanatory" xlink:to="ifrs-full_DisclosureOfTreasurySharesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfTreasurySharesExplanatory_lbl" xml:lang="en-US">Treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" xlink:label="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" xlink:to="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_lbl" xml:lang="en-US">Schedule of Company&#8217;s subsidiaries and associate</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:label="afya_ScheduleOfEstimatedUsefulLivesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:to="afya_ScheduleOfEstimatedUsefulLivesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfEstimatedUsefulLivesTableTextBlock_lbl" xml:lang="en-US">Schedule of estimated useful lives of the assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" xlink:label="afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" xlink:to="afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_lbl" xml:lang="en-US">Schedule of changes in accounting policies and disclosures</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" xlink:label="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" xlink:to="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_lbl" xml:lang="en-US">Schedule of presents assets and liabilities information for the Company&#8217;s operating segments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_lbl" xml:lang="en-US">Schedule of statements of income for the Company&#8217;s operating segments</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">Schedule of fair values of the identifiable assets acquired and liabilities assumed acquisition in 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfAcquisitionOfDelReyExplanatory" xlink:label="afya_ScheduleOfAcquisitionOfDelReyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfDelReyExplanatory" xlink:to="afya_ScheduleOfAcquisitionOfDelReyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfDelReyExplanatory_lbl" xml:lang="en-US">Schedule of intangible assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock" xlink:label="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock" xlink:to="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock_lbl" xml:lang="en-US">Schedule of fair values of the identifiable assets acquired and liabilities assumed as of acquisition in 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory" xlink:label="afya_ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory" xlink:to="afya_ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory_lbl" xml:lang="en-US">Schedule of acquisition of al&#63;m da medicina intangible assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfAcquisitionOfCardioPapersExplanatory" xlink:label="afya_ScheduleOfAcquisitionOfCardioPapersExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfCardioPapersExplanatory" xlink:to="afya_ScheduleOfAcquisitionOfCardioPapersExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfCardioPapersExplanatory_lbl" xml:lang="en-US">Schedule of acquisition of cardio papers intangible assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfAcquisitionOfGlicExplanatory" xlink:label="afya_ScheduleOfAcquisitionOfGlicExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfGlicExplanatory" xlink:to="afya_ScheduleOfAcquisitionOfGlicExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfGlicExplanatory_lbl" xml:lang="en-US">Schedule of acquisition of Glic intangible assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:to="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_lbl" xml:lang="en-US">Schedule of cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfTradeAndOtherReceivables1Explanatory" xlink:label="afya_DisclosureOfTradeAndOtherReceivables1Explanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfTradeAndOtherReceivables1Explanatory" xlink:to="afya_DisclosureOfTradeAndOtherReceivables1Explanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfTradeAndOtherReceivables1Explanatory_lbl" xml:lang="en-US">Schedule of trade accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" xlink:label="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" xlink:to="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory_lbl" xml:lang="en-US">Schedule of aging of trade accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory" xlink:label="afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory" xlink:to="afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory_lbl" xml:lang="en-US">Schedule of allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfRelatedPartiesExplanatory" xlink:label="afya_DisclosureOfRelatedPartiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfRelatedPartiesExplanatory" xlink:to="afya_DisclosureOfRelatedPartiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfRelatedPartiesExplanatory_lbl" xml:lang="en-US">Schedule of balances and transactions with related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" xlink:label="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" xlink:to="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock_lbl" xml:lang="en-US">Schedule of key management personnel compensation included in the Company's consolidated statement of income</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfOtherAssetsTableTextBlock" xlink:label="afya_DisclosureOfOtherAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfOtherAssetsTableTextBlock" xlink:to="afya_DisclosureOfOtherAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfOtherAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfInvestmentsExplanatory" xlink:label="afya_DisclosureOfInvestmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfInvestmentsExplanatory" xlink:to="afya_DisclosureOfInvestmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfInvestmentsExplanatory_lbl" xml:lang="en-US">Schedule of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Schedule of detailed information about property, plant and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfIntangibleAssetsTableTextBlock" xlink:label="afya_SummaryOfIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfIntangibleAssetsTableTextBlock" xlink:to="afya_SummaryOfIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" xlink:label="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" xlink:to="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_lbl" xml:lang="en-US">Schedule of assumptions for impairment test</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" xlink:label="afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" xlink:to="afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of estimated useful lives of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialAssetsExplanatory" xlink:label="afya_FinancialAssetsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialAssetsExplanatory" xlink:to="afya_FinancialAssetsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialAssetsExplanatory_lbl" xml:lang="en-US">Schedule of financial assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialLiabilitiesExplanatory" xlink:label="afya_FinancialLiabilitiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialLiabilitiesExplanatory" xlink:to="afya_FinancialLiabilitiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialLiabilitiesExplanatory_lbl" xml:lang="en-US">Schedule of financial liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingExplanatory" xlink:label="afya_LoansAndFinancingExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingExplanatory" xlink:to="afya_LoansAndFinancingExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingExplanatory_lbl" xml:lang="en-US">Schedule of loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfLeasesExplanatory" xlink:label="afya_ScheduleOfLeasesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfLeasesExplanatory" xlink:to="afya_ScheduleOfLeasesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfLeasesExplanatory_lbl" xml:lang="en-US">Schedule of right-of-use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersExplanatory" xlink:label="afya_AccountsPayableToSellingShareholdersExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersExplanatory" xlink:to="afya_AccountsPayableToSellingShareholdersExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersExplanatory_lbl" xml:lang="en-US">Schedule of accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholders1Explanatory" xlink:label="afya_AccountsPayableToSellingShareholders1Explanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholders1Explanatory" xlink:to="afya_AccountsPayableToSellingShareholders1Explanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholders1Explanatory_lbl" xml:lang="en-US">Schedule of accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock" xlink:label="afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock" xlink:to="afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_lbl" xml:lang="en-US">Schedule of carrying amount of notes payable and the movements</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfFairValuesExplanatory" xlink:label="afya_ScheduleOfFairValuesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFairValuesExplanatory" xlink:to="afya_ScheduleOfFairValuesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFairValuesExplanatory_lbl" xml:lang="en-US">Schedule of fair values of the company's financial instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" xlink:label="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" xlink:to="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_lbl" xml:lang="en-US">Schedule of income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" xlink:label="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" xlink:to="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_lbl" xml:lang="en-US">Schedule of sensitivity foreign currency</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" xlink:label="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" xlink:to="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of maturity profile of financial liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:label="afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:to="afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl" xml:lang="en-US">Schedule of changes in liabilities arising from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfFairValueMeasurementExplanaory" xlink:label="afya_ScheduleOfFairValueMeasurementExplanaory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFairValueMeasurementExplanaory" xlink:to="afya_ScheduleOfFairValueMeasurementExplanaory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFairValueMeasurementExplanaory_lbl" xml:lang="en-US">Schedule of fair value measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable_lbl" xml:lang="en-US">Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions" xlink:label="afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions" xlink:to="afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions_lbl" xml:lang="en-US">Schedule of model used to determine the fair value of the stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions" xlink:label="afya_ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions" xlink:to="afya_ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions_lbl" xml:lang="en-US">Schedule of model used to determine incremental fair value of the stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfAdditionalStockOptionsExplanatory" xlink:label="afya_ScheduleOfAdditionalStockOptionsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAdditionalStockOptionsExplanatory" xlink:to="afya_ScheduleOfAdditionalStockOptionsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAdditionalStockOptionsExplanatory_lbl" xml:lang="en-US">Schedule of additional stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfSharebasedCompensationPlanExplanatory" xlink:label="afya_ScheduleOfSharebasedCompensationPlanExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfSharebasedCompensationPlanExplanatory" xlink:to="afya_ScheduleOfSharebasedCompensationPlanExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfSharebasedCompensationPlanExplanatory_lbl" xml:lang="en-US">Schedule of share-based compensation plan</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfStockOptionExplanatory" xlink:label="afya_ScheduleOfStockOptionExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfStockOptionExplanatory" xlink:to="afya_ScheduleOfStockOptionExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfStockOptionExplanatory_lbl" xml:lang="en-US">Schedule of stock option</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfTreasurySharesMovementExplanatory" xlink:label="afya_ScheduleOfTreasurySharesMovementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfTreasurySharesMovementExplanatory" xlink:to="afya_ScheduleOfTreasurySharesMovementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfTreasurySharesMovementExplanatory_lbl" xml:lang="en-US">Schedule illustrates the number and movements in treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfEarningsPerShareTableExplanatory" xlink:label="afya_DisclosureOfEarningsPerShareTableExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfEarningsPerShareTableExplanatory" xlink:to="afya_DisclosureOfEarningsPerShareTableExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfEarningsPerShareTableExplanatory_lbl" xml:lang="en-US">Schedule of earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfNetSalesRevenueExplanatory" xlink:label="afya_ScheduleOfNetSalesRevenueExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfNetSalesRevenueExplanatory" xlink:to="afya_ScheduleOfNetSalesRevenueExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfNetSalesRevenueExplanatory_lbl" xml:lang="en-US">Schedule of net sales revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfRevenueBySegmentTableTextBlock" xlink:label="afya_ScheduleOfRevenueBySegmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfRevenueBySegmentTableTextBlock" xlink:to="afya_ScheduleOfRevenueBySegmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfRevenueBySegmentTableTextBlock_lbl" xml:lang="en-US">Schedule of revenue by segment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfExpensesByNatureTableTextBlock" xlink:label="afya_SummaryOfExpensesByNatureTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfExpensesByNatureTableTextBlock" xlink:to="afya_SummaryOfExpensesByNatureTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfExpensesByNatureTableTextBlock_lbl" xml:lang="en-US">Schedule of expenses by nature</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfFinanceResultTableTextBlock" xlink:label="afya_ScheduleOfFinanceResultTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFinanceResultTableTextBlock" xlink:to="afya_ScheduleOfFinanceResultTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFinanceResultTableTextBlock_lbl" xml:lang="en-US">Schedule of finance result</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" xlink:label="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" xlink:to="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_lbl" xml:lang="en-US">Schedule of reconciliation of income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfLegalProceedingsAndContingencies" xlink:label="afya_ScheduleOfLegalProceedingsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfLegalProceedingsAndContingencies" xlink:to="afya_ScheduleOfLegalProceedingsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfLegalProceedingsAndContingencies_lbl" xml:lang="en-US">Schedule of legal proceedings and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement" xlink:label="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement" xlink:to="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement_lbl" xml:lang="en-US">Schedule of social security proceedings assessed by Management</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NonCashTransactionsTableTextBlock" xlink:label="afya_NonCashTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NonCashTransactionsTableTextBlock" xlink:to="afya_NonCashTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NonCashTransactionsTableTextBlock_lbl" xml:lang="en-US">Schedule of non-cash transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_lbl" xml:lang="en-US">Disclosure of transactions between related parties [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquiredShares" xlink:label="afya_AcquiredShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AcquiredShares" xlink:to="afya_AcquiredShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AcquiredShares_lbl" xml:lang="en-US">Acquired shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl" xml:lang="en-US">Own percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl" xml:lang="en-US">Voting interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="ifrs-full_ConsiderationPaidReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConsiderationPaidReceived" xlink:to="ifrs-full_ConsiderationPaidReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConsiderationPaidReceived_lbl" xml:lang="en-US">Aggregate consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_lbl" xml:lang="en-US">Disclosure of subsidiaries [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PrincipalActivities" xlink:label="afya_PrincipalActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PrincipalActivities" xlink:to="afya_PrincipalActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PrincipalActivities_lbl" xml:lang="en-US">Principal activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:to="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_lbl" xml:lang="en-US">Location</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InvestmentType" xlink:label="afya_InvestmentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InvestmentType" xlink:to="afya_InvestmentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InvestmentType_lbl" xml:lang="en-US">Investment type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:to="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_lbl" xml:lang="en-US">Direct and indirect interest of subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xml:lang="en-US">Useful lives of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TitleOfInitiallyAppliedIFRS" xlink:label="ifrs-full_TitleOfInitiallyAppliedIFRS" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TitleOfInitiallyAppliedIFRS" xlink:to="ifrs-full_TitleOfInitiallyAppliedIFRS_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TitleOfInitiallyAppliedIFRS_lbl" xml:lang="en-US">Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:label="ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:to="ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy_lbl" xml:lang="en-US">Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_lbl" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ApplicableTaxRate" xlink:label="ifrs-full_ApplicableTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ApplicableTaxRate_lbl" xml:lang="en-US">Tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable_lbl" xml:lang="en-US">Disclosure of operating segments [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Assets_2_lbl" xml:lang="en-US">Total assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentAssets_2_lbl" xml:lang="en-US">Current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentAssets_2_lbl" xml:lang="en-US">Non-current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAndLiabilities_2_lbl" xml:lang="en-US">Total liabilities and equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentLiabilities_2_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentLiabilities_2_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Equity_4_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="ifrs-full_InvestmentsInAssociates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInAssociates" xlink:to="ifrs-full_InvestmentsInAssociates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentsInAssociates_lbl" xml:lang="en-US">Investments in associate</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CapitalExpenditures" xlink:label="afya_CapitalExpenditures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CapitalExpenditures" xlink:to="afya_CapitalExpenditures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CapitalExpenditures_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DepositsFromExternalCustomer" xlink:label="afya_DepositsFromExternalCustomer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DepositsFromExternalCustomer" xlink:to="afya_DepositsFromExternalCustomer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DepositsFromExternalCustomer_lbl" xml:lang="en-US">External customer</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InterSegment" xlink:label="afya_InterSegment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InterSegment" xlink:to="afya_InterSegment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InterSegment_lbl" xml:lang="en-US">Inter-segment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Revenue_2_lbl" xml:lang="en-US">Net revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CostOfSale" xlink:label="afya_CostOfSale" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CostOfSale" xlink:to="afya_CostOfSale_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CostOfSale_lbl" xml:lang="en-US">Cost of services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossProfit_2_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherGainsLosses" xlink:label="ifrs-full_OtherGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherGainsLosses" xlink:to="ifrs-full_OtherGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherGainsLosses_lbl" xml:lang="en-US">Other expenses, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_2_lbl" xml:lang="en-US">Operating income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncome" xlink:to="ifrs-full_FinanceIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinanceIncome_2_lbl" xml:lang="en-US">Finance income</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinanceExpense" xlink:label="afya_FinanceExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinanceExpense" xlink:to="afya_FinanceExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinanceExpense_lbl" xml:lang="en-US">Finance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xml:lang="en-US">Share of income of associate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossBeforeTax_2_lbl" xml:lang="en-US">Income before income taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_2_lbl" xml:lang="en-US">Income taxes expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Cash and cash and equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeReceivablesAsOfAcquisitionDate" xlink:label="afya_TradeReceivablesAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeReceivablesAsOfAcquisitionDate" xlink:to="afya_TradeReceivablesAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TradeReceivablesAsOfAcquisitionDate_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Inventories1" xlink:label="afya_Inventories1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Inventories1" xlink:to="afya_Inventories1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_Inventories1_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RecoverableTaxesAsOfAcquisitionDate" xlink:label="afya_RecoverableTaxesAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RecoverableTaxesAsOfAcquisitionDate" xlink:to="afya_RecoverableTaxesAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_RecoverableTaxesAsOfAcquisitionDate_lbl" xml:lang="en-US">Recoverable taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssetsAsOfAcquisitionDate" xlink:label="afya_OtherAssetsAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssetsAsOfAcquisitionDate" xlink:to="afya_OtherAssetsAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherAssetsAsOfAcquisitionDate_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="afya_RightOfUseAssetsAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:to="afya_RightOfUseAssetsAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_RightOfUseAssetsAsOfAcquisitionDate_lbl" xml:lang="en-US">Right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:label="afya_LeaseLiabilitiesAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:to="afya_LeaseLiabilitiesAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LeaseLiabilitiesAsOfAcquisitionDate_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:label="afya_LaborAndSocialObligationsAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:to="afya_LaborAndSocialObligationsAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LaborAndSocialObligationsAsOfAcquisitionDate_lbl" xml:lang="en-US">Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxesPayableAsOfAcquisitionDate" xlink:label="afya_TaxesPayableAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesPayableAsOfAcquisitionDate" xlink:to="afya_TaxesPayableAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxesPayableAsOfAcquisitionDate_lbl" xml:lang="en-US">Taxes and contributions payable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:label="afya_AdvancesFromCustomersAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:to="afya_AdvancesFromCustomersAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AdvancesFromCustomersAsOfAcquisitionDate_lbl" xml:lang="en-US">Advances from customers</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:label="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:to="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate_lbl" xml:lang="en-US">Provision for legal proceedings</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:label="afya_OtherLiabilitiesAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:to="afya_OtherLiabilitiesAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherLiabilitiesAsOfAcquisitionDate_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Financial liabilities recognised as of acquisition date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Total identifiable net assets at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Goodwill arising on acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl" xml:lang="en-US">Purchase consideration transferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashTransferred" xlink:label="ifrs-full_CashTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashTransferred" xlink:to="ifrs-full_CashTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashTransferred_lbl" xml:lang="en-US">Cash paid</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ConsiderationToBeTransferred" xlink:label="afya_ConsiderationToBeTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ConsiderationToBeTransferred" xlink:to="afya_ConsiderationToBeTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ConsiderationToBeTransferred_lbl" xml:lang="en-US">Consideration to be transferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CirculationRevenue" xlink:label="ifrs-full_CirculationRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CirculationRevenue" xlink:to="ifrs-full_CirculationRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CirculationRevenue_lbl" xml:lang="en-US">Digital solutions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:to="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl" xml:lang="en-US">Transaction costs of the acquisition (included in cash flows from operating activities)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:to="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_lbl" xml:lang="en-US">Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NetOfCashFlowOnAcquisition" xlink:label="afya_NetOfCashFlowOnAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NetOfCashFlowOnAcquisition" xlink:to="afya_NetOfCashFlowOnAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NetOfCashFlowOnAcquisition_lbl" xml:lang="en-US">Net of cash flow on acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:to="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_lbl" xml:lang="en-US">Valuation technique</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssetsAsOfAcquisitionDate" xlink:to="afya_OtherAssetsAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherAssetsAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Property, plant and equipment recognised as of acquisition date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Property, plant and equipment recognised as of acquisition date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Identifiable intangible assets recognised as of acquisition date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Trade and other payables recognised as of acquisition date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:to="afya_LaborAndSocialObligationsAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaborAndSocialObligationsAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Labor And Social Obligations As Of Acquisition Date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesPayableAsOfAcquisitionDate" xlink:to="afya_TaxesPayableAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TaxesPayableAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Taxes Payable As Of Acquisition Date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:to="afya_AdvancesFromCustomersAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdvancesFromCustomersAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Advances From Customers As Of Acquisition Date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:to="afya_OtherLiabilitiesAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherLiabilitiesAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Other Liabilities As Of Acquisition Date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Indemnification assets recognised as of acquisition date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Goodwill recognised as of acquisition date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_2_lbl" xml:lang="en-US">Consideration transferred, acquisition-date fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashTransferred" xlink:to="ifrs-full_CashTransferred_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashTransferred_2_lbl" xml:lang="en-US">Cash transferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Contingent consideration recognised as of acquisition date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ConsiderationToBeTransferred" xlink:to="afya_ConsiderationToBeTransferred_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ConsiderationToBeTransferred_2_lbl" xml:lang="en-US">Consideration To Be Transferred</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:to="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_2_lbl" xml:lang="en-US">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:to="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_2_lbl" xml:lang="en-US">Cash and cash equivalents in subsidiary or businesses acquired or disposed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsTable_lbl" xml:lang="en-US">Disclosure of detailed information about business combination [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_2_lbl" xml:lang="en-US">Acquired share capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAcquiree" xlink:label="ifrs-full_DescriptionOfAcquiree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAcquiree" xlink:to="ifrs-full_DescriptionOfAcquiree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAcquiree_lbl" xml:lang="en-US">Acquired purchase price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:to="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_3_lbl" xml:lang="en-US">Transaction costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_3_lbl" xml:lang="en-US">Income loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseInRevenue" xlink:label="afya_IncreaseInRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseInRevenue" xlink:to="afya_IncreaseInRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseInRevenue_lbl" xml:lang="en-US">Increase in revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseInIncomeBeforeIncomeTaxes" xlink:label="afya_IncreaseInIncomeBeforeIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseInIncomeBeforeIncomeTaxes" xlink:to="afya_IncreaseInIncomeBeforeIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseInIncomeBeforeIncomeTaxes_lbl" xml:lang="en-US">Increase in income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DecreaseInIncomeBeforeIncomeTaxes" xlink:label="afya_DecreaseInIncomeBeforeIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DecreaseInIncomeBeforeIncomeTaxes" xlink:to="afya_DecreaseInIncomeBeforeIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DecreaseInIncomeBeforeIncomeTaxes_lbl" xml:lang="en-US">Decrease in income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Cash" xlink:label="ifrs-full_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Cash" xlink:to="ifrs-full_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Cash_lbl" xml:lang="en-US">Cash and bank deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashEquivalents" xlink:label="ifrs-full_CashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashEquivalents" xlink:to="ifrs-full_CashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashEquivalents_lbl" xml:lang="en-US">Cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="ifrs-full_DisclosureOfFinancialAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsTable" xlink:to="ifrs-full_DisclosureOfFinancialAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsTable_lbl" xml:lang="en-US">Disclosure of financial assets [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PercenatgeOfAverageInterestOnFinancialInstrument" xlink:label="afya_PercenatgeOfAverageInterestOnFinancialInstrument" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PercenatgeOfAverageInterestOnFinancialInstrument" xlink:to="afya_PercenatgeOfAverageInterestOnFinancialInstrument_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PercenatgeOfAverageInterestOnFinancialInstrument_lbl" xml:lang="en-US">Percentage of average interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReceivablesGross" xlink:label="afya_ReceivablesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ReceivablesGross" xlink:to="afya_ReceivablesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ReceivablesGross_lbl" xml:lang="en-US">Trade receivables, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AllowanceForDoubtfulAccountsFoReceivable1" xlink:label="afya_AllowanceForDoubtfulAccountsFoReceivable1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForDoubtfulAccountsFoReceivable1" xlink:to="afya_AllowanceForDoubtfulAccountsFoReceivable1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AllowanceForDoubtfulAccountsFoReceivable1_lbl" xml:lang="en-US">(-) Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivables" xlink:label="ifrs-full_TradeReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeReceivables_lbl" xml:lang="en-US">Trade receivables, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentTradeReceivables_2_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="ifrs-full_NoncurrentTradeReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentTradeReceivables" xlink:to="ifrs-full_NoncurrentTradeReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentTradeReceivables_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:label="ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_lbl" xml:lang="en-US">Disclosure of financial assets that are either past due or impaired [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ReceivablesGross" xlink:to="afya_ReceivablesGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ReceivablesGross_2_lbl" xml:lang="en-US">Trade receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:to="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_lbl" xml:lang="en-US">Balances at the beginning of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" xlink:label="afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" xlink:to="afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" xlink:label="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" xlink:to="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_lbl" xml:lang="en-US">Write-offs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:to="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_2_lbl" xml:lang="en-US">Balances at the end of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeReceivablesRelatedPartyTransactions" xlink:label="afya_TradeReceivablesRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeReceivablesRelatedPartyTransactions" xlink:to="afya_TradeReceivablesRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeReceivablesRelatedPartyTransactions_lbl" xml:lang="en-US">Trade receivables (i)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssetsRelatedPartyTransactions" xlink:label="afya_OtherAssetsRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssetsRelatedPartyTransactions" xlink:to="afya_OtherAssetsRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherAssetsRelatedPartyTransactions_lbl" xml:lang="en-US">Other assets (ii)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="ifrs-full_AmountsReceivableRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsReceivableRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmountsReceivableRelatedPartyTransactions_lbl" xml:lang="en-US">&#160;Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeAndOtherCurrentPayablesToRelatedParties1" xlink:label="afya_TradeAndOtherCurrentPayablesToRelatedParties1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeAndOtherCurrentPayablesToRelatedParties1" xlink:to="afya_TradeAndOtherCurrentPayablesToRelatedParties1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeAndOtherCurrentPayablesToRelatedParties1_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentAssetsOfRelatedParty1" xlink:label="afya_NoncurrentAssetsOfRelatedParty1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentAssetsOfRelatedParty1" xlink:to="afya_NoncurrentAssetsOfRelatedParty1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentAssetsOfRelatedParty1_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholders" xlink:label="afya_AccountsPayableToSellingShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholders" xlink:to="afya_AccountsPayableToSellingShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholders_lbl" xml:lang="en-US">Accounts payable to selling shareholders (iii)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl" xml:lang="en-US">&#160;Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableCurrent1" xlink:label="afya_AccountsPayableCurrent1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableCurrent1" xlink:to="afya_AccountsPayableCurrent1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AccountsPayableCurrent1_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentPayablesToRelatedParties1" xlink:label="afya_NoncurrentPayablesToRelatedParties1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentPayablesToRelatedParties1" xlink:to="afya_NoncurrentPayablesToRelatedParties1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentPayablesToRelatedParties1_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherIncomeRelatedPartyTransactions" xlink:label="afya_OtherIncomeRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherIncomeRelatedPartyTransactions" xlink:to="afya_OtherIncomeRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherIncomeRelatedPartyTransactions_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeasesAsLesseeRelatedPartyTransactions" xlink:label="ifrs-full_LeasesAsLesseeRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeasesAsLesseeRelatedPartyTransactions" xlink:to="ifrs-full_LeasesAsLesseeRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeasesAsLesseeRelatedPartyTransactions_lbl" xml:lang="en-US">Lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xml:lang="en-US">Short-term employee benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US">Share-based compensation plans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:label="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:to="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OperatingLeaseTermOfContract" xlink:label="afya_OperatingLeaseTermOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OperatingLeaseTermOfContract" xlink:to="afya_OperatingLeaseTermOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OperatingLeaseTermOfContract_lbl" xml:lang="en-US">Lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="ifrs-full_PercentageOfEntitysRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfEntitysRevenue" xlink:to="ifrs-full_PercentageOfEntitysRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfEntitysRevenue_lbl" xml:lang="en-US">Percentage of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LesseeFinancesLeaseRenewalTerm" xlink:label="afya_LesseeFinancesLeaseRenewalTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LesseeFinancesLeaseRenewalTerm" xlink:to="afya_LesseeFinancesLeaseRenewalTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LesseeFinancesLeaseRenewalTerm_lbl" xml:lang="en-US">Renewal term</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DescriptionOfLeaseTerm" xlink:label="afya_DescriptionOfLeaseTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DescriptionOfLeaseTerm" xlink:to="afya_DescriptionOfLeaseTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DescriptionOfLeaseTerm_lbl" xml:lang="en-US">Description of lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashOutflowForLeases" xlink:label="ifrs-full_CashOutflowForLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashOutflowForLeases" xlink:to="ifrs-full_CashOutflowForLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashOutflowForLeases_lbl" xml:lang="en-US">Lease expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DescriptionOfLeaseTerms" xlink:label="afya_DescriptionOfLeaseTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DescriptionOfLeaseTerms" xlink:to="afya_DescriptionOfLeaseTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DescriptionOfLeaseTerms_lbl" xml:lang="en-US">Description of lease term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_3_lbl" xml:lang="en-US">Indemnification assets (i)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Advances1" xlink:label="afya_Advances1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Advances1" xlink:to="afya_Advances1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Advances1_lbl" xml:lang="en-US">Advances</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_JudicialDeposits" xlink:label="afya_JudicialDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_JudicialDeposits" xlink:to="afya_JudicialDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_JudicialDeposits_lbl" xml:lang="en-US">Judicial deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaidExpenses" xlink:to="ifrs-full_CurrentPrepaidExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepaidExpenses_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherReceivables" xlink:label="ifrs-full_OtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReceivables" xlink:to="ifrs-full_OtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherReceivables_lbl" xml:lang="en-US">Other FIES receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Dividend" xlink:label="afya_Dividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Dividend" xlink:to="afya_Dividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_Dividend_lbl" xml:lang="en-US">Dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxAssets_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssets1" xlink:label="afya_OtherAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssets1" xlink:to="afya_OtherAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherAssets1_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Assets1" xlink:label="afya_Assets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Assets1" xlink:to="afya_Assets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="afya_Assets1_lbl" xml:lang="en-US">&#160;Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CurrentAssets1" xlink:label="afya_CurrentAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentAssets1" xlink:to="afya_CurrentAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_CurrentAssets1_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentAssets1" xlink:label="afya_NoncurrentAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentAssets1" xlink:to="afya_NoncurrentAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentAssets1_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAsset" xlink:label="afya_OtherAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAsset" xlink:to="afya_OtherAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherAsset_lbl" xml:lang="en-US">Other assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CurrentLiabilities_3_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NoncurrentLiabilities_3_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EquityInAssociate" xlink:label="afya_EquityInAssociate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EquityInAssociate" xlink:to="afya_EquityInAssociate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_EquityInAssociate_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CompanyShareInEquity1" xlink:label="afya_CompanyShareInEquity1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CompanyShareInEquity1" xlink:to="afya_CompanyShareInEquity1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CompanyShareInEquity1_lbl" xml:lang="en-US">Company&#8217;s share in equity - 30%</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Goodwill" xlink:label="ifrs-full_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Goodwill" xlink:to="ifrs-full_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InvestmentGrossAmount" xlink:label="afya_InvestmentGrossAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InvestmentGrossAmount" xlink:to="afya_InvestmentGrossAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InvestmentGrossAmount_lbl" xml:lang="en-US">Carrying amount of the investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncome" xlink:to="ifrs-full_FinanceIncome_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_FinanceIncome_3_lbl" xml:lang="en-US">Finance results</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CompanyShareOfProfitss" xlink:label="afya_CompanyShareOfProfitss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CompanyShareOfProfitss" xlink:to="afya_CompanyShareOfProfitss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CompanyShareOfProfitss_lbl" xml:lang="en-US">Company&#8217;s share of income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInAssociates" xlink:to="ifrs-full_InvestmentsInAssociates_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_InvestmentsInAssociates_2_lbl" xml:lang="en-US">Opening balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DividendsReceived1" xlink:label="afya_DividendsReceived1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsReceived1" xlink:to="afya_DividendsReceived1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="afya_DividendsReceived1_lbl" xml:lang="en-US">Dividends received</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsReceived" xlink:to="ifrs-full_DividendsReceived_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DividendsReceived_2_lbl" xml:lang="en-US">Dividends receivable (included in Other assets)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="ifrs-full_ProfitLossOfAcquiree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossOfAcquiree" xlink:to="ifrs-full_ProfitLossOfAcquiree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossOfAcquiree_lbl" xml:lang="en-US">Share of income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInAssociates" xlink:to="ifrs-full_InvestmentsInAssociates_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_InvestmentsInAssociates_3_lbl" xml:lang="en-US">Closing balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_lbl" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PropertyPlantAndEquipments" xlink:label="afya_PropertyPlantAndEquipments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PropertyPlantAndEquipments" xlink:to="afya_PropertyPlantAndEquipments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="afya_PropertyPlantAndEquipments_lbl" xml:lang="en-US">As of December 31, 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WritOffOfPropertyPlantAndEquipment" xlink:label="afya_WritOffOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WritOffOfPropertyPlantAndEquipment" xlink:to="afya_WritOffOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WritOffOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Write-off (i)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Transfer</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PropertyPlantAndEquipments" xlink:to="afya_PropertyPlantAndEquipments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="afya_PropertyPlantAndEquipments_2_lbl" xml:lang="en-US">As of December 31, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PropertyPlantAndEquipmentNetBookValue" xlink:label="afya_PropertyPlantAndEquipmentNetBookValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PropertyPlantAndEquipmentNetBookValue" xlink:to="afya_PropertyPlantAndEquipmentNetBookValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PropertyPlantAndEquipmentNetBookValue_lbl" xml:lang="en-US">Net book value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_lbl" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="ifrs-full_IntangibleAssetsAndGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsAndGoodwill" xlink:to="ifrs-full_IntangibleAssetsAndGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_IntangibleAssetsAndGoodwill_lbl" xml:lang="en-US">Intangible assets and goodwill, balance at beginnning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WriteoffOfIntangibleAssets" xlink:to="afya_WriteoffOfIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_WriteoffOfIntangibleAssets_2_lbl" xml:lang="en-US">Write-off</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl" xml:lang="en-US">Business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Remesurement" xlink:label="afya_Remesurement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Remesurement" xlink:to="afya_Remesurement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Remesurement_lbl" xml:lang="en-US">Remesurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Transfer" xlink:label="afya_Transfer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Transfer" xlink:to="afya_Transfer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Transfer_lbl" xml:lang="en-US">Transfer amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsAndGoodwill" xlink:to="ifrs-full_IntangibleAssetsAndGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_IntangibleAssetsAndGoodwill_2_lbl" xml:lang="en-US">Intangible assets and goodwill, balance at end</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IntangibleAssetsAndGoodwillNetBookValue" xlink:label="afya_IntangibleAssetsAndGoodwillNetBookValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IntangibleAssetsAndGoodwillNetBookValue" xlink:to="afya_IntangibleAssetsAndGoodwillNetBookValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_IntangibleAssetsAndGoodwillNetBookValue_lbl" xml:lang="en-US">Net book value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:to="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_lbl" xml:lang="en-US">Licenses with indefinite useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CashGeneratingUnits" xlink:label="afya_CashGeneratingUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CashGeneratingUnits" xlink:to="afya_CashGeneratingUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CashGeneratingUnits_lbl" xml:lang="en-US">Cash generating units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Estimated useful lives of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_lbl" xml:lang="en-US">Disclosure of detailed information about borrowings [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl" xml:lang="en-US">Discount rate applied to cash flow projections</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExplicitProjectionPeriod" xlink:label="afya_ExplicitProjectionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ExplicitProjectionPeriod" xlink:to="afya_ExplicitProjectionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ExplicitProjectionPeriod_lbl" xml:lang="en-US">Explicit projection period</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PerpetuityGrowthRate" xlink:label="afya_PerpetuityGrowthRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PerpetuityGrowthRate" xlink:to="afya_PerpetuityGrowthRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PerpetuityGrowthRate_lbl" xml:lang="en-US">Growth rates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:label="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:to="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_lbl" xml:lang="en-US">Description of key assumptions on which management has based cash flow projections</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeReceivables_2_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssets" xlink:label="ifrs-full_FinancialAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialAssets_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialAssets" xlink:label="ifrs-full_CurrentFinancialAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssets" xlink:to="ifrs-full_CurrentFinancialAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentFinancialAssets_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="ifrs-full_NoncurrentFinancialAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentFinancialAssets_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesTable_lbl" xml:lang="en-US">Disclosure of financial liabilities [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancing" xlink:label="afya_LoansAndFinancing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancing" xlink:to="afya_LoansAndFinancing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoansAndFinancing_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilities" xlink:label="ifrs-full_LeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_LeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotePayable" xlink:label="afya_NotePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotePayable" xlink:to="afya_NotePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NotePayable_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialLiabilities_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="ifrs-full_CurrentFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilities" xlink:to="ifrs-full_CurrentFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentFinancialLiabilities_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="ifrs-full_NoncurrentFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilities" xlink:to="ifrs-full_NoncurrentFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentFinancialLiabilities_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_lbl" xml:lang="en-US">Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialInstitution" xlink:label="afya_FinancialInstitution" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialInstitution" xlink:to="afya_FinancialInstitution_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialInstitution_lbl" xml:lang="en-US">Financial institution</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="ifrs-full_BorrowingsInterestRateBasis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRateBasis" xlink:to="ifrs-full_BorrowingsInterestRateBasis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsInterestRateBasis_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsMaturity" xlink:label="ifrs-full_BorrowingsMaturity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsMaturity" xlink:to="ifrs-full_BorrowingsMaturity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsMaturity_lbl" xml:lang="en-US">Maturity</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingCurrent" xlink:label="afya_LoansAndFinancingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingCurrent" xlink:to="afya_LoansAndFinancingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoansAndFinancingCurrent_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingNonCurrent" xlink:label="afya_LoansAndFinancingNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingNonCurrent" xlink:to="afya_LoansAndFinancingNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoansAndFinancingNonCurrent_lbl" xml:lang="en-US">Non-current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_RightofuseAssets_2_lbl" xml:lang="en-US">Right-of-use assets, balance at beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_LeaseLiabilities_2_lbl" xml:lang="en-US">Lease liabilities, balance at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="ifrs-full_AdditionsToRightofuseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsToRightofuseAssets" xlink:to="ifrs-full_AdditionsToRightofuseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl" xml:lang="en-US">Right-of-use assets, additions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdditionsToLeaseLiabilities" xlink:label="afya_AdditionsToLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsToLeaseLiabilities" xlink:to="afya_AdditionsToLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsToLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities, additions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsRemeasurement" xlink:label="afya_RightofuseAssetsRemeasurement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsRemeasurement" xlink:to="afya_RightofuseAssetsRemeasurement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsRemeasurement_lbl" xml:lang="en-US">Right-of-use assets, remeasurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseLiabilitiesRemeasurement" xlink:label="afya_LeaseLiabilitiesRemeasurement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesRemeasurement" xlink:to="afya_LeaseLiabilitiesRemeasurement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesRemeasurement_lbl" xml:lang="en-US">Lease liabilities, remeasurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsBusinessCombinations" xlink:label="afya_RightofuseAssetsBusinessCombinations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsBusinessCombinations" xlink:to="afya_RightofuseAssetsBusinessCombinations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsBusinessCombinations_lbl" xml:lang="en-US">Right-of-use assets, business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BusinessCombinationsLeaseLiabilities" xlink:label="afya_BusinessCombinationsLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BusinessCombinationsLeaseLiabilities" xlink:to="afya_BusinessCombinationsLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BusinessCombinationsLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities, business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRightofuseAssets" xlink:to="ifrs-full_DepreciationRightofuseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US">Right-of-use assets, depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DepreciationExpenseLeaseLiabilities" xlink:label="afya_DepreciationExpenseLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DepreciationExpenseLeaseLiabilities" xlink:to="afya_DepreciationExpenseLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DepreciationExpenseLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities, depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsInterestExpense" xlink:label="afya_RightofuseAssetsInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsInterestExpense" xlink:to="afya_RightofuseAssetsInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsInterestExpense_lbl" xml:lang="en-US">Right-of-use assets, interest expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_2_lbl" xml:lang="en-US">Lease liabilities, interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsPaymentsOfLeaseLiabilities" xlink:label="afya_RightofuseAssetsPaymentsOfLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsPaymentsOfLeaseLiabilities" xlink:to="afya_RightofuseAssetsPaymentsOfLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsPaymentsOfLeaseLiabilities_lbl" xml:lang="en-US">Right-of-use assets, payments of lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" xlink:label="afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" xlink:to="afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_lbl" xml:lang="en-US">Lease liabilities, payments of lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsPaymentsOfInterest" xlink:label="afya_RightofuseAssetsPaymentsOfInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsPaymentsOfInterest" xlink:to="afya_RightofuseAssetsPaymentsOfInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsPaymentsOfInterest_lbl" xml:lang="en-US">Right-of-use assets, payments of interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentsOfInterestLeaseLiabilities" xlink:label="afya_PaymentsOfInterestLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfInterestLeaseLiabilities" xlink:to="afya_PaymentsOfInterestLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaymentsOfInterestLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities, payments of interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsWriteoff" xlink:label="afya_RightofuseAssetsWriteoff" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsWriteoff" xlink:to="afya_RightofuseAssetsWriteoff_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsWriteoff_lbl" xml:lang="en-US">Right-of-use assets, Write-off</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseLiabilitiesWriteoff" xlink:label="afya_LeaseLiabilitiesWriteoff" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesWriteoff" xlink:to="afya_LeaseLiabilitiesWriteoff_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesWriteoff_lbl" xml:lang="en-US">Lease liabilities, Write-off</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_RightofuseAssets_3_lbl" xml:lang="en-US">Right-of-use assets, balance at ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_LeaseLiabilities_3_lbl" xml:lang="en-US">Lease liabilities, balance at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsCurrent" xlink:label="afya_RightofuseAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsCurrent" xlink:to="afya_RightofuseAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsCurrent_lbl" xml:lang="en-US">Right-of-use assets, current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentLeaseLiabilities_2_lbl" xml:lang="en-US">Lease liabilities, current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsNonCurrent" xlink:label="afya_RightofuseAssetsNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsNonCurrent" xlink:to="afya_RightofuseAssetsNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsNonCurrent_lbl" xml:lang="en-US">Right-of-use assets, non-current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_2_lbl" xml:lang="en-US">Lease liabilities, non-current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties_2_lbl" xml:lang="en-US">Opening balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersCurrent" xlink:label="afya_AccountsPayableToSellingShareholdersCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AccountsPayableToSellingShareholdersCurrent_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:label="afya_AccountsPayableToSellingShareholdersNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AccountsPayableToSellingShareholdersNonCurrent_lbl" xml:lang="en-US">Non-current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties_3_lbl" xml:lang="en-US">Opening balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholderCashFlows" xlink:label="afya_AccountsPayableToSellingShareholderCashFlows" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholderCashFlows" xlink:to="afya_AccountsPayableToSellingShareholderCashFlows_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholderCashFlows_lbl" xml:lang="en-US">Cash flows payments and deductions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Payment of interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" xlink:label="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" xlink:to="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec_lbl" xml:lang="en-US">Acquisition of licenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpense" xlink:label="ifrs-full_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpense" xlink:to="ifrs-full_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpense_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:label="afya_AccountsPayableToSellingShareholdersBusinessCombinations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:to="afya_AccountsPayableToSellingShareholdersBusinessCombinations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersBusinessCombinations_lbl" xml:lang="en-US">Additions consideration to be transferred on business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContingentConsiderationOnBusinessCombinations" xlink:label="afya_ContingentConsiderationOnBusinessCombinations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContingentConsiderationOnBusinessCombinations" xlink:to="afya_ContingentConsiderationOnBusinessCombinations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContingentConsiderationOnBusinessCombinations_lbl" xml:lang="en-US">Consideration to be transferred on business combinations (earn-outs)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Reversals" xlink:label="afya_Reversals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Reversals" xlink:to="afya_Reversals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Reversals_lbl" xml:lang="en-US">Reversals</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RemeasurementOfEarnouts" xlink:label="afya_RemeasurementOfEarnouts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RemeasurementOfEarnouts" xlink:to="afya_RemeasurementOfEarnouts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RemeasurementOfEarnouts_lbl" xml:lang="en-US">Remeasurement of earn-outs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_2_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties_4_lbl" xml:lang="en-US">Closing balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotesPayables" xlink:label="afya_NotesPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayables" xlink:to="afya_NotesPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="afya_NotesPayables_lbl" xml:lang="en-US">Notes payable beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Payments" xlink:label="afya_Payments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Payments" xlink:to="afya_Payments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Payments_lbl" xml:lang="en-US">Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentsOfInterest" xlink:label="afya_PaymentsOfInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfInterest" xlink:to="afya_PaymentsOfInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaymentsOfInterest_lbl" xml:lang="en-US">Payments of interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MonetaryIndexation" xlink:label="afya_MonetaryIndexation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MonetaryIndexation" xlink:to="afya_MonetaryIndexation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MonetaryIndexation_lbl" xml:lang="en-US">Monetary indexation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayables" xlink:to="afya_NotesPayables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="afya_NotesPayables_2_lbl" xml:lang="en-US">Notes payable ending</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CurrentLiabilities1" xlink:label="afya_CurrentLiabilities1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentLiabilities1" xlink:to="afya_CurrentLiabilities1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_CurrentLiabilities1_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentLiabilities1" xlink:label="afya_NoncurrentLiabilities1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentLiabilities1" xlink:to="afya_NoncurrentLiabilities1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentLiabilities1_lbl" xml:lang="en-US">Non-current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssets_2_lbl" xml:lang="en-US">Financial assets, at carrying amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="ifrs-full_FinancialAssetsAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsAtFairValue" xlink:to="ifrs-full_FinancialAssetsAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsAtFairValue_lbl" xml:lang="en-US">Financial assets, at fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilities_2_lbl" xml:lang="en-US">Financial liabilities, at carrying amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue_lbl" xml:lang="en-US">Financial liabilities, at fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialAssets_3_lbl" xml:lang="en-US">Balance as of ending</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IndexRatePerYear" xlink:label="afya_IndexRatePerYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IndexRatePerYear" xlink:to="afya_IndexRatePerYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IndexRatePerYear_lbl" xml:lang="en-US">Index - % per year</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BaseRate" xlink:label="afya_BaseRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BaseRate" xlink:to="afya_BaseRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BaseRate_lbl" xml:lang="en-US">Base rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:to="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_lbl" xml:lang="en-US">Effect on profit before tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:to="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_lbl" xml:lang="en-US">Effect on profit before tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table_lbl" xml:lang="en-US">Disclosure of sensitivity analysis to changes in risk variables that arise from contracts within scope of IFRS 17 [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotePayables" xlink:label="afya_NotePayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotePayables" xlink:to="afya_NotePayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NotePayables_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Advances" xlink:label="ifrs-full_Advances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Advances" xlink:to="ifrs-full_Advances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Advances_lbl" xml:lang="en-US">Advances from customers</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialLiabilitiesContractualUndiscounted" xlink:label="afya_FinancialLiabilitiesContractualUndiscounted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialLiabilitiesContractualUndiscounted" xlink:to="afya_FinancialLiabilitiesContractualUndiscounted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialLiabilitiesContractualUndiscounted_lbl" xml:lang="en-US">Financial liabilities contractual undiscounted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_lbl" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Liabilities arising from financing activities, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Payments of principal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">Payments of interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Addition</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:label="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:to="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_2_lbl" xml:lang="en-US">Liabilities arising from financing activities, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContractualLeaseTerm" xlink:label="afya_ContractualLeaseTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContractualLeaseTerm" xlink:to="afya_ContractualLeaseTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContractualLeaseTerm_lbl" xml:lang="en-US">Contractual lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:to="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_lbl" xml:lang="en-US">Amount recognized lease expense from short-term leases and low-value assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:to="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_2_lbl" xml:lang="en-US">Ownership Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:label="afya_RemainingTradeAndOtherPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:to="afya_RemainingTradeAndOtherPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RemainingTradeAndOtherPayablesToRelatedParties_lbl" xml:lang="en-US">Remaining accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EqualInstallmentsPayablesToRelatedParties1" xlink:label="afya_EqualInstallmentsPayablesToRelatedParties1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EqualInstallmentsPayablesToRelatedParties1" xlink:to="afya_EqualInstallmentsPayablesToRelatedParties1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EqualInstallmentsPayablesToRelatedParties1_lbl" xml:lang="en-US">Equal installments payables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EqualInstallmentsPayablesToRelatedParties" xlink:label="afya_EqualInstallmentsPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EqualInstallmentsPayablesToRelatedParties" xlink:to="afya_EqualInstallmentsPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_EqualInstallmentsPayablesToRelatedParties_lbl" xml:lang="en-US">Equal installments payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xml:lang="en-US">Defined benefit obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xml:lang="en-US">Transaction price allocated to remaining performance obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" xlink:label="ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" xlink:to="ifrs-full_NoncurrentPayablesForPurchaseOfEnergy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentPayablesForPurchaseOfEnergy_lbl" xml:lang="en-US">Non-current payables for purchase of energy</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RemainingBalancePaid" xlink:label="afya_RemainingBalancePaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RemainingBalancePaid" xlink:to="afya_RemainingBalancePaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RemainingBalancePaid_lbl" xml:lang="en-US">Remaining balance paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConsiderationPaidReceived" xlink:to="ifrs-full_ConsiderationPaidReceived_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ConsiderationPaidReceived_2_lbl" xml:lang="en-US">Adjustment for purchase consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FirstAnnualInstallmentsPayable" xlink:label="afya_FirstAnnualInstallmentsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FirstAnnualInstallmentsPayable" xlink:to="afya_FirstAnnualInstallmentsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FirstAnnualInstallmentsPayable_lbl" xml:lang="en-US">First annual installment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SecondAnnualInstallmentsPayable" xlink:label="afya_SecondAnnualInstallmentsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SecondAnnualInstallmentsPayable" xlink:to="afya_SecondAnnualInstallmentsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SecondAnnualInstallmentsPayable_lbl" xml:lang="en-US">Second annual installment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ThirdAnnualInstallmentsPayable" xlink:label="afya_ThirdAnnualInstallmentsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ThirdAnnualInstallmentsPayable" xlink:to="afya_ThirdAnnualInstallmentsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ThirdAnnualInstallmentsPayable_lbl" xml:lang="en-US">Third annual installment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitiondateFairValueOfTotalConsiderationTransferred1" xlink:label="afya_AcquisitiondateFairValueOfTotalConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AcquisitiondateFairValueOfTotalConsiderationTransferred1" xlink:to="afya_AcquisitiondateFairValueOfTotalConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AcquisitiondateFairValueOfTotalConsiderationTransferred1_lbl" xml:lang="en-US">Fair value at the date of acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CreditExposure" xlink:label="ifrs-full_CreditExposure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CreditExposure" xlink:to="ifrs-full_CreditExposure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CreditExposure_lbl" xml:lang="en-US">Exposure risk</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SensitivityChangeInTheEuroExchangeRate" xlink:label="afya_SensitivityChangeInTheEuroExchangeRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SensitivityChangeInTheEuroExchangeRate" xlink:to="afya_SensitivityChangeInTheEuroExchangeRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SensitivityChangeInTheEuroExchangeRate_lbl" xml:lang="en-US">Percentage of sensitivity change in the Euro exchange rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClosingForeignExchangeRate" xlink:to="ifrs-full_ClosingForeignExchangeRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClosingForeignExchangeRate_lbl" xml:lang="en-US">Closing foreign exchange rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_lbl" xml:lang="en-US">Disclosure of fair value measurement of assets [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentTradeReceivables" xlink:to="ifrs-full_NoncurrentTradeReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentTradeReceivables_2_lbl" xml:lang="en-US">Trade receivable (non-current)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingLiabilities" xlink:label="afya_LoansAndFinancingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingLiabilities" xlink:to="afya_LoansAndFinancingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoansAndFinancingLiabilities_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseLiabilities1" xlink:label="afya_LeaseLiabilities1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilities1" xlink:to="afya_LeaseLiabilities1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LeaseLiabilities1_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" xlink:label="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" xlink:to="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FairValueNotesPayables1" xlink:label="afya_FairValueNotesPayables1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FairValueNotesPayables1" xlink:to="afya_FairValueNotesPayables1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_FairValueNotesPayables1_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGranted" xlink:label="afya_StrikePriceeAtMeasurementDateShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_StrikePriceeAtMeasurementDateShareOptionsGranted" xlink:to="afya_StrikePriceeAtMeasurementDateShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_StrikePriceeAtMeasurementDateShareOptionsGranted_lbl" xml:lang="en-US">Strike price at the measurement date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExpectedLifeOfStockOptions" xlink:label="afya_ExpectedLifeOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ExpectedLifeOfStockOptions" xlink:to="afya_ExpectedLifeOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ExpectedLifeOfStockOptions_lbl" xml:lang="en-US">Expected life of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:to="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted_lbl" xml:lang="en-US">Share price at the measurement date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted_lbl" xml:lang="en-US">Model used</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:to="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_lbl" xml:lang="en-US">Weighted average fair value at the measurement date</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGrante" xlink:label="afya_StrikePriceeAtMeasurementDateShareOptionsGrante" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_StrikePriceeAtMeasurementDateShareOptionsGrante" xlink:to="afya_StrikePriceeAtMeasurementDateShareOptionsGrante_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_StrikePriceeAtMeasurementDateShareOptionsGrante_lbl" xml:lang="en-US">Strike price at the measurement date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price (in Reais), Outstanding at the beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US">Number of stock options, Outstanding at the beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price (in Reais), Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of stock options, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price (in Reais), Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of stock options, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" xlink:label="afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" xlink:to="afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price (in Reais), Stock options exchanged</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:label="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:to="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of stock options, Stock options exchanged</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price (in Reais), Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of stock options, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price (in Reais), Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of stock options, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2_lbl" xml:lang="en-US">Weighted average exercise price (in Reais), Outstanding at the ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_2_lbl" xml:lang="en-US">Number of stock options, Outstanding at the ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price (in Reais), Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfStockOptionsExercisable" xlink:label="afya_NumberOfStockOptionsExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfStockOptionsExercisable" xlink:to="afya_NumberOfStockOptionsExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfStockOptionsExercisable_lbl" xml:lang="en-US">Number of stock options, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:to="ifrs-full_DisclosureOfDefinedBenefitPlansTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansTable_lbl" xml:lang="en-US">Disclosure of defined benefit plans [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:to="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Number of stock options, Stock options exchanged</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShareBasedCompensationOfEmployees" xlink:label="afya_ShareBasedCompensationOfEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShareBasedCompensationOfEmployees" xlink:to="afya_ShareBasedCompensationOfEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShareBasedCompensationOfEmployees_lbl" xml:lang="en-US">Compensation of employees</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_StrikePrice" xlink:label="afya_StrikePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_StrikePrice" xlink:to="afya_StrikePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_StrikePrice_lbl" xml:lang="en-US">Strike price</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AverageIncrementalFairValue" xlink:label="afya_AverageIncrementalFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AverageIncrementalFairValue" xlink:to="afya_AverageIncrementalFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AverageIncrementalFairValue_lbl" xml:lang="en-US">Average incremental fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Number of stock option granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xml:lang="en-US">Share-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:label="ifrs-full_ProportionOfOwnershipInterestInJointVenture" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:to="ifrs-full_ProportionOfOwnershipInterestInJointVenture_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestInJointVenture_lbl" xml:lang="en-US">Proportion percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" xlink:label="afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" xlink:to="afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xml:lang="en-US">Fair values at grant date</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SocialObligationsLiabilities" xlink:label="afya_SocialObligationsLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SocialObligationsLiabilities" xlink:to="afya_SocialObligationsLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SocialObligationsLiabilities_lbl" xml:lang="en-US">social obligations liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="ifrs-full_NumberOfSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl" xml:lang="en-US">Number of shares, Outstanding, at beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Average price, at beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfSharesRepurchased" xlink:label="afya_NumberOfSharesRepurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfSharesRepurchased" xlink:to="afya_NumberOfSharesRepurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfSharesRepurchased_lbl" xml:lang="en-US">Number of shares, Repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AveragePriceRepurchased" xlink:label="afya_AveragePriceRepurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AveragePriceRepurchased" xlink:to="afya_AveragePriceRepurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AveragePriceRepurchased_lbl" xml:lang="en-US">Average price repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" xlink:label="afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" xlink:to="afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_lbl" xml:lang="en-US">Number of treasury shares, delivered under the share-based compensation plan</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AveragePriceDeliveredUnderSharebasedCompensationPlan" xlink:label="afya_AveragePriceDeliveredUnderSharebasedCompensationPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AveragePriceDeliveredUnderSharebasedCompensationPlan" xlink:to="afya_AveragePriceDeliveredUnderSharebasedCompensationPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AveragePriceDeliveredUnderSharebasedCompensationPlan_lbl" xml:lang="en-US">Average price, delivered under the share-based compensation plan</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TransferredFromExerciseOfStockOptions" xlink:label="afya_TransferredFromExerciseOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TransferredFromExerciseOfStockOptions" xlink:to="afya_TransferredFromExerciseOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TransferredFromExerciseOfStockOptions_lbl" xml:lang="en-US">Number of shares, Transferred from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AveragePriceTransferredFromExerciseOfStockOptions" xlink:label="afya_AveragePriceTransferredFromExerciseOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AveragePriceTransferredFromExerciseOfStockOptions" xlink:to="afya_AveragePriceTransferredFromExerciseOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AveragePriceTransferredFromExerciseOfStockOptions_lbl" xml:lang="en-US">Average price transferred from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TransferredFromSharesContribution" xlink:label="afya_TransferredFromSharesContribution" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TransferredFromSharesContribution" xlink:to="afya_TransferredFromSharesContribution_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TransferredFromSharesContribution_lbl" xml:lang="en-US">Number of shares, Transferred from shares contribution</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AveragePriceTransferredFromSharesContribution" xlink:label="afya_AveragePriceTransferredFromSharesContribution" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AveragePriceTransferredFromSharesContribution" xlink:to="afya_AveragePriceTransferredFromSharesContribution_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AveragePriceTransferredFromSharesContribution_lbl" xml:lang="en-US">Average price transferred from shares contribution</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_2_lbl" xml:lang="en-US">Number of shares, Outstanding, at ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_2_lbl" xml:lang="en-US">Average price, at ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfSharesIssued1" xlink:label="afya_NumberOfSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfSharesIssued1" xlink:to="afya_NumberOfSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfSharesIssued1_lbl" xml:lang="en-US">Total number of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US">Total number of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IssuedCapitals" xlink:label="afya_IssuedCapitals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IssuedCapitals" xlink:to="afya_IssuedCapitals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IssuedCapitals_lbl" xml:lang="en-US">Authorized capital</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentOfDividends" xlink:label="afya_PaymentOfDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentOfDividends" xlink:to="afya_PaymentOfDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaymentOfDividends_lbl" xml:lang="en-US">Payment of dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DividendDistributed" xlink:label="afya_DividendDistributed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendDistributed" xlink:to="afya_DividendDistributed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendDistributed_lbl" xml:lang="en-US">Dividend distributed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:label="ifrs-full_DividendsPaidToNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:to="ifrs-full_DividendsPaidToNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaidToNoncontrollingInterests_lbl" xml:lang="en-US">Dividends paid to non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RepurchaseOfOrdinaryShares" xlink:label="afya_RepurchaseOfOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RepurchaseOfOrdinaryShares" xlink:to="afya_RepurchaseOfOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RepurchaseOfOrdinaryShares_lbl" xml:lang="en-US">Repurchase of ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CashOutflow" xlink:label="afya_CashOutflow" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CashOutflow" xlink:to="afya_CashOutflow_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CashOutflow_lbl" xml:lang="en-US">Cash outflow</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumeratorAbstract" xlink:label="afya_NumeratorAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumeratorAbstract" xlink:to="afya_NumeratorAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumeratorAbstract_lbl" xml:lang="en-US">Numerator</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:label="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:to="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends_lbl" xml:lang="en-US">Net income attributable to equity holders of the parent</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DenominatorAbstract" xlink:label="afya_DenominatorAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DenominatorAbstract" xlink:to="afya_DenominatorAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DenominatorAbstract_lbl" xml:lang="en-US">Denominator</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageShares" xlink:label="ifrs-full_WeightedAverageShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageShares_lbl" xml:lang="en-US">Weighted average number of outstanding shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:to="ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_lbl" xml:lang="en-US">Effects of dilution from stock options and restricted share units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="ifrs-full_AdjustedWeightedAverageShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl" xml:lang="en-US">Weighted average number of outstanding shares adjusted for the effect of dilution</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShare_2_lbl" xml:lang="en-US">Basic earnings per share (R$)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerShare_2_lbl" xml:lang="en-US">Diluted earnings per share (R$)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ProfessionalFeesExpenses" xlink:label="afya_ProfessionalFeesExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProfessionalFeesExpenses" xlink:to="afya_ProfessionalFeesExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProfessionalFeesExpenses_lbl" xml:lang="en-US">Tuition fees</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherRevenue1" xlink:label="afya_OtherRevenue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherRevenue1" xlink:to="afya_OtherRevenue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherRevenue1_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DeductionAbstract" xlink:label="afya_DeductionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionAbstract" xlink:to="afya_DeductionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionAbstract_lbl" xml:lang="en-US">Deductions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DeductionOfGrantedDiscounts" xlink:label="afya_DeductionOfGrantedDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfGrantedDiscounts" xlink:to="afya_DeductionOfGrantedDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfGrantedDiscounts_lbl" xml:lang="en-US">&#160;&#160;Discount and scholarships</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DeductionOfEarlyPaymentDiscounts" xlink:label="afya_DeductionOfEarlyPaymentDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfEarlyPaymentDiscounts" xlink:to="afya_DeductionOfEarlyPaymentDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfEarlyPaymentDiscounts_lbl" xml:lang="en-US">&#160;&#160;Early payment discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DeductionOfReturnsOfNetRevenue" xlink:label="afya_DeductionOfReturnsOfNetRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfReturnsOfNetRevenue" xlink:to="afya_DeductionOfReturnsOfNetRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfReturnsOfNetRevenue_lbl" xml:lang="en-US">&#160;&#160;Returns</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DeductionOfTaxes" xlink:label="afya_DeductionOfTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfTaxes" xlink:to="afya_DeductionOfTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfTaxes_lbl" xml:lang="en-US">&#160;&#160;Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DeductionOfProuni" xlink:label="afya_DeductionOfProuni" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfProuni" xlink:to="afya_DeductionOfProuni_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfProuni_lbl" xml:lang="en-US">&#160;&#160;PROUNI</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US">Revenue from contracts with customers</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" xlink:label="afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" xlink:to="afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_lbl" xml:lang="en-US">Timing of revenue recognition of revenue from contracts with customers:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FeeAndCommissionIncome" xlink:label="ifrs-full_FeeAndCommissionIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FeeAndCommissionIncome" xlink:to="ifrs-full_FeeAndCommissionIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FeeAndCommissionIncome_lbl" xml:lang="en-US">Tuition, digital content and app subscription fees - Transferred over time</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NetRevenueOtherTransferredPoint" xlink:label="afya_NetRevenueOtherTransferredPoint" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NetRevenueOtherTransferredPoint" xlink:to="afya_NetRevenueOtherTransferredPoint_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NetRevenueOtherTransferredPoint_lbl" xml:lang="en-US">Other - Transferred at a point in time</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_lbl" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="ifrs-full_PaymentsToSuppliersForGoodsAndServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:to="ifrs-full_PaymentsToSuppliersForGoodsAndServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsToSuppliersForGoodsAndServices_lbl" xml:lang="en-US">Types of services or goods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="ifrs-full_ProfessionalFeesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfessionalFeesExpense" xlink:to="ifrs-full_ProfessionalFeesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfessionalFeesExpense_lbl" xml:lang="en-US">Tuition fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherRevenue" xlink:label="ifrs-full_OtherRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherRevenue" xlink:to="ifrs-full_OtherRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherRevenue_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TimingRevenueRecognition" xlink:label="afya_TimingRevenueRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TimingRevenueRecognition" xlink:to="afya_TimingRevenueRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TimingRevenueRecognition_lbl" xml:lang="en-US">Timing of revenue recognition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FeeAndCommissionIncome" xlink:to="ifrs-full_FeeAndCommissionIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FeeAndCommissionIncome_2_lbl" xml:lang="en-US">Transferred over time</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NetRevenueOtherTransferredPoint" xlink:to="afya_NetRevenueOtherTransferredPoint_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NetRevenueOtherTransferredPoint_2_lbl" xml:lang="en-US">Transferred at a point in time</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseByNature" xlink:label="ifrs-full_ExpenseByNature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseByNature" xlink:to="ifrs-full_ExpenseByNature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ExpenseByNature_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Payroll" xlink:label="afya_Payroll" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Payroll" xlink:to="afya_Payroll_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Payroll_lbl" xml:lang="en-US">Payroll</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_HospitalAndMedicalAgreements" xlink:label="afya_HospitalAndMedicalAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_HospitalAndMedicalAgreements" xlink:to="afya_HospitalAndMedicalAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_HospitalAndMedicalAgreements_lbl" xml:lang="en-US">Hospital and medical agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationExpense" xlink:label="ifrs-full_DepreciationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationExpense_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseExpenses" xlink:label="afya_LeaseExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseExpenses" xlink:to="afya_LeaseExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LeaseExpenses_lbl" xml:lang="en-US">Lease expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UtilitiesExpense" xlink:label="ifrs-full_UtilitiesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UtilitiesExpense" xlink:to="ifrs-full_UtilitiesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UtilitiesExpense_lbl" xml:lang="en-US">Utilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RepairsAndMaintenanceExpense" xlink:label="ifrs-full_RepairsAndMaintenanceExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepairsAndMaintenanceExpense" xlink:to="ifrs-full_RepairsAndMaintenanceExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RepairsAndMaintenanceExpense_lbl" xml:lang="en-US">Maintenance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SharesBasedCompensation" xlink:label="afya_SharesBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharesBasedCompensation" xlink:to="afya_SharesBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_SharesBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxExpenses" xlink:label="afya_TaxExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxExpenses" xlink:to="afya_TaxExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxExpenses_lbl" xml:lang="en-US">Tax expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ServicesExpense" xlink:label="ifrs-full_ServicesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ServicesExpense" xlink:to="ifrs-full_ServicesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ServicesExpense_lbl" xml:lang="en-US">Pedagogical services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="ifrs-full_SalesAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SalesAndMarketingExpense" xlink:to="ifrs-full_SalesAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_SalesAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AllowanceForExpectedCreditLosses" xlink:label="afya_AllowanceForExpectedCreditLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForExpectedCreditLosses" xlink:to="afya_AllowanceForExpectedCreditLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AllowanceForExpectedCreditLosses_lbl" xml:lang="en-US">Allowance for expected credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TravelExpense" xlink:label="ifrs-full_TravelExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TravelExpense" xlink:to="ifrs-full_TravelExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TravelExpense_lbl" xml:lang="en-US">Travel expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ConsultingFees" xlink:label="afya_ConsultingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ConsultingFees" xlink:to="afya_ConsultingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ConsultingFees_lbl" xml:lang="en-US">Consulting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Other" xlink:label="afya_Other" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Other" xlink:to="afya_Other_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_Other_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExpenseByNatureOne" xlink:label="afya_ExpenseByNatureOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ExpenseByNatureOne" xlink:to="afya_ExpenseByNatureOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ExpenseByNatureOne_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InvestmentIncome" xlink:label="ifrs-full_InvestmentIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentIncome" xlink:to="ifrs-full_InvestmentIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentIncome_lbl" xml:lang="en-US">Income from financial investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromInterest" xlink:label="ifrs-full_RevenueFromInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromInterest" xlink:to="ifrs-full_RevenueFromInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromInterest_lbl" xml:lang="en-US">Interest received</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherFinanceIncome" xlink:label="ifrs-full_OtherFinanceIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceIncome" xlink:to="ifrs-full_OtherFinanceIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherFinanceIncome_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InterestExpense1" xlink:label="afya_InterestExpense1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InterestExpense1" xlink:to="afya_InterestExpense1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InterestExpense1_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InterestExpenseOnLeaseLiabilities1" xlink:label="afya_InterestExpenseOnLeaseLiabilities1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InterestExpenseOnLeaseLiabilities1" xlink:to="afya_InterestExpenseOnLeaseLiabilities1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InterestExpenseOnLeaseLiabilities1_lbl" xml:lang="en-US">Interest expense on lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialDiscountsGrantedExpenses" xlink:label="afya_FinancialDiscountsGrantedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialDiscountsGrantedExpenses" xlink:to="afya_FinancialDiscountsGrantedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialDiscountsGrantedExpenses_lbl" xml:lang="en-US">Financial discounts granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BankAndSimilarCharges" xlink:label="ifrs-full_BankAndSimilarCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BankAndSimilarCharges" xlink:to="ifrs-full_BankAndSimilarCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_BankAndSimilarCharges_lbl" xml:lang="en-US">Bank fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="ifrs-full_NetForeignExchangeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="ifrs-full_NetForeignExchangeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NetForeignExchangeLoss_lbl" xml:lang="en-US">Foreign exchange loss, net</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxOnFinancialOperations" xlink:label="afya_TaxOnFinancialOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxOnFinancialOperations" xlink:to="afya_TaxOnFinancialOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxOnFinancialOperations_lbl" xml:lang="en-US">IOF taxes (taxes on financial transactions)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherFinanceCost" xlink:label="ifrs-full_OtherFinanceCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceCost" xlink:to="ifrs-full_OtherFinanceCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_OtherFinanceCost_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_FinanceCosts_2_lbl" xml:lang="en-US">Finance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinanceResult" xlink:label="afya_FinanceResult" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinanceResult" xlink:to="afya_FinanceResult_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_FinanceResult_lbl" xml:lang="en-US">Finance result</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ApplicableTaxRate_2_lbl" xml:lang="en-US">Combined statutory income taxes rate - %</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xml:lang="en-US">Income taxes at statutory rates</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReconciliationAdjustmentsAbstract" xlink:label="afya_ReconciliationAdjustmentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ReconciliationAdjustmentsAbstract" xlink:to="afya_ReconciliationAdjustmentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ReconciliationAdjustmentsAbstract_lbl" xml:lang="en-US">Reconciliation adjustments:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" xlink:label="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" xlink:to="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_lbl" xml:lang="en-US">Tax effect on loss from entities not subject to taxation</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ProgramaUniversidadeParaTodosFiscalIncentive" xlink:label="afya_ProgramaUniversidadeParaTodosFiscalIncentive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProgramaUniversidadeParaTodosFiscalIncentive" xlink:to="afya_ProgramaUniversidadeParaTodosFiscalIncentive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProgramaUniversidadeParaTodosFiscalIncentive_lbl" xml:lang="en-US">PROUNI - Fiscal Incentive (i)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UnrecognisedDeferredTaxAssets" xlink:label="afya_UnrecognisedDeferredTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UnrecognisedDeferredTaxAssets" xlink:to="afya_UnrecognisedDeferredTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UnrecognisedDeferredTaxAssets_lbl" xml:lang="en-US">Unrecognized deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RecognisedDeferredTaxAssets" xlink:label="afya_RecognisedDeferredTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RecognisedDeferredTaxAssets" xlink:to="afya_RecognisedDeferredTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RecognisedDeferredTaxAssets_lbl" xml:lang="en-US">Recognized deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl" xml:lang="en-US">Presumed profit income tax regime effect (ii)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PermanentAdjustments" xlink:label="afya_PermanentAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PermanentAdjustments" xlink:to="afya_PermanentAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PermanentAdjustments_lbl" xml:lang="en-US">Permanent adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:label="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:to="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="ifrs-full_CurrentTaxExpenseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxExpenseIncome" xlink:to="ifrs-full_CurrentTaxExpenseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxExpenseIncome_lbl" xml:lang="en-US">Income taxes expense - current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:label="ifrs-full_TaxRateEffectFromChangeInTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:to="ifrs-full_TaxRateEffectFromChangeInTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxRateEffectFromChangeInTaxRate_lbl" xml:lang="en-US">Effective rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="ifrs-full_DeferredTaxExpenseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncome" xlink:to="ifrs-full_DeferredTaxExpenseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncome_lbl" xml:lang="en-US">Unrecognized deferred income tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RecognizedDeferredTaxAssets" xlink:label="afya_RecognizedDeferredTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RecognizedDeferredTaxAssets" xlink:to="afya_RecognizedDeferredTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RecognizedDeferredTaxAssets_lbl" xml:lang="en-US">Recognized deferred income tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_lbl" xml:lang="en-US">Disclosure of contingent liabilities in business combination [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Provisions" xlink:label="ifrs-full_Provisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Provisions" xlink:to="ifrs-full_Provisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Provisions_lbl" xml:lang="en-US">Balance as of beginning of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_lbl" xml:lang="en-US">Business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="ifrs-full_UnusedProvisionReversedOtherProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:to="ifrs-full_UnusedProvisionReversedOtherProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_UnusedProvisionReversedOtherProvisions_lbl" xml:lang="en-US">Reversals</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Provisions" xlink:to="ifrs-full_Provisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Provisions_2_lbl" xml:lang="en-US">Balance as of ending of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherProvisions" xlink:label="ifrs-full_OtherProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherProvisions" xlink:to="ifrs-full_OtherProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherProvisions_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContingenciesCorrespondentAmount" xlink:label="afya_ContingenciesCorrespondentAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContingenciesCorrespondentAmount" xlink:to="afya_ContingenciesCorrespondentAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContingenciesCorrespondentAmount_lbl" xml:lang="en-US">Contingencies correspondent amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Issuance of shares for acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RemeasurementOfEarnOut" xlink:label="afya_RemeasurementOfEarnOut" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RemeasurementOfEarnOut" xlink:to="afya_RemeasurementOfEarnOut_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RemeasurementOfEarnOut_lbl" xml:lang="en-US">Remeasurement of earn-out of Alem da Medicina, CardioPapers</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets" xlink:label="afya_ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets" xlink:to="afya_ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_lbl" xml:lang="en-US">Provision for legal proceedings with corresponding indemnification asset</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" xlink:label="afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" xlink:to="afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_lbl" xml:lang="en-US">Additions and remeasurements of right-of-use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable" xlink:label="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable" xlink:to="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable_lbl" xml:lang="en-US">Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PotentialAdditionalPayment" xlink:label="afya_PotentialAdditionalPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PotentialAdditionalPayment" xlink:to="afya_PotentialAdditionalPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PotentialAdditionalPayment_lbl" xml:lang="en-US">Potential additional payment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TotalNumberOfSeatsApporved" xlink:label="afya_TotalNumberOfSeatsApporved" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TotalNumberOfSeatsApporved" xlink:to="afya_TotalNumberOfSeatsApporved_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TotalNumberOfSeatsApporved_lbl" xml:lang="en-US">Total number of seats apporved</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialInstitution" xlink:to="afya_FinancialInstitution_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_FinancialInstitution_doc" xml:lang="en-US">Information about financial institution.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentySevenMember" xlink:to="afya_TwentyTwentySevenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_TwentyTwentySevenMember_doc" xml:lang="en-US">This member stands for twenty twenty seven.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentyFourMember" xlink:to="afya_TwentyTwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_TwentyTwentyFourMember_doc" xml:lang="en-US">The member stands for twenty twenty four.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingCurrent" xlink:to="afya_LoansAndFinancingCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_LoansAndFinancingCurrent_doc" xml:lang="en-US">The amount refers to loans and financing current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingNonCurrent" xlink:to="afya_LoansAndFinancingNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_LoansAndFinancingNonCurrent_doc" xml:lang="en-US">The amount refers to loans and financing non current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsRemeasurement" xlink:to="afya_RightofuseAssetsRemeasurement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RightofuseAssetsRemeasurement_doc" xml:lang="en-US">The amount of right of use assets re measurement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsBusinessCombinations" xlink:to="afya_RightofuseAssetsBusinessCombinations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RightofuseAssetsBusinessCombinations_doc" xml:lang="en-US">The amount of business combinations right to use of assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsInterestExpense" xlink:to="afya_RightofuseAssetsInterestExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RightofuseAssetsInterestExpense_doc" xml:lang="en-US">The amount of Interest expense right to use of assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsPaymentsOfLeaseLiabilities" xlink:to="afya_RightofuseAssetsPaymentsOfLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RightofuseAssetsPaymentsOfLeaseLiabilities_doc" xml:lang="en-US">The amount of Payments of lease liabilities right to use of assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsCurrent" xlink:to="afya_RightofuseAssetsCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RightofuseAssetsCurrent_doc" xml:lang="en-US">The amount of current right to use of assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsNonCurrent" xlink:to="afya_RightofuseAssetsNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RightofuseAssetsNonCurrent_doc" xml:lang="en-US">The amount of non current right to use of assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsToLeaseLiabilities" xlink:to="afya_AdditionsToLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AdditionsToLeaseLiabilities_doc" xml:lang="en-US">The amount of additions to lease liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesRemeasurement" xlink:to="afya_LeaseLiabilitiesRemeasurement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_LeaseLiabilitiesRemeasurement_doc" xml:lang="en-US">The amount of lease liabilities re measurement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BusinessCombinationsLeaseLiabilities" xlink:to="afya_BusinessCombinationsLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_BusinessCombinationsLeaseLiabilities_doc" xml:lang="en-US">The amount of business combinations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DepreciationExpenseLeaseLiabilities" xlink:to="afya_DepreciationExpenseLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_DepreciationExpenseLeaseLiabilities_doc" xml:lang="en-US">The amount of depreciation expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholdersCurrent_doc" xml:lang="en-US">The amount refers to accounts payable to selling shareholders current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholdersNonCurrent_doc" xml:lang="en-US">The amount refers to accounts payable to selling shareholders non current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersMember" xlink:to="afya_AccountsPayableToSellingShareholdersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholdersMember_doc" xml:lang="en-US">This member stands for accounts payable to selling shareholders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholderCashFlows" xlink:to="afya_AccountsPayableToSellingShareholderCashFlows_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholderCashFlows_doc" xml:lang="en-US">The amount refers to accounts payable to selling shareholder cash flows.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" xlink:to="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec_doc" xml:lang="en-US">The amount refers to accounts payable to selling shareholders acquisition of ipec.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:to="afya_AccountsPayableToSellingShareholdersBusinessCombinations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholdersBusinessCombinations_doc" xml:lang="en-US">The amount refers to accounts payable to selling shareholders business combinations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Payments" xlink:to="afya_Payments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_Payments_doc" xml:lang="en-US">The amount of payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MonetaryIndexation" xlink:to="afya_MonetaryIndexation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_MonetaryIndexation_doc" xml:lang="en-US">The amount of monetary indexation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingMember" xlink:to="afya_LoansAndFinancingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_LoansAndFinancingMember_doc" xml:lang="en-US">This member stands for loans and financing.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayableMember" xlink:to="afya_NotesPayableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_NotesPayableMember_doc" xml:lang="en-US">The member stands for notes payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CashEquivalents1Member" xlink:to="afya_CashEquivalents1Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_CashEquivalents1Member_doc" xml:lang="en-US">This member stands for cash equivalents1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IndexRatePerYear" xlink:to="afya_IndexRatePerYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_IndexRatePerYear_doc" xml:lang="en-US">Information about index rate per year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BaseRate" xlink:to="afya_BaseRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_BaseRate_doc" xml:lang="en-US">The amount refers to base rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersOneMember" xlink:to="afya_AccountsPayableToSellingShareholdersOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholdersOneMember_doc" xml:lang="en-US">This member stands for accounts payable to selling shareholders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseBasisPointsMember" xlink:to="afya_IncreaseBasisPointsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_IncreaseBasisPointsMember_doc" xml:lang="en-US">This member stands for increase basis points.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseBasisPointsOneMember" xlink:to="afya_IncreaseBasisPointsOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_IncreaseBasisPointsOneMember_doc" xml:lang="en-US">This member stands for increase basis points one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SensitivityChangeInTheEuroExchangeRate" xlink:to="afya_SensitivityChangeInTheEuroExchangeRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_SensitivityChangeInTheEuroExchangeRate_doc" xml:lang="en-US">Information about percentage of sensitivity change in the euro exchange rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ForeignCurrencyExposuresMember" xlink:to="afya_ForeignCurrencyExposuresMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_ForeignCurrencyExposuresMember_doc" xml:lang="en-US">The member represent foreign currency exposures.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseForeignCurrencyMember" xlink:to="afya_IncreaseForeignCurrencyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_IncreaseForeignCurrencyMember_doc" xml:lang="en-US">The member represent increse in foreign currency sensitivity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DecreaseForeignCurrencyMember" xlink:to="afya_DecreaseForeignCurrencyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_DecreaseForeignCurrencyMember_doc" xml:lang="en-US">The member represent decrease in foreign currency sensitivity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialLiabilitiesContractualUndiscounted" xlink:to="afya_FinancialLiabilitiesContractualUndiscounted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_FinancialLiabilitiesContractualUndiscounted_doc" xml:lang="en-US">The amount of financial liabilities contractual undiscounted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotePayables" xlink:to="afya_NotePayables_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_NotePayables_doc" xml:lang="en-US">The amount of note payables.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsPayableMember" xlink:to="afya_DividendsPayableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_DividendsPayableMember_doc" xml:lang="en-US">This member stands for the dividends payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:to="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_doc" xml:lang="en-US">The amount of increase through interest on liabilities arising from financing activities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:to="afya_RemainingTradeAndOtherPayablesToRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RemainingTradeAndOtherPayablesToRelatedParties_doc" xml:lang="en-US">The remaining amount of payables due to related parties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EqualInstallmentsPayablesToRelatedParties" xlink:to="afya_EqualInstallmentsPayablesToRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_EqualInstallmentsPayablesToRelatedParties_doc" xml:lang="en-US">The amount of equal installments payables due to related parties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssets_3_lbl" xml:lang="en-US">Current assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentTradeReceivable" xlink:to="afya_NoncurrentTradeReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentTradeReceivable_2_lbl" xml:lang="en-US">NoncurrentTradeReceivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentAssets_2_lbl" xml:lang="en-US">Other non-current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssets_3_lbl" xml:lang="en-US">Non-current assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilities_4_lbl" xml:lang="en-US">Current liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermBorrowings" xlink:to="ifrs-full_LongtermBorrowings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LongtermBorrowings_2_lbl" xml:lang="en-US">Non-current portion of non-current borrowings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayablesToRelatedParties" xlink:to="ifrs-full_NoncurrentPayablesToRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties_2_lbl" xml:lang="en-US">Non-current payables to related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentTaxesPayable" xlink:to="afya_NoncurrentTaxesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentTaxesPayable_2_lbl" xml:lang="en-US">NoncurrentTaxesPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentLiabilities_2_lbl" xml:lang="en-US">Other non-current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilities_4_lbl" xml:lang="en-US">Non-current liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Liabilities_2_lbl" xml:lang="en-US">Liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasuryShares" xlink:to="ifrs-full_TreasuryShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TreasuryShares_2_lbl" xml:lang="en-US">Treasury shares [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent_2_lbl" xml:lang="en-US">Equity attributable to owners of parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Equity_5_lbl" xml:lang="en-US">Equity [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CostOfSales_2_lbl" xml:lang="en-US">Cost of sales</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeneralAndAdministrativeExpense" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">General and administrative expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceCosts_3_lbl" xml:lang="en-US">Finance costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncomeCost_2_lbl" xml:lang="en-US">Finance income (cost)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ComprehensiveIncomeLoss" xlink:to="afya_ComprehensiveIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ComprehensiveIncomeLoss_2_lbl" xml:lang="en-US">ComprehensiveIncomeLoss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaid" xlink:to="ifrs-full_DividendsPaid_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaid_2_lbl" xml:lang="en-US">Dividends recognised as distributions to owners</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncomeLossBeforeIncomeTaxes" xlink:to="afya_IncomeLossBeforeIncomeTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncomeLossBeforeIncomeTaxes_2_lbl" xml:lang="en-US">IncomeLossBeforeIncomeTaxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShareOfIncomeOfAssociateOfOpeartingActivities" xlink:to="afya_ShareOfIncomeOfAssociateOfOpeartingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShareOfIncomeOfAssociateOfOpeartingActivities_2_lbl" xml:lang="en-US">ShareOfIncomeOfAssociateOfOpeartingActivities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_2_lbl" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_2_lbl" xml:lang="en-US">Adjustments for decrease (increase) in inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseDecreaseInRecoverableTaxes" xlink:to="afya_IncreaseDecreaseInRecoverableTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseDecreaseInRecoverableTaxes_2_lbl" xml:lang="en-US">IncreaseDecreaseInRecoverableTaxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_2_lbl" xml:lang="en-US">Adjustments for decrease (increase) in other assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense_2_lbl" xml:lang="en-US">Adjustments for income tax expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_2_lbl" xml:lang="en-US">Adjustments for decrease (increase) in loans and advances to customers</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherAdjustmentsForNoncashItems" xlink:to="ifrs-full_OtherAdjustmentsForNoncashItems_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems_2_lbl" xml:lang="en-US">Other adjustments for non-cash items</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_2_lbl" xml:lang="en-US">Adjustments for increase (decrease) in other liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss_2_lbl" xml:lang="en-US">Adjustments to reconcile profit (loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_2_lbl" xml:lang="en-US">Income taxes paid (refund), classified as operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_2_lbl" xml:lang="en-US">Cash flows from (used in) operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2_lbl" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:to="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities_2_lbl" xml:lang="en-US">PurchaseOfIntangibleAssetClassifiedAsInvestingActivities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PurchaseOfAcquisitionOfNoncontrollingInterests" xlink:to="afya_PurchaseOfAcquisitionOfNoncontrollingInterests_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PurchaseOfAcquisitionOfNoncontrollingInterests_2_lbl" xml:lang="en-US">PurchaseOfAcquisitionOfNoncontrollingInterests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_2_lbl" xml:lang="en-US">Purchase of other long-term assets, classified as investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" xlink:to="afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles_2_lbl" xml:lang="en-US">PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_2_lbl" xml:lang="en-US">Cash flows from (used in) investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">Repayments of borrowings, classified as financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" xlink:to="afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_DividendsPaidClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaidClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">Dividends paid, classified as financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_2_lbl" xml:lang="en-US">Cash flows from (used in) financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_2_lbl" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_3_lbl" xml:lang="en-US">Increase (decrease) in cash and cash equivalents after effect of exchange rate changes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_3_lbl" xml:lang="en-US">Restricted cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosuresOfCashAndCashEquivalentsExplanatory" xlink:to="afya_DisclosuresOfCashAndCashEquivalentsExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosuresOfCashAndCashEquivalentsExplanatory_2_lbl" xml:lang="en-US">DisclosuresOfCashAndCashEquivalentsExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2_lbl" xml:lang="en-US">Disclosure of trade and other receivables [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfOtherAssetExplanatory" xlink:to="afya_DisclosureOfOtherAssetExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfOtherAssetExplanatory_2_lbl" xml:lang="en-US">DisclosureOfOtherAssetExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory_2_lbl" xml:lang="en-US">Disclosure of joint ventures [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_2_lbl" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsExplanatory" xlink:to="afya_LaborAndSocialObligationsExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaborAndSocialObligationsExplanatory_2_lbl" xml:lang="en-US">LaborAndSocialObligationsExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfEquityExplanatory" xlink:to="afya_DisclosureOfEquityExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfEquityExplanatory_2_lbl" xml:lang="en-US">DisclosureOfEquityExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory_2_lbl" xml:lang="en-US">Disclosure of revenue [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_2_lbl" xml:lang="en-US">Description of accounting policy for fair value measurement [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2_lbl" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_2_lbl" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_2_lbl" xml:lang="en-US">Description of accounting policy for intangible assets other than goodwill [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersPolicyExplanatory" xlink:to="afya_AccountsPayableToSellingShareholdersPolicyExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersPolicyExplanatory_2_lbl" xml:lang="en-US">AccountsPayableToSellingShareholdersPolicyExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsPolicyExplanatory" xlink:to="afya_LaborAndSocialObligationsPolicyExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaborAndSocialObligationsPolicyExplanatory_2_lbl" xml:lang="en-US">LaborAndSocialObligationsPolicyExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTreasurySharesExplanatory" xlink:to="ifrs-full_DisclosureOfTreasurySharesExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTreasurySharesExplanatory_2_lbl" xml:lang="en-US">Disclosure of treasury shares [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">Selling, general and administrative expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_2_lbl" xml:lang="en-US">Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeReceivablesAsOfAcquisitionDate" xlink:to="afya_TradeReceivablesAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeReceivablesAsOfAcquisitionDate_2_lbl" xml:lang="en-US">TradeReceivablesAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Inventories1" xlink:to="afya_Inventories1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Inventories1_2_lbl" xml:lang="en-US">Inventories1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RecoverableTaxesAsOfAcquisitionDate" xlink:to="afya_RecoverableTaxesAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RecoverableTaxesAsOfAcquisitionDate_2_lbl" xml:lang="en-US">RecoverableTaxesAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_3_lbl" xml:lang="en-US">Property, plant and equipment recognised as of acquisition date [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:to="afya_RightOfUseAssetsAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightOfUseAssetsAsOfAcquisitionDate_2_lbl" xml:lang="en-US">RightOfUseAssetsAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:to="afya_LeaseLiabilitiesAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesAsOfAcquisitionDate_2_lbl" xml:lang="en-US">LeaseLiabilitiesAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:to="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate_2_lbl" xml:lang="en-US">ProvisionForLegalProceedingsAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:to="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_3_lbl" xml:lang="en-US">Allowance account for credit losses of financial assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentAssetsOfRelatedParty1" xlink:to="afya_NoncurrentAssetsOfRelatedParty1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentAssetsOfRelatedParty1_2_lbl" xml:lang="en-US">NoncurrentAssetsOfRelatedParty1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions_2_lbl" xml:lang="en-US">Amounts payable, related party transactions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableCurrent1" xlink:to="afya_AccountsPayableCurrent1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableCurrent1_2_lbl" xml:lang="en-US">AccountsPayableCurrent1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentPayablesToRelatedParties1" xlink:to="afya_NoncurrentPayablesToRelatedParties1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentPayablesToRelatedParties1_2_lbl" xml:lang="en-US">NoncurrentPayablesToRelatedParties1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:to="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_2_lbl" xml:lang="en-US">Amount incurred by entity for provision of key management personnel services provided by separate management entity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DescriptionOfLeaseTerms" xlink:to="afya_DescriptionOfLeaseTerms_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DescriptionOfLeaseTerms_2_lbl" xml:lang="en-US">DescriptionOfLeaseTerms</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Dividend" xlink:to="afya_Dividend_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Dividend_2_lbl" xml:lang="en-US">Dividend</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssets1" xlink:to="afya_OtherAssets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherAssets1_2_lbl" xml:lang="en-US">OtherAssets1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Assets1" xlink:to="afya_Assets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Assets1_2_lbl" xml:lang="en-US">Assets1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentAssets1" xlink:to="afya_CurrentAssets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CurrentAssets1_2_lbl" xml:lang="en-US">CurrentAssets1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentAssets1" xlink:to="afya_NoncurrentAssets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentAssets1_2_lbl" xml:lang="en-US">NoncurrentAssets1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAsset" xlink:to="afya_OtherAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherAsset_2_lbl" xml:lang="en-US">OtherAsset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EquityInAssociate" xlink:to="afya_EquityInAssociate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EquityInAssociate_2_lbl" xml:lang="en-US">EquityInAssociate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsReceived1" xlink:to="afya_DividendsReceived1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendsReceived1_2_lbl" xml:lang="en-US">DividendsReceived1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PropertyPlantAndEquipments" xlink:to="afya_PropertyPlantAndEquipments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PropertyPlantAndEquipments_3_lbl" xml:lang="en-US">PropertyPlantAndEquipments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Depreciation, property, plant and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsAndGoodwill" xlink:to="ifrs-full_IntangibleAssetsAndGoodwill_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsAndGoodwill_3_lbl" xml:lang="en-US">Intangible assets and goodwill [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_2_lbl" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_2_lbl" xml:lang="en-US">Acquisitions through business combinations, intangible assets and goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IntangibleAssetsAndGoodwillNetBookValue" xlink:to="afya_IntangibleAssetsAndGoodwillNetBookValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IntangibleAssetsAndGoodwillNetBookValue_2_lbl" xml:lang="en-US">IntangibleAssetsAndGoodwillNetBookValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssets" xlink:to="ifrs-full_CurrentFinancialAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialAssets_2_lbl" xml:lang="en-US">Current financial assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialAssets_2_lbl" xml:lang="en-US">Non-current financial assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_2_lbl" xml:lang="en-US">Trade payables [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancing" xlink:to="afya_LoansAndFinancing_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancing_2_lbl" xml:lang="en-US">Loans And Financing</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilities_4_lbl" xml:lang="en-US">Lease liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotePayable" xlink:to="afya_NotePayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NotePayable_2_lbl" xml:lang="en-US">Note Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilities" xlink:to="ifrs-full_CurrentFinancialLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialLiabilities_2_lbl" xml:lang="en-US">Current financial liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilities" xlink:to="ifrs-full_NoncurrentFinancialLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialLiabilities_2_lbl" xml:lang="en-US">Non-current financial liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingCurrent" xlink:to="afya_LoansAndFinancingCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingCurrent_3_lbl" xml:lang="en-US">Loans And Financing Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingNonCurrent" xlink:to="afya_LoansAndFinancingNonCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingNonCurrent_3_lbl" xml:lang="en-US">Loans And Financing Non Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRightofuseAssets" xlink:to="ifrs-full_DepreciationRightofuseAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationRightofuseAssets_2_lbl" xml:lang="en-US">Depreciation, right-of-use assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersCurrent_3_lbl" xml:lang="en-US">Accounts Payable To Selling Shareholders Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersNonCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersNonCurrent_3_lbl" xml:lang="en-US">Accounts Payable To Selling Shareholders Non Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_3_lbl" xml:lang="en-US">Interest paid, classified as financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayables" xlink:to="afya_NotesPayables_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NotesPayables_3_lbl" xml:lang="en-US">Notes Payables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentLiabilities1" xlink:to="afya_CurrentLiabilities1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CurrentLiabilities1_2_lbl" xml:lang="en-US">Current Liabilities1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentLiabilities1" xlink:to="afya_NoncurrentLiabilities1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentLiabilities1_2_lbl" xml:lang="en-US">Noncurrent Liabilities1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:to="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_2_lbl" xml:lang="en-US">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotePayables" xlink:to="afya_NotePayables_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NotePayables_3_lbl" xml:lang="en-US">DerivativeLiabilitiesCrossCurrencyInterestRateSwaps</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Advances" xlink:to="ifrs-full_Advances_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Advances_2_lbl" xml:lang="en-US">Advances received, representing contract liabilities for performance obligations satisfied at point in time</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_3_lbl" xml:lang="en-US">Liabilities arising from financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:to="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_3_lbl" xml:lang="en-US">IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_2_lbl" xml:lang="en-US">Increase (decrease) through obtaining or losing control of subsidiaries or other businesses, liabilities arising from financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_2_lbl" xml:lang="en-US">Increase (decrease) through other changes, liabilities arising from financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EqualInstallmentsPayablesToRelatedParties" xlink:to="afya_EqualInstallmentsPayablesToRelatedParties_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EqualInstallmentsPayablesToRelatedParties_3_lbl" xml:lang="en-US">Equal installments payables [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingLiabilities" xlink:to="afya_LoansAndFinancingLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingLiabilities_2_lbl" xml:lang="en-US">Loans And Financing Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilities1" xlink:to="afya_LeaseLiabilities1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilities1_2_lbl" xml:lang="en-US">LeaseLiabilities1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" xlink:to="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities_2_lbl" xml:lang="en-US">TradeAndOtherPayablesToRelatedPartiesLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FairValueNotesPayables1" xlink:to="afya_FairValueNotesPayables1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FairValueNotesPayables1_2_lbl" xml:lang="en-US">FairValueNotesPayables1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_2_lbl" xml:lang="en-US">Expected volatility, share options granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_StrikePriceeAtMeasurementDateShareOptionsGrante" xlink:to="afya_StrikePriceeAtMeasurementDateShareOptionsGrante_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_StrikePriceeAtMeasurementDateShareOptionsGrante_2_lbl" xml:lang="en-US">Strike Pricee At Measurement Date Share Options Grante</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_3_lbl" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_3_lbl" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Number of share options expired in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2_lbl" xml:lang="en-US">Expense from share-based payment transactions with employees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesOutstanding_3_lbl" xml:lang="en-US">Number of shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_3_lbl" xml:lang="en-US">WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssued_2_lbl" xml:lang="en-US">Number of shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherRevenue1" xlink:to="afya_OtherRevenue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherRevenue1_2_lbl" xml:lang="en-US">OtherRevenue1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_2_lbl" xml:lang="en-US">Revenue from contracts with customers [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfessionalFeesExpense" xlink:to="ifrs-full_ProfessionalFeesExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfessionalFeesExpense_2_lbl" xml:lang="en-US">Professional fees expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherRevenue" xlink:to="ifrs-full_OtherRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherRevenue_2_lbl" xml:lang="en-US">Other revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseByNature" xlink:to="ifrs-full_ExpenseByNature_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseByNature_2_lbl" xml:lang="en-US">Expenses, by nature</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationExpense_2_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseExpenses" xlink:to="afya_LeaseExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseExpenses_2_lbl" xml:lang="en-US">LeaseExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepairsAndMaintenanceExpense" xlink:to="ifrs-full_RepairsAndMaintenanceExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepairsAndMaintenanceExpense_2_lbl" xml:lang="en-US">Repairs and maintenance expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharesBasedCompensation" xlink:to="afya_SharesBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SharesBasedCompensation_2_lbl" xml:lang="en-US">SharesBasedCompensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ServicesExpense" xlink:to="ifrs-full_ServicesExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ServicesExpense_2_lbl" xml:lang="en-US">Services expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SalesAndMarketingExpense" xlink:to="ifrs-full_SalesAndMarketingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SalesAndMarketingExpense_2_lbl" xml:lang="en-US">Sales and marketing expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForExpectedCreditLosses" xlink:to="afya_AllowanceForExpectedCreditLosses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AllowanceForExpectedCreditLosses_2_lbl" xml:lang="en-US">AllowanceForExpectedCreditLosses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TravelExpense" xlink:to="ifrs-full_TravelExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TravelExpense_2_lbl" xml:lang="en-US">Travel expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Other" xlink:to="afya_Other_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Other_2_lbl" xml:lang="en-US">Other [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ExpenseByNatureOne" xlink:to="afya_ExpenseByNatureOne_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ExpenseByNatureOne_2_lbl" xml:lang="en-US">ExpenseByNatureOne</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceIncome" xlink:to="ifrs-full_OtherFinanceIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherFinanceIncome_2_lbl" xml:lang="en-US">Other finance income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BankAndSimilarCharges" xlink:to="ifrs-full_BankAndSimilarCharges_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BankAndSimilarCharges_2_lbl" xml:lang="en-US">Bank and similar charges</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="ifrs-full_NetForeignExchangeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetForeignExchangeLoss_2_lbl" xml:lang="en-US">Net foreign exchange loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceCost" xlink:to="ifrs-full_OtherFinanceCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherFinanceCost_2_lbl" xml:lang="en-US">Other finance cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinanceResult" xlink:to="afya_FinanceResult_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinanceResult_2_lbl" xml:lang="en-US">FinanceResult</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_2_lbl" xml:lang="en-US">Tax effect of expense not deductible in determining taxable profit (tax loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:to="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_2_lbl" xml:lang="en-US">Tax expense other than income tax expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Provisions" xlink:to="ifrs-full_Provisions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Provisions_3_lbl" xml:lang="en-US">Provisions [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_2_lbl" xml:lang="en-US">Acquisitions through business combinations, other provisions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions_2_lbl" xml:lang="en-US">Additional provisions, other provisions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:to="ifrs-full_UnusedProvisionReversedOtherProvisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnusedProvisionReversedOtherProvisions_2_lbl" xml:lang="en-US">Unused provision reversed, other provisions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherProvisions" xlink:to="ifrs-full_OtherProvisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherProvisions_2_lbl" xml:lang="en-US">Other provisions</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>36
<FILENAME>afya-20231231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://afya.com.br/role/Cover" xlink:href="afya-20231231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfFinancialPosition" xlink:href="afya-20231231.xsd#StatementsOfFinancialPosition" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" xlink:href="afya-20231231.xsd#StatementsOfIncomeAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfChangesInEquity" xlink:href="afya-20231231.xsd#StatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfCashFlows" xlink:href="afya-20231231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CorporateInformation" xlink:href="afya-20231231.xsd#CorporateInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPolicies" xlink:href="afya-20231231.xsd#MaterialAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingJudgmentsEstimatesAndAssumptions" xlink:href="afya-20231231.xsd#SignificantAccountingJudgmentsEstimatesAndAssumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformation" xlink:href="afya-20231231.xsd#SegmentInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinations" xlink:href="afya-20231231.xsd#BusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalents" xlink:href="afya-20231231.xsd#CashAndCashEquivalents" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivables" xlink:href="afya-20231231.xsd#TradeReceivables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedParties" xlink:href="afya-20231231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssets" xlink:href="afya-20231231.xsd#OtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociate" xlink:href="afya-20231231.xsd#InvestmentInAssociate" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipment" xlink:href="afya-20231231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwill" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurement" xlink:href="afya-20231231.xsd#FairValueMeasurement" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CapitalManagement" xlink:href="afya-20231231.xsd#CapitalManagement" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligations" xlink:href="afya-20231231.xsd#LaborAndSocialObligations" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Equity" xlink:href="afya-20231231.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEps" xlink:href="afya-20231231.xsd#EarningsPerShareEps" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Revenue" xlink:href="afya-20231231.xsd#Revenue" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNature" xlink:href="afya-20231231.xsd#ExpensesAndCostsByNature" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResult" xlink:href="afya-20231231.xsd#FinanceResult" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxes" xlink:href="afya-20231231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingencies" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Non-cashTransactions" xlink:href="afya-20231231.xsd#Non-cashTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SubsequentEvent" xlink:href="afya-20231231.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesTables" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformationTables" xlink:href="afya-20231231.xsd#SegmentInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsTables" xlink:href="afya-20231231.xsd#BusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:href="afya-20231231.xsd#CashAndCashEquivalentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesTables" xlink:href="afya-20231231.xsd#TradeReceivablesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesTables" xlink:href="afya-20231231.xsd#RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsTables" xlink:href="afya-20231231.xsd#OtherAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociateTables" xlink:href="afya-20231231.xsd#InvestmentInAssociateTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:href="afya-20231231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurementTables" xlink:href="afya-20231231.xsd#FairValueMeasurementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityTables" xlink:href="afya-20231231.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEpsTables" xlink:href="afya-20231231.xsd#EarningsPerShareEpsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RevenueTables" xlink:href="afya-20231231.xsd#RevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNatureTables" xlink:href="afya-20231231.xsd#ExpensesAndCostsByNatureTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResultTables" xlink:href="afya-20231231.xsd#FinanceResultTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesTables" xlink:href="afya-20231231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Non-cashTransactionsTables" xlink:href="afya-20231231.xsd#Non-cashTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:href="afya-20231231.xsd#CorporateInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" xlink:href="afya-20231231.xsd#MaterialAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformationDetails" xlink:href="afya-20231231.xsd#SegmentInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformationDetails1" xlink:href="afya-20231231.xsd#SegmentInformationDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails1" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails2" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails3" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails4" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetails5" xlink:href="afya-20231231.xsd#BusinessCombinationsDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:href="afya-20231231.xsd#BusinessCombinationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetails" xlink:href="afya-20231231.xsd#CashAndCashEquivalentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:href="afya-20231231.xsd#CashAndCashEquivalentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesDetails" xlink:href="afya-20231231.xsd#TradeReceivablesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesDetails1" xlink:href="afya-20231231.xsd#TradeReceivablesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesDetails2" xlink:href="afya-20231231.xsd#TradeReceivablesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesDetails" xlink:href="afya-20231231.xsd#RelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesDetails1" xlink:href="afya-20231231.xsd#RelatedPartiesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:href="afya-20231231.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsDetails" xlink:href="afya-20231231.xsd#OtherAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsDetailsNarrative" xlink:href="afya-20231231.xsd#OtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociateDetails" xlink:href="afya-20231231.xsd#InvestmentInAssociateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipmentDetails" xlink:href="afya-20231231.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" xlink:href="afya-20231231.xsd#IntangibleAssetsAndGoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails6" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails7" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails8" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails9" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails10" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetails11" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:href="afya-20231231.xsd#FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurementDetails" xlink:href="afya-20231231.xsd#FairValueMeasurementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails1" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails2" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails3" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails4" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails5" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:href="afya-20231231.xsd#LaborAndSocialObligationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityDetails" xlink:href="afya-20231231.xsd#EquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityDetailsNarrative" xlink:href="afya-20231231.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEpsDetails" xlink:href="afya-20231231.xsd#EarningsPerShareEpsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RevenueDetails" xlink:href="afya-20231231.xsd#RevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RevenueDetails1" xlink:href="afya-20231231.xsd#RevenueDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNatureDetails" xlink:href="afya-20231231.xsd#ExpensesAndCostsByNatureDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResultDetails" xlink:href="afya-20231231.xsd#FinanceResultDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesDetails" xlink:href="afya-20231231.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:href="afya-20231231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingenciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" xlink:href="afya-20231231.xsd#InsuranceContractsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Non-cashTransactionsDetails" xlink:href="afya-20231231.xsd#Non-cashTransactionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SubsequentEventDetailsNarrative" xlink:href="afya-20231231.xsd#SubsequentEventDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassAOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassBOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_deiContactPersonnelEmailAddress" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelEmailAddress" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="640" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfFinancialPosition" xlink:title="00000002 - Statement - Consolidated statements of financial position">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-fullStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-fullAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-fullCurrentAssetsAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullCurrentAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-fullCurrentTradeReceivables" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCurrentTradeReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-fullInventories" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullInventories" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTaxAssets" xlink:label="loc_ifrs-fullCurrentTaxAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCurrentTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-fullOtherCurrentAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullOtherCurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-fullNoncurrentAssetsAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentTradeReceivable" xlink:label="loc_afyaNoncurrentTradeReceivable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_afyaNoncurrentTradeReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-fullOtherNoncurrentAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-fullInvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullRightofuseAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-fullLiabilitiesAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-fullCurrentLiabilitiesAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayables" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermBorrowings" xlink:label="loc_ifrs-fullShorttermBorrowings" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullShorttermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-fullCurrentLeaseLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotePayableCurrent" xlink:label="loc_afyaNotePayableCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_afyaNotePayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentDepositsFromCustomers" xlink:label="loc_ifrs-fullCurrentDepositsFromCustomers" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentDepositsFromCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-fullCurrentRecognisedLiabilitiesDefinedBenefitPlan" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CurrentTaxesPayable" xlink:label="loc_afyaCurrentTaxesPayable" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_afyaCurrentTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="loc_ifrs-fullOtherCurrentLiabilities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullOtherCurrentLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-fullNoncurrentLiabilitiesAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-fullLongtermBorrowings" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullLongtermBorrowings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-fullNoncurrentLeaseLiabilities" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayablesToRelatedParties" xlink:label="loc_ifrs-fullNoncurrentPayablesToRelatedParties" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentPayablesToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentTaxesPayable" xlink:label="loc_afyaNoncurrentTaxesPayable" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_afyaNoncurrentTaxesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LongtermLegalProceedingsProvision" xlink:label="loc_ifrs-fullLongtermLegalProceedingsProvision" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullLongtermLegalProceedingsProvision" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-fullOtherNoncurrentLiabilities" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullOtherNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-fullEquityAbstract" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullIssuedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionalPaidinCapital" xlink:label="loc_ifrs-fullAdditionalPaidinCapital" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullAdditionalPaidinCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-fullTreasuryShares" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullTreasuryShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-fullReserveOfSharebasedPayments" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullReserveOfSharebasedPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-fullRetainedEarnings" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullRetainedEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-fullEquityAttributableToOwnersOfParent" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-fullNoncontrollingInterests" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullEquityAndLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" xlink:title="00000003 - Statement - Consolidated statements of income and comprehensive income">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-fullIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-fullGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-fullOtherOperatingIncomeExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullOtherOperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-fullFinanceIncomeCost" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullFinanceIncomeCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-fullShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-fullOtherComprehensiveIncome" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullOtherComprehensiveIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullComprehensiveIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="loc_ifrs-fullProfitLossAttributableToAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLossAttributableToAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-fullProfitLossAttributableToOwnersOfParent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProfitLossAttributableToAbstract" xlink:to="loc_ifrs-fullProfitLossAttributableToOwnersOfParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-fullProfitLossAttributableToNoncontrollingInterests" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProfitLossAttributableToAbstract" xlink:to="loc_ifrs-fullProfitLossAttributableToNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ComprehensiveIncomeLoss" xlink:label="loc_afyaComprehensiveIncomeLoss" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_afyaComprehensiveIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsPerShareAbstract" xlink:label="loc_ifrs-fullBasicEarningsPerShareAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullBasicEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-fullBasicEarningsLossPerShare" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBasicEarningsPerShareAbstract" xlink:to="loc_ifrs-fullBasicEarningsLossPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="loc_ifrs-fullDilutedEarningsPerShareAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBasicEarningsPerShareAbstract" xlink:to="loc_ifrs-fullDilutedEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-fullDilutedEarningsLossPerShare" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBasicEarningsPerShareAbstract" xlink:to="loc_ifrs-fullDilutedEarningsLossPerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfChangesInEquity" xlink:title="00000004 - Statement - Consolidated statements of changes in equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-fullStatementOfChangesInEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityAbstract" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-fullComponentsOfEquityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullComponentsOfEquityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-fullEquityMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullEquityMember" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-fullIssuedCapitalMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullIssuedCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionalPaidinCapitalMember" xlink:label="loc_ifrs-fullAdditionalPaidinCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullAdditionalPaidinCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-fullTreasurySharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullTreasurySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-fullReserveOfSharebasedPaymentsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullReserveOfSharebasedPaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-fullRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="loc_ifrs-fullEquityAttributableToOwnersOfParentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullEquityAttributableToOwnersOfParentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-fullNoncontrollingInterestsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullNoncontrollingInterestsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullComprehensiveIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CapitalIncreaseWithCash" xlink:label="loc_afyaCapitalIncreaseWithCash" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalIncreaseWithCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasuryShares1" xlink:label="loc_afyaTreasuryShares1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasuryShares1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasurySharesTransferredFromExerciseOfOptions" xlink:label="loc_afyaTreasurySharesTransferredFromExerciseOfOptions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesTransferredFromExerciseOfOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination" xlink:label="loc_afyaTreasurySharesTransferredFromSharesContributionOnBusinessCombination" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesTransferredFromSharesContributionOnBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfNoncontrollingInterests" xlink:label="loc_afyaAcquisitionOfNoncontrollingInterests" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquisitionOfNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedSharesTransferredToExecutives" xlink:label="loc_afyaRestrictedSharesTransferredToExecutives" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRestrictedSharesTransferredToExecutives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" xlink:label="loc_afyaTreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaid" xlink:label="loc_ifrs-fullDividendsPaid" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaid" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated statements of cash flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-fullStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncomeLossBeforeIncomeTaxes" xlink:label="loc_afyaIncomeLossBeforeIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="loc_afyaIncomeLossBeforeIncomeTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-fullAdjustmentsForDepreciationAndAmortisationExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForDepreciationAndAmortisationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WriteoffOfPropertyAndEquipment" xlink:label="loc_afyaWriteoffOfPropertyAndEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaWriteoffOfPropertyAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WriteoffOfIntangibleAssets" xlink:label="loc_afyaWriteoffOfIntangibleAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaWriteoffOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:label="loc_afyaAllowanceForDoubtfulAccountsOfOpeartingActivities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaAllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-fullAdjustmentsForSharebasedPayments" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForSharebasedPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccruedInterestOfOpeartingActivities" xlink:label="loc_afyaAccruedInterestOfOpeartingActivities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaAccruedInterestOfOpeartingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShareOfIncomeOfAssociateOfOpeartingActivities" xlink:label="loc_afyaShareOfIncomeOfAssociateOfOpeartingActivities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaShareOfIncomeOfAssociateOfOpeartingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="loc_ifrs-fullAdjustmentsForProvisions" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForProvisions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseDecreaseInOperatingLiabilities1Abstract" xlink:label="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAccountReceivable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInInventories" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseDecreaseInRecoverableTaxes" xlink:label="loc_afyaIncreaseDecreaseInRecoverableTaxes" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_afyaIncreaseDecreaseInRecoverableTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="loc_ifrs-fullOtherAdjustmentsForNoncashItems" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullOtherAdjustmentsForNoncashItems" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherLiabilities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-fullIncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullIncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:label="loc_afyaPurchaseOfIntangibleAssetClassifiedAsInvestingActivities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_afyaPurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsReceived" xlink:label="loc_ifrs-fullDividendsReceived" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullDividendsReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PurchaseOfAcquisitionOfNoncontrollingInterests" xlink:label="loc_afyaPurchaseOfAcquisitionOfNoncontrollingInterests" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_afyaPurchaseOfAcquisitionOfNoncontrollingInterests" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullPurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" xlink:label="loc_afyaPaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_afyaPaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedCashOfInvestingActivities" xlink:label="loc_afyaRestrictedCashOfInvestingActivities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_afyaRestrictedCashOfInvestingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullRepaymentsOfBorrowingsClassifiedAsFinancingActivities" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullRepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_afyaRepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_afyaRepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullProceedsFromBorrowingsClassifiedAsFinancingActivities" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_afyaPaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_afyaPaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TreasuryShares1" xlink:label="loc_afyaTreasuryShares1" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_afyaTreasuryShares1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-fullProceedsFromExerciseOfOptions" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullProceedsFromExerciseOfOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullDividendsPaidClassifiedAsFinancingActivities" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullDividendsPaidClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-fullRestrictedCashAndCashEquivalents" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullRestrictedCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-fullRestrictedCashAndCashEquivalents_2" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullRestrictedCashAndCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformation" xlink:title="00000006 - Disclosure - Corporate information">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CorporateInformationAbstract" xlink:label="loc_afyaCorporateInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaCorporateInformationAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPolicies" xlink:title="00000007 - Disclosure - Material accounting policies">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfMaterialAccountingPoliciesExplanatory" xlink:label="loc_afyaDisclosureOfMaterialAccountingPoliciesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaDisclosureOfMaterialAccountingPoliciesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingJudgmentsEstimatesAndAssumptions" xlink:title="00000008 - Disclosure - Significant accounting judgments, estimates and assumptions">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract" xlink:label="loc_afyaDisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory" xlink:label="loc_afyaSignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract" xlink:to="loc_afyaSignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformation" xlink:title="00000009 - Disclosure - Segment information">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfEntitysReportableSegmentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfEntitysReportableSegmentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinations" xlink:title="00000010 - Disclosure - Business combinations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalents" xlink:title="00000011 - Disclosure - Cash and cash equivalents">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureCashAndCashEquivalentsAbstract" xlink:label="loc_afyaDisclosureCashAndCashEquivalentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosuresOfCashAndCashEquivalentsExplanatory" xlink:label="loc_afyaDisclosuresOfCashAndCashEquivalentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCashAndCashEquivalentsAbstract" xlink:to="loc_afyaDisclosuresOfCashAndCashEquivalentsExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivables" xlink:title="00000012 - Disclosure - Trade receivables">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfTradeAndOtherReceivablesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTradeAndOtherReceivablesExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedParties" xlink:title="00000013 - Disclosure - Related parties">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-fullDisclosureOfRelatedPartyExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfRelatedPartyExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssets" xlink:title="00000014 - Disclosure - Other assets">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOtherAssetsAbstract" xlink:label="loc_afyaDisclosureOtherAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfOtherAssetExplanatory" xlink:label="loc_afyaDisclosureOfOtherAssetExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaDisclosureOfOtherAssetExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociate" xlink:title="00000015 - Disclosure - Investment in associate">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfJointVenturesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfJointVenturesExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipment" xlink:title="00000016 - Disclosure - Property and equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwill" xlink:title="00000017 - Disclosure - Intangible assets and goodwill">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureIntangibleAssetsAndGoodwillAbstract" xlink:label="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfIntangibleAssetExplanatory" xlink:label="loc_afyaDisclosureOfIntangibleAssetExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" xlink:to="loc_afyaDisclosureOfIntangibleAssetExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" xlink:title="00000018 - Disclosure - Financial assets and financial liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurement" xlink:title="00000019 - Disclosure - Fair value measurement">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureFairValueMeasurementAbstract" xlink:label="loc_afyaDisclosureFairValueMeasurementAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FairValueMeasurementExplanatory" xlink:label="loc_afyaFairValueMeasurementExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureFairValueMeasurementAbstract" xlink:to="loc_afyaFairValueMeasurementExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CapitalManagement" xlink:title="00000020 - Disclosure - Capital management">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureCapitalManagementAbstract" xlink:label="loc_afyaDisclosureCapitalManagementAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CapitalManagementExplanatory" xlink:label="loc_afyaCapitalManagementExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCapitalManagementAbstract" xlink:to="loc_afyaCapitalManagementExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligations" xlink:title="00000021 - Disclosure - Labor and social obligations">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaborAndSocialObligationsExplanatory" xlink:label="loc_afyaLaborAndSocialObligationsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_afyaLaborAndSocialObligationsExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Equity" xlink:title="00000022 - Disclosure - Equity">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureEquityAbstract" xlink:label="loc_afyaDisclosureEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfEquityExplanatory" xlink:label="loc_afyaDisclosureOfEquityExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaDisclosureOfEquityExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEps" xlink:title="00000023 - Disclosure - Earnings per share (EPS)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-fullDisclosureOfEarningsPerShareExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfEarningsPerShareExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Revenue" xlink:title="00000024 - Disclosure - Revenue">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="loc_ifrs-fullDisclosureOfRevenueExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfRevenueExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNature" xlink:title="00000025 - Disclosure - Expenses and costs by nature">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:label="loc_ifrs-fullDisclosureOfExpensesByNatureExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfExpensesByNatureExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResult" xlink:title="00000026 - Disclosure - Finance result">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinanceIncomeExpenseExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinanceIncomeExpenseExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxes" xlink:title="00000027 - Disclosure - Income taxes">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureIncomeTaxesAbstract" xlink:label="loc_afyaDisclosureIncomeTaxesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfIncomeTaxesExplanatory" xlink:label="loc_afyaDisclosureOfIncomeTaxesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaDisclosureOfIncomeTaxesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingencies" xlink:title="00000028 - Disclosure - Insurance contracts and contingencies">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureInsuranceContractsAndContingenciesAbstract" xlink:label="loc_afyaDisclosureInsuranceContractsAndContingenciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfInsuranceContractsAndContingenciesExplanatory" xlink:label="loc_afyaDisclosureOfInsuranceContractsAndContingenciesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureInsuranceContractsAndContingenciesAbstract" xlink:to="loc_afyaDisclosureOfInsuranceContractsAndContingenciesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactions" xlink:title="00000029 - Disclosure - Non-cash transactions">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureNoncashTransactionsAbstract" xlink:label="loc_afyaDisclosureNoncashTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureNoncashTransactionsExplanatory" xlink:label="loc_afyaDisclosureNoncashTransactionsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureNoncashTransactionsAbstract" xlink:to="loc_afyaDisclosureNoncashTransactionsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEvent" xlink:title="00000030 - Disclosure - Subsequent event">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-fullDisclosureOfEventsAfterReportingPeriodExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfEventsAfterReportingPeriodExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" xlink:title="00000031 - Disclosure - Material accounting policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BusinessCombinationsAndGoodwillPolicyExplanatory" xlink:label="loc_afyaBusinessCombinationsAndGoodwillPolicyExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaBusinessCombinationsAndGoodwillPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" xlink:label="loc_afyaCurrentVersusNoncurrentClassificationPoliciesExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaCurrentVersusNoncurrentClassificationPoliciesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" xlink:label="loc_afyaFinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaFinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForLeasesExplanatory" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForLeasesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" xlink:label="loc_afyaImpairmentOfNonfinancialAssetsPolicyExplanatory" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaImpairmentOfNonfinancialAssetsPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory" xlink:label="loc_afyaDescriptionOfAccountingPolicyForInvestmentsExplanatory" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaDescriptionOfAccountingPolicyForInvestmentsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersPolicyExplanatory" xlink:label="loc_afyaAccountsPayableToSellingShareholdersPolicyExplanatory" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaAccountsPayableToSellingShareholdersPolicyExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForProvisionsExplanatory" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DividendsPolicyExplanatory" xlink:label="loc_afyaDividendsPolicyExplanatory" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaDividendsPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaborAndSocialObligationsPolicyExplanatory" xlink:label="loc_afyaLaborAndSocialObligationsPolicyExplanatory" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaLaborAndSocialObligationsPolicyExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SharebasedPaymentsPolicyExplanatory" xlink:label="loc_afyaSharebasedPaymentsPolicyExplanatory" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaSharebasedPaymentsPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:label="loc_ifrs-fullDisclosureOfRevenueFromContractsWithCustomersExplanatory" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxesPolicyExplanation" xlink:label="loc_afyaTaxesPolicyExplanation" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaTaxesPolicyExplanation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTreasurySharesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfTreasurySharesExplanatory" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfTreasurySharesExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesTables" xlink:title="00000032 - Disclosure - Material accounting policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" xlink:label="loc_afyaSummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaSummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:label="loc_afyaScheduleOfEstimatedUsefulLivesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" xlink:label="loc_afyaScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationTables" xlink:title="00000033 - Disclosure - Segment information (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" xlink:label="loc_afyaScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsTables" xlink:title="00000034 - Disclosure - Business combinations (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_afyaScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfAcquisitionOfDelReyExplanatory" xlink:label="loc_afyaScheduleOfAcquisitionOfDelReyExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfAcquisitionOfDelReyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock" xlink:label="loc_afyaScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory" xlink:label="loc_afyaScheduleOfAcquisitionOfAlemDaMedicinaExplanatory" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfAcquisitionOfAlemDaMedicinaExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfAcquisitionOfCardioPapersExplanatory" xlink:label="loc_afyaScheduleOfAcquisitionOfCardioPapersExplanatory" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfAcquisitionOfCardioPapersExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfAcquisitionOfGlicExplanatory" xlink:label="loc_afyaScheduleOfAcquisitionOfGlicExplanatory" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfAcquisitionOfGlicExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:title="00000035 - Disclosure - Cash and cash equivalents (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureCashAndCashEquivalentsAbstract" xlink:label="loc_afyaDisclosureCashAndCashEquivalentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="loc_afyaDisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCashAndCashEquivalentsAbstract" xlink:to="loc_afyaDisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesTables" xlink:title="00000036 - Disclosure - Trade receivables (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfTradeAndOtherReceivables1Explanatory" xlink:label="loc_afyaDisclosureOfTradeAndOtherReceivables1Explanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDisclosureOfTradeAndOtherReceivables1Explanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" xlink:label="loc_afyaDisclosureOfTradeAccountsReceivableByAgingExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDisclosureOfTradeAccountsReceivableByAgingExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory" xlink:label="loc_afyaDisclosureOfAllowanceForDoubtfulAccountsExplanatory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDisclosureOfAllowanceForDoubtfulAccountsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesTables" xlink:title="00000037 - Disclosure - Related parties (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfRelatedPartiesExplanatory" xlink:label="loc_afyaDisclosureOfRelatedPartiesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDisclosureOfRelatedPartiesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" xlink:label="loc_afyaSummaryOfKeyManagementPersonnelCompensationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaSummaryOfKeyManagementPersonnelCompensationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsTables" xlink:title="00000038 - Disclosure - Other assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOtherAssetsAbstract" xlink:label="loc_afyaDisclosureOtherAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfOtherAssetsTableTextBlock" xlink:label="loc_afyaDisclosureOfOtherAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaDisclosureOfOtherAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateTables" xlink:title="00000039 - Disclosure - Investment in associate (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfInvestmentsExplanatory" xlink:label="loc_afyaDisclosureOfInvestmentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDisclosureOfInvestmentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:title="00000040 - Disclosure - Property and equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" xlink:title="00000041 - Disclosure - Intangible assets and goodwill (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureIntangibleAssetsAndGoodwillAbstract" xlink:label="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfIntangibleAssetsTableTextBlock" xlink:label="loc_afyaSummaryOfIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" xlink:to="loc_afyaSummaryOfIntangibleAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" xlink:label="loc_afyaSummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" xlink:to="loc_afyaSummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" xlink:label="loc_afyaSummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" xlink:to="loc_afyaSummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" xlink:title="00000042 - Disclosure - Financial assets and financial liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialAssetsExplanatory" xlink:label="loc_afyaFinancialAssetsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaFinancialAssetsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialLiabilitiesExplanatory" xlink:label="loc_afyaFinancialLiabilitiesExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaFinancialLiabilitiesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingExplanatory" xlink:label="loc_afyaLoansAndFinancingExplanatory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaLoansAndFinancingExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfLeasesExplanatory" xlink:label="loc_afyaScheduleOfLeasesExplanatory" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfLeasesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersExplanatory" xlink:label="loc_afyaAccountsPayableToSellingShareholdersExplanatory" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaAccountsPayableToSellingShareholdersExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholders1Explanatory" xlink:label="loc_afyaAccountsPayableToSellingShareholders1Explanatory" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaAccountsPayableToSellingShareholders1Explanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock" xlink:label="loc_afyaScheduleOfCarryingAmountOfNotesPayableTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfCarryingAmountOfNotesPayableTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfFairValuesExplanatory" xlink:label="loc_afyaScheduleOfFairValuesExplanatory" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfFairValuesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" xlink:label="loc_afyaSummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaSummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" xlink:label="loc_afyaSummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaSummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" xlink:label="loc_afyaSummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaSummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:label="loc_afyaChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurementTables" xlink:title="00000043 - Disclosure - Fair value measurement (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureFairValueMeasurementAbstract" xlink:label="loc_afyaDisclosureFairValueMeasurementAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfFairValueMeasurementExplanaory" xlink:label="loc_afyaScheduleOfFairValueMeasurementExplanaory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureFairValueMeasurementAbstract" xlink:to="loc_afyaScheduleOfFairValueMeasurementExplanaory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:title="00000044 - Disclosure - Labor and social obligations (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:label="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RSUsMember" xlink:label="loc_afyaRSUsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:to="loc_afyaRSUsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions" xlink:label="loc_afyaScheduleOfModelUsedToDetermineFairValueOfStockOptions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfModelUsedToDetermineFairValueOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions" xlink:label="loc_afyaScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfAdditionalStockOptionsExplanatory" xlink:label="loc_afyaScheduleOfAdditionalStockOptionsExplanatory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAdditionalStockOptionsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfSharebasedCompensationPlanExplanatory" xlink:label="loc_afyaScheduleOfSharebasedCompensationPlanExplanatory" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfSharebasedCompensationPlanExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfStockOptionExplanatory" xlink:label="loc_afyaScheduleOfStockOptionExplanatory" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfStockOptionExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityTables" xlink:title="00000045 - Disclosure - Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureEquityAbstract" xlink:label="loc_afyaDisclosureEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfTreasurySharesMovementExplanatory" xlink:label="loc_afyaScheduleOfTreasurySharesMovementExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaScheduleOfTreasurySharesMovementExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEpsTables" xlink:title="00000046 - Disclosure - Earnings per share (EPS) (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOfEarningsPerShareTableExplanatory" xlink:label="loc_afyaDisclosureOfEarningsPerShareTableExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDisclosureOfEarningsPerShareTableExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueTables" xlink:title="00000047 - Disclosure - Revenue (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfNetSalesRevenueExplanatory" xlink:label="loc_afyaScheduleOfNetSalesRevenueExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfNetSalesRevenueExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfRevenueBySegmentTableTextBlock" xlink:label="loc_afyaScheduleOfRevenueBySegmentTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfRevenueBySegmentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNatureTables" xlink:title="00000048 - Disclosure - Expenses and costs by nature (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SummaryOfExpensesByNatureTableTextBlock" xlink:label="loc_afyaSummaryOfExpensesByNatureTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaSummaryOfExpensesByNatureTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultTables" xlink:title="00000049 - Disclosure - Finance result (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfFinanceResultTableTextBlock" xlink:label="loc_afyaScheduleOfFinanceResultTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfFinanceResultTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesTables" xlink:title="00000050 - Disclosure - Income taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureIncomeTaxesAbstract" xlink:label="loc_afyaDisclosureIncomeTaxesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" xlink:label="loc_afyaScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" xlink:title="00000051 - Disclosure - Insurance contracts and contingencies (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureInsuranceContractsAndContingenciesAbstract" xlink:label="loc_afyaDisclosureInsuranceContractsAndContingenciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfLegalProceedingsAndContingencies" xlink:label="loc_afyaScheduleOfLegalProceedingsAndContingencies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureInsuranceContractsAndContingenciesAbstract" xlink:to="loc_afyaScheduleOfLegalProceedingsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement" xlink:label="loc_afyaScheduleOfSocialSecurityProceedingsAssessedByManagement" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureInsuranceContractsAndContingenciesAbstract" xlink:to="loc_afyaScheduleOfSocialSecurityProceedingsAssessedByManagement" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactionsTables" xlink:title="00000052 - Disclosure - Non-cash transactions (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureNoncashTransactionsAbstract" xlink:label="loc_afyaDisclosureNoncashTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NonCashTransactionsTableTextBlock" xlink:label="loc_afyaNonCashTransactionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureNoncashTransactionsAbstract" xlink:to="loc_afyaNonCashTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:title="00000053 - Disclosure - Corporate information (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CorporateInformationAbstract" xlink:label="loc_afyaCorporateInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaCorporateInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BertelsmannMember" xlink:label="loc_afyaBertelsmannMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaBertelsmannMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-fullOrdinarySharesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_ifrs-fullOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SubsidiariesMember" xlink:label="loc_ifrs-fullSubsidiariesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_ifrs-fullSubsidiariesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquiredShares" xlink:label="loc_afyaAcquiredShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquiredShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestInSubsidiary" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestInSubsidiary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-fullConsiderationPaidReceived" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullConsiderationPaidReceived" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails" xlink:title="00000054 - Disclosure - Material accounting policies (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AfyaParticipacoesSAMember" xlink:label="loc_afyaAfyaParticipacoesSAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAfyaParticipacoesSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" xlink:label="loc_afyaUniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" xlink:label="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" xlink:label="loc_afyaCentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroIntegradoDeSaudeDeTeresinaCISMember" xlink:label="loc_afyaCentroIntegradoDeSaudeDeTeresinaCISMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroIntegradoDeSaudeDeTeresinaCISMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" xlink:label="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedcelEditoraEventosS.A.MedcelMember" xlink:label="loc_afyaMedcelEditoraEventosS.A.MedcelMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedcelEditoraEventosS.A.MedcelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoS.A.FASAMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoS.A.FASAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ESMCEducacaoSuperiorLtdaESMCMember" xlink:label="loc_afyaESMCEducacaoSuperiorLtdaESMCMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaESMCEducacaoSuperiorLtdaESMCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" xlink:label="loc_afyaInstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" xlink:label="loc_afyaInstitutoParaenseDeEducacaoECulturaLtda.IPECMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoParaenseDeEducacaoECulturaLtda.IPECMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember" xlink:label="loc_afyaSociedadeUniversitariaRedentorS.A.UniRedentorMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeUniversitariaRedentorS.A.UniRedentorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroDeEnsinoSaoLucasLtda.UniSLMember" xlink:label="loc_afyaCentroDeEnsinoSaoLucasLtda.UniSLMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroDeEnsinoSaoLucasLtda.UniSLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" xlink:label="loc_afyaPebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaPebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" xlink:label="loc_afyaSociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" xlink:label="loc_afyaCentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" xlink:label="loc_afyaIClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedicinaeSolutionsS.A.MedicinaeMember" xlink:label="loc_afyaMedicinaeSolutionsS.A.MedicinaeMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicinaeSolutionsS.A.MedicinaeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" xlink:label="loc_afyaCliquefarmaDrogariasOnlineLtda.CliquefarmaMember" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCliquefarmaDrogariasOnlineLtda.CliquefarmaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShospTecnologiaDaInformacaoLtda.ShospMember" xlink:label="loc_afyaShospTecnologiaDaInformacaoLtda.ShospMember" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospTecnologiaDaInformacaoLtda.ShospMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" xlink:label="loc_afyaSociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember" xlink:label="loc_afyaNucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaNucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" xlink:label="loc_afyaCompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" xlink:label="loc_afyaPoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaPoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadeEducacionalDePalhocaSALtda.Member" xlink:label="loc_afyaSociedadeEducacionalDePalhocaSALtda.Member" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeEducacionalDePalhocaSALtda.Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember" xlink:label="loc_afyaRXPROSolucoesDeTecnologiaLtda.RXPROMember" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROSolucoesDeTecnologiaLtda.RXPROMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember" xlink:label="loc_afyaRXPROLOGTransporteELogisticaLtda.RXPROLOGMember" />
      <link:presentationArc order="650" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROLOGTransporteELogisticaLtda.RXPROLOGMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BMVAtividadesMedicasLtda.AlemDaMedicinaMember" xlink:label="loc_afyaBMVAtividadesMedicasLtda.AlemDaMedicinaMember" />
      <link:presentationArc order="670" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaBMVAtividadesMedicasLtda.AlemDaMedicinaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CardiopapersSolucoesDigitaisLtda.CardioPapersMember" xlink:label="loc_afyaCardiopapersSolucoesDigitaisLtda.CardioPapersMember" />
      <link:presentationArc order="690" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCardiopapersSolucoesDigitaisLtda.CardioPapersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" xlink:label="loc_afyaQuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" />
      <link:presentationArc order="710" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaQuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" xlink:label="loc_afyaSociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" />
      <link:presentationArc order="730" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" xlink:label="loc_afyaUniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" />
      <link:presentationArc order="740" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PrincipalActivities" xlink:label="loc_afyaPrincipalActivities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPrincipalActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="loc_ifrs-fullPrincipalPlaceOfBusinessOfSubsidiary" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPrincipalPlaceOfBusinessOfSubsidiary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InvestmentType" xlink:label="loc_afyaInvestmentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInvestmentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" xlink:title="00000055 - Disclosure - Material accounting policies (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-fullBuildingsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullBuildingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="loc_afyaMachineryAndEquipmentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaMachineryAndEquipmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-fullVehiclesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullFixturesAndFittingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ItEquipmentMember" xlink:label="loc_afyaItEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaItEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LibraryBooksMember" xlink:label="loc_afyaLibraryBooksMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaLibraryBooksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-fullLeaseholdImprovementsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" xlink:title="00000056 - Disclosure - Material accounting policies (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InitiallyAppliedIFRSsAxis" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InitiallyAppliedIFRSsMember" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsAxis" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS1Member" xlink:label="loc_afyaAmendmentsToIAS1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIAS1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS8Member" xlink:label="loc_afyaAmendmentsToIAS8Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIAS8Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS12Member" xlink:label="loc_afyaAmendmentsToIAS12Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIAS12Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS12OneMember" xlink:label="loc_afyaAmendmentsToIAS12OneMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIAS12OneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IFRS17Member" xlink:label="loc_ifrs-fullIFRS17Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_ifrs-fullIFRS17Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIFRS16Member" xlink:label="loc_afyaAmendmentsToIFRS16Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIFRS16Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS1OneMember" xlink:label="loc_afyaAmendmentsToIAS1OneMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIAS1OneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AmendmentsToIAS7AndIFRS7Member" xlink:label="loc_afyaAmendmentsToIAS7AndIFRS7Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsMember" xlink:to="loc_afyaAmendmentsToIAS7AndIFRS7Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TitleOfInitiallyAppliedIFRS" xlink:label="loc_ifrs-fullTitleOfInitiallyAppliedIFRS" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTitleOfInitiallyAppliedIFRS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:label="loc_ifrs-fullDescriptionOfNatureOfChangeInAccountingPolicy" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfNatureOfChangeInAccountingPolicy" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" xlink:title="00000057 - Disclosure - Material accounting policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ProgramOfSocialIntegrationMember" xlink:label="loc_afyaProgramOfSocialIntegrationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="loc_afyaProgramOfSocialIntegrationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContributionForTheFinancingOfSocialSecurityMember" xlink:label="loc_afyaContributionForTheFinancingOfSocialSecurityMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="loc_afyaContributionForTheFinancingOfSocialSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-fullProductsAndServicesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="loc_ifrs-fullProductsAndServicesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="loc_ifrs-fullProductsAndServicesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProductsAndServicesAxis" xlink:to="loc_ifrs-fullProductsAndServicesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TeachingActivitiesMember" xlink:label="loc_afyaTeachingActivitiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProductsAndServicesMember" xlink:to="loc_afyaTeachingActivitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NonTeachingActivitiesMember" xlink:label="loc_afyaNonTeachingActivitiesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProductsAndServicesMember" xlink:to="loc_afyaNonTeachingActivitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-fullApplicableTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullApplicableTaxRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationDetails" xlink:title="00000058 - Disclosure - Segment information (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-fullSegmentConsolidationItemsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentConsolidationItemsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-fullOperatingSegmentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" xlink:to="loc_ifrs-fullOperatingSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaUndergradMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaContinuingEducationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DigitalServicesMember" xlink:label="loc_afyaDigitalServicesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaDigitalServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TotalReportableSegmentsMember" xlink:label="loc_afyaTotalReportableSegmentsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaTotalReportableSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdjustmentsAndEliminationsMember" xlink:label="loc_afyaAdjustmentsAndEliminationsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaAdjustmentsAndEliminationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquityAndLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CapitalExpenditures" xlink:label="loc_afyaCapitalExpenditures" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalExpenditures" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationDetails1" xlink:title="00000059 - Disclosure - Segment information (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-fullSegmentConsolidationItemsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentConsolidationItemsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-fullOperatingSegmentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" xlink:to="loc_ifrs-fullOperatingSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaUndergradMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaContinuingEducationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DigitalServicesMember" xlink:label="loc_afyaDigitalServicesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaDigitalServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TotalReportableSegmentsMember" xlink:label="loc_afyaTotalReportableSegmentsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaTotalReportableSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdjustmentsAndEliminationsMember" xlink:label="loc_afyaAdjustmentsAndEliminationsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaAdjustmentsAndEliminationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DepositsFromExternalCustomer" xlink:label="loc_afyaDepositsFromExternalCustomer" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDepositsFromExternalCustomer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InterSegment" xlink:label="loc_afyaInterSegment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInterSegment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CostOfSale" xlink:label="loc_afyaCostOfSale" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCostOfSale" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-fullGrossProfit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGrossProfit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullSellingGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherGainsLosses" xlink:label="loc_ifrs-fullOtherGainsLosses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherGainsLosses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinanceExpense" xlink:label="loc_afyaFinanceExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinanceExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-fullAdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails" xlink:title="00000060 - Disclosure - Business combinations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaDelReyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeReceivablesAsOfAcquisitionDate" xlink:label="loc_afyaTradeReceivablesAsOfAcquisitionDate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Inventories1" xlink:label="loc_afyaInventories1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInventories1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RecoverableTaxesAsOfAcquisitionDate" xlink:label="loc_afyaRecoverableTaxesAsOfAcquisitionDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRecoverableTaxesAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssetsAsOfAcquisitionDate" xlink:label="loc_afyaOtherAssetsAsOfAcquisitionDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_afyaRightOfUseAssetsAsOfAcquisitionDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRightOfUseAssetsAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:label="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxesPayableAsOfAcquisitionDate" xlink:label="loc_afyaTaxesPayableAsOfAcquisitionDate" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTaxesPayableAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:label="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:label="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaOtherLiabilitiesAsOfAcquisitionDate" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherLiabilitiesAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-fullCashTransferred" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ConsiderationToBeTransferred" xlink:label="loc_afyaConsiderationToBeTransferred" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsiderationToBeTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CirculationRevenue" xlink:label="loc_ifrs-fullCirculationRevenue" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCirculationRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NetOfCashFlowOnAcquisition" xlink:label="loc_afyaNetOfCashFlowOnAcquisition" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetOfCashFlowOnAcquisition" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails1" xlink:title="00000061 - Disclosure - Business combinations (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="loc_ifrs-fullLicencesAndFranchisesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullLicencesAndFranchisesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfDelReyMember" xlink:label="loc_afyaAcquisitionOfDelReyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAcquisitionOfDelReyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesMember" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WithAndWithoutMethodMember" xlink:label="loc_afyaWithAndWithoutMethodMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaWithAndWithoutMethodMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:label="loc_ifrs-fullMultiperiodExcessEarningsMethodMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_ifrs-fullMultiperiodExcessEarningsMethodMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails2" xlink:title="00000062 - Disclosure - Business combinations (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAlemDaMedicinaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CardioPapersMember" xlink:label="loc_afyaCardioPapersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCardioPapersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GlicMember" xlink:label="loc_afyaGlicMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaGlicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeReceivablesAsOfAcquisitionDate" xlink:label="loc_afyaTradeReceivablesAsOfAcquisitionDate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssetsAsOfAcquisitionDate" xlink:label="loc_afyaOtherAssetsAsOfAcquisitionDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:label="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxesPayableAsOfAcquisitionDate" xlink:label="loc_afyaTaxesPayableAsOfAcquisitionDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTaxesPayableAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:label="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaOtherLiabilitiesAsOfAcquisitionDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherLiabilitiesAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-fullCashTransferred" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashTransferred" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullContingentConsiderationRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ConsiderationToBeTransferred" xlink:label="loc_afyaConsiderationToBeTransferred" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsiderationToBeTransferred" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NetOfCashFlowOnAcquisition" xlink:label="loc_afyaNetOfCashFlowOnAcquisition" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetOfCashFlowOnAcquisition" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails3" xlink:title="00000063 - Disclosure - Business combinations (Details 3)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationalContentMember" xlink:label="loc_afyaEducationalContentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_afyaEducationalContentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAlemDaMedicinaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesMember" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReliefFromRoyaltyMember" xlink:label="loc_afyaReliefFromRoyaltyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaReliefFromRoyaltyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:label="loc_ifrs-fullMultiperiodExcessEarningsMethodMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_ifrs-fullMultiperiodExcessEarningsMethodMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReplacementCostMember" xlink:label="loc_afyaReplacementCostMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaReplacementCostMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails4" xlink:title="00000064 - Disclosure - Business combinations (Details 4)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationalContentMember" xlink:label="loc_afyaEducationalContentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_afyaEducationalContentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CopyrightMember" xlink:label="loc_afyaCopyrightMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_afyaCopyrightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfCardioPapersMember" xlink:label="loc_afyaAcquisitionOfCardioPapersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAcquisitionOfCardioPapersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesMember" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReliefFromRoyaltyMember" xlink:label="loc_afyaReliefFromRoyaltyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaReliefFromRoyaltyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:label="loc_ifrs-fullMultiperiodExcessEarningsMethodMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_ifrs-fullMultiperiodExcessEarningsMethodMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReplacementCostMember" xlink:label="loc_afyaReplacementCostMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaReplacementCostMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails5" xlink:title="00000065 - Disclosure - Business combinations (Details 5)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfGlicMember" xlink:label="loc_afyaAcquisitionOfGlicMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAcquisitionOfGlicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesMember" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReliefFromRoyaltyMember" xlink:label="loc_afyaReliefFromRoyaltyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaReliefFromRoyaltyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:label="loc_ifrs-fullMultiperiodExcessEarningsMethodMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_ifrs-fullMultiperiodExcessEarningsMethodMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReplacementCostMember" xlink:label="loc_afyaReplacementCostMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesMember" xlink:to="loc_afyaReplacementCostMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:title="00000066 - Disclosure - Business combinations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfDelReyMember" xlink:label="loc_afyaAcquisitionOfDelReyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaAcquisitionOfDelReyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaAlemDaMedicinaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfCardioPapersMember" xlink:label="loc_afyaAcquisitionOfCardioPapersMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaAcquisitionOfCardioPapersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CardioPapersMember" xlink:label="loc_afyaCardioPapersMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaCardioPapersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitionOfGlicMember" xlink:label="loc_afyaAcquisitionOfGlicMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaAcquisitionOfGlicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GlicMember" xlink:label="loc_afyaGlicMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaGlicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAcquiree" xlink:label="loc_ifrs-fullDescriptionOfAcquiree" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfAcquiree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseInRevenue" xlink:label="loc_afyaIncreaseInRevenue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseInRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseInIncomeBeforeIncomeTaxes" xlink:label="loc_afyaIncreaseInIncomeBeforeIncomeTaxes" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseInIncomeBeforeIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DecreaseInIncomeBeforeIncomeTaxes" xlink:label="loc_afyaDecreaseInIncomeBeforeIncomeTaxes" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDecreaseInIncomeBeforeIncomeTaxes" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetails" xlink:title="00000067 - Disclosure - Cash and cash equivalents (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureCashAndCashEquivalentsAbstract" xlink:label="loc_afyaDisclosureCashAndCashEquivalentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-fullCash" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCashAndCashEquivalentsAbstract" xlink:to="loc_ifrs-fullCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashEquivalents" xlink:label="loc_ifrs-fullCashEquivalents" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCashAndCashEquivalentsAbstract" xlink:to="loc_ifrs-fullCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCashAndCashEquivalentsAbstract" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:title="00000068 - Disclosure - Cash and cash equivalents (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureCashAndCashEquivalentsAbstract" xlink:label="loc_afyaDisclosureCashAndCashEquivalentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCashAndCashEquivalentsAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BankCertificatesOfDepositMember" xlink:label="loc_afyaBankCertificatesOfDepositMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaBankCertificatesOfDepositMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_srtCurrencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_USDMember" xlink:label="loc_afyaUSDMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_afyaUSDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PercenatgeOfAverageInterestOnFinancialInstrument" xlink:label="loc_afyaPercenatgeOfAverageInterestOnFinancialInstrument" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPercenatgeOfAverageInterestOnFinancialInstrument" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashEquivalents" xlink:label="loc_ifrs-fullCashEquivalents" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashEquivalents" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails" xlink:title="00000069 - Disclosure - Trade receivables (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TuitionFeesMember" xlink:label="loc_afyaTuitionFeesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaTuitionFeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationalContentMember" xlink:label="loc_afyaEducationalContentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaEducationalContentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FIESMember" xlink:label="loc_afyaFIESMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaFIESMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationalCreditsMember" xlink:label="loc_afyaEducationalCreditsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaEducationalCreditsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MobileAppSubscriptionMember" xlink:label="loc_afyaMobileAppSubscriptionMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaMobileAppSubscriptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OthersMember" xlink:label="loc_afyaOthersMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaOthersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReceivablesGross" xlink:label="loc_afyaReceivablesGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReceivablesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AllowanceForDoubtfulAccountsFoReceivable1" xlink:label="loc_afyaAllowanceForDoubtfulAccountsFoReceivable1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAllowanceForDoubtfulAccountsFoReceivable1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-fullTradeReceivables" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-fullCurrentTradeReceivables" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentTradeReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="loc_ifrs-fullNoncurrentTradeReceivables" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentTradeReceivables" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails1" xlink:title="00000070 - Disclosure - Trade receivables (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" xlink:label="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" xlink:label="loc_ifrs-fullFinancialAssetsNeitherPastDueNorImpairedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember" xlink:to="loc_ifrs-fullFinancialAssetsNeitherPastDueNorImpairedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PastDueStatusAxis" xlink:label="loc_ifrs-fullPastDueStatusAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_ifrs-fullPastDueStatusAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PastDueStatusMember" xlink:label="loc_ifrs-fullPastDueStatusMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusAxis" xlink:to="loc_ifrs-fullPastDueStatusMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentMember" xlink:label="loc_ifrs-fullCurrentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_ifrs-fullCurrentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:label="loc_afyaLaterThanOneMonthsAndNotLaterThanThreeMonthsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_afyaLaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="loc_ifrs-fullLaterThanThreeMonthsAndNotLaterThanSixMonthsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_ifrs-fullLaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LaterThanOneEightyMember" xlink:label="loc_afyaLaterThanOneEightyMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_afyaLaterThanOneEightyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReceivablesGross" xlink:label="loc_afyaReceivablesGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReceivablesGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails2" xlink:title="00000071 - Disclosure - Trade receivables (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="loc_ifrs-fullAllowanceAccountForCreditLossesOfFinancialAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAllowanceAccountForCreditLossesOfFinancialAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" xlink:label="loc_afyaAdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaAdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" xlink:label="loc_afyaWriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaWriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="loc_ifrs-fullAllowanceAccountForCreditLossesOfFinancialAssets_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAllowanceAccountForCreditLossesOfFinancialAssets_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetails" xlink:title="00000072 - Disclosure - Related parties (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UEPCMember" xlink:label="loc_afyaUEPCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaUEPCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EMIVEPatrulha24HorasLtdaMember" xlink:label="loc_afyaEMIVEPatrulha24HorasLtdaMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaEMIVEPatrulha24HorasLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RVLEstevesGestaoImobiliariaSAMember" xlink:label="loc_afyaRVLEstevesGestaoImobiliariaSAMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaRVLEstevesGestaoImobiliariaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UNIVACOPatrimonialLtdaMember" xlink:label="loc_afyaUNIVACOPatrimonialLtdaMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaUNIVACOPatrimonialLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IESVAPPatrimonialLtdaMember" xlink:label="loc_afyaIESVAPPatrimonialLtdaMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaIESVAPPatrimonialLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeReceivablesRelatedPartyTransactions" xlink:label="loc_afyaTradeReceivablesRelatedPartyTransactions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesRelatedPartyTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssetsRelatedPartyTransactions" xlink:label="loc_afyaOtherAssetsRelatedPartyTransactions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsRelatedPartyTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeAndOtherCurrentPayablesToRelatedParties1" xlink:label="loc_afyaTradeAndOtherCurrentPayablesToRelatedParties1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherCurrentPayablesToRelatedParties1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentAssetsOfRelatedParty1" xlink:label="loc_afyaNoncurrentAssetsOfRelatedParty1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNoncurrentAssetsOfRelatedParty1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholders" xlink:label="loc_afyaAccountsPayableToSellingShareholders" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-fullAmountsPayableRelatedPartyTransactions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmountsPayableRelatedPartyTransactions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableCurrent1" xlink:label="loc_afyaAccountsPayableCurrent1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableCurrent1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentPayablesToRelatedParties1" xlink:label="loc_afyaNoncurrentPayablesToRelatedParties1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNoncurrentPayablesToRelatedParties1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherIncomeRelatedPartyTransactions" xlink:label="loc_afyaOtherIncomeRelatedPartyTransactions" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherIncomeRelatedPartyTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeasesAsLesseeRelatedPartyTransactions" xlink:label="loc_ifrs-fullLeasesAsLesseeRelatedPartyTransactions" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeasesAsLesseeRelatedPartyTransactions" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetails1" xlink:title="00000073 - Disclosure - Related parties (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensationShorttermEmployeeBenefits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:label="loc_ifrs-fullAmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:title="00000074 - Disclosure - Related parties (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseAgreements1Member" xlink:label="loc_afyaLeaseAgreements1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaLeaseAgreements1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:label="loc_afyaInstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RVLEstevesGestaoImobiliariaSAMember" xlink:label="loc_afyaRVLEstevesGestaoImobiliariaSAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaRVLEstevesGestaoImobiliariaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UNIVACOPatrimonialLtdaMember" xlink:label="loc_afyaUNIVACOPatrimonialLtdaMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaUNIVACOPatrimonialLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IESVAPPatrimonialLtdaMember" xlink:label="loc_afyaIESVAPPatrimonialLtdaMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaIESVAPPatrimonialLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OperatingLeaseTermOfContract" xlink:label="loc_afyaOperatingLeaseTermOfContract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOperatingLeaseTermOfContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-fullPercentageOfEntitysRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfEntitysRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LesseeFinancesLeaseRenewalTerm" xlink:label="loc_afyaLesseeFinancesLeaseRenewalTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLesseeFinancesLeaseRenewalTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DescriptionOfLeaseTerm" xlink:label="loc_afyaDescriptionOfLeaseTerm" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDescriptionOfLeaseTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-fullCashOutflowForLeases" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashOutflowForLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DescriptionOfLeaseTerms" xlink:label="loc_afyaDescriptionOfLeaseTerms" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDescriptionOfLeaseTerms" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsDetails" xlink:title="00000075 - Disclosure - Other assets (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOtherAssetsAbstract" xlink:label="loc_afyaDisclosureOtherAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Advances1" xlink:label="loc_afyaAdvances1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaAdvances1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_JudicialDeposits" xlink:label="loc_afyaJudicialDeposits" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaJudicialDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-fullCurrentPrepaidExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_ifrs-fullCurrentPrepaidExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-fullOtherReceivables" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_ifrs-fullOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Dividend" xlink:label="loc_afyaDividend" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-fullDeferredTaxAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_ifrs-fullDeferredTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssets1" xlink:label="loc_afyaOtherAssets1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaOtherAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Assets1" xlink:label="loc_afyaAssets1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CurrentAssets1" xlink:label="loc_afyaCurrentAssets1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaCurrentAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentAssets1" xlink:label="loc_afyaNoncurrentAssets1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaNoncurrentAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsDetailsNarrative" xlink:title="00000076 - Disclosure - Other assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureOtherAssetsAbstract" xlink:label="loc_afyaDisclosureOtherAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAsset" xlink:label="loc_afyaOtherAsset" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaOtherAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateDetails" xlink:title="00000077 - Disclosure - Investment in associate (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AssociatesMember" xlink:label="loc_ifrs-fullAssociatesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_ifrs-fullAssociatesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EquityInAssociate" xlink:label="loc_afyaEquityInAssociate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEquityInAssociate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CompanyShareInEquity1" xlink:label="loc_afyaCompanyShareInEquity1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompanyShareInEquity1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-fullGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InvestmentGrossAmount" xlink:label="loc_afyaInvestmentGrossAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInvestmentGrossAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullSellingGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CompanyShareOfProfitss" xlink:label="loc_afyaCompanyShareOfProfitss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompanyShareOfProfitss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DividendsReceived1" xlink:label="loc_afyaDividendsReceived1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendsReceived1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsReceived" xlink:label="loc_ifrs-fullDividendsReceived" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsReceived" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="loc_ifrs-fullProfitLossOfAcquiree" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossOfAcquiree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates_2" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentDetails" xlink:title="00000078 - Disclosure - Property and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" />
      <link:presentationArc order="710" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-fullBuildingsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullBuildingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="loc_afyaMachineryAndEquipmentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaMachineryAndEquipmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-fullLandMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullLandMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-fullVehiclesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullFixturesAndFittingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ItEquipmentMember" xlink:label="loc_afyaItEquipmentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaItEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LibraryBooksMember" xlink:label="loc_afyaLibraryBooksMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaLibraryBooksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-fullLeaseholdImprovementsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-fullConstructionInProgressMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullConstructionInProgressMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PropertyPlantAndEquipments" xlink:label="loc_afyaPropertyPlantAndEquipments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPropertyPlantAndEquipments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullDepreciationPropertyPlantAndEquipment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDepreciationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WritOffOfPropertyPlantAndEquipment" xlink:label="loc_afyaWritOffOfPropertyPlantAndEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWritOffOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PropertyPlantAndEquipments" xlink:label="loc_afyaPropertyPlantAndEquipments_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPropertyPlantAndEquipments_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PropertyPlantAndEquipmentNetBookValue" xlink:label="loc_afyaPropertyPlantAndEquipmentNetBookValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPropertyPlantAndEquipmentNetBookValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails" xlink:title="00000079 - Disclosure - Intangible assets and goodwill (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureIntangibleAssetsAndGoodwillAbstract" xlink:label="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-fullGoodwillMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullGoodwillMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-fullLicencesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullLicencesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-fullComputerSoftwareMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullComputerSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationContentMember" xlink:label="loc_afyaEducationContentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationContentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationalPlatformMember" xlink:label="loc_afyaEducationalPlatformMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationalPlatformMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SoftwareInProgressMember" xlink:label="loc_afyaSoftwareInProgressMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaSoftwareInProgressMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherMember" xlink:label="loc_afyaOtherMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" />
      <link:presentationArc order="740" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WriteoffOfIntangibleAssets" xlink:label="loc_afyaWriteoffOfIntangibleAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWriteoffOfIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Remesurement" xlink:label="loc_afyaRemesurement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemesurement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Transfer" xlink:label="loc_afyaTransfer" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTransfer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwill_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwill_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IntangibleAssetsAndGoodwillNetBookValue" xlink:label="loc_afyaIntangibleAssetsAndGoodwillNetBookValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIntangibleAssetsAndGoodwillNetBookValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1" xlink:title="00000080 - Disclosure - Intangible assets and goodwill (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureIntangibleAssetsAndGoodwillAbstract" xlink:label="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CarryingAmountsMember" xlink:label="loc_afyaCarryingAmountsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_afyaCarryingAmountsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:label="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:label="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:label="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:label="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniRedentorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniSLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FESARMember" xlink:label="loc_afyaFESARMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFESARMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFCMPBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ITPACGaranhunsMember" xlink:label="loc_afyaITPACGaranhunsMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaITPACGaranhunsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedcelAndCBBWMember" xlink:label="loc_afyaMedcelAndCBBWMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedcelAndCBBWMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PracticeManagementToolsAndElectronicPrescriptionMember" xlink:label="loc_afyaPracticeManagementToolsAndElectronicPrescriptionMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaPracticeManagementToolsAndElectronicPrescriptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ClinicalDecisionSoftwareMember" xlink:label="loc_afyaClinicalDecisionSoftwareMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaClinicalDecisionSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CliquefarmaMember" xlink:label="loc_afyaCliquefarmaMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCliquefarmaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UnifipMocMember" xlink:label="loc_afyaUnifipMocMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUnifipMocMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUnigranrioMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GlicMember" xlink:label="loc_afyaGlicMember" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaGlicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaDelReyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-fullGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CashGeneratingUnits" xlink:label="loc_afyaCashGeneratingUnits" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCashGeneratingUnits" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2" xlink:title="00000081 - Disclosure - Intangible assets and goodwill (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureIntangibleAssetsAndGoodwillAbstract" xlink:label="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CustomerRelationshipsMedicineMember" xlink:label="loc_afyaCustomerRelationshipsMedicineMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaCustomerRelationshipsMedicineMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CustomerRelationshipsOtherCoursesMember" xlink:label="loc_afyaCustomerRelationshipsOtherCoursesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaCustomerRelationshipsOtherCoursesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-fullComputerSoftwareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullComputerSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EducationContentMember" xlink:label="loc_afyaEducationContentMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationContentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DevelopedTechnologyMember" xlink:label="loc_afyaDevelopedTechnologyMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaDevelopedTechnologyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" xlink:title="00000082 - Disclosure - Intangible assets and goodwill (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureIntangibleAssetsAndGoodwillAbstract" xlink:label="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAndGoodwillAbstract" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-fullGoodwillMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullGoodwillMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfDiscountRatesAppliedToCashFlowProjections" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExplicitProjectionPeriod" xlink:label="loc_afyaExplicitProjectionPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExplicitProjectionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PerpetuityGrowthRate" xlink:label="loc_afyaPerpetuityGrowthRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPerpetuityGrowthRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails" xlink:title="00000083 - Disclosure - Financial assets and financial liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="loc_ifrs-fullFinancialAssetsAtAmortisedCostMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_ifrs-fullFinancialAssetsAtAmortisedCostMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-fullTradeReceivables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialAssets" xlink:label="loc_ifrs-fullCurrentFinancialAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="loc_ifrs-fullNoncurrentFinancialAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1" xlink:title="00000084 - Disclosure - Financial assets and financial liabilities (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtAmortisedCostMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtAmortisedCostMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotePayable" xlink:label="loc_afyaNotePayable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNotePayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentFinancialLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentFinancialLiabilities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2" xlink:title="00000085 - Disclosure - Financial assets and financial liabilities (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-fullAggregatedTimeBandsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullAggregatedTimeBandsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentyFiveMember" xlink:label="loc_afyaTwentyTwentyFiveMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentySevenMember" xlink:label="loc_afyaTwentyTwentySevenMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentySevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentyFourMember" xlink:label="loc_afyaTwentyTwentyFourMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentySixMember" xlink:label="loc_afyaTwentyTwentySixMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentySixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TwentyTwentyEightMember" xlink:label="loc_afyaTwentyTwentyEightMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyEightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialInstitution" xlink:label="loc_afyaFinancialInstitution" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialInstitution" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-fullBorrowingsInterestRateBasis" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsInterestRateBasis" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-fullBorrowingsMaturity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsMaturity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingCurrent" xlink:label="loc_afyaLoansAndFinancingCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingNonCurrent" xlink:label="loc_afyaLoansAndFinancingNonCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingNonCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3" xlink:title="00000086 - Disclosure - Financial assets and financial liabilities  (Details 3)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullRightofuseAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-fullAdditionsToRightofuseAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAdditionsToRightofuseAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdditionsToLeaseLiabilities" xlink:label="loc_afyaAdditionsToLeaseLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaAdditionsToLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsRemeasurement" xlink:label="loc_afyaRightofuseAssetsRemeasurement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsRemeasurement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseLiabilitiesRemeasurement" xlink:label="loc_afyaLeaseLiabilitiesRemeasurement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaLeaseLiabilitiesRemeasurement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsBusinessCombinations" xlink:label="loc_afyaRightofuseAssetsBusinessCombinations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsBusinessCombinations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BusinessCombinationsLeaseLiabilities" xlink:label="loc_afyaBusinessCombinationsLeaseLiabilities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaBusinessCombinationsLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-fullDepreciationRightofuseAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDepreciationRightofuseAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DepreciationExpenseLeaseLiabilities" xlink:label="loc_afyaDepreciationExpenseLeaseLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDepreciationExpenseLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsInterestExpense" xlink:label="loc_afyaRightofuseAssetsInterestExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsPaymentsOfLeaseLiabilities" xlink:label="loc_afyaRightofuseAssetsPaymentsOfLeaseLiabilities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsPaymentsOfLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" xlink:label="loc_afyaPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsPaymentsOfInterest" xlink:label="loc_afyaRightofuseAssetsPaymentsOfInterest" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsPaymentsOfInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentsOfInterestLeaseLiabilities" xlink:label="loc_afyaPaymentsOfInterestLeaseLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaPaymentsOfInterestLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsWriteoff" xlink:label="loc_afyaRightofuseAssetsWriteoff" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsWriteoff" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseLiabilitiesWriteoff" xlink:label="loc_afyaLeaseLiabilitiesWriteoff" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaLeaseLiabilitiesWriteoff" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullRightofuseAssets_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullLeaseLiabilities_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsCurrent" xlink:label="loc_afyaRightofuseAssetsCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-fullCurrentLeaseLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullCurrentLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RightofuseAssetsNonCurrent" xlink:label="loc_afyaRightofuseAssetsNonCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsNonCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-fullNoncurrentLeaseLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullNoncurrentLeaseLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4" xlink:title="00000087 - Disclosure - Financial assets and financial liabilities (Details 4)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IPEMEDMember" xlink:label="loc_afyaIPEMEDMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIPEMEDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniRedentorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniSLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFCMPBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUnigranrioMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GuaranhunsMember" xlink:label="loc_afyaGuaranhunsMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaGuaranhunsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAlemDaMedicinaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CardiPapersMember" xlink:label="loc_afyaCardiPapersMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCardiPapersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GlicMember" xlink:label="loc_afyaGlicMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaGlicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaDelReyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersCurrent" xlink:label="loc_afyaAccountsPayableToSellingShareholdersCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:label="loc_afyaAccountsPayableToSellingShareholdersNonCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersNonCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5" xlink:title="00000088 - Disclosure - Financial assets and financial liabilities (Details 5)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholderCashFlows" xlink:label="loc_afyaAccountsPayableToSellingShareholderCashFlows" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholderCashFlows" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" xlink:label="loc_afyaAccountsPayableToSellingShareholdersAcquisitionOfIpec" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersAcquisitionOfIpec" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpense" xlink:label="loc_ifrs-fullInterestExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:label="loc_afyaAccountsPayableToSellingShareholdersBusinessCombinations" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersBusinessCombinations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContingentConsiderationOnBusinessCombinations" xlink:label="loc_afyaContingentConsiderationOnBusinessCombinations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContingentConsiderationOnBusinessCombinations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Reversals" xlink:label="loc_afyaReversals" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReversals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RemeasurementOfEarnouts" xlink:label="loc_afyaRemeasurementOfEarnouts" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemeasurementOfEarnouts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6" xlink:title="00000089 - Disclosure - Financial assets and financial liabilities (Details 6)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotesPayables" xlink:label="loc_afyaNotesPayables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaNotesPayables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Payments" xlink:label="loc_afyaPayments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentsOfInterest" xlink:label="loc_afyaPaymentsOfInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaPaymentsOfInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MonetaryIndexation" xlink:label="loc_afyaMonetaryIndexation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaMonetaryIndexation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotesPayables" xlink:label="loc_afyaNotesPayables_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaNotesPayables_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CurrentLiabilities1" xlink:label="loc_afyaCurrentLiabilities1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaCurrentLiabilities1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NoncurrentLiabilities1" xlink:label="loc_afyaNoncurrentLiabilities1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaNoncurrentLiabilities1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7" xlink:title="00000090 - Disclosure - Financial assets and financial liabilities (Details 7)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivablesMember" xlink:label="loc_ifrs-fullTradeReceivablesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_ifrs-fullTradeReceivablesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-fullLeaseLiabilitiesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_ifrs-fullLeaseLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotesPayableMember" xlink:label="loc_afyaNotesPayableMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaNotesPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="loc_ifrs-fullFinancialAssetsAtFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8" xlink:title="00000091 - Disclosure - Financial assets and financial liabilities (Details 8)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CashEquivalents1Member" xlink:label="loc_afyaCashEquivalents1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaCashEquivalents1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="loc_ifrs-fullTypesOfInterestRatesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullTypesOfInterestRatesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateTypesMember" xlink:label="loc_ifrs-fullInterestRateTypesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfInterestRatesAxis" xlink:to="loc_ifrs-fullInterestRateTypesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FloatingInterestRateMember" xlink:label="loc_ifrs-fullFloatingInterestRateMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInterestRateTypesMember" xlink:to="loc_ifrs-fullFloatingInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateRiskMember" xlink:label="loc_ifrs-fullInterestRateRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullInterestRateRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingOneMember" xlink:label="loc_afyaLoansAndFinancingOneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingTwoMember" xlink:label="loc_afyaLoansAndFinancingTwoMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingThreeMember" xlink:label="loc_afyaLoansAndFinancingThreeMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersOneMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersOneMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AccountsPayableToSellingShareholdersTwoMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersTwoMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CashEquivalents1Member" xlink:label="loc_afyaCashEquivalents1Member_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaCashEquivalents1Member_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProbabilityOfDefaultAxis" xlink:label="loc_ifrs-fullProbabilityOfDefaultAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullProbabilityOfDefaultAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForProbabilityOfDefaultMember" xlink:label="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProbabilityOfDefaultAxis" xlink:to="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseBasisPointsMember" xlink:label="loc_afyaIncreaseBasisPointsMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:to="loc_afyaIncreaseBasisPointsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseBasisPointsOneMember" xlink:label="loc_afyaIncreaseBasisPointsOneMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:to="loc_afyaIncreaseBasisPointsOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IndexRatePerYear" xlink:label="loc_afyaIndexRatePerYear" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIndexRatePerYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_BaseRate" xlink:label="loc_afyaBaseRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaBaseRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9" xlink:title="00000092 - Disclosure - Financial assets and financial liabilities (Details 9)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:label="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RiskExposuresAxis" xlink:label="loc_ifrs-fullRiskExposuresAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:to="loc_ifrs-fullRiskExposuresAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RiskExposuresMember" xlink:label="loc_ifrs-fullRiskExposuresMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRiskExposuresAxis" xlink:to="loc_ifrs-fullRiskExposuresMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ForeignCurrencyExposuresMember" xlink:label="loc_afyaForeignCurrencyExposuresMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRiskExposuresMember" xlink:to="loc_afyaForeignCurrencyExposuresMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseForeignCurrencyMember" xlink:label="loc_afyaIncreaseForeignCurrencyMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRiskExposuresMember" xlink:to="loc_afyaIncreaseForeignCurrencyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DecreaseForeignCurrencyMember" xlink:label="loc_afyaDecreaseForeignCurrencyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRiskExposuresMember" xlink:to="loc_afyaDecreaseForeignCurrencyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-fullCurrencyRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullCurrencyRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10" xlink:title="00000093 - Disclosure - Financial assets and financial liabilities (Details 10)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-fullAggregatedTimeBandsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullAggregatedTimeBandsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-fullLaterThanOneYearMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanOneYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanThreeYearsAndNotLaterThanFiveYearsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanFiveYearsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanFiveYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-fullLiquidityRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullLiquidityRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NotePayables" xlink:label="loc_afyaNotePayables" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNotePayables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Advances" xlink:label="loc_ifrs-fullAdvances" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdvances" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialLiabilitiesContractualUndiscounted" xlink:label="loc_afyaFinancialLiabilitiesContractualUndiscounted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialLiabilitiesContractualUndiscounted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11" xlink:title="00000094 - Disclosure - Financial assets and financial liabilities (Details 11)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:to="loc_afyaLoansAndFinancingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-fullLeaseLiabilitiesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:to="loc_ifrs-fullLeaseLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DividendsPayableMember" xlink:label="loc_afyaDividendsPayableMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:to="loc_afyaDividendsPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:label="loc_afyaIncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:title="00000095 - Disclosure - Financial assets and financial liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniRedentorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniSLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFCMPBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUnigranrioMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ITPACGaranhunsMember" xlink:label="loc_afyaITPACGaranhunsMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaITPACGaranhunsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAlemDaMedicinaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CardioPapersMember" xlink:label="loc_afyaCardioPapersMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCardioPapersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_GlicMember" xlink:label="loc_afyaGlicMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaGlicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaDelReyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-fullCurrencyRiskMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullCurrencyRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_srtCurrencyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_EUR" xlink:label="loc_currencyEUR" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyEUR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContractualLeaseTerm" xlink:label="loc_afyaContractualLeaseTerm" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContractualLeaseTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-fullExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:label="loc_afyaRemainingTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemainingTradeAndOtherPayablesToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EqualInstallmentsPayablesToRelatedParties1" xlink:label="loc_afyaEqualInstallmentsPayablesToRelatedParties1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEqualInstallmentsPayablesToRelatedParties1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EqualInstallmentsPayablesToRelatedParties" xlink:label="loc_afyaEqualInstallmentsPayablesToRelatedParties" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEqualInstallmentsPayablesToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="loc_ifrs-fullDefinedBenefitObligationAtPresentValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDefinedBenefitObligationAtPresentValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="loc_ifrs-fullTransactionPriceAllocatedToRemainingPerformanceObligations" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTransactionPriceAllocatedToRemainingPerformanceObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" xlink:label="loc_ifrs-fullNoncurrentPayablesForPurchaseOfEnergy" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentPayablesForPurchaseOfEnergy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RemainingBalancePaid" xlink:label="loc_afyaRemainingBalancePaid" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemainingBalancePaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ConsiderationToBeTransferred" xlink:label="loc_afyaConsiderationToBeTransferred" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsiderationToBeTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-fullConsiderationPaidReceived" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullConsiderationPaidReceived" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FirstAnnualInstallmentsPayable" xlink:label="loc_afyaFirstAnnualInstallmentsPayable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFirstAnnualInstallmentsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SecondAnnualInstallmentsPayable" xlink:label="loc_afyaSecondAnnualInstallmentsPayable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSecondAnnualInstallmentsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ThirdAnnualInstallmentsPayable" xlink:label="loc_afyaThirdAnnualInstallmentsPayable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaThirdAnnualInstallmentsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AcquisitiondateFairValueOfTotalConsiderationTransferred1" xlink:label="loc_afyaAcquisitiondateFairValueOfTotalConsiderationTransferred1" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquisitiondateFairValueOfTotalConsiderationTransferred1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CreditExposure" xlink:label="loc_ifrs-fullCreditExposure" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCreditExposure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SensitivityChangeInTheEuroExchangeRate" xlink:label="loc_afyaSensitivityChangeInTheEuroExchangeRate" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSensitivityChangeInTheEuroExchangeRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-fullClosingForeignExchangeRate" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullClosingForeignExchangeRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurementDetails" xlink:title="00000096 - Disclosure - Fair value measurement (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureFairValueMeasurementAbstract" xlink:label="loc_afyaDisclosureFairValueMeasurementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureFairValueMeasurementAbstract" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-fullMeasurementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullMeasurementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-fullAggregatedMeasurementMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMeasurementAxis" xlink:to="loc_ifrs-fullAggregatedMeasurementMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" xlink:label="loc_ifrs-fullNotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedMeasurementMember" xlink:to="loc_ifrs-fullNotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:to="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel2OfFairValueHierarchyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" xlink:to="loc_ifrs-fullLevel2OfFairValueHierarchyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel3OfFairValueHierarchyMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" xlink:to="loc_ifrs-fullLevel3OfFairValueHierarchyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="loc_ifrs-fullNoncurrentTradeReceivables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentTradeReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LoansAndFinancingLiabilities" xlink:label="loc_afyaLoansAndFinancingLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseLiabilities1" xlink:label="loc_afyaLeaseLiabilities1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilities1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" xlink:label="loc_afyaTradeAndOtherPayablesToRelatedPartiesLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherPayablesToRelatedPartiesLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FairValueNotesPayables1" xlink:label="loc_afyaFairValueNotesPayables1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFairValueNotesPayables1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails" xlink:title="00000097 - Disclosure - Labor and social obligations (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ModifiedPlanMember" xlink:label="loc_afyaModifiedPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaModifiedPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OriginalPlanMember" xlink:label="loc_afyaOriginalPlanMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaOriginalPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IncrementalStockOptionsMember" xlink:label="loc_afyaIncrementalStockOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:to="loc_afyaIncrementalStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExpectedLifeOfStockOptions" xlink:label="loc_afyaExpectedLifeOfStockOptions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExpectedLifeOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails1" xlink:title="00000098 - Disclosure - Labor and social obligations (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ModifiedPlanMember" xlink:label="loc_afyaModifiedPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaModifiedPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RSUsMember" xlink:label="loc_afyaRSUsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:to="loc_afyaRSUsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExpectedLifeOfStockOptions" xlink:label="loc_afyaExpectedLifeOfStockOptions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExpectedLifeOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails2" xlink:title="00000099 - Disclosure - Labor and social obligations (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ModifiedPlanMember" xlink:label="loc_afyaModifiedPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaModifiedPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OriginalPlanMember" xlink:label="loc_afyaOriginalPlanMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaOriginalPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IPCAMember" xlink:label="loc_afyaIPCAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:to="loc_afyaIPCAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CDIMember" xlink:label="loc_afyaCDIMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:to="loc_afyaCDIMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExpectedLifeOfStockOptions" xlink:label="loc_afyaExpectedLifeOfStockOptions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExpectedLifeOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails3" xlink:title="00000100 - Disclosure - Labor and social obligations (Details 3)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:label="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="loc_ifrs-fullAntidilutiveInstrumentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfAntidilutiveInstrumentsAxis" xlink:to="loc_ifrs-fullAntidilutiveInstrumentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOptionsMember" xlink:label="loc_ifrs-fullShareOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAntidilutiveInstrumentsMember" xlink:to="loc_ifrs-fullShareOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGrante" xlink:label="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGrante" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGrante" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExpectedLifeOfStockOptions" xlink:label="loc_afyaExpectedLifeOfStockOptions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExpectedLifeOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails4" xlink:title="00000101 - Disclosure - Labor and social obligations (Details 4)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOptionsMember" xlink:label="loc_ifrs-fullShareOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_ifrs-fullShareOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" xlink:label="loc_afyaWeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExpiredInSharebasedPaymentArrangement" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfStockOptionsExercisable" xlink:label="loc_afyaNumberOfStockOptionsExercisable" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfStockOptionsExercisable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails5" xlink:title="00000102 - Disclosure - Labor and social obligations (Details 5)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-fullDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="loc_ifrs-fullDefinedBenefitPlansMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnitsMember" xlink:label="loc_afyaRestrictedStockUnitsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansMember" xlink:to="loc_afyaRestrictedStockUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:title="00000103 - Disclosure - Labor and social obligations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OptionsGrantedMember" xlink:label="loc_afyaOptionsGrantedMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaOptionsGrantedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnitsMember" xlink:label="loc_afyaRestrictedStockUnitsMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaRestrictedStockUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnits1Member" xlink:label="loc_afyaRestrictedStockUnits1Member" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaRestrictedStockUnits1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnits2Member" xlink:label="loc_afyaRestrictedStockUnits2Member" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaRestrictedStockUnits2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnits3Member" xlink:label="loc_afyaRestrictedStockUnits3Member" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaRestrictedStockUnits3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-fullDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullDefinedBenefitPlansAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="loc_ifrs-fullDefinedBenefitPlansMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShareBasedCompensationPlansMember" xlink:label="loc_afyaShareBasedCompensationPlansMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansMember" xlink:to="loc_afyaShareBasedCompensationPlansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RestrictedStockUnitsMember" xlink:label="loc_afyaRestrictedStockUnitsMember_2" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansMember" xlink:to="loc_afyaRestrictedStockUnitsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ShareBasedCompensationOfEmployees" xlink:label="loc_afyaShareBasedCompensationOfEmployees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaShareBasedCompensationOfEmployees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_StrikePrice" xlink:label="loc_afyaStrikePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AverageIncrementalFairValue" xlink:label="loc_afyaAverageIncrementalFairValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAverageIncrementalFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestInJointVenture" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestInJointVenture" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-fullWeightedAverageSharePriceShareOptionsGranted2019" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageSharePriceShareOptionsGranted2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SocialObligationsLiabilities" xlink:label="loc_afyaSocialObligationsLiabilities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSocialObligationsLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetails" xlink:title="00000104 - Disclosure - Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureEquityAbstract" xlink:label="loc_afyaDisclosureEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-fullNumberOfSharesOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_ifrs-fullNumberOfSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_afyaWeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaWeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfSharesRepurchased" xlink:label="loc_afyaNumberOfSharesRepurchased" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaNumberOfSharesRepurchased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AveragePriceRepurchased" xlink:label="loc_afyaAveragePriceRepurchased" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaAveragePriceRepurchased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" xlink:label="loc_afyaNumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaNumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AveragePriceDeliveredUnderSharebasedCompensationPlan" xlink:label="loc_afyaAveragePriceDeliveredUnderSharebasedCompensationPlan" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaAveragePriceDeliveredUnderSharebasedCompensationPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TransferredFromExerciseOfStockOptions" xlink:label="loc_afyaTransferredFromExerciseOfStockOptions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaTransferredFromExerciseOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AveragePriceTransferredFromExerciseOfStockOptions" xlink:label="loc_afyaAveragePriceTransferredFromExerciseOfStockOptions" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaAveragePriceTransferredFromExerciseOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TransferredFromSharesContribution" xlink:label="loc_afyaTransferredFromSharesContribution" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaTransferredFromSharesContribution" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AveragePriceTransferredFromSharesContribution" xlink:label="loc_afyaAveragePriceTransferredFromSharesContribution" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaAveragePriceTransferredFromSharesContribution" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-fullNumberOfSharesOutstanding_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_ifrs-fullNumberOfSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_afyaWeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaWeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetailsNarrative" xlink:title="00000105 - Disclosure - Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureEquityAbstract" xlink:label="loc_afyaDisclosureEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassAOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassBOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIssuedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumberOfSharesIssued1" xlink:label="loc_afyaNumberOfSharesIssued1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-fullNumberOfSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IssuedCapitals" xlink:label="loc_afyaIssuedCapitals" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIssuedCapitals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PaymentOfDividends" xlink:label="loc_afyaPaymentOfDividends" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPaymentOfDividends" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DividendDistributed" xlink:label="loc_afyaDividendDistributed" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendDistributed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:label="loc_ifrs-fullDividendsPaidToNoncontrollingInterests" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaidToNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RepurchaseOfOrdinaryShares" xlink:label="loc_afyaRepurchaseOfOrdinaryShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRepurchaseOfOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CashOutflow" xlink:label="loc_afyaCashOutflow" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCashOutflow" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEpsDetails" xlink:title="00000106 - Disclosure - Earnings per share (EPS) (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NumeratorAbstract" xlink:label="loc_afyaNumeratorAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaNumeratorAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:label="loc_ifrs-fullAdjustmentToProfitLossForPreferenceShareDividends" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAdjustmentToProfitLossForPreferenceShareDividends" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DenominatorAbstract" xlink:label="loc_afyaDenominatorAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDenominatorAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-fullWeightedAverageShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullWeightedAverageShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-fullDilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-fullAdjustedWeightedAverageShares" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAdjustedWeightedAverageShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-fullBasicEarningsLossPerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullBasicEarningsLossPerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-fullDilutedEarningsLossPerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDilutedEarningsLossPerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueDetails" xlink:title="00000107 - Disclosure - Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ProfessionalFeesExpenses" xlink:label="loc_afyaProfessionalFeesExpenses" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaProfessionalFeesExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherRevenue1" xlink:label="loc_afyaOtherRevenue1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaOtherRevenue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DeductionAbstract" xlink:label="loc_afyaDeductionAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDeductionAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DeductionOfGrantedDiscounts" xlink:label="loc_afyaDeductionOfGrantedDiscounts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDeductionOfGrantedDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DeductionOfEarlyPaymentDiscounts" xlink:label="loc_afyaDeductionOfEarlyPaymentDiscounts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDeductionOfEarlyPaymentDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DeductionOfReturnsOfNetRevenue" xlink:label="loc_afyaDeductionOfReturnsOfNetRevenue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDeductionOfReturnsOfNetRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DeductionOfTaxes" xlink:label="loc_afyaDeductionOfTaxes" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDeductionOfTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DeductionOfProuni" xlink:label="loc_afyaDeductionOfProuni" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDeductionOfProuni" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="loc_ifrs-fullRevenueFromContractsWithCustomers" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullRevenueFromContractsWithCustomers" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" xlink:label="loc_afyaTimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaTimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FeeAndCommissionIncome" xlink:label="loc_ifrs-fullFeeAndCommissionIncome" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullFeeAndCommissionIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NetRevenueOtherTransferredPoint" xlink:label="loc_afyaNetRevenueOtherTransferredPoint" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaNetRevenueOtherTransferredPoint" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueDetails1" xlink:title="00000108 - Disclosure - Revenue (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_ifrs-fullSegmentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaUndergradMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaContinuingEducationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DigitalServicesMember" xlink:label="loc_afyaDigitalServicesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaDigitalServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_EliminationInterSegmentTransactionsMember" xlink:label="loc_afyaEliminationInterSegmentTransactionsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaEliminationInterSegmentTransactionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-fullProfessionalFeesExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfessionalFeesExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-fullOtherRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TimingRevenueRecognition" xlink:label="loc_afyaTimingRevenueRecognition" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTimingRevenueRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FeeAndCommissionIncome" xlink:label="loc_ifrs-fullFeeAndCommissionIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFeeAndCommissionIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_NetRevenueOtherTransferredPoint" xlink:label="loc_afyaNetRevenueOtherTransferredPoint" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetRevenueOtherTransferredPoint" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNatureDetails" xlink:title="00000109 - Disclosure - Expenses and costs by nature (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullGeneralAndAdministrativeExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-fullExpenseByNature" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullExpenseByNature" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Payroll" xlink:label="loc_afyaPayroll" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaPayroll" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_HospitalAndMedicalAgreements" xlink:label="loc_afyaHospitalAndMedicalAgreements" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaHospitalAndMedicalAgreements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-fullDepreciationExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDepreciationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LeaseExpenses" xlink:label="loc_afyaLeaseExpenses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaLeaseExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UtilitiesExpense" xlink:label="loc_ifrs-fullUtilitiesExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullUtilitiesExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RepairsAndMaintenanceExpense" xlink:label="loc_ifrs-fullRepairsAndMaintenanceExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullRepairsAndMaintenanceExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_SharesBasedCompensation" xlink:label="loc_afyaSharesBasedCompensation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaSharesBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxExpenses" xlink:label="loc_afyaTaxExpenses" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaTaxExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-fullServicesExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullServicesExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-fullSalesAndMarketingExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullSalesAndMarketingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AllowanceForExpectedCreditLosses" xlink:label="loc_afyaAllowanceForExpectedCreditLosses" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaAllowanceForExpectedCreditLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TravelExpense" xlink:label="loc_ifrs-fullTravelExpense" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullTravelExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ConsultingFees" xlink:label="loc_afyaConsultingFees" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaConsultingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_Other" xlink:label="loc_afyaOther" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ExpenseByNatureOne" xlink:label="loc_afyaExpenseByNatureOne" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaExpenseByNatureOne" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultDetails" xlink:title="00000110 - Disclosure - Finance result (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InvestmentIncome" xlink:label="loc_ifrs-fullInvestmentIncome" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullInvestmentIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromInterest" xlink:label="loc_ifrs-fullRevenueFromInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullRevenueFromInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherFinanceIncome" xlink:label="loc_ifrs-fullOtherFinanceIncome" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullOtherFinanceIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InterestExpense1" xlink:label="loc_afyaInterestExpense1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaInterestExpense1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_InterestExpenseOnLeaseLiabilities1" xlink:label="loc_afyaInterestExpenseOnLeaseLiabilities1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaInterestExpenseOnLeaseLiabilities1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinancialDiscountsGrantedExpenses" xlink:label="loc_afyaFinancialDiscountsGrantedExpenses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaFinancialDiscountsGrantedExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BankAndSimilarCharges" xlink:label="loc_ifrs-fullBankAndSimilarCharges" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullBankAndSimilarCharges" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-fullNetForeignExchangeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullNetForeignExchangeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxOnFinancialOperations" xlink:label="loc_afyaTaxOnFinancialOperations" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaTaxOnFinancialOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherFinanceCost" xlink:label="loc_ifrs-fullOtherFinanceCost" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullOtherFinanceCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FinanceResult" xlink:label="loc_afyaFinanceResult" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaFinanceResult" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetails" xlink:title="00000111 - Disclosure - Income taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureIncomeTaxesAbstract" xlink:label="loc_afyaDisclosureIncomeTaxesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-fullApplicableTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullApplicableTaxRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-fullTaxExpenseIncomeAtApplicableTaxRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullTaxExpenseIncomeAtApplicableTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ReconciliationAdjustmentsAbstract" xlink:label="loc_afyaReconciliationAdjustmentsAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaReconciliationAdjustmentsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" xlink:label="loc_afyaTaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaTaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ProgramaUniversidadeParaTodosFiscalIncentive" xlink:label="loc_afyaProgramaUniversidadeParaTodosFiscalIncentive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaProgramaUniversidadeParaTodosFiscalIncentive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_UnrecognisedDeferredTaxAssets" xlink:label="loc_afyaUnrecognisedDeferredTaxAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaUnrecognisedDeferredTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RecognisedDeferredTaxAssets" xlink:label="loc_afyaRecognisedDeferredTaxAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaRecognisedDeferredTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-fullTaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullTaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PermanentAdjustments" xlink:label="loc_afyaPermanentAdjustments" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaPermanentAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:label="loc_ifrs-fullTaxExpenseOtherThanIncomeTaxExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullTaxExpenseOtherThanIncomeTaxExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-fullCurrentTaxExpenseIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullCurrentTaxExpenseIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:label="loc_ifrs-fullTaxRateEffectFromChangeInTaxRate" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullTaxRateEffectFromChangeInTaxRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:title="00000112 - Disclosure - Income taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureIncomeTaxesAbstract" xlink:label="loc_afyaDisclosureIncomeTaxesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_ifrs-fullSegmentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OneSubsidiaryMember" xlink:label="loc_afyaOneSubsidiaryMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaOneSubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-fullDeferredTaxExpenseIncome" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDeferredTaxExpenseIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RecognizedDeferredTaxAssets" xlink:label="loc_afyaRecognizedDeferredTaxAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRecognizedDeferredTaxAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails" xlink:title="00000113 - Disclosure - Insurance contracts and contingencies (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureInsuranceContractsAndContingenciesAbstract" xlink:label="loc_afyaDisclosureInsuranceContractsAndContingenciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureInsuranceContractsAndContingenciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-fullContingentLiabilitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullContingentLiabilitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-fullLegalProceedingsContingentLiabilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullContingentLiabilitiesMember" xlink:to="loc_ifrs-fullLegalProceedingsContingentLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-fullClassesOfProvisionsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfProvisionsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherProvisionsMember" xlink:label="loc_ifrs-fullOtherProvisionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullOtherProvisionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LabourMember" xlink:label="loc_afyaLabourMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaLabourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CivilMember" xlink:label="loc_afyaCivilMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaCivilMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxesMember" xlink:label="loc_afyaTaxesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaTaxesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-fullProvisions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsOtherProvisions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="loc_ifrs-fullAdditionalProvisionsOtherProvisions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionalProvisionsOtherProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="loc_ifrs-fullUnusedProvisionReversedOtherProvisions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUnusedProvisionReversedOtherProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-fullProvisions_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProvisions_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1" xlink:title="00000114 - Disclosure - Insurance contracts and contingencies (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureInsuranceContractsAndContingenciesAbstract" xlink:label="loc_afyaDisclosureInsuranceContractsAndContingenciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureInsuranceContractsAndContingenciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-fullContingentLiabilitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullContingentLiabilitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-fullLegalProceedingsContingentLiabilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullContingentLiabilitiesMember" xlink:to="loc_ifrs-fullLegalProceedingsContingentLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-fullClassesOfProvisionsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfProvisionsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherProvisionsMember" xlink:label="loc_ifrs-fullOtherProvisionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullOtherProvisionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_LabourMember" xlink:label="loc_afyaLabourMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaLabourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CivilMember" xlink:label="loc_afyaCivilMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaCivilMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TaxesAndSocialSecurityMember" xlink:label="loc_afyaTaxesAndSocialSecurityMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaTaxesAndSocialSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TypesOfRiskMember" xlink:label="loc_afyaTypesOfRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_afyaTypesOfRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-fullOtherProvisions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" xlink:title="00000115 - Disclosure - Insurance contracts and contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureInsuranceContractsAndContingenciesAbstract" xlink:label="loc_afyaDisclosureInsuranceContractsAndContingenciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureInsuranceContractsAndContingenciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-fullClassesOfAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullClassesOfAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-fullClassesOfAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfAssetsAxis" xlink:to="loc_ifrs-fullClassesOfAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_OtherAssetsNonCurrentMember" xlink:label="loc_afyaOtherAssetsNonCurrentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfAssetsMember" xlink:to="loc_afyaOtherAssetsNonCurrentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_JudicialDeposits" xlink:label="loc_afyaJudicialDeposits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaJudicialDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ContingenciesCorrespondentAmount" xlink:label="loc_afyaContingenciesCorrespondentAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContingenciesCorrespondentAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactionsDetails" xlink:title="00000116 - Disclosure - Non-cash transactions (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_DisclosureNoncashTransactionsAbstract" xlink:label="loc_afyaDisclosureNoncashTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureNoncashTransactionsAbstract" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IClinicMember" xlink:label="loc_afyaIClinicMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaIClinicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_CliquefarmaMember" xlink:label="loc_afyaCliquefarmaMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaCliquefarmaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaRXPROMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_RemeasurementOfEarnOut" xlink:label="loc_afyaRemeasurementOfEarnOut" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemeasurementOfEarnOut" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets" xlink:label="loc_afyaProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" xlink:label="loc_afyaAdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEventDetailsNarrative" xlink:title="00000117 - Disclosure - Subsequent event (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:label="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember" xlink:label="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:to="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_FaculdadesIntegradasPadraoMember" xlink:label="loc_afyaFaculdadesIntegradasPadraoMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember" xlink:to="loc_afyaFaculdadesIntegradasPadraoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_PotentialAdditionalPayment" xlink:label="loc_afyaPotentialAdditionalPayment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPotentialAdditionalPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20231231.xsd#afya_TotalNumberOfSeatsApporved" xlink:label="loc_afyaTotalNumberOfSeatsApporved" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTotalNumberOfSeatsApporved" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639611660128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AFYA LIMITED<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001771007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Alameda Oscar Niemeyer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">No. 119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minas Gerais<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">BR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A common shares, par value US$0.00005 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AFYA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">ERNST
& YOUNG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Belo
Horizonte, Brazil<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember', window );">Class A Ordinary Shares [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">47,920,068<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember', window );">Class B Ordinary Shares [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">45,802,763<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Alameda Oscar Niemeyer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">No. 119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minas Gerais<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">BR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">3515-7550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Virgilio Deloy Capobianco Gibbon<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">ir@afya.com.br<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639612162304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated statements of financial position - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">R$ 553,030<span></span>
</td>
<td class="nump">R$ 1,093,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade receivables</a></td>
<td class="nump">546,438<span></span>
</td>
<td class="nump">452,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">1,382<span></span>
</td>
<td class="nump">12,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxAssets', window );">Recoverable taxes</a></td>
<td class="nump">43,751<span></span>
</td>
<td class="nump">27,809<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentAssets', window );">Other assets</a></td>
<td class="nump">58,905<span></span>
</td>
<td class="nump">51,745<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">1,203,506<span></span>
</td>
<td class="nump">1,637,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NoncurrentTradeReceivable', window );">Trade receivables</a></td>
<td class="nump">39,485<span></span>
</td>
<td class="nump">42,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">117,346<span></span>
</td>
<td class="nump">191,756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Investment in associate</a></td>
<td class="nump">51,834<span></span>
</td>
<td class="nump">53,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">608,685<span></span>
</td>
<td class="nump">542,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">767,609<span></span>
</td>
<td class="nump">690,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">4,796,016<span></span>
</td>
<td class="nump">4,041,491<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">6,380,975<span></span>
</td>
<td class="nump">5,561,882<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">7,584,481<span></span>
</td>
<td class="nump">7,199,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade payables</a></td>
<td class="nump">108,222<span></span>
</td>
<td class="nump">71,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Loans and financing</a></td>
<td class="nump">179,252<span></span>
</td>
<td class="nump">145,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">36,898<span></span>
</td>
<td class="nump">32,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">353,998<span></span>
</td>
<td class="nump">261,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NotePayableCurrent', window );">Notes payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">62,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDepositsFromCustomers', window );">Advances from customers</a></td>
<td class="nump">153,485<span></span>
</td>
<td class="nump">133,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan', window );">Labor and social obligations</a></td>
<td class="nump">192,294<span></span>
</td>
<td class="nump">154,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CurrentTaxesPayable', window );">Taxes payable</a></td>
<td class="nump">27,765<span></span>
</td>
<td class="nump">26,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Income taxes payable</a></td>
<td class="nump">3,880<span></span>
</td>
<td class="nump">16,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentLiabilities', window );">Other liabilities</a></td>
<td class="nump">2,773<span></span>
</td>
<td class="nump">2,719<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">1,058,567<span></span>
</td>
<td class="nump">905,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Loans and financing</a></td>
<td class="nump">1,621,523<span></span>
</td>
<td class="nump">1,737,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">837,671<span></span>
</td>
<td class="nump">737,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">212,869<span></span>
</td>
<td class="nump">266,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NoncurrentTaxesPayable', window );">Taxes payable</a></td>
<td class="nump">88,198<span></span>
</td>
<td class="nump">92,888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermLegalProceedingsProvision', window );">Provision for legal proceedings</a></td>
<td class="nump">104,361<span></span>
</td>
<td class="nump">195,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other liabilities</a></td>
<td class="nump">18,280<span></span>
</td>
<td class="nump">13,218<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">2,882,902<span></span>
</td>
<td class="nump">3,043,692<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">3,941,469<span></span>
</td>
<td class="nump">3,949,381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalPaidinCapital', window );">Additional paid-in capital</a></td>
<td class="nump">2,365,200<span></span>
</td>
<td class="nump">2,375,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Treasury shares</a></td>
<td class="num">(299,150)<span></span>
</td>
<td class="num">(304,947)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfSharebasedPayments', window );">Share-based compensation reserve</a></td>
<td class="nump">155,073<span></span>
</td>
<td class="nump">123,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Retained earnings</a></td>
<td class="nump">1,380,365<span></span>
</td>
<td class="nump">1,004,886<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAttributableToOwnersOfParent', window );">Equity attributable to equity holders of the parent</a></td>
<td class="nump">3,601,505<span></span>
</td>
<td class="nump">3,198,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="nump">41,507<span></span>
</td>
<td class="nump">51,320<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">3,643,012<span></span>
</td>
<td class="nump">3,250,158<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">R$ 7,584,481<span></span>
</td>
<td class="nump">R$ 7,199,539<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CurrentTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CurrentTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentTradeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentTradeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NotePayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NotePayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalPaidinCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalPaidinCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDepositsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current deposits from customers. [Refer: Deposits from customers]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDepositsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current net defined benefit liability. [Refer: Net defined benefit liability]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The excess of amount paid for current tax in respect of current and prior periods over the amount due for those periods. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph r<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_r&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermLegalProceedingsProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provision for legal proceedings. [Refer: Legal proceedings provision]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2023-01-01<br> -Section Example 10 A court case<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2023-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS37_IE_C_ex10_TI<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2023-01-01<br> -Paragraph 87<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_87&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermLegalProceedingsProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2023-01-01<br> -Paragraph 22<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity resulting from share-based payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An entity&#8217;s own equity instruments, held by the entity or other members of the consolidated group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2023-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639611514544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated statements of income and comprehensive income - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">R$ 2,875,913<span></span>
</td>
<td class="nump">R$ 2,329,057<span></span>
</td>
<td class="nump">R$ 1,719,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="num">(1,109,813)<span></span>
</td>
<td class="num">(859,552)<span></span>
</td>
<td class="num">(652,300)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,766,100<span></span>
</td>
<td class="nump">1,469,505<span></span>
</td>
<td class="nump">1,067,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="num">(1,014,684)<span></span>
</td>
<td class="num">(798,153)<span></span>
</td>
<td class="num">(622,615)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other income (expenses), net</a></td>
<td class="nump">15,645<span></span>
</td>
<td class="num">(7,252)<span></span>
</td>
<td class="num">(3,561)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="nump">767,061<span></span>
</td>
<td class="nump">664,100<span></span>
</td>
<td class="nump">440,895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">&#160;&#160;Finance income</a></td>
<td class="nump">110,642<span></span>
</td>
<td class="nump">102,042<span></span>
</td>
<td class="nump">64,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">&#160;&#160;Finance expenses</a></td>
<td class="num">(457,616)<span></span>
</td>
<td class="num">(349,893)<span></span>
</td>
<td class="num">(243,796)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Finance result</a></td>
<td class="num">(346,974)<span></span>
</td>
<td class="num">(247,851)<span></span>
</td>
<td class="num">(179,230)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of income of associate</a></td>
<td class="nump">9,495<span></span>
</td>
<td class="nump">12,184<span></span>
</td>
<td class="nump">11,797<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="nump">429,582<span></span>
</td>
<td class="nump">428,433<span></span>
</td>
<td class="nump">273,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="num">(24,166)<span></span>
</td>
<td class="num">(35,677)<span></span>
</td>
<td class="num">(31,179)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">405,416<span></span>
</td>
<td class="nump">392,756<span></span>
</td>
<td class="nump">242,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="nump">405,416<span></span>
</td>
<td class="nump">392,756<span></span>
</td>
<td class="nump">242,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToAbstract', window );"><strong>Income attributable to</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">&#160;&#160;Equity holders of the parent</a></td>
<td class="nump">386,324<span></span>
</td>
<td class="nump">373,569<span></span>
</td>
<td class="nump">223,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">&#160;&#160;Non-controlling interests</a></td>
<td class="nump">19,092<span></span>
</td>
<td class="nump">19,187<span></span>
</td>
<td class="nump">18,957<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ComprehensiveIncomeLoss', window );">Total comprehensive income</a></td>
<td class="nump">R$ 405,416<span></span>
</td>
<td class="nump">R$ 392,756<span></span>
</td>
<td class="nump">R$ 242,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsPerShareAbstract', window );"><strong>Basic earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Per common share</a></td>
<td class="nump">R$ 4.30<span></span>
</td>
<td class="nump">R$ 4.14<span></span>
</td>
<td class="nump">R$ 2.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsPerShareAbstract', window );"><strong>Diluted earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Per common share</a></td>
<td class="nump">R$ 4.27<span></span>
</td>
<td class="nump">R$ 4.12<span></span>
</td>
<td class="nump">R$ 2.37<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2023-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639632987536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated statements of changes in equity - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Issued capital [member]</div></th>
<th class="th"><div>Additional paid-in capital [member]</div></th>
<th class="th"><div>Treasury shares [member]</div></th>
<th class="th"><div>Reserve of share-based payments [member]</div></th>
<th class="th"><div>Retained earnings [member]</div></th>
<th class="th"><div>Equity attributable to owners of parent [member]</div></th>
<th class="th"><div>Non-controlling interests [member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance, value at Dec. 31, 2020</a></td>
<td class="nump">R$ 17<span></span>
</td>
<td class="nump">R$ 2,323,488<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">R$ 50,724<span></span>
</td>
<td class="nump">R$ 407,991<span></span>
</td>
<td class="nump">R$ 2,782,220<span></span>
</td>
<td class="nump">R$ 51,560<span></span>
</td>
<td class="nump">R$ 2,833,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">223,326<span></span>
</td>
<td class="nump">223,326<span></span>
</td>
<td class="nump">18,957<span></span>
</td>
<td class="nump">242,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">223,326<span></span>
</td>
<td class="nump">223,326<span></span>
</td>
<td class="nump">18,957<span></span>
</td>
<td class="nump">242,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalIncreaseWithCash', window );">Capital increase</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">74,500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">74,500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">74,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasuryShares1', window );">Treasury shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(213,722)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(213,722)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(213,722)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasurySharesTransferredFromExerciseOfOptions', window );">Treasury shares transferred from exercise of options</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(21,861)<span></span>
</td>
<td class="nump">55,197<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">33,336<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">33,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination', window );">Treasury shares transferred from shares contribution on business combinations</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(783)<span></span>
</td>
<td class="nump">5,895<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,112<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">43,377<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">43,377<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">43,377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Dividends declared</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(18,648)<span></span>
</td>
<td class="num">(18,648)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance, value at Dec. 31, 2021</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">2,375,344<span></span>
</td>
<td class="num">(152,630)<span></span>
</td>
<td class="nump">94,101<span></span>
</td>
<td class="nump">631,317<span></span>
</td>
<td class="nump">2,948,149<span></span>
</td>
<td class="nump">51,869<span></span>
</td>
<td class="nump">3,000,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">373,569<span></span>
</td>
<td class="nump">373,569<span></span>
</td>
<td class="nump">19,187<span></span>
</td>
<td class="nump">392,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">373,569<span></span>
</td>
<td class="nump">373,569<span></span>
</td>
<td class="nump">19,187<span></span>
</td>
<td class="nump">392,756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasuryShares1', window );">Treasury shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(152,317)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(152,317)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(152,317)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">29,437<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">29,437<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">29,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Dividends declared</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(19,736)<span></span>
</td>
<td class="num">(19,736)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance, value at Dec. 31, 2022</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">2,375,344<span></span>
</td>
<td class="num">(304,947)<span></span>
</td>
<td class="nump">123,538<span></span>
</td>
<td class="nump">1,004,886<span></span>
</td>
<td class="nump">3,198,838<span></span>
</td>
<td class="nump">51,320<span></span>
</td>
<td class="nump">3,250,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">386,324<span></span>
</td>
<td class="nump">386,324<span></span>
</td>
<td class="nump">19,092<span></span>
</td>
<td class="nump">405,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">386,324<span></span>
</td>
<td class="nump">386,324<span></span>
</td>
<td class="nump">19,092<span></span>
</td>
<td class="nump">405,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasuryShares1', window );">Treasury shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,369)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,369)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,369)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">31,535<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">31,535<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">31,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AcquisitionOfNoncontrollingInterests', window );">Acquisition of non-controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(10,845)<span></span>
</td>
<td class="num">(10,845)<span></span>
</td>
<td class="num">(10,155)<span></span>
</td>
<td class="num">(21,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RestrictedSharesTransferredToExecutives', window );">Restricted shares transferred to executives</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(7,491)<span></span>
</td>
<td class="nump">5,722<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,769)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,769)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions', window );">Treasury shares transferred to executives from exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,653)<span></span>
</td>
<td class="nump">12,444<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,791<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Dividends declared</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(18,750)<span></span>
</td>
<td class="num">(18,750)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance, value at Dec. 31, 2023</a></td>
<td class="nump">R$ 17<span></span>
</td>
<td class="nump">R$ 2,365,200<span></span>
</td>
<td class="num">R$ (299,150)<span></span>
</td>
<td class="nump">R$ 155,073<span></span>
</td>
<td class="nump">R$ 1,380,365<span></span>
</td>
<td class="nump">R$ 3,601,505<span></span>
</td>
<td class="nump">R$ 41,507<span></span>
</td>
<td class="nump">R$ 3,643,012<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AcquisitionOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AcquisitionOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CapitalIncreaseWithCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CapitalIncreaseWithCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RestrictedSharesTransferredToExecutives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RestrictedSharesTransferredToExecutives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TreasuryShares1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TreasuryShares1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TreasurySharesTransferredFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TreasurySharesTransferredFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends recognised as distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 107<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_107&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639610630320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated statements of cash flows - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncomeLossBeforeIncomeTaxes', window );">Income before income taxes</a></td>
<td class="nump">R$ 429,582<span></span>
</td>
<td class="nump">R$ 428,433<span></span>
</td>
<td class="nump">R$ 273,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments to reconcile income before income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">289,511<span></span>
</td>
<td class="nump">206,220<span></span>
</td>
<td class="nump">154,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfPropertyAndEquipment', window );">Write-off of property and equipment</a></td>
<td class="nump">1,910<span></span>
</td>
<td class="nump">1,697<span></span>
</td>
<td class="nump">1,604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off of intangible assets</a></td>
<td class="nump">413<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">2,374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceForDoubtfulAccountsOfOpeartingActivities', window );">Allowance for expected credit losses</a></td>
<td class="nump">74,552<span></span>
</td>
<td class="nump">42,708<span></span>
</td>
<td class="nump">47,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation expense</a></td>
<td class="nump">31,535<span></span>
</td>
<td class="nump">31,274<span></span>
</td>
<td class="nump">43,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains', window );">Net foreign exchange differences</a></td>
<td class="nump">681<span></span>
</td>
<td class="nump">852<span></span>
</td>
<td class="nump">17,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccruedInterestOfOpeartingActivities', window );">Accrued interest</a></td>
<td class="nump">285,447<span></span>
</td>
<td class="nump">200,081<span></span>
</td>
<td class="nump">108,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Accrued lease interest</a></td>
<td class="nump">100,849<span></span>
</td>
<td class="nump">88,571<span></span>
</td>
<td class="nump">67,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ShareOfIncomeOfAssociateOfOpeartingActivities', window );">Share of income of associate</a></td>
<td class="num">(9,495)<span></span>
</td>
<td class="num">(12,184)<span></span>
</td>
<td class="num">(11,797)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForProvisions', window );">Provision (reversal) for legal proceedings</a></td>
<td class="num">(56,825)<span></span>
</td>
<td class="num">(766)<span></span>
</td>
<td class="nump">10,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseDecreaseInOperatingLiabilities1Abstract', window );"><strong>Changes in assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">Trade receivables</a></td>
<td class="num">(131,336)<span></span>
</td>
<td class="num">(129,165)<span></span>
</td>
<td class="num">(79,665)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Inventories</a></td>
<td class="nump">10,947<span></span>
</td>
<td class="num">(363)<span></span>
</td>
<td class="num">(3,720)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseDecreaseInRecoverableTaxes', window );">Recoverable taxes</a></td>
<td class="num">(15,353)<span></span>
</td>
<td class="num">(2,230)<span></span>
</td>
<td class="num">(2,327)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets', window );">Other assets</a></td>
<td class="nump">77,480<span></span>
</td>
<td class="num">(1,048)<span></span>
</td>
<td class="num">(19,425)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Trade payables</a></td>
<td class="nump">24,500<span></span>
</td>
<td class="nump">9,975<span></span>
</td>
<td class="nump">14,479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncomeTaxExpense', window );">Taxes payable</a></td>
<td class="nump">3,278<span></span>
</td>
<td class="num">(3,915)<span></span>
</td>
<td class="num">(14,902)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers', window );">Advances from customers</a></td>
<td class="num">(17,892)<span></span>
</td>
<td class="nump">8,387<span></span>
</td>
<td class="nump">36,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsForNoncashItems', window );">Labor and social obligations</a></td>
<td class="nump">31,525<span></span>
</td>
<td class="nump">21,247<span></span>
</td>
<td class="nump">23,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities', window );">Other liabilities</a></td>
<td class="num">(42,542)<span></span>
</td>
<td class="num">(12,811)<span></span>
</td>
<td class="num">(2,693)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLoss', window );">Total</a></td>
<td class="nump">1,088,767<span></span>
</td>
<td class="nump">876,988<span></span>
</td>
<td class="nump">666,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities', window );">Income taxes paid</a></td>
<td class="num">(45,144)<span></span>
</td>
<td class="num">(33,089)<span></span>
</td>
<td class="num">(35,683)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash flows from operating activities</a></td>
<td class="nump">1,043,623<span></span>
</td>
<td class="nump">843,899<span></span>
</td>
<td class="nump">630,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Acquisition of property and equipment</a></td>
<td class="num">(118,435)<span></span>
</td>
<td class="num">(168,132)<span></span>
</td>
<td class="num">(125,869)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities', window );">Acquisition of intangibles assets</a></td>
<td class="num">(126,993)<span></span>
</td>
<td class="num">(128,892)<span></span>
</td>
<td class="num">(150,931)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsReceived', window );">Dividends received</a></td>
<td class="nump">9,900<span></span>
</td>
<td class="nump">6,754<span></span>
</td>
<td class="nump">11,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PurchaseOfAcquisitionOfNoncontrollingInterests', window );">Acquisition of non-controlling interest</a></td>
<td class="num">(21,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities', window );">Acquisition of subsidiaries, net of cash acquired</a></td>
<td class="num">(815,005)<span></span>
</td>
<td class="num">(277,649)<span></span>
</td>
<td class="num">(1,005,017)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles', window );">Payments of interest from acquisition of subsidiaries and intangibles</a></td>
<td class="num">(71,518)<span></span>
</td>
<td class="num">(23,550)<span></span>
</td>
<td class="num">(12,108)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RestrictedCashOfInvestingActivities', window );">Restricted cash</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,103<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash flows used in investing activities</a></td>
<td class="num">(1,143,051)<span></span>
</td>
<td class="num">(591,469)<span></span>
</td>
<td class="num">(1,274,052)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Payments of principal of loans and financing</a></td>
<td class="num">(112,630)<span></span>
</td>
<td class="num">(1,791)<span></span>
</td>
<td class="num">(107,766)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities', window );">Payments of interest of loans and financing</a></td>
<td class="num">(175,889)<span></span>
</td>
<td class="num">(116,587)<span></span>
</td>
<td class="num">(50,310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from loans and financing</a></td>
<td class="nump">5,288<span></span>
</td>
<td class="nump">496,885<span></span>
</td>
<td class="nump">809,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments of lease liabilities</a></td>
<td class="num">(31,473)<span></span>
</td>
<td class="num">(28,511)<span></span>
</td>
<td class="num">(20,075)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments of interest of lease liabilities</a></td>
<td class="num">(103,911)<span></span>
</td>
<td class="num">(85,001)<span></span>
</td>
<td class="num">(67,676)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasuryShares1', window );">Treasury shares buy back</a></td>
<td class="num">(12,369)<span></span>
</td>
<td class="num">(152,317)<span></span>
</td>
<td class="num">(213,722)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">9,791<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">33,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidClassifiedAsFinancingActivities', window );">Dividends paid to non-controlling shareholders</a></td>
<td class="num">(18,750)<span></span>
</td>
<td class="num">(19,736)<span></span>
</td>
<td class="num">(18,648)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash flows generated (used) in financing activities</a></td>
<td class="num">(439,943)<span></span>
</td>
<td class="nump">92,942<span></span>
</td>
<td class="nump">364,678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Net foreign exchange differences</a></td>
<td class="num">(681)<span></span>
</td>
<td class="num">(852)<span></span>
</td>
<td class="num">(17,973)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(540,052)<span></span>
</td>
<td class="nump">344,520<span></span>
</td>
<td class="num">(296,480)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Cash and cash equivalents at the beginning of the year</a></td>
<td class="nump">1,093,082<span></span>
</td>
<td class="nump">748,562<span></span>
</td>
<td class="nump">1,045,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Cash and cash equivalents at the end of the year</a></td>
<td class="nump">R$ 553,030<span></span>
</td>
<td class="nump">R$ 1,093,082<span></span>
</td>
<td class="nump">R$ 748,562<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccruedInterestOfOpeartingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccruedInterestOfOpeartingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForDoubtfulAccountsOfOpeartingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForDoubtfulAccountsOfOpeartingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncomeLossBeforeIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncomeLossBeforeIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseDecreaseInOperatingLiabilities1Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseDecreaseInOperatingLiabilities1Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseDecreaseInRecoverableTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseDecreaseInRecoverableTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PurchaseOfAcquisitionOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PurchaseOfAcquisitionOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RestrictedCashOfInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RestrictedCashOfInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ShareOfIncomeOfAssociateOfOpeartingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ShareOfIncomeOfAssociateOfOpeartingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TreasuryShares1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TreasuryShares1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WriteoffOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WriteoffOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WriteoffOfPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WriteoffOfPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in loans and advances to customers to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Loans and advances to customers; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in other liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other liabilities; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for dividends paid by the entity, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 14<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_14_f&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAdjustmentsForNoncashItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAdjustmentsForNoncashItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of long-term assets that the entity does not separately disclose in the same statement or note, classified as investing activities. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639606277824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Corporate information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CorporateInformationAbstract', window );"><strong>Corporate Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory', window );">Corporate information</a></td>
<td class="text"><p id="xdx_801_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_z8WrEoWNcR0j" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><span id="fp_006"></span>1</td><td><span id="xdx_820_zqi6LYe3Ozy1">Corporate information</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-right: 0; margin-left: 0">Afya Limited (&#8220;Afya&#8221;),
collectively with its subsidiaries referred to as the &#8220;Company&#8221;, is a holding company incorporated under the laws of the Cayman
Islands on March 22, 2019. The Company completed its initial public offering (IPO) on July 19, 2019, and its shares are listed on the
Nasdaq under the symbol &#8220;AFYA&#8221;. The Company&#8217;s ultimate parent company is Bertelsmann SE&amp; Co. KGaA (&#8220;Bertelsmann&#8221;),
as a result of Bertelsmann&#8217;s acquisition of control on May 5, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company is formed by a network of higher education and post-graduate
institutions focused on medical schools located in 19 Brazilian States forming the largest educational group by the number of medical
seats in the country. In non-regulated education, Afya provides services that comprise the development and sale of electronically distributed
educational courses on medicine science, related printed and soft skills educational content. The Company also offers solutions to empower
the physicians in their daily routine including supporting clinic decisions through mobile app subscription, delivering practice management
tools through a SaaS (&#8220;Software as a Service&#8221;) model and supporting the patient-physician relationship.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">During the year ended December 31, 2022, the Ministry
of Education (&#8220;MEC&#8221;) authorized the operations of 200 seats of medical schools, under the Mais M&#233;dicos II program across
four medical schools. Each medical school will contribute with 50 seats. In March 2022, MEC authorized the increase of 28 seats of Centro
Universit&#225;rio S&#227;o Lucas, located in the city of Ji-Parana, State of Rond&#244;nia and 64 medical seats of Faculdade Santo
Agostinho, located in the city of Itabuna, State of Bahia. These operations of such medical schools and additional seats started between
the second semester of 2022 and first semester of 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">In November 2021, MEC authorized the operation of 120 medical school seats
in Garanhuns, in the city of Garanhuns, State of Pernambuco. These operations of the medical school started in the second semester of
2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="text-decoration: underline">Bertelsmann increases stake in Afya</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On May 5, 2022, Afya was notified of the closing of the transaction where
Bertelsmann SE&amp; Co. KGaA, or &#8220;Bertelsmann&#8221; acquired <span id="xdx_904_ecustom--AcquiredShares_pip0_c20220504__20220505__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z9fRcbP4TgP5" title="Acquired shares">6,000,000</span> Class B common shares of Afya at the purchase price of US$26.90
per share, from Nicolau Carvalho Esteves, Ros&#226;ngela de Oliveira Tavares Esteves and NRE Capital Ventures Ltd (together with Nicolau
Carvalho Esteves and Ros&#226;ngela de Oliveira Tavares Esteves, the &#8220;Esteves Family&#8221;). As result of the closing of the transaction,
Bertelsmann and the Esteves family will beneficially own ~<span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pip0_dp_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember_zyAvSgUPOknf" title="Own percentage">57.5</span>% and ~<span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pip0_dp_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember_zJIYVz0I4j1g" title="Own percentage">33.0</span>% voting interest, and ~<span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember_zjAUGW38VYB3" title="Voting interest">31.0</span>% and ~<span id="xdx_909_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember_z4Xtn55IxDa8" title="Voting interest">18.0</span>% of the total shares,
respectively, in Afya. The transaction had no effect on Afya&#8217;s consolidated financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="text-decoration: underline">Acquisitions</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span>On January 2, 2023, Afya Participa&#231;&#245;es
S.A. (hereafter referred to as </span>&#8220;<span>Afya Brazil&#8221;), a wholly owned subsidiary of the
Company, acquired </span>Sociedade Educacional e Cultural Sergipe DelRey Ltda<span>. (&#8220;DelRey&#8221;).
DelRey is a post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate
programs in medicine and health, as well as other courses, and </span>encompasses the operations of Centro Universit&#225;rio Tiradentes
Alagoas (&#8220;UNIMA&#8221;) and Faculdade Tiradentes Jaboat&#227;o dos Guararapes (&#8220;FCM Jaboat&#227;o&#8221;)<span>.
See Note 5.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="background-color: white">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span>During the
year ended December 31, 2022, Afya Brazil entered into business combinations transactions for the acquisition of three entities under
the Digital segment. The aggregate consideration transferred was R$ <span id="xdx_90B_eifrs-full--ConsiderationPaidReceived_pn3n3_c20220101__20221231_zFIrnyg4i0A4" title="Aggregate consideration">99,399</span>, of which R$ <span id="xdx_90E_eifrs-full--ConsiderationPaidReceived_pn3n3_c20220101__20221231__dei--LegalEntityAxis__ifrs-full--SubsidiariesMember_zYlDmSFd9PJ7" title="Aggregate consideration">67,381</span> represents the cash paid net of cash acquired
with the subsidiaries (included in cash flows from investing activities) for such business combinations.</span></p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span style="background-color: white"></span></p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span>During the year ended December 31,
2021, Afya Brazil entered into business combinations transactions for the acquisition of two entities under the Undergrad segment and
four entities under the Digital segment. The aggregate consideration transferred was R$ <span id="xdx_901_eifrs-full--ConsiderationPaidReceived_pn3n3_c20210101__20211231_zgUIoDnO0Aof" title="Aggregate consideration">1,234,460</span>, of which R$ <span id="xdx_906_eifrs-full--ConsiderationPaidReceived_pn3n3_c20210101__20211231__dei--LegalEntityAxis__ifrs-full--SubsidiariesMember_zmv6Vi9Spxwf" title="Aggregate consideration">842,197</span> represents the
cash paid net of cash acquired with the subsidiaries (included in cash flows from investing activities).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="text-decoration: underline">Conflicts worldwide</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">During 2022 and 2023, international conflicts with potential large scale
occurred, including Russia and Ukraine and Israel and Hamas. Those conflicts trigger a number of IFRS accounting considerations affecting
the financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company&#8217;s operations are focused in Brazil and was not directly
impacted by such conflicts. However, the continuous development of such conflicts may impact entities other than those with direct interests
in the involved countries, for instance, as a result of exposure to fluctuations in commodity prices and foreign exchange rates, which
may impact inflation, as well as the possibility of economic sanctions against such countries.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">As of the date of these consolidated financial statements, both conflicts
mentioned above have not significantly impacted Afya&#8217;s operations and results.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CorporateInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CorporateInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639605353808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureMaterialAccountingPoliciesAbstract', window );"><strong>Material Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfMaterialAccountingPoliciesExplanatory', window );">Material accounting policies</a></td>
<td class="text"><p id="xdx_80D_ecustom--DisclosureOfMaterialAccountingPoliciesExplanatory_zSJak3PGdxqf" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in">2</td><td><span id="xdx_82A_zTtrBktcqFw4">Material accounting policies</span></td></tr></table>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">&#160;</p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">2.1 Basis for preparation of the consolidated financial
statements</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company&#8217;s consolidated financial statements have been prepared
in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB)
and considers the assumption that the Company will continue in operation for the foreseeable future.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The consolidated financial statements have been prepared on a historical
cost basis, except for contingent consideration (earn-outs) that have been measured at fair value.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Afya Limited is a holding company, as such the primary source of revenue
derives from its interest on the operational companies in Brazil. As result, the Brazilian Real has been determined as the Company&#8217;s
functional currency.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The consolidated financial statements are presented in Brazilian reais (&#8220;BRL&#8221;
or &#8220;R$&#8221;), which is the Company&#8217;s functional and presentation currency. All amounts are rounded to the nearest thousand.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The Company segregated the payments of principal
and interest of loans and financing, lease liabilities, notes payable and accounts payables to selling shareholders in the consolidated
statements of cash flows for the year ended December 31, 2023, in accordance with the provisions set forth in IAS 7 &#8211; Statement
of Cash Flows. As a result, Management revised, retrospectively, the prior periods consolidated statements of cash flows for the years
ended December 31, 2022 and 2021, for comparative purposes. The Company assessed the materiality of this matter and, based on an analysis
of quantitative and qualitative considerations, determined that the segregation of payments of principal and interest on prior periods
over such transactions is not material to its consolidated financial statements. However, even if it is not material, the segregation
of payments of principal and interest regarding such transactions for the years ended December 31, 2022 and 2021 are appropriate for
the users of the consolidated financial statements, considering the comparability of such information over the years presented. The payments
of interest of loans and financing, lease liabilities, notes payable and accounts payables to selling shareholders are classified within
the consolidated statements of cash flows under the same activities of which the payments of principal are classified. As a result, no
change occurred in the net cash flows used in investing activities and net cash flows generated (used) in financing activities in the
consolidated statements of cash flows for the years ended December 31, 2022 and 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">These consolidated financial statements as of and
for the year ended December 31, 2023 were approved by the Board of Directors for issuance on March 14, 2024.<br/>
</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>2.2 Basis consolidation</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The table below is a list of the Company&#8217;s subsidiaries and associate:</p>

<p style="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zOClrtiiWnDb" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B7_zcTUTkK5xnpc" style="display: none">Schedule of Company&#8217;s subsidiaries and associate</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Direct and indirect interest</b></span></td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; width: 36%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Name</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 23%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Main activities</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Location</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Investment type</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>December 31, 2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>December 31, 2022</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Afya Participa&#231;&#245;es S.A. (&#8220;Afya Brazil&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zalwy9CGxxW1" title="Principal activities">Holding</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z1RptsvM2mMk" title="Location">Nova Lima - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zrpmZKKEiJsd" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z5CjixoKcEja" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zXyR3NNOcrQ4" title="Direct and indirect interest of subsidiary"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zv9VS7TatyJd" title="Direct and indirect interest of subsidiary">100</span></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto Tocantinense Presidente Ant&#244;nio Carlos Porto S.A. - (&#8220;ITPAC Porto&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zH1Ln5sRdeol" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zwF6v291aIDb" title="Location">Porto Nacional - TO</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zoUGV6PYurG8" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zB1OKm3apal5" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zrSl5jEFEnm8" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto Tocantinense Presidente Ant&#244;nio Carlos S.A. - (&#8220;ITPAC Aragua&#237;na&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zGzEFgreoAt6" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_z11eSmIJKfBi" title="Location">Aragua&#237;na - TO</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zYznHUPdaUMi" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zdBbdHbYg3Vk" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zFZWmVBs9oEh" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Uni&#227;o Educacional do Vale do A&#231;o S.A. - (&#8220;UNIVA&#199;O&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zgWRd2JlcEhk" title="Principal activities">Medicine undergraduate degree program</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zPgTSpa6ctni" title="Location">Ipatinga - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zCMh7K0hmkh7" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z0Z1JBdEy9Hg" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z2XOJzLnvsv1" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#8220;IPTAN&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zSbG3bJ6WCT5" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zYs5VwOf1rs8" title="Location">S&#227;o Jo&#227;o Del Rei - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zLGxbgGFRCG8" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zycMe0FDSUxl" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zQZQwj3pfEwk" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A. (&#8220;IESVAP&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zHwpFCvWTRWg" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zmc5S9CWO1hb" title="Location">Parna&#237;ba - PI</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zoUNMxDFdDv1" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zykEQvDEg8k8" title="Direct and indirect interest of subsidiary">80</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_z4qvPwneKpTb" title="Direct and indirect interest of subsidiary">80</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Centro de Ci&#234;ncias em Sa&#250;de de Itajub&#225; S.A. (&#8220;CCSI&#8221;) (vi)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z8zjHa6BIeV6" title="Principal activities">Medicine undergraduate degree program</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zdPwPLBL5Om4" title="Location">Itajub&#225; - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z40USpEPBNzg" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zQmOpVIxyxr" title="Direct and indirect interest of subsidiary">75</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zIrK3aOB0ueb" title="Direct and indirect interest of subsidiary">60</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto de Ensino Superior do Piau&#237; S.A. (&#8220;IESP&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zWQzPmy7n1Ff" title="Principal activities">Undergraduate and graduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_za6I0FudD4Hk" title="Location">Teresina - PI</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_znvFnrd2wAR4" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_z38eqmX67Z3l" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zRcqMXWCruCa" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Centro Integrado de Sa&#250;de de Teresina (&#8220;CIS&#8221;) (v)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zSnBVWW5NM2a" title="Principal activities">Outpatient care</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zaXqNKFgDxR" title="Location">Teresina - PI</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zdFi64odxsi7" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_z8MiPemDdctg" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">FADEP - Faculdade Educacional de Pato Branco Ltda. (&#8220;FADEP&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zdJiDucq4gx8" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zKnEUEBh4UXf" title="Location">Pato Branco - PR</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zL3TPqtol0Hc" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zuJUXviDKN55" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zK5N5l65p6td" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Medcel Editora e Eventos S.A. (&#8220;Medcel&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zOYAsenPo6M8" title="Principal activities">Medical education content</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_z8IqdtmzImEj" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zZ3VzZhSfMEb" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zbxIRxfn1QZb" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_z5abhnmUIGai" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto Educacional Santo Agostinho S.A. (&#8220;FASA&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_z3CNx3A8HgYa" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zMddJ12yLnac" title="Location">Montes Claros - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zcG6gvWygcLe" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zHzTjkrPxdYl" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zrzeDyWOonPe" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">ESMC Educa&#231;&#227;o Superior Ltda. (&#8220;ESMC&#8221;) (iii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zYckGhqslUua" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zyWCdAa85Bhd" title="Location">Montes Claros - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_z5BGUTEEMtyl" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zHh5b58t4B32" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto de Pesquisa e Ensino M&#233;dico do Estado de Minas Gerais Ltda. (&#8220;IPEMED&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_ztZbZLKvSEe5" title="Principal activities">Graduate</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zjcYM0e8Fgtk" title="Location">Belo Horizonte - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zXl2ZbkjAJO" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_z0Wxdk02ZiVe" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zkwIlA8E2VDh" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto Paraense de Educa&#231;&#227;o e Cultura Ltda. (&#8220;IPEC&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_ztm4EYaPUOTc" title="Principal activities">Medicine degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zMUQ5LY4iHEh" title="Location">Marab&#225; - PA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_ziftmOqfGtl5" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zxQognVwrJUf" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zCzYBJmQOj9b" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Sociedade Universit&#225;ria Redentor S.A. (&#8220;UniRedentor&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z1PnvuFrbxW4" title="Principal activities">Undergraduate and graduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zNkch2awVkZ8" title="Location">Itaperuna - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zQGcr5wQuMWf" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zRe0lOTWDiYh" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zYIOhEv10Nfh" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Centro de Ensino S&#227;o Lucas Ltda. (&#8220;UniSL&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zuBWx7tdWpQ6" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_z3opKGOaCFXh" title="Location">Porto Velho - RO</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zwFO7NNBiXzh" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zc8YlpZTM9J5" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zQz09AuUBlhi" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Peb Med Institui&#231;&#227;o de Pesquisa M&#233;dica e Servi&#231;os Ltda. (&#8220;PebMed&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zwGFvmIXDyef" title="Principal activities">Content and clinical tools and online platform</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zM5A2jZsx6Aj" title="Location">Rio de Janeiro - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zlkaSuMeMzIg" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zWvNQFwIR4rd" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zl0z015dT019" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Sociedade de Educa&#231;&#227;o, Cultura e Tecnologia da Amaz&#244;nia S.A. - (&#8220;FESAR&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zhvG7Pp3hpca" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zyqWTj49rf01" title="Location">Reden&#231;&#227;o - PA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zTqDWnFqMr9d" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zpVj7zYLaL92" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zxS06FOXcYy8" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Centro Superior de Ci&#234;ncias da Sa&#250;de S/S Ltda. (&#8220;FCMPB&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zxhl3lsinqO2" title="Principal activities">Medicine degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_ziVT5yMMuZId" title="Location">Jo&#227;o Pessoa - PB</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zheIgQ0Dh8U9" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zfmHirGKCZNd" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zuhISMhBKnS8" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">iClinic Desenvolvimento de Software Ltda. (&#8220;iClinic&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zzGrJmynyihb" title="Principal activities">Electronic Medical Record, Clinical Management System</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zkcxMakLVvWa" title="Location">Ribeir&#227;o Preto - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zsUxdBU8E9i2" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zLb3w41wSBWh" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zx6WPAE9Qkjl" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Medicinae Solutions S.A. (&#8220;Medicinae&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z4DTs95RBlw3" title="Principal activities">Healthcare payments and financial services</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zb5c1OY9Rbsd" title="Location">Rio de Janeiro - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zFoDbLSmb2B6" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zXqWbgktuVw5" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z6KZl2oqbbP1" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Medical Harbour Aparelhos M&#233;dico Hospitalares e Servi&#231;os em Tecnologia Ltda. (&#8220;Medical Harbour&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zZhaYklSCn2" title="Principal activities">Educational health and medical imaging</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zpa5PemScH7b" title="Location">Florian&#243;polis - SC</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zBjdZFmGiZEd" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zeFv4DEjEF3b" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zYA3VDldq1e3" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Cliquefarma Drogarias Online Ltda. (&#8220;Cliquefarma&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zvLiXQTf8LMh" title="Principal activities">Online platform</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zFusXC5ny7Kc" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zbGVANp4Wyce" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zl9pB8ZtT1Kk" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_ztbeofn3M1Bi" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Shosp Tecnologia da Informa&#231;&#227;o Ltda. (&#8220;Shosp&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zQ3WpInHHkl8" title="Principal activities">Electronic Medical Record, Clinical Management System</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zVA7XuIDuRoe" title="Location">Rio de Janeiro - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zgNHFinkpyvi" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_z1QpxW0v4xQc" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zAZiw8SIWO57" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Sociedade Padr&#227;o de Educa&#231;&#227;o Superior Ltda. (&#8220;UnifipMoc&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zCVP4KK3mVB6" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zS8FV1BAmsq3" title="Location">Montes Claros - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zO0xBtbGQNik" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zVhbUTgSUfoi" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zjFwRhLh9Sml" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">N&#250;cleo de Aten&#231;&#227;o &#224; Sa&#250;de e de Pr&#225;ticas Profissionalizantes (&#8220;NASPP) (iv)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zvgSfVHkAPV8" title="Principal activities">Outpatient care</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zotfy6njizG1" title="Location">Montes Claros - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zxUrxG5UIAP1" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zInDB4qUV6T9" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Companhia Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura (&#8220;Unigranrio&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zRFOdKj3VQif" title="Principal activities">Undergraduate and graduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zqrwrvNl4p75" title="Location">Duque de Caxias - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zoR14pVTkY8d" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zEHW5VKRSVA4" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zIvk9bsGePvd" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Policl&#237;nica e Centro de Est&#233;tica Duque de Caxias Ltda. (&#8220;Policl&#237;nica&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zP3K1mwjxI3" title="Principal activities">Outpatient care</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zkV1063VGF7l" title="Location">Duque de Caxias - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zoHQsfI7pAAg" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zb3hc3cKhzP3" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zt053CJMdDD8" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt">Sociedade Educacional de Palho&#231;a S/A Ltda. (&#8220;SOCIESP&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_z9rg0MXal5Yl" title="Principal activities">Basic Education</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_ztDKDpmWFDIl" title="Location">Palho&#231;a - SC</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-size: 7pt"><span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_zwZW0J56ukC" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_z30vgAAgnQoc" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt">Instituto de Ensino Superior de Palho&#231;a S/S Ltda. (&#8220;IESP PALHO&#199;A&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt"><span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zORhaIV6bks" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_z9mQI2YTVdM7" title="Location">Palho&#231;a - SC</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-size: 7pt"><span id="xdx_908_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zePtyvgsKgOf" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zYWb6iWvlh58" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">RX PRO Solu&#231;&#245;es de Tecnologia Ltda. (&#8220;RX PRO&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zbsKqs9ZcXG1" title="Principal activities">Marketing for pharmaceutical industry</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zgsq6dFy4YT5" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z037R5g6cbE4" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z8R6nYdjZy99" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zNYzlvXy3qJg" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">RX PRO LOG Transporte e Log&#237;stica Ltda. (&#8220;RX PRO LOG&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_z5twhHGud3Mc" title="Principal activities">Marketing for pharmaceutical industry</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zGUG4PmwWgnf" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zzS98P9svIwk" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zoFtLfXjEffh" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_ztZcgDeoVuTh" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">BMV Atividades M&#233;dicas Ltda. (&#8220;Al&#233;m da Medicina&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zWxNA72laWWk" title="Principal activities">Medical education content</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_znFBaUleq8vj" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_z02DjhG0PmQc" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zjWrfOlfth4f" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zQly09pywIFk" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Cardiopapers Solu&#231;&#245;es Digitais Ltda. (&#8220;CardioPapers&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zWa0LFTFxvhe" title="Principal activities">Medical education content</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zIY7kQcj0aca" title="Location">Recife - PE</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_z676l82ua159" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zGzZJe8ufh85" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zYuIkYxF7ki4" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Quasar Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&#8220;Glic&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zTRc3v0p3fg2" title="Principal activities">Patient physician relationship</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zegdjERLTTKf" title="Location">Barueri - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zmHwMNmfa6s4" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zZmHBrwxCsO6" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zt3uNVeIaDHk" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#8220;DelRey&#8221;) (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_znVw5RN6Zl6d" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_ztuAsEFtnwf4" title="Location">Macei&#243; - AL</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zkSsxRXrU1dk" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zDY9l0MpmWxe" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Uni&#227;o Educacional do Planalto Central S.A. (&#8220;UEPC&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zzFJjJxjPXp3" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zGU3ji6QI6n2" title="Location">Bras&#237;lia - DF</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zC2ujciWITa5" title="Investment type">Associate</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zBGaKF5Qyzdd" title="Direct and indirect interest of subsidiary">30</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zX52vJW5Spj2" title="Direct and indirect interest of subsidiary">30</span>%</span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">See Note 5 for further details of the business combination in 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">IESP was merged by Unigranrio and SOCIESP had its operations closed down, both in January
2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"></td><td style="text-align: justify"><span style="color: #212121">ESMC was merged with UnifipMoc in February 2023.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iv)</td><td style="width: 5pt"></td><td style="text-align: justify">NASPP was merged with UnifipMoc in July 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(v)</td><td style="width: 5pt"></td><td style="text-align: justify">CIS was merged with IESP in December 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="color: #212121">(vi)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="color: #212121">Acquisition</span> of additional interest in CCSI: On October
31, 2023, Afya Brazil acquired an additional 15% interest in CCSI, increasing its ownership interest to 75% of total shares. A cash consideration
of R$21,000 was paid to the non-controlling shareholders. The carrying value of the net assets of CCSI (excluding goodwill on the original
acquisition) was R$10,155, and the difference were recorded in retained earnings in the equity attributable to equity holders of the
parent.</td>
</tr></table>

<p id="xdx_8A1_z1VldA3Ni6u9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">The financial information
of the acquired subsidiaries is included in the Company&#8217;s consolidated financial statements beginning on the respective acquisition
dates.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company consolidates the financial information for all entities it controls.
Control is achieved when the Company is exposed to, or has rights, to variable returns from its involvement with the investee and has
the ability to affect those returns through its power over the investee.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Consolidation of a subsidiary begins when the Company obtains control over
the subsidiary and it ceases when the Company loses control of the subsidiary. Assets, liabilities, income and expenses of a subsidiary
acquired or disposed of during the year are included in the consolidated financial statements from the date the Company gains control
until the date the Company ceases to control the subsidiary.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">When necessary, adjustments are made to the financial statements of subsidiaries
in order to bring their accounting policies in line with the Company&#8217;s accounting policies. All intra-group assets and liabilities,
equity, income, expenses and cash flows relating to transactions are eliminated in full on consolidation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">A change in the ownership interest of a subsidiary, without a change of
control, is accounted for as an equity transaction. If the Company loses control over a subsidiary, it derecognizes the related assets
(including goodwill), liabilities, non-controlling interest and other components of equity, while any resulting gain or loss is recognized
in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Non-controlling interests in the results and equity of subsidiaries are
shown separately in the consolidated statements of financial position, consolidated statements of income and comprehensive income and
consolidated statements of changes in equity.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>2.3 Summary of material accounting policies</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">This note provides a description of the material accounting policies adopted
in the preparation of these consolidated financial statements in addition to other policies that have been disclosed in other notes to
these consolidated financial statements. These policies have been consistently applied to all periods presented.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The accounting policies have been consistently applied
to all consolidated companies.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_842_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zeqybfC7yksh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>a) <span id="xdx_866_zre99Xd2lFob">Business combinations and goodwill</span> </b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Business combinations are accounted for using the acquisition method. The
cost of an acquisition is measured as the aggregate of the consideration transferred, which is measured at acquisition date fair value,
and the amount of any non-controlling interests in the acquiree. For each business combination, the Company elects whether to measure
the non-controlling interests in the acquiree at fair value or at the proportionate share of the acquiree&#8217;s identifiable net assets.
Acquisition-related costs are expensed as incurred and included in selling, general and administrative expenses.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">When the Company acquires a business, it assesses the financial assets and
liabilities assumed for appropriate classification and designation in accordance with the contractual terms, economic circumstances and
pertinent conditions as of the acquisition date.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Goodwill is initially measured at cost (being the excess of the aggregate
of the consideration transferred and the amount recognized for non-controlling interests and any previous interest held over the net
identifiable assets acquired and liabilities assumed). If the fair value of the net assets acquired is in excess of the aggregate consideration
transferred, the Company re-assesses whether it has correctly identified all of the assets acquired and all of the liabilities assumed
and reviews the procedures used to measure the amounts to be recognized at the acquisition date. If the reassessment still results in
an excess of the fair value of net assets acquired over the aggregate consideration transferred, then the gain is recognized in the consolidated
statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">After initial recognition, goodwill is measured at cost less any accumulated
impairment losses. For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated
to each of the Company&#8217;s cash-generating units that are expected to benefit from the combination, irrespective of whether other
assets or liabilities of the acquire are assigned to those units.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Where goodwill has been allocated to a cash-generating unit (CGU) and part
of the operation within that unit is disposed of, the goodwill associated with the disposed operation is included in the carrying amount
of the operation when determining the gain or loss on disposal. Goodwill disposed in these circumstances is measured based on the relative
values of the disposed operation and the portion of the cash-generating unit retained.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_848_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zvIOto8tCKJa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b) <span id="xdx_86D_zgfWBvd54Hjf">Current versus non-current classification</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company presents assets and liabilities in the statement of financial
position based on current and non-current classification. An asset is current when it is:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Expected to be realized
or intended to be sold or consumed in the normal operating cycle;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Held primarily for
the purpose of trading;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Expected to be realized
within twelve months after the reporting period; or</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Cash or cash equivalent
unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">All other assets are classified as non-current.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">A liability is current when:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It is expected to
be settled in the normal operating cycle;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It is held primarily
for the purpose of trading;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It is due to be
settled within twelve months after the reporting period; or</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">There is no unconditional
right to defer the settlement of the liability for at least twelve months after the reporting period.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company classifies all other liabilities as non-current.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Deferred tax assets and liabilities are classified as non-current assets
and liabilities.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zVRK63da52x4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>c) <span id="xdx_866_zgQOUctiUb3i">Fair value measurement</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Fair value is the price that would be received to sell an asset or paid
to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based
on the presumption that the transaction to sell the asset or transfer the liability takes place either: (i) in the principal market for
the asset or liability; or (ii) in the absence of a principal market, in the most advantageous market for the asset or liability.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The principal or the most advantageous market must be accessible by the
Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The fair value of an asset or a liability is measured using the assumptions
that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">A fair value measurement of a non-financial asset takes into account a market
participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market
participant that would use the asset in its highest and best use.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company uses valuation techniques that are appropriate in the circumstances
and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the
use of unobservable inputs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">All assets and liabilities for which fair value is measured or disclosed
in the financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that
is significant to the fair value measurement as a whole:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level 1 - Quoted
(unadjusted) market prices in active markets for identical assets or liabilities.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level 2 - Valuation
techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level 3 - Valuation
techniques for which the lowest level input that is significant to the fair value measurement is unobservable.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For assets and liabilities that are recognized in the financial statements
at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy by re-assessing
categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting
period.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">At each reporting date, the Company analyzes the movements in the values
of assets and liabilities which are required to be remeasured or reassessed as per the Company&#8217;s accounting policies. For this analysis,
the Company verifies the major inputs applied in the latest valuation by agreeing the information in the valuation computation to contracts
and other relevant documents.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company also compares the change in the fair value of each asset and
liability with relevant external sources to determine whether the change is reasonable.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For the purpose of fair value disclosures, the Company has determined classes
of assets and liabilities on the basis of the nature, characteristics and risks of the asset or liability and the level of the fair value
hierarchy, as explained above.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_840_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_zKvg01UWdcJ7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>d) <span id="xdx_866_zTFTz8xv3zk6">Financial instruments - initial recognition and measurement</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">A financial instrument is any contract that gives rise to a financial asset
of one entity and a financial liability or equity instrument of another entity.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 14.2pt"></td><td style="width: 14.15pt"><b>i)</b></td><td><b>Financial assets</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><b>&#160;</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Initial recognition and measurement</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The classification of financial assets at initial recognition
depends on the financial asset&#8217;s contractual cash flow characteristics and the Company&#8217;s business model for managing them.
With the exception of trade receivables that do not contain a significant financing component or for which the Company has applied the
practical expedient, the Company initially measures a financial asset at its fair value plus, in the case of a financial asset not at
fair value through profit or loss, transaction costs. Trade receivables that do not contain a significant financing component or for
which the Company has applied the practical expedient, are measured at the transaction price determined under IFRS 15.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">In order for a financial asset to be classified and measured
at amortized cost or fair value through OCI (Other Comprehensive Income), it needs to give rise to cash flows that are &#8220;solely payments
of principal and interest (SPPI)&#8221; on the principal amount outstanding. This assessment is referred to as the SPPI test and is performed
at an instrument level.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company&#8217;s business model for managing financial assets
refers to how it manages its financial assets in order to generate cash flows. The business model determines whether cash flows will result
from collecting contractual cash flows, selling the financial assets, or both.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Purchases or sales of financial assets that require delivery
of assets within a time frame established by regulation or convention in the market place (regular way trades) are recognized on the trade
date, i.e., the date that the Company commits to purchase or sell the asset.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Subsequent measurement</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">For purposes of subsequent measurement, financial assets are
classified as: financial assets at amortized cost or financial assets at fair value through profit or loss. There are no financial assets
designated as fair value through OCI.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Financial assets at amortized cost</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company measures financial assets at amortized cost if both
of the following conditions are met:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#8226; The financial asset is held within a business model with
the objective to hold financial assets in order to collect contractual cash flows, and</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#8226; The contractual terms of the financial asset give rise
on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial assets at amortized cost are subsequently measured
using the effective interest (EIR) method and are subject to impairment. Gains and losses are recognized in the statement of income when
the asset is derecognized, modified or impaired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Financial assets at fair value through profit
or loss</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial assets at fair value through profit or loss include
financial assets held for trading, financial assets designated upon initial recognition at fair value through profit or loss, or financial
assets mandatorily required to be measured at fair value. Financial assets are classified as held for trading if they are acquired for
the purpose of selling or repurchasing in the near term. Derivatives, including separated embedded derivatives, are also classified as
held for trading unless they are designated as effective hedging instruments. Financial assets with cash flows that are not solely payments
of principal and interest are classified and measured at fair value through profit or loss, irrespective of the business model.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial assets at fair value through profit or loss are carried
in the statement of financial position at fair value with net changes in fair value recognized in the statement of income. This category
includes derivative instruments.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Derecognition</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">A financial asset (or, where applicable, a part of a financial
asset or part of a group of similar financial assets) is primarily derecognized (i.e., removed from the Company&#8217;s statement of financial
position) when:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"></td><td style="text-align: justify">The rights to receive cash flows from the asset have expired; or</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"></td><td style="text-align: justify">The Company has transferred its rights to receive cash flows from the asset or has assumed
an obligation to pay the received cash flows in full without material delay to a third party under a &#8216;pass-through&#8217; arrangement;
and either (a) the Company has transferred substantially all the risks and rewards of the asset, or (b) the Company has neither transferred
nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset.</td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">When the Company has transferred its rights to receive cash flows
from an asset or has entered into a pass-through arrangement, it evaluates if, and to what extent, it has retained the risks and rewards
of ownership. When it has neither transferred nor retained substantially all of the risks and rewards of the asset, nor transferred control
of the asset, the Company continues to recognize the transferred asset to the extent of its continuing involvement. In that case, the
Company also recognizes an associated liability. The transferred asset and the associated liability are measured on a basis that reflects
the rights and obligations that the Company has retained.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Continuing involvement that takes the form of a guarantee over
the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that
the Company could be required to repay.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Impairment of financial assets</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Further disclosures relating to impairment of financial assets
are also provided in the following notes:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"></td><td style="text-align: justify">Significant accounting judgments, estimates and assumptions - Note 3</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"></td><td style="text-align: justify">Trade receivables - Note 7</td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company recognizes an allowance for expected credit losses
(ECLs) for all debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual
cash flows due in accordance with the contract and the cash flows the Company expects to receive, discounted at an approximation of the
original effective interest rate. The expected cash flows will include cash flows from the sale of collateral held or other credit enhancements
that are integral to the contractual terms.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">For trade receivables, the Company applies a simplified approach
in calculating ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for credit losses
based on lifetime ECLs at each reporting date. The Company has established a provision matrix that is based on its historical credit loss
experience, adjusted for forward-looking factors specific to the debtors and the economic environment.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company considers a financial asset to be in default
when internal or external information indicates that the Company is unlikely to receive the outstanding contractual amounts in full
before considering any credit enhancements held by the Company. A financial asset is written off when there is no reasonable
expectation of recovering the contractual cash flows.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><b>ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
liabilities</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Initial recognition and measurement</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial liabilities are classified, at initial recognition,
as financial liabilities at fair value through profit or loss, loans and borrowings, payables, or as derivatives designated as hedging
instruments in an effective hedge, as appropriate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">All financial liabilities are recognized initially at fair value
and, in the case of loans and borrowings and payables, net of directly attributable transaction costs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company&#8217;s financial liabilities include trade payables,
loans and financing, notes payable, lease liabilities, advances from customers and accounts payable to selling shareholders.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Subsequent measurement</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The measurement of financial liabilities depends on their classification,
as described below:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Financial liabilities at fair value through
profit or loss</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial liabilities at fair value through profit or loss include
financial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value through profit or
loss.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial liabilities are classified as held for trading if they
are incurred for the purpose of repurchasing in the near term. This category also includes, when applicable, derivative financial instruments
entered into by the Company that are not designated as hedging instruments in hedge relationships as defined by IFRS 9. Gains or losses
on liabilities held for trading are recognized in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial liabilities designated upon initial recognition at
fair value through profit or loss are designated at the initial date of recognition, and only if the criteria in IFRS 9 are satisfied.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Loans and borrowings</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">After initial recognition, interest-bearing loans and borrowings
are subsequently measured at amortized cost using the EIR method. Gains and losses are recognized in the statement of income when the
liabilities are derecognized as well as through the EIR amortization process.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Amortized cost is calculated by considering any discount or premium
on acquisition and fees or costs that are an integral part of the EIR. The EIR amortization is included as finance expenses in the statement
of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Derecognition</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">A financial liability is derecognized when the obligation under
the liability is discharged or cancelled or expires. When an existing financial liability is replaced by another from the same lender
on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is
treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying
amounts is recognized in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><br/>
</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Offsetting of financial instruments</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial assets and financial liabilities are offset and the
net amount is reported in the statement of financial position if there is a currently enforceable legal right to offset the recognized
amounts and there is an intention to settle on a net basis, to realize the assets and settle the liabilities simultaneously.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zSLNqDO7dt11" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>e) <span id="xdx_867_zWpp7npZLiub">Cash and cash equivalents</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Cash and cash equivalents in the statement of financial position comprise
cash at banks and on hand, and short-term financial investments with an original maturity of three months or less, which are subject to
an insignificant risk of changes in value.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For the purpose of the statement of cash flows, cash and cash equivalents
consist of cash and short-term financial investments, as they are considered an integral part of the Company&#8217;s cash management.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zNJh9Hmg1eQ9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>f) <span id="xdx_860_zaQrZT2wqJl8">Property and equipment</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Property and equipment are stated at cost, net of accumulated depreciation
and accumulated impairment losses, if any.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Subsequent expenditures are capitalized only if it is probable that the
future economic benefits associated with the expenditure will flow to the Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Depreciation is calculated on a straight-line basis over the estimated useful
lives of the assets, as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zAZYZOz6Ydq" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details 1)">
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B0_zaC2EnOUWqdf" style="display: none">Schedule of estimated useful
lives of the assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Building</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zGZ0Olisj3R3" title="Useful lives of assets">25</span> years</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Machinery and equipment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zlijIYD854z1" title="Useful lives of assets">10</span> years</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Vehicles</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zWn083WDFBIa" title="Useful lives of assets">4</span> years</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Furniture and fixtures</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zVPzrKtB97bi" title="Useful lives of assets">10</span> years</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">IT equipment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zdCqKpUaMbQj" title="Useful lives of assets">5</span> years</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Library books</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_z35nlPvrCfH9" title="Useful lives of assets">10</span> years</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Leasehold improvements</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGUH789gLle1" title="Useful lives of assets">5</span> - <span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zr85b7n2lei4" title="Useful lives of assets">20</span> years</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><br/>
</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">An item of property and equipment and any significant part initially recognized
is derecognized upon disposal or when no future economic benefit is expected from its use or disposal. Any gain or loss arising on the
derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included
in the statement of income when the asset is derecognized.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The residual values, useful lives and methods of depreciation of property
and equipment are reviewed at each financial year end and adjusted prospectively, if appropriate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zjIX2ELhTcF6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>g) <span id="xdx_864_zMeHdQwI1tq">Leases</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company assess at contract inception whether an arrangement is (or contains)
a lease is based on the substance of the arrangement at the inception of the contract. The arrangement is, or contains, a lease if the
arrangement conveys the right to control the use of the identified asset (or assets), even if that asset is (or those assets are) not
explicitly specified in an arrangement for a period of time in exchange for consideration.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><br/>
</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Company as a lessee</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company applies a single recognition and measurement approach for all
leases, except for short-term leases and leases of low-value assets. The Company recognizes lease liabilities to make lease payments and
right-of-use assets representing the right to use the underlying assets.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Right-of-use assets</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company recognizes right-of-use assets at the commencement date of the
lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation
and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of
lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease
incentives received. Unless the Company is reasonably certain to obtain ownership of the leased asset at the end of the lease term, the
recognized right-of-use assets are depreciated on a straight-line basis over the shorter of its estimated useful life and the lease term.
Right-of-use assets are subject to impairment.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Lease liabilities</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">At the commencement date of the lease, the Company recognizes lease liabilities
measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance
fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected
to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain
to be exercised by the Company and payments of penalties for terminating a lease, if the lease term reflects the Company exercising the
option to terminate. The variable lease payments that do not depend on an index or a rate are recognized as expense in the period on which
the event or condition that triggers the payment occurs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">In calculating the present value of lease payments, the Company uses the
incremental borrowing rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After
the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments
made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change
in the in-substance fixed lease payments or a change in the assessment to purchase the underlying asset.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Short-term leases and leases of low-value assets</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company applies the short-term lease recognition exemption to its short-term
leases of properties (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase
option). It also applies the lease of low-value assets recognition exemption to leases that are considered of low value. Lease payments
on short-term leases and leases of low-value assets are recognized as expense on a straight-line basis over the lease term.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_z7U4La36slmi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>h) <span id="xdx_866_zpxVucjDvpRh">Intangible assets</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets acquired separately are measured on initial recognition
at cost. The cost of intangible assets acquired in a business combination is their fair value at the date of acquisition. Following initial
recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally generated
intangibles are not capitalized and the related expenditure is reflected in the statement of income in the period in which the expenditure
is incurred.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The useful lives of intangible assets are assessed as finite or indefinite.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets with finite lives are amortized over the useful economic
life and assessed for impairment whenever there is an indication that the intangible asset may be impaired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The amortization period and the amortization method for an intangible asset
with a finite useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected
pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as
appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized
in the statement of income in the expense category that is consistent with the function of the intangible assets.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets with indefinite useful lives are not amortized, but are
tested for impairment annually, either individually or at the cash-generating unit level. The assessment of indefinite life is reviewed
annually to determine whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite
is made on a prospective basis.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">An intangible asset is derecognized upon disposal or when no future economic
benefits are expected from its use or disposal. Any gain or loss arising upon derecognition of the asset (calculated as the difference
between the net disposal proceeds and the carrying amount of the asset) is included in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_84A_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_zlZZxcLm8cke" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>i) <span id="xdx_862_zW60XKT14Avf">Impairment of non-financial assets</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company assesses, at each reporting date, whether there is an indication
that an asset may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Company estimates
the asset&#8217;s recoverable amount. An asset&#8217;s recoverable amount is the higher of an asset&#8217;s or CGU&#8217;s fair value
less costs of disposal and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate
cash inflows that are largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU
exceeds its recoverable amount, the asset is considered impaired and is written down to its recoverable amount.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">In assessing value in use, the estimated future cash flows are discounted
to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks
specific to the asset. In determining fair value less costs of disposal, recent market transactions are considered. If no such transactions
can be identified, an appropriate valuation model is used. These calculations are corroborated by valuation multiples, quoted share prices
for publicly traded companies or other available fair value indicators.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company bases its impairment calculation on detailed budgets and forecast
calculations, which are prepared separately for each of the Company&#8217;s CGUs to which the individual assets are allocated. These budgets
and forecast calculations generally cover a period of five years, considering the companies activities and maturation period of its graduate
and undergraduate courses. A long-term growth rate is calculated and applied to project future cash flows after the last projected year.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For impairment testing, goodwill acquired through business combinations
and licenses with indefinite useful lives are allocated to their respective CGUs. The Company defined each of its operating subsidiaries
as a CGU, except for digital services segment, which combines subsidiaries of (i) &#8220;Content &amp; Technology for medical education&#8221;;
(ii) &#8220;Clinical Decision Software&#8221;; and (iii) &#8220;Practice Management Tools &amp; Electronic Prescription&#8221;, where
the subsidiaries were combined as one CGU following the business strategic pillars.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Whenever applicable, impairment losses of continuing operations are recognized
in the statement of income in expense categories consistent with the function of the impaired asset.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For assets excluding goodwill, an assessment is made at each reporting date
to determine whether there is an indication that previously recognized impairment losses no longer exist or have decreased. If such indication
exists, the Company estimates the asset&#8217;s or CGU&#8217;s recoverable amount. A previously recognized impairment loss is reversed
only if there has been a change in the assumptions used to determine the asset&#8217;s recoverable amount since the last impairment loss
was recognized. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the
carrying amount that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years.
Such reversal is recognized in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Goodwill is tested for impairment annually as at December 31 and when circumstances
indicate that the carrying value may be impaired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Impairment is determined for goodwill by assessing the recoverable amount
of each CGU (or group of CGUs) to which the goodwill relates. When the recoverable amount of the CGU is less than its carrying amount,
an impairment loss is recognized. Impairment losses relating to goodwill cannot be reversed in future periods.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets with indefinite useful lives are tested for impairment
annually as at December 31 at the CGU level, as appropriate, and when circumstances indicate that the carrying value may be impaired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>&#160;</b></p>

<p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForInvestmentsExplanatory_zmHC9D4CmwBi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>j) <span id="xdx_865_zqfOzwRP2TGf">Investments</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Investments in associates are initially recognized at consideration transferred
and adjusted thereafter for the equity method, being increased or reduced from its interest in the investee's income after the acquisition
date. An associate is an entity over which the Company has significant influence. Significant influence is the power to participate in
the financial and operating policy decisions of the investee, but is not control or joint control over those policies.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_845_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_ziQoQhjATxuc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>k) <span id="xdx_86A_zGCeAo5CyYs9">Accounts payable to selling shareholders</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">These amounts represent liabilities related to the acquisitions made by
the Company which are not yet due. Accounts payable to selling shareholders are presented as current liabilities unless payment is not
due within 12 months after the reporting period. They are recognized initially at their fair value and subsequently measured at amortized
cost using the effective interest method, except for the contingent consideration related to earn-outs, which are measured at fair value
through profit or loss.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_z8grFXjufnd3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>l) <span id="xdx_865_zy328twd4Mji">Provisions</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Provisions are recognized when the Company has a present obligation (legal
or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required
to settle the obligation, and a reliable estimate can be made of the amount of the obligation. The expense relating to a provision is
presented in the statement of income, net of any reimbursement, when applicable.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>






<p id="xdx_84C_ecustom--DividendsPolicyExplanatory_zJIeCotkaNFe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>m) <span id="xdx_865_zZ0HxIVUJ3wi">Dividends</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company recognizes a liability to pay a dividend when the distribution
is authorized and the distribution is no longer at the discretion of the Company. The distribution is authorized when it is required to
pay a minimum dividend of the net income for the year in accordance with the Brazilian Corporate Law (applicable for Afya Brazil and its
subsidiaries) and the Company&#8217;s By-Laws or is approved by the shareholders. In respect to the consolidated statement of changes
in equity, the amount corresponding to the non-controlling interest over the dividends declared are recognized directly in equity.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_847_ecustom--LaborAndSocialObligationsPolicyExplanatory_z1fYGR5TdZ9b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>n) <span id="xdx_86C_z1YEpve974k6">Labor and social obligations</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Labor and social obligations are expensed as the related service is provided.
A liability is recognized for the amount expected to be paid if the Company has a present legal or constructive obligation to pay this
amount as a result of past service provided by the employee and the obligation can be estimated reliably.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_843_ecustom--SharebasedPaymentsPolicyExplanatory_zalIcnHJTBeb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>o) <span id="xdx_861_zL9WHXQMQFG">Share-based payments</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Certain key executives of the Company receive remuneration in the form of
share-based payments, which includes Stock Options and Restricted Stock Units (&#8220;RSUs&#8221;), whereby the executives render services
as consideration for equity instruments (equity-settled transactions).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The expense of equity-settled transactions is determined by the fair value
at the date when the grant is made using an appropriate valuation model.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">That expense is recognized in selling, general and administrative expenses,
together with a corresponding increase in equity, over the period in which the service and, where applicable, the performance conditions
are fulfilled (the vesting period). The cumulative expense recognized for equity-settled transactions at each reporting date until the
vesting date reflects the extent to which the vesting period has expired and the Company&#8217;s best estimate of the number of equity
instruments that will ultimately vest. The expense or credit in the statement of income for a period represents the movement in cumulative
expense recognized as at the beginning and end of that period.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Service and non-market performance conditions are not considered when determining
the grant date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Company&#8217;s best estimate
of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair
value. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting conditions.
Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless there are also
service and/or performance conditions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">No expense is recognized for awards that do not ultimately vest because
non-market performance and/or service conditions have not been met. Where awards include a market or non-vesting condition, the transactions
are treated as vested irrespective of whether the market or non-vesting condition is satisfied, provided that all other performance and/or
service conditions are satisfied.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">When the terms of an equity-settled award are modified, the minimum expense
recognized is the grant date fair value of the unmodified award, provided the original vesting terms of the award are met. An additional
expense, measured as at the date of modification, is recognized for any modification that increases the total fair value of the share-based
payment transaction, or is otherwise beneficial to the employee. Where an award is cancelled by the entity or by the counterparty, any
remaining element of the fair value of the award is expensed immediately through the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The dilutive effect of outstanding options is reflected as additional share
dilution in the computation of diluted earnings per share.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_840_eifrs-full--DisclosureOfRevenueFromContractsWithCustomersExplanatory_zQ6ltLqCkpUh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>p) <span id="xdx_861_ztnxnOBSMQ0a">Revenue from contracts with customers</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><i>Revenue recognition transferred over time </i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company's revenue consists primarily of tuition fees charged for medical
courses. The Company also generates revenue from tuition fees for other undergraduate courses, student fees, certain education-related
activities, digital education content and subscription of digital services.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Revenues are recognized when services are rendered to the customer and the
performance obligation is satisfied.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Revenue from tuitions, digital education content and electronic medical
records are recognized over time when services are rendered to the customer and the Company satisfies its performance obligation under
the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services.
Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Other revenues are recognized at a point in time when the service is rendered
to the customer at an amount that reflects the consideration to which the Company expects to be entitled in exchange for the service.
Other revenues are presented net of the corresponding discounts, returns and taxes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><i>Revenue recognition transferred at point in time </i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Revenue from sale of printed books, e-books, healthcare payments, online
platforms and marketing for pharmaceutical industry are recognized at the point in time when control of the asset or services is transferred
to the customer, generally on delivery of the goods at the customer&#8217;s location and permission to access the digital content. The
Company considers whether there are other promises in the contract that are separate performance obligations to which a portion of the
transaction price needs to be allocated. In determining the transaction price for the printed books and e-books, the Company considers
the effects of variable consideration, financing component, noncash consideration, and consideration payable to the customer to be not
significant.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company concluded that it is the principal in its revenue arrangements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company assesses collectability on a portfolio basis prior to recording
revenue. Generally, students cannot re-enroll for the next academic session without satisfactory resolution of any past-due amounts. If
a student withdraws from an institution, the Company's obligation to issue a refund depends on the refund policy at that institution and
the timing of the student's withdrawal. Generally, the refund obligations are reduced over the course of the academic term.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Trade receivables</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Trade receivables represent the Company&#8217;s right to an amount of consideration
that is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to accounting policies
of financial assets in Financial instruments - initial recognition and subsequent measurement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Advances from customers</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Advances from customers (a contract liability) are the obligation to transfer
services to a customer for which the Company has received consideration (or an amount of consideration is due) from the customer, as a
result of pre-paid tuition, digital education content and mobile app subscription for digital medical content received from customers
and is recognized separately in current liabilities, when the payment is received. Advances from customers are recognized as revenue when
the Company performs all obligations related to the contract, generally in the following month.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_84D_ecustom--TaxesPolicyExplanation_zC3K6LF1DSpc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>q) <span id="xdx_867_znYtC1b6UUee">Taxes</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">The Company&#8217;s
subsidiaries in the undergrad segment joined the PROUNI (<i>Programa Universidade para Todos</i> - University for All Program) program,
which is a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number of
student enrollment for low-income students, and benefits from the exemption of the following federal taxes:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">&#8226; Income taxes
and social contribution</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">&#8226; PIS and COFINS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">The regulation of
PROUNI defines that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS. For income from
other teaching activities, PIS and COFINS are charged at rates of <span id="xdx_906_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_z8nnaMF0qRR8" title="Tax rate">0.65</span>% and <span id="xdx_904_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zyr4XxR9tIq7" title="Tax rate">3.00</span>%, respectively, and for non-teaching activities, PIS
is charged at a rate of <span id="xdx_909_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_z184b5bPceb4" title="Tax rate">1.65</span>% and to COFINS at <span id="xdx_907_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zSw58OThkk16" title="Tax rate">7.6</span>%.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-weight: normal"><i>Current income taxes</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">Current income taxes
were calculated based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service, specifically
regarding the PROUNI program, which allows exemption of these taxes from traditional and technological graduation activities.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Current income tax assets and liabilities are measured at the amount expected
to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted
or substantively enacted at the reporting date.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Management periodically evaluates positions taken in the tax returns with
respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_84D_eifrs-full--DisclosureOfTreasurySharesExplanatory_zJ6WY0CRmfy3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>r) <span id="xdx_86A_zaUc3hC5yrHg">Treasury shares</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Own equity instruments that are reacquired (treasury shares) are recognized
at cost and deducted from equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the
Company&#8217;s own equity instruments. Any difference between the carrying amount and the consideration, if reissued, is recognized in
the share premium.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><br/>
</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>2.4 Changes in accounting policies and disclosures</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b><i>New standards, interpretations and amendments issued
and adopted by the Company</i></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">In the current year, the Company applied a series of changes to the
IFRSs issued by the International Accounting Standards Board (IASB) that are mandatorily for an accounting period beginning on or after
January 1, 2023, as listed below:</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_zPaMGbNj4N6b" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details 2)">
  <tr>
    <td style="padding-right: 5.4pt; text-align: center"><span id="xdx_8B0_z2WPlSwTKOIj" style="display: none">Schedule of changes in accounting policies and disclosures</span></td>
    <td style="padding-right: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amendments / standards</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Description</span></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_909_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zVRMHPj7cMrl" title="Standard">Amendments to IAS 1 and IFRS Practice Statement 2 - Making Materiality Judgments</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zPZEstU5FyG8" title="Description">The amendments to IAS 1 and IFRS Practice Statement 2 provide guidance and
    examples to help entities apply materiality judgments to accounting policy disclosures. The amendments aim to help entities provide more
    useful accounting policy disclosures by replacing the requirement for entities to disclose their "material" accounting policies
    with a requirement to disclose their "material" accounting policies and adding guidance on how entities apply the concept of
    materiality when making decisions about accounting policy disclosures.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The amendments have had an impact on the Company&#8217;s disclosures of accounting
    policies, but not on the measurement, recognition or presentation of any items in the Company&#8217;s consolidated financial statements.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_905_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_zRiqeDN4JEgk" title="Standard">Amendments to IAS 8 - Accounting Policies, Changes in Accounting Estimates and Errors - Definition of Accounting Estimates</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90D_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_z7GzDbcsH3N" title="Description">The amendments to IAS 8 clarify the distinction between changes in accounting
    estimates, changes in accounting policies and correction of errors. They also clarify how entities use measurement techniques and inputs
    to develop accounting estimates.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">These amendments have no significant impact on the Company&#8217;s consolidated
    financial statements.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_z8uwC8KO8NO6" title="Standard">Amendments to IAS 12 - Income Taxes - International Tax Reform - Pillar Two Model Rules</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_zKFcJhEckc75" title="Description">In October 2021, more than 130 countries agreed to implement a minimum tax
    regime for multinational groups, known as Pillar Two, to reform the international corporate taxation. Pillar Two aims to ensure that multinational
    groups in scope are liable to a minimum effective corporate tax rate of 15 per cent per country.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">In December 2021, the OECD released the Pillar Two model rules - accompanied
    by commentary and guidelines - which are due to be passed into national legislation but adapted by local conditions.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">In response to the OECD's Pillar Two rules, the amendments to IAS 12 were
    introduced and include: (i) a mandatory temporary exception to the recognition and disclosure of deferred taxes arising from the jurisdictional
    implementation of the Pillar Two model rules; and (ii) disclosure requirements for affected entities to help users of the financial statements
    better understand an entity's exposure to Pillar Two income taxes arising from this legislation, especially prior to the effective date.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The countries where the Company has its tax domicile have not yet enacted
    any tax legislation in connection with Pillar Two. Therefore, these amendments have no significant impact on the Company&#8217;s consolidated
    financial statements as of December 2023</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zFXXi5Sw5Jqk" title="Standard">Amendments to IAS 12 Income Taxes - Deferred Tax related to Assets and Liabilities arising from a Single Transaction</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zIcy5ow2bcGl" title="Description">The amendments to IAS 12 Income Taxes narrow the scope of the initial recognition
    exception, so that it no longer applies to transactions that generate equal taxable and deductible temporary differences, such as leases
    and decommissioning liabilities.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">These amendments have no significant impact on the Company&#8217;s consolidated
    financial statements.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_907_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zKw3rf1kHu1g" title="Standard">IFRS 17 - Insurance Contracts</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_903_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zPE0liHDKlPd" title="Description">IFRS 17 is a new accounting standard with scope for insurance contracts,
    covering recognition and measurement, presentation and disclosure. IFRS 17 replaces IFRS 4 - Insurance Contracts. IFRS 17 applies to all
    types of insurance contracts (such as life, property and casualty, direct insurance and reinsurance), regardless of the type of entities
    issuing them, as well as to certain guarantees and financial instruments with discretionary participation characteristics; Some scope
    exceptions will apply.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The overall objective of IFRS 17 is to provide a comprehensive accounting
    model for insurance contracts that is most useful and consistent for insurers, covering all relevant accounting aspects.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The Company does not have any contracts that meet the definition of an insurance
    contract under IFRS 17.</p></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>





<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b><i>New standards, interpretations and amendments issued
but not yet effective</i></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt">&#160;</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">The new and amended standards and interpretations that are issued,
but not yet effective, up to the date of issuance of the Company&#8217;s consolidated financial statements are presented below. The Company
intends to adopt these new and amended standards and interpretations, if applicable, when they become effective.</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amendments / standards</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Description</span></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_900_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_zfzybCODwgX4" title="Standard">Amendments to IFRS 16: Lease Liability in a Sale and Leaseback</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_z0omFgjvhnbj" title="Description">In September 2022, the IASB issued amendments to IFRS 16 to specify the requirements
    that a seller-lessee uses in measuring lease liability arising from a sale and lease back transaction, in order to ensure that the seller-lessee
    does not recognise any amount of the gain or loss that relates to the right of use that it holds.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The amendments are effective for annual financial statements periods beginning
    on or after January 1, 2024 and shall apply retrospectively to sale and leaseback transactions entered into after the initial application
    date of IFRS 16. Early adoption is permitted but must be disclosed.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_90A_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_zDc4i8S4nvJ" title="Standard">Amendments to IAS 1: Classification of Liabilities as Current or Non-Current</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_z57sh07ltKLl" title="Description">In January 2020 and October 2022, the IASB issued amendments to paragraphs
    69 to 76 of IAS 1 to specify the requirements for classifying liabilities as current or non-current. The amendments clarify:</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; What is meant by the right to postpone liquidation;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; That the right to defer should exist at the end of the financial reporting
    period;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; That the rating is not affected by the likelihood that the entity
    will exercise its right to defer;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; That only if a derivative embedded in a convertible liability is itself
    an equity instrument, the terms of a liability will not affect its classification.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">In addition, a disclosure requirement has been introduced where a liability
    arising from a loan agreement is classified as non-current and the entity's right to postpone liquidation is contingent on the fulfilment
    of future covenants within twelve months.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024 and should be applied retrospectively.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_90B_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zkHivH8FOKyc" title="Standard">Supplier Financing Agreements - Amendments to IAS 7 and IFRS 7</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zJDKXm04GSWl" title="Description">In May 2023, the IASB issued amendments to IAS 7 and IFRS 7 to clarify the
    characteristics of supplier financing arrangements and require additional disclosures of such arrangements. The disclosure requirements
    in the amendments are intended to assist users of the financial statements in understanding the effects of financing arrangements with
    suppliers on an entity's obligations, cash flows, and exposure to liquidity risk.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024. Early adoption is permitted but must be disclosed.</p></td></tr>
  </table>
<p id="xdx_8AA_zkwwkyU46Ft2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">These amendments are not expected to have significant impact on the Company&#8217;s
consolidated financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureMaterialAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureMaterialAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfMaterialAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfMaterialAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639606805312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting judgments, estimates and assumptions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract', window );"><strong>Significant Accounting Judgments Estimates And Assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory', window );">Significant accounting judgments, estimates and assumptions</a></td>
<td class="text"><p id="xdx_80E_ecustom--SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory_zEQCK9HJIjt7" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in">3</td><td><span id="xdx_824_zv0WS9BcVUMc">Significant accounting judgments, estimates and assumptions</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The preparation of the Company&#8217;s consolidated financial statements
requires management to make judgments, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities,
and the accompanying disclosures. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment
to the carrying amount of assets or liabilities affected in future periods. Accounting estimates and judgments are continually evaluated
and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under
the circumstances. Revisions to estimates are recognized prospectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Other disclosures relating to the Company&#8217;s exposure to risks and
uncertainties includes:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Financial instruments
risk management objectives and policies - Note 13.4</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Sensitivity analysis
disclosures - Note 13.4.1<br/></span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>Estimates and assumptions</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The key assumptions about the future and other key sources of estimated
uncertainty as of the reporting date that include a significant risk of a material adjustment to the carrying amounts of assets and liabilities
within the next financial year, are described below. The Company based its assumptions and estimates on parameters available when the
consolidated financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change
due to market changes or circumstances that arise and that are beyond the Company&#8217;s control. Such changes are reflected in the assumptions
when they occur.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Identification and fair-value measurement of assets and
liabilities acquired in a business combination</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>&#160;</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Business combinations are accounted for using the acquisition method. Such
method requires recognizing and measuring the identifiable assets acquired, the liabilities assumed and any non-controlling interest in
the acquiree. The Company, as the acquirer, must classify or designate the identifiable assets and liabilities assumed on the basis of
its own contractual terms, economic conditions, operating and accounting policies and other relevant conditions as at the acquisition
date. Such assessment requires judgments from the Company on the methods used to determine the fair value of the assets acquired and liabilities
assumed, including valuation techniques that may require prospective financial information inputs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Impairment of non-financial assets</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Impairment exists when the carrying value of an asset or cash generating
unit (&#8220;CGU&#8221;) or group of CGUs exceeds its recoverable amount, defined as the higher of its fair value less costs of disposal
and its value in use. The fair value less costs of disposal calculation is based on data available from binding sales transactions, conducted
at arm&#8217;s length, for similar assets or observable market prices less incremental costs of disposing of the asset. The value in use
calculation is based on a discounted cash flow model (&#8220;DCF&#8221; model). The cash flows are derived from the budget for the next
five years and do not include restructuring activities to which the Company has not yet committed or significant future investments that
will enhance the performance of the assets of the CGU being tested. The recoverable amount is sensitive to the discount rate used for
the DCF model as well as to expected future cash-inflows and the growth rate used for extrapolation purposes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">These estimates are most relevant to goodwill and indefinite lived intangible
assets recognized by the Company. The key assumptions used to determine the recoverable amount for each CGU, including a sensitivity analysis,
are disclosed and further explained in Note 12.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Share-based compensation</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>&#160;</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Estimating fair value for share-based payment transactions requires determination
of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination
of the most appropriate inputs to the valuation model including the expected life of the share option or appreciation right, volatility
and dividend yield and making assumptions about them. For the measurement of the fair value of equity-settled transactions, the Company
uses the Binomial model. The assumptions and models used for estimating fair value for share-based payment transactions are disclosed
in Note 16 (b).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Leases - Estimating the incremental borrowing rate</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #263238">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company cannot readily determine the interest rate implicit in the
lease, therefore, it uses its incremental borrowing rate (IBR) to measure lease liabilities. The IBR is the rate of interest that the
Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar
value to the right-of-use asset in a similar economic environment. The IBR therefore reflects what the Company &#8216;would have to pay&#8217;,
which requires estimation when no observable rates are available (such as for subsidiaries that do not enter into financing transactions)
or when they need to be adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary&#8217;s
functional currency).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>







<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company estimates the IBR using observable inputs (such as market interest
rates) when available and is required to make certain entity-specific estimates.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639605942720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">Segment information</a></td>
<td class="text"><p id="xdx_807_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_z9bigRnVCgcd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>4</b></td><td><b><span id="xdx_829_zc3pYihvQUs5">Segment information</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company has three reportable segments as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#8226; Undergrad, which provides educational services
through undergraduate courses related to medicine, other health sciences and other undergraduate programs;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#8226; Continuing Education, which provides specialization
programs and graduate courses in medicine; and</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; Digital Services, which provides content and technology for medical
education, clinical decisions software, practice management tools and electronic medical records, doctor-patient relationship, telemedicine
and digital prescription for physicians and provides access and demand and efficiency for the healthcare players.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Segment information is presented consistently with the internal reports
provided to the Company's Chief Executive Officer (CEO), which is the Chief Operating Decision Maker (CODM) and is responsible for allocating
resources, assessing the performance of the Company's operating segments, and making the Company's strategic decisions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">No operating segments have been aggregated to form the reportable operating
segments. There is only one geographic region, and the results are monitored and evaluated as a single business.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The tables below presents assets and liabilities information for the Company&#8217;s
operating segments as of December 31, 2023 and 2022, respectively:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_zowoJGpjNH8b" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Segment information (Details)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zxn9q4EBFVyh" style="display: none">Schedule of presents assets and liabilities information for the Company&#8217;s
operating segments</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As of December 31, 2023</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total assets</b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zO3h7Wp7wPYa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,104,154</b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOnePnSHCcM4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>180,555</b></span></td>
    <td id="xdx_989_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQHxd17TMF8g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>310,989</b></span></td>
    <td id="xdx_988_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziqurXkxL0o" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,595,698</b></span></td>
    <td id="xdx_982_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zYfNrCb1ugAd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(11,217)</b></span></td>
    <td id="xdx_98C_eifrs-full--Assets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z09d5Usgxfz9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,584,481</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current assets</span></td>
    <td id="xdx_981_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z978Uxo0Fvo4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,001,156</span></td>
    <td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgQXgq4yiOY7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">86,361</span></td>
    <td id="xdx_988_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zAz7p10yNFD8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">127,206</span></td>
    <td id="xdx_981_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zCCVSl4lGYof" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,214,723</span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zSoFSdMQOXz8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(11,217)</span></td>
    <td id="xdx_98A_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvAvnDhotSz2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,203,506</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current assets</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zo7FtF97xjSc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,102,998</span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhwudu40q5Gd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">94,194</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQkIY81gJtul" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">183,783</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvz1b87huqn1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,380,975</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentAssets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z7JU9ksbNGrl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1270">-</span></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zm6uiTPVAxOi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,380,975</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total liabilities and equity</b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z1HSAdrO9dTl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,104,154</b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvzxiZAwqO9c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>180,555</b></span></td>
    <td id="xdx_983_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zUYttPlXFpt8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>310,989</b></span></td>
    <td id="xdx_984_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_znu2YfB7XU5e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,595,698</b></span></td>
    <td id="xdx_981_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNfHEyX1x9D5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(11,217)</b></span></td>
    <td id="xdx_98E_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmABx0VRazH7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,584,481</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current liabilities</span></td>
    <td id="xdx_98B_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zJtwLR0yTTIl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">787,658</span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zTazWYbkDmqh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,447</span></td>
    <td id="xdx_981_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zNDe9qws43Nl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">194,679</span></td>
    <td id="xdx_980_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zy7c74KbQpFa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,069,784</span></td>
    <td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAc9o0e8BeTi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(11,217)</span></td>
    <td id="xdx_98D_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2iJpLRb7Ht5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,058,567</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current liabilities</span></td>
    <td id="xdx_984_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zk3Z5c31fPe5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,783,855</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRbxmmQl1BLj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">57,608</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zWoOZ6DgfyQd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">41,439</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zardOyOBcGbf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,882,902</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zTAxgdvOK1aj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1306">-</span></span></td>
    <td id="xdx_989_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFFJ8YvbNnHf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,882,902</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Equity</span></td>
    <td id="xdx_986_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zGLpQZe6BhZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,532,641</span></td>
    <td id="xdx_986_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrQeQvNTqpq" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">35,500</span></td>
    <td id="xdx_98A_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zr1fyIJnaO12" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">74,871</span></td>
    <td id="xdx_98E_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zj0ZjBPXfoLg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,643,012</span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zdPUe7GA2Uef" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1318">-</span></span></td>
    <td id="xdx_988_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIfaBXPvaDOf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,643,012</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other disclosures</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Investments in associate (i) </span></td>
    <td id="xdx_987_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zIZE99QliOdl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,834</span></td>
    <td id="xdx_98D_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7i1VEzE3UI" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1324">-</span></span></td>
    <td id="xdx_989_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zluDbMWRN4b2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1326">-</span></span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdfQgvy0pgHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,834</span></td>
    <td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zR8Puf19h888" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1330">-</span></span></td>
    <td id="xdx_98C_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXQqHAwn0WCa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,834</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital expenditures (ii)</span></td>
    <td id="xdx_98E_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zYncj3Y1jT32" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">139,361</span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeODFZuHLEk8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,178</span></td>
    <td id="xdx_98C_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zOC6zMUjDJ52" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">63,889</span></td>
    <td id="xdx_980_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zV6QAQdK9Rvj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">218,428</span></td>
    <td id="xdx_98F_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zDOKDulTzbg1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1342">-</span></span></td>
    <td id="xdx_987_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zrnAuiua6BD6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">218,428</span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Investment in UEPC is included in non-current assets in the statement of financial position.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Capital expenditures consider the acquisitions of property and equipment and intangible assets.<br/></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>






<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As of December 31, 2022</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total assets</b></span></td>
    <td id="xdx_987_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zRAE7oqgHOZj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,775,829</b></span></td>
    <td id="xdx_98B_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zolFo5EsoCe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>149,254</b></span></td>
    <td id="xdx_987_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrxROVSHQG4l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>275,564</b></span></td>
    <td id="xdx_989_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zzCfWCJ2B3Ld" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,200,647</b></span></td>
    <td id="xdx_988_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zy6vUZYt5VN8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,108)</b></span></td>
    <td id="xdx_98A_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zK1l5zvbmCUk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,199,539</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current assets</span></td>
    <td id="xdx_984_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zshj11nVrpl8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,461,802</span></td>
    <td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsXRmXsQCIU7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">61,673</span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxScDUIatEKc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">115,290</span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zeAPq0wY2kUk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,638,765</span></td>
    <td id="xdx_983_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_ztMO7e8l3Jr8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,108)</span></td>
    <td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zyyCbYGJunJi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,637,657</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current assets</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCedULKzJPCa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,314,027</span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRvtPJWlYvF2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,581</span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zRAmoep2HWz8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">160,274</span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zHNzsijeAbN8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,561,882</span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zI0Jap3CKnaf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1379">-</span></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWCCeMuPxVrk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,561,882</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total liabilities and equity</b></span></td>
    <td id="xdx_987_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zlniwGjMLN6e" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,775,829</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zxUdxdfwqZi1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>149,254</b></span></td>
    <td id="xdx_982_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z04O7PeF0stc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>275,564</b></span></td>
    <td id="xdx_98F_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zlEIAGUNMGcd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,200,647</b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z101S8P55Iuf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,108)</b></span></td>
    <td id="xdx_982_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMMmVLAM4sz" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,199,539</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current liabilities</span></td>
    <td id="xdx_980_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zHVKXGs4H7p5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">711,896</span></td>
    <td id="xdx_983_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zHopmEGqqt4k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">57,605</span></td>
    <td id="xdx_982_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjmiwW8MXK33" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">137,296</span></td>
    <td id="xdx_98F_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zx46wlx3Egg1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">906,797</span></td>
    <td id="xdx_985_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zMp4XkIcdPSf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,108)</span></td>
    <td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIZ2sxlozLk2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">905,689</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current liabilities</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z8OoURKNYyr4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,938,960</span></td>
    <td id="xdx_987_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFRiL5i2DiC8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">63,990</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z4wWdA0Xp815" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">40,742</span></td>
    <td id="xdx_98C_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z9Ok6sNrLFn1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,043,692</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3mYAqKKub6d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1415">-</span></span></td>
    <td id="xdx_980_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z54MqKjr7J7l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,043,692</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Equity</span></td>
    <td id="xdx_98B_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zDh6dEkO4ubb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,124,973</span></td>
    <td id="xdx_983_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJZxGYHnmPA7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27,659</span></td>
    <td id="xdx_983_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zRHmFb2ANLMh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">97,526</span></td>
    <td id="xdx_984_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZLrnFO41nMf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,250,158</span></td>
    <td id="xdx_984_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z5tNTpv4DqB4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1427">-</span></span></td>
    <td id="xdx_985_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJYqDzfUm4Bk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,250,158</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other disclosures</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Investments in associate (i)</span></td>
    <td id="xdx_984_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zAepd5cXq3vf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">53,907</span></td>
    <td id="xdx_98E_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgYTecDoKIs5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1433">-</span></span></td>
    <td id="xdx_988_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zfteJHFLGTeb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1435">-</span></span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_znDri24KICR2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">53,907</span></td>
    <td id="xdx_980_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z8cwUgmkU74c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></span></td>
    <td id="xdx_981_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbzIGiW2NEy8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">53,907</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital expenditures (ii)</span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zh3P3Ecp5p9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">247,634</span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zb9Vt4QPZHX4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,827</span></td>
    <td id="xdx_986_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxrEh4Ekk5e8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">61,694</span></td>
    <td id="xdx_98F_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z6ZTUL27BiNe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">318,155</span></td>
    <td id="xdx_984_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zmSDKqDW3PP2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1451">-</span></span></td>
    <td id="xdx_98C_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z15F3L6LktE3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">318,155</span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Investment in UEPC is included in non-current assets in the statement of financial position.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Capital expenditures consider the acquisitions of property and equipment and intangible assets.</td>
</tr></table>

<p id="xdx_8A1_zB7AHgA9k2c8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">The tables below presents the statements of income for the Company&#8217;s
operating segments for the years ended December 31, 2023, 2022 and 2021:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_z5E4H2uYt6ki" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Segment information (Details 1)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_ztBZVrPUOngh" style="display: none">Schedule of statements of income for the Company&#8217;s
operating segments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td colspan="6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2023</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External customer</span></td>
    <td id="xdx_985_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zW0ANW1KaFfi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,511,018</span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhE8onfeMyv1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">146,827</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zEwTz4RrCU9j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">218,068</span></td>
    <td id="xdx_98B_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z96KAADCrMyk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,875,913</span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_znadHpbyXdl5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1465">-</span></span></td>
    <td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfQcC7bwFHll" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,875,913</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_986_ecustom--InterSegment_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeSteVLWbEf1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1469">-</span></span></td>
    <td id="xdx_981_ecustom--InterSegment_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrPhohTH1rJi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1471">-</span></span></td>
    <td id="xdx_98A_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0997bcfBvbb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,217</span></td>
    <td id="xdx_987_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJZt8gZkzBkg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,217</span></td>
    <td id="xdx_981_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zyknu0nHf7P4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(11,217)</span></td>
    <td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpsu85eiSUDk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1479">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zgozywOfGwKk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,511,018</b></span></td>
    <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z8kLyeqFU1He" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>146,827</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zv6DROL7NhS5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>229,285</b></span></td>
    <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zaUJT6aOECd2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,887,130</b></span></td>
    <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zfKAs0NIPNFe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(11,217)</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfPMenSdwgGg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,875,913</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zzAqL1FANVn4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(997,973)</span></td>
    <td id="xdx_984_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbPoUGNXCgwh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(62,792)</span></td>
    <td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z7Fix8dOMcsb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(60,265)</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zHjDYMwJ1A7b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,121,030)</span></td>
    <td id="xdx_980_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zqdzPpPTpl6l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,217</span></td>
    <td id="xdx_988_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfDHZe3oNdt1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,109,813)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z6Sv5xr9jVM3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,513,045</b></span></td>
    <td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z66xVUinoqwc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>84,035</b></span></td>
    <td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z6ln8JQJdHKb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>169,020</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z1aFBm0be9ge" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,766,100</b></span></td>
    <td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z5HgvmdusNxe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1513">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ze9ihgOAvg6j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,766,100</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Selling, general and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zptqXWW6DbI" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,014,684)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other income, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--OtherGainsLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCPeGXd4czr3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,645</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_982_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2XXFSoS4Eld" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>767,061</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_981_eifrs-full--FinanceIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbX7VPruAHJ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">110,642</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_ecustom--FinanceExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8amPsYdnHVj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(457,616)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_983_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpcY5FVQSeve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,495</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_981_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKA8fykmO3p2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>429,582</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMXxKIy3ZZ6d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(24,166)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_983_eifrs-full--ProfitLoss_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGoN0F0mskdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>405,416</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td colspan="6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External customer</span></td>
    <td id="xdx_985_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zrDg9ZxJO0qh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,037,889</span></td>
    <td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWmjDFLpNA6g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">108,806</span></td>
    <td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zLviOjNWqDza" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">182,362</span></td>
    <td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zff82wLFEEr9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,329,057</span></td>
    <td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAwdwMCw591k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1543">-</span></span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zBb48rrVbBCc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,329,057</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_98A_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zR9b7A66bmh2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1547">-</span></span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zm8xymixof9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1549">-</span></span></td>
    <td id="xdx_981_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrtJg8w7fnac" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,622</span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zn1Uz7HokGC" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,622</span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zViKI05Caqej" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(7,622)</span></td>
    <td id="xdx_987_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zaTCjiIL9lA9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1557">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCNpeMSCSDY3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,037,889</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj8tKXLhpsJ9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>108,806</b></span></td>
    <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zT4NkcA9XyFe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>189,984</b></span></td>
    <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z4QFcNDPOl9a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,336,679</b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zdIOqhh8D5R3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(7,622)</b></span></td>
    <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxfGQ8E2iOkl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,329,057</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zKtH1D5Ets5f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(763,185)</span></td>
    <td id="xdx_983_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFNJGttMao2k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(56,554)</span></td>
    <td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjCAFpWbYSQj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(47,435)</span></td>
    <td id="xdx_988_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zBbtTvMEcN35" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(867,174)</span></td>
    <td id="xdx_981_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zrUu600CUNb2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,622</span></td>
    <td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYpF51iHSKo" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(859,552)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_981_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z0UsPRksf61j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,274,704</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvX1RALBKoe4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>52,252</b></span></td>
    <td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z8o6gf7mDcJ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>142,549</b></span></td>
    <td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zasbSJr62DU3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,469,505</b></span></td>
    <td id="xdx_98D_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zXxEeGt8tQm6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1591">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpFvcPmzkbE4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,469,505</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Selling, general and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_985_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zR32kNqjmMzl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(798,153)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other expenses, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_985_eifrs-full--OtherGainsLosses_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zb5dNzrx0YT3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(7,252)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zb1ilX8tm4bg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>664,100</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpdBLMb4p1ih" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">102,042</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_ecustom--FinanceExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zV1veEhJqvG9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(349,893)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zSh6wnAB1hBf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,184</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98C_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdBl0ViKWKz5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>428,433</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5leDQZLP5Q2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(35,677)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98C_eifrs-full--ProfitLoss_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zK1M6l0qy6mk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>392,756</b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="6" style="padding-right: 2pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External customer</span></td>
    <td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zTDgKya8BrL1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,498,408</span></td>
    <td id="xdx_98D_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znB33mhLHpXc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">72,983</span></td>
    <td id="xdx_98A_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3NiTetUm9v8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">147,980</span></td>
    <td id="xdx_98C_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zXOtu2LDqxzk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,719,371</span></td>
    <td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zUTZBGCjUI21" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1623">-</span></span></td>
    <td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmSQ08quN9A4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,719,371</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_983_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zbxTcecIlGD3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1627">-</span></span></td>
    <td id="xdx_980_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeU9L9pqKpck" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1629">-</span></span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zV7pWJ2sOTw5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,978</span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zr2BdGWTuYL1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,978</span></td>
    <td id="xdx_984_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zqqiAKynUJJf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,978)</span></td>
    <td id="xdx_985_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z59UgQfM2YTd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1637">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zcCuU4qd1v68" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,498,408</b></span></td>
    <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z5uusyxhU9ed" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>72,983</b></span></td>
    <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zFsFtlKBbnzb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>151,958</b></span></td>
    <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvkeGmqp2E87" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,723,349</b></span></td>
    <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNFh0pI1WF27" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(3,978)</b></span></td>
    <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zN6qV1KSHbD" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,719,371</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z2vwf64uAxAe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(554,995)</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhppPyNVwig" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(50,773)</span></td>
    <td id="xdx_988_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxztpPHBrttb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(50,510)</span></td>
    <td id="xdx_981_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zpgvmYjn1LT2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(656,278)</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zfM0kbiJVqnl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,978</span></td>
    <td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvUd1hIQasq9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(652,300)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zItmGSX2wqna" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>943,413</b></span></td>
    <td id="xdx_988_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z2aBvSMdA4mc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>22,210</b></span></td>
    <td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zTzBxFJpmTNf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>101,448</b></span></td>
    <td id="xdx_982_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zPbfZadgLDx1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,067,071</b></span></td>
    <td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z29oWpfJhM3a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1671">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAtBRk0UFuG4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,067,071</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Selling, general and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_987_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpwd2qreyvWj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(622,615)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other expenses, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_987_eifrs-full--OtherGainsLosses_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbHVHeJ1sTAi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,561)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zPdnODlGRfjd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>440,895</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcAoFk3YfpDf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">64,566</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_982_ecustom--FinanceExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zwG1A8fWY1Q9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(243,796)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zPccjhkJAwqb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,797</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_986_eifrs-full--ProfitLossBeforeTax_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8nsMy8kF56" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>273,462</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z11LPtW5MSV2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(31,179)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net income </b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98B_eifrs-full--ProfitLoss_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zk9F8EQJpzRc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>242,283</b></span></td></tr>
  </table>
<p id="xdx_8A6_z4vVXsFx2NA4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>Seasonality of operations</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Undergrad&#8217;s tuition revenues are related to the intake process and
monthly tuition fees charged to students over the period; thus, does not have significant fluctuations during the year. Continuing Education
revenues are related to monthly intakes and tuition fees and do not have a considerable concentration in any period. Digital Services
is comprised mainly of Medcel, Pebmed, and iClinic revenues. While Pebmed and iClinic do not have significant fluctuation regarding seasonality,
Medcel&#8217;s revenue is concentrated in the first and last quarter of the year due to the enrollments. In addition, the majority of
Medcel&#8217;s revenues are derived from printed books and e-books, which are recognized at the point in time when control is transferred
to the customer. Consequently, the Digital Services segment generally has higher revenues and results of operations in the first and last
quarters of the year than in the second and third quarters.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639668549632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory', window );">Business combinations</a></td>
<td class="text"><p id="xdx_808_eifrs-full--DisclosureOfBusinessCombinationsExplanatory_zsom6hNqSvmf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>5</b></td><td><b><span id="xdx_820_zwktbLeR2yxj">Business combinations</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>5.1 Acquisition in 2023</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The fair values of the identifiable assets acquired and liabilities assumed
as of acquisition date were:</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zimvmswtXyFh" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; line-height: 106%"><span id="xdx_8B0_zdO2J5A9ZQwd" style="display: none">Schedule
    of fair values of the identifiable assets acquired and liabilities assumed acquisition in 2023</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 106%">&#160;</td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 142px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>DelRey</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Cash and cash and equivalents</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zx7q3y2GhePk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">7,804</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Trade receivables</span></td>
    <td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztZyakB37YR8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">33,741</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Inventories</span></td>
    <td id="xdx_984_ecustom--Inventories1_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zq4Bedf61RX7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">139</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Recoverable taxes</span></td>
    <td id="xdx_981_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zQacF6a5jItb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">589</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Other assets</span></td>
    <td id="xdx_984_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zE4qyvle0vg9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">8,563</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Property and equipment</span></td>
    <td id="xdx_986_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zB3oTwyMWPQk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">24,980</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Right-of-use assets</span></td>
    <td id="xdx_980_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zBFT0oR3njE6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">65,408</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Intangible assets</span></td>
    <td id="xdx_98C_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zHPO44bCNul2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">728,777</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%">&#160;</td>
    <td id="xdx_983_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z1B1YccetCjc" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>870,001</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Trade payables</span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5Gta590Aknc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">12,253</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Lease liabilities</span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zEGz0l2HWMzd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">65,408</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Labor and social obligations</span></td>
    <td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztrARYUpLdo2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">6,252</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Taxes and contributions payable</span></td>
    <td id="xdx_98E_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zB8UM0w71vU7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Taxes and contributions payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">2,282</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Advances from customers</span></td>
    <td id="xdx_986_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zdhzX7I0nXih" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">38,327</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Provision for legal proceedings</span></td>
    <td id="xdx_982_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmyGKUsIkL5d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">152</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Other liabilities</span></td>
    <td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWc3HKBsjTBl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">4,189</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%">&#160;</td>
    <td id="xdx_98B_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z51nK7lk5Uu" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Financial liabilities recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>128,863</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Total identifiable net assets at fair value</b></span></td>
    <td id="xdx_98A_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5tECIZgEYFj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>741,138</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Goodwill arising on acquisition</span></td>
    <td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztQ18ge7ggB6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">75,098</span></td></tr>

<tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Purchase consideration transferred</b></span></td>
    <td id="xdx_984_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zXh6Ovd8Lzc5" style="border-bottom: black 1pt solid; white-space: nowrap; width: 142px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>816,236</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Cash paid</span></td>
    <td id="xdx_98D_eifrs-full--CashTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmxeILVsOurd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">575,000</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Consideration to be transferred</span></td>
    <td id="xdx_980_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zbGfwW67QsFf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Consideration to be transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">234,000</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Digital solutions (i)</span></td>
    <td id="xdx_985_eifrs-full--CirculationRevenue_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztkxOsTSLjsk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Digital solutions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">7,236</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b><i>Analysis of cash flows on acquisition:</i></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Transaction costs of the acquisition (included in cash flows from operating activities) </span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zVb799D9T362" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Transaction costs of the acquisition (included in cash flows from operating activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">12,332</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)</span></td>
    <td id="xdx_989_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zUYh2rKgST19" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">567,196</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Net of cash flow on acquisition </b></span></td>
    <td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zRTlufGOZPqe" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>579,528</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The total consideration transferred included the obligation to offer digital solutions, especially
from Medcel, Pebmed and Medical Harbour, through access (free-of-charge) to medical students of other medical schools held by the selling
shareholders, not subject to this acquisition, from 2023 to 2030. This purchase consideration was measured using assumptions such as
numbers of approved medical seats, current digital solutions prices, inflation and present value discount rates. The balances of such
consideration are classified as other liabilities on the statement of financial position.</td>
</tr></table>

<p id="xdx_8A1_z2PncZqL5zCc" style="margin-top: 0; margin-bottom: 0">&#160;</p>







<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><b>(a) Acquisition
of DelRey</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On January 2, 2023, Afya Brazil acquired <span id="xdx_90B_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_uPure_c20230102__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zqblTZoz79E8" title="Acquired share capital">100</span>% of the share capital of DelRey.
<span id="xdx_90C_eifrs-full--DescriptionOfAcquiree_c20221229__20230102__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zwnxUuSFia14" title="Acquired purchase price">The original aggregate purchase price of R$832,236 was adjusted by R$16,000, in favor of the Company, to R$816,236 comprised by: i) R$809,000
of which R$575,000 was paid in cash on the transaction closing date, and R$234,000 is payable in cash in three annual installments, respectively,
of R$134,000 in January 2024, R$50,000 in January 2025 and R$50,000 in January 2026, adjusted by the SELIC rate; and ii) offer of AFYA&#8217;s
digital solutions free of charge until December 31, 2030, for students of medicine of universities owned by the sellers which are not
part of the transaction. The fair value of this service was estimated at R$7,236 at the acquisition date. There are 84 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$105,000. Given the future event
that will trigger the potential payout is not under the Company&#8217;s control, the probability of such payout cannot be reliably estimated
and accordingly the contingent consideration was not measured at the acquisition date. Should the additional seats be approved, it will
result in additional licenses, which will be measured accordingly if and when approved.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">DelRey is a post-secondary education institution with governmental authorization
to offer on-campus, undergraduate degrees and graduate programs in medicine and health, as well as other courses, in the States of Alagoas
and Pernambuco. The acquisition contributes 340 medical school seats to Afya. With the acquisition, Afya further consolidates its presence
in the Brazilian Northeast, entering a new State in the region.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The acquisition of DelRey was accounted for under IFRS 3 - Business Combinations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Transaction costs to date amount to R$<span id="xdx_907_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20221229__20230102__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zZjlJGWUVo95" title="Transaction costs">12,332</span> and were expensed and are included
in selling, general and administrative expenses in the consolidated statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">At the acquisition date, the fair value of the trade receivables acquired
is substantially the same as its carrying amount.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The goodwill recognized includes the value of expected synergies arising
from the acquisition, which is not separately recognized. Goodwill is allocated entirely to the Undergrad segment. The goodwill recognized
is not expected to be deductible for income taxes purposes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company did not recognize deferred taxes related
to the business combination because the tax basis and the accounting basis, including fair value adjustments, were the same at the date
of the business combination.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company engaged an independent valuation specialist
to assist Management to assess the fair value of the assets acquired and liabilities assumed at date of acquisition. The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>






<table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfAcquisitionOfDelReyExplanatory_zlxEWMMhwBM9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 1)">
  <tr>
    <td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span id="xdx_8BC_zKltqkMykQWc" style="display: none">Schedule of intangible assets acquired</span></td>
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center; line-height: 106%">&#160;</td></tr>
  <tr style="background-color: white">
    <td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 106%"><b>Valuation technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Licenses</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>With-and-without method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20230101__20230102__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesAndFranchisesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfDelReyMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--WithAndWithoutMethodMember_zwY6rn3TsBfc" title="Valuation technique">The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Customer relationships</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Multi-period excess earnings method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20230101__20230102__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfDelReyMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zwWi3nnsHwla" title="Valuation technique">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</span></p></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The valuation technique for property and equipment consists of determining
the fair value of an asset by using methodologies like replacement costs and market value.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">DelRey has contributed R$<span id="xdx_90B_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zBLrCkMk6ez9" title="Net revenue">240,107</span> of revenue and R$<span id="xdx_907_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zEaPt8ixA39k" title="Income loss before income taxes">82,147</span> of income before
income taxes to the Company in 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">5.2 Acquisitions in 2022</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The fair values of the identifiable assets acquired and liabilities assumed
as of acquisition date were:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock_z7pRsCeViO3d" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 2)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B4_zpvBWvTaPcqf" style="display: none">Schedule of fair values of the identifiable assets acquired and liabilities assumed
as of acquisition in 2022</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 55%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Al&#233;m da Medicina</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 15%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>CardioPapers</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 15%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Glic</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash and cash and equivalents</span></td>
    <td id="xdx_984_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zZIiyCYjvmrb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">298</span></td>
    <td id="xdx_98F_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zh54ljKNPFUk" style="text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,648</span></td>
    <td id="xdx_983_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zGjraiCgRBj7" style="text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">151</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade receivables</span></td>
    <td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zT3Go2JZ4FZ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,705</span></td>
    <td id="xdx_98F_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zYAaVFYffyg1" style="text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,350</span></td>
    <td id="xdx_988_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zNLidwplezO" style="text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">94</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other assets</span></td>
    <td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zTgi5Q9GrNLd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other Assets As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">266</span></td>
    <td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zBgPEIGbCPPf" style="text-align: right" title="Other Assets As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1</span></td>
    <td id="xdx_98B_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z38j0DjSkSOa" style="text-align: right" title="Property, plant and equipment recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">36</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Property and equipment</span></td>
    <td id="xdx_987_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zf4v2hxMUcQe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Property, plant and equipment recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">37</span></td>
    <td id="xdx_98C_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zVNHOGk50XQg" style="text-align: right" title="Property, plant and equipment recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">43</span></td>
    <td id="xdx_984_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zPLTq0N2g24c" style="text-align: right" title="Property, plant and equipment recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1792">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Intangible assets</span></td>
    <td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zLXUROZduKWk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Identifiable intangible assets recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">20,299</span></td>
    <td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zmS9Vi0Wy22j" style="text-align: right" title="Identifiable intangible assets recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">28,655</span></td>
    <td id="xdx_982_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zuOXjEssz5zi" style="text-align: right" title="Identifiable intangible assets recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,395</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_986_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zAW2EF13e6gk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>22,605</b></span></td>
    <td id="xdx_98A_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zoFyaTsS3RX7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>33,697</b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zZ9h5n2G5ZV5" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>15,676</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade payables</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zbShxV6woIni" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade and other payables recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">705</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zERhoS0Ry21l" style="text-align: right" title="Trade and other payables recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,703</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zPCa2JdtRuL2" style="text-align: right" title="Trade and other payables recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Labor and social obligations</span></td>
    <td id="xdx_986_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zlx2EepCblV9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Labor And Social Obligations As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">79</span></td>
    <td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z8YmyMNVWFG3" style="text-align: right" title="Labor And Social Obligations As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">60</span></td>
    <td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zCQXZrQGIX69" style="text-align: right" title="Labor And Social Obligations As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1816">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Taxes and contributions payable</span></td>
    <td id="xdx_984_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zbBEZ5JfSSs" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Taxes Payable As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,182</span></td>
    <td id="xdx_98A_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zMuVJGVuvrv7" style="text-align: right" title="Taxes Payable As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">352</span></td>
    <td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zK3d05uactzg" style="text-align: right" title="Taxes Payable As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">91</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Advances from customers</span></td>
    <td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zv2fEdTDm4ul" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Advances From Customers As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,185</span></td>
    <td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zyY2k6Cw4Hke" style="text-align: right" title="Advances From Customers As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,893</span></td>
    <td id="xdx_982_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z2d2nxKZ7nph" style="text-align: right" title="Advances From Customers As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1828">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other liabilities</span></td>
    <td id="xdx_986_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zVKPx78yXUtf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other Liabilities As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1830">-</span></span></td>
    <td id="xdx_987_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zRstoWPCZmkk" style="text-align: right" title="Other Liabilities As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1832">-</span></span></td>
    <td id="xdx_98F_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zMP0RLEp2bFi" style="text-align: right" title="Other Liabilities As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">574</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_987_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zrO1lf7KyW47" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>8,151</b></span></td>
    <td id="xdx_985_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zPPw8EG1sAkj" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,008</b></span></td>
    <td id="xdx_981_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqjfv8Vj4x07" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>666</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total identifiable net assets at fair value</b></span></td>
    <td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zM7X2sxvzGEd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Indemnification assets recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>14,454</b></span></td>
    <td id="xdx_98A_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zKqKfGbHRVwk" style="text-align: right" title="Indemnification assets recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>27,689</b></span></td>
    <td id="xdx_98F_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zEQ3nRtWIrra" style="text-align: right" title="Indemnification assets recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>15,010</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Goodwill arising on acquisition</span></td>
    <td id="xdx_984_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zLuLArMFsagh" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,335</span></td>
    <td id="xdx_98B_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zilRbSQmW8Ta" style="border-bottom: black 1pt solid; text-align: right" title="Goodwill recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,324</span></td>
    <td id="xdx_980_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zNam2rVisFS2" style="border-bottom: black 1pt solid; text-align: right" title="Goodwill recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,587</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Purchase consideration transferred</b></span></td>
    <td id="xdx_98A_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zumHhHtK96Ej" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Consideration transferred, acquisition-date fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>26,789</b></span></td>
    <td id="xdx_981_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zHoIrWBEllo5" style="border-bottom: black 1pt solid; text-align: right" title="Consideration transferred, acquisition-date fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>42,013</b></span></td>
    <td id="xdx_982_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zw32cmPQpCo6" style="border-bottom: black 1pt solid; text-align: right" title="Consideration transferred, acquisition-date fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>30,597</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash paid</span></td>
    <td id="xdx_989_eifrs-full--CashTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zDzK2xio0bjf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,952</span></td>
    <td id="xdx_986_eifrs-full--CashTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zkUj9j1s4cqi" style="text-align: right" title="Cash transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">34,924</span></td>
    <td id="xdx_984_eifrs-full--CashTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zDG7s0ngkyQ3" style="text-align: right" title="Cash transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21,602</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Contingent consideration</span></td>
    <td id="xdx_987_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zFdDMp3rUcE6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Contingent consideration recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,074</span></td>
    <td id="xdx_98B_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zdg6jS358aC9" style="text-align: right" title="Contingent consideration recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,422</span></td>
    <td id="xdx_980_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zvvvsA44uSNh" style="text-align: right" title="Contingent consideration recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,995</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Consideration to be transferred (Price adjustment)</span></td>
    <td id="xdx_982_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zTVZdxqreU7c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Consideration To Be Transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">763</span></td>
    <td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zzci5QDow1ck" style="text-align: right" title="Consideration To Be Transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(333)</span></td>
    <td id="xdx_988_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z6VexzhOC941" style="text-align: right" title="Consideration To Be Transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1876">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><i>Analysis of cash flows on acquisition:</i></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transaction costs of the acquisition (included in cash flows from operating activities) </span></td>
    <td id="xdx_987_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zSfoV1AZqZy2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">227</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zbUM9v1mcATd" style="text-align: right" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">274</span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zzVPSnEeW1Z3" style="text-align: right" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">222</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zN0f44lV96rk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,654</span></td>
    <td id="xdx_984_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zPcPrt3DJFs8" style="text-align: right" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">31,276</span></td>
    <td id="xdx_985_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zyu1k6k3vZeh" style="text-align: right" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21,451</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net of cash flow on acquisition </b></span></td>
    <td id="xdx_980_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zYKuETlqF8S" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>14,881</b></span></td>
    <td id="xdx_98B_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zGhZTDSsTxzh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>31,550</b></span></td>
    <td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqs1AvI6cNY7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>21,673</b></span></td></tr>
  </table>
<p id="xdx_8A8_zqEBuY98Mkg6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><b>(a) Acquisition
of Al&#233;m da Medicina</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On March 4, 2022, Afya Brazil acquired <span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zkEkZBk9dmi4">100</span>% of the share capital of BMV
Atividades M&#233;dicas Ltda. (&#8220;Al&#233;m da Medicina&#8221;). <span id="xdx_90E_eifrs-full--DescriptionOfAcquiree_c20220303__20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zB6SuHPnunO" title="Acquired purchase price">The aggregate purchase price of R$26,789 is comprised by: i)
R$14,952 paid in cash on the transaction closing date; ii) an earn-out (&#8220;contingent consideration&#8221;) of up to R$19,200 is payable
in connection with revenue target achievements for 2023 and 2024; and iii) price adjustment related to net debt of R$763 in favor of selling
shareholders. The contingent consideration of R$11,074 is based on the present value of the obligation considering the facts and circumstances
at the acquisition date.</span> See Note 13.2.3 for further details of the earn-out amounts as of December 31, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="background-color: white">A</span>l&#233;m da Medicina is
a medical content online platform for physicians and medical students that provides educational tools besides technical medical content
that can assist them throughout their careers. Its contents include mentoring for residency, soft skills and finance, accounting, and
investment basics for physicians.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The acquisition of <span style="background-color: white">A</span>l&#233;m
da Medicina was accounted for under IFRS 3 - Business Combinations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Transaction costs to date amount to R$<span id="xdx_903_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20220303__20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_z2VjyNZVa0te" title="Transaction costs">227</span> and were expensed and are included
in selling, general and administrative expenses in the consolidated statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">At the acquisition date, the fair value of the trade receivables acquired
equals its carrying amount.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The goodwill recognized includes the value of expected synergies arising
from the acquisition, which is not separately recognized. Goodwill is allocated entirely to Digital Services segment. The goodwill recognized
is not expected to be deductible for income taxes purposes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company did not recognize deferred taxes related to the business combination
because the tax basis and the accounting basis, including fair value adjustments, were the same at the date of the business combination.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The valuation techniques used for measuring the fair value of separately
identified intangible assets acquired were as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory_zPFM8XBGUaq9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 3)">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span id="xdx_8BC_zVhuVsSsJZwf" style="display: none">Schedule of acquisition
of al&#233;m da medicina intangible assets acquired</span></td>
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Trademark</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Relief from royalty</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_905_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zrrJInQTzh4k" title="Valuation technique">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Customer relationships</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Multi-period excess earnings method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zUPkDFOqXpX3" title="Valuation technique">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Educational content</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Replacement cost</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--EducationalContentMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zyoHUCxfxK79" title="Valuation technique">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Developed technology intangible assets</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Replacement cost</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zDUiICHyzMXf" title="Valuation technique">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="background-color: white">A</span>l&#233;m da Medicina has
contributed R$<span id="xdx_90B_eifrs-full--Revenue_pn3n3_c20220303__20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zm3znlRbd2t" title="Net revenue">12,859</span> of revenue and R$<span id="xdx_90D_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220303__20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zUdnwFPlfQdj" title="Income loss before income taxes">1,448</span> of income before income taxes to the Company in 2022. Should the acquisition had taken place
at the beginning of the year, revenue for the year ended December 31, 2022 would have been increased by R$<span id="xdx_90D_ecustom--IncreaseInRevenue_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_z36o73efrD48" title="Increase in revenue">2,529</span> and income before income
taxes would have been increased by R$<span id="xdx_90B_ecustom--IncreaseInIncomeBeforeIncomeTaxes_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zBx8NWkaNmDe" title="Increase in income before income taxes">867</span>.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>&#160;</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><b>(b) Acquisition
of CardioPapers</b></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><b>&#160;</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On April 5, 2022, Afya Brazil acquired <span id="xdx_900_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_c20220405__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfCardioPapersMember_z32Ct6u1c6Q8">100</span>% of the share capital of Cardiopapers
Solu&#231;&#245;es Digitais Ltda. (&#8220;CardioPapers&#8221;). <span id="xdx_909_eifrs-full--DescriptionOfAcquiree_c20220404__20220405__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfCardioPapersMember_zibz7rj4QHge">The aggregate purchase price of R$42,013 is comprised by: i) R$34,924
paid in cash on the transaction closing date; ii) an earn-out (&#8220;contingent consideration&#8221;) of up of R$15,000 is payable in
connection with revenue target achievements for 2023 and 2024 and other goals; and iii) price adjustment related to net debt of R$333
in favor of Afya Brazil. The contingent consideration of R$7,422 is based on the present value of the obligation considering the facts
and circumstances at the acquisition date.</span> <span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">See Note 13.2.3 for
further details of the earn-out amounts as of December 31, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#160;</span></p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">CardioPapers is the main medical content and education platform in the Cardiology
field, offering courses and books developed by physicians and for physicians, covering all phases of the medical career, aligned with
Afya&#8217;s overall business strategy.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The acquisition of <span style="background-color: white">CardioPapers</span>
was accounted for under IFRS 3 &#8211; Business Combinations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Transaction costs to date amount to R$<span id="xdx_900_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20220404__20220405__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfCardioPapersMember_zkushzi6bj5c">274</span> and were
expensed and are included in selling, general and administrative expenses in the consolidated statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">At the acquisition date, the fair value of the trade
receivables acquired equals its carrying amount.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The goodwill recognized includes the value of expected synergies arising
from the acquisition, which is not separately recognized. Goodwill is allocated entirely to Digital Services segment. The goodwill recognized
is not expected to be deductible for income taxes purposes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company did not recognize deferred taxes related
to the business combination because the tax basis and the accounting basis, including fair value adjustments, were the same at the date
of the business combination.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The valuation techniques used for measuring the fair value of separately
identified intangible assets acquired were as follows:</p>

<p style="font: 5pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--ScheduleOfAcquisitionOfCardioPapersExplanatory_zKJ2Kqk2FVP8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 4)">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span id="xdx_8B8_zabiY7ZPWmx4" style="display: none">Schedule of acquisition
of cardio papers intangible assets acquired</span></td>
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: Black 1pt solid; width: 22%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 78%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Trademark</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Relief from royalty</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zFfWk9vmNik3" title="Valuation technique">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Customer relationships</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Multi-period excess earnings method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zMMkPniWK904" title="Valuation technique">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Educational content</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Replacement cost</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--EducationalContentMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zVwXPUnY1zN4" title="Valuation technique">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Copyrights</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Relief from royalty</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_902_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--CopyrightMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zJr5B1aMXUGf" title="Valuation technique">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</span></p></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="background-color: white">CardioPapers </span>has contributed
R$<span id="xdx_906_eifrs-full--Revenue_pn3n3_c20220404__20220405__ifrs-full--BusinessCombinationsAxis__custom--CardioPapersMember_zTFmy9KUdMf6" title="Net revenue">9,934</span> of revenue and R$<span id="xdx_900_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220404__20220405__ifrs-full--BusinessCombinationsAxis__custom--CardioPapersMember_z97oyFhRnRek" title="Income loss before income taxes">2,352</span> of income before income taxes to the Company in 2022. Should the acquisition had taken place at the beginning
of the year, revenue for the year ended December 31, 2022 would have been increased by R$<span id="xdx_908_ecustom--IncreaseInRevenue_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--CardioPapersMember_zvaKBKHlRgPl" title="Increase in revenue">2,117</span> and income before income taxes would have
been decreased by R$<span id="xdx_903_ecustom--DecreaseInIncomeBeforeIncomeTaxes_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--CardioPapersMember_zsqZhyyuWVoh" title="Decrease in income before income taxes">2,041</span>.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><b>(c) Acquisition
of Glic</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On May 23, 2022, Afya Brazil acquired <span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_uPure_c20220523__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfGlicMember_zsysAriQbSrb">100</span>% of the share capital of Quasar
Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&#8220;Glic&#8221;). <span id="xdx_904_eifrs-full--DescriptionOfAcquiree_c20220522__20220523__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfGlicMember_zaIDgHpaSHm5">The aggregate purchase price of R$30,597 is comprised
by: i) R$21,602 paid in cash on the transaction closing date and ii) an earn-out (&#8220;contingent consideration&#8221;) of up of R$12,000
is payable in connection with revenue target achievements for 2023 and 2024 and product development goals. The contingent consideration
of R$8,995 is based on the present value of the obligation considering the facts and circumstances at the acquisition date.</span> See Note 13.2.3
for further details of the earn-out amounts as of December 31, 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Glic is a free diabetes care and management app solution for physicians
and patients that uses technology to improve diabetes education and daily routine practices, connecting users, devices and healthcare
providers.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The acquisition of <span style="background-color: white">Glic</span>
was accounted for under IFRS 3 - Business Combinations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Transaction costs to date amount to R$<span id="xdx_904_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20220522__20220523__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfGlicMember_zx1IgnkR03el">222</span> and were
expensed and are included in selling, general and administrative expenses in the consolidated statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">At the acquisition date, the fair value of the trade
receivables acquired equals its carrying amount.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The goodwill recognized includes the value of expected synergies arising
from the acquisition, which is not separately recognized. Goodwill is allocated entirely to Digital Services segment. The goodwill recognized
is not expected to be deductible for income taxes purposes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company did not recognize deferred taxes related
to the business combination because the tax basis and the accounting basis, including fair value adjustments, were the same at the date
of the business combination.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The valuation techniques used for measuring the fair value of separately
identified intangible assets acquired were as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfAcquisitionOfGlicExplanatory_zVSBwnyvEeja" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 5)">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span id="xdx_8B6_zDGdRJU8YAq6" style="display: none">Schedule of acquisition
of Glic intangible assets acquired</span></td>
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Trademark</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Relief from royalty</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zMuveJAULSJ" title="Valuation technique">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Customer relationships</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Multi-period excess earnings method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zfqTDuTn1yae" title="Valuation technique">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Developed technology intangible assets</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Replacement cost</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zIj8UB7xA1mb" title="Valuation technique">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="background-color: white">Glic </span>has contributed R$<span id="xdx_900_eifrs-full--Revenue_pn3n3_c20220522__20220523__ifrs-full--BusinessCombinationsAxis__custom--GlicMember_z049UNtYpJKf" title="Net revenue">389</span>
of revenue and R$<span id="xdx_90E_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220522__20220523__ifrs-full--BusinessCombinationsAxis__custom--GlicMember_zSeY7IqBrJGd" title="Income loss before income taxes">1,539</span> of losses before income taxes to the Company in 2022. Should the acquisition had taken place at the beginning of
the year, revenue for the year ended December 31, 2022 would have been increased by R$<span id="xdx_905_ecustom--IncreaseInRevenue_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--GlicMember_zI8bptSokOTd" title="Increase in revenue">173</span> and income before income taxes would have been
decreased by R$<span id="xdx_90A_ecustom--DecreaseInIncomeBeforeIncomeTaxes_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--GlicMember_zRXspcH7RoQj" title="Decrease in income before income taxes">700</span>.</p>






<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IFRS03_g59-63_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639607355536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureCashAndCashEquivalentsAbstract', window );"><strong>Cash And Cash Equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosuresOfCashAndCashEquivalentsExplanatory', window );">Cash and cash equivalents</a></td>
<td class="text"><p id="xdx_803_ecustom--DisclosuresOfCashAndCashEquivalentsExplanatory_z2KL5dOjhBxe" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>6</b></td><td><b><span id="xdx_820_z1xV6vyTUaOa">Cash and cash equivalents</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_zEeZBx7XZqLa" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Cash and cash equivalents (Details)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span><span id="xdx_8BF_zh5yt5OeTomj" style="display: none">Schedule of cash and cash equivalents</span></span></td>
    <td id="xdx_49D_20231231_zpL6JYrCXYmk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_490_20221231_zFavAx2C4l85" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--Cash_iI_pn3n3_zUzq34o500ya" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash and bank deposits</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,746</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,509</span></td></tr>
  <tr id="xdx_403_eifrs-full--CashEquivalents_iI_pn3n3_z6QuZBiS8NNj" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash equivalents</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">541,284</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,035,573</span></td></tr>
  <tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_zbWW3LBgxapa" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Cash and cash equivalents&#160;</b></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>553,030</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,093,082</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Cash equivalents correspond mainly to financial investments in Bank Certificates
of Deposit (&#8220;CDB&#8221;) with highly rated financial institutions and investments funds managed by highly rated financial institutions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">As of December 31, 2023, the average interest on these investments is equivalent
to <span id="xdx_90C_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_zFvZ0TtIdNIi" title="Percentage of average interest">100.8</span>% of the CDI rate (December 31, 2022: <span id="xdx_90F_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_zfa4v61mjQHf" title="Percentage of average interest">99.21</span>%). These funds are available for immediate use and have an insignificant risk of changes
in value. Cash equivalents denominated in U.S. dollars totaled R$<span id="xdx_90D_eifrs-full--CashEquivalents_iI_pn3n3_uBRL_c20231231__srt--CurrencyAxis__custom--USDMember_zq46QBMxHa53" title="Cash equivalents">23,173</span> as of December 31, 2023 (December 31, 2022: R$<span id="xdx_903_eifrs-full--CashEquivalents_iI_pn3n3_uBRL_c20221231__srt--CurrencyAxis__custom--USDMember_zeLc7Qj5iEB4" title="Cash equivalents">24,447</span>).</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureCashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureCashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosuresOfCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosuresOfCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639612240720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">Trade receivables</a></td>
<td class="text"><p id="xdx_80D_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_zJgHmSqC7mO3" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>7</b></td><td><b><span id="xdx_823_zj3jcZCDfsVc">Trade receivables</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_zcXX8G9OWaqa" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade receivables (Details)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B5_z600CWMlcfbj" style="display: none">Schedule of trade accounts receivable</span>&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 56%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Tuition fees</span></td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_z3RSpDso4iwg" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">461,066</span></td>
    <td id="xdx_983_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zfmx0OUvksu1" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">356,074</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Educational content (i)</span></td>
    <td id="xdx_986_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zq6uvsPNNe01" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">49,135</span></td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_ztC1kAzguAJ8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">50,913</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">FIES</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zwEBjGFWoAPl" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">62,971</span></td>
    <td id="xdx_985_ecustom--ReceivablesGross_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zSKLt0sGWCq5" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">62,325</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Educational credits (ii)</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zJmkdW14iD8c" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">29,391</span></td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zU9d4l0KR0Kj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">27,535</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Mobile app subscription (iii)</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zSAOFkLWGrfh" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">29,091</span></td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_z7tDP54jTal" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">27,675</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Other</span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zGuN1wrWvZQ1" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">15,667</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zXIa9zvlJUak" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">14,923</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98B_ecustom--ReceivablesGross_pn3n3_c20231231_zJKrwenrbyDi" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>647,321</b></span></td>
    <td id="xdx_989_ecustom--ReceivablesGross_pn3n3_c20221231_zYn0FhkjQsek" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>539,445</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(-) Allowance for expected credit losses</span></td>
    <td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20231231_z4sRESQJxHBf" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(61,398)</span></td>
    <td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20221231_zD35E3TKZRmj" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="(-) Allowance for doubtful accounts"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(44,046)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_988_eifrs-full--TradeReceivables_pn3n3_c20231231_zBebXSeRT3z1" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>585,923</b></span></td>
    <td id="xdx_989_eifrs-full--TradeReceivables_pn3n3_c20221231_zJxF016G6r9k" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>495,399</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Current</span></td>
    <td id="xdx_98A_eifrs-full--CurrentTradeReceivables_pn3n3_c20231231_zUoYhNL0Pdr3" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">546,438</span></td>
    <td id="xdx_989_eifrs-full--CurrentTradeReceivables_pn3n3_c20221231_zAZJhkuW58G2" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">452,831</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Non-current</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20231231_z8BDiOu7MSmj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">39,485</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20221231_zUPatsWoPpCg" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">42,568</span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Related to trade receivables from sales of printed books, e-books and medical courses through
digital platform from Medcel, Al&#233;m da Medicina e Cardiopapers.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Related to the financing programs offered by our subsidiaries to its students that existed
prior to the acquisitions. The Company closed such programs to new enrolments and maintained only the agreements that were outstanding
as of the acquisition date.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"></td><td style="text-align: justify">Related to trade receivables from mobile applications subscriptions for digital medical content.</td>
</tr></table>

<p id="xdx_8AB_zgWRTXlSuju2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">As of December 31, 2023 and 2022, the aging of trade receivables was as
follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_pn3n3_z31tj6BqoTDc" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade receivables (Details 1)">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B1_zXTgmwrQUDpe" style="display: none">Schedule of aging of trade accounts receivable</span>&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; width: 56%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Neither past due nor impaired</span></td>
    <td id="xdx_980_ecustom--ReceivablesGross_pn3n3_c20231231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zNQsuiwSbyN" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">323,614</span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z48gbuvhYxg4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">261,025</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Past due</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">1 to 30 days</span></td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_z9drAPElUfBe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">73,563</span></td>
    <td id="xdx_98C_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zlanM58Kw6u2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 90%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 90%">56,280</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">31 to 90 days</span></td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zWIip0U18ppi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">109,908</span></td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_ztSGptPZz5u4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">90,734</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">91 to 180 days</span></td>
    <td id="xdx_987_ecustom--ReceivablesGross_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zA6OZSZInBqc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">85,193</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zbuHuUw6UjC7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">80,522</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">More than 180 days</span></td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zaHR3SoL7D5b" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">55,043</span></td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zLCdbo4UkXl4" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">50,884</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20231231_zwVCoyJStdvi" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>647,321</b></span></td>
    <td id="xdx_987_ecustom--ReceivablesGross_iI_pn3n3_c20221231_zVYakiJsJrua" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>539,445</b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>





<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The changes in the allowance for doubtful accounts for the years ended December
31, 2023, 2022 and 2021, was as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--DisclosureOfAllowanceForDoubtfulAccountsExplanatory_pn3n3_z0nx7rfM7TMh" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade receivables (Details 2)">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B6_zdzK6AXX31de" style="display: none">Schedule of allowance for doubtful accounts</span>&#160;</td>
    <td id="xdx_49C_20230101__20231231_z2BOwPN5i6Xg" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_497_20220101__20221231_z0RVueHiCAv6" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49A_20210101__20211231_zMoJJjpuzmI" style="vertical-align: top; text-align: center; line-height: 115%">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; width: 46%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2021</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iNS_pn3n3_di_zUam11NOQEEa" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Balances at the beginning of the year</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(44,046)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(45,013)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(32,980)</span></td></tr>
  <tr id="xdx_40B_ecustom--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_pn3n3_zyXSCfdrfozl" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Additions</span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(74,552)</span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(42,708)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;(47,819)</span></td></tr>
  <tr id="xdx_40C_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_pn3n3_zZgTPY05MKAa" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Write-offs</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">57,200</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">43,675</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">35,786</span></td></tr>
  <tr id="xdx_405_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iNE_pn3n3_di_z6giHqWxwlq" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Balances at the end of the year</span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(61,398)</b></span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(44,046)</b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>&#160;(45,013)</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639607355536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related parties</a></td>
<td class="text"><p id="xdx_808_eifrs-full--DisclosureOfRelatedPartyExplanatory_zfeJh2uC6cW9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>8</b></td><td><b><span id="xdx_82F_zvW4OCjo3Nn9">Related parties</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The table below summarizes the balances and transactions with related parties:</p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfRelatedPartiesExplanatory_zz5MME0AnKVe" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Related parties (Details)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BE_zJDaeOUYjZyl" style="display: none">Schedule of balances and transactions with related
    parties</span>&#160;</td>
    <td id="xdx_491_20231231_zn3QmHsq48Al" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20221231_zvnu1iuT7Mf4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Assets</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn3n3_zFuYFNUYKIGc" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade receivables (i)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">693</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">917</span></td></tr>
  <tr id="xdx_401_ecustom--OtherAssetsRelatedPartyTransactions_iI_pn3n3_zWvxBoejrbc3" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other assets (ii)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">285</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,975</span></td></tr>
  <tr id="xdx_406_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_pn3n3" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;<b style="display: none">Total</b></td>
    <td style="border-top: black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>978</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,892</b></span></td></tr>
  <tr id="xdx_40A_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_pn3n3_zzaygYW3CdC7" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">792</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,892</span></td></tr>
  <tr id="xdx_40B_ecustom--NoncurrentAssetsOfRelatedParty1_iI_pn3n3_zzcllqmLXdW9" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">186</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2094">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Liabilities</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_407_ecustom--AccountsPayableToSellingShareholders_iI_pn3n3_zu0Csl4m73X5" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders (iii)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2096">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">30,653</span></td></tr>
  <tr id="xdx_40C_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pn3n3_zonsfZ4FmrJ6" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;<b style="display: none">Total</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2099">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>30,653</b></span></td></tr>
  <tr id="xdx_404_ecustom--AccountsPayableCurrent1_iI_pn3n3_zvFhnwbCB46k" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2102">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">30,653</span></td></tr>
  <tr id="xdx_40F_ecustom--NoncurrentPayablesToRelatedParties1_iI_pn3n3_zxXlnAUn3k9f" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2105">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2106">-</span></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Other income (expenses)</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UEPC (i)</span></td>
    <td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zOeqym0A9OJ2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">465</span></td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zZPmWg6lv2Ih" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">477</span></td>
    <td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zpvWO0rnBgql" style="vertical-align: top; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">752</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">EMIVE Patrulha 24 Horas Ltda. (iv)</span></td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_z0WxnDBVN9n3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6)</span></td>
    <td id="xdx_982_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zifXlPlTqD3a" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2116">-</span></span></td>
    <td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zd7RROSFS2jd" style="border-bottom: Black 1pt solid; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2118">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231_zkP58e0Bsoy2" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>459</b></span></td>
    <td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231_zg8lFoEYk5Kc" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>477</b></span></td>
    <td id="xdx_98F_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231_zUeHmV78JCRj" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>752</b></span></td>
    </tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Leases </b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">RVL Esteves Gest&#227;o Imobili&#225;ria S.A.</span></td>
    <td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zZzd9A7zYkok" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,434</span></td>
    <td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zBfY98haxil2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,394</span></td>
    <td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zDMGimCI7L9b" style="vertical-align: top; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,336</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UNIVA&#199;O Patrimonial Ltda.</span></td>
    <td id="xdx_986_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_z5mGjRiVnkab" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,582</span></td>
    <td id="xdx_986_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zinEMFibxGe3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,409</span></td>
    <td id="xdx_981_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zBhwlsaVSYt5" style="vertical-align: top; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,210</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IESVAP Patrimonial Ltda.</span></td>
    <td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zUwhPZ2Jm8k3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,170</span></td>
    <td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zjRKIcxl4Xo9" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,920</span></td>
    <td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zjbwRaMG2wIh" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,560</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231_zUkngkGsrAJg" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>32,186</b></span></td>
    <td id="xdx_98E_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231_zekJvbzrD7vl" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>28,723</b></span></td>
    <td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231_zO694S6i5Dg8" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>23,106</b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to sales of educational content from Medcel to UEPC.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to expenses to be reimbursed by Bertelsmann SE&amp; Co. KGaA.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to amounts payable to our shareholder Nicolau Carvalho Esteves regarding the agreement
to which Afya Brazil acquired the right to develop ITPAC Garanhuns medical school, a greenfield unit. The last installment was paid in
November 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iv)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to amounts of expenses related to security services provided by a company of which
one of Afya&#8217;s main shareholders has significant influence.</td>
</tr></table>

<p id="xdx_8AB_zFucREYGSd8g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Lease agreements with RVL Esteves Gest&#227;o Imobili&#225;ria
S.A.</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Afya Brazil has entered into lease agreements with RVL Esteves Gest&#227;o
Imobili&#225;ria S.A. (&#8220;RVL&#8221;), an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato
Esteves is an executive officer, as described below:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">On June 21, 2016, RVL entered into lease agreements (as
amended on April 26, 2018) with ITPAC Aragua&#237;na and ITPAC Porto, pursuant to which RVL agreed to lease campuses to those entities
in the cities of Aragua&#237;na and Porto Nacional, both located in the State of Tocantins. The lease agreements are adjustable in
accordance with the provisions of each lease agreement. The lease agreements are for an initial term of <span id="xdx_90B_ecustom--OperatingLeaseTermOfContract_dtY_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_zfQw1xHVqju6" title="Lease term">20</span> years and are renewable for
an additional 20 years subject to the provisions of each lease agreement.</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">On November 1, 2016, RVL entered into a lease
agreement with Afya Brazil, pursuant to which RVL agreed to lease to Afya Brazil certain offices in the city of Nova Lima, State of
Minas Gerais, where Afya Brazil&#8217;s executive offices are located. On February 9, 2019, the agreement was amended to extend
lease terms and adjust the lease amounts, subject to certain discount conditions set forth in the lease agreement and adjustable in
accordance with the provisions of the lease agreement. The lease agreement had an initial term of five years which ended on January
31, 2024 and was renewed until the end of June, 2024, subject to the provisions of the lease agreement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">On September 6, 2018, RVL entered into a lease agreement
with ITPAC Aragua&#237;na, pursuant to which RVL agreed to lease to ITPAC the new ITPAC campus by RVL in the city of Palmas, State of
Tocantins. The lease agreement is for an amount equal to <span id="xdx_907_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20180905__20180906__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zEABlcqjtS5i" title="Percentage of revenue">7.5</span>% of the monthly revenue of ITPAC during the prior semester and will be effective
(and become due) once the new ITPAC campus becomes operational, subject to the provisions of the lease agreement. Since 2022, the campus
is fully operational. The lease agreement is for an initial term of <span id="xdx_907_ecustom--OperatingLeaseTermOfContract_dtY_c20180905__20180906__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_zDLnUDyZaPol" title="Lease term">20</span> years and is renewable for an additional <span id="xdx_901_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_zjNtSN0BymS3" title="Renewal term">20</span> years.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On October 30, 2019, RVL entered into a lease agreement with IPTAN, pursuant
to which RVL agreed to lease to IPTAN the new IPTAN medical campus, in the city of Santa In&#234;s, State of Maranh&#227;o. The lease
agreement is for a monthly amount equal to <span id="xdx_900_ecustom--DescriptionOfLeaseTerm_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zsJOIn9Hqqoi" title="Description of lease term">(i) up to June 2020, R$<span id="xdx_90E_eifrs-full--CashOutflowForLeases_pn3n3_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zD8XWnRwUzC1" title="Lease expenses">12</span> and (ii) from July 2020 until March 2024, <span id="xdx_904_eifrs-full--PercentageOfEntitysRevenue_pip0_dp_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zzHtitsQwWed" title="Percentage of revenue">6.5</span>% of the monthly revenue
of IPTAN during the prior semester, adjusted in accordance with the provisions of the lease agreement.</span> The lease agreement is for an initial
term of five years starting in January 2021, when the campus becomes operational and may be renewable for an additional five years subject
to the provisions of the lease agreement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On August 2, 2021, RVL entered into a lease agreement with ITPAC Aragua&#237;na,
pursuant to which RVL agreed to lease to ITPAC the new ITPAC Garanhuns medical campus, in the city of Garanhuns, State of Pernambuco.
The lease agreement is for a monthly amount equal to <span id="xdx_90D_ecustom--DescriptionOfLeaseTerm_c20210728__20210802__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zanoKdLvfMVk" title="Description of lease term">(i) up to June 2022, R$<span id="xdx_900_eifrs-full--CashOutflowForLeases_pn3n3_c20210728__20210802__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zFt7xfBZKfxa" title="Lease expenses">40</span>; (ii) from July 2022 until December 2028, <span id="xdx_90E_eifrs-full--PercentageOfEntitysRevenue_pip0_dp_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zIn7t5Lltjhg" title="Percentage of revenue">6.5</span>% of the monthly
revenue of ITPAC Garanhuns during the prior semester, adjusted in accordance with the provisions of the lease agreement</span>; and (iii) as
from January 2029, the monthly amount should be adjusted by the inflation rate (IPCA). The lease agreement is for a term of 20 years.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The lease payments in connection with the lease agreements with RVL totaled
R$<span id="xdx_908_eifrs-full--CashOutflowForLeases_pn3n3_uBRL_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zOXhlnBB2999" title="Lease expenses">23,434</span>, R$<span id="xdx_90B_eifrs-full--CashOutflowForLeases_pn3n3_uBRL_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zByW7E0ZE0nd" title="Lease expenses">20,394</span> and R$<span id="xdx_901_eifrs-full--CashOutflowForLeases_pn3n3_uBRL_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zdU9ftn8i426" title="Lease expenses">15,336</span> in the years ended December 31, 2023, 2022 and 2021, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Lease agreement with UNIVA&#199;O Patrimonial Ltda.</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On July 14, 2016, UNIVA&#199;O Patrimonial Ltda., an entity controlled
by the shareholder Nicolau Carvalho Esteves and of which Ms. Ros&#226;ngela Esteves is the chief executive officer, entered into a lease
agreement with UNIVA&#199;O, a subsidiary of Afya Brazil, pursuant to which UNIVA&#199;O Patrimonial Ltda. agreed to lease the UNIVA&#199;O
campus to UNIVA&#199;O, located in the city of Ipatinga, State of Minas Gerais. The lease agreement is adjustable in accordance with
the provisions of the lease agreement. The lease agreement is for an initial term of 20 years and is renewable for an additional <span id="xdx_906_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_z0qzgTVGtTyi" title="Renewal term">20</span> years
subject to the provisions of the lease agreement. The lease payments in connection with this lease agreement totaled R$<span id="xdx_901_eifrs-full--CashOutflowForLeases_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zP9Ey9k6ZNih" title="Lease expenses">3,582</span>, R$<span id="xdx_90A_eifrs-full--CashOutflowForLeases_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zwiGr7Fnv1B1" title="Lease expenses">3,409</span>
and R$<span id="xdx_900_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zPE0BgUjutBd" title="Lease expenses">3,210</span> in the years ended December 31, 2023, 2022 and 2021, respectively.</p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Lease agreement with IESVAP Patrimonial Ltda.</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On April 25, 2018, IESVAP Patrimonial Ltda., an entity controlled by the
shareholder Nicolau Carvalho Esteves and of which Mr. Renato Esteves is an executive officer, entered into a lease agreement with IESVAP,
a subsidiary of Afya Brazil, pursuant to which IESVAP Patrimonial Ltda. agreed to lease the IESVAP campus to IESVAP located in the city
of Parna&#237;ba, State of Piau&#237;. <span id="xdx_908_ecustom--DescriptionOfLeaseTerms_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_z5MRq2KPff9g" title="Description of lease term">The lease agreement is for an amount equal to <span id="xdx_909_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zuYYL8WtjOUf" title="Percentage of revenue">7.5</span>% of the monthly revenue of IESVAP until maturation.</span>
The lease agreement is for an initial term of <span id="xdx_909_ecustom--OperatingLeaseTermOfContract_dtY_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zUK7vDZH8qsd" title="Lease term">20</span> years and is renewable for an additional <span id="xdx_903_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zHoVOVXHhwE1" title="Renewal term">20</span> years subject to the provisions of the lease
agreement. The lease payments in connection with this lease agreement totaled R$<span id="xdx_902_eifrs-full--CashOutflowForLeases_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zTToMiCfTpMi" title="Lease expenses">5,170</span>, R$<span id="xdx_90A_eifrs-full--CashOutflowForLeases_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zk426Pg8a0Q8" title="Lease expenses">4,920</span> and R$<span id="xdx_90F_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zOlPlmavbRZk" title="Lease expenses">4,560</span> in the years ended December
31, 2023, 2022 and 2021, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Key management personnel compensation</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Key management personnel compensation included in the Company&#8217;s consolidated
statement of income comprised the following:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_pn3n3_zBHQ94Gh3mnb" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Related parties (Details 1)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;<span id="xdx_8BA_zXPCFHzISisi" style="display: none">Schedule of key management personnel compensation included in the
    Company's consolidated statement of income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 46%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Short-term employee benefits</span></td>
    <td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20230101__20231231_zBefWbpKb0kj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">16,979</span></td>
    <td id="xdx_982_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20220101__20221231_zL4DpyCzWcT6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,564</span></td>
    <td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20210101__20211231_z0tr1vF34wid" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,933</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share-based compensation plans</span></td>
    <td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20230101__20231231_zzQ6LmZGaqj9" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">21,380</span></td>
    <td id="xdx_98A_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20220101__20221231_z1rBtliWHAm5" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,116</span></td>
    <td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20210101__20211231_zumE8186z1wl" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,251</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_988_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20230101__20231231_zwdO4xCpG5Fc" style="border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>38,359</b></span></td>
    <td id="xdx_989_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20220101__20221231_zWXbVKaXNqnb" style="border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>26,680</b></span></td>
    <td id="xdx_986_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20210101__20211231_zE7BELZG7xjb" style="border-bottom: black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>32,184</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Compensation of the Company&#8217;s key management includes short-term employee
benefits comprised by salaries, labor and social charges, and other ordinary short-term employee benefits. The amounts disclosed in the
table above are the amounts recognized as an expense in selling, general and administrative expenses during the reporting period related
to key management personnel.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The executive officers participate in share-based compensation plans described
in Note 16 (b).</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639669694864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOtherAssetsAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfOtherAssetExplanatory', window );">Other assets</a></td>
<td class="text"><p id="xdx_808_ecustom--DisclosureOfOtherAssetExplanatory_zUkQX8TCfXTe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>9</b></td><td><b><span id="xdx_82D_zbvN17fWIDej">Other assets</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">As of December 31, 2023, the Company has R$<span id="xdx_90A_ecustom--OtherAsset_iI_pn3n3_c20231231_zR4sTiSx85Y7" title="Other assets">176,251</span> (December 31, 2022: R$<span id="xdx_900_ecustom--OtherAsset_iI_pn3n3_c20221231_zSm84EOT9jQ" title="Other assets">243,501</span>)
accounted for as Other assets as follow:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfOtherAssetsTableTextBlock_z6H21WFiSn0i" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Other assets (Details)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B6_zkyRIMEwd1Lg" style="display: none">&#160;Schedule of other assets</span></td>
    <td id="xdx_499_20231231_zFbdpRwdlcQf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_491_20221231_zkNqgAseLwQ9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_maAzYGA_z9Mu56LaUtra" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Indemnification assets (i)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">81,855</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">145,300</span></td></tr>
  <tr id="xdx_40D_ecustom--Advances1_iI_pn3n3_maAzYGA_zIrYAazBnCx8" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">39,890</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">30,626</span></td></tr>
  <tr id="xdx_40D_ecustom--JudicialDeposits_iI_pn3n3_maAzYGA_zcrVnF3w1gud" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Judicial deposits</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,187</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,693</span></td></tr>
  <tr id="xdx_403_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_maAzYGA_zR8k57OIjvd" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Prepaid expenses</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,820</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">18,441</span></td></tr>
  <tr id="xdx_40E_eifrs-full--OtherReceivables_iI_pn3n3_maAzYGA_zw1VrfPkYxai" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other FIES receivables</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8,674</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">26,440</span></td></tr>
  <tr id="xdx_40F_ecustom--Dividend_iI_pn3n3_maAzYGA_zKYcIZiUb9F4" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,668</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2244">-</span></span></td></tr>
  <tr id="xdx_407_eifrs-full--DeferredTaxAssets_iI_maAzYGA_zM1PBMEoHB5" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Deferred tax assets</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,233</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2247">-</span></span></td></tr>
  <tr id="xdx_40E_ecustom--OtherAssets1_iI_pn3n3_maAzYGA_zVaPkYCCBasc" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other assets</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,924</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,001</span></td></tr>
  <tr id="xdx_403_ecustom--Assets1_iTI_pn3n3_mtAzYGA_zRz7Mjg08wGi" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;<b style="display: none">Total</b></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>176,251</b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>243,501</b></span></td></tr>
  <tr id="xdx_40C_ecustom--CurrentAssets1_iI_pn3n3_zJyR4AWUv5Kl" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,905</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">51,745</span></td></tr>
  <tr id="xdx_409_ecustom--NoncurrentAssets1_iI_pn3n3_zxnLTgTCEtZj" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">117,346</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">191,756</span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Under the terms of the Share Purchase and Sale Agreements (&#8220;Agreements&#8221;) between
the Company and the selling shareholders of subsidiaries acquired, the Company assesses that the selling shareholders are exclusively
responsible for any provisions (including labor, tax and civil), which are or will be the subject of a claim by any third party, arising
from the act or fact occurred, by action or omission, prior to or on the closing dates of the acquisitions. As disclosed in Note 23(b),
Unigranrio has entered into a tax amnesty program in August 2023 for settling a tax proceeding, which resulted in the write-off of R$20,000
of indemnification assets. The remaining variance is due to the expiration of the related contingent liabilities recognized at business
combinations, mostly due to R$ 28,500 related to tax matters.<br/></td>
</tr></table>

<p id="xdx_8A5_zs4mvPalaBV4" style="margin-top: 0; margin-bottom: 0">&#160;</p>






<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfOtherAssetExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfOtherAssetExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639754028480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in associate<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointVenturesExplanatory', window );">Investment in associate</a></td>
<td class="text"><p id="xdx_80C_eifrs-full--DisclosureOfJointVenturesExplanatory_zbV3XaqofAI" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>10</b></td><td><b><span id="xdx_823_zX8vooFvyF94">Investment in associate</span></b></td></tr></table>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company holds a 30% interest in UEPC, a medical school located in the
Federal District that offers higher education and post-graduate courses, both in person and long-distance learning. The Company&#8217;s
interest in UEPC is accounted for using the equity method. The table below illustrates the summarized financial information of the Company&#8217;s
investment in UEPC:</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfInvestmentsExplanatory_z4HLGBn3Kjw5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Investment in associate (Details)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span id="xdx_8B2_zf9ZwfDtHIt9" style="display: none">Schedule of investment</span></td>
    <td id="xdx_49B_20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zDQwzPX1OZYj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_496_20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z1EfWHBaGETh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentAssets_iI_pn3n3" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">29,004</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">32,651</span></td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentAssets_iI_pn3n3" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">120,289</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">122,378</span></td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentLiabilities_iNI_pn3n3_di_ztVAsEnp3ln1" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(28,842)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(22,840)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentLiabilities_iNI_pn3n3_di_zy25DbP2Jjoc" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current liabilities</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(91,613)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(96,442)</span></td></tr>
  <tr id="xdx_409_ecustom--EquityInAssociate_iI_pn3n3_zw26ITe7A3k4" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Equity</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>28,838</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>35,747</b></span></td></tr>
  <tr id="xdx_40D_ecustom--CompanyShareInEquity1_iI_pn3n3_zM8iJDlzm1Hd" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Company&#8217;s share in equity - 30%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8,651</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,724</span></td></tr>
  <tr id="xdx_40D_eifrs-full--Goodwill_iI_pn3n3" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Goodwill</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">43,183</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">43,183</span></td></tr>
  <tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_pn3n3_z2MVr3LINuJ4" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying amount of the investment</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>51,834</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>53,907</b></span></td></tr>
  </table>
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td id="xdx_498_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zfETjZvp0ou9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_499_20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zjMNmgOWvvce" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_498_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zDIQZLfmuTqi" style="text-align: center; line-height: 10.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--Revenue_pn3n3_z9ofUQhFc654" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Revenue</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">148,042</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">138,584</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">127,618</span></td></tr>
  <tr id="xdx_40A_eifrs-full--CostOfSales_iN_pn3n3_di_zqw2Xki9QeKl" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cost of services</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(71,282)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(57,421)</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(57,935)</span></td></tr>
  <tr id="xdx_407_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_zkVc8qUOLd4l" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Selling, general and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(37,205)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(34,991)</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(24,025)</span></td></tr>
  <tr id="xdx_403_eifrs-full--FinanceIncome_iN_pn3n3_di_zDFrby0MZLra" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Finance results</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,123)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,103)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,585)</span></td></tr>
  <tr id="xdx_40F_eifrs-full--ProfitLossBeforeTax_pn3n3_ztihFdewGr5" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Income before income taxes</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>33,432</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>42,069</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>41,073</b></span></td></tr>
  <tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_z50VfcbUIrC1" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes expenses</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,782)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,456)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,748)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--ProfitLoss_pn3n3_zHwWe177BJZk" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net income</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>31,650</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>40,613</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>39,325</b></span></td></tr>
  <tr id="xdx_40C_ecustom--CompanyShareOfProfitss_pn3n3_zHRPkXt37XY3" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Company&#8217;s share of income</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>9,495</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>12,184</b></span></td>
    <td style="border-bottom: black 1.5pt double; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>11,797</b></span></td></tr>
  </table>
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td id="xdx_49C_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zGArAD1AUiTf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_49D_20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zwY9uhvj2sSc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_49E_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zEcDMIw7jRRk" style="text-align: center; line-height: 10.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023 </b></span></td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 18%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iS_pn3n3_zm2ggDiW1Gy5" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening balance</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">53,907</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">48,477</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">51,410</span></td></tr>
  <tr id="xdx_402_ecustom--DividendsReceived1_iS_pn3n3_zOXCrcFwrJi1" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends received</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(9,900)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,754)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,770)</span></td></tr>
  <tr id="xdx_40C_eifrs-full--DividendsReceived_iN_pn3n3_di_zU7jtTViQvE9" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends receivable (included in Other assets)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,668)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2331">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,960)</span></td></tr>
  <tr id="xdx_408_eifrs-full--ProfitLossOfAcquiree_pn3n3_zqpKcWwd2MJa" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share of income</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">9,495</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,184</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,797</span></td></tr>
  <tr id="xdx_40E_eifrs-full--InvestmentsInAssociates_iE_pn3n3_zYyHYwFGiFNf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Closing balance</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>51,834</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>53,907</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>48,477</b></span></td></tr>
  </table>
<p id="xdx_8A5_z5xunlZ3Ow7l" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company tests the recoverability of the carrying amount of goodwill
at least annually. As of December 31, 2023 and 2022, no impairment had to be recognized for this goodwill.</p>






<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfJointVenturesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of joint ventures. [Refer: Joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B4<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B4_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfJointVenturesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639605092720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property and equipment</a></td>
<td class="text"><p id="xdx_80D_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zY4WDSc7NPAb" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>11</b></td><td><b><span id="xdx_828_z7ejdPwclIY5">Property and equipment</span></b></td></tr></table>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_892_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_zZEWCyy555d6" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Property and equipment (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B3_zQEl9A6uJj73" style="display: none">Schedule of detailed information about property, plant and
    equipment</span>&#160;</td>
    <td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_z8abgi33upzh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zf8tcOwIqf1k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BD_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zj6SHCcJcB2f" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BF_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zSXYrBl1WoPj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zzUG5hGgRyI7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zo3Rg6lcN4we" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_zZynmJgem435" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zMfBeWOSeudc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zMWIdTkS11c4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B1_zIDp1piHuHJd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 26%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Cost</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Building</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Machinery and equipment</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Lands</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Vehicles</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Furniture and fixtures</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>IT equipment</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Library books</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Leasehold improvements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Construction in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z4MBeggb45d2" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of January 1, 2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>25,919</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>68,503</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>13,401</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>1,215</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>29,131</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>28,511</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>21,624</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>122,005</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>3,706</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>314,015</b></span></td></tr>
  <tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zetNm5W9g4k1" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1,384</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">10,268</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">5,451</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">111</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">21,075</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">19,511</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">3,392</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">4,720</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">59,957</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">125,869</span></td></tr>
  <tr id="xdx_43B_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zSwL6zuRCjI2" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Business combinations</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2369">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">12,810</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2371">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">346</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">16,684</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">10,138</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">5,142</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">17,425</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">3,078</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">65,623</span></td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zlQD5dHwykTi" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">62</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(14,213)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2382">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(205)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">2,862</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(4,985)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(86)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(550)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(417)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(17,532)</span></td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z7IveAahZWEa" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">25,068</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">3</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2393">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2394">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">82</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">9</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2397">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">9,376</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(34,538)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2400">-</span></span></td></tr>
  <tr id="xdx_436_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z2YDC1xxeiS7" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>52,433</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>77,371</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>18,852</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>1,467</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>69,834</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>53,184</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>30,072</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>152,976</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>31,786</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>487,975</b></span></td></tr>
  <tr id="xdx_43F_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zHSDlIFCglCf" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">527</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">36,486</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2415">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">968</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">26,047</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">15,766</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">645</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">2,667</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">85,026</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">168,132</span></td></tr>
  <tr id="xdx_433_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zP3l848kiefg" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Business combinations</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2424">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">45</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2426">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2427">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2428">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">35</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2430">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2431">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2432">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">80</span></td></tr>
  <tr id="xdx_431_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zbiz6XlzuRn8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">13</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(8,159)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2437">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(933)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">500</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(6,992)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2441">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2442">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(78)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(15,649)</span></td></tr>
  <tr id="xdx_43B_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zqvhraoiPuhd" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">38,884</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(5,353)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2448">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(449)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(5,669)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">6,600</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">6,645</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(9,797)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(30,046)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">815</span></td></tr>
  <tr id="xdx_43F_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z8apsVYXq2f3" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>91,857</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>100,390</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>18,852</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>1,053</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>90,712</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>68,593</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>37,362</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>145,846</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>86,688</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>641,353</b></span></td></tr>
  <tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zV4EVRHS5eck" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">96</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">20,071</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2470">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">776</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">17,914</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">21,135</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">985</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">49</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">57,409</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">118,435</span></td></tr>
  <tr id="xdx_439_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zm0dNpdiARqb" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Business combination</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2479">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">7,729</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2481">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2482">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">4,384</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">734</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1,329</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">10,741</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">63</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">24,980</span></td></tr>
  <tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zzRl6ps9NjDi" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2490">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(9,411)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2492">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(475)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(1,443)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(7,979)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(7,788)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(286)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2498">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(27,382)</span></td></tr>
  <tr id="xdx_434_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z35FEaZs37ga" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1,279</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1,202</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2503">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2504">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(708)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">327</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2507">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">108,098</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(110,198)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2510">-</span></span></td></tr>
  <tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zfmaaXRvZw0j" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>93,232</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>119,981</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>18,852</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>1,354</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>110,859</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>82,810</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>31,888</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>264,448</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>33,962</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>757,386</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Depreciation</b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_434_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zpno1fGEG8C5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of January 1, 2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2523">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(19,322)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2525">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(171)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(8,089)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(10,851)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(10,817)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(4,384)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2531">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(53,634)</b></span></td></tr>
  <tr id="xdx_430_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iNP2custom--WritOffOfPropertyPlantAndEquipment_pn3n3_di_zxG07a0Rjdzl" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(1,673)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(7,215)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2536">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(196)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(5,601)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(7,529)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(3,416)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(4,831)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2542">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(30,461)</span></td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zKgSeDrT9dXc" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">&#160;Write-off (i)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2545">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">10,146</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2547">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">147</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1,194</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">3,458</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">633</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">350</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2553">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">15,928</span></td></tr>
  <tr id="xdx_435_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zYE8bGKtX2m1" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(1,673)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(16,391)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2558">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(220)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(12,496)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(14,922)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(13,600)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(8,865)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2564">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(68,167)</b></span></td></tr>
  <tr id="xdx_439_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zCgvb9aKLUn" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(3,472)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(11,166)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2569">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(284)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(7,725)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(10,140)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(3,415)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(8,849)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2575">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(45,051)</span></td></tr>
  <tr id="xdx_43B_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zanpP2KrUvwe" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2578">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">5,474</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2580">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">791</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">153</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">7,350</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">67</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">117</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2586">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">13,952</span></td></tr>
  <tr id="xdx_438_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zII350CFvQ64" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(606)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1,453</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2591">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">9,719</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(4,125)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(5,940)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(502)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2597">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2598">-</span></span></td></tr>
  <tr id="xdx_436_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zvwRCn5kCssk" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(5,751)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(20,630)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2602">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>288</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(10,349)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(21,837)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(22,888)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(18,099)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2608">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(99,266)</b></span></td></tr>
  <tr id="xdx_435_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_ztOLxx2Lfebb" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Depreciation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(4,242)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(14,900)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2613">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(325)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(12,556)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(13,286)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(3,327)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(26,271)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2619">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(74,907)</span></td></tr>
  <tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zM1HTf8u42sb" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">118</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">6,684</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2624">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">235</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">2,528</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">8,254</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">7,563</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">90</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2630">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">25,472</span></td></tr>
  <tr id="xdx_43F_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zJlU59QXGju4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">196</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">3</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2635">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2636">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2637">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(3)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2639">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(196)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2641">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2642">-</span></span></td></tr>
  <tr id="xdx_43D_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zoFejK1dwQzc" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(9,679)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(28,843)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2646">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>198</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(20,377)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(26,872)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(18,652)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(44,476)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2652">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(148,701)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Net book value</b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>83,553</b></span></td>
    <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>91,138</b></span></td>
    <td id="xdx_984_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>18,852</b></span></td>
    <td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>1,552</b></span></td>
    <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>90,482</b></span></td>
    <td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>55,938</b></span></td>
    <td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>13,236</b></span></td>
    <td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>219,972</b></span></td>
    <td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>33,962</b></span></td>
    <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>608,685</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>86,106</b></span></td>
    <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>79,760</b></span></td>
    <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>18,852</b></span></td>
    <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>1,341</b></span></td>
    <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>80,363</b></span></td>
    <td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>46,756</b></span></td>
    <td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>14,474</b></span></td>
    <td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>127,747</b></span></td>
    <td id="xdx_983_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>86,688</b></span></td>
    <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>542,087</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to items written-off as result of lack of expectation of future use, in connection
with the Company&#8217;s physical inventory procedures.</td>
</tr></table>

<p id="xdx_8AD_zVDj9SFMVf41" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-size: 11pt">The Company assesses at each reporting date,
whether there is an indication that a property and equipment asset may be impaired. If any indication exists, the Company estimates the
asset&#8217;s recoverable amount. There were no indications of impairment of property and equipment as of and for the </span>years <span style="font-size: 11pt">ended
December 31, 2023, 2022 and 2021.</span></p>






<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639668587536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureIntangibleAssetsAndGoodwillAbstract', window );"><strong>Intangible Assets And Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfIntangibleAssetExplanatory', window );">Intangible assets and goodwill</a></td>
<td class="text"><p id="xdx_808_ecustom--DisclosureOfIntangibleAssetExplanatory_zpxk3ip5an1f" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>12</b></td><td><b><span id="xdx_82D_zQhFoc3ybzM4">Intangible assets and goodwill</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_z9SFZ004WEei" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets and goodwill (Details)">
  <tr>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt"><span id="xdx_8BB_zLquPfqPr8Bb" style="display: none">&#160;Schedule of intangible assets</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td></tr>
  <tr>
    <td style="width: 28%; padding-right: 1.45pt; padding-left: 1.45pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Goodwill </b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Licenses with indefinite useful life </b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Trademark</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Customer relationships</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Software</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Education content</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Developed technology</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Educational platform</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Software in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 4%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Cost</b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of January 1, 2021</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrVs4nJUBvA9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>810,656</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zOsUP4LXxWQd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,451,270</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfZqZIoN3gme" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>75,014</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQYrwcgh78ma" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>283,539</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkLKk2HrHMi3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>16,221</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zke8tn0YX0Rb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>17,305</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zT3slotvRSR7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>355</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zViySlwYFhm8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>27,902</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxPWglJrrwsg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,297</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeN9grCjSwI7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2718">-</span></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6CMpPtVlLZ4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,684,559</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Additions (vi)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvF23pO4yaQg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">108,000</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyULZJr7rUy4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">684</span></td>
    <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMuHgpTac5ed" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,044</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zN4HWHJwhbai" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">996</span></td>
    <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zE7NuDfp5Gnc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">39,686</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zK9nOPUKaPG8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">23,700</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3VGszF3dGSh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">176,110</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zG89zNqyy2R7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,020</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbCREwHIf1s" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(2,743)</span></td>
    <td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvIOCCM6fxme" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(417)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsEaR8AObK8j" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(2,140)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Business combinations</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zGCFGqPXmtZ8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">373,680</span></td>
    <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRZauQn34Qef" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">606,136</span></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhW6NlxD9l6l" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">58,355</span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziCEbjJ2VSi6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">147,054</span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCWFJKgYx14g" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,474</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5M5uUxiZUW9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">33,046</span></td>
    <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z61g1bMg0Ftf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">11,599</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgBP8vMOjDcl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,267</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAc5XlVajV9c" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,234,611</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2021</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuKUQ0QxcNR6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,184,336</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkyMX8gPOepg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,165,406</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztvE8u7ibCCf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>133,369</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7wa0fhFQBfg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>431,277</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zh6bZ8xBT71e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>21,759</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZRiz76GAXY" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>17,305</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zF6u2yMw22Oa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>34,397</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvTgObYwq03e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>76,444</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zA0Wf5zyLd66" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>28,847</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRjp7MXSscPk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2780">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKIR6xabatC6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,093,140</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Additions (i) (ii)</span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zFy6RuIPCYK6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">39,100</span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUvoPygPAq3d" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">24,408</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoLJxtcViQL8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">80</span></td>
    <td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxKt1ZXxt9Y2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,423</span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zpBPCLzDBTZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">11,231</span></td>
    <td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR7ixPmQ1mU2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">32,879</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6E7Vd03Mz5e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">14,761</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwNbbNuomi8k" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">26,141</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7FnFfMH9im4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">150,023</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_982_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zs7brwltqOag" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(22)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zr2u6gQHBWQ" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(381)</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zC2lw0uZlgF4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(7)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zXrK5HfiWKSd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(9)</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z3V02sLT2tk3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(28)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zAHqoxFsK382" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(447)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Remeasurement (iii)</span></td>
    <td id="xdx_98A_ecustom--Remesurement_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zt4LxZk4o1b5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(8,637)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_987_ecustom--Remesurement_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zSjSRpRi6Ry7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(8,637)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transfer</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zm7EzOl2JYqf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(2,472)</span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9KFNs0Bmz96" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">530</span></td>
    <td id="xdx_98F_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLvMGXy2m4la" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">20,466</span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zE2VFXVKUvl4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">38,433</span></td>
    <td id="xdx_989_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMhiJG9r6d2k" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">17,953</span></td>
    <td id="xdx_989_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxpjg8n9eJWg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(35,499)</span></td>
    <td id="xdx_982_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgLVjYOX7nSb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(40,226)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zacZqLhiLYSh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(815)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Business combinations</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsw3RHiwQQ0e" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">42,246</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhNOvEBUHzQ9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">51,185</span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2UV5YPjjBHl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,929</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLxhpCOVnyO4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">33</span></td>
    <td id="xdx_988_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zj7IBwHMhQZ" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">2,627</span></td>
    <td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvI0Eg58qRd7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,520</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgA0OV25wTO3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,055</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfhtXkzWgI6i" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">106,595</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZGbWiJzMptc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,257,045</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zid4tDg6Duzk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,189,814</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmgtpoFnBs7i" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>182,060</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLz7s3H970df" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>435,816</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfGdNwDCzqY1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>43,300</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqzm1nUYnHBk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>69,589</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvs2JUEzY892" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>90,749</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztWrXATFPEUe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>55,697</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2wUNIGwCnn8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>14,734</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRMz5IwE6sO1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,055</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVF2wAQplVF7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,339,859</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Additions</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zGiZtIR7jDNd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,314</span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zn5r3EFssVV3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">9,827</span></td>
    <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zAvY8yKtbY7a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">37,712</span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zrGW628YStRh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">23,164</span></td>
    <td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____z2Wf7ULHomg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">27,976</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____za619doDJEQc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">99,993</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsqfToq76mWl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(2,235)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHIvsvqICiF4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(911)</span></td>
    <td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAqOqcUZ1fV7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(125)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4CyNOZlxFif" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(3,271)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Remeasurement (iv)</span></td>
    <td id="xdx_988_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkkyKSrbQW4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">2,556</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98E_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zT3GK1cRZFjd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">2,556</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transfer</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkFVkkEILxHk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">28,708</span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQG1r1Cc4mCc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,785</span></td>
    <td id="xdx_980_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7wH2IadM7u6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">16</span></td>
    <td id="xdx_98F_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6c1L7rUz7uc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(3,058)</span></td>
    <td id="xdx_984_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziSvCId07ll4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(30,451)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Business combination (v)</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHKkn2F9f5R2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">75,098</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsTwMyWH84za" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">586,263</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmHQbEFXgH02" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">142,451</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlcFMWXcg90h" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">63</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKUlaNc2BSt9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">803,875</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfTVpOiyKlCj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,334,699</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyBhyK3VHgF9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,776,077</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXvGNXVeCyx5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>182,060</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCTz7fEVcqWf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>578,267</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMlTARrHb4A3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>71,150</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRMES8oDqJ57" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>84,201</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z43C2DF0VF5i" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>128,477</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zdFlphCY2aH4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>74,892</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3pRmdFD5jec" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>12,134</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLsa5CtlazLg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,055</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3HBoyN7Umbe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>5,243,012</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Amortization</b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of January 1, 2021</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJdlYZWxNtn8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2938">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z5kPPI9XB7u3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2940">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxvAAkhuktK5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(3,502)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8Q9IsXNzc9h" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(85,832)</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmbW62Qc5m14" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(6,256)</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z7bke0i420q7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(7,692)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zg0tZNg5jOMl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(32)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8WB1A0dvnh" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(8,235)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkE5CAAvBZFg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2954">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>-</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z9bRG8BBvKZc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(111,549)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Amortization</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iP2custom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvngUNyQYOW8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl2958">-</span></span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z6PTZmw3J3Ca" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl2959">-</span></span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4EPdygNyKVc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(5,027)</span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjeS2aFfrBW7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(56,438)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zudlFPP8ECCj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(5,844)</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zPn81oAhimq4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(8,980)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1oi55s6Gaa9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(625)</span></td>
    <td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUkudD4TwWhg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(3,608)</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvxlt8PwE4g2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl2968">-</span></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRgYc87MKQ78" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(80,522)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_986_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zB9o870cnC7e" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(599)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_980_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRmp754MQROa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">365</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zrdK0dZxDzq9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(234)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2021</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUVFqH5h9816" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2977">-</span></b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zOprGAmmEoQa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2979">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzpzAPhoTcr" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(8,529)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQJtlGdy8rrk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(142,270)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3f7gnY7krYd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(12,699)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkfYhmtObfk9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(16,672)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zU9b3749VCr9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(657)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKdgQGoYTPkh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(11,478)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlEmY6swP4sb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2993">-</span></b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zk6Bl2dBFlHi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2995">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAOztK89xXnc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(192,305)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Amortization</span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRIqLr58LeHc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl2999">-</span></span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zZ7uEvAsvJn4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3000">-</span></span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zaOFsDGvO1Kj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(6,426)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z5SHk6zZZtp1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(70,093)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIBzUyzLtzXe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(4,943)</span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1KLnEPPvsL5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(9,634)</span></td>
    <td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzUZSVylsrPi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(9,436)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zspCp7XfNRz9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(5,874)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFcICCaZcy54" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3008">-</span></span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDgSWPcpEpNk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(79)</span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zpqGiDSi1IJ4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(106,485)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_986_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhw7RbRISOna" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">365</span></td>
    <td id="xdx_985_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKE3GEPFeF56" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">57</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFCuvVlZuYL9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">422</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFvp4ObR37Kd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(313)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zw5xUo9Mgk51" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">313</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1Q7lutEHQO8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3022">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zu5EFWbDZEMe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3024">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlBnkyvk0ev7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(14,955)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zR9jM67yGAG3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(212,363)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgDyDdWjDuWa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(17,277)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZdbPDLMuWx2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(26,562)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbN3g81tOMI6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(10,093)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhxf7VctRsmj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(17,039)</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zukZwSmCdKsd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3038">-</span></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zV5tIWM2QCOa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(79)</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSRIPuk60oai" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(298,368)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Amortization</span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIIclee4CFP3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3044">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zLujbAMj9hQ8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3045">-</span></span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQpffWkfUrO" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(11,083)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z95ZNUJtiHD6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(89,584)</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1dLqJhChIH5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(8,764)</span></td>
    <td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmhdnex591ga" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(15,668)</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zPPtr2Ph0rf6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(21,504)</span></td>
    <td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvWZ4NvXxo4h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(4,778)</span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuMvzAD5mG47" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3053">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTjLK0f2CxId" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(105)</span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNiowokeDkqg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(151,486)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98C_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8kFhGgLh35b" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,947</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFrYtYTNmaE9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">911</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTzdX7Tjbo3f" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">2,858</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transfer</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zcQtpkZ8TRzi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(6)</span></td>
    <td id="xdx_982_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zl3R7RlPDiy3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zakSIViJpJRd" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3067">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zxFpcVDfyLo8" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3069">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zf2zfeQdub9b" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(26,038)</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0nNI8J2TV18" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(301,947)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z7snqh43ffZh" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(24,094)</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHJJPLfjeOa7" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(42,230)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqfARSPMviJc" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(31,603)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8WDvcsqHa9h" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(20,900)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zsAddT3S3ePl" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3083">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztQmxjLn3pcj" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(184)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUWCWpRFgOx9" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(446,996)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Net book value:</b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zZGSmpyy3nLe" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,334,699</b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zzybL6jFJ5sl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,776,077</b></span></td>
    <td id="xdx_988_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zEzdVnnyc3Sg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>156,022</b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zdJp51vna8dk" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>276,320</b></span></td>
    <td id="xdx_98B_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z7haIx8TeALb" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>47,056</b></span></td>
    <td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zM3WVlTyWfa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>41,971</b></span></td>
    <td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zlhXNCCNXK0i" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>96,874</b></span></td>
    <td id="xdx_980_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zhwgLjcKB0Ie" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>53,992</b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zweSqKpBdCcg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>12,134</b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zxd75R6u9n5k" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>871</b></span></td>
    <td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231_zjABLBpRPTtl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,796,016</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_98A_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zhOroOPXFxC8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,257,045</b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zonPhVoD51rh" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,189,814</b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zYCJD4dpY14h" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>167,105</b></span></td>
    <td id="xdx_98E_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zZMrU3EO4Npb" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>223,453</b></span></td>
    <td id="xdx_98D_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zqlvgHB4BsE6" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>26,023</b></span></td>
    <td id="xdx_987_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zRNXNQ7OmQYb" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>43,027</b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zu3tByWXgf42" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>80,656</b></span></td>
    <td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zdtvT4oTgRKa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>38,658</b></span></td>
    <td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zMGUPMHfcb2k" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>14,734</b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zg4WqQp94Ppg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>976</b></span></td>
    <td id="xdx_983_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231_zPLbXUJyuXWf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,041,491</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">*</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to intangible assets written-off as result of lack of expectation of future use.</td>
</tr></table>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Licenses with indefinite useful life: On March 18, 2022, MEC authorized the increase of 28
seats of Centro de Ensino S&#227;o Lucas, located in the city of Ji-Parana, State of Rond&#244;nia. The earn-out related to the seats
approval is R$800 per seat, adjusted by the CDI rate from the closing until the payment date, of which 50% was paid in April 2022 and
the remaining amount is payable in cash in two equal installments through 2024.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Goodwill: During the measurement period, the preliminary goodwill for the acquisition of
Unigranrio was adjusted by R$39,100 (R$130,073 initial goodwill) as a result of an increase of liabilities regarding tax contingencies
and judicial deposits to be reimbursed by the selling shareholders.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"></td><td style="text-align: justify">Goodwill: During the measurement period, R$8,637 of goodwill arising from the acquisition
of RX PRO was reduced, in connection with management&#8217;s view of remote likelihood of RX PRO achieving the revenue goals estimated
at the terms of the earn-out.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iv)</td><td style="width: 5pt"></td><td style="text-align: justify">Goodwill: During the measurement period, results of operation such as revenue differed from
the foreseen, resulting in a remeasurement of the contingent consideration for the acquisitions of Al&#233;m da Medicina, CardioPapers
and Glic by R$4,773, R$5,082 and (R$7,299), respectively, totaling R$2,556 for the year ended December 31, 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(v)</td><td style="width: 5pt"></td><td style="text-align: justify">Business combination: On January 2, 2023, Afya Brazil acquired DelRey, a post-secondary education
institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs in medicine and health, as
well as other courses. See Note 5.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(vi)</td><td style="width: 5pt"></td><td style="text-align: justify">On November 5, 2021, MEC authorized the operation of 120 medical school seats in Garanhuns,
for which our shareholder Nicolau Carvalho Esteves entered into an agreement with Afya Brazil pursuant to which he assigned to Afya Brazil
the right to develop the ITPAC Garanhuns greenfield unit, a medical school in the city of Garanhuns, State of Pernambuco. Management
assessed the aspects of such transaction and concluded that the transaction does not fall under the definition of business, but an acquisition
of license with indefinite useful life recognized in intangible assets. Total purchase price was R$108,000 of which 50% was paid in cash
on the transaction closing date and 50% in two equal annual installments, adjusted by the CDI rate.</td>
</tr></table>

<p id="xdx_8AC_z9mMr2cF8Upi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Licenses with indefinite useful life include intangible assets acquired
through business combinations. The licenses for medicine and other courses granted by MEC to the companies acquired have no expiration
date and the Company has determined that these assets have indefinite useful lives.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For impairment testing goodwill and licenses with indefinite useful lives
acquired through business combinations are allocated to the respective CGUs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company performed its annual impairment test on December 31, 2023, 2022
and 2021. There was no impairment for goodwill and licenses with indefinite useful lives for the years ended December 31, 2023, 2022 and
2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company tests at least annually the recoverability of the carrying amount
of goodwill and licenses with indefinite useful lives for each CGU. The Company determines the recoverable amount of its CGUs based on
the value-in-use. Estimating these values involves the use of assumptions, judgments and estimates of future cash flows that represent
the Company's best estimate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The carrying amounts of goodwill and licenses with indefinite useful life
by CGU and their carrying amount as of December 31, 2023 and 2022 were as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_zzqMOzqQmxu5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets and goodwill (Details 1)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B9_ziu210ar3Zf5" style="display: none">Schedule of assumptions for impairment test</span>&#160;</td>
    <td colspan="6" style="padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in">&#160;</td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Carrying amount</b></span></td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CGU</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Goodwill</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses with indefinite useful life</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CGU</b></span></td></tr>
  <tr>
    <td style="width: 42%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IPTAN</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zMEWTMkMpEH4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">17,446</span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zIkXUBa16O7k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">17,446</span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z6Fls3KSSqnb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,214</span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zvfNAJ2RJIMb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,214</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_znwjueBf1G89" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">125,974</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zMDNzNIOnjHl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">126,024</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IESVAP</span></td>
    <td id="xdx_98B_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z7ebTmxWG6p4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,956</span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zQvCNbegZtXc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,956</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zPHJHpr2rKTb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">81,366</span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zbxbycrv7g5a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">81,366</span></td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z5S3vE0ekyYh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">126,996</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zgwRU3M123M6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">129,305</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">CCSI</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zKcobUcnJMq9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,664</span></td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zJLjxQJG5AKb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,664</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zuLKXhrw9nU4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">56,737</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zG64JkeD6Elc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">56,737</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zilNfsjrdUSc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,550</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zYALhgNLVtI2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">53,540</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IESP</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zCXXn4mdrD33" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">73,838</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zjUFSH9gJEhb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">73,838</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zoqOobLHD47c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">179,693</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z1jem8KIGXv7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">179,693</span></td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zjxNITJg7NW9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">332,104</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zef18tATxUUa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">322,968</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FADEP</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zHtXp28SMVod" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">49,661</span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zw6olpzqlRBg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">49,661</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z5uunxL2nnZc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,606</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zunecelcRBY8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,606</span></td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z6YdRN9vxIl4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">148,032</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zewHKSZ1p6Bh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">153,100</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FASA</span></td>
    <td id="xdx_986_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zfgPda5LeHDj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,903</span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zjY43R9RRDu1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,903</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zhesAjMK4rp2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">144,507</span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zhZ9picPDTC3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">144,507</span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zjxz2LQitxP5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">322,061</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zCayavTFR9J7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">314,967</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IPEMED</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zu2mPxcHrT0c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">87,647</span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zcshSisPUGgj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">87,647</span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pdn3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z25VZU1CGw25" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3211">-</span></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pdn3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zmqwQXQ9rgZ" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3213">-</span></span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zOlGb0N0iB6a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">183,862</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zidgkAWSlAnj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">192,079</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IPEC</span></td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zm2QANN48k4a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3219">-</span></span></td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z1QBDqes9YSd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3221">-</span></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zqF6wqcDIPh2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,000</span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zFdSO4LRWNJe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,000</span></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zgDqQM9L7Sy7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">157,984</span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zAKstAcVKdlc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">148,067</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UniRedentor</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z87ar33N0chl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">77,662</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zvJu3I9tjZC9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">77,662</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zfrMkXMcAvT8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">121,477</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zGOd5FyX8iqj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">121,477</span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zjCpXIc7VDhh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">234,054</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zsMODGEGb8Ei" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">242,600</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UniSL</span></td>
    <td id="xdx_986_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z4cbjCoukwRb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,420</span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z7fmhq1wbJb2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,420</span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____zGllazCKwied" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">273,795</span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____zfYzpiAOaFo" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">273,795</span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z35OmdMnPQQ6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">401,143</span></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z5JFUJwEUbt6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">398,492</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FESAR</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_ziAUqEIV6Xeg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71,664</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z5FfmjHVNTJi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71,664</span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zxzIvEcbBHw6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">141,616</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zqGIL1Pb9mFf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">141,616</span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zZEQer5sJGkl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">244,412</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zRvY34SNW7gg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">244,084</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FCMPB</span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zmPG9b50T1m1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">110,483</span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zIx1Xlu3zKY1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">110,483</span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z8AxymdEeI6i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">235,018</span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z4vMseSAXgUj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">235,018</span></td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z2g3pY63APJ" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">402,140</span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z7G87aGR4nG4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">415,453</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">ITPAC Garanhuns</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zuzXHHupWVZ8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3279">-</span></span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zMDyE9rgVERa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3281">-</span></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zWVTlzHZlvM9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,000</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zisSFrJbq6y6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,000</span></td>
    <td id="xdx_986_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zlQmANWZhK4d" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">116,162</span></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z9YGEQwdzpAg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">112,628</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Content &amp; Technology for medical education (Pillar 1) *</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zA9Sh42jmvwj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">179,830</span></td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zNUCwkxzTvod" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">169,975</span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zg6GdQT9FNji" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3295">-</span></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zP9b2nin9i7a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3297">-</span></span></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z0LxoxdVQMeh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">238,921</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zAR0hZyZQx94" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">279,684</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Practice Management Tools &amp; Electronic Prescription (Pillar 3)</span></td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zwD8e2Eeiah" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">106,774</span></td>
    <td id="xdx_982_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zP3HhvHaUjbe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">106,774</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zxwqa8mctp32" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3307">-</span></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zk2PgnYtM1F5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3309">-</span></span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zXVQvmlYTnJj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">221,171</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zhgPYaB7lNjg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">216,297</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Clinical Decision Software (Pillar 2)</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zmXoVN7WMiqj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">87,018</span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zY6LpWaXdXS2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">87,018</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zcbeoEv95rN4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3319">-</span></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zP2DQyhrM7N6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3321">-</span></span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zbeRK6tHqDub" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">147,897</span></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z0yd02PIVl3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">153,526</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cliquefarma</span></td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z00tGT2dLwBa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">6,588</span></td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8FSSDGoHb77" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">6,588</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zeLIPp5lD43h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3331">-</span></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zVigd7Gvnm44" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3333">-</span></span></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zzThE07eOMJ6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">18,789</span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z9eg68e21K3f" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,045</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UnifipMoc</span></td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z9nQd8jYobjk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">87,777</span></td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zOvXG46sKnDd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">87,777</span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zOH7Ro3LmCib" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">190,247</span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zWwTbNSDZeh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">190,247</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z7FFrIMLKMT7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">361,383</span></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zXKUarNtCjY" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">369,007</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Unigranrio</span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zd07evq26Hfi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">169,173</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zWodhmw7xVpk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">169,173</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zK7zhR1rGyue" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">421,538</span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zRfKUwMsXaH2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">421,538</span></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z2BmuzPN04A6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">833,665</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z1Cu9Vl17eKk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">854,861</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">RX PRO</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zKbhW2JhCXMj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">29,809</span></td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHhuDacaoLC8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">29,809</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zMSRaaenPP52" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3367">-</span></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zG4okLxpIDGd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3369">-</span></span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zWRot9sQMbpa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">34,748</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zePr6UTv1Ad3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">36,675</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Glic *</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zjKwCcFuEwB7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8,288</span></td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zmHxJFF8oZ98" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,587</span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zhsqTTZH106k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3379">-</span></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zwzdBxCxvZX" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3381">-</span></span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z56RqCQj2qG9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,721</span></td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z7BXg6aWZJN7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">31,022</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">DelRey</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z0YiVmvMZTl6" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">75,098</span></td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmErMfBrBxa" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3389">-</span></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zp0ur8iXCXEf" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">586,263</span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zYqywOBu3Ab8" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3393">-</span></span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zojQOdUk38M4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">854,313</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zIRyssqpra5a" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3397">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zvS7L22Rtc7b" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,334,699</b></span></td>
    <td id="xdx_982_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zQD2BSZC53P4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,257,045</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zXhS9fbGkxSb" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,776,077</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zQV4XxDhUbV7" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,189,814</b></span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zYT2Rx9a5Aw" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>5,584,082</b></span></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zYA2RckZNPlh" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>4,814,424</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">*</td><td style="width: 5pt"></td><td style="text-align: justify">See above for further details on goodwill changes in 2023.</td>
</tr></table>

<p id="xdx_8A1_zuQkIsJ3rwSe" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">The main assumptions used by the Company to determine
the value in use of the CGUs were:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">Student enrollment - refers to the number of students
that are currently enrolled in each CGU. The growth of students enrolled considers maturation of operations, limited by regulatory seats
approved for each CGU.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Tuition fees - the monthly fee charged to students. Tuition fees are consistent
with Management best expectations on prices charged and considers inflation for future periods.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Occupancy rate - the occupancy rate of the medical schools is the ratio
of the number of students effectively enrolled divided by the regulatory capacity in a given period.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Regulatory capacity - the regulatory capacity is defined by the number of
medical schools seats available per year awarded by MEC, multiplied by the number of years of operations since the seats were awarded.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Faculty - refers to the cost with faculty in the CGU, which means the amount
paid to teachers and doctors.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Digital content platform revenues - refer to mobile app subscription, clinical
management system, healthcare payments, medical imaging, online courses for digital content users and marketing for pharmaceutical industry.
Business assumptions include management best expectations on long term targets for digital services segment operations, including total
addressable market, market share and target prices including inflation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Capital expenditures - refers to investments to be made on intangible assets
related to developments and platform improvements especially on the digital services CGUs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">Discount rates - discount rates represent the current
market assessment of the risks specific to the CGU being tested. The pre-tax discount rate applied to cash flow projections is between
<span id="xdx_90E_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pid_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z3b2HImOwvag" title="Discount rate applied to cash flow projections">12.48</span>% and <span id="xdx_900_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pid_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zS0zXiFEg0uf" title="Discount rate applied to cash flow projections">15.14</span>% in 2023 (between <span id="xdx_902_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pid_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zo9WACMhePx8" title="Discount rate applied to cash flow projections">13.14</span>% and <span id="xdx_908_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pid_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8Y29Il9xQVh" title="Discount rate applied to cash flow projections">15.40</span>% in 2022).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">Perpetuity growth rate - refers to growth rate considered
by management on long term periods after the explicit projection period of five <span id="xdx_901_ecustom--ExplicitProjectionPeriod_dtY_c20230101__20231231_z7uvymfzDPXf" style="display: none" title="Explicit projection period">5</span>
years. The growth rates range from <span id="xdx_90C_ecustom--PerpetuityGrowthRate_pid_dp_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_za6Ng84ehhjg" title="Growth rates">3.5</span>%
to <span id="xdx_90B_ecustom--PerpetuityGrowthRate_pid_dp_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zZHxGzW4x9C3" title="Growth rates">7.8</span>%.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt 10.9pt; text-indent: -10.9pt"><span style="text-decoration: underline">Significant estimate: impact of possible
changes in key assumptions</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span id="xdx_90B_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_z6Laoxh51uUc" title="Description of key assumptions on which management has based cash flow projections">An increase of 25 basis points in management&#8217;s estimated
discount rate applied to the cash flow projections of each CGU for the year ended December 31, 2023, or a decrease of 25 basis points
on estimated EBITDA would have not resulted in significant impacts on these consolidated financial statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt; color: #C00000">Other intangible assets</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets, other than goodwill and licenses with indefinite useful
lives, are valued separately for each acquisition and are amortized during each useful life. The useful lives and methods of amortization
of other intangibles are reviewed at each financial year end and adjusted prospectively, if appropriate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The estimated useful lives of intangible assets are as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zElzYaU0osM5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets and goodwill (Details 2)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_zjb6IUsUqjg5" style="display: none">Schedule of estimated
    useful lives of intangible assets</span>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="width: 72%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Customer relationships - medicine</span></td>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsMedicineMember_zq8afRnHTbud" title="Estimated useful lives of intangible assets">6</span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Customer relationships - other courses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsOtherCoursesMember_zAOTCaqrU9O3" title="Estimated useful lives of intangible assets">4.5</span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Software license</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zjo7dH7vBiXd" title="Estimated useful lives of intangible assets">5</span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Education content</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zyWGqGGxn1N5" title="Estimated useful lives of intangible assets">3</span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trademarks</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zvRcOQGbg7X5" title="Estimated useful lives of intangible assets">2</span> - <span id="xdx_903_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zIBFrQClh4Ga" title="Estimated useful lives of intangible assets">30</span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Developed technology</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyMember_z3qO4r0lhFHe" title="Estimated useful lives of intangible assets">5</span> years</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For the years ended December 31, 2023, 2022 and 2021, there were no indicatives
that the Company&#8217;s intangible assets with finite useful lives might be impaired.</p>






<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureIntangibleAssetsAndGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureIntangibleAssetsAndGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfIntangibleAssetExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfIntangibleAssetExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639607525616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and financial liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">Financial assets and financial liabilities</a></td>
<td class="text"><p id="xdx_806_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_z1Fsf8NZRM34" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>13</b></td><td><b><span id="xdx_82D_zorj3lSPc0a3">Financial assets and financial liabilities</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #0D0E00">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>13.1</b></td><td><b>Financial assets </b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--FinancialAssetsExplanatory_pn3n3_zJLMLzaNeYWi" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B4_zdIUHg3WDrwj" style="display: none">Schedule of financial assets</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>At amortized cost:</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade receivables</span></td>
    <td id="xdx_987_eifrs-full--TradeReceivables_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_znvhRTpgqlal" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">585,923</span></td>
    <td id="xdx_98B_eifrs-full--TradeReceivables_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zltSo2FYUQFj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">495,399</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRijhHHmHUsi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>585,923</b></span></td>
    <td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z8eNeDWDgcWj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>495,399</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_98F_eifrs-full--CurrentFinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zDSNLhZailvk" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">546,438</span></td>
    <td id="xdx_98A_eifrs-full--CurrentFinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zDH89V548f0l" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">452,831</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98F_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z8gvKyGqExqj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">39,485</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zbyrwCdiwf9h" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">42,568</span></td></tr>
  </table>
<p id="xdx_8A5_zgYPot13SO5b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>13.2</b></td><td><b>Financial liabilities</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--FinancialLiabilitiesExplanatory_pn3n3_zNAamn5fgTHj" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BB_zVLBJXM1nqMi" style="display: none">Schedule of financial liabilities</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>At amortized cost:</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade payables</span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zsZ5z4tBNd16" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,222</span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zaflng1uIr16" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71,482</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGCVA33rQQZe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,800,775</span></td>
    <td id="xdx_983_ecustom--LoansAndFinancing_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zZDf2YxUiPyj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,882,901</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease liabilities</span></td>
    <td id="xdx_98A_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zCR0jnW0qx3f" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">874,569</span></td>
    <td id="xdx_987_eifrs-full--LeaseLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zahkjH53tg56" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">769,525</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zvd44yXvyfvi" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">566,867</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zBUVkdriNaCl" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">528,678</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes payable</span></td>
    <td id="xdx_987_ecustom--NotePayable_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zG5S5iOcosV8" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3482">-</span></span></td>
    <td id="xdx_982_ecustom--NotePayable_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zA0iGBXV1x2k" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,176</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGG5suRO9WQ3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,350,433</b></span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4vSHarrOjr4" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,314,762</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_989_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4zKHRNZy307" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">678,370</span></td>
    <td id="xdx_980_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zPLNPpcSDgD1" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">573,030</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_znNl3Ionj775" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,672,063</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zcjxZaF92JNi" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,741,732</span></td></tr>
  </table>
<p id="xdx_8A3_zCXdCLXKngY3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #C00000"><b>13.2.1</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #C00000"><b>Loans and financing</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--LoansAndFinancingExplanatory_pn3n3_zx8gg8As9Cd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span id="xdx_8BF_z3FjGsB32I6k" style="display: none">Schedule
    of loans and financing</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial institution</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Currency</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Interest rate</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Maturity</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zwhEO91dhfLf" title="Financial institution">Banco Ita&#250; Unibanco S.A</span>. (a)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zPovUXEsgu85" title="Interest rate">CDI + 1.90% p.y.</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90C_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_z9FbYff3t5Pi" title="Maturity">2025</span></span></td>
    <td id="xdx_986_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zxtdhVhnUYl9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">412,880</span></td>
    <td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zuTknWjmk7z3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,134</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_z63efS7dHPW6" title="Financial institution">FINEP</span> (b)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zYY7ZOaEGG5i" title="Interest rate">TJLP p.y.</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_za4bA5mRwBMi" title="Maturity">2027</span></span></td>
    <td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zLWcQNCImBv8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,193</span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zz5NcqU4jFkf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8,418</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zixPvLe2cUm2" title="Financial institution">Banco Ita&#250; Unibanco S.A.</span> (c)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_ze6xeIWghk6h" title="Interest rate">CDI + 1.75% p.y.</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_ziloWsxWkwZe" title="Maturity">2024</span></span></td>
    <td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zAXlGIXZMIRj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">21,405</span></td>
    <td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zZsdujsDMr63" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">32,252</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zTtQj1dKJQH5" title="Financial institution">Softbank</span> (d)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zgAcYMbOeJd" title="Interest rate">6.5% p.y.</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_z9JbBX8Z8CKb" title="Maturity">2026</span></span></td>
    <td id="xdx_98F_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zvFybhC9AJYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">825,957</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zkLfVMdMdmXk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">824,258</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zhKl4Fl7Ir0j" title="Financial institution">Debentures</span> (e)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zwYtnJrmhQml" title="Interest rate">CDI + 1.80% p.y.</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zhF90K588Ozc" title="Maturity">2028</span></span></td>
    <td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zuEihA0v0K7i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">529,340</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zoalALfixzve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">499,839</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_988_ecustom--LoansAndFinancing_iI_pn3n3_c20231231_zJH3pY03LGDf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,800,775</b></span></td>
    <td id="xdx_982_ecustom--LoansAndFinancing_iI_pn3n3_c20221231_z5cUqIHiEmq3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,882,901</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_98C_ecustom--LoansAndFinancingCurrent_pn3n3_c20231231_zE9O3pNmyqHg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">179,252</span></td>
    <td id="xdx_98C_ecustom--LoansAndFinancingCurrent_pn3n3_c20221231_z8ClKkSIN7q8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">145,202</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_982_ecustom--LoansAndFinancingNonCurrent_pn3n3_c20231231_zG4Rcw4uOJcb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,621,523</span></td>
    <td id="xdx_98A_ecustom--LoansAndFinancingNonCurrent_pn3n3_c20221231_zkCz0TP20Am7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,737,699</span></td></tr>
  </table>
<p id="xdx_8AA_zdrHceVnbSW2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(a) On October 1, 2020, Afya Brazil entered into a loan with Banco Ita&#250;
Unibanco S.A. in the amount of R$500,000 adjusted by the CDI rate plus an interest rate of 1.62% per year and is repayable in three installments
in October 2022, April 2023 and October 2023. This agreement has financial covenants and the Company should not reduce its EBITDA by 50%
or more year over year. As of December 31, 2023, the Company is compliant with all obligations set forth in this agreement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On September 28, 2022, Afya Brazil signed an amendment with Banco Ita&#250;
Unibanco S.A in order to extend its debt profile, postponing the original repayments dates from 2022 and 2023 to 2023, 2024 and 2025.
Due to such extension, the spread over CDI rate increased from 1.62% p.y to 1.90% p.y.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(b) On July 23, 2019, Medcel entered into a loan of R$16,153 with Financiadora
de Estudos e Projetos (&#8220;FINEP&#8221;), a governmental agency focused on financing investments on R&amp;D, which has an interest
rate based on TJLP (Long term interest rate), and maturity in 2027. The first and second tranches of R$6,734 and R$4,130, respectively,
were drawdown in October 2019 and December 2020, respectively, and new tranches were drawdown in March and June 2023 totaling R$5,288
in order to develop the Medical web series and other digital content. There is no financial covenant related to this agreement. The total
balance is guaranteed by a bank financial guarantee.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(c) On October 28, 2020, UnifipMoc entered into a loan with Banco Ita&#250;
Unibanco S.A. in the amount of R$30,000. On June 30, 2021, this agreement was amended and is now adjusted by the CDI rate plus an interest
rate of 1.75% per year and is repayable in three installments in July 2023, January 2024 and July 2024. There is no financial covenant
related to this agreement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(d) On April 26, 2021, the Company issued and sold 150,000 shares of perpetual
convertible preferred shares designated as Series A perpetual convertible preferred shares, with a par value of US$0.00005 per share of
the Company for US$150,000 thousands, equivalent to R$821,805 on the issuance date. The Series A perpetual convertible preferred shares
is a class of equity security that ranks senior to the common shares with respect to dividend rights or rights upon liquidation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Each Series A perpetual convertible preferred share is entitled to a cash
dividend of 6.5% per annum and is convertible, at the holder&#8217;s discretion, into the Company&#8217;s Class A common shares at an
initial conversion price of US$25.35. The Company may require the conversion of any or all of the Series A perpetual convertible preferred
shares at any time on or after the three-year anniversary of the original issuance date if certain conditions set forth in the certificate
of designation are met (if for 20 out of 30 consecutive trading days prior, Afya&#8217;s stock price is equal or above 150% of the conversion
rate). The Company may also redeem any or all of the Series A perpetual convertible preferred shares for cash, shares of its common shares
or a combination thereof at its election, at any time on or after the seven-year anniversary of the original issuance date as determined
in the certificate of designation. On or after the five-year anniversary of the original issuance date, the holders of the Series A convertible
perpetual preferred shares shall have the right to redeem all of the outstanding Series A convertible perpetual preferred shares for cash,
the Company&#8217;s common shares or a combination thereof (at the Company&#8217;s election, subject to certain conditions) to be determined
in the certificate of designation. Upon the occurrence of a change of control, the holders will have the right to redeem their Series
A convertible perpetual preferred shares for cash at a price set forth in the certificate of designation.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Series A convertible perpetual preferred shares will be entitled with
the same voting rights of the common shares only when converted into it.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company determined that the Series A perpetual convertible preferred
shares should be classified as financial liability at amortized cost upon their issuance since is redeemable primarily according to the
decision of the holder and there is a contractual obligation to deliver assets (cash, shares of its common shares or a combination thereof)
that could not be avoided by the Company in an event of redemption. The financial liability is denominated in Brazilian Reais and thus
not subject to foreign exchange changes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">In addition, as the entire instrument is classified as a liability, the
embedded put option to redeem the Series A perpetual convertible preferred shares for cash is an embedded derivative. The embedded derivative
will not be treated separately once the exercise price of the option is closely related to the host contract.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The initial transaction costs that are directly attributable to the issuance
of Series A perpetual convertible preferred shares were measured at fair value together with the financial liability on initial measurement.
The transaction costs totaled R$13,030, including legal counsels and advisors.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(e) On December 16, 2022, Afya Brazil issued 500,000 simple, non-convertible,
unsecured debentures in a single series, each with a par value of R$1, totaling an aggregate amount of R$500.000, by means of a public
distribution with restricted placement efforts in the Brazilian market, under the terms of the Brazilian Securities Commission (&#8220;CVM&#8221;)
Rule No. 476. Afya expects to use the proceeds of the offering for general corporate purposes, strengthening its cash position, and extending
its debt maturity profile. The debentures were issued with a maturity date of January 15, 2028, with the principal to be amortized in
two equal installments payable on January 15, 2027 and January 15, 2028, corresponding to the fourth and fifth years of the transaction,
respectively. The debentures bear interest at 100% of the CDI rate (the average of interbank overnight rates in Brazil, based on 252
business days) plus 1.80% per year, payable semi-annually on January 15 and July 15 of each year, until the maturity date.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>







<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">This transaction is subject to certain obligations including financial covenants.
According to this offering, Afya shall maintain net debt (excluding Softbank transaction and lease liabilities) to adjusted EBITDA ratio
below or equal to 3.0 x, at the end of each fiscal year, until maturity date. Adjusted EBITDA considers net income plus (i) income taxes
expenses, (ii) net financial result (excluding interest expenses on lease liabilities), (iii) depreciation and amortization expenses (excluding
right-of-use depreciation expenses), (iv) share-based compensation expenses, (v) share of income of associate, (vi) interest received
and (vii) non-recurring expenses. As of December 31, 2023, the Company is compliant with all obligations set forth in the deed of issuance.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The transaction costs that are directly attributable to the issuance of
debentures were measured at fair value together with the financial liability on initial measurement. The transaction costs totaled R$3,115,
including legal counsels and advisors.</p>

<p id="xdx_8A7_zrzHNk8nsqGi" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><b>13.2.2</b></td><td><b>Leases</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company has lease contracts for properties. The lease contracts generally
have maturities in the lease terms between five <span id="xdx_90E_ecustom--ContractualLeaseTerm_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zD6PbyEzv0B9" style="display: none" title="Contractual lease term">5</span>
and <span id="xdx_908_ecustom--ContractualLeaseTerm_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zkzUL9zRuq3b">30
</span>years. There are no sublease or variable payments in-substance lease agreements in the period.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The carrying amounts of right-of-use assets and lease liabilities as of
December 31, 2023, 2022 and 2021 and the movements during the years are described below:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfLeasesExplanatory_pn3n3_z2S2V2JTiUQe" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities  (Details 3)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B3_z8bEv5AvX4ng" style="display: none">Schedule of  right-of-use assets and lease liabilities</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Right-of-use assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease liabilities</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As of January 1, 2021</span></td>
    <td id="xdx_985_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231_zzm8oscCEqVe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">419,074</span></td>
    <td id="xdx_985_eifrs-full--LeaseLiabilities_iS_pn3n3_c20210101__20211231_zHUcS7LloIqb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,703</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_984_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20210101__20211231_zXFrKAWoPbvc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,689</span></td>
    <td id="xdx_983_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20210101__20211231_zU6X8OtdP12c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,689</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_988_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20210101__20211231_zLg8S1jXq9r" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">95,962</span></td>
    <td id="xdx_988_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20210101__20211231_zNaiKcv9cc01" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">95,962</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business combinations</span></td>
    <td id="xdx_981_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20210101__20211231_z69SVDxa9073" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">139,514</span></td>
    <td id="xdx_981_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20210101__20211231_zoUsD3VfM932" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">139,514</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation expense</span></td>
    <td id="xdx_98E_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20210101__20211231_zPMkXpuVkZgb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(43,237)</span></td>
    <td id="xdx_98F_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20210101__20211231_zs8qnE6TIHy7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3587">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense</span></td>
    <td id="xdx_981_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20210101__20211231_zjDVV5t6wSg1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3589">-</span></span></td>
    <td id="xdx_981_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20210101__20211231_zTmLwJhXFUpa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">67,212</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of lease liabilities</span></td>
    <td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20210101__20211231_zOurIa33N2ai" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3593">-</span></span></td>
    <td id="xdx_986_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20210101__20211231_zkH2q38KAUWb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(20,075)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of interest</span></td>
    <td id="xdx_98F_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20210101__20211231_zDG9GQPJ2pw3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3597">-</span></span></td>
    <td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20210101__20211231_zcpRlWrsnwAi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(67,676)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Write-off (i)</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsWriteoff_pn3n3_c20210101__20211231_zxJjvDTk9Rbh" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(10,316)</span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20210101__20211231_znB8p8dHSy8a" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,244)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2021</b></span></td>
    <td id="xdx_98A_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231_ztFQuSUk4o81" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>663,686</b></span></td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iE_pn3n3_c20210101__20211231_zwU995Xr7y9l" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>714,085</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_989_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20211231_zCnkvKVjjYff" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3609">-</span></span></td>
    <td id="xdx_98B_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20211231_zgohRItwed46" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,955</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98E_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20211231_zR0hVh8DWdq4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">663,686</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20211231_zd0zw6pM76v9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">689,130</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Right-of-use assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease liabilities</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As of January 1, 2022</span></td>
    <td id="xdx_989_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231_zlxdHP7lsB6g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">663,686</span></td>
    <td id="xdx_98D_eifrs-full--LeaseLiabilities_iS_pn3n3_c20220101__20221231_zMy7EivATDh1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">714,085</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20220101__20221231_zkUzBAjoZudl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">42,250</span></td>
    <td id="xdx_98F_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20220101__20221231_zdMwpGke2J8g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">42,250</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_983_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20220101__20221231_zLo27DxLkySg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,623</span></td>
    <td id="xdx_983_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20220101__20221231_zpczl7PdsrKb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,623</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation expense</span></td>
    <td id="xdx_98A_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20220101__20221231_zsIqOT0TD00l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(54,684)</span></td>
    <td id="xdx_988_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20220101__20221231_zc61iPN2iafb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3631">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20220101__20221231_z8ZyVH5YJXK2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3633">-</span></span></td>
    <td id="xdx_989_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20220101__20221231_zaS3bgdrcWL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">88,571</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of lease liabilities</span></td>
    <td id="xdx_98D_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20220101__20221231_zAtnAxV0hK3l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3637">-</span></span></td>
    <td id="xdx_988_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20220101__20221231_zFp1eQhddoLb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(28,511)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of interest</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20220101__20221231_zWPvjnbneWN1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3641">-</span></span></td>
    <td id="xdx_98D_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20220101__20221231_zIEYWMHuW9A7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(85,001)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Write-off (i)</span></td>
    <td id="xdx_989_ecustom--RightofuseAssetsWriteoff_pn3n3_c20220101__20221231_zEp14ubf4aE9" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(19,802)</span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20220101__20221231_zy8tQ3J8uoIk" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(20,492)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_98A_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231_zt20Zm1Edac1" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>690,073</b></span></td>
    <td id="xdx_980_eifrs-full--LeaseLiabilities_iE_pn3n3_c20220101__20221231_zwh8Cddthstb" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>769,525</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_98F_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20221231_zhOdB4doCdzd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3653">-</span></span></td>
    <td id="xdx_98E_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20221231_zeTGzTc8NqR4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">32,459</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_988_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20221231_zKAgb5I4C169" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">690,073</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20221231_zG4fAtsBel0h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">737,066</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>




<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Right-of-use assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease liabilities</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As of January 1, 2023</span></td>
    <td id="xdx_98E_eifrs-full--RightofuseAssets_iS_pn3n3_c20230101__20231231_zJ5QW0knYgvg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">690,073</span></td>
    <td id="xdx_988_eifrs-full--LeaseLiabilities_iS_pn3n3_c20230101__20231231_z9rzREO9aZ4e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">769,525</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_987_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20230101__20231231_zL8q1ZMxF01d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,328</span></td>
    <td id="xdx_986_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20230101__20231231_zF8PDKKNoA74" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,328</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_984_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20230101__20231231_zmlrYcYftY4e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,387</span></td>
    <td id="xdx_981_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20230101__20231231_zjshxc8CiJ9g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,387</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business combination</span></td>
    <td id="xdx_985_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20230101__20231231_zQkxIXV3QY0j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">65,408</span></td>
    <td id="xdx_98A_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20230101__20231231_znya9xJSI7m3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">65,408</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation expense</span></td>
    <td id="xdx_986_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20230101__20231231_zpWBB2SsLyMe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(63,118)</span></td>
    <td id="xdx_981_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20230101__20231231_zf88jHsLHpl8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3679">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense</span></td>
    <td id="xdx_987_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20230101__20231231_zSvjvWhL4v8k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3681">-</span></span></td>
    <td id="xdx_98A_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20230101__20231231_zvrn5y18fJYe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">100,849</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of lease liabilities</span></td>
    <td id="xdx_981_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20230101__20231231_zhP3jV9zQof1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3685">-</span></span></td>
    <td id="xdx_981_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20230101__20231231_zHbnyGwOKiMa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(31,473)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of interest</span></td>
    <td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20230101__20231231_zP0thVavb4e3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3689">-</span></span></td>
    <td id="xdx_98C_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20230101__20231231_zumiwKY2X5v" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(103,911)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Write-off (i)</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsWriteoff_pn3n3_c20230101__20231231_zb3dBBxzfvNi" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,469)</span></td>
    <td id="xdx_98C_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20230101__20231231_zh7AKxCRTijl" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,544)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20230101__20231231_zlUoyhlLZswa" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>767,609</b></span></td>
    <td id="xdx_984_eifrs-full--LeaseLiabilities_iE_pn3n3_c20230101__20231231_z16B5lRhZuCj" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>874,569</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_982_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20231231_zTtXFjUW87M8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3701">-</span></span></td>
    <td id="xdx_985_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20231231_zmhwLxJW1k0k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">36,898</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_pn3n3_c20231231_zQCPpLweoxoh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">767,609</span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20231231_zrM76p2JsvJf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">837,671</span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to anticipated termination of real estate leasing contracts.</td>
</tr></table>

<p id="xdx_8A4_zqpyw4oH6tNc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company recognized lease expense from short-term leases and low-value
assets of R$<span id="xdx_90D_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20230101__20231231_zqK6BzOCK2Q5" title="Amount recognized lease expense from short-term leases and low-value assets">10,871</span> for the year ended December 31, 2023 (R$<span id="xdx_903_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20220101__20221231_z9XznHz792Yl" title="Amount recognized lease expense from short-term leases and low-value assets">12,153</span> and R$<span id="xdx_909_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20210101__20211231_zoUspIehOUO9" title="Amount recognized lease expense from short-term leases and low-value assets">11,229</span> for the years ended December 31, 2022 and 2021, respectively).</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><b>13.2.3</b></td><td><b>Accounts payable to selling shareholders</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--AccountsPayableToSellingShareholdersExplanatory_pn3n3_ziliB0JMP9W1" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 4)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zOKpbQr6YHl" style="display: none">Schedule of accounts payable to selling shareholders</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 74%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of IPEMED (a)</span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPEMEDMember_zjtgI6j1eYq" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,805</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPEMEDMember_zTQZ7KUP2jZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">22,654</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of UniRedentor (b)</span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zF6jWThx2Bkb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,155</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z6NHOhGMEWHl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,064</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of UniSL (c)</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zh977wXaQTj2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,064</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zBaa6vYEC4Y4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">37,301</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of FCMPB (d)</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zLPciQs1PG4k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">63,168</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z3z4bxuy59Tf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">111,755</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Medical Harbour (e)</span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zrBoO00mwD1d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,000</span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zkUvv1YP0P5a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,053</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Shosp (f)</span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zRMEfKuajtPa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">454</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_ztbJtUFpYAbc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,206</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Unigranrio (g)</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zXDpRmTor8Jf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">156,235</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zUAtEZPbz5Ff" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">216,716</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of RX PRO (h)</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zcJm9tHQRXEb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3745">-</span></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zqCSbNCSdrC8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,781</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Guaranhuns (i)</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_ziwmClvDXXSf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3749">-</span></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_zDNXLGfPllpc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">30,653</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Al&#233;m da Medicina (j)</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_z3BMOhOC4469" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">18,325</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zf1cqHzkk09b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,996</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of CardioPapers (k)</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_znB8g3Ng7FWg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,173</span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zoCnYH4KGU7g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,979</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Glic (l)</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zZpgf1L6hkHi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3761">-</span></span></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqUaAylbsOW3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">9,520</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of DelRey (m)</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zkGSxhB2heV2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">256,488</span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWh1tD0PtqQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3767">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231_zw28pc3pfnra" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>566,867</b></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231_zcGlMoRUF3nf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>528,678</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersCurrent_pn3n3_c20231231_ztoL7CLqVncc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">353,998</span></td>
    <td id="xdx_985_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_pn3n3_c20221231_zhwIzkX0JYLl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">261,711</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_988_ecustom--AccountsPayableToSellingShareholdersNonCurrent_pn3n3_c20231231_zXtBCJlRGiag" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">212,869</span></td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_pn3n3_c20221231_zQI82jJ7MbM5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">266,967</span></td></tr>
  </table>
<p id="xdx_8A4_zmAq9VsnJSLj" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--AccountsPayableToSellingShareholders1Explanatory_pn3n3_zXgQenVehkk4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 5)">
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B5_zEraxvDL7gzi" style="display: none">Schedule of accounts payable</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; width: 64%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening balance</span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zbJULWSraGt8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">528,678</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z3cUwk7UaRKc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">679,826</span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zgQlOb5Rvnt2" style="text-align: right; line-height: 10pt" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,240</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash flows - Payments and deductions</span></td>
    <td id="xdx_985_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZq02NmwYUpj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows payments and deductions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(225,460)</span></td>
    <td id="xdx_989_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zNM1Z8mB8kx" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows payments and deductions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(236,760)</span></td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zeRVdp0I9zxk" style="text-align: right; line-height: 10pt" title="Cash flows payments and deductions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(180,020)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payment of interest (i) </span></td>
    <td id="xdx_982_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwCc7jojqdJj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payment of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(55,989)</span></td>
    <td id="xdx_989_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOeaGHJ3JUqh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payment of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(24,428)</span></td>
    <td id="xdx_982_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zhYXmvlVfi0b" style="text-align: right; line-height: 10pt" title="Payment of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(12,661)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of licenses </span></td>
    <td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZi0w3oiADTg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Acquisition of licenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3801">-</span></span></td>
    <td id="xdx_983_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zurbn4TXoPs2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Acquisition of licenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,408</span></td>
    <td id="xdx_98B_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zvhjw41RaIQf" style="text-align: right; line-height: 10pt" title="Acquisition of licenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,000</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest</span></td>
    <td id="xdx_98D_eifrs-full--InterestExpense_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZU9mamIs1j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">85,069</span></td>
    <td id="xdx_985_eifrs-full--InterestExpense_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z2dfGwU41v29" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">68,064</span></td>
    <td id="xdx_982_eifrs-full--InterestExpense_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zcLYGoNRMarl" style="text-align: right; line-height: 10pt" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">31,915</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions - Consideration to be transferred on business combinations</span></td>
    <td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zEDIzqwicxb2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Additions consideration to be transferred on business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">234,000</span></td>
    <td id="xdx_987_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zx3JNTpsDtS5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Additions consideration to be transferred on business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3815">-</span></span></td>
    <td id="xdx_987_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zJ5p0YmMzi74" style="text-align: right; line-height: 10pt" title="Additions consideration to be transferred on business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">243,816</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Consideration to be transferred on business combinations (earn-outs)</span></td>
    <td id="xdx_988_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zROvmhfczSih" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt" title="Consideration to be transferred on business combinations (earn-outs)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3819">-</span></span></td>
    <td id="xdx_980_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zL5vNj3woY48" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Consideration to be transferred on business combinations (earn-outs)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,921</span></td>
    <td id="xdx_984_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFV1daN0l1Wi" style="text-align: right; line-height: 10pt" title="Consideration to be transferred on business combinations (earn-outs)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,536</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_98C_ecustom--Reversals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zWVhsxfBtqvh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3825">-</span></span></td>
    <td id="xdx_981_ecustom--Reversals_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z2hWFxLGnHRb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(10,353)</span></td>
    <td id="xdx_98C_ecustom--Reversals_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zumMbbBxg1m" style="text-align: right; line-height: 10pt" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3829">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement of earn-outs (ii)</span></td>
    <td id="xdx_987_ecustom--RemeasurementOfEarnouts_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoN25Pe3anMi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Remeasurement of earn-outs"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,556</span></td>
    <td id="xdx_98F_ecustom--RemeasurementOfEarnouts_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zrZSalRvocjg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Remeasurement of earn-outs"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3833">-</span></span></td>
    <td id="xdx_985_ecustom--RemeasurementOfEarnouts_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zRBb15aXcrxd" style="text-align: right; line-height: 10pt" title="Remeasurement of earn-outs"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3835">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_98F_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmH6rqDHXHr6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,987)</span></td>
    <td id="xdx_98C_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmbGyYVfm2Lb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3839">-</span></span></td>
    <td id="xdx_983_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zJbOADQBxQk5" style="text-align: right; line-height: 10pt" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3841">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Closing balance</b></span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zKGOsQlY0Zx7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>566,867</b></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFeodshF64R1" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>528,678</b></span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zLsXqSNbZcEe" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right; line-height: 10pt" title="Closing balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>679,826</b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Payment of interest from acquisition of subsidiaries are included in cash flows from investing
activities.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">During the measurement period, management&#8217;s expectation has been reviewed based on
performance for revenue goals and the contingent consideration for the acquisition of Al&#233;m da Medicina, CardioPapers and Glic
have been remeasured by R$4,773, R$5,082 and (R$7,299), respectively, totaling R$2,556 as of December 31, 2023. These are measured by
the Company at the present value.</td>
</tr></table>

<p id="xdx_8A3_zA6YlBl3bCH1" style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(a) On May 9, 2019, Afya Brazil acquired <span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20190508__20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zNaLsrutma48" title="Ownership Interest">100</span>% of IPEMED and R$<span id="xdx_909_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zeDHUUO3ZRpf" title="Remaining accounts payable">45,303</span> is
payable in five equal installments of R$<span id="xdx_90B_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20240229__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zUnFiMnhmLbb" title="Equal installments payables"><span id="xdx_908_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20230228__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zIe25HgbZQQe" title="Equal installments payables"><span id="xdx_903_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20220228__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zz6QYvafjC81" title="Equal installments payables"><span id="xdx_90E_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20210228__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zOHR3I3FOlYa" title="Equal installments payables"><span id="xdx_90A_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20200229__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zuEeDAKl6fdl" title="Equal installments payables">9,061</span></span></span></span></span>, adjusted by the CDI rate, and due annually in February 2020, 2021, 2022, 2023 and 2024.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(b) On January 31, 2020, Afya Brazil acquired <span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20200101__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zkfreht98Uj6" title="Ownership Interest">100</span>% of UniRedentor and R$<span id="xdx_908_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_pn3n3" title="Remaining accounts payable">100,000</span>
is payable in five equal installments from January 2021 through July 2024, adjusted by the CDI rate. The purchase consideration was adjusted
by R$<span id="xdx_90F_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_pn3n3_c20210131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zr8NiXdFSxXk" title="Equal installments payables">4,503</span> and such amount was deducted from the first installment paid in February 2021.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(c) On May 5, 2020, Afya Brazil acquired <span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zInQgBxYkVV" title="Ownership Interest">100</span>% of UniSL and R$<span id="xdx_907_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z8JajKv9URsg" title="Remaining accounts payable">60,456</span> was
paid in three equal installments through May 2023, adjusted by the CDI rate. The purchase consideration was adjusted by R$<span id="xdx_90B_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_pn3n3_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zeOyypnp911d" title="Equal installments payables">7,816</span> and such
amount was deducted from the first installment paid on May 5, 2021. The open balance as of December 2023 relates to the amount due from
additional seats and will be paid in 2024.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(d) On November 9, 2020, Afya Brazil acquired <span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z6arrEWXkLd7" title="Ownership Interest">100</span>% of FCMPB and R$<span id="xdx_904_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zLbHV73MmT0d" title="Remaining accounts payable">188,894</span>
is payable in four installments through November 2024, adjusted by the CDI rate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(e) On April 8, 2021, Afya Brazil acquired <span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20210407__20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zWNxN06TjmSd" title="Ownership Interest">100</span>% of Medical Harbour and an
earn-out of R$<span id="xdx_904_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zdbyudcIhrsj" title="Remaining accounts payable">9,000</span> is payable in relation to product development goals for 2021 and 2022 and revenue achievements for 2023. The contingent
consideration of R$<span id="xdx_904_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zORIqtkKYUzj" title="Defined benefit obligation, at present value">3,000</span> will be paid in 2024 and is based on the facts and circumstances as of December 31, 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(f) On May 13, 2021, Afya Brazil acquired <span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20210512__20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zFVnHV9gQCNh" title="Ownership Interest">100</span>% of Shosp which included an
earn-out of R$<span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_ztPBqontJGc5" title="Remaining accounts payable">513</span> paid in August 2023 related to product development and R$<span id="xdx_90E_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_pn3n3_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zDFDXUVpHG4e" title="Transaction price allocated to remaining performance obligations">454</span> will be paid until 2026.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(g) On August 4, 2021, Afya Brazil acquired <span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20210803__20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zgguQYh1FrL8" title="Ownership Interest">100</span>% of Unigranrio. The adjusted
aggregate purchase price was R$<span id="xdx_908_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_pn3n3_c20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zoSIYbJoyvTf" title="Non-current payables for purchase of energy">618,956</span> of which 60% was paid in cash on the transaction closing date, and 40% is payable in cash in four
equal installments through 2022 to 2025, adjusted by the CDI rate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(h) On October 1, 2021, Afya Brazil acquired <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20211001__20211002__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zFwBc8lIZZf7" title="Ownership Interest">100</span>% of RX PRO and an earn-out
of up to R$<span id="xdx_90F_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20211002__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zUwl7uEGbFe6" title="Remaining accounts payable">21,000</span> is payable in relation to revenue achievements until 2024. The contingent consideration of R$<span id="xdx_903_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_pn3n3_c20211002__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zjx7Q72tYwFg" title="Transaction price allocated to remaining performance obligations">1,781</span> accounted for on
December 31, 2022 was remeasured and reversed in 2023 based on the facts and circumstances as of December 31, 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(i) On November 5, 2021, Afya Brazil concluded the acquisition of <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20211104__20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zAk2yb8ODmEe" title="Ownership Interest">100</span>% of
ITPAC Garanhuns and R$<span id="xdx_90B_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_pn3n3_c20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zvFMVjlzAei" title="Transaction price allocated to remaining performance obligations">54,000</span> was paid in cash on the transaction closing date, and (ii) R$<span id="xdx_90B_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zCGkegGMMGNe" title="Remaining accounts payable">54,000</span> was paid in two equal installments, adjusted
by the CDI rate, in November 2022 and November 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(j) On March 4, 2022, Afya Brazil acquired <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zRvJ7Tr9vwDe" title="Ownership Interest">100</span>% of Al&#233;m da Medicina
and an earn-out of up to R$<span id="xdx_90F_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zaipSB9YW1kd" title="Remaining accounts payable">19,200</span> is payable in connection with revenue target achievements and product development goals for 2023 and
2024. The purchase consideration was adjusted by R$<span id="xdx_909_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zUixRAB4BPke" title="Equal installments payables">763</span> in favor of the selling shareholders. The contingent consideration of R$<span id="xdx_909_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zri2fyk8BQzl" title="Defined benefit obligation">18,325</span>
is based on the estimated payment considering the facts and circumstances as of December 31, 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(k) On <span style="background-color: white">April 5, 2022</span>, Afya
Brazil acquired <span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z6TuhmRGQfN8" title="Ownership Interest">100</span>% of CardioPapers and an earn-out of up to R$<span id="xdx_902_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zDZYFeZEv1tj" title="Remaining accounts payable">15,000</span> is payable in connection with revenue target achievements and other
goals regarding credentials in the market for 2023 and 2024. The purchase consideration was adjusted by R$<span id="xdx_90D_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zDl995KdqYej" title="Equal installments payables">333</span> in favor of Afya. The contingent
consideration of R$<span id="xdx_906_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z5Wdbvnx4NHb" title="Defined benefit obligation">14,173</span> is based on the estimated payment considering the facts and circumstances as of December 31, 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(l) On March 23, 2022, Afya Brazil acquired <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20220322__20220323__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zbLmxfxgsZT" title="Ownership Interest">100</span>% of Glic and an earn-out
of up to R$<span id="xdx_909_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20220323__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zPkbB0l7Fz06" title="Remaining accounts payable">12,000</span> is payable in connection with revenue target achievements for 2023 and 2024 and product development goals. The contingent
consideration of R$<span id="xdx_90D_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20220323__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zfk0kiRffsbh" title="Defined benefit obligation">9,520</span> accounted for in December 31, 2022, was partially paid in 2023 (R$<span id="xdx_908_ecustom--RemainingBalancePaid_pn3n3_c20220322__20220323__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zcgXSxLuKnXb" title="Remaining balance paid">3,000</span>) and the remaining balance was remeasured
and reversed in 2023 considering the facts and circumstances as of December 31, 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">(m) On January 2, 2023, Afya Brazil acquired <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zYn0G7J6lxl" title="Ownership Interest">100</span>% of DelRey. The aggregate
purchase price is R$<span id="xdx_904_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z3tEjbF5GGBg" title="Non-current payables for purchase of energy">816,236</span> of which R$<span id="xdx_909_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zZWfE1HpBBg3" title="Transaction price allocated to remaining performance obligations">575,000</span> was paid in cash on the transaction closing date, and R$<span id="xdx_908_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zBeNyGONvF09" title="Consideration to be transferred">234,000</span> (which includes R$<span id="xdx_903_eifrs-full--ConsiderationPaidReceived_pn3n3_c20221229__20230201__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zIklZy815Di7" title="Adjustment for purchase consideration">16,000</span>
purchase consideration adjustment, in favor of the Company) is payable in cash in three annual installments, respectively, of R$<span id="xdx_900_ecustom--FirstAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zQqzf5Nv5JLf" title="First annual installment">134,000</span>
in January 2024, R$<span id="xdx_90F_ecustom--SecondAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zPYWZaMSjgne" title="Second annual installment">50,000</span> in January 2025 and R$<span id="xdx_90B_ecustom--ThirdAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zZJpWC6k9luk" title="Third annual installment">50,000</span> in January 2026, adjusted by the SELIC rate. The aggregate purchase also includes
R$<span id="xdx_90C_ecustom--AcquisitiondateFairValueOfTotalConsiderationTransferred1_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zeJa0QV0XJXe" title="Fair value at the date of acquisition">7,236</span> estimated at fair value at the date of acquisition related to an offer of AFYA&#8217;s digital solutions free of charge until
December 31, 2030, for students of medicine of universities owned by the sellers and not part of the transaction.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><b>13.2.4</b></td><td><b>Notes payable</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">With the acquisition of UniSL, Afya Brazil assumed notes payable regarding
the previous acquisition of a portion of the operations of Universidade Luterana do Brasil (ULBRA) by UniSL in auction by the end of 2018.
Two of the UniSL campuses, located in the cities of Ji-Paran&#225; and Porto Velho, State of Rond&#244;nia, were acquired in such transaction.
As of December 31, 2023, all balances of Notes payable were paid and adjusted by 100% of IPCA-E. Below are the carrying amounts of notes
payable and the movements during the years ended December 31, 2023, 2022 and 2021:</p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_pn3n3_zI1MwJVprYy8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 6)">
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BD_zNNBqtHMecB5" style="display: none">Schedule of carrying amount of notes payable and the movements</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; width: 64%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 12%; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening balance</span></td>
    <td id="xdx_98E_ecustom--NotesPayables_iS_pn3n3_c20230101__20231231_zZumwW3dqNMe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,176</span></td>
    <td id="xdx_989_ecustom--NotesPayables_iS_pn3n3_c20220101__20221231_z8LuCR28ybW6" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,726</span></td>
    <td id="xdx_981_ecustom--NotesPayables_iS_pn3n3_c20210101__20211231_zCzrVPC8Pap" style="text-align: right; line-height: 10pt" title="Notes payable beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,181</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments (i)</span></td>
    <td id="xdx_988_ecustom--Payments_pn3n3_c20230101__20231231_zhHb4Q3WxSR" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(49,347)</span></td>
    <td id="xdx_988_ecustom--Payments_pn3n3_c20220101__20221231_z8mKdNAzbTLi" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(12,000)</span></td>
    <td id="xdx_98B_ecustom--Payments_pn3n3_c20210101__20211231_zaNihkfhfaXh" style="text-align: right; line-height: 10pt" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(9,800)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of interest (i)</span></td>
    <td id="xdx_98D_ecustom--PaymentsOfInterest_pn3n3_c20230101__20231231_z1pus9OrYdvj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(15,529)</span></td>
    <td id="xdx_986_ecustom--PaymentsOfInterest_pn3n3_c20220101__20221231_zBtjwhQXhlVh" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,008)</span></td>
    <td id="xdx_981_ecustom--PaymentsOfInterest_pn3n3_c20210101__20211231_zJ0XArvCtfM" style="text-align: right; line-height: 10pt" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,268)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Monetary indexation</span></td>
    <td id="xdx_98C_ecustom--MonetaryIndexation_pn3n3_c20230101__20231231_zQeOkg94T5fg" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Monetary indexation"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,700</span></td>
    <td id="xdx_98B_ecustom--MonetaryIndexation_pn3n3_c20220101__20221231_zP3D6TCwiAq" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Monetary indexation"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,458</span></td>
    <td id="xdx_98E_ecustom--MonetaryIndexation_pn3n3_c20210101__20211231_z6xRxKGRfURc" style="border-bottom: black 1pt solid; text-align: right; line-height: 10pt" title="Monetary indexation"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,613</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Closing balance</b></span></td>
    <td id="xdx_987_ecustom--NotesPayables_iE_pn3n3_c20230101__20231231_zy2Doo6v6gLd" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3975">-</span></b></span></td>
    <td id="xdx_98A_ecustom--NotesPayables_iE_pn3n3_c20220101__20221231_zDHYCKvhFUb7" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>62,176</b></span></td>
    <td id="xdx_987_ecustom--NotesPayables_iE_pn3n3_c20210101__20211231_zUJgfkDY7lp6" style="border-bottom: black 1.5pt double; text-align: right; line-height: 10pt" title="Notes payable ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>72,726</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_988_ecustom--CurrentLiabilities1_iI_pn3n3_c20231231_zImjJr5t7W39" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3981">-</span></span></td>
    <td id="xdx_982_ecustom--CurrentLiabilities1_pn3n3_c20221231_zTy8tYFM8lri" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,176</span></td>
    <td id="xdx_98C_ecustom--CurrentLiabilities1_iI_pn3n3_c20211231_z4pe24LUNx24" style="text-align: right; line-height: 10pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,478</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98E_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20231231_zmPCI95aXc28" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3987">-</span></span></td>
    <td id="xdx_981_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20221231_zTEgZTr2iPGj" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3989">-</span></span></td>
    <td id="xdx_98C_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20211231_zyS8sbnU0fqb" style="text-align: right; line-height: 10pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,248</span></td></tr>
  </table>
<p style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 0 7.1pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The amounts are included in cash flows from investing activities.</td>
</tr></table>

<p id="xdx_8AC_zFeoaMuMnWZf" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>13.3</b></td><td><b>Fair values</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The table below is a comparison of the carrying amounts and fair values
of the Company&#8217;s financial instruments, other than those carrying amounts that are reasonable approximation of fair values:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfFairValuesExplanatory_pn3n3_zswu6R4455O9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 7)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B5_zJK6pWxh0tri" style="display: none">Schedule
    of fair values of the company's financial instruments</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td colspan="2">
    <p style="border-bottom: black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2022</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 48%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying amount</b></span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair value</b></span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying amount</b></span></td>
    <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair value</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>Financial assets</b></span></td>
    <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Trade receivables (non-current)</span></td>
    <td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zFs837uome8d" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">39,485</span></td>
    <td id="xdx_987_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zclm8DkYb8lj" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">39,485</span></td>
    <td id="xdx_981_eifrs-full--FinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zImlu8DZ2jLj" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">42,568</span></td>
    <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zHcJvwaLckM6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">42,568</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--FinancialAssets_pn3n3_c20231231_zw4KhUxubaoa" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>39,485</b></span></td>
    <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20231231_zTh2iJY77cBb" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>39,485</b></span></td>
    <td id="xdx_98A_eifrs-full--FinancialAssets_pn3n3_c20221231_zNNI9Ii9Tml5" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>42,568</b></span></td>
    <td id="xdx_988_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20221231_zNfF5MeDj0j" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>42,568</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial liabilities</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Loans and financing</span></td>
    <td id="xdx_985_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zeDFNFKeKwPd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">1,800,775</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z3UdWKCoXkw7" style="text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">1,795,752</span></td>
    <td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z8MVsGWTu2Pi" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">1,882,901</span></td>
    <td id="xdx_980_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zqE5UmRKe8D2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">1,934,295</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Lease liabilities</span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvTlrrv9bz48" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">874,569</span></td>
    <td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvZo3z2OSNbj" style="text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">874,569</span></td>
    <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zG2y35CZMkdc" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">769,525</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zUFNrm8MIGVk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">769,525</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Accounts payable to selling shareholders</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOjtCh58N4Gi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">566,867</span></td>
    <td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zWvIfRtuHp5d" style="text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">566,867</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zS0Bu4opkWi2" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">528,678</span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zyRmfh5Q3zq9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">528,678</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Notes payable</span></td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zpjqJYyhcRva" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl4035">-</span></span></td>
    <td id="xdx_981_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zuGeihlFqowa" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl4037">-</span></span></td>
    <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zSwW9FMkts7f" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">62,176</span></td>
    <td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_z4xfn4Oxzt9h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">62,176</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td>
    <td id="xdx_988_eifrs-full--FinancialLiabilities_pn3n3_c20231231_zUSx8wBY3LO7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>3,242,211</b></span></td>
    <td id="xdx_98D_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231_zLqaidjInSg2" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>3,237,188</b></span></td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231_zeaXcLuRojA" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>3,243,280</b></span></td>
    <td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231_z4truBUYVEW9" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>3,294,674</b></span></td></tr>
  </table>
<p id="xdx_8A7_zpsam74a5Oih" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The Company assessed that the fair values of current
trade receivables and other current assets, trade payables, advances from customers and other current liabilities approximate their carrying
amounts largely due to the short-term maturities of these instruments. The financial instruments for which the fair value are disclosed
are based on Level 2 fair value measurement hierarchy. There has been no change in fair value hierarchy during the years ended December
31, 2023 and 2022.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The fair value of interest-bearing borrowings and
loans are determined by using the DCF method using a discount rate that reflects the issuer&#8217;s borrowing rate as of the end of the
reporting period. The own non-performance risk at December 31, 2023 was assessed to be insignificant.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>13.4</b></td><td><b>Financial instruments risk management objectives and policies</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The Company&#8217;s main financial liabilities
comprise loans and financing, lease liabilities, accounts payable to selling shareholders, notes payable, trade payables and advances
from customers. The main purpose of these financial liabilities is to finance the Company&#8217;s operations. The Company&#8217;s main
financial assets include trade receivables and cash and cash equivalents.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company is exposed to market risk, credit risk and liquidity risk. The
Company monitors market, credit and liquidity risks in line with the objectives of capital management and counts on the support, monitoring
and oversight of the Board of Directors in decisions related to capital management and its alignment with the objectives and risks. The
Company&#8217;s policy is that no trading of derivatives for speculative purposes may be undertaken. The Board of Directors reviews and
agrees with policies for managing each of these risks, which are summarized below.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><b>13.4.1</b></td><td><b>Market risk</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">Market risk is the risk that the fair value or
future cash flows of a financial instrument will fluctuate because of changes in market prices. The Company&#8217;s exposure to market
risk is related to interest rate and foreign currency risk. The sensitivity analysis in the following sections relates to the position
as of December 31, 2023.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>a) Interest rate risk</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">Interest rate risk is the risk that the fair value
or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company&#8217;s exposure
to the risk of changes in market interest rates relates primarily to the Company&#8217;s cash equivalents, loans and financing, accounts
payable to selling shareholders and notes payable, with floating interest rates.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"><span style="text-decoration: underline">Sensitivity analysis</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below demonstrates the sensitivity to
a reasonably possible change in interest on cash equivalents, loans and financing, accounts payable to selling shareholders and notes
payable. With all variables held constant, the Company&#8217;s income before income taxes is affected through the impact on floating interest
rates, as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_pn3n3_zub13kxFjHY3" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 8)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B7_zn2xVc5VR2Zd" style="display: none">Schedule
    of income before income taxes</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Index - % per year</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Base rate</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash equivalents</span></td>
    <td id="xdx_982_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z1CmwrgwRFh5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,111</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z1Zhg3fb22H1" title="Index - % per year">100.8% of CDI</span></span></td>
    <td id="xdx_988_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zteHpc4PvDha" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">60,846</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zxzsN62UahW1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(529,340)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zzKeMlQQ3cX6" title="Index - % per year">CDI + 1.8%</span></span></td>
    <td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zulfA3LnOXTg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(71,196)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_988_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zjkWW6BQAR6h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(412,880)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zlfYUqzJPSGg" title="Index - % per year">CDI + 1.9%</span></span></td>
    <td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zBlEYBtmvmW8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(55,945)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98D_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zTyOM3VjasWk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,193)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zrvQk1NqrTW9" title="Index - % per year">TJLP</span></span></td>
    <td id="xdx_980_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zCH9Hf3BA766" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(733)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98A_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z9h6xH398M0f" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(21,405)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zcUlDXObefI1" title="Index - % per year">CDI + 1.75%</span></span></td>
    <td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zCtn58HiZyJ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,868)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zM3Xtnp8qMQ8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(274,428)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_ztQoSudqoWe8" title="Index - % per year">CDI</span></span></td>
    <td id="xdx_984_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zAT1MraOlzd6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(31,971)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_981_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z2uOMoIpL1Td" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(256,488)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zDlhhU9QYMhe" title="Index - % per year">SELIC</span></span></td>
    <td id="xdx_98D_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zh7hDPdKbm16" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(29,881)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net exposure</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_980_ecustom--BaseRate_pn3n3_c20230101__20231231_zgkCjjYp6LOh" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(131,748)</b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>





<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Increase in basis points</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; width: 62%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>+75</b></span></td>
    <td style="width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>+150</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effect on profit before tax</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zYFdfJzbbPTi" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,407)</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zN17YZqVBUr" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(14,814)</span></td></tr>
  </table>
<p id="xdx_8A1_zyGjjL0N75va" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b) Foreign currency risk</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">Foreign currency risk is the risk that the fair
value or future cash flows of exposure will fluctuate because of changes in foreign exchange rates. The Company&#8217;s exposure to the
risk of changes in foreign exchange rates relates to cash and cash equivalents denominated in U.S. dollars in the amount of R$<span id="xdx_90F_eifrs-full--CreditExposure_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zgN12uDQPqW7" title="Exposure risk">23,173</span> as
of December 31, 2023 (December 31, 2022: R$<span id="xdx_902_eifrs-full--CreditExposure_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zWVXyRnu6jSf" title="Exposure risk">24,447</span>).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"><span style="text-decoration: underline">Sensitivity analysis</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below demonstrates the sensitivity in
the Company&#8217;s income before income taxes of a <span id="xdx_901_ecustom--SensitivityChangeInTheEuroExchangeRate_pid_dp_c20230101__20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_ztjWtcwc24Vi" title="Percentage of sensitivity change in the Euro exchange rate">10</span>% change in the U.S. dollar exchange rate (R$<span id="xdx_902_eifrs-full--ClosingForeignExchangeRate_iI_uN_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zkXDuPDCpQQ6" title="Closing foreign exchange rate">4.8413</span> to U.S. dollar <span id="xdx_900_eifrs-full--ClosingForeignExchangeRate_iI_uN_c20231231__srt--CurrencyAxis__currency--EUR__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zSsy2TIyIqjd" title="Closing foreign exchange rate">1.00</span>) as of December
31, 2023, with all other variables held constant.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_pn3n3_zJDMahFm18Ra" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 9)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B4_z3XcUWgWtd94" style="display: none">Schedule of sensitivity foreign currency</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 52%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Exposure</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>+10%</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>-10%</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash equivalents</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zdZM8iqCNood" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,173</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zbBLT6FZyP9k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,317</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zx1YxzqAts9c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,317)</span></td></tr>
  </table>
<p id="xdx_8A7_zPyEWEyTMBW1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><b>13.4.2</b></td><td><b>Credit risk</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white">Credit risk is the risk that
a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Company
is exposed to credit risk from its operating activities (primarily trade receivables) and from its financing activities, including cash
and cash equivalents.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white">Customer credit risk is managed
by the Company based on the established policy, procedures and control relating to customer credit risk management. Outstanding customer
receivables are regularly monitored. See Note 7 for additional information on the Company&#8217;s trade receivables.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white">Credit risk from balances
with banks and financial institutions is managed by the Company&#8217;s treasury department in accordance with the Company&#8217;s policy.
Investments of surplus funds are made only with approved counterparties and within limits assigned to each counterparty.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The Company&#8217;s maximum exposure to credit
risk for the components of the statements of financial position on December 31, 2023 and 2022 is the carrying amounts of its financial
assets.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><b>13.4.3</b></td><td><b>Liquidity risk</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company&#8217;s Management has responsibility for monitoring liquidity
risk. In order to achieve the Company&#8217;s objective, Management regularly reviews the risk and maintains appropriate reserves, including
bank credit facilities with first tier financial institutions. Management also continuously monitors projected and actual cash flows and
the combination of the maturity profiles of the financial assets and liabilities.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The main requirements for financial resources used by the Company arise
from the need to make payments for suppliers, operating expenses, labor and social obligations, loans and financing and accounts payable
to selling shareholders.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The tables below summarize the maturity profile
of the Company&#8217;s financial liabilities based on contractual undiscounted amounts:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>






<table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_pn3n3_zfb5sP9cHG2" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 10)">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B6_z7Ix2AYP9vgb" style="display: none">Schedule of maturity profile of financial liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Less than 1 year</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1 to 3 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3 to 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>More than 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade payables</span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zKqpogNzeLQ8" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,222</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zlXoRe7b9DBi" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4125">-</span></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zKGhZQnf6hEf" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4127">-</span></span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zd9BIrkyDVK5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4129">-</span></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zBPpQDCGIrla" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,222</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_988_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjfA8ZBcwEm7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">298,981</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVKkdOpEPvcb" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,383,255</span></td>
    <td id="xdx_986_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2ND2SJ83wp5" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">568,326</span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zsgghcZXp1nd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4139">-</span></span></td>
    <td id="xdx_987_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zsZWmnYIZTO4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,250,562</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease liabilities</span></td>
    <td id="xdx_986_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvCWqPqgEbi7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">137,735</span></td>
    <td id="xdx_984_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zB2AA8LB5gPf" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">268,724</span></td>
    <td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z76RVpz4aMNc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">255,456</span></td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJRt5StHaGXh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,261,213</span></td>
    <td id="xdx_98D_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmJTIANl8Q96" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,923,128</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znPsXiOMCp12" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">387,693</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zNz2H9JulMXd" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">231,478</span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zX4EmWKbXqT" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4157">-</span></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zB3yZUZGzu3f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4159">-</span></span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zXfVv6dplGkf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">619,171</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances from customers</span></td>
    <td id="xdx_98B_eifrs-full--Advances_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zME4b62JV7sl" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">153,485</span></td>
    <td id="xdx_985_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zwzkYT7f58kk" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4165">-</span></span></td>
    <td id="xdx_98C_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr1apcQkETf1" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4167">-</span></span></td>
    <td id="xdx_984_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zUElOKxFqFMj" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4169">-</span></span></td>
    <td id="xdx_98D_eifrs-full--Advances_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeem7BEz0hn3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">153,485</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98F_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zZ8hDu6SFyzh" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,086,116</b></span></td>
    <td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z5BDQH8bxtsa" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,883,457</b></span></td>
    <td id="xdx_985_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zT1uFCFjemLb" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>823,782</b></span></td>
    <td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zovJFtW5v6Cl" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,261,213</b></span></td>
    <td id="xdx_982_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zU2V63uMcu62" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>5,054,568</b></span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2022</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Less than 1 year</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1 to 3 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3 to 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>More than 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade payables</span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFYjRLe0sr3k" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71,482</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVAgiBhQkOc8" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4185">-</span></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zv6qSV9PNFWe" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4187">-</span></span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJV2gX82sHJ8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4189">-</span></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zEo3Amrr3gX4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71,482</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGMolnuvMz5j" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">287,741</span></td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmDIPpbkjg9d" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">788,190</span></td>
    <td id="xdx_983_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zBbcXIg611D3" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,237,599</span></td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zS3uZwei8xPe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4199">-</span></span></td>
    <td id="xdx_98F_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjj4Qt9o90Xi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,313,530</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease liabilities</span></td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z1LhxyYQUb04" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">117,506</span></td>
    <td id="xdx_986_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zyjqz9jJLsv6" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">234,688</span></td>
    <td id="xdx_985_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr9cmg2QCVU5" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">219,127</span></td>
    <td id="xdx_986_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zz9FvZfCyw8j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,139,771</span></td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFnZkptdDykf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,711,092</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z5eY9D2z3HK1" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">282,481</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zMnsKPFukR34" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">339,281</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zttMMmQPyQVl" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4217">-</span></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zL5Ew6XkyqPd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4219">-</span></span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgdhI4OV14Yb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">621,762</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes payable</span></td>
    <td id="xdx_983_ecustom--NotePayables_iIP3ifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOfQHd3SH4o3" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,176</span></td>
    <td id="xdx_984_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zDTh1pftWl9g" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4225">-</span></span></td>
    <td id="xdx_983_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zkh3l2fqtjIc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4227">-</span></span></td>
    <td id="xdx_98D_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVFde30t5472" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4229">-</span></span></td>
    <td id="xdx_981_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztrWQM5u61f4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,176</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances from customers</span></td>
    <td id="xdx_98C_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zXGrzgZK41s7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">133,050</span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr6ZS3rPKD85" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4235">-</span></span></td>
    <td id="xdx_98E_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zANnTznH1kXj" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4237">-</span></span></td>
    <td id="xdx_98D_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGd6AVfTyGj2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4239">-</span></span></td>
    <td id="xdx_982_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zNY8vWl2W63e" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">133,050</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z93TKGcwfCkd" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>954,436</b></span></td>
    <td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOLa5MgMrUbc" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,362,159</b></span></td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztILcbHGFaq7" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,456,726</b></span></td>
    <td id="xdx_983_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znJijWd3Flt9" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,139,771</b></span></td>
    <td id="xdx_98C_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOUKujqThra2" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>4,913,092</b></span></td></tr>
  </table>
<p id="xdx_8A2_zLSjA1Ef5pi3" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>13.5</b></td><td><b>Changes in liabilities arising from financing activities</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_pn3n3_znD3NLxzm0s8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 11)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zOrYKxtipXZd" style="display: none">Schedule of changes in liabilities arising from financing activities</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January 1, 2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 9%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business combination</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: -5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2023</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing (i)</span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zb5oCuVF2yU9" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,882,901</span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z1OkdgyXg4N" style="text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(112,630)</span></td>
    <td id="xdx_988_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zz91xZ7KP0W2" style="vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(175,889)</span></td>
    <td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzpSINmYrvi" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,288</span></td>
    <td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zdUuGXkS87J4" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">197,678</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zRc9ScNgC2Le" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4265">-</span></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0YRYzOiAbDk" style="padding-right: 0.15pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,427</span></td>
    <td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0hWMvdNrn02" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,800,775</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities (i)</span></td>
    <td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYf8cRihXEla" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">769,525</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zR2nMfRekJq7" style="text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(31,473)</span></td>
    <td id="xdx_985_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zC97GDXfYtG7" style="vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(103,911)</span></td>
    <td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxjk1h1PbXRj" style="padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">77,715</span></td>
    <td id="xdx_982_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYAjczM65A1j" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">100,849</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zVDA8oIuDHE" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">65,408</span></td>
    <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYfhJaueJrFa" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,544)</span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zo0m5A5acNlj" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">874,569</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zwtzRK5Fwffl" style="border-bottom: black 1pt solid; text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(18,750)</span></td>
    <td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zFo3dpzJSFqe" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4289">-</span></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z8Z0JZ93uE4f" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18,750</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: -0.15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231_zMKwqychlUL5" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,652,426</b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zl9R91ymLWLc" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(162,853)</b></span></td>
    <td id="xdx_98E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231_zCKkWkERt6cg" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(279,800)</b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z7rZ7YHdggYe" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>101,753</b></span></td>
    <td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zUFpLWbFA4je" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>298,527</b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zlxTmIH9PCDc" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>65,408</b></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zebvvVZYquEf" style="border-bottom: black 1pt solid; padding-right: -5.15pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(117)</b></span></td>
    <td id="xdx_98E_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231_zIINH3EzP9p1" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,675,344</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January 1, 2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: -5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2022</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing (i)</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zjeEFgq56np2" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,374,876</span></td>
    <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zEwNAVSAqorj" style="text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,791)</span></td>
    <td id="xdx_980_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zrrRt69nvtx9" style="vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(116,587)</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzU4iMhnx5gk" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">496,885</span></td>
    <td id="xdx_988_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zCK1Hw1ilUDi" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">127,559</span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zr0qvCHNkJw7" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4319">-</span></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zK6r0rlPGix8" style="padding-right: 0.15pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,959</span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zCJjUkT2tLHk" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,882,901</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities (i)</span></td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zoi3iYocDHK3" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">714,085</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvuyDODzqePk" style="text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(28,511)</span></td>
    <td id="xdx_984_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zX3KJ3Ib6cSa" style="vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(85,001)</span></td>
    <td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zHioC4pfibIa" style="padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">100,873</span></td>
    <td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zD32aHFrwWrf" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">88,571</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zi3ngNPHWwB8" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4335">-</span></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zBaY0ypLltl" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(20,492)</span></td>
    <td id="xdx_98B_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxn0fQ2cPZPj" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">769,525</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z0p2NsGW2d24" style="border-bottom: black 1pt solid; text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(19,736)</span></td>
    <td id="xdx_984_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zmB1yGQcQtXg" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4343">-</span></span></td>
    <td id="xdx_98C_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zCFdrY8qXPDl" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19,736</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: -0.15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231_zUhWEPSqKU1b" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,088,961</b></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zPpSwvF3ojPl" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(50,038)</b></span></td>
    <td id="xdx_98A_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231_z4ktVBIa9ha" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(201,588)</b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zPBmJguotbH7" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>617,494</b></span></td>
    <td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_z0KOyBp9fS01" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>216,130</b></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zaq1pYbwsTIg" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4357">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zB1yN3yN8WUc" style="border-bottom: black 1pt solid; padding-right: -5.15pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(18,533)</b></span></td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231_zJxvR9gCYeu4" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,652,426</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January 1, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions (ii)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing (i)</span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z37iLiWRrR8d" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">617,485</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zsMxQRR4XKhb" style="text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(107,766)</span></td>
    <td id="xdx_986_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z5WS9nNRhurf" style="vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(50,310)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zNuOgl1HATC5" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">809,539</span></td>
    <td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znkh4kSlZoF5" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">68,909</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zApx8FKVHoU" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">36,591</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z7krHWyRiHb4" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">428</span></td>
    <td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zuxfOb5h6wX2" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,374,876</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities (i)</span></td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zkn1nQd2fRw2" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">447,703</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zaY7drP9ILG7" style="text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(20,075)</span></td>
    <td id="xdx_98B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zGeUJ84mQfvc" style="vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(67,676)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zkdzaSaZnVEf" style="padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">158,651</span></td>
    <td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zx11PdTD5kS7" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">67,212</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z8sAB1z40ZS3" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">139,514</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zfzKIphO7WAi" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(11,244)</span></td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zUrlgU4Npwe2" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">714,085</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zjFMBOqxMtgf" style="border-bottom: black 1pt solid; text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(18,648)</span></td>
    <td id="xdx_98E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zcTlfTDcIkP7" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4397">-</span></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zU4HEg0KiGh5" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18,648</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231_zGrVTs3PHlR5" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,065,188</b></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zyWwyGmVEAtl" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(146,489)</b></span></td>
    <td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231_zOWleRFSl2wh" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(117,986)</b></span></td>
    <td id="xdx_982_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zDU1ZF6KtwW6" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>986,838</b></span></td>
    <td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_z8sHp1aaRVdd" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>136,121</b></span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zEVPUtEuD818" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>176,105</b></span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zEjF0FDq0qMk" style="border-bottom: black 1pt solid; padding-right: -6.25pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(10,816)</b></span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231_z4jiUHg6srUk" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,088,961</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Payment of interest of loan and financing and lease liabilities are included in cash flows
from financing activities.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">The additions of loans and financing in 2021 include proceeds from the SoftBank transaction
of R$822,569, net of the transaction costs of R$13,030.</td>
</tr></table>

<p id="xdx_8A9_zJbhsBFl9oN8" style="margin-top: 0; margin-bottom: 0">&#160;</p>






<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Section Scope<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639608798880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureFairValueMeasurementAbstract', window );"><strong>Fair Value Measurement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FairValueMeasurementExplanatory', window );">Fair value measurement</a></td>
<td class="text"><p id="xdx_808_ecustom--FairValueMeasurementExplanatory_zLFuIZiL3ZG2" style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>14</b></td><td><b><span id="xdx_829_z6gXIlRuPYLc">Fair value measurement</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below provides the fair value measurement
hierarchy of the Company&#8217;s assets and liabilities as of December 31, 2023 and 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfFairValueMeasurementExplanaory_pn3n3_zXkxqugiNX1j" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Fair value measurement (Details)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span id="xdx_8B3_zoPsNlrfXFT9" style="display: none">Schedule of fair value measurement</span></td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td colspan="4" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Fair value measurement</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 15%; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Quoted prices in active markets (Level 1)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Significant observable inputs (Level 2)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Significant unobservable inputs (Level 3)</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2023 </b></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Assets for which fair values are disclosed</b></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade receivables (non-current)</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231_z6nW6UYVwKll" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">39,485</span></td>
    <td id="xdx_983_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zgMAMHa7C9Y7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4424">-</span></span></td>
    <td id="xdx_988_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zgnKNB61vcL5" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">39,485</span></td>
    <td id="xdx_986_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zz4qBjgPLW78" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4428">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Liabilities for which fair values are disclosed</b></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_989_ecustom--LoansAndFinancingLiabilities_pn3n3_c20231231_zmOBDC8nlVr4" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,795,752)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_988_ecustom--LoansAndFinancingLiabilities_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z1ChD5t69aU5" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,795,752)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_98B_ecustom--LeaseLiabilities1_pn3n3_c20231231_zrCCfiQbcn9l" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(874,569)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilities1_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zMnXzltPJyUl" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(874,569)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_984_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_pn3n3_c20231231_zCnINyUm3Rqg" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(566,867)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z0poaPp6EtI8" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(566,867)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2022</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Assets for which fair values are disclosed</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade receivables (non-current)</span></td>
    <td id="xdx_98F_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231_zeLkFJ30Gtqc" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,568</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zJf8rpjzeG77" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4444">-</span></span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zJnkrYIYbxX7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,568</span></td>
    <td id="xdx_984_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zQcI0wGyDQo7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4448">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Liabilities for which fair values are disclosed</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_pn3n3_c20221231_zQQuhRJa4IT7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,934,295)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_ecustom--LoansAndFinancingLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zCK7lwe0y5Y7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,934,295)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_98B_ecustom--LeaseLiabilities1_iI_pn3n3_c20221231_zvBBXzWtfAna" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(769,525)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilities1_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zZ2rXoEUcwBl" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(769,525)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_988_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_pn3n3_c20221231_zOLekkhCkSCj" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(528,678)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zgzRSQHH0qJf" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(528,678)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Notes payable</span></td>
    <td id="xdx_986_ecustom--FairValueNotesPayables1_iI_pn3n3_c20221231_zsYf6f6VbNT1" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(62,176)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98C_ecustom--FairValueNotesPayables1_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zb3OjtRK3R49" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(62,176)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">There were no transfers between Levels during the
period or year presented.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureFairValueMeasurementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureFairValueMeasurementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FairValueMeasurementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FairValueMeasurementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639611378656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureCapitalManagementAbstract', window );"><strong>Capital Management</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalManagementExplanatory', window );">Capital management</a></td>
<td class="text"><p id="xdx_804_ecustom--CapitalManagementExplanatory_zMEDYPMJEDqa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>15</b></td><td><b><span id="xdx_820_zLAVEuMVQG5g">Capital management</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">For the purposes of the Company&#8217;s capital
management, capital considers total equity. The primary objective of the Company&#8217;s capital management is to maximize shareholder
value.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The Company manages its capital structure and makes
adjustments in light of changes in economic conditions and the requirements of the financial covenants.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">In order to achieve this overall objective, the
Company&#8217;s capital management, among other things, aims to ensure that it meets financial covenants that define capital structure
requirements. Breaches in meeting the financial covenants would permit the bank to immediately call loans or debentures. There have been
no breaches of the financial covenants of any loans or debentures in the current and previous periods.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">No changes were made in the objectives, policies
or processes for managing capital during the years ended December 31, 2023 and 2022.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CapitalManagementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CapitalManagementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureCapitalManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureCapitalManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639608716784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureLaborAndSocialObligationsAbstract', window );"><strong>Labor And Social Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LaborAndSocialObligationsExplanatory', window );">Labor and social obligations</a></td>
<td class="text"><p id="xdx_80F_ecustom--LaborAndSocialObligationsExplanatory_zdY28qPb1jb4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>16</b></td><td><b><span id="xdx_82C_zV2NQ8v9LAmh">Labor and social obligations</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>a) Variable compensation (bonuses)</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company recorded bonuses related to variable compensation of employees and management in cost of services and selling, general and administrative
expenses of R$<span id="xdx_908_ecustom--ShareBasedCompensationOfEmployees_pn3n3_c20230101__20231231_zlUo7BjI9FKb" title="Compensation of employees">22,185</span></span><span style="font-size: 8pt; font-weight: normal">, </span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">R$<span id="xdx_908_ecustom--ShareBasedCompensationOfEmployees_pn3n3_c20220101__20221231_zrYRy1wf5zX4" title="Compensation of employees">24,248</span>
and R$<span id="xdx_90A_ecustom--ShareBasedCompensationOfEmployees_pn3n3_c20210101__20211231_zMPu8NPpfAFd" title="Compensation of employees">25,587</span> in the years ended December 31, 2023, 2022 and 2021, respectively.</span></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b) Afya Limited share-based compensation plans</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b.1) Stock options plan</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">The stock options plan was approved on
August 30, 2019 and granted to senior executives and other employees of the Company from that date, with subsequent changes in the strike
price, as approved, on July 29, 2020 and July 8, 2022, resulting in the strike price of the tranches still to be vested, at the later
date, having their strike price modified to the IPO price in Brazilian Reais (R$<span id="xdx_902_ecustom--StrikePrice_pid_c20200701__20200729_zyG7ZxYyGXPd" title="Strike price"><span id="xdx_902_ecustom--StrikePrice_pid_c20220701__20220708_zoFbPmC0VAZ" title="Strike price">71.22</span></span>), adjusted from the IPO date until the exercise
date using the Certificado de Dep&#243;sito Interbanc&#225;rio (CDI index), excluding dividends. Such changes were assessed as modifications
by the Company and were accounted in accordance with IFRS 2.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">As result of those modifications, the expense related to the share-based
payment of the Company reflects the cost of the original award at grant date over the vesting period plus the incremental fair values
of the repriced options at modification dates over the vesting period of the stock options.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The average incremental fair value, as result of the modification occurred
on July 8, 2022, was R$<span id="xdx_901_ecustom--AverageIncrementalFairValue_pid_c20230101__20231231_zHt4fVP51zO1" title="Average incremental fair value">3.84</span> Brazilian Reais per option. The table below lists the inputs to the valuation model used to determine the
incremental fair value of the stock options as result of the modification:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_z3DhwKnLSwik" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span id="xdx_8B4_zIvYQZf8uCva" style="display: none">Schedule of model used to determine the fair value of the stock options</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Modified plan</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Original plan</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_900_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zWfQ7kJCZOq4" title="Strike price at the measurement date">83</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z3r4lWano4O7" title="Strike price at the measurement date">91</span> - R$<span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zAH4XplbAaUb" title="Strike price at the measurement date">140</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zUsG4r93xNva" title="Dividend yield">0.0</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zuOh5KUvGx59" title="Dividend yield">0.0</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_907_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zWjxJMy2IuV5" title="Expected volatility">48</span>% - <span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zlXH4siWVndd" title="Expected volatility">59</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zcBR9APRGgy7" title="Expected volatility">48</span>% - <span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zrjadRuXnnVh" title="Expected volatility">59</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zTFwDO4nXAq9" title="Risk-free interest rate">13</span>% - <span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zsdoDHHhSQLk" title="Risk-free interest rate">15</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z8Nn5M5wUes1" title="Risk-free interest rate">13</span>% - <span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z1zWoDL4DXTh" title="Risk-free interest rate">15</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zk2G9NZm5Vtk" title="Expected life of stock options">1</span> - <span id="xdx_905_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zEZ5SsV37D82" title="Expected life of stock options">4</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zouL0Up0DR1b" title="Expected life of stock options">1</span> - <span id="xdx_901_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zmuhF1ZxeeVj" title="Expected life of stock options">4</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90D_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zE6LFCFQ2Rw8" title="Share price at the measurement date">48</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zq2Tsqgjg3F4" title="Share price at the measurement date">48</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Valuation model</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zdRMlGQk6ZPh" title="Model used">Binomial</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zIBsj6YJ7XSi" title="Model used">Binomial</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_902_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zhM8zKh65ZZb" title="Weighted average fair value at the measurement date">53.06</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zXwRwA9w7zki" title="Weighted average fair value at the measurement date">49.22</span></span></td></tr>
  </table>
<p id="xdx_8AD_zC0bIJyQTvzf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On July 31, 2023, the People and ESG Committee approved a further change
in the share-based compensation plan to retain talents and reinforce the compensation plan. All the holders of stock options granted before
July 11, 2022, with strike price based on the IPO price in Brazilian Reais or above, were offered the possibility to exchange the stock
options for a number of Restricted Stock Units (RSUs) with conversion ratios based on fair value of the original plan, at modification
date, so that the total fair value of the modified award remains the same as the original plan, resulting in a weighted average conversion
ratio of 0.12 RSUs per stock option. As result, the exchange from stock options to RSUs was deemed as a replacement award and thus assessed
as a modification by the Company and accounted in accordance with IFRS 2, since the beneficiaries will have a 'value for value&#8217;
benefit of settling its award for no cash consideration.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The key inputs to the valuation model used to determine the total fair value
of the stock options for conversion to RSUs are as follows:</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_hifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zhLIGEa0rpP3" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 1)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span id="xdx_8BA_z5mSy3N2tTS3" style="display: none">Schedule of model used to determine the fair value of the stock options</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 71%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Modified plan</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90A_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zWPeKZFIDhb8" title="Strike price at the measurement date">95</span> - R$<span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBTa2NxzE0j2" title="Strike price at the measurement date">160</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zMdWZ0PcHFH8" title="Dividend yield">0.0</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zSLeWRkJ4E96" title="Expected volatility">45</span>% - <span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zEhGVs7g9Bn9" title="Expected volatility">48</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z7xF29NAJTU5" title="Risk-free interest rate">10</span>% - <span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zkn5cnlFJlwg" title="Risk-free interest rate">12</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zieLowKDGYmg" title="Expected life of stock options">1</span> - <span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zZVQFRInH7Tc" title="Expected life of stock options">5</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z2A86MvYyVSj" title="Share price at the measurement date">75</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Valuation model</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zOBhyh8aoE2e" title="Model used">Binomial</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average conversion rate (RSUs/Stock options)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z2XpObBbdqna" title="Weighted average fair value at the measurement date">0.12</span></span></td></tr>
  </table>
<p id="xdx_8AF_zY1LSx8SakB9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">Moreover, the People and ESG Committee also approved, on July 31,
2023, a modification in the index rate to the strike prices of its granted stock options. The result is that strike prices are now adjusted
by the Brazilian inflation rate (IPCA) instead of the CDI rate. These changes were accounted as modifications in accordance with IFRS
2. The average incremental fair value, as result of the modification occurred on such date, was R$2.10 Brazilian Reais per stock option.
The table below lists the inputs to the valuation model used to determine the incremental fair value of the stock options as result of
the modification:</p>
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"></p>






<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions_pn3n3_z4UiQERxB4J9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 2)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span id="xdx_8BA_zhccjbnvCi5d" style="display: none">Schedule of model used to determine incremental  fair
    value of the stock options</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Modified plan</b></span></td>
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Original plan</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price index</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IPCA</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">CDI</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_z2El9m7f9SL2" title="Strike price at the measurement date">59</span> - <span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zGASxYwoQ787" title="Strike price at the measurement date">104</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zgtuU9sx9Kl8" title="Strike price at the measurement date">59</span> - <span id="xdx_902_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zW3rkReTWqZe" title="Strike price at the measurement date">104</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zOvIgzedMDbd" title="Dividend yield">0.0</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zeE3cOTGw10a" title="Dividend yield">0.0</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zuBMdNKzQm22" title="Expected volatility">45</span>% - <span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_z3DAcRpFac0e" title="Expected volatility">54</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zdzLDkpixhT2" title="Expected volatility">45</span>% - <span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zbgMv89A3FK4" title="Expected volatility">54</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zZIS1Sllneeg" title="Risk-free interest rate">10</span>% - <span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zwx37XikBnI1" title="Risk-free interest rate">12</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zr2bWwddO581" title="Risk-free interest rate">10</span>% - <span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zd19mY7PKgma" title="Risk-free interest rate">12</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">0 - <span id="xdx_904_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zfRypSrhfeS5" title="Expected life of stock options">5</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">0 - <span id="xdx_90C_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zmJPSCo43017" title="Expected life of stock options">5</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zLmNlPfUZTRl" title="Share price at the measurement date">75</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_903_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zKZajR5DadLk" title="Share price at the measurement date">75</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Valuation model</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_znoVYBLM5xC4" title="Model used">Binomial</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zo834EhhMccg" title="Model used">Binomial</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zzuwfH439Zmf" title="Weighted average fair value at the measurement date">28.10</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zoJYkVFxtvj5" title="Weighted average fair value at the measurement date">26.00</span></span></td></tr>
  </table>
<p id="xdx_8A1_zi6FQMLADhGc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On February 13, 2023, April 17, 2023, August 1, 2023, October 1, 2023 and
December 1, 2023 the Company granted <span id="xdx_909_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20230212__20230213__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zwk3KsPLh7d1" title="Number of stock option granted">15,000</span>, <span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20230416__20230417__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zbHAVDMpu31k" title="Number of stock option granted">30,000</span>, <span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20230730__20230801__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zeCHYaxBMSgc" title="Number of stock option granted">153,000</span>, <span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20230930__20231001__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zJ8xlD5mKkvb" title="Number of stock option granted">37,000</span> and <span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20231129__20231201__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zAQddLSdfYnd" title="Number of stock option granted">232,000</span>, respectively, additional stock options:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfAdditionalStockOptionsExplanatory_zmBpLXFOmjr6" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 3)">
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span id="xdx_8BB_zQI6LsFh3s81" style="display: none">Schedule of additional stock
    options</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>February</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>April</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>August</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>October</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>December</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90E_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zI2m5yXju4wc" title="Strike price at the measurement date">56</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zqAwQb03Hrke" title="Strike price at the measurement date">57</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zF76UYqapkn8" title="Strike price at the measurement date">59</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_900_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zUagWImKfRN9" title="Strike price at the measurement date">59</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zVYLYb5D7G52" title="Strike price at the measurement date">60</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z04rFiBw2J8f" title="Dividend yield">0.0</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z55pl3l2FVE2" title="Dividend yield">0.0</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_903_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zOdnqiZFeUa2" title="Dividend yield">0.0</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zhWYF66lggNc" title="Dividend yield">0.0</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zKh0Ngq5PZP9" title="Dividend yield">0.0</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zMSmQ4Ih25dl" title="Expected volatility">46</span>% - <span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zXpdMIq8WQk8" title="Expected volatility">56</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEoAq7hSxmIa" title="Expected volatility">48</span>% - <span id="xdx_906_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zt4vzQUSOsG9" title="Expected volatility">55</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zcggEqL8SdS1" title="Expected volatility">47</span>% - <span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zueJbo5qPCKh" title="Expected volatility">56</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zzJSvMekUEo2" title="Expected volatility">44</span>% - <span id="xdx_90C_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zSKOFhusMje" title="Expected volatility">56</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z9tUL74e6hyb" title="Expected volatility">34</span>% - <span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_znKqUGV6FTvj" title="Expected volatility">56</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zzU2gnFznmKi" title="Risk-free interest rate">13</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0rsPOleYlb9" title="Risk-free interest rate">11</span>% - <span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zZ6GDBaK4WVj" title="Risk-free interest rate">13</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zPdY2n4TWJm5" title="Risk-free interest rate">10</span>% - <span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zXnNe5r1zhWe" title="Risk-free interest rate">12</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zf6lAnJ8vAxa" title="Risk-free interest rate">11</span>% - <span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zCUrA8wWBcY9" title="Risk-free interest rate">12</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zwJfvFgpns6d" title="Risk-free interest rate">10</span>% - <span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zudkK9AKu8Y3" title="Risk-free interest rate">11</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_907_ecustom--ExpectedLifeOfStockOptions_dtY_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zIH3opcItc9" title="Expected life of stock options">1</span> - <span id="xdx_902_ecustom--ExpectedLifeOfStockOptions_dtY_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zJLwkIeZm43" title="Expected life of stock options">5</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_ecustom--ExpectedLifeOfStockOptions_dtY_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zz0380XqIJ4a" title="Expected life of stock options">1</span> - <span id="xdx_902_ecustom--ExpectedLifeOfStockOptions_dtY_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z18q86bm81ng" title="Expected life of stock options">5</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_ecustom--ExpectedLifeOfStockOptions_dtY_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zHPbANDExjOf" title="Expected life of stock options">1</span> - <span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zj5WY5cQGlzi" title="Expected life of stock options">5</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_907_ecustom--ExpectedLifeOfStockOptions_dtY_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zKnS23omez9g" title="Expected life of stock options">1</span> - <span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zMVpTQMsb6J8" title="Expected life of stock options">5</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zXePdAhlCI5" title="Expected life of stock options">1</span> - <span id="xdx_90A_ecustom--ExpectedLifeOfStockOptions_dtY_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEW7JPY4XvLh" title="Expected life of stock options">5</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_907_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zQLko8vfA155" title="Share price at the measurement date">70.69</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90F_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_ztxGlOcwWQsd" title="Share price at the measurement date">62.51</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90E_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zRgfyPUMecrg" title="Share price at the measurement date">76.45</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zLmZDYCaTePi" title="Share price at the measurement date">79.12</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_909_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zdhuK5StwODi" title="Share price at the measurement date">100.97</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Valuation model</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z9NaZQH24Yl3" title="Model used">Binomial</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zfh2wf93wE5e" title="Model used">Binomial</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zYdHs8qHNpv9" title="Model used">Binomial</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z0lRaXRCmcT7" title="Model used">Binomial</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zapjHNvYimal" title="Model used">Binomial</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90B_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z8ySNMeVPjg3" title="Weighted average fair value at the measurement date">29.54</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zHByWqOzRNP" title="Weighted average fair value at the measurement date">32.04</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zK6XFMlKrTHb" title="Weighted average fair value at the measurement date">37.04</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_900_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zwf3EIImkkjl" title="Weighted average fair value at the measurement date">38.67</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_908_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zkTKEzdVV6V7" title="Weighted average fair value at the measurement date">54.25</span></span></td></tr>
  </table>
<p id="xdx_8A1_zATLrZGTKqMa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below illustrates the number and movements
in stock options for the years ended December 31, 2023, 2022 and 2021:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfSharebasedCompensationPlanExplanatory_pn3n3_zCdRaKCRhkqc" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 4)">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8BF_zUvAvdriz7vi" style="display: none">Schedule of share-based compensation plan</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td colspan="3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>Weighted average strike price</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>(in Brazilian Reais)</b></p></td>
    <td colspan="3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>Number of stock options</b></p></td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="border-top: Black 1pt solid; width: 40%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Outstanding at January 1</span></td>
    <td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zYUJ3ITX4Gtc" style="width: 18%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">79.47</span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKFFpHaJiCm9" style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,729,287</span></td>
    <td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z1iQtKHjDEKi" style="white-space: nowrap; width: 14%; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,086,728</span></td>
    <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z81sVx0CqOIa" style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,510,983</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Granted</span></td>
    <td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zu5nUAFKx6Uj" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Granted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">60.83</span></td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z2URd955qre7" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">467,000</span></td>
    <td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zPP6bNbwVI39" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,234,919</span></td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zqM5i7m1Jse8" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,170,000</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Exercised</span></td>
    <td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zBh72c7DyEE1" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">59.67</span></td>
    <td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zBZ0H1MWhg6a" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(164,214)</span></td>
    <td id="xdx_986_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zob9axieXdni" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4746">-</span></span></td>
    <td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zfdjfqnv4EMh" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(442,669)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Stock options exchanged to RSUs</span></td>
    <td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKYMMLtl20F6" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Stock options exchanged"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4750">-</span></span></td>
    <td id="xdx_98C_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z776cNP8Myfj" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,751,599)</span></td>
    <td id="xdx_982_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zIRw7ywFjna2" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4754">-</span></span></td>
    <td id="xdx_985_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKRjgHtN0oM6" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4756">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Forfeited</span></td>
    <td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z5cH8H3KI0wf" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">110.95</span></td>
    <td id="xdx_98C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zMMHPPyJOMof" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(333,111)</span></td>
    <td id="xdx_98D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zusifHyb97b6" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(365,749)</span></td>
    <td id="xdx_98C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zlY5Vp34ZyCj" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(60,000)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expired</span></td>
    <td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3lvNhkaYni" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Expired"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">94.17</span></td>
    <td id="xdx_98E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHJf011QlSra" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(251,299)</span></td>
    <td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmtG1BROVopg" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Expired"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(226,611)</span></td>
    <td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zZhb1XM6sLSg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(91,586)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31</b></span></td>
    <td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zVZOpG0sn9N9" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>64.33</b></span></td>
    <td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zxl2aIAuewL3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,696,064</b></span></td>
    <td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zI6s6YVB2tQf" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,729,287</b></span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zLHmal4NBHD3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,086,728</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Exercisable</b></span></td>
    <td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z8pqSfZnW3Ul" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Exercisable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>86.23</b></span></td>
    <td id="xdx_98A_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z99Nlqh8pCk2" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>242,235</b></span></td>
    <td id="xdx_980_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zT5QMo9sX9a6" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,133,774</b></span></td>
    <td id="xdx_98D_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z54x29IexhT1" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>542,061</b></span></td></tr>
  </table>
<p id="xdx_8A0_zEkDfwM96Ltd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The share-based compensation expense recognized
in selling, general and administrative expenses in the statement of income for the year ended December 31, 2023 was R$<span id="xdx_903_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zTPfzF8mBysa" title="Share-based compensation expense">20,850</span> (R$<span id="xdx_903_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zsiKuCfZAUBh" title="Share-based compensation expense">27,242</span>
and R$<span id="xdx_90A_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zmp61F7AO3Cd" title="Share-based compensation expense">43,377</span> in 2022 and 2021, respectively).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b.2) Restricted Stock Units (RSU) Program</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">On July 8, 2022, the Company approved the new Restricted
Stock Units (RSU) program for employees. The participant's right to effectively receive ownership of the restricted shares will be conditioned
on the participant's continuance as an employee or director in the business group from the grant date until vesting.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The executives will be entitled to these shares
in a proportion of <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zaTBGtbnU0hk" title="Proportion percentage">10</span>%, <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits1Member_zQSSqBNnx72g" title="Proportion percentage">20</span>%, <span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits2Member_z4zU3ehqId59" title="Proportion percentage">30</span>%, <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits3Member_zFdm4VF76ggk" title="Proportion percentage">40</span>% each year.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">In July 2022 and September 2022, <span id="xdx_903_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20220701__20220731_zP0s67hBCEFg" title="Granted">442,546</span> and <span id="xdx_907_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20220901__20220930_z0SF2xRFKkgd" title="Granted">4,678</span>
RSUs were granted, respectively, to Afya&#8217;s executives, with vesting periods from May 2023 to May 2026. Fair values at grant date
were R$<span id="xdx_908_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20220701__20220731_zbBpWgy9n692" title="Fair values at grant date">48.24</span> and R$<span id="xdx_904_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20220901__20220930_zkSjtGj2N7z1" title="Fair values at grant date">72.59</span>, respectively. On February 2, April 17, August 1, October 1 and December 1, 2023, <span id="xdx_90C_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20230129__20230202_zIIJjqZNHFR7" title="Granted">8,000</span>, <span id="xdx_90A_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20230416__20230417_zUaT08e1peC" title="Granted">16,000</span>, <span id="xdx_903_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20230730__20230801_zCbG0wSyovcd" title="Granted">153,490</span>, <span id="xdx_90C_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20230930__20231001_zn3KGsYDqKB7" title="Granted">63,000</span>
and <span id="xdx_90A_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20231129__20231201_zyMbike8uY0h" title="Granted">76,600</span> RSUs were granted to Afya&#8217;s executives, respectively, with vesting periods from May 2024 to May 2027. Fair value at grant
date was R$<span id="xdx_90F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230129__20230202_zQt0rZ1DaeT" title="Fair values at grant date">70.69</span>, R$<span id="xdx_903_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230416__20230417_zqHacIFVkLMd" title="Fair values at grant date">62.51</span>, R$<span id="xdx_905_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230730__20230801_zJciokgHtPj8" title="Fair values at grant date">76.45</span>, R$<span id="xdx_904_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230930__20231001_zWXVoU1BSkSk" title="Fair values at grant date">79.12</span> and R$<span id="xdx_90A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20231129__20231201_z8jnt5T7S355" title="Fair values at grant date">100.97</span>, respectively.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">As described above, on July 31, 2023, the holders
of stock options granted before July 11, 2022 were offered the possibility to exchange the stock options for a number of Restricted Stock
Units (RSUs).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below illustrates the number and movements
in RSUs for the years ended December 31, 2023 and 2022:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfStockOptionExplanatory_pn3n3_zQUnx2ZSX7zd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 5)">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8B7_zjd0OcZzxoZa" style="display: none">Schedule of stock option</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Outstanding at January 1</span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zkHv5O8K8dfl" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,224</span></td>
    <td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zBnbf1RfTczd" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4836">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Granted</span></td>
    <td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zyvE4WkwR7e3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">317,090</span></td>
    <td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zn3u7iko1Pae" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,224</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Stock options exchanged to RSUs</span></td>
    <td id="xdx_988_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z4aqmEnnuOm4" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">215,797</span></td>
    <td id="xdx_981_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zgky3WtW64Eb" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4844">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Exercised</span></td>
    <td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zxFBoDpvVtAd" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(99,576)</span></td>
    <td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z0sMyiI5LCJi" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4848">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Forfeited</span></td>
    <td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zbRUJFWkGI72" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(26,104)</span></td>
    <td id="xdx_988_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zYjd6BBvYxBg" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4852">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31</b></span></td>
    <td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zJWV5I3j3oZ7" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>854,431</b></span></td>
    <td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zOBt3BH1QZxk" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>447,224</b></span></td></tr>
  </table>
<p id="xdx_8A6_z5uEUPnk23Ri" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company accounts for the RSU plan as an equity-settled plan, except
for the portion of labor and social securities obligations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Total RSU expense recognized in selling, general and administrative expenses
in the statement of income for the year ended December 31, 2023 amount R$<span id="xdx_900_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zzktHujnkHb8" title="Share-based compensation expense">10,685</span> (December 31, 2022: R$<span id="xdx_90C_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zfY9QHQc5f0k" title="Share-based compensation expense">4,032</span>). Labor and social obligations
amount R$<span id="xdx_905_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20231231_zHzP4bgJGO7a" title="social obligations liabilities">7,171</span> as of December 31, 2023 (December 31, 2022: R$<span id="xdx_90A_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20221231_zaHBtmBssjGk" title="social obligations liabilities">2,167</span>).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureLaborAndSocialObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureLaborAndSocialObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LaborAndSocialObligationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LaborAndSocialObligationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639633870704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureEquityAbstract', window );"><strong>Disclosure Equity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfEquityExplanatory', window );">Equity</a></td>
<td class="text"><p id="xdx_80E_ecustom--DisclosureOfEquityExplanatory_zUs68iYmlM9h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>17</b></td><td><b><span id="xdx_829_zYIWHLrTQ4s1">Equity</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>a) Share capital</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">As of December 31, 2023 and 2022, the Company&#8217;s
share capital was R$<span id="xdx_900_eifrs-full--IssuedCapital_iI_pn3n3_c20231231_z3U78Qe3SOxi" title="Share capital"><span id="xdx_90B_eifrs-full--IssuedCapital_c20221231_pn3n3" title="Share capital">17</span> </span>represented by <span id="xdx_900_ecustom--NumberOfSharesIssued1_iI_pid_c20231231_zKV5sBJb9CV4" title="Total number of shares"><span id="xdx_90B_ecustom--NumberOfSharesIssued1_iI_pid_c20221231_zyT2swYCvkJ7" title="Total number of shares">93,722,831</span></span> shares comprised by <span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zK25BtmdMgi" title="Total number of shares"><span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zHVnzKNLP7Sb" title="Total number of shares">47,920,068</span></span> class A common shares and <span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zfVdiuLkcjt1" title="Total number of shares"><span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zx3yWa6vpTx" title="Total number of shares">45,802,763</span></span> class B common shares.
As of December 31, 2023 and 2022, the Company&#8217;s authorized capital was US$<span id="xdx_90E_ecustom--IssuedCapitals_iI_pn3n3_c20231231_zMGknDOh2RDk" title="Authorized capital"><span id="xdx_908_ecustom--IssuedCapitals_iI_pn3n3_c20221231_zgIEldpDLn36" title="Authorized capital">50</span></span> thousand.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b) Dividends</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">In the year ended December 31, 2023, CCSI and IESVAP
approved the payment of dividends of R$<span id="xdx_90F_ecustom--PaymentOfDividends_pn3n3_c20230101__20231231_zIelqDRK6FZi" title="Payment of dividends">65,539</span>, which R$<span id="xdx_902_ecustom--DividendDistributed_pn3n3_c20230101__20231231_zSfYzNROHDmj" title="Dividend distributed">46,788</span> was distributed to Afya and R$<span id="xdx_90D_eifrs-full--DividendsPaidToNoncontrollingInterests_pn3n3_c20230101__20231231_zMK6ph4Gzcg3" title="Dividends paid to non-controlling interests">18,750</span> to non-controlling shareholders (December
31, 2022: R$<span id="xdx_903_ecustom--PaymentOfDividends_pn3n3_c20220101__20221231_zNjTzy7YWTV7" title="Payment of dividends">66,828</span>, which R$<span id="xdx_906_ecustom--DividendDistributed_pn3n3_c20220101__20221231_z7klf6bBQAB4" title="Dividend distributed">47,092</span> was distributed to Afya and R$<span id="xdx_909_eifrs-full--DividendsPaidToNoncontrollingInterests_pn3n3_c20220101__20221231_zWZxAh1TdLoe" title="Dividends paid to non-controlling interests">19,736</span> to non-controlling shareholders and December 31, 2021: R$<span id="xdx_903_ecustom--PaymentOfDividends_pn3n3_c20210101__20211231_zfAfWUK98FYl" title="Payment of dividends">65,521</span>,
which R$<span id="xdx_902_ecustom--DividendDistributed_pn3n3_c20210101__20211231_zSWbOU2yYtxc" title="Dividend distributed">46,873</span> was distributed to Afya and R$<span id="xdx_90E_eifrs-full--DividendsPaidToNoncontrollingInterests_pn3n3_c20210101__20211231_zGnw9nmOQdGf" title="Dividends paid to non-controlling interests">18,648</span> to non-controlling shareholders).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>c) Share repurchase program</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On October 27, 2021, the Company&#8217;s board of directors approved a
new share repurchase program. Afya may repurchase up to <span id="xdx_906_ecustom--RepurchaseOfOrdinaryShares_c20211027__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_pdd" title="Repurchase of ordinary shares">1,383,108</span> of its outstanding Class A common shares in the open market, based
on prevailing market prices, beginning on October 28, 2021, until the earlier of the completion of the repurchase or December 31, 2022,
depending upon market conditions. The Company completed the acquisition of the approved shares repurchase under this buy-back program.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>







<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On January 27, 2022, the Company&#8217;s board of directors approved a new
share repurchase program. Afya may repurchase up to <span id="xdx_902_ecustom--RepurchaseOfOrdinaryShares_iI_c20220127__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zusIXkhOnwl9" title="Repurchase of ordinary shares">1,874,457</span> of its outstanding Class A common shares in the open market, based on prevailing
market prices, beginning on January 27, 2022, until the earlier of the completion of the repurchase or December 31, 2022, depending upon
market conditions. The Company completed the acquisition of the approved shares repurchase under this buy-back program.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On March 24, 2023, the Company&#8217;s board of directors approved the fourth
share repurchase program. Afya may repurchase up to <span id="xdx_900_ecustom--RepurchaseOfOrdinaryShares_iI_c20230324__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zdtV3YxqxRl" title="Repurchase of ordinary shares">2,000,000</span> of its outstanding Class A common shares in the open market, based on prevailing
market prices, beginning on March 24, 2023, until the earlier of the completion of the repurchase or December 31, 2024, depending upon
market conditions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">During the year ended December 31, 2023, the Company&#8217;s cash outflow
was R$<span id="xdx_903_ecustom--CashOutflow_pn3n3_c20230101__20231231_zL44vnn2TwX8" title="Cash outflow">12,369</span> (December 31, 2022: R$<span id="xdx_90A_ecustom--CashOutflow_pn3n3_c20220101__20221231_zyzBQh0e8Y8d" title="Cash outflow">152,317</span> and December 31, 2021: R$<span id="xdx_90C_ecustom--CashOutflow_pn3n3_c20210101__20211231_zGiGKAVVk1si" title="Cash outflow">213,722</span>).</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below illustrates the number and movements
in treasury shares during the years ended December 31, 2023, 2022 and 2021:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--ScheduleOfTreasurySharesMovementExplanatory_zvIQsmqLNYQb" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Equity (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: left; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8B5_z1twcLhelyU4" style="display: none">Schedule illustrates the number and
    movements in treasury shares</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 58%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 19%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Number of treasury shares</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><b>Average price</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><b>(in Brazilian Reais)</b></p></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Outstanding at January 1, 2021</span></td>
    <td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iS_pid_c20210101__20211231_z4RHt0jx9BO8" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4922">-</span></span></td>
    <td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20210101__20211231_zk7ah6CmKiPh" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4924">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Repurchased</span></td>
    <td id="xdx_985_ecustom--NumberOfSharesRepurchased_pid_c20210101__20211231_zDKZeSbvIu7b" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,142,051</span></td>
    <td id="xdx_98E_ecustom--AveragePriceRepurchased_pid_c20210101__20211231_zvkKxHfuJpEb" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">119.99</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred from exercise of stock options</span></td>
    <td id="xdx_98B_ecustom--TransferredFromExerciseOfStockOptions_pid_c20210101__20211231_z2R8UthoK2Ef" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Transferred from exercise of stock options"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(442,669)</span></td>
    <td id="xdx_985_ecustom--AveragePriceTransferredFromExerciseOfStockOptions_pid_c20210101__20211231_z4Jj6TDZ2CZf" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price transferred from exercise of stock options"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">124.26</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred from shares contribution</span></td>
    <td id="xdx_98B_ecustom--TransferredFromSharesContribution_pid_c20210101__20211231_zkJMM1kVKYtg" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Transferred from shares contribution"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(44,455)</span></td>
    <td id="xdx_989_ecustom--AveragePriceTransferredFromSharesContribution_pid_c20210101__20211231_zAFOAIVGSfJk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price transferred from shares contribution"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">111.94</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31, 2021</b></span></td>
    <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20210101__20211231_z4040Jq3feud" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,654,927</b></span></td>
    <td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20220101__20221231_zvNZYSC5Hm97" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>92.23</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Repurchased</span></td>
    <td id="xdx_98D_ecustom--NumberOfSharesRepurchased_pid_c20220101__20221231_zDwhGvaAOFgf" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,131,358</span></td>
    <td id="xdx_98D_ecustom--AveragePriceRepurchased_pid_c20220101__20221231_zIPESYXXKEHk" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71.46</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31, 2022</b></span></td>
    <td id="xdx_984_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20220101__20221231_zYa0l4tCDBp1" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at ending balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,786,285</b></span></td>
    <td id="xdx_981_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231_z1XsVHTiQ6h4" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>80.54</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Repurchased</span></td>
    <td id="xdx_98A_ecustom--NumberOfSharesRepurchased_pid_c20230101__20231231_zI4y64Htsdgg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">216,339</span></td>
    <td id="xdx_982_ecustom--AveragePriceRepurchased_pid_c20230101__20231231_z1weBiUo8r8d" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57.17</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Delivered under the share-based compensation plan</span></td>
    <td id="xdx_98A_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_iP3custom--AveragePriceRepurchased_pid_c20230101__20231231_zx7lFam1NYQ8" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(229,146)</span></td>
    <td id="xdx_982_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_iP3custom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pid_c20230101__20231231_zSVHvaAjjgN" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">79.28</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31, 2023</b></span></td>
    <td id="xdx_985_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20230101__20231231_zfcB7fnh7kIc" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at ending balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,773,478</b></span></td>
    <td id="xdx_986_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231_zJMM77CMs9Ti" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at ending balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>79.28</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfEquityExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfEquityExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639608789472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (EPS)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Earnings per share (EPS)</a></td>
<td class="text"><p id="xdx_806_eifrs-full--DisclosureOfEarningsPerShareExplanatory_z11RJZojxrId" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>18</b></td><td><b><span id="xdx_82D_z8uVul6IeIn5">Earnings per share (EPS)</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">Basic EPS is calculated by dividing net income
attributable to the equity holders of the Company by the weighted average number of common shares outstanding during the year.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">Diluted EPS is calculated by dividing net income
attributable to the equity holders of the parent by the weighted average number of common shares outstanding during the year plus the
weighted average number of shares that would be issued on conversion of all potential shares with dilutive effects.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Diluted earnings per share are computed including stock options granted
to key management using the treasury shares method when the effect is dilutive. The Company has the stock option and restricted share
unit plans in the category of potentially dilutive shares.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Softbank&#8217;s series A perpetual convertible preferred shares are antidilutive
as of December 31, 2023, 2022 and 2021 and are not included on diluted earnings per share.</p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">The table below reflects the net income and share
data used in the basic and diluted EPS calculations:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfEarningsPerShareTableExplanatory_zh4dEsEpi4ga" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Earnings per share (EPS) (Details)">
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"><span id="xdx_8BD_ztMuxzx63bp4" style="display: none">Schedule of earnings per share</span></td>
    <td id="xdx_494_20230101__20231231_zJeOJSBUDycl" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center">&#160;</td>
    <td id="xdx_491_20220101__20221231_zIvykMcHKZ1h" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center">&#160;</td>
    <td id="xdx_49E_20210101__20211231_zmcGCgKoYDfh" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 58%; padding-right: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr id="xdx_404_ecustom--NumeratorAbstract_iB_zX2qshDNvgyi">
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Numerator</b></span></td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_pn3n3_zdsv90uET2l4" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Net income attributable to equity holders of the parent</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">386,324</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">373,569</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">223,326</span></td></tr>
  <tr id="xdx_404_ecustom--DenominatorAbstract_iB_pn3n3_zIugD1pFkXh7" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Denominator</b></span></td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--WeightedAverageShares_pid_z8fIXOPUpdyh" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 8.6pt; text-align: justify; text-indent: -8.6pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average number of outstanding shares</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">89,830,351</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">90,335,037</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">93,291,480</span></td></tr>
  <tr id="xdx_40C_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pid_zGU1Tq0ty0Ic" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effects of dilution from stock options and restricted share units</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">706,492</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">329,085</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">811,818</span></td></tr>
  <tr id="xdx_40E_eifrs-full--AdjustedWeightedAverageShares_pid_uShares_zrEuz15uV5B1" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify; line-height: 115%; text-indent: -7.1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Weighted average number of outstanding shares adjusted for the effect of dilution</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">90,536,843</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">90,664,122</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">94,103,298</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--BasicEarningsLossPerShare_pid_z17TAETfE2Zc" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Basic earnings per share (R$)</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4.30</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4.14</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2.39</span></td></tr>
  <tr id="xdx_40C_eifrs-full--DilutedEarningsLossPerShare_pid_ziW3dWZ5nqO4" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Diluted earnings per share (R$)</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4.27</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4.12</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2.37</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639665776304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueExplanatory', window );">Revenue</a></td>
<td class="text"><p id="xdx_806_eifrs-full--DisclosureOfRevenueExplanatory_zimIU8wyTOx" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>19</b></td><td><b><span id="xdx_82C_zUsf9qG7uO5f">Revenue</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfNetSalesRevenueExplanatory_pn3n3_znfpDm4BOzIc" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Revenue (Details)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span id="xdx_8B9_z5BUwrB1hwy9" style="display: none">Schedule of net sales revenue</span></td>
    <td id="xdx_49F_20230101__20231231_z1WObxgz0xtc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49E_20220101__20221231_zcrwSmtQvjz7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49B_20210101__20211231_zs61v7tgdhUl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 58%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ProfessionalFeesExpenses_pn3n3_zwk9c80ObZK8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Tuition fees</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">3,505,250</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">2,827,567</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">2,124,589</span></td></tr>
  <tr id="xdx_404_ecustom--OtherRevenue1_pn3n3_zp8xAYUrIeNa" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Other</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">263,937</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">213,040</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">167,441</span></td></tr>
  <tr id="xdx_402_ecustom--DeductionAbstract_iB_zdCBlY7sJgra" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Deductions</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeductionOfGrantedDiscounts_pn3n3_zC9iOk8mpbAj" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;Discount and scholarships</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(240,314)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(241,404)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(229,254)</span></td></tr>
  <tr id="xdx_408_ecustom--DeductionOfEarlyPaymentDiscounts_pn3n3_zmb02L9Q1O94" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;Early payment discounts</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(195,054)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(92,234)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(49,879)</span></td></tr>
  <tr id="xdx_404_ecustom--DeductionOfReturnsOfNetRevenue_pn3n3_zlIFg3qx6xXk" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;Returns</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(27,743)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(45,402)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(42,373)</span></td></tr>
  <tr id="xdx_40C_ecustom--DeductionOfTaxes_pn3n3_zvkgH40LOO89" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;Taxes</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(142,825)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(107,004)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(74,232)</span></td></tr>
  <tr id="xdx_405_ecustom--DeductionOfProuni_pn3n3_zvB87VooQBn" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;PROUNI</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(287,338)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(225,506)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(176,921)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--RevenueFromContractsWithCustomers_pn3n3_zifnEgvdKpp2" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>Revenue from contracts with customers</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2,875,913</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2,329,057</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>1,719,371</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_zQUWx9J7t8ff" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>Timing of revenue recognition of revenue from contracts with customers:</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--FeeAndCommissionIncome_pn3n3_zj1zLfWnUIA3" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Tuition, digital content and app subscription fees - Transferred over time</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">2,821,251</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">2,273,578</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">1,640,889</span></td></tr>
  <tr id="xdx_401_ecustom--NetRevenueOtherTransferredPoint_pn3n3_zjDCMstxDC6e" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Other - Transferred at a point in time</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">54,662</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">55,479</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">78,482</span></td></tr>
  </table>
<p id="xdx_8A9_zJhXqCdkot71" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">The Company&#8217;s revenue from contracts
with customers are all in Brazil. The Company is not subject to the payment of the Social Integration Program tax (Programa de Integra&#231;&#227;o
Social, or PIS) and the Social Contribution on Revenue tax (Contribui&#231;&#227;o para o Financiamento da Seguridade Social, or COFINS)
on the revenue from under graduation degrees under the PROUNI program.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">The table below presents statements of
income for the Company&#8217;s operating segments for the years ended December 31, 2023, 2022 and 2021:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfRevenueBySegmentTableTextBlock_pn3n3_zYeN0mE0ZXFe" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Revenue (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span id="xdx_8BC_zLB23Iq3EQPg" style="display: none">Schedule of revenue by segment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: -0.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zi0ZP7NAhEbe" style="text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,511,018</b></span></td>
    <td id="xdx_98B_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z3TEEuYkhEo4" style="text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>146,827</b></span></td>
    <td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zAzJ1KuKMhUf" style="text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>229,285</b></span></td>
    <td id="xdx_984_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zn2QPvTh437l" style="text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(11,217)</b></span></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231_zKtBvJTdd82g" style="text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,875,913</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_98B_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zISyUUEzkRoc" style="text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,494,121</span></td>
    <td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zuipgDQ2Xuh7" style="text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">146,477</span></td>
    <td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zgqcuZM55Fvc" style="text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5067">-</span></span></td>
    <td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zM8zwEXoyww4" style="text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5069">-</span></span></td>
    <td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231_zB9QgWnGCdNl" style="text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,640,598</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zy90ntUDoZRd" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">16,897</span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7luo5JNsp16" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">350</span></td>
    <td id="xdx_986_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zzNooKxN9xl4" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">229,285</span></td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zrvYooQ9jcLi" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,217)</span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231_zc4LmfnEaQad" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">235,315</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_z693lSPU446" style="text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,511,018</b></span></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj839nXLhoB1" style="text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>146,827</b></span></td>
    <td id="xdx_982_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zkryQ0ogpLc4" style="text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>229,285</b></span></td>
    <td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zNRuFiSGn6vk" style="text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(11,217)</b></span></td>
    <td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231_z6VZkjduxU9k" style="text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,875,913</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zpQcRHDtECl6" style="text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,494,121</span></td>
    <td id="xdx_986_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zb4nPaGgjvHb" style="text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">146,827</span></td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zP3BPBeb1ej7" style="text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">191,520</span></td>
    <td id="xdx_98C_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zMZqSEbuQcy4" style="text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,217)</span></td>
    <td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231_zEC2CgkqhdB8" style="text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,821,251</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in time</span></td>
    <td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zvwDIInIJVu" style="text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">16,897</span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7tg3Vfmfxc9" style="text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5105">-</span></span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0rOvSDeONg7" style="text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">37,765</span></td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_ztHSmt5Fr2lc" style="text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5109">-</span></span></td>
    <td id="xdx_98E_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231_z04tHxkw1m65" style="text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,662</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: -0.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_98B_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQ9uzv3KS3x2" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,037,889</b></span></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7AzcS5SYmsb" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>108,806</b></span></td>
    <td id="xdx_984_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zGfMf0AXWjk" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>189,984</b></span></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zwlcrNDR31k" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(7,622)</b></span></td>
    <td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231_z1oJNuCApja3" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,329,057</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zfiWouZlsJ6d" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,023,128</span></td>
    <td id="xdx_988_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zz4Tkh7VbVQa" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,648</span></td>
    <td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zkm0oXD1pMal" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5129">-</span></span></td>
    <td id="xdx_98B_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zj0KHscAEw7e" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5131">-</span></span></td>
    <td id="xdx_980_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231_zEHSri1DoqWk" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,131,776</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zHqJpB7G0MXd" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,761</span></td>
    <td id="xdx_98F_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z5VjxSw1Mnej" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">158</span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrBSxDtJMa7g" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">189,984</span></td>
    <td id="xdx_982_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zDTJ3NPMQ4L4" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,622)</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231_zR24lXnHcO73" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">197,281</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zBdqUnzNNjtl" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,037,889</b></span></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z1wI19CkMpC1" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>108,806</b></span></td>
    <td id="xdx_98A_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zSncGdjYg1z3" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>189,984</b></span></td>
    <td id="xdx_98E_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zPijWuOF51W4" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(7,622)</b></span></td>
    <td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231_zZ7zF2FahVs4" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,329,057</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqLQFUfnWqD7" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,024,373</span></td>
    <td id="xdx_983_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zfyDXLtSlg5e" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,806</span></td>
    <td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z4roRCgvHBkk" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">145,939</span></td>
    <td id="xdx_989_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zeDCAinVuQO2" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5,540)</span></td>
    <td id="xdx_984_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231_znnnB9B3fWTb" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,273,578</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in time</span></td>
    <td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zKSWsRcjNfi9" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,516</span></td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znBWIkid4crl" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5167">-</span></span></td>
    <td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zC2BilU7YKg2" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">44,045</span></td>
    <td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zJJ1A9BQuwDb" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,082)</span></td>
    <td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231_zfmFpyOK6dXj" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">55,479</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_989_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zZxFCjZ6r5ie" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,498,408</b></span></td>
    <td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zuLSwLLKmn2a" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>72,983</b></span></td>
    <td id="xdx_989_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zBR5ly7nxCE" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>151,958</b></span></td>
    <td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zpogD8yKpbGj" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(3,978)</b></span></td>
    <td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231_zJyTK0ykkOS7" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,719,371</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_987_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zZjXDbIvuRi9" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,486,111</span></td>
    <td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zaDp4rTLcIE8" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,983</span></td>
    <td id="xdx_984_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zv1OXCLX4i5" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5189">-</span></span></td>
    <td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zFmDKQXGjsg5" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5191">-</span></span></td>
    <td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231_z3KM0dsLcufj" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,559,094</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zaWzuaj8hPwe" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,297</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zmWHomzrJQLe" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5197">-</span></span></td>
    <td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjLntB2JdBp2" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">151,958</span></td>
    <td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zlJiGX2JoqDd" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,978)</span></td>
    <td id="xdx_987_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231_zKkpucWMzCL1" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">160,277</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zrWrviu9ORm2" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,498,408</b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zVJQuehlkY3i" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>72,983</b></span></td>
    <td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zGMiHnPqPGRh" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>151,958</b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zmn1hMMQ44tc" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(3,978)</b></span></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231_zIIrnf2aaSWl" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,719,371</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zeb6DMrsKRP1" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,486,111</span></td>
    <td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zmucLbC6xnUl" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,983</span></td>
    <td id="xdx_986_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zmOf4zHFDOt3" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">81,795</span></td>
    <td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z14jonW2j8rc" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5221">-</span></span></td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231_zTeq3L4xEou" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,640,889</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in time</span></td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zTlNEe34zHqf" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,297</span></td>
    <td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zIRJ5K2ZkY44" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5227">-</span></span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z7iVqnvXaiz4" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,163</span></td>
    <td id="xdx_983_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_za2aC8xbX7m" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,978)</span></td>
    <td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231_ztARH3Qyy1T5" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">78,482</span></td></tr>
  </table>
<p id="xdx_8A5_zyEqTRdfdRWl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639686996672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Expenses and costs by nature<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfExpensesByNatureExplanatory', window );">Expenses and costs by nature</a></td>
<td class="text"><p id="xdx_804_eifrs-full--DisclosureOfExpensesByNatureExplanatory_zoroR9a7ZPqa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>20</b></td><td><b><span id="xdx_824_zaRDdm9ppif2">Expenses and costs by nature</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--SummaryOfExpensesByNatureTableTextBlock_pn3n3_zfdljIcQLPa5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Expenses and costs by nature (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BE_zl35bW6LMvNe" style="display: none">Schedule of expenses by nature</span></td>
    <td id="xdx_491_20230101__20231231_zLMbmlAE426i" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49B_20220101__20221231_zWeF1SzHqZLc" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49F_20210101__20211231_zHcU4TYvXS4f" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td></tr>
<tr>
    <td style="width: 46%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2021</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--CostOfSales_iN_pn3n3_di_z9lzEJIic082" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Cost of services</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(1,109,813)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(859,552)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(652,300)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--GeneralAndAdministrativeExpense_iN_pn3n3_di_zwHCywEaduul" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Selling, general and administrative expenses</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(1,014,684)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(798,153)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(622,615)</span></td></tr>
  <tr id="xdx_402_eifrs-full--ExpenseByNature_iN_pn3n3_di_zZgzKIs284T8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b style="display: none">Total</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(2,124,497)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(1,657,705)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(1,274,915)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--Payroll_pn3n3_zxs1ZZSg5kS" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payroll</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(1,085,144)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(880,664)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(677,564)</span></td></tr>
  <tr id="xdx_40F_ecustom--HospitalAndMedicalAgreements_pn3n3_zlphn7Uriw63" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Hospital and medical agreements</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(86,151)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(66,065)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(37,449)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--DepreciationExpense_iN_pn3n3_di_zyIEmwhLbal" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation and amortization</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(289,511)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(206,220)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(154,220)</span></td></tr>
  <tr id="xdx_400_ecustom--LeaseExpenses_pn3n3_zVrgo5WrYMe3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease expenses</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(10,871)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(12,153)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(11,229)</span></td></tr>
  <tr id="xdx_407_eifrs-full--UtilitiesExpense_pn3n3_zDPxw4HSsQD8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Utilities</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(20,403)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(17,682)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(10,643)</span></td></tr>
  <tr id="xdx_402_eifrs-full--RepairsAndMaintenanceExpense_iN_pn3n3_di_z8HqLPNNcpic" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Maintenance</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(105,919)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(76,475)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(47,141)</span></td></tr>
  <tr id="xdx_40C_ecustom--SharesBasedCompensation_pn3n3_zF0LsEahKDA3" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share-based compensation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(31,535)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(31,274)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(43,377)</span></td></tr>
  <tr id="xdx_409_ecustom--TaxExpenses_pn3n3_zYSaAQpnfqB8" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tax expenses</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(14,447)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(10,518)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(7,997)</span></td></tr>
  <tr id="xdx_40D_eifrs-full--ServicesExpense_iN_pn3n3_di_zpVtYAfw4CBf" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Pedagogical services</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(64,081)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(48,084)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(47,881)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--SalesAndMarketingExpense_iN_pn3n3_di_zzIlxPHPw6v3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Sales and marketing</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(74,140)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(48,217)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(39,506)</span></td></tr>
  <tr id="xdx_40C_ecustom--AllowanceForExpectedCreditLosses_pn3n3_z5XH2J91guek" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Allowance for expected credit losses</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(74,552)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(42,708)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(47,819)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--TravelExpense_iN_pn3n3_di_zV4ukGYKc7B5" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Travel expenses</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(16,098)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(14,003)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(7,542)</span></td></tr>
  <tr id="xdx_40D_ecustom--ConsultingFees_pn3n3_zoyNP63WDNx7" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Consulting fees</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(62,630)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(35,326)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(38,818)</span></td></tr>
  <tr id="xdx_40E_ecustom--Other_pn3n3_zZaZ1uhnusJj" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(189,015)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(168,316)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(103,729)</span></td></tr>
  <tr id="xdx_40C_ecustom--ExpenseByNatureOne_pn3n3_zBmYGmeYmzgl" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b style="display: none">Total</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(2,124,497)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(1,657,705)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(1,274,915)</b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfExpensesByNatureExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of expenses by nature. [Refer: Expenses, by nature]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfExpensesByNatureExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639668558272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance result<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">Finance result</a></td>
<td class="text"><p id="xdx_808_eifrs-full--DisclosureOfFinanceIncomeExpenseExplanatory_zdhfhvX96DFe" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>21</b></td><td><b><span id="xdx_822_zTixJmUYcWqc">Finance result</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--ScheduleOfFinanceResultTableTextBlock_zFCcfPpIzMbf" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Finance result (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zysruc05zkJ2" style="display: none">Schedule of finance result</span></td>
    <td id="xdx_493_20230101__20231231_zB1aXru0IUpa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_499_20220101__20221231_zOpB2wKCv3nl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49C_20210101__20211231_zXwR7e35HFp" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--InvestmentIncome_pn3n3_z8DyQCHSraPi" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income from financial investments</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">73,672</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">67,810</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,773</span></td></tr>
  <tr id="xdx_40E_eifrs-full--RevenueFromInterest_pn3n3_zr6uiRUlIq0h" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest received</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">33,450</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,197</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,040</span></td></tr>
  <tr id="xdx_400_eifrs-full--OtherFinanceIncome_pn3n3_zZCv6TxcaGa8" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,520</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,035</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,753</span></td></tr>
  <tr id="xdx_40D_eifrs-full--FinanceIncome_pn3n3_zaLIzb89Yo15" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance income</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>110,642</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>102,042</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>64,566</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_408_ecustom--InterestExpense1_pn3n3_z4uac0wnG8d4" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(285,447)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(200,081)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(108,437)</span></td></tr>
  <tr id="xdx_40B_ecustom--InterestExpenseOnLeaseLiabilities1_pn3n3_zL7kY0iBWH3g" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense on lease liabilities</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(100,849)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(88,571)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(67,212)</span></td></tr>
  <tr id="xdx_40F_ecustom--FinancialDiscountsGrantedExpenses_pn3n3_zbFKVp3xCoe" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Financial discounts granted</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(30,891)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(24,092)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(23,193)</span></td></tr>
  <tr id="xdx_400_eifrs-full--BankAndSimilarCharges_iN_pn3n3_di_zx7WykHrEgmi" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bank fees</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,163)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(8,623)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,878)</span></td></tr>
  <tr id="xdx_405_eifrs-full--NetForeignExchangeLoss_iN_pn3n3_di_zXz9mKYFxafi" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Foreign exchange loss, net</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(681)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(852)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(17,973)</span></td></tr>
  <tr id="xdx_405_ecustom--TaxOnFinancialOperations_pn3n3_zhEMHixPeMT1" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IOF taxes (taxes on financial transactions)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,947)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(178)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,306)</span></td></tr>
  <tr id="xdx_400_eifrs-full--OtherFinanceCost_iN_pn3n3_di_zShhuNZiILe4" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(30,638)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(27,496)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(15,797)</span></td></tr>
  <tr id="xdx_409_eifrs-full--FinanceCosts_iN_pn3n3_di_z4ojR9SPoIwd" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance expenses</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(457,616)</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(349,893)</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(243,796)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--FinanceResult_pn3n3_zOFbUfqRwHU6" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance result</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(346,974)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(247,851)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(179,230)</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of finance income (cost). [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639668620864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureIncomeTaxesAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfIncomeTaxesExplanatory', window );">Income taxes</a></td>
<td class="text"><p id="xdx_808_ecustom--DisclosureOfIncomeTaxesExplanatory_z24BJebmWxMb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>22</b></td><td><b><span id="xdx_82B_zTsPcwNP20Td">Income taxes</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Income taxes are comprised of taxation over operations in Brazil, related
to Corporate Income Tax ("IRPJ") and Social Contribution on Net Profit ("CSLL"). According to Brazilian tax legislation,
income taxes and social contribution are assessed and paid by legal entity and not on a consolidated basis.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Reconciliation of income taxes expense</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-weight: normal">The table below is a
reconciliation of income tax expense to profit for the year, calculated by applying the combined Brazilian statutory rates at 34% for
the years ended December 31, 2023, 2022 and 2021:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_z0ZfbEW2o3Kl" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details)">
  <tr style="background-color: White">
    <td style="white-space: nowrap"><span id="xdx_8B9_z0wBWQB93Ms1" style="display: none">Schedule of reconciliation of income tax expense</span></td>
    <td id="xdx_496_20230101__20231231_zMYAmTrC9ZKc" style="vertical-align: bottom; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_499_20220101__20221231_zM9haULjtd83" style="vertical-align: bottom; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_493_20210101__20211231_zQVh9XsezGlg" style="vertical-align: bottom; text-align: center; line-height: 115%">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 46%">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2021</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zX3IuBaK0bf4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income before income taxes</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">429,582</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">428,433</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">273,462</span></td></tr>
  <tr id="xdx_400_eifrs-full--ApplicableTaxRate_pid_dp_zNs4jixl3bt6" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Combined statutory income taxes rate - %</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">34%</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">34%</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">34%</span></td></tr>
  <tr id="xdx_406_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pn3n3_zQ9TPK77mgUj" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes at statutory rates</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(146,058)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(145,667)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(92,977)</span></td></tr>
  <tr id="xdx_405_ecustom--ReconciliationAdjustmentsAbstract_iB_pn3n3_zvRRDuKiX1v7" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reconciliation adjustments:</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_409_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pn3n3_z6DWPRcfgcDe" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tax effect on loss from entities not subject to taxation</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(32,274)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(32,859)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(37,794)</span></td></tr>
  <tr id="xdx_401_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pn3n3_zaZp3u2abVuh" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">PROUNI - Fiscal Incentive (i)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">309,952</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">270,062</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">194,830</span></td></tr>
  <tr id="xdx_40A_ecustom--UnrecognisedDeferredTaxAssets_pn3n3_zvEmwvIZLIua" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Unrecognized deferred tax assets</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(154,062)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(117,377)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(86,233)</span></td></tr>
  <tr id="xdx_407_ecustom--RecognisedDeferredTaxAssets_pn3n3_zscGF7xEYmqe" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Recognized deferred tax assets</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">3,233</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl5400">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl5401">-</span></span></td></tr>
  <tr id="xdx_403_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_iN_pn3n3_di_zHCeXWnO33ig" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Presumed profit income tax regime effect (ii)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(8,787)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(1,549)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(7,066)</span></td></tr>
  <tr id="xdx_402_ecustom--PermanentAdjustments_pn3n3_zMCum4XkC7Cl" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Permanent adjustments</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(4,687)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(12,226)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(6,232)</span></td></tr>
  <tr id="xdx_40D_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_pn3n3_zNMf0z9h5Ib1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">8,517</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">3,939</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">4,293</span></td></tr>
  <tr id="xdx_40E_eifrs-full--CurrentTaxExpenseIncome_pn3n3_zUrRtF3ayOx1" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes expense - current</span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(24,166)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(35,677)</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(31,179)</b></span></td></tr>
  <tr id="xdx_400_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_zOWlunh9KMe4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effective rate</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">5.62%</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">8.33%</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">11.40%</span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The Company adhered to PROUNI, established by Law 11,096 / 2005, which is a federal program
that exempts companies of paying income taxes and social contribution upon compliance with certain requirements required by said Law.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Brazilian tax law establishes that companies that generate gross revenues of up to R$78,000
in the prior fiscal year may calculate income taxes as a percentage of gross revenue, using the presumed profit tax regime. The effect
of the presumed profit of certain subsidiaries represents the difference between the taxation based on this method and the amount that
would be due based on the statutory rate applied to the taxable profit of the subsidiaries.<br/></td>
</tr></table>

<p id="xdx_8AA_zqdPE0dPTsr4" style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 10.9pt; text-indent: -10.9pt; color: #C00000">Deferred income taxes</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">As of December 31, 2023, the Company had accumulated unrecognized deferred
income tax assets on temporary differences and tax losses in the amount of R$<span id="xdx_906_eifrs-full--DeferredTaxExpenseIncome_pn3n3_c20230101__20231231_zMJZAHVrVsa9" title="Unrecognized deferred income tax assets">1,211,909</span> (tax-basis) (December 31, 2022: R$<span id="xdx_905_eifrs-full--DeferredTaxExpenseIncome_pn3n3_c20220101__20221231_zDev7o4A6mC9" title="Unrecognized deferred income tax assets">778,080</span> (tax-basis))
which does not have any tax planning opportunities available that could support the recognition of these temporary differences as deferred
tax assets. Accordingly, the Company did not recognize deferred tax assets over these amounts, except the amount as of R$<span id="xdx_902_ecustom--RecognizedDeferredTaxAssets_iI_pn3n3_c20231231__ifrs-full--SegmentsAxis__custom--OneSubsidiaryMember_z22Z42u4NxDe" title="Recognized deferred income tax assets">9,508</span> of tax
basis from one subsidiary, where the Company recognize deferred tax assets that is expected to be compensated in next years.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfIncomeTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfIncomeTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639609519888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insurance contracts and contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureInsuranceContractsAndContingenciesAbstract', window );"><strong>Insurance Contracts And Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfInsuranceContractsAndContingenciesExplanatory', window );">Insurance contracts and contingencies</a></td>
<td class="text"><p id="xdx_80F_ecustom--DisclosureOfInsuranceContractsAndContingenciesExplanatory_zMmZukpJabKd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>23</b></td><td><b><span id="xdx_827_zvlwkEEDUlD9">Insurance contracts and contingencies</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>a) Insurance contracts</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company and its subsidiaries have a risk management program with the
purpose of delimiting the risks, seeking in the market coverage compatible with its size and operations.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b) Legal proceedings and contingencies</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The provisions related to labor, civil and taxes proceedings whose likelihood
of loss is assessed as probable are as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfLegalProceedingsAndContingencies_zybwi3fywxDd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Insurance contracts and contingencies (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BE_zC3Fs1DV8usk" style="display: none">Schedule of legal proceedings and contingencies</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 39%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Labor</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Civil</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Taxes</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances as of December 31, 2020</b></span></td>
    <td id="xdx_98E_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zkAEFLwgWsWf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>4,519</b></span></td>
    <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zeJEVRyDBJ6g" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>13,280</b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zQjqkpw49QV" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>35,340</b></span></td>
    <td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zKg9FIM4sXQh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>53,139</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business combinations</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zZbNZQTZkAxa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">16,597</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zRJ3dLRzO7L6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">6,017</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z9AmhRyjC2Fk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,638</span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zTExp6siSNxi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">80,252</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions </span></td>
    <td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zHdWklvfywg7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,418</span></td>
    <td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuTloi09neO1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,101</span></td>
    <td id="xdx_980_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z8IGVEt5w2l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,225</span></td>
    <td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zKAZqSs0Ec77" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,744</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zFObFYsdLgRf" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,044)</span></td>
    <td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zq63heHtDPHk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,470)</span></td>
    <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z4W12NxhRy4l" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,334)</span></td>
    <td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zctkMbHAwS41" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(9,848)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances as of December 31, 2021</b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgELEUzlVt3f" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>25,490</b></span></td>
    <td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zInWUUH8rfGc" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>22,928</b></span></td>
    <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zNBuyde8auG4" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>99,869</b></span></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z4jjBQdk6Pfh" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>148,287</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zaa4p2aDUa78" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,300</span></td>
    <td id="xdx_98C_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zOPFThM3ldlk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,911</span></td>
    <td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zS3IfXYifnjf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">63,698</span></td>
    <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z7A21rdqDsJf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">73,909</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_987_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgVm3uVxqj5h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5,306)</span></td>
    <td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zIMOVd5S00i1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,175)</span></td>
    <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zoRjkyJ1PWc6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(14,861)</span></td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zcJdsSU4gCP6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(26,342)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances as of December 31, 2022</b></span></td>
    <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zWwJ6gsnjOw1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>22,484</b></span></td>
    <td id="xdx_98F_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zTk8bzyfkLw7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>24,664</b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zTewyI7913L9" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>148,706</b></span></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zLKZD5wnpf6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>195,854</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business combination</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z47gSBFcAYO7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">64</span></td>
    <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zDS8ELjItj52" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">88</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zzpqhMprank8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5501">-</span></span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhNpTKiEmi5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">152</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zzCKWAvCASWl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,424</span></td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zGIv7povfvL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,875</span></td>
    <td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zB17EajSVgGd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">9,037</span></td>
    <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z79sULeFZkRj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">18,336</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals (i)</span></td>
    <td id="xdx_986_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zbr9LPc9GaP4" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,251)</span></td>
    <td id="xdx_98F_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zGf03daQkbmc" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(9,327)</span></td>
    <td id="xdx_987_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zkIeF1ZbZleh" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(97,403)</span></td>
    <td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zNgpBoucs75k" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(109,981)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances as of December 31, 2023</b></span></td>
    <td id="xdx_98A_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zPRVY89kuhXa" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>22,721</b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zCHKohCTPeI4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>21,300</b></span></td>
    <td id="xdx_986_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zWm7ralE2xOk" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>60,340</b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zjJOiJq4GCMe" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>104,361</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">On August 10, 2023, Unigranrio entered into a tax amnesty program on interest and penalties
to settle a tax proceeding with respect to ISS (tax on services) with the municipality of Rio de Janeiro, which result in a payment of
R$14,819. The selling shareholders of Unigranrio agreed to pay R$5,438 regarding this matter, which was deducted from the accounts payable
to selling shareholders. The Company had a provision of R$53,302 and an indemnification asset from the selling shareholders of R$20,000
(in light of the indemnification clauses as defined at acquisition of Unigranrio), in respect to such tax proceedings. The difference
between the provision, indemnification asset and the actual paid amount was recorded as Other income (expenses), net on the consolidated
statements of income and comprehensive income.</td>
</tr></table>

<p id="xdx_8A8_zI4JcdacR5wi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The major labor proceedings to which the Company is a party were filed by
former employees or service providers seeking enforcement of labor rights allegedly not provided by us. The judicial proceedings relates
to employment bonds (judicial proceedings filed by former service providers), overtime, premiums for hazardous workplace conditions, statutory
severance, fines for severance payment delays, and compensation for workplace-related accidents.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The civil claims to which the Company is a party generally relate to consumer
claims, including those related to student complaints.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The tax claims to which the Company is party are mostly tax foreclosures
filed by Brazilian federal and municipal tax authorities.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">There are other civil, labor, taxes and social security proceedings assessed
by Management and its legal counsels as possible risk of loss, for which no provisions are recognized, as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagement_z5p7yyyTT2k7" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Insurance contracts and contingencies (Details 1)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B1_z6q7eUhZ4jv2" style="display: none">Schedule of social
    security proceedings assessed by Management</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Labor</span></td>
    <td id="xdx_986_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zN3rjculUHBh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">32,683</span></td>
    <td id="xdx_985_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zVqVER4Uby4j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,914</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Civil</span></td>
    <td id="xdx_981_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zsVNSqtEaQ3j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">51,319</span></td>
    <td id="xdx_983_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2MRQw4TB9bl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">59,603</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Taxes and social security</span></td>
    <td id="xdx_989_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zhuJU4lLveEg" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,669</span></td>
    <td id="xdx_98E_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_znf651RM4Sq6" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,931</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Total</b></td>
    <td id="xdx_98D_eifrs-full--OtherProvisions_iI_pn3n3_c20231231_zwOEl0M4UJQi" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>89,671</b></span></td>
    <td id="xdx_981_eifrs-full--OtherProvisions_iI_pn3n3_c20221231_zQzrT2Rqmn3j" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>78,448</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company has judicial deposits, related to taxes, civil and labor proceedings,
recorded in other assets (non-current) in the amount of R$<span id="xdx_90E_ecustom--JudicialDeposits_iI_pn3n3_c20231231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zPeCG2M068xe" title="Judicial deposits">14,187</span> as of December 31, 2023 (December 31, 2022: R$<span id="xdx_909_ecustom--JudicialDeposits_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zPzXZ9P9GPRe" title="Judicial deposits">12,693</span>).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Under the terms of the Share Purchase and Sale Agreements ("Agreements")
between the Company and the selling shareholders of the subsidiaries acquired, the Company assesses that the selling shareholders are
exclusively responsible for any provisions (including labor, tax and civil), which are or will be the subject of a claim by any third
party, arising from the act or fact occurred, by action or omission, prior to or on the closing dates of the acquisitions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Considering that the provisions for legal proceedings recorded by the Company
that result from causes arising from events occurring prior to the closing dates of the acquisitions, any liability for the amounts to
be disbursed, in case of their effective materialization in loss, belongs exclusively to the selling shareholders. In this context, the
Agreements state that the Company and its subsidiaries are indemnified and therefore exempt from any liability related to said contingent
liabilities and, therefore, the provision amounts related to such contingencies are presented in the non-current liabilities and the correspondent
amount of R$<span id="xdx_90A_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20231231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zXUPlbVGEqEk" title="Contingencies correspondent amount">81,855</span> (December 31, 2022: R$<span id="xdx_905_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zYCST1h2fHu9" title="Contingencies correspondent amount">145,300</span>) is presented in non-current other assets.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureInsuranceContractsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureInsuranceContractsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfInsuranceContractsAndContingenciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfInsuranceContractsAndContingenciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639608702912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-cash transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureNoncashTransactionsAbstract', window );"><strong>Non-cash Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureNoncashTransactionsExplanatory', window );">Non-cash transactions</a></td>
<td class="text"><p id="xdx_80B_ecustom--DisclosureNoncashTransactionsExplanatory_z2yKhkIen5Ya" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>24</b></td><td><b><span id="xdx_828_zZJBPFFeQxph">Non-cash transactions</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">During the years ended December 31, 2023, 2022 and 2021, the Company carried
out non-cash transactions which are not reflected in the statements of cash flows. The main non-cash transactions are as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--NonCashTransactionsTableTextBlock_zX9Gtt2uTYv9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Non-cash transactions (Details)">
  <tr style="background-color: White">
    <td><span id="xdx_8BF_zv0UAG0oUoZ2" style="display: none">Schedule
    of non-cash transactions</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 67%; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Issuance of shares for acquisition of iClinic</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zM9oStIYWZi9" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5559">-</span></span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zVnc83yDKE36" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5561">-</span></span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zj2vqVXci4le" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71,500</span></td></tr>
  <tr style="background-color: White">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Issuance of shares for acquisition of Cliquefarma</span></td>
    <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zv9e8vZ4SiPf" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5565">-</span></span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zRkRritwJ53k" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5567">-</span></span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zitgAeiaFCXa" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,000</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Issuance of shares for acquisition of RX PRO</span></td>
    <td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zsawovGyVgfa" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5571">-</span></span></td>
    <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zHIakik5bL7i" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5573">-</span></span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zeGRggvdhfJl" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,112</span></td></tr>
  <tr style="background-color: White">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement of earn-out of Al&#233;m da Medicina, CardioPapers and Glic</span></td>
    <td id="xdx_98C_ecustom--RemeasurementOfEarnOut_pn3n3_c20230101__20231231_zwNYmjkz5dfd" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,556</span></td>
    <td id="xdx_982_ecustom--RemeasurementOfEarnOut_pn3n3_c20220101__20221231_zgj6oKDoCSZa" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5579">-</span></span></td>
    <td id="xdx_980_ecustom--RemeasurementOfEarnOut_pn3n3_c20210101__20211231_zfK7P4Wk73ef" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5581">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Provision for legal proceedings with corresponding indemnification asset</span></td>
    <td id="xdx_98E_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20230101__20231231_ztPbmOAMgq39" style="text-align: right" title="Provision for legal proceedings with corresponding indemnification asset"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,000</span></td>
    <td id="xdx_98F_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20220101__20221231_zAzcZdv0lrhf" style="text-align: right" title="Provision for legal proceedings with corresponding indemnification asset"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">48,333</span></td>
    <td id="xdx_98F_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20210101__20211231_zi0x4gkt7eNd" style="text-align: right" title="Provision for legal proceedings with corresponding indemnification asset"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,232</span></td></tr>
  <tr style="background-color: White">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions and remeasurements of right-of-use assets and lease liabilities</span></td>
    <td id="xdx_98C_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20230101__20231231_zHgJRFYaOd25" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">77,715</span></td>
    <td id="xdx_981_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20220101__20221231_z53G9TtT22ae" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">100,873</span></td>
    <td id="xdx_98C_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20210101__20211231_zXmS2MAg6DMc" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">158,651</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureNoncashTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureNoncashTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureNoncashTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureNoncashTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639606765888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent event<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Subsequent event</a></td>
<td class="text"><p id="xdx_809_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zDf51uYxiqu5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"><b>25</b></td><td><b><span id="xdx_824_ztzEJnpd5j0c">Subsequent event</span></b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>Medical seats increase in FIP Guanambi</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">On January 24, 2024, MEC authorized the increase of 40 medical seats of
Faculdades Integradas Padr&#227;o (FIP Guanambi) located in the city of Guanambi, State of Bahia, which will result in an additional
payment of R$<span id="xdx_909_ecustom--PotentialAdditionalPayment_pn3n3_c20240123__20240124__ifrs-full--TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis__custom--FaculdadesIntegradasPadraoMember_z8bTPlVtHgX6" title="Potential additional payment">49,600</span>. With the authorization, Afya reaches 100 medical seats on this campus, and <span id="xdx_90A_ecustom--TotalNumberOfSeatsApporved_iI_uN_c20240124__ifrs-full--TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis__custom--FaculdadesIntegradasPadraoMember_zLbSYb63UOKd" title="Total number of seats apporved">3,203</span> total approved seats.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639609091712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureMaterialAccountingPoliciesAbstract', window );"><strong>Material Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BusinessCombinationsAndGoodwillPolicyExplanatory', window );">Business combinations and goodwill</a></td>
<td class="text"><p id="xdx_842_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zeqybfC7yksh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>a) <span id="xdx_866_zre99Xd2lFob">Business combinations and goodwill</span> </b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Business combinations are accounted for using the acquisition method. The
cost of an acquisition is measured as the aggregate of the consideration transferred, which is measured at acquisition date fair value,
and the amount of any non-controlling interests in the acquiree. For each business combination, the Company elects whether to measure
the non-controlling interests in the acquiree at fair value or at the proportionate share of the acquiree&#8217;s identifiable net assets.
Acquisition-related costs are expensed as incurred and included in selling, general and administrative expenses.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">When the Company acquires a business, it assesses the financial assets and
liabilities assumed for appropriate classification and designation in accordance with the contractual terms, economic circumstances and
pertinent conditions as of the acquisition date.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Goodwill is initially measured at cost (being the excess of the aggregate
of the consideration transferred and the amount recognized for non-controlling interests and any previous interest held over the net
identifiable assets acquired and liabilities assumed). If the fair value of the net assets acquired is in excess of the aggregate consideration
transferred, the Company re-assesses whether it has correctly identified all of the assets acquired and all of the liabilities assumed
and reviews the procedures used to measure the amounts to be recognized at the acquisition date. If the reassessment still results in
an excess of the fair value of net assets acquired over the aggregate consideration transferred, then the gain is recognized in the consolidated
statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">After initial recognition, goodwill is measured at cost less any accumulated
impairment losses. For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated
to each of the Company&#8217;s cash-generating units that are expected to benefit from the combination, irrespective of whether other
assets or liabilities of the acquire are assigned to those units.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Where goodwill has been allocated to a cash-generating unit (CGU) and part
of the operation within that unit is disposed of, the goodwill associated with the disposed operation is included in the carrying amount
of the operation when determining the gain or loss on disposal. Goodwill disposed in these circumstances is measured based on the relative
values of the disposed operation and the portion of the cash-generating unit retained.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory', window );">Current versus non-current classification</a></td>
<td class="text"><p id="xdx_848_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zvIOto8tCKJa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>b) <span id="xdx_86D_zgfWBvd54Hjf">Current versus non-current classification</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company presents assets and liabilities in the statement of financial
position based on current and non-current classification. An asset is current when it is:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Expected to be realized
or intended to be sold or consumed in the normal operating cycle;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Held primarily for
the purpose of trading;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Expected to be realized
within twelve months after the reporting period; or</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Cash or cash equivalent
unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">All other assets are classified as non-current.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">A liability is current when:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It is expected to
be settled in the normal operating cycle;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It is held primarily
for the purpose of trading;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It is due to be
settled within twelve months after the reporting period; or</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">There is no unconditional
right to defer the settlement of the liability for at least twelve months after the reporting period.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company classifies all other liabilities as non-current.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Deferred tax assets and liabilities are classified as non-current assets
and liabilities.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory', window );">Fair value measurement</a></td>
<td class="text"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zVRK63da52x4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>c) <span id="xdx_866_zgQOUctiUb3i">Fair value measurement</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Fair value is the price that would be received to sell an asset or paid
to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based
on the presumption that the transaction to sell the asset or transfer the liability takes place either: (i) in the principal market for
the asset or liability; or (ii) in the absence of a principal market, in the most advantageous market for the asset or liability.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The principal or the most advantageous market must be accessible by the
Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The fair value of an asset or a liability is measured using the assumptions
that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">A fair value measurement of a non-financial asset takes into account a market
participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market
participant that would use the asset in its highest and best use.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company uses valuation techniques that are appropriate in the circumstances
and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the
use of unobservable inputs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">All assets and liabilities for which fair value is measured or disclosed
in the financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that
is significant to the fair value measurement as a whole:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level 1 - Quoted
(unadjusted) market prices in active markets for identical assets or liabilities.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level 2 - Valuation
techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level 3 - Valuation
techniques for which the lowest level input that is significant to the fair value measurement is unobservable.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For assets and liabilities that are recognized in the financial statements
at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy by re-assessing
categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting
period.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">At each reporting date, the Company analyzes the movements in the values
of assets and liabilities which are required to be remeasured or reassessed as per the Company&#8217;s accounting policies. For this analysis,
the Company verifies the major inputs applied in the latest valuation by agreeing the information in the valuation computation to contracts
and other relevant documents.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company also compares the change in the fair value of each asset and
liability with relevant external sources to determine whether the change is reasonable.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For the purpose of fair value disclosures, the Company has determined classes
of assets and liabilities on the basis of the nature, characteristics and risks of the asset or liability and the level of the fair value
hierarchy, as explained above.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory', window );">Financial instruments - initial recognition and measurement</a></td>
<td class="text"><p id="xdx_840_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_zKvg01UWdcJ7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>d) <span id="xdx_866_zTFTz8xv3zk6">Financial instruments - initial recognition and measurement</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">A financial instrument is any contract that gives rise to a financial asset
of one entity and a financial liability or equity instrument of another entity.</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 14.2pt"></td><td style="width: 14.15pt"><b>i)</b></td><td><b>Financial assets</b></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><b>&#160;</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Initial recognition and measurement</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The classification of financial assets at initial recognition
depends on the financial asset&#8217;s contractual cash flow characteristics and the Company&#8217;s business model for managing them.
With the exception of trade receivables that do not contain a significant financing component or for which the Company has applied the
practical expedient, the Company initially measures a financial asset at its fair value plus, in the case of a financial asset not at
fair value through profit or loss, transaction costs. Trade receivables that do not contain a significant financing component or for
which the Company has applied the practical expedient, are measured at the transaction price determined under IFRS 15.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">In order for a financial asset to be classified and measured
at amortized cost or fair value through OCI (Other Comprehensive Income), it needs to give rise to cash flows that are &#8220;solely payments
of principal and interest (SPPI)&#8221; on the principal amount outstanding. This assessment is referred to as the SPPI test and is performed
at an instrument level.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company&#8217;s business model for managing financial assets
refers to how it manages its financial assets in order to generate cash flows. The business model determines whether cash flows will result
from collecting contractual cash flows, selling the financial assets, or both.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Purchases or sales of financial assets that require delivery
of assets within a time frame established by regulation or convention in the market place (regular way trades) are recognized on the trade
date, i.e., the date that the Company commits to purchase or sell the asset.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Subsequent measurement</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">For purposes of subsequent measurement, financial assets are
classified as: financial assets at amortized cost or financial assets at fair value through profit or loss. There are no financial assets
designated as fair value through OCI.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Financial assets at amortized cost</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company measures financial assets at amortized cost if both
of the following conditions are met:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#8226; The financial asset is held within a business model with
the objective to hold financial assets in order to collect contractual cash flows, and</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#8226; The contractual terms of the financial asset give rise
on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial assets at amortized cost are subsequently measured
using the effective interest (EIR) method and are subject to impairment. Gains and losses are recognized in the statement of income when
the asset is derecognized, modified or impaired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Financial assets at fair value through profit
or loss</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial assets at fair value through profit or loss include
financial assets held for trading, financial assets designated upon initial recognition at fair value through profit or loss, or financial
assets mandatorily required to be measured at fair value. Financial assets are classified as held for trading if they are acquired for
the purpose of selling or repurchasing in the near term. Derivatives, including separated embedded derivatives, are also classified as
held for trading unless they are designated as effective hedging instruments. Financial assets with cash flows that are not solely payments
of principal and interest are classified and measured at fair value through profit or loss, irrespective of the business model.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial assets at fair value through profit or loss are carried
in the statement of financial position at fair value with net changes in fair value recognized in the statement of income. This category
includes derivative instruments.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Derecognition</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">A financial asset (or, where applicable, a part of a financial
asset or part of a group of similar financial assets) is primarily derecognized (i.e., removed from the Company&#8217;s statement of financial
position) when:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"></td><td style="text-align: justify">The rights to receive cash flows from the asset have expired; or</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"></td><td style="text-align: justify">The Company has transferred its rights to receive cash flows from the asset or has assumed
an obligation to pay the received cash flows in full without material delay to a third party under a &#8216;pass-through&#8217; arrangement;
and either (a) the Company has transferred substantially all the risks and rewards of the asset, or (b) the Company has neither transferred
nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset.</td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">When the Company has transferred its rights to receive cash flows
from an asset or has entered into a pass-through arrangement, it evaluates if, and to what extent, it has retained the risks and rewards
of ownership. When it has neither transferred nor retained substantially all of the risks and rewards of the asset, nor transferred control
of the asset, the Company continues to recognize the transferred asset to the extent of its continuing involvement. In that case, the
Company also recognizes an associated liability. The transferred asset and the associated liability are measured on a basis that reflects
the rights and obligations that the Company has retained.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Continuing involvement that takes the form of a guarantee over
the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that
the Company could be required to repay.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Impairment of financial assets</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Further disclosures relating to impairment of financial assets
are also provided in the following notes:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"></td><td style="text-align: justify">Significant accounting judgments, estimates and assumptions - Note 3</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"></td><td style="text-align: justify">Trade receivables - Note 7</td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company recognizes an allowance for expected credit losses
(ECLs) for all debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual
cash flows due in accordance with the contract and the cash flows the Company expects to receive, discounted at an approximation of the
original effective interest rate. The expected cash flows will include cash flows from the sale of collateral held or other credit enhancements
that are integral to the contractual terms.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">For trade receivables, the Company applies a simplified approach
in calculating ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for credit losses
based on lifetime ECLs at each reporting date. The Company has established a provision matrix that is based on its historical credit loss
experience, adjusted for forward-looking factors specific to the debtors and the economic environment.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company considers a financial asset to be in default
when internal or external information indicates that the Company is unlikely to receive the outstanding contractual amounts in full
before considering any credit enhancements held by the Company. A financial asset is written off when there is no reasonable
expectation of recovering the contractual cash flows.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><b>ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
liabilities</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Initial recognition and measurement</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial liabilities are classified, at initial recognition,
as financial liabilities at fair value through profit or loss, loans and borrowings, payables, or as derivatives designated as hedging
instruments in an effective hedge, as appropriate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">All financial liabilities are recognized initially at fair value
and, in the case of loans and borrowings and payables, net of directly attributable transaction costs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The Company&#8217;s financial liabilities include trade payables,
loans and financing, notes payable, lease liabilities, advances from customers and accounts payable to selling shareholders.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Subsequent measurement</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">The measurement of financial liabilities depends on their classification,
as described below:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Financial liabilities at fair value through
profit or loss</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial liabilities at fair value through profit or loss include
financial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value through profit or
loss.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial liabilities are classified as held for trading if they
are incurred for the purpose of repurchasing in the near term. This category also includes, when applicable, derivative financial instruments
entered into by the Company that are not designated as hedging instruments in hedge relationships as defined by IFRS 9. Gains or losses
on liabilities held for trading are recognized in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial liabilities designated upon initial recognition at
fair value through profit or loss are designated at the initial date of recognition, and only if the criteria in IFRS 9 are satisfied.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Loans and borrowings</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">After initial recognition, interest-bearing loans and borrowings
are subsequently measured at amortized cost using the EIR method. Gains and losses are recognized in the statement of income when the
liabilities are derecognized as well as through the EIR amortization process.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Amortized cost is calculated by considering any discount or premium
on acquisition and fees or costs that are an integral part of the EIR. The EIR amortization is included as finance expenses in the statement
of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Derecognition</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">A financial liability is derecognized when the obligation under
the liability is discharged or cancelled or expires. When an existing financial liability is replaced by another from the same lender
on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is
treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying
amounts is recognized in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><br/>
</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><i>Offsetting of financial instruments</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt">Financial assets and financial liabilities are offset and the
net amount is reported in the statement of financial position if there is a currently enforceable legal right to offset the recognized
amounts and there is an intention to settle on a net basis, to realize the assets and settle the liabilities simultaneously.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text"><p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zSLNqDO7dt11" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>e) <span id="xdx_867_zWpp7npZLiub">Cash and cash equivalents</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Cash and cash equivalents in the statement of financial position comprise
cash at banks and on hand, and short-term financial investments with an original maturity of three months or less, which are subject to
an insignificant risk of changes in value.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For the purpose of the statement of cash flows, cash and cash equivalents
consist of cash and short-term financial investments, as they are considered an integral part of the Company&#8217;s cash management.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property and equipment</a></td>
<td class="text"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zNJh9Hmg1eQ9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>f) <span id="xdx_860_zaQrZT2wqJl8">Property and equipment</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Property and equipment are stated at cost, net of accumulated depreciation
and accumulated impairment losses, if any.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Subsequent expenditures are capitalized only if it is probable that the
future economic benefits associated with the expenditure will flow to the Company.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Depreciation is calculated on a straight-line basis over the estimated useful
lives of the assets, as follows:</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zAZYZOz6Ydq" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details 1)">
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B0_zaC2EnOUWqdf" style="display: none">Schedule of estimated useful
lives of the assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Building</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zGZ0Olisj3R3" title="Useful lives of assets">25</span> years</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Machinery and equipment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zlijIYD854z1" title="Useful lives of assets">10</span> years</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Vehicles</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zWn083WDFBIa" title="Useful lives of assets">4</span> years</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Furniture and fixtures</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zVPzrKtB97bi" title="Useful lives of assets">10</span> years</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">IT equipment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zdCqKpUaMbQj" title="Useful lives of assets">5</span> years</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Library books</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_z35nlPvrCfH9" title="Useful lives of assets">10</span> years</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Leasehold improvements</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGUH789gLle1" title="Useful lives of assets">5</span> - <span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zr85b7n2lei4" title="Useful lives of assets">20</span> years</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><br/>
</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">An item of property and equipment and any significant part initially recognized
is derecognized upon disposal or when no future economic benefit is expected from its use or disposal. Any gain or loss arising on the
derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included
in the statement of income when the asset is derecognized.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The residual values, useful lives and methods of depreciation of property
and equipment are reviewed at each financial year end and adjusted prospectively, if appropriate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases</a></td>
<td class="text"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zjIX2ELhTcF6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>g) <span id="xdx_864_zMeHdQwI1tq">Leases</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company assess at contract inception whether an arrangement is (or contains)
a lease is based on the substance of the arrangement at the inception of the contract. The arrangement is, or contains, a lease if the
arrangement conveys the right to control the use of the identified asset (or assets), even if that asset is (or those assets are) not
explicitly specified in an arrangement for a period of time in exchange for consideration.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><br/>
</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Company as a lessee</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company applies a single recognition and measurement approach for all
leases, except for short-term leases and leases of low-value assets. The Company recognizes lease liabilities to make lease payments and
right-of-use assets representing the right to use the underlying assets.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Right-of-use assets</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company recognizes right-of-use assets at the commencement date of the
lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation
and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of
lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease
incentives received. Unless the Company is reasonably certain to obtain ownership of the leased asset at the end of the lease term, the
recognized right-of-use assets are depreciated on a straight-line basis over the shorter of its estimated useful life and the lease term.
Right-of-use assets are subject to impairment.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Lease liabilities</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">At the commencement date of the lease, the Company recognizes lease liabilities
measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance
fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected
to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain
to be exercised by the Company and payments of penalties for terminating a lease, if the lease term reflects the Company exercising the
option to terminate. The variable lease payments that do not depend on an index or a rate are recognized as expense in the period on which
the event or condition that triggers the payment occurs.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">In calculating the present value of lease payments, the Company uses the
incremental borrowing rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After
the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments
made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change
in the in-substance fixed lease payments or a change in the assessment to purchase the underlying asset.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000">Short-term leases and leases of low-value assets</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company applies the short-term lease recognition exemption to its short-term
leases of properties (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase
option). It also applies the lease of low-value assets recognition exemption to leases that are considered of low value. Lease payments
on short-term leases and leases of low-value assets are recognized as expense on a straight-line basis over the lease term.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Intangible assets</a></td>
<td class="text"><p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_z7U4La36slmi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>h) <span id="xdx_866_zpxVucjDvpRh">Intangible assets</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets acquired separately are measured on initial recognition
at cost. The cost of intangible assets acquired in a business combination is their fair value at the date of acquisition. Following initial
recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally generated
intangibles are not capitalized and the related expenditure is reflected in the statement of income in the period in which the expenditure
is incurred.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The useful lives of intangible assets are assessed as finite or indefinite.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets with finite lives are amortized over the useful economic
life and assessed for impairment whenever there is an indication that the intangible asset may be impaired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The amortization period and the amortization method for an intangible asset
with a finite useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected
pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as
appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized
in the statement of income in the expense category that is consistent with the function of the intangible assets.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets with indefinite useful lives are not amortized, but are
tested for impairment annually, either individually or at the cash-generating unit level. The assessment of indefinite life is reviewed
annually to determine whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite
is made on a prospective basis.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">An intangible asset is derecognized upon disposal or when no future economic
benefits are expected from its use or disposal. Any gain or loss arising upon derecognition of the asset (calculated as the difference
between the net disposal proceeds and the carrying amount of the asset) is included in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory', window );">Impairment of non-financial assets</a></td>
<td class="text"><p id="xdx_84A_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_zlZZxcLm8cke" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>i) <span id="xdx_862_zW60XKT14Avf">Impairment of non-financial assets</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company assesses, at each reporting date, whether there is an indication
that an asset may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Company estimates
the asset&#8217;s recoverable amount. An asset&#8217;s recoverable amount is the higher of an asset&#8217;s or CGU&#8217;s fair value
less costs of disposal and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate
cash inflows that are largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU
exceeds its recoverable amount, the asset is considered impaired and is written down to its recoverable amount.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">In assessing value in use, the estimated future cash flows are discounted
to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks
specific to the asset. In determining fair value less costs of disposal, recent market transactions are considered. If no such transactions
can be identified, an appropriate valuation model is used. These calculations are corroborated by valuation multiples, quoted share prices
for publicly traded companies or other available fair value indicators.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company bases its impairment calculation on detailed budgets and forecast
calculations, which are prepared separately for each of the Company&#8217;s CGUs to which the individual assets are allocated. These budgets
and forecast calculations generally cover a period of five years, considering the companies activities and maturation period of its graduate
and undergraduate courses. A long-term growth rate is calculated and applied to project future cash flows after the last projected year.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For impairment testing, goodwill acquired through business combinations
and licenses with indefinite useful lives are allocated to their respective CGUs. The Company defined each of its operating subsidiaries
as a CGU, except for digital services segment, which combines subsidiaries of (i) &#8220;Content &amp; Technology for medical education&#8221;;
(ii) &#8220;Clinical Decision Software&#8221;; and (iii) &#8220;Practice Management Tools &amp; Electronic Prescription&#8221;, where
the subsidiaries were combined as one CGU following the business strategic pillars.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Whenever applicable, impairment losses of continuing operations are recognized
in the statement of income in expense categories consistent with the function of the impaired asset.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">For assets excluding goodwill, an assessment is made at each reporting date
to determine whether there is an indication that previously recognized impairment losses no longer exist or have decreased. If such indication
exists, the Company estimates the asset&#8217;s or CGU&#8217;s recoverable amount. A previously recognized impairment loss is reversed
only if there has been a change in the assumptions used to determine the asset&#8217;s recoverable amount since the last impairment loss
was recognized. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the
carrying amount that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years.
Such reversal is recognized in the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Goodwill is tested for impairment annually as at December 31 and when circumstances
indicate that the carrying value may be impaired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Impairment is determined for goodwill by assessing the recoverable amount
of each CGU (or group of CGUs) to which the goodwill relates. When the recoverable amount of the CGU is less than its carrying amount,
an impairment loss is recognized. Impairment losses relating to goodwill cannot be reversed in future periods.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Intangible assets with indefinite useful lives are tested for impairment
annually as at December 31 at the CGU level, as appropriate, and when circumstances indicate that the carrying value may be impaired.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory', window );">Investments</a></td>
<td class="text"><p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForInvestmentsExplanatory_zmHC9D4CmwBi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>j) <span id="xdx_865_zqfOzwRP2TGf">Investments</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Investments in associates are initially recognized at consideration transferred
and adjusted thereafter for the equity method, being increased or reduced from its interest in the investee's income after the acquisition
date. An associate is an entity over which the Company has significant influence. Significant influence is the power to participate in
the financial and operating policy decisions of the investee, but is not control or joint control over those policies.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersPolicyExplanatory', window );">Accounts payable to selling shareholders</a></td>
<td class="text"><p id="xdx_845_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_ziQoQhjATxuc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>k) <span id="xdx_86A_zGCeAo5CyYs9">Accounts payable to selling shareholders</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">These amounts represent liabilities related to the acquisitions made by
the Company which are not yet due. Accounts payable to selling shareholders are presented as current liabilities unless payment is not
due within 12 months after the reporting period. They are recognized initially at their fair value and subsequently measured at amortized
cost using the effective interest method, except for the contingent consideration related to earn-outs, which are measured at fair value
through profit or loss.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Provisions</a></td>
<td class="text"><p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_z8grFXjufnd3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>l) <span id="xdx_865_zy328twd4Mji">Provisions</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Provisions are recognized when the Company has a present obligation (legal
or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required
to settle the obligation, and a reliable estimate can be made of the amount of the obligation. The expense relating to a provision is
presented in the statement of income, net of any reimbursement, when applicable.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>






<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DividendsPolicyExplanatory', window );">Dividends</a></td>
<td class="text"><p id="xdx_84C_ecustom--DividendsPolicyExplanatory_zJIeCotkaNFe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>m) <span id="xdx_865_zZ0HxIVUJ3wi">Dividends</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company recognizes a liability to pay a dividend when the distribution
is authorized and the distribution is no longer at the discretion of the Company. The distribution is authorized when it is required to
pay a minimum dividend of the net income for the year in accordance with the Brazilian Corporate Law (applicable for Afya Brazil and its
subsidiaries) and the Company&#8217;s By-Laws or is approved by the shareholders. In respect to the consolidated statement of changes
in equity, the amount corresponding to the non-controlling interest over the dividends declared are recognized directly in equity.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LaborAndSocialObligationsPolicyExplanatory', window );">Labor and social obligations</a></td>
<td class="text"><p id="xdx_847_ecustom--LaborAndSocialObligationsPolicyExplanatory_z1fYGR5TdZ9b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>n) <span id="xdx_86C_z1YEpve974k6">Labor and social obligations</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Labor and social obligations are expensed as the related service is provided.
A liability is recognized for the amount expected to be paid if the Company has a present legal or constructive obligation to pay this
amount as a result of past service provided by the employee and the obligation can be estimated reliably.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SharebasedPaymentsPolicyExplanatory', window );">Share-based payments</a></td>
<td class="text"><p id="xdx_843_ecustom--SharebasedPaymentsPolicyExplanatory_zalIcnHJTBeb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>o) <span id="xdx_861_zL9WHXQMQFG">Share-based payments</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Certain key executives of the Company receive remuneration in the form of
share-based payments, which includes Stock Options and Restricted Stock Units (&#8220;RSUs&#8221;), whereby the executives render services
as consideration for equity instruments (equity-settled transactions).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The expense of equity-settled transactions is determined by the fair value
at the date when the grant is made using an appropriate valuation model.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">That expense is recognized in selling, general and administrative expenses,
together with a corresponding increase in equity, over the period in which the service and, where applicable, the performance conditions
are fulfilled (the vesting period). The cumulative expense recognized for equity-settled transactions at each reporting date until the
vesting date reflects the extent to which the vesting period has expired and the Company&#8217;s best estimate of the number of equity
instruments that will ultimately vest. The expense or credit in the statement of income for a period represents the movement in cumulative
expense recognized as at the beginning and end of that period.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Service and non-market performance conditions are not considered when determining
the grant date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Company&#8217;s best estimate
of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair
value. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting conditions.
Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless there are also
service and/or performance conditions.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">No expense is recognized for awards that do not ultimately vest because
non-market performance and/or service conditions have not been met. Where awards include a market or non-vesting condition, the transactions
are treated as vested irrespective of whether the market or non-vesting condition is satisfied, provided that all other performance and/or
service conditions are satisfied.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">When the terms of an equity-settled award are modified, the minimum expense
recognized is the grant date fair value of the unmodified award, provided the original vesting terms of the award are met. An additional
expense, measured as at the date of modification, is recognized for any modification that increases the total fair value of the share-based
payment transaction, or is otherwise beneficial to the employee. Where an award is cancelled by the entity or by the counterparty, any
remaining element of the fair value of the award is expensed immediately through the statement of income.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The dilutive effect of outstanding options is reflected as additional share
dilution in the computation of diluted earnings per share.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory', window );">Revenue from contracts with customers</a></td>
<td class="text"><p id="xdx_840_eifrs-full--DisclosureOfRevenueFromContractsWithCustomersExplanatory_zQ6ltLqCkpUh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>p) <span id="xdx_861_ztnxnOBSMQ0a">Revenue from contracts with customers</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><i>Revenue recognition transferred over time </i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company's revenue consists primarily of tuition fees charged for medical
courses. The Company also generates revenue from tuition fees for other undergraduate courses, student fees, certain education-related
activities, digital education content and subscription of digital services.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Revenues are recognized when services are rendered to the customer and the
performance obligation is satisfied.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Revenue from tuitions, digital education content and electronic medical
records are recognized over time when services are rendered to the customer and the Company satisfies its performance obligation under
the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services.
Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Other revenues are recognized at a point in time when the service is rendered
to the customer at an amount that reflects the consideration to which the Company expects to be entitled in exchange for the service.
Other revenues are presented net of the corresponding discounts, returns and taxes.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><i>Revenue recognition transferred at point in time </i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Revenue from sale of printed books, e-books, healthcare payments, online
platforms and marketing for pharmaceutical industry are recognized at the point in time when control of the asset or services is transferred
to the customer, generally on delivery of the goods at the customer&#8217;s location and permission to access the digital content. The
Company considers whether there are other promises in the contract that are separate performance obligations to which a portion of the
transaction price needs to be allocated. In determining the transaction price for the printed books and e-books, the Company considers
the effects of variable consideration, financing component, noncash consideration, and consideration payable to the customer to be not
significant.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company concluded that it is the principal in its revenue arrangements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">The Company assesses collectability on a portfolio basis prior to recording
revenue. Generally, students cannot re-enroll for the next academic session without satisfactory resolution of any past-due amounts. If
a student withdraws from an institution, the Company's obligation to issue a refund depends on the refund policy at that institution and
the timing of the student's withdrawal. Generally, the refund obligations are reduced over the course of the academic term.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Trade receivables</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Trade receivables represent the Company&#8217;s right to an amount of consideration
that is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to accounting policies
of financial assets in Financial instruments - initial recognition and subsequent measurement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>






<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><i>Advances from customers</i></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Advances from customers (a contract liability) are the obligation to transfer
services to a customer for which the Company has received consideration (or an amount of consideration is due) from the customer, as a
result of pre-paid tuition, digital education content and mobile app subscription for digital medical content received from customers
and is recognized separately in current liabilities, when the payment is received. Advances from customers are recognized as revenue when
the Company performs all obligations related to the contract, generally in the following month.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TaxesPolicyExplanation', window );">Taxes</a></td>
<td class="text"><p id="xdx_84D_ecustom--TaxesPolicyExplanation_zC3K6LF1DSpc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>q) <span id="xdx_867_znYtC1b6UUee">Taxes</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">The Company&#8217;s
subsidiaries in the undergrad segment joined the PROUNI (<i>Programa Universidade para Todos</i> - University for All Program) program,
which is a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number of
student enrollment for low-income students, and benefits from the exemption of the following federal taxes:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">&#8226; Income taxes
and social contribution</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">&#8226; PIS and COFINS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">The regulation of
PROUNI defines that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS. For income from
other teaching activities, PIS and COFINS are charged at rates of <span id="xdx_906_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_z8nnaMF0qRR8" title="Tax rate">0.65</span>% and <span id="xdx_904_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zyr4XxR9tIq7" title="Tax rate">3.00</span>%, respectively, and for non-teaching activities, PIS
is charged at a rate of <span id="xdx_909_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_z184b5bPceb4" title="Tax rate">1.65</span>% and to COFINS at <span id="xdx_907_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zSw58OThkk16" title="Tax rate">7.6</span>%.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-weight: normal"><i>Current income taxes</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="background-color: white">Current income taxes
were calculated based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service, specifically
regarding the PROUNI program, which allows exemption of these taxes from traditional and technological graduation activities.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Current income tax assets and liabilities are measured at the amount expected
to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted
or substantively enacted at the reporting date.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Management periodically evaluates positions taken in the tax returns with
respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTreasurySharesExplanatory', window );">Treasury shares</a></td>
<td class="text"><p id="xdx_84D_eifrs-full--DisclosureOfTreasurySharesExplanatory_zJ6WY0CRmfy3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>r) <span id="xdx_86A_zaUc3hC5yrHg">Treasury shares</span></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Own equity instruments that are reacquired (treasury shares) are recognized
at cost and deducted from equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the
Company&#8217;s own equity instruments. Any difference between the carrying amount and the consideration, if reissued, is recognized in
the share premium.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><br/>
</p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b>2.4 Changes in accounting policies and disclosures</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b><i>New standards, interpretations and amendments issued
and adopted by the Company</i></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt">In the current year, the Company applied a series of changes to the
IFRSs issued by the International Accounting Standards Board (IASB) that are mandatorily for an accounting period beginning on or after
January 1, 2023, as listed below:</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_zPaMGbNj4N6b" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details 2)">
  <tr>
    <td style="padding-right: 5.4pt; text-align: center"><span id="xdx_8B0_z2WPlSwTKOIj" style="display: none">Schedule of changes in accounting policies and disclosures</span></td>
    <td style="padding-right: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amendments / standards</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Description</span></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_909_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zVRMHPj7cMrl" title="Standard">Amendments to IAS 1 and IFRS Practice Statement 2 - Making Materiality Judgments</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zPZEstU5FyG8" title="Description">The amendments to IAS 1 and IFRS Practice Statement 2 provide guidance and
    examples to help entities apply materiality judgments to accounting policy disclosures. The amendments aim to help entities provide more
    useful accounting policy disclosures by replacing the requirement for entities to disclose their "material" accounting policies
    with a requirement to disclose their "material" accounting policies and adding guidance on how entities apply the concept of
    materiality when making decisions about accounting policy disclosures.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The amendments have had an impact on the Company&#8217;s disclosures of accounting
    policies, but not on the measurement, recognition or presentation of any items in the Company&#8217;s consolidated financial statements.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_905_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_zRiqeDN4JEgk" title="Standard">Amendments to IAS 8 - Accounting Policies, Changes in Accounting Estimates and Errors - Definition of Accounting Estimates</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90D_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_z7GzDbcsH3N" title="Description">The amendments to IAS 8 clarify the distinction between changes in accounting
    estimates, changes in accounting policies and correction of errors. They also clarify how entities use measurement techniques and inputs
    to develop accounting estimates.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">These amendments have no significant impact on the Company&#8217;s consolidated
    financial statements.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_z8uwC8KO8NO6" title="Standard">Amendments to IAS 12 - Income Taxes - International Tax Reform - Pillar Two Model Rules</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_zKFcJhEckc75" title="Description">In October 2021, more than 130 countries agreed to implement a minimum tax
    regime for multinational groups, known as Pillar Two, to reform the international corporate taxation. Pillar Two aims to ensure that multinational
    groups in scope are liable to a minimum effective corporate tax rate of 15 per cent per country.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">In December 2021, the OECD released the Pillar Two model rules - accompanied
    by commentary and guidelines - which are due to be passed into national legislation but adapted by local conditions.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">In response to the OECD's Pillar Two rules, the amendments to IAS 12 were
    introduced and include: (i) a mandatory temporary exception to the recognition and disclosure of deferred taxes arising from the jurisdictional
    implementation of the Pillar Two model rules; and (ii) disclosure requirements for affected entities to help users of the financial statements
    better understand an entity's exposure to Pillar Two income taxes arising from this legislation, especially prior to the effective date.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The countries where the Company has its tax domicile have not yet enacted
    any tax legislation in connection with Pillar Two. Therefore, these amendments have no significant impact on the Company&#8217;s consolidated
    financial statements as of December 2023</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zFXXi5Sw5Jqk" title="Standard">Amendments to IAS 12 Income Taxes - Deferred Tax related to Assets and Liabilities arising from a Single Transaction</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zIcy5ow2bcGl" title="Description">The amendments to IAS 12 Income Taxes narrow the scope of the initial recognition
    exception, so that it no longer applies to transactions that generate equal taxable and deductible temporary differences, such as leases
    and decommissioning liabilities.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">These amendments have no significant impact on the Company&#8217;s consolidated
    financial statements.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_907_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zKw3rf1kHu1g" title="Standard">IFRS 17 - Insurance Contracts</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_903_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zPE0liHDKlPd" title="Description">IFRS 17 is a new accounting standard with scope for insurance contracts,
    covering recognition and measurement, presentation and disclosure. IFRS 17 replaces IFRS 4 - Insurance Contracts. IFRS 17 applies to all
    types of insurance contracts (such as life, property and casualty, direct insurance and reinsurance), regardless of the type of entities
    issuing them, as well as to certain guarantees and financial instruments with discretionary participation characteristics; Some scope
    exceptions will apply.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The overall objective of IFRS 17 is to provide a comprehensive accounting
    model for insurance contracts that is most useful and consistent for insurers, covering all relevant accounting aspects.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The Company does not have any contracts that meet the definition of an insurance
    contract under IFRS 17.</p></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>





<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b><i>New standards, interpretations and amendments issued
but not yet effective</i></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt">&#160;</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">The new and amended standards and interpretations that are issued,
but not yet effective, up to the date of issuance of the Company&#8217;s consolidated financial statements are presented below. The Company
intends to adopt these new and amended standards and interpretations, if applicable, when they become effective.</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amendments / standards</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Description</span></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_900_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_zfzybCODwgX4" title="Standard">Amendments to IFRS 16: Lease Liability in a Sale and Leaseback</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_z0omFgjvhnbj" title="Description">In September 2022, the IASB issued amendments to IFRS 16 to specify the requirements
    that a seller-lessee uses in measuring lease liability arising from a sale and lease back transaction, in order to ensure that the seller-lessee
    does not recognise any amount of the gain or loss that relates to the right of use that it holds.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The amendments are effective for annual financial statements periods beginning
    on or after January 1, 2024 and shall apply retrospectively to sale and leaseback transactions entered into after the initial application
    date of IFRS 16. Early adoption is permitted but must be disclosed.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_90A_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_zDc4i8S4nvJ" title="Standard">Amendments to IAS 1: Classification of Liabilities as Current or Non-Current</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_z57sh07ltKLl" title="Description">In January 2020 and October 2022, the IASB issued amendments to paragraphs
    69 to 76 of IAS 1 to specify the requirements for classifying liabilities as current or non-current. The amendments clarify:</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; What is meant by the right to postpone liquidation;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; That the right to defer should exist at the end of the financial reporting
    period;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; That the rating is not affected by the likelihood that the entity
    will exercise its right to defer;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; That only if a derivative embedded in a convertible liability is itself
    an equity instrument, the terms of a liability will not affect its classification.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">In addition, a disclosure requirement has been introduced where a liability
    arising from a loan agreement is classified as non-current and the entity's right to postpone liquidation is contingent on the fulfilment
    of future covenants within twelve months.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024 and should be applied retrospectively.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_90B_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zkHivH8FOKyc" title="Standard">Supplier Financing Agreements - Amendments to IAS 7 and IFRS 7</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zJDKXm04GSWl" title="Description">In May 2023, the IASB issued amendments to IAS 7 and IFRS 7 to clarify the
    characteristics of supplier financing arrangements and require additional disclosures of such arrangements. The disclosure requirements
    in the amendments are intended to assist users of the financial statements in understanding the effects of financing arrangements with
    suppliers on an entity's obligations, cash flows, and exposure to liquidity risk.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024. Early adoption is permitted but must be disclosed.</p></td></tr>
  </table>
<p id="xdx_8AA_zkwwkyU46Ft2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">These amendments are not expected to have significant impact on the Company&#8217;s
consolidated financial statements.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_BusinessCombinationsAndGoodwillPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_BusinessCombinationsAndGoodwillPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureMaterialAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureMaterialAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DividendsPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DividendsPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LaborAndSocialObligationsPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LaborAndSocialObligationsPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharebasedPaymentsPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharebasedPaymentsPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxesPolicyExplanation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxesPolicyExplanation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 46<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue from contracts with customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Section Presentation<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g105-109_TI<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g110-129_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTreasurySharesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTreasurySharesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639612020384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureMaterialAccountingPoliciesAbstract', window );"><strong>Material Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock', window );">Schedule of Company&#8217;s subsidiaries and associate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zOClrtiiWnDb" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B7_zcTUTkK5xnpc" style="display: none">Schedule of Company&#8217;s subsidiaries and associate</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Direct and indirect interest</b></span></td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; width: 36%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Name</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 23%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Main activities</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Location</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>Investment type</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>December 31, 2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><b>December 31, 2022</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Afya Participa&#231;&#245;es S.A. (&#8220;Afya Brazil&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zalwy9CGxxW1" title="Principal activities">Holding</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z1RptsvM2mMk" title="Location">Nova Lima - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zrpmZKKEiJsd" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z5CjixoKcEja" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zXyR3NNOcrQ4" title="Direct and indirect interest of subsidiary"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zv9VS7TatyJd" title="Direct and indirect interest of subsidiary">100</span></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto Tocantinense Presidente Ant&#244;nio Carlos Porto S.A. - (&#8220;ITPAC Porto&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zH1Ln5sRdeol" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zwF6v291aIDb" title="Location">Porto Nacional - TO</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zoUGV6PYurG8" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zB1OKm3apal5" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zrSl5jEFEnm8" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto Tocantinense Presidente Ant&#244;nio Carlos S.A. - (&#8220;ITPAC Aragua&#237;na&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zGzEFgreoAt6" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_z11eSmIJKfBi" title="Location">Aragua&#237;na - TO</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zYznHUPdaUMi" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zdBbdHbYg3Vk" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zFZWmVBs9oEh" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Uni&#227;o Educacional do Vale do A&#231;o S.A. - (&#8220;UNIVA&#199;O&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zgWRd2JlcEhk" title="Principal activities">Medicine undergraduate degree program</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zPgTSpa6ctni" title="Location">Ipatinga - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zCMh7K0hmkh7" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z0Z1JBdEy9Hg" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z2XOJzLnvsv1" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#8220;IPTAN&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zSbG3bJ6WCT5" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zYs5VwOf1rs8" title="Location">S&#227;o Jo&#227;o Del Rei - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zLGxbgGFRCG8" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zycMe0FDSUxl" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zQZQwj3pfEwk" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A. (&#8220;IESVAP&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zHwpFCvWTRWg" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zmc5S9CWO1hb" title="Location">Parna&#237;ba - PI</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zoUNMxDFdDv1" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zykEQvDEg8k8" title="Direct and indirect interest of subsidiary">80</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_z4qvPwneKpTb" title="Direct and indirect interest of subsidiary">80</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Centro de Ci&#234;ncias em Sa&#250;de de Itajub&#225; S.A. (&#8220;CCSI&#8221;) (vi)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z8zjHa6BIeV6" title="Principal activities">Medicine undergraduate degree program</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zdPwPLBL5Om4" title="Location">Itajub&#225; - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z40USpEPBNzg" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zQmOpVIxyxr" title="Direct and indirect interest of subsidiary">75</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zIrK3aOB0ueb" title="Direct and indirect interest of subsidiary">60</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto de Ensino Superior do Piau&#237; S.A. (&#8220;IESP&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zWQzPmy7n1Ff" title="Principal activities">Undergraduate and graduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_za6I0FudD4Hk" title="Location">Teresina - PI</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_znvFnrd2wAR4" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_z38eqmX67Z3l" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zRcqMXWCruCa" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Centro Integrado de Sa&#250;de de Teresina (&#8220;CIS&#8221;) (v)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zSnBVWW5NM2a" title="Principal activities">Outpatient care</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zaXqNKFgDxR" title="Location">Teresina - PI</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zdFi64odxsi7" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_z8MiPemDdctg" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">FADEP - Faculdade Educacional de Pato Branco Ltda. (&#8220;FADEP&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zdJiDucq4gx8" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zKnEUEBh4UXf" title="Location">Pato Branco - PR</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zL3TPqtol0Hc" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zuJUXviDKN55" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zK5N5l65p6td" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Medcel Editora e Eventos S.A. (&#8220;Medcel&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zOYAsenPo6M8" title="Principal activities">Medical education content</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_z8IqdtmzImEj" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zZ3VzZhSfMEb" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zbxIRxfn1QZb" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_z5abhnmUIGai" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto Educacional Santo Agostinho S.A. (&#8220;FASA&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_z3CNx3A8HgYa" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zMddJ12yLnac" title="Location">Montes Claros - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zcG6gvWygcLe" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zHzTjkrPxdYl" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zrzeDyWOonPe" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">ESMC Educa&#231;&#227;o Superior Ltda. (&#8220;ESMC&#8221;) (iii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zYckGhqslUua" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zyWCdAa85Bhd" title="Location">Montes Claros - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_z5BGUTEEMtyl" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zHh5b58t4B32" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto de Pesquisa e Ensino M&#233;dico do Estado de Minas Gerais Ltda. (&#8220;IPEMED&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_ztZbZLKvSEe5" title="Principal activities">Graduate</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zjcYM0e8Fgtk" title="Location">Belo Horizonte - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zXl2ZbkjAJO" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_z0Wxdk02ZiVe" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zkwIlA8E2VDh" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Instituto Paraense de Educa&#231;&#227;o e Cultura Ltda. (&#8220;IPEC&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_ztm4EYaPUOTc" title="Principal activities">Medicine degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zMUQ5LY4iHEh" title="Location">Marab&#225; - PA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_ziftmOqfGtl5" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zxQognVwrJUf" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zCzYBJmQOj9b" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Sociedade Universit&#225;ria Redentor S.A. (&#8220;UniRedentor&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z1PnvuFrbxW4" title="Principal activities">Undergraduate and graduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zNkch2awVkZ8" title="Location">Itaperuna - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zQGcr5wQuMWf" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zRe0lOTWDiYh" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zYIOhEv10Nfh" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Centro de Ensino S&#227;o Lucas Ltda. (&#8220;UniSL&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zuBWx7tdWpQ6" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_z3opKGOaCFXh" title="Location">Porto Velho - RO</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zwFO7NNBiXzh" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zc8YlpZTM9J5" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zQz09AuUBlhi" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Peb Med Institui&#231;&#227;o de Pesquisa M&#233;dica e Servi&#231;os Ltda. (&#8220;PebMed&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zwGFvmIXDyef" title="Principal activities">Content and clinical tools and online platform</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zM5A2jZsx6Aj" title="Location">Rio de Janeiro - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zlkaSuMeMzIg" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zWvNQFwIR4rd" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zl0z015dT019" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Sociedade de Educa&#231;&#227;o, Cultura e Tecnologia da Amaz&#244;nia S.A. - (&#8220;FESAR&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zhvG7Pp3hpca" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zyqWTj49rf01" title="Location">Reden&#231;&#227;o - PA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zTqDWnFqMr9d" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zpVj7zYLaL92" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zxS06FOXcYy8" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Centro Superior de Ci&#234;ncias da Sa&#250;de S/S Ltda. (&#8220;FCMPB&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zxhl3lsinqO2" title="Principal activities">Medicine degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_ziVT5yMMuZId" title="Location">Jo&#227;o Pessoa - PB</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zheIgQ0Dh8U9" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zfmHirGKCZNd" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zuhISMhBKnS8" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">iClinic Desenvolvimento de Software Ltda. (&#8220;iClinic&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zzGrJmynyihb" title="Principal activities">Electronic Medical Record, Clinical Management System</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zkcxMakLVvWa" title="Location">Ribeir&#227;o Preto - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zsUxdBU8E9i2" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zLb3w41wSBWh" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zx6WPAE9Qkjl" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Medicinae Solutions S.A. (&#8220;Medicinae&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z4DTs95RBlw3" title="Principal activities">Healthcare payments and financial services</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zb5c1OY9Rbsd" title="Location">Rio de Janeiro - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zFoDbLSmb2B6" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zXqWbgktuVw5" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z6KZl2oqbbP1" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Medical Harbour Aparelhos M&#233;dico Hospitalares e Servi&#231;os em Tecnologia Ltda. (&#8220;Medical Harbour&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zZhaYklSCn2" title="Principal activities">Educational health and medical imaging</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zpa5PemScH7b" title="Location">Florian&#243;polis - SC</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90D_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zBjdZFmGiZEd" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zeFv4DEjEF3b" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zYA3VDldq1e3" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Cliquefarma Drogarias Online Ltda. (&#8220;Cliquefarma&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_908_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zvLiXQTf8LMh" title="Principal activities">Online platform</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zFusXC5ny7Kc" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zbGVANp4Wyce" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zl9pB8ZtT1Kk" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_ztbeofn3M1Bi" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Shosp Tecnologia da Informa&#231;&#227;o Ltda. (&#8220;Shosp&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zQ3WpInHHkl8" title="Principal activities">Electronic Medical Record, Clinical Management System</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zVA7XuIDuRoe" title="Location">Rio de Janeiro - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zgNHFinkpyvi" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_z1QpxW0v4xQc" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zAZiw8SIWO57" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Sociedade Padr&#227;o de Educa&#231;&#227;o Superior Ltda. (&#8220;UnifipMoc&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zCVP4KK3mVB6" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zS8FV1BAmsq3" title="Location">Montes Claros - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zO0xBtbGQNik" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zVhbUTgSUfoi" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zjFwRhLh9Sml" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">N&#250;cleo de Aten&#231;&#227;o &#224; Sa&#250;de e de Pr&#225;ticas Profissionalizantes (&#8220;NASPP) (iv)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zvgSfVHkAPV8" title="Principal activities">Outpatient care</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zotfy6njizG1" title="Location">Montes Claros - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zxUrxG5UIAP1" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zInDB4qUV6T9" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Companhia Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura (&#8220;Unigranrio&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zRFOdKj3VQif" title="Principal activities">Undergraduate and graduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zqrwrvNl4p75" title="Location">Duque de Caxias - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zoR14pVTkY8d" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zEHW5VKRSVA4" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zIvk9bsGePvd" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Policl&#237;nica e Centro de Est&#233;tica Duque de Caxias Ltda. (&#8220;Policl&#237;nica&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zP3K1mwjxI3" title="Principal activities">Outpatient care</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zkV1063VGF7l" title="Location">Duque de Caxias - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zoHQsfI7pAAg" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zb3hc3cKhzP3" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zt053CJMdDD8" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt">Sociedade Educacional de Palho&#231;a S/A Ltda. (&#8220;SOCIESP&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_z9rg0MXal5Yl" title="Principal activities">Basic Education</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_ztDKDpmWFDIl" title="Location">Palho&#231;a - SC</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-size: 7pt"><span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_zwZW0J56ukC" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_z30vgAAgnQoc" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt">Instituto de Ensino Superior de Palho&#231;a S/S Ltda. (&#8220;IESP PALHO&#199;A&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt"><span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zORhaIV6bks" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"><span style="font-size: 7pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_z9mQI2YTVdM7" title="Location">Palho&#231;a - SC</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font-size: 7pt"><span id="xdx_908_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zePtyvgsKgOf" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zYWb6iWvlh58" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">RX PRO Solu&#231;&#245;es de Tecnologia Ltda. (&#8220;RX PRO&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zbsKqs9ZcXG1" title="Principal activities">Marketing for pharmaceutical industry</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zgsq6dFy4YT5" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z037R5g6cbE4" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z8R6nYdjZy99" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zNYzlvXy3qJg" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">RX PRO LOG Transporte e Log&#237;stica Ltda. (&#8220;RX PRO LOG&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_z5twhHGud3Mc" title="Principal activities">Marketing for pharmaceutical industry</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zGUG4PmwWgnf" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zzS98P9svIwk" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zoFtLfXjEffh" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_ztZcgDeoVuTh" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">BMV Atividades M&#233;dicas Ltda. (&#8220;Al&#233;m da Medicina&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zWxNA72laWWk" title="Principal activities">Medical education content</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_znFBaUleq8vj" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_z02DjhG0PmQc" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zjWrfOlfth4f" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zQly09pywIFk" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Cardiopapers Solu&#231;&#245;es Digitais Ltda. (&#8220;CardioPapers&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zWa0LFTFxvhe" title="Principal activities">Medical education content</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zIY7kQcj0aca" title="Location">Recife - PE</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_z676l82ua159" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zGzZJe8ufh85" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zYuIkYxF7ki4" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Quasar Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&#8220;Glic&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_901_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zTRc3v0p3fg2" title="Principal activities">Patient physician relationship</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zegdjERLTTKf" title="Location">Barueri - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zmHwMNmfa6s4" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zZmHBrwxCsO6" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zt3uNVeIaDHk" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#8220;DelRey&#8221;) (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_znVw5RN6Zl6d" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_ztuAsEFtnwf4" title="Location">Macei&#243; - AL</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zkSsxRXrU1dk" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zDY9l0MpmWxe" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Uni&#227;o Educacional do Planalto Central S.A. (&#8220;UEPC&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zzFJjJxjPXp3" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zGU3ji6QI6n2" title="Location">Bras&#237;lia - DF</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zC2ujciWITa5" title="Investment type">Associate</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zBGaKF5Qyzdd" title="Direct and indirect interest of subsidiary">30</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zX52vJW5Spj2" title="Direct and indirect interest of subsidiary">30</span>%</span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">See Note 5 for further details of the business combination in 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">IESP was merged by Unigranrio and SOCIESP had its operations closed down, both in January
2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"></td><td style="text-align: justify"><span style="color: #212121">ESMC was merged with UnifipMoc in February 2023.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iv)</td><td style="width: 5pt"></td><td style="text-align: justify">NASPP was merged with UnifipMoc in July 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(v)</td><td style="width: 5pt"></td><td style="text-align: justify">CIS was merged with IESP in December 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="color: #212121">(vi)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="color: #212121">Acquisition</span> of additional interest in CCSI: On October
31, 2023, Afya Brazil acquired an additional 15% interest in CCSI, increasing its ownership interest to 75% of total shares. A cash consideration
of R$21,000 was paid to the non-controlling shareholders. The carrying value of the net assets of CCSI (excluding goodwill on the original
acquisition) was R$10,155, and the difference were recorded in retained earnings in the equity attributable to equity holders of the
parent.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfEstimatedUsefulLivesTableTextBlock', window );">Schedule of estimated useful lives of the assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zAZYZOz6Ydq" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details 1)">
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B0_zaC2EnOUWqdf" style="display: none">Schedule of estimated useful
lives of the assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Building</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zGZ0Olisj3R3" title="Useful lives of assets">25</span> years</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Machinery and equipment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zlijIYD854z1" title="Useful lives of assets">10</span> years</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Vehicles</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zWn083WDFBIa" title="Useful lives of assets">4</span> years</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Furniture and fixtures</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zVPzrKtB97bi" title="Useful lives of assets">10</span> years</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">IT equipment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zdCqKpUaMbQj" title="Useful lives of assets">5</span> years</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Library books</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_z35nlPvrCfH9" title="Useful lives of assets">10</span> years</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Leasehold improvements</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGUH789gLle1" title="Useful lives of assets">5</span> - <span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zr85b7n2lei4" title="Useful lives of assets">20</span> years</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory', window );">Schedule of changes in accounting policies and disclosures</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_zPaMGbNj4N6b" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details 2)">
  <tr>
    <td style="padding-right: 5.4pt; text-align: center"><span id="xdx_8B0_z2WPlSwTKOIj" style="display: none">Schedule of changes in accounting policies and disclosures</span></td>
    <td style="padding-right: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amendments / standards</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Description</span></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_909_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zVRMHPj7cMrl" title="Standard">Amendments to IAS 1 and IFRS Practice Statement 2 - Making Materiality Judgments</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zPZEstU5FyG8" title="Description">The amendments to IAS 1 and IFRS Practice Statement 2 provide guidance and
    examples to help entities apply materiality judgments to accounting policy disclosures. The amendments aim to help entities provide more
    useful accounting policy disclosures by replacing the requirement for entities to disclose their "material" accounting policies
    with a requirement to disclose their "material" accounting policies and adding guidance on how entities apply the concept of
    materiality when making decisions about accounting policy disclosures.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The amendments have had an impact on the Company&#8217;s disclosures of accounting
    policies, but not on the measurement, recognition or presentation of any items in the Company&#8217;s consolidated financial statements.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_905_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_zRiqeDN4JEgk" title="Standard">Amendments to IAS 8 - Accounting Policies, Changes in Accounting Estimates and Errors - Definition of Accounting Estimates</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90D_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_z7GzDbcsH3N" title="Description">The amendments to IAS 8 clarify the distinction between changes in accounting
    estimates, changes in accounting policies and correction of errors. They also clarify how entities use measurement techniques and inputs
    to develop accounting estimates.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">These amendments have no significant impact on the Company&#8217;s consolidated
    financial statements.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_z8uwC8KO8NO6" title="Standard">Amendments to IAS 12 - Income Taxes - International Tax Reform - Pillar Two Model Rules</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_zKFcJhEckc75" title="Description">In October 2021, more than 130 countries agreed to implement a minimum tax
    regime for multinational groups, known as Pillar Two, to reform the international corporate taxation. Pillar Two aims to ensure that multinational
    groups in scope are liable to a minimum effective corporate tax rate of 15 per cent per country.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">In December 2021, the OECD released the Pillar Two model rules - accompanied
    by commentary and guidelines - which are due to be passed into national legislation but adapted by local conditions.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">In response to the OECD's Pillar Two rules, the amendments to IAS 12 were
    introduced and include: (i) a mandatory temporary exception to the recognition and disclosure of deferred taxes arising from the jurisdictional
    implementation of the Pillar Two model rules; and (ii) disclosure requirements for affected entities to help users of the financial statements
    better understand an entity's exposure to Pillar Two income taxes arising from this legislation, especially prior to the effective date.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The countries where the Company has its tax domicile have not yet enacted
    any tax legislation in connection with Pillar Two. Therefore, these amendments have no significant impact on the Company&#8217;s consolidated
    financial statements as of December 2023</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zFXXi5Sw5Jqk" title="Standard">Amendments to IAS 12 Income Taxes - Deferred Tax related to Assets and Liabilities arising from a Single Transaction</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zIcy5ow2bcGl" title="Description">The amendments to IAS 12 Income Taxes narrow the scope of the initial recognition
    exception, so that it no longer applies to transactions that generate equal taxable and deductible temporary differences, such as leases
    and decommissioning liabilities.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">These amendments have no significant impact on the Company&#8217;s consolidated
    financial statements.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_907_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zKw3rf1kHu1g" title="Standard">IFRS 17 - Insurance Contracts</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_903_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zPE0liHDKlPd" title="Description">IFRS 17 is a new accounting standard with scope for insurance contracts,
    covering recognition and measurement, presentation and disclosure. IFRS 17 replaces IFRS 4 - Insurance Contracts. IFRS 17 applies to all
    types of insurance contracts (such as life, property and casualty, direct insurance and reinsurance), regardless of the type of entities
    issuing them, as well as to certain guarantees and financial instruments with discretionary participation characteristics; Some scope
    exceptions will apply.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The overall objective of IFRS 17 is to provide a comprehensive accounting
    model for insurance contracts that is most useful and consistent for insurers, covering all relevant accounting aspects.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The Company does not have any contracts that meet the definition of an insurance
    contract under IFRS 17.</p></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>





<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><b><i>New standards, interpretations and amendments issued
but not yet effective</i></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt">&#160;</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">The new and amended standards and interpretations that are issued,
but not yet effective, up to the date of issuance of the Company&#8217;s consolidated financial statements are presented below. The Company
intends to adopt these new and amended standards and interpretations, if applicable, when they become effective.</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amendments / standards</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Description</span></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_900_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_zfzybCODwgX4" title="Standard">Amendments to IFRS 16: Lease Liability in a Sale and Leaseback</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_z0omFgjvhnbj" title="Description">In September 2022, the IASB issued amendments to IFRS 16 to specify the requirements
    that a seller-lessee uses in measuring lease liability arising from a sale and lease back transaction, in order to ensure that the seller-lessee
    does not recognise any amount of the gain or loss that relates to the right of use that it holds.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The amendments are effective for annual financial statements periods beginning
    on or after January 1, 2024 and shall apply retrospectively to sale and leaseback transactions entered into after the initial application
    date of IFRS 16. Early adoption is permitted but must be disclosed.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_90A_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_zDc4i8S4nvJ" title="Standard">Amendments to IAS 1: Classification of Liabilities as Current or Non-Current</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_z57sh07ltKLl" title="Description">In January 2020 and October 2022, the IASB issued amendments to paragraphs
    69 to 76 of IAS 1 to specify the requirements for classifying liabilities as current or non-current. The amendments clarify:</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; What is meant by the right to postpone liquidation;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; That the right to defer should exist at the end of the financial reporting
    period;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; That the rating is not affected by the likelihood that the entity
    will exercise its right to defer;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#8226; That only if a derivative embedded in a convertible liability is itself
    an equity instrument, the terms of a liability will not affect its classification.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">In addition, a disclosure requirement has been introduced where a liability
    arising from a loan agreement is classified as non-current and the entity's right to postpone liquidation is contingent on the fulfilment
    of future covenants within twelve months.</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024 and should be applied retrospectively.</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span id="xdx_90B_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zkHivH8FOKyc" title="Standard">Supplier Financing Agreements - Amendments to IAS 7 and IFRS 7</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zJDKXm04GSWl" title="Description">In May 2023, the IASB issued amendments to IAS 7 and IFRS 7 to clarify the
    characteristics of supplier financing arrangements and require additional disclosures of such arrangements. The disclosure requirements
    in the amendments are intended to assist users of the financial statements in understanding the effects of financing arrangements with
    suppliers on an entity's obligations, cash flows, and exposure to liquidity risk.</span></p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024. Early adoption is permitted but must be disclosed.</p></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureMaterialAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureMaterialAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfEstimatedUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfEstimatedUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639612223216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory', window );">Schedule of presents assets and liabilities information for the Company&#8217;s operating segments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_zowoJGpjNH8b" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Segment information (Details)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zxn9q4EBFVyh" style="display: none">Schedule of presents assets and liabilities information for the Company&#8217;s
operating segments</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As of December 31, 2023</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total assets</b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zO3h7Wp7wPYa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,104,154</b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOnePnSHCcM4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>180,555</b></span></td>
    <td id="xdx_989_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQHxd17TMF8g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>310,989</b></span></td>
    <td id="xdx_988_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziqurXkxL0o" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,595,698</b></span></td>
    <td id="xdx_982_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zYfNrCb1ugAd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(11,217)</b></span></td>
    <td id="xdx_98C_eifrs-full--Assets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z09d5Usgxfz9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,584,481</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current assets</span></td>
    <td id="xdx_981_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z978Uxo0Fvo4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,001,156</span></td>
    <td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgQXgq4yiOY7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">86,361</span></td>
    <td id="xdx_988_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zAz7p10yNFD8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">127,206</span></td>
    <td id="xdx_981_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zCCVSl4lGYof" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,214,723</span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zSoFSdMQOXz8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(11,217)</span></td>
    <td id="xdx_98A_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvAvnDhotSz2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,203,506</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current assets</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zo7FtF97xjSc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,102,998</span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhwudu40q5Gd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">94,194</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQkIY81gJtul" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">183,783</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvz1b87huqn1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,380,975</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentAssets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z7JU9ksbNGrl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1270">-</span></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zm6uiTPVAxOi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,380,975</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total liabilities and equity</b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z1HSAdrO9dTl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,104,154</b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvzxiZAwqO9c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>180,555</b></span></td>
    <td id="xdx_983_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zUYttPlXFpt8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>310,989</b></span></td>
    <td id="xdx_984_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_znu2YfB7XU5e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,595,698</b></span></td>
    <td id="xdx_981_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNfHEyX1x9D5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(11,217)</b></span></td>
    <td id="xdx_98E_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmABx0VRazH7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,584,481</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current liabilities</span></td>
    <td id="xdx_98B_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zJtwLR0yTTIl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">787,658</span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zTazWYbkDmqh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,447</span></td>
    <td id="xdx_981_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zNDe9qws43Nl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">194,679</span></td>
    <td id="xdx_980_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zy7c74KbQpFa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,069,784</span></td>
    <td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAc9o0e8BeTi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(11,217)</span></td>
    <td id="xdx_98D_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2iJpLRb7Ht5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,058,567</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current liabilities</span></td>
    <td id="xdx_984_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zk3Z5c31fPe5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,783,855</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRbxmmQl1BLj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">57,608</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zWoOZ6DgfyQd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">41,439</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zardOyOBcGbf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,882,902</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zTAxgdvOK1aj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1306">-</span></span></td>
    <td id="xdx_989_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFFJ8YvbNnHf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,882,902</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Equity</span></td>
    <td id="xdx_986_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zGLpQZe6BhZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,532,641</span></td>
    <td id="xdx_986_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrQeQvNTqpq" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">35,500</span></td>
    <td id="xdx_98A_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zr1fyIJnaO12" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">74,871</span></td>
    <td id="xdx_98E_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zj0ZjBPXfoLg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,643,012</span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zdPUe7GA2Uef" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1318">-</span></span></td>
    <td id="xdx_988_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIfaBXPvaDOf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,643,012</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other disclosures</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Investments in associate (i) </span></td>
    <td id="xdx_987_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zIZE99QliOdl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,834</span></td>
    <td id="xdx_98D_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7i1VEzE3UI" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1324">-</span></span></td>
    <td id="xdx_989_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zluDbMWRN4b2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1326">-</span></span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdfQgvy0pgHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,834</span></td>
    <td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zR8Puf19h888" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1330">-</span></span></td>
    <td id="xdx_98C_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXQqHAwn0WCa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,834</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital expenditures (ii)</span></td>
    <td id="xdx_98E_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zYncj3Y1jT32" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">139,361</span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeODFZuHLEk8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,178</span></td>
    <td id="xdx_98C_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zOC6zMUjDJ52" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">63,889</span></td>
    <td id="xdx_980_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zV6QAQdK9Rvj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">218,428</span></td>
    <td id="xdx_98F_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zDOKDulTzbg1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1342">-</span></span></td>
    <td id="xdx_987_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zrnAuiua6BD6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">218,428</span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Investment in UEPC is included in non-current assets in the statement of financial position.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Capital expenditures consider the acquisitions of property and equipment and intangible assets.<br/></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>






<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As of December 31, 2022</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total assets</b></span></td>
    <td id="xdx_987_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zRAE7oqgHOZj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,775,829</b></span></td>
    <td id="xdx_98B_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zolFo5EsoCe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>149,254</b></span></td>
    <td id="xdx_987_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrxROVSHQG4l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>275,564</b></span></td>
    <td id="xdx_989_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zzCfWCJ2B3Ld" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,200,647</b></span></td>
    <td id="xdx_988_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zy6vUZYt5VN8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,108)</b></span></td>
    <td id="xdx_98A_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zK1l5zvbmCUk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,199,539</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current assets</span></td>
    <td id="xdx_984_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zshj11nVrpl8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,461,802</span></td>
    <td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsXRmXsQCIU7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">61,673</span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxScDUIatEKc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">115,290</span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zeAPq0wY2kUk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,638,765</span></td>
    <td id="xdx_983_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_ztMO7e8l3Jr8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,108)</span></td>
    <td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zyyCbYGJunJi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,637,657</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current assets</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCedULKzJPCa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,314,027</span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRvtPJWlYvF2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,581</span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zRAmoep2HWz8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">160,274</span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zHNzsijeAbN8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,561,882</span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zI0Jap3CKnaf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1379">-</span></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWCCeMuPxVrk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,561,882</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total liabilities and equity</b></span></td>
    <td id="xdx_987_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zlniwGjMLN6e" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,775,829</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zxUdxdfwqZi1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>149,254</b></span></td>
    <td id="xdx_982_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z04O7PeF0stc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>275,564</b></span></td>
    <td id="xdx_98F_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zlEIAGUNMGcd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,200,647</b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z101S8P55Iuf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,108)</b></span></td>
    <td id="xdx_982_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMMmVLAM4sz" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,199,539</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current liabilities</span></td>
    <td id="xdx_980_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zHVKXGs4H7p5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">711,896</span></td>
    <td id="xdx_983_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zHopmEGqqt4k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">57,605</span></td>
    <td id="xdx_982_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjmiwW8MXK33" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">137,296</span></td>
    <td id="xdx_98F_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zx46wlx3Egg1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">906,797</span></td>
    <td id="xdx_985_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zMp4XkIcdPSf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,108)</span></td>
    <td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIZ2sxlozLk2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">905,689</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current liabilities</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z8OoURKNYyr4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,938,960</span></td>
    <td id="xdx_987_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFRiL5i2DiC8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">63,990</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z4wWdA0Xp815" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">40,742</span></td>
    <td id="xdx_98C_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z9Ok6sNrLFn1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,043,692</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3mYAqKKub6d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1415">-</span></span></td>
    <td id="xdx_980_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z54MqKjr7J7l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,043,692</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Equity</span></td>
    <td id="xdx_98B_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zDh6dEkO4ubb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,124,973</span></td>
    <td id="xdx_983_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJZxGYHnmPA7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27,659</span></td>
    <td id="xdx_983_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zRHmFb2ANLMh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">97,526</span></td>
    <td id="xdx_984_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZLrnFO41nMf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,250,158</span></td>
    <td id="xdx_984_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z5tNTpv4DqB4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1427">-</span></span></td>
    <td id="xdx_985_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJYqDzfUm4Bk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,250,158</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other disclosures</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Investments in associate (i)</span></td>
    <td id="xdx_984_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zAepd5cXq3vf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">53,907</span></td>
    <td id="xdx_98E_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgYTecDoKIs5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1433">-</span></span></td>
    <td id="xdx_988_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zfteJHFLGTeb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1435">-</span></span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_znDri24KICR2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">53,907</span></td>
    <td id="xdx_980_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z8cwUgmkU74c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></span></td>
    <td id="xdx_981_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbzIGiW2NEy8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">53,907</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital expenditures (ii)</span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zh3P3Ecp5p9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">247,634</span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zb9Vt4QPZHX4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,827</span></td>
    <td id="xdx_986_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxrEh4Ekk5e8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">61,694</span></td>
    <td id="xdx_98F_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z6ZTUL27BiNe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">318,155</span></td>
    <td id="xdx_984_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zmSDKqDW3PP2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1451">-</span></span></td>
    <td id="xdx_98C_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z15F3L6LktE3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">318,155</span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Investment in UEPC is included in non-current assets in the statement of financial position.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Capital expenditures consider the acquisitions of property and equipment and intangible assets.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">Schedule of statements of income for the Company&#8217;s operating segments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_z5E4H2uYt6ki" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Segment information (Details 1)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_ztBZVrPUOngh" style="display: none">Schedule of statements of income for the Company&#8217;s
operating segments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td colspan="6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2023</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External customer</span></td>
    <td id="xdx_985_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zW0ANW1KaFfi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,511,018</span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhE8onfeMyv1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">146,827</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zEwTz4RrCU9j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">218,068</span></td>
    <td id="xdx_98B_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z96KAADCrMyk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,875,913</span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_znadHpbyXdl5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1465">-</span></span></td>
    <td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfQcC7bwFHll" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,875,913</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_986_ecustom--InterSegment_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeSteVLWbEf1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1469">-</span></span></td>
    <td id="xdx_981_ecustom--InterSegment_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrPhohTH1rJi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1471">-</span></span></td>
    <td id="xdx_98A_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0997bcfBvbb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,217</span></td>
    <td id="xdx_987_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJZt8gZkzBkg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,217</span></td>
    <td id="xdx_981_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zyknu0nHf7P4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(11,217)</span></td>
    <td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpsu85eiSUDk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1479">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zgozywOfGwKk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,511,018</b></span></td>
    <td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z8kLyeqFU1He" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>146,827</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zv6DROL7NhS5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>229,285</b></span></td>
    <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zaUJT6aOECd2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,887,130</b></span></td>
    <td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zfKAs0NIPNFe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(11,217)</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfPMenSdwgGg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,875,913</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zzAqL1FANVn4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(997,973)</span></td>
    <td id="xdx_984_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbPoUGNXCgwh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(62,792)</span></td>
    <td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z7Fix8dOMcsb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(60,265)</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zHjDYMwJ1A7b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,121,030)</span></td>
    <td id="xdx_980_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zqdzPpPTpl6l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,217</span></td>
    <td id="xdx_988_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfDHZe3oNdt1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,109,813)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z6Sv5xr9jVM3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,513,045</b></span></td>
    <td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z66xVUinoqwc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>84,035</b></span></td>
    <td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z6ln8JQJdHKb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>169,020</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z1aFBm0be9ge" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,766,100</b></span></td>
    <td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z5HgvmdusNxe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1513">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ze9ihgOAvg6j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,766,100</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Selling, general and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zptqXWW6DbI" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,014,684)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other income, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--OtherGainsLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCPeGXd4czr3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,645</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_982_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2XXFSoS4Eld" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>767,061</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_981_eifrs-full--FinanceIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbX7VPruAHJ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">110,642</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_ecustom--FinanceExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8amPsYdnHVj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(457,616)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_983_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpcY5FVQSeve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,495</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_981_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKA8fykmO3p2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>429,582</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMXxKIy3ZZ6d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(24,166)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_983_eifrs-full--ProfitLoss_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGoN0F0mskdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>405,416</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td colspan="6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External customer</span></td>
    <td id="xdx_985_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zrDg9ZxJO0qh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,037,889</span></td>
    <td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWmjDFLpNA6g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">108,806</span></td>
    <td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zLviOjNWqDza" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">182,362</span></td>
    <td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zff82wLFEEr9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,329,057</span></td>
    <td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAwdwMCw591k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1543">-</span></span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zBb48rrVbBCc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,329,057</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_98A_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zR9b7A66bmh2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1547">-</span></span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zm8xymixof9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1549">-</span></span></td>
    <td id="xdx_981_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrtJg8w7fnac" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,622</span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zn1Uz7HokGC" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,622</span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zViKI05Caqej" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(7,622)</span></td>
    <td id="xdx_987_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zaTCjiIL9lA9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1557">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_986_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCNpeMSCSDY3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,037,889</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj8tKXLhpsJ9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>108,806</b></span></td>
    <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zT4NkcA9XyFe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>189,984</b></span></td>
    <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z4QFcNDPOl9a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,336,679</b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zdIOqhh8D5R3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(7,622)</b></span></td>
    <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxfGQ8E2iOkl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,329,057</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zKtH1D5Ets5f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(763,185)</span></td>
    <td id="xdx_983_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFNJGttMao2k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(56,554)</span></td>
    <td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjCAFpWbYSQj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(47,435)</span></td>
    <td id="xdx_988_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zBbtTvMEcN35" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(867,174)</span></td>
    <td id="xdx_981_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zrUu600CUNb2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,622</span></td>
    <td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYpF51iHSKo" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(859,552)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_981_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z0UsPRksf61j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,274,704</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvX1RALBKoe4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>52,252</b></span></td>
    <td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z8o6gf7mDcJ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>142,549</b></span></td>
    <td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zasbSJr62DU3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,469,505</b></span></td>
    <td id="xdx_98D_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zXxEeGt8tQm6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1591">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpFvcPmzkbE4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,469,505</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Selling, general and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_985_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zR32kNqjmMzl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(798,153)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other expenses, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_985_eifrs-full--OtherGainsLosses_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zb5dNzrx0YT3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(7,252)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zb1ilX8tm4bg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>664,100</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpdBLMb4p1ih" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">102,042</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_ecustom--FinanceExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zV1veEhJqvG9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(349,893)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zSh6wnAB1hBf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,184</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98C_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdBl0ViKWKz5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>428,433</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5leDQZLP5Q2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(35,677)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98C_eifrs-full--ProfitLoss_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zK1M6l0qy6mk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>392,756</b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="6" style="padding-right: 2pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External customer</span></td>
    <td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zTDgKya8BrL1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,498,408</span></td>
    <td id="xdx_98D_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znB33mhLHpXc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">72,983</span></td>
    <td id="xdx_98A_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3NiTetUm9v8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">147,980</span></td>
    <td id="xdx_98C_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zXOtu2LDqxzk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,719,371</span></td>
    <td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zUTZBGCjUI21" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1623">-</span></span></td>
    <td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmSQ08quN9A4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,719,371</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_983_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zbxTcecIlGD3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1627">-</span></span></td>
    <td id="xdx_980_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeU9L9pqKpck" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1629">-</span></span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zV7pWJ2sOTw5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,978</span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zr2BdGWTuYL1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,978</span></td>
    <td id="xdx_984_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zqqiAKynUJJf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,978)</span></td>
    <td id="xdx_985_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z59UgQfM2YTd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1637">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zcCuU4qd1v68" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,498,408</b></span></td>
    <td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z5uusyxhU9ed" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>72,983</b></span></td>
    <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zFsFtlKBbnzb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>151,958</b></span></td>
    <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvkeGmqp2E87" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,723,349</b></span></td>
    <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNFh0pI1WF27" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(3,978)</b></span></td>
    <td id="xdx_982_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zN6qV1KSHbD" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,719,371</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z2vwf64uAxAe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(554,995)</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhppPyNVwig" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(50,773)</span></td>
    <td id="xdx_988_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxztpPHBrttb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(50,510)</span></td>
    <td id="xdx_981_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zpgvmYjn1LT2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(656,278)</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zfM0kbiJVqnl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,978</span></td>
    <td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvUd1hIQasq9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(652,300)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zItmGSX2wqna" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>943,413</b></span></td>
    <td id="xdx_988_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z2aBvSMdA4mc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>22,210</b></span></td>
    <td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zTzBxFJpmTNf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>101,448</b></span></td>
    <td id="xdx_982_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zPbfZadgLDx1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,067,071</b></span></td>
    <td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z29oWpfJhM3a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1671">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAtBRk0UFuG4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,067,071</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Selling, general and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_987_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpwd2qreyvWj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(622,615)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other expenses, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_987_eifrs-full--OtherGainsLosses_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbHVHeJ1sTAi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,561)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zPdnODlGRfjd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>440,895</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcAoFk3YfpDf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">64,566</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_982_ecustom--FinanceExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zwG1A8fWY1Q9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(243,796)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zPccjhkJAwqb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,797</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_986_eifrs-full--ProfitLossBeforeTax_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8nsMy8kF56" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>273,462</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z11LPtW5MSV2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(31,179)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net income </b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98B_eifrs-full--ProfitLoss_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zk9F8EQJpzRc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>242,283</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639606731200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of fair values of the identifiable assets acquired and liabilities assumed acquisition in 2023</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zimvmswtXyFh" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; line-height: 106%"><span id="xdx_8B0_zdO2J5A9ZQwd" style="display: none">Schedule
    of fair values of the identifiable assets acquired and liabilities assumed acquisition in 2023</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 106%">&#160;</td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 142px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>DelRey</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Cash and cash and equivalents</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zx7q3y2GhePk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">7,804</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Trade receivables</span></td>
    <td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztZyakB37YR8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">33,741</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Inventories</span></td>
    <td id="xdx_984_ecustom--Inventories1_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zq4Bedf61RX7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">139</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Recoverable taxes</span></td>
    <td id="xdx_981_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zQacF6a5jItb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">589</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Other assets</span></td>
    <td id="xdx_984_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zE4qyvle0vg9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">8,563</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Property and equipment</span></td>
    <td id="xdx_986_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zB3oTwyMWPQk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">24,980</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Right-of-use assets</span></td>
    <td id="xdx_980_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zBFT0oR3njE6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">65,408</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Intangible assets</span></td>
    <td id="xdx_98C_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zHPO44bCNul2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">728,777</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%">&#160;</td>
    <td id="xdx_983_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z1B1YccetCjc" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>870,001</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Trade payables</span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5Gta590Aknc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">12,253</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Lease liabilities</span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zEGz0l2HWMzd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">65,408</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Labor and social obligations</span></td>
    <td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztrARYUpLdo2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">6,252</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Taxes and contributions payable</span></td>
    <td id="xdx_98E_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zB8UM0w71vU7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Taxes and contributions payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">2,282</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Advances from customers</span></td>
    <td id="xdx_986_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zdhzX7I0nXih" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">38,327</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Provision for legal proceedings</span></td>
    <td id="xdx_982_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmyGKUsIkL5d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">152</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Other liabilities</span></td>
    <td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWc3HKBsjTBl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">4,189</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%">&#160;</td>
    <td id="xdx_98B_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z51nK7lk5Uu" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Financial liabilities recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>128,863</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Total identifiable net assets at fair value</b></span></td>
    <td id="xdx_98A_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5tECIZgEYFj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>741,138</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Goodwill arising on acquisition</span></td>
    <td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztQ18ge7ggB6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">75,098</span></td></tr>

<tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Purchase consideration transferred</b></span></td>
    <td id="xdx_984_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zXh6Ovd8Lzc5" style="border-bottom: black 1pt solid; white-space: nowrap; width: 142px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>816,236</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Cash paid</span></td>
    <td id="xdx_98D_eifrs-full--CashTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmxeILVsOurd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">575,000</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Consideration to be transferred</span></td>
    <td id="xdx_980_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zbGfwW67QsFf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Consideration to be transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">234,000</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Digital solutions (i)</span></td>
    <td id="xdx_985_eifrs-full--CirculationRevenue_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztkxOsTSLjsk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Digital solutions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">7,236</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b><i>Analysis of cash flows on acquisition:</i></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Transaction costs of the acquisition (included in cash flows from operating activities) </span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zVb799D9T362" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Transaction costs of the acquisition (included in cash flows from operating activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">12,332</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)</span></td>
    <td id="xdx_989_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zUYh2rKgST19" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%">567,196</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>Net of cash flow on acquisition </b></span></td>
    <td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zRTlufGOZPqe" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"><b>579,528</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The total consideration transferred included the obligation to offer digital solutions, especially
from Medcel, Pebmed and Medical Harbour, through access (free-of-charge) to medical students of other medical schools held by the selling
shareholders, not subject to this acquisition, from 2023 to 2030. This purchase consideration was measured using assumptions such as
numbers of approved medical seats, current digital solutions prices, inflation and present value discount rates. The balances of such
consideration are classified as other liabilities on the statement of financial position.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfDelReyExplanatory', window );">Schedule of intangible assets acquired</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfAcquisitionOfDelReyExplanatory_zlxEWMMhwBM9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 1)">
  <tr>
    <td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span id="xdx_8BC_zKltqkMykQWc" style="display: none">Schedule of intangible assets acquired</span></td>
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center; line-height: 106%">&#160;</td></tr>
  <tr style="background-color: white">
    <td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center; line-height: 106%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 106%"><b>Valuation technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Licenses</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>With-and-without method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20230101__20230102__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesAndFranchisesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfDelReyMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--WithAndWithoutMethodMember_zwY6rn3TsBfc" title="Valuation technique">The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Customer relationships</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Multi-period excess earnings method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20230101__20230102__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfDelReyMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zwWi3nnsHwla" title="Valuation technique">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</span></p></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock', window );">Schedule of fair values of the identifiable assets acquired and liabilities assumed as of acquisition in 2022</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock_z7pRsCeViO3d" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 2)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B4_zpvBWvTaPcqf" style="display: none">Schedule of fair values of the identifiable assets acquired and liabilities assumed
as of acquisition in 2022</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 55%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Al&#233;m da Medicina</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 15%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>CardioPapers</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 15%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Glic</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash and cash and equivalents</span></td>
    <td id="xdx_984_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zZIiyCYjvmrb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">298</span></td>
    <td id="xdx_98F_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zh54ljKNPFUk" style="text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,648</span></td>
    <td id="xdx_983_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zGjraiCgRBj7" style="text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">151</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade receivables</span></td>
    <td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zT3Go2JZ4FZ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,705</span></td>
    <td id="xdx_98F_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zYAaVFYffyg1" style="text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,350</span></td>
    <td id="xdx_988_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zNLidwplezO" style="text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">94</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other assets</span></td>
    <td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zTgi5Q9GrNLd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other Assets As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">266</span></td>
    <td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zBgPEIGbCPPf" style="text-align: right" title="Other Assets As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1</span></td>
    <td id="xdx_98B_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z38j0DjSkSOa" style="text-align: right" title="Property, plant and equipment recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">36</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Property and equipment</span></td>
    <td id="xdx_987_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zf4v2hxMUcQe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Property, plant and equipment recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">37</span></td>
    <td id="xdx_98C_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zVNHOGk50XQg" style="text-align: right" title="Property, plant and equipment recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">43</span></td>
    <td id="xdx_984_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zPLTq0N2g24c" style="text-align: right" title="Property, plant and equipment recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1792">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Intangible assets</span></td>
    <td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zLXUROZduKWk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Identifiable intangible assets recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">20,299</span></td>
    <td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zmS9Vi0Wy22j" style="text-align: right" title="Identifiable intangible assets recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">28,655</span></td>
    <td id="xdx_982_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zuOXjEssz5zi" style="text-align: right" title="Identifiable intangible assets recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,395</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_986_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zAW2EF13e6gk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>22,605</b></span></td>
    <td id="xdx_98A_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zoFyaTsS3RX7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>33,697</b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zZ9h5n2G5ZV5" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>15,676</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade payables</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zbShxV6woIni" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade and other payables recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">705</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zERhoS0Ry21l" style="text-align: right" title="Trade and other payables recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,703</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zPCa2JdtRuL2" style="text-align: right" title="Trade and other payables recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Labor and social obligations</span></td>
    <td id="xdx_986_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zlx2EepCblV9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Labor And Social Obligations As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">79</span></td>
    <td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z8YmyMNVWFG3" style="text-align: right" title="Labor And Social Obligations As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">60</span></td>
    <td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zCQXZrQGIX69" style="text-align: right" title="Labor And Social Obligations As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1816">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Taxes and contributions payable</span></td>
    <td id="xdx_984_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zbBEZ5JfSSs" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Taxes Payable As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,182</span></td>
    <td id="xdx_98A_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zMuVJGVuvrv7" style="text-align: right" title="Taxes Payable As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">352</span></td>
    <td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zK3d05uactzg" style="text-align: right" title="Taxes Payable As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">91</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Advances from customers</span></td>
    <td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zv2fEdTDm4ul" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Advances From Customers As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,185</span></td>
    <td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zyY2k6Cw4Hke" style="text-align: right" title="Advances From Customers As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,893</span></td>
    <td id="xdx_982_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z2d2nxKZ7nph" style="text-align: right" title="Advances From Customers As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1828">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other liabilities</span></td>
    <td id="xdx_986_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zVKPx78yXUtf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other Liabilities As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1830">-</span></span></td>
    <td id="xdx_987_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zRstoWPCZmkk" style="text-align: right" title="Other Liabilities As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1832">-</span></span></td>
    <td id="xdx_98F_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zMP0RLEp2bFi" style="text-align: right" title="Other Liabilities As Of Acquisition Date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">574</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_987_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zrO1lf7KyW47" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>8,151</b></span></td>
    <td id="xdx_985_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zPPw8EG1sAkj" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,008</b></span></td>
    <td id="xdx_981_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqjfv8Vj4x07" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>666</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total identifiable net assets at fair value</b></span></td>
    <td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zM7X2sxvzGEd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Indemnification assets recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>14,454</b></span></td>
    <td id="xdx_98A_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zKqKfGbHRVwk" style="text-align: right" title="Indemnification assets recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>27,689</b></span></td>
    <td id="xdx_98F_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zEQ3nRtWIrra" style="text-align: right" title="Indemnification assets recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>15,010</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Goodwill arising on acquisition</span></td>
    <td id="xdx_984_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zLuLArMFsagh" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,335</span></td>
    <td id="xdx_98B_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zilRbSQmW8Ta" style="border-bottom: black 1pt solid; text-align: right" title="Goodwill recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,324</span></td>
    <td id="xdx_980_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zNam2rVisFS2" style="border-bottom: black 1pt solid; text-align: right" title="Goodwill recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,587</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Purchase consideration transferred</b></span></td>
    <td id="xdx_98A_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zumHhHtK96Ej" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Consideration transferred, acquisition-date fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>26,789</b></span></td>
    <td id="xdx_981_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zHoIrWBEllo5" style="border-bottom: black 1pt solid; text-align: right" title="Consideration transferred, acquisition-date fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>42,013</b></span></td>
    <td id="xdx_982_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zw32cmPQpCo6" style="border-bottom: black 1pt solid; text-align: right" title="Consideration transferred, acquisition-date fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>30,597</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash paid</span></td>
    <td id="xdx_989_eifrs-full--CashTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zDzK2xio0bjf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,952</span></td>
    <td id="xdx_986_eifrs-full--CashTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zkUj9j1s4cqi" style="text-align: right" title="Cash transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">34,924</span></td>
    <td id="xdx_984_eifrs-full--CashTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zDG7s0ngkyQ3" style="text-align: right" title="Cash transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21,602</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Contingent consideration</span></td>
    <td id="xdx_987_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zFdDMp3rUcE6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Contingent consideration recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,074</span></td>
    <td id="xdx_98B_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zdg6jS358aC9" style="text-align: right" title="Contingent consideration recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,422</span></td>
    <td id="xdx_980_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zvvvsA44uSNh" style="text-align: right" title="Contingent consideration recognised as of acquisition date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,995</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Consideration to be transferred (Price adjustment)</span></td>
    <td id="xdx_982_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zTVZdxqreU7c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Consideration To Be Transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">763</span></td>
    <td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zzci5QDow1ck" style="text-align: right" title="Consideration To Be Transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(333)</span></td>
    <td id="xdx_988_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z6VexzhOC941" style="text-align: right" title="Consideration To Be Transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1876">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><i>Analysis of cash flows on acquisition:</i></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transaction costs of the acquisition (included in cash flows from operating activities) </span></td>
    <td id="xdx_987_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zSfoV1AZqZy2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">227</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zbUM9v1mcATd" style="text-align: right" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">274</span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zzVPSnEeW1Z3" style="text-align: right" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">222</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zN0f44lV96rk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,654</span></td>
    <td id="xdx_984_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zPcPrt3DJFs8" style="text-align: right" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">31,276</span></td>
    <td id="xdx_985_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zyu1k6k3vZeh" style="text-align: right" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21,451</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net of cash flow on acquisition </b></span></td>
    <td id="xdx_980_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zYKuETlqF8S" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>14,881</b></span></td>
    <td id="xdx_98B_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zGhZTDSsTxzh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>31,550</b></span></td>
    <td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqs1AvI6cNY7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>21,673</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory', window );">Schedule of acquisition of al?m da medicina intangible assets acquired</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory_zPFM8XBGUaq9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 3)">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span id="xdx_8BC_zVhuVsSsJZwf" style="display: none">Schedule of acquisition
of al&#233;m da medicina intangible assets acquired</span></td>
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Trademark</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Relief from royalty</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_905_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zrrJInQTzh4k" title="Valuation technique">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Customer relationships</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Multi-period excess earnings method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zUPkDFOqXpX3" title="Valuation technique">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Educational content</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Replacement cost</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--EducationalContentMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zyoHUCxfxK79" title="Valuation technique">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Developed technology intangible assets</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Replacement cost</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zDUiICHyzMXf" title="Valuation technique">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfCardioPapersExplanatory', window );">Schedule of acquisition of cardio papers intangible assets acquired</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--ScheduleOfAcquisitionOfCardioPapersExplanatory_zKJ2Kqk2FVP8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 4)">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span id="xdx_8B8_zabiY7ZPWmx4" style="display: none">Schedule of acquisition
of cardio papers intangible assets acquired</span></td>
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: Black 1pt solid; width: 22%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 78%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Trademark</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Relief from royalty</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zFfWk9vmNik3" title="Valuation technique">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Customer relationships</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Multi-period excess earnings method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zMMkPniWK904" title="Valuation technique">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Educational content</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Replacement cost</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--EducationalContentMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zVwXPUnY1zN4" title="Valuation technique">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Copyrights</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Relief from royalty</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_902_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--CopyrightMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zJr5B1aMXUGf" title="Valuation technique">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</span></p></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfGlicExplanatory', window );">Schedule of acquisition of Glic intangible assets acquired</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfAcquisitionOfGlicExplanatory_zVSBwnyvEeja" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 5)">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span id="xdx_8B6_zDGdRJU8YAq6" style="display: none">Schedule of acquisition
of Glic intangible assets acquired</span></td>
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Trademark</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Relief from royalty</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zMuveJAULSJ" title="Valuation technique">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Customer relationships</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Multi-period excess earnings method</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_900_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zfqTDuTn1yae" title="Valuation technique">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"><b>Developed technology intangible assets</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Replacement cost</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zIj8UB7xA1mb" title="Valuation technique">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfCardioPapersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfCardioPapersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfDelReyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfDelReyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfGlicExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfGlicExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639608716144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureCashAndCashEquivalentsAbstract', window );"><strong>Cash And Cash Equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory', window );">Schedule of cash and cash equivalents</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_zEeZBx7XZqLa" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Cash and cash equivalents (Details)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span><span id="xdx_8BF_zh5yt5OeTomj" style="display: none">Schedule of cash and cash equivalents</span></span></td>
    <td id="xdx_49D_20231231_zpL6JYrCXYmk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_490_20221231_zFavAx2C4l85" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--Cash_iI_pn3n3_zUzq34o500ya" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash and bank deposits</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,746</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,509</span></td></tr>
  <tr id="xdx_403_eifrs-full--CashEquivalents_iI_pn3n3_z6QuZBiS8NNj" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash equivalents</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">541,284</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,035,573</span></td></tr>
  <tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_zbWW3LBgxapa" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Cash and cash equivalents&#160;</b></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>553,030</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,093,082</b></span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureCashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureCashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639605025584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfTradeAndOtherReceivables1Explanatory', window );">Schedule of trade accounts receivable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_zcXX8G9OWaqa" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade receivables (Details)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B5_z600CWMlcfbj" style="display: none">Schedule of trade accounts receivable</span>&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 56%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Tuition fees</span></td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_z3RSpDso4iwg" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">461,066</span></td>
    <td id="xdx_983_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zfmx0OUvksu1" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">356,074</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Educational content (i)</span></td>
    <td id="xdx_986_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zq6uvsPNNe01" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">49,135</span></td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_ztC1kAzguAJ8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">50,913</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">FIES</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zwEBjGFWoAPl" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">62,971</span></td>
    <td id="xdx_985_ecustom--ReceivablesGross_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zSKLt0sGWCq5" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">62,325</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Educational credits (ii)</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zJmkdW14iD8c" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">29,391</span></td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zU9d4l0KR0Kj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">27,535</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Mobile app subscription (iii)</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zSAOFkLWGrfh" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">29,091</span></td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_z7tDP54jTal" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">27,675</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Other</span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zGuN1wrWvZQ1" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">15,667</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zXIa9zvlJUak" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">14,923</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98B_ecustom--ReceivablesGross_pn3n3_c20231231_zJKrwenrbyDi" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>647,321</b></span></td>
    <td id="xdx_989_ecustom--ReceivablesGross_pn3n3_c20221231_zYn0FhkjQsek" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>539,445</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(-) Allowance for expected credit losses</span></td>
    <td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20231231_z4sRESQJxHBf" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(61,398)</span></td>
    <td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20221231_zD35E3TKZRmj" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="(-) Allowance for doubtful accounts"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(44,046)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_988_eifrs-full--TradeReceivables_pn3n3_c20231231_zBebXSeRT3z1" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>585,923</b></span></td>
    <td id="xdx_989_eifrs-full--TradeReceivables_pn3n3_c20221231_zJxF016G6r9k" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>495,399</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Current</span></td>
    <td id="xdx_98A_eifrs-full--CurrentTradeReceivables_pn3n3_c20231231_zUoYhNL0Pdr3" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">546,438</span></td>
    <td id="xdx_989_eifrs-full--CurrentTradeReceivables_pn3n3_c20221231_zAZJhkuW58G2" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">452,831</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Non-current</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20231231_z8BDiOu7MSmj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">39,485</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20221231_zUPatsWoPpCg" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">42,568</span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Related to trade receivables from sales of printed books, e-books and medical courses through
digital platform from Medcel, Al&#233;m da Medicina e Cardiopapers.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Related to the financing programs offered by our subsidiaries to its students that existed
prior to the acquisitions. The Company closed such programs to new enrolments and maintained only the agreements that were outstanding
as of the acquisition date.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"></td><td style="text-align: justify">Related to trade receivables from mobile applications subscriptions for digital medical content.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory', window );">Schedule of aging of trade accounts receivable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_pn3n3_z31tj6BqoTDc" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade receivables (Details 1)">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B1_zXTgmwrQUDpe" style="display: none">Schedule of aging of trade accounts receivable</span>&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; width: 56%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Neither past due nor impaired</span></td>
    <td id="xdx_980_ecustom--ReceivablesGross_pn3n3_c20231231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zNQsuiwSbyN" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">323,614</span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z48gbuvhYxg4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">261,025</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Past due</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">1 to 30 days</span></td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_z9drAPElUfBe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">73,563</span></td>
    <td id="xdx_98C_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zlanM58Kw6u2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 90%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 90%">56,280</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">31 to 90 days</span></td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zWIip0U18ppi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">109,908</span></td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_ztSGptPZz5u4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">90,734</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">91 to 180 days</span></td>
    <td id="xdx_987_ecustom--ReceivablesGross_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zA6OZSZInBqc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">85,193</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zbuHuUw6UjC7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">80,522</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">More than 180 days</span></td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zaHR3SoL7D5b" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">55,043</span></td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zLCdbo4UkXl4" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">50,884</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20231231_zwVCoyJStdvi" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>647,321</b></span></td>
    <td id="xdx_987_ecustom--ReceivablesGross_iI_pn3n3_c20221231_zVYakiJsJrua" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>539,445</b></span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory', window );">Schedule of allowance for doubtful accounts</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--DisclosureOfAllowanceForDoubtfulAccountsExplanatory_pn3n3_z0nx7rfM7TMh" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade receivables (Details 2)">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B6_zdzK6AXX31de" style="display: none">Schedule of allowance for doubtful accounts</span>&#160;</td>
    <td id="xdx_49C_20230101__20231231_z2BOwPN5i6Xg" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_497_20220101__20221231_z0RVueHiCAv6" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49A_20210101__20211231_zMoJJjpuzmI" style="vertical-align: top; text-align: center; line-height: 115%">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; width: 46%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2021</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iNS_pn3n3_di_zUam11NOQEEa" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Balances at the beginning of the year</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(44,046)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(45,013)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(32,980)</span></td></tr>
  <tr id="xdx_40B_ecustom--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_pn3n3_zyXSCfdrfozl" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Additions</span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(74,552)</span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(42,708)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;(47,819)</span></td></tr>
  <tr id="xdx_40C_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_pn3n3_zZgTPY05MKAa" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Write-offs</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">57,200</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">43,675</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">35,786</span></td></tr>
  <tr id="xdx_405_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iNE_pn3n3_di_z6giHqWxwlq" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Balances at the end of the year</span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(61,398)</b></span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(44,046)</b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>&#160;(45,013)</b></span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfTradeAndOtherReceivables1Explanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfTradeAndOtherReceivables1Explanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639668620864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfRelatedPartiesExplanatory', window );">Schedule of balances and transactions with related parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfRelatedPartiesExplanatory_zz5MME0AnKVe" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Related parties (Details)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BE_zJDaeOUYjZyl" style="display: none">Schedule of balances and transactions with related
    parties</span>&#160;</td>
    <td id="xdx_491_20231231_zn3QmHsq48Al" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20221231_zvnu1iuT7Mf4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Assets</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn3n3_zFuYFNUYKIGc" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade receivables (i)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">693</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">917</span></td></tr>
  <tr id="xdx_401_ecustom--OtherAssetsRelatedPartyTransactions_iI_pn3n3_zWvxBoejrbc3" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other assets (ii)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">285</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,975</span></td></tr>
  <tr id="xdx_406_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_pn3n3" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;<b style="display: none">Total</b></td>
    <td style="border-top: black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>978</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,892</b></span></td></tr>
  <tr id="xdx_40A_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_pn3n3_zzaygYW3CdC7" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">792</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,892</span></td></tr>
  <tr id="xdx_40B_ecustom--NoncurrentAssetsOfRelatedParty1_iI_pn3n3_zzcllqmLXdW9" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">186</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2094">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Liabilities</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_407_ecustom--AccountsPayableToSellingShareholders_iI_pn3n3_zu0Csl4m73X5" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders (iii)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2096">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">30,653</span></td></tr>
  <tr id="xdx_40C_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pn3n3_zonsfZ4FmrJ6" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;<b style="display: none">Total</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2099">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>30,653</b></span></td></tr>
  <tr id="xdx_404_ecustom--AccountsPayableCurrent1_iI_pn3n3_zvFhnwbCB46k" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2102">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">30,653</span></td></tr>
  <tr id="xdx_40F_ecustom--NoncurrentPayablesToRelatedParties1_iI_pn3n3_zxXlnAUn3k9f" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2105">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2106">-</span></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Other income (expenses)</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UEPC (i)</span></td>
    <td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zOeqym0A9OJ2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">465</span></td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zZPmWg6lv2Ih" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">477</span></td>
    <td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zpvWO0rnBgql" style="vertical-align: top; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">752</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">EMIVE Patrulha 24 Horas Ltda. (iv)</span></td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_z0WxnDBVN9n3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6)</span></td>
    <td id="xdx_982_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zifXlPlTqD3a" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2116">-</span></span></td>
    <td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zd7RROSFS2jd" style="border-bottom: Black 1pt solid; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2118">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231_zkP58e0Bsoy2" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>459</b></span></td>
    <td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231_zg8lFoEYk5Kc" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>477</b></span></td>
    <td id="xdx_98F_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231_zUeHmV78JCRj" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>752</b></span></td>
    </tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Leases </b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">RVL Esteves Gest&#227;o Imobili&#225;ria S.A.</span></td>
    <td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zZzd9A7zYkok" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,434</span></td>
    <td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zBfY98haxil2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,394</span></td>
    <td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zDMGimCI7L9b" style="vertical-align: top; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,336</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UNIVA&#199;O Patrimonial Ltda.</span></td>
    <td id="xdx_986_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_z5mGjRiVnkab" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,582</span></td>
    <td id="xdx_986_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zinEMFibxGe3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,409</span></td>
    <td id="xdx_981_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zBhwlsaVSYt5" style="vertical-align: top; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,210</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IESVAP Patrimonial Ltda.</span></td>
    <td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zUwhPZ2Jm8k3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,170</span></td>
    <td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zjRKIcxl4Xo9" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,920</span></td>
    <td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zjbwRaMG2wIh" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,560</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231_zUkngkGsrAJg" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>32,186</b></span></td>
    <td id="xdx_98E_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231_zekJvbzrD7vl" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>28,723</b></span></td>
    <td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231_zO694S6i5Dg8" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>23,106</b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to sales of educational content from Medcel to UEPC.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to expenses to be reimbursed by Bertelsmann SE&amp; Co. KGaA.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to amounts payable to our shareholder Nicolau Carvalho Esteves regarding the agreement
to which Afya Brazil acquired the right to develop ITPAC Garanhuns medical school, a greenfield unit. The last installment was paid in
November 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iv)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to amounts of expenses related to security services provided by a company of which
one of Afya&#8217;s main shareholders has significant influence.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock', window );">Schedule of key management personnel compensation included in the Company's consolidated statement of income</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_pn3n3_zBHQ94Gh3mnb" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Related parties (Details 1)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;<span id="xdx_8BA_zXPCFHzISisi" style="display: none">Schedule of key management personnel compensation included in the
    Company's consolidated statement of income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 46%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Short-term employee benefits</span></td>
    <td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20230101__20231231_zBefWbpKb0kj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">16,979</span></td>
    <td id="xdx_982_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20220101__20221231_zL4DpyCzWcT6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,564</span></td>
    <td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20210101__20211231_z0tr1vF34wid" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,933</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share-based compensation plans</span></td>
    <td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20230101__20231231_zzQ6LmZGaqj9" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">21,380</span></td>
    <td id="xdx_98A_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20220101__20221231_z1rBtliWHAm5" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,116</span></td>
    <td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20210101__20211231_zumE8186z1wl" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,251</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_988_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20230101__20231231_zwdO4xCpG5Fc" style="border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>38,359</b></span></td>
    <td id="xdx_989_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20220101__20221231_zWXbVKaXNqnb" style="border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>26,680</b></span></td>
    <td id="xdx_986_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20210101__20211231_zE7BELZG7xjb" style="border-bottom: black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>32,184</b></span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639606247152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOtherAssetsAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfOtherAssetsTableTextBlock', window );">Schedule of other assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfOtherAssetsTableTextBlock_z6H21WFiSn0i" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Other assets (Details)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B6_zkyRIMEwd1Lg" style="display: none">&#160;Schedule of other assets</span></td>
    <td id="xdx_499_20231231_zFbdpRwdlcQf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_491_20221231_zkNqgAseLwQ9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_maAzYGA_z9Mu56LaUtra" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Indemnification assets (i)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">81,855</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">145,300</span></td></tr>
  <tr id="xdx_40D_ecustom--Advances1_iI_pn3n3_maAzYGA_zIrYAazBnCx8" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">39,890</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">30,626</span></td></tr>
  <tr id="xdx_40D_ecustom--JudicialDeposits_iI_pn3n3_maAzYGA_zcrVnF3w1gud" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Judicial deposits</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,187</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,693</span></td></tr>
  <tr id="xdx_403_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_maAzYGA_zR8k57OIjvd" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Prepaid expenses</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,820</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">18,441</span></td></tr>
  <tr id="xdx_40E_eifrs-full--OtherReceivables_iI_pn3n3_maAzYGA_zw1VrfPkYxai" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other FIES receivables</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8,674</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">26,440</span></td></tr>
  <tr id="xdx_40F_ecustom--Dividend_iI_pn3n3_maAzYGA_zKYcIZiUb9F4" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,668</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2244">-</span></span></td></tr>
  <tr id="xdx_407_eifrs-full--DeferredTaxAssets_iI_maAzYGA_zM1PBMEoHB5" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Deferred tax assets</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,233</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2247">-</span></span></td></tr>
  <tr id="xdx_40E_ecustom--OtherAssets1_iI_pn3n3_maAzYGA_zVaPkYCCBasc" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other assets</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,924</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,001</span></td></tr>
  <tr id="xdx_403_ecustom--Assets1_iTI_pn3n3_mtAzYGA_zRz7Mjg08wGi" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;<b style="display: none">Total</b></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>176,251</b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>243,501</b></span></td></tr>
  <tr id="xdx_40C_ecustom--CurrentAssets1_iI_pn3n3_zJyR4AWUv5Kl" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,905</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">51,745</span></td></tr>
  <tr id="xdx_409_ecustom--NoncurrentAssets1_iI_pn3n3_zxnLTgTCEtZj" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">117,346</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">191,756</span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Under the terms of the Share Purchase and Sale Agreements (&#8220;Agreements&#8221;) between
the Company and the selling shareholders of subsidiaries acquired, the Company assesses that the selling shareholders are exclusively
responsible for any provisions (including labor, tax and civil), which are or will be the subject of a claim by any third party, arising
from the act or fact occurred, by action or omission, prior to or on the closing dates of the acquisitions. As disclosed in Note 23(b),
Unigranrio has entered into a tax amnesty program in August 2023 for settling a tax proceeding, which resulted in the write-off of R$20,000
of indemnification assets. The remaining variance is due to the expiration of the related contingent liabilities recognized at business
combinations, mostly due to R$ 28,500 related to tax matters.<br/></td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639633878160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in associate (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfInvestmentsExplanatory', window );">Schedule of investment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfInvestmentsExplanatory_z4HLGBn3Kjw5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Investment in associate (Details)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span id="xdx_8B2_zf9ZwfDtHIt9" style="display: none">Schedule of investment</span></td>
    <td id="xdx_49B_20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zDQwzPX1OZYj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_496_20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z1EfWHBaGETh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentAssets_iI_pn3n3" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">29,004</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">32,651</span></td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentAssets_iI_pn3n3" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">120,289</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">122,378</span></td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentLiabilities_iNI_pn3n3_di_ztVAsEnp3ln1" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(28,842)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(22,840)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentLiabilities_iNI_pn3n3_di_zy25DbP2Jjoc" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current liabilities</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(91,613)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(96,442)</span></td></tr>
  <tr id="xdx_409_ecustom--EquityInAssociate_iI_pn3n3_zw26ITe7A3k4" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Equity</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>28,838</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>35,747</b></span></td></tr>
  <tr id="xdx_40D_ecustom--CompanyShareInEquity1_iI_pn3n3_zM8iJDlzm1Hd" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Company&#8217;s share in equity - 30%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8,651</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,724</span></td></tr>
  <tr id="xdx_40D_eifrs-full--Goodwill_iI_pn3n3" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Goodwill</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">43,183</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">43,183</span></td></tr>
  <tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_pn3n3_z2MVr3LINuJ4" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying amount of the investment</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>51,834</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>53,907</b></span></td></tr>
  </table>
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td id="xdx_498_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zfETjZvp0ou9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_499_20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zjMNmgOWvvce" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_498_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zDIQZLfmuTqi" style="text-align: center; line-height: 10.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--Revenue_pn3n3_z9ofUQhFc654" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Revenue</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">148,042</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">138,584</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">127,618</span></td></tr>
  <tr id="xdx_40A_eifrs-full--CostOfSales_iN_pn3n3_di_zqw2Xki9QeKl" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cost of services</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(71,282)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(57,421)</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(57,935)</span></td></tr>
  <tr id="xdx_407_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_zkVc8qUOLd4l" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Selling, general and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(37,205)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(34,991)</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(24,025)</span></td></tr>
  <tr id="xdx_403_eifrs-full--FinanceIncome_iN_pn3n3_di_zDFrby0MZLra" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Finance results</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,123)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,103)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,585)</span></td></tr>
  <tr id="xdx_40F_eifrs-full--ProfitLossBeforeTax_pn3n3_ztihFdewGr5" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Income before income taxes</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>33,432</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>42,069</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>41,073</b></span></td></tr>
  <tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_z50VfcbUIrC1" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes expenses</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,782)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,456)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,748)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--ProfitLoss_pn3n3_zHwWe177BJZk" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net income</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>31,650</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>40,613</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>39,325</b></span></td></tr>
  <tr id="xdx_40C_ecustom--CompanyShareOfProfitss_pn3n3_zHRPkXt37XY3" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Company&#8217;s share of income</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>9,495</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>12,184</b></span></td>
    <td style="border-bottom: black 1.5pt double; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>11,797</b></span></td></tr>
  </table>
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td id="xdx_49C_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zGArAD1AUiTf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_49D_20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zwY9uhvj2sSc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_49E_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zEcDMIw7jRRk" style="text-align: center; line-height: 10.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023 </b></span></td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 18%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iS_pn3n3_zm2ggDiW1Gy5" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening balance</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">53,907</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">48,477</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">51,410</span></td></tr>
  <tr id="xdx_402_ecustom--DividendsReceived1_iS_pn3n3_zOXCrcFwrJi1" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends received</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(9,900)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,754)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,770)</span></td></tr>
  <tr id="xdx_40C_eifrs-full--DividendsReceived_iN_pn3n3_di_zU7jtTViQvE9" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends receivable (included in Other assets)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,668)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2331">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,960)</span></td></tr>
  <tr id="xdx_408_eifrs-full--ProfitLossOfAcquiree_pn3n3_zqpKcWwd2MJa" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share of income</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">9,495</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,184</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,797</span></td></tr>
  <tr id="xdx_40E_eifrs-full--InvestmentsInAssociates_iE_pn3n3_zYyHYwFGiFNf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Closing balance</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>51,834</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>53,907</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>48,477</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfInvestmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfInvestmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639612159472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of detailed information about property, plant and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_zZEWCyy555d6" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Property and equipment (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B3_zQEl9A6uJj73" style="display: none">Schedule of detailed information about property, plant and
    equipment</span>&#160;</td>
    <td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_z8abgi33upzh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zf8tcOwIqf1k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BD_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zj6SHCcJcB2f" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BF_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zSXYrBl1WoPj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zzUG5hGgRyI7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zo3Rg6lcN4we" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_zZynmJgem435" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zMfBeWOSeudc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zMWIdTkS11c4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B1_zIDp1piHuHJd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 26%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Cost</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Building</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Machinery and equipment</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Lands</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Vehicles</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Furniture and fixtures</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>IT equipment</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Library books</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Leasehold improvements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Construction in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z4MBeggb45d2" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of January 1, 2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>25,919</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>68,503</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>13,401</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>1,215</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>29,131</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>28,511</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>21,624</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>122,005</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>3,706</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>314,015</b></span></td></tr>
  <tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zetNm5W9g4k1" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1,384</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">10,268</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">5,451</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">111</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">21,075</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">19,511</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">3,392</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">4,720</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">59,957</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">125,869</span></td></tr>
  <tr id="xdx_43B_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zSwL6zuRCjI2" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Business combinations</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2369">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">12,810</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2371">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">346</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">16,684</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">10,138</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">5,142</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">17,425</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">3,078</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">65,623</span></td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zlQD5dHwykTi" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">62</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(14,213)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2382">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(205)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">2,862</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(4,985)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(86)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(550)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(417)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(17,532)</span></td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z7IveAahZWEa" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">25,068</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">3</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2393">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2394">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">82</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">9</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2397">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">9,376</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(34,538)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2400">-</span></span></td></tr>
  <tr id="xdx_436_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z2YDC1xxeiS7" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>52,433</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>77,371</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>18,852</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>1,467</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>69,834</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>53,184</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>30,072</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>152,976</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>31,786</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>487,975</b></span></td></tr>
  <tr id="xdx_43F_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zHSDlIFCglCf" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">527</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">36,486</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2415">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">968</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">26,047</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">15,766</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">645</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">2,667</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">85,026</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">168,132</span></td></tr>
  <tr id="xdx_433_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zP3l848kiefg" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Business combinations</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2424">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">45</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2426">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2427">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2428">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">35</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2430">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2431">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2432">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">80</span></td></tr>
  <tr id="xdx_431_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zbiz6XlzuRn8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">13</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(8,159)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2437">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(933)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">500</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(6,992)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2441">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2442">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(78)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(15,649)</span></td></tr>
  <tr id="xdx_43B_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zqvhraoiPuhd" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">38,884</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(5,353)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2448">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(449)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(5,669)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">6,600</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">6,645</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(9,797)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(30,046)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">815</span></td></tr>
  <tr id="xdx_43F_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z8apsVYXq2f3" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>91,857</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>100,390</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>18,852</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>1,053</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>90,712</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>68,593</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>37,362</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>145,846</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>86,688</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>641,353</b></span></td></tr>
  <tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zV4EVRHS5eck" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">96</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">20,071</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2470">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">776</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">17,914</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">21,135</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">985</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">49</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">57,409</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">118,435</span></td></tr>
  <tr id="xdx_439_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zm0dNpdiARqb" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Business combination</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2479">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">7,729</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2481">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2482">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">4,384</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">734</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1,329</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">10,741</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">63</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">24,980</span></td></tr>
  <tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zzRl6ps9NjDi" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2490">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(9,411)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2492">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(475)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(1,443)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(7,979)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(7,788)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(286)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2498">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(27,382)</span></td></tr>
  <tr id="xdx_434_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z35FEaZs37ga" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1,279</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1,202</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2503">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2504">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(708)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">327</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2507">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">108,098</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(110,198)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2510">-</span></span></td></tr>
  <tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zfmaaXRvZw0j" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>93,232</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>119,981</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>18,852</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>1,354</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>110,859</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>82,810</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>31,888</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>264,448</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>33,962</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>757,386</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Depreciation</b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_434_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zpno1fGEG8C5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of January 1, 2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2523">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(19,322)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2525">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(171)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(8,089)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(10,851)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(10,817)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(4,384)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2531">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(53,634)</b></span></td></tr>
  <tr id="xdx_430_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iNP2custom--WritOffOfPropertyPlantAndEquipment_pn3n3_di_zxG07a0Rjdzl" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(1,673)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(7,215)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2536">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(196)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(5,601)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(7,529)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(3,416)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(4,831)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2542">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(30,461)</span></td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zKgSeDrT9dXc" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">&#160;Write-off (i)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2545">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">10,146</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2547">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">147</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1,194</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">3,458</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">633</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">350</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2553">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">15,928</span></td></tr>
  <tr id="xdx_435_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zYE8bGKtX2m1" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(1,673)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(16,391)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2558">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(220)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(12,496)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(14,922)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(13,600)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(8,865)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2564">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(68,167)</b></span></td></tr>
  <tr id="xdx_439_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zCgvb9aKLUn" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(3,472)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(11,166)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2569">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(284)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(7,725)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(10,140)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(3,415)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(8,849)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2575">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(45,051)</span></td></tr>
  <tr id="xdx_43B_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zanpP2KrUvwe" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2578">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">5,474</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2580">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">791</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">153</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">7,350</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">67</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">117</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2586">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">13,952</span></td></tr>
  <tr id="xdx_438_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zII350CFvQ64" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(606)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1,453</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2591">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">1</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">9,719</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(4,125)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(5,940)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(502)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2597">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2598">-</span></span></td></tr>
  <tr id="xdx_436_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zvwRCn5kCssk" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(5,751)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(20,630)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2602">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>288</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(10,349)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(21,837)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(22,888)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(18,099)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2608">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(99,266)</b></span></td></tr>
  <tr id="xdx_435_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_ztOLxx2Lfebb" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Depreciation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(4,242)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(14,900)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2613">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(325)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(12,556)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(13,286)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(3,327)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(26,271)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2619">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(74,907)</span></td></tr>
  <tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zM1HTf8u42sb" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">118</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">6,684</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2624">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">235</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">2,528</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">8,254</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">7,563</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">90</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2630">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">25,472</span></td></tr>
  <tr id="xdx_43F_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zJlU59QXGju4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">196</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">3</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2635">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2636">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2637">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(3)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2639">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt">(196)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2641">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2642">-</span></span></td></tr>
  <tr id="xdx_43D_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zoFejK1dwQzc" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(9,679)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(28,843)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2646">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>198</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(20,377)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(26,872)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(18,652)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(44,476)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2652">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>(148,701)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>Net book value</b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>83,553</b></span></td>
    <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>91,138</b></span></td>
    <td id="xdx_984_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>18,852</b></span></td>
    <td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>1,552</b></span></td>
    <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>90,482</b></span></td>
    <td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>55,938</b></span></td>
    <td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>13,236</b></span></td>
    <td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>219,972</b></span></td>
    <td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>33,962</b></span></td>
    <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>608,685</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>86,106</b></span></td>
    <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>79,760</b></span></td>
    <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>18,852</b></span></td>
    <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>1,341</b></span></td>
    <td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>80,363</b></span></td>
    <td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>46,756</b></span></td>
    <td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>14,474</b></span></td>
    <td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>127,747</b></span></td>
    <td id="xdx_983_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>86,688</b></span></td>
    <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"><b>542,087</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to items written-off as result of lack of expectation of future use, in connection
with the Company&#8217;s physical inventory procedures.</td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639606673376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureIntangibleAssetsAndGoodwillAbstract', window );"><strong>Intangible Assets And Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_z9SFZ004WEei" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets and goodwill (Details)">
  <tr>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt"><span id="xdx_8BB_zLquPfqPr8Bb" style="display: none">&#160;Schedule of intangible assets</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt">&#160;</td></tr>
  <tr>
    <td style="width: 28%; padding-right: 1.45pt; padding-left: 1.45pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Goodwill </b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Licenses with indefinite useful life </b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Trademark</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Customer relationships</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Software</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Education content</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Developed technology</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Educational platform</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Software in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 4%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>&#160;</b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Cost</b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of January 1, 2021</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrVs4nJUBvA9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>810,656</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zOsUP4LXxWQd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,451,270</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfZqZIoN3gme" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>75,014</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQYrwcgh78ma" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>283,539</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkLKk2HrHMi3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>16,221</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zke8tn0YX0Rb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>17,305</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zT3slotvRSR7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>355</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zViySlwYFhm8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>27,902</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxPWglJrrwsg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,297</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeN9grCjSwI7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2718">-</span></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6CMpPtVlLZ4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,684,559</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Additions (vi)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvF23pO4yaQg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">108,000</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyULZJr7rUy4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">684</span></td>
    <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMuHgpTac5ed" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,044</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zN4HWHJwhbai" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">996</span></td>
    <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zE7NuDfp5Gnc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">39,686</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zK9nOPUKaPG8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">23,700</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3VGszF3dGSh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">176,110</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zG89zNqyy2R7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,020</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbCREwHIf1s" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(2,743)</span></td>
    <td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvIOCCM6fxme" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(417)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsEaR8AObK8j" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(2,140)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Business combinations</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zGCFGqPXmtZ8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">373,680</span></td>
    <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRZauQn34Qef" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">606,136</span></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhW6NlxD9l6l" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">58,355</span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziCEbjJ2VSi6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">147,054</span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCWFJKgYx14g" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,474</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5M5uUxiZUW9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">33,046</span></td>
    <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z61g1bMg0Ftf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">11,599</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgBP8vMOjDcl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,267</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAc5XlVajV9c" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,234,611</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2021</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuKUQ0QxcNR6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,184,336</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkyMX8gPOepg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,165,406</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztvE8u7ibCCf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>133,369</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7wa0fhFQBfg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>431,277</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zh6bZ8xBT71e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>21,759</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZRiz76GAXY" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>17,305</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zF6u2yMw22Oa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>34,397</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvTgObYwq03e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>76,444</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zA0Wf5zyLd66" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>28,847</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRjp7MXSscPk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2780">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKIR6xabatC6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,093,140</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Additions (i) (ii)</span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zFy6RuIPCYK6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">39,100</span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUvoPygPAq3d" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">24,408</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoLJxtcViQL8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">80</span></td>
    <td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxKt1ZXxt9Y2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,423</span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zpBPCLzDBTZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">11,231</span></td>
    <td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR7ixPmQ1mU2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">32,879</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6E7Vd03Mz5e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">14,761</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwNbbNuomi8k" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">26,141</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7FnFfMH9im4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">150,023</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_982_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zs7brwltqOag" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(22)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zr2u6gQHBWQ" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(381)</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zC2lw0uZlgF4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(7)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zXrK5HfiWKSd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(9)</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z3V02sLT2tk3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(28)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zAHqoxFsK382" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(447)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Remeasurement (iii)</span></td>
    <td id="xdx_98A_ecustom--Remesurement_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zt4LxZk4o1b5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(8,637)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_987_ecustom--Remesurement_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zSjSRpRi6Ry7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(8,637)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transfer</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zm7EzOl2JYqf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(2,472)</span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9KFNs0Bmz96" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">530</span></td>
    <td id="xdx_98F_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLvMGXy2m4la" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">20,466</span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zE2VFXVKUvl4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">38,433</span></td>
    <td id="xdx_989_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMhiJG9r6d2k" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">17,953</span></td>
    <td id="xdx_989_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxpjg8n9eJWg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(35,499)</span></td>
    <td id="xdx_982_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgLVjYOX7nSb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(40,226)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zacZqLhiLYSh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(815)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Business combinations</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsw3RHiwQQ0e" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">42,246</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhNOvEBUHzQ9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">51,185</span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2UV5YPjjBHl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,929</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLxhpCOVnyO4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">33</span></td>
    <td id="xdx_988_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zj7IBwHMhQZ" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">2,627</span></td>
    <td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvI0Eg58qRd7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,520</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgA0OV25wTO3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,055</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfhtXkzWgI6i" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">106,595</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZGbWiJzMptc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,257,045</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zid4tDg6Duzk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,189,814</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmgtpoFnBs7i" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>182,060</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLz7s3H970df" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>435,816</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfGdNwDCzqY1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>43,300</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqzm1nUYnHBk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>69,589</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvs2JUEzY892" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>90,749</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztWrXATFPEUe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>55,697</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2wUNIGwCnn8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>14,734</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRMz5IwE6sO1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,055</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVF2wAQplVF7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,339,859</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Additions</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zGiZtIR7jDNd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,314</span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zn5r3EFssVV3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">9,827</span></td>
    <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zAvY8yKtbY7a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">37,712</span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zrGW628YStRh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">23,164</span></td>
    <td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____z2Wf7ULHomg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">27,976</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____za619doDJEQc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">99,993</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsqfToq76mWl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(2,235)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHIvsvqICiF4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(911)</span></td>
    <td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAqOqcUZ1fV7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(125)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4CyNOZlxFif" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(3,271)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Remeasurement (iv)</span></td>
    <td id="xdx_988_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkkyKSrbQW4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">2,556</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98E_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zT3GK1cRZFjd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">2,556</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transfer</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkFVkkEILxHk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">28,708</span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQG1r1Cc4mCc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,785</span></td>
    <td id="xdx_980_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7wH2IadM7u6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">16</span></td>
    <td id="xdx_98F_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6c1L7rUz7uc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(3,058)</span></td>
    <td id="xdx_984_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziSvCId07ll4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(30,451)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Business combination (v)</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHKkn2F9f5R2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">75,098</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsTwMyWH84za" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">586,263</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmHQbEFXgH02" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">142,451</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlcFMWXcg90h" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">63</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKUlaNc2BSt9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">803,875</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfTVpOiyKlCj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,334,699</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyBhyK3VHgF9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,776,077</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXvGNXVeCyx5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>182,060</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCTz7fEVcqWf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>578,267</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMlTARrHb4A3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>71,150</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRMES8oDqJ57" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>84,201</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z43C2DF0VF5i" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>128,477</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zdFlphCY2aH4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>74,892</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3pRmdFD5jec" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>12,134</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLsa5CtlazLg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,055</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3HBoyN7Umbe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>5,243,012</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Amortization</b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of January 1, 2021</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJdlYZWxNtn8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2938">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z5kPPI9XB7u3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2940">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxvAAkhuktK5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(3,502)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8Q9IsXNzc9h" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(85,832)</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmbW62Qc5m14" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(6,256)</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z7bke0i420q7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(7,692)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zg0tZNg5jOMl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(32)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8WB1A0dvnh" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(8,235)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkE5CAAvBZFg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2954">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>-</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z9bRG8BBvKZc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(111,549)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Amortization</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iP2custom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvngUNyQYOW8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl2958">-</span></span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z6PTZmw3J3Ca" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl2959">-</span></span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4EPdygNyKVc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(5,027)</span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjeS2aFfrBW7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(56,438)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zudlFPP8ECCj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(5,844)</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zPn81oAhimq4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(8,980)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1oi55s6Gaa9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(625)</span></td>
    <td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUkudD4TwWhg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(3,608)</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvxlt8PwE4g2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl2968">-</span></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRgYc87MKQ78" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(80,522)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_986_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zB9o870cnC7e" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(599)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_980_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRmp754MQROa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">365</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zrdK0dZxDzq9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(234)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2021</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUVFqH5h9816" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2977">-</span></b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zOprGAmmEoQa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2979">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzpzAPhoTcr" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(8,529)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQJtlGdy8rrk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(142,270)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3f7gnY7krYd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(12,699)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkfYhmtObfk9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(16,672)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zU9b3749VCr9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(657)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKdgQGoYTPkh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(11,478)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlEmY6swP4sb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2993">-</span></b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zk6Bl2dBFlHi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2995">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAOztK89xXnc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(192,305)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Amortization</span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRIqLr58LeHc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl2999">-</span></span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zZ7uEvAsvJn4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3000">-</span></span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zaOFsDGvO1Kj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(6,426)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z5SHk6zZZtp1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(70,093)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIBzUyzLtzXe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(4,943)</span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1KLnEPPvsL5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(9,634)</span></td>
    <td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzUZSVylsrPi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(9,436)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zspCp7XfNRz9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(5,874)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFcICCaZcy54" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3008">-</span></span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDgSWPcpEpNk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(79)</span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zpqGiDSi1IJ4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(106,485)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_986_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhw7RbRISOna" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">365</span></td>
    <td id="xdx_985_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKE3GEPFeF56" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">57</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98B_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFCuvVlZuYL9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">422</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFvp4ObR37Kd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(313)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zw5xUo9Mgk51" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">313</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1Q7lutEHQO8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3022">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zu5EFWbDZEMe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3024">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlBnkyvk0ev7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(14,955)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zR9jM67yGAG3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(212,363)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgDyDdWjDuWa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(17,277)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZdbPDLMuWx2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(26,562)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbN3g81tOMI6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(10,093)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhxf7VctRsmj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(17,039)</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zukZwSmCdKsd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3038">-</span></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zV5tIWM2QCOa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(79)</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSRIPuk60oai" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(298,368)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Amortization</span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIIclee4CFP3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3044">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zLujbAMj9hQ8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3045">-</span></span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQpffWkfUrO" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(11,083)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z95ZNUJtiHD6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(89,584)</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1dLqJhChIH5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(8,764)</span></td>
    <td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmhdnex591ga" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(15,668)</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zPPtr2Ph0rf6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(21,504)</span></td>
    <td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvWZ4NvXxo4h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(4,778)</span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuMvzAD5mG47" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl3053">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTjLK0f2CxId" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(105)</span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNiowokeDkqg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(151,486)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Write-off *</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_98C_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8kFhGgLh35b" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,947</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFrYtYTNmaE9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">911</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTzdX7Tjbo3f" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">2,858</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transfer</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td id="xdx_981_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zcQtpkZ8TRzi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(6)</span></td>
    <td id="xdx_982_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zl3R7RlPDiy3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zakSIViJpJRd" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3067">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zxFpcVDfyLo8" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3069">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zf2zfeQdub9b" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(26,038)</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0nNI8J2TV18" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(301,947)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z7snqh43ffZh" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(24,094)</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHJJPLfjeOa7" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(42,230)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqfARSPMviJc" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(31,603)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8WDvcsqHa9h" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(20,900)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zsAddT3S3ePl" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3083">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztQmxjLn3pcj" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(184)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUWCWpRFgOx9" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>(446,996)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Net book value:</b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zZGSmpyy3nLe" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,334,699</b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zzybL6jFJ5sl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,776,077</b></span></td>
    <td id="xdx_988_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zEzdVnnyc3Sg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>156,022</b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zdJp51vna8dk" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>276,320</b></span></td>
    <td id="xdx_98B_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z7haIx8TeALb" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>47,056</b></span></td>
    <td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zM3WVlTyWfa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>41,971</b></span></td>
    <td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zlhXNCCNXK0i" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>96,874</b></span></td>
    <td id="xdx_980_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zhwgLjcKB0Ie" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>53,992</b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zweSqKpBdCcg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>12,134</b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zxd75R6u9n5k" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>871</b></span></td>
    <td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231_zjABLBpRPTtl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,796,016</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_98A_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zhOroOPXFxC8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,257,045</b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zonPhVoD51rh" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2,189,814</b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zYCJD4dpY14h" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>167,105</b></span></td>
    <td id="xdx_98E_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zZMrU3EO4Npb" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>223,453</b></span></td>
    <td id="xdx_98D_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zqlvgHB4BsE6" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>26,023</b></span></td>
    <td id="xdx_987_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zRNXNQ7OmQYb" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>43,027</b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zu3tByWXgf42" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>80,656</b></span></td>
    <td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zdtvT4oTgRKa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>38,658</b></span></td>
    <td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zMGUPMHfcb2k" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>14,734</b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zg4WqQp94Ppg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>976</b></span></td>
    <td id="xdx_983_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231_zPLbXUJyuXWf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,041,491</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">*</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to intangible assets written-off as result of lack of expectation of future use.</td>
</tr></table>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Licenses with indefinite useful life: On March 18, 2022, MEC authorized the increase of 28
seats of Centro de Ensino S&#227;o Lucas, located in the city of Ji-Parana, State of Rond&#244;nia. The earn-out related to the seats
approval is R$800 per seat, adjusted by the CDI rate from the closing until the payment date, of which 50% was paid in April 2022 and
the remaining amount is payable in cash in two equal installments through 2024.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Goodwill: During the measurement period, the preliminary goodwill for the acquisition of
Unigranrio was adjusted by R$39,100 (R$130,073 initial goodwill) as a result of an increase of liabilities regarding tax contingencies
and judicial deposits to be reimbursed by the selling shareholders.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"></td><td style="text-align: justify">Goodwill: During the measurement period, R$8,637 of goodwill arising from the acquisition
of RX PRO was reduced, in connection with management&#8217;s view of remote likelihood of RX PRO achieving the revenue goals estimated
at the terms of the earn-out.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iv)</td><td style="width: 5pt"></td><td style="text-align: justify">Goodwill: During the measurement period, results of operation such as revenue differed from
the foreseen, resulting in a remeasurement of the contingent consideration for the acquisitions of Al&#233;m da Medicina, CardioPapers
and Glic by R$4,773, R$5,082 and (R$7,299), respectively, totaling R$2,556 for the year ended December 31, 2023.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(v)</td><td style="width: 5pt"></td><td style="text-align: justify">Business combination: On January 2, 2023, Afya Brazil acquired DelRey, a post-secondary education
institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs in medicine and health, as
well as other courses. See Note 5.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(vi)</td><td style="width: 5pt"></td><td style="text-align: justify">On November 5, 2021, MEC authorized the operation of 120 medical school seats in Garanhuns,
for which our shareholder Nicolau Carvalho Esteves entered into an agreement with Afya Brazil pursuant to which he assigned to Afya Brazil
the right to develop the ITPAC Garanhuns greenfield unit, a medical school in the city of Garanhuns, State of Pernambuco. Management
assessed the aspects of such transaction and concluded that the transaction does not fall under the definition of business, but an acquisition
of license with indefinite useful life recognized in intangible assets. Total purchase price was R$108,000 of which 50% was paid in cash
on the transaction closing date and 50% in two equal annual installments, adjusted by the CDI rate.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock', window );">Schedule of assumptions for impairment test</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_zzqMOzqQmxu5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets and goodwill (Details 1)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B9_ziu210ar3Zf5" style="display: none">Schedule of assumptions for impairment test</span>&#160;</td>
    <td colspan="6" style="padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in">&#160;</td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Carrying amount</b></span></td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CGU</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Goodwill</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses with indefinite useful life</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CGU</b></span></td></tr>
  <tr>
    <td style="width: 42%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IPTAN</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zMEWTMkMpEH4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">17,446</span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zIkXUBa16O7k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">17,446</span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z6Fls3KSSqnb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,214</span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zvfNAJ2RJIMb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,214</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_znwjueBf1G89" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">125,974</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zMDNzNIOnjHl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">126,024</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IESVAP</span></td>
    <td id="xdx_98B_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z7ebTmxWG6p4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,956</span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zQvCNbegZtXc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,956</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zPHJHpr2rKTb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">81,366</span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zbxbycrv7g5a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">81,366</span></td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z5S3vE0ekyYh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">126,996</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zgwRU3M123M6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">129,305</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">CCSI</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zKcobUcnJMq9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,664</span></td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zJLjxQJG5AKb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,664</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zuLKXhrw9nU4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">56,737</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zG64JkeD6Elc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">56,737</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zilNfsjrdUSc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,550</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zYALhgNLVtI2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">53,540</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IESP</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zCXXn4mdrD33" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">73,838</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zjUFSH9gJEhb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">73,838</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zoqOobLHD47c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">179,693</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z1jem8KIGXv7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">179,693</span></td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zjxNITJg7NW9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">332,104</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zef18tATxUUa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">322,968</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FADEP</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zHtXp28SMVod" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">49,661</span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zw6olpzqlRBg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">49,661</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z5uunxL2nnZc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,606</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zunecelcRBY8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,606</span></td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z6YdRN9vxIl4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">148,032</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zewHKSZ1p6Bh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">153,100</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FASA</span></td>
    <td id="xdx_986_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zfgPda5LeHDj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,903</span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zjY43R9RRDu1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,903</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zhesAjMK4rp2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">144,507</span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zhZ9picPDTC3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">144,507</span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zjxz2LQitxP5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">322,061</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zCayavTFR9J7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">314,967</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IPEMED</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zu2mPxcHrT0c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">87,647</span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zcshSisPUGgj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">87,647</span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pdn3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z25VZU1CGw25" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3211">-</span></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pdn3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zmqwQXQ9rgZ" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3213">-</span></span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zOlGb0N0iB6a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">183,862</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zidgkAWSlAnj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">192,079</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IPEC</span></td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zm2QANN48k4a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3219">-</span></span></td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z1QBDqes9YSd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3221">-</span></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zqF6wqcDIPh2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,000</span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zFdSO4LRWNJe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,000</span></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zgDqQM9L7Sy7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">157,984</span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zAKstAcVKdlc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">148,067</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UniRedentor</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z87ar33N0chl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">77,662</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zvJu3I9tjZC9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">77,662</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zfrMkXMcAvT8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">121,477</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zGOd5FyX8iqj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">121,477</span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zjCpXIc7VDhh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">234,054</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zsMODGEGb8Ei" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">242,600</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UniSL</span></td>
    <td id="xdx_986_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z4cbjCoukwRb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,420</span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z7fmhq1wbJb2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,420</span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____zGllazCKwied" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">273,795</span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____zfYzpiAOaFo" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">273,795</span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z35OmdMnPQQ6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">401,143</span></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z5JFUJwEUbt6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">398,492</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FESAR</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_ziAUqEIV6Xeg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71,664</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z5FfmjHVNTJi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71,664</span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zxzIvEcbBHw6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">141,616</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zqGIL1Pb9mFf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">141,616</span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zZEQer5sJGkl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">244,412</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zRvY34SNW7gg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">244,084</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FCMPB</span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zmPG9b50T1m1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">110,483</span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zIx1Xlu3zKY1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">110,483</span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z8AxymdEeI6i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">235,018</span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z4vMseSAXgUj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">235,018</span></td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z2g3pY63APJ" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">402,140</span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z7G87aGR4nG4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">415,453</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">ITPAC Garanhuns</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zuzXHHupWVZ8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3279">-</span></span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zMDyE9rgVERa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3281">-</span></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zWVTlzHZlvM9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,000</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zisSFrJbq6y6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,000</span></td>
    <td id="xdx_986_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zlQmANWZhK4d" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">116,162</span></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z9YGEQwdzpAg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">112,628</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Content &amp; Technology for medical education (Pillar 1) *</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zA9Sh42jmvwj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">179,830</span></td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zNUCwkxzTvod" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">169,975</span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zg6GdQT9FNji" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3295">-</span></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zP9b2nin9i7a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3297">-</span></span></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z0LxoxdVQMeh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">238,921</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zAR0hZyZQx94" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">279,684</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Practice Management Tools &amp; Electronic Prescription (Pillar 3)</span></td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zwD8e2Eeiah" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">106,774</span></td>
    <td id="xdx_982_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zP3HhvHaUjbe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">106,774</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zxwqa8mctp32" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3307">-</span></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zk2PgnYtM1F5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3309">-</span></span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zXVQvmlYTnJj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">221,171</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zhgPYaB7lNjg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">216,297</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Clinical Decision Software (Pillar 2)</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zmXoVN7WMiqj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">87,018</span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zY6LpWaXdXS2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">87,018</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zcbeoEv95rN4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3319">-</span></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zP2DQyhrM7N6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3321">-</span></span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zbeRK6tHqDub" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">147,897</span></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z0yd02PIVl3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">153,526</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cliquefarma</span></td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z00tGT2dLwBa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">6,588</span></td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8FSSDGoHb77" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">6,588</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zeLIPp5lD43h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3331">-</span></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zVigd7Gvnm44" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3333">-</span></span></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zzThE07eOMJ6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">18,789</span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z9eg68e21K3f" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,045</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UnifipMoc</span></td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z9nQd8jYobjk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">87,777</span></td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zOvXG46sKnDd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">87,777</span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zOH7Ro3LmCib" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">190,247</span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zWwTbNSDZeh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">190,247</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z7FFrIMLKMT7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">361,383</span></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zXKUarNtCjY" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">369,007</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Unigranrio</span></td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zd07evq26Hfi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">169,173</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zWodhmw7xVpk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">169,173</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zK7zhR1rGyue" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">421,538</span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zRfKUwMsXaH2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">421,538</span></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z2BmuzPN04A6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">833,665</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z1Cu9Vl17eKk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">854,861</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">RX PRO</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zKbhW2JhCXMj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">29,809</span></td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHhuDacaoLC8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">29,809</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zMSRaaenPP52" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3367">-</span></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zG4okLxpIDGd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3369">-</span></span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zWRot9sQMbpa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">34,748</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zePr6UTv1Ad3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">36,675</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Glic *</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zjKwCcFuEwB7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8,288</span></td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zmHxJFF8oZ98" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,587</span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zhsqTTZH106k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3379">-</span></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zwzdBxCxvZX" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3381">-</span></span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z56RqCQj2qG9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,721</span></td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z7BXg6aWZJN7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">31,022</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">DelRey</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z0YiVmvMZTl6" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">75,098</span></td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmErMfBrBxa" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3389">-</span></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zp0ur8iXCXEf" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">586,263</span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zYqywOBu3Ab8" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3393">-</span></span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zojQOdUk38M4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">854,313</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zIRyssqpra5a" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3397">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zvS7L22Rtc7b" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,334,699</b></span></td>
    <td id="xdx_982_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zQD2BSZC53P4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,257,045</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zXhS9fbGkxSb" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,776,077</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zQV4XxDhUbV7" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,189,814</b></span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zYT2Rx9a5Aw" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>5,584,082</b></span></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zYA2RckZNPlh" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>4,814,424</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">*</td><td style="width: 5pt"></td><td style="text-align: justify">See above for further details on goodwill changes in 2023.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock', window );">Schedule of estimated useful lives of intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zElzYaU0osM5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets and goodwill (Details 2)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_zjb6IUsUqjg5" style="display: none">Schedule of estimated
    useful lives of intangible assets</span>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="width: 72%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Customer relationships - medicine</span></td>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsMedicineMember_zq8afRnHTbud" title="Estimated useful lives of intangible assets">6</span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Customer relationships - other courses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsOtherCoursesMember_zAOTCaqrU9O3" title="Estimated useful lives of intangible assets">4.5</span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Software license</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zjo7dH7vBiXd" title="Estimated useful lives of intangible assets">5</span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Education content</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zyWGqGGxn1N5" title="Estimated useful lives of intangible assets">3</span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trademarks</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zvRcOQGbg7X5" title="Estimated useful lives of intangible assets">2</span> - <span id="xdx_903_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zIBFrQClh4Ga" title="Estimated useful lives of intangible assets">30</span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Developed technology</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyMember_z3qO4r0lhFHe" title="Estimated useful lives of intangible assets">5</span> years</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureIntangibleAssetsAndGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureIntangibleAssetsAndGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639611660288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialAssetsExplanatory', window );">Schedule of financial assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--FinancialAssetsExplanatory_pn3n3_zJLMLzaNeYWi" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B4_zdIUHg3WDrwj" style="display: none">Schedule of financial assets</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>At amortized cost:</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade receivables</span></td>
    <td id="xdx_987_eifrs-full--TradeReceivables_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_znvhRTpgqlal" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">585,923</span></td>
    <td id="xdx_98B_eifrs-full--TradeReceivables_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zltSo2FYUQFj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">495,399</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRijhHHmHUsi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>585,923</b></span></td>
    <td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z8eNeDWDgcWj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>495,399</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_98F_eifrs-full--CurrentFinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zDSNLhZailvk" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">546,438</span></td>
    <td id="xdx_98A_eifrs-full--CurrentFinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zDH89V548f0l" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">452,831</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98F_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z8gvKyGqExqj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">39,485</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zbyrwCdiwf9h" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">42,568</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesExplanatory', window );">Schedule of financial liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--FinancialLiabilitiesExplanatory_pn3n3_zNAamn5fgTHj" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BB_zVLBJXM1nqMi" style="display: none">Schedule of financial liabilities</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>At amortized cost:</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade payables</span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zsZ5z4tBNd16" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,222</span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zaflng1uIr16" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71,482</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGCVA33rQQZe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,800,775</span></td>
    <td id="xdx_983_ecustom--LoansAndFinancing_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zZDf2YxUiPyj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,882,901</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease liabilities</span></td>
    <td id="xdx_98A_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zCR0jnW0qx3f" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">874,569</span></td>
    <td id="xdx_987_eifrs-full--LeaseLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zahkjH53tg56" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">769,525</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zvd44yXvyfvi" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">566,867</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zBUVkdriNaCl" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">528,678</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes payable</span></td>
    <td id="xdx_987_ecustom--NotePayable_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zG5S5iOcosV8" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3482">-</span></span></td>
    <td id="xdx_982_ecustom--NotePayable_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zA0iGBXV1x2k" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,176</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGG5suRO9WQ3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,350,433</b></span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4vSHarrOjr4" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,314,762</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_989_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4zKHRNZy307" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">678,370</span></td>
    <td id="xdx_980_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zPLNPpcSDgD1" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">573,030</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_znNl3Ionj775" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,672,063</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zcjxZaF92JNi" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,741,732</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancingExplanatory', window );">Schedule of loans and financing</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--LoansAndFinancingExplanatory_pn3n3_zx8gg8As9Cd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span id="xdx_8BF_z3FjGsB32I6k" style="display: none">Schedule
    of loans and financing</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial institution</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Currency</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Interest rate</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Maturity</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zwhEO91dhfLf" title="Financial institution">Banco Ita&#250; Unibanco S.A</span>. (a)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zPovUXEsgu85" title="Interest rate">CDI + 1.90% p.y.</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90C_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_z9FbYff3t5Pi" title="Maturity">2025</span></span></td>
    <td id="xdx_986_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zxtdhVhnUYl9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">412,880</span></td>
    <td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zuTknWjmk7z3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,134</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_z63efS7dHPW6" title="Financial institution">FINEP</span> (b)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zYY7ZOaEGG5i" title="Interest rate">TJLP p.y.</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_za4bA5mRwBMi" title="Maturity">2027</span></span></td>
    <td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zLWcQNCImBv8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,193</span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zz5NcqU4jFkf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8,418</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zixPvLe2cUm2" title="Financial institution">Banco Ita&#250; Unibanco S.A.</span> (c)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_ze6xeIWghk6h" title="Interest rate">CDI + 1.75% p.y.</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_ziloWsxWkwZe" title="Maturity">2024</span></span></td>
    <td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zAXlGIXZMIRj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">21,405</span></td>
    <td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zZsdujsDMr63" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">32,252</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zTtQj1dKJQH5" title="Financial institution">Softbank</span> (d)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zgAcYMbOeJd" title="Interest rate">6.5% p.y.</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_z9JbBX8Z8CKb" title="Maturity">2026</span></span></td>
    <td id="xdx_98F_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zvFybhC9AJYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">825,957</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zkLfVMdMdmXk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">824,258</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zhKl4Fl7Ir0j" title="Financial institution">Debentures</span> (e)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian real</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zwYtnJrmhQml" title="Interest rate">CDI + 1.80% p.y.</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zhF90K588Ozc" title="Maturity">2028</span></span></td>
    <td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zuEihA0v0K7i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">529,340</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zoalALfixzve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">499,839</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_988_ecustom--LoansAndFinancing_iI_pn3n3_c20231231_zJH3pY03LGDf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,800,775</b></span></td>
    <td id="xdx_982_ecustom--LoansAndFinancing_iI_pn3n3_c20221231_z5cUqIHiEmq3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,882,901</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_98C_ecustom--LoansAndFinancingCurrent_pn3n3_c20231231_zE9O3pNmyqHg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">179,252</span></td>
    <td id="xdx_98C_ecustom--LoansAndFinancingCurrent_pn3n3_c20221231_z8ClKkSIN7q8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">145,202</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt">&#160;</td>
    <td id="xdx_982_ecustom--LoansAndFinancingNonCurrent_pn3n3_c20231231_zG4Rcw4uOJcb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,621,523</span></td>
    <td id="xdx_98A_ecustom--LoansAndFinancingNonCurrent_pn3n3_c20221231_zkCz0TP20Am7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,737,699</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfLeasesExplanatory', window );">Schedule of right-of-use assets and lease liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfLeasesExplanatory_pn3n3_z2S2V2JTiUQe" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities  (Details 3)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B3_z8bEv5AvX4ng" style="display: none">Schedule of  right-of-use assets and lease liabilities</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Right-of-use assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease liabilities</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As of January 1, 2021</span></td>
    <td id="xdx_985_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231_zzm8oscCEqVe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">419,074</span></td>
    <td id="xdx_985_eifrs-full--LeaseLiabilities_iS_pn3n3_c20210101__20211231_zHUcS7LloIqb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,703</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_984_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20210101__20211231_zXFrKAWoPbvc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,689</span></td>
    <td id="xdx_983_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20210101__20211231_zU6X8OtdP12c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,689</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_988_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20210101__20211231_zLg8S1jXq9r" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">95,962</span></td>
    <td id="xdx_988_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20210101__20211231_zNaiKcv9cc01" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">95,962</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business combinations</span></td>
    <td id="xdx_981_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20210101__20211231_z69SVDxa9073" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">139,514</span></td>
    <td id="xdx_981_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20210101__20211231_zoUsD3VfM932" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">139,514</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation expense</span></td>
    <td id="xdx_98E_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20210101__20211231_zPMkXpuVkZgb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(43,237)</span></td>
    <td id="xdx_98F_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20210101__20211231_zs8qnE6TIHy7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3587">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense</span></td>
    <td id="xdx_981_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20210101__20211231_zjDVV5t6wSg1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3589">-</span></span></td>
    <td id="xdx_981_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20210101__20211231_zTmLwJhXFUpa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">67,212</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of lease liabilities</span></td>
    <td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20210101__20211231_zOurIa33N2ai" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3593">-</span></span></td>
    <td id="xdx_986_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20210101__20211231_zkH2q38KAUWb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(20,075)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of interest</span></td>
    <td id="xdx_98F_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20210101__20211231_zDG9GQPJ2pw3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3597">-</span></span></td>
    <td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20210101__20211231_zcpRlWrsnwAi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(67,676)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Write-off (i)</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsWriteoff_pn3n3_c20210101__20211231_zxJjvDTk9Rbh" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(10,316)</span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20210101__20211231_znB8p8dHSy8a" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,244)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2021</b></span></td>
    <td id="xdx_98A_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231_ztFQuSUk4o81" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>663,686</b></span></td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iE_pn3n3_c20210101__20211231_zwU995Xr7y9l" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>714,085</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_989_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20211231_zCnkvKVjjYff" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3609">-</span></span></td>
    <td id="xdx_98B_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20211231_zgohRItwed46" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,955</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98E_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20211231_zR0hVh8DWdq4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">663,686</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20211231_zd0zw6pM76v9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">689,130</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Right-of-use assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease liabilities</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As of January 1, 2022</span></td>
    <td id="xdx_989_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231_zlxdHP7lsB6g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">663,686</span></td>
    <td id="xdx_98D_eifrs-full--LeaseLiabilities_iS_pn3n3_c20220101__20221231_zMy7EivATDh1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">714,085</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20220101__20221231_zkUzBAjoZudl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">42,250</span></td>
    <td id="xdx_98F_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20220101__20221231_zdMwpGke2J8g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">42,250</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_983_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20220101__20221231_zLo27DxLkySg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,623</span></td>
    <td id="xdx_983_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20220101__20221231_zpczl7PdsrKb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,623</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation expense</span></td>
    <td id="xdx_98A_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20220101__20221231_zsIqOT0TD00l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(54,684)</span></td>
    <td id="xdx_988_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20220101__20221231_zc61iPN2iafb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3631">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20220101__20221231_z8ZyVH5YJXK2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3633">-</span></span></td>
    <td id="xdx_989_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20220101__20221231_zaS3bgdrcWL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">88,571</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of lease liabilities</span></td>
    <td id="xdx_98D_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20220101__20221231_zAtnAxV0hK3l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3637">-</span></span></td>
    <td id="xdx_988_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20220101__20221231_zFp1eQhddoLb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(28,511)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of interest</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20220101__20221231_zWPvjnbneWN1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3641">-</span></span></td>
    <td id="xdx_98D_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20220101__20221231_zIEYWMHuW9A7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(85,001)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Write-off (i)</span></td>
    <td id="xdx_989_ecustom--RightofuseAssetsWriteoff_pn3n3_c20220101__20221231_zEp14ubf4aE9" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(19,802)</span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20220101__20221231_zy8tQ3J8uoIk" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(20,492)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2022</b></span></td>
    <td id="xdx_98A_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231_zt20Zm1Edac1" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>690,073</b></span></td>
    <td id="xdx_980_eifrs-full--LeaseLiabilities_iE_pn3n3_c20220101__20221231_zwh8Cddthstb" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>769,525</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_98F_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20221231_zhOdB4doCdzd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3653">-</span></span></td>
    <td id="xdx_98E_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20221231_zeTGzTc8NqR4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">32,459</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_988_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20221231_zKAgb5I4C169" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">690,073</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20221231_zG4fAtsBel0h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">737,066</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>




<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Right-of-use assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease liabilities</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As of January 1, 2023</span></td>
    <td id="xdx_98E_eifrs-full--RightofuseAssets_iS_pn3n3_c20230101__20231231_zJ5QW0knYgvg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">690,073</span></td>
    <td id="xdx_988_eifrs-full--LeaseLiabilities_iS_pn3n3_c20230101__20231231_z9rzREO9aZ4e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">769,525</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_987_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20230101__20231231_zL8q1ZMxF01d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,328</span></td>
    <td id="xdx_986_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20230101__20231231_zF8PDKKNoA74" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,328</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_984_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20230101__20231231_zmlrYcYftY4e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,387</span></td>
    <td id="xdx_981_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20230101__20231231_zjshxc8CiJ9g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,387</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business combination</span></td>
    <td id="xdx_985_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20230101__20231231_zQkxIXV3QY0j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">65,408</span></td>
    <td id="xdx_98A_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20230101__20231231_znya9xJSI7m3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">65,408</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation expense</span></td>
    <td id="xdx_986_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20230101__20231231_zpWBB2SsLyMe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(63,118)</span></td>
    <td id="xdx_981_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20230101__20231231_zf88jHsLHpl8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3679">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense</span></td>
    <td id="xdx_987_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20230101__20231231_zSvjvWhL4v8k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3681">-</span></span></td>
    <td id="xdx_98A_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20230101__20231231_zvrn5y18fJYe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">100,849</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of lease liabilities</span></td>
    <td id="xdx_981_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20230101__20231231_zhP3jV9zQof1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3685">-</span></span></td>
    <td id="xdx_981_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20230101__20231231_zHbnyGwOKiMa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(31,473)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of interest</span></td>
    <td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20230101__20231231_zP0thVavb4e3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3689">-</span></span></td>
    <td id="xdx_98C_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20230101__20231231_zumiwKY2X5v" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(103,911)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Write-off (i)</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsWriteoff_pn3n3_c20230101__20231231_zb3dBBxzfvNi" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,469)</span></td>
    <td id="xdx_98C_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20230101__20231231_zh7AKxCRTijl" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, Write-off"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,544)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20230101__20231231_zlUoyhlLZswa" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>767,609</b></span></td>
    <td id="xdx_984_eifrs-full--LeaseLiabilities_iE_pn3n3_c20230101__20231231_z16B5lRhZuCj" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>874,569</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_982_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20231231_zTtXFjUW87M8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3701">-</span></span></td>
    <td id="xdx_985_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20231231_zmhwLxJW1k0k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">36,898</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_pn3n3_c20231231_zQCPpLweoxoh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">767,609</span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20231231_zrM76p2JsvJf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">837,671</span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to anticipated termination of real estate leasing contracts.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersExplanatory', window );">Schedule of accounts payable to selling shareholders</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--AccountsPayableToSellingShareholdersExplanatory_pn3n3_ziliB0JMP9W1" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 4)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zOKpbQr6YHl" style="display: none">Schedule of accounts payable to selling shareholders</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 74%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of IPEMED (a)</span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPEMEDMember_zjtgI6j1eYq" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,805</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPEMEDMember_zTQZ7KUP2jZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">22,654</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of UniRedentor (b)</span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zF6jWThx2Bkb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,155</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z6NHOhGMEWHl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,064</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of UniSL (c)</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zh977wXaQTj2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,064</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zBaa6vYEC4Y4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">37,301</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of FCMPB (d)</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zLPciQs1PG4k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">63,168</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z3z4bxuy59Tf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">111,755</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Medical Harbour (e)</span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zrBoO00mwD1d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,000</span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zkUvv1YP0P5a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,053</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Shosp (f)</span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zRMEfKuajtPa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">454</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_ztbJtUFpYAbc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,206</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Unigranrio (g)</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zXDpRmTor8Jf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">156,235</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zUAtEZPbz5Ff" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">216,716</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of RX PRO (h)</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zcJm9tHQRXEb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3745">-</span></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zqCSbNCSdrC8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,781</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Guaranhuns (i)</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_ziwmClvDXXSf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3749">-</span></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_zDNXLGfPllpc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">30,653</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Al&#233;m da Medicina (j)</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_z3BMOhOC4469" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">18,325</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zf1cqHzkk09b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,996</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of CardioPapers (k)</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_znB8g3Ng7FWg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,173</span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zoCnYH4KGU7g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,979</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of Glic (l)</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zZpgf1L6hkHi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3761">-</span></span></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqUaAylbsOW3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">9,520</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of DelRey (m)</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zkGSxhB2heV2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">256,488</span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWh1tD0PtqQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3767">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231_zw28pc3pfnra" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>566,867</b></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231_zcGlMoRUF3nf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>528,678</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersCurrent_pn3n3_c20231231_ztoL7CLqVncc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">353,998</span></td>
    <td id="xdx_985_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_pn3n3_c20221231_zhwIzkX0JYLl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">261,711</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_988_ecustom--AccountsPayableToSellingShareholdersNonCurrent_pn3n3_c20231231_zXtBCJlRGiag" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">212,869</span></td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_pn3n3_c20221231_zQI82jJ7MbM5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">266,967</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholders1Explanatory', window );">Schedule of accounts payable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--AccountsPayableToSellingShareholders1Explanatory_pn3n3_zXgQenVehkk4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 5)">
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B5_zEraxvDL7gzi" style="display: none">Schedule of accounts payable</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; width: 64%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening balance</span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zbJULWSraGt8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">528,678</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z3cUwk7UaRKc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">679,826</span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zgQlOb5Rvnt2" style="text-align: right; line-height: 10pt" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,240</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash flows - Payments and deductions</span></td>
    <td id="xdx_985_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZq02NmwYUpj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows payments and deductions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(225,460)</span></td>
    <td id="xdx_989_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zNM1Z8mB8kx" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows payments and deductions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(236,760)</span></td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zeRVdp0I9zxk" style="text-align: right; line-height: 10pt" title="Cash flows payments and deductions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(180,020)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payment of interest (i) </span></td>
    <td id="xdx_982_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwCc7jojqdJj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payment of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(55,989)</span></td>
    <td id="xdx_989_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOeaGHJ3JUqh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payment of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(24,428)</span></td>
    <td id="xdx_982_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zhYXmvlVfi0b" style="text-align: right; line-height: 10pt" title="Payment of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(12,661)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition of licenses </span></td>
    <td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZi0w3oiADTg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Acquisition of licenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3801">-</span></span></td>
    <td id="xdx_983_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zurbn4TXoPs2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Acquisition of licenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,408</span></td>
    <td id="xdx_98B_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zvhjw41RaIQf" style="text-align: right; line-height: 10pt" title="Acquisition of licenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,000</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest</span></td>
    <td id="xdx_98D_eifrs-full--InterestExpense_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZU9mamIs1j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">85,069</span></td>
    <td id="xdx_985_eifrs-full--InterestExpense_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z2dfGwU41v29" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">68,064</span></td>
    <td id="xdx_982_eifrs-full--InterestExpense_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zcLYGoNRMarl" style="text-align: right; line-height: 10pt" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">31,915</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions - Consideration to be transferred on business combinations</span></td>
    <td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zEDIzqwicxb2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Additions consideration to be transferred on business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">234,000</span></td>
    <td id="xdx_987_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zx3JNTpsDtS5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Additions consideration to be transferred on business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3815">-</span></span></td>
    <td id="xdx_987_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zJ5p0YmMzi74" style="text-align: right; line-height: 10pt" title="Additions consideration to be transferred on business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">243,816</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Consideration to be transferred on business combinations (earn-outs)</span></td>
    <td id="xdx_988_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zROvmhfczSih" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt" title="Consideration to be transferred on business combinations (earn-outs)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3819">-</span></span></td>
    <td id="xdx_980_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zL5vNj3woY48" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Consideration to be transferred on business combinations (earn-outs)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,921</span></td>
    <td id="xdx_984_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFV1daN0l1Wi" style="text-align: right; line-height: 10pt" title="Consideration to be transferred on business combinations (earn-outs)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,536</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_98C_ecustom--Reversals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zWVhsxfBtqvh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3825">-</span></span></td>
    <td id="xdx_981_ecustom--Reversals_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z2hWFxLGnHRb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(10,353)</span></td>
    <td id="xdx_98C_ecustom--Reversals_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zumMbbBxg1m" style="text-align: right; line-height: 10pt" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3829">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement of earn-outs (ii)</span></td>
    <td id="xdx_987_ecustom--RemeasurementOfEarnouts_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoN25Pe3anMi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Remeasurement of earn-outs"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,556</span></td>
    <td id="xdx_98F_ecustom--RemeasurementOfEarnouts_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zrZSalRvocjg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Remeasurement of earn-outs"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3833">-</span></span></td>
    <td id="xdx_985_ecustom--RemeasurementOfEarnouts_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zRBb15aXcrxd" style="text-align: right; line-height: 10pt" title="Remeasurement of earn-outs"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3835">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_98F_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmH6rqDHXHr6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,987)</span></td>
    <td id="xdx_98C_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmbGyYVfm2Lb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3839">-</span></span></td>
    <td id="xdx_983_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zJbOADQBxQk5" style="text-align: right; line-height: 10pt" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3841">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Closing balance</b></span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zKGOsQlY0Zx7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>566,867</b></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFeodshF64R1" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>528,678</b></span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zLsXqSNbZcEe" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right; line-height: 10pt" title="Closing balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>679,826</b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Payment of interest from acquisition of subsidiaries are included in cash flows from investing
activities.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">During the measurement period, management&#8217;s expectation has been reviewed based on
performance for revenue goals and the contingent consideration for the acquisition of Al&#233;m da Medicina, CardioPapers and Glic
have been remeasured by R$4,773, R$5,082 and (R$7,299), respectively, totaling R$2,556 as of December 31, 2023. These are measured by
the Company at the present value.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock', window );">Schedule of carrying amount of notes payable and the movements</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_pn3n3_zI1MwJVprYy8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 6)">
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BD_zNNBqtHMecB5" style="display: none">Schedule of carrying amount of notes payable and the movements</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; width: 64%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 12%; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening balance</span></td>
    <td id="xdx_98E_ecustom--NotesPayables_iS_pn3n3_c20230101__20231231_zZumwW3dqNMe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,176</span></td>
    <td id="xdx_989_ecustom--NotesPayables_iS_pn3n3_c20220101__20221231_z8LuCR28ybW6" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,726</span></td>
    <td id="xdx_981_ecustom--NotesPayables_iS_pn3n3_c20210101__20211231_zCzrVPC8Pap" style="text-align: right; line-height: 10pt" title="Notes payable beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,181</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments (i)</span></td>
    <td id="xdx_988_ecustom--Payments_pn3n3_c20230101__20231231_zhHb4Q3WxSR" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(49,347)</span></td>
    <td id="xdx_988_ecustom--Payments_pn3n3_c20220101__20221231_z8mKdNAzbTLi" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(12,000)</span></td>
    <td id="xdx_98B_ecustom--Payments_pn3n3_c20210101__20211231_zaNihkfhfaXh" style="text-align: right; line-height: 10pt" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(9,800)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments of interest (i)</span></td>
    <td id="xdx_98D_ecustom--PaymentsOfInterest_pn3n3_c20230101__20231231_z1pus9OrYdvj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(15,529)</span></td>
    <td id="xdx_986_ecustom--PaymentsOfInterest_pn3n3_c20220101__20221231_zBtjwhQXhlVh" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,008)</span></td>
    <td id="xdx_981_ecustom--PaymentsOfInterest_pn3n3_c20210101__20211231_zJ0XArvCtfM" style="text-align: right; line-height: 10pt" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,268)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Monetary indexation</span></td>
    <td id="xdx_98C_ecustom--MonetaryIndexation_pn3n3_c20230101__20231231_zQeOkg94T5fg" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Monetary indexation"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,700</span></td>
    <td id="xdx_98B_ecustom--MonetaryIndexation_pn3n3_c20220101__20221231_zP3D6TCwiAq" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Monetary indexation"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,458</span></td>
    <td id="xdx_98E_ecustom--MonetaryIndexation_pn3n3_c20210101__20211231_z6xRxKGRfURc" style="border-bottom: black 1pt solid; text-align: right; line-height: 10pt" title="Monetary indexation"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,613</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Closing balance</b></span></td>
    <td id="xdx_987_ecustom--NotesPayables_iE_pn3n3_c20230101__20231231_zy2Doo6v6gLd" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3975">-</span></b></span></td>
    <td id="xdx_98A_ecustom--NotesPayables_iE_pn3n3_c20220101__20221231_zDHYCKvhFUb7" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>62,176</b></span></td>
    <td id="xdx_987_ecustom--NotesPayables_iE_pn3n3_c20210101__20211231_zUJgfkDY7lp6" style="border-bottom: black 1.5pt double; text-align: right; line-height: 10pt" title="Notes payable ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>72,726</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_988_ecustom--CurrentLiabilities1_iI_pn3n3_c20231231_zImjJr5t7W39" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3981">-</span></span></td>
    <td id="xdx_982_ecustom--CurrentLiabilities1_pn3n3_c20221231_zTy8tYFM8lri" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,176</span></td>
    <td id="xdx_98C_ecustom--CurrentLiabilities1_iI_pn3n3_c20211231_z4pe24LUNx24" style="text-align: right; line-height: 10pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,478</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98E_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20231231_zmPCI95aXc28" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3987">-</span></span></td>
    <td id="xdx_981_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20221231_zTEgZTr2iPGj" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3989">-</span></span></td>
    <td id="xdx_98C_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20211231_zyS8sbnU0fqb" style="text-align: right; line-height: 10pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,248</span></td></tr>
  </table>
<p style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 0 7.1pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The amounts are included in cash flows from investing activities.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfFairValuesExplanatory', window );">Schedule of fair values of the company's financial instruments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfFairValuesExplanatory_pn3n3_zswu6R4455O9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 7)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B5_zJK6pWxh0tri" style="display: none">Schedule
    of fair values of the company's financial instruments</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td colspan="2">
    <p style="border-bottom: black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2022</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 48%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying amount</b></span></td>
    <td style="width: 10%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair value</b></span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying amount</b></span></td>
    <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair value</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>Financial assets</b></span></td>
    <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Trade receivables (non-current)</span></td>
    <td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zFs837uome8d" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">39,485</span></td>
    <td id="xdx_987_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zclm8DkYb8lj" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">39,485</span></td>
    <td id="xdx_981_eifrs-full--FinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zImlu8DZ2jLj" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">42,568</span></td>
    <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zHcJvwaLckM6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">42,568</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--FinancialAssets_pn3n3_c20231231_zw4KhUxubaoa" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>39,485</b></span></td>
    <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20231231_zTh2iJY77cBb" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>39,485</b></span></td>
    <td id="xdx_98A_eifrs-full--FinancialAssets_pn3n3_c20221231_zNNI9Ii9Tml5" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>42,568</b></span></td>
    <td id="xdx_988_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20221231_zNfF5MeDj0j" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>42,568</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial liabilities</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Loans and financing</span></td>
    <td id="xdx_985_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zeDFNFKeKwPd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">1,800,775</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z3UdWKCoXkw7" style="text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">1,795,752</span></td>
    <td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z8MVsGWTu2Pi" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">1,882,901</span></td>
    <td id="xdx_980_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zqE5UmRKe8D2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">1,934,295</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Lease liabilities</span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvTlrrv9bz48" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">874,569</span></td>
    <td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvZo3z2OSNbj" style="text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">874,569</span></td>
    <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zG2y35CZMkdc" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">769,525</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zUFNrm8MIGVk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">769,525</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Accounts payable to selling shareholders</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOjtCh58N4Gi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">566,867</span></td>
    <td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zWvIfRtuHp5d" style="text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">566,867</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zS0Bu4opkWi2" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">528,678</span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zyRmfh5Q3zq9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">528,678</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Notes payable</span></td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zpjqJYyhcRva" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl4035">-</span></span></td>
    <td id="xdx_981_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zuGeihlFqowa" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl4037">-</span></span></td>
    <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zSwW9FMkts7f" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">62,176</span></td>
    <td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_z4xfn4Oxzt9h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">62,176</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td>
    <td id="xdx_988_eifrs-full--FinancialLiabilities_pn3n3_c20231231_zUSx8wBY3LO7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>3,242,211</b></span></td>
    <td id="xdx_98D_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231_zLqaidjInSg2" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>3,237,188</b></span></td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231_zeaXcLuRojA" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>3,243,280</b></span></td>
    <td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231_z4truBUYVEW9" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>3,294,674</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock', window );">Schedule of income before income taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_pn3n3_zub13kxFjHY3" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 8)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B7_zn2xVc5VR2Zd" style="display: none">Schedule
    of income before income taxes</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Index - % per year</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Base rate</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash equivalents</span></td>
    <td id="xdx_982_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z1CmwrgwRFh5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,111</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z1Zhg3fb22H1" title="Index - % per year">100.8% of CDI</span></span></td>
    <td id="xdx_988_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zteHpc4PvDha" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">60,846</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zxzsN62UahW1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(529,340)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zzKeMlQQ3cX6" title="Index - % per year">CDI + 1.8%</span></span></td>
    <td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zulfA3LnOXTg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(71,196)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_988_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zjkWW6BQAR6h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(412,880)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zlfYUqzJPSGg" title="Index - % per year">CDI + 1.9%</span></span></td>
    <td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zBlEYBtmvmW8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(55,945)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98D_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zTyOM3VjasWk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,193)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zrvQk1NqrTW9" title="Index - % per year">TJLP</span></span></td>
    <td id="xdx_980_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zCH9Hf3BA766" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(733)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98A_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z9h6xH398M0f" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(21,405)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zcUlDXObefI1" title="Index - % per year">CDI + 1.75%</span></span></td>
    <td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zCtn58HiZyJ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,868)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zM3Xtnp8qMQ8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(274,428)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_ztQoSudqoWe8" title="Index - % per year">CDI</span></span></td>
    <td id="xdx_984_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zAT1MraOlzd6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(31,971)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_981_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z2uOMoIpL1Td" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(256,488)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zDlhhU9QYMhe" title="Index - % per year">SELIC</span></span></td>
    <td id="xdx_98D_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zh7hDPdKbm16" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(29,881)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net exposure</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_980_ecustom--BaseRate_pn3n3_c20230101__20231231_zgkCjjYp6LOh" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(131,748)</b></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>





<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Increase in basis points</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; width: 62%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>+75</b></span></td>
    <td style="width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>+150</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effect on profit before tax</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zYFdfJzbbPTi" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,407)</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zN17YZqVBUr" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(14,814)</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock', window );">Schedule of sensitivity foreign currency</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_pn3n3_zJDMahFm18Ra" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 9)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B4_z3XcUWgWtd94" style="display: none">Schedule of sensitivity foreign currency</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 52%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Exposure</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>+10%</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>-10%</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash equivalents</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zdZM8iqCNood" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,173</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zbBLT6FZyP9k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,317</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zx1YxzqAts9c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,317)</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock', window );">Schedule of maturity profile of financial liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_pn3n3_zfb5sP9cHG2" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 10)">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B6_z7Ix2AYP9vgb" style="display: none">Schedule of maturity profile of financial liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Less than 1 year</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1 to 3 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3 to 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>More than 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade payables</span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zKqpogNzeLQ8" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,222</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zlXoRe7b9DBi" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4125">-</span></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zKGhZQnf6hEf" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4127">-</span></span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zd9BIrkyDVK5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4129">-</span></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zBPpQDCGIrla" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,222</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_988_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjfA8ZBcwEm7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">298,981</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVKkdOpEPvcb" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,383,255</span></td>
    <td id="xdx_986_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2ND2SJ83wp5" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">568,326</span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zsgghcZXp1nd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4139">-</span></span></td>
    <td id="xdx_987_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zsZWmnYIZTO4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,250,562</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease liabilities</span></td>
    <td id="xdx_986_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvCWqPqgEbi7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">137,735</span></td>
    <td id="xdx_984_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zB2AA8LB5gPf" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">268,724</span></td>
    <td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z76RVpz4aMNc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">255,456</span></td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJRt5StHaGXh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,261,213</span></td>
    <td id="xdx_98D_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmJTIANl8Q96" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,923,128</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znPsXiOMCp12" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">387,693</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zNz2H9JulMXd" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">231,478</span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zX4EmWKbXqT" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4157">-</span></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zB3yZUZGzu3f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4159">-</span></span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zXfVv6dplGkf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">619,171</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances from customers</span></td>
    <td id="xdx_98B_eifrs-full--Advances_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zME4b62JV7sl" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">153,485</span></td>
    <td id="xdx_985_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zwzkYT7f58kk" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4165">-</span></span></td>
    <td id="xdx_98C_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr1apcQkETf1" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4167">-</span></span></td>
    <td id="xdx_984_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zUElOKxFqFMj" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4169">-</span></span></td>
    <td id="xdx_98D_eifrs-full--Advances_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeem7BEz0hn3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">153,485</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98F_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zZ8hDu6SFyzh" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,086,116</b></span></td>
    <td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z5BDQH8bxtsa" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,883,457</b></span></td>
    <td id="xdx_985_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zT1uFCFjemLb" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>823,782</b></span></td>
    <td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zovJFtW5v6Cl" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,261,213</b></span></td>
    <td id="xdx_982_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zU2V63uMcu62" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>5,054,568</b></span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As of December 31, 2022</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Less than 1 year</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1 to 3 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3 to 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>More than 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade payables</span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFYjRLe0sr3k" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71,482</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVAgiBhQkOc8" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4185">-</span></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zv6qSV9PNFWe" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4187">-</span></span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJV2gX82sHJ8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4189">-</span></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zEo3Amrr3gX4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71,482</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans and financing</span></td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGMolnuvMz5j" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">287,741</span></td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmDIPpbkjg9d" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">788,190</span></td>
    <td id="xdx_983_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zBbcXIg611D3" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,237,599</span></td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zS3uZwei8xPe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4199">-</span></span></td>
    <td id="xdx_98F_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjj4Qt9o90Xi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,313,530</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease liabilities</span></td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z1LhxyYQUb04" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">117,506</span></td>
    <td id="xdx_986_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zyjqz9jJLsv6" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">234,688</span></td>
    <td id="xdx_985_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr9cmg2QCVU5" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">219,127</span></td>
    <td id="xdx_986_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zz9FvZfCyw8j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,139,771</span></td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFnZkptdDykf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,711,092</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z5eY9D2z3HK1" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">282,481</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zMnsKPFukR34" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">339,281</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zttMMmQPyQVl" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4217">-</span></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zL5Ew6XkyqPd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4219">-</span></span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgdhI4OV14Yb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">621,762</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes payable</span></td>
    <td id="xdx_983_ecustom--NotePayables_iIP3ifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOfQHd3SH4o3" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,176</span></td>
    <td id="xdx_984_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zDTh1pftWl9g" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4225">-</span></span></td>
    <td id="xdx_983_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zkh3l2fqtjIc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4227">-</span></span></td>
    <td id="xdx_98D_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVFde30t5472" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4229">-</span></span></td>
    <td id="xdx_981_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztrWQM5u61f4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,176</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances from customers</span></td>
    <td id="xdx_98C_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zXGrzgZK41s7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">133,050</span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr6ZS3rPKD85" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4235">-</span></span></td>
    <td id="xdx_98E_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zANnTznH1kXj" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4237">-</span></span></td>
    <td id="xdx_98D_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGd6AVfTyGj2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4239">-</span></span></td>
    <td id="xdx_982_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zNY8vWl2W63e" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">133,050</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z93TKGcwfCkd" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>954,436</b></span></td>
    <td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOLa5MgMrUbc" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,362,159</b></span></td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztILcbHGFaq7" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,456,726</b></span></td>
    <td id="xdx_983_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znJijWd3Flt9" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,139,771</b></span></td>
    <td id="xdx_98C_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOUKujqThra2" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>4,913,092</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory', window );">Schedule of changes in liabilities arising from financing activities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_pn3n3_znD3NLxzm0s8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 11)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zOrYKxtipXZd" style="display: none">Schedule of changes in liabilities arising from financing activities</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January 1, 2023</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 9%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business combination</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: -5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2023</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing (i)</span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zb5oCuVF2yU9" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,882,901</span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z1OkdgyXg4N" style="text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(112,630)</span></td>
    <td id="xdx_988_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zz91xZ7KP0W2" style="vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(175,889)</span></td>
    <td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzpSINmYrvi" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,288</span></td>
    <td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zdUuGXkS87J4" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">197,678</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zRc9ScNgC2Le" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4265">-</span></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0YRYzOiAbDk" style="padding-right: 0.15pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,427</span></td>
    <td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0hWMvdNrn02" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,800,775</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities (i)</span></td>
    <td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYf8cRihXEla" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">769,525</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zR2nMfRekJq7" style="text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(31,473)</span></td>
    <td id="xdx_985_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zC97GDXfYtG7" style="vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(103,911)</span></td>
    <td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxjk1h1PbXRj" style="padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">77,715</span></td>
    <td id="xdx_982_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYAjczM65A1j" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">100,849</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zVDA8oIuDHE" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">65,408</span></td>
    <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYfhJaueJrFa" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,544)</span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zo0m5A5acNlj" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">874,569</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zwtzRK5Fwffl" style="border-bottom: black 1pt solid; text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(18,750)</span></td>
    <td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zFo3dpzJSFqe" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4289">-</span></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z8Z0JZ93uE4f" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18,750</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: -0.15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231_zMKwqychlUL5" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,652,426</b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zl9R91ymLWLc" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(162,853)</b></span></td>
    <td id="xdx_98E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231_zCKkWkERt6cg" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(279,800)</b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z7rZ7YHdggYe" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>101,753</b></span></td>
    <td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zUFpLWbFA4je" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>298,527</b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zlxTmIH9PCDc" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>65,408</b></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zebvvVZYquEf" style="border-bottom: black 1pt solid; padding-right: -5.15pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(117)</b></span></td>
    <td id="xdx_98E_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231_zIINH3EzP9p1" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,675,344</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January 1, 2022</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: -5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2022</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: -5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing (i)</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zjeEFgq56np2" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,374,876</span></td>
    <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zEwNAVSAqorj" style="text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,791)</span></td>
    <td id="xdx_980_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zrrRt69nvtx9" style="vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(116,587)</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzU4iMhnx5gk" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">496,885</span></td>
    <td id="xdx_988_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zCK1Hw1ilUDi" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">127,559</span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zr0qvCHNkJw7" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4319">-</span></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zK6r0rlPGix8" style="padding-right: 0.15pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,959</span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zCJjUkT2tLHk" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,882,901</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities (i)</span></td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zoi3iYocDHK3" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">714,085</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvuyDODzqePk" style="text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(28,511)</span></td>
    <td id="xdx_984_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zX3KJ3Ib6cSa" style="vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(85,001)</span></td>
    <td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zHioC4pfibIa" style="padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">100,873</span></td>
    <td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zD32aHFrwWrf" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">88,571</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zi3ngNPHWwB8" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4335">-</span></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zBaY0ypLltl" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(20,492)</span></td>
    <td id="xdx_98B_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxn0fQ2cPZPj" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">769,525</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z0p2NsGW2d24" style="border-bottom: black 1pt solid; text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(19,736)</span></td>
    <td id="xdx_984_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zmB1yGQcQtXg" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4343">-</span></span></td>
    <td id="xdx_98C_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zCFdrY8qXPDl" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19,736</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: -0.15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231_zUhWEPSqKU1b" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,088,961</b></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zPpSwvF3ojPl" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(50,038)</b></span></td>
    <td id="xdx_98A_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231_z4ktVBIa9ha" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(201,588)</b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zPBmJguotbH7" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>617,494</b></span></td>
    <td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_z0KOyBp9fS01" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>216,130</b></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zaq1pYbwsTIg" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4357">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zB1yN3yN8WUc" style="border-bottom: black 1pt solid; padding-right: -5.15pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(18,533)</b></span></td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231_zJxvR9gCYeu4" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,652,426</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January 1, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions (ii)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing (i)</span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z37iLiWRrR8d" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">617,485</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zsMxQRR4XKhb" style="text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(107,766)</span></td>
    <td id="xdx_986_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z5WS9nNRhurf" style="vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(50,310)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zNuOgl1HATC5" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">809,539</span></td>
    <td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znkh4kSlZoF5" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">68,909</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zApx8FKVHoU" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">36,591</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z7krHWyRiHb4" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">428</span></td>
    <td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zuxfOb5h6wX2" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,374,876</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities (i)</span></td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zkn1nQd2fRw2" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">447,703</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zaY7drP9ILG7" style="text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(20,075)</span></td>
    <td id="xdx_98B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zGeUJ84mQfvc" style="vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(67,676)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zkdzaSaZnVEf" style="padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">158,651</span></td>
    <td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zx11PdTD5kS7" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">67,212</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z8sAB1z40ZS3" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">139,514</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zfzKIphO7WAi" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(11,244)</span></td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zUrlgU4Npwe2" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">714,085</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zjFMBOqxMtgf" style="border-bottom: black 1pt solid; text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(18,648)</span></td>
    <td id="xdx_98E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zcTlfTDcIkP7" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4397">-</span></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zU4HEg0KiGh5" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18,648</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231_zGrVTs3PHlR5" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,065,188</b></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zyWwyGmVEAtl" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(146,489)</b></span></td>
    <td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231_zOWleRFSl2wh" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(117,986)</b></span></td>
    <td id="xdx_982_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zDU1ZF6KtwW6" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>986,838</b></span></td>
    <td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_z8sHp1aaRVdd" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>136,121</b></span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zEVPUtEuD818" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>176,105</b></span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zEjF0FDq0qMk" style="border-bottom: black 1pt solid; padding-right: -6.25pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(10,816)</b></span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231_z4jiUHg6srUk" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,088,961</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Payment of interest of loan and financing and lease liabilities are included in cash flows
from financing activities.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">The additions of loans and financing in 2021 include proceeds from the SoftBank transaction
of R$822,569, net of the transaction costs of R$13,030.</td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholders1Explanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholders1Explanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFairValuesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFairValuesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639606805312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureFairValueMeasurementAbstract', window );"><strong>Fair Value Measurement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfFairValueMeasurementExplanaory', window );">Schedule of fair value measurement</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfFairValueMeasurementExplanaory_pn3n3_zXkxqugiNX1j" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Fair value measurement (Details)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span id="xdx_8B3_zoPsNlrfXFT9" style="display: none">Schedule of fair value measurement</span></td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td colspan="4" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Fair value measurement</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 15%; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Quoted prices in active markets (Level 1)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Significant observable inputs (Level 2)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Significant unobservable inputs (Level 3)</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2023 </b></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Assets for which fair values are disclosed</b></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade receivables (non-current)</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231_z6nW6UYVwKll" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">39,485</span></td>
    <td id="xdx_983_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zgMAMHa7C9Y7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4424">-</span></span></td>
    <td id="xdx_988_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zgnKNB61vcL5" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">39,485</span></td>
    <td id="xdx_986_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zz4qBjgPLW78" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4428">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Liabilities for which fair values are disclosed</b></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_989_ecustom--LoansAndFinancingLiabilities_pn3n3_c20231231_zmOBDC8nlVr4" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,795,752)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_988_ecustom--LoansAndFinancingLiabilities_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z1ChD5t69aU5" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,795,752)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_98B_ecustom--LeaseLiabilities1_pn3n3_c20231231_zrCCfiQbcn9l" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(874,569)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilities1_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zMnXzltPJyUl" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(874,569)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_984_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_pn3n3_c20231231_zCnINyUm3Rqg" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(566,867)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z0poaPp6EtI8" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(566,867)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December 31, 2022</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Assets for which fair values are disclosed</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade receivables (non-current)</span></td>
    <td id="xdx_98F_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231_zeLkFJ30Gtqc" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,568</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zJf8rpjzeG77" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4444">-</span></span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zJnkrYIYbxX7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,568</span></td>
    <td id="xdx_984_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zQcI0wGyDQo7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4448">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Liabilities for which fair values are disclosed</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_pn3n3_c20221231_zQQuhRJa4IT7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,934,295)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_ecustom--LoansAndFinancingLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zCK7lwe0y5Y7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,934,295)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_98B_ecustom--LeaseLiabilities1_iI_pn3n3_c20221231_zvBBXzWtfAna" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(769,525)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilities1_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zZ2rXoEUcwBl" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(769,525)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accounts payable to selling shareholders</span></td>
    <td id="xdx_988_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_pn3n3_c20221231_zOLekkhCkSCj" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(528,678)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zgzRSQHH0qJf" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(528,678)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Notes payable</span></td>
    <td id="xdx_986_ecustom--FairValueNotesPayables1_iI_pn3n3_c20221231_zsYf6f6VbNT1" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(62,176)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98C_ecustom--FairValueNotesPayables1_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zb3OjtRK3R49" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(62,176)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureFairValueMeasurementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureFairValueMeasurementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFairValueMeasurementExplanaory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFairValueMeasurementExplanaory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639633477792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions', window );">Schedule of model used to determine the fair value of the stock options</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_z3DhwKnLSwik" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span id="xdx_8B4_zIvYQZf8uCva" style="display: none">Schedule of model used to determine the fair value of the stock options</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Modified plan</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Original plan</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_900_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zWfQ7kJCZOq4" title="Strike price at the measurement date">83</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z3r4lWano4O7" title="Strike price at the measurement date">91</span> - R$<span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zAH4XplbAaUb" title="Strike price at the measurement date">140</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zUsG4r93xNva" title="Dividend yield">0.0</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zuOh5KUvGx59" title="Dividend yield">0.0</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_907_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zWjxJMy2IuV5" title="Expected volatility">48</span>% - <span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zlXH4siWVndd" title="Expected volatility">59</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zcBR9APRGgy7" title="Expected volatility">48</span>% - <span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zrjadRuXnnVh" title="Expected volatility">59</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zTFwDO4nXAq9" title="Risk-free interest rate">13</span>% - <span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zsdoDHHhSQLk" title="Risk-free interest rate">15</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z8Nn5M5wUes1" title="Risk-free interest rate">13</span>% - <span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z1zWoDL4DXTh" title="Risk-free interest rate">15</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zk2G9NZm5Vtk" title="Expected life of stock options">1</span> - <span id="xdx_905_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zEZ5SsV37D82" title="Expected life of stock options">4</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zouL0Up0DR1b" title="Expected life of stock options">1</span> - <span id="xdx_901_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zmuhF1ZxeeVj" title="Expected life of stock options">4</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90D_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zE6LFCFQ2Rw8" title="Share price at the measurement date">48</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zq2Tsqgjg3F4" title="Share price at the measurement date">48</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Valuation model</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zdRMlGQk6ZPh" title="Model used">Binomial</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zIBsj6YJ7XSi" title="Model used">Binomial</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_902_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zhM8zKh65ZZb" title="Weighted average fair value at the measurement date">53.06</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zXwRwA9w7zki" title="Weighted average fair value at the measurement date">49.22</span></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions', window );">Schedule of model used to determine incremental fair value of the stock options</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions_pn3n3_z4UiQERxB4J9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 2)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span id="xdx_8BA_zhccjbnvCi5d" style="display: none">Schedule of model used to determine incremental  fair
    value of the stock options</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Modified plan</b></span></td>
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Original plan</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price index</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IPCA</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">CDI</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_z2El9m7f9SL2" title="Strike price at the measurement date">59</span> - <span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zGASxYwoQ787" title="Strike price at the measurement date">104</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zgtuU9sx9Kl8" title="Strike price at the measurement date">59</span> - <span id="xdx_902_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zW3rkReTWqZe" title="Strike price at the measurement date">104</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zOvIgzedMDbd" title="Dividend yield">0.0</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zeE3cOTGw10a" title="Dividend yield">0.0</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zuBMdNKzQm22" title="Expected volatility">45</span>% - <span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_z3DAcRpFac0e" title="Expected volatility">54</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zdzLDkpixhT2" title="Expected volatility">45</span>% - <span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zbgMv89A3FK4" title="Expected volatility">54</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zZIS1Sllneeg" title="Risk-free interest rate">10</span>% - <span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zwx37XikBnI1" title="Risk-free interest rate">12</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zr2bWwddO581" title="Risk-free interest rate">10</span>% - <span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zd19mY7PKgma" title="Risk-free interest rate">12</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">0 - <span id="xdx_904_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zfRypSrhfeS5" title="Expected life of stock options">5</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">0 - <span id="xdx_90C_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zmJPSCo43017" title="Expected life of stock options">5</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zLmNlPfUZTRl" title="Share price at the measurement date">75</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_903_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zKZajR5DadLk" title="Share price at the measurement date">75</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Valuation model</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_znoVYBLM5xC4" title="Model used">Binomial</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zo834EhhMccg" title="Model used">Binomial</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zzuwfH439Zmf" title="Weighted average fair value at the measurement date">28.10</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zoJYkVFxtvj5" title="Weighted average fair value at the measurement date">26.00</span></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfAdditionalStockOptionsExplanatory', window );">Schedule of additional stock options</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfAdditionalStockOptionsExplanatory_zmBpLXFOmjr6" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 3)">
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span id="xdx_8BB_zQI6LsFh3s81" style="display: none">Schedule of additional stock
    options</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>February</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>April</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>August</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>October</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>December</b></p>
    <p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>2023</b></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90E_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zI2m5yXju4wc" title="Strike price at the measurement date">56</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zqAwQb03Hrke" title="Strike price at the measurement date">57</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zF76UYqapkn8" title="Strike price at the measurement date">59</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_900_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zUagWImKfRN9" title="Strike price at the measurement date">59</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zVYLYb5D7G52" title="Strike price at the measurement date">60</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z04rFiBw2J8f" title="Dividend yield">0.0</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z55pl3l2FVE2" title="Dividend yield">0.0</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_903_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zOdnqiZFeUa2" title="Dividend yield">0.0</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zhWYF66lggNc" title="Dividend yield">0.0</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zKh0Ngq5PZP9" title="Dividend yield">0.0</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zMSmQ4Ih25dl" title="Expected volatility">46</span>% - <span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zXpdMIq8WQk8" title="Expected volatility">56</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEoAq7hSxmIa" title="Expected volatility">48</span>% - <span id="xdx_906_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zt4vzQUSOsG9" title="Expected volatility">55</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zcggEqL8SdS1" title="Expected volatility">47</span>% - <span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zueJbo5qPCKh" title="Expected volatility">56</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zzJSvMekUEo2" title="Expected volatility">44</span>% - <span id="xdx_90C_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zSKOFhusMje" title="Expected volatility">56</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z9tUL74e6hyb" title="Expected volatility">34</span>% - <span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_znKqUGV6FTvj" title="Expected volatility">56</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zzU2gnFznmKi" title="Risk-free interest rate">13</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0rsPOleYlb9" title="Risk-free interest rate">11</span>% - <span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zZ6GDBaK4WVj" title="Risk-free interest rate">13</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zPdY2n4TWJm5" title="Risk-free interest rate">10</span>% - <span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zXnNe5r1zhWe" title="Risk-free interest rate">12</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zf6lAnJ8vAxa" title="Risk-free interest rate">11</span>% - <span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zCUrA8wWBcY9" title="Risk-free interest rate">12</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zwJfvFgpns6d" title="Risk-free interest rate">10</span>% - <span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zudkK9AKu8Y3" title="Risk-free interest rate">11</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_907_ecustom--ExpectedLifeOfStockOptions_dtY_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zIH3opcItc9" title="Expected life of stock options">1</span> - <span id="xdx_902_ecustom--ExpectedLifeOfStockOptions_dtY_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zJLwkIeZm43" title="Expected life of stock options">5</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_ecustom--ExpectedLifeOfStockOptions_dtY_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zz0380XqIJ4a" title="Expected life of stock options">1</span> - <span id="xdx_902_ecustom--ExpectedLifeOfStockOptions_dtY_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z18q86bm81ng" title="Expected life of stock options">5</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_ecustom--ExpectedLifeOfStockOptions_dtY_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zHPbANDExjOf" title="Expected life of stock options">1</span> - <span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zj5WY5cQGlzi" title="Expected life of stock options">5</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_907_ecustom--ExpectedLifeOfStockOptions_dtY_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zKnS23omez9g" title="Expected life of stock options">1</span> - <span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zMVpTQMsb6J8" title="Expected life of stock options">5</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zXePdAhlCI5" title="Expected life of stock options">1</span> - <span id="xdx_90A_ecustom--ExpectedLifeOfStockOptions_dtY_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEW7JPY4XvLh" title="Expected life of stock options">5</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_907_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zQLko8vfA155" title="Share price at the measurement date">70.69</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90F_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_ztxGlOcwWQsd" title="Share price at the measurement date">62.51</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90E_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zRgfyPUMecrg" title="Share price at the measurement date">76.45</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zLmZDYCaTePi" title="Share price at the measurement date">79.12</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_909_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zdhuK5StwODi" title="Share price at the measurement date">100.97</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Valuation model</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z9NaZQH24Yl3" title="Model used">Binomial</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zfh2wf93wE5e" title="Model used">Binomial</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zYdHs8qHNpv9" title="Model used">Binomial</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z0lRaXRCmcT7" title="Model used">Binomial</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zapjHNvYimal" title="Model used">Binomial</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90B_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z8ySNMeVPjg3" title="Weighted average fair value at the measurement date">29.54</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zHByWqOzRNP" title="Weighted average fair value at the measurement date">32.04</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zK6XFMlKrTHb" title="Weighted average fair value at the measurement date">37.04</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_900_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zwf3EIImkkjl" title="Weighted average fair value at the measurement date">38.67</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_908_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zkTKEzdVV6V7" title="Weighted average fair value at the measurement date">54.25</span></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfSharebasedCompensationPlanExplanatory', window );">Schedule of share-based compensation plan</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfSharebasedCompensationPlanExplanatory_pn3n3_zCdRaKCRhkqc" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 4)">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8BF_zUvAvdriz7vi" style="display: none">Schedule of share-based compensation plan</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td colspan="3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>Weighted average strike price</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>(in Brazilian Reais)</b></p></td>
    <td colspan="3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>Number of stock options</b></p></td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="border-top: Black 1pt solid; width: 40%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Outstanding at January 1</span></td>
    <td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zYUJ3ITX4Gtc" style="width: 18%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">79.47</span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKFFpHaJiCm9" style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,729,287</span></td>
    <td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z1iQtKHjDEKi" style="white-space: nowrap; width: 14%; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,086,728</span></td>
    <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z81sVx0CqOIa" style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,510,983</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Granted</span></td>
    <td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zu5nUAFKx6Uj" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Granted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">60.83</span></td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z2URd955qre7" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">467,000</span></td>
    <td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zPP6bNbwVI39" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,234,919</span></td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zqM5i7m1Jse8" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,170,000</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Exercised</span></td>
    <td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zBh72c7DyEE1" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">59.67</span></td>
    <td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zBZ0H1MWhg6a" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(164,214)</span></td>
    <td id="xdx_986_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zob9axieXdni" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4746">-</span></span></td>
    <td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zfdjfqnv4EMh" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(442,669)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Stock options exchanged to RSUs</span></td>
    <td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKYMMLtl20F6" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Stock options exchanged"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4750">-</span></span></td>
    <td id="xdx_98C_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z776cNP8Myfj" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,751,599)</span></td>
    <td id="xdx_982_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zIRw7ywFjna2" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4754">-</span></span></td>
    <td id="xdx_985_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKRjgHtN0oM6" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4756">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Forfeited</span></td>
    <td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z5cH8H3KI0wf" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">110.95</span></td>
    <td id="xdx_98C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zMMHPPyJOMof" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(333,111)</span></td>
    <td id="xdx_98D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zusifHyb97b6" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(365,749)</span></td>
    <td id="xdx_98C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zlY5Vp34ZyCj" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(60,000)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expired</span></td>
    <td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3lvNhkaYni" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Expired"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">94.17</span></td>
    <td id="xdx_98E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHJf011QlSra" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(251,299)</span></td>
    <td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmtG1BROVopg" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Expired"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(226,611)</span></td>
    <td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zZhb1XM6sLSg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(91,586)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31</b></span></td>
    <td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zVZOpG0sn9N9" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>64.33</b></span></td>
    <td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zxl2aIAuewL3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,696,064</b></span></td>
    <td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zI6s6YVB2tQf" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,729,287</b></span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zLHmal4NBHD3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,086,728</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Exercisable</b></span></td>
    <td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z8pqSfZnW3Ul" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Exercisable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>86.23</b></span></td>
    <td id="xdx_98A_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z99Nlqh8pCk2" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>242,235</b></span></td>
    <td id="xdx_980_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zT5QMo9sX9a6" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,133,774</b></span></td>
    <td id="xdx_98D_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z54x29IexhT1" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>542,061</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfStockOptionExplanatory', window );">Schedule of stock option</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfStockOptionExplanatory_pn3n3_zQUnx2ZSX7zd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 5)">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8B7_zjd0OcZzxoZa" style="display: none">Schedule of stock option</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Outstanding at January 1</span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zkHv5O8K8dfl" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,224</span></td>
    <td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zBnbf1RfTczd" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4836">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Granted</span></td>
    <td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zyvE4WkwR7e3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">317,090</span></td>
    <td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zn3u7iko1Pae" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,224</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Stock options exchanged to RSUs</span></td>
    <td id="xdx_988_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z4aqmEnnuOm4" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">215,797</span></td>
    <td id="xdx_981_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zgky3WtW64Eb" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4844">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Exercised</span></td>
    <td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zxFBoDpvVtAd" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(99,576)</span></td>
    <td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z0sMyiI5LCJi" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4848">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Forfeited</span></td>
    <td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zbRUJFWkGI72" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(26,104)</span></td>
    <td id="xdx_988_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zYjd6BBvYxBg" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4852">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31</b></span></td>
    <td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zJWV5I3j3oZ7" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>854,431</b></span></td>
    <td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zOBt3BH1QZxk" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>447,224</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=afya_RSUsMember', window );">R S Us [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions', window );">Schedule of model used to determine the fair value of the stock options</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_hifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zhLIGEa0rpP3" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 1)">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span id="xdx_8BA_z5mSy3N2tTS3" style="display: none">Schedule of model used to determine the fair value of the stock options</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 71%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt">&#160;</td>
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Modified plan</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90A_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zWPeKZFIDhb8" title="Strike price at the measurement date">95</span> - R$<span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBTa2NxzE0j2" title="Strike price at the measurement date">160</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zMdWZ0PcHFH8" title="Dividend yield">0.0</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zSLeWRkJ4E96" title="Expected volatility">45</span>% - <span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zEhGVs7g9Bn9" title="Expected volatility">48</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z7xF29NAJTU5" title="Risk-free interest rate">10</span>% - <span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zkn5cnlFJlwg" title="Risk-free interest rate">12</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zieLowKDGYmg" title="Expected life of stock options">1</span> - <span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zZVQFRInH7Tc" title="Expected life of stock options">5</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z2A86MvYyVSj" title="Share price at the measurement date">75</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Valuation model</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zOBhyh8aoE2e" title="Model used">Binomial</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average conversion rate (RSUs/Stock options)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z2XpObBbdqna" title="Weighted average fair value at the measurement date">0.12</span></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAdditionalStockOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAdditionalStockOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfSharebasedCompensationPlanExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfSharebasedCompensationPlanExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfStockOptionExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfStockOptionExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=afya_RSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=afya_RSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639611255216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureEquityAbstract', window );"><strong>Disclosure Equity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfTreasurySharesMovementExplanatory', window );">Schedule illustrates the number and movements in treasury shares</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--ScheduleOfTreasurySharesMovementExplanatory_zvIQsmqLNYQb" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Equity (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: left; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8B5_z1twcLhelyU4" style="display: none">Schedule illustrates the number and
    movements in treasury shares</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 58%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 19%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Number of treasury shares</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><b>Average price</b></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><b>(in Brazilian Reais)</b></p></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Outstanding at January 1, 2021</span></td>
    <td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iS_pid_c20210101__20211231_z4RHt0jx9BO8" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4922">-</span></span></td>
    <td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20210101__20211231_zk7ah6CmKiPh" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4924">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Repurchased</span></td>
    <td id="xdx_985_ecustom--NumberOfSharesRepurchased_pid_c20210101__20211231_zDKZeSbvIu7b" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,142,051</span></td>
    <td id="xdx_98E_ecustom--AveragePriceRepurchased_pid_c20210101__20211231_zvkKxHfuJpEb" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">119.99</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred from exercise of stock options</span></td>
    <td id="xdx_98B_ecustom--TransferredFromExerciseOfStockOptions_pid_c20210101__20211231_z2R8UthoK2Ef" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Transferred from exercise of stock options"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(442,669)</span></td>
    <td id="xdx_985_ecustom--AveragePriceTransferredFromExerciseOfStockOptions_pid_c20210101__20211231_z4Jj6TDZ2CZf" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price transferred from exercise of stock options"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">124.26</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred from shares contribution</span></td>
    <td id="xdx_98B_ecustom--TransferredFromSharesContribution_pid_c20210101__20211231_zkJMM1kVKYtg" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Transferred from shares contribution"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(44,455)</span></td>
    <td id="xdx_989_ecustom--AveragePriceTransferredFromSharesContribution_pid_c20210101__20211231_zAFOAIVGSfJk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price transferred from shares contribution"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">111.94</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31, 2021</b></span></td>
    <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20210101__20211231_z4040Jq3feud" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,654,927</b></span></td>
    <td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20220101__20221231_zvNZYSC5Hm97" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>92.23</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Repurchased</span></td>
    <td id="xdx_98D_ecustom--NumberOfSharesRepurchased_pid_c20220101__20221231_zDwhGvaAOFgf" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,131,358</span></td>
    <td id="xdx_98D_ecustom--AveragePriceRepurchased_pid_c20220101__20221231_zIPESYXXKEHk" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71.46</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31, 2022</b></span></td>
    <td id="xdx_984_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20220101__20221231_zYa0l4tCDBp1" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at ending balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,786,285</b></span></td>
    <td id="xdx_981_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231_z1XsVHTiQ6h4" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>80.54</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Repurchased</span></td>
    <td id="xdx_98A_ecustom--NumberOfSharesRepurchased_pid_c20230101__20231231_zI4y64Htsdgg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">216,339</span></td>
    <td id="xdx_982_ecustom--AveragePriceRepurchased_pid_c20230101__20231231_z1weBiUo8r8d" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57.17</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Delivered under the share-based compensation plan</span></td>
    <td id="xdx_98A_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_iP3custom--AveragePriceRepurchased_pid_c20230101__20231231_zx7lFam1NYQ8" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(229,146)</span></td>
    <td id="xdx_982_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_iP3custom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pid_c20230101__20231231_zSVHvaAjjgN" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">79.28</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Outstanding at December 31, 2023</b></span></td>
    <td id="xdx_985_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20230101__20231231_zfcB7fnh7kIc" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at ending balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,773,478</b></span></td>
    <td id="xdx_986_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231_zJMM77CMs9Ti" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at ending balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>79.28</b></span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfTreasurySharesMovementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfTreasurySharesMovementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639605948592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (EPS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfEarningsPerShareTableExplanatory', window );">Schedule of earnings per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfEarningsPerShareTableExplanatory_zh4dEsEpi4ga" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Earnings per share (EPS) (Details)">
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"><span id="xdx_8BD_ztMuxzx63bp4" style="display: none">Schedule of earnings per share</span></td>
    <td id="xdx_494_20230101__20231231_zJeOJSBUDycl" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center">&#160;</td>
    <td id="xdx_491_20220101__20221231_zIvykMcHKZ1h" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center">&#160;</td>
    <td id="xdx_49E_20210101__20211231_zmcGCgKoYDfh" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 58%; padding-right: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr id="xdx_404_ecustom--NumeratorAbstract_iB_zX2qshDNvgyi">
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Numerator</b></span></td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_pn3n3_zdsv90uET2l4" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Net income attributable to equity holders of the parent</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">386,324</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">373,569</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">223,326</span></td></tr>
  <tr id="xdx_404_ecustom--DenominatorAbstract_iB_pn3n3_zIugD1pFkXh7" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Denominator</b></span></td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--WeightedAverageShares_pid_z8fIXOPUpdyh" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 8.6pt; text-align: justify; text-indent: -8.6pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted average number of outstanding shares</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">89,830,351</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">90,335,037</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">93,291,480</span></td></tr>
  <tr id="xdx_40C_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pid_zGU1Tq0ty0Ic" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effects of dilution from stock options and restricted share units</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">706,492</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">329,085</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">811,818</span></td></tr>
  <tr id="xdx_40E_eifrs-full--AdjustedWeightedAverageShares_pid_uShares_zrEuz15uV5B1" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify; line-height: 115%; text-indent: -7.1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Weighted average number of outstanding shares adjusted for the effect of dilution</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">90,536,843</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">90,664,122</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">94,103,298</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--BasicEarningsLossPerShare_pid_z17TAETfE2Zc" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Basic earnings per share (R$)</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4.30</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4.14</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2.39</span></td></tr>
  <tr id="xdx_40C_eifrs-full--DilutedEarningsLossPerShare_pid_ziW3dWZ5nqO4" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Diluted earnings per share (R$)</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4.27</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4.12</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2.37</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfEarningsPerShareTableExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfEarningsPerShareTableExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639633878160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfNetSalesRevenueExplanatory', window );">Schedule of net sales revenue</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfNetSalesRevenueExplanatory_pn3n3_znfpDm4BOzIc" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Revenue (Details)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span id="xdx_8B9_z5BUwrB1hwy9" style="display: none">Schedule of net sales revenue</span></td>
    <td id="xdx_49F_20230101__20231231_z1WObxgz0xtc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49E_20220101__20221231_zcrwSmtQvjz7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49B_20210101__20211231_zs61v7tgdhUl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 58%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ProfessionalFeesExpenses_pn3n3_zwk9c80ObZK8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Tuition fees</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">3,505,250</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">2,827,567</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">2,124,589</span></td></tr>
  <tr id="xdx_404_ecustom--OtherRevenue1_pn3n3_zp8xAYUrIeNa" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Other</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">263,937</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">213,040</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">167,441</span></td></tr>
  <tr id="xdx_402_ecustom--DeductionAbstract_iB_zdCBlY7sJgra" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Deductions</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_409_ecustom--DeductionOfGrantedDiscounts_pn3n3_zC9iOk8mpbAj" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;Discount and scholarships</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(240,314)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(241,404)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(229,254)</span></td></tr>
  <tr id="xdx_408_ecustom--DeductionOfEarlyPaymentDiscounts_pn3n3_zmb02L9Q1O94" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;Early payment discounts</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(195,054)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(92,234)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(49,879)</span></td></tr>
  <tr id="xdx_404_ecustom--DeductionOfReturnsOfNetRevenue_pn3n3_zlIFg3qx6xXk" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;Returns</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(27,743)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(45,402)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(42,373)</span></td></tr>
  <tr id="xdx_40C_ecustom--DeductionOfTaxes_pn3n3_zvkgH40LOO89" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;Taxes</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(142,825)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(107,004)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(74,232)</span></td></tr>
  <tr id="xdx_405_ecustom--DeductionOfProuni_pn3n3_zvB87VooQBn" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">&#160;&#160;PROUNI</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(287,338)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(225,506)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(176,921)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--RevenueFromContractsWithCustomers_pn3n3_zifnEgvdKpp2" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>Revenue from contracts with customers</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2,875,913</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2,329,057</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>1,719,371</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_zQUWx9J7t8ff" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>Timing of revenue recognition of revenue from contracts with customers:</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--FeeAndCommissionIncome_pn3n3_zj1zLfWnUIA3" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Tuition, digital content and app subscription fees - Transferred over time</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">2,821,251</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">2,273,578</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">1,640,889</span></td></tr>
  <tr id="xdx_401_ecustom--NetRevenueOtherTransferredPoint_pn3n3_zjDCMstxDC6e" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Other - Transferred at a point in time</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">54,662</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">55,479</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">78,482</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfRevenueBySegmentTableTextBlock', window );">Schedule of revenue by segment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfRevenueBySegmentTableTextBlock_pn3n3_zYeN0mE0ZXFe" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Revenue (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span id="xdx_8BC_zLB23Iq3EQPg" style="display: none">Schedule of revenue by segment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: -0.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zi0ZP7NAhEbe" style="text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,511,018</b></span></td>
    <td id="xdx_98B_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z3TEEuYkhEo4" style="text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>146,827</b></span></td>
    <td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zAzJ1KuKMhUf" style="text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>229,285</b></span></td>
    <td id="xdx_984_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zn2QPvTh437l" style="text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(11,217)</b></span></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231_zKtBvJTdd82g" style="text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,875,913</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_98B_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zISyUUEzkRoc" style="text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,494,121</span></td>
    <td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zuipgDQ2Xuh7" style="text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">146,477</span></td>
    <td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zgqcuZM55Fvc" style="text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5067">-</span></span></td>
    <td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zM8zwEXoyww4" style="text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5069">-</span></span></td>
    <td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231_zB9QgWnGCdNl" style="text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,640,598</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zy90ntUDoZRd" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">16,897</span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7luo5JNsp16" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">350</span></td>
    <td id="xdx_986_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zzNooKxN9xl4" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">229,285</span></td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zrvYooQ9jcLi" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,217)</span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231_zc4LmfnEaQad" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">235,315</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_z693lSPU446" style="text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,511,018</b></span></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj839nXLhoB1" style="text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>146,827</b></span></td>
    <td id="xdx_982_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zkryQ0ogpLc4" style="text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>229,285</b></span></td>
    <td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zNRuFiSGn6vk" style="text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(11,217)</b></span></td>
    <td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231_z6VZkjduxU9k" style="text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,875,913</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zpQcRHDtECl6" style="text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,494,121</span></td>
    <td id="xdx_986_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zb4nPaGgjvHb" style="text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">146,827</span></td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zP3BPBeb1ej7" style="text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">191,520</span></td>
    <td id="xdx_98C_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zMZqSEbuQcy4" style="text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,217)</span></td>
    <td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231_zEC2CgkqhdB8" style="text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,821,251</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in time</span></td>
    <td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zvwDIInIJVu" style="text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">16,897</span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7tg3Vfmfxc9" style="text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5105">-</span></span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0rOvSDeONg7" style="text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">37,765</span></td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_ztHSmt5Fr2lc" style="text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5109">-</span></span></td>
    <td id="xdx_98E_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231_z04tHxkw1m65" style="text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,662</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: -0.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_98B_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQ9uzv3KS3x2" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,037,889</b></span></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7AzcS5SYmsb" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>108,806</b></span></td>
    <td id="xdx_984_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zGfMf0AXWjk" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>189,984</b></span></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zwlcrNDR31k" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(7,622)</b></span></td>
    <td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231_z1oJNuCApja3" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,329,057</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zfiWouZlsJ6d" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,023,128</span></td>
    <td id="xdx_988_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zz4Tkh7VbVQa" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,648</span></td>
    <td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zkm0oXD1pMal" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5129">-</span></span></td>
    <td id="xdx_98B_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zj0KHscAEw7e" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5131">-</span></span></td>
    <td id="xdx_980_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231_zEHSri1DoqWk" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,131,776</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zHqJpB7G0MXd" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,761</span></td>
    <td id="xdx_98F_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z5VjxSw1Mnej" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">158</span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrBSxDtJMa7g" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">189,984</span></td>
    <td id="xdx_982_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zDTJ3NPMQ4L4" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,622)</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231_zR24lXnHcO73" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">197,281</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zBdqUnzNNjtl" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,037,889</b></span></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z1wI19CkMpC1" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>108,806</b></span></td>
    <td id="xdx_98A_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zSncGdjYg1z3" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>189,984</b></span></td>
    <td id="xdx_98E_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zPijWuOF51W4" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(7,622)</b></span></td>
    <td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231_zZ7zF2FahVs4" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,329,057</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqLQFUfnWqD7" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,024,373</span></td>
    <td id="xdx_983_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zfyDXLtSlg5e" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">108,806</span></td>
    <td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z4roRCgvHBkk" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">145,939</span></td>
    <td id="xdx_989_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zeDCAinVuQO2" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5,540)</span></td>
    <td id="xdx_984_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231_znnnB9B3fWTb" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,273,578</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in time</span></td>
    <td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zKSWsRcjNfi9" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,516</span></td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znBWIkid4crl" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5167">-</span></span></td>
    <td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zC2BilU7YKg2" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">44,045</span></td>
    <td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zJJ1A9BQuwDb" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,082)</span></td>
    <td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231_zfmFpyOK6dXj" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">55,479</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_989_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zZxFCjZ6r5ie" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,498,408</b></span></td>
    <td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zuLSwLLKmn2a" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>72,983</b></span></td>
    <td id="xdx_989_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zBR5ly7nxCE" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>151,958</b></span></td>
    <td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zpogD8yKpbGj" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(3,978)</b></span></td>
    <td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231_zJyTK0ykkOS7" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,719,371</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_987_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zZjXDbIvuRi9" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,486,111</span></td>
    <td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zaDp4rTLcIE8" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,983</span></td>
    <td id="xdx_984_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zv1OXCLX4i5" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5189">-</span></span></td>
    <td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zFmDKQXGjsg5" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5191">-</span></span></td>
    <td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231_z3KM0dsLcufj" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,559,094</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zaWzuaj8hPwe" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,297</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zmWHomzrJQLe" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5197">-</span></span></td>
    <td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjLntB2JdBp2" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">151,958</span></td>
    <td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zlJiGX2JoqDd" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,978)</span></td>
    <td id="xdx_987_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231_zKkpucWMzCL1" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">160,277</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zrWrviu9ORm2" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,498,408</b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zVJQuehlkY3i" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>72,983</b></span></td>
    <td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zGMiHnPqPGRh" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>151,958</b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zmn1hMMQ44tc" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(3,978)</b></span></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231_zIIrnf2aaSWl" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,719,371</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zeb6DMrsKRP1" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,486,111</span></td>
    <td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zmucLbC6xnUl" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,983</span></td>
    <td id="xdx_986_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zmOf4zHFDOt3" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">81,795</span></td>
    <td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z14jonW2j8rc" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5221">-</span></span></td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231_zTeq3L4xEou" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,640,889</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in time</span></td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zTlNEe34zHqf" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,297</span></td>
    <td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zIRJ5K2ZkY44" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5227">-</span></span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z7iVqnvXaiz4" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,163</span></td>
    <td id="xdx_983_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_za2aC8xbX7m" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,978)</span></td>
    <td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231_ztARH3Qyy1T5" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">78,482</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfNetSalesRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfNetSalesRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfRevenueBySegmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfRevenueBySegmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639668613824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Expenses and costs by nature (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfExpensesByNatureTableTextBlock', window );">Schedule of expenses by nature</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--SummaryOfExpensesByNatureTableTextBlock_pn3n3_zfdljIcQLPa5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Expenses and costs by nature (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BE_zl35bW6LMvNe" style="display: none">Schedule of expenses by nature</span></td>
    <td id="xdx_491_20230101__20231231_zLMbmlAE426i" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49B_20220101__20221231_zWeF1SzHqZLc" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_49F_20210101__20211231_zHcU4TYvXS4f" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td></tr>
<tr>
    <td style="width: 46%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2021</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_402_eifrs-full--CostOfSales_iN_pn3n3_di_z9lzEJIic082" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Cost of services</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(1,109,813)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(859,552)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(652,300)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--GeneralAndAdministrativeExpense_iN_pn3n3_di_zwHCywEaduul" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">Selling, general and administrative expenses</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(1,014,684)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(798,153)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(622,615)</span></td></tr>
  <tr id="xdx_402_eifrs-full--ExpenseByNature_iN_pn3n3_di_zZgzKIs284T8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b style="display: none">Total</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(2,124,497)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(1,657,705)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(1,274,915)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--Payroll_pn3n3_zxs1ZZSg5kS" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payroll</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(1,085,144)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(880,664)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(677,564)</span></td></tr>
  <tr id="xdx_40F_ecustom--HospitalAndMedicalAgreements_pn3n3_zlphn7Uriw63" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Hospital and medical agreements</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(86,151)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(66,065)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(37,449)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--DepreciationExpense_iN_pn3n3_di_zyIEmwhLbal" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation and amortization</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(289,511)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(206,220)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(154,220)</span></td></tr>
  <tr id="xdx_400_ecustom--LeaseExpenses_pn3n3_zVrgo5WrYMe3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease expenses</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(10,871)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(12,153)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(11,229)</span></td></tr>
  <tr id="xdx_407_eifrs-full--UtilitiesExpense_pn3n3_zDPxw4HSsQD8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Utilities</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(20,403)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(17,682)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(10,643)</span></td></tr>
  <tr id="xdx_402_eifrs-full--RepairsAndMaintenanceExpense_iN_pn3n3_di_z8HqLPNNcpic" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Maintenance</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(105,919)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(76,475)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(47,141)</span></td></tr>
  <tr id="xdx_40C_ecustom--SharesBasedCompensation_pn3n3_zF0LsEahKDA3" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share-based compensation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(31,535)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(31,274)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(43,377)</span></td></tr>
  <tr id="xdx_409_ecustom--TaxExpenses_pn3n3_zYSaAQpnfqB8" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tax expenses</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(14,447)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(10,518)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(7,997)</span></td></tr>
  <tr id="xdx_40D_eifrs-full--ServicesExpense_iN_pn3n3_di_zpVtYAfw4CBf" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Pedagogical services</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(64,081)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(48,084)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(47,881)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--SalesAndMarketingExpense_iN_pn3n3_di_zzIlxPHPw6v3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Sales and marketing</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(74,140)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(48,217)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(39,506)</span></td></tr>
  <tr id="xdx_40C_ecustom--AllowanceForExpectedCreditLosses_pn3n3_z5XH2J91guek" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Allowance for expected credit losses</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(74,552)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(42,708)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(47,819)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--TravelExpense_iN_pn3n3_di_zV4ukGYKc7B5" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Travel expenses</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(16,098)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(14,003)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(7,542)</span></td></tr>
  <tr id="xdx_40D_ecustom--ConsultingFees_pn3n3_zoyNP63WDNx7" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Consulting fees</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(62,630)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(35,326)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(38,818)</span></td></tr>
  <tr id="xdx_40E_ecustom--Other_pn3n3_zZaZ1uhnusJj" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(189,015)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(168,316)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(103,729)</span></td></tr>
  <tr id="xdx_40C_ecustom--ExpenseByNatureOne_pn3n3_zBmYGmeYmzgl" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b style="display: none">Total</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(2,124,497)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(1,657,705)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(1,274,915)</b></span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfExpensesByNatureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfExpensesByNatureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639605942720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance result (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfFinanceResultTableTextBlock', window );">Schedule of finance result</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--ScheduleOfFinanceResultTableTextBlock_zFCcfPpIzMbf" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Finance result (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zysruc05zkJ2" style="display: none">Schedule of finance result</span></td>
    <td id="xdx_493_20230101__20231231_zB1aXru0IUpa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_499_20220101__20221231_zOpB2wKCv3nl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49C_20210101__20211231_zXwR7e35HFp" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--InvestmentIncome_pn3n3_z8DyQCHSraPi" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income from financial investments</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">73,672</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">67,810</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,773</span></td></tr>
  <tr id="xdx_40E_eifrs-full--RevenueFromInterest_pn3n3_zr6uiRUlIq0h" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest received</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">33,450</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,197</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,040</span></td></tr>
  <tr id="xdx_400_eifrs-full--OtherFinanceIncome_pn3n3_zZCv6TxcaGa8" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,520</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,035</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,753</span></td></tr>
  <tr id="xdx_40D_eifrs-full--FinanceIncome_pn3n3_zaLIzb89Yo15" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance income</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>110,642</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>102,042</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>64,566</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_408_ecustom--InterestExpense1_pn3n3_z4uac0wnG8d4" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(285,447)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(200,081)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(108,437)</span></td></tr>
  <tr id="xdx_40B_ecustom--InterestExpenseOnLeaseLiabilities1_pn3n3_zL7kY0iBWH3g" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest expense on lease liabilities</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(100,849)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(88,571)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(67,212)</span></td></tr>
  <tr id="xdx_40F_ecustom--FinancialDiscountsGrantedExpenses_pn3n3_zbFKVp3xCoe" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Financial discounts granted</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(30,891)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(24,092)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(23,193)</span></td></tr>
  <tr id="xdx_400_eifrs-full--BankAndSimilarCharges_iN_pn3n3_di_zx7WykHrEgmi" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bank fees</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,163)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(8,623)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,878)</span></td></tr>
  <tr id="xdx_405_eifrs-full--NetForeignExchangeLoss_iN_pn3n3_di_zXz9mKYFxafi" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Foreign exchange loss, net</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(681)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(852)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(17,973)</span></td></tr>
  <tr id="xdx_405_ecustom--TaxOnFinancialOperations_pn3n3_zhEMHixPeMT1" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IOF taxes (taxes on financial transactions)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,947)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(178)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,306)</span></td></tr>
  <tr id="xdx_400_eifrs-full--OtherFinanceCost_iN_pn3n3_di_zShhuNZiILe4" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(30,638)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(27,496)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(15,797)</span></td></tr>
  <tr id="xdx_409_eifrs-full--FinanceCosts_iN_pn3n3_di_z4ojR9SPoIwd" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance expenses</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(457,616)</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(349,893)</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(243,796)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--FinanceResult_pn3n3_zOFbUfqRwHU6" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance result</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(346,974)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(247,851)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(179,230)</b></span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFinanceResultTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFinanceResultTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639668617424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureIncomeTaxesAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory', window );">Schedule of reconciliation of income tax expense</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_z0ZfbEW2o3Kl" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details)">
  <tr style="background-color: White">
    <td style="white-space: nowrap"><span id="xdx_8B9_z0wBWQB93Ms1" style="display: none">Schedule of reconciliation of income tax expense</span></td>
    <td id="xdx_496_20230101__20231231_zMYAmTrC9ZKc" style="vertical-align: bottom; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_499_20220101__20221231_zM9haULjtd83" style="vertical-align: bottom; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_493_20210101__20211231_zQVh9XsezGlg" style="vertical-align: bottom; text-align: center; line-height: 115%">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 46%">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2023</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2022</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>2021</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zX3IuBaK0bf4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income before income taxes</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">429,582</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">428,433</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">273,462</span></td></tr>
  <tr id="xdx_400_eifrs-full--ApplicableTaxRate_pid_dp_zNs4jixl3bt6" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Combined statutory income taxes rate - %</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">34%</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">34%</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">34%</span></td></tr>
  <tr id="xdx_406_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pn3n3_zQ9TPK77mgUj" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes at statutory rates</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(146,058)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(145,667)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(92,977)</span></td></tr>
  <tr id="xdx_405_ecustom--ReconciliationAdjustmentsAbstract_iB_pn3n3_zvRRDuKiX1v7" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reconciliation adjustments:</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%">&#160;</td></tr>
  <tr id="xdx_409_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pn3n3_z6DWPRcfgcDe" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tax effect on loss from entities not subject to taxation</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(32,274)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(32,859)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(37,794)</span></td></tr>
  <tr id="xdx_401_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pn3n3_zaZp3u2abVuh" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">PROUNI - Fiscal Incentive (i)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">309,952</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">270,062</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">194,830</span></td></tr>
  <tr id="xdx_40A_ecustom--UnrecognisedDeferredTaxAssets_pn3n3_zvEmwvIZLIua" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Unrecognized deferred tax assets</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(154,062)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(117,377)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(86,233)</span></td></tr>
  <tr id="xdx_407_ecustom--RecognisedDeferredTaxAssets_pn3n3_zscGF7xEYmqe" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Recognized deferred tax assets</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">3,233</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl5400">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><span style="-sec-ix-hidden: xdx2ixbrl5401">-</span></span></td></tr>
  <tr id="xdx_403_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_iN_pn3n3_di_zHCeXWnO33ig" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Presumed profit income tax regime effect (ii)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(8,787)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(1,549)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(7,066)</span></td></tr>
  <tr id="xdx_402_ecustom--PermanentAdjustments_pn3n3_zMCum4XkC7Cl" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Permanent adjustments</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(4,687)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(12,226)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">(6,232)</span></td></tr>
  <tr id="xdx_40D_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_pn3n3_zNMf0z9h5Ib1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">8,517</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">3,939</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">4,293</span></td></tr>
  <tr id="xdx_40E_eifrs-full--CurrentTaxExpenseIncome_pn3n3_zUrRtF3ayOx1" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes expense - current</span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(24,166)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(35,677)</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"><b>(31,179)</b></span></td></tr>
  <tr id="xdx_400_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_zOWlunh9KMe4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effective rate</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">5.62%</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">8.33%</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%">11.40%</span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The Company adhered to PROUNI, established by Law 11,096 / 2005, which is a federal program
that exempts companies of paying income taxes and social contribution upon compliance with certain requirements required by said Law.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Brazilian tax law establishes that companies that generate gross revenues of up to R$78,000
in the prior fiscal year may calculate income taxes as a percentage of gross revenue, using the presumed profit tax regime. The effect
of the presumed profit of certain subsidiaries represents the difference between the taxation based on this method and the amount that
would be due based on the statutory rate applied to the taxable profit of the subsidiaries.<br/></td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639669718656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insurance contracts and contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureInsuranceContractsAndContingenciesAbstract', window );"><strong>Insurance Contracts And Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfLegalProceedingsAndContingencies', window );">Schedule of legal proceedings and contingencies</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfLegalProceedingsAndContingencies_zybwi3fywxDd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Insurance contracts and contingencies (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BE_zC3Fs1DV8usk" style="display: none">Schedule of legal proceedings and contingencies</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 39%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Labor</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Civil</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Taxes</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances as of December 31, 2020</b></span></td>
    <td id="xdx_98E_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zkAEFLwgWsWf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>4,519</b></span></td>
    <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zeJEVRyDBJ6g" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>13,280</b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zQjqkpw49QV" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>35,340</b></span></td>
    <td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zKg9FIM4sXQh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>53,139</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business combinations</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zZbNZQTZkAxa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">16,597</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zRJ3dLRzO7L6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">6,017</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z9AmhRyjC2Fk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,638</span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zTExp6siSNxi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">80,252</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions </span></td>
    <td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zHdWklvfywg7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,418</span></td>
    <td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuTloi09neO1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,101</span></td>
    <td id="xdx_980_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z8IGVEt5w2l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,225</span></td>
    <td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zKAZqSs0Ec77" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,744</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zFObFYsdLgRf" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,044)</span></td>
    <td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zq63heHtDPHk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,470)</span></td>
    <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z4W12NxhRy4l" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,334)</span></td>
    <td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zctkMbHAwS41" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(9,848)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances as of December 31, 2021</b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgELEUzlVt3f" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>25,490</b></span></td>
    <td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zInWUUH8rfGc" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>22,928</b></span></td>
    <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zNBuyde8auG4" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>99,869</b></span></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z4jjBQdk6Pfh" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>148,287</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zaa4p2aDUa78" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,300</span></td>
    <td id="xdx_98C_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zOPFThM3ldlk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,911</span></td>
    <td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zS3IfXYifnjf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">63,698</span></td>
    <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z7A21rdqDsJf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">73,909</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_987_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgVm3uVxqj5h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5,306)</span></td>
    <td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zIMOVd5S00i1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,175)</span></td>
    <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zoRjkyJ1PWc6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(14,861)</span></td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zcJdsSU4gCP6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(26,342)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances as of December 31, 2022</b></span></td>
    <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zWwJ6gsnjOw1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>22,484</b></span></td>
    <td id="xdx_98F_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zTk8bzyfkLw7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>24,664</b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zTewyI7913L9" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>148,706</b></span></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zLKZD5wnpf6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>195,854</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business combination</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z47gSBFcAYO7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">64</span></td>
    <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zDS8ELjItj52" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">88</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zzpqhMprank8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5501">-</span></span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhNpTKiEmi5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">152</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zzCKWAvCASWl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,424</span></td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zGIv7povfvL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,875</span></td>
    <td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zB17EajSVgGd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">9,037</span></td>
    <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z79sULeFZkRj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">18,336</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals (i)</span></td>
    <td id="xdx_986_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zbr9LPc9GaP4" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,251)</span></td>
    <td id="xdx_98F_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zGf03daQkbmc" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(9,327)</span></td>
    <td id="xdx_987_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zkIeF1ZbZleh" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(97,403)</span></td>
    <td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zNgpBoucs75k" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(109,981)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances as of December 31, 2023</b></span></td>
    <td id="xdx_98A_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zPRVY89kuhXa" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>22,721</b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zCHKohCTPeI4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>21,300</b></span></td>
    <td id="xdx_986_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zWm7ralE2xOk" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>60,340</b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zjJOiJq4GCMe" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>104,361</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">On August 10, 2023, Unigranrio entered into a tax amnesty program on interest and penalties
to settle a tax proceeding with respect to ISS (tax on services) with the municipality of Rio de Janeiro, which result in a payment of
R$14,819. The selling shareholders of Unigranrio agreed to pay R$5,438 regarding this matter, which was deducted from the accounts payable
to selling shareholders. The Company had a provision of R$53,302 and an indemnification asset from the selling shareholders of R$20,000
(in light of the indemnification clauses as defined at acquisition of Unigranrio), in respect to such tax proceedings. The difference
between the provision, indemnification asset and the actual paid amount was recorded as Other income (expenses), net on the consolidated
statements of income and comprehensive income.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement', window );">Schedule of social security proceedings assessed by Management</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagement_z5p7yyyTT2k7" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Insurance contracts and contingencies (Details 1)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B1_z6q7eUhZ4jv2" style="display: none">Schedule of social
    security proceedings assessed by Management</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Labor</span></td>
    <td id="xdx_986_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zN3rjculUHBh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">32,683</span></td>
    <td id="xdx_985_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zVqVER4Uby4j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,914</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Civil</span></td>
    <td id="xdx_981_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zsVNSqtEaQ3j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">51,319</span></td>
    <td id="xdx_983_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2MRQw4TB9bl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">59,603</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Taxes and social security</span></td>
    <td id="xdx_989_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zhuJU4lLveEg" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,669</span></td>
    <td id="xdx_98E_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_znf651RM4Sq6" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,931</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Total</b></td>
    <td id="xdx_98D_eifrs-full--OtherProvisions_iI_pn3n3_c20231231_zwOEl0M4UJQi" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>89,671</b></span></td>
    <td id="xdx_981_eifrs-full--OtherProvisions_iI_pn3n3_c20221231_zQzrT2Rqmn3j" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>78,448</b></span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureInsuranceContractsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureInsuranceContractsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfLegalProceedingsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfLegalProceedingsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639612216304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-cash transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureNoncashTransactionsAbstract', window );"><strong>Non-cash Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NonCashTransactionsTableTextBlock', window );">Schedule of non-cash transactions</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--NonCashTransactionsTableTextBlock_zX9Gtt2uTYv9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Non-cash transactions (Details)">
  <tr style="background-color: White">
    <td><span id="xdx_8BF_zv0UAG0oUoZ2" style="display: none">Schedule
    of non-cash transactions</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 67%; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Issuance of shares for acquisition of iClinic</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zM9oStIYWZi9" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5559">-</span></span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zVnc83yDKE36" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5561">-</span></span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zj2vqVXci4le" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">71,500</span></td></tr>
  <tr style="background-color: White">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Issuance of shares for acquisition of Cliquefarma</span></td>
    <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zv9e8vZ4SiPf" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5565">-</span></span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zRkRritwJ53k" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5567">-</span></span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zitgAeiaFCXa" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,000</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Issuance of shares for acquisition of RX PRO</span></td>
    <td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zsawovGyVgfa" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5571">-</span></span></td>
    <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zHIakik5bL7i" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5573">-</span></span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zeGRggvdhfJl" style="text-align: right" title="Issuance of shares for acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,112</span></td></tr>
  <tr style="background-color: White">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement of earn-out of Al&#233;m da Medicina, CardioPapers and Glic</span></td>
    <td id="xdx_98C_ecustom--RemeasurementOfEarnOut_pn3n3_c20230101__20231231_zwNYmjkz5dfd" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,556</span></td>
    <td id="xdx_982_ecustom--RemeasurementOfEarnOut_pn3n3_c20220101__20221231_zgj6oKDoCSZa" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5579">-</span></span></td>
    <td id="xdx_980_ecustom--RemeasurementOfEarnOut_pn3n3_c20210101__20211231_zfK7P4Wk73ef" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5581">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Provision for legal proceedings with corresponding indemnification asset</span></td>
    <td id="xdx_98E_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20230101__20231231_ztPbmOAMgq39" style="text-align: right" title="Provision for legal proceedings with corresponding indemnification asset"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,000</span></td>
    <td id="xdx_98F_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20220101__20221231_zAzcZdv0lrhf" style="text-align: right" title="Provision for legal proceedings with corresponding indemnification asset"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">48,333</span></td>
    <td id="xdx_98F_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20210101__20211231_zi0x4gkt7eNd" style="text-align: right" title="Provision for legal proceedings with corresponding indemnification asset"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,232</span></td></tr>
  <tr style="background-color: White">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions and remeasurements of right-of-use assets and lease liabilities</span></td>
    <td id="xdx_98C_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20230101__20231231_zHgJRFYaOd25" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">77,715</span></td>
    <td id="xdx_981_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20220101__20221231_z53G9TtT22ae" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">100,873</span></td>
    <td id="xdx_98C_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20210101__20211231_zXmS2MAg6DMc" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">158,651</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureNoncashTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureNoncashTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NonCashTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NonCashTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639633624800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Corporate information (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 05, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 99,399<span></span>
</td>
<td class="nump">R$ 1,234,460<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 67,381<span></span>
</td>
<td class="nump">R$ 842,197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_BertelsmannMember', window );">Bertelsmann [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Own percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57.50%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Voting interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_BertelsmannMember', window );">Bertelsmann [Member] | Ordinary shares [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AcquiredShares', window );">Acquired shares</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsiderationPaidReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 40<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_40_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsiderationPaidReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ifrs-full_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ifrs-full_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_BertelsmannMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_BertelsmannMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639634716160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AfyaParticipacoesSAMember', window );">Afya Participacoes S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Holding<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Nova Lima - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember', window );">Instituto Tocantinense Presidente Antonio Carlos Porto S. A. I T P A C Porto [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Porto Nacional - TO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember', window );">Instituto Tocantinense Presidente Antonio Carlos S. A. I T P A C Araguaina [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Aragua&#237;na - TO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember', window );">Uniao Educacional Do Vale Fo Aco S. A. U N I V A C O [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medicine undergraduate degree program<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Ipatinga - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember', window );">I P T A N Instituto De Ensino Superior Presidente Tancredo De Almeida Neves S. A. I P T A N [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o Jo&#227;o Del Rei - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember', window );">Instituto De Educacao Superior Do Vale Do Parnaiba S. A. I E S V A P [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Parna&#237;ba - PI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember', window );">Centro De Ciencias Em Saude De Itajuba S. A. C C S I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medicine undergraduate degree program<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Itajub&#225; - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember', window );">Instituto De Ensino Superior Do Piaui S. A. I E S P [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate and graduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Teresina - PI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroIntegradoDeSaudeDeTeresinaCISMember', window );">Centro Integrado De Saude De Teresina C I S [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Outpatient care<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Teresina - PI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember', window );">F A D E P Faculdade Educacional De Pato Branco Ltda F A D E P [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Pato Branco - PR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedcelEditoraEventosS.A.MedcelMember', window );">Medcel Editora Eventos S. A. Medcel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medical education content<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o Paulo - SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember', window );">Instituto Educacional Santo Agostinho S. A. F A S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Montes Claros - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ESMCEducacaoSuperiorLtdaESMCMember', window );">E S M C Educacao Superior Ltda E S M C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Montes Claros - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember', window );">Instituto De Pesquisa E Ensino Medico Fo Estado De Minas Gerais Ltda I P E M E D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Graduate<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Belo Horizonte - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember', window );">Instituto Paraense De Educacao E Cultura Ltda. I P E C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medicine degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Marab&#225; - PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember', window );">Sociedade Universitaria Redentor S. A. Uni Redentor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate and graduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Itaperuna - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeEnsinoSaoLucasLtda.UniSLMember', window );">Centro De Ensino Sao Lucas Ltda. Uni S L [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Porto Velho - RO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember', window );">Peb Med Instituicao De Pesquisa Medica E Servicos Ltda. Peb Med [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Content and clinical tools and online platform<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Rio de Janeiro - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember', window );">Sociedade De Educacao Cultura E Tecnologia Da Amazonia S. A. F E S A R [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Reden&#231;&#227;o - PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember', window );">Centro Superior De Ciencias Da Saude S S Ltda. F C M P B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medicine degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Jo&#227;o Pessoa - PB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember', window );">I Clinic Desenvolvimento De Software Ltda.i Clinic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Electronic Medical Record, Clinical Management System<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Ribeir&#227;o Preto - SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeSolutionsS.A.MedicinaeMember', window );">Medicinae Solutions S. A. Medicinae [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Healthcare payments and financial services<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Rio de Janeiro - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember', window );">Medical Harbour Aparelhos Medico Hospitalares E Servicos Em Tecnologia Ltda. Medical Harbour [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Educational health and medical imaging<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Florian&#243;polis - SC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember', window );">Cliquefarma Drogarias Online Ltda. Cliquefarma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Online platform<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o Paulo - SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospTecnologiaDaInformacaoLtda.ShospMember', window );">Shosp Tecnologia Da Informacao Ltda. Shosp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Electronic Medical Record, Clinical Management System<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Rio de Janeiro - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember', window );">Sociedade Padrao De Educacao Superior Ltda. Unifip Moc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Montes Claros - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember', window );">Nucleo De Atencao A Saude E De Praticas Profissionalizantes N A S P P [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Outpatient care<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Montes Claros - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember', window );">Companhia Nilza Cordeiro Herdy De Educacao E Cultura Unigranrio [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate and graduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Duque de Caxias - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember', window );">Policlinica E Centro De Estetica Duque De Caxias Ltda. Policlinica [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Outpatient care<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Duque de Caxias - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeEducacionalDePalhocaSALtda.Member', window );">Sociedade Educacional De Palhoca S A Ltda. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Basic Education<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Palho&#231;a - SC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember', window );">Instituto De Ensino Superior De Palhoca S S Ltda. I E S P P A L H O C A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Palho&#231;a - SC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember', window );">R X P R O Solucoes De Tecnologia Ltda. R X P R O [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Marketing for pharmaceutical industry<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o Paulo - SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember', window );">R X P R O L O G Transporte E Logistica Ltda. R X P R O L O G [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Marketing for pharmaceutical industry<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o Paulo - SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_BMVAtividadesMedicasLtda.AlemDaMedicinaMember', window );">B M V Atividades Medicas Ltda. Alem Da Medicina [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medical education content<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o Paulo - SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardiopapersSolucoesDigitaisLtda.CardioPapersMember', window );">Cardiopapers Solucoes Digitais Ltda. Cardio Papers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medical education content<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Recife - PE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember', window );">Quasar Telemedicina Desenvolvimento De Sistemas Computacionais Ltda. Glic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Patient physician relationship<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Barueri - SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember', window );">Sociedade Educacional E Cultural Sergipe Del Rey Ltda. Del Rey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Macei&#243; - AL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember', window );">Uniao Educacional Do Planalto Central S. A. U E P C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Bras&#237;lia - DF<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Associate<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InvestmentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InvestmentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PrincipalActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PrincipalActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The principal place of business of a subsidiary. [Refer: Principal place of business; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 12<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_12_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 19B<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_19B_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 12<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_12_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AfyaParticipacoesSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AfyaParticipacoesSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroIntegradoDeSaudeDeTeresinaCISMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroIntegradoDeSaudeDeTeresinaCISMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedcelEditoraEventosS.A.MedcelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedcelEditoraEventosS.A.MedcelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ESMCEducacaoSuperiorLtdaESMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ESMCEducacaoSuperiorLtdaESMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeEnsinoSaoLucasLtda.UniSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeEnsinoSaoLucasLtda.UniSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeSolutionsS.A.MedicinaeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeSolutionsS.A.MedicinaeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospTecnologiaDaInformacaoLtda.ShospMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospTecnologiaDaInformacaoLtda.ShospMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeEducacionalDePalhocaSALtda.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeEducacionalDePalhocaSALtda.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_BMVAtividadesMedicasLtda.AlemDaMedicinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_BMVAtividadesMedicasLtda.AlemDaMedicinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardiopapersSolucoesDigitaisLtda.CardioPapersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardiopapersSolucoesDigitaisLtda.CardioPapersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639632025248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Details 1)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">25 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember', window );">Machinery And Equipments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Fixtures and fittings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember', window );">It Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember', window );">Library Books [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639607500800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Details 2)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS1Member', window );">Amendments To I A S 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Standard</a></td>
<td class="text">Amendments to IAS 1 and IFRS Practice Statement 2 - Making Materiality Judgments<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy', window );">Description</a></td>
<td class="text">The amendments to IAS 1 and IFRS Practice Statement 2 provide guidance and
    examples to help entities apply materiality judgments to accounting policy disclosures. The amendments aim to help entities provide more
    useful accounting policy disclosures by replacing the requirement for entities to disclose their "material" accounting policies
    with a requirement to disclose their "material" accounting policies and adding guidance on how entities apply the concept of
    materiality when making decisions about accounting policy disclosures.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS8Member', window );">Amendments To I A S 8 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Standard</a></td>
<td class="text">Amendments to IAS 8 - Accounting Policies, Changes in Accounting Estimates and Errors - Definition of Accounting Estimates<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy', window );">Description</a></td>
<td class="text">The amendments to IAS 8 clarify the distinction between changes in accounting
    estimates, changes in accounting policies and correction of errors. They also clarify how entities use measurement techniques and inputs
    to develop accounting estimates.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS12Member', window );">Amendments To I A S 12 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Standard</a></td>
<td class="text">Amendments to IAS 12 - Income Taxes - International Tax Reform - Pillar Two Model Rules<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy', window );">Description</a></td>
<td class="text">In October 2021, more than 130 countries agreed to implement a minimum tax
    regime for multinational groups, known as Pillar Two, to reform the international corporate taxation. Pillar Two aims to ensure that multinational
    groups in scope are liable to a minimum effective corporate tax rate of 15 per cent per country.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS12OneMember', window );">Amendments To I A S 12 One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Standard</a></td>
<td class="text">Amendments to IAS 12 Income Taxes - Deferred Tax related to Assets and Liabilities arising from a Single Transaction<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy', window );">Description</a></td>
<td class="text">The amendments to IAS 12 Income Taxes narrow the scope of the initial recognition
    exception, so that it no longer applies to transactions that generate equal taxable and deductible temporary differences, such as leases
    and decommissioning liabilities.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=ifrs-full_IFRS17Member', window );">IFRS 17 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Standard</a></td>
<td class="text">IFRS 17 - Insurance Contracts<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy', window );">Description</a></td>
<td class="text">IFRS 17 is a new accounting standard with scope for insurance contracts,
    covering recognition and measurement, presentation and disclosure. IFRS 17 replaces IFRS 4 - Insurance Contracts. IFRS 17 applies to all
    types of insurance contracts (such as life, property and casualty, direct insurance and reinsurance), regardless of the type of entities
    issuing them, as well as to certain guarantees and financial instruments with discretionary participation characteristics; Some scope
    exceptions will apply.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIFRS16Member', window );">Amendments To I F R S 16 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Standard</a></td>
<td class="text">Amendments to IFRS 16: Lease Liability in a Sale and Leaseback<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy', window );">Description</a></td>
<td class="text">In September 2022, the IASB issued amendments to IFRS 16 to specify the requirements
    that a seller-lessee uses in measuring lease liability arising from a sale and lease back transaction, in order to ensure that the seller-lessee
    does not recognise any amount of the gain or loss that relates to the right of use that it holds.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS1OneMember', window );">Amendments To I A S 1 One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Standard</a></td>
<td class="text">Amendments to IAS 1: Classification of Liabilities as Current or Non-Current<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy', window );">Description</a></td>
<td class="text">In January 2020 and October 2022, the IASB issued amendments to paragraphs
    69 to 76 of IAS 1 to specify the requirements for classifying liabilities as current or non-current. The amendments clarify:<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS7AndIFRS7Member', window );">Amendments To I A S 7 And I F R S 7 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Standard</a></td>
<td class="text">Supplier Financing Agreements - Amendments to IAS 7 and IFRS 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy', window );">Description</a></td>
<td class="text">In May 2023, the IASB issued amendments to IAS 7 and IFRS 7 to clarify the
    characteristics of supplier financing arrangements and require additional disclosures of such arrangements. The disclosure requirements
    in the amendments are intended to assist users of the financial statements in understanding the effects of financing arrangements with
    suppliers on an entity's obligations, cash flows, and exposure to liquidity risk.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the nature of a change in accounting policy related to an initial application of an IFRS. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TitleOfInitiallyAppliedIFRS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of an initially applied IFRS. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TitleOfInitiallyAppliedIFRS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS8Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS8Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS12Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS12Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS12OneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS12OneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=ifrs-full_IFRS17Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=ifrs-full_IFRS17Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIFRS16Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIFRS16Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS1OneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS1OneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS7AndIFRS7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS7AndIFRS7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639633898960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Details Narrative)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ProgramOfSocialIntegrationMember', window );">Program Of Social Integration [Member] | Teaching Activities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="nump">0.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ProgramOfSocialIntegrationMember', window );">Program Of Social Integration [Member] | Non Teaching Activities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="nump">1.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ContributionForTheFinancingOfSocialSecurityMember', window );">Contribution For The Financing Of Social Security [Member] | Teaching Activities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ContributionForTheFinancingOfSocialSecurityMember', window );">Contribution For The Financing Of Social Security [Member] | Non Teaching Activities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="nump">7.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ProgramOfSocialIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ProgramOfSocialIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=afya_TeachingActivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=afya_TeachingActivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=afya_NonTeachingActivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=afya_NonTeachingActivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ContributionForTheFinancingOfSocialSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ContributionForTheFinancingOfSocialSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639635394944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment information (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">R$ 7,584,481<span></span>
</td>
<td class="nump">R$ 7,199,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">1,203,506<span></span>
</td>
<td class="nump">1,637,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">6,380,975<span></span>
</td>
<td class="nump">5,561,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">7,584,481<span></span>
</td>
<td class="nump">7,199,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">1,058,567<span></span>
</td>
<td class="nump">905,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">2,882,902<span></span>
</td>
<td class="nump">3,043,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">3,643,012<span></span>
</td>
<td class="nump">3,250,158<span></span>
</td>
<td class="nump">R$ 3,000,018<span></span>
</td>
<td class="nump">R$ 2,833,780<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">7,584,481<span></span>
</td>
<td class="nump">7,199,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">1,203,506<span></span>
</td>
<td class="nump">1,637,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">6,380,975<span></span>
</td>
<td class="nump">5,561,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">7,584,481<span></span>
</td>
<td class="nump">7,199,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">1,058,567<span></span>
</td>
<td class="nump">905,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">2,882,902<span></span>
</td>
<td class="nump">3,043,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">3,643,012<span></span>
</td>
<td class="nump">3,250,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="nump">51,834<span></span>
</td>
<td class="nump">53,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="nump">218,428<span></span>
</td>
<td class="nump">318,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Undergrad [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">7,104,154<span></span>
</td>
<td class="nump">6,775,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">1,001,156<span></span>
</td>
<td class="nump">1,461,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">6,102,998<span></span>
</td>
<td class="nump">5,314,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">7,104,154<span></span>
</td>
<td class="nump">6,775,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">787,658<span></span>
</td>
<td class="nump">711,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">2,783,855<span></span>
</td>
<td class="nump">2,938,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">3,532,641<span></span>
</td>
<td class="nump">3,124,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="nump">51,834<span></span>
</td>
<td class="nump">53,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="nump">139,361<span></span>
</td>
<td class="nump">247,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Continuing Education [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">180,555<span></span>
</td>
<td class="nump">149,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">86,361<span></span>
</td>
<td class="nump">61,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">94,194<span></span>
</td>
<td class="nump">87,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">180,555<span></span>
</td>
<td class="nump">149,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">87,447<span></span>
</td>
<td class="nump">57,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">57,608<span></span>
</td>
<td class="nump">63,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">35,500<span></span>
</td>
<td class="nump">27,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="nump">15,178<span></span>
</td>
<td class="nump">8,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Digital Services [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">310,989<span></span>
</td>
<td class="nump">275,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">127,206<span></span>
</td>
<td class="nump">115,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">183,783<span></span>
</td>
<td class="nump">160,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">310,989<span></span>
</td>
<td class="nump">275,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">194,679<span></span>
</td>
<td class="nump">137,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">41,439<span></span>
</td>
<td class="nump">40,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">74,871<span></span>
</td>
<td class="nump">97,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="nump">63,889<span></span>
</td>
<td class="nump">61,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Total Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">7,595,698<span></span>
</td>
<td class="nump">7,200,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">1,214,723<span></span>
</td>
<td class="nump">1,638,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">6,380,975<span></span>
</td>
<td class="nump">5,561,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">7,595,698<span></span>
</td>
<td class="nump">7,200,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">1,069,784<span></span>
</td>
<td class="nump">906,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">2,882,902<span></span>
</td>
<td class="nump">3,043,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">3,643,012<span></span>
</td>
<td class="nump">3,250,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="nump">51,834<span></span>
</td>
<td class="nump">53,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="nump">218,428<span></span>
</td>
<td class="nump">318,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Adjustments And Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="num">(11,217)<span></span>
</td>
<td class="num">(1,108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="num">(11,217)<span></span>
</td>
<td class="num">(1,108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="num">(11,217)<span></span>
</td>
<td class="num">(1,108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(11,217)<span></span>
</td>
<td class="num">(1,108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CapitalExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CapitalExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in associates in an entity's separate financial statements. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_UndergradMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_UndergradMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_ContinuingEducationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_ContinuingEducationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_DigitalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_DigitalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_TotalReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_TotalReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_AdjustmentsAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_AdjustmentsAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639636873632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">R$ 2,875,913<span></span>
</td>
<td class="nump">R$ 2,329,057<span></span>
</td>
<td class="nump">R$ 1,719,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,766,100<span></span>
</td>
<td class="nump">1,469,505<span></span>
</td>
<td class="nump">1,067,071<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="nump">767,061<span></span>
</td>
<td class="nump">664,100<span></span>
</td>
<td class="nump">440,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="nump">110,642<span></span>
</td>
<td class="nump">102,042<span></span>
</td>
<td class="nump">64,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="nump">429,582<span></span>
</td>
<td class="nump">428,433<span></span>
</td>
<td class="nump">273,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="nump">24,166<span></span>
</td>
<td class="nump">35,677<span></span>
</td>
<td class="nump">31,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">405,416<span></span>
</td>
<td class="nump">392,756<span></span>
</td>
<td class="nump">242,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="nump">2,875,913<span></span>
</td>
<td class="nump">2,329,057<span></span>
</td>
<td class="nump">1,719,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">2,875,913<span></span>
</td>
<td class="nump">2,329,057<span></span>
</td>
<td class="nump">1,719,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostOfSale', window );">Cost of services</a></td>
<td class="num">(1,109,813)<span></span>
</td>
<td class="num">(859,552)<span></span>
</td>
<td class="num">(652,300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,766,100<span></span>
</td>
<td class="nump">1,469,505<span></span>
</td>
<td class="nump">1,067,071<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="num">(1,014,684)<span></span>
</td>
<td class="num">(798,153)<span></span>
</td>
<td class="num">(622,615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherGainsLosses', window );">Other expenses, net</a></td>
<td class="nump">15,645<span></span>
</td>
<td class="num">(7,252)<span></span>
</td>
<td class="num">(3,561)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="nump">767,061<span></span>
</td>
<td class="nump">664,100<span></span>
</td>
<td class="nump">440,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="nump">110,642<span></span>
</td>
<td class="nump">102,042<span></span>
</td>
<td class="nump">64,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinanceExpense', window );">Finance expenses</a></td>
<td class="num">(457,616)<span></span>
</td>
<td class="num">(349,893)<span></span>
</td>
<td class="num">(243,796)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Share of income of associate</a></td>
<td class="nump">9,495<span></span>
</td>
<td class="nump">12,184<span></span>
</td>
<td class="nump">11,797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="nump">429,582<span></span>
</td>
<td class="nump">428,433<span></span>
</td>
<td class="nump">273,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="num">(24,166)<span></span>
</td>
<td class="num">(35,677)<span></span>
</td>
<td class="num">(31,179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">405,416<span></span>
</td>
<td class="nump">392,756<span></span>
</td>
<td class="nump">242,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Undergrad [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="nump">2,511,018<span></span>
</td>
<td class="nump">2,037,889<span></span>
</td>
<td class="nump">1,498,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">2,511,018<span></span>
</td>
<td class="nump">2,037,889<span></span>
</td>
<td class="nump">1,498,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostOfSale', window );">Cost of services</a></td>
<td class="num">(997,973)<span></span>
</td>
<td class="num">(763,185)<span></span>
</td>
<td class="num">(554,995)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,513,045<span></span>
</td>
<td class="nump">1,274,704<span></span>
</td>
<td class="nump">943,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Continuing Education [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="nump">146,827<span></span>
</td>
<td class="nump">108,806<span></span>
</td>
<td class="nump">72,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">146,827<span></span>
</td>
<td class="nump">108,806<span></span>
</td>
<td class="nump">72,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostOfSale', window );">Cost of services</a></td>
<td class="num">(62,792)<span></span>
</td>
<td class="num">(56,554)<span></span>
</td>
<td class="num">(50,773)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">84,035<span></span>
</td>
<td class="nump">52,252<span></span>
</td>
<td class="nump">22,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Digital Services [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="nump">218,068<span></span>
</td>
<td class="nump">182,362<span></span>
</td>
<td class="nump">147,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="nump">11,217<span></span>
</td>
<td class="nump">7,622<span></span>
</td>
<td class="nump">3,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">229,285<span></span>
</td>
<td class="nump">189,984<span></span>
</td>
<td class="nump">151,958<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostOfSale', window );">Cost of services</a></td>
<td class="num">(60,265)<span></span>
</td>
<td class="num">(47,435)<span></span>
</td>
<td class="num">(50,510)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">169,020<span></span>
</td>
<td class="nump">142,549<span></span>
</td>
<td class="nump">101,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Total Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="nump">2,875,913<span></span>
</td>
<td class="nump">2,329,057<span></span>
</td>
<td class="nump">1,719,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="nump">11,217<span></span>
</td>
<td class="nump">7,622<span></span>
</td>
<td class="nump">3,978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">2,887,130<span></span>
</td>
<td class="nump">2,336,679<span></span>
</td>
<td class="nump">1,723,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostOfSale', window );">Cost of services</a></td>
<td class="num">(1,121,030)<span></span>
</td>
<td class="num">(867,174)<span></span>
</td>
<td class="num">(656,278)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,766,100<span></span>
</td>
<td class="nump">1,469,505<span></span>
</td>
<td class="nump">1,067,071<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Adjustments And Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="num">(11,217)<span></span>
</td>
<td class="num">(7,622)<span></span>
</td>
<td class="num">(3,978)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="num">(11,217)<span></span>
</td>
<td class="num">(7,622)<span></span>
</td>
<td class="num">(3,978)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostOfSale', window );">Cost of services</a></td>
<td class="nump">11,217<span></span>
</td>
<td class="nump">7,622<span></span>
</td>
<td class="nump">3,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CostOfSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CostOfSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DepositsFromExternalCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DepositsFromExternalCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InterSegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InterSegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gain (loss) on disposals investments in subsidiaries, joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries, joint ventures and associates reported in separate financial statements; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2023-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_UndergradMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_UndergradMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_ContinuingEducationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_ContinuingEducationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_DigitalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_DigitalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_TotalReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_TotalReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_AdjustmentsAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_AdjustmentsAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639641048912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business combinations (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Jan. 02, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable net assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 81,855<span></span>
</td>
<td class="nump">R$ 145,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember', window );">Del Rey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="nump">R$ 7,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade receivables</a></td>
<td class="nump">33,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Inventories1', window );">Inventories</a></td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">Recoverable taxes</a></td>
<td class="nump">589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">Other assets</a></td>
<td class="nump">8,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property and equipment</a></td>
<td class="nump">24,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">Right-of-use assets</a></td>
<td class="nump">65,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">728,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="nump">870,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade payables</a></td>
<td class="nump">12,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">Lease liabilities</a></td>
<td class="nump">65,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">Labor and social obligations</a></td>
<td class="nump">6,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">Taxes and contributions payable</a></td>
<td class="nump">2,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">Advances from customers</a></td>
<td class="nump">38,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">Provision for legal proceedings</a></td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">Other liabilities</a></td>
<td class="nump">4,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Financial liabilities recognised as of acquisition date</a></td>
<td class="nump">128,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable net assets at fair value</a></td>
<td class="nump">741,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill arising on acquisition</a></td>
<td class="nump">75,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Purchase consideration transferred</a></td>
<td class="nump">816,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="nump">575,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">Consideration to be transferred</a></td>
<td class="nump">234,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CirculationRevenue', window );">Digital solutions</a></td>
<td class="nump">7,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs of the acquisition (included in cash flows from operating activities)</a></td>
<td class="nump">12,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)</a></td>
<td class="nump">567,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">Net of cash flow on acquisition</a></td>
<td class="nump">R$ 579,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdvancesFromCustomersAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdvancesFromCustomersAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ConsiderationToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ConsiderationToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Inventories1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Inventories1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LaborAndSocialObligationsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NetOfCashFlowOnAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NetOfCashFlowOnAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherLiabilitiesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherLiabilitiesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProvisionForLegalProceedingsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RecoverableTaxesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RecoverableTaxesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightOfUseAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightOfUseAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxesPayableAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxesPayableAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeReceivablesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeReceivablesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents in subsidiaries or other businesses over which control is obtained or lost. [Refer: Subsidiaries [member]; Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 40<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_40_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CirculationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of newspapers, magazines, periodicals as well as digital applications and formats. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CirculationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial assets acquired in a business combination. [Refer: Financial assets; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial liabilities assumed in a business combination. [Refer: Financial liabilities; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639608285888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business combinations (Details 1) - Acquisition Of Del Rey [Member]<br></strong></div></th>
<th class="th"><div>Jan. 02, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesAndFranchisesMember', window );">Licences and franchises [member] | With And Without Method [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Multi-period excess earnings method [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Business combinations [member]; Valuation techniques [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_o_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesAndFranchisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesAndFranchisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AcquisitionOfDelReyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AcquisitionOfDelReyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_WithAndWithoutMethodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_WithAndWithoutMethodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=ifrs-full_MultiperiodExcessEarningsMethodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=ifrs-full_MultiperiodExcessEarningsMethodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639632480656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business combinations (Details 2) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>May 23, 2022</div></th>
<th class="th"><div>Apr. 05, 2022</div></th>
<th class="th"><div>Mar. 04, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 81,855<span></span>
</td>
<td class="nump">R$ 145,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember', window );">Alem Da Medicina [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">Labor And Social Obligations As Of Acquisition Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">Taxes Payable As Of Acquisition Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">Advances From Customers As Of Acquisition Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">Other Liabilities As Of Acquisition Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">Consideration To Be Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash and cash equivalents in subsidiary or businesses acquired or disposed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">Net of cash flow on acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 14,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardioPapersMember', window );">Cardio Papers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 3,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">Labor And Social Obligations As Of Acquisition Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">Taxes Payable As Of Acquisition Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">Advances From Customers As Of Acquisition Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">Other Liabilities As Of Acquisition Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">Consideration To Be Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(333)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash and cash equivalents in subsidiary or businesses acquired or disposed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">Net of cash flow on acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 31,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GlicMember', window );">Glic [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="nump">R$ 151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade receivables</a></td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="nump">15,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="nump">15,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables recognised as of acquisition date</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">Labor And Social Obligations As Of Acquisition Date</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">Taxes Payable As Of Acquisition Date</a></td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">Advances From Customers As Of Acquisition Date</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">Other Liabilities As Of Acquisition Date</a></td>
<td class="nump">574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="nump">666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets recognised as of acquisition date</a></td>
<td class="nump">15,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill recognised as of acquisition date</a></td>
<td class="nump">15,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="nump">30,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="nump">21,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration recognised as of acquisition date</a></td>
<td class="nump">8,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">Consideration To Be Transferred</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</a></td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash and cash equivalents in subsidiary or businesses acquired or disposed</a></td>
<td class="nump">21,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">Net of cash flow on acquisition</a></td>
<td class="nump">R$ 21,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdvancesFromCustomersAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdvancesFromCustomersAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ConsiderationToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ConsiderationToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LaborAndSocialObligationsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NetOfCashFlowOnAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NetOfCashFlowOnAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherLiabilitiesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherLiabilitiesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxesPayableAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxesPayableAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeReceivablesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeReceivablesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents in subsidiaries or other businesses over which control is obtained or lost. [Refer: Subsidiaries [member]; Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 40<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_40_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial assets acquired in a business combination. [Refer: Financial assets; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial liabilities assumed in a business combination. [Refer: Financial liabilities; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardioPapersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardioPapersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GlicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GlicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639611435792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business combinations (Details 3) - Alem Da Medicina [member]<br></strong></div></th>
<th class="th"><div>Mar. 04, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Relief From Royalty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Multi-period excess earnings method [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=afya_EducationalContentMember', window );">Educational Content [Member] | Replacement Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member] | Replacement Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Business combinations [member]; Valuation techniques [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_o_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_ReliefFromRoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_ReliefFromRoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=ifrs-full_MultiperiodExcessEarningsMethodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=ifrs-full_MultiperiodExcessEarningsMethodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=afya_EducationalContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=afya_EducationalContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_ReplacementCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_ReplacementCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639608670512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business combinations (Details 4) - Acquisition Of Cardio Papers [Member]<br></strong></div></th>
<th class="th"><div>Apr. 05, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Relief From Royalty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Multi-period excess earnings method [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=afya_EducationalContentMember', window );">Educational Content [Member] | Replacement Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=afya_CopyrightMember', window );">Copyright [Member] | Relief From Royalty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Business combinations [member]; Valuation techniques [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_o_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AcquisitionOfCardioPapersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AcquisitionOfCardioPapersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_ReliefFromRoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_ReliefFromRoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=ifrs-full_MultiperiodExcessEarningsMethodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=ifrs-full_MultiperiodExcessEarningsMethodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=afya_EducationalContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=afya_EducationalContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_ReplacementCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_ReplacementCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=afya_CopyrightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=afya_CopyrightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639611677008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business combinations (Details 5) - Acquisition Of Glic [Member]<br></strong></div></th>
<th class="th"><div>May 23, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Relief From Royalty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Multi-period excess earnings method [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member] | Replacement Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Business combinations [member]; Valuation techniques [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_o_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AcquisitionOfGlicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AcquisitionOfGlicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_ReliefFromRoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_ReliefFromRoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=ifrs-full_MultiperiodExcessEarningsMethodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=ifrs-full_MultiperiodExcessEarningsMethodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_ReplacementCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_ReplacementCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639637665792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 02, 2023</div></th>
<th class="th"><div>May 23, 2022</div></th>
<th class="th"><div>Apr. 05, 2022</div></th>
<th class="th"><div>Mar. 04, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 2,875,913<span></span>
</td>
<td class="nump">R$ 2,329,057<span></span>
</td>
<td class="nump">R$ 1,719,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">429,582<span></span>
</td>
<td class="nump">428,433<span></span>
</td>
<td class="nump">R$ 273,462<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_AcquisitionOfDelReyMember', window );">Acquisition Of Del Rey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Acquired share capital</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Acquired purchase price</a></td>
<td class="text">The original aggregate purchase price of R$832,236 was adjusted by R$16,000, in favor of the Company, to R$816,236 comprised by: i) R$809,000
of which R$575,000 was paid in cash on the transaction closing date, and R$234,000 is payable in cash in three annual installments, respectively,
of R$134,000 in January 2024, R$50,000 in January 2025 and R$50,000 in January 2026, adjusted by the SELIC rate; and ii) offer of AFYA&#8217;s
digital solutions free of charge until December 31, 2030, for students of medicine of universities owned by the sellers which are not
part of the transaction. The fair value of this service was estimated at R$7,236 at the acquisition date. There are 84 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$105,000. Given the future event
that will trigger the potential payout is not under the Company&#8217;s control, the probability of such payout cannot be reliably estimated
and accordingly the contingent consideration was not measured at the acquisition date. Should the additional seats be approved, it will
result in additional licenses, which will be measured accordingly if and when approved.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="nump">R$ 12,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_AlemDaMedicinaMember', window );">Alem Da Medicina [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Acquired share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Acquired purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The aggregate purchase price of R$26,789 is comprised by: i)
R$14,952 paid in cash on the transaction closing date; ii) an earn-out (&#8220;contingent consideration&#8221;) of up to R$19,200 is payable
in connection with revenue target achievements for 2023 and 2024; and iii) price adjustment related to net debt of R$763 in favor of selling
shareholders. The contingent consideration of R$11,074 is based on the present value of the obligation considering the facts and circumstances
at the acquisition date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseInIncomeBeforeIncomeTaxes', window );">Increase in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_AcquisitionOfCardioPapersMember', window );">Acquisition Of Cardio Papers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Acquired share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Acquired purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The aggregate purchase price of R$42,013 is comprised by: i) R$34,924
paid in cash on the transaction closing date; ii) an earn-out (&#8220;contingent consideration&#8221;) of up of R$15,000 is payable in
connection with revenue target achievements for 2023 and 2024 and other goals; and iii) price adjustment related to net debt of R$333
in favor of Afya Brazil. The contingent consideration of R$7,422 is based on the present value of the obligation considering the facts
and circumstances at the acquisition date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_CardioPapersMember', window );">Cardio Papers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 2,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DecreaseInIncomeBeforeIncomeTaxes', window );">Decrease in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 2,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_AcquisitionOfGlicMember', window );">Acquisition Of Glic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Acquired share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Acquired purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The aggregate purchase price of R$30,597 is comprised
by: i) R$21,602 paid in cash on the transaction closing date and ii) an earn-out (&#8220;contingent consideration&#8221;) of up of R$12,000
is payable in connection with revenue target achievements for 2023 and 2024 and product development goals. The contingent consideration
of R$8,995 is based on the present value of the obligation considering the facts and circumstances at the acquisition date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_GlicMember', window );">Glic [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DecreaseInIncomeBeforeIncomeTaxes', window );">Decrease in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DecreaseInIncomeBeforeIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DecreaseInIncomeBeforeIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseInIncomeBeforeIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseInIncomeBeforeIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseInRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseInRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the business or businesses that the acquirer obtains control of in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_AcquisitionOfDelReyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_AcquisitionOfDelReyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_AlemDaMedicinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_AlemDaMedicinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_AcquisitionOfCardioPapersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_AcquisitionOfCardioPapersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_CardioPapersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_CardioPapersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_AcquisitionOfGlicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_AcquisitionOfGlicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_GlicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_GlicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639606473824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and cash equivalents (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureCashAndCashEquivalentsAbstract', window );"><strong>Cash And Cash Equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash and bank deposits</a></td>
<td class="nump">R$ 11,746<span></span>
</td>
<td class="nump">R$ 57,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Cash equivalents</a></td>
<td class="nump">541,284<span></span>
</td>
<td class="nump">1,035,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents&#160;</a></td>
<td class="nump">R$ 553,030<span></span>
</td>
<td class="nump">R$ 1,093,082<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureCashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureCashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639609104816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and cash equivalents (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Cash equivalents</a></td>
<td class="nump">R$ 541,284<span></span>
</td>
<td class="nump">R$ 1,035,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=afya_USDMember', window );">U S D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Cash equivalents</a></td>
<td class="nump">R$ 23,173<span></span>
</td>
<td class="nump">R$ 24,447<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_BankCertificatesOfDepositMember', window );">Bank Certificates Of Deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PercenatgeOfAverageInterestOnFinancialInstrument', window );">Percentage of average interest</a></td>
<td class="nump">100.80%<span></span>
</td>
<td class="nump">99.21%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PercenatgeOfAverageInterestOnFinancialInstrument">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PercenatgeOfAverageInterestOnFinancialInstrument</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=afya_USDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=afya_USDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_BankCertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_BankCertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639610131568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade receivables (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">R$ 647,321<span></span>
</td>
<td class="nump">R$ 539,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceForDoubtfulAccountsFoReceivable1', window );">(-) Allowance for doubtful accounts</a></td>
<td class="num">(61,398)<span></span>
</td>
<td class="num">(44,046)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables, net</a></td>
<td class="nump">585,923<span></span>
</td>
<td class="nump">495,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Current</a></td>
<td class="nump">546,438<span></span>
</td>
<td class="nump">452,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentTradeReceivables', window );">Non-current</a></td>
<td class="nump">39,485<span></span>
</td>
<td class="nump">42,568<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_TuitionFeesMember', window );">Tuition Fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">461,066<span></span>
</td>
<td class="nump">356,074<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalContentMember', window );">Educational Content [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">49,135<span></span>
</td>
<td class="nump">50,913<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_FIESMember', window );">F I E S [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">62,971<span></span>
</td>
<td class="nump">62,325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalCreditsMember', window );">Educational Credits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">29,391<span></span>
</td>
<td class="nump">27,535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_MobileAppSubscriptionMember', window );">Mobile App Subscription [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">29,091<span></span>
</td>
<td class="nump">27,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_OthersMember', window );">Others [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">R$ 15,667<span></span>
</td>
<td class="nump">R$ 14,923<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForDoubtfulAccountsFoReceivable1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForDoubtfulAccountsFoReceivable1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ReceivablesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ReceivablesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_TuitionFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_TuitionFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_FIESMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_FIESMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalCreditsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalCreditsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_MobileAppSubscriptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_MobileAppSubscriptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_OthersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_OthersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639611949808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade receivables (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">R$ 647,321<span></span>
</td>
<td class="nump">R$ 539,445<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=ifrs-full_CurrentMember', window );">Current [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">73,563<span></span>
</td>
<td class="nump">56,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember', window );">Later Than One Months And Not Later Than Three Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">109,908<span></span>
</td>
<td class="nump">90,734<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember', window );">Later than three months and not later than six months [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">85,193<span></span>
</td>
<td class="nump">80,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=afya_LaterThanOneEightyMember', window );">Later Than One Eighty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">55,043<span></span>
</td>
<td class="nump">50,884<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentOfFinancialAssetsAxis=ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember', window );">Financial assets neither past due nor impaired [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">R$ 323,614<span></span>
</td>
<td class="nump">R$ 261,025<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ReceivablesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ReceivablesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_CurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_CurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=afya_LaterThanOneEightyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=afya_LaterThanOneEightyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentOfFinancialAssetsAxis=ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentOfFinancialAssetsAxis=ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639635372736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade receivables (Details 2) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">Balances at the beginning of the year</a></td>
<td class="num">R$ (44,046)<span></span>
</td>
<td class="num">R$ (45,013)<span></span>
</td>
<td class="num">R$ (32,980)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset', window );">Additions</a></td>
<td class="num">(74,552)<span></span>
</td>
<td class="num">(42,708)<span></span>
</td>
<td class="num">(47,819)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable', window );">Write-offs</a></td>
<td class="nump">57,200<span></span>
</td>
<td class="nump">43,675<span></span>
</td>
<td class="nump">35,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">Balances at the end of the year</a></td>
<td class="num">R$ (61,398)<span></span>
</td>
<td class="num">R$ (44,046)<span></span>
</td>
<td class="num">R$ (45,013)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an allowance account used to record impairments to financial assets due to credit losses. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_16&amp;doctype=Standard&amp;book=b<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639633206880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TradeReceivablesRelatedPartyTransactions', window );">Trade receivables (i)</a></td>
<td class="nump">R$ 693<span></span>
</td>
<td class="nump">R$ 917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherAssetsRelatedPartyTransactions', window );">Other assets (ii)</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">1,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsReceivableRelatedPartyTransactions', window );">&#160;Total</a></td>
<td class="nump">978<span></span>
</td>
<td class="nump">2,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TradeAndOtherCurrentPayablesToRelatedParties1', window );">Current</a></td>
<td class="nump">792<span></span>
</td>
<td class="nump">2,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NoncurrentAssetsOfRelatedParty1', window );">Non-current</a></td>
<td class="nump">186<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholders', window );">Accounts payable to selling shareholders (iii)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">30,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">&#160;Total</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">30,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableCurrent1', window );">Current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">30,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NoncurrentPayablesToRelatedParties1', window );">Non-current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherIncomeRelatedPartyTransactions', window );">Other income</a></td>
<td class="nump">459<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="nump">R$ 752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeasesAsLesseeRelatedPartyTransactions', window );">Lease</a></td>
<td class="nump">32,186<span></span>
</td>
<td class="nump">28,723<span></span>
</td>
<td class="nump">23,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UEPCMember', window );">U E P C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherIncomeRelatedPartyTransactions', window );">Other income</a></td>
<td class="nump">465<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="nump">752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_EMIVEPatrulha24HorasLtdaMember', window );">E M I V E Patrulha 24 Horas Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherIncomeRelatedPartyTransactions', window );">Other income</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_RVLEstevesGestaoImobiliariaSAMember', window );">R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeasesAsLesseeRelatedPartyTransactions', window );">Lease</a></td>
<td class="nump">23,434<span></span>
</td>
<td class="nump">20,394<span></span>
</td>
<td class="nump">15,336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UNIVACOPatrimonialLtdaMember', window );">U N I V A C O Patrimonial Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeasesAsLesseeRelatedPartyTransactions', window );">Lease</a></td>
<td class="nump">3,582<span></span>
</td>
<td class="nump">3,409<span></span>
</td>
<td class="nump">3,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_IESVAPPatrimonialLtdaMember', window );">I E S V A P Patrimonial Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeasesAsLesseeRelatedPartyTransactions', window );">Lease</a></td>
<td class="nump">R$ 5,170<span></span>
</td>
<td class="nump">R$ 4,920<span></span>
</td>
<td class="nump">R$ 4,560<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableCurrent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableCurrent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentAssetsOfRelatedParty1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentAssetsOfRelatedParty1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentPayablesToRelatedParties1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentPayablesToRelatedParties1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherAssetsRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherAssetsRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherIncomeRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherIncomeRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeAndOtherCurrentPayablesToRelatedParties1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeAndOtherCurrentPayablesToRelatedParties1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeReceivablesRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeReceivablesRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsPayableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts payable resulting from related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsPayableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsReceivableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsReceivableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeasesAsLesseeRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of leases where the entity was the lessee in related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 21<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_21_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeasesAsLesseeRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UEPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UEPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_EMIVEPatrulha24HorasLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_EMIVEPatrulha24HorasLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_RVLEstevesGestaoImobiliariaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_RVLEstevesGestaoImobiliariaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UNIVACOPatrimonialLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UNIVACOPatrimonialLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_IESVAPPatrimonialLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_IESVAPPatrimonialLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639608222960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Short-term employee benefits</a></td>
<td class="nump">R$ 16,979<span></span>
</td>
<td class="nump">R$ 13,564<span></span>
</td>
<td class="nump">R$ 11,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Share-based compensation plans</a></td>
<td class="nump">21,380<span></span>
</td>
<td class="nump">13,116<span></span>
</td>
<td class="nump">20,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity', window );">Total</a></td>
<td class="nump">R$ 38,359<span></span>
</td>
<td class="nump">R$ 26,680<span></span>
</td>
<td class="nump">R$ 32,184<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount incurred by the entity for provision of key management personnel services that are provided by a separate management entity. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 18A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18A&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639635332784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Details Narrative) - Lease Agreements 1 [Member] - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 02, 2021</div></th>
<th class="th"><div>Oct. 30, 2019</div></th>
<th class="th"><div>Sep. 06, 2018</div></th>
<th class="th"><div>Apr. 25, 2018</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LesseeFinancesLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member', window );">R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Lease expenses</a></td>
<td class="nump">R$ 40<span></span>
</td>
<td class="nump">R$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 23,434<span></span>
</td>
<td class="nump">R$ 20,394<span></span>
</td>
<td class="nump">R$ 15,336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member', window );">U N I V A C O Patrimonial Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LesseeFinancesLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 3,582<span></span>
</td>
<td class="nump">3,409<span></span>
</td>
<td class="nump">3,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member', window );">I E S V A P Patrimonial Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LesseeFinancesLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 5,170<span></span>
</td>
<td class="nump">R$ 4,920<span></span>
</td>
<td class="nump">R$ 4,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DescriptionOfLeaseTerms', window );">Description of lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The lease agreement is for an amount equal to 7.5% of the monthly revenue of IESVAP until maturation.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member', window );">Instituto Tocantinense Presidente Antonio Carlos S A [Member] | R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member', window );">Institutode Ensino Superior Presidente Trancredode Almeida Neves S A [Member] | R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DescriptionOfLeaseTerm', window );">Description of lease term</a></td>
<td class="text">(i) up to June 2022, R$40; (ii) from July 2022 until December 2028, 6.5% of the monthly
revenue of ITPAC Garanhuns during the prior semester, adjusted in accordance with the provisions of the lease agreement<span></span>
</td>
<td class="text">(i) up to June 2020, R$12 and (ii) from July 2020 until March 2024, 6.5% of the monthly revenue
of IPTAN during the prior semester, adjusted in accordance with the provisions of the lease agreement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DescriptionOfLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DescriptionOfLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DescriptionOfLeaseTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DescriptionOfLeaseTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LesseeFinancesLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LesseeFinancesLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOutflowForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_g&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOutflowForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfEntitysRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of the entity's revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfEntitysRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=afya_RVLEstevesGestaoImobiliariaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=afya_RVLEstevesGestaoImobiliariaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=afya_UNIVACOPatrimonialLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=afya_UNIVACOPatrimonialLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=afya_IESVAPPatrimonialLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=afya_IESVAPPatrimonialLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639606389520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other assets (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOtherAssetsAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets (i)</a></td>
<td class="nump">R$ 81,855<span></span>
</td>
<td class="nump">R$ 145,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Advances1', window );">Advances</a></td>
<td class="nump">39,890<span></span>
</td>
<td class="nump">30,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_JudicialDeposits', window );">Judicial deposits</a></td>
<td class="nump">14,187<span></span>
</td>
<td class="nump">12,693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="nump">15,820<span></span>
</td>
<td class="nump">18,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherReceivables', window );">Other FIES receivables</a></td>
<td class="nump">8,674<span></span>
</td>
<td class="nump">26,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Dividend', window );">Dividends</a></td>
<td class="nump">1,668<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">3,233<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherAssets1', window );">Other assets</a></td>
<td class="nump">10,924<span></span>
</td>
<td class="nump">10,001<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Assets1', window );">&#160;Total</a></td>
<td class="nump">176,251<span></span>
</td>
<td class="nump">243,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CurrentAssets1', window );">Current</a></td>
<td class="nump">58,905<span></span>
</td>
<td class="nump">51,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NoncurrentAssets1', window );">Non-current</a></td>
<td class="nump">R$ 117,346<span></span>
</td>
<td class="nump">R$ 191,756<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Advances1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Advances1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Assets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Assets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CurrentAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CurrentAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Dividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Dividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_JudicialDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_JudicialDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount receivable by the entity that it does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639670689600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other assets (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOtherAssetsAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherAsset', window );">Other assets</a></td>
<td class="nump">R$ 176,251<span></span>
</td>
<td class="nump">R$ 243,501<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639611520400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in associate (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">R$ 1,203,506<span></span>
</td>
<td class="nump">R$ 1,637,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">6,380,975<span></span>
</td>
<td class="nump">5,561,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(1,058,567)<span></span>
</td>
<td class="num">(905,689)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="num">(2,882,902)<span></span>
</td>
<td class="num">(3,043,692)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">2,875,913<span></span>
</td>
<td class="nump">2,329,057<span></span>
</td>
<td class="nump">R$ 1,719,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="num">(1,109,813)<span></span>
</td>
<td class="num">(859,552)<span></span>
</td>
<td class="num">(652,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance results</a></td>
<td class="num">(110,642)<span></span>
</td>
<td class="num">(102,042)<span></span>
</td>
<td class="num">(64,566)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="nump">429,582<span></span>
</td>
<td class="nump">428,433<span></span>
</td>
<td class="nump">273,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="nump">24,166<span></span>
</td>
<td class="nump">35,677<span></span>
</td>
<td class="nump">31,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">405,416<span></span>
</td>
<td class="nump">392,756<span></span>
</td>
<td class="nump">242,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsReceived', window );">Dividends receivable (included in Other assets)</a></td>
<td class="num">(9,900)<span></span>
</td>
<td class="num">(6,754)<span></span>
</td>
<td class="num">(11,770)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_AssociatesMember', window );">Associates [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">29,004<span></span>
</td>
<td class="nump">32,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">120,289<span></span>
</td>
<td class="nump">122,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(28,842)<span></span>
</td>
<td class="num">(22,840)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="num">(91,613)<span></span>
</td>
<td class="num">(96,442)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_EquityInAssociate', window );">Equity</a></td>
<td class="nump">28,838<span></span>
</td>
<td class="nump">35,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CompanyShareInEquity1', window );">Company&#8217;s share in equity - 30%</a></td>
<td class="nump">8,651<span></span>
</td>
<td class="nump">10,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">43,183<span></span>
</td>
<td class="nump">43,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentGrossAmount', window );">Carrying amount of the investment</a></td>
<td class="nump">51,834<span></span>
</td>
<td class="nump">53,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">148,042<span></span>
</td>
<td class="nump">138,584<span></span>
</td>
<td class="nump">127,618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="num">(71,282)<span></span>
</td>
<td class="num">(57,421)<span></span>
</td>
<td class="num">(57,935)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="num">(37,205)<span></span>
</td>
<td class="num">(34,991)<span></span>
</td>
<td class="num">(24,025)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance results</a></td>
<td class="num">(6,123)<span></span>
</td>
<td class="num">(4,103)<span></span>
</td>
<td class="num">(4,585)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="nump">33,432<span></span>
</td>
<td class="nump">42,069<span></span>
</td>
<td class="nump">41,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="num">(1,782)<span></span>
</td>
<td class="num">(1,456)<span></span>
</td>
<td class="num">(1,748)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">31,650<span></span>
</td>
<td class="nump">40,613<span></span>
</td>
<td class="nump">39,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CompanyShareOfProfitss', window );">Company&#8217;s share of income</a></td>
<td class="nump">9,495<span></span>
</td>
<td class="nump">12,184<span></span>
</td>
<td class="nump">11,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Opening balance</a></td>
<td class="nump">53,907<span></span>
</td>
<td class="nump">48,477<span></span>
</td>
<td class="nump">51,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DividendsReceived1', window );">Dividends received</a></td>
<td class="num">(9,900)<span></span>
</td>
<td class="num">(6,754)<span></span>
</td>
<td class="num">(11,770)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsReceived', window );">Dividends receivable (included in Other assets)</a></td>
<td class="num">(1,668)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,960)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossOfAcquiree', window );">Share of income</a></td>
<td class="nump">9,495<span></span>
</td>
<td class="nump">12,184<span></span>
</td>
<td class="nump">11,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Closing balance</a></td>
<td class="nump">R$ 51,834<span></span>
</td>
<td class="nump">R$ 53,907<span></span>
</td>
<td class="nump">R$ 48,477<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CompanyShareInEquity1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CompanyShareInEquity1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CompanyShareOfProfitss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CompanyShareOfProfitss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DividendsReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DividendsReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_EquityInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_EquityInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InvestmentGrossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InvestmentGrossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in associates in an entity's separate financial statements. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph q<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_q_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_AssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_AssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639636692368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">R$ 608,685<span></span>
</td>
<td class="nump">R$ 542,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">83,553<span></span>
</td>
<td class="nump">86,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember', window );">Machinery And Equipments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">91,138<span></span>
</td>
<td class="nump">79,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">18,852<span></span>
</td>
<td class="nump">18,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">1,552<span></span>
</td>
<td class="nump">1,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Fixtures and fittings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">90,482<span></span>
</td>
<td class="nump">80,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember', window );">It Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">55,938<span></span>
</td>
<td class="nump">46,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember', window );">Library Books [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">13,236<span></span>
</td>
<td class="nump">14,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">219,972<span></span>
</td>
<td class="nump">127,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Construction in progress [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">33,962<span></span>
</td>
<td class="nump">86,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="nump">641,353<span></span>
</td>
<td class="nump">487,975<span></span>
</td>
<td class="nump">R$ 314,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">118,435<span></span>
</td>
<td class="nump">168,132<span></span>
</td>
<td class="nump">125,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="nump">24,980<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">65,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(27,382)<span></span>
</td>
<td class="num">(15,649)<span></span>
</td>
<td class="num">(17,532)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">815<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="nump">757,386<span></span>
</td>
<td class="nump">641,353<span></span>
</td>
<td class="nump">487,975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="nump">91,857<span></span>
</td>
<td class="nump">52,433<span></span>
</td>
<td class="nump">25,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">527<span></span>
</td>
<td class="nump">1,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="nump">1,279<span></span>
</td>
<td class="nump">38,884<span></span>
</td>
<td class="nump">25,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="nump">93,232<span></span>
</td>
<td class="nump">91,857<span></span>
</td>
<td class="nump">52,433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Machinery And Equipments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="nump">100,390<span></span>
</td>
<td class="nump">77,371<span></span>
</td>
<td class="nump">68,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">20,071<span></span>
</td>
<td class="nump">36,486<span></span>
</td>
<td class="nump">10,268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="nump">7,729<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">12,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(9,411)<span></span>
</td>
<td class="num">(8,159)<span></span>
</td>
<td class="num">(14,213)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="nump">1,202<span></span>
</td>
<td class="num">(5,353)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="nump">119,981<span></span>
</td>
<td class="nump">100,390<span></span>
</td>
<td class="nump">77,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Land [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="nump">18,852<span></span>
</td>
<td class="nump">18,852<span></span>
</td>
<td class="nump">13,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="nump">18,852<span></span>
</td>
<td class="nump">18,852<span></span>
</td>
<td class="nump">18,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Vehicles [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="nump">1,053<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">776<span></span>
</td>
<td class="nump">968<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(475)<span></span>
</td>
<td class="num">(933)<span></span>
</td>
<td class="num">(205)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(449)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="nump">1,354<span></span>
</td>
<td class="nump">1,053<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Fixtures and fittings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="nump">90,712<span></span>
</td>
<td class="nump">69,834<span></span>
</td>
<td class="nump">29,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">17,914<span></span>
</td>
<td class="nump">26,047<span></span>
</td>
<td class="nump">21,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="nump">4,384<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(1,443)<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">2,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="num">(708)<span></span>
</td>
<td class="num">(5,669)<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="nump">110,859<span></span>
</td>
<td class="nump">90,712<span></span>
</td>
<td class="nump">69,834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | It Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="nump">68,593<span></span>
</td>
<td class="nump">53,184<span></span>
</td>
<td class="nump">28,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">21,135<span></span>
</td>
<td class="nump">15,766<span></span>
</td>
<td class="nump">19,511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="nump">734<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">10,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(7,979)<span></span>
</td>
<td class="num">(6,992)<span></span>
</td>
<td class="num">(4,985)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="nump">327<span></span>
</td>
<td class="nump">6,600<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="nump">82,810<span></span>
</td>
<td class="nump">68,593<span></span>
</td>
<td class="nump">53,184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Library Books [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="nump">37,362<span></span>
</td>
<td class="nump">30,072<span></span>
</td>
<td class="nump">21,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">985<span></span>
</td>
<td class="nump">645<span></span>
</td>
<td class="nump">3,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="nump">1,329<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(7,788)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(86)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,645<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="nump">31,888<span></span>
</td>
<td class="nump">37,362<span></span>
</td>
<td class="nump">30,072<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Leasehold improvements [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="nump">145,846<span></span>
</td>
<td class="nump">152,976<span></span>
</td>
<td class="nump">122,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">2,667<span></span>
</td>
<td class="nump">4,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="nump">10,741<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">17,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(286)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(550)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="nump">108,098<span></span>
</td>
<td class="num">(9,797)<span></span>
</td>
<td class="nump">9,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="nump">264,448<span></span>
</td>
<td class="nump">145,846<span></span>
</td>
<td class="nump">152,976<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Construction in progress [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="nump">86,688<span></span>
</td>
<td class="nump">31,786<span></span>
</td>
<td class="nump">3,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">57,409<span></span>
</td>
<td class="nump">85,026<span></span>
</td>
<td class="nump">59,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="nump">63<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="num">(417)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="num">(110,198)<span></span>
</td>
<td class="num">(30,046)<span></span>
</td>
<td class="num">(34,538)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="nump">33,962<span></span>
</td>
<td class="nump">86,688<span></span>
</td>
<td class="nump">31,786<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="num">(99,266)<span></span>
</td>
<td class="num">(68,167)<span></span>
</td>
<td class="num">(53,634)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(74,907)<span></span>
</td>
<td class="num">(45,051)<span></span>
</td>
<td class="num">(30,461)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">25,472<span></span>
</td>
<td class="nump">13,952<span></span>
</td>
<td class="nump">15,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="num">(148,701)<span></span>
</td>
<td class="num">(99,266)<span></span>
</td>
<td class="num">(68,167)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="num">(5,751)<span></span>
</td>
<td class="num">(1,673)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(4,242)<span></span>
</td>
<td class="num">(3,472)<span></span>
</td>
<td class="num">(1,673)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">118<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="nump">196<span></span>
</td>
<td class="num">(606)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="num">(9,679)<span></span>
</td>
<td class="num">(5,751)<span></span>
</td>
<td class="num">(1,673)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Machinery And Equipments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="num">(20,630)<span></span>
</td>
<td class="num">(16,391)<span></span>
</td>
<td class="num">(19,322)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(14,900)<span></span>
</td>
<td class="num">(11,166)<span></span>
</td>
<td class="num">(7,215)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">6,684<span></span>
</td>
<td class="nump">5,474<span></span>
</td>
<td class="nump">10,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="num">(28,843)<span></span>
</td>
<td class="num">(20,630)<span></span>
</td>
<td class="num">(16,391)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Land [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Vehicles [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="nump">288<span></span>
</td>
<td class="num">(220)<span></span>
</td>
<td class="num">(171)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(325)<span></span>
</td>
<td class="num">(284)<span></span>
</td>
<td class="num">(196)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">791<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="num">(220)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Fixtures and fittings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="num">(10,349)<span></span>
</td>
<td class="num">(12,496)<span></span>
</td>
<td class="num">(8,089)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(12,556)<span></span>
</td>
<td class="num">(7,725)<span></span>
</td>
<td class="num">(5,601)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">2,528<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="nump">1,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="num">(20,377)<span></span>
</td>
<td class="num">(10,349)<span></span>
</td>
<td class="num">(12,496)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | It Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="num">(21,837)<span></span>
</td>
<td class="num">(14,922)<span></span>
</td>
<td class="num">(10,851)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(13,286)<span></span>
</td>
<td class="num">(10,140)<span></span>
</td>
<td class="num">(7,529)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">8,254<span></span>
</td>
<td class="nump">7,350<span></span>
</td>
<td class="nump">3,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4,125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="num">(26,872)<span></span>
</td>
<td class="num">(21,837)<span></span>
</td>
<td class="num">(14,922)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Library Books [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="num">(22,888)<span></span>
</td>
<td class="num">(13,600)<span></span>
</td>
<td class="num">(10,817)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(3,327)<span></span>
</td>
<td class="num">(3,415)<span></span>
</td>
<td class="num">(3,416)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">7,563<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(5,940)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="num">(18,652)<span></span>
</td>
<td class="num">(22,888)<span></span>
</td>
<td class="num">(13,600)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Leasehold improvements [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="num">(18,099)<span></span>
</td>
<td class="num">(8,865)<span></span>
</td>
<td class="num">(4,384)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(26,271)<span></span>
</td>
<td class="num">(8,849)<span></span>
</td>
<td class="num">(4,831)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="num">(196)<span></span>
</td>
<td class="num">(502)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="num">(44,476)<span></span>
</td>
<td class="num">(18,099)<span></span>
</td>
<td class="num">(8,865)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Construction in progress [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PropertyPlantAndEquipmentNetBookValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PropertyPlantAndEquipmentNetBookValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PropertyPlantAndEquipments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PropertyPlantAndEquipments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WritOffOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WritOffOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639609223664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="nump">R$ 413<span></span>
</td>
<td class="nump">R$ 25<span></span>
</td>
<td class="nump">R$ 2,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">4,796,016<span></span>
</td>
<td class="nump">4,041,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">4,339,859<span></span>
</td>
<td class="nump">4,093,140<span></span>
</td>
<td class="nump">2,684,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">99,993<span></span>
</td>
<td class="nump">150,023<span></span>
</td>
<td class="nump">176,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="num">(3,271)<span></span>
</td>
<td class="num">(447)<span></span>
</td>
<td class="num">(2,140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="nump">803,875<span></span>
</td>
<td class="nump">106,595<span></span>
</td>
<td class="nump">1,234,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Remesurement', window );">Remesurement</a></td>
<td class="nump">2,556<span></span>
</td>
<td class="num">(8,637)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(815)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">5,243,012<span></span>
</td>
<td class="nump">4,339,859<span></span>
</td>
<td class="nump">4,093,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(298,368)<span></span>
</td>
<td class="num">(192,305)<span></span>
</td>
<td class="num">(111,549)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(151,486)<span></span>
</td>
<td class="num">(106,485)<span></span>
</td>
<td class="num">(80,522)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="nump">2,858<span></span>
</td>
<td class="nump">422<span></span>
</td>
<td class="num">(234)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(446,996)<span></span>
</td>
<td class="num">(298,368)<span></span>
</td>
<td class="num">(192,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">1,334,699<span></span>
</td>
<td class="nump">1,257,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">1,257,045<span></span>
</td>
<td class="nump">1,184,336<span></span>
</td>
<td class="nump">810,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="nump">75,098<span></span>
</td>
<td class="nump">42,246<span></span>
</td>
<td class="nump">373,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Remesurement', window );">Remesurement</a></td>
<td class="nump">2,556<span></span>
</td>
<td class="num">(8,637)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">1,334,699<span></span>
</td>
<td class="nump">1,257,045<span></span>
</td>
<td class="nump">1,184,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">2,189,814<span></span>
</td>
<td class="nump">2,165,406<span></span>
</td>
<td class="nump">1,451,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,408<span></span>
</td>
<td class="nump">108,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="nump">586,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">606,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">2,776,077<span></span>
</td>
<td class="nump">2,189,814<span></span>
</td>
<td class="nump">2,165,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">2,776,077<span></span>
</td>
<td class="nump">2,189,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 167,105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">182,060<span></span>
</td>
<td class="nump">133,369<span></span>
</td>
<td class="nump">75,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,185<span></span>
</td>
<td class="nump">58,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,472)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">182,060<span></span>
</td>
<td class="nump">182,060<span></span>
</td>
<td class="nump">133,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(14,955)<span></span>
</td>
<td class="num">(8,529)<span></span>
</td>
<td class="num">(3,502)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(11,083)<span></span>
</td>
<td class="num">(6,426)<span></span>
</td>
<td class="num">(5,027)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(26,038)<span></span>
</td>
<td class="num">(14,955)<span></span>
</td>
<td class="num">(8,529)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">276,320<span></span>
</td>
<td class="nump">223,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">435,816<span></span>
</td>
<td class="nump">431,277<span></span>
</td>
<td class="nump">283,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="nump">142,451<span></span>
</td>
<td class="nump">3,929<span></span>
</td>
<td class="nump">147,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">578,267<span></span>
</td>
<td class="nump">435,816<span></span>
</td>
<td class="nump">431,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(212,363)<span></span>
</td>
<td class="num">(142,270)<span></span>
</td>
<td class="num">(85,832)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(89,584)<span></span>
</td>
<td class="num">(70,093)<span></span>
</td>
<td class="num">(56,438)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(301,947)<span></span>
</td>
<td class="num">(212,363)<span></span>
</td>
<td class="num">(142,270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">47,056<span></span>
</td>
<td class="nump">26,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">43,300<span></span>
</td>
<td class="nump">21,759<span></span>
</td>
<td class="nump">16,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">1,423<span></span>
</td>
<td class="nump">3,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="num">(2,235)<span></span>
</td>
<td class="num">(381)<span></span>
</td>
<td class="nump">1,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">1,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer amount</a></td>
<td class="nump">28,708<span></span>
</td>
<td class="nump">20,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">71,150<span></span>
</td>
<td class="nump">43,300<span></span>
</td>
<td class="nump">21,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(17,277)<span></span>
</td>
<td class="num">(12,699)<span></span>
</td>
<td class="num">(6,256)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(8,764)<span></span>
</td>
<td class="num">(4,943)<span></span>
</td>
<td class="num">(5,844)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="nump">1,947<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="num">(599)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(24,094)<span></span>
</td>
<td class="num">(17,277)<span></span>
</td>
<td class="num">(12,699)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember', window );">Education Content [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">41,971<span></span>
</td>
<td class="nump">43,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember', window );">Education Content [Member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">69,589<span></span>
</td>
<td class="nump">17,305<span></span>
</td>
<td class="nump">17,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">9,827<span></span>
</td>
<td class="nump">11,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer amount</a></td>
<td class="nump">4,785<span></span>
</td>
<td class="nump">38,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">84,201<span></span>
</td>
<td class="nump">69,589<span></span>
</td>
<td class="nump">17,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember', window );">Education Content [Member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(26,562)<span></span>
</td>
<td class="num">(16,672)<span></span>
</td>
<td class="num">(7,692)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(15,668)<span></span>
</td>
<td class="num">(9,634)<span></span>
</td>
<td class="num">(8,980)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(313)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(42,230)<span></span>
</td>
<td class="num">(26,562)<span></span>
</td>
<td class="num">(16,672)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">96,874<span></span>
</td>
<td class="nump">80,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">90,749<span></span>
</td>
<td class="nump">34,397<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">37,712<span></span>
</td>
<td class="nump">32,879<span></span>
</td>
<td class="nump">996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,520<span></span>
</td>
<td class="nump">33,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer amount</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">17,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">128,477<span></span>
</td>
<td class="nump">90,749<span></span>
</td>
<td class="nump">34,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(10,093)<span></span>
</td>
<td class="num">(657)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(21,504)<span></span>
</td>
<td class="num">(9,436)<span></span>
</td>
<td class="num">(625)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer amount</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(31,603)<span></span>
</td>
<td class="num">(10,093)<span></span>
</td>
<td class="num">(657)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember', window );">Educational Platform [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">53,992<span></span>
</td>
<td class="nump">38,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember', window );">Educational Platform [Member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">55,697<span></span>
</td>
<td class="nump">76,444<span></span>
</td>
<td class="nump">27,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">23,164<span></span>
</td>
<td class="nump">14,761<span></span>
</td>
<td class="nump">39,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="num">(911)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(2,743)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer amount</a></td>
<td class="num">(3,058)<span></span>
</td>
<td class="num">(35,499)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">74,892<span></span>
</td>
<td class="nump">55,697<span></span>
</td>
<td class="nump">76,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember', window );">Educational Platform [Member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(17,039)<span></span>
</td>
<td class="num">(11,478)<span></span>
</td>
<td class="num">(8,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(4,778)<span></span>
</td>
<td class="num">(5,874)<span></span>
</td>
<td class="num">(3,608)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="nump">911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer amount</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(20,900)<span></span>
</td>
<td class="num">(17,039)<span></span>
</td>
<td class="num">(11,478)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_SoftwareInProgressMember', window );">Software In Progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">12,134<span></span>
</td>
<td class="nump">14,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_SoftwareInProgressMember', window );">Software In Progress [Member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">14,734<span></span>
</td>
<td class="nump">28,847<span></span>
</td>
<td class="nump">2,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">27,976<span></span>
</td>
<td class="nump">26,141<span></span>
</td>
<td class="nump">23,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="num">(125)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(417)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer amount</a></td>
<td class="num">(30,451)<span></span>
</td>
<td class="num">(40,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">12,134<span></span>
</td>
<td class="nump">14,734<span></span>
</td>
<td class="nump">28,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_SoftwareInProgressMember', window );">Software In Progress [Member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_OtherMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">871<span></span>
</td>
<td class="nump">976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_OtherMember', window );">Other [Member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">1,055<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">1,055<span></span>
</td>
<td class="nump">1,055<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_OtherMember', window );">Other [Member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(79)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">R$ (184)<span></span>
</td>
<td class="num">R$ (79)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IntangibleAssetsAndGoodwillNetBookValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IntangibleAssetsAndGoodwillNetBookValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Remesurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Remesurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Transfer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Transfer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WriteoffOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WriteoffOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_LicencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_LicencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_SoftwareInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_SoftwareInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639633158320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible assets and goodwill (Details 1) - Carrying Amounts [Member] - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">R$ 1,334,699<span></span>
</td>
<td class="nump">R$ 1,257,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">2,776,077<span></span>
</td>
<td class="nump">2,189,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">5,584,082<span></span>
</td>
<td class="nump">4,814,424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">I P T A N Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">17,446<span></span>
</td>
<td class="nump">17,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">57,214<span></span>
</td>
<td class="nump">57,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">125,974<span></span>
</td>
<td class="nump">126,024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Instituto De Educacao Superior Do Vale Do Parnaiba S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">27,956<span></span>
</td>
<td class="nump">27,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">81,366<span></span>
</td>
<td class="nump">81,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">126,996<span></span>
</td>
<td class="nump">129,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Centro De Ciencias Em Saude De Itajuba S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,664<span></span>
</td>
<td class="nump">4,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">56,737<span></span>
</td>
<td class="nump">56,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">54,550<span></span>
</td>
<td class="nump">53,540<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Instituto De Ensino Superior Do Piaui S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">73,838<span></span>
</td>
<td class="nump">73,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">179,693<span></span>
</td>
<td class="nump">179,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">332,104<span></span>
</td>
<td class="nump">322,968<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">F A D E P Faculdade Educacional De Pato Branco Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">49,661<span></span>
</td>
<td class="nump">49,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">70,606<span></span>
</td>
<td class="nump">70,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">148,032<span></span>
</td>
<td class="nump">153,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Instituto Educacional Santo Agostinho S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">58,903<span></span>
</td>
<td class="nump">58,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">144,507<span></span>
</td>
<td class="nump">144,507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">322,061<span></span>
</td>
<td class="nump">314,967<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Institutode Pesquisae Ensino Medicodo Estadode Minas Gerais Ltda [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">87,647<span></span>
</td>
<td class="nump">87,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">183,862<span></span>
</td>
<td class="nump">192,079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Instituto Paraensede Educacaoe Cultura Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">108,000<span></span>
</td>
<td class="nump">108,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">157,984<span></span>
</td>
<td class="nump">148,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Uni Redentor [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">77,662<span></span>
</td>
<td class="nump">77,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">121,477<span></span>
</td>
<td class="nump">121,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">234,054<span></span>
</td>
<td class="nump">242,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Uni S L [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,420<span></span>
</td>
<td class="nump">4,420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">273,795<span></span>
</td>
<td class="nump">273,795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">401,143<span></span>
</td>
<td class="nump">398,492<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">F E S A R [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">71,664<span></span>
</td>
<td class="nump">71,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">141,616<span></span>
</td>
<td class="nump">141,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">244,412<span></span>
</td>
<td class="nump">244,084<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">FCMPB [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">110,483<span></span>
</td>
<td class="nump">110,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">235,018<span></span>
</td>
<td class="nump">235,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">402,140<span></span>
</td>
<td class="nump">415,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">I T P A C Garanhuns [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">108,000<span></span>
</td>
<td class="nump">108,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">116,162<span></span>
</td>
<td class="nump">112,628<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Medcel And C B B W [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">179,830<span></span>
</td>
<td class="nump">169,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">238,921<span></span>
</td>
<td class="nump">279,684<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Practice Management Tools And Electronic Prescription [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">106,774<span></span>
</td>
<td class="nump">106,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">221,171<span></span>
</td>
<td class="nump">216,297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Clinical Decision Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">87,018<span></span>
</td>
<td class="nump">87,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">147,897<span></span>
</td>
<td class="nump">153,526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Cliquefarma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">6,588<span></span>
</td>
<td class="nump">6,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">18,789<span></span>
</td>
<td class="nump">20,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Unifip Moc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">87,777<span></span>
</td>
<td class="nump">87,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">190,247<span></span>
</td>
<td class="nump">190,247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">361,383<span></span>
</td>
<td class="nump">369,007<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Unigranrio [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">169,173<span></span>
</td>
<td class="nump">169,173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">421,538<span></span>
</td>
<td class="nump">421,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">833,665<span></span>
</td>
<td class="nump">854,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">RXPRO [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">29,809<span></span>
</td>
<td class="nump">29,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">34,748<span></span>
</td>
<td class="nump">36,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Glic [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">8,288<span></span>
</td>
<td class="nump">15,587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">23,721<span></span>
</td>
<td class="nump">31,022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Del Rey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">75,098<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">586,263<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">R$ 854,313<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CashGeneratingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CashGeneratingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 122<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_122_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 134<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_134_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaensedeEducacaoeCulturaLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaensedeEducacaoeCulturaLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FESARMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FESARMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ITPACGaranhunsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ITPACGaranhunsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedcelAndCBBWMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedcelAndCBBWMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PracticeManagementToolsAndElectronicPrescriptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PracticeManagementToolsAndElectronicPrescriptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ClinicalDecisionSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ClinicalDecisionSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnifipMocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnifipMocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GlicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GlicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639605380176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill (Details 2)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_CustomerRelationshipsMedicineMember', window );">Customer Relationships Medicine [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_CustomerRelationshipsOtherCoursesMember', window );">Customer Relationships Other Courses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember', window );">Education Content [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_DevelopedTechnologyMember', window );">Developed Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_CustomerRelationshipsMedicineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_CustomerRelationshipsMedicineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_CustomerRelationshipsOtherCoursesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_CustomerRelationshipsOtherCoursesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639606525328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExplicitProjectionPeriod', window );">Explicit projection period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections', window );">Description of key assumptions on which management has based cash flow projections</a></td>
<td class="text">An increase of 25 basis points in management&#8217;s estimated
discount rate applied to the cash flow projections of each CGU for the year ended December 31, 2023, or a decrease of 25 basis points
on estimated EBITDA would have not resulted in significant impacts on these consolidated financial statements.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections', window );">Discount rate applied to cash flow projections</a></td>
<td class="nump">12.48%<span></span>
</td>
<td class="nump">13.14%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PerpetuityGrowthRate', window );">Growth rates</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections', window );">Discount rate applied to cash flow projections</a></td>
<td class="nump">15.14%<span></span>
</td>
<td class="nump">15.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PerpetuityGrowthRate', window );">Growth rates</a></td>
<td class="nump">7.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ExplicitProjectionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ExplicitProjectionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PerpetuityGrowthRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PerpetuityGrowthRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_134_d_v&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 134<br> -Subparagraph e<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_134_e_v&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of key assumptions on which management has based its cash flow projections for the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). Key assumptions are those to which the unit's (group of units') recoverable amount is most sensitive. [Refer: Cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_134_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639635369440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">R$ 585,923<span></span>
</td>
<td class="nump">R$ 495,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="nump">39,485<span></span>
</td>
<td class="nump">42,568<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">585,923<span></span>
</td>
<td class="nump">495,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="nump">585,923<span></span>
</td>
<td class="nump">495,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssets', window );">Current</a></td>
<td class="nump">546,438<span></span>
</td>
<td class="nump">452,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Non-current</a></td>
<td class="nump">R$ 39,485<span></span>
</td>
<td class="nump">R$ 42,568<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639612420176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 1,800,775<span></span>
</td>
<td class="nump">R$ 1,882,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">874,569<span></span>
</td>
<td class="nump">769,525<span></span>
</td>
<td class="nump">R$ 714,085<span></span>
</td>
<td class="nump">R$ 447,703<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">566,867<span></span>
</td>
<td class="nump">528,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="nump">3,242,211<span></span>
</td>
<td class="nump">3,243,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">108,222<span></span>
</td>
<td class="nump">71,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">1,800,775<span></span>
</td>
<td class="nump">1,882,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">874,569<span></span>
</td>
<td class="nump">769,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">566,867<span></span>
</td>
<td class="nump">528,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NotePayable', window );">Lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">62,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="nump">3,350,433<span></span>
</td>
<td class="nump">3,314,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current</a></td>
<td class="nump">678,370<span></span>
</td>
<td class="nump">573,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current</a></td>
<td class="nump">R$ 2,672,063<span></span>
</td>
<td class="nump">R$ 2,741,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NotePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NotePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payables due to related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639612129712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Details 2) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 1,800,775<span></span>
</td>
<td class="nump">R$ 1,882,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancingCurrent', window );">Current</a></td>
<td class="nump">179,252<span></span>
</td>
<td class="nump">145,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancingNonCurrent', window );">Non-current</a></td>
<td class="nump">R$ 1,621,523<span></span>
</td>
<td class="nump">1,737,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_TwentyTwentyFiveMember', window );">2025 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="text">Banco Ita&#250; Unibanco S.A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">CDI + 1.90% p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 412,880<span></span>
</td>
<td class="nump">518,134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_TwentyTwentySevenMember', window );">2027 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="text">FINEP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">TJLP p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="text">2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 11,193<span></span>
</td>
<td class="nump">8,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_TwentyTwentyFourMember', window );">2024 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="text">Banco Ita&#250; Unibanco S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">CDI + 1.75% p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 21,405<span></span>
</td>
<td class="nump">32,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_TwentyTwentySixMember', window );">2026 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="text">Softbank<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">6.5% p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 825,957<span></span>
</td>
<td class="nump">824,258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_TwentyTwentyEightMember', window );">2028 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="text">Debentures<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">CDI + 1.80% p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="text">2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 529,340<span></span>
</td>
<td class="nump">R$ 499,839<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialInstitution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Information about financial institution.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialInstitution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancingCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount refers to loans and financing current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancingCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancingNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount refers to loans and financing non current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancingNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maturity of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_TwentyTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_TwentyTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_TwentyTwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_TwentyTwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_TwentyTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_TwentyTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_TwentyTwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_TwentyTwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_TwentyTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_TwentyTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639607419440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and financial liabilities  (Details 3) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets, balance at beginning</a></td>
<td class="nump">R$ 690,073<span></span>
</td>
<td class="nump">R$ 663,686<span></span>
</td>
<td class="nump">R$ 419,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities, balance at beginning</a></td>
<td class="nump">769,525<span></span>
</td>
<td class="nump">714,085<span></span>
</td>
<td class="nump">447,703<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Right-of-use assets, additions</a></td>
<td class="nump">7,328<span></span>
</td>
<td class="nump">42,250<span></span>
</td>
<td class="nump">62,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsToLeaseLiabilities', window );">Lease liabilities, additions</a></td>
<td class="nump">7,328<span></span>
</td>
<td class="nump">42,250<span></span>
</td>
<td class="nump">62,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsRemeasurement', window );">Right-of-use assets, remeasurement</a></td>
<td class="nump">70,387<span></span>
</td>
<td class="nump">58,623<span></span>
</td>
<td class="nump">95,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LeaseLiabilitiesRemeasurement', window );">Lease liabilities, remeasurement</a></td>
<td class="nump">70,387<span></span>
</td>
<td class="nump">58,623<span></span>
</td>
<td class="nump">95,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsBusinessCombinations', window );">Right-of-use assets, business combinations</a></td>
<td class="nump">65,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BusinessCombinationsLeaseLiabilities', window );">Lease liabilities, business combinations</a></td>
<td class="nump">65,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139,514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Right-of-use assets, depreciation expense</a></td>
<td class="num">(63,118)<span></span>
</td>
<td class="num">(54,684)<span></span>
</td>
<td class="num">(43,237)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepreciationExpenseLeaseLiabilities', window );">Lease liabilities, depreciation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsInterestExpense', window );">Right-of-use assets, interest expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Lease liabilities, interest expense</a></td>
<td class="nump">100,849<span></span>
</td>
<td class="nump">88,571<span></span>
</td>
<td class="nump">67,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsPaymentsOfLeaseLiabilities', window );">Right-of-use assets, payments of lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1', window );">Lease liabilities, payments of lease liabilities</a></td>
<td class="num">(31,473)<span></span>
</td>
<td class="num">(28,511)<span></span>
</td>
<td class="num">(20,075)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsPaymentsOfInterest', window );">Right-of-use assets, payments of interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PaymentsOfInterestLeaseLiabilities', window );">Lease liabilities, payments of interest</a></td>
<td class="num">(103,911)<span></span>
</td>
<td class="num">(85,001)<span></span>
</td>
<td class="num">(67,676)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsWriteoff', window );">Right-of-use assets, Write-off</a></td>
<td class="num">(2,469)<span></span>
</td>
<td class="num">(19,802)<span></span>
</td>
<td class="num">(10,316)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LeaseLiabilitiesWriteoff', window );">Lease liabilities, Write-off</a></td>
<td class="num">(3,544)<span></span>
</td>
<td class="num">(20,492)<span></span>
</td>
<td class="num">(11,244)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets, balance at ending</a></td>
<td class="nump">767,609<span></span>
</td>
<td class="nump">690,073<span></span>
</td>
<td class="nump">663,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities, balance at ending</a></td>
<td class="nump">874,569<span></span>
</td>
<td class="nump">769,525<span></span>
</td>
<td class="nump">714,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsCurrent', window );">Right-of-use assets, current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liabilities, current</a></td>
<td class="nump">36,898<span></span>
</td>
<td class="nump">32,459<span></span>
</td>
<td class="nump">24,955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsNonCurrent', window );">Right-of-use assets, non-current</a></td>
<td class="nump">767,609<span></span>
</td>
<td class="nump">690,073<span></span>
</td>
<td class="nump">663,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities, non-current</a></td>
<td class="nump">R$ 837,671<span></span>
</td>
<td class="nump">R$ 737,066<span></span>
</td>
<td class="nump">R$ 689,130<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsToLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsToLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_BusinessCombinationsLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_BusinessCombinationsLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DepreciationExpenseLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DepreciationExpenseLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of lease liabilities re measurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaymentsOfInterestLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaymentsOfInterestLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of business combinations right to use of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current right to use of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Interest expense right to use of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non current right to use of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsPaymentsOfInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsPaymentsOfInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsPaymentsOfLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Payments of lease liabilities right to use of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsPaymentsOfLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of right of use assets re measurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639637092240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Details 4) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">R$ 566,867<span></span>
</td>
<td class="nump">R$ 528,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersCurrent', window );">Current</a></td>
<td class="nump">353,998<span></span>
</td>
<td class="nump">261,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersNonCurrent', window );">Non-current</a></td>
<td class="nump">212,869<span></span>
</td>
<td class="nump">266,967<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPEMEDMember', window );">IPEMED [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">12,805<span></span>
</td>
<td class="nump">22,654<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember', window );">Uni Redentor [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">27,155<span></span>
</td>
<td class="nump">72,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember', window );">Uni S L [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">15,064<span></span>
</td>
<td class="nump">37,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember', window );">FCMPB [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">63,168<span></span>
</td>
<td class="nump">111,755<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember', window );">Medical Harbour [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">4,053<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember', window );">Shosp [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">454<span></span>
</td>
<td class="nump">2,206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember', window );">Unigranrio [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">156,235<span></span>
</td>
<td class="nump">216,716<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember', window );">RXPRO [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,781<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GuaranhunsMember', window );">Guaranhuns [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">30,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember', window );">Alem Da Medicina [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">18,325<span></span>
</td>
<td class="nump">11,996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardiPapersMember', window );">Cardi Papers [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">14,173<span></span>
</td>
<td class="nump">7,979<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GlicMember', window );">Glic [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,520<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember', window );">Del Rey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">R$ 256,488<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount refers to accounts payable to selling shareholders current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount refers to accounts payable to selling shareholders non current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payables due to related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPEMEDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPEMEDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GuaranhunsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GuaranhunsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardiPapersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardiPapersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GlicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GlicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639632770336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Details 5) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">R$ 528,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Payment of interest</a></td>
<td class="num">(279,800)<span></span>
</td>
<td class="num">R$ (201,588)<span></span>
</td>
<td class="num">R$ (117,986)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Other</a></td>
<td class="nump">24,500<span></span>
</td>
<td class="nump">9,975<span></span>
</td>
<td class="nump">14,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Closing balance</a></td>
<td class="nump">566,867<span></span>
</td>
<td class="nump">528,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember', window );">Accounts Payable To Selling Shareholders [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">528,678<span></span>
</td>
<td class="nump">679,826<span></span>
</td>
<td class="nump">518,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholderCashFlows', window );">Cash flows payments and deductions</a></td>
<td class="num">(225,460)<span></span>
</td>
<td class="num">(236,760)<span></span>
</td>
<td class="num">(180,020)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Payment of interest</a></td>
<td class="num">(55,989)<span></span>
</td>
<td class="num">(24,428)<span></span>
</td>
<td class="num">(12,661)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec', window );">Acquisition of licenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">24,408<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest</a></td>
<td class="nump">85,069<span></span>
</td>
<td class="nump">68,064<span></span>
</td>
<td class="nump">31,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersBusinessCombinations', window );">Additions consideration to be transferred on business combinations</a></td>
<td class="nump">234,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">243,816<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ContingentConsiderationOnBusinessCombinations', window );">Consideration to be transferred on business combinations (earn-outs)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">27,921<span></span>
</td>
<td class="nump">24,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Reversals', window );">Reversals</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(10,353)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemeasurementOfEarnouts', window );">Remeasurement of earn-outs</a></td>
<td class="nump">2,556<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Other</a></td>
<td class="num">(1,987)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Closing balance</a></td>
<td class="nump">R$ 566,867<span></span>
</td>
<td class="nump">R$ 528,678<span></span>
</td>
<td class="nump">R$ 679,826<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholderCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount refers to accounts payable to selling shareholder cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholderCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount refers to accounts payable to selling shareholders acquisition of ipec.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount refers to accounts payable to selling shareholders business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ContingentConsiderationOnBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ContingentConsiderationOnBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RemeasurementOfEarnouts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RemeasurementOfEarnouts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Reversals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Reversals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payables due to related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639607264480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Details 6) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NotesPayables', window );">Notes payable beginning</a></td>
<td class="nump">R$ 62,176<span></span>
</td>
<td class="nump">R$ 72,726<span></span>
</td>
<td class="nump">R$ 76,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Payments', window );">Payments</a></td>
<td class="num">(49,347)<span></span>
</td>
<td class="num">(12,000)<span></span>
</td>
<td class="num">(9,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PaymentsOfInterest', window );">Payments of interest</a></td>
<td class="num">(15,529)<span></span>
</td>
<td class="num">(3,008)<span></span>
</td>
<td class="num">(1,268)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_MonetaryIndexation', window );">Monetary indexation</a></td>
<td class="nump">2,700<span></span>
</td>
<td class="nump">4,458<span></span>
</td>
<td class="nump">7,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NotesPayables', window );">Notes payable ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">62,176<span></span>
</td>
<td class="nump">72,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CurrentLiabilities1', window );">Current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">62,176<span></span>
</td>
<td class="nump">14,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NoncurrentLiabilities1', window );">Non-current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">R$ 58,248<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CurrentLiabilities1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CurrentLiabilities1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_MonetaryIndexation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of monetary indexation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_MonetaryIndexation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentLiabilities1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentLiabilities1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NotesPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NotesPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Payments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Payments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaymentsOfInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaymentsOfInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639609963904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Details 7) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets, at carrying amount</a></td>
<td class="nump">R$ 39,485<span></span>
</td>
<td class="nump">R$ 42,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">39,485<span></span>
</td>
<td class="nump">42,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, at carrying amount</a></td>
<td class="nump">3,242,211<span></span>
</td>
<td class="nump">3,243,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">3,237,188<span></span>
</td>
<td class="nump">3,294,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember', window );">Loans And Financing [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, at carrying amount</a></td>
<td class="nump">1,800,775<span></span>
</td>
<td class="nump">1,882,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">1,795,752<span></span>
</td>
<td class="nump">1,934,295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, at carrying amount</a></td>
<td class="nump">874,569<span></span>
</td>
<td class="nump">769,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">874,569<span></span>
</td>
<td class="nump">769,525<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember', window );">Accounts Payable To Selling Shareholders [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, at carrying amount</a></td>
<td class="nump">566,867<span></span>
</td>
<td class="nump">528,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">566,867<span></span>
</td>
<td class="nump">528,678<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_NotesPayableMember', window );">Notes Payable [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, at carrying amount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">62,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">62,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets, at carrying amount</a></td>
<td class="nump">39,485<span></span>
</td>
<td class="nump">42,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">R$ 39,485<span></span>
</td>
<td class="nump">R$ 42,568<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial assets. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639632654384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Details 8) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="nump">R$ 39,485<span></span>
</td>
<td class="nump">R$ 42,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">(131,748)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Loans And Financing [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (529,340)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">CDI + 1.8%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (71,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Loans And Financing One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (412,880)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">CDI + 1.9%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (55,945)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Loans And Financing Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (11,193)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">TJLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (733)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Loans And Financing Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (21,405)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">CDI + 1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (2,868)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Accounts Payable To Selling Shareholders One [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (274,428)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">CDI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (31,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Accounts Payable To Selling Shareholders Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (256,488)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">SELIC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (29,881)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Cash Equivalents [member] | Increase in basis points +75 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Effect on profit before tax</a></td>
<td class="num">(7,407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Cash Equivalents [member] | Increase in basis points +150 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Effect on profit before tax</a></td>
<td class="num">(14,814)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_CashEquivalents1Member', window );">Cash Equivalents [member] | Floating interest rate [member] | Interest rate risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="nump">R$ 518,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">100.8% of CDI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="nump">R$ 60,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_BaseRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount refers to base rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_BaseRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IndexRatePerYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Information about index rate per year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IndexRatePerYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of assets, recognised in profit or loss before tax, due to a reasonably possible decrease in an unobservable input. [Refer: Tax income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of assets, recognised in profit or loss before tax, due to a reasonably possible increase in an unobservable input. [Refer: Tax income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_CashEquivalents1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_CashEquivalents1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProbabilityOfDefaultAxis=afya_IncreaseBasisPointsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProbabilityOfDefaultAxis=afya_IncreaseBasisPointsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProbabilityOfDefaultAxis=afya_IncreaseBasisPointsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProbabilityOfDefaultAxis=afya_IncreaseBasisPointsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_CashEquivalents1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_CashEquivalents1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639612424496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Details 9) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">R$ (540,052)<span></span>
</td>
<td class="nump">R$ 344,520<span></span>
</td>
<td class="num">R$ (296,480)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RiskExposuresAxis=afya_ForeignCurrencyExposuresMember', window );">Exposure [member] | Currency risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">23,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RiskExposuresAxis=afya_IncreaseForeignCurrencyMember', window );">Increase in Foreign Currency Sensitivity +10% [member] | Currency risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">2,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RiskExposuresAxis=afya_DecreaseForeignCurrencyMember', window );">Decrease in Foreign Currency Sensitivity -10% [member] | Currency risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">R$ (2,317)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RiskExposuresAxis=afya_ForeignCurrencyExposuresMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RiskExposuresAxis=afya_ForeignCurrencyExposuresMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RiskExposuresAxis=afya_IncreaseForeignCurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RiskExposuresAxis=afya_IncreaseForeignCurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RiskExposuresAxis=afya_DecreaseForeignCurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RiskExposuresAxis=afya_DecreaseForeignCurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639633369472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Details 10) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 1,800,775<span></span>
</td>
<td class="nump">R$ 1,882,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">874,569<span></span>
</td>
<td class="nump">769,525<span></span>
</td>
<td class="nump">R$ 714,085<span></span>
</td>
<td class="nump">R$ 447,703<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">566,867<span></span>
</td>
<td class="nump">528,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">108,222<span></span>
</td>
<td class="nump">71,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">2,250,562<span></span>
</td>
<td class="nump">2,313,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,923,128<span></span>
</td>
<td class="nump">1,711,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">619,171<span></span>
</td>
<td class="nump">621,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NotePayables', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Advances', window );">Advances from customers</a></td>
<td class="nump">153,485<span></span>
</td>
<td class="nump">133,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">5,054,568<span></span>
</td>
<td class="nump">4,913,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember', window );">Later than one year [member] | Liquidity risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">108,222<span></span>
</td>
<td class="nump">71,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">298,981<span></span>
</td>
<td class="nump">287,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">137,735<span></span>
</td>
<td class="nump">117,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">387,693<span></span>
</td>
<td class="nump">282,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NotePayables', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Advances', window );">Advances from customers</a></td>
<td class="nump">153,485<span></span>
</td>
<td class="nump">133,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">1,086,116<span></span>
</td>
<td class="nump">954,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">Later than one year and not later than three years [member] | Liquidity risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">1,383,255<span></span>
</td>
<td class="nump">788,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">268,724<span></span>
</td>
<td class="nump">234,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">231,478<span></span>
</td>
<td class="nump">339,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NotePayables', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Advances', window );">Advances from customers</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">1,883,457<span></span>
</td>
<td class="nump">1,362,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">Later than three years and not later than five years [member] | Liquidity risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">568,326<span></span>
</td>
<td class="nump">1,237,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">255,456<span></span>
</td>
<td class="nump">219,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NotePayables', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Advances', window );">Advances from customers</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">823,782<span></span>
</td>
<td class="nump">1,456,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Later than five years [member] | Liquidity risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,261,213<span></span>
</td>
<td class="nump">1,139,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NotePayables', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Advances', window );">Advances from customers</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">R$ 1,261,213<span></span>
</td>
<td class="nump">R$ 1,139,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialLiabilitiesContractualUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities contractual undiscounted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialLiabilitiesContractualUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NotePayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of note payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NotePayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Advances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of advances received representing contract liabilities for performance obligations satisfied at a point in time. [Refer: Contract liabilities; Performance obligations satisfied at point in time [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Advances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payables due to related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639611641872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Details 11) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning</a></td>
<td class="nump">R$ 2,652,426<span></span>
</td>
<td class="nump">R$ 2,088,961<span></span>
</td>
<td class="nump">R$ 1,065,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Payments of principal</a></td>
<td class="num">(162,853)<span></span>
</td>
<td class="num">(50,038)<span></span>
</td>
<td class="num">(146,489)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Payments of interest</a></td>
<td class="num">(279,800)<span></span>
</td>
<td class="num">(201,588)<span></span>
</td>
<td class="num">(117,986)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Addition</a></td>
<td class="nump">101,753<span></span>
</td>
<td class="nump">617,494<span></span>
</td>
<td class="nump">986,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities', window );">Interest</a></td>
<td class="nump">298,527<span></span>
</td>
<td class="nump">216,130<span></span>
</td>
<td class="nump">136,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Business combination</a></td>
<td class="nump">65,408<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">176,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other</a></td>
<td class="num">(117)<span></span>
</td>
<td class="num">(18,533)<span></span>
</td>
<td class="num">(10,816)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="nump">2,675,344<span></span>
</td>
<td class="nump">2,652,426<span></span>
</td>
<td class="nump">2,088,961<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_LoansAndFinancingMember', window );">Loans And Financing [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning</a></td>
<td class="nump">1,882,901<span></span>
</td>
<td class="nump">1,374,876<span></span>
</td>
<td class="nump">617,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Payments of principal</a></td>
<td class="num">(112,630)<span></span>
</td>
<td class="num">(1,791)<span></span>
</td>
<td class="num">(107,766)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Payments of interest</a></td>
<td class="num">(175,889)<span></span>
</td>
<td class="num">(116,587)<span></span>
</td>
<td class="num">(50,310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Addition</a></td>
<td class="nump">5,288<span></span>
</td>
<td class="nump">496,885<span></span>
</td>
<td class="nump">809,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities', window );">Interest</a></td>
<td class="nump">197,678<span></span>
</td>
<td class="nump">127,559<span></span>
</td>
<td class="nump">68,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">36,591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other</a></td>
<td class="nump">3,427<span></span>
</td>
<td class="nump">1,959<span></span>
</td>
<td class="nump">428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="nump">1,800,775<span></span>
</td>
<td class="nump">1,882,901<span></span>
</td>
<td class="nump">1,374,876<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning</a></td>
<td class="nump">769,525<span></span>
</td>
<td class="nump">714,085<span></span>
</td>
<td class="nump">447,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Payments of principal</a></td>
<td class="num">(31,473)<span></span>
</td>
<td class="num">(28,511)<span></span>
</td>
<td class="num">(20,075)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Payments of interest</a></td>
<td class="num">(103,911)<span></span>
</td>
<td class="num">(85,001)<span></span>
</td>
<td class="num">(67,676)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Addition</a></td>
<td class="nump">77,715<span></span>
</td>
<td class="nump">100,873<span></span>
</td>
<td class="nump">158,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities', window );">Interest</a></td>
<td class="nump">100,849<span></span>
</td>
<td class="nump">88,571<span></span>
</td>
<td class="nump">67,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Business combination</a></td>
<td class="nump">65,408<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">139,514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other</a></td>
<td class="num">(3,544)<span></span>
</td>
<td class="num">(20,492)<span></span>
</td>
<td class="num">(11,244)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="nump">874,569<span></span>
</td>
<td class="nump">769,525<span></span>
</td>
<td class="nump">714,085<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_DividendsPayableMember', window );">Dividends Payable [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Payments of principal</a></td>
<td class="num">(18,750)<span></span>
</td>
<td class="num">(19,736)<span></span>
</td>
<td class="num">(18,648)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Payments of interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Addition</a></td>
<td class="nump">R$ 18,750<span></span>
</td>
<td class="nump">R$ 19,736<span></span>
</td>
<td class="nump">R$ 18,648<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase through interest on liabilities arising from financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 44B<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_44B_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from obtaining or losing control of subsidiaries or other businesses. [Refer: Liabilities arising from financing activities; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 44B<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_44B_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 44B<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_44B_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 44B<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_44B&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 44D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_LoansAndFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_LoansAndFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_DividendsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_DividendsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639607171312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Details Narrative)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 02, 2023 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Apr. 05, 2022 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Mar. 23, 2022 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Mar. 04, 2022 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Nov. 05, 2021 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Oct. 02, 2021 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Aug. 04, 2021 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>May 13, 2021 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Apr. 08, 2021 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Nov. 09, 2020 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>May 05, 2020 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>May 09, 2019 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Feb. 01, 2023 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>BRL (R$) </div>
<div>Number</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Feb. 29, 2024 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>May 23, 2022 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Feb. 29, 2020 </div>
<div>BRL (R$)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed', window );">Amount recognized lease expense from short-term leases and low-value assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 10,871<span></span>
</td>
<td class="nump">R$ 12,153<span></span>
</td>
<td class="nump">R$ 11,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Adjustment for purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,399<span></span>
</td>
<td class="nump">R$ 1,234,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CreditExposure', window );">Exposure risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 23,173<span></span>
</td>
<td class="nump">R$ 24,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SensitivityChangeInTheEuroExchangeRate', window );">Percentage of sensitivity change in the Euro exchange rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Closing foreign exchange rate | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.8413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member] | Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Closing foreign exchange rate | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember', window );">Institutode Pesquisae Ensino Medicodo Estadode Minas Gerais Ltda [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 45,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_EqualInstallmentsPayablesToRelatedParties1', window );">Equal installments payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 9,061<span></span>
</td>
<td class="nump">R$ 9,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 9,061<span></span>
</td>
<td class="nump">R$ 9,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 9,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember', window );">Uni Redentor [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_EqualInstallmentsPayablesToRelatedParties', window );">Equal installments payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 4,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember', window );">Uni S L [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 60,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_EqualInstallmentsPayablesToRelatedParties', window );">Equal installments payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 7,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember', window );">FCMPB [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 188,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember', window );">Medical Harbour [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember', window );">Shosp [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Transaction price allocated to remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember', window );">Unigranrio [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPayablesForPurchaseOfEnergy', window );">Non-current payables for purchase of energy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 618,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember', window );">RXPRO [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Transaction price allocated to remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ITPACGaranhunsMember', window );">I T P A C Garanhuns [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Transaction price allocated to remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember', window );">Alem Da Medicina [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 19,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_EqualInstallmentsPayablesToRelatedParties', window );">Equal installments payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">Consideration to be transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardioPapersMember', window );">Cardio Papers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_EqualInstallmentsPayablesToRelatedParties', window );">Equal installments payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">Consideration to be transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">R$ (333)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GlicMember', window );">Glic [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingBalancePaid', window );">Remaining balance paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">Consideration to be transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember', window );">Del Rey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Transaction price allocated to remaining performance obligations</a></td>
<td class="nump">R$ 575,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPayablesForPurchaseOfEnergy', window );">Non-current payables for purchase of energy</a></td>
<td class="nump">816,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">Consideration to be transferred</a></td>
<td class="nump">234,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Adjustment for purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FirstAnnualInstallmentsPayable', window );">First annual installment</a></td>
<td class="nump">134,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SecondAnnualInstallmentsPayable', window );">Second annual installment</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ThirdAnnualInstallmentsPayable', window );">Third annual installment</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AcquisitiondateFairValueOfTotalConsiderationTransferred1', window );">Fair value at the date of acquisition</a></td>
<td class="nump">R$ 7,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ContractualLeaseTerm', window );">Contractual lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ContractualLeaseTerm', window );">Contractual lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AcquisitiondateFairValueOfTotalConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AcquisitiondateFairValueOfTotalConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ConsiderationToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ConsiderationToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ContractualLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ContractualLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_EqualInstallmentsPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equal installments payables due to related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_EqualInstallmentsPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_EqualInstallmentsPayablesToRelatedParties1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_EqualInstallmentsPayablesToRelatedParties1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FirstAnnualInstallmentsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FirstAnnualInstallmentsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RemainingBalancePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RemainingBalancePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RemainingTradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining amount of payables due to related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RemainingTradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SecondAnnualInstallmentsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SecondAnnualInstallmentsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SensitivityChangeInTheEuroExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Information about percentage of sensitivity change in the euro exchange rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SensitivityChangeInTheEuroExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ThirdAnnualInstallmentsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ThirdAnnualInstallmentsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClosingForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClosingForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsiderationPaidReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 40<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_40_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsiderationPaidReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CreditExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exposure to loss resulting from credit risk. [Refer: Credit risk [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 36<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_36_c&amp;doctype=Standard&amp;book=b<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph IG24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_IG24_b&amp;doctype=Implementation%20Guidance&amp;book=b<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph IG25<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_IG25_a&amp;doctype=Implementation%20Guidance&amp;book=b<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CreditExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the expense relating to leases of low-value assets accounted for applying paragraph 6 of IFRS 16. This expense shall not include the expense relating to short-term leases of low-value assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPayablesForPurchaseOfEnergy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current payables for the purchase of energy. [Refer: Payables for purchase of energy]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPayablesForPurchaseOfEnergy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 12<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_12_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ITPACGaranhunsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ITPACGaranhunsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardioPapersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardioPapersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GlicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GlicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639635436496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair value measurement (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentTradeReceivables', window );">Trade receivable (non-current)</a></td>
<td class="nump">R$ 39,485<span></span>
</td>
<td class="nump">R$ 42,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancingLiabilities', window );">Loans and financing</a></td>
<td class="num">(1,795,752)<span></span>
</td>
<td class="num">(1,934,295)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LeaseLiabilities1', window );">Lease liabilities</a></td>
<td class="num">(874,569)<span></span>
</td>
<td class="num">(769,525)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TradeAndOtherPayablesToRelatedPartiesLiabilities', window );">Accounts payable to selling shareholders</a></td>
<td class="num">(566,867)<span></span>
</td>
<td class="num">(528,678)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FairValueNotesPayables1', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62,176)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level 2 of fair value hierarchy [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentTradeReceivables', window );">Trade receivable (non-current)</a></td>
<td class="nump">39,485<span></span>
</td>
<td class="nump">42,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancingLiabilities', window );">Loans and financing</a></td>
<td class="num">(1,795,752)<span></span>
</td>
<td class="num">(1,934,295)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LeaseLiabilities1', window );">Lease liabilities</a></td>
<td class="num">(874,569)<span></span>
</td>
<td class="num">(769,525)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TradeAndOtherPayablesToRelatedPartiesLiabilities', window );">Accounts payable to selling shareholders</a></td>
<td class="num">(566,867)<span></span>
</td>
<td class="num">(528,678)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FairValueNotesPayables1', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62,176)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level 3 of fair value hierarchy [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentTradeReceivables', window );">Trade receivable (non-current)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember', window );">Not measured at fair value in statement of financial position but for which fair value is disclosed [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentTradeReceivables', window );">Trade receivable (non-current)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FairValueNotesPayables1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FairValueNotesPayables1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilities1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilities1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeAndOtherPayablesToRelatedPartiesLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeAndOtherPayablesToRelatedPartiesLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639611929232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Details) - Incremental Stock Options [Member]<br> R$ / shares in Units, R$ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>BRL (R$) </div>
<div>R$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember', window );">Modified Plan [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted', window );">Strike price at the measurement date | R$</a></td>
<td class="nump">R$ 83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted', window );">Share price at the measurement date</a></td>
<td class="nump">R$ 48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted', window );">Model used</a></td>
<td class="text">Binomial<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne', window );">Weighted average fair value at the measurement date</a></td>
<td class="nump">R$ 53.06<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember', window );">Modified Plan [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">48.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpectedLifeOfStockOptions', window );">Expected life of stock options</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember', window );">Modified Plan [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">59.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpectedLifeOfStockOptions', window );">Expected life of stock options</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember', window );">Original Plan [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted', window );">Share price at the measurement date</a></td>
<td class="nump">R$ 48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted', window );">Model used</a></td>
<td class="text">Binomial<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne', window );">Weighted average fair value at the measurement date</a></td>
<td class="nump">R$ 49.22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember', window );">Original Plan [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted', window );">Strike price at the measurement date | R$</a></td>
<td class="nump">R$ 91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">48.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpectedLifeOfStockOptions', window );">Expected life of stock options</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember', window );">Original Plan [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted', window );">Strike price at the measurement date | R$</a></td>
<td class="nump">R$ 140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">59.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpectedLifeOfStockOptions', window );">Expected life of stock options</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ExpectedLifeOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ExpectedLifeOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_StrikePriceeAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the option pricing model used for share options granted. [Refer: Option pricing model [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=afya_IncrementalStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=afya_IncrementalStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639609125072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Details 1) - Modified Plan [member] - R S Us [Member]<br> R$ / shares in Units, R$ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>BRL (R$) </div>
<div>R$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted', window );">Share price at the measurement date | R$ / shares</a></td>
<td class="nump">R$ 75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted', window );">Model used</a></td>
<td class="text">Binomial<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne', window );">Weighted average fair value at the measurement date | R$ / shares</a></td>
<td class="nump">R$ 0.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted', window );">Strike price at the measurement date | R$</a></td>
<td class="nump">R$ 95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">45.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpectedLifeOfStockOptions', window );">Expected life of stock options</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted', window );">Strike price at the measurement date | R$</a></td>
<td class="nump">R$ 160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">48.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpectedLifeOfStockOptions', window );">Expected life of stock options</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ExpectedLifeOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ExpectedLifeOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_StrikePriceeAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the option pricing model used for share options granted. [Refer: Option pricing model [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=afya_RSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=afya_RSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639636875376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Details 2)<br> R$ / shares in Units, R$ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>BRL (R$) </div>
<div>R$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember', window );">Modified Plan [member] | I P C A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpectedLifeOfStockOptions', window );">Expected life of stock options</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted', window );">Share price at the measurement date | R$ / shares</a></td>
<td class="nump">R$ 75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted', window );">Model used</a></td>
<td class="text">Binomial<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne', window );">Weighted average fair value at the measurement date | R$ / shares</a></td>
<td class="nump">R$ 28.10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember', window );">Modified Plan [member] | Bottom of range [member] | I P C A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted', window );">Strike price at the measurement date | R$</a></td>
<td class="nump">R$ 59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">45.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember', window );">Modified Plan [member] | Top of range [member] | I P C A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted', window );">Strike price at the measurement date | R$</a></td>
<td class="nump">R$ 104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">54.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember', window );">Original Plan [member] | C D I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpectedLifeOfStockOptions', window );">Expected life of stock options</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted', window );">Share price at the measurement date | R$ / shares</a></td>
<td class="nump">R$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted', window );">Model used</a></td>
<td class="text">Binomial<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne', window );">Weighted average fair value at the measurement date | R$ / shares</a></td>
<td class="nump">R$ 26.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember', window );">Original Plan [member] | Bottom of range [member] | C D I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted', window );">Strike price at the measurement date | R$</a></td>
<td class="nump">R$ 59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">45.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember', window );">Original Plan [member] | Top of range [member] | C D I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted', window );">Strike price at the measurement date | R$</a></td>
<td class="nump">R$ 104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">54.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ExpectedLifeOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ExpectedLifeOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_StrikePriceeAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the option pricing model used for share options granted. [Refer: Option pricing model [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=afya_IPCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=afya_IPCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=afya_CDIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=afya_CDIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639646595152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Labor and social obligations (Details 3) - Share options [member] - BRL (R$)<br> R$ / shares in Units, R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 01, 2023</div></th>
<th class="th"><div>Oct. 01, 2023</div></th>
<th class="th"><div>Aug. 01, 2023</div></th>
<th class="th"><div>Apr. 17, 2023</div></th>
<th class="th"><div>Feb. 13, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_StrikePriceeAtMeasurementDateShareOptionsGrante', window );">Strike price at the measurement date</a></td>
<td class="nump">R$ 60<span></span>
</td>
<td class="nump">R$ 59<span></span>
</td>
<td class="nump">R$ 59<span></span>
</td>
<td class="nump">R$ 57<span></span>
</td>
<td class="nump">R$ 56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted', window );">Share price at the measurement date</a></td>
<td class="nump">R$ 100.97<span></span>
</td>
<td class="nump">R$ 79.12<span></span>
</td>
<td class="nump">R$ 76.45<span></span>
</td>
<td class="nump">R$ 62.51<span></span>
</td>
<td class="nump">R$ 70.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted', window );">Model used</a></td>
<td class="text">Binomial<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne', window );">Weighted average fair value at the measurement date</a></td>
<td class="nump">R$ 54.25<span></span>
</td>
<td class="nump">R$ 38.67<span></span>
</td>
<td class="nump">R$ 37.04<span></span>
</td>
<td class="nump">R$ 32.04<span></span>
</td>
<td class="nump">R$ 29.54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ShareOptionsMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpectedLifeOfStockOptions', window );">Expected life of stock options</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ShareOptionsMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">56.00%<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpectedLifeOfStockOptions', window );">Expected life of stock options</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ExpectedLifeOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ExpectedLifeOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_StrikePriceeAtMeasurementDateShareOptionsGrante">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_StrikePriceeAtMeasurementDateShareOptionsGrante</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the option pricing model used for share options granted. [Refer: Option pricing model [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639609620656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Details 4) - Share options [member]<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Number </div>
<div>R$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Number </div>
<div>R$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Number </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price (in Reais), Outstanding at the beginning</a></td>
<td class="nump">R$ 79.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of stock options, Outstanding at the beginning | Number</a></td>
<td class="nump">3,729,287<span></span>
</td>
<td class="nump">3,086,728<span></span>
</td>
<td class="nump">2,510,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price (in Reais), Granted</a></td>
<td class="nump">R$ 60.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of stock options, Granted | Number</a></td>
<td class="nump">467,000<span></span>
</td>
<td class="nump">1,234,919<span></span>
</td>
<td class="nump">1,170,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price (in Reais), Exercised</a></td>
<td class="nump">R$ 59.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of stock options, Exercised | Number</a></td>
<td class="num">(164,214)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(442,669)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price (in Reais), Stock options exchanged</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement', window );">Number of stock options, Stock options exchanged | Number</a></td>
<td class="num">(1,751,599)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price (in Reais), Forfeited</a></td>
<td class="nump">R$ 110.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Number of stock options, Forfeited | Number</a></td>
<td class="num">(333,111)<span></span>
</td>
<td class="num">(365,749)<span></span>
</td>
<td class="num">(60,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019', window );">Weighted average exercise price (in Reais), Expired</a></td>
<td class="nump">R$ 94.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement', window );">Number of stock options, Expired | Number</a></td>
<td class="num">(251,299)<span></span>
</td>
<td class="num">(226,611)<span></span>
</td>
<td class="num">(91,586)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price (in Reais), Outstanding at the ending</a></td>
<td class="nump">R$ 64.33<span></span>
</td>
<td class="nump">R$ 79.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of stock options, Outstanding at the ending | Number</a></td>
<td class="nump">1,696,064<span></span>
</td>
<td class="nump">3,729,287<span></span>
</td>
<td class="nump">3,086,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Weighted average exercise price (in Reais), Exercisable</a></td>
<td class="nump">R$ 86.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfStockOptionsExercisable', window );">Number of stock options, Exercisable | shares</a></td>
<td class="nump">242,235<span></span>
</td>
<td class="nump">1,133,774<span></span>
</td>
<td class="nump">542,061<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfStockOptionsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfStockOptionsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639637395088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Details 5) - Restricted stock units [member] - Number<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of stock options, Outstanding at the beginning</a></td>
<td class="nump">447,224<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of stock options, Granted</a></td>
<td class="nump">317,090<span></span>
</td>
<td class="nump">447,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement', window );">Number of stock options, Stock options exchanged</a></td>
<td class="nump">215,797<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of stock options, Exercised</a></td>
<td class="num">(99,576)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Number of stock options, Forfeited</a></td>
<td class="num">(26,104)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of stock options, Outstanding at the ending</a></td>
<td class="nump">854,431<span></span>
</td>
<td class="nump">447,224<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639633681600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Details Narrative)<br> R$ / shares in Units, R$ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 01, 2023 </div>
<div>Number </div>
<div>R$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 01, 2023 </div>
<div>Number </div>
<div>R$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 01, 2023 </div>
<div>Number </div>
<div>R$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 17, 2023 </div>
<div>Number </div>
<div>R$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 13, 2023 </div>
<div>Number</div>
</th>
<th class="th">
<div>Feb. 02, 2023 </div>
<div>R$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 08, 2022 </div>
<div>R$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>R$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>R$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 29, 2020 </div>
<div>R$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>BRL (R$) </div>
<div>Number </div>
<div>R$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>BRL (R$) </div>
<div>Number</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>BRL (R$)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ShareBasedCompensationOfEmployees', window );">Compensation of employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 22,185<span></span>
</td>
<td class="nump">R$ 24,248<span></span>
</td>
<td class="nump">R$ 25,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_StrikePrice', window );">Strike price | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 71.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 71.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AverageIncrementalFairValue', window );">Average incremental fair value | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 3.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement', window );">Granted | shares</a></td>
<td class="nump">76,600<span></span>
</td>
<td class="nump">63,000<span></span>
</td>
<td class="nump">153,490<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,678<span></span>
</td>
<td class="nump">442,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Fair values at grant date | R$ / shares</a></td>
<td class="nump">R$ 100.97<span></span>
</td>
<td class="nump">R$ 79.12<span></span>
</td>
<td class="nump">R$ 76.45<span></span>
</td>
<td class="nump">R$ 62.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 70.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 72.59<span></span>
</td>
<td class="nump">R$ 48.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SocialObligationsLiabilities', window );">social obligations liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 7,171<span></span>
</td>
<td class="nump">2,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_ShareBasedCompensationPlansMember', window );">Share based compensation plans [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 20,850<span></span>
</td>
<td class="nump">R$ 27,242<span></span>
</td>
<td class="nump">R$ 43,377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_RestrictedStockUnitsMember', window );">Restricted stock units [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of stock option granted | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">317,090<span></span>
</td>
<td class="nump">447,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 10,685<span></span>
</td>
<td class="nump">R$ 4,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OptionsGrantedMember', window );">Options Granted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of stock option granted | Number</a></td>
<td class="nump">232,000<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="nump">153,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnitsMember', window );">Restricted stock units [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits1Member', window );">Restricted stock units 1 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits2Member', window );">Restricted stock units 2 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits3Member', window );">Restricted stock units 3 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AverageIncrementalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AverageIncrementalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ShareBasedCompensationOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ShareBasedCompensationOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SocialObligationsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SocialObligationsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_StrikePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_StrikePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_ShareBasedCompensationPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_ShareBasedCompensationPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OptionsGrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OptionsGrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639635825584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details) - R$ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureEquityAbstract', window );"><strong>Disclosure Equity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares, Outstanding, at beginning balance</a></td>
<td class="nump">3,786,285<span></span>
</td>
<td class="nump">1,654,927<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Average price, at beginning balance</a></td>
<td class="nump">R$ 80.54<span></span>
</td>
<td class="nump">R$ 92.23<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfSharesRepurchased', window );">Number of shares, Repurchased</a></td>
<td class="nump">216,339<span></span>
</td>
<td class="nump">2,131,358<span></span>
</td>
<td class="nump">2,142,051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AveragePriceRepurchased', window );">Average price repurchased</a></td>
<td class="nump">R$ 57.17<span></span>
</td>
<td class="nump">R$ 71.46<span></span>
</td>
<td class="nump">R$ 119.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan', window );">Number of treasury shares, delivered under the share-based compensation plan</a></td>
<td class="num">(229,146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AveragePriceDeliveredUnderSharebasedCompensationPlan', window );">Average price, delivered under the share-based compensation plan</a></td>
<td class="nump">R$ 79.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TransferredFromExerciseOfStockOptions', window );">Number of shares, Transferred from exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(442,669)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AveragePriceTransferredFromExerciseOfStockOptions', window );">Average price transferred from exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 124.26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TransferredFromSharesContribution', window );">Number of shares, Transferred from shares contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,455)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AveragePriceTransferredFromSharesContribution', window );">Average price transferred from shares contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 111.94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares, Outstanding, at ending balance</a></td>
<td class="nump">3,773,478<span></span>
</td>
<td class="nump">3,786,285<span></span>
</td>
<td class="nump">1,654,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Average price, at ending balance</a></td>
<td class="nump">R$ 79.28<span></span>
</td>
<td class="nump">R$ 80.54<span></span>
</td>
<td class="nump">R$ 92.23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AveragePriceDeliveredUnderSharebasedCompensationPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AveragePriceDeliveredUnderSharebasedCompensationPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AveragePriceRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AveragePriceRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AveragePriceTransferredFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AveragePriceTransferredFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AveragePriceTransferredFromSharesContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AveragePriceTransferredFromSharesContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TransferredFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TransferredFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TransferredFromSharesContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TransferredFromSharesContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639636676800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 24, 2023</div></th>
<th class="th"><div>Jan. 27, 2022</div></th>
<th class="th"><div>Oct. 27, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">R$ 17<span></span>
</td>
<td class="nump">R$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfSharesIssued1', window );">Total number of shares</a></td>
<td class="nump">93,722,831<span></span>
</td>
<td class="nump">93,722,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IssuedCapitals', window );">Authorized capital</a></td>
<td class="nump">R$ 50<span></span>
</td>
<td class="nump">R$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PaymentOfDividends', window );">Payment of dividends</a></td>
<td class="nump">65,539<span></span>
</td>
<td class="nump">66,828<span></span>
</td>
<td class="nump">R$ 65,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DividendDistributed', window );">Dividend distributed</a></td>
<td class="nump">46,788<span></span>
</td>
<td class="nump">47,092<span></span>
</td>
<td class="nump">46,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidToNoncontrollingInterests', window );">Dividends paid to non-controlling interests</a></td>
<td class="nump">18,750<span></span>
</td>
<td class="nump">19,736<span></span>
</td>
<td class="nump">18,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashOutflow', window );">Cash outflow</a></td>
<td class="nump">R$ 12,369<span></span>
</td>
<td class="nump">R$ 152,317<span></span>
</td>
<td class="nump">R$ 213,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember', window );">Class A Ordinary Shares [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Total number of shares</a></td>
<td class="nump">47,920,068<span></span>
</td>
<td class="nump">47,920,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RepurchaseOfOrdinaryShares', window );">Repurchase of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">1,874,457<span></span>
</td>
<td class="nump">1,383,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember', window );">Class B Ordinary Shares [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Total number of shares</a></td>
<td class="nump">45,802,763<span></span>
</td>
<td class="nump">45,802,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CashOutflow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CashOutflow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DividendDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DividendDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IssuedCapitals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IssuedCapitals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaymentOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaymentOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RepurchaseOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RepurchaseOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends paid to non-controlling interests. [Refer: Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639610138320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (EPS) (Details) - BRL (R$)<br> R$ / shares in Units, R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumeratorAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends', window );">Net income attributable to equity holders of the parent</a></td>
<td class="nump">R$ 386,324<span></span>
</td>
<td class="nump">R$ 373,569<span></span>
</td>
<td class="nump">R$ 223,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DenominatorAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average number of outstanding shares</a></td>
<td class="nump">89,830,351<span></span>
</td>
<td class="nump">90,335,037<span></span>
</td>
<td class="nump">93,291,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares', window );">Effects of dilution from stock options and restricted share units</a></td>
<td class="nump">706,492<span></span>
</td>
<td class="nump">329,085<span></span>
</td>
<td class="nump">811,818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average number of outstanding shares adjusted for the effect of dilution</a></td>
<td class="nump">90,536,843<span></span>
</td>
<td class="nump">90,664,122<span></span>
</td>
<td class="nump">94,103,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic earnings per share (R$)</a></td>
<td class="nump">R$ 4.30<span></span>
</td>
<td class="nump">R$ 4.14<span></span>
</td>
<td class="nump">R$ 2.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted earnings per share (R$)</a></td>
<td class="nump">R$ 4.27<span></span>
</td>
<td class="nump">R$ 4.12<span></span>
</td>
<td class="nump">R$ 2.37<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to profit (loss) for non-participating preference share dividends to calculate profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Preference shares [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Section Example 12 Calculation and presentation of basic and diluted earnings per share (comprehensive example)<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS33_ex12_TI<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The potential dilutive effect on the weighted average number of ordinary shares that relate to the assumed exercise of the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639632472448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ProfessionalFeesExpenses', window );">Tuition fees</a></td>
<td class="nump">R$ 3,505,250<span></span>
</td>
<td class="nump">R$ 2,827,567<span></span>
</td>
<td class="nump">R$ 2,124,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherRevenue1', window );">Other</a></td>
<td class="nump">263,937<span></span>
</td>
<td class="nump">213,040<span></span>
</td>
<td class="nump">167,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeductionAbstract', window );"><strong>Deductions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeductionOfGrantedDiscounts', window );">&#160;&#160;Discount and scholarships</a></td>
<td class="num">(240,314)<span></span>
</td>
<td class="num">(241,404)<span></span>
</td>
<td class="num">(229,254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeductionOfEarlyPaymentDiscounts', window );">&#160;&#160;Early payment discounts</a></td>
<td class="num">(195,054)<span></span>
</td>
<td class="num">(92,234)<span></span>
</td>
<td class="num">(49,879)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeductionOfReturnsOfNetRevenue', window );">&#160;&#160;Returns</a></td>
<td class="num">(27,743)<span></span>
</td>
<td class="num">(45,402)<span></span>
</td>
<td class="num">(42,373)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeductionOfTaxes', window );">&#160;&#160;Taxes</a></td>
<td class="num">(142,825)<span></span>
</td>
<td class="num">(107,004)<span></span>
</td>
<td class="num">(74,232)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeductionOfProuni', window );">&#160;&#160;PROUNI</a></td>
<td class="num">(287,338)<span></span>
</td>
<td class="num">(225,506)<span></span>
</td>
<td class="num">(176,921)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">2,875,913<span></span>
</td>
<td class="nump">2,329,057<span></span>
</td>
<td class="nump">1,719,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Tuition, digital content and app subscription fees - Transferred over time</a></td>
<td class="nump">2,821,251<span></span>
</td>
<td class="nump">2,273,578<span></span>
</td>
<td class="nump">1,640,889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Other - Transferred at a point in time</a></td>
<td class="nump">R$ 54,662<span></span>
</td>
<td class="nump">R$ 55,479<span></span>
</td>
<td class="nump">R$ 78,482<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfEarlyPaymentDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfEarlyPaymentDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfGrantedDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfGrantedDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfProuni">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfProuni</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfReturnsOfNetRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfReturnsOfNetRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NetRevenueOtherTransferredPoint">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NetRevenueOtherTransferredPoint</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherRevenue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherRevenue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProfessionalFeesExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProfessionalFeesExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FeeAndCommissionIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income relating to fees and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FeeAndCommissionIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639633434768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="nump">R$ 2,875,913<span></span>
</td>
<td class="nump">R$ 2,329,057<span></span>
</td>
<td class="nump">R$ 1,719,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="nump">2,640,598<span></span>
</td>
<td class="nump">2,131,776<span></span>
</td>
<td class="nump">1,559,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="nump">235,315<span></span>
</td>
<td class="nump">197,281<span></span>
</td>
<td class="nump">160,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="nump">2,875,913<span></span>
</td>
<td class="nump">2,329,057<span></span>
</td>
<td class="nump">1,719,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="nump">2,821,251<span></span>
</td>
<td class="nump">2,273,578<span></span>
</td>
<td class="nump">1,640,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="nump">54,662<span></span>
</td>
<td class="nump">55,479<span></span>
</td>
<td class="nump">78,482<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_UndergradMember', window );">Undergrad [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="nump">2,511,018<span></span>
</td>
<td class="nump">2,037,889<span></span>
</td>
<td class="nump">1,498,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="nump">2,494,121<span></span>
</td>
<td class="nump">2,023,128<span></span>
</td>
<td class="nump">1,486,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="nump">16,897<span></span>
</td>
<td class="nump">14,761<span></span>
</td>
<td class="nump">12,297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="nump">2,511,018<span></span>
</td>
<td class="nump">2,037,889<span></span>
</td>
<td class="nump">1,498,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="nump">2,494,121<span></span>
</td>
<td class="nump">2,024,373<span></span>
</td>
<td class="nump">1,486,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="nump">16,897<span></span>
</td>
<td class="nump">13,516<span></span>
</td>
<td class="nump">12,297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_ContinuingEducationMember', window );">Continuing Education [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="nump">146,827<span></span>
</td>
<td class="nump">108,806<span></span>
</td>
<td class="nump">72,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="nump">146,477<span></span>
</td>
<td class="nump">108,648<span></span>
</td>
<td class="nump">72,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="nump">146,827<span></span>
</td>
<td class="nump">108,806<span></span>
</td>
<td class="nump">72,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="nump">146,827<span></span>
</td>
<td class="nump">108,806<span></span>
</td>
<td class="nump">72,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_DigitalServicesMember', window );">Digital Services [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="nump">229,285<span></span>
</td>
<td class="nump">189,984<span></span>
</td>
<td class="nump">151,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="nump">229,285<span></span>
</td>
<td class="nump">189,984<span></span>
</td>
<td class="nump">151,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="nump">229,285<span></span>
</td>
<td class="nump">189,984<span></span>
</td>
<td class="nump">151,958<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="nump">191,520<span></span>
</td>
<td class="nump">145,939<span></span>
</td>
<td class="nump">81,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="nump">37,765<span></span>
</td>
<td class="nump">44,045<span></span>
</td>
<td class="nump">70,163<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_EliminationInterSegmentTransactionsMember', window );">Elimination (inter-segment transactions) [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="num">(11,217)<span></span>
</td>
<td class="num">(7,622)<span></span>
</td>
<td class="num">(3,978)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="num">(11,217)<span></span>
</td>
<td class="num">(7,622)<span></span>
</td>
<td class="num">(3,978)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="num">(11,217)<span></span>
</td>
<td class="num">(7,622)<span></span>
</td>
<td class="num">(3,978)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="num">(11,217)<span></span>
</td>
<td class="num">(5,540)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="text"> <span></span>
</td>
<td class="num">R$ (2,082)<span></span>
</td>
<td class="num">R$ (3,978)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NetRevenueOtherTransferredPoint">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NetRevenueOtherTransferredPoint</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TimingRevenueRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TimingRevenueRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FeeAndCommissionIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income relating to fees and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FeeAndCommissionIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to suppliers for goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 14<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_14_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsToSuppliersForGoodsAndServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_UndergradMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_UndergradMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_ContinuingEducationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_ContinuingEducationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_DigitalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_DigitalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_EliminationInterSegmentTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_EliminationInterSegmentTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639611853008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Expenses and costs by nature (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="num">R$ (1,109,813)<span></span>
</td>
<td class="num">R$ (859,552)<span></span>
</td>
<td class="num">R$ (652,300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="num">(1,014,684)<span></span>
</td>
<td class="num">(798,153)<span></span>
</td>
<td class="num">(622,615)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseByNature', window );">Total</a></td>
<td class="num">(2,124,497)<span></span>
</td>
<td class="num">(1,657,705)<span></span>
</td>
<td class="num">(1,274,915)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Payroll', window );">Payroll</a></td>
<td class="num">(1,085,144)<span></span>
</td>
<td class="num">(880,664)<span></span>
</td>
<td class="num">(677,564)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_HospitalAndMedicalAgreements', window );">Hospital and medical agreements</a></td>
<td class="num">(86,151)<span></span>
</td>
<td class="num">(66,065)<span></span>
</td>
<td class="num">(37,449)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation and amortization</a></td>
<td class="num">(289,511)<span></span>
</td>
<td class="num">(206,220)<span></span>
</td>
<td class="num">(154,220)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LeaseExpenses', window );">Lease expenses</a></td>
<td class="num">(10,871)<span></span>
</td>
<td class="num">(12,153)<span></span>
</td>
<td class="num">(11,229)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UtilitiesExpense', window );">Utilities</a></td>
<td class="num">(20,403)<span></span>
</td>
<td class="num">(17,682)<span></span>
</td>
<td class="num">(10,643)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepairsAndMaintenanceExpense', window );">Maintenance</a></td>
<td class="num">(105,919)<span></span>
</td>
<td class="num">(76,475)<span></span>
</td>
<td class="num">(47,141)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SharesBasedCompensation', window );">Share-based compensation</a></td>
<td class="num">(31,535)<span></span>
</td>
<td class="num">(31,274)<span></span>
</td>
<td class="num">(43,377)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TaxExpenses', window );">Tax expenses</a></td>
<td class="num">(14,447)<span></span>
</td>
<td class="num">(10,518)<span></span>
</td>
<td class="num">(7,997)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ServicesExpense', window );">Pedagogical services</a></td>
<td class="num">(64,081)<span></span>
</td>
<td class="num">(48,084)<span></span>
</td>
<td class="num">(47,881)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="num">(74,140)<span></span>
</td>
<td class="num">(48,217)<span></span>
</td>
<td class="num">(39,506)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceForExpectedCreditLosses', window );">Allowance for expected credit losses</a></td>
<td class="num">(74,552)<span></span>
</td>
<td class="num">(42,708)<span></span>
</td>
<td class="num">(47,819)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TravelExpense', window );">Travel expenses</a></td>
<td class="num">(16,098)<span></span>
</td>
<td class="num">(14,003)<span></span>
</td>
<td class="num">(7,542)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsultingFees', window );">Consulting fees</a></td>
<td class="num">(62,630)<span></span>
</td>
<td class="num">(35,326)<span></span>
</td>
<td class="num">(38,818)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Other', window );">Other</a></td>
<td class="num">(189,015)<span></span>
</td>
<td class="num">(168,316)<span></span>
</td>
<td class="num">(103,729)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpenseByNatureOne', window );">Total</a></td>
<td class="num">R$ (2,124,497)<span></span>
</td>
<td class="num">R$ (1,657,705)<span></span>
</td>
<td class="num">R$ (1,274,915)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForExpectedCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForExpectedCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ConsultingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ConsultingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ExpenseByNatureOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ExpenseByNatureOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_HospitalAndMedicalAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_HospitalAndMedicalAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Other">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Other</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Payroll">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Payroll</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharesBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharesBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepairsAndMaintenanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepairsAndMaintenanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to the marketing and selling of goods or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ServicesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ServicesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TravelExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from travel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TravelExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UtilitiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from purchased utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UtilitiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639633871472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance result (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentIncome', window );">Income from financial investments</a></td>
<td class="nump">R$ 73,672<span></span>
</td>
<td class="nump">R$ 67,810<span></span>
</td>
<td class="nump">R$ 35,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromInterest', window );">Interest received</a></td>
<td class="nump">33,450<span></span>
</td>
<td class="nump">27,197<span></span>
</td>
<td class="nump">23,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncome', window );">Other</a></td>
<td class="nump">3,520<span></span>
</td>
<td class="nump">7,035<span></span>
</td>
<td class="nump">5,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="nump">110,642<span></span>
</td>
<td class="nump">102,042<span></span>
</td>
<td class="nump">64,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterestExpense1', window );">Interest expense</a></td>
<td class="num">(285,447)<span></span>
</td>
<td class="num">(200,081)<span></span>
</td>
<td class="num">(108,437)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterestExpenseOnLeaseLiabilities1', window );">Interest expense on lease liabilities</a></td>
<td class="num">(100,849)<span></span>
</td>
<td class="num">(88,571)<span></span>
</td>
<td class="num">(67,212)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialDiscountsGrantedExpenses', window );">Financial discounts granted</a></td>
<td class="num">(30,891)<span></span>
</td>
<td class="num">(24,092)<span></span>
</td>
<td class="num">(23,193)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankAndSimilarCharges', window );">Bank fees</a></td>
<td class="num">(7,163)<span></span>
</td>
<td class="num">(8,623)<span></span>
</td>
<td class="num">(7,878)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeLoss', window );">Foreign exchange loss, net</a></td>
<td class="num">(681)<span></span>
</td>
<td class="num">(852)<span></span>
</td>
<td class="num">(17,973)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TaxOnFinancialOperations', window );">IOF taxes (taxes on financial transactions)</a></td>
<td class="num">(1,947)<span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="num">(3,306)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinanceCost', window );">Other</a></td>
<td class="num">(30,638)<span></span>
</td>
<td class="num">(27,496)<span></span>
</td>
<td class="num">(15,797)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Finance expenses</a></td>
<td class="num">(457,616)<span></span>
</td>
<td class="num">(349,893)<span></span>
</td>
<td class="num">(243,796)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinanceResult', window );">Finance result</a></td>
<td class="num">R$ (346,974)<span></span>
</td>
<td class="num">R$ (247,851)<span></span>
</td>
<td class="num">R$ (179,230)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinanceResult">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinanceResult</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialDiscountsGrantedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialDiscountsGrantedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InterestExpense1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InterestExpense1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InterestExpenseOnLeaseLiabilities1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InterestExpenseOnLeaseLiabilities1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxOnFinancialOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxOnFinancialOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BankAndSimilarCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of bank and similar charges recognised by the entity as an expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BankAndSimilarCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investment income, such as interest and dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2023-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of finance income that the entity does not separately disclose in the same statement or note. [Refer: Finance income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639634902640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureIncomeTaxesAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="nump">R$ 429,582<span></span>
</td>
<td class="nump">R$ 428,433<span></span>
</td>
<td class="nump">R$ 273,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Combined statutory income taxes rate - %</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Income taxes at statutory rates</a></td>
<td class="num">R$ (146,058)<span></span>
</td>
<td class="num">R$ (145,667)<span></span>
</td>
<td class="num">R$ (92,977)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReconciliationAdjustmentsAbstract', window );"><strong>Reconciliation adjustments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation', window );">Tax effect on loss from entities not subject to taxation</a></td>
<td class="num">(32,274)<span></span>
</td>
<td class="num">(32,859)<span></span>
</td>
<td class="num">(37,794)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ProgramaUniversidadeParaTodosFiscalIncentive', window );">PROUNI - Fiscal Incentive (i)</a></td>
<td class="nump">309,952<span></span>
</td>
<td class="nump">270,062<span></span>
</td>
<td class="nump">194,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_UnrecognisedDeferredTaxAssets', window );">Unrecognized deferred tax assets</a></td>
<td class="num">(154,062)<span></span>
</td>
<td class="num">(117,377)<span></span>
</td>
<td class="num">(86,233)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RecognisedDeferredTaxAssets', window );">Recognized deferred tax assets</a></td>
<td class="nump">3,233<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Presumed profit income tax regime effect (ii)</a></td>
<td class="num">(8,787)<span></span>
</td>
<td class="num">(1,549)<span></span>
</td>
<td class="num">(7,066)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PermanentAdjustments', window );">Permanent adjustments</a></td>
<td class="num">(4,687)<span></span>
</td>
<td class="num">(12,226)<span></span>
</td>
<td class="num">(6,232)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense', window );">Other</a></td>
<td class="nump">8,517<span></span>
</td>
<td class="nump">3,939<span></span>
</td>
<td class="nump">4,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Income taxes expense - current</a></td>
<td class="num">R$ (24,166)<span></span>
</td>
<td class="num">R$ (35,677)<span></span>
</td>
<td class="num">R$ (31,179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxRateEffectFromChangeInTaxRate', window );">Effective rate</a></td>
<td class="nump">5.62%<span></span>
</td>
<td class="nump">8.33%<span></span>
</td>
<td class="nump">11.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PermanentAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PermanentAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProgramaUniversidadeParaTodosFiscalIncentive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProgramaUniversidadeParaTodosFiscalIncentive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RecognisedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RecognisedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ReconciliationAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ReconciliationAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_UnrecognisedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_UnrecognisedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense exclusive of income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseOtherThanIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectFromChangeInTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from a change in tax rate. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectFromChangeInTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639632993776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Unrecognized deferred income tax assets</a></td>
<td class="nump">R$ 1,211,909<span></span>
</td>
<td class="nump">R$ 778,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_OneSubsidiaryMember', window );">One Subsidiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RecognizedDeferredTaxAssets', window );">Recognized deferred income tax assets</a></td>
<td class="nump">R$ 9,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RecognizedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RecognizedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_OneSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_OneSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639609908992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insurance contracts and contingencies (Details) - Legal proceedings contingent liability [member] - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of beginning of the year</a></td>
<td class="nump">R$ 195,854<span></span>
</td>
<td class="nump">R$ 148,287<span></span>
</td>
<td class="nump">R$ 53,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Business combinations</a></td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">18,336<span></span>
</td>
<td class="nump">73,909<span></span>
</td>
<td class="nump">24,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversals</a></td>
<td class="num">(109,981)<span></span>
</td>
<td class="num">(26,342)<span></span>
</td>
<td class="num">(9,848)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of ending of the year</a></td>
<td class="nump">104,361<span></span>
</td>
<td class="nump">195,854<span></span>
</td>
<td class="nump">148,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Labour [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of beginning of the year</a></td>
<td class="nump">22,484<span></span>
</td>
<td class="nump">25,490<span></span>
</td>
<td class="nump">4,519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Business combinations</a></td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">3,424<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="nump">5,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversals</a></td>
<td class="num">(3,251)<span></span>
</td>
<td class="num">(5,306)<span></span>
</td>
<td class="num">(1,044)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of ending of the year</a></td>
<td class="nump">22,721<span></span>
</td>
<td class="nump">22,484<span></span>
</td>
<td class="nump">25,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Civil [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of beginning of the year</a></td>
<td class="nump">24,664<span></span>
</td>
<td class="nump">22,928<span></span>
</td>
<td class="nump">13,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Business combinations</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">5,875<span></span>
</td>
<td class="nump">7,911<span></span>
</td>
<td class="nump">5,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversals</a></td>
<td class="num">(9,327)<span></span>
</td>
<td class="num">(6,175)<span></span>
</td>
<td class="num">(1,470)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of ending of the year</a></td>
<td class="nump">21,300<span></span>
</td>
<td class="nump">24,664<span></span>
</td>
<td class="nump">22,928<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Taxes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of beginning of the year</a></td>
<td class="nump">148,706<span></span>
</td>
<td class="nump">99,869<span></span>
</td>
<td class="nump">35,340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Business combinations</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">9,037<span></span>
</td>
<td class="nump">63,698<span></span>
</td>
<td class="nump">14,225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversals</a></td>
<td class="num">(97,403)<span></span>
</td>
<td class="num">(14,861)<span></span>
</td>
<td class="num">(7,334)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of ending of the year</a></td>
<td class="nump">R$ 60,340<span></span>
</td>
<td class="nump">R$ 148,706<span></span>
</td>
<td class="nump">R$ 99,869<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in other provisions resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2023-01-01<br> -Paragraph 84<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalProvisionsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additional other provisions made. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2023-01-01<br> -Paragraph 84<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_84_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalProvisionsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Provisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities of uncertain timing or amount, including provisions for employee benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Provisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnusedProvisionReversedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount reversed for unused other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2023-01-01<br> -Paragraph 84<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_84_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnusedProvisionReversedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_LabourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_LabourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_CivilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_CivilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_TaxesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_TaxesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639608901616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Insurance contracts and contingencies (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Total</a></td>
<td class="nump">R$ 89,671<span></span>
</td>
<td class="nump">R$ 78,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability [member] | Labour [Member] | Types Of Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Total</a></td>
<td class="nump">32,683<span></span>
</td>
<td class="nump">13,914<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability [member] | Civil [Member] | Types Of Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Total</a></td>
<td class="nump">51,319<span></span>
</td>
<td class="nump">59,603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability [member] | Taxes And Social Security [Member] | Types Of Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Total</a></td>
<td class="nump">R$ 5,669<span></span>
</td>
<td class="nump">R$ 4,931<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provisions other than provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2023-01-01<br> -Paragraph 84<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_84_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_LabourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_LabourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=afya_TypesOfRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=afya_TypesOfRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_CivilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_CivilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_TaxesAndSocialSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_TaxesAndSocialSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639636533904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Insurance contracts and contingencies (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_JudicialDeposits', window );">Judicial deposits</a></td>
<td class="nump">R$ 14,187<span></span>
</td>
<td class="nump">R$ 12,693<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=afya_OtherAssetsNonCurrentMember', window );">Other Assets Non Current [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_JudicialDeposits', window );">Judicial deposits</a></td>
<td class="nump">14,187<span></span>
</td>
<td class="nump">12,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ContingenciesCorrespondentAmount', window );">Contingencies correspondent amount</a></td>
<td class="nump">R$ 81,855<span></span>
</td>
<td class="nump">R$ 145,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ContingenciesCorrespondentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ContingenciesCorrespondentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_JudicialDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_JudicialDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=afya_OtherAssetsNonCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=afya_OtherAssetsNonCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639609694432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-cash transactions (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemeasurementOfEarnOut', window );">Remeasurement of earn-out of Alem da Medicina, CardioPapers</a></td>
<td class="nump">R$ 2,556<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets', window );">Provision for legal proceedings with corresponding indemnification asset</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">48,333<span></span>
</td>
<td class="nump">4,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities', window );">Additions and remeasurements of right-of-use assets and lease liabilities</a></td>
<td class="nump">77,715<span></span>
</td>
<td class="nump">100,873<span></span>
</td>
<td class="nump">158,651<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_IClinicMember', window );">I Clinic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Issuance of shares for acquisition</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">71,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_CliquefarmaMember', window );">Cliquefarma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Issuance of shares for acquisition</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_RXPROMember', window );">RXPRO [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Issuance of shares for acquisition</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">R$ 5,112<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RemeasurementOfEarnOut">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RemeasurementOfEarnOut</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_IClinicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_IClinicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_CliquefarmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_CliquefarmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_RXPROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_RXPROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140639605964816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent event (Details Narrative) - Faculdades Integradas Padrao [Member]<br> R$ in Thousands</strong></div></th>
<th class="th">
<div>Jan. 24, 2024 </div>
<div>BRL (R$) </div>
<div>Number</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PotentialAdditionalPayment', window );">Potential additional payment | R$</a></td>
<td class="nump">R$ 49,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TotalNumberOfSeatsApporved', window );">Total number of seats apporved | Number</a></td>
<td class="nump">3,203<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PotentialAdditionalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PotentialAdditionalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TotalNumberOfSeatsApporved">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TotalNumberOfSeatsApporved</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=afya_FaculdadesIntegradasPadraoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=afya_FaculdadesIntegradasPadraoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>155
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M$X5$@5(A)?J'S:0J])CY%PIUY<J#79F)Y$INV)S?C'1.)2^>^&CR\T^8.K]
M83JGL_A,S@Y"Z#4A]&S>)P_\B>=;#@6L,J1#AJ\0"0,_PF 9';=U2>3X 12.
MH[8XP)$;V K(;]C[5O93(949U":JR9R#0[3RX)<>S'KQ-+G V(E"0_QIGS,
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M1G$-5.!J0/I2"$=.U%W>0!@.NVL!!-.*>6#-)JVL(G99]7TS0>W,\HF_FQB
M#:JCMKO) MB=.FJ[FT"&!T"KS8A]<^J6R62.."MRG6/]8:[7&&GD&AB0LVY.
MG=5;?"YOAV%LU2"QJ\'[:FW.1&X)W]$M(^_2B&T@5"=88@\,R_$MKDLWLH6@
M58[$MU92G*1;LQ%]8BU99>AWU](YO<7G\G88R%:P$KM@/:F6Z/&*(-"^Y?04
M2PSOFA^UU+440"$8[YUQ9+Q8E6=%4I/<YJHZ%6B>-N=1[\I3F,[S6WP55Z=*
MK9OJD.LC*U9)+E'*E]JE<QGH'!;5N5%UH\2F/$F9":5$5EZN.=.+N@'H]TLA
MU.[&--"<WDW^ U!+ P04    " "AA)I85]YZ<,4(  !110  &    'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;+6<[V^C.!K'_Q64&YWNI.T$VSC 7%MI6GY*
M>ZM19V_OQ>E>4' :- ED@+0S__T:PH1@C('=9ZO1E"3/\WEL^,;&WSJY?<N+
M+^6.L4K[=MAGY=UJ5U7'#^MU&>_8(2K?YT>6\5>V>7&(*OZP>%F7QX)%29-T
MV*^QKF_6ARC-5O>WS7.?BOO;_%3MTXQ]*K3R=#A$Q?<'ML_?[E9H]>.)I_1E
M5]5/K.]OC]$+^\RJ_QP_%?S1^D))T@/+RC3/M()M[U8?T8<0VW5"$_%;RM[*
MJV.M[LISGG^I'X3)W4JO6\3V+*YJ1,1_O;)'MM_7)-Z.KRUT=:E9)UX?_Z![
M3>=Y9YZCDCWF^_^F2;6[6UDK+6';Z+2OGO*W@+4=HC4OSO=E\[_V=HXU>7!\
M*JO\T";S%AS2[/P[^M:>B*L$;(PDX#8!"PED,Y) V@0B5J C"4:;8 @)!AI)
MH&T"%2N8(PF;-F$C5K!'$LPVP10[/=8'JTVPA 0TEF"W"8V^UN?KUUQ\)ZJB
M^]LB?].*.IK3ZH-&04TVO^9I5HO]<U7P5U.>5]T_YEF9[],DJEBBE17_Q95<
ME5J^U>)=E+VP4DLSC7T]I=5W[49[>/I9^\?3NW]J3^_JYW_=Y:<RRI+R=EWQ
MQM3(==P6?C@7QB.%P[(\\9)Q=$RK:*_][\ .SZSXOP3TJ 9]3)*T?M]PR#%*
MDQO>K!E01PW]E0\<Y:GXKI6[J.#G0$%RU:0G5K+BE=4GM&'=U&_-A#?U^_E$
M*\C>%+GB@QEGL:C(TNQ%R?+5+/=\@:.J*M+G4Q4][YE6Y5K^EK&B$<.1-SVK
M5!4"=85?\NPFSK.JR/?\I1>NGHKQ,ZL^ ^'$5<KY5>ZGK;G^+V\"?'D3X(9C
MC' >V$N:U:>0CYO[*(O93]IKM#\Q?CXTA\7O-8)^TK".=9G,S^C-V$5ZIR%3
M)NK)-$PP,2Q+IEUE;^KI\4-YC&)VM^+S7Z.^U;TF4^YD&ZAN8D.FS,E,0S=M
M&\F$.-UQT\)8>JZ#Z08CNI%EAM-5+4),2U>HB5S41!H8&1O9MD7Y^<=(^C-_
M,>2'7.;UH=8<RZ3^0)9?U+__#6WT?\G4!0ES(&$N),R#A/F0L  2%@+!>FHV
M+FHVE&/C+_R&.\WB_,!DHE7FSA^)'H$X#A#'!>)X9PYM./6ZX_4>8T+PYG;]
M>BV]>6'!, Q9-C7[4:$$9F ^O%W">CJ@%QU0I0Z:N5;C.N ]WM6+'7Y/,ZX+
M)6N!+H X#A#'!>)X=)XNYH4%PS"9+B0PA2XV%UULE+IX;.^UN1;J>V:I&I2$
M!6K8#'I@&E37^_UT@*JY0!P/B.//ZGT 5"V<JM83BWD1BZD>1/K+*IE6E( %
M6@'B..;@/-Q@1$R,^^?=!:KG 7'\F>T.@.J%T_5ZBK$NBK&6*$:KBB@KMZPH
M^+IW6^0'C7UC19R6S0([/]9&@%16RBH+9&7)NFEMD# &#<,H1;8P(KM C?*
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MS,;QY3@HS0&EN: T#Y3F@]("4%H(1>OKNC.;L=IL5B_'U<D+YC4HD ,%<J%
M'AY:M<3:$"R,LO[,N$ 2AVS=%OX$%DK"#)T::&12PE>[F=4.\;+EN!JV1"%
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MF[ORX5=E]O,"YTO+O*9_Q0,_>_K+@4C;NBE79C! L-(%_R^_&CP$ WY^NF7
MJ1EP2G#S0@3E.]G(-Z^J\D%4^#3,AC_05FDT *<+),JTJ>!;#>.:-S>R4966
M.: G+=NBT<5"K,M<IUK5KYXTL (^]R0UL[WEV4ZWS'9R*F[*HEG6XJ+(5!9/
M\ 1 <_"=6OC>GNZ<\9U*Q^+9R4B</CU]MF.^9VZ_SVB^9X_M=^+W>[MCOSS;
M\^'94&)>UFN9JM<'(!*UJN[5P9M__7#RX].S'; ^=[ ^WS7[=]-FYVS#L *]
M=BPB3L<GXJVL=2U _ 4,6\M*DC25<]$LE4C+HH:',Y@D$W-=R"*%N9*Z@0]
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M\'.(JYP^/7M[=TT_G9PE0!'SX=U_F<^.1N)AJ0%G>A!"$4"('&E69")ZD"?
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MG91Z]1'/T=4- QYC+WKJ@=$U30@#F+WK7S]R1#^) 7HLGG@4O+O_@3CC(]F
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M+K714>-Y10_(#B'"P1 FC0ZU<:&'HPOQR=;*1RAJW FYA)32^J#VO"(KD\_
MUC3P(D",A 9:?81QE9W/$ @I:+4G@&3S&>)"L5< @]RII??L2@J+HLH1.%\&
MD*% _#AGU4>X+#8PZAIX7M3,/J CTD)B/;*&-;TT9B?4G30]I8^!H;>DLHU
MSEL-_?/@CV%8O58 ALTY>.S%"IKN/*#6MC9]PZ=B71UEP@@A9 <I/7%()1VA
MC,:SAIBPI)3*X*Q<&B5Z*).O&!#MZ[X#DW H0GNO[G1(A'!E<)ZVUPY,_Q?L
M;;P+Y %:C=DMQ-_9SR*Y6&LDXY-AOT]H!, KZ;W7X9;AJ_J1$92!%*X*SRO(
MQ;/S"_%F)+ZV(?H^,Q_;2]:[Y>?D64K)!G53D[DC\3<7E3@]7SP9#'Z@MHNE
MFAAHI=D%':HRC&+/XK10Q4-E?*MV^]0=*#UD9\HH+0VN]T"<LC? 7 ) M@8U
M2*7(]8-5*;T9') ]%/+#6!"E#Y6 .%P"H:B!>U5<;75LP7_:9=776$C/3DD_
M9UH@0[772[!B2<//@L'(^<XDUV3ZNU6-$B#]ZQ0\QKL[J0US=-LJ/KKZH?J)
MK?*#CJIF(5Y_14E1A'OD_B9K*4,Y.PT*Q;A-ULG6;?$9$79R)^I6VK6JFEXE
M2?6W&"/30Y:-_5-R]>F0,EX4X\YE33P@[]$[LQ ?^KH=+:>:6YE1AEA.)_^K
M :"=<'7=^X5XV\![YD*:!7'<2FI_1-JC1(?R1Z2I2,J45WNZ5[.*\H%2+/N
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M"?#S:HP#>\,_69)WK]Z<6/,D@5>O23E*&3*1(U,J2^=A"="Q@. :"-+$C 2
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M+=(C8U3&9A8;^03S'(]7N5R4R%NT_ 9\RM6L24L;4GU3=$4LU?3#X" A.VM
M'D+\@?AG6_+L95S.!O.F<BP50!.=,2.Z-B[-I<IS/-JTH64AOB]IB30U"H^B
M5A5''6JMC96C%0HYI$.#/NN[%,4I).7T"8,3--F(>/OM[0<1BXM=PW?=:_A
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M_^U.-_AY\@VFT49JY5#)LV[%2=I.4$L8_7PO#U6,9H6IJX83T=/>P1&D<-[
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M<?@CTC]\D1[ _7E9UNT7VJ#[_P^\^A]02P,$%     @ HH2:6&J&4X_A @
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M3IF9<2UF*DV$=NMBX2/6:H3=3JM<M[I=+EL]6%_U"&M6)M-/LS1)YK'*!#L
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MH64#6E\:*O]VP [V7UJ+?P%02P,$%     @ HH2:6$!RW8\)!0  G0H  !D
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MT[)$',9IS #G)FA$PF'FX-  TPE-&%+*:1(/[ZP NP^Z,AUJ#H2$&8>9%P^
MGJ:4IXQP1N-)27A"XSS=V0\6CX$D- _Y))1GD_#.>0$5EGZ'"=UUDL6$QUA:
MDI8T9=D+)0RJ#$XEY64&/$*5@$X +7\B_S.$@*6;BS8D/)2(0"EXGF/=>!)'
M5^I>U5)#A[&RDL!A#=H"N_@(B<DSCB$#? ZJ_-$V[,EW$%#;UT/'^1QZ^B#]
MD.MD4AR!W-XQ6DX X>X_9#%KC7L2]J' =M$?-DCH W[H!!"6N0=MA/VRV8FU
M^EG#RZW:(^B%T+= A$+K7K3MYH1<.+2 <T]V<TAF=_8%N2&YE&A#%"RM;-@
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M#)U:#)6H]$*)KVU>PK.TW\0YZ[=J8=U53D;:K?2F$S?-HK_/6R4NRZ'@YZ*
M3JFZ%Q?J#GYDHTK1JV)5-U6S?-A.RRNQ 2!R55L@NA:;MEF"V$[\VJ^PV]>F
MSROGO.EZYZPCBOXGKP=X)&&4S!>I[[EQ%.->1KX;))Y((M?SI0C2T(W"3/BQ
M&V">G[BA%XDPBD20N)D7B, -LD0<8XQ3Z491YIR5I6;2Q.&=/L(KWTM=S_-P
MA2DB=#TI<9UEL0@SK(I%$+H)O_>3V/5]S_E/"Q8>-XN%>(6GYN>[7N#QU6'@
M)C(\$H?23X[,O2^](^?#T$'V(+IHUK>Z-OP581)B$T_$'F"'L8A2E]#W9>)Z
MD22*$T(G)+S  -^-L@Q(!G'"FP:A=&/?MWR#::KU+3@:CISS71]TAP ,+.+(
ME1Z  %@89T*&Q,M$!+Z;1-G$/$P'RT"JE,1@-Y6TE72]+"1"Y@P$_PXU_L H
M'QP*)."GF QZ@'@0$KY!Z(LP<-,$.T@WB7T1@%+I$_J1!ZZ%3_AY& 3,N##U
ML8%A8H:K(.5+*9,CYUJM5=X-+0:H(; @7%(W#GGZXY]]XT#5ZVX!!EE!R00[
M12%0]UP90^*I*\.06)%%(1  PS+:67K0KYAW3_WH.5E*:!N$="PB8CM8Z68!
MA!62]@6)B-S(J@B4A60,D4=9](SL I)N!"V0$<DNS=P4"N^G@>O%'F07X3[&
M"*%!>S(W2C.1>5"]3$21&T.$Q.Y0VLU("0!BQP"VNAL"--X"R3!Q$[@?Z+P?
M2[:B)&9S<+/LJ:0L&X,P,EP_S'P2F1]$1H#0+_^IK.Z.0%$4Q7L$Q<]WQ<2/
M4YA@"B(2L!5D [(701L.0X]< F^^5R@P\B-V%ED*TX*7B$,B&)+",L$WXR_U
M0FCI<^((B4MD;# _&#C,PX/IC.*(DI1-,H'@(T_ Y (/Q@>T)68ETDTSR!-B
MG.01055 A!\X9^NF[?5?C.XS_N_8,#/R E)R2#ZD"U 3Q60@0(KN^6$Z$X9/
M[D)F1SM;F%?@2 !+.8Q@YB$Q$D"EY/59ZA%P$B'VC+W40DL]Z&]PM%\'(C(3
MN@KCR&I%*(^>=4O6)J. C(ND 9_.>D/\I8O8C1.F,2(L?7*#(QY^%I"CVD<5
MB F8(QYY*[);-V-7#$<>2AYE&!MJ$\DJFO!VL$291OMI(XJB9+J50?!4/P]#
M/R1P&,R39XW:D "\(N)O (K#F#"$RX$OID=P"G' 2%DB\,H+LRVV0888$:?[
M& !&>2FM2<DA&'DF,8T^?$*<\I;0(\F\20Q/L5/$,\#E--[/!!^,-#R A5M+
M3:/T*2>,'(Y$_%T^A%9'8$6A,6/>@-"C0,/HD5LAI<"2V".:X*,SSS,8,VU2
MQO!*P/@+BB4J-,1=7@WJ]<M,&"9 @@EP'\(_<^"%8P5"B2^RF#0%(0(;31:<
MX@6XAW>>'[_,?<<)(B6>P+]*1!AB / B3P#?FYHL!T$HCM+1?9/_!4^ C\Q\
MYY6X5F!W)_KF:=XG[B$YI&4LN[Q#%M>A%B+LJKSX1J/Z<X/JRR@,;A=##Z],
MR>")0\'\GZ2+K\6OM?B<M\4*WL^0ZHK/E^<B'_I5T^J_*!=<49I7H"CM.$,-
M4J=3*%;I^APQH&U0J*$@@;]NQ,U//P1!\J81OR!K[%Q1-4@> 01Y(L$I=/_
M/E$?7^70MMP5-Z" X5XW=8G54KZI=7XBOF*ZREO0/_0FA25<&@;#^SOY!JDG
ME$3H3ES_F")R;B R>N>*O/P=Z2]6W#[PBO.+3Z*EC19MLS:H5 TP7HJA[G7%
M3S;Y \>T$O-<PNA^I<&8R/LO<0\!;'+-=)QM6BQ@K4 6[]!*!$-4Z 0M7S<
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M:PU%7O)N/_V0!G[RIA-WU#(!!"#10.LJ_0TR6F%?L06;%RNM[D:<6Q1?]:"
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MRYM_GUUQ=Q+9F1U25/?Q--!4ZN'[04;=(N?\_.83ZN@XEO8?97^"W'X<Z'#
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M- 'O%TW3CS>TP?0M^_O_ U!+ P04    " "BA)I8>HY(GP0@  "A7@  &0
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M /)!26#V-J=-06!M9$THTRW7DL0QKP2 _:"H\7G?6]S7V]8* G9D+6ZRXL"
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MUYQ =@!/JX?R"63Q [1LLQO%+RQ:2 X8U/4X U%!795,0E.SB'MFZ?!G38F
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MU,&(F\(8<JWG9TX>W-#GTR*]5?67Y=I.$L%QBOCD!^_XUC;?CA-OL,30=L*
M3Y?.I3;__:A1UQ3JY=YS9Z$'6,2!*^($#F!*22%T$!2F*2/&=WT[])TIQ+AH
MY42<^A EB? (?G2!GDT9_C&ES%+ZH>VDWN,1XR4>%NH*'T-X^%4G5BY?83@^
MR]+G6!>#0ZWSJ/-](, QJ%-_62E0$OB$.)_ZARF>0%E\Q-UO(K!3*G9-^2K$
M4%SVOLCHX ERC<O4:.(I(W%\0/]G!SG.2Q^>K?=%D),G[GUF8Q=$F\Q)5TF!
M)[)CVNW.YX,#3SCKGAWYG,@9AWB=S@7?H27<-.93R0L!!F$2T0>G$V1%8YKC
M4).VWN>GBQC$ZH8F\=UDT.O\]"[__*6^4F=X]#ES(4!"A].!^4F3PX5%N=,@
M.Z!]YH(2$LJCG'FQRE_ 5)3?[+, "[%X,R7H?\Y79H:V'P36<:G&WX^:Y@QN
MIME:X<8'0)*8-F;'J<NE+9$=4KIGD$9 $2#I@8W#E).D4^:!\Q>7,FY4Z4E7
M[-%5=2B<P)M4U2*Z#H?J.;IC[6FT@,_\B-'"3P.T.!@JI>1!2J#R$ZX0<;%\
M/$60/D$:</:WZSL:OZ'O,TX4.JWCXJ8_A1-./OU3B''/(H973T!T'=!S1#5'
M(14?@=P2![#R.2\Y=5*JGPA32"$OZ;%Y!C.Z9*LK?^KJG*"L$L#$U?537266
MJ7/JRHG.L4T4))IM\-3A!Z(=O$ 9 S.7;NOEO&S2"FF".?&/G?A8-7;@ O8N
M90TYO&5*RR0T:?2>S2:NU+VR$X;<1"'>V70=ZZPXU8G%G/73H;N:O,Q6WVSH
M=F>.70U]9\M2(?&+HT)BBR-)B4>9):G-Y;BGE>&ZJE)=2\#W*BS$U%733P?7
MAD.M7?/EZ(WR%-4-XMW;[O[UY^K:\;ZYNKS]759?DR]3R VZ.HLX?*+J"\T?
M;;7G2\B750L=RH];"?.BI@;XOJF@C/4?-$%W*_U/_P]02P,$%     @ HH2:
M6&(56X6) P  V @  !D   !X;"]W;W)K<VAE971S+W-H965T,3DN>&ULK591
M;^(X$'[/KQAEI54KI00"!.@"4MN]U9W4GGK;WMZS22;$JF/G; >V__[&#@2J
MI>A6VI=D;,]\,]_GV)/Y5ND74R):^%X):19A:6U]'<<F*[%BIJ=JE+12*%TQ
M2T.]CDVMD>4^J!)QTN^G<<6X#)=S/_>HEW/56,$E/FHP354Q_7J+0FT7X2#<
M3WSEZ]*ZB7@YK]D:G]#^73]J&L4=2LXKE(8K"1J+17@SN+X=.7_O\(WCUAS9
MX)BLE'IQ@S_R1=AW!:' S#H$1J\-WJ$0#HC*^'>'&78I7>"QO4?_XKD3EQ4S
M>*?$/SRWY2*<AI!CP1IAOZKM[[CC,W9XF1+&/V';^B;#$++&6%7M@JF"BLOV
MS;[O=#@*F/;?"4AV 8FONTWDJ_S,+%O.M=J"=MZ$Y@Q/U4=3<5RZ37FRFE8Y
MQ=GE%\8U;)AH$"IDIM%(BMMY; G;><39#N>VQ4G>P1DD\*"D+0W\)G/,WP+$
M5%176;*O[#8YB_@9LQX,!Q$D_61X!F_8,1UZO.$YIM\\TX?S3%N<T6D<=TJN
M3<TR7(1T# SJ#8;+CQ\&:?_3F2I'796C<^@_L1_G<08C. T%SR6"92N!L')'
M$FJM-CQ' Y86BI,Q0<E1,YV5KZ *[W>GJIK)UX\?ILE@\LD ,P8MO60.@K,5
M%]QR=-,N@'82JQ7J;C>]'QE)+WBB6R9OJ!CR>R?Y:1[!L[),P%^-LI@3"9Y1
M/KX_YG1$](NKZ.(>-RA@< E/?"UYP3-&&JB5VS<O I=U<_!+WOHU\EW/X67P
M Z_@II6![DK8ECPKCRB1&!HAYR83RF >/&N6(UUK&7(/3\!2R:NLT9K87<)P
M%HVF8[CJC.#^2-C_D^%>,=EN2<$EDQF7:[@81)/9.)J,B>C5VU%P3^+BF^V[
MF$Y&T3B=>=^#'=QDF6HD$:W9JY?&*J"+5K@,IJ0J2B5RU 0P3M-HFDX\P,'^
M0;GD5RHW2JC.*67<&[]*N=EP%"6S\4ZYP^B4<I-T%HV3UO=@_XQRR31*)]-6
MN<X._J3/_1!]D2;18))ZIX-))YSH;-U#*K":R!0.<X5VBRC!?\ &\D:[M'2<
M@QHU5SF0-*_(-/A[3=*YZIVZT>*C;E.A7ON>:L 3:QM/-]NU[9NV6QW<VY[_
MP/2:D]0""PKM]R;C$'3;1]N!5;7O72MEJ1-ZLZ1?#]3.@=8+17KL!BY!]S.S
M_ ]02P,$%     @ HH2:6"WJVON# P  -P@  !D   !X;"]W;W)K<VAE971S
M+W-H965T,C N>&ULC59-<]LX#+W[5V#4F9XREBTG;3:U/5.GN[,]9"?3;G?/
MM 1;;$A"):FX[J]?@+(4=^HX>['X 3R\!Y"@YSOR#Z%&C/#=&A<661UC<Y/G
MH:S1JC"F!AWO;,A;%7GJMWEH/*HJ.5F3%Y/)F]PJ[;+E/*W=^^6<VFBTPWL/
MH;56^?T*#>T6V33K%S[I;1UE(5_.&[7%SQB_-/>>9_F 4FF++FARX'&SR-Y/
M;U:78I\,_M&X"T=C$"5KH@>9?*P6V40(H<$R"H+BSR/>HC$"Q#2^'3"S(:0X
M'H][]#^2=M:R5@%OR?RKJU@OLNL,*MRHUL1/M/L3#WJN!*\D$](O[#K;Z6\9
ME&V(9 _.S,!JUWW5]T,>CARN)\\X% >'(O'N B66'U14R[FG'7BQ9C09)*G)
MF\EI)T7Y'#WO:O:+RUO5Z*@,0SJN 6<[SO/(N+*;EP>,58=1/(,Q+>".7*P#
M_.XJK'X&R)G0P*KH6:V*LX@?L!S#;'H!Q:28G<&;#2IG"6_V@LJ[LRH[C,O3
M&'([;D*C2EQD?/P#^D?,EJ]?3=],WIUA>#DPO#R'_C_K<!;C-,/I%?R*#7RB
M(=8(3>L;"AB -FE^2[91;O_ZU74Q??LN0-FYCIY<+_HU*(FO9H4^0"29X[=6
MQ_T8_A9<K^6. ZV_8KIW+P0XYJ8%4,ZXMOH'0JB5QYH,1QH]*M-B%^$ =' ,
MH.,36(B^+6/K$92KV.(!PTA57_DV20"V=6#DM@JILE8N^3M 5D16EZ*LTM(T
M0@(0WE[4>>S\#UHVVBE7ZI2*1^0QMT?XZ( \<Q4-JJPULO98LR8V\<J8IY1<
M",CHY81<@++DMD!L+E73;AMX3=N4)^Z/(C36BC,7P7(C"*>8=1;<K_C0_)JH
MT;&^,:RXOW/[3UD11 [YG&+NNJVIH$%O.;P8K95[$&;:6JRTBFCV')"5&U*<
M43YY%:XY#H<-J99,OU:<IC6B&SF"=1_]^3S+EE3_!*1P%J^R]5Z.DU20K\.C
MIC8(34T5A_V+ALKOA(!5%?:>0X4XS0T976H^/QRC\51BD-O"CV%7($E,G\RJ
M]7V>]JCX6J!T0^!>AG;-E>O[66+$@V(,IQI'?M3,+?IM>K+X7%#K8M?7A]7A
M57S?/09/YMV3>J<\,PQ@<,.ND_';JPQ\]TQUDTA->AK6%/FA2<.:7W;T8L#[
M&Z+83R3 \%]A^1]02P,$%     @ HH2:6-.Q"EE0"P  SR   !D   !X;"]W
M;W)K<VAE971S+W-H965T,C$N>&ULM5IM<]LV$O[.7X%1>ZTU0]-\EY0FGG&2
MII=.<_'$3?H9(B&)%XI0 =*.^^OO68"D1%F2G;3WP10) HM]?7:Q]/,[J3[K
ME1 U^[(N*_UBM*KKS;.+"YVMQ)IK3VY$A3<+J=:\QJ-:7NB-$CPWB];E1>C[
MZ<6:%]7H\KD9NU:7SV53ET4EKA73S7K-U?U+4<J[%Z-@U U\*):KF@8N+I]O
M^%+<B/KCYEKAZ:*GDA=K4>E"5DR)Q8O15?#L94SSS81/A;C3._>,))E+^9D>
MWN8O1CXQ)$J1U42!X^=6O!)E283 QI\MS5&_)2W<O>^HOS&R0Y8YU^*5+/\H
M\GKU8C0=L5PL>%/6'^3=OT4K3T+T,EEJ<V5W=FXX&[&LT;5<MXO!P;JH["__
MTNIA9\'4/[(@;!>$AF^[D>'R-:_YY7,E[YBBV:!&-T94LQK,%149Y:96>%M@
M77WY&Y]+Q7B5,RVS@I=,SLMBR4EC^OE%C1UHWD764GMIJ85'J 4A>R>K>J79
MSU4N\B&!"[#6\Q=V_+T,3U)\+3*/18'+0C^,3M"+>GDC0R\Z*>\5Y+VQ\KX_
M+:^E%A^F1A'S3&]X)EZ,$!):J%LQNOSANR#U?SK!:]SS&I^B_M6V.4GM,*]!
MRD[MPOB8?>*JX/-2L$RN 07:O&%G<UDU6N@Q^WTEG%=XQ:M[1&DF%0S/VK<8
M*'F-YUJRVX-TY(*)]::4]P*SB8DUKP &"/N:%17FZIKF$+M%UDY!3$.XI<N6
MHA(*'-,@SQ$=A:X5IS!WQ!?: PNP^,/W+ S=8)HPU]S';AA/69BXR73"YF-V
MM;CG[+=B71"G>L65.*= SX><;DH.A<R]8,QN:IE]9G)C=40O2 M,/QR^XV!Y
MLU'R%N1DY5PU2\0TBWQRZ&!F.%\J7K4ZTJ(J8 SQ160-B6'EE?5*J!TU022,
ML$[I"R77&. URZ%K%P!2KP"R<RW^;$B-V8I72RR#.FO#I2H^"V>CH$^7[?#G
M@D'V:U/>LW!FXLTWNYN1J1D(71A4 ^^@_2$Y9LAUG,$(%;*'QLNB+$FPN6"0
MIJ9-P"?-(;]0CN5XQ6^)(H8+-22XEGFQ**QR:-7;Z_?M&VS_4O&_BK* FC\(
M7FAV!N-. B\,V95N&;4<2=U1RJQ?NX98ZR.[3FHDVGJ L^'WQA7W5([,06E%
MF\'.1^E>JF)95.22=USE)*NQKK$,@Y*5F46J(($W0A4RAZ<TEE)19<JX/@@L
M.'1QR\M&:*<EKH01/>]=#.1WQ3*[Z*/;M%0&7NH9Q^58@: [LK]QDEUU#I7)
M9)8U2D%9G?OTSD+>#YM$WC1V;N 0>5,:'\%R4;)&6YWG IZ X!6&]';?@PP[
M[SJ/,/'UOM,W/3DWNZ[3^ME:<-U8J:P5P- THNLL8$'L.Z^+VR(7</3[0I0Y
M._O7F/F>3W_.SW"0C#SC5L)#X&KUO7D/]$AF]NI\*/3G\X42I#W( 94S1=O0
MO"!B06*O6UIEL3"B#='B[%YP!30-6$Q_S@TYX>.2@ =S=3Y!8]8<5KDOBTJN
M"<V[&^</4Z" @<[:.YH^L4,2>7YJ-IE19+UO;=RE9!M)UT)N8%J"BY]O?J$P
M 9C6T$F/?9PM&F5PS,*1T\''*;@E[U"BYC27E^#*XJ$2185R-!-M^.VM\M@5
M@0Y>K629"Z4?:KN#W+D '>$8B8*@=UL#H+N^9/F3U>,81*ET#HE!!<Z G1?X
MR<VZC=2ZF%LO@F#BB]7$UL>=CKT%46%5LYY#7Y3 !'%CO,>FGH]541/>W7R$
MRQAV,UG!K+94)E7H+<\/(TKN1HV[#R,M*&MIDXH!=#F$A"$.D'D-W,%U8"N+
M99JO!0''@?T&.81#47N.N97%,;+0;KZ'VI+D)30;6-/;HGT'ZZUB36(<&AYZ
M-T0(F7(!3\]-!B1H+5$:&<]OH;LBJP&8N4890;G 3!P@W_Q^D!5,&9)ELC&^
M1;)E5 XA%PIKI+=O/MPP.)@NJM9YYZA@0*Y ;03DOJ-LB60(Q;$?K:+)%<S=
M#]]-PV#RDV-7M$5138<LJ)$"PW!-TRO),JZ-2V@@FU%A98'^L[@'7YNFUEVR
MN]W#C<.@O&]_YQ TF\UW_+#3-0$9I[<E3H#ZV?\G$SP9^V< Y/08ZA]'_(1
M]B36^RP(GX[RR5,1?I(<Q?:'D#Y$ 6$1XF)0KHYM*+T#[E&A\!A^EX"!AP4B
MT-^QZ+\7$2VJ%SC]?;$L=$75CGD,()//=C!\H"1IZXU"6Q :+B?%53A+\?R_
M#1653AN(6S!&@B@M1U8/;Z]?78TQBMF\KX1>O7YK7IL=40=VA;)![FT@PW<'
MQ>.QR';"?[*:(EWK)EMU1;TII4(/;K:?<AX HD-<U.:L-:>N"YQ1UUV%^?7!
M?UB.@S$YD,W9E^UIH;^_G?-/%(/6(<D+R.I/!@M4>8$?;^^^J5A,6!+;Z^,
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M)".+I]U#+3?FD_5<UK5<F]L5#NY"T02\7TA9=P^T0?\_#)?_ U!+ P04
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M=!R"Z>Y4W<;IQM]CEMKAK<@O*[R&<D,"^'VEL;O[#1G87VP7_P)02P,$%
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MU.QD^(D=GD5NOI_P>Z$>FJTV<9%,M/['?5SE)\/ .:1*-;4.0>+O7IVKLG1
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M :*8E91G")L+07.>3:,OQ@/"1% N))6S8HH6>5;0@F5!%H6D,]2\5<_6M&U
M+#/*)2*6):-YCE)>%#0#*?IDW+;Q(ZU.UTV%\MIJ#8\5Y&E2YD""HTE.68Y>
MTH)*.9M&UQJ27#5#BX6H.F-]\VW8F(@2<L'14K"<"L&08":#%/VJX?$YCIO1
MLD!=+L:8.00CP,M7W[2-;U!),"I9."L@19AE,,ME.HUNX,'VNE=]I7$S@QS,
M,(,YE052E@5D@$,Q-LKJG_#APS[HT/O(%FYEEH;H0A+1)J5I44#.U=,Q4<B[
M+ ;7&2_1"9U!(:);7:NU68?\O39'+B']&)<L09 #E;)$*JH=&Q+FQX/VT".
M)8$G&]0%1S<I))'ET^BBA8D3XH-K'?A4'H.P4#)/6N,".[ ?VD\*:(ER= >Y
MB+Y8]:C;XT"@G#/4@(A8R"ITA!13Z/#>P11 /BL=8H#F2Y%4FM%4Y"B4 %I.
MH]_#JS/A4&G&0P/F)4UY'M*3T@+K]Y];EKSUG"1'PZ#3=AU&GH/:[7H_S(7#
M[F&J7@S#Y%5]&,DWRJZ;WI%6K\"4G1593.PPYH:%-]LP6NZ-AT$5Q U\&6B+
M"G"^,O#<C@MT</C66'X'4$L#!!0    ( **$FEAT.CA+=P,  "T'   9
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M'E>/3\AM[YR_POOWYX&;K2#Q$BN"IE>3<=1+/DR<;H./;K0C5P[#FIY!-#Z
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M>%^U(PNH4M N(P/T7$A4Z+19@5#UP_8OY!?.K#/\3G[O.H7:1W>W#U\[Y[;
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MS [U^//*V8V2XSXG(UE T-)H4GNDP'Y NH(^0%W!)8-13%8M7N_46OO-/;+
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M=FWMO ;S,S5XF5_D_V]LT5(]&YNB_!.XA2O/_8%#J=$S4$:6)?_.:\98R3K
M<K%YN8Q[NH*>_J%DEADR"\M_8KKY1TV7[$=!=$B_#O_RE#$9WO/_[/ LC3)
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M9APB!Q#'C:D& 3'?3<G&QDDZD7- 1])CW\4 +2]P9+B6L)$],%C^%OY^WT>
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M$RJ^',[S1_7GW[)QKK9Z.*N)&/=E0)C/V*&,WXF7WU[W@%L_<DM4ITVKF)E
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M[U5H; 3-5T:^D:F<*6X$Q@N7*S+N!%:M05J5KV?T<I>2(,4%Y83E%.('-'V
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M6"OSNMQ',REM260ON_4$-2'24^&FR!H/7"K9031>>T@/NX-^D-P-.PW,+U1
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M#ZU)Q\&UGE@R&%TX\O-K)9V:FQANDL"?'Y7O*8ZA\!>4>U(K]V3CK8=SF<X
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M/Y':#6)6R4A\RLLV*Q=YY%OGR]FW0%SQE+B&6JNI$T"A\E0 Y0+/VB@2F<>
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M'PRP*AG[#,H>[9O"82, 9([H<)U5RJ4;'HIC'V4O?R&002!42_T,D&7LB@\
M6:'+=*B?GP$9\-;&',"Q0 #6_U%-QN&$UO<8CH5%(LRS11D8Y=8_P;$ Z84[
M^%UKNO--#VA:I"^7L=%;EVWW>6\8'3Z.ONR^"6Y?[[ZL_I35BQRM8!'NL)2=
M6710=?>ULGMHJU7Z0GA;M8!N$N]#!B+%%S!_5U7MYB$:&#X97_X'4$L#!!0
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M1=,"/)\JU6XO2,'P'M7YOP!02P,$%     @ HH2:6%;N\=%* @  4@4  !D
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MOZCS"M3.=;,FN6R$:4N^F^T>C'G;)^_P]K5YIFK'A"8<MI@:#$:I1U3;P>W
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MT^/E^:&_,Q[#^YOWBW8KTWI2PQ)3V7F6)L3UMUF_"';3W2 +&_ ^ZJ9K_ ,
M+@;@^Z7%CKI?Q V.?REF?P-02P,$%     @ HH2:6"82DS@D!P  *P\  !D
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MB\"Y<9ZYR(,VS&HND9D62 .?8! ]P<Q]<,P$C\=CM*WR3#MN\!%A("[EN#!
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M M[/:]37XPUML/D'@%?_ 5!+ P04    " "BA)I89I 5:F4.  !N*P  &0
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M)J)50^3*&*\8R27.D]&08CA:18D_T"8(DH+D1\6OD H,:4JJ3@',D1''*T:
M*L2P$HDA!*Y-?.:^[+D=N=NH?;H1PO>K3H(IJZA37?,4&*@DEJ0X2?V5P1TL
MRU/U]29B'/TE;>(0;JSKXOSX*O8$*KS'8@'KFW+%6=CS<[^'M9K6;'D01O[\
M:8/=G/SF >4!QV]*&B_8X+%EG3GI,RR#^?@FZ? ,N(:#.0X>:VX)"B#"1/I$
M4:KP&N<C!1/2C)O4$\!3D+?8VV?+40=LFL;LF&>7LE_GYED*3^&J2_IWU8,V
M-]_GWJ\@L*G+IYLL<P3:E*K(IS_]76N+IP'EBF'SL+D1AQEJRM. 832'0$Q%
M^5SIT5-A\=V4<+ZQK_$K<*LXV"U3_?&JJ?;H9AA3&MU("$2GM#$<!K@OZR6A
MHG12;$#.@:7 BU IXY/"QCO@_B\MO&Z:LEM?Z.HK6HU.$.J;2EE;@Z1:5G^"
M&%8+G%PF7BW^;D,M$88R"2P+H2F2VE?'.):/NP30%YO89[NYC%K]*M!.UJLS
MV"WL?I-.?'+KFQ3#]RK&KYZ$R"/8<T+U5D6%5YB;CB KZ?.>)C)4.U(&$"CT
M6IM[--.6J_O2;U_C1:3$P4OQMG;<5Z&[&F]?2MWG-DFL6[?!7:\?Q!7X AW.
M0&R)3AMO7RDX!N;$GU!+K!H[X) ]I]1+Y+=,*5=24ZO>O=G*]H.4'?D-UOL/
MY#R"O7#:)BY]ZJ17]_!7,#2D-Z%V#B* $^>F;9RC7 -]$W)!WX3XQ+'U>70Z
M_-V^T((.\29DN:N[S,1&(_]YE)_X]@7WGQ$-)F/.-SZ!1$B]]Q]ZDATBJC=?
M0_9O^X])WS:?4*Z;-U^B?K3E?88M+MP,72.<P4Z:3RNZA[IX\!]4WA4UXK>_
MG3M0FY(:X/=9 2+0/M $_2>V;_X?4$L#!!0    ( **$FEBH.> \) ,  /D'
M   9    >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;*U546^;,!!^YU=83)I2
MB98$ DFZ)%*[K=JD=NK6KGMVX A6C<ULDW3_?F>3D%1+HTWK"]R9N^^^[[!]
MT[54C[H$,.2IXD+/_-*8^CP,=59"1?69K$'@ET*JBAITU3+4M0*:NZ2*AU&_
MGX859<*?3]W:K9I/96,X$W"KB&ZJBJI?E\#E>N8/_.W"-[8LC5T(Y].:+N$.
MS/?Z5J$7=B@YJT!H)@514,S\B\'YY=#&NX '!FN]9Q.K9"'EHW4^YS._;PD!
MA\Q8!(JO%;P'SBT0TOBYP?2[DC9QW]ZB7SGMJ&5!-;R7_ ?+33GSQS[)H: -
M-]_D^A-L]"06+Y-<NR=9M[%QXI.LT496FV1D4#'1ONG3I@][">/^"PG1)B%R
MO-M"CN4':NA\JN2:*!N-:-9P4ETVDF/"_I0[H_ KPSPSOZ),D17E#9 *J&X4
M8,<-Z=W3!0=],@T-%K&A8;8!O&P!HQ< !Q&YD<*4FGP4.>3/ 4)DUU&,MA0O
MHZ.('R [(_$@(%$_BH_@Q9WDV.'%QR0_.,DW.\F'E+8XP\,X]KB<ZYIF,//Q
M/&A0*_#G;]\,TOZ[(RR''<OA,?3Y'1Z_O.% 9$&*@S_I$./_Q?0.[P?O7AK*
MR==&&LA)K5@&FK#MF<+]J![!:-*[AA5P,C@A=VPI6,$RBGM)+FQO['["E+K9
MQ47/XQKQ8F1\XN$N@&H!JML)WH76MBA>3&1=LJS<DZ0)54!RIC,N->3>O:(Y
MX!V2 7/P""RD.,T:I5#="8DGP7"<D-/.\*X973#.#(._JW MJ< UD9.""2HR
M)I:D-PA&DR08)2CT]+GG76-S@?"]*KWQ:!@DZ<3%[FSO(LMD(U!H37^YUAA)
M\%;CMH(ND44I>0X* 9(T#<;IR 'L[#\Z%[UFYX81\AQCQ:WQ6IV;Q,,@FB2;
MSNV\0YT;I9,@B=K8G?TOG8O&03H:MYWK;.\+;O===B^-@L$H=4&=>>BDAWO7
M<05JZ8:.)HY,>S-WJ]U<NVBO\UUX.Q1OJ%HR; ^' E/[9R,<(ZH=-*UC9.TN
M]X4T."J<6>)L!F4#\'LA4</&L06Z:3__#5!+ P04    " "BA)I8"-I#<L@%
M  #_$P  &0   'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6S%6-MRVS80?>=7
M8-3+2#,T!8 W,;4UXTO2NA,W'KM)'C)]@$A(PI@D% #RI5_?!2C1<B+3JNND
M#P07('"PNSB[!+!_(]65GG-NT&U5UOJ@-S=F\6HXU/F<5TP'<L%K^#*5JF(&
MJFHVU O%6>$&5>608IP,*R;JWGC?M9VK\;Y<FE+4_%PAO:PJINZ.>"EO#GJD
MMVZX$+.YL0W#\?Z"S?@E-^\7YPIJPQ:E$!6OM9 U4GQZT#LDKXZ(&^!Z?!#\
M1F_(R)HRD?+*5DZ+@QZV&O&2Y\9",'A=\V->EA8)]/B\ NVU<]J!F_(:_8TS
M'HR9,,V/9?E1%&9^T!OU4,&G;%F:"WGS&U\9%%N\7);:E>AFU1?W4+[41E:K
MP:!!)>KFS6Y7CMAE %T-H$[O9B*GY0DS;+ROY U2MC>@6<&9ZD:#<J*VJW)I
M%'P5,,Z,W[*)5(C5!=(R%ZQ$<E**&;,>TZC_)YN47 _VAP:FL@.&^0KVJ(&E
MC\ 2BLYD;>8:O:X+7CP$&(*.K:)TK>@1[40\X7F 0N(CBFG8@1>VAH<.+WP$
M[W2J]*5AA@/%S%OX> JB1I^LB)S\US:S&]!H.Z@-H5=ZP7)^T(,8T5Q=\][X
MYQ](@G_I4#EJ58ZZT,>7$)+%LN1(3E$E"UZBI>8%,A)H:+BJK.9FSM&4"86N
M6;ET/6T+T"B_0G+AEG6;6=]E8N],%F(J8.2B9#5ZI\1,U$ Y6_-@/G'%T4*)
MG"-FW.B*,[U4;H50 4N%+GY$H]"6&4$DPMZ)N!8%!_+>"5X6J/_3 .$ V\=[
M?;N P(>YKF4)="Z%N7/?HQ&*LZ;T+H2^VILJSI&HP0ZN#5)V&MN/A(C$37F/
M58JI,^V!6:A_QYG2, 1%]O$NYTSM8 GHX$KO WC,1=S*N4>BEI6-Q;7@?73)
M!11@UUQ!LMST=,<,<1C@Q$V2!91V,#!N&1C_9R*(.F_4  .>P<275\!["48*
M2&.WZ/3\^! =GYSNS%:@&L'1O?0LQL8HCIJRF[$80=IUY:Z,Q6@/Q4VY*VO3
MN"F_'6OI*  CK) $&'>P-FE9F^Q,&E84PBH->CY)Q>>C>FM^O>$3M83=COMK
M>8?@W7(E+F?P<V_D=[F1$ZZ:"OSG>-76=N:9"_,X73&M+9.N'+GY/,Z^Q(+;
M?!FC*'5R9,O0ED]F4.+*AIAD34^R>T*-OWQVIBD.DL8#-(B):TF"J.%N%H B
M(!",@RQ]FL@=PK,YG@6Q2PLA#9K\$*9K810DS3I& 8T[Z)^V]$]W)JJVWMNS
MV]@"Y;*"O;UN3+<9;UL,O!#TUW[2F\SNBQH=*?8WT [2\ 5G0@^\/Y8N#KYD
MAV<#PT8'M07QWBV--K"!%?7,>OQW5KN (W:=@;"AG]+,IR,KX5$"M1&B?DRP
MGXU"[U?%:JM5@@/86$1)ZF,,#/5I&/D9@93MDQ3;-J L5[FPQL697: ^22*?
MDF@ R;,?1=1/DFP \;K)8WZ;SUD]:WY0%Y?OM>U+_#0F?IQE=N2>!V>+*1=6
M!T* CC'JAV'H$T(&("6QGT;0L9\X)08V<(2"OED4$-"! A*U2'U*$S]Q@S(
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MZ+'-O,DH3K$<;F89KAJD%; +F-!UF1_-*]O'*^ZR$DTO*8CD"!><%XR6H.$
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M\;D'2P[X?6WPZAP6E.#X#\3R'U!+ P04    " "BA)I8= X1''L#   P!P
M&0   'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6R=54MOXS80ON=7$"I0Q  1
M4:2>J6U@O=N@.6PWV/1Q*'J@I;%-1")=DHZS_[Y#2G:R:))#+^)#WWPSWPPY
MG!^-?7 [ $^>AEZ[1;+S?G^=IJ[=P2#=E=F#QC\;8P?I<6FWJ=M;D%TT&OJ4
M,U:F@U0Z6<[CWIU=SLW!]TK#G27N, S2?EM!;XZ+)$M.&U_5=N?#1KJ<[^46
M[L'_OK^SN$K/+)T:0#ME-+&P620?LNM5'O 1\(>"HWLQ)T')VIB'L+CM%@D+
M 4$/K0\,$H='^ A]'X@PC'\FSN3L,AB^G)_8;Z)VU+*6#CZ:_D_5^=TBJ1/2
MP48>>O_5''^!24\1^%K3N_@EQQ%;H,?VX+P9)F-<#TJ/HWR:\O#"H&9O&/#)
M@,>X1T<QRD_2R^7<FB.Q 8UL81*E1FL,3NE0E'MO\:]".[^\45KJ%C"_#G60
MR]_DN@<WFZ<>R0,D;2>BU4C$WR#*./ELM-\Y\K/NH/N>(,6HSJ'Q4V@K_B[C
M)VBOB,@HX8R+=_C$6:J(?.(-OE^-!T>D[HCQ.[ $GO:]U-(;^XTH/9[O<%#^
MDFOG+1Z7OU_+PN@C?]U'N$+7;B];6"1X1QS81TB6/_Z0E>RG=Q3D9P7Y>^S+
M>[R2W:$'8C9D\UWA7HOT_W)=A'R'I//PR2YN=6L&(!MKA@FI9(\9>P3G\7IZ
M1RI!RXJ3LJ)UQH@H:%4)-/. A!Y96\";UQ$A:%XPPBN:-17A@K*<77R)M1"T
MX(Q4E(F"H'DA+DX'4XW>LXS1,N<D8QS-T%=.B[)\=H+%Q$X!Y)+7!<WS:H8S
MQBBK,YQEK*:YJ&;_A6.Y>\!+37HEUZI77N$103RC==Z@95W3H@H4J(UG?#:%
M%1+0*=>:0Y"_M1)Y.W(IT*P):)Y3UO P$:A5S"Y64C^0#01R5%^*0$U+'D9,
M6E4CL;'8031&UNZDWF)$QCE*-/;ERS*JJ(O F%6TJ9#Q]LL-\?(I,(X#2GFN
M#IY?[61L?"X8T2:F)$-/&"85K)Q-F0]!ER)L8UWRI@PHK$!3S<XEF)*%GO*B
MHF46,")O4*N(6@7"RV?XJ96(O,10\PA!D46L1-50+MCLM<N0ONAB ]AM[-6.
MQ"2/#>V\>WX./HQ=\!D^OB6?I=TJ[;"V&S1E5U61$#OVYW'AS3[VQ+7QV&'C
M=(=/&M@ P/\;@\UB6@0'YT=R^2]02P,$%     @ HH2:6+/7HO[-!   *PH
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MR*KEV?1<O+U(@_U@\)=66W=P3R&3A3&?P\.[^FS* R'5J,H'!(G+K;I431.
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M9W?L"YMKJIT5CV*4BT[C5,IQ!%:I&._9#^J>#](M4!V5P!5:M09 K' GQ$O
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MR&%#QPOV$6=BMZ:>?EP]H:VG)U]/Q\:>7IP]>\#:L^?(VY/ .=TX#@=LG7H
M4N_@[TG$[@P^O\GPV>RX>*AWCL,Q6F<(_#U[W0T^"0C"/0Z/;ITB\/CL^6SV
ME>BHRR<ZYF#BP.>S1P@A^=VL%9>61<HL4\ %Y=WN)=/XTU53R[CDZC(.=??$
M7_MTEO+B[]D#!I\]/PZ?/;<6GZ[@#NH 3#Y[CEP^"9S9;B-<?MDL]9/Y/KDL
MCL,T?RC. ]@F%)FY9TE]+;P8?_: \V>O@_4G$?N@8OT9Q7X3D51)?%1+$S"M
MDP3NG[WN]I\$!,7@7I08-%C'W<N[,CBG#_GA8PXF#EW1B=6C_5H'7&HN%YIO
MV1>YC.(P?E*"W0AVM19_Q9$2^_UTM_E^N@><R%U9H)>%\**YH*4Z]]("Y*Z<
MTLLZ>%%FT'F=,$YO;JF/X[3PU/>BV* K.V'+CO(V$9NO&1H3(_ZZW/5\;'&:
M@&J=*%!XI)4[S=T$!,'=?GS7H?$Z[FK>F;OI9B$^YF#B0$@1/N?%DHBUR@#.
M1IJL=\>U%V91)!?=[]B,W;,YNR;8VFG+T!G<096 Q.)>NH;<E6=Z60<O*@QZ
ML!,6ZLW9VEWKD,!J??<3(,P(;W;\_B=XK+4#U5]HTS@_SGU=FR8.U#I-(.,(
M-_<F-$U $#3MQ9"= T=VCMN==Z7I@.XEXF,.)@YD$F& ?L=F^;=3S<^IC%[B
M\,7<S7*W]6X1/V8_1")W%*W*D2A!N_)%+Y/VHJ6 SSH/O'04N2L3];(.7J06
M,&7GA*=Z8X(F<&[-?4Z3V+R/RM.##W(9)ZM_%F\O_<"]B,137G"V^)GJ&M>7
MQ(LT T;NG'!RQ]D;CWU0WZ5*]@R>R.SXN4("JW6F0,M1]N]-"+Q+SY&(;ITB
M$&*X\7EG J?[COB8@XD#Y418H1>*1QBZ#K?F_0@.=A?/X(SMM.WH#.[@CFM
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M0\.1B&W(TSA*ZQR!9",<Y9OP- %!\+07EW@.;.(Y[L'>E:?=^L67<$TH'=C
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MPO4O6A=]'0M%*RYH6H!E!"G)\G_\4 BQ Y 3K0=X!<#;![2> /@%P'\NH%4
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M"D%378P!SX"I#K)]3JG85-0 97HW^ M02P,$%     @ HH2:6%=$3#\$"P
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MBF_-%X](U5)2M3F56K_?3A;QB3'P55 RSHQ4+255FU.I]?O'\)? ^>OB*DL
MJN)0.:4%%"<3;A?$*9Z.MWECL)<P["5P]KH,K\+%J5@#7^D0GFFGNL#3\39O
M#.82AKD$SES#P%4 \U62)4Y=X8;%+68QVT!2RJ)2ZQMH*$O@E.4+K0)8!@@.
M92 .',JDN$6EUC?3X); <6L@L@J7H.)(2GN6%0A3D0[M604\)V\'Q\ L83!+
MX)CE :P"F+EJ[;&Y'PC3(DEL6,7S\G9Q#.:2AKDDSESG854"4U5*A98;,R",
M1UK9YYOP-+S7XH]!6-(0EL0)RP=4<2DXU0 J*JF$TM<((5TQ!J=)PVD2Y[2A
ML"O=)7I,L<C^"@#"XM@Y%XWGY.W@&,0D#3%)?$())]VT>-SY>]=NMUCD^,IB
M?$N^%$6JEI*JS:G4^GUV<B65'(-R)24,S4C54E*U.95:OW\,J,DABQ*1"]U<
M_A(L3.Q5<3,@CD=*:;LTQM/Q-F\,4),&U.2P)8B(?<#J0QYQ]SI!((XI[E1T
M>$+>]HV!:=)@FAR^^!"Q$((S$<7"MA"(TR&/G#V0%,ZHU/H6&CB3.)SYDJX$
MEAB"PQF:.(.&,RFG4:GUS32<)G%.&TBZTH4OED@=.1X"<2+BSN0LGI6WAV-0
MFC*4IG!*\V!=Y?*89-)>M#Z#PL)(.I< DV(;E5K?18-M"L>V\ZRKW"FN2,:1
M?=H4"$LBQ>U=#T_#V[0Q $L9P%(X8/FP+B[EP;I40NEKA)"N&(/4E"$U=>&"
MJX&LJX"5?2)VCD90&-/VJ>X43\K;PC' 21EP4OCT$PZ[^^/^;?Y<5DUVO\J#
MNV/0C^>I%]^D+U61JJ6D:G,JM7[GG=P$0XU!O8H2CF:D:BFIVIQ*K=\_!MS4
MD%6-R/U)H/MJ)$H[BT*AP.X&:/:\1XHGY&W?&."F#+BI8:L8$0,!&.-,1MRF
M-BBP/01$VIX1PE/R-G ,;%,&V]3P)8R(B2Z$G;E-#C"I!M\GAQ37J-3Z)AI<
M4SBN^;*O<GGLS* & N%!34IN5&K]&P\9<M,7+B ;1FW:Q3$6ZB2*[84'0& 2
MMI1LFXBGY6LBE5K?1 -N&@<W#_S5P&)%\'I:(!"^GA;/S=O),6A.&YK3.,V=
M1V#MSGS!U]-"@>#UM'@JWL:-P5[:L)?&V<L'@[4+5M#:9"@,6)N,)^9MXQC\
MI0U_:9R_AB*L=I?W@=?3 G'@];1X6MXFCL%!VG"0QF>7<(A]O_SO]NN>^KX]
M=,]7Q;K8[)8HXQR+;]67DTC54E*U.95:O_].[D:HQ^!830D[,U*UE%1M3J76
M[Q\#8GK(0L?S!*%=NGK#6A"S5^7!<?:RLQ3/QMN[,1A,&P;3P]8U(NZY6 6[
M!\:Y[I'"%Y5:WST#7WKXFD;$P5<@#7B:G4HH?8T0T@EC(%MDD"W"D<V7@",7
MR< =&HYS=F@\.U\OJ=3Z7AIRBRY<BS;PAK$NC,$6@G&NA:3(1J76M] @6X0C
MFP?\XDH>7PQ40NEKA)">&(,!(\. $<Z Y^$9;^A;FKU&#7:?%!VIU/KN&W2,
M<'3T(7!<RF<@$ FEKQ%"NF(, (T,@$87KD,;2/&XC$\W$ FEKQ%"NH&4(Z<G
M/^;2_5;/CUGU6+3,OLH?6OGP;;>U:O_S-_LG3?F\^WV7^[)IRO7NX5.>+?.J
M"VC??RC+YNN3[B=CCC]"=/-_4$L#!!0    ( **$FEB9=/1@20D  .\\   9
M    >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;+6;;6_CN!''OXK@'HH[8+,6
MGZ5M8F WVFL#W/86R5W[HN@+Q69L]6S))RD/!?KA2\F.:8FCD7W+O$ED^\^1
M9BAR?D-*E\]%^5NUTKH.7C;KO+J:K.IZ^V$ZK>8KO4FK]\56Y^:7AZ+<I+7Y
M6"ZGU;;4Z:)MM%E/:1C*Z2;-\LGLLOWN:SF[+![K=9;KKV50/6XV:?G?3WI=
M/%]-R.3UB]MLN:J;+Z:SRVVZU'>Z_G7[M32?I@<KBVRC\RHK\J#4#U>3C^1#
M(ML&K>(?F7ZNCHZ#QI7[HOBM^7"SN)J$S17IM9[7C8G4_'O2UWJ];BR9Z_A]
M;W1R.&?3\/CXU?J/K?/&F?NTTM?%^I_9HEY=3:))L- /Z>.ZOBV>_Z;W#HG&
MWKQ85^W?X'FGE48\?ZSJ8K-O;*Y@D^6[_^G+/A!'#8@<:$#W#6B_@1AHP/8-
MV*D-^+X!;R.S<Z6-0Y+6Z>RR+)Z#LE$;:\U!&\RVM7$_RYM^OZM+\VMFVM6S
M.[TTO5@'6;Z[AYJ^^#[1=9JMJX#\$%P$GVY_"KZ__>Z'X/8[HPI^616/59HO
MJLMI;<[?6)G.]^?ZM#L7'3@7H<&7(J]75? Y7^A%U\#47/CAZNGKU7^BJ,5$
MS]\'C+P+:$@9<$'7IS>G0//D].8$\88=^H*U]MB O9N'LKJKTUHW/?*3^?'&
M'%;!OYK#H#W^-Q3TG5$.&VWFC0_5-IWKJXF9&"I=/NG)[,]_(C+\"Q0PG\82
M3\8ZP>2'8'+,^NSO9LXL]9/.'S44M%UC.=#8W.HT4B(FX$TUWI;1.!0*"LEH
M6Z)(S!1V.XE#! 0:@;^6154%V[)XR&HH!+O6HFW=I(>G&5%2DC"\G#X=NPOH
MN(Q%*+JZ!-"%4H6-+T^ &_+@AD3=^'FK2S,OY4LS^\R+#=B;TCFU,F>6I.>)
M*Y.2.PXGKHSS,(H%[(<Z^*%0/W[,\C2?:\0+Y0;01)#3GA> +*1A7Y:X,LF%
ME+ 3T<&)"'7BIKWXX%Z;;/'J2E"G+QI,!Y$;2!J+J.\0)(LX8SV'7!E5C$L*
M>Q0?/(I/\:CU(= OAJ<JV)G8/3TG1_'<^>*JF)!*]5P!5(2H&/:$A#:7AZ-S
MWO#MM6_<B7,HC \]%P =BZD2/5T"Z"BG-&(#;APA"3EQQ%<[.C$Y<*,W][H$
M\Q]N[=P$Z-5:XLM:-Y+41I*^!5'LK?J*J$]KB2]KW8A:1",HM,P^O]2ZS-/U
MGLUU"<:/N2/C%2>Z0PT0OK)#=ZRYP@,H@(/-8A+!.>DF-PY=[ <:Z S:'@YX
M -X'G@PE'@QU@V6)BN!(-0*5Q$6@@7X'A'"_0Y"&];NE*H)CU751U4'Q$#3Q
MR>9PRB,N"5T8)(DCUR% &8E8B#Z50$(I*#N"L*Y#%J\(SE=CN$L ;@)Y%Q*"
MP L),>(EEK((CEEW>FV^6KX+ECHWN7 =F(([2!>F_L^JNLF-3QIE%>*RT@4)
MC1<1[SL+*)7I8-&G+T@H*95D (N)!3""$]C/]4J7!W?>!;F&^\^%)B(,TO8=
M<F47BKKW(2 SI#;0<]0B&,41[)1JA;K@!)8K@ ZL5P =5K!0"V(4!['QDF5O
M8+1F@710T0+HD*J%6A"B*!8</,$&S=Y$YY;@0DD'D"$AXW$4]\<,)*2<J7C(
M'XLA%,>0NU5JZB\S?>]+,'.45E4QSPSK@;ZY_!#SN#]V !6AI#]G))#,5"]J
MP"F+(G0,1<XI+O?&1JM+4 >4EX .JR^IA0:*0\/)%29UD_T%5&-".JC*!'7#
M=2:U[$!Q=L#K3 JLGT!U)J #ZTQ A]69U!(#Q8D!J3.#_P6_Y@M=+LMT@1:?
M^"G.+96\6DM\6>N&UT(,C=ZB^*0H&IT=49_6$E_6NA&UI$1Q4CJI^*3 0I4P
M29E$_?$'"$.FHBCN#T" O$RZ,X@!CT!F:8GAM#1:?.+MSR@^?1E*/!CJ!LO2
M&,-I;*3X9"XZP?T."<%^!X1XOUL<8SB.G5)\,@">XMA@1K_VA(1*,A+UZS5(
M* 2/AT"9'6W<X3@V5GLR@)@$8:%3O4!"JK@*^PP&"&/..!E(BLQ"&,,A#$^*
MUT5N?GML?OZ\>)SO]HNQ_(B?[>S=29_6$E_6NI&V7,C$FVSWHK1Y=D1]6DM\
M6>M&U'(IP[GTI/S(7)QL%D:HZ@]%0!=&4=C'4T"G:#Q$I\S2*</I=#PW_@&\
M@W.C)T.)!T/=8%G69/B"V5AN=!>OX#X'=&"?NSJLSRW@,1SP3LJ+P,J5I"KN
MU[V03DB3[_J^0+I0J0%GN(4[CL/=6%+D[K*580O63XF 3%!W00^044K)P+(R
MM]3%__!FI,F'2;;,:C/AW.T[#,V%^)G.G;F]6DM\6>M&V0(A?Y.-2NYUH]*K
MM<27M6Y$+9)R#QN5'-A_)&:ZZY<,@(Y$E$EG$ (ZKN)H:!0>/<SUC;N4W%V]
M(X22_@0/R)2DCANNBL5JH.KA%OCX-^T><F!3D,:T7\9< SH2Q;&S3 OI!(G%
MD!\6L_BW;QUR:)\OI-)Q!M!QQ?M9((%T(A2#\[O%+/YMVX8<V.23<4C[NX:0
MCE-37?8=@38-">=#O6(1B.,(A">J7XHF3=WJ;5'6Z?U:!W<'T1<D8WE=B_-J
M+?%EK1MNBVH\?I.,A0+@V1'U:2WQ9:W[M*KE18'SXDD92P"8!SYB 0G!1RP
M(?J(A;#H*'!T'$U: MH]=9,6( .2%J :3EK"DIG E^I&DI9PU]1H%"G"G*>(
M 2%C4JK^! D(B3)2/K!M)2P2"1R)3LE;PB68BZ9/0M<A0!E)150_#T-"*4S)
M-M0WEHH$3D6C3W@#4 0_X@T(X6>\ 2'VR(LX>E@=AR,\?7U<_,=,"KNO/^:+
MX/,ZVV1YN_R(9S#\K.?.MUZM);ZL=2-N,4[(M\A@ H7#LR/JTUKBRUHWHI8E
M!<Z2IV4P7\MVO@PE'@QU V:958R]3C"6(:$'V: 4"3W&!N1(0(8D20N# E^W
M&TN2P!(;Z 7T[!K@!?3LVJ 7T@*8Q 'LE/PH 5H"/ %D@". "O'#<I?$N6LL
M+>+-SQB!O@PE'@SM8C4]>A/4S#_+]HW:*I@7CWF]>ZWR\.WAK=V/[;NJO>\_
MD0_)[MU;:V;W*O"7M%QF)NNN]8,Q&;Y7IOO*W=NUNP]UL6W?-[TO:C,)MH<K
MG2YTV0C,[P]%4;]^:$YP>,=Y]G]02P,$%     @ HH2:6*H[JQAI!@  JB8
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M@LYO$'MA+>\GOB\._VI6_P!02P,$%     @ HH2:6/2\\=T6#   FH<  !D
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M99:53U\,)?\ARW_4-:;_ U!+ P04    " "BA)I8FR82GXP$  "7#P  &0
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M84$O9W2\@.2YM6$SX<=<]Q:?_PM02P,$%     @ HH2:6/<%/L&4!   ^@\
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MA.GI*T ^ZR"?_8@P[1?"9&N?)J/B('.TD:S/N,3,8P)FPI504+&GAUW71.S
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M2_IK@)8/T'YAC-].N%OM_FS,_@-02P,$%     @ HH2:6-['5^R<#   0',
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M]9/SJB&J!I(594^Q8%)U*&68J!X2N5Z@YF/&Y.- MREU5QK^ 5!+ P04
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M>#=!N' H+?Z*Z4X<C4%!9<[8]^+B>3&RG"(BFM!(%A!$_6WIA"9)@:3B^/<
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M;:"@^?[X>'\AV:8\@9TS*5E:#M=4L>2%@7J^9$R^712'NM4A_OA_4$L#!!0
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MLK08QJ#X<6V@YE>,R=<+?9Y1GU_-_@=02P,$%     @ HH2:6&.LD*D/ P
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M/[\3N]\.?=RU4>2GC>#(_ 95?@-M?I]I=CK;G>.@.S '7BM';0?J\(&JDH_
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M(6A:-)<$1X3E!O+ZG%+Q>I!W4'TD,OH/4$L#!!0    ( **$FEAB-:-6Z@(
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M!F9_+LP]U4ZL@^[W)/L'4$L#!!0    ( **$FEC']EM@E@<  &9"   9
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M=#<V+GAM;*V476_;(!2&_PIBU=1*6[!QXDZ9;:E)-&W2/J)T']?$/HE1L?&
MU-V_'V#'2B2GZ\5N# =X7LX+/B2M5 ^Z!##HJ1*U3G%I3#,G1.<E5$Q/9 .U
MG=E)53%C0[4GNE' "@]5@M @B$G%>(VSQ(^M59;(@Q&\AK5"^E!53/U9@)!M
MBD-\'-CP?6G< ,F2ANWA'LR/9JUL1 :5@E=0:RYKI&"7XKMPOHS<>K_@)X=6
MG_21<[*5\L$%GXH4!RXA$) ;I\!L\PA+$,()V31^]YIXV-*!I_VC^@?OW7K9
M,@U+*7[QPI0I?H=1 3MV$&8CVX_0^YDYO5P*[;^H[=;& 4;Y01M9];#-H.)U
MU[*G_AQ.@'!Z : ]0%\*1#W@3XYTF7E;*V98EBC9(N566S77\6?C:>N&U^X6
M[XVRL]QR)OMF2E"(:0U&H^L5&,:%1E^94LR=[PUZBQ:;S^AZ<W6#-E>(U^A[
M*0^:U85.B+$).!F2]YLMNLWHA<U6D$]0%+Y!-*#1"+Y\.4[/<6)M#][IX)UZ
MO>A9[W?>^YB9CIZ.TZZ\YKIA.:38UH\&]0@X>_TJC(/W8];^D]B9T6@P&CVG
M?G;)8T8[.KY VVL/;V,Z"\=L_1.ETV@6A&,FR,E?ZUZ,+TSM>:V1@)T5"R:W
M,XQ45X5=8&3C?^2M-+8L?+>T#Q<HM\#.[Z0TQ\#5QO 49G\!4$L#!!0    (
M **$FEC2<$0%'P<  +<D   9    >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM
M;+6:V6[;.!2&7X5P.T4+-#47B9+2Q$!CMS,!NB&9Y6(P%[+-V$*UN")M)V\_
ME*Q8#GE$.X9[DTCRSR/^AXL^4KI8%^4/.1="H?LLS>5E;Z[4XKS?EY.YR&+Y
MKEB(7/]R5Y19K/1I.>O+12GB:5TH2_L48][/XB3O#2[J:]_+P46Q5&F2B^\E
MDLLLB\N'*Y$6Z\L>Z3U>N$EF<U5=Z \N%O%,W KUU^)[J<_ZVRC3)!.Y3(H<
ME>+NLO>!G(]84!6H%7\G8BUWCE%E95P4/ZJ3Z^EE#U<U$JF8J"I$K/^MQ%"D
M:15)U^-G$[2WO6=5</?X,?JGVKPV,XZE&!;I/\E4S2][80]-Q5V\3-5-L?Y#
M-(;\*MZD2&7]%ZTW6J[O.%E*561-87V>)?GF?WS?)&*G .$=!6A3@)H%_(X"
MK"G #BW@-06\.C,;*W4>1K&*!Q=EL49EI=;1JH,ZF75I;3_)JW:_5:7^-='E
MU. Z7PFI=$,JE.A6D+*8)+$2Z/5(J#A)Y1MTAJYN/J/7-R_?H)N7E>C/>;&4
M<3Z5%WVE:U#%Z4^:NUUM[D8[[D8H^E+D:B[1QWPJID\#]'75M_6GC_6_HLZ(
M(S%YAQAYBRBF#*C0\/#B%"@^.KPX<;AAV]9@=3S6U1IWI;Q5.O]5@WS6/U[K
M0XG^K0Y1??P?E/1-4 \.6LT<YW(13\1E3T\-4I0KT1N\>D$X?@\E[)3!1B<*
M]B29WC:9GBOZ8+@LRZI?ZTXM%-A9-^5Y1WG=VPG%S,<<2M/^LIP%W ^@K#CK
M?616_&U6?&=6OA;YV61O9C8Q_#I&]>A8#3@+<13X%_W5;A9LG>]S$H;TJ6[D
MK-.1COG6,3^H'Z1)/$[21"4"M,PM*V<$^Z'/ \,S((RPS\/(\.RLU9&>@ZWG
MX.!6WN,[L.U0W8 1-MIP" @9]AB/S,9V5NU(X^'6>.@T?B-6(E\*R&AHU9^&
M@1\19O@$=$RGPS?ZP2C<.P,$)&*!Z[D0;5U%[BY<2(6*.U1E*YG [1@!_9?@
M*+3\ <+0CWS?;$9 QWW*,-[JGG@AN$4.['3S*<GC?"(T-DI-9S!&8- -]\Q.
M"0HQQ:9P! FYYW/>X68'H(C3S74^*3*!QD)#N-!\5)^I^!YNI2;8;C4\&OGF
MA#D$=:''F&G+UM& >9QVV**M+7J(K=H($O=ZG2$['%&[!A[9R6MCR)8Q/;>:
M@PJ2$1)$'79:L").U!A\%:II&] #L[.-?>W"-&'K6$0#GYLN;!WU* U9AXT6
M:8B;:4;)*ID*S=YZ\$Q$LHK'J69U;2Q=:IZNZ/R;FHNR>;*_ ;UZP/,KVAG5
MC55 Q@/?,YT",MU>0=<DT6(*<7/*A\>EB,;?3&1C48+HZX[R7/8]:;31J:(]
MS6"+/83_BL4$.1&W-!D]9;31J:(]S6@+5<1-5?M7%,2&)(T.V#,'ERUCE/O$
M'%R_@J1(BU+$S5*'+16(S4MZV41-'!Z".LJ"T#3MK-2QIEO2(GM0ZS!J)@ =
M:6RV^032Z0<Y-ET[:W6D:]HB&74CV3/6"Q0 J8AP"S-!'?<L,'/7[%CG+;Y1
M-[Y]_+E,U -H%$"K,&2AZ=.6,3_P3+!Q5^-8FRW.43?.#8ML$></KUZ$E 3O
M)9+SN*95)&K_Z PQ_!N8!1O(0FNF&@(J@@-JTH*[DL<FH85 ZH; WXMBND[2
M%/0)(" CH=6K#Y*-W!4YUFB+B73/UE=<E@])/D-Q5BSS>NFHL5 W]^-F+Y@!
M&^5\[<Q\=D$R%F&KO_^*32[:XB-UXZ-C'X#:FU;$"ZT5XQ#2L= /K4X-Z&C
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MP@1[WIZ3^=ZV\7+8MA(D [:5()EC6XFU7,#<7'""#31F/^_/".?FNL!=$1B
M$/@.%;@?C7A7*EJ\8&Z\N#U@H-DT  TT6P4.-$#F&&@M6; ]NS)I(?<-M&#?
MNYJ&=('7X?N+;H8LT'![BS;#V.;=_LX7'9DH9_67,1)-*IK??!RQO;K]^N9#
M_<V)<?V*G(\VW]"T83:?]'R)RUF22Y2*.QT2OPMTPY2;KV0V)ZI8U-^-C NE
MBJP^G(MX*LI*H'^_*PKU>%+=8/NMTN!_4$L#!!0    ( **$FEB7")%M>!0
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M&\]KMXILSU/591B-%?,4@J6#D05@X6 4-LA).)Z7<,54/ZH*.'_2ZCR%6C&
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MY!4:1P*SE6U2$ "AN(SG]B 4)0.K>-)I8%F8J\P)')G.)RH5KR  ("/C*B,
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M!3S15?!>R2>T$?-8<-K&8K*CF([HI)Z\R]N-U.5-H.*-<*W:9#H'0@+=V8+
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M (B0)%\"*#:XEY-GP4+RCB3Y?*D*2[BO+0!@(K9;MH4K&=VG/+$VRAT%SH6
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MQL#" CJ>%M 4!"CGDY(V(^4:9G$!I>$%Y$$!+LCXU&)6S#VGM<2 (Q$#GI(
MHXS!D9T^,<(HW&.GY05\""^,SB@Z2LC5)I]-!^$/.?AL/ 4BX,%Z1)H%B;@K
M$BD0 5M$P,<C I[6?D$RDHV/V#DQUS2+"#@-(N!I[4="<DG&=L_*N89;2,"1
M( %/BS\A&,%QQO7)82SYOA!;2,!A2'ACIOLE> T6X(U:;HJ56GT]E\BK4A5=
MJE@HDS)>=<L,%7C?KE0X/42EA5C:W.!86L!): %'I858VMP86%K Q],"]G"
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MOE@!S4&Y ;:_D-(\5=P$_2/0\B=02P,$%     @ HH2:6)BH9]MJ!   *A4
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M0=3F86[3,;)T;UMW3J^X9@8L!64GX/>%E&;;L0O4SZ.S?P%02P,$%     @
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MD0&^R7/,?MZ0C&Y'%K+V)Z;I<B7*$_9XN,9+\D3$U_4CDT=VXS)/<U+PE!:
MD<7(^HBN)R@H!57$7RG9\J,Q*"]E1NGW\N!^/K)@F1')2")*"RP_GLDMR;+2
M2>;Q;VUJ-;]9"H_'>_>[ZN+EQ<PP)[<T^SN=B]7(BBPP)PN\R<24;C^1^H+\
MTB^A&:_^@FT="RV0;+B@>2V6&>1IL?O$/VH01P+IHQ8XM<"Y5.#6 K<K\%X0
M>+7 NU3@UX+JTNW=M5?@8BSP>,CH%K R6KJ5@XI^I9:\TJ*\49X$D]^F4B?&
M=VF!BR3%&<"<$\$!+N9@T9S,4CQ+LU2DA(.W,1$XS3A [\ '<#-] &^G;]Z!
MZ1N0%N#+BFZXU/*A+61:I;F=U"G<[%)P7D@A)LD5<-%[X$#'5<AO+Y<["GE\
MN1PIY)/+Y; MM^54-//A-//A5'[N"W[W"\:?!!9$/HSB07YY+X<<?"N'H!K_
MHR*\,_74IN5B<\W7."$C2ZXFG+!G8HU__PT%\ \5;Y-FL4FSB2&SULRXS<RX
M.O?Q \5%Z_$HEJJ9V)D$+YC(AP5%$(:AKP)_@39R!E!UF\;:Y/MR-F36XNPU
MG#T]9R+7_>.%1T5Y9^%7%N6[\'D<A9X?#(;V\S'0T[ P&/B.WPZ+O7/<0^3!
M2#5ED[-2SPM#Z&JX^ T77\OE8Y+032%7Z#7^B6<9 8("^<*584O 5YB1%<WF
MA"EQ^2<<_""(@K"#2Q'FR*BH@TN;9]];S9!9"VG0( VT2+]0@3,5K^ $A.MX
MCH-0!Y@RSG4BV"&F3:,O,4-F+6)A0RS4$KM35@98 )Q3)E).YB"A7+P'22;K
M"? M)_F,,.4K2_M#?5]9)LUBDV830V:MV8J:V8I>HYB(3,Z,2;/8I-G$D%EK
M9@;-S ST*P_#<[)?R95+]N!D:4$P<LH*M[4"G8;)=U74B8JUR?3E9LBLQ0W!
M0[\"391AM4N+W[[P:@%4!M955HNA/J^^$$VYM2D>=7WHUXNLVN-LE:6(4Y99
M^IQZ$S3DUB9XZ-.0MMGXI7*LMCY;CZGB5 69/M7>8%^CRT*'-@N=Z;,NNC7_
M1X<"E'L+[@GBP$%AT"5LM+TRY=8F?&BPD+[#>K'L1:?]DNOZT'/=[HVI"D1>
M&'1?//I,>G,SY-;F=FC D+X#N]TP)@LI);G3UDD^IFX(N^ 4+5;H0K?;,.@S
MZ<WM-9HL=.BRD+[-^DR+#XF&77"NAW:"T(&!>F_PO#CT4.BJ=P:-]F6FW':4
M[:,]W7++_D_,EJFL?#*RD/;P*I1SRG:[X+L#0=?5-N^,"D'S:K@BLLID98#\
M?D&IV!^4.\?-_R+&_P%02P,$%     @ HH2:6-(KFM)6!0  GR$  !D   !X
M;"]W;W)K<VAE971S+W-H965T.#4N>&ULM9I=<]HX%(;_BL;M=MK9+5B2;>P4
MF,E'.\M.TLDD[>Y%9R\$"/#$MEA+A.;?KVR,!;OBF##X)O'7>SBOL%\_R.ZO
M1?XD%YPK]#--,CEP%DHM+[I=.5GPE,F.6/),[YF)/&5*K^;SKESFG$U+49IT
MB>L&W93%F3/LE]ON\V%?K%029_P^1W*5IBQ_N>*)6 \<[&PW/,3SA2HV=(?]
M)9OS1ZZ^+^]SO=:MJTSCE&<R%AG*^6S@7.*+:QH4@O*(/V.^ECO+J+ R%N*I
M6!E-!XY;=,03/E%%":;_/?-KGB1%)=W'/U51I_[,0KB[O*W^I32OS8R9Y-<B
M^2N>JL7 "1TTY3.V2M2#6/_.*T-^46\B$EG^1>OJ6-=!DY54(JW$NH,TSC;_
MV<]J('8$Q#\@()6 _$> #PEH):"ET4UGI:T;IMBPGXLURHNC=;5BH1R;4JW=
MQ%GQ-3ZJ7.^-M4X-O\09RR8Q2Q"3DBN)6#9%LWIC$K-QG,0JYA*]O^&*Q8E$
MY /ZB*X>;M'[A[<?T,-;%&?HVT*LI-;*?E?IMHKBW4G5PM6F!7*@!4S0G<C4
M0J+/V91/]PMTM9_:%-F:NB)@Q1L^Z2"*?T/$)=32T/7Q<@*T0^LQIF4]>J#>
M:);+1\44UZ>_NM4[1WI1HA_%(BJ7_[:-VJ:H9R]:7-X7<LDF?.#HZU?R_)D[
MPW=O<.!^LCD^4[$]_U[MWX.J#V\%R_9.K&QN\[LI$APHHD\S'+INK^?;[!VA
M#4GD8L"-7[OQ03?7JSS7WZ/-P4;HE\(B/Y^'N!<17Y]#S[O-6@[S?'VNU8?M
M]174?05@7U]%]G%RN+>@<80"@GW[Y1)8?-%>$$7VCGMUQSVP8VW91S]2GHYY
M;KT"0/EKKX S%=MS&M9.PS82(#RG_S,5V_,?U?XC\)LV=YDXDRI6J^(6;G,,
ME[G2180>+_;N#?'=3^A[%H_+38^=2YMEL-J)EK%K[JPNV.TH4US752C77[SU
MM@CKKV]&Z%>$.Y'["UIV7CHVAW")4RWNP ,&6[QC:I7'ZL7J#I86%[_5$2@[
MU1$QCL@Y[E55%2!./4S"T+4Z)/^+4Q^'F'KV-,4&,S!X%R^&M ?F*:Q_;:"<
MJ]J^6P,5V&LC4S'(*J\>@S-5VQ\#@R(89I&C<[6ISNCKYWNK/U!WJC^#-!AF
MFN8(A?7?_KB]/YR=H/94;P9^,$P_8'8V@E//ZJ@-QL$&<C#($$=G9]B(HAA'
M5A"MI+O1&7HX/!"<ADXPS!5Z/#TX.,]$$I6+-KB$&"XA;AO!2<Z$&M4O\#;
MA1AP(3!]'!V<#74@(K6&#ESO5-\&;PB,-XV!VJ#?,FG//\RD<(E3+1H*(C %
M0;G:("URP.JH#=(AAG3(6>9/2.,D",&>:X7N2KJ;JY3L3ESL=V[XA,!<H0<T
M (,5UK\Z5-J@%6)HA02M!.N9.*0:@S:HAABJ(3":'!^L<)U',5,Z29^L%MO
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MQ=/B<<TH5.L\ 'Y?<J[V+WD#]=WVY#]02P,$%     @ HH2:6 7,GMAR P
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MRH< ?@?.[(]7?NS]:8O?2Y)E+T1V$-NHCVTTQ-[%ML$/>%4!6L&&4$KHQA;
MEB@^0Z2R( [\)+9%ZTED$B2!#9D]C8S]=.B.C?HXC ;C<(L?5#&7UNQMD2.#
MU)^1N]E5- ZC9.+>[:NTF/GJZ^,=FF46LW&Z9W7@?MR['U_D/F)KE1(2U$61
M-BFQQ<?1*!@?2;&8A9Z7'BFQD05Q:E>2]$J2026J$JHJ:S*[@'N3V#8AR<G>
M07(<ZL6I412-CE6<&JD[%=I%I+V(]!E9!;0XDU*#+/;,1[8$2T\T=+EXH/34
MJLL[F]1Q+W4\*'6QY5S=/)NZ0> SU(TO4G=JY4=1<N8V^M[O]L![XBCI57Y>
MXS#Z&2)?BBCKB 9JYB@-HM16,]V]-JH&OC'MJ$ YVU+9-A_]:M_ROC>-WM'Z
M7+?"ICW[3=/VT5\Q5Y\8@2I8*TKO.E$'QMO6M)U(UIAF;<6D:OW,L%3M/'!M
MH-ZOF<JM;J(WZ/\@S'X!4$L#!!0    ( **$FE@Q]!IR;@0  # 9   9
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M<)^'!K'(.(PU'.9X?)J/%2@D+H@QP8.>2SIM.(P^D\.H2T[,<X@94)' F4Y
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MR=-J<Z.BE2I*@?U]G>?F8:?LH/Z*:O8_4$L#!!0    ( **$FEAK1%^Y^"
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MH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ:B6H%J*:AFJY:A6H%I):?WL[:K
MSL158$=>*(5V@6TUT<5(X]WEE0JZ(RJJ::BFHYJ!:B:J6:AFHYJ#:BZJ>:CF
MHUJ :B&J1:@6HUJ":BFJ9:B6HUJ!:B6E];.Y*_XZ$Q:4''VA%%KXM=5>+H,>
M#H??3I'1'B]4TU!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BU M1K4$U5)4
MRU M1[4"U4I*Z\=PU^-U)N[Q.O)"*;3/:ZOU+D8:#<Z_RV&TJ O5-%334<U
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MM:4B4,+84?.PZ_IA[H&'W4)TB3S\&W(=U].DW[P^W>VGVTIVJ]UMM;L5GG<
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M5&;-ZP.E^D*R374FLV12LJP:)J#F@9<!ZOZ*J0VSN2B/>=ICO?G_4$L#!!0
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M#3HO+AF-F;05S/.Y$/KYP@:HOK*,_P-02P,$%     @ HH2:6*"'T5_$ P
M,0X  !D   !X;"]W;W)K<VAE971S+W-H965T.3@N>&ULM5=M;]LV$/XK!ZT8
M6J"U1#E^RVP#==-A 1(@L)OU0]$/M'2R"4NB1M)V NS'[RC9DCO(3)8N7VR^
MW7,/CWSNQ/%>JHU>(QIXR-)<3[RU,<6E[^MHC1G7'5E@3C.)5!DWU%4K7Q<*
M>5P:9:D?!D'?S[C(O>FX'+M3T['<FE3D>*= ;[.,J\<9IG(_\9AW')B+U=K8
M 7\Z+O@*%VCNBSM%/;]&B46&N18R!X7)Q/O(+F=L9 W*%7\*W.N3-MBM+*7<
MV,YU//$"RPA3C(R%X/2WPT^8IA:)>/QU /5JG];PM'U$_[W</&UFR35^DNE7
M$9OUQ!MZ$&/"MZF9R_T?>-A0S^)%,M7E+^P/:P,/HJTV,CL8$X-,Y-4_?S@$
MXL2@VSMC$!X,PI)WY:AD><4-GXZ5W(.RJPG--LJMEM9$3N3V5!9&T:P@.S.]
MX4NI@.<Q:!D)GH)<IF+%;<0TO+U"PT6J@;V##W K8Y$(C.$NY3E\RS!;HOI.
M$W-8P+V&;[>'D?D;\$&ON4(-(H?[7!C]WHY2Y\M:;C6YTV/?$'U+PH\.5&<5
MU? ,5182A=RL-7S.8XQ_!/!IW_7FP^/F9Z$3\0JC#G39>PB#L NS^0V\G;]Y
M=\K?X:1;1[A;.NF><7*=*+TPW"#=97-#D]?4I&C9)I3M[VVQJ$ OVD&M5B]U
MP2.<>"1&C6J'WO377U@_^,U!^:*F?.%"GWY^*$@T=-([F=)52(5Y;*-8@0Q+
M$*O^W308^[L6O[W:;\_I=V%C#H42$0(W8-8(&7*]567L(*8@PM_GCZ=B5;GH
MGW%!QH.>(T3]FFK?297$@"EL];_O8<7!;3L3N<Q(:PX:@YK&P GUM<PZ=%)\
MAXJR*"1<*-CQ=/L3$1P\%<&@PT('^6%-?NB.@S24WD FH'A.W(\II8V3$^F%
M<AC5/$>OH>#1*U!F09/7 [>6C!*;YXBI-1$'3UV!D4M$[*3ZL/\CTQQ0?D@U
MG8M>>[9A8>,]='J?"[WYD"A$JDP&Z10,W42#K0S"%@;L#(&F-#!G&F^VGXH$
MK1"HWD<;D$59?UMYN $9/")7KJ-I:@!S%X$OLGB>--TX+[WH3<U@O==0)W.6
MHI>R;LH'<]> GY-G_REY$D\7S::\,'=]>:X^!VWZ')Z11U,?F+M _!=]#MOT
M&9YAT&1^YLS2+Q&H&[!7"K3UN](_^8K/4*W*MXJ&2&YS4WW0UZ/U>^AC]0IH
MEE>/J5NN5H(^X%-,R#3H#.BRJ^I]4G6,+,HWP;(LP65S36\Z5'8!S2=2FF/'
M.JA?B=-_ %!+ P04    " "BA)I8:E$[RLH$  !?&0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970Y.2YX;6RU66UOXC@0_BNCW.JT)^V1Q 8*/4!:VEU=I597
MT=W;#]5],(D#5I.8LPVTTOWX<UX:TU7BI+1\ >=E9AX[\\PS<29[+A[DFE(%
MCTF<RJFS5FIS[KHR6-.$R![?T%1?B;A(B-*'8N7*C: DS(V2V$6>-W03PE)G
M-LG/W8K9A&]5S%)Z*T!NDX2(ISF-^7[J^,[SB05;K55VPIU--F1%[ZCZOKD5
M^LBMO(0LH:ED/ 5!HZGSV3^?XV%FD-_Q-Z-[>3"&;"I+SA^R@ZMPZG@9(AK3
M0&4NB/[;T0L:QYDGC>/?TJE3Q<P,#\?/WK_FD]>361))+WC\@X5J/75&#H0T
M(MM8+?C^3UI.:)#Y"W@L\U_8%_>>C1T(ME+QI#36"!*6%O_DL5R( P,\:#!
MI0'*<1>!<I271)'91/ ]B.QN[2T;Y%/-K34XEF9/Y4X)?95I.S6[)DLN@*0A
M2!XP$@-?QFQ%LA63\/&2*L)B">@W6'P %^2:""J!I? ]94I^RL[J@V]KOI7:
MAYRX2F/*/+M!&7]>Q$<-\7T$-SQ5:PE?TI"&+QVX>C+5C-#SC.;(ZO&2!CW
M_B= 'L(P7US#Q\6'%_@M07"U;#@/TF\(<L-#%C$:PFU,4KA/:+*DXA_X#Z[@
M%B[@,]S?%*?J5L3J.J/AN=R0@$X=S3-)Q8XZLU]_\8?>'Q;@_0IX/_>.&X!?
M14+>*:*H9I:ZUA>O]%#"?3:$?%P+N7\"R(,*\L"ZUE\>-YK">JUW/-:)&3/U
M5 >Q<#+*G62U:#?S)NZN)NZPBCOL%C=F$04>@29C\ !\DY.C#H+=WP">*!&V
M[#NKD)U9/=UE:0P;P0(*1(%:4T@HD5N1/U4(]>/5J=B8\078(L2P(80V/AM8
MH(XJJ*,VHM 8MO)G:A<8[+9SEO)$UR0+C'$%8VQU]2.OSOI9DAT56FT@(DS
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M=/>;=/>54C^JMD-,U7"#J&BCP!)B"C8P75_U'/1;ZXIONK);<M)*>GTSE#U
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M++F73,3.Q?D$6B(*U72H9D U$ZI94,V&:@Y4<Z&:5VN3=X-6J2\?7#Z%+C)
M:>TTT92,T@^5C,KB 0ZT:!2J:5!-AVH&5#.AF@75;*CF0#47JGE0S8=J 4IK
MYY:F:)2JGS+ 09:VW4$U#:KI4,V :B94LZ":#=4<J.9"-0^J^5 M0&GM[-(4
MC5)QT>CY QQHB2A4TZ":#M4,J&9"-0NJV5#-@6HN5/-JK3W H8<#'.@7:**T
M=IIHJDBIN(KTQ "'B@<XT#)2J*9!-1VJ&5#-A&H65+.AF@/57*CF034?J@4H
MK9U;FFI3.OZ4 0ZT\!2J:5!-AVH&5#.AF@75;*CF0#47JGE0S8=J 4IK9Y>F
M\)2*OX[T_ $.M-04JFE038=J!E0SH9H%U6RHYD U%ZIYM=8>X"B' QQH!2E*
M:Z>)IH*4BBM(3PQP%/$ !_I5IU!-@VHZ5#.@F@G5+*AF0S4'JKE0S8-J/E0+
M4%K[EP^;XE=%^HP!C@(M@(5J&E33H9H!U4RH9D$U&ZHY4,V%:AY4\Z%:@-+:
MV:4I@%6$)7#G#W#$SL7Y!%KR"M5TJ&9 -1.J65#-AFH.5'.AFE=K[0'.P3=W
M^-!%!BAMER8&[W[=?L72);MC<9R1>;)=Y[M?9=X_2U+V6-Y"=_6%]@9'S]OR
ME2MSGO?DJZ!Z?M#PL^M-D5O\,%U&Y<] L,=B45)_/.R1-%H^[1_DR>:F5ZSM
M0Y+GR:J:?&+A@J7E#,7KCTF2OSTH%_":I,_5ZLS^ E!+ P04    " "BA)I8
M87!/DS8$  ".$P  &@   'AL+W=O<FMS:&5E=',O<VAE970Q,#0N>&ULK5A;
M<ZLV$/XK&MKIM#,)6.)F4MLS23B=]N&TF9Q>GF58VTP <21A)_^^$A!\B8SM
MB5]L!/M]VOVT6A9--HR_B!6 1*]%7HJIM9*RNG,<D:R@H,)F%93JR8+Q@DHU
MY$M'5!QHVH"*W"&C4> 4-"NMV:2Y]\1G$U;+/"OAB2-1%P7E;P^0L\W4PM;[
MC>=LN9+ZAC.;5'0)WT#^4SUQ-7)ZEC0KH!09*Q&'Q=2ZQW<Q]C6@L?@W@XW8
MN48ZE#EC+WKP1SJU1MHCR"&1FH*JOS4\0IYK)N7']X[4ZN?4P-WK=_;?FN!5
M,',JX)'E_V6I7$VML8526- ZE\]L\SMT 34.)BP7S2_:M+9A:*&D%I(5'5AY
M4&1E^T]?.R%V #@X B =@!P"O", MP.XYP*\#N URK2A-#K$5-+9A+,-XMI:
ML>F+1LP&K<+/2KWNWR173S.%D[,OW^M,OJ&?8Y TR\4OZ!8]_X@<)%:4@Y@X
M4LVA+9VDXWMH^<@1/DS05U;*E4!?RA32?0)'.==[2-X]?""#C#$D-G+Q#2(C
MXAH<>CP?3@SP^'PX'HC&[?5V&S[W&%\FDIR)F@/JI+^?"\E5^INT;KD\,Y<N
M"7>BH@E,+;7G!? U6+.??L#!Z%>33M<DBZ]$MJ>AUVOH#;'/_JR+.7#$%EV6
MWJ"_:BDD+=.L7-X@*M$<EEE9JI&J"3DM$S")VT[B-Y/H\KB>N>$X(&-_XJQW
M=?MHAP/?BTBX;Q</.FV6! VHX?=J^(-JW*^!JPJ-*IXE<'[T+6EPA%35@/'(
M]CU3'IU$1L0V[M1X,)#+%0IZA8(+\^49JIHG*_6^2$W:!!]6G.# =:.#Q#"9
MN=CUQP>)8;+SR,C'O=U>6&$?5GC^PJMW\&!(X:E%\T,;AZ;E/HD,L>T%IN4^
MB<0XLJ-H8(7'O13C,U=8JN9'5=>W?JE3R%5CP2%%M7HA<217T#Z[U>U"BA)6
MJ!Y*T*8+J=1V,:DW_K""MX1$6(>]EQ&#7EY:8J]$MB=HU L:75)4KB)B=#*1
M(IN,32DXZ.NELEZ);$]6/-JV6Z,+:]'?G)9B 5RKN^"L0/ */,D$-$:2)2^(
M55I8<S<V.-VE+<)5V>*.;6_;>!X)@LA<^/!.TXHO*'WR<PH.3G6Q@M=DBSNV
MH1)*/)L$0ZE)MJ*2SZ9F^T!M]U+R;%YK38V2#DYTL:379(L[MH.D]'S_2$YN
M&WL\V/.>RLESI;MJRW]5MKAC&WRA8SORAK)QV^/CSS;YT%P.];C8U.*'KA<>
M=&B/1D/#MT!L,#S\&-B/=]O%XTO;^#/B.]F*'WVEGH8>Z__CTU##!T"KBK-S
M4%$ 7S8'/GI3U*5L3P3ZN_VATGUSE')P_T$?-C4'(%N:]J3J*^7JZT>@'!:*
M<F2'REO>'OZT \FJYCADSJ1D17.Y JJZ&FV@GB\8D^\#/4%_!#?['U!+ P04
M    " "BA)I8$+H+DR\%  !L(P  &@   'AL+W=O<FMS:&5E=',O<VAE970Q
M,#4N>&ULM9IK<^(V%(;_BH;N='9GNO$-7TB!F8#!36>WFR';]D.G'Q0LP+.V
MQ4HB;/KK*]F.P<0H>.=L/@1?]#Z2>8_LHX.'>\J^\ TA GW+TIR/>ALAMM>&
MP9<;DF%^1;<DEV=6E&58R%VV-OB6$1P7HBPU;-/TC PG>6\\+([=L?&0[D2:
MY.2.(;[+,LR>)B2E^U'/ZCT?6"3KC5 'C/%PB]?DGH@_MW=,[ADU)4XRDO.$
MYHB1U:AW8UU'EJ\$18N_$K+G1]M(7<H#I5_4SFT\ZIEJ1"0E2Z$06'X\DBE)
M4T62X_A:07MUGTIXO/U,GQ<7+R_F 7,RI>G?22PVHU[00S%9X5TJ%G3_&ZDN
MR%6\)4UY\1_MR[9NOX>6.RYH5HGE"+(D+S_QM^J+.!)8WAF!70GL4\&Y'IQ*
MX%PJZ%>"_J4"MQ*XEPJ\2N!=*O K0>&^47Z[A34A%G@\9'2/F&HM:6JC\+=0
M2T>27(7BO6#R;")U8CS[NDO$$WH;$H&3E*,_,&-81<<[]!Y-%A_0V\6;=VCQ
M!B4Y^KRA.X[SF \-(;M6 &-9=3,IN['/=&/9Z"/-Q8:C61Z3N DPY)CK@=O/
M Y_86F)(EE?(L7Y!MFD[+0.:7BZW6^3AY7*K13[3RS]B=H7L_MG!S_7RWW$N
MY?[9P4=Z^:>EJ.66Q@JGCB&GX#EG>+<KQN\%%D3>HL0'>?)6;G+TC]I$Q?:_
M;1%30OOM4'4+ON9;O"2CGKS'<L(>26_\\T^69_[:YC8D+(2$S2!A<TA8! 1K
MQ$R_CIF^CCZ^WV!&T!)O$X'3MN@HY=X9N;PA67Y;''R?+-0.MJOCD+ Y)"P"
M@C4<=VO'7:WCGZET&N6[[($P1%>(JPAH?924'+?@J%3J<3QP?-L.''FS>CPV
M^]*&H79D7>V%A,TA81$0K&&O5]OK:>V]V8D-9<E_)-;-:N^UZ>F:;;/Z^V2A
M=L1=;8>$S2%A$1"L8;M?V^YK;;_#3^JIKR9TG#PF,3F3'OHOIJKGNL[@9$*W
MM/(".SB9S?YKT2#1[5F9]EJZ>@@)BX!@#0^#VL- ZV%8&2<=Y((E#SMQFJ&7
M'@8OW.E[?G#BSK2EE6\.[!,/VUB![S1;S;3C[NH7)"P"@C7\&M1^#2[RBZ,M
M3F(D*,II_GXIUU>,IK+Q6B[6!)']BM:I.'CQU5N!KVZ@#1M;6@U\QSNQL8WE
M]4]"8J:]G*XV0L(B(%C#1LL\K+U-K9%3S#>([L0JI?O6-;7Y:C9K.]Z@[8EY
M@=2UG?9D^'6M;:D\J^T.J[_BKEZ#TB(H6M/MHTJ+I7<[Q9RC&_2)Q4F.V1,J
MUD!RG9P1E1.WKI'UR*Z+9%!:"$J;@=+FH+0(BM8,'/L0./:/J*]45*C8@:2%
MH+09*&T.2HN@:,W8.93F+&T5I\.JNP(U$[>!^DGC-,.[N&6H'UQGFT%+::"T
M"(K6M/E03;/TY;0%V>[8<H,Y42;3YR>,QFW(NM(4E!:"TF85[3A:9:BJOV:P
MSEL:RL2XWW?]9L.HK:$3.)9Y"/^FC8<2F:6OD94IPJ1;B@!90IJ"TD)0V@R4
M-@>E15"T9N <BF^6]T-2!,@ZU!24%H+29J"T.2@M@J(U8^=0P;/T);P.*<++
M^ES?#4S;]YS3%.'2EJ%^<)UM!JWP@=(B*%IILW'TFW]&V+IXG8.C)=WEHOP5
MO3Y:OS)R4[PH<7)\8EV'Y8L?!TSY'LI'S-9)SE%*5A)I7OG23E:^VE'N"+HM
MWBQXH$+0K-C<$!P3IAK(\RM*Q?..ZJ!^P6;\/U!+ P04    " "BA)I8^&5/
MR],#   Y#0  &@   'AL+W=O<FMS:&5E=',O<VAE970Q,#8N>&ULK5==;]LV
M%/TKA%8,"=!9'Y1D.;,-U%&*#5B+P%G79UJB+2T2Z9*4W?[[75**:CNTG %^
ML47JGB.>0^K>J^F>BV=94*K0][IB<N842FWO7%=F!:V)'/$M97!GS45-% S%
MQI5;04EN0'7E!IX7NS4IF3.?FKE',9_R1E4EHX\"R::NB?BQH!7?SQS?>9E8
MEIM"Z0EW/MV2#7VBZLOV4<#([5GRLJ9,EIPA0=<SYX-_E_J>!IB(?TJZEP?7
M2$M9<?ZL!W_F,\?3*Z(5S92F(/"WH_>TJC03K.-;1^KTS]3 P^L7]H]&/(A9
M$4GO>?6US%4Q<Q('Y71-FDHM^?X/V@F*-%_&*VE^T;Z+]1R4-5+QN@/#"NJ2
MM?_D>V?$ <"/SP""#A"< L(S -P!\%L!80<(C3.M%.-#2A293P7?(Z&C@4U?
M&#,-&N273._[DQ)PMP2<FC\0P4JVD6A+X3041%!T\_#X=(MN4JI(6<E;]!M:
M+/]"-\MWMVCY#KEME$0E0U]8J>1[/0N#OPO>2,)R.745+$S3NUFWB$6[B.#,
M(OP ?>),%1(]L)SFQP0N*.IE!2^R%L$@8TJS$<+^>Q1X ;8LZ/[M\, "3]\.
M]P?4X'Z3L.'#9_@^-S451'%AL[:%AG:H3AMW<DLR.G,@+T@J=M29__J+'WN_
MVVRY)EEZ);(CR\+>LG"(??X94F;),EY31)02Y:I19%51I#BBWYI2_4 %KW(J
M).)KI J*MG"HF;(9W#XH/O,@./PXB7$0VNR\#!WC*)[8S+L(#0*,@WC JJBW
M*AH\72EE'#++N?,57?-\79,LO1+9D6EQ;UH\>+Z^FH)"<T1V\&IN*&)-O8(4
M"J<)JJM4D @AK7:YTF9K2Q\9>EV<=_-DDF /1Y P=H>6O0Z<>!A''AX?!Z:6
M0!Q,_##Q^L CJ>->ZGA0ZL-Z#47:O"AY636F7*\%KQ$4I^P9\:V>D0@40R,@
MX5W+M"]M+6ETA;#)'[]:[-B+PTEP(OYU&$CRDNA$^NNPQ/<3/[$+3WKAR?7V
M&)'\7RC7$ W-F,DHU/AV:)O-B,2RO1&.DQ"?6&$+C./0#TX\2RV!H>^!;V?L
MF/1V3 ;M6!!99HA:&@9H#6S2)I=26#C"GBU+O 'HV_)M>A$8C/!DX.WWO9]M
MDS=H1JJW%#;[?]C1,0[*"L8V/]Z"]*U]RF4D.#*V.>(>])30?6Q,;RY1QANF
MVCZLG^W[_P^FZSV97^CO M.K_J1I/RH^$;$I(7-4= V4WF@,9U:T?7H[4'QK
M.M<55] 'F\L"OFVHT %P?\VY>AGH!_1?2_/_ %!+ P04    " "BA)I8H4Y[
MW%8$  !<$   &@   'AL+W=O<FMS:&5E=',O<VAE970Q,#<N>&ULK5A=;]LV
M%/TKA!8,+=!&(D6)4F8;:*(6*["V@9MN#\,>:)NVA$JB1M)V\N]'4HIBR[03
M+'ZQOLZYY#G\NM>C+1<_9<Z8 O=56<NQERO57/F^G.>LHO*2-ZS67Y9<5%3I
M1['R92,875A25?HH"&*_HD7M34;VW:V8C/A:E47-;@60ZZJBXN&:E7P[]J#W
M^&):K')E7OB344-7[#M3/YI;H9_\/LJBJ%@M"UX#P99C[P.\RB V!(OXLV!;
MN7,/C)09YS_-P^?%V M,CUC)YLJ$H/JR83>L+$TDW8]_NZ!>WZ8A[MX_1O]D
MQ6LQ,RK9#2__*A8J'WN)!Q9L2=>EFO+M[ZP3%)EX<UY*^PNV+99$'IBOI>)5
M1]8]J(JZO=+[SH@= HR/$%!'0$/"L1;"CA"^E( [@K7:;Z58'S*JZ&0D^!8(
M@];1S(TUT[*U_*(VX_Y="?VUT#PUF;(-J]<,O,F8HD4IWX+WX'KZ!W@SO7@+
MIA>@J,%=SM>2U@LY\I5NT?#\>1?]NHV.CD2'"'SAM<HE^%@OV&(_@*^[VO<7
M/?;W&IV,F+'Y)0CA.X "%#HZ=/-R.G+0LY?3X0DU8>]^:..%1^)]Y8I)H+T%
M7.5, ';?E+2FBHL'[7R[JLWJ^)O.I!)ZC?SC&H.V#>QNPVP<5[*A<S;V],X@
MF=@P;_+K+S .?G/Y=\Y@V9F"[7F+>V_QJ>B3NW5AO5LRYIRY+3L^MBXN0!@%
M$8H"ETG/<E&"2!03ER?/<R'"49*>L"#J+8A.6O#-3"J7]I8669HY&383%(=I
MJ/N[V97I@,$PP,$^+#N$P9A@#'O87N?COO/QR;61L<7:G@W.T8O/.>?/&2P[
M4[ ]STCO&?F_T=O?K)!SOJZ5W7-T$L%+*F1>-$Z/R<&XOD<X""$>3!,G#N)@
M@,M<.)2B"+LG2M*+3EXG^B,5Y0-HZ(/.5Q18=!8X)2>'782IW@>&DAVX%*%P
MJ-@!PVE"4K?@M!><OD[PE*FU<*^;U#$&A.!PH,\!PQ$.T$"?"X9"$KKUP> I
M*0E>I_".WKMW]2[P_@ABO1U' X5.8$""@UGK A*M$AT1N9-YP=>)O)U^^_'U
MLU,E= QC0L(P&:IT 5$4!?%0I0,(29RB([LX1$\RT<E#Z#'#7 I>@;G.!DT>
M(W6:J_(NP67"/93H\/A)2)3"X61U 4.4!A$9BCP$0@+UN7=,Y%,>!T^F,H_)
MQCN]NZP*14LKE'7[+&T:75?-Y%P439^2Z#S[3M!:+ID03.=_&YW^*5U1.9T(
M'4[H-"&"0R<<0$3"B"1#)PZ!,,9!DAS9FN!3U@5/IUTVYQB(H]H'T/!"^Z'K
MB:,JG\V,(AS'KJS]Y@74")/4=5P_3R4)3I#K</9WRBX]B5>V?)7 GBYM1=._
M[4OD#[8P'+R_-J6S+>>>PK1U]Q<J5D4M0<F6.F1P:0I5T9:R[8/BC2WN9ESI
ME61O<UW^,V$ ^ON2ZQ*C>S -]'\H3/X#4$L#!!0    ( **$FEA&. N(V08
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M@^Q%4Y[2!..104C[04A'!^'*9]FB7K]%:U4K(\LFUN3*9Y<B!%1(Q"'HFKP
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M+W=O<FMS:&5E=',O<VAE970Q,3 N>&ULK5AM;^(X$/XK5FYU:J5MB>TD3GJ
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M.5=%"8#?%QHFE^:A7*#]=\7X/U!+ P04    " "BA)I8A^!#+9X$  #Y$0
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M%TF:I;3:.>??8)N K5C)>Y,:X367CVLZFUS)V9&(42UBU)M6L-HBMEA ]X%
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M-$XP:V;XC0'2',#]A1#ZV3%CK/UJB?\ 4$L#!!0    ( **$FEB%$@BG+P0
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MS17W*M+.@=<7BNO9#MS[Z;I?]@]02P,$%     @ HH2:6&#Q+O($ P  U1
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M?9/]T KJALZ-FX#_H3?G>^@V>I;?H.9WRGQ:VW1D._^Y5H9=:U;R33O?E+T
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M'(9IFWB1"<J9H!S'\B%Y^\'B^#FIO?R9IFD<)PE6T3SW*LBQNB4)?/W>,&W
MP.) I#^K-;[;>(<\W@?8GC[6(5BF>"=BF>*U!L1?-V"DJ7^WL3C P'8!ZQV(
M[X\#/>7GQ#'L*J8->X)Q)$TQ!'K1WZ-)@E0G@8]_?["G)([3U(\ YE<0QQ@"
M3R..8 I  X;$<7L.'IU'X>Z<"O<_9,Q^ U!+ P04    " "BA)I8EXJ[',
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M=-&*[T<FSJ*QTWHF=3QQ)EL-1,$2&@I0 <J.\^L+4E(-R- WW5QK98NBR"-
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MWL38XRWKVEL=#7_&:Z5Y,6R8O]]VW0=[[+/\I-CB\/BKPZ.[WO\+4$L#!!0
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M5>\*T+NJWA6@=U6]*T#OJGI7@-Y5]:X O:OJ70%Z5]6[ O2NYF9!@-Y5]:X
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M6?[EX>8G4$L! A0#%     @ H82:6 =!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "AA)I8@DV2E>\
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M=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ H82:6)L#.H#[!0
MR1L  !@              ("!81<  'AL+W=O<FMS:&5E=',O<VAE970S+GAM
M;%!+ 0(4 Q0    ( *&$FEA7WGIPQ0@  %%%   8              " @9(=
M  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " "AA)I8UI0'
M"D\*  "S,0  &               @(&-)@  >&PO=V]R:W-H965T<R]S:&5E
M=#4N>&UL4$L! A0#%     @ H82:6#$K#]G>"   TA0  !@
M ("!$C$  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( *&$
MFE@L+ZXX2B@  /^(   8              " @28Z  !X;"]W;W)K<VAE971S
M+W-H965T-RYX;6Q02P$"% ,4    " "AA)I8) 18+"L*  !]&@  &
M        @(&F8@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%
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M+GAM;%!+ 0(4 Q0    ( **$FEBIYS2MK0D  .,:   9              "
M@:&1  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ HH2:
M6,O O(VE!   =0D  !D              ("!A9L  'AL+W=O<FMS:&5E=',O
M<VAE970Q-"YX;6Q02P$"% ,4    " "BA)I80'+=CPD%  "="@  &0
M        @(%AH   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0
M   ( **$FE@*CRY#LP<  &$0   9              " @:&E  !X;"]W;W)K
M<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ HH2:6,C06[Q0$P  URX
M !D              ("!BZT  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q0
M2P$"% ,4    " "BA)I8>HY(GP0@  "A7@  &0              @($2P0
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( **$FEAB%5N%
MB0,  -@(   9              " @4WA  !X;"]W;W)K<VAE971S+W-H965T
M,3DN>&UL4$L! A0#%     @ HH2:6"WJVON# P  -P@  !D
M ("!#>4  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "B
MA)I8T[$*65 +  #/(   &0              @(''Z   >&PO=V]R:W-H965T
M<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( **$FEA.&J]NA 0  )T*   9
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M970R-BYX;6Q02P$"% ,4    " "BA)I8T(#"$-\%  #X#   &0
M    @('P"P$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (
M **$FE@4<[9[  D  $85   9              " @082 0!X;"]W;W)K<VAE
M971S+W-H965T,C@N>&UL4$L! A0#%     @ HH2:6,1]\V]+ P  9 <  !D
M             ("!/1L! 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"
M% ,4    " "BA)I8C1A]X[H"  #9!0  &0              @(&_'@$ >&PO
M=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( **$FE@\#[G]<C<
M !'%   9              " @; A 0!X;"]W;W)K<VAE971S+W-H965T,S$N
M>&UL4$L! A0#%     @ HH2:6 VGB&3:$@  SCD  !D              ("!
M65D! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " "BA)I8
MSQ25!:<'   ^%@  &0              @(%J; $ >&PO=V]R:W-H965T<R]S
M:&5E=#,S+GAM;%!+ 0(4 Q0    ( **$FEAM4!GZ7@D  %,E   9
M      " @4AT 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%
M  @ HH2:6%;N\=%* @  4@4  !D              ("!W7T! 'AL+W=O<FMS
M:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " "BA)I8Y[4RKO4$  !\"P
M&0              @(%>@ $ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+
M 0(4 Q0    ( **$FECO"''M.@4  "D+   9              " @8J% 0!X
M;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ HH2:6+>N>4.3
M!   *0D  !D              ("!^XH! 'AL+W=O<FMS:&5E=',O<VAE970S
M."YX;6Q02P$"% ,4    " "BA)I8<0;*_ <$  !>"   &0
M@('%CP$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( **$
MFE@F$I,X) <  "L/   9              " @0.4 0!X;"]W;W)K<VAE971S
M+W-H965T-# N>&UL4$L! A0#%     @ HH2:6(9[6>8,#@  #"   !D
M         ("!7IL! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
M    " "BA)I89I 5:F4.  !N*P  &0              @(&AJ0$ >&PO=V]R
M:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( **$FEBH.> \) ,  /D'
M   9              " @3VX 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL
M4$L! A0#%     @ HH2:6 C:0W+(!0  _Q,  !D              ("!F+L!
M 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " "BA)I8K32@
M,BL#  #Q!@  &0              @(&7P0$ >&PO=V]R:W-H965T<R]S:&5E
M=#0U+GAM;%!+ 0(4 Q0    ( **$FEC5'G?5+P,  ,L&   9
M  " @?G$ 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @
MHH2:6(1EG(T0!0  8 T  !D              ("!7\@! 'AL+W=O<FMS:&5E
M=',O<VAE970T-RYX;6Q02P$"% ,4    " "BA)I8=^"E3P@$  !,"   &0
M            @(&FS0$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4
M Q0    ( **$FEAT#A$<>P,  # '   9              " @>71 0!X;"]W
M;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ HH2:6+/7HO[-!
M*PH  !D              ("!E]4! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX
M;6Q02P$"% ,4    " "BA)I8<!Y>3E(%  #H"P  &0              @(&;
MV@$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( **$FEC9
M$>Z6]P(  )$&   9              " @23@ 0!X;"]W;W)K<VAE971S+W-H
M965T-3(N>&UL4$L! A0#%     @ HH2:6!S6FKK] P  V18  !D
M     ("!4N,! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( **$FEA71$P_! L  )!H   9              "
M@9P/ @!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ HH2:
M6)ET]&!)"0  [SP  !D              ("!UQH" 'AL+W=O<FMS:&5E=',O
M<VAE970U.2YX;6Q02P$"% ,4    " "BA)I8JCNK&&D&  "J)@  &0
M        @(%7) ( >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0
M   ( **$FECPQ]T-6 ,  .$(   9              " @?<J @!X;"]W;W)K
M<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ HH2:6/2\\=T6#   FH<
M !D              ("!ABX" 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q0
M2P$"% ,4    " "BA)I8FR82GXP$  "7#P  &0              @('3.@(
M>&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( **$FECW!3[!
ME 0  /H/   9              " @98_ @!X;"]W;W)K<VAE971S+W-H965T
M-C0N>&UL4$L! A0#%     @ HH2:6& >T.%/!   > P  !D
M ("!840" 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " "B
MA)I8WL=7[)P,  ! <P  &0              @('G2 ( >&PO=V]R:W-H965T
M<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( **$FEBAU0"49 (  +X&   9
M          " @;I5 @!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#
M%     @ HH2:6!$@N'#A @  H0H  !D              ("!55@" 'AL+W=O
M<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " "BA)I8J_QU2ET$  #0
M%P  &0              @(%M6P( >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM
M;%!+ 0(4 Q0    ( **$FEB-5,C.Q ,  ,L2   9              " @0%@
M @!X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ HH2:6&.L
MD*D/ P  ? D  !D              ("!_&," 'AL+W=O<FMS:&5E=',O<VAE
M970W,2YX;6Q02P$"% ,4    " "BA)I8KPJ0CWL%   P(@  &0
M    @(%"9P( >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    (
M **$FEAB-:-6Z@(  *H(   9              " @?1L @!X;"]W;W)K<VAE
M971S+W-H965T-S,N>&UL4$L! A0#%     @ HH2:6,?V6V"6!P  9D(  !D
M             ("!%7 " 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"
M% ,4    " "BA)I88\#J!U<#  #&"P  &0              @('B=P( >&PO
M=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( **$FEC\V$,Z# (
M !8%   9              " @7![ @!X;"]W;W)K<VAE971S+W-H965T-S8N
M>&UL4$L! A0#%     @ HH2:6-)P1 4?!P  MR0  !D              ("!
MLWT" 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    " "BA)I8
MEPB1;7@4   7P   &0              @($)A0( >&PO=V]R:W-H965T<R]S
M:&5E=#<X+GAM;%!+ 0(4 Q0    ( **$FEBV31FT2!8  .+Y   9
M      " @;B9 @!X;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%
M  @ HH2:6$.OF(#A"P  36(  !D              ("!-[ " 'AL+W=O<FMS
M:&5E=',O<VAE970X,"YX;6Q02P$"% ,4    " "BA)I8'[TQ7X\#   0$@
M&0              @(%/O ( >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+
M 0(4 Q0    ( **$FEB8J&?;:@0  "H5   9              " @17  @!X
M;"]W;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%     @ HH2:6(@50^SY
M @  @ H  !D              ("!ML0" 'AL+W=O<FMS:&5E=',O<VAE970X
M,RYX;6Q02P$"% ,4    " "BA)I8BJ7DG6T$  "7&   &0
M@('FQP( >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( **$
MFEC2*YK25@4  )\A   9              " @8K, @!X;"]W;W)K<VAE971S
M+W-H965T.#4N>&UL4$L! A0#%     @ HH2:6)MT"Z&0!0  B!T  !D
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M=#DP+GAM;%!+ 0(4 Q0    ( **$FEA+;8%*-08  #4O   9
M  " @6'K @!X;"]W;W)K<VAE971S+W-H965T.3$N>&UL4$L! A0#%     @
MHH2:6$!3V$R: P  E1(  !D              ("!S?$" 'AL+W=O<FMS:&5E
M=',O<VAE970Y,BYX;6Q02P$"% ,4    " "BA)I84:KFW$L(   M2P  &0
M            @(&>]0( >&PO=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4
M Q0    ( **$FEA8<]B$?08  %$E   9              " @2#^ @!X;"]W
M;W)K<VAE971S+W-H965T.30N>&UL4$L! A0#%     @ HH2:6&M$7[GX(
M>,L" !D              ("!U 0# 'AL+W=O<FMS:&5E=',O<VAE970Y-2YX
M;6Q02P$"% ,4    " "BA)I8*C\G#1H$  #B$P  &0              @($#
M)@, >&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4 Q0    ( **$FE@/
ML,QUT@0  '$9   9              " @50J P!X;"]W;W)K<VAE971S+W-H
M965T.3<N>&UL4$L! A0#%     @ HH2:6*"'T5_$ P  ,0X  !D
M     ("!72\# 'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6Q02P$"% ,4
M" "BA)I8:E$[RLH$  !?&0  &0              @(%8,P, >&PO=V]R:W-H
M965T<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    ( **$FE@*2^(&\00  !<?   :
M              " @5DX P!X;"]W;W)K<VAE971S+W-H965T,3 P+GAM;%!+
M 0(4 Q0    ( **$FEB,>0^VW@0  (L8   :              " @8(] P!X
M;"]W;W)K<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0    ( **$FEC![AP3
M%0,   H*   :              " @9A" P!X;"]W;W)K<VAE971S+W-H965T
M,3 R+GAM;%!+ 0(4 Q0    ( **$FEA'4($W^@D  ,^#   :
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M,3 W+GAM;%!+ 0(4 Q0    ( **$FEA&. N(V08  ) J   :
M  " @85B P!X;"]W;W)K<VAE971S+W-H965T,3 X+GAM;%!+ 0(4 Q0    (
M **$FEB>4[@ 5 4  -@4   :              " @99I P!X;"]W;W)K<VAE
M971S+W-H965T,3 Y+GAM;%!+ 0(4 Q0    ( **$FEAU^K<AC00  +H0   :
M              " @2)O P!X;"]W;W)K<VAE971S+W-H965T,3$P+GAM;%!+
M 0(4 Q0    ( **$FEB'X$,MG@0  /D1   :              " @>=S P!X
M;"]W;W)K<VAE971S+W-H965T,3$Q+GAM;%!+ 0(4 Q0    ( **$FEC)"&>S
MN0(  - (   :              " @;UX P!X;"]W;W)K<VAE971S+W-H965T
M,3$R+GAM;%!+ 0(4 Q0    ( **$FEBC1[U;K04  /T>   :
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M,3$W+GAM;%!+ 0(4 Q0    ( **$FEA@\2[R! ,  -40   -
M  "  ?J. P!X;"]S='EL97,N>&UL4$L! A0#%     @ HH2:6)>*NQS
M$P(   L              ( !*9(# %]R96QS+RYR96QS4$L! A0#%     @
MHH2:6,Y8PP$[!P  /DP   \              ( !$I,# 'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( **$FE@A<?>R.P,  *Q$   :              "
M 7J: P!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( **$
MFEA&M$XJCP(  .U!   3              "  >V= P!;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@    !] 'T ="(  *V@ P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>953</ContextCount>
  <ElementCount>571</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>236</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated statements of financial position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/StatementsOfFinancialPosition</Role>
      <ShortName>Consolidated statements of financial position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated statements of income and comprehensive income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome</Role>
      <ShortName>Consolidated statements of income and comprehensive income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated statements of changes in equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/StatementsOfChangesInEquity</Role>
      <ShortName>Consolidated statements of changes in equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated statements of cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated statements of cash flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Disclosure - Corporate information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CorporateInformation</Role>
      <ShortName>Corporate information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Material accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPolicies</Role>
      <ShortName>Material accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Significant accounting judgments, estimates and assumptions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SignificantAccountingJudgmentsEstimatesAndAssumptions</Role>
      <ShortName>Significant accounting judgments, estimates and assumptions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Segment information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SegmentInformation</Role>
      <ShortName>Segment information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Business combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinations</Role>
      <ShortName>Business combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Cash and cash equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CashAndCashEquivalents</Role>
      <ShortName>Cash and cash equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Trade receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TradeReceivables</Role>
      <ShortName>Trade receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Related parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RelatedParties</Role>
      <ShortName>Related parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Other assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/OtherAssets</Role>
      <ShortName>Other assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Investment in associate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InvestmentInAssociate</Role>
      <ShortName>Investment in associate</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Property and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/PropertyAndEquipment</Role>
      <ShortName>Property and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Intangible assets and goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsAndGoodwill</Role>
      <ShortName>Intangible assets and goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Financial assets and financial liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities</Role>
      <ShortName>Financial assets and financial liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Fair value measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FairValueMeasurement</Role>
      <ShortName>Fair value measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Capital management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CapitalManagement</Role>
      <ShortName>Capital management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Labor and social obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligations</Role>
      <ShortName>Labor and social obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Earnings per share (EPS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EarningsPerShareEps</Role>
      <ShortName>Earnings per share (EPS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Expenses and costs by nature</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ExpensesAndCostsByNature</Role>
      <ShortName>Expenses and costs by nature</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Finance result</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinanceResult</Role>
      <ShortName>Finance result</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IncomeTaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Insurance contracts and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InsuranceContractsAndContingencies</Role>
      <ShortName>Insurance contracts and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Non-cash transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Non-cashTransactions</Role>
      <ShortName>Non-cash transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Subsequent event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SubsequentEvent</Role>
      <ShortName>Subsequent event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Material accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesPolicies</Role>
      <ShortName>Material accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Material accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesTables</Role>
      <ShortName>Material accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/MaterialAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Segment information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SegmentInformationTables</Role>
      <ShortName>Segment information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/SegmentInformation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Business combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsTables</Role>
      <ShortName>Business combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinations</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Cash and cash equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CashAndCashEquivalentsTables</Role>
      <ShortName>Cash and cash equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/CashAndCashEquivalents</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Trade receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TradeReceivablesTables</Role>
      <ShortName>Trade receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/TradeReceivables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Related parties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RelatedPartiesTables</Role>
      <ShortName>Related parties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/RelatedParties</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Other assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/OtherAssetsTables</Role>
      <ShortName>Other assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/OtherAssets</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Investment in associate (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InvestmentInAssociateTables</Role>
      <ShortName>Investment in associate (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/InvestmentInAssociate</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Property and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/PropertyAndEquipment</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Intangible assets and goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsAndGoodwillTables</Role>
      <ShortName>Intangible assets and goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/IntangibleAssetsAndGoodwill</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Financial assets and financial liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</Role>
      <ShortName>Financial assets and financial liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Fair value measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FairValueMeasurementTables</Role>
      <ShortName>Fair value measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/FairValueMeasurement</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Labor and social obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsTables</Role>
      <ShortName>Labor and social obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligations</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/Equity</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Earnings per share (EPS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EarningsPerShareEpsTables</Role>
      <ShortName>Earnings per share (EPS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/EarningsPerShareEps</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/Revenue</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Expenses and costs by nature (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ExpensesAndCostsByNatureTables</Role>
      <ShortName>Expenses and costs by nature (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/ExpensesAndCostsByNature</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Finance result (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinanceResultTables</Role>
      <ShortName>Finance result (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinanceResult</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Income taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IncomeTaxesTables</Role>
      <ShortName>Income taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/IncomeTaxes</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Insurance contracts and contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InsuranceContractsAndContingenciesTables</Role>
      <ShortName>Insurance contracts and contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/InsuranceContractsAndContingencies</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Non-cash transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Non-cashTransactionsTables</Role>
      <ShortName>Non-cash transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/Non-cashTransactions</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Corporate information (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CorporateInformationDetailsNarrative</Role>
      <ShortName>Corporate information (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/CorporateInformation</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Material accounting policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesDetails</Role>
      <ShortName>Material accounting policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/MaterialAccountingPoliciesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Material accounting policies (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesDetails1</Role>
      <ShortName>Material accounting policies (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/MaterialAccountingPoliciesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Material accounting policies (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesDetails2</Role>
      <ShortName>Material accounting policies (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/MaterialAccountingPoliciesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Material accounting policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Material accounting policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/MaterialAccountingPoliciesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Segment information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SegmentInformationDetails</Role>
      <ShortName>Segment information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/SegmentInformationTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Segment information (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SegmentInformationDetails1</Role>
      <ShortName>Segment information (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/SegmentInformationTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Business combinations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsDetails</Role>
      <ShortName>Business combinations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinationsTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - Business combinations (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsDetails1</Role>
      <ShortName>Business combinations (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinationsTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Business combinations (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsDetails2</Role>
      <ShortName>Business combinations (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinationsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - Business combinations (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsDetails3</Role>
      <ShortName>Business combinations (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinationsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Business combinations (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsDetails4</Role>
      <ShortName>Business combinations (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinationsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - Business combinations (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsDetails5</Role>
      <ShortName>Business combinations (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinationsTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - Business combinations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsDetailsNarrative</Role>
      <ShortName>Business combinations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinationsTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - Cash and cash equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CashAndCashEquivalentsDetails</Role>
      <ShortName>Cash and cash equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/CashAndCashEquivalentsTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - Cash and cash equivalents (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative</Role>
      <ShortName>Cash and cash equivalents (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/CashAndCashEquivalentsTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - Trade receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TradeReceivablesDetails</Role>
      <ShortName>Trade receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/TradeReceivablesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - Trade receivables (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TradeReceivablesDetails1</Role>
      <ShortName>Trade receivables (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/TradeReceivablesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - Trade receivables (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TradeReceivablesDetails2</Role>
      <ShortName>Trade receivables (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/TradeReceivablesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - Related parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RelatedPartiesDetails</Role>
      <ShortName>Related parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/RelatedPartiesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - Related parties (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RelatedPartiesDetails1</Role>
      <ShortName>Related parties (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/RelatedPartiesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - Related parties (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RelatedPartiesDetailsNarrative</Role>
      <ShortName>Related parties (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/RelatedPartiesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - Other assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/OtherAssetsDetails</Role>
      <ShortName>Other assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/OtherAssetsTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - Other assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/OtherAssetsDetailsNarrative</Role>
      <ShortName>Other assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/OtherAssetsTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - Investment in associate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InvestmentInAssociateDetails</Role>
      <ShortName>Investment in associate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/InvestmentInAssociateTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - Property and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/PropertyAndEquipmentDetails</Role>
      <ShortName>Property and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/PropertyAndEquipmentTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - Intangible assets and goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails</Role>
      <ShortName>Intangible assets and goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IntangibleAssetsAndGoodwillTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - Intangible assets and goodwill (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1</Role>
      <ShortName>Intangible assets and goodwill (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IntangibleAssetsAndGoodwillTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - Intangible assets and goodwill (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2</Role>
      <ShortName>Intangible assets and goodwill (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IntangibleAssetsAndGoodwillTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - Intangible assets and goodwill (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative</Role>
      <ShortName>Intangible assets and goodwill (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IntangibleAssetsAndGoodwillTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - Financial assets and financial liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails</Role>
      <ShortName>Financial assets and financial liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>00000084 - Disclosure - Financial assets and financial liabilities (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1</Role>
      <ShortName>Financial assets and financial liabilities (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>00000085 - Disclosure - Financial assets and financial liabilities (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2</Role>
      <ShortName>Financial assets and financial liabilities (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>00000086 - Disclosure - Financial assets and financial liabilities  (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3</Role>
      <ShortName>Financial assets and financial liabilities  (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>00000087 - Disclosure - Financial assets and financial liabilities (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4</Role>
      <ShortName>Financial assets and financial liabilities (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>00000088 - Disclosure - Financial assets and financial liabilities (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5</Role>
      <ShortName>Financial assets and financial liabilities (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>00000089 - Disclosure - Financial assets and financial liabilities (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6</Role>
      <ShortName>Financial assets and financial liabilities (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>00000090 - Disclosure - Financial assets and financial liabilities (Details 7)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7</Role>
      <ShortName>Financial assets and financial liabilities (Details 7)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>00000091 - Disclosure - Financial assets and financial liabilities (Details 8)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8</Role>
      <ShortName>Financial assets and financial liabilities (Details 8)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>00000092 - Disclosure - Financial assets and financial liabilities (Details 9)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9</Role>
      <ShortName>Financial assets and financial liabilities (Details 9)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>00000093 - Disclosure - Financial assets and financial liabilities (Details 10)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10</Role>
      <ShortName>Financial assets and financial liabilities (Details 10)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>00000094 - Disclosure - Financial assets and financial liabilities (Details 11)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11</Role>
      <ShortName>Financial assets and financial liabilities (Details 11)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>00000095 - Disclosure - Financial assets and financial liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative</Role>
      <ShortName>Financial assets and financial liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>00000096 - Disclosure - Fair value measurement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FairValueMeasurementDetails</Role>
      <ShortName>Fair value measurement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FairValueMeasurementTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>00000097 - Disclosure - Labor and social obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsDetails</Role>
      <ShortName>Labor and social obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligationsTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>00000098 - Disclosure - Labor and social obligations (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsDetails1</Role>
      <ShortName>Labor and social obligations (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligationsTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>00000099 - Disclosure - Labor and social obligations (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsDetails2</Role>
      <ShortName>Labor and social obligations (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligationsTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>00000100 - Disclosure - Labor and social obligations (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsDetails3</Role>
      <ShortName>Labor and social obligations (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligationsTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>00000101 - Disclosure - Labor and social obligations (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsDetails4</Role>
      <ShortName>Labor and social obligations (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligationsTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>00000102 - Disclosure - Labor and social obligations (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsDetails5</Role>
      <ShortName>Labor and social obligations (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligationsTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>00000103 - Disclosure - Labor and social obligations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative</Role>
      <ShortName>Labor and social obligations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligationsTables</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>00000104 - Disclosure - Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EquityDetails</Role>
      <ShortName>Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/EquityTables</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>00000105 - Disclosure - Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EquityDetailsNarrative</Role>
      <ShortName>Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/EquityTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>00000106 - Disclosure - Earnings per share (EPS) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EarningsPerShareEpsDetails</Role>
      <ShortName>Earnings per share (EPS) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/EarningsPerShareEpsTables</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>00000107 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/RevenueTables</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>00000108 - Disclosure - Revenue (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RevenueDetails1</Role>
      <ShortName>Revenue (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/RevenueTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>00000109 - Disclosure - Expenses and costs by nature (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ExpensesAndCostsByNatureDetails</Role>
      <ShortName>Expenses and costs by nature (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/ExpensesAndCostsByNatureTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>00000110 - Disclosure - Finance result (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinanceResultDetails</Role>
      <ShortName>Finance result (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinanceResultTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>00000111 - Disclosure - Income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IncomeTaxesDetails</Role>
      <ShortName>Income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IncomeTaxesTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>00000112 - Disclosure - Income taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IncomeTaxesTables</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>00000113 - Disclosure - Insurance contracts and contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InsuranceContractsAndContingenciesDetails</Role>
      <ShortName>Insurance contracts and contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/InsuranceContractsAndContingenciesTables</ParentRole>
      <Position>113</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>00000114 - Disclosure - Insurance contracts and contingencies (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1</Role>
      <ShortName>Insurance contracts and contingencies (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/InsuranceContractsAndContingenciesTables</ParentRole>
      <Position>114</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>00000115 - Disclosure - Insurance contracts and contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative</Role>
      <ShortName>Insurance contracts and contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/InsuranceContractsAndContingenciesTables</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>00000116 - Disclosure - Non-cash transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Non-cashTransactionsDetails</Role>
      <ShortName>Non-cash transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/Non-cashTransactionsTables</ParentRole>
      <Position>116</Position>
    </Report>
    <Report instance="afyaform20f_2023.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>00000117 - Disclosure - Subsequent event (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SubsequentEventDetailsNarrative</Role>
      <ShortName>Subsequent event (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/SubsequentEvent</ParentRole>
      <Position>117</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>afya-20231231.xsd</File>
    <File>afya-20231231_cal.xml</File>
    <File>afya-20231231_def.xml</File>
    <File>afya-20231231_lab.xml</File>
    <File>afya-20231231_pre.xml</File>
    <File doctype="20-F" isDefinitelyFs="true" isIfrs="true" original="afyaform20f_2023.htm">afyaform20f_2023.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_023.jpg</File>
    <File>image_026.jpg</File>
    <File>image_028.jpg</File>
    <File>image_029.jpg</File>
    <File>image_030.jpg</File>
    <File>image_031.jpg</File>
    <File>image_032.jpg</File>
    <File>image_033.jpg</File>
    <File>image_034.jpg</File>
    <File>image_035.jpg</File>
    <File>image_036.jpg</File>
    <File>image_037.jpg</File>
    <File>image_038.jpg</File>
    <File>image_039.jpg</File>
    <File>image_040.jpg</File>
    <File>image_041.jpg</File>
    <File>image_042.jpg</File>
    <File>image_044.jpg</File>
    <File>image_045.jpg</File>
    <File>image_046.jpg</File>
    <File>image_047.jpg</File>
    <File>image_048.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="46">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="1920">https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>161
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "afyaform20f_2023.htm": {
   "nsprefix": "afya",
   "nsuri": "http://afya.com.br/20231231",
   "dts": {
    "schema": {
     "local": [
      "afya-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "afya-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "afya-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "afya-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "afya-20231231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "afyaform20f_2023.htm"
     ]
    }
   },
   "keyStandard": 296,
   "keyCustom": 275,
   "axisStandard": 38,
   "axisCustom": 0,
   "memberStandard": 52,
   "memberCustom": 164,
   "hidden": {
    "total": 364,
    "http://afya.com.br/20231231": 142,
    "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 218,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 953,
   "entityCount": 1,
   "segmentCount": 236,
   "elementCount": 954,
   "unitCount": 7,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 1920,
    "http://xbrl.sec.gov/dei/2023": 46
   },
   "report": {
    "R1": {
     "role": "http://afya.com.br/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://afya.com.br/role/StatementsOfFinancialPosition",
     "longName": "00000002 - Statement - Consolidated statements of financial position",
     "shortName": "Consolidated statements of financial position",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:Inventories",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome",
     "longName": "00000003 - Statement - Consolidated statements of income and comprehensive income",
     "shortName": "Consolidated statements of income and comprehensive income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:Revenue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:OtherOperatingIncomeExpense",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://afya.com.br/role/StatementsOfChangesInEquity",
     "longName": "00000004 - Statement - Consolidated statements of changes in equity",
     "shortName": "Consolidated statements of changes in equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "AsOf2020-12-31_ifrs-full_IssuedCapitalMember",
      "name": "ifrs-full:Equity",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2020-12-31_ifrs-full_IssuedCapitalMember",
      "name": "ifrs-full:Equity",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://afya.com.br/role/StatementsOfCashFlows",
     "longName": "00000005 - Statement - Consolidated statements of cash flows",
     "shortName": "Consolidated statements of cash flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:IncomeLossBeforeIncomeTaxes",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:IncomeLossBeforeIncomeTaxes",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://afya.com.br/role/CorporateInformation",
     "longName": "00000006 - Disclosure - Corporate information",
     "shortName": "Corporate information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://afya.com.br/role/MaterialAccountingPolicies",
     "longName": "00000007 - Disclosure - Material accounting policies",
     "shortName": "Material accounting policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://afya.com.br/role/SignificantAccountingJudgmentsEstimatesAndAssumptions",
     "longName": "00000008 - Disclosure - Significant accounting judgments, estimates and assumptions",
     "shortName": "Significant accounting judgments, estimates and assumptions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://afya.com.br/role/SegmentInformation",
     "longName": "00000009 - Disclosure - Segment information",
     "shortName": "Segment information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://afya.com.br/role/BusinessCombinations",
     "longName": "00000010 - Disclosure - Business combinations",
     "shortName": "Business combinations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://afya.com.br/role/CashAndCashEquivalents",
     "longName": "00000011 - Disclosure - Cash and cash equivalents",
     "shortName": "Cash and cash equivalents",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://afya.com.br/role/TradeReceivables",
     "longName": "00000012 - Disclosure - Trade receivables",
     "shortName": "Trade receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://afya.com.br/role/RelatedParties",
     "longName": "00000013 - Disclosure - Related parties",
     "shortName": "Related parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://afya.com.br/role/OtherAssets",
     "longName": "00000014 - Disclosure - Other assets",
     "shortName": "Other assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfOtherAssetExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfOtherAssetExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://afya.com.br/role/InvestmentInAssociate",
     "longName": "00000015 - Disclosure - Investment in associate",
     "shortName": "Investment in associate",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfJointVenturesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfJointVenturesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://afya.com.br/role/PropertyAndEquipment",
     "longName": "00000016 - Disclosure - Property and equipment",
     "shortName": "Property and equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://afya.com.br/role/IntangibleAssetsAndGoodwill",
     "longName": "00000017 - Disclosure - Intangible assets and goodwill",
     "shortName": "Intangible assets and goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfIntangibleAssetExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfIntangibleAssetExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities",
     "longName": "00000018 - Disclosure - Financial assets and financial liabilities",
     "shortName": "Financial assets and financial liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://afya.com.br/role/FairValueMeasurement",
     "longName": "00000019 - Disclosure - Fair value measurement",
     "shortName": "Fair value measurement",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:FairValueMeasurementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:FairValueMeasurementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://afya.com.br/role/CapitalManagement",
     "longName": "00000020 - Disclosure - Capital management",
     "shortName": "Capital management",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:CapitalManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:CapitalManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://afya.com.br/role/LaborAndSocialObligations",
     "longName": "00000021 - Disclosure - Labor and social obligations",
     "shortName": "Labor and social obligations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:LaborAndSocialObligationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:LaborAndSocialObligationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://afya.com.br/role/Equity",
     "longName": "00000022 - Disclosure - Equity",
     "shortName": "Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfEquityExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfEquityExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://afya.com.br/role/EarningsPerShareEps",
     "longName": "00000023 - Disclosure - Earnings per share (EPS)",
     "shortName": "Earnings per share (EPS)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://afya.com.br/role/Revenue",
     "longName": "00000024 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://afya.com.br/role/ExpensesAndCostsByNature",
     "longName": "00000025 - Disclosure - Expenses and costs by nature",
     "shortName": "Expenses and costs by nature",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://afya.com.br/role/FinanceResult",
     "longName": "00000026 - Disclosure - Finance result",
     "shortName": "Finance result",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://afya.com.br/role/IncomeTaxes",
     "longName": "00000027 - Disclosure - Income taxes",
     "shortName": "Income taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfIncomeTaxesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfIncomeTaxesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://afya.com.br/role/InsuranceContractsAndContingencies",
     "longName": "00000028 - Disclosure - Insurance contracts and contingencies",
     "shortName": "Insurance contracts and contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfInsuranceContractsAndContingenciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfInsuranceContractsAndContingenciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://afya.com.br/role/Non-cashTransactions",
     "longName": "00000029 - Disclosure - Non-cash transactions",
     "shortName": "Non-cash transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureNoncashTransactionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureNoncashTransactionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://afya.com.br/role/SubsequentEvent",
     "longName": "00000030 - Disclosure - Subsequent event",
     "shortName": "Subsequent event",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesPolicies",
     "longName": "00000031 - Disclosure - Material accounting policies (Policies)",
     "shortName": "Material accounting policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:BusinessCombinationsAndGoodwillPolicyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:BusinessCombinationsAndGoodwillPolicyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesTables",
     "longName": "00000032 - Disclosure - Material accounting policies (Tables)",
     "shortName": "Material accounting policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://afya.com.br/role/SegmentInformationTables",
     "longName": "00000033 - Disclosure - Segment information (Tables)",
     "shortName": "Segment information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://afya.com.br/role/BusinessCombinationsTables",
     "longName": "00000034 - Disclosure - Business combinations (Tables)",
     "shortName": "Business combinations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://afya.com.br/role/CashAndCashEquivalentsTables",
     "longName": "00000035 - Disclosure - Cash and cash equivalents (Tables)",
     "shortName": "Cash and cash equivalents (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://afya.com.br/role/TradeReceivablesTables",
     "longName": "00000036 - Disclosure - Trade receivables (Tables)",
     "shortName": "Trade receivables (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://afya.com.br/role/RelatedPartiesTables",
     "longName": "00000037 - Disclosure - Related parties (Tables)",
     "shortName": "Related parties (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfRelatedPartiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfRelatedPartiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://afya.com.br/role/OtherAssetsTables",
     "longName": "00000038 - Disclosure - Other assets (Tables)",
     "shortName": "Other assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://afya.com.br/role/InvestmentInAssociateTables",
     "longName": "00000039 - Disclosure - Investment in associate (Tables)",
     "shortName": "Investment in associate (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfInvestmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfInvestmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://afya.com.br/role/PropertyAndEquipmentTables",
     "longName": "00000040 - Disclosure - Property and equipment (Tables)",
     "shortName": "Property and equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://afya.com.br/role/IntangibleAssetsAndGoodwillTables",
     "longName": "00000041 - Disclosure - Intangible assets and goodwill (Tables)",
     "shortName": "Intangible assets and goodwill (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:SummaryOfIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:SummaryOfIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables",
     "longName": "00000042 - Disclosure - Financial assets and financial liabilities (Tables)",
     "shortName": "Financial assets and financial liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:FinancialAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:FinancialAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://afya.com.br/role/FairValueMeasurementTables",
     "longName": "00000043 - Disclosure - Fair value measurement (Tables)",
     "shortName": "Fair value measurement (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfFairValueMeasurementExplanaory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:FairValueMeasurementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfFairValueMeasurementExplanaory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:FairValueMeasurementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsTables",
     "longName": "00000044 - Disclosure - Labor and social obligations (Tables)",
     "shortName": "Labor and social obligations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://afya.com.br/role/EquityTables",
     "longName": "00000045 - Disclosure - Equity (Tables)",
     "shortName": "Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfTreasurySharesMovementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfEquityExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfTreasurySharesMovementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfEquityExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://afya.com.br/role/EarningsPerShareEpsTables",
     "longName": "00000046 - Disclosure - Earnings per share (EPS) (Tables)",
     "shortName": "Earnings per share (EPS) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfEarningsPerShareTableExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:DisclosureOfEarningsPerShareTableExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://afya.com.br/role/RevenueTables",
     "longName": "00000047 - Disclosure - Revenue (Tables)",
     "shortName": "Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfNetSalesRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfNetSalesRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://afya.com.br/role/ExpensesAndCostsByNatureTables",
     "longName": "00000048 - Disclosure - Expenses and costs by nature (Tables)",
     "shortName": "Expenses and costs by nature (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:SummaryOfExpensesByNatureTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:SummaryOfExpensesByNatureTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://afya.com.br/role/FinanceResultTables",
     "longName": "00000049 - Disclosure - Finance result (Tables)",
     "shortName": "Finance result (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfFinanceResultTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfFinanceResultTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://afya.com.br/role/IncomeTaxesTables",
     "longName": "00000050 - Disclosure - Income taxes (Tables)",
     "shortName": "Income taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://afya.com.br/role/InsuranceContractsAndContingenciesTables",
     "longName": "00000051 - Disclosure - Insurance contracts and contingencies (Tables)",
     "shortName": "Insurance contracts and contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfLegalProceedingsAndContingencies",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfInsuranceContractsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ScheduleOfLegalProceedingsAndContingencies",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfInsuranceContractsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://afya.com.br/role/Non-cashTransactionsTables",
     "longName": "00000052 - Disclosure - Non-cash transactions (Tables)",
     "shortName": "Non-cash transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:NonCashTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureNoncashTransactionsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:NonCashTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureNoncashTransactionsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://afya.com.br/role/CorporateInformationDetailsNarrative",
     "longName": "00000053 - Disclosure - Corporate information (Details Narrative)",
     "shortName": "Corporate information (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "From2022-01-012022-12-31",
      "name": "ifrs-full:ConsiderationPaidReceived",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31_ifrs-full_SubsidiariesMember",
      "name": "ifrs-full:ConsiderationPaidReceived",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesDetails",
     "longName": "00000054 - Disclosure - Material accounting policies (Details)",
     "shortName": "Material accounting policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_AfyaParticipacoesSAMember",
      "name": "afya:PrincipalActivities",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_AfyaParticipacoesSAMember",
      "name": "afya:PrincipalActivities",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
     "longName": "00000055 - Disclosure - Material accounting policies (Details 1)",
     "shortName": "Material accounting policies (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_ifrs-full_BuildingsMember",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfEstimatedUsefulLivesTableTextBlock",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_ifrs-full_BuildingsMember",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfEstimatedUsefulLivesTableTextBlock",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesDetails2",
     "longName": "00000056 - Disclosure - Material accounting policies (Details 2)",
     "shortName": "Material accounting policies (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_AmendmentsToIAS1Member",
      "name": "ifrs-full:TitleOfInitiallyAppliedIFRS",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory",
       "ifrs-full:DisclosureOfTreasurySharesExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_AmendmentsToIAS1Member",
      "name": "ifrs-full:TitleOfInitiallyAppliedIFRS",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory",
       "ifrs-full:DisclosureOfTreasurySharesExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative",
     "longName": "00000057 - Disclosure - Material accounting policies (Details Narrative)",
     "shortName": "Material accounting policies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:ApplicableTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember",
      "name": "ifrs-full:ApplicableTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "afya:TaxesPolicyExplanation",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://afya.com.br/role/SegmentInformationDetails",
     "longName": "00000058 - Disclosure - Segment information (Details)",
     "shortName": "Segment information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:Assets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_ifrs-full_OperatingSegmentsMember",
      "name": "ifrs-full:Assets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://afya.com.br/role/SegmentInformationDetails1",
     "longName": "00000059 - Disclosure - Segment information (Details 1)",
     "shortName": "Segment information (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:Revenue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember",
      "name": "afya:DepositsFromExternalCustomer",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://afya.com.br/role/BusinessCombinationsDetails",
     "longName": "00000060 - Disclosure - Business combinations (Details)",
     "shortName": "Business combinations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfOtherAssetsTableTextBlock",
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-01-02_custom_DelReyMember",
      "name": "ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://afya.com.br/role/BusinessCombinationsDetails1",
     "longName": "00000061 - Disclosure - Business combinations (Details 1)",
     "shortName": "Business combinations (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-01-02_ifrs-full_LicencesAndFranchisesMember_custom_AcquisitionOfDelReyMember_custom_WithAndWithoutMethodMember",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfDelReyExplanatory",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-01-02_ifrs-full_LicencesAndFranchisesMember_custom_AcquisitionOfDelReyMember_custom_WithAndWithoutMethodMember",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfDelReyExplanatory",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://afya.com.br/role/BusinessCombinationsDetails2",
     "longName": "00000062 - Disclosure - Business combinations (Details 2)",
     "shortName": "Business combinations (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfOtherAssetsTableTextBlock",
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921",
      "name": "ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://afya.com.br/role/BusinessCombinationsDetails3",
     "longName": "00000063 - Disclosure - Business combinations (Details 3)",
     "shortName": "Business combinations (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "From2022-03-032022-03-04_ifrs-full_BrandNamesMember_custom_AlemDaMedicinaMember_custom_ReliefFromRoyaltyMember",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-03-032022-03-04_ifrs-full_BrandNamesMember_custom_AlemDaMedicinaMember_custom_ReliefFromRoyaltyMember",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://afya.com.br/role/BusinessCombinationsDetails4",
     "longName": "00000064 - Disclosure - Business combinations (Details 4)",
     "shortName": "Business combinations (Details 4)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "From2022-04-042022-04-05_ifrs-full_BrandNamesMember_custom_AcquisitionOfCardioPapersMember_custom_ReliefFromRoyaltyMember",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfCardioPapersExplanatory",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-04-042022-04-05_ifrs-full_BrandNamesMember_custom_AcquisitionOfCardioPapersMember_custom_ReliefFromRoyaltyMember",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfCardioPapersExplanatory",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://afya.com.br/role/BusinessCombinationsDetails5",
     "longName": "00000065 - Disclosure - Business combinations (Details 5)",
     "shortName": "Business combinations (Details 5)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "From2022-05-222022-05-23_ifrs-full_BrandNamesMember_custom_AcquisitionOfGlicMember_custom_ReliefFromRoyaltyMember",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfGlicExplanatory",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-05-222022-05-23_ifrs-full_BrandNamesMember_custom_AcquisitionOfGlicMember_custom_ReliefFromRoyaltyMember",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfGlicExplanatory",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
     "longName": "00000066 - Disclosure - Business combinations (Details Narrative)",
     "shortName": "Business combinations (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:Revenue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-01-02_custom_AcquisitionOfDelReyMember",
      "name": "ifrs-full:PercentageOfVotingEquityInterestsAcquired",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://afya.com.br/role/CashAndCashEquivalentsDetails",
     "longName": "00000067 - Disclosure - Cash and cash equivalents (Details)",
     "shortName": "Cash and cash equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:Cash",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:Cash",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
     "longName": "00000068 - Disclosure - Cash and cash equivalents (Details Narrative)",
     "shortName": "Cash and cash equivalents (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:CashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_USDMember",
      "name": "ifrs-full:CashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://afya.com.br/role/TradeReceivablesDetails",
     "longName": "00000069 - Disclosure - Trade receivables (Details)",
     "shortName": "Trade receivables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:ReceivablesGross",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:AllowanceForDoubtfulAccountsFoReceivable1",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://afya.com.br/role/TradeReceivablesDetails1",
     "longName": "00000070 - Disclosure - Trade receivables (Details 1)",
     "shortName": "Trade receivables (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:ReceivablesGross",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_ifrs-full_CurrentMember",
      "name": "afya:ReceivablesGross",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAccountsReceivableByAgingExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://afya.com.br/role/TradeReceivablesDetails2",
     "longName": "00000071 - Disclosure - Trade receivables (Details 2)",
     "shortName": "Trade receivables (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfAllowanceForDoubtfulAccountsExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2020-12-31",
      "name": "ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfAllowanceForDoubtfulAccountsExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://afya.com.br/role/RelatedPartiesDetails",
     "longName": "00000072 - Disclosure - Related parties (Details)",
     "shortName": "Related parties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:TradeReceivablesRelatedPartyTransactions",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfRelatedPartiesExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:TradeReceivablesRelatedPartyTransactions",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfRelatedPartiesExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://afya.com.br/role/RelatedPartiesDetails1",
     "longName": "00000073 - Disclosure - Related parties (Details 1)",
     "shortName": "Related parties (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://afya.com.br/role/RelatedPartiesDetailsNarrative",
     "longName": "00000074 - Disclosure - Related parties (Details Narrative)",
     "shortName": "Related parties (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "From2018-09-052018-09-06_custom_LeaseAgreements1Member",
      "name": "afya:OperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2018-09-052018-09-06_custom_LeaseAgreements1Member",
      "name": "afya:OperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://afya.com.br/role/OtherAssetsDetails",
     "longName": "00000075 - Disclosure - Other assets (Details)",
     "shortName": "Other assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfOtherAssetsTableTextBlock",
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:Advances1",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfOtherAssetsTableTextBlock",
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://afya.com.br/role/OtherAssetsDetailsNarrative",
     "longName": "00000076 - Disclosure - Other assets (Details Narrative)",
     "shortName": "Other assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:OtherAsset",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:OtherAsset",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://afya.com.br/role/InvestmentInAssociateDetails",
     "longName": "00000077 - Disclosure - Investment in associate (Details)",
     "shortName": "Investment in associate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:CurrentAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_ifrs-full_AssociatesMember",
      "name": "ifrs-full:CurrentAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfInvestmentsExplanatory",
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://afya.com.br/role/PropertyAndEquipmentDetails",
     "longName": "00000078 - Disclosure - Property and equipment (Details)",
     "shortName": "Property and equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:PropertyPlantAndEquipmentNetBookValue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:PropertyPlantAndEquipmentNetBookValue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
     "longName": "00000079 - Disclosure - Intangible assets and goodwill (Details)",
     "shortName": "Intangible assets and goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:WriteoffOfIntangibleAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:IntangibleAssetsAndGoodwillNetBookValue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfIntangibleAssetsTableTextBlock",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1",
     "longName": "00000080 - Disclosure - Intangible assets and goodwill (Details 1)",
     "shortName": "Intangible assets and goodwill (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_custom_CarryingAmountsMember",
      "name": "ifrs-full:Goodwill",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_CarryingAmountsMember",
      "name": "ifrs-full:Goodwill",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2",
     "longName": "00000081 - Disclosure - Intangible assets and goodwill (Details 2)",
     "shortName": "Intangible assets and goodwill (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_CustomerRelationshipsMedicineMember",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_CustomerRelationshipsMedicineMember",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative",
     "longName": "00000082 - Disclosure - Intangible assets and goodwill (Details Narrative)",
     "shortName": "Intangible assets and goodwill (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ExplicitProjectionPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ExplicitProjectionPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails",
     "longName": "00000083 - Disclosure - Financial assets and financial liabilities (Details)",
     "shortName": "Financial assets and financial liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:TradeReceivables",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember",
      "name": "ifrs-full:TradeReceivables",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:FinancialAssetsExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1",
     "longName": "00000084 - Disclosure - Financial assets and financial liabilities (Details 1)",
     "shortName": "Financial assets and financial liabilities (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:LoansAndFinancing",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:LoansAndFinancingExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember",
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:FinancialLiabilitiesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2",
     "longName": "00000085 - Disclosure - Financial assets and financial liabilities (Details 2)",
     "shortName": "Financial assets and financial liabilities (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:LoansAndFinancing",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:LoansAndFinancingExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:LoansAndFinancingCurrent",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:LoansAndFinancingExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3",
     "longName": "00000086 - Disclosure - Financial assets and financial liabilities  (Details 3)",
     "shortName": "Financial assets and financial liabilities  (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "ifrs-full:RightofuseAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2020-12-31",
      "name": "ifrs-full:RightofuseAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfLeasesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R87": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
     "longName": "00000087 - Disclosure - Financial assets and financial liabilities (Details 4)",
     "shortName": "Financial assets and financial liabilities (Details 4)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:TradeAndOtherPayablesToRelatedParties",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:AccountsPayableToSellingShareholdersExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:AccountsPayableToSellingShareholdersCurrent",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:AccountsPayableToSellingShareholdersExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5",
     "longName": "00000088 - Disclosure - Financial assets and financial liabilities (Details 5)",
     "shortName": "Financial assets and financial liabilities (Details 5)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "ifrs-full:TradeAndOtherPayablesToRelatedParties",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:AccountsPayableToSellingShareholdersExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2020-12-31_custom_AccountsPayableToSellingShareholdersMember",
      "name": "ifrs-full:TradeAndOtherPayablesToRelatedParties",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:AccountsPayableToSellingShareholders1Explanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R89": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6",
     "longName": "00000089 - Disclosure - Financial assets and financial liabilities (Details 6)",
     "shortName": "Financial assets and financial liabilities (Details 6)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "afya:NotesPayables",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfCarryingAmountOfNotesPayableTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2020-12-31",
      "name": "afya:NotesPayables",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfCarryingAmountOfNotesPayableTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R90": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7",
     "longName": "00000090 - Disclosure - Financial assets and financial liabilities (Details 7)",
     "shortName": "Financial assets and financial liabilities (Details 7)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:FinancialAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValuesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:FinancialAssetsAtFairValue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValuesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R91": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8",
     "longName": "00000091 - Disclosure - Financial assets and financial liabilities (Details 8)",
     "shortName": "Financial assets and financial liabilities (Details 8)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:FinancialAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValuesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:BaseRate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R92": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9",
     "longName": "00000092 - Disclosure - Financial assets and financial liabilities (Details 9)",
     "shortName": "Financial assets and financial liabilities (Details 9)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_ForeignCurrencyExposuresMember_ifrs-full_CurrencyRiskMember",
      "name": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R93": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10",
     "longName": "00000093 - Disclosure - Financial assets and financial liabilities (Details 10)",
     "shortName": "Financial assets and financial liabilities (Details 10)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:LoansAndFinancing",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:LoansAndFinancingExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_ifrs-full_LiquidityRiskMember",
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R94": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11",
     "longName": "00000094 - Disclosure - Financial assets and financial liabilities (Details 11)",
     "shortName": "Financial assets and financial liabilities (Details 11)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2020-12-31",
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R95": {
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
     "longName": "00000095 - Disclosure - Financial assets and financial liabilities (Details Narrative)",
     "shortName": "Financial assets and financial liabilities (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://afya.com.br/role/FairValueMeasurementDetails",
     "longName": "00000096 - Disclosure - Fair value measurement (Details)",
     "shortName": "Fair value measurement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:NoncurrentTradeReceivables",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:LoansAndFinancingLiabilities",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValueMeasurementExplanaory",
       "afya:FairValueMeasurementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R97": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsDetails",
     "longName": "00000097 - Disclosure - Labor and social obligations (Details)",
     "shortName": "Labor and social obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember",
      "name": "afya:StrikePriceeAtMeasurementDateShareOptionsGranted",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember",
      "name": "afya:StrikePriceeAtMeasurementDateShareOptionsGranted",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
     "longName": "00000098 - Disclosure - Labor and social obligations (Details 1)",
     "shortName": "Labor and social obligations (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_RSUsMember",
      "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_RSUsMember",
      "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
     "longName": "00000099 - Disclosure - Labor and social obligations (Details 2)",
     "shortName": "Labor and social obligations (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IPCAMember",
      "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IPCAMember",
      "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R100": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
     "longName": "00000100 - Disclosure - Labor and social obligations (Details 3)",
     "shortName": "Labor and social obligations (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-01_ifrs-full_ShareOptionsMember",
      "name": "afya:StrikePriceeAtMeasurementDateShareOptionsGrante",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAdditionalStockOptionsExplanatory",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-01_ifrs-full_ShareOptionsMember",
      "name": "afya:StrikePriceeAtMeasurementDateShareOptionsGrante",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAdditionalStockOptionsExplanatory",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R101": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsDetails4",
     "longName": "00000101 - Disclosure - Labor and social obligations (Details 4)",
     "shortName": "Labor and social obligations (Details 4)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31_ifrs-full_ShareOptionsMember",
      "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
      "unitRef": "BRLPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfSharebasedCompensationPlanExplanatory",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2020-12-31_ifrs-full_ShareOptionsMember",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "N",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfSharebasedCompensationPlanExplanatory",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R102": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsDetails5",
     "longName": "00000102 - Disclosure - Labor and social obligations (Details 5)",
     "shortName": "Labor and social obligations (Details 5)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31_custom_RestrictedStockUnitsMember",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "N",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfStockOptionExplanatory",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_RestrictedStockUnitsMember1360072343",
      "name": "afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement",
      "unitRef": "N",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfStockOptionExplanatory",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R103": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative",
     "longName": "00000103 - Disclosure - Labor and social obligations (Details Narrative)",
     "shortName": "Labor and social obligations (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ShareBasedCompensationOfEmployees",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ShareBasedCompensationOfEmployees",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R104": {
     "role": "http://afya.com.br/role/EquityDetails",
     "longName": "00000104 - Disclosure - Equity (Details)",
     "shortName": "Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "ifrs-full:NumberOfSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfTreasurySharesMovementExplanatory",
       "afya:DisclosureOfEquityExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:NumberOfSharesRepurchased",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfTreasurySharesMovementExplanatory",
       "afya:DisclosureOfEquityExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R105": {
     "role": "http://afya.com.br/role/EquityDetailsNarrative",
     "longName": "00000105 - Disclosure - Equity (Details Narrative)",
     "shortName": "Equity (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:IssuedCapital",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:NumberOfSharesIssued1",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "afya:DisclosureOfEquityExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R106": {
     "role": "http://afya.com.br/role/EarningsPerShareEpsDetails",
     "longName": "00000106 - Disclosure - Earnings per share (EPS) (Details)",
     "shortName": "Earnings per share (EPS) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfEarningsPerShareTableExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfEarningsPerShareTableExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R107": {
     "role": "http://afya.com.br/role/RevenueDetails",
     "longName": "00000107 - Disclosure - Revenue (Details)",
     "shortName": "Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ProfessionalFeesExpenses",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfNetSalesRevenueExplanatory",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:ProfessionalFeesExpenses",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfNetSalesRevenueExplanatory",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R108": {
     "role": "http://afya.com.br/role/RevenueDetails1",
     "longName": "00000108 - Disclosure - Revenue (Details 1)",
     "shortName": "Revenue (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:PaymentsToSuppliersForGoodsAndServices",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfRevenueBySegmentTableTextBlock",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:PaymentsToSuppliersForGoodsAndServices",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfRevenueBySegmentTableTextBlock",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R109": {
     "role": "http://afya.com.br/role/ExpensesAndCostsByNatureDetails",
     "longName": "00000109 - Disclosure - Expenses and costs by nature (Details)",
     "shortName": "Expenses and costs by nature (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:CostOfSales",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:ExpenseByNature",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfExpensesByNatureTableTextBlock",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R110": {
     "role": "http://afya.com.br/role/FinanceResultDetails",
     "longName": "00000110 - Disclosure - Finance result (Details)",
     "shortName": "Finance result (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:InvestmentIncome",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFinanceResultTableTextBlock",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:InvestmentIncome",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFinanceResultTableTextBlock",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R111": {
     "role": "http://afya.com.br/role/IncomeTaxesDetails",
     "longName": "00000111 - Disclosure - Income taxes (Details)",
     "shortName": "Income taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:ProfitLossBeforeTax",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:TaxExpenseIncomeAtApplicableTaxRate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R112": {
     "role": "http://afya.com.br/role/IncomeTaxesDetailsNarrative",
     "longName": "00000112 - Disclosure - Income taxes (Details Narrative)",
     "shortName": "Income taxes (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DeferredTaxExpenseIncome",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ifrs-full:DeferredTaxExpenseIncome",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R113": {
     "role": "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails",
     "longName": "00000113 - Disclosure - Insurance contracts and contingencies (Details)",
     "shortName": "Insurance contracts and contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember",
      "name": "ifrs-full:Provisions",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfLegalProceedingsAndContingencies",
       "afya:DisclosureOfInsuranceContractsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember",
      "name": "ifrs-full:Provisions",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfLegalProceedingsAndContingencies",
       "afya:DisclosureOfInsuranceContractsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R114": {
     "role": "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1",
     "longName": "00000114 - Disclosure - Insurance contracts and contingencies (Details 1)",
     "shortName": "Insurance contracts and contingencies (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:OtherProvisions",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfSocialSecurityProceedingsAssessedByManagement",
       "afya:DisclosureOfInsuranceContractsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "ifrs-full:OtherProvisions",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfSocialSecurityProceedingsAssessedByManagement",
       "afya:DisclosureOfInsuranceContractsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R115": {
     "role": "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative",
     "longName": "00000115 - Disclosure - Insurance contracts and contingencies (Details Narrative)",
     "shortName": "Insurance contracts and contingencies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "115",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "afya:JudicialDeposits",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfOtherAssetsTableTextBlock",
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_OtherAssetsNonCurrentMember",
      "name": "afya:JudicialDeposits",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfInsuranceContractsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "unique": true
     }
    },
    "R116": {
     "role": "http://afya.com.br/role/Non-cashTransactionsDetails",
     "longName": "00000116 - Disclosure - Non-cash transactions (Details)",
     "shortName": "Non-cash transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "116",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:RemeasurementOfEarnOut",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:NonCashTransactionsTableTextBlock",
       "afya:DisclosureNoncashTransactionsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "afya:RemeasurementOfEarnOut",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:NonCashTransactionsTableTextBlock",
       "afya:DisclosureNoncashTransactionsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    },
    "R117": {
     "role": "http://afya.com.br/role/SubsequentEventDetailsNarrative",
     "longName": "00000117 - Disclosure - Subsequent event (Details Narrative)",
     "shortName": "Subsequent event (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "117",
     "firstAnchor": {
      "contextRef": "From2024-01-232024-01-24_custom_FaculdadesIntegradasPadraoMember",
      "name": "afya:PotentialAdditionalPayment",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-232024-01-24_custom_FaculdadesIntegradasPadraoMember",
      "name": "afya:PotentialAdditionalPayment",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2023.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "afya_AccountsPayableCurrent1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccountsPayableCurrent1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "label": "AccountsPayableCurrent1"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholderCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccountsPayableToSellingShareholderCashFlows",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows payments and deductions",
        "documentation": "The amount refers to accounts payable to selling shareholder cash flows."
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccountsPayableToSellingShareholders",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable to selling shareholders (iii)"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholders1Explanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccountsPayableToSellingShareholders1Explanatory",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of accounts payable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccountsPayableToSellingShareholdersAcquisitionOfIpec",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition of licenses",
        "documentation": "The amount refers to accounts payable to selling shareholders acquisition of ipec."
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersBusinessCombinations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccountsPayableToSellingShareholdersBusinessCombinations",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions consideration to be transferred on business combinations",
        "documentation": "The amount refers to accounts payable to selling shareholders business combinations."
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccountsPayableToSellingShareholdersCurrent",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "documentation": "The amount refers to accounts payable to selling shareholders current.",
        "label": "Accounts Payable To Selling Shareholders Current"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccountsPayableToSellingShareholdersExplanatory",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of accounts payable to selling shareholders"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccountsPayableToSellingShareholdersMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable To Selling Shareholders [member]",
        "documentation": "This member stands for accounts payable to selling shareholders."
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccountsPayableToSellingShareholdersNonCurrent",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "documentation": "The amount refers to accounts payable to selling shareholders non current.",
        "label": "Accounts Payable To Selling Shareholders Non Current"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccountsPayableToSellingShareholdersOneMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable To Selling Shareholders One [member]",
        "documentation": "This member stands for accounts payable to selling shareholders."
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccountsPayableToSellingShareholdersPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable to selling shareholders",
        "label": "AccountsPayableToSellingShareholdersPolicyExplanatory"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccountsPayableToSellingShareholdersTwoMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable To Selling Shareholders Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccruedInterestOfOpeartingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AccruedInterestOfOpeartingActivities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated depreciation and amortisation [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]"
       }
      }
     },
     "auth_ref": [
      "r53",
      "r355",
      "r362",
      "r366",
      "r367"
     ]
    },
    "afya_AcquiredShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AcquiredShares",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired shares"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AcquisitionOfCardioPapersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AcquisitionOfCardioPapersMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition Of Cardio Papers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AcquisitionOfDelReyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AcquisitionOfDelReyMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition Of Del Rey [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AcquisitionOfGlicMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AcquisitionOfGlicMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails5",
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition Of Glic [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AcquisitionOfNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AcquisitionOfNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition of non-controlling interests"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase consideration transferred",
        "verboseLabel": "Consideration transferred, acquisition-date fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "afya_AcquisitiondateFairValueOfTotalConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value at the date of acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2",
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction costs of the acquisition (included in cash flows from operating activities)",
        "verboseLabel": "Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination",
        "terseLabel": "Transaction costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Business combinations",
        "label": "Acquisitions through business combinations, intangible assets and goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares for acquisition"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Business combinations",
        "label": "Acquisitions through business combinations, other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in other provisions resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r361"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combination"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionalPaidinCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdditionalPaidinCapital",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_AdditionalPaidinCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdditionalPaidinCapitalMember",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for amounts received from issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "ifrs-full_AdditionalProvisionsOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdditionalProvisionsOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Additions",
        "label": "Additional provisions, other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additional other provisions made. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions and remeasurements of right-of-use assets and lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Additions",
        "label": "Additions other than through business combinations, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Additions",
        "label": "Additions other than through business combinations, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "afya_AdditionsToLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AdditionsToLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, additions",
        "documentation": "The amount of additions to lease liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdditionsToRightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, additions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustedWeightedAverageShares",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of outstanding shares adjusted for the effect of dilution"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentToProfitLossForPreferenceShareDividends",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income attributable to equity holders of the parent"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustment to profit (loss) for non-participating preference share dividends to calculate profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Preference shares [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r270",
      "r271"
     ]
    },
    "afya_AdjustmentsAndEliminationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AdjustmentsAndEliminationsMember",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments And Eliminations [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "label": "Adjustments for decrease (increase) in inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Advances from customers",
        "label": "Adjustments for decrease (increase) in loans and advances to customers"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in loans and advances to customers to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Loans and advances to customers; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "label": "Adjustments for decrease (increase) in other assets"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade receivables",
        "label": "Adjustments for decrease (increase) in trade accounts receivable"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDepreciationAndAmortisationExpense",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share of income of associate",
        "label": "Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for gain (loss) on disposals investments in subsidiaries, joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries, joint ventures and associates reported in separate financial statements; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "ifrs-full_AdjustmentsForIncomeTaxExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForIncomeTaxExpense",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Taxes payable",
        "label": "Adjustments for income tax expense"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInOtherLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Adjustments for increase (decrease) in other liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in other liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other liabilities; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5",
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade payables",
        "label": "Other"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "ifrs-full_AdjustmentsForProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForProvisions",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision (reversal) for legal proceedings"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "ifrs-full_AdjustmentsForReconcileProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLoss",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Adjustments to reconcile profit (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile income before income taxes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net foreign exchange differences"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r288",
      "r370"
     ]
    },
    "ifrs-full_Advances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Advances",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Advances from customers",
        "label": "Advances received, representing contract liabilities for performance obligations satisfied at point in time"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of advances received representing contract liabilities for performance obligations satisfied at a point in time. [Refer: Contract liabilities; Performance obligations satisfied at point in time [member]]"
       }
      }
     },
     "auth_ref": [
      "r349",
      "r351"
     ]
    },
    "afya_Advances1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "Advances1",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advances"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdvancesFromCustomersAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AdvancesFromCustomersAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Advances from customers",
        "label": "Advances From Customers As Of Acquisition Date"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AfyaParticipacoesSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AfyaParticipacoesSAMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Afya Participacoes S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AggregatedMeasurementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AggregatedMeasurementMember",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r109",
      "r157"
     ]
    },
    "ifrs-full_AggregatedTimeBandsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AggregatedTimeBandsMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r167",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r189",
      "r218",
      "r267",
      "r306",
      "r311"
     ]
    },
    "afya_AlemDaMedicinaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AlemDaMedicinaMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails2",
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Alem Da Medicina [member]"
       }
      }
     },
     "auth_ref": []
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "auth_ref": []
    },
    "ifrs-full_AllLevelsOfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AllLevelsOfFairValueHierarchyMember",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r158"
     ]
    },
    "ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AllowanceAccountForCreditLossesOfFinancialAssets",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodStartLabel": "Balances at the beginning of the year",
        "negatedPeriodEndLabel": "Balances at the end of the year",
        "label": "Allowance account for credit losses of financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of an allowance account used to record impairments to financial assets due to credit losses. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r252"
     ]
    },
    "afya_AllowanceForDoubtfulAccountsFoReceivable1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AllowanceForDoubtfulAccountsFoReceivable1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(-) Allowance for doubtful accounts"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AllowanceForDoubtfulAccountsOfOpeartingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AllowanceForDoubtfulAccountsOfOpeartingActivities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for expected credit losses"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AllowanceForExpectedCreditLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AllowanceForExpectedCreditLosses",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Allowance for expected credit losses",
        "label": "AllowanceForExpectedCreditLosses"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "afya_AmendmentsToIAS12Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AmendmentsToIAS12Member",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendments To I A S 12 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AmendmentsToIAS12OneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AmendmentsToIAS12OneMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendments To I A S 12 One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AmendmentsToIAS1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AmendmentsToIAS1Member",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendments To I A S 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AmendmentsToIAS1OneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AmendmentsToIAS1OneMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendments To I A S 1 One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AmendmentsToIAS7AndIFRS7Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AmendmentsToIAS7AndIFRS7Member",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendments To I A S 7 And I F R S 7 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AmendmentsToIAS8Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AmendmentsToIAS8Member",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendments To I A S 8 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AmendmentsToIFRS16Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AmendmentsToIFRS16Member",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendments To I F R S 16 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Amount incurred by entity for provision of key management personnel services provided by separate management entity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount incurred by the entity for provision of key management personnel services that are provided by a separate management entity. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "ifrs-full_AmountsPayableRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AmountsPayableRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Amounts payable, related party transactions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r60",
      "r65"
     ]
    },
    "ifrs-full_AmountsReceivableRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AmountsReceivableRelatedPartyTransactions",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r60",
      "r65"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "ifrs-full_AntidilutiveInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AntidilutiveInstrumentsMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for antidilutive instruments. Instruments are antidilutive when their conversion to ordinary shares would increase earnings per share or decrease loss per share from continuing operations. The calculation of diluted earnings per share does not assume conversion, exercise, or other issue of potential ordinary shares that would have an antidilutive effect on earnings per share. It also represents the standard value for the \u2018Types of antidilutive instruments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ifrs-full_ApplicableTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ApplicableTaxRate",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax rate",
        "verboseLabel": "Combined statutory income taxes rate - %"
       }
      },
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ifrs-full_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Total assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r157",
      "r158",
      "r159",
      "r239",
      "r242"
     ]
    },
    "afya_Assets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "Assets1",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Assets1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AssociatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AssociatesMember",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Associates [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entities over which the investor has significant influence."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r72",
      "r75",
      "r156"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r331",
      "r333",
      "r334"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r331",
      "r333",
      "r334"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r331",
      "r333",
      "r334"
     ]
    },
    "afya_AverageIncrementalFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AverageIncrementalFairValue",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average incremental fair value"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AveragePriceDeliveredUnderSharebasedCompensationPlan": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AveragePriceDeliveredUnderSharebasedCompensationPlan",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average price, delivered under the share-based compensation plan"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AveragePriceRepurchased": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AveragePriceRepurchased",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average price repurchased"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AveragePriceTransferredFromExerciseOfStockOptions": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AveragePriceTransferredFromExerciseOfStockOptions",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average price transferred from exercise of stock options"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AveragePriceTransferredFromSharesContribution": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "AveragePriceTransferredFromSharesContribution",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average price transferred from shares contribution"
       }
      }
     },
     "auth_ref": []
    },
    "afya_BMVAtividadesMedicasLtda.AlemDaMedicinaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "BMVAtividadesMedicasLtda.AlemDaMedicinaMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "B M V Atividades Medicas Ltda. Alem Da Medicina [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BankAndSimilarCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BankAndSimilarCharges",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Bank fees",
        "label": "Bank and similar charges"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of bank and similar charges recognised by the entity as an expense."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "afya_BankCertificatesOfDepositMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "BankCertificatesOfDepositMember",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bank Certificates Of Deposit [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_BaseRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "BaseRate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Base rate",
        "documentation": "The amount refers to base rate."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BasicEarningsLossPerShare",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareEpsDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Per common share",
        "verboseLabel": "Basic earnings per share (R$)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78"
     ]
    },
    "ifrs-full_BasicEarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BasicEarningsPerShareAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings per share"
       }
      }
     },
     "auth_ref": []
    },
    "afya_BertelsmannMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "BertelsmannMember",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bertelsmann [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BorrowingsInterestRateBasis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BorrowingsInterestRateBasis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "ifrs-full_BorrowingsMaturity": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BorrowingsMaturity",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity"
       }
      },
      "en": {
       "role": {
        "documentation": "The maturity of borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bottom of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r183",
      "r198",
      "r292",
      "r293",
      "r377"
     ]
    },
    "ifrs-full_BrandNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BrandNamesMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brand names [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing rights to a group of complementary assets such as a trademark (or service mark) and its related trade name, formulas, recipes and technological expertise. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ifrs-full_BuildingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BuildingsMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Buildings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "afya_BusinessCombinationsAndGoodwillPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "BusinessCombinationsAndGoodwillPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combinations and goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BusinessCombinationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BusinessCombinationsAxis",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combinations [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r211"
     ]
    },
    "afya_BusinessCombinationsLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "BusinessCombinationsLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, business combinations",
        "documentation": "The amount of business combinations."
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r333",
      "r334"
     ]
    },
    "afya_CDIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CDIMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "C D I [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CapitalExpenditures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CapitalExpenditures",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital expenditures"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CapitalIncreaseWithCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CapitalIncreaseWithCash",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital increase"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CapitalManagementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CapitalManagementExplanatory",
     "presentation": [
      "http://afya.com.br/role/CapitalManagement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital management"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CardiPapersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CardiPapersMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cardi Papers [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CardioPapersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CardioPapersMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails2",
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cardio Papers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CardiopapersSolucoesDigitaisLtda.CardioPapersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CardiopapersSolucoesDigitaisLtda.CardioPapersMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cardiopapers Solucoes Digitais Ltda. Cardio Papers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r50",
      "r99",
      "r102",
      "r106",
      "r107",
      "r108",
      "r109",
      "r110",
      "r213",
      "r223",
      "r224"
     ]
    },
    "ifrs-full_CarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CarryingAmountMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r102",
      "r106",
      "r108",
      "r109",
      "r213",
      "r223",
      "r224"
     ]
    },
    "afya_CarryingAmountsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CarryingAmountsMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying Amounts [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and bank deposits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r123",
      "r150"
     ]
    },
    "ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)",
        "verboseLabel": "Cash and cash equivalents in subsidiary or businesses acquired or disposed"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents in subsidiaries or other businesses over which control is obtained or lost. [Refer: Subsidiaries [member]; Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashAndCashEquivalentsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash and equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "ifrs-full_CashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetails",
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "afya_CashEquivalents1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CashEquivalents1Member",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Equivalents [member]",
        "documentation": "This member stands for cash equivalents1."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows generated (used) in financing activities",
        "label": "Cash flows from (used in) financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r125"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows used in investing activities",
        "label": "Cash flows from (used in) investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r125"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investing activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows from operating activities",
        "label": "Cash flows from (used in) operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r111",
      "r125"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CashGeneratingUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CashGeneratingUnits",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash generating units"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CashOutflow": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CashOutflow",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash outflow"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashOutflowForLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashOutflowForLeases",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for leases."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ifrs-full_CashTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashTransferred",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid",
        "verboseLabel": "Cash transferred"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesAxis",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/RelatedPartiesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro De Ciencias Em Saude De Itajuba S. A. C C S I [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CentroDeCienciasEmSaudeDeItajubaSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CentroDeCienciasEmSaudeDeItajubaSAMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro De Ciencias Em Saude De Itajuba S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CentroDeEnsinoSaoLucasLtda.UniSLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CentroDeEnsinoSaoLucasLtda.UniSLMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro De Ensino Sao Lucas Ltda. Uni S L [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CentroIntegradoDeSaudeDeTeresinaCISMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CentroIntegradoDeSaudeDeTeresinaCISMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro Integrado De Saude De Teresina C I S [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro Superior De Ciencias Da Saude S S Ltda. F C M P B [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of changes in liabilities arising from financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CirculationRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CirculationRevenue",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Digital solutions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the sale of newspapers, magazines, periodicals as well as digital applications and formats. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CivilMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CivilMember",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Civil [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ClassAOrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ClassAOrdinarySharesMember",
     "presentation": [
      "http://afya.com.br/role/Cover",
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Ordinary Shares [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ClassBOrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ClassBOrdinarySharesMember",
     "presentation": [
      "http://afya.com.br/role/Cover",
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Ordinary Shares [member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfAssetsAxis",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r83",
      "r160",
      "r178"
     ]
    },
    "ifrs-full_ClassesOfAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfAssetsMember",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r160",
      "r178"
     ]
    },
    "ifrs-full_ClassesOfContingentLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfContingentLiabilitiesAxis",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of contingent liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r212"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfFinancialAssetsAxis",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8",
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r228",
      "r229",
      "r250",
      "r251"
     ]
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfFinancialLiabilitiesAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r229",
      "r250",
      "r251"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets and goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ifrs-full_ClassesOfProvisionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfProvisionsAxis",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of other provisions [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfShareCapitalAxis",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/Cover",
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfShareCapitalMember",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/Cover",
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "afya_ClinicalDecisionSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ClinicalDecisionSoftwareMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Clinical Decision Software [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CliquefarmaDrogariasOnlineLtda.CliquefarmaMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cliquefarma Drogarias Online Ltda. Cliquefarma [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CliquefarmaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CliquefarmaMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1",
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cliquefarma [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClosingForeignExchangeRate": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClosingForeignExchangeRate",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing foreign exchange rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Companhia Nilza Cordeiro Herdy De Educacao E Cultura Unigranrio [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CompanyShareInEquity1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CompanyShareInEquity1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company\u2019s share in equity - 30%"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CompanyShareOfProfitss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CompanyShareOfProfitss",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company\u2019s share of income"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_ComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive income",
        "label": "Total comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r29",
      "r130",
      "r132",
      "r147",
      "r290"
     ]
    },
    "afya_ComprehensiveIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ComprehensiveIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive income",
        "label": "ComprehensiveIncomeLoss"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComputerSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComputerSoftwareMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer software [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "ifrs-full_ConsiderationPaidReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ConsiderationPaidReceived",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate consideration",
        "verboseLabel": "Adjustment for purchase consideration"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "afya_ConsiderationToBeTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ConsiderationToBeTransferred",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration to be transferred",
        "verboseLabel": "Consideration To Be Transferred"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Construction in progress [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "afya_ConsultingFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ConsultingFees",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consulting fees"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ContingenciesCorrespondentAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ContingenciesCorrespondentAmount",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingencies correspondent amount"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ContingentConsiderationOnBusinessCombinations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ContingentConsiderationOnBusinessCombinations",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration to be transferred on business combinations (earn-outs)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ContingentConsiderationRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent consideration recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "ifrs-full_ContingentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ContingentLiabilitiesMember",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the entity; or, present obligations that arise from past events but are not recognised because (a) it is probable that an outflow of resources embodying economic benefits will be required to settle the obligations; or (b) the amount of the obligations cannot be measured with sufficient reliability. It also represents the standard value for the 'Classes of contingent liabilities' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r212"
     ]
    },
    "afya_ContinuingEducationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ContinuingEducationMember",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Continuing Education [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ContractualLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ContractualLeaseTerm",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual lease term"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ContributionForTheFinancingOfSocialSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ContributionForTheFinancingOfSocialSecurityMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contribution For The Financing Of Social Security [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CopyrightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CopyrightMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Copyright [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CorporateInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CorporateInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate Information"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CostOfSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CostOfSale",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of services"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of services",
        "label": "Cost of sales"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r37"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CreditExposure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CreditExposure",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exposure risk"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of exposure to loss resulting from credit risk. [Refer: Credit risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r253",
      "r318",
      "r319"
     ]
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrencyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrencyRiskMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r187",
      "r232"
     ]
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "verboseLabel": "Current assets",
        "label": "Current assets [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r21",
      "r143",
      "r290"
     ]
    },
    "afya_CurrentAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CurrentAssets1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "label": "CurrentAssets1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentAssetsAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentDepositsFromCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentDepositsFromCustomers",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advances from customers"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current deposits from customers. [Refer: Deposits from customers]"
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_CurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentFinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "label": "Current financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "ifrs-full_CurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "label": "Current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "verboseLabel": "Lease liabilities, current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "verboseLabel": "Current liabilities",
        "negatedLabel": "Current liabilities",
        "label": "Current liabilities [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r145",
      "r290"
     ]
    },
    "afya_CurrentLiabilities1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CurrentLiabilities1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "label": "Current Liabilities1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentLiabilitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a current time band."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r314"
     ]
    },
    "ifrs-full_CurrentPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentPrepaidExpenses",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentRecognisedLiabilitiesDefinedBenefitPlan",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Labor and social obligations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current net defined benefit liability. [Refer: Net defined benefit liability]"
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_CurrentTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recoverable taxes"
       }
      },
      "en": {
       "role": {
        "documentation": "The excess of amount paid for current tax in respect of current and prior periods over the amount due for those periods. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentTaxExpenseIncome",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes expense - current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "ifrs-full_CurrentTaxLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentTaxLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes payable"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of current tax liabilities. [Refer: Current tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "afya_CurrentTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CurrentTaxesPayable",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes payable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentTradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition",
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivables",
        "verboseLabel": "Current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r259",
      "r260"
     ]
    },
    "afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CurrentVersusNoncurrentClassificationPoliciesExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current versus non-current classification"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CustomerRelationshipsMedicineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CustomerRelationshipsMedicineMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships Medicine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CustomerRelationshipsOtherCoursesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "CustomerRelationshipsOtherCoursesMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships Other Courses [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CustomerrelatedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CustomerrelatedIntangibleAssetsMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer-related intangible assets [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships."
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "afya_DecreaseForeignCurrencyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DecreaseForeignCurrencyMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease in Foreign Currency Sensitivity -10% [member]",
        "documentation": "The member represent decrease in foreign currency sensitivity."
       }
      }
     },
     "auth_ref": []
    },
    "afya_DecreaseInIncomeBeforeIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DecreaseInIncomeBeforeIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease in income before income taxes"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeductionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DeductionAbstract",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deductions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeductionOfEarlyPaymentDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DeductionOfEarlyPaymentDiscounts",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Early payment discounts"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeductionOfGrantedDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DeductionOfGrantedDiscounts",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount and scholarships"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeductionOfProuni": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DeductionOfProuni",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROUNI"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeductionOfReturnsOfNetRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DeductionOfReturnsOfNetRevenue",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Returns"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeductionOfTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DeductionOfTaxes",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DeferredTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r18",
      "r42"
     ]
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DeferredTaxExpenseIncome",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized deferred income tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ifrs-full_DefinedBenefitObligationAtPresentValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DefinedBenefitObligationAtPresentValue",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined benefit obligation"
       }
      },
      "en": {
       "role": {
        "documentation": "The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]"
       }
      }
     },
     "auth_ref": [
      "r357"
     ]
    },
    "ifrs-full_DefinedBenefitPlansAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DefinedBenefitPlansAxis",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails5",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined benefit plans [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ifrs-full_DefinedBenefitPlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DefinedBenefitPlansMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails5",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "afya_DelReyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DelReyMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Del Rey [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DenominatorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DenominatorAbstract",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Denominator"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DepositsFromExternalCustomer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DepositsFromExternalCustomer",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "External customer"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DepreciationExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation and amortization",
        "label": "Depreciation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "afya_DepreciationExpenseLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DepreciationExpenseLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, depreciation expense",
        "documentation": "The amount of depreciation expense."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DepreciationPropertyPlantAndEquipment",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation",
        "label": "Depreciation, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r49",
      "r52"
     ]
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DepreciationRightofuseAssets",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Right-of-use assets, depreciation expense",
        "label": "Depreciation, right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
     "presentation": [
      "http://afya.com.br/role/CorporateInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate information"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for business combinations. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value measurement",
        "label": "Description of accounting policy for fair value measurement [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible assets",
        "label": "Description of accounting policy for intangible assets other than goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DescriptionOfAccountingPolicyForInvestmentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment",
        "label": "Description of accounting policy for property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for provisions. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ifrs-full_DescriptionOfAcquiree": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAcquiree",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired purchase price"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the business or businesses that the acquirer obtains control of in a business combination. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfDiscountRatesAppliedToCashFlowProjections",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount rate applied to cash flow projections"
       }
      },
      "en": {
       "role": {
        "documentation": "The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88"
     ]
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected volatility",
        "label": "Expected volatility, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of key assumptions on which management has based cash flow projections"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of key assumptions on which management has based its cash flow projections for the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). Key assumptions are those to which the unit's (group of units') recoverable amount is most sensitive. [Refer: Cash-generating units [member]]"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r91"
     ]
    },
    "afya_DescriptionOfLeaseTerm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DescriptionOfLeaseTerm",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of lease term"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DescriptionOfLeaseTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DescriptionOfLeaseTerms",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Description of lease term",
        "label": "DescriptionOfLeaseTerms"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfNatureOfChangeInAccountingPolicy",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the nature of a change in accounting policy related to an initial application of an IFRS. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfOptionPricingModelShareOptionsGranted",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Model used"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the option pricing model used for share options granted. [Refer: Option pricing model [member]]"
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation technique"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Business combinations [member]; Valuation techniques [member]]"
       }
      }
     },
     "auth_ref": [
      "r209"
     ]
    },
    "afya_DevelopedTechnologyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DevelopedTechnologyMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Developed Technology [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DigitalServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DigitalServicesMember",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Digital Services [member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DilutedEarningsLossPerShare",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareEpsDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Per common share",
        "label": "Diluted earnings per share (R$)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78"
     ]
    },
    "ifrs-full_DilutedEarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DilutedEarningsPerShareAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted earnings per share"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of dilution from stock options and restricted share units"
       }
      },
      "en": {
       "role": {
        "documentation": "The potential dilutive effect on the weighted average number of ordinary shares that relate to the assumed exercise of the entity's share options."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "afya_DisclosureCapitalManagementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureCapitalManagementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Management"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureCashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureCashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash And Cash Equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equity"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureFairValueMeasurementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureFairValueMeasurementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureIncomeTaxesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureIncomeTaxesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureInsuranceContractsAndContingenciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureInsuranceContractsAndContingenciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance Contracts And Contingencies"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureIntangibleAssetsAndGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureIntangibleAssetsAndGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets And Goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureLaborAndSocialObligationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureLaborAndSocialObligationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Labor And Social Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureMaterialAccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureMaterialAccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Accounting Policies"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureNoncashTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureNoncashTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureNoncashTransactionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureNoncashTransactionsExplanatory",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash transactions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfAllowanceForDoubtfulAccountsExplanatory",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of allowance for doubtful accounts"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more, and more than, twelve months after reporting date."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsExplanatory",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combinations"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for business combinations."
       }
      }
     },
     "auth_ref": [
      "r215"
     ]
    },
    "ifrs-full_DisclosureOfBusinessCombinationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsTable",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of business combinations."
       }
      }
     },
     "auth_ref": [
      "r211"
     ]
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesInBusinessCombinationTable",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities in business combination [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to contingent liabilities in business combinations."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r212"
     ]
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansTable",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to defined benefit plans."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of borrowings."
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of cash and cash equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of detailed information about property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetailsNarrative",
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareEps"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share (EPS)"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "afya_DisclosureOfEarningsPerShareTableExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfEarningsPerShareTableExplanatory",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareEpsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of earnings per share"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment information"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "afya_DisclosureOfEquityExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfEquityExplanatory",
     "presentation": [
      "http://afya.com.br/role/Equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equity",
        "label": "DisclosureOfEquityExplanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "presentation": [
      "http://afya.com.br/role/SubsequentEvent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent event"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ifrs-full_DisclosureOfExpensesByNatureExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfExpensesByNatureExplanatory",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNature"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses and costs by nature"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of expenses by nature. [Refer: Expenses, by nature]"
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsTable",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementDetails",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the fair value measurement of assets."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "presentation": [
      "http://afya.com.br/role/FinanceResult"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance result"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]"
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "ifrs-full_DisclosureOfFinancialAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsTable",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8",
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial assets."
       }
      }
     },
     "auth_ref": [
      "r230"
     ]
    },
    "ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets that are either past due or impaired [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial assets that are either past due or impaired."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets and financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      }
     },
     "auth_ref": [
      "r233"
     ]
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesTable",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial liabilities [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial liabilities."
       }
      }
     },
     "auth_ref": [
      "r230"
     ]
    },
    "afya_DisclosureOfIncomeTaxesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfIncomeTaxesExplanatory",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table]"
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "afya_DisclosureOfInsuranceContractsAndContingenciesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfInsuranceContractsAndContingenciesExplanatory",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance contracts and contingencies"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureOfIntangibleAssetExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfIntangibleAssetExplanatory",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwill"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets and goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsTable",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "afya_DisclosureOfInvestmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfInvestmentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of investment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfJointVenturesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfJointVenturesExplanatory",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociate"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investment in associate",
        "label": "Disclosure of joint ventures [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of joint ventures. [Refer: Joint ventures [member]]"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r75",
      "r155"
     ]
    },
    "afya_DisclosureOfMaterialAccountingPoliciesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfMaterialAccountingPoliciesExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material accounting policies"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of statements of income for the Company\u2019s operating segments"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      }
     },
     "auth_ref": [
      "r239"
     ]
    },
    "ifrs-full_DisclosureOfOperatingSegmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsTable",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to operating segments."
       }
      }
     },
     "auth_ref": [
      "r239"
     ]
    },
    "afya_DisclosureOfOtherAssetExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfOtherAssetExplanatory",
     "presentation": [
      "http://afya.com.br/role/OtherAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "label": "DisclosureOfOtherAssetExplanatory"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureOfOtherAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfOtherAssetsTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/OtherAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment",
        "label": "Disclosure of property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in goodwill [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill."
       }
      }
     },
     "auth_ref": [
      "r213"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of changes in intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of liabilities arising from financing activities."
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "afya_DisclosureOfRelatedPartiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfRelatedPartiesExplanatory",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of balances and transactions with related parties"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "presentation": [
      "http://afya.com.br/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related parties"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ifrs-full_DisclosureOfRevenueExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfRevenueExplanatory",
     "presentation": [
      "http://afya.com.br/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue",
        "label": "Disclosure of revenue [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue."
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from contracts with customers"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r169"
     ]
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis to changes in risk variables that arise from contracts within scope of IFRS 17 [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the sensitivity analysis to changes in risk variables that arise from contracts within the scope of IFRS 17."
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to subsidiaries."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r75",
      "r154"
     ]
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfTradeAccountsReceivableByAgingExplanatory",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of aging of trade accounts receivable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureOfTradeAndOtherReceivables1Explanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOfTradeAndOtherReceivables1Explanatory",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of trade accounts receivable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://afya.com.br/role/TradeReceivables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade receivables",
        "label": "Disclosure of trade and other receivables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/RelatedPartiesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to transactions between related parties."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable",
     "presentation": [
      "http://afya.com.br/role/SubsequentEventDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations."
       }
      }
     },
     "auth_ref": [
      "r207"
     ]
    },
    "ifrs-full_DisclosureOfTreasurySharesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTreasurySharesExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Treasury shares",
        "label": "Disclosure of treasury shares [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of treasury shares. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "afya_DisclosureOtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureOtherAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Judgments Estimates And Assumptions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosuresOfCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DisclosuresOfCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "DisclosuresOfCashAndCashEquivalentsExplanatory"
       }
      }
     },
     "auth_ref": []
    },
    "afya_Dividend": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "Dividend",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Dividends",
        "label": "Dividend"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DividendDistributed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DividendDistributed",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend distributed"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DividendsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DividendsPaid",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Dividends declared",
        "label": "Dividends recognised as distributions to owners"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends recognised as distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ifrs-full_DividendsPaidClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DividendsPaidClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Dividends paid to non-controlling shareholders",
        "label": "Dividends paid, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for dividends paid by the entity, classified as financing activities."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "ifrs-full_DividendsPaidToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DividendsPaidToNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends paid to non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends paid to non-controlling interests. [Refer: Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "afya_DividendsPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DividendsPayableMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends Payable [member]",
        "documentation": "This member stands for the dividends payable."
       }
      }
     },
     "auth_ref": []
    },
    "afya_DividendsPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DividendsPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DividendsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DividendsReceived",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends received",
        "negatedLabel": "Dividends receivable (included in Other assets)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends received."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "afya_DividendsReceived1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "DividendsReceived1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Dividends received",
        "label": "DividendsReceived1"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r333",
      "r334"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r333",
      "r334",
      "r336"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "afya_EMIVEPatrulha24HorasLtdaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "EMIVEPatrulha24HorasLtdaMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "E M I V E Patrulha 24 Horas Ltda [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ESMCEducacaoSuperiorLtdaESMCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ESMCEducacaoSuperiorLtdaESMCMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "E S M C Educacao Superior Ltda E S M C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "currency_EUR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "EUR",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro"
       }
      }
     },
     "auth_ref": []
    },
    "afya_EducationContentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "EducationContentMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Education Content [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_EducationalContentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "EducationalContentMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Educational Content [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_EducationalCreditsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "EducationalCreditsMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Educational Credits [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_EducationalPlatformMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "EducationalPlatformMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Educational Platform [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net foreign exchange differences",
        "label": "Effect of exchange rate changes on cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r114",
      "r115"
     ]
    },
    "afya_EliminationInterSegmentTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "EliminationInterSegmentTransactionsMember",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elimination (inter-segment transactions) [member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r338"
     ]
    },
    "ifrs-full_EntitysTotalForBusinessCombinationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EntitysTotalForBusinessCombinationsMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r214"
     ]
    },
    "ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EntitysTotalForImpairmentOfFinancialAssetsMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Impairment of financial assets' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "ifrs-full_EntitysTotalForProbabilityOfDefaultMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EntitysTotalForProbabilityOfDefaultMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Probability of default' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r313"
     ]
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EntitysTotalForRelatedPartiesMember",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/RelatedPartiesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ifrs-full_EntitysTotalForSegmentConsolidationItemsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EntitysTotalForSegmentConsolidationItemsMember",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r245"
     ]
    },
    "ifrs-full_EntitysTotalForSubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EntitysTotalForSubsidiariesMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetails2",
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r75",
      "r154"
     ]
    },
    "afya_EqualInstallmentsPayablesToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "EqualInstallmentsPayablesToRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equal installments payables",
        "documentation": "The amount of equal installments payables due to related parties.",
        "label": "Equal installments payables [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_EqualInstallmentsPayablesToRelatedParties1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "EqualInstallmentsPayablesToRelatedParties1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equal installments payables"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementsOfChangesInEquity",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity",
        "periodStartLabel": "Beginning balance, value",
        "periodEndLabel": "Ending balance, value",
        "verboseLabel": "Equity",
        "label": "Equity [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r24",
      "r129",
      "r131",
      "r157",
      "r158",
      "r159"
     ]
    },
    "ifrs-full_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and equity",
        "label": "Total liabilities and equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "ifrs-full_EquityAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Equity attributable to equity holders of the parent",
        "label": "Equity attributable to owners of parent"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "ifrs-full_EquityAttributableToOwnersOfParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityAttributableToOwnersOfParentMember",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity attributable to the owners of the parent."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "afya_EquityInAssociate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "EquityInAssociate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equity",
        "label": "EquityInAssociate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityMember",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "afya_ExpectedLifeOfStockOptions": {
     "xbrltype": "durationItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ExpectedLifeOfStockOptions",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected life of stock options"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseByNature": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpenseByNature",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total",
        "label": "Expenses, by nature"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "afya_ExpenseByNatureOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ExpenseByNatureOne",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "ExpenseByNatureOne"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation expense",
        "label": "Expense from share-based payment transactions with employees"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]"
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount recognized lease expense from short-term leases and low-value assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the expense relating to leases of low-value assets accounted for applying paragraph 6 of IFRS 16. This expense shall not include the expense relating to short-term leases of low-value assets."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "afya_ExplicitProjectionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ExplicitProjectionPeriod",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Explicit projection period"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "F A D E P Faculdade Educacional De Pato Branco Ltda F A D E P [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FADEPFaculdadeEducacionalDePatoBrancoLtdaMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "F A D E P Faculdade Educacional De Pato Branco Ltda [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FCMPBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FCMPBMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FCMPB [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FESARMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FESARMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "F E S A R [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FIESMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FIESMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "F I E S [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FaculdadesIntegradasPadraoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FaculdadesIntegradasPadraoMember",
     "presentation": [
      "http://afya.com.br/role/SubsequentEventDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Faculdades Integradas Padrao [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FairValueMeasurementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FairValueMeasurementExplanatory",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value measurement"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FairValueNotesPayables1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FairValueNotesPayables1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes payable",
        "label": "FairValueNotesPayables1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FeeAndCommissionIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FeeAndCommissionIncome",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails",
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tuition, digital content and app subscription fees - Transferred over time",
        "verboseLabel": "Transferred over time"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income relating to fees and commissions."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "ifrs-full_FinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Finance expenses",
        "negatedTerseLabel": "Finance expenses",
        "label": "Finance costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "afya_FinanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FinanceExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinanceIncome",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance income",
        "verboseLabel": "Finance income",
        "negatedLabel": "Finance results"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "ifrs-full_FinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinanceIncomeCost",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Finance result",
        "label": "Finance income (cost)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income or cost associated with interest and other financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "afya_FinanceResult": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FinanceResult",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Finance result",
        "label": "FinanceResult"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Financial assets, at carrying amount",
        "terseLabel": "Balance as of ending"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r219",
      "r223",
      "r224",
      "r226",
      "r305"
     ]
    },
    "ifrs-full_FinancialAssetsAtAmortisedCostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialAssetsAtAmortisedCostMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets at amortised cost, class [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial assets measured at amortised cost class. [Refer: Financial assets at amortised cost]"
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "ifrs-full_FinancialAssetsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialAssetsAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets, at fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "afya_FinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FinancialAssetsExplanatory",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of financial assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialAssetsMember",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8",
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r190",
      "r228",
      "r229",
      "r250",
      "r251"
     ]
    },
    "ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialAssetsNeitherPastDueNorImpairedMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets neither past due nor impaired [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for financial assets that are neither past due nor impaired. A financial asset is past due when a counterparty has failed to make a payment when contractually due. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialAssetsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for financial assets acquired in a business combination. [Refer: Financial assets; Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r298",
      "r300"
     ]
    },
    "afya_FinancialDiscountsGrantedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FinancialDiscountsGrantedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial discounts granted"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FinancialInstitution": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FinancialInstitution",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial institution",
        "documentation": "Information about financial institution."
       }
      }
     },
     "auth_ref": []
    },
    "afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial instruments - initial recognition and measurement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Financial liabilities, at carrying amount"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtAmortisedCostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialLiabilitiesAtAmortisedCostMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities at amortised cost, class [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial liabilities measured at amortised cost class. [Refer: Financial liabilities at amortised cost]"
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialLiabilitiesAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities, at fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "afya_FinancialLiabilitiesContractualUndiscounted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FinancialLiabilitiesContractualUndiscounted",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities contractual undiscounted",
        "documentation": "The amount of financial liabilities contractual undiscounted."
       }
      }
     },
     "auth_ref": []
    },
    "afya_FinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FinancialLiabilitiesExplanatory",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of financial liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialLiabilitiesMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r228",
      "r229",
      "r250",
      "r251"
     ]
    },
    "ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialLiabilitiesRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities recognised as of acquisition date",
        "verboseLabel": "Total"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for financial liabilities assumed in a business combination. [Refer: Financial liabilities; Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r298",
      "r300"
     ]
    },
    "afya_FirstAnnualInstallmentsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "FirstAnnualInstallmentsPayable",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "First annual installment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FixturesAndFittingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FixturesAndFittingsMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixtures and fittings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r265"
     ]
    },
    "ifrs-full_FloatingInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FloatingInterestRateMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Floating interest rate [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a non-fixed interest rate. [Refer: Interest rate risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "afya_ForeignCurrencyExposuresMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ForeignCurrencyExposuresMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exposure [member]",
        "documentation": "The member represent foreign currency exposures."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Selling, general and administrative expenses",
        "label": "General and administrative expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to general and administrative activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "afya_GlicMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "GlicMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails2",
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Glic [member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Goodwill",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1",
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r84",
      "r89",
      "r213"
     ]
    },
    "ifrs-full_GoodwillMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GoodwillMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ifrs-full_GoodwillRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GoodwillRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill arising on acquisition",
        "verboseLabel": "Goodwill recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300"
     ]
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GrossCarryingAmountMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross carrying amount [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r99",
      "r107",
      "r110",
      "r213",
      "r224",
      "r226",
      "r305"
     ]
    },
    "ifrs-full_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross profit"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]"
       }
      }
     },
     "auth_ref": [
      "r257"
     ]
    },
    "afya_GuaranhunsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "GuaranhunsMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guaranhuns [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_HospitalAndMedicalAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "HospitalAndMedicalAgreements",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hospital and medical agreements"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "I Clinic Desenvolvimento De Software Ltda.i Clinic [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IClinicMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IClinicMember",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "I Clinic [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IESVAPPatrimonialLtdaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IESVAPPatrimonialLtdaMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "I E S V A P Patrimonial Ltda [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IFRS17Member": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IFRS17Member",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IFRS 17 [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for IFRS 17 Insurance Contracts."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r374"
     ]
    },
    "afya_IPCAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IPCAMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "I P C A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IPEMEDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IPEMEDMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPEMED [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "I P T A N Instituto De Ensino Superior Presidente Tancredo De Almeida Neves S. A. I P T A N [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "I P T A N Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ITPACGaranhunsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ITPACGaranhunsMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "I T P A C Garanhuns [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r331",
      "r333",
      "r334"
     ]
    },
    "ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible assets",
        "label": "Identifiable intangible assets recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r298",
      "r300"
     ]
    },
    "afya_IfrsStatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IfrsStatementLineItems",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetails2",
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5",
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/FairValueMeasurementDetails",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IncomeTaxesDetailsNarrative",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails5",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative",
      "http://afya.com.br/role/LaborAndSocialObligationsTables",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative",
      "http://afya.com.br/role/Non-cashTransactionsDetails",
      "http://afya.com.br/role/PropertyAndEquipmentDetails",
      "http://afya.com.br/role/RelatedPartiesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative",
      "http://afya.com.br/role/RevenueDetails1",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementsOfChangesInEquity",
      "http://afya.com.br/role/SubsequentEventDetailsNarrative",
      "http://afya.com.br/role/TradeReceivablesDetails",
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IfrsStatementLineItems [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ImpairmentOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ImpairmentOfFinancialAssetsAxis",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ImpairmentOfNonfinancialAssetsPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of non-financial assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncomeLossBeforeIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IncomeLossBeforeIncomeTaxes",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income before income taxes",
        "label": "IncomeLossBeforeIncomeTaxes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income taxes expenses",
        "label": "Income taxes expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r35",
      "r39",
      "r40",
      "r41",
      "r68",
      "r153",
      "r238"
     ]
    },
    "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income taxes paid",
        "label": "Income taxes paid (refund), classified as operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]"
       }
      }
     },
     "auth_ref": [
      "r117",
      "r280"
     ]
    },
    "afya_IncreaseBasisPointsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IncreaseBasisPointsMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in basis points +75 [member]",
        "documentation": "This member stands for increase basis points."
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncreaseBasisPointsOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IncreaseBasisPointsOneMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in basis points +150 [member]",
        "documentation": "This member stands for increase basis points one."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9",
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect on profit before tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of increase (decrease) in the fair value measurement of assets, recognised in profit or loss before tax, due to a reasonably possible decrease in an unobservable input. [Refer: Tax income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Effect on profit before tax",
        "label": "Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of increase (decrease) in the fair value measurement of assets, recognised in profit or loss before tax, due to a reasonably possible increase in an unobservable input. [Refer: Tax income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "afya_IncreaseDecreaseInOperatingLiabilities1Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IncreaseDecreaseInOperatingLiabilities1Abstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncreaseDecreaseInRecoverableTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IncreaseDecreaseInRecoverableTaxes",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Recoverable taxes",
        "label": "IncreaseDecreaseInRecoverableTaxes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of principal"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Business combination",
        "label": "Increase (decrease) through obtaining or losing control of subsidiaries or other businesses, liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from obtaining or losing control of subsidiaries or other businesses. [Refer: Liabilities arising from financing activities; Subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Increase (decrease) through other changes, liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transfer"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r356"
     ]
    },
    "afya_IncreaseForeignCurrencyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IncreaseForeignCurrencyMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in Foreign Currency Sensitivity +10% [member]",
        "documentation": "The member represent increse in foreign currency sensitivity."
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncreaseInIncomeBeforeIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IncreaseInIncomeBeforeIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in income before income taxes"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncreaseInRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IncreaseInRevenue",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in revenue"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest",
        "documentation": "The amount of increase through interest on liabilities arising from financing activities.",
        "label": "IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Addition"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r285",
      "r288"
     ]
    },
    "afya_IncrementalStockOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IncrementalStockOptionsMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Stock Options [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IndemnificationAssetsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2",
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total identifiable net assets at fair value",
        "verboseLabel": "Indemnification assets recognised as of acquisition date",
        "terseLabel": "Indemnification assets (i)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "afya_IndexRatePerYear": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IndexRatePerYear",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Index - % per year",
        "documentation": "Information about index rate per year."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InitiallyAppliedIFRSsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InitiallyAppliedIFRSsAxis",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initially applied IFRSs [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ifrs-full_InitiallyAppliedIFRSsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InitiallyAppliedIFRSsMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for IFRSs that have been initially applied by the entity. It also represents the standard value for the 'Initially applied IFRSs' axis if no other member is used. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto De Educacao Superior Do Vale Do Parnaiba S. A. I E S V A P [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto De Educacao Superior Do Vale Do Parnaiba S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto De Ensino Superior De Palhoca S S Ltda. I E S P P A L H O C A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto De Ensino Superior Do Piaui S. A. I E S P [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutoDeEnsinoSuperiorDoPiauiSAMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto De Ensino Superior Do Piaui S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto De Pesquisa E Ensino Medico Fo Estado De Minas Gerais Ltda I P E M E D [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutoEducacionalSantoAgostinhoS.A.FASAMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Educacional Santo Agostinho S. A. F A S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoEducacionalSantoAgostinhoSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutoEducacionalSantoAgostinhoSAMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Educacional Santo Agostinho S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutoParaenseDeEducacaoECulturaLtda.IPECMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Paraense De Educacao E Cultura Ltda. I P E C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoParaensedeEducacaoeCulturaLtdaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutoParaensedeEducacaoeCulturaLtdaMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Paraensede Educacaoe Cultura Ltda [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Tocantinense Presidente Antonio Carlos Porto S. A. I T P A C Porto [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Tocantinense Presidente Antonio Carlos S. A. I T P A C Araguaina [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutoTocantinensePresidenteAntonioCarlosSAMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Tocantinense Presidente Antonio Carlos S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Institutode Ensino Superior Presidente Trancredode Almeida Neves S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Institutode Pesquisae Ensino Medicodo Estadode Minas Gerais Ltda [member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsAndGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IntangibleAssetsAndGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Intangible assets and goodwill, balance at beginnning",
        "periodEndLabel": "Intangible assets and goodwill, balance at end",
        "label": "Intangible assets and goodwill [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_IntangibleAssetsAndGoodwillMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IntangibleAssetsAndGoodwillMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "afya_IntangibleAssetsAndGoodwillNetBookValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IntangibleAssetsAndGoodwillNetBookValue",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net book value",
        "label": "IntangibleAssetsAndGoodwillNetBookValue"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r102"
     ]
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwillMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r103",
      "r272",
      "r295"
     ]
    },
    "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IntangibleAssetsWithIndefiniteUsefulLife",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licenses with indefinite useful life"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r90",
      "r104"
     ]
    },
    "afya_InterSegment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InterSegment",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inter-segment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from interest."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r236",
      "r244"
     ]
    },
    "afya_InterestExpense1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InterestExpense1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestExpenseOnLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3",
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued lease interest",
        "verboseLabel": "Lease liabilities, interest expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "afya_InterestExpenseOnLeaseLiabilities1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InterestExpenseOnLeaseLiabilities1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense on lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestPaidClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestPaidClassifiedAsFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of interest",
        "negatedTerseLabel": "Payments of interest",
        "label": "Interest paid, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as financing activities."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "ifrs-full_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. [Refer: Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r187",
      "r232"
     ]
    },
    "ifrs-full_InterestRateTypesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestRateTypesMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of interest rates. It also represents the standard value for the 'Types of interest rates' axis if no other member is used. [Refer: Interest rate risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "ifrs-full_Inventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Inventories",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r57",
      "r259"
     ]
    },
    "afya_Inventories1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "Inventories1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "label": "Inventories1"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InvestmentGrossAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InvestmentGrossAmount",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount of the investment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InvestmentIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InvestmentIncome",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income from financial investments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investment income, such as interest and dividends."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r353"
     ]
    },
    "afya_InvestmentType": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "InvestmentType",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment type"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InvestmentsInAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InvestmentsInAssociates",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in associate",
        "periodStartLabel": "Opening balance",
        "periodEndLabel": "Closing balance"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investments in associates in an entity's separate financial statements. [Refer: Associates [member]]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociates",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in associate"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "afya_IssuedCapitals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "IssuedCapitals",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Authorized capital"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ItEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ItEquipmentMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "It Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_JudicialDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "JudicialDeposits",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative",
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Judicial deposits"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "KeyManagementPersonnelCompensation",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation plans"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "afya_LaborAndSocialObligationsAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LaborAndSocialObligationsAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Labor and social obligations",
        "label": "Labor And Social Obligations As Of Acquisition Date"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LaborAndSocialObligationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LaborAndSocialObligationsExplanatory",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Labor and social obligations",
        "label": "LaborAndSocialObligationsExplanatory"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LaborAndSocialObligationsPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LaborAndSocialObligationsPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Labor and social obligations",
        "label": "LaborAndSocialObligationsPolicyExplanatory"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LabourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LabourMember",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Labour [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LandMember",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Land [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing land held by the entity for use in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LaterThanFiveYearsMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r180",
      "r189",
      "r306",
      "r310",
      "r315"
     ]
    },
    "afya_LaterThanOneEightyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LaterThanOneEightyMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later Than One Eighty [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LaterThanOneMonthsAndNotLaterThanThreeMonthsMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later Than One Months And Not Later Than Three Months [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanThreeYearsMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than one year and not later than three years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than three years."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r308",
      "r315"
     ]
    },
    "ifrs-full_LaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LaterThanOneYearMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than one year [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LaterThanThreeMonthsAndNotLaterThanSixMonthsMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than three months and not later than six months [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three months and not later than six months."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r307",
      "r315"
     ]
    },
    "ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LaterThanThreeYearsAndNotLaterThanFiveYearsMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than three years and not later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three years and not later than five years."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r309",
      "r315"
     ]
    },
    "afya_LeaseAgreements1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LeaseAgreements1Member",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Agreements 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LeaseExpenses",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease expenses",
        "label": "LeaseExpenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liabilities",
        "periodStartLabel": "Lease liabilities, balance at beginning",
        "periodEndLabel": "Lease liabilities, balance at ending",
        "label": "Lease liabilities [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "afya_LeaseLiabilities1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LeaseLiabilities1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liabilities",
        "label": "LeaseLiabilities1"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseLiabilitiesAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LeaseLiabilitiesAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liabilities",
        "label": "LeaseLiabilitiesAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LeaseLiabilitiesMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r286",
      "r289"
     ]
    },
    "afya_LeaseLiabilitiesRemeasurement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LeaseLiabilitiesRemeasurement",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, remeasurement",
        "documentation": "The amount of lease liabilities re measurement."
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseLiabilitiesWriteoff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LeaseLiabilitiesWriteoff",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, Write-off"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold improvements [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement."
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "ifrs-full_LeasesAsLesseeRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LeasesAsLesseeRelatedPartyTransactions",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of leases where the entity was the lessee in related party transactions. [Refer: Related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r268"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LegalProceedingsContingentLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LegalProceedingsContingentLiabilityMember",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal proceedings contingent liability [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a contingent liability for legal proceedings. [Refer: Contingent liabilities [member]]"
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "afya_LesseeFinancesLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LesseeFinancesLeaseRenewalTerm",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Renewal term"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Level2OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Level2OfFairValueHierarchyMember",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 2 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ifrs-full_Level3OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Level3OfFairValueHierarchyMember",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 3 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LevelsOfFairValueHierarchyAxis",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r158"
     ]
    },
    "ifrs-full_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r157",
      "r158",
      "r159",
      "r239",
      "r243"
     ]
    },
    "ifrs-full_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Liabilities arising from financing activities, beginning",
        "periodEndLabel": "Liabilities arising from financing activities, ending",
        "label": "Liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "afya_LibraryBooksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LibraryBooksMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Library Books [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LicencesAndFranchisesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LicencesAndFranchisesMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licences and franchises [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity and the right to operate a business using the name, merchandise, services, methodologies, promotional support, marketing and supplies granted by another entity. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r278"
     ]
    },
    "ifrs-full_LicencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LicencesMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licences [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "ifrs-full_LiquidityRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LiquidityRiskMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r301"
     ]
    },
    "afya_LoansAndFinancing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LoansAndFinancing",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loans and financing",
        "label": "Loans And Financing"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancingCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LoansAndFinancingCurrent",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "documentation": "The amount refers to loans and financing current.",
        "label": "Loans And Financing Current"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancingExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LoansAndFinancingExplanatory",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of loans and financing"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LoansAndFinancingLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loans and financing",
        "label": "Loans And Financing Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LoansAndFinancingMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails11",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans And Financing [member]",
        "documentation": "This member stands for loans and financing."
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancingNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LoansAndFinancingNonCurrent",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "documentation": "The amount refers to loans and financing non current.",
        "label": "Loans And Financing Non Current"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancingOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LoansAndFinancingOneMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans And Financing One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancingThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LoansAndFinancingThreeMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans And Financing Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancingTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "LoansAndFinancingTwoMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans And Financing Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LongtermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LongtermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loans and financing",
        "label": "Non-current portion of non-current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_LongtermLegalProceedingsProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LongtermLegalProceedingsProvision",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for legal proceedings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current provision for legal proceedings. [Refer: Legal proceedings provision]"
       }
      }
     },
     "auth_ref": [
      "r273",
      "r275"
     ]
    },
    "afya_MachineryAndEquipmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "MachineryAndEquipmentsMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Machinery And Equipments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MaturityAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r167",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r189",
      "r218",
      "r227",
      "r267",
      "r306"
     ]
    },
    "ifrs-full_MeasurementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MeasurementAxis",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r109",
      "r157"
     ]
    },
    "afya_MedcelAndCBBWMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "MedcelAndCBBWMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medcel And C B B W [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_MedcelEditoraEventosS.A.MedcelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "MedcelEditoraEventosS.A.MedcelMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medcel Editora Eventos S. A. Medcel [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical Harbour Aparelhos Medico Hospitalares E Servicos Em Tecnologia Ltda. Medical Harbour [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_MedicalHarbourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "MedicalHarbourMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical Harbour [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_MedicinaeSolutionsS.A.MedicinaeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "MedicinaeSolutionsS.A.MedicinaeMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medicinae Solutions S. A. Medicinae [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MethodOfAssessmentOfExpectedCreditLossesAxis",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Method of assessment of expected credit losses [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r303",
      "r312"
     ]
    },
    "ifrs-full_MethodOfAssessmentOfExpectedCreditLossesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MethodOfAssessmentOfExpectedCreditLossesMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all methods of assessment of expected credit losses. Expected credit losses are the weighted average of credit losses with the respective risks of a default occurring as the weights. This member also represents the standard value for the 'Method of assessment of expected credit losses' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r303",
      "r312"
     ]
    },
    "afya_MobileAppSubscriptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "MobileAppSubscriptionMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mobile App Subscription [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ModifiedPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ModifiedPlanMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Modified Plan [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_MonetaryIndexation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "MonetaryIndexation",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Monetary indexation",
        "documentation": "The amount of monetary indexation."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MultiperiodExcessEarningsMethodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MultiperiodExcessEarningsMethodMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Multi-period excess earnings method [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a specific valuation technique consistent with the income approach that involves analysing the excess earnings over periods of time, and is used to measure the fair value of some intangible assets. [Refer: Income approach [member]]"
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "ifrs-full_NetForeignExchangeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NetForeignExchangeLoss",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign exchange loss, net",
        "label": "Net foreign exchange loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      }
     },
     "auth_ref": [
      "r348",
      "r358"
     ]
    },
    "afya_NetOfCashFlowOnAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NetOfCashFlowOnAcquisition",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net of cash flow on acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NetRevenueOtherTransferredPoint": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NetRevenueOtherTransferredPoint",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails",
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other - Transferred at a point in time",
        "verboseLabel": "Transferred at a point in time"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "afya_NonCashTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NonCashTransactionsTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of non-cash transactions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NonTeachingActivitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NonTeachingActivitiesMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Teaching Activities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r15",
      "r133",
      "r137"
     ]
    },
    "ifrs-full_NoncontrollingInterestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncontrollingInterestsMember",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-controlling interests [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "verboseLabel": "Non-current assets",
        "label": "Non-current assets [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r21",
      "r144",
      "r290"
     ]
    },
    "afya_NoncurrentAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NoncurrentAssets1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "label": "NoncurrentAssets1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentAssetsAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NoncurrentAssetsOfRelatedParty1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NoncurrentAssetsOfRelatedParty1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "label": "NoncurrentAssetsOfRelatedParty1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentFinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "label": "Non-current financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "ifrs-full_NoncurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "label": "Non-current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liabilities",
        "label": "Lease liabilities, non-current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current liabilities",
        "verboseLabel": "Non-current liabilities",
        "negatedLabel": "Non-current liabilities",
        "label": "Non-current liabilities [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r22",
      "r146",
      "r290"
     ]
    },
    "afya_NoncurrentLiabilities1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NoncurrentLiabilities1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "label": "Noncurrent Liabilities1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentLiabilitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentPayablesForPurchaseOfEnergy": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentPayablesForPurchaseOfEnergy",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current payables for purchase of energy"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current payables for the purchase of energy. [Refer: Payables for purchase of energy]"
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "ifrs-full_NoncurrentPayablesToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentPayablesToRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable to selling shareholders",
        "label": "Non-current payables to related parties"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]"
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "afya_NoncurrentPayablesToRelatedParties1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NoncurrentPayablesToRelatedParties1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "label": "NoncurrentPayablesToRelatedParties1"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NoncurrentTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NoncurrentTaxesPayable",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Taxes payable",
        "label": "NoncurrentTaxesPayable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NoncurrentTradeReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NoncurrentTradeReceivable",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade receivables",
        "label": "NoncurrentTradeReceivable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentTradeReceivables",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementDetails",
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current",
        "verboseLabel": "Trade receivable (non-current)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Not measured at fair value in statement of financial position but for which fair value is disclosed [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for items not measured at fair value in the statement of financial position but for which fair value is disclosed. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "afya_NotePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NotePayable",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liabilities",
        "label": "Note Payable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NotePayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NotePayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes payable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NotePayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NotePayables",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes payable",
        "documentation": "The amount of note payables.",
        "label": "DerivativeLiabilitiesCrossCurrencyInterestRateSwaps"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NotesAndOtherExplanatoryInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes and other explanatory information [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NotesPayableMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable [member]",
        "documentation": "The member stands for notes payable."
       }
      }
     },
     "auth_ref": []
    },
    "afya_NotesPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NotesPayables",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Notes payable beginning",
        "periodEndLabel": "Notes payable ending",
        "label": "Notes Payables"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nucleo De Atencao A Saude E De Praticas Profissionalizantes N A S P P [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfOutstandingShareOptions",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of stock options, Outstanding at the beginning",
        "periodEndLabel": "Number of stock options, Outstanding at the ending",
        "label": "Number of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r196",
      "r198"
     ]
    },
    "afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NumberOfShareOptionsExchangedInSharebasedPaymentArrangement",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of stock options, Stock options exchanged",
        "label": "Number of stock options, Stock options exchanged"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of stock options, Exercised",
        "label": "Number of share options exercised in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of stock options, Expired",
        "label": "Number of share options expired in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options expired in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of stock options, Forfeited",
        "label": "Number of share options forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails5",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of stock options, Granted",
        "verboseLabel": "Number of stock option granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total number of shares",
        "label": "Number of shares issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "afya_NumberOfSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NumberOfSharesIssued1",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total number of shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfSharesOutstanding",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of shares, Outstanding, at beginning balance",
        "periodEndLabel": "Number of shares, Outstanding, at ending balance",
        "label": "Number of shares outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "afya_NumberOfSharesRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NumberOfSharesRepurchased",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares, Repurchased"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NumberOfStockOptionsExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NumberOfStockOptionsExercisable",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of stock options, Exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of treasury shares, delivered under the share-based compensation plan"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NumeratorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "NumeratorAbstract",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Numerator"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OneSubsidiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OneSubsidiaryMember",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Subsidiary [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OperatingLeaseTermOfContract",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease term"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating segments [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for operating segments. An operating segment is a component of an entity: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same entity); (b) whose operating results are regularly reviewed by the entity\u2019s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance; and (c) for which discrete financial information is available. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r245"
     ]
    },
    "afya_OptionsGrantedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OptionsGrantedMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Granted [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OrdinarySharesMember",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r352"
     ]
    },
    "afya_OriginalPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OriginalPlanMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Original Plan [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_Other": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "Other",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Other [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherAdjustmentsForNoncashItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherAdjustmentsForNoncashItems",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Labor and social obligations",
        "label": "Other adjustments for non-cash items"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "afya_OtherAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OtherAsset",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "label": "OtherAsset"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OtherAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OtherAssets1",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "label": "OtherAssets1"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OtherAssetsAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OtherAssetsAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "label": "Property, plant and equipment recognised as of acquisition date"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OtherAssetsNonCurrentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OtherAssetsNonCurrentMember",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets Non Current [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OtherAssetsRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OtherAssetsRelatedPartyTransactions",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets (ii)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r28",
      "r36",
      "r149"
     ]
    },
    "ifrs-full_OtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherCurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_OtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_OtherFinanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherFinanceCost",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Other finance cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]"
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "ifrs-full_OtherFinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherFinanceIncome",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Other finance income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of finance income that the entity does not separately disclose in the same statement or note. [Refer: Finance income]"
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "ifrs-full_OtherGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherGainsLosses",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expenses, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343"
     ]
    },
    "afya_OtherIncomeRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OtherIncomeRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OtherLiabilitiesAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OtherLiabilitiesAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Other Liabilities As Of Acquisition Date"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OtherMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "label": "Other non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_OtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherNoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Other non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherOperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income (expenses), net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "ifrs-full_OtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of provisions other than provisions for employee benefits. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r23",
      "r92"
     ]
    },
    "ifrs-full_OtherProvisionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherProvisionsMember",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for provisions other than provisions for employee benefits. It also represents the standard value for the 'Classes of other provisions' axis if no other member is used. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ifrs-full_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other FIES receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "ifrs-full_OtherRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherRevenue",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Other revenue"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "afya_OtherRevenue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OtherRevenue1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "OtherRevenue1"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OthersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "OthersMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Others [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PastDueStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PastDueStatusAxis",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Past due status [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r305"
     ]
    },
    "ifrs-full_PastDueStatusMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PastDueStatusMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all past-due statuses. It also represents the standard value for the 'Past due status' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r305"
     ]
    },
    "afya_PaymentOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PaymentOfDividends",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment of dividends"
       }
      }
     },
     "auth_ref": []
    },
    "afya_Payments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "Payments",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments",
        "documentation": "The amount of payments."
       }
      }
     },
     "auth_ref": []
    },
    "afya_PaymentsOfInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PaymentsOfInterest",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of interest"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of interest from acquisition of subsidiaries and intangibles",
        "label": "PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PaymentsOfInterestLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PaymentsOfInterestLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, payments of interest"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of interest of lease liabilities",
        "label": "PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of lease liabilities",
        "label": "Payments of lease liabilities, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, payments of lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsToSuppliersForGoodsAndServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PaymentsToSuppliersForGoodsAndServices",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of services or goods"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow to suppliers for goods and services."
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "afya_Payroll": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "Payroll",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payroll"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peb Med Instituicao De Pesquisa Medica E Servicos Ltda. Peb Med [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PercenatgeOfAverageInterestOnFinancialInstrument": {
     "xbrltype": "percentItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PercenatgeOfAverageInterestOnFinancialInstrument",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of average interest"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PercentageOfEntitysRevenue": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PercentageOfEntitysRevenue",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of revenue"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of the entity's revenue. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "ifrs-full_PercentageOfVotingEquityInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PercentageOfVotingEquityInterestsAcquired",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Voting interest",
        "verboseLabel": "Acquired share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "afya_PermanentAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PermanentAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Permanent adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PerpetuityGrowthRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PerpetuityGrowthRate",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Growth rates"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Policlinica E Centro De Estetica Duque De Caxias Ltda. Policlinica [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PotentialAdditionalPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PotentialAdditionalPayment",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/SubsequentEventDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Potential additional payment"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PracticeManagementToolsAndElectronicPrescriptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PracticeManagementToolsAndElectronicPrescriptionMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Practice Management Tools And Electronic Prescription [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r327"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "afya_PrincipalActivities": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PrincipalActivities",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PrincipalPlaceOfBusinessOfSubsidiary",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Location"
       }
      },
      "en": {
       "role": {
        "documentation": "The principal place of business of a subsidiary. [Refer: Principal place of business; Subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r73",
      "r134",
      "r138"
     ]
    },
    "ifrs-full_ProbabilityOfDefaultAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProbabilityOfDefaultAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Probability of default [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r313"
     ]
    },
    "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from loans and financing"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "ifrs-full_ProceedsFromExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromExerciseOfOptions",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of stock options"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of options."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProductsAndServicesAxis",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r294"
     ]
    },
    "ifrs-full_ProductsAndServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProductsAndServicesMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r294"
     ]
    },
    "ifrs-full_ProfessionalFeesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfessionalFeesExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Tuition fees",
        "label": "Professional fees expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable for professional services."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "afya_ProfessionalFeesExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ProfessionalFeesExpenses",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tuition fees"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementsOfChangesInEquity",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "label": "Net income"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r27",
      "r112",
      "r130",
      "r132",
      "r239",
      "r241",
      "r290",
      "r296"
     ]
    },
    "ifrs-full_ProfitLossAttributableToAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossAttributableToAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income attributable to"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "afya_ComprehensiveIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r30",
      "r136"
     ]
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "afya_ComprehensiveIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity holders of the parent"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/IncomeTaxesDetails",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before income taxes",
        "label": "Income before income taxes",
        "verboseLabel": "Income loss before income taxes"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r216",
      "r256",
      "r257",
      "r316",
      "r317"
     ]
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossFromOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating income",
        "label": "Operating income"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r269",
      "r353"
     ]
    },
    "ifrs-full_ProfitLossOfAcquiree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossOfAcquiree",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share of income"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r210"
     ]
    },
    "afya_ProgramOfSocialIntegrationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ProgramOfSocialIntegrationMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Program Of Social Integration [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ProgramaUniversidadeParaTodosFiscalIncentive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ProgramaUniversidadeParaTodosFiscalIncentive",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROUNI - Fiscal Incentive (i)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r50"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r272",
      "r295"
     ]
    },
    "afya_PropertyPlantAndEquipmentNetBookValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PropertyPlantAndEquipmentNetBookValue",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net book value"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment",
        "terseLabel": "Property, plant and equipment recognised as of acquisition date",
        "label": "Property, plant and equipment recognised as of acquisition date [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r298",
      "r300"
     ]
    },
    "afya_PropertyPlantAndEquipments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PropertyPlantAndEquipments",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "As of December 31, 2022",
        "periodEndLabel": "As of December 31, 2023",
        "label": "PropertyPlantAndEquipments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProportionOfOwnershipInterestInJointVenture": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProportionOfOwnershipInterestInJointVenture",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proportion percentage"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Joint ventures [member]]"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r74",
      "r140"
     ]
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Own percentage"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r74",
      "r139"
     ]
    },
    "ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProportionOfOwnershipInterestsHeldByNoncontrollingInterests",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Direct and indirect interest of subsidiary",
        "verboseLabel": "Ownership Interest"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "afya_ProvisionForLegalProceedingsAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ProvisionForLegalProceedingsAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Provision for legal proceedings",
        "label": "ProvisionForLegalProceedingsAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for legal proceedings with corresponding indemnification asset"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Provisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Provisions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance as of beginning of the year",
        "periodEndLabel": "Balance as of ending of the year",
        "label": "Provisions [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities of uncertain timing or amount, including provisions for employee benefits."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "afya_PurchaseOfAcquisitionOfNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PurchaseOfAcquisitionOfNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of non-controlling interest",
        "label": "PurchaseOfAcquisitionOfNoncontrollingInterests"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "PurchaseOfIntangibleAssetClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of intangibles assets",
        "label": "PurchaseOfIntangibleAssetClassifiedAsInvestingActivities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of subsidiaries, net of cash acquired",
        "label": "Purchase of other long-term assets, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of long-term assets that the entity does not separately disclose in the same statement or note, classified as investing activities. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of property and equipment",
        "label": "Purchase of property, plant and equipment, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "afya_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quasar Telemedicina Desenvolvimento De Sistemas Computacionais Ltda. Glic [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RSUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RSUsMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "R S Us [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RVLEstevesGestaoImobiliariaSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RVLEstevesGestaoImobiliariaSAMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "R V L Esteves Gestao Imobiliaria S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RXPROLOGTransporteELogisticaLtda.RXPROLOGMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "R X P R O L O G Transporte E Logistica Ltda. R X P R O L O G [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RXPROMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RXPROMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1",
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RXPRO [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RXPROSolucoesDeTecnologiaLtda.RXPROMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "R X P R O Solucoes De Tecnologia Ltda. R X P R O [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r183",
      "r198",
      "r292",
      "r293",
      "r377"
     ]
    },
    "ifrs-full_RangesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RangesMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r183",
      "r198",
      "r292",
      "r293",
      "r377"
     ]
    },
    "afya_ReceivablesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ReceivablesGross",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails",
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivables, gross",
        "verboseLabel": "Trade receivable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RecognisedDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RecognisedDeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognized deferred tax assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RecognizedDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RecognizedDeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognized deferred income tax assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ReconciliationAdjustmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ReconciliationAdjustmentsAbstract",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation adjustments:"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RecoverableTaxesAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RecoverableTaxesAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Recoverable taxes",
        "label": "RecoverableTaxesAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ReliefFromRoyaltyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ReliefFromRoyaltyMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Relief From Royalty [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RemainingBalancePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RemainingBalancePaid",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining balance paid"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RemainingTradeAndOtherPayablesToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RemainingTradeAndOtherPayablesToRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining accounts payable",
        "documentation": "The remaining amount of payables due to related parties."
       }
      }
     },
     "auth_ref": []
    },
    "afya_RemeasurementOfEarnOut": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RemeasurementOfEarnOut",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remeasurement of earn-out of Alem da Medicina, CardioPapers"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RemeasurementOfEarnouts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RemeasurementOfEarnouts",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remeasurement of earn-outs"
       }
      }
     },
     "auth_ref": []
    },
    "afya_Remesurement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "Remesurement",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remesurement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RepairsAndMaintenanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RepairsAndMaintenanceExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Maintenance",
        "label": "Repairs and maintenance expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of principal of loans and financing",
        "label": "Repayments of borrowings, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r283"
     ]
    },
    "afya_RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of interest of loans and financing",
        "label": "RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ReplacementCostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ReplacementCostMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Replacement Cost [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RepurchaseOfOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RepurchaseOfOrdinaryShares",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repurchase of ordinary shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReserveOfSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReserveOfSharebasedPayments",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation reserve"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity resulting from share-based payments."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "ifrs-full_ReserveOfSharebasedPaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReserveOfSharebasedPaymentsMember",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve of share-based payments [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from share-based payments."
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "ifrs-full_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at the beginning of the year",
        "periodEndLabel": "Cash and cash equivalents at the end of the year",
        "label": "Restricted cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "afya_RestrictedCashOfInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RestrictedCashOfInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted cash"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RestrictedSharesTransferredToExecutives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RestrictedSharesTransferredToExecutives",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted shares transferred to executives"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RestrictedStockUnits1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RestrictedStockUnits1Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock units 1 [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RestrictedStockUnits2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RestrictedStockUnits2Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock units 2 [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RestrictedStockUnits3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RestrictedStockUnits3Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock units 3 [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RestrictedStockUnitsMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails5",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock units [member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RetainedEarnings",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained earnings"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r262"
     ]
    },
    "ifrs-full_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained earnings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r258"
     ]
    },
    "ifrs-full_Revenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Revenue",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "verboseLabel": "Net revenue"
       }
      },
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r148",
      "r216",
      "r234",
      "r240",
      "r246",
      "r247",
      "r248",
      "r256",
      "r257",
      "r290"
     ]
    },
    "ifrs-full_RevenueFromContractsWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RevenueFromContractsWithCustomers",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue from contracts with customers",
        "label": "Revenue from contracts with customers [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r164"
     ]
    },
    "ifrs-full_RevenueFromInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RevenueFromInterest",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest received"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income arising from interest."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r235",
      "r244",
      "r346"
     ]
    },
    "afya_Reversals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "Reversals",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reversals"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightOfUseAssetsAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RightOfUseAssetsAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Right-of-use assets",
        "label": "RightOfUseAssetsAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "periodStartLabel": "Right-of-use assets, balance at beginning",
        "periodEndLabel": "Right-of-use assets, balance at ending"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r177"
     ]
    },
    "afya_RightofuseAssetsBusinessCombinations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RightofuseAssetsBusinessCombinations",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, business combinations",
        "documentation": "The amount of business combinations right to use of assets."
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RightofuseAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, current",
        "documentation": "The amount of current right to use of assets."
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RightofuseAssetsInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, interest expense",
        "documentation": "The amount of Interest expense right to use of assets."
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RightofuseAssetsNonCurrent",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, non-current",
        "documentation": "The amount of non current right to use of assets."
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsPaymentsOfInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RightofuseAssetsPaymentsOfInterest",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, payments of interest"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsPaymentsOfLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RightofuseAssetsPaymentsOfLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, payments of lease liabilities",
        "documentation": "The amount of Payments of lease liabilities right to use of assets."
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsRemeasurement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RightofuseAssetsRemeasurement",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, remeasurement",
        "documentation": "The amount of right of use assets re measurement."
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsWriteoff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "RightofuseAssetsWriteoff",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, Write-off"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RiskExposuresAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RiskExposuresAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk variables [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "ifrs-full_RiskExposuresMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RiskExposuresMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the risk variables. It also represents the standard value for the 'Risk variables' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "ifrs-full_SalesAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SalesAndMarketingExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sales and marketing",
        "label": "Sales and marketing expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to the marketing and selling of goods or services."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "afya_ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of acquisition of al?m da medicina intangible assets acquired"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfAcquisitionOfCardioPapersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfAcquisitionOfCardioPapersExplanatory",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of acquisition of cardio papers intangible assets acquired"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfAcquisitionOfDelReyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfAcquisitionOfDelReyExplanatory",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of intangible assets acquired"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfAcquisitionOfGlicExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfAcquisitionOfGlicExplanatory",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of acquisition of Glic intangible assets acquired"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfAdditionalStockOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfAdditionalStockOptionsExplanatory",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of additional stock options"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of presents assets and liabilities information for the Company\u2019s operating segments"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfCarryingAmountOfNotesPayableTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of carrying amount of notes payable and the movements"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of changes in accounting policies and disclosures"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfEstimatedUsefulLivesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfEstimatedUsefulLivesTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of estimated useful lives of the assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfFairValueMeasurementExplanaory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfFairValueMeasurementExplanaory",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair value measurement"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfFairValuesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfFairValuesExplanatory",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair values of the company's financial instruments"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair values of the identifiable assets acquired and liabilities assumed as of acquisition in 2022"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair values of the identifiable assets acquired and liabilities assumed acquisition in 2023"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfFinanceResultTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfFinanceResultTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinanceResultTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of finance result"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfLeasesExplanatory",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of right-of-use assets and lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfLegalProceedingsAndContingencies": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfLegalProceedingsAndContingencies",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of legal proceedings and contingencies"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfModelUsedToDetermineFairValueOfStockOptions",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of model used to determine the fair value of the stock options"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of model used to determine incremental fair value of the stock options"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfNetSalesRevenueExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfNetSalesRevenueExplanatory",
     "presentation": [
      "http://afya.com.br/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of net sales revenue"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of reconciliation of income tax expense"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfRevenueBySegmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfRevenueBySegmentTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of revenue by segment"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfSharebasedCompensationPlanExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfSharebasedCompensationPlanExplanatory",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of share-based compensation plan"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfSocialSecurityProceedingsAssessedByManagement",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of social security proceedings assessed by Management"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfStockOptionExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfStockOptionExplanatory",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock option"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfTreasurySharesMovementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ScheduleOfTreasurySharesMovementExplanatory",
     "presentation": [
      "http://afya.com.br/role/EquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule illustrates the number and movements in treasury shares"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SecondAnnualInstallmentsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SecondAnnualInstallmentsPayable",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second annual installment"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r325"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r324"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "ifrs-full_SegmentConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SegmentConsolidationItemsAxis",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment consolidation items [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r239"
     ]
    },
    "ifrs-full_SegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SegmentsAxis",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetailsNarrative",
      "http://afya.com.br/role/RevenueDetails1",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r165",
      "r239",
      "r266",
      "r297"
     ]
    },
    "ifrs-full_SegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SegmentsMember",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetailsNarrative",
      "http://afya.com.br/role/RevenueDetails1",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r165",
      "r245",
      "r266",
      "r297"
     ]
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Selling, general and administrative expenses",
        "label": "Selling, general and administrative expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to selling, general and administrative activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "afya_SensitivityChangeInTheEuroExchangeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SensitivityChangeInTheEuroExchangeRate",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of sensitivity change in the Euro exchange rate",
        "documentation": "Information about percentage of sensitivity change in the euro exchange rate."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ServicesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ServicesExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Pedagogical services",
        "label": "Services expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from services."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "afya_ShareBasedCompensationOfEmployees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ShareBasedCompensationOfEmployees",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation of employees"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ShareBasedCompensationPlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ShareBasedCompensationPlansMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share based compensation plans [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ShareOfIncomeOfAssociateOfOpeartingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ShareOfIncomeOfAssociateOfOpeartingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share of income of associate",
        "label": "ShareOfIncomeOfAssociateOfOpeartingActivities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share of income of associate"
       }
      },
      "en": {
       "role": {
        "documentation": "The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r34",
      "r237",
      "r244"
     ]
    },
    "ifrs-full_ShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShareOptionsMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share options [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of antidilutive instrument representing share options."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SharePriceFairValueAtMeasurementDateShareOptionsGranted",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price at the measurement date"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SharebasedPaymentArrangementsMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "afya_SharebasedPaymentsPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SharebasedPaymentsPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payments"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SharesBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SharesBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation",
        "label": "SharesBasedCompensation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShorttermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShorttermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans and financing"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "afya_ShospMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ShospMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shosp [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ShospTecnologiaDaInformacaoLtda.ShospMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ShospTecnologiaDaInformacaoLtda.ShospMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shosp Tecnologia Da Informacao Ltda. Shosp [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingJudgmentsEstimatesAndAssumptions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant accounting judgments, estimates and assumptions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetails2",
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails4",
      "http://afya.com.br/role/BusinessCombinationsDetails5",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r75",
      "r154"
     ]
    },
    "afya_SocialObligationsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SocialObligationsLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "social obligations liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade De Educacao Cultura E Tecnologia Da Amazonia S. A. F E S A R [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SociedadeEducacionalDePalhocaSALtda.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SociedadeEducacionalDePalhocaSALtda.Member",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Educacional De Palhoca S A Ltda. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Educacional E Cultural Sergipe Del Rey Ltda. Del Rey [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Padrao De Educacao Superior Ltda. Unifip Moc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SociedadeUniversitariaRedentorS.A.UniRedentorMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Universitaria Redentor S. A. Uni Redentor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SoftwareInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SoftwareInProgressMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software In Progress [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfChangesInEquityAbstract",
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2",
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_StrikePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "StrikePrice",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Strike price"
       }
      }
     },
     "auth_ref": []
    },
    "afya_StrikePriceeAtMeasurementDateShareOptionsGrante": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "StrikePriceeAtMeasurementDateShareOptionsGrante",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Strike price at the measurement date",
        "label": "Strike Pricee At Measurement Date Share Options Grante"
       }
      }
     },
     "auth_ref": []
    },
    "afya_StrikePriceeAtMeasurementDateShareOptionsGranted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "StrikePriceeAtMeasurementDateShareOptionsGranted",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Strike price at the measurement date"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SubsidiariesMember",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for entities that are controlled by another entity."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r72",
      "r75",
      "r154"
     ]
    },
    "afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of assumptions for impairment test"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of maturity profile of financial liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of sensitivity foreign currency"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of estimated useful lives of intangible assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfExpensesByNatureTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SummaryOfExpensesByNatureTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of expenses by nature"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SummaryOfIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of intangible assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SummaryOfKeyManagementPersonnelCompensationTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of key management personnel compensation included in the Company's consolidated statement of income"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of income before income taxes"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Company\u2019s subsidiaries and associate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Presumed profit income tax regime effect (ii)",
        "label": "Tax effect of expense not deductible in determining taxable profit (tax loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax effect on loss from entities not subject to taxation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TaxExpenseIncomeAtApplicableTaxRate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes at statutory rates"
       }
      },
      "en": {
       "role": {
        "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "ifrs-full_TaxExpenseOtherThanIncomeTaxExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TaxExpenseOtherThanIncomeTaxExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Tax expense other than income tax expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tax expense exclusive of income tax expense."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "afya_TaxExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TaxExpenses",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax expenses"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TaxOnFinancialOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TaxOnFinancialOperations",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IOF taxes (taxes on financial transactions)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxRateEffectFromChangeInTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TaxRateEffectFromChangeInTaxRate",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from a change in tax rate. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "afya_TaxesAndSocialSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TaxesAndSocialSecurityMember",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes And Social Security [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TaxesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TaxesMember",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TaxesPayableAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TaxesPayableAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes and contributions payable",
        "verboseLabel": "Taxes Payable As Of Acquisition Date"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TaxesPolicyExplanation": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TaxesPolicyExplanation",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TeachingActivitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TeachingActivitiesMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Teaching Activities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TechnologybasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TechnologybasedIntangibleAssetsMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails3",
      "http://afya.com.br/role/BusinessCombinationsDetails5",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Technology-based intangible assets [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing assets based on technology. Such assets may include patented and unpatented technology, databases as well as trade secrets. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "afya_ThirdAnnualInstallmentsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "ThirdAnnualInstallmentsPayable",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Third annual installment"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of revenue recognition of revenue from contracts with customers:"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TimingRevenueRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TimingRevenueRecognition",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of revenue recognition"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TitleOfInitiallyAppliedIFRS": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TitleOfInitiallyAppliedIFRS",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Standard"
       }
      },
      "en": {
       "role": {
        "documentation": "The title of an initially applied IFRS. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Top of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r183",
      "r198",
      "r292",
      "r293",
      "r377"
     ]
    },
    "afya_TotalNumberOfSeatsApporved": {
     "xbrltype": "integerItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TotalNumberOfSeatsApporved",
     "presentation": [
      "http://afya.com.br/role/SubsequentEventDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total number of seats apporved"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TotalReportableSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TotalReportableSegmentsMember",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Reportable Segments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherCurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesToRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable to selling shareholders"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]"
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "afya_TradeAndOtherCurrentPayablesToRelatedParties1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TradeAndOtherCurrentPayablesToRelatedParties1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherPayablesRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade payables",
        "label": "Trade and other payables recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "ifrs-full_TradeAndOtherPayablesToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherPayablesToRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable to selling shareholders",
        "label": "Opening balance",
        "periodStartLabel": "Opening balance",
        "periodEndLabel": "Closing balance"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of payables due to related parties. [Refer: Related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "afya_TradeAndOtherPayablesToRelatedPartiesLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TradeAndOtherPayablesToRelatedPartiesLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable to selling shareholders",
        "label": "TradeAndOtherPayablesToRelatedPartiesLiabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherPayablesToTradeSuppliers",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade payables",
        "label": "Trade payables [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business."
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "ifrs-full_TradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeReceivables",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails",
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivables, net",
        "verboseLabel": "Trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount due from customers for goods and services sold."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "afya_TradeReceivablesAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TradeReceivablesAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade receivables",
        "label": "TradeReceivablesAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeReceivablesMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivables [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r222",
      "r225",
      "r305",
      "r346"
     ]
    },
    "afya_TradeReceivablesRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TradeReceivablesRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivables (i)"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TransactionPriceAllocatedToRemainingPerformanceObligations",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction price allocated to remaining performance obligations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis",
     "presentation": [
      "http://afya.com.br/role/SubsequentEventDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r207"
     ]
    },
    "ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember",
     "presentation": [
      "http://afya.com.br/role/SubsequentEventDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for transactions that are recognised separately from the acquisition of assets and assumption of liabilities in business combinations. It also represents the standard value for the 'Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination' axis if no other member is used. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r207"
     ]
    },
    "afya_Transfer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "Transfer",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transfer amount"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TransferredFromExerciseOfStockOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TransferredFromExerciseOfStockOptions",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares, Transferred from exercise of stock options"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TransferredFromSharesContribution": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TransferredFromSharesContribution",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares, Transferred from shares contribution"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TravelExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TravelExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Travel expenses",
        "label": "Travel expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from travel."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "ifrs-full_TreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TreasuryShares",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury shares",
        "label": "Treasury shares [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r261"
     ]
    },
    "afya_TreasuryShares1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TreasuryShares1",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows",
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares",
        "verboseLabel": "Treasury shares buy back"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TreasurySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TreasurySharesMember",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "afya_TreasurySharesTransferredFromExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TreasurySharesTransferredFromExerciseOfOptions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares transferred from exercise of options"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TreasurySharesTransferredFromSharesContributionOnBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares transferred from shares contribution on business combinations"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares transferred to executives from exercise of stock options"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TuitionFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TuitionFeesMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tuition Fees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TwentyTwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TwentyTwentyEightMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028 [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TwentyTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TwentyTwentyFiveMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025 [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TwentyTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TwentyTwentyFourMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2024 [member]",
        "documentation": "The member stands for twenty twenty four."
       }
      }
     },
     "auth_ref": []
    },
    "afya_TwentyTwentySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TwentyTwentySevenMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027 [member]",
        "documentation": "This member stands for twenty twenty seven."
       }
      }
     },
     "auth_ref": []
    },
    "afya_TwentyTwentySixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TwentyTwentySixMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026 [member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfAntidilutiveInstrumentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfAntidilutiveInstrumentsAxis",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of antidilutive instruments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ifrs-full_TypesOfInterestRatesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfInterestRatesAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of interest rates [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "afya_TypesOfRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "TypesOfRiskMember",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types Of Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfRisksAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfRisksAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of risks [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r188",
      "r217",
      "r220",
      "r221"
     ]
    },
    "ifrs-full_TypesOfRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfRisksMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails8",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails9",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r188",
      "r217",
      "r220",
      "r221"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "afya_UEPCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "UEPCMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "U E P C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UNIVACOPatrimonialLtdaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "UNIVACOPatrimonialLtdaMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "U N I V A C O Patrimonial Ltda [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_USDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "USDMember",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "U S D [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UndergradMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "UndergradMember",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Undergrad [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UniRedentorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "UniRedentorMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uni Redentor [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UniSLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "UniSLMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uni S L [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uniao Educacional Do Planalto Central S. A. U E P C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uniao Educacional Do Vale Fo Aco S. A. U N I V A C O [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UnifipMocMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "UnifipMocMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unifip Moc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UnigranrioMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "UnigranrioMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetails4",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unigranrio [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UnrecognisedDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "UnrecognisedDeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized deferred tax assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UnusedProvisionReversedOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "UnusedProvisionReversedOtherProvisions",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Reversals",
        "label": "Unused provision reversed, other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount reversed for unused other provisions. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated useful lives of intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Useful lives of assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "ifrs-full_UtilitiesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "UtilitiesExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Utilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from purchased utilities."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "ifrs-full_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "VehiclesMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vehicles [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price (in Reais), Stock options exchanged"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price (in Reais), Exercisable"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price (in Reais), Exercised"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price (in Reais), Expired"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price (in Reais), Forfeited"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price (in Reais), Granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average exercise price (in Reais), Outstanding at the beginning",
        "periodEndLabel": "Weighted average exercise price (in Reais), Outstanding at the ending",
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r191",
      "r196"
     ]
    },
    "afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Average price, at beginning balance",
        "periodEndLabel": "Average price, at ending balance",
        "label": "WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019"
       }
      }
     },
     "auth_ref": []
    },
    "afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average fair value at the measurement date"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair values at grant date"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "ifrs-full_WeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageShares",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareEpsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of outstanding shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "afya_WithAndWithoutMethodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "WithAndWithoutMethodMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "With And Without Method [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_WritOffOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "WritOffOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Write-off (i)"
       }
      }
     },
     "auth_ref": []
    },
    "afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Write-offs"
       }
      }
     },
     "auth_ref": []
    },
    "afya_WriteoffOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "WriteoffOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetails",
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Write-off of intangible assets",
        "verboseLabel": "Write-off"
       }
      }
     },
     "auth_ref": []
    },
    "afya_WriteoffOfPropertyAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20231231",
     "localname": "WriteoffOfPropertyAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Write-off of property and equipment"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "107",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_107&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "l",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_l&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "n",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_n&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_q&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "r",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_r&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "61",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2023-03-23"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2023-03-23"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "138",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "142",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "18A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18A&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "19",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "19",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2023-03-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2023-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2023-03-23"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "130",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "134",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "134",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "134",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_d_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "134",
   "Subparagraph": "d",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_d_v&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "134",
   "Subparagraph": "e",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_e_v&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "135",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "135",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "135",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2023-01-01",
   "Paragraph": "84",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2023-01-01",
   "Paragraph": "84",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2023-01-01",
   "Paragraph": "84",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2023-01-01",
   "Paragraph": "84",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2023-01-01",
   "Paragraph": "86",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_86&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2023-01-01",
   "Paragraph": "88",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_88&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_122_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "32A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_32A&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2023-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "40",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_40_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "40",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_40_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "44B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44B_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "44B",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44B_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "44B",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44B_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "10",
   "IssueDate": "2023-01-01",
   "Paragraph": "22",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2023-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "12",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "12",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "19B",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "21",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_21_a_iv&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_a&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_e&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B4",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B4",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "113",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_113_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "114",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "120",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_120_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "120",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS15_g110-129_TI",
   "URIDate": "2023-03-23"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS15_g105-109_TI",
   "URIDate": "2023-03-23"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "C32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2023-03-23"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_v&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_a&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_j&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "l",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_l&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "m",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_m&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "o",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_o_ii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "q",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_q_i&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B67",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS03_g59-63_TI",
   "URIDate": "2023-03-23"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "21C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H_b_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35M",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M_b_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "42I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B2",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B2_a&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Section": "Defined terms",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI",
   "URIDate": "2023-03-23"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI",
   "URIDate": "2023-03-23"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI",
   "URIDate": "2023-03-23"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2023-01-01",
   "Paragraph": "7.2.34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2023-01-01",
   "Paragraph": "7.2.42",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expired 2023-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b",
   "URIDate": "2023-03-23"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expired 2023-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "36",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_36_c&doctype=Standard&book=b",
   "URIDate": "2023-03-23"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expired 2023-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37&doctype=Standard&book=b",
   "URIDate": "2023-03-23"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2025-01-01",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "C1",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_C1&doctype=Appendix&subtype=C",
   "URIDate": "2023-03-23"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2023-03-23"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "21",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_21_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2023-01-01",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2023-03-23"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "70",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Section": "Example 12 Calculation and presentation of basic and diluted earnings per share (comprehensive example)",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS33_ex12_TI",
   "URIDate": "2023-03-23"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2023-01-01",
   "Paragraph": "87",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_87&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2023-01-01",
   "Paragraph": "88",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_88&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2023-01-01",
   "Section": "Example 10 A court case",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex10_TI",
   "URIDate": "2023-03-23"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "119",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "119",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "119",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "14",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_14_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "14",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_14_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "44B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44B&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "44C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "44D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44D&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI",
   "URIDate": "2023-03-23"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI",
   "URIDate": "2023-03-23"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "B11",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B11_c&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2023-03-23"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "IE72",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_IE72&doctype=Illustrative%20Examples",
   "URIDate": "2023-03-23"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B35",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_c&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B35",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_e&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B35",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_f&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG20B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG20B&doctype=Implementation%20Guidance",
   "URIDate": "2023-03-23"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG20C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG20C&doctype=Implementation%20Guidance",
   "URIDate": "2023-03-23"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG20D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG20D&doctype=Implementation%20Guidance",
   "URIDate": "2023-03-23"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2023-03-23"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expired 2023-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG24_b&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2023-03-23"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expired 2023-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG25",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG25_a&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2023-03-23"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r342": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r343": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r344": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r345": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r346": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r347": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r348": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r349": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r350": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r351": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r352": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r353": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r354": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r355": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r356": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r357": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "57",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_57_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r358": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2023-01-01",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r359": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r360": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r361": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2023-01-01",
   "Paragraph": "84",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r362": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r363": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r364": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r365": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r366": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r367": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r368": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r369": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r370": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r371": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r372": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r373": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "h",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_h_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r374": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "C3",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_C3&doctype=Appendix&subtype=C",
   "URIDate": "2023-03-23"
  },
  "r375": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r376": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "39",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r377": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r378": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2023-03-23"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>162
<FILENAME>0001292814-24-001607-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001292814-24-001607-xbrl.zip
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M#NA+[G%420+;[F)ZD>>XE$U$!>5@UI8,E/Z52?'-'3"O<$BW\LJ#R;XU"YP
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MW<H.-E0H8AS6_)D5':[>BVXBBC?&[9'NL[8=;,<7FV.RR0!M]H PRE[0W:Q
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MKQ>:MX%= )5[-+8/+A>QI?><JJO,4MTS 1!XE]F&48""\=T-VW!73S+#;^*
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M(AY1F?+51M%#.")!<G"YPRB, ZP"N*B/INUT0R+DW2$?+94H CMH(><6/=&
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MWJ 3"SR/3QES356-ZAX6P]^4JP]="P^DZD4OR5]UE=\)+&D^;]F$%R^9/#@
MP19M>^RDDDB2F?6(N,17QDK8L?5'<*O!)J<=1-! "!\#C,)8^M+@OD-9^^[>
M>%0"#"095&4&XO2 0QP\X^V3BD^(&;-3])*<LN2@23MW]U2D$H)J](.ZS4@X
M(R8>[(Y0X/.8NPJ&93WF9;?,3 (.)!I"2\_MK2;LR$$4!>0ICOAAYI%.?O@X
M8%;8%/$<"54;4SY&ZW[':HA68@.,[1F(\3WUN3G.),:^MTRN+>!097,5=IR7
MA<G,05-.>[-AIR:6J7P1SK^T#$H-GU>&4HL.!-. +DAT2TL3&?;-#JUL0")'
M+6@TFH>&($0!N11SS6W !R(;- =K @4]V)X>_]B'^3$#_TZBU1"%*R & ;0V
M6,XRJD$[3J^8CP]Q977Z>;-<*\/%6D8M:#(U*<[DKLX"!P%V;Q@OHY\X<$C(
MSEN3#50!L4B_;!"KP%!B!K2-6L0J_27/LDL,<D;;Q-_=/V0[XQ/QH90'*=.*
M0]N,:Q46(;2UY.IJ]IQO-^IKG/[W<170>+DJ>$\2:2 '6N,'3W6-\0R>%J?S
M!<V%NAG$P,H?..P4D":W3!; 60U8V2I=#8:H$@L0&G4SB $T'M@' ^)$V"WL
M)8^4:0@GYE4.($ 4>QN.214NP'-KW5AC5?V8I>A8BR<7:6H:-VJC&HZC#NYL
M"G-=DV?B8M\-><Q.I.J.&AH,HH!@$)>,BZ*C-%!^:KSQZ(\#.T=IA1\JI!6R
MD<X6Z5 -944.=Q>X,L7GRNG^R&B])B'/,8L#G!"^[7I&LGT;(G176?QPV7^:
M5!W'@)@_Y<G=#7"&]B.<;?9#-)5T2I9^\GQCMDK!/V,W28$)1V%$F-AP./#=
M01C&Z^/-^IBASWF&,F-G>?KW;O3_YPSOQD^R;5'V"TWQFR;W2"?3EP(S:<=6
MIE+)X:=<YN?O\F3NNO+4Y4S?IA8G6_\\"YO]A[O*GY&',R47CTD]+RQ/OGDD
M6=;\!YSMWQ"YO$(Q?L .9E]Z\H"%>7Z1)S3I=A9D^S5$X /V^"X[14$$[1OG
MEWGRMIW.-KM>#1&75,Y@NP"&$'Z?IRSIP9<U;A#4L<^,I"A=U(PZZI#,:_;'
M!'[($WCHRS/CT:%W0[1. [K!0?3"U@Q?+YMLGN$QJ05EMNN:K!A\Z-R85"/D
M+PF;[2GBC.*OE+H_B.>5$UQ09X<1MC,@H7RY'Z0APO=W7/9T[W]S2] 3\0B\
MM H:;-\UR\+ASHN7'; I?A )OB,OQG?)60'#4Z:@LGC7LV?>]VR=[=R8,DA3
M\)"/EC"9%P65M>UWMLYT;(C$6_1$ S8E9GR=>X<2TN7SX:*@LI+^R21(=@KO
MC&:':(AHP16@BX*NVC5NBI9M"M$4!\FA=;0!1%?04KN>9VP7.PMYW[/_&$UG
M?VM0ESYC/R[7!!<%5;5OW93@?FZP'R:&])"&47CU<H\B]NER\@J*:M=]>RN-
M#7#V]'+F;X=H="ME!E.8ILN7$%I04]L^S%I*.S6FGGB$^1']!+;RBQ)UE-SJ
MB](NC9'%OL;Y3X(9R(E2O)-S#_;!L^!%0?'L!SIS=B-MH3\:JR$V[JG_AAOE
M99&)8\(+.F?7]2PZZMO4:2Y^"IDMQ%3&Z!E2.)<%A7/H=8:?FU0WL$M Z!JX
M+.@=D6O@[#]V@S6WE\*,/,('J<N"<A*SD0[5'!/%H[^(^(("*W$ -$]SF2=
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M3,B;X=WT2F$GKC#._-(NNZ@F@R"0VJ-:0]:&.-<XQ/XS]9YY,A6WT6=T$?U
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M"=WPSE)">JY3=S[LTQ H8P/T;1NH$AZYSW*R*!.", 0!=[/!/RTC7\$#;0J
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MEB1/2&7<;+@,:NOX>B,:#+H.SJ 943>?!=H8R7(531;?0EQU22KT-!BB*AQ
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MQ&9&WL5%>=[%1<6\BXL^[Z)*WD5?X?J$_(R^PO4K]]OW%:Y[7W[OR^]]^:_
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M!0)'TLMT.)3(!P/7FF^";B\[;J?#(YUAC_5:SE8HP"OJL6]":DJEJ^E0J/,
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M4B]O;+JT150W>G[2'=L/5Y,X6GCT!SOLIZE0XHA^L;W)4"D0#J&E.5V_?,)
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M^-*U9)?]9'0X)#I\/G7[0_EE0'.#P9"2K?O0"=7*P<$&1S&)7KXR>SQ:\6D
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M:3$_MTNI%4@'Q:I;K7V-$0-U%?OP\82WRS>;G]NEX<KI!Z6L6]$-V"'J.E4
MQ$="29<U;3^Z<)JT81Y B>O6=4,4N&2*-C@03^Q".V:H6R5K@ '89Z)[ _&(
M(]XZ]@WF%W9IO#SEH$QUZ[IK[#W@%Z%4LTWF%W9INR+MH&1KJSO[RP-<6/ H
M1P5.((@U.^T&3O(H4K@EYI'.L,=Z+6<K%. 5]=@W0W&4O\(()F-4BY66O( J
M=$FS,:H-\AJ@RG,#[IKFYVQ\*$]G^*PCG>%#G\Y0)9VA+ZE:CS?8OV1)>D)?
M4A68 'U)U;ZDJIG9!7U)53-+JIY@YXJ=@<H#6% +M3I#%NVR+3D%S,TRK\&(
M.2Z!W4.AD%U?90B#,:K%BD6+<'=W;8J(FR@/LB#8'83[6P\#)R+/TK)I%88Q
M&.S:["BX%=I2C@/GSYB$)'WT=[S!S@EZLC"6P=B=QA-HWIB[8D<_-\QL%+H<
M<DT-1D](,@2.YMMM*K/G*@X9"V$XI.LGMA= KXVK3L:RX0Q&Z62V("3KUH"%
M(MGLW,1(8JRPGT+"/I'0,/$KP%=I#,,QJ\X+!%3=6J]0AA)^9M,%>1 (^[\;
M+N!C.B'A?=(MO#5&W&''R9LL1BCP:5SZ6%Y*8FEKXP4+4PV)^;-Y.GO@_CO>
MWNVXH<'8=P)>[_\:I_\=^^D!,-U9X5KM^_%J#&<PSB>S!4V$+^8']3Z6!_6^
MZ CJ?33D'O:G4AZ_O-/!XZ<^<%DK<)GB5B]F>=3W]80K2T3RJB*5VZ5:.4B9
M[6=:?+(,,WEHLB@)*UQU.?HK!+&..Y@3BRP!0O((N=41R)-PLRWN6!=;ZQYP
M3*S2!^Q@\IS$;>3XEO?H/AQ9NL1*8U6EQ%NTE?[5\GCJZ4GE%)ZZ80Z+TCY,
M4IM]"D^?PE,-[U93> J%\X3Y.D#K[DHL5,O.$9$/QJT,U(CY!TCEZZN\1W=E
M'-1Q4V$!#(!T<*]#5[Y;9S=B&TMX:[,4!'][=$>3$)%BPPX+0U03/40Z[ XS
M<"O+6;T53MKS<PO>=RRE&0+(9&MNZR&(;A )OB,O%GJBX5XV@E8@WZ*S<]F.
M4M4.MPNS N&6GX.K+KGRKM9BJ+SX,LE_IL://Y?'5L]UQ%8_]['5/K;:QU;[
MV&H?6^UCJZ:[AOO8:F>Q5;"<6+@:_1F39^3QC+YS24VQLL9FAT3%=%NT^3VR
MK[+IE7W&3*K+X#XVZC&9!*PXZF6I3QB2[X9@EZ[TF!0(Z+X0P+0=6DP?<F9K
M,EWH6I<C=.-1Q&_@9/E1L%7 7ITI1MER*Y@A0A8LVERW4_>!A'^HZL9,6XMU
M8H%C*R[)9HE72,@K:=VQ!BR*782/C4KO5(BL4'5U8+1.NV4W=\Y'->OET*,S
MK2982B*+Y)ARBW;'/OU5:_IKW3H$%J5,FN39[--?^_37:GA;F/[:6=E_/>FO
M;3[=5J!AXHL3]. .UF8='W, *JJF)?_X0_R@$]S!AKQA!0X@R>M.&RZ2P9I7
MG/69+K:D!DMY@.2O.QE8)4=9M@U5&L.:%.(:7(&A,MT/[ZC0)MO"*HW1X8-U
M^E'+<06BIEN_ZP@DGW^P P<1^:# /Q@84YX&]"GE]V6RN$Y/!3+/ MS'1H>"
M3 +ZJN"U]S9[&4_RHVB%0;KR,DC!DKR[+A>,';Z&=O$VVQ/1W)QHU1^QJZ-V
MA4(23BF3F/A"(=B^0R5:?;51989@M5HW#*T.A.R((.IBSGNR)\.1XPE$Y*.!
MB0&GW#:TH"9C*<T00-IW+A?_Y(&V*0[^-T;P(CEN9K)<87K!2:]7IFS58?YM
M0):[/YLNPV,Z00O+O.VB6-5T?QGM[E#I]CK&_/D/%%*?G3%>IC0,"3MK'#I]
M\^E3B(.D!-/8W\31 W;HTB<A=L<^VX\7))H$MZS;%5[0 #^BG_+MJ6/23)YR
M9LD(M!Q?V73?=39PNI].VNN?[KID!$:SS+^>^V5/_='UW L=UW._]-=S9;M/
MUG<WXWZ!Y-&>EX&/O!=V^'BDPQ7RES@<^SR5:_1SD[0-'U<H&@1L=MZPM</?
M3@B0$X6_DVA%_)E#-VRT\<W#[/Q3I3N^#1)@_47AQL&Q^+;Q$?<R%WI)8T-\
MY\U#G)]@H."LN)1W1+W<YUK:O"MO.BQY(48V.LQ/A\EL)_A)4+;JY[YAEB-9
M^L,X"+#OO,A!X;W$G3I+2!<M"UJ%^I:\2CM3/T>0DF^[M$\#BT*OZ.74@Z+7
M+/O=V:R*[(5]NLL]592]G'I0@QBHZ%_%S<+VK3OUZXD&>H'[ZXG&&W;]]<37
M<CUQIQ_4KB866]MP+;&<:HMVQ**GF:="#GPWEQ%9S:-?/D;KMSRT>-X%O"C$
MXTWUD&<VDR,7^:4.%_GYN]Y'7L5'/E@G2>"/](J_\$.?<8#=23##$4/&'2PB
M'#S^P-XSOF/Z9L7?Z-Q?UMM#G4&8&WK<OF,K0SCP%8U6]_2.&?.L/_\/Z^AG
M/Y1\^0%O:,!+B5SSTB-5'.^V<66]-]\V@5L?(KA#41SPHY?D^'C<SI"CHZ6S
M);\ RC"P(M P6"X#O&3\N8\,N2NF5A7..X).79U,2P$H/#$M8]:.PZE>S,P^
MJIZ&JW6GU5O$=SRV&4U\S+-#Y;B6]^CLU"I?8H5GF$ &+-I&\TPPM7)/H_UO
MDXO*_/<J+VM5&ZJ[6,GI4*NPICV0TL8L.'"28_&&/%>>!ZJ#=1>Y.6$F5&+.
MIL#.29#GF6_[K14=R);Q *IB P%\%9&Y5W*\ZL-]?;C/9(C,/D/]E<)]M^3/
MF+CLP*@6[RMI;D/ #R#;IDTQ0"[7#I-HA8-MW1FF39)?S^+-QB,X$*M<E0'F
MYVV?CFHXSRMPHA#J:Z2^&!#E*K0S6=X"@FUR-.0>K19N;KFV)J,C(=K^G>T!
M>_P8-46!##:E :S L@(GH(VA=V?C3USO" $VM6P3DZ5<3BLD1P.K5 _<9[8)
MB]?"KHW)0 #$0DC4K?,%77PHR:[9Y=7&R/OFNR1,JOL=$GCRMR#41S 9AEJL
M0"!]M"!WZKP\=^J]EMRI\SYWJDKN%/>!,7$R6?)I,%EDJY8')&26)L]WWYN=
M R?)EN<NM2JY3*=^Q?K<(CUBMCC71YEAF<>ZXD"&N+,UX5]TI]20JAW'157.
M5%QE%8?JRFM=#\W:<\)&?W=WT\)L3WDG4\?"]TFZ<I'7790*;Y;8[0946*>E
M/;K++#@12A6^M&<;0'>P&:4N.^;MZN>++U^7-N[N 10-2TK $GB^-G%-J4I"
MBSJ<7[1=3[F.,[X:-[K#4RW>.'Q<!31>KO:L\8MV-Q[]$6J9%?J_9L7T:8IM
MBQ3U[L70*2)NDEM%%@2[@[#R!%(>QI*949$?BP* NUF_G>WW^$=BH^C=26H/
M;LGTT,)E2T'%'+6[N3WQ3T$\6V:H_L FHZV30XO"GH!2G#SQM%K^F".OA<N5
M(X];46^RF,5/(7$)"ABWDR")I5_%K 4.=6\J+9-D\N0T0S:Z8\@=3&O._[84
M5*-SM<YWK)Z ]1FV..A]CX( ,6X.L9RCV/<'';'O_3?Z$'B5$'@J/E[3?4&#
M=1*@&SS1.+JB04!_L&E8+=:M/)SU0>V*@K,X>OW =RMI$>M#(T.BSE4!*M3&
MS;-MA><BH5JEJ/%1N\Z*3A=D7(J"E=':.DB8'6>MAI9UEY"N:!31]621,"''
MK:1Y=[6GRU9)'AR 8(LVMT>Z488GW[;#ZM0JX)22"T)C(#8SLO3)@CC(C\;^
M,PXCOIF$8S][L)89$>ICO!(;HZK0K/"DYUX:S?(B7[8*G;LR5BJ#)7EK&!:,
M'09.LSB;;0HU/Q=:?F\Z9.3$$77Q%(=_QB1$>,1DY=,[[!*'NG041LAE?[XC
M/@J_X@"1\#9RD>2UB)-&G9OR=+5@H5*]W(*>8\VY3]]\\H!=-F4I7*N,-RRT
MFY]W5JZH%B@  Z!A5;LF$2SHV:U,Q+L6YCS6KBS<8])!L>J>OS?#N^F54*R9
M%O/S3U:)M4 Z*-9/FL6:;%3(^PT%S(@5[PQE3>?G7ZP2-,P#*/$OFB4^6]%P
M(Q1TIL7\HK,S;"WY%D@'K5O=[RNQG6D9(#\@5+;W'C6;7W266%UW RZA'Y2R
M[@SJAW]-'R9" 6=:M!^U/4VV!=)!L>I6;N/'Z6#X%3%@5[$O?@JOK.G\PBYU
M!_, 2ERWWANP@]]UJ@Z8:2Z4>%G3^85=>@_F 92X;KTW1(%+Z!1ML*#")F]9
M;#B_M$L+0AR 9WO=RO"K1QRAC \-YI=V*< \Y:!,M5\>PMX#EKW7>&@RO[1+
M^15I!R5;6_OU16";C2VH5U^MFUAM<&G/OOJJ\1"9[>#_*U5?/?FQQ<O/%E1?
MA>@&D?JL1;,M4/B4L!@&48+26^Q%(?]78E8D4+!_[$$ ]!5K<MS";BU58 ="
M0<M5D! [OR[I\UMG^\D4A]V_#CCL?L,.A+OIPI.8C[;\#":[YJ6M6]8_D$"I
M JG-:IWVA6^D9JD/4 OZI#)&HV\/ DS87^?OVSZEJTQQ"M )[CZZS^*9LH;)
MW<A''*PAST=)T_G[ML_GU2X&PC1#$C;0'!K]W+#%CI-ZMTR!/=+T%NMD<4M_
M/",OQNF5%W:8_GU%G!6O;K9,Q3_ZB=<;_L-O*+S"V/\6EI;O/)S-M7[)Y,G1
M*,M@M,Z\N34-:/)\"B^#-_GAXR!<D<WN_FSX&_;<JY=[ZCOIM41&TW+_1]%$
M.F%8*V;-R?R!)H[FB!A>I_=+ZY833R)/E08Q&;^ZW.AV5 %HC?YD>HJG;2'/
M2_+W(*K. :34!S =I:J<Z#ZNG8K0J0"]&GS$\!AX _V:RQB[5]AG/T23)X\L
M4R]"-&7[-V/U.[<*1,I/;023$:[%"H3Q1_,P9EN_'[)C >-D&A 'LR,:IP"[
M?/9NU<,4!XD'R7?P@6_9BQLU1[5B+IS*'C0_/IDW/[CIEAS)H]VVQNS_:1PX
M*W8VF"Q&S.!;OHBF@M( 5J!>@1,(X,\-V;17R.,3C1?_DEFNF:8F2UU,,R3?
M+]I=0B%A R=KE[_,F2S\!6:3 )*SJ(OI\I;3#A[G#?05'7'#I\X#=C!Y%KM]
MP$XF8Z=*/8B>[BL ) BC@>^7V\7 PA%W,EG\JM2#XM?LZ9CQ-QW<JO*7]#(=
M "7R000T>R\>5R2H#("XD^GR5Z$>%+]FU\3 X5?\$K&XC/8;1(+D<#99)*EV
MQVKNH.(@5U+=X4R'[#2^0# -=&0,&=DD&OW<))D10OU_U-)D!(4D@^#4]4"
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M3 ND&A:H08'/EE8XQ4&"]&@3"J,V'POQD.T 9QL<G(5\B+/_&$UG?VLACO.
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M87Y#3J?M[_G_/:$0L]_\_U!+ P04    " "BA)I8 8'>Y;V]  ! U0H %0
M &%F>6$M,C R,S$R,S%?;&%B+GAM;.R]>W/D.)(G^/^9W7? 5=O-==N6JBJS
M9OHYLVN1>F1K1IF*52BSYZYLK0P*(D+H8A!1)$.9FD]_ /@FWHP@@&C;Z9Y.
M271W_IS\T?%R./[U?WS=I> %Y04FV;]]\^:['[X!*%N3!&?;?_OFT^IBL;J\
MO?T&%"7,$IB2#/W;-QGYYG_\]__S_P#T__[U_[JX #<8I<F?P1597]QF&_(7
M\!'NT)_!>Y2A')8D_POX#-,#^PNYP2G*P279[5-4(GJANO&?P;]\]_8M!!<7
M%G8_HRPA^:>'V];N<UGNBS]___V7+U^^R\@+_$+R7XKOUF1G9W!5PO)0M-9^
M^/I#_7^5^K^F./OES^Q_GF"! 'U>6?'GKP7^MV_8?>O;?OGQ.Y)OOW_[PP]O
MOO_/#W>K]3/:P0N<L>>V1M\T6LR*3._-G_[TI^_YU494D/SZE*?-/7[\OH'3
M6J97L4:^AZ3 ?RXXO#NRAB5_[<;; *4$^^VB$;M@?[IX\_;BQS???2V2;YJ'
MSY]@3E+T@#: N_GG\G5/J51@QH1OZK\]YV@C!Y/F^?=,__L,;6&)$G:C/[$;
MO?D]N]%OZC_?P2>4?@.8).6'TJ\_#6S52M_[!KM$.2;)=38-]5@[$'SZ[>3E
M$0[T];V[\$A*F$X"W]?T#OLCFO;$.SW_3YK&>33M2?<T9X%=BI"='Z_\N:;L
MCW?TIP%$]+6D#1A*&I#,A"8"\SOPAJ&VW5HGZX'=E$5SDHN^LY:1VRS0^KLM
M>?D^09C:?OLC^^&"_<#=IK_\?)V5N'Q=)$F.B@(5]0^/U/[B*RX:T]RO?_O&
M1N'[,6BFNL@;Y#!?&]RO);Y?$]IX[<N+M'K0E?HF)SL['/6#(C;2/Z=/[1VJ
M1TM!*%P9B%$CY)"OD=.;[?MC_6!KB+N4JK!^&LHN/JV^^>^5$FBUOFU^!$P1
M_,14_]>_?M_=RP.EWAT*G%$(ER0KX;K\@'9/*)<XK)#S12 MS(8W4J$HZ*)#
M-F9)(PMJ8?!3)7Y:9N!-7G#P)?Q*,K)[Y?RXH-U#RI+-(4U_9A+=3Q=KDO_<
MB7#^\+]SB<L4,D+?;U;/,$>7<(]I^RN)258:/CCE )VQRT(\.,_L,8X95\L#
ML@$%TP#K2@7\!$\1D>#F%?*@\^9M->[X#?M+A7)QG].A+,Q?.=1"&GZ,TCX(
M8PF9D<4@&IPH=OBD) $+T*B 2@?\M#M-=-*QY)T32Q32?EFBA3QDB50T(I;H
M\,E9\FXVELS9AI'=GF0H*VG@O/[UP+IWV@9,(>ZY]=*"'C5=4MG@1+,$*#"M
M%6;M%N+B)VJP9B39;5$<4%(WR=(X9I#U2R\-W"&W)((1$4N-;LRJ2K+K ,4?
MMN@0$K-98I@N(:9!UXY;!BV_++-R8<@WK4I$S+/!.>9@IP/V5.D"9^?$Q\<<
MP>*@[:J9A/VR3P=X2#J99$1<T\ ;4ZP1K<9[9]$]>T %RE]0/:AEJUG)$K[N
M6 ? 0#(+3;^,LW9E2#^C6D1<M,4Z)F:MUTY%7'!5&@<KW?,@:@EQAI)KF&<X
MVYK9*1?W34D=Z#$/9;)1D4\#4&1<)0Q0+7T.'*M'1V69XZ=#"9]2]$CNOV0H
MIR.G)?UL,OE$_A0#?GGHZMB0F;;:$7'5$;*PI%2->V%/'Y0$$&Z!1=$]MW$.
MG/Y(^4&RDCXS>K_M;58B^K2-C;M!RR][K5P84E:K$A%/;7".R4EU+GI* #=:
MYT#'2UBB+<DQ6T=Y0"E/B8%Y27_73PL:U#Q/#UHY,9HFU.I$1$DKH,*T8:O$
MHF->J;$HR?3F7?!ZA_(2I<4.9IEZ!4,BY&WA0@FP7:\0)(+300M+6%KOY,YA
M5=UBU<LD[#?<F-:\])+!N60%;\RI=J5KSJD4<Q[/'=K"M,Y*DN>""1*^<G<4
MT)JLG='EX"Q08QJ_>BX%ZJRN&;*W3AM-5H>G B<8LK;/$$MDHGXCB1KL,(Z(
M<L'Y8P%N3*2^X#GTC5=XF^$-7L.LO,U>:(^>3\[=9GT_M+UD>P.>:>?HV(B,
MEMHQ4=0-LIZX<W:>%_1_>.]^C?=P35"Q6J@[T1IA;YUI(^"V4ZV4#,X3*WC"
M\B65!P,%L *+D_6W%?RXS0K:#!]*\D@8F7&&L@(MZ8/ "64T6F0ER3"YA'E*
MBB7)2[+Z;O'=[>-R<<E_4W/I1(:]\>ZD#Z+EZ$FLQL'G4[HBI(\TMD'?..BL
M@]H\J.P#;A*LO@.+[\ M> 1+^J5<UG^-Z(MI'\$BA]L#I .>TWPP:KM1?B^F
MQS#I<U$9/;^OQ>#)T1_+^#-I;S/WI_(IPY!<)X<U7/.\G"OR&:;HABS6/#A\
M^GC[>7%YK_XDW/2]47^*6RW%793CH/($Q&/*<A.@9P-<$;8O'8$; JB=FJ*?
MP$=*T\^<I/>SQ_'EX^)C^RU=H>NLP!E9'?9L V_>?4V/,%OG**$2BW2'< (_
M(MKAY]\LLZ )Z*>]@;_(/L>#Z4+\*:W'\8',X9(0]&GL?J0?!OU VO!_A4!U
M*]#<J]\(-'=C8O7] +]AVQXT%GUUF.B3X1$ ML^F"B57A Y[,HB?('\6UZO/
MBZ5%/VF*.?_=H^E.B[TB=UN1?"!'.Z#N [&/H+;9?09-ZT+_;0RWK+^FPVK6
MQ"SGYOTE8DOX5^@2HVR-87&]6\%#@J[0;0G_?JA<O;Q<W6JV93E:\+=5:Y)K
MW?8M)_4X.#P)L["*SHTPSC9FP/4.<$/LC[6IFJJ7]#\K2EB/X7G0<-&/$L,#
MKK](RXAL8R%($+9W31IWS>IQT'029GUT'74Q6$QEE@8!U5,P9?E3VQRR+E3]
M]3VRS"@ZE+V\79GBJ)6RYQ#JX- H>EIHQL%(5[B*F-D:8)QL(V9CA(;*6TK#
MF4EXL[BZ7M[ ]2%-8(+Z0V*TI$;>Y;3+3>[*!')!-1^GV?%&S6/<;%DZQ4@<
MA#T"^9B[-[2?>44#Y!*T]H:S( @PDZ"R"9A1T.G,S.8/*%FC]#K!5 %>O]#/
MK)J*K/ZN9J^=GC>VNKC1LM-&*0XV.B =LZ\2 ;4NJ)7K=KN^Z*MSV6/]"E(8
MBRVA5[)G/H5XL]"M2KO;\-_!='1/[&):&HB#DQ-1J[N9_9C(#8'64DU7%A4]
M+(=?KSY<CJ<H6%1F?U<SU$;+&R?M76A9:%:)@W?6.(7M/I0['V@?49PIXDUN
M<]G?2'N)BE\/N(#7U>B*!F.\)C?DNBAY%_D#[=(6[U$.<<$ WBZO/UQ?60W
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MX[<7I.[_6NKX;5PLX ^;%XU"<*JYH!2(UV@ W%,YAZ[- W4#:>>(>A)^V25
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MT,H>J) D3WEU!VIE4&F#GCI8@<7L#<W'V\^+RWM&;DP[/1BF^@"EE_?7&%G
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M$K["IQ0]DA5*J=9V]0QS]$S21$L#%VUO_'!WJ26.O6H<C'+&*SDDKZJI75L
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M\N,9S1LMLA(G.#V4^ 7=9M2=@_6,D58UR%R1A3/262*-7G!J3@"KG!F"/56
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MRQ )I[TW,H )A7K-5ZA8YYAW@75^#,2\OW0)2.'=]V3BHH (3,V$GFR@P/Z
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MC/OLW:&@W>R"_G7WA#.>?^O\G*SMQL%DQ\=@QV]+HV? >C=/G+^%^N_KGGU
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MV07?[]_7"<$HZS!HTHV#5W9!3J]X!NPRA["68.4)">9K\N^%%W#9E*S$ *N
MQ:K=5B<SN$X#VED*."'HXJIF:M#&3'!>'X]=*'9V>"K0KP>V:Y%-;\\UPR*K
M8=7;]5,5JC=$4G<;WB+J5/?:R.IJ(#@3CT%M5:KLI!MO5)F<ASQ';(]O7AP*
MUDA4OS?G>JXY$LOZ[]-M^<L /=+=+CMTHJ$X6'LD>B&KM%('+]Q>=9AK_:?U
MP&3,?0?#^2%NFRU.:#>N4V8<MFV<S&B$B^<G<2CH/A#97KK;#)?T+P]H3;;L
M1Y+1IJSG@E4?Y42&_6U$.N6#Z+8KG<)J'(W%*5U1[\W$G7%P07_C]EFIM^8&
MO#=TPN\B5%OR2*X0':;L:'^/=AKW)&,NJRH_3HM CK>(J(69]' <&ALG^V?6
M[DSQ[1^BCJBA,3ZNKL])C$?TA3D^$+>.W)G6!#J=5W[J! 7\F.[8T=<G.5Y3
M8BFNST3IJMLW(9@)WJL['KNP'8O+G3&MQ^68>+'%QV>8-1-YIV"\VTWB^ABF
M/""W[\3E#N?7ADSPSEB8:::9@=O='N*<M5/WFX\D:ROE5,"MY@"<37@;[4]T
MKAW7.^H'C_5'@!;XUUIAI\NS2=[-J++27+D'QF^K*3MJS$28:,E?7L)1KG99
M"I/,Q$'6H["K*]+.1<X:8;&$K^Q$@D>R0BG5VO(M?L\D35!N%S,G&O)&S:,<
M;9DYR4HLS?W1'HSIV=@"^\H8* DH*G/5?L_:WAGWK.D(^ 47UL>P3;,65U]9
MZ[+SA(IH*GB</@U^R5Q)+3M;#N,+3E"6V,5CG;3'/$43Y%YFHDHT.%_L\(WY
MT"KXKA5D10\7[?!U@\STL5>-JC5VAAU!)2'>4WB"!3M:Z)7W3:T89Z7F[_!U
M>R>Z\]7-.G'$*GN@0C(IT[S@JJQ3=Y*1A]]R'3?T';?;7OZ&R^?+0U&2'>V%
M3BSD86DP>(D/)\>-Q3^LK 5G^\E<4%0* >RY]S9 ?:%6P+HQ,U-\Y5M?AQ\L
MC>:R[UPEZ2V*ZJ&V@5,N%IP]9FS" 8ZGV&?L[4Q2GFSTRD/ZA)-(E=HASQ\U
MN*0[=52A&DMW<!IL\8312KZ:?IFM!WC8[6#^>K]A>T]P@F&.43$X;(MV:?GO
M]WN45YW11S[;A+Z6[^B=?I'V6DY@U5__\62/H.M>'FTRCHAZ,C^$SNGZ&26'
M%+'U&Y8B!K/7?_K-']^^^<-?"E#T[L6'0R<[ODWU#=1@[C?718EW[.S43P6B
M'_ =?D$V;'?2]\?K"6YU#'90CH2K[HAUK$2-$7#@5D#*S+ KY?/,R]Z=)Y?/
M%!XJ;K/1A";F'U[7NIA6&X^U&("SQ[@N8?$4<['Q^@@?=$Q?5V;Y09FM8;"O
M+?,(G'2V9^=\>PK=77<<TFVV(?F.MR\W)*\;C*)N<[+M"FUMUMQ/?X\ W\5I
M'X_D2SG-#6+[=D[JE>YKVE,'^-:1WA%?O8.]Z%?6WA30GWAK,NX!D08"*&H,
M9S)0=?@BIQ@(-URU_9;<M8-_*),AZ[Z"HJ1=IVH+%?T-5Z7=_-'=V,BTVR*+
M^\UM0F^)-QAV1Z"N?SW@'"7#<$&O'78H<1D/G/ V 9J:DS\D26MSLGL$_XYF
M=DSWM6W:[;KM  7W;MDV1?5-A38)5O>M!(IJCR/M#;(/:/[N7G?/^\T52A^0
M<?716C=$]\S*'5FW2ZL8&[NMT.HHB\6S?6MVQAS[J=FWGN*_[%;GU0:H']9I
MVP'Q/K%]+7,XYZ4]X.IBJ_#6;ZNP2-'N"GY "5[C#$YK'30V0K<21O=,K872
M0&S?@1-J'<'[E&2_IO_TF]__^)<=2"#8U09#MC #/R]AGF"RA'MMWLHD"Z&9
M:W#-Q%N%>M2LU6-VX.R:&P)[;BD:LKY/\7H:207-T.14N&(BY4@M:C+*L3J0
MD!GPS[W^/-,5*B%.4=*;BUT\D4,IKQ5B3)0_B>$@%<^/?A#2ZN>3K<;!^U.Z
MHET"FZO8C,47\)C#!%$'^#[L![1&]-[T6RS>.)#=SD807KNX)Z6PC8'XV.J
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M%?>E>56]>BKCA!C+E(VI\ 2,6&"47+0E9,EB92M:0YZE,XTS0[DK@<ZO=5+
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MD",=S3W@-UY[GA.'>6 K RR_9QY2XG 13/#,UGG L^X=$%-[@VXH27W?_:C
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M,]N %"^U#\]I#B78ZK@^T7GRUE9-Y>LE75Y)]#[Z1\2K8Q_!RH]1KVJE*,6
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MXVY")M:D:D.9!B6HXBI*P-2#M]GF=>3>9J XIT81/A"(-^7_GYUR"1-"0XM
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M.Z4U5(<-9G';LV*1\03$UL</H:6INJ(8YKYWO)E1L"*0YE3$IEN8404 #%Y
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MQ%;6F:IA@M='-7&;"V/5E_0KHI;*CZ40(H/B&@@$P_T<N$9KDJ+H@0]L(9\
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M?VT(/\<?VRG^M\T*AX:[]!:_=#G+0.OP6]_V9V-*2'Z;>8.C1PRYP "3=]J
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MNTZ!PA#!GH!*&EO6[A1#W90!TOIQ?%>@+S-M6CS<J_TAF_J.\I&*W*\4JR9
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MT;_>Q()UO1!.&G8I0+R2QX),^-CGF#<)[W.^I2/,AO>,XR>6X*RM?_(43V]
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M:';]HFL<IZ^3B.^)190O9WXM(*N]AZG;8Y="@)JAYN'\?R2+93J>?TJPJ1$
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MUF1,]]/KCO*]]49LWB0(FW?C?U!./;XZX<OII-_-\!(3[F4[LZ-E%J,0/^(
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M$74A.^[^=JN_W6K11I._-B3DYP?8]59E<_?;:X/[+07#/EMC\;;GSCVYK?W
M#4[VZ^EFO8X(CM4F&M9!AZZVC"!I^5[+2F4@B5.THEU'DB>E'+J4QAE?;%0:
MTE+;#J1T*D9_T8*5F)I''(G#P 3%.FD#.^A2GJ41)AZ:7W'AMQNVQ/(>-^E
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MJ3H:OM"31QQ@\JQV'BF(H&+SPA&D9=[#4_LMB9-T2&GU'ELRU71$4*FY],9
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M9[A+BUNR3DJJ([=D@9)UF:!Z7ZK:X6B),D(W)F8:5NIK!"J<8B8S1"!.P;8
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ML@)HS..N9"MKM6GQI<TNF>(IN_H4T]#DPXPU07\--1Z,J;8M@\_Y%$&QR&_
M!^1^G1G3I[,3]1C4@SC/&&2"UPO]U;#_:;+]Q^B#'@2D;+, O*[QUI$FA::[
MD/:P/D6Q1N"?^3WJ<WV/(GB+BJ:MU5"8=#6L7QA!_78@3N!HK&_Y&38;E].6
M J5\G=>:G4 '!HWH28[R"%QSN5. N._<I-D&QQ/:6T8?U%3$GR&<6U9Y[ME]
M1Y-"T_N.]K":>O,9@MZ,P+_O?A=;?MO%V90VF_;GM+V4$%31(L,]V\"TZ#,W
MU[0&=9<&-9JU9L"\[W[O@AZJ^_W"9?87G'#=[Q?]5?8H3+,D4)767KC.1(E
M><,E],Q<&8S]MPP@-;'77/>3NJKGI^/<C/&V75BM+*'6_%1N*E$O7<FY+H.I
M23Y\,/Y/?##^13\P_D\!C&\'C'^--U0=HRM,Z#\*]JY:;H2W%_>?(:1>3&Q
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MLJIO0%I 1EK<DC=<%W57H]U.V\X"<R%B 6"SOI7$MW]]1^[YY#2?!TA"P@G
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M8M4\G[PMJ;(DZU__.#/QJ_F>4^@]_=9[ZY&__(_S\\H=P8K\H3+&YL^5)[3
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MHPHH$Q;89A4LLQ0LJ]J5!0!>4I?'ZK963%,GSRO3.LAN\%W%.OW"$+%]".7
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M10"!)8O5!^&)@\U'PZFEZ.X X%($N&3@7:Q:9"$RMK8QQR8R5WOVWY*S/-X
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M@'K6%6KQT0T5YJ(@7(A]O8*B'"K$!02\$!5B4;$/%=ZB #[["J_@&(<*;4%
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MH<);%,!G7^$5'.-0H2T(R(79URL4RJ'"6DC$"U=A%1__4"$M)@%$J9 *R@"
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ME,G:D/W)//N3@=4A^R-H]B?MF1^R/]EG?]*V.61_1,C^9!'90?9'W.Q/!GB
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M]5$FO$/7!G1M "N.S0+0=0%=%Z5!/71-0-=$V3 /E5RHY.8=V7:W0F/=K="
M7 [D<@1AP%8O0R-"+T,CZ2Z??=Y +@AR0<"7*/,,Y)(@EP2L2F86@EP4Y**
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M@LX"Z"P 5B4W9T%G G0F />RG-&@LP$Z&X!;L7(+.B.@,P*8E02SH+,".BN
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MR0%CQ)QCADA'U"!87I?Y<6>EF"L= 3]RSX\@QH7Y ]@ ;("Y8<.&3RH9809
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M&FU5MG6DSHII>>]9P$?XHM,>3"^:Z5-C_<;C/V!D8)=N2F+\S8>]%5!T[@,
MQ 1 VO/^DV9B9_53$LMSO[\O=]$9#P87P^#I-\,:\]ZW%5W4**PGH69)Z9H
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MSVF9Y*HT)@EYM*35LY@Z1:Y+8X^09TBV^2T@B*[(Z6K#("9;"O*R55J6N<G
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MLN"RQXL,97)2-R"('"=;).^R9C)+]O?39/_AHQ=WHR@FMG_NU&]'&;:#&L#
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M= YAFN!=PV_IMBG.LXHFA:(W%@,I-:<17I_3(U-K2GH7G(-@L,*T$RTZQ*[
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M0#9+=/$15V&"1%5V0?C3.$6,F2S!4''&2Y Y6!.W7%:;75CHQHE:B9IKOM!
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MVJ8[UJ!^;:$D$:EP8I.97"@0[XA.)PLJ7]9-;LXN2N.RKA,#2>W=6;W16?U
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M6H%%UHOQS2@;+7M,?%0,N_A?=@"TJYK &]VN=U!<:*ON+=:@,WJ9%8)89V
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MGPO;')N3/NMH><]C8H605Y<,WU_+']]E99N\XZXT\(:Z1:8*90=0LJ9D1"!
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M',&7D<>FK.^KDG#>!/@NEQ4LHC0<5C=V;OK-V<!QQG0<L*R/<)\^$(,\@8'
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M6E'C8*_YA"Z:G7JSTC[8834-6>-2@G8Q"FDV9VJEZYB' CQ71>CHMM.1J8P
M/1T<)\[_9D]LS/<Y!%4:#O3F_DJN2!0=[)YQ9J3#2"@VK=U03A9CD,H$NUN
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M#7T+Z6_'J;]N%]5JW-_C.<_&Z3GV /V"(U\/C8);1R"+B<@Z+@S-+-\CIS*
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M+U0CG<D(^3S,EU-+*(WV?5:P-2*BYF8MP2Z$B/F2*^51>0(OY29CU]3$_+.
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MG8YRK2A7>/J*#X6%,GBP7;.@F[ ]"Z)7]2&D&W!U/:F/W6]YY[WL,-L1S)0
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M8IPUP'/:]R1ET5(1Y>Z<UF71"1P7.EEFX0-7KGPF0HV1]0M&S9/>^ER<#6D
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M)DZ>9I.1IGN:EJ N0Y%>\V=KI)TCX)? 6A.!$?)X0K9-TY?0]!A&@NRL$G4
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M1>O\9GW'JDKF^!=?J*.7U<;NGNX.+EB-)4XS!#3" :=(+=_2L;0.9H:UK/+
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MDZS=P(D5@]3("[4L>CA'B#C&LNDMN_[(1:)DULP=A%FIBSDI=$@GS86E@BZ
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MI-BRVB5J:)=VM? 0_JAO13ZB8O'H=M9QU[/"Z>W=\ZX/6*V7LT!%#\ "9>[
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M@YN #!^B,#<RUD<J%DEQC!.P\Y FA.+N:V%_@24:_6>&K:'D:J-NA[J3(>^
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MGTKVGT \_F[0X76CXY-!F4S7CZ.\0TS^2Z7^[?'[*)CFG^L$/ 7MW_N*^==
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M).&U%':H>59DBZI9B\&D.337P7'O["M/_D7"N9&*\GKU[EI29[ ^"%BIA!<
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M.6R;K'07.5:&<\M167=R%V&=HP[R4;IO)#P%EF2A.ZNS*:!$NIK973F]DSB
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M\NF6'GRRK1$?(>-H*T)B2P/V,,^M/?CWKSU^:C3U<+17YNYLY>(<;>M\2S;
M-AY\N*T;>;BM)]LT@__$V[-MQV3-E3G9VI4YV];)[A]O38L=#[;TY-.M79I!
MTN__QUZ:G:B<5^-5:OF2#6?O+6+ZJG,&6[E I[VSK3@%@^TX&^0O;^.QO/"#
M[9S![3UYA]?&I''O60FZ6 FZ^0@X=RCJ2@[VN09^^Q*2DU];0;*Q>(04OBT(
MN;0%"UHY\>3B@3_M*@W<*@4:8!$VON,,L:];S0:#OR=87<=U]<PE&)L)U+Z@
MB."?H$<2,K&?N':9[XOFTUVV\V^WGAQY5;BB:4X-Y,(Q3FID*J=Y5F0+\/*,
MHG7YXISBR SH.3,[C5'+(YG,4I\M>8](_.2^HC:GM\:?)XM;F\C(CT,.+R?T
M9?L*_4V%9W^[H<V3!-Y1W$B%]G*3.S. OR$E=\.E1*ZL:U[.#945N.PF.*-*
MXS].:^[R4$G;<.ZY( T](BF_7/7B5YJNW!Q)P/=V=MH;^+SY&[._ZUON&3 J
ME]A^SAT]:Q0ON#%'PFS#C+?]X[4?D[S2HR.M44 .]9130I.N-J1^KO*HRN^R
MQ.9,!\OK<E*C(+^<FZJ8ZY78'.N.Q.H'\JZ]%.I)E35S:T&/+D4%_=[Y5XUJ
M@TB3;ON:=-L_23QJ?,VP[^8Q[LX=1[\'R3OGRKE"CXJWQAWIY29EOYG,;IB[
M5%"P%'$\B76.!%",V>/5^UTJS-^I@+A^? 6$%0F5<%D^K7JB=:)P^98%:H<B
MU(24![8,(BON\JKD[GOH5VB.1N*)HB'WMQ6V-VXZR T-3@ZUA^9M>I.#<+(V
MI1"N*U'=9KR^X'8X$4AK]+G>N/G N5>@L: K'YUS?23>J85$"[K1W2S<S08@
MM&9'O<,SOW#(/BWR9N!X2&^RJ;!.AL\XYEO(3*GOJTE:F!(C_/;2+.GKLJ2G
MN\OWQI&B<YGQ^\O7;Q+'>[F_1$^Z1*\6BTK+I5WY#B13@=]YNK1]2[C)UG*(
MK;DC6?>V\QI!T&M/]&PVGY8K;$0BI[].I]S6*V(3"I\LW2%SO3ZDN<R"=P*/
M8L+<-&QMRX\2DE4QSMPH:EN$1/987F1,\V3)-OE(3=-[5I$1R#3IP!_USM>\
MKP OE3!J.O+=SN>6H"FX=]25KEYE?T"?).6;]6A>S5IGO8X[LAXA@.U &U9Q
MNT[S3O*Q*2_DDC>KB'MLN)JT:3[+%WY+>"GVS0N4-PE5K[;^FD),U:Y+T5&B
MAH5:/.A@,RG(GT#[H4?6X16N2-7KN)1T]S7S[I+VJ1U)]SMM>B3$B1#<&U='
M;$>FW?"_&(5?;'>INTN'6K?8,H6# 3292XUAQ27 06U9DWA7VJ_);Z7KEO9E
M9M$A)EN51+C"!WIT1J@I+IR2\328E4&@;4Y'M,U2>MC=MJ_K#F^NDKK85TD]
M7"5UO*^2^D-62>T5V'H%!@:;R\_TVSI03JC2S(,.9)UT-49Z>EYK64Q*?--5
MB"K1OF>B67[]4;6<U$G4XN!OM!9J]+%D/,!_)TUB;[<\:=M_LBL^9(NZ*.\L
M_H3ES;M(-]SQ,&;$)"LRUVZQR0YAVBEX!G=%0C.GK><V]RD#4^EPB+]CHPS?
MQE"D"?FHC$<I$\1-7EH2%:SA-%-;X@86B6--FDS+&U:Y=(C(ZH858N&,PQ-%
MFZ0; FCO4:>!0V1),2P9AA"@*W&\CA/,YZ9@3ZQS?%J6:W%;CLPIKK))6HW8
MO:65F99#]PW+G:\&"O<4W)_?)YW?']72K8?D?K.7\SFOV7BE\P;Z*&GX3+]0
M)_&[E1Y6' RVDW/;BG%<#I?<V@RT5'?YB"FN&,>K@U:/-FCBFH@,5T,XC.2E
M&J(#3_ YBC<^IO6"I-UDJLSZRWPZ8HZ5*KO-2/K>V9;!>!K963[3)"Y1C@N2
MTHF0IF5! S4E_F7P2*<9L[&F#:0G'$:(Y]-T@=-K[$FQX8?#Y4S)S\P(_$,.
MMI4Q.0*YX,@+.K-T6UPGMIHAW++2E<^B&^!!GQ!3(+V=X];3P[3-,%]<6+[<
MFX67EUO&Z(MWS>CE&?$>-\3!)FZ(B.'M/* 2 BAO^'!O<.C8=1=+/^/NO@Q@
MTXK5?$18Q=&OR!?GB(TBO,P,MK2\M19C8P68%2P+EK6/CD>&4 %?\Y,YGI^#
MZSV]X34=UVR1FVK%'6\-\Y\5X%<"JU&Q<G9(Q(!-ZBXR<][0$E69D\_*M"64
M<\:8Z<7_*.^A)Q+:A#N^-_)TR'"]O_!VEE[/F2&O F/K-5RZ,(3F.C;3L 4;
M7+<;S[M:9E@CFO40-[6L6*#IOWB)A,>#CO?BH 8J/ (L!56<+_P9LNQLN-LU
MGH=5+P,F.D&@G,PS'\Z%Z 6$;6-R%LN0F8I^@FZ.QE7*8>1,>&!LM(JE127;
M[J V,!!JXZ-'#MFC8?F)Z3FG4[%K1;'6F;1[1G\BOD!YH<N8V^Z9+7" #H4/
ML3!$PVV(;M.14K2]R889?T,3,8[:X=0_ L<"?1&*][_^,K!C^D/6I;Z3KIX8
M#VW.*[.%!A*^QA8^O6QU+1G%^>D?M8#WM0C6!RN4C_^H$WQ5ZREP]?>MN_H'
M*F!&)H\*N&WD;!XE_=-GJ,/;7B[XAVFZ0FAO*QG?R?GQX ]R#G0=!MM9AY/S
MTS_ (3C:QN1/S@__6$?@>"NK,.BOR=+]0W1*_>DV(..U@9J6L5A'S*C,R3L,
M60K?\9A^JF=(8ICS(M?&K!?2NKQ^H/'G%SI='P30$&O4)Q'9MD,A)O4BL)NM
MH2] +@\L8O91DZ1$'NEZ>EG7(G)8E8#&P 5I^\FC,26R%'-&C!?W9?4I)!8M
M@X3>1EQQ<]_/+V\'9<U%>=T^07(#0O<J'B\!M'G8TQ!N''?2'2ZGRQE<0#Y@
M@K&P^Q5&K1V*+&<%%Q ?&Z:S^;+>I](\:3]T[5H(O21/";)MT">$]C/I?\J.
M=K4<FAMO\4.T*:!+:,  ['-5U+?Y'-2LRZD!17+[2NT$D#AL!*V=,W7^(9=3
MYG,F]]N//=B!ZHO&^1A(#P1._AD_#=-1ACPLH/S[$_&$$]$-5"3:[5M!=$ :
M@WYR?'SJ1+=#)YG*/AUIIJ_7#<8TI O;:G&;UD%R<G;4.V,#96?_IRU8+9$Z
MAX2$/KUC!>2$VM[$]*&C ;C;,=TSL$5P4V"Z*<TJB; !LUFPW4XUB+UAD-ZV
MA..SN5^=NQ6F,O?B[O,R:)^7W4ZW?Y9<G)X_W^$\I*V^B)YP7@:=Y^6P=Z'G
MY:S7?^)YL7.(=K*%_8XK#_Z+_ID[P5^VJN1!]M%=X0FKVN]8U6APVAOHJIY@
M?=>L*G[WP,I^P>6(.E;VR>E6YX?[=*N'TZU.]NE6?]1TJVW[8)8U-_:8=GU:
MT;W=M\;NNPH,>DVTX<(CS;V1P'_#/>O,["FR>W+QC,@<!>FJI;9]X:CMS$^%
MCER^:O9Y7;+J?O,Z-^_:N68:MWWZ5FY 4#0K9%320K(GJ)C.?HN>P:_B0ETR
M79*3TZ,.BT3CY>W>M1WMDS98X_=9Q ;<,;WF8DNOZ=O)T(^G1_W.UT2/?\UC
M<GZ>38/\8"R\O;)X^##_L XJYVJH+T/OM/K4?0X]G!IP%-)K(C7I'P-+[075
MK](ES?4TJ@1:>Y3S-A?KVMG6#?7BI5!N[#)'6QHU2V;VV_=\>N8XN3CK .V,
M F@M_2:5H@\<D-O:!BF>^$"G/(Z2_OD&%?6XP[$M-<$M"Q!Z8Q1@KR0VG$19
MJB*UPF-3G =JH%,U=.$V1E=\X_,RC+))E9E&>J05;NIL 1V!)KCMCS%KA#8Q
ML]WC\%6O*M8^THQ3R8-<(BBB%<5=5FN[/P0KAES',-J+K&<).62U![FQM"$#
M]OP1N.X&V/'TXJC7;X*.T5.A_],S _T/^H ?UX".3X<8HV?#W]N+=Y@,C@:/
M7[RH"PD?'*,7[Y<BX:>*@P\&&^(F+9QY-\&+?O?BG23]PW[T)2?O^.R\=_:E
M<'=\=D1+QC& P?&&(,)S@MM=B[=3M6MZY6@;WCK,=MF+U6Y#_J8>5OD<&W@@
M_:-GY0VJA=+YG _#?793Y]AWL,I,I4I"NDRG=:UE4[KB#7J,PCM67$ PG.:%
MM,8F)P ?.YBEZ,G,%71'AVN=A,5M52XGM[0^P)D,Y85U*],IBH*D*>_P-JWT
M%"_G(\T=88?$5^:X)V;6^)*.*ZIA?WBD Z[:5+DT;DJ%'QA]I%L]*TV#T[T#
M\H1C]ST8'KK]QGN;.U9ZH'#B6W'KS]FOB*;U]]&TAZ-II_MHVA\RFK87/[\*
M_PB)R :GA\E9G]03O>"6:UZ94XK4(&L<4B&J!DV)E_GF-\B%.#FZ@-NGQX2E
ME:V?7['F:]&(TFC(JCL['? 7C=)\HTHSOB['BWN2@QAT<G%T&GSJ;5K0[@.9
MBW]B=<G\@LGQV1$^]L'V2O] ;\*'/F9"_H?TN[T&>P)PL50_7HI]L?<?+K][
M>_E&LL5'VJE^P:$VH;GH-D_IA^$")<XVM]%4KM)JU\K$I3"YP:K!3QFY<FAI
M<]\]&C%Z,BE%Y#J*F[+\9!)VS%OI55GSV/<')PF*)OWCWAP(,XM9ODC^B_+.
M*F<GT\5*@CN#<W:2Z92^,UK9;'ACXZU9I5W7=H<%GVQ5>@6?K8II-)77$F%A
MU1R68&%\J*+S5X]_TTWIUB%_RV>3N*Z&__47VM])]G\/CX][/\\G?Z&-6/S7
M7W!%ME%^\*-!\8V,^U%0?,@K49I;KD1X4-*K2UR.H_/C9# 8K(T]F5/L^Q'-
M[%9%GT.'V7,FA&!K#:)P9 .PSQ'F9;G_ ([?[6_Y3&"[);$V=WZHU! Z%152
M$?-=Y+6N:%Z0 F3>:O(B5I:<,(G!IL'*-8GG]6IX:WZF>SI+A_R34JAD3N'R
M[]B/2^?\L$656\X5PQV#5T8LN^I2G11!?QTHPH7H7A6[P-L6779SJY<W/V>F
M,&>4T^_G4P#,YM@90@$%;@R:[9V^*#QFS/11UAU<<C0.AUZ/9F0HU"JA$X1+
MP2[*"\=4D</\+I^&M(^T:TL4UZ3![^6%V2B=T/+V(@G(=LW4#_N"@,ZD_O.T
M@/>;P6D7"J]FWOJ"X"=T#,Y,93PT%";#S#R-IY5-\F'DZ4*>OY!>"Z<@DPV!
MK/# +CL28DP:B]!W+JK2X1IV*F:;K=JL5.G1@M"3##Q"-YR^!G46>0NR:1U
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M@18%8$!?%CG=7*./'$'1D@6+:-MI-C3:"!D=-*ETOI /,&$*1!W]"L^/7-Y
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M)[\90_A5\('3LP8H"%UUA0W2^)^%M$$88:(?TBJ-?BI'Y4[@A/5CB'D,";
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M);Q,GN VT<3H/O%U2F< 4^NXR.#.<*9(*;:>!.1F9A5NLB(;HYD+C8'3*!#
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M&Y&4S<C^HFG#0BO!!,G_*/-A)O\0V;:L;Q%00)9 JCD:^/VG+)O#ZD(1MR3
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MG.O/'2*<=J'"TLXBYUX"0 ! 8[H2:FD#H3KH=&%B95#>EJ_("$[$MIGLT00
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M2V.K&KT?E)$(X[ 7!29!R)&5*J]M-CP&-RL\PM3[C-LZ\ @7VK>@%-D1J>R
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MRG;1KO3IF3[4SZWF/W+_'<ZJ>G\'$SJ[WTFS&J\,N72EREX/+:^N-A+]"A_
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M;=6.<BVX:(=0XRC/B1\']J)]*NBZ!!Q\!.YWN7WAT6*DZ)*9ID&7U_JW?S;
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M=.6WO>WE7Z1/%/DLD!*<+Z?8ZUV0.F3-LKJ\(MJ]G24QAV+M@]&F5!J#78.
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M=#NHS.\X5"Q ?2Y':9AYH(]12HPPJ\(>X#&@8DA7S>Q0H*$@>#/BJ%,-&CQ
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MNUE"VN)?_A+V[D:@QM\^4NZ&\D7KP.ZA/NE5'2&<#^A"[FEO EJ5^SEXI.#
M3N[@-DO'7IOK\',2CMVS>)JD( #X(IY].'=/W-]KG[?F+FQ[S3G-QDL",FO
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M4]PVN$[BH&\3$EW;T'F,I^;>SB<:(CVP7\+L/%;]\$M<W)L8B1OY%IL#:<A
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M#0NP_C?U'!I+"HD#]P9.](20O])I.L8KA^?'FA_!3(GJ%TPG=W$2_8]< U4
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MBGL9I7\KJT?^>L8H6P[^E(+M,^"3AJU%Q5A/!D_@0O19>1.Q&D"&3D[2$ 4
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MJ=:\=KO.?\'B+P(+00 2#TLZ[3_7/1M!6N$IO T'E^&C#7DJ=>)1=.S84^O
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M\?RL&U)=8$2#J*A9OG>4F;4V>5#EBC3:E<:6;&A]/9!Z'0U*V7L4R-8HZ9^
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M=!V<?A56G^.]J34K7<<:OP"!WH+M%]79\N DX74"3]-C-PC-F=JM-7H!:+S
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M3[6S[IH(G/IT.<O2:E"F[A;*=#>4J=W<0IF^"RC3(]M/(2D, ,)")B03 4_
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M>=7NOU)'P+)(OK8S,;K2A;R*Y$)47&WQN=V';(YD6M[4!$FN!M009L?50$X
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M$1&B,]JADZ)K=>J^;KBG 0V+VLS'W'(/I*(*<O>R+"'Y:SW_)L@&:<AEI/$
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M>#QF:(,9=INO:CBA[0@GO D&<M31=P=W,T-EFDO8@F8LEWV>Q6(>64TI>55
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M<2'APZ+&!! @BTTZ)<@0C,"N,DF(*>"9C&\X7T;>P&;EK31*K;UG(,@$\,7
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M)[2@"4/;22[-T:"( ;,0BICB V8^P7F*N/XS  ,2NJ2JXP(7V2,Y]G!44.#
MAB0_8Y85/.K*6V//'SW2[!?&J+0X3943G V+%B?P+FI#A1*CG)!2&%E?\&'[
M4HI+824"G8J:<M,%.TX^U?2DTV5]M80(B(R0WM"LE!$^(,!TSONE.PRL6IF1
M\WI)LC;HC3<UR.JZ3;ZO&]"QBTQ,,;:V7^=0K Q-S-]ZG5#5R:F0G?[HIPT
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MI]HQUUD%3_.,^J1RV]0?H=%7OI":/@*KV/:KHYD3I^]P3ZB8'&XC"+,V08H
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MR5WZ.H_W?0X=K*I%C[3A;D/B[_;QTGD[;XJU0#'WNSO_81;T"# VBE-@BF$
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MJC&[&XTYT2X&.OC0QSH>/A)=!$8/+/#:/*<A!</4F0J0"VRBCAQ:7XB)/42
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M$"@N"MR!6BBY,4S<;H*Z='"S2WC9Z=O7T34_'%;EF:!0G&*%R5=F]I-QI]#
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M&8, T)*/(,O(V-U#3;E$G# )+7B6)<#[5Q!?@+)J!Y^6Q#:AF9G F!B=]>Z
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M5] 66682];-_]#A-'AT].CI,?JD$ISGYK1"M3LSB]&OPK([3H^.GZ8LG3S2
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M@N$ HK/@##4,%IPR'3*<=@HZQ^XM1NR;G&G.J7E 3F3AVYFA\;S'J^N=%K#
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MO%,(#739YC]'_-KZ^]9))U4&/4AC;,F3PW(4B\+;4J&W,7%B5!#%@8;E8A+
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M$%)M7V>^/YD-!)QG:#(^#0/%IT$#96A92!]D-47EG:!#Z+#1ZS&(A76=$%$
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M,X OC<U"Y)'' QB7<Z&+;S"X\2)$)Q2\!"IJE"5D(<:7!BG]@\[^[[YN^M4
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MUXQYX=2S*$8%:Z[LM9L,@"L5I3OX<;&,\$-B%6'Q^!"C9 E-([^FN%<()M7
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M*.UM$<H212BU;1'*JRA"61_HF;J+A"28Z)3C$V3WS;H5+@(1&Q63MF(>2>_
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MS$<H##:B_+G>X*NGO5X#7$5MD=2XE:L;U'JY0 T1%XE$$@%YX?JQ\JJUY[Y
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MF_)C72^0(N"4;)[+31"&R C"?Q3NOB>;X6NDK(Q@P/$Q2^R*1C"D=)B7LC-
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M%X0LCF_)R"8#+QU+1I/&0-XW<O5LUMWU;+;R:_W06%ZF" D3'.FB- C@W4T
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M*PIF3QQJQQ*P8D[ .UQ5IWKXK4CC)TSCP97+[<!X(ON!"T9$AX@/'R+\YD1
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M\-[N5.:P2&IEDZATX60HJD*F=#K!7)W5$$,.-'_[0L40"\]8PH86C5GG0<;
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MZR^?.LBE33,7&6.L:9AJ3IG.)I(G'0(/D32.?F^6Z$9"!4M@\#B=^0AIH:[
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MGC@:I^--59ZV6&K#X[$+DZ<!PS)H^"8-L:?9T*"O@\ ++TED)5,U69PGF8Y
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M5JZ5"M/+VZ>7Z<=%K_8Z'JDFM6DJ_7%-GH/+-V%6G.A""EJ%*9I#/4*:D>]
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MX?[MDO]21^W9HW<48S20)G#<*3RU;K;[<F=LC7@)+LJ;YG1N\<@;%KK$XBJ
M/? ]__N-^;;U%;UF$G];"2#6L'TI&&LM!V-XJ)/=91=)P'9';TG!,*]6L U#
MZZ<%-NPTP=(!_H:%'EM3V;9VK/!'O-X?AOA;;II9]VX,&[-WNY90[C'H=NJ
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M- O)P4N'VV/M(BBBYXR<D)J0B+,"YM+-%UO(G_=^1U@>MNUC+>E16@^^<G'
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M90);Q!?!8I4-8D4?HI\L@/1\/C]1%[PP?BM%VT.VK0RE ;8EL_8O"8<TVV@
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M="8#HRMK\5^[^7;,R%PTI/ROK,6_FR\N,(Z.Q;9F[*FR&,LU\#5-G(?7$=Q
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MF,!*4*/,=1-"2F9M9;H_WW2?J*47Q&TLH=&G^R$9LP"T $XHAVR(@MQO\P/
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M( Q3#9<K._IYU0:%4ZZ4*U=7\%<%!IA<:7??HWF()YVIM]FY<\+4)9*RX1>
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M[ H?RR_%>O[5)VAZ5?R9OE!/G\Y0R#V9='U$DD_+NA:A52MZA;QXX^?G@W<
M.HWU:;!>?MT#U#!X(U.OF,(ZGP0]02NIS/: 8/<@)!+]D)##L"D$YGSFEP9
M%EVA!V+7!I0+Q#155MYGP]SA"^I:. 11]ADZV"5&S>1&;@^%F#>A)>EEQT4^
M_B)4=ZBE8Y<7C,A.H!6G8Q&OZ8U,N8-0,IUH^</R%JS:X8+:1AP;<,ZP0@[J
MNG7U1%@NT)^'JDJOA=$YS)BLK G8T&&W5%N# (%)$1H(N<D\,;-0 OCQ>\D&
M%G=$932%PI2\<'%9_0G%9:C#PZ(JR2;N=C6^/OI1/?C<NV@?;A5=-M:=+!O;
MO!I_81_LK[='E>BWL'P7MRY6QU*D0?54%B8 6+E\,Z2U&I .>)G)-  0]=<T
MM1O0W\,UPQ(P*#JJ):H-ZBQKJX)/_2ZJGUH^3?Q&KH.ZO]+/+9G:<V'0CG@N
M ;SJO\61XJ/05(CV-&V6ID' AW%2ANK84#(O( ?$7!\Y@*=DLB$3=?O0&BIU
MW6NL:(5:UF2\XAJT^ />(A3:0%5_,BF6$(KT!2(LKSE ,P(7 CBCCM9MUZ%7
M3=#?"]$,3^Q3JT[K4]NZ&@_>>R.G:SO!S^ZJ3VVR3ZU98)]:\VI<O]WL;IUM
MGIWZU56?VJI/[6_K4YL\D9.3#,\#3BJVP,>MAH#M=5UV'YR@0L:6$.X&GG8P
M2N .SDS\6.M]H&\)5H+^1.RWVW5".:%S*@U7K6%B3P"9 >/WK1LFOE%SS/G]
M#3Q1U_W.>IP<@ %8S"&C8M/4L0L_PB,76M==<CQH,8NT49.<=3;YEHNTX*D#
M O)V1UA;W'/K,P$VK2!L$$X$-UG,%$3'$K[,VS5L-!Q:CHO'"? @?\S:AIE#
MK?34(=5Z@%H*I>&^YH.<AH.4%X5"@2^>@6R;X&3B>40- <">G'6J,9MHI$JG
MV)B4"7T:O$("0M!$ 2 B,:E*B1PFHM,'?$$+$4D$)'C^GB@"X?4P!!3$:DC/
MQS%Q&^:E&GVM(Y4KW.\1/YD#,).QA;2%?ZFQ6]+PQ=NK\5'$(>"MZE\C@@3-
MJ=)B([DLAB@T8A<?U4: RHMF)4&H)%N9C?C[*FB1K&;#F,9K2:N<QCX+KF4^
M9YELD9;[ZMW._8J#MB4]G.&^4\7(3LL2AX: XE+BJV1&3+D'R5%\H[$"BG;F
M$HGGV7'NF)U\_#J9/\\-8^6;&NF?K66DSYR0/L*$&UJ<@M2NG5XON(F$#XD2
M@+,%V!WBVN*8$:'&1/^V#!@:])Z<9VTQQS$=KDJFD86Y[ZQ#V(F6)!:TP0@<
M! XYX)8I(/'XO\CCGM068AGRXNPH HD:2\^$L!CS+!<U(\+,82\SC>^P)&<X
M666BQLUEYKK@(X7Q8(@5@O$M;BHF;=Q/=U^@[$TG?Q9KRPHE1)/L"I8^N4<]
MN(CX T& 2 0?;$?-8C,CK@B[ .Z*%]):3)\?:X5 N!8IQT?IZ2J/$+VT4,<A
M'8]P&M%9RUE3H:()TD;:5D]J#,$)J:$[)@Z":4/TW-,N=FBZ"V=0FP8?"R[@
M&[]A(H*;D:N52ND3/,>JI>AV0"<?(B$@,])U;?Z%C$6I9=)823MN:TB3:4H9
MH)YPLB,XUH0E-R7.GKL@9<+8&8 ('6X)PETB-)0B%9W/\CL9L=<UG%"$&8%!
MB4C?D(*!-!713[1%GA58 '?/#\M]\L[G,[I)BR6[>1ZDLI^TMTIYDURA]I42
M!?,J^;61O+C(:V!?H#3^(:HI?H%*#D=,6[H&YQ=6JAG(@@2H;%+R@=A"-XOH
MK78:"5W/78BCB,XQ_1WIJ3E;-/UE];5G.O[I/@(CP?R<EF( 59N13^XY31XV
M?S4S9NF2/ELY]84/I6F.^,Y[78?K\!TDW@EHN@NN@=[[O@UMT]/S0?LSY8-F
M>=#5N'&Y^=FJ;85NWRDZ5=2;3!5!P/SN6]R^WA\.SGIP+LNU9GM/%RUM-+%2
MPM+$\>!L8,%I[DX.&LX!6C5$)"#MESO3;X_JH@58JJ!GN'IIH95)C>L$P*[!
M^0HK1#HI&N#GAGFHYJ>*=1E9 -CL&@(ZQITD@)$?OTAA@3X(G@#& HTAXR3K
M,@]2/)ANE\\/%62T#EJ0X";2?77< ;0CT):Y'T$V;>4ZPLK-PA@83A++*%H[
M/3.#-6ONJC8M=[5_-=X[V#V_B6\O#NO.*G<UF;O:+A9C\?+KU[W/]9/;UJ"W
MREVM<E=+F;N:-O=KYVI\T_C1NSBNEG=[S6<8$G,:]D5>1)RIR,P_\,@/5#C6
M3H0E;!!(H7\M7&@C^Q((S"-6+LJ[ J9ALRL37-!#EO(9*N*L2  >OW9\0]4;
M$U=KH(NVQ$16XT.SE.4+'N%H4KS70A;(I:'AR3Z0%D?J.ZJ3$QF8B3<U".U.
MTC\5R\^4RX$'E,T\9&;LTCHVS+T$X4Z:*NULJD $9U1,=6!%8&319&9/#EQ'
ML+]IZ$ZLW_)M)[&@1&XD[45"9A0B,Z-)TLC@82"(!"A(AE;>)Z*_D/I)H+,U
M]#X-L$<-C!>54/IC-"=S4H0GN3^%BGU?4:=&7;B]FI BAQ8+^#V4! E^U8F]
MME[ -;&@!6/U*>HB46^9PE!AAROM06.E^<<&WYMH4D58GA>#75\RF8/E<Z >
MAAC+Y\8^R(Q(J5AA;UW8_K#?L0=CG[ER<<6&)]$XW""U/.1UW%*2)$,^$1A3
MADJ9JMZC/4E?#0$ QXN9S*^$\0 $CN*K1QUX81'"5 %"7="HNCFY)[\)_05N
M ^5J/)I]K9#:,?:Q8)RP,RD]$Y, 'EL%;B0 <0%[5ATX/?&)5>#&'*K YPNC
M_]*!JUH*Z.U(R>U)Y]CWE'%,@2.**$T/2^TD.&XSWNAJ[/[Z==?^W&^V;UC1
M82=G,NQ4O1I_WRK_^'11V=P9=K@23/25#^+NK6=&C"]N'&JR?!EK0Z*LY4#Y
M($T+YMAK!@6)O2DV&JA"K*Q(##P<HD&%R#0G#'6OKO_A5, 9'V0>*;42, IG
MI?-JZI0WE/ IW%DQJQU]7Q)24!L/_DA$Q<R>T^U1=865O8@O;>_]93(7,QD@
MZE*(+:3\KM(>6)'#/Z,0&QT'=$SE/U\=0YJ9*$]!6HOR^1+-9ON,\GXR(D;
MRXZ'L,!)0-^%<2LN;@MF>IG47I"Y0(U+HU/$\<Z?#_VR ZT'38QDF:(&U:X1
MF0RHMP/-Z41YY"ZENV T.U'R$5&/VQF!PPU2KMS]6Y65R=GCQ1*W(T](&=!(
MW_Y2!@I4'(@)CC-5!(DQ3%3B0,':=.*99F2!M<#6(^LN&=P44 F:%245 P(Q
M']9WPR+-1%( CEA'KS+:?=]CVK@9)[P)#5&5WY;1$<IG0O96,BU*;Q)0SA>)
M$I:#)&O1IN2&&8=!F%0T44?_'>=O#Q6.ZD H(?,E_@(N07A=OLU<8"-.>QME
M#RUTD=-/GAH$?LL/Y%@L[?K8C9P!COO]'?OP-4Z<I0*1T  Q'<0M?DZ!(0FC
M<&T$0+<\AR9D"9E*2O\2"@G]Z"]<U8-^5K0PB0<RIREKC7XFFET C0J4B^VN
MF@WA\YWFCJJA$UM':.><.[ R>1 @)QY(4S#%N5Y!XSN)OF<5I A:N*X/;IC:
M<;$R0U]9F@U(>X(_@*HEU6;2 5L<>T]+J8EI(F\K=AO8<RA&8$!1,J#5I_U;
MJMCK<C:)04_#K[!$0'[";Q8'F.C8X=:MUZ6<*E?#M]S5HL*/%.8P>L68]D7W
MFO,_%O+EZ!0<WX?I4WAQ\4-^%;S4@G'?8=HQ%(9!R>R*-&22X9)3^O*27+35
M7"YICMR#SJKB&%,I7&UB%O!=N@A<SA65W H;"T4!Y)5"%8EC.]PYX3H":^SY
M'5(EZ+;3A0059_Y@")J$_]&%]Y420J\"GVNW@@>]YG8JR$.U_';/Q[DEYO^S
M^H.WY@5K]SQNUG9)C/H,M(MK0@T.4@0OJKQ]:[QVM%NXG![PLWT&=62<5\_]
M3G3+*2)_CDS&+TFN.85&,RB/^Z+ _<T+WW=#L9 #.'4"G]_7/ V2I+.X(1J7
M$ 80K6[JW6X9*F)\;?31^"D$9!-PV%+>U&9#E4#$NOPI \X55O%:](4S;IO3
M,F[-J_&GZFVP&7T/G<O&*N,VD7&KE@O,N#6NQI%_W+P<'WZ\&#17&;=5QNU?
ME7'C[+W-OKEGYW?=\(N]B!FW[S)9I \3GZ@%$>D)B,<B#,1 ]/MFB\L>B-MG
M8O9P#CTJ6J]\U(+*.HLVH(0M3'L"!)+64TGZZ2)([B0--CF1(&-:;'QJ%F\
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M:12(ICJ>:R">^J5DXG)%)@2E)>TN\E#/ W(3>1-5I84BBP1+D]#A9S*ZZI+
M%-F<D8,"1]NXD&T8>7M+POIJP(F\)>A[-'O'9:Z7-Y./5*B[4JU@O'=.KE_>
M0KV10GV_<>Z3S3=(6M(%G,&:$L45L#0'+Q1X4F16ZFE8SB/NEN1"&5K=X&N6
M40DW,-P#<+V4**Z((R6**Y+,:FV)<RD %U7+^;R[?KP_N3WFPMVQ]RA</26*
MIW$<0@-1R LK(;"81P3&I$)-*NVGRAE39B_D/1*QIT3Q+)9&A@Q%D4)DQZM8
M3(IYQ&1\+M18&#V\_+;YQZMP(^RM@F5L>Q><N$S5TH7E>:PM74@ZHDQ[DGZM
MI<T#=').:_QDU.Q7'GK;C*Y-@"L$&ASN1H&DBT62CRRDOA.-63V?/47[%O?1
MG,CG.;?=ZK[1M/YH#C1QKO71%FV99*V0-N:\\U@\)I(3:%),7_4]LN=;3@"X
MQ'^WGN_ZS]9MY?2AL(=B!FZ\@,.) H@4"NQZ;5ORA<@%COSG?:OZ<"K9M?/6
M'HV8W7D!A_-$TSS)%%-77\XS%&,\>J5T\TY]_&9Z >-V#TF\?KVPFO,4UMP"
M*Y(%(773-3;'X(QW[>W+ZX(B:NR9N<VV9-+&K5_GX NK^6II'?R<VIB3\;C2
M_'U\-M3/YOL!;P_,-HBR$'KP^"8"6R %_D]HW)K(Z6<65#_/B?">\_LKBOQP
M<3XYNPE4!)I?]"YLI# O-N#^%W!X6CS)TAQ),<NW6(I"_#F!XK*FK2/[YNQ)
M^SVJ,WM09A<(*.!PO\0"R8MK=B;)'387Q +N2GU#&3 G3Q-QC\ML0@(%+'Z7
M0)%,(77MQ7*^01D3%3BYFECJFU)J7NW!F7%PH(#CD PFH="P?>..Z?7X^, I
M=28-V,JY+D4WUMDBI":LC%(H)JZ,(GPE=R=/E8IR.;SY?#1[V\Z:C0J16?D@
MXK'[D\B'C1R@IVUR@?F>YQ:\$ /P\[R\[7_A]H:@_(LB@7YS?BT7V"8Y9=ZT
MTXD,J.;H-N$YB4MINOIQ_'9Y<26$L_BCR; 5*BD^H2N*.1L(5(DX(@%K73(I
MYA^C2P)6GP_RI]S^>']1Z3U:-QC!$K%$"U:_D<+D'[4+0ED4=UVX4>J49;?V
MB-U0;$O$$398X_9*/?]HC8EQ:;73TO'#U>5Q*WR798_:K(->(H[SXK5NNI3S
MC]_XX!=-T??B#<^?#MN[!.'8;)GL,)PN:::X6FP&^ZV8+S<=)I>7_<>+TB5G
M378)B)O'80A?>"X$[O@%F@#$XEL1S">8Y4GDSX4N3A[/GX\M[J0PX.?RTK0@
MZ+9@/R5+3MMLL**(P^DKT#0I%@4LB;EY0N.2(,6),>C7CM_?;6X^;7R/2YQA
MB2*6\^$"*5"I,\>9O -T03SBK:]^/(F7S^<LNP=G9A&((I:<7Q9X<>E%9SWO
MR(R)/7QRPH?VR=8ZP>8M>X1F$VW@*!Q'Z$5*( O%U(FS?-Z1&A]EN!QPS[W3
MEGQSW]YVL":]A_.U<06.6LWOR_XRS@8C"J<OC/6I&9.+'K/MJ-LTZ$)@PN'B
M%"F>%&)Z_VUO6D0P*RUY-&'1]9P\2?>Y@()X;3S<G5_]'IM<9%+>CFVM2*YD
M'U?@*"S'<V21%<FBD/H^>F$+D+DDN%"_4R]XE:FJE>CL\SU&\<88. J'*R>P
M9#%]Z01Q"Z"Z(,S ?3S))>IY(-+\'J891QLX&H</QU%D@5NS]%$^(1H3;RA>
M]P3KRKRHZ_0>JIL*.] X3N]8DN)84BBF1NTV6*?QL0>V_[OT?GX^; KR3@ W
MV1T?#FB4I'=\J"_G\X3G+M_/W\S"64';"29M7KJ$! <.YR&9X-BR(_^:>TTA
M=6K7EXNZ.4>\VA7D6N^:&S:;_J:I;4]R3*+,F TXVC0.UX4E:88CB^EK$+)Y
MA-H2S_KLY?/X]XG>ORD5]J##X3DS>)H(D *_/+:Z+=A;5.SBI%]O,J6KB\ON
M'G?KNL(,#K^B6"!Y)O6Y.Y='S,7XOB\7IEZ_YFC]LKW''B[?EL%QJ,22#$^1
M-#]_.+F-,(QW9GG[JC$8<=7W,K>-2$SHNS*%Q+XKOWD^3LY^OU<G[8<^5^YM
M(Q,V( Y".QV/@9UDIV_^ #FW51GV;]N_;;WHS-I5,+#>I+FVNXI)R*K5T@QK
M:,9W\-XE-N[?MIUOPZ2/<K033_61XC5"5W58@<MHJ9*M$'^K<?F LS9W8*!3
MO>0-\_4G2G-AUI(RD/G6\SL[FGI_BZBP"P;@ L9L(!++8BE4QI)%*G62=6TK
ML+DD+MOYW5!:5>/\U.)W Z4)?4663>PKBEO!XP7QS[:MG)W4+XX;2O//XF_R
M<VQ^*_@;$VO4JZ;*<.>GE3MF-_C\E=HF13B2Q7))<B7=0VT%;N.#DV+KXZ'3
M[ST4N-9N0#>IB$I>3I?. :LGS<GIL?K$7-7&XF[PZ2M$S*STX#9DN>Y(.*<B
M#:"-0RB? T6751N&<X #&>M!%E\5WQ1VAJ@%1GA53[]<2LYYCUWVAJVU!OR@
M.+V#%K'Z[=UG4GLL?8_@Q@;\10[',3;#%4B!3=V=0<P]%)<XB\WBH\W=WKR<
M/'-[5&:7VL/A..(623%]LR4A]^A<U-_6K'6Y6J_'*^(>F=DD_W X/!W8<+F8
M6FC6<P_+&.]<>&D\7#"%LGJE[.&9K4/.8<D:H$62YE.7+>)RC]-X;[Q_7SU_
MKSZQ-S?,]D,UH2?.TXD]\<H7LWA"\W7V0KCHV35V^_FS05$R*R5X+#?D$D@)
MW_/^%TFN7P<_!T'"(4+$4*TOF1T5$)^:'A$/?AT<_$0#$BU%TUR^_>^0.D3_
M!J]O>?]>Z65' "3@A9#][@>.U_^=$.!G'ZIL=[\3-$7]!9@XC2E$0BV('RA\
MU/;X$)!A&F#P1N,7H V=$$-2SCT"GCC\-_AYY+NF<1P8HGJHW50(%4:K6MI0
M5F3XF3[7&PI^:G<5,*X$MB?\W&@3;2 K]1:@'C$P+!6R^ILC)A"3?0[_29Q9
MDS61 1VPRRT5N.^( 5+K?:@ZQ+8@#P:F ?:W/?9+^@X0=^"_5-V6](X*2>\P
M<0%WW.UZ->P#PK9^@0WIB7>Q1+].RH722:=4[#$M,<0CFEYYKP[F1_J7I@I_
M)1^N 8B!EF 1344S/@ E% O%76=PBH@$L&WT%2C@T)<5HP_DT?C__B,R=.&'
M=6!X$I*P7!'I_W2L2*9% %Z C5%56DAR$BQ-$D#4LNC_,XC6X _Z^^*UK4BE
M&<;,2/NZ:?3A%(XH&OR?;:"_D>0_)!0@GP<08>90"4EYX$B'H[I5/Q/LNCVG
M*H"ZT21@$!GF&&X??QL'MVUX6_O@*<Y>UT_ZHM<)7^-.F.%O6^BI ''#/B#/
M&(WYG9@.0AP1[L. O8[J@BKS[ZIB2ZIF$?0_8;0R@ \-M0\ <Z5\$'=&7]))
MYP/ #8<1 7'Q@V@:)MAU,!JL20,+Z&COK\-0Z#A"F&"XH^G3L<R\3NSRRZ-Y
M\W"M=[K^LF35 D0#1@; ")C3?:NKR$/ ( #X->&_+!T03T[O?A2<HSA&56:(
M7* 9HY8!M@B$SO\.A<,U7],"0 16:DP68)X6ZLH+S_XH:U*K1T#ACWR;E7T,
MCQ 8<X#G--F2^O/),CU=P<F(?ZV\SJ7DCB9Q,TSB16=SGERG5Y]>!FSP#V7B
M4K!W:]G3J#_AA_VSI@"5*PJXT67""R]GO7HV5ZMWVI&8?O0R8'9D2P8A5V0(
M!!N)OU4X_)%+",(VP:-.\,1:W'5F)X4# D>"=BBX;>Z<6G;[4999O-M8X;;V
M";:,#@2@$S97S/AL7/^L5T%Q-@LZ_]XP%7>40)B=I6B*?GV%?^4C=^>)*ET]
MT>=2O:U.+_J&R;"NO["Y4/PR-APNB=),8S28\G9X/*5M>9HF*3KUU?_BU@%S
M229/MR8:>ENY'(_H/40S2>+AL30IX815TGAJ6P?5!6D]M8_&A+LS*P_%MSU,
ML6?T"%A*2-$B20FII6EYZR :5^A6."^5JA7S<MS;0S6S[!X!2^HN*19XLDBG
M+KHG)@6MG!/,QJ?[Z))\,FB.GV6-WQ[8)DSK$9+? 2SD3!Q-VK>M2J'Y43_1
MM.WAR]>*DY"DP.,L))$46U;*]C08>TN>$(X><RF>'PDWYWPK][;R>/'4K+7I
MP"VUP(KSMFF2"K-4MP7SS;0ECJEYTS6ZC1/:/%-WBGV%Y"FFI47LRXTIO,!;
MHXK%0K/5+H^:S>W@W6)]%23\%WAF!1QF+DV3#)TZ=E#(/?IB'+&S%UOLO/0F
MY5YGCT(L3E<!QWVTU="X4)7E!HWQ+M:XIP\I_:1=N.&V I +6I5FCLATG4H+
MJ]GWBSJ51J,S[F(Y\\7PG RLH<@KZOU#M;<5V$IL+BVP=K?W'/1G\]>=,E+T
MH;(PP6%1&T7WN1P)O3FOJV-,QA_7[>./\RD.KQ2;,)VIYPV%S=CB'W?>Q#=X
MOBEBB<<O.=^,Q5TUY[A;XCB*O8NQ\EY_H$^4/0+7/[X4L7@@"X\O8Y$HYAR)
M"US@D5"]N[XH7'7O^3T*U_.!11Q>!\,424:,NJ(9B\!2SA$8XP9+#V<-0;JN
M561FCT0\?K"(Z4A!+) T&]6O>.LQ&>\,M\]+%G5U>G-5WQ(UO< ;SAR7Z;QA
M<;5LH]3><,[U]J1]<ZGH]_)'Y[BS'?#:,+IF45/$XW L/B.-36O/\SEIQ;#0
MM7_+O[62-*,)/GG=O@?TRI%LGO/9)Z7W"[I>NGK4 ]7<0FO.V899%IJ<$GVC
M3GMQ-4=I@>0M%@N1W4 3]$C(-?B6%16\,1Z.KYXKG8_N'H88//?B:G[3 D *
M#%F(Z.0<A\=:SO&XP'TOU-5/4;Z^;%G-/1;7]-^+6 ]H!(IDA'D_/L4!32YQ
M&./$G[Q5?U]^G-&EPAZ/N+SX(EY7B:09FJ0BW/DX:%(YAV:\+_\N3VX&-XV!
M)FC;@LXO 6<J5YZG<#AEJV5;B%\*R4F[>O*BL,:5;-/;@J?-2KL04+!Z'D"0
M4452C'#C_]F9 _ACT[ L6$*NK=H)8EGEF5@6>O@&/9LC*3WGU0OW(_[3++X]
M7D[K@P;7G;,-E" $%B#\)CU[GL*2]D;R8"-0W$I'4-06 '")9R\(GX\/JFZ\
M?[3V4,3CW?,4CC,HD0,6ZTJ(W :1N,"W%S1=/+L]DT_.FWLTKN_?\Q26"^Y"
MD:28E<Y"BUL Q1CWGI;JY3[55(H=90])?"X^3V-QH<B"( "C>"5PLEL SG@'
MGS_IC/KRT+KZW!I\)LLO!C99,+]X"]@Y48IJMW-=&G6$MVWAQ>9E14@,X#'@
MDXJ!+3O>OE<T#0Q.$AU%!\344%UO209"0+5L2-R1XM1EMQ8<?6/!&XY*:?N!
MTP\\<W0\(ZD0*HX=3 "]4)I!1,T!Q*MZY4H^6=W(-1?[_?GI2:@V3WW9EP:^
M.9.-L2EER9B0D=#$X6#""P@<*8CSG;YV))AX;7<5TRTT3Q*Z$EU'8?O$PG[@
MZ&2&H)""K#^65-VZ /;+3-OEC*5@Y48Y?I:YUL2<AG8=('J"#D$Q9](N3MB%
MZ9F16,,2K>!)(3*2N[5&(##3??*YXBRN_O(6;>']P-$I,0%AX_A?<.?!G>9C
MH020/5)M=9/BC7E^KM\;]UQ-DZ?B+03.O,FV>"\WEL#9R#L&1PBL(!1(2J#Q
M>+ZYM./JJ*6;XHN^O=C;K8%G*HD$A)#+]U/$]LV)N.9SX?'&')9.SGP)-XO
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ML!-_$*X<!AM(DP86$ [>7X<AVW>DF)"4FH<_(#>F=F^DN0)&@BKI?X?"(G.
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MS8%P*5F6 N24!-=CNMI& U^I&DKM@M^#S2\?2.AQ*;!L8) #":N8RO<%<V7
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MO=:),TD?PK '0R(+@R20&' VPC10,MLPL4C-WKJY44PHM  TK]N/!@R/P-B
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M(WA]J?Z[Y#6F/YCW=:#[A^)&R/T#V\P&HK&JM! L")8FD4]&HDOF07\0.5,
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M&?I12^H/AL@# &SLF)(\A$);5H#X=FLP^1\"FH&_^Q;D@K_GX2^ZBJ398)L
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M)Z+23P^:2DL: AL8 5CZ1):%8X<XS/-,$.<+T@4",F.F&V :P "_0*(#Q>*
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MO*LV4G8!(^@M] %;]4[ WP0,N-)/=^WNT+J^K_;F\_8BFH#Y6+CH!K9R-[!
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MB7UB#92",=;9-XC'$2HE[ALT29SVITU[$XACYB$O9PNK7PU]T 0/_9_]?>)
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M\XO>07 5RE[Z*A3[)W%CVO#>3OAEM(&4SSX'_#$'^>EH:BNH* 4E&=&[&5B
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M*@='X^-;X/K.-M#4[)ZNC/XA *> M]\V.FISH#N1]WL:<7#6/1&)_[,H#$2
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M%2P(EMPWCI3EO%N0%8X_M7%A*1SQ,,.1%)/*N"Q..#UPFO"HQT;#[/IL2/7
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MA?Y8A_Y8TZT_@P-+ FX7FDJ92R:55\G,?G; ^>"HW;M3&KS:+$1Q+:*(*1>
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MW;LQCJ-73S@TT01!A$83FA:'9U^:(CWD[>Q5[X&\3;JIC4MXJ4D)+[6/LA.
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M\,NU+>%Z<!R.>ERJ)ATU^XV[#_DV31223-,V*G)1L@L81!'*L#0NBK$B&>X
M,+BRRG;45RN?MYVTDI&3.#H&!%<)=@&!*"(5DL)).I86/ 0$SI9.C@8*SY:Y
MKFBP2;@< W0SLES &8I@1(CG#**)1$8?J?1=NE,N59TDZ1P!&@LX0!(7X#QP
MO AR<USZA44I>UC)I,+UU3J$-/GB2F;SP3(?2J_Y049(R!0K2;YF)9,D4<0V
M)$ZQ/$XPRZ<\[B%)C@AV![^2:1JEYK.994FKF? @%@^V7,DD210Q&'" !1$7
MR%A.\+9<(7:UDOF6N<DR2N>-9!)PA@$G$6TEDR21!%\<CP<=Q1L">+G#4-(A
M5S+?[ZTG.O? %#O)JE$\51E])9,D4<1M%$7C#+O<EB$$1+,' M$5*YF?>J]Q
MG6;2=HY+,!D/DYM7,DD21= (.U!2L3#(?R$&-ZUDEHNOQ4?^H?WXEBC%*  ,
MOY1)4BB"*88&Z(M5YW8@D53(I<PN[:2'+Z^-.D,E>(RE$&,L95(H0AB!P+EX
ME1[,(>G'Y:5,Q>E5&;/:*-\FU1[;J,CU2YD4BEB&%@ &@\YE/ H,KE[*O+]Z
M*MU?U^4:E:PJQ8!@N*5,"LE)YPS.QUO*W';O!@H$SBUE-IB7S\>.R)0ZR?IY
M#-"M7,JDD)Q5S<<RM302D(U*=[77IYMA]_6EGD C/#3F<4 CB0MP@B%Q1MR\
ML#U9ROS;D<!+_+[XIS,KLY^8 *9DO<#:DM70@-R)Z<;/SN^+BW_<&V*RJNOC
M.?N_;\0W]]]P]=/_=ZR'>;T("#CSXP]\)''PL[ZF.$T #H+X#YB_Z2)M3[7@
M'74?*> N\]#Y "S0ZL-O0 PS*[;CNZT"VO]Z@ERZ &Z%_7OV\\ G@4E3+1L,
M!=.6FC/U+<T!\2,\Y!M\A $3U=4=N&3KT@7\MSKHJ++C^E'PG_6NT[54K&NK
M/SRJN[,[F=JOG5OQ&.?VN_;75K/K+B,!:PN&[33!#"MJ70-,=><(F&-,U^I
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M6'6.QL8WW"C3H-=&4O DC@N>@$9>638VF3HJ\M1]_8OY2S^G^79AXKK3?/,
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MYTR],_K4R^E&DBE# G04<7X\H">[,^.R@.UVC<$=91CO2=YL9WFS[6B%(@W
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MG!7$0!&Y4CR-\R(;E1IDDL-93XWZVZBCI1ZDO)DD<= D<5:0 $G@&X\$5(3
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M,^H^M@KV#6WU*^J"[$E P;])@O]/S.GN+-\N[)W&8H4N%KR4T(QOOZM-%?P
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M\&:0KHHI@RDZ-#YFM8;F "RX@3%0/AT )!C; C$ )G1=#>=*!+Y/VZQI !_
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M9>@Y1^1F\C]6QQ(';GK _XC@UR3Q0YS4$O@/NO0^72A@<7\"1&-Z^9^?0!C
M[L!LUK??,[MD,!!Y ^DYZD^8R !"@?:D8]HVQ-G%3.% 2QW.)JPFE2"[D%H
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M!N8')J]<,@%I2G;S8B("(%5OHY<*.6YTVS[39^X)W%['%6L3P%>U8+1 \K\
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M1<&$GUR>1#&Y#(_SQ/H&%%NIJQ7=;KY"1XWKMX+]OBEPF3G@3JZJFDLJ:@V
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MX.JA]E8\F)J'D/0)='@RT%0D5E?$\I5_K%?RCY*>YP]%++M28XYU6M-@2$H
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M-V+/?'@[1XR'S# ("608@$V>'[J"G]8.7:-;Y^>>4I-ALYZFS^UMIZG+[8'
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MUX$_<$%>T-:Y.#RLA7_J]GFV[0 N_])YDIN>!.8K/-+QZ) V^?+7\IB&,03
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ME][V<)[,_P,WS@&T=%9J>IP*;%W!S5T"7G"4-,>YH^T+S*Z)N_'-2U]_G_)
M70Z[8-&FYBW^SA04 ^:*AD#DL!!D7B<#]JAL'Z<LBV=41:PKJ@7TGP5Y("JJ
MD6'_7-? L$[E2>F"7ZK(8X#RKMC#K ^ Z#Q4L%U\!A2M*O8-^>_,_*<?L$8%
M%C-9I2H.#0J["\[A$H+?[FEC7>S_DUG7QI8._R=CK^RYKK3:X/&H"Z8_6'X*
M"W?L#]<G /.YPN]9I9+[&ES=R8T<LWA/23'ZJCB%MP;!SJ^Y9$P#O+IE%CLF
MX[MC%F,A@6[?S7NN5BZ9O_X/D&U//F_+UG<)'*Z&H]YM_<'2^ S ^L:XJFE.
M4<#,AC1+_Q$)<AM><*THL[Y>E!GG\0@RRN.%7<^59B"H!<Z;8E=1IW\'*&_S
M5PUE!IY?L%TAJ(TM7\=_6P0MS!&L 8EZ#<S=X5R ?;P5L?Y6R'8?FAWG><M=
MZK2#UI_^W8!ZJ_Z3)"@,GGV /W_^0+[R"4+WOB\[BU,\-^4BB<,7EQZ;TR\S
M?BN/:YD9BV"1(L#_?L\^AMWQ*R5]5>YDQY&XTW&HR\#/A0_R(](&,:6:7F7G
MGQ1:63V?(C7;:W?ZZ0R2Z7TD1G"^:1T_T0NA1$\N1$]:HN?+PWR-Y*?U5S:T
MZ+^1E E/*2,9MD=B'!E9RD0H*1,+*1.6E/,S_:6:YZMB/[20#TA(N*>04.3E
M.18C_$D-PYN@5ZLA?5<15H*"JEKM:2 $5_X,P*JCPF/^K4U&J'U5IQ^HU\EC
M;8'1^=>.R>C\W #UY?N&31FM(#[>D8(!7AQ\YIH?(& 4S;F@OYW0W>:G>RM5
MLK/Z4UGQE_HW$3!I"=C7MXA7+N(C7I_FB2#QYC:*UV5WQ(K2[C3;3?&M[2_>
M Q$/L1"/IU/ QG/]?,0C8'R0=)*,?0[$!FG-C&+75(>P1P4W=N^;\YKL39:)
MZ \-X5Y_ET:?+A0[G^&[F:GEZL4S6&P\/]I/HS$80PJ1-1H;$A4NTY4;?([;
M#V]M]<6MVSQ1\>T $&#0V'@>NH_X8;L/'UGZ1$CINRS;#?Z6U4?Y0?,NG/ /
M3GA!Y@ZILTE@)!L@O&\69]UI/7D "[Z4GB1/S!J# "@["KCF7[Y>?'>3>7N0
M[SLM@7YBFLN&&(_;^]%UQ#L92K?RV[!]W&L;T_BAJ/XF,<Z_;#"$#[\1*"Z+
M5Z4*[%-^K&2_D.#DNT$BP!QR*'+'-$8S;D4:_M1@(R!<1I"=U":WE[7F<ZV!
M!!&')M$ &\DAR1-CK/\<T&]R"/9O_5?>;BE;G(/Y'% O4<WYILJ+FZSAE"QH
M&CMB6V7))U<N]R1GHMP;U'!-,I(V!%\X#HM87[W4N2$WSI7)>5N1)!D\ 5AS
M4IG4=17 GOGQZWPAG$ Y94/)R66,"E?O^=M1N_1<YY#)Z?!$@OP$DT-1E^Y[
M@HEHT[H,T?--J]DIO'-JW^\4,SH8#DN8W@8(A8_I>U#I6TSS'>*SO-7A'_XT
MQ/Y">5G%NMXO8T'YNOMYHS,#[I5R-"1;WSVF_&)88\(33F.R<;')S8N]TKT&
M5_IIR@_>2W>\JBN^*WU@B[JA+]V](N&- H]D=&^LLI9\A!UD&P.Z+Y-T^;DR
M(6E?N1Z<7#SU.X^$1@W$C-SFF/'['C4YB&&BE-[-"6 "M7VWFK\6&/&M0?)>
M9#3?4N-SH34^$6W-YWJ_V/IXTDFE>OFY<<V/='F%T,N;C[:\MOJ=/O)&O?>,
M-[_J&Y<W-2K8^]W":V$!1>*.X3&2#JF%Y^V7'OUJ?Q$X]T?8IC7SO]P%X2RJ
MCMOY&NG>=L,KW"1N;N]U>NB-':^KNPRV%BK-J6<;+.&])\TYO/.^U[6OP(+]
MO_RXK!?W,OOM[19%V+NHS"?VSDE3FJHVADW26A=\!-O>+6+6@3(RD79A;;_U
MSMJ_5GH((1_SHC,LF_\]*\F:>#>\Z[U^-#UZD"/!X$C;GB\8I3?O;Z;6NYN7
MM %&VGN;(;X&=I$N[(]5 ,S  G7[HJX8RU9D5[NLV3VY?,VS57J?13O_LL$2
M\FKH0YO+Q^0%!U\031YQP^/ZX.\&)N!U603/8?47]ONZ-H&L W:3M.,!?)IL
MMUA6U%VV<.209Y?M@A/"*$[ZJM@3!YH^C=%0RWDUU'I>?-X[:XR';(VF&>9>
M0-X[RR7?.[NY8],=(:QY5\P%[?:NS _=W;+,[]G-+=M_G;3Q 0SH-W?+FC=>
MQ>=B(UD;Y/_SV1J>/A-X;_CI__M!_HCQ*EYM4HXK!C0\);"V 0\4XXK6919;
M/^@@T,*C$'<>@C5G8JVCL^\OL[T^'KGR>%L(V-Z:-.]N,/47C:=+M*E)T=[_
M[-8W07DXN&J;@KI7%SK,JQ$5Z8,MW8RPS^39')N&Q?+H+-^?P/W7=5-/;\A4
MTZ;76HU0">8/5*_E?6GPIFN&W5=<'OHY3 (CK SG.FOKEM[HET"FRQ"E,5,+
M%W-L!W#'(4VI16']L[=,O 25PI(KQ*X+W&5-V+DRETY>M[P*L6D 5W;U2Q:7
MVRI1M"37EL\W)W8K&3S%#;6NS$L.%LY5X&.0MVPM" D]06P;".U\TP?PTJXM
ML@\-G1GL+-?^M_?2K\4_*(X3* &C>=^!Q1O._?W!EQTL8J1D<=A0NWRA\U[G
MU<_-.%R&#:$A>&BX<BPZ2HBA*"^)!S$BI'XCT>/JNJL.^<('^5D.P%5<_79H
MX-IT]!P542AJ7&@28SP:$ (0Q4176@F ZZIQ,QJ+Y4;GCD6NM([8;@;IMSAH
MI'$<21%W,!JWJ;;:,A&T4KD9P6.<C>G;]O-D6!<U$:467"G:.RC ^I7\Q?+U
MUG"(HF+'U\X&EG%2<=VYV5.;5&[>.:Z1JR/29M&*.M,G])".V)K\$W7EP]1T
M1_"U9I7*M7"M"$]=E4E,,QR@Y,,6Z %QHW"K?<U.H+CYN([0K-(L,7=RX1-'
M%7!](VL0TH-90TJB[G*,DG"$^;8HY(;;8V'#O?9_@23?=D>^)\KC J^#\*"#
MCQ-@=@J8 \Z[ES7P^\Z*BUXK7N; 47\8,='I^.;J!!7SV;(]J31_LL4PE4*I
M4KJ5;\=5KYR[8Y]L=+P.RL*&-:^.Q=R8^K2'O/@L\:K=)9!,[H*L4!C'1<Y]
MLH%XBY]CCPX]ZEEZO<UK;YTQ%P)Z'J[?04(I;$(]$JI0A/D$Q@D,QC%D5%3Y
M1'E.+>91?X\:3?S=BW'Y^C0DJ\H6BNP@(;4Q<1D)1T@:B3">)S$!W\R7ZH$C
M/))VV@&DOHK,<[=V*_,%,IZ".G:S&#9Y'@F#*'(8!"9 _U'8;"%W$L'LW N5
MX9B_E0!GXZZC$_=!';]M/ISC%^8[;?2DZOI(J,]H_N2%QO-"EP=4WHN\MLM0
MY']XCL88ULVU&*_"*!DO- SX/C1J1MX_5NI>V<?O[H=&PQ6)(KZ)B:O"+OS0
M$'BZ)*<4D_^XZTB-DR?J>80>"DE(6+-8 6/(A./DG8#JN531N_S=]>5+Y^2+
M;N.+1D0AFO$1P2@\]N1HMM&P^@7G3$P#S1SI"S6?T19UN:VIDJP'>:O!.Q-5
MVFK^P/.9EMJC];2/CH>=;\[[ST&^S? 5^G*;W,.Q[] PZ:[PJ[ZV3U%$C0S+
M8CSK'G:1)G\V#CQ?1]?-VF!XU6?"Y/B_FX.[+?)01%(QD1="&Z)+DT5!W".>
M&]):O_.JA,F<?1\7>$NL44@H1D@>8P.8GF+EB9+)SD:!W;36;;:9!VKV)9R<
M9 0)V]@X11&[A<'I469P5QA+XS5,)> /.[E'Y_NM__EU\SYM-VHCKU+NL&K^
MJ+H/0M%O@1W"1&$WV[U[Z27MX:6LM-72ES8.(^V#[(T+*[WPW'0[24INDMKC
M^%4HW74&!M=,<(_N7W0)N6KN)5TS=2C<_WB<J,%U%\EX9%XHHR?-'GT_F0V$
M=C*ZX:",0/*>61 LZ1U-H$Y%VG)S>YI/5\(F%VGV_#CAQ[EWJGP?IC3MU*@6
M-^VW!EHDW6H829,827B5'P5VL 1;ZXU=:^4O49$^KWN/K9@%0\?6P!0]';>&
M""3]:T#I<!C!Q^II"A%@>9$+R^);HSRL:9_99/7'H:(A?*<2C80J B@%\(?W
M&I(6"('@*OT /VM&#_1A[OG]I?@:,R]ULB01?*0U_*!PT %V!!IC.3I\L]N"
MG7D3@R_W>]8WQ"Y'B\R]THY.I^M@%G2[76,K[^7D2C7)4N6)R4S\Z]__.8>,
MH;(J_9VIBBV H4?Y:RCW(+<\2=*9\W-[-TC*:/',),7\GN$"-YJ]Y'"R1X5V
MX-T,SS]^+:D6 ZB G6\1C9EXG43:C\?9(C9;(YTNG3O7:+XZ_V2>IGT9;@.
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M!;PJ^&1J?F2NY]G\,ET-!(::;MA76'S9_3VXNF;P"_3&P#*_CKT('1*QKPR
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MJ9$?4M@9=/Z;)@(]8:1!Q%&8 ,->.,2 (&2/O&G(TWP*FN">5[5)E!L>.^B
M<S%@-LH=DYZ0M9Q[YP^AL"\6:2E]1MVA>[-KX#Y,@#[Y V:LS<,$5._)I4F
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M$8>)[Y7%LJ&;,VC )JZ+D%R_KRFFTDB$[=%S_6V LB0RJE0$C*'HW;W_XYC
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M179\'X.'6NK0?$:HF\^\E#22Q&DTH>T-+ L1KJ*F*_;$EBR=U:<9QSDA[&H
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MG[4^;FG"X$)S;!^<8=J&6#L)3YE"4J5&41C.1&Y\8),%9;*>LLY^/%)Z];;
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M):JD#H1][Z?3UD':\T,GW?,3N$/RB>R0&*[9\^WP\PMH(1'5<(\3QA%@/ C
M#(IL XT)!.73A10T^</^1F78!2O6^/5O?X%M/DO^GI4?/[-$L<GT%6I]: <
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M;>?S1NP-@;W(6*.5J&TGOP1)@4C5RU?%:5>&;35 W_=U!:CROGLZS+9+8"I
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M0X=D9<"&FO]\:H/]U6HOWB0O&NV2JHV-\!C=#T")^X[4FKZUZ,H"GYZQVR[
M]S,(?>A7_<>&I+=COOMFP*[!--Y)O@%6%'SF)C8F,=:#8SQ(4_)K<+5"F*JH
M2'E5- REJ<A2UO#4E14;BI*R<S3.!&+RP=U6\5?2$X[SL'MS,?-^(1IZI9/
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M]?!#2 Z1I ,E.)S_XA )*"N/ Y%4YTG@RJWX=%L<M.ZXY!!).@F"(_ O#I&
M1N<8$$EW$(0X?#N[_GBV'.B$$$D\PH$CR)U#Y$!/3Q[-JTIM3 1O(W8EK /B
M,^P#!F@'?IKB2OTX0LA;,H@5HM94*?53%7[6N+Z2'NIOW:7CGT!Q@1'ZEC)
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M'/5DP::#108819S=//KR]=4CS8_"7^?E?JDSN1+8R]'RT C*;S?3D=(;-&5
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M]*Q7??!0/YMV^=F<V\]>^%%'YF&I=SE9!8V/M^$'W(QP_84HB=)=9ER\$&>
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MOBZL>!,Q==&ULEX\>+0LDS/VIC(RL&S,.M!K2HHVP61%&9O-"/#$"A8*6G*
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MD3GVE5!.)-L*[--*02L-/QY&^0C!\>+Q]Q+>">?G1-)8ZK8Z\>0 0<@Q7,A
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MW]B[T@M9?.GXV-S186,IHDE.#U;)SB!7C#5)GY"^O1\'[9QN&+H%QXQJ]0T
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M84,]TL5'# ];*A7SLOHPOJF1V<4,2BI+U)YUPGG?/IXUDV/H30K4L%,&>CM
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MFO_Y9X@WI!!G>A>3";!32Q7<U=I&J"P[H:IE*JH#OI[@BL6??_X5BHDB$+&
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MC:!Y70=G[W\H\A>[5:J;OMA/FT^/6X%OLE"/^A$&W$OZ52O%/(2>Z(/M[)F
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M*/GA$>NJW8=I[#D4"^CS U(ZH)#+E.&1K+JZOQ2=E>LBK&:B -;U% U0# 8
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M)^N(Z#ZTCSRC8,I+2/34O8DO-2<^"35[AL>&F.5\JE5?).-YJO]-S&] S'O
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M9" M#,<,\2&'GX=XW9#!BJ&Q98)OZ2% K*KW+; &;TBAL6SP&N3['^ 16W8
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M3"5Y;-JJ8T?V$P^]C)'(.MD1FOTO$F@C/[;YR*JQSCKQTICMT!_@_$] 95A
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M,%X%P(B'16WC5WD[W.D_F#D+"#T$O 7!A1U1O*HB$7+(:BW5"LF* D@#5N,
M,2)#2*G+5;4$+&GR4BP%63/A0?>)=;W!T\57.6-5TK46=1YW_-AC12\I=@?A
M??:#N9^'+&;M%5/!:HT5CUI>IC78DJR/U^ ]A,1^70,L;=JF%3H_M%UP BX7
MV:T7.<3X%HS[B\%"K,,<1;A%F"$,\["EC06R9Y6$CEZX3F:V5@P/2RY^7+)7
M8CO-E]A_;V)_A9BWP-O9+YUF51-:F=0DM2MK/]C-X8'6D+NH&OT.$ZB!0P81
M(&#0"$.>[;Y\I2%#WHO.( V;;H)KH -,R;KLNZ+S7LN'#&8(('FF=<7*]/%J
MB?;Y>I^G]WV0C1H[+ED,.B^<) _RPG?IU !80*H/&A;0:ZM#V*GY6.,-'M;-
M_3PHGD3B.P*\=H7G);8H#$8YV2"[?'#EEG?4E%_QMH.D;Y\ZIOW"%OB/7X'Y
MR5IRY"]2-59)I\0V"/<O_%<XSO_&F.=E+Q^OIM-R;3X>P (70%( \"%G#_);
MEU_8<_OW2F,?Q%Q*NFM+:=4FPH:M(P"CO/#P5K+0TWS@!_306!9Y8/?(T@_3
M=5;\=0R,/;,6UK "1:W)XIZB/:PU]AY78)G'JKQ5YS=\^V)=N.)'J@HAZ0/N
MAP+RB&,;D$ :X"UQS11'=]1_[#G9OLL#FX#-. [F-KI3]F*EQTD:WU9VO'U=
MQ]6A^A?5&NGGY11IQC*(V31[OM4:WC* !D^2VZ4$^]L**H+\]K9\XEQ]!$7_
MY]:"CRO+!5#T],J/6=SP>W;[HF+AH7>+WE)?\7XT?@]'W)U-$QB(<[;M>M5Q
ML 0,>M>K\,-1QQ U =QO57R+H;DYP^&-/HQ&K0QRSS9O#'@C8YH2C"Y=V<OJ
MU-J'GDIN=8B-;U)B3<[)==L]=>>;^$/CYP7T_NY!AB1[]2##^%NC!MNBYJ7_
M>#-J6H;(X(MD(853'Q0UU/4S)N\:-GH+:M M:M#7HV:(32>MCJ@2FOQHJ EF
M7J0O9$_V=T:W_9W1PU## ?@.#6TJB. "C4;(\[&%N[-)?K-^ 4":N++" V#X
M<$OBL77,WD$V'#-E96;:(SBUJCP:QUPKS,C'$6:OTS,GT%,?U2W5F>5)?/11
MT4-?C9[T8^N:$^A1G7Y,5OET8J\Q^8.@YR'US0L0'NF<(*[R<=B+\"UK!7ZS
M]JEW0M5ZY:81-0^G>.H=<(1M!1H_,Z>91:NO/!S37"G3Z.OM9^RQ5<X!8K(Y
M?J2.2*%(JQ\5,?C5B"$?6]D<($;.U/O]J310\MJC(>8AU<P>\ X5#!U(&68$
M(/1Q?9JZK,L\O'38]$*5><MX@C=+X.>8]C__A>'X/WI(XD,E&:;E&6"]!.Q!
M;%;YL9>294BAC.8;3]MKDW7PRHJ2 B^LN,X%[;&<E;OZ<+0D)47:F\QT<>/R
MA3V_'ZE[MU"GSW]IU-+A==<!B0:1A(I%@#%U:_D3=@-"C[7.LC^DS$+23' ]
M_L,@]%JE<GT@$[D!A,?Z8:D4Z"K1'M&XK'PV$#)G#*9'L<2W)0]GLAN]EO&[
M9"!XX7^RG[A_@>&&/+9O3)O6<:U8&[PML?^RW.&[5CKRDGAUJH)>B97Z$WQW
M>Q#4&=]9UKX></?)92:0,4&(KW-Z.B[R)F3S0HC'EF)/FB*:-5"^R>8JLL&V
M)NC)LB@F"'N3@+/9;VYA]59$\T)MJ<B<Z(\<6BY+WT1S%=&\\%N.B"8("Q"J
MR@=V4F+2>K*!YVU8^U:.E\'FX?C)5)Y<6,BRJG'S:N)DF+>_ETI^O9.R?67,
MD [,*J^B&KS.5,#+UDG$AE2$;]JKX+^D;K/]?#W=Y2L2G+FU9H' 3OC.//!*
ML-VI;(,(!--TA$;/)JI?J!L.GF)>:%H2S[ -IX%AO/Q-,5=0C(^>98,H;$ 1
M),+0-RO:-Q$Q+[1L1^>P4JQ/)4OB-\%<03 ^.I8-I'2"9"(4>66SC+/%ZF]=
M+\%NZR5V8=E=9G)%27G%=S'%D:VZ/#8M6+]2!>\VI?/5$X<7Z3>O]KQ,*B3J
M=N?JQ"6_*RG.5U*0?I44!/#UEZF\,9;((2+^_,6Y@NU-=G%6194?HHCB!-2$
M7UY0R^MZQ@.QI1JBY4DMU0BE<]50Q@6DI OJ9N3*HQS%&WV8YPV7MQ8AC/"*
M/L!_2ZG$9H+24I;6L_'6)P*"FD!"^L%Q3>4'8%]7DWA)MD,Y( +Z%B_Q=JC*
M2];__!>&T?^8H3_V ?%G2#-%?J\B1%P/-=Q\ 6S8*SB% UOX@<IO9PS"$NF]
M&8?@_VMQS&L_=O,.+S<CJ)H.^!J 4&S[;'7UZ)Y.(X XQCV=!G\B#MM1[14)
MU%<#2VQ9XN0Q;X%-:PLH^O;NDK;%?H8$?G#U\>K#/:60,T[<,QU>L>T@O ,P
MA"]O;N[=&*%1U5I.MM_997INC[H'I\W0M<O.Y%D8G51@!)3RP(?;_$1L+K?\
MMGTD_0-Q)F'_Q;-AJ[]"[<U$S0V->]".A+SA2(#*Q0&@8B! CZE\4R'-ZV-W
M/:KN0MVOUXL'Z$5PQHK"P15B8Z!AIK($2T3=\I;(/@)I%06N*U!XLU*0#IL-
MA0SOA-ZUK@<E?GW(B\1U'C8G*TY?1U+7.F>Y<GJ/DLHP-0<[W\83Z$-X?'!<
MRP3[7IT^^-X(%R9JHLCS4LU:0KQ@\.TQ_1 3-0\K6%93SG[^^M___=_UZ+R7
MBR,G*L?L  VG]YA=A]\\N^Y>N'@0.=RCL]D0())_0KFD]\,S JL6Y@X<X@H]
M,#B6T'M,SB_3'05=$+1:5X@\&R<Y5S0 .:5F-HT1X;P1'<](TNRB]H23Z')+
MML+]E):KF5TUG4\@]:B484EA'!_%N&A,,">"U6SI0J9>C=;X9(W'NTBFFM>8
M:G1DTX:1RE<-6JDZ,=:=,VI[6%CDNY*>J<]GA62Z.VWCC5DCC!=SPP::SQ-H
M@RTM)#%1B ]JU6ICSCI"8L V$526[6JLX2K&G&6K8QICH_FD%(T..6EDXT,R
M.66F@^2\WQ7MQE O)W)HTAYGU=Q0*TZ$^620Q-F"GI]/)Q-7T5,+@BN&ZX6N
M(D0;1G11P<ML66#4NDSUW%IG7EPPQ417J<ILV&'Q$<-RO;AD2HJ(]AII;F2Y
M.8//T/5TI1-=:&Y?G>?GBM$8J5(\G\^7[&EG,+0GW3DCC6;AAEM/= 2$E'-X
M!TD38@U)=ZT\)>(.K=1UIE4R<*V,]09Y88F2-2&5F:@=JHN/%K3:ZY;J-CKL
M+(LF173R;#,UUZD%E\]4!ZUXNM(71T*-[G<*8I]NZ5B^DH^GG#85;R,UA&OW
MK$PM9S"3<3P[U[E:SQ;*2J*GUXR65IKG\/'01-V:TF,[886V:N2<-L4YBU25
M?GK:B76+,:*2S\46X6+:(#2VGA%+VF0H11>M7+M@%07%RI6G?+YBU1AR*H_M
MRBB!]GI2*:[*?#_?:]6E1->R<N/&6,C5I1C++VND)5215&Z$IZ,D/NOJZ7:M
MSM")]M"L*F0K-^@XK3Z#*FAG;C)&JHS;::$13N3<]**6*,U2PJ)?:1=<@1K9
M<;/13>8!%1G)A#9-4[9=3"9S2&R,YNUD.CNOY6QFR'2ZX]$T6VY'M;33+67I
MQE(8#-K)+%]WK 8])XB&&.>X@2!S>+8RGRU*XT21Z(X$:T&4E$G2P=O#05^V
MVER,,>F*;,>EO&I-G)S3%KE!?MX-SZG,W&V:AI@5XQF$J"NUZH0JN8LR1E3)
M612)\_-%MD*F8M5I.ZQVU#K25N0"T9R+;6;9;]D5*U%756?8: #MBI2%66'1
M3G:X[I!C*29!)4MVGI]WTTV.( &_-8H=3&U6>IE.W:W7!XDY-1AEG7F]*,9J
M.IU)N/W*F,,;R% KE?NVTN(H<S 0^T98S6>&L>JDG.VJ"TR0^VBL..K')JDQ
MUPR7C)3=3?7S%8YF9LDLW>_FYOWZT,;&PBP_:_38-IOF&;7:I0O]; %C%FJL
M2<W[N2XY*T6EE+:LN&RGPG5*W=%8'+0F\RD_*3O(W&H3I4XB[';+PC#'U(:M
M?J464RNU5JZ!$9A+R1PM#=OC44M 6M/VD@Y7K"A?S AN-H&U"[,H%NUU&Y1N
M"+R3B_7R72Y!Y/J#J5!24ZE!O+E(\F&L6^T6V&J.G)=FUKS=7Q*8PZH%8QK+
M%E-R/+/(VPE%G"T*E1@>-[/# 4O4TU6W4:RTN,P$G)(?43ER(O2FLUA966;,
MA=!326?00]-E%:_-!,G2TQI732Q*^4&>U8O%4KF;=!!;[?;:=5X5A[&D9=!-
M?50LC>9H5M4E39'H^B37-KN(KC;S'([@1+?(=QV[80ZS>'%0E?MF:5BNE9T<
MV%73(,1>)F.GT[WY:)I#I' 1R4XZZK+58E+5@EVM16<*76AFLSE^-G+5X7*
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MO]4=750PI07\<^#HVJ__#U!+ P04    " "BA)I8?N%/78)+  #98P$ "@
M &5X,#(M,2YH=&WM?6ESVU;6YG=6\3]@,NF45 716KS+[2K9EA/UQ+'+4MZ>
M?+P$+T7$(,!@D<S^]7.VNP$@1=DRD^FHWS=.3&QW.??LYSDO?KIX]_/+X>#%
M3Z<G;^#?$?[OQ<79Q<^G+U\\X'_#U0=R^<6K]V]^B\XO?OOY])_?38N\?AX=
M["_JZ"*=ZRKZ15]''XNYRF/^(8[.=9E.OX,'X=$/X7/C(IML\/!Q-%?E99H_
MC_;A__#^XZC6G^L]E:67\&N97L[J[UZ>?IZEX[2.#D<'+QY\N)L/TKW[X><2
MG=>Z_.[EF]/SUQ_//ER<O?\E>O\V.C]]_>O'LXNST_/HX^F/9^<7IQ]/WT2_
M_O+F].-P !?IOH-#O/7BI]/H]/^^_NGDEQ]/HY/7%ZN&^Q5+D^83C:_8'QT^
M2O/O7E[,=#0MLJRX3O/+**TB%4UTE93IHDZ+/"JF4=&4\$]=U2J?P#W#0:63
MIDSK%+Y>ZLNT@DGK2=3 BTOX>$+/P7S@T1I>?OHYF:G\4D<G21TI?.2/)L4'
M%DU9-2JOH[J@&TN=Z2O\^UFMYY6\[VU1SJ/#_;VWH^BDPE>^T8F>CW4Y'!P=
MQ'#E\#".3J9+%?V<SM,:7KOS0S;YHRF.KW7\0TG_%<DO365_@:F87V%Z\NMN
M-%,3&HI;D H64].'^V=M)C$<P"S<Y'?&NWWS?VXW].+DU<^GT>O3GW\^_W#R
M^NR7'__YW?YW]/</)V_>F+_?>M.OTTD]PUOW_W$,1%W"$NXE,!FUJ#00J/S7
M=W287UQ\-!^XTF6=)BHSE#PNZKJ8?R=G_L7%&W.CO/_H(;Q^H29(#WMTRI[#
MZ7J&1&9^S?34_&C?8ZE81L:?>1Z]RE3R"2CR$4RP*K)T<AQYQ_+IHG[P[!8G
M$P]F=-CF!>9P7J1UIGD\L$%:);,HR515X<X 4WNS>LY'___.N51\<G%$Y\LY
M?&*GVOUOGO$O:M[:9&V.(9S/ZUD*O[A3;%<"_OAXT]FHBT7/P=AXF?K'^QI)
M,#J!$SJ?PP"KF2IQT@M51E<J:W3TZ_GW^Z-]^-^C: %LD6[HW[RO',G)V]].
MOLF+?U'51/T1_9@58Y7!=F; +*-WJORDZ];:/R#F^/(KQ=YW+W_(Q]7B> LR
M]-\ZN@8ZBM(\*<I%42J40["-,#N@,Y10A_L'SU#XJ>'@M5K"EZ*S*@,A5 %=
MZOD"[X>M7ZA\"2R\GD69"+,L5>,T2^ME-&FRI2]XZ#:4+ZWW?:1;2B <H/S7
M]$X06:/H/4AQ.SH46XNBTM5P '0$HA:HK2[3!#^)HO%:@RB\TO1^U=2SHL0A
M@(1+5%DN41N(<*C%^'?<Q+RHHT59D)(%+Q@OHTQ=XVSAQZMTPC\9V?ADYZ$5
MC79XPP$J!SLG./RKM-(3=TLPNS@JRO!)E*JC+6PQ+I^:3E5:PB;"DET6P!=R
M5 !*V/5TH3+8'ICF3KK+9 =J!<QJKO.)K.E'6&(BC'=Z#IN03YHY_7Z"["5C
M'>.DJHHD5;A0Q_ J\Z[.C%F!@1O\.X1WX-H'BS<<R.J1"F7W),U)L_N*(<91
MU3 % &6TR!!&$5LRFC99!J2S4 F0$6E*0D<Y[B<I>K7ZI(FFQDV5YAJ8(5Q1
M0#)7\$@<30JZ"#_@[\118 (U_PK4GE<JX2'!UV.0*\ B&SA[ALYC'@.Q+N2K
M!9Q7)/Z<-O JS?2E.23>&2NFTS31J!0G#PHXS0M<@]?V$ $%7<'URJB><?1A
M]'X4O2H^1T?[S^+HUTM<B^BGHJET'/V("RK+%$?_Y[>#O8.#_8=Q9Y.V8J*\
M_OGD_!SDS>OW[]Z!]7'^T\G'T_,[^[(Y2]^]1%4^>C:*?M2Y+E7V#;[P;'0R
M.HH^E!K9: K$QGN\!99PKK6Q(7Z83U0U.Z;9'NR/7K4.$')9=X*4.T'RG#=Z
M(-QSH*8,^/='FHBQ6,8:+)*[(XYP 1]%%\N%IK-.RG!H[VQA+4/;+A+3[HA&
MQ#:>XX'+'\H*EP3.;UI5C? NST)E[0@93EJ#JG$-DNCC]P=/8M">X'0O0-;A
M*2"I].PH?@)O?WIT(#H7B>$211!>?O@D?G:X'^\_?AKU:FCTY8>/XJ?[A_&3
MQT<@W.FN5^%=H^@LCU!-$@[5/]<X.GBT3V,\9YOS!#6]A:X;F$-2Y*2'CC.0
MW:6>ZA+YDPR"= ]O_O%P8*>)RZ$6P/0_IW/@62"D'H\>_Z/'K&^KGB#5LH8N
MX,K?=DCP(N1IJMJ3VW ]597"6H!%'\'A0&T)V/1<L9N!A=$M/P.,/-.J0M<!
M_ YZ"*HB.CHX&AV.#E HX3L5S (^/QS F\CL( DW37,%<AL^0"(/A&!=R9SA
MJLXJ?3UCE0[FCUZ1/,?1P+H6Y584CA4G(J8YU042MFAF_\')=4D>+ :F)Y">
MJ1'YL"8'])O\8_:KU]! NRG&49"]]!QUF^A1]UG\\$17(%\4K3-\N_>P^!K-
MX:,;7A/9M[QJO\6J/E'/6Y!Q-<:F'PZ UNB_X,K.K+BN"@W$Y'UFE]X&2HHA
M=)8>^'7\VZM"E1/8,5"_-<C-.6@FV]A[],G=1B^#>0:*602<NX0WPFFW-!+5
MUX5="[@]6-3G_3L6BZ6,6X.\I,Y@#'BL<AU=X4FSIFC,8JYWQU:]Y6"?7E*Y
MM]"DX,I< :7"/Y%"=15/'$P*R+JX!BVBFJ4+I&2--@N?3WCOE49'XDS5EM&J
MS(RGP[3Q7)/D (T8],<9"$_-]E+?^&G_A0U%R N J&9FR/ VMH5JV&@^8+T?
MA2W"Z=!?]H#O[?&$A2=>.,H3U7W=;M$$"KBKO 9!%:5(/.BAB-')H1?D964?
M[KBCY[/.>TM%GP>8SH';(J-4QC-,G'%"7)KFC)Y=L!/!E&R2NH%!7OO^7I"G
MY \%Y?H*%^2M CUG2=]]#;-*0$%D[F9-*IXO;T]EMGJIV;9%DYJ$J<+-X3W'
MWXTY84YTFL,E>->B&6=I@CH]G$6XQB(0Q4(@JKM:W0FL[MX%V"=H\H&F"?93
M!=^B :'!L&+1Y.F+:Z$(ON$U?^V<OR;*G6$IP%3^U]Y>]#;5V>1Y]$%=ZF,8
MSQ^-SA,-#.;)0;2W9_PR;\[^9ZV?[<!YV9CKV.N/4>OS'-"^P[GMD X=@NA6
MQD<_OO3<0EWS(G!#.S>,\?$8_\Z+!S"'ONF46GW:&VLX)3#K!:V"3*$N%G<^
M_LVY]]W,U-OA![C%O*??PNHZ&3T>L6U*!$F,ZP\XK2E8M?S+%F39+T6-"B@<
M/04JW+<P8.QLGX !CUQQ>R;@EB;78U)&*RS*[4<,/2W>")V*V/AK5L'Z3*:%
M8Z*5KM%=4\]0/GRU0VJ%IPQ^MHR^XQ^+K'OL@N29%_U$89^CC *E<@[+LQQ%
MOQ4-S*1H8$>!3_$PV?P0>^.&\;, 7C$!9X& 7).P-3.5@]%#:]#XI@A:3C9&
M2GXOBE^F%>@#+"IY-!U#XEL0ZYLP</S^EKO95F-7C1!-')#D7SQ08!9'CW"\
M/Z557: ?<LH"&0B"[*=M^)/SZ%_HT4<=AC69POH>2Z8%:YB2[DB;_';O(-IY
MFX(I_$L1'1T=[1T>'1[M/]ME/8B7.B:M:Z)!)4.M2X.^DY!K2?2O\]/73"=,
M3>O5HY8R*W8F&MY>\)[5^VN-^@;LM%BG\((#](S /P\/5MD7SN[LAK=B4JT[
M P/M,-%$*F"J'CR#I]PC6XD$P%[H<=D -X@>TUG:_^+->WSX\/$7;5YW67KW
M*VIO%SG?5^[747SX>#]^^'3_KK<KXMTZ?#)Z1+LE=+2E[3J!,631(6_6 84E
M@(<6#6C5$[89:6F+:?U*Y9^&@Y]A"W/D7#!T%;UM,** ?EFY 29Z66JV86%=
MDQEZH#Y^__3P, *#)B,YA#8/+)3F X*$"A.W5Y'-39?*^#%O<'L-!UV_EQ=X
M21I@8BB;P @K*O;DB3G4]CP:,RLZG32)2MBH/CNC*19 =7 W6&9HR:(="XK'
M!](RP!3[(8&U2K/C'XHZ!6OL&)GUNR9#[S!2_ ]:)4VMCR]3%?M&7N39> E:
M9:G8C3HMHRE?FY-<JKQ%K70&VQ4?/MF/#_=7>5XQW48V9#0<P#1AUKG$&"DV
M2FZ@"O: ")-L:IA8#'-JL@+^!#F3I]&T+.;V173X0)\KTEQ<4 JD#+F 6'C*
MQL716.-"@P@&6XM-VW>J3-5P<*%+_1\5G?P'I@]K"O-%]S4;T)\T'&)=SJV1
M?VMWI_+U)4Z0"C*G<(U9NV<.:1Q=2 LQN@W8B?=X].@?='!1E9@#!<V;3!&;
M84\A:FAJB2HMV@LEC%GV$*;SJE3_2;,4U"90?T _VC%WPK5?1^>C:())1FRN
MVWO1(8TWNV.QR]Y M_0P1=AU&W4F%=[WK<1$Z^*%2>N;#DW7)8V^F>'@4?SL
MX$G\].G3-FNC3UEIR&]"#548&*HNP-BJ&=)%3<SL$6@1Q^*)7#\-&#D,1.NY
MG0UH@=-:=N\1["5I:K ;*7X5SS)\XV ?=ZG4\[29&Z_GU2XGNUVGO5\!PDBT
M/WCWE2.@XLY7TNEP0,],_(=J>-^E+CT^0AZG"DBDFJ;H-;NX-?'RB,>A!Q#'
M58'D0S\@Y2>%WM?PP),B?CW3>>1""N1O:SEP,+XP;4HR!#WC!'BF\^R05?4(
MS$48N^(8"2SO6Q,3& XP#0$$#_[ZH2RJ!3"62APZK]"F!CJ>H*N+0[KL= ?U
M%B1PHLV-9W ^QS!*C&;+3W;-/M@U>^VM&7N%3,0OA6-S=_H^#=4+C^Q,=EL1
MDNC& ,EPT!\AN4.K)%H9][!'C#S-R '4=(K<!5W(UV20C76N@?NEE(Q17.<K
M(E\D"TCG<4$#+[P8[5#T*NH&K^Q,S#Z":-Z(^>S^J1$CXAB8VGH4/WER%#]\
M\K3E]237*G#HJ@$+]YM;73?D MQQTD[@0E:3@G*M5MGIH-1LZ&APFCF'<]^I
M9?30Y"/W6/'1K0QXX,J;G)70$R,N"G1:>.HASD*<?AP,P).#3+C4-64L^<G3
M5B/]VF@!C '^'Q/#K.N$'%4@ XCI@U9">DI>^[X@L6&^;F?:N664=UZ4YO>;
MO$#T\DFA>?24/U320H[IV46F:SW"+#YB^AA\%9VNH9R!AM/A)L"',#L,.22L
MN974<PUCRB^KZ!)()Q<9./\:'CH<K'+M?,.#M6G XO ^8/'W"5C<F8!P&78?
M)'UO2[*BFQ\;]:7'#@?;SH]=F^7Z-=&%"KU"[)]AY7,+*WUJ@]3Z,V8I5:":
M=;)25[B$V=/&-CG:MR#%DKH R3Z#UUVR8D$<O,FM]>(R97B/0 @5=1Q=EBA]
MBH6$QD!WB]EK1<+"1M<G&O-ITGI&R223M$*Z(%D&&]SDDH'FZ5$L8_P\-9>6
M Z]!VB"R0=7TBOUN15M/V0'5F@P8-%_(BZ90($Q9-X"9P#KCHR6- M0-5-ZL
MJ26?VP4M):6WL&..+4EZJ,87QNPG@;^;<5FU-48!Q@JL68P(C2 T!TR>0HE&
M/1\+=B^8,:?H&KC$'8+%-@Z%6&R\&*[534EN(+,LP7I+"@AG[\):T*M14\4?
M6-*2-\G:IC$K*3 GOH5H5"Q(1Q^<PY/ 6&(2TE7!GK^\D$5CPWUL,D-XS6"[
MDZ+):YM9@3DI";")"9T:FX/O=!@BV.[9)3]<ZT%4Q%9J,:25\9B0?="@8'0P
M4I-XLJVL]U6A*CFRDG13XRY(%HQQJ6)"#P95>OUWJ(GBI&(O86=-_@U9_VYW
M_/"#3;F7])KAH%ID:4U.4B2_2L)1QMB#!90,6R]QG(X!#]DYP2SM3]"QGP+=
M2%!PH5*;S\);$[R?CPCYVE5"V2_>1:>P)T:'M DUL*;3%!/47::< IVQO$3F
MY,QS9H1F<#9C'E9MG.;NLE<?@"ZXU&/V=A-,DF?_)@F#X>^XS.!9-U=/!4]V
M:CL](AH. D*G18>EI"(MEXE%1ZB7&M(J\"%9#[R*\L8X:?N?)+ID3P'*@&OT
M(@3I9G@B;T@X(\*EP[GC-E+E(CF,.87>\W ^*T94,/D0J1#[XB?BJ%D4N?./
M:=C[8@[*E6. XM.FR^2BC/D%-RV",LX2G5>8HN5]%0_:<'"[Y#N:KK_;Q6J6
ML4ML,"-G93%]'NTHKWI%C4$$>XST>#C8&7O7IUC[03LX;2BWC [O%*7EV*3P
M5:NG3>Y'41"HD*IJ,LD>1'END[_9AX.I8\6*!(8@^&+JM%@\L*LTK+%I47]8
MXD-.W<2;9:W19MB3!$N*,>"MP/GJ:ZW%(;AB8]$5V1^V0ZM3R-];J-6OHL6"
ML<_Q\%=IW4C^$"P/C$G(U=()_EH6F;'OYZJN\0N<]V?3\87$C-HC3@)X%@V3
MTG) 1V4X'UD#*M?A4=&"(U\"786<+,/!DDQG*9/#$Y5/,[) /7W>#,J:T06F
MQVL*7# ]K4A,KSKI@.N*-=H)?7^2:%89J#>^?(8-$TEE!$!>Y'NRNN'>2[HF
MZT_H8:65N)*$7]QC&.'OK$P;7^H,J-8O)5A9*\'C ':%TA9>4;,W'PL5^-6O
MT-N:5; L>?1&E#>BA%9 T5WCB!AJKU0A@V3;WJ\BT7I"7A<9,*5UDZ9FWG/C
MSGV%D?6673:_@?*V);KPG41C#4]10<:_5$Y)"P>F)AJ.#@>$4!A,Z![/EV06
MBR0,WO@M#-#_81+\N*V$/?28>BS0:1F]Q-K/'<GRMTG7MJ90+ 3BLCM^7>9-
M2D!+H>FFQ8.%0UH2T'I'SO7EMM^4JN^4RS43-.%Z+RYHU-J>VM,;Y6][7%9Z
M<"[ [=/\PX0DW*\'+!7"J"\IH_CRBK\[=JG_*_D],Y+-N;ZP#EZ8\+'7=O4,
M@XDN^I:K+TFR?R%I,^OBDFUMTKPQZ0/DF.CG6';EB>&=L)"+RNY%UEKK>!=5
MFCFR8UHC97F][Y3PJPN<XXJ6BO31RC/B3<[_<,#.KK^*K:HJ,;\J=%Z@C\+6
M_6@*\KH"4GS%EV_3\TT]Y$?W'O*_CX?\+B,P;]__<F&7%ZCCLBR:?()@/T7Y
M'%/\:OW=2Y!#+Q[@G3*/3?X4JT?4LHHSI'IY?(^W8$4!&*=529I\['QMMC9H
M*IZ&*\RBHB/+C@.7$E+7H+'8M)&T]$]LZ)F [\W 8""';M<)B'%NR2JZ+B(C
M KQ2*V<G&^<KR%!8#_I&2CH#E8-5*:=?X=M@-J[JT$M'0 5:)[6S!$F9NE9+
MXSQBT:2R;5@,3NQO\J>_^#!;XPW.;R8#Y[4<HY=(SZWDQ=UUA6#HM#:N-^M$
M,YD[(2'Y8CY"S(6(,IC(@-[.RGWITC'=BD-AK;JYQN7UQ2M*-HY94F/@J?R3
MA!12^ -N8U\M^J1CD843TG7X1=;!)C$/ES.#?^-C(=^7!!I^2X*F9I;1@&@<
M$H0Q8?)V[(34<53L^#"7JVG$>BGJF:?P67^H4<BMXA.; ,=PD-EJJ#AXC<YG
MBM*!T3#5^ )MO0_\OBUE\+CTSO6^HYA-Z2_74&*/@6:,L(($ULTI)%VPTD N
MG$7%+-#Y&4'=M'7HO578:."X$!4&T;3\911]5+AE<?A&K[#]MK-"]R7'"7H_
M&.V8! U67,//]@X>G1L^3L*N(?8^WXBW)4SR'5])X-&2WU:@6-QZ0^7=UCA
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MT*F 4<;/'"NE-H=*3&-B418X1 )@E#^[8C&W0=!954@I*DAT+IP5PK69>UB
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M-Z6^$\U!)L*XU]RN7O2(L ;0:1'R<:=,F'J*52J%8#'@1#]I/DO.5>,_F1+
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MPB+1UJ[E_:W;W>_X4*H;MI W?=E6F?5F8-P-T!]9]V:!(Z(,5E[YXQZ,U\[
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M4.C11%8(^IEJ:U'WJ'UX:E!MI&;+-7>E)+"N-F1;2\)@@+PE8"S!*6?EN,Y
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M)<!IN4N7[D-:)XJ*18E":"1&@C7$:+F([,GP&E-O\GHF%7*\F,@IV-=K>@<
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MNY?OLT>PFUW9Q0M8W,U!LW]&PA.9!IUK24(94:%!,)$QXBN&8C7C(K;0EHQ
M15T!DCA4<9D17RILLD')"]&YE 7MHM2(8OXFIQV$;$63G%I HURSKJ#M@M6
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M Z"[1[TOO<5C8K^U%ZHK-#@)ZIFM,_;[7S9&<#@(B,B 94S<2GX+"Q-W#,Y
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M]>JC>7?4O#-:OD1JWC7]$U!+ P04    " "BA)I8^*FFOR4'  !@'   "@
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M!40544KCB?5=2"-IA#0-VS&P,%(S>&@("!)^QG?7<-&*>#.C'5&"85M "I^
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M.16O3]^\.3\^.3E[]X^?'^T]HL\7Y\>OW6?[A&N=E%,$>>]_\59 VN5)5P6
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M-D#M(,6N1(SHGS/;GJKZ/2"K]2W8Z/J"B)&M\%%HLA(/9;G-Q*/D;A0'Q;R
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M\#T2KVZ:J_I6ONWS&_NVMX ?MW2 I<>OWI_\1N&+7R_?OGGY'U!+ P04
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M$)*2EI&54U/7.'Y"T]#(V.3T&5.+?RRMK"_:7'*\YN3LXNKF[G/+][;?'?^
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MA)8&WEM<JS8;Z2J?^73SE>=Y14[6UV-=#1R+'D*+5UDI=WIN/VAFU'D!OB=
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MZ0<D_7H!F0:BA'.G4,O/*S5>0JD+Q[T#[2X]\5T+*9_/-:(9)[E_X'KCALE
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M]ZM<OB$_QYK.H/,#9$^^0JF2\55V!$NJSEJ@];B1"VJS07M?6!K&L27O>/R
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MCB4QD%U>_&B3H\#T2G45=QI17XD[!K6!)Y>[/94@129!T V*9B:T5=EU4.1
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M;IU^//O49U^'<&+IZU'7[%PUE=%'SJU.;F8>+JV1)>KNK-<+*F:FYKL[LY"
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MHOU31QFZ%(5P'W;J<\U\E N1!C-.(M<T#Y\Y(IKYZ8PQ$"D+1"[WX_%8)/>
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M[AQ"(6O>U"*K*-CTI'7(._WPWSPVJH$W/UT!&;<1:59W!"B#2+BA#1PRJNR
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M>:P:@S;X5="\R\%D]H;>M76_"#OEI.&"Q 0Z>;3&(]:D3XV90,D"&(FEC3#
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M^5'P%_V]+VWY)%MY(*2ZS!^46/J_ZWF,[J!QZQMJIL/J77M7%,[NS]3X,#W
MCS;*?A6C5@UN.,_^_01S94RO?+W?L&#?5,^VE)</5_NE"W>>?8^HJ!Z_JGE5
MW2L[<J#R=]138NO?K B#?6^X2^1PR$+LX#>E9S_7+]Y"^/34%IZ)4K<L[.L2
ML:!Z*GY'+\WM BB#6Z;>,U1L 49%];4SCT.CB!<%%MOT ]YN?TUA(R'+>P0S
MZ2/F>HD*J--&AM6F4?'A4#& %)([%]9 E>V&QI#'>,Y51Y0 NXKP86PW@,R
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MS("N^5)YDAJ#JL4>>#S8V E3PE^G0XF/H"P^=HXZO@._V7C D!TRB%@M&[0
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M^ J)Z<C+$8Z)?/)JR=^0KQ"5'J(\2+?>TH,6PM;A;:!MPH55TZM/94Z$U;T
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M)SM[L@H7<I@*^",0?)SWF=V&TD1>@JG@_0<EYZLE=M P-J:V>T5!.;&RU84
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MO)7,/2K<0%1%J$O<A_ >H.LX2V)NG>PPV1%LW4K9\LMB00U=S<^YCOG@Y'A
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MZ. 0+MZA*R1J9;3S._$BZBO:I6 R:,.63OU7/L$]=1%] ("18]QI\WMGZA>
M$/INMQ7J$AT6G?-UZJ5#)UZ$T5*+K#,=Z17>(C'3E[F/#BB^K-=DYV_VUO7A
M(-H5(LEO]2<]>,IYM 51"&PMWI+F'IK] 71VYHQ74 S 1&&63W//O;#2%=(:
MMI*D$NTPU?-^S@E1K^X(QZN]9[MI'<""CB%CVPI 0 CY7Q,3P(6-'? C4[/V
M@$/;[+%A6B#\&! Q=V.TNB'INV;5V6^GJRK)G\:">"^S;L5>;NV:KC;Y^AZ?
M9B0$NLD.-F]P;(IAM1F$3A@(2;$P7.^.$!QLN1)4EB!3\W',N_!3^NP9'LM!
MXBI#G3@2I2[SZ/X+;MF3;?>6;HT;H3@/S?^XFT;[GLS2NNEA=L&I>!.!#L.V
MC<?)"L96B /7C;Q53XG\P%YN"#UQ+ZA/[CVYXMZ*_&D=[M-CUV[Z:EC%O$ L
M-K;NBB(S',=EQGPB9)FP(>_*H/ K-T8"?2#SP3F-2BY!FJ4CYF,D/PG-G,_U
M#6D^Q1]?.&BU\\J:2/\NFVKAWM4'9#NWFBXQ"N(-(<BZ;O'@(I7IB-/#*!X_
MLNG/,Z@)O0?Q)N'6#JD2%:>S)EW3>=(D)[2'IGLDY:ZFA6O*7AHR#G\RL#@A
M/=FEVO59]\?C"S#JK9+#Z*#5U;7J7,N!]TWAZ<-[ Q5?=?=!R0'*)Y3Q^  ]
MN]#SR1<^")W,O']VY-K-1T07]2\ *EA5X^E"F>1#A?JS 7TDHW<6UUXW^<1^
MW=*QM1&V%;%W_3H1ZO-U:[#?OVP&[F'P=%M;PTS"S,-?*V5L[$7M5+WO5H@&
MJ5E3_3/V2S]]@KQ:JUG6YGS4 V%:T/G[.DMX,,?ZS4R7OU] D8B/09*']=2L
M\Q7#EY.U^1(5+XN?%O_V[0'Z&7 C0)%.Z$&<:#$J\VK")\RK\<TB,ZQ&H#KW
M]HJJG$F39]1X4VK21;>S3H_ _35MQALI#J]^F!:F1:.$@;(BIB_@,(]),I0>
MT:))7&&L1;E1>#7,&5J)'DTSF0WCFW9^--G\!;GG+_MZE#5Z#Q/!QQC':^_7
M&<)V6/@?KBC]O?P(3N9I^D!\BQA]A<S5R5;8\ X]? T6,.\D<<5J>AG(=I F
MGJE-W1K?5..[4Y6=_7;6,R>I]>=&D]MDRV[R]4<_HB8P<0C>++.'B/A9KCNE
MM;D6.3?)!H?,5/,>#;?LH*J5=<Q<-0;T+3Q_M,M:*$&]'SP."SW-<13.@[SO
MD.#[D[X0(S^]G>ZIX616[+'NK_U6]46.$&[XZ_B"F9K\D"S&)/WG]V\[MSS*
MZG*-[(R=<)V$^*U0ORV#LJ@6*:_B\(+;]:POC?1O29RY6TXAGUE3C;O';)2\
MML+=5AL)I ]_G9V+MMP-Q^N>G*>MNK_A-!)ZU"-YKCO-2$#NII& LG^/I*>P
M+O7J@9O\%V\9';A]\2A(M&SHOWBR_QY(]&KO/DB!3.=B?29T@O<NUU_;/OI_
MV0=:^\\$/=#&M)Z NI+9Z:W+ '?.\9& YAYQM=B&*NL.O B^65@[A_7)U56E
M*R[;8.X5?ZSJ0O)5TRSUJ<:$X\\[$_9R6D(8BA1$VWH<2P]H)O. #Z(N,^#Q
M]\>#]D$\2P&]_O?*DBHJLH9_1O9KC0[RFIL(BV?8#P1!&VMGS+V_75?!.#"X
M(=]#/]]_:YGV;NW;K,BJ]<^$Q\=/]^BSX.O\B63#(][[H%@8_?7;8RGTOK:O
MR7B;<5YRJU:O-??OFNR>M=IX#L6U1-#FM?^R./-?P_#>'M90D>D&7**[63%P
M;07Q.2;$ <G)%9;H2$]\4.ZDCX_L<%"*YX1YZ^A5[6T;'9T_E^3'ZOFG'&8O
M,_9*L&)NJ6-D=&&@0XKERK7AZJ#<TQLS]E1S-G(%_G(5.;>T\V)\L#?,]00I
M)?O\E)/FH-P7T[3[ GR2;KUH]^@8LG'3@\!;XCV1";,R;3#Z!Z92?<:CJZA&
M(;>%0S$BZ\&VN,$#_Z6^Y[\&5PKS^A^NE(C#ZIK?(?P-!>JZ.?.R[P $X^"Y
MAW:7$H90'6]]"0%-E^HK%Q01#["20,$'9-U\TOD#$Y3;@\EI7,JL@XR<VK4,
MP3.N<@>\EVG;#^[<4Q/<E?H_TN4_D9)2E?_RPH[+]Y@=3'E),90CV8U+; F@
MOK[!-6#(29^(6XTP0/E/5 :J" PX$X8,14S*E[=R?)Z*MU+Z2H!4D]WPC=-J
MJL>J?'SMIKW_&+6<;!D2$-J1;K'M.$D@/T(]^/(\WA1P^)!A*,&2ESX]TQGE
M>V0>4A?VA* ]Y#SV?_17_D^@WNX^7"F 0'7H^O;CA(=[\ Y[.#%7!=UQYO!B
M\GQ-@;FX81&%1TKI9MRT9TE@^Y/SK;BG51/JI'YH<'5V]RBD8H6X#W)W6B3#
MGUU6TE MFR\\ :6O@C%0U?X8;RO_R#)#AU@9UO8/+AGI,O+FV(CQ< 91_8X%
MMC2[M/23=JYDVM+P"K?;T>7'=G)SK>:*K8*M[PV/7ARJB*";.6B)AR_I_]9S
MDW)([93%<X:Z8D33_Z_I=_3O'%4QEJE1S;RZE[O)ZW=YJ,'IRA6@[MVL>W9.
M9F;)V&QV8,$Q:%B@PHC\)WWR2Z<[=K/\OG6:(<+"(4F2&O8]09"A$U28( ];
ML/C09<YF63/TK?\<T8&<PL06\%^K.T((BGLDQ%,PPRE#1.W5'UA-?!N0_/O2
MCRSHZ9N]O5"^XHS7?RP+_\]MX7^A1.R5W4J6E$1WO)#<ZF5\%]TM>RVYMY9'
M>!;FBDSSCAC*12\G<@R% 72^,E[@L3XFMYRK<>B_T_K_'KV&5.EY <.*S]O+
M^@%+S@;SC3,,:ZKVT0_F!?%T@:,:T7CQK'EN,:>7A^\8#RE[_E"/37M>%7:(
M\.@/IDVZA^.Y"8(8C)6A&U(92E1S=?7R"93@08$).;V>^58]:YD_%V,C/%[9
MV3.?EJV;W>^(-$C]+^O__WN Q??>!J8H.0$2C"3S\8U^V)T1U0@18'IZJ:DD
MKV$S90A'WWH; ,HG+8M1,[Y\BI-X5AM;F"]:^JQXJ C[%FEB,;*!.0:$F0]7
M^FC.Z, ' \.4>'@DD%4^RJNTRGNI/%Y>R-NGXH[<.)1Z>DC6"'0VD<*Z\!HE
M!GS*J ?'2>O[$(UM93O%2P\(L-85&Y^L?^?_)0[6TWX>KIFG&_;'C?O'P1OH
MML<&?'J17O\?@WF@"W4U08&NDU*8>:C&;'Y.2"[MXW1E5>%L]Y=;/^ZE&QN#
M4.T? J*>18B>5>PL !6[I\G084^#C02>IFJQVFINFU(=E?W+;Y0G'CPF>6RA
M&OCEULY2M1YBGJ$(*0YJ9X2:,;7!7\?48A=#.C&@FF64"#FHYXV%\&>U7Z'!
M;_C6_O^&%KSW"O9CVA#$9A,1X-X^J-PFP9GL_']KA]X1>?1,G)'5I<^R4A_.
M)V=\)#\JRA+[$I5^[A),PFNNT39NT\?K%AVWNLMFINZY>L(S3:7&D<W=?5 \
M_.VON6-,_?)B#,_2#J$;+.ZI)]+YMT$T3V[7^!69YD 4S_R ^Y3JI=7TS$&7
M:WQGWJ5H^7UE>\'U47Y3.1\7C_/'M,DQQQY=FJ=*4C["HL,(Y!LH9;X[>1%2
M2"VGJ8A%/\!D8_73[+H"'*VY+K=8@NI$,]2VID:KJJ5A48BZ_+S2&?M^/X7,
MBHA!O$HV\3WNIH7@H7#(_'@%62'K<.#NM5[LLR3>#^:/DYTE$8<B1D@][3!N
M)+R#4(]MAT@QI89:M I_S8IF4/"Q_H7,VX >PJ(&]\&\WX$(X?O9,@'E+9O6
M:EI8[)X]3I\IR5K(_^WE=6["^\".H-$#]]"M)(J3HL5$BW[%OXW@S21=+5Y9
MQR$_FI83Q.;#)TP_#C\2I,_M5D.HSS-$^JH\S+IP/($_\7B/,QMNWD]D9S6%
M-W31-HG"P3;!?V9F9ITL3K16E535^VAU]?<3OZ5=\CMT;;@?6IUF)%[W>3G1
M G2G$'^J::].!>KR[ZE5+>9IQAQ-Y$3*UT;;"/W!M0VU TQQ7$O"=[@4K@L"
M61972**4-)Z\3FUKG#TS(\'QP#?84:O5A6&R-7?,#T8VBOBFT'86MW5C[VV+
M-UY.3&;=T*W]*OW[9=U#*\UW:CF:,F</;&N=8,B7T3(]YG>;]<$D6S(L%>UV
MN+DENF.J1UJF91#J3_==_HWX=**G"W+ 4^];"OG!2ZY\'<9/7.RAX)I>^3_V
MU=R[UX9_C[-(LUM?*!+-^A]/-M4W-V9=H%57^<H*3$U/P06AUE,#@LH?^@7K
M'Q-[Y;R'FFI =?_A59>5)E8\.1QRB\&5H!6NT;G#&>^J75;EE3.S5YU9M*3G
M4^FC-?ZV?-EVN-W-U<WGJ)G<MHZ@R3'3V.(@9R^J!]J;UZWG]XF]'#P7<INJ
MFOPP:])0<26["=8!>RK0\L3VTS#*A-J7HD,TU*A)O.K>/Q'5HH9UZ"/2X2JY
M)7V@, +M4+I.1W]@-^N.$[Q=I15% S ]LR)I+YZH=W2&RBJ@NF[8B9D]U2OP
MQ'[SDP;*MJ88F-@&"^$_\_&K<RI9;[73_/W*E@KJ19+ SRCA$*<1+:SJXF[(
M?%7V4YQETY-$$0Q14#F@R=2,__6.;\RN*^!V;;Q^@(<U" ,S@W8U@"2G9@<P
M>!9E*JY:11\AAM2:IG6Z%C+OTA\653,-S'MG3:W&>XCB/?&;/+BF!ESTN$-O
M;&UD^"LCS7.*HC+YQB:'0A?+#++U/W!/15KHL5.N&M$MK4./[UP_MCRKP9A(
M"$0<05I?:M0)[7F&,BF?\A"W+/ 5N^E,V=HRO6><8VOJ4SCMVO0Q72GL09:'
MBS%H^30VSH3FRN"@'!&!U$VL4JE8*:3G?//2/D@0K["B!V^'Q.]DUC]N0?L-
M>4.=$13#YM)IT>_VLQYX3G>'O0<8\9>GFCR9=GN-&UM>_=;S7&TJ$421%^YX
MGKVWT*OYI[5_B9O@U($1,CRV14MJEWBT@SW92KFOU9.>'H\+!.T6)OZ%M",:
MYJ(;U(268&!#9:1M]SZHCD"L"G:O8AJ0$4G!33Z-&,INKU2A.9P#=8V^]:Z:
MJ<UP_9&!G9P?#EP73'FX92;KI:(:]&ASL[8)[Y_/S24KQ0VY\EF&^O:PP['*
M-P=&_^DK6PZ&+ 4=&<$/V&QW%PB@;(N0&IW"ZB9^VMAJIZI*#6=+T2F/)M11
M.?Q8D->09%+9DM[MJH4R]"G-X. ZP\.HVH(&KFZXU'LGE-!>=@LBG-P7J3#"
M#&#T$'=@[082=@T9(9-K]=@C<ST4<*(Z"6%\>"RE:SLZ<".KGU+0-Z/>_09R
M&06?A9K073._1#$TCH%>KMG0$4EQ$KU9YS@?F;V .J+Z1@S;$7D1"HP"VKN0
MD/D]6_N] D,NH!#,#=1"!!M?T4>V8@@9Q!";#QY-)<FDB'R"$$L8";[H=)L\
M>OFA$]JR\>_#%"W3^VDM X\ KUT[)I2!3?2)D !PY@R_=D12MK]F(X('K[KD
M#X0X3KC<^#HA?71"9:T!<@1U$7=**0X!7&DQJ70NUAZ9AKOPUCXA<BQ?.RT9
M&>[.II[+P='PB]S0J$&W=S+@=S*ASY7Z(LXR/0 7NOG%>+;.$V0BR@#;Z\U-
M>A$9?OY28ULXBL&M=T%#3#5RE2K/.C\RU^YTU;D13155UL;%6D=-)3^A6AFN
M=T,(WMY=8]8@Z]S7?=#1?9"KDZWIX,S5)O2S?VW^GH5R=?2,DM-,LAB [)6D
M'MCQC0:N[91]$#<X;N.=LTR'Z(/GA1J"5!U:!GE#Q%F1#0LB &7<8!CN07>A
M_AZHAC[8HQE.4+:C(T0\MFNGWJJI%'D^2AB3M#=7GG44 (4/&*&H].RM-X K
MP]JYF2[ %GE&;#JD?'OE[1>$>(H0W##'<@$[/$9.?SS%C>(*^UVHO,+3J#]>
M>+[1!MK9(_E<GSXV[%HTP8:B8MS$J-675I;RX[EDYE\?O_2#_R)?8>+E1QK1
MX7$:JQ=D'B,E-V5UQ60.>$A$6FJTS\^[I;Z"'MMEK#B?9\1L10*WZ3KPD>J(
MD\CL5?N"9_)A?MR R=4/! 8LE>F*2A2K;)&?'P"WER.3'-/$"E,7%L;;EAIY
M_3D\;1N??ZF%<* Q!0V*20)LL8>N;<V.U2Q3WP>Y+2/J(5VM(NUZ66^/W#_5
MG-V>#QK&RR,K+B<?"OY8,[&J.6,/C?2^]+TV,HSP5)O]YW\ WRY']I@"MI_B
ML[/V00FP1/^/9Y6+)*G?TBT))V]F8GVPWU(D*(HT_WF$*+*G.__\7@X30MT%
MG[!'V@\O=,ZK=2=9>-D/%]+[L\J.X1I#X5VMBN3HE:%O34FUWW^-C^=DOSJ>
M0B$HZ$#,F9"]8I8PZF'+V :8=[FI-($ZQ]LASW#K($C]:L+$&"H@;U]/@N15
M .;.J;,[3N>@:<;Y)X<?C#+U_>5JY,0K:S^_OV@86?C\>-NY;T<./3BA*RM[
MMNUX^"50ZE,.<[:#$8R$EVG-%X@2/,"QA,.^FBDB1%)I626P3JRI TS(?E$;
M3N;=,$&H[9\6+X6T>1K?F4VA$6*:A21IH6KOU1O[7J&T&<\/ILWN'+._L'&Y
MU&R:#P6C3FV'U6X_A?*7G>=Q_U>^JNO1)%RCZ;9@7M'/0X;'1RA-NR^=/?[.
MM=RQYUU1S*)]^:PL5\\ *;O#A08[3G!U0 A[\*=MS5S9"@,:W@)3MVK_G6Y.
M1Q.E],F81*WZ\\_I)'=AG9WZU:/R,<?[+D(>#SF?IZ.I['N#3;6/>.M/WR82
M?,<TQ>XV,A!/M?)@-^@3&)18^(4@<X@H4A;1.,(T)_\EN5?+Q#GL:>LK]:I4
M6\3.3-\P/[4+VUAACXJ5 *?&=!10\(<E.7AP(CYBZ"2\ \WO>]M5O"SJ^]KW
M2[(]LR>46#7V\C*EMSYK-'O)EHIE\U (-"-Z)_DAP6=>X=^SYFS[9%^UEDV/
M)T?$AU#ASZSO? 0+E[U?RO';$7FZH0.?34%WBZ?&%/4=--V:")$_"GG-DD&N
M;'4#.++^'E<GH@[7,1"WE5,R'A_DMP_BP5*)<U/C]%\["WE53T)3L^G6'07\
MY&BO?=#J:*/=*0:G-^FG_8:3LJWPVH$=U3=K ?G<\VZZ[1=VW&2HU0&;:MBX
M?1"YD T8?IP?"BB8U7<5GCO'K>7W06P0<1MX9@@!WFGG/)-_(HX^N'(.@%"$
M"PLUGPP"Z(NC:T>-3IEYI_^]T;L1WU&04L##TD$&,6_2"5VDD,3Z9J^L#V/W
M<8+?5PREQFY>Z2U"%G4V%6OK[8/B@EZ.!.!?57LTBGB)_\VWS6)H1DJ_,Y*1
MB32Y? !RY5_ZC3\J/B9@J5^^\AK\,CDC^I'ZH[+45W]#*&XT5_IZ&^ML$^!%
MME#K(H@;JI$NUCDSU0"3$L4$K:J#%XZ;2;)T)N0^U='1G<"U>CF=9.BE8D=-
MVV#<^2DS-_5I$/@=F[4E*-NTLLK8IB&"&R(Z@J]!3G>8I1@QI+-.$:7<#6X/
MC!!F:@/Q;TK^9,HIV_=WY<3=\(WC_ LCE^$UD7)F 8RRK3N,V.PX&E5'/#Z5
MK:;JK@!C11["*W_,M=^1)4[0%[OD<74)%EUCW07SX<:PVK5 VT!7&8C_D#.:
M/D7!=*XGX84^, B=<!'W64UZ8XELIT_%KVQS?TE;_\,Z>KYOO3OT:;(V-=/O
MRG_MM#9D591]125-V;G]51K\M[OD=<[1#?KA9B1<^9$NZ+G&:#ZH5PYD =)K
ML:5$7:&B(ST_5\[1Z[6N2)R/.=U)MB4^E+]: XU-]$5LN*7>D% 7Y*2C"/_.
M25B/T22<6)[CPPNQA0.AWH18Q6=VE\$5&R%@[S%A#WNJ6I2NB^^G8A.D9<8T
MU>*E^5O-DI^;%\T!B4Z/Q>X'-0U3?-ZV9!#QJGL-3(]*))BH!V^;F]SNV)H%
M,[3F$K[%4^$DKBZ<L]RHRCI4"8OT-5!QI8,[+<(Z_!$.V@25'W]FO'*RTN5J
M3(O<OQ9X)7-LV"0"[A'CL./0@U4!NY<COD7HT]7B[AW=1@OB19=)MCW@>)*W
MY:^4)U5V@"8D08\SU[NVPLE3#QMITWONJ_Q\87C(_+HD$D:!Q 5BQ !!8HY.
M$O,,=BH<:\0 QP=).-E>&WW+*_=8PJO/S/5I[Z$A,Y\ GEH+KQ#)QI S)T:M
MKD9*W1:*_'%0[SAX\5\:=IZ*(\'[DZFI2,5WNM\X'YG*H'I^'L*DH*ZPQ:G+
MK?$@& ]K@'6 0:"I42SXEBJUI@AQ/5>'6>+(L!NVYPU2/S%BNL5+X^D;<U=.
MM82(!\>\!V)N-&:=H:U5T=8*?XMRK)*4R'% Q:[O]+D6'""X>^&[736%9%FU
M>P79SC0YA9LQ?3B(/[:,/R%@W&(Z(7TR3CO@Y>L#&5!T(Q]V7AN\:\;D9:RW
MYW$[W<N@/$P(+T(Y 28\YP,=\AR(^:"/HUK[H"-VG_=!9YV0 QTY\O5W_^(T
MIJX<2WT#>733;@?R+%!-T$//F4!N=;G.X(RION.P;*^-*T20/)N,J\J<NA4:
M1C5IU[H]5M>]?4^YIO,T/RG&O7*"?A++N_2=K6K.-LS\K$II[9I9I9/L[2_)
MC\W,?*V9(I'L.R7Z#-A^[>OS]D/\1G)UYK+OC<0U/AWE?L.C1?&>8Z3=18^=
MX"K:9LQ+&=MN<'W2#\ (X/=J*YGWPL)*(_H1W,PGN\:Y$J_J=P<D@>#%RW23
M]B3S7_"!8X@3T"?E[CG@!-; "Z^T^=.H.V<2C;3Q85SGZ 7T](@I-<9A0UET
M1^;>:QM%^B-Z#M*+);*8XD#$\(]GVSLTM";-]P$>'=<(;DB16_<K46WK8J<B
M84:GL0G*^R#O) 2WT^1DQ#":FQFR>^%*V.,LX0C]B744C(J)T0FI/?ZA,X!A
MTB9>BBM".M NY3@8,\:PL<\+U1WA0LLU,)*V;6-H2DD5JR#(+]PES.?PSTQ:
M\= TR?G.C'&=@Q/)L6. M[^!J)K>#E5EF L6IS7+GI$1+O^WEE49'D(49R=L
ME;D30[BFU%U< >.J753A93_&-G7%'L'"OYPINS='L25Q7[X,SW#^75.5-Z58
MB7T^Y$:] _/F=>A)D=G+8?US=):);F&F>,7E[1UX!R+FCP7_[^)<<X8)4:)5
MWYD1'MO:^UL.3X?'!O5Y99F$*255/*K]R#5]R[9CA6&]-9=HW%0P#U_]&7;W
MXF2Q!Z)>,3F;6),%-?)7P-']C.F3>37/F*UL ]2'=Y\(J)Z-9<\ +[/Q0"S;
MGB' +?YL>Q;CT&*A<QD/).XHU-%'$*.N#TR]-;')TCRC0>OQE!URGF&?2_6*
MN#RS7UE[82R(.^LS*#S7R+A6R47L;Z1LY@6NMW_-_L)%_9I"5$47BMD)II3%
MP*0P9>G;G?:$Y)8 BH%(AZ'@H$_L0AT%=GS9)M0RK72JYFK*&E;M89SNK$=Q
MXBQ)VJVI*4?""UF2[SX4J7<'/4;PU4O^X?:Q35$6)\J5T>W5$P$YBR7"4I5/
MW,*((:\IRO8IKQ)XF6<[C,\(/=!7_I+L^D2TT,?B36$!"-90ELJ2B8&M;N[J
M =0>ENC'.[D60"Y#\?9PQ!&4X6A+W=G.H*))Y"".6'#<(UN];<FO?"F?0]@J
MTLG5]. T0?X-LFYK@I[:3$4+S#)Y]PJ8MWVH!B%P!O<@2IZQW;65+S^284$?
M3R#7CT#_-;/0&((J!83X\R6JV7CY6%\;<<E9-BWQF"EN?@,>.JOTP^\0:P+/
M/0HU+T89 I_("''6-X( RD@S&"]-G^BJ"->;NL3P^=-T51G*R]#I)*7BV*^&
MQL"5SSDLB8<DC#CBLQZ8JRC\J)Q%C'_9K?O]H:?:P%0V^LFANS')TGIQH ,;
M_V,YW3:3:0W,T+'SI2E>U4PXHSJ-K&]@/#_Y:WS"QV"V@2+!P+'D9\7I"Z]X
MUY]!3<JE&)2^JR-^U?!78K\[FFK^SNR#O/P@7G>=F-I[&+0[0<Q#($:E%$NY
M#?C3[RM-^7193(LCNL%22)A3ZF2[38-7E?I,==&#-%G'0:ZI%[;$F*VQ8>:9
M!-8%U'%@A:YA1NK728)>(2O!I9&"EOP5FH0I0S7 [!U O38D=/J/ -7:787W
M@XX?] ;'R9V53F=E^D#RAI1.ER'_1#U&$/"Z$^FX9,^**I]<$3<L\OYVTU=Y
M4\K0*]?\F;F2$O3QAX2QHMR^-"DACK?_[=D-(D,D 65 ECJU#R(:GIW0Q/ B
MT>91U4$6(8C1U<!P"0N<(V?^/LAZU*VQKOZ90 7>X[G ,N?C1P<Z4?YR* F@
MT:0/1\9@((\$-.Y!U=Z_/B"HM'<N++](9KL)K*>=CEX6*<-4>].^/7IL@EB'
MO%M!<#%O[M5'\" 7VR#\+4KTV@D*MML)?H>.3H)JN*JQ9S*:G^E1U%?IJ6?$
MRCM<J4?#QK\97'\Q[7CY07[/C:9ZN]PG'W7OZJN!6=-S=3^C?S4IIFZJ23$E
M"!]Q=34XB#A>!+E-SGKM>Z_Q5I9^"IH8>H(0KTGE3TDW'@U*,L6!:GIESIIR
MD>IM(EZ]7R+UI^2_*T;<6<YQ+O*16BAXMS01/$$*WRS^(BV1J]]G]A#7A,L4
MA09<DDMK>OZERU3Q\G_;*5#J-E2-&(0<81UQ\$A'F3 R\U/*O6HUI:7H_;&-
M;RE@<63^#Q-H-)@7J=,YWE20$%3$2CG;VI65J979#,+9:N^.%ASU(Q$H#ZL/
M#T2A76 D"-'^>I1KS V&<0D=0Y;_V?6)PYO:R?;*K%. %_'XDZ*%.%*X-L^[
M&VN[>J9R*2##Z4+\:?B45P?;U;,5;1CJ-#"R:SCYF4<G@1DP_Y,ATOE1")=5
M=A-(H,_N=D<(#UG26??&_0*_RZ1$# 5 ;_BF1;0/;=)$B/9.<9_(>PX6$X%.
M-H>:1K12Q'<F;@]O*GEP\T]_]Q1'X82SL]:C;;R>/'@6:<GB VG]!\4+*QQG
M'>X8&71-#Y&F[-OEQ\;&.BN%&\>'V"Z"N"WP(E'W7HJT6;$;]U'5O]?.6%T\
MA[H'R247")B\]J.OU;\RX-Q3W7P<\:K_/DI!'B\*',HOZK _6K#K5CK5#6.,
M'L3[,$)HGW;UOP6M\P!7B!$*0$.5?,I"7H 7W86\G6)XFM1I,-/0U7)$:_WH
M+]RLZ*N2S)8&A_"']R5X89D\RO$OZ!!:%3VD#<]+Q\<P3$R ?GJ6#\1L)#"I
MWYSBU@Y.B) <I#3'Z=)>F%=WD?=,3./$( =4RUH29VY>SQ8@MH(,]T&%G]#<
MP%2'M,%@)?/F/$;0W5F-/EM8_-UK5GQ,N:%58?7=05,R8>3A)YS&Y<6^?,ZT
MAW$W[F=I/KH5.!\G)G5A8]4_GWME8F*4(^TBSW^6,Y^ NS"I^Z"CAD>6&L4+
MB -B2[,2>JWMM716JLNG,:@%)6E>8PMR#' PC6;/1?O-05T;S/61_X>I=P]G
M^O_C_W64Q))8B+U+J"0='(K9*D5(2Y(0>Y>*6:Q"%K.]2\RQ?4HH8I6$'):8
M16S8\"Y)CLN4G3HYOU[%O-YV\%V_W_6]KN]U[7J]KOVQY[77\_5\WN^W^W-[
M/9Y1AIM_]C?Y./U+TN+@$:D"$9P#0X?2!-;M3CN2WC,'21A'+B*I*I9PKRJF
MT;&=84;T#V0E/]"+8@T9UIYU.QT^Q;^^?ME4H[7DB))9AUUMD"?-:R7<H2^U
M>Q5,;R=O!3+-[ &#>\G_W:F18I/C\[)FO?6N:5N/UP8=V-3=WVW F;&>$,*@
M4BYY1^_LC![1/[@/Z256AGP.Q@5^3RH;'E]P*[[<_1)SL>R3MTO)^X-)UAYK
MJN^^ROE?\=]K=<;_GU_7D'MEE^["95>@9=F9)#AT[I,,.)[6?X>RAO]Z.OA)
M;:N1T?)UN]],WWVS;[G42 1BL]D;%C5NT<C_TFO9=^56J@\(0_)65S$GW6P?
M9 N<^H0K/CQDKV-U&+L.\C_T$I!#G)"ZNNRCP#C>\4YO0//4QS,2MX:F>T-K
M2S@'D 20)18F-6E+A'!&9A,\7K4.R.5(LDL9&7;>\]O$2L/?_O<&D''93O^!
MPW4ZV[<D&P@.,%@XEB:^Q')F)EP0:,5X$S/'KC^-RC9I)87E7OQO)^'A%;K>
MW]>JMW2]^/X9_4"R!_F]2'M?U];S5K>K:%TU>[O"O/1OG4F/SKRZ\=,->Y,>
MV*K "BA/5@1)15@#/$)?@0;W2JJS '?9?B7]P]U0.481/-04!+L5TV,,]037
MLMCUD)YF%A(JX)(-^F.J,&K6**\(^)"W4-<X1^-V:55.T['AS4D'H+=R>^+Q
M&1&V5:BM. 8YBC-Z,D,,!IB$X3=B\DW&3Z>S0KTF W'W9K[?H#TZV<RP-G&!
M3XWY8OQ]Q*>9W2]RF,'MZ;FZHS:MB!W1H"R*[<G  MX4,Y)6K=G& ?(F<B]6
M@[P%.SH>LI]YY*,M>R<IIG^.MH[2YB.Q:;S.L&D,F,C_]DBBLD$M_,:D]#EG
MG'G?ZP;_Y=PB?,GJ1%,YK)Y)"HA#X]&?LB4_.@C#W-;?Q,V_17&I]A@C""W1
M3%+!?Z(U0J'$9R0#P.5;:6K3D5+HCHGRDK0]4%4EO4'2%@=CO >8/#"J5HS=
M<&;XH+CN?L'UH*G?R+,[E^WN3#Q_9J.NK0EF14IY9J>7UNW.4(M;K7T1]E=?
M/Q!=V;=P_TK=A8&(TQ7'LPRLWH%KK][#]G:4@P3QI0S0BLO1M*>GJE;UHW9"
M;]KB9^XHK($N7]"P$"^EK86LVGXKZ;S1'7U(EQU=Y2'A*$3C".$%]IG-BON,
M5X<JCS*<7RHK_RQ#8@\#40WGY.XD/0[ YZEG..D@2/UGS@^Z*9[_V!0GPJ;L
M$08H?$ S6O3UB=(),T/@;+VCC&W[QM:RX'S]_#;2,7PV= ,T%QM6@0FR)E!3
ML1ZK,M&6>0,,7L]P?R=ZI5VAB?AT'ICD#F*X/51ZK6D1-1KHD9HE@?J2K^QE
M_4W^C_%LVP&5.?3OF2"<4S#G)I.^_HAHB&^HG7;^=3_Y_."BABA?M0<J!?@B
MUB2NBCS J9E)\A4M:DS.RUTA<Y%F*LD1]/<%&9F4\(/RPZ2_DZ2.W$)W'D7W
M L!*IG(Y*\='-]:B#$"GGZ.64%)B]9D(Q_CZFT[/NXC'_9L+<SB&?7(!+B[>
M)L9E>Y-->\S^+V0#B:?9A_PJ=.3_KAJL6+V'Z]MQJ"1 0@S36:U7GE3E"H>'
M5&V5KYZ-B':*Q?F5R^\"M=)%C19ZRKPCU@A]$9:.6@D5R#=AB?WN *-S44.+
MA!Q:U*A7( !8.\JVX7 ORI:XZ?H6L@F04I(8&QD).K:=UJ/!VG&Q>&GBDLLE
MM?RG#<K;J=,'6N=O>>CD_/V./+'TB?^:U^=N9CH<;#7X+U)NKT IJYAR6X$)
M%UW_K;,UT5W,X)6H:17(%L>U370[\VHAF+A[/MD^4;,S! 9:9<[VI*!78]+J
M&D95[]!++4O$7=VAKGV5EE3?H3D=M_%MQ?.<3R.2Z;MEY&ZACMT, I)S;:24
M%0$3=&V%;_0+B.I>,S!G&BUV3YNCIRS<J4HX9_\Y^LSG"+[9!J?LP$;5&$$_
M%(DQJ0EC%BH1_V$!9.9.A,&=B'W'=EH;.,+PDR]?7W;;7HE[8[_?5=M5WV)E
MB='V1^D%F6/O]EY]M)']\=(R\WV7U^WKJ=XGM;JSTNTJ]@%V?1,.)W<3*KP&
MD#Z:&7.43_.B2Q5E$/X4P. FPK @-1T=@4TW0^1J4_1_ E!TZ]U@(JT#L0:Y
MY$4/G.K?&K(QY09Y"R00!K$&0IL^QFRHG$85*8O)2*)_"V(IVY;8SPUQ! I[
M4IO0P&\>*\0LO8O7:,=WY>W%_1X./]FZWO^>EUU-!.LZS;0I_,+K*_4@67;*
MO =I W!Y9BN5A21;($_<42(.UF^/1W"K3 Z\&B)=%7\)XY$-7X,;%Q*9P@Q"
MD\]C8AC/3 \T+,8S)OSCO[0OC)EM[67NFK^6F/O+T60 5]4?4L[HW@QN0(;H
M^MRQU<IH\\2]=H<GMY^[:)?OW;:OTL'8UZ.NX-8][V>"2.P/#!4+^!(^%7?0
M]=EKR1]&UX)Q67:P-(Y^DR^H+P[CSB3G\ULHZ6A8-6FWU#;)Z3)+90\E2G4<
MSP I#Y\K;(84^XL%S5-T:I.',LOB>]X.Q_S$>P%GVZ9FL5D<'.<65I>] T=?
M1HJ4:OXIHE?H+Z+Q" *'$:_7'YEYO7]!:(!^LK^.DVJV@P.:,I\5(?HO?"3$
M!ME%6L[X9/AP6/?P&<[[_[XIX.Q5P2FMUHI08.0TI"5!K%;U(59_A9( N.RY
M\AD:'P94(K2;,+% ,^D(."'6Z6Q3PEL6W*F6$+=,<>RC0E\D?_L$-"PO@[@=
M*$O0*M4F<.)H_<!L86](ZT=5KQ# P#(IS#@>S5 1""YJ3.$ ;&M5M'PO'OO*
M[QE:DVQ(S/9,X@K7L+>0/  8C8SL8A S>%CCIF-![46[>I%6E43SMKC3UH\%
M1.PQ</,X/Y>]B?U*^WJF*?)0=@:7?S*D\PN1=.C> N_^E?F,Q\_8+[]M$"N%
MLC3/W4^F/C\MF;V>LZBQ8H?R-BE.1!@.Y;U4!/?/8:E"%CWSS]X0Z-K)T2V
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M&PWFN$DZS<UJ\__W[[1!,[+CSO?7!"^+'_Z]^]-J9G@?K[?T3JMDEV]5"L/
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M>V95$\&>1;6C+8G8-4+,X_'GA]"?AN G@EVWY.=SIN+D:\B]\V132$\J7]2
M!Q KVK$&EU%P'!:FVJK8!N4 5 F5RTE?H/YC2]Y*M#W1A-4/-T:DHW3PJ,T
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M8&[<6+I!:G'[?K$1Y>"\6NT6-<X)!;+^%K+!1W0X^K;* 0QIEM#T<,(5R(.
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M%U/::>2F#EW[2Z_=TV]LW:Y;.7Z%8R"^<2Z-ZV5TJ"[7*KF\K7#[ZZ->1O!
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MM3?^E?%1,>N07:'N)F?Y@4\YD[F>'$3RN-E Z$AY+647[BKPXWD#8/*H-CF
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MP".DD"FQWGS8O)AG$=C%=(0KJ88EAK2*._?7H1#V*'6LOKHM5:\V,;Y"U/Z
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M:P0_F\*6FWZZ"YIBDT@*T2DR^MUWC[5_/_$BH^!W$EN7^3G'#Z1.97*=YO*
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MYR1P)QM211D2WUJMW;%F.P)V+*X>M/IN-L2?!I[QHF/6/'<TV#:LR00,AOF
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M+7E_UTP\->_\;/>V8_$;VCH?$OEU.4>++,?ME*WIP\QX:U=\_M0<'WB8.\^
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M;)W<6EJ4&IOR+3(CO^<$P2^'^_<8O%(ZG?[=O_!5+EPD6BPHW79IRZ9@"RS
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M!AZ4KWA/FUTI,*5KRG#&!D)^DT.T).D_?+]\W<(:12C3WN^!C#$=IIR3* L
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M='U)D'TTZ2?U52Z#OT[QW>(.30UA4"AU@+E+SI9^OY5P]2Q-[@(0P=?HDO#
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MVK7LAQA_\#AG@3J<U4A)# U.W)K NQ*]6MH;9JF^(VNU@@F:JUK[2=/+VQ<
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M16F_1.8@+#>W/\T841_LP@]R05ZD?N!.7]);;0X7R-%L"WRM6]YCD1$P8CI
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MB9UOXQQ ISC[J"D<!^6S&CM[R#4,B?\<BR_W(LAB]S')7N=L*!*F5Q'(V%3
MB>FWA??M AG=YGGEILF:?N)O%\&Y.=$EG1Z.?7H%ZTDONMN;XE'^OM8"F9W!
M/05CS/$!HBW2J;?49623(_[1?R[_?"5>Y#+B0;3Z['>],[[=_Q<>Y?(SD6=(
ME%EDT,#U#B50'0(GUI+85HJ2P^B[73",Y(>31Y@D(+/OF)4-'OA^^=!YUH]'
M5K=Y1DJXHR/])H?O&8]G\?3A8 8O/-A9J$&P?#3HU3)[LN>#3 1ST9ADSLY<
M=Y%!UZV]#K'1/T&_$A7,LC<XZOFI+X^#DM%VX0-.-=BO^;7T:BZ@3Z_N1I5:
M3'Y?_Z5BX?UQSP+H^H0ZLMR,R;%<Y8%/F)8)4!8*.H-K4(9.H/GQ]!&A(J0Y
M'K[!,&8_7;D4"I*L_O0EN;!"6OO99- #+XZE(0&]0=JM-3;;#QR,Z3I1&\5>
MX-(A[WL]@K\?O.O6DC_XA3)CZ$WZ&3\ZW1ZYM/*4'RW([GP[K3,M^M<[9J)/
MNSVL]77ZO!4X4&+N<".[?%4&NBCUW=FF0E-L](&-9X@! Y!_:/4!)%&22:4X
M<O "X/JJ=ETI44N4N5%<@X^W\%:],*6X$2?[Q_&4N7+3 EVS;J#L^33?;36&
M%57-R S(XH M?13L+S 9>.OH3-+#YWDK<II(WFEL:VD%;<;F/'7+U>-X)AU7
M*ODKZ\;) P?I) <GLXSHL\.?THG8;(5QY4$LQVIJ\WH8"X(2*D#:IHJZ0VI8
M@0D/SJ%O$GBZ$SJEK]?,AQKEP!<'"0/!G*@E.^I)?LG3X!09E$L2I[7=E8S$
MTO86&'3N C#O82RO+Z4E@":B]!SGO=UE]+KRXHU+MX)^/W"F55&\$W[CSN\;
M=U*?^%WE?72]X%G259,R=Q8+9M$:$0L+;M&:9!;S%Z(I60]I/@.N:93]5[DH
M_A=4[XW+=3:DN'FUM2FVAX21]:'Y)]B%KM1ZN&?+N];TY7^"RU_U1;L+::)O
MYK=,4C@-6KM&"K<^!@P/!F>"4\N2:NQH+0+R6Y#) &T!)X$LNN^K:JG_!)N+
M+"HZO$+G#H[89';*FKRLA]VRUM!)*)KQTN9BO]&_5HU:%J=6/\:?TWU^:["6
M_K"'UQ*;F/RXD%Y)S51]4DOY.<?C;--1I5=6ZV)<K#WL_QYQK*2ZK17][MIO
MK?Q7[-,[;M7$;%^@G0^J&LIJ4V[^69)9<K!_,"Z#TFT%RIW/:#) Z?&;W]$L
ML]  '(RK-\@/,Z@9X<^:DSNPII V\;:(L5,VT+?A7ZOEZ*YKA1W:7=$SZGS8
M&:2^EC;"[2)[]/8;72O-N_YPZG7OLQ4*5-B"1UD 7)C4B+?# H<\F SQW0,8
MRBVT\J1OE_]0/\J_H*YN+SMH/(N_J^!O9_;TXD]N@6CJ$IE_9M^GGZB9:J]1
M[XZXALZ=I^DM"V4TZL']*G#+;6VVB6V6^6,#(A7Y=;FN]8^W!?0$/+_JW(M)
M?NI]3X^+//4C_4K/U&1M[?4[X0]T-\IJ6D:N=;(2Y_!EMY\POWUTU9T_F;WX
M$:<6)T6D;M;C>[2 SQ3?:\U18.]EA_H&?W!-:&BMQ;+<+))&I"3UOQZT_X+W
M_[MH1J<F\?4%(.,MB?("\!J(C3DOMA4,C@) 3T_U0B=XF<\J0CG14'E"="T.
M>.MAH2 ^+(DLC;L 7'/?+28-]?"JXNECY0Z9(;*#&APS94U=K1%6D_+["G/$
M&X<>4N*>L[QSO]$&@05B:X=4Y[W Q@O _[ZE.,[W YD1]TCSN.7NA% YLB=!
M*I'LC$L2!;*0+@#]& X$LP'>;.#\/L'7UC*A?"N;TS%M)3)&#^]94+D(XC1*
MX,T,G^- 4?>=?[I]HV?B.42 ]P9_ZJ,=99X;*VN,8@.(NU Z?$I_8*>1_$C*
M[4<O5[UH>E8NA6<[UZ@B6T$%G>-R$IG[II5_[X^#3G"%7O52<U-VXZ*6J,+(
MCX-LI>EV-YR[67CY?LUT::#^S.QB9F[0@@(RJ-FW/FMV;YX.>IT7IN. W;:H
MGU7Z8W%N^Q9VS06E5V69B]C7%-.,E\.0A!7W\C[WK?!PGCK,RH\I]H8*GWWR
M/(+30^#][:RP,DB"^5E>* VD ZO9)\%F/^WE._RFN=:8 4(/G&_FNVVM=T6H
M(=#YVEEN#TO<HR30!> JEF2P\@]*AY.*O  TM0Z%1;PC<^+I4Z#T6)C==X0J
MWG#5#7.='$A@0(@.K?"8=.I=CO9VGW"$FC#LB4+>2B!WGU\9Q'9Z_FG*\\[6
M+]$OB>]"1[MI7^1.'PP9SOB.=-B\*5-4L+(<%NRUWLXMC$XU^FJ[=#^I">9J
MWIB4P<;:<NSI(=2:FBKG>P%8V/S.^?I<,G>:SE*D$[3RC4Q58U.^)+UHMQ57
M.5"A^X9%XNGDDKU=S\W#7(-8C_788; 7I8%(1O&J<(")$[A-7MX]<R:#&)\O
M5$XM3 5!6G;R+ELFI*U_]"ATB&G/XOCSV$AFHUAIIGQ$Z:=,?&))?6;67\.R
MY7/9Z>Z5HC *"80(.(SA;TI2$0O4=66D*$4V%*D(I)0/XX: SAGA0ZJNTT?#
MY)#:K79@C$?SF/-1@9,NTH]+G<ELSNA#.2GZ>C>8S8FNTZ)3^?*ISI. *YCH
MXPL Y5\OE,'J!2!.XY:.7S$DI@]#JV:S*G6%AZ^'+92%U%U"MD;^]:)'_R+)
M&A*N/E[L1[T#O=.K=4=E?9MNYNIP"%_=FUX,R? X58 JQ<$.FF_(PYPLXEZS
MJ:"KPYA1]56N,W;F;>=3P<$&$*'DG?W,"3#S U3[HUMWK-#[.67G/XMN-,'<
MD< 4HSG)9E5U(:2.7K.ZH\?3KN:4>$DUJZM?NT;%)_S.BGT$&W6-AI"6-RVU
MW/C3. ?-284R,-Q,Z8@V@[X)Z76F$WLU9K_JSWZ@7+K965Z490HQY,9P3:HI
M,</G;>U]?=]U9:-WOGGYN168QB2,.%.'QCL"WQ[3J;![>\Q^%K/B_#G[MPM
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MJ/Z)JV2>^B?NV'.Q.SNM"!>;&$_!8"8/;"+T( :ZL7MFW[CT,IYZ;?U4/BW
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MA,.KE_O5VRC=]]6#"=DQPPNCZ59[/;I772TTN:-KFZ%: -^%E%L,<3-A(K8
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M,86#NHVE\=UCQ4HQ\T$KWC6?+NSI\'OV_<O'+Y[_K@J3T#I0[51]UN(\7U$
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ML[JI>\E=%ESR0Q?QY"KJ6SPJG%>6!(_.DQCHV <='#\+<![^+:UWN[ B&IG
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M(3CB%8G#6Q)5%%_ZBF]XK"PZR.SC#9IEC=KX*O^"A68R4M$314GY9.>'"^B
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MQW4!2N-K4HA]_Y]YO[.1$6Y$^0!K[\Q_M@_CG)O>]1N7360LR_I)'-;7?'!
M>O%>VKWY-)H;KDNEA3OZ6R2M)T D::NM/1,JKFI]FVK: WW@(Z+0DOR*090J
MI(#8-LLA>-N MZJD8H(804B'6V%>-A-B#KT_Y+G<F,O63/(=O(4R!LH*B_.>
M-*7]NW1IWJM37T*_7Y#6$X9B3UF?V=A[8@?LK/B@TKL+2!E)(ENA-H!B1?*Z
ME<G' 5%TV5>CJG%\1MHEC:3+X8%: ZR<RU4YA\>Q> 7>+CRR5R*_X+R6XW+1
M88E9^NIWE;53 I#QY9TOIUD]O ,]$M>98[T.N_^YDT=3).^J[A, YR?C-<ZG
M_W8'E)\%!A)]<J<J[[W"??OV^%SVBT?GCTO<*0T-.3Q3]ON6._</JNK^K]-U
MUF5B0,:OPP@NZ1*&!0GLR[\"2*>>?O.U4<KR^>NN(IN7G!L?560E>#ZY]^CY
M4]JS-0*37#3O-=KORI%U6$P-;X_N ^E'8((.1/VN?EL5&:8YY,A#T+A2R,!R
M+"FD%;$=:<N8S>C]9EN8==F0SZ=68LV_BUR[\!M/]GKJ9K@D7A1U:[Q7N5+!
M2")K (M\7(<IGRH/J? 9*60=7B-"/:!!CQ9'/C7TS[O*KP#/@+UQ*G$FL%56
M>L<"E*L<[M2%>+E\L8BU-_Y9+=3@C=F=A')7#UTB1>,&F'9\ A4A) --9=3P
MDG'<!:_V%R1TVZU:RUO+A]@$ B'T<EV"9T2$@8?NR4:+!_:)KG<L"\<B1GW3
M_C1X96+L%GYK;YPX;83\$J,I,$N_G3'QVW.@\N.3 Y5M$P<OWCJ:^D7'R;1(
M,UK&7KX8)RV[HZDLT\6Q/VS?QZJST:LE?&([)HXK2=8*^=^66R*C/J3\Q*@6
MANVI-QE?4Y=N:\UU!S,2_E E29X='K%6/HH$RKZA/Y'*'XX%1LP?&[<D/?F<
MQ%>7FN]<W0^5\&.X+1@9H3^PF" RP&<N%/'*<"T430[3L3R@84]-'BE7J/3:
MD]#IU+-09K:I"CP7XD\++_TV/*PQ>OM)4,YA_=",Y2^0"4!<OKN6B=(E6ZV]
M$&)N3W"CDO \6CQ:7NA,*)E6E_5TB&V"0YULEHKQ0EC*52_.DK.E"\!&WQ/0
MVD.Z_"MIVQQ?R]B,'?K]OC^0I<M46E6AMI@A-X A3M ]<;7M W'WD%=7'80H
MD-Z&B[U%402I+5X1I^)XM';:]@"1514XQ'9<ZKZ/VI/1VJ3QAIFY)E3ASSNY
MIN\S_!/CN%@3RPD:^WGJ"W?(#0P;L.4\HE2DI3;=,: SO"76JM ^Z[!$=?I]
ML:JC:J$0)*X;**H PX\ /O18<_L!7W!;#:"\,-XIV)91M):Y[VJ$N)K7>5B\
MF05.@B=?SHS-/[J6KI+1'4J$]JG,.3)F1D31!:)>E(QU9TP:/TZH:V&Y[+VW
MM[#O&J3/NTTF@#?'IY=2-G;H,:%(WF%<F[9^A7M$EXFSO[%OK<_;.D>6"<N/
M.QPBDKX'E/!-6KGQW,K%^4D!;N,XI.(*WGHV8;)E>AVFU*0*3;)7[I1R-QHN
M4/9S[?+(;I ??SYHF:A.UH*P1$$*]6)5D_(>Q-8QPKCB6T[9B:72+R"C!0/I
M6LYO"..[#Z&O8W%:14G"\-7_R)>9O68F\>-2H.P=E_K5,T(UP"&*LG<6F*[5
MWM1/-$LQ:/:6'2)K". ; ZP3DYRE/(?F&$N$=^%.Z;8'3G9SI*D3A=0WGU74
MN_)9U7[WVSOCN+PYZVK"2U+O^ @UZ1 ;SMY[51ZZG+X@X$NXE$U,&79]SMEU
M(C/PD,U3HR OZQ3,\CIL[4%HQ+MCG\Y#D[RN0X(354#V9#RUVHRJ/(*%L"+%
MK#%K=JMG>-)"$<#WA)S:U)<&&04G?'@T^6]XU&[JO(Q#Y"'5HE2[OXX"="P.
M<*0G6%LFD>71\X/+::2B$VO13$=J6" (YW7U<LRHPV%A""G*%Y%N)<T+"J'R
MV+GDT_W$_-JA<G,;@S&5#L]J#:19:-CO%]9B#=U"A_;XQ9.-P"R>T:1PQ^[?
M)Z$04,#O;G76%V#N7@&YS7(:[!Q;B'N5+R?VZ\+<RZ^\R#I)9_J(J%T!8ES>
MW6L>@=Y :/"[%^;$@',]IY4]O;YGN$P@ZNEPU'XA&BHC\I.ZXRA&O4(O_ 1=
M&VKDA2?Y].D]^M]86IL);.:0O^@0D+V*]%=T!Y9?I_A0MRZD^+A>R3SW_9\>
MV6M5EKQ[[;E(0;ASR'?MB= [QQ2R 4,$^AV(E!&7XJLE>&MN7%G8.DP+ZOC+
MO"JFURW>T^J^&9N\=P#<A.MA<AJ.;QJ<QIPPV'W7%\V=AG>9X/Q[-BI(N4I1
M,$1/?/J!<VK;E7E'PS:G'FG]_ON#1/*O(PO[+D@\3VWV^YH3^<::/HG3$WW5
MM@7"8T1;H4G,8--^\9^6#5MS.TD[#?SO\R/S>;0C]!"=N!3QWHBI5T@Z)?,T
M3/I'_9#Y0 V'J*ML;]:'.YN#;92Y$&0N@TT^EYU%L%\L\O/Y?0L'8#!Z'T&U
M<>*3'ZJDP>7Z]*M1+=;5!RXP.TAW+I0Z[U<ZB#[;;$^:\Q@H[B^.SY8U]+KH
MFHM]4J1!OWB[YSLC2YDW0&Y_/]OOIY,KI.467-2AUN^VU"67EGU\+M^"C#JB
M4S$Q]#M%8-!%<($B"V8\J2F*/(_DT&7@QU *R@#2<.R+HU5GFP?MS.I47ZAG
M8,E8D "],[R"+<SLM >>_YIQ/_M)[QT],TE#)(+@[4U:("4F/X"B :*B^9\N
MAHX=\A@@HTN&9]U#DDK$SOFC?.YYKN6+R,)#8.NOCG&_)ZI7\B[V)N-_%UN,
MUKP;Q;.RZD)+<S)NW5IU00*S2BVJE^HT#%M\+Y I-H>;^Y=O!UDDMG;O)UW@
ME+FI?3!L.-.)=)[FY6%GWWJXG#OX6! ?<T*;<:%O;NF=J6OOHN^[Q-'S;QHX
M"W3G 7,YC;.IX[^4Z]*Q<AZ.#94#H8W5]E<#7^&';M75IFW.&>2K"1Q56M&\
MIQ2U\NU0G"#V_!W$"&XY9JSNIY45E$U?O!FQC>GQ 0V<Y6I06XXS-<I%'QEB
M*H0 BP10\=P[,1-.4PZ3G#J41XSB[I&/ BLN4$2)4\'4^#YPH9AH-,G.#>$[
MEBY6.T<XD((6:\J,AXYE%U3T!UVF?A1+_6"QE_ ]20AL'-_B(?@:DV#M,!?"
MF&W2H,I2OG"WY?8@,:NN%TBSRX_?5%8T5M9 -OPU:]*"\'^SZ:,\W+6U^I$A
MP)"]Z$._V;R]FLF27(AK!?VY<$*40$:OHLEHX$M]P>R_6_5@4*3=R49LXTGS
M;AI+@^R0[W2H8T;QC#C,XE$[9^[L*9$<EM'PPF :ZPR5/E\\0_@6K0\[]'P;
M3.=%=]%JT2]4+.NID5CR"Y5?H^-'(N.BF>;@RH6U; 1[7"N2P#=)7H?Y<F,R
M_3I7=7-6)DKI:F&1B.;T\1V]U<X.':C-HD$H 0^@C[X#KN";+/KFEQ)JLA$=
M=9YRR;\CXN:E5NW$J<8-B180/M&&&3S+3I8661+HGOO!-XD%2'2^5 LQKA:G
MQL2OGB4M-H_K@.%L;HH;9#:MK5 ?W?J_D!O3:<F1!.TSBDC*0RTK*Q0#4"<@
M_98'1?N-^@.I/QKOK(F7)A&DL([@H7*KSB+;?7;[ICZ2I*+@FZXA<C5I9_M8
M.T56PH U1@UF.&+Y#I0&1-M#*R^$]GW&9HN0M[@'PW687T8%5 ^ZB-B\Q^QS
MP$H<$8D!!'R3F"9%-KK-("O2?;1=O8C]B24[>PB?PEOUBFA=MG0NJ>OVW@9]
M6H=M=F$!+/:[8^NP5K2&(<O?-F2Y$@I[*72#3@@P]ZG;_BP.=S=SJ\39*I%\
MQ'CT.#3$@\=ZEE>4V4 [2!=%.B3!J4&A\RL\1=_Z-2F"W:3ZYGS%"_@4K&'#
MHQG)DQ_^D[2_:65KO\WA.N*4Y8M=3L:8G4%J.JE'OD30/GO\Q@"S@CBA\B]Q
MYRBE>M"#35-V /G\V6;"!".NH:B5MGF:6[68S-2+Y)LDGB&?&Z"@R':50'M1
M/$J+U,@>M/:[_Q)P?_("2FJ6QTTG\+)FZ7*D^U">1P.GD1J'J,8(E>!LJA++
MS\NNHVGK6@&2N(KV#D!)XD:N"+S7,LF[ D&#8]"]$O)N<&"H#;V9I,/.V0)0
MX\R=6/?4I=KN ]=R$%"TW]52*"9(.+9?T-&DS]%_>P<FBK^W:>.6G7>/2NV,
M?K\S=8M.;L'K.V$CW*\7<8:6MSY%$#;S1W&CCCZ1074'2_DRHU9/?*L;[Z,S
M0@+W)_SWS'N?Y)+YS;M;][Z\J_%3?X7# K=U2K&NMORQQ3>%ZL ^J>K.(YC>
M6+41J^^"YV&=MOLE76^<VWBH;5YM0ADIJRG\)A]E%Y*<BMYICAOQ$$1!+'YM
M-%\L/3V5XR*!E0YK1FRU$S$F@R53S=V*RU?>/FMQ",I&'?0D4 S[R\O*ROE]
MYG3H^$)@QFI0Y[G:ZJ@]B69E>8Y=(Y9$AT 3QJ/9"*PSL6%ZZ;E.2WV1FGMG
M[R?"Q"MF9>S66OU9 X1KP8FG5W=E\'[<9_^ #(-VO]LK,#A3E%#\R?'R],>P
MF5-GH@O785>.2N5*L39IV^()/^A?5_CA[? DK@32!I3BCS_AI9BT>>_L-R>D
MF)-WUE5,K33M( A)6-?AB)!P0\_LGX^7?Q%N]3HO$VS/&Y<*$G4VQ=/=W&\F
M)3_WGJ76HX=PIFU=OYCVCID_K5"'"A5J30PZKAQ0S7PK>^[@UWU#;,SP .F2
MEW5H;GQ>-ZDC'^_&S'55N.]WZN56@[],Z-XZ3&J3Y3V4L= !LK.<2^ G)3'B
MN-63G?![1H)5%N+2-$LFC"%'UH7"RB&6$^A,2_D.1:(>C)N"Q'CF/OZBS#>R
M:2)^"2-SD12PTM90GK\<[JY<IZ6W*%1!M%OC[I.5!#;KL'MHZ2L5H,I<-G75
M*\#3ECN_H=0?I=<(U#XI)=MP@D0:0IL^LAT0YTS4%I[JWPU.9;&5;WPJP'OO
MSCC]JXRHX_35YR)2\ _QDB5+]:%!1I)QJ_:0G[AR*Y*=)N!QB TB%?(>*+A4
M: \5F+314^2(H,**$\<89?A^A;J%K(R4]H.WV4JR72""K/IX8T@I%!:(=(M@
MD+P_?A0MMJXHCB]2.G# 1?06T0 *!2D!G]K687"R$>#1P55L0I!O@W :TI*/
M2QKQ^5('<#IQTLC; (<]K@R1,[V+> PY;U(.-0$E"Q7S:%K3F?G;IQGX'8OY
M6'QFA7T_3&H^1@F*!.FBK7_+R"K0:C&E&V4(64T@Y$BC;50U >0!!).]P+BS
M;WJ8)W@FT,GK9DZ,5+J\D)!+/@RJ1*'4A*@WCZ:OF]LJ_,8-( F%$/T\P(TM
MK[Y'+>Y>-D8(](4J6X3;AH01O$CJ\LUZ\,<*FY[BC8!.O(8R> ZI2P@EH15H
MLCPT%U,BXG2](AET5)(D/W:[@QO'O]KQYM$MIJ,CL^H9]ZG5R,B?GBW70N-@
M:W]?LC8MKL,FJIIVO@&#6$"+"$[6RNB@J )#24SJ*[(];D1[ 3V<=@%@Q5"V
M0HH"W1Q9@-;A!WDTXB">>5WJY1XB2K.3]_1E'[4*T6;I*<!;IQ1RWXJ;I*_#
MZE9BT4'=DJ25MF6*4C5TM1RRXZ-R)R"*!L'[ ,><&)_P DNR:Q[?5PM*)2(/
MRA7$YO%*JDQ2)-,BBFS?S6>_Z\C6K9CAJ#&?-J./^;],A-G[G$W_+Z_PPEW3
MZ;0S'W2OOU789?-@XH#N?%C0W;11^M%')(8IU ZBCT-V$Q_(/HRON(!;!P,:
M7-*T<IY?'_R)';LR??UZYS-JF!]!]AA^0R;>5T;=YTWP0YX%O28FY<^^D$+A
M3BC!VN)797LXL/+]UU?=>P-"__*WAMN_PY^]/:QC?<+^0YWNV$BEL_\<HY$;
M::N(BC;A&>M\.8 >4:.<]U#,^%ASVF3P79-DS#[W@KFULKU,%Y]H.M*VP(Q;
M]8.98?@#?W/MQE7G?&'I^?L)SR?WCMYU^^#NKG9,4B,5?LKQ;'Y*!OYFLX+:
MF<FHFTZY*0W?)[4.2,J1<_7G77O:=?N$NZ#DI*W5C]2,1=H.ZAV)7L]^HBQ&
MDFHN5"$:\L+-_TBQ,8AIW ZD#(^K/77&"XNGZ+ZQ'+RU$K4K;&OIK]&&TX$_
M,M7@SR0>/U+SWJ=SC31V[T,3P6P@7QR;OZIZEYS*RP>'RCZ;>JMV5]XQ Y^5
M;RQ7D?%L8-O7U;6>+P0/11=_4ILX"#T[4WS8(;O&\W'!IR]Y1KYWY)0F&^+:
M<;$C)ZJ\ UCRR V%PZ4-I49A5($)?!@K76T _>D*T+'M$IXU;'#),[QSJU@M
M<,1'^/#BV%QVZ_FW%!UH6X3\ZZ,"FB2FH#8AG!_6SP/MXY>EV!8JB"M-X/8&
MI[\[K96>0!:6F6\SYI3KKATUXY_8?P-YM>XE<](+J@/8K4,/IL?WBG7""CLS
MIBLQH';0>B59:)7GW5WPB=G^BHU_->/^^]/E_3K,\-Z\4>N\2IN8PAF6*DK)
MWZ-B>F2RC1OG:9QG6/OF1-%,DR4P2(_4:U]ZKAZ3?'!D;.;,EU_C7\>PWI['
M*S+JJ^OK&NZ;F>ILAY]\R7PC)$*6R[8.9Q'*(I5L&_O&FC>#_QOT0P$O*OL6
M&3_?UE54]@>Q:CZK1X[]60Y_,#PZQ@RY],DG?,=9YH.3Q7W33=8 I4(O6=TA
MB6Q0<BF \-HB2_(97VZ_*/!HJ-65:&R$:IGQ9/J\640"+^Z\Q8<#G/Q,W<:#
MR,1\B?*7#Z[=Q;AN0$_J_Z67&<&4LE]-IWN6;AQ9WI,NU])&,.SY\5@K_P-1
MU_5>['\>E*'NSZ7'!/:)DEG.A^O4C/+KO./HU%89WCT9;'EZU]9O#C>W<P-T
M\P$'S8,?-"++O \5*]Q(SHTW/.IWD^,T,;:56GD[DUQJ>+4VM==9]+)8P=,P
M"78^=OI\;>F7TFL?GAQ+.)VUH3SC;/_UZB2G%#NW=[45G'F=1X22V=%7@66!
MN4>Z=*LPIIVR!U_AGGT//;\I_; F-) Q;P#L7\6FL6NY2D@-B])'9H'7PRZ\
MB.LZ,M&^K>!PDE-]VLT#TDK3WS9<OA>-'0N]?R=\",0E5BY&PIUDG-"?=5P+
MM^:$T8IB?Y*>\=Y <\</])P-["\[_#KUR8[<(%^!1KO>0EX3=3,I\OG)?SX?
M'I@VO.T/VSGURS!@+K4NJZ>!K:I[X/")5PSA09[3R07S=Z<Z^&9]9=_[];*-
MS?'JAZ^G1]3O45YV=33__/#UMY,*APO>/@,2*QM?YRR,'T_?D6YY4>>!5.KQ
M&U/@F\U:FC?>S]@9R$;E;S^Y,Z/Z\E.+X+I--ZSO-FLNJ<HV!^Z_;:6KZ7[S
MT<#>=D(#:PEZGJ26VDC42@EW37Y<<BXZ^$E_WMYZQW8;,SY_?MCTN_G:"ZKO
MU;6<9='N(6G.J0\^= FAU]K0/\RH4M9GH'PZ_NEWZ<]/,6/R53]4S#!)Z["J
MNGCS,ILC?4MEOI%N;1Z3IRJBB%N%YZL39]9A%W).G] ;$$43BT8-.5_F)\>[
MB83 E9$+>4<,9@3RMKY9P#7$A\WZ#V<-VVX>N'3U@<-_4I,/9^ ^77GNN%OC
M$8L^__T;U#E>H9ISKOZV3WSQX5]%GU^^_'8EP_)=/LK(D^BFX]ACUK6;D)6D
M$1Z+[8^RB37]]KZ\EN)?M_9MH3?/7O>&VG8KN9KL)PJU(^;7HP[O+)9(W08/
MLM_R?C+*<='E;/5F+2F)Y/]NJ2ZK(F*,'),GK1\]GG%Q>UYVVW&L4?<)%ZO[
M@*U>L2G]XR-[U94O1VV#N\>^C,,Z8#LX6__;\ #6W/)%\N!=#8/DL$N!MBW%
M_B_2?BQNIW10JVA)+'_<-DK_N#&P:=P &IH8=<+B-D-);>,F8%/C"\@":V#U
MOPRUE8SL%SJ$ +-'0%V+.DOYHL10[E8LE*SV(V/5[<O#[VCGI]M7KOL=EG7@
MT9F2AT>VN/6G<,V=3\#,/?P['#]\T%=#;NB!P9HU]THT'7+4LTZ$_;^^&E#Z
MWPJ^^L*LN&;$ZFXQO:"7MO8:?/N_,XU>Y1\^N+3:^<?5_D[P RF!:[^K0,+V
MB^F7.]KW;TI/_^5XULSH5S7<=/;\X-6X[.%1N_H'K=9D2OK4_,\A<1UVG6!$
M:,]1Z@O;4A,!_:CL7S1['W1Z2*R%#ER.Z5OTK'SR\^T]08I2]6I-ND'\O"!V
M3EZ"#R7Q%^\5@G[)N;@=0N.TEA64',BX9V06 U0++MS_2OGLZ5*'Y]/F![C^
M'R(8G\)XA1S%DR<]G8ZE_])8 ^A]:$W1!VY549L7SAN42D%M)]FT67<GZM6^
M!97S(OT.=95=&FG!$P)OO\K")@6'12J5Q<0TC)],N1DX=_UAX66_Z[L[B%\G
MEV\^/M0%?.D5I)OL]B$J0CUQ=Q<^N\ 3-C)OAP?2'CA5[*PZ:/NZ\H?3D]7B
MSLC%[X.#TY'SK_&(WOKPA'$MSJ<;H2&:<"TG-0>YF(*$Y7.' YJ4S0_\16SU
M<2VY7Q+?>1DTF\?&Z2?FS>/''P=<SMMWZFNUR *R$L W$^@:+)^D0)EVBNK@
MHF\?V2N80"S@XC-4#JF*5(5'WF:_Q#J'7\@>T9"S<WDTM:7T[.70E(5G>=:A
MB+*,(-"^KU,VX]")'7T.@1IM*<&Z^*;#YW]>B[5\V+_?R>RAG<:#/F?5[\+5
M"=QPR'(DY%<V-;X;@+<2MT!^6&#I75=AS&M\;95,E_KX<E?U:#7'&SM]XAF3
MDY^&>?L(]LC1QW#P2X=:04I3XI4-E\KY(=4P:8%4O>I\-TSS6JI!9F&9#;:
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M+84A5.GP=-(:3!%QA,O>.MVHZ76NAS/=ZEHUHZ,'GJSDRKL9Q2P8T:,;&UF
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M=>WV'31-D2[O)-DR _ Q(*:#*H>#"S8 9@RR*B3D8&@8.,X%/2#1$YFK^>B
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M%Q[&&\+VE06N?%2!N9ZC[&3!7*6VO(9M22PKV [;M%^:1JS[T:&XXU55)BZ
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MT]M[!C751NW"441$FDB3&I6J2%% E)*("*B($94N1!X>P("(#0D0$@4A]-@
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MU<KQ0^24[QCT[-731\ZR[II9U?=/MX7>C^-.^N2>[/IGV_%6G+G/C>Z3;9Q
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M6FG!$+S+KQ8]> 1Y6*2701Z"2WA&@<]\K> ?(09$I;?(<!;3)M4@)$#GZCT
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M2()8 A>ACJA("*.IXO=@%X]()$3YD'7@>KIW@D<D0R-^DL8->#K?8O\(&WD
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M$.QQ^WM];]_^NOO=?OW>&/WC[1KS1XVSSJX]]]ZUUEQKG_.R\+(.P)21D)8
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MU'?<NZJ7$9P#I=03_R"X$B\+^_O002A90/WF.>-=)E-/Z=&V?&QY%Z*6O(B
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M^HC,HL9@6S^!R7&"D$V0!U8.?PCE@L/B61T_>%PWW$))-CERH&>V-DWY^9G
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M/7\K,3?0U0 S:3<S-(2'#!VJJ-Q.1W3@ 9Z#M2&R1).,57R#A.@E60.4,Q_
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MVS&FRK'Z;&Y74'_HE)#7SEC*+*+GLW^1,0&IQ[<[!9FJ':LO5W>6+P#_LA=
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MW.?Z\F'GI3\H&:2B,\T[^VF(9A.F,R3K/3;<R^V-QVZE<7_X]H=O-_QB84#
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M.-%^ 9Q'+^@*W9\P4[H^C.(4$=QTPMU/6E*B& (36XK,2K48?(JYD4?"NCT
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M;:O8%/OP8?U2\A2.DG4H,Y.V^RDSA<@DGK,Z*87__^CN*Z/B^I8]FP"! (%
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M_)R%* SM:8#=;J28!+7C8?LI[P&D'F?S%IUIWRU!5]#*?8*2,3!_R: 1,$2
MD4Y:S9BM+HZ>2Z\IPJ"9=E5[O ,'%T\K!+FX*]VW,,<&]X(W3 %NE!138J7T
MZW0!7#-$EE;B'H0%MHA=8,B_%TT[D0#"(/%UK'A7LG'( @\6XB,#:DKU3>(*
MN4.HC]-MF3+@=H I8:>U8 )+N:<*?6-FZA@K6Z;@J:H^S!]EBM-(OHS5 8H+
MT04E'KEC60 (ZS"D"S3Q.GP&UV5:,>+8+"0AF-47<XD00NSBX+K6P8V9B3\W
M#>,#]-WM0 "L<A+#Z%L>2SYYB9]_?XQ>7QT8%(7*9IH9<$L)=1'TNQ,53MI0
M !/4NRRHV147/B*+P@!KX7;NR7%U*-,*:=: _PE=M N9F'!Y):_P]]?D6/0B
M%28 KA'0U1$^2#"<Q*IT31N#.4S<3?VRJ'1A[9SGYS_I^?9TX:<&".(&-ZP0
M4B[Y;J(-2"#$)?$BAA!"B"@%HOY5Q]/2;Y@RH'U1M*F5O&$E*/86F>;(P^I:
M< 7]'W/G\KSFR1X0]AP(=LA!T^]-_'OF_L'\@Z#.;PHYO^,1+K!$RBM,O/VL
MTY8!+KC(ZOMTZ7_G0=+89@S-/O*R?]Y+ J\,$E"FP&IJ5DQ!%Q7>PPX3A9)G
M?M1N9"[_7OE/3 NPY+0)-M7'AE%63@5M;?>N@NX,7P<U6R!7^(.W]H!,=\#$
M=@T=<2%ARER/6XRD[9 +ZO<+9D^]CHV;;70NTP&(<UI*RGI3A\=Y$C'07AB(
M7<BA*@TND'(:/&65V>@R1:O&W":!($3V'P:XML0.6LS3K@(#.J'NNYP)FNN;
M">,;EHTB]BE>Z&5J00GN 7A*AY^W\<.X7T4K:W\Y)=*SBCB*4K^Y0"G\_)2M
MB43E.'0AY_OZ%LDS2"'**@N3]3&-__!Q?$^^ :(5,ZD0U [(X#X[[?QE#&),
M)I2OM-*\GK'/>K,7:7V9[B"'*@4 XH+MO#FD'E&-.WD9&;K"[G-@AVZYD"A=
MX'?&!LU@3A:VE88S28^P?/WF=[W9IW@**TEC1U:)+E1*N&$C_9[3!],)(2C/
M&[WY1N'42'_?$21=WDT0N8W QU0(T>"M9LF97Y_7O<+60_$"G1A<!N2C8 "S
M!&,7&JU,B0PLBVQT;%\GF(/@+$WZ\H93P5L CI$FRGEJ^1GKM*RQ"F:,1%]@
MI!P8E"WPX(P!GRC*29 6<!Y6"47)U3$(?N&3_),"K31S$S@=W$7%M .\?/?J
MZB LZ>)PQ2D#/[XSD*085)943,L,6R="Y+614%25%/\]:6!E9A6[LI['^[WI
M?7DJQHG"$%?@4N=G:04U ?R\*4B_U[4/I5RFEB-2?B2)5C0( W.*U!V-B%+6
M4(4+PI2[V<>O;GD_2'=+?R2*!GU-TIW#4X<T=E. V;?E 59B@?OC(9K#W10,
M 2<T@TKAB,S#32S5/I"PK_$MW^SA04W VYC+/=F2OPA 7KF,E*>&,;Y#!RN9
M&1)*44*ZB&UL$7!OU4Z]/?&C(LU<=]UBBI0N<O\]RF^V#K/>H;SIN]G%X9+<
MY?R>YLN^(5VP"%IM[3AYP2*1!I>K8Z$PFCN*9F3*]FY.#WNE_;I%*F0=V'4D
M'$JW?'J 3% D[8CM ?$%/W2X]BOA%7Z8P22F\^Y6Z(Z^*)+%*P")J=-DWM,4
MN!PS_,I0]G>TL2'F*D(+3W/DKF]%=/CY^  J@J(Z,!"BLP"]!SR1<3098KQO
M809@9CIKWYH>ULW93"PT-U02S@&H,,LU+'(-LG*L<M:^:> TL:ID54/,X8O0
M\:]%,NC8.J=>!Z:#,T,\]E*2M7:-U9''H1$NURN&@Z$:!%,]8T8%$^GD"D'N
MJ"]>=5;BX+T-XP8]- =AI34^PPZ+!Z%AW"7I;.]M<[;6@L=EKFQ/_$GM9K(7
M"H'F,-#Y'K+85AYVI\9BT9LMPM7YW543FV4WO>[G97#QC5]Z\*;?=U2])K\#
MD9F)?_$*_>+'8'[?:97!I"N_U8J&!U=PIL?3!HXK&7]+C+C#7X!&)@5C-)?$
M2B) -(U AL"!W\)]ZNV?*G0"<XP(L7"$E&*S3GU+AT6!$3OR\TY6I.N(A&WX
MBX:(P[UWLS[[5.4)SULF.IS5Z\K%]P9BYVV.6/T=W+Z\,7IHV;9OT"ANYWY2
M=IKICZ(R@_H +)!DK$BN$\W\=9S]>%YMZPN.Q=@#ZB+I.2O)-CO9$6*N[[^M
M#47\3)-Z4W>%3QA.3DYC)!.X6Y$K0!]I9J3L:<,!A,W?]<0K48G\4<L$?=#U
M)!\NCF5JZIBU/OO@[G1 [!>+18ZQ,2S_G;$!G,K39K_LQXFZG;<!?W%ENYR\
MB+I:[K]4K+^LM[\JL4C4#1E3&L>K*\T7%<V-A1"=L .4<8UR4=&\3]7SOJ&8
M\[/ED7-KFQ\[5Q/VF6>#HU7"E0\>Y-+[KMD5FX^DO<1<X/58--.7;;O9WCG[
M<\SCD;A*)N_0'PUA><*G*D=[(L%H7^6A&4B2DMR<Y\$UNPU4GK[P8)#Q#W8:
MZ+F_N:%9_=%>JK&2@GX%2G7J4"1?C82;H\Q?]M&7S86;5C9!EUZA)&67%D+V
M $%4=!!*-?O@6H#[[+>"JIY?.YW?]'?>:&O.>$MUAQUX=8(=V_2VC3T8L@3:
M3R+,;-/M@N:$@:^[UUPU$:_NGK+D*.?V46[9)&'7L>+<)?V#9_@G#T4NCN>X
M+<(,3G1PUN,N(*:HBA2&)KY$(M.=,/;K!X^C3]HD %GL06[MN"K@D(?']&?]
MFH[;<[D;B5"268+X#H'OE9K\R?7,J!ERX4;"6NM/Y@@TKB3;K'ZP0I0%[QB-
M6JUK8737>M2T<W$OY;"2'W9Q1*1K%_2]ZG"K=;XO?,&7@*][ M1C:6#2D!;H
M54I2C\W@ISZ;(U\+SO3;+XQ,1,C\=A\IT\Y4TJ1*],X]/$ZR-@=:Z&%_N:$D
M[%0=\]?02&/DP(YI8PVTU_G63X(/0,-7@$GXQ/ 0L/V'Z %!;IG[!S,K*J$S
MQ)7\2QZP[P]S6N;,C/$SY![IY/X[V5=&;GYYRA;^&>Y/HKYA7T]@2,_>S,>&
MUG*Z>Y8G<7PWD#PY.R F+D+A3\[4X?20GKVT?<[M\@.S!8E<1[,)93&/?#CT
M0)WYOD:D&K#@)?T'"P:U V\,X' T;UCX@R'MW.WDGOCHFX<-*J[99$A\O?ND
MX&P:4Z0%,\ZCR40RLA%O+3Z;5,)>5H619W<\=^[A3N3L?/YRZ^[1!*L%:C:D
MJ*&RM&H@)^O.SL@".9DJH!5<HMN%\]XY198HNG,+#$H?M!T7T'JFH 6#RF4V
MS!=UQMD!-8$>M;Q3'YX==K-_;S,[T[8H$4"A4V(2\&16WQ[P,;#^[34W_EV^
MTB?I96&YEJ:V"E_9#U DA8;DY#H6]4O>80F[5R,V_J>5B//^W[P>V:VO;B<<
M_1'IV?E +>F8K6W#P9J>RO43(%2TO7<8H"$*P.1^J=@/:(PVEUW3+3E_I(*O
MU"C7(::UX:P^6#-:^TM?JL<>\&Z^7DMO]MG=57%QIK1;J48]>HE;0^&+-S2
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M*9Z0M..MWR1XF,3]HE.2E<,-!ZZ3*2Z8^>1638F?BL JL,YTR;1^?#-OJ+]
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M)U>5MUXO1Z>N1! WOHW6SI;3(X5L;7Y[//W1W^[C].3*0"GN"[I0C/EU#HI
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MQ<_7J[.:$D!!*D&'QS23SX_RA7/.R:]>NL&[6=;^JAV7$AN6Y5?8_5%8(=;
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M0AG_N[0 5S>I19M+LG\/)D#%KT1^W8[VM0=%P 0D]^+^<[<"OOQBK'.6$"G
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MK6)A&/ SBTQE.-RIIZR5$M.LC1;H"')ZA8YX9Y(4'>@8P%GJPIBOS2>EFBG
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M*!-X*:X]!.P+Y2QMWGII%;"Q@;Z>L0?GXZ>%DFTS -J,4$:_FVC1&CTK>]]
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MOPGPIO)->ZAX%FFPD=??5SO8H6HXJ?V;5ZFK"/:S_W0-4OQ:F77\1_7NA0Z
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MBYU,E?'D\(O=N(.X:+>B^52(0WZ=2@7(/=AVJ\E0]'SV[W6@6WFA?1VX^#2
ME8>@DZWC(QI]'"<5\:YO<MK[E;6#GA>0NN<FR&)B($XEEDCMD!TR)XQJC34G
M;Y;C_#8WHT:?FB0=:GMZ[]%6XZ^,H"[G)&2))W<#.6*<F.=@ D0$UUQP^B#
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M3$&^ZHLM:DWV]'(?!1KT$7=<*DB^-&8:LNM$%M?9FSM=3=%]+7ZY0_IH)(
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M!SYN1N:X*JV.;*7O71D?E^@*Q^^77#)'1(13[4]4J]SXYWDBFJ29[W%>(-!
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M(ZI=M5T'3K7<_9X&,D?RY@C#9%+*M;47%@U?>+>C5&90W6'N'G!"H\=Y0$I
M<YA4^_I>-K%[0673NTL0-(JG?+P1US05=73XR=MUX/2I;N.]P;Z=I;/K0*CM
M3/JL/3N/'W8::@C5<5B;]@]09$\KFV:Z7?6P.MJY>Z@HK%&'Y^^/E(*C'!5>
MZT$;X+&Q^?=<V0!C)H92R8;C*RM&XMJ&61GK@/61AR^PU\XJ+VXL6\VA9T\=
M<H1=T/M$,G8Z<X+4O0ZP.U?5B6[ N:Z5*,5=8;==.5U^0)R.I[B#,.HYUP!C
M"4Y*V&Y7* E48A:PA-I&#^C_HNJ[H^&*_GV/$+U$BQ$U0;3HB5Y3, 31>XD:
M1.^]!2&C!\$8$35"1/1.E-%B1(GH8P83?48=;;S\WKWKOOO6.OO_L]<^WT]9
M9^W/1W#AI]C]LG,VK1?::$A#5^I*WFNM[:E7)*?V(><9NY-98P_ W P1[&F>
MT<:/8,O@\F;:</RL'.M\1SHIK;HOQ3$F(]G8^>!/TZ0I/CTZ+&;<9^K5H#HZ
MAR?C\3O/X2^GOU=*[D[K6XV/*"UF>(6 %$)O19XI*;V%8W2E)$!"WA%PY0^]
M9+61<2V#;M\E/XP[[7@O8D##_*S<J>C95"+6%\RDCEEQA17\2CY0F ;QWXCZ
MG[[*7U7\NV^4"(PH;NG[;#L7YIH>6-\N^_!]Q_@<F:[&4TXJC_Y\A($$,3L9
MB?K (G1#C:E<DM:\OS,\9O >TR2*1B^4^\"66N4!AU85P_R<ZIU'O 26L?9B
MF,6![^)!I,-S >+X4;NT?2Z-:X#(('MXW"P"%'-N&%X'7:_?;L%T1_43G-.'
MA634$EY#8V =CK2T*D0&G&J<785NDG'%SI@ZOZ'S%S>*>=FAZ3Y3'#&$AG.W
MCS9O#K? '*WP6@[7::+_&YGYY++DL]O=_[X),T'TW_7O__]Z^(V:!9H!@P;M
MX^\$_.]?G [Q_+(]BC!XLVTH\ F]/B@W!.\&O?8G V'R?Z9[MCCZ7TTDJ^=>
MI7L3*<DJ<DH-*:71M>2K_GE^C+ A&A<'(YY$DP%T'XZKIA;/Q!M.WWSBOB$.
MB CT\HHC,_;\8#XQT"65I/.HC!0+^MH'#YR$U4&PP+WLG?VA_8XHQH-Z J4Y
M3L9DHH-X=25!F1Y'4YL8KH.CW8H0_7%PL+WCL\!;U^5YOT7C<;*33^.'E [.
M'UTA>*4+L^!N),O.(3*-! 3OITL^E5^#T7Y+"#OSO-M5^(Y5=/[E!M)B[T$?
M";.5BYBMYF7(55* U[S,2>S4/\U,&S;:G3#_**5C7C?+@S>#40 BK/Z]?VAH
M=390;=@9'HI%<%P#O4K*W'C=U4?[<<WIS_@3.[1%VTO,W-(PFF6Y[\'.OKU)
M"KJL00>M6T(2%&[HP)S:-G!(.&+AP W*8\A?$CV@&S?8YIOENP8>0>1(Y*29
MNW:>-&M?1%3 B^:;^E9/.ODAX13(&OX!NDHUSG<1 9_!M(DG MG6HJQER8J+
M/QP#SD*9'8ILV;&)ETRF@R;R+OTU,JC(Q-4L%(*XCWC.ZI6I[VC%UJFA_( +
M<1Y3?4C!#/131DS,\$\PS@7IM1N$JUCM>D_@R=5+,Y[TI"_Z<0)S),<)QV%&
ML)I=/@5[;1@A6G$-GF%_%3Q_[:#>K2W;6UZ*)@]IB#J>K([2X36J=SQX,_E^
M^P\DH65$(?V:X9G=4ASP?W,$<YPR;<AU+[L*4O"UXB)]B;$QAWIO4>H,"&6\
MMVQ?LVC?=U_H=I=B-,(OX0X'N]F5:?$%*/B;(TLNFFO V<;]W*QNVG/W-T+'
M8/96XR ]2;*^H1#%H,\@;<2C:P#YJ9NQR%K'11U[#<3RX7U\4.0=]SB\1!?,
M\@P<7GD%QBO8OZ\,9] 4&T)N>%"=V%Y]OO1"K21@+]7BU+YC*^*.M+OI=!Z:
M2)4L/[[WZFGJ:/SX#*C/,557LWKE9N1 %',7&S[+!'ND3(N=?:O(S)]\[W>-
MV-[._8S50[%G?4R^/4*?H(*#D](QT:X'1H79,BXS9U'_E$RO#%R4.MO+ XS\
M/&GA*WB_9@H5JE2D[7ZXV1%T$1$>^!UG^^Y(+$&%ID.L.CBJU^+A'4+S9S>6
M7'<?$EIM+9$,>\%NJ@-269'E.O^TA<-!%88&!!/>!:Y,?(<V ]5-K%/Y5WZI
M<W=(QIU)C&GW#LBH_UYN<)J#IYTD':]IO3EAV/;63K@:KMT(%D9U%T?\PT%C
M<L=CY[[9S5YJGA0P")VNKFG@MV_CJK+#@PO=UL1Z9HHZ-&5I8CTVLJ3.S /<
M\^[[&RGZ-* ])65H2_T\$^Y:KH1^V3]C-2@B&<VK^O.J<TH7=C(G,_648.,B
M@<6<=..:X\.ID%X)*B3A(!@/;KG.ZWX%]ZRGZ,;W_"47QUQ:W$_N+"#3,N[@
M0 *QK?=/?+*&:^!LWU3SX]^MOO5781)4BV ;HDFD3N$-3+37VFUZ')U.RN0W
M$&FR>0W4->]R8,M/_SF12)"-*TO7O8F&]A1.C%Y'T_(D;^9^IF8?'13)6;*^
M]E*5FU!Q2:3"Y*DHE&M[&SVU>ZEY2J+M3B5T<_XEVWL7;L8.#^#&R!_@P%/B
MO?W[PK7FR*_;V*B-<#W&ZBK]+P_HZO+=%.O?I2QEIN;L3.EAO,3*)RH-6O=Z
MJ.GALB YGIA!/358-H@[Y@BDC ;0?X-W-5CM0V/![-Z2/E-*+,2Q&C9KTV6F
M+Q49&](C<"U1W!$7.*-(/ZZD!>.9L[/PP1O$@HJ KE[%B,;APZH>"7MOVDNN
M+S=4)'YR4_LU$,>EZLKU*,-0T9IR/;R.MT(#6*^>D<:V"]/'DA/5X[/A!U>"
M KR9LOI_B!;KB(M&LJ"[/4OI$AF0C Q$RR;<1H!H(,;H10AHZ.A'NA\>IX.\
M%3&=M4..6+NI]%ZHN(>F1W;_ (G9A!#8 \JST@Y3.WS#Z Q5J=ANCJ,A56CE
M.<1ZA@Z"-Z;7WB]5V5D!?'Y2II\#[/! HWOK>W=78%'4D_&(#U_&*=&*_O8^
M65 T";$J#:(. SHEBTFK]?K]OBC;%!_'H.%-BY(Z2QLOK/L.I0:B#Z=<A\\G
M95:\*J^!"9-H!MC_)!+I4*[=8+*#I!7470KV6CI04^>04)][_",9 ,+UGO8B
M!MZ<"R&$1[B&VIU+9AV1,&K2>OOTRB*Z9/S/@XXKA+XPMK@ #IGR.8C'2C<!
M!O'7'G(_FGSV(9'!#_\.+1(NTWQ:6Z\T-@2KB^F(@:^A64/;T^?TC[F*R.(2
M0 AO4YXCQ%0^ /OR4^9]Y&L[)/7QZ^,3XJ*IE<2A"ZV4!5_0R?"@Q#17>.AO
MQU-.BYP1\7>2FI,>/U)#7?BY Y7H#*-OTCD_+' 5+>>'! @VK%"[!_W^)?73
MU>EA 1.TTFR4TR]: G)T?%([X*Z2$,6DXJH'PL,BI ;K-F^9K2S*-;O.V0@\
MC95@[>->#!^76-B&;\K H])L:+!B\8^^:"^ISVMO+YCO$L9$>485;GQP6FHA
M/BAL@1-SU)]%8%E6$8-1[,&C1KBH^&,%!!7^]L:!Y6@[7,Q]8ZYCQ"I!E*E\
MDDT1"HG+2$9],9G5/3V8$[9>.&^=K-0183C[9^IIE#6F""S_L#(D6%(AZ!IX
MLSU@VM;X>TID[9=5KEE_R /S_!?B %5F/Y(93C(;@%KY<XHT*<#VV7;]$EG/
M]+CW [6Q\"*$OG MX2ZO6ZETI,MBZ[ <=8341M&=2&6UU9C2< Y\5-7/6GRB
M=<?WYFDQ9*METK^SM+HG_L"H$.-ME3..7J1[A5^(8ND3FVO3MFR_!NK=9T\F
MGCWJR.6VRFE]_C*]Q;OX0UP\B*W+"G(#NA!_(2(S)R)V#0 _?-9#]X,B9ZV[
MGPS^ _ZBT)RR$*?J^9\/NYVF]O<]1 P,6QZ\0+QY\8=#;4@6\_&X=J9E.CUY
M)5A@::>5/:JG;HJ_FY^=$$3X 6.(D.K)=/=5G9NN""M<#XR>$K>'>[,N@VZ1
M[J0&KQ7]>D:BM1QSBW%_7.5Y%C[T]VC UMO[^Y! ]BL_^&K:[Y*0&[?$P3R*
MD2JK!HZATXP,$CV#4GO2__3^D2)16GBLN_-DXWD[@+N7KO<X1/C2RF=WUSC_
MF80'8DPJ8UA6R%=72<;A\V8&--H=K$ F!*(&>FZ)R]LY(C%%\.(!@\[?-0_Q
M8_56CP'%/<%,@'_V<P]'*YH5Z3=352)J.F5]WG4-S.KS5_VZ6MEX];":=MG,
M@V:*W:65-Y $ [D2ZJB.F2E,I\Z<D[515^%:E1T,5DQ==D*))1&XIEY*@:/(
M,XA&*!Q(OAY(Q'H_7F.WBY;%0()9DKI=:VA_Y0O4<D=4A3"H^T!\?3+)>4#<
M?M-!$KN3NI/N&/QY))F3;&MM0$M[HW_VKM.*8[?4CKG7Q[<2AR4&)8K?[AJY
MQ(+)%(F/UB X\Q24M0ASL_4/UDCL\@<2=L;4N>UIM-*YZ49MTC7@UNYO/OG[
M6'M7\4%2:F(%B#< R2F[;:OBUMW(AU:L%'46'4AU2&?F".93 XZ1#"$8YJ+?
M6_Z9S;5G*D-1IE5KTT9%5VV-%]EI\Q2*+J6#K98?>)_[DF1 #V%R&![8$A@>
MFA3N]6DL^JJ*U[-=6QW$]4(R!$Y,%NL#.\:;7 ,-.74/!CYUM+)CO/(367LP
M#SK!RATG@T(F5Z7'S[C?G:F3$V,,^KYJ$OOPU*IM3F1I;P>H%(:N$.C0!#5V
M#HOL3)/)V0Z.W\-'2^ZG7*TZ:!TAGD,$VYH3V'&('4/FS9.Z%-F9K>A3,GQ/
MG2_)? C(20/H5S:V4T,PD(NT/I\+K6V&6^HETGO0-?8@Q8^<A72*=J%*4:XZ
MQJQF;HQ2PBZL^C"P'(]R8:(!!8ES_J"1CHW[?M1&*D3=5K_23[;R51F_KH6'
M9\Y26?%%.VVMUUTBSQHM;Q:&2A Z5E*N=QOJ\KE7=L+RBXG7LAZ]/15_;F,,
MN^\:IZH<HHZXLG8@A>VDI)O3MLA'8!!X@+FIJ:NA"\J46"2>\+/97*V=+Q]^
M+F%C=:_CC61N#D\+]8V/4,>('2@N%9[<_57[;+9FY1K@?3+B:JY2_;FI=J2$
MJE;)),D#7U3QZO=DU)?T>@=OH@19UHN/&.()+CO7!00U,M9;[J\J*UG%XR6E
M(7O=F^$IJ[;S5$^G9T6B &<0\!/@;H-0NU3R$W.I1BBM/,$1TJHLA:ZZ;J=#
MBI:+><AXO1=A$L,(LEAOVNDO(XW'[QIS:KL]K$\N4]G5R?ZT5.J*-! XC>NU
ME\'[L]A#):[(7PF&J27-MG#H0428W00OV5ZQ<HD/>^#^>,@UL+U1_W)&A)>\
MZ[6D5P\;JT0L'5^<]_)'_YT0T(0@U]!?_,TFY"U5_I:S)'9JVC[EXW;75_,7
MOW[N;)?7-%O:ZB'._TP8MJKU<MD0KH$42;/^+PVXV-!K0*Q85@[S4?8GT 48
M&P#$<DBL5)H^3&I7SX0D.MCC8\;F5%KE$"K.Z5,3P>4N*HK*M4MD:N7YC >#
M)MB>.(8;*)<;(N:2>>Z@%!IG"UNYW?U2C,H]B&&[BZ6E>ZJ1],'8@U@!$YH6
MZ8F_?;SG1\BX"4+>91DTQZ"ZU+N/_ZXZP(Z)@Q@_>C=JP&,HP-<LN'9CZ7"V
MFR-5:MHD@$7^EVV$X8SDYL]>\]='W<8;D7P#I83)[OJ3,@Y"X=>MMM/$!V#G
M;^\52),?Z3<F;&H :!"&0U?X;Q1%Y$04:=2K=W+A?+BPOA-.-MP= <T]L1*C
M3-2+6$':DQ35I7%:9#"_)ZG>W\&ZU2LIJ_K,R8/)Z=*1K=YICO[X/755I+0&
M.BL]D@H_=P'"APW0B=:NRA+ZOJAK*YCGI,0QK#%1C:N-ZP'4-VC!<NJI7<>[
M!V<!#PTW)O=_-05S#:C,/>FW)?- ]._'YI]-/RS0D(?FZ"M8\V?6G*34G?%]
MZS([Z%G(B)48".WN$5NX,V7N'L$VZ%3S*+@D=6[2_D5#=)5\?$1U=4T+='=P
MTB?.1A"+0<'[T^:F!DT(-_$Q(N,UR)3'2+,E&M-PW /&YLSAC;;H8H?T;X/D
M-G/L%_R#:7.)O=V,#X_QQ=C7&N5NWD258VWA9>B.^Y*##S7G$@X6O\TK>W[$
M,/%YUISYV\2I:#9<:?7IIZZ\F/K*X-2J6?HGGNTN6J27; IT K=)#$,80Q32
ME9T-=XR@1YQ]S7+,^)\7*I%3D7Q8Z4ZQ&&4^JH)_QS#?*_WQTPT3?O(W4B0C
M&1/1%!P)[L>SJK,[X1JEEEOR5EB;)P^=K0:$1O1M:1J0N*QQM35O<JLL'WSN
M\:^,1V4747G3#V)2Y=D=J8_9#X_0G9KD/#SI;A"',9A"]%K"XQL^\>/!W(%G
MNG1RW%QE#6>^I2G]^_"7+6CB/_1G1:&_M]V_G)=PB_9DU*72V<B=5OS2<::*
M]4NS\E;N>M\3P/03B7US>T=J=O;HIU N_P9 '2BW$4UJ3WLC!UT)7]>BX&8@
M/U%R35W7)5W.6T,>/UQ7>,\IA]#5,/A/KB)5M.;\9:C@@*!=Y*:)9Y\W9K:B
MZ171M%$8-&(=?06M0TQ-+1=VAJU'+;/Y'8U+I1*@+XAY]<0AR)MK#%+#/!!'
M?[CBZ:!0Y_"?"N^17:J6TT&)8UZ8QH72N%#0>['GS "#AM(_6Y.F>\R^6A:?
MZZ4BN)FN[DL)NW10SMN(EK-LOQ .H_JR,$M!\T:&Q;?^%C,#Z'1(TKNT"ND7
M[0O(UHZL@/YYMJ>*YE7!]?J3A%OA++.$>W\C6:;O("QG_%T#+7HR1EYF@JDL
MG_-21MKQ.)'$P&1K?ZF\RW<NJ0Q_A$M)>,\G8_A7/K_'8S3IS>2\A/%-\3X%
M.N! JW+<SS;3]IOMX'Z""G4D5S"B=X7^D8(>13#B.<[DB_1GSGK*/I_/\XT[
MR41!9K!G\SWPC<^C1 VY"QK'GX_.G"E3W/3?K]YI9'\?8MW0F9UKV;YBS5)\
MGK%JF]+%WH%-2$33,2'(8LIG=C/!_C6!6U1RJ[Y \ R?](Y6IJH/B)^5.'GK
M'CX7J>E?.K/0WR:Y&>1WF7O@9H):@I0UW<S>..CQ9O/ZF=J=B$KK3_%:+1JP
MG7]GDH:*>KM7BG_51<,2R7+A-#UODG+2LIJI^J#<)$&N.WC.0$9J/;$5OV)S
MI[P1J<3S@VL^:!\['_7N7=F\[3,_/^;!LK*H5Y*6?RP1[,D6'!!Z1VHUCL$0
MG8,O!,LB2T[J49R_49W(RTU$]O"($1K4OL0[ ZO568$E'KU#>:6M4/F+W<37
M#GY&<0B;3G8(NO#]_M06<=4P\";, O2^M+K]SQK$)3U"XD6XY%5Q%].E-O85
MKC;^^"WW9$G<KDS"UAZII>%Z=;F<L6,?J.\F+[*9%]5-??D26_0,2_=.F>_R
M$?9(!M[[3_=2SYK&J;=VP%P7C*0GBB2=7:T+F?)();60CNS.'82SAUPTD4/+
M5$6K-6OY?(O+]^-T<6MW(L9J?$X<E$=[PT 9L&59-,T&1]4-"+M/[*.:B).M
M_5-/?WWL2J(SZK<DQ8KI[6T%RZ=H5M>:8U?^YB?G\G5X!';4?&JO44=J()]F
ML*@B=G86'.7^_59IROZ&EIFX4!_KL'!JR*.BZG!?O)?K:J%E/RZXX%GWI#\;
MQ2,:C:'.IDS]UQFLI,S.O _>C632M6[:(A@O.7_/&J6^"M<O>8;L9G!MTUUB
M[+/HA0E7.CD>>HIU)$'?_1CK_?7!@S<K*_\HZE:XR,0E&ZX$KDS\RZ&3D[X#
M+^%2:340$.5]4AOE4^:9\3;$6JW78S0]R)^,&:'X1*\V:#3,!M7O?=OP\67+
MVVF(:=O*WE+N^]-('U?_QE\7 5@'-"(Z4B781,FOU[3J]6[ [3/%OZ59CO=>
M)ACY:BKXI$H<H;I(\*?7P$T*'"(V\BZ^^PE6(^:HTTL3RUAJPVNYW?W=IJ=
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M]GF804PL.4 _E?9"0Q9>6P/<N^HEX*^!7_[M08Q#(.+//'*(8@Z)_=EF?V*
MM@>SHA!X? 1OMKGZK$E62;:M2M[W:E!M%4$"&X;SGD<V;(I;$A-S6'X;#^;A
M2?<94KSA!S>A'R0-S50E;%)!O4-X?8X>T?1E@RDS('L/-(E,A>!Q$Y=+49P
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MHS8\FJ]CB3C?WR8\T=I;")"*I,<S]J\TR@R4X@)+^6RIS:R=+Y?O_OE56CE
M7ZC%1-$!D/K@XXZX=F5PGQ;ZP Y8E55%/>*%AX$L!W\N_[[=O -F%<\1:L\X
MA&)@@5E%1OBXFF"O$W6\!-F;#J638$6=D(JW!NM3$3]_[M3)*[[YNA@]Q@;)
M@/IOH[J_!_7J:/2?UZST%]VQ7+2UWO9C6Q491-^IUQRC=C-._FA*&=+#DY5A
MS)44>@WD:2]FAAU/G"#FGIP$-F%A4,5G*!+W0DN#].4L;B>A@YO>NIIP10^E
M,,A&UV'LQ*"IHX.;T"<Q(/KC(01W&(B&G%H9BHC8?TM>_CTO\,D( D3399L"
M1(N<M#ZI%)[1#O8/C3&*L#@E!7H(-",.UH,!_ I'/IL6/<W\)9(9-77'5.4^
M4GR.&PT]#]C.F%VH,4I_+=:R_MX)+,LMS [EE.OU1(8Y&O_FR\CS9L.#V2&W
MY,X)[/3'U>WMI8VQEN^@GU75N*&W9*E#8\8U%.EJG+?X CP*++\FT+KESQIC
M:FVWEN/6VQ/FQ:1-GD)HZ13>LONT./P?NMX[JNG?#Q]]EQ8*B&R42EE292-#
MH66#6D"4)<@44$!DC[)G@8^[EHV*M8 @>RBR9Q'9T"(@&RFTLD'V!J_?<^_O
MCWO.O7_DGYPD)\GK2?)Z7B?)@P3C]G;*/D1=CGC<?ZQ<C9C,Y4+PJVFNWP-C
MQV82,113TC+>D";<WN/#OKBEQ].2LL4#.9D\SO2:2B1S&)L.80Y8-C"T:_//
M?;Q%7_I<$@^UL),<M0V5PB9C^PAR.A"J,S>CJVI_B@OOU'CYX.":JGP%47H_
M^LR/JDJ',*.]+\O-Y_\"CU]->7O4>[",ZJYLR+/Q62DS(XJ"I#C4_?WPF'5+
MW'&H2Y[N(>5EY:O[8(-JI3N!!0[W;U[0+SS0M$EKB<QF!5J.43.:DA$VZ]/?
M*"S+FLB-X2]NV6[CD3D#KP0*;@1;5K/6OG8RTU'KG,!K'JZ29Z4/+$^*FKVF
MGT]7!#^_]N'RM$U=_ZE0:[@?^XL\-_SN&^ZQ%\*>;^XDU[H(O=<W48KIFM.<
M%IM9G(7+>G2[*0\T$@\KJTM2T_*65%8U_@*,%NNN3ZYI6+9D,*[.;Z"+EW;[
M2N00%>6)?*UJYQSYE6@"AB LR[+#"RVN)N2QP7Y+Z2]W>Y4-]">$I>*;>,/J
M].L^GT5,LLXX0:CLK+C-.Z%L7 =61ZHW>:B(9+F]&D+,7D[P[P\O1&M +\2;
M/*+:+YD9?K]=K/P,+#X'ABBQR0G,P<#P(#ZYKJFBZ=+7>Y,G=R5F0OI?+[>?
M;0]^Y8?[4%8Y:?_*I=#0EOWS8%OY\V$6T:[)C_=.9NPXA8?FQ5%4=NU%?/H9
M]$.5L[T'9%H2:\&X*H%Z-L\')BY^[1[S)*>-7NI[<.\;QNZ_@*]CY$]Q%*57
M46UXYR/W!O86CKZSEI.\'#.HH:@XY>[2/?##YO#7],_FTF<+!T:V-YMNI-P;
M1Z3UE!MNGK%U@B$ 5CIW6)*1JA?"$82?#.>ZSU<NH:T(^D9WPB6P^\7%ABZV
MHXVU;W/=*+G,'BKBS("DH,FHKA8-7QW^%JCW\$\5"0$R5 R.BR&'T.9(-'5V
MTDMJ2JI*[T#PB'F&BY=/^''\UYYRRJ/9_'H#\?"K=4U%(X.##X<XG[EH@V2^
M;QJ+H83BH&6"VK!K_>,VSX<>^/*H69U#5/G[49RP84(U2'BKR^-W9E 460<.
M)N8(,;$KM8<Q,%\;O.Z=E.!_5WPMUA?5KH"G$8DY.S!:F9F21ZK$P<U+T;6!
M1WM#1^IR4)B<@_OVGM<?E;SZ<9M%#Z]#C@K<YS.Q1BM<24@QA' _@3T;AZ\W
M'?LJ,J//;J1&YT0*KC-!-9"[^:)5K-JWT\1A (%6#><AP.%.XEJ2;8'G3!Y>
M-27XAPHK^]OB8M&8N*%D$IS'2KKQVO+PA'!@JDM2*G)I[UYP\(F:K?'F&8%[
M;*PQR2U(H$H>!<Z$N\8R0_XY](9GBR3$W=.@&B 8C?_L8#[E=A!BPT(VTQQ3
MD:! @./H.&S(DCP2D23/#"0/V$QX@_ &EO1@))"1XJ3!#H7&)(6Q.7\Z'RP9
M-#71''D:=@I=M+YW5D?G3M/+P^JZY9.H&[YZ&*R861X@ 6U:)?%,>@M\7202
M7(LK!@?T'Y['W]A(LBA)X58<@Z'(_=J3H6I&F(4C:62GW=,>)S _OUCUYU4*
M5#"TE$CNO_Y4NVUTQE?3DXW.@XL.+V5GF4>6LNX@<MY<S6C;S8B\VCSU%X <
M%6M:8MOR![[_V"UT[ZH\[U&D81-VT.A%#S/&:DJ$Y,V<]"HMC+]>G62Y""N1
MNY2:^@[*<@'UH")?+-@HT]]C&S,3O"J:M3^N]CAP[X)F9GY<\)FFVZD6B/(C
MP'<4)IY^7%51):F57M]#S'HNEK_-#\U'TG'SPW5JAI?Q5'O$H Y*ROS[;UXD
MHH $1?#]VY1QLZ5XR?:NZO!&N_=AC=>:)P^]OJQ/NFT'=(5\Y;#/%8#&!/Z^
MA?FXP>T;]4/7I@N=<=%N(%ZFK/?GQ'#'GV=/(VPQ>;]:\D=_7?T!YO%^>3L9
M)OI,[8 :,<G +N^Q?9=*616XJF@[?G536JT]Z:"W7INU4+_'"5H::="B/K)E
MN/Z*%E0]\^'6].T-C2/C''W3Z\URBN92:0_U@.TET%Y?5$J(9=O%-;4[MGKU
MUE<W*LI)5*,S$@_F.#MB"#A?9A(2'KY_8>_KW)1T^%34WE\ C#G^L?&>=$S#
M%AGEJH#O#.Q^M6R5"[F:LW*0?:<JO;I1P\%!:W'ZFY#&EY'B['08-?CQS[?2
ML2K5D.TU;1B$JR_L3N/0>=$@YR]D3'<UA,XS2FNVFVUFTSQ[VE]]:+=Q4^:3
M5X+(A.3DA#46U<KN:T#[K(YQ*/P+L$5)N@E=KM(5O_<N%3 7P36XAZV).*>2
MEHD$FO!U8RZC\?LGN\=7/ (7HE'AYZ6_I9O^_CGEK_SFCKE#]\CT]07F"^C@
ML[7F\*<M!_&Y4#$<?)<J]-/-!)YV\-R;I1-)$IN.O>/:XHLP.R[EZ Y[1A4>
M1%',5#%]5K^HL4:_/1G0(9 D+39G[^5)?]0O6?.).]MWY#[([H<>?&5!^[Z1
M2:J>WO\+)%\4EO14_F7E*"T$AK-A]>C^R.VVFU<]%XJ$^&"W] &@O !%@<0,
MK0?#B94A.C"!.$T.K7#!: X;\^=R!JB[R7AC..TO('B89("8Y\OX&AP]GWM2
MO[<@1H\?#Z=6QG^/9FZH"JJO% B,XK-XI9AK\19/8B/X=:B_/%#9O;G?4Q)R
MY7O8LQ9A0?3'[EZ^+W5UER6^-206ZK+%_9823!'"J7BK6RZ+5KWB_KX@B+C4
M^2!5[<7]FI8=?G R(8 <+=7L:1Q[(?>U;P9W@^#N*X\^9>K49&4]QUNFU#%!
MT^N*IZM&@_UR>C ^Q0@\>:1RUVQSJHR4W]T]O(7\,TZAYA:M#[97.?"?"JM=
M?E8XV>%7-#Y6<&8>;BC3:_)V8O\Y N<M B@Y^)_V19\OB;H<8D2V*DUP&+_Q
M()V%W^>1A2\RZKJD'36 HF&@Z;;.,8M^<H2.$'G?TB3Z^-+/V?*:+^_@A;=<
M7BJ=^\UFQ,\'7R4;S.,LVQS.7KL3O.N[O_8+^I-HZ,6Z9YFF=NU-T"ZN?D7M
M+9:Z/<E+#>>QKDM?/8QBW"IR?W?T1BCH<HC:>3&1K1BB'G0)^0D 8>51M&6K
M<>\BK\+1F\&/YO1_Z]/ANX%LV@\&@:?4C"AVZ3O!:29&.O<HMZG;9+7MXYIV
M 0V_?:=3O@.QBXZ9\)C#=)N''^,2#,1.BH_\);=)NID[PN37V?P=0BG#%N*(
M!+^3E;!!+"L HXTD:[,R,4%U2!]Q\:9HG06,-J,(X"IX.##@'-!)R?V?:&:G
MH+[P:Q@_&:V!Z<C;RF1]C=46<A3 M@BRHS%DA1'Q,G5PW'41*1T$_JVX6%FF
M<.H=A,L[*[A_SF:X4#@-XH=' 8>_;T<5AP<)-7V+M7NXDV1<7QX6>,SJQ4\2
MN![4SN_HM'C:*9QJ %=K.>7.87/>E%<8%#9RC\Q853G9^ L,YWU<I2#H6XGX
MN$$&[*VDX&=MBUZJ*_<V;QV\%;1D?/$7< X0-"[0'.T288WO2: >Z,77Z<!=
M!ZNW2U@E)'(2OK33OB8$K:MRX0(URJ.R"\@(!21DC0*%$UGX*9H9/7GJYCDL
MO,HH.#9$!-\QFABWVIE+XY>K$5Y),D"J<RT.G6AGLLT[)HI$6?P.(:SV<+:0
M02LL=M7JU#"_ X4CYQ"TSS-AO@;)#6'=2FD/C&SM$,*"-=<IP&*,@/-F7C+R
MJ^!$,>J?8)0W/LK3TWPGG6F7OG38\U9'S..H6YO3JX'K?X%3GN@G=:F-#?9>
MOQ/"WYO?9/)?PG^7AG]HEL)J-3#Y^V$Y;N];SWI$"^P;&@^MR)G^+/%J6!>0
MG6,VUS1BU_>,#<.!%NTS(-8N4(@G.$N=BVB@OED+WX82:%H9S9_)]25M,Q[-
M;,LV45DN& ^QCXV]-P03J>L.@G6!RSO7#H7A#PP<,4E&:K&811))_ Q912C,
M!"(K(/W '/X78-:R2_R?N%D@Q)4?E<N+>=U5X2J2Q,Z!),&3%Z1UT[OY 4S+
MO^GLAS" V^5KYG'SN2BQ)I:=?RS 77^HP/,(<T+#8O;9.,C$PO-(BF:>AN00
MB-?UTE-_)N5#4!I8:)2!T,WP!0QAT.E:@O(2S>A$="2+T#_#YV0R7[*0R8QY
M2J91UF/P&:GB:6])GD[(@Q!!S)!K<MR(NI]1X-F+L2S\PKE;(]7($\F(U-5#
M7/^-VC]KJP\+GGS]\!?(1:X@CRG- ^D/J:YG][[4XZB$50URV#R,]KGH/4#3
M2B)$I11F\2:30U&P]G#0_JEXV6<)^\VFDZ@MK:X$6JE28K>C<\9[L/IFI'$>
M\IIH3'?FE78#P0/8<LR_;OH:(Q<M&1A =&=7H7>+!Y%NG] <(H?Q@\-QQFZ6
M'_'O']=YC?27BBELU1JT"$N*/@W/\%;>)?O]*KV2!<<Y'^ZT4,(>7MQ=[1";
MULR+=T\0-L5_P/R#&_SWY=H!LT6?#E-6:7@"RV(?DHV-/2[&]/-#'59^IP)$
MV.'=#ATB$AYFPI"8H+,0<K7_);LN5B_L\6M_9@3U+Q"2V*:O+VBD60$XY56+
M;8H=\*!5CS:C9:)%)$LJGYX)7O&CZ!PO6NCBV'8HXE=!_/^_?Y6]$\K>RF3^
MJ1^$<!0\WB!;<?7/YY48_G_(U/X7,Q0S090254>4O^!-(3V@P!8G,EJO+HIQ
MRTTFJ'A3'.[BL_'N9:.B6\[O(16X'&P0]CP1RVED?!N(S&>8?ONVTW,/":'Q
M+\=TV"OA\'J\TZJR;2JQ) ;M+C"J0X0K(V6#@'/&W;6!.))>UQ]X%8>(<"J0
M$)Q&*QG&^8^K3'%$ !R#H]5S&QG;-W*(33(0>G/ODW *M_U!2.]NWPY<P-WQ
MTO;LQY/ZHN:I8"B6R1:>I+VXB%<UO^/$HWJ+VI!(R)HT#P(CH0BG:0WVFW?H
M(!'?U4%&3,*O=X=^\?,+P,CF.U[P/T %< ?+H^ \.*$0<1C<%98/\>/V?;VY
M/J5I%K+:M7R,HB5W7'/+0H_+GW\@P+K#CUK$L0D1B*&[.?*QFF;F='^.7_,H
M;Y0Z(0J^^9@A;RWH9+:P!%?%T4<BW3NHZ5RH 6N@"LY=0W?-Z)GQLCESRUO&
M)?;CJ.?(DE&M7)T/R3GS;&&8!)UY(K"ZO&*-X.I4KW)EKH4K0$%OG?=$_(AZ
ML(XL(", B>CT533H 8#YP<_'QL/9#T"B\>3_7-6L$A-8DUNHI2B1 #K=1)86
MSYPMT2I@H,'.NS629$EL51?"%3U*?'$CU%CEJ5H/U3GRIP@H0=45G(#,9!+^
MRL25:A%TGP07?G/4 > X='56<;,9<[HP\]YZ:_]GOC!4NZ(::$2\^:J,875P
M;QN4K6\KH6'U0056@=2"XE</8&@O2@@NISZ!NJZUM.OZD7T5;:%E<"IPY1U+
M9&(G[+/!?1(M"TZ$PI"="' ']&RHD]6KK]@GY0))\N9ECD;^[&A%!<+#HL:/
M?&*]:8JCE[*E.'K(J!:QO.L3B0.YRE]B+7IZ/^E(T9U02_)J-"Q:;2V3A9ZD
M/ J61#P%UT*4D3L4[Z:AOL6:7/1.1T^['FUP4SU0G?5UYBNZ8PU)!/YZ@9=H
MB7,2@R<P&9<(W2K_+)+4^N[Z0SL"=Q@GBJ+V'B9^=@ K].BFB\"('[D_I$M*
MNSV$YBM.8-_/_31T(]4@\;E7WH<)*V=Y)-7E2Y*1$G$N57;DT4]71G_PUZ>.
M^F1_$U=4RV+"'96N5SYI/&#?1U*6E]Z(/I^)VN+V#Z$AH;$@>2\Z_.G84R3_
M>"TD>9\=F"_CS7GZ2"Q!OX4>8*)V]/)AZ=1WCJ889F@NB#7<-;ZQW6">]]17
M0.P?'<>TM)Q:+PY@V7W9F:%9-*+2Z'R>>LS!CUK=NN0>5S"4D ^N4MTPTEKZ
MY]!A_P(+3 F2GM3\EG9V3#]\8R(=./^G;.A?MJQN>;8F#9>,9R'#MOK#7_+(
MD+8!AFBJSK-%]+ ,E5,>0PZ=2M*2 LXP>19TDF M\-^-41^3!_$-[(0$W_##
M!%3'[SX(IZ]O"#0^ O\7N,4QA=Y^1#MELOT+N'30M)EFOCZ*\IJ2CVY.[J3E
M-?+/QW1MMQM'Y0F]HP^D>IZ'.,;NSR-1GJZYX29Q,NSH\X1@%,0YJ$/KDV2$
MXG9T @/Q>A! )3*MU@)_ 9*!QK,F]W3%WN<3,0RZ):- CA*#D5*%G$8+J:O-
MGIF!SY]YF8AFZF\F:GT('?DN&Z@N/5/_X<:MM$4(YA9L5'*21X,%@G__#+F8
M3/0%SQI/N,ZN4IX&O*=P/+;L/,S-Z7$]V\"-3#%00M@5XM+&O[MF0K"AJ(*C
MBQ%B5?O7_YW;UOMEM&P>]PN?*MYL&OARY5:R"+^O?75>2B<!RS*I+PX%:\F&
M\-S>@*Y*'QE4O#%YIWXMVV'2_KX=H^OS5[Y& W3% IE"<]Q>"YSU4&QW<K^1
MXVD$*CM"8-UC;>@:R^Q@6=*O>Z[G-F7\JGYKH_NC-L10@LBNL]GK9<M%FOY)
MD=&[5?L_+ERM-MOWT!L>M48FGO9ZB;UC1;&9<+?YLCB\B=TWL6E^U" \4]/
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M:@4G4^")_73),@^O"@+'S$%,2R?J($XHRU>]7#?!@.K,-6!E/6.ZK@V%4>"
MCCC\LS@TOKZ:-SKQ\*EA2J'"CVO>1V,3]W<&UQS\W+N'BF[ 5+@/4-(MB,1C
MJZ.:/QW@9%R @BWC0>PF(!+8.<D:;S3:'@SWZ^!C+ ?&J()+.F*9\\ V"N$<
M<#1)]%61_<>*9:#\\T1FI%B>] 0,^@7UXE?/X>J^</:,O&^:8&7A+97-7]WC
MT?8Y:</4F!J%+E0W <[^3*QZ'6^<V07\L9F(-=U-1;7KMX=<BO_<U0E-IO#V
M/'YAQ[38KKPU"(<GDEG4X9BN=@]_A(QBS^D" (3ET^%)2HO34-RP5WA9G];R
M8?\A+H.1M\Q+H-S'*RV;6G596_?0"1+0(Q>6B/?51OWI?U0G'<)G;8U)^U;5
M[T=J#P/%C&X1/Z *TWXXK['*:YK&#3D54$SQC9U=T)C[9S_4<QKW=0%>'1$\
MBQWJH)&)Y@\O)NC-RI'M%C'V@QZ14W^!O+TWLB(W!/1^B?K+&R-W@#UR*+Q
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M,2XHGQ^*".>CE37G^3C=XS]G!H7BF[X++VHS1+;]!0*C$_+,)$C@?M !JPV
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MASHXH&&J%*83#YRJ2P"P>L"!K][Q&0_J$?N[$V2;NEZ-]V1K<%],ORLABG=
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M=.I(SN*%M7>S9ZX-JZ/R;4+B##_H/#64SI\6>-$^:T7'XP#(IH;'IL?L%?S
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M/+(C*C.J]0;[&*RJ2)$M!N>,!3I)?RC\[=,VY'0_NY+0Z=\>5N1HGH,H_0%
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MBE]B)_8>+9WSR_@EMVV"G3$ICY5.DN>1[5&(LWW)1:SCYM:"ZDZID6ZHF<<
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M>4YF<="*MN8A$ S"I[2.N/C+F*WL&]102RKF3\:_]PU>7YN>G7(8,(W G8C
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M8F7%74$ 25!&"/;M$E>[']VL.O%URF]? 0H@X?S*QVEH<;IL@48+0 S7H:"
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M#U]P2XCSG09I0W+Y #):Y#6D5OFY#WZ.36I"\X/@!];>(KO&*BLRAX#23$M
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M*;I$("L&O7WWEK;PR'2^RMS.^JJZ3=O2Q=OK)M4R*,GLG<*KG3TKYRLJMDW
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M5'I%[*,[R8:7#[S"PJ4MC&KU)8F</!"&W3?U7J1/ ORXS3CJSQM/(<\OE(1
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M#'\+37F70,9-^N)T.?KEYD@ '#)B1-@MZUGZI#+[IT.Q+T\S!]!/4*7>2"#
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M%H 4D@&3A$*@8;4/+FE)T+39K!$)=CAQ]K:WGZJ!@;Q-LKQ4^FU[+[3Z0+E
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MD)M2D3I$'6)8&+%^ .^QO#+) 'U8DL>2R"8,#2]$XQ*O^)" 8RH,!F&<#NU
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MAZ;!PP[D"!!#-03:8&1SFP;PTY2%GR,A,"5XGEV(!IN--\!2B&6_F?[!A;(
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M=C36SO\X8?;S@!+R)R6EZ=?*08/-7$57Z0R[U;DI-3;>M_G2^3&C-JD=0O5
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MU;.DB)7!H3ON-S;I^>J&QID7Y+0,.#2.U=E7'/*]#U)>>_'L>_RUJ<F+WUU
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MXE)]Q%70]:N_6>NV3_:N7_T0@6E_H<,6P<-)Y"UXP]IY'A?+V,;6E:_.B]"
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MI/CH)WNK/^'1W(+[LQRG"3#\O?L#&5]C.54]YA]B:+UR;9XTV#V)X *685>
MEK'S.Y'X/F9G3XZ$^MM\(BLY\Q3D("!"DW./#C08D'<G]KE(U<-7C.R.*$I[
M+1W&V#Z[7S1(JYNQ(_*0%4<1?DA9D7/PUBYV8$_>DUO8:7P&<7>1MW2GEKPM
M6Z3^L+9&^0Z1- R#$MAK[^'A>9FNQ-!8/[)[5*P02CE YGIBSJ@9Q9QF,'7
M^-JELYY)"D/1)IA^8H_O4APOVP7/:[GFA?@3%U!+!_,:3,[/3IS(3="52Z:#
M%A'Z9RLIE[S=^5J0E.0_U)_54Q[$^JJ^[B.-)=NQ[U6*9B^X)L2L]^X59P\-
M$O'VXL>JYW,EVX7!)4ZRY<2_17(!H^_Y\WX[%=76C.PZSKCZPQ;P;Z!%Q=N5
M)N+'3[]ZY"-3_9O\@RS$'(Z;F[;"H>&U_]@RACG N,>6&>94A \5:>%;<J=<
MGY"9SBYA0K.TSM7F&E8^Y3CC'%"??]JGO(6*%CA1V)<N?TT4(DA]6KJ.66IG
M6E@OS@_P6AKKEEKS>\[L0)Z2G?2[/B2FGL(F%WO$N-P>K<2,3UJ\2*(-*-9_
M9S!R+^/7GF:\AW5JHQ><FIX&[9D#SU;B#.OBH0UCP<<1F;8III=.32L^Q'[@
MVA1Y2T9K\OKMX0&9 059N&S(]?CU5+TYUX)C^^U7 961:(=[PJ7I#UBXH*H#
M:7IE+P[F-T1%;Q P^:WP"A_-#W9:;]-=!@<C!_[8.UB0((-2QKQDLCQ>??<U
M44%_ 22/2?DJMD#+I B>E_TUU2\6_IBI.<YVSL7'/HWZG@N0),H?1D:TOK(Q
M76!7"7.DUMQ,O )6#M$O4_>I#V.TQP7TO'YX>>G4SEP!<?P)#[X#]KS7CWF=
M)D/!S.=J%\4HNF'THH[JF_\1?OV_B#'_1=Q&^SE#?J^F<)0&K;YBW160H)%U
M[*5AS:3@/3-:"MS[AQL#PX]N/A:J)Y/ S$U%HS+L4]>-"_L+%;6CSPU(O_]O
M>W0QL0ZD60Q2B?2<F$-FR:U.(R_]^4 <XNCX3$WSP:HG9._S*;L<L9:3A"3*
M7T9+69?Q4@W@)9_YJ_PC**25$DU\':YM8K!?MG5LC^;2(<5[Z[#Q2.QF.<U0
M>YX=ZMK7QL<*@=B ""AP>GHG@BZ#^W52;\H,:;T=^'.!4.2?.GVX-0JJ+I X
MUC5T.)EU@?*^?-D#AOBL;_<HIW0#ZC@$PV^D9U;B1X'/;%Q@][%,1)1WFGTM
M5YS^-Z[]9*6/F)!$(0OY>Q<+%\+&!B16,,+G,+*Z<!A]?P3W-Z'<:H<(N-+7
MK\\ZZM@;UGN):TJH_!)09.20AQ#%!0:5P7X%M#V.@$@Z.,Y.DF*GE/'?M#N^
M]S[OY2OL7=E>W\Y*\E#ZP+;X?F6E@BRUCRQ"8P7\QZCOE'[\GW)5&%)&V=E(
MV?ZI&GP@+<EDXK!R(!FTI\E.('^(2-DQX?$P=^ 9*0& #C;26L"L >+@F0Q:
MG\*""VP_'O>N=WMRR^W5YKPC2'Q?J^^#I#SI%-%KH47FO@9'H\"_.P7X][/,
M0GK+Q+OXKH"Q\,]%DFB&9*F;U+F$V3T-@&ZN@9_[&^QO55%96NG+$[\U\/*]
MSM]NIR?!^,NB &.+>\Z+<S;X3A>V0(\D)=\$=A#@077QV:EQJ=UA6PS7$#6Q
M]'LB^%7M+#*ZV7,S&4 K-J_@'#@(ZY?U82SP\(*NY2?4(.Z"7.&%C$6!7R3,
MA^_%&-R@-G@![JERY\L4HL@5\.,77B.O2M?*?&^C-#$?F?+WN8PC+\)+RWHE
M\74*@M9QX'(]'*=+7\ZH _LTZ&'&QA\]X&"W8A]!"7%2^GB=^>&XFE%%RE^F
M_DE3/]HW80<1$AB!1+G=S<0/8?7YI<RU0:US\SBI 0,O*G"=1&2/'!DC!MH+
M0SH?&3X&:8*A?8KJ5&R;J @Z5*OG6*;E?W>+?R/\QZ%T!13]7PNN"<IU[Z0>
M:T7X;%H<L W_B@K/@16Z." @KI @VF4^ =2U%\;:-S>*PCX;("WYD5L12[6[
M-&NH.QIZ&GI5[6\CXTTRV584''4=WUK721VL+*H:1L?CBY?N;4%QM@POS=+/
MF;V=O9$"D:[LV\/\9_629U:JUQIV.CB38'3"1S=,5%Z3\S*!* &!<N,4=%AK
MC'H4"X(WH:Z"-H ?J0+EK_/NP"B^HD[VRDP7KFKRMSIJJAY6;EN0_'KV!--=
M2&0A#K63^D*EX>!7EG5YCJZ"!]N.@4ZJ3%YF XZ=#X<$;3XN\U=L@+=S]CD8
MTL*D\.XW"CPI>@N<?;HRXO?OL(^^($, 2G9:G5S@S5]#EK^O=]^N<2O+TTR[
M[:&Z08=;695;TP^76*T/IR6P%/[2&XQ\VH+\81H)NC:&,O 34924U.!]K'WM
M_M'H^99QIG.Q(KQOEY4X= 70P,*_O#SW^[+WP0?#T$A"\V9K'J8Y8ZK9"]A%
MA-GN^G1TGE^<"%9,N(1P>9RF6%LY>TE)Y[5T)_+=SO:R0K"X//7P8-T(/0^/
M:+^V(]8V+!/C=).LP5V4U%V=UORIJH!"."/&\CB4567DR%7Q_J7,_%U1!M ?
M]4@-THC)SEZP<I*1A&5&9DJ%<TK<0\J.[9F-8$]DN.3+.?646^33%":N8!1K
M!>2(-+[T[C3>-IT,)3%Y1WZU\4X9:G<XS(5J)=T>A.:#PI;!R8%LN"3O9+#E
M[TQK/A+2:PW3#WW8;NL/Z7O0>7C)1T!_K<KU:('K5,#M3[?/QH4S$BH.322H
MOV/J&T2:DP3FJO&'EL6^,^4?LQP-A3ST!O5N#[RZF+[7^#&HRMG[EOG+4TO7
M%EF=-UN[_&^YK1$??K8D=_$B"GD^KWS9@\>6/+X"MC@H4EYQY[F)SIN++LYX
M7%=6:*+/>--[K2%*7#NG19DK_-6]-QQ_L-OIBW 2ZX"%;GF9:)F<&[EITTPZ
MMT+SK,]T/"1E8B\R>F2R$+1F[5T70<Y*'/N).7M69GMUC9Y+.3(3HDP:XK%M
MHUC!DSZJ#^;W/PO21)\V1U"ZF5ROG<B^W[2[<'@%1)Y4+-()Q!KJ!T"L1POO
M#DI\LQ&O2F^I^81(';?9#"VK#?\J0R3;L^0,?F=+N\XXIW'=ZO<MJT<Q?1ML
MR\E;5'8*621 M[/&XC6*$?:$I-BC3P'W?B5OG*R[LET\:3NY BQ;X62QO%[T
M@->K@X5NGCU#6X;US+I2T?(?V4:8'T3.B<0/Y1M&6HPZ&JQ:;MBDBXF[7^I9
M5ME<[/8MB')70-1'YR;9^&^UPS!%_R*U@JX"3*%B<Y>XN.VMBD7'SA\'2O^F
M//3MM?#[84>F2C3+\?@@7PFV++5"P6:8MO5,;<O6;MYTE9G?6ECN;]P]<FOG
M]JFT)HH4B'Q(E8XK)&WXXS;17J1-TU$HG@:2W? GFL1#;2"<_H6DQ4SMA\3D
MD^0J#;N)X>XJFH2.1D013KX*A_-QL4=@_]Y[>P6XA]K:8%F[YBGQGDM<-M.V
MM)CBC<SL[Y'Z'^O3U#(%#.5<'@0:F62!&I*%^PF*%S[."U1MW&LW)-[M,KTZ
M+_TS^.5$4?V118D]4F\4S:85YL=9 >*Y:^"EVBTM1)6?1R\:TF8[(E_1PM5=
M.UK \8%SW.O23703BT\Z'.:IMIVT9$Z9G<R^T[W->TUQZ )FY;;SCDI68MK?
M&]L&(DTU7]B+Q4O^W4$_CNX*>ODR6;OT]>N;FF/RR/Y<L2%S>X0'5/1WF/7<
M%="IG=NRM_-.( 9V_?O&>4_U_7?DF=T<H1^[>*W2O1P4HK9O:\T6D'))V'Q:
M<I]Y]Q,>O&A+3Y##>Q;AH[O;!*OK4PTJKP#U:P561:#OOR0$Y=XY(.G3V=8T
M>VQKM-:6L Y;1/_'<OL0KFXYZ 754I'1^]SI<.N$3_ZG3_Z>+CC5EH4E6:[?
MD-=J#=93FIX654697<!>9OA:+_:#LEAPH.R91KZ;0>^8U"KXGSY(:M$H9(<=
M+\_P1);W_*?95Z<>9T=F<X 1#T7)>6(<L\;/_?G^_*5!<\SY(\VOMAE1A/YB
M1%4$G7Q85@@K_IW]OGL'-^<^\:.8ZU;MMHQP@ZO85T;YC%O&8L<K#M#)C*<?
MSR,"J8V,:DO/=@*@2=>>3YF$MCELF)Q4V0RZY;[TOOW-.7^K;'RTNC43[CT5
M51PC\+=_Q8F=%Q<]Q"U/7SBH=?] I8.?=@]<7E'DV;PB^&,;'+,69,\]R8M2
M5/!!P5O %P)GB6'MVJD]B/=9R NQ!=_TA;)OSY,\Y,AV-B10GA'J%!JZ3-!5
MZ%)+_9)31,T"%]YK^>&8IKG8S116(5MV98EG(#:NR/799"F;<O;;@=!./H')
MH?W<>-,Q<=Y"\- Q.X1H<B-,8I[8R\/4HEP\9XDW[N8HS7\K@F2$2/;RF?)1
MXR2@: ' >VNJ<*O]F?M;UFJ7,8)MR=Q-N\%27Z%="S ?34P'0!HA'B@0;5LE
MZ.H6S_@4<7=-1I!HEXH?_:6I05T4P/N/*(:Q?'@A.*]UVQ%+)+$+LW!NWX//
MB;*[28MJ&!C)!GXJO^WHQ]?P#UV@0C5W7FWN1ET!( +?7N)T@,]OQ><M67=E
M]1&8#S.Q3$QT<QVKDROVL>5?,^=OR<B)\,#L$]6IY(ZY@GQR=327G[Q-+OA.
M=GB^>ESFJ]67MW.Z.3H<.F]G#F^2]]F.D)JE!77 PN5]I<U>QFPF"HYCV0ZZ
MQ1:PQVL@-6;3_P*AY_KEJXCVA!=G!GX&RF+.M"^T;JO#[V2I\)$Y<(\!0Z8-
M<\WM+N=^I-CCSX4\WJ18/NBYP_[8ZJ8VH\D*0*_M2U+5NE4^ES?T1N1SZ")6
M6;QO38YM&>*Y4.:M:?1 540.HZ*NNN6AP15Z!AL;,U!H_Q-W?'"+AA>@, !7
M*A?V?3'L_!-+->LA'NJ9HWMRA"G540/Y$RIL<O9^V'EN>2G?4D[)9[%3_\$,
M0D!2L%!T>:N6&N@ WK>E5@??C9#* BU E0BHEL/1/"@-UTRSS'"/O#_!&YX+
MT.)\/UM> 2)F^5= "KN)\9A#%N(8L@)"V)'(#6K83!5*),MZ(WA^&K$8>:E@
M2A4 '[;/H>$*1V$VMM*%[(\QO1U!"=\(4ACED>22.'QZXFNZ;.6N'#=YCF1
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M[7+S<H B%&=#>]QCS(Q[#LAZ47OL/K]?I&B]>S?(=13?5Y>^,^QF+_0=?@F
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MPI]Z/LPW +,)RD]3P'(IP43>X='$4TV95[78KCEB'F%UBA3-E!$-&Z!;/P[
MV6+<>Q)I36'Q.-F5,5)8U8W1H<_Y5I691BM[75$E)U$ .Z>TV-%JDK A>ZOS
MCS7,?3A.Y+#S23-6M]#9BJVV,Y.][SQC7,W;W9=M5=4AJ00\N"Y$C]$@U>BN
M_LGE3LQILI?OI*,E#>;(KAX:'M/1H;+()2EE<52^TH^@_PBZGV(.CASS3'B'
MV#_!,Q@BH7ZLR5>GXG8L[APNWF% \M'Q#V!\=9 'W7"CXLUY:6 '(LB["W^-
M^\!>@"N[;=M%.X0L((-SYO394!D \J/R7_H!SA.H73BRE/6>XZ?_$(+R[\&/
M@M-ZM[^4QR+!QWL)-_6&"9&.J_%QG@,;@"\Z-W*B,!^_1+>Y<[_ZB('*@C*3
MPW,F!:]?AP@ ?04=_8=WD?_3]ZZKN@'>D@"%2(*4X#"B#W6JVZ8FHI'P""FT
MW 9D$!68(KWQYF, W(9B$3M 4,:,]"#!!;Z>=OF!P$?\T'S\050]QF;4.T58
M5?(NL@ M?Q?T1)NY:P&OB_ME\HW<'R!1\RE?F(ZQ(ZO&P1:<+O'I?&- OP;>
M.^(:$AICUG-7;B\-7EYY[$88\<J'PN';&'7?JS>17>ZZ![[2TE#V]Y0 _N*K
M1L8'![ZO?0DK6\DS'=+L$B&$'0$/[AAGA_61>ZFY["GVA[#]_(4LVCZ[!0]#
MOZCL&8M<$ G3JH=#HX%5]H>O1K>&1L:H4]@SC9CB=8>DI#>IKKC]N#A2L^(F
MIL6M%WO20]N=2.(93-ZR?K#?DUK^VH>7XHD$PIRO/T&3O_F3,UJL?MY79]X4
M#3[LQU^G%:V]!Y*-'1L"Y'+E/1397Q6LYN>J); F=,4DU_Z"((>(Z"E?1[,A
MBQ](<<=YS)]S1:;] LX(T#/Y^QZP?;Q/;C:0D3BQR>HG&._$L<G3XN-QBI$!
MO-')YJ204D=D!UZ_(=?!17)%@3E9&@!?3>X&9=OXRGF)_>",LT&.J#C6)#4C
MJ*"^)ZS!%Z,B2DQ/?@!D,F'>D=D1X [PQ5BQY)XP/)43[]=J]ND9:PM:_EJZ
M@#YU8(([?8A#*:@"A5_(JCR(0"V*C'M'* =Y[M^VCY8O$AF5OBH*GSK90L!P
MF_@;<\\1!Q(/?!;;6J00(I<;U:\R-9YGVTUFKP8FVNWCG>+7-&K0R]HWJAFE
M2H%S"IK\D#JE;L+TF,"?LVY[KBMTPW)Z?5Q=3O:&\5ZJ"^G=8^!.%44SH$W;
M:*$@#.%]2<O/-V;UXY3D%JNB8<VW+-''R68+*N+OZI=K8U?+QKAX2^6FXV3N
MWFNF?0,'I4YE^T 3O(1%-+?/M@FFGH*@;K8%Z@.HC;\SVVO*=M^3DHO,!6/(
MLS&NE !T9!>$^6#L&T711+ ?3G&$Q+$DFB<'UK.'K.;B%=^V^<<K:_\/GA@)
MF$ ]8,B?,7)YNJ^ X'\GH/Q/0:["1\S-YHT<I]K2_10'V-VS+:)^D)T78GAX
M\73S7PS8[7>>7VB,FR)T/>???H$*(#+U%:"6'E-\J%BI\"^V6"*:SJ<,<AH\
M7]-E3U-($N8.\U(#S^-6PACCJB:+0G>8C<^C5-7T9'TAO#.E#>H\#_O]R0^1
M#^7?CEGK@-%*E*I+8G#OA)"P/X 9\Z.("E%*484W-)=QX3S:>:T>?6OA;F_P
MX/C$)R!YL=0]S<E/T7<>DU(J=RL*B:3XVQU _39AJ]3 6I0>PQ.^;#9@P$9Y
MK%3J#R!%/].D*LVJU#56>L&]4:7[M8C)@X%B78B$E.I)BE@7+V[5VT#@8POY
MAYV%%$5AO&X0]/)*#]03)K(MK/L0A@@="TP<9":0)2<G9XO\RM;E<9?NWN!"
MOOT7.'1-@R UFR8)!@2_GM3N<^9\/*'*6G>TD2(LK,;+/# @C?X&J-=P1@"H
M4]:WI\C.HQW-PQC+TC!B+M;8S^D^=O5:;'M]>!$D\^?-B[G7K_W!=;A5CO<O
MO$HIZL,3I.5RI9'>,Y6 Y  A@Y;D<%MVKC^;FIOBY<D?X)YW,A*"3K@8#2W5
M=!Z):QO^K'Q>-[@!V525/07C5#,?II.W^454_DHQ\1TX03;)!^J!5)K)3428
M$2+SK#5;DPDQT,DW?"3<J=T0WI)@>9E<,/V!B(?H5NKX<>38\^PKW_.S8B%@
M\ 6$60%%Z4%"$"*-]%2BZ<?O&3$N]&4]QK7E391^65^F7*SJE!(B >^3XP?"
MC[RSPPCO-;^UU,]V\R"%^TE!LY.G$G418;R?,K\I]\IX>>1#H9=L.KJ3] 'O
MQI,@ON#/YY<T8Q-A["H2O[ZD0P:05ME)]Z: IZ:-:9!1=&(I1ZB^3DEM-)^&
MXKT!9(CR1N)S)<I/F5P, -SWX(2WANW]Y7\:8QG]9!^ASJ*JM.EE KTQG/.^
M_@-@2?\ #TK&\6Y":0;*WJ\9YA8K7_/=RE3XR\);%9/RP?]33OKAQOY4_CAO
M8[)T]2X'U/XEF&M;=N*'$K$2%SCY1IM%3<X7+_BK6'ABW\2/Y!TE"M+"?.1X
M\@7J>"\W&UTI] ,1T$U@GQHA%CEX?F,5D1X'/"&/#$_.#2D$GP!Z -LW[T'>
M;+N6O\/+5E^OAT\(K%)ZPD^E!N5UR[CSGDXG?<JV]R&@5 >HE2%@5JJC$XBO
MJ!SN8NP2@0B6NKX+^!*J;P*7-A[J9V#6SF(/!0%,0VE<O=:B*$J;;)@\0HRB
ME^NO<Q#QI8H*P*@C9),\7I]=E9:6<B2/@3F\GWUO?SVM'?F:FHR(8T\N26R<
M%H]+6NIT/4R1)BAX.32.O<XZ,719]D?5Z7PB60,FU;#):5^(S+R\O"[VYV(+
M2S@!.JT+N'6MB94XS.CIA+2+/:_"^MV(??Y6K_W9J6Z <47:]&'G1_HW,E\Y
M,('PU%'^\79+U#557Y;OSX3*4K-7C.</)A]Q&R=?)%.)D$8/$$8F?*;RG&&N
M1OX!8D- ATV[!>BM=E]4Z90#9KW 8W)QJP8W[=EG;\Q/[YEZ%!O)9O@::B2&
MS1L^4@KYP91BH*K,<406!AO@8I5%':EQWT-XVBX)%D6#"0X;WI';D.?93<ZD
M)A%I!_W&W#\+P\0@W*FZ0XL7!&YU)]JW.C\I]USOB^7IX@-8L-(6Y!M2G!VQ
M$3X/M^WO;I,X)O+0U3!O0*FE$+I6HH-NWXS7PWYV$61[>:;N)+QOR&'=?(\K
MR_8@5IB5\Q] V4%X%YZ=N/9*=8]2$?CLB_TZ/=LR#]O^5V8TP*KSCUM%[Q(D
M">OR_L:MI__G4</_?\%)KKK-Y@_P6R#TPV?TU1%5Z4T,C_I\\SQ\]:5"]@8N
M[FTFP[OG;PDVP""N*KPKI#3*_W*<R*] [D&-I:6%G&>W,WW=H$#Q,SOUR1%;
MT_ ND+>'J,@^?X_/7X;T!R!KJ%06EPUEW-+?]F=R=4[U8>0<T*1?"C%ZT34
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M0Z+T(;R/;?#41,RX(',L?C&_.&>D8C7GP;A J\_9F^@'K2N>&$IB(/+$/ 4
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M)R?YMJ296.*O9.X.W1&<"$94ZWDV?\&!7-C? WBONUC+!,\[==)SN9#.F_.
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MIWX_.P0<'8__Q\7SSYZBH2F++>O-,UE$KXDR>F8X4I=-")R4U+MR3DV^D%Z
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MKTD@97AX25!DI+?ZD.U%1PVT('^J(Z!$B*_8IP":U%[0HKEJ2Y7^2XBF>X<
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MCR,EC"4M,94U<C'1<#>G\BQKJCCGP@3L^/Y9X'WJRU*^*6^O3G"Y5N-+8M1
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MJZB>.!RLF VY;,4W[EYJNO5XV]9KEUBH:\8G74]G6"Q/R" <-'X6V\"0+5P
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M)_ DRI:\$-C[>DL%;_L"%(91;=PGJDB(8;]SKQ\M+$%U&$G4(_R0\V3X(:Z
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MWF$-TCZ$>[1H@:/#?S6:-;H1%>:8=_#6[9Q#G"[[]H,[I84(6SZA*[4",AY
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MU"/XVM1-'2SG8%[)-H@&)AFI648B> !^F!'.-3RBX+7<?(YUC^2Y*)FGTZT
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M@0C[$K";U4/%AL_NKAL8A.Y+_@\9JNN5GQ+<7??8MA;\]/*M!,^2 _M;XN7
MEMH48^/#<L"Y9<U+FE/QHNG0IZBIVTN=E(R]R.)L43'_@V_N4-16#6\O5NY<
M$E>RN<5T:2E1_*AP)J8IAYPQ#UK%G!3$EMNW(_#+JT8.Y(XD?NZWK[<:T43^
M?ERZS>'0@[O0BT-$OPDV_5N[!,P=/0#C3P5,2X\XC&F*59='7TLVB""EB M\
MBW2$+<Y6T'OUB'B/)U<ZORP'TN1 /?JQ9$.EGV.IKW--R.5%_FGR9S[JC<?E
M6NV"L0LB1+ME=Q6Y^;2:+5\?PT2>YMP*7LY*.N\\G=:LJN-+^@+7F'5N@EHE
MRX'NA4[95FFU$P7O;[JT]1@K5P^]N&S2C?.5&3,F:L+ 0:#;XIKFFA.WCHC/
MJ97)U"4A!'Z<$]B5!JMB*]CB'8@02OEG7U) #N_E2\DZ[)O7R;XZIOX$#@)!
MF/"SDTQYG:T?$'Z&[!Q4,V7Q6G4/KB/I6D?\_CMK8A_(IJ<]EDA32V0L1N-'
MAO^;J=N[#V/-$K?"0;6!#83TF?A2>$[8 G((8BH;)IT2VW7BDA=GQUBHDH!;
M\%9IQZOM_>F0!H_/K6;4X.1OS_J=(#DXTG2O;%9LSG1>EGSZQ"4F6N%/R#;6
ML\:<"OK$UA.>7"LH;,Q;^\Z+F5:^IL. R4&EFRUO(2VI$O/4:_P8@]JL\%NR
MOO#^^L]T81@Y.0D0T;KS'<+6/3':8\Y&1UZ:B2'<T7J$F?0YVK9^>!6RMR96
M2 Y"+S;^1OB K>>.YKEIGT%3K0ZEO'B:M*^HR3U7_VE( :=YU&42\[AY]BY\
M$&G((O5+/)^?7 G"@42!,W*@33N\KEI_S-LF;+YZL/SH9^N!4\XMUAOY&R_R
M9<_5)U[>P9HP&%1%:#I]I\PR&I[A,S#)JTT6R'0GRJM<1<C./I,#2:3;/.4G
M7.N-S'1_S[&"CYYCUE:D\S[BZS.CEQ2D_'1-=639_!6%A%_PO'<YH*?<[&EP
ME]8!133].11MK,7<3#OXO87[ELP>49,8,?:B JGMTEI<A1G[F#!TB0V9I/G)
M@61)*/B=OO,64941\>6ND_#%OFB/EUH@CJ.4GL, =^,VG(7.*IRQ#V2A_EGP
MC);)7K0R$L W8I++"/>L0;5^"\_;"L9J]9['BJUB/8\L#@1&J+7C6]YFO!8'
M?2+L+,;Q3DCPO0NQZQCV@2K?.1^?\;FDS?<H>)7*ZR&%<D"6=T1LSK6\G <K
M'K/]<4!PDPK>)42W6!"U%@1*L#_-U[XR8(;=;&!]5IEZ*W])Z1R-+"2.!LM.
M^__]W2A#E#GE?Z)S?;]&0NGH&&QP227CO0#Q?:&1^.N7*Q&)+5FL W9[7'_Y
M<4#,4".S7&QNOF>#PA>-0WSU+G29[938]C87I4SU3:*_@:\M$#+0P>!8:=7S
M.Q9\-:XKS-.I82<\\6]<_'*1J91:31:31:Q0F#\QR;_A6!B&7J7K,F.]/,7.
M3#7&X]3?5]'B+1,A\<U11-D22CUA^\F%'0(/,<5D5;8T-.]T3)$$2O]6GPYJ
MXU ?!T-U!$IPJ>H"=90\V.(6( >>EPR"%[<QUK5'\3A4Z8D$!7R;AODX^)S?
M<&&XH2L,L.Z9ED3PM<_Q3C<]6V<G#1"$,16TEW)@TOSU-'BWW11$-<RR)OE"
MXV,2PU.F,P?1B'L40.)[8B,JYW=QW[Z%-TE49)W*#_)O@ETSCR4=PBH$;T9B
MYY*EK5&H)R1VD0]F0 0+G_#^@<X#S.55JP^W!D@+=,)$-0.IP,5$T8(B)!\'
M_(KN*#0<ULOU%)]NP>VYPEG3:!F/ <V_L7Z2?@S7$9=WOF8M</<$>"I$=!$\
M8ZZ@VXC66Z$^@AR<"=MF7:6/#.;XSN*>ZPA1)Y"=XM7!KU>AA1OA:J*G5P_7
M-PP71.W W/' ;4Z)<,-,I*[OL+K+6[F]5'T&UX)\- 5.U1(^"-_EJST31Y",
M/$=VX<ID^R1^0S:_^CQ^2COM8B-5@)HPEW2JL<FW]VJM%\>A:C71B1(>5?T!
M=VP6"GV,26CV&FGSD_'7+FOJ0$#5B^4\#**"&^#/'#M4+_HX95";=+6LL?F^
M/IPX(\F0 Z]&9MO(.G;3_3OL8CZ1PS*_O013:QA/)C80^:,INDC3&/QH5-.(
MT+E EE_.LQ ;^^B434;\7,GM9N^,6[;G*W6UPN/+ORJDI&ZG^.%RS&%G&26H
MM;Q#+^W71OMXCQ;!Q1_/6H(,,#N2K$+7%;D>&%<M,R#O?D<,;FB%I8*D=V+$
MJ]]'92>_1"V<"N=$)UKY1D'R@W-BC)6C6DO!]*7E.R_*7M6)@J=,*JB?:C+5
M7^",>L1RX'ZQ%'.K]EB2^O<L_^+#)!=QK^28'#".EQ%Q ;(!K44MDPS53L(]
M=K!W]('S-ZX)& 52=\CBZ!?+<,R.G&!X\*;$7^ZI>X0=-AP41"%?D 90HLJ5
M?F8YY6#<CYTAMUC8PN7:V"Z2<0//*P5NGMCEHM[,&<.0&/17VW&/,>IF:BF"
M:OW*2%F.+B=M$+1:-]J3!!9)F:C]SA%[-(V+YS#M<+B0)EV?EER;/GVVN_ 7
M(F55K= W<_4*$565+C+:=7>&I9IQA[$T&(JBP5:#Q2>C_/MNT<!T+$/M\)6Q
M%K()FX%<\$*)?;_;.&N^\'CM-M9V1*W^8XZ>_Y=FZ:ASUDBKYCOPP1;GR?CK
M]S@H?%0?P[RUFP<2JW]>^-(A4#.AK/F*C/)>"7A[R;5N,WE"=#LWO7"_*".\
MV(E(0]5'?NU;ZL%/>,W(,JLF0BQ+R\H#P6.U;%I",TI'O"KL;I<#^WSCEML\
MM?KJ0=QB*3-S$L7T43LW_^_.HY:4D<=?_>2PC-.6! Q%:<?_.11@I5B</ #2
MC.6ZVQR/6VM(A"Q"->2 XUO(A -6J-$"DN(D27?-5LF[PDB_OEV&XPX7B"LE
MZEW0@Z=X(P\BOH4EL#)>5 NS6&L+1M/*3U@\B[O<:)6;[D2T\ I8")U.+"^$
M/LIEE>1/D6+R;XHIS,!E4'5O[I$A5I/S2'$_Z*'8@<8L?P#:IYO>T0PE(H?C
MH;5#7"JMI^E-TPW90KO)"NY^E/]F;@>UQ">\(&1T_:$<B*&CTEK[!7 ^;+6P
MOE)DY18*CI95ZLS&Y4$+MA8X-#09GIOKOO&FO9LZF"48O2LS,\_'%K:P33EK
MX7(@7:8<T%D^KT'%%HU3_8S[B,C1\[B_9#^^[\*8RLS4X]76Y Y]Z"^CVXQ
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MQ50R_F6+5N'KR,@*F)0M_)SE0)E+ O,ND7]NV9A8XHLL$)\Q8+;B'9,GGC5
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MLH?GJ.N0T(S-P;NM/?W//"+J[-QS;(UI<?_YM:H"^T9[  "NF5;33Q1K(C^
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M[QQ8_UO9X&8NR[T^L@F\:LZK10DB$\GVX]0/!(9_>Z<,/5R&>T7;?+77"DR
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M8G<Q'24N&XI_4C $:L0B#.>G;C)0P[8%D_A @;= 7#^(2K6O2.QB2U.,AE]
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MM[IB+V0V;A $XP<,;VZPUF:[>&//7)R%J:)VDCM"YJ3 15*P^+(XFX]N/B8
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MVC^PT(NW:NE+L=:4#!+%/I2%ET(\$[/'\C#3$[U' &LE@?JE@"PT5Q.*NI/
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M/_8!>3I#EICY>:S1VQ#;HE!+\]F4CPY>(NPDFLR'M86;W,;MG5V:41W*<11
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MIHX>ZKSB-U^J&?G02B^JG6D]85Z'@P;[P.)J9PP+T.]V5:$9FX<M<1"A-CN
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M/HX;%^6]?#\68;=J?RL_UO22RZ@4W8#D8,W!PH)8CWZ.'@[#4XH-A@-CHJ$
MEF>'7W@/?KN@X% /54@K\XK.6^YPJ6RULUBT%@[VUWFE*7:U>.J-.")^2O%2
M76.CMYN8^\VK<5>#)$-*6M;>SSLNN9=\16K<3K:P'7M(5'E^F01\%"DT.+G(
M+)JH!]R3NWP7\V)A[&GUR@&#<V>EO\[;G0/$WH;^7SO2/L[>Q:F]/HJMCZH1
M.)Z=.7GM D!5U)!1HL]I;F5'V9B!2G)2GI^8#*<VN[O8XUP]Q5\G@+U>(TM
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MO4)\/^<=C\_<F:>)!QS!9%1!P9?:2,"*4?LL"<!0HTD R@NZQ@938PK*_J#
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MB"-R;&6!U7+]LPP>+"G!5#")K)O!G+,?+-T]3LB?WA: $!D(<'5R=4TW.C'
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M45TG\:HFN[%VUET((W3<S@F'A4_FS76.0W>.NK6_JT%4R:3K!S_M6&[2'U7
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M=BPC>1[UE>&>.;9LCO!]J]M*ZA?G-KS][L<R>+NWJU:1^BP3:KN[-]O4\JM
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M'PQ25W%E=#+8 [>Y3_2L(_M7K9D6OP(:Q"'"3@'I_?[+/;^B)VZ94_LMK"A
M^)A+[(SE@(!(<6Z8.;$W_^'A-F3--]2=B:C4RNJ; 16\^I-B5,G_'K:BUVS5
MW1L)6>T>1]4D?1YG:!(*'UJ-I*I+5 <^I Y8DX?K=&#IP]*W=>?L/0KS3 ?H
MO73%AWCI=*CV.! T ?LM&<C6#<1&_;MM%<AJ+71[W-@Q\*.57935R_XS>8E#
M$TFWV_1&KE[&UL%>KB'M@,B_0[4CTN_>!@AMJT!_7'YQZY?OU;(<Y/VT5"_J
MZET<:I-V2)Q0:Q:_JVE,Q1PE[7\U2%%1CJ)@O 9T9SL8Z[\#YMH'"7/$\@ZJ
M2?9S)44:Y?F40(Y=;,QVJ5H&1,ST!?+LJJPZA%?.),@3GK+&VJ^_'^+6C;.:
MT"BLHRW79J= _STAXF_WU[5CK72P,W*#&GU=QQW*6[F#+M9H+93 #KHM*HYT
M3?SWLO!7P8G[_O0SPO2T:<>UE2,\'ITIQ196^\X?B7D6M8<HRO69L9_V"442
M(^JPU-8DZ,GDGX&53,Q=X>](^,9B::&>KQ#/>: K1_A!D6>8C7.MM,9)+M40
MI)JJFV%8C8&M0KYTAH*+WI']I\5O:88G$49J:1;P5]:3&)=^3OGNEW>-J0L>
M24%JJK03AEJJ5W3%I)O+S]YEIVJTO'K/J7XJS]T=S+"_P[(C6W4T_V5GRH\<
MTB'[QL_-.^21/+]"]8D#L3/++R7GDNW9,GKCE>F]@ETB7K%XU8]U!2A!?K?K
M56RUR=>/D<?:!M>R??,9I1)\6R:T&\.O.XYR9OIT%N4=O=!OE1=D;V]XW4/V
M-*O9ON<LX=N/:D_@WWF,"0:<^)6WL?/+B*WK$+*?2E9T:\;\E$\%#9V\4KC_
MR(: C4P]ZRLQKJG@J40%NIG;E-!_60+Y.[ QH3NR47>\&CH10PZ3)1&9,>MM
MG>RH]T J3=>#\;V+^/'LJ. !=H:K.E.B28<#%'Y%-/*G89DF%U<\.O.1?HPI
MX9?,9E"40V<Q<4Y#46JGPOF38U_Y&"=^^&BGY)]LG]_5FR&2*,:=<%'DEEOX
MQS$N/K;8%K:^ 'G\OVQ*S/JQN,^(:@49S]P9O76QHW'7!77&;WKI4D6]<A"^
M<F_)BO\_2CHQEC-*9\"5?9#DA'7*,QZ6N4>=P696>ZEI8/QL_ZMC+!1!7DO=
M!PUHT+&<^%7][7'#7WG/\74SI,:DSXHP?D+)W41F9OWQ/?<VO:RX6U=8:9@;
M@T433W*(/L+K^KR[76>>DQ,TIO]DT)&O0=Q,A+%5R("Y,=QC+DJ,ZMV_0.;T
M'M$,0W(N%1&<JI%ILRNV*ZI/M1O8OHJ,AP>(7TMBH&K^4I=((_F.+_1_! U_
M(8O!P4?NY!YQT1CZ*(]1]WQ[2FEV4.-80?#DB\P4,>EDQ3U4#5.Q-8#=UN_P
M;;F8,LI_2B0_Y'S60QWKFJ64[?/!)P[V/QAA*XQ=&VG]L!FZ+L5<@[1]YJQG
MNVY<_+197 , Y@THOO(A'%5K '?KG_.<O?( &RI+ B@X@M/G[G4E0B+-\IXT
M*<,_/9ZPJ/.X6;]'K(_YI"*NJ_-53N-UIR,KCR8].U]3-'4)"?O3!$#^HYAI
M*)VY3Z24.-?8E8FE5Q8Z@: N#0],U"I\^E8P0/^*'@#[!_">6.$?G(Q[VW#=
M'BCO%%H]H/QX[]F.PY/" 3KS-+3.=L9='O1H)O-9;P=D=LS9TH;@;RD7CX@?
M.4ZC+P1! HY_P^:A(+8N8>@RJV5MRNB,PYJ> )'W3("=Z5&1U>>C>0)F\*$L
M/AM>[2*.3]\)%ZQL3N5TV'R*:;)X5)6[W^/TC#K/00"@ MPIG_WU76G*U#1[
MU<77JGEY8[U?)>+8W@8U)(ZISAWKKW*B#6D_MWV-@JIV'<684WNHYY1A@3!K
M].9DP702@X_J 1]&M86C2RMP#YD$B_P'? 54BS9<GVMEE_3:W>T'9:L:4C4_
MTL2([&.LLHB,TU*4?,73]S9 5LZ*6\XS$PX7J:D9F!P=M96F+Z+PI J03@)4
M)2_\7!%]?6IBDRER42^WZ9UP!16[6I( \YBI\1 [=/F)Y73"DZ2-9ZO,Z(D'
MSC5A!T1%W0Y,B9:Y/S6@ 3/&BSIOQL%:N^/8-=-G\^H!U1^9!J1.!WWS6K1+
M*;C?ZBOEDC0XK*-R/*;RIEX,C:B+JX[R\X)O.K/VJ6\#CLOY,<P4W(OOYHST
M\O/ZU!@7=; R7(Q."1YAW_K7]R!/J#?R2IRH/1C0T\2,="N&!UOS"QFT88^>
MT],:(@B;]8[M$XKGNF8*N0!P_?AA1RN0 C3/6',[J&W"!NSV6UO5V:\K"GMV
MGG&YP7?%0_B]\/;=#RJJ27IO+ :KNTF G<]CAD9)#8YO(4NR?/CJE6D 8))T
M#07J6M9\RB1TNXLZRGO7/_B.J@0*=!^D"F>K!9"_OFE>M,!;=<DVWOQ!MU)T
MF4+UBX2S&B7>C+W;'_=1J ,W$M_%MK2J\TU&?A=N6SPR'H/3?9/VN:OKT)B1
M=*U+U-GM.KIDT;;4UEQ>I 01,ZFGX^C?-:GCYLC16WS,5$#C/1UM$D>))G#E
MMAH_0JM#*G.B(V)L2,;+_*SZW3OXHCMKAI\- ,J"Z9\_<5.=VY)YM%3;([WA
M_;[REA-;#HX*@LS%H5O?3TVEB2(=6M6Y3B3R',"]NW?<6BY_?557%5D4SBPR
MWC16\F%[*5*O8XYQ/['9LJ3C9A?/]V-G!]D^)]LQS*M_7J89];XQ/ED@EL1@
MNB;^TCKD4FD'SWC_D3#'A^P:@2N%!_BB,9$7[I\4S'\/+D)20:F[W^V3_O;A
MQ9?#_JINX3;+2 E <N_TO;3JB'2X75#*&7OZ?G',V*R1Q4ENE=B.$6^ZP;<!
MTLP/(]?C7Q4TY6M-6_.>XED5HWI-<(EB4O5I*1<H%I#P<\ :1W%@VH;.GF+5
M'C28"H^.<8F="Z!V KW[TE>M3?N1@_RC8_)[A8,F+?*#I6YBAG1D"Q<&@_>\
MB@)HW]2/%G_Y&:\L)SG>.03KZ8^'LV;8A5C-<^GJ7W!=8]+^IJ5UP7E?C9.A
M.M_@U(-K19W'%I/+$KBD$@Z7%NS-$)%!Q._!%$V[=/=E#$TK</H+Y74^?)/G
M$'O'6>50Y=02BUL5:^"K_;3G;TPY@FG3D:N39U%(;'T/[>%H.VV7': K)30U
M%Q[@@NNJ^?D3 :;>3<%N'^V>*43;.5":Q<Q0/%+B)&YQ<Q^\P3#%+5^D";@5
MHX-ITGU4*^W8^H\.%O=;O14L2 C5X1)=1#P/7ZVSNYOVO<C)T7TJ#WV@Q50,
MX] W<#:PCF)+*$J1>Z8;)=]BJ,[EG1AXXLW=5>WW9<4#%O06N:PTJP8'A/80
MVE?1*MAU9)Y!*+L[%0A&/WYG19*MVGQ/\7*N$5I:TTDJX9K,OOW&$/>L^B;F
M@^Y-S%<MW UH#J1\WUK*%"P.N>1C'WVGZY-298:(5H6*0(C0P>W$/('D[Q\<
M[ZQM2S+J9""/+/M&BMPP.S?F.#\2M;=)B:VKF$>,2FE;Q^I"5QM]0W@80X-<
M@!CEM:+/0EF#]R/M6G_^VHND:+622M]D8KZMK\/;8SQ&F =!1GSS5^ AJB[=
M:1JGNMX&R&2N682]SQ"Q.OVEX\[&GB(6RKU7'U++A@LHKP0:+>&E-WBH4Z-M
M/^C8,BC[M@DQ3@5V6J3MP8!7GYN^G<3 J%_UR<X^]>OA-_GK%2^>77+,>&)&
MM]]@FZVE<X%>.T2]U2'WZSV;4.K/1X#FD].*5(E!N;?_K_\ Z7_V8";U_C=0
M2P,$%     @ HH2:6!7TY\@$,   TC@   T   !I;6%G95\P,S(N:G!GK7L'
M5!3+TO\@ HI(4**$!4$DB$B4Z)K(*DF"2U@%):V ),DLX1)<,@@H DL.DI4E
M!\D(*I*C(#GGM,"R^Q],U_ON?>]]WW?^R^ES:GJJJZM^U=-5U3,0^@E? 6IE
M>25Y@(B("+@/_@&$(> &<(R4E(R4Y!@9&=GQX\?(*6A/4IPX0<%TZC05+>L9
M"!OK&186=JZ+Y]G/7N!D8>&YS'OADI"HJ"CDO*2LA+#,11%1X4,A1,>.'Z<X
M0<%X\B2C, <+A_#_^D=X!] <([I(U$Q,=!8X0D-$3$-$:  @ $!$0O3M!_SX
M$1TA/DI"2G;L./D)D %##1PA(B8^<I28A.3H4?"N.W@?.$I#<HI#Z!KI:?4'
M9&=M:(6]PI..<5XOK*73Z%CE$C&R]3Y.3L_ R'3F'/=Y'EX^43'QRQ*24C=N
MRLDK*"HI:][5TM;1O0<S?OC(Q-3,W,+.WN&IHY.SB\\?OG[^ <]0$9'/HZ)C
M7KR,34Y)34O/R,QZ_>9M$::XI+2LO*Z^H;&IN>5]:V=7=T]O7__ X-CXQ.34
M],SLW/S:^L;FUO8.=G?OT"XB@)CHY^\?[:(![3IR]"CQ4;)#NXB..!XRT!PE
MX1 B/75-G>R!S>FSPE[':*^')Q76'N<4T5BE,[+M(*?G$AT[MW9HVC?+_F>&
M>?^?+/MEV)]V#0(4Q$2@\XAI "BPL\>3[$G^[]JMSCZA"44W!;LT!<18<PCO
M=+C&O?Z@IC^"PJC<3#RE#+JM9]*<Z2.S+3P8L+X.8[V]7#T7C+L&YU4ECJPI
MDKKLN6K3=..T&'PYUD:W)WTGRX9[7RG$3"[O)[IL37O*KCAPSZ];4V-C&@NP
M-=<-BGO+SPW/<PJ)SW&1*$E7\:*I'1;:D RUZ1:PKMER:3W1@G9JYK0PMC^^
M?B;+\XF%C573(6#I%5]+\\7N5<[)S"BF#]*V>*XJT@U_)I*C5?N/35&/]K27
MO@)J<Y06(=6#B8KO[]J\FK9L9?Q@^A098)HA2C0T'>F(<7*("1'K=V,>Y^'L
M]NWY6)P<+7XYQR>L@0*M0?+8O&NAFG*M.BIC!'%J7EPJ/KOBF>?P6[X(1?8G
M$HE4L"]*I>2[O5W-.F>J%F-*/ 0C56M<XZ.+%ZQ?T#@^X9)8V<KKTBCMQ>E-
M+.0>&=6-:&U7?:/T<JF;F"OUB:U=\UE/63T/J2"-Y7R@K](\!^U7X+P7V(PT
MSV;F?_4B)OI:!;IM5VN%?!YV>^79)M;2S2'+\-9#"H%)3T]\P[BG; M+QVW-
MN*Y,(!G%\[]J>2+CLC,!EI4B7(9G2J)5YCZU"PM644]PN?:9*J& M15B\Y)+
ME>7N?;[YB155OKT+VN61=D*<-6ZF&"-6:.,I)PTH$$_ZY+U=R=+H>EMK.SS7
M=9JG=BN12F;-SP=IE^5T]]Z[]4;3)Q0Y4-_KX9&ZAA<[!8M6V%1RX;.V3OZW
M2TN$;I"?;/KR=E9>,O]^(V,B)=68MG_F; )#N. 8PEBLOHTU2W)=+8'$,27M
M/WF80R+M(T"K+@=PS!D:K%V?:'2TTYN+E?6=F%OR*X_N\70FV[FV9)AV:%&6
M/7^NSCL=F$?,F'.1:R"3<:DWKYY-V2/V"-6LQGM=9WMQCR9NG]W;D4??*NI<
M2E4PWZM,>[JV]-%E6G:VN0IPPXY >G)DH.Y?5[ W!UU?+BOY:V@QBT?O-TRP
M>R)22PMZ<503##VYF]G!VIWK3=+.,B'W'JH'Q6WGPYNK&*\4$7TMS_?>FL8Z
M6W)TP5SWX^%+&S!*Y0P)S=T- _IG6:/IA::A?ED/57P14>R,S7:=5<:T1IXD
M:8DV<M_L^Z]-1VR\_932V)!$.HKD187QT?$RCC7E#;Q7(0$8=;BHQ%IT26RA
M.2'.*E3](U.^( 'P37,D %?["<!*.73,W(  ?!:'[B_'2%W&OV\D !SS3"EB
M4P1@M2B/ ,PR0PYV%' "_#5[I,T$P+WCD\_^>0:<?Z9)4%\,LJZK@@ D/D;N
M?(&L%N5#OS-+42T&F:ZSI<2*&,()P GEE>^*V"/KNG]RL\RR:0;![V]1=,2N
M$P L+ :Y21&*WT\%5<OXI9IL,L/V'<%=JG]4^LL/I4/LH8MQX&Q)/V;3 &<+
M_S[;-]T>?IL-/J!;,RE[-8$_P=)DUFE+%!FSV/1NV'5Y-'1*WQG[IV#5$TXH
M51JW.^93);JW7!ZH$7VRXS;/XGZD1Q20PN82_D;V#NJ:RMTGOK3J5TE^M&/R
M<O<5LH=+@L]UAHQR6-ZLDOP2.R+YT1G]#'?MO+\'NW/'.V[A_HFC$XQG(Y^*
MIBEKF2219,M>%C6IK,#31\T<$*<0@.K9OYB78.^8DT&/KYV7_$]^\#\(#\+?
MZ!:11[01@#^]&(J%Z2 W3X)HIL23;<N+[%*I_0T_52S,\4^>?\;XD ?]S2O?
M>$ Y&LF591X\7XHR:P8Z/#^0.O:EU0V-*\R5$J-2N_HG&QY8C"TM:>7=EJ/5
ME/1&\20>^;V%Q6ETP9<3;)IA0)[#B6O.V]"BQNTXT]:1RQYWT8/B:,0^;UG@
M$F-[5*45+OM#TTMS=Y=RCZ!\.SY#ICR'+$83D3ZC$NW-=WF.6J?F]AX6!O.T
M91( !.EM[<MDDC8XPYK%SV3EJC)/5XO>E*=:"']H!LA]'?@O8RZK.-"4L#ZD
M%,<[M&/+[.?L,[EZ+L;?1VD)6#)PCV$;G%8B!\NRH>0C%F'P$2YJ\VS1M3;2
M>)YA3Q[.&?4NQS3 1;',-YSKGEI*'#]Q[=[=@?'*O$]FF]PEE)VCKYSCZND*
M=KF>!U4/;]YES%?HW#J&,1 >V:;8U61_U X#)JK/AV*C]) UAOHN?5ENJ@0@
M[';^@7V^@"PB-J/!O5H)O[1AI"Y'1X9YU"\"[FCT!H>PB5)TR-&2QGN'F"5'
M>;<5J,?RI)\!UYERW9M%CKS(,33N.0)<WVHK!PEE;PW.UPON\C) MRFA>Y>T
MP["A$(DNBG9+VM,HDH=.Z>9+.*&LVY9H27:C%PMQ.DJKD]%X]LYE!TG[66M.
MU]+JS?OK_*I/-L4F2L*N(58)0&W?=I+<OJ%>26S*3/B+^*\)&3)KAOZ(K.+R
MOEBW09,4LU=/G3N;U"[OIWN*C5>5))@GAVB9>H[+D2VC73(>C0OPJU=&=';N
M\9K>\D8Y3^3)(CYM"C"-^S=+:44--=2Y/Q/M?!B4_Q2'D'+.T]19O4EC)I Q
M?,.>,^(QT;1;C?BQ_587,%U(U>C2V?@HY7D&T53-%8K-XR  ^2*X1E?>!4.Q
M-7Z\0@!RX0,!$%+7')-ER3^8/\\O1ZLCM >8'")WF,U\YDE&'6DK4#,#23?H
MVAK#_L1NW^?MT;4EAOV479UV:@+0W !?"9V!W]0#R4KX<NB4GD;_[BT",.[_
MP;6E,,GT_FNI"(NJIA1S\S/O;>QH%4<=XCU)RY#/7(SFV4Z7&=O)<+-(T%RY
M;"MQI<<_NXGA;N=R1N>G7+)MH\P2#<8ZFS9+V:H%XVG56PKW:(4O/9+QIH)Y
MRU[O1,24A$QSQT*KO?QTYOE]L-:RC>WU9<91^'9.V;IW3.OJ1!-DI61BS:TE
M:H)^.99%[]FK$-%^[LKB9$OD'AND$#>VZFZBI0*XGOXSBLLT+9P2MCF4H[FJ
M+(%G2368%%LXJYSU8V\E0*)UK:S.UM\H5C?QM:&>7YIO3GOJ0=>7NV7&-LA_
MS_(AACR=28%#]0LT()$RY.?#&3O/JISPAU&\'& K3@ HBYA5HA*^6*7P<SSG
MB2]>EKW#I^M&G%2;S;SE9S1B4TI=E&-TRE2Z;O.C@Z@:F70F5E"Q>\*^+,2X
MW!IJV_K.?XL,H]N!$S%..E=W#U-[^H  B&O,K'ZT5+_*LC3C(QKX18KY/$JQ
MDT&0N9E#1UOVSHK'5N$C8])XXY-I;Q[[T0T&SO+U<,Q=92%KP(M6P'<6VBKZ
M<MSDWY97=K'3?Y9IA'.QO\^_C*_O<34O@>PT/E 7W[S2S)U[1P*AK"3]<E.+
M "P*Z.&]P'NU*?LGM,$08-E\L(JXHNT*U4W#M:WPJ.L0@ *,]1[I,'*4-/1/
MYBC_7EZD\'XK[;\183;U8 L%_U"][DN'_*T77]=3,\ML0P#<SDCJNAO%; A6
M)LG!?^N%_IHL1!OR?U A#;05E&7W;0;X_;U&P6FX<QPB%6M* ,ZQS>!K1_<E
M<FH6975 =NA.;6Z-_U-'<?BIO%/3(XJZ<P-$32(;J-+S=JT?%S2C63/?BPS(
MB>M&F U>5FNII\A(HAV[D^<S'J+1]\[%$H,[S90WY=U[0P"3$V'"HQ\7D<*&
MQW0O74D'EX:1W%BP.*^8SOJ7&@RS>^O;AZ>#;.;N%M40S^U9'E0-#1L:5"4_
M?\L@O$(_[RHXUH3(3/:DIM#HD ,N5SGU-:!WV7X]R?GL6!]3.^>)S.A!LI?@
M[LK^29).I(=U]_%S&Z''$_OH7+JD ]]LR*[?7]')\]!V[^LUAQ95;UQ!U8 <
MR,_B$WBL*/*!Q>CFR5(PBIZ\J W-T< _VGG.DTT ^F$E!\16T!4?A6WZ7#"J
M#87N?^UHK5^@K7GI/D7.1P!^Z_Y3FFW!=X"O_SY%S9^R^!F^NTC(QN;;UM)!
M_W-K\6E,FJ]VN]=E)?'$8VPKWZFXI22 ^AJY,+^%>5K6!M.4XB>U*<=ADZ2,
MH?FG&C #;NQ#1C!*-/7@F-(6!!YO! :DEH2V*GAK^)ONW)%"S<[FJL8+):Y^
M>FG1FTM2W8CQ30HFDKY^63]D2U-E53L\=1YN61)B.Z_;$*%XCV/8]BEQ9[DR
M#['PQ(V"<M?BA%/3\T*T9>>C6*M>"U#5/V6#*&F_?RC 2ZH0U?;6./'](K\1
M"@!WRK^W=*6S3<++M*YQ=^&($@* #@!S@:2KB^\#R'*YA^TS\3W6!$!V @2[
M$6(!WD]8 W,MH[![$49!=Y%_=H1BP,VUW0D<6WA+$FYT2QT5N@0^,1LCT/U%
M]>ULY.X*Y&";AU*G/Y+6*&5?JP:W ^89M.ZO1_&NA\D-BCAJFZN1\=_,YCGE
M_DQ(G@_ZYQP*@Z G9RJ1._V)_XO9\H:1;4XU*X57;:L;7FS3-1<0@, RR(&W
M*CXH[^W2$^0WV4GZ >%<V!(F!6W( %E2.ZXH\4+?C2+6.7,2@2._5]'4FV(M
MB:" >.B!3S/^#_Y<L9;C-%>X/QCT*&P[3<8AZ8 2J34E5(#^T,2!&W+G<]HO
M/<CX_[VI7NN@:BETD%_VI?PR3(TEOY";IU'AEWV_"5Q40@FI'_Q"\\J?LHE:
M]T\9/:>,8O@3L2]ZH;O6D(/-0X 24%Y6#YX.ON4\W7_FA1J_GHW9OZP/7F%9
MA#^Z"19?-&H9HSR4\BK_+?]+(+QLJ()Q+C9$E64>7M-]ME,D96C8/7[2&0@O
M>*(KF 8X%ID4N"F-$R?-T7QI)D-?6$]52U]*?&L/KL.$*U<J?*URK'(X;VN/
MF(VQWZ*X67KNSJ*K&ADREC^RT\W00;%H4T^CA(%R@?U+U-6JVP[*ME+3GA(U
MSQZW)29IL^_Z)#7;&-Z>5@(MA./WQ!8@IZ&3 'KK,U)J'3:3^:7][?L'3 \P
M!@K.;Y#MX+9;'<SV&+W1 WHVY7;RVXIE5X]/D-;J2>F/D7B7FH--LXV'(/;Y
M(&IG+&GS]OW?^J_GEU'^V2DS )T!]Y91^5=R#.[U _6[.L/^_R0YL'IL<0R7
MO7RC\N> 4''5W7D"L-.1WB$W^F3["5YKAV/DYP"%5^=Q6\C]V2ZSY)525PDD
MWW[8RD_^E!^JF1>I.P[+QD&CW%L<?[!W?#/[X>'<XBA']\;%)'#*Z[L1R':%
MPSY[Y$FF5^.R3?="1">Z9_ P'5$P:CP"H\99,&J *T->.ZS"-/Q5'4V]>(1L
M$3F,Y&YWOLZ=KCQ!)J9>VHM:4G&4/9_=E!"<O3%B,]D3 A8=HO&JZI@2 VFM
M4EUC+]MS/AY/HV6IB$5[UXJS[*R1N0-Z-PZ",SX81;'@M]6.#;?U$\4"F\JW
M0F%9)'OZ<X4C#<=#%/_(GK_&U&@3.)Y//?@QW=""OKBP?_[R69+BH[MKI!(:
M[NZSQ#4?Z68</41[]52[Q?:979]V+'*;Q?)2G@OCK;^T*+F5M]ZZ))B36!ZZ
M?,NK[\H?:D<S)/.9L6'WW*PI.Q7V(,8AXU7/M_+/8",) &<#=&L:^2(S:S7!
M3S>R47Y&</H]"!@+\MWOOBK+VT>[+F81@']&7:-B&6I*-06W9?TV&%QDHK\\
M+HZZ^/]AC>#  3GHG8[4C7.@C#?(PY'2U>/;=PD Z.R15;<(--T E= GW57=
M/9W2?.7545)DRY Q?@VOM:S\A-]%#P))D).OO*M5='V2<K,L[[+VFDD6988[
MZ<O4P #1V8:84^\O?AQ@&JS&OG[C-*I6Y;,$N_/<L)?Y;GG\M'N9-M-@I4,3
M0K-.NA(%JW_5$/T9:[ U':+*\6#C*8O5)O%&C@K\S$C=LICEI:'=XEP'"YIZ
M:W7<^<_K/,0E'^F:S!.$2\LQ+ZTLJ0VRY:92-4BU3]G/=%,F5QQKHV7VHY1,
M) /K&:(IV)?B['R#P=J+SYRM<V##^.5UD4!WK^H=0P_#+W:*##H]8FFO##]C
M3/Q.Q!?HZ2U1TY$]@\05KAAFHX2NLD"#DZI[1;F]1 .?)7EOBPB4AYUQ\M>H
M"5W/62''>ESN=GBI=R.V2ZXL6'S0P%-%4>J-MQ+K0J>-/ _Q!P<!?AV?VR'3
MG:W++<I3#_U5FU^24](*%LJ@L_(6Z@F U1FZL&Z[[5K&4\OSJC55%D:>EWB(
MGV%?$@#VHP0@SV>W+Z(OUPVL#L*.(/NNX1;>(V+39P8GT<OMW>!^^&FFXGXR
MBJ=4%Z0OLO^BZ,&($.BI+D>K#^;7R5\/Z[88W/- ]#X9Y(!"1P*1@C6!CD\,
M(_LEP,+>J"BC;&+FQ,'+A$&^]#1I6+^^O@)1@N+G-PU4H^Q/^/H3^Y16FY_/
MKE_,S8'-2VU59P@L%%+#F&T%%I]]->[V&LD>'(+/XNEZ93C/^;:-&@Q+#0DW
M/P^'0"2M?%AFSHLM5"BD,;N&B5QE\7LY%JRIQ&O'5N)P"35@?%MV;8J4G(PL
MWV):[/BK!EA(H -]L*OUN,3%L%NUQQ35(&BN5?!1=2EC2E]DO<JT14LT/L+9
MP56-[^L2$,"X(EZ5K4;37-X3+6M>L0LBFA<QK$D=( "F<]K1+]_[G;ONX:E5
M53E#?*5H'K!V6<M_!E^7J24 AB95SQ,031[GD"UK5 ?.Z&D^/K?S*5$$H.KF
M5&;B5G*9ZN?#DN0"K;H< RM8#B>/_<!W!03SY+=U_P!<]_)5;8GCE=*U->OB
MN@2@$AF>;PN;32M<<U[9KZNQ[DE C&OF6, .&G-[PU^+AQZ_<49W"6(A,>-\
M7F(IR X5VJ#DZFIZ,<INS+6D:Y!+'/)0&B8^%/S&KHEJS#!>GE^S5D+E%:O)
M3)TPUD-/DFWVGO?%$)GB)[:G^V2,7J7FI>4M[#WN&[Q5?,F\]T/$[E>C>XPD
M?"FE[[@KEKL]U<@2YETH/E]#BH=G*)E$-S]6>7S5V=;#$;Y=V+66.TJ2EQE[
M10Q2M#3LAL:$F0RA)YI=YFR4_W9$2\S<('64C?T-?9<*UWUQVWA$# 'PA3\@
M %!'2)KCYGT-&U7-]&@^#,]ZG;8"$0$@KZ['(R]"E:%C.OW(]JGF.0,\3^/%
MNXB#I&=X.\_?QD)6LQ>A,\L3FWD$X$B0>JO/_HW3N)F_2?@"2C@XQY)=@#0;
M1\9]1?X4JX#C.X!^XUO)S&CQ/4@!Q7L=BL\ <['O]_>I=G&E!_S5R2$WH4LL
MJAMQ5-_Z]DL/>'ZWH5MCRL!G7P&<G/C[Y![+OT^^16N;5_NG^+]IOX>2U+F/
M[V@@ )+O"$!=/IB\H2M".[.PR/K/3J[CX7Y,#\.4TNBE]SW6J_A*=XCQ])O&
M^,09,.AIJLMK"46];HZV+9?F4%'D-8^K_>U8F5AQNG+&8'63C0,;<#_A'K6<
M<9CF/'_'0H3J+N];9!\(Y>=,E^0Q2<T848.7,3\U1RK#L5K;D(T=FST=I)>2
M9FL%*W*0$3TC ?G6O6NSIPZRUJB"2K:%=E;,\TQ=^R?H_ANT/^]GF4U^'^_Y
MS_?7Y'EMDPC -]?]@O30-9!#-_#7)(?<A8#J34M\.?^.WD4[X^2\_H<EFA;M
MII-/$2.1*/T]K7.6(1:8>6VW+D>C#J4$7C/A?WQSQ'O\2)A406N80F$BF;I2
MJ2EMT+S/A2>RMP$IE'GX-2!!55D_:-R36#^A;.*5+)4Z@C<Q:I*<F;\K=D&J
M+PAW@P"$%ZONC6-.Q_"5S4[UFQDA;%41K HX 59IO/M%*!]TS,Q\=&,..LG?
MYIS"_68[9T]U\=9E](A+#$[@Y#<6#A4"<.+&'1!6E= 6G6@/40]15WE(OY,U
MM')+$ L[XXC;T_>X'OJ+JBQ9.V31AOZK'(5?E*$>M@/;M9T#+;PT@G2>1ZX6
MB:[L;J+7:='?J5*<K_-3<V%WL^V@O[$@ZSYWU<QT(D%5U"-5!B_A&^J=#V:R
MOG?W3JS3J5Q?HZL)\.!]F3L>?M1%NZL4V:6\D=]4+N@'7U=?1BZR(#<?Z9L,
M%<Y,,SVBD&60L'*UZ,I*B76P<&M1OR6<7*#-+F)/5B66]T IFCO\9I#P:\7W
M$&4@&G5K+=9T\.R7D@_Z,XS#/$>4^4X['/E0*/J:R^KZ*6$D^0N6S\2WG4=*
MQD\@J=QNB@PK<#Z[\.2(*XUA #(7+,[S=UF_?B_.;\5'?:ID9>S-R6HS<8"
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M+-TPLJZ@!SJS/;H.;NV%/RA72;+MO-.[GQBWOA^;NT9^_]P)0U5_4A./M"0
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MG@KD:VM.*)=@=E(KS>/FD]\+)K\7SL\DK/V?4<54WL,%0(&>QVKN_6)OE^+
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MGNL4W:P[(5\$IHE+^CSE[E]T_MW?Z?R;.9+*,6_*XH:*&2CU=T->"00F%RK
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M]Q\=H (Q=J,#GV4?J*VE40[[7?VRNL$P<D09.*G"VHM^?ET ^URWB_MJ+M&
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MWB 8/1^*T U97H<S2SYG6R/YD_%WW5WT@B6?;S4<IUI\O4:2+2*Y[3[K7C[
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M"?_'EZW6RQ1>4;0_$#:,6-3K970@SYH9!2GZ_0@Z2T4UER=.O-(@P3M*53"
MQG;P6E%3OJ1S=%&C/0!;&-I$/YGG-OX<_R^\^/G6&0\837!@8'@J#0PL=Y(\
MT/Y&G__2LNQ"5^/EN3SU@J6.>%(IQ?# W1?>4+AKFX4Q@0!H@4#L6"[6,8-M
M"=W,DOY,'5^&0+6^7"PDU+8F%FD^\;Q(Y'\.VO_597GDD%]3G]@.WB_))VA4
MA%/[URYH2I>]_$QH;O,YFCJ[NTM'PGVQ9L&R^08N@#V/_[5:"4ZD>IID1M2F
M@)R-:H8[-_$X5)VY[>.-?%6.,<KA5UYK$1Q(A=\,4"44E49I<VF4%7)A 6C@
MB09 DQ[X=Z0F24)]0FE(IZ'$E(PXMIK^=7M[KQ)[>.E*Y_QA\[4<<[)M(+"3
M76C3UXD]56FC@XBX7AJX-!BQG?ZU#09)']KAI)FXSF$=+1'T>NXJVF!\OWRO
M@4ZAN*X> W>M&HT0OA5=2D)O$!2,,;R%"54C9EUR)S6:6<89H)>3('E@?L1(
M=1)I7L_ZW-#Q^L0*JENA*Q2*<+PJ6:#8%PPHCYFG.A_MFV?&Z6.(N+;APH2D
MR^Y,Y>5^^N3MU VG*68S[%0S<#"NJN$VCRYJ^+BY]$,&2TR,:L@;GMYN&2Q<
M.,  ??Y+*5/P\I?[9 8ZI4@E=7P\MG,TYY+:W$J\X&1=FMWFHTZNP4,:Z,ST
M$LN*2F+\J@DS7X'AR5N8XK)H=4HQ;C%N2E@^Z'$5K63.JK%RNA"E^XQJ;][.
MBE#)5PZMLAF;J\Z8SU6>?L/N>?Z%._5I;>!:!FA?]/5$QT3PL+$*-JI.P5[]
M6YZ>)D++[H5R\VXB H=%5D=)4%)H0X8)SHT!NORS&-&Y;\.2'96' (_D2&+8
MQ=41!&R:0I2V1<[H>N8LK26-7=6;SY//LQ?IF5L%!C#6?5>B,*\U34)&W]JP
MQF^?>:!KFL9.35XX5(G3<?-EU5IY<[AE7^DF6%]KRR\\\N3X4/ATKJM*?8K!
M@H'<31PQ+F-TV?_%K5) ,.U3J74N@NYE.+A'WP31\NT2>.'/>]X^#'_ECA*F
MM*;-[1TY0J3W^HJ>M2%[T+*6"3ABJCYS6QWCR'I<F(0\[,O_<E;>05\4L38#
M)]C@L)O4UI.+E%TVU:F&/4'[18>1H\T4QX@\?[L"O77+YB-5FS@\7RLGI:M#
MH4U/'A<ZK\8K'TL/<V?8< I19V-G@^!.22IDPEACC#7]QC'OMJ=8OBN=+A:Z
MN[6Q=U0JM421LV*$LW93YO3#;)]9I/ !P'[M\O,#)M2(HA;[4OL]@;@:V22E
MY.&#9;E_9C"]=&GYQV9'%2MIYCE<A^:=[OZJ%/2S.MZ\KX,I.3*6ED3C(?;X
M'1OAEEZ,4%\$D41.,BA!X0. 0Y0J0;ZK](BK()N"R8B6^CR/\P#2T)-ZJT-:
M2M*>4VAO$:JMM<.MP#*X=B+8M?:]U"XKY+Z: $(I/&2JA3D'V%,XO.O QVL$
MI4*D1+*8BD*/_RUYK3W)-3/OHPP3\1%*Z&EZKIH)QVSB(]/7%"][\;33[)#@
MNVG5D,*L5;:!]$!3*7P6NMH\R3D%#.\NF&67Q$<>T)!K @,LR$US&#Z]_S!B
M8-BRHE8,)ZALV>OY+#U[QA0;/SB$*+.WM\4Q^!%TH76-U$HL!1X>EF&AGF;U
M@3J(S7^4?/DD]PWSD!QBT980^H@8)J#X+XB*]I9?>=]%S>TK%IX%_0.TH !L
M;JM'=]VX= ; 4PG2M^LJF=8WWS22!OHCIA?DL=KQ<V&J1$1Z.<0NNRG6IW$3
MO5_(0;VM!A8$2,8\1OV^K/*FMG[X?$AAWHMYEU#YR9,;>JF LI%X['L$ B6.
M+$,=J]CS^@07"^U\:(M!>.C@-0JN ;VKCZH-XX9CQ$Y4H2JF45]YT9]\B;#
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M:0GT8=\*[W_$]WM G:;R4[N5/1^:97<2&+#GDT%G[>3,C8!YBS,[32_,![P
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M0OSHD\>ZY9C''N2"8=F/(4Z./Q_;*TY?+9(^\+D)*D >K;_U>Q=4GRY_7O0
M*E+]C? ?H,HAV<S22>)!U..BH^EKX6&U/#P8Z+9\F*XZQ5H8_G=&!%C=@+>W
M\K[V- WF\V'9> _1RQ5GRNTB'XWU^"E%LD"X14GK(2O1J]9^XK1M\]9:$S'9
M-XO$*35*Q,8A$*VA=UI_[]U0 *< MA"I_<-,M?U#CX P^+6T.Q=WY:X1.<;!
M[38T$:P=GM<S*1+VZ?55;8*HW\J4RR<Y92QRL;D5;?;"=!7#NO9T0K),)O'+
M!<Q#QFVS]\I/!#*R"[L'9/27F9V>3!MKF,K=(T8I*EM6$#!P8+ ?]"N0XO55
MLIX1[0[2=/3,TNY7Z+P&X;2C[>+D9,ZACFC4L'#QL:[AWG'?[0X%-)*SMYL;
MI\>&X.H=XNJ%E88NZ51L+<C):VSF*/*CG<?)J?+87)Q'IXC=%/]L%D109*Y4
ML4G'-\X_3)T@>12X$%DO(>?/+K4Q\"*Y?7]O#P;L]#R^LD]/F;-_R#CM'S5Q
MZ@UQK)K_,>8:)?[I3L=/\X%JS92O4]N#^('\0YV'L-KD] TCR0/?O>!K]$":
MPM?[(4NP$(\O?8>0#[(^-?X2__CH;[_9S2@!U0O?.=W\LDG1-?C[5.O\,F5/
M]WY-ITA'D?IF"@PX#4/_& <6_UAIK9+_D$3_0WY'FK&_9R$Y0)[B?AA2F-*D
M,#II&>2!CFQ9-@@]=UET.BQ(K_:I$J.%$^]D^6: WQS;>D14F(<<LB-?I8DK
M%/^B]W-Y<+^U=_NU7Y-.38$V\>AJFT1Y66W,<T-O9CRG+^G%BEXMU(10BYY,
M_S$/B]F4->3WF-.*\9*A=>]4T^E[BXL+\9<)H0[E[DR.\)4MS7;@2VWP]K!D
MJ^Z51S@)3)BABDN05\NBM+E4ACE:/[NOYPF6MV;U0GTR."J!RD)T$"K-)7A$
MW!7:)E,9,2196O'U$_T+2@OAY2^I)!M"V-M_VXUVN#J^HW=5MZ^PBO2)<SHG
M?$B=JE!% +%*8>Q8[7Y B;.8(R&9MSSFNMNCS07Q!\?79@9*'3 (=I_T0AIR
ME/J?,HBR@SA2L+*?E94Q32JB[JSJLO[!%-?9:<*=25U=]US23,)$J"Q'(()B
MX S$;\+"?XQ5^4".^#<!L-K3M&&V'2RU*5#&T&] ^#)4K@DOJ"P=X#9(4@1]
MV KW]?WSLT>CI>PD"HTOC+-V)B^LU\R8<Y$<F_=4/J37#?5G4E/-+?P@QO_K
MU1Q*5:F.@\=NBM:K7Y],JM.Y4/\!0PH,; T*WNY/7OH+KD,[/FP_O*O?].0)
MNY*E!@,I7)!'E$G<445"IIE$C\N90IU X,B.P4%6QSC#"5N00?BQ)G=![YHK
M#A@@B=4][_?@V<_^8X?\"+&N.C_M]#VUA77S@!(8^.S==COJL82YA J)0]:'
M60:;<JA)CU9AO?L=P:- P172XH>SE,L.&SL%.%M31ZQU 3/*@T%NW)P].@A^
M)TA@P"M^XF?8T^HJ?&]&-34_HR#E*H]?8K%C(G,DC9P^E'QO#,^;GY;J\>F&
MFW#Y=/TN>ZK 5>08-%X^,6Z> ;LYCK[\5$< ,O[H#M;'5&<1J^J?O6K"+GF#
M>5- 4G1'!$EFV;RM?^;O']*0T3Q+NR- $B@19CXQC-XKK^4!?P=UUU-(T"Q
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M4A@J917E&E@  [6"7XNXBUY.?9,8/HPF4@\,!FSDR>LA 9+PX QI"ESC@=!
MC]]T<\;P^$59(2+JG\,.!9:N+I*4Y@D2-NZ1ML=_IN/(OZACW%]C-LEMXFPA
MNR44U,Q]7JBO#P:LFV@A/<]!R/WD7?8T&)BW[/7D24'Y);!A355*V7!>CKW8
MQSSBPP@<_RN? #<(%YFNMR&>R/C5X3109Z^5)Q[V8&\(1WZ\V_;SSEZJISA\
M-YNB$.%AYG((HI**H+ZFL^:#AO )JGL2RH96TE+K7 7ES.Z+;EZ$+SEWG:9C
MV=EVJS?$(4A#6&(:K&-#NOT@Q*''3M[=2;-V$=D/-/ >P[;JEIDFS(1260M9
MM\/%#]%G1%@)Z77)B5S>N3IG&+<CITW3AWYW=9 J[8KOLC,U=$E?2' __152
M+VZP W6Z^L?N]6+O;N\\EHG13%?,'0X\@V1J\([(S4@2WE7M/^"9C-&8)@29
M6KD4RA3?5=^;3M+DOM$?W\Q+>6=X_(RDZY3K@&YE,-SP5 >G,?*^*5KB#H9D
MTS2WHJRRQ%/8&,;J)3<"O@])IKS8A_28KG!-+(VZ!BG.>X<?I2TC\9_9@J9E
MA:&,>!<<N?0AAR85_F$([@X4]G"-Z9:,<KU&<G]"*TWS2+"L!0SP07S8*$;\
M4O"T1_ H7*O)_\@>6; ]AO-+C\,DQV2IC*TYDF%[<[WQL >Z+[V ;\FSVBF*
MZ@K\S/$OUU,V4BP$E5627K[8:'[*9C[TS4^#A3<]^5&Z@QZ<J>]/:$[((0[_
M0=[ T_)Q=C$<%@T=G2$72TO]:J^9.+TJ7<X^JZ:VD!)/">V%/0GUVJ^:)J,<
MF6ZP&<@Y'*@O-UZF5"-7,PK8:%7W#')<=  .[B^YNJ(@#K!3O' 2W KVN.PN
MXHRX;:\\G=<J&%B/&3/AX&C4).NG0&5E 5UJV@4N7ET6^K4XXN! *W#&(C]K
MKHXR__@]//IE(0YS]",!H!.A._5IROZQQQ N)#>$2\PL0[1E!@-+Y-_2/2EN
M^01/.P5OUW]_UG\"X^HY05XF2#PUQ=@  9YCYV)*1#Y*O@]5NVC(QB,:<" Q
M\GMPZOH! 9^_QU;4#YW9RB;NI.GM^NA\QU&#/C1.N9 Q/L@<6+)9B8-ZB1%P
M&4*C^A8DU./AEXM3%'U)6';)^!R1K>O-@O,R2A\)T4\/6@GCD7OR\W;[_0HR
MV>\@[R7<.[%O--R5BD]>8@^7>QM5!8JUUUCMYK]Y,2W'^JE#VI+)8X5Z/./6
MH/&5BZOL^R;SR$U;#'1%AU4=H6<!<%F84(MNR83Z/7^QD.07"^D&#AGOA(W>
M?7&>"N+2C#64TC%#*;$0;8C"N&V67-8KA77Z5CE^OG2 J,USL??:%SY?7S.O
MXG-$KQH:#:_DO#A:J(#N5Y#G!^A1][]B]^N=<5I5;;5W7N,I697,]Q!:TF_J
MD7]JHXM6ZK6Q#I\KL%2 \3#Z]"MX K]>C/4,$XKDKXX*^RN#I<0 B0LGVX?O
M/WRV#NE2^3)^?&W5^+P6]#CIH<P^:\#F(L<<4T"DT+6T!43O]$ Z)TSLQ_>N
M:,@C6R#37!]I[#[3WGM,'&IURI0P66!K86L*N@"P=_\U,B3"4>Y.?FBPQ2Q?
M.'=EXE!;6^-K>,O72EWK8!K-C*[\?N[KS%>26,O'S"-E&E6QLV?>! 4"O"GL
MC)_31U=$XE[O^W=2[6=96[C $2<JP.E?.,G?E?R12G1#X@5Y,DBLVA6CM"U(
M,25QBPN%B 9-9 0?O3'A!^'XSHO$?Q 0Y>_&<;#SKWBT_8S'7ZB;L7\,J6Z_
ML%Q)40CM_E<'T/S&\3?1 P,%R+P=4Z EK5(-9 $$,A$$I-OO2^6.9C#+'Q7@
MA/^*YP\^.TO\PK8^MX_M#M\63;!C07,=?(YA&)VX"<ZB=)T<6P*OL?26B/)T
M6R--'3E/A/.DN,SY\0BC6^?Q).TMW7(Y0//QP)[ WS?E=P-(?G=^1"!@(AYP
MB::ZS2S&\^_^"_A_B.3O)<#>:NHDB=R3*[R*&4%5;";R'6V;VB"-W%.CRZ93
M;Q_K*$Q0-OU&SOLQC5'F$PD 1_'>2AXZC7083E?,>5]J%9I6PI8Q"VL<A2U6
M"29&,AX-]Z35AY2;H6I#A.#(;L#<R45;94G)7%"ALL95N%I;BJ)XS0(*]WF$
M##'15SMN@!G8I2E$'S2W+HC'+3R*V3@<Y7P_M@5+$QR,>QA5;MGYX@W NZX<
MI-G@@OPX:[R(">:$\G$2?10;95^)-ZEH#-TG;X)DH19$(:(DK+:RW2 7BYES
MFK6/:FL?N_>KAHIEG\/U38N?U+%P6.$F91"J\X16&Y:6(K](=HI9F>L5:N7J
MLUP.AO580$)K<>AD;OYATLW"GBK^&QQ5I=UB6:SV-*K ]@&:UZC--&_E.-%9
M-T*3/ ++S0FT(G@#CM[&\W;X-+]1$F$.G8\6X0E9?,^<[.O)<T/W*507=;J/
MC?SA05[@XJ/0E$+185#QBUZ_MTAIH@9(7N'-G73U__[KN8&TOF58=S<&X<8%
M^//,BK%172<&%E#>)4KB0EQ<@Q\>W6,U#Z1>><MRBG_>B7FIKJ7978)X<3\B
M]8E5OZ_E&L ;%%KPM/UDT]4V=2.>8U&IB&>W8C6HLJ9'8Y/13R"]X<]PBMH%
MS]H'Z>VBR4@?20%/OTWA%#@Y*C<T3E)7Q=N%.IOC<Z%VE%KY.&+3(R*]/:-+
M=,Q^7UM?.DEO%X=/X]K2U(<CC'L8HX--]E#FV!-Y1VIPF?IT];E^,F8\'K;D
M-X7N;9M\%%)OGD W:P<-7?_\<DT9&NUQ"4LSDGX],A7X53$" U'/EVZX*$7<
M\Z/F%31%AP9-R>H4)WJ25:B8Q;J+',-R"&;VU'.-0APTA3)M-W)%^EES7=9;
MXL.9M=]$#&>;N$^=X. V* I=K <TO)%5;WE&+-+JC4\3AFA7A!VFG>43'\LN
M^/):3WKR\-!%\CCZ4]5X9=;5OF0E']CH3\7M*)FWGF,%N+8B@Y^:=,99KD+G
M:,IZ<$R_E-HD%;)95$!"0'_K?DK]F3JL(=23"'$ 4QY?BIQ">HX"J1G'#,-K
MUPKA!EJ^4-SMR87VA^X2K2Z2BY):5LIE%*;]$!)H!XE!AV2HEC,\M/FVU1D<
M>>8,RJ#WCWO4<3:C6J\?^#/0L;;]IJP(%> ,Q6PK8S2*1RLT-2MC]"G)S/L+
MOY7AOA&DR!JJ*R($==)^3TB=WYGET9B1L#93P=/R)/U<OZ% Y9H*M>TLD+CI
MR3-+YXWO,YFYNC<@.(1._VJ%H7TN2&_M.ED@/->S&>.RZM,45E'.K.GJZ.OO
M ]2SSQR7-KG>8@QIU[TI!JXU_1Z[IYX*$;%C]6FJ.X58F'V>REP1P1<_>>$Q
MR4SG)0C]?J+G]"GW7N)X@@P(46-:LN!YH]JF^G<6<1W^L58A)2?H/I5EZRYN
M?B%>:;K/$^S(,K*Q<J6U-2>O8E^OK-=-'^ D-^H,"TY6Q9X<#+J_E6<?W@69
MR$V][S Z1?[.H/U,^67L5@^MO&!+L+>@!C";7C/W<I)ARXA9N\>$\<TWECX"
M:8H32;.D:8K^EMOV!RSHF;W.WIV[OD_6M="$[Q3]E$,0"T61:ZR:B[F)A"B\
MH<9'M)(Z8@.,ZAJL'2Y Q>UTF'K' EI(<9[[MCZOIS9WM+$3+9XFP<VFGAC-
M^84-L+P% _4NPX]S_]&VR=^*2)HO/(P1W^B(T&.JCJ6F#PO!%EU<F7\YB=\=
M^J8T#XM;*WCYK/MNX'_#&\W_=Z4^1:/<KXL$]]"5H2A.5VSLK,4>.4(:E'^"
MGEJ'19IHT8QW<-YW)G,;!ILD_W*,J+!\3Q=-?;IYZM4H;GHUFK,_ <5A+->0
MB/, X%* M9G,#\(N P/P8"!8K[@VM*<\IT"%.T/U%(\([2OL4X[*S;UM^"YN
M]*NZ3I>MST7YYD?OBP,G-6V&<AH36#7+;[O1DDHC43L7Y1ZR0FF@1[*+*(Z7
M M@UY;'NI&O&*ZK7BT?;+=$'(]@4T0O?I!_QJD(CY2+H>\-W(M-Y!-W<$KD\
MMZL>V2__E*,IY:CW+,>5AXDY3JN4Z!H)UXB(!GK6A-7ZR3Q#33PS*^,*GEYU
MF)9]AS,?&,"T/R#?69E@8.NY6T+Q,)N[CZ.4S;?UGRXC:OO4W35:S+ZWH.*!
MU96]5[)3Q2*SO%<7CES:'1Y-,[!1-:AV8Z&"1\0L1'PIYBSGLVIN;#>$LL-#
M5!EIA.AD>2OU&31 &F:L/)W1WT/R8G>&,#'9-S0-%'A(A"'9N) US7_Q=<JD
M3$/6YEDBM_"3S_;3"+KU,YA0^U&J"&LY1XP"B":Q.+TEBS+?X9(4GSRV@7H+
M11DJA4LY%;\=K]P8=KQ(<'V'AAP[NS$*LN;X=EKPL#644$*(Z]_]MD' %=4Z
M$(",FZ=$\EW)Y*6?.GCB)3(]C#[@[%F\^V# ,NCWWOWME1+T><M0ZJ[Z&DJ
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M;1!6)#?3QNYT<[N6!YC4Q_/)8IS+6SQHY^;1\<G68UQQ6Y K)<P_46QTRMD
MO/%TP4V@HYEWR+ IA*$GVK@JFFDX2<AUM'5DM#;[_8^8Q D/'U6P#[B=]<EH
M;NLO(8JR'6#<Y;>0&0-#QXE>LYZ<VX5*4QU351RO-"5"&40D_/8GAQRC[:*P
M10Y1]TGI#@$.CF--=OI%R@F&!</(EP'FY$YZ]?H?;Z<-(BU$4F4+\QJD>,?#
M$Y^^$.(QH?OLUU5;L% ?,7MEP2'P\O+%=:VG JAU@[('+>);4IWX4QL;5<)M
M3:=9WB$,9!9$H<GOBF9&IUU?G[VXGF&&2F$R1FP2=%K#O<Z&SDNO#AI"VXO1
M89Q(Y1@>,+1$3M>8R^Q^33G6O9UYBBW4O87DX-.-)/=X9;5N[.-W8TC"92;8
MRXLSWU*NNY\G5D/JQTUE?$(8%D7XY2DW*71.>K4@QE6L[MAYDLUD+YUEJ?HV
M:)&RT>A(<>8[X$.C7*H/_=@3,*+FPF%R-?R8!6W^,5-#-$?&[HOFRUE?,L,/
ML[)'SX7+GH3"/YGWA.+N!O9I"D6U0=AI3)_L%F0D%(V=L^<U7P;9XEK2]*Y(
MZ@VOL8FM;M6"L+ZA9FOSFR%WC!T,4AHLHI(H*T8([J3_V'RU=C$*M:APXIC9
M066?7Y2936OHER<,W.?KP7K:I1S21XH<%@MS.$!/3#N.OJXY8* #2HV;).%_
MZ?ZV]D01$680=IGS!NF RI.7ARZB$?0^XSM_O6/M^R2D./GRM GAMT7/A?1T
MF>P2D9=>A&4#D8F<LI/L"4VP2TMB"0G;%8C94?3ZCM%$8]^QA(#B$+EAER^L
MB3^4LKEP.3@?3,MBB)Q=,BZ%= L,;76B+PSL"5YI<AG.8WJK1LPS LRR:W1A
ME1+ZQIG?IEZKSVJUEFI%*8W5!RI_)2.E":[<)SSK .S_5WOO'1?%LZ4/-X*"
M1)&<5:+D()(9! $!"8+D**(DR3D.2%!R!@$E2DZ2<\Y9LN2<\Y!AF'G;^[V[
MJW?OW=U[[[Z__$=_>FJZIOO4J7.>\YRJZIHR=3RGY:!ZAHZ;-=\"+9XT3 A_
M#TKQ-O0W]#,4@CJO,^,_T_TAP.PLR*='/YH^%E)>$6'%EE-%'#%(OQB2H(+^
M^6M6K/5G/[;(IJ.R0&!SHQ#:=%F86NC,(SMZ\M3;LK!@6(VS^+XWX//^UK"'
M0&=.X?N_;Y#GUX,E_M"R.-?TKBG,]%O =YY>!T!^D)4)Q3IY]R:=]XR7T+C)
M87N;(!U? ,Z7E<ANCWMX]O?FL0FB;T!B*JN5J]!-A%?]?NYY([!88*PR=D)E
MHC,]G1%2_SUT<ESMB-,PI,F("5@\^M(9%6P3-6"J]VA<-Z0YP(%)=H ^@%!Z
M1;;2D#0<HAA_F_]=<I0 \!T]_85.-(*ML6QTJ:QZA-6ZI/5FUX<7\\QUO@:=
M9"'//Z9^CZ57X#.@JAM3I-81\8L.R=H\F-.7JV!Q.:&E"4_EJYRZ'<3%O_F-
M!>:ZG #L;A1R0ZD&<>!<A:'D(SNG/#/RI_G"XEM2(6+RC8_'485#;Q\WER[N
MRNF/P_FR^P4UIW4#]A9*$QYB^]C;R9#O*P<"-\6VG%"2HS\KH:M*VM1 @ZP<
M."U3_>?X+8XWC*I"EU[<+9CYZKDYXU-I0'F@.,#/>"-/PWEX[TJ_5(52SO)
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M@3(')H83B*[R58>M9*S&%70W)*"O?_5@=/@\M&__NO^RJ&\=P0CMZD>_=N5
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M F%L-AW!,93D=HB%D,8*NURG0;QGB2W,6B*!AY+0G Q KM'4V30'EXQSO)"
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MOQQ9OS-[G=R$M-)-DNQ S01T%+%N1M.OIX^R#CO'/$TN8(&-UQ_ VM^9KY
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M@PP*[0!ZC9E @\!*10)+)DC EZ 9I 7,)M!S]@]((*#P_?^K]O^J_8^MMN
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M45ESFYG+8VO+&;-.^:W.5'B/,R;W#HQC<CJFK5.XGJRL)+PY^V#04&N*F'!
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M"[B?D\K_\G'_&Q_HR,G_#U!+ P04    " "BA)I8MSB?#_$F   /,P  #0
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MUFH4T@1AVO@57#9Y);*783OV&(IZ4X$&XHJ(4ZOK2Z4;SXU3D%O;4OVH:VB
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M) "%W?B/0J3RHA"1!0L18Z0UWXM:^N73>FV4#U]UTHF<&P.256+Z'%>8!$D
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MG[GR#6N5?/1\<+'E_2>;<CR,CZBP=I=#AC'&?WHB^?];PT"/_P]02P,$%
M  @ HH2:6.[OM4F>*P  C3H   T   !I;6%G95\P,S8N:G!G[;L'4%3;UBZZ
M2 *2! %)$@0$B1(%"0TH627GI.0@(I)!:$!!R4E 4#)(!LF91LDY-2!@DR5*
MSM#A+CQ[G^W^Z]_WWO?J5MUZK\ZB)E5=:ZXYYOCF&-\W1M=JS#?,''!%14%9
M <#"P@(>@W\ 9AJX!Q!<NH1_"8\ 'Q^?D)#@,C$E"3$1$3$MQ54RRNMT3(S7
MZ1@8F-GX.)AO\+ R,'#>N<5S6T!86)B)0UQ*3%"23TA8\&(1+ )"0F(B8AH2
M$AI!%@86P?_'%Z8%("< RK#K<+!N -CD6#CD6)@V@ D L/"P?EW 'Q<6-@XN
MWB5\ L++1."$JBL -A8.#C8N#AX>+BYXUQ>\#^"2XU&P",A>NJKQ!/^&,Z5@
M0$P& :M<V1<JS>$=-B'S%X&$EZFOT=#2L=_DX+S%)2PB>D=,_.Z]^_(*BDK*
M*EK:.KIZ^@:&%I96UC:V=O8NKF[N'IY>WJ]>!P6_>1L2&AOW+CXA\7U2<F96
M=LZGW+S\@O**RJKJFMJZ^J^M;>T=G5W=/2.C\+'QB6^34_,+BTL_EE=6U]9W
M]_8/#H^.3T[/+OS" G"P_KS^6[_(0;^P<7%Q</$O_,+"]KB80(Z+QR)PB4)6
M _^)\]4;@@$$E'(Q&65?"%F%-'>HS%\,7Z9F$YYGW[UP[9=G_WN.!?Z_\NS?
MCOWEUQ1 C(,%'AX..0 !CL\X,_TO_]\87$V'/^G<LA#&M)*5'?<UA".5Q0"N
MP#Y??Q&9DRPE$W:WF[4QC^U>^@?/R HDBNTABYNM,<"1^PK#(B56J;S6J)L1
MKVF;J8':\KVZ=PF:X>&YQ$5%6+JXCP.QJ-)L%E#4J!55HZ0<VXP[6/+9D\G,
MSTW):XY[1]\?D^K!+7%>A*YD[99$<0_2\158!V@LO5Z[9BY3I*15T?-=ELL+
MI\IL1&2#Q(V/KKV$;#)[[Y/!IE5 S X]GJ6.%(&4Q-"E>$H-&;R+0=7C66$&
M/Z"=2QUW%-4WU+= #[I:N#DWRQ19L+30X(M-S;HN17:Y-5G.*GN6VV4I1VD9
M7:K>^_B=H;X=UC=;R200,%VQ==R=3EH>NBRI46IJYYWPP<;)+7=M",%3RI>1
MUS%XF7*Z6A)?MJZ&0K#UM23CMUW/5E-XEJJO( EDL_K,YBAHM)?^_:=>P4P%
M'.R,(Z%+[-6!C:*V.+#,VLI=G?'LHVON4]4Q.7;'NM0U]O5!#1)=(Q4_=!J7
M<&@TAO9FYO3L_N4'I0Z)/:^<+_7>=2[MT#.ET%;6ZJ%PSP'W:H+-O50?.L"J
M&I:#Z,]K)_EI53D^[=YWN4B15MS\]G.L;MQ%7 9R76&$RJ#>:#J<Y^;5J4<-
MF='8.&2F7B7W9$;IQK?U/X^[^O)-JU!_YN:8FEJ^LRSG07OCX21; H=DZFF_
MK:>B5GGU3DI@]_, Y"!;04K?]24669R8C\>;@RK 4,VN:9A;<<H-^J\3 3.W
MB?E8/603Y:-+.JRV"I1IQ!D8Y"3MTN/KK1L2A*MK8M=2C0QB3&G0YQT&,O&*
M#)^VLN!Z>)]D/=TV^;8XX<JB^=ZE6:<OH&VUMZ-]TRD\+>"QHC4?7E_V<HP]
M,T''SZ.D]T1C9T@$[\-UR ?C:%_?WZTS58]%B$%N294#$E(<AI7CF5X\(SLW
MYI:7>QQ\6PZXEV]L,3T8#W*98NVH'T,TI[W87],PE+F2E&QEX*%$H,>V7WE3
MP?/4DW8E(QT[E//__"A8ITL)CG,X*E8YF^J9?6XFNJP3(>A-7(8C8E_N-DG!
MR>P&&^5YUI:VNK].[A5*2N"8Y<VPR9'EV@^H^BR07'M855/?/'9P;N03\)X]
M]0<Y.\V =MRK+_BA#;@["*-V9R<>%UDN_$BE;X+U,=&R#%<4Q4LAGT,'5K[6
M2PZ6*J>;3K+WJ3\RI6#'JI;T5\D6?BKWN87A]I+S(]C$H939/-[W65[8V^7A
MJ?E-EIZ>]"4G[?,6!@;H81Y. 09X7=-J^K!M=B=Z35JGH> 1!G",>OK Q;_3
M W=3#'_H3*?_CNYH59AU[<@AD=$J52BMH[6!]FU@D4MI@&!QIHZ$R8Q."EV(
M.]4%KR2!/ Q=-:4,>1G<^^J*0$$&O8X2S7<A^)*.!O[;E9WF#RMKB1-JA<92
MRR75L>T,^5>)LYD:73M[?V0PKQ @!FQQAGA+'C=61RZ/>ZX$ZI QE(E9N4D1
ML 9R&:Z\)!+JG^N_XQL^_N0&05F/5OQU@F]] H=?%G-<M0$->4I [VKA^EE$
M5*1K@YB(1!8)8C!1I*D]L]T^YO1^ $.??V../XO.]$EY^N7-0M+]5HWUN^\\
M[M3'(X_*'B4*?!,(EXO]=+E:CI"4YMF7%T+3H+8H#/#*371<T6>B6+\SW&D[
M<>?V]_:GEVA^1KU?4*!E&32;*_#CK-O%2WS+5J_L]K91"B^P:\^NT'J:3<^%
MQ?DVGXS,1V:I'2&CH5789*S#W:!7]!&:R-. ;2:B>&-%1IT79?F#YG[6DG':
MB5_!7*D^2DR].9:C\?2S2>9;.02C1ZRAX$8#V\NBVP*17NF$(D2;C_AI;*/E
MG8&1DECUW8)G7C0LCU7=<7  M^[N30/OCKI",EK;F$F3;$,M>]XGDBJAR_/(
M-S&1"Z1#.3H*(Z0>KX9TFW/G$^%N$JJKA_TJ;5/8S*&3CCU\"B-^GN\_1MY=
M'*4BP0#^2)$\^_'DC\GR'ST2CLWL!3L=:>S2B"&>[C^"C3S,&K$V9:ZS_T&W
MM/6;DQ4CV=%06T[S*[VYTR'+81ST7QT=OVT'.1D_IA#CGC8Z?<G&ZD-_ZF@Y
MWCB<1V2 AW2^VK IK5+P.5I:&Z@E"E0OT6V2#@7F7U))C<?/GPCG'W3/+"CS
M153&*IC[9#]@DGZ^5"X<_GWEXV<VON<"2'PKWR<+!"4D$;NOUX+X--<'](,_
M,#_^.O.MKK7CD<(UC^]:C1&933(=P3KO,I.H5 H7HTD%L0[$F*)SU?%9YVNW
MG@H[ZK731<0/'@5_>K@Q622?&\G^0!XPS0F,?'\^,%8Z_\'GK2L-6^/K>QXO
M3-<]&SKVREZ\/IYN<$)>JEK](\]OQ?93<M<;4(@,"/8!_4#\T6U)G8S9DRCE
MQN'6*44'URM$P;J"LL&XT4VTP8+%\5]87T5:-.T45QW5.$%1\=GMDGKD?6=O
M8AG7U=^W("JIV()PMYS>D4>^N-,\:X,!(,^ALU_0PK[-@VB_.0P >X6T,VY6
M=H<Z]]_+<4B<J@INRIM:PP!V-9'+G$79;%[D/3W:V_2=R53N93CXSL!BL809
M[NR:IJIHO+,5#D)?ZF/,Z5/65X(2'<,!<([DWLI%9GYNDZCIGQA@98OL_ 32
M$54SB0$&OS,=[T CKI'^LF0O3=58N^.!O*$;9]B>2R_VL[TU6)#-/L-H:;5/
M9F[I<>H;AD/GCK+[,:4(^<M"JUQ,ORWQD"&$"S]B#'Y@)7[I_4=#!&EF*"<;
M9V:CB_'NHSK'TO7;]_(?Q"BZW+@1_AAHP](0S]ORF/LLU*'<0<+M(169&3M#
MF!-L\"1B*2"LK2_]_;=\3>TC,7-!"0J)B;<8X.N3!;*SRX.G43M9Z*MD5Z!#
MNM ^:)#-9@R(2.$A!DCQXZ@;-J7% (1OWD)6N2'+D*]1)P\D93& K $&$$!3
M^E@RK:.@*V8A6ZYZ$;8S7!//1/JE:=UNI8KS62AJA5_1Q[ZK5SX>G9S0F131
M,HC/3ENY_8TS,[3"'_P'_&^/(H21V6BEL"(L5EL!+TS1B2V#TLV&,]<\?*\_
M8%NGRHS:[BX7+;_A<9=^XW+M*[7:U"MI,X(*X5D!J958-?*:M6-%FZXY\!PO
MO HNP<V@R6EW;'__9SS*.,^$-@U:.[RO&F9ON E5] R%658FE7CDX;UKN=J'
MBTW8LT/#^%K]TB'5&^>%S9M3 _35YR\3]CHL*60_?>^A)'X%L[1Y@LM0^#B<
M(71T='NSRN3N#+J_+V&"/,3<74&N1T&V%5!<X,3N_R.[&9XE+81ME-)41U =
MQ17*L20H3WT5O6?>TW)#!6T1S*-*_$2MZY&$;MH;-U]5#;A;[T,5>OWLT:VL
M(.K)I.#Q8'%Q:QSGWIB/_(_B\9&LWO'C#58%ZX8YV2-K"V9EJ-2VKR\V*D^S
MNZ8G:"3T'K/A?#//]N8/.7B+E/5U\GT"S;.W8N1<K!#=H)RFN+)46?I.1[W=
M.>Y5Y%=_WO7]D^1!S0HCU4WVS:UM:LI 54*<@B<IW=$/ ^58R?=>/!<P.$J]
M0_<F9*:;G_?GICG,%V(Y+J3TC/W!$F$KCT89\SSI,C,.4D9/9NK^OF?HA'9M
MTSY+5;5M1C6Y([8NJVOV2EPE'@Z#59UX4=2)G)"?XE$44B7RDXA3^5O\I*.4
M>0PPOD)_)V+:?:7ZI[,,8:YGKCI<T@HONBJ8]\;R^++2=?CI"(UEA&3?"A9]
MGQC- *6HWU/2^CH??AQ]NV;VSV-%6Z7Q/)M6-49VI38I?B_>=YP2J&.3U]"(
MXQ>$KG,"8+X F07K'OQ6.:8F"I2-5R1#Z3.XLL/1.LN0G4J1M-.#SQB@F0D#
MA.:]@WM(?*[S?:GY(CLAU5W*/#UT8(:^;BLKY/Y^$$4W(O!5I>\EM>OB''6E
M?!@@**,(3-*<-Z@=#(#48?K[4OE'91*0S[LIB3/>[51+&.#O=[/0U,$5&$ Z
M@>FX%0/L:OOHOSEB%"H_']3/K(W"/^E5WR4MY<V!4P]W1--BA>@S!&M\3S/<
M7%]D9W?UJOTH\D!$S4;K>68H5Z2+A,Z$*^+*?3?Z&/P/*6FLHL[A!_AP70\D
MAQ\=!DA_#_*=('17I!^I<UZO-NZ$BFV<^9RB>,UB;8=6GEB!4<0:@3CW.)"J
M0%^%D4"''D!GDR GR9!YB9T)%&XGZC0. X247LW,FE;:1+>T0H5A9'O_J[E1
MCLQ_3I4.J:D-W9KB?DO_4C/=]2EY/"OSON:XS1O(DL$(;&.$'P7HIK@61T7F
M4]'V<&=!/X!=4Q)^V)VHETHT49M8$VA/10S0-@QRSW$(=)49LMT&13YT<3R.
M&H^M]?KQ'<6QKN]T>LQ4=YT?R3'##GKK#WI+#L(I#/WJNV!V1D!VO@N"?=5X
MC-*EM]97%=1BZ<5CUARP-CMO@QU<83I>@*!O5C=R+*!<M'>E4E)^S,42WMDR
MNW7I>;@BLTT>58N>XASD]+HP!CBWPP"94P6"\>.YHOSX;R(9'65-.(;=I4I"
M.4M:]W=*^!<\D&&WH1-3&&"5S"3'&7H5MF3P"MT\@0%DO$/3B"3V9H][_&#+
M7KR4&L:*JQGRE.I8IJ-S3*<4/_W*H:L=I=2E=CMDR!!WB 'DP$(7[L?:,H@!
M$(DGB4L#":"-K(7 QJMMT#TA>]CA,3\ZV&%FXXLDB ZK:"$&,'L!6K7^7%PN
M'?<&%@:1/TUZIR'OPO284D,>L%UEVA-8@QX>7T,'<\\ZM%22G=(<P,[.PS#
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MGCGRQ;Z$SJY&A?$6E7?YJ0^!<PO11.BW.)T=1$V;JNT3V$@FG+VZ-G)!.%F
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M@8^#:).5-MYGVO<U])17^C?\Q=EP!HT0)U#Y47[74S<'B0^W#AP<'DJ%]V
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M5L=C?Q V19L^Y<H04EI%?GK[5RKZJ[MC$-@A_],Q6])<O[ K^7E1: ]60S"
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M$:12^VL2,#""QG$4^!5 UV&$R*&"O8!/).!%<FU9,^XB+U%LCVWNMKX&2UM
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M80'@UHV*B/AHE-,I'O5&V2<1?DZR'UYO2WW(=(KJ6SL1,<\:DDXF615TZ"[
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M(VMU-D/>(76VL["_6O3ZS=4=G Y4SKP1"Z^=";J68/N,"1F9[W<"! 2Z,D#
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M5;)J):S8TKWPJ>5E!)3'A<B=_V@?V3$H%61LSXR#2H@]BD,U8TGS1ILZ>UE
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M$1<Y+/D2OY5[,^6%/_TWH/]+P@1^_ ]02P,$%     @ HH2:6+C)#=XD&P
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MXC?T@G)&RYQ7/#H9N(3D)X17OJ7V>V;_76+!_ZO,_DCLS[P& 288!50\&!N
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MAMMK]GP.+2^+XE3,(X=],?D&N=!K.VX@@#$G7J_PT"O=BY(W=5MDE-HAEH,
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M=Q5DR&'IN7C:_O'6=+3GV ^KRB1SG0H'@9GL)M*NO&=3!<9A$C\SM!=3$DF
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MHW./>IJ8Z_V$PWX*=WOH%6&N7\;,3.ZU.]5&0=(3"0'7YT#V>H/9MYQU).W
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MUU?[* -^30?*K!NE[>^HS(:SIE1T!!DK-IO;[YGUV-W^FE5[U,:OOC_JG.;
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MU&HA0PZP9KL:JK)96ZLY.'.6X?3@;"(Z4VIW\A0!$]P/CS3 @?\!4$L#!!0
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M9IU0L+A#?Z#><H;SZ]/"G% 5BF"59L:F&XZ+-]8\8JS9DDN9'YIUG/NL^R!
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MCBS%?2]9*$&JC<O12.,!#Z^@#?#\)3+&87M@$9\%9X%L@7,:*1A5KPOA%+7
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M/4$5[&C*COX![LUW/__%/U\2<F(-/O7G_FK2OYA&7S,H9,6%Z8=X*$]4O_0
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MXI+@YA,4$A459;TF)2LI+",@(BK\XR$8^ 0$Q$3$="0D=,*7F2X+_],'^C-
MC@^X8#9B85P!,,DQL,@QT"T *P!@X&#\[0!^/S PL;!Q</'P"0B)0(=R,@ 3
M PL+$QL+!P<;&[SK#]X'L,EQ*"X+*>!2:MW#N^)*)1P0FXG/?O-C([7VX!:'
MB(5;( $A#2T=/0/GU6M<W#RB8N(2DE(W%&\I09555-5T=._JP?0-#"WO/["R
MMK&U<W_H\<C3R]OGZ;.@X)#GH6%Q\0DO$I.24U*SLM_DO,U]E_>^I+2LO**R
MJKJFJ;FEM:V]H[-K:'AD= SQ91PY-[^P^'5I>65U;7MG=V__X/#H^.0'+@P
M"^/G\9_B(@=Q86)C8V'C_<"%@>GYPX$<&^>R$"Z%@A;>/5?**\(!^%0W8S,_
M-A*PBVAO45NX#1+2<(C.<6[_@/8W9/\]8('_(V1_!_8'+B1 C(4!DH=%#D"
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M!\&WXL3I85!LUDPJX#]DJ_VIB?L\U>#W@O1IV\(W-0'/ IJOW,C';9]R3M/
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M@FB'G\/H1TLT<)G(^62MH0<V,+K;&WWVC+]A_3T:$#)3A"FQY'9ND[9J+I^
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MRA)+84L3![]4+<PJ)V,,OR5/=2V![''I(TRR4'ME?*T*.- _>N,:GFY@6<T
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M^$@,/U(J&2GN;K0.Q&I8W5MDNT[G#7)S\G9J59RB>UQ%ET58GZLMY_X2T6*
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MS\3OJ"O!)R($'4CIDP40'KY)18#AY/ ,FGM?NI)6PB*?H6_,FK/"P.T;IBB
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M)7FT@4526U:&N%[(C0TRW-0OP)]<>7J.,-FBK$_>V_TJVCYH'4H@%ED(0Y=
MQ/@B3K@K@I$#>*+8P"SU^Q0\1C/;X+2J,.2$AKOM'MS<(:?]]EBQ$ R!.'X[
M>0*L]1RC:&=&#$H%UZW"M09^W:,GJ&T+AL_,Q%/,OK]26X;5*W>GL$EPMGF5
MK/!PR(N.820 '+"R[1_ )"?74Z'RO8@1;R!U[;^B2'W9V//M1+@H?Z[:)O"0
M7IU A-.UQR[BVH^5NJ4^2@OELJU2]B&QB:0G-78CY G(3;Q[ HY1)R4<*%:V
M0K3'=3/K^::7#&)ES*5%WZSG6["<]V6@'XI(#IAAAIXN#LV=U@[D!0@>;*7X
M:N2TU+RGB]?_9A9!8B;4!VB?TT\W'W7K6>9YK[' 8MBYENC9U"7PCM-8$D+,
M8V"R;"P9$0?2OQWWYLAFL?1^YJZ=YDXLV:^QL]?;W87,J!E\MV\U^$Q)P3[?
M'#'X\W;K"X8"G_8*WM )G/E22;-)&6F4@ZSHZN=#DUK#B5%2*;A-693VO>GZ
M)AO*$TT?E5M&/2EPEG&/Z>>@0G@OW#@3@+J>GPC.>=@UUG;FD>XGCUU13@0K
M=P2WS15&W<:=*V=B.VSE?M1W"J]0X,+.;E!_DLW.%74;'>7E2J!HBN:4AG*4
M:NAL:9Z[G:OHJM2\/C=*73ED9$O$>W1%>_OWA\(P/._Q..(^@\(QOZF=!DUB
M*(38<ZG4:[[>M\_1/2L75NAPG2$BU2ID@"FRJ67C=N6)JU+$A.'C>&$.FXO.
MWZUL&I%]AFIM;&/8Y1HT:341ZH\+TB;C[9DM>#\ >1[^VJ\^SDFN@QJVE#]O
MU,+&M>D OWRP^9DC)_L<L Z;+C6L(@U(UGH4V-JK0_#J*(,PQ7$0\GL5-&OJ
M(N?W^^$4 <+3.,# QRQ'41J0=K9S]"2(<X73D$W9CX9%?4#C71T8/Z0-W9PF
MRM*(DZ=&1?A)G!8*O-=GDC^(A^CKFK_CJ*4/QR/<>3?^B;F$I?8A;9JP%H9@
M,)SUIS>EV0SL:<%V!J+V^-QSZY@EVHAD9_% F+D1Y[VDI% &4!2N"R=73_%8
M:I]<OT:XN8^3$OW<BI"8*T7?QLP&!1/I>I14_];"Y%?59W+G+:(OC'3W[6-D
MX82*&5%@9^A)-]/MS*S,"?7T.@ _A],LI!2?U6(U<3QCI?(8AM68@;FL\)A/
M8R^05=3A^8N0B&6;3!D/:9-AB>@;\J!6Z EYB3%F9K86X4#4>NE&[RM2Y]!X
M12&;4NHT?2\CZ\?U\,#*!PPU#35QM-.)H3->UGO[Q4CGG:3/;TNP=TKCI_'J
MWX1\DX%-+]C3&!/'2U"N5*QRJ_78<Y&G>X/]<:N,?YC:II;%_3*WLI:/"&&$
M@_4^\B/_L%YF()6=HE6$F:]7(E9=X5<X^!$7A+(686G"N!RL_.A ;2<!2C>X
M1_JSO+'_<9M?JTF1)"%R_,0^QX;SI)-=FZ6N -EGC3IM[JI(:\C6N9>NI:B?
M#J4S,S],)*BZZ>3B=&WTIRJ"3.UQD<P@ZILLPT^2X84G[>>DZ"+YH4LH?C?L
MO>0^^ZI<-SI1N_@G<]="NI'&59W,K=@8,/J]&\5[=5N61 )N0O#^-%=K-9-N
MN+&O*FL44UDA^PO%E\<H8$:FVI=F&X(.M#V<"U8D4B:K@8+RU2VBOPJ2>J;5
M&SJ\M"IB8R=]8FSUDX7L9KL\M8]' @]1&.&!VU\S8=>7)V75(B^R*]^/R-GS
MU-.$SAZ&^3DU<DB]BZ/!^4GNY%U:IE$3TG^.-UZR$F+S-H]O$/G9HOVEQTTZ
MF7C"8,<%/9D2X .$\CBM<J,36)L(P$[L*/'6[A?G(GZRPL94=>F\;FU&]R\:
MJG[@Y+XF0^G'BY^/( ?\BL LLW@&'^U[/==?]+N[VKCZ?V<R2%64^5GVYO,\
MG;S9D R2Q*$<X1/@31PH0NS/V[/[AJ<[KGH\$/!^KFTBFJUA53VAM,XUZFAW
MF>=4(?^<]=($Z4?LB+BZUSY&SAO#;2.RJ6:!#9O/)FENY/ZIPXVY^]]1*XO0
ME4ELZ)?3:H9*%KN/.N\H<!4K>,@TM"J:8,1^::?Q3[/[?*'^=1O3VP+X_/ZB
M-*;!'&3I&8'VSQ',#;_93GO1N0(XM>(2AHB7X3!5[_IA^?].#;RVJK<!,Y=E
M%?H/>0)GS3G+Z09KW)D]/PU:^FH"E=?L!JA)OOG@3)X7X:K"/@]A('BK1F/7
MBYB!#L"> P%X>DK42HEQ.1,EI/D_XH.5X5U[R;/3>TJA:\)BXJV59.QK?;G@
MH6 C6LJZJP8R_UTP'?5S^0VZ\V=JM>'Y(N(BC1@#Z?_R6H;B'?4K3N'TN>GD
M9:'Y/H-:G_6UE&G9L)+':0@NB8D]).E$., 47)!0N&YU5FK7BW]JLSGD%<!#
M3J5HHVU]?OV>;S;2KU=SA \>HD%_1"Y8 _CPQ1)\J_2VV62,TX9P@GK$15,P
M!K)B1J;MP%6#]B@=3X!P(LAX,,?)$Z*WV_C50X\W/<=05S&S@]352*Y="H<K
MV$WUHW,O_T(J@FC">0GU(Q.:A %D@43?E\;&@:6YGS#80<J!1+['AQC8,ZFH
MKIU;U^O ;Y>\<0Z&8- 3[J0@OVUT_WKR;;.J+H9S4[(,^XONQ5NLF:7F512/
ML&Y!K:[:XY+LI(/C.P.L@T1:>/'HOKE-OILF=TWRBP 4MCK;6P-]%OT'>MVW
MAA*;9??^Z&'1HZW6L*U8,CF($1+2D&R,1OY?/N@(&Z]X:S=?F/*>$&[0] 7#
MDZ9E1]Z4L4T^;YH0I=D3[$GYM#R7Y!^SH)\!*;/M4:,;FRV=<A*;[?6I^J6;
MU5Q[/%6:A<HY%X7139OTZEU<SN+=..B08. 67C07RF3(P'3_:WO[[^]TUS]E
M(2/=,_K\XKXC@>X(/T&2=>D2:5/T+.)'SYT9WVT:^/\@?+9S=*L#_O?]%UPM
M6:$N63=(TW35*R-F&8@HC=3\TDGZ*Z,W5Z7$*#.0,F9@6C53T=J $5=U+"A8
M&%,D4E!3,7NG +:]T;^PD^K9&F:^-G6NC$ 1-/-[E%=YQ=!5!_82?WW)$<X8
M_1[81UP-\Q<=&#:T+Z%\9WP$]8]D[]VP;F8@HU2.S?3=?1B*;EU$226>8>?/
M7Z[:PM_NCX0&5?@<AN]D#EJ<TQ6@M1..5SM^7)X&O[SK-*6OGU#]"5 7O,AW
MX"[2#ZZ4(I0KH<.1Q09PG.!8901A7#@BQ8NJ_Y??PH+3P:^]BO;689<6]A[I
M5V4?+47C7>H9GW@4*3'Y&-'6%,Y&1$_J&WLS>:X*Y]R!JWNZ^O+' 8DFNHAH
MRJ2&S30? 8KPM/;I4'U7%'85JMMZ^%02 XS8<[(FO^R>@VN(Z*5K>JGWL+1H
MJH5;: *^QVEA3+L\=CE<2FS?KM)K:'6)'(=@OM0^H63 /!#GS,JX14U[$6-S
MJ:&?TUSK<00'=N']K%#VTPRF&)I$Z,;/[S[CRQ?;6[B!M-+P3(%MT/.2L7\N
M:_#3W/\&4$L#!!0    ( **$FEA0C^:;L18# %AW P -    :6UA9V5?,#0U
M+FIP9^R\!S1<_?LONG41O?<1)'KT*,$0T8,@T5N4((+HW2C1RRA!(F$(@@@2
M-8G>@XCHT7MO,\(8C)D[^97WE_?\WWO./?>LL^Y9=[UC#7O/_C[/]^G/Y]E[
M#>P/[") K:VNI0[@X>$!#K@? #L#J/XZ^U]Z_6+RO\H##]L&T)#B%Q%R$.!Q
M _@T> 0T>-@N  0 >$3_7 #\ZX6'3T!(1$Q">HGL,FY!'36 CT= @$](0$1$
M2(B[&HJ[#A#2$-%>$5<AIC-X0,+M22\1D59 RG/K0SN#X3"<5]+.*_(2&2,3
M,POKU6M\_ *"4M(W9&3EY%5OJZEK:&II&]V[;VQB:F9N[^#XT,G9Y9&WCZ^?
M?T!@4-33Z)C8N/B$](QGF5G9SU_DO"XL*GY34EKVMKJFMJZ^X>.GSQV=7=T]
MO5_Z^D=&Q\8G)G],32\MKZRNK6]L;FTC#G\>'2-/4*=GO_3" PC^4/TO]:+!
MZ85/2$A 2/)++SQ\_U\+: B)KH@3TZH8D#SPI..6B""EOY56\*']$H^D(9S!
MSFN8C)%7:NDJXI=J_]#L_YEBD?^O-/M#L?_H-0V0$^#AG$=  X !#(;_=0+P
M/_ON^/C)M&ND86HJJLEB_7-W_O1@M-"WJ6?DLE.]=R9?H1*7>SL/"-RB>L+
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MF1J161?OL8 +C"B$"H$%=D57(%$Y)/$GTI.)OC\\EAO>W[YU_J5Q]'$$8=7
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M2Z55SJ?:+EGT0#/((+50H_#UD^6KL5USH(X;0<3-^2B3[B"9Q'V^X1"=)2Q
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M*!\3<A9A\TT#K;BSLG#!VIL,QC4H>"D,0W:.@+-33=GW-(,;<2/-E#,2CG%
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M<ED+%8>UX8!89$M(&#'.$N2%*\ZK3M1]Y.?(KMMF#]D*C?G\]+^63GU3YHI
M0<[MPX9AM&#GUA29>5X$Q602AM-ZVM1\:AK%<=RLHU<G+IYIONS Z.'>%:F_
M/U>=D)\ZU7&VREV;.3TRW>LFVGK\,-2$-)3E8V.BI*4Z\;O#YZ%ZT 9WV:_T
M,]6)+E7N%0X3S3[5GYU.H$L'])LM/#7!S9QG,T8-Z<3.HC[G7ZJN?#19,W-,
M,"%Y0QST,R5S=/J NL Q4VMCW>[2"5@1(KD OW40/W]M7%0! C\P0=RH6%9D
MZSB3=17:&9B[M<W_YMS;#1JZUT0C*5BC1G?+E)"0LQ \RE$3^?3]BA\]71)
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ME;*^]_DT&)G_4 LLGM7UH'G2'_?0]YY783@IIIJ5J[]MA<]O-(5)KH?D#M0
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MB58Y;A9NUCG5T"D#AT"5!Y_%F94]6=^&$W^7(R'X)%TD"P3=4Y=088L%[^+
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MV!M3ZG][DB__>E6>)Z3K6!#8#LB/^R:1S9V^7K=[Y#=3D2Q,!?F*!9*9.;'
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MFY2Y\(H)C4+WY3?&4H(LN5'T=_WQ6\6_;!,!SK]M,"X>E*2116O9,_)8Z^[
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MHJ=AQ>A28EM?5+A,H<SU_J*D<)GK$^R(5YQJ_PJ+D;%+L@_2\8$9K8<V39K
M$^W5C!YF3,B]*<["G_1 [;^^-J+<ZJ5?"-D=IX/-?5E!,43,90Z='I<]HTXG
M9T_]P2PG-X>1UMY=YTNV((K]B@?\S/O40T4BMW%48=]49\-D %Y1.UJW.3-
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MJ,J'0\J5AC^-IHMBPRTS5EK=I&'&7U]4-,L4I&%-D?3'S7LKXQ#WH1C8^:T
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M!T"./+!?!QA5K,;*1.12<.+G)Y5:V<O_'>S,S=@[ :=XW5Y;ER$DO_+0$JZ
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M'Q,@=SLE?J;XZN?<2P9"?!S5IZW1+.#$,(HT)Q_M.U/Z<&)W .65/I3JL$+
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MS"$=M'B=>><F)RX  J%OD^]@5[5D%.V='\<RN.RS(71S2&(>[EPCBMMO/NS
M@-B^!<:D#WM#8PDG(+D<^M,HNU##F"HL[B<G'D;E:R38DI_&E\T_TQ2(.-74
MR:SYC4Z"E%CR7_B224CA3+JP0_.[+^E7!N][-<G6T?7]A9!%]L,!CR-SJLXH
M31XI1'F:3MQF>.8K4(6-$^K]8VTB^<C1]4)SZ]W7UYWAEIR24O0+"M-B+K>;
MY'N^#VET6G3*:#]R:W0(6*>OZ;JE\5)*/I]W*5SPVM,+R>_H(M9\WYA4R/4L
MZ)(/PNKL-WUPP?45V7FVG=(_-_>HY)ZS==Q]OTWO7;;](+&4L%S[:A660KMZ
M&E <,+;_@<*12S;:EQKC6>F!!DE9(2TH9R/[ 1_C$<]EKF?I:5K]TH.?.VJF
MRY:Z""Y2;GRM5LO).?.+W_:NBD(^DL[WW'N=PTW;J=M_#>^9N0LUDWJ7.76_
M&8RFAAR7MK.CAF;$)NM)BP*KPEY=<\V=17U^HLW98Z!OP[,S)0M#:5I1YS2D
M*+ P;)U,ET\BAFRUS35'?0*$Y"\"(1THYE1'E0X?(M/,?"NT5AD:5/3)4-<D
MYYH@_(;4H<TJ- R"3U_@H]C$;.I*T<;%%29TU1$_2%:C7O6@0\./N0L.R_4,
M1Y<21OI>,-082NZ^8BGMV$);:4L2.-F1$/+O3 *, QX8_#0QO^M"=56D."O"
M60R4>L\Q<^)PZ?#OQVELVD#HWRE82\D!$M*KX18%?-%HT#<53!A\;R/\7II_
MW.UZGJ6LE47V\:_CTO6G\RG4&M1W&-D8FZP+!L;()"($EQG*>G<,24<RU[)'
MI&YOJO/P9<RL9B@IT.VR?MF!*@QYHPN4XH*-<,SM0HBU;D(!E1L8W.Y6'T'H
MLMORK@ZOOYF]%J=P$RI*CO<R-+C&+:]TGMGP?E+[RE)BU(VNBYZ/PD"#=(.&
MS)();L/.2;+$Z<#B)^J/SD%D&9**QG?'=!CO!)0=VKI7AMK1VDDK2'V*9 S2
M8%#VMU"%R/31C:]CJ8G&/4=WC;_+:)A3KT%#KX\>8G\[X]TVRHF0&7J23_<_
M[= CN748G7>[$&Q]00YX2])QTV^HJZ5LQZTDL2OV0IGJXTIR%B8/?Y,L38C\
M(_)L+,4WZ+,H-F%8;\PTQA)8/I)%7@-LRH ^PD%O99SN10HZ$B7]AU(VH_:*
ML"@&/PRM*"A:*]A<SAC=/;KMN. @B_QFUO0$ET'+3YWD":L.O'*70Z5CL\GE
M55*3SG/C3<L^'\'OL73:+LURW*OA1\9].LQ]C?[(2(A;_ZS'#-QUJF#O[]=_
M'S^=#J[%#NPO$J%O8Y-@KCQD0[GM=.X$]%J-N,;-<(ZUS6(^(/.;]'LVBOUT
M:#-\.47-Z_93P748&VT$0H:BXX732LB':.99^ F(IRQCX-Y(VO5Q_A%=D<7U
M%[^&W(ARB((GWHEU@;MIS9&W2YJ^<5["YL9ZC2O^D[26ZTJ-&6QITA*LY1NB
M.&_[:Q3;W&V0E^XTD=1].L'R]9=?.(C>Q_7;4=&KA#@6[5*\4?A><C2$#:E!
M4 A>T_KI9UJ?)+?*X_S\>=^%=.^'HOY@$L93C'$XL&]U=O7!-Q#/.0[F;_B<
MJ\K!68%#=R<>!W-^HMW_GQ7<_]]&@#5=BJW[HA7WL_P?L=!T\QK'"E05%/14
MRFN$'#_4Y8(\O;]))VL_HONCL6EWX[_/275T!LZ1'VJ^?.V5HM\N7E+\D41=
M$22M/SSLF4AZ[Q8:4MS6&NQ5GXAKE+!YN+SCK"]''6IDK1?=Z?#7.>M_!Y2J
MS19*P^@Y%"7Z?ZA?Y/3(4,69Z+07Y<-^S=T:N*BB[^LAY27<>J?&<*C%/>6A
MUU#%9?I=U!"-Q8-\WFD,*4/D9';4+T.8.5&R<NC'D1[[ZY?KQ,Y;U$]L^<>7
MZMS:,DE.V]^=%<R7XGH=D<4^L9^=W)O\>J8Q>B^9?P9I#KQ$?T(@VR;SONB1
M%%3K=&0Y,S+W/)8QWVH=9],/PJCX5UG"- <:%ZH_^&XN>;?C5$F3R:JT[%,.
M['[@D;$=[V^L*M?TT/T:,'M_O&+)8_7S2VYO^:[J:UO/P4N6S^5^;\^$[(=0
M^KH=0_8SAY&2_'EXSNG4 9);N+85!=E3S&YFG$Q(BB?*5M0')DW=G_0?XGG&
M./#>SBR4X^&"Y<^=#_MQ(-H 4H"B3YCJ41!3'8I>N$'&)M197&\877=BIXAA
M8OX>A<3$O7SS7>==C9?[P&>^SIE+2Z ^+2N/0Q9'F'U[;:'(/#@0\T4U*1<4
M*F&/L\\T&"]_7=V6IU,3^\XT[,,@Y;TG9B6>QC3V&7%ND=B(&Q)&]2_(3=4K
M35N;\["*J1BI^:TZ\6?B*&U9S=E+@1FD]87+'E4[^)00O@K=/S?.?$'Z'%?Z
M<T[;D*8V_^&5P-W$V?]F7CP:;V4D@E_SVSU]&QK@49SMUC&4SU06<#9VDQ@W
MLS8Z+[7+()_:;^*P=9WNB!1"V<6G11?_6IWIZ\%$IVG6SV-G_Z[;GX!$5M,4
M0HH<!H?[GJ>-.LJ9;DI>=[]]IVR@[H9$8[L4TI(,[8)%ZTH#!<2V6Z,#G0NL
MPS[:!L7KC>K7[.WT/W=Z'[QPZ [<D7\QRWO;]1'@F0="5.+3)KL)#9E'#GJ?
M4"-VG/$55"=,M;(M #&.QJ4W'O [W6B>,LPF9,:7L@O2B\]./TJUR:[)C'V7
MDD%K:C4A-_;FZ)Q2H#,"2RC" 23*4RP1/7T"<AC!UBAN6_9?BD1>\_5Y['6<
MZ\I/D,MMC&?_2.U.7[KVB1,*G"J>LPS'[VCJ2/&Q=G5W&!\-O ICWZOD=@("
MA^PI;O'7YY5,)@(RN1@F;_W^'7@'Q^0J]:CI ;T?RY%6]ZD[/6UK5AUT=W#:
M^PKWJ;0%KXI<0K;=HM6HXD77*^(+:PL6O%]X0!QS25=5!M%1VV%@1O13GS 8
M4SN#.ZS!K1O*_1#5WWQ=5WML3XM):>^H1><\D>]WR]F%;+\7VCJ"DTJ27^L3
M>< *RJE7%1?N^<*&,51NDA'%.H(<1!+/8UEK#NH$"R#O4Q;*CS3@.1=;8C^B
M1-MSGVO?\"K?XO6099^/;4"<VL)+YZ]<E?^4ZD[? @6NV$1(4I8T TO(]D2U
M:/*L)9!<1OUOYZK9LM5X-_ROO7D9J[:1&8/WRXI>[)LIKRYQ,SR5S)HR*$%W
MWFMG B>?@,@%5(TBCW;YD>N;T+LCIUQD;U[OD7P6@/4<=C^SSO")WMZ[=-$R
MI,VP?V:!+T'[SF[OR\IOD)G&_7"RVZ9T,4(&S]A5'F)/QO;IB)#.G=87=-\_
MM<\\ODL9B(9.[CUHG=I&6O@*WTEK9$'7,50[NA:XW'RIX #NQ-(AA@C,0,D1
M"[#;M?V9-@P3.0&Y@Z-A@JWGB^$'#<)1\>K1VBK$9, TX*./:O3'M'XS>R5V
MAX[]Y*N7S/[PGO_Z"D2KVTOF :RZT\)/0#B[WQ\)(U_,W*U/0%;CN=51.VZ1
M=M<\75/HS_,++--+^PY>LU5?T"9GOVXNW]R.04*\"O\$[A\<MI'6][EF5S4?
M_(!*V445;FO^>_Z,6U^J6HC.EF=^\0:#S<HBE==C'T%1[ZN<UD5S(F X 4U8
M7"MW$&&(Z^$:Q/.5Y+BB?.;&0;/?3Z\K^7!AD]]G1I'+89V"E5U*\78RF[84
MCWT5:+PX7<LX4G$&V[-"-NK[QSX@X@*XD<W,?<XL.$J75(U7R A,3JK;5+=C
MI+\&95@_EFSF ]$J6]4I\02W)&VM+XC&+A@7$DP$L[L'-HZMV6U'M]H\?ID/
MWW81-UG!YK"^23'RX6#;:7Z?&/PVKH?<M\E(AA+/)99XT,X !>0C7$90I$+9
M[(-QI#IQ4_<$9#RVW :_6&/^9&OF14-*NFWCQW<;YAL#/6A9&,@+J<(9CM*@
MWCO^6+FG)(JD;P*N$9>FRMA.?;X3.,$.CG;#)K[%"5>\K_A>/.MP4[&AD\'K
M>C\WO6$/-)H*(D?N529#GD&B,.QNDV\)V%ZE:.%R3$2]H]Q@U"!MJ]]D6W[+
M+M#+;,,F.+*LQMRSHKBZ[<TMH\QPNN/D.=388NV#BJ3FBCQ*.L&U_2/_I^OJ
M[>)JH]C:NY7+K-V/]W.?<U7=^39]@>.URY.V(./).G/TW2K*N>A2NV>'AD4^
M?+2/NO%?#$**GMWK#W_LZQ'"VWZ_P5M0V^_<KR=:86>PR9 9]+[-<2;6%1V^
M6/L^K21_SMVKS [1^*!=_&(FCB8SW HG3J<*CBX\+-O+!EN-[C$]L98+NBB,
MZJZZ[&FSU;BA\@5I2&&DGF_LV)_Q>:V@34=" S8TN5IR<M2C<86]%?O'9W<0
MP53'[Z7?%+RV-Q/;>MK:)L9W.L]?^2YY5?ZF[M]X4F.7N94-12GZ.D8<H>Y(
M$8C:5 I0X@9\NMM5QGQ:#0I-"NU$2BYD&C6T"%@85_TO]MX[J*GO^_L-':1W
MD!(4$!0!07H+B%*E"%*D2A,"TEN0$HKT#@(?:D"DB8#T*J$7D8X@("4!07I"
M"0%"<OD\<^?.\_L]<Y]Y9NY_=[Y_G)GDS)Q9Z^R]UGN_UMEG[_/I[5\'0"R=
M3TWFNLV_^W=0;(A'ASW"=M:Z8GCI4-OOQ:3U[EL.690519"7O&L9VEJB%/<H
MTXK>HW;6]1/C6<$J[UU\OBX*4480 .PA(5AWQ%KX.YEO)?B%5=9V="M.:CCA
MC%9G=T//_<&V 9JG<;$YN3=',QNIV37]WLA23UC7J"SVGYI4=6S-30EM<2\6
M$7^3IO0TNZE7#W;AS&=R7<\0B9:+*BN^:+:KWM7[C:B?/U<F<AL.5P?V3G;N
MRDU;<$N-WVTH-B*Z9@\;@3?'AD/=0*2[-P2GPEOHNM _7R0(4]/-G[_]Z79N
M0[@F1&HYWRWQDYN:]X.+C%)A&H#=B?=!8X@=5AX4+Q[& 4_M(B, J-Y]?\O5
M)[-Z?W8R3M?!Q])ZYXE3)Y,6E>A;AP!_P2<9WK8?H*BG<)))5";&X"8VRK$!
M!,#36>:AU3OS2LK%>KZL@[._K#EOC9(-E0AV3S^LUR!YK@7@OJ.4NIV(B4"?
M79\?/$.[(6/?^]48]T&;*J+QH-WIWRY+GLO^^7ONTOZ6PDUZ9N:#%]/WFF2<
M#M^TSC*,3 DD)#CQ,= ?I)ICMU%F6O.U2OQ0M"VB.Q.IR[4G$5ABBUW3;H)_
M[4Q&B)1IVY\_0<H#*3_^_&AU!!C.C&J&HDL1Y+'(;\Q]%D<#=90[18\6#FR-
M9G$@*#*1B]8(LWB+C^W2JI5*>D3\;G32TQM<W2"Y(,-.NU\I0(+7*>*8D;8Q
M(9;!5V]V04U2%@N)9]<*5^8R2RWMP1N5&:LGVC\=/+&:IXFL$0=1EK8"Z99Q
MGU)>WFL(NX_E1=JFYAW&HCN'.I)LFP*3<&:HF9/U\:$XU.IJX2UK34M']G>3
MF.3L*)Z:KFC>:W>IG.R7O29+Q.'T>R28?NQ5,?X'E*C+#@T;O*\\$?')!N*A
MN/C6^JZ;0]6>S+N0P$9=D8%Z2[*V> O5 >\D7^L;J*-/6;L5)HSU6;-!F:5V
M,2(5@PM51/:VIW"VY6MC9<N_+46O;@),0%:PQK$E!4RS._9/%D=FQ/"6)H[5
M$[&=J*1) )#68PO7#1C,U[![ W6?<,JS9XG6HF)B0O#69G1*1)5UE_T@7UJ7
MJ6'RCX2VM\<]27C-$'*L&\*6&6<S(PZR3Z6#Y/>":$.X4,&#[V2'KD+UKVP;
M<\S09-O]VNXM8,R[0YA?3978YX6 FH>RZ<MV?/>Y/;X<$ET_7PV;)@"(I&K$
M/!EV;3E46)8@O@;M"L&V@QO)]W2?=4L&D=\7T&[)S_CAD '*/=;7(/-3B!T"
MQ5P*14VF2GMR8C4U40+WB9]MN&L.6EC#8WE_?N]BDOFTH$&)_\EES]^6 WU(
MYVT[PCY8%PFE"0.$"%UGX[FQ=;V>Q5A/I$W69TCLT!K3V22+U=[M)A"3DGHI
MM@!L\5"!IZB>Z4N-E]^BZ2M[2Y>IM&4G;@A\_QR9K&Z#)4- Z<*FEFP3/4!O
M0#% IBY9)[2F.KRM.?)P=\%7K<P-@UYT._ABX[+G[TG9UMK\H\@RJC5*%;CP
M>ZU9J-_=<AA/AY*-.G,7'^PP2V[2K6/$0@>ZF>?<N]2*UVJR?OZP2,LQ;0YB
M$FKENXA8HQ[98#V\73$H'MT-1.UA9U^AUR)/K]F^(_:A+4==FDZ>9>9Z7 *T
M8$QVSO<,2)E7TC\"B@]X]=TNTF,1L7'=@G\) %JE&X0C7=7S11CTU1A=#=NB
M4I<A&5IB! #"[N_\4DM-!:166>),7II64V-6HZI\6:70XX ,Z[+T1MQ=C'[D
MAHY6$S?R"8!;89-FJ]*SS;:Q\$90?V)JO TS]JQXQ4;O2SX\?I[]>+S"C3VE
M=4FF[O'N[9KY7&$VLJ;II#N,%!8W8V[8 _PO H XC &[@ #V$P <D#6M'$LL
M&IG,I8]]5[YUQSW$G]*QO3%[R?"YC[I<?9Z6M:3 [TY]VE!F)# 6SXIN:C':
M>\>;7DT ..*60EKG95JGGFQ1(=29M5*^KQO@^/D8DS)M?P#CH,[Y>S!: J!7
M%B\)61VSPE:50O@W B/NMMY F#VH7@DD]2[I7>A GD=JT,-1)P>R34.-ADFE
MSS*Y1>KMJ6?:B(L:YZ;6SJ83OI@+TQV2XKMV#TI>&3[,N/#N6'_PF+A-GJ2-
M]-(TQ]G9B2>Z\)/,J!MK%Y'H07(3KY5$W,;3FZKXY:]>$Z);E.O>%EO2U\MM
M7/9<B@61$A$%#IR]0K#A/\P':],GJ1BM(>U3D:)_<,H[?4K<&93#SU^'??KW
M-8^/T\M=$6TC7OU_Y(64'#=:O.37'5!?M7HW_90'7_6< M/*BDEMHOZ"LD3_
MGR50L>$&Q5* II=W-?FXQ56V<<*2<J0(R#D(H<K\XAD+X'\^7NHG?-8BY4[9
MYOY*$>G]&U,%YO#@D.=1\%_?[@X5)NZF4+D.DN:RU.1_W,CJWFTKP+I$^3H
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M<04K;C9W;&^!A2SF/#*4XWV5T<V/M;W":3/85MH<,S-AQ4E! H>OE=E)9MN
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MT$*&G\%1YPEX'HCL@ 5O=65+?15883C6+_]:Y>1E0/3JY=8\DB+!,A9R)TC
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M.VZK?O#=[P#W\L^#"[FC%*]WOK_2%*;$7M4E9BR#13HOPYPZ'@CWD'V5Z",
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M"GXVG-G+QB9N$/<WUF8'U'+&D8+1:G?BY'KX@&:EV:1?ZK\*%!D\7X_F#N#
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MF.D^.]<_-PPXKWVWO6<OZ<QXY^_ >94(4]^A=HEN).OS]$/&+"4:V#^%*R,
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M#(RKDYIDVEEZK\)NV5\G'8VT[BYJ$3Y9L5SA6.P>]?N\JU3%*4"D"2"F.+Y
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MZ@ .+8&^'BU__E!E-- ]N'(7ML1LQ7'^3+I3M5--T%(IR'D0_FNY%\0-!1,
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M@S V5=:[&.'26__FQ"""T%JS'?9/&5RY"P1>8=LFB21>RZ(_8?#*L&LK?=/
M X=U623<ZDRH(/+CC3:[T]S>-RK"V<?JME&NL\E*\NPH+:MDQ;[[$M5&5E8U
MB?I.6ZO<';3XF)Y,1,S'W"CHW4[L0&1%81..^:='Q8*^1T&!7P&+G!"?L(:
M#A])AL'Z8Q*;:**4"A?8_Z@W!]")"^^OP$D97W[Q 49QL^7V9W(GV=D5@"ME
MHGOZQ;?3S!G3^U&2KXPB6)J3M<W8AY+4R+4R[?#>-J7@F%.+*T!(W")QW!._
M [RU#16?\"$_!G*YI&%0GZ4I#5E=Z/'Q4UK1W5V\&7QUC6UODC;I^:CJ)!,?
MDE[HX+UP64A0GQ[;"2BR0W9"V<J#<;)P*'_'R]KP9L.:A3X;/%Y=,L^K*915
MK5?.B-SAFGE$M!3@XV<'!OP!;5C-[R()T=_=W+O>3<2UY9,+S#"[_I@=?ECL
MR>\:89DJ$?0F'!A\S79UTB=/KH&BDX$0B)WER%9"IJ:%>Q52TP<JGJ\XU8/?
M3JZGG4X>[AJWQ.]HO8_Z*UO3/RG=RO<<H"QX.GB9UB%"'+MVNM![>$%D?W,9
M^(C(+5>&;WS&/ENDG+@ $9JU:T[H:_!EN(XO,H1%J>N<2REX9(J2I#QC4E1Y
M)MP0&(L+Y3_XRH&NN556 F/FRG=')DRL*XI+ =6A\[<IA#^\HM(A ;K%-9Q,
M"=T[2DKPF)$)X))[EF71WADLO4BMHJ][\,I9W5RKZ"G'N =5KB=9L%E/I9ZG
M=P@UC,Z$FR[]U Z?@3H@,RP KZ*N +VTY*L$16Q_:8'B M[E%&$4TY4ILE\'
M0SXQP=7'N%;<7*U'^\TU$"$)GMC'!1;PA$L3B-I4AQ#!Y3(><UP5P0[-R@.7
M]%O?QA*_+0"C#@3\CD<H1SC>')0[3KOQ1LM-0Z+<Z=S3EE3Y)1KGAR.,2#:
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MXGRCH#3.Z7-0J49X]I[=%&^\W@^!=]$"248F5F'/^-\:W'ZJL.07>'Q$3&H
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MWXMWV>',LM:"Z?K3/M3RX%##*62DH1[E=%WSL\RQXU8G$=O@7\8-\0_-7C\
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MDRTJ!Z>_CIB]EZ+CQ]>L[3:^'L][?R$O_#E=[N1(F$Z>D[T5KNU];<GR$BL
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MWIMY[_,*F4I+_NS\M>*VI./<,'NEOOCRZAUQ011[1$K/-I['B$+WY9GM7S6
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M(DN*63#U09RDDS5> C4(@-%!K6&)_]KU;XZBW@76NY8V7_&!A[!<>=Z'#NO
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M!+)O<.$/D9QC)C&AGB/1]G\0-[?Z4U"@^L>+R/!)GJ(DKCB)NTIJ/98%)TI
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M+N15D@S_R!E>_L\W:QHLCO1"3T8&1/Y\28SAO+PO#0J]Q.('FUY7W0"<IF*
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M[."AT#@</=-O7!U0\FL8[FJQIS(6%%&N'CS;V.ZG%R#]QGBRFQ("*UACQ3[
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M0:US4O<SE^XZ27@J'_I21GBQ]#Y.XI\]I<9?(?@"3.MI*072@ -.\2Z>X7B
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MJV#<P+SYY"]WS](5NXZ?P9G7S&U;=@B/F(UK.@UKIPQY#A#QB-:+@#"A"9]
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M@5$MN-C.W,#([$--R#W3LR6S)$)P4G"F?V;P1E=A^@4[.*LM+D+TZ&JX.&'
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M>"<I)P>WW9Y!K>G-UE)N]*UL#?O2.+^=T8C)"+:WV-N%@#1YW%<%)N&*X+@
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M&']YTP5&G$#X/[4C)PY9^V0Q&2>\GATG)]DD.AJV#Y\1RK"NK\%'D=#NJYM
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M,H:SN!^1RFP<&A?M=R9(*'Q55]=6_KO2B4?L,?'W<Q>YS@Z24SEZP=P4&18
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MF<3S8YF[ECEP.F#/TG?80JUJ^-B^12IOJG3M?*6D'E4&F6V<6,YW\_>,.[+
M?>'+9UA^,XQ4N ([S@:]%:K M(1MO@:@;.Z-BCR"JGL_JO.R;D=6NA1\Z[=;
MIWU"_(PFJ&#BY_TV1#?H9U]-+E0:N[.RCFG*_+,F$MMJ@JJ;T(QY.-6/(G%,
M^O0<OQ,<%,48J>]$.%6R<]3<,J8D(NQ;>G)0/Z60LR9-+#"6?I;@%>WB^:;)
M)7>I]JK?W;3"(.FS__;>[Z]KP/GQKB$<WP_<$[1"#4:J;TE@+*NGQF[J6&45
M6PND,I[M]2E:A-DYF&^?_S%6?UK^LZ;>0JAE[B6!U;W&)MA*02;-A#SQ#VS\
M<[1!4\7-F)%$A0?6'@$D)MMJRRL^_QFX!M@K[*GFJ1+^/NS9L'I_6Y41& M[
M#X^450KO;H.MQ/<(@]0QRZ$X ?\588.M'N/7K56MHW6"[/ZRQX</1L,TE67*
MG0\M,S)"C9AE/,P\J''TP!X\)]8YWQAB@G*.PMFA&WJB18#SV+X_*DFF3'[)
MMF[.DNES>JICSG:;[_\<+,8V\A8Q/EP4GKIJ-P2;XF&"[ORK./8W"TTRE5RV
M_%*"_1*2Q?G%B\^'P(Q^$EYKV-E+0^QYWS)) "_60P^]5(GV0V4%EH%J7<3]
MG /&\0-'ZA-._$W(K:S7U9"7[F)%RZRZ@YGY'Q&CUP [$VIJG")65+*E!#OX
M%J,.Y4/B=/R<+7? >8O&,UA)O[;G_*F'ZS:KO:T#+7UL&K8R]]O8MLXHL:5K
M\50XM6344<\RM1E4&YMLY?S#9 'K_2)S4"E:';F?7UUS:3;.^Z1&[>NMC6<<
MWA(U_M< HA,,4S%*FQB2AV>BC*U5H,1^6+HUP<WF-'S.#$='F-JYO^M- [8X
M1F?52N/O-AXO,'OZ'28;S$JF^9F:%EQY;NOCY,^@,Q$R W<TE3/2HS*2W#?<
M"[W9"_O_+/4+G(A@'VQ%/ )VI&]%XLEW\918<\PM$Y9:$>9EAU2VMK_,HW_1
M[+&"VHMBFN(6@[B#NF:F-1G\/[O'OVQGLDS*&Y9#_%:!$3@=]%YG YMR&@K$
M.#-R.Z-0;[)?<LKM[5)?<NLH9;7&"@.9^'M)#[-/*/B,A]%$  V.%*T_'<,=
M!@KVL/=-BW#9WZ>!1SJ=M$G:<?7-"9!<R"./3).ROMX)3M)RQ RN;05+<$KU
M9-$H,.(>8Z@C/^X!V1W-J*; \D 4.U%K[<3]NLR+I<W-95W=\3G9@KJFAXW$
MM^*-=_17&:W)Y'H%+XN7!G:\#)$M)IZV>4$=6/\OJVYT'7UOW'3R(F+L)\H%
M^+7VSN-T7IUR\I'Q7DW,MQK$X//;F;'-2 2>"KT5Y[3O<C+S#_7B>1,TO*M:
MX.CGV)B.(EVWP]+GNQ,\WCE_)N^VO1*GT A4[%-Q^I,1M^ U!*GL>,ITV0TG
MEV?/WM5!4!Y&K\*H=PX8'HU0J(%_F*QZM[-N4(S[Q/B 1-S,)D1#K^1LVUVI
MP5LC;1[#K[1V]_S/#P,XHT,Y%$3H0[M*]0J-"]N_KST0&'1I+@77M"&\S<_3
MK@'/&2U+S_]UE_TKTE<=?WD-N&O.BY^M?E>YWXE9=/Z0NJ2$A54N='Z,Z6V?
M9/P<1OY ]\GF84LB'==C\E?:]]I;.D[VIAKA3%C;EQBOV'*L1P_3CE^>HV1\
MH0.3V#T?=Q-3[MBLQ,'2Q]8>YW>"%+:SJ5=:5BH/I"XU<7)8SK7X6;VU^^&K
M\1% ZCJ1X  BS%'@D3#8,_[@@/94V+O+MV IRY-RLA;#-YF262E1Z]9A]8>-
M0@" :BOL Z'US.<$.[TSR=(ZO.#4"HP0P15XN),U$D>/H3.%J6+ O6"LJL0!
MZ&4JYZVI)0*P&V.T0P.SB'@3X?ZZU>80S" -]+-P?U AQ\/'#=WRO#$53-V]
M^N5.7Q>FMNV!<41VE-+Q&)>,D+#&JT,&)P*O.)(-[X/>FY2RQ% ?@->.2'?;
MN3#AW5D$T*?(@X][HM9%.+D)%WF?'$2.(XWC\Q'5J9-*EK>S_5R%PC__9/JY
M[T8':J$>$&*TC;#)EY90/NS8I09^"DZ$4UR-%>RB@2J.>L+I<*"I(\^=BJ-E
MC7'+9@S=SNBLD!OIVD3H59F")=UL/T?ZE>5-]L #YD$<4,)+B8"1S/M8<ROG
M54YFU*.459$(KGL8QKCZ.9O"U:F)CW*5- MS#\'UZ1BV3?$7=ZKE_C;V[5Y]
M05X#K$9FQY<[8U>=]58K(L:PU>QOY96\/8A_)^^EITS"9X\.?P0?2$4ZN[EC
MR&.KU7E?(6L>/_IMKZ" [S:OF3X07 &3XQYC\U;^5N!D5EF<A#]&"[)7<M_/
M*E"^T(RMH<F!AM9QU[XG:."Y'0C*!$9> ]"Z1W$P)IS%I1 6M KO 8>!2,0/
MY%8+/^$?0>)1YKU,&&#X"3C"=ZD 9GN[X1_IFR6IQK2W2>,S"SP+K0D#TW=(
M.9(Q<968\[-2+/6E(7YJN<ZV&T8'";@&=%J=!6/E5N! K-BT/D90J<QA+KZK
M=&]E"=A0BUPBM'/.JTOYW8+W(9.?/O7$\.#)VBZYH*_';A(4U@N\(ZZ,Q--H
M6U.'+/4-R)G4IG>8E"?OTO=$G'MAV-_<EU$O%MK*D=B>:]CWN!13HFJ>SJ*
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M]\/S''*79):?-</A?XP(Y2D=_7,UN*2X/W\4/3(@HNGFWJH\6MXO+^&T.O/
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ME=.);7 )^/ Y@ 6&P%5>VC3"*_:>='NX#.D'9Z$%-FP7([!,#%K#9<'P8]4
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ME4O0]R4M((-OX77\IU_5X\>-2?-O[@'/1H9/IXZ:D/T]$ #:Z5OON@N.]HQ
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MIB@'.;/G=!K>$$=:7G@-V3JI/W/NUNN$#AI9;'[<E*>&+_SQ?=4%>RFLP/<
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MJ<>+<[< _.F#(:_Z^^Z8TO#JH%H_"HC*.?T,&V--P<?=OGQZ_!*U66*W=Q%
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M6K)70L(Q&5P'8U6WU3QZY9/+KNF)LI+:!M.GX]7IOJ OR?#AHP*.5G33=\=
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MD7F^3ER@V EA=G?:UH&?7:B'V"8G9T^;F1MKL/9;TIKU^]EZ!%!OZKB5K 1
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M0'+6WWJX@ FE'W? PHBR2-\DZ)XF-+N-NYA9?\X\$,4F]IF1=R>_DMS9C1O
MDHGYC:Z\"$&'(5DW73._^Q<-MRM<- (UOON/O_@%QFW)AO!EOTQ_W95K'#-
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MO9>(?&=5T8ECTS*^>HQ;5-YV,[Z0R/C(138Y5LL,3.O"E <Q$0KE\6H9E+D
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M[ I6GG&9 .P]O<LWP238J-6#'M"-!ZX5/ZZUG)H7:1<&J]X3289Z!4;G$7P
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M(@ !H#V5"QXPRGIN%!AN306CS\..Z4PLW7$OA-88()ZT2<2_VF[0_[$C._G
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MGI^NX@;%W'UIZ*Q<GHT(00IN=908[E,%GM]_E-2^$9\QDJPY82Q9[0CT^QS
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M*V'<DC5=),<T^4GZ;(!\UC,QR_/N&TE"$(]DT(+6+HMO)3\&OCN)5D+1Q(C
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M*&R%PY'D]MHL"8<!ZR="4>YBWM#&O5%Y^=%[)QR&1H:W!Y9,-+_?N^>E3C#
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M[YU)^SPL4X<[EV][KKGO5F[DA/N1#X*M$Y[:NW%[IGILJ_L5B[S?P$:1%#T
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M3WHS0L6!6_HQ=."[#NZWF'@J0$PHVA*[MW"5QY!+W9;9TX7ID_<0:]$U>FF
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M<QPHY87?\Z/:L]Q:[<5F?RSR;,5LSO[[9/6 ,/M=,^^+Q,I'CJ%6]_&7LN>
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MU?!&$(4CA\HH5F1*T(3$B3+"-%=%::$#A-\Q-7VX)=5> 9-/N<KY* S^BZ?
M.XZBUQBA/W7-?]G?:=Y;-/S,MCB(QM6B&\XVDN "GMJB) TCHND G(Z$2!4=
M^%>3%>8!? -Y*T'<5<U6#<KQQ51VETF>M"](N]7R6FO;,P7X,T4>(7:_7#"_
MW%DFZ)6C\Y.)3@:*48[U;%5)*'VCC+X.B2=2"XMA5ASSI]6@YKN.TGPWYQWD
MZ*7YCY^QCNJR%XZ+7VDN3;J(/"_\: /.E!'J;#(.I"/Y:'IY(;BPQL WRR@D
M=AD:K'<H\_:MF/[)[.&/?HZ::.D*P.D<E>%BR&F'R'-$*4(CF+-3GL([#N?<
M=A+\EFEB&[#W9LPBSS[-I*%YZM5O,^EX"T@PK93_N@H\\.<Y0/OUI;,''G-2
M&O)T00ZEC/>MGAA:=%V_5&"B_V7'+NNC^Q#7".WK]QPY^1_D?H_J+S%?90H>
M$+JL%U*M\?_<,W)7G1YK38['/;OX0O27;<]',=0_%-IPE<_,H<,+]O]EV"?%
M5Q/B#:7K'UMRJ.5('V@:7"[R+9,3:^:^QN,*</WF+49 8,+9/9F*W+6UB075
M%9UGN4%Y-5O!UF._.-N\F]KWY!W*!:-PJ3I;8.'P;D/E?:'-<T #I#<>2%=$
MKK2:46:[1)YPB>ZYYS!<J=4H\+"1B.THM\U>A]H9[,VJZH?PW:U]Q4[..96&
M&9QE=M([4#3K2> N-%8.MS&PI(FG_(M-(D 2!*S0'GC3:]MIN)U\(U-#.=G
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M\&Y5:/U,7_=7YW+=Z8JL[YA0=,'/L9F1YU<)0:(K>LX^;(##PV>DU#AMZGM
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M!8"I_\W+2I6K$2H<[)6"=9&4V2C3&(7H0!+>P8.A=2F\EE+XP17$6UN1S%P
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M*QSF83(4:O*IP>V/I,V$X^ZLU;Y:(0>X!$2N'6XQ1^VXD1YD$J^UUT#[^R\
M#:@8*=B5"<V:"P!;!^>-+/3AA(9$7F\ K/SF5P,)9FE!OM4KW61AZL3A2_H@
M"A%$SRNZW>C9%F$&F0A54P2<10=]:_=7U4_)"6H36]NVQC/)K Z1T9;SI>:I
MIR(0"AZ/,Z9I D,)-/-NHA&.)3JF!>(42+O4H?JFC.U;^1=)07U5Q/.,H@R%
M_)?/26] %=_X81MZS><7-VO1;T@:M\_=FT)O#VRR ITZ"AZ=[\Q:[-)G*=1\
M63<4LG@JM1"_: ((,X3W:GMY$[PN>WIMTV2']M7U:E R@0$[@; QMGU^8HE[
MULPIW%QY4P]Q'91]V/KDWJQY_@E!#5^WPI4: Z1[<0' BZ@B/7AOX&W1^Y'P
MR^[[K/#J\K"CA%QO$+K]MSJ_=$13D-DKDQ\>]H+8E))9V9M1KA6HY/+7XF</
MNK#*,;\T>*7IMVR4LN!%O<SW=4KMW8]S5!_+]#!K,UO(]<UL<O,_O)/(_O#:
ME8B()*[]:""=(H_65FYJ%$$ZI#*9TY3VO&M;9U*D@Q>8X>8M]&UPH'E7=,(^
MQ",H.0;MZ1(CIM[YN0P 9^]NLL\J(VCA:OM-*8G?NL2QB/[]F%/+G6DG4-\M
M_T<XF 4C/H_(E&/GB_$8(]L/?;@@H'.UL^\W-8W!^>/52KS_6Q@=3B05)HG=
M."["1V%>A['\!%[IN%-((7W$],'J\79VH/*Z"O_4C>N+054L:_*255W#=QF+
MT[+9@=/[@Z;S:L?!^#'WDDT@4Q@C%(C@5(X)S[L]J:Y=[%Z_F:N>*JXV_(1U
M;B1I[_VXMQ#K[T<^[+Y6-0UG8C 2'+<]=_,TD1U_,X2>?!-A@EV4@4+TC4.5
M[[T>2'5T>SM6H :6DUF7YZ?9^:(E_([TM]AYIC^(%:9RG@.3+8=)FI@;8:-3
M(SJ@N>J<36,+B;;H&UU7SX\J*SAJ*"</Y>I%(0K%/]^V[XH/%F+O[4<1@=,=
MEF?\XSCIH<ON4X9GJ$YE=D<M( ?$0P"?)AQ$S-ER;?K:9I'2^T8OW:;90)IT
M^K]J/;#&Z$?962XEF\0KV.R<HGGD8VM;=U9[X,1*G9*E13URZ;;7@WF^>1\/
MA>\CQ4KU[:13LZ^@RL<*YZ_#.*6ZELGQDEA4?RTFQZ_&S@;JI.\.06=K2P[F
MMS9@J#/(?W'8]5K5K#T @))-YT^&NFDZE/W10!8\!'PI>1*'5^!QQUW*WQJA
MZKI52YNY6=DMQ4J%Y&W(2F-Y<<E,IS,UBJC\#<'3Y//\]<;O%X"5@@+&*8(1
MSLJMN?!:A[7"R7'DL=J9.$?F([?EV7L)\V76 M%_[03Q:O5G& R?2J-;=LS/
MI&#B#06(/A1%&$>OMS_7V$,3Z9<OW*4<.J<^NAH'Y<XIR-:9['*F4?/,C2L>
MZ>9$'4$56A7$0XPI&\T]%*/<=.XVF$A^6+>TKL[X[G30-2832!-M\!SQ7$6!
MA*#ZL_"ZMR8Y-!:Q3']>*&V+X>W$Q:)W?Q&[<2)W/\V^(8BMJ(VY2W<8Y)['
ME#+?;!O,?N/B!Z&<! QX>>LYTX/OP#2QLP2F7.?.R0O TUTXIJ 49XR!].QS
M(:%?@_QY#/!/++NQ8YM3=[.5 S*6J"LKW(T^90O'/PKR#0-O)?;"ZVM[Z&,G
M/&:7K^&-5TQIEJ 9MG%-[8FFM.Z\8:6.P8D\YU%B#8]2ONZ(4SG<?Q(Z)BC.
MZMF/O0 <WSG/[^)8WN*LB BCA:ECE^O>Z02Y2/Z*C6ZTDM;-.F5?;V;2?9JA
MX_F]\=W,SSO>-2-;_0+AH!Q(O"8M/OV,$=_0*T,<3M^:69;%70!Z;OV8NM>M
M5/Q^<SP0@K%=?6?(%'8N69-C.)[%G1U!M392<6U1I-\N$.T:W6&+U;_,S;K4
M1)AQZ)D1_N\W0]>;SG1MH!D'I\?+XP/?W.6E.J0DA"8QDRN-QDTS)AG6(QE!
MXD#-I[1P9PHT(CIY*:98*;JXN;1B;KQ<^YUAN?N^#V^>+VS8RVR].3U[,:LW
M1NY=H)+^?9AM+[ >N+.-/1Q0/4E6)\66HD]>=EAC)/4P^[8XUF3T&WZ(HG:(
M1#U*Y[E0DP!E+7]K+E=YLUM2O,++-%, $!'X4J%[WM@41]%#SP.CQ%'$U79[
M+GF/FW;B?C0=EV-4&@=Q%JVA@<"$F>V[6289\_2-CW\;<WE9-9-DVB-P"SW+
MU_$1:'@L+Q>.;2!4O*^+'[L(8B18E^"9!K.)_#G]RR(YAHE])TSV;LBN5+I4
M?]X/UC1*/ENTQP\F*M/R+7^9HB%S_<>/L?HI>V$B>.65PKYSMJ&6&!V1>"]U
MR7($W/N083W/PHIBOM<Q+5TNQ;1R#!4/JN_>V<5Y:RA -]#@2'4]=9G#MS&S
MIY+%>29,ZHP>K#-RGM)>[M#FF;>V4*/21H9L"H<>BN%NK"$P7A\#WVFH6$HE
MWR)2VM$/!-<4(.U;Y!87#1P21 >.)Q+S2KX]!H@D:0PD,>I2D%T'/?R0R.46
MS\[%Y+8:H)3:F4)R?#3D$8N-C2#(KIBP3FIA4V,;:VDV6<LZ.+U3(3Q-'^Z.
MO'_\,EG9X//[\L\2^L-I ,5EK7;S@M:U58X5>O/)"O//"B2*_Y'X$;ZM?0T.
MSJN3^8=;LI/=SYY\?>G293:70:E9^D.$_:1((MZ 1B:(][7@;_,[;JKT4Q>
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MXN^YD@!8@Z.Y</M_@X6G%[D ,.D3!,,N%6MQPF542-8N !B/R;#O%.-G<Q>
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M-)BN;=%VG'%(P41:FOO]]W9Y+I/W(\#G%$*KK;4_)H\K+P!1CEU,8=] 32^
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M.2<];O^([[TL/Q:"!+ZSPOTY5/ XX./LK^UYKQDSC.$1F,0]^^3C0MFI<V7
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M#X>>#;2!XL9V]G\TSS4ONA^7B)(*D)OD&0@!7VJ*AWWKQMZGC[D 7.DB-\;
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M$TF;4,X-T_89U(,D'9[\RN=C"BW4/W[?BXBL6;0\[#U3MH**K.0,0.9+5RX
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MF7!=JWOLO(#LNMQ+L44HIFL-[X@]O(N'H#6H>T_E;LYO7I>]S_!(J^#!XDU
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M><B_'19\-AODU\80O;E@T\"JR[2,#_$T28*G/8CHBA"$*T[:17"Z3")&D"9
M.!\FD6XHDP>.@5X 9^OZ9U#MCL\L?4BJD[Q0P-X;R;/M@%-/KW*79V#A36 L
M\-FX^NK??FM\6K(",+]*RX%D'+8("*M$PZZHV_/_EBXD\</I.FO821C9\UCS
MHK8D<;X$Y6LURRC-##.CI 6_JSO+A'Y,DBHJ7%G'Z2KR-'B?U&E;;*:'7V0'
M<>1]25]J8R8]KM'[KL/<QAVR$,:'6GG::YYH5, =(L>J=?^Z"GEU?(M3H3X
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M=PGN$ER"#+_WWO?>6;-FS??-[%YU^H_:7><\9]>N>JKVZK>EMTW !UDI&2D
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M^'F^-%0"%EG&/NV$:S7MB!>2@R=9PF_ Z =JG80#$$XV;?OZY'#?@P[W/-/
M*%_5P)AUAJ*6(Z!:8B*Q]IQEHB0.%HXJ:?*@K0A%9^.\95/0%M47&"MS!$^8
MP(M$A39"M2+&F*'3TBHVZ4NTVP4P7'O=#QF1ITUS+[H<> P2X9/Z]9PN76@P
MG<)RI"2.LMF_PQKNI&W3SS2]$L42W%H_%Q;[[ B"0>CF86KK0@[>#6%7F=I"
MWA60"Q5P"U.._1#!9V4&\C%]=&/@$.3U^9."C)($*I;P]^82B"HE@CDYZ6O#
MK&T*I3 _6IT]9@TU_7Z-A?U)'0\'5PA6@-^*!^Y(LLG [LI:Q1L PP>DG8-$
MR"^U:)B?#K1TQPG2GE_\B4OS]=!SM>!#RZX3DTME)AR.BEC0?S@ZWVW/^]?!
MK=$'?3T;VY*E)>ZU5Z.,):>?4LX;96L/F5IU@26M4SE\5#V>UTF;%LGCR01<
M[DG((((9KQDQ)P()=#\;PPZ&=!UP/P+.9?"XM!A?(?SWII^KMCQA#"Y5_#(X
MWT;\Q"OMZ;1;9]BP@0M+CD+B+IR-*H=*I@96_)5GEM)-"\R&2&&<(\W');4X
MA .Z+D,ST;TN NI!S6=D&LW3%V'1%5WX;P"I%F$:F-I[W$4F^)[;XB\%%C*2
M--!!</^S9_^W2-SFP318'J]D$2IFL^SUFO -.*_]16X0&H5EH^J<5Y:AOL$=
MT$6X# /?#4N@,<Y?XMB_ 5CT/47R@X%23QT1;O8"?BY_;'W*]]@S]3P.(X_]
M3JHU5O@VU4S%">&4 22 GQ%Y=+2_XSA]U*SR@S_E_:&O-,)>6].S%CS;9>>/
M5Z\Y1?=G1 [Q7H^*5NKW3%F)[F]GEZRC6\$/\D7ORG;U3%7R=KGG*+30Y,??
M<82!=5T$16?(F&?H[.I04R4H&8VYKF9D*H9]G+./3^&'&?VAF@U__OB:'-DF
M LIF5"_PM?V:XJFZ9##H2MK+X2+SRAF<X'TR[BY@%''A4+T#\LK'K!T0HZH5
M=CW3WR^!9:C0ERHC=A[XJZ&!,,89PWXV+A9-K2K-S$'MP $#,TMW%*@@B XF
MU"@82\Z.U22>6: +/6>MXAJP+4-I'1E!NL&_V&@\T5M[7!Y,47AW&W$H<3[8
M:9VGALT&"-_?\7Z R8G6;ZO<4:76!B.E)KWT;'W+O:'MLL3$YELZ[BDK71M]
M73FF>N@#*T8G,5SFHI^(/TR#ZSG(:7BB7 V8L3CU"A,V>=:::LOQ5NB#G)G6
M1FDW C+J[B*1V_JIRN/D&/B-AFY^4B#?WXTA,T^G" &4U"3!(9B,38EDF?-I
MZ+>#RY3"YV9H#2YO (8#T)'Q0L+V@@X6G6HP,@8_7S&,NZ ?J_4;8(8:B9U$
M_-5]\IC05X<C[A<P-]E9ZV8II+$)6^9#\A*6# '_P>*1G+T]Q>P%\]YC C<Z
M^-!9MCO*USNZ?93\U+:^(4M?K YFH=FAP\>B$2(X$T-N&KB28&HI)TE>5$']
M3UJ6F'I:I+RV>>KL\+>W+GU)(++0 $CA9T7=5C7?<(]9&5UQVN;>SHLFDRB"
M=&E'"!4:YINB-@17ZUW9E@8OD$-?19)M!SPSF;$50;3>CNA]3(%!B!6Z@S_V
M.N="=[$&8I2E>NX]A$'Q^NN_PQHBF5;U?E*T8_*;1";&COU]36:3J,H,V2]<
M%@G]&,ZM9PU]@F&_"S1A3TO:P;_07>$^+T&(H)VYJ.J?"6_O]\L$[I?\R0;/
M=S2LKHN9>%<1BI54H3-"1*]4:-X U4;'#/'\#++ $_Y\$$..OXIX3QD4?'X1
M D[ Q,*-H)_-5/^GE1%/ZLA>AEOX>B'ABK5>KR?6\MZSFJB"NV1!,K#;YJ[F
MQ_ ;FGF6&2NRD8Z \S"-VQN1.:+/,E4Z)-!9-T>*N)->EGH"X)\R<T5K"*/I
M&/B.^KZ+8@SILD)58^[_'9;^4QC0  Q'\M^#3V1U:]I5*DDXY1W)S]LS[STN
MWP#>A\1:G'4<[G_3W<<UA:&G8Q-$?(?57Z8$V'8,)),+>32'83'+OQ0$(. F
M;D630,Y$QW/WVYM%S,Y]4H2[D-?I<*)IS\[SZ'#)?#"XU#B;WY,/(A-3G_\5
M5,MM]ZM[A?8KK5\K=45MIK?&HSC?\+%?F7 T@Z@WL446[%-1%D=*/))*HW@
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M9ES%=-AF&]H22",%IVUF$H]'(\Q$I?'G61>\QDN[;641(5OQ98E/V-8$A$#
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MZPW1OZ=:P=#B0R8B8:EC_H^'O[,YF'VJ([_)B<3:V]U)$1#*(#>;9J'Z:B&
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M!3;#/0>.6.YV*\3X'_=Z-4(>%3/'C?^CD^N,:FK;U@&D2+6$$GI3.D@QM"2
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MJUEQ3H55"DOZGMO7.7"-;90CDYIDFJ)F\8-8"YL.'@@ES2M-&0^P'X4LB$W
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M4QS;EN<#JCX<_N2KU/#CB8&C98XM],&(H]P\NI(B<4;'Q'T$#=)^15^L6/'
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M1^UNI )W7K5U$SP<84YWTG[,50U'J+,%##&_/WS.&F<KD/@4GUY2X&LS8(>
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M0^65(HM1<68>][TT.HC2LZ#9&1*$\Y%^%YNJON72NWL_BD7QY/CX%.G]1;H
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M3S=M>X[,O%P2['5Z4+4 FWNV"ID<A.Z0YEBKO8MEW5R\5L1Z'",81&-;_D1
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MG97X-R#MOX,XGX,(_ IB =_?9_L[".P_@]" S02 33$PF?(% \SQ],%6UC#
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M2#?'8('V0M/X+5??!F,8=0AC@NX75Y;6]],MI; Y3I T*^4B##2U19X=0NF
M]_2B[ GDW&"U(.8':/B<-*V@-A3)Z@[R]1D%:PA%*)6"0'=/S^D\5W\$1ELD
MR!.9_^%/77.<(R390%-@%<F"8C1H@4PID72>^[/VN5Y$H+>DR:QG=C>L,8#1
M, 8X%;+6^!JBTR2F,JD=)@.C"/<JG]PD^!*F6)#XV_N _X.#SU,6 UPG(<$
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MUTN.J"$V:_R"T_',(F$\4_&M2*$4@M*DV7+?O:I#YH''<;Y)=?3Q"J]QZ#O
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MK9*RYS'<YE&>F:EYLS"<^GW0&D(]^XFM]O1MC*B@+1^V@^^)NHFIE)'9K$,
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M$2D4VNF7[RI*BT9F68RK)[:2B#8#IB(3E]6I!'PT7F*0LK$^[C$M5I<B)VQ
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MH:W 1<J+5K_ B1(B1,Y*?)Q@'T$NGP&TK2,0<3X,0)^.8-T]<+V$3M;#!_^
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M2TTO14;?#=]%CTW-+!BWE&7:>1#:\#E&<+US.,_@V3I7$$C/!71*(G%@0&]
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MM4./;+)*) 7N:CCP:'('1]=JU=:SFW.EZ)R(/KOIE&+AX\7CW3M*W5I$?<:
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M;,+OWR,#CK3F:=[(]#EG1-G(405_P( EC9%9DKS(X*O/=?.ZK.-U)65D@&4
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M@CG31E2O+$]&%0L5BXN$+L_T*:(WPA='#4V7)C\ZFZFX$'[%4>?;)"VE*1<
MO:V3;:PN$/OTL7EJX51\3BI]QE^Y$W:311KVE?A?U?!!4=(M0) 89CV5K/\6
MZ>))K>Q1<;V#;#IWWS<_!7\J#G97%&'I]!B\# MQAJ.93^#C[QXHMLL:14)%
MMV6%I"(X3N.\0Y<9Y^A89\:+R]R<_/ERH*[UH>P;7%9?,"V]SCV5V"TT"=!N
M4I*0NP5A! D._!QP'7YB21LM[\!CIHHSMS8U=;+P61.**[L7ER3#>Y'J-@5A
M[ %>):<L538OO=R'AV?7Z-'9F_?K0F<44'*0+6*ER<B[U;+L+VHG__/ +V'G
MQ.$S.-1+T9GRL8H%<9S(2I8R>IC=#HV]R V(]^'RR;<BB^:43XU%3?>PP6\4
M.G('9J>4O&.U_)+U%25&Y!U<8^7UY-\PSCR[)WI<&H6H5 G-=9*SP*:C7TQH
MRR1W9D@'#O7=(@'N-XQG6G_*X,"G7>$,C[] W)@ W8EY7M]8/<I/'/T@76*=
M*%]=/NWI<D=YJV[Y$DUE@[5[A;)??U +2W00:P[F5?SF&<-##R'IEZ[MB_S?
M6&;\&@)KE8'%,#@"ST:[ N/R'NV W3+M  EBXY8W'4OPCG'I7N83GCLL#+-Z
MA)1KW+)1\R,='!J>KNHES;%S P%9-O/$@)^2[;S5+(3=C==M[,:#RTK4P,<E
M9A?2 IB]9#)IKOV=NA6M=W'UG/A;@D_E_@5E9:CEP=3Y:/3.)+Y]SBH5WER5
MG'=LE<K([W%#012:7LC^XJN)\H@B_Y=GUS$_6G%QSW*;;*XSNRH![W5W/E[=
M>#FMHDE/G+@AZ_OB;BW;@,W[':YU4_9@Q"MY(0_.W #^_$'1*S([6GVG1TM.
M,R;G! *L'TDE=$.$,31S[UZO:]VP_T\5+^(#G?Z#"$B-0DV;"[-W<*O7!-S9
M0;#O]Y[*#&\U9J5RXIA3)OD41(^@C;/*$S6KI_E]^;,P_A8$I3=5S!O_9VO6
M@N]23%49;E$M0_Y*&[8+S=581QL"LT?<U8ELDIQ#=<F;9)04L,:Q U%?O;\P
M7.@[L>RD?*YB<C8B K+C\^%B_M:Z[SXXW3R#$'LS"-#MD>ZD9"FM;5VKW'FU
M5=O)$'5@IR3Q06+<>>_4F 1X)B^#$@RHB*;OJP#=:3%LURV]Y@PTC(AZ8^'J
M'O&E9#1O=T7\:,*L=/)X&+:8@YK[=ML)_$A=HXY0'+)^G86SK3F\+5$_X/$*
MR^I8Q-^Z=92:=;:_SDF$VVPF"K@$B:,W18IO]&%"%UBYO/*)V^=6):SSY^:F
MN'7K(:*\1^0+Y+2XD[/Z^[WNXG+S>MY&AEW_M*8H*+65Y\L7+C C3%6CSD0^
M;#%WQD>-S8G2]Z/';>)8NE<)E5LBBLO(M;L7(]9E?XX\L2)D9V'7?MBSI3%!
MK.G5(QP1=@XQ C?]EP5?:S:%YC#/WH@NK%/MX]@'2YI -AQZOT2UKE]I&;S>
M_Z1+&G##8[14 D=# ER:"Y%"#99@=-A5G>E81@RE9XN\S]S* BV;+[T^X<_U
M6,9,*=)*,=[*RGW XQ)",ZO4F!2&_] )N_A;),A;Y6:J:S4S8TAFBO%04:=>
MO@ F_A.SUKR)0%HQZ,#+^CAH_@5E]"V76M;;KX[L-&XF9.Q%OLX@"&I!>*]#
M94[.7WA?JP 4J(<=(B@H-]84KU\_[1H;_VI<4>U[Y;;_0X?%[W?1^E&5X<X3
M& V=%!* !PM^D+/"H2(&W3-B?$?L-84,Y?O^:Y*2@/CMBD7K_1.*LJ-\02-$
M#V2B=_T/7-ZGOE8$?T4;G!F0]NNH$TQOZ,RH*O]>80AG<?S:GZQ& 22 0-!*
MWA*!+4Z%M=1,HC'CQ^HZG[G\K6:6OF:$M^"CLVA?H'8BWA<Z"JZ\DIP-_0.D
MK]RR.KRCA$JR.A2^R8UG7CHS=C%G>L'^<5=LG<.&YQ( _&O 9R5"?2("/RWK
M(_ ^C03(:9N*&^7A^LJ(9X%.?J2=<5FV?"0RF''#T"IXC;\YXQ;KD*-G]Z!@
M0<GK7\_#HQ(J)<OKGX=/[GN=V<-<_"]O"7G=VHA-0M2V=PZ9NK?6U:QA_(M\
M"7E[4EDFC#A)^!K+JL\?0LG>22^:A17ADRGI<5/4248WO?D*($(-IV.;5+W'
M8?*>AT4..OG>73&9HSI@H.V1@L^F]W(3H])J9)[FAOP)0:#M"CU#/54719IG
MRZ+'*/^.J>[0O(F8]HENJCKN0]W1C@-PFTLJ]%X)4R[(^%!#3*TO^46V16HX
MPK96+7<=5['[H70F^&F&S(.UD=,VWABQO%D79E'9<C%G"&T(JYXRQ676;L"A
M"<_)CY%CZL_"_-73O+-^IX<E[ .8T=<0 6\?1DF!"YA[\VG5VFK8IT;);NSZ
M^3)M-OFG6]I]50V[PU?NKSD*LDK/89VUW3)DK15VKJ*O9]4:[F4UGM1HF!!5
MWK]IJ\P.ZUO/9B1G.V>=^>VMT8:&V7*$><R>&)'*?[E/A!DZR";\_6WJ'1+@
M8WU'_ND/EQ0:O6$6XLG,-"+2K8+#5=L=_/Q+4#97\)G12A>>_G<1A$P[H:<_
ME1,ZB0K =_=[)IP,/%N&^N(F\>!73MG&RV=J<D-?U6YC>FLY+FSM^^_<7T[B
M._2TQR$U$.1T=AEOD_,36]7Y93E%=P"=?UX0.]N#)++\R0H7%#L,^.^8/6\
MSX$9$+6,N)IB,&]9X(M]^.<DP$AL]V/16-A0KT,741B-6NFT(>8"R5"XE6Q8
M^BJ4X'5&W"H%8NM) %YD)_SD'C:9!-!,*;YW?$1XN?,:CC% =1%"%\''@A=A
M5R!<5& .T,-5$F#@!3:*!,AW+K90\CE-(!QL5NW .?]!:<O_B=(F#='_@=(A
MI6@^##Z.!'B,IR7_4.@-$F"JD$RG/Q;5F.> H1A&"VUDS%$AO7\+%L9MN+I'
MEFWU_O/O_XF>F_[2,V*U!W2)_-7/UB1 'H)N$GU9"N^C03PD 383(+,'>(99
MHF;"H@XA+ E\_@%-XRM.',HB7P!=_(4C' D0#PXA.[PMXICM^SDO8D<8O),
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M_V %W[J6TKR/<N3=[MJ/,MZ'!DNWN[\;U &?]+-E3.ZW$,](@&$:7?!\ N&
M\*-*X?=MQ0S,3:R/B&GI$@(M0N"#KZT>#Y S^T\5;$OR9E9X^\[_SL]]&)@.
M91)@G0%\6=DWU"BB58]) +;X?]4W_DO;SQ]?GJ:&#6H#!D5=55E;R-)&99<;
M("WSL^&XG^=[HH9U0LTU=M8N!;<,@4*S)-&KO>I_I,.M&+.IN:/XKS%.)>"^
M63D6BJZ%=;_JS62NB5$\AT6Q=WTG@#NS(@]B?%CD7U-T/=GUM^N]\'A* 2,J
M#8"[V .@Z$V8#CK;^PB<AQV[WOZ.PQ?>%8U,-V2.2Y5LM*Q^%.D^, &YMW&5
M!3__,+C4;0!@&WHI< BL@\Z;D)\<8IR9Z;B:EFK88"??0A=-<3^R5D4?87DA
MO##4:>K:0RUCC9&IWE*9K?IJ:.6%[TH29@]7SL]7_NC_LRS?A=)3G25\AR'Y
M1L>\)P$"89NT.CZ\AZP O897A_ ZJHWWLK@;8-GPK?&XN$%F7@:QM*4062G'
MM,7P4+W[LZ9G@L2L'X3"^'#HCIO7"R/MP8&%':TAS!19+ZL\-?K V/NT@<Z[
MT14T1V" 5@-#G[75!-0 QDF4SMOW,I53 R;++\L /_SR_O8UPV%-9,K:E!#<
M((=RZ*!&BRR7AOD)HID[,KC&&A26R>I/3;DD&7,RSW5@C(Z\,M*EB7ZPK$&S
MLF73=D#=E<<;\G3DP+;D^1".G$,H>6$MH@A[D9F\DPV42PR1%6MR^APU#F\5
M+.;.@S#Z*50<RB,CX(P2]?S10#KOC;;3V*(DW^*&#-W1->,6S(SJ.H,*\' &
M@7HF,INRLIOL!:'>W:WI\.0MIOW<=*/N6>S 1=:&2FSUB"KZSH%6\>\WXQ<>
M-/_(Z-4ASL/6790_[O0^_['D?5_&0^L)WZU9+[N%'BF,'/ B%%D-*>O:(R?1
MJSJ[*\M]YM8G'A.>0&8LHM,()!#<DB$TX=)@6-!2LNDJ;\$[?*P%UJBHBD>V
M02_4,<4BI]_"JAK43\X_OA@E0'#D[-=BAG^ >^+G@1U8*J6S?RC52AN^P!33
M+%676)S\4>AVS;"\+BH:?!D;LD)DD(.Q6YB\[+D\/M 3A!8181A9OEWQ>(]]
M&AYN3>8S7N+4=J]IR\E@D[7JYGEI:[5:#8]PSRB1:?* [M'+IQD)*AS?>J]%
M [%WF/?"[I@:H%JHUN:4/8K]A/J;W-5"DH&,X^:+0A;S85SZGQP99.HUSMZ<
MPEKN6QY4^8EDMRN!";?'"7DP!YU/34R$+Y7@:9W%Z-PW!5@I/;3%MY+ME,3.
M[]^QX9B%#T,AY^2,'+'K8 +YO&]=$\TI@%1+XYU1O)H;5[+J7M'EB,R$H^P*
M!N&HY_./V(QM*J*UU 59L^0R5+]C[^-4E0=X"HJ$00;TE8\OUHH<LN%10-0S
M\"Q_=W4-C.HQVL2L[=T/+=,ETV^15+^47&D[BM0N1< E'Q9 ^-<!RXCO(E@I
M?B(5 O<4V@^N[O5[@HW)4<G=C*W\P6Y;ZL>L4."#O :2L2VG]GY'RX4-6IZ&
M3BY3,[F=2!ZRGKI&B/]*.8Y,3E5'IN(_Z=_8:AD8;^L1_%"YT^GA96?'>&OA
MU'>SY!RX*0$\)R>8$CCNSGCB7V9YH96XV!!N%$![WSE(D+.]_"JWC;0EZW7.
M:96^/[1?-B1R. (H.?QAG<'4=NXF @\V_D 1*WHW'H,RGU\<^Y?Q5DG\RX ?
MWRJE4[NMV"S3,R@KD('X!),&5CLVP?8H2N4_\B<N#E#:23]_/Q/*J4:9[*+]
M=0\RO(9C=&H.4'GZA"<V./,VL0J/A,[D.T-E[9?>NF*P'FT3_0:,(+,DWO@;
MR,;XAVJ"S;UI1O4)RGHG\0T&UM*;\^DSX[E.[R%N!-.C)]]#.K!1:99Y@VB&
MI2+-;%LI+AV[6Z5RTZ"W^\55J;[9:/V3^%0]8-7I;D)^5]Z"V58=) 0D_&!M
MO"IM5)%R!L\#<W':&$3\#M/B-@SMCQ>1*+_ITSJIBU.!#H,841T+@:AM(M(T
M61DM7Y,"^VSYJVJ$3W0K<Y,YGG]F7\+;V;'&U%XL6/PI,Z">BKE/364BF<@^
M(N&OKS->^HZ3QVCLG89BGEU-39U_Y.D+.L8,&9.9]?W[_$&FFQO>!R8SJGKO
MHIA43R(Y:"!++H%X14^^TS 0!U;,HM'A0Z&W\W'I#:R706V%U'N(Y8<(F0-'
MFZ2%=>DD*NY$R&K*Q'AX>7,8*'?\QV)V?TDB@MH9YK,L+6I<E))[[RG'85>/
ML'VXX$*[FF#3BR0"@@?3M>(<F+L#XB? F^[X":*2:BB#\<!E$N"3;$B%PD!3
M?K[FJ#?L^7C5@/+21LBI\6CVQRWWK<&.8^I;RM=W'[R*U1(I@781Z= !A"P2
MP!;\V3<Z5*(Z<!F(-02^JOL]>ASQQF47?A&;^K@.L^;-U'*RL!N%KY^-RDV$
M]'[[R'\D,-EBP5Z-.O2V$KF,=5?@WUV??C"J/CS,[?*K)*/&M34I:T9N:N\+
MKQ?U%0/ =[]?#)5'Q=>0BA5U92/B7\6G7.1C*E-IRU[VB$ROQ=MZI1I_-YH:
M56?N5YGA]:_7>"3;F<.M+JQGRO^CW@-R*-&'E306ZDR7_1/N[:LNMIJ24A?Y
M9K\R/KXRJ<[!LQ;W5Y<G7XES6L<KFF]3)T2F3UA<6EVA3I@,C#QB*9T0?&X(
M5Y!RRY!#_"KM.<#>/13<G$%CVC63S[.__@GD<*YNNM)O_]V5Y^G[G_I1F8#Y
MG6-7^0BZ6*?;\<9TWF?=P(X,CRT(:ZK*;$^!TX<1];W9/<D:A"*^!+V>P987
MX7UN[*.EGIJ?D[58S*J3<NJ\D_Y2N#[UBZZ2]\::I:'P^1,2 /((=K?04^\@
M!WA\R(RQ'TE&\VR3 $??4O2(O/X08H+80UB)"Y:6&&R\<(\$B%6:)/B:D0";
M$0537\[<&1HV./V_^%I/E#5H>F2;P<_?U9*I3<K0D 003SE:(P==MU6'N38?
M&VFRKR6+@[N);.#%[PB,!Y()O M>UB&\S) MC9,0P1)2B=/DO?[<V4%@[[G@
MTTX[8G"TV 2R/=E$%ZYJ:1#!;_^I#0G(8@IZE'X<S"I!-W DP-*M+WYBBYWG
MJU-O#M?>L+G[+V')PJ.5Q[\ C,%()%?%V,$6A0C"]!O3';#P%_A1\5?L.9]@
M#>B8@8#2+23Q*LS5&NNV?$\LH"ZXY*$8!HM8H=_@!^=-(+Z&4;WDMARW$!4;
MY0Y<1^2Y8+G7RK50&^TUUP<Y[+7?YU\ N;#XO59LT?.]'I-:NF:B'U$PEUD9
M4W?6..E5\GGAW!,<WT2^ CHMJ6H=AS9';&OQ2?#G!57E+VP.<*]T9&/.-N!X
MM_LW"<8D !G_CEBV)=P/Q$,OQ/0$CG*9V<C'>V!79M)R]G2G*LB7Y3Z1<7,X
M,JMQQXDQ&Z$,BQ8;Y51$C-O + S=R:FD*(%X@03(3(G/_A]V_?ST3*2'7F,)
M=HPI):;%#I^F$BGP!=31\- C^[3_V[->WP/_5OJ"_YD-^,X03P^=@&/<,N3)
M\9N+@P08$VLU)&SOE#>\GT!GZM5P.2\WQU\7?0K58WW<PR]#&6E-=OS+B*HO
MVB1 )2Q&WS>39NG>MW#F60[B-529EP"O7H?DQ4SZN+@@U3L%2I4S594[FS 7
MPL7"T=SE'X[;,D^$&!UZ.C"SVYY5C7O6&S:;(,2?<8'MRH-KV!A3YOBIK=XZ
M93AOT([%AT+^<-'XEDMN,.O&\6)<Y8C%RS@A#]EG_#/="P8E%9M-U\8]";3F
MZ,M9A)1)Y>KP=6H?<OS3,E:=U.W/=Q4N(@$JFKI/HHT'[#Q.8I>LC$]<8* <
MWO0C;+(^0;$P]4U<V[I;AA3M%;2G8:XN/\R.9E#V/[F["+4WLSG:J3/W2BI#
MZ*BXQH#6R@-[$X<^_AKET1=JI<5ZW-RU44KK=\/%#AUC7XL(*C0D/=4P5[Y;
MW11CDWJQCZ,@%<WK'<^7)#E/G8TOEZ1VDGYE\&YT^ERD^[C"L8]"7ME\%VU@
M#VO5?Y$G; -[HY-51@B&M; A5H<K17"<#3YD14L5( 3^\PPV5.'OG\[AVW \
MMF\N)I( 'V>[OG8?30@A9C@)A2=7[G1 72]PN(VR<.TA%79*'.9=M"9+YV"!
M4+$743I,V&$E':+RU&3_XACL,V7C7JGV6N_?L0.Y_SEV4,%PZ;5OZ7%!],$P
M45DZZKX489-HFX-$8Z!Y),#C4@$LN47R#OTSOQ+^S_Q*W]Y,NPB.C5F6-9TJ
M'Y&.$A [=D!%<4F$@> S[ DY'$GQ.E,2Z<@8U.43YEOR+IRW_F7^H(G_8@TX
M'$9C#^(8(0&<:,.,H/R_HR>U8Y81'?.' UZ7O^CN_T8W.#1]2(VPG7R',<U:
M?Y+T*GC=\P5.3A<=7;P,#D>RSBY?8N,\;=V$LD*&%LWU:&NV,$HE/X*7OAXS
MFUNQ[]"(Z-YWE3 SE9C(O./P*MXT+\XU&+.RLE9/ K3N8 <?[!\(O4U8KFE7
MJ$D22W68]6]Z./ZM:<@UHDE$0D-)6*R)V7OHN@.E*1:^,@!I2_$*N8M6;G1Y
MDQ>E?%^XZ+CQ+:>B0;"A#^_OZO$\_Z?&I4Y?5(<5J4VSA+BM8U4O\//KI9GG
MWK];HRYE8?Y!C)#:YNT1LWP]]'[G'P/PC'L1(AG.?$U+P%M302K[QTQ]'M)\
M:'2(SAP+6Z:-1MA$P=I,!J(&@U&]&TL".V\W=,O?E=6@+,HD]G-^^#\JR8YZ
M4'3PJF_;*"DZ\-L!;Z"F>PTC&MF1!.1LHM'@#Y*0TX*T+P"G-^Q<W-ZX"9
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M_=IVV=7:-*KG4ZIS2R)D&;QSP3[LZ=HME.Q/$L!A)D#XMJ9?$^$0N?UA= M
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MUFW$&.8N.NES1"[CG TZ&N2Y36L7+,VW?-Z=MXRF!MGQ.++J?K[7MG:J6<E
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MD9&Y;[J37"20F;[N5TT(TN/G,HYN^+&<X ?S( OT["]47GMTQ?CJ*;OF6@!
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M15%5&9Y!E?)PYYH_?=!9/&?[^,\IX-/$[IJTAM^YWK??K.7-"BSD)E-\=CW
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M@'4'O6H:Y"D#2_=,, Z3X*YVU*0;[\HC\9[^C7NAH0^&ZW&'3G]EK/8G+03
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M^N9+^Y0'UQ1A?-IM$?H+#3RZ-5>@\B(';<T&F?@$#>R=[DO/H5L?X9OO<OM
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M)_JZYRE@"!#UJ"9QR8U5T5ZLHWI%(^Y01AT.ZN**)*,4+V![</4]MQ3N1M3
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MG@Q CZ^6YEY&_V.:9O?]OWFO#DPV"KI0!0UE(@Z.H;NWK9+L8NY7Q#_*3\&
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M;&6?](40 2S;[[:=.C('Q^[;W.]4]Z$3OZ+Q!]E\O&=ZDZ//FXSS])/2 YK
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M:T4.)!(V>\6*$OMXNBX5;93BN2QZ$Q[O]GSR3>WD;04%'1"EZHKCD]&S<0U
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M8-Q]BUA<PLQ%?B+MGQTKK3U$,UQ#M/,3UA3R0&6(E4C6?(//T]EN_IUNB@M
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MMV_'FSC6FN-0ZUR,H53,]RSBA\7Y^U?@+R%+Q*' .,:M,JAG!WSW@PL+!+9
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M@OFY1TN<MSGXQ*/73JVQ1,5\.K4N9&)3^0BB\6.KZ!8"7MHN>Q62XLJM?Y+
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M[<LM3&I!>C#?1?"2Q?[':N;]RF2GBJ$'?;YZ&QE/R2P)\G$<;0<2)> U:M.
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M^BIYU/?%Q$JBU^XXRV^A7BL(.'/+)IH:/?E3&WVV UQ$:-]+^</T^$9#G5E
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MG=T9RO_H:O&SGZV0#&O/CY?I15JH+J4Y/90571V V52NVZO-VQ2M8/?P*[?
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M3.ASLD_2-0RVD._EPED\[QUVD"X::)WP3WI1[.B'0&A>!W=+A.7M0YT&F&W
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MKT\!D-J@7GC+('H\9E6TI>@_:%B?$U=,\)B/F7F7X8%IZD]_.SAGH&1[*TB
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M52(4-!VE;F''G@@)?YWU5YA^_YT.0R/D+4XTYEB-HM>.SR(\'F2I/%L41@G
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M5!B"L32I @-<==_+L_@OWRY)>\>JHT=LD^?^'5*O0$7:()3'%?)-SX)8SG!
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MAY740;R=P[@X:(#^-PC$#VW1PD19 3%L/$>=;;I 1HR\V7X)];;!7Z'RQP+
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MTVC_(B-'+KC:**:[]JG6WKF4;G[XVY[?<B!RRH9)[4?;N,&IE>O^:]@28>+
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MB$%Y7Q3D^-]*!1C!<6B]+[9%_\>R]@2Z3IOJLH@[-EQ9>3EE0+BG5-Q5^[I
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M$7Q_OL#RY^F^ /C<S2=]W*GLLPM.>DJ>?0Z[L<%@.8P],"F$B-+/1[*;=&T
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M4$L! A0#%     @ HH2:6/",)<H;+   _5H" !$              ( !
M &%F>6$M,C R,S$R,S$N>'-D4$L! A0#%     @ HH2:6 =]?W;X&   :&<!
M !4              ( !2BP  &%F>6$M,C R,S$R,S%?8V%L+GAM;%!+ 0(4
M Q0    ( **$FEAP6!'P_6\  +U/"  5              "  75%  !A9GEA
M+3(P,C,Q,C,Q7V1E9BYX;6Q02P$"% ,4    " "BA)I8 8'>Y;V]  ! U0H
M%0              @ &EM0  869Y82TR,#(S,3(S,5]L86(N>&UL4$L! A0#
M%     @ HH2:6(DD[6,SC@  A+P* !4              ( !E7,! &%F>6$M
M,C R,S$R,S%?<')E+GAM;%!+ 0(4 Q0    ( **$FEA\<.)ZRSD' (R]1@ 4
M              "  ?L! @!A9GEA9F]R;3(P9E\R,#(S+FAT;5!+ 0(4 Q0
M   ( **$FEA^X4]=@DL  -EC 0 *              "  ?@["0!E># R+3$N
M:'1M4$L! A0#%     @ HH2:6!N8LV48!@  <BH   H              ( !
MHH<) &5X,#@M,2YH=&U02P$"% ,4    " "BA)I8^*FFOR4'  !@'   "@
M            @ 'BC0D 97@Q,BTQ+FAT;5!+ 0(4 Q0    ( **$FE@$J-O"
M'@<  $H<   *              "  2^5"0!E>#$R+3(N:'1M4$L! A0#%
M  @ HH2:6-C"ZYZ3 P  1 @   H              ( !=9P) &5X,3,M,2YH
M=&U02P$"% ,4    " "BA)I8UMMX[9X#  "Q"   "@              @ $P
MH D 97@Q,RTR+FAT;5!+ 0(4 Q0    ( **$FEAMI8_X:@,  /$1   *
M          "  ?:C"0!E>#(S+3$N:'1M4$L! A0#%     @ HH2:6*R^\H>T
M'@  *Y,   H              ( !B*<) &5X.3<M,2YH=&U02P$"% ,4
M" "BA)I8  ^L8E[Y @!""0, #0              @ %DQ@D :6UA9V5?,#(S
M+FIP9U!+ 0(4 Q0    ( **$FEBV]49=Q'H  %6*   -              "
M >V_# !I;6%G95\P,C8N:G!G4$L! A0#%     @ HH2:6&S%*[0D' , M2L#
M  T              ( !W#H- &EM86=E7S R."YJ<&=02P$"% ,4    " "B
MA)I8Y6GIQWZ#  !:F@  #0              @ $K5Q  :6UA9V5?,#(Y+FIP
M9U!+ 0(4 Q0    ( **$FEAE^<9FTTT  ,!B   -              "  =3:
M$ !I;6%G95\P,S N:G!G4$L! A0#%     @ HH2:6-SE&6@J-   <E@   T
M             ( !TB@1 &EM86=E7S S,2YJ<&=02P$"% ,4    " "BA)I8
M%?3GR 0P  #2.   #0              @ $G71$ :6UA9V5?,#,R+FIP9U!+
M 0(4 Q0    ( **$FEAK_BV)$E$  !AM   -              "  5:-$0!I
M;6%G95\P,S,N:G!G4$L! A0#%     @ HH2:6*,Z0_N:>P  ;:,   T
M         ( !D]X1 &EM86=E7S S-"YJ<&=02P$"% ,4    " "BA)I8MSB?
M#_$F   /,P  #0              @ %86A( :6UA9V5?,#,U+FIP9U!+ 0(4
M Q0    ( **$FECN[[5)GBL  (TZ   -              "  72!$@!I;6%G
M95\P,S8N:G!G4$L! A0#%     @ HH2:6#JNL=1P#@  01D   T
M     ( !/:T2 &EM86=E7S S-RYJ<&=02P$"% ,4    " "BA)I8VE@S!?(:
M  !<(@  #0              @ '8NQ( :6UA9V5?,#,X+FIP9U!+ 0(4 Q0
M   ( **$FEC[L-#/NA8   8I   -              "  ?76$@!I;6%G95\P
M,SDN:G!G4$L! A0#%     @ HH2:6+C)#=XD&P  .R(   T
M ( !VNT2 &EM86=E7S T,"YJ<&=02P$"% ,4    " "BA)I8.3!K)C4Q   =
M5   #0              @ $I"1, :6UA9V5?,#0Q+FIP9U!+ 0(4 Q0    (
M **$FEB,%D6BE1H  *PC   -              "  8DZ$P!I;6%G95\P-#(N
M:G!G4$L! A0#%     @ HH2:6'DML5%6/   +DH   T              ( !
M2543 &EM86=E7S T-"YJ<&=02P$"% ,4    " "BA)I84(_FF[$6 P!8=P,
M#0              @ '*D1, :6UA9V5?,#0U+FIP9U!+ 0(4 Q0    ( **$
MFECZZY*T>%8  !%:   -              "  ::H%@!I;6%G95\P-#8N:G!G
M4$L! A0#%     @ HH2:6.HL/]KX>0  &9(   T              ( !2?\6
M &EM86=E7S T-RYJ<&=02P$"% ,4    " "BA)I8D9@3E8&1 0#[K@$ #0
M            @ %L>1< :6UA9V5?,#0X+FIP9U!+!08     )  D %\(   8
%"QD    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>afyaform20f_2023_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:afya="http://afya.com.br/20231231"
  xmlns:currency="http://xbrl.sec.gov/currency/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="afya-20231231.xsd" xlink:type="simple"/>
    <context id="From2023-01-01to2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2022-05-042022-05-05_custom_BertelsmannMember_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BertelsmannMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-04</startDate>
            <endDate>2022-05-05</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_BertelsmannMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BertelsmannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_BertelsmannMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BertelsmannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BertelsmannMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BertelsmannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_BertelsmannMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BertelsmannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_SubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_SubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AfyaParticipacoesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AfyaParticipacoesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroIntegradoDeSaudeDeTeresinaCISMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroIntegradoDeSaudeDeTeresinaCISMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_MedcelEditoraEventosS.A.MedcelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelEditoraEventosS.A.MedcelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_MedcelEditoraEventosS.A.MedcelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelEditoraEventosS.A.MedcelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoS.A.FASAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoS.A.FASAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ESMCEducacaoSuperiorLtdaESMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ESMCEducacaoSuperiorLtdaESMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaenseDeEducacaoECulturaLtda.IPECMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaenseDeEducacaoECulturaLtda.IPECMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorS.A.UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorS.A.UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeEnsinoSaoLucasLtda.UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeEnsinoSaoLucasLtda.UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeSolutionsS.A.MedicinaeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeSolutionsS.A.MedicinaeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtda.CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtda.CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiaDaInformacaoLtda.ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiaDaInformacaoLtda.ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SociedadeEducacionalDePalhocaSALtda.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalDePalhocaSALtda.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SociedadeEducacionalDePalhocaSALtda.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalDePalhocaSALtda.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesDeTecnologiaLtda.RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesDeTecnologiaLtda.RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROLOGTransporteELogisticaLtda.RXPROLOGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROLOGTransporteELogisticaLtda.RXPROLOGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:BMVAtividadesMedicasLtda.AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:BMVAtividadesMedicasLtda.AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardiopapersSolucoesDigitaisLtda.CardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardiopapersSolucoesDigitaisLtda.CardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:TeachingActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ProgramOfSocialIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_TeachingActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:TeachingActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ContributionForTheFinancingOfSocialSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ProgramOfSocialIntegrationMember_custom_NonTeachingActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:NonTeachingActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ProgramOfSocialIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_NonTeachingActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:NonTeachingActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ContributionForTheFinancingOfSocialSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AmendmentsToIAS1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AmendmentsToIAS8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AmendmentsToIAS12Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AmendmentsToIAS12OneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS12OneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_IFRS17Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">ifrs-full:IFRS17Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AmendmentsToIFRS16Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIFRS16Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AmendmentsToIAS1OneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS1OneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AmendmentsToIAS7AndIFRS7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS7AndIFRS7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-02_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-02</instant>
        </period>
    </context>
    <context id="From2023-01-012023-01-02_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-02</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-02_custom_AcquisitionOfDelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfDelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-02</instant>
        </period>
    </context>
    <context id="From2022-12-292023-01-02_custom_AcquisitionOfDelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfDelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-29</startDate>
            <endDate>2023-01-02</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AcquisitionOfDelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfDelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-04_custom_AlemDaMedicinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-04</instant>
        </period>
    </context>
    <context id="From2022-03-032022-03-04_custom_AlemDaMedicinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-03</startDate>
            <endDate>2022-03-04</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AlemDaMedicinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-05_custom_AcquisitionOfCardioPapersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfCardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-05</instant>
        </period>
    </context>
    <context id="From2022-04-042022-04-05_custom_AcquisitionOfCardioPapersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfCardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="From2022-04-042022-04-05_custom_CardioPapersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CardioPapersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-05-23_custom_AcquisitionOfGlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfGlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-23</instant>
        </period>
    </context>
    <context id="From2022-05-222022-05-23_custom_AcquisitionOfGlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfGlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-22</startDate>
            <endDate>2022-05-23</endDate>
        </period>
    </context>
    <context id="From2022-05-222022-05-23_custom_GlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:GlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-22</startDate>
            <endDate>2022-05-23</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:GlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-01-02_ifrs-full_LicencesAndFranchisesMember_custom_AcquisitionOfDelReyMember_custom_WithAndWithoutMethodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:WithAndWithoutMethodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfDelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-02</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-01-02_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfDelReyMember_ifrs-full_MultiperiodExcessEarningsMethodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">ifrs-full:MultiperiodExcessEarningsMethodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfDelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-02</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-04</instant>
        </period>
    </context>
    <context id="AsOf2022-04-05_custom_CardioPapersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-05</instant>
        </period>
    </context>
    <context id="AsOf2022-05-23_custom_GlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-23</instant>
        </period>
    </context>
    <context id="From2022-03-032022-03-04_custom_AlemDaMedicinaMember1360038046">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-03</startDate>
            <endDate>2022-03-04</endDate>
        </period>
    </context>
    <context id="From2022-04-042022-04-05_custom_CardioPapersMember1360038093">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="From2022-05-222022-05-23_custom_GlicMember1360038140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-22</startDate>
            <endDate>2022-05-23</endDate>
        </period>
    </context>
    <context id="From2022-03-032022-03-04_ifrs-full_BrandNamesMember_custom_AlemDaMedicinaMember_custom_ReliefFromRoyaltyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReliefFromRoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-03</startDate>
            <endDate>2022-03-04</endDate>
        </period>
    </context>
    <context id="From2022-03-032022-03-04_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AlemDaMedicinaMember_ifrs-full_MultiperiodExcessEarningsMethodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">ifrs-full:MultiperiodExcessEarningsMethodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-03</startDate>
            <endDate>2022-03-04</endDate>
        </period>
    </context>
    <context id="From2022-03-032022-03-04_custom_EducationalContentMember_custom_AlemDaMedicinaMember_custom_ReplacementCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">afya:EducationalContentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReplacementCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-03</startDate>
            <endDate>2022-03-04</endDate>
        </period>
    </context>
    <context id="From2022-03-032022-03-04_ifrs-full_TechnologybasedIntangibleAssetsMember_custom_AlemDaMedicinaMember_custom_ReplacementCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReplacementCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-03</startDate>
            <endDate>2022-03-04</endDate>
        </period>
    </context>
    <context id="From2022-04-042022-04-05_ifrs-full_BrandNamesMember_custom_AcquisitionOfCardioPapersMember_custom_ReliefFromRoyaltyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReliefFromRoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfCardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="From2022-04-042022-04-05_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfCardioPapersMember_ifrs-full_MultiperiodExcessEarningsMethodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">ifrs-full:MultiperiodExcessEarningsMethodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfCardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="From2022-04-042022-04-05_custom_EducationalContentMember_custom_AcquisitionOfCardioPapersMember_custom_ReplacementCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">afya:EducationalContentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReplacementCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfCardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="From2022-04-042022-04-05_custom_CopyrightMember_custom_AcquisitionOfCardioPapersMember_custom_ReliefFromRoyaltyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">afya:CopyrightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReliefFromRoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfCardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="From2022-05-222022-05-23_ifrs-full_BrandNamesMember_custom_AcquisitionOfGlicMember_custom_ReliefFromRoyaltyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReliefFromRoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfGlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-22</startDate>
            <endDate>2022-05-23</endDate>
        </period>
    </context>
    <context id="From2022-05-222022-05-23_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfGlicMember_ifrs-full_MultiperiodExcessEarningsMethodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">ifrs-full:MultiperiodExcessEarningsMethodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfGlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-22</startDate>
            <endDate>2022-05-23</endDate>
        </period>
    </context>
    <context id="From2022-05-222022-05-23_ifrs-full_TechnologybasedIntangibleAssetsMember_custom_AcquisitionOfGlicMember_custom_ReplacementCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:ReplacementCostMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfGlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-22</startDate>
            <endDate>2022-05-23</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BankCertificatesOfDepositMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:BankCertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_BankCertificatesOfDepositMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:BankCertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_USDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">afya:USDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_USDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">afya:USDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TuitionFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:TuitionFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TuitionFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:TuitionFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EducationalContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EducationalContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_FIESMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:FIESMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_FIESMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:FIESMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EducationalCreditsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EducationalCreditsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_MobileAppSubscriptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:MobileAppSubscriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_MobileAppSubscriptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:MobileAppSubscriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OthersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OthersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsNeitherPastDueNorImpairedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsNeitherPastDueNorImpairedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_CurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_CurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LaterThanOneEightyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneEightyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LaterThanOneEightyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneEightyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_UEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_UEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EMIVEPatrulha24HorasLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:EMIVEPatrulha24HorasLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_EMIVEPatrulha24HorasLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:EMIVEPatrulha24HorasLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EMIVEPatrulha24HorasLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:EMIVEPatrulha24HorasLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LeaseAgreements1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2018-09-052018-09-06_custom_LeaseAgreements1Member_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-05</startDate>
            <endDate>2018-09-06</endDate>
        </period>
    </context>
    <context id="From2018-09-052018-09-06_custom_LeaseAgreements1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-05</startDate>
            <endDate>2018-09-06</endDate>
        </period>
    </context>
    <context id="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-28</startDate>
            <endDate>2019-10-30</endDate>
        </period>
    </context>
    <context id="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-28</startDate>
            <endDate>2019-10-30</endDate>
        </period>
    </context>
    <context id="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-28</startDate>
            <endDate>2019-10-30</endDate>
        </period>
    </context>
    <context id="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-08-02</endDate>
        </period>
    </context>
    <context id="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-08-02</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-23</startDate>
            <endDate>2018-04-25</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EducationContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EducationalPlatformMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SoftwareInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EducationContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EducationalPlatformMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SoftwareInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ITPACGaranhunsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ITPACGaranhunsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelAndCBBWMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelAndCBBWMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PracticeManagementToolsAndElectronicPrescriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PracticeManagementToolsAndElectronicPrescriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ClinicalDecisionSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ClinicalDecisionSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnifipMocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnifipMocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_GlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_GlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CarryingAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CarryingAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CustomerRelationshipsMedicineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:CustomerRelationshipsMedicineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CustomerRelationshipsOtherCoursesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:CustomerRelationshipsOtherCoursesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EducationContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DevelopedTechnologyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwentyTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwentyTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TwentyTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwentyTwentySevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwentyTwentySevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TwentyTwentySevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwentyTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwentyTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TwentyTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwentyTwentySixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwentyTwentySixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TwentyTwentySixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwentyTwentyEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwentyTwentyEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TwentyTwentyEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2019-05-082019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-08</startDate>
            <endDate>2019-05-09</endDate>
        </period>
    </context>
    <context id="AsOf2019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-09</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2021-02-28_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="AsOf2020-02-29_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="From2020-01-012020-01-31_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-01-31_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="AsOf2021-01-31_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="From2020-05-042020-05-05_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-05</endDate>
        </period>
    </context>
    <context id="AsOf2020-05-05_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-05</instant>
        </period>
    </context>
    <context id="From2020-11-082020-11-09_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-08</startDate>
            <endDate>2020-11-09</endDate>
        </period>
    </context>
    <context id="AsOf2020-11-09_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-09</instant>
        </period>
    </context>
    <context id="From2021-04-072021-04-08_custom_MedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-07</startDate>
            <endDate>2021-04-08</endDate>
        </period>
    </context>
    <context id="AsOf2021-04-08_custom_MedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-08</instant>
        </period>
    </context>
    <context id="From2021-05-122021-05-13_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-12</startDate>
            <endDate>2021-05-13</endDate>
        </period>
    </context>
    <context id="AsOf2021-05-13_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-13</instant>
        </period>
    </context>
    <context id="From2021-08-032021-08-04_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-03</startDate>
            <endDate>2021-08-04</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-04_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-04</instant>
        </period>
    </context>
    <context id="From2021-10-012021-10-02_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-02</endDate>
        </period>
    </context>
    <context id="AsOf2021-10-02_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-02</instant>
        </period>
    </context>
    <context id="From2021-11-042021-11-05_custom_ITPACGaranhunsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ITPACGaranhunsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-04</startDate>
            <endDate>2021-11-05</endDate>
        </period>
    </context>
    <context id="AsOf2021-11-05_custom_ITPACGaranhunsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ITPACGaranhunsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-05</instant>
        </period>
    </context>
    <context id="From2022-03-222022-03-23_custom_GlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-22</startDate>
            <endDate>2022-03-23</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-23_custom_GlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-23</instant>
        </period>
    </context>
    <context id="From2022-12-292023-01-02_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-29</startDate>
            <endDate>2023-01-02</endDate>
        </period>
    </context>
    <context id="From2022-12-292023-02-01_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-29</startDate>
            <endDate>2023-02-01</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_currency_EUR_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_IPEMEDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPEMEDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_IPEMEDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPEMEDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_MedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_MedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_GuaranhunsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GuaranhunsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_GuaranhunsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GuaranhunsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AlemDaMedicinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AlemDaMedicinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CardiPapersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardiPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CardiPapersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardiPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_GlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_GlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_TradeReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_TradeReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LoansAndFinancingTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LoansAndFinancingTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LoansAndFinancingThreeMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LoansAndFinancingThreeMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ForeignCurrencyExposuresMember_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:ForeignCurrencyExposuresMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_IncreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:IncreaseForeignCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DecreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:DecreaseForeignCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LoansAndFinancingMember1360068625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LoansAndFinancingMember1360068953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember1360068984">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember1360069062">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DividendsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_DividendsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_DividendsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_Level2OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_Level2OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2020-07-012020-07-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-29</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-07-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-08</endDate>
        </period>
    </context>
    <context id="From2023-02-122023-02-13_custom_OptionsGrantedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OptionsGrantedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-12</startDate>
            <endDate>2023-02-13</endDate>
        </period>
    </context>
    <context id="From2023-04-162023-04-17_custom_OptionsGrantedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OptionsGrantedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-16</startDate>
            <endDate>2023-04-17</endDate>
        </period>
    </context>
    <context id="From2023-07-302023-08-01_custom_OptionsGrantedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OptionsGrantedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-30</startDate>
            <endDate>2023-08-01</endDate>
        </period>
    </context>
    <context id="From2023-09-302023-10-01_custom_OptionsGrantedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OptionsGrantedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-30</startDate>
            <endDate>2023-10-01</endDate>
        </period>
    </context>
    <context id="From2023-11-292023-12-01_custom_OptionsGrantedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OptionsGrantedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-29</startDate>
            <endDate>2023-12-01</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ShareBasedCompensationPlansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ShareBasedCompensationPlansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ShareBasedCompensationPlansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RestrictedStockUnits1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnits1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RestrictedStockUnits2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnits2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RestrictedStockUnits3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnits3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="From2022-09-012022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-292023-02-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2023-01-29</startDate>
            <endDate>2023-02-02</endDate>
        </period>
    </context>
    <context id="From2023-04-162023-04-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2023-04-16</startDate>
            <endDate>2023-04-17</endDate>
        </period>
    </context>
    <context id="From2023-07-302023-08-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2023-07-30</startDate>
            <endDate>2023-08-01</endDate>
        </period>
    </context>
    <context id="From2023-09-302023-10-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2023-09-30</startDate>
            <endDate>2023-10-01</endDate>
        </period>
    </context>
    <context id="From2023-11-292023-12-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2023-11-29</startDate>
            <endDate>2023-12-01</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember1360072343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RSUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_IncrementalStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OriginalPlanMember_custom_IncrementalStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IncrementalStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_RSUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_RSUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_RSUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:RSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IPCAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IPCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IPCAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IPCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_CDIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:CDIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_CDIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:CDIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IPCAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IPCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_CDIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:CDIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IPCAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IPCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IPCAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IPCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_CDIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:CDIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_CDIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:CDIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IPCAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:IPCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OriginalPlanMember_custom_CDIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">afya:CDIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-02-13_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-13</instant>
        </period>
    </context>
    <context id="AsOf2023-04-17_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-17</instant>
        </period>
    </context>
    <context id="AsOf2023-08-01_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="AsOf2023-10-01_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-01</instant>
        </period>
    </context>
    <context id="AsOf2023-12-01_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-01</instant>
        </period>
    </context>
    <context id="From2023-02-122023-02-13_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-12</startDate>
            <endDate>2023-02-13</endDate>
        </period>
    </context>
    <context id="From2023-04-162023-04-17_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-16</startDate>
            <endDate>2023-04-17</endDate>
        </period>
    </context>
    <context id="From2023-07-302023-08-01_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-30</startDate>
            <endDate>2023-08-01</endDate>
        </period>
    </context>
    <context id="From2023-09-292023-10-01_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-10-01</endDate>
        </period>
    </context>
    <context id="From2023-11-302023-12-01_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-30</startDate>
            <endDate>2023-12-01</endDate>
        </period>
    </context>
    <context id="From2023-02-122023-02-13_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-12</startDate>
            <endDate>2023-02-13</endDate>
        </period>
    </context>
    <context id="From2023-02-122023-02-13_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-12</startDate>
            <endDate>2023-02-13</endDate>
        </period>
    </context>
    <context id="From2023-04-162023-04-17_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-16</startDate>
            <endDate>2023-04-17</endDate>
        </period>
    </context>
    <context id="From2023-04-162023-04-17_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-16</startDate>
            <endDate>2023-04-17</endDate>
        </period>
    </context>
    <context id="From2023-07-302023-08-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-30</startDate>
            <endDate>2023-08-01</endDate>
        </period>
    </context>
    <context id="From2023-07-302023-08-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-30</startDate>
            <endDate>2023-08-01</endDate>
        </period>
    </context>
    <context id="From2023-09-292023-10-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-10-01</endDate>
        </period>
    </context>
    <context id="From2023-09-292023-10-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-10-01</endDate>
        </period>
    </context>
    <context id="From2023-11-302023-12-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-30</startDate>
            <endDate>2023-12-01</endDate>
        </period>
    </context>
    <context id="From2023-11-302023-12-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-30</startDate>
            <endDate>2023-12-01</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-10-27_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-27</instant>
        </period>
    </context>
    <context id="AsOf2022-01-27_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-27</instant>
        </period>
    </context>
    <context id="AsOf2023-03-24_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-24</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OneSubsidiaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:OneSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OtherAssetsNonCurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">afya:OtherAssetsNonCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OtherAssetsNonCurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">afya:OtherAssetsNonCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_IClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_IClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_IClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-232024-01-24_custom_FaculdadesIntegradasPadraoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">afya:FaculdadesIntegradasPadraoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-23</startDate>
            <endDate>2024-01-24</endDate>
        </period>
    </context>
    <context id="AsOf2024-01-24_custom_FaculdadesIntegradasPadraoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">afya:FaculdadesIntegradasPadraoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-24</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="N">
        <measure>afya:Number</measure>
    </unit>
    <unit id="BRL">
        <measure>iso4217:BRL</measure>
    </unit>
    <unit id="BRLPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:BRL</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="From2023-01-01to2023-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2023-01-01to2023-12-31" id="Fact000004">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2023-01-01to2023-12-31" id="Fact000005">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2023-01-01to2023-12-31" id="Fact000006">0001771007</dei:EntityCentralIndexKey>
    <afya:NotePayableCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0140"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0270"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0271"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0272"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0312"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0319"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0320"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0321"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0322"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0328"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0329"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0330"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0331"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0337"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0339"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0340"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0341"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0343"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0346"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0347"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0349"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0350"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0352"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0355"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0358"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0359"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0361"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0364"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0367"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0368"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0370"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0373"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0374"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0375"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0377"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0379"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0382"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0383"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0384"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0385"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0386"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      id="xdx2ixbrl0387"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0400"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2022-01-012022-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0401"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2022-01-012022-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0402"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0403"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0409"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-01-012022-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0410"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-01-012022-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0411"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0412"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0418"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2022-01-012022-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0419"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0421"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2022-01-012022-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0422"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2022-01-012022-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0424"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0427"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2022-01-012022-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0428"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2022-01-012022-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0429"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2022-01-012022-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0431"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2022-01-012022-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0433"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0436"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2022-01-012022-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0437"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2022-01-012022-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0438"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0439"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2022-01-012022-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0440"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2022-01-012022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      id="xdx2ixbrl0441"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0454"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0455"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0456"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0457"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0463"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0464"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0465"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0466"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0472"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0473"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0475"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0476"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0478"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0481"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0482"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0483"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0485"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0487"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0490"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0491"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0492"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0493"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0499"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0502"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0503"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0505"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0508"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0511"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0512"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0514"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0517"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0518"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0519"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0520"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0521"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      id="xdx2ixbrl0522"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PurchaseOfAcquisitionOfNoncontrollingInterests
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0656"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PurchaseOfAcquisitionOfNoncontrollingInterests
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0657"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedCashOfInvestingActivities
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl0667"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedCashOfInvestingActivities
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0668"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0704"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1270"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1306"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1318"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1324"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      id="xdx2ixbrl1326"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1330"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalExpenditures
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1342"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1379"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1415"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1427"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1433"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      id="xdx2ixbrl1435"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1439"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalExpenditures
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1451"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepositsFromExternalCustomer
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1465"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      id="xdx2ixbrl1469"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1471"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      id="xdx2ixbrl1479"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1513"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepositsFromExternalCustomer
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1543"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      id="xdx2ixbrl1547"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1549"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      id="xdx2ixbrl1557"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1591"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepositsFromExternalCustomer
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1623"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      id="xdx2ixbrl1627"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1629"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      id="xdx2ixbrl1637"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1671"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      id="xdx2ixbrl1792"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      id="xdx2ixbrl1816"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      id="xdx2ixbrl1828"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      id="xdx2ixbrl1830"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      id="xdx2ixbrl1832"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2022-05-23_custom_GlicMember"
      id="xdx2ixbrl1876"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NoncurrentAssetsOfRelatedParty1
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2094"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AccountsPayableToSellingShareholders
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2096"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2099"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AccountsPayableCurrent1
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2102"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NoncurrentPayablesToRelatedParties1
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2105"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NoncurrentPayablesToRelatedParties1
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2106"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2022-01-012022-12-31_custom_EMIVEPatrulha24HorasLtdaMember"
      id="xdx2ixbrl2116"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2021-01-012021-12-31_custom_EMIVEPatrulha24HorasLtdaMember"
      id="xdx2ixbrl2118"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Dividend
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2244"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxAssets
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2247"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsReceived
      contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember"
      id="xdx2ixbrl2331"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2369"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2371"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2382"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2393"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2394"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2397"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl2400"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2415"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2424"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2426"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2427"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      id="xdx2ixbrl2428"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2430"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      id="xdx2ixbrl2431"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2432"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2437"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2441"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      id="xdx2ixbrl2442"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2448"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2470"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2479"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2481"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2482"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2490"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2492"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2498"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2503"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2504"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2507"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl2510"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2523"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2525"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2531"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2536"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2542"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2545"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2547"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2553"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2558"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2564"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2569"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2575"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2578"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2580"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2586"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2591"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2597"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2598"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2602"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2608"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2613"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2619"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2624"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2630"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2635"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2636"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      id="xdx2ixbrl2637"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2639"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2641"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2642"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2646"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2652"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl2718"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl2780"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2938"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2940"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2954"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2958"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2959"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2968"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2977"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2979"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2993"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2995"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2999"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3000"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3008"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3022"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3024"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3038"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3044"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3045"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3053"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3067"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3069"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3083"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      id="xdx2ixbrl3211"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      id="xdx2ixbrl3213"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      id="xdx2ixbrl3219"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      id="xdx2ixbrl3221"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember"
      id="xdx2ixbrl3279"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember"
      id="xdx2ixbrl3281"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember"
      id="xdx2ixbrl3295"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember"
      id="xdx2ixbrl3297"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember"
      id="xdx2ixbrl3307"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember"
      id="xdx2ixbrl3309"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember"
      id="xdx2ixbrl3319"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember"
      id="xdx2ixbrl3321"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember"
      id="xdx2ixbrl3331"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember"
      id="xdx2ixbrl3333"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_RXPROMember"
      id="xdx2ixbrl3367"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_RXPROMember"
      id="xdx2ixbrl3369"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_GlicMember"
      id="xdx2ixbrl3379"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_GlicMember"
      id="xdx2ixbrl3381"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_DelReyMember"
      id="xdx2ixbrl3389"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_DelReyMember"
      id="xdx2ixbrl3393"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_DelReyMember"
      id="xdx2ixbrl3397"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotePayable
      contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      id="xdx2ixbrl3482"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepreciationExpenseLeaseLiabilities
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl3587"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsInterestExpense
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl3589"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfLeaseLiabilities
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl3593"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfInterest
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl3597"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsCurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl3609"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepreciationExpenseLeaseLiabilities
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3631"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsInterestExpense
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3633"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfLeaseLiabilities
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3637"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfInterest
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3641"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl3653"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepreciationExpenseLeaseLiabilities
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl3679"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsInterestExpense
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl3681"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfLeaseLiabilities
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl3685"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfInterest
      contextRef="From2023-01-01to2023-12-31"
      id="xdx2ixbrl3689"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl3701"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_RXPROMember"
      id="xdx2ixbrl3745"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_GuaranhunsMember"
      id="xdx2ixbrl3749"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_GlicMember"
      id="xdx2ixbrl3761"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_DelReyMember"
      id="xdx2ixbrl3767"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      id="xdx2ixbrl3801"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AccountsPayableToSellingShareholdersBusinessCombinations
      contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      id="xdx2ixbrl3815"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ContingentConsiderationOnBusinessCombinations
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      id="xdx2ixbrl3819"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Reversals
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      id="xdx2ixbrl3825"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Reversals
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      id="xdx2ixbrl3829"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RemeasurementOfEarnouts
      contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      id="xdx2ixbrl3833"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RemeasurementOfEarnouts
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      id="xdx2ixbrl3835"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      id="xdx2ixbrl3839"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      id="xdx2ixbrl3841"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotesPayables
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl3975"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CurrentLiabilities1
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl3981"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NoncurrentLiabilities1
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl3987"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NoncurrentLiabilities1
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl3989"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_custom_NotesPayableMember"
      id="xdx2ixbrl4035"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2023-12-31_custom_NotesPayableMember"
      id="xdx2ixbrl4037"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4125"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4127"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4129"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LoansAndFinancing
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4139"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4157"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4159"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Advances
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4165"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Advances
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4167"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Advances
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4169"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4185"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4187"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4189"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LoansAndFinancing
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4199"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4217"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4219"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotePayables
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4225"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotePayables
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4227"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotePayables
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4229"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Advances
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4235"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Advances
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4237"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Advances
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl4239"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember"
      id="xdx2ixbrl4265"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_DividendsPayableMember"
      id="xdx2ixbrl4289"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31_custom_LoansAndFinancingMember"
      id="xdx2ixbrl4319"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember"
      id="xdx2ixbrl4335"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2022-01-012022-12-31_custom_DividendsPayableMember"
      id="xdx2ixbrl4343"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl4357"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_DividendsPayableMember"
      id="xdx2ixbrl4397"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2023-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember"
      id="xdx2ixbrl4424"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      id="xdx2ixbrl4428"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2022-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember"
      id="xdx2ixbrl4444"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2022-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      id="xdx2ixbrl4448"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2022-01-012022-12-31_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl4746"
      unitRef="N"
      xsi:nil="true"/>
    <afya:WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl4750"
      unitRef="BRLPShares"
      xsi:nil="true"/>
    <afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement
      contextRef="From2022-01-012022-12-31_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl4754"
      unitRef="N"
      xsi:nil="true"/>
    <afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement
      contextRef="From2021-01-012021-12-31_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl4756"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2021-12-31_custom_RestrictedStockUnitsMember"
      id="xdx2ixbrl4836"
      unitRef="N"
      xsi:nil="true"/>
    <afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement
      contextRef="From2022-01-012022-12-31_custom_RestrictedStockUnitsMember"
      id="xdx2ixbrl4844"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2022-01-012022-12-31_custom_RestrictedStockUnitsMember"
      id="xdx2ixbrl4848"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2022-01-012022-12-31_custom_RestrictedStockUnitsMember"
      id="xdx2ixbrl4852"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl4922"
      unitRef="Shares"
      xsi:nil="true"/>
    <afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl4924"
      unitRef="BRLPShares"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2023-01-012023-12-31_custom_DigitalServicesMember"
      id="xdx2ixbrl5067"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember"
      id="xdx2ixbrl5069"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember"
      id="xdx2ixbrl5105"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember"
      id="xdx2ixbrl5109"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2022-01-012022-12-31_custom_DigitalServicesMember"
      id="xdx2ixbrl5129"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember"
      id="xdx2ixbrl5131"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2022-01-012022-12-31_custom_ContinuingEducationMember"
      id="xdx2ixbrl5167"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember"
      id="xdx2ixbrl5189"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember"
      id="xdx2ixbrl5191"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherRevenue
      contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember"
      id="xdx2ixbrl5197"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember"
      id="xdx2ixbrl5221"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember"
      id="xdx2ixbrl5227"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RecognisedDeferredTaxAssets
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl5400"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RecognisedDeferredTaxAssets
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl5401"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      id="xdx2ixbrl5501"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_IClinicMember"
      id="xdx2ixbrl5559"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_custom_IClinicMember"
      id="xdx2ixbrl5561"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_CliquefarmaMember"
      id="xdx2ixbrl5565"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_custom_CliquefarmaMember"
      id="xdx2ixbrl5567"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_RXPROMember"
      id="xdx2ixbrl5571"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_custom_RXPROMember"
      id="xdx2ixbrl5573"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RemeasurementOfEarnOut
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl5579"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RemeasurementOfEarnOut
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl5581"
      unitRef="BRL"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2023-01-01to2023-12-31" id="Fact000016">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="From2023-01-01to2023-12-31" id="Fact000017">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="From2023-01-01to2023-12-31" id="Fact000018">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2023-01-01to2023-12-31" id="Fact000019">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-01-01to2023-12-31" id="Fact000020">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="From2023-01-01to2023-12-31" id="Fact000021">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="From2023-01-01to2023-12-31" id="Fact000022">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="From2023-01-01to2023-12-31" id="Fact000023">001-38992</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2023-01-01to2023-12-31" id="Fact000024">AFYA LIMITED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-01-01to2023-12-31" id="Fact000025">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="From2023-01-01to2023-12-31" id="Fact000026">Alameda Oscar Niemeyer</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-01-01to2023-12-31" id="Fact000027">No. 119</dei:EntityAddressAddressLine2>
    <dei:EntityAddressPostalZipCode contextRef="From2023-01-01to2023-12-31" id="Fact000028">504</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown contextRef="From2023-01-01to2023-12-31" id="Fact000029">Minas Gerais</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2023-01-01to2023-12-31" id="Fact000030">BR</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="From2023-01-012023-12-31_dei_BusinessContactMember"
      id="Fact000032">Virgilio Deloy Capobianco Gibbon</dei:ContactPersonnelName>
    <dei:CityAreaCode
      contextRef="From2023-01-012023-12-31_dei_BusinessContactMember"
      id="Fact000034">55</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2023-01-012023-12-31_dei_BusinessContactMember"
      id="Fact000036">3515-7550</dei:LocalPhoneNumber>
    <dei:ContactPersonnelEmailAddress
      contextRef="From2023-01-012023-12-31_dei_BusinessContactMember"
      id="Fact000038">ir@afya.com.br</dei:ContactPersonnelEmailAddress>
    <dei:EntityAddressAddressLine1
      contextRef="From2023-01-012023-12-31_dei_BusinessContactMember"
      id="Fact000040">Alameda Oscar Niemeyer</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2023-01-012023-12-31_dei_BusinessContactMember"
      id="Fact000042">No. 119</dei:EntityAddressAddressLine2>
    <dei:EntityAddressPostalZipCode
      contextRef="From2023-01-012023-12-31_dei_BusinessContactMember"
      id="Fact000043">504</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="From2023-01-012023-12-31_dei_BusinessContactMember"
      id="Fact000045">Minas Gerais</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="From2023-01-012023-12-31_dei_BusinessContactMember"
      id="Fact000047">BR</dei:EntityAddressCountry>
    <dei:Security12bTitle contextRef="From2023-01-01to2023-12-31" id="Fact000048">Class A common shares, par value US$0.00005 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-01to2023-12-31" id="Fact000049">AFYA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-01to2023-12-31" id="Fact000050">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000051"
      unitRef="Shares">47920068</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000052"
      unitRef="Shares">45802763</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2023-01-01to2023-12-31" id="Fact000053">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2023-01-01to2023-12-31" id="Fact000054">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2023-01-01to2023-12-31" id="Fact000055">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2023-01-01to2023-12-31" id="Fact000056">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2023-01-01to2023-12-31" id="Fact000057">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-01-01to2023-12-31" id="Fact000059">false</dei:EntityEmergingGrowthCompany>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2023-01-01to2023-12-31" id="Fact000061">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:IcfrAuditorAttestationFlag contextRef="From2023-01-01to2023-12-31" id="Fact000062">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentAccountingStandard contextRef="From2023-01-01to2023-12-31" id="Fact000064">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="From2023-01-01to2023-12-31" id="Fact000066">false</dei:EntityShellCompany>
    <dei:AuditorFirmId contextRef="From2023-01-01to2023-12-31" id="Fact000067">1448</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2023-01-01to2023-12-31" id="Fact000068">ERNST &amp; YOUNG</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2023-01-01to2023-12-31" id="Fact000069">Belo Horizonte, Brazil</dei:AuditorLocation>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000077"
      unitRef="BRL">553030000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000078"
      unitRef="BRL">1093082000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentTradeReceivables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000080"
      unitRef="BRL">546438000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000081"
      unitRef="BRL">452831000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:Inventories
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000083"
      unitRef="BRL">1382000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000084"
      unitRef="BRL">12190000</ifrs-full:Inventories>
    <ifrs-full:CurrentTaxAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000086"
      unitRef="BRL">43751000</ifrs-full:CurrentTaxAssets>
    <ifrs-full:CurrentTaxAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000087"
      unitRef="BRL">27809000</ifrs-full:CurrentTaxAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000089"
      unitRef="BRL">58905000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000090"
      unitRef="BRL">51745000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000092"
      unitRef="BRL">1203506000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000093"
      unitRef="BRL">1637657000</ifrs-full:CurrentAssets>
    <afya:NoncurrentTradeReceivable
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000098"
      unitRef="BRL">39485000</afya:NoncurrentTradeReceivable>
    <afya:NoncurrentTradeReceivable
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000099"
      unitRef="BRL">42568000</afya:NoncurrentTradeReceivable>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000101"
      unitRef="BRL">117346000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000102"
      unitRef="BRL">191756000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000104"
      unitRef="BRL">51834000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000105"
      unitRef="BRL">53907000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000107"
      unitRef="BRL">608685000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000108"
      unitRef="BRL">542087000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000110"
      unitRef="BRL">767609000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000111"
      unitRef="BRL">690073000</ifrs-full:RightofuseAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000113"
      unitRef="BRL">4796016000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000114"
      unitRef="BRL">4041491000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000116"
      unitRef="BRL">6380975000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000117"
      unitRef="BRL">5561882000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000119"
      unitRef="BRL">7584481000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000120"
      unitRef="BRL">7199539000</ifrs-full:Assets>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000128"
      unitRef="BRL">108222000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000129"
      unitRef="BRL">71482000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:ShorttermBorrowings
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000131"
      unitRef="BRL">179252000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000132"
      unitRef="BRL">145202000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000134"
      unitRef="BRL">36898000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000135"
      unitRef="BRL">32459000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000137"
      unitRef="BRL">353998000</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000138"
      unitRef="BRL">261711000</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <afya:NotePayableCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000141"
      unitRef="BRL">62176000</afya:NotePayableCurrent>
    <ifrs-full:CurrentDepositsFromCustomers
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000143"
      unitRef="BRL">153485000</ifrs-full:CurrentDepositsFromCustomers>
    <ifrs-full:CurrentDepositsFromCustomers
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000144"
      unitRef="BRL">133050000</ifrs-full:CurrentDepositsFromCustomers>
    <ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000146"
      unitRef="BRL">192294000</ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000147"
      unitRef="BRL">154518000</ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <afya:CurrentTaxesPayable
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000149"
      unitRef="BRL">27765000</afya:CurrentTaxesPayable>
    <afya:CurrentTaxesPayable
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000150"
      unitRef="BRL">26221000</afya:CurrentTaxesPayable>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000152"
      unitRef="BRL">3880000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000153"
      unitRef="BRL">16151000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:OtherCurrentLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000155"
      unitRef="BRL">2773000</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:OtherCurrentLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000156"
      unitRef="BRL">2719000</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000158"
      unitRef="BRL">1058567000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000159"
      unitRef="BRL">905689000</ifrs-full:CurrentLiabilities>
    <ifrs-full:LongtermBorrowings
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000164"
      unitRef="BRL">1621523000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000165"
      unitRef="BRL">1737699000</ifrs-full:LongtermBorrowings>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000167"
      unitRef="BRL">837671000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000168"
      unitRef="BRL">737066000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentPayablesToRelatedParties
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000170"
      unitRef="BRL">212869000</ifrs-full:NoncurrentPayablesToRelatedParties>
    <ifrs-full:NoncurrentPayablesToRelatedParties
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000171"
      unitRef="BRL">266967000</ifrs-full:NoncurrentPayablesToRelatedParties>
    <afya:NoncurrentTaxesPayable
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000173"
      unitRef="BRL">88198000</afya:NoncurrentTaxesPayable>
    <afya:NoncurrentTaxesPayable
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000174"
      unitRef="BRL">92888000</afya:NoncurrentTaxesPayable>
    <ifrs-full:LongtermLegalProceedingsProvision
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000176"
      unitRef="BRL">104361000</ifrs-full:LongtermLegalProceedingsProvision>
    <ifrs-full:LongtermLegalProceedingsProvision
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000177"
      unitRef="BRL">195854000</ifrs-full:LongtermLegalProceedingsProvision>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000179"
      unitRef="BRL">18280000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000180"
      unitRef="BRL">13218000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000182"
      unitRef="BRL">2882902000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000183"
      unitRef="BRL">3043692000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000185"
      unitRef="BRL">3941469000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000186"
      unitRef="BRL">3949381000</ifrs-full:Liabilities>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000191"
      unitRef="BRL">17000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000192"
      unitRef="BRL">17000</ifrs-full:IssuedCapital>
    <ifrs-full:AdditionalPaidinCapital
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000194"
      unitRef="BRL">2365200000</ifrs-full:AdditionalPaidinCapital>
    <ifrs-full:AdditionalPaidinCapital
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000195"
      unitRef="BRL">2375344000</ifrs-full:AdditionalPaidinCapital>
    <ifrs-full:TreasuryShares
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000197"
      unitRef="BRL">299150000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000198"
      unitRef="BRL">304947000</ifrs-full:TreasuryShares>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000200"
      unitRef="BRL">155073000</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000201"
      unitRef="BRL">123538000</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000203"
      unitRef="BRL">1380365000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000204"
      unitRef="BRL">1004886000</ifrs-full:RetainedEarnings>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000206"
      unitRef="BRL">3601505000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000207"
      unitRef="BRL">3198838000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:NoncontrollingInterests
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000209"
      unitRef="BRL">41507000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000210"
      unitRef="BRL">51320000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000212"
      unitRef="BRL">3643012000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000213"
      unitRef="BRL">3250158000</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000215"
      unitRef="BRL">7584481000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000216"
      unitRef="BRL">7199539000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:Revenue
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000218"
      unitRef="BRL">2875913000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000219"
      unitRef="BRL">2329057000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000220"
      unitRef="BRL">1719371000</ifrs-full:Revenue>
    <ifrs-full:CostOfSales
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000222"
      unitRef="BRL">1109813000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000223"
      unitRef="BRL">859552000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000224"
      unitRef="BRL">652300000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000226"
      unitRef="BRL">1766100000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000227"
      unitRef="BRL">1469505000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000228"
      unitRef="BRL">1067071000</ifrs-full:GrossProfit>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000230"
      unitRef="BRL">1014684000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000231"
      unitRef="BRL">798153000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000232"
      unitRef="BRL">622615000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000234"
      unitRef="BRL">15645000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000235"
      unitRef="BRL">-7252000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000236"
      unitRef="BRL">-3561000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000238"
      unitRef="BRL">767061000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000239"
      unitRef="BRL">664100000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000240"
      unitRef="BRL">440895000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000242"
      unitRef="BRL">110642000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000243"
      unitRef="BRL">102042000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000244"
      unitRef="BRL">64566000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000246"
      unitRef="BRL">457616000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000247"
      unitRef="BRL">349893000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000248"
      unitRef="BRL">243796000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceIncomeCost
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000250"
      unitRef="BRL">-346974000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000251"
      unitRef="BRL">-247851000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000252"
      unitRef="BRL">-179230000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000254"
      unitRef="BRL">9495000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000255"
      unitRef="BRL">12184000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000256"
      unitRef="BRL">11797000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000258"
      unitRef="BRL">429582000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000259"
      unitRef="BRL">428433000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000260"
      unitRef="BRL">273462000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000262"
      unitRef="BRL">24166000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000263"
      unitRef="BRL">35677000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000264"
      unitRef="BRL">31179000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000266"
      unitRef="BRL">405416000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000267"
      unitRef="BRL">392756000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000268"
      unitRef="BRL">242283000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000274"
      unitRef="BRL">405416000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000275"
      unitRef="BRL">392756000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000276"
      unitRef="BRL">242283000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000282"
      unitRef="BRL">386324000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000283"
      unitRef="BRL">373569000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000284"
      unitRef="BRL">223326000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000286"
      unitRef="BRL">19092000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000287"
      unitRef="BRL">19187000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000288"
      unitRef="BRL">18957000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <afya:ComprehensiveIncomeLoss
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000290"
      unitRef="BRL">405416000</afya:ComprehensiveIncomeLoss>
    <afya:ComprehensiveIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000291"
      unitRef="BRL">392756000</afya:ComprehensiveIncomeLoss>
    <afya:ComprehensiveIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000292"
      unitRef="BRL">242283000</afya:ComprehensiveIncomeLoss>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact000298"
      unitRef="BRLPShares">4.30</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000299"
      unitRef="BRLPShares">4.14</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact000300"
      unitRef="BRLPShares">2.39</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact000306"
      unitRef="BRLPShares">4.27</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000307"
      unitRef="BRLPShares">4.12</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact000308"
      unitRef="BRLPShares">2.37</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      id="Fact000310"
      unitRef="BRL">17000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000311"
      unitRef="BRL">2323488000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000313"
      unitRef="BRL">50724000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000314"
      unitRef="BRL">407991000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000315"
      unitRef="BRL">2782220000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000316"
      unitRef="BRL">51560000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact000317"
      unitRef="BRL">2833780000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000323"
      unitRef="BRL">223326000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000324"
      unitRef="BRL">223326000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000325"
      unitRef="BRL">18957000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000326"
      unitRef="BRL">242283000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000332"
      unitRef="BRL">223326000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000333"
      unitRef="BRL">223326000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000334"
      unitRef="BRL">18957000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000335"
      unitRef="BRL">242283000</ifrs-full:ComprehensiveIncome>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000338"
      unitRef="BRL">74500000</afya:CapitalIncreaseWithCash>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000342"
      unitRef="BRL">74500000</afya:CapitalIncreaseWithCash>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000344"
      unitRef="BRL">74500000</afya:CapitalIncreaseWithCash>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000348"
      unitRef="BRL">-213722000</afya:TreasuryShares1>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000351"
      unitRef="BRL">-213722000</afya:TreasuryShares1>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000353"
      unitRef="BRL">-213722000</afya:TreasuryShares1>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000356"
      unitRef="BRL">-21861000</afya:TreasurySharesTransferredFromExerciseOfOptions>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000357"
      unitRef="BRL">55197000</afya:TreasurySharesTransferredFromExerciseOfOptions>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000360"
      unitRef="BRL">33336000</afya:TreasurySharesTransferredFromExerciseOfOptions>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000362"
      unitRef="BRL">33336000</afya:TreasurySharesTransferredFromExerciseOfOptions>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000365"
      unitRef="BRL">-783000</afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000366"
      unitRef="BRL">5895000</afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000369"
      unitRef="BRL">5112000</afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000371"
      unitRef="BRL">5112000</afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000376"
      unitRef="BRL">43377000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000378"
      unitRef="BRL">43377000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000380"
      unitRef="BRL">43377000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:DividendsPaid
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000388"
      unitRef="BRL">18648000</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000389"
      unitRef="BRL">18648000</ifrs-full:DividendsPaid>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      id="Fact000391"
      unitRef="BRL">17000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000392"
      unitRef="BRL">2375344000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000393"
      unitRef="BRL">-152630000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000394"
      unitRef="BRL">94101000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000395"
      unitRef="BRL">631317000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000396"
      unitRef="BRL">2948149000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000397"
      unitRef="BRL">51869000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact000398"
      unitRef="BRL">3000018000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2022-01-012022-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000404"
      unitRef="BRL">373569000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2022-01-012022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000405"
      unitRef="BRL">373569000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2022-01-012022-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000406"
      unitRef="BRL">19187000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000407"
      unitRef="BRL">392756000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-01-012022-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000413"
      unitRef="BRL">373569000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-01-012022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000414"
      unitRef="BRL">373569000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-01-012022-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000415"
      unitRef="BRL">19187000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000416"
      unitRef="BRL">392756000</ifrs-full:ComprehensiveIncome>
    <afya:TreasuryShares1
      contextRef="From2022-01-012022-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000420"
      unitRef="BRL">-152317000</afya:TreasuryShares1>
    <afya:TreasuryShares1
      contextRef="From2022-01-012022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000423"
      unitRef="BRL">-152317000</afya:TreasuryShares1>
    <afya:TreasuryShares1
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000425"
      unitRef="BRL">-152317000</afya:TreasuryShares1>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000430"
      unitRef="BRL">29437000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2022-01-012022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000432"
      unitRef="BRL">29437000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000434"
      unitRef="BRL">29437000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:DividendsPaid
      contextRef="From2022-01-012022-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000442"
      unitRef="BRL">19736000</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000443"
      unitRef="BRL">19736000</ifrs-full:DividendsPaid>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      id="Fact000445"
      unitRef="BRL">17000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000446"
      unitRef="BRL">2375344000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000447"
      unitRef="BRL">-304947000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000448"
      unitRef="BRL">123538000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000449"
      unitRef="BRL">1004886000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000450"
      unitRef="BRL">3198838000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000451"
      unitRef="BRL">51320000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000452"
      unitRef="BRL">3250158000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000458"
      unitRef="BRL">386324000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000459"
      unitRef="BRL">386324000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000460"
      unitRef="BRL">19092000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000461"
      unitRef="BRL">405416000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000467"
      unitRef="BRL">386324000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000468"
      unitRef="BRL">386324000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000469"
      unitRef="BRL">19092000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000470"
      unitRef="BRL">405416000</ifrs-full:ComprehensiveIncome>
    <afya:TreasuryShares1
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000474"
      unitRef="BRL">-12369000</afya:TreasuryShares1>
    <afya:TreasuryShares1
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000477"
      unitRef="BRL">-12369000</afya:TreasuryShares1>
    <afya:TreasuryShares1
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000479"
      unitRef="BRL">-12369000</afya:TreasuryShares1>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000484"
      unitRef="BRL">31535000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000486"
      unitRef="BRL">31535000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000488"
      unitRef="BRL">31535000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000494"
      unitRef="BRL">-10845000</afya:AcquisitionOfNoncontrollingInterests>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000495"
      unitRef="BRL">-10845000</afya:AcquisitionOfNoncontrollingInterests>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000496"
      unitRef="BRL">-10155000</afya:AcquisitionOfNoncontrollingInterests>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000497"
      unitRef="BRL">-21000000</afya:AcquisitionOfNoncontrollingInterests>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000500"
      unitRef="BRL">-7491000</afya:RestrictedSharesTransferredToExecutives>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000501"
      unitRef="BRL">5722000</afya:RestrictedSharesTransferredToExecutives>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000504"
      unitRef="BRL">-1769000</afya:RestrictedSharesTransferredToExecutives>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000506"
      unitRef="BRL">-1769000</afya:RestrictedSharesTransferredToExecutives>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000509"
      unitRef="BRL">-2653000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000510"
      unitRef="BRL">12444000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000513"
      unitRef="BRL">9791000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000515"
      unitRef="BRL">9791000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000523"
      unitRef="BRL">18750000</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000524"
      unitRef="BRL">18750000</ifrs-full:DividendsPaid>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      id="Fact000526"
      unitRef="BRL">17000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000527"
      unitRef="BRL">2365200000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000528"
      unitRef="BRL">-299150000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000529"
      unitRef="BRL">155073000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000530"
      unitRef="BRL">1380365000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000531"
      unitRef="BRL">3601505000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000532"
      unitRef="BRL">41507000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000533"
      unitRef="BRL">3643012000</ifrs-full:Equity>
    <afya:IncomeLossBeforeIncomeTaxes
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000539"
      unitRef="BRL">-429582000</afya:IncomeLossBeforeIncomeTaxes>
    <afya:IncomeLossBeforeIncomeTaxes
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000540"
      unitRef="BRL">-428433000</afya:IncomeLossBeforeIncomeTaxes>
    <afya:IncomeLossBeforeIncomeTaxes
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000541"
      unitRef="BRL">-273462000</afya:IncomeLossBeforeIncomeTaxes>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000547"
      unitRef="BRL">289511000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000548"
      unitRef="BRL">206220000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000549"
      unitRef="BRL">154220000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <afya:WriteoffOfPropertyAndEquipment
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000551"
      unitRef="BRL">1910000</afya:WriteoffOfPropertyAndEquipment>
    <afya:WriteoffOfPropertyAndEquipment
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000552"
      unitRef="BRL">1697000</afya:WriteoffOfPropertyAndEquipment>
    <afya:WriteoffOfPropertyAndEquipment
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000553"
      unitRef="BRL">1604000</afya:WriteoffOfPropertyAndEquipment>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000555"
      unitRef="BRL">413000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000556"
      unitRef="BRL">25000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000557"
      unitRef="BRL">2374000</afya:WriteoffOfIntangibleAssets>
    <afya:AllowanceForDoubtfulAccountsOfOpeartingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000559"
      unitRef="BRL">74552000</afya:AllowanceForDoubtfulAccountsOfOpeartingActivities>
    <afya:AllowanceForDoubtfulAccountsOfOpeartingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000560"
      unitRef="BRL">42708000</afya:AllowanceForDoubtfulAccountsOfOpeartingActivities>
    <afya:AllowanceForDoubtfulAccountsOfOpeartingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000561"
      unitRef="BRL">47819000</afya:AllowanceForDoubtfulAccountsOfOpeartingActivities>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000563"
      unitRef="BRL">31535000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000564"
      unitRef="BRL">31274000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000565"
      unitRef="BRL">43377000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000567"
      unitRef="BRL">681000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000568"
      unitRef="BRL">852000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000569"
      unitRef="BRL">17973000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <afya:AccruedInterestOfOpeartingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000571"
      unitRef="BRL">285447000</afya:AccruedInterestOfOpeartingActivities>
    <afya:AccruedInterestOfOpeartingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000572"
      unitRef="BRL">200081000</afya:AccruedInterestOfOpeartingActivities>
    <afya:AccruedInterestOfOpeartingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000573"
      unitRef="BRL">108437000</afya:AccruedInterestOfOpeartingActivities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000575"
      unitRef="BRL">100849000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000576"
      unitRef="BRL">88571000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000577"
      unitRef="BRL">67212000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <afya:ShareOfIncomeOfAssociateOfOpeartingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000579"
      unitRef="BRL">9495000</afya:ShareOfIncomeOfAssociateOfOpeartingActivities>
    <afya:ShareOfIncomeOfAssociateOfOpeartingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000580"
      unitRef="BRL">12184000</afya:ShareOfIncomeOfAssociateOfOpeartingActivities>
    <afya:ShareOfIncomeOfAssociateOfOpeartingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000581"
      unitRef="BRL">11797000</afya:ShareOfIncomeOfAssociateOfOpeartingActivities>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000583"
      unitRef="BRL">-56825000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000584"
      unitRef="BRL">-766000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000585"
      unitRef="BRL">10664000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000591"
      unitRef="BRL">-131336000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000592"
      unitRef="BRL">-129165000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000593"
      unitRef="BRL">-79665000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000595"
      unitRef="BRL">10947000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000596"
      unitRef="BRL">-363000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000597"
      unitRef="BRL">-3720000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <afya:IncreaseDecreaseInRecoverableTaxes
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000599"
      unitRef="BRL">15353000</afya:IncreaseDecreaseInRecoverableTaxes>
    <afya:IncreaseDecreaseInRecoverableTaxes
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000600"
      unitRef="BRL">2230000</afya:IncreaseDecreaseInRecoverableTaxes>
    <afya:IncreaseDecreaseInRecoverableTaxes
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000601"
      unitRef="BRL">2327000</afya:IncreaseDecreaseInRecoverableTaxes>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000603"
      unitRef="BRL">77480000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000604"
      unitRef="BRL">-1048000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000605"
      unitRef="BRL">-19425000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000607"
      unitRef="BRL">24500000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000608"
      unitRef="BRL">9975000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000609"
      unitRef="BRL">14479000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000611"
      unitRef="BRL">3278000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000612"
      unitRef="BRL">-3915000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000613"
      unitRef="BRL">-14902000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000615"
      unitRef="BRL">-17892000</ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000616"
      unitRef="BRL">8387000</ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000617"
      unitRef="BRL">36009000</ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000619"
      unitRef="BRL">31525000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000620"
      unitRef="BRL">21247000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000621"
      unitRef="BRL">23449000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000623"
      unitRef="BRL">-42542000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000624"
      unitRef="BRL">-12811000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000625"
      unitRef="BRL">-2693000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000627"
      unitRef="BRL">1088767000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000628"
      unitRef="BRL">876988000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000629"
      unitRef="BRL">666550000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000631"
      unitRef="BRL">45144000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000632"
      unitRef="BRL">33089000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000633"
      unitRef="BRL">35683000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000635"
      unitRef="BRL">1043623000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000636"
      unitRef="BRL">843899000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000637"
      unitRef="BRL">630867000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000643"
      unitRef="BRL">118435000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000644"
      unitRef="BRL">168132000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000645"
      unitRef="BRL">125869000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000647"
      unitRef="BRL">126993000</afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities>
    <afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000648"
      unitRef="BRL">128892000</afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities>
    <afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000649"
      unitRef="BRL">150931000</afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities>
    <ifrs-full:DividendsReceived
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000651"
      unitRef="BRL">9900000</ifrs-full:DividendsReceived>
    <ifrs-full:DividendsReceived
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000652"
      unitRef="BRL">6754000</ifrs-full:DividendsReceived>
    <ifrs-full:DividendsReceived
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000653"
      unitRef="BRL">11770000</ifrs-full:DividendsReceived>
    <afya:PurchaseOfAcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000655"
      unitRef="BRL">21000000</afya:PurchaseOfAcquisitionOfNoncontrollingInterests>
    <ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000659"
      unitRef="BRL">815005000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000660"
      unitRef="BRL">277649000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000661"
      unitRef="BRL">1005017000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
    <afya:PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000663"
      unitRef="BRL">71518000</afya:PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles>
    <afya:PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000664"
      unitRef="BRL">23550000</afya:PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles>
    <afya:PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000665"
      unitRef="BRL">12108000</afya:PaymentsOfInterestFromAcquisitionOfSubsidiariesAndIntangibles>
    <afya:RestrictedCashOfInvestingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000669"
      unitRef="BRL">8103000</afya:RestrictedCashOfInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000671"
      unitRef="BRL">-1143051000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000672"
      unitRef="BRL">-591469000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000673"
      unitRef="BRL">-1274052000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000679"
      unitRef="BRL">112630000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000680"
      unitRef="BRL">1791000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000681"
      unitRef="BRL">107766000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <afya:RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000683"
      unitRef="BRL">175889000</afya:RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities>
    <afya:RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000684"
      unitRef="BRL">116587000</afya:RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities>
    <afya:RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000685"
      unitRef="BRL">50310000</afya:RepaymentsOfInterestOnBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000687"
      unitRef="BRL">5288000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000688"
      unitRef="BRL">496885000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000689"
      unitRef="BRL">809539000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000691"
      unitRef="BRL">31473000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000692"
      unitRef="BRL">28511000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000693"
      unitRef="BRL">20075000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000695"
      unitRef="BRL">103911000</afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities>
    <afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000696"
      unitRef="BRL">85001000</afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities>
    <afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000697"
      unitRef="BRL">67676000</afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities>
    <afya:TreasuryShares1
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000699"
      unitRef="BRL">-12369000</afya:TreasuryShares1>
    <afya:TreasuryShares1
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000700"
      unitRef="BRL">-152317000</afya:TreasuryShares1>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000701"
      unitRef="BRL">-213722000</afya:TreasuryShares1>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000703"
      unitRef="BRL">9791000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000705"
      unitRef="BRL">33336000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:DividendsPaidClassifiedAsFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000707"
      unitRef="BRL">18750000</ifrs-full:DividendsPaidClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidClassifiedAsFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000708"
      unitRef="BRL">19736000</ifrs-full:DividendsPaidClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidClassifiedAsFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000709"
      unitRef="BRL">18648000</ifrs-full:DividendsPaidClassifiedAsFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000711"
      unitRef="BRL">-439943000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000712"
      unitRef="BRL">92942000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000713"
      unitRef="BRL">364678000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000715"
      unitRef="BRL">-681000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000716"
      unitRef="BRL">-852000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000717"
      unitRef="BRL">-17973000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact000719"
      unitRef="BRL">-540052000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000720"
      unitRef="BRL">344520000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000721"
      unitRef="BRL">-296480000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000723"
      unitRef="BRL">1093082000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact000724"
      unitRef="BRL">748562000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact000725"
      unitRef="BRL">1045042000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000727"
      unitRef="BRL">553030000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000728"
      unitRef="BRL">1093082000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact000729"
      unitRef="BRL">748562000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000731">&lt;p id="xdx_801_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_z8WrEoWNcR0j" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;span id="fp_006"&gt;&lt;/span&gt;1&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_820_zqi6LYe3Ozy1"&gt;Corporate information&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-right: 0; margin-left: 0"&gt;Afya Limited (&#x201c;Afya&#x201d;),
collectively with its subsidiaries referred to as the &#x201c;Company&#x201d;, is a holding company incorporated under the laws of the Cayman
Islands on March 22, 2019. The Company completed its initial public offering (IPO) on July 19, 2019, and its shares are listed on the
Nasdaq under the symbol &#x201c;AFYA&#x201d;. The Company&#x2019;s ultimate parent company is Bertelsmann SE&amp;amp; Co. KGaA (&#x201c;Bertelsmann&#x201d;),
as a result of Bertelsmann&#x2019;s acquisition of control on May 5, 2022.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company is formed by a network of higher education and post-graduate
institutions focused on medical schools located in 19 Brazilian States forming the largest educational group by the number of medical
seats in the country. In non-regulated education, Afya provides services that comprise the development and sale of electronically distributed
educational courses on medicine science, related printed and soft skills educational content. The Company also offers solutions to empower
the physicians in their daily routine including supporting clinic decisions through mobile app subscription, delivering practice management
tools through a SaaS (&#x201c;Software as a Service&#x201d;) model and supporting the patient-physician relationship.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"&gt;During the year ended December 31, 2022, the Ministry
of Education (&#x201c;MEC&#x201d;) authorized the operations of 200 seats of medical schools, under the Mais M&#xe9;dicos II program across
four medical schools. Each medical school will contribute with 50 seats. In March 2022, MEC authorized the increase of 28 seats of Centro
Universit&#xe1;rio S&#xe3;o Lucas, located in the city of Ji-Parana, State of Rond&#xf4;nia and 64 medical seats of Faculdade Santo
Agostinho, located in the city of Itabuna, State of Bahia. These operations of such medical schools and additional seats started between
the second semester of 2022 and first semester of 2023.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In November 2021, MEC authorized the operation of 120 medical school seats
in Garanhuns, in the city of Garanhuns, State of Pernambuco. These operations of the medical school started in the second semester of
2022.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="text-decoration: underline"&gt;Bertelsmann increases stake in Afya&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On May 5, 2022, Afya was notified of the closing of the transaction where
Bertelsmann SE&amp;amp; Co. KGaA, or &#x201c;Bertelsmann&#x201d; acquired &lt;span id="xdx_904_ecustom--AcquiredShares_pip0_c20220504__20220505__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z9fRcbP4TgP5" title="Acquired shares"&gt;6,000,000&lt;/span&gt; Class B common shares of Afya at the purchase price of US$26.90
per share, from Nicolau Carvalho Esteves, Ros&#xe2;ngela de Oliveira Tavares Esteves and NRE Capital Ventures Ltd (together with Nicolau
Carvalho Esteves and Ros&#xe2;ngela de Oliveira Tavares Esteves, the &#x201c;Esteves Family&#x201d;). As result of the closing of the transaction,
Bertelsmann and the Esteves family will beneficially own ~&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pip0_dp_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember_zyAvSgUPOknf" title="Own percentage"&gt;57.5&lt;/span&gt;% and ~&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pip0_dp_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember_zJIYVz0I4j1g" title="Own percentage"&gt;33.0&lt;/span&gt;% voting interest, and ~&lt;span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember_zjAUGW38VYB3" title="Voting interest"&gt;31.0&lt;/span&gt;% and ~&lt;span id="xdx_909_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BertelsmannMember_z4Xtn55IxDa8" title="Voting interest"&gt;18.0&lt;/span&gt;% of the total shares,
respectively, in Afya. The transaction had no effect on Afya&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="text-decoration: underline"&gt;Acquisitions&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span&gt;On January 2, 2023, Afya Participa&#xe7;&#xf5;es
S.A. (hereafter referred to as &lt;/span&gt;&#x201c;&lt;span&gt;Afya Brazil&#x201d;), a wholly owned subsidiary of the
Company, acquired &lt;/span&gt;Sociedade Educacional e Cultural Sergipe DelRey Ltda&lt;span&gt;. (&#x201c;DelRey&#x201d;).
DelRey is a post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate
programs in medicine and health, as well as other courses, and &lt;/span&gt;encompasses the operations of Centro Universit&#xe1;rio Tiradentes
Alagoas (&#x201c;UNIMA&#x201d;) and Faculdade Tiradentes Jaboat&#xe3;o dos Guararapes (&#x201c;FCM Jaboat&#xe3;o&#x201d;)&lt;span&gt;.
See Note 5.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="background-color: white"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"&gt;&lt;span&gt;During the
year ended December 31, 2022, Afya Brazil entered into business combinations transactions for the acquisition of three entities under
the Digital segment. The aggregate consideration transferred was R$ &lt;span id="xdx_90B_eifrs-full--ConsiderationPaidReceived_pn3n3_c20220101__20221231_zFIrnyg4i0A4" title="Aggregate consideration"&gt;99,399&lt;/span&gt;, of which R$ &lt;span id="xdx_90E_eifrs-full--ConsiderationPaidReceived_pn3n3_c20220101__20221231__dei--LegalEntityAxis__ifrs-full--SubsidiariesMember_zYlDmSFd9PJ7" title="Aggregate consideration"&gt;67,381&lt;/span&gt; represents the cash paid net of cash acquired
with the subsidiaries (included in cash flows from investing activities) for such business combinations.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"&gt;&lt;span style="background-color: white"&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span&gt;During the year ended December 31,
2021, Afya Brazil entered into business combinations transactions for the acquisition of two entities under the Undergrad segment and
four entities under the Digital segment. The aggregate consideration transferred was R$ &lt;span id="xdx_901_eifrs-full--ConsiderationPaidReceived_pn3n3_c20210101__20211231_zgUIoDnO0Aof" title="Aggregate consideration"&gt;1,234,460&lt;/span&gt;, of which R$ &lt;span id="xdx_906_eifrs-full--ConsiderationPaidReceived_pn3n3_c20210101__20211231__dei--LegalEntityAxis__ifrs-full--SubsidiariesMember_zmv6Vi9Spxwf" title="Aggregate consideration"&gt;842,197&lt;/span&gt; represents the
cash paid net of cash acquired with the subsidiaries (included in cash flows from investing activities).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="text-decoration: underline"&gt;Conflicts worldwide&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;During 2022 and 2023, international conflicts with potential large scale
occurred, including Russia and Ukraine and Israel and Hamas. Those conflicts trigger a number of IFRS accounting considerations affecting
the financial statements.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company&#x2019;s operations are focused in Brazil and was not directly
impacted by such conflicts. However, the continuous development of such conflicts may impact entities other than those with direct interests
in the involved countries, for instance, as a result of exposure to fluctuations in commodity prices and foreign exchange rates, which
may impact inflation, as well as the possibility of economic sanctions against such countries.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;As of the date of these consolidated financial statements, both conflicts
mentioned above have not significantly impacted Afya&#x2019;s operations and results.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory>
    <afya:AcquiredShares
      contextRef="From2022-05-042022-05-05_custom_BertelsmannMember_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      id="Fact000733"
      unitRef="Shares">6000000</afya:AcquiredShares>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2023-01-012023-12-31_custom_BertelsmannMember"
      decimals="INF"
      id="Fact000735"
      unitRef="Pure">0.575</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2022-01-012022-12-31_custom_BertelsmannMember"
      decimals="INF"
      id="Fact000737"
      unitRef="Pure">0.330</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2023-12-31_custom_BertelsmannMember"
      decimals="INF"
      id="Fact000739"
      unitRef="Pure">0.310</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2022-12-31_custom_BertelsmannMember"
      decimals="INF"
      id="Fact000741"
      unitRef="Pure">0.180</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:ConsiderationPaidReceived
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact000743"
      unitRef="BRL">99399000</ifrs-full:ConsiderationPaidReceived>
    <ifrs-full:ConsiderationPaidReceived
      contextRef="From2022-01-012022-12-31_ifrs-full_SubsidiariesMember"
      decimals="-3"
      id="Fact000745"
      unitRef="BRL">67381000</ifrs-full:ConsiderationPaidReceived>
    <ifrs-full:ConsiderationPaidReceived
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact000747"
      unitRef="BRL">1234460000</ifrs-full:ConsiderationPaidReceived>
    <ifrs-full:ConsiderationPaidReceived
      contextRef="From2021-01-012021-12-31_ifrs-full_SubsidiariesMember"
      decimals="-3"
      id="Fact000749"
      unitRef="BRL">842197000</ifrs-full:ConsiderationPaidReceived>
    <afya:DisclosureOfMaterialAccountingPoliciesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000751">&lt;p id="xdx_80D_ecustom--DisclosureOfMaterialAccountingPoliciesExplanatory_zSJak3PGdxqf" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;2&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82A_zTtrBktcqFw4"&gt;Material accounting policies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;2.1 Basis for preparation of the consolidated financial
statements&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company&#x2019;s consolidated financial statements have been prepared
in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB)
and considers the assumption that the Company will continue in operation for the foreseeable future.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The consolidated financial statements have been prepared on a historical
cost basis, except for contingent consideration (earn-outs) that have been measured at fair value.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Afya Limited is a holding company, as such the primary source of revenue
derives from its interest on the operational companies in Brazil. As result, the Brazilian Real has been determined as the Company&#x2019;s
functional currency.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The consolidated financial statements are presented in Brazilian reais (&#x201c;BRL&#x201d;
or &#x201c;R$&#x201d;), which is the Company&#x2019;s functional and presentation currency. All amounts are rounded to the nearest thousand.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"&gt;The Company segregated the payments of principal
and interest of loans and financing, lease liabilities, notes payable and accounts payables to selling shareholders in the consolidated
statements of cash flows for the year ended December 31, 2023, in accordance with the provisions set forth in IAS 7 &#x2013; Statement
of Cash Flows. As a result, Management revised, retrospectively, the prior periods consolidated statements of cash flows for the years
ended December 31, 2022 and 2021, for comparative purposes. The Company assessed the materiality of this matter and, based on an analysis
of quantitative and qualitative considerations, determined that the segregation of payments of principal and interest on prior periods
over such transactions is not material to its consolidated financial statements. However, even if it is not material, the segregation
of payments of principal and interest regarding such transactions for the years ended December 31, 2022 and 2021 are appropriate for
the users of the consolidated financial statements, considering the comparability of such information over the years presented. The payments
of interest of loans and financing, lease liabilities, notes payable and accounts payables to selling shareholders are classified within
the consolidated statements of cash flows under the same activities of which the payments of principal are classified. As a result, no
change occurred in the net cash flows used in investing activities and net cash flows generated (used) in financing activities in the
consolidated statements of cash flows for the years ended December 31, 2022 and 2021.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"&gt;These consolidated financial statements as of and
for the year ended December 31, 2023 were approved by the Board of Directors for issuance on March 14, 2024.&lt;br/&gt;
&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;2.2 Basis consolidation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The table below is a list of the Company&#x2019;s subsidiaries and associate:&lt;/p&gt;

&lt;p style="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zOClrtiiWnDb" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B7_zcTUTkK5xnpc" style="display: none"&gt;Schedule of Company&#x2019;s subsidiaries and associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;Direct and indirect interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 36%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 23%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;Main activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;Investment type&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Afya Participa&#xe7;&#xf5;es S.A. (&#x201c;Afya Brazil&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zalwy9CGxxW1" title="Principal activities"&gt;Holding&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z1RptsvM2mMk" title="Location"&gt;Nova Lima - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zrpmZKKEiJsd" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z5CjixoKcEja" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zXyR3NNOcrQ4" title="Direct and indirect interest of subsidiary"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zv9VS7TatyJd" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto Tocantinense Presidente Ant&#xf4;nio Carlos Porto S.A. - (&#x201c;ITPAC Porto&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zH1Ln5sRdeol" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zwF6v291aIDb" title="Location"&gt;Porto Nacional - TO&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zoUGV6PYurG8" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zB1OKm3apal5" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zrSl5jEFEnm8" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto Tocantinense Presidente Ant&#xf4;nio Carlos S.A. - (&#x201c;ITPAC Aragua&#xed;na&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zGzEFgreoAt6" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_z11eSmIJKfBi" title="Location"&gt;Aragua&#xed;na - TO&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zYznHUPdaUMi" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zdBbdHbYg3Vk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zFZWmVBs9oEh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Uni&#xe3;o Educacional do Vale do A&#xe7;o S.A. - (&#x201c;UNIVA&#xc7;O&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zgWRd2JlcEhk" title="Principal activities"&gt;Medicine undergraduate degree program&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zPgTSpa6ctni" title="Location"&gt;Ipatinga - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zCMh7K0hmkh7" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z0Z1JBdEy9Hg" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z2XOJzLnvsv1" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#x201c;IPTAN&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zSbG3bJ6WCT5" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zYs5VwOf1rs8" title="Location"&gt;S&#xe3;o Jo&#xe3;o Del Rei - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zLGxbgGFRCG8" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zycMe0FDSUxl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zQZQwj3pfEwk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto de Educa&#xe7;&#xe3;o Superior do Vale do Parna&#xed;ba S.A. (&#x201c;IESVAP&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zHwpFCvWTRWg" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zmc5S9CWO1hb" title="Location"&gt;Parna&#xed;ba - PI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zoUNMxDFdDv1" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zykEQvDEg8k8" title="Direct and indirect interest of subsidiary"&gt;80&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_z4qvPwneKpTb" title="Direct and indirect interest of subsidiary"&gt;80&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Centro de Ci&#xea;ncias em Sa&#xfa;de de Itajub&#xe1; S.A. (&#x201c;CCSI&#x201d;) (vi)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z8zjHa6BIeV6" title="Principal activities"&gt;Medicine undergraduate degree program&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zdPwPLBL5Om4" title="Location"&gt;Itajub&#xe1; - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z40USpEPBNzg" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zQmOpVIxyxr" title="Direct and indirect interest of subsidiary"&gt;75&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zIrK3aOB0ueb" title="Direct and indirect interest of subsidiary"&gt;60&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto de Ensino Superior do Piau&#xed; S.A. (&#x201c;IESP&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zWQzPmy7n1Ff" title="Principal activities"&gt;Undergraduate and graduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_za6I0FudD4Hk" title="Location"&gt;Teresina - PI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_znvFnrd2wAR4" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_z38eqmX67Z3l" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zRcqMXWCruCa" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Centro Integrado de Sa&#xfa;de de Teresina (&#x201c;CIS&#x201d;) (v)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zSnBVWW5NM2a" title="Principal activities"&gt;Outpatient care&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zaXqNKFgDxR" title="Location"&gt;Teresina - PI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zdFi64odxsi7" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_z8MiPemDdctg" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;FADEP - Faculdade Educacional de Pato Branco Ltda. (&#x201c;FADEP&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zdJiDucq4gx8" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zKnEUEBh4UXf" title="Location"&gt;Pato Branco - PR&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zL3TPqtol0Hc" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zuJUXviDKN55" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zK5N5l65p6td" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Medcel Editora e Eventos S.A. (&#x201c;Medcel&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zOYAsenPo6M8" title="Principal activities"&gt;Medical education content&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_z8IqdtmzImEj" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zZ3VzZhSfMEb" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zbxIRxfn1QZb" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_z5abhnmUIGai" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto Educacional Santo Agostinho S.A. (&#x201c;FASA&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_z3CNx3A8HgYa" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zMddJ12yLnac" title="Location"&gt;Montes Claros - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zcG6gvWygcLe" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zHzTjkrPxdYl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zrzeDyWOonPe" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;ESMC Educa&#xe7;&#xe3;o Superior Ltda. (&#x201c;ESMC&#x201d;) (iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zYckGhqslUua" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zyWCdAa85Bhd" title="Location"&gt;Montes Claros - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_z5BGUTEEMtyl" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zHh5b58t4B32" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto de Pesquisa e Ensino M&#xe9;dico do Estado de Minas Gerais Ltda. (&#x201c;IPEMED&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_ztZbZLKvSEe5" title="Principal activities"&gt;Graduate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zjcYM0e8Fgtk" title="Location"&gt;Belo Horizonte - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zXl2ZbkjAJO" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_z0Wxdk02ZiVe" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zkwIlA8E2VDh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto Paraense de Educa&#xe7;&#xe3;o e Cultura Ltda. (&#x201c;IPEC&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_ztm4EYaPUOTc" title="Principal activities"&gt;Medicine degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zMUQ5LY4iHEh" title="Location"&gt;Marab&#xe1; - PA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_ziftmOqfGtl5" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zxQognVwrJUf" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zCzYBJmQOj9b" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Sociedade Universit&#xe1;ria Redentor S.A. (&#x201c;UniRedentor&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z1PnvuFrbxW4" title="Principal activities"&gt;Undergraduate and graduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zNkch2awVkZ8" title="Location"&gt;Itaperuna - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zQGcr5wQuMWf" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zRe0lOTWDiYh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zYIOhEv10Nfh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Centro de Ensino S&#xe3;o Lucas Ltda. (&#x201c;UniSL&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zuBWx7tdWpQ6" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_z3opKGOaCFXh" title="Location"&gt;Porto Velho - RO&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zwFO7NNBiXzh" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zc8YlpZTM9J5" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zQz09AuUBlhi" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Peb Med Institui&#xe7;&#xe3;o de Pesquisa M&#xe9;dica e Servi&#xe7;os Ltda. (&#x201c;PebMed&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zwGFvmIXDyef" title="Principal activities"&gt;Content and clinical tools and online platform&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zM5A2jZsx6Aj" title="Location"&gt;Rio de Janeiro - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zlkaSuMeMzIg" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zWvNQFwIR4rd" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zl0z015dT019" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Sociedade de Educa&#xe7;&#xe3;o, Cultura e Tecnologia da Amaz&#xf4;nia S.A. - (&#x201c;FESAR&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zhvG7Pp3hpca" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zyqWTj49rf01" title="Location"&gt;Reden&#xe7;&#xe3;o - PA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zTqDWnFqMr9d" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zpVj7zYLaL92" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zxS06FOXcYy8" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Centro Superior de Ci&#xea;ncias da Sa&#xfa;de S/S Ltda. (&#x201c;FCMPB&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zxhl3lsinqO2" title="Principal activities"&gt;Medicine degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_ziVT5yMMuZId" title="Location"&gt;Jo&#xe3;o Pessoa - PB&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zheIgQ0Dh8U9" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zfmHirGKCZNd" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zuhISMhBKnS8" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;iClinic Desenvolvimento de Software Ltda. (&#x201c;iClinic&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zzGrJmynyihb" title="Principal activities"&gt;Electronic Medical Record, Clinical Management System&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zkcxMakLVvWa" title="Location"&gt;Ribeir&#xe3;o Preto - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zsUxdBU8E9i2" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zLb3w41wSBWh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zx6WPAE9Qkjl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Medicinae Solutions S.A. (&#x201c;Medicinae&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z4DTs95RBlw3" title="Principal activities"&gt;Healthcare payments and financial services&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zb5c1OY9Rbsd" title="Location"&gt;Rio de Janeiro - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zFoDbLSmb2B6" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zXqWbgktuVw5" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z6KZl2oqbbP1" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Medical Harbour Aparelhos M&#xe9;dico Hospitalares e Servi&#xe7;os em Tecnologia Ltda. (&#x201c;Medical Harbour&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zZhaYklSCn2" title="Principal activities"&gt;Educational health and medical imaging&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zpa5PemScH7b" title="Location"&gt;Florian&#xf3;polis - SC&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zBjdZFmGiZEd" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zeFv4DEjEF3b" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zYA3VDldq1e3" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Cliquefarma Drogarias Online Ltda. (&#x201c;Cliquefarma&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zvLiXQTf8LMh" title="Principal activities"&gt;Online platform&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zFusXC5ny7Kc" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zbGVANp4Wyce" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zl9pB8ZtT1Kk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_ztbeofn3M1Bi" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Shosp Tecnologia da Informa&#xe7;&#xe3;o Ltda. (&#x201c;Shosp&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zQ3WpInHHkl8" title="Principal activities"&gt;Electronic Medical Record, Clinical Management System&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zVA7XuIDuRoe" title="Location"&gt;Rio de Janeiro - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zgNHFinkpyvi" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_z1QpxW0v4xQc" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zAZiw8SIWO57" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Sociedade Padr&#xe3;o de Educa&#xe7;&#xe3;o Superior Ltda. (&#x201c;UnifipMoc&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zCVP4KK3mVB6" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zS8FV1BAmsq3" title="Location"&gt;Montes Claros - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zO0xBtbGQNik" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zVhbUTgSUfoi" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zjFwRhLh9Sml" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;N&#xfa;cleo de Aten&#xe7;&#xe3;o &#xe0; Sa&#xfa;de e de Pr&#xe1;ticas Profissionalizantes (&#x201c;NASPP) (iv)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zvgSfVHkAPV8" title="Principal activities"&gt;Outpatient care&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zotfy6njizG1" title="Location"&gt;Montes Claros - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zxUrxG5UIAP1" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zInDB4qUV6T9" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Companhia Nilza Cordeiro Herdy de Educa&#xe7;&#xe3;o e Cultura (&#x201c;Unigranrio&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zRFOdKj3VQif" title="Principal activities"&gt;Undergraduate and graduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zqrwrvNl4p75" title="Location"&gt;Duque de Caxias - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zoR14pVTkY8d" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zEHW5VKRSVA4" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zIvk9bsGePvd" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Policl&#xed;nica e Centro de Est&#xe9;tica Duque de Caxias Ltda. (&#x201c;Policl&#xed;nica&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zP3K1mwjxI3" title="Principal activities"&gt;Outpatient care&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zkV1063VGF7l" title="Location"&gt;Duque de Caxias - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zoHQsfI7pAAg" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zb3hc3cKhzP3" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zt053CJMdDD8" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font-size: 7pt"&gt;Sociedade Educacional de Palho&#xe7;a S/A Ltda. (&#x201c;SOCIESP&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font-size: 7pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_z9rg0MXal5Yl" title="Principal activities"&gt;Basic Education&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font-size: 7pt"&gt;&lt;span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_ztDKDpmWFDIl" title="Location"&gt;Palho&#xe7;a - SC&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font-size: 7pt"&gt;&lt;span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_zwZW0J56ukC" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_z30vgAAgnQoc" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font-size: 7pt"&gt;Instituto de Ensino Superior de Palho&#xe7;a S/S Ltda. (&#x201c;IESP PALHO&#xc7;A&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font-size: 7pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zORhaIV6bks" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_z9mQI2YTVdM7" title="Location"&gt;Palho&#xe7;a - SC&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font-size: 7pt"&gt;&lt;span id="xdx_908_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zePtyvgsKgOf" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zYWb6iWvlh58" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;RX PRO Solu&#xe7;&#xf5;es de Tecnologia Ltda. (&#x201c;RX PRO&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zbsKqs9ZcXG1" title="Principal activities"&gt;Marketing for pharmaceutical industry&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zgsq6dFy4YT5" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z037R5g6cbE4" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z8R6nYdjZy99" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zNYzlvXy3qJg" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;RX PRO LOG Transporte e Log&#xed;stica Ltda. (&#x201c;RX PRO LOG&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_z5twhHGud3Mc" title="Principal activities"&gt;Marketing for pharmaceutical industry&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zGUG4PmwWgnf" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zzS98P9svIwk" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zoFtLfXjEffh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_ztZcgDeoVuTh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;BMV Atividades M&#xe9;dicas Ltda. (&#x201c;Al&#xe9;m da Medicina&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zWxNA72laWWk" title="Principal activities"&gt;Medical education content&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_znFBaUleq8vj" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_z02DjhG0PmQc" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zjWrfOlfth4f" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zQly09pywIFk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Cardiopapers Solu&#xe7;&#xf5;es Digitais Ltda. (&#x201c;CardioPapers&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zWa0LFTFxvhe" title="Principal activities"&gt;Medical education content&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zIY7kQcj0aca" title="Location"&gt;Recife - PE&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_z676l82ua159" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zGzZJe8ufh85" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zYuIkYxF7ki4" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Quasar Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&#x201c;Glic&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zTRc3v0p3fg2" title="Principal activities"&gt;Patient physician relationship&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zegdjERLTTKf" title="Location"&gt;Barueri - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zmHwMNmfa6s4" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zZmHBrwxCsO6" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zt3uNVeIaDHk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#x201c;DelRey&#x201d;) (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_znVw5RN6Zl6d" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_ztuAsEFtnwf4" title="Location"&gt;Macei&#xf3; - AL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zkSsxRXrU1dk" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zDY9l0MpmWxe" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Uni&#xe3;o Educacional do Planalto Central S.A. (&#x201c;UEPC&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zzFJjJxjPXp3" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zGU3ji6QI6n2" title="Location"&gt;Bras&#xed;lia - DF&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zC2ujciWITa5" title="Investment type"&gt;Associate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zBGaKF5Qyzdd" title="Direct and indirect interest of subsidiary"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zX52vJW5Spj2" title="Direct and indirect interest of subsidiary"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;See Note 5 for further details of the business combination in 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;IESP was merged by Unigranrio and SOCIESP had its operations closed down, both in January
2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="color: #212121"&gt;ESMC was merged with UnifipMoc in February 2023.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iv)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;NASPP was merged with UnifipMoc in July 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(v)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;CIS was merged with IESP in December 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="color: #212121"&gt;(vi)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="color: #212121"&gt;Acquisition&lt;/span&gt; of additional interest in CCSI: On October
31, 2023, Afya Brazil acquired an additional 15% interest in CCSI, increasing its ownership interest to 75% of total shares. A cash consideration
of R$21,000 was paid to the non-controlling shareholders. The carrying value of the net assets of CCSI (excluding goodwill on the original
acquisition) was R$10,155, and the difference were recorded in retained earnings in the equity attributable to equity holders of the
parent.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A1_z1VldA3Ni6u9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="background-color: white"&gt;The financial information
of the acquired subsidiaries is included in the Company&#x2019;s consolidated financial statements beginning on the respective acquisition
dates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company consolidates the financial information for all entities it controls.
Control is achieved when the Company is exposed to, or has rights, to variable returns from its involvement with the investee and has
the ability to affect those returns through its power over the investee.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Consolidation of a subsidiary begins when the Company obtains control over
the subsidiary and it ceases when the Company loses control of the subsidiary. Assets, liabilities, income and expenses of a subsidiary
acquired or disposed of during the year are included in the consolidated financial statements from the date the Company gains control
until the date the Company ceases to control the subsidiary.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;When necessary, adjustments are made to the financial statements of subsidiaries
in order to bring their accounting policies in line with the Company&#x2019;s accounting policies. All intra-group assets and liabilities,
equity, income, expenses and cash flows relating to transactions are eliminated in full on consolidation.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;A change in the ownership interest of a subsidiary, without a change of
control, is accounted for as an equity transaction. If the Company loses control over a subsidiary, it derecognizes the related assets
(including goodwill), liabilities, non-controlling interest and other components of equity, while any resulting gain or loss is recognized
in the statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Non-controlling interests in the results and equity of subsidiaries are
shown separately in the consolidated statements of financial position, consolidated statements of income and comprehensive income and
consolidated statements of changes in equity.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;2.3 Summary of material accounting policies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;This note provides a description of the material accounting policies adopted
in the preparation of these consolidated financial statements in addition to other policies that have been disclosed in other notes to
these consolidated financial statements. These policies have been consistently applied to all periods presented.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The accounting policies have been consistently applied
to all consolidated companies.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zeqybfC7yksh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;a) &lt;span id="xdx_866_zre99Xd2lFob"&gt;Business combinations and goodwill&lt;/span&gt; &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Business combinations are accounted for using the acquisition method. The
cost of an acquisition is measured as the aggregate of the consideration transferred, which is measured at acquisition date fair value,
and the amount of any non-controlling interests in the acquiree. For each business combination, the Company elects whether to measure
the non-controlling interests in the acquiree at fair value or at the proportionate share of the acquiree&#x2019;s identifiable net assets.
Acquisition-related costs are expensed as incurred and included in selling, general and administrative expenses.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;When the Company acquires a business, it assesses the financial assets and
liabilities assumed for appropriate classification and designation in accordance with the contractual terms, economic circumstances and
pertinent conditions as of the acquisition date.&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Goodwill is initially measured at cost (being the excess of the aggregate
of the consideration transferred and the amount recognized for non-controlling interests and any previous interest held over the net
identifiable assets acquired and liabilities assumed). If the fair value of the net assets acquired is in excess of the aggregate consideration
transferred, the Company re-assesses whether it has correctly identified all of the assets acquired and all of the liabilities assumed
and reviews the procedures used to measure the amounts to be recognized at the acquisition date. If the reassessment still results in
an excess of the fair value of net assets acquired over the aggregate consideration transferred, then the gain is recognized in the consolidated
statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;After initial recognition, goodwill is measured at cost less any accumulated
impairment losses. For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated
to each of the Company&#x2019;s cash-generating units that are expected to benefit from the combination, irrespective of whether other
assets or liabilities of the acquire are assigned to those units.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Where goodwill has been allocated to a cash-generating unit (CGU) and part
of the operation within that unit is disposed of, the goodwill associated with the disposed operation is included in the carrying amount
of the operation when determining the gain or loss on disposal. Goodwill disposed in these circumstances is measured based on the relative
values of the disposed operation and the portion of the cash-generating unit retained.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zvIOto8tCKJa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;b) &lt;span id="xdx_86D_zgfWBvd54Hjf"&gt;Current versus non-current classification&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company presents assets and liabilities in the statement of financial
position based on current and non-current classification. An asset is current when it is:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Expected to be realized
or intended to be sold or consumed in the normal operating cycle;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Held primarily for
the purpose of trading;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Expected to be realized
within twelve months after the reporting period; or&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Cash or cash equivalent
unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;All other assets are classified as non-current.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;A liability is current when:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;It is expected to
be settled in the normal operating cycle;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;It is held primarily
for the purpose of trading;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;It is due to be
settled within twelve months after the reporting period; or&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;There is no unconditional
right to defer the settlement of the liability for at least twelve months after the reporting period.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company classifies all other liabilities as non-current.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Deferred tax assets and liabilities are classified as non-current assets
and liabilities.&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zVRK63da52x4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;c) &lt;span id="xdx_866_zgQOUctiUb3i"&gt;Fair value measurement&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Fair value is the price that would be received to sell an asset or paid
to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based
on the presumption that the transaction to sell the asset or transfer the liability takes place either: (i) in the principal market for
the asset or liability; or (ii) in the absence of a principal market, in the most advantageous market for the asset or liability.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The principal or the most advantageous market must be accessible by the
Company.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The fair value of an asset or a liability is measured using the assumptions
that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;A fair value measurement of a non-financial asset takes into account a market
participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market
participant that would use the asset in its highest and best use.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company uses valuation techniques that are appropriate in the circumstances
and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the
use of unobservable inputs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;All assets and liabilities for which fair value is measured or disclosed
in the financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that
is significant to the fair value measurement as a whole:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Level 1 - Quoted
(unadjusted) market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Level 2 - Valuation
techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Level 3 - Valuation
techniques for which the lowest level input that is significant to the fair value measurement is unobservable.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;For assets and liabilities that are recognized in the financial statements
at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy by re-assessing
categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting
period.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;At each reporting date, the Company analyzes the movements in the values
of assets and liabilities which are required to be remeasured or reassessed as per the Company&#x2019;s accounting policies. For this analysis,
the Company verifies the major inputs applied in the latest valuation by agreeing the information in the valuation computation to contracts
and other relevant documents.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company also compares the change in the fair value of each asset and
liability with relevant external sources to determine whether the change is reasonable.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;For the purpose of fair value disclosures, the Company has determined classes
of assets and liabilities on the basis of the nature, characteristics and risks of the asset or liability and the level of the fair value
hierarchy, as explained above.&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_zKvg01UWdcJ7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;d) &lt;span id="xdx_866_zTFTz8xv3zk6"&gt;Financial instruments - initial recognition and measurement&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;A financial instrument is any contract that gives rise to a financial asset
of one entity and a financial liability or equity instrument of another entity.&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 14.2pt"&gt;&lt;/td&gt;&lt;td style="width: 14.15pt"&gt;&lt;b&gt;i)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Financial assets&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Initial recognition and measurement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The classification of financial assets at initial recognition
depends on the financial asset&#x2019;s contractual cash flow characteristics and the Company&#x2019;s business model for managing them.
With the exception of trade receivables that do not contain a significant financing component or for which the Company has applied the
practical expedient, the Company initially measures a financial asset at its fair value plus, in the case of a financial asset not at
fair value through profit or loss, transaction costs. Trade receivables that do not contain a significant financing component or for
which the Company has applied the practical expedient, are measured at the transaction price determined under IFRS 15.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;In order for a financial asset to be classified and measured
at amortized cost or fair value through OCI (Other Comprehensive Income), it needs to give rise to cash flows that are &#x201c;solely payments
of principal and interest (SPPI)&#x201d; on the principal amount outstanding. This assessment is referred to as the SPPI test and is performed
at an instrument level.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The Company&#x2019;s business model for managing financial assets
refers to how it manages its financial assets in order to generate cash flows. The business model determines whether cash flows will result
from collecting contractual cash flows, selling the financial assets, or both.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Purchases or sales of financial assets that require delivery
of assets within a time frame established by regulation or convention in the market place (regular way trades) are recognized on the trade
date, i.e., the date that the Company commits to purchase or sell the asset.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Subsequent measurement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;For purposes of subsequent measurement, financial assets are
classified as: financial assets at amortized cost or financial assets at fair value through profit or loss. There are no financial assets
designated as fair value through OCI.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Financial assets at amortized cost&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The Company measures financial assets at amortized cost if both
of the following conditions are met:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#x2022; The financial asset is held within a business model with
the objective to hold financial assets in order to collect contractual cash flows, and&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#x2022; The contractual terms of the financial asset give rise
on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial assets at amortized cost are subsequently measured
using the effective interest (EIR) method and are subject to impairment. Gains and losses are recognized in the statement of income when
the asset is derecognized, modified or impaired.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Financial assets at fair value through profit
or loss&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial assets at fair value through profit or loss include
financial assets held for trading, financial assets designated upon initial recognition at fair value through profit or loss, or financial
assets mandatorily required to be measured at fair value. Financial assets are classified as held for trading if they are acquired for
the purpose of selling or repurchasing in the near term. Derivatives, including separated embedded derivatives, are also classified as
held for trading unless they are designated as effective hedging instruments. Financial assets with cash flows that are not solely payments
of principal and interest are classified and measured at fair value through profit or loss, irrespective of the business model.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial assets at fair value through profit or loss are carried
in the statement of financial position at fair value with net changes in fair value recognized in the statement of income. This category
includes derivative instruments.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Derecognition&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;A financial asset (or, where applicable, a part of a financial
asset or part of a group of similar financial assets) is primarily derecognized (i.e., removed from the Company&#x2019;s statement of financial
position) when:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&#x2022;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The rights to receive cash flows from the asset have expired; or&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&#x2022;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company has transferred its rights to receive cash flows from the asset or has assumed
an obligation to pay the received cash flows in full without material delay to a third party under a &#x2018;pass-through&#x2019; arrangement;
and either (a) the Company has transferred substantially all the risks and rewards of the asset, or (b) the Company has neither transferred
nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;When the Company has transferred its rights to receive cash flows
from an asset or has entered into a pass-through arrangement, it evaluates if, and to what extent, it has retained the risks and rewards
of ownership. When it has neither transferred nor retained substantially all of the risks and rewards of the asset, nor transferred control
of the asset, the Company continues to recognize the transferred asset to the extent of its continuing involvement. In that case, the
Company also recognizes an associated liability. The transferred asset and the associated liability are measured on a basis that reflects
the rights and obligations that the Company has retained.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Continuing involvement that takes the form of a guarantee over
the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that
the Company could be required to repay.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Impairment of financial assets&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Further disclosures relating to impairment of financial assets
are also provided in the following notes:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&#x2022;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Significant accounting judgments, estimates and assumptions - Note 3&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&#x2022;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Trade receivables - Note 7&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The Company recognizes an allowance for expected credit losses
(ECLs) for all debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual
cash flows due in accordance with the contract and the cash flows the Company expects to receive, discounted at an approximation of the
original effective interest rate. The expected cash flows will include cash flows from the sale of collateral held or other credit enhancements
that are integral to the contractual terms.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;For trade receivables, the Company applies a simplified approach
in calculating ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for credit losses
based on lifetime ECLs at each reporting date. The Company has established a provision matrix that is based on its historical credit loss
experience, adjusted for forward-looking factors specific to the debtors and the economic environment.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The Company considers a financial asset to be in default
when internal or external information indicates that the Company is unlikely to receive the outstanding contractual amounts in full
before considering any credit enhancements held by the Company. A financial asset is written off when there is no reasonable
expectation of recovering the contractual cash flows.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;b&gt;ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
liabilities&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Initial recognition and measurement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial liabilities are classified, at initial recognition,
as financial liabilities at fair value through profit or loss, loans and borrowings, payables, or as derivatives designated as hedging
instruments in an effective hedge, as appropriate.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;All financial liabilities are recognized initially at fair value
and, in the case of loans and borrowings and payables, net of directly attributable transaction costs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The Company&#x2019;s financial liabilities include trade payables,
loans and financing, notes payable, lease liabilities, advances from customers and accounts payable to selling shareholders.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Subsequent measurement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The measurement of financial liabilities depends on their classification,
as described below:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Financial liabilities at fair value through
profit or loss&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial liabilities at fair value through profit or loss include
financial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value through profit or
loss.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial liabilities are classified as held for trading if they
are incurred for the purpose of repurchasing in the near term. This category also includes, when applicable, derivative financial instruments
entered into by the Company that are not designated as hedging instruments in hedge relationships as defined by IFRS 9. Gains or losses
on liabilities held for trading are recognized in the statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial liabilities designated upon initial recognition at
fair value through profit or loss are designated at the initial date of recognition, and only if the criteria in IFRS 9 are satisfied.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Loans and borrowings&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;After initial recognition, interest-bearing loans and borrowings
are subsequently measured at amortized cost using the EIR method. Gains and losses are recognized in the statement of income when the
liabilities are derecognized as well as through the EIR amortization process.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Amortized cost is calculated by considering any discount or premium
on acquisition and fees or costs that are an integral part of the EIR. The EIR amortization is included as finance expenses in the statement
of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Derecognition&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;A financial liability is derecognized when the obligation under
the liability is discharged or cancelled or expires. When an existing financial liability is replaced by another from the same lender
on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is
treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying
amounts is recognized in the statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;br/&gt;
&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Offsetting of financial instruments&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial assets and financial liabilities are offset and the
net amount is reported in the statement of financial position if there is a currently enforceable legal right to offset the recognized
amounts and there is an intention to settle on a net basis, to realize the assets and settle the liabilities simultaneously.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zSLNqDO7dt11" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;e) &lt;span id="xdx_867_zWpp7npZLiub"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Cash and cash equivalents in the statement of financial position comprise
cash at banks and on hand, and short-term financial investments with an original maturity of three months or less, which are subject to
an insignificant risk of changes in value.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;For the purpose of the statement of cash flows, cash and cash equivalents
consist of cash and short-term financial investments, as they are considered an integral part of the Company&#x2019;s cash management.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zNJh9Hmg1eQ9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;f) &lt;span id="xdx_860_zaQrZT2wqJl8"&gt;Property and equipment&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Property and equipment are stated at cost, net of accumulated depreciation
and accumulated impairment losses, if any.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Subsequent expenditures are capitalized only if it is probable that the
future economic benefits associated with the expenditure will flow to the Company.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Depreciation is calculated on a straight-line basis over the estimated useful
lives of the assets, as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zAZYZOz6Ydq" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B0_zaC2EnOUWqdf" style="display: none"&gt;Schedule of estimated useful
lives of the assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Building&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zGZ0Olisj3R3" title="Useful lives of assets"&gt;25&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zlijIYD854z1" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zWn083WDFBIa" title="Useful lives of assets"&gt;4&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zVPzrKtB97bi" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;IT equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zdCqKpUaMbQj" title="Useful lives of assets"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Library books&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_z35nlPvrCfH9" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGUH789gLle1" title="Useful lives of assets"&gt;5&lt;/span&gt; - &lt;span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zr85b7n2lei4" title="Useful lives of assets"&gt;20&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;br/&gt;
&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;An item of property and equipment and any significant part initially recognized
is derecognized upon disposal or when no future economic benefit is expected from its use or disposal. Any gain or loss arising on the
derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included
in the statement of income when the asset is derecognized.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The residual values, useful lives and methods of depreciation of property
and equipment are reviewed at each financial year end and adjusted prospectively, if appropriate.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zjIX2ELhTcF6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;g) &lt;span id="xdx_864_zMeHdQwI1tq"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company assess at contract inception whether an arrangement is (or contains)
a lease is based on the substance of the arrangement at the inception of the contract. The arrangement is, or contains, a lease if the
arrangement conveys the right to control the use of the identified asset (or assets), even if that asset is (or those assets are) not
explicitly specified in an arrangement for a period of time in exchange for consideration.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;br/&gt;
&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;Company as a lessee&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company applies a single recognition and measurement approach for all
leases, except for short-term leases and leases of low-value assets. The Company recognizes lease liabilities to make lease payments and
right-of-use assets representing the right to use the underlying assets.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;Right-of-use assets&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company recognizes right-of-use assets at the commencement date of the
lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation
and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of
lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease
incentives received. Unless the Company is reasonably certain to obtain ownership of the leased asset at the end of the lease term, the
recognized right-of-use assets are depreciated on a straight-line basis over the shorter of its estimated useful life and the lease term.
Right-of-use assets are subject to impairment.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;Lease liabilities&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;At the commencement date of the lease, the Company recognizes lease liabilities
measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance
fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected
to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain
to be exercised by the Company and payments of penalties for terminating a lease, if the lease term reflects the Company exercising the
option to terminate. The variable lease payments that do not depend on an index or a rate are recognized as expense in the period on which
the event or condition that triggers the payment occurs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In calculating the present value of lease payments, the Company uses the
incremental borrowing rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After
the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments
made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change
in the in-substance fixed lease payments or a change in the assessment to purchase the underlying asset.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;Short-term leases and leases of low-value assets&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company applies the short-term lease recognition exemption to its short-term
leases of properties (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase
option). It also applies the lease of low-value assets recognition exemption to leases that are considered of low value. Lease payments
on short-term leases and leases of low-value assets are recognized as expense on a straight-line basis over the lease term.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_z7U4La36slmi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;h) &lt;span id="xdx_866_zpxVucjDvpRh"&gt;Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Intangible assets acquired separately are measured on initial recognition
at cost. The cost of intangible assets acquired in a business combination is their fair value at the date of acquisition. Following initial
recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally generated
intangibles are not capitalized and the related expenditure is reflected in the statement of income in the period in which the expenditure
is incurred.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The useful lives of intangible assets are assessed as finite or indefinite.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Intangible assets with finite lives are amortized over the useful economic
life and assessed for impairment whenever there is an indication that the intangible asset may be impaired.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The amortization period and the amortization method for an intangible asset
with a finite useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected
pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as
appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized
in the statement of income in the expense category that is consistent with the function of the intangible assets.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Intangible assets with indefinite useful lives are not amortized, but are
tested for impairment annually, either individually or at the cash-generating unit level. The assessment of indefinite life is reviewed
annually to determine whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite
is made on a prospective basis.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;An intangible asset is derecognized upon disposal or when no future economic
benefits are expected from its use or disposal. Any gain or loss arising upon derecognition of the asset (calculated as the difference
between the net disposal proceeds and the carrying amount of the asset) is included in the statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_zlZZxcLm8cke" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;i) &lt;span id="xdx_862_zW60XKT14Avf"&gt;Impairment of non-financial assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company assesses, at each reporting date, whether there is an indication
that an asset may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Company estimates
the asset&#x2019;s recoverable amount. An asset&#x2019;s recoverable amount is the higher of an asset&#x2019;s or CGU&#x2019;s fair value
less costs of disposal and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate
cash inflows that are largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU
exceeds its recoverable amount, the asset is considered impaired and is written down to its recoverable amount.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In assessing value in use, the estimated future cash flows are discounted
to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks
specific to the asset. In determining fair value less costs of disposal, recent market transactions are considered. If no such transactions
can be identified, an appropriate valuation model is used. These calculations are corroborated by valuation multiples, quoted share prices
for publicly traded companies or other available fair value indicators.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company bases its impairment calculation on detailed budgets and forecast
calculations, which are prepared separately for each of the Company&#x2019;s CGUs to which the individual assets are allocated. These budgets
and forecast calculations generally cover a period of five years, considering the companies activities and maturation period of its graduate
and undergraduate courses. A long-term growth rate is calculated and applied to project future cash flows after the last projected year.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;For impairment testing, goodwill acquired through business combinations
and licenses with indefinite useful lives are allocated to their respective CGUs. The Company defined each of its operating subsidiaries
as a CGU, except for digital services segment, which combines subsidiaries of (i) &#x201c;Content &amp;amp; Technology for medical education&#x201d;;
(ii) &#x201c;Clinical Decision Software&#x201d;; and (iii) &#x201c;Practice Management Tools &amp;amp; Electronic Prescription&#x201d;, where
the subsidiaries were combined as one CGU following the business strategic pillars.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Whenever applicable, impairment losses of continuing operations are recognized
in the statement of income in expense categories consistent with the function of the impaired asset.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;For assets excluding goodwill, an assessment is made at each reporting date
to determine whether there is an indication that previously recognized impairment losses no longer exist or have decreased. If such indication
exists, the Company estimates the asset&#x2019;s or CGU&#x2019;s recoverable amount. A previously recognized impairment loss is reversed
only if there has been a change in the assumptions used to determine the asset&#x2019;s recoverable amount since the last impairment loss
was recognized. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the
carrying amount that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years.
Such reversal is recognized in the statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Goodwill is tested for impairment annually as at December 31 and when circumstances
indicate that the carrying value may be impaired.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Impairment is determined for goodwill by assessing the recoverable amount
of each CGU (or group of CGUs) to which the goodwill relates. When the recoverable amount of the CGU is less than its carrying amount,
an impairment loss is recognized. Impairment losses relating to goodwill cannot be reversed in future periods.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Intangible assets with indefinite useful lives are tested for impairment
annually as at December 31 at the CGU level, as appropriate, and when circumstances indicate that the carrying value may be impaired.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForInvestmentsExplanatory_zmHC9D4CmwBi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;j) &lt;span id="xdx_865_zqfOzwRP2TGf"&gt;Investments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Investments in associates are initially recognized at consideration transferred
and adjusted thereafter for the equity method, being increased or reduced from its interest in the investee's income after the acquisition
date. An associate is an entity over which the Company has significant influence. Significant influence is the power to participate in
the financial and operating policy decisions of the investee, but is not control or joint control over those policies.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_ziQoQhjATxuc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;k) &lt;span id="xdx_86A_zGCeAo5CyYs9"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;These amounts represent liabilities related to the acquisitions made by
the Company which are not yet due. Accounts payable to selling shareholders are presented as current liabilities unless payment is not
due within 12 months after the reporting period. They are recognized initially at their fair value and subsequently measured at amortized
cost using the effective interest method, except for the contingent consideration related to earn-outs, which are measured at fair value
through profit or loss.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_z8grFXjufnd3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;l) &lt;span id="xdx_865_zy328twd4Mji"&gt;Provisions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Provisions are recognized when the Company has a present obligation (legal
or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required
to settle the obligation, and a reliable estimate can be made of the amount of the obligation. The expense relating to a provision is
presented in the statement of income, net of any reimbursement, when applicable.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






&lt;p id="xdx_84C_ecustom--DividendsPolicyExplanatory_zJIeCotkaNFe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;m) &lt;span id="xdx_865_zZ0HxIVUJ3wi"&gt;Dividends&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company recognizes a liability to pay a dividend when the distribution
is authorized and the distribution is no longer at the discretion of the Company. The distribution is authorized when it is required to
pay a minimum dividend of the net income for the year in accordance with the Brazilian Corporate Law (applicable for Afya Brazil and its
subsidiaries) and the Company&#x2019;s By-Laws or is approved by the shareholders. In respect to the consolidated statement of changes
in equity, the amount corresponding to the non-controlling interest over the dividends declared are recognized directly in equity.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_ecustom--LaborAndSocialObligationsPolicyExplanatory_z1fYGR5TdZ9b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;n) &lt;span id="xdx_86C_z1YEpve974k6"&gt;Labor and social obligations&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Labor and social obligations are expensed as the related service is provided.
A liability is recognized for the amount expected to be paid if the Company has a present legal or constructive obligation to pay this
amount as a result of past service provided by the employee and the obligation can be estimated reliably.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_ecustom--SharebasedPaymentsPolicyExplanatory_zalIcnHJTBeb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;o) &lt;span id="xdx_861_zL9WHXQMQFG"&gt;Share-based payments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Certain key executives of the Company receive remuneration in the form of
share-based payments, which includes Stock Options and Restricted Stock Units (&#x201c;RSUs&#x201d;), whereby the executives render services
as consideration for equity instruments (equity-settled transactions).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The expense of equity-settled transactions is determined by the fair value
at the date when the grant is made using an appropriate valuation model.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;That expense is recognized in selling, general and administrative expenses,
together with a corresponding increase in equity, over the period in which the service and, where applicable, the performance conditions
are fulfilled (the vesting period). The cumulative expense recognized for equity-settled transactions at each reporting date until the
vesting date reflects the extent to which the vesting period has expired and the Company&#x2019;s best estimate of the number of equity
instruments that will ultimately vest. The expense or credit in the statement of income for a period represents the movement in cumulative
expense recognized as at the beginning and end of that period.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Service and non-market performance conditions are not considered when determining
the grant date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Company&#x2019;s best estimate
of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair
value. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting conditions.
Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless there are also
service and/or performance conditions.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;No expense is recognized for awards that do not ultimately vest because
non-market performance and/or service conditions have not been met. Where awards include a market or non-vesting condition, the transactions
are treated as vested irrespective of whether the market or non-vesting condition is satisfied, provided that all other performance and/or
service conditions are satisfied.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;When the terms of an equity-settled award are modified, the minimum expense
recognized is the grant date fair value of the unmodified award, provided the original vesting terms of the award are met. An additional
expense, measured as at the date of modification, is recognized for any modification that increases the total fair value of the share-based
payment transaction, or is otherwise beneficial to the employee. Where an award is cancelled by the entity or by the counterparty, any
remaining element of the fair value of the award is expensed immediately through the statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The dilutive effect of outstanding options is reflected as additional share
dilution in the computation of diluted earnings per share.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_eifrs-full--DisclosureOfRevenueFromContractsWithCustomersExplanatory_zQ6ltLqCkpUh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;p) &lt;span id="xdx_861_ztnxnOBSMQ0a"&gt;Revenue from contracts with customers&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;i&gt;Revenue recognition transferred over time &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company's revenue consists primarily of tuition fees charged for medical
courses. The Company also generates revenue from tuition fees for other undergraduate courses, student fees, certain education-related
activities, digital education content and subscription of digital services.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Revenues are recognized when services are rendered to the customer and the
performance obligation is satisfied.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Revenue from tuitions, digital education content and electronic medical
records are recognized over time when services are rendered to the customer and the Company satisfies its performance obligation under
the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services.
Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Other revenues are recognized at a point in time when the service is rendered
to the customer at an amount that reflects the consideration to which the Company expects to be entitled in exchange for the service.
Other revenues are presented net of the corresponding discounts, returns and taxes.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;i&gt;Revenue recognition transferred at point in time &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Revenue from sale of printed books, e-books, healthcare payments, online
platforms and marketing for pharmaceutical industry are recognized at the point in time when control of the asset or services is transferred
to the customer, generally on delivery of the goods at the customer&#x2019;s location and permission to access the digital content. The
Company considers whether there are other promises in the contract that are separate performance obligations to which a portion of the
transaction price needs to be allocated. In determining the transaction price for the printed books and e-books, the Company considers
the effects of variable consideration, financing component, noncash consideration, and consideration payable to the customer to be not
significant.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company concluded that it is the principal in its revenue arrangements.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company assesses collectability on a portfolio basis prior to recording
revenue. Generally, students cannot re-enroll for the next academic session without satisfactory resolution of any past-due amounts. If
a student withdraws from an institution, the Company's obligation to issue a refund depends on the refund policy at that institution and
the timing of the student's withdrawal. Generally, the refund obligations are reduced over the course of the academic term.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;Trade receivables&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Trade receivables represent the Company&#x2019;s right to an amount of consideration
that is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to accounting policies
of financial assets in Financial instruments - initial recognition and subsequent measurement.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;Advances from customers&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Advances from customers (a contract liability) are the obligation to transfer
services to a customer for which the Company has received consideration (or an amount of consideration is due) from the customer, as a
result of pre-paid tuition, digital education content and mobile app subscription for digital medical content received from customers
and is recognized separately in current liabilities, when the payment is received. Advances from customers are recognized as revenue when
the Company performs all obligations related to the contract, generally in the following month.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--TaxesPolicyExplanation_zC3K6LF1DSpc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;q) &lt;span id="xdx_867_znYtC1b6UUee"&gt;Taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="background-color: white"&gt;The Company&#x2019;s
subsidiaries in the undergrad segment joined the PROUNI (&lt;i&gt;Programa Universidade para Todos&lt;/i&gt; - University for All Program) program,
which is a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number of
student enrollment for low-income students, and benefits from the exemption of the following federal taxes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="background-color: white"&gt;&#x2022; Income taxes
and social contribution&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="background-color: white"&gt;&#x2022; PIS and COFINS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="background-color: white"&gt;The regulation of
PROUNI defines that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS. For income from
other teaching activities, PIS and COFINS are charged at rates of &lt;span id="xdx_906_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_z8nnaMF0qRR8" title="Tax rate"&gt;0.65&lt;/span&gt;% and &lt;span id="xdx_904_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zyr4XxR9tIq7" title="Tax rate"&gt;3.00&lt;/span&gt;%, respectively, and for non-teaching activities, PIS
is charged at a rate of &lt;span id="xdx_909_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_z184b5bPceb4" title="Tax rate"&gt;1.65&lt;/span&gt;% and to COFINS at &lt;span id="xdx_907_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zSw58OThkk16" title="Tax rate"&gt;7.6&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;Current income taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="background-color: white"&gt;Current income taxes
were calculated based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service, specifically
regarding the PROUNI program, which allows exemption of these taxes from traditional and technological graduation activities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Current income tax assets and liabilities are measured at the amount expected
to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted
or substantively enacted at the reporting date.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Management periodically evaluates positions taken in the tax returns with
respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eifrs-full--DisclosureOfTreasurySharesExplanatory_zJ6WY0CRmfy3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;r) &lt;span id="xdx_86A_zaUc3hC5yrHg"&gt;Treasury shares&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Own equity instruments that are reacquired (treasury shares) are recognized
at cost and deducted from equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the
Company&#x2019;s own equity instruments. Any difference between the carrying amount and the consideration, if reissued, is recognized in
the share premium.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;br/&gt;
&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;2.4 Changes in accounting policies and disclosures&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;&lt;i&gt;New standards, interpretations and amendments issued
and adopted by the Company&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"&gt;In the current year, the Company applied a series of changes to the
IFRSs issued by the International Accounting Standards Board (IASB) that are mandatorily for an accounting period beginning on or after
January 1, 2023, as listed below:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_zPaMGbNj4N6b" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; text-align: center"&gt;&lt;span id="xdx_8B0_z2WPlSwTKOIj" style="display: none"&gt;Schedule of changes in accounting policies and disclosures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Amendments / standards&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_909_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zVRMHPj7cMrl" title="Standard"&gt;Amendments to IAS 1 and IFRS Practice Statement 2 - Making Materiality Judgments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zPZEstU5FyG8" title="Description"&gt;The amendments to IAS 1 and IFRS Practice Statement 2 provide guidance and
    examples to help entities apply materiality judgments to accounting policy disclosures. The amendments aim to help entities provide more
    useful accounting policy disclosures by replacing the requirement for entities to disclose their "material" accounting policies
    with a requirement to disclose their "material" accounting policies and adding guidance on how entities apply the concept of
    materiality when making decisions about accounting policy disclosures.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The amendments have had an impact on the Company&#x2019;s disclosures of accounting
    policies, but not on the measurement, recognition or presentation of any items in the Company&#x2019;s consolidated financial statements.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_905_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_zRiqeDN4JEgk" title="Standard"&gt;Amendments to IAS 8 - Accounting Policies, Changes in Accounting Estimates and Errors - Definition of Accounting Estimates&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_z7GzDbcsH3N" title="Description"&gt;The amendments to IAS 8 clarify the distinction between changes in accounting
    estimates, changes in accounting policies and correction of errors. They also clarify how entities use measurement techniques and inputs
    to develop accounting estimates.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;These amendments have no significant impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_z8uwC8KO8NO6" title="Standard"&gt;Amendments to IAS 12 - Income Taxes - International Tax Reform - Pillar Two Model Rules&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_zKFcJhEckc75" title="Description"&gt;In October 2021, more than 130 countries agreed to implement a minimum tax
    regime for multinational groups, known as Pillar Two, to reform the international corporate taxation. Pillar Two aims to ensure that multinational
    groups in scope are liable to a minimum effective corporate tax rate of 15 per cent per country.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In December 2021, the OECD released the Pillar Two model rules - accompanied
    by commentary and guidelines - which are due to be passed into national legislation but adapted by local conditions.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In response to the OECD's Pillar Two rules, the amendments to IAS 12 were
    introduced and include: (i) a mandatory temporary exception to the recognition and disclosure of deferred taxes arising from the jurisdictional
    implementation of the Pillar Two model rules; and (ii) disclosure requirements for affected entities to help users of the financial statements
    better understand an entity's exposure to Pillar Two income taxes arising from this legislation, especially prior to the effective date.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The countries where the Company has its tax domicile have not yet enacted
    any tax legislation in connection with Pillar Two. Therefore, these amendments have no significant impact on the Company&#x2019;s consolidated
    financial statements as of December 2023&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zFXXi5Sw5Jqk" title="Standard"&gt;Amendments to IAS 12 Income Taxes - Deferred Tax related to Assets and Liabilities arising from a Single Transaction&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zIcy5ow2bcGl" title="Description"&gt;The amendments to IAS 12 Income Taxes narrow the scope of the initial recognition
    exception, so that it no longer applies to transactions that generate equal taxable and deductible temporary differences, such as leases
    and decommissioning liabilities.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;These amendments have no significant impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_907_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zKw3rf1kHu1g" title="Standard"&gt;IFRS 17 - Insurance Contracts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zPE0liHDKlPd" title="Description"&gt;IFRS 17 is a new accounting standard with scope for insurance contracts,
    covering recognition and measurement, presentation and disclosure. IFRS 17 replaces IFRS 4 - Insurance Contracts. IFRS 17 applies to all
    types of insurance contracts (such as life, property and casualty, direct insurance and reinsurance), regardless of the type of entities
    issuing them, as well as to certain guarantees and financial instruments with discretionary participation characteristics; Some scope
    exceptions will apply.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The overall objective of IFRS 17 is to provide a comprehensive accounting
    model for insurance contracts that is most useful and consistent for insurers, covering all relevant accounting aspects.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company does not have any contracts that meet the definition of an insurance
    contract under IFRS 17.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;





&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;&lt;i&gt;New standards, interpretations and amendments issued
but not yet effective&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;The new and amended standards and interpretations that are issued,
but not yet effective, up to the date of issuance of the Company&#x2019;s consolidated financial statements are presented below. The Company
intends to adopt these new and amended standards and interpretations, if applicable, when they become effective.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Amendments / standards&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_900_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_zfzybCODwgX4" title="Standard"&gt;Amendments to IFRS 16: Lease Liability in a Sale and Leaseback&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_z0omFgjvhnbj" title="Description"&gt;In September 2022, the IASB issued amendments to IFRS 16 to specify the requirements
    that a seller-lessee uses in measuring lease liability arising from a sale and lease back transaction, in order to ensure that the seller-lessee
    does not recognise any amount of the gain or loss that relates to the right of use that it holds.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The amendments are effective for annual financial statements periods beginning
    on or after January 1, 2024 and shall apply retrospectively to sale and leaseback transactions entered into after the initial application
    date of IFRS 16. Early adoption is permitted but must be disclosed.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_90A_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_zDc4i8S4nvJ" title="Standard"&gt;Amendments to IAS 1: Classification of Liabilities as Current or Non-Current&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_z57sh07ltKLl" title="Description"&gt;In January 2020 and October 2022, the IASB issued amendments to paragraphs
    69 to 76 of IAS 1 to specify the requirements for classifying liabilities as current or non-current. The amendments clarify:&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#x2022; What is meant by the right to postpone liquidation;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#x2022; That the right to defer should exist at the end of the financial reporting
    period;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#x2022; That the rating is not affected by the likelihood that the entity
    will exercise its right to defer;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#x2022; That only if a derivative embedded in a convertible liability is itself
    an equity instrument, the terms of a liability will not affect its classification.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In addition, a disclosure requirement has been introduced where a liability
    arising from a loan agreement is classified as non-current and the entity's right to postpone liquidation is contingent on the fulfilment
    of future covenants within twelve months.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024 and should be applied retrospectively.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_90B_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zkHivH8FOKyc" title="Standard"&gt;Supplier Financing Agreements - Amendments to IAS 7 and IFRS 7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zJDKXm04GSWl" title="Description"&gt;In May 2023, the IASB issued amendments to IAS 7 and IFRS 7 to clarify the
    characteristics of supplier financing arrangements and require additional disclosures of such arrangements. The disclosure requirements
    in the amendments are intended to assist users of the financial statements in understanding the effects of financing arrangements with
    suppliers on an entity's obligations, cash flows, and exposure to liquidity risk.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024. Early adoption is permitted but must be disclosed.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AA_zkwwkyU46Ft2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;These amendments are not expected to have significant impact on the Company&#x2019;s
consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</afya:DisclosureOfMaterialAccountingPoliciesExplanatory>
    <afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000753">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zOClrtiiWnDb" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B7_zcTUTkK5xnpc" style="display: none"&gt;Schedule of Company&#x2019;s subsidiaries and associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;Direct and indirect interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 36%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 23%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;Main activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;Investment type&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;b&gt;December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Afya Participa&#xe7;&#xf5;es S.A. (&#x201c;Afya Brazil&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zalwy9CGxxW1" title="Principal activities"&gt;Holding&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z1RptsvM2mMk" title="Location"&gt;Nova Lima - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zrpmZKKEiJsd" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z5CjixoKcEja" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zXyR3NNOcrQ4" title="Direct and indirect interest of subsidiary"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zv9VS7TatyJd" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto Tocantinense Presidente Ant&#xf4;nio Carlos Porto S.A. - (&#x201c;ITPAC Porto&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zH1Ln5sRdeol" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zwF6v291aIDb" title="Location"&gt;Porto Nacional - TO&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zoUGV6PYurG8" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zB1OKm3apal5" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zrSl5jEFEnm8" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto Tocantinense Presidente Ant&#xf4;nio Carlos S.A. - (&#x201c;ITPAC Aragua&#xed;na&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zGzEFgreoAt6" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_z11eSmIJKfBi" title="Location"&gt;Aragua&#xed;na - TO&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zYznHUPdaUMi" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zdBbdHbYg3Vk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zFZWmVBs9oEh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Uni&#xe3;o Educacional do Vale do A&#xe7;o S.A. - (&#x201c;UNIVA&#xc7;O&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zgWRd2JlcEhk" title="Principal activities"&gt;Medicine undergraduate degree program&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zPgTSpa6ctni" title="Location"&gt;Ipatinga - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zCMh7K0hmkh7" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z0Z1JBdEy9Hg" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z2XOJzLnvsv1" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#x201c;IPTAN&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zSbG3bJ6WCT5" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zYs5VwOf1rs8" title="Location"&gt;S&#xe3;o Jo&#xe3;o Del Rei - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zLGxbgGFRCG8" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zycMe0FDSUxl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zQZQwj3pfEwk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto de Educa&#xe7;&#xe3;o Superior do Vale do Parna&#xed;ba S.A. (&#x201c;IESVAP&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zHwpFCvWTRWg" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zmc5S9CWO1hb" title="Location"&gt;Parna&#xed;ba - PI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zoUNMxDFdDv1" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zykEQvDEg8k8" title="Direct and indirect interest of subsidiary"&gt;80&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_z4qvPwneKpTb" title="Direct and indirect interest of subsidiary"&gt;80&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Centro de Ci&#xea;ncias em Sa&#xfa;de de Itajub&#xe1; S.A. (&#x201c;CCSI&#x201d;) (vi)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z8zjHa6BIeV6" title="Principal activities"&gt;Medicine undergraduate degree program&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zdPwPLBL5Om4" title="Location"&gt;Itajub&#xe1; - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z40USpEPBNzg" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zQmOpVIxyxr" title="Direct and indirect interest of subsidiary"&gt;75&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zIrK3aOB0ueb" title="Direct and indirect interest of subsidiary"&gt;60&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto de Ensino Superior do Piau&#xed; S.A. (&#x201c;IESP&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zWQzPmy7n1Ff" title="Principal activities"&gt;Undergraduate and graduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_za6I0FudD4Hk" title="Location"&gt;Teresina - PI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_znvFnrd2wAR4" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_z38eqmX67Z3l" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zRcqMXWCruCa" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Centro Integrado de Sa&#xfa;de de Teresina (&#x201c;CIS&#x201d;) (v)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zSnBVWW5NM2a" title="Principal activities"&gt;Outpatient care&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zaXqNKFgDxR" title="Location"&gt;Teresina - PI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zdFi64odxsi7" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_z8MiPemDdctg" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;FADEP - Faculdade Educacional de Pato Branco Ltda. (&#x201c;FADEP&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zdJiDucq4gx8" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zKnEUEBh4UXf" title="Location"&gt;Pato Branco - PR&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zL3TPqtol0Hc" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zuJUXviDKN55" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zK5N5l65p6td" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Medcel Editora e Eventos S.A. (&#x201c;Medcel&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zOYAsenPo6M8" title="Principal activities"&gt;Medical education content&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_z8IqdtmzImEj" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zZ3VzZhSfMEb" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_zbxIRxfn1QZb" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEventosS.A.MedcelMember_z5abhnmUIGai" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto Educacional Santo Agostinho S.A. (&#x201c;FASA&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_z3CNx3A8HgYa" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zMddJ12yLnac" title="Location"&gt;Montes Claros - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zcG6gvWygcLe" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zHzTjkrPxdYl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zrzeDyWOonPe" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;ESMC Educa&#xe7;&#xe3;o Superior Ltda. (&#x201c;ESMC&#x201d;) (iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zYckGhqslUua" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zyWCdAa85Bhd" title="Location"&gt;Montes Claros - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_z5BGUTEEMtyl" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zHh5b58t4B32" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto de Pesquisa e Ensino M&#xe9;dico do Estado de Minas Gerais Ltda. (&#x201c;IPEMED&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_ztZbZLKvSEe5" title="Principal activities"&gt;Graduate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zjcYM0e8Fgtk" title="Location"&gt;Belo Horizonte - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zXl2ZbkjAJO" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_z0Wxdk02ZiVe" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember_zkwIlA8E2VDh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Instituto Paraense de Educa&#xe7;&#xe3;o e Cultura Ltda. (&#x201c;IPEC&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_ztm4EYaPUOTc" title="Principal activities"&gt;Medicine degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zMUQ5LY4iHEh" title="Location"&gt;Marab&#xe1; - PA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_ziftmOqfGtl5" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zxQognVwrJUf" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zCzYBJmQOj9b" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Sociedade Universit&#xe1;ria Redentor S.A. (&#x201c;UniRedentor&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z1PnvuFrbxW4" title="Principal activities"&gt;Undergraduate and graduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zNkch2awVkZ8" title="Location"&gt;Itaperuna - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zQGcr5wQuMWf" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zRe0lOTWDiYh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zYIOhEv10Nfh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Centro de Ensino S&#xe3;o Lucas Ltda. (&#x201c;UniSL&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zuBWx7tdWpQ6" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_z3opKGOaCFXh" title="Location"&gt;Porto Velho - RO&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zwFO7NNBiXzh" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zc8YlpZTM9J5" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zQz09AuUBlhi" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Peb Med Institui&#xe7;&#xe3;o de Pesquisa M&#xe9;dica e Servi&#xe7;os Ltda. (&#x201c;PebMed&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zwGFvmIXDyef" title="Principal activities"&gt;Content and clinical tools and online platform&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zM5A2jZsx6Aj" title="Location"&gt;Rio de Janeiro - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zlkaSuMeMzIg" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zWvNQFwIR4rd" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember_zl0z015dT019" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Sociedade de Educa&#xe7;&#xe3;o, Cultura e Tecnologia da Amaz&#xf4;nia S.A. - (&#x201c;FESAR&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zhvG7Pp3hpca" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zyqWTj49rf01" title="Location"&gt;Reden&#xe7;&#xe3;o - PA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zTqDWnFqMr9d" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zpVj7zYLaL92" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zxS06FOXcYy8" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Centro Superior de Ci&#xea;ncias da Sa&#xfa;de S/S Ltda. (&#x201c;FCMPB&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zxhl3lsinqO2" title="Principal activities"&gt;Medicine degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_ziVT5yMMuZId" title="Location"&gt;Jo&#xe3;o Pessoa - PB&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zheIgQ0Dh8U9" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zfmHirGKCZNd" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zuhISMhBKnS8" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;iClinic Desenvolvimento de Software Ltda. (&#x201c;iClinic&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zzGrJmynyihb" title="Principal activities"&gt;Electronic Medical Record, Clinical Management System&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zkcxMakLVvWa" title="Location"&gt;Ribeir&#xe3;o Preto - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zsUxdBU8E9i2" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zLb3w41wSBWh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zx6WPAE9Qkjl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Medicinae Solutions S.A. (&#x201c;Medicinae&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z4DTs95RBlw3" title="Principal activities"&gt;Healthcare payments and financial services&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zb5c1OY9Rbsd" title="Location"&gt;Rio de Janeiro - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zFoDbLSmb2B6" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zXqWbgktuVw5" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z6KZl2oqbbP1" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Medical Harbour Aparelhos M&#xe9;dico Hospitalares e Servi&#xe7;os em Tecnologia Ltda. (&#x201c;Medical Harbour&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zZhaYklSCn2" title="Principal activities"&gt;Educational health and medical imaging&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zpa5PemScH7b" title="Location"&gt;Florian&#xf3;polis - SC&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90D_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zBjdZFmGiZEd" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zeFv4DEjEF3b" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zYA3VDldq1e3" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Cliquefarma Drogarias Online Ltda. (&#x201c;Cliquefarma&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_908_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zvLiXQTf8LMh" title="Principal activities"&gt;Online platform&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zFusXC5ny7Kc" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zbGVANp4Wyce" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zl9pB8ZtT1Kk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_ztbeofn3M1Bi" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Shosp Tecnologia da Informa&#xe7;&#xe3;o Ltda. (&#x201c;Shosp&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zQ3WpInHHkl8" title="Principal activities"&gt;Electronic Medical Record, Clinical Management System&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zVA7XuIDuRoe" title="Location"&gt;Rio de Janeiro - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zgNHFinkpyvi" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_z1QpxW0v4xQc" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zAZiw8SIWO57" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Sociedade Padr&#xe3;o de Educa&#xe7;&#xe3;o Superior Ltda. (&#x201c;UnifipMoc&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zCVP4KK3mVB6" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zS8FV1BAmsq3" title="Location"&gt;Montes Claros - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zO0xBtbGQNik" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zVhbUTgSUfoi" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zjFwRhLh9Sml" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;N&#xfa;cleo de Aten&#xe7;&#xe3;o &#xe0; Sa&#xfa;de e de Pr&#xe1;ticas Profissionalizantes (&#x201c;NASPP) (iv)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zvgSfVHkAPV8" title="Principal activities"&gt;Outpatient care&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zotfy6njizG1" title="Location"&gt;Montes Claros - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zxUrxG5UIAP1" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember_zInDB4qUV6T9" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Companhia Nilza Cordeiro Herdy de Educa&#xe7;&#xe3;o e Cultura (&#x201c;Unigranrio&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zRFOdKj3VQif" title="Principal activities"&gt;Undergraduate and graduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zqrwrvNl4p75" title="Location"&gt;Duque de Caxias - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zoR14pVTkY8d" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zEHW5VKRSVA4" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zIvk9bsGePvd" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Policl&#xed;nica e Centro de Est&#xe9;tica Duque de Caxias Ltda. (&#x201c;Policl&#xed;nica&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zP3K1mwjxI3" title="Principal activities"&gt;Outpatient care&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zkV1063VGF7l" title="Location"&gt;Duque de Caxias - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zoHQsfI7pAAg" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zb3hc3cKhzP3" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember_zt053CJMdDD8" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font-size: 7pt"&gt;Sociedade Educacional de Palho&#xe7;a S/A Ltda. (&#x201c;SOCIESP&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font-size: 7pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_z9rg0MXal5Yl" title="Principal activities"&gt;Basic Education&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font-size: 7pt"&gt;&lt;span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_ztDKDpmWFDIl" title="Location"&gt;Palho&#xe7;a - SC&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font-size: 7pt"&gt;&lt;span id="xdx_901_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_zwZW0J56ukC" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtda.Member_z30vgAAgnQoc" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font-size: 7pt"&gt;Instituto de Ensino Superior de Palho&#xe7;a S/S Ltda. (&#x201c;IESP PALHO&#xc7;A&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font-size: 7pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zORhaIV6bks" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_z9mQI2YTVdM7" title="Location"&gt;Palho&#xe7;a - SC&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font-size: 7pt"&gt;&lt;span id="xdx_908_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zePtyvgsKgOf" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember_zYWb6iWvlh58" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;RX PRO Solu&#xe7;&#xf5;es de Tecnologia Ltda. (&#x201c;RX PRO&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zbsKqs9ZcXG1" title="Principal activities"&gt;Marketing for pharmaceutical industry&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zgsq6dFy4YT5" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z037R5g6cbE4" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z8R6nYdjZy99" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zNYzlvXy3qJg" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;RX PRO LOG Transporte e Log&#xed;stica Ltda. (&#x201c;RX PRO LOG&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_z5twhHGud3Mc" title="Principal activities"&gt;Marketing for pharmaceutical industry&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zGUG4PmwWgnf" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zzS98P9svIwk" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_zoFtLfXjEffh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtda.RXPROLOGMember_ztZcgDeoVuTh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;BMV Atividades M&#xe9;dicas Ltda. (&#x201c;Al&#xe9;m da Medicina&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zWxNA72laWWk" title="Principal activities"&gt;Medical education content&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_znFBaUleq8vj" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_z02DjhG0PmQc" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zjWrfOlfth4f" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--BMVAtividadesMedicasLtda.AlemDaMedicinaMember_zQly09pywIFk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Cardiopapers Solu&#xe7;&#xf5;es Digitais Ltda. (&#x201c;CardioPapers&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zWa0LFTFxvhe" title="Principal activities"&gt;Medical education content&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zIY7kQcj0aca" title="Location"&gt;Recife - PE&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_z676l82ua159" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zGzZJe8ufh85" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiopapersSolucoesDigitaisLtda.CardioPapersMember_zYuIkYxF7ki4" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Quasar Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&#x201c;Glic&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_901_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zTRc3v0p3fg2" title="Principal activities"&gt;Patient physician relationship&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zegdjERLTTKf" title="Location"&gt;Barueri - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zmHwMNmfa6s4" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zZmHBrwxCsO6" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember_zt3uNVeIaDHk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#x201c;DelRey&#x201d;) (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_znVw5RN6Zl6d" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_ztuAsEFtnwf4" title="Location"&gt;Macei&#xf3; - AL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zkSsxRXrU1dk" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zDY9l0MpmWxe" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;Uni&#xe3;o Educacional do Planalto Central S.A. (&#x201c;UEPC&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zzFJjJxjPXp3" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zGU3ji6QI6n2" title="Location"&gt;Bras&#xed;lia - DF&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zC2ujciWITa5" title="Investment type"&gt;Associate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zBGaKF5Qyzdd" title="Direct and indirect interest of subsidiary"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zX52vJW5Spj2" title="Direct and indirect interest of subsidiary"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;See Note 5 for further details of the business combination in 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;IESP was merged by Unigranrio and SOCIESP had its operations closed down, both in January
2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="color: #212121"&gt;ESMC was merged with UnifipMoc in February 2023.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iv)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;NASPP was merged with UnifipMoc in July 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(v)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;CIS was merged with IESP in December 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="color: #212121"&gt;(vi)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="color: #212121"&gt;Acquisition&lt;/span&gt; of additional interest in CCSI: On October
31, 2023, Afya Brazil acquired an additional 15% interest in CCSI, increasing its ownership interest to 75% of total shares. A cash consideration
of R$21,000 was paid to the non-controlling shareholders. The carrying value of the net assets of CCSI (excluding goodwill on the original
acquisition) was R$10,155, and the difference were recorded in retained earnings in the equity attributable to equity holders of the
parent.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_AfyaParticipacoesSAMember"
      id="Fact000755">Holding</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_AfyaParticipacoesSAMember"
      id="Fact000757">Nova Lima - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_AfyaParticipacoesSAMember"
      id="Fact000759">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_AfyaParticipacoesSAMember"
      decimals="INF"
      id="Fact000761"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_AfyaParticipacoesSAMember"
      decimals="INF"
      id="Fact000763"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_AfyaParticipacoesSAMember"
      decimals="INF"
      id="Fact000765"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember"
      id="Fact000767">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember"
      id="Fact000769">Porto Nacional - TO</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember"
      id="Fact000771">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember"
      decimals="INF"
      id="Fact000773"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember"
      decimals="INF"
      id="Fact000775"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember"
      id="Fact000777">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember"
      id="Fact000779">Aragua&#xed;na - TO</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember"
      id="Fact000781">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember"
      decimals="INF"
      id="Fact000783"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember"
      decimals="INF"
      id="Fact000785"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember"
      id="Fact000787">Medicine undergraduate degree program</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember"
      id="Fact000789">Ipatinga - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember"
      id="Fact000791">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember"
      decimals="INF"
      id="Fact000793"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember"
      decimals="INF"
      id="Fact000795"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember"
      id="Fact000797">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember"
      id="Fact000799">S&#xe3;o Jo&#xe3;o Del Rei - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember"
      id="Fact000801">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember"
      decimals="INF"
      id="Fact000803"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember"
      decimals="INF"
      id="Fact000805"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember"
      id="Fact000807">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember"
      id="Fact000809">Parna&#xed;ba - PI</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember"
      id="Fact000811">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember"
      decimals="INF"
      id="Fact000813"
      unitRef="Pure">0.80</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember"
      decimals="INF"
      id="Fact000815"
      unitRef="Pure">0.80</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember"
      id="Fact000817">Medicine undergraduate degree program</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember"
      id="Fact000819">Itajub&#xe1; - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember"
      id="Fact000821">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember"
      decimals="INF"
      id="Fact000823"
      unitRef="Pure">0.75</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember"
      decimals="INF"
      id="Fact000825"
      unitRef="Pure">0.60</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember"
      id="Fact000827">Undergraduate and graduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember"
      id="Fact000829">Teresina - PI</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember"
      id="Fact000831">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember"
      decimals="INF"
      id="Fact000833"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember"
      decimals="INF"
      id="Fact000835"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember"
      id="Fact000837">Outpatient care</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember"
      id="Fact000839">Teresina - PI</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember"
      id="Fact000841">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember"
      decimals="INF"
      id="Fact000843"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember"
      id="Fact000845">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember"
      id="Fact000847">Pato Branco - PR</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember"
      id="Fact000849">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember"
      decimals="INF"
      id="Fact000851"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember"
      decimals="INF"
      id="Fact000853"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_MedcelEditoraEventosS.A.MedcelMember"
      id="Fact000855">Medical education content</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_MedcelEditoraEventosS.A.MedcelMember"
      id="Fact000857">S&#xe3;o Paulo - SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_MedcelEditoraEventosS.A.MedcelMember"
      id="Fact000859">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_MedcelEditoraEventosS.A.MedcelMember"
      decimals="INF"
      id="Fact000861"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_MedcelEditoraEventosS.A.MedcelMember"
      decimals="INF"
      id="Fact000863"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember"
      id="Fact000865">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember"
      id="Fact000867">Montes Claros - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember"
      id="Fact000869">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember"
      decimals="INF"
      id="Fact000871"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember"
      decimals="INF"
      id="Fact000873"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember"
      id="Fact000875">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember"
      id="Fact000877">Montes Claros - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember"
      id="Fact000879">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember"
      decimals="INF"
      id="Fact000881"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember"
      id="Fact000883">Graduate</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember"
      id="Fact000885">Belo Horizonte - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember"
      id="Fact000887">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember"
      decimals="INF"
      id="Fact000889"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_InstitutoDePesquisaEEnsinoMedicoFoEstadoDeMinasGeraisLtdaIPEMEDMember"
      decimals="INF"
      id="Fact000891"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember"
      id="Fact000893">Medicine degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember"
      id="Fact000895">Marab&#xe1; - PA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember"
      id="Fact000897">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember"
      decimals="INF"
      id="Fact000899"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember"
      decimals="INF"
      id="Fact000901"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember"
      id="Fact000903">Undergraduate and graduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember"
      id="Fact000905">Itaperuna - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember"
      id="Fact000907">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember"
      decimals="INF"
      id="Fact000909"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember"
      decimals="INF"
      id="Fact000911"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember"
      id="Fact000913">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember"
      id="Fact000915">Porto Velho - RO</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember"
      id="Fact000917">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember"
      decimals="INF"
      id="Fact000919"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember"
      decimals="INF"
      id="Fact000921"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember"
      id="Fact000923">Content and clinical tools and online platform</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember"
      id="Fact000925">Rio de Janeiro - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember"
      id="Fact000927">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember"
      decimals="INF"
      id="Fact000929"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtda.PebMedMember"
      decimals="INF"
      id="Fact000931"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember"
      id="Fact000933">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember"
      id="Fact000935">Reden&#xe7;&#xe3;o - PA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember"
      id="Fact000937">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember"
      decimals="INF"
      id="Fact000939"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember"
      decimals="INF"
      id="Fact000941"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember"
      id="Fact000943">Medicine degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember"
      id="Fact000945">Jo&#xe3;o Pessoa - PB</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember"
      id="Fact000947">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember"
      decimals="INF"
      id="Fact000949"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember"
      decimals="INF"
      id="Fact000951"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember"
      id="Fact000953">Electronic Medical Record, Clinical Management System</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember"
      id="Fact000955">Ribeir&#xe3;o Preto - SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember"
      id="Fact000957">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember"
      decimals="INF"
      id="Fact000959"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember"
      decimals="INF"
      id="Fact000961"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember"
      id="Fact000963">Healthcare payments and financial services</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember"
      id="Fact000965">Rio de Janeiro - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember"
      id="Fact000967">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember"
      decimals="INF"
      id="Fact000969"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember"
      decimals="INF"
      id="Fact000971"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember"
      id="Fact000973">Educational health and medical imaging</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember"
      id="Fact000975">Florian&#xf3;polis - SC</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember"
      id="Fact000977">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember"
      decimals="INF"
      id="Fact000979"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember"
      decimals="INF"
      id="Fact000981"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember"
      id="Fact000983">Online platform</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember"
      id="Fact000985">S&#xe3;o Paulo - SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember"
      id="Fact000987">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember"
      decimals="INF"
      id="Fact000989"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember"
      decimals="INF"
      id="Fact000991"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember"
      id="Fact000993">Electronic Medical Record, Clinical Management System</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember"
      id="Fact000995">Rio de Janeiro - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember"
      id="Fact000997">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember"
      decimals="INF"
      id="Fact000999"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember"
      decimals="INF"
      id="Fact001001"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember"
      id="Fact001003">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember"
      id="Fact001005">Montes Claros - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember"
      id="Fact001007">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember"
      decimals="INF"
      id="Fact001009"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember"
      decimals="INF"
      id="Fact001011"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember"
      id="Fact001013">Outpatient care</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember"
      id="Fact001015">Montes Claros - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember"
      id="Fact001017">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_NucleoDeAtencaoASaudeEDePraticasProfissionalizantesNASPPMember"
      decimals="INF"
      id="Fact001019"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember"
      id="Fact001021">Undergraduate and graduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember"
      id="Fact001023">Duque de Caxias - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember"
      id="Fact001025">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember"
      decimals="INF"
      id="Fact001027"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember"
      decimals="INF"
      id="Fact001029"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember"
      id="Fact001031">Outpatient care</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember"
      id="Fact001033">Duque de Caxias - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember"
      id="Fact001035">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember"
      decimals="INF"
      id="Fact001037"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtda.PoliclinicaMember"
      decimals="INF"
      id="Fact001039"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalDePalhocaSALtda.Member"
      id="Fact001041">Basic Education</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalDePalhocaSALtda.Member"
      id="Fact001043">Palho&#xe7;a - SC</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalDePalhocaSALtda.Member"
      id="Fact001045">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_SociedadeEducacionalDePalhocaSALtda.Member"
      decimals="INF"
      id="Fact001047"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember"
      id="Fact001049">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember"
      id="Fact001051">Palho&#xe7;a - SC</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember"
      id="Fact001053">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtda.IESPPALHOCAMember"
      decimals="INF"
      id="Fact001055"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember"
      id="Fact001057">Marketing for pharmaceutical industry</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember"
      id="Fact001059">S&#xe3;o Paulo - SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember"
      id="Fact001061">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember"
      decimals="INF"
      id="Fact001063"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember"
      decimals="INF"
      id="Fact001065"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember"
      id="Fact001067">Marketing for pharmaceutical industry</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember"
      id="Fact001069">S&#xe3;o Paulo - SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember"
      id="Fact001071">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember"
      decimals="INF"
      id="Fact001073"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_RXPROLOGTransporteELogisticaLtda.RXPROLOGMember"
      decimals="INF"
      id="Fact001075"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember"
      id="Fact001077">Medical education content</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember"
      id="Fact001079">S&#xe3;o Paulo - SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember"
      id="Fact001081">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember"
      decimals="INF"
      id="Fact001083"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_BMVAtividadesMedicasLtda.AlemDaMedicinaMember"
      decimals="INF"
      id="Fact001085"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember"
      id="Fact001087">Medical education content</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember"
      id="Fact001089">Recife - PE</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember"
      id="Fact001091">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember"
      decimals="INF"
      id="Fact001093"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_CardiopapersSolucoesDigitaisLtda.CardioPapersMember"
      decimals="INF"
      id="Fact001095"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember"
      id="Fact001097">Patient physician relationship</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember"
      id="Fact001099">Barueri - SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember"
      id="Fact001101">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember"
      decimals="INF"
      id="Fact001103"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_QuasarTelemedicinaDesenvolvimentoDeSistemasComputacionaisLtda.GlicMember"
      decimals="INF"
      id="Fact001105"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember"
      id="Fact001107">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember"
      id="Fact001109">Macei&#xf3; - AL</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember"
      id="Fact001111">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember"
      decimals="INF"
      id="Fact001113"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember"
      id="Fact001115">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember"
      id="Fact001117">Bras&#xed;lia - DF</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember"
      id="Fact001119">Associate</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember"
      decimals="INF"
      id="Fact001121"
      unitRef="Pure">0.30</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-01-012022-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember"
      decimals="INF"
      id="Fact001123"
      unitRef="Pure">0.30</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:BusinessCombinationsAndGoodwillPolicyExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001125">&lt;p id="xdx_842_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zeqybfC7yksh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;a) &lt;span id="xdx_866_zre99Xd2lFob"&gt;Business combinations and goodwill&lt;/span&gt; &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Business combinations are accounted for using the acquisition method. The
cost of an acquisition is measured as the aggregate of the consideration transferred, which is measured at acquisition date fair value,
and the amount of any non-controlling interests in the acquiree. For each business combination, the Company elects whether to measure
the non-controlling interests in the acquiree at fair value or at the proportionate share of the acquiree&#x2019;s identifiable net assets.
Acquisition-related costs are expensed as incurred and included in selling, general and administrative expenses.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;When the Company acquires a business, it assesses the financial assets and
liabilities assumed for appropriate classification and designation in accordance with the contractual terms, economic circumstances and
pertinent conditions as of the acquisition date.&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Goodwill is initially measured at cost (being the excess of the aggregate
of the consideration transferred and the amount recognized for non-controlling interests and any previous interest held over the net
identifiable assets acquired and liabilities assumed). If the fair value of the net assets acquired is in excess of the aggregate consideration
transferred, the Company re-assesses whether it has correctly identified all of the assets acquired and all of the liabilities assumed
and reviews the procedures used to measure the amounts to be recognized at the acquisition date. If the reassessment still results in
an excess of the fair value of net assets acquired over the aggregate consideration transferred, then the gain is recognized in the consolidated
statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;After initial recognition, goodwill is measured at cost less any accumulated
impairment losses. For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated
to each of the Company&#x2019;s cash-generating units that are expected to benefit from the combination, irrespective of whether other
assets or liabilities of the acquire are assigned to those units.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Where goodwill has been allocated to a cash-generating unit (CGU) and part
of the operation within that unit is disposed of, the goodwill associated with the disposed operation is included in the carrying amount
of the operation when determining the gain or loss on disposal. Goodwill disposed in these circumstances is measured based on the relative
values of the disposed operation and the portion of the cash-generating unit retained.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</afya:BusinessCombinationsAndGoodwillPolicyExplanatory>
    <afya:CurrentVersusNoncurrentClassificationPoliciesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001128">&lt;p id="xdx_848_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zvIOto8tCKJa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;b) &lt;span id="xdx_86D_zgfWBvd54Hjf"&gt;Current versus non-current classification&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company presents assets and liabilities in the statement of financial
position based on current and non-current classification. An asset is current when it is:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Expected to be realized
or intended to be sold or consumed in the normal operating cycle;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Held primarily for
the purpose of trading;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Expected to be realized
within twelve months after the reporting period; or&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Cash or cash equivalent
unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;All other assets are classified as non-current.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;A liability is current when:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;It is expected to
be settled in the normal operating cycle;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;It is held primarily
for the purpose of trading;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;It is due to be
settled within twelve months after the reporting period; or&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;There is no unconditional
right to defer the settlement of the liability for at least twelve months after the reporting period.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company classifies all other liabilities as non-current.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Deferred tax assets and liabilities are classified as non-current assets
and liabilities.&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</afya:CurrentVersusNoncurrentClassificationPoliciesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001130">&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zVRK63da52x4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;c) &lt;span id="xdx_866_zgQOUctiUb3i"&gt;Fair value measurement&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Fair value is the price that would be received to sell an asset or paid
to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based
on the presumption that the transaction to sell the asset or transfer the liability takes place either: (i) in the principal market for
the asset or liability; or (ii) in the absence of a principal market, in the most advantageous market for the asset or liability.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The principal or the most advantageous market must be accessible by the
Company.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The fair value of an asset or a liability is measured using the assumptions
that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;A fair value measurement of a non-financial asset takes into account a market
participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market
participant that would use the asset in its highest and best use.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company uses valuation techniques that are appropriate in the circumstances
and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the
use of unobservable inputs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;All assets and liabilities for which fair value is measured or disclosed
in the financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that
is significant to the fair value measurement as a whole:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Level 1 - Quoted
(unadjusted) market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Level 2 - Valuation
techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Level 3 - Valuation
techniques for which the lowest level input that is significant to the fair value measurement is unobservable.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;For assets and liabilities that are recognized in the financial statements
at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy by re-assessing
categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting
period.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;At each reporting date, the Company analyzes the movements in the values
of assets and liabilities which are required to be remeasured or reassessed as per the Company&#x2019;s accounting policies. For this analysis,
the Company verifies the major inputs applied in the latest valuation by agreeing the information in the valuation computation to contracts
and other relevant documents.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company also compares the change in the fair value of each asset and
liability with relevant external sources to determine whether the change is reasonable.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;For the purpose of fair value disclosures, the Company has determined classes
of assets and liabilities on the basis of the nature, characteristics and risks of the asset or liability and the level of the fair value
hierarchy, as explained above.&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory>
    <afya:FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001132">&lt;p id="xdx_840_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_zKvg01UWdcJ7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;d) &lt;span id="xdx_866_zTFTz8xv3zk6"&gt;Financial instruments - initial recognition and measurement&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;A financial instrument is any contract that gives rise to a financial asset
of one entity and a financial liability or equity instrument of another entity.&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 14.2pt"&gt;&lt;/td&gt;&lt;td style="width: 14.15pt"&gt;&lt;b&gt;i)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Financial assets&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Initial recognition and measurement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The classification of financial assets at initial recognition
depends on the financial asset&#x2019;s contractual cash flow characteristics and the Company&#x2019;s business model for managing them.
With the exception of trade receivables that do not contain a significant financing component or for which the Company has applied the
practical expedient, the Company initially measures a financial asset at its fair value plus, in the case of a financial asset not at
fair value through profit or loss, transaction costs. Trade receivables that do not contain a significant financing component or for
which the Company has applied the practical expedient, are measured at the transaction price determined under IFRS 15.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;In order for a financial asset to be classified and measured
at amortized cost or fair value through OCI (Other Comprehensive Income), it needs to give rise to cash flows that are &#x201c;solely payments
of principal and interest (SPPI)&#x201d; on the principal amount outstanding. This assessment is referred to as the SPPI test and is performed
at an instrument level.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The Company&#x2019;s business model for managing financial assets
refers to how it manages its financial assets in order to generate cash flows. The business model determines whether cash flows will result
from collecting contractual cash flows, selling the financial assets, or both.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Purchases or sales of financial assets that require delivery
of assets within a time frame established by regulation or convention in the market place (regular way trades) are recognized on the trade
date, i.e., the date that the Company commits to purchase or sell the asset.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Subsequent measurement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;For purposes of subsequent measurement, financial assets are
classified as: financial assets at amortized cost or financial assets at fair value through profit or loss. There are no financial assets
designated as fair value through OCI.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Financial assets at amortized cost&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The Company measures financial assets at amortized cost if both
of the following conditions are met:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#x2022; The financial asset is held within a business model with
the objective to hold financial assets in order to collect contractual cash flows, and&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#x2022; The contractual terms of the financial asset give rise
on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial assets at amortized cost are subsequently measured
using the effective interest (EIR) method and are subject to impairment. Gains and losses are recognized in the statement of income when
the asset is derecognized, modified or impaired.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Financial assets at fair value through profit
or loss&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial assets at fair value through profit or loss include
financial assets held for trading, financial assets designated upon initial recognition at fair value through profit or loss, or financial
assets mandatorily required to be measured at fair value. Financial assets are classified as held for trading if they are acquired for
the purpose of selling or repurchasing in the near term. Derivatives, including separated embedded derivatives, are also classified as
held for trading unless they are designated as effective hedging instruments. Financial assets with cash flows that are not solely payments
of principal and interest are classified and measured at fair value through profit or loss, irrespective of the business model.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial assets at fair value through profit or loss are carried
in the statement of financial position at fair value with net changes in fair value recognized in the statement of income. This category
includes derivative instruments.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Derecognition&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;A financial asset (or, where applicable, a part of a financial
asset or part of a group of similar financial assets) is primarily derecognized (i.e., removed from the Company&#x2019;s statement of financial
position) when:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&#x2022;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The rights to receive cash flows from the asset have expired; or&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&#x2022;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company has transferred its rights to receive cash flows from the asset or has assumed
an obligation to pay the received cash flows in full without material delay to a third party under a &#x2018;pass-through&#x2019; arrangement;
and either (a) the Company has transferred substantially all the risks and rewards of the asset, or (b) the Company has neither transferred
nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;When the Company has transferred its rights to receive cash flows
from an asset or has entered into a pass-through arrangement, it evaluates if, and to what extent, it has retained the risks and rewards
of ownership. When it has neither transferred nor retained substantially all of the risks and rewards of the asset, nor transferred control
of the asset, the Company continues to recognize the transferred asset to the extent of its continuing involvement. In that case, the
Company also recognizes an associated liability. The transferred asset and the associated liability are measured on a basis that reflects
the rights and obligations that the Company has retained.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Continuing involvement that takes the form of a guarantee over
the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that
the Company could be required to repay.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Impairment of financial assets&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Further disclosures relating to impairment of financial assets
are also provided in the following notes:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&#x2022;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Significant accounting judgments, estimates and assumptions - Note 3&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&#x2022;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Trade receivables - Note 7&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The Company recognizes an allowance for expected credit losses
(ECLs) for all debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual
cash flows due in accordance with the contract and the cash flows the Company expects to receive, discounted at an approximation of the
original effective interest rate. The expected cash flows will include cash flows from the sale of collateral held or other credit enhancements
that are integral to the contractual terms.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;For trade receivables, the Company applies a simplified approach
in calculating ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for credit losses
based on lifetime ECLs at each reporting date. The Company has established a provision matrix that is based on its historical credit loss
experience, adjusted for forward-looking factors specific to the debtors and the economic environment.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The Company considers a financial asset to be in default
when internal or external information indicates that the Company is unlikely to receive the outstanding contractual amounts in full
before considering any credit enhancements held by the Company. A financial asset is written off when there is no reasonable
expectation of recovering the contractual cash flows.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;b&gt;ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
liabilities&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Initial recognition and measurement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial liabilities are classified, at initial recognition,
as financial liabilities at fair value through profit or loss, loans and borrowings, payables, or as derivatives designated as hedging
instruments in an effective hedge, as appropriate.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;All financial liabilities are recognized initially at fair value
and, in the case of loans and borrowings and payables, net of directly attributable transaction costs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The Company&#x2019;s financial liabilities include trade payables,
loans and financing, notes payable, lease liabilities, advances from customers and accounts payable to selling shareholders.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Subsequent measurement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;The measurement of financial liabilities depends on their classification,
as described below:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Financial liabilities at fair value through
profit or loss&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial liabilities at fair value through profit or loss include
financial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value through profit or
loss.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial liabilities are classified as held for trading if they
are incurred for the purpose of repurchasing in the near term. This category also includes, when applicable, derivative financial instruments
entered into by the Company that are not designated as hedging instruments in hedge relationships as defined by IFRS 9. Gains or losses
on liabilities held for trading are recognized in the statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial liabilities designated upon initial recognition at
fair value through profit or loss are designated at the initial date of recognition, and only if the criteria in IFRS 9 are satisfied.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Loans and borrowings&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;After initial recognition, interest-bearing loans and borrowings
are subsequently measured at amortized cost using the EIR method. Gains and losses are recognized in the statement of income when the
liabilities are derecognized as well as through the EIR amortization process.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Amortized cost is calculated by considering any discount or premium
on acquisition and fees or costs that are an integral part of the EIR. The EIR amortization is included as finance expenses in the statement
of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Derecognition&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;A financial liability is derecognized when the obligation under
the liability is discharged or cancelled or expires. When an existing financial liability is replaced by another from the same lender
on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is
treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying
amounts is recognized in the statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;br/&gt;
&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;i&gt;Offsetting of financial instruments&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;Financial assets and financial liabilities are offset and the
net amount is reported in the statement of financial position if there is a currently enforceable legal right to offset the recognized
amounts and there is an intention to settle on a net basis, to realize the assets and settle the liabilities simultaneously.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</afya:FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="From2023-01-01to2023-12-31" id="Fact001136">&lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zSLNqDO7dt11" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;e) &lt;span id="xdx_867_zWpp7npZLiub"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Cash and cash equivalents in the statement of financial position comprise
cash at banks and on hand, and short-term financial investments with an original maturity of three months or less, which are subject to
an insignificant risk of changes in value.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;For the purpose of the statement of cash flows, cash and cash equivalents
consist of cash and short-term financial investments, as they are considered an integral part of the Company&#x2019;s cash management.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001138">&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zNJh9Hmg1eQ9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;f) &lt;span id="xdx_860_zaQrZT2wqJl8"&gt;Property and equipment&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Property and equipment are stated at cost, net of accumulated depreciation
and accumulated impairment losses, if any.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Subsequent expenditures are capitalized only if it is probable that the
future economic benefits associated with the expenditure will flow to the Company.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Depreciation is calculated on a straight-line basis over the estimated useful
lives of the assets, as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zAZYZOz6Ydq" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B0_zaC2EnOUWqdf" style="display: none"&gt;Schedule of estimated useful
lives of the assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Building&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zGZ0Olisj3R3" title="Useful lives of assets"&gt;25&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zlijIYD854z1" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zWn083WDFBIa" title="Useful lives of assets"&gt;4&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zVPzrKtB97bi" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;IT equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zdCqKpUaMbQj" title="Useful lives of assets"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Library books&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_z35nlPvrCfH9" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGUH789gLle1" title="Useful lives of assets"&gt;5&lt;/span&gt; - &lt;span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zr85b7n2lei4" title="Useful lives of assets"&gt;20&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;br/&gt;
&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;An item of property and equipment and any significant part initially recognized
is derecognized upon disposal or when no future economic benefit is expected from its use or disposal. Any gain or loss arising on the
derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included
in the statement of income when the asset is derecognized.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The residual values, useful lives and methods of depreciation of property
and equipment are reviewed at each financial year end and adjusted prospectively, if appropriate.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <afya:ScheduleOfEstimatedUsefulLivesTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001140">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zAZYZOz6Ydq" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B0_zaC2EnOUWqdf" style="display: none"&gt;Schedule of estimated useful
lives of the assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Building&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zGZ0Olisj3R3" title="Useful lives of assets"&gt;25&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zlijIYD854z1" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zWn083WDFBIa" title="Useful lives of assets"&gt;4&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zVPzrKtB97bi" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;IT equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zdCqKpUaMbQj" title="Useful lives of assets"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Library books&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_z35nlPvrCfH9" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGUH789gLle1" title="Useful lives of assets"&gt;5&lt;/span&gt; - &lt;span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zr85b7n2lei4" title="Useful lives of assets"&gt;20&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:ScheduleOfEstimatedUsefulLivesTableTextBlock>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_BuildingsMember"
      id="Fact001142">P25Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_custom_MachineryAndEquipmentsMember"
      id="Fact001144">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_VehiclesMember"
      id="Fact001146">P4Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_FixturesAndFittingsMember"
      id="Fact001148">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_custom_ItEquipmentMember"
      id="Fact001150">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_custom_LibraryBooksMember"
      id="Fact001152">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_BottomOfRangeMember"
      id="Fact001154">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_TopOfRangeMember"
      id="Fact001156">P20Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001158">&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zjIX2ELhTcF6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;g) &lt;span id="xdx_864_zMeHdQwI1tq"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company assess at contract inception whether an arrangement is (or contains)
a lease is based on the substance of the arrangement at the inception of the contract. The arrangement is, or contains, a lease if the
arrangement conveys the right to control the use of the identified asset (or assets), even if that asset is (or those assets are) not
explicitly specified in an arrangement for a period of time in exchange for consideration.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;br/&gt;
&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;Company as a lessee&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company applies a single recognition and measurement approach for all
leases, except for short-term leases and leases of low-value assets. The Company recognizes lease liabilities to make lease payments and
right-of-use assets representing the right to use the underlying assets.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;Right-of-use assets&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company recognizes right-of-use assets at the commencement date of the
lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation
and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of
lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease
incentives received. Unless the Company is reasonably certain to obtain ownership of the leased asset at the end of the lease term, the
recognized right-of-use assets are depreciated on a straight-line basis over the shorter of its estimated useful life and the lease term.
Right-of-use assets are subject to impairment.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;Lease liabilities&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;At the commencement date of the lease, the Company recognizes lease liabilities
measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance
fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected
to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain
to be exercised by the Company and payments of penalties for terminating a lease, if the lease term reflects the Company exercising the
option to terminate. The variable lease payments that do not depend on an index or a rate are recognized as expense in the period on which
the event or condition that triggers the payment occurs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In calculating the present value of lease payments, the Company uses the
incremental borrowing rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After
the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments
made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change
in the in-substance fixed lease payments or a change in the assessment to purchase the underlying asset.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;Short-term leases and leases of low-value assets&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company applies the short-term lease recognition exemption to its short-term
leases of properties (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase
option). It also applies the lease of low-value assets recognition exemption to leases that are considered of low value. Lease payments
on short-term leases and leases of low-value assets are recognized as expense on a straight-line basis over the lease term.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001160">&lt;p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_z7U4La36slmi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;h) &lt;span id="xdx_866_zpxVucjDvpRh"&gt;Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Intangible assets acquired separately are measured on initial recognition
at cost. The cost of intangible assets acquired in a business combination is their fair value at the date of acquisition. Following initial
recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally generated
intangibles are not capitalized and the related expenditure is reflected in the statement of income in the period in which the expenditure
is incurred.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The useful lives of intangible assets are assessed as finite or indefinite.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Intangible assets with finite lives are amortized over the useful economic
life and assessed for impairment whenever there is an indication that the intangible asset may be impaired.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The amortization period and the amortization method for an intangible asset
with a finite useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected
pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as
appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized
in the statement of income in the expense category that is consistent with the function of the intangible assets.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Intangible assets with indefinite useful lives are not amortized, but are
tested for impairment annually, either individually or at the cash-generating unit level. The assessment of indefinite life is reviewed
annually to determine whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite
is made on a prospective basis.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;An intangible asset is derecognized upon disposal or when no future economic
benefits are expected from its use or disposal. Any gain or loss arising upon derecognition of the asset (calculated as the difference
between the net disposal proceeds and the carrying amount of the asset) is included in the statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <afya:ImpairmentOfNonfinancialAssetsPolicyExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001163">&lt;p id="xdx_84A_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_zlZZxcLm8cke" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;i) &lt;span id="xdx_862_zW60XKT14Avf"&gt;Impairment of non-financial assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company assesses, at each reporting date, whether there is an indication
that an asset may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Company estimates
the asset&#x2019;s recoverable amount. An asset&#x2019;s recoverable amount is the higher of an asset&#x2019;s or CGU&#x2019;s fair value
less costs of disposal and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate
cash inflows that are largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU
exceeds its recoverable amount, the asset is considered impaired and is written down to its recoverable amount.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In assessing value in use, the estimated future cash flows are discounted
to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks
specific to the asset. In determining fair value less costs of disposal, recent market transactions are considered. If no such transactions
can be identified, an appropriate valuation model is used. These calculations are corroborated by valuation multiples, quoted share prices
for publicly traded companies or other available fair value indicators.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company bases its impairment calculation on detailed budgets and forecast
calculations, which are prepared separately for each of the Company&#x2019;s CGUs to which the individual assets are allocated. These budgets
and forecast calculations generally cover a period of five years, considering the companies activities and maturation period of its graduate
and undergraduate courses. A long-term growth rate is calculated and applied to project future cash flows after the last projected year.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;For impairment testing, goodwill acquired through business combinations
and licenses with indefinite useful lives are allocated to their respective CGUs. The Company defined each of its operating subsidiaries
as a CGU, except for digital services segment, which combines subsidiaries of (i) &#x201c;Content &amp;amp; Technology for medical education&#x201d;;
(ii) &#x201c;Clinical Decision Software&#x201d;; and (iii) &#x201c;Practice Management Tools &amp;amp; Electronic Prescription&#x201d;, where
the subsidiaries were combined as one CGU following the business strategic pillars.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Whenever applicable, impairment losses of continuing operations are recognized
in the statement of income in expense categories consistent with the function of the impaired asset.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;For assets excluding goodwill, an assessment is made at each reporting date
to determine whether there is an indication that previously recognized impairment losses no longer exist or have decreased. If such indication
exists, the Company estimates the asset&#x2019;s or CGU&#x2019;s recoverable amount. A previously recognized impairment loss is reversed
only if there has been a change in the assumptions used to determine the asset&#x2019;s recoverable amount since the last impairment loss
was recognized. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the
carrying amount that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years.
Such reversal is recognized in the statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Goodwill is tested for impairment annually as at December 31 and when circumstances
indicate that the carrying value may be impaired.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Impairment is determined for goodwill by assessing the recoverable amount
of each CGU (or group of CGUs) to which the goodwill relates. When the recoverable amount of the CGU is less than its carrying amount,
an impairment loss is recognized. Impairment losses relating to goodwill cannot be reversed in future periods.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Intangible assets with indefinite useful lives are tested for impairment
annually as at December 31 at the CGU level, as appropriate, and when circumstances indicate that the carrying value may be impaired.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</afya:ImpairmentOfNonfinancialAssetsPolicyExplanatory>
    <afya:DescriptionOfAccountingPolicyForInvestmentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001166">&lt;p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForInvestmentsExplanatory_zmHC9D4CmwBi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;j) &lt;span id="xdx_865_zqfOzwRP2TGf"&gt;Investments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Investments in associates are initially recognized at consideration transferred
and adjusted thereafter for the equity method, being increased or reduced from its interest in the investee's income after the acquisition
date. An associate is an entity over which the Company has significant influence. Significant influence is the power to participate in
the financial and operating policy decisions of the investee, but is not control or joint control over those policies.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</afya:DescriptionOfAccountingPolicyForInvestmentsExplanatory>
    <afya:AccountsPayableToSellingShareholdersPolicyExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001168">&lt;p id="xdx_845_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_ziQoQhjATxuc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;k) &lt;span id="xdx_86A_zGCeAo5CyYs9"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;These amounts represent liabilities related to the acquisitions made by
the Company which are not yet due. Accounts payable to selling shareholders are presented as current liabilities unless payment is not
due within 12 months after the reporting period. They are recognized initially at their fair value and subsequently measured at amortized
cost using the effective interest method, except for the contingent consideration related to earn-outs, which are measured at fair value
through profit or loss.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</afya:AccountsPayableToSellingShareholdersPolicyExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001170">&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_z8grFXjufnd3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;l) &lt;span id="xdx_865_zy328twd4Mji"&gt;Provisions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Provisions are recognized when the Company has a present obligation (legal
or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required
to settle the obligation, and a reliable estimate can be made of the amount of the obligation. The expense relating to a provision is
presented in the statement of income, net of any reimbursement, when applicable.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <afya:DividendsPolicyExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001173">&lt;p id="xdx_84C_ecustom--DividendsPolicyExplanatory_zJIeCotkaNFe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;m) &lt;span id="xdx_865_zZ0HxIVUJ3wi"&gt;Dividends&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company recognizes a liability to pay a dividend when the distribution
is authorized and the distribution is no longer at the discretion of the Company. The distribution is authorized when it is required to
pay a minimum dividend of the net income for the year in accordance with the Brazilian Corporate Law (applicable for Afya Brazil and its
subsidiaries) and the Company&#x2019;s By-Laws or is approved by the shareholders. In respect to the consolidated statement of changes
in equity, the amount corresponding to the non-controlling interest over the dividends declared are recognized directly in equity.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</afya:DividendsPolicyExplanatory>
    <afya:LaborAndSocialObligationsPolicyExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001175">&lt;p id="xdx_847_ecustom--LaborAndSocialObligationsPolicyExplanatory_z1fYGR5TdZ9b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;n) &lt;span id="xdx_86C_z1YEpve974k6"&gt;Labor and social obligations&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Labor and social obligations are expensed as the related service is provided.
A liability is recognized for the amount expected to be paid if the Company has a present legal or constructive obligation to pay this
amount as a result of past service provided by the employee and the obligation can be estimated reliably.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</afya:LaborAndSocialObligationsPolicyExplanatory>
    <afya:SharebasedPaymentsPolicyExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001177">&lt;p id="xdx_843_ecustom--SharebasedPaymentsPolicyExplanatory_zalIcnHJTBeb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;o) &lt;span id="xdx_861_zL9WHXQMQFG"&gt;Share-based payments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Certain key executives of the Company receive remuneration in the form of
share-based payments, which includes Stock Options and Restricted Stock Units (&#x201c;RSUs&#x201d;), whereby the executives render services
as consideration for equity instruments (equity-settled transactions).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The expense of equity-settled transactions is determined by the fair value
at the date when the grant is made using an appropriate valuation model.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;That expense is recognized in selling, general and administrative expenses,
together with a corresponding increase in equity, over the period in which the service and, where applicable, the performance conditions
are fulfilled (the vesting period). The cumulative expense recognized for equity-settled transactions at each reporting date until the
vesting date reflects the extent to which the vesting period has expired and the Company&#x2019;s best estimate of the number of equity
instruments that will ultimately vest. The expense or credit in the statement of income for a period represents the movement in cumulative
expense recognized as at the beginning and end of that period.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Service and non-market performance conditions are not considered when determining
the grant date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Company&#x2019;s best estimate
of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair
value. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting conditions.
Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless there are also
service and/or performance conditions.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;No expense is recognized for awards that do not ultimately vest because
non-market performance and/or service conditions have not been met. Where awards include a market or non-vesting condition, the transactions
are treated as vested irrespective of whether the market or non-vesting condition is satisfied, provided that all other performance and/or
service conditions are satisfied.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;When the terms of an equity-settled award are modified, the minimum expense
recognized is the grant date fair value of the unmodified award, provided the original vesting terms of the award are met. An additional
expense, measured as at the date of modification, is recognized for any modification that increases the total fair value of the share-based
payment transaction, or is otherwise beneficial to the employee. Where an award is cancelled by the entity or by the counterparty, any
remaining element of the fair value of the award is expensed immediately through the statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The dilutive effect of outstanding options is reflected as additional share
dilution in the computation of diluted earnings per share.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</afya:SharebasedPaymentsPolicyExplanatory>
    <ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001180">&lt;p id="xdx_840_eifrs-full--DisclosureOfRevenueFromContractsWithCustomersExplanatory_zQ6ltLqCkpUh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;p) &lt;span id="xdx_861_ztnxnOBSMQ0a"&gt;Revenue from contracts with customers&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;i&gt;Revenue recognition transferred over time &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company's revenue consists primarily of tuition fees charged for medical
courses. The Company also generates revenue from tuition fees for other undergraduate courses, student fees, certain education-related
activities, digital education content and subscription of digital services.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Revenues are recognized when services are rendered to the customer and the
performance obligation is satisfied.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Revenue from tuitions, digital education content and electronic medical
records are recognized over time when services are rendered to the customer and the Company satisfies its performance obligation under
the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services.
Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Other revenues are recognized at a point in time when the service is rendered
to the customer at an amount that reflects the consideration to which the Company expects to be entitled in exchange for the service.
Other revenues are presented net of the corresponding discounts, returns and taxes.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;i&gt;Revenue recognition transferred at point in time &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Revenue from sale of printed books, e-books, healthcare payments, online
platforms and marketing for pharmaceutical industry are recognized at the point in time when control of the asset or services is transferred
to the customer, generally on delivery of the goods at the customer&#x2019;s location and permission to access the digital content. The
Company considers whether there are other promises in the contract that are separate performance obligations to which a portion of the
transaction price needs to be allocated. In determining the transaction price for the printed books and e-books, the Company considers
the effects of variable consideration, financing component, noncash consideration, and consideration payable to the customer to be not
significant.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company concluded that it is the principal in its revenue arrangements.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company assesses collectability on a portfolio basis prior to recording
revenue. Generally, students cannot re-enroll for the next academic session without satisfactory resolution of any past-due amounts. If
a student withdraws from an institution, the Company's obligation to issue a refund depends on the refund policy at that institution and
the timing of the student's withdrawal. Generally, the refund obligations are reduced over the course of the academic term.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;Trade receivables&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Trade receivables represent the Company&#x2019;s right to an amount of consideration
that is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to accounting policies
of financial assets in Financial instruments - initial recognition and subsequent measurement.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;Advances from customers&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Advances from customers (a contract liability) are the obligation to transfer
services to a customer for which the Company has received consideration (or an amount of consideration is due) from the customer, as a
result of pre-paid tuition, digital education content and mobile app subscription for digital medical content received from customers
and is recognized separately in current liabilities, when the payment is received. Advances from customers are recognized as revenue when
the Company performs all obligations related to the contract, generally in the following month.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory>
    <afya:TaxesPolicyExplanation contextRef="From2023-01-01to2023-12-31" id="Fact001183">&lt;p id="xdx_84D_ecustom--TaxesPolicyExplanation_zC3K6LF1DSpc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;q) &lt;span id="xdx_867_znYtC1b6UUee"&gt;Taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="background-color: white"&gt;The Company&#x2019;s
subsidiaries in the undergrad segment joined the PROUNI (&lt;i&gt;Programa Universidade para Todos&lt;/i&gt; - University for All Program) program,
which is a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number of
student enrollment for low-income students, and benefits from the exemption of the following federal taxes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="background-color: white"&gt;&#x2022; Income taxes
and social contribution&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="background-color: white"&gt;&#x2022; PIS and COFINS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="background-color: white"&gt;The regulation of
PROUNI defines that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS. For income from
other teaching activities, PIS and COFINS are charged at rates of &lt;span id="xdx_906_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_z8nnaMF0qRR8" title="Tax rate"&gt;0.65&lt;/span&gt;% and &lt;span id="xdx_904_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zyr4XxR9tIq7" title="Tax rate"&gt;3.00&lt;/span&gt;%, respectively, and for non-teaching activities, PIS
is charged at a rate of &lt;span id="xdx_909_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_z184b5bPceb4" title="Tax rate"&gt;1.65&lt;/span&gt;% and to COFINS at &lt;span id="xdx_907_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zSw58OThkk16" title="Tax rate"&gt;7.6&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;Current income taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="background-color: white"&gt;Current income taxes
were calculated based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service, specifically
regarding the PROUNI program, which allows exemption of these taxes from traditional and technological graduation activities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Current income tax assets and liabilities are measured at the amount expected
to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted
or substantively enacted at the reporting date.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Management periodically evaluates positions taken in the tax returns with
respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</afya:TaxesPolicyExplanation>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2023-01-012023-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember"
      decimals="INF"
      id="Fact001185"
      unitRef="Pure">0.0065</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2023-01-012023-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_TeachingActivitiesMember"
      decimals="INF"
      id="Fact001187"
      unitRef="Pure">0.0300</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2023-01-012023-12-31_custom_ProgramOfSocialIntegrationMember_custom_NonTeachingActivitiesMember"
      decimals="INF"
      id="Fact001189"
      unitRef="Pure">0.0165</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2023-01-012023-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_NonTeachingActivitiesMember"
      decimals="INF"
      id="Fact001191"
      unitRef="Pure">0.076</ifrs-full:ApplicableTaxRate>
    <ifrs-full:DisclosureOfTreasurySharesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001193">&lt;p id="xdx_84D_eifrs-full--DisclosureOfTreasurySharesExplanatory_zJ6WY0CRmfy3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;r) &lt;span id="xdx_86A_zaUc3hC5yrHg"&gt;Treasury shares&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Own equity instruments that are reacquired (treasury shares) are recognized
at cost and deducted from equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the
Company&#x2019;s own equity instruments. Any difference between the carrying amount and the consideration, if reissued, is recognized in
the share premium.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;br/&gt;
&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;2.4 Changes in accounting policies and disclosures&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;&lt;i&gt;New standards, interpretations and amendments issued
and adopted by the Company&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt"&gt;In the current year, the Company applied a series of changes to the
IFRSs issued by the International Accounting Standards Board (IASB) that are mandatorily for an accounting period beginning on or after
January 1, 2023, as listed below:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_zPaMGbNj4N6b" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; text-align: center"&gt;&lt;span id="xdx_8B0_z2WPlSwTKOIj" style="display: none"&gt;Schedule of changes in accounting policies and disclosures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Amendments / standards&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_909_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zVRMHPj7cMrl" title="Standard"&gt;Amendments to IAS 1 and IFRS Practice Statement 2 - Making Materiality Judgments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zPZEstU5FyG8" title="Description"&gt;The amendments to IAS 1 and IFRS Practice Statement 2 provide guidance and
    examples to help entities apply materiality judgments to accounting policy disclosures. The amendments aim to help entities provide more
    useful accounting policy disclosures by replacing the requirement for entities to disclose their "material" accounting policies
    with a requirement to disclose their "material" accounting policies and adding guidance on how entities apply the concept of
    materiality when making decisions about accounting policy disclosures.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The amendments have had an impact on the Company&#x2019;s disclosures of accounting
    policies, but not on the measurement, recognition or presentation of any items in the Company&#x2019;s consolidated financial statements.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_905_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_zRiqeDN4JEgk" title="Standard"&gt;Amendments to IAS 8 - Accounting Policies, Changes in Accounting Estimates and Errors - Definition of Accounting Estimates&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_z7GzDbcsH3N" title="Description"&gt;The amendments to IAS 8 clarify the distinction between changes in accounting
    estimates, changes in accounting policies and correction of errors. They also clarify how entities use measurement techniques and inputs
    to develop accounting estimates.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;These amendments have no significant impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_z8uwC8KO8NO6" title="Standard"&gt;Amendments to IAS 12 - Income Taxes - International Tax Reform - Pillar Two Model Rules&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_zKFcJhEckc75" title="Description"&gt;In October 2021, more than 130 countries agreed to implement a minimum tax
    regime for multinational groups, known as Pillar Two, to reform the international corporate taxation. Pillar Two aims to ensure that multinational
    groups in scope are liable to a minimum effective corporate tax rate of 15 per cent per country.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In December 2021, the OECD released the Pillar Two model rules - accompanied
    by commentary and guidelines - which are due to be passed into national legislation but adapted by local conditions.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In response to the OECD's Pillar Two rules, the amendments to IAS 12 were
    introduced and include: (i) a mandatory temporary exception to the recognition and disclosure of deferred taxes arising from the jurisdictional
    implementation of the Pillar Two model rules; and (ii) disclosure requirements for affected entities to help users of the financial statements
    better understand an entity's exposure to Pillar Two income taxes arising from this legislation, especially prior to the effective date.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The countries where the Company has its tax domicile have not yet enacted
    any tax legislation in connection with Pillar Two. Therefore, these amendments have no significant impact on the Company&#x2019;s consolidated
    financial statements as of December 2023&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zFXXi5Sw5Jqk" title="Standard"&gt;Amendments to IAS 12 Income Taxes - Deferred Tax related to Assets and Liabilities arising from a Single Transaction&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zIcy5ow2bcGl" title="Description"&gt;The amendments to IAS 12 Income Taxes narrow the scope of the initial recognition
    exception, so that it no longer applies to transactions that generate equal taxable and deductible temporary differences, such as leases
    and decommissioning liabilities.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;These amendments have no significant impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_907_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zKw3rf1kHu1g" title="Standard"&gt;IFRS 17 - Insurance Contracts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zPE0liHDKlPd" title="Description"&gt;IFRS 17 is a new accounting standard with scope for insurance contracts,
    covering recognition and measurement, presentation and disclosure. IFRS 17 replaces IFRS 4 - Insurance Contracts. IFRS 17 applies to all
    types of insurance contracts (such as life, property and casualty, direct insurance and reinsurance), regardless of the type of entities
    issuing them, as well as to certain guarantees and financial instruments with discretionary participation characteristics; Some scope
    exceptions will apply.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The overall objective of IFRS 17 is to provide a comprehensive accounting
    model for insurance contracts that is most useful and consistent for insurers, covering all relevant accounting aspects.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company does not have any contracts that meet the definition of an insurance
    contract under IFRS 17.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;





&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;&lt;i&gt;New standards, interpretations and amendments issued
but not yet effective&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;The new and amended standards and interpretations that are issued,
but not yet effective, up to the date of issuance of the Company&#x2019;s consolidated financial statements are presented below. The Company
intends to adopt these new and amended standards and interpretations, if applicable, when they become effective.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Amendments / standards&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_900_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_zfzybCODwgX4" title="Standard"&gt;Amendments to IFRS 16: Lease Liability in a Sale and Leaseback&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_z0omFgjvhnbj" title="Description"&gt;In September 2022, the IASB issued amendments to IFRS 16 to specify the requirements
    that a seller-lessee uses in measuring lease liability arising from a sale and lease back transaction, in order to ensure that the seller-lessee
    does not recognise any amount of the gain or loss that relates to the right of use that it holds.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The amendments are effective for annual financial statements periods beginning
    on or after January 1, 2024 and shall apply retrospectively to sale and leaseback transactions entered into after the initial application
    date of IFRS 16. Early adoption is permitted but must be disclosed.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_90A_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_zDc4i8S4nvJ" title="Standard"&gt;Amendments to IAS 1: Classification of Liabilities as Current or Non-Current&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_z57sh07ltKLl" title="Description"&gt;In January 2020 and October 2022, the IASB issued amendments to paragraphs
    69 to 76 of IAS 1 to specify the requirements for classifying liabilities as current or non-current. The amendments clarify:&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#x2022; What is meant by the right to postpone liquidation;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#x2022; That the right to defer should exist at the end of the financial reporting
    period;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#x2022; That the rating is not affected by the likelihood that the entity
    will exercise its right to defer;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#x2022; That only if a derivative embedded in a convertible liability is itself
    an equity instrument, the terms of a liability will not affect its classification.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In addition, a disclosure requirement has been introduced where a liability
    arising from a loan agreement is classified as non-current and the entity's right to postpone liquidation is contingent on the fulfilment
    of future covenants within twelve months.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024 and should be applied retrospectively.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_90B_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zkHivH8FOKyc" title="Standard"&gt;Supplier Financing Agreements - Amendments to IAS 7 and IFRS 7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zJDKXm04GSWl" title="Description"&gt;In May 2023, the IASB issued amendments to IAS 7 and IFRS 7 to clarify the
    characteristics of supplier financing arrangements and require additional disclosures of such arrangements. The disclosure requirements
    in the amendments are intended to assist users of the financial statements in understanding the effects of financing arrangements with
    suppliers on an entity's obligations, cash flows, and exposure to liquidity risk.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024. Early adoption is permitted but must be disclosed.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AA_zkwwkyU46Ft2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;These amendments are not expected to have significant impact on the Company&#x2019;s
consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfTreasurySharesExplanatory>
    <afya:ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001195">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_zPaMGbNj4N6b" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Material accounting policies (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; text-align: center"&gt;&lt;span id="xdx_8B0_z2WPlSwTKOIj" style="display: none"&gt;Schedule of changes in accounting policies and disclosures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Amendments / standards&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_909_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zVRMHPj7cMrl" title="Standard"&gt;Amendments to IAS 1 and IFRS Practice Statement 2 - Making Materiality Judgments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1Member_zPZEstU5FyG8" title="Description"&gt;The amendments to IAS 1 and IFRS Practice Statement 2 provide guidance and
    examples to help entities apply materiality judgments to accounting policy disclosures. The amendments aim to help entities provide more
    useful accounting policy disclosures by replacing the requirement for entities to disclose their "material" accounting policies
    with a requirement to disclose their "material" accounting policies and adding guidance on how entities apply the concept of
    materiality when making decisions about accounting policy disclosures.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The amendments have had an impact on the Company&#x2019;s disclosures of accounting
    policies, but not on the measurement, recognition or presentation of any items in the Company&#x2019;s consolidated financial statements.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_905_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_zRiqeDN4JEgk" title="Standard"&gt;Amendments to IAS 8 - Accounting Policies, Changes in Accounting Estimates and Errors - Definition of Accounting Estimates&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS8Member_z7GzDbcsH3N" title="Description"&gt;The amendments to IAS 8 clarify the distinction between changes in accounting
    estimates, changes in accounting policies and correction of errors. They also clarify how entities use measurement techniques and inputs
    to develop accounting estimates.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;These amendments have no significant impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_z8uwC8KO8NO6" title="Standard"&gt;Amendments to IAS 12 - Income Taxes - International Tax Reform - Pillar Two Model Rules&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12Member_zKFcJhEckc75" title="Description"&gt;In October 2021, more than 130 countries agreed to implement a minimum tax
    regime for multinational groups, known as Pillar Two, to reform the international corporate taxation. Pillar Two aims to ensure that multinational
    groups in scope are liable to a minimum effective corporate tax rate of 15 per cent per country.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In December 2021, the OECD released the Pillar Two model rules - accompanied
    by commentary and guidelines - which are due to be passed into national legislation but adapted by local conditions.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In response to the OECD's Pillar Two rules, the amendments to IAS 12 were
    introduced and include: (i) a mandatory temporary exception to the recognition and disclosure of deferred taxes arising from the jurisdictional
    implementation of the Pillar Two model rules; and (ii) disclosure requirements for affected entities to help users of the financial statements
    better understand an entity's exposure to Pillar Two income taxes arising from this legislation, especially prior to the effective date.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The countries where the Company has its tax domicile have not yet enacted
    any tax legislation in connection with Pillar Two. Therefore, these amendments have no significant impact on the Company&#x2019;s consolidated
    financial statements as of December 2023&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zFXXi5Sw5Jqk" title="Standard"&gt;Amendments to IAS 12 Income Taxes - Deferred Tax related to Assets and Liabilities arising from a Single Transaction&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS12OneMember_zIcy5ow2bcGl" title="Description"&gt;The amendments to IAS 12 Income Taxes narrow the scope of the initial recognition
    exception, so that it no longer applies to transactions that generate equal taxable and deductible temporary differences, such as leases
    and decommissioning liabilities.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;These amendments have no significant impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_907_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zKw3rf1kHu1g" title="Standard"&gt;IFRS 17 - Insurance Contracts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__ifrs-full--IFRS17Member_zPE0liHDKlPd" title="Description"&gt;IFRS 17 is a new accounting standard with scope for insurance contracts,
    covering recognition and measurement, presentation and disclosure. IFRS 17 replaces IFRS 4 - Insurance Contracts. IFRS 17 applies to all
    types of insurance contracts (such as life, property and casualty, direct insurance and reinsurance), regardless of the type of entities
    issuing them, as well as to certain guarantees and financial instruments with discretionary participation characteristics; Some scope
    exceptions will apply.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The overall objective of IFRS 17 is to provide a comprehensive accounting
    model for insurance contracts that is most useful and consistent for insurers, covering all relevant accounting aspects.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company does not have any contracts that meet the definition of an insurance
    contract under IFRS 17.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;





&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;&lt;i&gt;New standards, interpretations and amendments issued
but not yet effective&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;The new and amended standards and interpretations that are issued,
but not yet effective, up to the date of issuance of the Company&#x2019;s consolidated financial statements are presented below. The Company
intends to adopt these new and amended standards and interpretations, if applicable, when they become effective.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border: Black 1pt solid; width: 19%; padding-right: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Amendments / standards&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 81%; padding-right: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_900_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_zfzybCODwgX4" title="Standard"&gt;Amendments to IFRS 16: Lease Liability in a Sale and Leaseback&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIFRS16Member_z0omFgjvhnbj" title="Description"&gt;In September 2022, the IASB issued amendments to IFRS 16 to specify the requirements
    that a seller-lessee uses in measuring lease liability arising from a sale and lease back transaction, in order to ensure that the seller-lessee
    does not recognise any amount of the gain or loss that relates to the right of use that it holds.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The amendments are effective for annual financial statements periods beginning
    on or after January 1, 2024 and shall apply retrospectively to sale and leaseback transactions entered into after the initial application
    date of IFRS 16. Early adoption is permitted but must be disclosed.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_90A_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_zDc4i8S4nvJ" title="Standard"&gt;Amendments to IAS 1: Classification of Liabilities as Current or Non-Current&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS1OneMember_z57sh07ltKLl" title="Description"&gt;In January 2020 and October 2022, the IASB issued amendments to paragraphs
    69 to 76 of IAS 1 to specify the requirements for classifying liabilities as current or non-current. The amendments clarify:&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#x2022; What is meant by the right to postpone liquidation;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#x2022; That the right to defer should exist at the end of the financial reporting
    period;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#x2022; That the rating is not affected by the likelihood that the entity
    will exercise its right to defer;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#x2022; That only if a derivative embedded in a convertible liability is itself
    an equity instrument, the terms of a liability will not affect its classification.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In addition, a disclosure requirement has been introduced where a liability
    arising from a loan agreement is classified as non-current and the entity's right to postpone liquidation is contingent on the fulfilment
    of future covenants within twelve months.&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024 and should be applied retrospectively.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span id="xdx_90B_eifrs-full--TitleOfInitiallyAppliedIFRS_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zkHivH8FOKyc" title="Standard"&gt;Supplier Financing Agreements - Amendments to IAS 7 and IFRS 7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20230101__20231231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS7AndIFRS7Member_zJDKXm04GSWl" title="Description"&gt;In May 2023, the IASB issued amendments to IAS 7 and IFRS 7 to clarify the
    characteristics of supplier financing arrangements and require additional disclosures of such arrangements. The disclosure requirements
    in the amendments are intended to assist users of the financial statements in understanding the effects of financing arrangements with
    suppliers on an entity's obligations, cash flows, and exposure to liquidity risk.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The changes are effective for annual financial statement periods beginning
    on or after January 1, 2024. Early adoption is permitted but must be disclosed.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory>
    <ifrs-full:TitleOfInitiallyAppliedIFRS
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS1Member"
      id="Fact001197">Amendments to IAS 1 and IFRS Practice Statement 2 - Making Materiality Judgments</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS1Member"
      id="Fact001199">The amendments to IAS 1 and IFRS Practice Statement 2 provide guidance and
    examples to help entities apply materiality judgments to accounting policy disclosures. The amendments aim to help entities provide more
    useful accounting policy disclosures by replacing the requirement for entities to disclose their "material" accounting policies
    with a requirement to disclose their "material" accounting policies and adding guidance on how entities apply the concept of
    materiality when making decisions about accounting policy disclosures.</ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy>
    <ifrs-full:TitleOfInitiallyAppliedIFRS
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS8Member"
      id="Fact001201">Amendments to IAS 8 - Accounting Policies, Changes in Accounting Estimates and Errors - Definition of Accounting Estimates</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS8Member"
      id="Fact001203">The amendments to IAS 8 clarify the distinction between changes in accounting
    estimates, changes in accounting policies and correction of errors. They also clarify how entities use measurement techniques and inputs
    to develop accounting estimates.</ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy>
    <ifrs-full:TitleOfInitiallyAppliedIFRS
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS12Member"
      id="Fact001205">Amendments to IAS 12 - Income Taxes - International Tax Reform - Pillar Two Model Rules</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS12Member"
      id="Fact001207">In October 2021, more than 130 countries agreed to implement a minimum tax
    regime for multinational groups, known as Pillar Two, to reform the international corporate taxation. Pillar Two aims to ensure that multinational
    groups in scope are liable to a minimum effective corporate tax rate of 15 per cent per country.</ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy>
    <ifrs-full:TitleOfInitiallyAppliedIFRS
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS12OneMember"
      id="Fact001209">Amendments to IAS 12 Income Taxes - Deferred Tax related to Assets and Liabilities arising from a Single Transaction</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS12OneMember"
      id="Fact001211">The amendments to IAS 12 Income Taxes narrow the scope of the initial recognition
    exception, so that it no longer applies to transactions that generate equal taxable and deductible temporary differences, such as leases
    and decommissioning liabilities.</ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy>
    <ifrs-full:TitleOfInitiallyAppliedIFRS
      contextRef="From2023-01-012023-12-31_ifrs-full_IFRS17Member"
      id="Fact001213">IFRS 17 - Insurance Contracts</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy
      contextRef="From2023-01-012023-12-31_ifrs-full_IFRS17Member"
      id="Fact001215">IFRS 17 is a new accounting standard with scope for insurance contracts,
    covering recognition and measurement, presentation and disclosure. IFRS 17 replaces IFRS 4 - Insurance Contracts. IFRS 17 applies to all
    types of insurance contracts (such as life, property and casualty, direct insurance and reinsurance), regardless of the type of entities
    issuing them, as well as to certain guarantees and financial instruments with discretionary participation characteristics; Some scope
    exceptions will apply.</ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy>
    <ifrs-full:TitleOfInitiallyAppliedIFRS
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIFRS16Member"
      id="Fact001218">Amendments to IFRS 16: Lease Liability in a Sale and Leaseback</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIFRS16Member"
      id="Fact001220">In September 2022, the IASB issued amendments to IFRS 16 to specify the requirements
    that a seller-lessee uses in measuring lease liability arising from a sale and lease back transaction, in order to ensure that the seller-lessee
    does not recognise any amount of the gain or loss that relates to the right of use that it holds.</ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy>
    <ifrs-full:TitleOfInitiallyAppliedIFRS
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS1OneMember"
      id="Fact001222">Amendments to IAS 1: Classification of Liabilities as Current or Non-Current</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS1OneMember"
      id="Fact001224">In January 2020 and October 2022, the IASB issued amendments to paragraphs
    69 to 76 of IAS 1 to specify the requirements for classifying liabilities as current or non-current. The amendments clarify:</ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy>
    <ifrs-full:TitleOfInitiallyAppliedIFRS
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS7AndIFRS7Member"
      id="Fact001226">Supplier Financing Agreements - Amendments to IAS 7 and IFRS 7</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy
      contextRef="From2023-01-012023-12-31_custom_AmendmentsToIAS7AndIFRS7Member"
      id="Fact001228">In May 2023, the IASB issued amendments to IAS 7 and IFRS 7 to clarify the
    characteristics of supplier financing arrangements and require additional disclosures of such arrangements. The disclosure requirements
    in the amendments are intended to assist users of the financial statements in understanding the effects of financing arrangements with
    suppliers on an entity's obligations, cash flows, and exposure to liquidity risk.</ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy>
    <afya:SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001230">&lt;p id="xdx_80E_ecustom--SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory_zEQCK9HJIjt7" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;3&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_824_zv0WS9BcVUMc"&gt;Significant accounting judgments, estimates and assumptions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The preparation of the Company&#x2019;s consolidated financial statements
requires management to make judgments, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities,
and the accompanying disclosures. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment
to the carrying amount of assets or liabilities affected in future periods. Accounting estimates and judgments are continually evaluated
and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under
the circumstances. Revisions to estimates are recognized prospectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Other disclosures relating to the Company&#x2019;s exposure to risks and
uncertainties includes:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Financial instruments
risk management objectives and policies - Note 13.4&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Sensitivity analysis
disclosures - Note 13.4.1&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;Estimates and assumptions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The key assumptions about the future and other key sources of estimated
uncertainty as of the reporting date that include a significant risk of a material adjustment to the carrying amounts of assets and liabilities
within the next financial year, are described below. The Company based its assumptions and estimates on parameters available when the
consolidated financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change
due to market changes or circumstances that arise and that are beyond the Company&#x2019;s control. Such changes are reflected in the assumptions
when they occur.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;Identification and fair-value measurement of assets and
liabilities acquired in a business combination&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Business combinations are accounted for using the acquisition method. Such
method requires recognizing and measuring the identifiable assets acquired, the liabilities assumed and any non-controlling interest in
the acquiree. The Company, as the acquirer, must classify or designate the identifiable assets and liabilities assumed on the basis of
its own contractual terms, economic conditions, operating and accounting policies and other relevant conditions as at the acquisition
date. Such assessment requires judgments from the Company on the methods used to determine the fair value of the assets acquired and liabilities
assumed, including valuation techniques that may require prospective financial information inputs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;Impairment of non-financial assets&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Impairment exists when the carrying value of an asset or cash generating
unit (&#x201c;CGU&#x201d;) or group of CGUs exceeds its recoverable amount, defined as the higher of its fair value less costs of disposal
and its value in use. The fair value less costs of disposal calculation is based on data available from binding sales transactions, conducted
at arm&#x2019;s length, for similar assets or observable market prices less incremental costs of disposing of the asset. The value in use
calculation is based on a discounted cash flow model (&#x201c;DCF&#x201d; model). The cash flows are derived from the budget for the next
five years and do not include restructuring activities to which the Company has not yet committed or significant future investments that
will enhance the performance of the assets of the CGU being tested. The recoverable amount is sensitive to the discount rate used for
the DCF model as well as to expected future cash-inflows and the growth rate used for extrapolation purposes.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;These estimates are most relevant to goodwill and indefinite lived intangible
assets recognized by the Company. The key assumptions used to determine the recoverable amount for each CGU, including a sensitivity analysis,
are disclosed and further explained in Note 12.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;Share-based compensation&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Estimating fair value for share-based payment transactions requires determination
of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination
of the most appropriate inputs to the valuation model including the expected life of the share option or appreciation right, volatility
and dividend yield and making assumptions about them. For the measurement of the fair value of equity-settled transactions, the Company
uses the Binomial model. The assumptions and models used for estimating fair value for share-based payment transactions are disclosed
in Note 16 (b).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;Leases - Estimating the incremental borrowing rate&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #263238"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company cannot readily determine the interest rate implicit in the
lease, therefore, it uses its incremental borrowing rate (IBR) to measure lease liabilities. The IBR is the rate of interest that the
Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar
value to the right-of-use asset in a similar economic environment. The IBR therefore reflects what the Company &#x2018;would have to pay&#x2019;,
which requires estimation when no observable rates are available (such as for subsidiaries that do not enter into financing transactions)
or when they need to be adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary&#x2019;s
functional currency).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company estimates the IBR using observable inputs (such as market interest
rates) when available and is required to make certain entity-specific estimates.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</afya:SignificantAccountingJudgmentsEstimatesAndAssumptionsExplanatory>
    <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001234">&lt;p id="xdx_807_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_z9bigRnVCgcd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;4&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_829_zc3pYihvQUs5"&gt;Segment information&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company has three reportable segments as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#x2022; Undergrad, which provides educational services
through undergraduate courses related to medicine, other health sciences and other undergraduate programs;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#x2022; Continuing Education, which provides specialization
programs and graduate courses in medicine; and&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#x2022; Digital Services, which provides content and technology for medical
education, clinical decisions software, practice management tools and electronic medical records, doctor-patient relationship, telemedicine
and digital prescription for physicians and provides access and demand and efficiency for the healthcare players.&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Segment information is presented consistently with the internal reports
provided to the Company's Chief Executive Officer (CEO), which is the Chief Operating Decision Maker (CODM) and is responsible for allocating
resources, assessing the performance of the Company's operating segments, and making the Company's strategic decisions.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;No operating segments have been aggregated to form the reportable operating
segments. There is only one geographic region, and the results are monitored and evaluated as a single business.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The tables below presents assets and liabilities information for the Company&#x2019;s
operating segments as of December 31, 2023 and 2022, respectively:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_zowoJGpjNH8b" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Segment information (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BF_zxn9q4EBFVyh" style="display: none"&gt;Schedule of presents assets and liabilities information for the Company&#x2019;s
operating segments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Adjustments and eliminations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zO3h7Wp7wPYa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,104,154&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOnePnSHCcM4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;180,555&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQHxd17TMF8g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;310,989&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziqurXkxL0o" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,595,698&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zYfNrCb1ugAd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Assets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z09d5Usgxfz9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,584,481&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z978Uxo0Fvo4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,001,156&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgQXgq4yiOY7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;86,361&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zAz7p10yNFD8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;127,206&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zCCVSl4lGYof" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,214,723&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentAssets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zSoFSdMQOXz8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(11,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvAvnDhotSz2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,203,506&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zo7FtF97xjSc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,102,998&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhwudu40q5Gd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;94,194&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQkIY81gJtul" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;183,783&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvz1b87huqn1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,380,975&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentAssets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z7JU9ksbNGrl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1270"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zm6uiTPVAxOi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,380,975&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total liabilities and equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z1HSAdrO9dTl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,104,154&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvzxiZAwqO9c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;180,555&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zUYttPlXFpt8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;310,989&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_znu2YfB7XU5e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,595,698&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNfHEyX1x9D5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmABx0VRazH7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,584,481&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zJtwLR0yTTIl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;787,658&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zTazWYbkDmqh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,447&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zNDe9qws43Nl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;194,679&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zy7c74KbQpFa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,069,784&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAc9o0e8BeTi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(11,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2iJpLRb7Ht5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,058,567&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zk3Z5c31fPe5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,783,855&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRbxmmQl1BLj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;57,608&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zWoOZ6DgfyQd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;41,439&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zardOyOBcGbf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,882,902&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zTAxgdvOK1aj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1306"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFFJ8YvbNnHf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,882,902&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Equity&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zGLpQZe6BhZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,532,641&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrQeQvNTqpq" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;35,500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zr1fyIJnaO12" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;74,871&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zj0ZjBPXfoLg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,643,012&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zdPUe7GA2Uef" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1318"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIfaBXPvaDOf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,643,012&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other disclosures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Investments in associate (i) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zIZE99QliOdl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,834&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7i1VEzE3UI" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1324"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zluDbMWRN4b2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1326"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdfQgvy0pgHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,834&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zR8Puf19h888" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1330"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXQqHAwn0WCa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,834&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Capital expenditures (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zYncj3Y1jT32" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;139,361&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeODFZuHLEk8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;15,178&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zOC6zMUjDJ52" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;63,889&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zV6QAQdK9Rvj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;218,428&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zDOKDulTzbg1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1342"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zrnAuiua6BD6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;218,428&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Investment in UEPC is included in non-current assets in the statement of financial position.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Capital expenditures consider the acquisitions of property and equipment and intangible assets.&lt;br/&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;






&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Adjustments and eliminations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zRAE7oqgHOZj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,775,829&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zolFo5EsoCe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;149,254&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrxROVSHQG4l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;275,564&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zzCfWCJ2B3Ld" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,200,647&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zy6vUZYt5VN8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,108)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zK1l5zvbmCUk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,199,539&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zshj11nVrpl8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,461,802&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsXRmXsQCIU7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;61,673&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxScDUIatEKc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;115,290&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zeAPq0wY2kUk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,638,765&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_ztMO7e8l3Jr8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,108)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zyyCbYGJunJi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,637,657&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCedULKzJPCa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,314,027&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRvtPJWlYvF2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,581&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zRAmoep2HWz8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;160,274&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zHNzsijeAbN8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,561,882&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zI0Jap3CKnaf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1379"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWCCeMuPxVrk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,561,882&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total liabilities and equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zlniwGjMLN6e" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,775,829&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zxUdxdfwqZi1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;149,254&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z04O7PeF0stc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;275,564&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zlEIAGUNMGcd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,200,647&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z101S8P55Iuf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,108)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMMmVLAM4sz" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,199,539&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zHVKXGs4H7p5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;711,896&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zHopmEGqqt4k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;57,605&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjmiwW8MXK33" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;137,296&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zx46wlx3Egg1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;906,797&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zMp4XkIcdPSf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,108)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIZ2sxlozLk2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;905,689&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z8OoURKNYyr4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,938,960&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFRiL5i2DiC8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;63,990&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z4wWdA0Xp815" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;40,742&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z9Ok6sNrLFn1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,043,692&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3mYAqKKub6d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1415"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z54MqKjr7J7l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,043,692&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Equity&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zDh6dEkO4ubb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,124,973&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJZxGYHnmPA7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;27,659&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zRHmFb2ANLMh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;97,526&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZLrnFO41nMf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,250,158&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z5tNTpv4DqB4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1427"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJYqDzfUm4Bk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,250,158&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other disclosures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Investments in associate (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zAepd5cXq3vf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;53,907&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgYTecDoKIs5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1433"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zfteJHFLGTeb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1435"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_znDri24KICR2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;53,907&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z8cwUgmkU74c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1439"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbzIGiW2NEy8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;53,907&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Capital expenditures (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zh3P3Ecp5p9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;247,634&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zb9Vt4QPZHX4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;8,827&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxrEh4Ekk5e8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;61,694&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z6ZTUL27BiNe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;318,155&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zmSDKqDW3PP2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1451"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z15F3L6LktE3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;318,155&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Investment in UEPC is included in non-current assets in the statement of financial position.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Capital expenditures consider the acquisitions of property and equipment and intangible assets.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A1_zB7AHgA9k2c8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;The tables below presents the statements of income for the Company&#x2019;s
operating segments for the years ended December 31, 2023, 2022 and 2021:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_z5E4H2uYt6ki" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Segment information (Details 1)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B2_ztBZVrPUOngh" style="display: none"&gt;Schedule of statements of income for the Company&#x2019;s
operating segments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;External customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zW0ANW1KaFfi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,511,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhE8onfeMyv1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;146,827&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zEwTz4RrCU9j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;218,068&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z96KAADCrMyk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,875,913&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DepositsFromExternalCustomer_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_znadHpbyXdl5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1465"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfQcC7bwFHll" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,875,913&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--InterSegment_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeSteVLWbEf1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1469"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--InterSegment_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrPhohTH1rJi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1471"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0997bcfBvbb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,217&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJZt8gZkzBkg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,217&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zyknu0nHf7P4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(11,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpsu85eiSUDk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1479"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zgozywOfGwKk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,511,018&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z8kLyeqFU1He" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;146,827&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zv6DROL7NhS5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;229,285&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zaUJT6aOECd2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,887,130&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zfKAs0NIPNFe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfPMenSdwgGg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zzAqL1FANVn4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(997,973)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbPoUGNXCgwh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(62,792)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z7Fix8dOMcsb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(60,265)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zHjDYMwJ1A7b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,121,030)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zqdzPpPTpl6l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,217&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfDHZe3oNdt1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,109,813)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z6Sv5xr9jVM3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,513,045&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z66xVUinoqwc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;84,035&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z6ln8JQJdHKb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;169,020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z1aFBm0be9ge" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,766,100&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z5HgvmdusNxe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1513"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ze9ihgOAvg6j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,766,100&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zptqXWW6DbI" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,014,684)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherGainsLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCPeGXd4czr3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;15,645&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Operating income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2XXFSoS4Eld" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;767,061&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinanceIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbX7VPruAHJ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;110,642&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--FinanceExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8amPsYdnHVj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(457,616)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Share of income of associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpcY5FVQSeve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,495&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKA8fykmO3p2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;429,582&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMXxKIy3ZZ6d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(24,166)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfitLoss_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGoN0F0mskdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;405,416&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;External customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zrDg9ZxJO0qh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,037,889&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWmjDFLpNA6g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;108,806&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zLviOjNWqDza" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;182,362&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zff82wLFEEr9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,329,057&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAwdwMCw591k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1543"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zBb48rrVbBCc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,329,057&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zR9b7A66bmh2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1547"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zm8xymixof9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1549"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrtJg8w7fnac" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,622&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zn1Uz7HokGC" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,622&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zViKI05Caqej" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(7,622)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zaTCjiIL9lA9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1557"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCNpeMSCSDY3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,037,889&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj8tKXLhpsJ9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;108,806&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zT4NkcA9XyFe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;189,984&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z4QFcNDPOl9a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,336,679&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zdIOqhh8D5R3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(7,622)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxfGQ8E2iOkl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,329,057&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zKtH1D5Ets5f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(763,185)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFNJGttMao2k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(56,554)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjCAFpWbYSQj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(47,435)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zBbtTvMEcN35" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(867,174)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zrUu600CUNb2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,622&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYpF51iHSKo" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(859,552)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z0UsPRksf61j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,274,704&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvX1RALBKoe4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;52,252&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z8o6gf7mDcJ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;142,549&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zasbSJr62DU3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,469,505&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zXxEeGt8tQm6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1591"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpFvcPmzkbE4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,469,505&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zR32kNqjmMzl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(798,153)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other expenses, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherGainsLosses_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zb5dNzrx0YT3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(7,252)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Operating income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zb1ilX8tm4bg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;664,100&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpdBLMb4p1ih" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;102,042&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--FinanceExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zV1veEhJqvG9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(349,893)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Share of income of associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zSh6wnAB1hBf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,184&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdBl0ViKWKz5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;428,433&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5leDQZLP5Q2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(35,677)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfitLoss_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zK1M6l0qy6mk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;392,756&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="padding-right: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;External customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zTDgKya8BrL1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,498,408&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znB33mhLHpXc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;72,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3NiTetUm9v8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;147,980&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zXOtu2LDqxzk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,719,371&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zUTZBGCjUI21" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1623"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmSQ08quN9A4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,719,371&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zbxTcecIlGD3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1627"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeU9L9pqKpck" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1629"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zV7pWJ2sOTw5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,978&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zr2BdGWTuYL1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,978&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zqqiAKynUJJf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,978)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z59UgQfM2YTd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1637"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zcCuU4qd1v68" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,498,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z5uusyxhU9ed" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;72,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zFsFtlKBbnzb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;151,958&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvkeGmqp2E87" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,723,349&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNFh0pI1WF27" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(3,978)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zN6qV1KSHbD" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z2vwf64uAxAe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(554,995)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhppPyNVwig" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(50,773)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxztpPHBrttb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(50,510)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zpgvmYjn1LT2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(656,278)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zfM0kbiJVqnl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,978&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvUd1hIQasq9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(652,300)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zItmGSX2wqna" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;943,413&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z2aBvSMdA4mc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;22,210&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zTzBxFJpmTNf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;101,448&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zPbfZadgLDx1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,067,071&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z29oWpfJhM3a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1671"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAtBRk0UFuG4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,067,071&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpwd2qreyvWj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(622,615)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other expenses, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--OtherGainsLosses_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbHVHeJ1sTAi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,561)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Operating income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zPdnODlGRfjd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;440,895&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcAoFk3YfpDf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;64,566&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinanceExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zwG1A8fWY1Q9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(243,796)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Share of income of associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zPccjhkJAwqb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,797&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--ProfitLossBeforeTax_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8nsMy8kF56" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;273,462&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z11LPtW5MSV2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(31,179)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net income &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--ProfitLoss_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zk9F8EQJpzRc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;242,283&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_z4vVXsFx2NA4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;Seasonality of operations&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Undergrad&#x2019;s tuition revenues are related to the intake process and
monthly tuition fees charged to students over the period; thus, does not have significant fluctuations during the year. Continuing Education
revenues are related to monthly intakes and tuition fees and do not have a considerable concentration in any period. Digital Services
is comprised mainly of Medcel, Pebmed, and iClinic revenues. While Pebmed and iClinic do not have significant fluctuation regarding seasonality,
Medcel&#x2019;s revenue is concentrated in the first and last quarter of the year due to the enrollments. In addition, the majority of
Medcel&#x2019;s revenues are derived from printed books and e-books, which are recognized at the point in time when control is transferred
to the customer. Consequently, the Digital Services segment generally has higher revenues and results of operations in the first and last
quarters of the year than in the second and third quarters.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
    <afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001236">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_zowoJGpjNH8b" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Segment information (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BF_zxn9q4EBFVyh" style="display: none"&gt;Schedule of presents assets and liabilities information for the Company&#x2019;s
operating segments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Adjustments and eliminations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zO3h7Wp7wPYa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,104,154&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOnePnSHCcM4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;180,555&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQHxd17TMF8g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;310,989&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziqurXkxL0o" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,595,698&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Assets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zYfNrCb1ugAd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Assets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z09d5Usgxfz9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,584,481&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z978Uxo0Fvo4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,001,156&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgQXgq4yiOY7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;86,361&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zAz7p10yNFD8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;127,206&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zCCVSl4lGYof" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,214,723&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentAssets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zSoFSdMQOXz8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(11,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvAvnDhotSz2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,203,506&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zo7FtF97xjSc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,102,998&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhwudu40q5Gd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;94,194&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQkIY81gJtul" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;183,783&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvz1b87huqn1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,380,975&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentAssets_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z7JU9ksbNGrl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1270"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentAssets_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zm6uiTPVAxOi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,380,975&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total liabilities and equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z1HSAdrO9dTl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,104,154&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvzxiZAwqO9c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;180,555&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zUYttPlXFpt8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;310,989&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_znu2YfB7XU5e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,595,698&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNfHEyX1x9D5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--EquityAndLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmABx0VRazH7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,584,481&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zJtwLR0yTTIl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;787,658&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zTazWYbkDmqh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,447&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zNDe9qws43Nl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;194,679&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zy7c74KbQpFa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,069,784&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAc9o0e8BeTi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(11,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2iJpLRb7Ht5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,058,567&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zk3Z5c31fPe5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,783,855&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRbxmmQl1BLj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;57,608&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zWoOZ6DgfyQd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;41,439&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zardOyOBcGbf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,882,902&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zTAxgdvOK1aj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1306"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentLiabilities_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFFJ8YvbNnHf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,882,902&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Equity&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zGLpQZe6BhZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,532,641&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrQeQvNTqpq" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;35,500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zr1fyIJnaO12" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;74,871&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zj0ZjBPXfoLg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,643,012&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zdPUe7GA2Uef" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1318"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Equity_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIfaBXPvaDOf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,643,012&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other disclosures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Investments in associate (i) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zIZE99QliOdl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,834&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7i1VEzE3UI" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1324"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zluDbMWRN4b2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1326"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdfQgvy0pgHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,834&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zR8Puf19h888" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1330"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--InvestmentsInAssociates_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXQqHAwn0WCa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,834&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Capital expenditures (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zYncj3Y1jT32" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;139,361&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeODFZuHLEk8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;15,178&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zOC6zMUjDJ52" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;63,889&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zV6QAQdK9Rvj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;218,428&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zDOKDulTzbg1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1342"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CapitalExpenditures_iI_pn3n3_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zrnAuiua6BD6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;218,428&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Investment in UEPC is included in non-current assets in the statement of financial position.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Capital expenditures consider the acquisitions of property and equipment and intangible assets.&lt;br/&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;






&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Adjustments and eliminations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zRAE7oqgHOZj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,775,829&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zolFo5EsoCe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;149,254&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrxROVSHQG4l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;275,564&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zzCfWCJ2B3Ld" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,200,647&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zy6vUZYt5VN8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,108)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Assets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zK1l5zvbmCUk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,199,539&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zshj11nVrpl8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,461,802&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsXRmXsQCIU7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;61,673&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxScDUIatEKc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;115,290&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zeAPq0wY2kUk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,638,765&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_ztMO7e8l3Jr8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,108)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zyyCbYGJunJi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,637,657&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCedULKzJPCa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,314,027&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRvtPJWlYvF2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,581&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zRAmoep2HWz8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;160,274&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zHNzsijeAbN8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,561,882&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zI0Jap3CKnaf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1379"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentAssets_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWCCeMuPxVrk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,561,882&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total liabilities and equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zlniwGjMLN6e" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,775,829&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zxUdxdfwqZi1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;149,254&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z04O7PeF0stc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;275,564&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zlEIAGUNMGcd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,200,647&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z101S8P55Iuf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,108)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--EquityAndLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMMmVLAM4sz" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,199,539&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zHVKXGs4H7p5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;711,896&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zHopmEGqqt4k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;57,605&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjmiwW8MXK33" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;137,296&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zx46wlx3Egg1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;906,797&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zMp4XkIcdPSf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,108)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIZ2sxlozLk2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;905,689&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z8OoURKNYyr4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,938,960&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFRiL5i2DiC8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;63,990&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z4wWdA0Xp815" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;40,742&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z9Ok6sNrLFn1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,043,692&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3mYAqKKub6d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1415"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentLiabilities_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z54MqKjr7J7l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,043,692&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Equity&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zDh6dEkO4ubb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,124,973&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJZxGYHnmPA7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;27,659&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zRHmFb2ANLMh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;97,526&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZLrnFO41nMf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,250,158&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z5tNTpv4DqB4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1427"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Equity_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJYqDzfUm4Bk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,250,158&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other disclosures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Investments in associate (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zAepd5cXq3vf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;53,907&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgYTecDoKIs5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1433"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zfteJHFLGTeb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1435"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_znDri24KICR2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;53,907&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z8cwUgmkU74c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1439"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--InvestmentsInAssociates_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbzIGiW2NEy8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;53,907&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Capital expenditures (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zh3P3Ecp5p9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;247,634&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zb9Vt4QPZHX4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;8,827&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxrEh4Ekk5e8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;61,694&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z6ZTUL27BiNe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;318,155&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zmSDKqDW3PP2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1451"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CapitalExpenditures_iI_pn3n3_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z15F3L6LktE3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;318,155&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Investment in UEPC is included in non-current assets in the statement of financial position.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Capital expenditures consider the acquisitions of property and equipment and intangible assets.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory>
    <ifrs-full:Assets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001238"
      unitRef="BRL">7104154000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001240"
      unitRef="BRL">180555000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001242"
      unitRef="BRL">310989000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001244"
      unitRef="BRL">7595698000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001246"
      unitRef="BRL">-11217000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001248"
      unitRef="BRL">7584481000</ifrs-full:Assets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001250"
      unitRef="BRL">1001156000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001252"
      unitRef="BRL">86361000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001254"
      unitRef="BRL">127206000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001256"
      unitRef="BRL">1214723000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001258"
      unitRef="BRL">-11217000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001260"
      unitRef="BRL">1203506000</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001262"
      unitRef="BRL">6102998000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001264"
      unitRef="BRL">94194000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001266"
      unitRef="BRL">183783000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001268"
      unitRef="BRL">6380975000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001272"
      unitRef="BRL">6380975000</ifrs-full:NoncurrentAssets>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001274"
      unitRef="BRL">7104154000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001276"
      unitRef="BRL">180555000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001278"
      unitRef="BRL">310989000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001280"
      unitRef="BRL">7595698000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001282"
      unitRef="BRL">-11217000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001284"
      unitRef="BRL">7584481000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001286"
      unitRef="BRL">787658000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001288"
      unitRef="BRL">87447000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001290"
      unitRef="BRL">194679000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001292"
      unitRef="BRL">1069784000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001294"
      unitRef="BRL">-11217000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001296"
      unitRef="BRL">1058567000</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001298"
      unitRef="BRL">2783855000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001300"
      unitRef="BRL">57608000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001302"
      unitRef="BRL">41439000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001304"
      unitRef="BRL">2882902000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001308"
      unitRef="BRL">2882902000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001310"
      unitRef="BRL">3532641000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001312"
      unitRef="BRL">35500000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001314"
      unitRef="BRL">74871000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001316"
      unitRef="BRL">3643012000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001320"
      unitRef="BRL">3643012000</ifrs-full:Equity>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001322"
      unitRef="BRL">51834000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001328"
      unitRef="BRL">51834000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001332"
      unitRef="BRL">51834000</ifrs-full:InvestmentsInAssociates>
    <afya:CapitalExpenditures
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001334"
      unitRef="BRL">139361000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001336"
      unitRef="BRL">15178000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001338"
      unitRef="BRL">63889000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001340"
      unitRef="BRL">218428000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001344"
      unitRef="BRL">218428000</afya:CapitalExpenditures>
    <ifrs-full:Assets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001347"
      unitRef="BRL">6775829000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001349"
      unitRef="BRL">149254000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001351"
      unitRef="BRL">275564000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001353"
      unitRef="BRL">7200647000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001355"
      unitRef="BRL">-1108000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001357"
      unitRef="BRL">7199539000</ifrs-full:Assets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001359"
      unitRef="BRL">1461802000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001361"
      unitRef="BRL">61673000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001363"
      unitRef="BRL">115290000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001365"
      unitRef="BRL">1638765000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001367"
      unitRef="BRL">-1108000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001369"
      unitRef="BRL">1637657000</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001371"
      unitRef="BRL">5314027000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001373"
      unitRef="BRL">87581000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001375"
      unitRef="BRL">160274000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001377"
      unitRef="BRL">5561882000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001381"
      unitRef="BRL">5561882000</ifrs-full:NoncurrentAssets>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001383"
      unitRef="BRL">6775829000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001385"
      unitRef="BRL">149254000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001387"
      unitRef="BRL">275564000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001389"
      unitRef="BRL">7200647000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001391"
      unitRef="BRL">-1108000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001393"
      unitRef="BRL">7199539000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001395"
      unitRef="BRL">711896000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001397"
      unitRef="BRL">57605000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001399"
      unitRef="BRL">137296000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001401"
      unitRef="BRL">906797000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001403"
      unitRef="BRL">-1108000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001405"
      unitRef="BRL">905689000</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001407"
      unitRef="BRL">2938960000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001409"
      unitRef="BRL">63990000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001411"
      unitRef="BRL">40742000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001413"
      unitRef="BRL">3043692000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001417"
      unitRef="BRL">3043692000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001419"
      unitRef="BRL">3124973000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001421"
      unitRef="BRL">27659000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001423"
      unitRef="BRL">97526000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001425"
      unitRef="BRL">3250158000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001429"
      unitRef="BRL">3250158000</ifrs-full:Equity>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001431"
      unitRef="BRL">53907000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001437"
      unitRef="BRL">53907000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001441"
      unitRef="BRL">53907000</ifrs-full:InvestmentsInAssociates>
    <afya:CapitalExpenditures
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001443"
      unitRef="BRL">247634000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001445"
      unitRef="BRL">8827000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001447"
      unitRef="BRL">61694000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001449"
      unitRef="BRL">318155000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001453"
      unitRef="BRL">318155000</afya:CapitalExpenditures>
    <ifrs-full:DisclosureOfOperatingSegmentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001455">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_z5E4H2uYt6ki" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Segment information (Details 1)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B2_ztBZVrPUOngh" style="display: none"&gt;Schedule of statements of income for the Company&#x2019;s
operating segments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;External customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zW0ANW1KaFfi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,511,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhE8onfeMyv1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;146,827&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zEwTz4RrCU9j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;218,068&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z96KAADCrMyk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,875,913&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DepositsFromExternalCustomer_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_znadHpbyXdl5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1465"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfQcC7bwFHll" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,875,913&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--InterSegment_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeSteVLWbEf1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1469"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--InterSegment_pdn3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrPhohTH1rJi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1471"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0997bcfBvbb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,217&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJZt8gZkzBkg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,217&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zyknu0nHf7P4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(11,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpsu85eiSUDk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1479"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zgozywOfGwKk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,511,018&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z8kLyeqFU1He" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;146,827&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zv6DROL7NhS5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;229,285&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zaUJT6aOECd2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,887,130&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zfKAs0NIPNFe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfPMenSdwgGg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zzAqL1FANVn4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(997,973)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbPoUGNXCgwh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(62,792)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z7Fix8dOMcsb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(60,265)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zHjDYMwJ1A7b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,121,030)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zqdzPpPTpl6l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,217&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfDHZe3oNdt1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,109,813)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z6Sv5xr9jVM3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,513,045&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z66xVUinoqwc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;84,035&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z6ln8JQJdHKb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;169,020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z1aFBm0be9ge" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,766,100&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z5HgvmdusNxe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1513"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ze9ihgOAvg6j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,766,100&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zptqXWW6DbI" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,014,684)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherGainsLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCPeGXd4czr3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;15,645&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Operating income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2XXFSoS4Eld" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;767,061&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinanceIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbX7VPruAHJ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;110,642&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--FinanceExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8amPsYdnHVj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(457,616)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Share of income of associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpcY5FVQSeve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,495&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKA8fykmO3p2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;429,582&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMXxKIy3ZZ6d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(24,166)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfitLoss_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGoN0F0mskdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;405,416&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;External customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zrDg9ZxJO0qh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,037,889&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWmjDFLpNA6g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;108,806&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zLviOjNWqDza" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;182,362&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zff82wLFEEr9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,329,057&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAwdwMCw591k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1543"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DepositsFromExternalCustomer_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zBb48rrVbBCc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,329,057&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zR9b7A66bmh2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1547"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zm8xymixof9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1549"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrtJg8w7fnac" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,622&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zn1Uz7HokGC" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,622&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zViKI05Caqej" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(7,622)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--InterSegment_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zaTCjiIL9lA9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1557"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCNpeMSCSDY3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,037,889&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj8tKXLhpsJ9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;108,806&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zT4NkcA9XyFe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;189,984&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z4QFcNDPOl9a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,336,679&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zdIOqhh8D5R3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(7,622)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxfGQ8E2iOkl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,329,057&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zKtH1D5Ets5f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(763,185)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFNJGttMao2k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(56,554)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjCAFpWbYSQj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(47,435)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zBbtTvMEcN35" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(867,174)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zrUu600CUNb2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,622&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYpF51iHSKo" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(859,552)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z0UsPRksf61j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,274,704&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvX1RALBKoe4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;52,252&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z8o6gf7mDcJ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;142,549&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zasbSJr62DU3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,469,505&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zXxEeGt8tQm6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1591"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpFvcPmzkbE4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,469,505&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zR32kNqjmMzl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(798,153)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other expenses, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherGainsLosses_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zb5dNzrx0YT3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(7,252)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Operating income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zb1ilX8tm4bg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;664,100&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpdBLMb4p1ih" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;102,042&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--FinanceExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zV1veEhJqvG9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(349,893)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Share of income of associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zSh6wnAB1hBf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,184&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdBl0ViKWKz5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;428,433&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5leDQZLP5Q2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(35,677)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfitLoss_pn3n3_c20220101__20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zK1M6l0qy6mk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;392,756&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="padding-right: 2pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;External customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zTDgKya8BrL1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,498,408&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znB33mhLHpXc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;72,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3NiTetUm9v8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;147,980&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zXOtu2LDqxzk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,719,371&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zUTZBGCjUI21" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1623"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmSQ08quN9A4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,719,371&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zbxTcecIlGD3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1627"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeU9L9pqKpck" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1629"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zV7pWJ2sOTw5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,978&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zr2BdGWTuYL1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,978&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zqqiAKynUJJf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,978)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InterSegment_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z59UgQfM2YTd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1637"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zcCuU4qd1v68" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,498,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z5uusyxhU9ed" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;72,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zFsFtlKBbnzb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;151,958&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvkeGmqp2E87" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,723,349&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNFh0pI1WF27" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(3,978)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zN6qV1KSHbD" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z2vwf64uAxAe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(554,995)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhppPyNVwig" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(50,773)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zxztpPHBrttb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(50,510)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zpgvmYjn1LT2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(656,278)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zfM0kbiJVqnl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,978&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvUd1hIQasq9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(652,300)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zItmGSX2wqna" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;943,413&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z2aBvSMdA4mc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;22,210&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zTzBxFJpmTNf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;101,448&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zPbfZadgLDx1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,067,071&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z29oWpfJhM3a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1671"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--GrossProfit_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAtBRk0UFuG4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,067,071&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpwd2qreyvWj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(622,615)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other expenses, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--OtherGainsLosses_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbHVHeJ1sTAi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,561)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Operating income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zPdnODlGRfjd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;440,895&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinanceIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcAoFk3YfpDf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;64,566&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinanceExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zwG1A8fWY1Q9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(243,796)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Share of income of associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zPccjhkJAwqb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,797&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--ProfitLossBeforeTax_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8nsMy8kF56" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;273,462&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z11LPtW5MSV2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(31,179)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net income &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--ProfitLoss_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zk9F8EQJpzRc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;242,283&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
    <afya:DepositsFromExternalCustomer
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001457"
      unitRef="BRL">2511018000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001459"
      unitRef="BRL">146827000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001461"
      unitRef="BRL">218068000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001463"
      unitRef="BRL">2875913000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001467"
      unitRef="BRL">2875913000</afya:DepositsFromExternalCustomer>
    <afya:InterSegment
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001473"
      unitRef="BRL">11217000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001475"
      unitRef="BRL">11217000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001477"
      unitRef="BRL">-11217000</afya:InterSegment>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001481"
      unitRef="BRL">2511018000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001483"
      unitRef="BRL">146827000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001485"
      unitRef="BRL">229285000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001487"
      unitRef="BRL">2887130000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001489"
      unitRef="BRL">-11217000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001491"
      unitRef="BRL">2875913000</ifrs-full:Revenue>
    <afya:CostOfSale
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001493"
      unitRef="BRL">-997973000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001495"
      unitRef="BRL">-62792000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001497"
      unitRef="BRL">-60265000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001499"
      unitRef="BRL">-1121030000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001501"
      unitRef="BRL">11217000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001503"
      unitRef="BRL">-1109813000</afya:CostOfSale>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001505"
      unitRef="BRL">1513045000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001507"
      unitRef="BRL">84035000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001509"
      unitRef="BRL">169020000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001511"
      unitRef="BRL">1766100000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001515"
      unitRef="BRL">1766100000</ifrs-full:GrossProfit>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001517"
      unitRef="BRL">1014684000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:OtherGainsLosses
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001519"
      unitRef="BRL">15645000</ifrs-full:OtherGainsLosses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001521"
      unitRef="BRL">767061000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001523"
      unitRef="BRL">110642000</ifrs-full:FinanceIncome>
    <afya:FinanceExpense
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001525"
      unitRef="BRL">-457616000</afya:FinanceExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001527"
      unitRef="BRL">9495000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001529"
      unitRef="BRL">429582000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001531"
      unitRef="BRL">-24166000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001533"
      unitRef="BRL">405416000</ifrs-full:ProfitLoss>
    <afya:DepositsFromExternalCustomer
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001535"
      unitRef="BRL">2037889000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001537"
      unitRef="BRL">108806000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001539"
      unitRef="BRL">182362000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001541"
      unitRef="BRL">2329057000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001545"
      unitRef="BRL">2329057000</afya:DepositsFromExternalCustomer>
    <afya:InterSegment
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001551"
      unitRef="BRL">7622000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001553"
      unitRef="BRL">7622000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001555"
      unitRef="BRL">-7622000</afya:InterSegment>
    <ifrs-full:Revenue
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001559"
      unitRef="BRL">2037889000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001561"
      unitRef="BRL">108806000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001563"
      unitRef="BRL">189984000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001565"
      unitRef="BRL">2336679000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001567"
      unitRef="BRL">-7622000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001569"
      unitRef="BRL">2329057000</ifrs-full:Revenue>
    <afya:CostOfSale
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001571"
      unitRef="BRL">-763185000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001573"
      unitRef="BRL">-56554000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001575"
      unitRef="BRL">-47435000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001577"
      unitRef="BRL">-867174000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001579"
      unitRef="BRL">7622000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001581"
      unitRef="BRL">-859552000</afya:CostOfSale>
    <ifrs-full:GrossProfit
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001583"
      unitRef="BRL">1274704000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001585"
      unitRef="BRL">52252000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001587"
      unitRef="BRL">142549000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001589"
      unitRef="BRL">1469505000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001593"
      unitRef="BRL">1469505000</ifrs-full:GrossProfit>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001595"
      unitRef="BRL">798153000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:OtherGainsLosses
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001597"
      unitRef="BRL">-7252000</ifrs-full:OtherGainsLosses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001599"
      unitRef="BRL">664100000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001601"
      unitRef="BRL">102042000</ifrs-full:FinanceIncome>
    <afya:FinanceExpense
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001603"
      unitRef="BRL">-349893000</afya:FinanceExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001605"
      unitRef="BRL">12184000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001607"
      unitRef="BRL">428433000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001609"
      unitRef="BRL">-35677000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2022-01-012022-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001611"
      unitRef="BRL">392756000</ifrs-full:ProfitLoss>
    <afya:DepositsFromExternalCustomer
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001615"
      unitRef="BRL">1498408000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001617"
      unitRef="BRL">72983000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001619"
      unitRef="BRL">147980000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001621"
      unitRef="BRL">1719371000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001625"
      unitRef="BRL">1719371000</afya:DepositsFromExternalCustomer>
    <afya:InterSegment
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001631"
      unitRef="BRL">3978000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001633"
      unitRef="BRL">3978000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001635"
      unitRef="BRL">-3978000</afya:InterSegment>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001639"
      unitRef="BRL">1498408000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001641"
      unitRef="BRL">72983000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001643"
      unitRef="BRL">151958000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001645"
      unitRef="BRL">1723349000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001647"
      unitRef="BRL">-3978000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001649"
      unitRef="BRL">1719371000</ifrs-full:Revenue>
    <afya:CostOfSale
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001651"
      unitRef="BRL">-554995000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001653"
      unitRef="BRL">-50773000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001655"
      unitRef="BRL">-50510000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001657"
      unitRef="BRL">-656278000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001659"
      unitRef="BRL">3978000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001661"
      unitRef="BRL">-652300000</afya:CostOfSale>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001663"
      unitRef="BRL">943413000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001665"
      unitRef="BRL">22210000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001667"
      unitRef="BRL">101448000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001669"
      unitRef="BRL">1067071000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001673"
      unitRef="BRL">1067071000</ifrs-full:GrossProfit>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001675"
      unitRef="BRL">622615000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:OtherGainsLosses
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001677"
      unitRef="BRL">-3561000</ifrs-full:OtherGainsLosses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001679"
      unitRef="BRL">440895000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001681"
      unitRef="BRL">64566000</ifrs-full:FinanceIncome>
    <afya:FinanceExpense
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001683"
      unitRef="BRL">-243796000</afya:FinanceExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001685"
      unitRef="BRL">11797000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001687"
      unitRef="BRL">273462000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001689"
      unitRef="BRL">-31179000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001691"
      unitRef="BRL">242283000</ifrs-full:ProfitLoss>
    <ifrs-full:DisclosureOfBusinessCombinationsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001693">&lt;p id="xdx_808_eifrs-full--DisclosureOfBusinessCombinationsExplanatory_zsom6hNqSvmf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;5&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_820_zwktbLeR2yxj"&gt;Business combinations&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;5.1 Acquisition in 2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The fair values of the identifiable assets acquired and liabilities assumed
as of acquisition date were:&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zimvmswtXyFh" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; line-height: 106%"&gt;&lt;span id="xdx_8B0_zdO2J5A9ZQwd" style="display: none"&gt;Schedule
    of fair values of the identifiable assets acquired and liabilities assumed acquisition in 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 106%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 142px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;DelRey&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Cash and cash and equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zx7q3y2GhePk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;7,804&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztZyakB37YR8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;33,741&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--Inventories1_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zq4Bedf61RX7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;139&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Recoverable taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zQacF6a5jItb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;589&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zE4qyvle0vg9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;8,563&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zB3oTwyMWPQk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;24,980&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zBFT0oR3njE6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;65,408&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zHPO44bCNul2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;728,777&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z1B1YccetCjc" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;870,001&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5Gta590Aknc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;12,253&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zEGz0l2HWMzd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;65,408&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Labor and social obligations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztrARYUpLdo2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;6,252&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Taxes and contributions payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zB8UM0w71vU7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Taxes and contributions payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;2,282&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Advances from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zdhzX7I0nXih" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;38,327&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Provision for legal proceedings&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmyGKUsIkL5d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWc3HKBsjTBl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;4,189&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z51nK7lk5Uu" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Financial liabilities recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;128,863&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;Total identifiable net assets at fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5tECIZgEYFj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;741,138&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Goodwill arising on acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztQ18ge7ggB6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;75,098&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;Purchase consideration transferred&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zXh6Ovd8Lzc5" style="border-bottom: black 1pt solid; white-space: nowrap; width: 142px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;816,236&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Cash paid&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CashTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmxeILVsOurd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;575,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Consideration to be transferred&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zbGfwW67QsFf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Consideration to be transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;234,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Digital solutions (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CirculationRevenue_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztkxOsTSLjsk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Digital solutions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;7,236&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;&lt;i&gt;Analysis of cash flows on acquisition:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Transaction costs of the acquisition (included in cash flows from operating activities) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zVb799D9T362" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Transaction costs of the acquisition (included in cash flows from operating activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;12,332&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zUYh2rKgST19" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;567,196&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;Net of cash flow on acquisition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zRTlufGOZPqe" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;579,528&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The total consideration transferred included the obligation to offer digital solutions, especially
from Medcel, Pebmed and Medical Harbour, through access (free-of-charge) to medical students of other medical schools held by the selling
shareholders, not subject to this acquisition, from 2023 to 2030. This purchase consideration was measured using assumptions such as
numbers of approved medical seats, current digital solutions prices, inflation and present value discount rates. The balances of such
consideration are classified as other liabilities on the statement of financial position.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A1_z2PncZqL5zCc" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"&gt;&lt;b&gt;(a) Acquisition
of DelRey&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On January 2, 2023, Afya Brazil acquired &lt;span id="xdx_90B_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_uPure_c20230102__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zqblTZoz79E8" title="Acquired share capital"&gt;100&lt;/span&gt;% of the share capital of DelRey.
&lt;span id="xdx_90C_eifrs-full--DescriptionOfAcquiree_c20221229__20230102__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zwnxUuSFia14" title="Acquired purchase price"&gt;The original aggregate purchase price of R$832,236 was adjusted by R$16,000, in favor of the Company, to R$816,236 comprised by: i) R$809,000
of which R$575,000 was paid in cash on the transaction closing date, and R$234,000 is payable in cash in three annual installments, respectively,
of R$134,000 in January 2024, R$50,000 in January 2025 and R$50,000 in January 2026, adjusted by the SELIC rate; and ii) offer of AFYA&#x2019;s
digital solutions free of charge until December 31, 2030, for students of medicine of universities owned by the sellers which are not
part of the transaction. The fair value of this service was estimated at R$7,236 at the acquisition date. There are 84 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$105,000. Given the future event
that will trigger the potential payout is not under the Company&#x2019;s control, the probability of such payout cannot be reliably estimated
and accordingly the contingent consideration was not measured at the acquisition date. Should the additional seats be approved, it will
result in additional licenses, which will be measured accordingly if and when approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;DelRey is a post-secondary education institution with governmental authorization
to offer on-campus, undergraduate degrees and graduate programs in medicine and health, as well as other courses, in the States of Alagoas
and Pernambuco. The acquisition contributes 340 medical school seats to Afya. With the acquisition, Afya further consolidates its presence
in the Brazilian Northeast, entering a new State in the region.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The acquisition of DelRey was accounted for under IFRS 3 - Business Combinations.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Transaction costs to date amount to R$&lt;span id="xdx_907_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20221229__20230102__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zZjlJGWUVo95" title="Transaction costs"&gt;12,332&lt;/span&gt; and were expensed and are included
in selling, general and administrative expenses in the consolidated statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;At the acquisition date, the fair value of the trade receivables acquired
is substantially the same as its carrying amount.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The goodwill recognized includes the value of expected synergies arising
from the acquisition, which is not separately recognized. Goodwill is allocated entirely to the Undergrad segment. The goodwill recognized
is not expected to be deductible for income taxes purposes.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company did not recognize deferred taxes related
to the business combination because the tax basis and the accounting basis, including fair value adjustments, were the same at the date
of the business combination.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company engaged an independent valuation specialist
to assist Management to assess the fair value of the assets acquired and liabilities assumed at date of acquisition. The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;






&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfAcquisitionOfDelReyExplanatory_zlxEWMMhwBM9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span id="xdx_8BC_zKltqkMykQWc" style="display: none"&gt;Schedule of intangible assets acquired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center; line-height: 106%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Intangible assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 106%"&gt;&lt;b&gt;Valuation technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;With-and-without method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20230101__20230102__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesAndFranchisesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfDelReyMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--WithAndWithoutMethodMember_zwY6rn3TsBfc" title="Valuation technique"&gt;The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Multi-period excess earnings method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20230101__20230102__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfDelReyMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zwWi3nnsHwla" title="Valuation technique"&gt;The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The valuation technique for property and equipment consists of determining
the fair value of an asset by using methodologies like replacement costs and market value.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;DelRey has contributed R$&lt;span id="xdx_90B_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zBLrCkMk6ez9" title="Net revenue"&gt;240,107&lt;/span&gt; of revenue and R$&lt;span id="xdx_907_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfDelReyMember_zEaPt8ixA39k" title="Income loss before income taxes"&gt;82,147&lt;/span&gt; of income before
income taxes to the Company in 2023.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;5.2 Acquisitions in 2022&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The fair values of the identifiable assets acquired and liabilities assumed
as of acquisition date were:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock_z7pRsCeViO3d" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B4_zpvBWvTaPcqf" style="display: none"&gt;Schedule of fair values of the identifiable assets acquired and liabilities assumed
as of acquisition in 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 55%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Al&#xe9;m da Medicina&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 15%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;CardioPapers&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 15%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Glic&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash and cash and equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zZIiyCYjvmrb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;298&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zh54ljKNPFUk" style="text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,648&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zGjraiCgRBj7" style="text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;151&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zT3Go2JZ4FZ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,705&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zYAaVFYffyg1" style="text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,350&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zNLidwplezO" style="text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;94&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zTgi5Q9GrNLd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other Assets As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;266&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zBgPEIGbCPPf" style="text-align: right" title="Other Assets As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z38j0DjSkSOa" style="text-align: right" title="Property, plant and equipment recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zf4v2hxMUcQe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Property, plant and equipment recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;37&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zVNHOGk50XQg" style="text-align: right" title="Property, plant and equipment recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;43&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zPLTq0N2g24c" style="text-align: right" title="Property, plant and equipment recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1792"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zLXUROZduKWk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Identifiable intangible assets recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;20,299&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zmS9Vi0Wy22j" style="text-align: right" title="Identifiable intangible assets recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;28,655&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zuOXjEssz5zi" style="text-align: right" title="Identifiable intangible assets recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;15,395&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zAW2EF13e6gk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;22,605&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zoFyaTsS3RX7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;33,697&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zZ9h5n2G5ZV5" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;15,676&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zbShxV6woIni" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade and other payables recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;705&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zERhoS0Ry21l" style="text-align: right" title="Trade and other payables recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,703&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zPCa2JdtRuL2" style="text-align: right" title="Trade and other payables recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Labor and social obligations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zlx2EepCblV9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Labor And Social Obligations As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;79&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z8YmyMNVWFG3" style="text-align: right" title="Labor And Social Obligations As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;60&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zCQXZrQGIX69" style="text-align: right" title="Labor And Social Obligations As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1816"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Taxes and contributions payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zbBEZ5JfSSs" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Taxes Payable As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,182&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zMuVJGVuvrv7" style="text-align: right" title="Taxes Payable As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;352&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zK3d05uactzg" style="text-align: right" title="Taxes Payable As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Advances from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zv2fEdTDm4ul" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Advances From Customers As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,185&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zyY2k6Cw4Hke" style="text-align: right" title="Advances From Customers As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,893&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z2d2nxKZ7nph" style="text-align: right" title="Advances From Customers As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1828"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zVKPx78yXUtf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other Liabilities As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1830"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zRstoWPCZmkk" style="text-align: right" title="Other Liabilities As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1832"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zMP0RLEp2bFi" style="text-align: right" title="Other Liabilities As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;574&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zrO1lf7KyW47" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;8,151&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zPPw8EG1sAkj" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,008&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqjfv8Vj4x07" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;666&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total identifiable net assets at fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zM7X2sxvzGEd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Indemnification assets recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;14,454&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zKqKfGbHRVwk" style="text-align: right" title="Indemnification assets recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;27,689&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zEQ3nRtWIrra" style="text-align: right" title="Indemnification assets recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;15,010&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Goodwill arising on acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zLuLArMFsagh" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,335&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zilRbSQmW8Ta" style="border-bottom: black 1pt solid; text-align: right" title="Goodwill recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;14,324&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zNam2rVisFS2" style="border-bottom: black 1pt solid; text-align: right" title="Goodwill recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;15,587&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Purchase consideration transferred&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zumHhHtK96Ej" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Consideration transferred, acquisition-date fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;26,789&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zHoIrWBEllo5" style="border-bottom: black 1pt solid; text-align: right" title="Consideration transferred, acquisition-date fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;42,013&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zw32cmPQpCo6" style="border-bottom: black 1pt solid; text-align: right" title="Consideration transferred, acquisition-date fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;30,597&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash paid&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CashTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zDzK2xio0bjf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;14,952&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zkUj9j1s4cqi" style="text-align: right" title="Cash transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;34,924&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CashTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zDG7s0ngkyQ3" style="text-align: right" title="Cash transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;21,602&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zFdDMp3rUcE6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Contingent consideration recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,074&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zdg6jS358aC9" style="text-align: right" title="Contingent consideration recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,422&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zvvvsA44uSNh" style="text-align: right" title="Contingent consideration recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;8,995&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Consideration to be transferred (Price adjustment)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zTVZdxqreU7c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Consideration To Be Transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;763&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zzci5QDow1ck" style="text-align: right" title="Consideration To Be Transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(333)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z6VexzhOC941" style="text-align: right" title="Consideration To Be Transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1876"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;i&gt;Analysis of cash flows on acquisition:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transaction costs of the acquisition (included in cash flows from operating activities) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zSfoV1AZqZy2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;227&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zbUM9v1mcATd" style="text-align: right" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;274&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zzVPSnEeW1Z3" style="text-align: right" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;222&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zN0f44lV96rk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;14,654&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zPcPrt3DJFs8" style="text-align: right" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;31,276&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zyu1k6k3vZeh" style="text-align: right" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;21,451&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net of cash flow on acquisition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zYKuETlqF8S" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;14,881&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zGhZTDSsTxzh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;31,550&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqs1AvI6cNY7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;21,673&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A8_zqEBuY98Mkg6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"&gt;&lt;b&gt;(a) Acquisition
of Al&#xe9;m da Medicina&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On March 4, 2022, Afya Brazil acquired &lt;span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zkEkZBk9dmi4"&gt;100&lt;/span&gt;% of the share capital of BMV
Atividades M&#xe9;dicas Ltda. (&#x201c;Al&#xe9;m da Medicina&#x201d;). &lt;span id="xdx_90E_eifrs-full--DescriptionOfAcquiree_c20220303__20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zB6SuHPnunO" title="Acquired purchase price"&gt;The aggregate purchase price of R$26,789 is comprised by: i)
R$14,952 paid in cash on the transaction closing date; ii) an earn-out (&#x201c;contingent consideration&#x201d;) of up to R$19,200 is payable
in connection with revenue target achievements for 2023 and 2024; and iii) price adjustment related to net debt of R$763 in favor of selling
shareholders. The contingent consideration of R$11,074 is based on the present value of the obligation considering the facts and circumstances
at the acquisition date.&lt;/span&gt; See Note 13.2.3 for further details of the earn-out amounts as of December 31, 2022.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="background-color: white"&gt;A&lt;/span&gt;l&#xe9;m da Medicina is
a medical content online platform for physicians and medical students that provides educational tools besides technical medical content
that can assist them throughout their careers. Its contents include mentoring for residency, soft skills and finance, accounting, and
investment basics for physicians.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The acquisition of &lt;span style="background-color: white"&gt;A&lt;/span&gt;l&#xe9;m
da Medicina was accounted for under IFRS 3 - Business Combinations.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Transaction costs to date amount to R$&lt;span id="xdx_903_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20220303__20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_z2VjyNZVa0te" title="Transaction costs"&gt;227&lt;/span&gt; and were expensed and are included
in selling, general and administrative expenses in the consolidated statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;At the acquisition date, the fair value of the trade receivables acquired
equals its carrying amount.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The goodwill recognized includes the value of expected synergies arising
from the acquisition, which is not separately recognized. Goodwill is allocated entirely to Digital Services segment. The goodwill recognized
is not expected to be deductible for income taxes purposes.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company did not recognize deferred taxes related to the business combination
because the tax basis and the accounting basis, including fair value adjustments, were the same at the date of the business combination.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The valuation techniques used for measuring the fair value of separately
identified intangible assets acquired were as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory_zPFM8XBGUaq9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span id="xdx_8BC_zVhuVsSsJZwf" style="display: none"&gt;Schedule of acquisition
of al&#xe9;m da medicina intangible assets acquired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Intangible assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Relief from royalty&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zrrJInQTzh4k" title="Valuation technique"&gt;This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Multi-period excess earnings method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zUPkDFOqXpX3" title="Valuation technique"&gt;The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Educational content&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Replacement cost&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--EducationalContentMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zyoHUCxfxK79" title="Valuation technique"&gt;This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Developed technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Replacement cost&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zDUiICHyzMXf" title="Valuation technique"&gt;This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="background-color: white"&gt;A&lt;/span&gt;l&#xe9;m da Medicina has
contributed R$&lt;span id="xdx_90B_eifrs-full--Revenue_pn3n3_c20220303__20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zm3znlRbd2t" title="Net revenue"&gt;12,859&lt;/span&gt; of revenue and R$&lt;span id="xdx_90D_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220303__20220304__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zUdnwFPlfQdj" title="Income loss before income taxes"&gt;1,448&lt;/span&gt; of income before income taxes to the Company in 2022. Should the acquisition had taken place
at the beginning of the year, revenue for the year ended December 31, 2022 would have been increased by R$&lt;span id="xdx_90D_ecustom--IncreaseInRevenue_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_z36o73efrD48" title="Increase in revenue"&gt;2,529&lt;/span&gt; and income before income
taxes would have been increased by R$&lt;span id="xdx_90B_ecustom--IncreaseInIncomeBeforeIncomeTaxes_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--AlemDaMedicinaMember_zBx8NWkaNmDe" title="Increase in income before income taxes"&gt;867&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"&gt;&lt;b&gt;(b) Acquisition
of CardioPapers&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On April 5, 2022, Afya Brazil acquired &lt;span id="xdx_900_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_c20220405__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfCardioPapersMember_z32Ct6u1c6Q8"&gt;100&lt;/span&gt;% of the share capital of Cardiopapers
Solu&#xe7;&#xf5;es Digitais Ltda. (&#x201c;CardioPapers&#x201d;). &lt;span id="xdx_909_eifrs-full--DescriptionOfAcquiree_c20220404__20220405__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfCardioPapersMember_zibz7rj4QHge"&gt;The aggregate purchase price of R$42,013 is comprised by: i) R$34,924
paid in cash on the transaction closing date; ii) an earn-out (&#x201c;contingent consideration&#x201d;) of up of R$15,000 is payable in
connection with revenue target achievements for 2023 and 2024 and other goals; and iii) price adjustment related to net debt of R$333
in favor of Afya Brazil. The contingent consideration of R$7,422 is based on the present value of the obligation considering the facts
and circumstances at the acquisition date.&lt;/span&gt; &lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;See Note 13.2.3 for
further details of the earn-out amounts as of December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;CardioPapers is the main medical content and education platform in the Cardiology
field, offering courses and books developed by physicians and for physicians, covering all phases of the medical career, aligned with
Afya&#x2019;s overall business strategy.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The acquisition of &lt;span style="background-color: white"&gt;CardioPapers&lt;/span&gt;
was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Transaction costs to date amount to R$&lt;span id="xdx_900_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20220404__20220405__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfCardioPapersMember_zkushzi6bj5c"&gt;274&lt;/span&gt; and were
expensed and are included in selling, general and administrative expenses in the consolidated statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;At the acquisition date, the fair value of the trade
receivables acquired equals its carrying amount.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The goodwill recognized includes the value of expected synergies arising
from the acquisition, which is not separately recognized. Goodwill is allocated entirely to Digital Services segment. The goodwill recognized
is not expected to be deductible for income taxes purposes.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company did not recognize deferred taxes related
to the business combination because the tax basis and the accounting basis, including fair value adjustments, were the same at the date
of the business combination.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The valuation techniques used for measuring the fair value of separately
identified intangible assets acquired were as follows:&lt;/p&gt;

&lt;p style="font: 5pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--ScheduleOfAcquisitionOfCardioPapersExplanatory_zKJ2Kqk2FVP8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 4)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span id="xdx_8B8_zabiY7ZPWmx4" style="display: none"&gt;Schedule of acquisition
of cardio papers intangible assets acquired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: Black 1pt solid; width: 22%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Intangible assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 78%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Relief from royalty&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zFfWk9vmNik3" title="Valuation technique"&gt;This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Multi-period excess earnings method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zMMkPniWK904" title="Valuation technique"&gt;The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Educational content&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Replacement cost&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--EducationalContentMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zVwXPUnY1zN4" title="Valuation technique"&gt;This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Copyrights&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Relief from royalty&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--CopyrightMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zJr5B1aMXUGf" title="Valuation technique"&gt;This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="background-color: white"&gt;CardioPapers &lt;/span&gt;has contributed
R$&lt;span id="xdx_906_eifrs-full--Revenue_pn3n3_c20220404__20220405__ifrs-full--BusinessCombinationsAxis__custom--CardioPapersMember_zTFmy9KUdMf6" title="Net revenue"&gt;9,934&lt;/span&gt; of revenue and R$&lt;span id="xdx_900_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220404__20220405__ifrs-full--BusinessCombinationsAxis__custom--CardioPapersMember_z97oyFhRnRek" title="Income loss before income taxes"&gt;2,352&lt;/span&gt; of income before income taxes to the Company in 2022. Should the acquisition had taken place at the beginning
of the year, revenue for the year ended December 31, 2022 would have been increased by R$&lt;span id="xdx_908_ecustom--IncreaseInRevenue_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--CardioPapersMember_zvaKBKHlRgPl" title="Increase in revenue"&gt;2,117&lt;/span&gt; and income before income taxes would have
been decreased by R$&lt;span id="xdx_903_ecustom--DecreaseInIncomeBeforeIncomeTaxes_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--CardioPapersMember_zsqZhyyuWVoh" title="Decrease in income before income taxes"&gt;2,041&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"&gt;&lt;b&gt;(c) Acquisition
of Glic&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On May 23, 2022, Afya Brazil acquired &lt;span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_uPure_c20220523__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfGlicMember_zsysAriQbSrb"&gt;100&lt;/span&gt;% of the share capital of Quasar
Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&#x201c;Glic&#x201d;). &lt;span id="xdx_904_eifrs-full--DescriptionOfAcquiree_c20220522__20220523__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfGlicMember_zaIDgHpaSHm5"&gt;The aggregate purchase price of R$30,597 is comprised
by: i) R$21,602 paid in cash on the transaction closing date and ii) an earn-out (&#x201c;contingent consideration&#x201d;) of up of R$12,000
is payable in connection with revenue target achievements for 2023 and 2024 and product development goals. The contingent consideration
of R$8,995 is based on the present value of the obligation considering the facts and circumstances at the acquisition date.&lt;/span&gt; See Note 13.2.3
for further details of the earn-out amounts as of December 31, 2022.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Glic is a free diabetes care and management app solution for physicians
and patients that uses technology to improve diabetes education and daily routine practices, connecting users, devices and healthcare
providers.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The acquisition of &lt;span style="background-color: white"&gt;Glic&lt;/span&gt;
was accounted for under IFRS 3 - Business Combinations.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;Transaction costs to date amount to R$&lt;span id="xdx_904_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20220522__20220523__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfGlicMember_zx1IgnkR03el"&gt;222&lt;/span&gt; and were
expensed and are included in selling, general and administrative expenses in the consolidated statement of income.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;At the acquisition date, the fair value of the trade
receivables acquired equals its carrying amount.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The goodwill recognized includes the value of expected synergies arising
from the acquisition, which is not separately recognized. Goodwill is allocated entirely to Digital Services segment. The goodwill recognized
is not expected to be deductible for income taxes purposes.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;The Company did not recognize deferred taxes related
to the business combination because the tax basis and the accounting basis, including fair value adjustments, were the same at the date
of the business combination.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The valuation techniques used for measuring the fair value of separately
identified intangible assets acquired were as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfAcquisitionOfGlicExplanatory_zVSBwnyvEeja" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 5)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span id="xdx_8B6_zDGdRJU8YAq6" style="display: none"&gt;Schedule of acquisition
of Glic intangible assets acquired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Intangible assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Relief from royalty&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zMuveJAULSJ" title="Valuation technique"&gt;This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Multi-period excess earnings method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zfqTDuTn1yae" title="Valuation technique"&gt;The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Developed technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Replacement cost&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zIj8UB7xA1mb" title="Valuation technique"&gt;This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="background-color: white"&gt;Glic &lt;/span&gt;has contributed R$&lt;span id="xdx_900_eifrs-full--Revenue_pn3n3_c20220522__20220523__ifrs-full--BusinessCombinationsAxis__custom--GlicMember_z049UNtYpJKf" title="Net revenue"&gt;389&lt;/span&gt;
of revenue and R$&lt;span id="xdx_90E_eifrs-full--ProfitLossBeforeTax_pn3n3_c20220522__20220523__ifrs-full--BusinessCombinationsAxis__custom--GlicMember_zSeY7IqBrJGd" title="Income loss before income taxes"&gt;1,539&lt;/span&gt; of losses before income taxes to the Company in 2022. Should the acquisition had taken place at the beginning of
the year, revenue for the year ended December 31, 2022 would have been increased by R$&lt;span id="xdx_905_ecustom--IncreaseInRevenue_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--GlicMember_zI8bptSokOTd" title="Increase in revenue"&gt;173&lt;/span&gt; and income before income taxes would have been
decreased by R$&lt;span id="xdx_90A_ecustom--DecreaseInIncomeBeforeIncomeTaxes_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--GlicMember_zRXspcH7RoQj" title="Decrease in income before income taxes"&gt;700&lt;/span&gt;.&lt;/p&gt;






&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfBusinessCombinationsExplanatory>
    <afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001695">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zimvmswtXyFh" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; line-height: 106%"&gt;&lt;span id="xdx_8B0_zdO2J5A9ZQwd" style="display: none"&gt;Schedule
    of fair values of the identifiable assets acquired and liabilities assumed acquisition in 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 106%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 142px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;DelRey&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Cash and cash and equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zx7q3y2GhePk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;7,804&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztZyakB37YR8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;33,741&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--Inventories1_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zq4Bedf61RX7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;139&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Recoverable taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zQacF6a5jItb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;589&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zE4qyvle0vg9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;8,563&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zB3oTwyMWPQk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;24,980&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zBFT0oR3njE6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;65,408&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zHPO44bCNul2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;728,777&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z1B1YccetCjc" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;870,001&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5Gta590Aknc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;12,253&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zEGz0l2HWMzd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;65,408&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Labor and social obligations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztrARYUpLdo2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;6,252&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Taxes and contributions payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zB8UM0w71vU7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Taxes and contributions payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;2,282&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Advances from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zdhzX7I0nXih" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;38,327&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Provision for legal proceedings&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmyGKUsIkL5d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWc3HKBsjTBl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;4,189&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z51nK7lk5Uu" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Financial liabilities recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;128,863&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;Total identifiable net assets at fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5tECIZgEYFj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;741,138&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Goodwill arising on acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztQ18ge7ggB6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;75,098&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;Purchase consideration transferred&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zXh6Ovd8Lzc5" style="border-bottom: black 1pt solid; white-space: nowrap; width: 142px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;816,236&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Cash paid&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CashTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmxeILVsOurd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;575,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Consideration to be transferred&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zbGfwW67QsFf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Consideration to be transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;234,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Digital solutions (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CirculationRevenue_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztkxOsTSLjsk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Digital solutions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;7,236&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;&lt;i&gt;Analysis of cash flows on acquisition:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Transaction costs of the acquisition (included in cash flows from operating activities) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zVb799D9T362" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Transaction costs of the acquisition (included in cash flows from operating activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;12,332&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zUYh2rKgST19" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;567,196&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;Net of cash flow on acquisition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20230101__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zRTlufGOZPqe" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 106%" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt; line-height: 106%"&gt;&lt;b&gt;579,528&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The total consideration transferred included the obligation to offer digital solutions, especially
from Medcel, Pebmed and Medical Harbour, through access (free-of-charge) to medical students of other medical schools held by the selling
shareholders, not subject to this acquisition, from 2023 to 2030. This purchase consideration was measured using assumptions such as
numbers of approved medical seats, current digital solutions prices, inflation and present value discount rates. The balances of such
consideration are classified as other liabilities on the statement of financial position.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001697"
      unitRef="BRL">7804000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001699"
      unitRef="BRL">33741000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:Inventories1
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001701"
      unitRef="BRL">139000</afya:Inventories1>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001703"
      unitRef="BRL">589000</afya:RecoverableTaxesAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001705"
      unitRef="BRL">8563000</afya:OtherAssetsAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001707"
      unitRef="BRL">24980000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001709"
      unitRef="BRL">65408000</afya:RightOfUseAssetsAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001711"
      unitRef="BRL">728777000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001713"
      unitRef="BRL">870001000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001715"
      unitRef="BRL">12253000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001717"
      unitRef="BRL">65408000</afya:LeaseLiabilitiesAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001719"
      unitRef="BRL">6252000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001721"
      unitRef="BRL">2282000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001723"
      unitRef="BRL">38327000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001725"
      unitRef="BRL">152000</afya:ProvisionForLegalProceedingsAsOfAcquisitionDate>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001727"
      unitRef="BRL">4189000</afya:OtherLiabilitiesAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001729"
      unitRef="BRL">128863000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001731"
      unitRef="BRL">741138000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001733"
      unitRef="BRL">75098000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001735"
      unitRef="BRL">816236000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001737"
      unitRef="BRL">575000000</ifrs-full:CashTransferred>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001739"
      unitRef="BRL">234000000</afya:ConsiderationToBeTransferred>
    <ifrs-full:CirculationRevenue
      contextRef="From2023-01-012023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001741"
      unitRef="BRL">7236000</ifrs-full:CirculationRevenue>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2023-01-012023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001743"
      unitRef="BRL">12332000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2023-01-012023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001745"
      unitRef="BRL">567196000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2023-01-012023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact001747"
      unitRef="BRL">579528000</afya:NetOfCashFlowOnAcquisition>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2023-01-02_custom_AcquisitionOfDelReyMember"
      decimals="INF"
      id="Fact001751"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree
      contextRef="From2022-12-292023-01-02_custom_AcquisitionOfDelReyMember"
      id="Fact001753">The original aggregate purchase price of R$832,236 was adjusted by R$16,000, in favor of the Company, to R$816,236 comprised by: i) R$809,000
of which R$575,000 was paid in cash on the transaction closing date, and R$234,000 is payable in cash in three annual installments, respectively,
of R$134,000 in January 2024, R$50,000 in January 2025 and R$50,000 in January 2026, adjusted by the SELIC rate; and ii) offer of AFYA&#x2019;s
digital solutions free of charge until December 31, 2030, for students of medicine of universities owned by the sellers which are not
part of the transaction. The fair value of this service was estimated at R$7,236 at the acquisition date. There are 84 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$105,000. Given the future event
that will trigger the potential payout is not under the Company&#x2019;s control, the probability of such payout cannot be reliably estimated
and accordingly the contingent consideration was not measured at the acquisition date. Should the additional seats be approved, it will
result in additional licenses, which will be measured accordingly if and when approved.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2022-12-292023-01-02_custom_AcquisitionOfDelReyMember"
      decimals="-3"
      id="Fact001755"
      unitRef="BRL">12332000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfDelReyExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001758">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfAcquisitionOfDelReyExplanatory_zlxEWMMhwBM9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span id="xdx_8BC_zKltqkMykQWc" style="display: none"&gt;Schedule of intangible assets acquired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center; line-height: 106%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Intangible assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center; line-height: 106%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 106%"&gt;&lt;b&gt;Valuation technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;With-and-without method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20230101__20230102__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesAndFranchisesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfDelReyMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--WithAndWithoutMethodMember_zwY6rn3TsBfc" title="Valuation technique"&gt;The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Multi-period excess earnings method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20230101__20230102__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfDelReyMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zwWi3nnsHwla" title="Valuation technique"&gt;The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:ScheduleOfAcquisitionOfDelReyExplanatory>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2023-01-012023-01-02_ifrs-full_LicencesAndFranchisesMember_custom_AcquisitionOfDelReyMember_custom_WithAndWithoutMethodMember"
      id="Fact001760">The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2023-01-012023-01-02_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfDelReyMember_ifrs-full_MultiperiodExcessEarningsMethodMember"
      id="Fact001762">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_custom_AcquisitionOfDelReyMember"
      decimals="-3"
      id="Fact001764"
      unitRef="BRL">240107000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-012023-12-31_custom_AcquisitionOfDelReyMember"
      decimals="-3"
      id="Fact001766"
      unitRef="BRL">82147000</ifrs-full:ProfitLossBeforeTax>
    <afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001768">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock_z7pRsCeViO3d" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B4_zpvBWvTaPcqf" style="display: none"&gt;Schedule of fair values of the identifiable assets acquired and liabilities assumed
as of acquisition in 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 55%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Al&#xe9;m da Medicina&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 15%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;CardioPapers&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 15%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Glic&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash and cash and equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zZIiyCYjvmrb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;298&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zh54ljKNPFUk" style="text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,648&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zGjraiCgRBj7" style="text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;151&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zT3Go2JZ4FZ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,705&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zYAaVFYffyg1" style="text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,350&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zNLidwplezO" style="text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;94&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zTgi5Q9GrNLd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other Assets As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;266&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zBgPEIGbCPPf" style="text-align: right" title="Other Assets As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z38j0DjSkSOa" style="text-align: right" title="Property, plant and equipment recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zf4v2hxMUcQe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Property, plant and equipment recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;37&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zVNHOGk50XQg" style="text-align: right" title="Property, plant and equipment recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;43&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zPLTq0N2g24c" style="text-align: right" title="Property, plant and equipment recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1792"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zLXUROZduKWk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Identifiable intangible assets recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;20,299&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zmS9Vi0Wy22j" style="text-align: right" title="Identifiable intangible assets recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;28,655&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zuOXjEssz5zi" style="text-align: right" title="Identifiable intangible assets recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;15,395&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zAW2EF13e6gk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;22,605&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zoFyaTsS3RX7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;33,697&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zZ9h5n2G5ZV5" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;15,676&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zbShxV6woIni" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade and other payables recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;705&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zERhoS0Ry21l" style="text-align: right" title="Trade and other payables recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,703&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zPCa2JdtRuL2" style="text-align: right" title="Trade and other payables recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Labor and social obligations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zlx2EepCblV9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Labor And Social Obligations As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;79&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z8YmyMNVWFG3" style="text-align: right" title="Labor And Social Obligations As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;60&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zCQXZrQGIX69" style="text-align: right" title="Labor And Social Obligations As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1816"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Taxes and contributions payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zbBEZ5JfSSs" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Taxes Payable As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,182&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zMuVJGVuvrv7" style="text-align: right" title="Taxes Payable As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;352&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zK3d05uactzg" style="text-align: right" title="Taxes Payable As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Advances from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zv2fEdTDm4ul" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Advances From Customers As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,185&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zyY2k6Cw4Hke" style="text-align: right" title="Advances From Customers As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,893&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z2d2nxKZ7nph" style="text-align: right" title="Advances From Customers As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1828"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zVKPx78yXUtf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other Liabilities As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1830"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zRstoWPCZmkk" style="text-align: right" title="Other Liabilities As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1832"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zMP0RLEp2bFi" style="text-align: right" title="Other Liabilities As Of Acquisition Date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;574&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zrO1lf7KyW47" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;8,151&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zPPw8EG1sAkj" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,008&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqjfv8Vj4x07" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;666&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total identifiable net assets at fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zM7X2sxvzGEd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Indemnification assets recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;14,454&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zKqKfGbHRVwk" style="text-align: right" title="Indemnification assets recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;27,689&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zEQ3nRtWIrra" style="text-align: right" title="Indemnification assets recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;15,010&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Goodwill arising on acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zLuLArMFsagh" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,335&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zilRbSQmW8Ta" style="border-bottom: black 1pt solid; text-align: right" title="Goodwill recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;14,324&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zNam2rVisFS2" style="border-bottom: black 1pt solid; text-align: right" title="Goodwill recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;15,587&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Purchase consideration transferred&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zumHhHtK96Ej" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Consideration transferred, acquisition-date fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;26,789&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zHoIrWBEllo5" style="border-bottom: black 1pt solid; text-align: right" title="Consideration transferred, acquisition-date fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;42,013&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zw32cmPQpCo6" style="border-bottom: black 1pt solid; text-align: right" title="Consideration transferred, acquisition-date fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;30,597&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash paid&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CashTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zDzK2xio0bjf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;14,952&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zkUj9j1s4cqi" style="text-align: right" title="Cash transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;34,924&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CashTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zDG7s0ngkyQ3" style="text-align: right" title="Cash transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;21,602&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zFdDMp3rUcE6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Contingent consideration recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,074&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zdg6jS358aC9" style="text-align: right" title="Contingent consideration recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,422&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zvvvsA44uSNh" style="text-align: right" title="Contingent consideration recognised as of acquisition date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;8,995&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Consideration to be transferred (Price adjustment)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zTVZdxqreU7c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Consideration To Be Transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;763&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zzci5QDow1ck" style="text-align: right" title="Consideration To Be Transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(333)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z6VexzhOC941" style="text-align: right" title="Consideration To Be Transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1876"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;i&gt;Analysis of cash flows on acquisition:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transaction costs of the acquisition (included in cash flows from operating activities) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zSfoV1AZqZy2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;227&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zbUM9v1mcATd" style="text-align: right" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;274&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zzVPSnEeW1Z3" style="text-align: right" title="Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;222&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zN0f44lV96rk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;14,654&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zPcPrt3DJFs8" style="text-align: right" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;31,276&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zyu1k6k3vZeh" style="text-align: right" title="Cash and cash equivalents in subsidiary or businesses acquired or disposed"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;21,451&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net of cash flow on acquisition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zYKuETlqF8S" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;14,881&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zGhZTDSsTxzh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;31,550&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20220522__20220523__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqs1AvI6cNY7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;21,673&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumed2022TableTextBlock>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001770"
      unitRef="BRL">298000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001772"
      unitRef="BRL">3648000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001774"
      unitRef="BRL">151000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001776"
      unitRef="BRL">1705000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001778"
      unitRef="BRL">1350000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001780"
      unitRef="BRL">94000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001782"
      unitRef="BRL">266000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001784"
      unitRef="BRL">1000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001786"
      unitRef="BRL">36000</afya:OtherAssetsAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001788"
      unitRef="BRL">37000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001790"
      unitRef="BRL">43000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001794"
      unitRef="BRL">20299000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001796"
      unitRef="BRL">28655000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001798"
      unitRef="BRL">15395000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001800"
      unitRef="BRL">22605000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001802"
      unitRef="BRL">33697000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001804"
      unitRef="BRL">15676000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001806"
      unitRef="BRL">705000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001808"
      unitRef="BRL">1703000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001810"
      unitRef="BRL">1000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001812"
      unitRef="BRL">79000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001814"
      unitRef="BRL">60000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001818"
      unitRef="BRL">1182000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001820"
      unitRef="BRL">352000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001822"
      unitRef="BRL">91000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001824"
      unitRef="BRL">6185000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001826"
      unitRef="BRL">3893000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001834"
      unitRef="BRL">574000</afya:OtherLiabilitiesAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001836"
      unitRef="BRL">8151000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001838"
      unitRef="BRL">6008000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001840"
      unitRef="BRL">666000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001842"
      unitRef="BRL">14454000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001844"
      unitRef="BRL">27689000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001846"
      unitRef="BRL">15010000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001848"
      unitRef="BRL">12335000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001850"
      unitRef="BRL">14324000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001852"
      unitRef="BRL">15587000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001854"
      unitRef="BRL">26789000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001856"
      unitRef="BRL">42013000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001858"
      unitRef="BRL">30597000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001860"
      unitRef="BRL">14952000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001862"
      unitRef="BRL">34924000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001864"
      unitRef="BRL">21602000</ifrs-full:CashTransferred>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001866"
      unitRef="BRL">11074000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001868"
      unitRef="BRL">7422000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001870"
      unitRef="BRL">8995000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact001872"
      unitRef="BRL">763000</afya:ConsiderationToBeTransferred>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001874"
      unitRef="BRL">-333000</afya:ConsiderationToBeTransferred>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember1360038046"
      decimals="-3"
      id="Fact001878"
      unitRef="BRL">227000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2022-04-042022-04-05_custom_CardioPapersMember1360038093"
      decimals="-3"
      id="Fact001880"
      unitRef="BRL">274000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2022-05-222022-05-23_custom_GlicMember1360038140"
      decimals="-3"
      id="Fact001882"
      unitRef="BRL">222000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember1360038046"
      decimals="-3"
      id="Fact001884"
      unitRef="BRL">14654000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2022-04-042022-04-05_custom_CardioPapersMember1360038093"
      decimals="-3"
      id="Fact001886"
      unitRef="BRL">31276000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2022-05-222022-05-23_custom_GlicMember1360038140"
      decimals="-3"
      id="Fact001888"
      unitRef="BRL">21451000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember1360038046"
      decimals="-3"
      id="Fact001890"
      unitRef="BRL">14881000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2022-04-042022-04-05_custom_CardioPapersMember1360038093"
      decimals="-3"
      id="Fact001892"
      unitRef="BRL">31550000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2022-05-222022-05-23_custom_GlicMember1360038140"
      decimals="-3"
      id="Fact001894"
      unitRef="BRL">21673000</afya:NetOfCashFlowOnAcquisition>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember"
      decimals="INF"
      id="Fact001895"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree
      contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember"
      id="Fact001897">The aggregate purchase price of R$26,789 is comprised by: i)
R$14,952 paid in cash on the transaction closing date; ii) an earn-out (&#x201c;contingent consideration&#x201d;) of up to R$19,200 is payable
in connection with revenue target achievements for 2023 and 2024; and iii) price adjustment related to net debt of R$763 in favor of selling
shareholders. The contingent consideration of R$11,074 is based on the present value of the obligation considering the facts and circumstances
at the acquisition date.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember"
      decimals="-3"
      id="Fact001900"
      unitRef="BRL">227000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001902">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory_zPFM8XBGUaq9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span id="xdx_8BC_zVhuVsSsJZwf" style="display: none"&gt;Schedule of acquisition
of al&#xe9;m da medicina intangible assets acquired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Intangible assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Relief from royalty&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zrrJInQTzh4k" title="Valuation technique"&gt;This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Multi-period excess earnings method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zUPkDFOqXpX3" title="Valuation technique"&gt;The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Educational content&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Replacement cost&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--EducationalContentMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zyoHUCxfxK79" title="Valuation technique"&gt;This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Developed technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Replacement cost&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220303__20220304__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zDUiICHyzMXf" title="Valuation technique"&gt;This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:ScheduleOfAcquisitionOfAlemDaMedicinaExplanatory>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2022-03-032022-03-04_ifrs-full_BrandNamesMember_custom_AlemDaMedicinaMember_custom_ReliefFromRoyaltyMember"
      id="Fact001904">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2022-03-032022-03-04_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AlemDaMedicinaMember_ifrs-full_MultiperiodExcessEarningsMethodMember"
      id="Fact001906">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2022-03-032022-03-04_custom_EducationalContentMember_custom_AlemDaMedicinaMember_custom_ReplacementCostMember"
      id="Fact001908">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2022-03-032022-03-04_ifrs-full_TechnologybasedIntangibleAssetsMember_custom_AlemDaMedicinaMember_custom_ReplacementCostMember"
      id="Fact001910">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember"
      decimals="-3"
      id="Fact001912"
      unitRef="BRL">12859000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember"
      decimals="-3"
      id="Fact001914"
      unitRef="BRL">1448000</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2022-01-012022-12-31_custom_AlemDaMedicinaMember"
      decimals="-3"
      id="Fact001916"
      unitRef="BRL">2529000</afya:IncreaseInRevenue>
    <afya:IncreaseInIncomeBeforeIncomeTaxes
      contextRef="From2022-01-012022-12-31_custom_AlemDaMedicinaMember"
      decimals="-3"
      id="Fact001918"
      unitRef="BRL">867000</afya:IncreaseInIncomeBeforeIncomeTaxes>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2022-04-05_custom_AcquisitionOfCardioPapersMember"
      decimals="INF"
      id="Fact001919"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree
      contextRef="From2022-04-042022-04-05_custom_AcquisitionOfCardioPapersMember"
      id="Fact001920">The aggregate purchase price of R$42,013 is comprised by: i) R$34,924
paid in cash on the transaction closing date; ii) an earn-out (&#x201c;contingent consideration&#x201d;) of up of R$15,000 is payable in
connection with revenue target achievements for 2023 and 2024 and other goals; and iii) price adjustment related to net debt of R$333
in favor of Afya Brazil. The contingent consideration of R$7,422 is based on the present value of the obligation considering the facts
and circumstances at the acquisition date.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2022-04-042022-04-05_custom_AcquisitionOfCardioPapersMember"
      decimals="-3"
      id="Fact001922"
      unitRef="BRL">274000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfCardioPapersExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001924">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--ScheduleOfAcquisitionOfCardioPapersExplanatory_zKJ2Kqk2FVP8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 4)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span id="xdx_8B8_zabiY7ZPWmx4" style="display: none"&gt;Schedule of acquisition
of cardio papers intangible assets acquired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: Black 1pt solid; width: 22%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Intangible assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 78%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Relief from royalty&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zFfWk9vmNik3" title="Valuation technique"&gt;This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Multi-period excess earnings method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zMMkPniWK904" title="Valuation technique"&gt;The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Educational content&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Replacement cost&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--EducationalContentMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zVwXPUnY1zN4" title="Valuation technique"&gt;This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Copyrights&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Relief from royalty&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220404__20220405__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__custom--CopyrightMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfCardioPapersMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zJr5B1aMXUGf" title="Valuation technique"&gt;This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:ScheduleOfAcquisitionOfCardioPapersExplanatory>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2022-04-042022-04-05_ifrs-full_BrandNamesMember_custom_AcquisitionOfCardioPapersMember_custom_ReliefFromRoyaltyMember"
      id="Fact001926">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2022-04-042022-04-05_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfCardioPapersMember_ifrs-full_MultiperiodExcessEarningsMethodMember"
      id="Fact001928">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2022-04-042022-04-05_custom_EducationalContentMember_custom_AcquisitionOfCardioPapersMember_custom_ReplacementCostMember"
      id="Fact001930">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2022-04-042022-04-05_custom_CopyrightMember_custom_AcquisitionOfCardioPapersMember_custom_ReliefFromRoyaltyMember"
      id="Fact001932">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2022-04-042022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001934"
      unitRef="BRL">9934000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2022-04-042022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001936"
      unitRef="BRL">2352000</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2022-01-012022-12-31_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001938"
      unitRef="BRL">2117000</afya:IncreaseInRevenue>
    <afya:DecreaseInIncomeBeforeIncomeTaxes
      contextRef="From2022-01-012022-12-31_custom_CardioPapersMember"
      decimals="-3"
      id="Fact001940"
      unitRef="BRL">2041000</afya:DecreaseInIncomeBeforeIncomeTaxes>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2022-05-23_custom_AcquisitionOfGlicMember"
      decimals="INF"
      id="Fact001942"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree
      contextRef="From2022-05-222022-05-23_custom_AcquisitionOfGlicMember"
      id="Fact001943">The aggregate purchase price of R$30,597 is comprised
by: i) R$21,602 paid in cash on the transaction closing date and ii) an earn-out (&#x201c;contingent consideration&#x201d;) of up of R$12,000
is payable in connection with revenue target achievements for 2023 and 2024 and product development goals. The contingent consideration
of R$8,995 is based on the present value of the obligation considering the facts and circumstances at the acquisition date.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2022-05-222022-05-23_custom_AcquisitionOfGlicMember"
      decimals="-3"
      id="Fact001944"
      unitRef="BRL">222000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfGlicExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001946">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfAcquisitionOfGlicExplanatory_zVSBwnyvEeja" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Business combinations (Details 5)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span id="xdx_8B6_zDGdRJU8YAq6" style="display: none"&gt;Schedule of acquisition
of Glic intangible assets acquired&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: Black 1pt solid; width: 23%; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Intangible assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Relief from royalty&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReliefFromRoyaltyMember_zMuveJAULSJ" title="Valuation technique"&gt;This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Multi-period excess earnings method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zfqTDuTn1yae" title="Valuation technique"&gt;The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 80%"&gt;&lt;b&gt;Developed technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;b&gt;Replacement cost&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20220522__20220523__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfGlicMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--ReplacementCostMember_zIj8UB7xA1mb" title="Valuation technique"&gt;This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:ScheduleOfAcquisitionOfGlicExplanatory>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2022-05-222022-05-23_ifrs-full_BrandNamesMember_custom_AcquisitionOfGlicMember_custom_ReliefFromRoyaltyMember"
      id="Fact001948">This methodology is based on the market remuneration of the use license
    granted to third parties. The value of the asset is restated by the savings of royalties that the owner would have to own the asset. It
    is necessary to determine a royalty rate that reflects the appropriate remuneration of the asset. The royalty payments, net of taxes,
    are discounted to present value.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2022-05-222022-05-23_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfGlicMember_ifrs-full_MultiperiodExcessEarningsMethodMember"
      id="Fact001950">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2022-05-222022-05-23_ifrs-full_TechnologybasedIntangibleAssetsMember_custom_AcquisitionOfGlicMember_custom_ReplacementCostMember"
      id="Fact001952">This methodology is based on the estimated cost of replacing the referred
    asset with a new one (acquisition or reconstruction), adjusted to reflect the losses in value resulting from the physical deterioration
    and the functional and economic obsolescence of that asset.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2022-05-222022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001954"
      unitRef="BRL">389000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2022-05-222022-05-23_custom_GlicMember"
      decimals="-3"
      id="Fact001956"
      unitRef="BRL">1539000</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2023-01-012023-12-31_custom_GlicMember"
      decimals="-3"
      id="Fact001958"
      unitRef="BRL">173000</afya:IncreaseInRevenue>
    <afya:DecreaseInIncomeBeforeIncomeTaxes
      contextRef="From2023-01-012023-12-31_custom_GlicMember"
      decimals="-3"
      id="Fact001960"
      unitRef="BRL">700000</afya:DecreaseInIncomeBeforeIncomeTaxes>
    <afya:DisclosuresOfCashAndCashEquivalentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001963">&lt;p id="xdx_803_ecustom--DisclosuresOfCashAndCashEquivalentsExplanatory_z2KL5dOjhBxe" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;6&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_820_z1xV6vyTUaOa"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_zEeZBx7XZqLa" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Cash and cash equivalents (Details)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span&gt;&lt;span id="xdx_8BF_zh5yt5OeTomj" style="display: none"&gt;Schedule of cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49D_20231231_zpL6JYrCXYmk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20221231_zFavAx2C4l85" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--Cash_iI_pn3n3_zUzq34o500ya" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash and bank deposits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,746&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,509&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CashEquivalents_iI_pn3n3_z6QuZBiS8NNj" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;541,284&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,035,573&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_zbWW3LBgxapa" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b style="display: none"&gt;Cash and cash equivalents&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;553,030&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,093,082&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Cash equivalents correspond mainly to financial investments in Bank Certificates
of Deposit (&#x201c;CDB&#x201d;) with highly rated financial institutions and investments funds managed by highly rated financial institutions.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;As of December 31, 2023, the average interest on these investments is equivalent
to &lt;span id="xdx_90C_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_zFvZ0TtIdNIi" title="Percentage of average interest"&gt;100.8&lt;/span&gt;% of the CDI rate (December 31, 2022: &lt;span id="xdx_90F_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_zfa4v61mjQHf" title="Percentage of average interest"&gt;99.21&lt;/span&gt;%). These funds are available for immediate use and have an insignificant risk of changes
in value. Cash equivalents denominated in U.S. dollars totaled R$&lt;span id="xdx_90D_eifrs-full--CashEquivalents_iI_pn3n3_uBRL_c20231231__srt--CurrencyAxis__custom--USDMember_zq46QBMxHa53" title="Cash equivalents"&gt;23,173&lt;/span&gt; as of December 31, 2023 (December 31, 2022: R$&lt;span id="xdx_903_eifrs-full--CashEquivalents_iI_pn3n3_uBRL_c20221231__srt--CurrencyAxis__custom--USDMember_zeLc7Qj5iEB4" title="Cash equivalents"&gt;24,447&lt;/span&gt;).&lt;/p&gt;

</afya:DisclosuresOfCashAndCashEquivalentsExplanatory>
    <afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001965">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_zEeZBx7XZqLa" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Cash and cash equivalents (Details)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span&gt;&lt;span id="xdx_8BF_zh5yt5OeTomj" style="display: none"&gt;Schedule of cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49D_20231231_zpL6JYrCXYmk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20221231_zFavAx2C4l85" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--Cash_iI_pn3n3_zUzq34o500ya" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash and bank deposits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,746&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,509&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CashEquivalents_iI_pn3n3_z6QuZBiS8NNj" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;541,284&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,035,573&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_zbWW3LBgxapa" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b style="display: none"&gt;Cash and cash equivalents&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;553,030&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,093,082&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory>
    <ifrs-full:Cash
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001967"
      unitRef="BRL">11746000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001968"
      unitRef="BRL">57509000</ifrs-full:Cash>
    <ifrs-full:CashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001970"
      unitRef="BRL">541284000</ifrs-full:CashEquivalents>
    <ifrs-full:CashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001971"
      unitRef="BRL">1035573000</ifrs-full:CashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001973"
      unitRef="BRL">553030000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001974"
      unitRef="BRL">1093082000</ifrs-full:CashAndCashEquivalents>
    <afya:PercenatgeOfAverageInterestOnFinancialInstrument
      contextRef="AsOf2023-12-31_custom_BankCertificatesOfDepositMember"
      decimals="INF"
      id="Fact001976"
      unitRef="Pure">1.008</afya:PercenatgeOfAverageInterestOnFinancialInstrument>
    <afya:PercenatgeOfAverageInterestOnFinancialInstrument
      contextRef="AsOf2022-12-31_custom_BankCertificatesOfDepositMember"
      decimals="INF"
      id="Fact001978"
      unitRef="Pure">0.9921</afya:PercenatgeOfAverageInterestOnFinancialInstrument>
    <ifrs-full:CashEquivalents
      contextRef="AsOf2023-12-31_custom_USDMember"
      decimals="-3"
      id="Fact001980"
      unitRef="BRL">23173000</ifrs-full:CashEquivalents>
    <ifrs-full:CashEquivalents
      contextRef="AsOf2022-12-31_custom_USDMember"
      decimals="-3"
      id="Fact001982"
      unitRef="BRL">24447000</ifrs-full:CashEquivalents>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001984">&lt;p id="xdx_80D_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_zJgHmSqC7mO3" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;7&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_823_zj3jcZCDfsVc"&gt;Trade receivables&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_zcXX8G9OWaqa" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade receivables (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B5_z600CWMlcfbj" style="display: none"&gt;Schedule of trade accounts receivable&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 56%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_z3RSpDso4iwg" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;461,066&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zfmx0OUvksu1" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;356,074&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Educational content (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zq6uvsPNNe01" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;49,135&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_ztC1kAzguAJ8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;50,913&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;FIES&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zwEBjGFWoAPl" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;62,971&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ReceivablesGross_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zSKLt0sGWCq5" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;62,325&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Educational credits (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zJmkdW14iD8c" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;29,391&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zU9d4l0KR0Kj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;27,535&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Mobile app subscription (iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zSAOFkLWGrfh" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;29,091&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_z7tDP54jTal" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;27,675&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zGuN1wrWvZQ1" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;15,667&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zXIa9zvlJUak" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;14,923&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_pn3n3_c20231231_zJKrwenrbyDi" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;647,321&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ReceivablesGross_pn3n3_c20221231_zYn0FhkjQsek" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;539,445&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(-) Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20231231_z4sRESQJxHBf" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(61,398)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20221231_zD35E3TKZRmj" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="(-) Allowance for doubtful accounts"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(44,046)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeReceivables_pn3n3_c20231231_zBebXSeRT3z1" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;585,923&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeReceivables_pn3n3_c20221231_zJxF016G6r9k" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;495,399&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentTradeReceivables_pn3n3_c20231231_zUoYhNL0Pdr3" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;546,438&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentTradeReceivables_pn3n3_c20221231_zAZJhkuW58G2" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;452,831&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20231231_z8BDiOu7MSmj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;39,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20221231_zUPatsWoPpCg" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;42,568&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Related to trade receivables from sales of printed books, e-books and medical courses through
digital platform from Medcel, Al&#xe9;m da Medicina e Cardiopapers.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Related to the financing programs offered by our subsidiaries to its students that existed
prior to the acquisitions. The Company closed such programs to new enrolments and maintained only the agreements that were outstanding
as of the acquisition date.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Related to trade receivables from mobile applications subscriptions for digital medical content.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AB_zgWRTXlSuju2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;As of December 31, 2023 and 2022, the aging of trade receivables was as
follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_pn3n3_z31tj6BqoTDc" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade receivables (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B1_zXTgmwrQUDpe" style="display: none"&gt;Schedule of aging of trade accounts receivable&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 56%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Neither past due nor impaired&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_pn3n3_c20231231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zNQsuiwSbyN" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;323,614&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z48gbuvhYxg4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;261,025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Past due&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;1 to 30 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_z9drAPElUfBe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;73,563&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zlanM58Kw6u2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 90%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 90%"&gt;56,280&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;31 to 90 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zWIip0U18ppi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;109,908&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_ztSGptPZz5u4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;90,734&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;91 to 180 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ReceivablesGross_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zA6OZSZInBqc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;85,193&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zbuHuUw6UjC7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;80,522&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;More than 180 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zaHR3SoL7D5b" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;55,043&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zLCdbo4UkXl4" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;50,884&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20231231_zwVCoyJStdvi" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;647,321&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ReceivablesGross_iI_pn3n3_c20221231_zVYakiJsJrua" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;539,445&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;





&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The changes in the allowance for doubtful accounts for the years ended December
31, 2023, 2022 and 2021, was as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--DisclosureOfAllowanceForDoubtfulAccountsExplanatory_pn3n3_z0nx7rfM7TMh" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade receivables (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B6_zdzK6AXX31de" style="display: none"&gt;Schedule of allowance for doubtful accounts&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20230101__20231231_z2BOwPN5i6Xg" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20220101__20221231_z0RVueHiCAv6" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20210101__20211231_zMoJJjpuzmI" style="vertical-align: top; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 46%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iNS_pn3n3_di_zUam11NOQEEa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Balances at the beginning of the year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(44,046)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(45,013)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(32,980)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_pn3n3_zyXSCfdrfozl" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(74,552)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(42,708)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&#160;(47,819)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_pn3n3_zZgTPY05MKAa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;57,200&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;43,675&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;35,786&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iNE_pn3n3_di_z6giHqWxwlq" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Balances at the end of the year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(61,398)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(44,046)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;&#160;(45,013)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <afya:DisclosureOfTradeAndOtherReceivables1Explanatory contextRef="From2023-01-01to2023-12-31" id="Fact001986">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_zcXX8G9OWaqa" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade receivables (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B5_z600CWMlcfbj" style="display: none"&gt;Schedule of trade accounts receivable&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 56%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_z3RSpDso4iwg" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;461,066&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zfmx0OUvksu1" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;356,074&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Educational content (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zq6uvsPNNe01" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;49,135&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_ztC1kAzguAJ8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;50,913&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;FIES&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zwEBjGFWoAPl" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;62,971&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ReceivablesGross_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zSKLt0sGWCq5" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;62,325&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Educational credits (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zJmkdW14iD8c" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;29,391&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zU9d4l0KR0Kj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;27,535&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Mobile app subscription (iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zSAOFkLWGrfh" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;29,091&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_z7tDP54jTal" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;27,675&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zGuN1wrWvZQ1" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;15,667&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zXIa9zvlJUak" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;14,923&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_pn3n3_c20231231_zJKrwenrbyDi" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;647,321&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ReceivablesGross_pn3n3_c20221231_zYn0FhkjQsek" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;539,445&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(-) Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20231231_z4sRESQJxHBf" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(61,398)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20221231_zD35E3TKZRmj" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="(-) Allowance for doubtful accounts"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(44,046)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeReceivables_pn3n3_c20231231_zBebXSeRT3z1" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;585,923&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeReceivables_pn3n3_c20221231_zJxF016G6r9k" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;495,399&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentTradeReceivables_pn3n3_c20231231_zUoYhNL0Pdr3" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;546,438&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentTradeReceivables_pn3n3_c20221231_zAZJhkuW58G2" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;452,831&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20231231_z8BDiOu7MSmj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;39,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20221231_zUPatsWoPpCg" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;42,568&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Related to trade receivables from sales of printed books, e-books and medical courses through
digital platform from Medcel, Al&#xe9;m da Medicina e Cardiopapers.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Related to the financing programs offered by our subsidiaries to its students that existed
prior to the acquisitions. The Company closed such programs to new enrolments and maintained only the agreements that were outstanding
as of the acquisition date.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Related to trade receivables from mobile applications subscriptions for digital medical content.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:DisclosureOfTradeAndOtherReceivables1Explanatory>
    <afya:ReceivablesGross
      contextRef="AsOf2023-12-31_custom_TuitionFeesMember"
      decimals="-3"
      id="Fact001988"
      unitRef="BRL">461066000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2022-12-31_custom_TuitionFeesMember"
      decimals="-3"
      id="Fact001990"
      unitRef="BRL">356074000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2023-12-31_custom_EducationalContentMember"
      decimals="-3"
      id="Fact001992"
      unitRef="BRL">49135000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2022-12-31_custom_EducationalContentMember"
      decimals="-3"
      id="Fact001994"
      unitRef="BRL">50913000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2023-12-31_custom_FIESMember"
      decimals="-3"
      id="Fact001996"
      unitRef="BRL">62971000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2022-12-31_custom_FIESMember"
      decimals="-3"
      id="Fact001998"
      unitRef="BRL">62325000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2023-12-31_custom_EducationalCreditsMember"
      decimals="-3"
      id="Fact002000"
      unitRef="BRL">29391000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2022-12-31_custom_EducationalCreditsMember"
      decimals="-3"
      id="Fact002002"
      unitRef="BRL">27535000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2023-12-31_custom_MobileAppSubscriptionMember"
      decimals="-3"
      id="Fact002004"
      unitRef="BRL">29091000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2022-12-31_custom_MobileAppSubscriptionMember"
      decimals="-3"
      id="Fact002006"
      unitRef="BRL">27675000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2023-12-31_custom_OthersMember"
      decimals="-3"
      id="Fact002008"
      unitRef="BRL">15667000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2022-12-31_custom_OthersMember"
      decimals="-3"
      id="Fact002010"
      unitRef="BRL">14923000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002012"
      unitRef="BRL">647321000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002014"
      unitRef="BRL">539445000</afya:ReceivablesGross>
    <afya:AllowanceForDoubtfulAccountsFoReceivable1
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002016"
      unitRef="BRL">-61398000</afya:AllowanceForDoubtfulAccountsFoReceivable1>
    <afya:AllowanceForDoubtfulAccountsFoReceivable1
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002018"
      unitRef="BRL">-44046000</afya:AllowanceForDoubtfulAccountsFoReceivable1>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002020"
      unitRef="BRL">585923000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002022"
      unitRef="BRL">495399000</ifrs-full:TradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002024"
      unitRef="BRL">546438000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002026"
      unitRef="BRL">452831000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002028"
      unitRef="BRL">39485000</ifrs-full:NoncurrentTradeReceivables>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002030"
      unitRef="BRL">42568000</ifrs-full:NoncurrentTradeReceivables>
    <afya:DisclosureOfTradeAccountsReceivableByAgingExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002032">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_pn3n3_z31tj6BqoTDc" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade receivables (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B1_zXTgmwrQUDpe" style="display: none"&gt;Schedule of aging of trade accounts receivable&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 56%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Neither past due nor impaired&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_pn3n3_c20231231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zNQsuiwSbyN" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;323,614&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z48gbuvhYxg4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;261,025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Past due&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;1 to 30 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_z9drAPElUfBe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;73,563&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zlanM58Kw6u2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 90%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 90%"&gt;56,280&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;31 to 90 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zWIip0U18ppi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;109,908&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_ztSGptPZz5u4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;90,734&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;91 to 180 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ReceivablesGross_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zA6OZSZInBqc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;85,193&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zbuHuUw6UjC7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;80,522&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;More than 180 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zaHR3SoL7D5b" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;55,043&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zLCdbo4UkXl4" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;50,884&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20231231_zwVCoyJStdvi" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;647,321&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ReceivablesGross_iI_pn3n3_c20221231_zVYakiJsJrua" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;539,445&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:DisclosureOfTradeAccountsReceivableByAgingExplanatory>
    <afya:ReceivablesGross
      contextRef="AsOf2023-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember"
      decimals="-3"
      id="Fact002034"
      unitRef="BRL">323614000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2022-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember"
      decimals="-3"
      id="Fact002036"
      unitRef="BRL">261025000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2023-12-31_ifrs-full_CurrentMember"
      decimals="-3"
      id="Fact002038"
      unitRef="BRL">73563000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2022-12-31_ifrs-full_CurrentMember"
      decimals="-3"
      id="Fact002040"
      unitRef="BRL">56280000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2023-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember"
      decimals="-3"
      id="Fact002042"
      unitRef="BRL">109908000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2022-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember"
      decimals="-3"
      id="Fact002044"
      unitRef="BRL">90734000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember"
      decimals="-3"
      id="Fact002046"
      unitRef="BRL">85193000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember"
      decimals="-3"
      id="Fact002048"
      unitRef="BRL">80522000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2023-12-31_custom_LaterThanOneEightyMember"
      decimals="-3"
      id="Fact002050"
      unitRef="BRL">55043000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2022-12-31_custom_LaterThanOneEightyMember"
      decimals="-3"
      id="Fact002052"
      unitRef="BRL">50884000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002054"
      unitRef="BRL">647321000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002056"
      unitRef="BRL">539445000</afya:ReceivablesGross>
    <afya:DisclosureOfAllowanceForDoubtfulAccountsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002059">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--DisclosureOfAllowanceForDoubtfulAccountsExplanatory_pn3n3_z0nx7rfM7TMh" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Trade receivables (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B6_zdzK6AXX31de" style="display: none"&gt;Schedule of allowance for doubtful accounts&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20230101__20231231_z2BOwPN5i6Xg" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20220101__20221231_z0RVueHiCAv6" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20210101__20211231_zMoJJjpuzmI" style="vertical-align: top; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 46%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iNS_pn3n3_di_zUam11NOQEEa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Balances at the beginning of the year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(44,046)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(45,013)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(32,980)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_pn3n3_zyXSCfdrfozl" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(74,552)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(42,708)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&#160;(47,819)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_pn3n3_zZgTPY05MKAa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;57,200&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;43,675&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;35,786&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iNE_pn3n3_di_z6giHqWxwlq" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Balances at the end of the year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(61,398)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(44,046)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;&#160;(45,013)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:DisclosureOfAllowanceForDoubtfulAccountsExplanatory>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002061"
      unitRef="BRL">44046000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact002062"
      unitRef="BRL">45013000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact002063"
      unitRef="BRL">32980000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002065"
      unitRef="BRL">-74552000</afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset>
    <afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002066"
      unitRef="BRL">-42708000</afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset>
    <afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact002067"
      unitRef="BRL">-47819000</afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset>
    <afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002069"
      unitRef="BRL">57200000</afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable>
    <afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002070"
      unitRef="BRL">43675000</afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable>
    <afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact002071"
      unitRef="BRL">35786000</afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002073"
      unitRef="BRL">61398000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002074"
      unitRef="BRL">44046000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact002075"
      unitRef="BRL">45013000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002077">&lt;p id="xdx_808_eifrs-full--DisclosureOfRelatedPartyExplanatory_zfeJh2uC6cW9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;8&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_82F_zvW4OCjo3Nn9"&gt;Related parties&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The table below summarizes the balances and transactions with related parties:&lt;/p&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfRelatedPartiesExplanatory_zz5MME0AnKVe" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Related parties (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BE_zJDaeOUYjZyl" style="display: none"&gt;Schedule of balances and transactions with related
    parties&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20231231_zn3QmHsq48Al" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20221231_zvnu1iuT7Mf4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn3n3_zFuYFNUYKIGc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade receivables (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;693&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;917&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--OtherAssetsRelatedPartyTransactions_iI_pn3n3_zWvxBoejrbc3" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other assets (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;285&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,975&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_pn3n3" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;978&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,892&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_pn3n3_zzaygYW3CdC7" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;792&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,892&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--NoncurrentAssetsOfRelatedParty1_iI_pn3n3_zzcllqmLXdW9" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;186&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2094"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AccountsPayableToSellingShareholders_iI_pn3n3_zu0Csl4m73X5" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts payable to selling shareholders (iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2096"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;30,653&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pn3n3_zonsfZ4FmrJ6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2099"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;30,653&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccountsPayableCurrent1_iI_pn3n3_zvFhnwbCB46k" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2102"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;30,653&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--NoncurrentPayablesToRelatedParties1_iI_pn3n3_zxXlnAUn3k9f" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2105"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2106"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Other income (expenses)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UEPC (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zOeqym0A9OJ2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;465&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zZPmWg6lv2Ih" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;477&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zpvWO0rnBgql" style="vertical-align: top; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;752&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;EMIVE Patrulha 24 Horas Ltda. (iv)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_z0WxnDBVN9n3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zifXlPlTqD3a" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2116"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zd7RROSFS2jd" style="border-bottom: Black 1pt solid; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2118"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231_zkP58e0Bsoy2" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;459&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231_zg8lFoEYk5Kc" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;477&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231_zUeHmV78JCRj" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;752&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Leases &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;RVL Esteves Gest&#xe3;o Imobili&#xe1;ria S.A.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zZzd9A7zYkok" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,434&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zBfY98haxil2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,394&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zDMGimCI7L9b" style="vertical-align: top; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,336&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UNIVA&#xc7;O Patrimonial Ltda.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_z5mGjRiVnkab" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,582&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zinEMFibxGe3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,409&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zBhwlsaVSYt5" style="vertical-align: top; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,210&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IESVAP Patrimonial Ltda.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zUwhPZ2Jm8k3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,170&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zjRKIcxl4Xo9" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,920&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zjbwRaMG2wIh" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,560&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231_zUkngkGsrAJg" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;32,186&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231_zekJvbzrD7vl" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;28,723&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231_zO694S6i5Dg8" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;23,106&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to sales of educational content from Medcel to UEPC.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to expenses to be reimbursed by Bertelsmann SE&amp;amp; Co. KGaA.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to amounts payable to our shareholder Nicolau Carvalho Esteves regarding the agreement
to which Afya Brazil acquired the right to develop ITPAC Garanhuns medical school, a greenfield unit. The last installment was paid in
November 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iv)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to amounts of expenses related to security services provided by a company of which
one of Afya&#x2019;s main shareholders has significant influence.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AB_zFucREYGSd8g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;Lease agreements with RVL Esteves Gest&#xe3;o Imobili&#xe1;ria
S.A.&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Afya Brazil has entered into lease agreements with RVL Esteves Gest&#xe3;o
Imobili&#xe1;ria S.A. (&#x201c;RVL&#x201d;), an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato
Esteves is an executive officer, as described below:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;On June 21, 2016, RVL entered into lease agreements (as
amended on April 26, 2018) with ITPAC Aragua&#xed;na and ITPAC Porto, pursuant to which RVL agreed to lease campuses to those entities
in the cities of Aragua&#xed;na and Porto Nacional, both located in the State of Tocantins. The lease agreements are adjustable in
accordance with the provisions of each lease agreement. The lease agreements are for an initial term of &lt;span id="xdx_90B_ecustom--OperatingLeaseTermOfContract_dtY_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_zfQw1xHVqju6" title="Lease term"&gt;20&lt;/span&gt; years and are renewable for
an additional 20 years subject to the provisions of each lease agreement.&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;On November 1, 2016, RVL entered into a lease
agreement with Afya Brazil, pursuant to which RVL agreed to lease to Afya Brazil certain offices in the city of Nova Lima, State of
Minas Gerais, where Afya Brazil&#x2019;s executive offices are located. On February 9, 2019, the agreement was amended to extend
lease terms and adjust the lease amounts, subject to certain discount conditions set forth in the lease agreement and adjustable in
accordance with the provisions of the lease agreement. The lease agreement had an initial term of five years which ended on January
31, 2024 and was renewed until the end of June, 2024, subject to the provisions of the lease agreement.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;On September 6, 2018, RVL entered into a lease agreement
with ITPAC Aragua&#xed;na, pursuant to which RVL agreed to lease to ITPAC the new ITPAC campus by RVL in the city of Palmas, State of
Tocantins. The lease agreement is for an amount equal to &lt;span id="xdx_907_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20180905__20180906__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zEABlcqjtS5i" title="Percentage of revenue"&gt;7.5&lt;/span&gt;% of the monthly revenue of ITPAC during the prior semester and will be effective
(and become due) once the new ITPAC campus becomes operational, subject to the provisions of the lease agreement. Since 2022, the campus
is fully operational. The lease agreement is for an initial term of &lt;span id="xdx_907_ecustom--OperatingLeaseTermOfContract_dtY_c20180905__20180906__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_zDLnUDyZaPol" title="Lease term"&gt;20&lt;/span&gt; years and is renewable for an additional &lt;span id="xdx_901_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_zjNtSN0BymS3" title="Renewal term"&gt;20&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On October 30, 2019, RVL entered into a lease agreement with IPTAN, pursuant
to which RVL agreed to lease to IPTAN the new IPTAN medical campus, in the city of Santa In&#xea;s, State of Maranh&#xe3;o. The lease
agreement is for a monthly amount equal to &lt;span id="xdx_900_ecustom--DescriptionOfLeaseTerm_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zsJOIn9Hqqoi" title="Description of lease term"&gt;(i) up to June 2020, R$&lt;span id="xdx_90E_eifrs-full--CashOutflowForLeases_pn3n3_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zD8XWnRwUzC1" title="Lease expenses"&gt;12&lt;/span&gt; and (ii) from July 2020 until March 2024, &lt;span id="xdx_904_eifrs-full--PercentageOfEntitysRevenue_pip0_dp_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zzHtitsQwWed" title="Percentage of revenue"&gt;6.5&lt;/span&gt;% of the monthly revenue
of IPTAN during the prior semester, adjusted in accordance with the provisions of the lease agreement.&lt;/span&gt; The lease agreement is for an initial
term of five years starting in January 2021, when the campus becomes operational and may be renewable for an additional five years subject
to the provisions of the lease agreement.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On August 2, 2021, RVL entered into a lease agreement with ITPAC Aragua&#xed;na,
pursuant to which RVL agreed to lease to ITPAC the new ITPAC Garanhuns medical campus, in the city of Garanhuns, State of Pernambuco.
The lease agreement is for a monthly amount equal to &lt;span id="xdx_90D_ecustom--DescriptionOfLeaseTerm_c20210728__20210802__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zanoKdLvfMVk" title="Description of lease term"&gt;(i) up to June 2022, R$&lt;span id="xdx_900_eifrs-full--CashOutflowForLeases_pn3n3_c20210728__20210802__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zFt7xfBZKfxa" title="Lease expenses"&gt;40&lt;/span&gt;; (ii) from July 2022 until December 2028, &lt;span id="xdx_90E_eifrs-full--PercentageOfEntitysRevenue_pip0_dp_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zIn7t5Lltjhg" title="Percentage of revenue"&gt;6.5&lt;/span&gt;% of the monthly
revenue of ITPAC Garanhuns during the prior semester, adjusted in accordance with the provisions of the lease agreement&lt;/span&gt;; and (iii) as
from January 2029, the monthly amount should be adjusted by the inflation rate (IPCA). The lease agreement is for a term of 20 years.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The lease payments in connection with the lease agreements with RVL totaled
R$&lt;span id="xdx_908_eifrs-full--CashOutflowForLeases_pn3n3_uBRL_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zOXhlnBB2999" title="Lease expenses"&gt;23,434&lt;/span&gt;, R$&lt;span id="xdx_90B_eifrs-full--CashOutflowForLeases_pn3n3_uBRL_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zByW7E0ZE0nd" title="Lease expenses"&gt;20,394&lt;/span&gt; and R$&lt;span id="xdx_901_eifrs-full--CashOutflowForLeases_pn3n3_uBRL_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zdU9ftn8i426" title="Lease expenses"&gt;15,336&lt;/span&gt; in the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;Lease agreement with UNIVA&#xc7;O Patrimonial Ltda.&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On July 14, 2016, UNIVA&#xc7;O Patrimonial Ltda., an entity controlled
by the shareholder Nicolau Carvalho Esteves and of which Ms. Ros&#xe2;ngela Esteves is the chief executive officer, entered into a lease
agreement with UNIVA&#xc7;O, a subsidiary of Afya Brazil, pursuant to which UNIVA&#xc7;O Patrimonial Ltda. agreed to lease the UNIVA&#xc7;O
campus to UNIVA&#xc7;O, located in the city of Ipatinga, State of Minas Gerais. The lease agreement is adjustable in accordance with
the provisions of the lease agreement. The lease agreement is for an initial term of 20 years and is renewable for an additional &lt;span id="xdx_906_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_z0qzgTVGtTyi" title="Renewal term"&gt;20&lt;/span&gt; years
subject to the provisions of the lease agreement. The lease payments in connection with this lease agreement totaled R$&lt;span id="xdx_901_eifrs-full--CashOutflowForLeases_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zP9Ey9k6ZNih" title="Lease expenses"&gt;3,582&lt;/span&gt;, R$&lt;span id="xdx_90A_eifrs-full--CashOutflowForLeases_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zwiGr7Fnv1B1" title="Lease expenses"&gt;3,409&lt;/span&gt;
and R$&lt;span id="xdx_900_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zPE0BgUjutBd" title="Lease expenses"&gt;3,210&lt;/span&gt; in the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;Lease agreement with IESVAP Patrimonial Ltda.&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On April 25, 2018, IESVAP Patrimonial Ltda., an entity controlled by the
shareholder Nicolau Carvalho Esteves and of which Mr. Renato Esteves is an executive officer, entered into a lease agreement with IESVAP,
a subsidiary of Afya Brazil, pursuant to which IESVAP Patrimonial Ltda. agreed to lease the IESVAP campus to IESVAP located in the city
of Parna&#xed;ba, State of Piau&#xed;. &lt;span id="xdx_908_ecustom--DescriptionOfLeaseTerms_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_z5MRq2KPff9g" title="Description of lease term"&gt;The lease agreement is for an amount equal to &lt;span id="xdx_909_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zuYYL8WtjOUf" title="Percentage of revenue"&gt;7.5&lt;/span&gt;% of the monthly revenue of IESVAP until maturation.&lt;/span&gt;
The lease agreement is for an initial term of &lt;span id="xdx_909_ecustom--OperatingLeaseTermOfContract_dtY_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zUK7vDZH8qsd" title="Lease term"&gt;20&lt;/span&gt; years and is renewable for an additional &lt;span id="xdx_903_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zHoVOVXHhwE1" title="Renewal term"&gt;20&lt;/span&gt; years subject to the provisions of the lease
agreement. The lease payments in connection with this lease agreement totaled R$&lt;span id="xdx_902_eifrs-full--CashOutflowForLeases_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zTToMiCfTpMi" title="Lease expenses"&gt;5,170&lt;/span&gt;, R$&lt;span id="xdx_90A_eifrs-full--CashOutflowForLeases_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zk426Pg8a0Q8" title="Lease expenses"&gt;4,920&lt;/span&gt; and R$&lt;span id="xdx_90F_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zOlPlmavbRZk" title="Lease expenses"&gt;4,560&lt;/span&gt; in the years ended December
31, 2023, 2022 and 2021, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;i&gt;Key management personnel compensation&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Key management personnel compensation included in the Company&#x2019;s consolidated
statement of income comprised the following:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_pn3n3_zBHQ94Gh3mnb" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Related parties (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;span id="xdx_8BA_zXPCFHzISisi" style="display: none"&gt;Schedule of key management personnel compensation included in the
    Company's consolidated statement of income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 46%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Short-term employee benefits&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20230101__20231231_zBefWbpKb0kj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;16,979&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20220101__20221231_zL4DpyCzWcT6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,564&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20210101__20211231_z0tr1vF34wid" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,933&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share-based compensation plans&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20230101__20231231_zzQ6LmZGaqj9" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;21,380&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20220101__20221231_z1rBtliWHAm5" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,116&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20210101__20211231_zumE8186z1wl" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,251&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20230101__20231231_zwdO4xCpG5Fc" style="border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;38,359&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20220101__20221231_zWXbVKaXNqnb" style="border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;26,680&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20210101__20211231_zE7BELZG7xjb" style="border-bottom: black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;32,184&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Compensation of the Company&#x2019;s key management includes short-term employee
benefits comprised by salaries, labor and social charges, and other ordinary short-term employee benefits. The amounts disclosed in the
table above are the amounts recognized as an expense in selling, general and administrative expenses during the reporting period related
to key management personnel.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The executive officers participate in share-based compensation plans described
in Note 16 (b).&lt;/p&gt;

</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <afya:DisclosureOfRelatedPartiesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002079">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfRelatedPartiesExplanatory_zz5MME0AnKVe" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Related parties (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BE_zJDaeOUYjZyl" style="display: none"&gt;Schedule of balances and transactions with related
    parties&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20231231_zn3QmHsq48Al" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20221231_zvnu1iuT7Mf4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn3n3_zFuYFNUYKIGc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade receivables (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;693&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;917&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--OtherAssetsRelatedPartyTransactions_iI_pn3n3_zWvxBoejrbc3" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other assets (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;285&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,975&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_pn3n3" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;978&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,892&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_pn3n3_zzaygYW3CdC7" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;792&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,892&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--NoncurrentAssetsOfRelatedParty1_iI_pn3n3_zzcllqmLXdW9" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;186&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2094"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AccountsPayableToSellingShareholders_iI_pn3n3_zu0Csl4m73X5" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts payable to selling shareholders (iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2096"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;30,653&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pn3n3_zonsfZ4FmrJ6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2099"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;30,653&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccountsPayableCurrent1_iI_pn3n3_zvFhnwbCB46k" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2102"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;30,653&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--NoncurrentPayablesToRelatedParties1_iI_pn3n3_zxXlnAUn3k9f" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2105"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2106"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Other income (expenses)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UEPC (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zOeqym0A9OJ2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;465&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zZPmWg6lv2Ih" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;477&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zpvWO0rnBgql" style="vertical-align: top; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;752&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;EMIVE Patrulha 24 Horas Ltda. (iv)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_z0WxnDBVN9n3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zifXlPlTqD3a" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2116"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zd7RROSFS2jd" style="border-bottom: Black 1pt solid; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2118"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231_zkP58e0Bsoy2" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;459&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20220101__20221231_zg8lFoEYk5Kc" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;477&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231_zUeHmV78JCRj" style="border-bottom: Black 1.5pt double; vertical-align: bottom; width: 17%; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;752&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Leases &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;RVL Esteves Gest&#xe3;o Imobili&#xe1;ria S.A.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zZzd9A7zYkok" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,434&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zBfY98haxil2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,394&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zDMGimCI7L9b" style="vertical-align: top; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,336&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UNIVA&#xc7;O Patrimonial Ltda.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_z5mGjRiVnkab" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,582&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zinEMFibxGe3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,409&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zBhwlsaVSYt5" style="vertical-align: top; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,210&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IESVAP Patrimonial Ltda.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zUwhPZ2Jm8k3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,170&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zjRKIcxl4Xo9" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,920&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zjbwRaMG2wIh" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,560&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20230101__20231231_zUkngkGsrAJg" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;32,186&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20220101__20221231_zekJvbzrD7vl" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;28,723&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231_zO694S6i5Dg8" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;23,106&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to sales of educational content from Medcel to UEPC.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to expenses to be reimbursed by Bertelsmann SE&amp;amp; Co. KGaA.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to amounts payable to our shareholder Nicolau Carvalho Esteves regarding the agreement
to which Afya Brazil acquired the right to develop ITPAC Garanhuns medical school, a greenfield unit. The last installment was paid in
November 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iv)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to amounts of expenses related to security services provided by a company of which
one of Afya&#x2019;s main shareholders has significant influence.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:DisclosureOfRelatedPartiesExplanatory>
    <afya:TradeReceivablesRelatedPartyTransactions
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002081"
      unitRef="BRL">693000</afya:TradeReceivablesRelatedPartyTransactions>
    <afya:TradeReceivablesRelatedPartyTransactions
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002082"
      unitRef="BRL">917000</afya:TradeReceivablesRelatedPartyTransactions>
    <afya:OtherAssetsRelatedPartyTransactions
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002084"
      unitRef="BRL">285000</afya:OtherAssetsRelatedPartyTransactions>
    <afya:OtherAssetsRelatedPartyTransactions
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002085"
      unitRef="BRL">1975000</afya:OtherAssetsRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002087"
      unitRef="BRL">978000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002088"
      unitRef="BRL">2892000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <afya:TradeAndOtherCurrentPayablesToRelatedParties1
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002090"
      unitRef="BRL">792000</afya:TradeAndOtherCurrentPayablesToRelatedParties1>
    <afya:TradeAndOtherCurrentPayablesToRelatedParties1
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002091"
      unitRef="BRL">2892000</afya:TradeAndOtherCurrentPayablesToRelatedParties1>
    <afya:NoncurrentAssetsOfRelatedParty1
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002093"
      unitRef="BRL">186000</afya:NoncurrentAssetsOfRelatedParty1>
    <afya:AccountsPayableToSellingShareholders
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002097"
      unitRef="BRL">30653000</afya:AccountsPayableToSellingShareholders>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002100"
      unitRef="BRL">30653000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <afya:AccountsPayableCurrent1
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002103"
      unitRef="BRL">30653000</afya:AccountsPayableCurrent1>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2023-01-012023-12-31_custom_UEPCMember"
      decimals="-3"
      id="Fact002108"
      unitRef="BRL">465000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2022-01-012022-12-31_custom_UEPCMember"
      decimals="-3"
      id="Fact002110"
      unitRef="BRL">477000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2021-01-012021-12-31_custom_UEPCMember"
      decimals="-3"
      id="Fact002112"
      unitRef="BRL">752000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2023-01-012023-12-31_custom_EMIVEPatrulha24HorasLtdaMember"
      decimals="-3"
      id="Fact002114"
      unitRef="BRL">-6000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002120"
      unitRef="BRL">459000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002122"
      unitRef="BRL">477000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact002124"
      unitRef="BRL">752000</afya:OtherIncomeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2023-01-012023-12-31_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      id="Fact002126"
      unitRef="BRL">23434000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2022-01-012022-12-31_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      id="Fact002128"
      unitRef="BRL">20394000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2021-01-012021-12-31_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      id="Fact002130"
      unitRef="BRL">15336000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2023-01-012023-12-31_custom_UNIVACOPatrimonialLtdaMember"
      decimals="-3"
      id="Fact002132"
      unitRef="BRL">3582000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2022-01-012022-12-31_custom_UNIVACOPatrimonialLtdaMember"
      decimals="-3"
      id="Fact002134"
      unitRef="BRL">3409000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2021-01-012021-12-31_custom_UNIVACOPatrimonialLtdaMember"
      decimals="-3"
      id="Fact002136"
      unitRef="BRL">3210000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2023-01-012023-12-31_custom_IESVAPPatrimonialLtdaMember"
      decimals="-3"
      id="Fact002138"
      unitRef="BRL">5170000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2022-01-012022-12-31_custom_IESVAPPatrimonialLtdaMember"
      decimals="-3"
      id="Fact002140"
      unitRef="BRL">4920000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2021-01-012021-12-31_custom_IESVAPPatrimonialLtdaMember"
      decimals="-3"
      id="Fact002142"
      unitRef="BRL">4560000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002144"
      unitRef="BRL">32186000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002146"
      unitRef="BRL">28723000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact002148"
      unitRef="BRL">23106000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <afya:OperatingLeaseTermOfContract
      contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member"
      id="Fact002150">P20Y</afya:OperatingLeaseTermOfContract>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="From2018-09-052018-09-06_custom_LeaseAgreements1Member_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="INF"
      id="Fact002153"
      unitRef="Pure">0.075</ifrs-full:PercentageOfEntitysRevenue>
    <afya:OperatingLeaseTermOfContract
      contextRef="From2018-09-052018-09-06_custom_LeaseAgreements1Member"
      id="Fact002155">P20Y</afya:OperatingLeaseTermOfContract>
    <afya:LesseeFinancesLeaseRenewalTerm
      contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member"
      id="Fact002157">P20Y</afya:LesseeFinancesLeaseRenewalTerm>
    <afya:DescriptionOfLeaseTerm
      contextRef="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember"
      id="Fact002159">(i) up to June 2020, R$12 and (ii) from July 2020 until March 2024, 6.5% of the monthly revenue
of IPTAN during the prior semester, adjusted in accordance with the provisions of the lease agreement.</afya:DescriptionOfLeaseTerm>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      id="Fact002161"
      unitRef="BRL">12000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="INF"
      id="Fact002163"
      unitRef="Pure">0.065</ifrs-full:PercentageOfEntitysRevenue>
    <afya:DescriptionOfLeaseTerm
      contextRef="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember"
      id="Fact002165">(i) up to June 2022, R$40; (ii) from July 2022 until December 2028, 6.5% of the monthly
revenue of ITPAC Garanhuns during the prior semester, adjusted in accordance with the provisions of the lease agreement</afya:DescriptionOfLeaseTerm>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      id="Fact002167"
      unitRef="BRL">40000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="INF"
      id="Fact002169"
      unitRef="Pure">0.065</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      id="Fact002171"
      unitRef="BRL">23434000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2022-01-012022-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      id="Fact002173"
      unitRef="BRL">20394000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      id="Fact002175"
      unitRef="BRL">15336000</ifrs-full:CashOutflowForLeases>
    <afya:LesseeFinancesLeaseRenewalTerm
      contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      id="Fact002177">P20Y</afya:LesseeFinancesLeaseRenewalTerm>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="-3"
      id="Fact002179"
      unitRef="BRL">3582000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2022-01-012022-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="-3"
      id="Fact002181"
      unitRef="BRL">3409000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="-3"
      id="Fact002183"
      unitRef="BRL">3210000</ifrs-full:CashOutflowForLeases>
    <afya:DescriptionOfLeaseTerms
      contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      id="Fact002186">The lease agreement is for an amount equal to 7.5% of the monthly revenue of IESVAP until maturation.</afya:DescriptionOfLeaseTerms>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      decimals="INF"
      id="Fact002188"
      unitRef="Pure">0.075</ifrs-full:PercentageOfEntitysRevenue>
    <afya:OperatingLeaseTermOfContract
      contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      id="Fact002190">P20Y</afya:OperatingLeaseTermOfContract>
    <afya:LesseeFinancesLeaseRenewalTerm
      contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      id="Fact002192">P20Y</afya:LesseeFinancesLeaseRenewalTerm>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2023-01-012023-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      decimals="-3"
      id="Fact002194"
      unitRef="BRL">5170000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2022-01-012022-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      decimals="-3"
      id="Fact002196"
      unitRef="BRL">4920000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      decimals="-3"
      id="Fact002198"
      unitRef="BRL">4560000</ifrs-full:CashOutflowForLeases>
    <afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002200">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_pn3n3_zBHQ94Gh3mnb" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Related parties (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;span id="xdx_8BA_zXPCFHzISisi" style="display: none"&gt;Schedule of key management personnel compensation included in the
    Company's consolidated statement of income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 46%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Short-term employee benefits&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20230101__20231231_zBefWbpKb0kj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;16,979&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20220101__20221231_zL4DpyCzWcT6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,564&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20210101__20211231_z0tr1vF34wid" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,933&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share-based compensation plans&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20230101__20231231_zzQ6LmZGaqj9" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;21,380&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20220101__20221231_z1rBtliWHAm5" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,116&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20210101__20211231_zumE8186z1wl" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,251&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20230101__20231231_zwdO4xCpG5Fc" style="border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;38,359&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20220101__20221231_zWXbVKaXNqnb" style="border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;26,680&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20210101__20211231_zE7BELZG7xjb" style="border-bottom: black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;32,184&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002202"
      unitRef="BRL">16979000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002204"
      unitRef="BRL">13564000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact002206"
      unitRef="BRL">11933000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002208"
      unitRef="BRL">21380000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002210"
      unitRef="BRL">13116000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact002212"
      unitRef="BRL">20251000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact002214"
      unitRef="BRL">38359000</ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity>
    <ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002216"
      unitRef="BRL">26680000</ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity>
    <ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact002218"
      unitRef="BRL">32184000</ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity>
    <afya:DisclosureOfOtherAssetExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002220">&lt;p id="xdx_808_ecustom--DisclosureOfOtherAssetExplanatory_zUkQX8TCfXTe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;9&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_82D_zbvN17fWIDej"&gt;Other assets&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;As of December 31, 2023, the Company has R$&lt;span id="xdx_90A_ecustom--OtherAsset_iI_pn3n3_c20231231_zR4sTiSx85Y7" title="Other assets"&gt;176,251&lt;/span&gt; (December 31, 2022: R$&lt;span id="xdx_900_ecustom--OtherAsset_iI_pn3n3_c20221231_zSm84EOT9jQ" title="Other assets"&gt;243,501&lt;/span&gt;)
accounted for as Other assets as follow:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfOtherAssetsTableTextBlock_z6H21WFiSn0i" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Other assets (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B6_zkyRIMEwd1Lg" style="display: none"&gt;&#160;Schedule of other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_499_20231231_zFbdpRwdlcQf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20221231_zkNqgAseLwQ9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_maAzYGA_z9Mu56LaUtra" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Indemnification assets (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;81,855&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;145,300&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--Advances1_iI_pn3n3_maAzYGA_zIrYAazBnCx8" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Advances&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;39,890&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;30,626&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--JudicialDeposits_iI_pn3n3_maAzYGA_zcrVnF3w1gud" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Judicial deposits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,187&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,693&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_maAzYGA_zR8k57OIjvd" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,820&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;18,441&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--OtherReceivables_iI_pn3n3_maAzYGA_zw1VrfPkYxai" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other FIES receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;8,674&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;26,440&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--Dividend_iI_pn3n3_maAzYGA_zKYcIZiUb9F4" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividends&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,668&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2244"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--DeferredTaxAssets_iI_maAzYGA_zM1PBMEoHB5" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,233&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2247"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--OtherAssets1_iI_pn3n3_maAzYGA_zVaPkYCCBasc" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,924&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,001&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--Assets1_iTI_pn3n3_mtAzYGA_zRz7Mjg08wGi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;176,251&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;243,501&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--CurrentAssets1_iI_pn3n3_zJyR4AWUv5Kl" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,905&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;51,745&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NoncurrentAssets1_iI_pn3n3_zxnLTgTCEtZj" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;117,346&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;191,756&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Under the terms of the Share Purchase and Sale Agreements (&#x201c;Agreements&#x201d;) between
the Company and the selling shareholders of subsidiaries acquired, the Company assesses that the selling shareholders are exclusively
responsible for any provisions (including labor, tax and civil), which are or will be the subject of a claim by any third party, arising
from the act or fact occurred, by action or omission, prior to or on the closing dates of the acquisitions. As disclosed in Note 23(b),
Unigranrio has entered into a tax amnesty program in August 2023 for settling a tax proceeding, which resulted in the write-off of R$20,000
of indemnification assets. The remaining variance is due to the expiration of the related contingent liabilities recognized at business
combinations, mostly due to R$ 28,500 related to tax matters.&lt;br/&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A5_zs4mvPalaBV4" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;






</afya:DisclosureOfOtherAssetExplanatory>
    <afya:OtherAsset
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002222"
      unitRef="BRL">176251000</afya:OtherAsset>
    <afya:OtherAsset
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002224"
      unitRef="BRL">243501000</afya:OtherAsset>
    <afya:DisclosureOfOtherAssetsTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002226">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfOtherAssetsTableTextBlock_z6H21WFiSn0i" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Other assets (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B6_zkyRIMEwd1Lg" style="display: none"&gt;&#160;Schedule of other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_499_20231231_zFbdpRwdlcQf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20221231_zkNqgAseLwQ9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_maAzYGA_z9Mu56LaUtra" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Indemnification assets (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;81,855&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;145,300&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--Advances1_iI_pn3n3_maAzYGA_zIrYAazBnCx8" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Advances&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;39,890&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;30,626&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--JudicialDeposits_iI_pn3n3_maAzYGA_zcrVnF3w1gud" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Judicial deposits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,187&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,693&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_maAzYGA_zR8k57OIjvd" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,820&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;18,441&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--OtherReceivables_iI_pn3n3_maAzYGA_zw1VrfPkYxai" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other FIES receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;8,674&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;26,440&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--Dividend_iI_pn3n3_maAzYGA_zKYcIZiUb9F4" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividends&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,668&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2244"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--DeferredTaxAssets_iI_maAzYGA_zM1PBMEoHB5" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,233&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2247"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--OtherAssets1_iI_pn3n3_maAzYGA_zVaPkYCCBasc" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,924&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,001&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--Assets1_iTI_pn3n3_mtAzYGA_zRz7Mjg08wGi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;176,251&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;243,501&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--CurrentAssets1_iI_pn3n3_zJyR4AWUv5Kl" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,905&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;51,745&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NoncurrentAssets1_iI_pn3n3_zxnLTgTCEtZj" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;117,346&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;191,756&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Under the terms of the Share Purchase and Sale Agreements (&#x201c;Agreements&#x201d;) between
the Company and the selling shareholders of subsidiaries acquired, the Company assesses that the selling shareholders are exclusively
responsible for any provisions (including labor, tax and civil), which are or will be the subject of a claim by any third party, arising
from the act or fact occurred, by action or omission, prior to or on the closing dates of the acquisitions. As disclosed in Note 23(b),
Unigranrio has entered into a tax amnesty program in August 2023 for settling a tax proceeding, which resulted in the write-off of R$20,000
of indemnification assets. The remaining variance is due to the expiration of the related contingent liabilities recognized at business
combinations, mostly due to R$ 28,500 related to tax matters.&lt;br/&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:DisclosureOfOtherAssetsTableTextBlock>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002228"
      unitRef="BRL">81855000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002229"
      unitRef="BRL">145300000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <afya:Advances1
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002231"
      unitRef="BRL">39890000</afya:Advances1>
    <afya:Advances1
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002232"
      unitRef="BRL">30626000</afya:Advances1>
    <afya:JudicialDeposits
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002234"
      unitRef="BRL">14187000</afya:JudicialDeposits>
    <afya:JudicialDeposits
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002235"
      unitRef="BRL">12693000</afya:JudicialDeposits>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002237"
      unitRef="BRL">15820000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002238"
      unitRef="BRL">18441000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002240"
      unitRef="BRL">8674000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002241"
      unitRef="BRL">26440000</ifrs-full:OtherReceivables>
    <afya:Dividend
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002243"
      unitRef="BRL">1668000</afya:Dividend>
    <ifrs-full:DeferredTaxAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002246"
      unitRef="BRL">3233000</ifrs-full:DeferredTaxAssets>
    <afya:OtherAssets1
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002249"
      unitRef="BRL">10924000</afya:OtherAssets1>
    <afya:OtherAssets1
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002250"
      unitRef="BRL">10001000</afya:OtherAssets1>
    <afya:Assets1
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002252"
      unitRef="BRL">176251000</afya:Assets1>
    <afya:Assets1
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002253"
      unitRef="BRL">243501000</afya:Assets1>
    <afya:CurrentAssets1
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002255"
      unitRef="BRL">58905000</afya:CurrentAssets1>
    <afya:CurrentAssets1
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002256"
      unitRef="BRL">51745000</afya:CurrentAssets1>
    <afya:NoncurrentAssets1
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002258"
      unitRef="BRL">117346000</afya:NoncurrentAssets1>
    <afya:NoncurrentAssets1
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002259"
      unitRef="BRL">191756000</afya:NoncurrentAssets1>
    <ifrs-full:DisclosureOfJointVenturesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002262">&lt;p id="xdx_80C_eifrs-full--DisclosureOfJointVenturesExplanatory_zbV3XaqofAI" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;10&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_823_zX8vooFvyF94"&gt;Investment in associate&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company holds a 30% interest in UEPC, a medical school located in the
Federal District that offers higher education and post-graduate courses, both in person and long-distance learning. The Company&#x2019;s
interest in UEPC is accounted for using the equity method. The table below illustrates the summarized financial information of the Company&#x2019;s
investment in UEPC:&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfInvestmentsExplanatory_z4HLGBn3Kjw5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Investment in associate (Details)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span id="xdx_8B2_zf9ZwfDtHIt9" style="display: none"&gt;Schedule of investment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49B_20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zDQwzPX1OZYj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z1EfWHBaGETh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CurrentAssets_iI_pn3n3" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;29,004&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;32,651&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--NoncurrentAssets_iI_pn3n3" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;120,289&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;122,378&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CurrentLiabilities_iNI_pn3n3_di_ztVAsEnp3ln1" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(28,842)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(22,840)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--NoncurrentLiabilities_iNI_pn3n3_di_zy25DbP2Jjoc" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(91,613)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(96,442)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--EquityInAssociate_iI_pn3n3_zw26ITe7A3k4" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;28,838&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;35,747&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CompanyShareInEquity1_iI_pn3n3_zM8iJDlzm1Hd" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Company&#x2019;s share in equity - 30%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;8,651&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,724&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--Goodwill_iI_pn3n3" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;43,183&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;43,183&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_pn3n3_z2MVr3LINuJ4" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Carrying amount of the investment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;51,834&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;53,907&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zfETjZvp0ou9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zjMNmgOWvvce" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zDIQZLfmuTqi" style="text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--Revenue_pn3n3_z9ofUQhFc654" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Revenue&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;148,042&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;138,584&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;127,618&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--CostOfSales_iN_pn3n3_di_zqw2Xki9QeKl" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(71,282)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(57,421)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(57,935)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_zkVc8qUOLd4l" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(37,205)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(34,991)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(24,025)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--FinanceIncome_iN_pn3n3_di_zDFrby0MZLra" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Finance results&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,123)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,103)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,585)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ProfitLossBeforeTax_pn3n3_ztihFdewGr5" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;33,432&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;42,069&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;41,073&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_z50VfcbUIrC1" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,782)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,456)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,748)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ProfitLoss_pn3n3_zHwWe177BJZk" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;31,650&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;40,613&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;39,325&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--CompanyShareOfProfitss_pn3n3_zHRPkXt37XY3" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Company&#x2019;s share of income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;9,495&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;12,184&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;11,797&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zGArAD1AUiTf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zwY9uhvj2sSc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zEcDMIw7jRRk" style="text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 18%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iS_pn3n3_zm2ggDiW1Gy5" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Opening balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;53,907&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;48,477&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;51,410&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DividendsReceived1_iS_pn3n3_zOXCrcFwrJi1" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividends received&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,754)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,770)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--DividendsReceived_iN_pn3n3_di_zU7jtTViQvE9" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividends receivable (included in Other assets)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,668)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2331"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,960)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--ProfitLossOfAcquiree_pn3n3_zqpKcWwd2MJa" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share of income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;9,495&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,184&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,797&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--InvestmentsInAssociates_iE_pn3n3_zYyHYwFGiFNf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Closing balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;51,834&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;53,907&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;48,477&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_z5xunlZ3Ow7l" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company tests the recoverability of the carrying amount of goodwill
at least annually. As of December 31, 2023 and 2022, no impairment had to be recognized for this goodwill.&lt;/p&gt;






</ifrs-full:DisclosureOfJointVenturesExplanatory>
    <afya:DisclosureOfInvestmentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002264">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfInvestmentsExplanatory_z4HLGBn3Kjw5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Investment in associate (Details)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span id="xdx_8B2_zf9ZwfDtHIt9" style="display: none"&gt;Schedule of investment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49B_20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zDQwzPX1OZYj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z1EfWHBaGETh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CurrentAssets_iI_pn3n3" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;29,004&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;32,651&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--NoncurrentAssets_iI_pn3n3" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;120,289&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;122,378&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CurrentLiabilities_iNI_pn3n3_di_ztVAsEnp3ln1" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(28,842)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(22,840)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--NoncurrentLiabilities_iNI_pn3n3_di_zy25DbP2Jjoc" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(91,613)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(96,442)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--EquityInAssociate_iI_pn3n3_zw26ITe7A3k4" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;28,838&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;35,747&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CompanyShareInEquity1_iI_pn3n3_zM8iJDlzm1Hd" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Company&#x2019;s share in equity - 30%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;8,651&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,724&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--Goodwill_iI_pn3n3" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;43,183&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;43,183&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_pn3n3_z2MVr3LINuJ4" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Carrying amount of the investment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;51,834&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;53,907&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zfETjZvp0ou9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zjMNmgOWvvce" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zDIQZLfmuTqi" style="text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--Revenue_pn3n3_z9ofUQhFc654" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Revenue&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;148,042&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;138,584&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;127,618&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--CostOfSales_iN_pn3n3_di_zqw2Xki9QeKl" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(71,282)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(57,421)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(57,935)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_zkVc8qUOLd4l" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(37,205)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(34,991)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(24,025)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--FinanceIncome_iN_pn3n3_di_zDFrby0MZLra" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Finance results&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,123)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,103)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,585)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ProfitLossBeforeTax_pn3n3_ztihFdewGr5" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;33,432&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;42,069&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;41,073&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_z50VfcbUIrC1" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,782)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,456)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,748)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ProfitLoss_pn3n3_zHwWe177BJZk" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;31,650&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;40,613&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;39,325&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--CompanyShareOfProfitss_pn3n3_zHRPkXt37XY3" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Company&#x2019;s share of income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;9,495&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;12,184&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;11,797&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zGArAD1AUiTf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zwY9uhvj2sSc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zEcDMIw7jRRk" style="text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 18%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iS_pn3n3_zm2ggDiW1Gy5" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Opening balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;53,907&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;48,477&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;51,410&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DividendsReceived1_iS_pn3n3_zOXCrcFwrJi1" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividends received&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,754)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,770)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--DividendsReceived_iN_pn3n3_di_zU7jtTViQvE9" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividends receivable (included in Other assets)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,668)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2331"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,960)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--ProfitLossOfAcquiree_pn3n3_zqpKcWwd2MJa" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share of income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;9,495&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,184&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,797&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--InvestmentsInAssociates_iE_pn3n3_zYyHYwFGiFNf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Closing balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;51,834&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;53,907&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;48,477&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:DisclosureOfInvestmentsExplanatory>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002266"
      unitRef="BRL">29004000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002267"
      unitRef="BRL">32651000</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002269"
      unitRef="BRL">120289000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002270"
      unitRef="BRL">122378000</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002272"
      unitRef="BRL">28842000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002273"
      unitRef="BRL">22840000</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002275"
      unitRef="BRL">91613000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002276"
      unitRef="BRL">96442000</ifrs-full:NoncurrentLiabilities>
    <afya:EquityInAssociate
      contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002278"
      unitRef="BRL">28838000</afya:EquityInAssociate>
    <afya:EquityInAssociate
      contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002279"
      unitRef="BRL">35747000</afya:EquityInAssociate>
    <afya:CompanyShareInEquity1
      contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002281"
      unitRef="BRL">8651000</afya:CompanyShareInEquity1>
    <afya:CompanyShareInEquity1
      contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002282"
      unitRef="BRL">10724000</afya:CompanyShareInEquity1>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002284"
      unitRef="BRL">43183000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002285"
      unitRef="BRL">43183000</ifrs-full:Goodwill>
    <afya:InvestmentGrossAmount
      contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002287"
      unitRef="BRL">51834000</afya:InvestmentGrossAmount>
    <afya:InvestmentGrossAmount
      contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002288"
      unitRef="BRL">53907000</afya:InvestmentGrossAmount>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002290"
      unitRef="BRL">148042000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002291"
      unitRef="BRL">138584000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002292"
      unitRef="BRL">127618000</ifrs-full:Revenue>
    <ifrs-full:CostOfSales
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002294"
      unitRef="BRL">71282000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002295"
      unitRef="BRL">57421000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002296"
      unitRef="BRL">57935000</ifrs-full:CostOfSales>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002298"
      unitRef="BRL">37205000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002299"
      unitRef="BRL">34991000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002300"
      unitRef="BRL">24025000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:FinanceIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002302"
      unitRef="BRL">6123000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002303"
      unitRef="BRL">4103000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002304"
      unitRef="BRL">4585000</ifrs-full:FinanceIncome>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002306"
      unitRef="BRL">33432000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002307"
      unitRef="BRL">42069000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002308"
      unitRef="BRL">41073000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002310"
      unitRef="BRL">-1782000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002311"
      unitRef="BRL">-1456000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002312"
      unitRef="BRL">-1748000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002314"
      unitRef="BRL">31650000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002315"
      unitRef="BRL">40613000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002316"
      unitRef="BRL">39325000</ifrs-full:ProfitLoss>
    <afya:CompanyShareOfProfitss
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002318"
      unitRef="BRL">9495000</afya:CompanyShareOfProfitss>
    <afya:CompanyShareOfProfitss
      contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002319"
      unitRef="BRL">12184000</afya:CompanyShareOfProfitss>
    <afya:CompanyShareOfProfitss
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002320"
      unitRef="BRL">11797000</afya:CompanyShareOfProfitss>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002322"
      unitRef="BRL">53907000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002323"
      unitRef="BRL">48477000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002324"
      unitRef="BRL">51410000</ifrs-full:InvestmentsInAssociates>
    <afya:DividendsReceived1
      contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002326"
      unitRef="BRL">-9900000</afya:DividendsReceived1>
    <afya:DividendsReceived1
      contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002327"
      unitRef="BRL">-6754000</afya:DividendsReceived1>
    <afya:DividendsReceived1
      contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002328"
      unitRef="BRL">-11770000</afya:DividendsReceived1>
    <ifrs-full:DividendsReceived
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002330"
      unitRef="BRL">1668000</ifrs-full:DividendsReceived>
    <ifrs-full:DividendsReceived
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002332"
      unitRef="BRL">2960000</ifrs-full:DividendsReceived>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002334"
      unitRef="BRL">9495000</ifrs-full:ProfitLossOfAcquiree>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="From2022-01-012022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002335"
      unitRef="BRL">12184000</ifrs-full:ProfitLossOfAcquiree>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002336"
      unitRef="BRL">11797000</ifrs-full:ProfitLossOfAcquiree>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002338"
      unitRef="BRL">51834000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002339"
      unitRef="BRL">53907000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002340"
      unitRef="BRL">48477000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002343">&lt;p id="xdx_80D_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zY4WDSc7NPAb" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;11&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_828_z7ejdPwclIY5"&gt;Property and equipment&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_zZEWCyy555d6" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Property and equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B3_zQEl9A6uJj73" style="display: none"&gt;Schedule of detailed information about property, plant and
    equipment&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_z8abgi33upzh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zf8tcOwIqf1k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BD_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zj6SHCcJcB2f" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BF_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zSXYrBl1WoPj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zzUG5hGgRyI7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zo3Rg6lcN4we" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_zZynmJgem435" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zMfBeWOSeudc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zMWIdTkS11c4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B1_zIDp1piHuHJd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 26%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Machinery and equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Lands&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Furniture and fixtures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;IT equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Library books&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Leasehold improvements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Construction in progress&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z4MBeggb45d2" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;25,919&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;68,503&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;13,401&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;1,215&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;29,131&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;28,511&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;21,624&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;122,005&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;3,706&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;314,015&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zetNm5W9g4k1" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1,384&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;10,268&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;5,451&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;111&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;21,075&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;19,511&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;3,392&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;4,720&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;59,957&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;125,869&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zSwL6zuRCjI2" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2369"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;12,810&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2371"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;346&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;16,684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;10,138&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;5,142&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;17,425&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;3,078&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;65,623&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zlQD5dHwykTi" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;62&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(14,213)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2382"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(205)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;2,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(4,985)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(86)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(550)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(417)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(17,532)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z7IveAahZWEa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;25,068&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2393"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2394"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;82&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2397"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;9,376&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(34,538)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2400"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z2YDC1xxeiS7" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;52,433&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;77,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;1,467&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;69,834&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;53,184&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;30,072&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;152,976&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;31,786&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;487,975&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zHSDlIFCglCf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;527&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;36,486&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2415"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;968&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;26,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;15,766&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;645&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;2,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;85,026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;168,132&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zP3l848kiefg" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2424"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;45&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2426"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2427"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2428"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;35&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2430"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2431"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2432"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;80&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zbiz6XlzuRn8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;13&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(8,159)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2437"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(933)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(6,992)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2441"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2442"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(78)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(15,649)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zqvhraoiPuhd" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;38,884&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(5,353)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2448"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(449)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(5,669)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;6,600&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;6,645&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(9,797)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(30,046)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;815&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z8apsVYXq2f3" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;91,857&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;100,390&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;1,053&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;90,712&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;68,593&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;37,362&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;145,846&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;86,688&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;641,353&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zV4EVRHS5eck" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;96&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;20,071&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2470"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;776&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;17,914&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;21,135&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;985&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;49&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;57,409&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;118,435&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zm0dNpdiARqb" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2479"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;7,729&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2481"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;4,384&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;734&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1,329&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;10,741&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;63&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;24,980&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zzRl6ps9NjDi" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2490"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(9,411)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2492"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(475)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(1,443)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(7,979)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(7,788)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(286)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2498"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(27,382)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z35FEaZs37ga" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1,279&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1,202&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2503"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2504"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(708)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;327&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2507"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;108,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(110,198)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2510"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zfmaaXRvZw0j" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;93,232&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;119,981&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;1,354&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;110,859&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;82,810&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;31,888&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;264,448&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;33,962&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;757,386&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zpno1fGEG8C5" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2523"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(19,322)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2525"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(171)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(8,089)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(10,851)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(10,817)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(4,384)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2531"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(53,634)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iNP2custom--WritOffOfPropertyPlantAndEquipment_pn3n3_di_zxG07a0Rjdzl" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(1,673)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(7,215)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2536"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(196)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(5,601)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(7,529)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(3,416)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(4,831)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2542"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(30,461)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zKgSeDrT9dXc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&#160;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2545"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;10,146&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2547"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;147&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1,194&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;3,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;633&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;350&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2553"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;15,928&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zYE8bGKtX2m1" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(1,673)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(16,391)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2558"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(220)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(12,496)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(14,922)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(13,600)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(8,865)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2564"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(68,167)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zCgvb9aKLUn" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(3,472)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(11,166)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2569"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(284)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(7,725)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(10,140)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(3,415)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(8,849)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2575"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(45,051)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zanpP2KrUvwe" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2578"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;5,474&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2580"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;791&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;153&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;7,350&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;117&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2586"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;13,952&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zII350CFvQ64" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(606)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1,453&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2591"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;9,719&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(4,125)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(5,940)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(502)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2597"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2598"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zvwRCn5kCssk" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(5,751)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(20,630)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2602"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;288&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(10,349)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(21,837)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(22,888)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(18,099)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2608"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(99,266)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_ztOLxx2Lfebb" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(4,242)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(14,900)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2613"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(325)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(12,556)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(13,286)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(3,327)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(26,271)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2619"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(74,907)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zM1HTf8u42sb" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;118&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;6,684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2624"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;235&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;2,528&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;8,254&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;7,563&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2630"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;25,472&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zJlU59QXGju4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;196&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2635"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2636"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2637"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2639"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(196)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2641"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2642"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zoFejK1dwQzc" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(9,679)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(28,843)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2646"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;198&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(20,377)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(26,872)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(18,652)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(44,476)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2652"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(148,701)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Net book value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;83,553&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;91,138&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;1,552&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;90,482&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;55,938&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;13,236&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;219,972&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;33,962&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;608,685&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;86,106&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;79,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;1,341&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;80,363&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;46,756&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;14,474&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;127,747&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;86,688&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;542,087&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to items written-off as result of lack of expectation of future use, in connection
with the Company&#x2019;s physical inventory procedures.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AD_zVDj9SFMVf41" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-size: 11pt"&gt;The Company assesses at each reporting date,
whether there is an indication that a property and equipment asset may be impaired. If any indication exists, the Company estimates the
asset&#x2019;s recoverable amount. There were no indications of impairment of property and equipment as of and for the &lt;/span&gt;years &lt;span style="font-size: 11pt"&gt;ended
December 31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;






</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002345">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_zZEWCyy555d6" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Property and equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B3_zQEl9A6uJj73" style="display: none"&gt;Schedule of detailed information about property, plant and
    equipment&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_z8abgi33upzh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zf8tcOwIqf1k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BD_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zj6SHCcJcB2f" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BF_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zSXYrBl1WoPj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zzUG5hGgRyI7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zo3Rg6lcN4we" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_zZynmJgem435" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zMfBeWOSeudc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zMWIdTkS11c4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B1_zIDp1piHuHJd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 26%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Machinery and equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Lands&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Furniture and fixtures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;IT equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Library books&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Leasehold improvements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Construction in progress&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z4MBeggb45d2" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;25,919&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;68,503&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;13,401&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;1,215&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;29,131&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;28,511&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;21,624&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;122,005&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;3,706&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;314,015&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zetNm5W9g4k1" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1,384&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;10,268&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;5,451&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;111&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;21,075&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;19,511&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;3,392&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;4,720&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;59,957&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;125,869&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zSwL6zuRCjI2" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2369"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;12,810&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2371"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;346&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;16,684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;10,138&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;5,142&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;17,425&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;3,078&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;65,623&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zlQD5dHwykTi" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;62&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(14,213)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2382"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(205)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;2,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(4,985)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(86)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(550)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(417)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(17,532)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z7IveAahZWEa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;25,068&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2393"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2394"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;82&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2397"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;9,376&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(34,538)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2400"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z2YDC1xxeiS7" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;52,433&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;77,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;1,467&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;69,834&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;53,184&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;30,072&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;152,976&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;31,786&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;487,975&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zHSDlIFCglCf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;527&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;36,486&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2415"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;968&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;26,047&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;15,766&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;645&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;2,667&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;85,026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;168,132&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zP3l848kiefg" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2424"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;45&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2426"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2427"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2428"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;35&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2430"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2431"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2432"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;80&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zbiz6XlzuRn8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;13&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(8,159)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2437"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(933)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(6,992)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2441"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2442"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(78)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(15,649)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zqvhraoiPuhd" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;38,884&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(5,353)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2448"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(449)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(5,669)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;6,600&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;6,645&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(9,797)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(30,046)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;815&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_z8apsVYXq2f3" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;91,857&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;100,390&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;1,053&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;90,712&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;68,593&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;37,362&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;145,846&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;86,688&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;641,353&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zV4EVRHS5eck" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;96&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;20,071&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2470"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;776&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;17,914&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;21,135&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;985&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;49&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;57,409&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;118,435&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zm0dNpdiARqb" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2479"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;7,729&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2481"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;4,384&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;734&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1,329&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;10,741&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;63&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;24,980&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zzRl6ps9NjDi" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2490"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(9,411)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2492"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(475)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(1,443)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(7,979)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(7,788)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(286)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2498"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(27,382)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z35FEaZs37ga" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1,279&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1,202&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2503"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2504"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(708)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;327&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2507"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;108,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(110,198)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2510"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zfmaaXRvZw0j" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;93,232&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;119,981&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;1,354&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;110,859&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;82,810&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;31,888&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;264,448&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;33,962&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;757,386&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zpno1fGEG8C5" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2523"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(19,322)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2525"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(171)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(8,089)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(10,851)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(10,817)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(4,384)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2531"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(53,634)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iNP2custom--WritOffOfPropertyPlantAndEquipment_pn3n3_di_zxG07a0Rjdzl" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(1,673)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(7,215)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2536"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(196)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(5,601)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(7,529)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(3,416)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(4,831)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2542"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(30,461)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zKgSeDrT9dXc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&#160;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2545"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;10,146&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2547"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;147&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1,194&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;3,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;633&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;350&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2553"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;15,928&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zYE8bGKtX2m1" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(1,673)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(16,391)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2558"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(220)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(12,496)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(14,922)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(13,600)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(8,865)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2564"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(68,167)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zCgvb9aKLUn" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(3,472)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(11,166)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2569"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(284)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(7,725)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(10,140)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(3,415)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(8,849)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2575"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(45,051)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zanpP2KrUvwe" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2578"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;5,474&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2580"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;791&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;153&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;7,350&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;117&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2586"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;13,952&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zII350CFvQ64" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(606)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1,453&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2591"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;9,719&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(4,125)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(5,940)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(502)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2597"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2598"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zvwRCn5kCssk" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(5,751)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(20,630)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2602"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;288&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(10,349)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(21,837)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(22,888)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(18,099)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2608"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(99,266)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_ztOLxx2Lfebb" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(4,242)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(14,900)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2613"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(325)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(12,556)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(13,286)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(3,327)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(26,271)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2619"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(74,907)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zM1HTf8u42sb" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;118&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;6,684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2624"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;235&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;2,528&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;8,254&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;7,563&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2630"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;25,472&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zJlU59QXGju4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;196&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2635"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2636"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2637"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2639"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;(196)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2641"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2642"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zoFejK1dwQzc" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(9,679)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(28,843)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2646"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;198&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(20,377)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(26,872)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(18,652)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(44,476)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2652"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;(148,701)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;Net book value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;83,553&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;91,138&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;1,552&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;90,482&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;55,938&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;13,236&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;219,972&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;33,962&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20231231_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;608,685&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;86,106&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;79,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;1,341&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;80,363&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;46,756&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;14,474&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;127,747&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;86,688&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_c20221231_pn3n3" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7.5pt"&gt;&lt;b&gt;542,087&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to items written-off as result of lack of expectation of future use, in connection
with the Company&#x2019;s physical inventory procedures.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002347"
      unitRef="BRL">25919000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002348"
      unitRef="BRL">68503000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      id="Fact002349"
      unitRef="BRL">13401000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002350"
      unitRef="BRL">1215000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002351"
      unitRef="BRL">29131000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002352"
      unitRef="BRL">28511000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002353"
      unitRef="BRL">21624000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002354"
      unitRef="BRL">122005000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002355"
      unitRef="BRL">3706000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002356"
      unitRef="BRL">314015000</afya:PropertyPlantAndEquipments>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002358"
      unitRef="BRL">1384000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002359"
      unitRef="BRL">10268000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      id="Fact002360"
      unitRef="BRL">5451000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002361"
      unitRef="BRL">111000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002362"
      unitRef="BRL">21075000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002363"
      unitRef="BRL">19511000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002364"
      unitRef="BRL">3392000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002365"
      unitRef="BRL">4720000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002366"
      unitRef="BRL">59957000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002367"
      unitRef="BRL">125869000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002370"
      unitRef="BRL">12810000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002372"
      unitRef="BRL">346000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002373"
      unitRef="BRL">16684000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002374"
      unitRef="BRL">10138000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002375"
      unitRef="BRL">5142000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002376"
      unitRef="BRL">17425000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002377"
      unitRef="BRL">3078000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002378"
      unitRef="BRL">65623000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002380"
      unitRef="BRL">62000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002381"
      unitRef="BRL">-14213000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002383"
      unitRef="BRL">-205000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002384"
      unitRef="BRL">2862000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002385"
      unitRef="BRL">-4985000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002386"
      unitRef="BRL">-86000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002387"
      unitRef="BRL">-550000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002388"
      unitRef="BRL">-417000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002389"
      unitRef="BRL">-17532000</afya:WritOffOfPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002391"
      unitRef="BRL">25068000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002392"
      unitRef="BRL">3000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002395"
      unitRef="BRL">82000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002396"
      unitRef="BRL">9000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002398"
      unitRef="BRL">9376000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002399"
      unitRef="BRL">-34538000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002402"
      unitRef="BRL">52433000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002403"
      unitRef="BRL">77371000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      id="Fact002404"
      unitRef="BRL">18852000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002405"
      unitRef="BRL">1467000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002406"
      unitRef="BRL">69834000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002407"
      unitRef="BRL">53184000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002408"
      unitRef="BRL">30072000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002409"
      unitRef="BRL">152976000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002410"
      unitRef="BRL">31786000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002411"
      unitRef="BRL">487975000</afya:PropertyPlantAndEquipments>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002413"
      unitRef="BRL">527000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002414"
      unitRef="BRL">36486000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002416"
      unitRef="BRL">968000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002417"
      unitRef="BRL">26047000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002418"
      unitRef="BRL">15766000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002419"
      unitRef="BRL">645000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002420"
      unitRef="BRL">2667000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002421"
      unitRef="BRL">85026000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002422"
      unitRef="BRL">168132000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002425"
      unitRef="BRL">45000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002429"
      unitRef="BRL">35000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002433"
      unitRef="BRL">80000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002435"
      unitRef="BRL">13000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002436"
      unitRef="BRL">-8159000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002438"
      unitRef="BRL">-933000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002439"
      unitRef="BRL">500000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002440"
      unitRef="BRL">-6992000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002443"
      unitRef="BRL">-78000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002444"
      unitRef="BRL">-15649000</afya:WritOffOfPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002446"
      unitRef="BRL">38884000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002447"
      unitRef="BRL">-5353000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002449"
      unitRef="BRL">-449000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002450"
      unitRef="BRL">-5669000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002451"
      unitRef="BRL">6600000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002452"
      unitRef="BRL">6645000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002453"
      unitRef="BRL">-9797000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002454"
      unitRef="BRL">-30046000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002455"
      unitRef="BRL">815000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002457"
      unitRef="BRL">91857000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002458"
      unitRef="BRL">100390000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      id="Fact002459"
      unitRef="BRL">18852000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002460"
      unitRef="BRL">1053000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002461"
      unitRef="BRL">90712000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002462"
      unitRef="BRL">68593000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002463"
      unitRef="BRL">37362000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002464"
      unitRef="BRL">145846000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002465"
      unitRef="BRL">86688000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002466"
      unitRef="BRL">641353000</afya:PropertyPlantAndEquipments>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002468"
      unitRef="BRL">96000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002469"
      unitRef="BRL">20071000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002471"
      unitRef="BRL">776000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002472"
      unitRef="BRL">17914000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002473"
      unitRef="BRL">21135000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002474"
      unitRef="BRL">985000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002475"
      unitRef="BRL">49000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002476"
      unitRef="BRL">57409000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002477"
      unitRef="BRL">118435000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002480"
      unitRef="BRL">7729000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002483"
      unitRef="BRL">4384000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002484"
      unitRef="BRL">734000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002485"
      unitRef="BRL">1329000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002486"
      unitRef="BRL">10741000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002487"
      unitRef="BRL">63000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002488"
      unitRef="BRL">24980000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002491"
      unitRef="BRL">-9411000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002493"
      unitRef="BRL">-475000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002494"
      unitRef="BRL">-1443000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002495"
      unitRef="BRL">-7979000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002496"
      unitRef="BRL">-7788000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002497"
      unitRef="BRL">-286000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002499"
      unitRef="BRL">-27382000</afya:WritOffOfPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002501"
      unitRef="BRL">1279000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002502"
      unitRef="BRL">1202000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002505"
      unitRef="BRL">-708000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002506"
      unitRef="BRL">327000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002508"
      unitRef="BRL">108098000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002509"
      unitRef="BRL">-110198000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002512"
      unitRef="BRL">93232000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002513"
      unitRef="BRL">119981000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      id="Fact002514"
      unitRef="BRL">18852000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002515"
      unitRef="BRL">1354000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002516"
      unitRef="BRL">110859000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002517"
      unitRef="BRL">82810000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002518"
      unitRef="BRL">31888000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002519"
      unitRef="BRL">264448000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002520"
      unitRef="BRL">33962000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002521"
      unitRef="BRL">757386000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002524"
      unitRef="BRL">-19322000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002526"
      unitRef="BRL">-171000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002527"
      unitRef="BRL">-8089000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002528"
      unitRef="BRL">-10851000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002529"
      unitRef="BRL">-10817000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002530"
      unitRef="BRL">-4384000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002532"
      unitRef="BRL">-53634000</afya:PropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002534"
      unitRef="BRL">1673000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002535"
      unitRef="BRL">7215000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002537"
      unitRef="BRL">196000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002538"
      unitRef="BRL">5601000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002539"
      unitRef="BRL">7529000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002540"
      unitRef="BRL">3416000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002541"
      unitRef="BRL">4831000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002543"
      unitRef="BRL">30461000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002546"
      unitRef="BRL">10146000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002548"
      unitRef="BRL">147000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002549"
      unitRef="BRL">1194000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002550"
      unitRef="BRL">3458000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002551"
      unitRef="BRL">633000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002552"
      unitRef="BRL">350000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002554"
      unitRef="BRL">15928000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002556"
      unitRef="BRL">-1673000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002557"
      unitRef="BRL">-16391000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002559"
      unitRef="BRL">-220000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002560"
      unitRef="BRL">-12496000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002561"
      unitRef="BRL">-14922000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002562"
      unitRef="BRL">-13600000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002563"
      unitRef="BRL">-8865000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002565"
      unitRef="BRL">-68167000</afya:PropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002567"
      unitRef="BRL">3472000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002568"
      unitRef="BRL">11166000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002570"
      unitRef="BRL">284000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002571"
      unitRef="BRL">7725000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002572"
      unitRef="BRL">10140000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002573"
      unitRef="BRL">3415000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002574"
      unitRef="BRL">8849000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002576"
      unitRef="BRL">45051000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002579"
      unitRef="BRL">5474000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002581"
      unitRef="BRL">791000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002582"
      unitRef="BRL">153000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002583"
      unitRef="BRL">7350000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002584"
      unitRef="BRL">67000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002585"
      unitRef="BRL">117000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002587"
      unitRef="BRL">13952000</afya:WritOffOfPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002589"
      unitRef="BRL">-606000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002590"
      unitRef="BRL">1453000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002592"
      unitRef="BRL">1000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002593"
      unitRef="BRL">9719000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002594"
      unitRef="BRL">-4125000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002595"
      unitRef="BRL">-5940000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002596"
      unitRef="BRL">-502000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002600"
      unitRef="BRL">-5751000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002601"
      unitRef="BRL">-20630000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002603"
      unitRef="BRL">288000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002604"
      unitRef="BRL">-10349000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002605"
      unitRef="BRL">-21837000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002606"
      unitRef="BRL">-22888000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002607"
      unitRef="BRL">-18099000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002609"
      unitRef="BRL">-99266000</afya:PropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002611"
      unitRef="BRL">4242000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002612"
      unitRef="BRL">14900000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002614"
      unitRef="BRL">325000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002615"
      unitRef="BRL">12556000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002616"
      unitRef="BRL">13286000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002617"
      unitRef="BRL">3327000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002618"
      unitRef="BRL">26271000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002620"
      unitRef="BRL">74907000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002622"
      unitRef="BRL">118000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002623"
      unitRef="BRL">6684000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002625"
      unitRef="BRL">235000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002626"
      unitRef="BRL">2528000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002627"
      unitRef="BRL">8254000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002628"
      unitRef="BRL">7563000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002629"
      unitRef="BRL">90000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002631"
      unitRef="BRL">25472000</afya:WritOffOfPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002633"
      unitRef="BRL">196000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002634"
      unitRef="BRL">3000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002638"
      unitRef="BRL">-3000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002640"
      unitRef="BRL">-196000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002644"
      unitRef="BRL">-9679000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002645"
      unitRef="BRL">-28843000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002647"
      unitRef="BRL">198000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002648"
      unitRef="BRL">-20377000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002649"
      unitRef="BRL">-26872000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002650"
      unitRef="BRL">-18652000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002651"
      unitRef="BRL">-44476000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002653"
      unitRef="BRL">-148701000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2023-12-31_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002655"
      unitRef="BRL">83553000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2023-12-31_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002657"
      unitRef="BRL">91138000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2023-12-31_ifrs-full_LandMember"
      decimals="-3"
      id="Fact002659"
      unitRef="BRL">18852000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2023-12-31_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002661"
      unitRef="BRL">1552000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2023-12-31_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002663"
      unitRef="BRL">90482000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2023-12-31_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002665"
      unitRef="BRL">55938000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2023-12-31_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002667"
      unitRef="BRL">13236000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2023-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002669"
      unitRef="BRL">219972000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2023-12-31_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002671"
      unitRef="BRL">33962000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002673"
      unitRef="BRL">608685000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2022-12-31_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002675"
      unitRef="BRL">86106000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2022-12-31_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002677"
      unitRef="BRL">79760000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2022-12-31_ifrs-full_LandMember"
      decimals="-3"
      id="Fact002679"
      unitRef="BRL">18852000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2022-12-31_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002681"
      unitRef="BRL">1341000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2022-12-31_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002683"
      unitRef="BRL">80363000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2022-12-31_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002685"
      unitRef="BRL">46756000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2022-12-31_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002687"
      unitRef="BRL">14474000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2022-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002689"
      unitRef="BRL">127747000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2022-12-31_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002691"
      unitRef="BRL">86688000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002693"
      unitRef="BRL">542087000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:DisclosureOfIntangibleAssetExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002696">&lt;p id="xdx_808_ecustom--DisclosureOfIntangibleAssetExplanatory_zpxk3ip5an1f" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;12&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_82D_zQhFoc3ybzM4"&gt;Intangible assets and goodwill&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_z9SFZ004WEei" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets and goodwill (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span id="xdx_8BB_zLquPfqPr8Bb" style="display: none"&gt;&#160;Schedule of intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Goodwill &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Licenses with indefinite useful life &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Education content&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Developed technology&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Educational platform&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Software in progress&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 4%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrVs4nJUBvA9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;810,656&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zOsUP4LXxWQd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,451,270&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfZqZIoN3gme" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;75,014&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQYrwcgh78ma" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;283,539&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkLKk2HrHMi3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;16,221&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zke8tn0YX0Rb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;17,305&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zT3slotvRSR7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;355&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zViySlwYFhm8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;27,902&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxPWglJrrwsg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,297&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeN9grCjSwI7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2718"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6CMpPtVlLZ4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,684,559&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Additions (vi)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvF23pO4yaQg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyULZJr7rUy4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;684&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMuHgpTac5ed" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,044&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zN4HWHJwhbai" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;996&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zE7NuDfp5Gnc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;39,686&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zK9nOPUKaPG8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;23,700&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3VGszF3dGSh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;176,110&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Write-off *&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zG89zNqyy2R7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbCREwHIf1s" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(2,743)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvIOCCM6fxme" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(417)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsEaR8AObK8j" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(2,140)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zGCFGqPXmtZ8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;373,680&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRZauQn34Qef" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;606,136&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhW6NlxD9l6l" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;58,355&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziCEbjJ2VSi6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;147,054&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCWFJKgYx14g" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,474&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5M5uUxiZUW9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;33,046&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z61g1bMg0Ftf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;11,599&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgBP8vMOjDcl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,267&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAc5XlVajV9c" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,234,611&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuKUQ0QxcNR6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,184,336&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkyMX8gPOepg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,165,406&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztvE8u7ibCCf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;133,369&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7wa0fhFQBfg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;431,277&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zh6bZ8xBT71e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;21,759&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZRiz76GAXY" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;17,305&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zF6u2yMw22Oa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;34,397&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvTgObYwq03e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;76,444&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zA0Wf5zyLd66" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;28,847&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRjp7MXSscPk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2780"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKIR6xabatC6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,093,140&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Additions (i) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zFy6RuIPCYK6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;39,100&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUvoPygPAq3d" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;24,408&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoLJxtcViQL8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;80&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxKt1ZXxt9Y2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,423&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zpBPCLzDBTZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;11,231&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR7ixPmQ1mU2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;32,879&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6E7Vd03Mz5e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;14,761&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwNbbNuomi8k" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;26,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7FnFfMH9im4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;150,023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Write-off *&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zs7brwltqOag" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(22)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zr2u6gQHBWQ" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(381)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zC2lw0uZlgF4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(7)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zXrK5HfiWKSd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(9)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z3V02sLT2tk3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(28)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zAHqoxFsK382" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Remeasurement (iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Remesurement_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zt4LxZk4o1b5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(8,637)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--Remesurement_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zSjSRpRi6Ry7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(8,637)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zm7EzOl2JYqf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(2,472)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9KFNs0Bmz96" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;530&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLvMGXy2m4la" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;20,466&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zE2VFXVKUvl4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;38,433&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMhiJG9r6d2k" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;17,953&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxpjg8n9eJWg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(35,499)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgLVjYOX7nSb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(40,226)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zacZqLhiLYSh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(815)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsw3RHiwQQ0e" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;42,246&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhNOvEBUHzQ9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;51,185&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2UV5YPjjBHl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,929&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLxhpCOVnyO4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;33&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zj7IBwHMhQZ" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;2,627&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvI0Eg58qRd7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,520&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgA0OV25wTO3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,055&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfhtXkzWgI6i" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;106,595&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZGbWiJzMptc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,257,045&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zid4tDg6Duzk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,189,814&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmgtpoFnBs7i" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;182,060&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLz7s3H970df" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;435,816&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfGdNwDCzqY1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;43,300&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqzm1nUYnHBk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;69,589&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvs2JUEzY892" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;90,749&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztWrXATFPEUe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;55,697&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2wUNIGwCnn8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;14,734&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRMz5IwE6sO1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,055&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVF2wAQplVF7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,339,859&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zGiZtIR7jDNd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,314&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zn5r3EFssVV3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;9,827&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zAvY8yKtbY7a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;37,712&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zrGW628YStRh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;23,164&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____z2Wf7ULHomg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;27,976&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____za619doDJEQc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;99,993&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Write-off *&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsqfToq76mWl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(2,235)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHIvsvqICiF4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(911)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAqOqcUZ1fV7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(125)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4CyNOZlxFif" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(3,271)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Remeasurement (iv)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkkyKSrbQW4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;2,556&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zT3GK1cRZFjd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;2,556&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkFVkkEILxHk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;28,708&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQG1r1Cc4mCc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,785&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7wH2IadM7u6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;16&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6c1L7rUz7uc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(3,058)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziSvCId07ll4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(30,451)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Business combination (v)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHKkn2F9f5R2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;75,098&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsTwMyWH84za" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;586,263&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmHQbEFXgH02" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;142,451&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlcFMWXcg90h" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;63&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKUlaNc2BSt9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;803,875&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfTVpOiyKlCj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,334,699&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyBhyK3VHgF9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,776,077&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXvGNXVeCyx5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;182,060&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCTz7fEVcqWf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;578,267&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMlTARrHb4A3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;71,150&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRMES8oDqJ57" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;84,201&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z43C2DF0VF5i" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;128,477&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zdFlphCY2aH4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;74,892&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3pRmdFD5jec" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;12,134&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLsa5CtlazLg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,055&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3HBoyN7Umbe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;5,243,012&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJdlYZWxNtn8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2938"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z5kPPI9XB7u3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2940"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxvAAkhuktK5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(3,502)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8Q9IsXNzc9h" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(85,832)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmbW62Qc5m14" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(6,256)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z7bke0i420q7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(7,692)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zg0tZNg5jOMl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(32)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8WB1A0dvnh" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(8,235)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkE5CAAvBZFg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2954"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z9bRG8BBvKZc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(111,549)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iP2custom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvngUNyQYOW8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2958"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z6PTZmw3J3Ca" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2959"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4EPdygNyKVc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(5,027)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjeS2aFfrBW7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(56,438)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zudlFPP8ECCj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(5,844)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zPn81oAhimq4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(8,980)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1oi55s6Gaa9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(625)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUkudD4TwWhg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(3,608)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvxlt8PwE4g2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2968"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRgYc87MKQ78" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(80,522)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Write-off *&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zB9o870cnC7e" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(599)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRmp754MQROa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;365&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zrdK0dZxDzq9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUVFqH5h9816" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2977"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zOprGAmmEoQa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2979"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzpzAPhoTcr" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(8,529)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQJtlGdy8rrk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(142,270)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3f7gnY7krYd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(12,699)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkfYhmtObfk9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(16,672)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zU9b3749VCr9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(657)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKdgQGoYTPkh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(11,478)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlEmY6swP4sb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2993"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zk6Bl2dBFlHi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2995"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAOztK89xXnc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(192,305)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRIqLr58LeHc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2999"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zZ7uEvAsvJn4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3000"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zaOFsDGvO1Kj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(6,426)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z5SHk6zZZtp1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(70,093)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIBzUyzLtzXe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(4,943)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1KLnEPPvsL5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(9,634)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzUZSVylsrPi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(9,436)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zspCp7XfNRz9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(5,874)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFcICCaZcy54" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3008"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDgSWPcpEpNk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(79)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zpqGiDSi1IJ4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(106,485)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Write-off *&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhw7RbRISOna" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;365&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKE3GEPFeF56" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;57&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFCuvVlZuYL9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;422&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFvp4ObR37Kd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(313)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zw5xUo9Mgk51" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;313&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1Q7lutEHQO8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3022"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zu5EFWbDZEMe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3024"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlBnkyvk0ev7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(14,955)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zR9jM67yGAG3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(212,363)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgDyDdWjDuWa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(17,277)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZdbPDLMuWx2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(26,562)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbN3g81tOMI6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(10,093)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhxf7VctRsmj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(17,039)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zukZwSmCdKsd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3038"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zV5tIWM2QCOa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(79)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSRIPuk60oai" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(298,368)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIIclee4CFP3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3044"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zLujbAMj9hQ8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3045"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQpffWkfUrO" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(11,083)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z95ZNUJtiHD6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(89,584)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1dLqJhChIH5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(8,764)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmhdnex591ga" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(15,668)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zPPtr2Ph0rf6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(21,504)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvWZ4NvXxo4h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(4,778)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuMvzAD5mG47" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3053"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTjLK0f2CxId" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(105)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNiowokeDkqg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(151,486)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Write-off *&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8kFhGgLh35b" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFrYtYTNmaE9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;911&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTzdX7Tjbo3f" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;2,858&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zcQtpkZ8TRzi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(6)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zl3R7RlPDiy3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zakSIViJpJRd" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3067"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zxFpcVDfyLo8" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3069"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zf2zfeQdub9b" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(26,038)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0nNI8J2TV18" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(301,947)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z7snqh43ffZh" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(24,094)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHJJPLfjeOa7" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(42,230)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqfARSPMviJc" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(31,603)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8WDvcsqHa9h" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(20,900)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zsAddT3S3ePl" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3083"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztQmxjLn3pcj" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(184)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUWCWpRFgOx9" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(446,996)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Net book value:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zZGSmpyy3nLe" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,334,699&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zzybL6jFJ5sl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,776,077&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zEzdVnnyc3Sg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;156,022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zdJp51vna8dk" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;276,320&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z7haIx8TeALb" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;47,056&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zM3WVlTyWfa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;41,971&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zlhXNCCNXK0i" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;96,874&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zhwgLjcKB0Ie" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;53,992&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zweSqKpBdCcg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;12,134&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zxd75R6u9n5k" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;871&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231_zjABLBpRPTtl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,796,016&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zhOroOPXFxC8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,257,045&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zonPhVoD51rh" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,189,814&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zYCJD4dpY14h" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;167,105&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zZMrU3EO4Npb" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;223,453&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zqlvgHB4BsE6" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;26,023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zRNXNQ7OmQYb" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;43,027&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zu3tByWXgf42" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;80,656&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zdtvT4oTgRKa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;38,658&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zMGUPMHfcb2k" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;14,734&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zg4WqQp94Ppg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;976&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231_zPLbXUJyuXWf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,041,491&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;*&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to intangible assets written-off as result of lack of expectation of future use.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Licenses with indefinite useful life: On March 18, 2022, MEC authorized the increase of 28
seats of Centro de Ensino S&#xe3;o Lucas, located in the city of Ji-Parana, State of Rond&#xf4;nia. The earn-out related to the seats
approval is R$800 per seat, adjusted by the CDI rate from the closing until the payment date, of which 50% was paid in April 2022 and
the remaining amount is payable in cash in two equal installments through 2024.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Goodwill: During the measurement period, the preliminary goodwill for the acquisition of
Unigranrio was adjusted by R$39,100 (R$130,073 initial goodwill) as a result of an increase of liabilities regarding tax contingencies
and judicial deposits to be reimbursed by the selling shareholders.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Goodwill: During the measurement period, R$8,637 of goodwill arising from the acquisition
of RX PRO was reduced, in connection with management&#x2019;s view of remote likelihood of RX PRO achieving the revenue goals estimated
at the terms of the earn-out.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iv)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Goodwill: During the measurement period, results of operation such as revenue differed from
the foreseen, resulting in a remeasurement of the contingent consideration for the acquisitions of Al&#xe9;m da Medicina, CardioPapers
and Glic by R$4,773, R$5,082 and (R$7,299), respectively, totaling R$2,556 for the year ended December 31, 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(v)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Business combination: On January 2, 2023, Afya Brazil acquired DelRey, a post-secondary education
institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs in medicine and health, as
well as other courses. See Note 5.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(vi)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On November 5, 2021, MEC authorized the operation of 120 medical school seats in Garanhuns,
for which our shareholder Nicolau Carvalho Esteves entered into an agreement with Afya Brazil pursuant to which he assigned to Afya Brazil
the right to develop the ITPAC Garanhuns greenfield unit, a medical school in the city of Garanhuns, State of Pernambuco. Management
assessed the aspects of such transaction and concluded that the transaction does not fall under the definition of business, but an acquisition
of license with indefinite useful life recognized in intangible assets. Total purchase price was R$108,000 of which 50% was paid in cash
on the transaction closing date and 50% in two equal annual installments, adjusted by the CDI rate.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AC_z9mMr2cF8Upi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Licenses with indefinite useful life include intangible assets acquired
through business combinations. The licenses for medicine and other courses granted by MEC to the companies acquired have no expiration
date and the Company has determined that these assets have indefinite useful lives.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;For impairment testing goodwill and licenses with indefinite useful lives
acquired through business combinations are allocated to the respective CGUs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company performed its annual impairment test on December 31, 2023, 2022
and 2021. There was no impairment for goodwill and licenses with indefinite useful lives for the years ended December 31, 2023, 2022 and
2021.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company tests at least annually the recoverability of the carrying amount
of goodwill and licenses with indefinite useful lives for each CGU. The Company determines the recoverable amount of its CGUs based on
the value-in-use. Estimating these values involves the use of assumptions, judgments and estimates of future cash flows that represent
the Company's best estimate.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The carrying amounts of goodwill and licenses with indefinite useful life
by CGU and their carrying amount as of December 31, 2023 and 2022 were as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_zzqMOzqQmxu5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets and goodwill (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B9_ziu210ar3Zf5" style="display: none"&gt;Schedule of assumptions for impairment test&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;CGU&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Goodwill&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Licenses with indefinite useful life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;CGU&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 42%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IPTAN&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zMEWTMkMpEH4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;17,446&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zIkXUBa16O7k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;17,446&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z6Fls3KSSqnb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,214&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zvfNAJ2RJIMb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,214&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_znwjueBf1G89" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;125,974&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zMDNzNIOnjHl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;126,024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IESVAP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z7ebTmxWG6p4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,956&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zQvCNbegZtXc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,956&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zPHJHpr2rKTb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;81,366&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zbxbycrv7g5a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;81,366&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z5S3vE0ekyYh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;126,996&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zgwRU3M123M6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;129,305&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;CCSI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zKcobUcnJMq9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,664&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zJLjxQJG5AKb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,664&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zuLKXhrw9nU4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;56,737&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zG64JkeD6Elc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;56,737&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zilNfsjrdUSc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,550&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zYALhgNLVtI2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;53,540&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IESP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zCXXn4mdrD33" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;73,838&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zjUFSH9gJEhb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;73,838&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zoqOobLHD47c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;179,693&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z1jem8KIGXv7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;179,693&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zjxNITJg7NW9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;332,104&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zef18tATxUUa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;322,968&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;FADEP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zHtXp28SMVod" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;49,661&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zw6olpzqlRBg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;49,661&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z5uunxL2nnZc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,606&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zunecelcRBY8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,606&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z6YdRN9vxIl4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;148,032&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zewHKSZ1p6Bh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;153,100&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;FASA&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zfgPda5LeHDj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,903&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zjY43R9RRDu1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,903&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zhesAjMK4rp2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;144,507&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zhZ9picPDTC3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;144,507&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zjxz2LQitxP5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;322,061&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zCayavTFR9J7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;314,967&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IPEMED&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zu2mPxcHrT0c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;87,647&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zcshSisPUGgj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;87,647&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pdn3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z25VZU1CGw25" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3211"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pdn3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zmqwQXQ9rgZ" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3213"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zOlGb0N0iB6a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;183,862&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zidgkAWSlAnj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;192,079&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IPEC&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zm2QANN48k4a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3219"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z1QBDqes9YSd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3221"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zqF6wqcDIPh2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zFdSO4LRWNJe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zgDqQM9L7Sy7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;157,984&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zAKstAcVKdlc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;148,067&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UniRedentor&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z87ar33N0chl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;77,662&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zvJu3I9tjZC9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;77,662&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zfrMkXMcAvT8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;121,477&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zGOd5FyX8iqj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;121,477&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zjCpXIc7VDhh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;234,054&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zsMODGEGb8Ei" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;242,600&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UniSL&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z4cbjCoukwRb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,420&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z7fmhq1wbJb2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,420&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____zGllazCKwied" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;273,795&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____zfYzpiAOaFo" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;273,795&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z35OmdMnPQQ6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;401,143&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z5JFUJwEUbt6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;398,492&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;FESAR&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_ziAUqEIV6Xeg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71,664&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z5FfmjHVNTJi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71,664&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zxzIvEcbBHw6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;141,616&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zqGIL1Pb9mFf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;141,616&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zZEQer5sJGkl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;244,412&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zRvY34SNW7gg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;244,084&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;FCMPB&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zmPG9b50T1m1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;110,483&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zIx1Xlu3zKY1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;110,483&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z8AxymdEeI6i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;235,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z4vMseSAXgUj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;235,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z2g3pY63APJ" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;402,140&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z7G87aGR4nG4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;415,453&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;ITPAC Garanhuns&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zuzXHHupWVZ8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3279"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zMDyE9rgVERa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3281"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zWVTlzHZlvM9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zisSFrJbq6y6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zlQmANWZhK4d" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;116,162&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z9YGEQwdzpAg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;112,628&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Content &amp;amp; Technology for medical education (Pillar 1) *&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zA9Sh42jmvwj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;179,830&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zNUCwkxzTvod" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;169,975&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zg6GdQT9FNji" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3295"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zP9b2nin9i7a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3297"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z0LxoxdVQMeh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;238,921&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zAR0hZyZQx94" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;279,684&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Practice Management Tools &amp;amp; Electronic Prescription (Pillar 3)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zwD8e2Eeiah" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;106,774&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zP3HhvHaUjbe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;106,774&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zxwqa8mctp32" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3307"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zk2PgnYtM1F5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3309"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zXVQvmlYTnJj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;221,171&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zhgPYaB7lNjg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;216,297&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Clinical Decision Software (Pillar 2)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zmXoVN7WMiqj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;87,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zY6LpWaXdXS2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;87,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zcbeoEv95rN4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3319"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zP2DQyhrM7N6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3321"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zbeRK6tHqDub" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;147,897&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z0yd02PIVl3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;153,526&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cliquefarma&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z00tGT2dLwBa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;6,588&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8FSSDGoHb77" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;6,588&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zeLIPp5lD43h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3331"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zVigd7Gvnm44" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3333"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zzThE07eOMJ6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;18,789&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z9eg68e21K3f" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UnifipMoc&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z9nQd8jYobjk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;87,777&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zOvXG46sKnDd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;87,777&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zOH7Ro3LmCib" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;190,247&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zWwTbNSDZeh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;190,247&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z7FFrIMLKMT7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;361,383&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zXKUarNtCjY" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;369,007&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Unigranrio&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zd07evq26Hfi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;169,173&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zWodhmw7xVpk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;169,173&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zK7zhR1rGyue" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;421,538&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zRfKUwMsXaH2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;421,538&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z2BmuzPN04A6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;833,665&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z1Cu9Vl17eKk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;854,861&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;RX PRO&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zKbhW2JhCXMj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;29,809&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHhuDacaoLC8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;29,809&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zMSRaaenPP52" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3367"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zG4okLxpIDGd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3369"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zWRot9sQMbpa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;34,748&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zePr6UTv1Ad3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;36,675&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Glic *&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zjKwCcFuEwB7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;8,288&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zmHxJFF8oZ98" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,587&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zhsqTTZH106k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3379"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zwzdBxCxvZX" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3381"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z56RqCQj2qG9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,721&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z7BXg6aWZJN7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;31,022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;DelRey&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z0YiVmvMZTl6" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;75,098&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmErMfBrBxa" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3389"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zp0ur8iXCXEf" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;586,263&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zYqywOBu3Ab8" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3393"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zojQOdUk38M4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;854,313&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zIRyssqpra5a" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3397"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zvS7L22Rtc7b" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,334,699&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zQD2BSZC53P4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,257,045&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zXhS9fbGkxSb" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,776,077&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zQV4XxDhUbV7" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,189,814&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zYT2Rx9a5Aw" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;5,584,082&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zYA2RckZNPlh" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;4,814,424&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;*&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;See above for further details on goodwill changes in 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A1_zuQkIsJ3rwSe" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;The main assumptions used by the Company to determine
the value in use of the CGUs were:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;Student enrollment - refers to the number of students
that are currently enrolled in each CGU. The growth of students enrolled considers maturation of operations, limited by regulatory seats
approved for each CGU.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Tuition fees - the monthly fee charged to students. Tuition fees are consistent
with Management best expectations on prices charged and considers inflation for future periods.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Occupancy rate - the occupancy rate of the medical schools is the ratio
of the number of students effectively enrolled divided by the regulatory capacity in a given period.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Regulatory capacity - the regulatory capacity is defined by the number of
medical schools seats available per year awarded by MEC, multiplied by the number of years of operations since the seats were awarded.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Faculty - refers to the cost with faculty in the CGU, which means the amount
paid to teachers and doctors.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Digital content platform revenues - refer to mobile app subscription, clinical
management system, healthcare payments, medical imaging, online courses for digital content users and marketing for pharmaceutical industry.
Business assumptions include management best expectations on long term targets for digital services segment operations, including total
addressable market, market share and target prices including inflation.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Capital expenditures - refers to investments to be made on intangible assets
related to developments and platform improvements especially on the digital services CGUs.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;Discount rates - discount rates represent the current
market assessment of the risks specific to the CGU being tested. The pre-tax discount rate applied to cash flow projections is between
&lt;span id="xdx_90E_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pid_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z3b2HImOwvag" title="Discount rate applied to cash flow projections"&gt;12.48&lt;/span&gt;% and &lt;span id="xdx_900_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pid_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zS0zXiFEg0uf" title="Discount rate applied to cash flow projections"&gt;15.14&lt;/span&gt;% in 2023 (between &lt;span id="xdx_902_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pid_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zo9WACMhePx8" title="Discount rate applied to cash flow projections"&gt;13.14&lt;/span&gt;% and &lt;span id="xdx_908_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pid_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8Y29Il9xQVh" title="Discount rate applied to cash flow projections"&gt;15.40&lt;/span&gt;% in 2022).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;Perpetuity growth rate - refers to growth rate considered
by management on long term periods after the explicit projection period of five &lt;span id="xdx_901_ecustom--ExplicitProjectionPeriod_dtY_c20230101__20231231_z7uvymfzDPXf" style="display: none" title="Explicit projection period"&gt;5&lt;/span&gt;
years. The growth rates range from &lt;span id="xdx_90C_ecustom--PerpetuityGrowthRate_pid_dp_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_za6Ng84ehhjg" title="Growth rates"&gt;3.5&lt;/span&gt;%
to &lt;span id="xdx_90B_ecustom--PerpetuityGrowthRate_pid_dp_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zZHxGzW4x9C3" title="Growth rates"&gt;7.8&lt;/span&gt;%.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt 10.9pt; text-indent: -10.9pt"&gt;&lt;span style="text-decoration: underline"&gt;Significant estimate: impact of possible
changes in key assumptions&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_z6Laoxh51uUc" title="Description of key assumptions on which management has based cash flow projections"&gt;An increase of 25 basis points in management&#x2019;s estimated
discount rate applied to the cash flow projections of each CGU for the year ended December 31, 2023, or a decrease of 25 basis points
on estimated EBITDA would have not resulted in significant impacts on these consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt; color: #C00000"&gt;Other intangible assets&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Intangible assets, other than goodwill and licenses with indefinite useful
lives, are valued separately for each acquisition and are amortized during each useful life. The useful lives and methods of amortization
of other intangibles are reviewed at each financial year end and adjusted prospectively, if appropriate.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The estimated useful lives of intangible assets are as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zElzYaU0osM5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets and goodwill (Details 2)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B2_zjb6IUsUqjg5" style="display: none"&gt;Schedule of estimated
    useful lives of intangible assets&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="width: 72%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Customer relationships - medicine&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsMedicineMember_zq8afRnHTbud" title="Estimated useful lives of intangible assets"&gt;6&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Customer relationships - other courses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsOtherCoursesMember_zAOTCaqrU9O3" title="Estimated useful lives of intangible assets"&gt;4.5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Software license&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zjo7dH7vBiXd" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Education content&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zyWGqGGxn1N5" title="Estimated useful lives of intangible assets"&gt;3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zvRcOQGbg7X5" title="Estimated useful lives of intangible assets"&gt;2&lt;/span&gt; - &lt;span id="xdx_903_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zIBFrQClh4Ga" title="Estimated useful lives of intangible assets"&gt;30&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyMember_z3qO4r0lhFHe" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;For the years ended December 31, 2023, 2022 and 2021, there were no indicatives
that the Company&#x2019;s intangible assets with finite useful lives might be impaired.&lt;/p&gt;






&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</afya:DisclosureOfIntangibleAssetExplanatory>
    <afya:SummaryOfIntangibleAssetsTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002698">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_z9SFZ004WEei" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets and goodwill (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span id="xdx_8BB_zLquPfqPr8Bb" style="display: none"&gt;&#160;Schedule of intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Goodwill &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Licenses with indefinite useful life &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Education content&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Developed technology&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Educational platform&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Software in progress&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 4%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrVs4nJUBvA9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;810,656&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zOsUP4LXxWQd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,451,270&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfZqZIoN3gme" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;75,014&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQYrwcgh78ma" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;283,539&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkLKk2HrHMi3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;16,221&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zke8tn0YX0Rb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;17,305&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zT3slotvRSR7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;355&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zViySlwYFhm8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;27,902&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxPWglJrrwsg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,297&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeN9grCjSwI7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2718"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6CMpPtVlLZ4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,684,559&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Additions (vi)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvF23pO4yaQg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyULZJr7rUy4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;684&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMuHgpTac5ed" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,044&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zN4HWHJwhbai" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;996&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zE7NuDfp5Gnc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;39,686&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zK9nOPUKaPG8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;23,700&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3VGszF3dGSh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;176,110&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Write-off *&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zG89zNqyy2R7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbCREwHIf1s" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(2,743)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvIOCCM6fxme" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(417)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsEaR8AObK8j" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(2,140)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zGCFGqPXmtZ8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;373,680&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRZauQn34Qef" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;606,136&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhW6NlxD9l6l" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;58,355&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziCEbjJ2VSi6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;147,054&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCWFJKgYx14g" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,474&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5M5uUxiZUW9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;33,046&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z61g1bMg0Ftf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;11,599&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgBP8vMOjDcl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,267&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAc5XlVajV9c" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,234,611&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuKUQ0QxcNR6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,184,336&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkyMX8gPOepg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,165,406&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztvE8u7ibCCf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;133,369&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7wa0fhFQBfg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;431,277&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zh6bZ8xBT71e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;21,759&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZRiz76GAXY" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;17,305&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zF6u2yMw22Oa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;34,397&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvTgObYwq03e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;76,444&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zA0Wf5zyLd66" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;28,847&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRjp7MXSscPk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2780"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKIR6xabatC6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,093,140&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Additions (i) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zFy6RuIPCYK6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;39,100&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUvoPygPAq3d" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;24,408&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoLJxtcViQL8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;80&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxKt1ZXxt9Y2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,423&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zpBPCLzDBTZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;11,231&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR7ixPmQ1mU2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;32,879&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6E7Vd03Mz5e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;14,761&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwNbbNuomi8k" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;26,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7FnFfMH9im4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;150,023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Write-off *&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zs7brwltqOag" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(22)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zr2u6gQHBWQ" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(381)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zC2lw0uZlgF4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(7)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zXrK5HfiWKSd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(9)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z3V02sLT2tk3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(28)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zAHqoxFsK382" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Remeasurement (iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Remesurement_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zt4LxZk4o1b5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(8,637)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--Remesurement_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zSjSRpRi6Ry7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(8,637)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zm7EzOl2JYqf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(2,472)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9KFNs0Bmz96" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;530&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLvMGXy2m4la" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;20,466&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zE2VFXVKUvl4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;38,433&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMhiJG9r6d2k" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;17,953&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxpjg8n9eJWg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(35,499)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgLVjYOX7nSb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(40,226)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zacZqLhiLYSh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(815)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsw3RHiwQQ0e" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;42,246&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhNOvEBUHzQ9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;51,185&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2UV5YPjjBHl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,929&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLxhpCOVnyO4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;33&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zj7IBwHMhQZ" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;2,627&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvI0Eg58qRd7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,520&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgA0OV25wTO3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,055&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfhtXkzWgI6i" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;106,595&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZGbWiJzMptc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,257,045&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zid4tDg6Duzk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,189,814&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmgtpoFnBs7i" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;182,060&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLz7s3H970df" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;435,816&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfGdNwDCzqY1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;43,300&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqzm1nUYnHBk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;69,589&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvs2JUEzY892" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;90,749&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztWrXATFPEUe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;55,697&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2wUNIGwCnn8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;14,734&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRMz5IwE6sO1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,055&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVF2wAQplVF7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,339,859&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zGiZtIR7jDNd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,314&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zn5r3EFssVV3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;9,827&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zAvY8yKtbY7a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;37,712&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zrGW628YStRh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;23,164&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____z2Wf7ULHomg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;27,976&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____za619doDJEQc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;99,993&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Write-off *&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsqfToq76mWl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(2,235)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHIvsvqICiF4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(911)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAqOqcUZ1fV7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(125)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4CyNOZlxFif" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(3,271)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Remeasurement (iv)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkkyKSrbQW4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;2,556&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zT3GK1cRZFjd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Remesurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;2,556&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkFVkkEILxHk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;28,708&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQG1r1Cc4mCc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,785&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7wH2IadM7u6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;16&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6c1L7rUz7uc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(3,058)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziSvCId07ll4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(30,451)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Business combination (v)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHKkn2F9f5R2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;75,098&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsTwMyWH84za" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;586,263&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmHQbEFXgH02" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;142,451&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlcFMWXcg90h" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;63&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKUlaNc2BSt9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;803,875&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfTVpOiyKlCj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,334,699&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyBhyK3VHgF9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,776,077&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXvGNXVeCyx5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;182,060&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCTz7fEVcqWf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;578,267&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMlTARrHb4A3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;71,150&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRMES8oDqJ57" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;84,201&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z43C2DF0VF5i" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;128,477&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zdFlphCY2aH4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;74,892&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3pRmdFD5jec" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;12,134&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLsa5CtlazLg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,055&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3HBoyN7Umbe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;5,243,012&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJdlYZWxNtn8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2938"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z5kPPI9XB7u3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2940"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxvAAkhuktK5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(3,502)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8Q9IsXNzc9h" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(85,832)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmbW62Qc5m14" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(6,256)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z7bke0i420q7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(7,692)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zg0tZNg5jOMl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(32)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8WB1A0dvnh" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(8,235)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkE5CAAvBZFg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2954"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z9bRG8BBvKZc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(111,549)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iP2custom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvngUNyQYOW8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2958"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z6PTZmw3J3Ca" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2959"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4EPdygNyKVc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(5,027)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjeS2aFfrBW7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(56,438)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zudlFPP8ECCj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(5,844)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zPn81oAhimq4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(8,980)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1oi55s6Gaa9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(625)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUkudD4TwWhg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(3,608)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvxlt8PwE4g2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2968"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRgYc87MKQ78" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(80,522)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Write-off *&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zB9o870cnC7e" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(599)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRmp754MQROa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;365&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zrdK0dZxDzq9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUVFqH5h9816" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2977"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zOprGAmmEoQa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2979"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzpzAPhoTcr" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(8,529)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQJtlGdy8rrk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(142,270)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3f7gnY7krYd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(12,699)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkfYhmtObfk9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(16,672)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zU9b3749VCr9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(657)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKdgQGoYTPkh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(11,478)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlEmY6swP4sb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2993"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zk6Bl2dBFlHi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2995"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAOztK89xXnc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(192,305)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRIqLr58LeHc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2999"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zZ7uEvAsvJn4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3000"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zaOFsDGvO1Kj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(6,426)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z5SHk6zZZtp1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(70,093)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIBzUyzLtzXe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(4,943)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1KLnEPPvsL5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(9,634)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzUZSVylsrPi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(9,436)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zspCp7XfNRz9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(5,874)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFcICCaZcy54" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3008"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDgSWPcpEpNk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(79)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zpqGiDSi1IJ4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(106,485)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Write-off *&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhw7RbRISOna" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;365&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKE3GEPFeF56" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;57&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFCuvVlZuYL9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;422&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFvp4ObR37Kd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(313)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Transfer_pn3n3_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zw5xUo9Mgk51" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;313&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1Q7lutEHQO8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3022"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zu5EFWbDZEMe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3024"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlBnkyvk0ev7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(14,955)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zR9jM67yGAG3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(212,363)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgDyDdWjDuWa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(17,277)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZdbPDLMuWx2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(26,562)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbN3g81tOMI6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(10,093)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhxf7VctRsmj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(17,039)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zukZwSmCdKsd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3038"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zV5tIWM2QCOa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(79)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSRIPuk60oai" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(298,368)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIIclee4CFP3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3044"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zLujbAMj9hQ8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3045"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQpffWkfUrO" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(11,083)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z95ZNUJtiHD6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(89,584)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1dLqJhChIH5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(8,764)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmhdnex591ga" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(15,668)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zPPtr2Ph0rf6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(21,504)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvWZ4NvXxo4h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(4,778)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuMvzAD5mG47" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3053"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTjLK0f2CxId" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(105)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNiowokeDkqg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(151,486)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Write-off *&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8kFhGgLh35b" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFrYtYTNmaE9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;911&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTzdX7Tjbo3f" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;2,858&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zcQtpkZ8TRzi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;(6)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zl3R7RlPDiy3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Transfer amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zakSIViJpJRd" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3067"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zxFpcVDfyLo8" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3069"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zf2zfeQdub9b" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(26,038)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0nNI8J2TV18" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(301,947)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z7snqh43ffZh" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(24,094)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHJJPLfjeOa7" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(42,230)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqfARSPMviJc" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(31,603)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8WDvcsqHa9h" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(20,900)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zsAddT3S3ePl" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3083"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztQmxjLn3pcj" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(184)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zUWCWpRFgOx9" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;(446,996)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Net book value:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zZGSmpyy3nLe" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,334,699&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zzybL6jFJ5sl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,776,077&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zEzdVnnyc3Sg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;156,022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zdJp51vna8dk" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;276,320&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z7haIx8TeALb" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;47,056&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zM3WVlTyWfa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;41,971&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zlhXNCCNXK0i" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;96,874&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zhwgLjcKB0Ie" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;53,992&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zweSqKpBdCcg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;12,134&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zxd75R6u9n5k" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;871&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20231231_zjABLBpRPTtl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,796,016&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zhOroOPXFxC8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,257,045&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkp_zonPhVoD51rh" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;2,189,814&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zYCJD4dpY14h" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;167,105&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zZMrU3EO4Npb" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;223,453&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zqlvgHB4BsE6" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;26,023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zRNXNQ7OmQYb" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;43,027&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zu3tByWXgf42" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;80,656&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zdtvT4oTgRKa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;38,658&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zMGUPMHfcb2k" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;14,734&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zg4WqQp94Ppg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;976&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20221231_zPLbXUJyuXWf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,041,491&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;*&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to intangible assets written-off as result of lack of expectation of future use.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Licenses with indefinite useful life: On March 18, 2022, MEC authorized the increase of 28
seats of Centro de Ensino S&#xe3;o Lucas, located in the city of Ji-Parana, State of Rond&#xf4;nia. The earn-out related to the seats
approval is R$800 per seat, adjusted by the CDI rate from the closing until the payment date, of which 50% was paid in April 2022 and
the remaining amount is payable in cash in two equal installments through 2024.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Goodwill: During the measurement period, the preliminary goodwill for the acquisition of
Unigranrio was adjusted by R$39,100 (R$130,073 initial goodwill) as a result of an increase of liabilities regarding tax contingencies
and judicial deposits to be reimbursed by the selling shareholders.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Goodwill: During the measurement period, R$8,637 of goodwill arising from the acquisition
of RX PRO was reduced, in connection with management&#x2019;s view of remote likelihood of RX PRO achieving the revenue goals estimated
at the terms of the earn-out.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iv)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Goodwill: During the measurement period, results of operation such as revenue differed from
the foreseen, resulting in a remeasurement of the contingent consideration for the acquisitions of Al&#xe9;m da Medicina, CardioPapers
and Glic by R$4,773, R$5,082 and (R$7,299), respectively, totaling R$2,556 for the year ended December 31, 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(v)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Business combination: On January 2, 2023, Afya Brazil acquired DelRey, a post-secondary education
institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs in medicine and health, as
well as other courses. See Note 5.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(vi)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On November 5, 2021, MEC authorized the operation of 120 medical school seats in Garanhuns,
for which our shareholder Nicolau Carvalho Esteves entered into an agreement with Afya Brazil pursuant to which he assigned to Afya Brazil
the right to develop the ITPAC Garanhuns greenfield unit, a medical school in the city of Garanhuns, State of Pernambuco. Management
assessed the aspects of such transaction and concluded that the transaction does not fall under the definition of business, but an acquisition
of license with indefinite useful life recognized in intangible assets. Total purchase price was R$108,000 of which 50% was paid in cash
on the transaction closing date and 50% in two equal annual installments, adjusted by the CDI rate.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:SummaryOfIntangibleAssetsTableTextBlock>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002700"
      unitRef="BRL">810656000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002702"
      unitRef="BRL">1451270000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002704"
      unitRef="BRL">75014000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002706"
      unitRef="BRL">283539000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002708"
      unitRef="BRL">16221000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002710"
      unitRef="BRL">17305000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002712"
      unitRef="BRL">355000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002714"
      unitRef="BRL">27902000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002716"
      unitRef="BRL">2297000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002720"
      unitRef="BRL">2684559000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002722"
      unitRef="BRL">108000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002724"
      unitRef="BRL">684000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002726"
      unitRef="BRL">3044000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002728"
      unitRef="BRL">996000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002730"
      unitRef="BRL">39686000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002732"
      unitRef="BRL">23700000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002734"
      unitRef="BRL">176110000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002736"
      unitRef="BRL">1020000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002738"
      unitRef="BRL">-2743000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002740"
      unitRef="BRL">-417000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002742"
      unitRef="BRL">-2140000</afya:WriteoffOfIntangibleAssets>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002744"
      unitRef="BRL">373680000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002746"
      unitRef="BRL">606136000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002748"
      unitRef="BRL">58355000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002750"
      unitRef="BRL">147054000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002752"
      unitRef="BRL">1474000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002754"
      unitRef="BRL">33046000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002756"
      unitRef="BRL">11599000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002758"
      unitRef="BRL">3267000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002760"
      unitRef="BRL">1234611000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002762"
      unitRef="BRL">1184336000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002764"
      unitRef="BRL">2165406000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002766"
      unitRef="BRL">133369000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002768"
      unitRef="BRL">431277000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002770"
      unitRef="BRL">21759000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002772"
      unitRef="BRL">17305000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002774"
      unitRef="BRL">34397000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002776"
      unitRef="BRL">76444000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002778"
      unitRef="BRL">28847000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002782"
      unitRef="BRL">4093140000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002784"
      unitRef="BRL">39100000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002786"
      unitRef="BRL">24408000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002788"
      unitRef="BRL">80000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002790"
      unitRef="BRL">1423000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002792"
      unitRef="BRL">11231000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002794"
      unitRef="BRL">32879000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002796"
      unitRef="BRL">14761000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002798"
      unitRef="BRL">26141000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002800"
      unitRef="BRL">150023000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2022-01-012022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002802"
      unitRef="BRL">-22000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002804"
      unitRef="BRL">-381000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002806"
      unitRef="BRL">-7000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002808"
      unitRef="BRL">-9000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2022-01-012022-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002810"
      unitRef="BRL">-28000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002812"
      unitRef="BRL">-447000</afya:WriteoffOfIntangibleAssets>
    <afya:Remesurement
      contextRef="From2022-01-012022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002814"
      unitRef="BRL">-8637000</afya:Remesurement>
    <afya:Remesurement
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002816"
      unitRef="BRL">-8637000</afya:Remesurement>
    <afya:Transfer
      contextRef="From2022-01-012022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002818"
      unitRef="BRL">-2472000</afya:Transfer>
    <afya:Transfer
      contextRef="From2022-01-012022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002820"
      unitRef="BRL">530000</afya:Transfer>
    <afya:Transfer
      contextRef="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002822"
      unitRef="BRL">20466000</afya:Transfer>
    <afya:Transfer
      contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002824"
      unitRef="BRL">38433000</afya:Transfer>
    <afya:Transfer
      contextRef="From2022-01-012022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002826"
      unitRef="BRL">17953000</afya:Transfer>
    <afya:Transfer
      contextRef="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002828"
      unitRef="BRL">-35499000</afya:Transfer>
    <afya:Transfer
      contextRef="From2022-01-012022-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002830"
      unitRef="BRL">-40226000</afya:Transfer>
    <afya:Transfer
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002832"
      unitRef="BRL">-815000</afya:Transfer>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002834"
      unitRef="BRL">42246000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002836"
      unitRef="BRL">51185000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002838"
      unitRef="BRL">3929000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002840"
      unitRef="BRL">33000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002842"
      unitRef="BRL">2627000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002844"
      unitRef="BRL">5520000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2022-01-012022-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002846"
      unitRef="BRL">1055000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002848"
      unitRef="BRL">106595000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002850"
      unitRef="BRL">1257045000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002852"
      unitRef="BRL">2189814000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002854"
      unitRef="BRL">182060000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002856"
      unitRef="BRL">435816000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002858"
      unitRef="BRL">43300000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002860"
      unitRef="BRL">69589000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002862"
      unitRef="BRL">90749000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002864"
      unitRef="BRL">55697000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002866"
      unitRef="BRL">14734000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002868"
      unitRef="BRL">1055000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002870"
      unitRef="BRL">4339859000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002872"
      unitRef="BRL">1314000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002874"
      unitRef="BRL">9827000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002876"
      unitRef="BRL">37712000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002878"
      unitRef="BRL">23164000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002880"
      unitRef="BRL">27976000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002882"
      unitRef="BRL">99993000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002884"
      unitRef="BRL">-2235000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002886"
      unitRef="BRL">-911000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002888"
      unitRef="BRL">-125000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002890"
      unitRef="BRL">-3271000</afya:WriteoffOfIntangibleAssets>
    <afya:Remesurement
      contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002892"
      unitRef="BRL">2556000</afya:Remesurement>
    <afya:Remesurement
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002894"
      unitRef="BRL">2556000</afya:Remesurement>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002896"
      unitRef="BRL">28708000</afya:Transfer>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002898"
      unitRef="BRL">4785000</afya:Transfer>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002900"
      unitRef="BRL">16000</afya:Transfer>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002902"
      unitRef="BRL">-3058000</afya:Transfer>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002904"
      unitRef="BRL">-30451000</afya:Transfer>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002906"
      unitRef="BRL">75098000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002908"
      unitRef="BRL">586263000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002910"
      unitRef="BRL">142451000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002912"
      unitRef="BRL">63000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002914"
      unitRef="BRL">803875000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002916"
      unitRef="BRL">1334699000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002918"
      unitRef="BRL">2776077000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002920"
      unitRef="BRL">182060000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002922"
      unitRef="BRL">578267000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002924"
      unitRef="BRL">71150000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002926"
      unitRef="BRL">84201000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002928"
      unitRef="BRL">128477000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002930"
      unitRef="BRL">74892000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002932"
      unitRef="BRL">12134000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002934"
      unitRef="BRL">1055000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002936"
      unitRef="BRL">5243012000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002942"
      unitRef="BRL">-3502000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002944"
      unitRef="BRL">-85832000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002946"
      unitRef="BRL">-6256000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002948"
      unitRef="BRL">-7692000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002950"
      unitRef="BRL">-32000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002952"
      unitRef="BRL">-8235000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002956"
      unitRef="BRL">-111549000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002961"
      unitRef="BRL">-5027000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002963"
      unitRef="BRL">-56438000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002964"
      unitRef="BRL">-5844000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002965"
      unitRef="BRL">-8980000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002966"
      unitRef="BRL">-625000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002967"
      unitRef="BRL">-3608000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002969"
      unitRef="BRL">-80522000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002971"
      unitRef="BRL">-599000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002973"
      unitRef="BRL">365000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002975"
      unitRef="BRL">-234000</afya:WriteoffOfIntangibleAssets>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002981"
      unitRef="BRL">-8529000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002983"
      unitRef="BRL">-142270000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002985"
      unitRef="BRL">-12699000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002987"
      unitRef="BRL">-16672000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002989"
      unitRef="BRL">-657000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002991"
      unitRef="BRL">-11478000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002997"
      unitRef="BRL">-192305000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003001"
      unitRef="BRL">-6426000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003003"
      unitRef="BRL">-70093000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003004"
      unitRef="BRL">-4943000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003005"
      unitRef="BRL">-9634000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003006"
      unitRef="BRL">-9436000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003007"
      unitRef="BRL">-5874000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003009"
      unitRef="BRL">-79000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003010"
      unitRef="BRL">-106485000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2022-01-012022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003012"
      unitRef="BRL">365000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003014"
      unitRef="BRL">57000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003016"
      unitRef="BRL">422000</afya:WriteoffOfIntangibleAssets>
    <afya:Transfer
      contextRef="From2022-01-012022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003018"
      unitRef="BRL">-313000</afya:Transfer>
    <afya:Transfer
      contextRef="From2022-01-012022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003020"
      unitRef="BRL">313000</afya:Transfer>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003026"
      unitRef="BRL">-14955000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003028"
      unitRef="BRL">-212363000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003030"
      unitRef="BRL">-17277000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003032"
      unitRef="BRL">-26562000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003034"
      unitRef="BRL">-10093000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003036"
      unitRef="BRL">-17039000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003040"
      unitRef="BRL">-79000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003042"
      unitRef="BRL">-298368000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003046"
      unitRef="BRL">-11083000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003048"
      unitRef="BRL">-89584000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003049"
      unitRef="BRL">-8764000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003050"
      unitRef="BRL">-15668000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003051"
      unitRef="BRL">-21504000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003052"
      unitRef="BRL">-4778000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003054"
      unitRef="BRL">-105000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003055"
      unitRef="BRL">-151486000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003057"
      unitRef="BRL">1947000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003059"
      unitRef="BRL">911000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003061"
      unitRef="BRL">2858000</afya:WriteoffOfIntangibleAssets>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003063"
      unitRef="BRL">-6000</afya:Transfer>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003065"
      unitRef="BRL">6000</afya:Transfer>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003071"
      unitRef="BRL">-26038000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003073"
      unitRef="BRL">-301947000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003075"
      unitRef="BRL">-24094000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003077"
      unitRef="BRL">-42230000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003079"
      unitRef="BRL">-31603000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003081"
      unitRef="BRL">-20900000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003085"
      unitRef="BRL">-184000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003087"
      unitRef="BRL">-446996000</ifrs-full:IntangibleAssetsAndGoodwill>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2023-12-31_ifrs-full_GoodwillMember"
      decimals="-3"
      id="Fact003089"
      unitRef="BRL">1334699000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003091"
      unitRef="BRL">2776077000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2022-12-31_ifrs-full_BrandNamesMember"
      decimals="-3"
      id="Fact003093"
      unitRef="BRL">156022000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember"
      decimals="-3"
      id="Fact003095"
      unitRef="BRL">276320000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember"
      decimals="-3"
      id="Fact003097"
      unitRef="BRL">47056000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2023-12-31_custom_EducationContentMember"
      decimals="-3"
      id="Fact003099"
      unitRef="BRL">41971000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fact003101"
      unitRef="BRL">96874000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2023-12-31_custom_EducationalPlatformMember"
      decimals="-3"
      id="Fact003103"
      unitRef="BRL">53992000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2023-12-31_custom_SoftwareInProgressMember"
      decimals="-3"
      id="Fact003105"
      unitRef="BRL">12134000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2023-12-31_custom_OtherMember"
      decimals="-3"
      id="Fact003107"
      unitRef="BRL">871000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003109"
      unitRef="BRL">4796016000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2022-12-31_ifrs-full_GoodwillMember"
      decimals="-3"
      id="Fact003111"
      unitRef="BRL">1257045000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003113"
      unitRef="BRL">2189814000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2020-12-31_ifrs-full_BrandNamesMember"
      decimals="-3"
      id="Fact003115"
      unitRef="BRL">167105000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember"
      decimals="-3"
      id="Fact003117"
      unitRef="BRL">223453000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember"
      decimals="-3"
      id="Fact003119"
      unitRef="BRL">26023000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2022-12-31_custom_EducationContentMember"
      decimals="-3"
      id="Fact003121"
      unitRef="BRL">43027000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fact003123"
      unitRef="BRL">80656000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2022-12-31_custom_EducationalPlatformMember"
      decimals="-3"
      id="Fact003125"
      unitRef="BRL">38658000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2022-12-31_custom_SoftwareInProgressMember"
      decimals="-3"
      id="Fact003127"
      unitRef="BRL">14734000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2022-12-31_custom_OtherMember"
      decimals="-3"
      id="Fact003129"
      unitRef="BRL">976000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003131"
      unitRef="BRL">4041491000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact003133">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_zzqMOzqQmxu5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets and goodwill (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B9_ziu210ar3Zf5" style="display: none"&gt;Schedule of assumptions for impairment test&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;CGU&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Goodwill&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Licenses with indefinite useful life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;CGU&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 42%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IPTAN&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zMEWTMkMpEH4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;17,446&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zIkXUBa16O7k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;17,446&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z6Fls3KSSqnb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,214&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zvfNAJ2RJIMb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,214&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_znwjueBf1G89" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;125,974&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zMDNzNIOnjHl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;126,024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IESVAP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z7ebTmxWG6p4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,956&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zQvCNbegZtXc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,956&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zPHJHpr2rKTb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;81,366&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zbxbycrv7g5a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;81,366&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z5S3vE0ekyYh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;126,996&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zgwRU3M123M6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;129,305&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;CCSI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zKcobUcnJMq9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,664&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zJLjxQJG5AKb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,664&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zuLKXhrw9nU4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;56,737&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zG64JkeD6Elc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;56,737&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zilNfsjrdUSc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,550&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zYALhgNLVtI2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;53,540&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IESP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zCXXn4mdrD33" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;73,838&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zjUFSH9gJEhb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;73,838&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zoqOobLHD47c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;179,693&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z1jem8KIGXv7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;179,693&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zjxNITJg7NW9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;332,104&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zef18tATxUUa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;322,968&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;FADEP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zHtXp28SMVod" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;49,661&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zw6olpzqlRBg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;49,661&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z5uunxL2nnZc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,606&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zunecelcRBY8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,606&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z6YdRN9vxIl4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;148,032&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zewHKSZ1p6Bh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;153,100&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;FASA&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zfgPda5LeHDj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,903&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zjY43R9RRDu1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,903&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zhesAjMK4rp2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;144,507&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zhZ9picPDTC3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;144,507&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zjxz2LQitxP5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;322,061&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zCayavTFR9J7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;314,967&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IPEMED&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zu2mPxcHrT0c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;87,647&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zcshSisPUGgj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;87,647&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pdn3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z25VZU1CGw25" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3211"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pdn3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zmqwQXQ9rgZ" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3213"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zOlGb0N0iB6a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;183,862&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zidgkAWSlAnj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;192,079&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IPEC&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zm2QANN48k4a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3219"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z1QBDqes9YSd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3221"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zqF6wqcDIPh2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zFdSO4LRWNJe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zgDqQM9L7Sy7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;157,984&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zAKstAcVKdlc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;148,067&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UniRedentor&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z87ar33N0chl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;77,662&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zvJu3I9tjZC9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;77,662&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zfrMkXMcAvT8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;121,477&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zGOd5FyX8iqj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;121,477&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zjCpXIc7VDhh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;234,054&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zsMODGEGb8Ei" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;242,600&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UniSL&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z4cbjCoukwRb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,420&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z7fmhq1wbJb2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,420&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____zGllazCKwied" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;273,795&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____zfYzpiAOaFo" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;273,795&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z35OmdMnPQQ6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;401,143&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_fKg_____z5JFUJwEUbt6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;398,492&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;FESAR&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_ziAUqEIV6Xeg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71,664&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z5FfmjHVNTJi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71,664&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zxzIvEcbBHw6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;141,616&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zqGIL1Pb9mFf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;141,616&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zZEQer5sJGkl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;244,412&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zRvY34SNW7gg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;244,084&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;FCMPB&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Goodwill_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zmPG9b50T1m1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;110,483&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zIx1Xlu3zKY1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;110,483&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z8AxymdEeI6i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;235,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z4vMseSAXgUj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;235,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z2g3pY63APJ" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;402,140&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z7G87aGR4nG4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;415,453&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;ITPAC Garanhuns&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zuzXHHupWVZ8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3279"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zMDyE9rgVERa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3281"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zWVTlzHZlvM9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zisSFrJbq6y6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zlQmANWZhK4d" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;116,162&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z9YGEQwdzpAg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;112,628&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Content &amp;amp; Technology for medical education (Pillar 1) *&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zA9Sh42jmvwj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;179,830&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zNUCwkxzTvod" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;169,975&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zg6GdQT9FNji" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3295"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zP9b2nin9i7a" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3297"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z0LxoxdVQMeh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;238,921&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zAR0hZyZQx94" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;279,684&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Practice Management Tools &amp;amp; Electronic Prescription (Pillar 3)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zwD8e2Eeiah" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;106,774&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zP3HhvHaUjbe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;106,774&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zxwqa8mctp32" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3307"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zk2PgnYtM1F5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3309"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zXVQvmlYTnJj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;221,171&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zhgPYaB7lNjg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;216,297&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Clinical Decision Software (Pillar 2)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zmXoVN7WMiqj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;87,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zY6LpWaXdXS2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;87,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zcbeoEv95rN4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3319"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zP2DQyhrM7N6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3321"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zbeRK6tHqDub" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;147,897&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z0yd02PIVl3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;153,526&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cliquefarma&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z00tGT2dLwBa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;6,588&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8FSSDGoHb77" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;6,588&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zeLIPp5lD43h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3331"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zVigd7Gvnm44" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3333"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zzThE07eOMJ6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;18,789&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z9eg68e21K3f" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UnifipMoc&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z9nQd8jYobjk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;87,777&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zOvXG46sKnDd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;87,777&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zOH7Ro3LmCib" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;190,247&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zWwTbNSDZeh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;190,247&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z7FFrIMLKMT7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;361,383&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zXKUarNtCjY" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;369,007&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Unigranrio&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zd07evq26Hfi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;169,173&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zWodhmw7xVpk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;169,173&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zK7zhR1rGyue" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;421,538&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zRfKUwMsXaH2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;421,538&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z2BmuzPN04A6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;833,665&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z1Cu9Vl17eKk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;854,861&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;RX PRO&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zKbhW2JhCXMj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;29,809&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHhuDacaoLC8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;29,809&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zMSRaaenPP52" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3367"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zG4okLxpIDGd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3369"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zWRot9sQMbpa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;34,748&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zePr6UTv1Ad3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;36,675&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Glic *&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zjKwCcFuEwB7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;8,288&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zmHxJFF8oZ98" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,587&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zhsqTTZH106k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3379"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zwzdBxCxvZX" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3381"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z56RqCQj2qG9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,721&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_z7BXg6aWZJN7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;31,022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;DelRey&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z0YiVmvMZTl6" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;75,098&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zmErMfBrBxa" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3389"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zp0ur8iXCXEf" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;586,263&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zYqywOBu3Ab8" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3393"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zojQOdUk38M4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;854,313&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zIRyssqpra5a" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3397"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zvS7L22Rtc7b" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,334,699&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zQD2BSZC53P4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,257,045&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zXhS9fbGkxSb" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,776,077&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zQV4XxDhUbV7" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,189,814&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zYT2Rx9a5Aw" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;5,584,082&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zYA2RckZNPlh" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;4,814,424&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;*&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;See above for further details on goodwill changes in 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      id="Fact003135"
      unitRef="BRL">17446000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      id="Fact003137"
      unitRef="BRL">17446000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      id="Fact003139"
      unitRef="BRL">57214000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      id="Fact003141"
      unitRef="BRL">57214000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      id="Fact003143"
      unitRef="BRL">125974000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      id="Fact003145"
      unitRef="BRL">126024000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      id="Fact003147"
      unitRef="BRL">27956000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      id="Fact003149"
      unitRef="BRL">27956000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      id="Fact003151"
      unitRef="BRL">81366000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      id="Fact003153"
      unitRef="BRL">81366000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      id="Fact003155"
      unitRef="BRL">126996000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      id="Fact003157"
      unitRef="BRL">129305000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      id="Fact003159"
      unitRef="BRL">4664000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      id="Fact003161"
      unitRef="BRL">4664000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      id="Fact003163"
      unitRef="BRL">56737000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      id="Fact003165"
      unitRef="BRL">56737000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      id="Fact003167"
      unitRef="BRL">54550000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      id="Fact003169"
      unitRef="BRL">53540000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      id="Fact003171"
      unitRef="BRL">73838000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      id="Fact003173"
      unitRef="BRL">73838000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      id="Fact003175"
      unitRef="BRL">179693000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      id="Fact003177"
      unitRef="BRL">179693000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      id="Fact003179"
      unitRef="BRL">332104000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      id="Fact003181"
      unitRef="BRL">322968000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      id="Fact003183"
      unitRef="BRL">49661000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      id="Fact003185"
      unitRef="BRL">49661000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      id="Fact003187"
      unitRef="BRL">70606000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      id="Fact003189"
      unitRef="BRL">70606000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      id="Fact003191"
      unitRef="BRL">148032000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      id="Fact003193"
      unitRef="BRL">153100000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      id="Fact003195"
      unitRef="BRL">58903000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      id="Fact003197"
      unitRef="BRL">58903000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      id="Fact003199"
      unitRef="BRL">144507000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      id="Fact003201"
      unitRef="BRL">144507000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      id="Fact003203"
      unitRef="BRL">322061000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      id="Fact003205"
      unitRef="BRL">314967000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      id="Fact003207"
      unitRef="BRL">87647000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      id="Fact003209"
      unitRef="BRL">87647000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      id="Fact003215"
      unitRef="BRL">183862000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      id="Fact003217"
      unitRef="BRL">192079000</afya:CashGeneratingUnits>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      id="Fact003223"
      unitRef="BRL">108000000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      id="Fact003225"
      unitRef="BRL">108000000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      id="Fact003227"
      unitRef="BRL">157984000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      id="Fact003229"
      unitRef="BRL">148067000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003231"
      unitRef="BRL">77662000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003233"
      unitRef="BRL">77662000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003235"
      unitRef="BRL">121477000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003237"
      unitRef="BRL">121477000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003239"
      unitRef="BRL">234054000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003241"
      unitRef="BRL">242600000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      id="Fact003243"
      unitRef="BRL">4420000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      id="Fact003245"
      unitRef="BRL">4420000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      id="Fact003247"
      unitRef="BRL">273795000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      id="Fact003249"
      unitRef="BRL">273795000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      id="Fact003251"
      unitRef="BRL">401143000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      id="Fact003253"
      unitRef="BRL">398492000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      id="Fact003255"
      unitRef="BRL">71664000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      id="Fact003257"
      unitRef="BRL">71664000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      id="Fact003259"
      unitRef="BRL">141616000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      id="Fact003261"
      unitRef="BRL">141616000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      id="Fact003263"
      unitRef="BRL">244412000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      id="Fact003265"
      unitRef="BRL">244084000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      id="Fact003267"
      unitRef="BRL">110483000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      id="Fact003269"
      unitRef="BRL">110483000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      id="Fact003271"
      unitRef="BRL">235018000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      id="Fact003273"
      unitRef="BRL">235018000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      id="Fact003275"
      unitRef="BRL">402140000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      id="Fact003277"
      unitRef="BRL">415453000</afya:CashGeneratingUnits>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember"
      decimals="-3"
      id="Fact003283"
      unitRef="BRL">108000000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember"
      decimals="-3"
      id="Fact003285"
      unitRef="BRL">108000000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember"
      decimals="-3"
      id="Fact003287"
      unitRef="BRL">116162000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember"
      decimals="-3"
      id="Fact003289"
      unitRef="BRL">112628000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember"
      decimals="-3"
      id="Fact003291"
      unitRef="BRL">179830000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember"
      decimals="-3"
      id="Fact003293"
      unitRef="BRL">169975000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember"
      decimals="-3"
      id="Fact003299"
      unitRef="BRL">238921000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember"
      decimals="-3"
      id="Fact003301"
      unitRef="BRL">279684000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember"
      decimals="-3"
      id="Fact003303"
      unitRef="BRL">106774000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember"
      decimals="-3"
      id="Fact003305"
      unitRef="BRL">106774000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember"
      decimals="-3"
      id="Fact003311"
      unitRef="BRL">221171000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember"
      decimals="-3"
      id="Fact003313"
      unitRef="BRL">216297000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember"
      decimals="-3"
      id="Fact003315"
      unitRef="BRL">87018000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember"
      decimals="-3"
      id="Fact003317"
      unitRef="BRL">87018000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember"
      decimals="-3"
      id="Fact003323"
      unitRef="BRL">147897000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember"
      decimals="-3"
      id="Fact003325"
      unitRef="BRL">153526000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember"
      decimals="-3"
      id="Fact003327"
      unitRef="BRL">6588000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember"
      decimals="-3"
      id="Fact003329"
      unitRef="BRL">6588000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember"
      decimals="-3"
      id="Fact003335"
      unitRef="BRL">18789000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_CliquefarmaMember"
      decimals="-3"
      id="Fact003337"
      unitRef="BRL">20045000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember"
      decimals="-3"
      id="Fact003339"
      unitRef="BRL">87777000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember"
      decimals="-3"
      id="Fact003341"
      unitRef="BRL">87777000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember"
      decimals="-3"
      id="Fact003343"
      unitRef="BRL">190247000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember"
      decimals="-3"
      id="Fact003345"
      unitRef="BRL">190247000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember"
      decimals="-3"
      id="Fact003347"
      unitRef="BRL">361383000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember"
      decimals="-3"
      id="Fact003349"
      unitRef="BRL">369007000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003351"
      unitRef="BRL">169173000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003353"
      unitRef="BRL">169173000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003355"
      unitRef="BRL">421538000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003357"
      unitRef="BRL">421538000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003359"
      unitRef="BRL">833665000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003361"
      unitRef="BRL">854861000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_RXPROMember"
      decimals="-3"
      id="Fact003363"
      unitRef="BRL">29809000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_RXPROMember"
      decimals="-3"
      id="Fact003365"
      unitRef="BRL">29809000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_RXPROMember"
      decimals="-3"
      id="Fact003371"
      unitRef="BRL">34748000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_RXPROMember"
      decimals="-3"
      id="Fact003373"
      unitRef="BRL">36675000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_GlicMember"
      decimals="-3"
      id="Fact003375"
      unitRef="BRL">8288000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_GlicMember"
      decimals="-3"
      id="Fact003377"
      unitRef="BRL">15587000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_GlicMember"
      decimals="-3"
      id="Fact003383"
      unitRef="BRL">23721000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember_custom_GlicMember"
      decimals="-3"
      id="Fact003385"
      unitRef="BRL">31022000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_DelReyMember"
      decimals="-3"
      id="Fact003387"
      unitRef="BRL">75098000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_DelReyMember"
      decimals="-3"
      id="Fact003391"
      unitRef="BRL">586263000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember_custom_DelReyMember"
      decimals="-3"
      id="Fact003395"
      unitRef="BRL">854313000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember"
      decimals="-3"
      id="Fact003399"
      unitRef="BRL">1334699000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember"
      decimals="-3"
      id="Fact003401"
      unitRef="BRL">1257045000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember"
      decimals="-3"
      id="Fact003403"
      unitRef="BRL">2776077000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember"
      decimals="-3"
      id="Fact003405"
      unitRef="BRL">2189814000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2023-12-31_custom_CarryingAmountsMember"
      decimals="-3"
      id="Fact003407"
      unitRef="BRL">5584082000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2022-12-31_custom_CarryingAmountsMember"
      decimals="-3"
      id="Fact003409"
      unitRef="BRL">4814424000</afya:CashGeneratingUnits>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections
      contextRef="AsOf2023-12-31_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact003411"
      unitRef="Pure">0.1248</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections
      contextRef="AsOf2023-12-31_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact003413"
      unitRef="Pure">0.1514</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections
      contextRef="AsOf2022-12-31_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact003415"
      unitRef="Pure">0.1314</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections
      contextRef="AsOf2022-12-31_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact003417"
      unitRef="Pure">0.1540</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <afya:ExplicitProjectionPeriod contextRef="From2023-01-01to2023-12-31" id="Fact003419">P5Y</afya:ExplicitProjectionPeriod>
    <afya:PerpetuityGrowthRate
      contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_ifrs-full_BrandNamesMember"
      decimals="INF"
      id="Fact003421"
      unitRef="Pure">0.035</afya:PerpetuityGrowthRate>
    <afya:PerpetuityGrowthRate
      contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_ifrs-full_BrandNamesMember"
      decimals="INF"
      id="Fact003423"
      unitRef="Pure">0.078</afya:PerpetuityGrowthRate>
    <ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections
      contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember"
      id="Fact003425">An increase of 25 basis points in management&#x2019;s estimated
discount rate applied to the cash flow projections of each CGU for the year ended December 31, 2023, or a decrease of 25 basis points
on estimated EBITDA would have not resulted in significant impacts on these consolidated financial statements.</ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections>
    <afya:SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact003427">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zElzYaU0osM5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible assets and goodwill (Details 2)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B2_zjb6IUsUqjg5" style="display: none"&gt;Schedule of estimated
    useful lives of intangible assets&lt;/span&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="width: 72%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Customer relationships - medicine&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsMedicineMember_zq8afRnHTbud" title="Estimated useful lives of intangible assets"&gt;6&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Customer relationships - other courses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsOtherCoursesMember_zAOTCaqrU9O3" title="Estimated useful lives of intangible assets"&gt;4.5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Software license&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zjo7dH7vBiXd" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Education content&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zyWGqGGxn1N5" title="Estimated useful lives of intangible assets"&gt;3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zvRcOQGbg7X5" title="Estimated useful lives of intangible assets"&gt;2&lt;/span&gt; - &lt;span id="xdx_903_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zIBFrQClh4Ga" title="Estimated useful lives of intangible assets"&gt;30&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyMember_z3qO4r0lhFHe" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_CustomerRelationshipsMedicineMember"
      id="Fact003429">P6Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_CustomerRelationshipsOtherCoursesMember"
      id="Fact003431">P4Y6M</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember"
      id="Fact003433">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_EducationContentMember"
      id="Fact003435">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_ifrs-full_BrandNamesMember"
      id="Fact003437">P2Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_ifrs-full_BrandNamesMember"
      id="Fact003439">P30Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_DevelopedTechnologyMember"
      id="Fact003441">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact003444">&lt;p id="xdx_806_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_z1Fsf8NZRM34" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;13&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_82D_zorj3lSPc0a3"&gt;Financial assets and financial liabilities&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #0D0E00"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;13.1&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Financial assets &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--FinancialAssetsExplanatory_pn3n3_zJLMLzaNeYWi" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B4_zdIUHg3WDrwj" style="display: none"&gt;Schedule of financial assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 56%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;At amortized cost:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeReceivables_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_znvhRTpgqlal" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;585,923&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeReceivables_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zltSo2FYUQFj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;495,399&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRijhHHmHUsi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;585,923&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z8eNeDWDgcWj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;495,399&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CurrentFinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zDSNLhZailvk" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;546,438&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentFinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zDH89V548f0l" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;452,831&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z8gvKyGqExqj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;39,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zbyrwCdiwf9h" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;42,568&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zgYPot13SO5b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;13.2&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Financial liabilities&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--FinancialLiabilitiesExplanatory_pn3n3_zNAamn5fgTHj" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BB_zVLBJXM1nqMi" style="display: none"&gt;Schedule of financial liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 56%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;At amortized cost:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zsZ5z4tBNd16" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,222&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zaflng1uIr16" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71,482&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGCVA33rQQZe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,800,775&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LoansAndFinancing_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zZDf2YxUiPyj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,882,901&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zCR0jnW0qx3f" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;874,569&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LeaseLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zahkjH53tg56" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;769,525&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zvd44yXvyfvi" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;566,867&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zBUVkdriNaCl" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;528,678&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NotePayable_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zG5S5iOcosV8" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NotePayable_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zA0iGBXV1x2k" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,176&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGG5suRO9WQ3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,350,433&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4vSHarrOjr4" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,314,762&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4zKHRNZy307" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;678,370&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zPLNPpcSDgD1" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;573,030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_znNl3Ionj775" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,672,063&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zcjxZaF92JNi" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,741,732&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A3_zCXdCLXKngY3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #C00000"&gt;&lt;b&gt;13.2.1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #C00000"&gt;&lt;b&gt;Loans and financing&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--LoansAndFinancingExplanatory_pn3n3_zx8gg8As9Cd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span id="xdx_8BF_z3FjGsB32I6k" style="display: none"&gt;Schedule
    of loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial institution&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Interest rate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zwhEO91dhfLf" title="Financial institution"&gt;Banco Ita&#xfa; Unibanco S.A&lt;/span&gt;. (a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian real&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zPovUXEsgu85" title="Interest rate"&gt;CDI + 1.90% p.y.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90C_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_z9FbYff3t5Pi" title="Maturity"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zxtdhVhnUYl9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;412,880&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zuTknWjmk7z3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,134&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90B_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_z63efS7dHPW6" title="Financial institution"&gt;FINEP&lt;/span&gt; (b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian real&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zYY7ZOaEGG5i" title="Interest rate"&gt;TJLP p.y.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90A_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_za4bA5mRwBMi" title="Maturity"&gt;2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zLWcQNCImBv8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,193&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zz5NcqU4jFkf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;8,418&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zixPvLe2cUm2" title="Financial institution"&gt;Banco Ita&#xfa; Unibanco S.A.&lt;/span&gt; (c)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian real&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_ze6xeIWghk6h" title="Interest rate"&gt;CDI + 1.75% p.y.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_ziloWsxWkwZe" title="Maturity"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zAXlGIXZMIRj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;21,405&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zZsdujsDMr63" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;32,252&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90B_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zTtQj1dKJQH5" title="Financial institution"&gt;Softbank&lt;/span&gt; (d)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian real&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zgAcYMbOeJd" title="Interest rate"&gt;6.5% p.y.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_909_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_z9JbBX8Z8CKb" title="Maturity"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zvFybhC9AJYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;825,957&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zkLfVMdMdmXk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;824,258&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90A_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zhKl4Fl7Ir0j" title="Financial institution"&gt;Debentures&lt;/span&gt; (e)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian real&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zwYtnJrmhQml" title="Interest rate"&gt;CDI + 1.80% p.y.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90B_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zhF90K588Ozc" title="Maturity"&gt;2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zuEihA0v0K7i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;529,340&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zoalALfixzve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;499,839&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancing_iI_pn3n3_c20231231_zJH3pY03LGDf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,800,775&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LoansAndFinancing_iI_pn3n3_c20221231_z5cUqIHiEmq3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,882,901&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancingCurrent_pn3n3_c20231231_zE9O3pNmyqHg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;179,252&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancingCurrent_pn3n3_c20221231_z8ClKkSIN7q8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;145,202&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LoansAndFinancingNonCurrent_pn3n3_c20231231_zG4Rcw4uOJcb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,621,523&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LoansAndFinancingNonCurrent_pn3n3_c20221231_zkCz0TP20Am7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,737,699&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AA_zdrHceVnbSW2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(a) On October 1, 2020, Afya Brazil entered into a loan with Banco Ita&#xfa;
Unibanco S.A. in the amount of R$500,000 adjusted by the CDI rate plus an interest rate of 1.62% per year and is repayable in three installments
in October 2022, April 2023 and October 2023. This agreement has financial covenants and the Company should not reduce its EBITDA by 50%
or more year over year. As of December 31, 2023, the Company is compliant with all obligations set forth in this agreement.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On September 28, 2022, Afya Brazil signed an amendment with Banco Ita&#xfa;
Unibanco S.A in order to extend its debt profile, postponing the original repayments dates from 2022 and 2023 to 2023, 2024 and 2025.
Due to such extension, the spread over CDI rate increased from 1.62% p.y to 1.90% p.y.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(b) On July 23, 2019, Medcel entered into a loan of R$16,153 with Financiadora
de Estudos e Projetos (&#x201c;FINEP&#x201d;), a governmental agency focused on financing investments on R&amp;amp;D, which has an interest
rate based on TJLP (Long term interest rate), and maturity in 2027. The first and second tranches of R$6,734 and R$4,130, respectively,
were drawdown in October 2019 and December 2020, respectively, and new tranches were drawdown in March and June 2023 totaling R$5,288
in order to develop the Medical web series and other digital content. There is no financial covenant related to this agreement. The total
balance is guaranteed by a bank financial guarantee.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(c) On October 28, 2020, UnifipMoc entered into a loan with Banco Ita&#xfa;
Unibanco S.A. in the amount of R$30,000. On June 30, 2021, this agreement was amended and is now adjusted by the CDI rate plus an interest
rate of 1.75% per year and is repayable in three installments in July 2023, January 2024 and July 2024. There is no financial covenant
related to this agreement.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(d) On April 26, 2021, the Company issued and sold 150,000 shares of perpetual
convertible preferred shares designated as Series A perpetual convertible preferred shares, with a par value of US$0.00005 per share of
the Company for US$150,000 thousands, equivalent to R$821,805 on the issuance date. The Series A perpetual convertible preferred shares
is a class of equity security that ranks senior to the common shares with respect to dividend rights or rights upon liquidation.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Each Series A perpetual convertible preferred share is entitled to a cash
dividend of 6.5% per annum and is convertible, at the holder&#x2019;s discretion, into the Company&#x2019;s Class A common shares at an
initial conversion price of US$25.35. The Company may require the conversion of any or all of the Series A perpetual convertible preferred
shares at any time on or after the three-year anniversary of the original issuance date if certain conditions set forth in the certificate
of designation are met (if for 20 out of 30 consecutive trading days prior, Afya&#x2019;s stock price is equal or above 150% of the conversion
rate). The Company may also redeem any or all of the Series A perpetual convertible preferred shares for cash, shares of its common shares
or a combination thereof at its election, at any time on or after the seven-year anniversary of the original issuance date as determined
in the certificate of designation. On or after the five-year anniversary of the original issuance date, the holders of the Series A convertible
perpetual preferred shares shall have the right to redeem all of the outstanding Series A convertible perpetual preferred shares for cash,
the Company&#x2019;s common shares or a combination thereof (at the Company&#x2019;s election, subject to certain conditions) to be determined
in the certificate of designation. Upon the occurrence of a change of control, the holders will have the right to redeem their Series
A convertible perpetual preferred shares for cash at a price set forth in the certificate of designation.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Series A convertible perpetual preferred shares will be entitled with
the same voting rights of the common shares only when converted into it.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company determined that the Series A perpetual convertible preferred
shares should be classified as financial liability at amortized cost upon their issuance since is redeemable primarily according to the
decision of the holder and there is a contractual obligation to deliver assets (cash, shares of its common shares or a combination thereof)
that could not be avoided by the Company in an event of redemption. The financial liability is denominated in Brazilian Reais and thus
not subject to foreign exchange changes.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;In addition, as the entire instrument is classified as a liability, the
embedded put option to redeem the Series A perpetual convertible preferred shares for cash is an embedded derivative. The embedded derivative
will not be treated separately once the exercise price of the option is closely related to the host contract.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The initial transaction costs that are directly attributable to the issuance
of Series A perpetual convertible preferred shares were measured at fair value together with the financial liability on initial measurement.
The transaction costs totaled R$13,030, including legal counsels and advisors.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(e) On December 16, 2022, Afya Brazil issued 500,000 simple, non-convertible,
unsecured debentures in a single series, each with a par value of R$1, totaling an aggregate amount of R$500.000, by means of a public
distribution with restricted placement efforts in the Brazilian market, under the terms of the Brazilian Securities Commission (&#x201c;CVM&#x201d;)
Rule No. 476. Afya expects to use the proceeds of the offering for general corporate purposes, strengthening its cash position, and extending
its debt maturity profile. The debentures were issued with a maturity date of January 15, 2028, with the principal to be amortized in
two equal installments payable on January 15, 2027 and January 15, 2028, corresponding to the fourth and fifth years of the transaction,
respectively. The debentures bear interest at 100% of the CDI rate (the average of interbank overnight rates in Brazil, based on 252
business days) plus 1.80% per year, payable semi-annually on January 15 and July 15 of each year, until the maturity date.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;This transaction is subject to certain obligations including financial covenants.
According to this offering, Afya shall maintain net debt (excluding Softbank transaction and lease liabilities) to adjusted EBITDA ratio
below or equal to 3.0 x, at the end of each fiscal year, until maturity date. Adjusted EBITDA considers net income plus (i) income taxes
expenses, (ii) net financial result (excluding interest expenses on lease liabilities), (iii) depreciation and amortization expenses (excluding
right-of-use depreciation expenses), (iv) share-based compensation expenses, (v) share of income of associate, (vi) interest received
and (vii) non-recurring expenses. As of December 31, 2023, the Company is compliant with all obligations set forth in the deed of issuance.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The transaction costs that are directly attributable to the issuance of
debentures were measured at fair value together with the financial liability on initial measurement. The transaction costs totaled R$3,115,
including legal counsels and advisors.&lt;/p&gt;

&lt;p id="xdx_8A7_zrzHNk8nsqGi" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 14.2pt"&gt;&lt;b&gt;13.2.2&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Leases&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company has lease contracts for properties. The lease contracts generally
have maturities in the lease terms between five &lt;span id="xdx_90E_ecustom--ContractualLeaseTerm_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zD6PbyEzv0B9" style="display: none" title="Contractual lease term"&gt;5&lt;/span&gt;
and &lt;span id="xdx_908_ecustom--ContractualLeaseTerm_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zkzUL9zRuq3b"&gt;30
&lt;/span&gt;years. There are no sublease or variable payments in-substance lease agreements in the period.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The carrying amounts of right-of-use assets and lease liabilities as of
December 31, 2023, 2022 and 2021 and the movements during the years are described below:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfLeasesExplanatory_pn3n3_z2S2V2JTiUQe" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities  (Details 3)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B3_z8bEv5AvX4ng" style="display: none"&gt;Schedule of  right-of-use assets and lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Right-of-use assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Lease liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;As of January 1, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231_zzm8oscCEqVe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;419,074&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--LeaseLiabilities_iS_pn3n3_c20210101__20211231_zHUcS7LloIqb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20210101__20211231_zXFrKAWoPbvc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,689&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20210101__20211231_zU6X8OtdP12c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,689&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20210101__20211231_zLg8S1jXq9r" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;95,962&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20210101__20211231_zNaiKcv9cc01" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;95,962&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20210101__20211231_z69SVDxa9073" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;139,514&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20210101__20211231_zoUsD3VfM932" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;139,514&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20210101__20211231_zPMkXpuVkZgb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(43,237)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20210101__20211231_zs8qnE6TIHy7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3587"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20210101__20211231_zjDVV5t6wSg1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3589"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20210101__20211231_zTmLwJhXFUpa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;67,212&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20210101__20211231_zOurIa33N2ai" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3593"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20210101__20211231_zkH2q38KAUWb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(20,075)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of interest&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20210101__20211231_zDG9GQPJ2pw3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3597"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20210101__20211231_zcpRlWrsnwAi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(67,676)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsWriteoff_pn3n3_c20210101__20211231_zxJjvDTk9Rbh" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(10,316)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20210101__20211231_znB8p8dHSy8a" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,244)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231_ztFQuSUk4o81" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;663,686&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iE_pn3n3_c20210101__20211231_zwU995Xr7y9l" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;714,085&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20211231_zCnkvKVjjYff" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3609"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20211231_zgohRItwed46" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,955&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20211231_zR0hVh8DWdq4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;663,686&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20211231_zd0zw6pM76v9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;689,130&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Right-of-use assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Lease liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231_zlxdHP7lsB6g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;663,686&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeaseLiabilities_iS_pn3n3_c20220101__20221231_zMy7EivATDh1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20220101__20221231_zkUzBAjoZudl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;42,250&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20220101__20221231_zdMwpGke2J8g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;42,250&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20220101__20221231_zLo27DxLkySg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,623&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20220101__20221231_zpczl7PdsrKb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,623&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20220101__20221231_zsIqOT0TD00l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(54,684)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20220101__20221231_zc61iPN2iafb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3631"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20220101__20221231_z8ZyVH5YJXK2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3633"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20220101__20221231_zaS3bgdrcWL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;88,571&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20220101__20221231_zAtnAxV0hK3l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3637"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20220101__20221231_zFp1eQhddoLb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(28,511)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of interest&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20220101__20221231_zWPvjnbneWN1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3641"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20220101__20221231_zIEYWMHuW9A7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(85,001)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightofuseAssetsWriteoff_pn3n3_c20220101__20221231_zEp14ubf4aE9" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(19,802)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20220101__20221231_zy8tQ3J8uoIk" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(20,492)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231_zt20Zm1Edac1" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;690,073&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--LeaseLiabilities_iE_pn3n3_c20220101__20221231_zwh8Cddthstb" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;769,525&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20221231_zhOdB4doCdzd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3653"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20221231_zeTGzTc8NqR4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;32,459&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20221231_zKAgb5I4C169" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;690,073&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20221231_zG4fAtsBel0h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;737,066&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Right-of-use assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Lease liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;As of January 1, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--RightofuseAssets_iS_pn3n3_c20230101__20231231_zJ5QW0knYgvg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;690,073&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--LeaseLiabilities_iS_pn3n3_c20230101__20231231_z9rzREO9aZ4e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;769,525&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20230101__20231231_zL8q1ZMxF01d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,328&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20230101__20231231_zF8PDKKNoA74" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,328&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20230101__20231231_zmlrYcYftY4e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,387&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20230101__20231231_zjshxc8CiJ9g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,387&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20230101__20231231_zQkxIXV3QY0j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;65,408&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20230101__20231231_znya9xJSI7m3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;65,408&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20230101__20231231_zpWBB2SsLyMe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(63,118)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20230101__20231231_zf88jHsLHpl8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3679"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20230101__20231231_zSvjvWhL4v8k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3681"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20230101__20231231_zvrn5y18fJYe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;100,849&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20230101__20231231_zhP3jV9zQof1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3685"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20230101__20231231_zHbnyGwOKiMa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(31,473)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of interest&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20230101__20231231_zP0thVavb4e3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3689"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20230101__20231231_zumiwKY2X5v" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(103,911)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsWriteoff_pn3n3_c20230101__20231231_zb3dBBxzfvNi" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,469)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20230101__20231231_zh7AKxCRTijl" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,544)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20230101__20231231_zlUoyhlLZswa" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;767,609&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LeaseLiabilities_iE_pn3n3_c20230101__20231231_z16B5lRhZuCj" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;874,569&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20231231_zTtXFjUW87M8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3701"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20231231_zmhwLxJW1k0k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;36,898&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_pn3n3_c20231231_zQCPpLweoxoh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;767,609&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20231231_zrM76p2JsvJf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;837,671&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to anticipated termination of real estate leasing contracts.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A4_zqpyw4oH6tNc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company recognized lease expense from short-term leases and low-value
assets of R$&lt;span id="xdx_90D_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20230101__20231231_zqK6BzOCK2Q5" title="Amount recognized lease expense from short-term leases and low-value assets"&gt;10,871&lt;/span&gt; for the year ended December 31, 2023 (R$&lt;span id="xdx_903_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20220101__20221231_z9XznHz792Yl" title="Amount recognized lease expense from short-term leases and low-value assets"&gt;12,153&lt;/span&gt; and R$&lt;span id="xdx_909_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20210101__20211231_zoUspIehOUO9" title="Amount recognized lease expense from short-term leases and low-value assets"&gt;11,229&lt;/span&gt; for the years ended December 31, 2022 and 2021, respectively).&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 14.2pt"&gt;&lt;b&gt;13.2.3&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Accounts payable to selling shareholders&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--AccountsPayableToSellingShareholdersExplanatory_pn3n3_ziliB0JMP9W1" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 4)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BF_zOKpbQr6YHl" style="display: none"&gt;Schedule of accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 74%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of IPEMED (a)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPEMEDMember_zjtgI6j1eYq" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,805&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPEMEDMember_zTQZ7KUP2jZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;22,654&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of UniRedentor (b)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zF6jWThx2Bkb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,155&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z6NHOhGMEWHl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,064&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of UniSL (c)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zh977wXaQTj2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,064&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zBaa6vYEC4Y4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;37,301&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of FCMPB (d)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zLPciQs1PG4k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;63,168&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z3z4bxuy59Tf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;111,755&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of Medical Harbour (e)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zrBoO00mwD1d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zkUvv1YP0P5a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,053&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of Shosp (f)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zRMEfKuajtPa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;454&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_ztbJtUFpYAbc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,206&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of Unigranrio (g)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zXDpRmTor8Jf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;156,235&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zUAtEZPbz5Ff" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;216,716&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of RX PRO (h)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zcJm9tHQRXEb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3745"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zqCSbNCSdrC8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,781&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of Guaranhuns (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_ziwmClvDXXSf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3749"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_zDNXLGfPllpc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;30,653&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of Al&#xe9;m da Medicina (j)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_z3BMOhOC4469" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;18,325&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zf1cqHzkk09b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,996&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of CardioPapers (k)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_znB8g3Ng7FWg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,173&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zoCnYH4KGU7g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,979&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of Glic (l)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zZpgf1L6hkHi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3761"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqUaAylbsOW3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;9,520&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of DelRey (m)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zkGSxhB2heV2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;256,488&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWh1tD0PtqQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3767"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231_zw28pc3pfnra" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;566,867&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231_zcGlMoRUF3nf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;528,678&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersCurrent_pn3n3_c20231231_ztoL7CLqVncc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;353,998&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_pn3n3_c20221231_zhwIzkX0JYLl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;261,711&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AccountsPayableToSellingShareholdersNonCurrent_pn3n3_c20231231_zXtBCJlRGiag" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;212,869&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_pn3n3_c20221231_zQI82jJ7MbM5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;266,967&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A4_zmAq9VsnJSLj" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--AccountsPayableToSellingShareholders1Explanatory_pn3n3_zXgQenVehkk4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 5)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B5_zEraxvDL7gzi" style="display: none"&gt;Schedule of accounts payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; width: 64%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Opening balance&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zbJULWSraGt8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;528,678&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z3cUwk7UaRKc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;679,826&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zgQlOb5Rvnt2" style="text-align: right; line-height: 10pt" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash flows - Payments and deductions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZq02NmwYUpj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows payments and deductions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(225,460)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zNM1Z8mB8kx" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows payments and deductions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(236,760)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zeRVdp0I9zxk" style="text-align: right; line-height: 10pt" title="Cash flows payments and deductions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(180,020)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payment of interest (i) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwCc7jojqdJj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payment of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(55,989)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOeaGHJ3JUqh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payment of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(24,428)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zhYXmvlVfi0b" style="text-align: right; line-height: 10pt" title="Payment of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(12,661)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of licenses &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZi0w3oiADTg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Acquisition of licenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3801"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zurbn4TXoPs2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Acquisition of licenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,408&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zvhjw41RaIQf" style="text-align: right; line-height: 10pt" title="Acquisition of licenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InterestExpense_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZU9mamIs1j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;85,069&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InterestExpense_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z2dfGwU41v29" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;68,064&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--InterestExpense_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zcLYGoNRMarl" style="text-align: right; line-height: 10pt" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;31,915&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions - Consideration to be transferred on business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zEDIzqwicxb2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Additions consideration to be transferred on business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;234,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zx3JNTpsDtS5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Additions consideration to be transferred on business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3815"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zJ5p0YmMzi74" style="text-align: right; line-height: 10pt" title="Additions consideration to be transferred on business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;243,816&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Consideration to be transferred on business combinations (earn-outs)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zROvmhfczSih" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt" title="Consideration to be transferred on business combinations (earn-outs)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3819"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zL5vNj3woY48" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Consideration to be transferred on business combinations (earn-outs)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,921&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFV1daN0l1Wi" style="text-align: right; line-height: 10pt" title="Consideration to be transferred on business combinations (earn-outs)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,536&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--Reversals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zWVhsxfBtqvh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3825"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--Reversals_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z2hWFxLGnHRb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(10,353)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--Reversals_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zumMbbBxg1m" style="text-align: right; line-height: 10pt" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3829"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement of earn-outs (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RemeasurementOfEarnouts_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoN25Pe3anMi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Remeasurement of earn-outs"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,556&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RemeasurementOfEarnouts_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zrZSalRvocjg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Remeasurement of earn-outs"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3833"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RemeasurementOfEarnouts_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zRBb15aXcrxd" style="text-align: right; line-height: 10pt" title="Remeasurement of earn-outs"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3835"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmH6rqDHXHr6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,987)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmbGyYVfm2Lb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3839"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zJbOADQBxQk5" style="text-align: right; line-height: 10pt" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3841"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Closing balance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zKGOsQlY0Zx7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;566,867&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFeodshF64R1" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;528,678&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zLsXqSNbZcEe" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right; line-height: 10pt" title="Closing balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;679,826&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Payment of interest from acquisition of subsidiaries are included in cash flows from investing
activities.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;During the measurement period, management&#x2019;s expectation has been reviewed based on
performance for revenue goals and the contingent consideration for the acquisition of Al&#xe9;m da Medicina, CardioPapers and Glic
have been remeasured by R$4,773, R$5,082 and (R$7,299), respectively, totaling R$2,556 as of December 31, 2023. These are measured by
the Company at the present value.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A3_zA6YlBl3bCH1" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(a) On May 9, 2019, Afya Brazil acquired &lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20190508__20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zNaLsrutma48" title="Ownership Interest"&gt;100&lt;/span&gt;% of IPEMED and R$&lt;span id="xdx_909_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zeDHUUO3ZRpf" title="Remaining accounts payable"&gt;45,303&lt;/span&gt; is
payable in five equal installments of R$&lt;span id="xdx_90B_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20240229__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zUnFiMnhmLbb" title="Equal installments payables"&gt;&lt;span id="xdx_908_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20230228__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zIe25HgbZQQe" title="Equal installments payables"&gt;&lt;span id="xdx_903_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20220228__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zz6QYvafjC81" title="Equal installments payables"&gt;&lt;span id="xdx_90E_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20210228__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zOHR3I3FOlYa" title="Equal installments payables"&gt;&lt;span id="xdx_90A_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_pn3n3_c20200229__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zuEeDAKl6fdl" title="Equal installments payables"&gt;9,061&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;, adjusted by the CDI rate, and due annually in February 2020, 2021, 2022, 2023 and 2024.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(b) On January 31, 2020, Afya Brazil acquired &lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20200101__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zkfreht98Uj6" title="Ownership Interest"&gt;100&lt;/span&gt;% of UniRedentor and R$&lt;span id="xdx_908_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_pn3n3" title="Remaining accounts payable"&gt;100,000&lt;/span&gt;
is payable in five equal installments from January 2021 through July 2024, adjusted by the CDI rate. The purchase consideration was adjusted
by R$&lt;span id="xdx_90F_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_pn3n3_c20210131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zr8NiXdFSxXk" title="Equal installments payables"&gt;4,503&lt;/span&gt; and such amount was deducted from the first installment paid in February 2021.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(c) On May 5, 2020, Afya Brazil acquired &lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zInQgBxYkVV" title="Ownership Interest"&gt;100&lt;/span&gt;% of UniSL and R$&lt;span id="xdx_907_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z8JajKv9URsg" title="Remaining accounts payable"&gt;60,456&lt;/span&gt; was
paid in three equal installments through May 2023, adjusted by the CDI rate. The purchase consideration was adjusted by R$&lt;span id="xdx_90B_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_pn3n3_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zeOyypnp911d" title="Equal installments payables"&gt;7,816&lt;/span&gt; and such
amount was deducted from the first installment paid on May 5, 2021. The open balance as of December 2023 relates to the amount due from
additional seats and will be paid in 2024.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(d) On November 9, 2020, Afya Brazil acquired &lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z6arrEWXkLd7" title="Ownership Interest"&gt;100&lt;/span&gt;% of FCMPB and R$&lt;span id="xdx_904_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zLbHV73MmT0d" title="Remaining accounts payable"&gt;188,894&lt;/span&gt;
is payable in four installments through November 2024, adjusted by the CDI rate.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(e) On April 8, 2021, Afya Brazil acquired &lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20210407__20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zWNxN06TjmSd" title="Ownership Interest"&gt;100&lt;/span&gt;% of Medical Harbour and an
earn-out of R$&lt;span id="xdx_904_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zdbyudcIhrsj" title="Remaining accounts payable"&gt;9,000&lt;/span&gt; is payable in relation to product development goals for 2021 and 2022 and revenue achievements for 2023. The contingent
consideration of R$&lt;span id="xdx_904_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zORIqtkKYUzj" title="Defined benefit obligation, at present value"&gt;3,000&lt;/span&gt; will be paid in 2024 and is based on the facts and circumstances as of December 31, 2023.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(f) On May 13, 2021, Afya Brazil acquired &lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20210512__20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zFVnHV9gQCNh" title="Ownership Interest"&gt;100&lt;/span&gt;% of Shosp which included an
earn-out of R$&lt;span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_ztPBqontJGc5" title="Remaining accounts payable"&gt;513&lt;/span&gt; paid in August 2023 related to product development and R$&lt;span id="xdx_90E_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_pn3n3_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zDFDXUVpHG4e" title="Transaction price allocated to remaining performance obligations"&gt;454&lt;/span&gt; will be paid until 2026.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(g) On August 4, 2021, Afya Brazil acquired &lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20210803__20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zgguQYh1FrL8" title="Ownership Interest"&gt;100&lt;/span&gt;% of Unigranrio. The adjusted
aggregate purchase price was R$&lt;span id="xdx_908_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_pn3n3_c20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zoSIYbJoyvTf" title="Non-current payables for purchase of energy"&gt;618,956&lt;/span&gt; of which 60% was paid in cash on the transaction closing date, and 40% is payable in cash in four
equal installments through 2022 to 2025, adjusted by the CDI rate.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(h) On October 1, 2021, Afya Brazil acquired &lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20211001__20211002__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zFwBc8lIZZf7" title="Ownership Interest"&gt;100&lt;/span&gt;% of RX PRO and an earn-out
of up to R$&lt;span id="xdx_90F_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20211002__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zUwl7uEGbFe6" title="Remaining accounts payable"&gt;21,000&lt;/span&gt; is payable in relation to revenue achievements until 2024. The contingent consideration of R$&lt;span id="xdx_903_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_pn3n3_c20211002__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zjx7Q72tYwFg" title="Transaction price allocated to remaining performance obligations"&gt;1,781&lt;/span&gt; accounted for on
December 31, 2022 was remeasured and reversed in 2023 based on the facts and circumstances as of December 31, 2023.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(i) On November 5, 2021, Afya Brazil concluded the acquisition of &lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20211104__20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zAk2yb8ODmEe" title="Ownership Interest"&gt;100&lt;/span&gt;% of
ITPAC Garanhuns and R$&lt;span id="xdx_90B_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_pn3n3_c20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zvFMVjlzAei" title="Transaction price allocated to remaining performance obligations"&gt;54,000&lt;/span&gt; was paid in cash on the transaction closing date, and (ii) R$&lt;span id="xdx_90B_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zCGkegGMMGNe" title="Remaining accounts payable"&gt;54,000&lt;/span&gt; was paid in two equal installments, adjusted
by the CDI rate, in November 2022 and November 2023.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(j) On March 4, 2022, Afya Brazil acquired &lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zRvJ7Tr9vwDe" title="Ownership Interest"&gt;100&lt;/span&gt;% of Al&#xe9;m da Medicina
and an earn-out of up to R$&lt;span id="xdx_90F_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zaipSB9YW1kd" title="Remaining accounts payable"&gt;19,200&lt;/span&gt; is payable in connection with revenue target achievements and product development goals for 2023 and
2024. The purchase consideration was adjusted by R$&lt;span id="xdx_909_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zUixRAB4BPke" title="Equal installments payables"&gt;763&lt;/span&gt; in favor of the selling shareholders. The contingent consideration of R$&lt;span id="xdx_909_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zri2fyk8BQzl" title="Defined benefit obligation"&gt;18,325&lt;/span&gt;
is based on the estimated payment considering the facts and circumstances as of December 31, 2023.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(k) On &lt;span style="background-color: white"&gt;April 5, 2022&lt;/span&gt;, Afya
Brazil acquired &lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z6TuhmRGQfN8" title="Ownership Interest"&gt;100&lt;/span&gt;% of CardioPapers and an earn-out of up to R$&lt;span id="xdx_902_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zDZYFeZEv1tj" title="Remaining accounts payable"&gt;15,000&lt;/span&gt; is payable in connection with revenue target achievements and other
goals regarding credentials in the market for 2023 and 2024. The purchase consideration was adjusted by R$&lt;span id="xdx_90D_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_zDl995KdqYej" title="Equal installments payables"&gt;333&lt;/span&gt; in favor of Afya. The contingent
consideration of R$&lt;span id="xdx_906_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z5Wdbvnx4NHb" title="Defined benefit obligation"&gt;14,173&lt;/span&gt; is based on the estimated payment considering the facts and circumstances as of December 31, 2023.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(l) On March 23, 2022, Afya Brazil acquired &lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20220322__20220323__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zbLmxfxgsZT" title="Ownership Interest"&gt;100&lt;/span&gt;% of Glic and an earn-out
of up to R$&lt;span id="xdx_909_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20220323__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zPkbB0l7Fz06" title="Remaining accounts payable"&gt;12,000&lt;/span&gt; is payable in connection with revenue target achievements for 2023 and 2024 and product development goals. The contingent
consideration of R$&lt;span id="xdx_90D_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20220323__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zfk0kiRffsbh" title="Defined benefit obligation"&gt;9,520&lt;/span&gt; accounted for in December 31, 2022, was partially paid in 2023 (R$&lt;span id="xdx_908_ecustom--RemainingBalancePaid_pn3n3_c20220322__20220323__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zcgXSxLuKnXb" title="Remaining balance paid"&gt;3,000&lt;/span&gt;) and the remaining balance was remeasured
and reversed in 2023 considering the facts and circumstances as of December 31, 2023.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;(m) On January 2, 2023, Afya Brazil acquired &lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zYn0G7J6lxl" title="Ownership Interest"&gt;100&lt;/span&gt;% of DelRey. The aggregate
purchase price is R$&lt;span id="xdx_904_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z3tEjbF5GGBg" title="Non-current payables for purchase of energy"&gt;816,236&lt;/span&gt; of which R$&lt;span id="xdx_909_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zZWfE1HpBBg3" title="Transaction price allocated to remaining performance obligations"&gt;575,000&lt;/span&gt; was paid in cash on the transaction closing date, and R$&lt;span id="xdx_908_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zBeNyGONvF09" title="Consideration to be transferred"&gt;234,000&lt;/span&gt; (which includes R$&lt;span id="xdx_903_eifrs-full--ConsiderationPaidReceived_pn3n3_c20221229__20230201__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zIklZy815Di7" title="Adjustment for purchase consideration"&gt;16,000&lt;/span&gt;
purchase consideration adjustment, in favor of the Company) is payable in cash in three annual installments, respectively, of R$&lt;span id="xdx_900_ecustom--FirstAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zQqzf5Nv5JLf" title="First annual installment"&gt;134,000&lt;/span&gt;
in January 2024, R$&lt;span id="xdx_90F_ecustom--SecondAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zPYWZaMSjgne" title="Second annual installment"&gt;50,000&lt;/span&gt; in January 2025 and R$&lt;span id="xdx_90B_ecustom--ThirdAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zZJpWC6k9luk" title="Third annual installment"&gt;50,000&lt;/span&gt; in January 2026, adjusted by the SELIC rate. The aggregate purchase also includes
R$&lt;span id="xdx_90C_ecustom--AcquisitiondateFairValueOfTotalConsiderationTransferred1_iI_pn3n3_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zeJa0QV0XJXe" title="Fair value at the date of acquisition"&gt;7,236&lt;/span&gt; estimated at fair value at the date of acquisition related to an offer of AFYA&#x2019;s digital solutions free of charge until
December 31, 2030, for students of medicine of universities owned by the sellers and not part of the transaction.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 14.2pt"&gt;&lt;b&gt;13.2.4&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Notes payable&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;With the acquisition of UniSL, Afya Brazil assumed notes payable regarding
the previous acquisition of a portion of the operations of Universidade Luterana do Brasil (ULBRA) by UniSL in auction by the end of 2018.
Two of the UniSL campuses, located in the cities of Ji-Paran&#xe1; and Porto Velho, State of Rond&#xf4;nia, were acquired in such transaction.
As of December 31, 2023, all balances of Notes payable were paid and adjusted by 100% of IPCA-E. Below are the carrying amounts of notes
payable and the movements during the years ended December 31, 2023, 2022 and 2021:&lt;/p&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_pn3n3_zI1MwJVprYy8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 6)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BD_zNNBqtHMecB5" style="display: none"&gt;Schedule of carrying amount of notes payable and the movements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; width: 64%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 12%; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Opening balance&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NotesPayables_iS_pn3n3_c20230101__20231231_zZumwW3dqNMe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,176&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NotesPayables_iS_pn3n3_c20220101__20221231_z8LuCR28ybW6" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,726&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NotesPayables_iS_pn3n3_c20210101__20211231_zCzrVPC8Pap" style="text-align: right; line-height: 10pt" title="Notes payable beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,181&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Payments_pn3n3_c20230101__20231231_zhHb4Q3WxSR" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(49,347)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Payments_pn3n3_c20220101__20221231_z8mKdNAzbTLi" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(12,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--Payments_pn3n3_c20210101__20211231_zaNihkfhfaXh" style="text-align: right; line-height: 10pt" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(9,800)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of interest (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PaymentsOfInterest_pn3n3_c20230101__20231231_z1pus9OrYdvj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(15,529)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaymentsOfInterest_pn3n3_c20220101__20221231_zBtjwhQXhlVh" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,008)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PaymentsOfInterest_pn3n3_c20210101__20211231_zJ0XArvCtfM" style="text-align: right; line-height: 10pt" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,268)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Monetary indexation&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--MonetaryIndexation_pn3n3_c20230101__20231231_zQeOkg94T5fg" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Monetary indexation"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,700&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--MonetaryIndexation_pn3n3_c20220101__20221231_zP3D6TCwiAq" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Monetary indexation"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,458&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--MonetaryIndexation_pn3n3_c20210101__20211231_z6xRxKGRfURc" style="border-bottom: black 1pt solid; text-align: right; line-height: 10pt" title="Monetary indexation"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,613&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Closing balance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NotesPayables_iE_pn3n3_c20230101__20231231_zy2Doo6v6gLd" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3975"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NotesPayables_iE_pn3n3_c20220101__20221231_zDHYCKvhFUb7" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;62,176&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NotesPayables_iE_pn3n3_c20210101__20211231_zUJgfkDY7lp6" style="border-bottom: black 1.5pt double; text-align: right; line-height: 10pt" title="Notes payable ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;72,726&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CurrentLiabilities1_iI_pn3n3_c20231231_zImjJr5t7W39" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3981"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CurrentLiabilities1_pn3n3_c20221231_zTy8tYFM8lri" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,176&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CurrentLiabilities1_iI_pn3n3_c20211231_z4pe24LUNx24" style="text-align: right; line-height: 10pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,478&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20231231_zmPCI95aXc28" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3987"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20221231_zTEgZTr2iPGj" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3989"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20211231_zyS8sbnU0fqb" style="text-align: right; line-height: 10pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,248&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 0 7.1pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The amounts are included in cash flows from investing activities.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AC_zFeoaMuMnWZf" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;13.3&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Fair values&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The table below is a comparison of the carrying amounts and fair values
of the Company&#x2019;s financial instruments, other than those carrying amounts that are reasonable approximation of fair values:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfFairValuesExplanatory_pn3n3_zswu6R4455O9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 7)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B5_zJK6pWxh0tri" style="display: none"&gt;Schedule
    of fair values of the company's financial instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="border-bottom: black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;
    &lt;p style="border-bottom: black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 48%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;Financial assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Trade receivables (non-current)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zFs837uome8d" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;39,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zclm8DkYb8lj" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;39,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zImlu8DZ2jLj" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;42,568&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zHcJvwaLckM6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;42,568&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialAssets_pn3n3_c20231231_zw4KhUxubaoa" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;39,485&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20231231_zTh2iJY77cBb" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;39,485&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialAssets_pn3n3_c20221231_zNNI9Ii9Tml5" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;42,568&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20221231_zNfF5MeDj0j" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;42,568&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zeDFNFKeKwPd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;1,800,775&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z3UdWKCoXkw7" style="text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;1,795,752&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z8MVsGWTu2Pi" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;1,882,901&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zqE5UmRKe8D2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;1,934,295&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvTlrrv9bz48" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;874,569&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvZo3z2OSNbj" style="text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;874,569&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zG2y35CZMkdc" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;769,525&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zUFNrm8MIGVk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;769,525&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOjtCh58N4Gi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;566,867&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zWvIfRtuHp5d" style="text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;566,867&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zS0Bu4opkWi2" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;528,678&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zyRmfh5Q3zq9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;528,678&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zpjqJYyhcRva" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4035"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zuGeihlFqowa" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4037"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zSwW9FMkts7f" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;62,176&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_z4xfn4Oxzt9h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;62,176&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FinancialLiabilities_pn3n3_c20231231_zUSx8wBY3LO7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;3,242,211&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231_zLqaidjInSg2" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;3,237,188&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231_zeaXcLuRojA" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;3,243,280&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231_z4truBUYVEW9" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;3,294,674&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A7_zpsam74a5Oih" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The Company assessed that the fair values of current
trade receivables and other current assets, trade payables, advances from customers and other current liabilities approximate their carrying
amounts largely due to the short-term maturities of these instruments. The financial instruments for which the fair value are disclosed
are based on Level 2 fair value measurement hierarchy. There has been no change in fair value hierarchy during the years ended December
31, 2023 and 2022.&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The fair value of interest-bearing borrowings and
loans are determined by using the DCF method using a discount rate that reflects the issuer&#x2019;s borrowing rate as of the end of the
reporting period. The own non-performance risk at December 31, 2023 was assessed to be insignificant.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;13.4&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Financial instruments risk management objectives and policies&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The Company&#x2019;s main financial liabilities
comprise loans and financing, lease liabilities, accounts payable to selling shareholders, notes payable, trade payables and advances
from customers. The main purpose of these financial liabilities is to finance the Company&#x2019;s operations. The Company&#x2019;s main
financial assets include trade receivables and cash and cash equivalents.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company is exposed to market risk, credit risk and liquidity risk. The
Company monitors market, credit and liquidity risks in line with the objectives of capital management and counts on the support, monitoring
and oversight of the Board of Directors in decisions related to capital management and its alignment with the objectives and risks. The
Company&#x2019;s policy is that no trading of derivatives for speculative purposes may be undertaken. The Board of Directors reviews and
agrees with policies for managing each of these risks, which are summarized below.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 14.2pt"&gt;&lt;b&gt;13.4.1&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Market risk&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;Market risk is the risk that the fair value or
future cash flows of a financial instrument will fluctuate because of changes in market prices. The Company&#x2019;s exposure to market
risk is related to interest rate and foreign currency risk. The sensitivity analysis in the following sections relates to the position
as of December 31, 2023.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;a) Interest rate risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;Interest rate risk is the risk that the fair value
or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company&#x2019;s exposure
to the risk of changes in market interest rates relates primarily to the Company&#x2019;s cash equivalents, loans and financing, accounts
payable to selling shareholders and notes payable, with floating interest rates.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"&gt;&lt;span style="text-decoration: underline"&gt;Sensitivity analysis&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The table below demonstrates the sensitivity to
a reasonably possible change in interest on cash equivalents, loans and financing, accounts payable to selling shareholders and notes
payable. With all variables held constant, the Company&#x2019;s income before income taxes is affected through the impact on floating interest
rates, as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_pn3n3_zub13kxFjHY3" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 8)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B7_zn2xVc5VR2Zd" style="display: none"&gt;Schedule
    of income before income taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Index - % per year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Base rate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z1CmwrgwRFh5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,111&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90A_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z1Zhg3fb22H1" title="Index - % per year"&gt;100.8% of CDI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zteHpc4PvDha" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;60,846&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zxzsN62UahW1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(529,340)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zzKeMlQQ3cX6" title="Index - % per year"&gt;CDI + 1.8%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zulfA3LnOXTg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(71,196)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zjkWW6BQAR6h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(412,880)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zlfYUqzJPSGg" title="Index - % per year"&gt;CDI + 1.9%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zBlEYBtmvmW8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(55,945)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zTyOM3VjasWk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,193)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zrvQk1NqrTW9" title="Index - % per year"&gt;TJLP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zCH9Hf3BA766" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(733)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z9h6xH398M0f" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(21,405)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90B_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zcUlDXObefI1" title="Index - % per year"&gt;CDI + 1.75%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zCtn58HiZyJ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,868)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zM3Xtnp8qMQ8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(274,428)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_ztQoSudqoWe8" title="Index - % per year"&gt;CDI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zAT1MraOlzd6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(31,971)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z2uOMoIpL1Td" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(256,488)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zDlhhU9QYMhe" title="Index - % per year"&gt;SELIC&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zh7hDPdKbm16" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(29,881)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Net exposure&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--BaseRate_pn3n3_c20230101__20231231_zgkCjjYp6LOh" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(131,748)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Increase in basis points&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; width: 62%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;+75&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;+150&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Effect on profit before tax&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zYFdfJzbbPTi" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,407)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zN17YZqVBUr" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(14,814)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_zyGjjL0N75va" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;b) Foreign currency risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;Foreign currency risk is the risk that the fair
value or future cash flows of exposure will fluctuate because of changes in foreign exchange rates. The Company&#x2019;s exposure to the
risk of changes in foreign exchange rates relates to cash and cash equivalents denominated in U.S. dollars in the amount of R$&lt;span id="xdx_90F_eifrs-full--CreditExposure_iI_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zgN12uDQPqW7" title="Exposure risk"&gt;23,173&lt;/span&gt; as
of December 31, 2023 (December 31, 2022: R$&lt;span id="xdx_902_eifrs-full--CreditExposure_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zWVXyRnu6jSf" title="Exposure risk"&gt;24,447&lt;/span&gt;).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"&gt;&lt;span style="text-decoration: underline"&gt;Sensitivity analysis&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The table below demonstrates the sensitivity in
the Company&#x2019;s income before income taxes of a &lt;span id="xdx_901_ecustom--SensitivityChangeInTheEuroExchangeRate_pid_dp_c20230101__20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_ztjWtcwc24Vi" title="Percentage of sensitivity change in the Euro exchange rate"&gt;10&lt;/span&gt;% change in the U.S. dollar exchange rate (R$&lt;span id="xdx_902_eifrs-full--ClosingForeignExchangeRate_iI_uN_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zkXDuPDCpQQ6" title="Closing foreign exchange rate"&gt;4.8413&lt;/span&gt; to U.S. dollar &lt;span id="xdx_900_eifrs-full--ClosingForeignExchangeRate_iI_uN_c20231231__srt--CurrencyAxis__currency--EUR__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zSsy2TIyIqjd" title="Closing foreign exchange rate"&gt;1.00&lt;/span&gt;) as of December
31, 2023, with all other variables held constant.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_pn3n3_zJDMahFm18Ra" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 9)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B4_z3XcUWgWtd94" style="display: none"&gt;Schedule of sensitivity foreign currency&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 52%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Exposure&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;+10%&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;-10%&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zdZM8iqCNood" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,173&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zbBLT6FZyP9k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,317&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zx1YxzqAts9c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,317)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A7_zPyEWEyTMBW1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 14.2pt"&gt;&lt;b&gt;13.4.2&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Credit risk&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"&gt;Credit risk is the risk that
a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Company
is exposed to credit risk from its operating activities (primarily trade receivables) and from its financing activities, including cash
and cash equivalents.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"&gt;Customer credit risk is managed
by the Company based on the established policy, procedures and control relating to customer credit risk management. Outstanding customer
receivables are regularly monitored. See Note 7 for additional information on the Company&#x2019;s trade receivables.&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"&gt;Credit risk from balances
with banks and financial institutions is managed by the Company&#x2019;s treasury department in accordance with the Company&#x2019;s policy.
Investments of surplus funds are made only with approved counterparties and within limits assigned to each counterparty.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The Company&#x2019;s maximum exposure to credit
risk for the components of the statements of financial position on December 31, 2023 and 2022 is the carrying amounts of its financial
assets.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 14.2pt"&gt;&lt;b&gt;13.4.3&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Liquidity risk&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company&#x2019;s Management has responsibility for monitoring liquidity
risk. In order to achieve the Company&#x2019;s objective, Management regularly reviews the risk and maintains appropriate reserves, including
bank credit facilities with first tier financial institutions. Management also continuously monitors projected and actual cash flows and
the combination of the maturity profiles of the financial assets and liabilities.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The main requirements for financial resources used by the Company arise
from the need to make payments for suppliers, operating expenses, labor and social obligations, loans and financing and accounts payable
to selling shareholders.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The tables below summarize the maturity profile
of the Company&#x2019;s financial liabilities based on contractual undiscounted amounts:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;






&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_pn3n3_zfb5sP9cHG2" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 10)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B6_z7Ix2AYP9vgb" style="display: none"&gt;Schedule of maturity profile of financial liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Less than 1 year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1 to 3 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3 to 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;More than 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zKqpogNzeLQ8" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,222&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zlXoRe7b9DBi" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4125"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zKGhZQnf6hEf" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4127"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zd9BIrkyDVK5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4129"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zBPpQDCGIrla" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,222&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjfA8ZBcwEm7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;298,981&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVKkdOpEPvcb" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,383,255&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2ND2SJ83wp5" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;568,326&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zsgghcZXp1nd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4139"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zsZWmnYIZTO4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,250,562&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvCWqPqgEbi7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;137,735&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zB2AA8LB5gPf" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;268,724&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z76RVpz4aMNc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;255,456&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJRt5StHaGXh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,261,213&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmJTIANl8Q96" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,923,128&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znPsXiOMCp12" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;387,693&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zNz2H9JulMXd" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;231,478&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zX4EmWKbXqT" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4157"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zB3yZUZGzu3f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4159"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zXfVv6dplGkf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;619,171&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Advances from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Advances_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zME4b62JV7sl" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;153,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zwzkYT7f58kk" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4165"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr1apcQkETf1" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4167"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zUElOKxFqFMj" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4169"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Advances_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeem7BEz0hn3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;153,485&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zZ8hDu6SFyzh" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,086,116&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z5BDQH8bxtsa" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,883,457&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zT1uFCFjemLb" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;823,782&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zovJFtW5v6Cl" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,261,213&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zU2V63uMcu62" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;5,054,568&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Less than 1 year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1 to 3 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3 to 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;More than 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFYjRLe0sr3k" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71,482&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVAgiBhQkOc8" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4185"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zv6qSV9PNFWe" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4187"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJV2gX82sHJ8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4189"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zEo3Amrr3gX4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71,482&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGMolnuvMz5j" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;287,741&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmDIPpbkjg9d" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;788,190&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zBbcXIg611D3" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,237,599&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zS3uZwei8xPe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4199"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjj4Qt9o90Xi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,313,530&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z1LhxyYQUb04" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;117,506&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zyjqz9jJLsv6" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;234,688&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr9cmg2QCVU5" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;219,127&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zz9FvZfCyw8j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,139,771&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFnZkptdDykf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,711,092&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z5eY9D2z3HK1" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;282,481&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zMnsKPFukR34" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;339,281&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zttMMmQPyQVl" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4217"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zL5Ew6XkyqPd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4219"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgdhI4OV14Yb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;621,762&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NotePayables_iIP3ifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOfQHd3SH4o3" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,176&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zDTh1pftWl9g" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4225"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zkh3l2fqtjIc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4227"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVFde30t5472" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4229"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztrWQM5u61f4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,176&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Advances from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zXGrzgZK41s7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;133,050&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr6ZS3rPKD85" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4235"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zANnTznH1kXj" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4237"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGd6AVfTyGj2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4239"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zNY8vWl2W63e" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;133,050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z93TKGcwfCkd" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;954,436&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOLa5MgMrUbc" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,362,159&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztILcbHGFaq7" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,456,726&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znJijWd3Flt9" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,139,771&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOUKujqThra2" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;4,913,092&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A2_zLSjA1Ef5pi3" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;13.5&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Changes in liabilities arising from financing activities&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_pn3n3_znD3NLxzm0s8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 11)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BF_zOrYKxtipXZd" style="display: none"&gt;Schedule of changes in liabilities arising from financing activities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments of principal&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 9%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments of interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Business combination&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: -5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zb5oCuVF2yU9" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,882,901&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z1OkdgyXg4N" style="text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(112,630)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zz91xZ7KP0W2" style="vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(175,889)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzpSINmYrvi" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,288&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zdUuGXkS87J4" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;197,678&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zRc9ScNgC2Le" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4265"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0YRYzOiAbDk" style="padding-right: 0.15pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,427&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0hWMvdNrn02" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,800,775&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYf8cRihXEla" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;769,525&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zR2nMfRekJq7" style="text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(31,473)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zC97GDXfYtG7" style="vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(103,911)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxjk1h1PbXRj" style="padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;77,715&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYAjczM65A1j" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;100,849&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zVDA8oIuDHE" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;65,408&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYfhJaueJrFa" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,544)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zo0m5A5acNlj" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;874,569&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zwtzRK5Fwffl" style="border-bottom: black 1pt solid; text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(18,750)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zFo3dpzJSFqe" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4289"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z8Z0JZ93uE4f" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;18,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: -0.15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231_zMKwqychlUL5" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,652,426&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zl9R91ymLWLc" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(162,853)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231_zCKkWkERt6cg" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(279,800)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z7rZ7YHdggYe" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;101,753&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zUFpLWbFA4je" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;298,527&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zlxTmIH9PCDc" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;65,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zebvvVZYquEf" style="border-bottom: black 1pt solid; padding-right: -5.15pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(117)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231_zIINH3EzP9p1" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,675,344&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;January 1, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments of principal&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 8%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments of interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Business combinations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: -5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zjeEFgq56np2" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,374,876&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zEwNAVSAqorj" style="text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,791)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zrrRt69nvtx9" style="vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(116,587)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzU4iMhnx5gk" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;496,885&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zCK1Hw1ilUDi" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;127,559&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zr0qvCHNkJw7" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4319"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zK6r0rlPGix8" style="padding-right: 0.15pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,959&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zCJjUkT2tLHk" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,882,901&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zoi3iYocDHK3" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvuyDODzqePk" style="text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(28,511)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zX3KJ3Ib6cSa" style="vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(85,001)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zHioC4pfibIa" style="padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;100,873&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zD32aHFrwWrf" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;88,571&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zi3ngNPHWwB8" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4335"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zBaY0ypLltl" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(20,492)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxn0fQ2cPZPj" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;769,525&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z0p2NsGW2d24" style="border-bottom: black 1pt solid; text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(19,736)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zmB1yGQcQtXg" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4343"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zCFdrY8qXPDl" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;19,736&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: -0.15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231_zUhWEPSqKU1b" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,088,961&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zPpSwvF3ojPl" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(50,038)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231_z4ktVBIa9ha" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(201,588)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zPBmJguotbH7" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;617,494&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_z0KOyBp9fS01" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;216,130&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zaq1pYbwsTIg" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4357"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zB1yN3yN8WUc" style="border-bottom: black 1pt solid; padding-right: -5.15pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(18,533)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231_zJxvR9gCYeu4" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,652,426&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments of principal&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 8%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments of interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Additions (ii)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Business combinations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z37iLiWRrR8d" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;617,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zsMxQRR4XKhb" style="text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(107,766)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z5WS9nNRhurf" style="vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(50,310)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zNuOgl1HATC5" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;809,539&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znkh4kSlZoF5" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;68,909&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zApx8FKVHoU" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;36,591&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z7krHWyRiHb4" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;428&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zuxfOb5h6wX2" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,374,876&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zkn1nQd2fRw2" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zaY7drP9ILG7" style="text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(20,075)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zGeUJ84mQfvc" style="vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(67,676)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zkdzaSaZnVEf" style="padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;158,651&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zx11PdTD5kS7" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;67,212&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z8sAB1z40ZS3" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;139,514&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zfzKIphO7WAi" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(11,244)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zUrlgU4Npwe2" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zjFMBOqxMtgf" style="border-bottom: black 1pt solid; text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(18,648)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zcTlfTDcIkP7" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4397"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zU4HEg0KiGh5" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;18,648&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231_zGrVTs3PHlR5" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,065,188&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zyWwyGmVEAtl" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(146,489)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231_zOWleRFSl2wh" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(117,986)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zDU1ZF6KtwW6" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;986,838&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_z8sHp1aaRVdd" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;136,121&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zEVPUtEuD818" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;176,105&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zEjF0FDq0qMk" style="border-bottom: black 1pt solid; padding-right: -6.25pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(10,816)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231_z4jiUHg6srUk" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,088,961&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Payment of interest of loan and financing and lease liabilities are included in cash flows
from financing activities.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The additions of loans and financing in 2021 include proceeds from the SoftBank transaction
of R$822,569, net of the transaction costs of R$13,030.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A9_zJbhsBFl9oN8" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;






</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <afya:FinancialAssetsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact003446">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--FinancialAssetsExplanatory_pn3n3_zJLMLzaNeYWi" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B4_zdIUHg3WDrwj" style="display: none"&gt;Schedule of financial assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 56%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;At amortized cost:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeReceivables_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_znvhRTpgqlal" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;585,923&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeReceivables_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zltSo2FYUQFj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;495,399&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRijhHHmHUsi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;585,923&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z8eNeDWDgcWj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;495,399&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CurrentFinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zDSNLhZailvk" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;546,438&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentFinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zDH89V548f0l" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;452,831&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z8gvKyGqExqj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;39,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zbyrwCdiwf9h" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;42,568&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:FinancialAssetsExplanatory>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2023-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003448"
      unitRef="BRL">585923000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2022-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003450"
      unitRef="BRL">495399000</ifrs-full:TradeReceivables>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2023-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003452"
      unitRef="BRL">585923000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2022-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003454"
      unitRef="BRL">495399000</ifrs-full:FinancialAssets>
    <ifrs-full:CurrentFinancialAssets
      contextRef="AsOf2023-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003456"
      unitRef="BRL">546438000</ifrs-full:CurrentFinancialAssets>
    <ifrs-full:CurrentFinancialAssets
      contextRef="AsOf2022-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003458"
      unitRef="BRL">452831000</ifrs-full:CurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="AsOf2023-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003460"
      unitRef="BRL">39485000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="AsOf2022-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003462"
      unitRef="BRL">42568000</ifrs-full:NoncurrentFinancialAssets>
    <afya:FinancialLiabilitiesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact003464">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--FinancialLiabilitiesExplanatory_pn3n3_zNAamn5fgTHj" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BB_zVLBJXM1nqMi" style="display: none"&gt;Schedule of financial liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 56%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 22%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;At amortized cost:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zsZ5z4tBNd16" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,222&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zaflng1uIr16" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71,482&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGCVA33rQQZe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,800,775&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LoansAndFinancing_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zZDf2YxUiPyj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,882,901&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zCR0jnW0qx3f" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;874,569&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LeaseLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zahkjH53tg56" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;769,525&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zvd44yXvyfvi" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;566,867&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zBUVkdriNaCl" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;528,678&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NotePayable_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zG5S5iOcosV8" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NotePayable_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zA0iGBXV1x2k" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,176&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGG5suRO9WQ3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,350,433&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4vSHarrOjr4" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,314,762&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4zKHRNZy307" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;678,370&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zPLNPpcSDgD1" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;573,030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_znNl3Ionj775" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,672,063&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zcjxZaF92JNi" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,741,732&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:FinancialLiabilitiesExplanatory>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003466"
      unitRef="BRL">108222000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003468"
      unitRef="BRL">71482000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <afya:LoansAndFinancing
      contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003470"
      unitRef="BRL">1800775000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003472"
      unitRef="BRL">1882901000</afya:LoansAndFinancing>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003474"
      unitRef="BRL">874569000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003476"
      unitRef="BRL">769525000</ifrs-full:LeaseLiabilities>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003478"
      unitRef="BRL">566867000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003480"
      unitRef="BRL">528678000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:NotePayable
      contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003484"
      unitRef="BRL">62176000</afya:NotePayable>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003486"
      unitRef="BRL">3350433000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003488"
      unitRef="BRL">3314762000</ifrs-full:FinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003490"
      unitRef="BRL">678370000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003492"
      unitRef="BRL">573030000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003494"
      unitRef="BRL">2672063000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003496"
      unitRef="BRL">2741732000</ifrs-full:NoncurrentFinancialLiabilities>
    <afya:LoansAndFinancingExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact003498">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--LoansAndFinancingExplanatory_pn3n3_zx8gg8As9Cd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span id="xdx_8BF_z3FjGsB32I6k" style="display: none"&gt;Schedule
    of loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial institution&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Interest rate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zwhEO91dhfLf" title="Financial institution"&gt;Banco Ita&#xfa; Unibanco S.A&lt;/span&gt;. (a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian real&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zPovUXEsgu85" title="Interest rate"&gt;CDI + 1.90% p.y.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90C_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_z9FbYff3t5Pi" title="Maturity"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zxtdhVhnUYl9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;412,880&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyFiveMember_zuTknWjmk7z3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,134&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90B_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_z63efS7dHPW6" title="Financial institution"&gt;FINEP&lt;/span&gt; (b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian real&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zYY7ZOaEGG5i" title="Interest rate"&gt;TJLP p.y.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90A_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_za4bA5mRwBMi" title="Maturity"&gt;2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zLWcQNCImBv8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,193&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_zz5NcqU4jFkf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;8,418&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zixPvLe2cUm2" title="Financial institution"&gt;Banco Ita&#xfa; Unibanco S.A.&lt;/span&gt; (c)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian real&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_ze6xeIWghk6h" title="Interest rate"&gt;CDI + 1.75% p.y.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_ziloWsxWkwZe" title="Maturity"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zAXlGIXZMIRj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;21,405&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_zZsdujsDMr63" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;32,252&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90B_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zTtQj1dKJQH5" title="Financial institution"&gt;Softbank&lt;/span&gt; (d)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian real&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zgAcYMbOeJd" title="Interest rate"&gt;6.5% p.y.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_909_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_z9JbBX8Z8CKb" title="Maturity"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zvFybhC9AJYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;825,957&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_zkLfVMdMdmXk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;824,258&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90A_ecustom--FinancialInstitution_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zhKl4Fl7Ir0j" title="Financial institution"&gt;Debentures&lt;/span&gt; (e)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian real&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--BorrowingsInterestRateBasis_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zwYtnJrmhQml" title="Interest rate"&gt;CDI + 1.80% p.y.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90B_eifrs-full--BorrowingsMaturity_dd_c20230101__20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zhF90K588Ozc" title="Maturity"&gt;2028&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zuEihA0v0K7i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;529,340&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__custom--TwentyTwentyEightMember_zoalALfixzve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;499,839&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancing_iI_pn3n3_c20231231_zJH3pY03LGDf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,800,775&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LoansAndFinancing_iI_pn3n3_c20221231_z5cUqIHiEmq3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,882,901&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancingCurrent_pn3n3_c20231231_zE9O3pNmyqHg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;179,252&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancingCurrent_pn3n3_c20221231_z8ClKkSIN7q8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;145,202&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LoansAndFinancingNonCurrent_pn3n3_c20231231_zG4Rcw4uOJcb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,621,523&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LoansAndFinancingNonCurrent_pn3n3_c20221231_zkCz0TP20Am7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,737,699&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:LoansAndFinancingExplanatory>
    <afya:FinancialInstitution
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentyFiveMember"
      id="Fact003500">Banco Ita&#xfa; Unibanco S.A</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentyFiveMember"
      id="Fact003502">CDI + 1.90% p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentyFiveMember"
      id="Fact003504">2025</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2023-12-31_custom_TwentyTwentyFiveMember"
      decimals="-3"
      id="Fact003506"
      unitRef="BRL">412880000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2022-12-31_custom_TwentyTwentyFiveMember"
      decimals="-3"
      id="Fact003508"
      unitRef="BRL">518134000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentySevenMember"
      id="Fact003510">FINEP</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentySevenMember"
      id="Fact003512">TJLP p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentySevenMember"
      id="Fact003514">2027</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2023-12-31_custom_TwentyTwentySevenMember"
      decimals="-3"
      id="Fact003516"
      unitRef="BRL">11193000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2022-12-31_custom_TwentyTwentySevenMember"
      decimals="-3"
      id="Fact003518"
      unitRef="BRL">8418000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentyFourMember"
      id="Fact003520">Banco Ita&#xfa; Unibanco S.A.</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentyFourMember"
      id="Fact003522">CDI + 1.75% p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentyFourMember"
      id="Fact003524">2024</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2023-12-31_custom_TwentyTwentyFourMember"
      decimals="-3"
      id="Fact003526"
      unitRef="BRL">21405000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2022-12-31_custom_TwentyTwentyFourMember"
      decimals="-3"
      id="Fact003528"
      unitRef="BRL">32252000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentySixMember"
      id="Fact003530">Softbank</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentySixMember"
      id="Fact003532">6.5% p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentySixMember"
      id="Fact003534">2026</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2023-12-31_custom_TwentyTwentySixMember"
      decimals="-3"
      id="Fact003536"
      unitRef="BRL">825957000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2022-12-31_custom_TwentyTwentySixMember"
      decimals="-3"
      id="Fact003538"
      unitRef="BRL">824258000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentyEightMember"
      id="Fact003540">Debentures</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentyEightMember"
      id="Fact003542">CDI + 1.80% p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2023-01-012023-12-31_custom_TwentyTwentyEightMember"
      id="Fact003544">2028</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2023-12-31_custom_TwentyTwentyEightMember"
      decimals="-3"
      id="Fact003546"
      unitRef="BRL">529340000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2022-12-31_custom_TwentyTwentyEightMember"
      decimals="-3"
      id="Fact003548"
      unitRef="BRL">499839000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003550"
      unitRef="BRL">1800775000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003552"
      unitRef="BRL">1882901000</afya:LoansAndFinancing>
    <afya:LoansAndFinancingCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003554"
      unitRef="BRL">179252000</afya:LoansAndFinancingCurrent>
    <afya:LoansAndFinancingCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003556"
      unitRef="BRL">145202000</afya:LoansAndFinancingCurrent>
    <afya:LoansAndFinancingNonCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003558"
      unitRef="BRL">1621523000</afya:LoansAndFinancingNonCurrent>
    <afya:LoansAndFinancingNonCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003560"
      unitRef="BRL">1737699000</afya:LoansAndFinancingNonCurrent>
    <afya:ContractualLeaseTerm
      contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember"
      id="Fact003564">P5Y</afya:ContractualLeaseTerm>
    <afya:ContractualLeaseTerm
      contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember"
      id="Fact003565">P30Y</afya:ContractualLeaseTerm>
    <afya:ScheduleOfLeasesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact003567">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfLeasesExplanatory_pn3n3_z2S2V2JTiUQe" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities  (Details 3)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B3_z8bEv5AvX4ng" style="display: none"&gt;Schedule of  right-of-use assets and lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Right-of-use assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Lease liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;As of January 1, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--RightofuseAssets_iS_pn3n3_c20210101__20211231_zzm8oscCEqVe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;419,074&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--LeaseLiabilities_iS_pn3n3_c20210101__20211231_zHUcS7LloIqb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20210101__20211231_zXFrKAWoPbvc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,689&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20210101__20211231_zU6X8OtdP12c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,689&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20210101__20211231_zLg8S1jXq9r" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;95,962&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20210101__20211231_zNaiKcv9cc01" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;95,962&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20210101__20211231_z69SVDxa9073" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;139,514&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20210101__20211231_zoUsD3VfM932" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;139,514&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20210101__20211231_zPMkXpuVkZgb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(43,237)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20210101__20211231_zs8qnE6TIHy7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3587"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20210101__20211231_zjDVV5t6wSg1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3589"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20210101__20211231_zTmLwJhXFUpa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;67,212&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20210101__20211231_zOurIa33N2ai" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3593"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20210101__20211231_zkH2q38KAUWb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(20,075)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of interest&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20210101__20211231_zDG9GQPJ2pw3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3597"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20210101__20211231_zcpRlWrsnwAi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(67,676)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsWriteoff_pn3n3_c20210101__20211231_zxJjvDTk9Rbh" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(10,316)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20210101__20211231_znB8p8dHSy8a" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,244)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--RightofuseAssets_iE_pn3n3_c20210101__20211231_ztFQuSUk4o81" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;663,686&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iE_pn3n3_c20210101__20211231_zwU995Xr7y9l" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;714,085&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20211231_zCnkvKVjjYff" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3609"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20211231_zgohRItwed46" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,955&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20211231_zR0hVh8DWdq4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;663,686&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20211231_zd0zw6pM76v9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;689,130&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Right-of-use assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Lease liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;As of January 1, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--RightofuseAssets_iS_pn3n3_c20220101__20221231_zlxdHP7lsB6g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;663,686&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeaseLiabilities_iS_pn3n3_c20220101__20221231_zMy7EivATDh1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20220101__20221231_zkUzBAjoZudl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;42,250&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20220101__20221231_zdMwpGke2J8g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;42,250&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20220101__20221231_zLo27DxLkySg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,623&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20220101__20221231_zpczl7PdsrKb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,623&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20220101__20221231_zsIqOT0TD00l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(54,684)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20220101__20221231_zc61iPN2iafb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3631"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20220101__20221231_z8ZyVH5YJXK2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3633"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20220101__20221231_zaS3bgdrcWL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;88,571&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20220101__20221231_zAtnAxV0hK3l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3637"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20220101__20221231_zFp1eQhddoLb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(28,511)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of interest&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20220101__20221231_zWPvjnbneWN1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3641"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20220101__20221231_zIEYWMHuW9A7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(85,001)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightofuseAssetsWriteoff_pn3n3_c20220101__20221231_zEp14ubf4aE9" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(19,802)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20220101__20221231_zy8tQ3J8uoIk" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(20,492)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--RightofuseAssets_iE_pn3n3_c20220101__20221231_zt20Zm1Edac1" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;690,073&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--LeaseLiabilities_iE_pn3n3_c20220101__20221231_zwh8Cddthstb" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;769,525&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20221231_zhOdB4doCdzd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3653"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20221231_zeTGzTc8NqR4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;32,459&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20221231_zKAgb5I4C169" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;690,073&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20221231_zG4fAtsBel0h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;737,066&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Right-of-use assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Lease liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;As of January 1, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--RightofuseAssets_iS_pn3n3_c20230101__20231231_zJ5QW0knYgvg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;690,073&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--LeaseLiabilities_iS_pn3n3_c20230101__20231231_z9rzREO9aZ4e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;769,525&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20230101__20231231_zL8q1ZMxF01d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,328&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20230101__20231231_zF8PDKKNoA74" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,328&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20230101__20231231_zmlrYcYftY4e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,387&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20230101__20231231_zjshxc8CiJ9g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,387&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20230101__20231231_zQkxIXV3QY0j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;65,408&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20230101__20231231_znya9xJSI7m3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;65,408&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20230101__20231231_zpWBB2SsLyMe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(63,118)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20230101__20231231_zf88jHsLHpl8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3679"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20230101__20231231_zSvjvWhL4v8k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3681"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20230101__20231231_zvrn5y18fJYe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;100,849&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_pn3n3_c20230101__20231231_zhP3jV9zQof1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3685"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_pn3n3_c20230101__20231231_zHbnyGwOKiMa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(31,473)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of interest&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20230101__20231231_zP0thVavb4e3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3689"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20230101__20231231_zumiwKY2X5v" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(103,911)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsWriteoff_pn3n3_c20230101__20231231_zb3dBBxzfvNi" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,469)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20230101__20231231_zh7AKxCRTijl" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, Write-off"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,544)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20230101__20231231_zlUoyhlLZswa" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;767,609&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LeaseLiabilities_iE_pn3n3_c20230101__20231231_z16B5lRhZuCj" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;874,569&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20231231_zTtXFjUW87M8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3701"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20231231_zmhwLxJW1k0k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;36,898&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_pn3n3_c20231231_zQCPpLweoxoh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;767,609&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20231231_zrM76p2JsvJf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;837,671&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to anticipated termination of real estate leasing contracts.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfLeasesExplanatory>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact003569"
      unitRef="BRL">419074000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact003571"
      unitRef="BRL">447703000</ifrs-full:LeaseLiabilities>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003573"
      unitRef="BRL">62689000</ifrs-full:AdditionsToRightofuseAssets>
    <afya:AdditionsToLeaseLiabilities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003575"
      unitRef="BRL">62689000</afya:AdditionsToLeaseLiabilities>
    <afya:RightofuseAssetsRemeasurement
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003577"
      unitRef="BRL">95962000</afya:RightofuseAssetsRemeasurement>
    <afya:LeaseLiabilitiesRemeasurement
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003579"
      unitRef="BRL">95962000</afya:LeaseLiabilitiesRemeasurement>
    <afya:RightofuseAssetsBusinessCombinations
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003581"
      unitRef="BRL">139514000</afya:RightofuseAssetsBusinessCombinations>
    <afya:BusinessCombinationsLeaseLiabilities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003583"
      unitRef="BRL">139514000</afya:BusinessCombinationsLeaseLiabilities>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003585"
      unitRef="BRL">43237000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003591"
      unitRef="BRL">67212000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003595"
      unitRef="BRL">-20075000</afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1>
    <afya:PaymentsOfInterestLeaseLiabilities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003599"
      unitRef="BRL">-67676000</afya:PaymentsOfInterestLeaseLiabilities>
    <afya:RightofuseAssetsWriteoff
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003601"
      unitRef="BRL">-10316000</afya:RightofuseAssetsWriteoff>
    <afya:LeaseLiabilitiesWriteoff
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003603"
      unitRef="BRL">-11244000</afya:LeaseLiabilitiesWriteoff>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact003605"
      unitRef="BRL">663686000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact003607"
      unitRef="BRL">714085000</ifrs-full:LeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact003611"
      unitRef="BRL">24955000</ifrs-full:CurrentLeaseLiabilities>
    <afya:RightofuseAssetsNonCurrent
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact003613"
      unitRef="BRL">663686000</afya:RightofuseAssetsNonCurrent>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact003615"
      unitRef="BRL">689130000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact003617"
      unitRef="BRL">663686000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact003619"
      unitRef="BRL">714085000</ifrs-full:LeaseLiabilities>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003621"
      unitRef="BRL">42250000</ifrs-full:AdditionsToRightofuseAssets>
    <afya:AdditionsToLeaseLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003623"
      unitRef="BRL">42250000</afya:AdditionsToLeaseLiabilities>
    <afya:RightofuseAssetsRemeasurement
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003625"
      unitRef="BRL">58623000</afya:RightofuseAssetsRemeasurement>
    <afya:LeaseLiabilitiesRemeasurement
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003627"
      unitRef="BRL">58623000</afya:LeaseLiabilitiesRemeasurement>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003629"
      unitRef="BRL">54684000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003635"
      unitRef="BRL">88571000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003639"
      unitRef="BRL">-28511000</afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1>
    <afya:PaymentsOfInterestLeaseLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003643"
      unitRef="BRL">-85001000</afya:PaymentsOfInterestLeaseLiabilities>
    <afya:RightofuseAssetsWriteoff
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003645"
      unitRef="BRL">-19802000</afya:RightofuseAssetsWriteoff>
    <afya:LeaseLiabilitiesWriteoff
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003647"
      unitRef="BRL">-20492000</afya:LeaseLiabilitiesWriteoff>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003649"
      unitRef="BRL">690073000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003651"
      unitRef="BRL">769525000</ifrs-full:LeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003655"
      unitRef="BRL">32459000</ifrs-full:CurrentLeaseLiabilities>
    <afya:RightofuseAssetsNonCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003657"
      unitRef="BRL">690073000</afya:RightofuseAssetsNonCurrent>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003659"
      unitRef="BRL">737066000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003661"
      unitRef="BRL">690073000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003663"
      unitRef="BRL">769525000</ifrs-full:LeaseLiabilities>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003665"
      unitRef="BRL">7328000</ifrs-full:AdditionsToRightofuseAssets>
    <afya:AdditionsToLeaseLiabilities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003667"
      unitRef="BRL">7328000</afya:AdditionsToLeaseLiabilities>
    <afya:RightofuseAssetsRemeasurement
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003669"
      unitRef="BRL">70387000</afya:RightofuseAssetsRemeasurement>
    <afya:LeaseLiabilitiesRemeasurement
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003671"
      unitRef="BRL">70387000</afya:LeaseLiabilitiesRemeasurement>
    <afya:RightofuseAssetsBusinessCombinations
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003673"
      unitRef="BRL">65408000</afya:RightofuseAssetsBusinessCombinations>
    <afya:BusinessCombinationsLeaseLiabilities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003675"
      unitRef="BRL">65408000</afya:BusinessCombinationsLeaseLiabilities>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003677"
      unitRef="BRL">63118000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003683"
      unitRef="BRL">100849000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003687"
      unitRef="BRL">-31473000</afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1>
    <afya:PaymentsOfInterestLeaseLiabilities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003691"
      unitRef="BRL">-103911000</afya:PaymentsOfInterestLeaseLiabilities>
    <afya:RightofuseAssetsWriteoff
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003693"
      unitRef="BRL">-2469000</afya:RightofuseAssetsWriteoff>
    <afya:LeaseLiabilitiesWriteoff
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003695"
      unitRef="BRL">-3544000</afya:LeaseLiabilitiesWriteoff>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003697"
      unitRef="BRL">767609000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003699"
      unitRef="BRL">874569000</ifrs-full:LeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003703"
      unitRef="BRL">36898000</ifrs-full:CurrentLeaseLiabilities>
    <afya:RightofuseAssetsNonCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003705"
      unitRef="BRL">767609000</afya:RightofuseAssetsNonCurrent>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003707"
      unitRef="BRL">837671000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003709"
      unitRef="BRL">10871000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003711"
      unitRef="BRL">12153000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003713"
      unitRef="BRL">11229000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <afya:AccountsPayableToSellingShareholdersExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact003715">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--AccountsPayableToSellingShareholdersExplanatory_pn3n3_ziliB0JMP9W1" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 4)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BF_zOKpbQr6YHl" style="display: none"&gt;Schedule of accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 74%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of IPEMED (a)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPEMEDMember_zjtgI6j1eYq" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,805&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPEMEDMember_zTQZ7KUP2jZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;22,654&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of UniRedentor (b)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zF6jWThx2Bkb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,155&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z6NHOhGMEWHl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,064&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of UniSL (c)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zh977wXaQTj2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,064&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zBaa6vYEC4Y4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;37,301&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of FCMPB (d)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zLPciQs1PG4k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;63,168&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z3z4bxuy59Tf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;111,755&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of Medical Harbour (e)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zrBoO00mwD1d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zkUvv1YP0P5a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,053&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of Shosp (f)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zRMEfKuajtPa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;454&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_ztbJtUFpYAbc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,206&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of Unigranrio (g)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zXDpRmTor8Jf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;156,235&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zUAtEZPbz5Ff" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;216,716&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of RX PRO (h)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zcJm9tHQRXEb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3745"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zqCSbNCSdrC8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,781&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of Guaranhuns (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_ziwmClvDXXSf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3749"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_zDNXLGfPllpc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;30,653&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of Al&#xe9;m da Medicina (j)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_z3BMOhOC4469" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;18,325&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zf1cqHzkk09b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,996&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of CardioPapers (k)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_znB8g3Ng7FWg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,173&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zoCnYH4KGU7g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,979&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of Glic (l)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zZpgf1L6hkHi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3761"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GlicMember_zqUaAylbsOW3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;9,520&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of DelRey (m)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zkGSxhB2heV2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;256,488&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWh1tD0PtqQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3767"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231_zw28pc3pfnra" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;566,867&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231_zcGlMoRUF3nf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;528,678&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersCurrent_pn3n3_c20231231_ztoL7CLqVncc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;353,998&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_pn3n3_c20221231_zhwIzkX0JYLl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;261,711&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AccountsPayableToSellingShareholdersNonCurrent_pn3n3_c20231231_zXtBCJlRGiag" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;212,869&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_pn3n3_c20221231_zQI82jJ7MbM5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;266,967&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:AccountsPayableToSellingShareholdersExplanatory>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_IPEMEDMember"
      decimals="-3"
      id="Fact003717"
      unitRef="BRL">12805000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_IPEMEDMember"
      decimals="-3"
      id="Fact003719"
      unitRef="BRL">22654000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003721"
      unitRef="BRL">27155000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003723"
      unitRef="BRL">72064000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_UniSLMember"
      decimals="-3"
      id="Fact003725"
      unitRef="BRL">15064000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_UniSLMember"
      decimals="-3"
      id="Fact003727"
      unitRef="BRL">37301000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_FCMPBMember"
      decimals="-3"
      id="Fact003729"
      unitRef="BRL">63168000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_FCMPBMember"
      decimals="-3"
      id="Fact003731"
      unitRef="BRL">111755000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_MedicalHarbourMember"
      decimals="-3"
      id="Fact003733"
      unitRef="BRL">3000000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_MedicalHarbourMember"
      decimals="-3"
      id="Fact003735"
      unitRef="BRL">4053000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_ShospMember"
      decimals="-3"
      id="Fact003737"
      unitRef="BRL">454000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_ShospMember"
      decimals="-3"
      id="Fact003739"
      unitRef="BRL">2206000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003741"
      unitRef="BRL">156235000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003743"
      unitRef="BRL">216716000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_RXPROMember"
      decimals="-3"
      id="Fact003747"
      unitRef="BRL">1781000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_GuaranhunsMember"
      decimals="-3"
      id="Fact003751"
      unitRef="BRL">30653000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_AlemDaMedicinaMember"
      decimals="-3"
      id="Fact003753"
      unitRef="BRL">18325000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_AlemDaMedicinaMember"
      decimals="-3"
      id="Fact003755"
      unitRef="BRL">11996000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_CardiPapersMember"
      decimals="-3"
      id="Fact003757"
      unitRef="BRL">14173000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_CardiPapersMember"
      decimals="-3"
      id="Fact003759"
      unitRef="BRL">7979000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_GlicMember"
      decimals="-3"
      id="Fact003763"
      unitRef="BRL">9520000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_DelReyMember"
      decimals="-3"
      id="Fact003765"
      unitRef="BRL">256488000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003769"
      unitRef="BRL">566867000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003771"
      unitRef="BRL">528678000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:AccountsPayableToSellingShareholdersCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003773"
      unitRef="BRL">353998000</afya:AccountsPayableToSellingShareholdersCurrent>
    <afya:AccountsPayableToSellingShareholdersCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003775"
      unitRef="BRL">261711000</afya:AccountsPayableToSellingShareholdersCurrent>
    <afya:AccountsPayableToSellingShareholdersNonCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003777"
      unitRef="BRL">212869000</afya:AccountsPayableToSellingShareholdersNonCurrent>
    <afya:AccountsPayableToSellingShareholdersNonCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003779"
      unitRef="BRL">266967000</afya:AccountsPayableToSellingShareholdersNonCurrent>
    <afya:AccountsPayableToSellingShareholders1Explanatory contextRef="From2023-01-01to2023-12-31" id="Fact003781">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--AccountsPayableToSellingShareholders1Explanatory_pn3n3_zXgQenVehkk4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 5)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B5_zEraxvDL7gzi" style="display: none"&gt;Schedule of accounts payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; width: 64%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Opening balance&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zbJULWSraGt8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;528,678&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z3cUwk7UaRKc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;679,826&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zgQlOb5Rvnt2" style="text-align: right; line-height: 10pt" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash flows - Payments and deductions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZq02NmwYUpj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows payments and deductions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(225,460)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zNM1Z8mB8kx" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows payments and deductions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(236,760)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccountsPayableToSellingShareholderCashFlows_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zeRVdp0I9zxk" style="text-align: right; line-height: 10pt" title="Cash flows payments and deductions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(180,020)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payment of interest (i) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwCc7jojqdJj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payment of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(55,989)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOeaGHJ3JUqh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payment of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(24,428)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zhYXmvlVfi0b" style="text-align: right; line-height: 10pt" title="Payment of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(12,661)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition of licenses &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZi0w3oiADTg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Acquisition of licenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3801"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zurbn4TXoPs2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Acquisition of licenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,408&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zvhjw41RaIQf" style="text-align: right; line-height: 10pt" title="Acquisition of licenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InterestExpense_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zZU9mamIs1j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;85,069&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InterestExpense_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z2dfGwU41v29" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;68,064&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--InterestExpense_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zcLYGoNRMarl" style="text-align: right; line-height: 10pt" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;31,915&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions - Consideration to be transferred on business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zEDIzqwicxb2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Additions consideration to be transferred on business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;234,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zx3JNTpsDtS5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Additions consideration to be transferred on business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3815"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zJ5p0YmMzi74" style="text-align: right; line-height: 10pt" title="Additions consideration to be transferred on business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;243,816&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Consideration to be transferred on business combinations (earn-outs)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zROvmhfczSih" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt" title="Consideration to be transferred on business combinations (earn-outs)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3819"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zL5vNj3woY48" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Consideration to be transferred on business combinations (earn-outs)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,921&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ContingentConsiderationOnBusinessCombinations_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFV1daN0l1Wi" style="text-align: right; line-height: 10pt" title="Consideration to be transferred on business combinations (earn-outs)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,536&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--Reversals_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zWVhsxfBtqvh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3825"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--Reversals_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z2hWFxLGnHRb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(10,353)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--Reversals_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zumMbbBxg1m" style="text-align: right; line-height: 10pt" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3829"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement of earn-outs (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RemeasurementOfEarnouts_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoN25Pe3anMi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Remeasurement of earn-outs"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,556&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RemeasurementOfEarnouts_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zrZSalRvocjg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Remeasurement of earn-outs"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3833"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RemeasurementOfEarnouts_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zRBb15aXcrxd" style="text-align: right; line-height: 10pt" title="Remeasurement of earn-outs"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3835"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmH6rqDHXHr6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,987)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmbGyYVfm2Lb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3839"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zJbOADQBxQk5" style="text-align: right; line-height: 10pt" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3841"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Closing balance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zKGOsQlY0Zx7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;566,867&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFeodshF64R1" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;528,678&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zLsXqSNbZcEe" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right; line-height: 10pt" title="Closing balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;679,826&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Payment of interest from acquisition of subsidiaries are included in cash flows from investing
activities.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;During the measurement period, management&#x2019;s expectation has been reviewed based on
performance for revenue goals and the contingent consideration for the acquisition of Al&#xe9;m da Medicina, CardioPapers and Glic
have been remeasured by R$4,773, R$5,082 and (R$7,299), respectively, totaling R$2,556 as of December 31, 2023. These are measured by
the Company at the present value.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:AccountsPayableToSellingShareholders1Explanatory>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003783"
      unitRef="BRL">528678000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003785"
      unitRef="BRL">679826000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003787"
      unitRef="BRL">518240000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:AccountsPayableToSellingShareholderCashFlows
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003789"
      unitRef="BRL">-225460000</afya:AccountsPayableToSellingShareholderCashFlows>
    <afya:AccountsPayableToSellingShareholderCashFlows
      contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003791"
      unitRef="BRL">-236760000</afya:AccountsPayableToSellingShareholderCashFlows>
    <afya:AccountsPayableToSellingShareholderCashFlows
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003793"
      unitRef="BRL">-180020000</afya:AccountsPayableToSellingShareholderCashFlows>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003795"
      unitRef="BRL">55989000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003797"
      unitRef="BRL">24428000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003799"
      unitRef="BRL">12661000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec
      contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003803"
      unitRef="BRL">24408000</afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec>
    <afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003805"
      unitRef="BRL">54000000</afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec>
    <ifrs-full:InterestExpense
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003807"
      unitRef="BRL">85069000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003809"
      unitRef="BRL">68064000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003811"
      unitRef="BRL">31915000</ifrs-full:InterestExpense>
    <afya:AccountsPayableToSellingShareholdersBusinessCombinations
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003813"
      unitRef="BRL">234000000</afya:AccountsPayableToSellingShareholdersBusinessCombinations>
    <afya:AccountsPayableToSellingShareholdersBusinessCombinations
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003817"
      unitRef="BRL">243816000</afya:AccountsPayableToSellingShareholdersBusinessCombinations>
    <afya:ContingentConsiderationOnBusinessCombinations
      contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003821"
      unitRef="BRL">27921000</afya:ContingentConsiderationOnBusinessCombinations>
    <afya:ContingentConsiderationOnBusinessCombinations
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003823"
      unitRef="BRL">24536000</afya:ContingentConsiderationOnBusinessCombinations>
    <afya:Reversals
      contextRef="From2022-01-012022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003827"
      unitRef="BRL">-10353000</afya:Reversals>
    <afya:RemeasurementOfEarnouts
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003831"
      unitRef="BRL">2556000</afya:RemeasurementOfEarnouts>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003837"
      unitRef="BRL">-1987000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003843"
      unitRef="BRL">566867000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003845"
      unitRef="BRL">528678000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003847"
      unitRef="BRL">679826000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2019-05-082019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="INF"
      id="Fact003849"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      id="Fact003851"
      unitRef="BRL">45303000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <afya:EqualInstallmentsPayablesToRelatedParties1
      contextRef="AsOf2024-02-29_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      id="Fact003853"
      unitRef="BRL">9061000</afya:EqualInstallmentsPayablesToRelatedParties1>
    <afya:EqualInstallmentsPayablesToRelatedParties1
      contextRef="AsOf2023-02-28_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      id="Fact003855"
      unitRef="BRL">9061000</afya:EqualInstallmentsPayablesToRelatedParties1>
    <afya:EqualInstallmentsPayablesToRelatedParties1
      contextRef="AsOf2022-02-28_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      id="Fact003857"
      unitRef="BRL">9061000</afya:EqualInstallmentsPayablesToRelatedParties1>
    <afya:EqualInstallmentsPayablesToRelatedParties1
      contextRef="AsOf2021-02-28_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      id="Fact003859"
      unitRef="BRL">9061000</afya:EqualInstallmentsPayablesToRelatedParties1>
    <afya:EqualInstallmentsPayablesToRelatedParties1
      contextRef="AsOf2020-02-29_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      id="Fact003861"
      unitRef="BRL">9061000</afya:EqualInstallmentsPayablesToRelatedParties1>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-01-31_custom_UniRedentorMember"
      decimals="INF"
      id="Fact003863"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-01-31_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003865"
      unitRef="BRL">100000000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <afya:EqualInstallmentsPayablesToRelatedParties
      contextRef="AsOf2021-01-31_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003867"
      unitRef="BRL">4503000</afya:EqualInstallmentsPayablesToRelatedParties>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-05-042020-05-05_custom_UniSLMember"
      decimals="INF"
      id="Fact003869"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-05-05_custom_UniSLMember"
      decimals="-3"
      id="Fact003871"
      unitRef="BRL">60456000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <afya:EqualInstallmentsPayablesToRelatedParties
      contextRef="AsOf2020-05-05_custom_UniSLMember"
      decimals="-3"
      id="Fact003873"
      unitRef="BRL">7816000</afya:EqualInstallmentsPayablesToRelatedParties>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-11-082020-11-09_custom_FCMPBMember"
      decimals="INF"
      id="Fact003875"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-11-09_custom_FCMPBMember"
      decimals="-3"
      id="Fact003877"
      unitRef="BRL">188894000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-04-072021-04-08_custom_MedicalHarbourMember"
      decimals="INF"
      id="Fact003879"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-04-08_custom_MedicalHarbourMember"
      decimals="-3"
      id="Fact003881"
      unitRef="BRL">9000000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="AsOf2021-04-08_custom_MedicalHarbourMember"
      decimals="-3"
      id="Fact003883"
      unitRef="BRL">3000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-05-122021-05-13_custom_ShospMember"
      decimals="INF"
      id="Fact003885"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-05-13_custom_ShospMember"
      decimals="-3"
      id="Fact003887"
      unitRef="BRL">513000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="AsOf2021-05-13_custom_ShospMember"
      decimals="-3"
      id="Fact003889"
      unitRef="BRL">454000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-08-032021-08-04_custom_UnigranrioMember"
      decimals="INF"
      id="Fact003891"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NoncurrentPayablesForPurchaseOfEnergy
      contextRef="AsOf2021-08-04_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003893"
      unitRef="BRL">618956000</ifrs-full:NoncurrentPayablesForPurchaseOfEnergy>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-10-012021-10-02_custom_RXPROMember"
      decimals="INF"
      id="Fact003895"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-10-02_custom_RXPROMember"
      decimals="-3"
      id="Fact003897"
      unitRef="BRL">21000000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="AsOf2021-10-02_custom_RXPROMember"
      decimals="-3"
      id="Fact003899"
      unitRef="BRL">1781000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-11-042021-11-05_custom_ITPACGaranhunsMember"
      decimals="INF"
      id="Fact003901"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="AsOf2021-11-05_custom_ITPACGaranhunsMember"
      decimals="-3"
      id="Fact003903"
      unitRef="BRL">54000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-11-05_custom_ITPACGaranhunsMember"
      decimals="-3"
      id="Fact003905"
      unitRef="BRL">54000000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember1360038046"
      decimals="INF"
      id="Fact003907"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact003909"
      unitRef="BRL">19200000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <afya:EqualInstallmentsPayablesToRelatedParties
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact003911"
      unitRef="BRL">763000</afya:EqualInstallmentsPayablesToRelatedParties>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember1360037921"
      decimals="-3"
      id="Fact003913"
      unitRef="BRL">18325000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-04-042022-04-05_custom_CardioPapersMember1360038093"
      decimals="INF"
      id="Fact003915"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact003917"
      unitRef="BRL">15000000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <afya:EqualInstallmentsPayablesToRelatedParties
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact003919"
      unitRef="BRL">333000</afya:EqualInstallmentsPayablesToRelatedParties>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact003921"
      unitRef="BRL">14173000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-03-222022-03-23_custom_GlicMember"
      decimals="INF"
      id="Fact003923"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-03-23_custom_GlicMember"
      decimals="-3"
      id="Fact003925"
      unitRef="BRL">12000000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="AsOf2022-03-23_custom_GlicMember"
      decimals="-3"
      id="Fact003927"
      unitRef="BRL">9520000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <afya:RemainingBalancePaid
      contextRef="From2022-03-222022-03-23_custom_GlicMember"
      decimals="-3"
      id="Fact003929"
      unitRef="BRL">3000000</afya:RemainingBalancePaid>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-12-292023-01-02_custom_DelReyMember"
      decimals="INF"
      id="Fact003931"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NoncurrentPayablesForPurchaseOfEnergy
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact003933"
      unitRef="BRL">816236000</ifrs-full:NoncurrentPayablesForPurchaseOfEnergy>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact003935"
      unitRef="BRL">575000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact003937"
      unitRef="BRL">234000000</afya:ConsiderationToBeTransferred>
    <ifrs-full:ConsiderationPaidReceived
      contextRef="From2022-12-292023-02-01_custom_DelReyMember"
      decimals="-3"
      id="Fact003939"
      unitRef="BRL">16000000</ifrs-full:ConsiderationPaidReceived>
    <afya:FirstAnnualInstallmentsPayable
      contextRef="From2022-12-292023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact003941"
      unitRef="BRL">134000000</afya:FirstAnnualInstallmentsPayable>
    <afya:SecondAnnualInstallmentsPayable
      contextRef="From2022-12-292023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact003943"
      unitRef="BRL">50000000</afya:SecondAnnualInstallmentsPayable>
    <afya:ThirdAnnualInstallmentsPayable
      contextRef="From2022-12-292023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact003945"
      unitRef="BRL">50000000</afya:ThirdAnnualInstallmentsPayable>
    <afya:AcquisitiondateFairValueOfTotalConsiderationTransferred1
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact003947"
      unitRef="BRL">7236000</afya:AcquisitiondateFairValueOfTotalConsiderationTransferred1>
    <afya:ScheduleOfCarryingAmountOfNotesPayableTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact003949">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_pn3n3_zI1MwJVprYy8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 6)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BD_zNNBqtHMecB5" style="display: none"&gt;Schedule of carrying amount of notes payable and the movements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; width: 64%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 12%; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Opening balance&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NotesPayables_iS_pn3n3_c20230101__20231231_zZumwW3dqNMe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,176&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NotesPayables_iS_pn3n3_c20220101__20221231_z8LuCR28ybW6" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,726&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NotesPayables_iS_pn3n3_c20210101__20211231_zCzrVPC8Pap" style="text-align: right; line-height: 10pt" title="Notes payable beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,181&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Payments_pn3n3_c20230101__20231231_zhHb4Q3WxSR" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(49,347)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Payments_pn3n3_c20220101__20221231_z8mKdNAzbTLi" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(12,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--Payments_pn3n3_c20210101__20211231_zaNihkfhfaXh" style="text-align: right; line-height: 10pt" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(9,800)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments of interest (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PaymentsOfInterest_pn3n3_c20230101__20231231_z1pus9OrYdvj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(15,529)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaymentsOfInterest_pn3n3_c20220101__20221231_zBtjwhQXhlVh" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,008)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PaymentsOfInterest_pn3n3_c20210101__20211231_zJ0XArvCtfM" style="text-align: right; line-height: 10pt" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,268)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Monetary indexation&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--MonetaryIndexation_pn3n3_c20230101__20231231_zQeOkg94T5fg" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Monetary indexation"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,700&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--MonetaryIndexation_pn3n3_c20220101__20221231_zP3D6TCwiAq" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Monetary indexation"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,458&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--MonetaryIndexation_pn3n3_c20210101__20211231_z6xRxKGRfURc" style="border-bottom: black 1pt solid; text-align: right; line-height: 10pt" title="Monetary indexation"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,613&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Closing balance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NotesPayables_iE_pn3n3_c20230101__20231231_zy2Doo6v6gLd" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3975"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NotesPayables_iE_pn3n3_c20220101__20221231_zDHYCKvhFUb7" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Notes payable ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;62,176&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NotesPayables_iE_pn3n3_c20210101__20211231_zUJgfkDY7lp6" style="border-bottom: black 1.5pt double; text-align: right; line-height: 10pt" title="Notes payable ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;72,726&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CurrentLiabilities1_iI_pn3n3_c20231231_zImjJr5t7W39" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3981"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CurrentLiabilities1_pn3n3_c20221231_zTy8tYFM8lri" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,176&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CurrentLiabilities1_iI_pn3n3_c20211231_z4pe24LUNx24" style="text-align: right; line-height: 10pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,478&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20231231_zmPCI95aXc28" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3987"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20221231_zTEgZTr2iPGj" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3989"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NoncurrentLiabilities1_iI_pn3n3_c20211231_zyS8sbnU0fqb" style="text-align: right; line-height: 10pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,248&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 0 7.1pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The amounts are included in cash flows from investing activities.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfCarryingAmountOfNotesPayableTableTextBlock>
    <afya:NotesPayables
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003951"
      unitRef="BRL">62176000</afya:NotesPayables>
    <afya:NotesPayables
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact003953"
      unitRef="BRL">72726000</afya:NotesPayables>
    <afya:NotesPayables
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact003955"
      unitRef="BRL">76181000</afya:NotesPayables>
    <afya:Payments
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003957"
      unitRef="BRL">-49347000</afya:Payments>
    <afya:Payments
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003959"
      unitRef="BRL">-12000000</afya:Payments>
    <afya:Payments
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003961"
      unitRef="BRL">-9800000</afya:Payments>
    <afya:PaymentsOfInterest
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003963"
      unitRef="BRL">-15529000</afya:PaymentsOfInterest>
    <afya:PaymentsOfInterest
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003965"
      unitRef="BRL">-3008000</afya:PaymentsOfInterest>
    <afya:PaymentsOfInterest
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003967"
      unitRef="BRL">-1268000</afya:PaymentsOfInterest>
    <afya:MonetaryIndexation
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact003969"
      unitRef="BRL">2700000</afya:MonetaryIndexation>
    <afya:MonetaryIndexation
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003971"
      unitRef="BRL">4458000</afya:MonetaryIndexation>
    <afya:MonetaryIndexation
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact003973"
      unitRef="BRL">7613000</afya:MonetaryIndexation>
    <afya:NotesPayables
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003977"
      unitRef="BRL">62176000</afya:NotesPayables>
    <afya:NotesPayables
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact003979"
      unitRef="BRL">72726000</afya:NotesPayables>
    <afya:CurrentLiabilities1
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003983"
      unitRef="BRL">62176000</afya:CurrentLiabilities1>
    <afya:CurrentLiabilities1
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact003985"
      unitRef="BRL">14478000</afya:CurrentLiabilities1>
    <afya:NoncurrentLiabilities1
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact003991"
      unitRef="BRL">58248000</afya:NoncurrentLiabilities1>
    <afya:ScheduleOfFairValuesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact003993">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfFairValuesExplanatory_pn3n3_zswu6R4455O9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 7)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B5_zJK6pWxh0tri" style="display: none"&gt;Schedule
    of fair values of the company's financial instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="border-bottom: black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;
    &lt;p style="border-bottom: black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 48%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;Financial assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Trade receivables (non-current)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialAssets_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zFs837uome8d" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;39,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zclm8DkYb8lj" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;39,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialAssets_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zImlu8DZ2jLj" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;42,568&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20221231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zHcJvwaLckM6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;42,568&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialAssets_pn3n3_c20231231_zw4KhUxubaoa" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;39,485&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20231231_zTh2iJY77cBb" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;39,485&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialAssets_pn3n3_c20221231_zNNI9Ii9Tml5" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;42,568&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FinancialAssetsAtFairValue_pn3n3_c20221231_zNfF5MeDj0j" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;42,568&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zeDFNFKeKwPd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;1,800,775&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z3UdWKCoXkw7" style="text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;1,795,752&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z8MVsGWTu2Pi" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;1,882,901&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zqE5UmRKe8D2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;1,934,295&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvTlrrv9bz48" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;874,569&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvZo3z2OSNbj" style="text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;874,569&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zG2y35CZMkdc" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;769,525&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zUFNrm8MIGVk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;769,525&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOjtCh58N4Gi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;566,867&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zWvIfRtuHp5d" style="text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;566,867&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zS0Bu4opkWi2" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;528,678&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zyRmfh5Q3zq9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;528,678&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialLiabilities_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zpjqJYyhcRva" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4035"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zuGeihlFqowa" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4037"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zSwW9FMkts7f" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;62,176&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_z4xfn4Oxzt9h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;62,176&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FinancialLiabilities_pn3n3_c20231231_zUSx8wBY3LO7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;3,242,211&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20231231_zLqaidjInSg2" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;3,237,188&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231_zeaXcLuRojA" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;3,243,280&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20221231_z4truBUYVEW9" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;3,294,674&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfFairValuesExplanatory>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2023-12-31_ifrs-full_TradeReceivablesMember"
      decimals="-3"
      id="Fact003995"
      unitRef="BRL">39485000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2023-12-31_ifrs-full_TradeReceivablesMember"
      decimals="-3"
      id="Fact003997"
      unitRef="BRL">39485000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2022-12-31_ifrs-full_TradeReceivablesMember"
      decimals="-3"
      id="Fact003999"
      unitRef="BRL">42568000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2022-12-31_ifrs-full_TradeReceivablesMember"
      decimals="-3"
      id="Fact004001"
      unitRef="BRL">42568000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004003"
      unitRef="BRL">39485000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004005"
      unitRef="BRL">39485000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004007"
      unitRef="BRL">42568000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004009"
      unitRef="BRL">42568000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004011"
      unitRef="BRL">1800775000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004013"
      unitRef="BRL">1795752000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2022-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004015"
      unitRef="BRL">1882901000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2022-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004017"
      unitRef="BRL">1934295000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004019"
      unitRef="BRL">874569000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004021"
      unitRef="BRL">874569000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004023"
      unitRef="BRL">769525000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004025"
      unitRef="BRL">769525000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact004027"
      unitRef="BRL">566867000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact004029"
      unitRef="BRL">566867000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact004031"
      unitRef="BRL">528678000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact004033"
      unitRef="BRL">528678000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2022-12-31_custom_NotesPayableMember"
      decimals="-3"
      id="Fact004039"
      unitRef="BRL">62176000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2022-12-31_custom_NotesPayableMember"
      decimals="-3"
      id="Fact004041"
      unitRef="BRL">62176000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004043"
      unitRef="BRL">3242211000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004045"
      unitRef="BRL">3237188000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004047"
      unitRef="BRL">3243280000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004049"
      unitRef="BRL">3294674000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <afya:SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact004051">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_pn3n3_zub13kxFjHY3" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 8)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B7_zn2xVc5VR2Zd" style="display: none"&gt;Schedule
    of income before income taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Index - % per year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Base rate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z1CmwrgwRFh5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,111&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90A_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z1Zhg3fb22H1" title="Index - % per year"&gt;100.8% of CDI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zteHpc4PvDha" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;60,846&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zxzsN62UahW1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(529,340)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zzKeMlQQ3cX6" title="Index - % per year"&gt;CDI + 1.8%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zulfA3LnOXTg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(71,196)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zjkWW6BQAR6h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(412,880)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zlfYUqzJPSGg" title="Index - % per year"&gt;CDI + 1.9%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zBlEYBtmvmW8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(55,945)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zTyOM3VjasWk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,193)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zrvQk1NqrTW9" title="Index - % per year"&gt;TJLP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zCH9Hf3BA766" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(733)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z9h6xH398M0f" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(21,405)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90B_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zcUlDXObefI1" title="Index - % per year"&gt;CDI + 1.75%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingThreeMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zCtn58HiZyJ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,868)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zM3Xtnp8qMQ8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(274,428)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_ztQoSudqoWe8" title="Index - % per year"&gt;CDI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zAT1MraOlzd6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(31,971)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialAssets_iI_pn3n3_c20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z2uOMoIpL1Td" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(256,488)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_ecustom--IndexRatePerYear_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zDlhhU9QYMhe" title="Index - % per year"&gt;SELIC&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--BaseRate_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zh7hDPdKbm16" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(29,881)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Net exposure&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--BaseRate_pn3n3_c20230101__20231231_zgkCjjYp6LOh" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(131,748)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Increase in basis points&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; width: 62%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;+75&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;+150&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Effect on profit before tax&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zYFdfJzbbPTi" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,407)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zN17YZqVBUr" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(14,814)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2023-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004053"
      unitRef="BRL">518111000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear
      contextRef="From2023-01-012023-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      id="Fact004055">100.8% of CDI</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2023-01-012023-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004057"
      unitRef="BRL">60846000</afya:BaseRate>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2023-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004059"
      unitRef="BRL">-529340000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      id="Fact004061">CDI + 1.8%</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004063"
      unitRef="BRL">-71196000</afya:BaseRate>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2023-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004065"
      unitRef="BRL">-412880000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      id="Fact004067">CDI + 1.9%</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004069"
      unitRef="BRL">-55945000</afya:BaseRate>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2023-12-31_custom_LoansAndFinancingTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004071"
      unitRef="BRL">-11193000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      id="Fact004073">TJLP</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004075"
      unitRef="BRL">-733000</afya:BaseRate>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2023-12-31_custom_LoansAndFinancingThreeMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004077"
      unitRef="BRL">-21405000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingThreeMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      id="Fact004079">CDI + 1.75%</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingThreeMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004081"
      unitRef="BRL">-2868000</afya:BaseRate>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004083"
      unitRef="BRL">-274428000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      id="Fact004085">CDI</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004087"
      unitRef="BRL">-31971000</afya:BaseRate>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004089"
      unitRef="BRL">-256488000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      id="Fact004091">SELIC</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004093"
      unitRef="BRL">-29881000</afya:BaseRate>
    <afya:BaseRate
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact004095"
      unitRef="BRL">-131748000</afya:BaseRate>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2023-01-012023-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004098"
      unitRef="BRL">-7407000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2023-01-012023-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact004100"
      unitRef="BRL">-14814000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:CreditExposure
      contextRef="AsOf2023-12-31_ifrs-full_CurrencyRiskMember"
      decimals="-3"
      id="Fact004102"
      unitRef="BRL">23173000</ifrs-full:CreditExposure>
    <ifrs-full:CreditExposure
      contextRef="AsOf2022-12-31_ifrs-full_CurrencyRiskMember"
      decimals="-3"
      id="Fact004104"
      unitRef="BRL">24447000</ifrs-full:CreditExposure>
    <afya:SensitivityChangeInTheEuroExchangeRate
      contextRef="From2023-01-012023-12-31_ifrs-full_CurrencyRiskMember"
      decimals="INF"
      id="Fact004106"
      unitRef="Pure">0.10</afya:SensitivityChangeInTheEuroExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="AsOf2023-12-31_ifrs-full_CurrencyRiskMember"
      decimals="INF"
      id="Fact004108"
      unitRef="N">4.8413</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="AsOf2023-12-31_currency_EUR_ifrs-full_CurrencyRiskMember"
      decimals="INF"
      id="Fact004110"
      unitRef="N">1.00</ifrs-full:ClosingForeignExchangeRate>
    <afya:SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact004112">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_pn3n3_zJDMahFm18Ra" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 9)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B4_z3XcUWgWtd94" style="display: none"&gt;Schedule of sensitivity foreign currency&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 52%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Exposure&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;+10%&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;-10%&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zdZM8iqCNood" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,173&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zbBLT6FZyP9k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,317&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20230101__20231231__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zx1YxzqAts9c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,317)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2023-01-012023-12-31_custom_ForeignCurrencyExposuresMember_ifrs-full_CurrencyRiskMember"
      decimals="-3"
      id="Fact004114"
      unitRef="BRL">23173000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2023-01-012023-12-31_custom_IncreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember"
      decimals="-3"
      id="Fact004116"
      unitRef="BRL">2317000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2023-01-012023-12-31_custom_DecreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember"
      decimals="-3"
      id="Fact004118"
      unitRef="BRL">-2317000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <afya:SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact004121">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_pn3n3_zfb5sP9cHG2" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 10)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B6_z7Ix2AYP9vgb" style="display: none"&gt;Schedule of maturity profile of financial liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Less than 1 year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1 to 3 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3 to 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;More than 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zKqpogNzeLQ8" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,222&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zlXoRe7b9DBi" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4125"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zKGhZQnf6hEf" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4127"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zd9BIrkyDVK5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4129"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zBPpQDCGIrla" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,222&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjfA8ZBcwEm7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;298,981&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVKkdOpEPvcb" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,383,255&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2ND2SJ83wp5" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;568,326&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zsgghcZXp1nd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4139"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LoansAndFinancing_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zsZWmnYIZTO4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,250,562&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvCWqPqgEbi7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;137,735&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zB2AA8LB5gPf" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;268,724&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z76RVpz4aMNc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;255,456&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJRt5StHaGXh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,261,213&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeaseLiabilities_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmJTIANl8Q96" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,923,128&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znPsXiOMCp12" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;387,693&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zNz2H9JulMXd" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;231,478&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zX4EmWKbXqT" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4157"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zB3yZUZGzu3f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4159"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zXfVv6dplGkf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;619,171&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Advances from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Advances_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zME4b62JV7sl" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;153,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zwzkYT7f58kk" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4165"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr1apcQkETf1" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4167"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Advances_iI_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zUElOKxFqFMj" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4169"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Advances_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeem7BEz0hn3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;153,485&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zZ8hDu6SFyzh" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,086,116&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z5BDQH8bxtsa" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,883,457&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zT1uFCFjemLb" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;823,782&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zovJFtW5v6Cl" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,261,213&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zU2V63uMcu62" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;5,054,568&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Less than 1 year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1 to 3 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3 to 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;More than 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFYjRLe0sr3k" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71,482&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVAgiBhQkOc8" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4185"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zv6qSV9PNFWe" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4187"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJV2gX82sHJ8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4189"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zEo3Amrr3gX4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71,482&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGMolnuvMz5j" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;287,741&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmDIPpbkjg9d" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;788,190&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zBbcXIg611D3" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,237,599&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zS3uZwei8xPe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4199"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LoansAndFinancing_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjj4Qt9o90Xi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,313,530&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z1LhxyYQUb04" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;117,506&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zyjqz9jJLsv6" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;234,688&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr9cmg2QCVU5" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;219,127&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zz9FvZfCyw8j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,139,771&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFnZkptdDykf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,711,092&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z5eY9D2z3HK1" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;282,481&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zMnsKPFukR34" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;339,281&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zttMMmQPyQVl" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4217"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zL5Ew6XkyqPd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4219"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgdhI4OV14Yb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;621,762&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NotePayables_iIP3ifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOfQHd3SH4o3" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,176&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zDTh1pftWl9g" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4225"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zkh3l2fqtjIc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4227"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVFde30t5472" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4229"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NotePayables_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztrWQM5u61f4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,176&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Advances from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zXGrzgZK41s7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;133,050&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zr6ZS3rPKD85" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4235"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zANnTznH1kXj" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4237"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGd6AVfTyGj2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4239"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Advances_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zNY8vWl2W63e" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;133,050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z93TKGcwfCkd" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;954,436&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOLa5MgMrUbc" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,362,159&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztILcbHGFaq7" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,456,726&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znJijWd3Flt9" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,139,771&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zOUKujqThra2" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;4,913,092&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004123"
      unitRef="BRL">108222000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004131"
      unitRef="BRL">108222000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <afya:LoansAndFinancing
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004133"
      unitRef="BRL">298981000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004135"
      unitRef="BRL">1383255000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004137"
      unitRef="BRL">568326000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004141"
      unitRef="BRL">2250562000</afya:LoansAndFinancing>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004143"
      unitRef="BRL">137735000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004145"
      unitRef="BRL">268724000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004147"
      unitRef="BRL">255456000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004149"
      unitRef="BRL">1261213000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004151"
      unitRef="BRL">1923128000</ifrs-full:LeaseLiabilities>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004153"
      unitRef="BRL">387693000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004155"
      unitRef="BRL">231478000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004161"
      unitRef="BRL">619171000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:Advances
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004163"
      unitRef="BRL">153485000</ifrs-full:Advances>
    <ifrs-full:Advances
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004171"
      unitRef="BRL">153485000</ifrs-full:Advances>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004173"
      unitRef="BRL">1086116000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004175"
      unitRef="BRL">1883457000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004177"
      unitRef="BRL">823782000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2023-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004179"
      unitRef="BRL">1261213000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2023-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004181"
      unitRef="BRL">5054568000</afya:FinancialLiabilitiesContractualUndiscounted>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004183"
      unitRef="BRL">71482000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004191"
      unitRef="BRL">71482000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <afya:LoansAndFinancing
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004193"
      unitRef="BRL">287741000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004195"
      unitRef="BRL">788190000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004197"
      unitRef="BRL">1237599000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004201"
      unitRef="BRL">2313530000</afya:LoansAndFinancing>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004203"
      unitRef="BRL">117506000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004205"
      unitRef="BRL">234688000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004207"
      unitRef="BRL">219127000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004209"
      unitRef="BRL">1139771000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004211"
      unitRef="BRL">1711092000</ifrs-full:LeaseLiabilities>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004213"
      unitRef="BRL">282481000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004215"
      unitRef="BRL">339281000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004221"
      unitRef="BRL">621762000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:NotePayables
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004223"
      unitRef="BRL">62176000</afya:NotePayables>
    <afya:NotePayables
      contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004231"
      unitRef="BRL">62176000</afya:NotePayables>
    <ifrs-full:Advances
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004233"
      unitRef="BRL">133050000</ifrs-full:Advances>
    <ifrs-full:Advances
      contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004241"
      unitRef="BRL">133050000</ifrs-full:Advances>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004243"
      unitRef="BRL">954436000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004245"
      unitRef="BRL">1362159000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004247"
      unitRef="BRL">1456726000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2022-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004249"
      unitRef="BRL">1139771000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2022-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact004251"
      unitRef="BRL">4913092000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact004253">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_pn3n3_znD3NLxzm0s8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Financial assets and financial liabilities (Details 11)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BF_zOrYKxtipXZd" style="display: none"&gt;Schedule of changes in liabilities arising from financing activities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments of principal&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 9%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments of interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Business combination&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: -5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zb5oCuVF2yU9" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,882,901&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z1OkdgyXg4N" style="text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(112,630)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zz91xZ7KP0W2" style="vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(175,889)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzpSINmYrvi" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,288&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zdUuGXkS87J4" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;197,678&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zRc9ScNgC2Le" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4265"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0YRYzOiAbDk" style="padding-right: 0.15pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,427&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0hWMvdNrn02" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,800,775&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYf8cRihXEla" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;769,525&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zR2nMfRekJq7" style="text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(31,473)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zC97GDXfYtG7" style="vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(103,911)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxjk1h1PbXRj" style="padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;77,715&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYAjczM65A1j" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;100,849&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zVDA8oIuDHE" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;65,408&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYfhJaueJrFa" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,544)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zo0m5A5acNlj" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;874,569&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zwtzRK5Fwffl" style="border-bottom: black 1pt solid; text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(18,750)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zFo3dpzJSFqe" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4289"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z8Z0JZ93uE4f" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;18,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: -0.15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231_zMKwqychlUL5" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,652,426&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zl9R91ymLWLc" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(162,853)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231_zCKkWkERt6cg" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(279,800)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z7rZ7YHdggYe" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;101,753&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zUFpLWbFA4je" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;298,527&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zlxTmIH9PCDc" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;65,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zebvvVZYquEf" style="border-bottom: black 1pt solid; padding-right: -5.15pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(117)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231_zIINH3EzP9p1" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,675,344&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;January 1, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments of principal&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 8%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments of interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Business combinations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: -5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.15pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: -5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zjeEFgq56np2" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,374,876&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zEwNAVSAqorj" style="text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,791)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zrrRt69nvtx9" style="vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(116,587)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzU4iMhnx5gk" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;496,885&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zCK1Hw1ilUDi" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;127,559&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zr0qvCHNkJw7" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4319"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zK6r0rlPGix8" style="padding-right: 0.15pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,959&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zCJjUkT2tLHk" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,882,901&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zoi3iYocDHK3" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvuyDODzqePk" style="text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(28,511)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zX3KJ3Ib6cSa" style="vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(85,001)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zHioC4pfibIa" style="padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;100,873&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zD32aHFrwWrf" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;88,571&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zi3ngNPHWwB8" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4335"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zBaY0ypLltl" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(20,492)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxn0fQ2cPZPj" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;769,525&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z0p2NsGW2d24" style="border-bottom: black 1pt solid; text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(19,736)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zmB1yGQcQtXg" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4343"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zCFdrY8qXPDl" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;19,736&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: -0.15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20220101__20221231_zUhWEPSqKU1b" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,088,961&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zPpSwvF3ojPl" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(50,038)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20220101__20221231_z4ktVBIa9ha" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(201,588)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zPBmJguotbH7" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;617,494&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_z0KOyBp9fS01" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;216,130&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zaq1pYbwsTIg" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4357"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20220101__20221231_zB1yN3yN8WUc" style="border-bottom: black 1pt solid; padding-right: -5.15pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(18,533)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20220101__20221231_zJxvR9gCYeu4" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,652,426&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments of principal&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 8%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments of interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Additions (ii)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Business combinations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z37iLiWRrR8d" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;617,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zsMxQRR4XKhb" style="text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(107,766)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z5WS9nNRhurf" style="vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(50,310)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zNuOgl1HATC5" style="padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;809,539&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znkh4kSlZoF5" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;68,909&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zApx8FKVHoU" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;36,591&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z7krHWyRiHb4" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;428&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zuxfOb5h6wX2" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,374,876&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zkn1nQd2fRw2" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zaY7drP9ILG7" style="text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(20,075)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zGeUJ84mQfvc" style="vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(67,676)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zkdzaSaZnVEf" style="padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;158,651&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zx11PdTD5kS7" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;67,212&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z8sAB1z40ZS3" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;139,514&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zfzKIphO7WAi" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(11,244)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zUrlgU4Npwe2" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zjFMBOqxMtgf" style="border-bottom: black 1pt solid; text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(18,648)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zcTlfTDcIkP7" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4397"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zU4HEg0KiGh5" style="border-bottom: black 1pt solid; padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;18,648&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20210101__20211231_zGrVTs3PHlR5" style="border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,065,188&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zyWwyGmVEAtl" style="border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(146,489)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20210101__20211231_zOWleRFSl2wh" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Payments of interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(117,986)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zDU1ZF6KtwW6" style="border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;986,838&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_z8sHp1aaRVdd" style="border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;136,121&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zEVPUtEuD818" style="border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;176,105&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20210101__20211231_zEjF0FDq0qMk" style="border-bottom: black 1pt solid; padding-right: -6.25pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(10,816)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20210101__20211231_z4jiUHg6srUk" style="border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,088,961&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Payment of interest of loan and financing and lease liabilities are included in cash flows
from financing activities.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The additions of loans and financing in 2021 include proceeds from the SoftBank transaction
of R$822,569, net of the transaction costs of R$13,030.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2022-12-31_custom_LoansAndFinancingMember1360068625"
      decimals="-3"
      id="Fact004255"
      unitRef="BRL">1882901000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004257"
      unitRef="BRL">-112630000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004259"
      unitRef="BRL">175889000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004261"
      unitRef="BRL">5288000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004263"
      unitRef="BRL">197678000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004267"
      unitRef="BRL">3427000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31_custom_LoansAndFinancingMember1360068953"
      decimals="-3"
      id="Fact004269"
      unitRef="BRL">1800775000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember1360068984"
      decimals="-3"
      id="Fact004271"
      unitRef="BRL">769525000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004273"
      unitRef="BRL">-31473000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004275"
      unitRef="BRL">103911000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004277"
      unitRef="BRL">77715000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004279"
      unitRef="BRL">100849000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004281"
      unitRef="BRL">65408000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004283"
      unitRef="BRL">-3544000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember1360069062"
      decimals="-3"
      id="Fact004285"
      unitRef="BRL">874569000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_DividendsPayableMember"
      decimals="-3"
      id="Fact004287"
      unitRef="BRL">-18750000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_DividendsPayableMember"
      decimals="-3"
      id="Fact004291"
      unitRef="BRL">18750000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004293"
      unitRef="BRL">2652426000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact004295"
      unitRef="BRL">-162853000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact004297"
      unitRef="BRL">279800000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact004299"
      unitRef="BRL">101753000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact004301"
      unitRef="BRL">298527000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact004303"
      unitRef="BRL">65408000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact004305"
      unitRef="BRL">-117000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004307"
      unitRef="BRL">2675344000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004309"
      unitRef="BRL">1374876000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004311"
      unitRef="BRL">-1791000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2022-01-012022-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004313"
      unitRef="BRL">116587000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004315"
      unitRef="BRL">496885000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004317"
      unitRef="BRL">127559000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004321"
      unitRef="BRL">1959000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2022-12-31_custom_LoansAndFinancingMember1360068625"
      decimals="-3"
      id="Fact004323"
      unitRef="BRL">1882901000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004325"
      unitRef="BRL">714085000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004327"
      unitRef="BRL">-28511000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004329"
      unitRef="BRL">85001000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004331"
      unitRef="BRL">100873000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004333"
      unitRef="BRL">88571000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004337"
      unitRef="BRL">-20492000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember1360068984"
      decimals="-3"
      id="Fact004339"
      unitRef="BRL">769525000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31_custom_DividendsPayableMember"
      decimals="-3"
      id="Fact004341"
      unitRef="BRL">-19736000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31_custom_DividendsPayableMember"
      decimals="-3"
      id="Fact004345"
      unitRef="BRL">19736000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact004347"
      unitRef="BRL">2088961000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004349"
      unitRef="BRL">-50038000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004351"
      unitRef="BRL">201588000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004353"
      unitRef="BRL">617494000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004355"
      unitRef="BRL">216130000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004359"
      unitRef="BRL">-18533000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004361"
      unitRef="BRL">2652426000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2020-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004363"
      unitRef="BRL">617485000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004365"
      unitRef="BRL">-107766000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004367"
      unitRef="BRL">50310000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004369"
      unitRef="BRL">809539000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004371"
      unitRef="BRL">68909000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004373"
      unitRef="BRL">36591000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004375"
      unitRef="BRL">428000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004377"
      unitRef="BRL">1374876000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004379"
      unitRef="BRL">447703000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004381"
      unitRef="BRL">-20075000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004383"
      unitRef="BRL">67676000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004385"
      unitRef="BRL">158651000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004387"
      unitRef="BRL">67212000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004389"
      unitRef="BRL">139514000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004391"
      unitRef="BRL">-11244000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004393"
      unitRef="BRL">714085000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_DividendsPayableMember"
      decimals="-3"
      id="Fact004395"
      unitRef="BRL">-18648000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_DividendsPayableMember"
      decimals="-3"
      id="Fact004399"
      unitRef="BRL">18648000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact004401"
      unitRef="BRL">1065188000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact004403"
      unitRef="BRL">-146489000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact004405"
      unitRef="BRL">117986000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact004407"
      unitRef="BRL">986838000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact004409"
      unitRef="BRL">136121000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact004411"
      unitRef="BRL">176105000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact004413"
      unitRef="BRL">-10816000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact004415"
      unitRef="BRL">2088961000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <afya:FairValueMeasurementExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact004418">&lt;p id="xdx_808_ecustom--FairValueMeasurementExplanatory_zLFuIZiL3ZG2" style="font: 8pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;14&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_829_z6gXIlRuPYLc"&gt;Fair value measurement&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The table below provides the fair value measurement
hierarchy of the Company&#x2019;s assets and liabilities as of December 31, 2023 and 2022.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfFairValueMeasurementExplanaory_pn3n3_zXkxqugiNX1j" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Fair value measurement (Details)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span id="xdx_8B3_zoPsNlrfXFT9" style="display: none"&gt;Schedule of fair value measurement&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Fair value measurement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 15%; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Quoted prices in active markets (Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Significant observable inputs (Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Significant unobservable inputs (Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2023 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Assets for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Trade receivables (non-current)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231_z6nW6UYVwKll" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;39,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zgMAMHa7C9Y7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4424"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zgnKNB61vcL5" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;39,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zz4qBjgPLW78" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4428"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Liabilities for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LoansAndFinancingLiabilities_pn3n3_c20231231_zmOBDC8nlVr4" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,795,752)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancingLiabilities_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z1ChD5t69aU5" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,795,752)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LeaseLiabilities1_pn3n3_c20231231_zrCCfiQbcn9l" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(874,569)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LeaseLiabilities1_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zMnXzltPJyUl" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(874,569)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_pn3n3_c20231231_zCnINyUm3Rqg" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(566,867)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z0poaPp6EtI8" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(566,867)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Assets for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Trade receivables (non-current)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231_zeLkFJ30Gtqc" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42,568&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zJf8rpjzeG77" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4444"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zJnkrYIYbxX7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42,568&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zQcI0wGyDQo7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4448"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Liabilities for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_pn3n3_c20221231_zQQuhRJa4IT7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,934,295)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LoansAndFinancingLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zCK7lwe0y5Y7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,934,295)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LeaseLiabilities1_iI_pn3n3_c20221231_zvBBXzWtfAna" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(769,525)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LeaseLiabilities1_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zZ2rXoEUcwBl" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(769,525)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_pn3n3_c20221231_zOLekkhCkSCj" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(528,678)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zgzRSQHH0qJf" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(528,678)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FairValueNotesPayables1_iI_pn3n3_c20221231_zsYf6f6VbNT1" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(62,176)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--FairValueNotesPayables1_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zb3OjtRK3R49" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(62,176)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;There were no transfers between Levels during the
period or year presented.&lt;/p&gt;

</afya:FairValueMeasurementExplanatory>
    <afya:ScheduleOfFairValueMeasurementExplanaory contextRef="From2023-01-01to2023-12-31" id="Fact004420">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfFairValueMeasurementExplanaory_pn3n3_zXkxqugiNX1j" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Fair value measurement (Details)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span id="xdx_8B3_zoPsNlrfXFT9" style="display: none"&gt;Schedule of fair value measurement&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Fair value measurement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 15%; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Quoted prices in active markets (Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Significant observable inputs (Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Significant unobservable inputs (Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2023 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Assets for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Trade receivables (non-current)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231_z6nW6UYVwKll" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;39,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zgMAMHa7C9Y7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4424"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zgnKNB61vcL5" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;39,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zz4qBjgPLW78" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4428"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Liabilities for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LoansAndFinancingLiabilities_pn3n3_c20231231_zmOBDC8nlVr4" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,795,752)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancingLiabilities_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z1ChD5t69aU5" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,795,752)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LeaseLiabilities1_pn3n3_c20231231_zrCCfiQbcn9l" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(874,569)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LeaseLiabilities1_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zMnXzltPJyUl" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(874,569)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_pn3n3_c20231231_zCnINyUm3Rqg" style="vertical-align: bottom; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(566,867)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_pn3n3_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z0poaPp6EtI8" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(566,867)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Assets for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Trade receivables (non-current)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231_zeLkFJ30Gtqc" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42,568&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zJf8rpjzeG77" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4444"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zJnkrYIYbxX7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42,568&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NoncurrentTradeReceivables_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zQcI0wGyDQo7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4448"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Liabilities for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_pn3n3_c20221231_zQQuhRJa4IT7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,934,295)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LoansAndFinancingLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zCK7lwe0y5Y7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,934,295)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LeaseLiabilities1_iI_pn3n3_c20221231_zvBBXzWtfAna" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(769,525)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LeaseLiabilities1_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zZ2rXoEUcwBl" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(769,525)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_pn3n3_c20221231_zOLekkhCkSCj" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(528,678)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zgzRSQHH0qJf" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(528,678)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FairValueNotesPayables1_iI_pn3n3_c20221231_zsYf6f6VbNT1" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(62,176)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--FairValueNotesPayables1_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zb3OjtRK3R49" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(62,176)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:ScheduleOfFairValueMeasurementExplanaory>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004422"
      unitRef="BRL">39485000</ifrs-full:NoncurrentTradeReceivables>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2023-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact004426"
      unitRef="BRL">39485000</ifrs-full:NoncurrentTradeReceivables>
    <afya:LoansAndFinancingLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004430"
      unitRef="BRL">-1795752000</afya:LoansAndFinancingLiabilities>
    <afya:LoansAndFinancingLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact004432"
      unitRef="BRL">-1795752000</afya:LoansAndFinancingLiabilities>
    <afya:LeaseLiabilities1
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004434"
      unitRef="BRL">-874569000</afya:LeaseLiabilities1>
    <afya:LeaseLiabilities1
      contextRef="AsOf2023-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact004436"
      unitRef="BRL">-874569000</afya:LeaseLiabilities1>
    <afya:TradeAndOtherPayablesToRelatedPartiesLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004438"
      unitRef="BRL">-566867000</afya:TradeAndOtherPayablesToRelatedPartiesLiabilities>
    <afya:TradeAndOtherPayablesToRelatedPartiesLiabilities
      contextRef="AsOf2023-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact004440"
      unitRef="BRL">-566867000</afya:TradeAndOtherPayablesToRelatedPartiesLiabilities>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004442"
      unitRef="BRL">42568000</ifrs-full:NoncurrentTradeReceivables>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2022-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact004446"
      unitRef="BRL">42568000</ifrs-full:NoncurrentTradeReceivables>
    <afya:LoansAndFinancingLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004450"
      unitRef="BRL">-1934295000</afya:LoansAndFinancingLiabilities>
    <afya:LoansAndFinancingLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact004452"
      unitRef="BRL">-1934295000</afya:LoansAndFinancingLiabilities>
    <afya:LeaseLiabilities1
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004454"
      unitRef="BRL">-769525000</afya:LeaseLiabilities1>
    <afya:LeaseLiabilities1
      contextRef="AsOf2022-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact004456"
      unitRef="BRL">-769525000</afya:LeaseLiabilities1>
    <afya:TradeAndOtherPayablesToRelatedPartiesLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004458"
      unitRef="BRL">-528678000</afya:TradeAndOtherPayablesToRelatedPartiesLiabilities>
    <afya:TradeAndOtherPayablesToRelatedPartiesLiabilities
      contextRef="AsOf2022-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact004460"
      unitRef="BRL">-528678000</afya:TradeAndOtherPayablesToRelatedPartiesLiabilities>
    <afya:FairValueNotesPayables1
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004462"
      unitRef="BRL">-62176000</afya:FairValueNotesPayables1>
    <afya:FairValueNotesPayables1
      contextRef="AsOf2022-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact004464"
      unitRef="BRL">-62176000</afya:FairValueNotesPayables1>
    <afya:CapitalManagementExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact004466">&lt;p id="xdx_804_ecustom--CapitalManagementExplanatory_zMEDYPMJEDqa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;15&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_820_zLAVEuMVQG5g"&gt;Capital management&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;For the purposes of the Company&#x2019;s capital
management, capital considers total equity. The primary objective of the Company&#x2019;s capital management is to maximize shareholder
value.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The Company manages its capital structure and makes
adjustments in light of changes in economic conditions and the requirements of the financial covenants.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;In order to achieve this overall objective, the
Company&#x2019;s capital management, among other things, aims to ensure that it meets financial covenants that define capital structure
requirements. Breaches in meeting the financial covenants would permit the bank to immediately call loans or debentures. There have been
no breaches of the financial covenants of any loans or debentures in the current and previous periods.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;No changes were made in the objectives, policies
or processes for managing capital during the years ended December 31, 2023 and 2022.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

</afya:CapitalManagementExplanatory>
    <afya:LaborAndSocialObligationsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact004468">&lt;p id="xdx_80F_ecustom--LaborAndSocialObligationsExplanatory_zdY28qPb1jb4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;16&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_82C_zV2NQ8v9LAmh"&gt;Labor and social obligations&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;a) Variable compensation (bonuses)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 14pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company recorded bonuses related to variable compensation of employees and management in cost of services and selling, general and administrative
expenses of R$&lt;span id="xdx_908_ecustom--ShareBasedCompensationOfEmployees_pn3n3_c20230101__20231231_zlUo7BjI9FKb" title="Compensation of employees"&gt;22,185&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 8pt; font-weight: normal"&gt;, &lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;R$&lt;span id="xdx_908_ecustom--ShareBasedCompensationOfEmployees_pn3n3_c20220101__20221231_zrYRy1wf5zX4" title="Compensation of employees"&gt;24,248&lt;/span&gt;
and R$&lt;span id="xdx_90A_ecustom--ShareBasedCompensationOfEmployees_pn3n3_c20210101__20211231_zMPu8NPpfAFd" title="Compensation of employees"&gt;25,587&lt;/span&gt; in the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;b) Afya Limited share-based compensation plans&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;b.1) Stock options plan&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;The stock options plan was approved on
August 30, 2019 and granted to senior executives and other employees of the Company from that date, with subsequent changes in the strike
price, as approved, on July 29, 2020 and July 8, 2022, resulting in the strike price of the tranches still to be vested, at the later
date, having their strike price modified to the IPO price in Brazilian Reais (R$&lt;span id="xdx_902_ecustom--StrikePrice_pid_c20200701__20200729_zyG7ZxYyGXPd" title="Strike price"&gt;&lt;span id="xdx_902_ecustom--StrikePrice_pid_c20220701__20220708_zoFbPmC0VAZ" title="Strike price"&gt;71.22&lt;/span&gt;&lt;/span&gt;), adjusted from the IPO date until the exercise
date using the Certificado de Dep&#xf3;sito Interbanc&#xe1;rio (CDI index), excluding dividends. Such changes were assessed as modifications
by the Company and were accounted in accordance with IFRS 2.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;As result of those modifications, the expense related to the share-based
payment of the Company reflects the cost of the original award at grant date over the vesting period plus the incremental fair values
of the repriced options at modification dates over the vesting period of the stock options.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The average incremental fair value, as result of the modification occurred
on July 8, 2022, was R$&lt;span id="xdx_901_ecustom--AverageIncrementalFairValue_pid_c20230101__20231231_zHt4fVP51zO1" title="Average incremental fair value"&gt;3.84&lt;/span&gt; Brazilian Reais per option. The table below lists the inputs to the valuation model used to determine the
incremental fair value of the stock options as result of the modification:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_z3DhwKnLSwik" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span id="xdx_8B4_zIvYQZf8uCva" style="display: none"&gt;Schedule of model used to determine the fair value of the stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Modified plan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Original plan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_900_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zWfQ7kJCZOq4" title="Strike price at the measurement date"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z3r4lWano4O7" title="Strike price at the measurement date"&gt;91&lt;/span&gt; - R$&lt;span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zAH4XplbAaUb" title="Strike price at the measurement date"&gt;140&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividend yield (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zUsG4r93xNva" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zuOh5KUvGx59" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected volatility (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_907_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zWjxJMy2IuV5" title="Expected volatility"&gt;48&lt;/span&gt;% - &lt;span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zlXH4siWVndd" title="Expected volatility"&gt;59&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zcBR9APRGgy7" title="Expected volatility"&gt;48&lt;/span&gt;% - &lt;span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zrjadRuXnnVh" title="Expected volatility"&gt;59&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Risk-free interest rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zTFwDO4nXAq9" title="Risk-free interest rate"&gt;13&lt;/span&gt;% - &lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zsdoDHHhSQLk" title="Risk-free interest rate"&gt;15&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z8Nn5M5wUes1" title="Risk-free interest rate"&gt;13&lt;/span&gt;% - &lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z1zWoDL4DXTh" title="Risk-free interest rate"&gt;15&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected life of stock options (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zk2G9NZm5Vtk" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_905_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zEZ5SsV37D82" title="Expected life of stock options"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zouL0Up0DR1b" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_901_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zmuhF1ZxeeVj" title="Expected life of stock options"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90D_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zE6LFCFQ2Rw8" title="Share price at the measurement date"&gt;48&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zq2Tsqgjg3F4" title="Share price at the measurement date"&gt;48&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Valuation model&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zdRMlGQk6ZPh" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zIBsj6YJ7XSi" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted average fair value at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_902_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zhM8zKh65ZZb" title="Weighted average fair value at the measurement date"&gt;53.06&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zXwRwA9w7zki" title="Weighted average fair value at the measurement date"&gt;49.22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AD_zC0bIJyQTvzf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On July 31, 2023, the People and ESG Committee approved a further change
in the share-based compensation plan to retain talents and reinforce the compensation plan. All the holders of stock options granted before
July 11, 2022, with strike price based on the IPO price in Brazilian Reais or above, were offered the possibility to exchange the stock
options for a number of Restricted Stock Units (RSUs) with conversion ratios based on fair value of the original plan, at modification
date, so that the total fair value of the modified award remains the same as the original plan, resulting in a weighted average conversion
ratio of 0.12 RSUs per stock option. As result, the exchange from stock options to RSUs was deemed as a replacement award and thus assessed
as a modification by the Company and accounted in accordance with IFRS 2, since the beneficiaries will have a 'value for value&#x2019;
benefit of settling its award for no cash consideration.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The key inputs to the valuation model used to determine the total fair value
of the stock options for conversion to RSUs are as follows:&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_hifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zhLIGEa0rpP3" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 1)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span id="xdx_8BA_z5mSy3N2tTS3" style="display: none"&gt;Schedule of model used to determine the fair value of the stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 71%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Modified plan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90A_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zWPeKZFIDhb8" title="Strike price at the measurement date"&gt;95&lt;/span&gt; - R$&lt;span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBTa2NxzE0j2" title="Strike price at the measurement date"&gt;160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividend yield (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zMdWZ0PcHFH8" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected volatility (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zSLeWRkJ4E96" title="Expected volatility"&gt;45&lt;/span&gt;% - &lt;span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zEhGVs7g9Bn9" title="Expected volatility"&gt;48&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Risk-free interest rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z7xF29NAJTU5" title="Risk-free interest rate"&gt;10&lt;/span&gt;% - &lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zkn5cnlFJlwg" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected life of stock options (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zieLowKDGYmg" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zZVQFRInH7Tc" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_904_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z2A86MvYyVSj" title="Share price at the measurement date"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Valuation model&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zOBhyh8aoE2e" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted average conversion rate (RSUs/Stock options)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z2XpObBbdqna" title="Weighted average fair value at the measurement date"&gt;0.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AF_zY1LSx8SakB9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;Moreover, the People and ESG Committee also approved, on July 31,
2023, a modification in the index rate to the strike prices of its granted stock options. The result is that strike prices are now adjusted
by the Brazilian inflation rate (IPCA) instead of the CDI rate. These changes were accounted as modifications in accordance with IFRS
2. The average incremental fair value, as result of the modification occurred on such date, was R$2.10 Brazilian Reais per stock option.
The table below lists the inputs to the valuation model used to determine the incremental fair value of the stock options as result of
the modification:&lt;/p&gt;
&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;






&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions_pn3n3_z4UiQERxB4J9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 2)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span id="xdx_8BA_zhccjbnvCi5d" style="display: none"&gt;Schedule of model used to determine incremental  fair
    value of the stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Modified plan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Original plan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike price index&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IPCA&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;CDI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_z2El9m7f9SL2" title="Strike price at the measurement date"&gt;59&lt;/span&gt; - &lt;span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zGASxYwoQ787" title="Strike price at the measurement date"&gt;104&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zgtuU9sx9Kl8" title="Strike price at the measurement date"&gt;59&lt;/span&gt; - &lt;span id="xdx_902_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zW3rkReTWqZe" title="Strike price at the measurement date"&gt;104&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividend yield (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zOvIgzedMDbd" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zeE3cOTGw10a" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected volatility (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zuBMdNKzQm22" title="Expected volatility"&gt;45&lt;/span&gt;% - &lt;span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_z3DAcRpFac0e" title="Expected volatility"&gt;54&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zdzLDkpixhT2" title="Expected volatility"&gt;45&lt;/span&gt;% - &lt;span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zbgMv89A3FK4" title="Expected volatility"&gt;54&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Risk-free interest rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zZIS1Sllneeg" title="Risk-free interest rate"&gt;10&lt;/span&gt;% - &lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zwx37XikBnI1" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zr2bWwddO581" title="Risk-free interest rate"&gt;10&lt;/span&gt;% - &lt;span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zd19mY7PKgma" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected life of stock options (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;0 - &lt;span id="xdx_904_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zfRypSrhfeS5" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;0 - &lt;span id="xdx_90C_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zmJPSCo43017" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_904_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zLmNlPfUZTRl" title="Share price at the measurement date"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_903_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zKZajR5DadLk" title="Share price at the measurement date"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Valuation model&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_znoVYBLM5xC4" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zo834EhhMccg" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted average fair value at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zzuwfH439Zmf" title="Weighted average fair value at the measurement date"&gt;28.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zoJYkVFxtvj5" title="Weighted average fair value at the measurement date"&gt;26.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_zi6FQMLADhGc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On February 13, 2023, April 17, 2023, August 1, 2023, October 1, 2023 and
December 1, 2023 the Company granted &lt;span id="xdx_909_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20230212__20230213__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zwk3KsPLh7d1" title="Number of stock option granted"&gt;15,000&lt;/span&gt;, &lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20230416__20230417__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zbHAVDMpu31k" title="Number of stock option granted"&gt;30,000&lt;/span&gt;, &lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20230730__20230801__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zeCHYaxBMSgc" title="Number of stock option granted"&gt;153,000&lt;/span&gt;, &lt;span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20230930__20231001__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zJ8xlD5mKkvb" title="Number of stock option granted"&gt;37,000&lt;/span&gt; and &lt;span id="xdx_902_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uN_c20231129__20231201__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OptionsGrantedMember_zAQddLSdfYnd" title="Number of stock option granted"&gt;232,000&lt;/span&gt;, respectively, additional stock options:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfAdditionalStockOptionsExplanatory_zmBpLXFOmjr6" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 3)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span id="xdx_8BB_zQI6LsFh3s81" style="display: none"&gt;Schedule of additional stock
    options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;February&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%"&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;April&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%"&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;August&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%"&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;October&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%"&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;December&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90E_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zI2m5yXju4wc" title="Strike price at the measurement date"&gt;56&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zqAwQb03Hrke" title="Strike price at the measurement date"&gt;57&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zF76UYqapkn8" title="Strike price at the measurement date"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_900_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zUagWImKfRN9" title="Strike price at the measurement date"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zVYLYb5D7G52" title="Strike price at the measurement date"&gt;60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividend yield (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z04rFiBw2J8f" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z55pl3l2FVE2" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_903_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zOdnqiZFeUa2" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zhWYF66lggNc" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_904_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zKh0Ngq5PZP9" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected volatility (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zMSmQ4Ih25dl" title="Expected volatility"&gt;46&lt;/span&gt;% - &lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zXpdMIq8WQk8" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEoAq7hSxmIa" title="Expected volatility"&gt;48&lt;/span&gt;% - &lt;span id="xdx_906_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zt4vzQUSOsG9" title="Expected volatility"&gt;55&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_909_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zcggEqL8SdS1" title="Expected volatility"&gt;47&lt;/span&gt;% - &lt;span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zueJbo5qPCKh" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zzJSvMekUEo2" title="Expected volatility"&gt;44&lt;/span&gt;% - &lt;span id="xdx_90C_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zSKOFhusMje" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z9tUL74e6hyb" title="Expected volatility"&gt;34&lt;/span&gt;% - &lt;span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_znKqUGV6FTvj" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Risk-free interest rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zzU2gnFznmKi" title="Risk-free interest rate"&gt;13&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0rsPOleYlb9" title="Risk-free interest rate"&gt;11&lt;/span&gt;% - &lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zZ6GDBaK4WVj" title="Risk-free interest rate"&gt;13&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zPdY2n4TWJm5" title="Risk-free interest rate"&gt;10&lt;/span&gt;% - &lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zXnNe5r1zhWe" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zf6lAnJ8vAxa" title="Risk-free interest rate"&gt;11&lt;/span&gt;% - &lt;span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zCUrA8wWBcY9" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zwJfvFgpns6d" title="Risk-free interest rate"&gt;10&lt;/span&gt;% - &lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zudkK9AKu8Y3" title="Risk-free interest rate"&gt;11&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected life of stock options (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_907_ecustom--ExpectedLifeOfStockOptions_dtY_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zIH3opcItc9" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_902_ecustom--ExpectedLifeOfStockOptions_dtY_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zJLwkIeZm43" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_ecustom--ExpectedLifeOfStockOptions_dtY_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zz0380XqIJ4a" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_902_ecustom--ExpectedLifeOfStockOptions_dtY_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z18q86bm81ng" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90B_ecustom--ExpectedLifeOfStockOptions_dtY_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zHPbANDExjOf" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zj5WY5cQGlzi" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_907_ecustom--ExpectedLifeOfStockOptions_dtY_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zKnS23omez9g" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zMVpTQMsb6J8" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zXePdAhlCI5" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_90A_ecustom--ExpectedLifeOfStockOptions_dtY_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEW7JPY4XvLh" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_907_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zQLko8vfA155" title="Share price at the measurement date"&gt;70.69&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90F_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_ztxGlOcwWQsd" title="Share price at the measurement date"&gt;62.51&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90E_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zRgfyPUMecrg" title="Share price at the measurement date"&gt;76.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zLmZDYCaTePi" title="Share price at the measurement date"&gt;79.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_909_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zdhuK5StwODi" title="Share price at the measurement date"&gt;100.97&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Valuation model&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z9NaZQH24Yl3" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zfh2wf93wE5e" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zYdHs8qHNpv9" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z0lRaXRCmcT7" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zapjHNvYimal" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted average fair value at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90B_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z8ySNMeVPjg3" title="Weighted average fair value at the measurement date"&gt;29.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zHByWqOzRNP" title="Weighted average fair value at the measurement date"&gt;32.04&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zK6XFMlKrTHb" title="Weighted average fair value at the measurement date"&gt;37.04&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_900_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zwf3EIImkkjl" title="Weighted average fair value at the measurement date"&gt;38.67&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_908_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zkTKEzdVV6V7" title="Weighted average fair value at the measurement date"&gt;54.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_zATLrZGTKqMa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The table below illustrates the number and movements
in stock options for the years ended December 31, 2023, 2022 and 2021:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfSharebasedCompensationPlanExplanatory_pn3n3_zCdRaKCRhkqc" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 4)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span id="xdx_8BF_zUvAvdriz7vi" style="display: none"&gt;Schedule of share-based compensation plan&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Weighted average strike price&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;(in Brazilian Reais)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;
    &lt;p style="border-bottom: Black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Number of stock options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="border-top: Black 1pt solid; width: 40%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Outstanding at January 1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zYUJ3ITX4Gtc" style="width: 18%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;79.47&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKFFpHaJiCm9" style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,729,287&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z1iQtKHjDEKi" style="white-space: nowrap; width: 14%; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,086,728&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z81sVx0CqOIa" style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,510,983&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zu5nUAFKx6Uj" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;60.83&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z2URd955qre7" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;467,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zPP6bNbwVI39" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,234,919&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zqM5i7m1Jse8" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,170,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zBh72c7DyEE1" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;59.67&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zBZ0H1MWhg6a" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(164,214)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zob9axieXdni" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4746"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zfdjfqnv4EMh" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(442,669)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Stock options exchanged to RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKYMMLtl20F6" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Stock options exchanged"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4750"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z776cNP8Myfj" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,751,599)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zIRw7ywFjna2" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4754"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKRjgHtN0oM6" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4756"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z5cH8H3KI0wf" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;110.95&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zMMHPPyJOMof" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(333,111)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zusifHyb97b6" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(365,749)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zlY5Vp34ZyCj" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(60,000)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expired&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3lvNhkaYni" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;94.17&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHJf011QlSra" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(251,299)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmtG1BROVopg" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(226,611)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zZhb1XM6sLSg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(91,586)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zVZOpG0sn9N9" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;64.33&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zxl2aIAuewL3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,696,064&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zI6s6YVB2tQf" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,729,287&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zLHmal4NBHD3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,086,728&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z8pqSfZnW3Ul" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Exercisable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;86.23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z99Nlqh8pCk2" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;242,235&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zT5QMo9sX9a6" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,133,774&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z54x29IexhT1" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;542,061&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zEkDfwM96Ltd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The share-based compensation expense recognized
in selling, general and administrative expenses in the statement of income for the year ended December 31, 2023 was R$&lt;span id="xdx_903_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zTPfzF8mBysa" title="Share-based compensation expense"&gt;20,850&lt;/span&gt; (R$&lt;span id="xdx_903_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zsiKuCfZAUBh" title="Share-based compensation expense"&gt;27,242&lt;/span&gt;
and R$&lt;span id="xdx_90A_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zmp61F7AO3Cd" title="Share-based compensation expense"&gt;43,377&lt;/span&gt; in 2022 and 2021, respectively).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;b.2) Restricted Stock Units (RSU) Program&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;On July 8, 2022, the Company approved the new Restricted
Stock Units (RSU) program for employees. The participant's right to effectively receive ownership of the restricted shares will be conditioned
on the participant's continuance as an employee or director in the business group from the grant date until vesting.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The executives will be entitled to these shares
in a proportion of &lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zaTBGtbnU0hk" title="Proportion percentage"&gt;10&lt;/span&gt;%, &lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits1Member_zQSSqBNnx72g" title="Proportion percentage"&gt;20&lt;/span&gt;%, &lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits2Member_z4zU3ehqId59" title="Proportion percentage"&gt;30&lt;/span&gt;%, &lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits3Member_zFdm4VF76ggk" title="Proportion percentage"&gt;40&lt;/span&gt;% each year.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;In July 2022 and September 2022, &lt;span id="xdx_903_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20220701__20220731_zP0s67hBCEFg" title="Granted"&gt;442,546&lt;/span&gt; and &lt;span id="xdx_907_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20220901__20220930_z0SF2xRFKkgd" title="Granted"&gt;4,678&lt;/span&gt;
RSUs were granted, respectively, to Afya&#x2019;s executives, with vesting periods from May 2023 to May 2026. Fair values at grant date
were R$&lt;span id="xdx_908_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20220701__20220731_zbBpWgy9n692" title="Fair values at grant date"&gt;48.24&lt;/span&gt; and R$&lt;span id="xdx_904_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20220901__20220930_zkSjtGj2N7z1" title="Fair values at grant date"&gt;72.59&lt;/span&gt;, respectively. On February 2, April 17, August 1, October 1 and December 1, 2023, &lt;span id="xdx_90C_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20230129__20230202_zIIJjqZNHFR7" title="Granted"&gt;8,000&lt;/span&gt;, &lt;span id="xdx_90A_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20230416__20230417_zUaT08e1peC" title="Granted"&gt;16,000&lt;/span&gt;, &lt;span id="xdx_903_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20230730__20230801_zCbG0wSyovcd" title="Granted"&gt;153,490&lt;/span&gt;, &lt;span id="xdx_90C_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20230930__20231001_zn3KGsYDqKB7" title="Granted"&gt;63,000&lt;/span&gt;
and &lt;span id="xdx_90A_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pid_c20231129__20231201_zyMbike8uY0h" title="Granted"&gt;76,600&lt;/span&gt; RSUs were granted to Afya&#x2019;s executives, respectively, with vesting periods from May 2024 to May 2027. Fair value at grant
date was R$&lt;span id="xdx_90F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230129__20230202_zQt0rZ1DaeT" title="Fair values at grant date"&gt;70.69&lt;/span&gt;, R$&lt;span id="xdx_903_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230416__20230417_zqHacIFVkLMd" title="Fair values at grant date"&gt;62.51&lt;/span&gt;, R$&lt;span id="xdx_905_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230730__20230801_zJciokgHtPj8" title="Fair values at grant date"&gt;76.45&lt;/span&gt;, R$&lt;span id="xdx_904_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20230930__20231001_zWXVoU1BSkSk" title="Fair values at grant date"&gt;79.12&lt;/span&gt; and R$&lt;span id="xdx_90A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20231129__20231201_z8jnt5T7S355" title="Fair values at grant date"&gt;100.97&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;As described above, on July 31, 2023, the holders
of stock options granted before July 11, 2022 were offered the possibility to exchange the stock options for a number of Restricted Stock
Units (RSUs).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The table below illustrates the number and movements
in RSUs for the years ended December 31, 2023 and 2022:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfStockOptionExplanatory_pn3n3_zQUnx2ZSX7zd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 5)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span id="xdx_8B7_zjd0OcZzxoZa" style="display: none"&gt;Schedule of stock option&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Outstanding at January 1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zkHv5O8K8dfl" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,224&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zBnbf1RfTczd" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4836"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zyvE4WkwR7e3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;317,090&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zn3u7iko1Pae" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,224&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Stock options exchanged to RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z4aqmEnnuOm4" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;215,797&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zgky3WtW64Eb" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4844"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zxFBoDpvVtAd" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(99,576)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z0sMyiI5LCJi" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4848"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zbRUJFWkGI72" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(26,104)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zYjd6BBvYxBg" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4852"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zJWV5I3j3oZ7" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;854,431&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zOBt3BH1QZxk" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;447,224&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_z5uEUPnk23Ri" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company accounts for the RSU plan as an equity-settled plan, except
for the portion of labor and social securities obligations.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Total RSU expense recognized in selling, general and administrative expenses
in the statement of income for the year ended December 31, 2023 amount R$&lt;span id="xdx_900_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zzktHujnkHb8" title="Share-based compensation expense"&gt;10,685&lt;/span&gt; (December 31, 2022: R$&lt;span id="xdx_90C_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zfY9QHQc5f0k" title="Share-based compensation expense"&gt;4,032&lt;/span&gt;). Labor and social obligations
amount R$&lt;span id="xdx_905_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20231231_zHzP4bgJGO7a" title="social obligations liabilities"&gt;7,171&lt;/span&gt; as of December 31, 2023 (December 31, 2022: R$&lt;span id="xdx_90A_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20221231_zaHBtmBssjGk" title="social obligations liabilities"&gt;2,167&lt;/span&gt;).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</afya:LaborAndSocialObligationsExplanatory>
    <afya:ShareBasedCompensationOfEmployees
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact004470"
      unitRef="BRL">22185000</afya:ShareBasedCompensationOfEmployees>
    <afya:ShareBasedCompensationOfEmployees
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004472"
      unitRef="BRL">24248000</afya:ShareBasedCompensationOfEmployees>
    <afya:ShareBasedCompensationOfEmployees
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact004474"
      unitRef="BRL">25587000</afya:ShareBasedCompensationOfEmployees>
    <afya:StrikePrice
      contextRef="From2020-07-012020-07-29"
      decimals="INF"
      id="Fact004477"
      unitRef="BRLPShares">71.22</afya:StrikePrice>
    <afya:StrikePrice
      contextRef="From2022-07-012022-07-08"
      decimals="INF"
      id="Fact004479"
      unitRef="BRLPShares">71.22</afya:StrikePrice>
    <afya:AverageIncrementalFairValue
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact004481"
      unitRef="BRLPShares">3.84</afya:AverageIncrementalFairValue>
    <afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions contextRef="From2023-01-01to2023-12-31" id="Fact004483">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_z3DhwKnLSwik" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span id="xdx_8B4_zIvYQZf8uCva" style="display: none"&gt;Schedule of model used to determine the fair value of the stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Modified plan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Original plan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_900_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zWfQ7kJCZOq4" title="Strike price at the measurement date"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z3r4lWano4O7" title="Strike price at the measurement date"&gt;91&lt;/span&gt; - R$&lt;span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zAH4XplbAaUb" title="Strike price at the measurement date"&gt;140&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividend yield (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zUsG4r93xNva" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zuOh5KUvGx59" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected volatility (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_907_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zWjxJMy2IuV5" title="Expected volatility"&gt;48&lt;/span&gt;% - &lt;span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zlXH4siWVndd" title="Expected volatility"&gt;59&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zcBR9APRGgy7" title="Expected volatility"&gt;48&lt;/span&gt;% - &lt;span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zrjadRuXnnVh" title="Expected volatility"&gt;59&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Risk-free interest rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zTFwDO4nXAq9" title="Risk-free interest rate"&gt;13&lt;/span&gt;% - &lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zsdoDHHhSQLk" title="Risk-free interest rate"&gt;15&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z8Nn5M5wUes1" title="Risk-free interest rate"&gt;13&lt;/span&gt;% - &lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_z1zWoDL4DXTh" title="Risk-free interest rate"&gt;15&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected life of stock options (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zk2G9NZm5Vtk" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_905_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zEZ5SsV37D82" title="Expected life of stock options"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zouL0Up0DR1b" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_901_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zmuhF1ZxeeVj" title="Expected life of stock options"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90D_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zE6LFCFQ2Rw8" title="Share price at the measurement date"&gt;48&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zq2Tsqgjg3F4" title="Share price at the measurement date"&gt;48&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Valuation model&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zdRMlGQk6ZPh" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zIBsj6YJ7XSi" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted average fair value at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_902_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zhM8zKh65ZZb" title="Weighted average fair value at the measurement date"&gt;53.06&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IncrementalStockOptionsMember_zXwRwA9w7zki" title="Weighted average fair value at the measurement date"&gt;49.22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember"
      decimals="-3"
      id="Fact004485"
      unitRef="BRL">83000</afya:StrikePriceeAtMeasurementDateShareOptionsGranted>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember"
      decimals="-3"
      id="Fact004487"
      unitRef="BRL">91000</afya:StrikePriceeAtMeasurementDateShareOptionsGranted>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember"
      decimals="-3"
      id="Fact004489"
      unitRef="BRL">140000</afya:StrikePriceeAtMeasurementDateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004491"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004493"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004495"
      unitRef="Pure">0.48</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004497"
      unitRef="Pure">0.59</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004499"
      unitRef="Pure">0.48</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004501"
      unitRef="Pure">0.59</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004503"
      unitRef="Pure">0.13</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004505"
      unitRef="Pure">0.15</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004507"
      unitRef="Pure">0.13</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004509"
      unitRef="Pure">0.15</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember"
      id="Fact004511">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember"
      id="Fact004513">P4Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_IncrementalStockOptionsMember"
      id="Fact004515">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_IncrementalStockOptionsMember"
      id="Fact004517">P4Y</afya:ExpectedLifeOfStockOptions>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004519"
      unitRef="BRLPShares">48</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_OriginalPlanMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004521"
      unitRef="BRLPShares">48</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember"
      id="Fact004523">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_IncrementalStockOptionsMember"
      id="Fact004525">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004527"
      unitRef="BRLPShares">53.06</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2023-12-31_custom_OriginalPlanMember_custom_IncrementalStockOptionsMember"
      decimals="INF"
      id="Fact004529"
      unitRef="BRLPShares">49.22</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions
      contextRef="From2023-01-012023-12-31_custom_RSUsMember"
      id="Fact004531">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_hifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zhLIGEa0rpP3" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 1)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span id="xdx_8BA_z5mSy3N2tTS3" style="display: none"&gt;Schedule of model used to determine the fair value of the stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 71%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Modified plan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90A_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zWPeKZFIDhb8" title="Strike price at the measurement date"&gt;95&lt;/span&gt; - R$&lt;span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBTa2NxzE0j2" title="Strike price at the measurement date"&gt;160&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividend yield (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zMdWZ0PcHFH8" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected volatility (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zSLeWRkJ4E96" title="Expected volatility"&gt;45&lt;/span&gt;% - &lt;span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zEhGVs7g9Bn9" title="Expected volatility"&gt;48&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Risk-free interest rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z7xF29NAJTU5" title="Risk-free interest rate"&gt;10&lt;/span&gt;% - &lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zkn5cnlFJlwg" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected life of stock options (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zieLowKDGYmg" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zZVQFRInH7Tc" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_904_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z2A86MvYyVSj" title="Share price at the measurement date"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Valuation model&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_zOBhyh8aoE2e" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted average conversion rate (RSUs/Stock options)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--RSUsMember_z2XpObBbdqna" title="Weighted average fair value at the measurement date"&gt;0.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember_ifrs-full_BottomOfRangeMember"
      decimals="-3"
      id="Fact004533"
      unitRef="BRL">95000</afya:StrikePriceeAtMeasurementDateShareOptionsGranted>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember_ifrs-full_TopOfRangeMember"
      decimals="-3"
      id="Fact004535"
      unitRef="BRL">160000</afya:StrikePriceeAtMeasurementDateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_RSUsMember"
      decimals="INF"
      id="Fact004537"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_RSUsMember"
      decimals="INF"
      id="Fact004539"
      unitRef="Pure">0.45</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_RSUsMember"
      decimals="INF"
      id="Fact004541"
      unitRef="Pure">0.48</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_RSUsMember"
      decimals="INF"
      id="Fact004543"
      unitRef="Pure">0.10</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_RSUsMember"
      decimals="INF"
      id="Fact004545"
      unitRef="Pure">0.12</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_RSUsMember"
      id="Fact004547">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_RSUsMember"
      id="Fact004549">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember"
      decimals="INF"
      id="Fact004551"
      unitRef="BRLPShares">75</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_RSUsMember"
      id="Fact004553">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_RSUsMember"
      decimals="INF"
      id="Fact004555"
      unitRef="BRLPShares">0.12</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions contextRef="From2023-01-01to2023-12-31" id="Fact004558">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions_pn3n3_z4UiQERxB4J9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 2)"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span id="xdx_8BA_zhccjbnvCi5d" style="display: none"&gt;Schedule of model used to determine incremental  fair
    value of the stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Modified plan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Original plan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike price index&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IPCA&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;CDI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_z2El9m7f9SL2" title="Strike price at the measurement date"&gt;59&lt;/span&gt; - &lt;span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zGASxYwoQ787" title="Strike price at the measurement date"&gt;104&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_907_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zgtuU9sx9Kl8" title="Strike price at the measurement date"&gt;59&lt;/span&gt; - &lt;span id="xdx_902_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zW3rkReTWqZe" title="Strike price at the measurement date"&gt;104&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividend yield (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zOvIgzedMDbd" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zeE3cOTGw10a" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected volatility (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zuBMdNKzQm22" title="Expected volatility"&gt;45&lt;/span&gt;% - &lt;span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_z3DAcRpFac0e" title="Expected volatility"&gt;54&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zdzLDkpixhT2" title="Expected volatility"&gt;45&lt;/span&gt;% - &lt;span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zbgMv89A3FK4" title="Expected volatility"&gt;54&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Risk-free interest rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zZIS1Sllneeg" title="Risk-free interest rate"&gt;10&lt;/span&gt;% - &lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zwx37XikBnI1" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zr2bWwddO581" title="Risk-free interest rate"&gt;10&lt;/span&gt;% - &lt;span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zd19mY7PKgma" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected life of stock options (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;0 - &lt;span id="xdx_904_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zfRypSrhfeS5" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;0 - &lt;span id="xdx_90C_ecustom--ExpectedLifeOfStockOptions_dtY_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zmJPSCo43017" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_904_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zLmNlPfUZTRl" title="Share price at the measurement date"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_903_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zKZajR5DadLk" title="Share price at the measurement date"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Valuation model&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_znoVYBLM5xC4" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zo834EhhMccg" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted average fair value at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--IPCAMember_zzuwfH439Zmf" title="Weighted average fair value at the measurement date"&gt;28.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--CDIMember_zoJYkVFxtvj5" title="Weighted average fair value at the measurement date"&gt;26.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfModelUsedToDetermineIncrementalFairValueOfStockOptions>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IPCAMember"
      decimals="-3"
      id="Fact004560"
      unitRef="BRL">59000</afya:StrikePriceeAtMeasurementDateShareOptionsGranted>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IPCAMember"
      decimals="-3"
      id="Fact004562"
      unitRef="BRL">104000</afya:StrikePriceeAtMeasurementDateShareOptionsGranted>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_CDIMember"
      decimals="-3"
      id="Fact004564"
      unitRef="BRL">59000</afya:StrikePriceeAtMeasurementDateShareOptionsGranted>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_CDIMember"
      decimals="-3"
      id="Fact004566"
      unitRef="BRL">104000</afya:StrikePriceeAtMeasurementDateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IPCAMember"
      decimals="INF"
      id="Fact004568"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_CDIMember"
      decimals="INF"
      id="Fact004570"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IPCAMember"
      decimals="INF"
      id="Fact004572"
      unitRef="Pure">0.45</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IPCAMember"
      decimals="INF"
      id="Fact004574"
      unitRef="Pure">0.54</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_CDIMember"
      decimals="INF"
      id="Fact004576"
      unitRef="Pure">0.45</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_CDIMember"
      decimals="INF"
      id="Fact004578"
      unitRef="Pure">0.54</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember_custom_IPCAMember"
      decimals="INF"
      id="Fact004580"
      unitRef="Pure">0.10</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember_custom_IPCAMember"
      decimals="INF"
      id="Fact004582"
      unitRef="Pure">0.12</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember_custom_CDIMember"
      decimals="INF"
      id="Fact004584"
      unitRef="Pure">0.10</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember_custom_CDIMember"
      decimals="INF"
      id="Fact004586"
      unitRef="Pure">0.12</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IPCAMember"
      id="Fact004588">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_CDIMember"
      id="Fact004590">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IPCAMember"
      decimals="INF"
      id="Fact004592"
      unitRef="BRLPShares">75</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-31_custom_OriginalPlanMember_custom_CDIMember"
      decimals="INF"
      id="Fact004594"
      unitRef="BRLPShares">75</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_ModifiedPlanMember_custom_IPCAMember"
      id="Fact004596">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-01-012023-12-31_custom_OriginalPlanMember_custom_CDIMember"
      id="Fact004598">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2023-12-31_custom_ModifiedPlanMember_custom_IPCAMember"
      decimals="INF"
      id="Fact004600"
      unitRef="BRLPShares">28.10</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2023-12-31_custom_OriginalPlanMember_custom_CDIMember"
      decimals="INF"
      id="Fact004602"
      unitRef="BRLPShares">26.00</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-02-122023-02-13_custom_OptionsGrantedMember"
      decimals="INF"
      id="Fact004604"
      unitRef="N">15000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-04-162023-04-17_custom_OptionsGrantedMember"
      decimals="INF"
      id="Fact004606"
      unitRef="N">30000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-07-302023-08-01_custom_OptionsGrantedMember"
      decimals="INF"
      id="Fact004608"
      unitRef="N">153000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-09-302023-10-01_custom_OptionsGrantedMember"
      decimals="INF"
      id="Fact004610"
      unitRef="N">37000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-11-292023-12-01_custom_OptionsGrantedMember"
      decimals="INF"
      id="Fact004612"
      unitRef="N">232000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <afya:ScheduleOfAdditionalStockOptionsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact004614">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfAdditionalStockOptionsExplanatory_zmBpLXFOmjr6" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 3)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span id="xdx_8BB_zQI6LsFh3s81" style="display: none"&gt;Schedule of additional stock
    options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;February&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%"&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;April&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%"&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;August&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%"&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;October&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%"&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;December&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90E_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zI2m5yXju4wc" title="Strike price at the measurement date"&gt;56&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zqAwQb03Hrke" title="Strike price at the measurement date"&gt;57&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zF76UYqapkn8" title="Strike price at the measurement date"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_900_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zUagWImKfRN9" title="Strike price at the measurement date"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_905_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_pn3n3_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zVYLYb5D7G52" title="Strike price at the measurement date"&gt;60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividend yield (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z04rFiBw2J8f" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z55pl3l2FVE2" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_903_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zOdnqiZFeUa2" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zhWYF66lggNc" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_904_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zKh0Ngq5PZP9" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected volatility (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zMSmQ4Ih25dl" title="Expected volatility"&gt;46&lt;/span&gt;% - &lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zXpdMIq8WQk8" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_908_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEoAq7hSxmIa" title="Expected volatility"&gt;48&lt;/span&gt;% - &lt;span id="xdx_906_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zt4vzQUSOsG9" title="Expected volatility"&gt;55&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_909_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zcggEqL8SdS1" title="Expected volatility"&gt;47&lt;/span&gt;% - &lt;span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zueJbo5qPCKh" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zzJSvMekUEo2" title="Expected volatility"&gt;44&lt;/span&gt;% - &lt;span id="xdx_90C_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zSKOFhusMje" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z9tUL74e6hyb" title="Expected volatility"&gt;34&lt;/span&gt;% - &lt;span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_znKqUGV6FTvj" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Risk-free interest rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zzU2gnFznmKi" title="Risk-free interest rate"&gt;13&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0rsPOleYlb9" title="Risk-free interest rate"&gt;11&lt;/span&gt;% - &lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zZ6GDBaK4WVj" title="Risk-free interest rate"&gt;13&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zPdY2n4TWJm5" title="Risk-free interest rate"&gt;10&lt;/span&gt;% - &lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zXnNe5r1zhWe" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zf6lAnJ8vAxa" title="Risk-free interest rate"&gt;11&lt;/span&gt;% - &lt;span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zCUrA8wWBcY9" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zwJfvFgpns6d" title="Risk-free interest rate"&gt;10&lt;/span&gt;% - &lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zudkK9AKu8Y3" title="Risk-free interest rate"&gt;11&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected life of stock options (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_907_ecustom--ExpectedLifeOfStockOptions_dtY_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zIH3opcItc9" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_902_ecustom--ExpectedLifeOfStockOptions_dtY_c20230212__20230213__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zJLwkIeZm43" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_ecustom--ExpectedLifeOfStockOptions_dtY_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zz0380XqIJ4a" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_902_ecustom--ExpectedLifeOfStockOptions_dtY_c20230416__20230417__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z18q86bm81ng" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90B_ecustom--ExpectedLifeOfStockOptions_dtY_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zHPbANDExjOf" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20230730__20230801__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zj5WY5cQGlzi" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_907_ecustom--ExpectedLifeOfStockOptions_dtY_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zKnS23omez9g" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230929__20231001__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zMVpTQMsb6J8" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zXePdAhlCI5" title="Expected life of stock options"&gt;1&lt;/span&gt; - &lt;span id="xdx_90A_ecustom--ExpectedLifeOfStockOptions_dtY_c20231130__20231201__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zEW7JPY4XvLh" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_907_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zQLko8vfA155" title="Share price at the measurement date"&gt;70.69&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90F_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_ztxGlOcwWQsd" title="Share price at the measurement date"&gt;62.51&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90E_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zRgfyPUMecrg" title="Share price at the measurement date"&gt;76.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zLmZDYCaTePi" title="Share price at the measurement date"&gt;79.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_909_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zdhuK5StwODi" title="Share price at the measurement date"&gt;100.97&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Valuation model&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230212__20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z9NaZQH24Yl3" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230416__20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zfh2wf93wE5e" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230730__20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zYdHs8qHNpv9" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20230929__20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z0lRaXRCmcT7" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20231130__20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zapjHNvYimal" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted average fair value at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90B_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230213__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_z8ySNMeVPjg3" title="Weighted average fair value at the measurement date"&gt;29.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_909_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230417__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zHByWqOzRNP" title="Weighted average fair value at the measurement date"&gt;32.04&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20230801__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zK6XFMlKrTHb" title="Weighted average fair value at the measurement date"&gt;37.04&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_900_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231001__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zwf3EIImkkjl" title="Weighted average fair value at the measurement date"&gt;38.67&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_908_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20231201__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--ShareOptionsMember_zkTKEzdVV6V7" title="Weighted average fair value at the measurement date"&gt;54.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAdditionalStockOptionsExplanatory>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGrante
      contextRef="AsOf2023-02-13_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact004616"
      unitRef="BRL">56000</afya:StrikePriceeAtMeasurementDateShareOptionsGrante>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGrante
      contextRef="AsOf2023-04-17_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact004618"
      unitRef="BRL">57000</afya:StrikePriceeAtMeasurementDateShareOptionsGrante>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGrante
      contextRef="AsOf2023-08-01_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact004620"
      unitRef="BRL">59000</afya:StrikePriceeAtMeasurementDateShareOptionsGrante>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGrante
      contextRef="AsOf2023-10-01_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact004622"
      unitRef="BRL">59000</afya:StrikePriceeAtMeasurementDateShareOptionsGrante>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGrante
      contextRef="AsOf2023-12-01_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact004624"
      unitRef="BRL">60000</afya:StrikePriceeAtMeasurementDateShareOptionsGrante>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-02-122023-02-13_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004626"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-04-162023-04-17_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004628"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-302023-08-01_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004630"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-09-292023-10-01_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004632"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-11-302023-12-01_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004634"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-02-122023-02-13_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004636"
      unitRef="Pure">0.46</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-02-122023-02-13_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004638"
      unitRef="Pure">0.56</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-04-162023-04-17_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004640"
      unitRef="Pure">0.48</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-04-162023-04-17_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004642"
      unitRef="Pure">0.55</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-302023-08-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004644"
      unitRef="Pure">0.47</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-07-302023-08-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004646"
      unitRef="Pure">0.56</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-09-292023-10-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004648"
      unitRef="Pure">0.44</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-09-292023-10-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004650"
      unitRef="Pure">0.56</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-11-302023-12-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004652"
      unitRef="Pure">0.34</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-11-302023-12-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004654"
      unitRef="Pure">0.56</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-02-122023-02-13_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004656"
      unitRef="Pure">0.13</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-04-162023-04-17_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004658"
      unitRef="Pure">0.11</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-04-162023-04-17_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004660"
      unitRef="Pure">0.13</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-07-302023-08-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004662"
      unitRef="Pure">0.10</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-07-302023-08-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004664"
      unitRef="Pure">0.12</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-09-292023-10-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004666"
      unitRef="Pure">0.11</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-09-292023-10-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004668"
      unitRef="Pure">0.12</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-11-302023-12-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004670"
      unitRef="Pure">0.10</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-11-302023-12-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004672"
      unitRef="Pure">0.11</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-02-122023-02-13_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      id="Fact004674">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-02-122023-02-13_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      id="Fact004676">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-04-162023-04-17_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      id="Fact004678">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-04-162023-04-17_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      id="Fact004680">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-07-302023-08-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      id="Fact004682">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-07-302023-08-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      id="Fact004684">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-09-292023-10-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      id="Fact004686">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-09-292023-10-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      id="Fact004688">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-11-302023-12-01_ifrs-full_BottomOfRangeMember_ifrs-full_ShareOptionsMember"
      id="Fact004690">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-11-302023-12-01_ifrs-full_TopOfRangeMember_ifrs-full_ShareOptionsMember"
      id="Fact004692">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-02-13_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004694"
      unitRef="BRLPShares">70.69</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-04-17_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004696"
      unitRef="BRLPShares">62.51</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-08-01_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004698"
      unitRef="BRLPShares">76.45</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-10-01_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004700"
      unitRef="BRLPShares">79.12</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2023-12-01_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004702"
      unitRef="BRLPShares">100.97</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-02-122023-02-13_ifrs-full_ShareOptionsMember"
      id="Fact004704">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-04-162023-04-17_ifrs-full_ShareOptionsMember"
      id="Fact004706">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-07-302023-08-01_ifrs-full_ShareOptionsMember"
      id="Fact004708">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-09-292023-10-01_ifrs-full_ShareOptionsMember"
      id="Fact004710">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-11-302023-12-01_ifrs-full_ShareOptionsMember"
      id="Fact004712">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2023-02-13_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004714"
      unitRef="BRLPShares">29.54</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2023-04-17_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004716"
      unitRef="BRLPShares">32.04</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2023-08-01_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004718"
      unitRef="BRLPShares">37.04</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2023-10-01_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004720"
      unitRef="BRLPShares">38.67</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2023-12-01_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004722"
      unitRef="BRLPShares">54.25</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:ScheduleOfSharebasedCompensationPlanExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact004724">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfSharebasedCompensationPlanExplanatory_pn3n3_zCdRaKCRhkqc" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 4)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span id="xdx_8BF_zUvAvdriz7vi" style="display: none"&gt;Schedule of share-based compensation plan&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Weighted average strike price&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;(in Brazilian Reais)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt"&gt;
    &lt;p style="border-bottom: Black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Number of stock options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="border-top: Black 1pt solid; width: 40%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Outstanding at January 1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zYUJ3ITX4Gtc" style="width: 18%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;79.47&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKFFpHaJiCm9" style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,729,287&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z1iQtKHjDEKi" style="white-space: nowrap; width: 14%; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,086,728&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z81sVx0CqOIa" style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,510,983&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zu5nUAFKx6Uj" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;60.83&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z2URd955qre7" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;467,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zPP6bNbwVI39" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,234,919&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zqM5i7m1Jse8" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,170,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zBh72c7DyEE1" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;59.67&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zBZ0H1MWhg6a" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(164,214)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zob9axieXdni" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4746"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zfdjfqnv4EMh" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(442,669)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Stock options exchanged to RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKYMMLtl20F6" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Stock options exchanged"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4750"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z776cNP8Myfj" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,751,599)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zIRw7ywFjna2" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4754"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zKRjgHtN0oM6" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4756"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z5cH8H3KI0wf" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;110.95&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zMMHPPyJOMof" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(333,111)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zusifHyb97b6" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(365,749)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zlY5Vp34ZyCj" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(60,000)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expired&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3lvNhkaYni" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;94.17&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHJf011QlSra" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(251,299)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmtG1BROVopg" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(226,611)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zZhb1XM6sLSg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(91,586)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zVZOpG0sn9N9" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;64.33&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zxl2aIAuewL3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,696,064&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zI6s6YVB2tQf" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,729,287&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zLHmal4NBHD3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,086,728&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z8pqSfZnW3Ul" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price (in Reais), Exercisable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;86.23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z99Nlqh8pCk2" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;242,235&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zT5QMo9sX9a6" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,133,774&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NumberOfStockOptionsExercisable_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z54x29IexhT1" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;542,061&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfSharebasedCompensationPlanExplanatory>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2022-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004726"
      unitRef="BRLPShares">79.47</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004728"
      unitRef="N">3729287</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2021-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004730"
      unitRef="N">3086728</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2020-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004732"
      unitRef="N">2510983</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004734"
      unitRef="BRLPShares">60.83</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004736"
      unitRef="N">467000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2022-01-012022-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004738"
      unitRef="N">1234919</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-01-012021-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004740"
      unitRef="N">1170000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004742"
      unitRef="BRLPShares">59.67</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004744"
      unitRef="N">164214</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2021-01-012021-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004748"
      unitRef="N">442669</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004752"
      unitRef="N">1751599</afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004758"
      unitRef="BRLPShares">110.95</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004760"
      unitRef="N">333111</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2022-01-012022-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004762"
      unitRef="N">365749</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2021-01-012021-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004764"
      unitRef="N">60000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004766"
      unitRef="BRLPShares">94.17</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004768"
      unitRef="N">251299</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2022-01-012022-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004770"
      unitRef="N">226611</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2021-01-012021-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004772"
      unitRef="N">91586</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004774"
      unitRef="BRLPShares">64.33</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004776"
      unitRef="N">1696064</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004778"
      unitRef="N">3729287</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2021-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004780"
      unitRef="N">3086728</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004782"
      unitRef="BRLPShares">86.23</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <afya:NumberOfStockOptionsExercisable
      contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004784"
      unitRef="Shares">242235</afya:NumberOfStockOptionsExercisable>
    <afya:NumberOfStockOptionsExercisable
      contextRef="AsOf2022-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004786"
      unitRef="Shares">1133774</afya:NumberOfStockOptionsExercisable>
    <afya:NumberOfStockOptionsExercisable
      contextRef="AsOf2021-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004788"
      unitRef="Shares">542061</afya:NumberOfStockOptionsExercisable>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2023-01-012023-12-31_custom_ShareBasedCompensationPlansMember"
      decimals="-3"
      id="Fact004790"
      unitRef="BRL">20850000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2022-01-012022-12-31_custom_ShareBasedCompensationPlansMember"
      decimals="-3"
      id="Fact004792"
      unitRef="BRL">27242000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2021-01-012021-12-31_custom_ShareBasedCompensationPlansMember"
      decimals="-3"
      id="Fact004794"
      unitRef="BRL">43377000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004796"
      unitRef="Pure">0.10</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnits1Member"
      decimals="INF"
      id="Fact004798"
      unitRef="Pure">0.20</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnits2Member"
      decimals="INF"
      id="Fact004800"
      unitRef="Pure">0.30</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnits3Member"
      decimals="INF"
      id="Fact004802"
      unitRef="Pure">0.40</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2022-07-012022-07-31"
      decimals="INF"
      id="Fact004804"
      unitRef="Shares">442546</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2022-09-012022-09-30"
      decimals="INF"
      id="Fact004806"
      unitRef="Shares">4678</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2022-07-012022-07-31"
      decimals="INF"
      id="Fact004808"
      unitRef="BRLPShares">48.24</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2022-09-012022-09-30"
      decimals="INF"
      id="Fact004810"
      unitRef="BRLPShares">72.59</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-292023-02-02"
      decimals="INF"
      id="Fact004812"
      unitRef="Shares">8000</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-04-162023-04-17"
      decimals="INF"
      id="Fact004814"
      unitRef="Shares">16000</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-07-302023-08-01"
      decimals="INF"
      id="Fact004816"
      unitRef="Shares">153490</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-09-302023-10-01"
      decimals="INF"
      id="Fact004818"
      unitRef="Shares">63000</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-11-292023-12-01"
      decimals="INF"
      id="Fact004820"
      unitRef="Shares">76600</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-01-292023-02-02"
      decimals="INF"
      id="Fact004822"
      unitRef="BRLPShares">70.69</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-04-162023-04-17"
      decimals="INF"
      id="Fact004824"
      unitRef="BRLPShares">62.51</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-07-302023-08-01"
      decimals="INF"
      id="Fact004826"
      unitRef="BRLPShares">76.45</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-09-302023-10-01"
      decimals="INF"
      id="Fact004828"
      unitRef="BRLPShares">79.12</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-11-292023-12-01"
      decimals="INF"
      id="Fact004830"
      unitRef="BRLPShares">100.97</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <afya:ScheduleOfStockOptionExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact004832">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfStockOptionExplanatory_pn3n3_zQUnx2ZSX7zd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Labor and social obligations (Details 5)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span id="xdx_8B7_zjd0OcZzxoZa" style="display: none"&gt;Schedule of stock option&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Outstanding at January 1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zkHv5O8K8dfl" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,224&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zBnbf1RfTczd" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4836"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zyvE4WkwR7e3" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;317,090&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zn3u7iko1Pae" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,224&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Stock options exchanged to RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z4aqmEnnuOm4" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;215,797&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zgky3WtW64Eb" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4844"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zxFBoDpvVtAd" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(99,576)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_di_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z0sMyiI5LCJi" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4848"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pid_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zbRUJFWkGI72" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(26,104)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_di_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zYjd6BBvYxBg" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4852"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zJWV5I3j3oZ7" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;854,431&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uN_c20220101__20221231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zOBt3BH1QZxk" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;447,224&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfStockOptionExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004834"
      unitRef="N">447224</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember1360072343"
      decimals="INF"
      id="Fact004838"
      unitRef="N">317090</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2022-01-012022-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004840"
      unitRef="N">447224</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember1360072343"
      decimals="INF"
      id="Fact004842"
      unitRef="N">215797</afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember1360072343"
      decimals="INF"
      id="Fact004846"
      unitRef="N">99576</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember1360072343"
      decimals="INF"
      id="Fact004850"
      unitRef="N">26104</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004854"
      unitRef="N">854431</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004856"
      unitRef="N">447224</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember1360072343"
      decimals="-3"
      id="Fact004858"
      unitRef="BRL">10685000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2022-01-012022-12-31_custom_RestrictedStockUnitsMember"
      decimals="-3"
      id="Fact004860"
      unitRef="BRL">4032000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <afya:SocialObligationsLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004862"
      unitRef="BRL">7171000</afya:SocialObligationsLiabilities>
    <afya:SocialObligationsLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004864"
      unitRef="BRL">2167000</afya:SocialObligationsLiabilities>
    <afya:DisclosureOfEquityExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact004866">&lt;p id="xdx_80E_ecustom--DisclosureOfEquityExplanatory_zUs68iYmlM9h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;17&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_829_zYIWHLrTQ4s1"&gt;Equity&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;a) Share capital&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;As of December 31, 2023 and 2022, the Company&#x2019;s
share capital was R$&lt;span id="xdx_900_eifrs-full--IssuedCapital_iI_pn3n3_c20231231_z3U78Qe3SOxi" title="Share capital"&gt;&lt;span id="xdx_90B_eifrs-full--IssuedCapital_c20221231_pn3n3" title="Share capital"&gt;17&lt;/span&gt; &lt;/span&gt;represented by &lt;span id="xdx_900_ecustom--NumberOfSharesIssued1_iI_pid_c20231231_zKV5sBJb9CV4" title="Total number of shares"&gt;&lt;span id="xdx_90B_ecustom--NumberOfSharesIssued1_iI_pid_c20221231_zyT2swYCvkJ7" title="Total number of shares"&gt;93,722,831&lt;/span&gt;&lt;/span&gt; shares comprised by &lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zK25BtmdMgi" title="Total number of shares"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zHVnzKNLP7Sb" title="Total number of shares"&gt;47,920,068&lt;/span&gt;&lt;/span&gt; class A common shares and &lt;span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pid_c20231231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zfVdiuLkcjt1" title="Total number of shares"&gt;&lt;span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zx3yWa6vpTx" title="Total number of shares"&gt;45,802,763&lt;/span&gt;&lt;/span&gt; class B common shares.
As of December 31, 2023 and 2022, the Company&#x2019;s authorized capital was US$&lt;span id="xdx_90E_ecustom--IssuedCapitals_iI_pn3n3_c20231231_zMGknDOh2RDk" title="Authorized capital"&gt;&lt;span id="xdx_908_ecustom--IssuedCapitals_iI_pn3n3_c20221231_zgIEldpDLn36" title="Authorized capital"&gt;50&lt;/span&gt;&lt;/span&gt; thousand.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;b) Dividends&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;In the year ended December 31, 2023, CCSI and IESVAP
approved the payment of dividends of R$&lt;span id="xdx_90F_ecustom--PaymentOfDividends_pn3n3_c20230101__20231231_zIelqDRK6FZi" title="Payment of dividends"&gt;65,539&lt;/span&gt;, which R$&lt;span id="xdx_902_ecustom--DividendDistributed_pn3n3_c20230101__20231231_zSfYzNROHDmj" title="Dividend distributed"&gt;46,788&lt;/span&gt; was distributed to Afya and R$&lt;span id="xdx_90D_eifrs-full--DividendsPaidToNoncontrollingInterests_pn3n3_c20230101__20231231_zMK6ph4Gzcg3" title="Dividends paid to non-controlling interests"&gt;18,750&lt;/span&gt; to non-controlling shareholders (December
31, 2022: R$&lt;span id="xdx_903_ecustom--PaymentOfDividends_pn3n3_c20220101__20221231_zNjTzy7YWTV7" title="Payment of dividends"&gt;66,828&lt;/span&gt;, which R$&lt;span id="xdx_906_ecustom--DividendDistributed_pn3n3_c20220101__20221231_z7klf6bBQAB4" title="Dividend distributed"&gt;47,092&lt;/span&gt; was distributed to Afya and R$&lt;span id="xdx_909_eifrs-full--DividendsPaidToNoncontrollingInterests_pn3n3_c20220101__20221231_zWZxAh1TdLoe" title="Dividends paid to non-controlling interests"&gt;19,736&lt;/span&gt; to non-controlling shareholders and December 31, 2021: R$&lt;span id="xdx_903_ecustom--PaymentOfDividends_pn3n3_c20210101__20211231_zfAfWUK98FYl" title="Payment of dividends"&gt;65,521&lt;/span&gt;,
which R$&lt;span id="xdx_902_ecustom--DividendDistributed_pn3n3_c20210101__20211231_zSWbOU2yYtxc" title="Dividend distributed"&gt;46,873&lt;/span&gt; was distributed to Afya and R$&lt;span id="xdx_90E_eifrs-full--DividendsPaidToNoncontrollingInterests_pn3n3_c20210101__20211231_zGnw9nmOQdGf" title="Dividends paid to non-controlling interests"&gt;18,648&lt;/span&gt; to non-controlling shareholders).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;c) Share repurchase program&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On October 27, 2021, the Company&#x2019;s board of directors approved a
new share repurchase program. Afya may repurchase up to &lt;span id="xdx_906_ecustom--RepurchaseOfOrdinaryShares_c20211027__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_pdd" title="Repurchase of ordinary shares"&gt;1,383,108&lt;/span&gt; of its outstanding Class A common shares in the open market, based
on prevailing market prices, beginning on October 28, 2021, until the earlier of the completion of the repurchase or December 31, 2022,
depending upon market conditions. The Company completed the acquisition of the approved shares repurchase under this buy-back program.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On January 27, 2022, the Company&#x2019;s board of directors approved a new
share repurchase program. Afya may repurchase up to &lt;span id="xdx_902_ecustom--RepurchaseOfOrdinaryShares_iI_c20220127__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zusIXkhOnwl9" title="Repurchase of ordinary shares"&gt;1,874,457&lt;/span&gt; of its outstanding Class A common shares in the open market, based on prevailing
market prices, beginning on January 27, 2022, until the earlier of the completion of the repurchase or December 31, 2022, depending upon
market conditions. The Company completed the acquisition of the approved shares repurchase under this buy-back program.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On March 24, 2023, the Company&#x2019;s board of directors approved the fourth
share repurchase program. Afya may repurchase up to &lt;span id="xdx_900_ecustom--RepurchaseOfOrdinaryShares_iI_c20230324__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zdtV3YxqxRl" title="Repurchase of ordinary shares"&gt;2,000,000&lt;/span&gt; of its outstanding Class A common shares in the open market, based on prevailing
market prices, beginning on March 24, 2023, until the earlier of the completion of the repurchase or December 31, 2024, depending upon
market conditions.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;During the year ended December 31, 2023, the Company&#x2019;s cash outflow
was R$&lt;span id="xdx_903_ecustom--CashOutflow_pn3n3_c20230101__20231231_zL44vnn2TwX8" title="Cash outflow"&gt;12,369&lt;/span&gt; (December 31, 2022: R$&lt;span id="xdx_90A_ecustom--CashOutflow_pn3n3_c20220101__20221231_zyzBQh0e8Y8d" title="Cash outflow"&gt;152,317&lt;/span&gt; and December 31, 2021: R$&lt;span id="xdx_90C_ecustom--CashOutflow_pn3n3_c20210101__20211231_zGiGKAVVk1si" title="Cash outflow"&gt;213,722&lt;/span&gt;).&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The table below illustrates the number and movements
in treasury shares during the years ended December 31, 2023, 2022 and 2021:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--ScheduleOfTreasurySharesMovementExplanatory_zvIQsmqLNYQb" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: left; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span id="xdx_8B5_z1twcLhelyU4" style="display: none"&gt;Schedule illustrates the number and
    movements in treasury shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 58%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 19%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Number of treasury shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"&gt;&lt;b&gt;Average price&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(in Brazilian Reais)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iS_pid_c20210101__20211231_z4RHt0jx9BO8" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4922"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20210101__20211231_zk7ah6CmKiPh" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4924"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Repurchased&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfSharesRepurchased_pid_c20210101__20211231_zDKZeSbvIu7b" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,142,051&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AveragePriceRepurchased_pid_c20210101__20211231_zvkKxHfuJpEb" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;119.99&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred from exercise of stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TransferredFromExerciseOfStockOptions_pid_c20210101__20211231_z2R8UthoK2Ef" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Transferred from exercise of stock options"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(442,669)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AveragePriceTransferredFromExerciseOfStockOptions_pid_c20210101__20211231_z4Jj6TDZ2CZf" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price transferred from exercise of stock options"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;124.26&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred from shares contribution&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TransferredFromSharesContribution_pid_c20210101__20211231_zkJMM1kVKYtg" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Transferred from shares contribution"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(44,455)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AveragePriceTransferredFromSharesContribution_pid_c20210101__20211231_zAFOAIVGSfJk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price transferred from shares contribution"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;111.94&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Outstanding at December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20210101__20211231_z4040Jq3feud" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,654,927&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20220101__20221231_zvNZYSC5Hm97" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;92.23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Repurchased&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NumberOfSharesRepurchased_pid_c20220101__20221231_zDwhGvaAOFgf" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,131,358&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AveragePriceRepurchased_pid_c20220101__20221231_zIPESYXXKEHk" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71.46&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Outstanding at December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20220101__20221231_zYa0l4tCDBp1" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at ending balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,786,285&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231_z1XsVHTiQ6h4" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;80.54&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Repurchased&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NumberOfSharesRepurchased_pid_c20230101__20231231_zI4y64Htsdgg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;216,339&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AveragePriceRepurchased_pid_c20230101__20231231_z1weBiUo8r8d" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57.17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Delivered under the share-based compensation plan&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_iP3custom--AveragePriceRepurchased_pid_c20230101__20231231_zx7lFam1NYQ8" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(229,146)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_iP3custom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pid_c20230101__20231231_zSVHvaAjjgN" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;79.28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Outstanding at December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20230101__20231231_zfcB7fnh7kIc" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at ending balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,773,478&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231_zJMM77CMs9Ti" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at ending balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;79.28&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

</afya:DisclosureOfEquityExplanatory>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004868"
      unitRef="BRL">17000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004870"
      unitRef="BRL">17000</ifrs-full:IssuedCapital>
    <afya:NumberOfSharesIssued1
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004872"
      unitRef="Shares">93722831</afya:NumberOfSharesIssued1>
    <afya:NumberOfSharesIssued1
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact004874"
      unitRef="Shares">93722831</afya:NumberOfSharesIssued1>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2023-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact004876"
      unitRef="Shares">47920068</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2022-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact004878"
      unitRef="Shares">47920068</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2023-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact004880"
      unitRef="Shares">45802763</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2022-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact004882"
      unitRef="Shares">45802763</ifrs-full:NumberOfSharesIssued>
    <afya:IssuedCapitals
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004884"
      unitRef="BRL">50000</afya:IssuedCapitals>
    <afya:IssuedCapitals
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004886"
      unitRef="BRL">50000</afya:IssuedCapitals>
    <afya:PaymentOfDividends
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact004888"
      unitRef="BRL">65539000</afya:PaymentOfDividends>
    <afya:DividendDistributed
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact004890"
      unitRef="BRL">46788000</afya:DividendDistributed>
    <ifrs-full:DividendsPaidToNoncontrollingInterests
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact004892"
      unitRef="BRL">18750000</ifrs-full:DividendsPaidToNoncontrollingInterests>
    <afya:PaymentOfDividends
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004894"
      unitRef="BRL">66828000</afya:PaymentOfDividends>
    <afya:DividendDistributed
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004896"
      unitRef="BRL">47092000</afya:DividendDistributed>
    <ifrs-full:DividendsPaidToNoncontrollingInterests
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004898"
      unitRef="BRL">19736000</ifrs-full:DividendsPaidToNoncontrollingInterests>
    <afya:PaymentOfDividends
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact004900"
      unitRef="BRL">65521000</afya:PaymentOfDividends>
    <afya:DividendDistributed
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact004902"
      unitRef="BRL">46873000</afya:DividendDistributed>
    <ifrs-full:DividendsPaidToNoncontrollingInterests
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact004904"
      unitRef="BRL">18648000</ifrs-full:DividendsPaidToNoncontrollingInterests>
    <afya:RepurchaseOfOrdinaryShares
      contextRef="AsOf2021-10-27_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact004906"
      unitRef="Shares">1383108</afya:RepurchaseOfOrdinaryShares>
    <afya:RepurchaseOfOrdinaryShares
      contextRef="AsOf2022-01-27_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact004910"
      unitRef="Shares">1874457</afya:RepurchaseOfOrdinaryShares>
    <afya:RepurchaseOfOrdinaryShares
      contextRef="AsOf2023-03-24_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact004912"
      unitRef="Shares">2000000</afya:RepurchaseOfOrdinaryShares>
    <afya:CashOutflow
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact004914"
      unitRef="BRL">12369000</afya:CashOutflow>
    <afya:CashOutflow
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004916"
      unitRef="BRL">152317000</afya:CashOutflow>
    <afya:CashOutflow
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact004918"
      unitRef="BRL">213722000</afya:CashOutflow>
    <afya:ScheduleOfTreasurySharesMovementExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact004920">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--ScheduleOfTreasurySharesMovementExplanatory_zvIQsmqLNYQb" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: left; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span id="xdx_8B5_z1twcLhelyU4" style="display: none"&gt;Schedule illustrates the number and
    movements in treasury shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 58%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 19%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Number of treasury shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt"&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"&gt;&lt;b&gt;Average price&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"&gt;&lt;b&gt;(in Brazilian Reais)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iS_pid_c20210101__20211231_z4RHt0jx9BO8" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4922"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20210101__20211231_zk7ah6CmKiPh" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4924"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Repurchased&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfSharesRepurchased_pid_c20210101__20211231_zDKZeSbvIu7b" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,142,051&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AveragePriceRepurchased_pid_c20210101__20211231_zvkKxHfuJpEb" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;119.99&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred from exercise of stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TransferredFromExerciseOfStockOptions_pid_c20210101__20211231_z2R8UthoK2Ef" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Transferred from exercise of stock options"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(442,669)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AveragePriceTransferredFromExerciseOfStockOptions_pid_c20210101__20211231_z4Jj6TDZ2CZf" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price transferred from exercise of stock options"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;124.26&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred from shares contribution&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TransferredFromSharesContribution_pid_c20210101__20211231_zkJMM1kVKYtg" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Transferred from shares contribution"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(44,455)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AveragePriceTransferredFromSharesContribution_pid_c20210101__20211231_zAFOAIVGSfJk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price transferred from shares contribution"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;111.94&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Outstanding at December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20210101__20211231_z4040Jq3feud" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,654,927&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20220101__20221231_zvNZYSC5Hm97" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;92.23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Repurchased&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NumberOfSharesRepurchased_pid_c20220101__20221231_zDwhGvaAOFgf" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,131,358&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AveragePriceRepurchased_pid_c20220101__20221231_zIPESYXXKEHk" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71.46&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Outstanding at December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20220101__20221231_zYa0l4tCDBp1" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at ending balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,786,285&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20231231_z1XsVHTiQ6h4" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;80.54&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Repurchased&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NumberOfSharesRepurchased_pid_c20230101__20231231_zI4y64Htsdgg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;216,339&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AveragePriceRepurchased_pid_c20230101__20231231_z1weBiUo8r8d" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57.17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Delivered under the share-based compensation plan&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_iP3custom--AveragePriceRepurchased_pid_c20230101__20231231_zx7lFam1NYQ8" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(229,146)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_iP3custom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pid_c20230101__20231231_zSVHvaAjjgN" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;79.28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Outstanding at December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NumberOfSharesOutstanding_iE_pid_c20230101__20231231_zfcB7fnh7kIc" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at ending balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,773,478&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20231231_zJMM77CMs9Ti" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at ending balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;79.28&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:ScheduleOfTreasurySharesMovementExplanatory>
    <afya:NumberOfSharesRepurchased
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact004926"
      unitRef="Shares">2142051</afya:NumberOfSharesRepurchased>
    <afya:AveragePriceRepurchased
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact004928"
      unitRef="BRLPShares">119.99</afya:AveragePriceRepurchased>
    <afya:TransferredFromExerciseOfStockOptions
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact004930"
      unitRef="Shares">-442669</afya:TransferredFromExerciseOfStockOptions>
    <afya:AveragePriceTransferredFromExerciseOfStockOptions
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact004932"
      unitRef="BRLPShares">124.26</afya:AveragePriceTransferredFromExerciseOfStockOptions>
    <afya:TransferredFromSharesContribution
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact004934"
      unitRef="Shares">-44455</afya:TransferredFromSharesContribution>
    <afya:AveragePriceTransferredFromSharesContribution
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact004936"
      unitRef="BRLPShares">111.94</afya:AveragePriceTransferredFromSharesContribution>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact004938"
      unitRef="Shares">1654927</ifrs-full:NumberOfSharesOutstanding>
    <afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact004940"
      unitRef="BRLPShares">92.23</afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019>
    <afya:NumberOfSharesRepurchased
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004942"
      unitRef="Shares">2131358</afya:NumberOfSharesRepurchased>
    <afya:AveragePriceRepurchased
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004944"
      unitRef="BRLPShares">71.46</afya:AveragePriceRepurchased>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact004946"
      unitRef="Shares">3786285</ifrs-full:NumberOfSharesOutstanding>
    <afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact004948"
      unitRef="BRLPShares">80.54</afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019>
    <afya:NumberOfSharesRepurchased
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact004950"
      unitRef="Shares">216339</afya:NumberOfSharesRepurchased>
    <afya:AveragePriceRepurchased
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact004952"
      unitRef="BRLPShares">57.17</afya:AveragePriceRepurchased>
    <afya:NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact004954"
      unitRef="Shares">-229146</afya:NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan>
    <afya:AveragePriceDeliveredUnderSharebasedCompensationPlan
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact004956"
      unitRef="BRLPShares">79.28</afya:AveragePriceDeliveredUnderSharebasedCompensationPlan>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004958"
      unitRef="Shares">3773478</ifrs-full:NumberOfSharesOutstanding>
    <afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004960"
      unitRef="BRLPShares">79.28</afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact004962">&lt;p id="xdx_806_eifrs-full--DisclosureOfEarningsPerShareExplanatory_z11RJZojxrId" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;18&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_82D_z8uVul6IeIn5"&gt;Earnings per share (EPS)&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;Basic EPS is calculated by dividing net income
attributable to the equity holders of the Company by the weighted average number of common shares outstanding during the year.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;Diluted EPS is calculated by dividing net income
attributable to the equity holders of the parent by the weighted average number of common shares outstanding during the year plus the
weighted average number of shares that would be issued on conversion of all potential shares with dilutive effects.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Diluted earnings per share are computed including stock options granted
to key management using the treasury shares method when the effect is dilutive. The Company has the stock option and restricted share
unit plans in the category of potentially dilutive shares.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Softbank&#x2019;s series A perpetual convertible preferred shares are antidilutive
as of December 31, 2023, 2022 and 2021 and are not included on diluted earnings per share.&lt;/p&gt;






&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;The table below reflects the net income and share
data used in the basic and diluted EPS calculations:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfEarningsPerShareTableExplanatory_zh4dEsEpi4ga" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Earnings per share (EPS) (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"&gt;&lt;span id="xdx_8BD_ztMuxzx63bp4" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_494_20230101__20231231_zJeOJSBUDycl" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20220101__20221231_zIvykMcHKZ1h" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20210101__20211231_zmcGCgKoYDfh" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 58%; padding-right: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--NumeratorAbstract_iB_zX2qshDNvgyi"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Numerator&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_pn3n3_zdsv90uET2l4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Net income attributable to equity holders of the parent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;386,324&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;373,569&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;223,326&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DenominatorAbstract_iB_pn3n3_zIugD1pFkXh7" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Denominator&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--WeightedAverageShares_pid_z8fIXOPUpdyh" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 8.6pt; text-align: justify; text-indent: -8.6pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted average number of outstanding shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;89,830,351&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;90,335,037&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;93,291,480&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pid_zGU1Tq0ty0Ic" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Effects of dilution from stock options and restricted share units&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;706,492&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;329,085&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;811,818&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--AdjustedWeightedAverageShares_pid_uShares_zrEuz15uV5B1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify; line-height: 115%; text-indent: -7.1pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Weighted average number of outstanding shares adjusted for the effect of dilution&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;90,536,843&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;90,664,122&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;94,103,298&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--BasicEarningsLossPerShare_pid_z17TAETfE2Zc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Basic earnings per share (R$)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4.30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4.14&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2.39&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--DilutedEarningsLossPerShare_pid_ziW3dWZ5nqO4" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Diluted earnings per share (R$)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4.27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4.12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2.37&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <afya:DisclosureOfEarningsPerShareTableExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact004965">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfEarningsPerShareTableExplanatory_zh4dEsEpi4ga" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Earnings per share (EPS) (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"&gt;&lt;span id="xdx_8BD_ztMuxzx63bp4" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_494_20230101__20231231_zJeOJSBUDycl" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20220101__20221231_zIvykMcHKZ1h" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20210101__20211231_zmcGCgKoYDfh" style="padding-right: 5.4pt; padding-left: 0.5in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 58%; padding-right: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--NumeratorAbstract_iB_zX2qshDNvgyi"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Numerator&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_pn3n3_zdsv90uET2l4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Net income attributable to equity holders of the parent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;386,324&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;373,569&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;223,326&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DenominatorAbstract_iB_pn3n3_zIugD1pFkXh7" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Denominator&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--WeightedAverageShares_pid_z8fIXOPUpdyh" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 8.6pt; text-align: justify; text-indent: -8.6pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted average number of outstanding shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;89,830,351&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;90,335,037&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;93,291,480&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pid_zGU1Tq0ty0Ic" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Effects of dilution from stock options and restricted share units&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;706,492&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;329,085&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;811,818&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--AdjustedWeightedAverageShares_pid_uShares_zrEuz15uV5B1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify; line-height: 115%; text-indent: -7.1pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Weighted average number of outstanding shares adjusted for the effect of dilution&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;90,536,843&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;90,664,122&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;94,103,298&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--BasicEarningsLossPerShare_pid_z17TAETfE2Zc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Basic earnings per share (R$)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4.30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4.14&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2.39&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--DilutedEarningsLossPerShare_pid_ziW3dWZ5nqO4" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Diluted earnings per share (R$)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4.27&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4.12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2.37&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:DisclosureOfEarningsPerShareTableExplanatory>
    <ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact004971"
      unitRef="BRL">386324000</ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends>
    <ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004972"
      unitRef="BRL">373569000</ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends>
    <ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact004973"
      unitRef="BRL">223326000</ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends>
    <ifrs-full:WeightedAverageShares
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact004979"
      unitRef="Shares">89830351</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004980"
      unitRef="Shares">90335037</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact004981"
      unitRef="Shares">93291480</ifrs-full:WeightedAverageShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact004983"
      unitRef="Shares">706492</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004984"
      unitRef="Shares">329085</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact004985"
      unitRef="Shares">811818</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact004987"
      unitRef="Shares">90536843</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004988"
      unitRef="Shares">90664122</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact004989"
      unitRef="Shares">94103298</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact004991"
      unitRef="BRLPShares">4.30</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004992"
      unitRef="BRLPShares">4.14</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact004993"
      unitRef="BRLPShares">2.39</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact004995"
      unitRef="BRLPShares">4.27</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004996"
      unitRef="BRLPShares">4.12</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact004997"
      unitRef="BRLPShares">2.37</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DisclosureOfRevenueExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact004999">&lt;p id="xdx_806_eifrs-full--DisclosureOfRevenueExplanatory_zimIU8wyTOx" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;19&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_82C_zUsf9qG7uO5f"&gt;Revenue&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfNetSalesRevenueExplanatory_pn3n3_znfpDm4BOzIc" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Revenue (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span id="xdx_8B9_z5BUwrB1hwy9" style="display: none"&gt;Schedule of net sales revenue&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49F_20230101__20231231_z1WObxgz0xtc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20220101__20221231_zcrwSmtQvjz7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20210101__20211231_zs61v7tgdhUl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 58%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ProfessionalFeesExpenses_pn3n3_zwk9c80ObZK8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;3,505,250&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;2,827,567&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;2,124,589&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--OtherRevenue1_pn3n3_zp8xAYUrIeNa" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;263,937&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;213,040&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;167,441&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeductionAbstract_iB_zdCBlY7sJgra" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DeductionOfGrantedDiscounts_pn3n3_zC9iOk8mpbAj" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&#160;&#160;Discount and scholarships&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(240,314)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(241,404)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(229,254)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DeductionOfEarlyPaymentDiscounts_pn3n3_zmb02L9Q1O94" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&#160;&#160;Early payment discounts&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(195,054)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(92,234)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(49,879)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DeductionOfReturnsOfNetRevenue_pn3n3_zlIFg3qx6xXk" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&#160;&#160;Returns&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(27,743)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(45,402)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(42,373)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeductionOfTaxes_pn3n3_zvkgH40LOO89" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&#160;&#160;Taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(142,825)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(107,004)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(74,232)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DeductionOfProuni_pn3n3_zvB87VooQBn" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&#160;&#160;PROUNI&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(287,338)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(225,506)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(176,921)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--RevenueFromContractsWithCustomers_pn3n3_zifnEgvdKpp2" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;Revenue from contracts with customers&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2,329,057&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_zQUWx9J7t8ff" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;Timing of revenue recognition of revenue from contracts with customers:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--FeeAndCommissionIncome_pn3n3_zj1zLfWnUIA3" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Tuition, digital content and app subscription fees - Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;2,821,251&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;2,273,578&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;1,640,889&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--NetRevenueOtherTransferredPoint_pn3n3_zjDCMstxDC6e" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Other - Transferred at a point in time&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;54,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;55,479&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;78,482&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A9_zJhXqCdkot71" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;The Company&#x2019;s revenue from contracts
with customers are all in Brazil. The Company is not subject to the payment of the Social Integration Program tax (Programa de Integra&#xe7;&#xe3;o
Social, or PIS) and the Social Contribution on Revenue tax (Contribui&#xe7;&#xe3;o para o Financiamento da Seguridade Social, or COFINS)
on the revenue from under graduation degrees under the PROUNI program.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;The table below presents statements of
income for the Company&#x2019;s operating segments for the years ended December 31, 2023, 2022 and 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfRevenueBySegmentTableTextBlock_pn3n3_zYeN0mE0ZXFe" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Revenue (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"&gt;&lt;span id="xdx_8BC_zLB23Iq3EQPg" style="display: none"&gt;Schedule of revenue by segment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Revenue by segment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zi0ZP7NAhEbe" style="text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,511,018&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z3TEEuYkhEo4" style="text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;146,827&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zAzJ1KuKMhUf" style="text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;229,285&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zn2QPvTh437l" style="text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231_zKtBvJTdd82g" style="text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zISyUUEzkRoc" style="text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,494,121&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zuipgDQ2Xuh7" style="text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;146,477&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zgqcuZM55Fvc" style="text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5067"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zM8zwEXoyww4" style="text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5069"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231_zB9QgWnGCdNl" style="text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,640,598&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zy90ntUDoZRd" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;16,897&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7luo5JNsp16" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;350&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zzNooKxN9xl4" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;229,285&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zrvYooQ9jcLi" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231_zc4LmfnEaQad" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;235,315&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_z693lSPU446" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,511,018&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj839nXLhoB1" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;146,827&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zkryQ0ogpLc4" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;229,285&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zNRuFiSGn6vk" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231_z6VZkjduxU9k" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zpQcRHDtECl6" style="text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,494,121&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zb4nPaGgjvHb" style="text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;146,827&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zP3BPBeb1ej7" style="text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;191,520&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zMZqSEbuQcy4" style="text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231_zEC2CgkqhdB8" style="text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,821,251&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred at a point in time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zvwDIInIJVu" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;16,897&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7tg3Vfmfxc9" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5105"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0rOvSDeONg7" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;37,765&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_ztHSmt5Fr2lc" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5109"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231_z04tHxkw1m65" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,662&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Revenue by segment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQ9uzv3KS3x2" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,037,889&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7AzcS5SYmsb" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;108,806&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zGfMf0AXWjk" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;189,984&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zwlcrNDR31k" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(7,622)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231_z1oJNuCApja3" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,329,057&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zfiWouZlsJ6d" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,023,128&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zz4Tkh7VbVQa" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,648&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zkm0oXD1pMal" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5129"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zj0KHscAEw7e" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5131"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231_zEHSri1DoqWk" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,131,776&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zHqJpB7G0MXd" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,761&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z5VjxSw1Mnej" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;158&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrBSxDtJMa7g" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;189,984&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zDTJ3NPMQ4L4" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,622)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231_zR24lXnHcO73" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;197,281&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zBdqUnzNNjtl" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,037,889&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z1wI19CkMpC1" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;108,806&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zSncGdjYg1z3" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;189,984&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zPijWuOF51W4" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(7,622)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231_zZ7zF2FahVs4" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,329,057&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqLQFUfnWqD7" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,024,373&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zfyDXLtSlg5e" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,806&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z4roRCgvHBkk" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;145,939&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zeDCAinVuQO2" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(5,540)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231_znnnB9B3fWTb" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,273,578&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred at a point in time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zKSWsRcjNfi9" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,516&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znBWIkid4crl" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5167"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zC2BilU7YKg2" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;44,045&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zJJ1A9BQuwDb" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,082)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231_zfmFpyOK6dXj" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;55,479&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Revenue by segment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zZxFCjZ6r5ie" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,498,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zuLSwLLKmn2a" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;72,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zBR5ly7nxCE" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;151,958&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zpogD8yKpbGj" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(3,978)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231_zJyTK0ykkOS7" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zZjXDbIvuRi9" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,486,111&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zaDp4rTLcIE8" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zv1OXCLX4i5" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5189"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zFmDKQXGjsg5" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5191"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231_z3KM0dsLcufj" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,559,094&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zaWzuaj8hPwe" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,297&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zmWHomzrJQLe" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5197"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjLntB2JdBp2" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;151,958&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zlJiGX2JoqDd" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,978)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231_zKkpucWMzCL1" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;160,277&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zrWrviu9ORm2" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,498,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zVJQuehlkY3i" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;72,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zGMiHnPqPGRh" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;151,958&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zmn1hMMQ44tc" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(3,978)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231_zIIrnf2aaSWl" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zeb6DMrsKRP1" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,486,111&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zmucLbC6xnUl" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zmOf4zHFDOt3" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;81,795&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z14jonW2j8rc" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5221"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231_zTeq3L4xEou" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,640,889&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred at a point in time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zTlNEe34zHqf" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,297&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zIRJ5K2ZkY44" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5227"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z7iVqnvXaiz4" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,163&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_za2aC8xbX7m" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,978)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231_ztARH3Qyy1T5" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;78,482&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zyEqTRdfdRWl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfRevenueExplanatory>
    <afya:ScheduleOfNetSalesRevenueExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact005001">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfNetSalesRevenueExplanatory_pn3n3_znfpDm4BOzIc" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Revenue (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span id="xdx_8B9_z5BUwrB1hwy9" style="display: none"&gt;Schedule of net sales revenue&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49F_20230101__20231231_z1WObxgz0xtc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20220101__20221231_zcrwSmtQvjz7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20210101__20211231_zs61v7tgdhUl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 58%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ProfessionalFeesExpenses_pn3n3_zwk9c80ObZK8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;3,505,250&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;2,827,567&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;2,124,589&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--OtherRevenue1_pn3n3_zp8xAYUrIeNa" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;263,937&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;213,040&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;167,441&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeductionAbstract_iB_zdCBlY7sJgra" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--DeductionOfGrantedDiscounts_pn3n3_zC9iOk8mpbAj" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&#160;&#160;Discount and scholarships&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(240,314)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(241,404)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(229,254)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DeductionOfEarlyPaymentDiscounts_pn3n3_zmb02L9Q1O94" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&#160;&#160;Early payment discounts&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(195,054)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(92,234)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(49,879)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DeductionOfReturnsOfNetRevenue_pn3n3_zlIFg3qx6xXk" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&#160;&#160;Returns&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(27,743)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(45,402)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(42,373)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeductionOfTaxes_pn3n3_zvkgH40LOO89" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&#160;&#160;Taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(142,825)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(107,004)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(74,232)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DeductionOfProuni_pn3n3_zvB87VooQBn" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&#160;&#160;PROUNI&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(287,338)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(225,506)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(176,921)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--RevenueFromContractsWithCustomers_pn3n3_zifnEgvdKpp2" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;Revenue from contracts with customers&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2,329,057&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_zQUWx9J7t8ff" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;Timing of revenue recognition of revenue from contracts with customers:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--FeeAndCommissionIncome_pn3n3_zj1zLfWnUIA3" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Tuition, digital content and app subscription fees - Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;2,821,251&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;2,273,578&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;1,640,889&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--NetRevenueOtherTransferredPoint_pn3n3_zjDCMstxDC6e" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Other - Transferred at a point in time&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;54,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;55,479&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;78,482&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfNetSalesRevenueExplanatory>
    <afya:ProfessionalFeesExpenses
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005003"
      unitRef="BRL">3505250000</afya:ProfessionalFeesExpenses>
    <afya:ProfessionalFeesExpenses
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005004"
      unitRef="BRL">2827567000</afya:ProfessionalFeesExpenses>
    <afya:ProfessionalFeesExpenses
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005005"
      unitRef="BRL">2124589000</afya:ProfessionalFeesExpenses>
    <afya:OtherRevenue1
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005007"
      unitRef="BRL">263937000</afya:OtherRevenue1>
    <afya:OtherRevenue1
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005008"
      unitRef="BRL">213040000</afya:OtherRevenue1>
    <afya:OtherRevenue1
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005009"
      unitRef="BRL">167441000</afya:OtherRevenue1>
    <afya:DeductionOfGrantedDiscounts
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005015"
      unitRef="BRL">-240314000</afya:DeductionOfGrantedDiscounts>
    <afya:DeductionOfGrantedDiscounts
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005016"
      unitRef="BRL">-241404000</afya:DeductionOfGrantedDiscounts>
    <afya:DeductionOfGrantedDiscounts
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005017"
      unitRef="BRL">-229254000</afya:DeductionOfGrantedDiscounts>
    <afya:DeductionOfEarlyPaymentDiscounts
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005019"
      unitRef="BRL">-195054000</afya:DeductionOfEarlyPaymentDiscounts>
    <afya:DeductionOfEarlyPaymentDiscounts
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005020"
      unitRef="BRL">-92234000</afya:DeductionOfEarlyPaymentDiscounts>
    <afya:DeductionOfEarlyPaymentDiscounts
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005021"
      unitRef="BRL">-49879000</afya:DeductionOfEarlyPaymentDiscounts>
    <afya:DeductionOfReturnsOfNetRevenue
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005023"
      unitRef="BRL">-27743000</afya:DeductionOfReturnsOfNetRevenue>
    <afya:DeductionOfReturnsOfNetRevenue
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005024"
      unitRef="BRL">-45402000</afya:DeductionOfReturnsOfNetRevenue>
    <afya:DeductionOfReturnsOfNetRevenue
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005025"
      unitRef="BRL">-42373000</afya:DeductionOfReturnsOfNetRevenue>
    <afya:DeductionOfTaxes
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005027"
      unitRef="BRL">-142825000</afya:DeductionOfTaxes>
    <afya:DeductionOfTaxes
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005028"
      unitRef="BRL">-107004000</afya:DeductionOfTaxes>
    <afya:DeductionOfTaxes
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005029"
      unitRef="BRL">-74232000</afya:DeductionOfTaxes>
    <afya:DeductionOfProuni
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005031"
      unitRef="BRL">-287338000</afya:DeductionOfProuni>
    <afya:DeductionOfProuni
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005032"
      unitRef="BRL">-225506000</afya:DeductionOfProuni>
    <afya:DeductionOfProuni
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005033"
      unitRef="BRL">-176921000</afya:DeductionOfProuni>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005035"
      unitRef="BRL">2875913000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005036"
      unitRef="BRL">2329057000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005037"
      unitRef="BRL">1719371000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005043"
      unitRef="BRL">2821251000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005044"
      unitRef="BRL">2273578000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005045"
      unitRef="BRL">1640889000</ifrs-full:FeeAndCommissionIncome>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005047"
      unitRef="BRL">54662000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005048"
      unitRef="BRL">55479000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005049"
      unitRef="BRL">78482000</afya:NetRevenueOtherTransferredPoint>
    <afya:ScheduleOfRevenueBySegmentTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact005051">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfRevenueBySegmentTableTextBlock_pn3n3_zYeN0mE0ZXFe" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Revenue (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"&gt;&lt;span id="xdx_8BC_zLB23Iq3EQPg" style="display: none"&gt;Schedule of revenue by segment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Revenue by segment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zi0ZP7NAhEbe" style="text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,511,018&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z3TEEuYkhEo4" style="text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;146,827&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zAzJ1KuKMhUf" style="text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;229,285&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zn2QPvTh437l" style="text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231_zKtBvJTdd82g" style="text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zISyUUEzkRoc" style="text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,494,121&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zuipgDQ2Xuh7" style="text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;146,477&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zgqcuZM55Fvc" style="text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5067"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zM8zwEXoyww4" style="text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5069"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231_zB9QgWnGCdNl" style="text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,640,598&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zy90ntUDoZRd" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;16,897&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7luo5JNsp16" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;350&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zzNooKxN9xl4" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;229,285&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zrvYooQ9jcLi" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231_zc4LmfnEaQad" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;235,315&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_z693lSPU446" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,511,018&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj839nXLhoB1" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;146,827&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zkryQ0ogpLc4" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;229,285&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zNRuFiSGn6vk" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20230101__20231231_z6VZkjduxU9k" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zpQcRHDtECl6" style="text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,494,121&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zb4nPaGgjvHb" style="text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;146,827&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zP3BPBeb1ej7" style="text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;191,520&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zMZqSEbuQcy4" style="text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231_zEC2CgkqhdB8" style="text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,821,251&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred at a point in time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zvwDIInIJVu" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;16,897&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7tg3Vfmfxc9" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5105"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0rOvSDeONg7" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;37,765&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_ztHSmt5Fr2lc" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5109"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20230101__20231231_z04tHxkw1m65" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,662&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Revenue by segment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQ9uzv3KS3x2" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,037,889&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z7AzcS5SYmsb" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;108,806&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zGfMf0AXWjk" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;189,984&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zwlcrNDR31k" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(7,622)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20220101__20221231_z1oJNuCApja3" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,329,057&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zfiWouZlsJ6d" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,023,128&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zz4Tkh7VbVQa" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,648&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zkm0oXD1pMal" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5129"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zj0KHscAEw7e" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5131"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ProfessionalFeesExpense_pn3n3_c20220101__20221231_zEHSri1DoqWk" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,131,776&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zHqJpB7G0MXd" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,761&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z5VjxSw1Mnej" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;158&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrBSxDtJMa7g" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;189,984&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zDTJ3NPMQ4L4" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,622)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20220101__20221231_zR24lXnHcO73" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;197,281&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zBdqUnzNNjtl" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,037,889&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z1wI19CkMpC1" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;108,806&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zSncGdjYg1z3" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;189,984&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zPijWuOF51W4" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(7,622)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20220101__20221231_zZ7zF2FahVs4" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,329,057&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqLQFUfnWqD7" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,024,373&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zfyDXLtSlg5e" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;108,806&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z4roRCgvHBkk" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;145,939&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zeDCAinVuQO2" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(5,540)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FeeAndCommissionIncome_pn3n3_c20220101__20221231_znnnB9B3fWTb" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,273,578&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred at a point in time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UndergradMember_zKSWsRcjNfi9" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,516&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znBWIkid4crl" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5167"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zC2BilU7YKg2" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;44,045&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zJJ1A9BQuwDb" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,082)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20220101__20221231_zfmFpyOK6dXj" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;55,479&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Revenue by segment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Continuing Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Digital Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zZxFCjZ6r5ie" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,498,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zuLSwLLKmn2a" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;72,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zBR5ly7nxCE" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;151,958&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zpogD8yKpbGj" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(3,978)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231_zJyTK0ykkOS7" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zZjXDbIvuRi9" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,486,111&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zaDp4rTLcIE8" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zv1OXCLX4i5" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5189"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zFmDKQXGjsg5" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5191"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231_z3KM0dsLcufj" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,559,094&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zaWzuaj8hPwe" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,297&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zmWHomzrJQLe" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5197"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zjLntB2JdBp2" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;151,958&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zlJiGX2JoqDd" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,978)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231_zKkpucWMzCL1" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;160,277&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zrWrviu9ORm2" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,498,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zVJQuehlkY3i" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;72,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zGMiHnPqPGRh" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;151,958&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zmn1hMMQ44tc" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(3,978)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231_zIIrnf2aaSWl" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zeb6DMrsKRP1" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,486,111&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zmucLbC6xnUl" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zmOf4zHFDOt3" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;81,795&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z14jonW2j8rc" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5221"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231_zTeq3L4xEou" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,640,889&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred at a point in time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zTlNEe34zHqf" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,297&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zIRJ5K2ZkY44" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5227"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z7iVqnvXaiz4" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,163&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_za2aC8xbX7m" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,978)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231_ztARH3Qyy1T5" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;78,482&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfRevenueBySegmentTableTextBlock>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2023-01-012023-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005053"
      unitRef="BRL">2511018000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005055"
      unitRef="BRL">146827000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2023-01-012023-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005057"
      unitRef="BRL">229285000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact005059"
      unitRef="BRL">-11217000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005061"
      unitRef="BRL">2875913000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2023-01-012023-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005063"
      unitRef="BRL">2494121000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005065"
      unitRef="BRL">146477000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005071"
      unitRef="BRL">2640598000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:OtherRevenue
      contextRef="From2023-01-012023-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005073"
      unitRef="BRL">16897000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005075"
      unitRef="BRL">350000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2023-01-012023-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005077"
      unitRef="BRL">229285000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact005079"
      unitRef="BRL">-11217000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005081"
      unitRef="BRL">235315000</ifrs-full:OtherRevenue>
    <afya:TimingRevenueRecognition
      contextRef="From2023-01-012023-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005083"
      unitRef="BRL">2511018000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005085"
      unitRef="BRL">146827000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2023-01-012023-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005087"
      unitRef="BRL">229285000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact005089"
      unitRef="BRL">-11217000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005091"
      unitRef="BRL">2875913000</afya:TimingRevenueRecognition>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2023-01-012023-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005093"
      unitRef="BRL">2494121000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005095"
      unitRef="BRL">146827000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2023-01-012023-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005097"
      unitRef="BRL">191520000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact005099"
      unitRef="BRL">-11217000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005101"
      unitRef="BRL">2821251000</ifrs-full:FeeAndCommissionIncome>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2023-01-012023-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005103"
      unitRef="BRL">16897000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2023-01-012023-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005107"
      unitRef="BRL">37765000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005111"
      unitRef="BRL">54662000</afya:NetRevenueOtherTransferredPoint>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2022-01-012022-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005115"
      unitRef="BRL">2037889000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2022-01-012022-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005117"
      unitRef="BRL">108806000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2022-01-012022-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005119"
      unitRef="BRL">189984000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact005121"
      unitRef="BRL">-7622000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005123"
      unitRef="BRL">2329057000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2022-01-012022-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005125"
      unitRef="BRL">2023128000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2022-01-012022-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005127"
      unitRef="BRL">108648000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005133"
      unitRef="BRL">2131776000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:OtherRevenue
      contextRef="From2022-01-012022-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005135"
      unitRef="BRL">14761000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2022-01-012022-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005137"
      unitRef="BRL">158000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2022-01-012022-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005139"
      unitRef="BRL">189984000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact005141"
      unitRef="BRL">-7622000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005143"
      unitRef="BRL">197281000</ifrs-full:OtherRevenue>
    <afya:TimingRevenueRecognition
      contextRef="From2022-01-012022-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005145"
      unitRef="BRL">2037889000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2022-01-012022-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005147"
      unitRef="BRL">108806000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2022-01-012022-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005149"
      unitRef="BRL">189984000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact005151"
      unitRef="BRL">-7622000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005153"
      unitRef="BRL">2329057000</afya:TimingRevenueRecognition>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2022-01-012022-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005155"
      unitRef="BRL">2024373000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2022-01-012022-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005157"
      unitRef="BRL">108806000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2022-01-012022-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005159"
      unitRef="BRL">145939000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact005161"
      unitRef="BRL">-5540000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005163"
      unitRef="BRL">2273578000</ifrs-full:FeeAndCommissionIncome>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2022-01-012022-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005165"
      unitRef="BRL">13516000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2022-01-012022-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005169"
      unitRef="BRL">44045000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2022-01-012022-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact005171"
      unitRef="BRL">-2082000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005173"
      unitRef="BRL">55479000</afya:NetRevenueOtherTransferredPoint>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2021-01-012021-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005175"
      unitRef="BRL">1498408000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005177"
      unitRef="BRL">72983000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005179"
      unitRef="BRL">151958000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact005181"
      unitRef="BRL">-3978000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005183"
      unitRef="BRL">1719371000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2021-01-012021-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005185"
      unitRef="BRL">1486111000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005187"
      unitRef="BRL">72983000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005193"
      unitRef="BRL">1559094000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:OtherRevenue
      contextRef="From2021-01-012021-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005195"
      unitRef="BRL">12297000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005199"
      unitRef="BRL">151958000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact005201"
      unitRef="BRL">-3978000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005203"
      unitRef="BRL">160277000</ifrs-full:OtherRevenue>
    <afya:TimingRevenueRecognition
      contextRef="From2021-01-012021-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005205"
      unitRef="BRL">1498408000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005207"
      unitRef="BRL">72983000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005209"
      unitRef="BRL">151958000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact005211"
      unitRef="BRL">-3978000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005213"
      unitRef="BRL">1719371000</afya:TimingRevenueRecognition>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2021-01-012021-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005215"
      unitRef="BRL">1486111000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact005217"
      unitRef="BRL">72983000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005219"
      unitRef="BRL">81795000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005223"
      unitRef="BRL">1640889000</ifrs-full:FeeAndCommissionIncome>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2021-01-012021-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact005225"
      unitRef="BRL">12297000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact005229"
      unitRef="BRL">70163000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2021-01-012021-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact005231"
      unitRef="BRL">-3978000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005233"
      unitRef="BRL">78482000</afya:NetRevenueOtherTransferredPoint>
    <ifrs-full:DisclosureOfExpensesByNatureExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact005235">&lt;p id="xdx_804_eifrs-full--DisclosureOfExpensesByNatureExplanatory_zoroR9a7ZPqa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;20&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_824_zaRDdm9ppif2"&gt;Expenses and costs by nature&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--SummaryOfExpensesByNatureTableTextBlock_pn3n3_zfdljIcQLPa5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Expenses and costs by nature (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BE_zl35bW6LMvNe" style="display: none"&gt;Schedule of expenses by nature&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_491_20230101__20231231_zLMbmlAE426i" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20220101__20221231_zWeF1SzHqZLc" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20210101__20211231_zHcU4TYvXS4f" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 46%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--CostOfSales_iN_pn3n3_di_z9lzEJIic082" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(1,109,813)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(859,552)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(652,300)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--GeneralAndAdministrativeExpense_iN_pn3n3_di_zwHCywEaduul" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(1,014,684)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(798,153)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(622,615)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--ExpenseByNature_iN_pn3n3_di_zZgzKIs284T8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(2,124,497)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(1,657,705)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(1,274,915)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--Payroll_pn3n3_zxs1ZZSg5kS" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payroll&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(1,085,144)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(880,664)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(677,564)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--HospitalAndMedicalAgreements_pn3n3_zlphn7Uriw63" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Hospital and medical agreements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(86,151)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(66,065)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(37,449)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DepreciationExpense_iN_pn3n3_di_zyIEmwhLbal" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(289,511)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(206,220)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(154,220)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--LeaseExpenses_pn3n3_zVrgo5WrYMe3" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(10,871)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(12,153)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(11,229)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--UtilitiesExpense_pn3n3_zDPxw4HSsQD8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Utilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(20,403)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(17,682)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(10,643)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--RepairsAndMaintenanceExpense_iN_pn3n3_di_z8HqLPNNcpic" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Maintenance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(105,919)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(76,475)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(47,141)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--SharesBasedCompensation_pn3n3_zF0LsEahKDA3" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(31,535)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(31,274)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(43,377)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--TaxExpenses_pn3n3_zYSaAQpnfqB8" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tax expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(14,447)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(10,518)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(7,997)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--ServicesExpense_iN_pn3n3_di_zpVtYAfw4CBf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Pedagogical services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(64,081)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(48,084)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(47,881)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--SalesAndMarketingExpense_iN_pn3n3_di_zzIlxPHPw6v3" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(74,140)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(48,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(39,506)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AllowanceForExpectedCreditLosses_pn3n3_z5XH2J91guek" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(74,552)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(42,708)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(47,819)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--TravelExpense_iN_pn3n3_di_zV4ukGYKc7B5" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Travel expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(16,098)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(14,003)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(7,542)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ConsultingFees_pn3n3_zoyNP63WDNx7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Consulting fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(62,630)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(35,326)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(38,818)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--Other_pn3n3_zZaZ1uhnusJj" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(189,015)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(168,316)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(103,729)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ExpenseByNatureOne_pn3n3_zBmYGmeYmzgl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(2,124,497)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(1,657,705)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(1,274,915)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;



</ifrs-full:DisclosureOfExpensesByNatureExplanatory>
    <afya:SummaryOfExpensesByNatureTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact005237">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--SummaryOfExpensesByNatureTableTextBlock_pn3n3_zfdljIcQLPa5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Expenses and costs by nature (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BE_zl35bW6LMvNe" style="display: none"&gt;Schedule of expenses by nature&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_491_20230101__20231231_zLMbmlAE426i" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20220101__20221231_zWeF1SzHqZLc" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20210101__20211231_zHcU4TYvXS4f" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 46%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--CostOfSales_iN_pn3n3_di_z9lzEJIic082" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(1,109,813)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(859,552)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(652,300)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--GeneralAndAdministrativeExpense_iN_pn3n3_di_zwHCywEaduul" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(1,014,684)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(798,153)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(622,615)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--ExpenseByNature_iN_pn3n3_di_zZgzKIs284T8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(2,124,497)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(1,657,705)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(1,274,915)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--Payroll_pn3n3_zxs1ZZSg5kS" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payroll&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(1,085,144)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(880,664)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(677,564)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--HospitalAndMedicalAgreements_pn3n3_zlphn7Uriw63" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Hospital and medical agreements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(86,151)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(66,065)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(37,449)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DepreciationExpense_iN_pn3n3_di_zyIEmwhLbal" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(289,511)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(206,220)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(154,220)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--LeaseExpenses_pn3n3_zVrgo5WrYMe3" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(10,871)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(12,153)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(11,229)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--UtilitiesExpense_pn3n3_zDPxw4HSsQD8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Utilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(20,403)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(17,682)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(10,643)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--RepairsAndMaintenanceExpense_iN_pn3n3_di_z8HqLPNNcpic" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Maintenance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(105,919)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(76,475)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(47,141)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--SharesBasedCompensation_pn3n3_zF0LsEahKDA3" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(31,535)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(31,274)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(43,377)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--TaxExpenses_pn3n3_zYSaAQpnfqB8" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tax expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(14,447)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(10,518)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(7,997)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--ServicesExpense_iN_pn3n3_di_zpVtYAfw4CBf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Pedagogical services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(64,081)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(48,084)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(47,881)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--SalesAndMarketingExpense_iN_pn3n3_di_zzIlxPHPw6v3" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(74,140)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(48,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(39,506)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AllowanceForExpectedCreditLosses_pn3n3_z5XH2J91guek" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(74,552)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(42,708)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(47,819)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--TravelExpense_iN_pn3n3_di_zV4ukGYKc7B5" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Travel expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(16,098)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(14,003)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(7,542)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ConsultingFees_pn3n3_zoyNP63WDNx7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Consulting fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(62,630)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(35,326)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(38,818)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--Other_pn3n3_zZaZ1uhnusJj" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(189,015)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(168,316)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(103,729)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ExpenseByNatureOne_pn3n3_zBmYGmeYmzgl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(2,124,497)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(1,657,705)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(1,274,915)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:SummaryOfExpensesByNatureTableTextBlock>
    <ifrs-full:CostOfSales
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005239"
      unitRef="BRL">1109813000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005240"
      unitRef="BRL">859552000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005241"
      unitRef="BRL">652300000</ifrs-full:CostOfSales>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005243"
      unitRef="BRL">1014684000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005244"
      unitRef="BRL">798153000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005245"
      unitRef="BRL">622615000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:ExpenseByNature
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005247"
      unitRef="BRL">2124497000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005248"
      unitRef="BRL">1657705000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005249"
      unitRef="BRL">1274915000</ifrs-full:ExpenseByNature>
    <afya:Payroll
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005251"
      unitRef="BRL">-1085144000</afya:Payroll>
    <afya:Payroll
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005252"
      unitRef="BRL">-880664000</afya:Payroll>
    <afya:Payroll
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005253"
      unitRef="BRL">-677564000</afya:Payroll>
    <afya:HospitalAndMedicalAgreements
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005255"
      unitRef="BRL">-86151000</afya:HospitalAndMedicalAgreements>
    <afya:HospitalAndMedicalAgreements
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005256"
      unitRef="BRL">-66065000</afya:HospitalAndMedicalAgreements>
    <afya:HospitalAndMedicalAgreements
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005257"
      unitRef="BRL">-37449000</afya:HospitalAndMedicalAgreements>
    <ifrs-full:DepreciationExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005259"
      unitRef="BRL">289511000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005260"
      unitRef="BRL">206220000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005261"
      unitRef="BRL">154220000</ifrs-full:DepreciationExpense>
    <afya:LeaseExpenses
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005263"
      unitRef="BRL">-10871000</afya:LeaseExpenses>
    <afya:LeaseExpenses
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005264"
      unitRef="BRL">-12153000</afya:LeaseExpenses>
    <afya:LeaseExpenses
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005265"
      unitRef="BRL">-11229000</afya:LeaseExpenses>
    <ifrs-full:UtilitiesExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005267"
      unitRef="BRL">-20403000</ifrs-full:UtilitiesExpense>
    <ifrs-full:UtilitiesExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005268"
      unitRef="BRL">-17682000</ifrs-full:UtilitiesExpense>
    <ifrs-full:UtilitiesExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005269"
      unitRef="BRL">-10643000</ifrs-full:UtilitiesExpense>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005271"
      unitRef="BRL">105919000</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005272"
      unitRef="BRL">76475000</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005273"
      unitRef="BRL">47141000</ifrs-full:RepairsAndMaintenanceExpense>
    <afya:SharesBasedCompensation
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005275"
      unitRef="BRL">-31535000</afya:SharesBasedCompensation>
    <afya:SharesBasedCompensation
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005276"
      unitRef="BRL">-31274000</afya:SharesBasedCompensation>
    <afya:SharesBasedCompensation
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005277"
      unitRef="BRL">-43377000</afya:SharesBasedCompensation>
    <afya:TaxExpenses
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005279"
      unitRef="BRL">-14447000</afya:TaxExpenses>
    <afya:TaxExpenses
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005280"
      unitRef="BRL">-10518000</afya:TaxExpenses>
    <afya:TaxExpenses
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005281"
      unitRef="BRL">-7997000</afya:TaxExpenses>
    <ifrs-full:ServicesExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005283"
      unitRef="BRL">64081000</ifrs-full:ServicesExpense>
    <ifrs-full:ServicesExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005284"
      unitRef="BRL">48084000</ifrs-full:ServicesExpense>
    <ifrs-full:ServicesExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005285"
      unitRef="BRL">47881000</ifrs-full:ServicesExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005287"
      unitRef="BRL">74140000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005288"
      unitRef="BRL">48217000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005289"
      unitRef="BRL">39506000</ifrs-full:SalesAndMarketingExpense>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005291"
      unitRef="BRL">-74552000</afya:AllowanceForExpectedCreditLosses>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005292"
      unitRef="BRL">-42708000</afya:AllowanceForExpectedCreditLosses>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005293"
      unitRef="BRL">-47819000</afya:AllowanceForExpectedCreditLosses>
    <ifrs-full:TravelExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005295"
      unitRef="BRL">16098000</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005296"
      unitRef="BRL">14003000</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005297"
      unitRef="BRL">7542000</ifrs-full:TravelExpense>
    <afya:ConsultingFees
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005299"
      unitRef="BRL">-62630000</afya:ConsultingFees>
    <afya:ConsultingFees
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005300"
      unitRef="BRL">-35326000</afya:ConsultingFees>
    <afya:ConsultingFees
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005301"
      unitRef="BRL">-38818000</afya:ConsultingFees>
    <afya:Other
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005303"
      unitRef="BRL">-189015000</afya:Other>
    <afya:Other
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005304"
      unitRef="BRL">-168316000</afya:Other>
    <afya:Other
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005305"
      unitRef="BRL">-103729000</afya:Other>
    <afya:ExpenseByNatureOne
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005307"
      unitRef="BRL">-2124497000</afya:ExpenseByNatureOne>
    <afya:ExpenseByNatureOne
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005308"
      unitRef="BRL">-1657705000</afya:ExpenseByNatureOne>
    <afya:ExpenseByNatureOne
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005309"
      unitRef="BRL">-1274915000</afya:ExpenseByNatureOne>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact005311">&lt;p id="xdx_808_eifrs-full--DisclosureOfFinanceIncomeExpenseExplanatory_zdhfhvX96DFe" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;21&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_822_zTixJmUYcWqc"&gt;Finance result&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--ScheduleOfFinanceResultTableTextBlock_zFCcfPpIzMbf" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Finance result (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BF_zysruc05zkJ2" style="display: none"&gt;Schedule of finance result&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_493_20230101__20231231_zB1aXru0IUpa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20220101__20221231_zOpB2wKCv3nl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20210101__20211231_zXwR7e35HFp" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--InvestmentIncome_pn3n3_z8DyQCHSraPi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income from financial investments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;73,672&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;67,810&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,773&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--RevenueFromInterest_pn3n3_zr6uiRUlIq0h" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest received&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;33,450&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,197&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,040&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--OtherFinanceIncome_pn3n3_zZCv6TxcaGa8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,520&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,753&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--FinanceIncome_pn3n3_zaLIzb89Yo15" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Finance income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;110,642&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;102,042&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;64,566&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--InterestExpense1_pn3n3_z4uac0wnG8d4" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(285,447)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(200,081)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(108,437)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--InterestExpenseOnLeaseLiabilities1_pn3n3_zL7kY0iBWH3g" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest expense on lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(100,849)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(88,571)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(67,212)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FinancialDiscountsGrantedExpenses_pn3n3_zbFKVp3xCoe" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Financial discounts granted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(30,891)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(24,092)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(23,193)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--BankAndSimilarCharges_iN_pn3n3_di_zx7WykHrEgmi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Bank fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,163)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(8,623)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,878)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NetForeignExchangeLoss_iN_pn3n3_di_zXz9mKYFxafi" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Foreign exchange loss, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(681)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(852)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(17,973)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--TaxOnFinancialOperations_pn3n3_zhEMHixPeMT1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IOF taxes (taxes on financial transactions)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,947)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(178)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,306)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--OtherFinanceCost_iN_pn3n3_di_zShhuNZiILe4" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(30,638)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(27,496)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(15,797)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--FinanceCosts_iN_pn3n3_di_z4ojR9SPoIwd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Finance expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(457,616)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(349,893)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(243,796)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--FinanceResult_pn3n3_zOFbUfqRwHU6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Finance result&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(346,974)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(247,851)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(179,230)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <afya:ScheduleOfFinanceResultTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact005313">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--ScheduleOfFinanceResultTableTextBlock_zFCcfPpIzMbf" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Finance result (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BF_zysruc05zkJ2" style="display: none"&gt;Schedule of finance result&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_493_20230101__20231231_zB1aXru0IUpa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20220101__20221231_zOpB2wKCv3nl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49C_20210101__20211231_zXwR7e35HFp" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--InvestmentIncome_pn3n3_z8DyQCHSraPi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income from financial investments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;73,672&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;67,810&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,773&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--RevenueFromInterest_pn3n3_zr6uiRUlIq0h" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest received&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;33,450&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,197&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,040&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--OtherFinanceIncome_pn3n3_zZCv6TxcaGa8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,520&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,753&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--FinanceIncome_pn3n3_zaLIzb89Yo15" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Finance income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;110,642&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;102,042&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;64,566&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--InterestExpense1_pn3n3_z4uac0wnG8d4" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(285,447)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(200,081)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(108,437)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--InterestExpenseOnLeaseLiabilities1_pn3n3_zL7kY0iBWH3g" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest expense on lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(100,849)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(88,571)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(67,212)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FinancialDiscountsGrantedExpenses_pn3n3_zbFKVp3xCoe" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Financial discounts granted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(30,891)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(24,092)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(23,193)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--BankAndSimilarCharges_iN_pn3n3_di_zx7WykHrEgmi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Bank fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,163)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(8,623)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,878)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--NetForeignExchangeLoss_iN_pn3n3_di_zXz9mKYFxafi" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Foreign exchange loss, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(681)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(852)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(17,973)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--TaxOnFinancialOperations_pn3n3_zhEMHixPeMT1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IOF taxes (taxes on financial transactions)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,947)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(178)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,306)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--OtherFinanceCost_iN_pn3n3_di_zShhuNZiILe4" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(30,638)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(27,496)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(15,797)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--FinanceCosts_iN_pn3n3_di_z4ojR9SPoIwd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Finance expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(457,616)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(349,893)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(243,796)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--FinanceResult_pn3n3_zOFbUfqRwHU6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Finance result&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(346,974)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(247,851)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(179,230)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:ScheduleOfFinanceResultTableTextBlock>
    <ifrs-full:InvestmentIncome
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005315"
      unitRef="BRL">73672000</ifrs-full:InvestmentIncome>
    <ifrs-full:InvestmentIncome
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005316"
      unitRef="BRL">67810000</ifrs-full:InvestmentIncome>
    <ifrs-full:InvestmentIncome
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005317"
      unitRef="BRL">35773000</ifrs-full:InvestmentIncome>
    <ifrs-full:RevenueFromInterest
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005319"
      unitRef="BRL">33450000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005320"
      unitRef="BRL">27197000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005321"
      unitRef="BRL">23040000</ifrs-full:RevenueFromInterest>
    <ifrs-full:OtherFinanceIncome
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005323"
      unitRef="BRL">3520000</ifrs-full:OtherFinanceIncome>
    <ifrs-full:OtherFinanceIncome
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005324"
      unitRef="BRL">7035000</ifrs-full:OtherFinanceIncome>
    <ifrs-full:OtherFinanceIncome
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005325"
      unitRef="BRL">5753000</ifrs-full:OtherFinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005327"
      unitRef="BRL">110642000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005328"
      unitRef="BRL">102042000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005329"
      unitRef="BRL">64566000</ifrs-full:FinanceIncome>
    <afya:InterestExpense1
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005331"
      unitRef="BRL">-285447000</afya:InterestExpense1>
    <afya:InterestExpense1
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005332"
      unitRef="BRL">-200081000</afya:InterestExpense1>
    <afya:InterestExpense1
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005333"
      unitRef="BRL">-108437000</afya:InterestExpense1>
    <afya:InterestExpenseOnLeaseLiabilities1
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005335"
      unitRef="BRL">-100849000</afya:InterestExpenseOnLeaseLiabilities1>
    <afya:InterestExpenseOnLeaseLiabilities1
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005336"
      unitRef="BRL">-88571000</afya:InterestExpenseOnLeaseLiabilities1>
    <afya:InterestExpenseOnLeaseLiabilities1
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005337"
      unitRef="BRL">-67212000</afya:InterestExpenseOnLeaseLiabilities1>
    <afya:FinancialDiscountsGrantedExpenses
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005339"
      unitRef="BRL">-30891000</afya:FinancialDiscountsGrantedExpenses>
    <afya:FinancialDiscountsGrantedExpenses
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005340"
      unitRef="BRL">-24092000</afya:FinancialDiscountsGrantedExpenses>
    <afya:FinancialDiscountsGrantedExpenses
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005341"
      unitRef="BRL">-23193000</afya:FinancialDiscountsGrantedExpenses>
    <ifrs-full:BankAndSimilarCharges
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005343"
      unitRef="BRL">7163000</ifrs-full:BankAndSimilarCharges>
    <ifrs-full:BankAndSimilarCharges
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005344"
      unitRef="BRL">8623000</ifrs-full:BankAndSimilarCharges>
    <ifrs-full:BankAndSimilarCharges
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005345"
      unitRef="BRL">7878000</ifrs-full:BankAndSimilarCharges>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005347"
      unitRef="BRL">681000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005348"
      unitRef="BRL">852000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005349"
      unitRef="BRL">17973000</ifrs-full:NetForeignExchangeLoss>
    <afya:TaxOnFinancialOperations
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005351"
      unitRef="BRL">-1947000</afya:TaxOnFinancialOperations>
    <afya:TaxOnFinancialOperations
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005352"
      unitRef="BRL">-178000</afya:TaxOnFinancialOperations>
    <afya:TaxOnFinancialOperations
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005353"
      unitRef="BRL">-3306000</afya:TaxOnFinancialOperations>
    <ifrs-full:OtherFinanceCost
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005355"
      unitRef="BRL">30638000</ifrs-full:OtherFinanceCost>
    <ifrs-full:OtherFinanceCost
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005356"
      unitRef="BRL">27496000</ifrs-full:OtherFinanceCost>
    <ifrs-full:OtherFinanceCost
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005357"
      unitRef="BRL">15797000</ifrs-full:OtherFinanceCost>
    <ifrs-full:FinanceCosts
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005359"
      unitRef="BRL">457616000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005360"
      unitRef="BRL">349893000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005361"
      unitRef="BRL">243796000</ifrs-full:FinanceCosts>
    <afya:FinanceResult
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005363"
      unitRef="BRL">-346974000</afya:FinanceResult>
    <afya:FinanceResult
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005364"
      unitRef="BRL">-247851000</afya:FinanceResult>
    <afya:FinanceResult
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005365"
      unitRef="BRL">-179230000</afya:FinanceResult>
    <afya:DisclosureOfIncomeTaxesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact005367">&lt;p id="xdx_808_ecustom--DisclosureOfIncomeTaxesExplanatory_z24BJebmWxMb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;22&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_82B_zTsPcwNP20Td"&gt;Income taxes&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Income taxes are comprised of taxation over operations in Brazil, related
to Corporate Income Tax ("IRPJ") and Social Contribution on Net Profit ("CSLL"). According to Brazilian tax legislation,
income taxes and social contribution are assessed and paid by legal entity and not on a consolidated basis.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;Reconciliation of income taxes expense&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;The table below is a
reconciliation of income tax expense to profit for the year, calculated by applying the combined Brazilian statutory rates at 34% for
the years ended December 31, 2023, 2022 and 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_z0ZfbEW2o3Kl" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span id="xdx_8B9_z0wBWQB93Ms1" style="display: none"&gt;Schedule of reconciliation of income tax expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20230101__20231231_zMYAmTrC9ZKc" style="vertical-align: bottom; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20220101__20221231_zM9haULjtd83" style="vertical-align: bottom; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20210101__20211231_zQVh9XsezGlg" style="vertical-align: bottom; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 46%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zX3IuBaK0bf4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;429,582&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;428,433&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;273,462&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--ApplicableTaxRate_pid_dp_zNs4jixl3bt6" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Combined statutory income taxes rate - %&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;34%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;34%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;34%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pn3n3_zQ9TPK77mgUj" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income taxes at statutory rates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(146,058)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(145,667)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(92,977)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ReconciliationAdjustmentsAbstract_iB_pn3n3_zvRRDuKiX1v7" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reconciliation adjustments:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pn3n3_z6DWPRcfgcDe" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tax effect on loss from entities not subject to taxation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(32,274)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(32,859)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(37,794)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pn3n3_zaZp3u2abVuh" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;PROUNI - Fiscal Incentive (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;309,952&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;270,062&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;194,830&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--UnrecognisedDeferredTaxAssets_pn3n3_zvEmwvIZLIua" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Unrecognized deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(154,062)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(117,377)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(86,233)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RecognisedDeferredTaxAssets_pn3n3_zscGF7xEYmqe" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Recognized deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;3,233&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5400"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5401"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_iN_pn3n3_di_zHCeXWnO33ig" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Presumed profit income tax regime effect (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(8,787)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(1,549)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(7,066)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PermanentAdjustments_pn3n3_zMCum4XkC7Cl" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Permanent adjustments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(4,687)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(12,226)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(6,232)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_pn3n3_zNMf0z9h5Ib1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;8,517&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;3,939&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;4,293&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--CurrentTaxExpenseIncome_pn3n3_zUrRtF3ayOx1" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income taxes expense - current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(24,166)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(35,677)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(31,179)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_zOWlunh9KMe4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Effective rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;5.62%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;8.33%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;11.40%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company adhered to PROUNI, established by Law 11,096 / 2005, which is a federal program
that exempts companies of paying income taxes and social contribution upon compliance with certain requirements required by said Law.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Brazilian tax law establishes that companies that generate gross revenues of up to R$78,000
in the prior fiscal year may calculate income taxes as a percentage of gross revenue, using the presumed profit tax regime. The effect
of the presumed profit of certain subsidiaries represents the difference between the taxation based on this method and the amount that
would be due based on the statutory rate applied to the taxable profit of the subsidiaries.&lt;br/&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AA_zqdPE0dPTsr4" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 10.9pt; text-indent: -10.9pt; color: #C00000"&gt;Deferred income taxes&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;As of December 31, 2023, the Company had accumulated unrecognized deferred
income tax assets on temporary differences and tax losses in the amount of R$&lt;span id="xdx_906_eifrs-full--DeferredTaxExpenseIncome_pn3n3_c20230101__20231231_zMJZAHVrVsa9" title="Unrecognized deferred income tax assets"&gt;1,211,909&lt;/span&gt; (tax-basis) (December 31, 2022: R$&lt;span id="xdx_905_eifrs-full--DeferredTaxExpenseIncome_pn3n3_c20220101__20221231_zDev7o4A6mC9" title="Unrecognized deferred income tax assets"&gt;778,080&lt;/span&gt; (tax-basis))
which does not have any tax planning opportunities available that could support the recognition of these temporary differences as deferred
tax assets. Accordingly, the Company did not recognize deferred tax assets over these amounts, except the amount as of R$&lt;span id="xdx_902_ecustom--RecognizedDeferredTaxAssets_iI_pn3n3_c20231231__ifrs-full--SegmentsAxis__custom--OneSubsidiaryMember_z22Z42u4NxDe" title="Recognized deferred income tax assets"&gt;9,508&lt;/span&gt; of tax
basis from one subsidiary, where the Company recognize deferred tax assets that is expected to be compensated in next years.&lt;/p&gt;

</afya:DisclosureOfIncomeTaxesExplanatory>
    <afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact005369">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_z0ZfbEW2o3Kl" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span id="xdx_8B9_z0wBWQB93Ms1" style="display: none"&gt;Schedule of reconciliation of income tax expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20230101__20231231_zMYAmTrC9ZKc" style="vertical-align: bottom; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20220101__20221231_zM9haULjtd83" style="vertical-align: bottom; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20210101__20211231_zQVh9XsezGlg" style="vertical-align: bottom; text-align: center; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 46%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 18%; text-align: center; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zX3IuBaK0bf4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;429,582&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;428,433&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;273,462&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--ApplicableTaxRate_pid_dp_zNs4jixl3bt6" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Combined statutory income taxes rate - %&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;34%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;34%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;34%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pn3n3_zQ9TPK77mgUj" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income taxes at statutory rates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(146,058)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(145,667)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(92,977)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ReconciliationAdjustmentsAbstract_iB_pn3n3_zvRRDuKiX1v7" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reconciliation adjustments:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pn3n3_z6DWPRcfgcDe" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tax effect on loss from entities not subject to taxation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(32,274)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(32,859)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(37,794)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pn3n3_zaZp3u2abVuh" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;PROUNI - Fiscal Incentive (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;309,952&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;270,062&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;194,830&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--UnrecognisedDeferredTaxAssets_pn3n3_zvEmwvIZLIua" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Unrecognized deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(154,062)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(117,377)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(86,233)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RecognisedDeferredTaxAssets_pn3n3_zscGF7xEYmqe" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Recognized deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;3,233&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5400"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5401"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_iN_pn3n3_di_zHCeXWnO33ig" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Presumed profit income tax regime effect (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(8,787)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(1,549)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(7,066)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PermanentAdjustments_pn3n3_zMCum4XkC7Cl" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Permanent adjustments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(4,687)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(12,226)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;(6,232)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_pn3n3_zNMf0z9h5Ib1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;8,517&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;3,939&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;4,293&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--CurrentTaxExpenseIncome_pn3n3_zUrRtF3ayOx1" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income taxes expense - current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(24,166)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(35,677)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;&lt;b&gt;(31,179)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--TaxRateEffectFromChangeInTaxRate_pid_dp_zOWlunh9KMe4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Effective rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;5.62%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;8.33%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 115%"&gt;11.40%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company adhered to PROUNI, established by Law 11,096 / 2005, which is a federal program
that exempts companies of paying income taxes and social contribution upon compliance with certain requirements required by said Law.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Brazilian tax law establishes that companies that generate gross revenues of up to R$78,000
in the prior fiscal year may calculate income taxes as a percentage of gross revenue, using the presumed profit tax regime. The effect
of the presumed profit of certain subsidiaries represents the difference between the taxation based on this method and the amount that
would be due based on the statutory rate applied to the taxable profit of the subsidiaries.&lt;br/&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005371"
      unitRef="BRL">429582000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005372"
      unitRef="BRL">428433000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005373"
      unitRef="BRL">273462000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact005375"
      unitRef="Pure">0.34</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact005376"
      unitRef="Pure">0.34</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact005377"
      unitRef="Pure">0.34</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005379"
      unitRef="BRL">-146058000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005380"
      unitRef="BRL">-145667000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005381"
      unitRef="BRL">-92977000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005387"
      unitRef="BRL">-32274000</afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation>
    <afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005388"
      unitRef="BRL">-32859000</afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation>
    <afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005389"
      unitRef="BRL">-37794000</afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation>
    <afya:ProgramaUniversidadeParaTodosFiscalIncentive
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005391"
      unitRef="BRL">309952000</afya:ProgramaUniversidadeParaTodosFiscalIncentive>
    <afya:ProgramaUniversidadeParaTodosFiscalIncentive
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005392"
      unitRef="BRL">270062000</afya:ProgramaUniversidadeParaTodosFiscalIncentive>
    <afya:ProgramaUniversidadeParaTodosFiscalIncentive
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005393"
      unitRef="BRL">194830000</afya:ProgramaUniversidadeParaTodosFiscalIncentive>
    <afya:UnrecognisedDeferredTaxAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005395"
      unitRef="BRL">-154062000</afya:UnrecognisedDeferredTaxAssets>
    <afya:UnrecognisedDeferredTaxAssets
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005396"
      unitRef="BRL">-117377000</afya:UnrecognisedDeferredTaxAssets>
    <afya:UnrecognisedDeferredTaxAssets
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005397"
      unitRef="BRL">-86233000</afya:UnrecognisedDeferredTaxAssets>
    <afya:RecognisedDeferredTaxAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005399"
      unitRef="BRL">3233000</afya:RecognisedDeferredTaxAssets>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005403"
      unitRef="BRL">8787000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005404"
      unitRef="BRL">1549000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005405"
      unitRef="BRL">7066000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <afya:PermanentAdjustments
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005407"
      unitRef="BRL">-4687000</afya:PermanentAdjustments>
    <afya:PermanentAdjustments
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005408"
      unitRef="BRL">-12226000</afya:PermanentAdjustments>
    <afya:PermanentAdjustments
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005409"
      unitRef="BRL">-6232000</afya:PermanentAdjustments>
    <ifrs-full:TaxExpenseOtherThanIncomeTaxExpense
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005411"
      unitRef="BRL">8517000</ifrs-full:TaxExpenseOtherThanIncomeTaxExpense>
    <ifrs-full:TaxExpenseOtherThanIncomeTaxExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005412"
      unitRef="BRL">3939000</ifrs-full:TaxExpenseOtherThanIncomeTaxExpense>
    <ifrs-full:TaxExpenseOtherThanIncomeTaxExpense
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005413"
      unitRef="BRL">4293000</ifrs-full:TaxExpenseOtherThanIncomeTaxExpense>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005415"
      unitRef="BRL">-24166000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005416"
      unitRef="BRL">-35677000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005417"
      unitRef="BRL">-31179000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact005419"
      unitRef="Pure">0.0562</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact005420"
      unitRef="Pure">0.0833</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact005421"
      unitRef="Pure">0.1140</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005423"
      unitRef="BRL">1211909000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005425"
      unitRef="BRL">778080000</ifrs-full:DeferredTaxExpenseIncome>
    <afya:RecognizedDeferredTaxAssets
      contextRef="AsOf2023-12-31_custom_OneSubsidiaryMember"
      decimals="-3"
      id="Fact005427"
      unitRef="BRL">9508000</afya:RecognizedDeferredTaxAssets>
    <afya:DisclosureOfInsuranceContractsAndContingenciesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact005429">&lt;p id="xdx_80F_ecustom--DisclosureOfInsuranceContractsAndContingenciesExplanatory_zMmZukpJabKd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;23&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_827_zvlwkEEDUlD9"&gt;Insurance contracts and contingencies&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;a) Insurance contracts&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company and its subsidiaries have a risk management program with the
purpose of delimiting the risks, seeking in the market coverage compatible with its size and operations.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;b) Legal proceedings and contingencies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The provisions related to labor, civil and taxes proceedings whose likelihood
of loss is assessed as probable are as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfLegalProceedingsAndContingencies_zybwi3fywxDd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Insurance contracts and contingencies (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BE_zC3Fs1DV8usk" style="display: none"&gt;Schedule of legal proceedings and contingencies&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 39%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Labor&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Civil&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances as of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zkAEFLwgWsWf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;4,519&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zeJEVRyDBJ6g" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;13,280&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zQjqkpw49QV" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;35,340&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zKg9FIM4sXQh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;53,139&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zZbNZQTZkAxa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;16,597&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zRJ3dLRzO7L6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;6,017&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z9AmhRyjC2Fk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,638&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zTExp6siSNxi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;80,252&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zHdWklvfywg7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,418&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuTloi09neO1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,101&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z8IGVEt5w2l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,225&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zKAZqSs0Ec77" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,744&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zFObFYsdLgRf" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,044)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zq63heHtDPHk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,470)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z4W12NxhRy4l" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,334)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zctkMbHAwS41" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(9,848)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances as of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgELEUzlVt3f" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;25,490&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zInWUUH8rfGc" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;22,928&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zNBuyde8auG4" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;99,869&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z4jjBQdk6Pfh" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;148,287&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zaa4p2aDUa78" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,300&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zOPFThM3ldlk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,911&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zS3IfXYifnjf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;63,698&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z7A21rdqDsJf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;73,909&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgVm3uVxqj5h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(5,306)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zIMOVd5S00i1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,175)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zoRjkyJ1PWc6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(14,861)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zcJdsSU4gCP6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(26,342)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances as of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zWwJ6gsnjOw1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;22,484&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zTk8bzyfkLw7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;24,664&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zTewyI7913L9" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;148,706&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zLKZD5wnpf6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;195,854&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z47gSBFcAYO7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;64&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zDS8ELjItj52" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;88&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zzpqhMprank8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5501"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhNpTKiEmi5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zzCKWAvCASWl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,424&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zGIv7povfvL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,875&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zB17EajSVgGd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;9,037&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z79sULeFZkRj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;18,336&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zbr9LPc9GaP4" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,251)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zGf03daQkbmc" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(9,327)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zkIeF1ZbZleh" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(97,403)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zNgpBoucs75k" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(109,981)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances as of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zPRVY89kuhXa" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;22,721&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zCHKohCTPeI4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;21,300&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zWm7ralE2xOk" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;60,340&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zjJOiJq4GCMe" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;104,361&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On August 10, 2023, Unigranrio entered into a tax amnesty program on interest and penalties
to settle a tax proceeding with respect to ISS (tax on services) with the municipality of Rio de Janeiro, which result in a payment of
R$14,819. The selling shareholders of Unigranrio agreed to pay R$5,438 regarding this matter, which was deducted from the accounts payable
to selling shareholders. The Company had a provision of R$53,302 and an indemnification asset from the selling shareholders of R$20,000
(in light of the indemnification clauses as defined at acquisition of Unigranrio), in respect to such tax proceedings. The difference
between the provision, indemnification asset and the actual paid amount was recorded as Other income (expenses), net on the consolidated
statements of income and comprehensive income.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A8_zI4JcdacR5wi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The major labor proceedings to which the Company is a party were filed by
former employees or service providers seeking enforcement of labor rights allegedly not provided by us. The judicial proceedings relates
to employment bonds (judicial proceedings filed by former service providers), overtime, premiums for hazardous workplace conditions, statutory
severance, fines for severance payment delays, and compensation for workplace-related accidents.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The civil claims to which the Company is a party generally relate to consumer
claims, including those related to student complaints.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The tax claims to which the Company is party are mostly tax foreclosures
filed by Brazilian federal and municipal tax authorities.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;There are other civil, labor, taxes and social security proceedings assessed
by Management and its legal counsels as possible risk of loss, for which no provisions are recognized, as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagement_z5p7yyyTT2k7" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Insurance contracts and contingencies (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_z6q7eUhZ4jv2" style="display: none"&gt;Schedule of social
    security proceedings assessed by Management&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Labor&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zN3rjculUHBh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;32,683&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zVqVER4Uby4j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,914&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Civil&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zsVNSqtEaQ3j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;51,319&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2MRQw4TB9bl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;59,603&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Taxes and social security&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zhuJU4lLveEg" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,669&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_znf651RM4Sq6" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,931&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--OtherProvisions_iI_pn3n3_c20231231_zwOEl0M4UJQi" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;89,671&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherProvisions_iI_pn3n3_c20221231_zQzrT2Rqmn3j" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;78,448&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;The Company has judicial deposits, related to taxes, civil and labor proceedings,
recorded in other assets (non-current) in the amount of R$&lt;span id="xdx_90E_ecustom--JudicialDeposits_iI_pn3n3_c20231231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zPeCG2M068xe" title="Judicial deposits"&gt;14,187&lt;/span&gt; as of December 31, 2023 (December 31, 2022: R$&lt;span id="xdx_909_ecustom--JudicialDeposits_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zPzXZ9P9GPRe" title="Judicial deposits"&gt;12,693&lt;/span&gt;).&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Under the terms of the Share Purchase and Sale Agreements ("Agreements")
between the Company and the selling shareholders of the subsidiaries acquired, the Company assesses that the selling shareholders are
exclusively responsible for any provisions (including labor, tax and civil), which are or will be the subject of a claim by any third
party, arising from the act or fact occurred, by action or omission, prior to or on the closing dates of the acquisitions.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;Considering that the provisions for legal proceedings recorded by the Company
that result from causes arising from events occurring prior to the closing dates of the acquisitions, any liability for the amounts to
be disbursed, in case of their effective materialization in loss, belongs exclusively to the selling shareholders. In this context, the
Agreements state that the Company and its subsidiaries are indemnified and therefore exempt from any liability related to said contingent
liabilities and, therefore, the provision amounts related to such contingencies are presented in the non-current liabilities and the correspondent
amount of R$&lt;span id="xdx_90A_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20231231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zXUPlbVGEqEk" title="Contingencies correspondent amount"&gt;81,855&lt;/span&gt; (December 31, 2022: R$&lt;span id="xdx_905_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zYCST1h2fHu9" title="Contingencies correspondent amount"&gt;145,300&lt;/span&gt;) is presented in non-current other assets.&lt;/p&gt;

</afya:DisclosureOfInsuranceContractsAndContingenciesExplanatory>
    <afya:ScheduleOfLegalProceedingsAndContingencies contextRef="From2023-01-01to2023-12-31" id="Fact005431">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfLegalProceedingsAndContingencies_zybwi3fywxDd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Insurance contracts and contingencies (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BE_zC3Fs1DV8usk" style="display: none"&gt;Schedule of legal proceedings and contingencies&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 39%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Labor&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Civil&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances as of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zkAEFLwgWsWf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;4,519&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zeJEVRyDBJ6g" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;13,280&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zQjqkpw49QV" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;35,340&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zKg9FIM4sXQh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;53,139&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zZbNZQTZkAxa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;16,597&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zRJ3dLRzO7L6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;6,017&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z9AmhRyjC2Fk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,638&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zTExp6siSNxi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;80,252&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zHdWklvfywg7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,418&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuTloi09neO1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,101&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z8IGVEt5w2l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,225&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zKAZqSs0Ec77" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,744&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zFObFYsdLgRf" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,044)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zq63heHtDPHk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,470)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z4W12NxhRy4l" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,334)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zctkMbHAwS41" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(9,848)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances as of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgELEUzlVt3f" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;25,490&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zInWUUH8rfGc" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;22,928&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zNBuyde8auG4" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;99,869&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z4jjBQdk6Pfh" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;148,287&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zaa4p2aDUa78" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,300&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zOPFThM3ldlk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,911&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zS3IfXYifnjf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;63,698&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z7A21rdqDsJf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;73,909&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgVm3uVxqj5h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(5,306)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zIMOVd5S00i1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,175)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zoRjkyJ1PWc6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(14,861)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zcJdsSU4gCP6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(26,342)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances as of December 31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zWwJ6gsnjOw1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;22,484&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zTk8bzyfkLw7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;24,664&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zTewyI7913L9" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;148,706&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zLKZD5wnpf6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;195,854&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z47gSBFcAYO7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;64&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zDS8ELjItj52" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;88&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zzpqhMprank8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5501"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhNpTKiEmi5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zzCKWAvCASWl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,424&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zGIv7povfvL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,875&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zB17EajSVgGd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;9,037&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z79sULeFZkRj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;18,336&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zbr9LPc9GaP4" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,251)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zGf03daQkbmc" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(9,327)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zkIeF1ZbZleh" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(97,403)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zNgpBoucs75k" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(109,981)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances as of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zPRVY89kuhXa" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;22,721&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zCHKohCTPeI4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;21,300&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zWm7ralE2xOk" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;60,340&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Provisions_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zjJOiJq4GCMe" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;104,361&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On August 10, 2023, Unigranrio entered into a tax amnesty program on interest and penalties
to settle a tax proceeding with respect to ISS (tax on services) with the municipality of Rio de Janeiro, which result in a payment of
R$14,819. The selling shareholders of Unigranrio agreed to pay R$5,438 regarding this matter, which was deducted from the accounts payable
to selling shareholders. The Company had a provision of R$53,302 and an indemnification asset from the selling shareholders of R$20,000
(in light of the indemnification clauses as defined at acquisition of Unigranrio), in respect to such tax proceedings. The difference
between the provision, indemnification asset and the actual paid amount was recorded as Other income (expenses), net on the consolidated
statements of income and comprehensive income.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfLegalProceedingsAndContingencies>
    <ifrs-full:Provisions
      contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005433"
      unitRef="BRL">4519000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005435"
      unitRef="BRL">13280000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005437"
      unitRef="BRL">35340000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005439"
      unitRef="BRL">53139000</ifrs-full:Provisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005441"
      unitRef="BRL">16597000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005443"
      unitRef="BRL">6017000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005445"
      unitRef="BRL">57638000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005447"
      unitRef="BRL">80252000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005449"
      unitRef="BRL">5418000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005451"
      unitRef="BRL">5101000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005453"
      unitRef="BRL">14225000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005455"
      unitRef="BRL">24744000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005457"
      unitRef="BRL">1044000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005459"
      unitRef="BRL">1470000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005461"
      unitRef="BRL">7334000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005463"
      unitRef="BRL">9848000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:Provisions
      contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005465"
      unitRef="BRL">25490000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005467"
      unitRef="BRL">22928000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005469"
      unitRef="BRL">99869000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005471"
      unitRef="BRL">148287000</ifrs-full:Provisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005473"
      unitRef="BRL">2300000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005475"
      unitRef="BRL">7911000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005477"
      unitRef="BRL">63698000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005479"
      unitRef="BRL">73909000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005481"
      unitRef="BRL">5306000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005483"
      unitRef="BRL">6175000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005485"
      unitRef="BRL">14861000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2022-01-012022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005487"
      unitRef="BRL">26342000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:Provisions
      contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005489"
      unitRef="BRL">22484000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005491"
      unitRef="BRL">24664000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005493"
      unitRef="BRL">148706000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005495"
      unitRef="BRL">195854000</ifrs-full:Provisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005497"
      unitRef="BRL">64000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005499"
      unitRef="BRL">88000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005503"
      unitRef="BRL">152000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005505"
      unitRef="BRL">3424000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005507"
      unitRef="BRL">5875000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005509"
      unitRef="BRL">9037000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005511"
      unitRef="BRL">18336000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005513"
      unitRef="BRL">3251000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005515"
      unitRef="BRL">9327000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005517"
      unitRef="BRL">97403000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005519"
      unitRef="BRL">109981000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:Provisions
      contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005521"
      unitRef="BRL">22721000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005523"
      unitRef="BRL">21300000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005525"
      unitRef="BRL">60340000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005527"
      unitRef="BRL">104361000</ifrs-full:Provisions>
    <afya:ScheduleOfSocialSecurityProceedingsAssessedByManagement contextRef="From2023-01-01to2023-12-31" id="Fact005529">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagement_z5p7yyyTT2k7" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Insurance contracts and contingencies (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_z6q7eUhZ4jv2" style="display: none"&gt;Schedule of social
    security proceedings assessed by Management&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Labor&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zN3rjculUHBh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;32,683&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zVqVER4Uby4j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,914&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Civil&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zsVNSqtEaQ3j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;51,319&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2MRQw4TB9bl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;59,603&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Taxes and social security&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--OtherProvisions_iI_pn3n3_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zhuJU4lLveEg" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,669&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherProvisions_iI_pn3n3_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_znf651RM4Sq6" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,931&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--OtherProvisions_iI_pn3n3_c20231231_zwOEl0M4UJQi" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;89,671&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherProvisions_iI_pn3n3_c20221231_zQzrT2Rqmn3j" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;78,448&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:ScheduleOfSocialSecurityProceedingsAssessedByManagement>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember"
      decimals="-3"
      id="Fact005531"
      unitRef="BRL">32683000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember"
      decimals="-3"
      id="Fact005533"
      unitRef="BRL">13914000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember"
      decimals="-3"
      id="Fact005535"
      unitRef="BRL">51319000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember"
      decimals="-3"
      id="Fact005537"
      unitRef="BRL">59603000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember"
      decimals="-3"
      id="Fact005539"
      unitRef="BRL">5669000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember"
      decimals="-3"
      id="Fact005541"
      unitRef="BRL">4931000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact005543"
      unitRef="BRL">89671000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact005545"
      unitRef="BRL">78448000</ifrs-full:OtherProvisions>
    <afya:JudicialDeposits
      contextRef="AsOf2023-12-31_custom_OtherAssetsNonCurrentMember"
      decimals="-3"
      id="Fact005547"
      unitRef="BRL">14187000</afya:JudicialDeposits>
    <afya:JudicialDeposits
      contextRef="AsOf2022-12-31_custom_OtherAssetsNonCurrentMember"
      decimals="-3"
      id="Fact005549"
      unitRef="BRL">12693000</afya:JudicialDeposits>
    <afya:ContingenciesCorrespondentAmount
      contextRef="AsOf2023-12-31_custom_OtherAssetsNonCurrentMember"
      decimals="-3"
      id="Fact005551"
      unitRef="BRL">81855000</afya:ContingenciesCorrespondentAmount>
    <afya:ContingenciesCorrespondentAmount
      contextRef="AsOf2022-12-31_custom_OtherAssetsNonCurrentMember"
      decimals="-3"
      id="Fact005553"
      unitRef="BRL">145300000</afya:ContingenciesCorrespondentAmount>
    <afya:DisclosureNoncashTransactionsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact005555">&lt;p id="xdx_80B_ecustom--DisclosureNoncashTransactionsExplanatory_z2yKhkIen5Ya" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;24&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_828_zZJBPFFeQxph"&gt;Non-cash transactions&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;During the years ended December 31, 2023, 2022 and 2021, the Company carried
out non-cash transactions which are not reflected in the statements of cash flows. The main non-cash transactions are as follows:&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--NonCashTransactionsTableTextBlock_zX9Gtt2uTYv9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Non-cash transactions (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BF_zv0UAG0oUoZ2" style="display: none"&gt;Schedule
    of non-cash transactions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 67%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Issuance of shares for acquisition of iClinic&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zM9oStIYWZi9" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5559"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zVnc83yDKE36" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5561"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zj2vqVXci4le" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71,500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Issuance of shares for acquisition of Cliquefarma&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zv9e8vZ4SiPf" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5565"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zRkRritwJ53k" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5567"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zitgAeiaFCXa" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Issuance of shares for acquisition of RX PRO&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zsawovGyVgfa" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5571"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zHIakik5bL7i" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5573"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zeGRggvdhfJl" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,112&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement of earn-out of Al&#xe9;m da Medicina, CardioPapers and Glic&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--RemeasurementOfEarnOut_pn3n3_c20230101__20231231_zwNYmjkz5dfd" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,556&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RemeasurementOfEarnOut_pn3n3_c20220101__20221231_zgj6oKDoCSZa" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5579"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RemeasurementOfEarnOut_pn3n3_c20210101__20211231_zfK7P4Wk73ef" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5581"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Provision for legal proceedings with corresponding indemnification asset&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20230101__20231231_ztPbmOAMgq39" style="text-align: right" title="Provision for legal proceedings with corresponding indemnification asset"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20220101__20221231_zAzcZdv0lrhf" style="text-align: right" title="Provision for legal proceedings with corresponding indemnification asset"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;48,333&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20210101__20211231_zi0x4gkt7eNd" style="text-align: right" title="Provision for legal proceedings with corresponding indemnification asset"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,232&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions and remeasurements of right-of-use assets and lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20230101__20231231_zHgJRFYaOd25" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;77,715&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20220101__20221231_z53G9TtT22ae" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;100,873&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20210101__20211231_zXmS2MAg6DMc" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;158,651&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:DisclosureNoncashTransactionsExplanatory>
    <afya:NonCashTransactionsTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact005557">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--NonCashTransactionsTableTextBlock_zX9Gtt2uTYv9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Non-cash transactions (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BF_zv0UAG0oUoZ2" style="display: none"&gt;Schedule
    of non-cash transactions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 67%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Issuance of shares for acquisition of iClinic&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zM9oStIYWZi9" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5559"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zVnc83yDKE36" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5561"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zj2vqVXci4le" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;71,500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Issuance of shares for acquisition of Cliquefarma&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zv9e8vZ4SiPf" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5565"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zRkRritwJ53k" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5567"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zitgAeiaFCXa" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Issuance of shares for acquisition of RX PRO&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zsawovGyVgfa" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5571"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zHIakik5bL7i" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5573"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--RXPROMember_zeGRggvdhfJl" style="text-align: right" title="Issuance of shares for acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,112&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement of earn-out of Al&#xe9;m da Medicina, CardioPapers and Glic&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--RemeasurementOfEarnOut_pn3n3_c20230101__20231231_zwNYmjkz5dfd" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,556&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RemeasurementOfEarnOut_pn3n3_c20220101__20221231_zgj6oKDoCSZa" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5579"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RemeasurementOfEarnOut_pn3n3_c20210101__20211231_zfK7P4Wk73ef" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5581"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Provision for legal proceedings with corresponding indemnification asset&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20230101__20231231_ztPbmOAMgq39" style="text-align: right" title="Provision for legal proceedings with corresponding indemnification asset"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20220101__20221231_zAzcZdv0lrhf" style="text-align: right" title="Provision for legal proceedings with corresponding indemnification asset"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;48,333&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets_pn3n3_c20210101__20211231_zi0x4gkt7eNd" style="text-align: right" title="Provision for legal proceedings with corresponding indemnification asset"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,232&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions and remeasurements of right-of-use assets and lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20230101__20231231_zHgJRFYaOd25" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;77,715&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20220101__20221231_z53G9TtT22ae" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;100,873&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20210101__20211231_zXmS2MAg6DMc" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;158,651&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:NonCashTransactionsTableTextBlock>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_IClinicMember"
      decimals="-3"
      id="Fact005563"
      unitRef="BRL">71500000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember"
      decimals="-3"
      id="Fact005569"
      unitRef="BRL">3000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_RXPROMember"
      decimals="-3"
      id="Fact005575"
      unitRef="BRL">5112000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <afya:RemeasurementOfEarnOut
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005577"
      unitRef="BRL">2556000</afya:RemeasurementOfEarnOut>
    <afya:ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005583"
      unitRef="BRL">20000000</afya:ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets>
    <afya:ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005585"
      unitRef="BRL">48333000</afya:ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets>
    <afya:ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005587"
      unitRef="BRL">4232000</afya:ProvisionForLegalProceedingsWithCorrespondingIndemnificationAssets>
    <afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities
      contextRef="From2023-01-01to2023-12-31"
      decimals="-3"
      id="Fact005589"
      unitRef="BRL">77715000</afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities>
    <afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact005591"
      unitRef="BRL">100873000</afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities>
    <afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      id="Fact005593"
      unitRef="BRL">158651000</afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact005595">&lt;p id="xdx_809_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zDf51uYxiqu5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;b&gt;25&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_824_ztzEJnpd5j0c"&gt;Subsequent event&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;b&gt;Medical seats increase in FIP Guanambi&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;On January 24, 2024, MEC authorized the increase of 40 medical seats of
Faculdades Integradas Padr&#xe3;o (FIP Guanambi) located in the city of Guanambi, State of Bahia, which will result in an additional
payment of R$&lt;span id="xdx_909_ecustom--PotentialAdditionalPayment_pn3n3_c20240123__20240124__ifrs-full--TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis__custom--FaculdadesIntegradasPadraoMember_z8bTPlVtHgX6" title="Potential additional payment"&gt;49,600&lt;/span&gt;. With the authorization, Afya reaches 100 medical seats on this campus, and &lt;span id="xdx_90A_ecustom--TotalNumberOfSeatsApporved_iI_uN_c20240124__ifrs-full--TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis__custom--FaculdadesIntegradasPadraoMember_zLbSYb63UOKd" title="Total number of seats apporved"&gt;3,203&lt;/span&gt; total approved seats.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <afya:PotentialAdditionalPayment
      contextRef="From2024-01-232024-01-24_custom_FaculdadesIntegradasPadraoMember"
      decimals="-3"
      id="Fact005597"
      unitRef="BRL">49600000</afya:PotentialAdditionalPayment>
    <afya:TotalNumberOfSeatsApporved
      contextRef="AsOf2024-01-24_custom_FaculdadesIntegradasPadraoMember"
      decimals="INF"
      id="Fact005599"
      unitRef="N">3203</afya:TotalNumberOfSeatsApporved>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
